Citrus Sinensis ID: 005102
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 714 | 2.2.26 [Sep-21-2011] | |||||||
| Q9C9N5 | 685 | Probable inactive leucine | no | no | 0.932 | 0.972 | 0.506 | 0.0 | |
| C0LGS3 | 768 | Probable LRR receptor-lik | no | no | 0.955 | 0.888 | 0.375 | 1e-123 | |
| Q94C77 | 757 | Receptor protein kinase-l | no | no | 0.934 | 0.881 | 0.349 | 1e-109 | |
| C0LGP9 | 784 | Probable leucine-rich rep | no | no | 0.850 | 0.774 | 0.316 | 2e-85 | |
| Q9FHK7 | 640 | Probable leucine-rich rep | no | no | 0.823 | 0.918 | 0.336 | 1e-83 | |
| Q9M9C5 | 670 | Probable leucine-rich rep | no | no | 0.809 | 0.862 | 0.337 | 3e-82 | |
| Q9SCT4 | 836 | Probably inactive leucine | no | no | 0.778 | 0.665 | 0.335 | 6e-78 | |
| C0LGQ5 | 1249 | LRR receptor-like serine/ | no | no | 0.805 | 0.460 | 0.332 | 7e-78 | |
| O48788 | 658 | Probable inactive recepto | no | no | 0.827 | 0.898 | 0.346 | 7e-78 | |
| Q9LVP0 | 1102 | Probable leucine-rich rep | no | no | 0.788 | 0.510 | 0.325 | 2e-77 |
| >sp|Q9C9N5|Y1668_ARATH Probable inactive leucine-rich repeat receptor-like protein kinase At1g66830 OS=Arabidopsis thaliana GN=At1g66830 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 671 bits (1732), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 365/721 (50%), Positives = 472/721 (65%), Gaps = 55/721 (7%)
Query: 7 LFLVLC----NFNGFVDSLNGEGYALLSFKQSVHEDPEGSLSNWNSSDENPCSWNGITCK 62
LFL+LC +F SLN +G ALLSFKQS+ + +NWNSSD NPCSW G+TC
Sbjct: 4 LFLILCFILTHFFAIATSLNDQGLALLSFKQSIQNQSDSVFTNWNSSDSNPCSWQGVTCN 63
Query: 63 -EQRVVSVSIPKKKLLGFLPSALGSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYG 121
+ RVVS+ +P K+L G L ++GSL LRH+NLR+N F G LP+EL +GLQSLVL G
Sbjct: 64 YDMRVVSIRLPNKRLSGSLDPSIGSLLSLRHINLRDNDFQGKLPVELFGLKGLQSLVLSG 123
Query: 122 NSFSGSVPNEIGKLKYLQILDLSQNFFNGSLPVSIVQCKRLKALDLSQNNFTGPLPNGFG 181
NSFSG VP EIG LK L LDLS+N FNGS+ +S++ CK+LK L LS+N+F+G LP G G
Sbjct: 124 NSFSGFVPEEIGSLKSLMTLDLSENSFNGSISLSLIPCKKLKTLVLSKNSFSGDLPTGLG 183
Query: 182 SGLVSLEKLNLSFNKFNGSIPSNTGNLSSLQGTVDFSHNLFSGSIPASLGNLPEKVYIDL 241
S LV L LNLSFN+ G+IP + G+L +L+GT+D SHN FSG IP SLGNLPE +Y+DL
Sbjct: 184 SNLVHLRTLNLSFNRLTGTIPEDVGSLENLKGTLDLSHNFFSGMIPTSLGNLPELLYVDL 243
Query: 242 TYNNLSGPIPQNGALMNRGPTAFIGNPRLCGPPLKNPCSSDVPGASSPASYPFLPNNYPP 301
+YNNLSGPIP+ L+N GP AF GNP LCG P+K CS+ Y N++
Sbjct: 244 SYNNLSGPIPKFNVLLNAGPNAFQGNPFLCGLPIKISCSTRNTQVVPSQLYTRRANHH-- 301
Query: 302 ENGDDGGGKREKGRGLSKSAIVAIIV-SDVIGICLVGLLFSYCYSRVCGFGEGKDEN--- 357
S+ I+ V GI + LF Y Y R KD+N
Sbjct: 302 ----------------SRLCIILTATGGTVAGIIFLASLFIY-YLRKASARANKDQNNRT 344
Query: 358 CY--AKGGKGRK-ECLCFR--KDESETLSENVEQYDLVPLDTQVAFDLDELLKASAFVLG 412
C+ K K K E LCF+ ESETL EN Q +P+D ++ FDLD+LLKASAF+LG
Sbjct: 345 CHINEKLKKTTKPEFLCFKTGNSESETLDENKNQQVFMPMDPEIEFDLDQLLKASAFLLG 404
Query: 413 KSGIGIVYKVVLEDGHTLAVRRLGEGGSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVD 472
KS IG+VYKVVLE+G LAVRRL + G R KEF +VEA+ KI+H N++ L+A WS +
Sbjct: 405 KSRIGLVYKVVLENGLMLAVRRLEDKGWLRLKEFLADVEAMAKIKHPNVLNLKACCWSPE 464
Query: 473 EKLLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHG 532
EKLLIYDYIPNG L +A+ G+PG VS + W+VR+KI++GIAKGL Y+HEFSPK+YVHG
Sbjct: 465 EKLLIYDYIPNGDLGSAIQGRPGSVSCKQLTWTVRLKILRGIAKGLTYIHEFSPKRYVHG 524
Query: 533 DLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTT 592
+ SNILLG N+EP VS FGL R I S ++S+++ P E +S E
Sbjct: 525 HINTSNILLGPNLEPKVSGFGLGR---IVDTSSDIRSDQI---SPMETSSPILSRE---- 574
Query: 593 NSSSNLGSYYQAPESL-KVVKPSQKWDIYSYGVILLEMITGRTAVVQVGSSEMDLVNWMQ 651
SYYQAPE+ K+ KPSQKWD+YS+G+++LEM+TG++ V SSEMDLV W++
Sbjct: 575 -------SYYQAPEAASKMTKPSQKWDVYSFGLVILEMVTGKSPV----SSEMDLVMWVE 623
Query: 652 LCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDALDRLIV 711
E KP VLDP LA D D E+ ++ V+KI +ACV +P+KRP MR + ++ ++L+
Sbjct: 624 SASERNKPAWYVLDPVLARDRDLEDSMVQVIKIGLACVQKNPDKRPHMRSVLESFEKLVT 683
Query: 712 S 712
S
Sbjct: 684 S 684
|
Arabidopsis thaliana (taxid: 3702) |
| >sp|C0LGS3|Y4372_ARATH Probable LRR receptor-like serine/threonine-protein kinase At4g37250 OS=Arabidopsis thaliana GN=At4g37250 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 442 bits (1138), Expect = e-123, Method: Compositional matrix adjust.
Identities = 288/767 (37%), Positives = 411/767 (53%), Gaps = 85/767 (11%)
Query: 6 VLFLVLCNFNGFVDSLNGEGYALLSFKQSVHEDPEGSLSNWNSSDENPCSWNGITCK-EQ 64
V+F C+ +LN +G L+ FK SV DP L WN E+PCSW GI+C +
Sbjct: 8 VIFFFFCSVLS-SSALNSDGLVLMKFKSSVLVDPLSLLQTWNYKHESPCSWRGISCNNDS 66
Query: 65 RVVSVSIPKKKLLGFLPSALGSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSF 124
+V+++S+P +LLG +PS LGSL L+ ++L NN F G LP+ A+ L+ L L N
Sbjct: 67 KVLTLSLPNSQLLGSIPSDLGSLLTLQSLDLSNNSFNGPLPVSFFNARELRFLDLSSNMI 126
Query: 125 SGSVPNEIGKLKYLQILDLSQNFFNGSLPVSIVQCKRLKALDLSQNNFTGPLPNGFGSGL 184
SG +P+ IG L L L+LS N G LP ++ + L + L N F+G +P G+
Sbjct: 127 SGEIPSAIGDLHNLLTLNLSDNALAGKLPTNLASLRNLTVVSLENNYFSGEIPGGWR--- 183
Query: 185 VSLEKLNLSFNKFNGSIPSNTGNLSSLQGTVDFSHNLFSGSIPASLG-NLPEKVYIDLTY 243
+E L+LS N NGS+P + G SLQ ++ S N SG IP +G N P V +DL++
Sbjct: 184 -VVEFLDLSSNLINGSLPPDFGGY-SLQ-YLNVSFNQISGEIPPEIGVNFPRNVTVDLSF 240
Query: 244 NNLSGPIPQNGALMNRGPTAFIGNPRLCGPPLKNPC----------SSDVPGASSP--AS 291
NNL+GPIP + +N+ F GNP LCG P +NPC +DVP S+P A+
Sbjct: 241 NNLTGPIPDSPVFLNQESNFFSGNPGLCGEPTRNPCLIPSSPSIVSEADVP-TSTPAIAA 299
Query: 292 YPFLPNNYPPENGDDGGGKREKGRGLSKSAIVAIIVSDVIGICLVGLLFSYCYSRVCGFG 351
P + P + + GL I+ I+V D+ GI ++ ++F Y Y C
Sbjct: 300 IPNTIGSNPVTDPNSQQTDPNPRTGLRPGVIIGIVVGDIAGIGILAVIFLYIYR--CKKN 357
Query: 352 EGKDENCYAK---------------------GGKGRKECLCFRKDESETLSE-------- 382
+ D N K + ++ C RKD T SE
Sbjct: 358 KIVDNNNNDKQRTETDTITLSTFSSSSSSPEESRRFRKWSCLRKDPETTPSEEEDEDDED 417
Query: 383 -----NVEQYD----LVPLDTQVAFDLDELLKASAFVLGKSGIGIVYKVVLEDGHTLAVR 433
N Q LV +D + +++ LLKASA++LG +G I+YK VLEDG AVR
Sbjct: 418 EESGYNANQRSGDNKLVTVDGEKEMEIETLLKASAYILGATGSSIMYKAVLEDGRVFAVR 477
Query: 434 RLGEGG--SQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGSLATALH 491
RLGE G +RFK+F+ + AIGK+ H N+V L +YW DEKL+IYD++PNGSL +
Sbjct: 478 RLGENGLSQRRFKDFEPHIRAIGKLVHPNLVRLCGFYWGTDEKLVIYDFVPNGSLVNPRY 537
Query: 492 GKPGMVSFTP--VPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHV 549
K G S +P +PW R+KI KGIA+GL YLHE KK+VHG+LKPSNILLGH+MEP +
Sbjct: 538 RKGGGSS-SPYHLPWETRLKIAKGIARGLAYLHE---KKHVHGNLKPSNILLGHDMEPKI 593
Query: 550 SDFGLARLAN------IAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQ 603
DFGL RL AGGS + S++ +E + + ++ + S Y
Sbjct: 594 GDFGLERLLTGETSYIRAGGSSRIFSSKRYTTSSREFSSIGPTPSPSPSSVGAM--SPYC 651
Query: 604 APESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGSSEMDLVNWMQLCIEEKKPLADV 663
APES + +KPS KWD+Y +GVILLE++TG+ V+ ++V L +E+ +
Sbjct: 652 APESFRSLKPSPKWDVYGFGVILLELLTGKIVSVE------EIVLGNGLTVEDGHRAVRM 705
Query: 664 LDPYLAPDAD-KEEEIIAVLKIAMACVHSSPEKRPTMRHISDALDRL 709
D + + D K+E ++ K+ +C P+KRPTM+ L+R
Sbjct: 706 ADVAIRGELDGKQEFLLDCFKLGYSCASPVPQKRPTMKESLAVLERF 752
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q94C77|RPKL_ARATH Receptor protein kinase-like protein At4g34220 OS=Arabidopsis thaliana GN=At4g34220 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 395 bits (1014), Expect = e-109, Method: Compositional matrix adjust.
Identities = 277/792 (34%), Positives = 391/792 (49%), Gaps = 125/792 (15%)
Query: 1 MCFWVVLFLVLCNFNGFV----DSLNGEGYALLSFKQSVHEDPEGSLSNWNSSDENPCSW 56
+ F +VLF L FV +LN +G LL+FK S+ DP L NWN D PC W
Sbjct: 8 LLFSLVLFHFL-----FVPTQLQALNTDGVLLLTFKYSILTDPLSVLRNWNYDDATPCLW 62
Query: 57 NGITCKEQ---------RVVSVSIPKKKLLGFLPSALGSLTDLRHVNLRNNKFFGSLPLE 107
G+TC E RV S+ +P K LLG + L S+ LR ++L +N F GSLP
Sbjct: 63 TGVTCTELGKPNTPDMFRVTSLVLPNKHLLGSITPDLFSIPYLRILDLSSNFFNGSLPDS 122
Query: 108 LLEAQGLQSLVLYGNSFSGSVPNEIGKLKYLQILDLSQNFFNGSLPVSIVQCKRLKALDL 167
+ A LQS+ L N+ SG +P + + LQ+L+LS N F G +P++I K L + L
Sbjct: 123 VFNATELQSISLGSNNLSGDLPKSVNSVTNLQLLNLSANAFTGEIPLNISLLKNLTVVSL 182
Query: 168 SQNNFTGPLPNGFGSGLVSLEKLNLSFNKFNGSIPSNTGNLSSLQGTVDFSHNLFSGSI- 226
S+N F+G +P+GF + + L+LS N NGS+P + G S ++ SHN G I
Sbjct: 183 SKNTFSGDIPSGFEAAQI----LDLSSNLLNGSLPKDLGGKS--LHYLNLSHNKVLGEIS 236
Query: 227 PASLGNLPEKVYIDLTYNNLSGPIPQNGALMNRGPTAFIGNPRLCGPPLKNPCS------ 280
P P +DL++NNL+GPIP + +L+N+ +F GN LCG PLK CS
Sbjct: 237 PNFAEKFPANATVDLSFNNLTGPIPSSLSLLNQKAESFSGNQELCGKPLKILCSIPSTLS 296
Query: 281 --SDVPGASSPASYPFLPNNYPPENGDDGGGKREKGRGLSKSAIVAIIVSDVIGICLVGL 338
++ +SPA P + P N + L S I AI V+D++G+ +GL
Sbjct: 297 NPPNISETTSPA-IAVKPRSTAPINPLTEKPNQTGKSKLKPSTIAAITVADIVGLAFIGL 355
Query: 339 LFSYCY-----------SRVCGFGEGKDENCYAKGGKGRKE---------------CLCF 372
L Y Y S+ F ++N K E C+
Sbjct: 356 LVLYVYQVRKRRRYPESSKFSFFKFCLEKNEAKKSKPSTTEVTVPESPEAKTTCGSCIIL 415
Query: 373 ---RKDESETLSENVE--------------------QYDLVPLDTQVAFDLDELLKASAF 409
R DE+ T +VE Q LV +D + DLD LLKASA+
Sbjct: 416 TGGRYDETSTSESDVENQQTVQAFTRTDGGQLKQSSQTQLVTVDGETRLDLDTLLKASAY 475
Query: 410 VLGKSGIGIVYKVVLEDGHTLAVRRLGEG--GSQRFKEFQTEVEAIGKIRHSNIVTLRAY 467
+LG +G GIVYK VLE+G AVRR+ + + KEF+ EV AI K+RH N+V +R +
Sbjct: 476 ILGTTGTGIVYKAVLENGTAFAVRRIETESCAAAKPKEFEREVRAIAKLRHPNLVRIRGF 535
Query: 468 YWSVDEKLLIYDYIPNGSLATALHGKPGMVSF-------TPVPWSVRVKIIKGIAKGLVY 520
W DEKLLI DY+PNGSL S P+ + R+KI +G+A+GL Y
Sbjct: 536 CWGDDEKLLISDYVPNGSLLCFFTATKASSSSSSSSSLQNPLTFEARLKIARGMARGLSY 595
Query: 521 LHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQER 580
++E KK VHG++KP+NILL EP ++D GL RL PA
Sbjct: 596 INE---KKQVHGNIKPNNILLNAENEPIITDLGLDRLMT-------------PAR----- 634
Query: 581 QQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVG 640
E TT +S+ S YQ PE +KP+ KWD+YS+GVILLE++T + V V
Sbjct: 635 -------ESHTTGPTSS--SPYQPPEWSTSLKPNPKWDVYSFGVILLELLTSK--VFSVD 683
Query: 641 SSEMDLVNWMQLCIEEKKPLADVLDPYLAPD-ADKEEEIIAVLKIAMACVHSSPEKRPTM 699
N EE ++D + D A E+ +A ++ + CV S P+KRP+M
Sbjct: 684 HDIDQFSNLSDSAAEENGRFLRLIDGAIRSDVARHEDAAMACFRLGIECVSSLPQKRPSM 743
Query: 700 RHISDALDRLIV 711
+ + L+++ V
Sbjct: 744 KELVQVLEKICV 755
|
Arabidopsis thaliana (taxid: 3702) |
| >sp|C0LGP9|IMK3_ARATH Probable leucine-rich repeat receptor-like protein kinase IMK3 OS=Arabidopsis thaliana GN=IMK3 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 317 bits (813), Expect = 2e-85, Method: Compositional matrix adjust.
Identities = 238/752 (31%), Positives = 362/752 (48%), Gaps = 145/752 (19%)
Query: 38 DPEGSLSNWNSSDENPCS--WNGITCKEQRVVSVSIPKKKLLGFL--------------- 80
DP G L +WN S + CS W GI C + +V+ + +P K L G +
Sbjct: 73 DPRGFLRSWNGSGFSACSGGWAGIKCAQGQVIVIQLPWKSLGGRISEKIGQLQALRKLSL 132
Query: 81 ---------PSALGSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSGSVPNE 131
P +LG + +LR V L NN+ GS+P L + LQ+L L N S +P
Sbjct: 133 HDNNLGGSIPMSLGLIPNLRGVQLFNNRLTGSIPASLGVSHFLQTLDLSNNLLSEIIPPN 192
Query: 132 IGKLKYLQILDLSQNFFNGSLPVSIVQCKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLN 191
+ L L+LS N +G +PVS+ + L+ L L NN +GP+ + +GS ++L L+
Sbjct: 193 LADSSKLLRLNLSFNSLSGQIPVSLSRSSSLQFLALDHNNLSGPILDTWGSKSLNLRVLS 252
Query: 192 LSFNKFNGSIPSNTGNLSSLQ----------GT-------------VDFSHNLFSGSIPA 228
L N +G P + NL+ LQ GT +D S N SG IP
Sbjct: 253 LDHNSLSGPFPFSLCNLTQLQDFSFSHNRIRGTLPSELSKLTKLRKMDISGNSVSGHIPE 312
Query: 229 SLGNLPEKVYIDL------------------------TYNNLSGPIPQNGALMNR--GPT 262
+LGN+ +++DL +YNNLSGP+P L+++ +
Sbjct: 313 TLGNISSLIHLDLSQNKLTGEIPISISDLESLNFFNVSYNNLSGPVP---TLLSQKFNSS 369
Query: 263 AFIGNPRLCGPPLKNPCSSDVPGASSPASYPFLPNNYPPENGDDGGGKREKGRGLSKSAI 322
+F+GN LCG + PC P LP+ P + ++ R LS I
Sbjct: 370 SFVGNSLLCGYSVSTPC-------------PTLPSPSPEKE------RKPSHRNLSTKDI 410
Query: 323 VAIIVSDVIGICLVGLLFSYCYSRVCGFGEGKDENCYAKGGKGRKECLCFRKD---ESET 379
+ I G L+ +L C +C K AKGG+ + + + E+E
Sbjct: 411 ILI----ASGALLIVMLILVCV--LCCLLRKKANETKAKGGEAGPGAVAAKTEKGGEAEA 464
Query: 380 LSENVEQYDLVPLDTQVAFDLDELLKASAFVLGKSGIGIVYKVVLEDGHTLAVRRLGEGG 439
E + LV D +AF D+LL A+A ++GKS G VYK LEDG +AV+RL E
Sbjct: 465 GGETGGK--LVHFDGPMAFTADDLLCATAEIMGKSTYGTVYKATLEDGSQVAVKRLREKI 522
Query: 440 SQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVD-EKLLIYDYIPNGSLATALHGKPGMVS 498
++ KEF+ E+ +G+IRH N++ LRAYY EKL+++DY+ GSLAT LH + V
Sbjct: 523 TKSQKEFENEINVLGRIRHPNLLALRAYYLGPKGEKLVVFDYMSRGSLATFLHARGPDVH 582
Query: 499 FTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLA 558
+ W R+ +IKG+A+GL YLH + +HG+L SN+LL N+ +SD+GL+RL
Sbjct: 583 ---INWPTRMSLIKGMARGLFYLHTHA--NIIHGNLTSSNVLLDENITAKISDYGLSRLM 637
Query: 559 NIAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWD 618
A GS + ++ LG Y+APE K+ K + K D
Sbjct: 638 TAAAGSSVIA-------------------------TAGALG--YRAPELSKLKKANTKTD 670
Query: 619 IYSYGVILLEMITGRTAVVQVGSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKE-EE 677
+YS GVI+LE++TG++ + +DL W+ ++E+ +V D L D + +E
Sbjct: 671 VYSLGVIILELLTGKSPSEALNG--VDLPQWVATAVKEEWT-NEVFDLELLNDVNTMGDE 727
Query: 678 IIAVLKIAMACVHSSPEKRPTMRHISDALDRL 709
I+ LK+A+ CV ++P RP + + L +
Sbjct: 728 ILNTLKLALHCVDATPSTRPEAQQVMTQLGEI 759
|
Can phosphorylate AGL24. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FHK7|Y5516_ARATH Probable leucine-rich repeat receptor-like protein kinase At5g05160 OS=Arabidopsis thaliana GN=At5g05160 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 311 bits (797), Expect = 1e-83, Method: Compositional matrix adjust.
Identities = 240/714 (33%), Positives = 346/714 (48%), Gaps = 126/714 (17%)
Query: 7 LFLVLCNFNGFVDS-LNGEGYALLSFKQSVHEDPEGSLSNWNSSDENPCSWNGITCKEQ- 64
FL+L V + L + ALL+F SV P+ NWN + SW GITC E
Sbjct: 14 FFLLLAATAVLVSADLASDEQALLNFAASVPHPPK---LNWNKNLSLCSSWIGITCDESN 70
Query: 65 ---RVVSVSIPKKKLLGFLPSALGSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYG 121
RVV+V +P L G +P
Sbjct: 71 PTSRVVAVRLPGVGLYGSIP---------------------------------------- 90
Query: 122 NSFSGSVPNEIGKLKYLQILDLSQNFFNGSLPVSIVQCKRLKALDLSQNNFTGPLP-NGF 180
P +GKL L++L L N G+LP I+ L+ L L NNF+G L N
Sbjct: 91 -------PATLGKLDALKVLSLRSNSLFGTLPSDILSLPSLEYLYLQHNNFSGELTTNSL 143
Query: 181 GSGLVSLEKLNLSFNKFNGSIPSNTGNLSSLQGTVDFSHNLFSGSIPASLGNLPEKVYID 240
S L L+LS+N +G+IPS NLS + + +N F G I + +LP ++
Sbjct: 144 PSISKQLVVLDLSYNSLSGNIPSGLRNLSQIT-VLYLQNNSFDGPIDSL--DLPSVKVVN 200
Query: 241 LTYNNLSGPIPQNGALMNRGPT-AFIGNPRLCGPPLKNPCSSDVPGASSPASYPFLPNNY 299
L+YNNLSGPIP++ + + P +FIGN LCGPPL N CS SS P N +
Sbjct: 201 LSYNNLSGPIPEH---LKKSPEYSFIGNSLLCGPPL-NACSGGAISPSSNLPRPLTENLH 256
Query: 300 PPENGDDGGGKREKGRGLSKSAIVAIIVSDVIGICLVGLLFSYCYSRVCGFGEGKDENCY 359
P R SK+ I+AI+V + + +G++F C + EG E
Sbjct: 257 PVR------------RRQSKAYIIAIVVGCSVAVLFLGIVFLVCLVKKTKKEEGGGEGVR 304
Query: 360 AK-GGKGRKECLCFRKDESETLSENVEQYDLVPLDTQVAFDLDELLKASAFVLGKSGIGI 418
+ GG K+ F + + ++ + FDL++LLKASA VLGK G
Sbjct: 305 TQMGGVNSKKPQDFGSGVQDPEKNKLFFFERCNHN----FDLEDLLKASAEVLGKGSFGT 360
Query: 419 VYKVVLEDGHTLAVRRLGEGGSQRFKEFQTEVEAIGKI-RHSNIVTLRAYYWSVDEKLLI 477
YK VLED + V+RL E + + KEF+ ++E +GKI +HSN V L AYY+S DEKLL+
Sbjct: 361 AYKAVLEDTTAVVVKRLREVVASK-KEFEQQMEIVGKINQHSNFVPLLAYYYSKDEKLLV 419
Query: 478 YDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPS 537
Y Y+ GSL +HG G V W R+KI G +K + YLH K+VHGD+K S
Sbjct: 420 YKYMTKGSLFGIMHGNRGDRG---VDWETRMKIATGTSKAISYLHSL---KFVHGDIKSS 473
Query: 538 NILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSN 597
NILL ++EP +SD L L N +P P+
Sbjct: 474 NILLTEDLEPCLSDTSLVTLFN------------LPTHTPR------------------T 503
Query: 598 LGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGSSE----MDLVNWMQLC 653
+G Y APE ++ + SQ+ D+YS+GV++LEM+TG+T + Q G + +DL W++
Sbjct: 504 IG--YNAPEVIETRRVSQRSDVYSFGVVILEMLTGKTPLTQPGLEDERVVIDLPRWVRSV 561
Query: 654 IEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDALD 707
+ E+ A+V D L + EEE++ +L++A+ACV +PE RP M ++ ++
Sbjct: 562 VREEWT-AEVFDVELLKFQNIEEEMVQMLQLALACVARNPESRPKMEEVARMIE 614
|
Probable leucine-rich repeat receptor-like protein kinase. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9M9C5|Y1680_ARATH Probable leucine-rich repeat receptor-like protein kinase At1g68400 OS=Arabidopsis thaliana GN=At1g68400 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 306 bits (784), Expect = 3e-82, Method: Compositional matrix adjust.
Identities = 234/694 (33%), Positives = 338/694 (48%), Gaps = 116/694 (16%)
Query: 27 ALLSFKQSVHEDPEGSLSNWNSSDENPCSWNGITCKEQRVVSVSIPKKKLLGFLPSALGS 86
LL+FK + D G L++WN++ NPC W G++C RV + + L G + S
Sbjct: 34 TLLNFKLTA--DSTGKLNSWNTT-TNPCQWTGVSCNRNRVTRLVLEDINLTGSISSLT-- 88
Query: 87 LTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSGSVPNEIGKLKYLQILDLSQN 146
L+ L L N+ SG +PN + L L++L LS N
Sbjct: 89 -----------------------SLTSLRVLSLKHNNLSGPIPN-LSNLTALKLLFLSNN 124
Query: 147 FFNGSLPVSIVQCKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLNLSFNKFNGSIPSNTG 206
F+G+ P SI RL LDLS NNF+G +P L S N+F+G IP+
Sbjct: 125 QFSGNFPTSITSLTRLYRLDLSFNNFSGQIPPDLTDLTHLLTLRLES-NRFSGQIPNI-- 181
Query: 207 NLSSLQGTVDFSHNLFSGSIPASLGNLPEKVYIDLTYNNLSGPIPQNGALMNRGPTAFIG 266
NLS LQ + S N F+G IP SL PE V F
Sbjct: 182 NLSDLQD-FNVSGNNFNGQIPNSLSQFPESV--------------------------FTQ 214
Query: 267 NPRLCGPPLK--NPCSSDVPGASSPASYPFLPNNYPPE-----NGDDGGGKREKGRGLSK 319
NP LCG PL SSD P P N P GG K +S
Sbjct: 215 NPSLCGAPLLKCTKLSSDPTKPGRPDEAKASPLNKPETVPSSPTSIHGGDKSNNTSRIST 274
Query: 320 SAIVAIIVSDVIGICLVGLLFSYCYSRVCGFGEGKDENCYAKGGKGRKECLCFRKDESET 379
+++AII+ D I + V LL YC+ R + K ++K +G K + T
Sbjct: 275 ISLIAIILGDFIILSFVSLLLYYCFWRQYAVNKKK----HSKILEGEKIVYSSNPYPTST 330
Query: 380 LSENV------EQYDLVPLDTQVAFDLDELLKASAFVLGKSGIGIVYKVVLEDGHTLAVR 433
+ N ++ +V + F+L++LL+ASA +LGK G G YK VLEDG+ +AV+
Sbjct: 331 QNNNNQNQQVGDKGKMVFFEGTRRFELEDLLRASAEMLGKGGFGTAYKAVLEDGNEVAVK 390
Query: 434 RLGEGGS-QRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGSLATALHG 492
RL + + KEF+ ++E +G++RH+N+V+L+AYY++ +EKLL+YDY+PNGSL LHG
Sbjct: 391 RLKDAVTVAGKKEFEQQMEVLGRLRHTNLVSLKAYYFAREEKLLVYDYMPNGSLFWLLHG 450
Query: 493 KPGMVSFTPVPWSVRVKIIKGIAKGLVYLH-EFSPKKYVHGDLKPSNILLGHNMEPHVSD 551
G TP+ W+ R+KI G A+GL ++H K HGD+K +N+LL + VSD
Sbjct: 451 NRG-PGRTPLDWTTRLKIAAGAARGLAFIHGSCKTLKLTHGDIKSTNVLLDRSGNARVSD 509
Query: 552 FGLARLANIAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVV 611
FGL+ A P + KS + Y+APE +
Sbjct: 510 FGLSIFA------------------PSQTVAKS---------------NGYRAPELIDGR 536
Query: 612 KPSQKWDIYSYGVILLEMITGRTA-VVQVGSS--EMDLVNWMQLCIEEKKPLADVLDPYL 668
K +QK D+YS+GV+LLE++TG+ +V+ G S +DL W+Q + E+ A+V D L
Sbjct: 537 KHTQKSDVYSFGVLLLEILTGKCPNMVETGHSGGAVDLPRWVQSVVREEWT-AEVFDLEL 595
Query: 669 APDADKEEEIIAVLKIAMACVHSSPEKRPTMRHI 702
D EEE++ +L+IAMAC + + RP M H+
Sbjct: 596 MRYKDIEEEMVGLLQIAMACTAVAADHRPKMGHV 629
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SCT4|IMK2_ARATH Probably inactive leucine-rich repeat receptor-like protein kinase IMK2 OS=Arabidopsis thaliana GN=IMK2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 292 bits (747), Expect = 6e-78, Method: Compositional matrix adjust.
Identities = 212/632 (33%), Positives = 319/632 (50%), Gaps = 76/632 (12%)
Query: 90 LRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSGSVPNEIGKLKYLQILDLSQNFFN 149
L+ +NL +N+F G++P+ L + L+ + + N SGS+P E G L +LQ LD S N N
Sbjct: 241 LKTLNLDHNRFSGAVPVSLCKHSLLEEVSISHNQLSGSIPRECGGLPHLQSLDFSYNSIN 300
Query: 150 GSLPVSIVQCKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLNLSFNKFNGSIPSNTGNLS 209
G++P S L +L+L N+ GP+P+ L +L +LNL NK NG IP GN+S
Sbjct: 301 GTIPDSFSNLSSLVSLNLESNHLKGPIPDAIDR-LHNLTELNLKRNKINGPIPETIGNIS 359
Query: 210 SLQGTVDFSHNLFSGSIPASLGNLPEKVYIDLTYNNLSGPIPQNGALMNR-GPTAFIGNP 268
++ +D S N F+G IP SL +L + +++YN LSGP+P L + ++F+GN
Sbjct: 360 GIK-KLDLSENNFTGPIPLSLVHLAKLSSFNVSYNTLSGPVPP--VLSKKFNSSSFLGNI 416
Query: 269 RLCGPPLKNPCSSDVPGASSPASYPFLPNNYPPENGDDGGGKREKGRGLSKSAIVAIIVS 328
+LCG NPC PA P P + + ++ R LS V
Sbjct: 417 QLCGYSSSNPC---------PAPDHHHPLTLSPTSSQEP--RKHHHRKLS--------VK 457
Query: 329 DVIGICLVGLLFSYCYSRVCGFGEGKDENCYAKGGKGRKECLCFRKDESETLSENVEQY- 387
DVI I + LL + K G+ K +T+S V
Sbjct: 458 DVILIAIGALLAILLLLCCILLCCLIKKRAALKQKDGKD------KTSEKTVSAGVAGTA 511
Query: 388 --------DLVPLDTQVAFDLDELLKASAFVLGKSGIGIVYKVVLEDGHTLAVRRLGEGG 439
LV D F D+LL A+A ++GKS G YK LEDG+ +AV+RL E
Sbjct: 512 SAGGEMGGKLVHFDGPFVFTADDLLCATAEIMGKSTYGTAYKATLEDGNEVAVKRLREKT 571
Query: 440 SQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVD-EKLLIYDYIPNGSLATALHGKPGMVS 498
++ KEF+ EV A+GKIRH N++ LRAYY EKLL++DY+ GSL+ LH +
Sbjct: 572 TKGVKEFEGEVTALGKIRHQNLLALRAYYLGPKGEKLLVFDYMSKGSLSAFLHARG---P 628
Query: 499 FTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLA 558
T +PW R+KI KGI++GL +LH S + +H +L SNILL H++D+GL+RL
Sbjct: 629 ETLIPWETRMKIAKGISRGLAHLH--SNENMIHENLTASNILLDEQTNAHIADYGLSRLM 686
Query: 559 NIAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWD 618
A + + ++ LG Y+APE K+ S K D
Sbjct: 687 TAAAATNVIA-------------------------TAGTLG--YRAPEFSKIKNASAKTD 719
Query: 619 IYSYGVILLEMITGRTAVVQVGSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADK-EEE 677
+YS G+I+LE++TG++ ++ MDL W+ ++E+ +V D L + +E
Sbjct: 720 VYSLGIIILELLTGKSP--GEPTNGMDLPQWVASIVKEEW-TNEVFDLELMRETQSVGDE 776
Query: 678 IIAVLKIAMACVHSSPEKRPTMRHISDALDRL 709
++ LK+A+ CV SP RP + + L+ +
Sbjct: 777 LLNTLKLALHCVDPSPAARPEANQVVEQLEEI 808
|
Arabidopsis thaliana (taxid: 3702) |
| >sp|C0LGQ5|GSO1_ARATH LRR receptor-like serine/threonine-protein kinase GSO1 OS=Arabidopsis thaliana GN=GSO1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 292 bits (747), Expect = 7e-78, Method: Compositional matrix adjust.
Identities = 221/665 (33%), Positives = 331/665 (49%), Gaps = 90/665 (13%)
Query: 59 ITCKEQRVVSVSIPKKKLLGFLPSALGSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLV 118
+ CK ++ + + L G +P LG L+ L + L +N+F SLP EL L L
Sbjct: 644 VLCK--KLTHIDLNNNFLSGPIPPWLGKLSQLGELKLSSNQFVESLPTELFNCTKLLVLS 701
Query: 119 LYGNSFSGSVPNEIGKLKYLQILDLSQNFFNGSLPVSIVQCKRLKALDLSQNNFTGPLPN 178
L GNS +GS+P EIG L L +L+L +N F+GSLP ++ + +L L LS+N+ TG +P
Sbjct: 702 LDGNSLNGSIPQEIGNLGALNVLNLDKNQFSGSLPQAMGKLSKLYELRLSRNSLTGEIPV 761
Query: 179 GFGSGLVSLEKLNLSFNKFNGSIPSNTGNLSSLQGTVDFSHNLFSGSIPASLGNLPEKVY 238
G L+LS+N F G IPS G LS L+ T+D SHN +G +P S+G++ Y
Sbjct: 762 EIGQLQDLQSALDLSYNNFTGDIPSTIGTLSKLE-TLDLSHNQLTGEVPGSVGDMKSLGY 820
Query: 239 IDLTYNNLSGPIPQNGALMNRGPT-AFIGNPRLCGPPLKNPCSSDVPGASSPASYPFLPN 297
+++++NNL G + + +R P +F+GN LCG PL C+ N
Sbjct: 821 LNVSFNNLGGKLKKQ---FSRWPADSFLGNTGLCGSPLSR-CNR------------VRSN 864
Query: 298 NYPPENGDDGGGKREKGRGLSKSAIV---AIIVSDVIG--ICLVGLLFSYCYSRVCGFGE 352
N K +GLS ++V AI IG I ++ L F + G
Sbjct: 865 N--------------KQQGLSARSVVIISAISALTAIGLMILVIALFFKQRHDFFKKVGH 910
Query: 353 GKDENCYAKGGKGRKECLCFRKDESETLSENVEQYDLVPLDTQVAFDLDELLKASAFVLG 412
G + FR S++ ++ D++ + +L E F++G
Sbjct: 911 GSTAYTSSSSSSQATHKPLFRNGASKS---DIRWEDIM----EATHNLSE-----EFMIG 958
Query: 413 KSGIGIVYKVVLEDGHTLAVRR-LGEGGSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSV 471
G G VYK LE+G T+AV++ L + K F EV+ +G+IRH ++V L Y S
Sbjct: 959 SGGSGKVYKAELENGETVAVKKILWKDDLMSNKSFSREVKTLGRIRHRHLVKLMGYCSSK 1018
Query: 472 DE--KLLIYDYIPNGSLATALH-GKPGMVSFTPV-PWSVRVKIIKGIAKGLVYLHEFSPK 527
E LLIY+Y+ NGS+ LH KP + + W R++I G+A+G+ YLH
Sbjct: 1019 SEGLNLLIYEYMKNGSIWDWLHEDKPVLEKKKKLLDWEARLRIAVGLAQGVEYLHHDCVP 1078
Query: 528 KYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQKSVSL 587
VH D+K SN+LL NME H+ DFGLA+ V
Sbjct: 1079 PIVHRDIKSSNVLLDSNMEAHLGDFGLAK----------------------------VLT 1110
Query: 588 EVTTTNSSSNLG---SY-YQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGSSE 643
E TN+ SN SY Y APE +K ++K D+YS G++L+E++TG+ V +E
Sbjct: 1111 ENCDTNTDSNTWFACSYGYIAPEYAYSLKATEKSDVYSMGIVLMEIVTGKMPTDSVFGAE 1170
Query: 644 MDLVNWMQLCIEEKKPLAD-VLDPYLAPDADKEEEIIA-VLKIAMACVHSSPEKRPTMRH 701
MD+V W++ +E D ++DP L P EE+ VL+IA+ C +SP++RP+ R
Sbjct: 1171 MDMVRWVETHLEVAGSARDKLIDPKLKPLLPFEEDAACQVLEIALQCTKTSPQERPSSRQ 1230
Query: 702 ISDAL 706
D+L
Sbjct: 1231 ACDSL 1235
|
Together with GSO2, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O48788|Y2267_ARATH Probable inactive receptor kinase At2g26730 OS=Arabidopsis thaliana GN=At2g26730 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 292 bits (747), Expect = 7e-78, Method: Compositional matrix adjust.
Identities = 248/715 (34%), Positives = 356/715 (49%), Gaps = 124/715 (17%)
Query: 4 WVV--LFLVLCNFNGFVDSLNGEGYALLSFKQSVHEDPEGSLSNWNSSDENPCSWNGITC 61
WV+ LF +L E ALL+F Q + P + WN SD + C+W G+ C
Sbjct: 6 WVLNSLFSILLLTQRVNSESTAEKQALLTFLQQI---PHENRLQWNESD-SACNWVGVEC 61
Query: 62 K--EQRVVSVSIPKKKLLGFLPSALGSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVL 119
+ + S+ +P L+G +PS GSL L L+ L L
Sbjct: 62 NSNQSSIHSLRLPGTGLVGQIPS--GSLGRLTE---------------------LRVLSL 98
Query: 120 YGNSFSGSVPNEIGKLKYLQILDLSQNFFNGSLPVSIVQCKRLKALDLSQNNFTGPLPNG 179
N SG +P++ L +L+ L L N F+G P S Q L LD+S NNFT
Sbjct: 99 RSNRLSGQIPSDFSNLTHLRSLYLQHNEFSGEFPTSFTQLNNLIRLDISSNNFT------ 152
Query: 180 FGSGLVSLEKLNLSFNKFNGSIPSNTGNLSSLQGTVDFSHNLFSGSIPA-SLGNLPEKVY 238
GSIP + NL+ L G +N FSG++P+ SLG V
Sbjct: 153 -------------------GSIPFSVNNLTHLTGLF-LGNNGFSGNLPSISLG----LVD 188
Query: 239 IDLTYNNLSGPIPQNGALMNRGPTAFIGNPRLCGPPLKNPCSSDVPGASSPASYPFLPNN 298
+++ NNL+G IP +L +F GN LCG PLK PC S SP+ P L N
Sbjct: 189 FNVSNNNLNGSIPS--SLSRFSAESFTGNVDLCGGPLK-PCKSFF---VSPSPSPSLIN- 241
Query: 299 YPPENGDDGGGKREKGRGLSKSAIVAIIVSDVIGICLVGLLFSYCYSR-VCGFGEGKDEN 357
P N K LSK+AIVAIIV+ + L+ L + R G E + +
Sbjct: 242 --PSNR-----LSSKKSKLSKAAIVAIIVASALVALLLLALLLFLCLRKRRGSNEARTKQ 294
Query: 358 CYAKGGKGRKECL----CFRKDE----SETLSENVEQYDLVPLDTQV-AFDLDELLKASA 408
G R L K+E S + E+ LV + V +FDL++LL+ASA
Sbjct: 295 PKPAGVATRNVDLPPGASSSKEEVTGTSSGMGGETERNKLVFTEGGVYSFDLEDLLRASA 354
Query: 409 FVLGKSGIGIVYKVVLEDGHTLAVRRLGEGGSQRFKEFQTEVEAIGKIRHSNIVTLRAYY 468
VLGK +G YK VLE+G T+ V+RL + + + KEF+T++E +GKI+H N++ LRAYY
Sbjct: 355 EVLGKGSVGTSYKAVLEEGTTVVVKRLKDVMASK-KEFETQMEVVGKIKHPNVIPLRAYY 413
Query: 469 WSVDEKLLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKK 528
+S DEKLL++D++P GSL+ LHG G TP+ W R++I A+GL +LH K
Sbjct: 414 YSKDEKLLVFDFMPTGSLSALLHGSRGS-GRTPLDWDNRMRIAITAARGLAHLH--VSAK 470
Query: 529 YVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQKSVSLE 588
VHG++K SNILL N + VSD+GL +L + SP NR+
Sbjct: 471 LVHGNIKASNILLHPNQDTCVSDYGLNQL--FSNSSP---PNRLAG-------------- 511
Query: 589 VTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTA-VVQVGSSEMDLV 647
Y APE L+ K + K D+YS+GV+LLE++TG++ +G +DL
Sbjct: 512 -------------YHAPEVLETRKVTFKSDVYSFGVLLLELLTGKSPNQASLGEEGIDLP 558
Query: 648 NWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHI 702
W+ L + ++ A+V D L + EEE++ +L+IAMACV + P++RP M+ +
Sbjct: 559 RWV-LSVVREEWTAEVFDVELMRYHNIEEEMVQLLQIAMACVSTVPDQRPVMQEV 612
|
Arabidopsis thaliana (taxid: 3702) |
| >sp|Q9LVP0|Y5639_ARATH Probable leucine-rich repeat receptor-like protein kinase At5g63930 OS=Arabidopsis thaliana GN=At5g63930 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 290 bits (743), Expect = 2e-77, Method: Compositional matrix adjust.
Identities = 228/700 (32%), Positives = 325/700 (46%), Gaps = 137/700 (19%)
Query: 60 TCKEQRVVSVSIPKKKLLGFLPSALGSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVL 119
TCK +V + + + L+G PS L ++ + L N+F GS+P E+ LQ L L
Sbjct: 455 TCKT--LVQLRLARNNLVGRFPSNLCKQVNVTAIELGQNRFRGSIPREVGNCSALQRLQL 512
Query: 120 YGNSFSGSVPNEIGKLKYLQILDLSQNFFNGSLPVSIVQCKRLKALDLSQNNFTGPLPNG 179
N F+G +P EIG L L L++S N G +P I CK L+ LD+ NNF+G LP+
Sbjct: 513 ADNGFTGELPREIGMLSQLGTLNISSNKLTGEVPSEIFNCKMLQRLDMCCNNFSGTLPSE 572
Query: 180 FGS-----------------------GLVSLEKLNLSFNKFNGSIPSNTGNLSSLQGTVD 216
GS L L +L + N FNGSIP G+L+ LQ ++
Sbjct: 573 VGSLYQLELLKLSNNNLSGTIPVALGNLSRLTELQMGGNLFNGSIPRELGSLTGLQIALN 632
Query: 217 FSHNLF------------------------SGSIPASLGNLPEKVYIDLTYNNLSGPIPQ 252
S+N SG IP+S NL + + +YN+L+GPIP
Sbjct: 633 LSYNKLTGEIPPELSNLVMLEFLLLNNNNLSGEIPSSFANLSSLLGYNFSYNSLTGPIP- 691
Query: 253 NGALMNRGPTAFIGNPRLCGPPLKNPCSSDVPGASSPASYPFLPNNYPPENGDDGGGKRE 312
L N ++FIGN LCGPPL N C P A S ++ G GG
Sbjct: 692 --LLRNISMSSFIGNEGLCGPPL-NQCIQTQPFAPSQST------------GKPGG---- 732
Query: 313 KGRGLSKSAIVAIIVSDVIGICLVGL-LFSYCYSRVCGFGEGKDENCYAKGGKGRKECL- 370
+ S I+AI + + G+ L+ + L Y R + A+ G+ + L
Sbjct: 733 ----MRSSKIIAITAAVIGGVSLMLIALIVYLMRRPV-----RTVASSAQDGQPSEMSLD 783
Query: 371 -CFRKDESETLSENVEQYDLVPLDTQVAFDLDELLKASAFVLGKSGIGIVYKVVLEDGHT 429
F E T + V D + DE +FV+G+ G VYK VL G+T
Sbjct: 784 IYFPPKEGFTFQDLVAATD----------NFDE-----SFVVGRGACGTVYKAVLPAGYT 828
Query: 430 LAVRRLG---EGGSQRFKE--FQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNG 484
LAV++L EGG+ + F+ E+ +G IRH NIV L + LL+Y+Y+P G
Sbjct: 829 LAVKKLASNHEGGNNNNVDNSFRAEILTLGNIRHRNIVKLHGFCNHQGSNLLLYEYMPKG 888
Query: 485 SLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHN 544
SL LH + WS R KI G A+GL YLH + H D+K +NILL
Sbjct: 889 SLGEILHDPS-----CNLDWSKRFKIALGAAQGLAYLHHDCKPRIFHRDIKSNNILLDDK 943
Query: 545 MEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSY-YQ 603
E HV DFGLA++ ++ P + +++ GSY Y
Sbjct: 944 FEAHVGDFGLAKVIDM----------------PHSKSMSAIA------------GSYGYI 975
Query: 604 APESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGSSEMDLVNWMQLCIEEKKPLADV 663
APE +K ++K DIYSYGV+LLE++TG+ A VQ D+VNW++ I + V
Sbjct: 976 APEYAYTMKVTEKSDIYSYGVVLLELLTGK-APVQPIDQGGDVVNWVRSYIRRDALSSGV 1034
Query: 664 LDPYLAPDADK-EEEIIAVLKIAMACVHSSPEKRPTMRHI 702
LD L + ++ ++ VLKIA+ C SP RP+MR +
Sbjct: 1035 LDARLTLEDERIVSHMLTVLKIALLCTSVSPVARPSMRQV 1074
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 714 | ||||||
| 255570657 | 715 | ATP binding protein, putative [Ricinus c | 0.981 | 0.980 | 0.826 | 0.0 | |
| 224111612 | 716 | predicted protein [Populus trichocarpa] | 0.983 | 0.980 | 0.823 | 0.0 | |
| 225424079 | 713 | PREDICTED: probable inactive leucine-ric | 0.980 | 0.981 | 0.838 | 0.0 | |
| 147787085 | 713 | hypothetical protein VITISV_040575 [Viti | 0.980 | 0.981 | 0.836 | 0.0 | |
| 224099409 | 717 | predicted protein [Populus trichocarpa] | 0.981 | 0.977 | 0.815 | 0.0 | |
| 356573811 | 710 | PREDICTED: probable inactive leucine-ric | 0.987 | 0.992 | 0.770 | 0.0 | |
| 356536282 | 712 | PREDICTED: probable inactive leucine-ric | 0.967 | 0.970 | 0.766 | 0.0 | |
| 356574230 | 710 | PREDICTED: probable inactive leucine-ric | 0.987 | 0.992 | 0.767 | 0.0 | |
| 449434592 | 718 | PREDICTED: probable inactive leucine-ric | 0.966 | 0.961 | 0.751 | 0.0 | |
| 449512843 | 718 | PREDICTED: probable inactive leucine-ric | 0.966 | 0.961 | 0.750 | 0.0 |
| >gi|255570657|ref|XP_002526283.1| ATP binding protein, putative [Ricinus communis] gi|223534364|gb|EEF36072.1| ATP binding protein, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 1204 bits (3116), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 582/704 (82%), Positives = 642/704 (91%), Gaps = 3/704 (0%)
Query: 13 NFNGFVDSLNGEGYALLSFKQSVHEDPEGSLSNWNSSDENPCSWNGITCKEQRVVSVSIP 72
N NG + SLN EG+ALLSFKQS+++DPEGSLSNWNSSDE PCSWNG+TCKE +VVSVSIP
Sbjct: 13 NSNGVI-SLNSEGFALLSFKQSIYQDPEGSLSNWNSSDETPCSWNGVTCKELKVVSVSIP 71
Query: 73 KKKLLGFLPSALGSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSGSVPNEI 132
KKKL GFLPS+LGSL+DLRHVNLRNN FFGSLP +L +AQGLQSLVLYGNS SGS+PN+I
Sbjct: 72 KKKLFGFLPSSLGSLSDLRHVNLRNNMFFGSLPSQLFQAQGLQSLVLYGNSLSGSLPNDI 131
Query: 133 GKLKYLQILDLSQNFFNGSLPVSIVQCKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLNL 192
GKLKYLQ LDLSQN FNGS+P+SIVQC+RL+ALDLSQNNF+G LP+GFGSG VSLEKL+L
Sbjct: 132 GKLKYLQTLDLSQNSFNGSIPISIVQCRRLRALDLSQNNFSGSLPDGFGSGFVSLEKLDL 191
Query: 193 SFNKFNGSIPSNTGNLSSLQGTVDFSHNLFSGSIPASLGNLPEKVYIDLTYNNLSGPIPQ 252
SFNKFNGSIPS+ GNLSSLQGTVD SHN FSGSIPASLGNLPEKVYIDLTYNNLSGPIPQ
Sbjct: 192 SFNKFNGSIPSDMGNLSSLQGTVDLSHNHFSGSIPASLGNLPEKVYIDLTYNNLSGPIPQ 251
Query: 253 NGALMNRGPTAFIGNPRLCGPPLKNPCSSDVPGASSPASYPFLPNNYPPENGDDGGGKRE 312
GALMNRGPTAFIGNP LCGPPLKNPCSS+ P A++P+S PFLP+NYPP++ D+ GGK
Sbjct: 252 TGALMNRGPTAFIGNPGLCGPPLKNPCSSETPNANAPSSIPFLPSNYPPQDLDNHGGKSV 311
Query: 313 KGRGLSKSAIVAIIVSDVIGICLVGLLFSYCYSRVCGFGEGKDENCYA--KGGKGRKECL 370
K RGLSKSA++AIIVSDVIGICLVGLLFSYCYSRVC G+ KDE+ Y K GKGRKECL
Sbjct: 312 KERGLSKSAVIAIIVSDVIGICLVGLLFSYCYSRVCACGKDKDESDYVFDKRGKGRKECL 371
Query: 371 CFRKDESETLSENVEQYDLVPLDTQVAFDLDELLKASAFVLGKSGIGIVYKVVLEDGHTL 430
CFRKDESETLSE+VEQYDLVPLDTQV FDLDELLKASAFVLGKSGIGIVYKVVLEDG TL
Sbjct: 372 CFRKDESETLSEHVEQYDLVPLDTQVTFDLDELLKASAFVLGKSGIGIVYKVVLEDGLTL 431
Query: 431 AVRRLGEGGSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGSLATAL 490
AVRRLGEGGSQRFKEFQTEVEAIGK+RH NI TLRAYYWSVDEKLLIYDYIPNGSL+TAL
Sbjct: 432 AVRRLGEGGSQRFKEFQTEVEAIGKLRHPNIATLRAYYWSVDEKLLIYDYIPNGSLSTAL 491
Query: 491 HGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVS 550
HGKPGMVSFTP+ W++R+KIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEP++S
Sbjct: 492 HGKPGMVSFTPLSWTMRLKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPYIS 551
Query: 551 DFGLARLANIAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKV 610
DFGL RLANIAGGSPTLQSNR+ EKP E+QQKS S++++GSYYQAPE+LKV
Sbjct: 552 DFGLGRLANIAGGSPTLQSNRITVEKPHEKQQKSAPSSEVAMVSATSMGSYYQAPEALKV 611
Query: 611 VKPSQKWDIYSYGVILLEMITGRTAVVQVGSSEMDLVNWMQLCIEEKKPLADVLDPYLAP 670
VKPSQKWD+YSYGVILLEMITGR+ +V VG+SEMDLV W+QLCIEE+KPLADVLDPYLAP
Sbjct: 612 VKPSQKWDVYSYGVILLEMITGRSPLVHVGTSEMDLVQWIQLCIEEQKPLADVLDPYLAP 671
Query: 671 DADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDALDRLIVSSD 714
D DKEEEIIAVLKIAMACVH+S E+RPTMRH+SD L RL++ SD
Sbjct: 672 DVDKEEEIIAVLKIAMACVHNSSERRPTMRHVSDVLSRLVIPSD 715
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224111612|ref|XP_002315920.1| predicted protein [Populus trichocarpa] gi|222864960|gb|EEF02091.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 1202 bits (3111), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 580/704 (82%), Positives = 635/704 (90%), Gaps = 2/704 (0%)
Query: 13 NFNGFVDSLNGEGYALLSFKQSVHEDPEGSLSNWNSSDENPCSWNGITCKEQRVVSVSIP 72
N + V LN EGYALLSFKQS++EDPEGSLSNWNSSD+NPCSWNG+TCK+ +V+SVSIP
Sbjct: 13 NCHSLVSCLNNEGYALLSFKQSIYEDPEGSLSNWNSSDDNPCSWNGVTCKDFKVMSVSIP 72
Query: 73 KKKLLGFLPSALGSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSGSVPNEI 132
KK+L GFLPSALGSL+DLRHVNLRNN+F GSLP EL +AQGLQSLVLYGNS SGS+PN+
Sbjct: 73 KKRLYGFLPSALGSLSDLRHVNLRNNRFSGSLPAELFQAQGLQSLVLYGNSLSGSLPNQF 132
Query: 133 GKLKYLQILDLSQNFFNGSLPVSIVQCKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLNL 192
GKLKYLQ LDLSQNFFNGS+P S V CKRL+ALDLSQNN TG LP GFG+ LVSLEKL+L
Sbjct: 133 GKLKYLQTLDLSQNFFNGSIPTSFVLCKRLRALDLSQNNLTGSLPVGFGASLVSLEKLDL 192
Query: 193 SFNKFNGSIPSNTGNLSSLQGTVDFSHNLFSGSIPASLGNLPEKVYIDLTYNNLSGPIPQ 252
SFNKFNGSIPS+ GNLSSLQGT D SHNLF+GSIPASLGNLPEKVYIDLTYNNLSGPIPQ
Sbjct: 193 SFNKFNGSIPSDMGNLSSLQGTADLSHNLFTGSIPASLGNLPEKVYIDLTYNNLSGPIPQ 252
Query: 253 NGALMNRGPTAFIGNPRLCGPPLKNPCSSDVPGASSPASYPFLPNNYPPENGDDGGGKRE 312
GALMNRGPTAFIGNP LCGPPLKNPCSSD GA++P+S PFLPNN PP++ D+ G K E
Sbjct: 253 TGALMNRGPTAFIGNPGLCGPPLKNPCSSDTDGAAAPSSIPFLPNNSPPQDSDNNGRKSE 312
Query: 313 KGRGLSKSAIVAIIVSDVIGICLVGLLFSYCYSRVCGFGEGKDENCYA--KGGKGRKECL 370
KGRGLSK+A+VAIIVSDVIGICLVGLLFSYCYSRVC + +D N Y KGGK R+EC
Sbjct: 313 KGRGLSKTAVVAIIVSDVIGICLVGLLFSYCYSRVCQRSKDRDGNSYGFEKGGKKRRECF 372
Query: 371 CFRKDESETLSENVEQYDLVPLDTQVAFDLDELLKASAFVLGKSGIGIVYKVVLEDGHTL 430
CFRKDESETLSENVEQYDLVPLD QVAFDLDELLKASAFVLGKSGIGIVYKVVLEDGHTL
Sbjct: 373 CFRKDESETLSENVEQYDLVPLDAQVAFDLDELLKASAFVLGKSGIGIVYKVVLEDGHTL 432
Query: 431 AVRRLGEGGSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGSLATAL 490
AVRRLGEGGSQRFKEFQTEVEAIGK+RH NIV LRAYYWSVDEKLLIYDYIPNGSLATAL
Sbjct: 433 AVRRLGEGGSQRFKEFQTEVEAIGKLRHPNIVILRAYYWSVDEKLLIYDYIPNGSLATAL 492
Query: 491 HGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVS 550
HGKPGMVS+TP+ WS R+KIIKGIAKGLVYLHEFSPKKYVHGDLKPSN+LLG NMEPH+S
Sbjct: 493 HGKPGMVSYTPLSWSDRLKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNVLLGQNMEPHIS 552
Query: 551 DFGLARLANIAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKV 610
DFGL RLA IAGGSPTL+SNR+ +EKPQERQQK T SS+NLGSYYQAPE+LKV
Sbjct: 553 DFGLGRLATIAGGSPTLESNRIASEKPQERQQKGAPSSEVATVSSTNLGSYYQAPEALKV 612
Query: 611 VKPSQKWDIYSYGVILLEMITGRTAVVQVGSSEMDLVNWMQLCIEEKKPLADVLDPYLAP 670
+KPSQKWD+YSYGVILLEMITGR+++V VG+SEM LV+W+QLCIEE+KPLADVLDPYLAP
Sbjct: 613 LKPSQKWDVYSYGVILLEMITGRSSMVHVGTSEMYLVHWIQLCIEEQKPLADVLDPYLAP 672
Query: 671 DADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDALDRLIVSSD 714
D DKEEEIIAVLKIAMACVHSSPE+RPTMRH+SD +RL +SSD
Sbjct: 673 DVDKEEEIIAVLKIAMACVHSSPERRPTMRHVSDVFNRLAMSSD 716
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225424079|ref|XP_002282768.1| PREDICTED: probable inactive leucine-rich repeat receptor-like protein kinase At1g66830 [Vitis vinifera] gi|297737773|emb|CBI26974.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1189 bits (3075), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 591/705 (83%), Positives = 640/705 (90%), Gaps = 5/705 (0%)
Query: 12 CNFNGFVDSLNGEGYALLSFKQSVHEDPEGSLSNWNSSDENPCSWNGITCKEQRVVSVSI 71
CN + V SLN EG ALLSFK+SV EDPE SL NWNSSDENPCSWNGITCKE+RVVSVSI
Sbjct: 12 CNSHALVGSLNEEGVALLSFKRSVGEDPERSLDNWNSSDENPCSWNGITCKEERVVSVSI 71
Query: 72 PKKKLLGFLPSALGSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSGSVPNE 131
PKKKLLGFLPSALGSLT LRHVNLRNNKFFGSLP+EL +AQGLQSLVLYGN+ SGSVP+E
Sbjct: 72 PKKKLLGFLPSALGSLTQLRHVNLRNNKFFGSLPVELFKAQGLQSLVLYGNNLSGSVPSE 131
Query: 132 IGKLKYLQILDLSQNFFNGSLPVSIVQCKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLN 191
IG LKYLQ LDLSQNFFNGSLP S++QCKRLK LDLSQNNFTG LP+GFG GL+SLEKL+
Sbjct: 132 IGSLKYLQTLDLSQNFFNGSLPTSLLQCKRLKTLDLSQNNFTGSLPDGFGKGLISLEKLD 191
Query: 192 LSFNKFNGSIPSNTGNLSSLQGTVDFSHNLFSGSIPASLGNLPEKVYIDLTYNNLSGPIP 251
LSFNKF+G IPS+ GNLS+LQGTVD SHN+FSGSIPASLG+LPEKVYIDLTYNNLSGPIP
Sbjct: 192 LSFNKFSGPIPSDIGNLSNLQGTVDLSHNIFSGSIPASLGDLPEKVYIDLTYNNLSGPIP 251
Query: 252 QNGALMNRGPTAFIGNPRLCGPPLKNPCSSDVPGASSPASYPFLPNNYPPENGDDGGGKR 311
QNGALMNRGPTAFIGNPRLCGPP KNPCS + ASSP+S PFLPNNYPP N D GK
Sbjct: 252 QNGALMNRGPTAFIGNPRLCGPPSKNPCSPET--ASSPSSIPFLPNNYPPPNSDGDSGK- 308
Query: 312 EKGRGLSKSAIVAIIVSDVIGICLVGLLFSYCYSRVCGFGEGKDENCYA--KGGKGRKEC 369
KGRGLSKSA++ I+V DV+GICL+GLLFSYCYSR+C G+GKDEN Y KGGK RKEC
Sbjct: 309 GKGRGLSKSAVIGIVVGDVVGICLIGLLFSYCYSRMCSCGKGKDENGYGFEKGGKARKEC 368
Query: 370 LCFRKDESETLSENVEQYDLVPLDTQVAFDLDELLKASAFVLGKSGIGIVYKVVLEDGHT 429
LCFRKDESETLSENVEQYDLVPLDTQVAFDLDELLKASAFVLGKSGIGIVYKVVLEDG T
Sbjct: 369 LCFRKDESETLSENVEQYDLVPLDTQVAFDLDELLKASAFVLGKSGIGIVYKVVLEDGST 428
Query: 430 LAVRRLGEGGSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGSLATA 489
LAVRRLGEGGSQRFKEFQTEVEAIGK+RH NIVTLRAYYWSVDEKLLIYDYIPNG+LATA
Sbjct: 429 LAVRRLGEGGSQRFKEFQTEVEAIGKLRHPNIVTLRAYYWSVDEKLLIYDYIPNGNLATA 488
Query: 490 LHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHV 549
+HGKPGMVSF P+PWSVR+KI++G AKGLVYLHEFSPKKYVHGDLKPSNILLG NMEPH+
Sbjct: 489 IHGKPGMVSFRPLPWSVRLKIMEGTAKGLVYLHEFSPKKYVHGDLKPSNILLGQNMEPHI 548
Query: 550 SDFGLARLANIAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLK 609
SDFGL RLANIAGGSPTLQS+RM +EKP +RQQ + EV +S+SNLGSYYQAPE+LK
Sbjct: 549 SDFGLGRLANIAGGSPTLQSSRMTSEKPPQRQQSNPPSEVGAVSSTSNLGSYYQAPEALK 608
Query: 610 VVKPSQKWDIYSYGVILLEMITGRTAVVQVGSSEMDLVNWMQLCIEEKKPLADVLDPYLA 669
VVKPSQKWD+YSYGVILLEMITGR VVQVGSSEMDLV W+QLCIEEKKPLADVLDPYLA
Sbjct: 609 VVKPSQKWDVYSYGVILLEMITGRLPVVQVGSSEMDLVRWIQLCIEEKKPLADVLDPYLA 668
Query: 670 PDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDALDRLIVSSD 714
DADKEEE++AVLKIAMACVHSSPE+RP MRH+SD LDRL +S+D
Sbjct: 669 QDADKEEEMVAVLKIAMACVHSSPERRPAMRHVSDILDRLAMSTD 713
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147787085|emb|CAN73490.1| hypothetical protein VITISV_040575 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1184 bits (3063), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 590/705 (83%), Positives = 639/705 (90%), Gaps = 5/705 (0%)
Query: 12 CNFNGFVDSLNGEGYALLSFKQSVHEDPEGSLSNWNSSDENPCSWNGITCKEQRVVSVSI 71
CN + V SLN EG ALLSFK+SV EDPE SL NWNSSDENPCSWNGITCKE+RVVSVSI
Sbjct: 12 CNSHAKVGSLNEEGVALLSFKRSVGEDPERSLDNWNSSDENPCSWNGITCKEERVVSVSI 71
Query: 72 PKKKLLGFLPSALGSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSGSVPNE 131
PKKKLLGFLPSALGSLT LRHVNLRNNKFFGSLP+EL +AQGLQSLVLYGN+ SGSVP+E
Sbjct: 72 PKKKLLGFLPSALGSLTQLRHVNLRNNKFFGSLPVELFKAQGLQSLVLYGNNLSGSVPSE 131
Query: 132 IGKLKYLQILDLSQNFFNGSLPVSIVQCKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLN 191
IG LKYLQ LDLSQNFFNGSLP S++QCKRLK L LSQNNFTG LP+GFG GL+SLEKL+
Sbjct: 132 IGSLKYLQTLDLSQNFFNGSLPTSLLQCKRLKTLXLSQNNFTGSLPDGFGKGLISLEKLD 191
Query: 192 LSFNKFNGSIPSNTGNLSSLQGTVDFSHNLFSGSIPASLGNLPEKVYIDLTYNNLSGPIP 251
LSFNKF+G IPS+ GNLS+LQGTVD SHN+FSGSIPASLG+LPEKVYIDLTYNNLSGPIP
Sbjct: 192 LSFNKFSGPIPSDIGNLSNLQGTVDLSHNIFSGSIPASLGDLPEKVYIDLTYNNLSGPIP 251
Query: 252 QNGALMNRGPTAFIGNPRLCGPPLKNPCSSDVPGASSPASYPFLPNNYPPENGDDGGGKR 311
QNGALMNRGPTAFIGNPRLCGPP KNPCS + ASSP+S PFLPNNYPP N D GK
Sbjct: 252 QNGALMNRGPTAFIGNPRLCGPPSKNPCSPET--ASSPSSIPFLPNNYPPPNSDGDSGK- 308
Query: 312 EKGRGLSKSAIVAIIVSDVIGICLVGLLFSYCYSRVCGFGEGKDENCYA--KGGKGRKEC 369
KGRGLSKSA++ I+V DV+GICL+GLLFSYCYSR+C G+GKDEN Y KGGK RKEC
Sbjct: 309 GKGRGLSKSAVIGIVVGDVVGICLIGLLFSYCYSRMCSCGKGKDENGYGFEKGGKARKEC 368
Query: 370 LCFRKDESETLSENVEQYDLVPLDTQVAFDLDELLKASAFVLGKSGIGIVYKVVLEDGHT 429
LCFRKDESETLSENVEQYDLVPLDTQVAFDLDELLKASAFVLGKSGIGIVYKVVLEDG T
Sbjct: 369 LCFRKDESETLSENVEQYDLVPLDTQVAFDLDELLKASAFVLGKSGIGIVYKVVLEDGST 428
Query: 430 LAVRRLGEGGSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGSLATA 489
LAVRRLGEGGSQRFKEFQTEVEAIGK+RH NIVTLRAYYWSVDEKLLIYDYIPNG+LATA
Sbjct: 429 LAVRRLGEGGSQRFKEFQTEVEAIGKLRHPNIVTLRAYYWSVDEKLLIYDYIPNGNLATA 488
Query: 490 LHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHV 549
+HGKPGMVSF P+PWSVR+KI++G AKGLVYLHEFSPKKYVHGDLKPSNILLG NMEPH+
Sbjct: 489 IHGKPGMVSFRPLPWSVRLKIMEGTAKGLVYLHEFSPKKYVHGDLKPSNILLGQNMEPHI 548
Query: 550 SDFGLARLANIAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLK 609
SDFGL RLANIAGGSPTLQS+RM +EKP +RQQ + EV +S+SNLGSYYQAPE+LK
Sbjct: 549 SDFGLGRLANIAGGSPTLQSSRMTSEKPPQRQQSNPPSEVGAVSSTSNLGSYYQAPEALK 608
Query: 610 VVKPSQKWDIYSYGVILLEMITGRTAVVQVGSSEMDLVNWMQLCIEEKKPLADVLDPYLA 669
VVKPSQKWD+YSYGVILLEMITGR VVQVGSSEMDLV W+QLCIEEKKPLADVLDPYLA
Sbjct: 609 VVKPSQKWDVYSYGVILLEMITGRLPVVQVGSSEMDLVRWIQLCIEEKKPLADVLDPYLA 668
Query: 670 PDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDALDRLIVSSD 714
DADKEEE++AVLKIAMACVHSSPE+RP MRH+SD LDRL +S+D
Sbjct: 669 QDADKEEEMVAVLKIAMACVHSSPERRPAMRHVSDILDRLAMSTD 713
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224099409|ref|XP_002311473.1| predicted protein [Populus trichocarpa] gi|222851293|gb|EEE88840.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 1176 bits (3041), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 574/704 (81%), Positives = 629/704 (89%), Gaps = 3/704 (0%)
Query: 13 NFNGFVDSLNGEGYALLSFKQSVHEDPEGSLSNWNSSDENPCSWNGITCKEQRVVSVSIP 72
N V SLN EGYALLSFKQS++EDPEGSLSNWNSSD+NPCSWNG+TCK+ +V+S+SIP
Sbjct: 13 NSYSLVTSLNSEGYALLSFKQSINEDPEGSLSNWNSSDDNPCSWNGVTCKDLKVMSLSIP 72
Query: 73 KKKLLGFLPSALGSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSGSVPNEI 132
KKKL GFLPSALGSL+DLRH+NLRNN+FFG LP EL +AQGLQSLVLYGNSFSGS+PN+I
Sbjct: 73 KKKLYGFLPSALGSLSDLRHINLRNNRFFGPLPAELFQAQGLQSLVLYGNSFSGSLPNQI 132
Query: 133 GKLKYLQILDLSQNFFNGSLPVSIVQCKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLNL 192
GKLKYLQ LDLSQNFFNGS+P SIVQC+R + LDLSQNNFTG LP GFG+GLVSLEKL+L
Sbjct: 133 GKLKYLQTLDLSQNFFNGSIPTSIVQCRRHRVLDLSQNNFTGSLPVGFGTGLVSLEKLDL 192
Query: 193 SFNKFNGSIPSNTGNLSSLQGTVDFSHNLFSGSIPASLGNLPEKVYIDLTYNNLSGPIPQ 252
SFNKFNGSIPS+ GNLSSLQGT D SHNLF+GSIPASLGNLPEKVYIDLTYNNLSGPIPQ
Sbjct: 193 SFNKFNGSIPSDMGNLSSLQGTADLSHNLFTGSIPASLGNLPEKVYIDLTYNNLSGPIPQ 252
Query: 253 NGALMNRGPTAFIGNPRLCGPPLKNPCSSDVPGASSPASYPFLPNNYPPENGDDGGGKRE 312
NGALMNRGPTAFIGNP LCGPPLKNPC SD GAS+P++ PFLPNN PP++ D+ G K E
Sbjct: 253 NGALMNRGPTAFIGNPGLCGPPLKNPCPSDTAGASAPSAIPFLPNNSPPQDSDNSGRKSE 312
Query: 313 KGRGLSKSAIVAIIVSDVIGICLVGLLFSYCYSRVCGFGEGKDE--NCYAKGGKGRKECL 370
KGRGLSKSA+VAIIVSDVIGICLVGLLFSYCYSR C + KDE N + KGGK RK CL
Sbjct: 313 KGRGLSKSAVVAIIVSDVIGICLVGLLFSYCYSRACPRRKDKDENDNGFEKGGKRRKGCL 372
Query: 371 CFRKDESETLSENVEQYDLVPLDTQVAFDLDELLKASAFVLGKSGIGIVYKVVLEDGHTL 430
FRKDESETLSENVEQ DLVPLD QVAFDLDELLKASAFVLGK GIGI YKVVLEDG+TL
Sbjct: 373 RFRKDESETLSENVEQCDLVPLDAQVAFDLDELLKASAFVLGKGGIGIAYKVVLEDGYTL 432
Query: 431 AVRRLGEGGSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGSLATAL 490
AVRRLGEGGSQRFKEFQTEVEAIGK+RH N+VTLRAYYWSVDEKLLIYDYIPNGSL TAL
Sbjct: 433 AVRRLGEGGSQRFKEFQTEVEAIGKLRHPNVVTLRAYYWSVDEKLLIYDYIPNGSLDTAL 492
Query: 491 HGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVS 550
HGKPGMVSFTP+ WSVR+KIIKGIA+GLVYLHEFS KKYVHGDLKPSN+LLG NMEPH+S
Sbjct: 493 HGKPGMVSFTPLSWSVRLKIIKGIARGLVYLHEFSTKKYVHGDLKPSNVLLGQNMEPHIS 552
Query: 551 DFGLARLANIAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKV 610
DFGL RLA IAGGSPT +SNR EKPQERQQK T SS+NL SYYQAPE+LKV
Sbjct: 553 DFGLGRLATIAGGSPTRESNRSTLEKPQERQQKGEPSSEVATVSSTNLVSYYQAPEALKV 612
Query: 611 VKPSQKWDIYSYGVILLEMITGRTAVVQVGSSEMDLVNWMQLCIEEKKPLADVLDPYLAP 670
+KPSQKWD+YS GVILLEMITGR+ VV VG+SEMDLV+W+QLCIEE+KPL DVLDPYLAP
Sbjct: 613 LKPSQKWDVYSCGVILLEMITGRSPVVCVGTSEMDLVHWIQLCIEEQKPLVDVLDPYLAP 672
Query: 671 DADK-EEEIIAVLKIAMACVHSSPEKRPTMRHISDALDRLIVSS 713
D DK EEEI+AVLKIAMACVHS+PE+RPTMRH+SD +RL++SS
Sbjct: 673 DVDKEEEEIVAVLKIAMACVHSNPERRPTMRHVSDVFNRLVISS 716
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356573811|ref|XP_003555049.1| PREDICTED: probable inactive leucine-rich repeat receptor-like protein kinase At1g66830-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1090 bits (2818), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 548/711 (77%), Positives = 613/711 (86%), Gaps = 6/711 (0%)
Query: 5 VVLFLVLCNFN-GFVDSLNGEGYALLSFKQSVHEDPEGSLSNWNSSDENPCSWNGITCKE 63
VVL + CNF+ V SL EG LL+ K+S+ DPEGSLSNWNSSD+ PCSWNGITCK+
Sbjct: 5 VVLLFLACNFHVAPVSSLTVEGSVLLALKKSIITDPEGSLSNWNSSDDTPCSWNGITCKD 64
Query: 64 QRVVSVSIPKKKLLGFLPSALGSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNS 123
Q VVS+SIPK+KL G LPS LGSL+ LRH+NLRNN FG LP+ L EAQGLQSLVLYGNS
Sbjct: 65 QSVVSISIPKRKLHGVLPSELGSLSHLRHLNLRNNNLFGDLPVGLFEAQGLQSLVLYGNS 124
Query: 124 FSGSVPNEIGKLKYLQILDLSQNFFNGSLPVSIVQCKRLKALDLSQNNFTGPLPNGFGSG 183
SGSVPNEIGKL+YLQ LDLSQNF+NGSLP +IVQCKRL+ L LS NNFTGPLP+GFG G
Sbjct: 125 LSGSVPNEIGKLRYLQALDLSQNFYNGSLPAAIVQCKRLRTLVLSHNNFTGPLPDGFGGG 184
Query: 184 LVSLEKLNLSFNKFNGSIPSNTGNLSSLQGTVDFSHNLFSGSIPASLGNLPEKVYIDLTY 243
L SLEKL+LSFN+FNG IPS+ G LSSLQGTVD SHN FSGSIPASLGNLPEKVYIDLTY
Sbjct: 185 LSSLEKLDLSFNEFNGLIPSDMGKLSSLQGTVDLSHNHFSGSIPASLGNLPEKVYIDLTY 244
Query: 244 NNLSGPIPQNGALMNRGPTAFIGNPRLCGPPLKNPCSSDVPGASSPASYPFLPNNYPPEN 303
NNLSGPIPQ GALMNRGPTAFIGN LCGPPLKN C+ D GASSP+S+P LP+NYPP++
Sbjct: 245 NNLSGPIPQTGALMNRGPTAFIGNSGLCGPPLKNLCAPDTHGASSPSSFPVLPDNYPPQD 304
Query: 304 GDDGGGKREKGRGLSKSAIVAIIVSDVIGICLVGLLFSYCYSRVCGFGEGKDENCYAKGG 363
DDG K K + LSK A+V I+V D++GICL+GLLFSYCYSRV GF + ++E + KG
Sbjct: 305 SDDGFVKSGKSKRLSKGAVVGIVVGDIVGICLLGLLFSYCYSRVWGFTQDQEEKGFDKGR 364
Query: 364 KGRKECLCFRKDESETLSENVEQYDLVPLDTQVAFDLDELLKASAFVLGKSGIGIVYKVV 423
+ RKECLCFRKDESETLS++ EQYDLVPLD QVAFDLDELLKASAFVLGKS IGIVYKVV
Sbjct: 365 RLRKECLCFRKDESETLSDHDEQYDLVPLDAQVAFDLDELLKASAFVLGKSEIGIVYKVV 424
Query: 424 LEDGHTLAVRRLGEGGSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPN 483
LE+G LAVRRLGEGGSQRFKEFQTEVEAIGK+RH NIVTLRAYYWSVDEKLLIYDY+PN
Sbjct: 425 LEEGLNLAVRRLGEGGSQRFKEFQTEVEAIGKLRHPNIVTLRAYYWSVDEKLLIYDYVPN 484
Query: 484 GSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGH 543
GSLATA+HGK G+ +FTP+ WSVRVKI+KG+AKGLVYLHEFSPKKYVHGDLKP NILLGH
Sbjct: 485 GSLATAIHGKAGLATFTPLSWSVRVKIMKGVAKGLVYLHEFSPKKYVHGDLKPGNILLGH 544
Query: 544 NMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQ 603
+ EP +SDFGL RLANIAGGSPTLQSNR+ AEK QER Q+S+S EVTT S LG+ YQ
Sbjct: 545 SQEPCISDFGLGRLANIAGGSPTLQSNRVAAEKSQER-QRSLSTEVTT----SILGNGYQ 599
Query: 604 APESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGSSEMDLVNWMQLCIEEKKPLADV 663
APE+LKVVKPSQKWD+YSYGVILLE+ITGR +VQVG+SEMDLV W+Q CI+EKKPL+DV
Sbjct: 600 APETLKVVKPSQKWDVYSYGVILLELITGRLPIVQVGNSEMDLVQWIQCCIDEKKPLSDV 659
Query: 664 LDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDALDRLIVSSD 714
LD YLA DADKEEEIIAVLKIA+ACVHSSPEKRP MRH+ D LDRL + SD
Sbjct: 660 LDLYLAEDADKEEEIIAVLKIAIACVHSSPEKRPIMRHVLDVLDRLSIPSD 710
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356536282|ref|XP_003536668.1| PREDICTED: probable inactive leucine-rich repeat receptor-like protein kinase At1g66830-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1075 bits (2780), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 535/698 (76%), Positives = 607/698 (86%), Gaps = 7/698 (1%)
Query: 18 VDSLNGEGYALLSFKQSVHEDPEGSLSNWNSSDENPCSWNGITCKEQRVVSVSIPKKKLL 77
V SLN EG LL+ KQ++ DP+GS+SNWNS DENPCSWNGITCK+Q VVS+SIPK+KL
Sbjct: 21 VYSLNAEGSVLLTLKQTL-TDPQGSMSNWNSFDENPCSWNGITCKDQTVVSISIPKRKLY 79
Query: 78 GFLPSALGSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSGSVPNEIGKLKY 137
G LPS+LGSL+ LRH+N RNNK FG+LP L +AQGLQS+VLYGNS SGSVP EI L+Y
Sbjct: 80 GSLPSSLGSLSQLRHINFRNNKLFGNLPPRLFQAQGLQSMVLYGNSLSGSVPTEIQNLRY 139
Query: 138 LQILDLSQNFFNGSLPVSIVQCKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLNLSFNKF 197
LQ LDLSQNFFNGSLP IVQCKRLK L LSQNNFTGPLP+GFG+GL SLE+L+LS+N F
Sbjct: 140 LQALDLSQNFFNGSLPAGIVQCKRLKTLILSQNNFTGPLPDGFGTGLSSLERLDLSYNHF 199
Query: 198 NGSIPSNTGNLSSLQGTVDFSHNLFSGSIPASLGNLPEKVYIDLTYNNLSGPIPQNGALM 257
NGSIPS+ GNLSSLQGTVD S+N FSGSIPASLGNLPEKVYIDLTYNNL+GPIPQNGALM
Sbjct: 200 NGSIPSDLGNLSSLQGTVDLSNNYFSGSIPASLGNLPEKVYIDLTYNNLNGPIPQNGALM 259
Query: 258 NRGPTAFIGNPRLCGPPLKNPCSSDVPGASSPASYPFLPNNYPPENGDDGGGKREKGRGL 317
NRGPTAFIGNP LCGPPLKN C+SD A+SP+S+PF+P+NY P+ +G EK +GL
Sbjct: 260 NRGPTAFIGNPGLCGPPLKNSCASDTSSANSPSSFPFIPDNYSPQGTGNGSMGSEKNKGL 319
Query: 318 SKSAIVAIIVSDVIGICLVGLLFSYCYSRVCGFGEGKDENCYAKGGKGRKECLCFRKDES 377
SK A+V I+V D+IGICL+GLLFS+CYSRVCGF + DEN +KG KGRKEC CFRKD+S
Sbjct: 320 SKGAVVGIVVGDIIGICLLGLLFSFCYSRVCGFNQDLDENDVSKGKKGRKECFCFRKDDS 379
Query: 378 ETLSE-NVEQYDLVPLDTQVAFDLDELLKASAFVLGKSGIGIVYKVVLEDGHTLAVRRLG 436
E LS+ NVEQYDLVPLD+ V FDLDELLKASAFVLGKSGIGI+YKVVLEDG LAVRRLG
Sbjct: 380 EVLSDNNVEQYDLVPLDSHVNFDLDELLKASAFVLGKSGIGIMYKVVLEDGLALAVRRLG 439
Query: 437 EGGSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGSLATALHGKPGM 496
EGGSQRFKEFQTEVEAIGK+RH NI TLRAYYWSVDEKLLIYDY+PNGSLATA+HGK G+
Sbjct: 440 EGGSQRFKEFQTEVEAIGKLRHPNIATLRAYYWSVDEKLLIYDYVPNGSLATAIHGKAGL 499
Query: 497 VSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLAR 556
+F P+ WS R+KI+KG AKGL+YLHEFSPKKYVHGDLKPSNILLG NMEPH+SDFG+ R
Sbjct: 500 DTFVPLSWSYRLKIMKGTAKGLLYLHEFSPKKYVHGDLKPSNILLGQNMEPHISDFGVGR 559
Query: 557 LANIAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQK 616
LANIAGGSPTLQSNR+ AEK Q R QKS+S EVT S+ LG+ Y APE++KVVKPSQK
Sbjct: 560 LANIAGGSPTLQSNRVAAEKLQGR-QKSLSNEVT----SNVLGNGYMAPEAMKVVKPSQK 614
Query: 617 WDIYSYGVILLEMITGRTAVVQVGSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEE 676
WD+YSYGVILLE+ITGR+++V VG+SEMDLV W+QLCIEEKKPL +VLDPYL DAD+EE
Sbjct: 615 WDVYSYGVILLEIITGRSSIVLVGNSEMDLVQWIQLCIEEKKPLLEVLDPYLGEDADREE 674
Query: 677 EIIAVLKIAMACVHSSPEKRPTMRHISDALDRLIVSSD 714
EII VLKIAMACVHSSPEKRPTMRH+ DALD+L +SSD
Sbjct: 675 EIIGVLKIAMACVHSSPEKRPTMRHVLDALDKLTISSD 712
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356574230|ref|XP_003555253.1| PREDICTED: probable inactive leucine-rich repeat receptor-like protein kinase At1g66830-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1073 bits (2774), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 548/714 (76%), Positives = 621/714 (86%), Gaps = 9/714 (1%)
Query: 3 FWVVLFLVLCN-FNGFVDSLNGEGYALLSFKQSVHEDPEGSLSNWNSSDENPCSWNGITC 61
F ++ FL+ CN V SLN EG LL+ KQS+ DP+GS+SNWNSSDENPCSWNGITC
Sbjct: 4 FALLFFLLSCNSLAPVVHSLNAEGSVLLTLKQSL-TDPQGSMSNWNSSDENPCSWNGITC 62
Query: 62 KEQRVVSVSIPKKKLLGFLPSALGSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYG 121
K+Q +VS+SIPK+KL G L S+LGSL+ LRHVN RNNK FG+LP +L +AQGLQSLVLYG
Sbjct: 63 KDQTIVSISIPKRKLYGSLTSSLGSLSQLRHVNFRNNKLFGNLPPQLFQAQGLQSLVLYG 122
Query: 122 NSFSGSVPNEIGKLKYLQILDLSQNFFNGSLPVSIVQCKRLKALDLSQNNFTGPLPNGFG 181
NS SGSVP+EI L+YLQ LDLSQNFFNGSLP IVQCKRLK L LS+NNFTGPLP+GFG
Sbjct: 123 NSLSGSVPSEIQNLRYLQALDLSQNFFNGSLPAGIVQCKRLKTLVLSKNNFTGPLPDGFG 182
Query: 182 SGLVSLEKLNLSFNKFNGSIPSNTGNLSSLQGTVDFSHNLFSGSIPASLGNLPEKVYIDL 241
+GL SLE+L+LSFNKFNGSIPS+ GNLSSLQGTVD SHN FSGSIPASLGNLPEKVYIDL
Sbjct: 183 TGLSSLERLDLSFNKFNGSIPSDLGNLSSLQGTVDLSHNHFSGSIPASLGNLPEKVYIDL 242
Query: 242 TYNNLSGPIPQNGALMNRGPTAFIGNPRLCGPPLKNPCSSDVPGASSPASYPFLPNNYPP 301
TYN+L+GPIPQNGALMNRGPTAFIGNP LCGPPLKN C SD+P ASSP+S+PF+P+NY P
Sbjct: 243 TYNSLNGPIPQNGALMNRGPTAFIGNPGLCGPPLKNSCGSDIPSASSPSSFPFIPDNYSP 302
Query: 302 ENGDDGGGKREKGRGLSKSAIVAIIVSDVIGICLVGLLFSYCYSRVCGFGEGKDENCYAK 361
+G+ G EK +GLSK A+V I+V D+IGICL+GLLFS+CYSRVCGF + DE+ +K
Sbjct: 303 RDGNGSRGS-EKNKGLSKGAVVGIVVGDIIGICLLGLLFSFCYSRVCGFNQDLDESDVSK 361
Query: 362 GGKGRKECLCFRKDESETLSE-NVEQYDLVPLDTQVAFDLDELLKASAFVLGKSGIGIVY 420
G KGRKEC CFRKD+SE LS+ NVEQYDLVPLD+ V FDLDELLKASAFVLGKSGIGI+Y
Sbjct: 362 GRKGRKECFCFRKDDSEVLSDNNVEQYDLVPLDSHVNFDLDELLKASAFVLGKSGIGIMY 421
Query: 421 KVVLEDGHTLAVRRLGEGGSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDY 480
KVVLEDG LAVRRLGEGGSQRFKEFQTEVEAIGK+RH NI TLRAYYWSVDEKLLIYDY
Sbjct: 422 KVVLEDGLALAVRRLGEGGSQRFKEFQTEVEAIGKLRHPNIATLRAYYWSVDEKLLIYDY 481
Query: 481 IPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNIL 540
IPNGSLATA+HGK G+ +F P+ WS R+KI+KG AKGL+YLHEFSPKKYVHGDLKPSNIL
Sbjct: 482 IPNGSLATAIHGKAGLDTFAPLSWSYRLKIMKGTAKGLLYLHEFSPKKYVHGDLKPSNIL 541
Query: 541 LGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGS 600
LGHNMEPH+SDFG+ RLANIAGGSPTLQSNR+ AE+ Q R QKS+S EVTT + LG+
Sbjct: 542 LGHNMEPHISDFGVGRLANIAGGSPTLQSNRVAAEQLQGR-QKSISTEVTT----NVLGN 596
Query: 601 YYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGSSEMDLVNWMQLCIEEKKPL 660
Y APE+LKVVKPSQKWD+YSYGVILLEMITGR+++V VG+SE+DLV W+QLCIEEKKP+
Sbjct: 597 GYMAPEALKVVKPSQKWDVYSYGVILLEMITGRSSIVLVGNSEIDLVQWIQLCIEEKKPV 656
Query: 661 ADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDALDRLIVSSD 714
+VLDPYL DADKEEEII VLKIAMACVHSSPEKRPTMRH+ DALDRL +SSD
Sbjct: 657 LEVLDPYLGEDADKEEEIIGVLKIAMACVHSSPEKRPTMRHVLDALDRLSISSD 710
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449434592|ref|XP_004135080.1| PREDICTED: probable inactive leucine-rich repeat receptor-like protein kinase At1g66830-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 1060 bits (2741), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 524/697 (75%), Positives = 606/697 (86%), Gaps = 7/697 (1%)
Query: 20 SLNGEGYALLSFKQSVHEDPEGSLSNWNSSDENPCSWNGITCKEQRVVSVSIPKKKLLGF 79
SLN EG ALLSFKQS+ EDPEG LSNWNSSDE PCSWNG+TCK+ RVVS+SIP+KKL G
Sbjct: 23 SLNNEGNALLSFKQSITEDPEGCLSNWNSSDETPCSWNGVTCKDLRVVSLSIPRKKLNGV 82
Query: 80 LPSALGSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSGSVPNEIGKLKYLQ 139
L S+LG L++LRHVNLR+NK G+LP+EL +A G+QSLVLYGNSF+GSVPNEIGKLK LQ
Sbjct: 83 LSSSLGFLSELRHVNLRSNKLHGTLPVELFQANGIQSLVLYGNSFTGSVPNEIGKLKNLQ 142
Query: 140 ILDLSQNFFNGSLPVSIVQCKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLNLSFNKFNG 199
I DLSQNF NGSLPVS++QC RL+ LDLSQNNFT LP+GFGS L LE L+LS+NKFNG
Sbjct: 143 IFDLSQNFLNGSLPVSLMQCTRLRILDLSQNNFTNSLPSGFGSSLNFLETLDLSYNKFNG 202
Query: 200 SIPSNTGNLSSLQGTVDFSHNLFSGSIPASLGNLPEKVYIDLTYNNLSGPIPQNGALMNR 259
SIP + GNLSSLQGTVDFSHNLFSGSIP SLGNLPEKVYIDLTYNNLSG IPQNGALMNR
Sbjct: 203 SIPMDIGNLSSLQGTVDFSHNLFSGSIPPSLGNLPEKVYIDLTYNNLSGSIPQNGALMNR 262
Query: 260 GPTAFIGNPRLCGPPLKNPCSSDVPGASSPASYPFLPNNYPPENGDDGGGKREKGRGLSK 319
GPTAFIGNP LCGPPLKNPCSS+ PGASSP+S+PF P+NYPP + + G K +KG GLS+
Sbjct: 263 GPTAFIGNPGLCGPPLKNPCSSETPGASSPSSFPFFPDNYPPGSSEGNGHKFDKG-GLSR 321
Query: 320 SAIVAIIVSDVIGICLVGLLFSYCYSRVCGFGEGK--DENCYA--KGGKGRKECLCFRKD 375
S +VAII+ D++GICL+GLLFSYCYSR C GK D++ Y KG KGRK+CLCF+K
Sbjct: 322 STLVAIIIGDIVGICLIGLLFSYCYSRFCTHRNGKKADQSSYGFEKGEKGRKDCLCFQKS 381
Query: 376 ESETLSENVEQYDLVPLDTQVAFDLDELLKASAFVLGKSGIGIVYKVVLEDGHTLAVRRL 435
ESE +SE++EQ+DLVPLD+QV FDLDELLKASAFVLGKSGIGIVYKVVLEDG TLAVRRL
Sbjct: 382 ESENVSEHIEQFDLVPLDSQVTFDLDELLKASAFVLGKSGIGIVYKVVLEDGLTLAVRRL 441
Query: 436 GEGGSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGSLATALHGKPG 495
GEGGSQR KEFQTEVEAIG++RH N+V+LRAYYWSVDEKLLIYDYIPNG+LA+A+HGKPG
Sbjct: 442 GEGGSQRLKEFQTEVEAIGRLRHPNVVSLRAYYWSVDEKLLIYDYIPNGNLASAVHGKPG 501
Query: 496 MVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLA 555
SFTP+PWSVR I+ GIAKGLVYLHE+SPKKYVHG+LK +NILLGH+M P +S+FGLA
Sbjct: 502 TTSFTPLPWSVRFGIMIGIAKGLVYLHEYSPKKYVHGNLKTNNILLGHDMTPKISNFGLA 561
Query: 556 RLANIAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQ 615
RL NIAGGSPT+QS+ + EK QE+Q KS + E +T SS++ +YYQAPE+LKVVKPSQ
Sbjct: 562 RLVNIAGGSPTVQSSHIAEEKSQEKQLKSATSEASTF--SSSMSTYYQAPEALKVVKPSQ 619
Query: 616 KWDIYSYGVILLEMITGRTAVVQVGSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKE 675
KWD+YSYGVILLEMITGR +VQVG+SEMDLV W+QLCIEEKKPL+DV+DP LAPD D +
Sbjct: 620 KWDVYSYGVILLEMITGRLPIVQVGTSEMDLVQWIQLCIEEKKPLSDVIDPSLAPDDDAD 679
Query: 676 EEIIAVLKIAMACVHSSPEKRPTMRHISDALDRLIVS 712
EEIIAVLKIA+ACV ++PE+RP MRH+ DAL +L V+
Sbjct: 680 EEIIAVLKIALACVQNNPERRPAMRHVCDALGKLAVT 716
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449512843|ref|XP_004164156.1| PREDICTED: probable inactive leucine-rich repeat receptor-like protein kinase At1g66830-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 1059 bits (2739), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 523/697 (75%), Positives = 605/697 (86%), Gaps = 7/697 (1%)
Query: 20 SLNGEGYALLSFKQSVHEDPEGSLSNWNSSDENPCSWNGITCKEQRVVSVSIPKKKLLGF 79
SLN EG ALLSFKQS+ EDPEG LSNWNSSDE PCSWNG+TCK+ RVVS+SIP+KKL G
Sbjct: 23 SLNNEGNALLSFKQSITEDPEGCLSNWNSSDETPCSWNGVTCKDLRVVSLSIPRKKLNGV 82
Query: 80 LPSALGSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSGSVPNEIGKLKYLQ 139
L S+LG L++LRHVNLR+NK G+LP+EL +A G+QSLVLYGNSF+GSVPNEIGKLK LQ
Sbjct: 83 LSSSLGFLSELRHVNLRSNKLHGTLPVELFQANGIQSLVLYGNSFTGSVPNEIGKLKNLQ 142
Query: 140 ILDLSQNFFNGSLPVSIVQCKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLNLSFNKFNG 199
I DLSQNF NGSLPVS++QC RL+ LDLSQNNFT LP+GFGS L LE L+LS+NKFNG
Sbjct: 143 IFDLSQNFLNGSLPVSLMQCTRLRILDLSQNNFTNSLPSGFGSSLNFLETLDLSYNKFNG 202
Query: 200 SIPSNTGNLSSLQGTVDFSHNLFSGSIPASLGNLPEKVYIDLTYNNLSGPIPQNGALMNR 259
SIP + GNLSSLQGTVDFSHNLFSGSIP SLGNLPEKVYIDLTYNNLSG IPQNGALMNR
Sbjct: 203 SIPMDIGNLSSLQGTVDFSHNLFSGSIPPSLGNLPEKVYIDLTYNNLSGSIPQNGALMNR 262
Query: 260 GPTAFIGNPRLCGPPLKNPCSSDVPGASSPASYPFLPNNYPPENGDDGGGKREKGRGLSK 319
GPTAFIGNP LCGPPLKNPCSS+ PGASSP+S+PF P+NYPP + + G K +KG GLS+
Sbjct: 263 GPTAFIGNPGLCGPPLKNPCSSETPGASSPSSFPFFPDNYPPGSSEGNGHKFDKG-GLSR 321
Query: 320 SAIVAIIVSDVIGICLVGLLFSYCYSRVCGFGEGK--DENCYA--KGGKGRKECLCFRKD 375
S +VAII+ D++GICL+GLLFSYCYSR C GK D++ Y KG KGRK+CLCF+K
Sbjct: 322 STLVAIIIGDIVGICLIGLLFSYCYSRFCTHRNGKKADQSSYGFEKGEKGRKDCLCFQKS 381
Query: 376 ESETLSENVEQYDLVPLDTQVAFDLDELLKASAFVLGKSGIGIVYKVVLEDGHTLAVRRL 435
ESE +SE++EQ+DLVPLD+QV FDLDELLKASAFVLGKSGIGIVYKVVLEDG TLAVRRL
Sbjct: 382 ESENVSEHIEQFDLVPLDSQVTFDLDELLKASAFVLGKSGIGIVYKVVLEDGLTLAVRRL 441
Query: 436 GEGGSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGSLATALHGKPG 495
GEGGSQR KEFQTEVEAIG++RH N+V+LRAYYWSVDEKLLIYDYIPNG+LA+A+HGKPG
Sbjct: 442 GEGGSQRLKEFQTEVEAIGRLRHPNVVSLRAYYWSVDEKLLIYDYIPNGNLASAVHGKPG 501
Query: 496 MVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLA 555
SFTP+PWSVR I+ GIAKGLVYLHE+SPKKYVHG+ K +NILLGH+M P +S+FGLA
Sbjct: 502 TTSFTPLPWSVRFGIMIGIAKGLVYLHEYSPKKYVHGNFKTNNILLGHDMTPKISNFGLA 561
Query: 556 RLANIAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQ 615
RL NIAGGSPT+QS+ + EK QE+Q KS + E +T SS++ +YYQAPE+LKVVKPSQ
Sbjct: 562 RLVNIAGGSPTVQSSHIAEEKSQEKQLKSATSEASTF--SSSMSTYYQAPEALKVVKPSQ 619
Query: 616 KWDIYSYGVILLEMITGRTAVVQVGSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKE 675
KWD+YSYGVILLEMITGR +VQVG+SEMDLV W+QLCIEEKKPL+DV+DP LAPD D +
Sbjct: 620 KWDVYSYGVILLEMITGRLPIVQVGTSEMDLVQWIQLCIEEKKPLSDVIDPSLAPDDDAD 679
Query: 676 EEIIAVLKIAMACVHSSPEKRPTMRHISDALDRLIVS 712
EEIIAVLKIA+ACV ++PE+RP MRH+ DAL +L V+
Sbjct: 680 EEIIAVLKIALACVQNNPERRPAMRHVCDALGKLAVT 716
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 714 | ||||||
| TAIR|locus:2038706 | 716 | AT2G01210 [Arabidopsis thalian | 0.985 | 0.983 | 0.688 | 1.7e-265 | |
| TAIR|locus:2033000 | 702 | AT1G25320 [Arabidopsis thalian | 0.957 | 0.974 | 0.628 | 1.4e-236 | |
| TAIR|locus:2033379 | 685 | AT1G66830 [Arabidopsis thalian | 0.385 | 0.401 | 0.585 | 5.9e-189 | |
| TAIR|locus:2008793 | 719 | AT1G67510 [Arabidopsis thalian | 0.956 | 0.949 | 0.427 | 2e-143 | |
| TAIR|locus:2115120 | 768 | AT4G37250 [Arabidopsis thalian | 0.448 | 0.416 | 0.450 | 2.2e-123 | |
| TAIR|locus:2058598 | 773 | AT2G23300 [Arabidopsis thalian | 0.449 | 0.415 | 0.433 | 5.9e-118 | |
| TAIR|locus:2157182 | 751 | RLK "receptor-like kinase" [Ar | 0.449 | 0.427 | 0.429 | 1.6e-115 | |
| TAIR|locus:2053751 | 646 | AT2G42290 [Arabidopsis thalian | 0.441 | 0.487 | 0.433 | 2.9e-99 | |
| TAIR|locus:2049108 | 744 | AT2G15300 [Arabidopsis thalian | 0.463 | 0.444 | 0.348 | 3.1e-99 | |
| TAIR|locus:2124296 | 757 | AT4G34220 [Arabidopsis thalian | 0.385 | 0.363 | 0.403 | 1.2e-98 |
| TAIR|locus:2038706 AT2G01210 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 2554 (904.1 bits), Expect = 1.7e-265, P = 1.7e-265
Identities = 494/717 (68%), Positives = 578/717 (80%)
Query: 5 VVLFLVLCNFNGFVDSLNGEGYALLSFKQSVHEDPEGSLSNWNSSDENPCSWNGITCKEQ 64
++ +LCN + LN EG+ALL+FKQSVH+DP GSL+NWNSSDEN CSWNG+TCKE
Sbjct: 6 IIFVALLCNVT-VISGLNDEGFALLTFKQSVHDDPTGSLNNWNSSDENACSWNGVTCKEL 64
Query: 65 RVVSVSIPKKKLLGFLPSALGSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSF 124
RVVS+SIP+K L G LPS+LG L+ LRH+NLR+N+F+GSLP++L QGLQSLVLYGNSF
Sbjct: 65 RVVSLSIPRKNLYGSLPSSLGFLSSLRHLNLRSNRFYGSLPIQLFHLQGLQSLVLYGNSF 124
Query: 125 SGSVPNEIGKLKYLQILDLSQNFFNGSLPVSIVQCKRLKALDLSQNNFTGPLPNGFGSGL 184
GS+ EIGKLK LQ LDLSQN FNGSLP+SI+QC RLK LD+S+NN +GPLP+GFGS
Sbjct: 125 DGSLSEEIGKLKLLQTLDLSQNLFNGSLPLSILQCNRLKTLDVSRNNLSGPLPDGFGSAF 184
Query: 185 VSLEKLNLSFNKFNGSIPSNTGNLSSLQGTVDFSHNLFSGSIPASLGNLPEKVYIDLTYN 244
VSLEKL+L+FN+FNGSIPS+ GNLS+LQGT DFSHN F+GSIP +LG+LPEKVYIDLT+N
Sbjct: 185 VSLEKLDLAFNQFNGSIPSDIGNLSNLQGTADFSHNHFTGSIPPALGDLPEKVYIDLTFN 244
Query: 245 NLSGPIPQNGALMNRGPTAFIGNPRLCGPPLKNPCSSDVPGASSPASYPFLPNNYPPXXX 304
NLSGPIPQ GALMNRGPTAFIGN LCGPPLK+ C G + ASYPF+P+N PP
Sbjct: 245 NLSGPIPQTGALMNRGPTAFIGNTGLCGPPLKDLCQGYQLGLN--ASYPFIPSNNPPEDS 302
Query: 305 XXXXXXXXXXXX-LXXXXXXXXXXXXXXXXCLVGLLFSYCYSRVCGFGEGKDENCYAKGG 363
L CLVGLLF+YCYS+ C +
Sbjct: 303 DSTNSETKQKSSGLSKSAVIAIVLCDVFGICLVGLLFTYCYSKFCACNRENQFGVEKESK 362
Query: 364 KGRKECLCFRKDESETLSENVEQYDLVPLDTQVAFDLDELLKASAFVLGKSGIGIVYKVV 423
K ECLCFRKDESET SENVE D+VPLD QVAF+L+ELLKASAFVLGKSGIGIVYKVV
Sbjct: 363 KRASECLCFRKDESETPSENVEHCDIVPLDAQVAFNLEELLKASAFVLGKSGIGIVYKVV 422
Query: 424 LEDGHTLAVRRLGEGGSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPN 483
LE+G TLAVRRLGEGGSQRFKEFQTEVEAIGK++H NI +LRAYYWSVDEKLLIYDY+ N
Sbjct: 423 LENGLTLAVRRLGEGGSQRFKEFQTEVEAIGKLKHPNIASLRAYYWSVDEKLLIYDYVSN 482
Query: 484 GSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGH 543
G+LATALHGKPGM++ P+ WS R++I+KGIA GLVYLHEFSPKKYVHGDLKPSNIL+G
Sbjct: 483 GNLATALHGKPGMMTIAPLTWSERLRIMKGIATGLVYLHEFSPKKYVHGDLKPSNILIGQ 542
Query: 544 NMEPHVSDFGLARLANIAGGS-PTLQSNRM--PAEKPQERQQ---KSVSLEVTTTNSSSN 597
+MEP +SDFGLARLANIAGGS PT+QSNR+ ++PQERQQ KSVS E T +SS
Sbjct: 543 DMEPKISDFGLARLANIAGGSSPTIQSNRIIQTDQQPQERQQHHHKSVSSEFTAHSSS-- 600
Query: 598 LGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGSSEMDLVNWMQLCIEEK 657
GSYYQAPE+LK+VKPSQKWD+YSYG+ILLE+I GR+ V+VG+SEMDLV W+Q+CIEEK
Sbjct: 601 -GSYYQAPETLKMVKPSQKWDVYSYGIILLELIAGRSPAVEVGTSEMDLVRWVQVCIEEK 659
Query: 658 KPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDALDRLIVSSD 714
KPL DVLDP LAP+A+ E+EI+AVLKIA++CV+SSPEKRPTMRH+SD LDRL V+ D
Sbjct: 660 KPLCDVLDPCLAPEAETEDEIVAVLKIAISCVNSSPEKRPTMRHVSDTLDRLPVAGD 716
|
|
| TAIR|locus:2033000 AT1G25320 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 2281 (808.0 bits), Expect = 1.4e-236, P = 1.4e-236
Identities = 446/710 (62%), Positives = 548/710 (77%)
Query: 7 LFLVLCNFNGFVDSLNGEGYALLSFKQSVHEDPEGSLSNWNSSDENPCSWNGITCKEQRV 66
+FL++ NFNG +++LN EG+ALL+ KQS+ +DP+GSLSNWNS ++NPCSWNG+TC + +V
Sbjct: 9 MFLLIWNFNGELNALNDEGFALLTLKQSISKDPDGSLSNWNSENQNPCSWNGVTCDDNKV 68
Query: 67 V-SVSIPKKKLLGFLPSALGSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFS 125
V S+SIPKKKLLG+LPS+LG L++LRH+NLR+N+ G+LP+EL +AQGLQSLVLYGN S
Sbjct: 69 VVSLSIPKKKLLGYLPSSLGLLSNLRHLNLRSNELSGNLPVELFKAQGLQSLVLYGNFLS 128
Query: 126 GSVPNEIGKLKYLQILDLSQNFFNGSLPVSIVQCKRLKALDLSQNNFTGPLPNGFGSGLV 185
GS+PNEIG LK+LQILDLS+N NGS+P S+++C RL++ DLSQNN TG +P+GFG L
Sbjct: 129 GSIPNEIGDLKFLQILDLSRNSLNGSIPESVLKCNRLRSFDLSQNNLTGSVPSGFGQSLA 188
Query: 186 SLEKLNLSFNKFNGSIPSNTGNLSSLQGTVDFSHNLFSGSIPASLGNLPEKVYIDLTYNN 245
SL+KL+LS N G +P + GNL+ LQGT+D SHN FSGSIPASLGNLPEKVY++L YNN
Sbjct: 189 SLQKLDLSSNNLIGLVPDDLGNLTRLQGTLDLSHNSFSGSIPASLGNLPEKVYVNLAYNN 248
Query: 246 LSGPIPQNGALMNRGPTAFIGNPRLCGPPLKNPCSSDVPGASSPASYPFLPNNYPPXXXX 305
LSGPIPQ GAL+NRGPTAF+GNPRLCGPPLK+PC D SS S+PF+P+N
Sbjct: 249 LSGPIPQTGALVNRGPTAFLGNPRLCGPPLKDPCLPDTD--SSSTSHPFVPDN-----NE 301
Query: 306 XXXXXXXXXXXLXXXXXXXXXXXXXXXXCLVGLLFSYCYSRVCGFGEGKDENCYA--KGG 363
L C+VG LFS CY ++C DE Y K G
Sbjct: 302 QGGGGSKKGEGLSKTAIVAIVVCDFIGICIVGFLFSCCYLKICARRNSVDEEGYVLEKEG 361
Query: 364 KGRKECLCFRKDESET-LSENVE-QYDLVPLDTQVAFDLDELLKASAFVLGKSGIGIVYK 421
K +K CFR+D SE+ SEN+E Q DLV LD +A DLDELLKASAFVLGK G GIVYK
Sbjct: 362 KEKKGSFCFRRDGSESPSSENLEPQQDLVLLDKHIALDLDELLKASAFVLGKGGNGIVYK 421
Query: 422 VVLEDGHTLAVRRLGEGGSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYI 481
VVLEDG T+AVRRLGEGGSQR KEFQTEVEAIGK+RH NIV+L+AYYWSV+EKLLIYDYI
Sbjct: 422 VVLEDGLTVAVRRLGEGGSQRCKEFQTEVEAIGKLRHPNIVSLKAYYWSVEEKLLIYDYI 481
Query: 482 PNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILL 541
PNGSL ALHG PGMVSF P+ W VR+KI++GI++GLVYLHEFSPKKYVHG LK SNILL
Sbjct: 482 PNGSLTNALHGNPGMVSFKPLSWGVRLKIMRGISRGLVYLHEFSPKKYVHGSLKLSNILL 541
Query: 542 GHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSY 601
G +MEPH+SDFGL L++IAG TL+S + ++P + S+ SS+NL S+
Sbjct: 542 GQDMEPHISDFGLMHLSSIAG---TLESTTV--DRPSNKTASSIG-------SSANLSSF 589
Query: 602 YQAPESLKV-VKPSQKWDIYSYGVILLEMITGRTAVVQVGSSEMDLVNWMQLCIEEKKPL 660
Y APE+ K VKPSQKWD+YS+GVILLEMITGR +V VG SEM++V W+Q+CI+EKK +
Sbjct: 590 YLAPEATKATVKPSQKWDVYSFGVILLEMITGRLPIVFVGKSEMEIVKWIQMCIDEKKEM 649
Query: 661 ADVLDPYLAP-DADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDALDRL 709
+D+LDPYL P D + EEE+IAVLKIAMACV +SPEKRP M+HI+DAL ++
Sbjct: 650 SDILDPYLVPNDTEIEEEVIAVLKIAMACVSTSPEKRPPMKHIADALTQI 699
|
|
| TAIR|locus:2033379 AT1G66830 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 859 (307.4 bits), Expect = 5.9e-189, Sum P(3) = 5.9e-189
Identities = 164/280 (58%), Positives = 204/280 (72%)
Query: 7 LFLVLC----NFNGFVDSLNGEGYALLSFKQSVHEDPEGSLSNWNSSDENPCSWNGITCK 62
LFL+LC +F SLN +G ALLSFKQS+ + +NWNSSD NPCSW G+TC
Sbjct: 4 LFLILCFILTHFFAIATSLNDQGLALLSFKQSIQNQSDSVFTNWNSSDSNPCSWQGVTCN 63
Query: 63 -EQRVVSVSIPKKKLLGFLPSALGSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYG 121
+ RVVS+ +P K+L G L ++GSL LRH+NLR+N F G LP+EL +GLQSLVL G
Sbjct: 64 YDMRVVSIRLPNKRLSGSLDPSIGSLLSLRHINLRDNDFQGKLPVELFGLKGLQSLVLSG 123
Query: 122 NSFSGSVPNEIGKLKYLQILDLSQNFFNGSLPVSIVQCKRLKALDLSQNNFTGPLPNGFG 181
NSFSG VP EIG LK L LDLS+N FNGS+ +S++ CK+LK L LS+N+F+G LP G G
Sbjct: 124 NSFSGFVPEEIGSLKSLMTLDLSENSFNGSISLSLIPCKKLKTLVLSKNSFSGDLPTGLG 183
Query: 182 SGLVSLEKLNLSFNKFNGSIPSNTGNLSSLQGTVDFSHNLFSGSIPASLGNLPEKVYIDL 241
S LV L LNLSFN+ G+IP + G+L +L+GT+D SHN FSG IP SLGNLPE +Y+DL
Sbjct: 184 SNLVHLRTLNLSFNRLTGTIPEDVGSLENLKGTLDLSHNFFSGMIPTSLGNLPELLYVDL 243
Query: 242 TYNNLSGPIPQNGALMNRGPTAFIGNPRLCGPPLKNPCSS 281
+YNNLSGPIP+ L+N GP AF GNP LCG P+K CS+
Sbjct: 244 SYNNLSGPIPKFNVLLNAGPNAFQGNPFLCGLPIKISCST 283
|
|
| TAIR|locus:2008793 AT1G67510 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1402 (498.6 bits), Expect = 2.0e-143, P = 2.0e-143
Identities = 312/730 (42%), Positives = 433/730 (59%)
Query: 7 LFLVLCNFNGFVDSLNGEGYALLSFKQSVHEDPEGSLSNWNSSDENPCSWNGITCKE--- 63
L L L N + + SL+ +G ALLS K +V + S+WN +D +PC W+GI+C
Sbjct: 10 LLLHLLNTSPSL-SLSPDGIALLSLKSAVDHSSSSAFSDWNDNDTDPCHWSGISCMNISD 68
Query: 64 ---QRVVSVSIPKKKLLGFLPSALGSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLY 120
RVV +S+ K L G++PS LGSL LR +NL NN+ +GS+P +L A L S+ LY
Sbjct: 69 SSTSRVVGISLAGKHLRGYIPSELGSLIYLRRLNLHNNELYGSIPTQLFNATSLHSIFLY 128
Query: 121 GNSFSGSVPNEIGKLKYLQILDLSQNFFNGSLPVSIVQCKRLKALDLSQNNFTGPLPNGF 180
GN+ SG++P I KL LQ LDLS N +G+L + +CK+L+ L LS NNF+G +P
Sbjct: 129 GNNLSGTLPPSICKLPKLQNLDLSMNSLSGTLSPDLNKCKQLQRLILSANNFSGEIPGDI 188
Query: 181 GSGLVSLEKLNLSFNKFNGSIPSNTGNLSSLQGTVDFSHNLFSGSIPASLGNLPEKVYID 240
L +L +L+LS N+F+G IP + G L SL GT++ S N SG IP SLGNLP V +D
Sbjct: 189 WPELTNLAQLDLSANEFSGEIPKDIGELKSLSGTLNLSFNHLSGQIPNSLGNLPVTVSLD 248
Query: 241 LTYNNLSGPIPQNGALMNRGPTAFIGNPRLCGPPLKNPCSSDVPGASSPASYPFLPNNYP 300
L N+ SG IPQ+G+ N+GPTAF+ NP+LCG PL+ C +SP + NN
Sbjct: 249 LRNNDFSGEIPQSGSFSNQGPTAFLNNPKLCGFPLQKTCKDT--DENSPGTRKSPENN-- 304
Query: 301 PXXXXXXXXXXXXXXXLXXXXXXXXXXXXXXXXCLVGLLFSYCYSRVCGFGEGKDENCYA 360
L +GL+ Y Y + G A
Sbjct: 305 ----------ADSRRGLSTGLIVLISVADAASVAFIGLVLVYLYWKKKDSEGGCSCTGNA 354
Query: 361 KGGKGR---KECLCF----RKDESET----LSENVEQYDLVPLDTQVAFDLDELLKASAF 409
K G G K C C ++D+SE E +LV +D +F+LDELL+ASA+
Sbjct: 355 KLGGGSVKGKSCCCITGFPKEDDSEAEGNERGEGKGDGELVAIDKGFSFELDELLRASAY 414
Query: 410 VLGKSGIGIVYKVVLEDGHTLAVRRLGEGGSQRFKEFQTEVEAIGKIRHSNIVTLRAYYW 469
VLGKSG+GIVYKVVL +G +AVRRLGEGG QR+KEF TEV+A+GK++H N+V LRAYYW
Sbjct: 415 VLGKSGLGIVYKVVLGNGVPVAVRRLGEGGEQRYKEFVTEVQAMGKVKHPNVVKLRAYYW 474
Query: 470 SVDEKLLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKY 529
+ DEKLLI D++ NGSLA AL G+ G S + WS R+KI KG A+GL YLHE SP+K
Sbjct: 475 APDEKLLISDFVNNGSLADALRGRNGQPS-PSLTWSTRIKIAKGAARGLAYLHECSPRKL 533
Query: 530 VHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQKSVSLEV 589
VHGD+KPSNILL + P++SDFGL RL I S + SN P+ +L
Sbjct: 534 VHGDVKPSNILLDSSFTPYISDFGLTRLITITAASAS--SNE-PSSSSAAGGFLGGALPY 590
Query: 590 TTTNSSSNLGSYYQAPES-LKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGSSEM---- 644
T+ S Y +APE+ L +P+QKWD+YS+GV+L+E++TG++ SS
Sbjct: 591 TSIKPSDRSNGY-KAPEARLPGGRPTQKWDVYSFGVVLMELLTGKSPDSSPLSSSSTSTV 649
Query: 645 -----DLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTM 699
DLV W++ EE+ PL+D++DP L + ++++++V +A+AC PE RP M
Sbjct: 650 VVEVPDLVKWVRKGFEEETPLSDMVDPMLLQEVHAKQQVLSVFHLALACTEGDPEVRPRM 709
Query: 700 RHISDALDRL 709
+++S+ +D++
Sbjct: 710 KNVSENIDKI 719
|
|
| TAIR|locus:2115120 AT4G37250 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 663 (238.4 bits), Expect = 2.2e-123, Sum P(3) = 2.2e-123
Identities = 158/351 (45%), Positives = 215/351 (61%)
Query: 375 DESETLSENVEQYD----LVPLDTQVAFDLDELLKASAFVLGKSGIGIVYKVVLEDGHTL 430
DE E N Q LV +D + +++ LLKASA++LG +G I+YK VLEDG
Sbjct: 415 DEDEESGYNANQRSGDNKLVTVDGEKEMEIETLLKASAYILGATGSSIMYKAVLEDGRVF 474
Query: 431 AVRRLGEGG-SQR-FKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGSLAT 488
AVRRLGE G SQR FK+F+ + AIGK+ H N+V L +YW DEKL+IYD++PNGSL
Sbjct: 475 AVRRLGENGLSQRRFKDFEPHIRAIGKLVHPNLVRLCGFYWGTDEKLVIYDFVPNGSLVN 534
Query: 489 ALHGKPGMVSFTP--VPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNME 546
+ K G S +P +PW R+KI KGIA+GL YLHE KK+VHG+LKPSNILLGH+ME
Sbjct: 535 PRYRKGGGSS-SPYHLPWETRLKIAKGIARGLAYLHE---KKHVHGNLKPSNILLGHDME 590
Query: 547 PHVSDFGLARLAN-----I-AGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLG- 599
P + DFGL RL I AGGS + S++ +E S+ T + S S++G
Sbjct: 591 PKIGDFGLERLLTGETSYIRAGGSSRIFSSKRYTTSSREFS----SIGPTPSPSPSSVGA 646
Query: 600 -SYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGSSEMDLVNWMQLCIEEKK 658
S Y APES + +KPS KWD+Y +GVILLE++TG+ +V V E+ L N L +E+
Sbjct: 647 MSPYCAPESFRSLKPSPKWDVYGFGVILLELLTGK--IVSV--EEIVLGNG--LTVEDGH 700
Query: 659 PLADVLDPYLAPDAD-KEEEIIAVLKIAMACVHSSPEKRPTMRHISDALDR 708
+ D + + D K+E ++ K+ +C P+KRPTM+ L+R
Sbjct: 701 RAVRMADVAIRGELDGKQEFLLDCFKLGYSCASPVPQKRPTMKESLAVLER 751
|
|
| TAIR|locus:2058598 AT2G23300 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 652 (234.6 bits), Expect = 5.9e-118, Sum P(2) = 5.9e-118
Identities = 152/351 (43%), Positives = 221/351 (62%)
Query: 377 SETLSENVEQYDLVPLDT-QVAFDLDELLKASAFVLGKSGIGIVYKVVLEDGHTLAVRRL 435
S + EN ++ LV +D + +++ LLKASA++LG +G I+YK VLEDG LAVRRL
Sbjct: 427 SGEIGEN-KKGTLVTIDGGEKELEVETLLKASAYILGATGSSIMYKTVLEDGTVLAVRRL 485
Query: 436 GEGG-SQ--RFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGSLATALHG 492
GE G SQ RFK+F+ + AIGK+ H N+V LR +YW DEKL+IYD++PNGSL A +
Sbjct: 486 GENGLSQQRRFKDFEAHIRAIGKLVHPNLVRLRGFYWGTDEKLVIYDFVPNGSLVNARYR 545
Query: 493 KPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDF 552
K G S +PW R+KI+KG+A+GL YLH+ KK+VHG+LKPSNILLG +MEP + DF
Sbjct: 546 KGGS-SPCHLPWETRLKIVKGLARGLAYLHD---KKHVHGNLKPSNILLGQDMEPKIGDF 601
Query: 553 GLARLA------NIAGGSPTL-QSNRMPAEKPQERQQKSVSLEVTTTNSSSNLG--SYYQ 603
GL RL N A GS + S R+ A R+ ++ T + S S++G S Y
Sbjct: 602 GLERLLAGDTSYNRASGSSRIFSSKRLTASS---REFGTIG--PTPSPSPSSVGPISPYC 656
Query: 604 APESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGSSEMDLVNWMQLCIEEKKPLADV 663
APESL+ +KP+ KWD++ +GVILLE++TG+ +V + E+ + N L +E+ +
Sbjct: 657 APESLRNLKPNPKWDVFGFGVILLELLTGK--IVSI--DEVGVGNG--LTVEDGNRALIM 710
Query: 664 LDPYLAPDAD-KEEEIIAVLKIAMACVHSSPEKRPTMRHISDALDRLIVSS 713
D + + + KE+ ++ + K+ +C P+KRPTM+ +R +SS
Sbjct: 711 ADVAIRSELEGKEDFLLGLFKLGYSCASQIPQKRPTMKEALVVFERYPISS 761
|
|
| TAIR|locus:2157182 RLK "receptor-like kinase" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 681 (244.8 bits), Expect = 1.6e-115, Sum P(2) = 1.6e-115
Identities = 144/335 (42%), Positives = 213/335 (63%)
Query: 380 LSENVEQYDLVPLDTQVAFDLDELLKASAFVLGKSGIGIVYKVVLEDGHTLAVRRLGEGG 439
L + ++ LV LD++ +++ LLKASA++LG +G I+YK VL+DG +AVRR+ E G
Sbjct: 427 LDDQEKKGTLVNLDSEKELEIETLLKASAYILGATGSSIMYKAVLQDGTAVAVRRIAECG 486
Query: 440 SQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGSLATALHGKPGMVSF 499
RF++F+ +V A+ K+ H N+V +R +YW DEKL+IYD++PNGSLA A + K G S
Sbjct: 487 LDRFRDFEAQVRAVAKLIHPNLVRIRGFYWGSDEKLVIYDFVPNGSLANARYRKVGS-SP 545
Query: 500 TPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLAN 559
+PW R+KI KGIA+GL Y+H+ KKYVHG+LKPSNILLG +MEP V+DFGL +L
Sbjct: 546 CHLPWDARLKIAKGIARGLTYVHD---KKYVHGNLKPSNILLGLDMEPKVADFGLEKL-- 600
Query: 560 IAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDI 619
+ G P +R S+ + + S S++G Y APESL+ +KP+ KWD+
Sbjct: 601 LIGDMSYRTGGSAPIFG-SKRSTTSLEFGPSPSPSPSSVGLPYNAPESLRSIKPNSKWDV 659
Query: 620 YSYGVILLEMITGRTAVVQVGSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDAD-KEEEI 678
YS+GVILLE++TG+ VV E+ VN L I++ + + D + + + KEE +
Sbjct: 660 YSFGVILLELLTGKIVVVD----ELGQVNG--LVIDDGERAIRMADSAIRAELEGKEEAV 713
Query: 679 IAVLKIAMACVHSSPEKRPTMRHISDALDRLIVSS 713
+A LK+ +AC P++RP ++ L+R V S
Sbjct: 714 LACLKMGLACASPIPQRRPNIKEALQVLERFPVHS 748
|
|
| TAIR|locus:2053751 AT2G42290 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 619 (223.0 bits), Expect = 2.9e-99, Sum P(2) = 2.9e-99
Identities = 146/337 (43%), Positives = 208/337 (61%)
Query: 382 ENVEQYDLVPLDTQVAFDLDELLKASAFVLGKSGIGIVYKVVL-EDGHTL-AVRRLGEGG 439
E ++ V D +L++LL+ASA+V+GKS GIVY+VV E T+ AVRRL +G
Sbjct: 322 EEGQEGKFVAFDEGFELELEDLLRASAYVIGKSRSGIVYRVVAAESSSTVVAVRRLSDGN 381
Query: 440 SQ-RFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGSLATALHGKPGMVS 498
RFK+F EVE+IG+I H NIV LRAYY++ DEKLLI D+I NGSL +ALHG P
Sbjct: 382 DTWRFKDFVNEVESIGRINHPNIVRLRAYYYAEDEKLLITDFINNGSLYSALHGGPSNTR 441
Query: 499 FTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLA 558
T + W+ R+ I +G A+GL+Y+HE+S +KYVHG+LK S ILL + + PHVS FGL RL
Sbjct: 442 PT-LSWAERLCIAQGTARGLMYIHEYSSRKYVHGNLKSSKILLDNELHPHVSGFGLTRLV 500
Query: 559 NIAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKV--VKPSQK 616
+ G P + + + + +S+ T S S + Y APE+ K S K
Sbjct: 501 S---GYPKVTDHSLSS------MTQSIDQGFATRLSVSAPAAAYLAPEARASSDCKLSHK 551
Query: 617 WDIYSYGVILLEMITGRTAVVQVGSSEMD----LVNWMQLCIEEKKPLADVLDPYLAPDA 672
D+YS+GVILLE++TGR + GSSE + LVN ++ +E++ LA++LDP L
Sbjct: 552 CDVYSFGVILLELLTGR---LPYGSSENEGEEELVNVLRKWHKEERSLAEILDPKLLKQD 608
Query: 673 DKEEEIIAVLKIAMACVHSSPEKRPTMRHISDALDRL 709
+++IA + +A+ C P+ RP MR +S+ L R+
Sbjct: 609 FANKQVIATIHVALNCTEMDPDMRPRMRSVSEILGRI 645
|
|
| TAIR|locus:2049108 AT2G15300 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 486 (176.1 bits), Expect = 3.1e-99, Sum P(3) = 3.1e-99
Identities = 124/356 (34%), Positives = 176/356 (49%)
Query: 7 LFLVLCNFNGFVDSLNGEGYALLSFKQSVHEDPEGSLSNWNSSDENPCSWNGITCKEQ-- 64
L L+L + + +LN +G ALLSFK S+ DP L NWN DE PCSW G+TC E
Sbjct: 10 LHLLLLHLPTLIQALNTDGVALLSFKYSILNDPLLVLRNWNYDDETPCSWTGVTCTELGI 69
Query: 65 -------RVVSVSIPKKKLLGFLPSALGSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSL 117
RV S+ +P K+LLG + L S+ LR ++L +N F GSLP + A L+ L
Sbjct: 70 PNTPDMFRVTSLVLPNKQLLGSVSPDLFSILHLRILDLSDNFFHGSLPDSVSNASELRIL 129
Query: 118 VLYGNSFSGSVPNEIGKLKYLQILDLSQNFFNGSLPVSIVQCKRLKALDLSQNNFTGPLP 177
L N SG +P I + LQ+L+LS N G +P ++ K L + L++N+F+G +P
Sbjct: 130 SLGNNKVSGELPRSISNVASLQLLNLSANALTGKIPPNLSLPKNLTVISLAKNSFSGDIP 189
Query: 178 NGFGSGLVSLEKLNLSFNKFNGSIPSNTGNLSSLQGTVDFSHNLFSGSI-PASLGNLPEK 236
+GF + ++ L++S N +GS+P + S L ++ S+N SG I P P
Sbjct: 190 SGFEA----VQVLDISSNLLDGSLPPDFRGTSLLY--LNLSNNQISGMISPPFAEKFPAS 243
Query: 237 VYIDLTYNNLSGPIPQNGALMNRGPTAFIGNPRLCGPPLKNPCS-----SDVPGAS---S 288
IDL++NNL+GPIP L+N+ +F GN LCG PLK CS SD P S S
Sbjct: 244 AIIDLSFNNLTGPIPNTPPLLNQKTESFSGNIGLCGQPLKTLCSIPSTLSDPPNISETTS 303
Query: 289 PASYPFLPNNYPPXXXXXXXXXXXXXXXLXXXXXXXXXXXXXXXXCLVGLLFSYCY 344
PA +P P L ++ + Y Y
Sbjct: 304 PA-IAVMPTTPTPTNSSTESTNQTAKSKLKPSTIIGITLADIAGLAIIAMFILYIY 358
|
|
| TAIR|locus:2124296 AT4G34220 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 486 (176.1 bits), Expect = 1.2e-98, Sum P(3) = 1.2e-98
Identities = 121/300 (40%), Positives = 169/300 (56%)
Query: 6 VLF-LVLCNFNGFV----DSLNGEGYALLSFKQSVHEDPEGSLSNWNSSDENPCSWNGIT 60
+LF LVL +F FV +LN +G LL+FK S+ DP L NWN D PC W G+T
Sbjct: 8 LLFSLVLFHFL-FVPTQLQALNTDGVLLLTFKYSILTDPLSVLRNWNYDDATPCLWTGVT 66
Query: 61 CKEQ---------RVVSVSIPKKKLLGFLPSALGSLTDLRHVNLRNNKFFGSLPLELLEA 111
C E RV S+ +P K LLG + L S+ LR ++L +N F GSLP + A
Sbjct: 67 CTELGKPNTPDMFRVTSLVLPNKHLLGSITPDLFSIPYLRILDLSSNFFNGSLPDSVFNA 126
Query: 112 QGLQSLVLYGNSFSGSVPNEIGKLKYLQILDLSQNFFNGSLPVSIVQCKRLKALDLSQNN 171
LQS+ L N+ SG +P + + LQ+L+LS N F G +P++I K L + LS+N
Sbjct: 127 TELQSISLGSNNLSGDLPKSVNSVTNLQLLNLSANAFTGEIPLNISLLKNLTVVSLSKNT 186
Query: 172 FTGPLPNGFGSGLVSLEKLNLSFNKFNGSIPSNTGNLSSLQGTVDFSHNLFSGSI-PASL 230
F+G +P+GF + + L+LS N NGS+P + G SL ++ SHN G I P
Sbjct: 187 FSGDIPSGFEAAQI----LDLSSNLLNGSLPKDLGG-KSLH-YLNLSHNKVLGEISPNFA 240
Query: 231 GNLPEKVYIDLTYNNLSGPIPQNGALMNRGPTAFIGNPRLCGPPLKNPCSSDVPGA-SSP 289
P +DL++NNL+GPIP + +L+N+ +F GN LCG PLK CS +P S+P
Sbjct: 241 EKFPANATVDLSFNNLTGPIPSSLSLLNQKAESFSGNQELCGKPLKILCS--IPSTLSNP 298
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.737 |
| 3rd Layer | 2.7.11 | 0.691 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 714 | |||
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 9e-38 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 9e-36 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 1e-32 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 5e-29 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-27 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-25 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 5e-25 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 6e-25 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 2e-24 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 2e-24 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 5e-24 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 7e-24 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 7e-24 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 1e-23 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-22 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 6e-22 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 9e-21 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 2e-20 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 6e-20 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 9e-20 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-19 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 2e-19 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-18 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 2e-18 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 5e-18 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 9e-18 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 1e-16 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 1e-16 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 2e-16 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 2e-16 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 3e-16 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 5e-16 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 7e-16 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 1e-15 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 2e-15 | |
| pfam08263 | 42 | pfam08263, LRRNT_2, Leucine rich repeat N-terminal | 6e-15 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 1e-14 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 1e-14 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 1e-14 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-14 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 5e-14 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 5e-14 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-13 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 2e-13 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 2e-13 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 2e-13 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 2e-13 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 2e-13 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 3e-13 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 3e-13 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 6e-13 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 9e-13 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 2e-12 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 2e-12 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 2e-12 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 2e-12 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 2e-12 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 3e-12 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 4e-12 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 4e-12 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 5e-12 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 6e-12 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 7e-12 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 8e-12 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 8e-12 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 8e-12 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 9e-12 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 1e-11 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 1e-11 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 1e-11 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 1e-11 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 2e-11 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 3e-11 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 3e-11 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 4e-11 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 5e-11 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 8e-11 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 8e-11 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 9e-11 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 1e-10 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 2e-10 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 2e-10 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 2e-10 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 2e-10 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 3e-10 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 3e-10 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 4e-10 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 5e-10 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 6e-10 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 6e-10 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 6e-10 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 7e-10 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 1e-09 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 1e-09 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 1e-09 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 2e-09 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 2e-09 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 2e-09 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 2e-09 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 3e-09 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 3e-09 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 3e-09 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 3e-09 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 3e-09 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 3e-09 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 4e-09 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 5e-09 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 5e-09 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 5e-09 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 5e-09 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 7e-09 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 7e-09 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 8e-09 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 1e-08 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 1e-08 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 1e-08 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 1e-08 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 1e-08 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 1e-08 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 1e-08 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-08 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 2e-08 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 2e-08 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 2e-08 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 2e-08 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 2e-08 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 2e-08 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 2e-08 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 2e-08 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 3e-08 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 3e-08 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 5e-08 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 6e-08 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 7e-08 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 8e-08 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 9e-08 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 1e-07 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 1e-07 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 1e-07 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 1e-07 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 1e-07 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 1e-07 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 2e-07 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 2e-07 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 2e-07 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 2e-07 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 2e-07 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 2e-07 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 2e-07 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 2e-07 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 2e-07 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 2e-07 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 3e-07 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 4e-07 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 4e-07 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 4e-07 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 4e-07 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 4e-07 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 4e-07 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 4e-07 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 5e-07 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 5e-07 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 5e-07 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 6e-07 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 7e-07 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 7e-07 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 8e-07 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 9e-07 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 1e-06 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 2e-06 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 2e-06 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 2e-06 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 2e-06 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 2e-06 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 2e-06 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 2e-06 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 2e-06 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 2e-06 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 3e-06 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 3e-06 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 3e-06 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 3e-06 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 3e-06 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 3e-06 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 4e-06 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 4e-06 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 5e-06 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 6e-06 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 6e-06 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 7e-06 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 7e-06 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 7e-06 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 7e-06 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 7e-06 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 8e-06 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 8e-06 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 9e-06 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 9e-06 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 1e-05 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 1e-05 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 1e-05 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 1e-05 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 1e-05 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 1e-05 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 1e-05 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-05 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 2e-05 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 2e-05 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 2e-05 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 2e-05 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 2e-05 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 2e-05 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 3e-05 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 3e-05 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 3e-05 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 3e-05 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 3e-05 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 4e-05 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 4e-05 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 4e-05 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 5e-05 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 5e-05 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 5e-05 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 5e-05 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 6e-05 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 6e-05 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 6e-05 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 6e-05 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 7e-05 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 7e-05 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 8e-05 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 8e-05 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 1e-04 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 1e-04 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 1e-04 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 2e-04 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 2e-04 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 2e-04 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 2e-04 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 2e-04 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 3e-04 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 3e-04 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 3e-04 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 3e-04 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 3e-04 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 4e-04 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 4e-04 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 5e-04 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 5e-04 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 5e-04 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 5e-04 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 6e-04 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 6e-04 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 7e-04 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 7e-04 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 7e-04 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 7e-04 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 8e-04 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 8e-04 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 0.001 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 0.001 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 0.001 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 0.001 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 0.002 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 0.002 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 0.002 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 0.003 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 0.004 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 0.004 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 151 bits (382), Expect = 9e-38
Identities = 93/226 (41%), Positives = 128/226 (56%), Gaps = 8/226 (3%)
Query: 28 LLSFKQSVHEDPEGSLSNWNSSDENPCSWNGITCKE-QRVVSVSIPKKKLLGFLPSALGS 86
LLSFK S+ DP LSNWNSS + C W GITC RVVS+ + K + G + SA+
Sbjct: 34 LLSFKSSI-NDPLKYLSNWNSSA-DVCLWQGITCNNSSRVVSIDLSGKNISGKISSAIFR 91
Query: 87 LTDLRHVNLRNNKFFGSLPLELLE-AQGLQSLVLYGNSFSGSVPNEIGKLKYLQILDLSQ 145
L ++ +NL NN+ G +P ++ + L+ L L N+F+GS+P G + L+ LDLS
Sbjct: 92 LPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPR--GSIPNLETLDLSN 149
Query: 146 NFFNGSLPVSIVQCKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLNLSFNKFNGSIPSNT 205
N +G +P I LK LDL N G +PN + L SLE L L+ N+ G IP
Sbjct: 150 NMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTN-LTSLEFLTLASNQLVGQIPREL 208
Query: 206 GNLSSLQGTVDFSHNLFSGSIPASLGNLPEKVYIDLTYNNLSGPIP 251
G + SL+ + +N SG IP +G L ++DL YNNL+GPIP
Sbjct: 209 GQMKSLK-WIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIP 253
|
Length = 968 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 133 bits (338), Expect = 9e-36
Identities = 64/225 (28%), Positives = 95/225 (42%), Gaps = 44/225 (19%)
Query: 411 LGKSGIGIVYKVV-LEDGHTLAVRRLGEGGSQRFKE-FQTEVEAIGKIRHSNIVTLRAYY 468
LG+ G G VY + G +A++ + + S E E+E + K+ H NIV L +
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 469 WSVDEKLLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKK 528
+ L+ +Y GSL L G + ++I+ I +GL YLH
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLKENEG-----KLSEDEILRILLQILEGLEYLHS---NG 112
Query: 529 YVHGDLKPSNILLGHNMEPHV--SDFGLARLANIAGGSPTLQSNRMPAEKPQERQQKSVS 586
+H DLKP NILL + V +DFGL++L
Sbjct: 113 IIHRDLKPENILL-DSDNGKVKLADFGLSKL----------------------------- 142
Query: 587 LEVTTTNSSSNLGS-YYQAPESLK-VVKPSQKWDIYSYGVILLEM 629
L + + +G+ Y APE L S+K DI+S GVIL E+
Sbjct: 143 LTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 126 bits (319), Expect = 1e-32
Identities = 79/297 (26%), Positives = 115/297 (38%), Gaps = 52/297 (17%)
Query: 410 VLGKSGIGIVYKVV-LEDGHTLAVRRLG--EGGSQRFKEFQTEVEAIGKIRHSNIVTLRA 466
LG G VYK G +AV+ L S++ + + E+ + ++ H NIV L
Sbjct: 6 KLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLID 65
Query: 467 YYWSVDEKLLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSP 526
+ D L+ +Y G L L P+ KI I +GL YLH
Sbjct: 66 AFEDKDHLYLVMEYCEGGDLFDYLSRG------GPLSEDEAKKIALQILRGLEYLHS--- 116
Query: 527 KKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQKSVS 586
+H DLKP NILL N ++DFGLA+ + S T +
Sbjct: 117 NGIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLT-------------------T 157
Query: 587 LEVTTTNSSSNLGSYYQAPESLKVVKP-SQKWDIYSYGVILLEMITGRTAVVQVGSSEMD 645
T +Y APE L K D++S GVIL E++TG+ G + +D
Sbjct: 158 FVGT---------PWYMAPEVLLGGNGYGPKVDVWSLGVILYELLTGKP-PFS-GENILD 206
Query: 646 LVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHI 702
QL + + + EE ++K C++ P KRPT I
Sbjct: 207 -----QLQLIRRILGPPLEFDEPKWS-SGSEEAKDLIK---KCLNKDPSKRPTAEEI 254
|
Length = 260 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 5e-29
Identities = 58/228 (25%), Positives = 93/228 (40%), Gaps = 42/228 (18%)
Query: 410 VLGKSGIGIVYKVV-LEDGHTLAVRRLG-EGGSQRFKEFQTEVEAIGKIRHSNIVTLRAY 467
LG+ G VY + G +A++ + + + + E++ + K++H NIV L
Sbjct: 6 KLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYDV 65
Query: 468 YWSVDEKLLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPK 527
+ D+ L+ +Y G L L + + ++ I L YLH K
Sbjct: 66 FEDEDKLYLVMEYCEGGDLFDLLKKRG---RLSE---DEARFYLRQILSALEYLHS---K 116
Query: 528 KYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQKSVSL 587
VH DLKP NILL + ++DFGLAR +
Sbjct: 117 GIVHRDLKPENILLDEDGHVKLADFGLARQLD---------------------------- 148
Query: 588 EVTTTNSSSNLGS-YYQAPESLKVVKPSQKWDIYSYGVILLEMITGRT 634
++ +G+ Y APE L + DI+S GVIL E++TG+
Sbjct: 149 --PGEKLTTFVGTPEYMAPEVLLGKGYGKAVDIWSLGVILYELLTGKP 194
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 118 bits (296), Expect = 3e-27
Identities = 76/223 (34%), Positives = 112/223 (50%), Gaps = 31/223 (13%)
Query: 76 LLGFLPSALGSLTDLRHVNLRNNKFFGSLPLELLEAQ----------------------- 112
L G +P +LG+ LR V L++N F G LP E +
Sbjct: 392 LEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDM 451
Query: 113 -GLQSLVLYGNSFSGSVPNEIGKLKYLQILDLSQNFFNGSLPVSIVQCKRLKALDLSQNN 171
LQ L L N F G +P+ G K L+ LDLS+N F+G++P + L L LS+N
Sbjct: 452 PSLQMLSLARNKFFGGLPDSFGS-KRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENK 510
Query: 172 FTGPLPNGFGS--GLVSLEKLNLSFNKFNGSIPSNTGNLSSLQGTVDFSHNLFSGSIPAS 229
+G +P+ S LVSL +LS N+ +G IP++ + L +D S N SG IP +
Sbjct: 511 LSGEIPDELSSCKKLVSL---DLSHNQLSGQIPASFSEMPVL-SQLDLSQNQLSGEIPKN 566
Query: 230 LGNLPEKVYIDLTYNNLSGPIPQNGALMNRGPTAFIGNPRLCG 272
LGN+ V +++++N+L G +P GA + +A GN LCG
Sbjct: 567 LGNVESLVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLCG 609
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 2e-25
Identities = 69/178 (38%), Positives = 95/178 (53%), Gaps = 2/178 (1%)
Query: 76 LLGFLPSALGSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSGSVPNEIGKL 135
L G +P +G LT L H++L N G +P L + LQ L LY N SG +P I L
Sbjct: 224 LSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSL 283
Query: 136 KYLQILDLSQNFFNGSLPVSIVQCKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLNLSFN 195
+ L LDLS N +G +P ++Q + L+ L L NNFTG +P S L L+ L L N
Sbjct: 284 QKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTS-LPRLQVLQLWSN 342
Query: 196 KFNGSIPSNTGNLSSLQGTVDFSHNLFSGSIPASLGNLPEKVYIDLTYNNLSGPIPQN 253
KF+G IP N G ++L +D S N +G IP L + + L N+L G IP++
Sbjct: 343 KFSGEIPKNLGKHNNLT-VLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKS 399
|
Length = 968 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 5e-25
Identities = 74/307 (24%), Positives = 121/307 (39%), Gaps = 55/307 (17%)
Query: 410 VLGKSGIGIVYKVVLEDG----HTLAVRRLGEGGS-QRFKEFQTEVEAIGKIRHSNIVTL 464
LG+ G VYK L+ +AV+ L E S + K+F E + K+ H N+V L
Sbjct: 2 KLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRL 61
Query: 465 RAYYWSVDEKLLIYDYIPNGSLATALHGKPGMVSF---TPVPWSVRVKIIKGIAKGLVYL 521
+ L+ +Y+ G L L + + + + IAKG+ YL
Sbjct: 62 LGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYL 121
Query: 522 HEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQ 581
KK+VH DL N L+G ++ +SDFGL+R ++P
Sbjct: 122 AS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPI------- 171
Query: 582 QKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMIT-GRTAVVQVG 640
+ APESLK + K D++S+GV+L E+ T G T +
Sbjct: 172 -------------------RWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLS 212
Query: 641 SSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMR 700
+ E+ L + Y P + + + ++ ++C PE RPT
Sbjct: 213 NEEV---------------LEYLRKGYRLPKPEYCPDELY--ELMLSCWQLDPEDRPTFS 255
Query: 701 HISDALD 707
+ + L+
Sbjct: 256 ELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 6e-25
Identities = 68/178 (38%), Positives = 98/178 (55%), Gaps = 2/178 (1%)
Query: 76 LLGFLPSALGSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSGSVPNEIGKL 135
L+G +P++L +LT L + L +N+ G +P EL + + L+ + L N+ SG +P EIG L
Sbjct: 176 LVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGL 235
Query: 136 KYLQILDLSQNFFNGSLPVSIVQCKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLNLSFN 195
L LDL N G +P S+ K L+ L L QN +GP+P L L L+LS N
Sbjct: 236 TSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSI-FSLQKLISLDLSDN 294
Query: 196 KFNGSIPSNTGNLSSLQGTVDFSHNLFSGSIPASLGNLPEKVYIDLTYNNLSGPIPQN 253
+G IP L +L+ FS+N F+G IP +L +LP + L N SG IP+N
Sbjct: 295 SLSGEIPELVIQLQNLEILHLFSNN-FTGKIPVALTSLPRLQVLQLWSNKFSGEIPKN 351
|
Length = 968 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 2e-24
Identities = 58/230 (25%), Positives = 99/230 (43%), Gaps = 42/230 (18%)
Query: 410 VLGKSGIGIVYK-VVLEDGHTLAVR--RLGEGGSQRFKEFQTEVEAIGKIRHSNIVTLRA 466
+LG+ G VY + + G +AV+ L + + + E+ + ++H NIV
Sbjct: 7 LLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYG 66
Query: 467 YYWSVDEK-LLIY-DYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEF 524
++ L I+ +Y+ GSL++ L F +P V K + I +GL YLH
Sbjct: 67 SERDEEKNTLNIFLEYVSGGSLSSLLK------KFGKLPEPVIRKYTRQILEGLAYLHS- 119
Query: 525 SPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQKS 584
VH D+K +NIL+ + ++DFG A K
Sbjct: 120 --NGIVHRDIKGANILVDSDGVVKLADFGCA---------------------------KR 150
Query: 585 VSLEVTTTNSSSNLGS-YYQAPESLKVVKPSQKWDIYSYGVILLEMITGR 633
+ T + S G+ Y+ APE ++ + + DI+S G ++EM TG+
Sbjct: 151 LGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGK 200
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 2e-24
Identities = 58/231 (25%), Positives = 95/231 (41%), Gaps = 50/231 (21%)
Query: 410 VLGKSGIGIVYKV-VLEDGHTLAVRRLGEGGSQRFKEFQTEVEAIGKIRHSNIVTLRAYY 468
+GK G G VYK G +A++ + ++ ++ E++ + K +H NIV Y
Sbjct: 7 KIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSY 66
Query: 469 WSVDEKLLIYDYIPNGSLATALHGKPG-----MVSFTPVPWSVRVKIIKGIAKGLVYLHE 523
DE ++ ++ GSL L +++ + K + KGL YLH
Sbjct: 67 LKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAY----------VCKELLKGLEYLHS 116
Query: 524 FSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQK 583
+H D+K +NILL + E + DFGL+ A S T N M
Sbjct: 117 ---NGIIHRDIKAANILLTSDGEVKLIDFGLS-----AQLSDTKARNTM----------- 157
Query: 584 SVSLEVTTTNSSSNLGS-YYQAPESLKVVKPSQKWDIYSYGVILLEMITGR 633
+G+ Y+ APE + K DI+S G+ +E+ G+
Sbjct: 158 --------------VGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGK 194
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 5e-24
Identities = 74/308 (24%), Positives = 119/308 (38%), Gaps = 66/308 (21%)
Query: 410 VLGKSGIGIVYKVVLEDGHTL-----AVRRLGEGGSQR-FKEFQTEVEAIGKIRHSNIVT 463
LG+ G VYK L+ AV+ L E S++ +EF E + K+ H NIV
Sbjct: 6 KLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVK 65
Query: 464 LRAYYWSVDEK--LLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYL 521
L +E+ +++ +Y+P G L L + S + IA+G+ YL
Sbjct: 66 L--LGVCTEEEPLMIVMEYMPGGDLLDYLRKNRP----KELSLSDLLSFALQIARGMEYL 119
Query: 522 HEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQ 581
K ++H DL N L+G N+ +SDFGL+R
Sbjct: 120 ES---KNFIHRDLAARNCLVGENLVVKISDFGLSRD------------------------ 152
Query: 582 QKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGS 641
+ + L + APESLK K + K D++S+GV+L E+ T G
Sbjct: 153 ---LYDDDYYKVKGGKLPIRWMAPESLKEGKFTSKSDVWSFGVLLWEIFTL-------GE 202
Query: 642 S---EMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPT 698
M ++ +++ L + E+ ++ C PE RPT
Sbjct: 203 EPYPGMSNAEVLEY-LKKGY--------RLPKPPNCPPELYKLML---QCWAEDPEDRPT 250
Query: 699 MRHISDAL 706
+ + L
Sbjct: 251 FSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 7e-24
Identities = 67/178 (37%), Positives = 97/178 (54%), Gaps = 2/178 (1%)
Query: 75 KLLGFLPSALGSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSGSVPNEIGK 134
+L+G +P LG + L+ + L N G +P E+ L L L N+ +G +P+ +G
Sbjct: 199 QLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGN 258
Query: 135 LKYLQILDLSQNFFNGSLPVSIVQCKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLNLSF 194
LK LQ L L QN +G +P SI ++L +LDLS N+ +G +P L +LE L+L
Sbjct: 259 LKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPE-LVIQLQNLEILHLFS 317
Query: 195 NKFNGSIPSNTGNLSSLQGTVDFSHNLFSGSIPASLGNLPEKVYIDLTYNNLSGPIPQ 252
N F G IP +L LQ + N FSG IP +LG +DL+ NNL+G IP+
Sbjct: 318 NNFTGKIPVALTSLPRLQ-VLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPE 374
|
Length = 968 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 7e-24
Identities = 73/308 (23%), Positives = 117/308 (37%), Gaps = 67/308 (21%)
Query: 410 VLGKSGIGIVYKVVLEDGHTL-----AVRRLGEGGS-QRFKEFQTEVEAIGKIRHSNIVT 463
LG+ G VYK L+ AV+ L E S Q+ +EF E + K+ H N+V
Sbjct: 6 KLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVK 65
Query: 464 LRAYYWSVDEK--LLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYL 521
L +E+ ++ +Y+ G L + L + S + IA+G+ YL
Sbjct: 66 L--LGVCTEEEPLYIVMEYMEGGDLLSYLRKNRP-----KLSLSDLLSFALQIARGMEYL 118
Query: 522 HEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQ 581
K ++H DL N L+G N+ +SDFGL+R
Sbjct: 119 ES---KNFIHRDLAARNCLVGENLVVKISDFGLSRD------------------------ 151
Query: 582 QKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGS 641
+ + L + APESLK K + K D++S+GV+L E+ T G
Sbjct: 152 ---LYDDDYYRKRGGKLPIRWMAPESLKEGKFTSKSDVWSFGVLLWEIFTL-------GE 201
Query: 642 S---EMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPT 698
M ++ ++ L + E+ ++ C PE RPT
Sbjct: 202 QPYPGMSNEEVLE-YLKNGY--------RLPQPPNCPPELYDLML---QCWAEDPEDRPT 249
Query: 699 MRHISDAL 706
+ + L
Sbjct: 250 FSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 1e-23
Identities = 77/304 (25%), Positives = 119/304 (39%), Gaps = 66/304 (21%)
Query: 410 VLGKSGIGIVYK---VVLEDGHTL--AVRRLGEGGSQR-FKEFQTEVEAIGKIRHSNIVT 463
LG+ G VYK +G AV+ L EG S+ +EF E + K+ H NIV
Sbjct: 6 KLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVR 65
Query: 464 LRAYYWSVDEK--LLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYL 521
L + ++ +Y+P G L L + +++ IAKG+ YL
Sbjct: 66 L--LGVCTQGEPLYIVTEYMPGGDLLDFLRKHGE-----KLTLKDLLQMALQIAKGMEYL 118
Query: 522 HEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQ 581
K +VH DL N L+ N+ +SDFGL+R ++P
Sbjct: 119 ES---KNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLP-------- 167
Query: 582 QKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGS 641
K + APESLK K + K D++S+GV+L E+ T G
Sbjct: 168 IK------------------WMAPESLKDGKFTSKSDVWSFGVLLWEIFTL-------GE 202
Query: 642 S---EMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPT 698
M ++L +E+ L P+ +E + ++ + C PE RPT
Sbjct: 203 QPYPGMSNEEVLEL-LEDGYRLP-------RPENCPDE----LYELMLQCWAYDPEDRPT 250
Query: 699 MRHI 702
+
Sbjct: 251 FSEL 254
|
Length = 258 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 1e-22
Identities = 62/176 (35%), Positives = 92/176 (52%), Gaps = 2/176 (1%)
Query: 76 LLGFLPSALGSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSGSVPNEIGKL 135
L G +P+ +GS + L+ ++L N G +P L L+ L L N G +P E+G++
Sbjct: 152 LSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQM 211
Query: 136 KYLQILDLSQNFFNGSLPVSIVQCKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLNLSFN 195
K L+ + L N +G +P I L LDL NN TGP+P+ G+ L +L+ L L N
Sbjct: 212 KSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGN-LKNLQYLFLYQN 270
Query: 196 KFNGSIPSNTGNLSSLQGTVDFSHNLFSGSIPASLGNLPEKVYIDLTYNNLSGPIP 251
K +G IP + +L L ++D S N SG IP + L + L NN +G IP
Sbjct: 271 KLSGPIPPSIFSLQKLI-SLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIP 325
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 6e-22
Identities = 66/179 (36%), Positives = 99/179 (55%), Gaps = 4/179 (2%)
Query: 73 KKKLLGFLPSALGSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSGSVPNEI 132
+ KL G +P ++ SL L ++L +N G +P +++ Q L+ L L+ N+F+G +P +
Sbjct: 269 QNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVAL 328
Query: 133 GKLKYLQILDLSQNFFNGSLPVSIVQCKRLKALDLSQNNFTGPLPNGF-GSGLVSLEKLN 191
L LQ+L L N F+G +P ++ + L LDLS NN TG +P G SG +L KL
Sbjct: 329 TSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSG--NLFKLI 386
Query: 192 LSFNKFNGSIPSNTGNLSSLQGTVDFSHNLFSGSIPASLGNLPEKVYIDLTYNNLSGPI 250
L N G IP + G SL+ V N FSG +P+ LP ++D++ NNL G I
Sbjct: 387 LFSNSLEGEIPKSLGACRSLR-RVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRI 444
|
Length = 968 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 92.3 bits (230), Expect = 9e-21
Identities = 73/292 (25%), Positives = 124/292 (42%), Gaps = 53/292 (18%)
Query: 410 VLGKSGIGIVYKVVL-EDGHTLAVRRLGEGGSQRF-KEFQTEVEAIGKIRHSNIVTLRAY 467
VLG+ G+VYKV G A++++ G + F K+ E++ + +V
Sbjct: 8 VLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGA 67
Query: 468 YWSVDEKLLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPK 527
++ E ++ +Y+ GSLA L K G +P V I + I KGL YLH + +
Sbjct: 68 FYKEGEISIVLEYMDGGSLAD-LLKKVG-----KIPEPVLAYIARQILKGLDYLH--TKR 119
Query: 528 KYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQKSVSL 587
+H D+KPSN+L+ E ++DFG+++ L
Sbjct: 120 HIIHRDIKPSNLLINSKGEVKIADFGISK-----------------------------VL 150
Query: 588 EVTTTNSSSNLGSY-YQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGSSEMDL 646
E T ++ +G+ Y +PE ++ S DI+S G+ LLE G+ + G
Sbjct: 151 ENTLDQCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQP---- 206
Query: 647 VNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPT 698
++ +L + D P P + E + AC+ P+KRP+
Sbjct: 207 -SFFELMQA----ICDG-PPPSLPAEEFSPEFRDFIS---ACLQKDPKKRPS 249
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.5 bits (228), Expect = 2e-20
Identities = 58/228 (25%), Positives = 101/228 (44%), Gaps = 42/228 (18%)
Query: 410 VLGKSGIGIVYKVV-LEDGHTLAVRR--LGEGGSQRFKEFQTEVEAIGKIRHSNIVTLRA 466
++G+ G+VYK + LE G +A+++ L + + K E++ + ++H NIV
Sbjct: 7 LIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIG 66
Query: 467 YYWSVDEKLLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSP 526
+ D +I +Y NGSL + F P P S+ + + +GL YLHE
Sbjct: 67 SIETSDSLYIILEYAENGSLRQIIK------KFGPFPESLVAVYVYQVLQGLAYLHE--- 117
Query: 527 KKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQKSVS 586
+ +H D+K +NIL + ++DFG+A N
Sbjct: 118 QGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDA-------------------- 157
Query: 587 LEVTTTNSSSNLGS-YYQAPESLKVVKPSQKWDIYSYGVILLEMITGR 633
S +G+ Y+ APE +++ S DI+S G ++E++TG
Sbjct: 158 ---------SVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGN 196
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 92.5 bits (228), Expect = 6e-20
Identities = 69/298 (23%), Positives = 108/298 (36%), Gaps = 43/298 (14%)
Query: 410 VLGKSGIGIVYKVVLEDGHTLAVRRL---GEGGSQRFKEFQTEVEAIGKIRH-SNIVTLR 465
LG+ G VY D +A++ L E S+ + F E++ + + H NIV L
Sbjct: 7 KLGEGSFGEVYLA--RDRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLY 64
Query: 466 AYYWSVDEKLLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFS 525
++ L+ +Y+ GSL L + S + I+ I L YLH
Sbjct: 65 DFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSE---SEALFILAQILSALEYLHS-- 119
Query: 526 PKKYVHGDLKPSNILLGHN-MEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQKS 584
K +H D+KP NILL + + DFGLA+L + S
Sbjct: 120 -KGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLP-------------------DPGSTS 159
Query: 585 VSLEVTTTNSSSNLGSYYQAPESLK---VVKPSQKWDIYSYGVILLEMITGRTAVVQVGS 641
+ +T+ + Y APE L + S DI+S G+ L E++TG +
Sbjct: 160 SIPALPSTSVGT---PGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKN 216
Query: 642 SEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTM 699
S + LA L P K + + P+ R +
Sbjct: 217 SSATSQTLKIILELPTPSLASPLSPSNPELISKA-----ASDLLKKLLAKDPKNRLSS 269
|
Length = 384 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 89.8 bits (223), Expect = 9e-20
Identities = 72/314 (22%), Positives = 124/314 (39%), Gaps = 57/314 (18%)
Query: 411 LGKSGIGIVYKVVLE---DGHTL--AVRRLG-EGGSQRFKEFQTEVEAIGKIRHSNIVTL 464
LG+ G V + D AV+ L G Q +F+ E+E + + H NIV
Sbjct: 12 LGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKY 71
Query: 465 R--AYYWSVDEKLLIYDYIPNGSLATALHG-KPGMVSFTPVPWSVRVKIIKGIAKGLVYL 521
+ LI +Y+P+GSL L + + + +S + I KG+ YL
Sbjct: 72 KGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQ------ICKGMDYL 125
Query: 522 HEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQ 581
++Y+H DL NIL+ +SDFGLA++ P+++
Sbjct: 126 GS---QRYIHRDLAARNILVESEDLVKISDFGLAKVL------------------PEDK- 163
Query: 582 QKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMIT-GRTAVVQVG 640
+ ++ APE L+ K S D++S+GV L E+ T G +
Sbjct: 164 ------DYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPS----- 212
Query: 641 SSEMDLVNWMQLCIEEKKPLADVLD-----PYLAPDADKEEEIIAVLKIAMACVHSSPEK 695
S M + + + +L+ L +E+ ++K+ C + P+
Sbjct: 213 QSPPAEFLRMIGIAQGQMIVTRLLELLKEGERLPRPPSCPDEVYDLMKL---CWEAEPQD 269
Query: 696 RPTMRHISDALDRL 709
RP+ + +DRL
Sbjct: 270 RPSFADLILIVDRL 283
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 93.8 bits (233), Expect = 1e-19
Identities = 69/235 (29%), Positives = 108/235 (45%), Gaps = 49/235 (20%)
Query: 64 QRVVSVSIPKKKLLGFLPSALGSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNS 123
Q+++S+ + L G +P + L +L ++L +N F G +P+ L LQ L L+ N
Sbjct: 284 QKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNK 343
Query: 124 FSGSVPNEIGKLKYLQILDLSQN---------------------FFN---GSLPVSIVQC 159
FSG +P +GK L +LDLS N F N G +P S+ C
Sbjct: 344 FSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGAC 403
Query: 160 KRLKALDLSQNNFTGPLPNGFGSGLVSLEKLNLSFNKFNGSIPSNTGNLSSLQGTVDFSH 219
+ L+ + L N+F+G LP+ F + L + L++S N G I S ++ SLQ + +
Sbjct: 404 RSLRRVRLQDNSFSGELPSEF-TKLPLVYFLDISNNNLQGRINSRKWDMPSLQ-MLSLAR 461
Query: 220 NLFSG-----------------------SIPASLGNLPEKVYIDLTYNNLSGPIP 251
N F G ++P LG+L E + + L+ N LSG IP
Sbjct: 462 NKFFGGLPDSFGSKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIP 516
|
Length = 968 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 88.5 bits (220), Expect = 2e-19
Identities = 80/296 (27%), Positives = 115/296 (38%), Gaps = 69/296 (23%)
Query: 417 GIVYKVV-LEDGHTLAVR--RLGEGGSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSV-- 471
G VY V L+ G +AV+ R+ + + KE E++ + ++H N+V Y+ V
Sbjct: 14 GKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVK----YYGVEV 69
Query: 472 -DEKLLIY-DYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKY 529
EK+ I+ +Y G+L L + V + +GL YLH
Sbjct: 70 HREKVYIFMEYCSGGTLEELLEHGRIL------DEHVIRVYTLQLLEGLAYLHS---HGI 120
Query: 530 VHGDLKPSNILLGHNMEPHVSDFGLA-RLANIAGGSPTLQSNRMPAEKPQERQQKSVSLE 588
VH D+KP+NI L HN + DFG A +L N E Q SL
Sbjct: 121 VHRDIKPANIFLDHNGVIKLGDFGCAVKLKN-------------NTTTMGEEVQ---SLA 164
Query: 589 VTTTNSSSNLGSYYQAPESLKVVKPSQKW---DIYSYGVILLEMITGRTAVVQVGSSEMD 645
T Y APE + K DI+S G ++LEM TG+ SE+D
Sbjct: 165 GTPA---------YMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPW-----SELD 210
Query: 646 LVNW---MQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPT 698
+ + K P+ D E L C+ S P+KRPT
Sbjct: 211 -NEFQIMFHVGAGHKPPIPD--------SLQLSPEGKDFLD---RCLESDPKKRPT 254
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 89.5 bits (222), Expect = 2e-18
Identities = 60/165 (36%), Positives = 89/165 (53%), Gaps = 9/165 (5%)
Query: 69 VSIPKKKLLGFLPSALGSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSGSV 128
+S+ + K G LP + GS L +++L N+F G++P +L L L L N SG +
Sbjct: 457 LSLARNKFFGGLPDSFGS-KRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEI 515
Query: 129 PNEIGKLKYLQILDLSQNFFNGSLPVSIVQCKRLKALDLSQNNFTGPLPNGFGSGLVSLE 188
P+E+ K L LDLS N +G +P S + L LDLSQN +G +P G + SL
Sbjct: 516 PDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLG-NVESLV 574
Query: 189 KLNLSFNKFNGSIPSNTG-----NLSSLQGTVDF-SHNLFSGSIP 227
++N+S N +GS+PS TG N S++ G +D + SG P
Sbjct: 575 QVNISHNHLHGSLPS-TGAFLAINASAVAGNIDLCGGDTTSGLPP 618
|
Length = 968 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 85.4 bits (211), Expect = 2e-18
Identities = 76/307 (24%), Positives = 137/307 (44%), Gaps = 56/307 (18%)
Query: 410 VLGKSGIGIVYKVVLE----DGHTLAVRRLGEGGSQRFK-EFQTEVEAIGKIRHSNIVTL 464
V+G G V++ +L+ +A++ L G +++ + +F +E +G+ H NI+ L
Sbjct: 12 VIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRL 71
Query: 465 RAYYWSVDEKLLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEF 524
++I +Y+ NG+L L G F+ V +++GIA G+ YL +
Sbjct: 72 EGVVTKFKPAMIITEYMENGALDKYLRDHDG--EFSSYQL---VGMLRGIAAGMKYLSDM 126
Query: 525 SPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQKS 584
+ YVH DL NIL+ N+E VSDFGL+R+ + P
Sbjct: 127 N---YVHRDLAARNILVNSNLECKVSDFGLSRVLE---------------DDP------- 161
Query: 585 VSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMIT-GRTAVVQVGSSE 643
E T T S + + APE++ K + D++S+G+++ E+++ G + + E
Sbjct: 162 ---EGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHE 218
Query: 644 MDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHIS 703
+ M+ I + L +D P AV ++ + C +RP I
Sbjct: 219 V-----MK-AINDGFRLPAPMD---CPS--------AVYQLMLQCWQQDRARRPRFVDIV 261
Query: 704 DALDRLI 710
+ LD+L+
Sbjct: 262 NLLDKLL 268
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 84.3 bits (209), Expect = 5e-18
Identities = 75/307 (24%), Positives = 128/307 (41%), Gaps = 57/307 (18%)
Query: 410 VLGKSGIGIVYKVVL----EDGHTLAVRRLGEGGSQRFK-EFQTEVEAIGKIRHSNIVTL 464
V+G G V + L + +A++ L G S + + +F TE +G+ H NI+ L
Sbjct: 11 VIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRL 70
Query: 465 RAYYWSVDEKLLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEF 524
++I +Y+ NGSL L G + V +++GIA G+ YL E
Sbjct: 71 EGVVTKSRPVMIITEYMENGSLDKFLRENDGKFT-----VGQLVGMLRGIASGMKYLSEM 125
Query: 525 SPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQKS 584
+ YVH DL NIL+ N+ VSDFGL+R + + T + ++P
Sbjct: 126 N---YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIR--------- 173
Query: 585 VSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGSSEM 644
+ APE++ K + D++S+G+++ E+++ E
Sbjct: 174 -----------------WTAPEAIAYRKFTSASDVWSFGIVMWEVMS---------YGER 207
Query: 645 DLVNWMQLCIEEKKPLADVLDPY-LAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHIS 703
+ + + V D Y L P D A+ ++ + C +RPT I
Sbjct: 208 PYWDM-----SNQDVIKAVEDGYRLPPPMDCPS---ALYQLMLDCWQKDRNERPTFSQIV 259
Query: 704 DALDRLI 710
LD++I
Sbjct: 260 STLDKMI 266
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 87.6 bits (217), Expect = 9e-18
Identities = 74/268 (27%), Positives = 117/268 (43%), Gaps = 46/268 (17%)
Query: 448 TEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGSLATALHGKPGMVSFTPVPWSVR 507
+E+ +GK++H NIV L S LI++YI +L+ L + W R
Sbjct: 732 SEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN---------LSWERR 782
Query: 508 VKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTL 567
KI GIAK L +LH V G+L P I++ EPH+ RL P L
Sbjct: 783 RKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHL------RL-----SLPGL 831
Query: 568 QSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILL 627
+ + SS+ Y APE+ + ++K DIY +G+IL+
Sbjct: 832 -----------------LCTDTKCFISSA-----YVAPETRETKDITEKSDIYGFGLILI 869
Query: 628 EMITGRT-AVVQVGSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDAD-KEEEIIAVLKIA 685
E++TG++ A + G +V W + C + L +DP + D + EI+ V+ +A
Sbjct: 870 ELLTGKSPADAEFGVHG-SIVEWARYCYSDCH-LDMWIDPSIRGDVSVNQNEIVEVMNLA 927
Query: 686 MACVHSSPEKRPTMRHISDALDRLIVSS 713
+ C + P RP + L+ SS
Sbjct: 928 LHCTATDPTARPCANDVLKTLESASRSS 955
|
Length = 968 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 1e-16
Identities = 71/297 (23%), Positives = 127/297 (42%), Gaps = 51/297 (17%)
Query: 411 LGKSGIGIVYKVVLEDGHTLAVRRLGEGGSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWS 470
LG G V++ + ++ +A++ L + ++FQ EV+A+ ++RH ++++L A
Sbjct: 14 LGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSV 73
Query: 471 VDEKLLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYV 530
+ +I + + GSL L G V +P + + + +A+G+ YL E + +
Sbjct: 74 GEPVYIITELMEKGSLLAFLRSPEGQV----LPVASLIDMACQVAEGMAYLEE---QNSI 126
Query: 531 HGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQKSVSLEVT 590
H DL NIL+G ++ V+DFGLARL E
Sbjct: 127 HRDLAARNILVGEDLVCKVADFGLARLIK----------------------------EDV 158
Query: 591 TTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGSSEMDLVNWM 650
+S + + APE+ S K D++S+G++L EM T V G +
Sbjct: 159 YLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFT-YGQVPYPGMN-------- 209
Query: 651 QLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDALD 707
+ + Y P K + + KI + C + PE RP+ + + + LD
Sbjct: 210 -----NHEVYDQITAGYRMPCPAKCPQ--EIYKIMLECWAAEPEDRPSFKALREELD 259
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 80.1 bits (198), Expect = 1e-16
Identities = 69/294 (23%), Positives = 112/294 (38%), Gaps = 56/294 (19%)
Query: 410 VLGKSGIGIVYKVV-LEDGHTLAVRR-LGEGGSQRFKEFQTEVEAIGKIRHSNIVTLRAY 467
LG G+V KV+ G +AV+ E K+ E++ + K IV
Sbjct: 8 ELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGA 67
Query: 468 YWSVDEKLLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPK 527
+++ + + +Y+ GSL L +P + KI + KGL YLHE
Sbjct: 68 FYNNGDISICMEYMDGGSLDKILK-----EVQGRIPERILGKIAVAVLKGLTYLHE--KH 120
Query: 528 KYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQKSVSL 587
K +H D+KPSNIL+ + + DFG VS
Sbjct: 121 KIIHRDVKPSNILVNSRGQIKLCDFG-------------------------------VSG 149
Query: 588 EVTTTNSSSNLG-SYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGSSEMDL 646
++ + + + +G S Y APE ++ S K DI+S G+ L+E+ TGR +
Sbjct: 150 QLVNSLAKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGI 209
Query: 647 VNWMQLCIEEKKPL--ADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPT 698
+Q + E P + P + C+ P +RP+
Sbjct: 210 FELLQYIVNEPPPRLPSGKFSPDFQDFVNL-------------CLIKDPRERPS 250
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 79.9 bits (198), Expect = 2e-16
Identities = 58/238 (24%), Positives = 97/238 (40%), Gaps = 38/238 (15%)
Query: 410 VLGKSGIGIVYKVVL-EDGHTLAVRRLGEGGSQRF-------KEFQTEVEAIGKI-RHSN 460
++G+ V E A++ L +R K + E E + ++ H
Sbjct: 8 IIGEGSFSTVVLAKEKETNKEYAIKIL----DKRQLIKEKKVKYVKIEKEVLTRLNGHPG 63
Query: 461 IVTLRAYYWSV--DEKL-LIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKG 517
I+ L Y++ +E L + +Y PNG L + K G + + I
Sbjct: 64 IIKL---YYTFQDEENLYFVLEYAPNGELLQYIR-KYGSLDEKCTRF-----YAAEILLA 114
Query: 518 LVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKP 577
L YLH K +H DLKP NILL +M ++DFG A++ L N P
Sbjct: 115 LEYLHS---KGIIHRDLKPENILLDKDMHIKITDFGTAKV---------LDPNSSPESNK 162
Query: 578 QERQQKSVSLEVTTTNSSSNLGS-YYQAPESLKVVKPSQKWDIYSYGVILLEMITGRT 634
+ +E +S +G+ Y +PE L + D+++ G I+ +M+TG+
Sbjct: 163 GDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKP 220
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 2e-16
Identities = 73/287 (25%), Positives = 126/287 (43%), Gaps = 56/287 (19%)
Query: 429 TLAVRRLGEGGSQR-FKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGSLA 487
+A++ L G +++ ++F +E +G+ H NI+ L ++I +++ NG+L
Sbjct: 34 FVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIITEFMENGALD 93
Query: 488 TALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEP 547
+ L G FT + V +++GIA G+ YL E + YVH DL NIL+ N+
Sbjct: 94 SFLRQNDG--QFTVIQL---VGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVC 145
Query: 548 HVSDFGLARLANIAGGSPTLQSN---RMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQA 604
VSDFGL+R PT S+ ++P + A
Sbjct: 146 KVSDFGLSRFLEDDTSDPTYTSSLGGKIPIR--------------------------WTA 179
Query: 605 PESLKVVKPSQKWDIYSYGVILLEMIT-GRTAVVQVGSSEMDLVNWMQLCIEEKKPLADV 663
PE++ K + D++SYG+++ E+++ G + S D++N IE+
Sbjct: 180 PEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDM--SNQDVIN----AIEQ------- 226
Query: 664 LDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDALDRLI 710
D L P D A+ ++ + C RP I LD++I
Sbjct: 227 -DYRLPPPMDCP---TALHQLMLDCWQKDRNARPKFGQIVSTLDKMI 269
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 82.2 bits (203), Expect = 3e-16
Identities = 46/123 (37%), Positives = 65/123 (52%), Gaps = 4/123 (3%)
Query: 164 ALDLSQNNFTGPLPNGFGSGLVSLEKLNLSFNKFNGSIPSNTGNLSSLQGTVDFSHNLFS 223
L L G +PN S L L+ +NLS N G+IP + G+++SL+ +D S+N F+
Sbjct: 422 GLGLDNQGLRGFIPNDI-SKLRHLQSINLSGNSIRGNIPPSLGSITSLE-VLDLSYNSFN 479
Query: 224 GSIPASLGNLPEKVYIDLTYNNLSGPIPQ--NGALMNRGPTAFIGNPRLCGPPLKNPCSS 281
GSIP SLG L ++L N+LSG +P G L++R F N LCG P C
Sbjct: 480 GSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIPGLRACGP 539
Query: 282 DVP 284
+
Sbjct: 540 HLS 542
|
Length = 623 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 78.6 bits (194), Expect = 5e-16
Identities = 59/244 (24%), Positives = 99/244 (40%), Gaps = 58/244 (23%)
Query: 410 VLGKSGIGIVYKVVL------EDGHTLAVRRLGEGGSQRFKE-FQTEVEAIGKIRHSNIV 462
LG+ G V+ D +AV+ L E S ++ F+ E E + +H NIV
Sbjct: 12 ELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIV 71
Query: 463 TLRAYYWSVDEKLLIYDYIPNGSLATAL--HGKPGMVSFTPVPWSVR------VKIIKGI 514
D +++++Y+ +G L L HG +P ++I I
Sbjct: 72 KFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQI 131
Query: 515 AKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANI-------AGGSPTL 567
A G+VYL + + +VH DL N L+G+++ + DFG++R ++ GG L
Sbjct: 132 ASGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSR--DVYTTDYYRVGGHTML 186
Query: 568 QSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILL 627
MP PES+ K + + D++S+GV+L
Sbjct: 187 PIRWMP-------------------------------PESIMYRKFTTESDVWSFGVVLW 215
Query: 628 EMIT 631
E+ T
Sbjct: 216 EIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 77.8 bits (192), Expect = 7e-16
Identities = 82/311 (26%), Positives = 128/311 (41%), Gaps = 93/311 (29%)
Query: 411 LGKSGIGIVYK-VVLEDGHTLAVRRL-----GEGGSQRFKEFQTEVEAIGKIRHSNIVTL 464
LG G VY+ + L+DG AV+ + G+ G + K+ + E+ + K++H NIV
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQ- 66
Query: 465 RAYYWSV--DEKLLIY-DYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYL 521
Y + ++ L I+ + +P GSLA L + P V + I GL YL
Sbjct: 67 --YLGTEREEDNLYIFLELVPGGSLAKLLK------KYGSFPEPVIRLYTRQILLGLEYL 118
Query: 522 HEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQ 581
H+ + VH D+K +NIL+ N ++DFG+A
Sbjct: 119 HD---RNTVHRDIKGANILVDTNGVVKLADFGMA-------------------------- 149
Query: 582 QKSVSLEVTTTNSSSNLGS-YYQAPESLKVVKPSQKW----DIYSYGVILLEMITGR--- 633
K V S GS Y+ APE V+ + DI+S G +LEM TG+
Sbjct: 150 -KQVVEFSFA---KSFKGSPYWMAPE---VIAQQGGYGLAADIWSLGCTVLEMATGKPPW 202
Query: 634 ------TAVVQVGSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMA 687
AV ++G S +E P+ D +L+ +A ++ I +
Sbjct: 203 SQLEGVAAVFKIGRS------------KELPPIPD----HLSDEA---KDFI------LK 237
Query: 688 CVHSSPEKRPT 698
C+ P RPT
Sbjct: 238 CLQRDPSLRPT 248
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 77.2 bits (191), Expect = 1e-15
Identities = 68/300 (22%), Positives = 120/300 (40%), Gaps = 61/300 (20%)
Query: 410 VLGKSGIGIVYKVV-LEDGHTLAVRRLG-EGGSQRFKEF-QTEVEAIGKIRHSNIVTLRA 466
+GK G VY V DG ++ + S++ +E EV+ + K+ H NI+
Sbjct: 7 QIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIK--- 63
Query: 467 YYWSVDEKLLIY---DYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHE 523
YY S +EK + +Y G L+ + K P P + + L YLH
Sbjct: 64 YYESFEEKGKLCIVMEYADGGDLSQKI--KKQKKEGKPFPEEQILDWFVQLCLALKYLHS 121
Query: 524 FSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQK 583
+K +H D+KP NI L N + DFG+++ L S
Sbjct: 122 ---RKILHRDIKPQNIFLTSNGLVKLGDFGISK---------VLSS-------------- 155
Query: 584 SVSLEVTTTNSSSNLGS-YYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGSS 642
++++ T +G+ YY +PE + + K DI+S G +L E+ T + G +
Sbjct: 156 --TVDLAKT----VVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPF--EGEN 207
Query: 643 EMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHI 702
++L ++ + P+ L ++ + + PE+RP++ I
Sbjct: 208 LLELAL--KILKGQYPPIPSQYSSEL-------RNLV------SSLLQKDPEERPSIAQI 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 76.9 bits (189), Expect = 2e-15
Identities = 78/300 (26%), Positives = 126/300 (42%), Gaps = 62/300 (20%)
Query: 412 GKSGIGIVYKVVLEDGHTLAVRRLGEGGSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSV 471
GK I + K L+ G+T RR +F +E +G+ H NI+ L
Sbjct: 29 GKREIPVAIKT-LKAGYTEKQRR----------DFLSEASIMGQFDHPNIIHLEGVVTKS 77
Query: 472 DEKLLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVH 531
+++ +Y+ NGSL L G FT + V +++GIA G+ YL + YVH
Sbjct: 78 KPVMIVTEYMENGSLDAFLRKHDG--QFTVIQL---VGMLRGIASGMKYLSDMG---YVH 129
Query: 532 GDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQKSVSLEVTT 591
DL NIL+ N+ VSDFGL+R+ + P E
Sbjct: 130 RDLAARNILVNSNLVCKVSDFGLSRVLE---------------DDP----------EAAY 164
Query: 592 TNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMIT-GRTAVVQVGSSEMDLVNWM 650
T + + APE++ K + D++SYG+++ E+++ G ++ S D++
Sbjct: 165 TTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEM--SNQDVI--- 219
Query: 651 QLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDALDRLI 710
IEE L +D P A+ ++ + C +RP I LD+LI
Sbjct: 220 -KAIEEGYRLPAPMD---CP--------AALHQLMLDCWQKDRNERPKFEQIVSILDKLI 267
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|219766 pfam08263, LRRNT_2, Leucine rich repeat N-terminal domain | Back alignment and domain information |
|---|
Score = 68.9 bits (169), Expect = 6e-15
Identities = 23/41 (56%), Positives = 31/41 (75%)
Query: 21 LNGEGYALLSFKQSVHEDPEGSLSNWNSSDENPCSWNGITC 61
LN + ALL+FK S++ DP G+LS+WN S +PCSW G+TC
Sbjct: 1 LNDDRDALLAFKSSLNGDPSGALSSWNPSSSDPCSWTGVTC 41
|
Leucine Rich Repeats pfam00560 are short sequence motifs present in a number of proteins with diverse functions and cellular locations. Leucine Rich Repeats are often flanked by cysteine rich domains. This domain is often found at the N-terminus of tandem leucine rich repeats. Length = 42 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 1e-14
Identities = 62/230 (26%), Positives = 99/230 (43%), Gaps = 37/230 (16%)
Query: 410 VLGKSGIGIVYKVVLEDGHTLAVRRLG------EGGSQRFKEFQTEVEAIGKIRHSNIVT 463
VLGK G VY + G +AV+++ + +++ Q EV+ + ++H NIV
Sbjct: 7 VLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQ 66
Query: 464 LRAYYWSVDEKLLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHE 523
+ + +++P GS+++ L+ F P+P V K K I G+ YLH
Sbjct: 67 YLGTCLDDNTISIFMEFVPGGSISSILN------RFGPLPEPVFCKYTKQILDGVAYLHN 120
Query: 524 FSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQK 583
VH D+K +N++L N + DFG AR G T SN +
Sbjct: 121 ---NCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGT-HSNML----------- 165
Query: 584 SVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGR 633
S + Y+ APE + +K DI+S G + EM TG+
Sbjct: 166 ----------KSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGK 205
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.7 bits (182), Expect = 1e-14
Identities = 66/230 (28%), Positives = 95/230 (41%), Gaps = 45/230 (19%)
Query: 411 LGKSGIGIVYKV-VLEDGHTLAVRRLGEGGSQRFKEFQ---TEVEAIGKIRHSNIVTLRA 466
LGK G V V + G A++ L + + KE + TE + +I H IV L
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKL-H 59
Query: 467 YYWSVDEKL-LIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFS 525
Y + +EKL L+ +Y P G L + L + + I L YLH
Sbjct: 60 YAFQTEEKLYLVLEYAPGGELFSHLSKEGRF----SEERARF--YAAEIVLALEYLHS-- 111
Query: 526 PKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQKSV 585
++ DLKP NILL + ++DFGLA K +
Sbjct: 112 -LGIIYRDLKPENILLDADGHIKLTDFGLA---------------------------KEL 143
Query: 586 SLEVTTTNSSSNLGSY-YQAPESLKVVKPSQKWDIYSYGVILLEMITGRT 634
S E + TN+ G+ Y APE L + D +S GV+L EM+TG+
Sbjct: 144 SSEGSRTNTFC--GTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKP 191
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 74.0 bits (182), Expect = 1e-14
Identities = 71/310 (22%), Positives = 121/310 (39%), Gaps = 78/310 (25%)
Query: 411 LGKSGIGIVYKVVLEDGHTLAVRRLGEGGSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWS 470
+GK G V G +AV+ L + + + F E + +RH N+V L
Sbjct: 14 IGKGEFGDVMLGDYR-GQKVAVKCLKDDSTAA-QAFLAEASVMTTLRHPNLVQLLGVVLQ 71
Query: 471 VDEKLLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYV 530
+ ++ +Y+ GSL L + V + + ++ + +G+ YL E K +V
Sbjct: 72 GNPLYIVTEYMAKGSLVDYLRSRGRAV----ITLAQQLGFALDVCEGMEYLEE---KNFV 124
Query: 531 HGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQKSVSLEVT 590
H DL N+L+ ++ VSDFGLA+ A+ S ++P +
Sbjct: 125 HRDLAARNVLVSEDLVAKVSDFGLAKEASQ-----GQDSGKLPVK--------------- 164
Query: 591 TTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMIT-GRTAVVQVGSSEMDLVNW 649
+ APE+L+ K S K D++S+G++L E+ + GR ++
Sbjct: 165 -----------WTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI---------- 203
Query: 650 MQLCIEEKKPLADVLD----------PYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTM 699
PL DV+ P P V K+ C P KRPT
Sbjct: 204 ---------PLKDVVPHVEKGYRMEAPEGCPP--------EVYKVMKDCWELDPAKRPTF 246
Query: 700 RHISDALDRL 709
+ + + L +
Sbjct: 247 KQLREQLALI 256
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 2e-14
Identities = 37/122 (30%), Positives = 62/122 (50%), Gaps = 14/122 (11%)
Query: 46 WNSSDENPCS-----WNGITCKEQRVVS------VSIPKKKLLGFLPSALGSLTDLRHVN 94
WN +PC W+G C+ + + + L GF+P+ + L L+ +N
Sbjct: 392 WNG---DPCVPQQHPWSGADCQFDSTKGKWFIDGLGLDNQGLRGFIPNDISKLRHLQSIN 448
Query: 95 LRNNKFFGSLPLELLEAQGLQSLVLYGNSFSGSVPNEIGKLKYLQILDLSQNFFNGSLPV 154
L N G++P L L+ L L NSF+GS+P +G+L L+IL+L+ N +G +P
Sbjct: 449 LSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPA 508
Query: 155 SI 156
++
Sbjct: 509 AL 510
|
Length = 623 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 72.3 bits (178), Expect = 5e-14
Identities = 57/240 (23%), Positives = 99/240 (41%), Gaps = 52/240 (21%)
Query: 398 FDLDELLKASAFVLGKSGIGIVYKVV-LEDGHTLAVRRLGEGGSQRFKEFQTEVEAIGKI 456
FD+ E LG+ G VYK + E G +A++ + +E E+ + +
Sbjct: 5 FDILE-------KLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQC 55
Query: 457 RHSNIVTLRAYYWSVDEKLLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAK 516
IV Y+ + ++ +Y GS++ + K + T + I+ K
Sbjct: 56 DSPYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIM--KITNKTLTEEEIAA---ILYQTLK 110
Query: 517 GLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEK 576
GL YLH K +H D+K NILL + ++DFG
Sbjct: 111 GLEYLHS---NKKIHRDIKAGNILLNEEGQAKLADFG----------------------- 144
Query: 577 PQERQQKSVSLEVTTTNSSSN--LGS-YYQAPESLKVVKPSQKWDIYSYGVILLEMITGR 633
VS ++T T + N +G+ ++ APE ++ + + K DI+S G+ +EM G+
Sbjct: 145 --------VSGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGK 196
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 5e-14
Identities = 72/293 (24%), Positives = 122/293 (41%), Gaps = 57/293 (19%)
Query: 425 EDGHTLAVRRLGEGGSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNG 484
+D +AV+ L + K+FQ E E + ++H +IV D +++++Y+ +G
Sbjct: 33 KDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHG 92
Query: 485 SLATAL--HGKPGMVSFTPVP--------WSVRVKIIKGIAKGLVYLHEFSPKKYVHGDL 534
L L HG M+ P S + I IA G+VYL + + +VH DL
Sbjct: 93 DLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYL---ASQHFVHRDL 149
Query: 535 KPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNS 594
N L+G N+ + DFG++R S +
Sbjct: 150 ATRNCLVGANLLVKIGDFGMSR--------------------------DVYSTDYYRVGG 183
Query: 595 SSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMIT-GRTAVVQVGSSEMDLVNWMQLC 653
+ L + PES+ K + + D++S+GVIL E+ T G+ Q+ ++E + C
Sbjct: 184 HTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE------VIEC 237
Query: 654 IEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDAL 706
I + + L P + P KE V I + C P++R ++ I L
Sbjct: 238 ITQGRVLE---RPRVCP---KE-----VYDIMLGCWQREPQQRLNIKEIYKIL 279
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 2e-13
Identities = 37/103 (35%), Positives = 60/103 (58%)
Query: 93 VNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSGSVPNEIGKLKYLQILDLSQNFFNGSL 152
+ L N G +P ++ + + LQS+ L GNS G++P +G + L++LDLS N FNGS+
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 153 PVSIVQCKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLNLSFN 195
P S+ Q L+ L+L+ N+ +G +P G L+ N + N
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDN 525
|
Length = 623 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 2e-13
Identities = 72/300 (24%), Positives = 116/300 (38%), Gaps = 55/300 (18%)
Query: 411 LGKSGIGIVYKVVLEDGHTLAVRRLGEGGSQRFKE-FQTEVEAIGKIRHSNIVTLRAYYW 469
+GK G VYK VL+ +AV+ K F E E + + H NIV L
Sbjct: 3 IGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCV 62
Query: 470 SVDEKLLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKY 529
++ + +P GSL T L K + +++ A G+ YL K
Sbjct: 63 QKQPIYIVMELVPGGSLLTFLRKKKNR-----LTVKKLLQMSLDAAAGMEYLES---KNC 114
Query: 530 VHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQKSVSLEV 589
+H DL N L+G N +SDFG++R GG T+ K + ++
Sbjct: 115 IHRDLAARNCLVGENNVLKISDFGMSR--EEEGGIYTVSDGL-----------KQIPIKW 161
Query: 590 TTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGSSEMDLVNW 649
T APE+L + + + D++SYG++L E + G + ++
Sbjct: 162 T-------------APEALNYGRYTSESDVWSYGILLWETFSL-------GDTPYPGMSN 201
Query: 650 MQL--CIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDALD 707
Q IE + P L P+ + ++ + C PE RP+ I + L
Sbjct: 202 QQTRERIESGYRMP---APQLCPE--------EIYRLMLQCWAYDPENRPSFSEIYNELQ 250
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 2e-13
Identities = 63/284 (22%), Positives = 105/284 (36%), Gaps = 54/284 (19%)
Query: 425 EDGHTLA---VRRLGEGGSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLL-IYDY 480
GH +A +R + F+ E ++ H NIV L + L +++Y
Sbjct: 1 MTGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEY 60
Query: 481 IPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNIL 540
+P +L L +P +++ + L H + VH DLKP NI+
Sbjct: 61 VPGRTLREVLAAD------GALPAGETGRLMLQVLDALACAHN---QGIVHRDLKPQNIM 111
Query: 541 LG-HNMEPH--VSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSN 597
+ + PH V DFG+ L +P + + + + EV
Sbjct: 112 VSQTGVRPHAKVLDFGIGTL--------------LPGVRDADVATLTRTTEV-------- 149
Query: 598 LGS-YYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVV----------QVGSSEMDL 646
LG+ Y APE L+ + D+Y++G+I LE +TG+ V Q+ ++ L
Sbjct: 150 LGTPTYCAPEQLRGEPVTPNSDLYAWGLIFLECLTGQRVVQGASVAEILYQQLSPVDVSL 209
Query: 647 VNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVH 690
W+ PL VL L D + L +
Sbjct: 210 PPWIA-----GHPLGQVLRKALNKDPRQRAASAPALAERFRALE 248
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.0 bits (175), Expect = 2e-13
Identities = 66/238 (27%), Positives = 101/238 (42%), Gaps = 75/238 (31%)
Query: 417 GIVYKVV-LEDGHTLAVRRL----GEGG----SQRFKEFQTEVEAIGKIRHSNIVTLRAY 467
G+VYK + G +A++++ E G + R E+ + +++H NIV L
Sbjct: 13 GVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALR------EISLLKELKHPNIVKLLDV 66
Query: 468 YWSVDEKLLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIA----KGLVYLHE 523
+ + L+++Y L L +PG +P +IK I +GL Y H
Sbjct: 67 IHTERKLYLVFEYCDM-DLKKYLDKRPG--PLSP-------NLIKSIMYQLLRGLAYCHS 116
Query: 524 FSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQK 583
+ +H DLKP NIL+ + ++DFGLAR A G P +
Sbjct: 117 ---HRILHRDLKPQNILINRDGVLKLADFGLAR----AFGIPL----------------R 153
Query: 584 SVSLEVTTTNSSSNLGSYYQAPE--------SLKVVKPSQKWDIYSYGVILLEMITGR 633
+ + EV T L +Y+APE S V DI+S G I EMITG+
Sbjct: 154 TYTHEVVT------L--WYRAPEILLGSKHYSTAV-------DIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.5 bits (176), Expect = 2e-13
Identities = 64/241 (26%), Positives = 101/241 (41%), Gaps = 32/241 (13%)
Query: 409 FVLGKSGIGIVYKVVLED-GHTLAVRRLG-EGGSQRFK--EFQTEVEAIGKIRHSNIVTL 464
+LGK +G V+ V L+ G A++ L + +R K TE E + + H + TL
Sbjct: 7 KLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTL 66
Query: 465 RAYYWSVDEKLLIY---DYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAK----G 517
Y S + + DY P G L L +PG + ++ + A
Sbjct: 67 ---YASFQTETYLCLVMDYCPGGELFRLLQRQPGKC--------LSEEVARFYAAEVLLA 115
Query: 518 LVYLHEFSPKKYVHGDLKPSNILL---GHNMEPHVSDFGLARLANIAGGSPTLQSNRMPA 574
L YLH V+ DLKP NILL GH M +SDF L++ +++ + +
Sbjct: 116 LEYLHL---LGIVYRDLKPENILLHESGHIM---LSDFDLSKQSDVEPPPVSKALRKGSR 169
Query: 575 EKPQERQQKSVSLEVTTTNSSSNLGSY-YQAPESLKVVKPSQKWDIYSYGVILLEMITGR 633
E + S+S +G+ Y APE + D ++ G++L EM+ G
Sbjct: 170 RSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGT 229
Query: 634 T 634
T
Sbjct: 230 T 230
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 70.5 bits (172), Expect = 2e-13
Identities = 77/298 (25%), Positives = 128/298 (42%), Gaps = 54/298 (18%)
Query: 411 LGKSGIGIVYKVVLEDGHTLAVRRLGEGGSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWS 470
LG+ G V+ +A++ L + G+ + F E + + K+RH +V L A S
Sbjct: 14 LGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV-S 71
Query: 471 VDEKLLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYV 530
+ ++ +Y+ GSL L G+ G P V + IA G+ Y+ + YV
Sbjct: 72 EEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQ----LVDMAAQIASGMAYVERMN---YV 124
Query: 531 HGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQKSVSLEVT 590
H DL+ +NIL+G N+ V+DFGLARL ++ N A RQ ++ T
Sbjct: 125 HRDLRAANILVGENLVCKVADFGLARL---------IEDNEYTA-----RQGAKFPIKWT 170
Query: 591 TTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMIT-GRTAVVQVGSSEMDLVNW 649
APE+ + + K D++S+G++L E+ T GR + + E+
Sbjct: 171 -------------APEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV----- 212
Query: 650 MQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDALD 707
L V Y P + E ++ + C PE+RPT ++ L+
Sbjct: 213 ----------LDQVERGYRMPCPPECPE--SLHDLMCQCWRKEPEERPTFEYLQAFLE 258
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 3e-13
Identities = 74/292 (25%), Positives = 120/292 (41%), Gaps = 57/292 (19%)
Query: 411 LGKSGIGIVYKVVLEDG------------HTLAVRRLGEGGSQRFKEFQTEVEAIGK-IR 457
LG G VYKV ++ H A + + + +EV I + +R
Sbjct: 8 LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67
Query: 458 HSNIVTLRAYYWSVDEKLLIYDYI---PNGSLATALHGKPGMVSFTPVPWSVRVKIIKGI 514
H NIV + D ++ D I P G +L K + + W++ V+++
Sbjct: 68 HPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERI-WNIFVQMVLA- 125
Query: 515 AKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPA 574
L YLH+ K+ VH DL P+NI+LG + + ++DFGLA+
Sbjct: 126 ---LRYLHK--EKRIVHRDLTPNNIMLGEDDKVTITDFGLAK------------------ 162
Query: 575 EKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRT 634
+K E + SV V T Y PE +K +K D++++G IL +M T +
Sbjct: 163 QKQPESKLTSV---VGTI--------LYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQP 211
Query: 635 AVVQVG--SSEMDLVNWMQLCIEEK---KPLADVLDPYLAPDADKEEEIIAV 681
S +V + + E + + DV+ L PDA+ +II V
Sbjct: 212 PFYSTNMLSLATKIVEAVYEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQV 263
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 3e-13
Identities = 62/228 (27%), Positives = 101/228 (44%), Gaps = 40/228 (17%)
Query: 411 LGKSGIGIVYKVV---LED--GHTLAVRRLGEGGSQRFKEFQTEVEAIGKIRHSNIVTLR 465
LGK G V L+D G +AV++L ++ ++F+ E+E + ++H NIV +
Sbjct: 12 LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYK 71
Query: 466 AYYWSVDEK--LLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHE 523
+S + L+ +Y+P GSL L + + + I KG+ YL
Sbjct: 72 GVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKL-----LLYASQICKGMEYL-- 124
Query: 524 FSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQK 583
K+YVH DL NIL+ + DFGL ++ PQ+++
Sbjct: 125 -GSKRYVHRDLATRNILVESENRVKIGDFGLTKVL------------------PQDKEYY 165
Query: 584 SVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMIT 631
V S + ++ APESL K S D++S+GV+L E+ T
Sbjct: 166 KV-----REPGESPI--FWYAPESLTESKFSVASDVWSFGVVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 69.3 bits (170), Expect = 6e-13
Identities = 70/283 (24%), Positives = 116/283 (40%), Gaps = 54/283 (19%)
Query: 427 GHT-LAVRRLGEGGSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGS 485
G T +AV+ L G + + F E + + K+RH +V L A + ++ +Y+ GS
Sbjct: 29 GTTKVAVKTLKPG-TMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMSKGS 87
Query: 486 LATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNM 545
L L G +P V + IA+G+ YL + Y+H DL NIL+G N+
Sbjct: 88 LLDFLKSGEG--KKLRLP--QLVDMAAQIAEGMAYLES---RNYIHRDLAARNILVGENL 140
Query: 546 EPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAP 605
++DFGLARL + + T + + AP
Sbjct: 141 VCKIADFGLARL---------------------------IEDDEYTAREGAKFPIKWTAP 173
Query: 606 ESLKVVKPSQKWDIYSYGVILLEMIT-GRTAVVQVGSSEMDLVNWMQLCIEEKKPLADVL 664
E+ + + K D++S+G++L E++T GR + + E+ L V
Sbjct: 174 EAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREV---------------LEQVE 218
Query: 665 DPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDALD 707
Y P E + L + C PE+RPT ++ L+
Sbjct: 219 RGYRMPRPPNCPEELYDLM--LQCWDKDPEERPTFEYLQSFLE 259
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.1 bits (170), Expect = 9e-13
Identities = 55/202 (27%), Positives = 92/202 (45%), Gaps = 57/202 (28%)
Query: 455 KIRHSNIVTLRAYYWSVDEK--LLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVK-II 511
K+RH NIV L+ S + ++++Y+ + L T L P V FT ++K +
Sbjct: 54 KLRHPNIVRLKEIVTSKGKGSIYMVFEYMDH-DL-TGLLDSPE-VKFTES----QIKCYM 106
Query: 512 KGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNR 571
K + +GL YLH +H D+K SNIL+ ++ ++DFGLAR + +NR
Sbjct: 107 KQLLEGLQYLHS---NGILHRDIKGSNILINNDGVLKLADFGLAR--PYTKRNSADYTNR 161
Query: 572 MPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESL--------KVVKPSQKWDIYSYG 623
+ ++L +Y+ PE L +V D++S G
Sbjct: 162 V------------ITL-------------WYRPPELLLGATRYGPEV-------DMWSVG 189
Query: 624 VILLEMITGRTAVVQVGSSEMD 645
IL E+ G+ + Q GS+E++
Sbjct: 190 CILAELFLGK-PIFQ-GSTELE 209
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 2e-12
Identities = 75/295 (25%), Positives = 128/295 (43%), Gaps = 51/295 (17%)
Query: 410 VLGKSGIGIVYKVV-LEDGHTLAVRRLG-EGGSQRFKEFQTEVEAIGKIRHSNIVTLRAY 467
V+G +VY + L + +A++R+ E E + EV+A+ + H N+V Y
Sbjct: 8 VIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVK---Y 64
Query: 468 YWS--VDEKL-LIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEF 524
Y S V ++L L+ Y+ GSL + + ++ ++K + KGL YLH
Sbjct: 65 YTSFVVGDELWLVMPYLSGGSLLDIMKSS---YPRGGLDEAIIATVLKEVLKGLEYLHS- 120
Query: 525 SPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQKS 584
+H D+K NILLG + ++DFG++ A++A +R +K
Sbjct: 121 --NGQIHRDIKAGNILLGEDGSVKIADFGVS--ASLA--------------DGGDRTRKV 162
Query: 585 VSLEVTTTNSSSNLGSYYQAPESLKVVKP-SQKWDIYSYGVILLEMITGRTAVVQVGSSE 643
V T + APE ++ V K DI+S+G+ +E+ TG + +
Sbjct: 163 RKTFVGT--------PCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMK 214
Query: 644 MDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPT 698
+ L+ +Q P P L AD ++ + K+ C+ P KRPT
Sbjct: 215 V-LMLTLQ-----NDP------PSLETGADYKKYSKSFRKMISLCLQKDPSKRPT 257
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 68.0 bits (167), Expect = 2e-12
Identities = 74/308 (24%), Positives = 122/308 (39%), Gaps = 82/308 (26%)
Query: 410 VLGKSGIGIVYK-VVLEDGHTLAVRRLGEGGSQRFKEFQTEVEAIGKIRHSNIVTLRAYY 468
+G+ G VYK G +A++++ Q + E+ + +H NIV YY
Sbjct: 26 KIGEGASGEVYKATDRATGKEVAIKKM-RLRKQNKELIINEILIMKDCKHPNIVD---YY 81
Query: 469 WS--VDEKL-LIYDYIPNGSLATALHGKP-----GMVSFTPVPWSVRVKIIKGIAKGLVY 520
S V ++L ++ +Y+ GSL + +++ + + + +GL Y
Sbjct: 82 DSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAY----------VCREVLQGLEY 131
Query: 521 LHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQER 580
LH + +H D+K NILL + ++DFG A A + +S R
Sbjct: 132 LHS---QNVIHRDIKSDNILLSKDGSVKLADFGFA--AQLT----KEKSKR--------- 173
Query: 581 QQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITG-------- 632
SV V T Y+ APE +K K DI+S G++ +EM G
Sbjct: 174 --NSV---VGTP--------YWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREP 220
Query: 633 ----RTAVVQVG----------SSEM-DLVNWMQLCIE-EKKPLADVL--DPYLAPDADK 674
+ G S E D +N L + EK+P A+ L P+L A
Sbjct: 221 PLRALFLITTKGIPPLKNPEKWSPEFKDFLNKC-LVKDPEKRPSAEELLQHPFLK-KACP 278
Query: 675 EEEIIAVL 682
+EE ++
Sbjct: 279 KEEFAPLI 286
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 67.6 bits (165), Expect = 2e-12
Identities = 48/187 (25%), Positives = 87/187 (46%), Gaps = 31/187 (16%)
Query: 447 QTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGSLATALHGKPGMVSFTPVPWSV 506
E+ + +++H NIV D + +Y+P GS+A L+ ++ ++
Sbjct: 54 AREIALLKELQHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLN------NYGAFEETL 107
Query: 507 RVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPT 566
++ I KGL YLH + +H D+K +NIL+ + +SDFG+ S
Sbjct: 108 VRNFVRQILKGLNYLHN---RGIIHRDIKGANILVDNKGGIKISDFGI---------SKK 155
Query: 567 LQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVIL 626
L++N S+S + S ++ APE +K ++K DI+S G ++
Sbjct: 156 LEAN-------------SLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLV 202
Query: 627 LEMITGR 633
+EM+TG+
Sbjct: 203 VEMLTGK 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 2e-12
Identities = 69/301 (22%), Positives = 129/301 (42%), Gaps = 59/301 (19%)
Query: 411 LGKSGIGIVYKVVLEDGHTLAVRRLGEGGSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWS 470
LG G V+ + +AV+ L + G+ + F E + ++H +V L A
Sbjct: 14 LGAGQFGEVWMGYYNNSTKVAVKTL-KPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTK 72
Query: 471 VDEKLLIYDYIPNGSLATALHGKPGMVSFTP--VPWSVRVKIIKGIAKGLVYLHEFSPKK 528
+ +I +Y+ GSL L G P + +S + IA+G+ Y+ K
Sbjct: 73 EEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQ------IAEGMAYIER---KN 123
Query: 529 YVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQKSVSLE 588
Y+H DL+ +N+L+ ++ ++DFGLAR+ ++ N A + + K
Sbjct: 124 YIHRDLRAANVLVSESLMCKIADFGLARV---------IEDNEYTAREGAKFPIK----- 169
Query: 589 VTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMIT-GRTAVVQVGSSEMDLV 647
+ APE++ + K D++S+G++L E++T G+ + G S D++
Sbjct: 170 -------------WTAPEAINFGSFTIKSDVWSFGILLYEIVTYGK--IPYPGMSNSDVM 214
Query: 648 NWMQLCIEEKKPLADVLDPYLAPDADK-EEEIIAVLKIAMACVHSSPEKRPTMRHISDAL 706
+ +Q Y P + +E+ ++K C E+RPT ++ L
Sbjct: 215 SALQ-------------RGYRMPRMENCPDELYDIMK---TCWKEKAEERPTFDYLQSVL 258
Query: 707 D 707
D
Sbjct: 259 D 259
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 67.6 bits (165), Expect = 2e-12
Identities = 58/222 (26%), Positives = 97/222 (43%), Gaps = 36/222 (16%)
Query: 411 LGKSGIGIVYKVVLED-GHTLAVRRLGEGGSQRFKEFQTEVEAIGKIRHSNIVTLRAYYW 469
LG G VY+ V + T+AV+ L E + +EF E + +I+H N+V L
Sbjct: 14 LGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 72
Query: 470 SVDEKLLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKY 529
+I +++ G+L L + V V + + I+ + YL + K +
Sbjct: 73 REPPFYIITEFMTYGNLLDYLR-ECNRQEVNAV---VLLYMATQISSAMEYLEK---KNF 125
Query: 530 VHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQKSVSLEV 589
+H DL N L+G N V+DFGL+RL ++ +
Sbjct: 126 IHRDLAARNCLVGENHLVKVADFGLSRL---------------------------MTGDT 158
Query: 590 TTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMIT 631
T ++ + + APESL K S K D++++GV+L E+ T
Sbjct: 159 YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 200
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 3e-12
Identities = 75/311 (24%), Positives = 126/311 (40%), Gaps = 74/311 (23%)
Query: 410 VLGKSGIGIVYKVV-LEDGHTLAVRR--LGEGGSQRFKEFQ--------TEVEAIGKIRH 458
++GK G VY + + G +AV++ L + R Q +E+E + + H
Sbjct: 8 LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67
Query: 459 SNIVTLRAYYWSVDEKLLIYDYIPNGSLATAL--HGK--PGMVSFTPVPWSVRVKIIKGI 514
NIV + + + + +Y+P GS+ + L +G+ +V F + +
Sbjct: 68 LNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRF----------FTEQV 117
Query: 515 AKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLAR-LANIAGGSPTLQSNRMP 573
+GL YLH K +H DLK N+L+ + +SDFG+++ +I Q+ M
Sbjct: 118 LEGLAYLHS---KGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDND---QNMSM- 170
Query: 574 AEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPE--SLKVVKPSQKWDIYSYGVILLEMIT 631
Q SV ++ APE S K DI+S G ++LEM
Sbjct: 171 --------QGSV---------------FWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFA 207
Query: 632 GRTAVVQVGSSEMDLVNWMQLCIEEKK--PLADVLDPYLAPDADKEEEIIAVLKIAMACV 689
GR S+ + + M ++ P+ + L+P A L AC
Sbjct: 208 GRRP-----WSDEEAIAAMFKLGNKRSAPPIPPDVSMNLSPVA---------LDFLNACF 253
Query: 690 HSSPEKRPTMR 700
+P+ RPT R
Sbjct: 254 TINPDNRPTAR 264
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 4e-12
Identities = 67/297 (22%), Positives = 119/297 (40%), Gaps = 54/297 (18%)
Query: 425 EDGHTLAVRRLGEGGSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNG 484
+D +AV+ L + K+F E E + ++H +IV D +++++Y+ +G
Sbjct: 33 QDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHG 92
Query: 485 SLATAL--HGKPGMVSF-----TPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPS 537
L L HG ++ + S + I + IA G+VYL + + +VH DL
Sbjct: 93 DLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYL---ASQHFVHRDLATR 149
Query: 538 NILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSN 597
N L+G N+ + DFG++R S + +
Sbjct: 150 NCLVGENLLVKIGDFGMSR--------------------------DVYSTDYYRVGGHTM 183
Query: 598 LGSYYQAPESLKVVKPSQKWDIYSYGVILLEMIT-GRTAVVQVGSSEMDLVNWMQLCIEE 656
L + PES+ K + + D++S GV+L E+ T G+ Q+ ++E + CI +
Sbjct: 184 LPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE------VIECITQ 237
Query: 657 KKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDALDRLIVSS 713
+ L P P V + + C P R ++ I L L +S
Sbjct: 238 GRVLQ---RPRTCPK--------EVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKAS 283
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 4e-12
Identities = 55/224 (24%), Positives = 98/224 (43%), Gaps = 36/224 (16%)
Query: 411 LGKSGIGIVYKVVLEDGHTLAVRRLGEGGSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWS 470
LG G V++ + + +AV+ L + G+ K+F E + + K+RH ++ L A
Sbjct: 14 LGAGQFGEVWEGLWNNTTPVAVKTL-KPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTL 72
Query: 471 VDEKLLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYV 530
+ ++ + + GSL L G G P + + +A G+ YL + Y+
Sbjct: 73 EEPIYIVTELMKYGSLLEYLQGGAGRALKLPQ----LIDMAAQVASGMAYLEA---QNYI 125
Query: 531 HGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQKSVSLEVT 590
H DL N+L+G N V+DFGLAR+ + ++
Sbjct: 126 HRDLAARNVLVGENNICKVADFGLARV---------------------------IKEDIY 158
Query: 591 TTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMIT-GR 633
+ + APE+ + S K D++S+G++L E++T GR
Sbjct: 159 EAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGR 202
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 5e-12
Identities = 75/313 (23%), Positives = 120/313 (38%), Gaps = 62/313 (19%)
Query: 411 LGKSGIGIVYKVVL------EDGHTLAVRRLGEGGS-QRFKEFQTEVEAIGKIRHSNIVT 463
LG+ G VYK L ++A++ L E + +EF+ E E + ++H NIV
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72
Query: 464 LRAYYWSVDEKLLIYDYIPNGSLATAL-----HGKPGMVSF-----TPVPWSVRVKIIKG 513
L ++++Y+ +G L L H G S + + S + I
Sbjct: 73 LLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQ 132
Query: 514 IAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMP 573
IA G+ YL S +VH DL N L+G + +SDFGL+R A
Sbjct: 133 IAAGMEYL---SSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSAD----------- 178
Query: 574 AEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGR 633
R Q S S L + PE++ K + + DI+S+GV+L E I
Sbjct: 179 ----YYRVQ-----------SKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWE-IFSY 222
Query: 634 TAVVQVGSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSP 693
G S +++ ++ P E+ V + + C + P
Sbjct: 223 GLQPYYGFSNQEVIEMIRSRQLLPCP---------------EDCPARVYALMIECWNEIP 267
Query: 694 EKRPTMRHISDAL 706
+RP + I L
Sbjct: 268 ARRPRFKDIHTRL 280
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 6e-12
Identities = 60/289 (20%), Positives = 115/289 (39%), Gaps = 54/289 (18%)
Query: 411 LGKSGIGIVYKVVLEDGHTLAVRRLGEGGSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWS 470
+G G+V+ + +A++ + EG ++F E + + K+ H +V L
Sbjct: 12 IGSGQFGLVWLGYWLEKRKVAIKTIREGAMSE-EDFIEEAQVMMKLSHPKLVQLYGVCTE 70
Query: 471 VDEKLLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYV 530
L+++++ +G L+ L + G S + + + + +G+ YL + +
Sbjct: 71 RSPICLVFEFMEHGCLSDYLRAQRGKFSQETL-----LGMCLDVCEGMAYLESSN---VI 122
Query: 531 HGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQKSVSLEVT 590
H DL N L+G N VSDFG+ R V +
Sbjct: 123 HRDLAARNCLVGENQVVKVSDFGMTRF---------------------------VLDDQY 155
Query: 591 TTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMIT-GRTAVVQVGSSEMDLVNW 649
T+++ + + +PE K S K D++S+GV++ E+ + G+T +SE+
Sbjct: 156 TSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEV----- 210
Query: 650 MQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPT 698
+E + P LA +V ++ C PE RP+
Sbjct: 211 ----VETINAGFRLYKPRLASQ--------SVYELMQHCWKERPEDRPS 247
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 7e-12
Identities = 60/280 (21%), Positives = 106/280 (37%), Gaps = 60/280 (21%)
Query: 431 AVRRLGEGGSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIY---DYIPNGSLA 487
A++ + EG + +F E + + K+ H N+V L Y ++ I+ +Y+ NG L
Sbjct: 32 AIKMIREG-AMSEDDFIEEAKVMMKLSHPNLVQL---YGVCTKQRPIFIVTEYMANGCLL 87
Query: 488 TALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEP 547
L + G + + + + + + YL ++H DL N L+G +
Sbjct: 88 NYLRERKGKLGT-----EWLLDMCSDVCEAMEYLES---NGFIHRDLAARNCLVGEDNVV 139
Query: 548 HVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPES 607
VSDFGLAR V + T++ + + PE
Sbjct: 140 KVSDFGLARY---------------------------VLDDQYTSSQGTKFPVKWAPPEV 172
Query: 608 LKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGSSEMDLVNWMQLCIEEKKPLADVLD-P 666
+ S K D++S+GV++ E+ + M + + E L P
Sbjct: 173 FDYSRFSSKSDVWSFGVLMWEVFSEGK---------MPYERFSNSEVVESVSAGYRLYRP 223
Query: 667 YLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDAL 706
LAP E+ ++ +C H PE RP + + L
Sbjct: 224 KLAP-----TEVYTIMY---SCWHEKPEDRPAFKKLLSQL 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 65.7 bits (160), Expect = 8e-12
Identities = 68/296 (22%), Positives = 116/296 (39%), Gaps = 60/296 (20%)
Query: 411 LGKSGIGIVYKVVLEDGHTLAVRRLGEGGSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWS 470
LG G+V + +A++ + EG S EF E + + K+ H +V L
Sbjct: 12 LGTGQFGVVKYGKWRGQYDVAIKMIKEG-SMSEDEFIEEAKVMMKLSHEKLVQLYGVCTK 70
Query: 471 VDEKLLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYV 530
++ +Y+ NG L L + F P +++ K + +G+ YL K+++
Sbjct: 71 QRPIYIVTEYMSNGCLLNYL--REHGKRFQPSQL---LEMCKDVCEGMAYLES---KQFI 122
Query: 531 HGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQKSVSLEVT 590
H DL N L+ VSDFGL+R V
Sbjct: 123 HRDLAARNCLVDDQGCVKVSDFGLSRY-------------------------------VL 151
Query: 591 TTNSSSNLGSYY----QAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGSSEMDL 646
+S++GS + PE L K S K D++++GV++ E V +G +
Sbjct: 152 DDEYTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWE-------VYSLGKMPYER 204
Query: 647 VNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHI 702
N + + + L + P+LA + V I +C H E+RPT + +
Sbjct: 205 FNNSETVEKVSQGLR-LYRPHLASE--------KVYAIMYSCWHEKAEERPTFQQL 251
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 8e-12
Identities = 45/192 (23%), Positives = 75/192 (39%), Gaps = 43/192 (22%)
Query: 445 EFQTEVEAIGKIRHSNIVTLRAYYWSVDEKL-LIYDYIPNGSLATALHGKPGMVSFTPVP 503
+F E + + H N++ R Y + L ++ + P GSL L K + +
Sbjct: 42 DFLKEAAIMHSLDHENLI--RLYGVVLTHPLMMVTELAPLGSLLDRLR-KDAL-GHFLIS 97
Query: 504 ----WSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLAN 559
++V+ IA G+ YL K+++H DL NILL + + + DFGL R
Sbjct: 98 TLCDYAVQ------IANGMRYLES---KRFIHRDLAARNILLASDDKVKIGDFGLMRALP 148
Query: 560 IAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDI 619
++ + + + APESL+ S D+
Sbjct: 149 QNEDHYVMEEHL-------------------------KVPFAWCAPESLRTRTFSHASDV 183
Query: 620 YSYGVILLEMIT 631
+ +GV L EM T
Sbjct: 184 WMFGVTLWEMFT 195
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 8e-12
Identities = 70/304 (23%), Positives = 128/304 (42%), Gaps = 66/304 (21%)
Query: 411 LGKSGIGIVYKVVLEDGHTLAVRRLGEGGSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWS 470
LG G V+ +A++ L +G S + F E + +++H +V L A +
Sbjct: 14 LGAGQFGEVWMGYYNGHTKVAIKSLKQG-SMSPEAFLAEANLMKQLQHPRLVRLYAVV-T 71
Query: 471 VDEKLLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIK------GIAKGLVYLHEF 524
+ +I +Y+ NGSL V F P +++ I K IA+G+ ++
Sbjct: 72 QEPIYIITEYMENGSL----------VDFLKTPEGIKLTINKLIDMAAQIAEGMAFIER- 120
Query: 525 SPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQKS 584
K Y+H DL+ +NIL+ + ++DFGLARL ++ N A + + K
Sbjct: 121 --KNYIHRDLRAANILVSETLCCKIADFGLARL---------IEDNEYTAREGAKFPIK- 168
Query: 585 VSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMIT-GRTAVVQVGSSE 643
+ APE++ + K D++S+G++L E++T GR + + E
Sbjct: 169 -----------------WTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPE 211
Query: 644 MDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHIS 703
+ + ++ Y P D E + ++ C PE+RPT ++
Sbjct: 212 V---------------IQNLERGYRMPRPDNCPE--ELYELMRLCWKEKPEERPTFEYLR 254
Query: 704 DALD 707
L+
Sbjct: 255 SVLE 258
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 9e-12
Identities = 78/325 (24%), Positives = 127/325 (39%), Gaps = 84/325 (25%)
Query: 411 LGKSGIGIVYKVVLEDGHTL---------AVRRLGEGGSQRFKEFQTEVEAIGKIRHSNI 461
LG+ G KV L + H L AV+ L E ++FQ E E + ++H +I
Sbjct: 13 LGEGAFG---KVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHI 69
Query: 462 VTLRAYYWSVDEKLLIYDYIPNGSLATAL--HGKPG-------MVSFTPVPWSVRVKIIK 512
V L++++Y+ +G L L HG V+ + + I
Sbjct: 70 VRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIAS 129
Query: 513 GIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANI-------AGGSP 565
IA G+VYL +VH DL N L+G + + DFG++R +I GG
Sbjct: 130 QIASGMVYLASL---HFVHRDLATRNCLVGQGLVVKIGDFGMSR--DIYSTDYYRVGGRT 184
Query: 566 TLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVI 625
L MP PES+ K + + DI+S+GV+
Sbjct: 185 MLPIRWMP-------------------------------PESILYRKFTTESDIWSFGVV 213
Query: 626 LLEMIT-GRTAVVQVGSSE-MDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLK 683
L E+ T G+ Q+ ++E ++ CI + + L P P E+ A+++
Sbjct: 214 LWEIFTYGKQPWYQLSNTEAIE-------CITQGRELE---RPRTCPP-----EVYAIMQ 258
Query: 684 IAMACVHSSPEKRPTMRHISDALDR 708
C P++R ++ I L
Sbjct: 259 ---GCWQREPQQRMVIKDIHSRLQA 280
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 65.7 bits (161), Expect = 1e-11
Identities = 60/236 (25%), Positives = 92/236 (38%), Gaps = 45/236 (19%)
Query: 410 VLGKSGIGIVYKVV-LEDGHTLAVRRLGEGGSQRFKEFQ---TEVEAIGKIRHSNIVTLR 465
+GK G V KV DG L + + G KE Q +EV + +++H NIV R
Sbjct: 7 TIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTE-KEKQQLVSEVNILRELKHPNIV--R 63
Query: 466 AYYWSVD---EKLLIY-DYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYL 521
Y +D + L I +Y G LA + + + +I+ + L
Sbjct: 64 YYDRIIDRSNQTLYIVMEYCEGGDLAQLI--QKCKKERKYIEEEFIWRILTQLLLALYEC 121
Query: 522 HEFSPKKYV--HGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQE 579
H S H DLKP+NI L N + DFGLA++ L + A
Sbjct: 122 HNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKI---------LGHDSSFA----- 167
Query: 580 RQQKSVSLEVTTTNSSSNLGS-YYQAPESLKVVKPSQKWDIYSYGVILLEMITGRT 634
+ +G+ YY +PE L + +K DI+S G ++ E+
Sbjct: 168 ---------------KTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSP 208
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 1e-11
Identities = 73/298 (24%), Positives = 128/298 (42%), Gaps = 54/298 (18%)
Query: 411 LGKSGIGIVYKVVLEDGHTLAVRRLGEGGSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWS 470
LG G V+ +AV+ L + G+ + F E + + K+RH +V L A S
Sbjct: 14 LGNGQFGEVWMGTWNGNTKVAVKTL-KPGTMSPESFLEEAQIMKKLRHDKLVQLYAVV-S 71
Query: 471 VDEKLLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYV 530
+ ++ +Y+ GSL L G P V + +A G+ Y+ + Y+
Sbjct: 72 EEPIYIVTEYMSKGSLLDFLKDGEGRALKLPN----LVDMAAQVAAGMAYIERMN---YI 124
Query: 531 HGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQKSVSLEVT 590
H DL+ +NIL+G + ++DFGLARL ++ N A RQ ++ T
Sbjct: 125 HRDLRSANILVGDGLVCKIADFGLARL---------IEDNEYTA-----RQGAKFPIKWT 170
Query: 591 TTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMIT-GRTAVVQVGSSEMDLVNW 649
APE+ + + K D++S+G++L E++T GR + + E+
Sbjct: 171 -------------APEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREV----- 212
Query: 650 MQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDALD 707
L V Y P ++ I++ ++ + C PE+RPT ++ L+
Sbjct: 213 ----------LEQVERGYRMPCP--QDCPISLHELMLQCWKKDPEERPTFEYLQSFLE 258
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 1e-11
Identities = 78/323 (24%), Positives = 133/323 (41%), Gaps = 77/323 (23%)
Query: 410 VLGKSGIGIVYKV-VLEDGHTL--AVRRLGEGGSQR-FKEFQTEVEAIGKI-RHSNIVTL 464
V+G+ G V K + +DG + A++R+ E S+ ++F E+E + K+ H NI+ L
Sbjct: 14 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 73
Query: 465 ------RAYYWSVDEKLLIYDYIPNGSL------ATALHGKPGMV----SFTPVPWSVRV 508
R Y + L +Y P+G+L + L P + + + +
Sbjct: 74 LGACEHRGYLY------LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL 127
Query: 509 KIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQ 568
+A+G+ YL S K+++H DL NIL+G N ++DFGL+R
Sbjct: 128 HFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR------------ 172
Query: 569 SNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLE 628
EV + L + A ESL + D++SYGV+L E
Sbjct: 173 -----------------GQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWE 215
Query: 629 MIT-GRTAVVQVGSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMA 687
+++ G T + +E+ EK P L+ L D + V +
Sbjct: 216 IVSLGGTPYCGMTCAEL----------YEKLPQGYRLEKPLNCDDE-------VYDLMRQ 258
Query: 688 CVHSSPEKRPTMRHISDALDRLI 710
C P +RP+ I +L+R++
Sbjct: 259 CWREKPYERPSFAQILVSLNRML 281
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 1e-11
Identities = 61/231 (26%), Positives = 99/231 (42%), Gaps = 48/231 (20%)
Query: 411 LGKSGIGIVYKVVLE-DGHTLAVRRLGEGGSQRF--KEFQTEVEAIGKIRHSNIVTLRAY 467
+GK G+V+KVV + D A++++ R +E E + K+ S I+ Y
Sbjct: 8 IGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIR---Y 64
Query: 468 YWSVDEKLLIY---DYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEF 524
Y S +K + +Y NG L L + G P+P + I GL +LH
Sbjct: 65 YESFLDKGKLNIVMEYAENGDLHKLLKMQRG----RPLPEDQVWRFFIQILLGLAHLHS- 119
Query: 525 SPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQKS 584
KK +H D+K N+ L + D G+A+L
Sbjct: 120 --KKILHRDIKSLNLFLDAYDNVKIGDLGVAKL--------------------------- 150
Query: 585 VSLEVTTTNSSSNLGS-YYQAPESLKVVKP-SQKWDIYSYGVILLEMITGR 633
L T +++ +G+ YY +PE L KP ++K D+++ GV+L E TG+
Sbjct: 151 --LSDNTNFANTIVGTPYYLSPE-LCEDKPYNEKSDVWALGVVLYECCTGK 198
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.8 bits (161), Expect = 2e-11
Identities = 43/176 (24%), Positives = 72/176 (40%), Gaps = 23/176 (13%)
Query: 467 YYWSVDEKL-LIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLV----YL 521
Y + +E L L+ +Y+P G L L K + + LV +
Sbjct: 68 YSFQDEEHLYLVMEYMPGGDLMNLLIRKD----------VFPEETARFYIAELVLALDSV 117
Query: 522 HEFSPKKYVHGDLKPSNILLGHNMEPHV--SDFGLARLANIAGGSPTLQSNRMPAEKPQE 579
H+ ++H D+KP NIL+ + H+ +DFGL + N A ++
Sbjct: 118 HKLG---FIHRDIKPDNILID--ADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDN 172
Query: 580 RQQKSVSLEVTTTNSSSNLGSY-YQAPESLKVVKPSQKWDIYSYGVILLEMITGRT 634
+ + ++S +G+ Y APE L+ + D +S GVIL EM+ G
Sbjct: 173 VLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFP 228
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 64.7 bits (158), Expect = 3e-11
Identities = 59/229 (25%), Positives = 96/229 (41%), Gaps = 43/229 (18%)
Query: 410 VLGKSGIGIVYKVV-LEDGHT----LAVRRLGEG-GSQRFKEFQTEVEAIGKIRHSNIVT 463
VLG G VYK V + +G +A++ L E + KE E + + H ++V
Sbjct: 14 VLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVR 73
Query: 464 LRAYYWSVDEKLLIYDYIPNGSLATALHGKPGMV-SFTPVPWSVRVKIIKGIAKGLVYLH 522
L S + LI +P G L + + S + W V+ IAKG+ YL
Sbjct: 74 LLGICLS-SQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQ------IAKGMSYLE 126
Query: 523 EFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQ 582
E K+ VH DL N+L+ ++DFGLA+L ++ + ++P +
Sbjct: 127 E---KRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIK------- 176
Query: 583 KSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMIT 631
+ A ES+ + K D++SYGV + E++T
Sbjct: 177 -------------------WMALESILHRIYTHKSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.3 bits (157), Expect = 3e-11
Identities = 63/274 (22%), Positives = 106/274 (38%), Gaps = 69/274 (25%)
Query: 449 EVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRV 508
EV+ + ++RH NIV L+ + L+++Y+ +L L PG + P +VR
Sbjct: 50 EVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYVER-TLLELLEASPGGLP----PDAVR- 103
Query: 509 KIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQ 568
I + + + Y H +H D+KP NIL+ + + DFG AR
Sbjct: 104 SYIWQLLQAIAYCHS---HNIIHRDIKPENILVSESGVLKLCDFGFARA----------- 149
Query: 569 SNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSY-----YQAPESLKVVKPSQ---KWDIY 620
+S L Y Y+APE L V + D++
Sbjct: 150 ---------------------LRARPASPLTDYVATRWYRAPELL--VGDTNYGKPVDVW 186
Query: 621 SYGVILLEMITGRTAVVQVGSSEMDLVNWMQLCIEEKKPLADVL---DPYLA----PDAD 673
+ G I+ E++ G + G S++D + +Q C+ P L +P A P+
Sbjct: 187 AIGCIMAELLDGEP--LFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVAFPEPS 244
Query: 674 KEEEIIA---------VLKIAMACVHSSPEKRPT 698
+ E + L AC+ P++R T
Sbjct: 245 QPESLERRYPGKVSSPALDFLKACLRMDPKERLT 278
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 4e-11
Identities = 38/114 (33%), Positives = 63/114 (55%)
Query: 64 QRVVSVSIPKKKLLGFLPSALGSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNS 123
+R+ ++ + + + G +P LGSL++L + L NK G +P EL + L SL L N
Sbjct: 475 KRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQ 534
Query: 124 FSGSVPNEIGKLKYLQILDLSQNFFNGSLPVSIVQCKRLKALDLSQNNFTGPLP 177
SG +P ++ L LDLSQN +G +P ++ + L +++S N+ G LP
Sbjct: 535 LSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLP 588
|
Length = 968 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 5e-11
Identities = 67/299 (22%), Positives = 128/299 (42%), Gaps = 56/299 (18%)
Query: 411 LGKSGIGIVYKVVLEDGHTLAVRRLGEGGSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWS 470
LG G V+ +AV+ + + GS + F E + ++H +V L A +
Sbjct: 14 LGAGQFGEVWMATYNKHTKVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLVKLHAVV-T 71
Query: 471 VDEKLLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYV 530
+ +I +++ GSL L G + P + IA+G+ ++ + + Y+
Sbjct: 72 KEPIYIITEFMAKGSLLDFLKSDEG----SKQPLPKLIDFSAQIAEGMAFIEQ---RNYI 124
Query: 531 HGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQKSVSLEVT 590
H DL+ +NIL+ ++ ++DFGLAR+ ++ N A + + K
Sbjct: 125 HRDLRAANILVSASLVCKIADFGLARV---------IEDNEYTAREGAKFPIK------- 168
Query: 591 TTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMIT-GRTAVVQVGSSEMDLVNW 649
+ APE++ + K D++S+G++L+E++T GR + + E+
Sbjct: 169 -----------WTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEV----- 212
Query: 650 MQLCIEEKKPLADVLDPYLAPDADK-EEEIIAVLKIAMACVHSSPEKRPTMRHISDALD 707
+ + Y P + EE+ ++ M C + PE+RPT +I LD
Sbjct: 213 ----------IRALERGYRMPRPENCPEELYNIM---MRCWKNRPEERPTFEYIQSVLD 258
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 63.0 bits (154), Expect = 8e-11
Identities = 49/195 (25%), Positives = 81/195 (41%), Gaps = 37/195 (18%)
Query: 442 RFKEFQTEVEAIGKIRHSNIVTLRAYYWSV--DEKL-LIYDYIPNGSLATALHGKPGMVS 498
+ + TE + + + + +V L Y+S + L L+ +Y+P G LA+ L +
Sbjct: 36 QVDQVLTERDILSQAQSPYVVKL---YYSFQGKKNLYLVMEYLPGGDLASLLE------N 86
Query: 499 FTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLA 558
+ V I I L YLH +H DLKP NIL+ N ++DFGL+++
Sbjct: 87 VGSLDEDVARIYIAEIVLALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKV- 142
Query: 559 NIAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGS-YYQAPESLKVVKPSQKW 617
G ++ ++L +G+ Y APE + S+
Sbjct: 143 ----GL----------------VRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTV 182
Query: 618 DIYSYGVILLEMITG 632
D +S G IL E + G
Sbjct: 183 DWWSLGCILYEFLVG 197
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 8e-11
Identities = 63/264 (23%), Positives = 114/264 (43%), Gaps = 57/264 (21%)
Query: 446 FQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGSLATALHGKPGMVSFTPVPWS 505
F E + K+ H N+V L + ++ + + G+L L + + V
Sbjct: 46 FLEETAVMTKLHHKNLVRLLGVILH-NGLYIVMELMSKGNLVNFLRTRGR--ALVSVIQL 102
Query: 506 VRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSP 565
++ + +A+G+ YL KK VH DL NIL+ + VSDFGLAR+ GS
Sbjct: 103 LQFSL--DVAEGMEYLES---KKLVHRDLAARNILVSEDGVAKVSDFGLARV-----GSM 152
Query: 566 TLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVI 625
+ ++++P + + APE+LK K S K D++SYGV+
Sbjct: 153 GVDNSKLPVK--------------------------WTAPEALKHKKFSSKSDVWSYGVL 186
Query: 626 LLEMIT-GRTAVVQVGSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKI 684
L E+ + GR ++ + ++ C+E+ ++P E V +
Sbjct: 187 LWEVFSYGRAPYPKMS------LKEVKECVEK----GYRMEP-------PEGCPADVYVL 229
Query: 685 AMACVHSSPEKRPTMRHISDALDR 708
+C + P+KRP+ + + L++
Sbjct: 230 MTSCWETEPKKRPSFHKLREKLEK 253
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 62.8 bits (152), Expect = 9e-11
Identities = 74/298 (24%), Positives = 130/298 (43%), Gaps = 54/298 (18%)
Query: 411 LGKSGIGIVYKVVLEDGHTLAVRRLGEGGSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWS 470
LG+ G V+ +A++ L + G+ + F E + + K+RH +V L A S
Sbjct: 14 LGQGCFGEVWMGTWNGTTKVAIKTL-KPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVV-S 71
Query: 471 VDEKLLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYV 530
+ ++ +++ GSL L K G + +P V + IA G+ Y+ + Y+
Sbjct: 72 EEPIYIVTEFMGKGSLLDFL--KEGDGKYLKLPQ--LVDMAAQIADGMAYIERMN---YI 124
Query: 531 HGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQKSVSLEVT 590
H DL+ +NIL+G N+ ++DFGLARL ++ N A RQ ++ T
Sbjct: 125 HRDLRAANILVGDNLVCKIADFGLARL---------IEDNEYTA-----RQGAKFPIKWT 170
Query: 591 TTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMIT-GRTAVVQVGSSEMDLVNW 649
APE+ + + K D++S+G++L E++T GR + + E+
Sbjct: 171 -------------APEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREV----- 212
Query: 650 MQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDALD 707
L V Y P E ++ ++ C P++RPT +I L+
Sbjct: 213 ----------LEQVERGYRMPCPQGCPE--SLHELMKLCWKKDPDERPTFEYIQSFLE 258
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.9 bits (151), Expect = 1e-10
Identities = 62/240 (25%), Positives = 101/240 (42%), Gaps = 60/240 (25%)
Query: 402 ELLKASAFVLGKSGIGIVYK-VVLEDGHTLAVR--RLGEGGSQRFKEFQTEVEAIGKIRH 458
EL++ +G G VYK + G +A++ +L G F+ Q E+ + + RH
Sbjct: 6 ELIQ----RIGSGTYGDVYKARDIATGELVAIKVIKLEPG--DDFEIIQQEISMLKECRH 59
Query: 459 SNIVTLRAYY--WSVDEKLLI-YDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIA 515
NIV AY+ + +KL I +Y GSL V+ P+ + +
Sbjct: 60 PNIV---AYFGSYLRRDKLWIVMEYCGGGSLQDIYQ-----VTRGPLSELQIAYVCRETL 111
Query: 516 KGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAE 575
KGL YLHE +H D+K +NILL + + ++DFG
Sbjct: 112 KGLAYLHE---TGKIHRDIKGANILLTEDGDVKLADFG---------------------- 146
Query: 576 KPQERQQKSVSLEVTTTNSSSN--LGS-YYQAPESLKVVKPS---QKWDIYSYGVILLEM 629
VS ++T T + +G+ Y+ APE V + K DI++ G+ +E+
Sbjct: 147 ---------VSAQLTATIAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIEL 197
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 2e-10
Identities = 74/332 (22%), Positives = 131/332 (39%), Gaps = 76/332 (22%)
Query: 402 ELLKASAFVL-GKSGIGIVYKVVLEDGHTLAVRRLGEGGSQ-RFKEFQTEVEAIGKIRHS 459
+++KA+AF L G++G T+AV+ L E S ++ +E + ++ H
Sbjct: 15 KVVKATAFRLKGRAGYT-----------TVAVKMLKENASSSELRDLLSEFNLLKQVNHP 63
Query: 460 NIVTLRAYYWSVDEKLLIYDYIPNGSLATALHGK----PGMVS----------FTPVPWS 505
+++ L LLI +Y GSL + L P + P +
Sbjct: 64 HVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERA 123
Query: 506 VRVKIIKG----IAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIA 561
+ + + I++G+ YL E K VH DL N+L+ + +SDFGL+R
Sbjct: 124 LTMGDLISFAWQISRGMQYLAEM---KLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEE 180
Query: 562 GGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYS 621
R+P + + A ESL + + D++S
Sbjct: 181 DSYVKRSKGRIPVK--------------------------WMAIESLFDHIYTTQSDVWS 214
Query: 622 YGVILLEMITGRTAVVQVGSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAV 681
+GV+L E++T G + L N ++ ++ P+ EE +
Sbjct: 215 FGVLLWEIVT-LGGNPYPGIAPERLFNLLKTGYRMER-----------PENCSEE----M 258
Query: 682 LKIAMACVHSSPEKRPTMRHISDALDRLIVSS 713
+ + C P+KRPT IS L++++V S
Sbjct: 259 YNLMLTCWKQEPDKRPTFADISKELEKMMVKS 290
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 2e-10
Identities = 59/229 (25%), Positives = 97/229 (42%), Gaps = 42/229 (18%)
Query: 411 LGKSGIGIVYKVV-LEDGHTLAVRRLGEGGSQRFKEFQ---TEVEAIGKIRHSNIVTLRA 466
LGK G VYKV L D A++ + + GS KE + E+ + + H NI++ +
Sbjct: 8 LGKGSYGSVYKVKRLSDNQFYALKEV-DLGSMSQKEREDAVNEIRILASVNHPNIISYKE 66
Query: 467 YYWSVDEKLLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSP 526
+ ++ ++ +Y P G L+ A+ +P +I + +GL LHE
Sbjct: 67 AFLDGNKLCIVMEYAPFGDLSKAI--SKRKKKRKLIPEQEIWRIFIQLLRGLQALHE--- 121
Query: 527 KKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQKSVS 586
+K +H DLK +NILL N + D G++++
Sbjct: 122 QKILHRDLKSANILLVANDLVKIGDLGISKVL---------------------------- 153
Query: 587 LEVTTTNSSSNLGS-YYQAPESLKVVKPSQKWDIYSYGVILLEMITGRT 634
+ + +G+ +Y APE K S K DI+S G +L EM T
Sbjct: 154 ---KKNMAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAP 199
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 2e-10
Identities = 57/231 (24%), Positives = 97/231 (41%), Gaps = 48/231 (20%)
Query: 411 LGKSGIGIVYKVV-LEDGHTLAVRRLGEG-----GSQRFKEFQTEVEAIGKIRHSNIVTL 464
LG+ G VY ++ G LAV+++ + + E++ + ++H IV
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQ- 68
Query: 465 RAYY--WSVDEKLLIY-DYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYL 521
YY DE L I+ +Y+P GS+ K + ++ + +V K + I +G+ YL
Sbjct: 69 --YYGCLRDDETLSIFMEYMPGGSV------KDQLKAYGALTETVTRKYTRQILEGVEYL 120
Query: 522 HEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQ 581
H VH D+K +NIL + DF G S LQ+
Sbjct: 121 HS---NMIVHRDIKGANILRDSAGNVKLGDF---------GASKRLQTICS--------- 159
Query: 582 QKSVSLEVTTTNSSSNLGS-YYQAPESLKVVKPSQKWDIYSYGVILLEMIT 631
+ T S G+ Y+ +PE + +K D++S G ++EM+T
Sbjct: 160 --------SGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLT 202
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 2e-10
Identities = 82/349 (23%), Positives = 146/349 (41%), Gaps = 76/349 (21%)
Query: 386 QYDLVPLDTQVAFDLDELLKASAFVLGKS-GIGIVYKVVL-----------EDGHTLAVR 433
+Y+L P D + F D+L LGK G G +VV+ ++ T+AV+
Sbjct: 1 EYEL-PEDPRWEFSRDKL------TLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVK 53
Query: 434 RLGEGGSQR-FKEFQTEVEAIGKI-RHSNIVTLRAYYWSVDEKLLIYDYIPNGSLATALH 491
L + +++ + +E+E + I +H NI+ L +I +Y G+L L
Sbjct: 54 MLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLR 113
Query: 492 GK--PGM--------VSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILL 541
+ PGM V + + V +A+G+ YL + +K +H DL N+L+
Sbjct: 114 ARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYL---ASQKCIHRDLAARNVLV 170
Query: 542 GHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSY 601
N ++DFGLAR N + R+P +
Sbjct: 171 TENNVMKIADFGLARDVNNIDYYKKTTNGRLPVK-------------------------- 204
Query: 602 YQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGSSEMDLVNWMQLCIEEKKPLA 661
+ APE+L + + D++S+GV++ E+ T +G S + + +EE L
Sbjct: 205 WMAPEALFDRVYTHQSDVWSFGVLMWEIFT-------LGGSP-----YPGIPVEELFKLL 252
Query: 662 DVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDALDRLI 710
P A+ E+ +++ C H+ P RPT + + + LDR++
Sbjct: 253 KEGHRMDKP-ANCTNELYMMMR---DCWHAIPSHRPTFKQLVEDLDRIL 297
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 3e-10
Identities = 72/313 (23%), Positives = 128/313 (40%), Gaps = 76/313 (24%)
Query: 410 VLGKS--GIGIVYKVVLEDGHTLAVR-----RLGEGGSQRFKEFQTEVEAIGKIRHSNIV 462
VLGK G +Y+ ED + + RL E ++ E+ + ++H NI+
Sbjct: 7 VLGKGAFGEATLYRRT-EDDSLVVWKEVNLTRLSEKER---RDALNEIVILSLLQHPNII 62
Query: 463 TLRAYYWSV--DEKLLI-YDYIPNGSLATAL-HGKPGMVSFTPVPWSVRVKIIKGIAKGL 518
AYY D LLI +Y G+L + K + V W +I+ ++
Sbjct: 63 ---AYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLW-YLFQIVSAVS--- 115
Query: 519 VYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQ 578
Y+H+ +H D+K NI L + DFG++++ L S AE
Sbjct: 116 -YIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKI---------LGSEYSMAE--- 159
Query: 579 ERQQKSVSLEVTTTNSSSNLGS-YYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVV 637
+ +G+ YY +PE + VK + K DI++ G +L E++T +
Sbjct: 160 -----------------TVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTF- 201
Query: 638 QVGSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRP 697
++ ++LV + V+ Y + E+I+++ + + PEKRP
Sbjct: 202 -DATNPLNLVVKIVQGNY-----TPVVSVYSS-------ELISLVH---SLLQQDPEKRP 245
Query: 698 TMRHISDALDRLI 710
T + LD+ +
Sbjct: 246 TA---DEVLDQPL 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 3e-10
Identities = 58/244 (23%), Positives = 98/244 (40%), Gaps = 52/244 (21%)
Query: 411 LGKSGIGIVYK------VVLEDGHTLAVRRLGEGGS-QRFKEFQTEVEAIGKIRHSNIVT 463
+G+ G V++ + E +AV+ L E S +FQ E + + H NIV
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72
Query: 464 LRAYYWSVDEKLLIYDYIPNGSLATAL------------HGKPGMVSFTPVPWSV----R 507
L L+++Y+ G L L H P + +
Sbjct: 73 LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132
Query: 508 VKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTL 567
+ I K +A G+ YL E +K+VH DL N L+G NM ++DFGL+R NI
Sbjct: 133 LCIAKQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVVKIADFGLSR--NI------- 180
Query: 568 QSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILL 627
S + + + + + PES+ + + + D+++YGV+L
Sbjct: 181 -----------------YSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLW 223
Query: 628 EMIT 631
E+ +
Sbjct: 224 EIFS 227
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 4e-10
Identities = 57/210 (27%), Positives = 87/210 (41%), Gaps = 44/210 (20%)
Query: 427 GHTLAVRRLGEGGSQRFKEFQT--EVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNG 484
G +A++++ + S +T E++ + +RH NI++L + S E + +
Sbjct: 35 GQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVTELLGT 94
Query: 485 SLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHN 544
L L +P F + I +GL Y+H VH DLKPSNIL+ N
Sbjct: 95 DLHRLLTSRPLEKQFIQY-------FLYQILRGLKYVHS---AGVVHRDLKPSNILINEN 144
Query: 545 MEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQA 604
+ + DFGLAR Q+ Q V+T YY+A
Sbjct: 145 CDLKICDFGLAR--------------------IQDPQMTGY---VST--------RYYRA 173
Query: 605 PE-SLKVVKPSQKWDIYSYGVILLEMITGR 633
PE L K + DI+S G I EM+ G+
Sbjct: 174 PEIMLTWQKYDVEVDIWSAGCIFAEMLEGK 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 5e-10
Identities = 57/188 (30%), Positives = 90/188 (47%), Gaps = 40/188 (21%)
Query: 449 EVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGSLATAL--HGKPGMVSFTPVPWSV 506
E+ + +++H NIV L + ++ +L+++Y+ + L + HG G + V S
Sbjct: 48 EISLMKELKHENIVRLHDVIHTENKLMLVFEYM-DKDLKKYMDTHGVRGALDPNTVK-SF 105
Query: 507 RVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPT 566
+++KGIA + HE + +H DLKP N+L+ E ++DFGLAR A G P
Sbjct: 106 TYQLLKGIA----FCHE---NRVLHRDLKPQNLLINKRGELKLADFGLAR----AFGIPV 154
Query: 567 LQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKP-SQKWDIYSYGVI 625
+ S EV T +Y+AP+ L + S DI+S G I
Sbjct: 155 ----------------NTFSNEVVTL--------WYRAPDVLLGSRTYSTSIDIWSVGCI 190
Query: 626 LLEMITGR 633
+ EMITGR
Sbjct: 191 MAEMITGR 198
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 6e-10
Identities = 38/126 (30%), Positives = 56/126 (44%), Gaps = 35/126 (27%)
Query: 509 KIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQ 568
KI + + KGL YLH +K +H D+KPSNILL + + DFG
Sbjct: 109 KIAESVLKGLSYLHS---RKIIHRDIKPSNILLTRKGQVKLCDFG--------------- 150
Query: 569 SNRMPAEKPQERQQKSVSLEVTTTNSSSNLG-SYYQAPESLKVVKPSQKWDIYSYGVILL 627
VS E+ + + + G S+Y APE ++ S D++S G+ LL
Sbjct: 151 ----------------VSGELVNSLAGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLL 194
Query: 628 EMITGR 633
E+ R
Sbjct: 195 EVAQNR 200
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 6e-10
Identities = 61/268 (22%), Positives = 106/268 (39%), Gaps = 61/268 (22%)
Query: 446 FQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIY---DYIPNGSLATALHGKPGMVSFTPV 502
F E + ++RHSN+V L V+EK +Y +Y+ GSL L + V +
Sbjct: 46 FLAEASVMTQLRHSNLVQLLGVI--VEEKGGLYIVTEYMAKGSLVDYLRSRGRSV----L 99
Query: 503 PWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAG 562
+K + + + YL +VH DL N+L+ + VSDFGL +
Sbjct: 100 GGDCLLKFSLDVCEAMEYLEA---NNFVHRDLAARNVLVSEDNVAKVSDFGLTK------ 150
Query: 563 GSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSY 622
E ++T + L + APE+L+ K S K D++S+
Sbjct: 151 -------------------------EASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSF 185
Query: 623 GVILLEMIT-GRTAVVQVGSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAV 681
G++L E+ + GR V + ++ +++ P + APD V
Sbjct: 186 GILLWEIYSFGR-------------VPYPRIPLKDVVPRVEKGYKMDAPDGCPP----VV 228
Query: 682 LKIAMACVHSSPEKRPTMRHISDALDRL 709
+ C H RP+ + + L+ +
Sbjct: 229 YDVMKQCWHLDAATRPSFLQLREQLEHI 256
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 6e-10
Identities = 58/171 (33%), Positives = 83/171 (48%), Gaps = 7/171 (4%)
Query: 77 LGFLPSALGSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSGSVPNEIGKLK 136
L S L LT+L ++L NN PL L L+ L L N S+P+ + L
Sbjct: 105 LRSNISELLELTNLTSLDLDNNNITDIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLP 163
Query: 137 YLQILDLSQNFFNGSLPVSIVQCKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLNLSFNK 196
L+ LDLS N + LP + L LDLS N + LP L +LE+L+LS N
Sbjct: 164 NLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPP-EIELLSALEELDLSNNS 220
Query: 197 FNGSIPSNTGNLSSLQGTVDFSHNLFSGSIPASLGNLPEKVYIDLTYNNLS 247
+ S+ NL +L G ++ S+N +P S+GNL +DL+ N +S
Sbjct: 221 II-ELLSSLSNLKNLSG-LELSNNKLE-DLPESIGNLSNLETLDLSNNQIS 268
|
Length = 394 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 60.0 bits (146), Expect = 7e-10
Identities = 57/238 (23%), Positives = 95/238 (39%), Gaps = 52/238 (21%)
Query: 411 LGKSGIGIVYK-----VVLEDGHT-LAVRRLGEGGSQRFK-EFQTEVEAIGKIRHSNIVT 463
LG+ G+VY+ VV + T +A++ + E S R + EF E + + ++V
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 464 LRAYYWSVDEKLLIYDYIPNGSLATALHGK-PGMVSFTPVPWSVRVKIIK---GIAKGLV 519
L + L++ + + G L + L + P + + K I+ IA G+
Sbjct: 74 LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMA 133
Query: 520 YLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLAN------IAGGSPTLQSNRMP 573
YL KK+VH DL N ++ ++ + DFG+ R G +P
Sbjct: 134 YLAA---KKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKG------LLP 184
Query: 574 AEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMIT 631
+ APESLK + K D++S+GV+L EM T
Sbjct: 185 VR--------------------------WMAPESLKDGVFTTKSDVWSFGVVLWEMAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.6 bits (145), Expect = 1e-09
Identities = 60/231 (25%), Positives = 99/231 (42%), Gaps = 52/231 (22%)
Query: 410 VLGKSGIGIVYK-VVLEDGHTLAVRRLG-EGGSQRFKEFQTEVEAIGKIRHSNIVTLRAY 467
+GK G VYK + +A++ + E ++ Q E++ + + R I Y
Sbjct: 8 CIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITK---Y 64
Query: 468 YWSV--DEKL-LIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEF 524
Y S KL +I +Y GS L KPG + + I++ + GL YLHE
Sbjct: 65 YGSFLKGSKLWIIMEYCGGGSCLDLL--KPG-----KLDETYIAFILREVLLGLEYLHE- 116
Query: 525 SPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQKS 584
+ +H D+K +NILL + ++DFG
Sbjct: 117 --EGKIHRDIKAANILLSEEGDVKLADFG------------------------------- 143
Query: 585 VSLEVTTTNSSSN--LGS-YYQAPESLKVVKPSQKWDIYSYGVILLEMITG 632
VS ++T+T S N +G+ ++ APE +K +K DI+S G+ +E+ G
Sbjct: 144 VSGQLTSTMSKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKG 194
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 1e-09
Identities = 56/223 (25%), Positives = 92/223 (41%), Gaps = 36/223 (16%)
Query: 410 VLGKSGIGIVYKVVLEDGHTLAVRRLGEGGSQRFK-EFQTEVEAIGKIRHSNIVTLRAYY 468
+LGK G V+K L+D +AV+ E Q K +F +E + + H NIV L
Sbjct: 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVC 61
Query: 469 WSVDEKLLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKK 528
++ + +P G + L K + + VK A G+ YL K
Sbjct: 62 TQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQL-----VKFALDAAAGMAYLES---KN 113
Query: 529 YVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQKSVSLE 588
+H DL N L+G N +SDFG++R QE
Sbjct: 114 CIHRDLAARNCLVGENNVLKISDFGMSR---------------------QEDDG------ 146
Query: 589 VTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMIT 631
+ +++ + + APE+L + S + D++SYG++L E +
Sbjct: 147 IYSSSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFS 189
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 1e-09
Identities = 59/257 (22%), Positives = 103/257 (40%), Gaps = 51/257 (19%)
Query: 410 VLGKSGIGIVYK-VVLEDGHTLAVRRLG-EGGSQRFKEFQTEVEAIGKIRHSNIVTLRAY 467
++G+ G VY+ + G +A++ + + + Q EV + ++R S + Y
Sbjct: 8 LIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKY 67
Query: 468 Y--WSVDEKL-LIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEF 524
Y + +L +I +Y GS+ T + P + V II+ + L Y+H+
Sbjct: 68 YGSYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYISV-------IIREVLVALKYIHK- 119
Query: 525 SPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQKS 584
+H D+K +NIL+ + + DFG+A
Sbjct: 120 --VGVIHRDIKAANILVTNTGNVKLCDFGVA----------------------------- 148
Query: 585 VSLEVTTTNSSSNLGS-YYQAPESLKVVKP-SQKWDIYSYGVILLEMITGRTAVVQVGSS 642
L ++ S+ +G+ Y+ APE + K K DI+S G+ + EM TG V
Sbjct: 149 ALLNQNSSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDV--- 205
Query: 643 EMDLVNWMQLCIEEKKP 659
D M L + K P
Sbjct: 206 --DAFRAMMLIPKSKPP 220
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 2e-09
Identities = 80/298 (26%), Positives = 128/298 (42%), Gaps = 65/298 (21%)
Query: 411 LGKSGIGIVYKVVLEDGHTLAVRRLGEGGSQ-RFKEFQTEVEAIGKIRHSNIVTL-RAYY 468
LG G VYK ++ LA ++ E S+ +++ E+E + H IV L A+Y
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79
Query: 469 WSVDEKLLIY-DYIPNGSL-ATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSP 526
W D KL I ++ P G++ A L G+ P ++V I + + + L YLH
Sbjct: 80 W--DGKLWIMIEFCPGGAVDAIMLELDRGLTE----P-QIQV-ICRQMLEALQYLHS--- 128
Query: 527 KKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQKSVS 586
K +H DLK N+LL + + ++DFG++ A TLQ
Sbjct: 129 MKIIHRDLKAGNVLLTLDGDIKLADFGVS-----AKNVKTLQRR---------------- 167
Query: 587 LEVTTTNSSSNLGS-YYQAP-----ESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVG 640
S +G+ Y+ AP E++K K DI+S G+ L+EM Q+
Sbjct: 168 --------DSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEM-------AQIE 212
Query: 641 SSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPT 698
+L N M++ ++ +A P L+ + E LK A+ PE RP+
Sbjct: 213 PPHHEL-NPMRVLLK----IAKSEPPTLSQPSKWSMEFRDFLKTAL---DKHPETRPS 262
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 2e-09
Identities = 72/319 (22%), Positives = 131/319 (41%), Gaps = 69/319 (21%)
Query: 410 VLGKSGIGIVYKVVL--EDGHTL--AVRRLGEGGSQR--FKEFQTEVEAIGKIRHSNIVT 463
+LG+ G V + L +DG L AV+ + +EF +E + H N++
Sbjct: 6 ILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMK 65
Query: 464 LRAYYWSVDEK------LLIYDYIPNGSLATAL-HGKPGMVSFTPVPWSVRVKIIKGIAK 516
L + ++I ++ +G L + L + + G + +P +K + IA
Sbjct: 66 LIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEK-LPLQTLLKFMVDIAL 124
Query: 517 GLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQS--NRMPA 574
G+ YL S + ++H DL N +L +M V+DFGL++ I G Q +MP
Sbjct: 125 GMEYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSK--KIYSGDYYRQGRIAKMPV 179
Query: 575 EKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMIT-GR 633
+ + A ESL + K D++++GV + E+ T G+
Sbjct: 180 K--------------------------WIAIESLADRVYTSKSDVWAFGVTMWEIATRGQ 213
Query: 634 TAVVQVGSSEMD--LVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHS 691
T V + E+ L + +L K+P D LD + + +C +
Sbjct: 214 TPYPGVENHEIYDYLRHGNRL----KQP-EDCLD--------------ELYDLMYSCWRA 254
Query: 692 SPEKRPTMRHISDALDRLI 710
P+ RPT + + L+ ++
Sbjct: 255 DPKDRPTFTKLREVLENIL 273
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.9 bits (143), Expect = 2e-09
Identities = 50/186 (26%), Positives = 86/186 (46%), Gaps = 38/186 (20%)
Query: 449 EVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRV 508
E + ++H+NIVTL + L+++Y+ + L + G +S +VR+
Sbjct: 53 EASLLKDLKHANIVTLHDIIHTKKTLTLVFEYL-DTDLKQYMDDCGGGLS----MHNVRL 107
Query: 509 KIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQ 568
+ + + +GL Y H+ ++ +H DLKP N+L+ E ++DFGLAR ++ P+
Sbjct: 108 FLFQ-LLRGLAYCHQ---RRVLHRDLKPQNLLISERGELKLADFGLARAKSV----PS-- 157
Query: 569 SNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESL-KVVKPSQKWDIYSYGVILL 627
K+ S EV T +Y+ P+ L + S D++ G I
Sbjct: 158 --------------KTYSNEVVTL--------WYRPPDVLLGSTEYSTSLDMWGVGCIFY 195
Query: 628 EMITGR 633
EM TGR
Sbjct: 196 EMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 2e-09
Identities = 55/232 (23%), Positives = 99/232 (42%), Gaps = 48/232 (20%)
Query: 411 LGKSGIGIVYKVV-LEDGHTLAVRRLGEGGSQRFKEFQTEVEAIGKIRHSNIVTL-RAYY 468
LG G VYK E G A + + + ++F E++ + + +H NIV L AY+
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72
Query: 469 WSVDEKLLIY-DYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPK 527
+ + KL I ++ G+L ++ + P +R + + + + L +LH
Sbjct: 73 Y--ENKLWILIEFCDGGAL-DSIMLELERGLTEP---QIRY-VCRQMLEALNFLHS---H 122
Query: 528 KYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQKSVSL 587
K +H DLK NILL + + ++DFG++ A+ Q++
Sbjct: 123 KVIHRDLKAGNILLTLDGDVKLADFGVS------------------AKNKSTLQKR---- 160
Query: 588 EVTTTNSSSNLGS-YYQAP-----ESLKVVKPSQKWDIYSYGVILLEMITGR 633
+ +G+ Y+ AP E+ K K DI+S G+ L+E+
Sbjct: 161 -------DTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQME 205
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 59.1 bits (144), Expect = 3e-09
Identities = 38/125 (30%), Positives = 58/125 (46%), Gaps = 35/125 (28%)
Query: 514 IAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMP 573
I +GL YLH +H DLKPSNIL+ N + + DFGLAR +
Sbjct: 112 ILRGLKYLHS---ANVIHRDLKPSNILVNSNCDLKICDFGLARGVD-------------- 154
Query: 574 AEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKW----DIYSYGVILLEM 629
P E ++ ++ V T +Y+APE ++ S ++ DI+S G I E+
Sbjct: 155 ---PDEDEKGFLTEYVVT--------RWYRAPE---LLLSSSRYTKAIDIWSVGCIFAEL 200
Query: 630 ITGRT 634
+T +
Sbjct: 201 LTRKP 205
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 58.5 bits (142), Expect = 3e-09
Identities = 61/253 (24%), Positives = 114/253 (45%), Gaps = 57/253 (22%)
Query: 411 LGKSGIGIVYK-VVLEDGHTLAVRRL----GEGGSQRFKEFQTEVEAIGKIRHSNIVTLR 465
+G+ GIV+K E G T+A++++ EGG + E++A+ +H +V L
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIP--NQALREIKALQACQHPYVVKLL 65
Query: 466 AYYWSVDEKLLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFS 525
+ +L+ +Y+P L+ L + P+P + ++ + KG+ Y+H
Sbjct: 66 DVFPHGSGFVLVMEYMP-SDLSEVLRDEE-----RPLPEAQVKSYMRMLLKGVAYMHA-- 117
Query: 526 PKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQKSV 585
+H DLKP+N+L+ + ++DFGLARL + E + +
Sbjct: 118 -NGIMHRDLKPANLLISADGVLKIADFGLARLFS-------------------EEEPRLY 157
Query: 586 SLEVTTTNSSSNLGSYYQAPESLKVVKPSQKW----DIYSYGVILLEMITGRTAVVQVGS 641
S +V T +Y+APE L ++K+ D+++ G I E++ G G
Sbjct: 158 SHQVAT--------RWYRAPELL---YGARKYDPGVDLWAVGCIFAELLNGSPLF--PGE 204
Query: 642 SEMDLVNWMQLCI 654
++++ QL I
Sbjct: 205 NDIE-----QLAI 212
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 3e-09
Identities = 69/265 (26%), Positives = 110/265 (41%), Gaps = 70/265 (26%)
Query: 398 FDLDELLKASAFVLGKSGIGIVYKVV-LEDGHTLAVRRLGEGGSQRFKEFQTEVEAIGKI 456
++ DE VLGK GIVY L +A++ + E S+ + E+ +
Sbjct: 5 YEYDE--NGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYL 62
Query: 457 RHSNIVTLRAYYWSVDEK--LLIY-DYIPNGSLATALHGKPGMVSFTPVPWSVRVKII-- 511
+H NIV Y S E I+ + +P GSL+ L K G P+ + + I
Sbjct: 63 KHRNIVQ---YLGSDSENGFFKIFMEQVPGGSLSALLRSKWG-----PLKDNEQTIIFYT 114
Query: 512 KGIAKGLVYLHEFSPKKYVHGDLKPSNILLG-HNMEPHVSDFGLARLANIAGGSP----- 565
K I +GL YLH+ + VH D+K N+L+ ++ +SDFG ++ +AG +P
Sbjct: 115 KQILEGLKYLHD---NQIVHRDIKGDNVLVNTYSGVVKISDFGTSK--RLAGINPCTETF 169
Query: 566 --TLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKW-----D 618
TLQ Y APE V+ + D
Sbjct: 170 TGTLQ---------------------------------YMAPE---VIDKGPRGYGAPAD 193
Query: 619 IYSYGVILLEMITGRTAVVQVGSSE 643
I+S G ++EM TG+ +++G +
Sbjct: 194 IWSLGCTIVEMATGKPPFIELGEPQ 218
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 3e-09
Identities = 54/186 (29%), Positives = 87/186 (46%), Gaps = 38/186 (20%)
Query: 449 EVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRV 508
EV + ++H+NIVTL + L+++Y+ + L L ++S +V++
Sbjct: 53 EVSLLKNLKHANIVTLHDIIHTERCLTLVFEYLDS-DLKQYLDNCGNLMSMH----NVKI 107
Query: 509 KIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQ 568
+ + + +GL Y H+ +K +H DLKP N+L+ E ++DFGLAR A PT
Sbjct: 108 FMFQ-LLRGLSYCHK---RKILHRDLKPQNLLINEKGELKLADFGLAR----AKSVPT-- 157
Query: 569 SNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPES-LKVVKPSQKWDIYSYGVILL 627
K+ S EV T +Y+ P+ L + S D++ G IL
Sbjct: 158 --------------KTYSNEVVTL--------WYRPPDVLLGSTEYSTPIDMWGVGCILY 195
Query: 628 EMITGR 633
EM TGR
Sbjct: 196 EMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 3e-09
Identities = 39/121 (32%), Positives = 55/121 (45%), Gaps = 31/121 (25%)
Query: 514 IAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMP 573
I +GL YLH +H D+KP N+L+ N + DFGLAR+
Sbjct: 112 ILRGLKYLHS---AGILHRDIKPGNLLVNSNCVLKICDFGLARV---------------- 152
Query: 574 AEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKP-SQKWDIYSYGVILLEMITG 632
E+P E K ++ EV T YY+APE L + + DI+S G I E++
Sbjct: 153 -EEPDES--KHMTQEVVT--------QYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGR 201
Query: 633 R 633
R
Sbjct: 202 R 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 58.5 bits (142), Expect = 3e-09
Identities = 63/265 (23%), Positives = 104/265 (39%), Gaps = 76/265 (28%)
Query: 411 LGKSGIGIVYKVV-LEDGHTLAVRRL-----GEG---GSQRFKEFQTEVEAIGKIRHSNI 461
LG+ G VYK ++ G +A++++ +G + R E++ + K++H N+
Sbjct: 16 LGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALR------EIKILKKLKHPNV 69
Query: 462 VTLRAYYWSVDEKLLIYDYIPNGSLATALHGKPGMVSFTPVPWSV----------RVKI- 510
V L +D + + K G V + P+ VK+
Sbjct: 70 VPL------ID---MAVERPDKS------KRKRGSV-YMVTPYMDHDLSGLLENPSVKLT 113
Query: 511 ---IKGIAK----GLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGG 563
IK G+ YLHE +H D+K +NIL+ + ++DFGLAR G
Sbjct: 114 ESQIKCYMLQLLEGINYLHE---NHILHRDIKAANILIDNQGILKIADFGLAR--PYDGP 168
Query: 564 SPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESL---KVVKPSQKWDIY 620
P P +K +L VT +Y+ PE L + + DI+
Sbjct: 169 PP------NPKGGGGGGTRKYTNLVVT---------RWYRPPELLLGERRYTTAV--DIW 211
Query: 621 SYGVILLEMITGRTAVVQVGSSEMD 645
G + EM T R + G S++D
Sbjct: 212 GIGCVFAEMFTRRP--ILQGKSDID 234
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 4e-09
Identities = 76/328 (23%), Positives = 133/328 (40%), Gaps = 87/328 (26%)
Query: 410 VLGKSGIGIVYKVVLE-DGHTL--AVRRLGEGGSQR-FKEFQTEVEAIGKI-RHSNIVTL 464
V+G+ G V + +++ DG + A++ L E S+ ++F E+E + K+ H NI+ L
Sbjct: 9 VIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINL 68
Query: 465 ------RAYYWSVDEKLLIYDYIPNGSLATAL---------------HGKPGMVSFTPVP 503
R Y + + +Y P G+L L HG ++ +
Sbjct: 69 LGACENRGYLY------IAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQL- 121
Query: 504 WSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGG 563
++ +A G+ YL E K+++H DL N+L+G N+ ++DFGL+R
Sbjct: 122 ----LQFASDVATGMQYLSE---KQFIHRDLAARNVLVGENLASKIADFGLSR------- 167
Query: 564 SPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYG 623
EV + L + A ESL + K D++S+G
Sbjct: 168 ----------------------GEEVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFG 205
Query: 624 VILLEMIT-GRTAVVQVGSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVL 682
V+L E+++ G T + +E+ EK P ++ + D E V
Sbjct: 206 VLLWEIVSLGGTPYCGMTCAEL----------YEKLPQGYRMEK--PRNCDDE-----VY 248
Query: 683 KIAMACVHSSPEKRPTMRHISDALDRLI 710
++ C P +RP IS L R++
Sbjct: 249 ELMRQCWRDRPYERPPFAQISVQLSRML 276
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 57.8 bits (139), Expect = 5e-09
Identities = 61/229 (26%), Positives = 99/229 (43%), Gaps = 43/229 (18%)
Query: 410 VLGKSGIGIVYK-VVLEDGHTL----AVRRLGEG-GSQRFKEFQTEVEAIGKIRHSNIVT 463
VLG G VYK + + +G T+ A++ L E G + EF E + + H ++V
Sbjct: 14 VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVR 73
Query: 464 LRAYYWSVDEKLLIYDYIPNGSLATALH-GKPGMVSFTPVPWSVRVKIIKGIAKGLVYLH 522
L S +L + +P+G L +H K + S + W V+ IAKG++YL
Sbjct: 74 LLGVCLSPTIQL-VTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQ------IAKGMMYLE 126
Query: 523 EFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQ 582
E ++ VH DL N+L+ ++DFGLARL +MP +
Sbjct: 127 E---RRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIK------- 176
Query: 583 KSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMIT 631
+ A E + K + + D++SYGV + E++T
Sbjct: 177 -------------------WMALECIHYRKFTHQSDVWSYGVTIWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 57.6 bits (140), Expect = 5e-09
Identities = 54/204 (26%), Positives = 91/204 (44%), Gaps = 44/204 (21%)
Query: 449 EVEAIGKIRHSNIVTLR--AYYWSVDEKLLIYDYIPNGSLATALHGKPGMVSFTPVPWSV 506
E+ + K++H NIVT++ ++D+ ++ +Y+ + L + + F
Sbjct: 54 EINILLKLQHPNIVTVKEVVVGSNLDKIYMVMEYVEH-DLKSLMETMKQ--PFLQS---- 106
Query: 507 RVK-IIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSP 565
VK ++ + G+ +LH+ +H DLK SN+LL + + DFGLAR GSP
Sbjct: 107 EVKCLMLQLLSGVAHLHD---NWILHRDLKTSNLLLNNRGILKICDFGLAREY----GSP 159
Query: 566 TLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKP-SQKWDIYSYGV 624
K + V T +Y+APE L K S D++S G
Sbjct: 160 L----------------KPYTQLVVTL--------WYRAPELLLGAKEYSTAIDMWSVGC 195
Query: 625 ILLEMITGRTAVVQVGSSEMDLVN 648
I E++T + + G SE+D +N
Sbjct: 196 IFAELLTKK--PLFPGKSEIDQLN 217
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.7 bits (140), Expect = 5e-09
Identities = 52/227 (22%), Positives = 92/227 (40%), Gaps = 41/227 (18%)
Query: 411 LGKSGIGIVYKVV-LEDGHTLAVRRLGEGGSQRFKEFQT--EVEAIGKIRHSNIVTLRAY 467
+G+ G+VYK G +A++++ E++ + ++ H NI+ L
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDV 66
Query: 468 YWSVDEKLLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPK 527
+ + L+++++ + L + +P S+ + + +GL + H
Sbjct: 67 FRHKGDLYLVFEFM-DTDLYKLIKD-----RQRGLPESLIKSYLYQLLQGLAFCHS---H 117
Query: 528 KYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQKSVSL 587
+H DLKP N+L+ ++DFGLAR GSP R
Sbjct: 118 GILHRDLKPENLLINTEGVLKLADFGLARSF----GSP----VRPYTH------------ 157
Query: 588 EVTTTNSSSNLGSYYQAPESLKVVKP-SQKWDIYSYGVILLEMITGR 633
V T +Y+APE L K S DI+S G I E+++ R
Sbjct: 158 YVVT--------RWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 57.4 bits (139), Expect = 5e-09
Identities = 71/309 (22%), Positives = 121/309 (39%), Gaps = 73/309 (23%)
Query: 411 LGKSGIGIVYKVV-LEDGHTLAVRRLGEGGSQRF-----KEFQ---TEVEAIGKIRHSNI 461
+GK +VYK + L DG +A++++ Q F K Q E++ + ++ H N+
Sbjct: 10 IGKGQFSVVYKAICLLDGRVVALKKV-----QIFEMMDAKARQDCLKEIDLLKQLDHPNV 64
Query: 462 VTLRAYYWSVDEKLLIYDYIPNGSLATAL-HGKPGMVSFTPVPWSVRVKIIKGIAKGLVY 520
+ A + +E ++ + G L+ + H K +P K + L +
Sbjct: 65 IKYLASFIENNELNIVLELADAGDLSRMIKHFKKQK---RLIPERTIWKYFVQLCSALEH 121
Query: 521 LHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQER 580
+H K+ +H D+KP+N+ + + D GL R
Sbjct: 122 MHS---KRIMHRDIKPANVFITATGVVKLGDLGLGRF----------------------- 155
Query: 581 QQKSVSLEVTTTNSSSNLGS-YYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQV 639
TT + S +G+ YY +PE + + K DI+S G +L EM A +Q
Sbjct: 156 ------FSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEM-----AALQ- 203
Query: 640 GSSEMDLVNWMQLC--IE--EKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEK 695
D +N LC IE + PL D Y D + C++ PEK
Sbjct: 204 SPFYGDKMNLYSLCKKIEKCDYPPLPA--DHYSEELRD----------LVSRCINPDPEK 251
Query: 696 RPTMRHISD 704
RP + ++
Sbjct: 252 RPDISYVLQ 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 7e-09
Identities = 77/299 (25%), Positives = 120/299 (40%), Gaps = 60/299 (20%)
Query: 410 VLGKSGIGIVYKVV-LEDGHTLAVRRLGEGGSQRFKEFQTEVEA--IGKIRHSNIVTLRA 466
V+GK G V V DG +++L + R + E EA + +++H NIV R
Sbjct: 7 VVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRE 66
Query: 467 YYWSVDEKL-LIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFS 525
+ D L ++ + G L L + G + +P + V+ IA L YLHE
Sbjct: 67 SWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKL----LPENQVVEWFVQIAMALQYLHE-- 120
Query: 526 PKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQKSV 585
K +H DLK N+ L V D G+AR+
Sbjct: 121 -KHILHRDLKTQNVFLTRTNIIKVGDLGIARV---------------------------- 151
Query: 586 SLEVTTTNSSSNLGS-YYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGSSEM 644
LE +S+ +G+ YY +PE + K D+++ G + EM T + A +
Sbjct: 152 -LENQCDMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAF-----NAK 205
Query: 645 DLVNWMQLCIEEK-KPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHI 702
D+ + + IE K P+ P L E+IA M PEKRP+++ I
Sbjct: 206 DMNSLVYRIIEGKLPPMPKDYSPELG-------ELIA----TMLS--KRPEKRPSVKSI 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 7e-09
Identities = 60/231 (25%), Positives = 99/231 (42%), Gaps = 47/231 (20%)
Query: 410 VLGKSGIGIVYK-VVLEDGHTL----AVRRLGE-GGSQRFKEFQTEVEAIGKIRHSNIVT 463
+LG G V+K + + +G ++ A++ + + G Q F+E + A+G + H+ IV
Sbjct: 14 LLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVR 73
Query: 464 LRAYYWSVDEKLLIYDYIPNGSLATALHGKPGMVSFTP---VPWSVRVKIIKGIAKGLVY 520
L +L + P GSL + S P + W V+ IAKG+ Y
Sbjct: 74 LLGICPGASLQL-VTQLSPLGSLLDHVRQHRD--SLDPQRLLNWCVQ------IAKGMYY 124
Query: 521 LHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQER 580
L E + VH +L NILL + ++DFG+A L P +K
Sbjct: 125 LEE---HRMVHRNLAARNILLKSDSIVQIADFGVADLL-------------YPDDK---- 164
Query: 581 QQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMIT 631
K E T + A ES+ + + + D++SYGV + EM++
Sbjct: 165 --KYFYSEHKTPIK-------WMALESILFGRYTHQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 8e-09
Identities = 51/188 (27%), Positives = 80/188 (42%), Gaps = 45/188 (23%)
Query: 514 IAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMP 573
+AKG+ YL KK+VH DL N +L + V+DFGLAR +
Sbjct: 107 VAKGMEYLAS---KKFVHRDLAARNCMLDESFTVKVADFGLAR-------------DIYD 150
Query: 574 AEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMIT-G 632
E L V + A ESL+ K + K D++S+GV+L E++T G
Sbjct: 151 KEYYSVHNHTGAKLPVK-----------WMALESLQTQKFTTKSDVWSFGVLLWELMTRG 199
Query: 633 RTAVVQVGSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSS 692
V S D+ ++ ++ ++ +L P PD + ++ ++C H
Sbjct: 200 APPYPDVDS--FDITVYL---LQGRR----LLQPEYCPD--------PLYEVMLSCWHPK 242
Query: 693 PEKRPTMR 700
PE RPT
Sbjct: 243 PEMRPTFS 250
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 1e-08
Identities = 60/240 (25%), Positives = 96/240 (40%), Gaps = 50/240 (20%)
Query: 411 LGKSGIGIVYKVVL-----EDGHTLAVRRLGE-GGSQRFKEFQTEVEAIGKIRHSNIVTL 464
LG+ G +YK L + +A++ L + Q++ EFQ E + ++ H NIV L
Sbjct: 13 LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCL 72
Query: 465 RAYYWSVDEKLLIYDYIPNGSLATAL-----HGKPGMVSFTPVPWSVRVKIIKG------ 513
++++Y+ G L L H G S +V+ + G
Sbjct: 73 LGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSS--DEDGTVKSSLDHGDFLHIA 130
Query: 514 --IAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNR 571
IA G+ YL S +VH DL NIL+G + +SD GL+R
Sbjct: 131 IQIAAGMEYL---SSHFFVHKDLAARNILIGEQLHVKISDLGLSR--------------- 172
Query: 572 MPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMIT 631
+ S + S L + PE++ K S DI+S+GV+L E+ +
Sbjct: 173 -----------EIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 56.6 bits (137), Expect = 1e-08
Identities = 62/234 (26%), Positives = 91/234 (38%), Gaps = 52/234 (22%)
Query: 410 VLGKSGIGIVYKVVLED-GHTLAVRRLGEGGSQRFKEFQT---EVEAIGKIRHSNIVTLR 465
V+GK G V V D A++ + + + E + ++ H +V L
Sbjct: 7 VIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLW 66
Query: 466 AYYWSVDEKL-LIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKI-IKGIAKGLVYLHE 523
Y + +E + L+ D + G L L K V F+ +VK I I L YLH
Sbjct: 67 -YSFQDEENMYLVVDLLLGGDLRYHLSQK---VKFS----EEQVKFWICEIVLALEYLHS 118
Query: 524 FSPKKYVHGDLKPSNILL---GHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQER 580
K +H D+KP NILL GH H++DF +A
Sbjct: 119 ---KGIIHRDIKPDNILLDEQGH---VHITDFNIATK----------------------- 149
Query: 581 QQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRT 634
V+ + TT++S G Y APE L S D +S GV E + G+
Sbjct: 150 ----VTPDTLTTSTSGTPG--YMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKR 197
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 1e-08
Identities = 66/248 (26%), Positives = 107/248 (43%), Gaps = 60/248 (24%)
Query: 411 LGKSGIGIVYKVV-LEDGHTLAVRRLGEGGSQRFKEFQTEVE-----AIGKI------RH 458
+G+ G+VYK G +A++++ TE E AI +I H
Sbjct: 8 IGEGTYGVVYKARNKLTGEVVALKKI---------RLDTETEGVPSTAIREISLLKELNH 58
Query: 459 SNIVTLRAYYWSVDEKLLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGL 518
NIV L + ++ L+++++ + L + P P+ S ++++G+A
Sbjct: 59 PNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLA--- 114
Query: 519 VYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQ 578
+ H + +H DLKP N+L+ ++DFGLAR A G P
Sbjct: 115 -FCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLAR----AFGVPV------------ 154
Query: 579 ERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVK-PSQKWDIYSYGVILLEMITGRTAVV 637
++ + EV T +Y+APE L K S DI+S G I EM+T R A+
Sbjct: 155 ----RTYTHEVVTL--------WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALF 201
Query: 638 QVGSSEMD 645
G SE+D
Sbjct: 202 P-GDSEID 208
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 1e-08
Identities = 77/350 (22%), Positives = 140/350 (40%), Gaps = 81/350 (23%)
Query: 390 VPLDTQVAFDLDELLKASAFVLGKS-GIGIVYKVVLEDGH-----------TLAVRRLGE 437
+PLD + F D L VLGK G G +VV + + T+AV+ L +
Sbjct: 1 LPLDPKWEFPRDRL------VLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKD 54
Query: 438 GGSQR-FKEFQTEVEAIGKI-RHSNIVTLRAYYWSVDEKLLIYDYIPNGSLATALHGK-- 493
+ + + +E+E + I +H NI+ L +I +Y G+L L +
Sbjct: 55 NATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRP 114
Query: 494 PGM--------VSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNM 545
PG V + + V +A+G+ YL ++ +H DL N+L+ +
Sbjct: 115 PGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLES---RRCIHRDLAARNVLVTEDN 171
Query: 546 EPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAP 605
++DFGLAR + + R+P + + AP
Sbjct: 172 VMKIADFGLARGVHDIDYYKKTSNGRLPVK--------------------------WMAP 205
Query: 606 ESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGSSEMDLVNWMQL--CIEEKKPLADV 663
E+L + + D++S+G+++ E+ T +G S + +L + E +
Sbjct: 206 EALFDRVYTHQSDVWSFGILMWEIFT-------LGGSPYPGIPVEELFKLLREGHRM--- 255
Query: 664 LDPYLAPDADKEEEIIAVLKIAM-ACVHSSPEKRPTMRHISDALDRLIVS 712
DK L + M C H+ P +RPT + + +ALD+++ +
Sbjct: 256 ---------DKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAA 296
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 1e-08
Identities = 51/194 (26%), Positives = 90/194 (46%), Gaps = 38/194 (19%)
Query: 449 EVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRV 508
E + ++H+NIV L + + +++Y+ + LA + PG + P++VR+
Sbjct: 53 EASLLKGLKHANIVLLHDIIHTKETLTFVFEYM-HTDLAQYMIQHPGGLH----PYNVRL 107
Query: 509 KIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQ 568
+ + + +GL Y+H + +H DLKP N+L+ + E ++DFGLAR +I
Sbjct: 108 FMFQ-LLRGLAYIHG---QHILHRDLKPQNLLISYLGELKLADFGLARAKSI-------- 155
Query: 569 SNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESL-KVVKPSQKWDIYSYGVILL 627
P++ + S EV T +Y+ P+ L S DI+ G I +
Sbjct: 156 ----PSQ--------TYSSEVVTL--------WYRPPDVLLGATDYSSALDIWGAGCIFI 195
Query: 628 EMITGRTAVVQVGS 641
EM+ G+ A V
Sbjct: 196 EMLQGQPAFPGVSD 209
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 1e-08
Identities = 77/317 (24%), Positives = 130/317 (41%), Gaps = 65/317 (20%)
Query: 410 VLGKSGIGIVYKVVLE-DGHTL--AVRRLGEGGSQR-FKEFQTEVEAIGKI-RHSNIVTL 464
V+G+ G V K ++ DG + A++R+ E S+ ++F E+E + K+ H NI+ L
Sbjct: 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 61
Query: 465 RAYYWSVDEKLLIYDYIPNGSL------ATALHGKPGMVS--FTPVPWSVR--VKIIKGI 514
L +Y P+G+L + L P T S + + +
Sbjct: 62 LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 121
Query: 515 AKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPA 574
A+G+ YL + K+++H DL NIL+G N ++DFGL+R
Sbjct: 122 ARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSR------------------ 160
Query: 575 EKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMIT-GR 633
EV + L + A ESL + D++SYGV+L E+++ G
Sbjct: 161 -----------GQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGG 209
Query: 634 TAVVQVGSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSP 693
T + +E+ EK P L+ + D E V + C P
Sbjct: 210 TPYCGMTCAEL----------YEKLPQGYRLEK--PLNCDDE-----VYDLMRQCWREKP 252
Query: 694 EKRPTMRHISDALDRLI 710
+RP+ I +L+R++
Sbjct: 253 YERPSFAQILVSLNRML 269
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 1e-08
Identities = 52/270 (19%), Positives = 101/270 (37%), Gaps = 65/270 (24%)
Query: 443 FKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGSLATALHGKPGMVSFTPV 502
+ + E+ + ++ H +I+ + L +++ GS++ L +
Sbjct: 47 VEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLS------KYGAF 100
Query: 503 PWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILL---GHNMEPHVSDFGLA-RLA 558
+V + + + +GL YLHE + +H D+K +N+L+ G + ++DFG A RLA
Sbjct: 101 KEAVIINYTEQLLRGLSYLHE---NQIIHRDVKGANLLIDSTGQRLR--IADFGAAARLA 155
Query: 559 NIAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSY-YQAPESLKVVKPSQKW 617
G+ Q LG+ + APE L+ + +
Sbjct: 156 AKGTGAGEFQGQL--------------------------LGTIAFMAPEVLRGEQYGRSC 189
Query: 618 DIYSYGVILLEMITGRTAVVQVGSSEMDLVNWMQL-----CIEEKKPLADVLDPYLAPDA 672
D++S G +++EM T + S N + L + + L P
Sbjct: 190 DVWSVGCVIIEMATAKPPWNAEKHS-----NHLALIFKIASATTAPSIPEHLSP------ 238
Query: 673 DKEEEIIAVLKIAMACVHSSPEKRPTMRHI 702
+ + + C+ PE RP R +
Sbjct: 239 -------GLRDVTLRCLELQPEDRPPSREL 261
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 2e-08
Identities = 48/154 (31%), Positives = 79/154 (51%), Gaps = 11/154 (7%)
Query: 100 FFGSLPLELLEAQGLQSLVLYGNSFSGSVPNEIGKLKYLQILDLSQNFFNGSLPVSIVQC 159
FF L +L A+ L+ L+ SF S+ + LKYL + S + ++
Sbjct: 17 FFLFLNFSMLHAEELELLL----SFKSSIND---PLKYLSNWNSSADVCLWQ-GITCNNS 68
Query: 160 KRLKALDLSQNNFTGPLPNGFGSGLVSLEKLNLSFNKFNGSIPSNTGNLSSLQGTVDFSH 219
R+ ++DLS N +G + + L ++ +NLS N+ +G IP + SS ++ S+
Sbjct: 69 SRVVSIDLSGKNISGKISSAI-FRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSN 127
Query: 220 NLFSGSIPASLGNLPEKVYIDLTYNNLSGPIPQN 253
N F+GSIP G++P +DL+ N LSG IP +
Sbjct: 128 NNFTGSIPR--GSIPNLETLDLSNNMLSGEIPND 159
|
Length = 968 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 56.6 bits (137), Expect = 2e-08
Identities = 36/121 (29%), Positives = 54/121 (44%), Gaps = 29/121 (23%)
Query: 514 IAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMP 573
+ +GL Y+H +H DLKPSN+L+ + E + DFG+AR
Sbjct: 116 LLRGLKYIHS---ANVIHRDLKPSNLLVNEDCELRIGDFGMARGL--------------- 157
Query: 574 AEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPE-SLKVVKPSQKWDIYSYGVILLEMITG 632
+ P E K E T +Y+APE L + + + D++S G I EM+ G
Sbjct: 158 SSSPTE--HKYFMTEYVATR-------WYRAPELLLSLPEYTTAIDMWSVGCIFAEML-G 207
Query: 633 R 633
R
Sbjct: 208 R 208
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 2e-08
Identities = 54/261 (20%), Positives = 97/261 (37%), Gaps = 35/261 (13%)
Query: 446 FQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGSLATALHGKPGMVSFTPVPWS 505
F EV+ ++ H N++ LL+ ++ P G L L GMV+
Sbjct: 42 FLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQK-D 100
Query: 506 VRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSP 565
V ++ +A GL++LH+ ++H DL N L ++ + D+GLA
Sbjct: 101 VLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLAL--------- 148
Query: 566 TLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVI 625
+ P + + +V L G L ++K +I+S GV
Sbjct: 149 ----EQYPEDYYITKDCHAVPLRWLAPELVEIRGQ------DLLPKDQTKKSNIWSLGVT 198
Query: 626 LLEMITGRTAVVQVGSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIA 685
+ E+ T S+ ++ + + K P + Y +D+ E++
Sbjct: 199 MWELFTAADQPYP-DLSDEQVLKQVVREQDIKLPKPQLDLKY----SDRWYEVM------ 247
Query: 686 MACVHSSPEKRPTMRHISDAL 706
C PE RPT + + L
Sbjct: 248 QFC-WLDPETRPTAEEVHELL 267
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 2e-08
Identities = 65/289 (22%), Positives = 113/289 (39%), Gaps = 60/289 (20%)
Query: 427 GHTLAVRRLGEGGSQRFKE-FQTEVEAIGKIRHSNIVTLRAYYWSVDEK--LLIYDYIPN 483
G +AV+ L Q+ ++ E+ + + H NIV + K LI +Y+P
Sbjct: 33 GEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPL 92
Query: 484 GSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGH 543
GSL L + + + + I +G+ YLH + Y+H DL N+LL +
Sbjct: 93 GSLRDYLPKHK-------LNLAQLLLFAQQICEGMAYLHS---QHYIHRDLAARNVLLDN 142
Query: 544 NMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQ 603
+ + DFGLA+ P+ + V + S + ++
Sbjct: 143 DRLVKIGDFGLAKAV------------------PEGHEYYRVR-----EDGDSPV--FWY 177
Query: 604 APESLKVVKPSQKWDIYSYGVILLEMITGRTA----------VVQVGSSEMDLVNWMQLC 653
A E LK K S D++S+GV L E++T + ++ +M +V ++L
Sbjct: 178 AVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIEL- 236
Query: 654 IEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHI 702
+E L P +E V + C + + RPT R +
Sbjct: 237 LERGMRLP-------CPKNCPQE----VYILMKNCWETEAKFRPTFRSL 274
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 2e-08
Identities = 72/315 (22%), Positives = 127/315 (40%), Gaps = 69/315 (21%)
Query: 410 VLGKSGIGIVYKVVL-----EDGHTLAVRRLGEGGSQRF--KEFQTEVEAIGKIRHSNIV 462
LG G G Y +V+ E G +A+++ E + K E+ + ++RH N+V
Sbjct: 5 NLGLVGEG-SYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLV 63
Query: 463 TLRAYYWSVDEKLLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLH 522
L + L+++++ + ++ L P + + V K + I +G+ + H
Sbjct: 64 NLIEVFRRKKRLYLVFEFVDH-TVLDDLEKYPNGLDESRVR-----KYLFQILRGIEFCH 117
Query: 523 EFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQ 582
+H D+KP NIL+ + + DFG AR TL + P E
Sbjct: 118 S---HNIIHRDIKPENILVSQSGVVKLCDFGFAR---------TLAA-------PGEVYT 158
Query: 583 KSVSLEVTTTNSSSNLGSYYQAPESL-KVVKPSQKWDIYSYGVILLEMITGRTAVVQVGS 641
V+ +Y+APE L K + DI++ G ++ EM+TG G
Sbjct: 159 DYVATR------------WYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFP--GD 204
Query: 642 SEMDLVNWMQLC----------IEEKKPLADVLDPYLAPDADKEEEI--------IAVLK 683
S++D + + C I +K PL + P+ + E + VL
Sbjct: 205 SDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGM---RLPEVKEIEPLEKRFPKLSGLVLD 261
Query: 684 IAMACVHSSPEKRPT 698
+A C+ P+ RP+
Sbjct: 262 LAKQCLRIDPDDRPS 276
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.5 bits (137), Expect = 2e-08
Identities = 39/121 (32%), Positives = 57/121 (47%), Gaps = 29/121 (23%)
Query: 514 IAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMP 573
I +GL Y+H +H DLKPSN+LL N + + DFGLAR+A+
Sbjct: 115 ILRGLKYIHS---ANVLHRDLKPSNLLLNTNCDLKICDFGLARIAD-------------- 157
Query: 574 AEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPE-SLKVVKPSQKWDIYSYGVILLEMITG 632
P+ ++ V T +Y+APE L ++ DI+S G IL EM++
Sbjct: 158 ---PEHDHTGFLTEYVAT--------RWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSN 206
Query: 633 R 633
R
Sbjct: 207 R 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 55.8 bits (135), Expect = 2e-08
Identities = 57/206 (27%), Positives = 91/206 (44%), Gaps = 44/206 (21%)
Query: 449 EVEAIGKIRHSNIVTLR--AYYWSVDEKLLIYDYIPNGSLATALHGKPGMVSFTPVPWSV 506
E+ + +RH NIV L+ +D L+ +Y LA+ L P TP S
Sbjct: 56 EITLLLNLRHPNIVELKEVVVGKHLDSIFLVMEYCEQ-DLASLLDNMP-----TPFSES- 108
Query: 507 RVK-IIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSP 565
+VK ++ + +GL YLHE +H DLK SN+LL ++DFGLAR G P
Sbjct: 109 QVKCLMLQLLRGLQYLHE---NFIIHRDLKVSNLLLTDKGCLKIADFGLARTY----GLP 161
Query: 566 TLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESL-KVVKPSQKWDIYSYGV 624
+ K V+L +Y+APE L + D+++ G
Sbjct: 162 -----------AKPMTPKVVTL-------------WYRAPELLLGCTTYTTAIDMWAVGC 197
Query: 625 ILLEMITGRTAVVQVGSSEMDLVNWM 650
IL E++ + + G SE++ ++ +
Sbjct: 198 ILAELLAHK--PLLPGKSEIEQLDLI 221
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 56.1 bits (136), Expect = 2e-08
Identities = 37/126 (29%), Positives = 57/126 (45%), Gaps = 35/126 (27%)
Query: 510 IIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQS 569
++ I +GL Y+H +H DLKPSNI + + E + DFGLAR +
Sbjct: 123 LVYQILRGLKYIHS---AGIIHRDLKPSNIAVNEDCELKILDFGLARHTD---------- 169
Query: 570 NRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPE-SLKVVKPSQKWDIYSYGVILLE 628
++ V T +Y+APE L + +Q DI+S G I+ E
Sbjct: 170 -------------DEMTGYVAT--------RWYRAPEIMLNWMHYNQTVDIWSVGCIMAE 208
Query: 629 MITGRT 634
++TG+T
Sbjct: 209 LLTGKT 214
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 2e-08
Identities = 66/300 (22%), Positives = 115/300 (38%), Gaps = 58/300 (19%)
Query: 411 LGKSGIGIVYKVVLEDGHTLAVRRLGEGGSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWS 470
LG G+V+ +A++ + EG ++F E + + K+ H +V L Y
Sbjct: 12 LGSGQFGVVHLGKWRAQIKVAIKAINEGAMSE-EDFIEEAKVMMKLSHPKLVQL--YGVC 68
Query: 471 VDEKLL--IYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKK 528
+K L + +++ NG L L + G +S + + + + + +G+ YL S
Sbjct: 69 TQQKPLYIVTEFMENGCLLNYLRQRQGKLS-----KDMLLSMCQDVCEGMEYLERNS--- 120
Query: 529 YVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQKSVSLE 588
++H DL N L+ VSDFG+ R V +
Sbjct: 121 FIHRDLAARNCLVSSTGVVKVSDFGMTRY---------------------------VLDD 153
Query: 589 VTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGSSEMDLVN 648
T++S + + PE K S K D++S+GV++ E+ T +M
Sbjct: 154 EYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFT---------EGKMPFEK 204
Query: 649 WMQLCIEEKKPLADVL-DPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDALD 707
+ E L P LA + V ++ +C H PE RPT + A+
Sbjct: 205 KSNYEVVEMISRGFRLYRPKLAS--------MTVYEVMYSCWHEKPEGRPTFAELLRAIT 256
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 3e-08
Identities = 52/186 (27%), Positives = 85/186 (45%), Gaps = 38/186 (20%)
Query: 449 EVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRV 508
EV + ++H+NIVTL + L+++Y+ + L L ++ +V++
Sbjct: 54 EVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYL-DKDLKQYLDDCGNSINMH----NVKL 108
Query: 509 KIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQ 568
+ + + +GL Y H +K +H DLKP N+L+ E ++DFGLAR +I PT
Sbjct: 109 FLFQ-LLRGLNYCHR---RKVLHRDLKPQNLLINERGELKLADFGLARAKSI----PT-- 158
Query: 569 SNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPES-LKVVKPSQKWDIYSYGVILL 627
K+ S EV T +Y+ P+ L S + D++ G I
Sbjct: 159 --------------KTYSNEVVTL--------WYRPPDILLGSTDYSTQIDMWGVGCIFY 196
Query: 628 EMITGR 633
EM TGR
Sbjct: 197 EMSTGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 3e-08
Identities = 49/204 (24%), Positives = 89/204 (43%), Gaps = 39/204 (19%)
Query: 428 HTLAVRRLGEGGSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGSLA 487
HTL R G QR + F E +G+ HSNIV L + +++ +Y+ NG+L
Sbjct: 39 HTL---RAGCSDKQR-RGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALD 94
Query: 488 TALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEP 547
+ L G + + + ++ G+A G+ YL E YVH L +L+ ++
Sbjct: 95 SFLRKHEGQLVAGQL-----MGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVC 146
Query: 548 HVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPES 607
+S F LQ ++ A + TT S + + APE+
Sbjct: 147 KISGFR------------RLQEDKSEA--------------IYTTMSGKSP-VLWAAPEA 179
Query: 608 LKVVKPSQKWDIYSYGVILLEMIT 631
++ S D++S+G+++ E+++
Sbjct: 180 IQYHHFSSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 5e-08
Identities = 80/314 (25%), Positives = 132/314 (42%), Gaps = 61/314 (19%)
Query: 410 VLGKSGIGIVYKVVL--EDG--HTLAVRRLGEG--GSQRFKEFQTEVEAIGKIRHSNIVT 463
+LGK G V + L EDG +AV+ L S +EF E + + H N++
Sbjct: 6 MLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIK 65
Query: 464 LRAYYWSVDEK------LLIYDYIPNGSLAT-ALHGKPGMVSFTPVPWSVRVKIIKGIAK 516
L K ++I ++ +G L T L + G FT +P V+ + IA
Sbjct: 66 LIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFT-LPLQTLVRFMIDIAS 124
Query: 517 GLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEK 576
G+ YL S K ++H DL N +L NM V+DFGL++
Sbjct: 125 GMEYL---SSKNFIHRDLAARNCMLNENMTVCVADFGLSK-------------------- 161
Query: 577 PQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMIT-GRTA 635
K S + +S L + A ESL + D++++GV + E++T G+T
Sbjct: 162 ------KIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTP 215
Query: 636 VVQVGSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEK 695
V +SE + N++ K+P PD ++ V ++ C P+
Sbjct: 216 YAGVENSE--IYNYLIKGNRLKQP----------PDCLED-----VYELMCQCWSPEPKC 258
Query: 696 RPTMRHISDALDRL 709
RP+ +H+ D L+ +
Sbjct: 259 RPSFQHLRDQLELI 272
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 6e-08
Identities = 53/187 (28%), Positives = 85/187 (45%), Gaps = 40/187 (21%)
Query: 449 EVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRV 508
EV + ++H+NIVTL + L+++Y+ + L + ++S V
Sbjct: 54 EVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYL-DKDLKQYMDDCGNIMSMH------NV 106
Query: 509 KI-IKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTL 567
KI + I +GL Y H +K +H DLKP N+L+ E ++DFGLAR ++ PT
Sbjct: 107 KIFLYQILRGLAYCHR---RKVLHRDLKPQNLLINERGELKLADFGLARAKSV----PT- 158
Query: 568 QSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPES-LKVVKPSQKWDIYSYGVIL 626
K+ S EV T +Y+ P+ L + S + D++ G I
Sbjct: 159 ---------------KTYSNEVVTL--------WYRPPDVLLGSSEYSTQIDMWGVGCIF 195
Query: 627 LEMITGR 633
EM +GR
Sbjct: 196 FEMASGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 7e-08
Identities = 46/207 (22%), Positives = 86/207 (41%), Gaps = 51/207 (24%)
Query: 499 FTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLA 558
P+P + KI + +GL YL ++ + +H D+KPSNIL+ + + DFG
Sbjct: 97 GGPIPVEILGKIAVAVVEGLTYL--YNVHRIMHRDIKPSNILVNSRGQIKLCDFG----- 149
Query: 559 NIAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLG-SYYQAPESLKVVKPSQKW 617
VS E+ + + + +G S Y +PE ++ K + K
Sbjct: 150 --------------------------VSGELINSIADTFVGTSTYMSPERIQGGKYTVKS 183
Query: 618 DIYSYGVILLEMITGR------TAVVQVGSSEMDLVNWMQLCIEEKKPLADVLDPYLAPD 671
D++S G+ ++E+ G+ M +++ +Q ++E P P
Sbjct: 184 DVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPP--------RLPS 235
Query: 672 ADKEEEIIAVLKIAMACVHSSPEKRPT 698
+D E++ + C+ P +RPT
Sbjct: 236 SDFPEDLRDFVDA---CLLKDPTERPT 259
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 8e-08
Identities = 53/187 (28%), Positives = 84/187 (44%), Gaps = 27/187 (14%)
Query: 449 EVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRV 508
E++ + +I+H NI+ L Y D L+ D + L + K + T +V
Sbjct: 70 ELKIMNEIKHENIMGLVDVYVEGDFINLVMDIM-ASDLKKVVDRK---IRLT----ESQV 121
Query: 509 K-IIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTL 567
K I+ I GL LH++ ++H DL P+NI + ++DFGLAR S TL
Sbjct: 122 KCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTL 178
Query: 568 QSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESL-KVVKPSQKWDIYSYGVIL 626
+ + +E K V+L +Y+APE L K D++S G I
Sbjct: 179 SKDETMQRR-EEMTSKVVTL-------------WYRAPELLMGAEKYHFAVDMWSVGCIF 224
Query: 627 LEMITGR 633
E++TG+
Sbjct: 225 AELLTGK 231
|
Length = 335 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 9e-08
Identities = 66/295 (22%), Positives = 121/295 (41%), Gaps = 59/295 (20%)
Query: 429 TLAVRRLGEGGSQR-FKEFQTEVEAIGKI-RHSNIVTLRAYYWSVDEKLLIYDYIPNGSL 486
T+AV+ L + + + + +E+E + I +H NI+ L ++ +Y G+L
Sbjct: 46 TVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNL 105
Query: 487 ATALHGK--PGM-VSFTP-------VPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKP 536
L + PGM SF + + V +A+G+ YL + +K +H DL
Sbjct: 106 REYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYL---ASQKCIHRDLAA 162
Query: 537 SNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSS 596
N+L+ + ++DFGLAR + + R+P +
Sbjct: 163 RNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVK--------------------- 201
Query: 597 NLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMIT-GRTAVVQVGSSEMDLVNWMQLCIE 655
+ APE+L + + D++S+GV+L E+ T G + + E L ++
Sbjct: 202 -----WMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE--LFKLLKEGHR 254
Query: 656 EKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDALDRLI 710
KP + Y+ I C H+ P +RPT + + + LDR++
Sbjct: 255 MDKPANCTHELYM---------------IMRECWHAVPSQRPTFKQLVEDLDRVL 294
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 1e-07
Identities = 63/231 (27%), Positives = 102/231 (44%), Gaps = 47/231 (20%)
Query: 410 VLGKSGIGIVY---KVVLED-GHTLAVRRLGEGGSQRFKEFQTEVE--AIGKIRHSNIVT 463
VLG+ G V+ K+ D G A++ L + + +T++E + ++ H IV
Sbjct: 3 VLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVK 62
Query: 464 LRAYYWSVDEKL-LIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKI-IKGIAKGLVYL 521
L Y + + KL LI D++ G L T L + V FT VK + +A L +L
Sbjct: 63 LH-YAFQTEGKLYLILDFLRGGDLFTRLSKE---VMFT----EEDVKFYLAELALALDHL 114
Query: 522 HEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQ 581
H ++ DLKP NILL ++DFGL++ + + +
Sbjct: 115 HSLG---IIYRDLKPENILLDEEGHIKLTDFGLSK-------------------ESIDHE 152
Query: 582 QKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITG 632
+K+ S T Y APE + +Q D +S+GV++ EM+TG
Sbjct: 153 KKAYSFCGTVE---------YMAPEVVNRRGHTQSADWWSFGVLMFEMLTG 194
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 1e-07
Identities = 44/154 (28%), Positives = 63/154 (40%), Gaps = 35/154 (22%)
Query: 485 SLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHN 544
SL+ L K + +F I I + Y+H K +H DLKP NILLG
Sbjct: 101 SLSKELAEKTSVGAFLS--------IFHKICATIEYVHS---KGVLHRDLKPDNILLGLF 149
Query: 545 MEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSN------L 598
E + D+G A + +E + ++ SS +
Sbjct: 150 GEVVILDWGAAIFKKL-----------------EEEDLLDIDVDERNICYSSMTIPGKIV 192
Query: 599 GSY-YQAPESLKVVKPSQKWDIYSYGVILLEMIT 631
G+ Y APE L V S+ DIY+ GVIL +M+T
Sbjct: 193 GTPDYMAPERLLGVPASESTDIYALGVILYQMLT 226
|
Length = 932 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 53.3 bits (129), Expect = 1e-07
Identities = 61/251 (24%), Positives = 109/251 (43%), Gaps = 64/251 (25%)
Query: 411 LGKSGIGIVYK-VVLEDGHTLAVRRLGEGGSQRFKEFQT--------EVEAIGKIRHSNI 461
LG+ +VYK E G +A++++ G KE + E++ + +++H NI
Sbjct: 8 LGEGTYAVVYKARDKETGRIVAIKKIKLG---ERKEAKDGINFTALREIKLLQELKHPNI 64
Query: 462 VTLRAYYWSVDEKLLIYDYIPNGSLATALHG--KPGMVSFTPVPWSVRVK-IIKGIAKGL 518
+ L + L++++ + T L K + TP +K + +GL
Sbjct: 65 IGLLDVFGHKSNINLVFEF-----METDLEKVIKDKSIVLTPA----DIKSYMLMTLRGL 115
Query: 519 VYLHEFSPKKYV-HGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKP 577
YLH ++ H DLKP+N+L+ + ++DFGLAR + GSP + +M
Sbjct: 116 EYLH----SNWILHRDLKPNNLLIASDGVLKLADFGLAR----SFGSP---NRKM----- 159
Query: 578 QERQQKSVSLEVTTTNSSSNLGSYYQAPESL---KVVKPSQKWDIYSYGVILLEMITGRT 634
+ +V T +Y+APE L + D++S G I E++ R
Sbjct: 160 --------THQVVTR--------WYRAPELLFGARHYGVGV--DMWSVGCIFAELLL-RV 200
Query: 635 AVVQVGSSEMD 645
+ G S++D
Sbjct: 201 PFLP-GDSDID 210
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 1e-07
Identities = 65/263 (24%), Positives = 108/263 (41%), Gaps = 45/263 (17%)
Query: 411 LGKSGIGIVYKVVLEDGHTLAVRRL--GEGGSQRFKEFQTEVEAIGKIRHSNIVTLRAYY 468
LG G+V+KV + + R+L E + E++ + + IV +
Sbjct: 13 LGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 72
Query: 469 WSVDEKLLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKK 528
+S E + +++ GSL L K G +P + K+ + KGL YL E K
Sbjct: 73 YSDGEISICMEHMDGGSLDQVLK-KAG-----RIPEQILGKVSIAVIKGLTYLRE--KHK 124
Query: 529 YVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQKSVSLE 588
+H D+KPSNIL+ E + DFG VS +
Sbjct: 125 IMHRDVKPSNILVNSRGEIKLCDFG-------------------------------VSGQ 153
Query: 589 VTTTNSSSNLGS-YYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGSSEMDLV 647
+ + ++S +G+ Y +PE L+ S + DI+S G+ L+EM GR + + E++L+
Sbjct: 154 LIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELM 213
Query: 648 NWMQLCIEEKKPLADVLDPYLAP 670
+ E P P P
Sbjct: 214 FGCPV---EGDPAESETSPRPRP 233
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 53.5 bits (129), Expect = 1e-07
Identities = 62/309 (20%), Positives = 104/309 (33%), Gaps = 93/309 (30%)
Query: 431 AVRRLGEGGSQR-FKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGSLA-- 487
AV+ L S ++F EV+ + ++ NI L +I +Y+ NG L
Sbjct: 50 AVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQF 109
Query: 488 ---------TALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSN 538
+ +S + + IA G+ YL +VH DL N
Sbjct: 110 LQKHVAETSGLACNSK------SLSFSTLLYMATQIASGMRYL---ESLNFVHRDLATRN 160
Query: 539 ILLGHNMEPHVSDFGLARLANIA-----GGSPTLQSNRMPAEKPQERQQKSVSLEVTTTN 593
L+G N ++DFG++R + G L M
Sbjct: 161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWM--------------------- 199
Query: 594 SSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGSSEMDLVNWMQLC 653
A ES+ + K + K D++++GV L E++T LC
Sbjct: 200 ----------AWESVLLGKFTTKSDVWAFGVTLWEILT--------------------LC 229
Query: 654 IEEKKPLADVLDPYLAPDA------DKEEEIIA--------VLKIAMACVHSSPEKRPTM 699
++P + D + +A D + + + ++ + C E RPT
Sbjct: 230 --REQPYEHLTDQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTF 287
Query: 700 RHISDALDR 708
R I L R
Sbjct: 288 REIHLFLQR 296
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 1e-07
Identities = 65/279 (23%), Positives = 116/279 (41%), Gaps = 63/279 (22%)
Query: 444 KEFQTEVEAIGKIRHSNIVTLRAYYWSVDEK------LLIYDYIPNGSLAT-ALHGKPGM 496
++F +E + + H N++ L E ++I ++ +G L + L+ + G
Sbjct: 45 EDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGD 104
Query: 497 VSFTPV--PWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGL 554
P P + VK + IA G+ YL S K ++H DL N +L NM V+DFGL
Sbjct: 105 ---CPQYLPTQMLVKFMTDIASGMEYL---SSKSFIHRDLAARNCMLNENMNVCVADFGL 158
Query: 555 ARLANIAGGSPTLQSN--RMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVK 612
++ I G Q +MP + + A ESL
Sbjct: 159 SK--KIYNGDYYRQGRIAKMPVK--------------------------WIAIESLADRV 190
Query: 613 PSQKWDIYSYGVILLEMIT-GRTAVVQVGSSEMDLVNWMQLCIEEKKPLADVLDPYLAPD 671
+ K D++S+GV + E+ T G+T V +SE + ++++ K+P D LD
Sbjct: 191 YTTKSDVWSFGVTMWEIATRGQTPYPGVENSE--IYDYLRQGNRLKQP-PDCLD------ 241
Query: 672 ADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDALDRLI 710
+ + +C +P+ RP+ + L++ +
Sbjct: 242 --------GLYSLMSSCWLLNPKDRPSFETLRCELEKAL 272
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 2e-07
Identities = 58/227 (25%), Positives = 96/227 (42%), Gaps = 42/227 (18%)
Query: 410 VLGKSGIGIVYKVVLEDGHTLAVRRL--GEGGSQRFKEFQTEVEAIGKIRHSNIVTLRAY 467
LG G+V KV+ + R+L E + E++ + + IV
Sbjct: 8 ELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGA 67
Query: 468 YWSVDEKLLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPK 527
++S E + +++ GSL L K G + P ++ KI + +GL YL E
Sbjct: 68 FYSDGEISICMEHMDGGSLDQVLK-KAGRI-----PENILGKISIAVLRGLTYLRE--KH 119
Query: 528 KYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQKSVSL 587
K +H D+KPSNIL+ E + DFG VS
Sbjct: 120 KIMHRDVKPSNILVNSRGEIKLCDFG-------------------------------VSG 148
Query: 588 EVTTTNSSSNLGS-YYQAPESLKVVKPSQKWDIYSYGVILLEMITGR 633
++ + ++S +G+ Y +PE L+ + + DI+S G+ L+EM GR
Sbjct: 149 QLIDSMANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGR 195
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 2e-07
Identities = 56/234 (23%), Positives = 96/234 (41%), Gaps = 47/234 (20%)
Query: 411 LGKSGIGIVYKVVL----EDGHTLAVRRLG--EGGSQRFKEFQTEVEAIGKIRHSNIVTL 464
+ K G G K +L EDG ++ + + + +E + EV + ++H NIV
Sbjct: 5 VKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQY 64
Query: 465 RAYYWSVDEKLLIYDYIPNGSLATALHGKPGMVSFTP---VPWSVRVKIIKGIAKGLVYL 521
+ + ++ DY G L ++ + G V F + W V+ I L ++
Sbjct: 65 QESFEENGNLYIVMDYCEGGDLYKKINAQRG-VLFPEDQILDWFVQ------ICLALKHV 117
Query: 522 HEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQ 581
H+ +K +H D+K NI L + + DFG+AR+ N
Sbjct: 118 HD---RKILHRDIKSQNIFLTKDGTIKLGDFGIARVLN---------------------- 152
Query: 582 QKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTA 635
+V L T + YY +PE + + K DI++ G +L EM T + A
Sbjct: 153 -STVELARTCIGT-----PYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHA 200
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 2e-07
Identities = 68/297 (22%), Positives = 112/297 (37%), Gaps = 63/297 (21%)
Query: 411 LGKSGIGIVYKVVLEDGHTLAVRRLG----EGGSQRFKEFQTEVEAIGKIRHSNIVTLRA 466
+GK G VYK + D T V + E ++ Q E+ + + I
Sbjct: 12 IGKGSFGEVYKGI--DNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYG 69
Query: 467 YYWSVDEKLLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSP 526
Y + +I +Y+ GS L KPG P+ + I++ I KGL YLH
Sbjct: 70 SYLKGTKLWIIMEYLGGGSALDLL--KPG-----PLEETYIATILREILKGLDYLHS--- 119
Query: 527 KKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQKSVS 586
++ +H D+K +N+LL + ++DFG+A
Sbjct: 120 ERKIHRDIKAANVLLSEQGDVKLADFGVAG-----------------------------Q 150
Query: 587 LEVTTTNSSSNLGS-YYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGSSEMD 645
L T ++ +G+ ++ APE +K K DI+S G+ +E+ G D
Sbjct: 151 LTDTQIKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGE-------PPNSD 203
Query: 646 LVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHI 702
L L + K + Y P + E AC++ P RPT + +
Sbjct: 204 LHPMRVLFLIPKNSPPTLEGQYSKPFKEFVE----------ACLNKDPRFRPTAKEL 250
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 2e-07
Identities = 68/300 (22%), Positives = 116/300 (38%), Gaps = 63/300 (21%)
Query: 410 VLGKSGIGIVYKVVLEDGHTLAVRRLGEGGSQRFKE---FQTEVEAIGKIRHSNIVTLRA 466
V+G+ GIV+ + L + + E Q E + + + H NI+
Sbjct: 7 VVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNII---E 63
Query: 467 YYWSV--DEKLLI-YDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHE 523
YY + D+ L+I +Y P G+LA + + S I+ + L+ LH
Sbjct: 64 YYENFLEDKALMIVMEYAPGGTLAEYIQKRCN--SLLD-----EDTILHFFVQILLALHH 116
Query: 524 FSPKKYVHGDLKPSNILLG-HNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQ 582
K +H DLK NILL H M + DFG+++
Sbjct: 117 VHTKLILHRDLKTQNILLDKHKMVVKIGDFGISK----------------------ILSS 154
Query: 583 KSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGSS 642
KS + V T Y +PE + +QK DI++ G +L E+ + + A
Sbjct: 155 KSKAYTVVGTPC-------YISPELCEGKPYNQKSDIWALGCVLYELASLKRA------- 200
Query: 643 EMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHI 702
+ N L ++ ++ AP +D+ + L ++M ++ P KRP + I
Sbjct: 201 -FEAANLPALVLK-------IMSGTFAPISDRYSPDLRQLILSM--LNLDPSKRPQLSQI 250
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 2e-07
Identities = 54/234 (23%), Positives = 96/234 (41%), Gaps = 44/234 (18%)
Query: 400 LDELLKASAFVLGKSGIGIV-YKVVLEDGHTLAVRRLGEGGSQRFKEFQTEVEAIGKIRH 458
LD +K +G+ GIV V G +AV+++ QR + EV + +H
Sbjct: 22 LDNFIK-----IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQH 76
Query: 459 SNIVTLRAYYWSVDEKLLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGL 518
N+V + Y DE ++ +++ G+L +V+ T + + + K L
Sbjct: 77 ENVVEMYNSYLVGDELWVVMEFLEGGALTD-------IVTHTRMNEEQIAAVCLAVLKAL 129
Query: 519 VYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQ 578
LH + +H D+K +ILL H+ +SDFG + K
Sbjct: 130 SVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVS----------------KEV 170
Query: 579 ERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITG 632
R++ V Y+ APE + + + DI+S G++++EM+ G
Sbjct: 171 PRRKSLVGT------------PYWMAPELISRLPYGPEVDIWSLGIMVIEMVDG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 2e-07
Identities = 58/233 (24%), Positives = 93/233 (39%), Gaps = 50/233 (21%)
Query: 411 LGKSGIGIVYKVVLED-GHTLAVRRLGEGGSQRFKEFQTEVEA------IGKIRHSNIVT 463
LGK G G V ++ G A ++L + +R K+ + E A + K+ IV+
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDK---KRLKKRKGEQMALNEKKILEKVSSRFIVS 57
Query: 464 LRAYYWSVDEKLLIYDYIPNGSLATAL--HGKPGMVSFTPVPWSVRVKIIKGIAKGLVYL 521
L + + D+ L+ + G L + G+PG + ++ + I GL +L
Sbjct: 58 LAYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQ------IICGLEHL 111
Query: 522 HEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQ 581
H+ ++ V+ DLKP N+LL + +SD GLA + GG P
Sbjct: 112 HQ---RRIVYRDLKPENVLLDDHGNVRISDLGLA--VELKGGKKIKGRAGTPG------- 159
Query: 582 QKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRT 634
Y APE L+ D ++ G L EMI GR+
Sbjct: 160 --------------------YMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRS 192
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.9 bits (128), Expect = 2e-07
Identities = 66/251 (26%), Positives = 106/251 (42%), Gaps = 67/251 (26%)
Query: 411 LGKSGIGIVYK-VVLEDGHTLAVRRLGEGGSQRFKEFQT-----EVEAIGKI-RHSNIVT 463
LG G VY E G +A++++ ++F ++ EV+++ K+ H NIV
Sbjct: 7 LGDGTFGSVYLARNKETGELVAIKKM----KKKFYSWEECMNLREVKSLRKLNEHPNIVK 62
Query: 464 LRAYYWSVDEKLLIYDYIPNGSLATALHGKPGMVSFTPVPWS---VRVKIIKGIAKGLVY 520
L+ + DE +++Y+ G+L M P+S +R II I +GL +
Sbjct: 63 LKEVFRENDELYFVFEYM-EGNLYQL------MKDRKGKPFSESVIR-SIIYQILQGLAH 114
Query: 521 LHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQER 580
+H+ + H DLKP N+L+ ++DFGLAR
Sbjct: 115 IHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAR------------------------ 147
Query: 581 QQKSVSLEVTTTNSSSNLGSY-----YQAPES-LKVVKPSQKWDIYSYGVILLEMITGRT 634
E+ S Y Y+APE L+ S DI++ G I+ E+ T R
Sbjct: 148 -------EI---RSRPPYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRP 197
Query: 635 AVVQVGSSEMD 645
+ GSSE+D
Sbjct: 198 --LFPGSSEID 206
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.6 bits (127), Expect = 2e-07
Identities = 46/165 (27%), Positives = 82/165 (49%), Gaps = 33/165 (20%)
Query: 411 LGKSGIGIVYKVV-LEDGHTLAVRR----LGEGGSQRFKEFQTEVEAIGKIR------HS 459
+G+ G VYK L G +A+++ L E G + + I ++ H
Sbjct: 7 IGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIP-----LSTLREIALLKQLESFEHP 61
Query: 460 NIVTLR--AYYWSVDEKL---LIYDYIPNGSLATAL--HGKPGMVSFTPVPWSVRVKIIK 512
NIV L + D +L L+++++ + LAT L KPG+ P +++ +++
Sbjct: 62 NIVRLLDVCHGPRTDRELKLTLVFEHV-DQDLATYLSKCPKPGLP-----PETIK-DLMR 114
Query: 513 GIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARL 557
+ +G+ +LH + VH DLKP NIL+ + + ++DFGLAR+
Sbjct: 115 QLLRGVDFLHS---HRIVHRDLKPQNILVTSDGQVKIADFGLARI 156
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 2e-07
Identities = 84/353 (23%), Positives = 140/353 (39%), Gaps = 80/353 (22%)
Query: 384 VEQYDLVPLDTQVAFDLDELLKASAFVLGKS-GIGIVYKVVLEDGHTL-----------A 431
V +Y+L P D + D L VLGK G G +VV+ + L A
Sbjct: 2 VSEYEL-PEDPRWEVPRDRL------VLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVA 54
Query: 432 VRRLGEGGSQR-FKEFQTEVEAIGKI-RHSNIVTLRAYYWSVDEKLLIYDYIPNGSLATA 489
V+ L +++ + +E+E + I +H NI+ L +I +Y G+L
Sbjct: 55 VKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREY 114
Query: 490 LHGK--PGM-VSFTPVPWSVRVKIIKG-------IAKGLVYLHEFSPKKYVHGDLKPSNI 539
L + PGM + P K +A+G+ YL + KK +H DL N+
Sbjct: 115 LRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNV 171
Query: 540 LLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLG 599
L+ + ++DFGLAR + + R+P +
Sbjct: 172 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVK------------------------ 207
Query: 600 SYYQAPESLKVVKPSQKWDIYSYGVILLEMIT-GRTAVVQVGSSEMDLVNWMQLCIEEKK 658
+ APE+L + + D++S+GV+L E+ T G + V E+ +L E +
Sbjct: 208 --WMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL-----FKLLKEGHR 260
Query: 659 PLADVLDPYLAPDADKEEEIIAVLKIAMA-CVHSSPEKRPTMRHISDALDRLI 710
DK L + M C H+ P +RPT + + + LDR++
Sbjct: 261 -------------MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 300
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 52.4 bits (126), Expect = 2e-07
Identities = 75/344 (21%), Positives = 135/344 (39%), Gaps = 75/344 (21%)
Query: 390 VPLDTQVAFDLDELLKASAFVLGKS-GIGIVYKVVLEDG---------HTLAVRRLGEGG 439
+PLD + D L LGK G G +VV + T+AV+ L +
Sbjct: 1 LPLDPEWELPRDRL------TLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA 54
Query: 440 SQR-FKEFQTEVEAIGKI-RHSNIVTLRAYYWSVDEKLLIYDYIPNGSLATALHG-KPGM 496
+++ + +E+E + I +H NI+ L ++ +Y +G+L L +P
Sbjct: 55 TEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPG 114
Query: 497 VSFTPVPWSVRVKIIK---------GIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEP 547
+P + + +A+G+ +L + KK +H DL N+L+ +
Sbjct: 115 EYASPDDPRPPEETLTQKDLVSFAYQVARGMEFL---ASKKCIHRDLAARNVLVTEDHVM 171
Query: 548 HVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPES 607
++DFGLAR + + TTN L + APE+
Sbjct: 172 KIADFGLARDIH------------------------HIDYYRKTTN--GRLPVKWMAPEA 205
Query: 608 LKVVKPSQKWDIYSYGVILLEMIT-GRTAVVQVGSSEMDLVNWMQLCIEEKKPLADVLDP 666
L + + D++S+GV+L E+ T G + + E L ++ +KP +
Sbjct: 206 LFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE--LFKLLKEGYRMEKPQNCTQEL 263
Query: 667 YLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDALDRLI 710
Y + C H P +RPT + + + LDR++
Sbjct: 264 Y---------------HLMRDCWHEVPSQRPTFKQLVEDLDRML 292
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 52.0 bits (125), Expect = 3e-07
Identities = 50/201 (24%), Positives = 73/201 (36%), Gaps = 61/201 (30%)
Query: 444 KEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKL-LIYDYIPNGSLATALHGKPGMVSFTPV 502
KEF E + ++ H IV L E L L+ + P G L L + +
Sbjct: 41 KEFLREASVMAQLDHPCIVRLIGV--CKGEPLMLVMELAPLGPLLKYLKKRREIPVSDLK 98
Query: 503 PWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAG 562
+ +V A G+ YL K +VH DL N+LL + + +SDFG++R +
Sbjct: 99 ELAHQV------AMGMAYLES---KHFVHRDLAARNVLLVNRHQAKISDFGMSR--ALGA 147
Query: 563 GSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQ------------APESLKV 610
GS YY+ APE +
Sbjct: 148 GS-----------------------------------DYYRATTAGRWPLKWYAPECINY 172
Query: 611 VKPSQKWDIYSYGVILLEMIT 631
K S K D++SYGV L E +
Sbjct: 173 GKFSSKSDVWSYGVTLWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 4e-07
Identities = 36/133 (27%), Positives = 64/133 (48%), Gaps = 9/133 (6%)
Query: 430 LAVRRLGEGGSQRFK-EFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGSLAT 488
+AV+ L E ++ + +F E++ + +++ NI+ L A + D +I +Y+ NG L
Sbjct: 49 VAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQ 108
Query: 489 AL-----HGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGH 543
L + +S + + IA G+ YL S +VH DL N L+G
Sbjct: 109 FLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYL---SSLNFVHRDLATRNCLVGK 165
Query: 544 NMEPHVSDFGLAR 556
N ++DFG++R
Sbjct: 166 NYTIKIADFGMSR 178
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 4e-07
Identities = 51/189 (26%), Positives = 83/189 (43%), Gaps = 42/189 (22%)
Query: 447 QTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGSLATALHGKPGMVSFTP---VP 503
+ EV + K++H NIVT A + ++ +Y G L ++ + G V F+ +
Sbjct: 47 KKEVILLAKMKHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRG-VLFSEDQILS 105
Query: 504 WSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHN-MEPHVSDFGLARLANIAG 562
W V+ I+ GL ++H+ +K +H D+K NI L N M + DFG+AR N
Sbjct: 106 WFVQ------ISLGLKHIHD---RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLN--- 153
Query: 563 GSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSY 622
S+E+ T + YY +PE + + K DI+S
Sbjct: 154 ----------------------DSMELAYTCVGT---PYYLSPEICQNRPYNNKTDIWSL 188
Query: 623 GVILLEMIT 631
G +L E+ T
Sbjct: 189 GCVLYELCT 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 4e-07
Identities = 51/224 (22%), Positives = 97/224 (43%), Gaps = 41/224 (18%)
Query: 411 LGKSGIGIVYKVV-LEDGHTLAVRRLGEGGSQRFKEFQTEVEAIGKIRHSNIVTLRAYYW 469
+G+ G VY + + G +A++++ + + E+ + + +H NIV Y
Sbjct: 27 IGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYL 86
Query: 470 SVDEKLLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKY 529
DE ++ +Y+ GSL +V+ T + + + + L +LH +
Sbjct: 87 VGDELWVVMEYLAGGSLTD-------VVTETCMDEGQIAAVCRECLQALEFLHS---NQV 136
Query: 530 VHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQKSVSLEV 589
+H D+K NILLG + ++DFG A I P++ ++
Sbjct: 137 IHRDIKSDNILLGMDGSVKLTDFGFC--AQIT---------------PEQSKR------- 172
Query: 590 TTTNSSSNLGS-YYQAPESLKVVKPSQKWDIYSYGVILLEMITG 632
S+ +G+ Y+ APE + K DI+S G++ +EM+ G
Sbjct: 173 -----STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.9 bits (125), Expect = 4e-07
Identities = 66/247 (26%), Positives = 102/247 (41%), Gaps = 70/247 (28%)
Query: 417 GIVYKVV-LEDGHTLAVRRLGEGGSQRFKEFQTEVE-----AIGKI------RHSNIVTL 464
G+VYK G +A++++ +TE E AI +I H NIV L
Sbjct: 13 GVVYKARDKLTGEIVALKKI---------RLETEDEGVPSTAIREISLLKELNHPNIVRL 63
Query: 465 RAYYWSVDEKL-LIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKG----IAKGLV 519
S + KL L+++++ + L + P P +IK + +G+
Sbjct: 64 LDVVHS-ENKLYLVFEFL-DLDLKKYMDSSPLT-GLDP-------PLIKSYLYQLLQGIA 113
Query: 520 YLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQE 579
Y H + +H DLKP N+L+ ++DFGLAR A G P
Sbjct: 114 YCHS---HRVLHRDLKPQNLLIDREGALKLADFGLAR----AFGVPV------------- 153
Query: 580 RQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKP-SQKWDIYSYGVILLEMITGRTAVVQ 638
++ + EV T +Y+APE L + S DI+S G I EM+ R +
Sbjct: 154 ---RTYTHEVVTL--------WYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRP--LF 200
Query: 639 VGSSEMD 645
G SE+D
Sbjct: 201 PGDSEID 207
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 4e-07
Identities = 67/300 (22%), Positives = 121/300 (40%), Gaps = 60/300 (20%)
Query: 410 VLGKSGIGIVYK-VVLEDGHTLAVRRLGEGGSQRF-KEFQTEVEAIGKIRHSNIVTLRAY 467
+LG G VYK L LAV+ + + K+ +E+E + K I+
Sbjct: 8 ILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGA 67
Query: 468 YWSVDEKLLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPK 527
++ + + +++ GSL + +P V +I + KGL YL
Sbjct: 68 FFVENRISICTEFMDGGSLDV----------YRKIPEHVLGRIAVAVVKGLTYLWSL--- 114
Query: 528 KYVHGDLKPSNILLGHNMEPHVSDFGLAR-LANIAGGSPTLQSNRMPAEKPQERQQKSVS 586
K +H D+KPSN+L+ + + DFG++ L N S++
Sbjct: 115 KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVN------------------------SIA 150
Query: 587 LEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGSSEMDL 646
TN+ Y APE + + D++S G+ +E+ GR Q+ ++ L
Sbjct: 151 KTYVGTNA-------YMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSL 203
Query: 647 VNWMQL--CIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISD 704
+ +QL CI ++ DP + P E+ + + C+ P++RP ++ D
Sbjct: 204 MP-LQLLQCIVDE-------DPPVLPVGQFSEKFVHFIT---QCMRKQPKERPAPENLMD 252
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 4e-07
Identities = 63/233 (27%), Positives = 102/233 (43%), Gaps = 47/233 (20%)
Query: 411 LGKSGIGIVYKVVLE-DGHTLAVR--RLGEGGSQRFKEFQTEVEAIGKIRHSNIVTLRAY 467
LGK G VYKV+ G T+A++ RL E +F + E++ + K IV
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMAMKEIRL-ELDESKFNQIIMELDILHKAVSPYIVDFYGA 67
Query: 468 YWSVDEKLLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPK 527
++ + +Y+ GSL L+ G V+ +P V +I + KGL +L E
Sbjct: 68 FFIEGAVYMCMEYMDAGSL-DKLYA--GGVATEGIPEDVLRRITYAVVKGLKFLKE--EH 122
Query: 528 KYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQKSVSL 587
+H D+KP+N+L+ N + + DFG VS
Sbjct: 123 NIIHRDVKPTNVLVNGNGQVKLCDFG-------------------------------VSG 151
Query: 588 EVTTTNSSSNLG-SYYQAPESLKVVKPSQ------KWDIYSYGVILLEMITGR 633
+ + + +N+G Y APE +K P+Q + D++S G+ +LEM GR
Sbjct: 152 NLVASLAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGR 204
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 4e-07
Identities = 37/168 (22%), Positives = 68/168 (40%), Gaps = 44/168 (26%)
Query: 468 YWSVDEK---LLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEF 524
Y+S K L+ +Y+ G A+ + + P W+ + I + G+ LH+
Sbjct: 63 YYSFQSKDYLYLVMEYLNGGDCASLIK----TLGGLPEDWAK--QYIAEVVLGVEDLHQ- 115
Query: 525 SPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQKS 584
+ +H D+KP N+L+ ++DFGL+R L++ +
Sbjct: 116 --RGIIHRDIKPENLLIDQTGHLKLTDFGLSRNG--------LENKKF------------ 153
Query: 585 VSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITG 632
V T + Y APE++ V + D +S G ++ E + G
Sbjct: 154 ----VGTPD--------YLAPETILGVGDDKMSDWWSLGCVIFEFLFG 189
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 5e-07
Identities = 71/307 (23%), Positives = 124/307 (40%), Gaps = 56/307 (18%)
Query: 411 LGKSGIGIVYK-----VVLEDGHT-LAVRRLGEGGSQRFK-EFQTEVEAIGKIRHSNIVT 463
LG+ G+VY+ VV ++ T +A++ + E S R + EF E + + ++V
Sbjct: 14 LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 464 LRAYYWSVDEKLLIYDYIPNGSLATALHG-KPGMVS---FTPVPWSVRVKIIKGIAKGLV 519
L L+I + + G L + L +P M + P +++ IA G+
Sbjct: 74 LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMA 133
Query: 520 YLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQE 579
YL + K+VH DL N ++ + + DFG+ R +I E
Sbjct: 134 YL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTR--DI-------------YETDYY 175
Query: 580 RQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQV 639
R+ L V + +PESLK + D++S+GV+L E+ T Q
Sbjct: 176 RKGGKGLLPVR-----------WMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQG 224
Query: 640 GSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTM 699
S+E L M+ + +K P PD + ++ C +P+ RP+
Sbjct: 225 MSNEQVLRFVMEGGLLDK--------PDNCPD--------MLFELMRMCWQYNPKMRPSF 268
Query: 700 RHISDAL 706
I ++
Sbjct: 269 LEIISSI 275
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 5e-07
Identities = 57/237 (24%), Positives = 102/237 (43%), Gaps = 48/237 (20%)
Query: 399 DLDELLKASAFVLGKSGIGIVYKVVLEDGHT---LAVRRLGEGGSQRFKEFQTEVEAIGK 455
LD +K +G+ GIV + D T +AV+++ QR + EV +
Sbjct: 20 YLDNFVK-----IGEGSTGIV--CIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRD 72
Query: 456 IRHSNIVTLRAYYWSVDEKLLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIA 515
+H NIV + + Y DE ++ +++ G+L +V+ T + + +
Sbjct: 73 YQHPNIVEMYSSYLVGDELWVVMEFLEGGALTD-------IVTHTRMNEEQIATVCLAVL 125
Query: 516 KGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAE 575
K L +LH + +H D+K +ILL + +SDFG ++ E
Sbjct: 126 KALSFLHA---QGVIHRDIKSDSILLTSDGRVKLSDFGFC--------------AQVSKE 168
Query: 576 KPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITG 632
P+ + SL V T Y+ APE + + + DI+S G++++EM+ G
Sbjct: 169 VPRRK-----SL-VGT--------PYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 5e-07
Identities = 58/229 (25%), Positives = 103/229 (44%), Gaps = 42/229 (18%)
Query: 411 LGKSGIGIVYKVVLE-DGHTLAVR--RLGEGGSQRFKEFQTEVEAIGKIRHSNIVTLRAY 467
LG+ VYK + +G +A++ RL E F + E + ++H+NIV L
Sbjct: 13 LGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIR-EASLLKGLKHANIVLLHDI 71
Query: 468 YWSVDEKLLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPK 527
+ + L+++Y+ + L + PG + P +V++ + + + +GL Y+H+ +
Sbjct: 72 IHTKETLTLVFEYV-HTDLCQYMDKHPGGLH----PENVKLFLFQ-LLRGLSYIHQ---R 122
Query: 528 KYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQKSVSL 587
+H DLKP N+L+ E ++DFGLAR ++ + S
Sbjct: 123 YILHRDLKPQNLLISDTGELKLADFGLARAKSVP--------------------SHTYSN 162
Query: 588 EVTTTNSSSNLGSYYQAPES-LKVVKPSQKWDIYSYGVILLEMITGRTA 635
EV T +Y+ P+ L + S D++ G I +EMI G A
Sbjct: 163 EVVTL--------WYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAA 203
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 6e-07
Identities = 57/236 (24%), Positives = 98/236 (41%), Gaps = 45/236 (19%)
Query: 411 LGKSGIGIVY----KVVLEDGH---TLAVRRLGEGGS-QRFKEFQTEVEAIGKIRHSNIV 462
LG G VY +L G +AV+ L +G + Q KEF E + H NIV
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIV 62
Query: 463 TLRAYYWSVDEKLLIYDYIPNGSLATALHGKPGMVSFTPVPWSVR--VKIIKGIAKGLVY 520
L + + +I + + G L + L + F P +++ + I +AKG VY
Sbjct: 63 KLLGVCLLNEPQYIIMELMEGGDLLSYLRDAR-VERFGPPLLTLKELLDICLDVAKGCVY 121
Query: 521 LHEFSPKKYVHGDLKPSNILLGHNMEP-----HVSDFGLARLANIAGGSPTLQSNRMPAE 575
L + ++H DL N L+ + DFGLAR + + +
Sbjct: 122 LEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDFGLAR---------DIYKS----D 165
Query: 576 KPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMIT 631
++ + + + + APESL K + + D++S+GV++ E++T
Sbjct: 166 YYRKEGEGLLPVR-------------WMAPESLLDGKFTTQSDVWSFGVLMWEILT 208
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 7e-07
Identities = 58/224 (25%), Positives = 91/224 (40%), Gaps = 43/224 (19%)
Query: 411 LGKSGIGIVYKVV-LEDGHTLAVRRLGEGGSQRFKEFQTEVEAIGKIRHSNIVTLRAYYW 469
+G G VYK L G AV+ + F Q E+ + + +H NIV Y
Sbjct: 17 VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYL 76
Query: 470 SVDEKLLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKY 529
S ++ + +Y GSL H G +S + + R + +GL YLH K
Sbjct: 77 SREKLWICMEYCGGGSLQDIYH-VTGPLSELQIAYVCRETL-----QGLAYLHS---KGK 127
Query: 530 VHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQKSVSLEV 589
+H D+K +NILL N + ++DFG+A +
Sbjct: 128 MHRDIKGANILLTDNGDVKLADFGVA-----------------------------AKITA 158
Query: 590 TTTNSSSNLGS-YYQAPESLKVVKP---SQKWDIYSYGVILLEM 629
T S +G+ Y+ APE V K +Q DI++ G+ +E+
Sbjct: 159 TIAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 7e-07
Identities = 69/299 (23%), Positives = 119/299 (39%), Gaps = 67/299 (22%)
Query: 411 LGKSGIGIVYKVVLEDGHTLAVRRLG----EGGSQRFKEFQTEVEAIGKIRHSNIVTLRA 466
+GK G V+K + D T V + E ++ Q E+ + + +
Sbjct: 12 IGKGSFGEVFKGI--DNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG 69
Query: 467 YYWSVDEKLLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSP 526
Y + +I +Y+ GS L +PG + T + I++ I KGL YLH
Sbjct: 70 SYLKDTKLWIIMEYLGGGSALDLL--EPGPLDETQI-----ATILREILKGLDYLHS--- 119
Query: 527 KKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQKSVS 586
+K +H D+K +N+LL + E ++DFG+A
Sbjct: 120 EKKIHRDIKAANVLLSEHGEVKLADFGVAG------------------------------ 149
Query: 587 LEVTTTNSSSN--LGS-YYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGSSE 643
++T T N +G+ ++ APE +K K DI+S G+ +E+ G SE
Sbjct: 150 -QLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPP-----HSE 203
Query: 644 MDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHI 702
+ + + L I + P P L + K + + AC++ P RPT + +
Sbjct: 204 LHPMKVLFL-IPKNNP------PTLEGNYSK-----PLKEFVEACLNKEPSFRPTAKEL 250
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 8e-07
Identities = 57/237 (24%), Positives = 101/237 (42%), Gaps = 50/237 (21%)
Query: 400 LDELLKASAFVLGKSGIGIVYKVVLEDGHT---LAVRRLGEGGSQRFKEFQTEVEAIGKI 456
LD +K +G+ GIV + + HT +AV+++ QR + EV +
Sbjct: 24 LDSFIK-----IGEGSTGIV--CIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDY 76
Query: 457 RHSNIVTLRAYYWSVDEKLLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAK 516
H N+V + Y DE ++ +++ G+L +V+ T + + + +
Sbjct: 77 HHENVVDMYNSYLVGDELWVVMEFLEGGALTD-------IVTHTRMNEEQIATVCLSVLR 129
Query: 517 GLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEK 576
L YLH + +H D+K +ILL + +SDFG A + S +P K
Sbjct: 130 ALSYLHN---QGVIHRDIKSDSILLTSDGRIKLSDFGFC--AQV--------SKEVPKRK 176
Query: 577 PQERQQKSVSLEVTTTNSSSNLGS-YYQAPESLKVVKPSQKWDIYSYGVILLEMITG 632
S +G+ Y+ APE + + + DI+S G++++EMI G
Sbjct: 177 -------------------SLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDG 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 9e-07
Identities = 71/325 (21%), Positives = 128/325 (39%), Gaps = 88/325 (27%)
Query: 402 ELLKASAFVLGKSGIGIVYKVVLEDGHTLAVRRLGEGGSQRFKE-FQTEVEAIGKI-RHS 459
++++A+A+ L KS + +AV+ L +E +E++ + + H
Sbjct: 50 KVVEATAYGLSKSDAVM----------KVAVKMLKPTAHSSEREALMSELKIMSHLGNHE 99
Query: 460 NIVTLRAYYWSVDEKLLIYDYIPNGSLATALHGKP-------GMVSFTPVPWSVRVKIIK 512
NIV L L+I +Y G L L K ++SF+
Sbjct: 100 NIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFS-----------Y 148
Query: 513 GIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQ--SN 570
+AKG+ +L + K +H DL N+LL H + DFGLAR +I S + +
Sbjct: 149 QVAKGMAFL---ASKNCIHRDLAARNVLLTHGKIVKICDFGLAR--DIMNDSNYVVKGNA 203
Query: 571 RMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMI 630
R+P + + APES+ + + D++SYG++L E+
Sbjct: 204 RLPVK--------------------------WMAPESIFNCVYTFESDVWSYGILLWEIF 237
Query: 631 TGRTAVVQVGSSEMDLVNWMQLCIEEK--KPLAD---VLDPYLAPDADKEEEIIAVLKIA 685
+ +GS+ + + ++ K K + + + P AP + I
Sbjct: 238 S-------LGSNP-----YPGMPVDSKFYKLIKEGYRMAQPEHAPA--------EIYDIM 277
Query: 686 MACVHSSPEKRPTMRHISDALDRLI 710
C + P KRPT + I + + +
Sbjct: 278 KTCWDADPLKRPTFKQIVQLIGKQL 302
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 50.5 bits (120), Expect = 1e-06
Identities = 51/223 (22%), Positives = 94/223 (42%), Gaps = 39/223 (17%)
Query: 411 LGKSGIGIVYKVV-LEDGHTLAVRRLGEGGSQRFKEFQTEVEAIGKIRHSNIVTLRAYYW 469
+G+ G VY + + G +A+R++ + + E+ + + ++ NIV Y
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 470 SVDEKLLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKY 529
DE ++ +Y+ GSL +V+ T + + + + L +LH +
Sbjct: 88 VGDELWVVMEYLAGGSLTD-------VVTETCMDEGQIAAVCRECLQALEFLHS---NQV 137
Query: 530 VHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQKSVSLEV 589
+H D+K NILLG + ++DFG A+ E+ ++S +
Sbjct: 138 IHRDIKSDNILLGMDGSVKLTDFGFC------------------AQITPEQSKRS---TM 176
Query: 590 TTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITG 632
T Y+ APE + K DI+S G++ +EMI G
Sbjct: 177 VGT-------PYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 50.1 bits (120), Expect = 2e-06
Identities = 57/218 (26%), Positives = 98/218 (44%), Gaps = 51/218 (23%)
Query: 449 EVEAIGKIRHSNIVTL--------RAYYWSVDEKLLIYDYIPNGSLATALHGKPGMVSFT 500
E++ + ++H N+V L Y L++++ + LA L K V FT
Sbjct: 61 EIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSNK--NVKFT 117
Query: 501 PVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANI 560
S K++K + GL Y+H K +H D+K +NIL+ + ++DFGLAR ++
Sbjct: 118 L---SEIKKVMKMLLNGLYYIHR---NKILHRDMKAANILITKDGILKLADFGLARAFSL 171
Query: 561 A-GGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESL---KVVKPSQK 616
+ P +NR+ V+L +Y+ PE L + P
Sbjct: 172 SKNSKPNRYTNRV------------VTL-------------WYRPPELLLGERDYGP--P 204
Query: 617 WDIYSYGVILLEMITGRTAVVQVGSSEMDLVNWM-QLC 653
D++ G I+ EM T R+ ++Q G++E + + QLC
Sbjct: 205 IDMWGAGCIMAEMWT-RSPIMQ-GNTEQHQLTLISQLC 240
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 2e-06
Identities = 48/193 (24%), Positives = 85/193 (44%), Gaps = 35/193 (18%)
Query: 445 EFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGSLATALHGKPGMVSFT---- 500
+F E++ + ++++ NI+ L S D +I +Y+ NG L L + +FT
Sbjct: 63 DFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANN 122
Query: 501 --PVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLA 558
V + + + IA G+ YL + +VH DL N L+G++ ++DFG++R
Sbjct: 123 IPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNCLVGNHYTIKIADFGMSR-- 177
Query: 559 NIAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWD 618
N+ G R Q L + + A ES+ + K + D
Sbjct: 178 NLYSGD-------------YYRIQGRAVLPIR-----------WMAWESILLGKFTTASD 213
Query: 619 IYSYGVILLEMIT 631
++++GV L EM T
Sbjct: 214 VWAFGVTLWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 2e-06
Identities = 50/209 (23%), Positives = 89/209 (42%), Gaps = 38/209 (18%)
Query: 427 GHTLAVRRLG-EGGSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEK--LLIYDYIPN 483
G +AV+ L E G + + E+E + + H NIV + LI +++P+
Sbjct: 33 GEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPS 92
Query: 484 GSLATALHGKPGMVSF-TPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLG 542
GSL L ++ + ++V+ I KG+ YL ++YVH DL N+L+
Sbjct: 93 GSLKEYLPRNKNKINLKQQLKYAVQ------ICKGMDYL---GSRQYVHRDLAARNVLVE 143
Query: 543 HNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYY 602
+ + DFGL + +++++ E T + ++
Sbjct: 144 SEHQVKIGDFGLTK---------AIETDK----------------EYYTVKDDLDSPVFW 178
Query: 603 QAPESLKVVKPSQKWDIYSYGVILLEMIT 631
APE L K D++S+GV L E++T
Sbjct: 179 YAPECLIQSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 49.7 bits (118), Expect = 2e-06
Identities = 55/224 (24%), Positives = 91/224 (40%), Gaps = 43/224 (19%)
Query: 411 LGKSGIGIVYKVV-LEDGHTLAVRRLGEGGSQRFKEFQTEVEAIGKIRHSNIVTLRAYYW 469
+G G VYK + G A++ + + F Q E+ + +HSNIV Y
Sbjct: 17 IGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYL 76
Query: 470 SVDEKLLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKY 529
D+ + ++ GSL H G +S + + + R + +GL YLH K
Sbjct: 77 RRDKLWICMEFCGGGSLQDIYH-VTGPLSESQIAYVSRETL-----QGLYYLHS---KGK 127
Query: 530 VHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQKSVSLEV 589
+H D+K +NILL N ++DFG+ S +
Sbjct: 128 MHRDIKGANILLTDNGHVKLADFGV-----------------------------SAQITA 158
Query: 590 TTTNSSSNLGS-YYQAPESLKVVKP---SQKWDIYSYGVILLEM 629
T S +G+ Y+ APE V + +Q DI++ G+ +E+
Sbjct: 159 TIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 2e-06
Identities = 52/214 (24%), Positives = 83/214 (38%), Gaps = 49/214 (22%)
Query: 468 YWSVDEKLLIY---DYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEF 524
Y+S +K +Y DYIP G + + L + + I + + +H+
Sbjct: 67 YYSFQDKDNLYFVMDYIPGGDMMSLL------IRLGIFEEDLARFYIAELTCAIESVHKM 120
Query: 525 SPKKYVHGDLKPSNILLGHNMEPHVSDFGL------------------ARLANIAGGSPT 566
++H D+KP NIL+ + ++DFGL R ++ S
Sbjct: 121 G---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSME-PSEE 176
Query: 567 LQSNRMPAEKPQE----RQQKSV---SLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDI 619
KP E RQ + SL V T N Y APE L +Q D
Sbjct: 177 WSEIDRCRLKPLERRRKRQHQRCLAHSL-VGTPN--------YIAPEVLLRTGYTQLCDW 227
Query: 620 YSYGVILLEMITGRTAVV--QVGSSEMDLVNWMQ 651
+S GVIL EM+ G+ + +++ ++NW
Sbjct: 228 WSVGVILYEMLVGQPPFLADTPAETQLKVINWET 261
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.6 bits (119), Expect = 2e-06
Identities = 45/169 (26%), Positives = 68/169 (40%), Gaps = 25/169 (14%)
Query: 398 FDLDELLKASAFVLGKSGIGIVYKVVLEDGHTLAVRRLGEGGSQRFKEFQTEVEAIGKI- 456
F+L E V+G+ G VYK + L ++ + +E + E + K
Sbjct: 8 FELVE-------VIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYS 60
Query: 457 RHSNIVTLR-AYYWSV-----DEKLLIYDYIPNGS---LATALHGKPGMVSFTPVPWSVR 507
H NI T A+ D+ L+ + GS L L K +
Sbjct: 61 NHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGK-----RLKEEWI 115
Query: 508 VKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLAR 556
I++ +GL YLHE K +H D+K NILL N E + DFG++
Sbjct: 116 AYILRETLRGLAYLHE---NKVIHRDIKGQNILLTKNAEVKLVDFGVSA 161
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 49.7 bits (119), Expect = 2e-06
Identities = 46/174 (26%), Positives = 74/174 (42%), Gaps = 18/174 (10%)
Query: 394 TQVAFDLDELLKASAFVLGKSGIGIVYK--VVLEDGHT----LAVRRLGEGGSQRFKE-F 446
+V D LL+A LG G VY+ DG +AV+ L E S++ + F
Sbjct: 1 PEVPRDSITLLRA----LGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDF 56
Query: 447 QTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGSLATAL-HGKPGMVSFTPVPWS 505
E + K H NIV L + + ++ + + G L + L +P + +
Sbjct: 57 LMEALIMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMK 116
Query: 506 VRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILL---GHNMEPHVSDFGLAR 556
+ + +AKG YL E ++H D+ N LL G ++DFG+AR
Sbjct: 117 DLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKIADFGMAR 167
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 45.2 bits (108), Expect = 2e-06
Identities = 26/60 (43%), Positives = 29/60 (48%), Gaps = 1/60 (1%)
Query: 138 LQILDLSQNFFNGSLPVSIVQCKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLNLSFNKF 197
L+ LDLS N + LK LDLS NN T P F SGL SL L+LS N
Sbjct: 2 LKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAF-SGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 50.1 bits (120), Expect = 2e-06
Identities = 34/117 (29%), Positives = 50/117 (42%), Gaps = 32/117 (27%)
Query: 517 GLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEK 576
G+ +LH +H DLKPSNI++ + + DFGLAR A +
Sbjct: 130 GIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS--------------- 171
Query: 577 PQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGR 633
++ V T YY+APE + + + DI+S G I+ EMI G
Sbjct: 172 ------FMMTPYVVT--------RYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 3e-06
Identities = 35/122 (28%), Positives = 53/122 (43%), Gaps = 35/122 (28%)
Query: 514 IAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMP 573
+ KGL Y+H +H DLKP N+ + + E + DFGLAR +
Sbjct: 127 MLKGLKYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQTD-------------- 169
Query: 574 AEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPES-LKVVKPSQKWDIYSYGVILLEMITG 632
++ V T +Y+APE L + +Q DI+S G I+ EM+TG
Sbjct: 170 ---------SEMTGYVVT--------RWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTG 212
Query: 633 RT 634
+
Sbjct: 213 KP 214
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 3e-06
Identities = 53/201 (26%), Positives = 94/201 (46%), Gaps = 57/201 (28%)
Query: 449 EVEAIGKIRHSNIVTLRAYYW----SVDEK------LLIYDYIPNGSLATALHG--KPGM 496
E++ + ++ H NIV L+ ++D K L+++Y+ + L G + G+
Sbjct: 56 EIKILRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHD-----LMGLLESGL 110
Query: 497 VSFTPVPWSVRVK-IIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLA 555
V F+ +K +K + +GL Y H+ K ++H D+K SNILL + + ++DFGLA
Sbjct: 111 VHFS----EDHIKSFMKQLLEGLNYCHK---KNFLHRDIKCSNILLNNKGQIKLADFGLA 163
Query: 556 RLANIAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESL---KVVK 612
RL N +E+ + K ++L +Y+ PE L +
Sbjct: 164 RLYN--------------SEESRPYTNKVITL-------------WYRPPELLLGEERYG 196
Query: 613 PSQKWDIYSYGVILLEMITGR 633
P+ D++S G IL E+ T +
Sbjct: 197 PAI--DVWSCGCILGELFTKK 215
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 3e-06
Identities = 56/203 (27%), Positives = 89/203 (43%), Gaps = 48/203 (23%)
Query: 449 EVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRV 508
E+ + +++H NIV L+ S L+++Y+ L K M S +P ++
Sbjct: 51 EISLLKEMQHGNIVRLQDVVHSEKRLYLVFEYLD-------LDLKKHMDS-SP-DFAKNP 101
Query: 509 KIIKG----IAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEP-HVSDFGLARLANIAGG 563
++IK I +G+ Y H + +H DLKP N+L+ ++DFGLAR A G
Sbjct: 102 RLIKTYLYQILRGIAYCHS---HRVLHRDLKPQNLLIDRRTNALKLADFGLAR----AFG 154
Query: 564 SPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKP-SQKWDIYSY 622
P ++ + EV T +Y+APE L + S DI+S
Sbjct: 155 IPV----------------RTFTHEVVTL--------WYRAPEILLGSRHYSTPVDIWSV 190
Query: 623 GVILLEMITGRTAVVQVGSSEMD 645
G I EM+ + G SE+D
Sbjct: 191 GCIFAEMVNQKPLF--PGDSEID 211
|
Length = 294 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 3e-06
Identities = 38/120 (31%), Positives = 55/120 (45%), Gaps = 35/120 (29%)
Query: 516 KGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAE 575
GL Y+H +H DLKP N+ + + E + DFGLAR A+ AE
Sbjct: 128 CGLKYIHS---AGIIHRDLKPGNLAVNEDCELKILDFGLARHAD--------------AE 170
Query: 576 KPQERQQKSVSLEVTTTNSSSNLGSYYQAPES-LKVVKPSQKWDIYSYGVILLEMITGRT 634
++ V T +Y+APE L + +Q DI+S G I+ EM+TG+T
Sbjct: 171 ---------MTGYVVT--------RWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKT 213
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 3e-06
Identities = 55/264 (20%), Positives = 102/264 (38%), Gaps = 53/264 (20%)
Query: 449 EVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGSLATALHGKPGMVSFTP--VPWSV 506
E++ + ++ H N++ A + +E ++ + G L+ + P W
Sbjct: 52 EIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKY 111
Query: 507 RVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPT 566
V++ L ++H ++ +H D+KP+N+ + + D GL R
Sbjct: 112 FVQL----CSALEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRF--------- 155
Query: 567 LQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGS-YYQAPESLKVVKPSQKWDIYSYGVI 625
TT + S +G+ YY +PE + + K DI+S G +
Sbjct: 156 --------------------FSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCL 195
Query: 626 LLEMITGRTAVVQVGSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIA 685
L EM ++ D +N LC K + P L D EE + ++
Sbjct: 196 LYEMAALQSPFYG------DKMNLYSLC----KKIEQCDYPPLPSDHYSEE----LRQLV 241
Query: 686 MACVHSSPEKRPTMRHISDALDRL 709
C++ PEKRP + ++ D R+
Sbjct: 242 NMCINPDPEKRPDITYVYDVAKRM 265
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 3e-06
Identities = 36/144 (25%), Positives = 65/144 (45%), Gaps = 39/144 (27%)
Query: 516 KGLVYLHEFSPKKYVHGDLKPSNILLG-HNMEPHVSDFGLARLANIAGGSPTLQSNRMPA 574
+GL Y+H +H DLKP+N+ + ++ + DFGLAR+ +
Sbjct: 125 RGLKYIHS---ANVLHRDLKPANVFINTEDLVLKIGDFGLARIVD--------------- 166
Query: 575 EKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKP---SQKWDIYSYGVILLEMIT 631
P + +S + T +Y++P L + P ++ D+++ G I EM+T
Sbjct: 167 --PHYSHKGYLSEGLVTK--------WYRSPRLL--LSPNNYTKAIDMWAAGCIFAEMLT 214
Query: 632 GRTAVVQVGSSEMDLVNWMQLCIE 655
G+ G+ E++ MQL +E
Sbjct: 215 GKPLF--AGAHELEQ---MQLILE 233
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 4e-06
Identities = 49/206 (23%), Positives = 86/206 (41%), Gaps = 38/206 (18%)
Query: 427 GHTLAVRRLGEGGSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGSL 486
G +AV+ + QR + EV + +H N+V + Y +E ++ +++ G+L
Sbjct: 46 GRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGAL 105
Query: 487 ATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNME 546
+VS T + + + + + L YLH + +H D+K +ILL +
Sbjct: 106 TD-------IVSQTRLNEEQIATVCESVLQALCYLHS---QGVIHRDIKSDSILLTLDGR 155
Query: 547 PHVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPE 606
+SDFG A I+ P K SL T Y+ APE
Sbjct: 156 VKLSDFGFC--AQISKDVP-----------------KRKSLVGT---------PYWMAPE 187
Query: 607 SLKVVKPSQKWDIYSYGVILLEMITG 632
+ + DI+S G++++EM+ G
Sbjct: 188 VISRTPYGTEVDIWSLGIMVIEMVDG 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 4e-06
Identities = 38/126 (30%), Positives = 56/126 (44%), Gaps = 35/126 (27%)
Query: 510 IIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQS 569
+I I +GL Y+H +H DLKPSN+ + + E + DFGLAR
Sbjct: 125 LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR------------- 168
Query: 570 NRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPE-SLKVVKPSQKWDIYSYGVILLE 628
++ V T +Y+APE L + +Q DI+S G I+ E
Sbjct: 169 ----------HTDDEMTGYVAT--------RWYRAPEIMLNWMHYNQTVDIWSVGCIMAE 210
Query: 629 MITGRT 634
++TGRT
Sbjct: 211 LLTGRT 216
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 48.5 bits (116), Expect = 5e-06
Identities = 54/233 (23%), Positives = 94/233 (40%), Gaps = 41/233 (17%)
Query: 410 VLGK--SGIGIVYKVVLEDGHTL-AVRR--LGEGGSQRFKEFQTEVEAIGKIRHSNIVTL 464
++GK + IV+ + +TL AV++ L + K Q E+ +++H NI+
Sbjct: 5 LIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPY 64
Query: 465 RAYYWSVDEKLLIYDYIPNGSLATAL---HGKPGMVSFTPVPWSVRVKIIKGIAKGLVYL 521
+ E ++ + GS L H G+ P I+K + L Y+
Sbjct: 65 VTSFIVDSELYVVSPLMAYGS-CEDLLKTHFPEGL------PELAIAFILKDVLNALDYI 117
Query: 522 HEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQ 581
H K ++H +K S+ILL S G L+ + + K +RQ
Sbjct: 118 HS---KGFIHRSVKASHILL--------SGDGKVVLSGL--------RYSVSMIKHGKRQ 158
Query: 582 QKSVSLEVTTTNSSSNLGSYYQAPESLK--VVKPSQKWDIYSYGVILLEMITG 632
+ +S NL + +PE L+ + ++K DIYS G+ E+ G
Sbjct: 159 RVVHDF---PKSSVKNL--PWLSPEVLQQNLQGYNEKSDIYSVGITACELANG 206
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 6e-06
Identities = 54/228 (23%), Positives = 98/228 (42%), Gaps = 48/228 (21%)
Query: 411 LGKSGIGIVYKVVLEDGHTLAVRRLGEGGSQ-RFKEFQTEVEAIGKIRHSNIVTL-RAYY 468
LG G VYK ++ LA ++ + S+ +++ E++ + H NIV L A+Y
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72
Query: 469 WSVDEKLLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKII-KGIAKGLVYLHEFSPK 527
+ + +LI ++ G++ M+ +++++ K + L YLHE
Sbjct: 73 YENNLWILI-EFCAGGAVDAV------MLELERPLTEPQIRVVCKQTLEALNYLHE---N 122
Query: 528 KYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQKSVSL 587
K +H DLK NIL + + ++DFG++ A + T+Q
Sbjct: 123 KIIHRDLKAGNILFTLDGDIKLADFGVS-----AKNTRTIQ------------------- 158
Query: 588 EVTTTNSSSNLGS-YYQAPESLKVVKPSQ-----KWDIYSYGVILLEM 629
S +G+ Y+ APE + K D++S G+ L+EM
Sbjct: 159 -----RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 6e-06
Identities = 46/175 (26%), Positives = 75/175 (42%), Gaps = 18/175 (10%)
Query: 399 DLDELLKASAFVLGKSGIGIVYKVV-LEDGHTLAVRRLGEGGSQRFKEFQ---TEVEAIG 454
D E L + +G G VY + + +A++++ G Q +++Q EV +
Sbjct: 11 DDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQ 70
Query: 455 KIRHSNIVTLRAYYWSVDEKLLIYDY-IPNGSLATALHGKPGMVSFTPVPWSVRVKIIKG 513
K+RH N + R Y L+ +Y + + S +H K P+ + G
Sbjct: 71 KLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKK-------PLQEVEIAAVTHG 123
Query: 514 IAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARL---ANIAGGSP 565
+GL YLH + +H D+K NILL + DFG A + AN G+P
Sbjct: 124 ALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFVGTP 175
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 7e-06
Identities = 58/232 (25%), Positives = 88/232 (37%), Gaps = 48/232 (20%)
Query: 411 LGKSGIGIVYKV-VLEDGHTLAVR-----RLGEGGSQRFKEFQTEVEAIGKIRHSNIVTL 464
LGK G G V V V G A + RL + ++ + E+ + K+ IV L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEI--LEKVNSPFIVNL 58
Query: 465 RAYYWSVDEKLLIYDYIPNGSLATALH--GKPGMVSFTPVPWSVRVKIIKGIAKGLVYLH 522
+ S L+ + G L ++ G+ G+ + +S + I G+++LH
Sbjct: 59 AYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQ------ITCGILHLH 112
Query: 523 EFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQ 582
V+ D+KP N+LL +SD GLA + G Q
Sbjct: 113 SM---DIVYRDMKPENVLLDDQGNCRLSDLGLA--VELKDGKTITQR------------- 154
Query: 583 KSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRT 634
TN Y APE LK S D ++ G + EM+ GRT
Sbjct: 155 -------AGTNG-------YMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRT 192
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 7e-06
Identities = 31/119 (26%), Positives = 55/119 (46%), Gaps = 4/119 (3%)
Query: 439 GSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGSLATALHGKPGMVS 498
Q +F E + ++HSN++ V LL+ ++ P G L L
Sbjct: 35 SVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAEL 94
Query: 499 FTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARL 557
TP P +++ ++ IA GL++LH+ ++H DL N LL ++ + D+GL+
Sbjct: 95 MTPDPTTLQ-RMACEIALGLLHLHK---NNFIHSDLALRNCLLTADLTVKIGDYGLSHN 149
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 7e-06
Identities = 39/146 (26%), Positives = 67/146 (45%), Gaps = 19/146 (13%)
Query: 427 GHTL--AVRRLGEGGSQRFK-EFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPN 483
G L AV+ L ++ + +F EV+ + +++ NI+ L D +I +Y+ N
Sbjct: 44 GRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMEN 103
Query: 484 GSLATAL----------HGKPGMVSFTPVP---WSVRVKIIKGIAKGLVYLHEFSPKKYV 530
G L L +G + +P +S + + IA G+ YL S +V
Sbjct: 104 GDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYL---SSLNFV 160
Query: 531 HGDLKPSNILLGHNMEPHVSDFGLAR 556
H DL N L+G N+ ++DFG++R
Sbjct: 161 HRDLATRNCLVGENLTIKIADFGMSR 186
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 7e-06
Identities = 59/239 (24%), Positives = 91/239 (38%), Gaps = 48/239 (20%)
Query: 411 LGKSGIGIVYKVVL------EDGHTLAVRRLGEGGSQRFKE-FQTEVEAIGKIRHSNIVT 463
LG+ G VYK L E +A++ L + +E F+ E +++H NIV
Sbjct: 13 LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVC 72
Query: 464 LRAYYWSVDEKLLIYDYIPNGSLATAL-----HGKPG------MVSFTPVPWSVRVKIIK 512
L +I+ Y + L L H G V T P V I+
Sbjct: 73 LLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADF-VHIVT 131
Query: 513 GIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRM 572
IA G+ +L S VH DL N+L+ + +SD GL R A + ++ +
Sbjct: 132 QIAAGMEFL---SSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLL 188
Query: 573 PAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMIT 631
P + +PE++ K S DI+SYGV+L E+ +
Sbjct: 189 PIR--------------------------WMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 48.2 bits (114), Expect = 7e-06
Identities = 48/223 (21%), Positives = 93/223 (41%), Gaps = 39/223 (17%)
Query: 411 LGKSGIGIVYKVV-LEDGHTLAVRRLGEGGSQRFKEFQTEVEAIGKIRHSNIVTLRAYYW 469
+G+ G VY + + G +A++++ + + E+ + + ++ NIV Y
Sbjct: 27 IGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 86
Query: 470 SVDEKLLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKY 529
DE ++ +Y+ GSL +V+ T + + + + L +LH +
Sbjct: 87 VGDELWVVMEYLAGGSLTD-------VVTETCMDEGQIAAVCRECLQALDFLHS---NQV 136
Query: 530 VHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQKSVSLEV 589
+H D+K NILLG + ++DFG A+ E+ ++S +
Sbjct: 137 IHRDIKSDNILLGMDGSVKLTDFGFC------------------AQITPEQSKRSTMVGT 178
Query: 590 TTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITG 632
Y+ APE + K DI+S G++ +EM+ G
Sbjct: 179 ----------PYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 47.6 bits (114), Expect = 8e-06
Identities = 58/231 (25%), Positives = 87/231 (37%), Gaps = 50/231 (21%)
Query: 411 LGKSGIGIVYKV-VLEDGHTLAVRRLG-----EGGSQRFKEFQTEVEAIGKIRHSNIVTL 464
LG G G V V V T A++ + E G Q + +E E + + H IV L
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQ--EHIFSEKEILEECNHPFIVKL 58
Query: 465 RAYYWSVDEKLL--IYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLH 522
+ D+K + + +Y G L T L + +T I + YLH
Sbjct: 59 YRTF--KDKKYIYMLMEYCLGGELWTILRDRGLFDEYTAR------FYIACVVLAFEYLH 110
Query: 523 EFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQ 582
+ ++ DLKP N+LL N + DFG A K + Q
Sbjct: 111 N---RGIIYRDLKPENLLLDSNGYVKLVDFGFA--------------------KKLKSGQ 147
Query: 583 KSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGR 633
K+ + T Y APE + D +S G++L E++TGR
Sbjct: 148 KTWTFCGT---------PEYVAPEIILNKGYDFSVDYWSLGILLYELLTGR 189
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 8e-06
Identities = 51/184 (27%), Positives = 78/184 (42%), Gaps = 49/184 (26%)
Query: 518 LVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKP 577
L+ +H K +H D+K +NILL N + DFG +++
Sbjct: 153 LLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKM-------------------- 192
Query: 578 QERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVV 637
+VS +V T + YY APE + S+K D++S GV+L E++T +
Sbjct: 193 ---YAATVSDDVGRTFCGT---PYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLK---- 242
Query: 638 QVGSSEMDLVNWMQLCIEE--KKPLADVLDPYLAPDADKE-EEIIAVLKIAMACVHSSPE 694
D N +EE K LA DP L P E +EI+ L + S P+
Sbjct: 243 ----RPFDGEN-----MEEVMHKTLAGRYDP-LPPSISPEMQEIVTAL------LSSDPK 286
Query: 695 KRPT 698
+RP+
Sbjct: 287 RRPS 290
|
Length = 496 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 47.8 bits (113), Expect = 9e-06
Identities = 45/223 (20%), Positives = 95/223 (42%), Gaps = 39/223 (17%)
Query: 411 LGKSGIGIVYKVV-LEDGHTLAVRRLGEGGSQRFKEFQTEVEAIGKIRHSNIVTLRAYYW 469
+G+ G V+ + + G +A++++ + + E+ + ++++ NIV +
Sbjct: 27 IGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFL 86
Query: 470 SVDEKLLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKY 529
DE ++ +Y+ GSL +V+ T + + + + + L +LH +
Sbjct: 87 VGDELFVVMEYLAGGSLTD-------VVTETCMDEAQIAAVCRECLQALEFLH---ANQV 136
Query: 530 VHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQKSVSLEV 589
+H D+K N+LLG + ++DFG A+ E+ ++S +
Sbjct: 137 IHRDIKSDNVLLGMDGSVKLTDFGFC------------------AQITPEQSKRSTMVGT 178
Query: 590 TTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITG 632
Y+ APE + K DI+S G++ +EM+ G
Sbjct: 179 ----------PYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 9e-06
Identities = 57/233 (24%), Positives = 95/233 (40%), Gaps = 44/233 (18%)
Query: 410 VLGKSGIGIVYKVVLED-GHTLAVRRL-----GEGGSQRFKEFQTEVEAIGKIRHSNIVT 463
+LG+ G VY D G LAV+++ S+ + E++ + + H IV
Sbjct: 9 LLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQ 68
Query: 464 LRAYYWSVDEKLL--IYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYL 521
E+ L +++P GS+ K + S+ + +V K + I +G+ YL
Sbjct: 69 YYGCLRDPMERTLSIFMEHMPGGSI------KDQLKSYGALTENVTRKYTRQILEGVSYL 122
Query: 522 HEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLA-RLANIAGGSPTLQSNRMPAEKPQER 580
H VH D+K +NIL + DFG + RL I ++S
Sbjct: 123 HS---NMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKS----------- 168
Query: 581 QQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGR 633
VT T Y+ +PE + +K DI+S G ++EM+T +
Sbjct: 169 --------VTGT-------PYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 48.0 bits (115), Expect = 1e-05
Identities = 66/250 (26%), Positives = 101/250 (40%), Gaps = 81/250 (32%)
Query: 411 LGKSGIGIVYKVVLED---GHTLAVRRLGEGGSQRFKEFQTEVEAIGKIR---------- 457
LGK GIV+K + D +A++++ F F+ +A R
Sbjct: 15 LGKGAYGIVWKAI--DRRTKEVVALKKI-------FDAFRNATDAQRTFREIMFLQELGD 65
Query: 458 HSNIVTLRAYYWSVDEK--LLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIA 515
H NIV L + ++K L+++Y+ T LH +R I++ +
Sbjct: 66 HPNIVKLLNVIKAENDKDIYLVFEYM-----ETDLHA------------VIRANILEDVH 108
Query: 516 KGLVYLHEFSPKKYVHG------DLKPSNILLGHNMEPHV--SDFGLARLANIAGGSPTL 567
K + KY+H DLKPSNILL N + V +DFGLAR +L
Sbjct: 109 KRYIMYQLLKALKYIHSGNVIHRDLKPSNILL--NSDCRVKLADFGLAR---------SL 157
Query: 568 QSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKW----DIYSYG 623
E P V + T +Y+APE L + S ++ D++S G
Sbjct: 158 SELEENPENP-------VLTDYVATR-------WYRAPEIL--LG-STRYTKGVDMWSVG 200
Query: 624 VILLEMITGR 633
IL EM+ G+
Sbjct: 201 CILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 47.4 bits (112), Expect = 1e-05
Identities = 56/233 (24%), Positives = 96/233 (41%), Gaps = 44/233 (18%)
Query: 410 VLGKSGIGIVYKVV-LEDGHTLAVRRL-----GEGGSQRFKEFQTEVEAIGKIRHSNIVT 463
+LG+ G VY ++ G LA +++ S+ + E++ + ++H IV
Sbjct: 9 LLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQ 68
Query: 464 LRAYYWSVDEKLL--IYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYL 521
EK L +Y+P GS+ K + ++ + SV K + I +G+ YL
Sbjct: 69 YYGCLRDRAEKTLTIFMEYMPGGSV------KDQLKAYGALTESVTRKYTRQILEGMSYL 122
Query: 522 HEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLA-RLANIAGGSPTLQSNRMPAEKPQER 580
H VH D+K +NIL + DFG + RL I ++S
Sbjct: 123 HS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRS----------- 168
Query: 581 QQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGR 633
VT T Y+ +PE + +K D++S G ++EM+T +
Sbjct: 169 --------VTGT-------PYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 1e-05
Identities = 40/161 (24%), Positives = 66/161 (40%), Gaps = 35/161 (21%)
Query: 411 LGKSGIGIVYKV------------VLEDGHTLAVRRLGEGGSQRFKEFQTEVEAIGKIRH 458
+G G VYKV V+ H VRR + E+E + + H
Sbjct: 82 IGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRR----------QICREIEILRDVNH 131
Query: 459 SNIVTLRAYYWSVDEKLLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGL 518
N+V + E ++ +++ GSL ++ V +I+ GIA
Sbjct: 132 PNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQFLA------DVARQILSGIA--- 182
Query: 519 VYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLAN 559
YLH + VH D+KPSN+L+ ++DFG++R+
Sbjct: 183 -YLHR---RHIVHRDIKPSNLLINSAKNVKIADFGVSRILA 219
|
Length = 353 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 47.4 bits (112), Expect = 1e-05
Identities = 51/227 (22%), Positives = 89/227 (39%), Gaps = 46/227 (20%)
Query: 411 LGKSGIGIVYKVVLEDGHTLAVRRLG----EGGSQRFKEFQTEVEAIGKIRHSNIVTLRA 466
+GK G V+K + D T V + E ++ Q E+ + + +
Sbjct: 12 IGKGSFGEVFKGI--DNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG 69
Query: 467 YYWSVDEKLLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSP 526
Y + +I +Y+ GS L P F + ++K I KGL YLH
Sbjct: 70 SYLKGTKLWIIMEYLGGGSALDLLRAGP----FDEFQIAT---MLKEILKGLDYLHS--- 119
Query: 527 KKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQKSVS 586
+K +H D+K +N+LL + ++DFG+A
Sbjct: 120 EKKIHRDIKAANVLLSEQGDVKLADFGVAG-----------------------------Q 150
Query: 587 LEVTTTNSSSNLGS-YYQAPESLKVVKPSQKWDIYSYGVILLEMITG 632
L T ++ +G+ ++ APE ++ K DI+S G+ +E+ G
Sbjct: 151 LTDTQIKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKG 197
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 1e-05
Identities = 59/229 (25%), Positives = 88/229 (38%), Gaps = 48/229 (20%)
Query: 411 LGKSGIGIVYKVV---LEDGHTLAVRR---LGEGGSQRFKEFQTEVEAIGKIRHSNIVTL 464
LGK G VY V L V + +GE + E + + K+ H IV
Sbjct: 8 LGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKF 67
Query: 465 RAYYWSVDEKLLIYDYIPNGSLATAL----HGKPGMVSFTPVPWSVRVKIIKGIAKGLVY 520
A + D +I +Y L L H + W +++ + G+ Y
Sbjct: 68 HASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLL------GVHY 121
Query: 521 LHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQER 580
+H+ ++ +H DLK NI L +N+ + DFG++RL
Sbjct: 122 MHQ---RRILHRDLKAKNIFLKNNL-LKIGDFGVSRLL---------------------- 155
Query: 581 QQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEM 629
S L T T + YY +PE+LK K DI+S G IL EM
Sbjct: 156 -MGSCDLATTFTGT-----PYYMSPEALKHQGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 47.4 bits (113), Expect = 1e-05
Identities = 52/202 (25%), Positives = 89/202 (44%), Gaps = 46/202 (22%)
Query: 449 EVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRV 508
E+ + +++H NIV L+ LI++++ ++ K + S P +
Sbjct: 49 EISLLKELQHPNIVCLQDVLMQESRLYLIFEFL-------SMDLKKYLDS-LPKGQYMDA 100
Query: 509 KIIKG----IAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGS 564
+++K I +G+++ H ++ +H DLKP N+L+ + ++DFGLAR A G
Sbjct: 101 ELVKSYLYQILQGILFCHS---RRVLHRDLKPQNLLIDNKGVIKLADFGLAR----AFGI 153
Query: 565 PTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESL-KVVKPSQKWDIYSYG 623
P + + EV T +Y+APE L + S DI+S G
Sbjct: 154 PV----------------RVYTHEVVTL--------WYRAPEVLLGSPRYSTPVDIWSIG 189
Query: 624 VILLEMITGRTAVVQVGSSEMD 645
I EM T + G SE+D
Sbjct: 190 TIFAEMATKKPLF--HGDSEID 209
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 1e-05
Identities = 70/307 (22%), Positives = 121/307 (39%), Gaps = 55/307 (17%)
Query: 410 VLGKSGIGIVYK-----VVLEDGHTL-AVRRLGEGGSQRFK-EFQTEVEAIGKIRHSNIV 462
LG+ G V+ + E G TL V+ L + + + EF+ E++ K+ H N+V
Sbjct: 12 TLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVV 71
Query: 463 TLRAYYWSVDEKLLIYDYIPNGSLATALH-GKPGMVSFTPVPWSV--RVKIIKGIAKGLV 519
L + +I +Y G L L K P P S +V + IA G+
Sbjct: 72 RLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMD 131
Query: 520 YLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQE 579
+L S ++VH DL N L+ E VS +L + +E +
Sbjct: 132 HL---SNARFVHRDLAARNCLVSSQREVKVS-------------LLSLSKDVYNSEYYKL 175
Query: 580 RQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQV 639
R + L + APE+++ S K D++S+GV++ E+ T + +
Sbjct: 176 RNAL-IPLR-------------WLAPEAVQEDDFSTKSDVWSFGVLMWEVFT-QGELPFY 220
Query: 640 GSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTM 699
G S+ +++N +Q E P+ + K+ C +P+ RP+
Sbjct: 221 GLSDEEVLNRLQAGKLELPV----------PEGCPSR----LYKLMTRCWAVNPKDRPSF 266
Query: 700 RHISDAL 706
+ AL
Sbjct: 267 SELVSAL 273
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 2e-05
Identities = 27/72 (37%), Positives = 42/72 (58%)
Query: 62 KEQRVVSVSIPKKKLLGFLPSALGSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYG 121
K + + S+++ + G +P +LGS+T L ++L N F GS+P L + L+ L L G
Sbjct: 440 KLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNG 499
Query: 122 NSFSGSVPNEIG 133
NS SG VP +G
Sbjct: 500 NSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 2e-05
Identities = 54/232 (23%), Positives = 94/232 (40%), Gaps = 60/232 (25%)
Query: 411 LGKSGIGIVYKVVLEDGHT---LAVRRLGEGGSQRFKEFQ---TEVEAIGKIRHSNIVTL 464
+G G VY + HT +AV+++ G Q +++Q EV+ + +++H N +
Sbjct: 29 IGHGSFGAVY--FATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEY 86
Query: 465 RAYYWSVDEKLLIYDY-IPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHE 523
+ Y L+ +Y + + S +H KP V + I G +GL YLH
Sbjct: 87 KGCYLKEHTAWLVMEYCLGSASDLLEVHKKP----LQEVEIAA---ITHGALQGLAYLHS 139
Query: 524 FSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAG---GSPTLQSNRMPAEKPQER 580
+ +H D+K NILL + ++DFG A ++ A G+P
Sbjct: 140 HN---MIHRDIKAGNILLTEPGQVKLADFGSASKSSPANSFVGTP--------------- 181
Query: 581 QQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQ---KWDIYSYGVILLEM 629
Y+ APE + + Q K D++S G+ +E+
Sbjct: 182 --------------------YWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 213
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 47.4 bits (112), Expect = 2e-05
Identities = 60/246 (24%), Positives = 97/246 (39%), Gaps = 44/246 (17%)
Query: 410 VLGKSGIGIVYKVVLED-GHTLAVRRLGEGGSQRFKEFQTEVEAIGKIRHSNIVTLRA-- 466
V+G+ G V V +D GH A++ L K E E +G IR + + A
Sbjct: 8 VIGRGAFGEVRLVQKKDTGHVYAMKILR-------KADMLEKEQVGHIRAERDILVEADS 60
Query: 467 -----YYWSVDEKL---LIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGL 518
++S +KL LI +++P G + T L K + + IA+ +
Sbjct: 61 LWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFY---------IAETV 111
Query: 519 VYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLA------------RLANIAGGSPT 566
+ + ++H D+KP N+LL +SDFGL R N + S
Sbjct: 112 LAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDF 171
Query: 567 LQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVIL 626
N K + ++ L +T + Y APE ++ D +S GVI+
Sbjct: 172 TFQNMNSKRKAETWKRNRRQLAFSTVGTPD-----YIAPEVFMQTGYNKLCDWWSLGVIM 226
Query: 627 LEMITG 632
EM+ G
Sbjct: 227 YEMLIG 232
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 2e-05
Identities = 52/216 (24%), Positives = 86/216 (39%), Gaps = 46/216 (21%)
Query: 464 LRAYYWSVDEKLLIY--DYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYL 521
+R YY D+ L + DYIP G + + L + P + I + + +
Sbjct: 64 VRLYYSFQDKDNLYFVMDYIPGGDMMSLL------IRMGIFPEDLARFYIAELTCAVESV 117
Query: 522 HEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAE------ 575
H+ ++H D+KP NIL+ + ++DFGL S QS +
Sbjct: 118 HKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFS 174
Query: 576 ---------------KPQERQ-----QKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQ 615
KP ER+ Q+ ++ + T + Y APE L +Q
Sbjct: 175 NEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPN-------YIAPEVLLRTGYTQ 227
Query: 616 KWDIYSYGVILLEMITGRTAVVQVG--SSEMDLVNW 649
D +S GVIL EM+ G+ + ++M ++NW
Sbjct: 228 LCDWWSVGVILYEMLVGQPPFLAQTPLETQMKVINW 263
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 47.0 bits (111), Expect = 2e-05
Identities = 45/165 (27%), Positives = 76/165 (46%), Gaps = 22/165 (13%)
Query: 411 LGKSGIGIVYKVVLEDGHT---LAVRRLGEGGSQRFKEFQ---TEVEAIGKIRHSNIVTL 464
+G G VY D T +A++++ G Q +++Q EV+ + +I+H N +
Sbjct: 33 IGHGSFGAVY--FARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEY 90
Query: 465 RAYYWSVDEKLLIYDY-IPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHE 523
+ Y L+ +Y + + S +H KP V + I G +GL YLH
Sbjct: 91 KGCYLREHTAWLVMEYCLGSASDLLEVHKKP----LQEVEIAA---ITHGALQGLAYLHS 143
Query: 524 FSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAG---GSP 565
+ +H D+K NILL + ++DFG A +A+ A G+P
Sbjct: 144 HN---MIHRDIKAGNILLTEPGQVKLADFGSASIASPANSFVGTP 185
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 2e-05
Identities = 57/234 (24%), Positives = 101/234 (43%), Gaps = 50/234 (21%)
Query: 410 VLGKSGIGIVYKVVLED-GHTLAVRRL-----GEGGSQRFKEFQTEVEAIGKIRHSNIVT 463
+LG+ G VY D G LAV+++ + S+ + E++ + +RH IV
Sbjct: 9 LLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQ 68
Query: 464 LRAYYWSV----DEKLLIY-DYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGL 518
YY + ++KL I+ +Y+P GS+ K + ++ + +V + + I +G+
Sbjct: 69 ---YYGCLRDPEEKKLSIFVEYMPGGSI------KDQLKAYGALTENVTRRYTRQILQGV 119
Query: 519 VYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLA-RLANIAGGSPTLQSNRMPAEKP 577
YLH VH D+K +NIL + DFG + R+ I ++S
Sbjct: 120 SYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKS-------- 168
Query: 578 QERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMIT 631
VT T Y+ +PE + +K D++S ++EM+T
Sbjct: 169 -----------VTGT-------PYWMSPEVISGEGYGRKADVWSVACTVVEMLT 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 2e-05
Identities = 55/240 (22%), Positives = 99/240 (41%), Gaps = 42/240 (17%)
Query: 411 LGKSGIGIVYKVVLEDGHTLAVRRL--GEGGSQRFKEFQTEVEAIGKIRHSNIVTLRAYY 468
LG G+V KV + + R+L E + E++ + + IV +
Sbjct: 13 LGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 72
Query: 469 WSVDEKLLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKK 528
+S E + +++ GSL L +P + K+ + +GL YL E +
Sbjct: 73 YSDGEISICMEHMDGGSLDQVLK------EAKRIPEEILGKVSIAVLRGLAYLRE--KHQ 124
Query: 529 YVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQKSVSLE 588
+H D+KPSNIL+ E + DFG VS +
Sbjct: 125 IMHRDVKPSNILVNSRGEIKLCDFG-------------------------------VSGQ 153
Query: 589 VTTTNSSSNLGS-YYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGSSEMDLV 647
+ + ++S +G+ Y +PE L+ S + DI+S G+ L+E+ GR + + E++ +
Sbjct: 154 LIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAI 213
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 47.0 bits (111), Expect = 3e-05
Identities = 49/196 (25%), Positives = 83/196 (42%), Gaps = 38/196 (19%)
Query: 439 GSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLI---YDYIPNGSLATALHGKPG 495
GS+ + + E+ A+G++ H NI+ + S +I YD+ L + ++ +
Sbjct: 203 GSRAAIQLENEILALGRLNHENILKIEEILRSEANTYMITQKYDF----DLYSFMYDEAF 258
Query: 496 MVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLA 555
P+ R I+K + + Y+H+ KK +H D+K NI L + + + DFG A
Sbjct: 259 DWKDRPLLKQTR-AIMKQLLCAVEYIHD---KKLIHRDIKLENIFLNCDGKIVLGDFGTA 314
Query: 556 RLANIAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQ 615
MP EK +E V T +PE L +
Sbjct: 315 ----------------MPFEKEREAFDYGWVGTVAT-----------NSPEILAGDGYCE 347
Query: 616 KWDIYSYGVILLEMIT 631
DI+S G+ILL+M++
Sbjct: 348 ITDIWSCGLILLDMLS 363
|
Length = 501 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 3e-05
Identities = 57/229 (24%), Positives = 94/229 (41%), Gaps = 53/229 (23%)
Query: 411 LGKSGIGIVYKVV-LEDGHTLAVRRL-----GEG-GSQRFKEFQTEVEAIGKIRHSNIVT 463
+G+ G V+K E +A++R+ EG S +E + + +++H NIV
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALRE----ICLLKELKHKNIVR 63
Query: 464 LRAYYWSVDEKLLIYDYIPNG--SLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYL 521
L S + L+++Y + +G + S +++KG+A +
Sbjct: 64 LYDVLHSDKKLTLVFEYCDQDLKKYFDSCNGDIDP----EIVKSFMFQLLKGLA----FC 115
Query: 522 HEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQ 581
H +H DLKP N+L+ N E ++DFGLAR A G P
Sbjct: 116 HS---HNVLHRDLKPQNLLINKNGELKLADFGLAR----AFGIPV--------------- 153
Query: 582 QKSVSLEVTTTNSSSNLGSYYQAPESLKVVKP-SQKWDIYSYGVILLEM 629
+ S EV T +Y+ P+ L K S D++S G I E+
Sbjct: 154 -RCYSAEVVTL--------WYRPPDVLFGAKLYSTSIDMWSAGCIFAEL 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 3e-05
Identities = 47/197 (23%), Positives = 78/197 (39%), Gaps = 44/197 (22%)
Query: 514 IAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMP 573
+A+G+ +L + K VH DL N+LL + DFGLAR +I S +
Sbjct: 246 VARGMEFL---ASKNCVHRDLAARNVLLAQGKIVKICDFGLAR--DIMHDSNYV------ 294
Query: 574 AEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGR 633
+ S+ L + APES+ + D++SYG++L E+ +
Sbjct: 295 ------------------SKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLG 336
Query: 634 TAVVQVGSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSP 693
+ N ++ KP + V I + C +S P
Sbjct: 337 GTPYPGMIVDSTFYNKIKSGYRMAKP---------------DHATQEVYDIMVKCWNSEP 381
Query: 694 EKRPTMRHISDALDRLI 710
EKRP+ H+SD ++ L+
Sbjct: 382 EKRPSFLHLSDIVESLL 398
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 3e-05
Identities = 43/164 (26%), Positives = 72/164 (43%), Gaps = 20/164 (12%)
Query: 411 LGKSGIGIVYKVV-LEDGHTLAVRRLGEGGSQRFKEFQ---TEVEAIGKIRHSNIVTLRA 466
+G G VY + +A++++ G Q +++Q EV + ++RH N + +
Sbjct: 23 IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKG 82
Query: 467 YYWSVDEKLLIYDY-IPNGSLATALHGKPGMVSFTPVPWSVRVK-IIKGIAKGLVYLHEF 524
Y L+ +Y + + S +H KP V + I G +GL YLH
Sbjct: 83 CYLREHTAWLVMEYCLGSASDILEVHKKPLQ--------EVEIAAICHGALQGLAYLHSH 134
Query: 525 SPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAG---GSP 565
+ +H D+K NILL ++DFG A L + A G+P
Sbjct: 135 ---ERIHRDIKAGNILLTEPGTVKLADFGSASLVSPANSFVGTP 175
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 45.8 bits (109), Expect = 3e-05
Identities = 40/137 (29%), Positives = 59/137 (43%), Gaps = 35/137 (25%)
Query: 501 PVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANI 560
P+P + K+ I K L YL E +H D+KPSNILL + + DFG I
Sbjct: 110 PIPEDILGKMTVAIVKALHYLKE--KHGVIHRDVKPSNILLDASGNVKLCDFG------I 161
Query: 561 AGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDI- 619
+G R+ K + R + Y APE + P+ K+DI
Sbjct: 162 SG--------RLVDSKAKTRSAGC---------------AAYMAPERIDPPDPNPKYDIR 198
Query: 620 ---YSYGVILLEMITGR 633
+S G+ L+E+ TG+
Sbjct: 199 ADVWSLGISLVELATGQ 215
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 4e-05
Identities = 58/240 (24%), Positives = 105/240 (43%), Gaps = 43/240 (17%)
Query: 410 VLGKSGIGIVYKVVLEDGHTL-AVRRLGEG-GSQRFKEFQ-TEVEAIGKIRHSNIVTLRA 466
V+G+ G+V K ++ + A+++ + ++ KE E++ + ++ NIV L+
Sbjct: 8 VVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKE 67
Query: 467 YYWSVDEKLLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSP 526
+ + L+++Y+ L L P V P VR I + I K + + H+
Sbjct: 68 AFRRRGKLYLVFEYVEKNMLEL-LEEMPNGV----PPEKVRSYIYQLI-KAIHWCHK--- 118
Query: 527 KKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQKSVS 586
VH D+KP N+L+ HN + DFG AR N++ G
Sbjct: 119 NDIVHRDIKPENLLISHNDVLKLCDFGFAR--NLSEG----------------------- 153
Query: 587 LEVTTTNSSSNLGS-YYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGSSEMD 645
+ N + + + +Y++PE L + D++S G IL E+ G+ G SE+D
Sbjct: 154 ---SNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLF--PGESEID 208
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.2 bits (110), Expect = 4e-05
Identities = 59/254 (23%), Positives = 94/254 (37%), Gaps = 57/254 (22%)
Query: 410 VLGKSGIGIVYKVVLED-GHTLAVRRLGEGGSQRFKEFQTE-VEAIGKI---RHSN-IVT 463
V+G+ G V V +D GH A+++L + S+ ++ Q V A I + +V
Sbjct: 8 VIGRGAFGEVRLVQKKDTGHIYAMKKLRK--SEMLEKEQVAHVRAERDILAEADNPWVVK 65
Query: 464 LRAYYWSVDEK--LLIYDYIPNGSLATALHGK----PGMVSFTPVPWSVRVKIIKGIAKG 517
L YY DE LI +Y+P G + T L K F IA+
Sbjct: 66 L--YYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFY-------------IAET 110
Query: 518 LVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEK- 576
++ + Y+H D+KP N+LL +SDFGL L+ +
Sbjct: 111 ILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGL---------CTGLKKSHRTEFYR 161
Query: 577 --PQERQQKSVSLEVTTTNSSSNLGSY----------------YQAPESLKVVKPSQKWD 618
+ +S ++ Y APE +++ D
Sbjct: 162 ILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECD 221
Query: 619 IYSYGVILLEMITG 632
+S GVI+ EM+ G
Sbjct: 222 WWSLGVIMYEMLVG 235
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 45.8 bits (109), Expect = 4e-05
Identities = 34/122 (27%), Positives = 51/122 (41%), Gaps = 32/122 (26%)
Query: 514 IAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMP 573
+ +GL Y+H +H DLKPSN+LL N + + DFGLAR + G T
Sbjct: 117 LLRGLKYIHS---ANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMT------- 166
Query: 574 AEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPES-LKVVKPSQKWDIYSYGVILLEMITG 632
V T +Y+APE L + + D++S G I E++
Sbjct: 167 -------------EYVVTR--------WYRAPELLLNCSEYTTAIDVWSVGCIFAELLGR 205
Query: 633 RT 634
+
Sbjct: 206 KP 207
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 5e-05
Identities = 75/310 (24%), Positives = 125/310 (40%), Gaps = 62/310 (20%)
Query: 411 LGKSGIGIVYKVVLED------GHTLAVRRLGEGGSQRFK-EFQTEVEAIGKIRHSNIVT 463
LG+ G+VY+ D +AV+ + E S R + EF E + ++V
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 73
Query: 464 LRAYYWSVDEKLLIYDYIPNGSLATALHG-KPGMVSFTPVPWSVRVKIIK---GIAKGLV 519
L L++ + + +G L + L +P + P ++I+ IA G+
Sbjct: 74 LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 133
Query: 520 YLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQE 579
YL + KK+VH DL N ++ H+ + DFG+ R +I E
Sbjct: 134 YL---NAKKFVHRDLAARNCMVAHDFTVKIGDFGMTR--DI-------------YETDYY 175
Query: 580 RQQKSVSLEVTTTNSSSNLGSYYQAPESLK--VVKPSQKWDIYSYGVILLEMITGRTAVV 637
R+ L V + APESLK V S D++S+GV+L E+ +
Sbjct: 176 RKGGKGLLPVR-----------WMAPESLKDGVFTTSS--DMWSFGVVLWEITSLAEQPY 222
Query: 638 QVGSSEMDLVNWMQLCIEEKKPLADVLD-PYLAPDADKEEEIIAVLKIAMACVHSSPEKR 696
Q S+E + L V+D YL + E + ++++ C +P+ R
Sbjct: 223 QGLSNE--------------QVLKFVMDGGYLDQPDNCPERVTDLMRM---CWQFNPKMR 265
Query: 697 PTMRHISDAL 706
PT I + L
Sbjct: 266 PTFLEIVNLL 275
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 5e-05
Identities = 71/311 (22%), Positives = 118/311 (37%), Gaps = 67/311 (21%)
Query: 410 VLGKSGIGIVYK-VVLEDGHTL----AVRRLGEGGSQRF-KEFQTEVEAIGKIRHSNIVT 463
VLG G VYK + + DG + A++ L E S + KE E + + +
Sbjct: 14 VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCR 73
Query: 464 LRAYYWSVDEKLLIYDYIPNGSLATALHGKPGMV-SFTPVPWSVRVKIIKGIAKGLVYLH 522
L + +L + +P G L + + S + W V+ IAKG+ YL
Sbjct: 74 LLGICLTSTVQL-VTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQ------IAKGMSYLE 126
Query: 523 EFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQ 582
E + VH DL N+L+ ++DFGLARL +I ++P +
Sbjct: 127 EV---RLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIK------- 176
Query: 583 KSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGSS 642
+ A ES+ + + + D++SYGV + E++T G+
Sbjct: 177 -------------------WMALESILHRRFTHQSDVWSYGVTVWELMT-------FGAK 210
Query: 643 EMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEE----IIAVLKIAMACVHSSPEKRPT 698
D + P ++ P L ++ + I V I + C E RP
Sbjct: 211 PYDGI-----------PAREI--PDLLEKGERLPQPPICTIDVYMIMVKCWMIDSECRPR 257
Query: 699 MRHISDALDRL 709
R + D R+
Sbjct: 258 FRELVDEFSRM 268
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.4 bits (108), Expect = 5e-05
Identities = 62/249 (24%), Positives = 93/249 (37%), Gaps = 85/249 (34%)
Query: 417 GIVYKVVLEDGHT---LAVRRL------GEGGSQ---RFKEFQTEVEAIGKIRHSNIVTL 464
G VYK ++G A+++ G SQ R E+ + +++H N+V+L
Sbjct: 14 GRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACR------EIALLRELKHENVVSL 67
Query: 465 RAYYWSVDEKL--LIYDY--------IPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGI 514
+ +K L++DY I A + P MV ++ I
Sbjct: 68 VEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVK----------SLLWQI 117
Query: 515 AKGLVYLHEFSPKKYV-HGDLKPSNILLGHNMEPH----VSDFGLARLANIAGGSPTLQS 569
G+ YLH +V H DLKP+NIL+ + D GLARL N
Sbjct: 118 LNGVHYLHS----NWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFN---------- 163
Query: 570 NRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESL-------KVVKPSQKWDIYSY 622
KP V VT +Y+APE L K + DI++
Sbjct: 164 ---APLKPLADLDPVV---VT---------IWYRAPELLLGARHYTKAI------DIWAI 202
Query: 623 GVILLEMIT 631
G I E++T
Sbjct: 203 GCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 5e-05
Identities = 35/135 (25%), Positives = 56/135 (41%), Gaps = 40/135 (29%)
Query: 500 TPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLAN 559
P+P + I K I +GL YLH ++ +H D+K NI + + + D G A+
Sbjct: 152 RPLPIDQALIIEKQILEGLRYLHA---QRIIHRDVKTENIFINDVDQVCIGDLGAAQFPV 208
Query: 560 IA----GGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQ 615
+A G + T+++N APE L K +
Sbjct: 209 VAPAFLGLAGTVETN---------------------------------APEVLARDKYNS 235
Query: 616 KWDIYSYGVILLEMI 630
K DI+S G++L EM+
Sbjct: 236 KADIWSAGIVLFEML 250
|
Length = 357 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 6e-05
Identities = 38/132 (28%), Positives = 60/132 (45%), Gaps = 34/132 (25%)
Query: 517 GLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEK 576
G+ +LH +H DLKPSNI++ + + DFGLAR A +N M
Sbjct: 135 GIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAC---------TNFM---- 178
Query: 577 PQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAV 636
++ V T YY+APE + + + DI+S G I+ E++ G +V
Sbjct: 179 --------MTPYVVT--------RYYRAPEVILGMGYKENVDIWSVGCIMGELVKG--SV 220
Query: 637 VQVGSSEMDLVN 648
+ G+ +D N
Sbjct: 221 IFQGTDHIDQWN 232
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.1 bits (107), Expect = 6e-05
Identities = 31/112 (27%), Positives = 50/112 (44%), Gaps = 13/112 (11%)
Query: 447 QTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGSLATALHGKPGMVSFTPVPWSV 506
E + ++ H I+ L ++ +Y+P G L + L + T + ++
Sbjct: 49 HNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYAS 108
Query: 507 RVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHV--SDFGLAR 556
I L YLH K+ V+ DLKP NILL + E H+ +DFG A+
Sbjct: 109 E------IVCALEYLHS---KEIVYRDLKPENILL--DKEGHIKLTDFGFAK 149
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 6e-05
Identities = 62/238 (26%), Positives = 106/238 (44%), Gaps = 52/238 (21%)
Query: 411 LGKSGIGIVYKVVLEDGHT---LAVRRLGEGGSQRFKEFQTEVEAIGKIRHSNIVTLRAY 467
+G+ G VYK +DG A++++ EG + E+ + +++H N+++L+
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALKQI-EGTGISMSACR-EIALLRELKHPNVISLQKV 66
Query: 468 YWS-VDEKL-LIYDYIPNGSLATALHGKPGMVSFTPVPWSVR--VKIIKGIAKGLVY--- 520
+ S D K+ L++DY A H ++ F + + V++ +G+ K L+Y
Sbjct: 67 FLSHADRKVWLLFDY--------AEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQIL 118
Query: 521 --LHEFSPKKYVHGDLKPSNIL-LGHNMEP---HVSDFGLARLANIAGGSPTLQSNRMPA 574
+H +H DLKP+NIL +G E ++D G ARL N SP
Sbjct: 119 DGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFN----SPL-------- 166
Query: 575 EKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKW-DIYSYGVILLEMIT 631
KP V + +Y+APE L + K DI++ G I E++T
Sbjct: 167 -KPLADLDPVV------------VTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 6e-05
Identities = 60/240 (25%), Positives = 101/240 (42%), Gaps = 47/240 (19%)
Query: 403 LLKASAF----VLGKSGIGIVYK-VVLEDGHTL----AVRRLGEGGSQRF-KEFQTEVEA 452
+LK + F VLG G VYK + + +G + A++ L E S + KE E
Sbjct: 3 ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYV 62
Query: 453 IGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGSLATAL-HGKPGMVSFTPVPWSVRVKII 511
+ + + ++ L + +L I +P G L + K + S + W V+
Sbjct: 63 MASVDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ---- 117
Query: 512 KGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNR 571
IAKG+ YL E ++ VH DL N+L+ ++DFGLA+L
Sbjct: 118 --IAKGMNYLEE---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG------------ 160
Query: 572 MPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMIT 631
EK + V ++ + A ES+ + + D++SYGV + E++T
Sbjct: 161 -ADEKEYHAEGGKVPIK-------------WMALESILHRIYTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 45.1 bits (107), Expect = 7e-05
Identities = 36/140 (25%), Positives = 57/140 (40%), Gaps = 43/140 (30%)
Query: 502 VPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLA-RLANI 560
+P + KI I K L YLH +H D+KPSN+L+ N + + DFG++ L +
Sbjct: 100 IPEDILGKIAVSIVKALEYLHS--KLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS 157
Query: 561 AGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQ----- 615
+ T+ + P Y APE + P
Sbjct: 158 V--AKTIDAGCKP----------------------------YMAPER---INPELNQKGY 184
Query: 616 --KWDIYSYGVILLEMITGR 633
K D++S G+ ++E+ TGR
Sbjct: 185 DVKSDVWSLGITMIELATGR 204
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 45.1 bits (107), Expect = 7e-05
Identities = 34/121 (28%), Positives = 51/121 (42%), Gaps = 28/121 (23%)
Query: 514 IAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMP 573
I GL Y+H +H DLKP N+L+ + E + DFGLAR G S
Sbjct: 114 ILCGLKYIHS---ANVLHRDLKPGNLLVNADCELKICDFGLAR-----GFSEN------- 158
Query: 574 AEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKW-DIYSYGVILLEMITG 632
++ V T +Y+APE + + K D++S G IL E++
Sbjct: 159 ----PGENAGFMTEYVAT--------RWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGR 206
Query: 633 R 633
+
Sbjct: 207 K 207
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 8e-05
Identities = 46/185 (24%), Positives = 76/185 (41%), Gaps = 39/185 (21%)
Query: 449 EVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGSLATALHGKPGMV--SFTPVPWSV 506
E + K++H NIV + + + ++ +Y G L + + G + T + W V
Sbjct: 48 EAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFV 107
Query: 507 RVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPT 566
+ + G+ ++HE K+ +H D+K NI L N + + DFG ARL SP
Sbjct: 108 Q------MCLGVQHIHE---KRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLT----SP- 153
Query: 567 LQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVIL 626
+ T + YY PE + + + K DI+S G IL
Sbjct: 154 ------------------GAYACTYVGT-----PYYVPPEIWENMPYNNKSDIWSLGCIL 190
Query: 627 LEMIT 631
E+ T
Sbjct: 191 YELCT 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 8e-05
Identities = 50/242 (20%), Positives = 95/242 (39%), Gaps = 49/242 (20%)
Query: 443 FKEFQTEVEAIGKIRHSNIVTLRAYYWSV-DEKLLIYDYIPNGSLATALHGKPGMVSFTP 501
F + ++ H ++V L Y V DE +++ +Y+ G L LH +
Sbjct: 45 SLAFFETASLMSQLSHKHLVKL--YGVCVRDENIMVEEYVKFGPLDVFLHREKN-----N 97
Query: 502 VPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIA 561
V ++ + K +A L YL + KK VHG++ NIL +AR
Sbjct: 98 VSLHWKLDVAKQLASALHYLED---KKLVHGNVCGKNIL-------------VARYGLNE 141
Query: 562 GGSPTLQSN----RMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLK--VVKPSQ 615
G P ++ + + +ER ++ + APE ++ +
Sbjct: 142 GYVPFIKLSDPGIPITVLSREERVERIPWI----------------APECIRNGQASLTI 185
Query: 616 KWDIYSYGVILLEMITGRTAVVQ-VGSSEMDLV--NWMQLCIEEKKPLADVLDPYLAPDA 672
D +S+G LLE+ + + + SSE + + +L + + LA++++ D
Sbjct: 186 AADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQDQHRLPMPDCAELANLINQCWTYDP 245
Query: 673 DK 674
K
Sbjct: 246 TK 247
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 1e-04
Identities = 51/202 (25%), Positives = 85/202 (42%), Gaps = 58/202 (28%)
Query: 514 IAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSN--R 571
+A+G+ +L + +K +H DL NILL N + DFGLAR +I ++ R
Sbjct: 182 VARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLAR--DIYKDPDYVRKGDAR 236
Query: 572 MPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESL--KVVKPSQKWDIYSYGVILLEM 629
+P + + APES+ KV + + D++S+GV+L E+
Sbjct: 237 LPLK--------------------------WMAPESIFDKVY--TTQSDVWSFGVLLWEI 268
Query: 630 ITGRTAVVQVGSSEMDLVNW-MQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMAC 688
+ +G+S V + C K+ AP+ E + I + C
Sbjct: 269 FS-------LGASPYPGVQIDEEFCRRLKEGTR-----MRAPEYATPE----IYSIMLDC 312
Query: 689 VHSSPEKRPT----MRHISDAL 706
H++PE RPT + + D L
Sbjct: 313 WHNNPEDRPTFSELVEILGDLL 334
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 1e-04
Identities = 51/165 (30%), Positives = 74/165 (44%), Gaps = 24/165 (14%)
Query: 402 ELLKASAFVLGKSGIGIVYKVVLEDGHT----LAVRRLGEG----GSQRFKEFQTEVEAI 453
ELLK VLG G V+ V GH A++ L + ++ + +TE + +
Sbjct: 3 ELLK----VLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVL 58
Query: 454 GKIRHSNIVTLRAYYWSVDEKL-LIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIK 512
IR S + Y + D KL LI DYI G L T L + F V+I
Sbjct: 59 EHIRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQR---ERFK----EQEVQIYS 111
Query: 513 G-IAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLAR 556
G I L +LH+ ++ D+K NILL N ++DFGL++
Sbjct: 112 GEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSK 153
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 1e-04
Identities = 52/192 (27%), Positives = 81/192 (42%), Gaps = 45/192 (23%)
Query: 447 QTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGSLATALHGKPGMVSFTPVPWSV 506
++E+ + H IV + S D+ LLI +Y G L + K + P
Sbjct: 113 RSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQI--KQRLKEHLP----- 165
Query: 507 RVKIIKGIAKGLVY------LHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANI 560
+ GL++ L E +K +H DLK +NI L + DFG ++
Sbjct: 166 ----FQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSK---- 217
Query: 561 AGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGS-YYQAPESLKVVKPSQKWDI 619
+ SVSL+V +SS G+ YY APE + + S+K D+
Sbjct: 218 -------------------QYSDSVSLDV----ASSFCGTPYYLAPELWERKRYSKKADM 254
Query: 620 YSYGVILLEMIT 631
+S GVIL E++T
Sbjct: 255 WSLGVILYELLT 266
|
Length = 478 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 2e-04
Identities = 38/151 (25%), Positives = 58/151 (38%), Gaps = 23/151 (15%)
Query: 80 LPSALGSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSGSVPNEIGKLKYLQ 139
LP L +L++L +++L NK LP E+ L+ L L NS + + + LK L
Sbjct: 178 LPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLS 235
Query: 140 ILDLSQNFFNGSL---------------------PVSIVQCKRLKALDLSQNNFTGPLPN 178
L+LS N S+ L+ LDLS N+ + LP
Sbjct: 236 GLELSNNKLEDLPESIGNLSNLETLDLSNNQISSISSLGSLTNLRELDLSGNSLSNALPL 295
Query: 179 GFGSGLVSLEKLNLSFNKFNGSIPSNTGNLS 209
L+ LNL + N+ L+
Sbjct: 296 IALLLLLLELLLNLLLTLKALELKLNSILLN 326
|
Length = 394 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 2e-04
Identities = 64/238 (26%), Positives = 104/238 (43%), Gaps = 52/238 (21%)
Query: 411 LGKSGIGIVYKVVLEDGH---TLAVRRLGEGGSQRFKEFQTEVEAIGKIRHSNIVTLRAY 467
+G+ G VYK +DG A++++ EG + E+ + +++H N++ L+
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYALKQI-EGTGISMSACR-EIALLRELKHPNVIALQKV 66
Query: 468 YWS-VDEKL-LIYDY-------IPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGL 518
+ S D K+ L++DY I A+ + KP +P S+ ++ I G+
Sbjct: 67 FLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKP-----MQLPRSMVKSLLYQILDGI 121
Query: 519 VYLHEFSPKKYVHGDLKPSNIL-LGHNMEP---HVSDFGLARLANIAGGSPTLQSNRMPA 574
YLH +H DLKP+NIL +G E ++D G ARL N SP
Sbjct: 122 HYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFN----SPL-------- 166
Query: 575 EKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKW-DIYSYGVILLEMIT 631
KP V + +Y+APE L + K DI++ G I E++T
Sbjct: 167 -KPLADLDPVV------------VTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 2e-04
Identities = 50/225 (22%), Positives = 92/225 (40%), Gaps = 45/225 (20%)
Query: 404 LKASAFVLGKSGIGIVYKVVLEDGHTLAVRRLGEGGSQRFKEFQTEVEAIGKIRHSNIVT 463
+K + + K I + KV L++ + +VR E E E + ++ + IV
Sbjct: 11 VKKGVYKMRKKQIDVAIKV-LKNENEKSVR----------DEMMREAEIMHQLDNPYIVR 59
Query: 464 LRAYYWSVDEKLLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHE 523
+ + +L+ + G L L GK ++ + V V+++ ++ G+ YL
Sbjct: 60 MIGV-CEAEALMLVMEMASGGPLNKFLSGKKDEITVSNV-----VELMHQVSMGMKYLEG 113
Query: 524 FSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQK 583
K +VH DL N+LL + +SDFGL++ G + R + P +
Sbjct: 114 ---KNFVHRDLAARNVLLVNQHYAKISDFGLSK---ALGADDSYYKARSAGKWPLK---- 163
Query: 584 SVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLE 628
+ APE + K S + D++SYG+ + E
Sbjct: 164 ------------------WYAPECINFRKFSSRSDVWSYGITMWE 190
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.5 bits (103), Expect = 2e-04
Identities = 31/116 (26%), Positives = 42/116 (36%), Gaps = 42/116 (36%)
Query: 521 LHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLAR----LANIAGGSPTLQSNRMPAEK 576
LHE Y+H DLKP N L+ + ++DFGL++ AN GSP
Sbjct: 117 LHELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGIVTYANSVVGSP----------- 162
Query: 577 PQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITG 632
Y APE L+ D +S G +L E + G
Sbjct: 163 ------------------------DYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCG 194
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 2e-04
Identities = 38/130 (29%), Positives = 59/130 (45%), Gaps = 34/130 (26%)
Query: 516 KGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAE 575
+GL +LH + VH DLKP NIL+ + + ++DFGLAR+ +
Sbjct: 121 RGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSF--------------- 162
Query: 576 KPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTA 635
Q +++ V T +Y+APE L + D++S G I EM R
Sbjct: 163 ------QMALTSVVVTL--------WYRAPEVLLQSSYATPVDLWSVGCIFAEMF--RRK 206
Query: 636 VVQVGSSEMD 645
+ GSS++D
Sbjct: 207 PLFRGSSDVD 216
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 43.2 bits (102), Expect = 3e-04
Identities = 69/284 (24%), Positives = 106/284 (37%), Gaps = 80/284 (28%)
Query: 410 VLGKSGIGIVYKVVLEDGH----TLAVRRLGEGGSQRFKEFQTEVEA----IGKIRHSNI 461
VLGK G G V++V G A++ L + R ++ +A + ++H I
Sbjct: 3 VLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFI 62
Query: 462 VTLRAYYWSVDEKL-LIYDYIPNGSLATALHGKPGM-----VSFTPVPWSVRVKIIKGIA 515
V L Y + KL LI +Y+ G L L + G+ F + I+
Sbjct: 63 VDL-IYAFQTGGKLYLILEYLSGGELFMHLE-REGIFMEDTACF----------YLSEIS 110
Query: 516 KGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAE 575
L +LH+ + ++ DLKP NILL ++DFGL + +I G+
Sbjct: 111 LALEHLHQ---QGIIYRDLKPENILLDAQGHVKLTDFGLCK-ESIHEGT----------- 155
Query: 576 KPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTA 635
VT T + Y APE L + D +S G ++ +M+TG
Sbjct: 156 -------------VTHTFCGT---IEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPP 199
Query: 636 VVQVGSSEMDLVNWMQLCIEEKKPLAD-------VLDPYLAPDA 672
E +K D L PYL P+A
Sbjct: 200 ----------------FTAENRKKTIDKILKGKLNLPPYLTPEA 227
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 43.2 bits (102), Expect = 3e-04
Identities = 33/120 (27%), Positives = 50/120 (41%), Gaps = 30/120 (25%)
Query: 516 KGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAE 575
+ L Y+H + H DLKP NIL + + + DFGLAR+A + ++
Sbjct: 114 RALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDY---- 166
Query: 576 KPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLK--VVKPSQKWDIYSYGVILLEMITGR 633
V T +Y+APE K + DI+S G I E++TG+
Sbjct: 167 -------------VAT--------RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 43.2 bits (102), Expect = 3e-04
Identities = 46/164 (28%), Positives = 67/164 (40%), Gaps = 19/164 (11%)
Query: 410 VLGKSGIGIVYKVV-LEDGHTLAVRRLGEGGSQRFKEFQTEVEA-----IGKIRHSNIVT 463
V+GK G V DG AV+ L + + KE Q + A + ++H +V
Sbjct: 2 VIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKE-QKHIMAERNVLLKNVKHPFLVG 60
Query: 464 LRAYYWSVDEKLLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKG-IAKGLVYLH 522
L + + D+ + DY+ G L L + SF R + IA L YLH
Sbjct: 61 LHYSFQTADKLYFVLDYVNGGELFFHLQRER---SFP----EPRARFYAAEIASALGYLH 113
Query: 523 EFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPT 566
++ DLKP NILL ++DFGL + I T
Sbjct: 114 S---LNIIYRDLKPENILLDSQGHVVLTDFGLCK-EGIEHSKTT 153
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 3e-04
Identities = 35/125 (28%), Positives = 56/125 (44%), Gaps = 35/125 (28%)
Query: 510 IIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQS 569
+I + +GL Y+H +H DLKPSN+ + + E + DFGLAR A+
Sbjct: 123 LIYQLLRGLKYIHS---AGIIHRDLKPSNVAVNEDCELRILDFGLARQAD---------- 169
Query: 570 NRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPE-SLKVVKPSQKWDIYSYGVILLE 628
++ V T +Y+APE L + +Q DI+S G I+ E
Sbjct: 170 -------------DEMTGYVAT--------RWYRAPEIMLNWMHYNQTVDIWSVGCIMAE 208
Query: 629 MITGR 633
++ G+
Sbjct: 209 LLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 3e-04
Identities = 54/238 (22%), Positives = 103/238 (43%), Gaps = 58/238 (24%)
Query: 410 VLGKSGIGIVYKVV-LEDGHTLAVRRLGEGGSQRFKEFQTEVEAIGKIRHSNIVTLRAYY 468
++G G+VY+ + ++ +A++++ + + +E + + H NI+ L+ YY
Sbjct: 73 IIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRELLI----MKNLNHINIIFLKDYY 128
Query: 469 WS----VDEKLL----IYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIK----GIAK 516
++ +EK + + ++IP +H M + ++ + ++K + +
Sbjct: 129 YTECFKKNEKNIFLNVVMEFIPQ-----TVHKY--MKHYARNNHALPLFLVKLYSYQLCR 181
Query: 517 GLVYLHEFSPKKYVHGDLKPSNILLGHNMEP-HVSDFGLARLANIAGGSPTLQSNRMPAE 575
L Y+H K H DLKP N+L+ N + DFG A+ N+ G
Sbjct: 182 ALAYIHS---KFICHRDLKPQNLLIDPNTHTLKLCDFGSAK--NLLAG------------ 224
Query: 576 KPQERQQKSVSLEVTTTNSSSNLGSYYQAPE-SLKVVKPSQKWDIYSYGVILLEMITG 632
Q+SVS + +Y+APE L + D++S G I+ EMI G
Sbjct: 225 ------QRSVSYICS---------RFYRAPELMLGATNYTTHIDLWSLGCIIAEMILG 267
|
Length = 440 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 4e-04
Identities = 60/234 (25%), Positives = 91/234 (38%), Gaps = 50/234 (21%)
Query: 410 VLGKSGIGIVYKV-VLEDGHTLAVRRLGEGGSQRFKEFQTEVEAIG------KIRHSNIV 462
VLGK G G V V G A ++L + +R K+ + E A+ K+ +V
Sbjct: 7 VLGKGGFGEVCACQVRATGKMYACKKLEK---KRIKKRKGEAMALNEKQILEKVNSRFVV 63
Query: 463 TLRAYYWSVDEKLLIYDYIPNGSLATALH--GKPGMVSFTPVPWSVRVKIIKGIAKGLVY 520
+L Y + D L+ + G L ++ G PG V ++ + GL
Sbjct: 64 SLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITC------GLED 117
Query: 521 LHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQER 580
LH ++ V+ DLKP NILL +SD GLA I G
Sbjct: 118 LHR---ERIVYRDLKPENILLDDYGHIRISDLGLA--VEIPEGET--------------- 157
Query: 581 QQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRT 634
+ V T Y APE +K + + D + G ++ EMI G++
Sbjct: 158 ----IRGRVGTVG--------YMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKS 199
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 4e-04
Identities = 61/234 (26%), Positives = 92/234 (39%), Gaps = 50/234 (21%)
Query: 410 VLGKSGIGIVYKV-VLEDGHTLAVRRLGEGGSQRFKEFQTEVEAIG------KIRHSNIV 462
VLGK G G V V G A +RL + +R K+ + E A+ K+ +V
Sbjct: 7 VLGKGGFGEVCACQVRATGKMYACKRLEK---KRIKKRKGESMALNEKQILEKVNSQFVV 63
Query: 463 TLRAYYWSVDEKLLIYDYIPNGSLATALH--GKPGMVSFTPVPWSVRVKIIKGIAKGLVY 520
L Y + D L+ + G L ++ G PG + ++ I GL
Sbjct: 64 NLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAE------ILCGLED 117
Query: 521 LHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQER 580
LH + V+ DLKP NILL +SD GLA ++P
Sbjct: 118 LHR---ENTVYRDLKPENILLDDYGHIRISDLGLAV--------------KIP------- 153
Query: 581 QQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRT 634
+ +S+ V T Y APE L + + D + G ++ EMI G++
Sbjct: 154 EGESIRGRVGTVG--------YMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQS 199
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 5e-04
Identities = 36/117 (30%), Positives = 50/117 (42%), Gaps = 32/117 (27%)
Query: 517 GLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEK 576
G+ +LH +H DLKPSNI++ + + DFGLAR AG S +
Sbjct: 138 GIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTP------- 184
Query: 577 PQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGR 633
V T YY+APE + + + DI+S G I+ EMI G
Sbjct: 185 -----------YVVT--------RYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 5e-04
Identities = 67/244 (27%), Positives = 105/244 (43%), Gaps = 56/244 (22%)
Query: 402 ELLKASAFVLGKSGIGIVY---KVVLED-GHTLAVRRLGEGG-SQRFKEFQ---TEVEAI 453
ELLK VLG G V+ KV D G A++ L + Q+ K + TE +
Sbjct: 3 ELLK----VLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVL 58
Query: 454 GKIRHSNIVTLRAYYWSVDEKL-LIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIK 512
+R S + Y + + KL LI DY+ G + T L+ + +F+ V+
Sbjct: 59 EHVRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRD---NFS----EDEVRFYS 111
Query: 513 G-IAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHV--SDFGLARLANIAGGSPTLQS 569
G I L +LH+ V+ D+K NILL + E HV +DFGL++
Sbjct: 112 GEIILALEHLHKLG---IVYRDIKLENILL--DSEGHVVLTDFGLSK------------- 153
Query: 570 NRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKW-DIYSYGVILLE 628
E E ++++ S T Y APE ++ K D +S G+++ E
Sbjct: 154 -----EFLSEEKERTYSFCGTIE---------YMAPEIIRGKGGHGKAVDWWSLGILIFE 199
Query: 629 MITG 632
++TG
Sbjct: 200 LLTG 203
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 5e-04
Identities = 55/209 (26%), Positives = 79/209 (37%), Gaps = 46/209 (22%)
Query: 444 KEFQTEVEAIGKIRHSNIVTL-RAYYW--SVDEKLLIYDYIPNGSLATALHGKPGMVSFT 500
K E++ + I H I+ L AY W +V + Y L T +
Sbjct: 131 KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPKYKC----DLFTYVDRS------G 180
Query: 501 PVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLA-RLAN 559
P+P + I + + + L YLH + +H D+K NI L + DFG A +L
Sbjct: 181 PLPLEQAITIQRRLLEALAYLHG---RGIIHRDVKTENIFLDEPENAVLGDFGAACKLD- 236
Query: 560 IAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDI 619
+ PQ S +LE TNS PE L + K DI
Sbjct: 237 ------------AHPDTPQCYGW-SGTLE---TNS----------PELLALDPYCAKTDI 270
Query: 620 YSYGVILLEMITGRTAV--VQVGSSEMDL 646
+S G++L EM + QV SS L
Sbjct: 271 WSAGLVLFEMSVKNVTLFGKQVKSSSSQL 299
|
Length = 392 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 5e-04
Identities = 40/144 (27%), Positives = 61/144 (42%), Gaps = 39/144 (27%)
Query: 510 IIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQS 569
+++ +GL +LH VH DLKP NIL+ + ++DFGLAR+ +
Sbjct: 113 LMRQFLRGLDFLHA---NCIVHRDLKPENILVTSGGQVKLADFGLARIYSC--------- 160
Query: 570 NRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEM 629
Q +++ V T +Y+APE L + D++S G I EM
Sbjct: 161 ------------QMALTPVVVTL--------WYRAPEVLLQSTYATPVDMWSVGCIFAEM 200
Query: 630 ITGRTAVVQVGSSEMDLVNWMQLC 653
R + G+SE D QL
Sbjct: 201 F--RRKPLFCGNSEAD-----QLG 217
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 6e-04
Identities = 57/245 (23%), Positives = 98/245 (40%), Gaps = 42/245 (17%)
Query: 410 VLGKSGIGIVYKVVLED-GHTLAVRRLGEGGSQRFKEFQTEVEAIGKIRHSNIVTLRA-- 466
V+G+ G V V +D GH A++ L K E E + IR + + A
Sbjct: 8 VIGRGAFGEVRLVQKKDTGHIYAMKILR-------KADMLEKEQVAHIRAERDILVEADG 60
Query: 467 -----YYWSVDEK---LLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGL 518
++S +K LI +++P G + T L K + + IA+ +
Sbjct: 61 AWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFY---------IAETV 111
Query: 519 VYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLAR----------LANIAGGSPT-L 567
+ + ++H D+KP N+LL +SDFGL N+ P+
Sbjct: 112 LAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDF 171
Query: 568 QSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILL 627
M +++ E +K+ +T + + Y APE ++ D +S GVI+
Sbjct: 172 SFQNMNSKRKAETWKKNRRQLAYSTVGTPD----YIAPEVFMQTGYNKLCDWWSLGVIMY 227
Query: 628 EMITG 632
EM+ G
Sbjct: 228 EMLIG 232
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 6e-04
Identities = 62/238 (26%), Positives = 96/238 (40%), Gaps = 50/238 (21%)
Query: 410 VLGKSGIGIVYKV-VLEDGHTLAVRRLGEGGSQRFKEFQTEVEAIG------KIRHSNIV 462
VLGK G G V V G A ++L + +R K+ + E A+ K+ +V
Sbjct: 7 VLGKGGFGEVCACQVRATGKMYACKKLEK---KRIKKRKGESMALNEKQILEKVNSRFVV 63
Query: 463 TLRAYYWSVDEKLLIYDYIPNGSLATALH--GKPGMVSFTPVPWSVRVKIIKGIAKGLVY 520
+L Y + D L+ + G L ++ G+ G V ++ I GL
Sbjct: 64 SLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAE------ICCGLED 117
Query: 521 LHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQER 580
LH+ ++ V+ DLKP NILL + +SD GLA P+ +
Sbjct: 118 LHQ---ERIVYRDLKPENILLDDHGHIRISDLGLA------------------VHVPEGQ 156
Query: 581 QQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQ 638
K V T Y APE +K + + D ++ G +L EMI G++ Q
Sbjct: 157 TIKG---RVGTVG--------YMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQ 203
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 7e-04
Identities = 43/164 (26%), Positives = 66/164 (40%), Gaps = 39/164 (23%)
Query: 476 LIYDYIPNGSLATALHGKPG-----MVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYV 530
L+ +Y P G L + L+ M F +A+ ++ +H YV
Sbjct: 78 LVMEYQPGGDLLSLLNRYEDQFDEDMAQFY-------------LAELVLAIHSVHQMGYV 124
Query: 531 HGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQKSVSLEVT 590
H D+KP N+L + G +LA+ G + L +N+M K ++ EV
Sbjct: 125 HRDIKPENVL--------IDRTGHIKLADF-GSAARLTANKMVNSKLPVGTPDYIAPEVL 175
Query: 591 TTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRT 634
TT + G+Y E D +S GVI EMI GR+
Sbjct: 176 TTMNGDGKGTY--GVEC----------DWWSLGVIAYEMIYGRS 207
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 41.8 bits (99), Expect = 7e-04
Identities = 45/186 (24%), Positives = 73/186 (39%), Gaps = 44/186 (23%)
Query: 449 EVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGSLATALH--GKPGMVSFTPVPWSV 506
E + IRH +V L + L+ +Y+P G L + L G+ P P +
Sbjct: 51 EKRILQSIRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRF------PEPVA- 103
Query: 507 RVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPT 566
R + + L YLH V+ DLKP N+LL + ++DFG A+ + G + T
Sbjct: 104 RFYAAQ-VVLALEYLHS---LDIVYRDLKPENLLLDSDGYIKITDFGFAKR--VKGRTYT 157
Query: 567 LQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVIL 626
L P+ Y APE + + D ++ G+++
Sbjct: 158 LCGT------PE-----------------------YLAPEIILSKGYGKAVDWWALGILI 188
Query: 627 LEMITG 632
EM+ G
Sbjct: 189 YEMLAG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 7e-04
Identities = 50/213 (23%), Positives = 88/213 (41%), Gaps = 47/213 (22%)
Query: 468 YWSVDEKLLIY---DYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEF 524
Y+S +K +Y DYIP G + + L + P + I + + +H+
Sbjct: 67 YYSFQDKDNLYFVMDYIPGGDMMSLL------IRMEVFPEVLARFYIAELTLAIESVHKM 120
Query: 525 SPKKYVHGDLKPSNILLGHNMEPHVSDFGLA---RLANIA----GGSPTLQSNRMPA--- 574
++H D+KP NIL+ + ++DFGL R + + GS Q + P+
Sbjct: 121 G---FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLW 177
Query: 575 ----------------EKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWD 618
++ ++ Q+ ++ + T + Y APE L +Q D
Sbjct: 178 DDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPN-------YIAPEVLLRKGYTQLCD 230
Query: 619 IYSYGVILLEMITGRTAVVQVGSSEMDL--VNW 649
+S GVIL EM+ G+ + +E L +NW
Sbjct: 231 WWSVGVILFEMLVGQPPFLAPTPTETQLKVINW 263
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 42.0 bits (99), Expect = 7e-04
Identities = 34/122 (27%), Positives = 51/122 (41%), Gaps = 35/122 (28%)
Query: 514 IAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHV--SDFGLARLANIAGGSPTLQSNR 571
I GL +LHE + ++ DLK N+LL E H+ +DFG+ + I GG T
Sbjct: 105 IVLGLQFLHE---RGIIYRDLKLDNVLLDS--EGHIKIADFGMCK-EGILGGVTT----- 153
Query: 572 MPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMIT 631
+T + + Y APE L D ++ GV+L EM+
Sbjct: 154 ------------------STFCGTPD----YIAPEILSYQPYGPAVDWWALGVLLYEMLA 191
Query: 632 GR 633
G+
Sbjct: 192 GQ 193
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 40.1 bits (94), Expect = 8e-04
Identities = 27/145 (18%), Positives = 51/145 (35%), Gaps = 18/145 (12%)
Query: 419 VYKVVLEDGHTLAVRRLGEGGSQRFKEFQTEVEAIGKIRHSNIVT--LRAYYWSVDEKLL 476
VY + +D ++ ++ + + EV + + + + A S L
Sbjct: 14 VYLLGTKDED-YVLKINPSR--EKGADREREVAILQLLARKGLPVPKVLASGESDGWSYL 70
Query: 477 IYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKP 536
+ ++I +L V + I + +A+ L LH+ HGDL P
Sbjct: 71 LMEWIEGETL-------------DEVSEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHP 117
Query: 537 SNILLGHNMEPHVSDFGLARLANIA 561
NIL+ + D+ A A
Sbjct: 118 GNILVDDGKILGIIDWEYAGYGPPA 142
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 8e-04
Identities = 57/240 (23%), Positives = 100/240 (41%), Gaps = 57/240 (23%)
Query: 410 VLGKSGIGIVYK-VVLEDGHTLAVRRLGEGGSQRFKEFQTEVEAIGKI-RHSNIVTLRAY 467
++G G VYK ++ G A++ + G + +E + E+ + K H NI T Y
Sbjct: 13 LVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEE-EEIKQEINMLKKYSHHRNIAT---Y 68
Query: 468 YWS--------VDEKL-LIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGL 518
Y + +D++L L+ ++ GS+ + G + W I + I +GL
Sbjct: 69 YGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKG--NTLKEEWIAY--ICREILRGL 124
Query: 519 VYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQ 578
+LH+ K +H D+K N+LL N E + DFG+
Sbjct: 125 SHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGV------------------------ 157
Query: 579 ERQQKSVSLEVTTTNSSSNLGS-YYQAPESLKVVKPSQ-----KWDIYSYGVILLEMITG 632
S L+ T ++ +G+ Y+ APE + + K D++S G+ +EM G
Sbjct: 158 -----SAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEG 212
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 37.1 bits (87), Expect = 0.001
Identities = 25/63 (39%), Positives = 34/63 (53%), Gaps = 4/63 (6%)
Query: 161 RLKALDLSQNNFTGPLPNGFGSGLVSLEKLNLSFNKFNGSIPSNT-GNLSSLQGTVDFSH 219
LK+LDLS N T +P+G GL +L+ L+LS N SI L SL+ ++D S
Sbjct: 1 NLKSLDLSNNRLTV-IPDGAFKGLPNLKVLDLSGNNLT-SISPEAFSGLPSLR-SLDLSG 57
Query: 220 NLF 222
N
Sbjct: 58 NNL 60
|
Length = 60 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 0.001
Identities = 50/200 (25%), Positives = 84/200 (42%), Gaps = 50/200 (25%)
Query: 514 IAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMP 573
+AKG+ +L + K +H DL NILL H + DFGLAR + R+P
Sbjct: 223 VAKGMSFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLP 279
Query: 574 AEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGR 633
+ + APES+ + + D++SYG++L E+ +
Sbjct: 280 VK--------------------------WMAPESIFNCVYTFESDVWSYGILLWEIFS-- 311
Query: 634 TAVVQVGSSE---MDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVH 690
+GSS M + + I+E + L P AP E+ ++K +C
Sbjct: 312 -----LGSSPYPGMPVDSKFYKMIKEGYRM---LSPECAP-----SEMYDIMK---SCWD 355
Query: 691 SSPEKRPTMRHISDALDRLI 710
+ P KRPT + I +++ +
Sbjct: 356 ADPLKRPTFKQIVQLIEQQL 375
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 0.001
Identities = 51/197 (25%), Positives = 87/197 (44%), Gaps = 44/197 (22%)
Query: 514 IAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMP 573
+A+G+ +L + +K +H DL NILL N + DFGLAR +I
Sbjct: 183 VARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLAR--DI------------- 224
Query: 574 AEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGR 633
+ P ++ S L + + APES+ + + D++S+GV+L E+ +
Sbjct: 225 YKDPDYVRKGSARLPLK-----------WMAPESIFDKVYTTQSDVWSFGVLLWEIFS-- 271
Query: 634 TAVVQVGSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSP 693
+G+S V Q+ E + L D AP+ E + +I +AC P
Sbjct: 272 -----LGASPYPGV---QINEEFCQRLKDGTR-MRAPENATPE----IYRIMLACWQGDP 318
Query: 694 EKRPTMRHISDALDRLI 710
++RPT + + L L+
Sbjct: 319 KERPTFSALVEILGDLL 335
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 0.001
Identities = 60/233 (25%), Positives = 90/233 (38%), Gaps = 52/233 (22%)
Query: 410 VLGKSGIGIVYKVVLE----DGHTLAVRRLGEGGSQRFKEFQTEVEA-----IGKIRHSN 460
V+GK G KV+L DG AV+ L + KE Q + A + ++H
Sbjct: 2 VIGKGSFG---KVLLAKRKLDGKCYAVKVLQKKIVLNRKE-QKHIMAERNVLLKNVKHPF 57
Query: 461 IVTLRAYYWSVDEKLLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKI-IKGIAKGLV 519
+V L + + ++ + D++ G L L + SF P P R + IA L
Sbjct: 58 LVGLHYSFQTTEKLYFVLDFVNGGELFFHLQRER---SF-PEP---RARFYAAEIASALG 110
Query: 520 YLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQE 579
YLH V+ DLKP NILL ++DFGL +
Sbjct: 111 YLHSI---NIVYRDLKPENILLDSQGHVVLTDFGLCK----------------------- 144
Query: 580 RQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITG 632
+ ++ TTT Y APE ++ D + G +L EM+ G
Sbjct: 145 ---EGIAQSDTTTTFCGT--PEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 0.002
Identities = 37/126 (29%), Positives = 55/126 (43%), Gaps = 32/126 (25%)
Query: 514 IAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMP 573
IA+ ++ +H YVH D+KP N+LL N ++DFG N G T+QS
Sbjct: 108 IAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDG---TVQS---- 160
Query: 574 AEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVV-----KPSQKWDIYSYGVILLE 628
S+ V T + Y +PE L+ + K + D +S GV + E
Sbjct: 161 ------------SVAVGTPD--------YISPEILQAMEDGMGKYGPECDWWSLGVCMYE 200
Query: 629 MITGRT 634
M+ G T
Sbjct: 201 MLYGET 206
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 40.5 bits (95), Expect = 0.002
Identities = 34/122 (27%), Positives = 56/122 (45%), Gaps = 33/122 (27%)
Query: 514 IAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMP 573
I GL +LH+ K ++ DLK N+LL + ++DFG+ + N+ G
Sbjct: 105 IICGLQFLHK---KGIIYRDLKLDNVLLDKDGHIKIADFGMCKE-NMNG----------- 149
Query: 574 AEKPQERQQKSVSLEVTTTNSSSNLGSY-YQAPESLKVVKPSQKWDIYSYGVILLEMITG 632
+S+ G+ Y APE LK K ++ D +S+GV+L EM+ G
Sbjct: 150 -----------------EGKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIG 192
Query: 633 RT 634
++
Sbjct: 193 QS 194
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 40.0 bits (94), Expect = 0.002
Identities = 38/159 (23%), Positives = 71/159 (44%), Gaps = 12/159 (7%)
Query: 411 LGKSGIGIVYKVV-LEDGHTLAVRRL--GEGGSQRFKEFQTEVEAIGKIRHSNIVTLRAY 467
+G+ G+V+K E G +A+++ E K E+ + +++H N+V L
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEV 68
Query: 468 YWSVDEKLLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPK 527
+ + L+++Y + ++ L P VP + KII + + + H+
Sbjct: 69 FRRKRKLHLVFEYCDH-TVLNELEKNP-----RGVPEHLIKKIIWQTLQAVNFCHK---H 119
Query: 528 KYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPT 566
+H D+KP NIL+ + + DFG AR+ G T
Sbjct: 120 NCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYT 158
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 39.8 bits (94), Expect = 0.003
Identities = 24/100 (24%), Positives = 45/100 (45%), Gaps = 10/100 (10%)
Query: 458 HSNIVTLRAYYWSVDEKLLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKG 517
+ N + L ++ +LI DYI +G L L + + + KII+ + +
Sbjct: 68 NPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEG------KLSEAEVKKIIRQLVEA 121
Query: 518 LVYLHEFSPKKYVHGDLKPSNILLGHNMEP-HVSDFGLAR 556
L LH+ +H D+K N+L + ++ D+GL +
Sbjct: 122 LNDLHK---HNIIHNDIKLENVLYDRAKDRIYLCDYGLCK 158
|
Length = 267 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 0.004
Identities = 31/111 (27%), Positives = 53/111 (47%), Gaps = 9/111 (8%)
Query: 447 QTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGSLATALHGKPGMVSFTPVPWSV 506
Q E +A+ + IV L S + L+ +Y+ G + + LH + + +V
Sbjct: 52 QAERDALALSKSPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLH----IYGYFDEEMAV 107
Query: 507 RVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARL 557
K I +A L YLH +H DLKP N+L+ + ++DFGL+++
Sbjct: 108 --KYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSKV 153
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.004
Identities = 58/234 (24%), Positives = 91/234 (38%), Gaps = 50/234 (21%)
Query: 410 VLGKSGIGIVYKV-VLEDGHTLAVRRLGEGGSQRFKEFQTEVEAIG------KIRHSNIV 462
VLGK G G V V G A ++L + +R K+ + E A+ K+ +V
Sbjct: 7 VLGKGGFGEVCACQVRATGKMYACKKLEK---KRIKKRKGEAMALNEKRILEKVNSRFVV 63
Query: 463 TLRAYYWSVDEKLLIYDYIPNGSLATALH--GKPGMVSFTPVPWSVRVKIIKGIAKGLVY 520
+L Y + D L+ + G L ++ G PG + ++ + GL
Sbjct: 64 SLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAE------LCCGLED 117
Query: 521 LHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQER 580
L ++ V+ DLKP NILL +SD GLA Q
Sbjct: 118 LQR---ERIVYRDLKPENILLDDRGHIRISDLGLA---------------------VQIP 153
Query: 581 QQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRT 634
+ ++V V T Y APE + K + D + G ++ EMI G++
Sbjct: 154 EGETVRGRVGTVG--------YMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQS 199
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 714 | |||
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.98 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.98 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.98 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.97 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.97 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.97 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.97 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.97 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.97 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.97 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.97 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.96 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.96 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.96 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.96 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.96 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.95 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.95 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.95 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.95 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.93 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.93 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.92 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.89 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.87 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.87 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.86 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.86 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.84 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.83 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.83 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.83 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.82 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.82 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.81 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.81 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.8 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.8 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.8 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 99.78 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 99.77 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.77 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.76 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.74 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.74 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.74 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.72 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 99.72 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.71 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 99.7 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.7 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.7 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.69 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 99.69 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.68 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.68 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 99.63 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.62 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.6 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 99.6 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.59 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.57 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.53 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.53 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.52 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.51 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.5 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.47 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.47 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.44 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.43 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.41 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 99.38 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.36 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.33 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.32 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.31 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.3 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.29 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.24 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.22 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.19 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.18 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.16 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.15 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.15 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.1 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.09 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 99.06 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.01 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.01 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.96 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.96 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 98.93 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 98.89 | |
| PF08263 | 43 | LRRNT_2: Leucine rich repeat N-terminal domain; In | 98.87 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.83 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.79 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 98.75 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.72 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.72 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.72 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.65 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 98.65 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.59 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.58 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 98.53 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 98.53 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.42 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.41 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.36 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 98.35 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 98.32 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.29 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 98.19 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.18 |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-68 Score=643.84 Aligned_cols=548 Identities=28% Similarity=0.473 Sum_probs=370.3
Q ss_pred CcEEEEEcCCCCccccCCccccCCCCCCEEEccCCCCcccCChhhcCCCCCCEEEcCCCcCcccCCcccCC---------
Q 005102 64 QRVVSVSIPKKKLLGFLPSALGSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSGSVPNEIGK--------- 134 (714)
Q Consensus 64 ~~~~~l~l~~~~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~--------- 134 (714)
.+++.|++.+|++.+.+|..++.+++|+.|+|++|++++.+|..+..+++|+.|+|++|.++|.+|..+..
T Consensus 380 ~~L~~L~l~~n~l~~~~p~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L 459 (968)
T PLN00113 380 GNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSL 459 (968)
T ss_pred CCCCEEECcCCEecccCCHHHhCCCCCCEEECcCCEeeeECChhHhcCCCCCEEECcCCcccCccChhhccCCCCcEEEC
Confidence 44555555555555555555555555555555555555555555555555555555555554444443333
Q ss_pred --------------CCCCCEEeccCccCCCCCCcccccccccceeecccCcCCCCCCcccccCccccccccccCCccccc
Q 005102 135 --------------LKYLQILDLSQNFFNGSLPVSIVQCKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLNLSFNKFNGS 200 (714)
Q Consensus 135 --------------l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~l~~L~~L~l~~N~l~g~ 200 (714)
+++|+.|+|++|++++.+|..+.++++|+.|+|++|++++.+|..+. .+++|+.|+|++|.++|.
T Consensus 460 ~~n~~~~~~p~~~~~~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~-~l~~L~~L~Ls~N~l~~~ 538 (968)
T PLN00113 460 ARNKFFGGLPDSFGSKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELS-SCKKLVSLDLSHNQLSGQ 538 (968)
T ss_pred cCceeeeecCcccccccceEEECcCCccCCccChhhhhhhccCEEECcCCcceeeCChHHc-CccCCCEEECCCCccccc
Confidence 35666677777777777777777778888888888888887887774 578888888888888888
Q ss_pred CCCCCCCCcccccccccccccCCcCcCccccCCCCcccccCcCCcCCCCCCCCccccCCCCcccccCCCCCCCCCCCCCC
Q 005102 201 IPSNTGNLSSLQGTVDFSHNLFSGSIPASLGNLPEKVYIDLTYNNLSGPIPQNGALMNRGPTAFIGNPRLCGPPLKNPCS 280 (714)
Q Consensus 201 ~p~~~~~l~~L~~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~~~~~~~~~~~~n~~~~~~~~~~~~~ 280 (714)
+|..+.++++|+ .|+|++|+++|.+|..+..+++|+.|++++|+++|.+|....+..+....+.||+.+|+.+....
T Consensus 539 ~p~~~~~l~~L~-~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~lc~~~~~~~-- 615 (968)
T PLN00113 539 IPASFSEMPVLS-QLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSG-- 615 (968)
T ss_pred CChhHhCcccCC-EEECCCCcccccCChhHhcCcccCEEeccCCcceeeCCCcchhcccChhhhcCCccccCCccccC--
Confidence 888888888888 88888888888888888888888888888888888888877777777777888888886431100
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCcccCCCCCcccEEEEeehhHHHHHHHHHHhheeeeeeecCCCCCCCcccc
Q 005102 281 SDVPGASSPASYPFLPNNYPPENGDDGGGKREKGRGLSKSAIVAIIVSDVIGICLVGLLFSYCYSRVCGFGEGKDENCYA 360 (714)
Q Consensus 281 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~s~~~iv~i~v~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 360 (714)
.| | ... .. +......++++++++++.++++ ++++.++|++++...+.. ..
T Consensus 616 -----------~~--~-------c~~-----~~-~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~--~~ 665 (968)
T PLN00113 616 -----------LP--P-------CKR-----VR-KTPSWWFYITCTLGAFLVLALV--AFGFVFIRGRNNLELKRV--EN 665 (968)
T ss_pred -----------CC--C-------Ccc-----cc-ccceeeeehhHHHHHHHHHHHH--HHHHHHHHhhhccccccc--cc
Confidence 00 0 000 00 0001111111111211111111 112222222111111000 00
Q ss_pred CCCCCCccccccccCCCccccccccccccccCCCccccCHHHHHHhc--cccccccCceEEEEEEE-CCCcEEEEEEeCC
Q 005102 361 KGGKGRKECLCFRKDESETLSENVEQYDLVPLDTQVAFDLDELLKAS--AFVLGKSGIGIVYKVVL-EDGHTLAVRRLGE 437 (714)
Q Consensus 361 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~--~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~ 437 (714)
..+ . .... .........++++++.... .++||+|+||.||+|+. .++..||||++..
T Consensus 666 ~~~---------------~--~~~~---~~~~~~~~~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~ 725 (968)
T PLN00113 666 EDG---------------T--WELQ---FFDSKVSKSITINDILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEIND 725 (968)
T ss_pred ccc---------------c--cccc---ccccccchhhhHHHHHhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccC
Confidence 000 0 0000 0000011234455544432 35899999999999997 4689999999875
Q ss_pred CCchhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHH
Q 005102 438 GGSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKG 517 (714)
Q Consensus 438 ~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~g 517 (714)
.... ...|++++++++|||||+++|+|.+.+..++||||+++|+|.++++ .++|.++.+|+.|+|+|
T Consensus 726 ~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~---------~l~~~~~~~i~~~ia~~ 792 (968)
T PLN00113 726 VNSI----PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLR---------NLSWERRRKIAIGIAKA 792 (968)
T ss_pred Cccc----cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCcHHHHHh---------cCCHHHHHHHHHHHHHH
Confidence 4332 2356889999999999999999999999999999999999999994 37899999999999999
Q ss_pred HHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCCCCccCCCCCCCCchhhhcccccceeecccCCCC
Q 005102 518 LVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSN 597 (714)
Q Consensus 518 L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 597 (714)
|+|||..+.++|+||||||+||+++.++.+++. ||.+..... .....
T Consensus 793 L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~--------------------------------~~~~~ 839 (968)
T PLN00113 793 LRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT--------------------------------DTKCF 839 (968)
T ss_pred HHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc--------------------------------CCCcc
Confidence 999996544799999999999999999888875 665432210 11124
Q ss_pred CCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCccccCCCCcchhHHHHHHHHhhcCCcccccCCCCCCCC-CcHH
Q 005102 598 LGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDA-DKEE 676 (714)
Q Consensus 598 gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~-~~~~ 676 (714)
+|..|+|||++.+..++.++|||||||++|||+||+.||.........+.+|++...... ....++|+.+.... ...+
T Consensus 840 ~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 918 (968)
T PLN00113 840 ISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDC-HLDMWIDPSIRGDVSVNQN 918 (968)
T ss_pred ccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCcc-chhheeCccccCCCCccHH
Confidence 578899999999999999999999999999999999999554444556777776554332 24556666654332 2345
Q ss_pred HHHHHHHHHhHccCCCCCCCCCHHHHHHHHhhhhcc
Q 005102 677 EIIAVLKIAMACVHSSPEKRPTMRHISDALDRLIVS 712 (714)
Q Consensus 677 ~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~~ 712 (714)
+..++.+++.+||+.||++||||+||+++|+++.+.
T Consensus 919 ~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~ 954 (968)
T PLN00113 919 EIVEVMNLALHCTATDPTARPCANDVLKTLESASRS 954 (968)
T ss_pred HHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhcc
Confidence 677889999999999999999999999999998764
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-54 Score=454.37 Aligned_cols=285 Identities=41% Similarity=0.702 Sum_probs=244.8
Q ss_pred CccccCHHHHHHhcc-----ccccccCceEEEEEEECCCcEEEEEEeCCCCchhHHHHHHHHHHHhccCCCCccceEEEE
Q 005102 394 TQVAFDLDELLKASA-----FVLGKSGIGIVYKVVLEDGHTLAVRRLGEGGSQRFKEFQTEVEAIGKIRHSNIVTLRAYY 468 (714)
Q Consensus 394 ~~~~~~~~~l~~~~~-----~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~ 468 (714)
....|+++++.+||. ++||+|+||.||+|...+|..||||++........++|.+|++++.+++|||+|+++|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 456799999999983 689999999999999999999999988876543135699999999999999999999999
Q ss_pred EeCC-ceeEEEeccCCCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCe
Q 005102 469 WSVD-EKLLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEP 547 (714)
Q Consensus 469 ~~~~-~~~lV~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~ 547 (714)
.+.+ +.+||||||++|+|.++|+..... .++|.+|++||.++|+||+|||+.++++||||||||+|||+|+++++
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~----~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~a 216 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGE----PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNA 216 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCC----CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCE
Confidence 9998 499999999999999999987531 68999999999999999999999887789999999999999999999
Q ss_pred EEcccchhhhhhc-cCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHH
Q 005102 548 HVSDFGLARLANI-AGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVIL 626 (714)
Q Consensus 548 kl~DFGla~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl 626 (714)
||+|||+|+.... .. .......||.+|+|||++..+..+.|+|||||||+|
T Consensus 217 KlsDFGLa~~~~~~~~----------------------------~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvl 268 (361)
T KOG1187|consen 217 KLSDFGLAKLGPEGDT----------------------------SVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVL 268 (361)
T ss_pred EccCccCcccCCcccc----------------------------ceeeecCCCCccCChhhhccCCcCcccccccchHHH
Confidence 9999999975432 10 000000679999999999999999999999999999
Q ss_pred HHHHhCCCccccCC-CCcchhHHHHHHHHhhcCCcccccCCCCCC-CCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 005102 627 LEMITGRTAVVQVG-SSEMDLVNWMQLCIEEKKPLADVLDPYLAP-DADKEEEIIAVLKIAMACVHSSPEKRPTMRHISD 704 (714)
Q Consensus 627 ~elltG~~p~~~~~-~~~~~l~~~~~~~~~~~~~~~~~~d~~~~~-~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 704 (714)
+||+||+.|.+... ..+..++.|+...+... .+.+++||.+.. .....+++.++..++.+|++.+|.+||+|.||++
T Consensus 269 lElitgr~~~d~~~~~~~~~l~~w~~~~~~~~-~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~ 347 (361)
T KOG1187|consen 269 LELITGRKAVDQSRPRGELSLVEWAKPLLEEG-KLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVK 347 (361)
T ss_pred HHHHhCCcccCCCCCcccccHHHHHHHHHHCc-chhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHH
Confidence 99999999886443 34455899998777776 589999999873 3333368888999999999999999999999999
Q ss_pred HHhhhhc
Q 005102 705 ALDRLIV 711 (714)
Q Consensus 705 ~L~~i~~ 711 (714)
+|+.+..
T Consensus 348 ~L~~~~~ 354 (361)
T KOG1187|consen 348 ELEGILS 354 (361)
T ss_pred HHHhhcc
Confidence 9977653
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-49 Score=389.74 Aligned_cols=256 Identities=27% Similarity=0.407 Sum_probs=216.7
Q ss_pred cCHHHHHHhccccccccCceEEEEEEEC-CCcEEEEEEeCCC-CchhHHHHHHHHHHHhccCCCCccceEEEEEeCCc-e
Q 005102 398 FDLDELLKASAFVLGKSGIGIVYKVVLE-DGHTLAVRRLGEG-GSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDE-K 474 (714)
Q Consensus 398 ~~~~~l~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~-~ 474 (714)
++..|+.+ ...||+|..|+|||+.++ +++.+|+|.+... +....+++.+|++++++++||+||.+||.|+..+. .
T Consensus 76 i~~~dle~--~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~i 153 (364)
T KOG0581|consen 76 ISLSDLER--LGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEI 153 (364)
T ss_pred cCHHHhhh--hhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceE
Confidence 56667765 347999999999999987 4889999999654 44556789999999999999999999999999985 9
Q ss_pred eEEEeccCCCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccch
Q 005102 475 LLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGL 554 (714)
Q Consensus 475 ~lV~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGl 554 (714)
.++||||.+|+|.+++... +++++...-+|+.+|++||.|||+. ++||||||||+|||++..|++||||||.
T Consensus 154 sI~mEYMDgGSLd~~~k~~------g~i~E~~L~~ia~~VL~GL~YLh~~--~~IIHRDIKPsNlLvNskGeVKicDFGV 225 (364)
T KOG0581|consen 154 SICMEYMDGGSLDDILKRV------GRIPEPVLGKIARAVLRGLSYLHEE--RKIIHRDIKPSNLLVNSKGEVKICDFGV 225 (364)
T ss_pred EeehhhcCCCCHHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHhhc--cCeeeccCCHHHeeeccCCCEEeccccc
Confidence 9999999999999999765 4589999999999999999999953 7999999999999999999999999999
Q ss_pred hhhhhccCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCC
Q 005102 555 ARLANIAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRT 634 (714)
Q Consensus 555 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~ 634 (714)
++.+.. +...+.+||..|||||-+.+..|+.++||||||++++|+++|+.
T Consensus 226 S~~lvn------------------------------S~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~Grf 275 (364)
T KOG0581|consen 226 SGILVN------------------------------SIANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRF 275 (364)
T ss_pred cHHhhh------------------------------hhcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCC
Confidence 987642 23456789999999999999999999999999999999999999
Q ss_pred ccccCCCCcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 005102 635 AVVQVGSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISD 704 (714)
Q Consensus 635 p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 704 (714)
||........+..+.+.....+.. |.++.. ....++.+++..||++||.+|||++|+++
T Consensus 276 P~~~~~~~~~~~~~Ll~~Iv~~pp-------P~lP~~----~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~ 334 (364)
T KOG0581|consen 276 PYPPPNPPYLDIFELLCAIVDEPP-------PRLPEG----EFSPEFRSFVSCCLRKDPSERPSAKQLLQ 334 (364)
T ss_pred CCCCcCCCCCCHHHHHHHHhcCCC-------CCCCcc----cCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 996554445566666665555432 222222 23346899999999999999999999875
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-48 Score=402.60 Aligned_cols=262 Identities=29% Similarity=0.456 Sum_probs=209.9
Q ss_pred ccCHHHHHHhccccccccCceEEEEEEECCCcEEEEEEeCCCCchh--HHHHHHHHHHHhccCCCCccceEEEEEeCC-c
Q 005102 397 AFDLDELLKASAFVLGKSGIGIVYKVVLEDGHTLAVRRLGEGGSQR--FKEFQTEVEAIGKIRHSNIVTLRAYYWSVD-E 473 (714)
Q Consensus 397 ~~~~~~l~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~H~niv~l~~~~~~~~-~ 473 (714)
.++.+++.. .+.||+|+||+||+|.++....||||++....... .++|.+|+.+|.+++|||||+++|+|.... .
T Consensus 37 ~i~~~~l~~--~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~ 114 (362)
T KOG0192|consen 37 EIDPDELPI--EEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGS 114 (362)
T ss_pred ecChHHhhh--hhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCc
Confidence 344455443 33599999999999999754449999998753322 568999999999999999999999999887 7
Q ss_pred eeEEEeccCCCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCC-ceecCCCCCCeeeCCCC-CeEEcc
Q 005102 474 KLLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKK-YVHGDLKPSNILLGHNM-EPHVSD 551 (714)
Q Consensus 474 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~-ivHrDlkp~NILl~~~~-~~kl~D 551 (714)
.++|||||++|+|.++++.... ..+++..+++|+.|||+||.|||+ .+ ||||||||+|||++.++ ++||+|
T Consensus 115 ~~iVtEy~~~GsL~~~l~~~~~----~~l~~~~~l~~aldiArGm~YLH~---~~~iIHrDLK~~NiLv~~~~~~~KI~D 187 (362)
T KOG0192|consen 115 LCIVTEYMPGGSLSVLLHKKRK----RKLPLKVRLRIALDIARGMEYLHS---EGPIIHRDLKSDNILVDLKGKTLKIAD 187 (362)
T ss_pred eEEEEEeCCCCcHHHHHhhccc----CCCCHHHHHHHHHHHHHHHHHHhc---CCCeeecccChhhEEEcCCCCEEEECC
Confidence 8999999999999999987411 569999999999999999999999 67 99999999999999998 999999
Q ss_pred cchhhhhhccCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccC--CCCCCchhhhHHHHHHHHHH
Q 005102 552 FGLARLANIAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLK--VVKPSQKWDIYSYGVILLEM 629 (714)
Q Consensus 552 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~s~~~DVwS~Gvvl~el 629 (714)
||+++...... ...+...||..|||||++. ...|+.|+|||||||++|||
T Consensus 188 FGlsr~~~~~~----------------------------~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl 239 (362)
T KOG0192|consen 188 FGLSREKVISK----------------------------TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWEL 239 (362)
T ss_pred Cccceeecccc----------------------------ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHH
Confidence 99998653210 1223357899999999999 56899999999999999999
Q ss_pred HhCCCccccCCCCcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhhh
Q 005102 630 ITGRTAVVQVGSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDALDRL 709 (714)
Q Consensus 630 ltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i 709 (714)
+||+.||..... ...+........ .|.++.. +...+..++.+||+.||++||++.+++..|+.+
T Consensus 240 ~t~~~Pf~~~~~-----~~~~~~v~~~~~------Rp~~p~~-----~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~ 303 (362)
T KOG0192|consen 240 LTGEIPFEDLAP-----VQVASAVVVGGL------RPPIPKE-----CPPHLSSLMERCWLVDPSRRPSFLEIVSRLESI 303 (362)
T ss_pred HHCCCCCCCCCH-----HHHHHHHHhcCC------CCCCCcc-----CCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHH
Confidence 999999954322 222222222221 1212111 334688999999999999999999999999988
Q ss_pred hc
Q 005102 710 IV 711 (714)
Q Consensus 710 ~~ 711 (714)
..
T Consensus 304 ~~ 305 (362)
T KOG0192|consen 304 MS 305 (362)
T ss_pred HH
Confidence 65
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-47 Score=396.95 Aligned_cols=265 Identities=28% Similarity=0.443 Sum_probs=214.1
Q ss_pred ccccCHHHHHHhccccccccCceEEEEEEECCCcEEEEEEeCCCCchhHHHHHHHHHHHhccCCCCccceEEEEEeCCce
Q 005102 395 QVAFDLDELLKASAFVLGKSGIGIVYKVVLEDGHTLAVRRLGEGGSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEK 474 (714)
Q Consensus 395 ~~~~~~~~l~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~ 474 (714)
.+.++.+++.. .+.||+|.||+||.|.+.....||+|.++.... ..+.|.+|+++|++++|+|||+++|+|...+..
T Consensus 200 ~wei~r~~l~l--~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m-~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~pi 276 (468)
T KOG0197|consen 200 PWEIPREELKL--IRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSM-SPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPI 276 (468)
T ss_pred CeeecHHHHHH--HHHhcCCccceEEEEEEcCCCcccceEEecccc-ChhHHHHHHHHHHhCcccCeEEEEEEEecCCce
Confidence 34555555544 457999999999999998777999999987633 347899999999999999999999999998899
Q ss_pred eEEEeccCCCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccch
Q 005102 475 LLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGL 554 (714)
Q Consensus 475 ~lV~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGl 554 (714)
|||||||+.|+|.++|....+ ..+...+.+.++.|||+|++||++ +++|||||.++|||++++..+||+|||+
T Consensus 277 yIVtE~m~~GsLl~yLr~~~~----~~l~~~~Ll~~a~qIaeGM~YLes---~~~IHRDLAARNiLV~~~~~vKIsDFGL 349 (468)
T KOG0197|consen 277 YIVTEYMPKGSLLDYLRTREG----GLLNLPQLLDFAAQIAEGMAYLES---KNYIHRDLAARNILVDEDLVVKISDFGL 349 (468)
T ss_pred EEEEEecccCcHHHHhhhcCC----CccchHHHHHHHHHHHHHHHHHHh---CCccchhhhhhheeeccCceEEEccccc
Confidence 999999999999999987433 568889999999999999999999 9999999999999999999999999999
Q ss_pred hhhhhccCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHh-CC
Q 005102 555 ARLANIAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMIT-GR 633 (714)
Q Consensus 555 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~ellt-G~ 633 (714)
||...++.. .. .....-...|.|||.+..++++.|||||||||+||||+| |+
T Consensus 350 Ar~~~d~~Y-~~--------------------------~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~ 402 (468)
T KOG0197|consen 350 ARLIGDDEY-TA--------------------------SEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGR 402 (468)
T ss_pred ccccCCCce-ee--------------------------cCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCC
Confidence 995443221 11 111111345999999999999999999999999999999 89
Q ss_pred CccccCCCCcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhhhhccC
Q 005102 634 TAVVQVGSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDALDRLIVSS 713 (714)
Q Consensus 634 ~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~~~ 713 (714)
.||.... ..+.+.. +..+..+ -.|. .++..++++|..||+.+|++|||++.+...|+++...+
T Consensus 403 ~py~~ms-----n~ev~~~-le~GyRl---p~P~--------~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~~ 465 (468)
T KOG0197|consen 403 VPYPGMS-----NEEVLEL-LERGYRL---PRPE--------GCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTST 465 (468)
T ss_pred CCCCCCC-----HHHHHHH-HhccCcC---CCCC--------CCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhcc
Confidence 8984332 2222322 2222221 1222 24457999999999999999999999999999987654
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-46 Score=392.90 Aligned_cols=242 Identities=23% Similarity=0.378 Sum_probs=206.3
Q ss_pred cccccccCceEEEEEEE-CCCcEEEEEEeCCC---CchhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCC
Q 005102 408 AFVLGKSGIGIVYKVVL-EDGHTLAVRRLGEG---GSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPN 483 (714)
Q Consensus 408 ~~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~ 483 (714)
+++||+|||++||+++. ..|..||+|++.+. .....+...+||++.+.++|||||+++++|++.+..|+|.|+|++
T Consensus 23 g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivLELC~~ 102 (592)
T KOG0575|consen 23 GRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVLELCHR 102 (592)
T ss_pred eeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEEEecCC
Confidence 56899999999999998 77999999999874 334457789999999999999999999999999999999999999
Q ss_pred CCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCC
Q 005102 484 GSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGG 563 (714)
Q Consensus 484 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 563 (714)
|+|..+++.+ ..+++.+++.+++||+.||.|||+ .+|+|||||..|+++++++++||+|||+|..+..++
T Consensus 103 ~sL~el~Krr------k~ltEpEary~l~QIv~GlkYLH~---~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~- 172 (592)
T KOG0575|consen 103 GSLMELLKRR------KPLTEPEARYFLRQIVEGLKYLHS---LGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDG- 172 (592)
T ss_pred ccHHHHHHhc------CCCCcHHHHHHHHHHHHHHHHHHh---cCceecccchhheeecCcCcEEecccceeeeecCcc-
Confidence 9999999854 579999999999999999999999 899999999999999999999999999998775331
Q ss_pred CCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCccccCCCCc
Q 005102 564 SPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGSSE 643 (714)
Q Consensus 564 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~~~~~~~~ 643 (714)
....+.+|||.|+|||++.....+..+||||+|||||.|++|++||..
T Consensus 173 ---------------------------Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFet----- 220 (592)
T KOG0575|consen 173 ---------------------------ERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFET----- 220 (592)
T ss_pred ---------------------------cccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCccc-----
Confidence 234467899999999999988999999999999999999999999932
Q ss_pred chhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 005102 644 MDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISD 704 (714)
Q Consensus 644 ~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 704 (714)
..+.+-..........++. ....+..++|.++|+.||.+|||+++|+.
T Consensus 221 k~vkety~~Ik~~~Y~~P~-------------~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~ 268 (592)
T KOG0575|consen 221 KTVKETYNKIKLNEYSMPS-------------HLSAEAKDLIRKLLRPNPSERPSLDEVLD 268 (592)
T ss_pred chHHHHHHHHHhcCccccc-------------ccCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 2333333333333322221 12235779999999999999999999975
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-46 Score=374.52 Aligned_cols=191 Identities=26% Similarity=0.439 Sum_probs=172.8
Q ss_pred cccccCceEEEEEEECC-CcEEEEEEeCCC--CchhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCCCH
Q 005102 410 VLGKSGIGIVYKVVLED-GHTLAVRRLGEG--GSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGSL 486 (714)
Q Consensus 410 ~lG~G~~g~Vy~~~~~~-g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL 486 (714)
.||+|+||+||+|+++. +..||||.+.+. .....+....|+.+|+.++|||||+++++++..+..|+|||||.+|||
T Consensus 17 ~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVMEyC~gGDL 96 (429)
T KOG0595|consen 17 EIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVMEYCNGGDL 96 (429)
T ss_pred hccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEEeCCCCCH
Confidence 49999999999999864 899999999876 445556788999999999999999999999999999999999999999
Q ss_pred hhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCC------CCeEEcccchhhhhhc
Q 005102 487 ATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHN------MEPHVSDFGLARLANI 560 (714)
Q Consensus 487 ~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~------~~~kl~DFGla~~~~~ 560 (714)
.++++.. ..+++..++.++.|+|.||++||+ ++||||||||+||||+.. -.+||+|||+|+.+..
T Consensus 97 s~yi~~~------~~l~e~t~r~Fm~QLA~alq~L~~---~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~~ 167 (429)
T KOG0595|consen 97 SDYIRRR------GRLPEATARHFMQQLASALQFLHE---NNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQP 167 (429)
T ss_pred HHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCcceEEeccCCCCCCCceEEecccchhhhCCc
Confidence 9999877 469999999999999999999999 999999999999999764 4589999999998763
Q ss_pred cCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCcccc
Q 005102 561 AGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQ 638 (714)
Q Consensus 561 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~~~ 638 (714)
. ....+..|++.|||||++..++|+.|+|+||+|+|+|||++|+.||..
T Consensus 168 ~-----------------------------~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a 216 (429)
T KOG0595|consen 168 G-----------------------------SMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDA 216 (429)
T ss_pred h-----------------------------hHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccc
Confidence 2 233456789999999999999999999999999999999999999953
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-45 Score=400.81 Aligned_cols=259 Identities=26% Similarity=0.441 Sum_probs=211.6
Q ss_pred ccccccCceEEEEEEEC------CCcEEEEEEeCCCCch-hHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEecc
Q 005102 409 FVLGKSGIGIVYKVVLE------DGHTLAVRRLGEGGSQ-RFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYI 481 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~ 481 (714)
+.||+|.||+||+|+.. +...||||.++..... ..++|++|+++++.++|||||+++|.|..++..++|+|||
T Consensus 492 ~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~MvFEYm 571 (774)
T KOG1026|consen 492 EELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLCMVFEYM 571 (774)
T ss_pred hhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeEEEEEec
Confidence 46999999999999853 3568999999987655 6789999999999999999999999999999999999999
Q ss_pred CCCCHhhhhhCCCCCCC--------cCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccc
Q 005102 482 PNGSLATALHGKPGMVS--------FTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFG 553 (714)
Q Consensus 482 ~~gsL~~~l~~~~~~~~--------~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFG 553 (714)
..|||.++|........ ..+|+..+.+.||.|||.|++||-+ +.+|||||..+|+||.++..+||+|||
T Consensus 572 ~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~---~~FVHRDLATRNCLVge~l~VKIsDfG 648 (774)
T KOG1026|consen 572 DHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSS---HHFVHRDLATRNCLVGENLVVKISDFG 648 (774)
T ss_pred ccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh---CcccccchhhhhceeccceEEEecccc
Confidence 99999999975432211 2348899999999999999999999 899999999999999999999999999
Q ss_pred hhhhhhccCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHh-C
Q 005102 554 LARLANIAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMIT-G 632 (714)
Q Consensus 554 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~ellt-G 632 (714)
++|.....+.+......- -...|||||.+..++||++||||||||+|||++| |
T Consensus 649 LsRdiYssDYYk~~~~t~--------------------------lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG 702 (774)
T KOG1026|consen 649 LSRDIYSSDYYKVRGNTL--------------------------LPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYG 702 (774)
T ss_pred cchhhhhhhhhcccCCce--------------------------eeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccc
Confidence 999765433221110000 1345999999999999999999999999999999 9
Q ss_pred CCccccCCCCcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhhhhcc
Q 005102 633 RTAVVQVGSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDALDRLIVS 712 (714)
Q Consensus 633 ~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~~ 712 (714)
+.||+...+++ .++ +++.+..+ ..++.++.++++||..||+.+|++||+++||-.+|++....
T Consensus 703 ~QPy~glSn~E--VIe----~i~~g~lL-----------~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~ 765 (774)
T KOG1026|consen 703 KQPYYGLSNQE--VIE----CIRAGQLL-----------SCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQA 765 (774)
T ss_pred cCcccccchHH--HHH----HHHcCCcc-----------cCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhc
Confidence 99996654433 222 23333211 11233556899999999999999999999999999987655
Q ss_pred C
Q 005102 713 S 713 (714)
Q Consensus 713 ~ 713 (714)
+
T Consensus 766 s 766 (774)
T KOG1026|consen 766 S 766 (774)
T ss_pred C
Confidence 4
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-46 Score=370.56 Aligned_cols=246 Identities=22% Similarity=0.367 Sum_probs=197.4
Q ss_pred cccccccCceEEEEEEEC-CCcEEEEEEeCCCCc-------hhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEe
Q 005102 408 AFVLGKSGIGIVYKVVLE-DGHTLAVRRLGEGGS-------QRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYD 479 (714)
Q Consensus 408 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e 479 (714)
.+.||+|+||.|-+|..+ +|+.||||++.+... ......++|+++|++++|||||+++++|...+..|||||
T Consensus 177 ~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds~YmVlE 256 (475)
T KOG0615|consen 177 SKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDSSYMVLE 256 (475)
T ss_pred eeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCceEEEEE
Confidence 468999999999999864 699999999986421 122346799999999999999999999999999999999
Q ss_pred ccCCCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCC---CCeEEcccchhh
Q 005102 480 YIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHN---MEPHVSDFGLAR 556 (714)
Q Consensus 480 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~---~~~kl~DFGla~ 556 (714)
||++|+|.+.+-.+ ..+.+..-+.+++|++.|+.|||+ +||+||||||+|||+..+ ..+||+|||+|+
T Consensus 257 ~v~GGeLfd~vv~n------k~l~ed~~K~~f~Qll~avkYLH~---~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK 327 (475)
T KOG0615|consen 257 YVEGGELFDKVVAN------KYLREDLGKLLFKQLLTAVKYLHS---QGIIHRDIKPENILLSNDAEDCLLKITDFGLAK 327 (475)
T ss_pred EecCccHHHHHHhc------cccccchhHHHHHHHHHHHHHHHH---cCcccccCCcceEEeccCCcceEEEecccchhh
Confidence 99999999999876 446777789999999999999999 999999999999999765 789999999999
Q ss_pred hhhccCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCC---CchhhhHHHHHHHHHHHhCC
Q 005102 557 LANIAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKP---SQKWDIYSYGVILLEMITGR 633 (714)
Q Consensus 557 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---s~~~DVwS~Gvvl~elltG~ 633 (714)
.... .....+.+||+.|.|||++.+..+ ..++|+||+||+||-+++|.
T Consensus 328 ~~g~-----------------------------~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~ 378 (475)
T KOG0615|consen 328 VSGE-----------------------------GSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGY 378 (475)
T ss_pred cccc-----------------------------ceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccC
Confidence 7642 223456789999999999976543 34889999999999999999
Q ss_pred CccccCCCCcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 005102 634 TAVVQVGSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISD 704 (714)
Q Consensus 634 ~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 704 (714)
+||.+...+. .+.+. .......+ ......+..++..++|.+||..||++|||+.|+++
T Consensus 379 pPFS~~~~~~-sl~eQ---I~~G~y~f---------~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~ 436 (475)
T KOG0615|consen 379 PPFSEEYTDP-SLKEQ---ILKGRYAF---------GPLQWDRISEEALDLINWMLVVDPENRPSADEALN 436 (475)
T ss_pred CCcccccCCc-cHHHH---HhcCcccc---------cChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence 9995433221 12221 11221111 11222345667899999999999999999999875
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-45 Score=351.05 Aligned_cols=252 Identities=25% Similarity=0.362 Sum_probs=200.9
Q ss_pred cccccCceEEEEEE-ECCCcEEEEEEeCCC--CchhHHHHHHHHHHHhccCCCCccceEEE-EEeCCc-eeEEEeccCCC
Q 005102 410 VLGKSGIGIVYKVV-LEDGHTLAVRRLGEG--GSQRFKEFQTEVEAIGKIRHSNIVTLRAY-YWSVDE-KLLIYDYIPNG 484 (714)
Q Consensus 410 ~lG~G~~g~Vy~~~-~~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~-~~~~~~-~~lV~e~~~~g 484 (714)
.||+|.||+|||+. ..+|..||.|.+.-+ +....++...|+.+|++++|||||++++. +.+..+ .++||||+..|
T Consensus 26 ~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivmE~c~~G 105 (375)
T KOG0591|consen 26 KIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVMELCDAG 105 (375)
T ss_pred HHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHHHhhccc
Confidence 79999999999998 467999999998743 45556789999999999999999999984 334444 79999999999
Q ss_pred CHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCC-ceecCCCCCCeeeCCCCCeEEcccchhhhhhccCC
Q 005102 485 SLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKK-YVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGG 563 (714)
Q Consensus 485 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~-ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 563 (714)
||.++++.-+.. .+.+++..+++++.|+++||.++|...+++ |+||||||.||+++.+|.+||+|||+++++...
T Consensus 106 DLsqmIk~~K~q--kr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l~s~-- 181 (375)
T KOG0591|consen 106 DLSQMIKHFKKQ--KRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFLSSK-- 181 (375)
T ss_pred CHHHHHHHHHhc--cccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHhcch--
Confidence 999998643221 156999999999999999999999965543 889999999999999999999999999988532
Q ss_pred CCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCccccCCCCc
Q 005102 564 SPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGSSE 643 (714)
Q Consensus 564 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~~~~~~~~ 643 (714)
++...+.+|||+||+||.+.+.+|+.|+||||+||++|||..-++||...
T Consensus 182 --------------------------~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~---- 231 (375)
T KOG0591|consen 182 --------------------------TTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD---- 231 (375)
T ss_pred --------------------------hHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc----
Confidence 34456778999999999999999999999999999999999999999432
Q ss_pred chhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHh
Q 005102 644 MDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDALD 707 (714)
Q Consensus 644 ~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~ 707 (714)
.+.+.-+.+..... |.+ +.+.....+.+++..|+..||+.||+...++..++
T Consensus 232 -n~~~L~~KI~qgd~-------~~~----p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~ 283 (375)
T KOG0591|consen 232 -NLLSLCKKIEQGDY-------PPL----PDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQ 283 (375)
T ss_pred -cHHHHHHHHHcCCC-------CCC----cHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHH
Confidence 22222221111111 111 12334557889999999999999998655554444
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=360.49 Aligned_cols=235 Identities=26% Similarity=0.352 Sum_probs=198.1
Q ss_pred ccccccCceEEEEEEECC-CcEEEEEEeCCCC---chhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCC
Q 005102 409 FVLGKSGIGIVYKVVLED-GHTLAVRRLGEGG---SQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNG 484 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~~-g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~g 484 (714)
++||+|+||+||.++.++ ++.+|+|++++.. ....+....|..+|.+++||.||+++..|++.++.|+|+||+.||
T Consensus 31 kviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylVld~~~GG 110 (357)
T KOG0598|consen 31 KVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLVLDYLNGG 110 (357)
T ss_pred eeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEEEeccCCc
Confidence 489999999999999765 8999999998752 334567889999999999999999999999999999999999999
Q ss_pred CHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCC
Q 005102 485 SLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGS 564 (714)
Q Consensus 485 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 564 (714)
+|..+|++. ..+++..++-++.+|+.||.|||+ .+||||||||+|||+|++|+++|+|||+++..-..
T Consensus 111 eLf~hL~~e------g~F~E~~arfYlaEi~lAL~~LH~---~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~--- 178 (357)
T KOG0598|consen 111 ELFYHLQRE------GRFSEDRARFYLAEIVLALGYLHS---KGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKD--- 178 (357)
T ss_pred cHHHHHHhc------CCcchhHHHHHHHHHHHHHHHHHh---CCeeeccCCHHHeeecCCCcEEEeccccchhcccC---
Confidence 999999866 468999999999999999999999 99999999999999999999999999999854221
Q ss_pred CCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCccccCCCCcc
Q 005102 565 PTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGSSEM 644 (714)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~~~~~~~~~ 644 (714)
...+.+.+||+.|||||++.+..|+..+|.||+||++|||++|.+||.. .
T Consensus 179 -------------------------~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~-----~ 228 (357)
T KOG0598|consen 179 -------------------------GDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYA-----E 228 (357)
T ss_pred -------------------------CCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcC-----c
Confidence 2334457899999999999999999999999999999999999999943 3
Q ss_pred hhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCC
Q 005102 645 DLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRP 697 (714)
Q Consensus 645 ~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RP 697 (714)
+..++.....+.+.... +.. ...+..+++.+.+..||++|.
T Consensus 229 ~~~~~~~~I~~~k~~~~---p~~---------ls~~ardll~~LL~rdp~~RL 269 (357)
T KOG0598|consen 229 DVKKMYDKILKGKLPLP---PGY---------LSEEARDLLKKLLKRDPRQRL 269 (357)
T ss_pred cHHHHHHHHhcCcCCCC---Ccc---------CCHHHHHHHHHHhccCHHHhc
Confidence 34445555544441110 010 112577899999999999995
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-44 Score=345.89 Aligned_cols=256 Identities=22% Similarity=0.383 Sum_probs=198.5
Q ss_pred cccccCceEEEEEEECC-CcEEEEEEeCCCCc--hhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCCCH
Q 005102 410 VLGKSGIGIVYKVVLED-GHTLAVRRLGEGGS--QRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGSL 486 (714)
Q Consensus 410 ~lG~G~~g~Vy~~~~~~-g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL 486 (714)
.+|+|+||.|||++.++ |+.||||++..... .-.+-..+|++.|++++|+|+|.++++|......++|+||++. ++
T Consensus 9 kvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~~dh-Tv 87 (396)
T KOG0593|consen 9 KVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEYCDH-TV 87 (396)
T ss_pred ccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeeecch-HH
Confidence 69999999999999876 99999999987533 3345688999999999999999999999999999999999977 55
Q ss_pred hhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCCCC
Q 005102 487 ATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPT 566 (714)
Q Consensus 487 ~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 566 (714)
.+-|...+ ..++...+++|+.|+++|+.|+|+ +++|||||||+||||+.++.+||||||+|+.+...+
T Consensus 88 L~eLe~~p-----~G~~~~~vk~~l~Q~l~ai~~cHk---~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pg---- 155 (396)
T KOG0593|consen 88 LHELERYP-----NGVPSELVKKYLYQLLKAIHFCHK---NNCIHRDIKPENILITQNGVVKLCDFGFARTLSAPG---- 155 (396)
T ss_pred HHHHHhcc-----CCCCHHHHHHHHHHHHHHhhhhhh---cCeecccCChhheEEecCCcEEeccchhhHhhcCCc----
Confidence 55555443 458889999999999999999999 899999999999999999999999999999875321
Q ss_pred ccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCC-CCCCchhhhHHHHHHHHHHHhCCCccccCCCCcch
Q 005102 567 LQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKV-VKPSQKWDIYSYGVILLEMITGRTAVVQVGSSEMD 645 (714)
Q Consensus 567 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DVwS~Gvvl~elltG~~p~~~~~~~~~~ 645 (714)
..-+..+.|++|+|||.+.+ .+|+..+||||+||++.||+||.+.|+ +..+.|
T Consensus 156 ------------------------d~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~P--G~SDiD 209 (396)
T KOG0593|consen 156 ------------------------DNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWP--GRSDID 209 (396)
T ss_pred ------------------------chhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCC--CcchHH
Confidence 12234456999999999987 679999999999999999999998884 334444
Q ss_pred hHHHHHHHH-----------hhcCCcccccCCCCCCCCCc----HHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 005102 646 LVNWMQLCI-----------EEKKPLADVLDPYLAPDADK----EEEIIAVLKIAMACVHSSPEKRPTMRHISD 704 (714)
Q Consensus 646 l~~~~~~~~-----------~~~~~~~~~~d~~~~~~~~~----~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 704 (714)
..-.++..+ ....-+..+.-|......+. .....-+++++..|++.||++|++-+|++.
T Consensus 210 QLy~I~ktLG~L~prhq~iF~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 210 QLYLIRKTLGNLIPRHQSIFSSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred HHHHHHHHHcccCHHHHHHhccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 333332222 11111111111111111110 122335789999999999999999998863
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-43 Score=357.80 Aligned_cols=257 Identities=24% Similarity=0.372 Sum_probs=197.6
Q ss_pred cccccCceEEEEEEE-CCCcEEEEEEeCCCC--chhHHHHHHHHHHHhccCCCCccceEEEEEeC--CceeEEEeccCCC
Q 005102 410 VLGKSGIGIVYKVVL-EDGHTLAVRRLGEGG--SQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSV--DEKLLIYDYIPNG 484 (714)
Q Consensus 410 ~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~~lV~e~~~~g 484 (714)
.||+|+||.||+|+. .+|+.||+|+++... ........+||.||++++||||+++.+...+. ...|||+|||++
T Consensus 124 kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlVFeYMdh- 202 (560)
T KOG0600|consen 124 KIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLVFEYMDH- 202 (560)
T ss_pred HhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEEEecccc-
Confidence 599999999999995 569999999998654 33445678999999999999999999998876 689999999987
Q ss_pred CHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCC
Q 005102 485 SLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGS 564 (714)
Q Consensus 485 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 564 (714)
||.-++.... -.++..+++.|++|++.||+|+|+ ++|+|||||.+|||||.+|.+||+|||+|+++.....
T Consensus 203 DL~GLl~~p~-----vkft~~qIKc~mkQLl~Gl~~cH~---~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~~- 273 (560)
T KOG0600|consen 203 DLSGLLSSPG-----VKFTEPQIKCYMKQLLEGLEYCHS---RGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPSGS- 273 (560)
T ss_pred hhhhhhcCCC-----cccChHHHHHHHHHHHHHHHHHhh---cCeeeccccccceEEcCCCCEEeccccceeeccCCCC-
Confidence 9998887543 469999999999999999999999 9999999999999999999999999999998764321
Q ss_pred CCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCC-CCCchhhhHHHHHHHHHHHhCCCccccCCCCc
Q 005102 565 PTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVV-KPSQKWDIYSYGVILLEMITGRTAVVQVGSSE 643 (714)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DVwS~Gvvl~elltG~~p~~~~~~~~ 643 (714)
...+..+-|.+|+|||.+.|. .|++++|+||.||||.||++|++.|. +..+
T Consensus 274 --------------------------~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~--G~tE 325 (560)
T KOG0600|consen 274 --------------------------APYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQ--GRTE 325 (560)
T ss_pred --------------------------cccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcC--CccH
Confidence 113344558999999999885 59999999999999999999998883 3333
Q ss_pred chhHH-HHHHHHh---hcCC---cc--cccCCCCCCCCCcH----HHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 005102 644 MDLVN-WMQLCIE---EKKP---LA--DVLDPYLAPDADKE----EEIIAVLKIAMACVHSSPEKRPTMRHISD 704 (714)
Q Consensus 644 ~~l~~-~~~~~~~---~~~~---~~--~~~d~~~~~~~~~~----~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 704 (714)
.+... .++.|-. +.++ +. ..+.+...-..... .-....++|+..+|..||++|.|+.++++
T Consensus 326 veQl~kIfklcGSP~e~~W~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~ 399 (560)
T KOG0600|consen 326 VEQLHKIFKLCGSPTEDYWPVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ 399 (560)
T ss_pred HHHHHHHHHHhCCCChhccccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence 33222 2221110 0111 00 11111110000001 11235688999999999999999998874
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-43 Score=362.84 Aligned_cols=255 Identities=22% Similarity=0.294 Sum_probs=205.8
Q ss_pred cccccccCceEEEEEEEC-CCcEEEEEEeCCC---CchhHHHHHHHHHHHhcc-CCCCccceEEEEEeCCceeEEEeccC
Q 005102 408 AFVLGKSGIGIVYKVVLE-DGHTLAVRRLGEG---GSQRFKEFQTEVEAIGKI-RHSNIVTLRAYYWSVDEKLLIYDYIP 482 (714)
Q Consensus 408 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~e~~~ 482 (714)
++.||+|+|++||+|+.. +++.+|||++.+. .+...+...+|-++|.+| .||.|++++-.|.+...+|+|+||++
T Consensus 78 g~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFvLe~A~ 157 (604)
T KOG0592|consen 78 GKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYFVLEYAP 157 (604)
T ss_pred hheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEEEEEecC
Confidence 458999999999999965 4899999999774 333446788899999999 89999999999999999999999999
Q ss_pred CCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccC
Q 005102 483 NGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAG 562 (714)
Q Consensus 483 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 562 (714)
+|+|.++|+.. ..+++...+.++.+|+.||+|||+ +|||||||||+|||+|+||++||+|||.|+.+....
T Consensus 158 nGdll~~i~K~------Gsfde~caR~YAAeIldAleylH~---~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~~ 228 (604)
T KOG0592|consen 158 NGDLLDLIKKY------GSFDETCARFYAAEILDALEYLHS---NGIIHRDLKPENILLDKDGHIKITDFGSAKILSPSQ 228 (604)
T ss_pred CCcHHHHHHHh------CcchHHHHHHHHHHHHHHHHHHHh---cCceeccCChhheeEcCCCcEEEeeccccccCChhh
Confidence 99999999876 568999999999999999999999 999999999999999999999999999999987543
Q ss_pred CCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCccccCCCC
Q 005102 563 GSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGSS 642 (714)
Q Consensus 563 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~~~~~~~ 642 (714)
.....+... ........+++||..|.+||++.+...++.+|+|+||||+|+|+.|++||... +
T Consensus 229 ~~~~~~~~~---------------~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~--N 291 (604)
T KOG0592|consen 229 KSQENPVDP---------------NQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAA--N 291 (604)
T ss_pred ccccCccCc---------------ccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccc--c
Confidence 322111000 00122236789999999999999999999999999999999999999999432 1
Q ss_pred cchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 005102 643 EMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISD 704 (714)
Q Consensus 643 ~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 704 (714)
+ ....+.++.-...+ .+.+. ..+.+|+.+.|..||.+|+|.++|.+
T Consensus 292 e---yliFqkI~~l~y~f--------p~~fp-----~~a~dLv~KLLv~dp~~Rlt~~qIk~ 337 (604)
T KOG0592|consen 292 E---YLIFQKIQALDYEF--------PEGFP-----EDARDLIKKLLVRDPSDRLTSQQIKA 337 (604)
T ss_pred H---HHHHHHHHHhcccC--------CCCCC-----HHHHHHHHHHHccCccccccHHHHhh
Confidence 1 12233333332222 22222 25779999999999999999987754
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=353.09 Aligned_cols=250 Identities=28% Similarity=0.428 Sum_probs=198.1
Q ss_pred cccccccCceEEEEEEECC-CcEEEEEEeCCCCchhHHHHHHHHHHHhccCCCCccceEEEEEeCC--ceeEEEeccCCC
Q 005102 408 AFVLGKSGIGIVYKVVLED-GHTLAVRRLGEGGSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVD--EKLLIYDYIPNG 484 (714)
Q Consensus 408 ~~~lG~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~--~~~lV~e~~~~g 484 (714)
.+.||+|+||.||++...+ |...|||.+........+.+.+|+.+|.+++|||||+.+|.....+ ..++.|||+++|
T Consensus 22 ~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy~~~G 101 (313)
T KOG0198|consen 22 GKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEYAPGG 101 (313)
T ss_pred hccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeeeccCCC
Confidence 4689999999999999865 8999999998764444677899999999999999999999866555 588999999999
Q ss_pred CHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCC-CCCeEEcccchhhhhhccCC
Q 005102 485 SLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGH-NMEPHVSDFGLARLANIAGG 563 (714)
Q Consensus 485 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~-~~~~kl~DFGla~~~~~~~~ 563 (714)
+|.+++....+ .+++..++++..||++||+|||+ ++||||||||+|||++. ++.+||+|||+++.......
T Consensus 102 sL~~~~~~~g~-----~l~E~~v~~ytr~iL~GL~ylHs---~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~ 173 (313)
T KOG0198|consen 102 SLSDLIKRYGG-----KLPEPLVRRYTRQILEGLAYLHS---KGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGT 173 (313)
T ss_pred cHHHHHHHcCC-----CCCHHHHHHHHHHHHHHHHHHHh---CCEeccCcccceEEEeCCCCeEEeccCccccccccccc
Confidence 99999987642 58999999999999999999999 99999999999999999 79999999999986542000
Q ss_pred CCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCC-CCCchhhhHHHHHHHHHHHhCCCccccCCCC
Q 005102 564 SPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVV-KPSQKWDIYSYGVILLEMITGRTAVVQVGSS 642 (714)
Q Consensus 564 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DVwS~Gvvl~elltG~~p~~~~~~~ 642 (714)
.........||+.|||||++..+ ....++||||+||++.||+||+.||...
T Consensus 174 -------------------------~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~--- 225 (313)
T KOG0198|consen 174 -------------------------KSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF--- 225 (313)
T ss_pred -------------------------cccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh---
Confidence 01123346789999999999853 3445999999999999999999999542
Q ss_pred cchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 005102 643 EMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDA 705 (714)
Q Consensus 643 ~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 705 (714)
.+...++-...... ..|.++.. ......+++.+|++.||++||||+++++.
T Consensus 226 -~~~~~~~~~ig~~~------~~P~ip~~-----ls~~a~~Fl~~C~~~~p~~Rpta~eLL~h 276 (313)
T KOG0198|consen 226 -FEEAEALLLIGRED------SLPEIPDS-----LSDEAKDFLRKCFKRDPEKRPTAEELLEH 276 (313)
T ss_pred -cchHHHHHHHhccC------CCCCCCcc-----cCHHHHHHHHHHhhcCcccCcCHHHHhhC
Confidence 12222222222222 11222222 22357789999999999999999999864
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-42 Score=354.34 Aligned_cols=261 Identities=18% Similarity=0.278 Sum_probs=208.1
Q ss_pred CccccCHHHHHHhccccccccCceEEEEEEECCCcEEEEEEeCCCCchh---HHHHHHHHHHHhccCCCCccceEEEEEe
Q 005102 394 TQVAFDLDELLKASAFVLGKSGIGIVYKVVLEDGHTLAVRRLGEGGSQR---FKEFQTEVEAIGKIRHSNIVTLRAYYWS 470 (714)
Q Consensus 394 ~~~~~~~~~l~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~H~niv~l~~~~~~ 470 (714)
..+.++.+++.......||+|+++.||+|.+ +|+.||||+++...... .+.|.+|+++|++++||||++++|++.+
T Consensus 11 ~~~~i~~~~i~~~~~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~ 89 (283)
T PHA02988 11 DIKCIESDDIDKYTSVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIID 89 (283)
T ss_pred cceecCHHHcCCCCCeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEe
Confidence 3445677777666667899999999999999 68999999998653322 4678899999999999999999999877
Q ss_pred ----CCceeEEEeccCCCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCC
Q 005102 471 ----VDEKLLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNME 546 (714)
Q Consensus 471 ----~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~ 546 (714)
....++||||+++|+|.+++... ..+++..+.+++.|++.||.|||+. .+++||||||+||++++++.
T Consensus 90 ~~~~~~~~~lv~Ey~~~g~L~~~l~~~------~~~~~~~~~~i~~~i~~~l~~lH~~--~~~~Hrdlkp~nill~~~~~ 161 (283)
T PHA02988 90 IVDDLPRLSLILEYCTRGYLREVLDKE------KDLSFKTKLDMAIDCCKGLYNLYKY--TNKPYKNLTSVSFLVTENYK 161 (283)
T ss_pred cccCCCceEEEEEeCCCCcHHHHHhhC------CCCChhHHHHHHHHHHHHHHHHHhc--CCCCCCcCChhhEEECCCCc
Confidence 34678999999999999999765 4588999999999999999999972 37889999999999999999
Q ss_pred eEEcccchhhhhhccCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCC--CCCCchhhhHHHHH
Q 005102 547 PHVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKV--VKPSQKWDIYSYGV 624 (714)
Q Consensus 547 ~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~~~DVwS~Gv 624 (714)
+||+|||+++..... .....|+..|+|||++.+ ..++.++|||||||
T Consensus 162 ~kl~dfg~~~~~~~~-------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGv 210 (283)
T PHA02988 162 LKIICHGLEKILSSP-------------------------------PFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGV 210 (283)
T ss_pred EEEcccchHhhhccc-------------------------------cccccCcccccCHHHhhhccccccchhhhhHHHH
Confidence 999999999864311 112235778999999976 67999999999999
Q ss_pred HHHHHHhCCCccccCCCCcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 005102 625 ILLEMITGRTAVVQVGSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISD 704 (714)
Q Consensus 625 vl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 704 (714)
++|||++|+.||.... ..+........... +.... .....+.+++.+||+.||++|||++|+++
T Consensus 211 il~el~~g~~Pf~~~~-----~~~~~~~i~~~~~~------~~~~~-----~~~~~l~~li~~cl~~dp~~Rps~~ell~ 274 (283)
T PHA02988 211 VLWEIFTGKIPFENLT-----TKEIYDLIINKNNS------LKLPL-----DCPLEIKCIVEACTSHDSIKRPNIKEILY 274 (283)
T ss_pred HHHHHHHCCCCCCCCC-----HHHHHHHHHhcCCC------CCCCC-----cCcHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence 9999999999995321 12222222222211 11111 12336889999999999999999999999
Q ss_pred HHhhhh
Q 005102 705 ALDRLI 710 (714)
Q Consensus 705 ~L~~i~ 710 (714)
.|+.+.
T Consensus 275 ~l~~~~ 280 (283)
T PHA02988 275 NLSLYK 280 (283)
T ss_pred HHHHHH
Confidence 999875
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-43 Score=356.70 Aligned_cols=256 Identities=24% Similarity=0.318 Sum_probs=197.1
Q ss_pred ccccccCceEEEEEEE-CCCcEEEEEEeCCCCchhH-HHHHHHHHHHhccC-CCCccceEEEEEeCC-ceeEEEeccCCC
Q 005102 409 FVLGKSGIGIVYKVVL-EDGHTLAVRRLGEGGSQRF-KEFQTEVEAIGKIR-HSNIVTLRAYYWSVD-EKLLIYDYIPNG 484 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~-~~~~~E~~~l~~l~-H~niv~l~~~~~~~~-~~~lV~e~~~~g 484 (714)
+.||.|+||.||+|+- .+|..||||++++.-.... -.=.||+..|++++ |||||++.+.+.+.+ ..++|||||+.
T Consensus 16 ~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fVfE~Md~- 94 (538)
T KOG0661|consen 16 RKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFVFEFMDC- 94 (538)
T ss_pred HHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeeeHHhhhh-
Confidence 3699999999999995 4589999999987533321 12368999999998 999999999999988 89999999965
Q ss_pred CHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCC
Q 005102 485 SLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGS 564 (714)
Q Consensus 485 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 564 (714)
+|++++++++ ..+++..++.|+.||++||+|+|. +|+.|||+||+|||+.....+||+|||+||.+....
T Consensus 95 NLYqLmK~R~-----r~fse~~irnim~QilqGL~hiHk---~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~Skp-- 164 (538)
T KOG0661|consen 95 NLYQLMKDRN-----RLFSESDIRNIMYQILQGLAHIHK---HGFFHRDLKPENILISGNDVIKIADFGLAREVRSKP-- 164 (538)
T ss_pred hHHHHHhhcC-----CcCCHHHHHHHHHHHHHHHHHHHh---cCcccccCChhheEecccceeEecccccccccccCC--
Confidence 9999998874 579999999999999999999999 999999999999999988899999999999764321
Q ss_pred CCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccC-CCCCCchhhhHHHHHHHHHHHhCCCccccCCCCc
Q 005102 565 PTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLK-VVKPSQKWDIYSYGVILLEMITGRTAVVQVGSSE 643 (714)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~s~~~DVwS~Gvvl~elltG~~p~~~~~~~~ 643 (714)
..+..+.|++|+|||++. .+.|+.+.||||+|||++|+.+-++.|. +..+
T Consensus 165 ---------------------------PYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFP--G~sE 215 (538)
T KOG0661|consen 165 ---------------------------PYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFP--GASE 215 (538)
T ss_pred ---------------------------CcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCC--CCcH
Confidence 223345699999999985 4668999999999999999999999884 3333
Q ss_pred chhHHHHHHHHhhc--------CCcccccCCCC---CCCCC---cHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 005102 644 MDLVNWMQLCIEEK--------KPLADVLDPYL---APDAD---KEEEIIAVLKIAMACVHSSPEKRPTMRHISD 704 (714)
Q Consensus 644 ~~l~~~~~~~~~~~--------~~~~~~~d~~~---~~~~~---~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 704 (714)
.|..--+...+... ..+...+.-.+ .+..- ......++.+++.+|+.+||++|||++|+++
T Consensus 216 ~Dqi~KIc~VLGtP~~~~~~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~ 290 (538)
T KOG0661|consen 216 IDQIYKICEVLGTPDKDSWPEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQ 290 (538)
T ss_pred HHHHHHHHHHhCCCccccchhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhc
Confidence 33222121111110 00111111111 11000 0124557889999999999999999999876
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=362.52 Aligned_cols=264 Identities=26% Similarity=0.422 Sum_probs=209.6
Q ss_pred CccccCHHHHHHhccccccccCceEEEEEEECCCcEEEEEEeCCCC--chhHHHHHHHHHHHhccCCCCccceEEEEEeC
Q 005102 394 TQVAFDLDELLKASAFVLGKSGIGIVYKVVLEDGHTLAVRRLGEGG--SQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSV 471 (714)
Q Consensus 394 ~~~~~~~~~l~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~ 471 (714)
..+.+.++|+.. .+.||+|+||+||+|+|. -.||||++.... ....+.|++|+.++++-||.||+-+.|||...
T Consensus 385 ~~WeIp~~ev~l--~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p 460 (678)
T KOG0193|consen 385 EEWEIPPEEVLL--GERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNP 460 (678)
T ss_pred cccccCHHHhhc--cceeccccccceeecccc--cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCC
Confidence 345666777665 468999999999999996 379999998753 34567899999999999999999999999887
Q ss_pred CceeEEEeccCCCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcc
Q 005102 472 DEKLLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSD 551 (714)
Q Consensus 472 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~D 551 (714)
+. .+|+.+|++-+|+.++|..+ .+++..+.+.||.|||+|+.|||. ++|||||||..||+++++++|||+|
T Consensus 461 ~~-AIiTqwCeGsSLY~hlHv~e-----tkfdm~~~idIAqQiaqGM~YLHA---K~IIHrDLKSnNIFl~~~~kVkIgD 531 (678)
T KOG0193|consen 461 PL-AIITQWCEGSSLYTHLHVQE-----TKFDMNTTIDIAQQIAQGMDYLHA---KNIIHRDLKSNNIFLHEDLKVKIGD 531 (678)
T ss_pred ce-eeeehhccCchhhhhccchh-----hhhhHHHHHHHHHHHHHhhhhhhh---hhhhhhhccccceEEccCCcEEEec
Confidence 77 99999999999999999775 569999999999999999999999 9999999999999999999999999
Q ss_pred cchhhhhhccCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCC---CCCCchhhhHHHHHHHHH
Q 005102 552 FGLARLANIAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKV---VKPSQKWDIYSYGVILLE 628 (714)
Q Consensus 552 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~s~~~DVwS~Gvvl~e 628 (714)
||++..-....+ ........|...|||||+++. .+|++.+||||||+|+||
T Consensus 532 FGLatvk~~w~g--------------------------~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YE 585 (678)
T KOG0193|consen 532 FGLATVKTRWSG--------------------------EQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYE 585 (678)
T ss_pred ccceeeeeeecc--------------------------ccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHH
Confidence 999864321110 111122335667999999963 468999999999999999
Q ss_pred HHhCCCccccCCCCcchhHHHHHHHHhhcCCcccccCCCCCCCC--CcHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHH
Q 005102 629 MITGRTAVVQVGSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDA--DKEEEIIAVLKIAMACVHSSPEKRPTMRHISDAL 706 (714)
Q Consensus 629 lltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~--~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L 706 (714)
|+||..||. ....+. .-|+ +-..++.++. ....+.+++.+|+..||..++++||.+.+|+..|
T Consensus 586 Lltg~lPys-i~~~dq--Iifm------------VGrG~l~pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l 650 (678)
T KOG0193|consen 586 LLTGELPYS-IQNRDQ--IIFM------------VGRGYLMPDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKL 650 (678)
T ss_pred HHhCcCCcC-CCChhh--eEEE------------ecccccCccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHH
Confidence 999999995 222111 1111 1111111111 1124556788999999999999999999999999
Q ss_pred hhhhc
Q 005102 707 DRLIV 711 (714)
Q Consensus 707 ~~i~~ 711 (714)
+++..
T Consensus 651 ~~l~~ 655 (678)
T KOG0193|consen 651 EELLP 655 (678)
T ss_pred HHhhh
Confidence 98765
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=377.97 Aligned_cols=255 Identities=28% Similarity=0.474 Sum_probs=212.0
Q ss_pred cccccccCceEEEEEEECC----CcEEEEEEeCCCCc-hhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccC
Q 005102 408 AFVLGKSGIGIVYKVVLED----GHTLAVRRLGEGGS-QRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIP 482 (714)
Q Consensus 408 ~~~lG~G~~g~Vy~~~~~~----g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~ 482 (714)
.++||.|.||+||+|+++- ...||||.++.+.. ..+.+|..|+.||.+++||||+++.|+.......++|.|||+
T Consensus 634 e~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiTEyME 713 (996)
T KOG0196|consen 634 EKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIITEYME 713 (996)
T ss_pred EEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEhhhhh
Confidence 5789999999999999863 46899999998744 445689999999999999999999999999999999999999
Q ss_pred CCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccC
Q 005102 483 NGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAG 562 (714)
Q Consensus 483 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 562 (714)
+|+|..+|+.+.+ ++++.+..-+.++||.|++||-+ .++|||||.++|||++.+..+|++|||++|.+.++.
T Consensus 714 NGsLDsFLR~~DG-----qftviQLVgMLrGIAsGMkYLsd---m~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~ 785 (996)
T KOG0196|consen 714 NGSLDSFLRQNDG-----QFTVIQLVGMLRGIASGMKYLSD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP 785 (996)
T ss_pred CCcHHHHHhhcCC-----ceEeehHHHHHHHHHHHhHHHhh---cCchhhhhhhhheeeccceEEEeccccceeecccCC
Confidence 9999999998864 48999999999999999999999 899999999999999999999999999999875432
Q ss_pred CCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHh-CCCccccCCC
Q 005102 563 GSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMIT-GRTAVVQVGS 641 (714)
Q Consensus 563 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~ellt-G~~p~~~~~~ 641 (714)
.. ..++....-...|.|||.+...++|.++|||||||||||.++ |.+||.+..+
T Consensus 786 ~~-------------------------~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSN 840 (996)
T KOG0196|consen 786 EA-------------------------AYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN 840 (996)
T ss_pred Cc-------------------------cccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccch
Confidence 10 000011111346999999999999999999999999999887 9999977655
Q ss_pred CcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhhhhcc
Q 005102 642 SEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDALDRLIVS 712 (714)
Q Consensus 642 ~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~~ 712 (714)
.+. ...++++..++ + +.+++..+.+||..||++|-.+||++.||+..|.++++.
T Consensus 841 QdV------IkaIe~gyRLP--------p---PmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrn 894 (996)
T KOG0196|consen 841 QDV------IKAIEQGYRLP--------P---PMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRN 894 (996)
T ss_pred HHH------HHHHHhccCCC--------C---CCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcC
Confidence 432 22233333221 1 123566899999999999999999999999999998765
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=358.44 Aligned_cols=248 Identities=29% Similarity=0.388 Sum_probs=202.6
Q ss_pred cccCHHHHHHhccccccccCceEEEEEEECCCcEEEEEEeCCCCchhHHHHHHHHHHHhccCCCCccceEEEEEeCCcee
Q 005102 396 VAFDLDELLKASAFVLGKSGIGIVYKVVLEDGHTLAVRRLGEGGSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKL 475 (714)
Q Consensus 396 ~~~~~~~l~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 475 (714)
+.+.++++.+ -+.||.|+.|.||+|+++ ++.||||+++... ..+|+-|++|+||||+.+.|+|.....+|
T Consensus 119 WeiPFe~IsE--LeWlGSGaQGAVF~Grl~-netVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtqsPcyC 188 (904)
T KOG4721|consen 119 WEIPFEEISE--LEWLGSGAQGAVFLGRLH-NETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQSPCYC 188 (904)
T ss_pred ccCCHHHhhh--hhhhccCcccceeeeecc-CceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecCCceeE
Confidence 3445555544 246999999999999996 7899999987533 35788899999999999999999999999
Q ss_pred EEEeccCCCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchh
Q 005102 476 LIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLA 555 (714)
Q Consensus 476 lV~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla 555 (714)
||||||+.|-|+..|+.. +.++....+.|..+||.|+.|||. +.|||||||+-||||..+..+||+|||-+
T Consensus 189 IiMEfCa~GqL~~VLka~------~~itp~llv~Wsk~IA~GM~YLH~---hKIIHRDLKSPNiLIs~~d~VKIsDFGTS 259 (904)
T KOG4721|consen 189 IIMEFCAQGQLYEVLKAG------RPITPSLLVDWSKGIAGGMNYLHL---HKIIHRDLKSPNILISYDDVVKISDFGTS 259 (904)
T ss_pred EeeeccccccHHHHHhcc------CccCHHHHHHHHHHhhhhhHHHHH---hhHhhhccCCCceEeeccceEEeccccch
Confidence 999999999999999876 568889999999999999999999 89999999999999999999999999999
Q ss_pred hhhhccCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCc
Q 005102 556 RLANIAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTA 635 (714)
Q Consensus 556 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p 635 (714)
+.... ..+...+.||..|||||++...++++|+||||||||||||+||..|
T Consensus 260 ~e~~~-----------------------------~STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiP 310 (904)
T KOG4721|consen 260 KELSD-----------------------------KSTKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIP 310 (904)
T ss_pred Hhhhh-----------------------------hhhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCC
Confidence 86643 1234567789999999999999999999999999999999999999
Q ss_pred cccCCCCcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHh
Q 005102 636 VVQVGSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDALD 707 (714)
Q Consensus 636 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~ 707 (714)
|.+...... ++.-+..... .+-+..+.+.+.-|+++||+..|..||++++++.-|+
T Consensus 311 YkdVdssAI--------IwGVGsNsL~--------LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~Hld 366 (904)
T KOG4721|consen 311 YKDVDSSAI--------IWGVGSNSLH--------LPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLD 366 (904)
T ss_pred ccccchhee--------EEeccCCccc--------ccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHh
Confidence 954322111 0001111111 1111234456778999999999999999999998876
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-42 Score=323.11 Aligned_cols=258 Identities=22% Similarity=0.349 Sum_probs=198.8
Q ss_pred ccccccCceEEEEEEE-CCCcEEEEEEeCCCCchh--HHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCCC
Q 005102 409 FVLGKSGIGIVYKVVL-EDGHTLAVRRLGEGGSQR--FKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGS 485 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gs 485 (714)
+++|+|.||.||+|++ ++|+.||||+++.....+ .....+||+.|+.++|+||+.++++|-..+..-+|+|||+. |
T Consensus 8 ~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfEfm~t-d 86 (318)
T KOG0659|consen 8 EKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFEFMPT-D 86 (318)
T ss_pred hhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEEeccc-c
Confidence 4799999999999996 469999999998764331 24678999999999999999999999999999999999976 9
Q ss_pred HhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCCC
Q 005102 486 LATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSP 565 (714)
Q Consensus 486 L~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 565 (714)
|+..+++.. ..++..+++.++.++++||+|+|+ +.|+||||||.|+|++++|.+||+|||+|+.+.....
T Consensus 87 Le~vIkd~~-----i~l~pa~iK~y~~m~LkGl~y~H~---~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~-- 156 (318)
T KOG0659|consen 87 LEVVIKDKN-----IILSPADIKSYMLMTLKGLAYCHS---KWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNR-- 156 (318)
T ss_pred HHHHhcccc-----cccCHHHHHHHHHHHHHHHHHHHh---hhhhcccCCccceEEcCCCcEEeecccchhccCCCCc--
Confidence 999998765 568999999999999999999999 9999999999999999999999999999998754321
Q ss_pred CccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCC-CCchhhhHHHHHHHHHHHhCCCccccCCCCcc
Q 005102 566 TLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVK-PSQKWDIYSYGVILLEMITGRTAVVQVGSSEM 644 (714)
Q Consensus 566 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s~~~DVwS~Gvvl~elltG~~p~~~~~~~~~ 644 (714)
.....+-|++|+|||.+.|.+ |+..+||||.|||+.||+-|.+-|. +..+.
T Consensus 157 --------------------------~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fp--G~sDi 208 (318)
T KOG0659|consen 157 --------------------------IQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFP--GDSDI 208 (318)
T ss_pred --------------------------ccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCC--CCchH
Confidence 111224589999999998764 8999999999999999998876552 33333
Q ss_pred hhHHHHHHHHhhc----C----CcccccCCCCCCCC----CcHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 005102 645 DLVNWMQLCIEEK----K----PLADVLDPYLAPDA----DKEEEIIAVLKIAMACVHSSPEKRPTMRHISDA 705 (714)
Q Consensus 645 ~l~~~~~~~~~~~----~----~~~~~~d~~~~~~~----~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 705 (714)
+....+-..+... + .+.+.+.-...+.. -........++++..++..||.+|+|++|+++.
T Consensus 209 dQL~~If~~LGTP~~~~WP~~~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 209 DQLSKIFRALGTPTPDQWPEMTSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred HHHHHHHHHcCCCCcccCccccccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 3333222222111 1 01111110000000 011233456899999999999999999998763
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=361.40 Aligned_cols=242 Identities=23% Similarity=0.358 Sum_probs=204.2
Q ss_pred cccccCceEEEEEEE-CCCcEEEEEEeCCCCchhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCCCHhh
Q 005102 410 VLGKSGIGIVYKVVL-EDGHTLAVRRLGEGGSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGSLAT 488 (714)
Q Consensus 410 ~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL~~ 488 (714)
.||+|..|.||.+.. .+++.||||++........+-..+|+.+|+..+|+|||.+++.|...++.++|||||++|+|.+
T Consensus 280 kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym~ggsLTD 359 (550)
T KOG0578|consen 280 KIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYMEGGSLTD 359 (550)
T ss_pred hhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeecCCCchhh
Confidence 699999999999985 4589999999988777776778999999999999999999999999999999999999999999
Q ss_pred hhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCCCCcc
Q 005102 489 ALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQ 568 (714)
Q Consensus 489 ~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 568 (714)
.+... .+++.++..|++++++||+|||. ++|+|||||.+|||++.++.+||+|||++..+...
T Consensus 360 vVt~~-------~~~E~qIA~Icre~l~aL~fLH~---~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~------- 422 (550)
T KOG0578|consen 360 VVTKT-------RMTEGQIAAICREILQGLKFLHA---RGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEE------- 422 (550)
T ss_pred hhhcc-------cccHHHHHHHHHHHHHHHHHHHh---cceeeeccccceeEeccCCcEEEeeeeeeeccccc-------
Confidence 98654 48999999999999999999999 99999999999999999999999999999876532
Q ss_pred CCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCccccCCCCcchhHH
Q 005102 569 SNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGSSEMDLVN 648 (714)
Q Consensus 569 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~~~~~~~~~~l~~ 648 (714)
.....+.+||++|||||+.....|++|+||||||++++||+-|.+||... ..+.
T Consensus 423 ---------------------~~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE----~Plr- 476 (550)
T KOG0578|consen 423 ---------------------QSKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNE----NPLR- 476 (550)
T ss_pred ---------------------cCccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCC----ChHH-
Confidence 22445678999999999999999999999999999999999999999531 1121
Q ss_pred HHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 005102 649 WMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISD 704 (714)
Q Consensus 649 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 704 (714)
.+......+. |.+.. .+.....+.+|+.+||..|+++||++.|+++
T Consensus 477 AlyLIa~ng~-------P~lk~---~~klS~~~kdFL~~cL~~dv~~RasA~eLL~ 522 (550)
T KOG0578|consen 477 ALYLIATNGT-------PKLKN---PEKLSPELKDFLDRCLVVDVEQRASAKELLE 522 (550)
T ss_pred HHHHHhhcCC-------CCcCC---ccccCHHHHHHHHHHhhcchhcCCCHHHHhc
Confidence 1222222221 22211 1233457889999999999999999999985
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=342.31 Aligned_cols=257 Identities=21% Similarity=0.317 Sum_probs=202.5
Q ss_pred ccccccCceEEEEEEE-CCCcEEEEEEeCCCC-chhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCCCH
Q 005102 409 FVLGKSGIGIVYKVVL-EDGHTLAVRRLGEGG-SQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGSL 486 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL 486 (714)
++||.|..+.||+|+. +.+..||||++.... ....+.+.+|+..|+.++||||++++..|..+...|+||.||.+|++
T Consensus 32 e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmpfMa~GS~ 111 (516)
T KOG0582|consen 32 EVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMPFMAGGSL 111 (516)
T ss_pred EEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeehhhcCCcH
Confidence 4899999999999995 468999999998653 23357899999999999999999999999999999999999999999
Q ss_pred hhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCCCC
Q 005102 487 ATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPT 566 (714)
Q Consensus 487 ~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 566 (714)
.++++..-. ..+++..+..|.+++++||.|||. +|.||||||+.||||+++|.+||+|||.+..+...+.
T Consensus 112 ldIik~~~~----~Gl~E~~Ia~iLre~LkaL~YLH~---~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~--- 181 (516)
T KOG0582|consen 112 LDIIKTYYP----DGLEEASIATILREVLKALDYLHQ---NGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGD--- 181 (516)
T ss_pred HHHHHHHcc----ccccHHHHHHHHHHHHHHHHHHHh---cCceecccccccEEEcCCCcEEEcCceeeeeecccCc---
Confidence 999976533 348899999999999999999999 9999999999999999999999999998776544321
Q ss_pred ccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCC--CCCCchhhhHHHHHHHHHHHhCCCccccCCCCcc
Q 005102 567 LQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKV--VKPSQKWDIYSYGVILLEMITGRTAVVQVGSSEM 644 (714)
Q Consensus 567 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~~~DVwS~Gvvl~elltG~~p~~~~~~~~~ 644 (714)
+. .......+||++|||||++.. ..|+.|+|||||||+..||++|..||......
T Consensus 182 ----R~-----------------~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPm-- 238 (516)
T KOG0582|consen 182 ----RQ-----------------VTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPM-- 238 (516)
T ss_pred ----ee-----------------eEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChH--
Confidence 00 111256788999999999643 45999999999999999999999999543322
Q ss_pred hhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 005102 645 DLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISD 704 (714)
Q Consensus 645 ~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 704 (714)
+.+...+....+... .... +........+.+.+++..||++||++|||++++++
T Consensus 239 ---kvLl~tLqn~pp~~~--t~~~-~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk 292 (516)
T KOG0582|consen 239 ---KVLLLTLQNDPPTLL--TSGL-DKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK 292 (516)
T ss_pred ---HHHHHHhcCCCCCcc--cccC-ChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 222222333222111 0011 11111233447889999999999999999999875
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-42 Score=355.10 Aligned_cols=240 Identities=23% Similarity=0.354 Sum_probs=204.6
Q ss_pred ccccccCceEEEEEEECC-CcEEEEEEeCCCC--chhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCCC
Q 005102 409 FVLGKSGIGIVYKVVLED-GHTLAVRRLGEGG--SQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGS 485 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~~-g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gs 485 (714)
+.||+|+||.||||+.+. .+.||+|.+.+.. ..+.+...+|++++++++|||||.+++.|++..+.++|.||+.+ +
T Consensus 8 e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte~a~g-~ 86 (808)
T KOG0597|consen 8 EMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTEYAVG-D 86 (808)
T ss_pred HHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEehhhhh-h
Confidence 369999999999999764 7899999998754 34467799999999999999999999999999999999999976 9
Q ss_pred HhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCCC
Q 005102 486 LATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSP 565 (714)
Q Consensus 486 L~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 565 (714)
|..+|... ..++++.+..|+.|+..||.|||+ .+|+|||+||.|||++..+++|++|||+|+.+...
T Consensus 87 L~~il~~d------~~lpEe~v~~~a~~LVsaL~yLhs---~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~---- 153 (808)
T KOG0597|consen 87 LFTILEQD------GKLPEEQVRAIAYDLVSALYYLHS---NRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTN---- 153 (808)
T ss_pred HHHHHHhc------cCCCHHHHHHHHHHHHHHHHHHHh---cCcccccCCcceeeecCCCceeechhhhhhhcccC----
Confidence 99999877 569999999999999999999999 99999999999999999999999999999976431
Q ss_pred CccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCccccCCCCcch
Q 005102 566 TLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGSSEMD 645 (714)
Q Consensus 566 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~~~~~~~~~~ 645 (714)
+...+...||+.|||||...+++|+..+|.||+|||+|||.+|++||.. ..
T Consensus 154 ------------------------t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a-----~s 204 (808)
T KOG0597|consen 154 ------------------------TSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYA-----RS 204 (808)
T ss_pred ------------------------ceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchH-----HH
Confidence 2334566789999999999999999999999999999999999999953 23
Q ss_pred hHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 005102 646 LVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISD 704 (714)
Q Consensus 646 l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 704 (714)
+.+.++.+..+..... ......+..++...+.+||.+|.|..+++.
T Consensus 205 i~~Lv~~I~~d~v~~p-------------~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~ 250 (808)
T KOG0597|consen 205 ITQLVKSILKDPVKPP-------------STASSSFVNFLQGLLIKDPAQRLTWTDLLG 250 (808)
T ss_pred HHHHHHHHhcCCCCCc-------------ccccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence 4445555444432111 123346888999999999999999988763
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-42 Score=385.11 Aligned_cols=259 Identities=27% Similarity=0.377 Sum_probs=207.1
Q ss_pred cccccccCceEEEEEEECC--Cc----EEEEEEeCCC-CchhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEec
Q 005102 408 AFVLGKSGIGIVYKVVLED--GH----TLAVRRLGEG-GSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDY 480 (714)
Q Consensus 408 ~~~lG~G~~g~Vy~~~~~~--g~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~ 480 (714)
...||+|.||.||+|.+.+ |. .||||.+++. +.+...+|.+|..+|++++|||||+++|+|.+....++++||
T Consensus 697 ~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~i~ley 776 (1025)
T KOG1095|consen 697 LRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPLILLEY 776 (1025)
T ss_pred eeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcEEEehh
Confidence 4689999999999999764 43 4999999876 456678899999999999999999999999999999999999
Q ss_pred cCCCCHhhhhhCCCCC-CCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhh
Q 005102 481 IPNGSLATALHGKPGM-VSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLAN 559 (714)
Q Consensus 481 ~~~gsL~~~l~~~~~~-~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~ 559 (714)
|++|||..+|++.+.. .....++..+.+.++.|||+|+.||++ +++|||||.++|+|+++...+||+|||+|+.+.
T Consensus 777 M~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~---~~fvHRDLAaRNCLL~~~r~VKIaDFGlArDiy 853 (1025)
T KOG1095|consen 777 MEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLES---KHFVHRDLAARNCLLDERRVVKIADFGLARDIY 853 (1025)
T ss_pred cccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHh---CCCcCcchhhhheeecccCcEEEcccchhHhhh
Confidence 9999999999876321 112468899999999999999999999 999999999999999999999999999999543
Q ss_pred ccCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHh-CCCcccc
Q 005102 560 IAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMIT-GRTAVVQ 638 (714)
Q Consensus 560 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~ellt-G~~p~~~ 638 (714)
..+... .... ..-...|||||.+.++.++.|+|||||||++||++| |..||..
T Consensus 854 ~~~yyr-~~~~-------------------------a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~ 907 (1025)
T KOG1095|consen 854 DKDYYR-KHGE-------------------------AMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPS 907 (1025)
T ss_pred hchhee-ccCc-------------------------cccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCC
Confidence 322111 0000 000234999999999999999999999999999999 8899954
Q ss_pred CCCCcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhhhhcc
Q 005102 639 VGSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDALDRLIVS 712 (714)
Q Consensus 639 ~~~~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~~ 712 (714)
..+.+ + +....+.+ . +-.|. .+...++++|..||+.+|++||++..++++++.+...
T Consensus 908 ~~n~~--v---~~~~~~gg-R---L~~P~--------~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~ 964 (1025)
T KOG1095|consen 908 RSNFE--V---LLDVLEGG-R---LDPPS--------YCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNA 964 (1025)
T ss_pred cchHH--H---HHHHHhCC-c---cCCCC--------CCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhh
Confidence 43322 2 22122222 1 11122 2344789999999999999999999999999988653
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=324.30 Aligned_cols=239 Identities=21% Similarity=0.309 Sum_probs=200.1
Q ss_pred cCHHHHHHhccccccccCceEEEEEEEC-CCcEEEEEEeCCCCchhH---HHHHHHHHHHhccCCCCccceEEEEEeCCc
Q 005102 398 FDLDELLKASAFVLGKSGIGIVYKVVLE-DGHTLAVRRLGEGGSQRF---KEFQTEVEAIGKIRHSNIVTLRAYYWSVDE 473 (714)
Q Consensus 398 ~~~~~l~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~---~~~~~E~~~l~~l~H~niv~l~~~~~~~~~ 473 (714)
+.+++... -..||.|+||+|..++.+ +|..+|+|++.+..-.+. +...+|..+|+.+.||.++++++.|.+.+.
T Consensus 41 ~~l~dfe~--~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~ 118 (355)
T KOG0616|consen 41 YSLQDFER--LKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSN 118 (355)
T ss_pred cchhhhhh--eeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCe
Confidence 44454433 347999999999999976 489999999988754443 456789999999999999999999999999
Q ss_pred eeEEEeccCCCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccc
Q 005102 474 KLLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFG 553 (714)
Q Consensus 474 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFG 553 (714)
.||||||+++|.|+.+++.. ++++++.++-+|.||+.||+|||+ .+|++|||||+|||+|.+|.+||+|||
T Consensus 119 lymvmeyv~GGElFS~Lrk~------~rF~e~~arFYAAeivlAleylH~---~~iiYRDLKPENiLlD~~G~iKitDFG 189 (355)
T KOG0616|consen 119 LYMVMEYVPGGELFSYLRKS------GRFSEPHARFYAAEIVLALEYLHS---LDIIYRDLKPENLLLDQNGHIKITDFG 189 (355)
T ss_pred EEEEEeccCCccHHHHHHhc------CCCCchhHHHHHHHHHHHHHHHHh---cCeeeccCChHHeeeccCCcEEEEecc
Confidence 99999999999999999876 569999999999999999999999 999999999999999999999999999
Q ss_pred hhhhhhccCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCC
Q 005102 554 LARLANIAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGR 633 (714)
Q Consensus 554 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~ 633 (714)
+|+.+. ..+.+.+||+.|+|||.++...++.++|.|||||++|||+.|.
T Consensus 190 FAK~v~-------------------------------~rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~ 238 (355)
T KOG0616|consen 190 FAKRVS-------------------------------GRTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGY 238 (355)
T ss_pred ceEEec-------------------------------CcEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCC
Confidence 998653 2355678999999999999999999999999999999999999
Q ss_pred CccccCCCCcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCC
Q 005102 634 TAVVQVGSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKR 696 (714)
Q Consensus 634 ~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~R 696 (714)
+||..... ....+.+...+-.++..+.+ .+.+++...++.|-.+|
T Consensus 239 pPF~~~~~-----~~iY~KI~~~~v~fP~~fs~-------------~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 239 PPFYDDNP-----IQIYEKILEGKVKFPSYFSS-------------DAKDLLKKLLQVDLTKR 283 (355)
T ss_pred CCCcCCCh-----HHHHHHHHhCcccCCcccCH-------------HHHHHHHHHHhhhhHhh
Confidence 99964432 33344444444433333322 46688888888888888
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-41 Score=357.86 Aligned_cols=259 Identities=26% Similarity=0.392 Sum_probs=198.5
Q ss_pred cccccccCceEEEEEEE------CCCcEEEEEEeCCCCc-hhHHHHHHHHHHHhcc-CCCCccceEEEEEeCC-ceeEEE
Q 005102 408 AFVLGKSGIGIVYKVVL------EDGHTLAVRRLGEGGS-QRFKEFQTEVEAIGKI-RHSNIVTLRAYYWSVD-EKLLIY 478 (714)
Q Consensus 408 ~~~lG~G~~g~Vy~~~~------~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~-~~~lV~ 478 (714)
.+.||+|+||.||+|.+ .+++.||||++..... ...+.+.+|++++.++ +||||++++++|...+ ..++||
T Consensus 12 ~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~lv~ 91 (338)
T cd05102 12 GKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNGPLMVIV 91 (338)
T ss_pred eeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCCceEEEE
Confidence 35799999999999974 2357899999976432 3346789999999999 8999999999987644 578999
Q ss_pred eccCCCCHhhhhhCCCCCC--------------------------------------------------------CcCCC
Q 005102 479 DYIPNGSLATALHGKPGMV--------------------------------------------------------SFTPV 502 (714)
Q Consensus 479 e~~~~gsL~~~l~~~~~~~--------------------------------------------------------~~~~l 502 (714)
||+++|+|.+++....... ....+
T Consensus 92 ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 171 (338)
T cd05102 92 EFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPL 171 (338)
T ss_pred ecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccccccCCC
Confidence 9999999999987532100 01358
Q ss_pred CHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCCCCccCCCCCCCCchhhhc
Q 005102 503 PWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQ 582 (714)
Q Consensus 503 ~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~ 582 (714)
++.++.+++.||++||+|||+ ++|+||||||+|||+++++.+||+|||+++.......
T Consensus 172 ~~~~~~~~~~qi~~aL~~LH~---~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~------------------- 229 (338)
T cd05102 172 TMEDLICYSFQVARGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPD------------------- 229 (338)
T ss_pred CHHHHHHHHHHHHHHHHHHHH---CCEECCCCccceEEEcCCCcEEEeecccccccccCcc-------------------
Confidence 889999999999999999999 8999999999999999999999999999975432110
Q ss_pred ccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHh-CCCccccCCCCcchhHHHHHHHHhhcCCcc
Q 005102 583 KSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMIT-GRTAVVQVGSSEMDLVNWMQLCIEEKKPLA 661 (714)
Q Consensus 583 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~ 661 (714)
........++..|+|||++.+..++.++|||||||++|||++ |+.||......+ .+.. .......
T Consensus 230 -------~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~----~~~~-~~~~~~~-- 295 (338)
T cd05102 230 -------YVRKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE----EFCQ-RLKDGTR-- 295 (338)
T ss_pred -------hhcccCCCCCccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccH----HHHH-HHhcCCC--
Confidence 001122334677999999998899999999999999999997 999995332211 1111 1111111
Q ss_pred cccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhhhhc
Q 005102 662 DVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDALDRLIV 711 (714)
Q Consensus 662 ~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~ 711 (714)
+.... .....+.+++.+||+.||++|||+.|+++.|+++..
T Consensus 296 ----~~~~~-----~~~~~l~~li~~cl~~dp~~RPs~~el~~~l~~~~~ 336 (338)
T cd05102 296 ----MRAPE-----NATPEIYRIMLACWQGDPKERPTFSALVEILGDLLQ 336 (338)
T ss_pred ----CCCCC-----CCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 11111 122368899999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=352.62 Aligned_cols=241 Identities=23% Similarity=0.306 Sum_probs=198.9
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeCCC----Cc-hhHHHHHHHHHHHhccC-CCCccceEEEEEeCCceeEEEecc
Q 005102 409 FVLGKSGIGIVYKVVLE-DGHTLAVRRLGEG----GS-QRFKEFQTEVEAIGKIR-HSNIVTLRAYYWSVDEKLLIYDYI 481 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~----~~-~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lV~e~~ 481 (714)
..||+|+||+||.|++. ++..||+|++... .. ...+.+.+|+.++++++ ||||+++++++......++||||+
T Consensus 23 ~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~~~ivmEy~ 102 (370)
T KOG0583|consen 23 RTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTKIYIVMEYC 102 (370)
T ss_pred eeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCeEEEEEEec
Confidence 47999999999999864 5899999977653 12 23456778999999998 999999999999999999999999
Q ss_pred CCCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCC-CCeEEcccchhhhhhc
Q 005102 482 PNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHN-MEPHVSDFGLARLANI 560 (714)
Q Consensus 482 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~-~~~kl~DFGla~~~~~ 560 (714)
.+|+|.+++... .++.+..+.+++.|++.|++|+|+ ++|+||||||+|||+|.+ +++||+|||++.....
T Consensus 103 ~gGdL~~~i~~~------g~l~E~~ar~~F~Qlisav~y~H~---~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~~ 173 (370)
T KOG0583|consen 103 SGGDLFDYIVNK------GRLKEDEARKYFRQLISAVAYCHS---RGIVHRDLKPENILLDGNEGNLKLSDFGLSAISPG 173 (370)
T ss_pred CCccHHHHHHHc------CCCChHHHHHHHHHHHHHHHHHHh---CCEeeCCCCHHHEEecCCCCCEEEeccccccccCC
Confidence 999999999874 468889999999999999999999 999999999999999999 9999999999986531
Q ss_pred cCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCC-CC-chhhhHHHHHHHHHHHhCCCcccc
Q 005102 561 AGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVK-PS-QKWDIYSYGVILLEMITGRTAVVQ 638 (714)
Q Consensus 561 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s-~~~DVwS~Gvvl~elltG~~p~~~ 638 (714)
. .....+..||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||.+
T Consensus 174 ~----------------------------~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d 225 (370)
T KOG0583|consen 174 E----------------------------DGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDD 225 (370)
T ss_pred C----------------------------CCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCC
Confidence 0 12345667899999999999877 75 789999999999999999999954
Q ss_pred CCCCcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHH
Q 005102 639 VGSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHIS 703 (714)
Q Consensus 639 ~~~~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl 703 (714)
................+...++ ..++..++.+|+..||.+|+|+.+++
T Consensus 226 -----~~~~~l~~ki~~~~~~~p~~~~------------S~~~~~Li~~mL~~~P~~R~t~~~i~ 273 (370)
T KOG0583|consen 226 -----SNVPNLYRKIRKGEFKIPSYLL------------SPEARSLIEKMLVPDPSTRITLLEIL 273 (370)
T ss_pred -----ccHHHHHHHHhcCCccCCCCcC------------CHHHHHHHHHHcCCCcccCCCHHHHh
Confidence 2223333333333332222221 23678999999999999999999998
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-41 Score=345.85 Aligned_cols=263 Identities=22% Similarity=0.312 Sum_probs=199.3
Q ss_pred cccccCceEEEEEEECC-CcEEEEEEeCCCCc---hhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCCC
Q 005102 410 VLGKSGIGIVYKVVLED-GHTLAVRRLGEGGS---QRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGS 485 (714)
Q Consensus 410 ~lG~G~~g~Vy~~~~~~-g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gs 485 (714)
+||+|+||+||.|+.++ |+.+|+|++++... ...+....|-++|...++|+||+++..|++.+.+||||||++|||
T Consensus 148 ~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLiMEylPGGD 227 (550)
T KOG0605|consen 148 VIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLIMEYLPGGD 227 (550)
T ss_pred eeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEEEEecCCcc
Confidence 79999999999999765 99999999998643 334567889999999999999999999999999999999999999
Q ss_pred HhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCCC
Q 005102 486 LATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSP 565 (714)
Q Consensus 486 L~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 565 (714)
+..+|... ..|++..++.++.+++-|++.+|. .|+|||||||+|+|||..|++||+||||+.-+.......
T Consensus 228 ~mTLL~~~------~~L~e~~arfYiaE~vlAI~~iH~---~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~~~ 298 (550)
T KOG0605|consen 228 MMTLLMRK------DTLTEDWARFYIAETVLAIESIHQ---LGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHRIE 298 (550)
T ss_pred HHHHHHhc------CcCchHHHHHHHHHHHHHHHHHHH---cCcccccCChhheeecCCCCEeeccccccchhhhhhhhh
Confidence 99999876 468999999999999999999999 999999999999999999999999999997554321110
Q ss_pred C------ccCCC---CCCCCc----------hhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHH
Q 005102 566 T------LQSNR---MPAEKP----------QERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVIL 626 (714)
Q Consensus 566 ~------~~~~~---~~~~~~----------~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl 626 (714)
. ..... .+...+ ...+..++...-.......+|||.|||||++.+..|+..+|.||+|||+
T Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG~Im 378 (550)
T KOG0605|consen 299 SYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLGCIM 378 (550)
T ss_pred hhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHHHHHH
Confidence 0 00000 000000 1111222223334445567899999999999999999999999999999
Q ss_pred HHHHhCCCccccCCCCc--chhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCC
Q 005102 627 LEMITGRTAVVQVGSSE--MDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPT 698 (714)
Q Consensus 627 ~elltG~~p~~~~~~~~--~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt 698 (714)
|||+.|.+||......+ ..++.|... ...++- .....+..++|.+|+. ||++|--
T Consensus 379 yEmLvGyPPF~s~tp~~T~rkI~nwr~~-----l~fP~~-----------~~~s~eA~DLI~rll~-d~~~RLG 435 (550)
T KOG0605|consen 379 YEMLVGYPPFCSETPQETYRKIVNWRET-----LKFPEE-----------VDLSDEAKDLITRLLC-DPENRLG 435 (550)
T ss_pred HHHHhCCCCCCCCCHHHHHHHHHHHhhh-----ccCCCc-----------CcccHHHHHHHHHHhc-CHHHhcC
Confidence 99999999994332211 112222211 111100 1112467899999999 9999965
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-40 Score=343.55 Aligned_cols=261 Identities=21% Similarity=0.319 Sum_probs=196.8
Q ss_pred ccccccCceEEEEEEECC-----------------CcEEEEEEeCCCC-chhHHHHHHHHHHHhccCCCCccceEEEEEe
Q 005102 409 FVLGKSGIGIVYKVVLED-----------------GHTLAVRRLGEGG-SQRFKEFQTEVEAIGKIRHSNIVTLRAYYWS 470 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~~-----------------g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~ 470 (714)
+.||+|+||.||+|.+++ +..||+|.+.... .....+|.+|++++.+++||||+++++++..
T Consensus 11 ~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 90 (304)
T cd05096 11 EKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVD 90 (304)
T ss_pred eEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEec
Confidence 479999999999998643 3479999987653 3335679999999999999999999999999
Q ss_pred CCceeEEEeccCCCCHhhhhhCCCCC-------------CCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCC
Q 005102 471 VDEKLLIYDYIPNGSLATALHGKPGM-------------VSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPS 537 (714)
Q Consensus 471 ~~~~~lV~e~~~~gsL~~~l~~~~~~-------------~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~ 537 (714)
.+..++||||+++|+|.+++...... .....++|..+.+++.||+.||+|||+ .+|+||||||+
T Consensus 91 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~ivH~dlkp~ 167 (304)
T cd05096 91 EDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSS---LNFVHRDLATR 167 (304)
T ss_pred CCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHH---CCccccCcchh
Confidence 99999999999999999998643210 011357889999999999999999999 89999999999
Q ss_pred CeeeCCCCCeEEcccchhhhhhccCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchh
Q 005102 538 NILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKW 617 (714)
Q Consensus 538 NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~ 617 (714)
|||+++++.+||+|||+++....... ........++..|+|||++.+..++.++
T Consensus 168 Nill~~~~~~kl~DfG~~~~~~~~~~--------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~ 221 (304)
T cd05096 168 NCLVGENLTIKIADFGMSRNLYAGDY--------------------------YRIQGRAVLPIRWMAWECILMGKFTTAS 221 (304)
T ss_pred heEEcCCccEEECCCccceecccCce--------------------------eEecCcCCCCccccCHHHHhcCCCCchh
Confidence 99999999999999999875432110 0111223346779999999888999999
Q ss_pred hhHHHHHHHHHHHh--CCCccccCCCCcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCC
Q 005102 618 DIYSYGVILLEMIT--GRTAVVQVGSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEK 695 (714)
Q Consensus 618 DVwS~Gvvl~ellt--G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~ 695 (714)
||||||+++|||++ +..||... ........+......... .. .....+ .....+.+++.+||+.||++
T Consensus 222 Dv~slG~~l~el~~~~~~~p~~~~--~~~~~~~~~~~~~~~~~~--~~-~~~~~~-----~~~~~~~~li~~cl~~~p~~ 291 (304)
T cd05096 222 DVWAFGVTLWEILMLCKEQPYGEL--TDEQVIENAGEFFRDQGR--QV-YLFRPP-----PCPQGLYELMLQCWSRDCRE 291 (304)
T ss_pred hhHHHHHHHHHHHHccCCCCCCcC--CHHHHHHHHHHHhhhccc--cc-cccCCC-----CCCHHHHHHHHHHccCCchh
Confidence 99999999999997 45566432 222222222222221110 00 000011 12236889999999999999
Q ss_pred CCCHHHHHHHHhh
Q 005102 696 RPTMRHISDALDR 708 (714)
Q Consensus 696 RPt~~evl~~L~~ 708 (714)
|||+++|.+.|++
T Consensus 292 RPs~~~i~~~l~~ 304 (304)
T cd05096 292 RPSFSDIHAFLTE 304 (304)
T ss_pred CcCHHHHHHHHhC
Confidence 9999999998864
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=342.64 Aligned_cols=242 Identities=22% Similarity=0.369 Sum_probs=199.9
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeCCC-CchhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCCCH
Q 005102 409 FVLGKSGIGIVYKVVLE-DGHTLAVRRLGEG-GSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGSL 486 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL 486 (714)
+.||+|.||.||||.+. +++.||+|++... .....++.++|+.++..++++||.++||.|..+...+++||||.+|++
T Consensus 19 ~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~~gGsv 98 (467)
T KOG0201|consen 19 ELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYCGGGSV 98 (467)
T ss_pred hhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHhcCcch
Confidence 47999999999999964 5899999999865 445567899999999999999999999999999999999999999999
Q ss_pred hhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCCCC
Q 005102 487 ATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPT 566 (714)
Q Consensus 487 ~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 566 (714)
.+.++.. ..+.+..+.-|+++++.||.|||+ .+.+|||||++|||+..+|.+||+|||++-.+...
T Consensus 99 ~~lL~~~------~~~~E~~i~~ilre~l~~l~ylH~---~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~----- 164 (467)
T KOG0201|consen 99 LDLLKSG------NILDEFEIAVILREVLKGLDYLHS---EKKIHRDIKAANILLSESGDVKLADFGVAGQLTNT----- 164 (467)
T ss_pred hhhhccC------CCCccceeeeehHHHHHHhhhhhh---cceecccccccceeEeccCcEEEEecceeeeeech-----
Confidence 9999765 334777788899999999999999 89999999999999999999999999998765422
Q ss_pred ccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCccccCCCCcchh
Q 005102 567 LQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGSSEMDL 646 (714)
Q Consensus 567 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~~~~~~~~~~l 646 (714)
.....+.+||++|||||++.+..|+.|+||||||++.+||++|.+|+........
T Consensus 165 -----------------------~~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrv-- 219 (467)
T KOG0201|consen 165 -----------------------VKRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRV-- 219 (467)
T ss_pred -----------------------hhccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceE--
Confidence 1123567899999999999988999999999999999999999999954322100
Q ss_pred HHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 005102 647 VNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISD 704 (714)
Q Consensus 647 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 704 (714)
+. .+.+-.-|.+.+ .....+.+++..||++||+.||+|.++++
T Consensus 220 ---lf-------lIpk~~PP~L~~-----~~S~~~kEFV~~CL~k~P~~RpsA~~LLK 262 (467)
T KOG0201|consen 220 ---LF-------LIPKSAPPRLDG-----DFSPPFKEFVEACLDKNPEFRPSAKELLK 262 (467)
T ss_pred ---EE-------eccCCCCCcccc-----ccCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence 00 011111222322 23335889999999999999999999875
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=321.67 Aligned_cols=254 Identities=23% Similarity=0.295 Sum_probs=194.5
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeCCCCchh--HHHHHHHHHHHhccCCCCccceEEEEEe--CCceeEEEeccCC
Q 005102 409 FVLGKSGIGIVYKVVLE-DGHTLAVRRLGEGGSQR--FKEFQTEVEAIGKIRHSNIVTLRAYYWS--VDEKLLIYDYIPN 483 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~H~niv~l~~~~~~--~~~~~lV~e~~~~ 483 (714)
+.|++|+||.||+|+++ +++.||+|+++...... .-...+||.+|.+++|||||.+..+... -+..|+|||||+.
T Consensus 82 nrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~VMe~~Eh 161 (419)
T KOG0663|consen 82 NRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIVMEYVEH 161 (419)
T ss_pred hhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeeeHHHHHh
Confidence 46999999999999975 58899999998653221 1245799999999999999999998875 4578999999987
Q ss_pred CCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCC
Q 005102 484 GSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGG 563 (714)
Q Consensus 484 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 563 (714)
||..+++... +++...+++.++.|+++|++|||. +.|+|||||++|+|+...|.+||+|||+|+.+....
T Consensus 162 -DLksl~d~m~-----q~F~~~evK~L~~QlL~glk~lH~---~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~- 231 (419)
T KOG0663|consen 162 -DLKSLMETMK-----QPFLPGEVKTLMLQLLRGLKHLHD---NWILHRDLKTSNLLLSHKGILKIADFGLAREYGSPL- 231 (419)
T ss_pred -hHHHHHHhcc-----CCCchHHHHHHHHHHHHHHHHHhh---ceeEecccchhheeeccCCcEEecccchhhhhcCCc-
Confidence 9999998664 578999999999999999999999 999999999999999999999999999999875431
Q ss_pred CCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCC-CCchhhhHHHHHHHHHHHhCCCccccCCCC
Q 005102 564 SPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVK-PSQKWDIYSYGVILLEMITGRTAVVQVGSS 642 (714)
Q Consensus 564 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s~~~DVwS~Gvvl~elltG~~p~~~~~~~ 642 (714)
...+..+-|.+|+|||.+.+.+ |+++.|+||+|||+.||+++++.|. +..
T Consensus 232 ---------------------------k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~--G~s 282 (419)
T KOG0663|consen 232 ---------------------------KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFP--GKS 282 (419)
T ss_pred ---------------------------ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCC--CCc
Confidence 1122334588999999998865 8999999999999999999999884 333
Q ss_pred cchhHHHHHHHHhhcCCcccccCCCC-----------CCCC--------CcHHHHHHHHHHHhHccCCCCCCCCCHHHHH
Q 005102 643 EMDLVNWMQLCIEEKKPLADVLDPYL-----------APDA--------DKEEEIIAVLKIAMACVHSSPEKRPTMRHIS 703 (714)
Q Consensus 643 ~~~l~~~~~~~~~~~~~~~~~~d~~~-----------~~~~--------~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl 703 (714)
+.+....+-..+.. ..+.+-|.+ ...+ ....-...-.+++...+.+||.+|.|++|.+
T Consensus 283 E~dQl~~If~llGt---Pte~iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L 359 (419)
T KOG0663|consen 283 EIDQLDKIFKLLGT---PSEAIWPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGL 359 (419)
T ss_pred hHHHHHHHHHHhCC---CccccCCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhh
Confidence 43333322221111 011111100 0000 0000124567899999999999999999876
Q ss_pred H
Q 005102 704 D 704 (714)
Q Consensus 704 ~ 704 (714)
+
T Consensus 360 ~ 360 (419)
T KOG0663|consen 360 K 360 (419)
T ss_pred c
Confidence 4
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=349.60 Aligned_cols=240 Identities=22% Similarity=0.261 Sum_probs=193.4
Q ss_pred cccccCceEEEEEEEC-CCcEEEEEEeCCCC---chhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCCC
Q 005102 410 VLGKSGIGIVYKVVLE-DGHTLAVRRLGEGG---SQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGS 485 (714)
Q Consensus 410 ~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gs 485 (714)
+||+|+||.||+++.+ +|+.||+|++.... ......+.+|++++++++||||+++++++...+..++||||+++|+
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~ 81 (323)
T cd05571 2 LLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGGE 81 (323)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCCc
Confidence 6999999999999975 58999999987532 2334567899999999999999999999999999999999999999
Q ss_pred HhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCCC
Q 005102 486 LATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSP 565 (714)
Q Consensus 486 L~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 565 (714)
|.+++... ..+++.++..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++.....
T Consensus 82 L~~~l~~~------~~~~~~~~~~~~~qi~~~L~~lH~---~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~---- 148 (323)
T cd05571 82 LFFHLSRE------RVFSEDRARFYGAEIVSALGYLHS---CDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISD---- 148 (323)
T ss_pred HHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccC----
Confidence 99998754 458999999999999999999999 89999999999999999999999999998743211
Q ss_pred CccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCccccCCCCcch
Q 005102 566 TLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGSSEMD 645 (714)
Q Consensus 566 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~~~~~~~~~~ 645 (714)
........||+.|+|||++.+..++.++|||||||++|||+||+.||....
T Consensus 149 ------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~----- 199 (323)
T cd05571 149 ------------------------GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD----- 199 (323)
T ss_pred ------------------------CCcccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCC-----
Confidence 011123457889999999999999999999999999999999999994321
Q ss_pred hHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCC-----CHHHHHH
Q 005102 646 LVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRP-----TMRHISD 704 (714)
Q Consensus 646 l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----t~~evl~ 704 (714)
............. ..... ...++.+++.+||+.||++|| ++.++++
T Consensus 200 ~~~~~~~~~~~~~--------~~p~~-----~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 250 (323)
T cd05571 200 HEKLFELILMEEI--------RFPRT-----LSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME 250 (323)
T ss_pred HHHHHHHHHcCCC--------CCCCC-----CCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence 1111111111111 11111 123578999999999999999 7888764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-40 Score=347.59 Aligned_cols=237 Identities=21% Similarity=0.261 Sum_probs=190.6
Q ss_pred ccccCceEEEEEEECC-CcEEEEEEeCCC---CchhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCCCH
Q 005102 411 LGKSGIGIVYKVVLED-GHTLAVRRLGEG---GSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGSL 486 (714)
Q Consensus 411 lG~G~~g~Vy~~~~~~-g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL 486 (714)
||+|+||.||+|+..+ ++.||+|++... .......+.+|++++++++||||+++++++...+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 6999999999999864 789999998753 233446788999999999999999999999999999999999999999
Q ss_pred hhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCCCC
Q 005102 487 ATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPT 566 (714)
Q Consensus 487 ~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 566 (714)
.+++... ..+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++.....
T Consensus 81 ~~~l~~~------~~~~~~~~~~~~~qi~~~l~~lH~---~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~----- 146 (312)
T cd05585 81 FHHLQRE------GRFDLSRARFYTAELLCALENLHK---FNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKD----- 146 (312)
T ss_pred HHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHeEECCCCcEEEEECcccccCccC-----
Confidence 9999754 458999999999999999999999 89999999999999999999999999998753211
Q ss_pred ccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCccccCCCCcchh
Q 005102 567 LQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGSSEMDL 646 (714)
Q Consensus 567 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~~~~~~~~~~l 646 (714)
........||+.|+|||++.+..++.++|||||||++|||+||+.||... ..
T Consensus 147 -----------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~-----~~ 198 (312)
T cd05585 147 -----------------------DDKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDE-----NV 198 (312)
T ss_pred -----------------------CCccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCC-----CH
Confidence 01112345788999999999999999999999999999999999999532 12
Q ss_pred HHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHH
Q 005102 647 VNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHI 702 (714)
Q Consensus 647 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev 702 (714)
.+..+........ .... ....+.+++.+||+.||++||++.++
T Consensus 199 ~~~~~~~~~~~~~--------~~~~-----~~~~~~~li~~~L~~dp~~R~~~~~~ 241 (312)
T cd05585 199 NEMYRKILQEPLR--------FPDG-----FDRDAKDLLIGLLSRDPTRRLGYNGA 241 (312)
T ss_pred HHHHHHHHcCCCC--------CCCc-----CCHHHHHHHHHHcCCCHHHcCCCCCH
Confidence 2223322222111 1111 12357799999999999999864333
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=351.24 Aligned_cols=252 Identities=25% Similarity=0.369 Sum_probs=200.7
Q ss_pred ccccccCceEEEEEEECC--C--cE-EEEEEeCCC---CchhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEec
Q 005102 409 FVLGKSGIGIVYKVVLED--G--HT-LAVRRLGEG---GSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDY 480 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~~--g--~~-vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~ 480 (714)
+.||+|.||+||+|+++. + .. ||||..+.. .....++|.+|+++|++++|||||+++|++......|+|||+
T Consensus 163 kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~ivmEl 242 (474)
T KOG0194|consen 163 KKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLMLVMEL 242 (474)
T ss_pred ceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccEEEEEe
Confidence 589999999999999754 2 23 899998852 345567899999999999999999999999999999999999
Q ss_pred cCCCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhc
Q 005102 481 IPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANI 560 (714)
Q Consensus 481 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 560 (714)
|.||+|.++|.... ..++..++.+++.+.|.||+|||+ +++|||||.++|+|++.++.+||+|||+++.-..
T Consensus 243 ~~gGsL~~~L~k~~-----~~v~~~ek~~~~~~AA~Gl~YLh~---k~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~~ 314 (474)
T KOG0194|consen 243 CNGGSLDDYLKKNK-----KSLPTLEKLRFCYDAARGLEYLHS---KNCIHRDIAARNCLYSKKGVVKISDFGLSRAGSQ 314 (474)
T ss_pred cCCCcHHHHHHhCC-----CCCCHHHHHHHHHHHHhHHHHHHH---CCCcchhHhHHHheecCCCeEEeCccccccCCcc
Confidence 99999999998774 248999999999999999999999 9999999999999999999999999999875321
Q ss_pred cCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHh-CCCccccC
Q 005102 561 AGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMIT-GRTAVVQV 639 (714)
Q Consensus 561 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~ellt-G~~p~~~~ 639 (714)
.. .......-...|+|||.+....|++++|||||||++||+++ |..||...
T Consensus 315 ~~----------------------------~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~ 366 (474)
T KOG0194|consen 315 YV----------------------------MKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGM 366 (474)
T ss_pred ee----------------------------eccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCC
Confidence 00 00000011345999999999999999999999999999999 88898433
Q ss_pred CCCcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhhhhcc
Q 005102 640 GSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDALDRLIVS 712 (714)
Q Consensus 640 ~~~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~~ 712 (714)
. ..+........+.... .. . .....+..++.+||..+|++||||.++.+.|+.+...
T Consensus 367 ~-----~~~v~~kI~~~~~r~~------~~-~----~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~ 423 (474)
T KOG0194|consen 367 K-----NYEVKAKIVKNGYRMP------IP-S----KTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKK 423 (474)
T ss_pred C-----HHHHHHHHHhcCccCC------CC-C----CCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhc
Confidence 2 2222222222222110 00 0 1233567888899999999999999999999998653
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=345.30 Aligned_cols=254 Identities=30% Similarity=0.419 Sum_probs=209.4
Q ss_pred cccccccCceEEEEEEECC-CcEEEEEEeCCCCchhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCCCH
Q 005102 408 AFVLGKSGIGIVYKVVLED-GHTLAVRRLGEGGSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGSL 486 (714)
Q Consensus 408 ~~~lG~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL 486 (714)
.+.||-|.||.||.|.|+. ...||||.++.. ....++|.+|..+|+.++|||+|+++|+|......|||+|||.+|+|
T Consensus 272 khKLGGGQYGeVYeGvWKkyslTvAVKtLKED-tMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM~yGNL 350 (1157)
T KOG4278|consen 272 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFMCYGNL 350 (1157)
T ss_pred eeccCCCcccceeeeeeeccceeeehhhhhhc-chhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEecccCccH
Confidence 4689999999999999976 678999999764 44568999999999999999999999999999999999999999999
Q ss_pred hhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCCCC
Q 005102 487 ATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPT 566 (714)
Q Consensus 487 ~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 566 (714)
.++|++... ..++-...+.+|.||+.|+.||.. +.+|||||.++|+|+.++..+||+|||+++++..+.
T Consensus 351 LdYLRecnr----~ev~avvLlyMAtQIsSaMeYLEk---knFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDT---- 419 (1157)
T KOG4278|consen 351 LDYLRECNR----SEVPAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDT---- 419 (1157)
T ss_pred HHHHHHhch----hhcchhHHHHHHHHHHHHHHHHHH---hhhhhhhhhhhhccccccceEEeeccchhhhhcCCc----
Confidence 999987754 456777789999999999999999 999999999999999999999999999999875321
Q ss_pred ccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHh-CCCccccCCCCcch
Q 005102 567 LQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMIT-GRTAVVQVGSSEMD 645 (714)
Q Consensus 567 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~ellt-G~~p~~~~~~~~~~ 645 (714)
.+.........-|.|||.+....++.|+|||+|||+|||+.| |-.||. +.+
T Consensus 420 -----------------------YTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYP-----Gid 471 (1157)
T KOG4278|consen 420 -----------------------YTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYP-----GID 471 (1157)
T ss_pred -----------------------eecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCC-----Ccc
Confidence 111222223445999999999999999999999999999999 888884 233
Q ss_pred hHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhhhhccC
Q 005102 646 LVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDALDRLIVSS 713 (714)
Q Consensus 646 l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~~~ 713 (714)
+.+.+ ..++.+..+ -.| +.+...++++|+.||+++|.+||+++|+-+.+|.+..++
T Consensus 472 lSqVY-~LLEkgyRM---~~P--------eGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~~s 527 (1157)
T KOG4278|consen 472 LSQVY-GLLEKGYRM---DGP--------EGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFSSS 527 (1157)
T ss_pred HHHHH-HHHhccccc---cCC--------CCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhccc
Confidence 33322 223333221 112 123457999999999999999999999999999987654
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=344.74 Aligned_cols=240 Identities=21% Similarity=0.275 Sum_probs=192.5
Q ss_pred cccccCceEEEEEEEC-CCcEEEEEEeCCC---CchhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCCC
Q 005102 410 VLGKSGIGIVYKVVLE-DGHTLAVRRLGEG---GSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGS 485 (714)
Q Consensus 410 ~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gs 485 (714)
.||+|+||.||+++.. +|+.||+|++... .......+.+|++++++++||||+++++++...+..++||||+++|+
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~~ 81 (323)
T cd05595 2 LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGE 81 (323)
T ss_pred eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCCc
Confidence 6999999999999975 5899999999764 22334567889999999999999999999999999999999999999
Q ss_pred HhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCCC
Q 005102 486 LATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSP 565 (714)
Q Consensus 486 L~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 565 (714)
|..++... ..+++..+..++.||+.||+|||+ ++|+||||||+|||+++++.+||+|||+++.....
T Consensus 82 L~~~l~~~------~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~---- 148 (323)
T cd05595 82 LFFHLSRE------RVFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD---- 148 (323)
T ss_pred HHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEEcCCCCEEecccHHhccccCC----
Confidence 99988654 458899999999999999999999 89999999999999999999999999998743111
Q ss_pred CccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCccccCCCCcch
Q 005102 566 TLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGSSEMD 645 (714)
Q Consensus 566 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~~~~~~~~~~ 645 (714)
........||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus 149 ------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~---- 200 (323)
T cd05595 149 ------------------------GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH---- 200 (323)
T ss_pred ------------------------CCccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCH----
Confidence 0011234578899999999999999999999999999999999999943211
Q ss_pred hHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCC-----CHHHHHH
Q 005102 646 LVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRP-----TMRHISD 704 (714)
Q Consensus 646 l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----t~~evl~ 704 (714)
............. .... ....+.+++.+||+.||++|| ++.++++
T Consensus 201 -~~~~~~~~~~~~~--------~p~~-----~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~ 250 (323)
T cd05595 201 -ERLFELILMEEIR--------FPRT-----LSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 250 (323)
T ss_pred -HHHHHHHhcCCCC--------CCCC-----CCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence 1111111111111 1111 123577999999999999998 7887764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=332.69 Aligned_cols=250 Identities=21% Similarity=0.365 Sum_probs=197.6
Q ss_pred cccccccCceEEEEEEEC----CCcEEEEEEeCCCCc-hhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccC
Q 005102 408 AFVLGKSGIGIVYKVVLE----DGHTLAVRRLGEGGS-QRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIP 482 (714)
Q Consensus 408 ~~~lG~G~~g~Vy~~~~~----~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~ 482 (714)
.+.||+|+||.||+|+++ .+..||+|.++.... .....|.+|+.++++++||||+++++++...+..++||||++
T Consensus 10 ~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 89 (266)
T cd05064 10 ERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMS 89 (266)
T ss_pred eeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEEEEeCC
Confidence 457999999999999864 367899999987533 334578999999999999999999999999999999999999
Q ss_pred CCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccC
Q 005102 483 NGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAG 562 (714)
Q Consensus 483 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 562 (714)
+|+|.+++.... ..+++.+++.++.|++.||+|||+ ++++||||||+||+++.++.+|++|||.+.......
T Consensus 90 ~~~L~~~l~~~~-----~~l~~~~~~~~~~~i~~al~~lH~---~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~~ 161 (266)
T cd05064 90 NGALDSFLRKHE-----GQLVAGQLMGMLPGLASGMKYLSE---MGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEA 161 (266)
T ss_pred CCcHHHHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHHH---CCEeeccccHhhEEEcCCCcEEECCCcccccccccc
Confidence 999999997643 358999999999999999999999 899999999999999999999999999765431110
Q ss_pred CCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHh-CCCccccCCC
Q 005102 563 GSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMIT-GRTAVVQVGS 641 (714)
Q Consensus 563 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~ellt-G~~p~~~~~~ 641 (714)
........++..|+|||.+.+..++.++|||||||++||+++ |+.||.....
T Consensus 162 ---------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~ 214 (266)
T cd05064 162 ---------------------------IYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSG 214 (266)
T ss_pred ---------------------------hhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCH
Confidence 001112223567999999999999999999999999999775 9999953321
Q ss_pred CcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhhh
Q 005102 642 SEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDALDRL 709 (714)
Q Consensus 642 ~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i 709 (714)
. +.... ..+... ..... .....+.+++.+||+.+|++|||++++.+.|+++
T Consensus 215 --~---~~~~~-~~~~~~------~~~~~-----~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 215 --Q---DVIKA-VEDGFR------LPAPR-----NCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred --H---HHHHH-HHCCCC------CCCCC-----CCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 1 11111 111111 00111 1233688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=349.55 Aligned_cols=268 Identities=25% Similarity=0.348 Sum_probs=202.4
Q ss_pred ccccCHHHHHHhccccccccCceEEEEEEE------CCCcEEEEEEeCCCC-chhHHHHHHHHHHHhcc-CCCCccceEE
Q 005102 395 QVAFDLDELLKASAFVLGKSGIGIVYKVVL------EDGHTLAVRRLGEGG-SQRFKEFQTEVEAIGKI-RHSNIVTLRA 466 (714)
Q Consensus 395 ~~~~~~~~l~~~~~~~lG~G~~g~Vy~~~~------~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~ 466 (714)
.+.|..+++.. .+.||+|+||.||+|++ .++..||||+++... ....+.+.+|++++..+ +||||+++++
T Consensus 29 ~~~~~~~~~~~--~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~ 106 (375)
T cd05104 29 KWEFPRNRLSF--GKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLG 106 (375)
T ss_pred ccccchHHeeh--hheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeee
Confidence 33444444332 45899999999999974 235689999997543 33346788999999999 8999999999
Q ss_pred EEEeCCceeEEEeccCCCCHhhhhhCCCCCC-------------------------------------------------
Q 005102 467 YYWSVDEKLLIYDYIPNGSLATALHGKPGMV------------------------------------------------- 497 (714)
Q Consensus 467 ~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~------------------------------------------------- 497 (714)
+|...+..++||||+++|+|.+++.......
T Consensus 107 ~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 186 (375)
T cd05104 107 ACTVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKR 186 (375)
T ss_pred eeccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccc
Confidence 9999999999999999999999986532100
Q ss_pred --------------------CcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhh
Q 005102 498 --------------------SFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARL 557 (714)
Q Consensus 498 --------------------~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 557 (714)
....+++..+.+++.||+.||+|||+ ++|+||||||+|||+++++.+||+|||+++.
T Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~ 263 (375)
T cd05104 187 RSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARD 263 (375)
T ss_pred cccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCchhhEEEECCCcEEEecCcccee
Confidence 01247899999999999999999999 8999999999999999999999999999875
Q ss_pred hhccCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHh-CCCcc
Q 005102 558 ANIAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMIT-GRTAV 636 (714)
Q Consensus 558 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~ellt-G~~p~ 636 (714)
...... ........++..|+|||.+.+..++.++|||||||++|||++ |..||
T Consensus 264 ~~~~~~--------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~ 317 (375)
T cd05104 264 IRNDSN--------------------------YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPY 317 (375)
T ss_pred ccCccc--------------------------ccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCC
Confidence 432110 001112234567999999999999999999999999999998 88888
Q ss_pred ccCCCCcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhhh
Q 005102 637 VQVGSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDALDRL 709 (714)
Q Consensus 637 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i 709 (714)
...... .....+ ....... ..+. . ...++.+++.+||+.||++|||++||++.|++.
T Consensus 318 ~~~~~~-~~~~~~----~~~~~~~---~~~~----~----~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 318 PGMPVD-SKFYKM----IKEGYRM---LSPE----C----APSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred CCCCch-HHHHHH----HHhCccC---CCCC----C----CCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 433211 112221 1111100 0111 1 123688999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=345.11 Aligned_cols=240 Identities=23% Similarity=0.280 Sum_probs=193.5
Q ss_pred cccccCceEEEEEEEC-CCcEEEEEEeCCC---CchhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCCC
Q 005102 410 VLGKSGIGIVYKVVLE-DGHTLAVRRLGEG---GSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGS 485 (714)
Q Consensus 410 ~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gs 485 (714)
.||+|+||.||++... +|+.||+|++... .......+.+|++++++++||||+++++++...+..++||||+++|+
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g~ 81 (328)
T cd05593 2 LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGGE 81 (328)
T ss_pred eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCCC
Confidence 6899999999999975 5899999999754 22344678899999999999999999999999999999999999999
Q ss_pred HhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCCC
Q 005102 486 LATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSP 565 (714)
Q Consensus 486 L~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 565 (714)
|.+++... ..+++.++..++.||+.||+|||+ ++|+||||||+|||+++++.+||+|||+++.....
T Consensus 82 L~~~l~~~------~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~---- 148 (328)
T cd05593 82 LFFHLSRE------RVFSEDRTRFYGAEIVSALDYLHS---GKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITD---- 148 (328)
T ss_pred HHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHh---CCeEecccCHHHeEECCCCcEEEecCcCCccCCCc----
Confidence 99988654 458999999999999999999999 89999999999999999999999999998743211
Q ss_pred CccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCccccCCCCcch
Q 005102 566 TLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGSSEMD 645 (714)
Q Consensus 566 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~~~~~~~~~~ 645 (714)
........||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 149 ------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~----- 199 (328)
T cd05593 149 ------------------------AATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD----- 199 (328)
T ss_pred ------------------------ccccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCC-----
Confidence 011123457889999999998899999999999999999999999994321
Q ss_pred hHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCC-----CHHHHHH
Q 005102 646 LVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRP-----TMRHISD 704 (714)
Q Consensus 646 l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----t~~evl~ 704 (714)
..+.......... .+... ....+.+++.+||+.||++|| ++.|+++
T Consensus 200 ~~~~~~~~~~~~~--------~~p~~-----~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~ 250 (328)
T cd05593 200 HEKLFELILMEDI--------KFPRT-----LSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMR 250 (328)
T ss_pred HHHHHHHhccCCc--------cCCCC-----CCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhc
Confidence 1122222111111 11111 123577899999999999997 8888875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-40 Score=307.05 Aligned_cols=251 Identities=24% Similarity=0.317 Sum_probs=204.4
Q ss_pred ccCHHHHHHhccccccccCceEEEEEEEC-CCcEEEEEEeCCCC---chhHHHHHHHHHHHhccCCCCccceEEEEEeCC
Q 005102 397 AFDLDELLKASAFVLGKSGIGIVYKVVLE-DGHTLAVRRLGEGG---SQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVD 472 (714)
Q Consensus 397 ~~~~~~l~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~ 472 (714)
.++++++.. +..||+|.||.||.|+.+ ++..||+|++.+.. .....++.+|+++-+.++||||+++++||.+..
T Consensus 18 ~~~l~dfei--gr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~ 95 (281)
T KOG0580|consen 18 TWTLDDFEI--GRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSK 95 (281)
T ss_pred ccchhhccc--cccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccc
Confidence 345555543 568999999999999965 47899999997752 223467899999999999999999999999999
Q ss_pred ceeEEEeccCCCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEccc
Q 005102 473 EKLLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDF 552 (714)
Q Consensus 473 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DF 552 (714)
..|+++||.+.|+++..|.+.+. .++++.....++.|+|.||.|+|. ++||||||||+|+|++.++..|++||
T Consensus 96 riyLilEya~~gel~k~L~~~~~----~~f~e~~~a~Yi~q~A~Al~y~h~---k~VIhRdiKpenlLlg~~~~lkiAdf 168 (281)
T KOG0580|consen 96 RIYLILEYAPRGELYKDLQEGRM----KRFDEQRAATYIKQLANALLYCHL---KRVIHRDIKPENLLLGSAGELKIADF 168 (281)
T ss_pred eeEEEEEecCCchHHHHHHhccc----ccccccchhHHHHHHHHHHHHhcc---CCcccCCCCHHHhccCCCCCeeccCC
Confidence 99999999999999999986543 468888999999999999999999 99999999999999999999999999
Q ss_pred chhhhhhccCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhC
Q 005102 553 GLARLANIAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITG 632 (714)
Q Consensus 553 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG 632 (714)
|-+...+ .....+..||..|.|||+..+...+..+|+|++||+.||++.|
T Consensus 169 GwsV~~p------------------------------~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg 218 (281)
T KOG0580|consen 169 GWSVHAP------------------------------SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVG 218 (281)
T ss_pred CceeecC------------------------------CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhc
Confidence 9775432 1123455789999999999999999999999999999999999
Q ss_pred CCccccCCCCcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 005102 633 RTAVVQVGSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISD 704 (714)
Q Consensus 633 ~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 704 (714)
.+||.... ..+..++..+.+ ..+|. .......++|.+|+..+|.+|.+..|+++
T Consensus 219 ~ppFes~~-----~~etYkrI~k~~-----~~~p~--------~is~~a~dlI~~ll~~~p~~r~~l~~v~~ 272 (281)
T KOG0580|consen 219 LPPFESQS-----HSETYKRIRKVD-----LKFPS--------TISGGAADLISRLLVKNPIERLALTEVMD 272 (281)
T ss_pred CCchhhhh-----hHHHHHHHHHcc-----ccCCc--------ccChhHHHHHHHHhccCccccccHHHHhh
Confidence 99995432 112222222222 12221 11225779999999999999999999875
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-40 Score=344.72 Aligned_cols=240 Identities=24% Similarity=0.329 Sum_probs=201.5
Q ss_pred ccccccCceEEEEEEE-CCCcEEEEEEeCCCC---chhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCC
Q 005102 409 FVLGKSGIGIVYKVVL-EDGHTLAVRRLGEGG---SQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNG 484 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~g 484 (714)
+-||+|+.|.|-.|++ .+|+.+|||++.+.. ......+.+|+-+|+-+.|||++++++++++..+.|+|.||+++|
T Consensus 18 kTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlEyv~gG 97 (786)
T KOG0588|consen 18 KTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLEYVPGG 97 (786)
T ss_pred ccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEEecCCc
Confidence 4699999999999996 469999999998752 222356889999999999999999999999999999999999999
Q ss_pred CHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCC
Q 005102 485 SLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGS 564 (714)
Q Consensus 485 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 564 (714)
.|++++-.+ .++++.++.+++.||+.|+.|+|. .+|+||||||+|+|+|.++++||+|||+|..-..+
T Consensus 98 ELFdylv~k------G~l~e~eaa~ff~QIi~gv~yCH~---~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~g--- 165 (786)
T KOG0588|consen 98 ELFDYLVRK------GPLPEREAAHFFRQILDGVSYCHA---FNICHRDLKPENLLLDVKNNIKIADFGMASLEVPG--- 165 (786)
T ss_pred hhHHHHHhh------CCCCCHHHHHHHHHHHHHHHHHhh---hcceeccCCchhhhhhcccCEeeeccceeecccCC---
Confidence 999999877 568999999999999999999999 89999999999999999999999999999764321
Q ss_pred CCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCC-CchhhhHHHHHHHHHHHhCCCccccCCCCc
Q 005102 565 PTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKP-SQKWDIYSYGVILLEMITGRTAVVQVGSSE 643 (714)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~~DVwS~Gvvl~elltG~~p~~~~~~~~ 643 (714)
....+.+|++.|.|||++.|.+| +.++||||.|||||.|+||+.||. +
T Consensus 166 --------------------------klLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFd-----D 214 (786)
T KOG0588|consen 166 --------------------------KLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFD-----D 214 (786)
T ss_pred --------------------------ccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCC-----C
Confidence 22345578999999999999998 678999999999999999999994 3
Q ss_pred chhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 005102 644 MDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISD 704 (714)
Q Consensus 644 ~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 704 (714)
+.+...+.........++.. ...++.+|+.+|+..||++|.|++||++
T Consensus 215 dNir~LLlKV~~G~f~MPs~-------------Is~eaQdLLr~ml~VDp~~RiT~~eI~k 262 (786)
T KOG0588|consen 215 DNIRVLLLKVQRGVFEMPSN-------------ISSEAQDLLRRMLDVDPSTRITTEEILK 262 (786)
T ss_pred ccHHHHHHHHHcCcccCCCc-------------CCHHHHHHHHHHhccCccccccHHHHhh
Confidence 34444443333333222211 1225779999999999999999999976
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-40 Score=340.43 Aligned_cols=260 Identities=22% Similarity=0.299 Sum_probs=206.8
Q ss_pred cccccccCceEEEEEEECCCcEEEEEEeCCCCch-hHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCCCH
Q 005102 408 AFVLGKSGIGIVYKVVLEDGHTLAVRRLGEGGSQ-RFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGSL 486 (714)
Q Consensus 408 ~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL 486 (714)
.+.||+|-||+|..+....+..||||+++..... .+++|.+|+++|.+++|||||+++|.|..++..++|+|||++|+|
T Consensus 543 ~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYmEnGDL 622 (807)
T KOG1094|consen 543 KEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYMENGDL 622 (807)
T ss_pred hhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHHhcCcH
Confidence 4679999999999999988899999999987544 358999999999999999999999999999999999999999999
Q ss_pred hhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCCCC
Q 005102 487 ATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPT 566 (714)
Q Consensus 487 ~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 566 (714)
.+++.++... .+.-...++|+.|||.|++||.+ .++|||||.++|+|+|.++++||+|||+++-+...+.+.
T Consensus 623 nqFl~aheap----t~~t~~~vsi~tqiasgmaYLes---~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~- 694 (807)
T KOG1094|consen 623 NQFLSAHELP----TAETAPGVSICTQIASGMAYLES---LNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYYR- 694 (807)
T ss_pred HHHHHhccCc----ccccchhHHHHHHHHHHHHHHHh---hchhhccccccceeecCcccEEecCcccccccccCCcee-
Confidence 9999877431 13345567899999999999999 899999999999999999999999999999654332111
Q ss_pred ccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHh--CCCccccCCCCcc
Q 005102 567 LQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMIT--GRTAVVQVGSSEM 644 (714)
Q Consensus 567 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~ellt--G~~p~~~~~~~~~ 644 (714)
. ....+-...|||||.+.-+++++++|||+||+++||+++ ...||.+.. +.
T Consensus 695 v-------------------------qgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt--~e 747 (807)
T KOG1094|consen 695 V-------------------------QGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLT--DE 747 (807)
T ss_pred e-------------------------ecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhh--HH
Confidence 0 111122356999999999999999999999999999987 678885432 23
Q ss_pred hhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhhhh
Q 005102 645 DLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDALDRLI 710 (714)
Q Consensus 645 ~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~ 710 (714)
+.++-..........-.-...|. -+...++++|.+||..|.++||+++++...|++..
T Consensus 748 ~vven~~~~~~~~~~~~~l~~P~--------~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~~ 805 (807)
T KOG1094|consen 748 QVVENAGEFFRDQGRQVVLSRPP--------ACPQGLYELMLRCWRRESEQRPSFEQLHLFLQEDA 805 (807)
T ss_pred HHHHhhhhhcCCCCcceeccCCC--------cCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHhc
Confidence 33443333333332211111222 23447899999999999999999999999998753
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=329.74 Aligned_cols=262 Identities=24% Similarity=0.360 Sum_probs=199.5
Q ss_pred cccccCceEEEEEEECCCcEEEEEEeCCCCchhHHHHHHHHHHHhc--cCCCCccceEEEEEeCC----ceeEEEeccCC
Q 005102 410 VLGKSGIGIVYKVVLEDGHTLAVRRLGEGGSQRFKEFQTEVEAIGK--IRHSNIVTLRAYYWSVD----EKLLIYDYIPN 483 (714)
Q Consensus 410 ~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~H~niv~l~~~~~~~~----~~~lV~e~~~~ 483 (714)
+||+|+||.||||.+. ++.||||++.... .+.|+.|-+|.+. ++|+||++++++-.... +.+||+||.+.
T Consensus 217 li~~Grfg~V~KaqL~-~~~VAVKifp~~~---kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~fh~k 292 (534)
T KOG3653|consen 217 LIGRGRFGCVWKAQLD-NRLVAVKIFPEQE---KQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTEFHPK 292 (534)
T ss_pred HhhcCccceeehhhcc-CceeEEEecCHHH---HHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEeeeccC
Confidence 7999999999999996 6999999997643 3567777777654 58999999999877555 78999999999
Q ss_pred CCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCC------CCceecCCCCCCeeeCCCCCeEEcccchhhh
Q 005102 484 GSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSP------KKYVHGDLKPSNILLGHNMEPHVSDFGLARL 557 (714)
Q Consensus 484 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~------~~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 557 (714)
|+|.++|..+ .++|....+|+..+++||+|||+..+ ++|+|||||++|||+.+|+++.|+|||+|..
T Consensus 293 GsL~dyL~~n-------tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~ 365 (534)
T KOG3653|consen 293 GSLCDYLKAN-------TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALR 365 (534)
T ss_pred CcHHHHHHhc-------cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeEE
Confidence 9999999865 48999999999999999999998543 3799999999999999999999999999987
Q ss_pred hhccCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCC-CC-----chhhhHHHHHHHHHHHh
Q 005102 558 ANIAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVK-PS-----QKWDIYSYGVILLEMIT 631 (714)
Q Consensus 558 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s-----~~~DVwS~Gvvl~ellt 631 (714)
+..... .......+||..|||||++.+.. +. .+.||||+|.|||||++
T Consensus 366 ~~p~~~--------------------------~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~S 419 (534)
T KOG3653|consen 366 LEPGKP--------------------------QGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIAS 419 (534)
T ss_pred ecCCCC--------------------------CcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHh
Confidence 753211 12334478999999999997643 22 36899999999999999
Q ss_pred CCCccccCCCCcc-----------hhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHH
Q 005102 632 GRTAVVQVGSSEM-----------DLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMR 700 (714)
Q Consensus 632 G~~p~~~~~~~~~-----------~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ 700 (714)
+..-++.....+. .-.+-++..+-.++ ..|.++........+.-+.+.+..||+.||+.|.|+.
T Consensus 420 RC~~~~~~~vp~Yqlpfe~evG~hPt~e~mq~~VV~kK-----~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~ 494 (534)
T KOG3653|consen 420 RCTDADPGPVPEYQLPFEAEVGNHPTLEEMQELVVRKK-----QRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAG 494 (534)
T ss_pred hcccccCCCCCcccCchhHHhcCCCCHHHHHHHHHhhc-----cCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhH
Confidence 7654421111100 01112222222221 1233333222234566789999999999999999999
Q ss_pred HHHHHHhhhhccC
Q 005102 701 HISDALDRLIVSS 713 (714)
Q Consensus 701 evl~~L~~i~~~~ 713 (714)
=|.+++.++....
T Consensus 495 Cv~eR~~~l~~~~ 507 (534)
T KOG3653|consen 495 CVEERMAELMMLW 507 (534)
T ss_pred HHHHHHHHHhccC
Confidence 9999999886543
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=336.77 Aligned_cols=246 Identities=21% Similarity=0.217 Sum_probs=192.8
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeCCCCc---hhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCC
Q 005102 409 FVLGKSGIGIVYKVVLE-DGHTLAVRRLGEGGS---QRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNG 484 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~g 484 (714)
+.||+|+||+||+|... +|+.||||.+..... .....+.+|++++++++|+||+++++++...+..++||||+++|
T Consensus 6 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~~~~g 85 (285)
T cd05631 6 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTIMNGG 85 (285)
T ss_pred EEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEecCCC
Confidence 47999999999999864 689999999875422 22346789999999999999999999999999999999999999
Q ss_pred CHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCC
Q 005102 485 SLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGS 564 (714)
Q Consensus 485 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 564 (714)
+|.+++..... ..+++..+..++.|++.||+|||+ .+|+||||||+|||+++++.+||+|||+++......
T Consensus 86 ~L~~~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~---~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~-- 156 (285)
T cd05631 86 DLKFHIYNMGN----PGFDEQRAIFYAAELCCGLEDLQR---ERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE-- 156 (285)
T ss_pred cHHHHHHhhCC----CCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC--
Confidence 99988764322 358899999999999999999999 899999999999999999999999999987542110
Q ss_pred CCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCccccCCCCcc
Q 005102 565 PTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGSSEM 644 (714)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~~~~~~~~~ 644 (714)
......||..|+|||++.+..++.++|||||||++|||++|+.||.......
T Consensus 157 ---------------------------~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~- 208 (285)
T cd05631 157 ---------------------------TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERV- 208 (285)
T ss_pred ---------------------------eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcch-
Confidence 1122356889999999999999999999999999999999999995432211
Q ss_pred hhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCC-----HHHHHH
Q 005102 645 DLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPT-----MRHISD 704 (714)
Q Consensus 645 ~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt-----~~evl~ 704 (714)
....+........ ...... ....+.+++.+||+.||++||+ ++++++
T Consensus 209 -~~~~~~~~~~~~~-------~~~~~~-----~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 260 (285)
T cd05631 209 -KREEVDRRVKEDQ-------EEYSEK-----FSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ 260 (285)
T ss_pred -hHHHHHHHhhccc-------ccCCcc-----CCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence 1111111111100 001111 1235789999999999999997 777765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=329.01 Aligned_cols=256 Identities=22% Similarity=0.325 Sum_probs=190.5
Q ss_pred cccccccCceEEEEEEECC-CcEEEEEEeCCCCchhHHHHHHHHHHHhccCCCCccceEEEEEeCC-----ceeEEEecc
Q 005102 408 AFVLGKSGIGIVYKVVLED-GHTLAVRRLGEGGSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVD-----EKLLIYDYI 481 (714)
Q Consensus 408 ~~~lG~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~-----~~~lV~e~~ 481 (714)
.+++|.|+||.||+|.... ++.||||++...... -.+|+++|++++|||||++.-+|.... ...+|||||
T Consensus 29 ~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~----knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVleym 104 (364)
T KOG0658|consen 29 VRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY----KNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLEYM 104 (364)
T ss_pred eEEEeecccceEEEEEEcCCCceeEEEEecCCCCc----CcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHHHhc
Confidence 3589999999999999754 799999998765432 247999999999999999998887532 235899999
Q ss_pred CCCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCC-CCeEEcccchhhhhhc
Q 005102 482 PNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHN-MEPHVSDFGLARLANI 560 (714)
Q Consensus 482 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~-~~~kl~DFGla~~~~~ 560 (714)
+. +|.+.++.-... .++++...++-+..||.+||+|||+ .+|+||||||.|+|+|.+ |.+||||||.|+.+..
T Consensus 105 P~-tL~~~~r~~~~~--~~~mp~~~iKLYt~Qlfrgl~yLh~---~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~ 178 (364)
T KOG0658|consen 105 PE-TLYRVIRHYTRA--NQRMPLLEIKLYTYQLFRGLAYLHS---HGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVK 178 (364)
T ss_pred hH-HHHHHHHHHhhc--CCCCceeeeHHHHHHHHHHHHHHHh---cCcccCCCChheEEEcCCCCeEEeccCCcceeecc
Confidence 87 999988742111 1457788899999999999999999 899999999999999976 9999999999998754
Q ss_pred cCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCC-CCCchhhhHHHHHHHHHHHhCCCccccC
Q 005102 561 AGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVV-KPSQKWDIYSYGVILLEMITGRTAVVQV 639 (714)
Q Consensus 561 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DVwS~Gvvl~elltG~~p~~~~ 639 (714)
.+. ..+...|++|+|||.+.+. .|+.+.||||.|||+.||+-|++.|...
T Consensus 179 ~ep-----------------------------niSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~ 229 (364)
T KOG0658|consen 179 GEP-----------------------------NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGD 229 (364)
T ss_pred CCC-----------------------------ceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCC
Confidence 321 1223347899999999875 4899999999999999999999988532
Q ss_pred CCCcchhHHHHHHHHhh---------cCCcccccCCCCCCCC----CcHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 005102 640 GSSEMDLVNWMQLCIEE---------KKPLADVLDPYLAPDA----DKEEEIIAVLKIAMACVHSSPEKRPTMRHISD 704 (714)
Q Consensus 640 ~~~~~~l~~~~~~~~~~---------~~~~~~~~d~~~~~~~----~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 704 (714)
.....+++.++ ++.- .....+...|.+.... .......+.++++.++++++|.+|.++.|++.
T Consensus 230 -s~~dQL~eIik-~lG~Pt~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~ 305 (364)
T KOG0658|consen 230 -SSVDQLVEIIK-VLGTPTREDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALA 305 (364)
T ss_pred -CHHHHHHHHHH-HhCCCCHHHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhc
Confidence 22223333322 1110 0011111122222211 11223346889999999999999999998874
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=339.60 Aligned_cols=238 Identities=19% Similarity=0.240 Sum_probs=193.1
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeCCCC---chhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCC
Q 005102 409 FVLGKSGIGIVYKVVLE-DGHTLAVRRLGEGG---SQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNG 484 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~g 484 (714)
+.||+|+||.||+|... +++.||+|++.... ....+.+.+|++++++++||||+++++++.+.+..++||||+++|
T Consensus 7 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~ 86 (291)
T cd05612 7 KTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEYVPGG 86 (291)
T ss_pred eeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEeCCCCC
Confidence 47999999999999976 58999999986532 223456889999999999999999999999999999999999999
Q ss_pred CHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCC
Q 005102 485 SLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGS 564 (714)
Q Consensus 485 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 564 (714)
+|.+++... ..+++..+..++.|++.||+|||+ ++|+||||||+|||+++++.+||+|||+++.....
T Consensus 87 ~L~~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~--- 154 (291)
T cd05612 87 ELFSYLRNS------GRFSNSTGLFYASEIVCALEYLHS---KEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR--- 154 (291)
T ss_pred CHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEEEecCcchhccCC---
Confidence 999999755 458899999999999999999999 89999999999999999999999999998754211
Q ss_pred CCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCccccCCCCcc
Q 005102 565 PTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGSSEM 644 (714)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~~~~~~~~~ 644 (714)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 155 ----------------------------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~---- 202 (291)
T cd05612 155 ----------------------------TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDN---- 202 (291)
T ss_pred ----------------------------cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC----
Confidence 112346888999999998889999999999999999999999994321
Q ss_pred hhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCC-----HHHHHH
Q 005102 645 DLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPT-----MRHISD 704 (714)
Q Consensus 645 ~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt-----~~evl~ 704 (714)
.............. ..... ...+.+++.+||+.||.+||+ ++|+++
T Consensus 203 -~~~~~~~i~~~~~~--------~~~~~-----~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 253 (291)
T cd05612 203 -PFGIYEKILAGKLE--------FPRHL-----DLYAKDLIKKLLVVDRTRRLGNMKNGADDVKN 253 (291)
T ss_pred -HHHHHHHHHhCCcC--------CCccC-----CHHHHHHHHHHcCCCHHHccCCccCCHHHHhc
Confidence 11222222222111 11111 225789999999999999995 777664
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=345.29 Aligned_cols=238 Identities=19% Similarity=0.253 Sum_probs=192.3
Q ss_pred cccccccCceEEEEEEEC-CCcEEEEEEeCCCC---chhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCC
Q 005102 408 AFVLGKSGIGIVYKVVLE-DGHTLAVRRLGEGG---SQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPN 483 (714)
Q Consensus 408 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~ 483 (714)
.+.||+|+||.||+|+.+ +++.||||++.... ....+.+.+|++++++++||||+++++++...+..++||||+++
T Consensus 23 ~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 102 (329)
T PTZ00263 23 GETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLEFVVG 102 (329)
T ss_pred EEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEEcCCCC
Confidence 357999999999999986 48899999987532 23345788999999999999999999999999999999999999
Q ss_pred CCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCC
Q 005102 484 GSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGG 563 (714)
Q Consensus 484 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 563 (714)
|+|.+++... ..+++..+..++.|++.||+|||+ ++|+||||||+|||+++++.+||+|||+++.....
T Consensus 103 ~~L~~~l~~~------~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~-- 171 (329)
T PTZ00263 103 GELFTHLRKA------GRFPNDVAKFYHAELVLAFEYLHS---KDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR-- 171 (329)
T ss_pred ChHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHEEECCCCCEEEeeccCceEcCCC--
Confidence 9999999765 457889999999999999999999 89999999999999999999999999998754211
Q ss_pred CCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCccccCCCCc
Q 005102 564 SPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGSSE 643 (714)
Q Consensus 564 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~~~~~~~~ 643 (714)
.....||+.|+|||++.+..++.++|||||||++|||+||+.||....
T Consensus 172 -----------------------------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~--- 219 (329)
T PTZ00263 172 -----------------------------TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDT--- 219 (329)
T ss_pred -----------------------------cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCC---
Confidence 112346888999999999889999999999999999999999994321
Q ss_pred chhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCC-----HHHHH
Q 005102 644 MDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPT-----MRHIS 703 (714)
Q Consensus 644 ~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt-----~~evl 703 (714)
..+...........+ ... ....+.+++.+||+.||++||+ +++++
T Consensus 220 --~~~~~~~i~~~~~~~--------p~~-----~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll 269 (329)
T PTZ00263 220 --PFRIYEKILAGRLKF--------PNW-----FDGRARDLVKGLLQTDHTKRLGTLKGGVADVK 269 (329)
T ss_pred --HHHHHHHHhcCCcCC--------CCC-----CCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHh
Confidence 112222222211111 111 1125779999999999999997 56665
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=349.54 Aligned_cols=267 Identities=22% Similarity=0.328 Sum_probs=202.0
Q ss_pred ccCHHHHHHhccccccccCceEEEEEEEC------CCcEEEEEEeCCCC-chhHHHHHHHHHHHhcc-CCCCccceEEEE
Q 005102 397 AFDLDELLKASAFVLGKSGIGIVYKVVLE------DGHTLAVRRLGEGG-SQRFKEFQTEVEAIGKI-RHSNIVTLRAYY 468 (714)
Q Consensus 397 ~~~~~~l~~~~~~~lG~G~~g~Vy~~~~~------~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~ 468 (714)
.+..++... .+.||+|+||.||+|+.. ++..||||++.... ......+.+|+++++.+ +|+||++++++|
T Consensus 34 ~~~~~~~~~--~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~ 111 (374)
T cd05106 34 EFPRDNLQF--GKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGAC 111 (374)
T ss_pred cccHHHcee--hheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEe
Confidence 344444332 458999999999998842 24589999997643 23345788999999999 899999999999
Q ss_pred EeCCceeEEEeccCCCCHhhhhhCCCCC----------------------------------------------------
Q 005102 469 WSVDEKLLIYDYIPNGSLATALHGKPGM---------------------------------------------------- 496 (714)
Q Consensus 469 ~~~~~~~lV~e~~~~gsL~~~l~~~~~~---------------------------------------------------- 496 (714)
...+..++||||+++|+|.+++......
T Consensus 112 ~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (374)
T cd05106 112 THGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSS 191 (374)
T ss_pred cCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccc
Confidence 9999999999999999999998643110
Q ss_pred ------------CCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCC
Q 005102 497 ------------VSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGS 564 (714)
Q Consensus 497 ------------~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 564 (714)
....++++.++++|+.||+.||+|||+ ++|+||||||+|||+++++.+||+|||+++.......
T Consensus 192 ~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~---~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~- 267 (374)
T cd05106 192 SQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLAS---KNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSN- 267 (374)
T ss_pred cccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHH---CCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcc-
Confidence 001357889999999999999999999 8999999999999999999999999999875432110
Q ss_pred CCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHh-CCCccccCCCCc
Q 005102 565 PTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMIT-GRTAVVQVGSSE 643 (714)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~ellt-G~~p~~~~~~~~ 643 (714)
........++..|+|||++.+..++.++|||||||++|||++ |+.||.......
T Consensus 268 -------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~ 322 (374)
T cd05106 268 -------------------------YVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS 322 (374)
T ss_pred -------------------------eeeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH
Confidence 001112234567999999998899999999999999999997 999995432211
Q ss_pred chhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhhhh
Q 005102 644 MDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDALDRLI 710 (714)
Q Consensus 644 ~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~ 710 (714)
.... ...... .+.... . ...++.+++.+||+.||++|||+.+|++.|+++.
T Consensus 323 -~~~~----~~~~~~------~~~~~~-~----~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 323 -KFYK----MVKRGY------QMSRPD-F----APPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred -HHHH----HHHccc------CccCCC-C----CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 1111 111111 011111 1 1236889999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=325.34 Aligned_cols=246 Identities=23% Similarity=0.407 Sum_probs=196.5
Q ss_pred ccccccCceEEEEEEECCCcEEEEEEeCCCCchhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCCCHhh
Q 005102 409 FVLGKSGIGIVYKVVLEDGHTLAVRRLGEGGSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGSLAT 488 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL~~ 488 (714)
+.||+|+||.||++.++++..+|+|.+..... ..++|.+|++++++++||||+++++++...+..++||||+++|+|.+
T Consensus 10 ~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~ 88 (256)
T cd05114 10 KELGSGQFGVVHLGKWRAQIKVAIKAINEGAM-SEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMENGCLLN 88 (256)
T ss_pred eEecCCcCceEEEEEeccCceEEEEecccCCc-cHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCCCCcHHH
Confidence 46999999999999998888999999875432 34678999999999999999999999999999999999999999999
Q ss_pred hhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCCCCcc
Q 005102 489 ALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQ 568 (714)
Q Consensus 489 ~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 568 (714)
+++... ..+++..+..++.|++.||+|||+ .+|+||||||+||++++++.+||+|||.++......
T Consensus 89 ~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~------ 154 (256)
T cd05114 89 YLRQRQ-----GKLSKDMLLSMCQDVCEGMEYLER---NSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDE------ 154 (256)
T ss_pred HHHhCc-----cCCCHHHHHHHHHHHHHHHHHHHH---CCccccccCcceEEEcCCCeEEECCCCCccccCCCc------
Confidence 987543 348899999999999999999999 899999999999999999999999999987542110
Q ss_pred CCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHh-CCCccccCCCCcchhH
Q 005102 569 SNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMIT-GRTAVVQVGSSEMDLV 647 (714)
Q Consensus 569 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~ellt-G~~p~~~~~~~~~~l~ 647 (714)
........++..|+|||.+.+..++.++||||||+++|||++ |+.||.... . .
T Consensus 155 ---------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~--~---~ 208 (256)
T cd05114 155 ---------------------YTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKS--N---Y 208 (256)
T ss_pred ---------------------eeccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCC--H---H
Confidence 001111223557999999988889999999999999999999 899984321 1 1
Q ss_pred HHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHh
Q 005102 648 NWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDALD 707 (714)
Q Consensus 648 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~ 707 (714)
+.+........ ...+.. ....+.+++.+||+.+|++||+++++++.|.
T Consensus 209 ~~~~~i~~~~~----~~~~~~--------~~~~~~~li~~c~~~~p~~Rps~~~l~~~l~ 256 (256)
T cd05114 209 EVVEMISRGFR----LYRPKL--------ASMTVYEVMYSCWHEKPEGRPTFAELLRAIT 256 (256)
T ss_pred HHHHHHHCCCC----CCCCCC--------CCHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 22222211111 111111 1236789999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-39 Score=340.96 Aligned_cols=241 Identities=23% Similarity=0.293 Sum_probs=191.9
Q ss_pred ccccccCceEEEEEEEC----CCcEEEEEEeCCC----CchhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEec
Q 005102 409 FVLGKSGIGIVYKVVLE----DGHTLAVRRLGEG----GSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDY 480 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~----~g~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~ 480 (714)
+.||+|+||.||+++.. +++.||||++... .......+.+|++++++++||||+++++++...+..|+||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 36999999999999863 4789999998753 122335678899999999999999999999999999999999
Q ss_pred cCCCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhc
Q 005102 481 IPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANI 560 (714)
Q Consensus 481 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 560 (714)
+++|+|.+++... ..+++..+..++.|++.||+|||+ .+|+||||||+|||+++++.+||+|||+++....
T Consensus 82 ~~~~~L~~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 152 (323)
T cd05584 82 LSGGELFMHLERE------GIFMEDTACFYLSEISLALEHLHQ---QGIIYRDLKPENILLDAQGHVKLTDFGLCKESIH 152 (323)
T ss_pred CCCchHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEeeCcCCeeccc
Confidence 9999999998755 357888999999999999999999 8999999999999999999999999999874321
Q ss_pred cCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCccccCC
Q 005102 561 AGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVG 640 (714)
Q Consensus 561 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~~~~~ 640 (714)
. ........||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 153 ~----------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~ 204 (323)
T cd05584 153 E----------------------------GTVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAEN 204 (323)
T ss_pred C----------------------------CCcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCC
Confidence 1 011123457889999999998889999999999999999999999994321
Q ss_pred CCcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCC-----CHHHHHH
Q 005102 641 SSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRP-----TMRHISD 704 (714)
Q Consensus 641 ~~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----t~~evl~ 704 (714)
....+......... +... ....+.+++.+||+.||++|| +++++++
T Consensus 205 -----~~~~~~~~~~~~~~--------~~~~-----~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~ 255 (323)
T cd05584 205 -----RKKTIDKILKGKLN--------LPPY-----LTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS 255 (323)
T ss_pred -----HHHHHHHHHcCCCC--------CCCC-----CCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence 11222222222111 1111 123578999999999999999 7777765
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-40 Score=307.81 Aligned_cols=266 Identities=26% Similarity=0.342 Sum_probs=203.7
Q ss_pred ccccccCceEEEEEE-ECCCcEEEEEEeCCCCchhHHHHHHHHHHHhccCCCCccceEEEEEeCC-----ceeEEEeccC
Q 005102 409 FVLGKSGIGIVYKVV-LEDGHTLAVRRLGEGGSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVD-----EKLLIYDYIP 482 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~-----~~~lV~e~~~ 482 (714)
+.+|+|||+-||.++ ..+++.+|+|++........+..++|++..++++|||+++++++..... ..|++++|..
T Consensus 27 ~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~yll~Pyy~ 106 (302)
T KOG2345|consen 27 RLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAYLLLPYYK 106 (302)
T ss_pred eeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEEEEeehhc
Confidence 479999999999998 5678999999999887777888999999999999999999999876433 4899999999
Q ss_pred CCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccC
Q 005102 483 NGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAG 562 (714)
Q Consensus 483 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 562 (714)
.|+|.+.+....... ..+++.++++|+.+|++||++||+..| ++.||||||.|||+.+++.+++.|||.++......
T Consensus 107 ~Gsl~d~i~~~k~kg--~~~sE~~iL~if~gic~gL~~lH~~~~-~yAH~DiKP~NILls~~~~~vl~D~GS~~~a~i~i 183 (302)
T KOG2345|consen 107 RGSLLDEIERLKIKG--NFVSEAQILWIFLGICRGLEALHEKEP-PYAHRDIKPANILLSDSGLPVLMDLGSATQAPIQI 183 (302)
T ss_pred cccHHHHHHHHhhcC--CccCHHHHHHHHHHHHHHHHHHhccCC-cccccCCCcceeEecCCCceEEEeccCccccceEe
Confidence 999999987654322 468999999999999999999999654 69999999999999999999999999987654221
Q ss_pred CCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccC---CCCCCchhhhHHHHHHHHHHHhCCCccccC
Q 005102 563 GSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLK---VVKPSQKWDIYSYGVILLEMITGRTAVVQV 639 (714)
Q Consensus 563 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~~~DVwS~Gvvl~elltG~~p~~~~ 639 (714)
... .+... .........|..|+|||.+. +...++++|||||||++|+|+.|..||...
T Consensus 184 ~~~--------------~~a~~-----lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~ 244 (302)
T KOG2345|consen 184 EGS--------------RQALR-----LQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERI 244 (302)
T ss_pred ech--------------HHHHH-----HHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHH
Confidence 100 00000 01112223477899999984 455799999999999999999999999432
Q ss_pred CCCcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhhhh
Q 005102 640 GSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDALDRLI 710 (714)
Q Consensus 640 ~~~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~ 710 (714)
...+..+. -.+..+.+.-... ....+.+.+++..|++.||.+||++.+++..++.+.
T Consensus 245 ~~~GgSla-------------LAv~n~q~s~P~~-~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 245 YQQGGSLA-------------LAVQNAQISIPNS-SRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred hhcCCeEE-------------EeeeccccccCCC-CCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 22111111 1111211111111 114457899999999999999999999999998764
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=343.47 Aligned_cols=235 Identities=22% Similarity=0.310 Sum_probs=193.8
Q ss_pred ccccccCceEEEEEEECC-CcEEEEEEeCCCC---chhHHHHHHHHHHHhcc-CCCCccceEEEEEeCCceeEEEeccCC
Q 005102 409 FVLGKSGIGIVYKVVLED-GHTLAVRRLGEGG---SQRFKEFQTEVEAIGKI-RHSNIVTLRAYYWSVDEKLLIYDYIPN 483 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~~-g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~e~~~~ 483 (714)
.+||+|+||+|+++..+. ++.+|||++++.. ..+.+..+.|.+|+... +||.+++++.+|++.++.|+||||+.|
T Consensus 374 ~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~fvmey~~G 453 (694)
T KOG0694|consen 374 AVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFFVMEYVAG 453 (694)
T ss_pred EEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEEEEEecCC
Confidence 489999999999999864 7899999999863 34456778888888877 599999999999999999999999999
Q ss_pred CCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCC
Q 005102 484 GSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGG 563 (714)
Q Consensus 484 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 563 (714)
||+..+.+. ..+++..+.-|+..|+.||+|||+ ++||+||||.+|||+|.+|++||+|||+++..-..
T Consensus 454 gdm~~~~~~-------~~F~e~rarfyaAev~l~L~fLH~---~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~-- 521 (694)
T KOG0694|consen 454 GDLMHHIHT-------DVFSEPRARFYAAEVVLGLQFLHE---NGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQ-- 521 (694)
T ss_pred CcEEEEEec-------ccccHHHHHHHHHHHHHHHHHHHh---cCceeeecchhheEEcccCcEEecccccccccCCC--
Confidence 996655543 359999999999999999999999 99999999999999999999999999999843210
Q ss_pred CCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCccccCCCCc
Q 005102 564 SPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGSSE 643 (714)
Q Consensus 564 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~~~~~~~~ 643 (714)
...+++..||+.|||||++.+..|+.++|.|||||+||||+.|..||.. +++
T Consensus 522 --------------------------g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~g--ddE 573 (694)
T KOG0694|consen 522 --------------------------GDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPG--DDE 573 (694)
T ss_pred --------------------------CCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCC--CCH
Confidence 3356678899999999999999999999999999999999999999942 233
Q ss_pred chhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCH
Q 005102 644 MDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTM 699 (714)
Q Consensus 644 ~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~ 699 (714)
.++. ..++.+.. ..+. ....+...|+++.+.++|++|.-+
T Consensus 574 ee~F---dsI~~d~~--------~yP~-----~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 574 EEVF---DSIVNDEV--------RYPR-----FLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred HHHH---HHHhcCCC--------CCCC-----cccHHHHHHHHHHhccCcccccCC
Confidence 3322 22222221 1111 123367889999999999999765
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-39 Score=339.54 Aligned_cols=192 Identities=26% Similarity=0.337 Sum_probs=166.9
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeCCCCc-hhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCCCH
Q 005102 409 FVLGKSGIGIVYKVVLE-DGHTLAVRRLGEGGS-QRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGSL 486 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL 486 (714)
..||+|+||.||+++.. +|..||+|.+..... ...+.+.+|++++++++||||+++++++...+..++||||+++|+|
T Consensus 11 ~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 90 (331)
T cd06649 11 SELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSL 90 (331)
T ss_pred EeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEeecCCCCcH
Confidence 47999999999999986 488999999876532 3346799999999999999999999999999999999999999999
Q ss_pred hhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCCCC
Q 005102 487 ATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPT 566 (714)
Q Consensus 487 ~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 566 (714)
.+++... ..+++..+..++.|++.||.|||+. .+|+||||||+|||+++++.+||+|||+++.....
T Consensus 91 ~~~l~~~------~~~~~~~~~~~~~~i~~~l~~lH~~--~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~----- 157 (331)
T cd06649 91 DQVLKEA------KRIPEEILGKVSIAVLRGLAYLREK--HQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----- 157 (331)
T ss_pred HHHHHHc------CCCCHHHHHHHHHHHHHHHHHHhhc--CCEEcCCCChhhEEEcCCCcEEEccCccccccccc-----
Confidence 9999765 3588999999999999999999982 25999999999999999999999999998754211
Q ss_pred ccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCcccc
Q 005102 567 LQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQ 638 (714)
Q Consensus 567 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~~~ 638 (714)
......||+.|+|||++.+..++.++|||||||++|||+||+.||..
T Consensus 158 -------------------------~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~ 204 (331)
T cd06649 158 -------------------------MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPP 204 (331)
T ss_pred -------------------------ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence 11223468889999999998999999999999999999999999943
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-40 Score=325.64 Aligned_cols=239 Identities=21% Similarity=0.322 Sum_probs=201.2
Q ss_pred cccccCceEEEEEEE-CCCcEEEEEEeCCC---CchhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCCC
Q 005102 410 VLGKSGIGIVYKVVL-EDGHTLAVRRLGEG---GSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGS 485 (714)
Q Consensus 410 ~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gs 485 (714)
.||+|.||+|-+|.. ..|+.||||.+++. +.++.-.+.+||+||+.++||||+.++.+|+..+...+||||..+|.
T Consensus 60 tLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivMEYaS~Ge 139 (668)
T KOG0611|consen 60 TLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVMEYASGGE 139 (668)
T ss_pred HhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEEEecCCcc
Confidence 699999999999985 56999999999875 44455678899999999999999999999999999999999999999
Q ss_pred HhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCCC
Q 005102 486 LATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSP 565 (714)
Q Consensus 486 L~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 565 (714)
|++++.+. +.|++.+++++++||..|+.|+|. ++++|||||.+|||+|+++++||+|||++-++....
T Consensus 140 LYDYiSer------~~LsErEaRhfFRQIvSAVhYCHk---nrVvHRDLKLENILLD~N~NiKIADFGLSNly~~~k--- 207 (668)
T KOG0611|consen 140 LYDYISER------GSLSEREARHFFRQIVSAVHYCHK---NRVVHRDLKLENILLDQNNNIKIADFGLSNLYADKK--- 207 (668)
T ss_pred HHHHHHHh------ccccHHHHHHHHHHHHHHHHHHhh---ccceecccchhheeecCCCCeeeeccchhhhhcccc---
Confidence 99999877 569999999999999999999999 999999999999999999999999999998775321
Q ss_pred CccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCC-CchhhhHHHHHHHHHHHhCCCccccCCCCcc
Q 005102 566 TLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKP-SQKWDIYSYGVILLEMITGRTAVVQVGSSEM 644 (714)
Q Consensus 566 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~~DVwS~Gvvl~elltG~~p~~~~~~~~~ 644 (714)
...+++|++-|.+||++.|.+| ++.+|-||+||+||.|+.|.-||+ +.
T Consensus 208 --------------------------fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFD-----G~ 256 (668)
T KOG0611|consen 208 --------------------------FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFD-----GR 256 (668)
T ss_pred --------------------------HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccC-----Cc
Confidence 2335678899999999999888 688999999999999999999994 23
Q ss_pred hhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 005102 645 DLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDA 705 (714)
Q Consensus 645 ~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 705 (714)
+....++.+-.... ..|.. .....-+|++||..||++|-|+.+|..-
T Consensus 257 Dhk~lvrQIs~GaY-----rEP~~---------PSdA~gLIRwmLmVNP~RRATieDiAsH 303 (668)
T KOG0611|consen 257 DHKRLVRQISRGAY-----REPET---------PSDASGLIRWMLMVNPERRATIEDIASH 303 (668)
T ss_pred hHHHHHHHhhcccc-----cCCCC---------CchHHHHHHHHHhcCcccchhHHHHhhh
Confidence 33334433322221 11211 1135578999999999999999999753
|
|
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=332.01 Aligned_cols=248 Identities=31% Similarity=0.504 Sum_probs=189.7
Q ss_pred ccccccCceEEEEEEEC-----CCcEEEEEEeCCCCc-hhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccC
Q 005102 409 FVLGKSGIGIVYKVVLE-----DGHTLAVRRLGEGGS-QRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIP 482 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~-----~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~ 482 (714)
+.||.|.||.||+|.+. .+..|+||.++.... ...+.|.+|++.+++++||||++++|++...+..++||||++
T Consensus 5 ~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~~~ 84 (259)
T PF07714_consen 5 KQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEYCP 84 (259)
T ss_dssp EEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE--T
T ss_pred eEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccccc
Confidence 47999999999999987 257899999976433 346789999999999999999999999998888999999999
Q ss_pred CCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccC
Q 005102 483 NGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAG 562 (714)
Q Consensus 483 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 562 (714)
+|+|.+++..... ..+++.++.+|+.||++||+|||+ ++++|+||+++||++++++.+||+|||+++......
T Consensus 85 ~g~L~~~L~~~~~----~~~~~~~~~~i~~~i~~~l~~Lh~---~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~ 157 (259)
T PF07714_consen 85 GGSLDDYLKSKNK----EPLSEQQRLSIAIQIAEALSYLHS---NNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKS 157 (259)
T ss_dssp TEBHHHHHHHTCT----TTSBHHHHHHHHHHHHHHHHHHHH---TTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSS
T ss_pred ccccccccccccc----cccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccccc
Confidence 9999999987622 458999999999999999999999 899999999999999999999999999987652111
Q ss_pred CCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHh-CCCccccCCC
Q 005102 563 GSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMIT-GRTAVVQVGS 641 (714)
Q Consensus 563 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~ellt-G~~p~~~~~~ 641 (714)
. ............|+|||.+.+..++.++||||||+++|||++ |+.||.+.
T Consensus 158 ~--------------------------~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~-- 209 (259)
T PF07714_consen 158 K--------------------------YKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDY-- 209 (259)
T ss_dssp S--------------------------EEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTS--
T ss_pred c--------------------------ccccccccccccccccccccccccccccccccccccccccccccccccccc--
Confidence 0 011112223566999999988889999999999999999999 67887433
Q ss_pred CcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHH
Q 005102 642 SEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDAL 706 (714)
Q Consensus 642 ~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L 706 (714)
+..++.... ..... ...... ....+.+++.+||+.||++|||++++++.|
T Consensus 210 ---~~~~~~~~~-~~~~~------~~~~~~-----~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 210 ---DNEEIIEKL-KQGQR------LPIPDN-----CPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp ---CHHHHHHHH-HTTEE------TTSBTT-----SBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred ---ccccccccc-ccccc------ceeccc-----hhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 122222222 22111 001111 123688999999999999999999999886
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=354.63 Aligned_cols=261 Identities=20% Similarity=0.292 Sum_probs=205.3
Q ss_pred ccccccccCceEEEEEEECCC-cEEEEEEeCCCCchhHHHHHHHHHHHhccC-CCCccceEEE-EEe---C---CceeEE
Q 005102 407 SAFVLGKSGIGIVYKVVLEDG-HTLAVRRLGEGGSQRFKEFQTEVEAIGKIR-HSNIVTLRAY-YWS---V---DEKLLI 477 (714)
Q Consensus 407 ~~~~lG~G~~g~Vy~~~~~~g-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~-~~~---~---~~~~lV 477 (714)
..++|.+|||+.||.|....+ ..+|+|++...++...+...+||++|++|+ |+|||.+++. ... . -+.+|.
T Consensus 41 V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~EvllL 120 (738)
T KOG1989|consen 41 VEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEVLLL 120 (738)
T ss_pred EEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeEEEee
Confidence 356899999999999998876 999999998888888899999999999997 9999999993 321 1 256899
Q ss_pred EeccCCCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhh
Q 005102 478 YDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARL 557 (714)
Q Consensus 478 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 557 (714)
||||.+|.|-+++..+-. ..|++.++++|+.|+++|+++||.+.| +|||||||-+||||+.+++.||||||.|..
T Consensus 121 mEyC~gg~Lvd~mn~Rlq----~~lte~eVLkIf~dv~~AVa~mH~~~p-PiIHRDLKiENvLls~~g~~KLCDFGSatt 195 (738)
T KOG1989|consen 121 MEYCKGGSLVDFMNTRLQ----TRLTEDEVLKIFYDVCEAVAAMHYLKP-PIIHRDLKIENVLLSADGNYKLCDFGSATT 195 (738)
T ss_pred hhhccCCcHHHHHHHHHh----ccCChHHHHHHHHHHHHHHHHHhcCCC-ccchhhhhhhheEEcCCCCEEeCccccccc
Confidence 999999999999986533 459999999999999999999999765 899999999999999999999999998864
Q ss_pred hhccCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCccc---CCCCCCchhhhHHHHHHHHHHHhCCC
Q 005102 558 ANIAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESL---KVVKPSQKWDIYSYGVILLEMITGRT 634 (714)
Q Consensus 558 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~---~~~~~s~~~DVwS~Gvvl~elltG~~ 634 (714)
.-.... ..++. ..........-|+-|+|||++ .+..+++|+||||+||+||-|.....
T Consensus 196 ~~~~~~------------~~~e~-------~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~ 256 (738)
T KOG1989|consen 196 KILSPT------------SAQEV-------NYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTT 256 (738)
T ss_pred ccCCCc------------cHHHH-------HHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCC
Confidence 321100 00000 001111122337789999998 46778999999999999999999999
Q ss_pred ccccCCCCcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhhhhc
Q 005102 635 AVVQVGSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDALDRLIV 711 (714)
Q Consensus 635 p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~ 711 (714)
||...+. ..+++....-. ........+.+||..||+.||++||++-+|+..+.++..
T Consensus 257 PFe~sg~-------------------laIlng~Y~~P-~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~ 313 (738)
T KOG1989|consen 257 PFEESGK-------------------LAILNGNYSFP-PFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELAN 313 (738)
T ss_pred CcCcCcc-------------------eeEEeccccCC-CCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhc
Confidence 9954322 12222222111 113456689999999999999999999999999988764
|
|
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=328.58 Aligned_cols=260 Identities=24% Similarity=0.374 Sum_probs=203.4
Q ss_pred ccccccCceEEEEEEEC------CCcEEEEEEeCCCCchhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccC
Q 005102 409 FVLGKSGIGIVYKVVLE------DGHTLAVRRLGEGGSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIP 482 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~ 482 (714)
+.||+|+||+||++... ++..+|+|.+........+.+.+|++++++++||||+++++++...+..++||||++
T Consensus 11 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 90 (288)
T cd05093 11 RELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMK 90 (288)
T ss_pred cccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEEcCC
Confidence 47999999999999852 346799999987665556789999999999999999999999999999999999999
Q ss_pred CCCHhhhhhCCCC-------CCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchh
Q 005102 483 NGSLATALHGKPG-------MVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLA 555 (714)
Q Consensus 483 ~gsL~~~l~~~~~-------~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla 555 (714)
+++|.+++..... ......+++.++++++.|++.||+|||+ ++++||||||+||++++++.+||+|||++
T Consensus 91 ~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~---~~i~H~dlkp~Nili~~~~~~kl~dfg~~ 167 (288)
T cd05093 91 HGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLAS---QHFVHRDLATRNCLVGENLLVKIGDFGMS 167 (288)
T ss_pred CCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccCcceEEEccCCcEEeccCCcc
Confidence 9999999874421 0111358999999999999999999999 89999999999999999999999999998
Q ss_pred hhhhccCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHh-CCC
Q 005102 556 RLANIAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMIT-GRT 634 (714)
Q Consensus 556 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~ellt-G~~ 634 (714)
+....... ........++..|+|||++.+..++.++|||||||++|||+| |+.
T Consensus 168 ~~~~~~~~--------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~ 221 (288)
T cd05093 168 RDVYSTDY--------------------------YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQ 221 (288)
T ss_pred ccccCCce--------------------------eecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCC
Confidence 75432110 001112234567999999998889999999999999999999 898
Q ss_pred ccccCCCCcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhhhhccCC
Q 005102 635 AVVQVGSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDALDRLIVSSD 714 (714)
Q Consensus 635 p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~~~~ 714 (714)
||..... .+. ...... ... . ..... ...++.+++.+||+.||.+|||+.++.+.|+++..+++
T Consensus 222 p~~~~~~--~~~---~~~i~~-~~~-~-----~~~~~-----~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~~~ 284 (288)
T cd05093 222 PWYQLSN--NEV---IECITQ-GRV-L-----QRPRT-----CPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKASP 284 (288)
T ss_pred CCCCCCH--HHH---HHHHHc-CCc-C-----CCCCC-----CCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHhcc
Confidence 8843321 111 111111 110 0 01111 12368899999999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=327.33 Aligned_cols=249 Identities=24% Similarity=0.435 Sum_probs=199.5
Q ss_pred ccccccCceEEEEEEECCCcEEEEEEeCCCCchhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCCCHhh
Q 005102 409 FVLGKSGIGIVYKVVLEDGHTLAVRRLGEGGSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGSLAT 488 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL~~ 488 (714)
+.||+|+||.||+|...++..||+|.+..... ..+.+.+|+.++++++|+||+++++++...+..++||||+++|+|.+
T Consensus 12 ~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 90 (261)
T cd05072 12 KKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTM-SVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLD 90 (261)
T ss_pred eecCCcCCceEEEEEecCCceEEEEEccCCch-hHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCCCCcHHH
Confidence 47999999999999988888999999875432 34689999999999999999999999999999999999999999999
Q ss_pred hhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCCCCcc
Q 005102 489 ALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQ 568 (714)
Q Consensus 489 ~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 568 (714)
+++.... ..+++.+++.++.|++.||+|||+ .+++||||||+||++++++.+||+|||+++......
T Consensus 91 ~l~~~~~----~~~~~~~~~~~~~~l~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~------ 157 (261)
T cd05072 91 FLKSDEG----GKVLLPKLIDFSAQIAEGMAYIER---KNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNE------ 157 (261)
T ss_pred HHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhhEEecCCCcEEECCCccceecCCCc------
Confidence 9975432 458899999999999999999999 899999999999999999999999999997643211
Q ss_pred CCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHh-CCCccccCCCCcchhH
Q 005102 569 SNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMIT-GRTAVVQVGSSEMDLV 647 (714)
Q Consensus 569 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~ellt-G~~p~~~~~~~~~~l~ 647 (714)
........++..|+|||++.+..++.++|||||||++|||+| |+.||.... ..+..
T Consensus 158 ---------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~--~~~~~ 214 (261)
T cd05072 158 ---------------------YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMS--NSDVM 214 (261)
T ss_pred ---------------------eeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCC--HHHHH
Confidence 001112234567999999988889999999999999999999 999984321 11122
Q ss_pred HHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhhh
Q 005102 648 NWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDALDRL 709 (714)
Q Consensus 648 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i 709 (714)
..+ ...... +.. . ....++.+++.+||..+|++|||++++.+.|+++
T Consensus 215 ~~~----~~~~~~-----~~~-~-----~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 261 (261)
T cd05072 215 SAL----QRGYRM-----PRM-E-----NCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF 261 (261)
T ss_pred HHH----HcCCCC-----CCC-C-----CCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence 111 111110 110 1 1223678999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=329.95 Aligned_cols=257 Identities=21% Similarity=0.271 Sum_probs=190.9
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeCCCCc-hhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCCCH
Q 005102 409 FVLGKSGIGIVYKVVLE-DGHTLAVRRLGEGGS-QRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGSL 486 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL 486 (714)
+.||+|+||.||+|+.+ +++.||+|+++.... .....+.+|++++++++||||+++++++...+..++||||++ |+|
T Consensus 11 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~-~~l 89 (288)
T cd07871 11 DKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEYLD-SDL 89 (288)
T ss_pred eEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeCCC-cCH
Confidence 47999999999999976 588999999875432 233567899999999999999999999999889999999997 499
Q ss_pred hhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCCCC
Q 005102 487 ATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPT 566 (714)
Q Consensus 487 ~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 566 (714)
.+++.... ..+++..+..++.||+.||+|||+ ++|+||||||+|||+++++.+||+|||+++......
T Consensus 90 ~~~l~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~---- 157 (288)
T cd07871 90 KQYLDNCG-----NLMSMHNVKIFMFQLLRGLSYCHK---RKILHRDLKPQNLLINEKGELKLADFGLARAKSVPT---- 157 (288)
T ss_pred HHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEECcCcceeeccCCC----
Confidence 99886543 347889999999999999999999 899999999999999999999999999987532110
Q ss_pred ccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCC-CCCCchhhhHHHHHHHHHHHhCCCccccCCCCcch
Q 005102 567 LQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKV-VKPSQKWDIYSYGVILLEMITGRTAVVQVGSSEMD 645 (714)
Q Consensus 567 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DVwS~Gvvl~elltG~~p~~~~~~~~~~ 645 (714)
.......+++.|+|||.+.+ ..++.++||||+||++|||+||+.||..... .+
T Consensus 158 ------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~--~~ 211 (288)
T cd07871 158 ------------------------KTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTV--KE 211 (288)
T ss_pred ------------------------ccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCH--HH
Confidence 01122345788999999865 5689999999999999999999999943221 11
Q ss_pred hHHHHHHHHhhcC-----------CcccccCCCCCCCCC---cHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 005102 646 LVNWMQLCIEEKK-----------PLADVLDPYLAPDAD---KEEEIIAVLKIAMACVHSSPEKRPTMRHISD 704 (714)
Q Consensus 646 l~~~~~~~~~~~~-----------~~~~~~d~~~~~~~~---~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 704 (714)
....+........ .......+....... ......++.+++.+|+..||.+|||++|+++
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 212 ELHLIFRLLGTPTEETWPGITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred HHHHHHHHhCCCChHHhhccccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 1111111111000 000001111000000 0011235779999999999999999999874
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-39 Score=341.51 Aligned_cols=239 Identities=19% Similarity=0.231 Sum_probs=191.8
Q ss_pred cccccccCceEEEEEEECC--CcEEEEEEeCCC---CchhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccC
Q 005102 408 AFVLGKSGIGIVYKVVLED--GHTLAVRRLGEG---GSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIP 482 (714)
Q Consensus 408 ~~~lG~G~~g~Vy~~~~~~--g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~ 482 (714)
.+.||+|+||.||+|.+++ +..||+|++... .....+.+.+|+++++.++||||+++++++.+.+..++||||++
T Consensus 35 ~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~Ey~~ 114 (340)
T PTZ00426 35 IRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVI 114 (340)
T ss_pred EEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEEEeCCC
Confidence 3579999999999998654 368999998653 22334578899999999999999999999999999999999999
Q ss_pred CCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccC
Q 005102 483 NGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAG 562 (714)
Q Consensus 483 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 562 (714)
+|+|.+++... ..+++..+..++.|++.||+|||+ .+|+||||||+|||++.++++||+|||+++.....
T Consensus 115 ~g~L~~~i~~~------~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~- 184 (340)
T PTZ00426 115 GGEFFTFLRRN------KRFPNDVGCFYAAQIVLIFEYLQS---LNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR- 184 (340)
T ss_pred CCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeEccCCCHHHEEECCCCCEEEecCCCCeecCCC-
Confidence 99999999765 458899999999999999999999 89999999999999999999999999998754210
Q ss_pred CCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCccccCCCC
Q 005102 563 GSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGSS 642 (714)
Q Consensus 563 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~~~~~~~ 642 (714)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus 185 ------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~- 233 (340)
T PTZ00426 185 ------------------------------TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEP- 233 (340)
T ss_pred ------------------------------cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCH-
Confidence 1123478899999999988899999999999999999999999953211
Q ss_pred cchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCC-----CHHHHHH
Q 005102 643 EMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRP-----TMRHISD 704 (714)
Q Consensus 643 ~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----t~~evl~ 704 (714)
............. .+... ...+.+++.+||+.||++|+ +++++++
T Consensus 234 ----~~~~~~i~~~~~~--------~p~~~-----~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~ 283 (340)
T PTZ00426 234 ----LLIYQKILEGIIY--------FPKFL-----DNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKE 283 (340)
T ss_pred ----HHHHHHHhcCCCC--------CCCCC-----CHHHHHHHHHHcccCHHHcCCCCCCCHHHHHc
Confidence 1111121111111 11111 12467899999999999995 7887764
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=316.74 Aligned_cols=260 Identities=22% Similarity=0.333 Sum_probs=194.5
Q ss_pred cccccCceEEEEEEEC-CCcEEEEEEeCCCCc--hhHHHHHHHHHHHhccCCCC-ccceEEEEEeCC------ceeEEEe
Q 005102 410 VLGKSGIGIVYKVVLE-DGHTLAVRRLGEGGS--QRFKEFQTEVEAIGKIRHSN-IVTLRAYYWSVD------EKLLIYD 479 (714)
Q Consensus 410 ~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~n-iv~l~~~~~~~~------~~~lV~e 479 (714)
.||+|+||+||+|+.+ +|+.||+|+++.... .......+|+.++++++|+| ||++++++...+ ..++|||
T Consensus 18 klGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~l~lvfe 97 (323)
T KOG0594|consen 18 KLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGKLYLVFE 97 (323)
T ss_pred HhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccceEEEEEE
Confidence 4999999999999964 689999999986533 23346789999999999999 999999999877 7889999
Q ss_pred ccCCCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhh
Q 005102 480 YIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLAN 559 (714)
Q Consensus 480 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~ 559 (714)
|++. +|.+++....... +.++...++.++.|+++||+|||+ ++|+||||||+||||+++|.+||+|||+|+...
T Consensus 98 ~~d~-DL~~ymd~~~~~~--~g~~~~~ik~~m~Qll~gl~~~H~---~~IlHRDLKPQNlLi~~~G~lKlaDFGlAra~~ 171 (323)
T KOG0594|consen 98 FLDR-DLKKYMDSLPKKP--QGLPPRLIKSFMRQLLRGLAFLHS---HGILHRDLKPQNLLISSSGVLKLADFGLARAFS 171 (323)
T ss_pred eecc-cHHHHHHhccccc--cCCCHHHHHHHHHHHHHHHHHHHh---CCeecccCCcceEEECCCCcEeeeccchHHHhc
Confidence 9965 9999998764211 246678899999999999999999 999999999999999999999999999999654
Q ss_pred ccCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCC-CCCchhhhHHHHHHHHHHHhCCCcccc
Q 005102 560 IAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVV-KPSQKWDIYSYGVILLEMITGRTAVVQ 638 (714)
Q Consensus 560 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DVwS~Gvvl~elltG~~p~~~ 638 (714)
.+. ...+...+|.+|+|||++.+. .|++..||||+|||+.||++++..|..
T Consensus 172 ip~----------------------------~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG 223 (323)
T KOG0594|consen 172 IPM----------------------------RTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPG 223 (323)
T ss_pred CCc----------------------------ccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCC
Confidence 221 112344568899999999987 689999999999999999999988843
Q ss_pred CCCCcchhHHHHHHHHh----hcCC-cccc--cCCCCCCCC---CcH----HHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 005102 639 VGSSEMDLVNWMQLCIE----EKKP-LADV--LDPYLAPDA---DKE----EEIIAVLKIAMACVHSSPEKRPTMRHISD 704 (714)
Q Consensus 639 ~~~~~~~l~~~~~~~~~----~~~~-~~~~--~d~~~~~~~---~~~----~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 704 (714)
... .+...-+-..+. +.++ .... .++...... ... .......+++.+|++.+|.+|.|++.++.
T Consensus 224 ~se--~~ql~~If~~lGtP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~ 301 (323)
T KOG0594|consen 224 DSE--IDQLFRIFRLLGTPNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALT 301 (323)
T ss_pred CcH--HHHHHHHHHHcCCCCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhc
Confidence 322 221111111111 1111 0000 011111110 000 01135779999999999999999999887
Q ss_pred H
Q 005102 705 A 705 (714)
Q Consensus 705 ~ 705 (714)
.
T Consensus 302 h 302 (323)
T KOG0594|consen 302 H 302 (323)
T ss_pred C
Confidence 4
|
|
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-39 Score=338.22 Aligned_cols=236 Identities=22% Similarity=0.282 Sum_probs=188.8
Q ss_pred cccccCceEEEEEEEC-CCcEEEEEEeCCC---CchhHHHHHHHHHHHhcc-CCCCccceEEEEEeCCceeEEEeccCCC
Q 005102 410 VLGKSGIGIVYKVVLE-DGHTLAVRRLGEG---GSQRFKEFQTEVEAIGKI-RHSNIVTLRAYYWSVDEKLLIYDYIPNG 484 (714)
Q Consensus 410 ~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~e~~~~g 484 (714)
+||+|+||.||+|+.+ +++.||||++.+. .....+.+..|..++..+ +||||+++++++...+..++||||+++|
T Consensus 2 ~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~g 81 (320)
T cd05590 2 VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNGG 81 (320)
T ss_pred eeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCCc
Confidence 6999999999999976 4889999998753 223345677899998877 6999999999999999999999999999
Q ss_pred CHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCC
Q 005102 485 SLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGS 564 (714)
Q Consensus 485 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 564 (714)
+|.+++... ..+++..+..++.|++.||+|||+ ++|+||||||+|||+++++.+||+|||+++.....
T Consensus 82 ~L~~~i~~~------~~l~~~~~~~~~~ql~~~L~~lH~---~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~--- 149 (320)
T cd05590 82 DLMFHIQKS------RRFDEARARFYAAEITSALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFN--- 149 (320)
T ss_pred hHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcC---
Confidence 999988755 458899999999999999999999 89999999999999999999999999998743211
Q ss_pred CCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCccccCCCCcc
Q 005102 565 PTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGSSEM 644 (714)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~~~~~~~~~ 644 (714)
........||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 150 -------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~---- 200 (320)
T cd05590 150 -------------------------GKTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAEN---- 200 (320)
T ss_pred -------------------------CCcccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCC----
Confidence 011123457889999999998899999999999999999999999994321
Q ss_pred hhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHH
Q 005102 645 DLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMR 700 (714)
Q Consensus 645 ~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ 700 (714)
.............. .... ....+.+++.+||+.||++||++.
T Consensus 201 -~~~~~~~i~~~~~~--------~~~~-----~~~~~~~li~~~L~~dP~~R~~~~ 242 (320)
T cd05590 201 -EDDLFEAILNDEVV--------YPTW-----LSQDAVDILKAFMTKNPTMRLGSL 242 (320)
T ss_pred -HHHHHHHHhcCCCC--------CCCC-----CCHHHHHHHHHHcccCHHHCCCCC
Confidence 11222222221111 1111 123578999999999999999983
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-38 Score=322.75 Aligned_cols=250 Identities=28% Similarity=0.392 Sum_probs=199.3
Q ss_pred ccccccCceEEEEEEECC-CcEEEEEEeCCCCchhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCCCHh
Q 005102 409 FVLGKSGIGIVYKVVLED-GHTLAVRRLGEGGSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGSLA 487 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL~ 487 (714)
+.||+|+||.||+|.+.+ ++.||+|.+.... ...+++.+|++++++++||||+++++++...+..++||||+++++|.
T Consensus 12 ~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 90 (263)
T cd05052 12 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLL 90 (263)
T ss_pred eecCCcccceEEEEEEecCCceEEEEEecCCc-hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeCCCCcHH
Confidence 479999999999999764 8899999987543 33567899999999999999999999999999999999999999999
Q ss_pred hhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCCCCc
Q 005102 488 TALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTL 567 (714)
Q Consensus 488 ~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 567 (714)
+++..... ..+++..++.++.|++.||+|||+ ++++||||||+||++++++.+||+|||+++......
T Consensus 91 ~~~~~~~~----~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~----- 158 (263)
T cd05052 91 DYLRECNR----QEVNAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT----- 158 (263)
T ss_pred HHHHhCCC----CCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccCcceEEEcCCCcEEeCCCccccccccce-----
Confidence 99875432 458999999999999999999999 899999999999999999999999999987653210
Q ss_pred cCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHh-CCCccccCCCCcchh
Q 005102 568 QSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMIT-GRTAVVQVGSSEMDL 646 (714)
Q Consensus 568 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~ellt-G~~p~~~~~~~~~~l 646 (714)
........++..|+|||.+.+..++.++|||||||++|||++ |..||... +.
T Consensus 159 ----------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~-----~~ 211 (263)
T cd05052 159 ----------------------YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI-----DL 211 (263)
T ss_pred ----------------------eeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCC-----CH
Confidence 000111223456999999998899999999999999999998 89998432 11
Q ss_pred HHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhhhh
Q 005102 647 VNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDALDRLI 710 (714)
Q Consensus 647 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~ 710 (714)
.+....... .. .+..... ...++.+++.+||+.||++|||+.++++.|+++.
T Consensus 212 ~~~~~~~~~-~~------~~~~~~~-----~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 263 (263)
T cd05052 212 SQVYELLEK-GY------RMERPEG-----CPPKVYELMRACWQWNPSDRPSFAEIHQAFETMF 263 (263)
T ss_pred HHHHHHHHC-CC------CCCCCCC-----CCHHHHHHHHHHccCCcccCCCHHHHHHHHHhhC
Confidence 222222111 11 1111111 2246889999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-39 Score=338.48 Aligned_cols=240 Identities=21% Similarity=0.300 Sum_probs=190.6
Q ss_pred cccccCceEEEEEEECC-CcEEEEEEeCCC---CchhHHHHHHHHHHHhcc-CCCCccceEEEEEeCCceeEEEeccCCC
Q 005102 410 VLGKSGIGIVYKVVLED-GHTLAVRRLGEG---GSQRFKEFQTEVEAIGKI-RHSNIVTLRAYYWSVDEKLLIYDYIPNG 484 (714)
Q Consensus 410 ~lG~G~~g~Vy~~~~~~-g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~e~~~~g 484 (714)
+||+|+||.||+|+... ++.||||++... .....+.+..|.+++..+ +||||+++++++...+..|+||||+++|
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 81 (321)
T cd05591 2 VLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNGG 81 (321)
T ss_pred ccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCCC
Confidence 69999999999999764 789999998763 223345677899998876 7999999999999999999999999999
Q ss_pred CHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCC
Q 005102 485 SLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGS 564 (714)
Q Consensus 485 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 564 (714)
+|...+... ..+++..+..++.|++.||+|||+ .+|+||||||+||++++++.+||+|||+++......
T Consensus 82 ~L~~~l~~~------~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~-- 150 (321)
T cd05591 82 DLMFQIQRS------RKFDEPRSRFYAAEVTLALMFLHR---HGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG-- 150 (321)
T ss_pred cHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEeecccceecccCC--
Confidence 999988755 458899999999999999999999 899999999999999999999999999987432110
Q ss_pred CCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCccccCCCCcc
Q 005102 565 PTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGSSEM 644 (714)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~~~~~~~~~ 644 (714)
.......||+.|+|||++.+..++.++|||||||++|||+||+.||.... ..
T Consensus 151 --------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~--~~ 202 (321)
T cd05591 151 --------------------------VTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADN--ED 202 (321)
T ss_pred --------------------------ccccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCC--HH
Confidence 11123357889999999998899999999999999999999999994321 11
Q ss_pred hhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCC-------CHHHHHH
Q 005102 645 DLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRP-------TMRHISD 704 (714)
Q Consensus 645 ~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RP-------t~~evl~ 704 (714)
............ .| .. ...++.+++.+||+.||++|| +++++++
T Consensus 203 ---~~~~~i~~~~~~-----~p---~~-----~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~ 253 (321)
T cd05591 203 ---DLFESILHDDVL-----YP---VW-----LSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQ 253 (321)
T ss_pred ---HHHHHHHcCCCC-----CC---CC-----CCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhc
Confidence 222222221111 01 01 123578999999999999999 6666653
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-39 Score=340.95 Aligned_cols=241 Identities=22% Similarity=0.277 Sum_probs=192.0
Q ss_pred cccccCceEEEEEEEC-CCcEEEEEEeCCC---CchhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCCC
Q 005102 410 VLGKSGIGIVYKVVLE-DGHTLAVRRLGEG---GSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGS 485 (714)
Q Consensus 410 ~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gs 485 (714)
.||+|+||.||++... +|+.||+|++... .......+.+|++++..++||||+++++++...+..++||||+++|+
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~~ 81 (325)
T cd05594 2 LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGE 81 (325)
T ss_pred eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCCc
Confidence 6999999999999975 5899999999753 22334567889999999999999999999999999999999999999
Q ss_pred HhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCCC
Q 005102 486 LATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSP 565 (714)
Q Consensus 486 L~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 565 (714)
|.+++... ..+++..+..++.||+.||+|||+. .+|+||||||+|||+++++.+||+|||+++......
T Consensus 82 L~~~l~~~------~~l~~~~~~~~~~qi~~aL~~lH~~--~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~--- 150 (325)
T cd05594 82 LFFHLSRE------RVFSEDRARFYGAEIVSALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG--- 150 (325)
T ss_pred HHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhc--CCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCC---
Confidence 99988654 4589999999999999999999952 589999999999999999999999999987432110
Q ss_pred CccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCccccCCCCcch
Q 005102 566 TLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGSSEMD 645 (714)
Q Consensus 566 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~~~~~~~~~~ 645 (714)
.......||+.|+|||++.+..++.++|||||||++|||+||+.||.....
T Consensus 151 -------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~---- 201 (325)
T cd05594 151 -------------------------ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH---- 201 (325)
T ss_pred -------------------------cccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCH----
Confidence 011223478899999999998999999999999999999999999943211
Q ss_pred hHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCC-----CHHHHHH
Q 005102 646 LVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRP-----TMRHISD 704 (714)
Q Consensus 646 l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----t~~evl~ 704 (714)
............. .... ....+.+++.+||+.||++|+ ++.++++
T Consensus 202 -~~~~~~i~~~~~~--------~p~~-----~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~ 251 (325)
T cd05594 202 -EKLFELILMEEIR--------FPRT-----LSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQ 251 (325)
T ss_pred -HHHHHHHhcCCCC--------CCCC-----CCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhc
Confidence 1122221111111 1111 123578999999999999996 8888864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=338.53 Aligned_cols=247 Identities=20% Similarity=0.257 Sum_probs=195.9
Q ss_pred ccccccCceEEEEEEECC-CcEEEEEEeCCCC---chhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCC
Q 005102 409 FVLGKSGIGIVYKVVLED-GHTLAVRRLGEGG---SQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNG 484 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~~-g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~g 484 (714)
+.||+|+||.||+|+..+ ++.||||++.... ....+.+.+|++++.+++||||+++++++...+..|+||||+++|
T Consensus 7 ~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~g~ 86 (333)
T cd05600 7 TQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAMEYVPGG 86 (333)
T ss_pred EEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEeCCCCC
Confidence 479999999999999864 8999999997542 233457889999999999999999999999999999999999999
Q ss_pred CHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCC
Q 005102 485 SLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGS 564 (714)
Q Consensus 485 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 564 (714)
+|.+++... ..+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++....
T Consensus 87 ~L~~~l~~~------~~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~---- 153 (333)
T cd05600 87 DFRTLLNNL------GVLSEDHARFYMAEMFEAVDALHE---LGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT---- 153 (333)
T ss_pred CHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCCEEEEeCcCCccccc----
Confidence 999999754 458899999999999999999999 8999999999999999999999999999875421
Q ss_pred CCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCccccCCCCcc
Q 005102 565 PTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGSSEM 644 (714)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~~~~~~~~~ 644 (714)
......||+.|+|||++.+..++.++|||||||++|||++|+.||..... .
T Consensus 154 ---------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~--~ 204 (333)
T cd05600 154 ---------------------------YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTP--N 204 (333)
T ss_pred ---------------------------ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCH--H
Confidence 11233568899999999998999999999999999999999999943221 1
Q ss_pred hhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 005102 645 DLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDA 705 (714)
Q Consensus 645 ~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 705 (714)
+. ..........+ ..+.... .......++.+++.+||..+|++||+++++++.
T Consensus 205 ~~---~~~i~~~~~~~---~~~~~~~--~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 205 ET---WENLKYWKETL---QRPVYDD--PRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred HH---HHHHHhccccc---cCCCCCc--cccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 11 11111111000 0111100 001123467899999999999999999999853
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=335.91 Aligned_cols=239 Identities=22% Similarity=0.283 Sum_probs=187.7
Q ss_pred cccccCceEEEEEEECC-CcEEEEEEeCCCC---chhHHHHHHHHHHHhcc-CCCCccceEEEEEeCCceeEEEeccCCC
Q 005102 410 VLGKSGIGIVYKVVLED-GHTLAVRRLGEGG---SQRFKEFQTEVEAIGKI-RHSNIVTLRAYYWSVDEKLLIYDYIPNG 484 (714)
Q Consensus 410 ~lG~G~~g~Vy~~~~~~-g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~e~~~~g 484 (714)
+||+|+||.||+|+..+ ++.||||+++... ....+.+..|..++... +||||+++++++...+..++||||+++|
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~gg 81 (316)
T cd05592 2 VLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNGG 81 (316)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCCC
Confidence 69999999999999754 7899999987532 22334566777777654 8999999999999999999999999999
Q ss_pred CHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCC
Q 005102 485 SLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGS 564 (714)
Q Consensus 485 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 564 (714)
+|.+++... ..+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||+++......
T Consensus 82 ~L~~~~~~~------~~~~~~~~~~~~~qi~~al~~LH~---~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-- 150 (316)
T cd05592 82 DLMFHIQSS------GRFDEARARFYAAEIICGLQFLHK---KGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE-- 150 (316)
T ss_pred cHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC--
Confidence 999998754 458899999999999999999999 899999999999999999999999999987532110
Q ss_pred CCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCccccCCCCcc
Q 005102 565 PTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGSSEM 644 (714)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~~~~~~~~~ 644 (714)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||.... .
T Consensus 151 --------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~--~- 201 (316)
T cd05592 151 --------------------------GKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGED--E- 201 (316)
T ss_pred --------------------------CccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCC--H-
Confidence 11123357889999999998899999999999999999999999995321 1
Q ss_pred hhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHH-HHH
Q 005102 645 DLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMR-HIS 703 (714)
Q Consensus 645 ~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~-evl 703 (714)
.+......... +..... ....+.+++.+||+.||++||++. +++
T Consensus 202 --~~~~~~i~~~~--------~~~~~~-----~~~~~~~ll~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05592 202 --DELFDSILNDR--------PHFPRW-----ISKEAKDCLSKLFERDPTKRLGVDGDIR 246 (316)
T ss_pred --HHHHHHHHcCC--------CCCCCC-----CCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 11122211111 111111 122577899999999999999875 443
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=317.15 Aligned_cols=239 Identities=23% Similarity=0.423 Sum_probs=202.1
Q ss_pred cccccCceEEEEEEECC-CcEEEEEEeCCCCchhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCCCHhh
Q 005102 410 VLGKSGIGIVYKVVLED-GHTLAVRRLGEGGSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGSLAT 488 (714)
Q Consensus 410 ~lG~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL~~ 488 (714)
.||+|+||.||++.++. |+.||||++... .+.+++.+|+.+|.+++.|++|++||.|......++|||||..|+..+
T Consensus 40 KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGAGSiSD 117 (502)
T KOG0574|consen 40 KLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGAGSISD 117 (502)
T ss_pred HhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCCCcHHH
Confidence 69999999999998764 999999998764 345789999999999999999999999999999999999999999999
Q ss_pred hhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCCCCcc
Q 005102 489 ALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQ 568 (714)
Q Consensus 489 ~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 568 (714)
+++.++ .+|++.++..|+++.++||+|||. ..-||||||+.|||++-+|.+||+|||.|-.+.+.
T Consensus 118 I~R~R~-----K~L~E~EIs~iL~~TLKGL~YLH~---~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDT------- 182 (502)
T KOG0574|consen 118 IMRARR-----KPLSEQEISAVLRDTLKGLQYLHD---LKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDT------- 182 (502)
T ss_pred HHHHhc-----CCccHHHHHHHHHHHHhHHHHHHH---HHHHHhhcccccEEEcccchhhhhhccccchhhhh-------
Confidence 998765 679999999999999999999999 77899999999999999999999999999765432
Q ss_pred CCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCccccCCCCcchhHH
Q 005102 569 SNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGSSEMDLVN 648 (714)
Q Consensus 569 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~~~~~~~~~~l~~ 648 (714)
.....+..||++|||||+++.-.|+.++||||+|++..||..|++||.+...
T Consensus 183 ---------------------MAKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHP------- 234 (502)
T KOG0574|consen 183 ---------------------MAKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHP------- 234 (502)
T ss_pred ---------------------HHhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccc-------
Confidence 2234456789999999999988999999999999999999999999954321
Q ss_pred HHHHHHhhcCCccccc-CCCC-CCCC-CcHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 005102 649 WMQLCIEEKKPLADVL-DPYL-APDA-DKEEEIIAVLKIAMACVHSSPEKRPTMRHISD 704 (714)
Q Consensus 649 ~~~~~~~~~~~~~~~~-d~~~-~~~~-~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 704 (714)
+..++ -|.- ++.+ .++.-..++-++++.||.++|++|-|+.++++
T Consensus 235 -----------MRAIFMIPT~PPPTF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~ 282 (502)
T KOG0574|consen 235 -----------MRAIFMIPTKPPPTFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCE 282 (502)
T ss_pred -----------cceeEeccCCCCCCCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhh
Confidence 11111 1111 1111 23455678999999999999999999988765
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=326.97 Aligned_cols=255 Identities=27% Similarity=0.418 Sum_probs=198.9
Q ss_pred ccccccCceEEEEEEECC------CcEEEEEEeCCCCc-hhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEecc
Q 005102 409 FVLGKSGIGIVYKVVLED------GHTLAVRRLGEGGS-QRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYI 481 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~~------g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~ 481 (714)
+.||+|+||.||+|.... ...||+|.+..... .....|.+|++++++++||||+++++++...+..+++|||+
T Consensus 11 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~ 90 (283)
T cd05048 11 EELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCMLFEYL 90 (283)
T ss_pred hcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceEEEEecC
Confidence 479999999999998643 25799999875533 33457899999999999999999999999888999999999
Q ss_pred CCCCHhhhhhCCCCCC----------CcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcc
Q 005102 482 PNGSLATALHGKPGMV----------SFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSD 551 (714)
Q Consensus 482 ~~gsL~~~l~~~~~~~----------~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~D 551 (714)
++|+|.+++....... ....+++..+..++.|++.||+|||+ ++++||||||+||++++++.+||+|
T Consensus 91 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~---~~i~H~dlkp~Nil~~~~~~~~L~d 167 (283)
T cd05048 91 AHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSS---HHFVHRDLAARNCLVGEGLTVKISD 167 (283)
T ss_pred CCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccccceEEEcCCCcEEECC
Confidence 9999999997542110 11458899999999999999999999 8999999999999999999999999
Q ss_pred cchhhhhhccCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHh
Q 005102 552 FGLARLANIAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMIT 631 (714)
Q Consensus 552 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~ellt 631 (714)
||+++....... ........+++.|+|||.+.+..++.++|||||||++|||++
T Consensus 168 fg~~~~~~~~~~--------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~ 221 (283)
T cd05048 168 FGLSRDIYSADY--------------------------YRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFS 221 (283)
T ss_pred Ccceeecccccc--------------------------ccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHc
Confidence 999875432110 001112234677999999988899999999999999999998
Q ss_pred -CCCccccCCCCcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhhh
Q 005102 632 -GRTAVVQVGSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDALDRL 709 (714)
Q Consensus 632 -G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i 709 (714)
|..||..... .++... +.... .. ... .....++.+++.+||+.||++|||++||++.|+++
T Consensus 222 ~g~~p~~~~~~--~~~~~~----i~~~~-~~-----~~~-----~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~~ 283 (283)
T cd05048 222 YGLQPYYGFSN--QEVIEM----IRSRQ-LL-----PCP-----EDCPARVYALMIECWNEIPARRPRFKDIHTRLRSW 283 (283)
T ss_pred CCCCCCCCCCH--HHHHHH----HHcCC-cC-----CCc-----ccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhcC
Confidence 9999853321 122211 11111 00 011 12234688999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=343.42 Aligned_cols=259 Identities=25% Similarity=0.314 Sum_probs=199.5
Q ss_pred cccccccCceEEEEEEECC------CcEEEEEEeCCCCc-hhHHHHHHHHHHHhccC-CCCccceEEEEEeCCceeEEEe
Q 005102 408 AFVLGKSGIGIVYKVVLED------GHTLAVRRLGEGGS-QRFKEFQTEVEAIGKIR-HSNIVTLRAYYWSVDEKLLIYD 479 (714)
Q Consensus 408 ~~~lG~G~~g~Vy~~~~~~------g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lV~e 479 (714)
.++||+|+||.||+|++.. +..||||++..... ...+.+.+|+++++++. ||||+++++++...+..++|||
T Consensus 42 ~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E 121 (400)
T cd05105 42 GRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGPIYIITE 121 (400)
T ss_pred hheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCceEEEEE
Confidence 3589999999999998632 35799999976433 33467999999999996 9999999999999999999999
Q ss_pred ccCCCCHhhhhhCCCCC---------------------------------------------------------------
Q 005102 480 YIPNGSLATALHGKPGM--------------------------------------------------------------- 496 (714)
Q Consensus 480 ~~~~gsL~~~l~~~~~~--------------------------------------------------------------- 496 (714)
|+++|+|.++++.....
T Consensus 122 y~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 201 (400)
T cd05105 122 YCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIKEASKYS 201 (400)
T ss_pred ecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhhhhhhhh
Confidence 99999999988653210
Q ss_pred ---------------------------CCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEE
Q 005102 497 ---------------------------VSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHV 549 (714)
Q Consensus 497 ---------------------------~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl 549 (714)
.....+++.++.+++.|++.||+|||+ .+|+||||||+|||+++++.+||
T Consensus 202 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivH~dikp~Nill~~~~~~kL 278 (400)
T cd05105 202 DIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLAS---KNCVHRDLAARNVLLAQGKIVKI 278 (400)
T ss_pred hcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChHhEEEeCCCEEEE
Confidence 001247889999999999999999999 89999999999999999999999
Q ss_pred cccchhhhhhccCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHH
Q 005102 550 SDFGLARLANIAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEM 629 (714)
Q Consensus 550 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~el 629 (714)
+|||+++....... ........++..|+|||.+.+..++.++|||||||++|||
T Consensus 279 ~DfGla~~~~~~~~--------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~el 332 (400)
T cd05105 279 CDFGLARDIMHDSN--------------------------YVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEI 332 (400)
T ss_pred EeCCcceecccccc--------------------------ccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHH
Confidence 99999875432110 0111222346679999999988999999999999999999
Q ss_pred Hh-CCCccccCCCCcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhh
Q 005102 630 IT-GRTAVVQVGSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDALDR 708 (714)
Q Consensus 630 lt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~ 708 (714)
++ |..||....... .. ......... +... ......+.+++.+||+.||++|||+.+|.+.|++
T Consensus 333 lt~g~~P~~~~~~~~-~~----~~~~~~~~~------~~~~-----~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~ 396 (400)
T cd05105 333 FSLGGTPYPGMIVDS-TF----YNKIKSGYR------MAKP-----DHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVES 396 (400)
T ss_pred HHCCCCCCcccchhH-HH----HHHHhcCCC------CCCC-----ccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHH
Confidence 97 999985322111 11 111111111 0011 1123468899999999999999999999999998
Q ss_pred hhc
Q 005102 709 LIV 711 (714)
Q Consensus 709 i~~ 711 (714)
+..
T Consensus 397 l~~ 399 (400)
T cd05105 397 LLP 399 (400)
T ss_pred HcC
Confidence 865
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=337.96 Aligned_cols=241 Identities=22% Similarity=0.322 Sum_probs=189.7
Q ss_pred cccccCceEEEEEEEC-CCcEEEEEEeCCC---CchhHHHHHHHHHHHhcc-CCCCccceEEEEEeCCceeEEEeccCCC
Q 005102 410 VLGKSGIGIVYKVVLE-DGHTLAVRRLGEG---GSQRFKEFQTEVEAIGKI-RHSNIVTLRAYYWSVDEKLLIYDYIPNG 484 (714)
Q Consensus 410 ~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~e~~~~g 484 (714)
.||+|+||.||+|+.. +++.||+|++.+. .....+.+.+|+.++.++ +||||+++++++...+..++||||+++|
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~~ 81 (329)
T cd05618 2 VIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGG 81 (329)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCCC
Confidence 6999999999999976 4789999999764 223345678899998877 7999999999999999999999999999
Q ss_pred CHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCC
Q 005102 485 SLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGS 564 (714)
Q Consensus 485 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 564 (714)
+|..++... ..+++..+..|+.|++.||+|||+ ++|+||||||+||+++.++.+||+|||+++.....
T Consensus 82 ~L~~~~~~~------~~l~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~--- 149 (329)
T cd05618 82 DLMFHMQRQ------RKLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP--- 149 (329)
T ss_pred CHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEECCCCCEEEeeCCccccccCC---
Confidence 999988654 458999999999999999999999 89999999999999999999999999998743211
Q ss_pred CCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCccccCCCCc-
Q 005102 565 PTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGSSE- 643 (714)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~~~~~~~~- 643 (714)
........||+.|+|||++.+..++.++|||||||++|||+||+.||.......
T Consensus 150 -------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~ 204 (329)
T cd05618 150 -------------------------GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDN 204 (329)
T ss_pred -------------------------CCccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCC
Confidence 001123457889999999999999999999999999999999999995322211
Q ss_pred --chhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCH
Q 005102 644 --MDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTM 699 (714)
Q Consensus 644 --~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~ 699 (714)
.....++........ ..++.. ....+.+++.+||+.||++||++
T Consensus 205 ~~~~~~~~~~~~i~~~~-------~~~p~~-----~~~~~~~ll~~~L~~dP~~R~~~ 250 (329)
T cd05618 205 PDQNTEDYLFQVILEKQ-------IRIPRS-----LSVKAASVLKSFLNKDPKERLGC 250 (329)
T ss_pred cccccHHHHHHHHhcCC-------CCCCCC-----CCHHHHHHHHHHhcCCHHHcCCC
Confidence 112222222221111 111111 12357799999999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=328.98 Aligned_cols=247 Identities=22% Similarity=0.268 Sum_probs=191.2
Q ss_pred ccccCceEEEEEEEC-CCcEEEEEEeCCCCc---hhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCCCH
Q 005102 411 LGKSGIGIVYKVVLE-DGHTLAVRRLGEGGS---QRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGSL 486 (714)
Q Consensus 411 lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL 486 (714)
||+|+||+||++..+ +++.||+|++..... ...+.+..|++++++++||||+++.+++...+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 699999999999975 589999999875422 2235678899999999999999999999999999999999999999
Q ss_pred hhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCCCC
Q 005102 487 ATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPT 566 (714)
Q Consensus 487 ~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 566 (714)
.+++...... ...+++..+..++.||+.||+|||+ ++|+||||||+||++++++.+||+|||+++......
T Consensus 81 ~~~~~~~~~~--~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~---- 151 (280)
T cd05608 81 RYHIYNVDEE--NPGFPEPRACFYTAQIISGLEHLHQ---RRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQ---- 151 (280)
T ss_pred HHHHHhcccc--CCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEeeCccceecCCCC----
Confidence 9887543211 1458999999999999999999999 899999999999999999999999999987543211
Q ss_pred ccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCccccCCCCcchh
Q 005102 567 LQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGSSEMDL 646 (714)
Q Consensus 567 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~~~~~~~~~~l 646 (714)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||....... ..
T Consensus 152 ------------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~-~~ 206 (280)
T cd05608 152 ------------------------SKTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKV-EN 206 (280)
T ss_pred ------------------------ccccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcch-hH
Confidence 01122356888999999999999999999999999999999999995332211 11
Q ss_pred HHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCC-----CHHHHHH
Q 005102 647 VNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRP-----TMRHISD 704 (714)
Q Consensus 647 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----t~~evl~ 704 (714)
........... .... ......+.+++.+||+.||++|| |++++++
T Consensus 207 ~~~~~~~~~~~--------~~~~-----~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~ 256 (280)
T cd05608 207 KELKQRILNDS--------VTYP-----DKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT 256 (280)
T ss_pred HHHHHhhcccC--------CCCc-----ccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence 11111111100 0011 11233678999999999999999 6666664
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=323.59 Aligned_cols=249 Identities=26% Similarity=0.433 Sum_probs=202.6
Q ss_pred ccccccCceEEEEEEECCCcEEEEEEeCCCCchhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCCCHhh
Q 005102 409 FVLGKSGIGIVYKVVLEDGHTLAVRRLGEGGSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGSLAT 488 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL~~ 488 (714)
+.||+|+||.||+|...++..+|+|.+..........+.+|++++++++||||+++++++...+..++||||+++|+|.+
T Consensus 12 ~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 91 (261)
T cd05148 12 RKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELMEKGSLLA 91 (261)
T ss_pred hhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeecccCCHHH
Confidence 47999999999999998899999999987766556789999999999999999999999999999999999999999999
Q ss_pred hhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCCCCcc
Q 005102 489 ALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQ 568 (714)
Q Consensus 489 ~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 568 (714)
++....+ ..+++.++.+++.|++.||+|||+ ++|+||||||+||++++++.+||+|||.+.......
T Consensus 92 ~~~~~~~----~~~~~~~~~~~~~~i~~al~~lH~---~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~------ 158 (261)
T cd05148 92 FLRSPEG----QVLPVASLIDMACQVAEGMAYLEE---QNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDV------ 158 (261)
T ss_pred HHhcCCC----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccCcceEEEcCCceEEEccccchhhcCCcc------
Confidence 9976543 458999999999999999999999 899999999999999999999999999997653211
Q ss_pred CCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHh-CCCccccCCCCcchhH
Q 005102 569 SNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMIT-GRTAVVQVGSSEMDLV 647 (714)
Q Consensus 569 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~ellt-G~~p~~~~~~~~~~l~ 647 (714)
.......++..|+|||.+.+..++.++||||||+++|+|++ |+.||.... ..+..
T Consensus 159 ----------------------~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~--~~~~~ 214 (261)
T cd05148 159 ----------------------YLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMN--NHEVY 214 (261)
T ss_pred ----------------------ccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCC--HHHHH
Confidence 00112224567999999988889999999999999999999 899984321 11121
Q ss_pred HHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhhh
Q 005102 648 NWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDALDRL 709 (714)
Q Consensus 648 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i 709 (714)
.. ...... +.... .....+.+++.+||+.||++|||++++++.|+++
T Consensus 215 ~~---~~~~~~-------~~~~~-----~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 215 DQ---ITAGYR-------MPCPA-----KCPQEIYKIMLECWAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred HH---HHhCCc-------CCCCC-----CCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence 11 111110 00111 1223688999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=332.45 Aligned_cols=258 Identities=19% Similarity=0.285 Sum_probs=192.3
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeCCCC--chhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCCC
Q 005102 409 FVLGKSGIGIVYKVVLE-DGHTLAVRRLGEGG--SQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGS 485 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gs 485 (714)
+.||+|+||.||+|+++ +++.||||++.... ....+.+.+|++++++++||||+++++++...+..++||||++++.
T Consensus 7 ~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 86 (287)
T cd07848 7 GVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEYVEKNM 86 (287)
T ss_pred EEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEecCCCCH
Confidence 47999999999999986 47899999987542 2234678899999999999999999999999999999999999877
Q ss_pred HhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCCC
Q 005102 486 LATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSP 565 (714)
Q Consensus 486 L~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 565 (714)
+..+.... ..+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++......
T Consensus 87 l~~~~~~~------~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~--- 154 (287)
T cd07848 87 LELLEEMP------NGVPPEKVRSYIYQLIKAIHWCHK---NDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGS--- 154 (287)
T ss_pred HHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEEeeccCcccccccc---
Confidence 66554322 358899999999999999999999 899999999999999999999999999987653211
Q ss_pred CccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCccccCCCCcch
Q 005102 566 TLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGSSEMD 645 (714)
Q Consensus 566 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~~~~~~~~~~ 645 (714)
........||+.|+|||++.+..++.++|||||||++|||++|+.||......+ .
T Consensus 155 ------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~-~ 209 (287)
T cd07848 155 ------------------------NANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEID-Q 209 (287)
T ss_pred ------------------------cccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHH-H
Confidence 001122346888999999998889999999999999999999999995432111 1
Q ss_pred hHHHHHHHH-----------hhcCCcccccCCCCCCCCCc-----HHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 005102 646 LVNWMQLCI-----------EEKKPLADVLDPYLAPDADK-----EEEIIAVLKIAMACVHSSPEKRPTMRHISD 704 (714)
Q Consensus 646 l~~~~~~~~-----------~~~~~~~~~~d~~~~~~~~~-----~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 704 (714)
+.. +.... ...........+........ ......+.+++.+||+.||++|||++|+++
T Consensus 210 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 210 LFT-IQKVLGPLPAEQMKLFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred HHH-HHHhhCCCCHHHHHhhhccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 111 00000 00000000000000000000 012346889999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=333.66 Aligned_cols=252 Identities=24% Similarity=0.367 Sum_probs=196.6
Q ss_pred ccccccCceEEEEEEECC-Cc----EEEEEEeCCCC-chhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccC
Q 005102 409 FVLGKSGIGIVYKVVLED-GH----TLAVRRLGEGG-SQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIP 482 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~~-g~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~ 482 (714)
+.||+|+||.||+|++.. +. .||+|++.... ....+++.+|+.+++.++||||++++|+|... ..++|+||++
T Consensus 13 ~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~v~e~~~ 91 (316)
T cd05108 13 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQLMP 91 (316)
T ss_pred eeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-CceeeeecCC
Confidence 479999999999998643 33 48999987543 33456789999999999999999999999764 5789999999
Q ss_pred CCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccC
Q 005102 483 NGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAG 562 (714)
Q Consensus 483 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 562 (714)
+|+|.+++.... ..+++..+++++.||+.||+|||+ ++|+||||||+|||+++++.+||+|||+++......
T Consensus 92 ~g~l~~~l~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~---~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 163 (316)
T cd05108 92 FGCLLDYVREHK-----DNIGSQYLLNWCVQIAKGMNYLEE---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADE 163 (316)
T ss_pred CCCHHHHHHhcc-----ccCCHHHHHHHHHHHHHHHHHHHh---cCeeccccchhheEecCCCcEEEccccccccccCCC
Confidence 999999998653 358899999999999999999999 899999999999999999999999999998654221
Q ss_pred CCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHh-CCCccccCCC
Q 005102 563 GSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMIT-GRTAVVQVGS 641 (714)
Q Consensus 563 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~ellt-G~~p~~~~~~ 641 (714)
.. .......++..|+|||++.+..++.++|||||||++|||++ |+.||....
T Consensus 164 ~~--------------------------~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~- 216 (316)
T cd05108 164 KE--------------------------YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP- 216 (316)
T ss_pred cc--------------------------eeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCC-
Confidence 10 00111223567999999999999999999999999999998 999984321
Q ss_pred CcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhhhhcc
Q 005102 642 SEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDALDRLIVS 712 (714)
Q Consensus 642 ~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~~ 712 (714)
..++.. ......... .+ + .....+.+++.+||+.||++|||+.+++..|..+...
T Consensus 217 ----~~~~~~-~~~~~~~~~---~~---~-----~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~ 271 (316)
T cd05108 217 ----ASEISS-ILEKGERLP---QP---P-----ICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 271 (316)
T ss_pred ----HHHHHH-HHhCCCCCC---CC---C-----CCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcC
Confidence 111111 111111100 01 1 1223578999999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=337.30 Aligned_cols=240 Identities=21% Similarity=0.310 Sum_probs=189.8
Q ss_pred cccccCceEEEEEEEC-CCcEEEEEEeCCC---CchhHHHHHHHHHHHhcc-CCCCccceEEEEEeCCceeEEEeccCCC
Q 005102 410 VLGKSGIGIVYKVVLE-DGHTLAVRRLGEG---GSQRFKEFQTEVEAIGKI-RHSNIVTLRAYYWSVDEKLLIYDYIPNG 484 (714)
Q Consensus 410 ~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~e~~~~g 484 (714)
+||+|+||.||+|+.. +++.||||+++.. .....+.+.+|..++.++ +||||+++++++...+..++||||+++|
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~g 81 (329)
T cd05588 2 VIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSGG 81 (329)
T ss_pred eEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 6999999999999975 4889999999764 223345688999999998 7999999999999999999999999999
Q ss_pred CHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCC
Q 005102 485 SLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGS 564 (714)
Q Consensus 485 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 564 (714)
+|.+++... ..+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||+++.....
T Consensus 82 ~L~~~~~~~------~~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~--- 149 (329)
T cd05588 82 DLMFHMQRQ------RKLPEEHARFYSAEISLALNFLHE---RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRP--- 149 (329)
T ss_pred CHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEECcCccccccccC---
Confidence 999988654 458999999999999999999999 89999999999999999999999999998642110
Q ss_pred CCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCccccCCCC--
Q 005102 565 PTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGSS-- 642 (714)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~~~~~~~-- 642 (714)
........||+.|+|||++.+..++.++|||||||++|||+||+.||...+..
T Consensus 150 -------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~ 204 (329)
T cd05588 150 -------------------------GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDN 204 (329)
T ss_pred -------------------------CCccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCccccccccc
Confidence 01112345788999999999999999999999999999999999999532211
Q ss_pred -cchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCC
Q 005102 643 -EMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPT 698 (714)
Q Consensus 643 -~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt 698 (714)
......+......... ..++.. ....+.+++.+||+.||++|||
T Consensus 205 ~~~~~~~~~~~~~~~~~-------~~~p~~-----~~~~~~~li~~~L~~dP~~R~~ 249 (329)
T cd05588 205 PDQNTEDYLFQVILEKQ-------IRIPRS-----LSVKASSVLKGFLNKDPKERLG 249 (329)
T ss_pred ccccchHHHHHHHHcCC-------CCCCCC-----CCHHHHHHHHHHhccCHHHcCC
Confidence 1112222222222211 111111 1235789999999999999998
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=331.43 Aligned_cols=263 Identities=22% Similarity=0.346 Sum_probs=209.5
Q ss_pred cccCHHHHHHhccccccccCceEEEEEEECC---C--cEEEEEEeCCC-CchhHHHHHHHHHHHhccCCCCccceEEEEE
Q 005102 396 VAFDLDELLKASAFVLGKSGIGIVYKVVLED---G--HTLAVRRLGEG-GSQRFKEFQTEVEAIGKIRHSNIVTLRAYYW 469 (714)
Q Consensus 396 ~~~~~~~l~~~~~~~lG~G~~g~Vy~~~~~~---g--~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~ 469 (714)
+.+.+..-......+||.|-||.||+|.+.+ | -.||||..+.. .....+.|..|..+|+.++|||||+++|+|.
T Consensus 382 rnyel~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~ 461 (974)
T KOG4257|consen 382 RNYELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCV 461 (974)
T ss_pred CcceeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeee
Confidence 3344433333345689999999999999754 2 46899999874 4455678999999999999999999999996
Q ss_pred eCCceeEEEeccCCCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEE
Q 005102 470 SVDEKLLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHV 549 (714)
Q Consensus 470 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl 549 (714)
+ ...++|||.++.|.|..+|+.+. ..++......++.||+.||+|||+ .++|||||..+|||+....-+||
T Consensus 462 e-~P~WivmEL~~~GELr~yLq~nk-----~sL~l~tL~ly~~Qi~talaYLeS---krfVHRDIAaRNiLVsSp~CVKL 532 (974)
T KOG4257|consen 462 E-QPMWIVMELAPLGELREYLQQNK-----DSLPLRTLTLYCYQICTALAYLES---KRFVHRDIAARNILVSSPQCVKL 532 (974)
T ss_pred c-cceeEEEecccchhHHHHHHhcc-----ccchHHHHHHHHHHHHHHHHHHHh---hchhhhhhhhhheeecCcceeee
Confidence 5 57899999999999999998775 458888999999999999999999 99999999999999999999999
Q ss_pred cccchhhhhhccCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHH
Q 005102 550 SDFGLARLANIAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEM 629 (714)
Q Consensus 550 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~el 629 (714)
+|||+++.+.+....... ...-..-|||||.+.-.+++.++|||-|||.+||+
T Consensus 533 aDFGLSR~~ed~~yYkaS---------------------------~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEI 585 (974)
T KOG4257|consen 533 ADFGLSRYLEDDAYYKAS---------------------------RGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEI 585 (974)
T ss_pred cccchhhhccccchhhcc---------------------------ccccceeecCccccchhcccchhhHHHHHHHHHHH
Confidence 999999998754322110 01112349999999999999999999999999999
Q ss_pred Hh-CCCccccCCCCcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhh
Q 005102 630 IT-GRTAVVQVGSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDALDR 708 (714)
Q Consensus 630 lt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~ 708 (714)
++ |..||....+.+. +..+-..... +.++.++..++.++.+||.+||.+||++.++...|.+
T Consensus 586 l~lGvkPfqgvkNsDV---------------I~~iEnGeRl--P~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsd 648 (974)
T KOG4257|consen 586 LSLGVKPFQGVKNSDV---------------IGHIENGERL--PCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSD 648 (974)
T ss_pred HHhcCCccccccccce---------------EEEecCCCCC--CCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHH
Confidence 88 9999965544432 1111111111 1122355579999999999999999999999999998
Q ss_pred hhc
Q 005102 709 LIV 711 (714)
Q Consensus 709 i~~ 711 (714)
++.
T Consensus 649 v~q 651 (974)
T KOG4257|consen 649 VLQ 651 (974)
T ss_pred HHH
Confidence 764
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=319.87 Aligned_cols=258 Identities=21% Similarity=0.330 Sum_probs=194.4
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeCC--CCchhHHHHHHHHHHHhccCCCCccceEEEEEe-----CCceeEEEec
Q 005102 409 FVLGKSGIGIVYKVVLE-DGHTLAVRRLGE--GGSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWS-----VDEKLLIYDY 480 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~-----~~~~~lV~e~ 480 (714)
+.||+|.||.|+.+..+ +|..||||++.. ......++..+|+++|+.++|+||+.+.+.+.. -+..|+|+|+
T Consensus 28 ~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvYiV~el 107 (359)
T KOG0660|consen 28 EPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVYLVFEL 107 (359)
T ss_pred ccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeEEehhH
Confidence 36999999999999975 589999999984 345556788999999999999999999999875 3568999999
Q ss_pred cCCCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhc
Q 005102 481 IPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANI 560 (714)
Q Consensus 481 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 560 (714)
| ..||...++.. +.++...+..++.|+++||+|+|+ .+|+||||||+|+|++.+..+||+|||+|+....
T Consensus 108 M-etDL~~iik~~------~~L~d~H~q~f~YQiLrgLKyiHS---AnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~ 177 (359)
T KOG0660|consen 108 M-ETDLHQIIKSQ------QDLTDDHAQYFLYQILRGLKYIHS---ANVIHRDLKPSNLLLNADCDLKICDFGLARYLDK 177 (359)
T ss_pred H-hhHHHHHHHcC------ccccHHHHHHHHHHHHHhcchhhc---ccccccccchhheeeccCCCEEeccccceeeccc
Confidence 9 45999999866 458899999999999999999999 8999999999999999999999999999997643
Q ss_pred cCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccC-CCCCCchhhhHHHHHHHHHHHhCCCccccC
Q 005102 561 AGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLK-VVKPSQKWDIYSYGVILLEMITGRTAVVQV 639 (714)
Q Consensus 561 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~s~~~DVwS~Gvvl~elltG~~p~~~~ 639 (714)
... ....+..+.|++|+|||.+. ...||.+.||||.|||+.||++|++.|..
T Consensus 178 ~~~--------------------------~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG- 230 (359)
T KOG0660|consen 178 FFE--------------------------DGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPG- 230 (359)
T ss_pred cCc--------------------------ccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCC-
Confidence 200 11223445699999999985 46799999999999999999999999842
Q ss_pred CCCcchhHHHHHHHHhhcCC----------cccccC--CCCCCCC-C--cHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 005102 640 GSSEMDLVNWMQLCIEEKKP----------LADVLD--PYLAPDA-D--KEEEIIAVLKIAMACVHSSPEKRPTMRHISD 704 (714)
Q Consensus 640 ~~~~~~l~~~~~~~~~~~~~----------~~~~~d--~~~~~~~-~--~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 704 (714)
.+..+..+.+......... ....+. |..+... . ........++++.+||..||.+|+|++|+++
T Consensus 231 -~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~ 309 (359)
T KOG0660|consen 231 -KDYVHQLQLILELLGTPSEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALA 309 (359)
T ss_pred -CchHHHHHHHHHhcCCCCHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhc
Confidence 2222222221111110000 000000 0000000 0 0112235789999999999999999999875
|
|
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-38 Score=327.39 Aligned_cols=258 Identities=25% Similarity=0.382 Sum_probs=202.9
Q ss_pred ccccccCceEEEEEEEC------CCcEEEEEEeCCCCchhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccC
Q 005102 409 FVLGKSGIGIVYKVVLE------DGHTLAVRRLGEGGSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIP 482 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~ 482 (714)
..||+|+||.||+|... ++..+++|.+........+.+.+|++++++++||||+++++++...+..++||||++
T Consensus 11 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 90 (291)
T cd05094 11 RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMK 90 (291)
T ss_pred eeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEEEEecCC
Confidence 47999999999999853 356799999887666556789999999999999999999999999999999999999
Q ss_pred CCCHhhhhhCCCCC----------CCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEccc
Q 005102 483 NGSLATALHGKPGM----------VSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDF 552 (714)
Q Consensus 483 ~gsL~~~l~~~~~~----------~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DF 552 (714)
+++|.+++...... .....+++..+++++.|++.||+|||+ ++|+||||||+||++++++.+||+||
T Consensus 91 ~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~df 167 (291)
T cd05094 91 HGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLAS---QHFVHRDLATRNCLVGANLLVKIGDF 167 (291)
T ss_pred CCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccCcceEEEccCCcEEECCC
Confidence 99999999754210 111358999999999999999999999 99999999999999999999999999
Q ss_pred chhhhhhccCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHh-
Q 005102 553 GLARLANIAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMIT- 631 (714)
Q Consensus 553 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~ellt- 631 (714)
|+++....... ........++..|+|||++.+..++.++|||||||++|||+|
T Consensus 168 g~a~~~~~~~~--------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~ 221 (291)
T cd05094 168 GMSRDVYSTDY--------------------------YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTY 221 (291)
T ss_pred CcccccCCCce--------------------------eecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhC
Confidence 99875432110 011122334677999999998899999999999999999999
Q ss_pred CCCccccCCCCcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhhhhc
Q 005102 632 GRTAVVQVGSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDALDRLIV 711 (714)
Q Consensus 632 G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~ 711 (714)
|+.||..... ... +... ..... .. .. ......+.+++.+||+.||++|||+++|+++|+++..
T Consensus 222 g~~p~~~~~~--~~~---~~~~-~~~~~-~~-----~~-----~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~ 284 (291)
T cd05094 222 GKQPWFQLSN--TEV---IECI-TQGRV-LE-----RP-----RVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGK 284 (291)
T ss_pred CCCCCCCCCH--HHH---HHHH-hCCCC-CC-----CC-----ccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHh
Confidence 9999843321 111 1111 11110 00 00 0123368899999999999999999999999999865
Q ss_pred c
Q 005102 712 S 712 (714)
Q Consensus 712 ~ 712 (714)
.
T Consensus 285 ~ 285 (291)
T cd05094 285 A 285 (291)
T ss_pred h
Confidence 4
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=341.14 Aligned_cols=238 Identities=24% Similarity=0.271 Sum_probs=190.0
Q ss_pred ccccccCceEEEEEEE----CCCcEEEEEEeCCCC--chhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccC
Q 005102 409 FVLGKSGIGIVYKVVL----EDGHTLAVRRLGEGG--SQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIP 482 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~----~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~ 482 (714)
+.||+|+||.||+++. .+|+.||+|++.... ......+.+|++++++++||||+++++++...+..|+||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 3699999999999885 357899999997642 2233467789999999999999999999999999999999999
Q ss_pred CCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccC
Q 005102 483 NGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAG 562 (714)
Q Consensus 483 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 562 (714)
+|+|.+++... ..+++..+..++.||+.||+|||+ .+|+||||||+||++++++.+||+|||+++......
T Consensus 82 ~~~L~~~l~~~------~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~ 152 (318)
T cd05582 82 GGDLFTRLSKE------VMFTEEDVKFYLAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE 152 (318)
T ss_pred CCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCC
Confidence 99999998654 458999999999999999999999 899999999999999999999999999987542110
Q ss_pred CCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCccccCCCC
Q 005102 563 GSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGSS 642 (714)
Q Consensus 563 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~~~~~~~ 642 (714)
.......||+.|+|||.+.+..++.++|||||||++|||+||+.||....
T Consensus 153 ----------------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~-- 202 (318)
T cd05582 153 ----------------------------KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKD-- 202 (318)
T ss_pred ----------------------------CceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCC--
Confidence 11123457889999999998889999999999999999999999994321
Q ss_pred cchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHH
Q 005102 643 EMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRH 701 (714)
Q Consensus 643 ~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~e 701 (714)
. ............. +... ....+.+++.+||+.||++||++.+
T Consensus 203 ~---~~~~~~i~~~~~~--------~p~~-----~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 203 R---KETMTMILKAKLG--------MPQF-----LSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred H---HHHHHHHHcCCCC--------CCCC-----CCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 1 1122222221111 1111 1235778999999999999999655
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=335.17 Aligned_cols=239 Identities=21% Similarity=0.283 Sum_probs=188.7
Q ss_pred cccccCceEEEEEEEC-CCcEEEEEEeCCCC---chhHHHHHHHHHHHhcc-CCCCccceEEEEEeCCceeEEEeccCCC
Q 005102 410 VLGKSGIGIVYKVVLE-DGHTLAVRRLGEGG---SQRFKEFQTEVEAIGKI-RHSNIVTLRAYYWSVDEKLLIYDYIPNG 484 (714)
Q Consensus 410 ~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~e~~~~g 484 (714)
.||+|+||.||+|+.+ +|+.||+|.++... ....+.+..|..++... +||||+++++++...+..|+||||+++|
T Consensus 2 ~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g 81 (316)
T cd05620 2 VLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNGG 81 (316)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCCC
Confidence 6999999999999986 48899999997642 22335567788888765 8999999999999999999999999999
Q ss_pred CHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCC
Q 005102 485 SLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGS 564 (714)
Q Consensus 485 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 564 (714)
+|.+++... ..+++.++..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++.....
T Consensus 82 ~L~~~i~~~------~~~~~~~~~~~~~qi~~~l~~lH~---~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--- 149 (316)
T cd05620 82 DLMFHIQDK------GRFDLYRATFYAAEIVCGLQFLHS---KGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFG--- 149 (316)
T ss_pred cHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEeCccCCCeecccC---
Confidence 999998754 358899999999999999999999 89999999999999999999999999998642110
Q ss_pred CCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCccccCCCCcc
Q 005102 565 PTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGSSEM 644 (714)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~~~~~~~~~ 644 (714)
........||+.|+|||++.+..++.++|||||||++|||++|+.||.... ..
T Consensus 150 -------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~--~~ 202 (316)
T cd05620 150 -------------------------DNRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDD--ED 202 (316)
T ss_pred -------------------------CCceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC--HH
Confidence 001123457889999999999999999999999999999999999994321 11
Q ss_pred hhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHH-HHH
Q 005102 645 DLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMR-HIS 703 (714)
Q Consensus 645 ~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~-evl 703 (714)
+......... +..... ...++.+++.+||+.||++||++. +++
T Consensus 203 ---~~~~~~~~~~--------~~~~~~-----~~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 203 ---ELFESIRVDT--------PHYPRW-----ITKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred ---HHHHHHHhCC--------CCCCCC-----CCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 1121111111 111111 123577899999999999999985 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=334.32 Aligned_cols=239 Identities=22% Similarity=0.302 Sum_probs=188.9
Q ss_pred cccccCceEEEEEEECC-CcEEEEEEeCCCC---chhHHHHHHHHHHHhcc-CCCCccceEEEEEeCCceeEEEeccCCC
Q 005102 410 VLGKSGIGIVYKVVLED-GHTLAVRRLGEGG---SQRFKEFQTEVEAIGKI-RHSNIVTLRAYYWSVDEKLLIYDYIPNG 484 (714)
Q Consensus 410 ~lG~G~~g~Vy~~~~~~-g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~e~~~~g 484 (714)
.||+|+||+||+|+..+ ++.||||+++... ......+..|..++... +||||+++++++.+.+..++||||+++|
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~g 81 (316)
T cd05619 2 MLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNGG 81 (316)
T ss_pred eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCCC
Confidence 68999999999999864 7899999987642 22335567788888765 8999999999999999999999999999
Q ss_pred CHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCC
Q 005102 485 SLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGS 564 (714)
Q Consensus 485 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 564 (714)
+|.+++... ..+++.++..++.|++.||+|||+ ++|+||||||+|||+++++.+||+|||+++......
T Consensus 82 ~L~~~l~~~------~~~~~~~~~~~~~qi~~al~~LH~---~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-- 150 (316)
T cd05619 82 DLMFHIQSC------HKFDLPRATFYAAEIICGLQFLHS---KGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD-- 150 (316)
T ss_pred cHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCC--
Confidence 999998754 458899999999999999999999 899999999999999999999999999986421110
Q ss_pred CCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCccccCCCCcc
Q 005102 565 PTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGSSEM 644 (714)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~~~~~~~~~ 644 (714)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||.... .
T Consensus 151 --------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~--~- 201 (316)
T cd05619 151 --------------------------AKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHD--E- 201 (316)
T ss_pred --------------------------CceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCC--H-
Confidence 01122346888999999998899999999999999999999999995322 1
Q ss_pred hhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHH-HHH
Q 005102 645 DLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMR-HIS 703 (714)
Q Consensus 645 ~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~-evl 703 (714)
.+..+...... +..... ....+.+++.+||+.||++||++. ++.
T Consensus 202 --~~~~~~i~~~~--------~~~~~~-----~~~~~~~li~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05619 202 --EELFQSIRMDN--------PCYPRW-----LTREAKDILVKLFVREPERRLGVKGDIR 246 (316)
T ss_pred --HHHHHHHHhCC--------CCCCcc-----CCHHHHHHHHHHhccCHhhcCCChHHHH
Confidence 11122111111 111111 122577899999999999999997 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-38 Score=325.76 Aligned_cols=254 Identities=24% Similarity=0.407 Sum_probs=199.2
Q ss_pred ccccccCceEEEEEEECC------CcEEEEEEeCCCCch-hHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEecc
Q 005102 409 FVLGKSGIGIVYKVVLED------GHTLAVRRLGEGGSQ-RFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYI 481 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~~------g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~ 481 (714)
+.||+|+||.||+|...+ +..||||.+...... ..+.|.+|++++++++||||+++++++...+..++||||+
T Consensus 11 ~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 90 (280)
T cd05049 11 RELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPIMVFEYM 90 (280)
T ss_pred hhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeEEEEecC
Confidence 479999999999998643 478999999875444 4568999999999999999999999999999999999999
Q ss_pred CCCCHhhhhhCCCC--------CCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccc
Q 005102 482 PNGSLATALHGKPG--------MVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFG 553 (714)
Q Consensus 482 ~~gsL~~~l~~~~~--------~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFG 553 (714)
++|+|.+++..... ......+++.++..++.|++.||+|||+ .+++||||||+||+++.++.+||+|||
T Consensus 91 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~---~~i~h~dlkp~nili~~~~~~kl~d~g 167 (280)
T cd05049 91 EHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLAS---QHFVHRDLATRNCLVGYDLVVKIGDFG 167 (280)
T ss_pred CCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhh---CCeeccccccceEEEcCCCeEEECCcc
Confidence 99999999975431 1112458899999999999999999999 899999999999999999999999999
Q ss_pred hhhhhhccCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHh-C
Q 005102 554 LARLANIAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMIT-G 632 (714)
Q Consensus 554 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~ellt-G 632 (714)
+++....... ........++..|+|||++.+..++.++|||||||++|||++ |
T Consensus 168 ~~~~~~~~~~--------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g 221 (280)
T cd05049 168 MSRDVYTTDY--------------------------YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYG 221 (280)
T ss_pred cceecccCcc--------------------------eecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcC
Confidence 9875422110 000112223567999999999999999999999999999999 9
Q ss_pred CCccccCCCCcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhh
Q 005102 633 RTAVVQVGSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDALDR 708 (714)
Q Consensus 633 ~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~ 708 (714)
+.||..... ....... . ... .. .... .....+.+++.+||+.||++|||+.||++.|++
T Consensus 222 ~~p~~~~~~--~~~~~~~---~-~~~-~~-----~~~~-----~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~ 280 (280)
T cd05049 222 KQPWYGLSN--EEVIECI---T-QGR-LL-----QRPR-----TCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280 (280)
T ss_pred CCCCCCCCH--HHHHHHH---H-cCC-cC-----CCCC-----CCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence 999853322 1122111 1 111 00 0000 122368899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-38 Score=321.62 Aligned_cols=249 Identities=25% Similarity=0.435 Sum_probs=199.2
Q ss_pred ccccccCceEEEEEEECCCcEEEEEEeCCCCchhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCCCHhh
Q 005102 409 FVLGKSGIGIVYKVVLEDGHTLAVRRLGEGGSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGSLAT 488 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL~~ 488 (714)
+.||+|+||.||+|.+.+++.||+|.++.... ..+++.+|++++++++||||+++++++...+..++||||+++++|.+
T Consensus 12 ~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 90 (261)
T cd05068 12 RKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTM-DPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLE 90 (261)
T ss_pred EEecccCCccEEEEEecCCeEEEEEeeCCCcc-cHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecccCCcHHH
Confidence 57999999999999988888999999876543 34678999999999999999999999999999999999999999999
Q ss_pred hhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCCCCcc
Q 005102 489 ALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQ 568 (714)
Q Consensus 489 ~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 568 (714)
++....+ ..+++..+.+++.|++.||+|||+ .+|+||||||+||++++++.+||+|||+++.......
T Consensus 91 ~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~----- 158 (261)
T cd05068 91 YLQGGAG----RALKLPQLIDMAAQVASGMAYLEA---QNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIY----- 158 (261)
T ss_pred HHhccCC----CCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCCcceEEEcCCCCEEECCcceEEEccCCcc-----
Confidence 9976532 358999999999999999999999 8999999999999999999999999999986542110
Q ss_pred CCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHh-CCCccccCCCCcchhH
Q 005102 569 SNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMIT-GRTAVVQVGSSEMDLV 647 (714)
Q Consensus 569 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~ellt-G~~p~~~~~~~~~~l~ 647 (714)
........+..|+|||++.+..++.++||||||+++|||+| |+.||.... .....
T Consensus 159 ----------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~--~~~~~ 214 (261)
T cd05068 159 ----------------------EAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMT--NAEVL 214 (261)
T ss_pred ----------------------cccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCC--HHHHH
Confidence 00011112346999999998899999999999999999999 998884321 11111
Q ss_pred HHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhhh
Q 005102 648 NWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDALDRL 709 (714)
Q Consensus 648 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i 709 (714)
. ........ + .. ......+.+++.+||+.+|++||++.++++.|+++
T Consensus 215 ---~-~~~~~~~~-----~-~~-----~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~ 261 (261)
T cd05068 215 ---Q-QVDQGYRM-----P-CP-----PGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF 261 (261)
T ss_pred ---H-HHHcCCCC-----C-CC-----CcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence 1 11111110 0 00 11234688999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-38 Score=332.65 Aligned_cols=192 Identities=28% Similarity=0.355 Sum_probs=166.4
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeCCCC-chhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCCCH
Q 005102 409 FVLGKSGIGIVYKVVLE-DGHTLAVRRLGEGG-SQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGSL 486 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL 486 (714)
+.||+|+||.||++.+. ++..+|+|.+.... ......+.+|++++++++||||++++++|...+..++||||+++|+|
T Consensus 11 ~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 90 (333)
T cd06650 11 SELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSL 90 (333)
T ss_pred ccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEecCCCCcH
Confidence 47999999999999986 48889999887643 23346789999999999999999999999999999999999999999
Q ss_pred hhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCCCC
Q 005102 487 ATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPT 566 (714)
Q Consensus 487 ~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 566 (714)
.+++... ..+++..+..++.|++.||.|||+. .+|+||||||+|||+++++.+||+|||+++.....
T Consensus 91 ~~~l~~~------~~~~~~~~~~~~~~l~~~l~~lH~~--~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~----- 157 (333)
T cd06650 91 DQVLKKA------GRIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----- 157 (333)
T ss_pred HHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHhc--CCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh-----
Confidence 9999754 3578899999999999999999972 36999999999999999999999999998754321
Q ss_pred ccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCcccc
Q 005102 567 LQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQ 638 (714)
Q Consensus 567 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~~~ 638 (714)
......|+..|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 158 -------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~ 204 (333)
T cd06650 158 -------------------------MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPP 204 (333)
T ss_pred -------------------------ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 01123467889999999988899999999999999999999999953
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-38 Score=321.55 Aligned_cols=252 Identities=28% Similarity=0.472 Sum_probs=199.6
Q ss_pred cccccccCceEEEEEEECC----CcEEEEEEeCCCC-chhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccC
Q 005102 408 AFVLGKSGIGIVYKVVLED----GHTLAVRRLGEGG-SQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIP 482 (714)
Q Consensus 408 ~~~lG~G~~g~Vy~~~~~~----g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~ 482 (714)
.+.||+|+||.||+|.++. ...||||.++... .....+|.+|+.++++++||||+++++++...+..++||||++
T Consensus 9 ~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~ 88 (266)
T cd05033 9 EKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMIITEYME 88 (266)
T ss_pred eeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEEEEcCC
Confidence 3579999999999999753 4589999987653 3334678999999999999999999999999999999999999
Q ss_pred CCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccC
Q 005102 483 NGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAG 562 (714)
Q Consensus 483 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 562 (714)
+++|.+++.... ..+++.++.+++.|++.||+|||+ ++|+||||||+||++++++.+||+|||+++......
T Consensus 89 ~~~L~~~~~~~~-----~~~~~~~~~~~~~~l~~~l~~Lh~---~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~ 160 (266)
T cd05033 89 NGSLDKFLREND-----GKFTVGQLVGMLRGIASGMKYLSE---MNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSE 160 (266)
T ss_pred CCCHHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEcCCCCEEECccchhhcccccc
Confidence 999999997653 358999999999999999999999 899999999999999999999999999998764111
Q ss_pred CCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHh-CCCccccCCC
Q 005102 563 GSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMIT-GRTAVVQVGS 641 (714)
Q Consensus 563 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~ellt-G~~p~~~~~~ 641 (714)
. ........++..|+|||.+.+..++.++||||||+++|||++ |..||.....
T Consensus 161 ~--------------------------~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~ 214 (266)
T cd05033 161 A--------------------------TYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSN 214 (266)
T ss_pred c--------------------------ceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCH
Confidence 0 000111223567999999998899999999999999999998 9999843221
Q ss_pred CcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhhhh
Q 005102 642 SEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDALDRLI 710 (714)
Q Consensus 642 ~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~ 710 (714)
..+ .... ...... +. . ......+.+++.+||+.+|++||+++||++.|+++.
T Consensus 215 --~~~---~~~~-~~~~~~-----~~-~-----~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~~ 266 (266)
T cd05033 215 --QDV---IKAV-EDGYRL-----PP-P-----MDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKMI 266 (266)
T ss_pred --HHH---HHHH-HcCCCC-----CC-C-----CCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhhC
Confidence 111 1111 111110 10 0 112346889999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=351.26 Aligned_cols=249 Identities=22% Similarity=0.240 Sum_probs=197.0
Q ss_pred cccccccCceEEEEEEECC--CcEEEEEEeCCCCchhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCCC
Q 005102 408 AFVLGKSGIGIVYKVVLED--GHTLAVRRLGEGGSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGS 485 (714)
Q Consensus 408 ~~~lG~G~~g~Vy~~~~~~--g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gs 485 (714)
.+.||+|+||.||+|.... +..||+|++..........+.+|++++++++|||||++++++...+..|+||||+++|+
T Consensus 72 ~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~~gg~ 151 (478)
T PTZ00267 72 TTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGD 151 (478)
T ss_pred EEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECCCCCC
Confidence 3579999999999998643 57888888766555555678899999999999999999999999999999999999999
Q ss_pred HhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCCC
Q 005102 486 LATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSP 565 (714)
Q Consensus 486 L~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 565 (714)
|.++++..... ...+++.++..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++.......
T Consensus 152 L~~~l~~~~~~--~~~l~~~~~~~i~~qi~~aL~~lH~---~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~-- 224 (478)
T PTZ00267 152 LNKQIKQRLKE--HLPFQEYEVGLLFYQIVLALDEVHS---RKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS-- 224 (478)
T ss_pred HHHHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHh---CCEEECCcCHHhEEECCCCcEEEEeCcCceecCCccc--
Confidence 99988643111 1458899999999999999999999 8999999999999999999999999999986532110
Q ss_pred CccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCccccCCCCcch
Q 005102 566 TLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGSSEMD 645 (714)
Q Consensus 566 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~~~~~~~~~~ 645 (714)
........||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 225 ------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~----- 275 (478)
T PTZ00267 225 ------------------------LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPS----- 275 (478)
T ss_pred ------------------------cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCC-----
Confidence 011223457899999999999899999999999999999999999994321
Q ss_pred hHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 005102 646 LVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISD 704 (714)
Q Consensus 646 l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 704 (714)
..+.+........ ++ ... .....+.+++.+||..||++||++++++.
T Consensus 276 ~~~~~~~~~~~~~------~~-~~~-----~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 276 QREIMQQVLYGKY------DP-FPC-----PVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred HHHHHHHHHhCCC------CC-CCc-----cCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 1222222222111 11 000 11235789999999999999999999864
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=333.00 Aligned_cols=258 Identities=21% Similarity=0.320 Sum_probs=190.4
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeCCCCc-hhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCCCH
Q 005102 409 FVLGKSGIGIVYKVVLE-DGHTLAVRRLGEGGS-QRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGSL 486 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL 486 (714)
+.||+|+||.||+|+.. +++.||||++..... .....+.+|++++++++||||+++++++...+..++||||+. ++|
T Consensus 11 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~-~~l 89 (303)
T cd07869 11 EKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFEYVH-TDL 89 (303)
T ss_pred eeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEECCC-cCH
Confidence 47999999999999986 589999999876432 223467889999999999999999999999999999999995 688
Q ss_pred hhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCCCC
Q 005102 487 ATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPT 566 (714)
Q Consensus 487 ~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 566 (714)
.+++.... ..+++..+..++.|++.||+|||+ .+|+||||||+|||+++++.+||+|||+++......
T Consensus 90 ~~~~~~~~-----~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~---- 157 (303)
T cd07869 90 CQYMDKHP-----GGLHPENVKLFLFQLLRGLSYIHQ---RYILHRDLKPQNLLISDTGELKLADFGLARAKSVPS---- 157 (303)
T ss_pred HHHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECCCCcceeccCCC----
Confidence 88886543 358889999999999999999999 899999999999999999999999999987432110
Q ss_pred ccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCC-CCCCchhhhHHHHHHHHHHHhCCCccccCCCCcch
Q 005102 567 LQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKV-VKPSQKWDIYSYGVILLEMITGRTAVVQVGSSEMD 645 (714)
Q Consensus 567 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DVwS~Gvvl~elltG~~p~~~~~~~~~~ 645 (714)
.......+|+.|+|||++.+ ..++.++||||+||++|||++|+.||.........
T Consensus 158 ------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~ 213 (303)
T cd07869 158 ------------------------HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQ 213 (303)
T ss_pred ------------------------ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHH
Confidence 11122346888999999865 45799999999999999999999999543221111
Q ss_pred hHHHHHHHHhhcC--Cccc-----ccCCCCCC---CCCcH------HHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 005102 646 LVNWMQLCIEEKK--PLAD-----VLDPYLAP---DADKE------EEIIAVLKIAMACVHSSPEKRPTMRHISD 704 (714)
Q Consensus 646 l~~~~~~~~~~~~--~~~~-----~~d~~~~~---~~~~~------~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 704 (714)
+ ..+........ .... ..++.... ..... .....+.+++.+||+.||++|||++|+++
T Consensus 214 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 214 L-ERIFLVLGTPNEDTWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred H-HHHHHHhCCCChhhccchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 1 11111110000 0000 00000000 00000 01235779999999999999999999875
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=334.89 Aligned_cols=240 Identities=23% Similarity=0.300 Sum_probs=191.4
Q ss_pred cccccCceEEEEEEECC-CcEEEEEEeCCC---CchhHHHHHHHHHHHhcc-CCCCccceEEEEEeCCceeEEEeccCCC
Q 005102 410 VLGKSGIGIVYKVVLED-GHTLAVRRLGEG---GSQRFKEFQTEVEAIGKI-RHSNIVTLRAYYWSVDEKLLIYDYIPNG 484 (714)
Q Consensus 410 ~lG~G~~g~Vy~~~~~~-g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~e~~~~g 484 (714)
.||+|+||+||+|+++. ++.||||++++. .......+.+|++++..+ +||||+++++++...+..++||||+++|
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 81 (318)
T cd05570 2 VLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNGG 81 (318)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCCC
Confidence 69999999999999864 789999999754 223345677899999888 7999999999999999999999999999
Q ss_pred CHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCC
Q 005102 485 SLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGS 564 (714)
Q Consensus 485 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 564 (714)
+|.+++... ..+++..+..++.|++.||+|||+ .+|+||||||+||++++++.+||+|||+++.....
T Consensus 82 ~L~~~~~~~------~~l~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~--- 149 (318)
T cd05570 82 DLMFHIQRS------GRFDEPRARFYAAEIVLGLQFLHE---RGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILG--- 149 (318)
T ss_pred CHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHh---CCeEccCCCHHHeEECCCCcEEecccCCCeecCcC---
Confidence 999988755 458999999999999999999999 89999999999999999999999999998642111
Q ss_pred CCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCccccCCCCcc
Q 005102 565 PTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGSSEM 644 (714)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~~~~~~~~~ 644 (714)
........||+.|+|||++.+..++.++|||||||++|||++|+.||.... .
T Consensus 150 -------------------------~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~--~- 201 (318)
T cd05570 150 -------------------------GVTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDD--E- 201 (318)
T ss_pred -------------------------CCcccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCC--H-
Confidence 001122346888999999999999999999999999999999999994321 1
Q ss_pred hhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCH-----HHHHH
Q 005102 645 DLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTM-----RHISD 704 (714)
Q Consensus 645 ~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~-----~evl~ 704 (714)
............ ..... ....+.+++.+||+.||++|||+ .++++
T Consensus 202 --~~~~~~i~~~~~--------~~~~~-----~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~ 251 (318)
T cd05570 202 --DELFQSILEDEV--------RYPRW-----LSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG 251 (318)
T ss_pred --HHHHHHHHcCCC--------CCCCc-----CCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence 112222111111 11111 12357899999999999999999 76654
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=340.51 Aligned_cols=253 Identities=20% Similarity=0.234 Sum_probs=189.9
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeCCCCchhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCCCHh
Q 005102 409 FVLGKSGIGIVYKVVLE-DGHTLAVRRLGEGGSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGSLA 487 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL~ 487 (714)
+.||+|+||.||++... +++.||+|+... ..+.+|++++++++||||+++++++......++|||++. ++|.
T Consensus 98 ~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~-~~L~ 170 (391)
T PHA03212 98 ETFTPGAEGFAFACIDNKTCEHVVIKAGQR------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYK-TDLY 170 (391)
T ss_pred EEEcCCCCeEEEEEEECCCCCEEEEechhh------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecCC-CCHH
Confidence 47999999999999975 588999997542 456889999999999999999999999999999999995 6899
Q ss_pred hhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCCCCc
Q 005102 488 TALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTL 567 (714)
Q Consensus 488 ~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 567 (714)
.++... ..+++.+++.|+.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+|+......
T Consensus 171 ~~l~~~------~~l~~~~~~~i~~qi~~aL~ylH~---~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~----- 236 (391)
T PHA03212 171 CYLAAK------RNIAICDILAIERSVLRAIQYLHE---NRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDIN----- 236 (391)
T ss_pred HHHHhc------CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHhEEEcCCCCEEEEeCCccccccccc-----
Confidence 888654 458899999999999999999999 899999999999999999999999999987532110
Q ss_pred cCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCccccCCCCcc--h
Q 005102 568 QSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGSSEM--D 645 (714)
Q Consensus 568 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~~~~~~~~~--~ 645 (714)
........||+.|+|||++.+..++.++|||||||++|||+||+.||........ +
T Consensus 237 ----------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~ 294 (391)
T PHA03212 237 ----------------------ANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCD 294 (391)
T ss_pred ----------------------ccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCc
Confidence 0112234579999999999998999999999999999999999988753321110 0
Q ss_pred hHHHHHHHHhhcCC------------cccc---------cCCCCCCCC-CcHHHHHHHHHHHhHccCCCCCCCCCHHHHH
Q 005102 646 LVNWMQLCIEEKKP------------LADV---------LDPYLAPDA-DKEEEIIAVLKIAMACVHSSPEKRPTMRHIS 703 (714)
Q Consensus 646 l~~~~~~~~~~~~~------------~~~~---------~d~~~~~~~-~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl 703 (714)
....+......... +.+. ..+...+.. ........+.+++.+||+.||++|||++|++
T Consensus 295 ~~~~l~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL 374 (391)
T PHA03212 295 SDRQIKLIIRRSGTHPNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALL 374 (391)
T ss_pred hhHHHHHHHHHhcCChhhcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHh
Confidence 00001111100000 0000 000000000 0112234688999999999999999999998
Q ss_pred H
Q 005102 704 D 704 (714)
Q Consensus 704 ~ 704 (714)
+
T Consensus 375 ~ 375 (391)
T PHA03212 375 D 375 (391)
T ss_pred c
Confidence 4
|
|
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-38 Score=319.41 Aligned_cols=246 Identities=24% Similarity=0.374 Sum_probs=196.0
Q ss_pred ccccccCceEEEEEEECCCcEEEEEEeCCCCchhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCCCHhh
Q 005102 409 FVLGKSGIGIVYKVVLEDGHTLAVRRLGEGGSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGSLAT 488 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL~~ 488 (714)
..||+|+||.||+|.+.++..+|+|.+..... ..+.|.+|+.++++++||||+++++++...+..++||||+++|+|.+
T Consensus 10 ~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~ 88 (256)
T cd05113 10 KELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLN 88 (256)
T ss_pred eEecCcccceEEEEEecCCCcEEEEEcCCCcc-cHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCCCCcHHH
Confidence 46999999999999988777899999875433 34679999999999999999999999998888999999999999999
Q ss_pred hhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCCCCcc
Q 005102 489 ALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQ 568 (714)
Q Consensus 489 ~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 568 (714)
++.... ..+++.++++++.||+.||+|||+ .+++|+||||+||++++++.+||+|||.++......
T Consensus 89 ~i~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~------ 154 (256)
T cd05113 89 YLREHG-----KRFQPSQLLEMCKDVCEGMAYLES---KQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDE------ 154 (256)
T ss_pred HHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccCcceEEEcCCCCEEECCCccceecCCCc------
Confidence 997543 358999999999999999999999 899999999999999999999999999987543210
Q ss_pred CCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHh-CCCccccCCCCcchhH
Q 005102 569 SNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMIT-GRTAVVQVGSSEMDLV 647 (714)
Q Consensus 569 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~ellt-G~~p~~~~~~~~~~l~ 647 (714)
........++..|+|||.+.+..++.++|||||||++|||+| |+.||..... .+
T Consensus 155 ---------------------~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~--~~-- 209 (256)
T cd05113 155 ---------------------YTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNN--SE-- 209 (256)
T ss_pred ---------------------eeecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCH--HH--
Confidence 001111224567999999988889999999999999999999 9999843221 11
Q ss_pred HHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHh
Q 005102 648 NWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDALD 707 (714)
Q Consensus 648 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~ 707 (714)
.......... +.... .....+.+++.+||+.+|++|||+.++++.|+
T Consensus 210 -~~~~~~~~~~-------~~~~~-----~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 210 -TVEKVSQGLR-------LYRPH-----LASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred -HHHHHhcCCC-------CCCCC-----CCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 1111111111 00011 11246889999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=338.04 Aligned_cols=241 Identities=23% Similarity=0.340 Sum_probs=186.7
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeCCCCc-hhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCCCH
Q 005102 409 FVLGKSGIGIVYKVVLE-DGHTLAVRRLGEGGS-QRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGSL 486 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL 486 (714)
+.||+|+||.||+|++. +++.||||++..... ...+.+.+|++++++++|+||+++++++...+..++||||+++|+|
T Consensus 80 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 159 (353)
T PLN00034 80 NRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSL 159 (353)
T ss_pred hhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecCCCCcc
Confidence 47999999999999975 589999999875433 3346789999999999999999999999999999999999999998
Q ss_pred hhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCCCC
Q 005102 487 ATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPT 566 (714)
Q Consensus 487 ~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 566 (714)
.+. ...++..+..++.||+.||+|||+ .+|+||||||+|||+++++.+||+|||+++......
T Consensus 160 ~~~----------~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~---- 222 (353)
T PLN00034 160 EGT----------HIADEQFLADVARQILSGIAYLHR---RHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM---- 222 (353)
T ss_pred ccc----------ccCCHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCEEEcccccceeccccc----
Confidence 653 225567788999999999999999 899999999999999999999999999987653210
Q ss_pred ccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCC-----CCCCchhhhHHHHHHHHHHHhCCCccccCCC
Q 005102 567 LQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKV-----VKPSQKWDIYSYGVILLEMITGRTAVVQVGS 641 (714)
Q Consensus 567 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~~~DVwS~Gvvl~elltG~~p~~~~~~ 641 (714)
.......||..|+|||++.. ...+.++|||||||++|||++|+.||.....
T Consensus 223 ------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~ 278 (353)
T PLN00034 223 ------------------------DPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQ 278 (353)
T ss_pred ------------------------ccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCC
Confidence 01123357889999998743 2345789999999999999999999952211
Q ss_pred CcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 005102 642 SEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISD 704 (714)
Q Consensus 642 ~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 704 (714)
.+....+........ +.... ....++.+++.+||+.||++|||+.|+++
T Consensus 279 --~~~~~~~~~~~~~~~-------~~~~~-----~~~~~l~~li~~~l~~~P~~Rpt~~ell~ 327 (353)
T PLN00034 279 --GDWASLMCAICMSQP-------PEAPA-----TASREFRHFISCCLQREPAKRWSAMQLLQ 327 (353)
T ss_pred --ccHHHHHHHHhccCC-------CCCCC-----ccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 111111111111100 11111 12236889999999999999999999986
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-39 Score=333.69 Aligned_cols=245 Identities=23% Similarity=0.336 Sum_probs=204.8
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeCCCC--chhHHHHHHHHHHHhccCCCCccceEEEEEeCCc-eeEEEeccCCC
Q 005102 409 FVLGKSGIGIVYKVVLE-DGHTLAVRRLGEGG--SQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDE-KLLIYDYIPNG 484 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~-~~lV~e~~~~g 484 (714)
+++|+|+||.++.++++ +++.+|+|++.... ....+...+|+.++++++|||||.+.+.+..++. .+|||+|++||
T Consensus 10 ~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm~Y~eGg 89 (426)
T KOG0589|consen 10 RQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVMEYCEGG 89 (426)
T ss_pred hhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEEeecCCC
Confidence 37999999999999875 47899999987643 3334578899999999999999999999999888 89999999999
Q ss_pred CHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCC
Q 005102 485 SLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGS 564 (714)
Q Consensus 485 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 564 (714)
++.+.+.+.++ ..++++++.+|+.|++.|+.|||+ ++|+|||||+.||+++.+..+||+|||+|+.+....
T Consensus 90 ~l~~~i~~~k~----~~f~E~~i~~~~~Q~~~av~ylH~---~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~-- 160 (426)
T KOG0589|consen 90 DLAQLIKEQKG----VLFPEERILKWFVQILLAVNYLHE---NRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPED-- 160 (426)
T ss_pred CHHHHHHHHhh----ccccHHHHHHHHHHHHHHHHHHHh---hhhhcccchhhhhhccccCceeecchhhhhhcCCch--
Confidence 99999988764 458999999999999999999998 899999999999999999999999999999875431
Q ss_pred CCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCccccCCCCcc
Q 005102 565 PTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGSSEM 644 (714)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~~~~~~~~~ 644 (714)
....+.+||+.||.||.+.+.+|+.|+||||+||++|||.+-+++|.. .
T Consensus 161 --------------------------~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a-----~ 209 (426)
T KOG0589|consen 161 --------------------------SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKA-----S 209 (426)
T ss_pred --------------------------hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCc-----c
Confidence 133456789999999999999999999999999999999999999942 2
Q ss_pred hhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 005102 645 DLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDA 705 (714)
Q Consensus 645 ~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 705 (714)
+....+....+.. ++|.- .....++..++..|+..+|+.||++.+++.+
T Consensus 210 ~m~~Li~ki~~~~------~~Plp------~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 210 NMSELILKINRGL------YSPLP------SMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred chHHHHHHHhhcc------CCCCC------ccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 2333333333322 12211 1233468899999999999999999999876
|
|
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=323.80 Aligned_cols=255 Identities=18% Similarity=0.284 Sum_probs=200.9
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeCCC---CchhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCC
Q 005102 409 FVLGKSGIGIVYKVVLE-DGHTLAVRRLGEG---GSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNG 484 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~g 484 (714)
+.||+|+||.||+|+.. +++.||||.+... .......+.+|++++++++||||+++++++...+..++||||+++|
T Consensus 8 ~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~ 87 (267)
T cd08228 8 KKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLELADAG 87 (267)
T ss_pred eeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEEEecCCC
Confidence 47999999999999975 5899999987643 2333457889999999999999999999999999999999999999
Q ss_pred CHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCC
Q 005102 485 SLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGS 564 (714)
Q Consensus 485 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 564 (714)
+|.+++...... ...+++..+.+++.|++.||+|||+ ++++|+||||+||+++.++.++|+|||+++......
T Consensus 88 ~L~~~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~-- 160 (267)
T cd08228 88 DLSQMIKYFKKQ--KRLIPERTVWKYFVQLCSAVEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT-- 160 (267)
T ss_pred cHHHHHHHhhhc--cCCCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCCHHHEEEcCCCCEEECccccceeccchh--
Confidence 999988643211 1347889999999999999999999 899999999999999999999999999987653211
Q ss_pred CCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCccccCCCCcc
Q 005102 565 PTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGSSEM 644 (714)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~~~~~~~~~ 644 (714)
.......++..|+|||.+.+..++.++||||||+++|||++|+.||......
T Consensus 161 --------------------------~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~-- 212 (267)
T cd08228 161 --------------------------TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN-- 212 (267)
T ss_pred --------------------------HHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCcccccc--
Confidence 0011234577899999998888999999999999999999999998543222
Q ss_pred hhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhhhh
Q 005102 645 DLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDALDRLI 710 (714)
Q Consensus 645 ~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~ 710 (714)
...+........ .+... .......+.+++.+||+.+|++||++++|++.|+++.
T Consensus 213 -~~~~~~~~~~~~-------~~~~~----~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~ 266 (267)
T cd08228 213 -LFSLCQKIEQCD-------YPPLP----TEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH 266 (267)
T ss_pred -HHHHHHHHhcCC-------CCCCC----hhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence 222222111111 11111 1123346889999999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-38 Score=318.65 Aligned_cols=248 Identities=22% Similarity=0.341 Sum_probs=194.4
Q ss_pred cccccCceEEEEEEEC-CCcEEEEEEeCCCC-chhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCCCHh
Q 005102 410 VLGKSGIGIVYKVVLE-DGHTLAVRRLGEGG-SQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGSLA 487 (714)
Q Consensus 410 ~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL~ 487 (714)
.||+|+||.||+|... +++.||+|.+.... ......|.+|++++++++||||+++++++...+..++||||+++++|.
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 81 (252)
T cd05084 2 RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFL 81 (252)
T ss_pred ccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcHH
Confidence 6999999999999975 68999999887543 233467999999999999999999999999999999999999999999
Q ss_pred hhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCCCCc
Q 005102 488 TALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTL 567 (714)
Q Consensus 488 ~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 567 (714)
+++.... ..+++.++..++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||+++.......
T Consensus 82 ~~~~~~~-----~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~---- 149 (252)
T cd05084 82 TFLRTEG-----PRLKVKELIQMVENAAAGMEYLES---KHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVY---- 149 (252)
T ss_pred HHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHHh---CCccccccchheEEEcCCCcEEECccccCcccccccc----
Confidence 9997542 358899999999999999999999 8999999999999999999999999999875321100
Q ss_pred cCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHh-CCCccccCCCCcchh
Q 005102 568 QSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMIT-GRTAVVQVGSSEMDL 646 (714)
Q Consensus 568 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~ellt-G~~p~~~~~~~~~~l 646 (714)
.........+..|+|||.+.+..++.++||||||+++|||++ |..||..... ..
T Consensus 150 ----------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~--~~- 204 (252)
T cd05084 150 ----------------------ASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSN--QQ- 204 (252)
T ss_pred ----------------------cccCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCH--HH-
Confidence 000011112446999999998889999999999999999998 8888843211 11
Q ss_pred HHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhh
Q 005102 647 VNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDALDR 708 (714)
Q Consensus 647 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~ 708 (714)
.......... .... ......+.+++.+||+.+|++|||+.++.++|++
T Consensus 205 ---~~~~~~~~~~------~~~~-----~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~ 252 (252)
T cd05084 205 ---TREAIEQGVR------LPCP-----ELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQS 252 (252)
T ss_pred ---HHHHHHcCCC------CCCc-----ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhC
Confidence 1111111110 0111 1123368899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=336.71 Aligned_cols=236 Identities=25% Similarity=0.336 Sum_probs=186.8
Q ss_pred cccccCceEEEEEEEC-CCcEEEEEEeCCCC---chhHHHHHHHHH-HHhccCCCCccceEEEEEeCCceeEEEeccCCC
Q 005102 410 VLGKSGIGIVYKVVLE-DGHTLAVRRLGEGG---SQRFKEFQTEVE-AIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNG 484 (714)
Q Consensus 410 ~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~g 484 (714)
+||+|+||+||+|+.. +|+.||+|++.... ....+.+..|.. +++.++||||+++++++...+..++||||+++|
T Consensus 2 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~g 81 (323)
T cd05575 2 VIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNGG 81 (323)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCCC
Confidence 6999999999999986 58999999987532 222344555655 467899999999999999999999999999999
Q ss_pred CHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCC
Q 005102 485 SLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGS 564 (714)
Q Consensus 485 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 564 (714)
+|.+++... ..+++..+..++.||+.||+|||+ ++|+||||||+|||+++++.+||+|||+++.....
T Consensus 82 ~L~~~l~~~------~~~~~~~~~~~~~qi~~~l~~lH~---~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~--- 149 (323)
T cd05575 82 ELFFHLQRE------RSFPEPRARFYAAEIASALGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEH--- 149 (323)
T ss_pred CHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHeEECCCCcEEEeccCCCcccccC---
Confidence 999998754 458899999999999999999999 89999999999999999999999999998743211
Q ss_pred CCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCccccCCCCcc
Q 005102 565 PTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGSSEM 644 (714)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~~~~~~~~~ 644 (714)
........||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 150 -------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~----- 199 (323)
T cd05575 150 -------------------------SKTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSR----- 199 (323)
T ss_pred -------------------------CCccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCC-----
Confidence 01112335788999999999999999999999999999999999999532
Q ss_pred hhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHH
Q 005102 645 DLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMR 700 (714)
Q Consensus 645 ~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ 700 (714)
+..+........... ..+.. ...+.+++.+||+.||++||++.
T Consensus 200 ~~~~~~~~i~~~~~~--------~~~~~-----~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 200 DTAEMYDNILNKPLR--------LKPNI-----SVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred CHHHHHHHHHcCCCC--------CCCCC-----CHHHHHHHHHHhhcCHHhCCCCC
Confidence 122222222221111 11111 23578999999999999999985
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-38 Score=325.82 Aligned_cols=247 Identities=24% Similarity=0.255 Sum_probs=191.4
Q ss_pred ccccCceEEEEEEEC-CCcEEEEEEeCCCC---chhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCCCH
Q 005102 411 LGKSGIGIVYKVVLE-DGHTLAVRRLGEGG---SQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGSL 486 (714)
Q Consensus 411 lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL 486 (714)
||+|+||.||+++.+ +|+.||+|++.... ....+.+..|++++++++||||+++++++....+.++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 699999999999975 48999999986532 12234566799999999999999999999999999999999999999
Q ss_pred hhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCCCC
Q 005102 487 ATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPT 566 (714)
Q Consensus 487 ~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 566 (714)
.+++..... ..+++..+..++.|++.||+|||+ .+|+||||||+||++++++.+||+|||++.......
T Consensus 81 ~~~~~~~~~----~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~---- 149 (277)
T cd05607 81 KYHIYNVGE----RGLEMERVIHYSAQITCGILHLHS---MDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK---- 149 (277)
T ss_pred HHHHHhccc----cCCCHHHHHHHHHHHHHHHHHHHH---CCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc----
Confidence 988865432 358899999999999999999999 899999999999999999999999999987543210
Q ss_pred ccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCccccCCCCcchh
Q 005102 567 LQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGSSEMDL 646 (714)
Q Consensus 567 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~~~~~~~~~~l 646 (714)
......|+..|+|||++.+..++.++||||+||++|||++|+.||...... ...
T Consensus 150 -------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~-~~~ 203 (277)
T cd05607 150 -------------------------TITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEK-VAK 203 (277)
T ss_pred -------------------------eeeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcch-hhH
Confidence 011234678899999999888999999999999999999999999432211 111
Q ss_pred HHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHH
Q 005102 647 VNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDAL 706 (714)
Q Consensus 647 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L 706 (714)
............ .. .. .....++.+++.+||+.||++||+++|+++.+
T Consensus 204 ~~~~~~~~~~~~------~~--~~----~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~ 251 (277)
T cd05607 204 EELKRRTLEDEV------KF--EH----QNFTEESKDICRLFLAKKPEDRLGSREKNDDP 251 (277)
T ss_pred HHHHHHhhcccc------cc--cc----ccCCHHHHHHHHHHhccCHhhCCCCccchhhh
Confidence 111111111110 00 00 01223578999999999999999998766443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=320.80 Aligned_cols=247 Identities=22% Similarity=0.296 Sum_probs=189.3
Q ss_pred cccccCceEEEEEEEC-CCcEEEEEEeCCCCc--------------hhHHHHHHHHHHHhccCCCCccceEEEEEeC--C
Q 005102 410 VLGKSGIGIVYKVVLE-DGHTLAVRRLGEGGS--------------QRFKEFQTEVEAIGKIRHSNIVTLRAYYWSV--D 472 (714)
Q Consensus 410 ~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--------------~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~ 472 (714)
.||+|.||.|-+|+.. +++.||||++.+... ...+...+||.+|++++|||||+++.+..+. +
T Consensus 104 eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiEvLDDP~s~ 183 (576)
T KOG0585|consen 104 EIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIEVLDDPESD 183 (576)
T ss_pred hhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEEeecCcccC
Confidence 6999999999999965 589999999976311 1135788999999999999999999998764 5
Q ss_pred ceeEEEeccCCCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEccc
Q 005102 473 EKLLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDF 552 (714)
Q Consensus 473 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DF 552 (714)
..|||+|||..|.+...=... ..+++.++++|++++..||+|||. ++||||||||+|+|++++|++||+||
T Consensus 184 ~~YlVley~s~G~v~w~p~d~------~els~~~Ar~ylrDvv~GLEYLH~---QgiiHRDIKPsNLLl~~~g~VKIsDF 254 (576)
T KOG0585|consen 184 KLYLVLEYCSKGEVKWCPPDK------PELSEQQARKYLRDVVLGLEYLHY---QGIIHRDIKPSNLLLSSDGTVKISDF 254 (576)
T ss_pred ceEEEEEeccCCccccCCCCc------ccccHHHHHHHHHHHHHHHHHHHh---cCeeccccchhheEEcCCCcEEeecc
Confidence 789999999988765432211 238999999999999999999999 89999999999999999999999999
Q ss_pred chhhhhhccCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCC----CCchhhhHHHHHHHHH
Q 005102 553 GLARLANIAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVK----PSQKWDIYSYGVILLE 628 (714)
Q Consensus 553 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~s~~~DVwS~Gvvl~e 628 (714)
|.+......... ..........||+.|+|||...++. .+.+.||||+||+||-
T Consensus 255 GVs~~~~~~~~~-----------------------~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYC 311 (576)
T KOG0585|consen 255 GVSNEFPQGSDE-----------------------GSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYC 311 (576)
T ss_pred ceeeecccCCcc-----------------------ccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHH
Confidence 998765322100 0011122357899999999997733 3678999999999999
Q ss_pred HHhCCCccccCCCCcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 005102 629 MITGRTAVVQVGSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISD 704 (714)
Q Consensus 629 lltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 704 (714)
|+.|+.||... ...+....++.+.-.+ +. ..+....+.+++.++|++||++|.+..+|..
T Consensus 312 llfG~~PF~~~-----~~~~l~~KIvn~pL~f---------P~--~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~ 371 (576)
T KOG0585|consen 312 LLFGQLPFFDD-----FELELFDKIVNDPLEF---------PE--NPEINEDLKDLIKRLLEKDPEQRITLPDIKL 371 (576)
T ss_pred hhhccCCcccc-----hHHHHHHHHhcCcccC---------CC--cccccHHHHHHHHHHhhcChhheeehhhhee
Confidence 99999999422 2233333333322111 11 1123446789999999999999999988754
|
|
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=328.17 Aligned_cols=258 Identities=25% Similarity=0.408 Sum_probs=196.7
Q ss_pred ccccccCceEEEEEEEC-----CCcEEEEEEeCCCCchhHHHHHHHHHHHhccCCCCccceEEEEEeC--CceeEEEecc
Q 005102 409 FVLGKSGIGIVYKVVLE-----DGHTLAVRRLGEGGSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSV--DEKLLIYDYI 481 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~-----~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~~lV~e~~ 481 (714)
+.||+|+||.||++..+ ++..||+|++........+.|.+|++++++++||||+++++++... ...++||||+
T Consensus 10 ~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~ 89 (284)
T cd05081 10 QQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYL 89 (284)
T ss_pred eeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceEEEEEec
Confidence 47999999999999853 4789999999877666667899999999999999999999987643 4678999999
Q ss_pred CCCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhcc
Q 005102 482 PNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIA 561 (714)
Q Consensus 482 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 561 (714)
++|+|.+++.... ..+++..+..++.|++.||+|||+ ++|+||||||+||++++++.+||+|||+++.....
T Consensus 90 ~~~~L~~~l~~~~-----~~l~~~~~~~~~~~l~~aL~~LH~---~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~ 161 (284)
T cd05081 90 PYGSLRDYLQKHR-----ERLDHRKLLLYASQICKGMEYLGS---KRYVHRDLATRNILVESENRVKIGDFGLTKVLPQD 161 (284)
T ss_pred CCCCHHHHHHhcC-----cCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCCHhhEEECCCCeEEECCCcccccccCC
Confidence 9999999997543 358999999999999999999999 89999999999999999999999999999865322
Q ss_pred CCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCccccCCC
Q 005102 562 GGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGS 641 (714)
Q Consensus 562 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~~~~~~ 641 (714)
... ........++..|+|||++.+..++.++|||||||++|||++|..|+.....
T Consensus 162 ~~~-------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~ 216 (284)
T cd05081 162 KEY-------------------------YKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPA 216 (284)
T ss_pred Ccc-------------------------eeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcch
Confidence 110 0001111234569999999988899999999999999999998877532211
Q ss_pred Ccc----------hhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhhhh
Q 005102 642 SEM----------DLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDALDRLI 710 (714)
Q Consensus 642 ~~~----------~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~ 710 (714)
... .....+......... ... .......+.+++.+||+.+|++|||+.||++.|+++.
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------~~~---~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~~ 284 (284)
T cd05081 217 EFMRMMGNDKQGQMIVYHLIELLKNNGR--------LPA---PPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAIR 284 (284)
T ss_pred hhhhhcccccccccchHHHHHHHhcCCc--------CCC---CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhcC
Confidence 000 000000011111100 000 0112336889999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=322.00 Aligned_cols=253 Identities=25% Similarity=0.364 Sum_probs=195.6
Q ss_pred ccccccCceEEEEEEECC-Cc----EEEEEEeCCCCc-hhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccC
Q 005102 409 FVLGKSGIGIVYKVVLED-GH----TLAVRRLGEGGS-QRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIP 482 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~~-g~----~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~ 482 (714)
+.||+|+||.||+|.+.. ++ .+++|.+..... ....++..|+..+++++||||+++++++. ....++++||++
T Consensus 13 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~~i~e~~~ 91 (279)
T cd05111 13 KLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQLVTQLSP 91 (279)
T ss_pred cccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccEEEEEeCC
Confidence 579999999999999743 44 478888764432 33467888999999999999999999875 456789999999
Q ss_pred CCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccC
Q 005102 483 NGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAG 562 (714)
Q Consensus 483 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 562 (714)
+|+|.+++.... ..+++..+..|+.||+.||+|||+ ++++||||||+||++++++.+||+|||+++......
T Consensus 92 ~gsL~~~l~~~~-----~~~~~~~~~~i~~qi~~~l~~lH~---~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~~ 163 (279)
T cd05111 92 LGSLLDHVRQHR-----DSLDPQRLLNWCVQIAKGMYYLEE---HRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDD 163 (279)
T ss_pred CCcHHHHHHhcc-----cCCCHHHHHHHHHHHHHHHHHHHH---CCEeccccCcceEEEcCCCcEEEcCCccceeccCCC
Confidence 999999997653 458999999999999999999999 899999999999999999999999999997653211
Q ss_pred CCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHh-CCCccccCCC
Q 005102 563 GSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMIT-GRTAVVQVGS 641 (714)
Q Consensus 563 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~ellt-G~~p~~~~~~ 641 (714)
. ........++..|+|||.+.+..++.++|||||||++|||+| |+.||....
T Consensus 164 ~--------------------------~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~- 216 (279)
T cd05111 164 K--------------------------KYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMR- 216 (279)
T ss_pred c--------------------------ccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCC-
Confidence 0 001112334667999999998899999999999999999998 999984321
Q ss_pred CcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhhhhccC
Q 005102 642 SEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDALDRLIVSS 713 (714)
Q Consensus 642 ~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~~~ 713 (714)
.....++ ....... ..+.. ....+.+++.+||..||++|||+.|+++.|+.+.+.+
T Consensus 217 -~~~~~~~----~~~~~~~---~~~~~--------~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~~ 272 (279)
T cd05111 217 -PHEVPDL----LEKGERL---AQPQI--------CTIDVYMVMVKCWMIDENVRPTFKELANEFTRMARDP 272 (279)
T ss_pred -HHHHHHH----HHCCCcC---CCCCC--------CCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhCC
Confidence 1111111 1211111 11111 1235778999999999999999999999999876543
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=321.34 Aligned_cols=255 Identities=23% Similarity=0.358 Sum_probs=194.2
Q ss_pred ccccccCceEEEEEEECCC-c--EEEEEEeCCC--CchhHHHHHHHHHHHhccCCCCccceEEEEEeC------CceeEE
Q 005102 409 FVLGKSGIGIVYKVVLEDG-H--TLAVRRLGEG--GSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSV------DEKLLI 477 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~~g-~--~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~------~~~~lV 477 (714)
+.||+|+||.||+|++.+. . .||+|.++.. .....+.+.+|++++++++||||+++++++... ...++|
T Consensus 5 ~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v 84 (272)
T cd05075 5 KTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPVVI 84 (272)
T ss_pred cccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCcEEE
Confidence 5799999999999997653 2 6899988754 234456789999999999999999999987542 246899
Q ss_pred EeccCCCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhh
Q 005102 478 YDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARL 557 (714)
Q Consensus 478 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 557 (714)
|||+++|+|.+++...........+++..+..++.|++.||+|||+ ++|+||||||+|||+++++.+||+|||+++.
T Consensus 85 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 161 (272)
T cd05075 85 LPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSS---KSFIHRDLAARNCMLNENMNVCVADFGLSKK 161 (272)
T ss_pred EEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhheEEcCCCCEEECCCCcccc
Confidence 9999999999987533211112458999999999999999999999 8999999999999999999999999999986
Q ss_pred hhccCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHh-CCCcc
Q 005102 558 ANIAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMIT-GRTAV 636 (714)
Q Consensus 558 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~ellt-G~~p~ 636 (714)
...... ........+++.|+|||+..+..++.++||||||+++|||++ |+.||
T Consensus 162 ~~~~~~--------------------------~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~ 215 (272)
T cd05075 162 IYNGDY--------------------------YRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPY 215 (272)
T ss_pred cCcccc--------------------------eecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCC
Confidence 532110 000111233567999999998889999999999999999999 78888
Q ss_pred ccCCCCcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhhh
Q 005102 637 VQVGSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDALDRL 709 (714)
Q Consensus 637 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i 709 (714)
.... ...+ ... ....... .... .....+.+++.+||+.||++|||+.++++.|+++
T Consensus 216 ~~~~--~~~~---~~~-~~~~~~~------~~~~-----~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 216 PGVE--NSEI---YDY-LRQGNRL------KQPP-----DCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred CCCC--HHHH---HHH-HHcCCCC------CCCC-----CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 4321 1111 111 1111110 0011 1223578999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-38 Score=325.85 Aligned_cols=265 Identities=24% Similarity=0.331 Sum_probs=196.3
Q ss_pred ccccccCceEEEEEEE-----CCCcEEEEEEeCCCCc-hhHHHHHHHHHHHhccCCCCccceEEEEEeC--CceeEEEec
Q 005102 409 FVLGKSGIGIVYKVVL-----EDGHTLAVRRLGEGGS-QRFKEFQTEVEAIGKIRHSNIVTLRAYYWSV--DEKLLIYDY 480 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~-----~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~~lV~e~ 480 (714)
..||+|+||+||++.+ .+++.||+|.+..... .....|.+|++++++++||||+++++++... ...++||||
T Consensus 10 ~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~ 89 (283)
T cd05080 10 RVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLIMEY 89 (283)
T ss_pred eecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEEecC
Confidence 4799999999988653 3578999999876532 3346788999999999999999999998754 357899999
Q ss_pred cCCCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhc
Q 005102 481 IPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANI 560 (714)
Q Consensus 481 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 560 (714)
+++|+|.+++... .+++.++..++.|++.||+|||+ ++|+||||||+||++++++.+||+|||+++....
T Consensus 90 ~~~~~l~~~~~~~-------~l~~~~~~~i~~~l~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~ 159 (283)
T cd05080 90 VPLGSLRDYLPKH-------KLNLAQLLLFAQQICEGMAYLHS---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE 159 (283)
T ss_pred CCCCCHHHHHHHc-------CCCHHHHHHHHHHHHHHHHHHHH---CCeeccccChheEEEcCCCcEEEeecccccccCC
Confidence 9999999998643 48999999999999999999999 8999999999999999999999999999886542
Q ss_pred cCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCccccCC
Q 005102 561 AGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVG 640 (714)
Q Consensus 561 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~~~~~ 640 (714)
.... ........++..|+|||.+.+..++.++||||||+++|||+||+.|+....
T Consensus 160 ~~~~-------------------------~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~ 214 (283)
T cd05080 160 GHEY-------------------------YRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPP 214 (283)
T ss_pred cchh-------------------------hccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCc
Confidence 1100 000111223556999999988889999999999999999999999984332
Q ss_pred CCcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhhhh
Q 005102 641 SSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDALDRLI 710 (714)
Q Consensus 641 ~~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~ 710 (714)
....+......... ....+.+..+....... ......++.+++.+||+.+|++|||++++++.|+++.
T Consensus 215 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 215 KKFEEMIGPKQGQM-TVVRLIELLERGMRLPC-PKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred chhhhhhccccccc-chhhhhhhhhcCCCCCC-CCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 21111110000000 00000111111110000 0112347889999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=318.64 Aligned_cols=250 Identities=23% Similarity=0.349 Sum_probs=194.4
Q ss_pred cccccCceEEEEEEEC---CCcEEEEEEeCCCCc-hhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCCC
Q 005102 410 VLGKSGIGIVYKVVLE---DGHTLAVRRLGEGGS-QRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGS 485 (714)
Q Consensus 410 ~lG~G~~g~Vy~~~~~---~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gs 485 (714)
.||+|+||.||+|.++ ++..||+|++..... ...+.|.+|+.++++++||||+++++++. .+..++||||+++|+
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence 3899999999999864 356799999876533 23467999999999999999999999885 457899999999999
Q ss_pred HhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCCC
Q 005102 486 LATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSP 565 (714)
Q Consensus 486 L~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 565 (714)
|.+++.... ..+++.++++++.|++.||+|||+ ++++||||||+||+++.++.+||+|||+++........
T Consensus 81 L~~~l~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~- 151 (257)
T cd05115 81 LNKFLSGKK-----DEITVSNVVELMHQVSMGMKYLEG---KNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSY- 151 (257)
T ss_pred HHHHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHHh---cCeeecccchheEEEcCCCcEEeccCCccccccCCccc-
Confidence 999987543 458999999999999999999999 89999999999999999999999999998754322110
Q ss_pred CccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHh-CCCccccCCCCcc
Q 005102 566 TLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMIT-GRTAVVQVGSSEM 644 (714)
Q Consensus 566 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~ellt-G~~p~~~~~~~~~ 644 (714)
........++..|+|||.+.+..++.++|||||||++||+++ |+.||..... .
T Consensus 152 ------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~--~ 205 (257)
T cd05115 152 ------------------------YKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKG--P 205 (257)
T ss_pred ------------------------eeccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCH--H
Confidence 000111123467999999988889999999999999999997 9999953321 1
Q ss_pred hhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhhhh
Q 005102 645 DLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDALDRLI 710 (714)
Q Consensus 645 ~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~ 710 (714)
.+.. .+..... +.... ....++.+++.+||..||++||++.+|.+.|+.+.
T Consensus 206 ---~~~~-~~~~~~~------~~~~~-----~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~~ 256 (257)
T cd05115 206 ---EVMS-FIEQGKR------LDCPA-----ECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTYY 256 (257)
T ss_pred ---HHHH-HHHCCCC------CCCCC-----CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhhc
Confidence 1111 1111111 11111 12346889999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-38 Score=332.14 Aligned_cols=240 Identities=23% Similarity=0.304 Sum_probs=187.1
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeCCCC---chhHHHHHHHHHHH---hccCCCCccceEEEEEeCCceeEEEecc
Q 005102 409 FVLGKSGIGIVYKVVLE-DGHTLAVRRLGEGG---SQRFKEFQTEVEAI---GKIRHSNIVTLRAYYWSVDEKLLIYDYI 481 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l---~~l~H~niv~l~~~~~~~~~~~lV~e~~ 481 (714)
..||+|+||.||+|.+. +++.||||+++... ....+.+.+|++++ ++++||||+++++++...+..|+||||+
T Consensus 5 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~E~~ 84 (324)
T cd05589 5 AVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFVMEYA 84 (324)
T ss_pred EEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEEEcCC
Confidence 47999999999999975 58999999997542 22334566676655 5678999999999999999999999999
Q ss_pred CCCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhcc
Q 005102 482 PNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIA 561 (714)
Q Consensus 482 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 561 (714)
++|+|..+++. ..+++..+..++.|++.||+|||+ .+|+||||||+||++++++.+||+|||+++.....
T Consensus 85 ~~~~L~~~~~~-------~~l~~~~~~~~~~qi~~al~~lH~---~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~ 154 (324)
T cd05589 85 AGGDLMMHIHT-------DVFSEPRAVFYAACVVLGLQYLHE---NKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGF 154 (324)
T ss_pred CCCcHHHHhhc-------CCCCHHHHHHHHHHHHHHHHHHHh---CCeEecCCCHHHeEECCCCcEEeCcccCCccCCCC
Confidence 99999988754 348999999999999999999999 89999999999999999999999999998642211
Q ss_pred CCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCccccCCC
Q 005102 562 GGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGS 641 (714)
Q Consensus 562 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~~~~~~ 641 (714)
........|++.|+|||.+.+..++.++|||||||++|||++|+.||....
T Consensus 155 ----------------------------~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~- 205 (324)
T cd05589 155 ----------------------------GDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDD- 205 (324)
T ss_pred ----------------------------CCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCC-
Confidence 011123457889999999999899999999999999999999999994321
Q ss_pred CcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCC-----HHHHHH
Q 005102 642 SEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPT-----MRHISD 704 (714)
Q Consensus 642 ~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt-----~~evl~ 704 (714)
. .+.......... ..... ....+.+++.+||+.||++||+ +.++++
T Consensus 206 -~---~~~~~~i~~~~~--------~~p~~-----~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~ 256 (324)
T cd05589 206 -E---EEVFDSIVNDEV--------RYPRF-----LSREAISIMRRLLRRNPERRLGSGEKDAEDVKK 256 (324)
T ss_pred -H---HHHHHHHHhCCC--------CCCCC-----CCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence 1 122222222111 11111 1235779999999999999994 555543
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=316.64 Aligned_cols=248 Identities=21% Similarity=0.306 Sum_probs=194.0
Q ss_pred cccccCceEEEEEEEC---CCcEEEEEEeCCCC--chhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCC
Q 005102 410 VLGKSGIGIVYKVVLE---DGHTLAVRRLGEGG--SQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNG 484 (714)
Q Consensus 410 ~lG~G~~g~Vy~~~~~---~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~g 484 (714)
.||+|+||.||+|.++ ++..+|+|+++... ....+++.+|+.++++++||||+++++++. .+..++||||+++|
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 5899999999999753 47899999987543 233567899999999999999999999885 45678999999999
Q ss_pred CHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCC
Q 005102 485 SLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGS 564 (714)
Q Consensus 485 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 564 (714)
+|.+++... ..+++..+.+++.|++.||+|||+ ++|+||||||+||++++++.+||+|||+++........
T Consensus 81 ~L~~~l~~~------~~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~ 151 (257)
T cd05116 81 PLNKFLQKN------KHVTEKNITELVHQVSMGMKYLEE---TNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENY 151 (257)
T ss_pred cHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccchhhEEEcCCCeEEECCCccccccCCCCCe
Confidence 999999654 358899999999999999999999 89999999999999999999999999998765322110
Q ss_pred CCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHh-CCCccccCCCCc
Q 005102 565 PTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMIT-GRTAVVQVGSSE 643 (714)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~ellt-G~~p~~~~~~~~ 643 (714)
........++..|+|||.+....++.++|||||||++|||+| |+.||.... .
T Consensus 152 -------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~--~ 204 (257)
T cd05116 152 -------------------------YKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMK--G 204 (257)
T ss_pred -------------------------eeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCC--H
Confidence 001111223567999999988889999999999999999998 999994321 1
Q ss_pred chhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhhh
Q 005102 644 MDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDALDRL 709 (714)
Q Consensus 644 ~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i 709 (714)
.. +.... ..... +..+.. ....+.+++.+||+.||++||++++|.+.|++.
T Consensus 205 ~~---~~~~i-~~~~~------~~~~~~-----~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 205 NE---VTQMI-ESGER------MECPQR-----CPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY 255 (257)
T ss_pred HH---HHHHH-HCCCC------CCCCCC-----CCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence 11 22211 11111 111111 223578999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-38 Score=333.52 Aligned_cols=259 Identities=27% Similarity=0.391 Sum_probs=198.3
Q ss_pred ccccccCceEEEEEEEC------CCcEEEEEEeCCCC-chhHHHHHHHHHHHhcc-CCCCccceEEEEEeC-CceeEEEe
Q 005102 409 FVLGKSGIGIVYKVVLE------DGHTLAVRRLGEGG-SQRFKEFQTEVEAIGKI-RHSNIVTLRAYYWSV-DEKLLIYD 479 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~------~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~-~~~~lV~e 479 (714)
++||+|+||.||+|... +++.||+|+++... ....+.+.+|++++.++ +|+||++++++|... ...+++||
T Consensus 13 ~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~~~~v~e 92 (337)
T cd05054 13 KPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGPLMVIVE 92 (337)
T ss_pred cccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCCEEEEEe
Confidence 58999999999999742 25789999987543 23345688899999999 899999999988754 56789999
Q ss_pred ccCCCCHhhhhhCCCCCC-------------------------------------------------------CcCCCCH
Q 005102 480 YIPNGSLATALHGKPGMV-------------------------------------------------------SFTPVPW 504 (714)
Q Consensus 480 ~~~~gsL~~~l~~~~~~~-------------------------------------------------------~~~~l~~ 504 (714)
|+++|+|.+++....... ....++|
T Consensus 93 y~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 172 (337)
T cd05054 93 YCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTL 172 (337)
T ss_pred cCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHhhcCCCH
Confidence 999999999986432100 0126899
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCCCCccCCCCCCCCchhhhccc
Q 005102 505 SVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQKS 584 (714)
Q Consensus 505 ~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 584 (714)
..+.+++.||+.||+|||+ ++|+||||||+|||+++++.+||+|||+++.+.....
T Consensus 173 ~~~~~~~~qi~~aL~~lH~---~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~--------------------- 228 (337)
T cd05054 173 EDLISYSFQVARGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPD--------------------- 228 (337)
T ss_pred HHHHHHHHHHHHHHHHHHh---CCeecCCCCcceEEEeCCCcEEEeccccchhcccCcc---------------------
Confidence 9999999999999999999 8999999999999999999999999999986532110
Q ss_pred ccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHh-CCCccccCCCCcchhHHHHHHHHhhcCCcccc
Q 005102 585 VSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMIT-GRTAVVQVGSSEMDLVNWMQLCIEEKKPLADV 663 (714)
Q Consensus 585 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 663 (714)
........++..|+|||++.+..++.++|||||||++|||++ |+.||......+ .+.. .......
T Consensus 229 -----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~-~~~~----~~~~~~~---- 294 (337)
T cd05054 229 -----YVRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE-EFCR----RLKEGTR---- 294 (337)
T ss_pred -----hhhccCCCCCccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccH-HHHH----HHhccCC----
Confidence 011122334667999999999999999999999999999998 999985322111 1111 1111110
Q ss_pred cCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhhhhcc
Q 005102 664 LDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDALDRLIVS 712 (714)
Q Consensus 664 ~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~~ 712 (714)
+... .....++.+++.+||+.+|++||++.|+++.|++++..
T Consensus 295 --~~~~-----~~~~~~~~~l~~~cl~~~p~~RPs~~ell~~l~~~~~~ 336 (337)
T cd05054 295 --MRAP-----EYATPEIYSIMLDCWHNNPEDRPTFSELVEILGDLLQE 336 (337)
T ss_pred --CCCC-----ccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 0011 11223688999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-38 Score=326.16 Aligned_cols=259 Identities=25% Similarity=0.365 Sum_probs=200.2
Q ss_pred ccccccCceEEEEEEECC------CcEEEEEEeCCCCc-hhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEecc
Q 005102 409 FVLGKSGIGIVYKVVLED------GHTLAVRRLGEGGS-QRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYI 481 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~~------g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~ 481 (714)
+.||+|+||.||+|+... ...+|+|.+..... ....++.+|+.++++++||||+++++++...+..++||||+
T Consensus 6 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 85 (290)
T cd05045 6 KTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLIVEYA 85 (290)
T ss_pred ccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEEEEEec
Confidence 479999999999998632 35789998876533 33467899999999999999999999999999999999999
Q ss_pred CCCCHhhhhhCCCCC------------------CCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCC
Q 005102 482 PNGSLATALHGKPGM------------------VSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGH 543 (714)
Q Consensus 482 ~~gsL~~~l~~~~~~------------------~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~ 543 (714)
.+|+|.+++...... .....+++..+..++.|++.||+|||+ .+|+||||||+||++++
T Consensus 86 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~---~~ivH~dikp~nill~~ 162 (290)
T cd05045 86 KYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAE---MKLVHRDLAARNVLVAE 162 (290)
T ss_pred CCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHH---CCeehhhhhhheEEEcC
Confidence 999999998643210 112458899999999999999999999 89999999999999999
Q ss_pred CCCeEEcccchhhhhhccCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHH
Q 005102 544 NMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYG 623 (714)
Q Consensus 544 ~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~G 623 (714)
++.+||+|||+++........ .......++..|+|||.+.+..++.++||||||
T Consensus 163 ~~~~kl~dfg~~~~~~~~~~~--------------------------~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG 216 (290)
T cd05045 163 GRKMKISDFGLSRDVYEEDSY--------------------------VKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFG 216 (290)
T ss_pred CCcEEeccccccccccCccch--------------------------hcccCCCCCccccCHHHHccCCcchHhHHHHHH
Confidence 999999999998754321110 001112235679999999888899999999999
Q ss_pred HHHHHHHh-CCCccccCCCCcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHH
Q 005102 624 VILLEMIT-GRTAVVQVGSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHI 702 (714)
Q Consensus 624 vvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev 702 (714)
+++|||+| |+.||... ....+.++. ..... ..... .....+.+++.+||+.+|++||++.++
T Consensus 217 ~~l~el~t~g~~p~~~~--~~~~~~~~~----~~~~~------~~~~~-----~~~~~~~~~i~~cl~~~P~~Rp~~~~i 279 (290)
T cd05045 217 VLLWEIVTLGGNPYPGI--APERLFNLL----KTGYR------MERPE-----NCSEEMYNLMLTCWKQEPDKRPTFADI 279 (290)
T ss_pred HHHHHHHhcCCCCCCCC--CHHHHHHHH----hCCCC------CCCCC-----CCCHHHHHHHHHHccCCcccCCCHHHH
Confidence 99999999 99998432 112222211 11110 10111 122368899999999999999999999
Q ss_pred HHHHhhhhccC
Q 005102 703 SDALDRLIVSS 713 (714)
Q Consensus 703 l~~L~~i~~~~ 713 (714)
++.|+++..++
T Consensus 280 ~~~l~~~~~~~ 290 (290)
T cd05045 280 SKELEKMMVKS 290 (290)
T ss_pred HHHHHHHHhcC
Confidence 99999987653
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-38 Score=334.25 Aligned_cols=246 Identities=22% Similarity=0.249 Sum_probs=191.0
Q ss_pred ccccccCceEEEEEEEC----CCcEEEEEEeCCC----CchhHHHHHHHHHHHhcc-CCCCccceEEEEEeCCceeEEEe
Q 005102 409 FVLGKSGIGIVYKVVLE----DGHTLAVRRLGEG----GSQRFKEFQTEVEAIGKI-RHSNIVTLRAYYWSVDEKLLIYD 479 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~----~g~~vavK~~~~~----~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~e 479 (714)
+.||+|+||.||+++.. +++.||+|++.+. .....+.+.+|++++.++ +||||+++++++...+..++|||
T Consensus 6 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e 85 (332)
T cd05614 6 KVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKLHLILD 85 (332)
T ss_pred EEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEEEEEEe
Confidence 47999999999999863 5789999998753 222345688899999999 59999999999999999999999
Q ss_pred ccCCCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhh
Q 005102 480 YIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLAN 559 (714)
Q Consensus 480 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~ 559 (714)
|+++|+|.+++... ..+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++...
T Consensus 86 ~~~~g~L~~~l~~~------~~~~~~~~~~~~~qi~~~l~~lH~---~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~ 156 (332)
T cd05614 86 YVSGGEMFTHLYQR------DNFSEDEVRFYSGEIILALEHLHK---LGIVYRDIKLENILLDSEGHVVLTDFGLSKEFL 156 (332)
T ss_pred CCCCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCcEecCCCHHHeEECCCCCEEEeeCcCCcccc
Confidence 99999999998754 458899999999999999999999 899999999999999999999999999987542
Q ss_pred ccCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCC-CCchhhhHHHHHHHHHHHhCCCcccc
Q 005102 560 IAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVK-PSQKWDIYSYGVILLEMITGRTAVVQ 638 (714)
Q Consensus 560 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s~~~DVwS~Gvvl~elltG~~p~~~ 638 (714)
... ........||+.|+|||++.+.. ++.++|||||||++|||+||+.||..
T Consensus 157 ~~~---------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~ 209 (332)
T cd05614 157 SEE---------------------------KERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTL 209 (332)
T ss_pred ccC---------------------------CCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCC
Confidence 211 00112345789999999997654 78899999999999999999999953
Q ss_pred CCCCcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCC-----CHHHHHH
Q 005102 639 VGSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRP-----TMRHISD 704 (714)
Q Consensus 639 ~~~~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----t~~evl~ 704 (714)
..... ............ ++..... ....+.+++.+||+.||++|| +++++++
T Consensus 210 ~~~~~-~~~~~~~~~~~~--------~~~~~~~-----~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 266 (332)
T cd05614 210 EGERN-TQSEVSRRILKC--------DPPFPSF-----IGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE 266 (332)
T ss_pred CCCCC-CHHHHHHHHhcC--------CCCCCCC-----CCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence 32211 111111111111 1111111 122577899999999999999 6667654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-38 Score=319.45 Aligned_cols=246 Identities=23% Similarity=0.384 Sum_probs=195.3
Q ss_pred ccccccCceEEEEEEECCCcEEEEEEeCCCCchhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCCCHhh
Q 005102 409 FVLGKSGIGIVYKVVLEDGHTLAVRRLGEGGSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGSLAT 488 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL~~ 488 (714)
+.||+|+||.||++.++++..+|+|.+..... ....|.+|++++++++||||+++++++...+..++||||+++++|.+
T Consensus 10 ~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 88 (256)
T cd05059 10 KELGSGQFGVVHLGKWRGKIDVAIKMIREGAM-SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANGCLLN 88 (256)
T ss_pred hhhccCCCceEEEeEecCCccEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCCCCHHH
Confidence 47999999999999988788999999875433 23578899999999999999999999999999999999999999999
Q ss_pred hhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCCCCcc
Q 005102 489 ALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQ 568 (714)
Q Consensus 489 ~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 568 (714)
++.... ..+++..++.++.|++.||+|||+ .+++||||||+||++++++.+||+|||+++.......
T Consensus 89 ~l~~~~-----~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~----- 155 (256)
T cd05059 89 YLRERK-----GKLGTEWLLDMCSDVCEAMEYLES---NGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQY----- 155 (256)
T ss_pred HHHhcc-----cCCCHHHHHHHHHHHHHHHHHHHH---CCcccccccHhhEEECCCCcEEECCcccceecccccc-----
Confidence 997543 358899999999999999999999 8999999999999999999999999999875432100
Q ss_pred CCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHh-CCCccccCCCCcchhH
Q 005102 569 SNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMIT-GRTAVVQVGSSEMDLV 647 (714)
Q Consensus 569 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~ellt-G~~p~~~~~~~~~~l~ 647 (714)
.......++..|+|||.+.+..++.++||||||+++|||++ |+.||..... .+..
T Consensus 156 ----------------------~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~--~~~~ 211 (256)
T cd05059 156 ----------------------TSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSN--SEVV 211 (256)
T ss_pred ----------------------cccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCH--HHHH
Confidence 00111122456999999998899999999999999999999 7888843211 1111
Q ss_pred HHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHh
Q 005102 648 NWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDALD 707 (714)
Q Consensus 648 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~ 707 (714)
. .. .... ....... ...++.+++.+||..+|++|||+.|+++.|.
T Consensus 212 ~---~~-~~~~------~~~~~~~-----~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l~ 256 (256)
T cd05059 212 E---SV-SAGY------RLYRPKL-----APTEVYTIMYSCWHEKPEDRPAFKKLLSQLT 256 (256)
T ss_pred H---HH-HcCC------cCCCCCC-----CCHHHHHHHHHHhcCChhhCcCHHHHHHHhC
Confidence 1 11 1111 1111111 2336889999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=320.49 Aligned_cols=255 Identities=21% Similarity=0.353 Sum_probs=196.9
Q ss_pred ccccccCceEEEEEEECC----CcEEEEEEeCCCC--chhHHHHHHHHHHHhccCCCCccceEEEEEeCCc------eeE
Q 005102 409 FVLGKSGIGIVYKVVLED----GHTLAVRRLGEGG--SQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDE------KLL 476 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~~----g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~------~~l 476 (714)
+.||+|+||.||+|.+.. +..||+|+++... ......+.+|++.+++++||||+++++++...+. .++
T Consensus 5 ~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~ 84 (273)
T cd05035 5 KILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPKPMV 84 (273)
T ss_pred cccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCcccEE
Confidence 479999999999998753 3689999987542 2334678999999999999999999999876554 789
Q ss_pred EEeccCCCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhh
Q 005102 477 IYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLAR 556 (714)
Q Consensus 477 V~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~ 556 (714)
||||+++|+|..++...........+++..+..++.|++.||+|||+ .+++||||||+||++++++.+||+|||+++
T Consensus 85 v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~ 161 (273)
T cd05035 85 ILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSN---RNFIHRDLAARNCMLREDMTVCVADFGLSK 161 (273)
T ss_pred EEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHh---CCeeccccchheEEECCCCeEEECCcccee
Confidence 99999999999998654322222468999999999999999999999 899999999999999999999999999998
Q ss_pred hhhccCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHh-CCCc
Q 005102 557 LANIAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMIT-GRTA 635 (714)
Q Consensus 557 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~ellt-G~~p 635 (714)
........ .......++..|+|||++.+..++.++|||||||++|||++ |..|
T Consensus 162 ~~~~~~~~--------------------------~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p 215 (273)
T cd05035 162 KIYSGDYY--------------------------RQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTP 215 (273)
T ss_pred eccccccc--------------------------cccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCC
Confidence 65322110 00011123456999999988889999999999999999999 8888
Q ss_pred cccCCCCcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhhh
Q 005102 636 VVQVGSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDALDRL 709 (714)
Q Consensus 636 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i 709 (714)
|.... ...+.+++ .. ... +.... .....+.+++.+||+.||++|||+.|+++.|+++
T Consensus 216 ~~~~~--~~~~~~~~---~~-~~~------~~~~~-----~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 216 YPGVE--NHEIYDYL---RH-GNR------LKQPE-----DCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred CCCCC--HHHHHHHH---Hc-CCC------CCCCc-----CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 84322 11222211 11 111 11111 1234688999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=315.18 Aligned_cols=246 Identities=26% Similarity=0.370 Sum_probs=195.8
Q ss_pred cccccCceEEEEEEECCCcEEEEEEeCCCCch-hHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCCCHhh
Q 005102 410 VLGKSGIGIVYKVVLEDGHTLAVRRLGEGGSQ-RFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGSLAT 488 (714)
Q Consensus 410 ~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL~~ 488 (714)
+||+|+||.||+|...++..||+|.+...... ....+.+|++++++++||||+++++++...+..++||||+++++|.+
T Consensus 2 ~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 81 (250)
T cd05085 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFLS 81 (250)
T ss_pred ccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHHH
Confidence 69999999999999888999999998765433 23468899999999999999999999999999999999999999999
Q ss_pred hhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCCCCcc
Q 005102 489 ALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQ 568 (714)
Q Consensus 489 ~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 568 (714)
++.... ..+++..+..++.|++.||.|+|+ ++++||||||+||++++++.+||+|||++.......
T Consensus 82 ~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~---~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~------ 147 (250)
T cd05085 82 FLRKKK-----DELKTKQLVKFALDAAAGMAYLES---KNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGI------ 147 (250)
T ss_pred HHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccChheEEEcCCCeEEECCCccceeccccc------
Confidence 987543 347899999999999999999999 899999999999999999999999999986432110
Q ss_pred CCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHh-CCCccccCCCCcchhH
Q 005102 569 SNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMIT-GRTAVVQVGSSEMDLV 647 (714)
Q Consensus 569 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~ellt-G~~p~~~~~~~~~~l~ 647 (714)
........++..|+|||++.+..++.++||||||+++||+++ |..||..... .
T Consensus 148 ---------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~-----~ 201 (250)
T cd05085 148 ---------------------YSSSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTN-----Q 201 (250)
T ss_pred ---------------------cccCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCH-----H
Confidence 000111123456999999998889999999999999999999 9999843211 1
Q ss_pred HHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHh
Q 005102 648 NWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDALD 707 (714)
Q Consensus 648 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~ 707 (714)
.... ....... ..... .....+.+++.+||..+|++||++.|+++.|.
T Consensus 202 ~~~~-~~~~~~~------~~~~~-----~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 202 QARE-QVEKGYR------MSCPQ-----KCPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred HHHH-HHHcCCC------CCCCC-----CCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 1111 1111110 01111 12246889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=336.75 Aligned_cols=258 Identities=22% Similarity=0.287 Sum_probs=199.4
Q ss_pred cccccccCceEEEEEEECC------CcEEEEEEeCCCCc-hhHHHHHHHHHHHhccC-CCCccceEEEEEeCCceeEEEe
Q 005102 408 AFVLGKSGIGIVYKVVLED------GHTLAVRRLGEGGS-QRFKEFQTEVEAIGKIR-HSNIVTLRAYYWSVDEKLLIYD 479 (714)
Q Consensus 408 ~~~lG~G~~g~Vy~~~~~~------g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lV~e 479 (714)
.+.||+|+||.||+|++++ +..||+|+++.... ...+.+.+|++++.++. ||||+++++++...+..++|||
T Consensus 42 ~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~~~iv~E 121 (401)
T cd05107 42 GRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGPIYIITE 121 (401)
T ss_pred hhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCCcEEEEe
Confidence 4689999999999998642 46899999986532 22357889999999997 9999999999999999999999
Q ss_pred ccCCCCHhhhhhCCCCC---------------------------------------------------------------
Q 005102 480 YIPNGSLATALHGKPGM--------------------------------------------------------------- 496 (714)
Q Consensus 480 ~~~~gsL~~~l~~~~~~--------------------------------------------------------------- 496 (714)
|+++|+|.++++.....
T Consensus 122 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 201 (401)
T cd05107 122 YCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDMKGTVKY 201 (401)
T ss_pred ccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcchhhhhh
Confidence 99999999999754210
Q ss_pred -----------------------------CCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCe
Q 005102 497 -----------------------------VSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEP 547 (714)
Q Consensus 497 -----------------------------~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~ 547 (714)
.....+++..+++|+.|++.||+|||+ ++|+||||||+|||+++++.+
T Consensus 202 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrdlkp~NiLl~~~~~~ 278 (401)
T cd05107 202 ADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLAS---KNCVHRDLAARNVLICEGKLV 278 (401)
T ss_pred hhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhc---CCcCcccCCcceEEEeCCCEE
Confidence 011347888899999999999999999 899999999999999999999
Q ss_pred EEcccchhhhhhccCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHH
Q 005102 548 HVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILL 627 (714)
Q Consensus 548 kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~ 627 (714)
||+|||+++....... ........++..|+|||.+.+..++.++|||||||++|
T Consensus 279 kL~DfGla~~~~~~~~--------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~ 332 (401)
T cd05107 279 KICDFGLARDIMRDSN--------------------------YISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLW 332 (401)
T ss_pred EEEecCcceecccccc--------------------------cccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHH
Confidence 9999999975432110 00111223467799999998888999999999999999
Q ss_pred HHHh-CCCccccCCCCcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHH
Q 005102 628 EMIT-GRTAVVQVGSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDAL 706 (714)
Q Consensus 628 ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L 706 (714)
||++ |+.||......+ ........... +..... ...++.+++.+||..+|++||+++||++.|
T Consensus 333 e~l~~g~~P~~~~~~~~-----~~~~~~~~~~~------~~~p~~-----~~~~l~~li~~cl~~~P~~RPs~~ell~~L 396 (401)
T cd05107 333 EIFTLGGTPYPELPMNE-----QFYNAIKRGYR------MAKPAH-----ASDEIYEIMQKCWEEKFEIRPDFSQLVHLV 396 (401)
T ss_pred HHHHcCCCCCCCCCchH-----HHHHHHHcCCC------CCCCCC-----CCHHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence 9998 888984332111 11111111111 111111 123688999999999999999999999999
Q ss_pred hhhh
Q 005102 707 DRLI 710 (714)
Q Consensus 707 ~~i~ 710 (714)
++++
T Consensus 397 ~~~~ 400 (401)
T cd05107 397 GDLL 400 (401)
T ss_pred HHHh
Confidence 9876
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-38 Score=332.00 Aligned_cols=236 Identities=21% Similarity=0.279 Sum_probs=186.9
Q ss_pred ccccccCceEEEEEEECC-CcEEEEEEeCCC---CchhHHHHHHHHHHHhccCC-CCccceEEEEEeCCceeEEEeccCC
Q 005102 409 FVLGKSGIGIVYKVVLED-GHTLAVRRLGEG---GSQRFKEFQTEVEAIGKIRH-SNIVTLRAYYWSVDEKLLIYDYIPN 483 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~~-g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H-~niv~l~~~~~~~~~~~lV~e~~~~ 483 (714)
+.||+|+||.||+|+..+ ++.||||++... .....+.+..|++++..++| ++|+++++++...+..|+||||+++
T Consensus 6 ~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 85 (324)
T cd05587 6 MVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNG 85 (324)
T ss_pred EEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEEcCCCC
Confidence 479999999999999764 789999998753 22334678889999999976 4688899999999999999999999
Q ss_pred CCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCC
Q 005102 484 GSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGG 563 (714)
Q Consensus 484 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 563 (714)
|+|.+++... ..+++..+..++.|++.||+|||+ ++|+||||||+|||+++++.+||+|||+++.....
T Consensus 86 g~L~~~~~~~------~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~-- 154 (324)
T cd05587 86 GDLMYHIQQV------GKFKEPHAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG-- 154 (324)
T ss_pred CcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEEcCCCCEEEeecCcceecCCC--
Confidence 9999998754 458899999999999999999999 89999999999999999999999999998642111
Q ss_pred CCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCccccCCCCc
Q 005102 564 SPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGSSE 643 (714)
Q Consensus 564 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~~~~~~~~ 643 (714)
........||+.|+|||++.+..++.++|||||||++|||+||+.||.... .
T Consensus 155 --------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~--~ 206 (324)
T cd05587 155 --------------------------GKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGED--E 206 (324)
T ss_pred --------------------------CCceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC--H
Confidence 001123357889999999999999999999999999999999999994321 1
Q ss_pred chhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCH
Q 005102 644 MDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTM 699 (714)
Q Consensus 644 ~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~ 699 (714)
. +.......... ..... ....+.+++.+||..||++|++.
T Consensus 207 ~---~~~~~i~~~~~--------~~~~~-----~~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 207 D---ELFQSIMEHNV--------SYPKS-----LSKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred H---HHHHHHHcCCC--------CCCCC-----CCHHHHHHHHHHhhcCHHHcCCC
Confidence 1 11222211111 11111 12357799999999999999986
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=323.11 Aligned_cols=261 Identities=23% Similarity=0.302 Sum_probs=194.9
Q ss_pred ccccccCceEEEEEEECC---------------CcEEEEEEeCCCC-chhHHHHHHHHHHHhccCCCCccceEEEEEeCC
Q 005102 409 FVLGKSGIGIVYKVVLED---------------GHTLAVRRLGEGG-SQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVD 472 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~~---------------g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~ 472 (714)
+.||+|+||.||+++.++ ...||+|+++... ......|.+|++++++++|+||+++++++...+
T Consensus 11 ~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~ 90 (295)
T cd05097 11 EKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDD 90 (295)
T ss_pred hccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEcCCC
Confidence 479999999999988643 2358999987653 333467999999999999999999999999999
Q ss_pred ceeEEEeccCCCCHhhhhhCCCCC------CCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCC
Q 005102 473 EKLLIYDYIPNGSLATALHGKPGM------VSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNME 546 (714)
Q Consensus 473 ~~~lV~e~~~~gsL~~~l~~~~~~------~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~ 546 (714)
..++||||+++++|.+++...... .....+++..+++++.|++.||+|||+ .+++||||||+||++++++.
T Consensus 91 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~Nill~~~~~ 167 (295)
T cd05097 91 PLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLAS---LNFVHRDLATRNCLVGNHYT 167 (295)
T ss_pred ccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHh---cCeeccccChhhEEEcCCCc
Confidence 999999999999999998653210 011247899999999999999999999 89999999999999999999
Q ss_pred eEEcccchhhhhhccCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHH
Q 005102 547 PHVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVIL 626 (714)
Q Consensus 547 ~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl 626 (714)
+||+|||+++....... ........++..|+|||++.+..++.++|||||||++
T Consensus 168 ~kl~dfg~~~~~~~~~~--------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l 221 (295)
T cd05097 168 IKIADFGMSRNLYSGDY--------------------------YRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTL 221 (295)
T ss_pred EEecccccccccccCcc--------------------------eeccCcCcCceeecChhhhccCCcCchhhHHHHHHHH
Confidence 99999999875432110 0111222345679999999888899999999999999
Q ss_pred HHHHh--CCCccccCCCCcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 005102 627 LEMIT--GRTAVVQVGSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISD 704 (714)
Q Consensus 627 ~ellt--G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 704 (714)
|||++ |..||.... ................. ..... ..+. ....+.+++.+||+.||++|||+++|++
T Consensus 222 ~el~~~~~~~p~~~~~--~~~~~~~~~~~~~~~~~--~~~~~-~~~~-----~~~~l~~li~~~l~~~p~~RPs~~~i~~ 291 (295)
T cd05097 222 WEMFTLCKEQPYSLLS--DEQVIENTGEFFRNQGR--QIYLS-QTPL-----CPSPVFKLMMRCWSRDIKDRPTFNKIHH 291 (295)
T ss_pred HHHHHcCCCCCCcccC--hHHHHHHHHHhhhhccc--cccCC-CCCC-----CCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 99998 556663221 12222211111111100 00000 0001 1236889999999999999999999999
Q ss_pred HHhh
Q 005102 705 ALDR 708 (714)
Q Consensus 705 ~L~~ 708 (714)
.|++
T Consensus 292 ~l~~ 295 (295)
T cd05097 292 FLRE 295 (295)
T ss_pred HHhC
Confidence 9864
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=332.89 Aligned_cols=259 Identities=19% Similarity=0.300 Sum_probs=189.2
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeCCC--CchhHHHHHHHHHHHhccCCCCccceEEEEEeCC-----ceeEEEec
Q 005102 409 FVLGKSGIGIVYKVVLE-DGHTLAVRRLGEG--GSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVD-----EKLLIYDY 480 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~-----~~~lV~e~ 480 (714)
+.||+|+||.||+|+.. +|+.||||++... .......+.+|++++++++||||+++++++...+ ..|+||||
T Consensus 6 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~lv~e~ 85 (338)
T cd07859 6 EVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFEL 85 (338)
T ss_pred EEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEEEEEec
Confidence 47999999999999975 5899999998753 2233456889999999999999999999886432 47999999
Q ss_pred cCCCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhc
Q 005102 481 IPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANI 560 (714)
Q Consensus 481 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 560 (714)
+. ++|.+++... ..+++..+..++.|++.||+|||+ .+|+||||||+|||+++++.+||+|||+++....
T Consensus 86 ~~-~~L~~~l~~~------~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~ 155 (338)
T cd07859 86 ME-SDLHQVIKAN------DDLTPEHHQFFLYQLLRALKYIHT---ANVFHRDLKPKNILANADCKLKICDFGLARVAFN 155 (338)
T ss_pred CC-CCHHHHHHhc------ccCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCcEEEccCcccccccc
Confidence 95 6999988654 458999999999999999999999 8999999999999999999999999999975432
Q ss_pred cCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCC--CCCCchhhhHHHHHHHHHHHhCCCcccc
Q 005102 561 AGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKV--VKPSQKWDIYSYGVILLEMITGRTAVVQ 638 (714)
Q Consensus 561 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~~~DVwS~Gvvl~elltG~~p~~~ 638 (714)
.... ........||+.|+|||++.+ ..++.++|||||||++|||+||+.||..
T Consensus 156 ~~~~-------------------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~ 210 (338)
T cd07859 156 DTPT-------------------------AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPG 210 (338)
T ss_pred ccCc-------------------------cccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCC
Confidence 1100 011123457889999999865 6789999999999999999999999943
Q ss_pred CCCCcchhHHHHHHHHhhcC-------------CcccccCCCCCCCCC--cHHHHHHHHHHHhHccCCCCCCCCCHHHHH
Q 005102 639 VGSSEMDLVNWMQLCIEEKK-------------PLADVLDPYLAPDAD--KEEEIIAVLKIAMACVHSSPEKRPTMRHIS 703 (714)
Q Consensus 639 ~~~~~~~l~~~~~~~~~~~~-------------~~~~~~d~~~~~~~~--~~~~~~~l~~li~~Cl~~dP~~RPt~~evl 703 (714)
... ......+........ .....+.+....... .......+.+++.+||+.||++|||++|++
T Consensus 211 ~~~--~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l 288 (338)
T cd07859 211 KNV--VHQLDLITDLLGTPSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEAL 288 (338)
T ss_pred CCh--HHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHh
Confidence 221 111111111000000 000000000000000 001123577999999999999999999998
Q ss_pred H
Q 005102 704 D 704 (714)
Q Consensus 704 ~ 704 (714)
+
T Consensus 289 ~ 289 (338)
T cd07859 289 A 289 (338)
T ss_pred c
Confidence 5
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=320.65 Aligned_cols=239 Identities=22% Similarity=0.314 Sum_probs=186.1
Q ss_pred cccccCceEEEEEEECC-------------------------CcEEEEEEeCCCCchhHHHHHHHHHHHhccCCCCccce
Q 005102 410 VLGKSGIGIVYKVVLED-------------------------GHTLAVRRLGEGGSQRFKEFQTEVEAIGKIRHSNIVTL 464 (714)
Q Consensus 410 ~lG~G~~g~Vy~~~~~~-------------------------g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l 464 (714)
.||+|+||.||+|.+.. ...||+|++..........|.+|+.++++++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 59999999999997521 13589998876544445678899999999999999999
Q ss_pred EEEEEeCCceeEEEeccCCCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCC
Q 005102 465 RAYYWSVDEKLLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHN 544 (714)
Q Consensus 465 ~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~ 544 (714)
++++......++||||+++|+|..++.... ..+++..+++++.|+++||+|||+ ++|+||||||+||++++.
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~-----~~~~~~~~~~i~~qi~~~l~~lH~---~~iiH~dlkp~Nill~~~ 153 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEK-----GRVPVAWKITVAQQLASALSYLED---KNLVHGNVCAKNILLARL 153 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHc---CCccCCCCCcccEEEecc
Confidence 999999999999999999999999986543 458899999999999999999999 899999999999999764
Q ss_pred C-------CeEEcccchhhhhhccCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCC-CCCCch
Q 005102 545 M-------EPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKV-VKPSQK 616 (714)
Q Consensus 545 ~-------~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~ 616 (714)
+ .+|++|||++...... ....++..|+|||.+.+ ..++.+
T Consensus 154 ~~~~~~~~~~kl~d~g~~~~~~~~--------------------------------~~~~~~~~~~aPe~~~~~~~~~~~ 201 (274)
T cd05076 154 GLAEGTSPFIKLSDPGVSFTALSR--------------------------------EERVERIPWIAPECVPGGNSLSTA 201 (274)
T ss_pred CcccCccceeeecCCccccccccc--------------------------------cccccCCcccCchhhcCCCCCCcH
Confidence 3 3799999987532110 11124667999998865 568999
Q ss_pred hhhHHHHHHHHHHH-hCCCccccCCCCcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCC
Q 005102 617 WDIYSYGVILLEMI-TGRTAVVQVGSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEK 695 (714)
Q Consensus 617 ~DVwS~Gvvl~ell-tG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~ 695 (714)
+|||||||++|||+ +|+.||......+ ...+ ...... .... ....+.+++.+||+.+|++
T Consensus 202 ~Dv~slG~~l~el~~~g~~p~~~~~~~~--~~~~----~~~~~~--------~~~~-----~~~~~~~li~~cl~~~p~~ 262 (274)
T cd05076 202 ADKWSFGTTLLEICFDGEVPLKERTPSE--KERF----YEKKHR--------LPEP-----SCKELATLISQCLTYEPTQ 262 (274)
T ss_pred HHHHHHHHHHHHHHhCCCCCccccChHH--HHHH----HHhccC--------CCCC-----CChHHHHHHHHHcccChhh
Confidence 99999999999994 6999985332211 1111 111111 1111 1125789999999999999
Q ss_pred CCCHHHHHHHHh
Q 005102 696 RPTMRHISDALD 707 (714)
Q Consensus 696 RPt~~evl~~L~ 707 (714)
|||+.+|++.|.
T Consensus 263 Rps~~~il~~L~ 274 (274)
T cd05076 263 RPSFRTILRDLT 274 (274)
T ss_pred CcCHHHHHHhhC
Confidence 999999998873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=316.00 Aligned_cols=253 Identities=25% Similarity=0.381 Sum_probs=192.9
Q ss_pred cccccCceEEEEEEECC----CcEEEEEEeCCC-CchhHHHHHHHHHHHhccCCCCccceEEEEEe-CCceeEEEeccCC
Q 005102 410 VLGKSGIGIVYKVVLED----GHTLAVRRLGEG-GSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWS-VDEKLLIYDYIPN 483 (714)
Q Consensus 410 ~lG~G~~g~Vy~~~~~~----g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~-~~~~~lV~e~~~~ 483 (714)
.||+|+||.||+|.+.+ +..||+|++... .....+.+.+|+.+++.++||||+++++++.. .+..++||||+++
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~ 81 (262)
T cd05058 2 VIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMKH 81 (262)
T ss_pred cccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCCC
Confidence 68999999999998642 457999998653 33345678899999999999999999998764 4567899999999
Q ss_pred CCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCC
Q 005102 484 GSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGG 563 (714)
Q Consensus 484 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 563 (714)
|+|.+++.... ..+++..++.++.|++.||+|||+ .+++||||||+|||+++++.+||+|||+++.......
T Consensus 82 ~~L~~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~ 153 (262)
T cd05058 82 GDLRNFIRSET-----HNPTVKDLIGFGLQVAKGMEYLAS---KKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEY 153 (262)
T ss_pred CCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHh---CCccccccCcceEEEcCCCcEEECCccccccccCCcc
Confidence 99999997543 346788889999999999999999 8999999999999999999999999999875432110
Q ss_pred CCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCC-ccccCCCC
Q 005102 564 SPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRT-AVVQVGSS 642 (714)
Q Consensus 564 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~-p~~~~~~~ 642 (714)
.. ........++..|+|||.+.+..++.++|||||||++|||++|.. ||...
T Consensus 154 ~~------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~--- 206 (262)
T cd05058 154 YS------------------------VHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV--- 206 (262)
T ss_pred ee------------------------ecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCC---
Confidence 00 001112234567999999988899999999999999999999654 55321
Q ss_pred cchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhhhhc
Q 005102 643 EMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDALDRLIV 711 (714)
Q Consensus 643 ~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~ 711 (714)
+..+.......... +... . .....+.+++.+||+.+|++||++.|+++.|+++..
T Consensus 207 --~~~~~~~~~~~~~~-------~~~~-~----~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~~ 261 (262)
T cd05058 207 --DSFDITVYLLQGRR-------LLQP-E----YCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFS 261 (262)
T ss_pred --CHHHHHHHHhcCCC-------CCCC-C----cCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence 11122222111111 0000 0 112368899999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=334.81 Aligned_cols=241 Identities=22% Similarity=0.303 Sum_probs=188.7
Q ss_pred cccccCceEEEEEEEC-CCcEEEEEEeCCC---CchhHHHHHHHHH-HHhccCCCCccceEEEEEeCCceeEEEeccCCC
Q 005102 410 VLGKSGIGIVYKVVLE-DGHTLAVRRLGEG---GSQRFKEFQTEVE-AIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNG 484 (714)
Q Consensus 410 ~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~-~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~g 484 (714)
.||+|+||+||+|+.. +|+.||+|++... .....+.+..|.. +++.++||||+++++++...+..++||||+++|
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~~ 81 (325)
T cd05604 2 VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNGG 81 (325)
T ss_pred ceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCCC
Confidence 6999999999999975 5899999998754 2223345566665 467789999999999999999999999999999
Q ss_pred CHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCC
Q 005102 485 SLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGS 564 (714)
Q Consensus 485 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 564 (714)
+|..++... ..+++..+..++.||+.||+|||+ .+|+||||||+|||+++++.+||+|||+++.....
T Consensus 82 ~L~~~l~~~------~~~~~~~~~~~~~qi~~al~~lH~---~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~--- 149 (325)
T cd05604 82 ELFFHLQRE------RSFPEPRARFYAAEIASALGYLHS---INIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQ--- 149 (325)
T ss_pred CHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEEeecCCcccCCCC---
Confidence 999988654 458999999999999999999999 89999999999999999999999999998642110
Q ss_pred CCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCccccCCCCcc
Q 005102 565 PTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGSSEM 644 (714)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~~~~~~~~~ 644 (714)
........||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 150 -------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~---- 200 (325)
T cd05604 150 -------------------------SDTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRD---- 200 (325)
T ss_pred -------------------------CCCcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCC----
Confidence 011123457889999999999999999999999999999999999995321
Q ss_pred hhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 005102 645 DLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDA 705 (714)
Q Consensus 645 ~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 705 (714)
..+.......... ...+. ....+.+++.+|++.+|.+||++++.++.
T Consensus 201 -~~~~~~~~~~~~~--------~~~~~-----~~~~~~~ll~~ll~~~p~~R~~~~~~~~~ 247 (325)
T cd05604 201 -VAEMYDNILHKPL--------VLRPG-----ASLTAWSILEELLEKDRQRRLGAKEDFLE 247 (325)
T ss_pred -HHHHHHHHHcCCc--------cCCCC-----CCHHHHHHHHHHhccCHHhcCCCCCCHHH
Confidence 1122222222111 11111 12357789999999999999998644433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=324.76 Aligned_cols=258 Identities=24% Similarity=0.379 Sum_probs=199.9
Q ss_pred cccccccCceEEEEEEECC------CcEEEEEEeCCCC-chhHHHHHHHHHHHhcc-CCCCccceEEEEEeCCceeEEEe
Q 005102 408 AFVLGKSGIGIVYKVVLED------GHTLAVRRLGEGG-SQRFKEFQTEVEAIGKI-RHSNIVTLRAYYWSVDEKLLIYD 479 (714)
Q Consensus 408 ~~~lG~G~~g~Vy~~~~~~------g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~e 479 (714)
.+.||+|+||.||++...+ ...+|+|.+.... .....++.+|+++++++ +|+||+++++++...+..++|||
T Consensus 17 ~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~li~e 96 (293)
T cd05053 17 GKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPLYVVVE 96 (293)
T ss_pred eeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCCeEEEEE
Confidence 3579999999999998743 3689999987643 23345688999999999 89999999999999999999999
Q ss_pred ccCCCCHhhhhhCCCC----------CCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEE
Q 005102 480 YIPNGSLATALHGKPG----------MVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHV 549 (714)
Q Consensus 480 ~~~~gsL~~~l~~~~~----------~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl 549 (714)
|+++|+|.++++.... ......+++..+++++.|++.||+|||+ .+|+||||||+||++++++.+||
T Consensus 97 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivH~dlkp~Nil~~~~~~~kL 173 (293)
T cd05053 97 YAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLAS---KKCIHRDLAARNVLVTEDHVMKI 173 (293)
T ss_pred eCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH---CCccccccceeeEEEcCCCeEEe
Confidence 9999999999965321 0112468999999999999999999999 89999999999999999999999
Q ss_pred cccchhhhhhccCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHH
Q 005102 550 SDFGLARLANIAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEM 629 (714)
Q Consensus 550 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~el 629 (714)
+|||+++.+..... ........++..|+|||.+.+..++.++|||||||++|||
T Consensus 174 ~Dfg~~~~~~~~~~--------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el 227 (293)
T cd05053 174 ADFGLARDIHHIDY--------------------------YRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEI 227 (293)
T ss_pred Cccccccccccccc--------------------------eeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHH
Confidence 99999986542210 0011112235679999999888899999999999999999
Q ss_pred Hh-CCCccccCCCCcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhh
Q 005102 630 IT-GRTAVVQVGSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDALDR 708 (714)
Q Consensus 630 lt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~ 708 (714)
++ |..||..... .+. ... ...... +.... .....+.+++.+||+.||++|||+.|+++.|++
T Consensus 228 ~~~g~~p~~~~~~--~~~---~~~-~~~~~~------~~~~~-----~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~ 290 (293)
T cd05053 228 FTLGGSPYPGIPV--EEL---FKL-LKEGYR------MEKPQ-----NCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDR 290 (293)
T ss_pred hcCCCCCCCCCCH--HHH---HHH-HHcCCc------CCCCC-----CCCHHHHHHHHHHcccCcccCcCHHHHHHHHHH
Confidence 98 9999843211 111 111 111110 00110 123368899999999999999999999999998
Q ss_pred hhc
Q 005102 709 LIV 711 (714)
Q Consensus 709 i~~ 711 (714)
+++
T Consensus 291 ~~~ 293 (293)
T cd05053 291 MLT 293 (293)
T ss_pred hhC
Confidence 863
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-38 Score=331.80 Aligned_cols=242 Identities=20% Similarity=0.294 Sum_probs=190.4
Q ss_pred cccccCceEEEEEEECC-CcEEEEEEeCCCC---chhHHHHHHHHHHHhcc-CCCCccceEEEEEeCCceeEEEeccCCC
Q 005102 410 VLGKSGIGIVYKVVLED-GHTLAVRRLGEGG---SQRFKEFQTEVEAIGKI-RHSNIVTLRAYYWSVDEKLLIYDYIPNG 484 (714)
Q Consensus 410 ~lG~G~~g~Vy~~~~~~-g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~e~~~~g 484 (714)
.||+|+||+||+|+... ++.||+|+++... ....+.+.+|+.++.++ +||||+++++++...+..++||||+++|
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 81 (327)
T cd05617 2 VIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNGG 81 (327)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCCC
Confidence 69999999999999754 7899999998642 23345688999999988 6999999999999999999999999999
Q ss_pred CHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCC
Q 005102 485 SLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGS 564 (714)
Q Consensus 485 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 564 (714)
+|..++... ..+++..+..++.|++.||+|||+ ++|+||||||+|||+++++.+||+|||+++.....
T Consensus 82 ~L~~~~~~~------~~l~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~--- 149 (327)
T cd05617 82 DLMFHMQRQ------RKLPEEHARFYAAEICIALNFLHE---RGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGP--- 149 (327)
T ss_pred cHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEeCCCCEEEeccccceeccCC---
Confidence 999988654 458999999999999999999999 89999999999999999999999999998742111
Q ss_pred CCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCccccCCCC-c
Q 005102 565 PTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGSS-E 643 (714)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~~~~~~~-~ 643 (714)
........||+.|+|||++.+..++.++|||||||++|||++|+.||...... .
T Consensus 150 -------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~ 204 (327)
T cd05617 150 -------------------------GDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPD 204 (327)
T ss_pred -------------------------CCceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcc
Confidence 01112345788999999999999999999999999999999999999532221 1
Q ss_pred chhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHH
Q 005102 644 MDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMR 700 (714)
Q Consensus 644 ~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ 700 (714)
....++......... ...+.. ....+.+++.+||+.||++|+++.
T Consensus 205 ~~~~~~~~~~~~~~~-------~~~p~~-----~~~~~~~li~~~L~~dP~~R~~~~ 249 (327)
T cd05617 205 MNTEDYLFQVILEKP-------IRIPRF-----LSVKASHVLKGFLNKDPKERLGCQ 249 (327)
T ss_pred cccHHHHHHHHHhCC-------CCCCCC-----CCHHHHHHHHHHhccCHHHcCCCC
Confidence 122222222222211 011111 113577999999999999999853
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-38 Score=332.91 Aligned_cols=241 Identities=23% Similarity=0.261 Sum_probs=187.4
Q ss_pred cccccCceEEEEEEECC-CcEEEEEEeCCCC---chhHHHHHHHHH-HHhccCCCCccceEEEEEeCCceeEEEeccCCC
Q 005102 410 VLGKSGIGIVYKVVLED-GHTLAVRRLGEGG---SQRFKEFQTEVE-AIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNG 484 (714)
Q Consensus 410 ~lG~G~~g~Vy~~~~~~-g~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~g 484 (714)
.||+|+||+||+|+... ++.||+|++.... ......+..|.. +++.++||||+++++++...+..++||||+++|
T Consensus 2 ~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~~ 81 (325)
T cd05602 2 VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGG 81 (325)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCCC
Confidence 69999999999999764 7889999987532 122234455544 467889999999999999999999999999999
Q ss_pred CHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCC
Q 005102 485 SLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGS 564 (714)
Q Consensus 485 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 564 (714)
+|.+++... ..+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++.....
T Consensus 82 ~L~~~~~~~------~~~~~~~~~~~~~qi~~~L~~lH~---~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~--- 149 (325)
T cd05602 82 ELFYHLQRE------RCFLEPRARFYAAEIASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEH--- 149 (325)
T ss_pred cHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEEccCCCCcccccC---
Confidence 999998754 347788899999999999999999 89999999999999999999999999998743211
Q ss_pred CCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCccccCCCCcc
Q 005102 565 PTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGSSEM 644 (714)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~~~~~~~~~ 644 (714)
........||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 150 -------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~---- 200 (325)
T cd05602 150 -------------------------NGTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRN---- 200 (325)
T ss_pred -------------------------CCCcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCC----
Confidence 011223457889999999999999999999999999999999999995321
Q ss_pred hhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 005102 645 DLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDA 705 (714)
Q Consensus 645 ~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 705 (714)
..+........... ..+ . ....+.+++.+||+.||.+||++.+.+..
T Consensus 201 -~~~~~~~i~~~~~~----~~~----~-----~~~~~~~li~~~l~~~p~~R~~~~~~~~~ 247 (325)
T cd05602 201 -TAEMYDNILNKPLQ----LKP----N-----ITNSARHLLEGLLQKDRTKRLGAKDDFME 247 (325)
T ss_pred -HHHHHHHHHhCCcC----CCC----C-----CCHHHHHHHHHHcccCHHHCCCCCCCHHH
Confidence 11222222221111 111 1 12257789999999999999998754433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=320.28 Aligned_cols=238 Identities=21% Similarity=0.297 Sum_probs=186.3
Q ss_pred cccccCceEEEEEEECC-------------CcEEEEEEeCCCCchhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeE
Q 005102 410 VLGKSGIGIVYKVVLED-------------GHTLAVRRLGEGGSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLL 476 (714)
Q Consensus 410 ~lG~G~~g~Vy~~~~~~-------------g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 476 (714)
.||+|+||.||+|...+ ...||+|.+..........|..|+.+++.++||||+++++++......++
T Consensus 2 ~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~l 81 (262)
T cd05077 2 HLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENIM 81 (262)
T ss_pred ccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCEE
Confidence 58999999999998532 23589998876555555678899999999999999999999999999999
Q ss_pred EEeccCCCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCC-------eEE
Q 005102 477 IYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNME-------PHV 549 (714)
Q Consensus 477 V~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~-------~kl 549 (714)
||||+++|+|..++.... ..+++..+.+++.||+.||+|||+ ++|+||||||+|||++.++. +|+
T Consensus 82 v~e~~~~~~l~~~~~~~~-----~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~~~~~~~~~l 153 (262)
T cd05077 82 VEEFVEFGPLDLFMHRKS-----DVLTTPWKFKVAKQLASALSYLED---KDLVHGNVCTKNILLAREGIDGECGPFIKL 153 (262)
T ss_pred EEecccCCCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHhhh---CCeECCCCCcccEEEecCCccCCCCceeEe
Confidence 999999999999886543 358999999999999999999999 89999999999999987654 899
Q ss_pred cccchhhhhhccCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccC-CCCCCchhhhHHHHHHHHH
Q 005102 550 SDFGLARLANIAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLK-VVKPSQKWDIYSYGVILLE 628 (714)
Q Consensus 550 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~s~~~DVwS~Gvvl~e 628 (714)
+|||++..... .....++..|+|||.+. +..++.++|||||||++||
T Consensus 154 ~d~g~~~~~~~--------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~e 201 (262)
T cd05077 154 SDPGIPITVLS--------------------------------RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWE 201 (262)
T ss_pred CCCCCCccccC--------------------------------cccccccccccChhhhcCCCCCCchhHHHHHHHHHHH
Confidence 99998864321 11123467799999986 4668999999999999999
Q ss_pred HH-hCCCccccCCCCcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHH
Q 005102 629 MI-TGRTAVVQVGSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDAL 706 (714)
Q Consensus 629 ll-tG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L 706 (714)
|+ +|+.||..... .+.. ...... .....+ ....+.+++.+||+.||++||++.++++.+
T Consensus 202 l~~~~~~p~~~~~~-----~~~~-~~~~~~---~~~~~~----------~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 202 ICYNGEIPLKDKTL-----AEKE-RFYEGQ---CMLVTP----------SCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred HHhCCCCCCCCcch-----hHHH-HHHhcC---ccCCCC----------ChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 98 58887732211 1110 111110 000010 123578999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=320.75 Aligned_cols=254 Identities=21% Similarity=0.344 Sum_probs=195.3
Q ss_pred ccccccCceEEEEEEEC------CCcEEEEEEeCCCCc-hhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEecc
Q 005102 409 FVLGKSGIGIVYKVVLE------DGHTLAVRRLGEGGS-QRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYI 481 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~------~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~ 481 (714)
+.||+|+||.||+|.++ .+..||||++..... ....+|.+|+.++++++||||+++++++...+..++||||+
T Consensus 12 ~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e~~ 91 (277)
T cd05062 12 RELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELM 91 (277)
T ss_pred eeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCeEEEEecC
Confidence 57999999999999864 256799999865432 33457899999999999999999999999999999999999
Q ss_pred CCCCHhhhhhCCCCCC----CcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhh
Q 005102 482 PNGSLATALHGKPGMV----SFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARL 557 (714)
Q Consensus 482 ~~gsL~~~l~~~~~~~----~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 557 (714)
++|+|.+++....... ....+++..+..++.|++.||+|||+ .+++||||||+||++++++.+||+|||+++.
T Consensus 92 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~~vH~dlkp~Nil~~~~~~~~l~dfg~~~~ 168 (277)
T cd05062 92 TRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRD 168 (277)
T ss_pred CCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCcchheEEEcCCCCEEECCCCCccc
Confidence 9999999986532210 01346788999999999999999999 8999999999999999999999999999875
Q ss_pred hhccCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHh-CCCcc
Q 005102 558 ANIAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMIT-GRTAV 636 (714)
Q Consensus 558 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~ellt-G~~p~ 636 (714)
...... ........++..|+|||++.+..++.++|||||||++|||++ |..||
T Consensus 169 ~~~~~~--------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~ 222 (277)
T cd05062 169 IYETDY--------------------------YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPY 222 (277)
T ss_pred cCCcce--------------------------eecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCC
Confidence 432110 000111233567999999998889999999999999999999 68888
Q ss_pred ccCCCCcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhh
Q 005102 637 VQVGSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDALDR 708 (714)
Q Consensus 637 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~ 708 (714)
.... .. ........... .. ... .....+.+++.+||+.||++|||+.|+++.|++
T Consensus 223 ~~~~--~~---~~~~~~~~~~~--~~-----~~~-----~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 223 QGMS--NE---QVLRFVMEGGL--LD-----KPD-----NCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred CCCC--HH---HHHHHHHcCCc--CC-----CCC-----CCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 4321 11 11211111111 00 011 122368899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=337.08 Aligned_cols=273 Identities=21% Similarity=0.255 Sum_probs=193.5
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeCCCC---chhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCC
Q 005102 409 FVLGKSGIGIVYKVVLE-DGHTLAVRRLGEGG---SQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNG 484 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~g 484 (714)
+.||+|+||+||+|+.. +++.||||++.... ......+.+|++++++++||||+++++++.+.+..++||||+++|
T Consensus 7 ~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E~~~gg 86 (381)
T cd05626 7 KTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGG 86 (381)
T ss_pred EEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEecCCCC
Confidence 47999999999999875 48899999997642 233457889999999999999999999999999999999999999
Q ss_pred CHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCC
Q 005102 485 SLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGS 564 (714)
Q Consensus 485 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 564 (714)
+|.+++... ..+++..+..++.|++.||+|||+ .+|+||||||+|||++.++++||+|||+++........
T Consensus 87 ~L~~~l~~~------~~~~e~~~~~~~~qi~~aL~~LH~---~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~ 157 (381)
T cd05626 87 DMMSLLIRM------EVFPEVLARFYIAELTLAIESVHK---MGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNS 157 (381)
T ss_pred cHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCcHHHEEECCCCCEEEeeCcCCccccccccc
Confidence 999998765 458889999999999999999999 89999999999999999999999999998754321111
Q ss_pred CCccCCCCCCCCchhh-------------------hcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHH
Q 005102 565 PTLQSNRMPAEKPQER-------------------QQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVI 625 (714)
Q Consensus 565 ~~~~~~~~~~~~~~~~-------------------~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvv 625 (714)
................ .................||+.|+|||++.+..++.++|||||||+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~i 237 (381)
T cd05626 158 KYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVI 237 (381)
T ss_pred ccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhH
Confidence 0000000000000000 000000000011124568999999999998889999999999999
Q ss_pred HHHHHhCCCccccCCCCcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhH--ccCCCCCCCCCHHHHH
Q 005102 626 LLEMITGRTAVVQVGSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMA--CVHSSPEKRPTMRHIS 703 (714)
Q Consensus 626 l~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~--Cl~~dP~~RPt~~evl 703 (714)
+|||+||+.||......+ ........... ........ ...++.+++.+ |+..+|..||+++|++
T Consensus 238 l~elltG~~Pf~~~~~~~-----~~~~i~~~~~~------~~~~~~~~---~s~~~~dli~~ll~~~~~~~~R~~~~~~l 303 (381)
T cd05626 238 LFEMLVGQPPFLAPTPTE-----TQLKVINWENT------LHIPPQVK---LSPEAVDLITKLCCSAEERLGRNGADDIK 303 (381)
T ss_pred HHHHHhCCCCCcCCCHHH-----HHHHHHccccc------cCCCCCCC---CCHHHHHHHHHHccCcccccCCCCHHHHh
Confidence 999999999995432111 11111111100 00111100 12246677777 6666777799999997
Q ss_pred H
Q 005102 704 D 704 (714)
Q Consensus 704 ~ 704 (714)
+
T Consensus 304 ~ 304 (381)
T cd05626 304 A 304 (381)
T ss_pred c
Confidence 5
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-38 Score=332.27 Aligned_cols=236 Identities=22% Similarity=0.309 Sum_probs=185.5
Q ss_pred cccccCceEEEEEEEC-CCcEEEEEEeCCCC---chhHHHHHHHHH-HHhccCCCCccceEEEEEeCCceeEEEeccCCC
Q 005102 410 VLGKSGIGIVYKVVLE-DGHTLAVRRLGEGG---SQRFKEFQTEVE-AIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNG 484 (714)
Q Consensus 410 ~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~g 484 (714)
+||+|+||.||+|+.. +++.||+|++.+.. ......+.+|.. +++.++||||+++++++...+..++||||+++|
T Consensus 2 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 81 (321)
T cd05603 2 VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNGG 81 (321)
T ss_pred eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCCC
Confidence 6999999999999986 48899999987532 222344556654 578899999999999999999999999999999
Q ss_pred CHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCC
Q 005102 485 SLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGS 564 (714)
Q Consensus 485 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 564 (714)
+|..++... ..+++..+..++.||+.||+|||+ .+|+||||||+||+++.++.+||+|||+++.....
T Consensus 82 ~L~~~l~~~------~~~~~~~~~~~~~qi~~~L~~lH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~--- 149 (321)
T cd05603 82 ELFFHLQRE------RCFLEPRARFYAAEVASAIGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEP--- 149 (321)
T ss_pred CHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEccCCCCccCCCC---
Confidence 999888654 457888999999999999999999 89999999999999999999999999998742111
Q ss_pred CCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCccccCCCCcc
Q 005102 565 PTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGSSEM 644 (714)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~~~~~~~~~ 644 (714)
........||+.|+|||.+.+..++.++|||||||++|||++|+.||...
T Consensus 150 -------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~----- 199 (321)
T cd05603 150 -------------------------EETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSR----- 199 (321)
T ss_pred -------------------------CCccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCC-----
Confidence 01112335788999999999888999999999999999999999999432
Q ss_pred hhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHH
Q 005102 645 DLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMR 700 (714)
Q Consensus 645 ~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ 700 (714)
+............. ..... ....+.+++.+||+.||++||++.
T Consensus 200 ~~~~~~~~i~~~~~--------~~~~~-----~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 200 DVSQMYDNILHKPL--------QLPGG-----KTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred CHHHHHHHHhcCCC--------CCCCC-----CCHHHHHHHHHHccCCHhhcCCCC
Confidence 11222222221110 11111 123578999999999999999864
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=316.36 Aligned_cols=247 Identities=25% Similarity=0.421 Sum_probs=195.7
Q ss_pred ccccccCceEEEEEEECCCcEEEEEEeCCCCchhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCCCHhh
Q 005102 409 FVLGKSGIGIVYKVVLEDGHTLAVRRLGEGGSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGSLAT 488 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL~~ 488 (714)
+.||+|+||.||+|..+++..||+|.+...... .+.|.+|+.++++++|+||+++++++. .+..++||||+++++|.+
T Consensus 12 ~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~~-~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~~~~L~~ 89 (260)
T cd05070 12 KKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMS-PESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYMSKGSLLD 89 (260)
T ss_pred heeccccCceEEEEEecCCceeEEEEecCCCCC-HHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEecCCCcHHH
Confidence 479999999999999988889999999765432 367999999999999999999999875 456899999999999999
Q ss_pred hhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCCCCcc
Q 005102 489 ALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQ 568 (714)
Q Consensus 489 ~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 568 (714)
+++.... ..+++.++.+++.|++.||+|||+ ++|+||||||+||++++++.+||+|||+++.......
T Consensus 90 ~~~~~~~----~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~----- 157 (260)
T cd05070 90 FLKDGEG----RALKLPNLVDMAAQVAAGMAYIER---MNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEY----- 157 (260)
T ss_pred HHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCccceEEEeCCceEEeCCceeeeeccCccc-----
Confidence 9976432 358999999999999999999999 8999999999999999999999999999976432110
Q ss_pred CCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHh-CCCccccCCCCcchhH
Q 005102 569 SNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMIT-GRTAVVQVGSSEMDLV 647 (714)
Q Consensus 569 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~ellt-G~~p~~~~~~~~~~l~ 647 (714)
.......++..|+|||.+.+..++.++||||||+++|||++ |+.||.... ..
T Consensus 158 ----------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~--~~--- 210 (260)
T cd05070 158 ----------------------TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMN--NR--- 210 (260)
T ss_pred ----------------------ccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCC--HH---
Confidence 00111123456999999988889999999999999999999 888884321 11
Q ss_pred HHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhh
Q 005102 648 NWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDALDR 708 (714)
Q Consensus 648 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~ 708 (714)
+....... ... +... ......+.+++.+||+.+|++|||++++.+.|+.
T Consensus 211 ~~~~~~~~-~~~------~~~~-----~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 211 EVLEQVER-GYR------MPCP-----QDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred HHHHHHHc-CCC------CCCC-----CcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 11111111 110 0011 1123468899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=319.84 Aligned_cols=255 Identities=20% Similarity=0.310 Sum_probs=201.4
Q ss_pred ccccccCceEEEEEEE-CCCcEEEEEEeCCCC---chhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCC
Q 005102 409 FVLGKSGIGIVYKVVL-EDGHTLAVRRLGEGG---SQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNG 484 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~g 484 (714)
+.||+|+||.||++.. .+++.+|||.+.... .....++.+|+++++.++||||+++++++...+..+++|||++++
T Consensus 8 ~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~ 87 (267)
T cd08229 8 KKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAG 87 (267)
T ss_pred hhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEEEecCCC
Confidence 3799999999999996 468999999886532 233467889999999999999999999999999999999999999
Q ss_pred CHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCC
Q 005102 485 SLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGS 564 (714)
Q Consensus 485 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 564 (714)
+|.+++...... ...+++..+..++.|++.||+|||+ ++++|+||||+||+++.++.++|+|||+++......
T Consensus 88 ~L~~~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~-- 160 (267)
T cd08229 88 DLSRMIKHFKKQ--KRLIPEKTVWKYFVQLCSALEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT-- 160 (267)
T ss_pred CHHHHHHHhhcc--CCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEECcchhhhccccCC--
Confidence 999988642211 1458999999999999999999999 899999999999999999999999999987653211
Q ss_pred CCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCccccCCCCcc
Q 005102 565 PTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGSSEM 644 (714)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~~~~~~~~~ 644 (714)
.......++..|+|||.+.+..++.++||||||+++|||++|..||.....
T Consensus 161 --------------------------~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~--- 211 (267)
T cd08229 161 --------------------------TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM--- 211 (267)
T ss_pred --------------------------cccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccc---
Confidence 011123457789999999888899999999999999999999999853221
Q ss_pred hhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhhhh
Q 005102 645 DLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDALDRLI 710 (714)
Q Consensus 645 ~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~ 710 (714)
+...+.+.... ...+.... ......+.+++.+||+.||++||||.+|++.++++.
T Consensus 212 ~~~~~~~~~~~-------~~~~~~~~----~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 266 (267)
T cd08229 212 NLYSLCKKIEQ-------CDYPPLPS----DHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH 266 (267)
T ss_pred hHHHHhhhhhc-------CCCCCCCc----ccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence 11122111111 11111111 123346889999999999999999999999998875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=310.46 Aligned_cols=271 Identities=25% Similarity=0.299 Sum_probs=205.7
Q ss_pred cccccCceEEEEEEECC-CcEEEEEEeCCCC---chhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCCC
Q 005102 410 VLGKSGIGIVYKVVLED-GHTLAVRRLGEGG---SQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGS 485 (714)
Q Consensus 410 ~lG~G~~g~Vy~~~~~~-g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gs 485 (714)
.||+|.-|+||++++++ +..+|+|++.+.. .....+.+.|-+||+.++||.++.+|+.++..+..|+|||||+||+
T Consensus 84 ~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~meyCpGGd 163 (459)
T KOG0610|consen 84 RLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVMEYCPGGD 163 (459)
T ss_pred HcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEecCCCcc
Confidence 79999999999999876 5899999998763 3345678889999999999999999999999999999999999999
Q ss_pred HhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCCC
Q 005102 486 LATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSP 565 (714)
Q Consensus 486 L~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 565 (714)
|..+.+.+++ +.+++..++-++.+|+-||+|||- .|||.|||||+||||.++|++.|+||-++..........
T Consensus 164 L~~LrqkQp~----~~fse~~aRFYaAEvl~ALEYLHm---lGivYRDLKPENILvredGHIMLsDFDLS~~~~~~Pt~~ 236 (459)
T KOG0610|consen 164 LHSLRQKQPG----KRFSESAARFYAAEVLLALEYLHM---LGIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSPTLV 236 (459)
T ss_pred HHHHHhhCCC----CccchhhHHHHHHHHHHHHHHHHh---hceeeccCCcceeEEecCCcEEeeeccccccCCCCCeee
Confidence 9999988765 569999999999999999999999 899999999999999999999999999987652211000
Q ss_pred Cc------------c-------CCCCCCC-Cc----hhhhccc----ccceeecccCCCCCCccccCCcccCCCCCCchh
Q 005102 566 TL------------Q-------SNRMPAE-KP----QERQQKS----VSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKW 617 (714)
Q Consensus 566 ~~------------~-------~~~~~~~-~~----~~~~~~~----~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~ 617 (714)
.. . ..+.... +. ......+ ............+||-.|.|||++.|...+.++
T Consensus 237 ~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHgsAV 316 (459)
T KOG0610|consen 237 KSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHGSAV 316 (459)
T ss_pred ccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCCchh
Confidence 00 0 0000000 00 0000000 012233445678999999999999999999999
Q ss_pred hhHHHHHHHHHHHhCCCccccCCCCcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCC
Q 005102 618 DIYSYGVILLEMITGRTAVVQVGSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRP 697 (714)
Q Consensus 618 DVwS~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RP 697 (714)
|.|+|||++|||+.|+.||...... ..+.+.+ ... ...+... .....+.+||++.|.+||.+|.
T Consensus 317 DWWtfGIflYEmLyG~TPFKG~~~~-~Tl~NIv----~~~--------l~Fp~~~---~vs~~akDLIr~LLvKdP~kRl 380 (459)
T KOG0610|consen 317 DWWTFGIFLYEMLYGTTPFKGSNNK-ETLRNIV----GQP--------LKFPEEP---EVSSAAKDLIRKLLVKDPSKRL 380 (459)
T ss_pred hHHHHHHHHHHHHhCCCCcCCCCch-hhHHHHh----cCC--------CcCCCCC---cchhHHHHHHHHHhccChhhhh
Confidence 9999999999999999999544332 2222222 111 1111111 3445788999999999999998
Q ss_pred C----HHHHH
Q 005102 698 T----MRHIS 703 (714)
Q Consensus 698 t----~~evl 703 (714)
. ++||.
T Consensus 381 g~~rGA~eIK 390 (459)
T KOG0610|consen 381 GSKRGAAEIK 390 (459)
T ss_pred ccccchHHhh
Confidence 7 66653
|
|
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=318.16 Aligned_cols=255 Identities=21% Similarity=0.305 Sum_probs=190.9
Q ss_pred cccccCceEEEEEEECC---CcEEEEEEeCCCCc-hhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCCC
Q 005102 410 VLGKSGIGIVYKVVLED---GHTLAVRRLGEGGS-QRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGS 485 (714)
Q Consensus 410 ~lG~G~~g~Vy~~~~~~---g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gs 485 (714)
.||+|+||.||+|...+ +..+|+|.++.... .....+.+|+.++++++||||+++++++.+....++||||+++|+
T Consensus 2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05087 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGD 81 (269)
T ss_pred cccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCCc
Confidence 58999999999998654 46799999876543 334578899999999999999999999999889999999999999
Q ss_pred HhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCCC
Q 005102 486 LATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSP 565 (714)
Q Consensus 486 L~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 565 (714)
|.+++...... .....++..+.+++.|++.||+|||+ .+++||||||+||++++++++||+|||+++.......
T Consensus 82 L~~~l~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~-- 155 (269)
T cd05087 82 LKGYLRSCRKA-ELMTPDPTTLQRMACEIALGLLHLHK---NNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDY-- 155 (269)
T ss_pred HHHHHHHhhhc-ccccccHHHHHHHHHHHHHHHHHHHH---CCEeccccCcceEEEcCCCcEEECCccccccccCcce--
Confidence 99999754321 11346778889999999999999999 8999999999999999999999999999864321100
Q ss_pred CccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCC-------CCCchhhhHHHHHHHHHHHh-CCCccc
Q 005102 566 TLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVV-------KPSQKWDIYSYGVILLEMIT-GRTAVV 637 (714)
Q Consensus 566 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-------~~s~~~DVwS~Gvvl~ellt-G~~p~~ 637 (714)
........++..|+|||++.+. .++.++||||||+++|||++ |+.||.
T Consensus 156 ------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~ 211 (269)
T cd05087 156 ------------------------YVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYR 211 (269)
T ss_pred ------------------------eecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCC
Confidence 0111223456779999998642 35889999999999999996 999995
Q ss_pred cCCCCcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHh
Q 005102 638 QVGSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDALD 707 (714)
Q Consensus 638 ~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~ 707 (714)
..... +.... ..... .....++..... ....+.+++.+|| .+|++|||++||+..|+
T Consensus 212 ~~~~~--~~~~~---~~~~~--~~~~~~~~~~~~-----~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 212 HLSDE--QVLTY---TVREQ--QLKLPKPRLKLP-----LSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCChH--HHHHH---Hhhcc--cCCCCCCccCCC-----CChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 43221 11111 11111 111222222211 1225778999999 68999999999999875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=320.87 Aligned_cols=254 Identities=25% Similarity=0.400 Sum_probs=196.4
Q ss_pred ccccccCceEEEEEEE-----CCCcEEEEEEeCCCCc-hhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccC
Q 005102 409 FVLGKSGIGIVYKVVL-----EDGHTLAVRRLGEGGS-QRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIP 482 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~-----~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~ 482 (714)
+.||+|+||.||+|.. .++..||+|.+..... .....|.+|++++++++||||+++++++...+..++||||++
T Consensus 11 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 90 (283)
T cd05090 11 EELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCMLFEYLN 90 (283)
T ss_pred eeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEEEEEcCC
Confidence 4799999999999985 2468899999975433 334678999999999999999999999999999999999999
Q ss_pred CCCHhhhhhCCCCC-----------CCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcc
Q 005102 483 NGSLATALHGKPGM-----------VSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSD 551 (714)
Q Consensus 483 ~gsL~~~l~~~~~~-----------~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~D 551 (714)
+|+|.+++...... .....+++.+++.++.|++.||+|||+ ++|+||||||+||++++++.+||+|
T Consensus 91 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~nili~~~~~~kl~d 167 (283)
T cd05090 91 QGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSS---HFFVHKDLAARNILIGEQLHVKISD 167 (283)
T ss_pred CCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---cCeehhccccceEEEcCCCcEEecc
Confidence 99999998633210 001347899999999999999999999 8999999999999999999999999
Q ss_pred cchhhhhhccCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHh
Q 005102 552 FGLARLANIAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMIT 631 (714)
Q Consensus 552 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~ellt 631 (714)
||+++....... ........++..|+|||++.+..++.++|||||||++|||++
T Consensus 168 fg~~~~~~~~~~--------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~ 221 (283)
T cd05090 168 LGLSREIYSADY--------------------------YRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221 (283)
T ss_pred ccccccccCCcc--------------------------eecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHc
Confidence 999976532110 001112223567999999988889999999999999999999
Q ss_pred -CCCccccCCCCcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhh
Q 005102 632 -GRTAVVQVGSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDALDR 708 (714)
Q Consensus 632 -G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~ 708 (714)
|..||.... ...+.+.+ ...... .... ....++.+++.+||+.||++||++.+|.+.|.+
T Consensus 222 ~g~~p~~~~~--~~~~~~~~----~~~~~~------~~~~-----~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 222 FGLQPYYGFS--NQEVIEMV----RKRQLL------PCSE-----DCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred CCCCCCCCCC--HHHHHHHH----HcCCcC------CCCC-----CCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 988984321 11111111 111110 0111 112367889999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=324.44 Aligned_cols=257 Identities=23% Similarity=0.313 Sum_probs=187.0
Q ss_pred ccccccCceEEEEEEEC--CCcEEEEEEeCCCC--chhHHHHHHHHHHHhcc---CCCCccceEEEEEe-----CCceeE
Q 005102 409 FVLGKSGIGIVYKVVLE--DGHTLAVRRLGEGG--SQRFKEFQTEVEAIGKI---RHSNIVTLRAYYWS-----VDEKLL 476 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~--~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~H~niv~l~~~~~~-----~~~~~l 476 (714)
+.||+|+||.||+|+.. +++.||+|+++... ......+.+|+++++++ +||||++++++|.. ....++
T Consensus 7 ~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~~~~~l 86 (290)
T cd07862 7 AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTL 86 (290)
T ss_pred eEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCCCcEEE
Confidence 47999999999999873 36889999987532 22234567788777766 69999999999863 345789
Q ss_pred EEeccCCCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhh
Q 005102 477 IYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLAR 556 (714)
Q Consensus 477 V~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~ 556 (714)
||||+. ++|.+++..... ..+++..+..++.|++.||+|||+ ++|+||||||+|||+++++.+||+|||+++
T Consensus 87 v~e~~~-~~l~~~~~~~~~----~~~~~~~~~~i~~qi~~aL~~lH~---~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~ 158 (290)
T cd07862 87 VFEHVD-QDLTTYLDKVPE----PGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLAR 158 (290)
T ss_pred EEccCC-CCHHHHHHhCCC----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEEcCCCCEEEccccceE
Confidence 999996 699999875432 358999999999999999999999 899999999999999999999999999987
Q ss_pred hhhccCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCcc
Q 005102 557 LANIAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAV 636 (714)
Q Consensus 557 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~ 636 (714)
..... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||
T Consensus 159 ~~~~~-----------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f 209 (290)
T cd07862 159 IYSFQ-----------------------------MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLF 209 (290)
T ss_pred eccCC-----------------------------cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCc
Confidence 54311 0112334688899999998888999999999999999999999999
Q ss_pred ccCCCCcchhHHHHHHHHhh----cCC----c-ccccCCCCCCCCC--cHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 005102 637 VQVGSSEMDLVNWMQLCIEE----KKP----L-ADVLDPYLAPDAD--KEEEIIAVLKIAMACVHSSPEKRPTMRHISD 704 (714)
Q Consensus 637 ~~~~~~~~~l~~~~~~~~~~----~~~----~-~~~~d~~~~~~~~--~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 704 (714)
.... ..+....+...... ..+ . .....+....... .......+.+++.+||+.||++|||+.|+++
T Consensus 210 ~~~~--~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 210 RGSS--DVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred CCCC--HHHHHHHHHHHhCCCChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 5332 22222211111100 000 0 0000000000000 0011235679999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=315.64 Aligned_cols=249 Identities=27% Similarity=0.416 Sum_probs=196.4
Q ss_pred ccccccCceEEEEEEECCCcEEEEEEeCCCCchhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCCCHhh
Q 005102 409 FVLGKSGIGIVYKVVLEDGHTLAVRRLGEGGSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGSLAT 488 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL~~ 488 (714)
+.||+|+||.||+|.+.+...||+|++..... ..+.|.+|++++++++||||+++++++. .+..++||||+++|+|.+
T Consensus 12 ~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~~~~L~~ 89 (262)
T cd05071 12 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMSKGSLLD 89 (262)
T ss_pred eecCCCCCCcEEEEEecCCceEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcCCCCcHHH
Confidence 47999999999999987777899999976433 3467899999999999999999999874 456899999999999999
Q ss_pred hhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCCCCcc
Q 005102 489 ALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQ 568 (714)
Q Consensus 489 ~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 568 (714)
++..... ..+++..+..++.|++.||+|||+ .+++||||||+||++++++.+||+|||.++.......
T Consensus 90 ~~~~~~~----~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~----- 157 (262)
T cd05071 90 FLKGEMG----KYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY----- 157 (262)
T ss_pred HHhhccc----cCCCHHHHHHHHHHHHHHHHHHHH---CCccccccCcccEEEcCCCcEEeccCCceeecccccc-----
Confidence 9975432 357899999999999999999999 8999999999999999999999999999876532110
Q ss_pred CCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHh-CCCccccCCCCcchhH
Q 005102 569 SNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMIT-GRTAVVQVGSSEMDLV 647 (714)
Q Consensus 569 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~ellt-G~~p~~~~~~~~~~l~ 647 (714)
.......++..|+|||+..+..++.++||||||+++|||+| |+.||......
T Consensus 158 ----------------------~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~----- 210 (262)
T cd05071 158 ----------------------TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR----- 210 (262)
T ss_pred ----------------------ccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChH-----
Confidence 00112234567999999988899999999999999999999 78888432211
Q ss_pred HHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhhhh
Q 005102 648 NWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDALDRLI 710 (714)
Q Consensus 648 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~ 710 (714)
+.... ...... ... .......+.+++.+||+.||++||++.++++.|++..
T Consensus 211 ~~~~~-~~~~~~------~~~-----~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~~ 261 (262)
T cd05071 211 EVLDQ-VERGYR------MPC-----PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 261 (262)
T ss_pred HHHHH-HhcCCC------CCC-----ccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHhc
Confidence 11111 111110 000 1123346889999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=315.96 Aligned_cols=249 Identities=27% Similarity=0.395 Sum_probs=195.9
Q ss_pred cccccCceEEEEEEECC----CcEEEEEEeCCCCc-hhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCC
Q 005102 410 VLGKSGIGIVYKVVLED----GHTLAVRRLGEGGS-QRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNG 484 (714)
Q Consensus 410 ~lG~G~~g~Vy~~~~~~----g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~g 484 (714)
.||+|+||.||+|.+.. +..+|+|.+..... ...+++.+|++++++++||||+++++++. .+..++||||+++|
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~~ 80 (257)
T cd05060 2 ELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPLG 80 (257)
T ss_pred ccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCCC
Confidence 69999999999998643 26899999886544 24467899999999999999999999876 45689999999999
Q ss_pred CHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCC
Q 005102 485 SLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGS 564 (714)
Q Consensus 485 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 564 (714)
+|.+++... ..+++..+..++.|++.||+|||+ .+++||||||+||++++++.+||+|||+++........
T Consensus 81 ~L~~~l~~~------~~~~~~~~~~~~~qi~~~l~~lh~---~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~ 151 (257)
T cd05060 81 PLLKYLKKR------REIPVSDLKELAHQVAMGMAYLES---KHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDY 151 (257)
T ss_pred cHHHHHHhC------CCCCHHHHHHHHHHHHHHHHHHhh---cCeeccCcccceEEEcCCCcEEeccccccceeecCCcc
Confidence 999999765 358899999999999999999999 89999999999999999999999999998865322110
Q ss_pred CCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHh-CCCccccCCCCc
Q 005102 565 PTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMIT-GRTAVVQVGSSE 643 (714)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~ellt-G~~p~~~~~~~~ 643 (714)
........++..|+|||.+.+..++.++||||||+++|||++ |+.||.... .
T Consensus 152 -------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~--~ 204 (257)
T cd05060 152 -------------------------YRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMK--G 204 (257)
T ss_pred -------------------------cccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCC--H
Confidence 000111123456999999998899999999999999999998 999984332 1
Q ss_pred chhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhhhh
Q 005102 644 MDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDALDRLI 710 (714)
Q Consensus 644 ~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~ 710 (714)
.++..++ ...... ... ......+.+++.+||..+|++|||+.++++.|+++.
T Consensus 205 ~~~~~~~----~~~~~~------~~~-----~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 205 AEVIAML----ESGERL------PRP-----EECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred HHHHHHH----HcCCcC------CCC-----CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence 2222222 111110 000 112236889999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=317.64 Aligned_cols=253 Identities=28% Similarity=0.475 Sum_probs=198.6
Q ss_pred cccccccCceEEEEEEECC-C---cEEEEEEeCCCC-chhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccC
Q 005102 408 AFVLGKSGIGIVYKVVLED-G---HTLAVRRLGEGG-SQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIP 482 (714)
Q Consensus 408 ~~~lG~G~~g~Vy~~~~~~-g---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~ 482 (714)
.+.||+|+||.||+|+.+. + ..+|+|++.... ....+.+..|++++++++||||+++++++...+..++||||++
T Consensus 10 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 89 (268)
T cd05063 10 QKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMIITEYME 89 (268)
T ss_pred eeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEEEEcCC
Confidence 4589999999999999753 3 379999987653 3345678999999999999999999999999999999999999
Q ss_pred CCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccC
Q 005102 483 NGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAG 562 (714)
Q Consensus 483 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 562 (714)
+++|.+++.... ..+++.++..++.|++.||+|||+ .+++||||||+||++++++.+||+|||++.......
T Consensus 90 ~~~L~~~~~~~~-----~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~ 161 (268)
T cd05063 90 NGALDKYLRDHD-----GEFSSYQLVGMLRGIAAGMKYLSD---MNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDP 161 (268)
T ss_pred CCCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhhEEEcCCCcEEECCCccceeccccc
Confidence 999999997543 358999999999999999999999 899999999999999999999999999987553211
Q ss_pred CCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHh-CCCccccCCC
Q 005102 563 GSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMIT-GRTAVVQVGS 641 (714)
Q Consensus 563 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~ellt-G~~p~~~~~~ 641 (714)
.. .........+..|+|||++.+..++.++|||||||++|||++ |+.||.....
T Consensus 162 ~~-------------------------~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~ 216 (268)
T cd05063 162 EG-------------------------TYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN 216 (268)
T ss_pred cc-------------------------ceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCH
Confidence 00 000111122456999999988889999999999999999998 9999943221
Q ss_pred CcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhhhh
Q 005102 642 SEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDALDRLI 710 (714)
Q Consensus 642 ~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~ 710 (714)
.++..... ..... +.. .....++.+++.+||+.+|++||++.+|++.|++++
T Consensus 217 -----~~~~~~i~-~~~~~-----~~~------~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~~ 268 (268)
T cd05063 217 -----HEVMKAIN-DGFRL-----PAP------MDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKLL 268 (268)
T ss_pred -----HHHHHHHh-cCCCC-----CCC------CCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhhC
Confidence 12222211 11110 100 112346889999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=300.54 Aligned_cols=244 Identities=25% Similarity=0.376 Sum_probs=196.2
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeCCCC-----c---hhHHHHHHHHHHHhcc-CCCCccceEEEEEeCCceeEEE
Q 005102 409 FVLGKSGIGIVYKVVLE-DGHTLAVRRLGEGG-----S---QRFKEFQTEVEAIGKI-RHSNIVTLRAYYWSVDEKLLIY 478 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~-----~---~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~ 478 (714)
+++|+|..+.|-++.++ +|+++|+|++.... + .-.+.-.+|+.+|+++ .||+|+.+.++|++....++|+
T Consensus 23 eilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~sF~FlVF 102 (411)
T KOG0599|consen 23 EILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDAFVFLVF 102 (411)
T ss_pred HHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcchhhhhh
Confidence 57999999999998765 58999999986431 1 1134567899999999 6999999999999999999999
Q ss_pred eccCCCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhh
Q 005102 479 DYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLA 558 (714)
Q Consensus 479 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~ 558 (714)
|.|+.|.|+++|... ..+++++..+|++|+..|++|||. +.||||||||+|||+|++.++||+|||+|+.+
T Consensus 103 dl~prGELFDyLts~------VtlSEK~tR~iMrqlfegVeylHa---~~IVHRDLKpENILlddn~~i~isDFGFa~~l 173 (411)
T KOG0599|consen 103 DLMPRGELFDYLTSK------VTLSEKETRRIMRQLFEGVEYLHA---RNIVHRDLKPENILLDDNMNIKISDFGFACQL 173 (411)
T ss_pred hhcccchHHHHhhhh------eeecHHHHHHHHHHHHHHHHHHHH---hhhhhcccChhheeeccccceEEeccceeecc
Confidence 999999999999876 569999999999999999999999 99999999999999999999999999999876
Q ss_pred hccCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCC------CCCCchhhhHHHHHHHHHHHhC
Q 005102 559 NIAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKV------VKPSQKWDIYSYGVILLEMITG 632 (714)
Q Consensus 559 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~s~~~DVwS~Gvvl~elltG 632 (714)
...+ .....+||++|.|||.+.- ..|+..+|+||.|||||.|+.|
T Consensus 174 ~~Ge-----------------------------kLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaG 224 (411)
T KOG0599|consen 174 EPGE-----------------------------KLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAG 224 (411)
T ss_pred CCch-----------------------------hHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcC
Confidence 5432 2344578999999999842 3478899999999999999999
Q ss_pred CCccccCCCCcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 005102 633 RTAVVQVGSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISD 704 (714)
Q Consensus 633 ~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 704 (714)
.+||..... .-.++.....+. ++-.| ...+......+++.+||+.||.+|.|++|+++
T Consensus 225 cpPFwHRkQ-----mlMLR~ImeGky---qF~sp------eWadis~~~KdLIsrlLqVdp~~Ritake~La 282 (411)
T KOG0599|consen 225 CPPFWHRKQ-----MLMLRMIMEGKY---QFRSP------EWADISATVKDLISRLLQVDPTKRITAKEALA 282 (411)
T ss_pred CCchhHHHH-----HHHHHHHHhccc---ccCCc------chhhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence 999943210 111112222221 12222 22334456789999999999999999999875
|
|
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=323.56 Aligned_cols=259 Identities=24% Similarity=0.376 Sum_probs=200.7
Q ss_pred cccccccCceEEEEEEEC--------CCcEEEEEEeCCCC-chhHHHHHHHHHHHhcc-CCCCccceEEEEEeCCceeEE
Q 005102 408 AFVLGKSGIGIVYKVVLE--------DGHTLAVRRLGEGG-SQRFKEFQTEVEAIGKI-RHSNIVTLRAYYWSVDEKLLI 477 (714)
Q Consensus 408 ~~~lG~G~~g~Vy~~~~~--------~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV 477 (714)
...||+|+||.||+|+.. ++..||+|.+.... ....+.+.+|+.+++.+ +||||+++++++...+..++|
T Consensus 20 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv 99 (304)
T cd05101 20 GKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVI 99 (304)
T ss_pred cceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecCCceEEE
Confidence 458999999999999742 24579999987542 33456789999999999 899999999999999999999
Q ss_pred EeccCCCCHhhhhhCCCCC----------CCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCe
Q 005102 478 YDYIPNGSLATALHGKPGM----------VSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEP 547 (714)
Q Consensus 478 ~e~~~~gsL~~~l~~~~~~----------~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~ 547 (714)
|||+++|+|.+++...... .....+++.++.+++.||+.||+|||+ ++|+||||||+||++++++.+
T Consensus 100 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~---~givH~dlkp~Nili~~~~~~ 176 (304)
T cd05101 100 VEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLAS---QKCIHRDLAARNVLVTENNVM 176 (304)
T ss_pred EecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHH---CCeeecccccceEEEcCCCcE
Confidence 9999999999999764221 011358899999999999999999999 899999999999999999999
Q ss_pred EEcccchhhhhhccCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHH
Q 005102 548 HVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILL 627 (714)
Q Consensus 548 kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~ 627 (714)
||+|||+++....... ........++..|+|||++.+..++.++||||||+++|
T Consensus 177 kl~D~g~~~~~~~~~~--------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ 230 (304)
T cd05101 177 KIADFGLARDVNNIDY--------------------------YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMW 230 (304)
T ss_pred EECCCccceecccccc--------------------------cccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHH
Confidence 9999999986532110 00111223456799999998888999999999999999
Q ss_pred HHHh-CCCccccCCCCcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHH
Q 005102 628 EMIT-GRTAVVQVGSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDAL 706 (714)
Q Consensus 628 ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L 706 (714)
||++ |..||... ...++.... ...... ... ......+.+++.+||+.+|++|||+.|+++.|
T Consensus 231 el~~~g~~p~~~~-----~~~~~~~~~-~~~~~~------~~~-----~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l 293 (304)
T cd05101 231 EIFTLGGSPYPGI-----PVEELFKLL-KEGHRM------DKP-----ANCTNELYMMMRDCWHAIPSHRPTFKQLVEDL 293 (304)
T ss_pred HHHcCCCCCcccC-----CHHHHHHHH-HcCCcC------CCC-----CCCCHHHHHHHHHHcccChhhCCCHHHHHHHH
Confidence 9999 77887322 122222222 111110 000 11234688999999999999999999999999
Q ss_pred hhhhcc
Q 005102 707 DRLIVS 712 (714)
Q Consensus 707 ~~i~~~ 712 (714)
+++...
T Consensus 294 ~~~~~~ 299 (304)
T cd05101 294 DRILTL 299 (304)
T ss_pred HHHHHh
Confidence 998753
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=316.31 Aligned_cols=255 Identities=20% Similarity=0.325 Sum_probs=202.1
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeCCC---CchhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCC
Q 005102 409 FVLGKSGIGIVYKVVLE-DGHTLAVRRLGEG---GSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNG 484 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~g 484 (714)
+.||+|+||.||+|... +|+.||+|.++.. .....+.+.+|++++++++|+||+++++++...+..++||||+++|
T Consensus 8 ~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 87 (267)
T cd08224 8 KKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVLELADAG 87 (267)
T ss_pred eeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEecCCCC
Confidence 47999999999999987 6899999988642 2233567899999999999999999999999999999999999999
Q ss_pred CHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCC
Q 005102 485 SLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGS 564 (714)
Q Consensus 485 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 564 (714)
+|.+++...... ...+++.++.+++.|++.||+|||+ .+|+||||||+||++++++.++|+|||+++.......
T Consensus 88 ~L~~~l~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~- 161 (267)
T cd08224 88 DLSRMIKHFKKQ--KRLIPERTIWKYFVQLCSALEHMHS---KRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT- 161 (267)
T ss_pred CHHHHHHHhccc--CCCcCHHHHHHHHHHHHHHHHHHHh---CCEecCCcChhhEEECCCCcEEEeccceeeeccCCCc-
Confidence 999998643211 1458899999999999999999999 8999999999999999999999999999875432110
Q ss_pred CCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCccccCCCCcc
Q 005102 565 PTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGSSEM 644 (714)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~~~~~~~~~ 644 (714)
......++..|+|||.+.+..++.++|||||||++|||++|+.||.... .
T Consensus 162 ---------------------------~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~---~ 211 (267)
T cd08224 162 ---------------------------AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK---M 211 (267)
T ss_pred ---------------------------ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCC---c
Confidence 0112235777999999998889999999999999999999999984332 2
Q ss_pred hhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhhhh
Q 005102 645 DLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDALDRLI 710 (714)
Q Consensus 645 ~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~ 710 (714)
+..+......... . +... .......+.+++.+||+.+|++|||+.+|+++|+++.
T Consensus 212 ~~~~~~~~~~~~~------~-~~~~----~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 212 NLYSLCKKIEKCD------Y-PPLP----ADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred cHHHHHhhhhcCC------C-CCCC----hhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 2222222111110 0 1011 1123346889999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=317.42 Aligned_cols=252 Identities=25% Similarity=0.417 Sum_probs=195.1
Q ss_pred cccccCceEEEEEEECC-Cc--EEEEEEeCCCC-chhHHHHHHHHHHHhcc-CCCCccceEEEEEeCCceeEEEeccCCC
Q 005102 410 VLGKSGIGIVYKVVLED-GH--TLAVRRLGEGG-SQRFKEFQTEVEAIGKI-RHSNIVTLRAYYWSVDEKLLIYDYIPNG 484 (714)
Q Consensus 410 ~lG~G~~g~Vy~~~~~~-g~--~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~e~~~~g 484 (714)
+||+|+||.||+|.+++ +. .+|+|.+.... ....+.+.+|++++.++ +||||+++++++...+..++||||+++|
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 81 (270)
T cd05047 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHG 81 (270)
T ss_pred cCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCCC
Confidence 68999999999999864 43 57888887543 33446789999999999 7999999999999999999999999999
Q ss_pred CHhhhhhCCCCC----------CCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccch
Q 005102 485 SLATALHGKPGM----------VSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGL 554 (714)
Q Consensus 485 sL~~~l~~~~~~----------~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGl 554 (714)
+|.+++...... .....+++.+++.++.|++.||+|||+ ++++||||||+||++++++.+||+|||+
T Consensus 82 ~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~---~~i~H~dikp~nili~~~~~~kl~dfgl 158 (270)
T cd05047 82 NLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGL 158 (270)
T ss_pred cHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccccceEEEcCCCeEEECCCCC
Confidence 999999754210 111358899999999999999999999 8999999999999999999999999998
Q ss_pred hhhhhccCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHh-CC
Q 005102 555 ARLANIAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMIT-GR 633 (714)
Q Consensus 555 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~ellt-G~ 633 (714)
++..... ........+..|+|||++....++.++|||||||++|||++ |.
T Consensus 159 ~~~~~~~-----------------------------~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~ 209 (270)
T cd05047 159 SRGQEVY-----------------------------VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGG 209 (270)
T ss_pred ccccchh-----------------------------hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCC
Confidence 7532110 00011122456999999988889999999999999999997 99
Q ss_pred CccccCCCCcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhhhh
Q 005102 634 TAVVQVGSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDALDRLI 710 (714)
Q Consensus 634 ~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~ 710 (714)
.||.... ..+..... ...... .... .....+.+++.+||+.||.+|||+.++++.|+++.
T Consensus 210 ~pf~~~~-----~~~~~~~~-~~~~~~------~~~~-----~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 210 TPYCGMT-----CAELYEKL-PQGYRL------EKPL-----NCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred CCccccC-----HHHHHHHH-hCCCCC------CCCC-----cCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 9984321 11112111 111100 0110 12235789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=320.71 Aligned_cols=254 Identities=24% Similarity=0.329 Sum_probs=196.4
Q ss_pred ccccccCceEEEEEEECC------CcEEEEEEeCCCCch-hHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEecc
Q 005102 409 FVLGKSGIGIVYKVVLED------GHTLAVRRLGEGGSQ-RFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYI 481 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~~------g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~ 481 (714)
+.||+|+||.||+|...+ ++.||+|++...... ..+.+.+|+.++.+++||||+++++++...+..++++||+
T Consensus 11 ~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~~~e~~ 90 (283)
T cd05091 11 EELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYC 90 (283)
T ss_pred HHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEEEEEcC
Confidence 369999999999998642 578999999865433 2456889999999999999999999999999999999999
Q ss_pred CCCCHhhhhhCCCC----------CCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcc
Q 005102 482 PNGSLATALHGKPG----------MVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSD 551 (714)
Q Consensus 482 ~~gsL~~~l~~~~~----------~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~D 551 (714)
++++|.+++..... ......+++..+.+++.|++.||+|||+ ++|+||||||+||++++++.+||+|
T Consensus 91 ~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~---~gi~H~dlkp~Nil~~~~~~~kl~D 167 (283)
T cd05091 91 SHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSS---HHVVHKDLATRNVLVFDKLNVKISD 167 (283)
T ss_pred CCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH---cCccccccchhheEecCCCceEecc
Confidence 99999999853211 0011358899999999999999999999 8999999999999999999999999
Q ss_pred cchhhhhhccCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHh
Q 005102 552 FGLARLANIAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMIT 631 (714)
Q Consensus 552 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~ellt 631 (714)
||+++....... ........+++.|+|||.+.+..++.++|||||||++|||++
T Consensus 168 fg~~~~~~~~~~--------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~ 221 (283)
T cd05091 168 LGLFREVYAADY--------------------------YKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221 (283)
T ss_pred cccccccccchh--------------------------eeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHc
Confidence 999875432110 011122234667999999988889999999999999999998
Q ss_pred -CCCccccCCCCcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhh
Q 005102 632 -GRTAVVQVGSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDALDR 708 (714)
Q Consensus 632 -G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~ 708 (714)
|..||.... . .++......... . + ... .....+.+++.+||+.+|++||++++|+..|+.
T Consensus 222 ~g~~p~~~~~--~---~~~~~~i~~~~~--~----~-~~~-----~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 222 YGLQPYCGYS--N---QDVIEMIRNRQV--L----P-CPD-----DCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred CCCCCCCCCC--H---HHHHHHHHcCCc--C----C-CCC-----CCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 888874321 1 122222221111 0 0 111 123358899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=345.96 Aligned_cols=248 Identities=23% Similarity=0.308 Sum_probs=194.9
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeCCC--CchhHHHHHHHHHHHhccCCCCccceEEEEEeCC--------ceeEE
Q 005102 409 FVLGKSGIGIVYKVVLE-DGHTLAVRRLGEG--GSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVD--------EKLLI 477 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~--------~~~lV 477 (714)
+.||+|+||+||+|+.. +|+.||||++... .......+.+|+..+..++|+||+++++.+...+ ..++|
T Consensus 38 ~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~~~~i~lV 117 (496)
T PTZ00283 38 RVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENVLMIALV 117 (496)
T ss_pred EEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcccceEEEEE
Confidence 47999999999999864 5899999998754 2334567889999999999999999988775432 25799
Q ss_pred EeccCCCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhh
Q 005102 478 YDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARL 557 (714)
Q Consensus 478 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 557 (714)
|||+++|+|.++++..... ...+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++.
T Consensus 118 ~Ey~~~gsL~~~l~~~~~~--~~~l~e~~~~~i~~qll~aL~~lH~---~~IiHrDLKP~NILl~~~~~vkL~DFGls~~ 192 (496)
T PTZ00283 118 LDYANAGDLRQEIKSRAKT--NRTFREHEAGLLFIQVLLAVHHVHS---KHMIHRDIKSANILLCSNGLVKLGDFGFSKM 192 (496)
T ss_pred EeCCCCCcHHHHHHHhhcc--CCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEeCCCCEEEEecccCee
Confidence 9999999999998754321 1468899999999999999999999 8999999999999999999999999999986
Q ss_pred hhccCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCccc
Q 005102 558 ANIAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVV 637 (714)
Q Consensus 558 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~~ 637 (714)
+..... ........||+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus 193 ~~~~~~--------------------------~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~ 246 (496)
T PTZ00283 193 YAATVS--------------------------DDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFD 246 (496)
T ss_pred cccccc--------------------------ccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCC
Confidence 532110 011223457899999999999999999999999999999999999994
Q ss_pred cCCCCcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 005102 638 QVGSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISD 704 (714)
Q Consensus 638 ~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 704 (714)
.. ...+.+........ ++ +... ...++.+++.+||+.||++||++.++++
T Consensus 247 ~~-----~~~~~~~~~~~~~~------~~-~~~~-----~~~~l~~li~~~L~~dP~~RPs~~ell~ 296 (496)
T PTZ00283 247 GE-----NMEEVMHKTLAGRY------DP-LPPS-----ISPEMQEIVTALLSSDPKRRPSSSKLLN 296 (496)
T ss_pred CC-----CHHHHHHHHhcCCC------CC-CCCC-----CCHHHHHHHHHHcccChhhCcCHHHHHh
Confidence 22 22233332222111 11 1111 2236889999999999999999999876
|
|
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=323.02 Aligned_cols=246 Identities=24% Similarity=0.230 Sum_probs=192.7
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeCCCCc---hhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCC
Q 005102 409 FVLGKSGIGIVYKVVLE-DGHTLAVRRLGEGGS---QRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNG 484 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~g 484 (714)
++||+|+||+||++... +++.||+|++..... .....+.+|++++++++||||+++++++...+..++||||+++|
T Consensus 6 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 85 (285)
T cd05605 6 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGG 85 (285)
T ss_pred EEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEeccCCC
Confidence 47999999999999975 589999999875422 22345788999999999999999999999999999999999999
Q ss_pred CHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCC
Q 005102 485 SLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGS 564 (714)
Q Consensus 485 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 564 (714)
+|.+++..... ..+++..+..++.|++.||+|||+ .+|+||||||+||++++++.++|+|||+++......
T Consensus 86 ~L~~~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~-- 156 (285)
T cd05605 86 DLKFHIYNMGN----PGFDEERAVFYAAEITCGLEDLHR---ERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE-- 156 (285)
T ss_pred cHHHHHHhcCc----CCCCHHHHHHHHHHHHHHHHHHHH---CCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCC--
Confidence 99988865421 358999999999999999999999 899999999999999999999999999987542110
Q ss_pred CCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCccccCCCCcc
Q 005102 565 PTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGSSEM 644 (714)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~~~~~~~~~ 644 (714)
......|+..|+|||++.+..++.++||||+||++|||++|+.||..... .
T Consensus 157 ---------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~--~ 207 (285)
T cd05605 157 ---------------------------TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKE--K 207 (285)
T ss_pred ---------------------------ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCch--h
Confidence 01123467889999999988899999999999999999999999953221 1
Q ss_pred hhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCC-----CHHHHHH
Q 005102 645 DLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRP-----TMRHISD 704 (714)
Q Consensus 645 ~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----t~~evl~ 704 (714)
...+.+...+.... .... ......+.+++.+||+.||++|| +++++++
T Consensus 208 ~~~~~~~~~~~~~~-------~~~~-----~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05605 208 VKREEVERRVKEDQ-------EEYS-----EKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKA 260 (285)
T ss_pred hHHHHHHHHhhhcc-------cccC-----cccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhc
Confidence 11111111111110 0011 11223578999999999999999 7778754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-38 Score=333.08 Aligned_cols=254 Identities=23% Similarity=0.355 Sum_probs=195.0
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeCCCCchhHHHHHHHHHHHhccC-CC-----CccceEEEEEeCCceeEEEecc
Q 005102 409 FVLGKSGIGIVYKVVLE-DGHTLAVRRLGEGGSQRFKEFQTEVEAIGKIR-HS-----NIVTLRAYYWSVDEKLLIYDYI 481 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~-----niv~l~~~~~~~~~~~lV~e~~ 481 (714)
++||+|+||.|-||++. +++.||||+++.... ...+...|+.+|..++ |. |+|++++||...++.|||+|.+
T Consensus 192 e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~-f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~HlciVfELL 270 (586)
T KOG0667|consen 192 EVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKR-FLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCIVFELL 270 (586)
T ss_pred EEecccccceeEEEEecCCCcEEEEEeeccChH-HHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceeeeehhh
Confidence 48999999999999965 599999999987533 3456788999999997 43 8999999999999999999999
Q ss_pred CCCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCC--CCeEEcccchhhhhh
Q 005102 482 PNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHN--MEPHVSDFGLARLAN 559 (714)
Q Consensus 482 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~--~~~kl~DFGla~~~~ 559 (714)
.. +|+++++.+.- ..++...++.|+.||+.||.+||+ .+|||+||||+||||.+- ..+||+|||.|.+..
T Consensus 271 ~~-NLYellK~n~f----~Glsl~~ir~~~~Qil~~L~~L~~---l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~~ 342 (586)
T KOG0667|consen 271 ST-NLYELLKNNKF----RGLSLPLVRKFAQQILTALLFLHE---LGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFES 342 (586)
T ss_pred hh-hHHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCChhheeeccCCcCceeEEecccccccC
Confidence 55 99999987743 669999999999999999999999 899999999999999653 479999999998754
Q ss_pred ccCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCccccC
Q 005102 560 IAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQV 639 (714)
Q Consensus 560 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~~~~ 639 (714)
... ....-+++|+|||++.|.+|+.+.||||||||+.||++|.+.|.
T Consensus 343 q~v-------------------------------ytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfp-- 389 (586)
T KOG0667|consen 343 QRV-------------------------------YTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFP-- 389 (586)
T ss_pred Ccc-------------------------------eeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccC--
Confidence 211 12233678999999999999999999999999999999987773
Q ss_pred CCCcchhHHHHHHHHh--------hcCCcccccCC--------------------------------CCCC-CCC-----
Q 005102 640 GSSEMDLVNWMQLCIE--------EKKPLADVLDP--------------------------------YLAP-DAD----- 673 (714)
Q Consensus 640 ~~~~~~l~~~~~~~~~--------~~~~~~~~~d~--------------------------------~~~~-~~~----- 673 (714)
+.++.+....+...+. ........++. ...+ ...
T Consensus 390 G~ne~DQl~~I~e~lG~Pp~~mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~ 469 (586)
T KOG0667|consen 390 GDNEYDQLARIIEVLGLPPPKMLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESG 469 (586)
T ss_pred CCCHHHHHHHHHHHhCCCCHHHHHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchh
Confidence 3344443332221111 00000001111 0011 000
Q ss_pred -cHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 005102 674 -KEEEIIAVLKIAMACVHSSPEKRPTMRHISD 704 (714)
Q Consensus 674 -~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 704 (714)
...+-..+.+++.+|+++||.+|+|..++++
T Consensus 470 ~~~~~~~~F~dflk~~L~~dP~~R~tp~qal~ 501 (586)
T KOG0667|consen 470 LPKADDKLFIDFLKRCLEWDPAERITPAQALN 501 (586)
T ss_pred cccccHHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 0123446899999999999999999998874
|
|
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=323.80 Aligned_cols=257 Identities=25% Similarity=0.408 Sum_probs=197.3
Q ss_pred ccccccCceEEEEEEE-----CCCcEEEEEEeCCCC-chhHHHHHHHHHHHhccCCCCccceEEEEEeC--CceeEEEec
Q 005102 409 FVLGKSGIGIVYKVVL-----EDGHTLAVRRLGEGG-SQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSV--DEKLLIYDY 480 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~-----~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~~lV~e~ 480 (714)
+.||+|+||.||++.+ .++..||+|.++... ......+.+|++++++++||||+++++++... ...++||||
T Consensus 10 ~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~ 89 (284)
T cd05079 10 RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEF 89 (284)
T ss_pred eecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceEEEEEc
Confidence 4799999999999984 247899999987553 33346799999999999999999999998875 567899999
Q ss_pred cCCCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhc
Q 005102 481 IPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANI 560 (714)
Q Consensus 481 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 560 (714)
+++++|.+++.... ..+++..+..++.|++.||+|||+ ++++||||||+||++++++.+||+|||+++....
T Consensus 90 ~~g~~L~~~l~~~~-----~~~~~~~~~~i~~~i~~aL~~lH~---~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~ 161 (284)
T cd05079 90 LPSGSLKEYLPRNK-----NKINLKQQLKYAVQICKGMDYLGS---RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIET 161 (284)
T ss_pred cCCCCHHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecccchheEEEcCCCCEEECCCcccccccc
Confidence 99999999986542 358999999999999999999999 9999999999999999999999999999886532
Q ss_pred cCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCccccCC
Q 005102 561 AGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVG 640 (714)
Q Consensus 561 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~~~~~ 640 (714)
.... ........++..|+|||++.+..++.++|||||||++|||+|++.|.....
T Consensus 162 ~~~~-------------------------~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~ 216 (284)
T cd05079 162 DKEY-------------------------YTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPM 216 (284)
T ss_pred Cccc-------------------------eeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCcccc
Confidence 2110 001122345667999999988889999999999999999999887653211
Q ss_pred C----------CcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhhhh
Q 005102 641 S----------SEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDALDRLI 710 (714)
Q Consensus 641 ~----------~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~ 710 (714)
. .......++.. ....... + ... .....+.+++.+||+.||++|||+.++++.|+++.
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~-----~-~~~-----~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~~ 284 (284)
T cd05079 217 TLFLKMIGPTHGQMTVTRLVRV-LEEGKRL-----P-RPP-----NCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAIL 284 (284)
T ss_pred chhhhhcccccccccHHHHHHH-HHcCccC-----C-CCC-----CCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhhC
Confidence 1 01111111111 1111100 0 011 12346889999999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=330.00 Aligned_cols=236 Identities=21% Similarity=0.282 Sum_probs=187.3
Q ss_pred ccccccCceEEEEEEECC-CcEEEEEEeCCCC---chhHHHHHHHHHHHhcc-CCCCccceEEEEEeCCceeEEEeccCC
Q 005102 409 FVLGKSGIGIVYKVVLED-GHTLAVRRLGEGG---SQRFKEFQTEVEAIGKI-RHSNIVTLRAYYWSVDEKLLIYDYIPN 483 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~~-g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~e~~~~ 483 (714)
+.||+|+||.||+|+... ++.||||++.+.. ....+.+..|..++..+ +|++|+++++++...+..++||||+++
T Consensus 6 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 85 (323)
T cd05616 6 MVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVMEYVNG 85 (323)
T ss_pred EEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEEcCCCC
Confidence 479999999999999764 7899999987642 22334567788888877 589999999999999999999999999
Q ss_pred CCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCC
Q 005102 484 GSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGG 563 (714)
Q Consensus 484 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 563 (714)
|+|.+++... ..+++.++..++.|++.||+|||+ .+|+||||||+|||+++++.+||+|||+++.....
T Consensus 86 g~L~~~~~~~------~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~-- 154 (323)
T cd05616 86 GDLMYQIQQV------GRFKEPHAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD-- 154 (323)
T ss_pred CCHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCEEecCCCHHHeEECCCCcEEEccCCCceecCCC--
Confidence 9999988654 458899999999999999999999 89999999999999999999999999998743211
Q ss_pred CCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCccccCCCCc
Q 005102 564 SPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGSSE 643 (714)
Q Consensus 564 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~~~~~~~~ 643 (714)
........||+.|+|||++.+..++.++|||||||++|||+||+.||.... .
T Consensus 155 --------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~--~ 206 (323)
T cd05616 155 --------------------------GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED--E 206 (323)
T ss_pred --------------------------CCccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCC--H
Confidence 011123457889999999999999999999999999999999999994321 1
Q ss_pred chhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCH
Q 005102 644 MDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTM 699 (714)
Q Consensus 644 ~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~ 699 (714)
. ............ .... ...++.+++.+|++.||++|++.
T Consensus 207 ~---~~~~~i~~~~~~--------~p~~-----~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 207 D---ELFQSIMEHNVA--------YPKS-----MSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred H---HHHHHHHhCCCC--------CCCc-----CCHHHHHHHHHHcccCHHhcCCC
Confidence 1 122222221111 1111 12357899999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=315.96 Aligned_cols=247 Identities=25% Similarity=0.406 Sum_probs=194.9
Q ss_pred ccccccCceEEEEEEECCCcEEEEEEeCCCCchhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCCCHhh
Q 005102 409 FVLGKSGIGIVYKVVLEDGHTLAVRRLGEGGSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGSLAT 488 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL~~ 488 (714)
..||+|+||.||+|.+.++..+|+|.+..... ..+.+.+|++++++++|||++++++++. .+..++||||+++|+|.+
T Consensus 12 ~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~~~L~~ 89 (260)
T cd05069 12 VKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTM-MPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMGKGSLLD 89 (260)
T ss_pred eeecCcCCCeEEEEEEcCCceEEEEEcccCCc-cHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCCCCCHHH
Confidence 47999999999999988777899998875433 3467899999999999999999999875 456899999999999999
Q ss_pred hhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCCCCcc
Q 005102 489 ALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQ 568 (714)
Q Consensus 489 ~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 568 (714)
+++.... ..+++..+..++.|++.||+|||+ .+++||||||+||++++++.+||+|||+++.......
T Consensus 90 ~~~~~~~----~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~----- 157 (260)
T cd05069 90 FLKEGDG----KYLKLPQLVDMAAQIADGMAYIER---MNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEY----- 157 (260)
T ss_pred HHhhCCC----CCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccCcceEEEcCCCeEEECCCccceEccCCcc-----
Confidence 9976432 348899999999999999999999 8999999999999999999999999999976532110
Q ss_pred CCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHh-CCCccccCCCCcchhH
Q 005102 569 SNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMIT-GRTAVVQVGSSEMDLV 647 (714)
Q Consensus 569 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~ellt-G~~p~~~~~~~~~~l~ 647 (714)
.......++..|+|||...+..++.++||||||+++|||+| |+.||.... .....
T Consensus 158 ----------------------~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~--~~~~~ 213 (260)
T cd05069 158 ----------------------TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMV--NREVL 213 (260)
T ss_pred ----------------------cccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCC--HHHHH
Confidence 00111223567999999988889999999999999999999 888984321 11111
Q ss_pred HHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhh
Q 005102 648 NWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDALDR 708 (714)
Q Consensus 648 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~ 708 (714)
.++ ..... +... ......+.+++.+||..||++||++++|++.|++
T Consensus 214 ~~~----~~~~~------~~~~-----~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 214 EQV----ERGYR------MPCP-----QGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred HHH----HcCCC------CCCC-----cccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 111 11110 1011 1123468899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=314.47 Aligned_cols=250 Identities=24% Similarity=0.372 Sum_probs=198.1
Q ss_pred cccccCceEEEEEEECC--C--cEEEEEEeCCCCc-hhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCC
Q 005102 410 VLGKSGIGIVYKVVLED--G--HTLAVRRLGEGGS-QRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNG 484 (714)
Q Consensus 410 ~lG~G~~g~Vy~~~~~~--g--~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~g 484 (714)
.||+|++|.||+|.+.+ + ..||||.+..... ...+.+.+|++++++++||||+++++++.. ...++||||+++|
T Consensus 2 ~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~~ 80 (257)
T cd05040 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPLG 80 (257)
T ss_pred cCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCCC
Confidence 68999999999999754 2 3699999987655 556789999999999999999999999988 8889999999999
Q ss_pred CHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCC
Q 005102 485 SLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGS 564 (714)
Q Consensus 485 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 564 (714)
+|.+++..... ..+++..+..++.|++.||+|||+ ++++||||||+||+++.++.+||+|||+++........
T Consensus 81 ~L~~~l~~~~~----~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~ 153 (257)
T cd05040 81 SLLDRLRKDAL----GHFLISTLCDYAVQIANGMRYLES---KRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDH 153 (257)
T ss_pred cHHHHHHhccc----ccCcHHHHHHHHHHHHHHHHHHHh---CCccccccCcccEEEecCCEEEeccccccccccccccc
Confidence 99999976532 358999999999999999999999 89999999999999999999999999999876432110
Q ss_pred CCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHh-CCCccccCCCCc
Q 005102 565 PTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMIT-GRTAVVQVGSSE 643 (714)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~ellt-G~~p~~~~~~~~ 643 (714)
........++..|+|||++.+..++.++|||||||++|||+| |+.||.... .
T Consensus 154 -------------------------~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~--~ 206 (257)
T cd05040 154 -------------------------YVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLS--G 206 (257)
T ss_pred -------------------------eecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCC--H
Confidence 001112335677999999998899999999999999999999 999984321 1
Q ss_pred chhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhh
Q 005102 644 MDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDALDR 708 (714)
Q Consensus 644 ~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~ 708 (714)
.+. .......... ...+ ......+.+++.+||+.+|++|||+.++++.|.+
T Consensus 207 ~~~---~~~~~~~~~~---~~~~--------~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~ 257 (257)
T cd05040 207 SQI---LKKIDKEGER---LERP--------EACPQDIYNVMLQCWAHNPADRPTFAALREFLPE 257 (257)
T ss_pred HHH---HHHHHhcCCc---CCCC--------ccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhcC
Confidence 111 1111111110 0001 1122468899999999999999999999998853
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=323.31 Aligned_cols=253 Identities=24% Similarity=0.327 Sum_probs=198.1
Q ss_pred cccccccCceEEEEEEEC------CCcEEEEEEeCCCC-chhHHHHHHHHHHHhcc-CCCCccceEEEEEeCCceeEEEe
Q 005102 408 AFVLGKSGIGIVYKVVLE------DGHTLAVRRLGEGG-SQRFKEFQTEVEAIGKI-RHSNIVTLRAYYWSVDEKLLIYD 479 (714)
Q Consensus 408 ~~~lG~G~~g~Vy~~~~~------~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~e 479 (714)
.+.||+|+||.||++... ++..||||+++... ....+.+.+|+++++++ +||||+++++++...+..++|||
T Consensus 40 ~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e 119 (302)
T cd05055 40 GKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPILVITE 119 (302)
T ss_pred cceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCceEEEEE
Confidence 468999999999999742 25689999987653 23346789999999999 79999999999999999999999
Q ss_pred ccCCCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhh
Q 005102 480 YIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLAN 559 (714)
Q Consensus 480 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~ 559 (714)
|+++|+|.++++.... ..+++.++.+++.|++.||+|||+ ++|+|+||||+||++++++.+|++|||+++...
T Consensus 120 ~~~~~~L~~~i~~~~~----~~l~~~~~~~i~~~i~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~~~ 192 (302)
T cd05055 120 YCCYGDLLNFLRRKRE----SFLTLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNVLLTHGKIVKICDFGLARDIM 192 (302)
T ss_pred cCCCCcHHHHHHhCCC----CCCCHHHHHHHHHHHHHHHHHHHH---CCeehhhhccceEEEcCCCeEEECCCccccccc
Confidence 9999999999975432 238999999999999999999999 899999999999999999999999999987543
Q ss_pred ccCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHh-CCCcccc
Q 005102 560 IAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMIT-GRTAVVQ 638 (714)
Q Consensus 560 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~ellt-G~~p~~~ 638 (714)
.... ........++..|+|||.+.+..++.++|||||||++|||+| |+.||..
T Consensus 193 ~~~~--------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~ 246 (302)
T cd05055 193 NDSN--------------------------YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPG 246 (302)
T ss_pred CCCc--------------------------eeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCC
Confidence 2110 001112234667999999998889999999999999999998 9999843
Q ss_pred CCCCcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhhh
Q 005102 639 VGSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDALDRL 709 (714)
Q Consensus 639 ~~~~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i 709 (714)
....+ .. ......... +.... ....++.+++.+||+.+|++|||+.|+++.|+++
T Consensus 247 ~~~~~-~~----~~~~~~~~~------~~~~~-----~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 247 MPVDS-KF----YKLIKEGYR------MAQPE-----HAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred CCchH-HH----HHHHHcCCc------CCCCC-----CCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 32111 11 111111110 00000 1123688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=319.79 Aligned_cols=252 Identities=26% Similarity=0.386 Sum_probs=196.5
Q ss_pred ccccccCceEEEEEEEC-CCc----EEEEEEeCCCCc-hhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccC
Q 005102 409 FVLGKSGIGIVYKVVLE-DGH----TLAVRRLGEGGS-QRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIP 482 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~-~g~----~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~ 482 (714)
+.||+|+||.||+|.+. +++ .||+|+++.... ...+.+.+|+.+++.++||||+++++++.. ...+++|||++
T Consensus 13 ~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~l~~~~~~ 91 (279)
T cd05109 13 KVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQLVTQLMP 91 (279)
T ss_pred eecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcEEEEEcCC
Confidence 47999999999999854 444 489999876433 335678899999999999999999999975 45789999999
Q ss_pred CCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccC
Q 005102 483 NGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAG 562 (714)
Q Consensus 483 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 562 (714)
+|+|.+++.... ..+++..++.++.|++.||+|||+ ++|+||||||+|||+++++.+||+|||+++......
T Consensus 92 ~g~l~~~l~~~~-----~~~~~~~~~~~~~qi~~~L~~lH~---~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~~~ 163 (279)
T cd05109 92 YGCLLDYVRENK-----DRIGSQDLLNWCVQIAKGMSYLEE---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDE 163 (279)
T ss_pred CCCHHHHHhhcc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccccceEEEcCCCcEEECCCCceeeccccc
Confidence 999999997643 358999999999999999999999 899999999999999999999999999998654221
Q ss_pred CCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHh-CCCccccCCC
Q 005102 563 GSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMIT-GRTAVVQVGS 641 (714)
Q Consensus 563 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~ellt-G~~p~~~~~~ 641 (714)
.. .......++..|+|||...+..++.++|||||||++|||+| |..||....
T Consensus 164 ~~--------------------------~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~- 216 (279)
T cd05109 164 TE--------------------------YHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIP- 216 (279)
T ss_pred ce--------------------------eecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCC-
Confidence 10 00111123567999999998899999999999999999998 888884321
Q ss_pred CcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhhhhcc
Q 005102 642 SEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDALDRLIVS 712 (714)
Q Consensus 642 ~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~~ 712 (714)
...+..++ ...... .... .....+.+++.+||+.||++||++.++++.|+++...
T Consensus 217 -~~~~~~~~----~~~~~~------~~~~-----~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~ 271 (279)
T cd05109 217 -AREIPDLL----EKGERL------PQPP-----ICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARD 271 (279)
T ss_pred -HHHHHHHH----HCCCcC------CCCc-----cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcC
Confidence 11122221 111110 0001 1233678999999999999999999999999988654
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=334.71 Aligned_cols=246 Identities=28% Similarity=0.412 Sum_probs=202.1
Q ss_pred cccccccCceEEEEEEECC-CcEEEEEEeCCCCchhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCCCH
Q 005102 408 AFVLGKSGIGIVYKVVLED-GHTLAVRRLGEGGSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGSL 486 (714)
Q Consensus 408 ~~~lG~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL 486 (714)
.-+||+|.||+||.|++.+ ...+|||-+...+....+-...||.+-++++|.|||+++|.+..+++.-+.||-++||+|
T Consensus 580 rvVLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSL 659 (1226)
T KOG4279|consen 580 RVVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSL 659 (1226)
T ss_pred eEEeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcH
Confidence 3589999999999999765 568999999888777777889999999999999999999999999999999999999999
Q ss_pred hhhhhCCCCCCCcCCC--CHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeC-CCCCeEEcccchhhhhhccCC
Q 005102 487 ATALHGKPGMVSFTPV--PWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLG-HNMEPHVSDFGLARLANIAGG 563 (714)
Q Consensus 487 ~~~l~~~~~~~~~~~l--~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~-~~~~~kl~DFGla~~~~~~~~ 563 (714)
.++|+..-+ ++ .+.+.-.+.+||++||.|||+ ..|||||||-.|||++ -.|.+||+|||-++.+.-
T Consensus 660 SsLLrskWG-----PlKDNEstm~fYtkQILeGLkYLHe---n~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAg--- 728 (1226)
T KOG4279|consen 660 SSLLRSKWG-----PLKDNESTMNFYTKQILEGLKYLHE---NKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAG--- 728 (1226)
T ss_pred HHHHHhccC-----CCccchhHHHHHHHHHHHHhhhhhh---cceeeccccCCcEEEeeccceEEecccccchhhcc---
Confidence 999987653 34 678888999999999999999 8999999999999996 578999999998876531
Q ss_pred CCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCC--CCchhhhHHHHHHHHHHHhCCCccccCCC
Q 005102 564 SPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVK--PSQKWDIYSYGVILLEMITGRTAVVQVGS 641 (714)
Q Consensus 564 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~s~~~DVwS~Gvvl~elltG~~p~~~~~~ 641 (714)
+...+.++.||.-|||||++..++ |+.++|||||||++.||.||++||...+.
T Consensus 729 -------------------------inP~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgs 783 (1226)
T KOG4279|consen 729 -------------------------INPCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGS 783 (1226)
T ss_pred -------------------------CCccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCC
Confidence 122344566899999999997654 89999999999999999999999976655
Q ss_pred CcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 005102 642 SEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISD 704 (714)
Q Consensus 642 ~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 704 (714)
....+.+ ..+.. +.|.+ +++...+...++.+|+.+||.+||++.+++.
T Consensus 784 pqAAMFk---VGmyK-------vHP~i-----Peelsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 784 PQAAMFK---VGMYK-------VHPPI-----PEELSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred hhHhhhh---hccee-------cCCCC-----cHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 4321111 00000 12222 2345567889999999999999999999875
|
|
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=325.46 Aligned_cols=200 Identities=24% Similarity=0.376 Sum_probs=159.9
Q ss_pred cccccccCceEEEEEEEC---CCcEEEEEEeCCCCchhHHHHHHHHHHHhccCCCCccceEEEEEe--CCceeEEEeccC
Q 005102 408 AFVLGKSGIGIVYKVVLE---DGHTLAVRRLGEGGSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWS--VDEKLLIYDYIP 482 (714)
Q Consensus 408 ~~~lG~G~~g~Vy~~~~~---~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~--~~~~~lV~e~~~ 482 (714)
+..||+|+||+||+|+.+ +++.||+|.+..... ...+.+|++++++++||||+++++++.. ....++||||+.
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC--cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 457999999999999975 467899999876432 2457889999999999999999999864 345789999995
Q ss_pred CCCHhhhhhCCCCC---CCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeee----CCCCCeEEcccchh
Q 005102 483 NGSLATALHGKPGM---VSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILL----GHNMEPHVSDFGLA 555 (714)
Q Consensus 483 ~gsL~~~l~~~~~~---~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl----~~~~~~kl~DFGla 555 (714)
++|.+++...... .....+++..+..++.||+.||+|||+ .+|+||||||+|||+ +.++.+||+|||++
T Consensus 84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 84 -HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred -CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHh---CCEEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 5888887533211 111358899999999999999999999 899999999999999 45678999999999
Q ss_pred hhhhccCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCC-CCCchhhhHHHHHHHHHHHhCCC
Q 005102 556 RLANIAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVV-KPSQKWDIYSYGVILLEMITGRT 634 (714)
Q Consensus 556 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DVwS~Gvvl~elltG~~ 634 (714)
+........ ........||+.|+|||++.+. .++.++||||+||++|||++|+.
T Consensus 160 ~~~~~~~~~-------------------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~ 214 (317)
T cd07868 160 RLFNSPLKP-------------------------LADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEP 214 (317)
T ss_pred eccCCCCcc-------------------------ccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCC
Confidence 865321100 0112234568899999999764 58999999999999999999999
Q ss_pred cccc
Q 005102 635 AVVQ 638 (714)
Q Consensus 635 p~~~ 638 (714)
||..
T Consensus 215 ~f~~ 218 (317)
T cd07868 215 IFHC 218 (317)
T ss_pred CccC
Confidence 9953
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-37 Score=321.10 Aligned_cols=255 Identities=24% Similarity=0.395 Sum_probs=196.5
Q ss_pred ccccccCceEEEEEEECC-C--cEEEEEEeCCC-CchhHHHHHHHHHHHhcc-CCCCccceEEEEEeCCceeEEEeccCC
Q 005102 409 FVLGKSGIGIVYKVVLED-G--HTLAVRRLGEG-GSQRFKEFQTEVEAIGKI-RHSNIVTLRAYYWSVDEKLLIYDYIPN 483 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~~-g--~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~e~~~~ 483 (714)
.+||+|+||.||+|..++ + ..+++|.++.. .....+.|.+|++++.++ +||||+++++++...+..++||||+++
T Consensus 8 ~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 87 (297)
T cd05089 8 DVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIAIEYAPY 87 (297)
T ss_pred eeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEEEEecCC
Confidence 479999999999999764 3 35788888753 233446789999999999 799999999999999999999999999
Q ss_pred CCHhhhhhCCCCC----------CCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccc
Q 005102 484 GSLATALHGKPGM----------VSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFG 553 (714)
Q Consensus 484 gsL~~~l~~~~~~----------~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFG 553 (714)
|+|.+++...... .....+++..+.+|+.|++.||+|||+ ++|+||||||+|||+++++.+||+|||
T Consensus 88 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~kl~dfg 164 (297)
T cd05089 88 GNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSE---KQFIHRDLAARNVLVGENLASKIADFG 164 (297)
T ss_pred CcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCcCCcceEEECCCCeEEECCcC
Confidence 9999999754210 011358899999999999999999999 899999999999999999999999999
Q ss_pred hhhhhhccCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHh-C
Q 005102 554 LARLANIAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMIT-G 632 (714)
Q Consensus 554 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~ellt-G 632 (714)
++...... ........+..|+|||++.+..++.++|||||||++|||+| |
T Consensus 165 ~~~~~~~~-----------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g 215 (297)
T cd05089 165 LSRGEEVY-----------------------------VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLG 215 (297)
T ss_pred CCccccce-----------------------------eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCC
Confidence 98632110 00011112346999999988889999999999999999998 9
Q ss_pred CCccccCCCCcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhhhhcc
Q 005102 633 RTAVVQVGSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDALDRLIVS 712 (714)
Q Consensus 633 ~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~~ 712 (714)
+.||.... ..+........ . .+.... .....+.+++.+||+.+|.+|||++++++.|+.+...
T Consensus 216 ~~pf~~~~-----~~~~~~~~~~~-~------~~~~~~-----~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~ 278 (297)
T cd05089 216 GTPYCGMT-----CAELYEKLPQG-Y------RMEKPR-----NCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEA 278 (297)
T ss_pred CCCCCCCC-----HHHHHHHHhcC-C------CCCCCC-----CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 99994321 11222211111 0 111111 1223678999999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=318.01 Aligned_cols=254 Identities=28% Similarity=0.481 Sum_probs=198.2
Q ss_pred cccccccCceEEEEEEECC-C---cEEEEEEeCCC-CchhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccC
Q 005102 408 AFVLGKSGIGIVYKVVLED-G---HTLAVRRLGEG-GSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIP 482 (714)
Q Consensus 408 ~~~lG~G~~g~Vy~~~~~~-g---~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~ 482 (714)
.+.||+|+||.||+|.+.. + ..||||.+... .....++|..|+.++++++||||+++++++...+..++||||++
T Consensus 9 ~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~ 88 (269)
T cd05065 9 EEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIITEFME 88 (269)
T ss_pred EeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEEecCC
Confidence 4579999999999999753 3 36999998765 33345689999999999999999999999999999999999999
Q ss_pred CCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccC
Q 005102 483 NGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAG 562 (714)
Q Consensus 483 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 562 (714)
+|+|.+++.... ..+++.+++.++.|++.||+|||+ .+++||||||+||+++.++.+||+|||+++......
T Consensus 89 ~~~L~~~l~~~~-----~~~~~~~~~~i~~~l~~al~~lH~---~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~ 160 (269)
T cd05065 89 NGALDSFLRQND-----GQFTVIQLVGMLRGIAAGMKYLSE---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 160 (269)
T ss_pred CCcHHHHHhhCC-----CCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccChheEEEcCCCcEEECCCccccccccCc
Confidence 999999987653 358999999999999999999999 899999999999999999999999999987654321
Q ss_pred CCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHh-CCCccccCCC
Q 005102 563 GSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMIT-GRTAVVQVGS 641 (714)
Q Consensus 563 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~ellt-G~~p~~~~~~ 641 (714)
.... .........+..|+|||++.+..++.++|||||||++|||++ |..||....
T Consensus 161 ~~~~-----------------------~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~- 216 (269)
T cd05065 161 SDPT-----------------------YTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMS- 216 (269)
T ss_pred cccc-----------------------cccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCC-
Confidence 1000 000011112346999999998899999999999999999887 999984322
Q ss_pred CcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhhh
Q 005102 642 SEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDALDRL 709 (714)
Q Consensus 642 ~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i 709 (714)
..+...++ ...... + .. .+....+.+++.+||+.+|++||++++|+..|+++
T Consensus 217 -~~~~~~~i----~~~~~~-----~-~~-----~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 217 -NQDVINAI----EQDYRL-----P-PP-----MDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred -HHHHHHHH----HcCCcC-----C-Cc-----ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 11222222 111110 0 00 11223578999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=317.85 Aligned_cols=247 Identities=25% Similarity=0.315 Sum_probs=193.3
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeCCCCchhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCCCHh
Q 005102 409 FVLGKSGIGIVYKVVLE-DGHTLAVRRLGEGGSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGSLA 487 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL~ 487 (714)
..||+|+||.||+|+.. +++.||+|++..........+.+|+.++++++||||+++++++...+..++||||+++++|.
T Consensus 15 ~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~~~~~L~ 94 (267)
T cd06646 15 QRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQ 94 (267)
T ss_pred heeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCCCCCcHH
Confidence 47999999999999974 58899999997655445567889999999999999999999999999999999999999999
Q ss_pred hhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCCCCc
Q 005102 488 TALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTL 567 (714)
Q Consensus 488 ~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 567 (714)
++++.. ..+++..+..++.|++.||+|||+ .+|+||||||+||++++++.+||+|||+++......
T Consensus 95 ~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~----- 160 (267)
T cd06646 95 DIYHVT------GPLSELQIAYVCRETLQGLAYLHS---KGKMHRDIKGANILLTDNGDVKLADFGVAAKITATI----- 160 (267)
T ss_pred HHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCCEEECcCccceeecccc-----
Confidence 998754 458899999999999999999999 899999999999999999999999999987543110
Q ss_pred cCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccC---CCCCCchhhhHHHHHHHHHHHhCCCccccCCCCcc
Q 005102 568 QSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLK---VVKPSQKWDIYSYGVILLEMITGRTAVVQVGSSEM 644 (714)
Q Consensus 568 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~~~DVwS~Gvvl~elltG~~p~~~~~~~~~ 644 (714)
.......|+..|+|||.+. ...++.++|||||||++|||++|+.||........
T Consensus 161 -----------------------~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~ 217 (267)
T cd06646 161 -----------------------AKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA 217 (267)
T ss_pred -----------------------cccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhh
Confidence 0111234677899999884 34578899999999999999999999843321110
Q ss_pred hhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 005102 645 DLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDA 705 (714)
Q Consensus 645 ~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 705 (714)
...+ .. .....+.... .......+.+++.+||..+|++|||++++++.
T Consensus 218 -~~~~------~~---~~~~~~~~~~---~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 265 (267)
T cd06646 218 -LFLM------SK---SNFQPPKLKD---KTKWSSTFHNFVKISLTKNPKKRPTAERLLTH 265 (267)
T ss_pred -heee------ec---CCCCCCCCcc---ccccCHHHHHHHHHHhhCChhhCcCHHHHhcC
Confidence 0000 00 0000111110 01123468899999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=334.21 Aligned_cols=246 Identities=22% Similarity=0.282 Sum_probs=191.7
Q ss_pred cccccccCceEEEEEEEC-CCcEEEEEEeCCC---CchhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCC
Q 005102 408 AFVLGKSGIGIVYKVVLE-DGHTLAVRRLGEG---GSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPN 483 (714)
Q Consensus 408 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~ 483 (714)
.+.||+|+||.||+++.. +++.||+|++.+. .....+.+.+|+.+++.++||||+++++++.+.+..++||||+++
T Consensus 48 ~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv~Ey~~g 127 (370)
T cd05596 48 IKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMVMEYMPG 127 (370)
T ss_pred EEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEEcCCCC
Confidence 357999999999999976 4889999998653 222335578999999999999999999999999999999999999
Q ss_pred CCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCC
Q 005102 484 GSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGG 563 (714)
Q Consensus 484 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 563 (714)
|+|.+++... .+++..+..++.|++.||+|||+ ++|+||||||+|||+++++.+||+|||+++......
T Consensus 128 g~L~~~l~~~-------~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~- 196 (370)
T cd05596 128 GDLVNLMSNY-------DIPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANG- 196 (370)
T ss_pred CcHHHHHHhc-------CCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEcCCCCEEEEeccceeeccCCC-
Confidence 9999998643 37788899999999999999999 899999999999999999999999999987543211
Q ss_pred CCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCC----CCCchhhhHHHHHHHHHHHhCCCccccC
Q 005102 564 SPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVV----KPSQKWDIYSYGVILLEMITGRTAVVQV 639 (714)
Q Consensus 564 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~s~~~DVwS~Gvvl~elltG~~p~~~~ 639 (714)
........||+.|+|||++.+. .++.++|||||||++|||++|+.||...
T Consensus 197 --------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~ 250 (370)
T cd05596 197 --------------------------MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYAD 250 (370)
T ss_pred --------------------------cccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCC
Confidence 0111234578999999998653 4789999999999999999999999432
Q ss_pred CCCcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCC--CCCHHHHHH
Q 005102 640 GSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEK--RPTMRHISD 704 (714)
Q Consensus 640 ~~~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~--RPt~~evl~ 704 (714)
. ....+.........+ ...... .....+.+++.+|++.+|++ |||++|+++
T Consensus 251 ~-----~~~~~~~i~~~~~~~------~~~~~~---~~s~~~~~li~~~L~~~p~r~~R~s~~ell~ 303 (370)
T cd05596 251 S-----LVGTYSKIMDHKNSL------TFPDDI---EISKQAKDLICAFLTDREVRLGRNGVDEIKS 303 (370)
T ss_pred C-----HHHHHHHHHcCCCcC------CCCCcC---CCCHHHHHHHHHHccChhhccCCCCHHHHhc
Confidence 1 122222222211110 011110 12236788999999999988 999999864
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=318.46 Aligned_cols=254 Identities=25% Similarity=0.401 Sum_probs=198.1
Q ss_pred ccccccCceEEEEEEEC------CCcEEEEEEeCCCCchhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccC
Q 005102 409 FVLGKSGIGIVYKVVLE------DGHTLAVRRLGEGGSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIP 482 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~ 482 (714)
..||+|+||.||++... ++..+|+|.+........+.|.+|++++++++|+||+++++++...+..++||||++
T Consensus 11 ~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 90 (280)
T cd05092 11 WELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLMVFEYMR 90 (280)
T ss_pred cccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEEEEecCC
Confidence 47999999999999742 356899999887666666789999999999999999999999999999999999999
Q ss_pred CCCHhhhhhCCCCC---------CCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccc
Q 005102 483 NGSLATALHGKPGM---------VSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFG 553 (714)
Q Consensus 483 ~gsL~~~l~~~~~~---------~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFG 553 (714)
+|+|.+++...... .....+++.+++.++.|++.||+|||+ .+++||||||+||++++++.+||+|||
T Consensus 91 ~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~~i~H~dlkp~nil~~~~~~~kL~dfg 167 (280)
T cd05092 91 HGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLAS---LHFVHRDLATRNCLVGQGLVVKIGDFG 167 (280)
T ss_pred CCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHH---CCeecccccHhhEEEcCCCCEEECCCC
Confidence 99999998754210 111358899999999999999999999 899999999999999999999999999
Q ss_pred hhhhhhccCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHh-C
Q 005102 554 LARLANIAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMIT-G 632 (714)
Q Consensus 554 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~ellt-G 632 (714)
+++....... ........+++.|+|||.+.+..++.++|||||||++|||++ |
T Consensus 168 ~~~~~~~~~~--------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g 221 (280)
T cd05092 168 MSRDIYSTDY--------------------------YRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYG 221 (280)
T ss_pred ceeEcCCCce--------------------------eecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCC
Confidence 9875431100 001112223567999999998899999999999999999999 8
Q ss_pred CCccccCCCCcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhh
Q 005102 633 RTAVVQVGSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDALDR 708 (714)
Q Consensus 633 ~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~ 708 (714)
+.||..... .+. +.... ..... ..+ . .....+.+++.+||+.||++||++.||++.|++
T Consensus 222 ~~p~~~~~~--~~~---~~~~~-~~~~~---~~~---~-----~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~ 280 (280)
T cd05092 222 KQPWYQLSN--TEA---IECIT-QGREL---ERP---R-----TCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA 280 (280)
T ss_pred CCCCccCCH--HHH---HHHHH-cCccC---CCC---C-----CCCHHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence 999843221 111 11111 11110 001 0 112357899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=316.01 Aligned_cols=247 Identities=24% Similarity=0.418 Sum_probs=196.5
Q ss_pred ccccccCceEEEEEEECCCcEEEEEEeCCCCchhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCCCHhh
Q 005102 409 FVLGKSGIGIVYKVVLEDGHTLAVRRLGEGGSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGSLAT 488 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL~~ 488 (714)
+.||+|+||.||+|..++++.||+|.+..... ...++.+|+.++++++|+||+++++++ ..+..++||||+++|+|.+
T Consensus 12 ~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~~v~e~~~~~~L~~ 89 (260)
T cd05067 12 KKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVV-TQEPIYIITEYMENGSLVD 89 (260)
T ss_pred eeeccCccceEEeeecCCCceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEE-ccCCcEEEEEcCCCCCHHH
Confidence 47999999999999998899999999876543 346789999999999999999999987 4567899999999999999
Q ss_pred hhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCCCCcc
Q 005102 489 ALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQ 568 (714)
Q Consensus 489 ~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 568 (714)
++....+ ..+++.++..++.|++.||+|||+ .+++||||||+||++++++.++|+|||++........
T Consensus 90 ~~~~~~~----~~~~~~~~~~i~~~i~~al~~LH~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~----- 157 (260)
T cd05067 90 FLKTPEG----IKLTINKLIDMAAQIAEGMAFIER---KNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEY----- 157 (260)
T ss_pred HHHhcCC----CCCCHHHHHHHHHHHHHHHHHHhc---CCeecccccHHhEEEcCCCCEEEccCcceeecCCCCc-----
Confidence 9875432 458999999999999999999999 8999999999999999999999999999875432110
Q ss_pred CCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHh-CCCccccCCCCcchhH
Q 005102 569 SNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMIT-GRTAVVQVGSSEMDLV 647 (714)
Q Consensus 569 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~ellt-G~~p~~~~~~~~~~l~ 647 (714)
.......++..|+|||++.+..++.++||||||+++|||++ |+.||.... ..+..
T Consensus 158 ----------------------~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~--~~~~~ 213 (260)
T cd05067 158 ----------------------TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMT--NPEVI 213 (260)
T ss_pred ----------------------ccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCC--hHHHH
Confidence 01112223567999999988889999999999999999999 999995322 11121
Q ss_pred HHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhh
Q 005102 648 NWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDALDR 708 (714)
Q Consensus 648 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~ 708 (714)
..+ ..... ..... ....++.+++.+||..+|++|||++++++.|+.
T Consensus 214 ~~~----~~~~~------~~~~~-----~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 214 QNL----ERGYR------MPRPD-----NCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred HHH----HcCCC------CCCCC-----CCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 111 11111 00111 112368899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-38 Score=333.01 Aligned_cols=246 Identities=20% Similarity=0.246 Sum_probs=192.9
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeCCCC---chhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCC
Q 005102 409 FVLGKSGIGIVYKVVLE-DGHTLAVRRLGEGG---SQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNG 484 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~g 484 (714)
+.||+|+||+||++... +|+.||+|+++... ....+.+.+|+.+++.++||||+++++++...+..++||||+++|
T Consensus 7 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 86 (330)
T cd05601 7 SLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVMEYQPGG 86 (330)
T ss_pred EEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEECCCCCC
Confidence 47999999999999976 58999999997642 223456889999999999999999999999999999999999999
Q ss_pred CHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCC
Q 005102 485 SLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGS 564 (714)
Q Consensus 485 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 564 (714)
+|.+++.... ..+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++.......
T Consensus 87 ~L~~~l~~~~-----~~l~~~~~~~~~~qi~~aL~~lH~---~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~- 157 (330)
T cd05601 87 DLLSLLNRYE-----DQFDEDMAQFYLAELVLAIHSVHQ---MGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKM- 157 (330)
T ss_pred CHHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeEcccCchHheEECCCCCEEeccCCCCeECCCCCc-
Confidence 9999997653 358999999999999999999999 8999999999999999999999999999976532110
Q ss_pred CCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccC------CCCCCchhhhHHHHHHHHHHHhCCCcccc
Q 005102 565 PTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLK------VVKPSQKWDIYSYGVILLEMITGRTAVVQ 638 (714)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~s~~~DVwS~Gvvl~elltG~~p~~~ 638 (714)
.......||+.|+|||++. ...++.++|||||||++|||++|+.||..
T Consensus 158 --------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~ 211 (330)
T cd05601 158 --------------------------VNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHE 211 (330)
T ss_pred --------------------------eeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCC
Confidence 0112235688899999986 45678999999999999999999999943
Q ss_pred CCCCcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 005102 639 VGSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISD 704 (714)
Q Consensus 639 ~~~~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 704 (714)
... ...+......... .. ..... .....+.+++..|+. +|++|||++++++
T Consensus 212 ~~~-----~~~~~~i~~~~~~-~~-----~~~~~---~~~~~~~~li~~ll~-~p~~R~t~~~l~~ 262 (330)
T cd05601 212 GTS-----AKTYNNIMNFQRF-LK-----FPEDP---KVSSDFLDLIQSLLC-GQKERLGYEGLCC 262 (330)
T ss_pred CCH-----HHHHHHHHcCCCc-cC-----CCCCC---CCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence 211 1122222211110 00 00010 122357789999997 9999999999874
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=334.65 Aligned_cols=272 Identities=21% Similarity=0.282 Sum_probs=195.0
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeCCCC---chhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCC
Q 005102 409 FVLGKSGIGIVYKVVLE-DGHTLAVRRLGEGG---SQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNG 484 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~g 484 (714)
+.||+|+||+||+|+.. +|+.||||++.... ......+.+|++++..++||||+++++++.+.+..++||||+++|
T Consensus 7 ~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~~~~g 86 (364)
T cd05599 7 KVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIMEYLPGG 86 (364)
T ss_pred EEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEECCCCCc
Confidence 47999999999999986 48999999997532 233456789999999999999999999999999999999999999
Q ss_pred CHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCC
Q 005102 485 SLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGS 564 (714)
Q Consensus 485 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 564 (714)
+|.+++... ..+++..+..|+.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++.+......
T Consensus 87 ~L~~~l~~~------~~l~~~~~~~~~~qi~~aL~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~ 157 (364)
T cd05599 87 DMMTLLMKK------DTFTEEETRFYIAETILAIDSIHK---LGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRT 157 (364)
T ss_pred HHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEeecccceeccccccc
Confidence 999999754 358999999999999999999999 89999999999999999999999999999765322111
Q ss_pred CCccCCCC--CC------CCch--hhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCC
Q 005102 565 PTLQSNRM--PA------EKPQ--ERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRT 634 (714)
Q Consensus 565 ~~~~~~~~--~~------~~~~--~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~ 634 (714)
........ .. ..+. ...................||+.|+|||++.+..++.++|||||||++|||++|+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~ 237 (364)
T cd05599 158 EFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYP 237 (364)
T ss_pred cccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCC
Confidence 00000000 00 0000 00000000000001123468999999999998899999999999999999999999
Q ss_pred ccccCCCCcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCC---HHHHHH
Q 005102 635 AVVQVGSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPT---MRHISD 704 (714)
Q Consensus 635 p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt---~~evl~ 704 (714)
||..... .+...........+ ...... .....+.+++.+|+. +|.+|++ ++|+++
T Consensus 238 Pf~~~~~-----~~~~~~i~~~~~~~------~~~~~~---~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~ 295 (364)
T cd05599 238 PFCSDNP-----QETYRKIINWKETL------QFPDEV---PLSPEAKDLIKRLCC-EAERRLGNNGVNEIKS 295 (364)
T ss_pred CCCCCCH-----HHHHHHHHcCCCcc------CCCCCC---CCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence 9943221 11111111111110 001110 112356788889996 9999998 887765
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-39 Score=299.50 Aligned_cols=244 Identities=24% Similarity=0.293 Sum_probs=195.3
Q ss_pred ccccccCceEEEEEEE-CCCcEEEEEEeCCC--CchhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCCC
Q 005102 409 FVLGKSGIGIVYKVVL-EDGHTLAVRRLGEG--GSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGS 485 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gs 485 (714)
++||+|.|+.||++.+ ++|+.+|+|.+... .....+++.+|+++.+.++||||+++.+.+.+.+..|+|+|+|.+|+
T Consensus 17 e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvFe~m~G~d 96 (355)
T KOG0033|consen 17 EELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGE 96 (355)
T ss_pred HHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEEecccchH
Confidence 3799999999999876 45999999987643 33456788999999999999999999999999999999999999999
Q ss_pred HhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCC---CCCeEEcccchhhhhhccC
Q 005102 486 LATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGH---NMEPHVSDFGLARLANIAG 562 (714)
Q Consensus 486 L~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~---~~~~kl~DFGla~~~~~~~ 562 (714)
|..-+-.+ .-+++..+-.++.||++||.|+|. ++|||||+||+|+++.. .--+||+|||+|..+..
T Consensus 97 l~~eIV~R------~~ySEa~aSH~~rQiLeal~yCH~---n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~-- 165 (355)
T KOG0033|consen 97 LFEDIVAR------EFYSEADASHCIQQILEALAYCHS---NGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVND-- 165 (355)
T ss_pred HHHHHHHH------HHHHHHHHHHHHHHHHHHHHHHHh---cCceeccCChhheeeeeccCCCceeecccceEEEeCC--
Confidence 98766544 236788889999999999999999 99999999999999953 34589999999987651
Q ss_pred CCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCccccCCCC
Q 005102 563 GSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGSS 642 (714)
Q Consensus 563 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~~~~~~~ 642 (714)
........||++|||||++...+|+..+|||+.|||||-|+.|+.||...
T Consensus 166 ---------------------------g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~--- 215 (355)
T KOG0033|consen 166 ---------------------------GEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDE--- 215 (355)
T ss_pred ---------------------------ccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCc---
Confidence 22344667899999999999999999999999999999999999999532
Q ss_pred cchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 005102 643 EMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISD 704 (714)
Q Consensus 643 ~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 704 (714)
+.....+........ +-.|... ...++..+++.+||..||.+|.|+.|.++
T Consensus 216 --~~~rlye~I~~g~yd---~~~~~w~------~is~~Ak~LvrrML~~dP~kRIta~EAL~ 266 (355)
T KOG0033|consen 216 --DQHRLYEQIKAGAYD---YPSPEWD------TVTPEAKSLIRRMLTVNPKKRITADEALK 266 (355)
T ss_pred --cHHHHHHHHhccccC---CCCcccC------cCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence 122223333333221 1111111 12235678999999999999999998764
|
|
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=321.68 Aligned_cols=243 Identities=22% Similarity=0.338 Sum_probs=195.1
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeCCCCchhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCCCHh
Q 005102 409 FVLGKSGIGIVYKVVLE-DGHTLAVRRLGEGGSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGSLA 487 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL~ 487 (714)
..||+|+||.||+|... +++.||+|.+........+.+.+|+.+++.++||||+++++++......++||||+++++|.
T Consensus 26 ~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~~~~~L~ 105 (296)
T cd06654 26 EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT 105 (296)
T ss_pred EEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecccCCCCHH
Confidence 46999999999999964 58999999998765555678899999999999999999999999999999999999999999
Q ss_pred hhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCCCCc
Q 005102 488 TALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTL 567 (714)
Q Consensus 488 ~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 567 (714)
+++... .+++.++..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++......
T Consensus 106 ~~~~~~-------~~~~~~~~~i~~ql~~aL~~LH~---~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~----- 170 (296)
T cd06654 106 DVVTET-------CMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ----- 170 (296)
T ss_pred HHHHhc-------CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCCCCEEECccccchhccccc-----
Confidence 998643 37889999999999999999999 899999999999999999999999999987543211
Q ss_pred cCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCccccCCCCcchhH
Q 005102 568 QSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGSSEMDLV 647 (714)
Q Consensus 568 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~~~~~~~~~~l~ 647 (714)
.......+++.|+|||.+.+..++.++|||||||++|||++|+.||...... .
T Consensus 171 -----------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~----~ 223 (296)
T cd06654 171 -----------------------SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL----R 223 (296)
T ss_pred -----------------------cccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHH----H
Confidence 0111234677899999998888999999999999999999999999533211 1
Q ss_pred HHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 005102 648 NWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISD 704 (714)
Q Consensus 648 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 704 (714)
.+.. ...... +... ........+.+++.+||..||++|||+.++++
T Consensus 224 ~~~~-~~~~~~-------~~~~---~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~ 269 (296)
T cd06654 224 ALYL-IATNGT-------PELQ---NPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (296)
T ss_pred hHHH-HhcCCC-------CCCC---CccccCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence 1111 111110 0000 01112345789999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=325.34 Aligned_cols=238 Identities=23% Similarity=0.399 Sum_probs=195.4
Q ss_pred cccccCceEEEEEEEC-CCcEEEEEEeCCCCc---hhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCCC
Q 005102 410 VLGKSGIGIVYKVVLE-DGHTLAVRRLGEGGS---QRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGS 485 (714)
Q Consensus 410 ~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gs 485 (714)
.||.|+||.||-++.. +...||||++.-... ....++.+|+..|.+++|||+|.+.|+|......||||||| -|+
T Consensus 33 EIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEYC-lGS 111 (948)
T KOG0577|consen 33 EIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEYC-LGS 111 (948)
T ss_pred HhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHHH-hcc
Confidence 4999999999999964 578999999975433 34567899999999999999999999999999999999999 558
Q ss_pred HhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCCC
Q 005102 486 LATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSP 565 (714)
Q Consensus 486 L~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 565 (714)
-.|++.-.. .++.+.++..|..+.+.||+|||+ .+.||||||+.|||+++.|.+||+|||.|....
T Consensus 112 AsDlleVhk-----KplqEvEIAAi~~gaL~gLaYLHS---~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~------ 177 (948)
T KOG0577|consen 112 ASDLLEVHK-----KPLQEVEIAAITHGALQGLAYLHS---HNRIHRDIKAGNILLSEPGLVKLADFGSASIMA------ 177 (948)
T ss_pred HHHHHHHHh-----ccchHHHHHHHHHHHHHHHHHHHH---hhHHhhhccccceEecCCCeeeeccccchhhcC------
Confidence 888886543 568889999999999999999999 899999999999999999999999999987643
Q ss_pred CccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccC---CCCCCchhhhHHHHHHHHHHHhCCCccccCCCC
Q 005102 566 TLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLK---VVKPSQKWDIYSYGVILLEMITGRTAVVQVGSS 642 (714)
Q Consensus 566 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~~~DVwS~Gvvl~elltG~~p~~~~~~~ 642 (714)
...+++|||+|||||++. .+.|+-|+||||+||+..||..+++|++....
T Consensus 178 --------------------------PAnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNA- 230 (948)
T KOG0577|consen 178 --------------------------PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA- 230 (948)
T ss_pred --------------------------chhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchH-
Confidence 234578999999999985 46799999999999999999999999865421
Q ss_pred cchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 005102 643 EMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISD 704 (714)
Q Consensus 643 ~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 704 (714)
...+..+.... .|.+. ..+....+..++..||++-|.+|||.++++.
T Consensus 231 ----MSALYHIAQNe-------sPtLq----s~eWS~~F~~Fvd~CLqKipqeRptse~ll~ 277 (948)
T KOG0577|consen 231 ----MSALYHIAQNE-------SPTLQ----SNEWSDYFRNFVDSCLQKIPQERPTSEELLK 277 (948)
T ss_pred ----HHHHHHHHhcC-------CCCCC----CchhHHHHHHHHHHHHhhCcccCCcHHHHhh
Confidence 11111111111 12222 2345567899999999999999999998875
|
|
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-37 Score=313.27 Aligned_cols=243 Identities=24% Similarity=0.388 Sum_probs=193.3
Q ss_pred ccccccCceEEEEEEECCCcEEEEEEeCCCCchhHHHHHHHHHHHhccCCCCccceEEEEE-eCCceeEEEeccCCCCHh
Q 005102 409 FVLGKSGIGIVYKVVLEDGHTLAVRRLGEGGSQRFKEFQTEVEAIGKIRHSNIVTLRAYYW-SVDEKLLIYDYIPNGSLA 487 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~-~~~~~~lV~e~~~~gsL~ 487 (714)
+.||+|+||.||++... |..||+|.++... ..+.|.+|+.++++++|+|++++++++. ..+..++||||+++++|.
T Consensus 12 ~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~~L~ 88 (256)
T cd05082 12 QTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLV 88 (256)
T ss_pred eeecccCCCeEEEEEEc-CCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECCCCCcHH
Confidence 57999999999999875 7889999987543 2467899999999999999999999865 456789999999999999
Q ss_pred hhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCCCCc
Q 005102 488 TALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTL 567 (714)
Q Consensus 488 ~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 567 (714)
+++..... ..+++..+.+++.|++.||+|||+ ++++||||||+||++++++.+||+|||+++......
T Consensus 89 ~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~----- 156 (256)
T cd05082 89 DYLRSRGR----SVLGGDCLLKFSLDVCEAMEYLEA---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ----- 156 (256)
T ss_pred HHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHh---CCEeccccchheEEEcCCCcEEecCCccceeccccC-----
Confidence 99976532 348899999999999999999999 899999999999999999999999999987432110
Q ss_pred cCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHh-CCCccccCCCCcchh
Q 005102 568 QSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMIT-GRTAVVQVGSSEMDL 646 (714)
Q Consensus 568 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~ellt-G~~p~~~~~~~~~~l 646 (714)
....++..|+|||++.+..++.++|||||||++|||++ |+.||... ..
T Consensus 157 --------------------------~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~-----~~ 205 (256)
T cd05082 157 --------------------------DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI-----PL 205 (256)
T ss_pred --------------------------CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCC-----CH
Confidence 11122456999999988889999999999999999998 99998422 12
Q ss_pred HHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhhh
Q 005102 647 VNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDALDRL 709 (714)
Q Consensus 647 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i 709 (714)
.+....... ... +.... .....+.+++.+||+.+|++|||+.++++.|+++
T Consensus 206 ~~~~~~~~~-~~~------~~~~~-----~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 206 KDVVPRVEK-GYK------MDAPD-----GCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred HHHHHHHhc-CCC------CCCCC-----CCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 222221111 110 11111 1233688999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-37 Score=321.82 Aligned_cols=259 Identities=24% Similarity=0.358 Sum_probs=199.3
Q ss_pred cccccccCceEEEEEEEC--------CCcEEEEEEeCCCC-chhHHHHHHHHHHHhcc-CCCCccceEEEEEeCCceeEE
Q 005102 408 AFVLGKSGIGIVYKVVLE--------DGHTLAVRRLGEGG-SQRFKEFQTEVEAIGKI-RHSNIVTLRAYYWSVDEKLLI 477 (714)
Q Consensus 408 ~~~lG~G~~g~Vy~~~~~--------~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV 477 (714)
.+.||+|+||.||++... ++..+|+|.+.... .....++.+|+++++++ +||||+++++++...+..++|
T Consensus 23 ~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv 102 (307)
T cd05098 23 GKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVI 102 (307)
T ss_pred eeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence 457999999999999853 23579999998642 33446788999999999 799999999999999999999
Q ss_pred EeccCCCCHhhhhhCCCCC----------CCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCe
Q 005102 478 YDYIPNGSLATALHGKPGM----------VSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEP 547 (714)
Q Consensus 478 ~e~~~~gsL~~~l~~~~~~----------~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~ 547 (714)
|||+++|+|.+++...... .....+++.++++++.|++.||+|||+ ++++||||||+||++++++.+
T Consensus 103 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~---~gi~H~dlkp~Nill~~~~~~ 179 (307)
T cd05098 103 VEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVM 179 (307)
T ss_pred EecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH---CCcccccccHHheEEcCCCcE
Confidence 9999999999999764321 011358999999999999999999999 899999999999999999999
Q ss_pred EEcccchhhhhhccCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHH
Q 005102 548 HVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILL 627 (714)
Q Consensus 548 kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~ 627 (714)
||+|||+++....... ........++..|+|||.+.+..++.++|||||||++|
T Consensus 180 kL~dfg~a~~~~~~~~--------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~ 233 (307)
T cd05098 180 KIADFGLARDIHHIDY--------------------------YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLW 233 (307)
T ss_pred EECCCcccccccccch--------------------------hhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHH
Confidence 9999999875432110 00011112345699999999888999999999999999
Q ss_pred HHHh-CCCccccCCCCcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHH
Q 005102 628 EMIT-GRTAVVQVGSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDAL 706 (714)
Q Consensus 628 ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L 706 (714)
||++ |+.||... ...+..... ..... ..... ....++.+++.+||+.+|++|||+.+|++.|
T Consensus 234 el~~~g~~p~~~~-----~~~~~~~~~-~~~~~------~~~~~-----~~~~~~~~li~~~l~~~p~~Rps~~evl~~l 296 (307)
T cd05098 234 EIFTLGGSPYPGV-----PVEELFKLL-KEGHR------MDKPS-----NCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 296 (307)
T ss_pred HHHcCCCCCCCcC-----CHHHHHHHH-HcCCC------CCCCC-----cCCHHHHHHHHHHcccChhhCcCHHHHHHHH
Confidence 9998 88888322 111222211 11110 00111 1223678999999999999999999999999
Q ss_pred hhhhcc
Q 005102 707 DRLIVS 712 (714)
Q Consensus 707 ~~i~~~ 712 (714)
+++...
T Consensus 297 ~~~~~~ 302 (307)
T cd05098 297 DRILAL 302 (307)
T ss_pred HHHHHH
Confidence 998754
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=326.57 Aligned_cols=236 Identities=21% Similarity=0.301 Sum_probs=187.4
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeCCC---CchhHHHHHHHHHHHhccC-CCCccceEEEEEeCCceeEEEeccCC
Q 005102 409 FVLGKSGIGIVYKVVLE-DGHTLAVRRLGEG---GSQRFKEFQTEVEAIGKIR-HSNIVTLRAYYWSVDEKLLIYDYIPN 483 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lV~e~~~~ 483 (714)
..||+|+||+||+|... +|+.||+|++... .....+.+..|..++..+. |++|+++++++...+..|+||||+++
T Consensus 6 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~Ey~~~ 85 (323)
T cd05615 6 MVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVMEYVNG 85 (323)
T ss_pred EEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEEcCCCC
Confidence 47999999999999975 5899999998753 2233456788999998885 57788899999999999999999999
Q ss_pred CCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCC
Q 005102 484 GSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGG 563 (714)
Q Consensus 484 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 563 (714)
|+|.+++... ..+++.++..|+.|++.||+|||+ ++|+||||||+|||+++++.+||+|||+++......
T Consensus 86 g~L~~~i~~~------~~l~~~~~~~i~~qi~~al~~lH~---~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~- 155 (323)
T cd05615 86 GDLMYHIQQV------GKFKEPQAVFYAAEISVGLFFLHR---RGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG- 155 (323)
T ss_pred CcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEeccccccccCCCC-
Confidence 9999998754 458999999999999999999999 899999999999999999999999999987432110
Q ss_pred CCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCccccCCCCc
Q 005102 564 SPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGSSE 643 (714)
Q Consensus 564 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~~~~~~~~ 643 (714)
.......||+.|+|||++.+..++.++|||||||++|||+||+.||.... .
T Consensus 156 ---------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~--~ 206 (323)
T cd05615 156 ---------------------------VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGED--E 206 (323)
T ss_pred ---------------------------ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCC--H
Confidence 11123347889999999998899999999999999999999999994321 1
Q ss_pred chhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCH
Q 005102 644 MDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTM 699 (714)
Q Consensus 644 ~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~ 699 (714)
....+........ .... ....+.+++.+||+.+|++|++.
T Consensus 207 ---~~~~~~i~~~~~~--------~p~~-----~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 207 ---DELFQSIMEHNVS--------YPKS-----LSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred ---HHHHHHHHhCCCC--------CCcc-----CCHHHHHHHHHHcccCHhhCCCC
Confidence 1122222222111 1111 12357789999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-37 Score=319.94 Aligned_cols=261 Identities=23% Similarity=0.329 Sum_probs=197.5
Q ss_pred ccccccCceEEEEEEECC-----------------CcEEEEEEeCCCCc-hhHHHHHHHHHHHhccCCCCccceEEEEEe
Q 005102 409 FVLGKSGIGIVYKVVLED-----------------GHTLAVRRLGEGGS-QRFKEFQTEVEAIGKIRHSNIVTLRAYYWS 470 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~~-----------------g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~ 470 (714)
+.||+|+||.||+|...+ +..||+|++..... ...+.+.+|++++++++||||+++++++..
T Consensus 11 ~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 90 (296)
T cd05051 11 EKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTV 90 (296)
T ss_pred ccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeEEEEEEec
Confidence 479999999999998653 24689999886533 345678999999999999999999999999
Q ss_pred CCceeEEEeccCCCCHhhhhhCCCCC-----CCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCC
Q 005102 471 VDEKLLIYDYIPNGSLATALHGKPGM-----VSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNM 545 (714)
Q Consensus 471 ~~~~~lV~e~~~~gsL~~~l~~~~~~-----~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~ 545 (714)
.+..++||||+++++|.+++...... .....+++..+..++.|++.||+|||+ .+|+||||||+||++++++
T Consensus 91 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~---~~i~H~dlkp~Nili~~~~ 167 (296)
T cd05051 91 DPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLES---LNFVHRDLATRNCLVGKNY 167 (296)
T ss_pred CCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHH---cCccccccchhceeecCCC
Confidence 99999999999999999999765311 011368999999999999999999999 8999999999999999999
Q ss_pred CeEEcccchhhhhhccCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHH
Q 005102 546 EPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVI 625 (714)
Q Consensus 546 ~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvv 625 (714)
.++|+|||+++....... ........++..|+|||++.+..++.++|||||||+
T Consensus 168 ~~~l~dfg~~~~~~~~~~--------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~ 221 (296)
T cd05051 168 TIKIADFGMSRNLYSSDY--------------------------YRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVT 221 (296)
T ss_pred ceEEccccceeecccCcc--------------------------eeecCcCCCCceecCHHHhhcCCCCccchhhhhHHH
Confidence 999999999875432110 011122334677999999988889999999999999
Q ss_pred HHHHHh--CCCccccCCCCcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHH
Q 005102 626 LLEMIT--GRTAVVQVGSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHIS 703 (714)
Q Consensus 626 l~ellt--G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl 703 (714)
+|||++ |..||.... ..+.............. ....+. . .....++.+++.+||+.||++|||+.||+
T Consensus 222 l~el~~~~~~~p~~~~~--~~~~~~~~~~~~~~~~~--~~~~~~-~-----~~~~~~l~~li~~cl~~~p~~Rpt~~el~ 291 (296)
T cd05051 222 LWEILTLCREQPYEHLT--DQQVIENAGHFFRDDGR--QIYLPR-P-----PNCPKDIYELMLECWRRDEEDRPTFREIH 291 (296)
T ss_pred HHHHHhcCCCCCCCCcC--hHHHHHHHHhccccccc--cccCCC-c-----cCCCHHHHHHHHHHhccChhcCCCHHHHH
Confidence 999998 667773221 12222222111111110 000000 0 11224688999999999999999999999
Q ss_pred HHHhh
Q 005102 704 DALDR 708 (714)
Q Consensus 704 ~~L~~ 708 (714)
+.|++
T Consensus 292 ~~L~~ 296 (296)
T cd05051 292 LFLQR 296 (296)
T ss_pred HHhcC
Confidence 98863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-37 Score=317.08 Aligned_cols=255 Identities=24% Similarity=0.383 Sum_probs=198.2
Q ss_pred cccccccCceEEEEEEECC------CcEEEEEEeCCCCc-hhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEec
Q 005102 408 AFVLGKSGIGIVYKVVLED------GHTLAVRRLGEGGS-QRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDY 480 (714)
Q Consensus 408 ~~~lG~G~~g~Vy~~~~~~------g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~ 480 (714)
...||+|+||.||+|...+ +..||+|.+..... .....+.+|+.+++.++||||+++++++......++||||
T Consensus 11 ~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 90 (277)
T cd05032 11 IRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPTLVVMEL 90 (277)
T ss_pred EeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCcEEEEec
Confidence 3579999999999998753 36899999876532 3345788999999999999999999999999999999999
Q ss_pred cCCCCHhhhhhCCCCCC----CcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhh
Q 005102 481 IPNGSLATALHGKPGMV----SFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLAR 556 (714)
Q Consensus 481 ~~~gsL~~~l~~~~~~~----~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~ 556 (714)
+++|+|.+++....... ....++|..+.+++.|++.||.|||+ .+|+||||||+||++++++.+||+|||+++
T Consensus 91 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~di~p~nill~~~~~~kl~dfg~~~ 167 (277)
T cd05032 91 MAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAA---KKFVHRDLAARNCMVAEDLTVKIGDFGMTR 167 (277)
T ss_pred CCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHh---CCccccccChheEEEcCCCCEEECCcccch
Confidence 99999999987543211 11347899999999999999999999 899999999999999999999999999987
Q ss_pred hhhccCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHh-CCCc
Q 005102 557 LANIAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMIT-GRTA 635 (714)
Q Consensus 557 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~ellt-G~~p 635 (714)
....... ........++..|+|||.+.+..++.++|||||||++||++| |+.|
T Consensus 168 ~~~~~~~--------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p 221 (277)
T cd05032 168 DIYETDY--------------------------YRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQP 221 (277)
T ss_pred hhccCcc--------------------------cccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCC
Confidence 6532210 001112234667999999988889999999999999999998 8888
Q ss_pred cccCCCCcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhh
Q 005102 636 VVQVGSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDALDR 708 (714)
Q Consensus 636 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~ 708 (714)
|... .......+. . .... +..... ...++.+++.+||+.+|++|||+.++++.|++
T Consensus 222 ~~~~--~~~~~~~~~---~-~~~~------~~~~~~-----~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 277 (277)
T cd05032 222 YQGL--SNEEVLKFV---I-DGGH------LDLPEN-----CPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277 (277)
T ss_pred CccC--CHHHHHHHH---h-cCCC------CCCCCC-----CCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence 8432 112222211 1 1110 011111 13468899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=331.06 Aligned_cols=220 Identities=22% Similarity=0.307 Sum_probs=170.8
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeCCCC---chhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCC
Q 005102 409 FVLGKSGIGIVYKVVLE-DGHTLAVRRLGEGG---SQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNG 484 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~g 484 (714)
+.||+|+||+||+|... +++.||||++.+.. ......+.+|+.++.+++||||+++++++.+.+..|+||||+++|
T Consensus 7 ~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~E~~~gg 86 (363)
T cd05628 7 KVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIMEFLPGG 86 (363)
T ss_pred EEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEEcCCCCC
Confidence 47999999999999876 48999999997532 223356888999999999999999999999999999999999999
Q ss_pred CHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCC
Q 005102 485 SLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGS 564 (714)
Q Consensus 485 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 564 (714)
+|.+++... ..+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++........
T Consensus 87 ~L~~~l~~~------~~l~~~~~~~~~~qi~~aL~~lH~---~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~ 157 (363)
T cd05628 87 DMMTLLMKK------DTLTEEETQFYIAETVLAIDSIHQ---LGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRT 157 (363)
T ss_pred cHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHh---CCeEecCCCHHHeEECCCCCEEEeeccCcccccccccc
Confidence 999999765 458999999999999999999999 89999999999999999999999999999865422110
Q ss_pred CCccC--CCCCCCC-----chhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCccc
Q 005102 565 PTLQS--NRMPAEK-----PQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVV 637 (714)
Q Consensus 565 ~~~~~--~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~~ 637 (714)
..... ...+... .....................||+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~ 237 (363)
T cd05628 158 EFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFC 237 (363)
T ss_pred cccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCC
Confidence 00000 0000000 0000000000000111234578999999999999999999999999999999999999994
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-37 Score=314.37 Aligned_cols=253 Identities=27% Similarity=0.468 Sum_probs=198.1
Q ss_pred cccccccCceEEEEEEEC----CCcEEEEEEeCCCC-chhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccC
Q 005102 408 AFVLGKSGIGIVYKVVLE----DGHTLAVRRLGEGG-SQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIP 482 (714)
Q Consensus 408 ~~~lG~G~~g~Vy~~~~~----~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~ 482 (714)
.+.||+|+||.||+|... .+..+|+|.++... ....+.|.+|+.++++++||||+++++++...+..++||||++
T Consensus 9 ~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 88 (267)
T cd05066 9 EKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYME 88 (267)
T ss_pred eeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEEcCC
Confidence 357999999999999864 23479999987643 2334678999999999999999999999999999999999999
Q ss_pred CCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccC
Q 005102 483 NGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAG 562 (714)
Q Consensus 483 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 562 (714)
+++|.+++.... ..+++.++.+|+.|++.||+|||+ .+++||||||+||+++.++.+||+|||+++......
T Consensus 89 ~~~L~~~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lH~---~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd05066 89 NGSLDAFLRKHD-----GQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP 160 (267)
T ss_pred CCCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHH---CCEeehhhchhcEEECCCCeEEeCCCCccccccccc
Confidence 999999997653 358999999999999999999999 899999999999999999999999999998654211
Q ss_pred CCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHh-CCCccccCCC
Q 005102 563 GSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMIT-GRTAVVQVGS 641 (714)
Q Consensus 563 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~ellt-G~~p~~~~~~ 641 (714)
.. ........++..|+|||++.+..++.++||||||+++||+++ |+.||.....
T Consensus 161 ~~-------------------------~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~ 215 (267)
T cd05066 161 EA-------------------------AYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSN 215 (267)
T ss_pred ce-------------------------eeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCH
Confidence 00 000111222456999999998889999999999999999887 9999853321
Q ss_pred CcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhhhh
Q 005102 642 SEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDALDRLI 710 (714)
Q Consensus 642 ~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~ 710 (714)
.+....+ .+.... + ... .....+.+++.+||+.+|++||++.++++.|++++
T Consensus 216 --~~~~~~~----~~~~~~-----~-~~~-----~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~ 267 (267)
T cd05066 216 --QDVIKAI----EEGYRL-----P-APM-----DCPAALHQLMLDCWQKDRNERPKFEQIVSILDKLI 267 (267)
T ss_pred --HHHHHHH----hCCCcC-----C-CCC-----CCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhhC
Confidence 1121111 111110 0 000 12236789999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-37 Score=325.94 Aligned_cols=260 Identities=25% Similarity=0.357 Sum_probs=197.2
Q ss_pred cccccccCceEEEEEEE------CCCcEEEEEEeCCCC-chhHHHHHHHHHHHhcc-CCCCccceEEEEEeC-CceeEEE
Q 005102 408 AFVLGKSGIGIVYKVVL------EDGHTLAVRRLGEGG-SQRFKEFQTEVEAIGKI-RHSNIVTLRAYYWSV-DEKLLIY 478 (714)
Q Consensus 408 ~~~lG~G~~g~Vy~~~~------~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~-~~~~lV~ 478 (714)
.+.||+|+||.||+|.+ .+++.||||+++... ......+.+|++++.++ +||||+++++++... ...++||
T Consensus 12 ~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~lv~ 91 (343)
T cd05103 12 GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIV 91 (343)
T ss_pred cccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCceEEEE
Confidence 45899999999999974 347899999997643 23346788999999999 689999999988654 4578999
Q ss_pred eccCCCCHhhhhhCCCCCC-------------------------------------------------------------
Q 005102 479 DYIPNGSLATALHGKPGMV------------------------------------------------------------- 497 (714)
Q Consensus 479 e~~~~gsL~~~l~~~~~~~------------------------------------------------------------- 497 (714)
||+++|+|.+++.......
T Consensus 92 ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (343)
T cd05103 92 EFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAEQEDL 171 (343)
T ss_pred eccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhhhhhhh
Confidence 9999999999986532100
Q ss_pred CcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCCCCccCCCCCCCCc
Q 005102 498 SFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKP 577 (714)
Q Consensus 498 ~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~ 577 (714)
....+++.++.+++.|++.||+|||+ ++|+||||||+||++++++.+||+|||+++.......
T Consensus 172 ~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~-------------- 234 (343)
T cd05103 172 YKKVLTLEDLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPD-------------- 234 (343)
T ss_pred hhccCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCccCeEEEcCCCcEEEEecccccccccCcc--------------
Confidence 01247888999999999999999999 8999999999999999999999999999876422110
Q ss_pred hhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHh-CCCccccCCCCcchhHHHHHHHHhh
Q 005102 578 QERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMIT-GRTAVVQVGSSEMDLVNWMQLCIEE 656 (714)
Q Consensus 578 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~ 656 (714)
........++..|+|||.+.+..++.++||||||+++|||++ |..||....... .. . .....
T Consensus 235 ------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-~~---~-~~~~~ 297 (343)
T cd05103 235 ------------YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE-EF---C-RRLKE 297 (343)
T ss_pred ------------hhhcCCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccH-HH---H-HHHhc
Confidence 001112234567999999988889999999999999999997 898984332211 11 1 11111
Q ss_pred cCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhhhhcc
Q 005102 657 KKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDALDRLIVS 712 (714)
Q Consensus 657 ~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~~ 712 (714)
... .... .. ...++.+++.+||+.||++|||+.||++.|+.+...
T Consensus 298 ~~~------~~~~-~~----~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~~ 342 (343)
T cd05103 298 GTR------MRAP-DY----TTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 342 (343)
T ss_pred cCC------CCCC-CC----CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 111 0001 01 112578999999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=316.63 Aligned_cols=239 Identities=21% Similarity=0.321 Sum_probs=186.8
Q ss_pred cccccCceEEEEEEECC--------CcEEEEEEeCCCCchhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEecc
Q 005102 410 VLGKSGIGIVYKVVLED--------GHTLAVRRLGEGGSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYI 481 (714)
Q Consensus 410 ~lG~G~~g~Vy~~~~~~--------g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~ 481 (714)
.||+|+||.||+|.... ...||+|.+........+.+..|+.+++.++||||+++++++...+..++||||+
T Consensus 2 ~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~ 81 (258)
T cd05078 2 SLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEYV 81 (258)
T ss_pred CCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEecC
Confidence 69999999999998643 2348888887655555567899999999999999999999999999999999999
Q ss_pred CCCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCC--------eEEcccc
Q 005102 482 PNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNME--------PHVSDFG 553 (714)
Q Consensus 482 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~--------~kl~DFG 553 (714)
++|+|.++++... ..+++..+++++.||+.||+|||+ ++|+||||||+||+++.++. +|++|||
T Consensus 82 ~~g~L~~~l~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~---~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g 153 (258)
T cd05078 82 KFGSLDTYLKKNK-----NLINISWKLEVAKQLAWALHFLED---KGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPG 153 (258)
T ss_pred CCCcHHHHHhcCC-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCccceEEEecccccccCCCceEEecccc
Confidence 9999999997653 358899999999999999999999 89999999999999987765 5899999
Q ss_pred hhhhhhccCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCC-CCCchhhhHHHHHHHHHHHhC
Q 005102 554 LARLANIAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVV-KPSQKWDIYSYGVILLEMITG 632 (714)
Q Consensus 554 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DVwS~Gvvl~elltG 632 (714)
++..... .....++..|+|||++.+. .++.++|||||||++|||++|
T Consensus 154 ~~~~~~~--------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g 201 (258)
T cd05078 154 ISITVLP--------------------------------KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSG 201 (258)
T ss_pred cccccCC--------------------------------chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcC
Confidence 8754321 1112346779999999864 579999999999999999999
Q ss_pred C-CccccCCCCcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHh
Q 005102 633 R-TAVVQVGSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDALD 707 (714)
Q Consensus 633 ~-~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~ 707 (714)
. .|+..... ..... ...... .++.. ...++.+++.+||+.||++|||++++++.|+
T Consensus 202 ~~~~~~~~~~-----~~~~~-~~~~~~--------~~~~~-----~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 202 GDKPLSALDS-----QKKLQ-FYEDRH--------QLPAP-----KWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred CCCChhhccH-----HHHHH-HHHccc--------cCCCC-----CcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 5 45422111 11111 111111 11111 1235789999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=334.37 Aligned_cols=272 Identities=22% Similarity=0.269 Sum_probs=198.5
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeCCCC---chhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCC
Q 005102 409 FVLGKSGIGIVYKVVLE-DGHTLAVRRLGEGG---SQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNG 484 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~g 484 (714)
+.||+|+||.||+|+.. +|+.||||++.... ......+.+|++++..++||||+++++++.+.+..++||||+++|
T Consensus 7 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 86 (350)
T cd05573 7 KVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVMEYMPGG 86 (350)
T ss_pred EEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEEcCCCCC
Confidence 47999999999999986 58999999997542 233467889999999999999999999999999999999999999
Q ss_pred CHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCC
Q 005102 485 SLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGS 564 (714)
Q Consensus 485 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 564 (714)
+|.+++... ..+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++........
T Consensus 87 ~L~~~l~~~------~~l~~~~~~~i~~qi~~aL~~LH~---~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~ 157 (350)
T cd05573 87 DLMNLLIRK------DVFPEETARFYIAELVLALDSVHK---LGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDR 157 (350)
T ss_pred CHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCcc
Confidence 999999765 358899999999999999999999 89999999999999999999999999999866433211
Q ss_pred CCccCCCCCCCCchhhhcc-cccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCccccCCCCc
Q 005102 565 PTLQSNRMPAEKPQERQQK-SVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGSSE 643 (714)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~~~~~~~~ 643 (714)
................... ..............||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~-- 235 (350)
T cd05573 158 EYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTL-- 235 (350)
T ss_pred cccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCH--
Confidence 0000000000000000000 0000001122345689999999999999999999999999999999999999954321
Q ss_pred chhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCC-HHHHHH
Q 005102 644 MDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPT-MRHISD 704 (714)
Q Consensus 644 ~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt-~~evl~ 704 (714)
............. ..-|. .. .....+.+++.+|+. ||.+||+ ++++++
T Consensus 236 ---~~~~~~i~~~~~~---~~~p~---~~---~~~~~~~~li~~ll~-dp~~R~~s~~~ll~ 284 (350)
T cd05573 236 ---QETYNKIINWKES---LRFPP---DP---PVSPEAIDLICRLLC-DPEDRLGSFEEIKS 284 (350)
T ss_pred ---HHHHHHHhccCCc---ccCCC---CC---CCCHHHHHHHHHHcc-ChhhcCCCHHHHhc
Confidence 1111111111000 00010 00 022357889999997 9999999 999986
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-37 Score=312.61 Aligned_cols=244 Identities=23% Similarity=0.335 Sum_probs=196.0
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeCCC--CchhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCCC
Q 005102 409 FVLGKSGIGIVYKVVLE-DGHTLAVRRLGEG--GSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGS 485 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gs 485 (714)
+.||+|++|.||+|..+ +++.|++|.+... .....+.+.+|++++++++||||+++++++...+..++||||+++++
T Consensus 6 ~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 85 (256)
T cd08529 6 NKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEYAENGD 85 (256)
T ss_pred EEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEeCCCCc
Confidence 47999999999999975 5899999998653 33445678999999999999999999999999999999999999999
Q ss_pred HhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCCC
Q 005102 486 LATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSP 565 (714)
Q Consensus 486 L~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 565 (714)
|.+++..... ..+++..+.+++.|++.||.|||+ .+++|+||||+||++++++.+||+|||+++......
T Consensus 86 L~~~l~~~~~----~~~~~~~~~~i~~~l~~al~~lH~---~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~--- 155 (256)
T cd08529 86 LHKLLKMQRG----RPLPEDQVWRFFIQILLGLAHLHS---KKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT--- 155 (256)
T ss_pred HHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEEeCCCCEEEcccccceeccCcc---
Confidence 9999976532 458899999999999999999999 899999999999999999999999999987653211
Q ss_pred CccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCccccCCCCcch
Q 005102 566 TLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGSSEMD 645 (714)
Q Consensus 566 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~~~~~~~~~~ 645 (714)
.......|+..|+|||+..+..++.++||||||+++|||++|+.||.... ...
T Consensus 156 -------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~--~~~ 208 (256)
T cd08529 156 -------------------------NFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANN--QGA 208 (256)
T ss_pred -------------------------chhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCC--HHH
Confidence 01112235678999999998889999999999999999999999994322 111
Q ss_pred hHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 005102 646 LVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISD 704 (714)
Q Consensus 646 l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 704 (714)
.......... +.... .....+.+++.+||+.+|++||++.++++
T Consensus 209 ---~~~~~~~~~~-------~~~~~-----~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 252 (256)
T cd08529 209 ---LILKIIRGVF-------PPVSQ-----MYSQQLAQLIDQCLTKDYRQRPDTFQLLR 252 (256)
T ss_pred ---HHHHHHcCCC-------CCCcc-----ccCHHHHHHHHHHccCCcccCcCHHHHhh
Confidence 1111111110 11110 12336889999999999999999999875
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=313.13 Aligned_cols=254 Identities=19% Similarity=0.287 Sum_probs=188.9
Q ss_pred cccccCceEEEEEEECCC---cEEEEEEeCCCC-chhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCCC
Q 005102 410 VLGKSGIGIVYKVVLEDG---HTLAVRRLGEGG-SQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGS 485 (714)
Q Consensus 410 ~lG~G~~g~Vy~~~~~~g---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gs 485 (714)
.||+|+||.||++...++ ..+++|.+.... ....+.|.+|+.+++.++||||++++++|......++||||+++|+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 81 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD 81 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence 599999999999986543 356677766543 2345689999999999999999999999999999999999999999
Q ss_pred HhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCCC
Q 005102 486 LATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSP 565 (714)
Q Consensus 486 L~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 565 (714)
|.++++..... ....++..+..++.||+.||+|||+ .+++||||||+|||++.++.+||+|||++........
T Consensus 82 L~~~l~~~~~~--~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~-- 154 (268)
T cd05086 82 LKSYLSQEQWH--RRNSQLLLLQRMACEIAAGVTHMHK---HNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDY-- 154 (268)
T ss_pred HHHHHHhhhcc--cccccHHHHHHHHHHHHHHHHHHHH---CCeeccCCccceEEEcCCccEEecccccccccCcchh--
Confidence 99999764321 1346777888999999999999999 8999999999999999999999999998753211000
Q ss_pred CccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCC-------CCCCchhhhHHHHHHHHHHHh-CCCccc
Q 005102 566 TLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKV-------VKPSQKWDIYSYGVILLEMIT-GRTAVV 637 (714)
Q Consensus 566 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~s~~~DVwS~Gvvl~ellt-G~~p~~ 637 (714)
........++..|+|||++.. ..++.++|||||||++|||++ |..||.
T Consensus 155 ------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~ 210 (268)
T cd05086 155 ------------------------IETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYS 210 (268)
T ss_pred ------------------------hhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCC
Confidence 011122345778999999743 245789999999999999997 466773
Q ss_pred cCCCCcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHh
Q 005102 638 QVGSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDALD 707 (714)
Q Consensus 638 ~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~ 707 (714)
... . .+.+........ ....++.+..... ..+.+++..|| .+|++||++++|++.|.
T Consensus 211 ~~~--~---~~~~~~~~~~~~--~~~~~~~~~~~~~-----~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 211 HLS--D---REVLNHVIKDQQ--VKLFKPQLELPYS-----ERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred CCC--H---HHHHHHHHhhcc--cccCCCccCCCCc-----HHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 221 1 122222222221 2233444333222 35778999999 67999999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=310.68 Aligned_cols=244 Identities=27% Similarity=0.449 Sum_probs=197.8
Q ss_pred ccccccCceEEEEEEECCCcEEEEEEeCCCCchhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCCCHhh
Q 005102 409 FVLGKSGIGIVYKVVLEDGHTLAVRRLGEGGSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGSLAT 488 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL~~ 488 (714)
+.||+|+||.||+|... |+.||+|.+..... ..+++.+|+.++++++|+||+++++++...+..++||||+++++|.+
T Consensus 12 ~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~ 89 (256)
T cd05039 12 ATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVD 89 (256)
T ss_pred eeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecCCCcHHH
Confidence 47999999999999985 88999999987644 45789999999999999999999999998889999999999999999
Q ss_pred hhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCCCCcc
Q 005102 489 ALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQ 568 (714)
Q Consensus 489 ~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 568 (714)
++..... ..+++..+..++.|++.||.|||+ ++++||||||+||++++++.+||+|||.++......
T Consensus 90 ~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lh~---~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~------ 156 (256)
T cd05039 90 YLRSRGR----AVITLAQQLGFALDVCEGMEYLEE---KNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ------ 156 (256)
T ss_pred HHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHh---CCccchhcccceEEEeCCCCEEEccccccccccccc------
Confidence 9976532 358999999999999999999999 899999999999999999999999999987653210
Q ss_pred CCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHh-CCCccccCCCCcchhH
Q 005102 569 SNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMIT-GRTAVVQVGSSEMDLV 647 (714)
Q Consensus 569 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~ellt-G~~p~~~~~~~~~~l~ 647 (714)
....++..|+|||++.+..++.++||||||+++|||++ |+.||.... ..++.
T Consensus 157 -------------------------~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~--~~~~~ 209 (256)
T cd05039 157 -------------------------DSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP--LKDVV 209 (256)
T ss_pred -------------------------ccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCC--HHHHH
Confidence 01112456999999988889999999999999999997 999984321 11111
Q ss_pred HHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhhh
Q 005102 648 NWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDALDRL 709 (714)
Q Consensus 648 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i 709 (714)
. ....... +.... .....+.+++.+||..+|++|||++|++++|+++
T Consensus 210 ~----~~~~~~~------~~~~~-----~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 256 (256)
T cd05039 210 P----HVEKGYR------MEAPE-----GCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI 256 (256)
T ss_pred H----HHhcCCC------CCCcc-----CCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence 1 1111111 00111 1124688999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-37 Score=318.00 Aligned_cols=245 Identities=20% Similarity=0.311 Sum_probs=193.5
Q ss_pred ccccccCceEEEEEEECC-CcEEEEEEeCCCCchhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCCCHh
Q 005102 409 FVLGKSGIGIVYKVVLED-GHTLAVRRLGEGGSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGSLA 487 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL~ 487 (714)
..||+|+||.||+|.... +..+|+|.+........+.+.+|+++++.++||||+++++++...+..++||||+++++|.
T Consensus 11 ~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~~~l~ 90 (282)
T cd06643 11 GELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVD 90 (282)
T ss_pred hhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCCCcHH
Confidence 469999999999999864 7888999987766666678999999999999999999999999999999999999999999
Q ss_pred hhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCCCCc
Q 005102 488 TALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTL 567 (714)
Q Consensus 488 ~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 567 (714)
.++.... ..+++..+..++.|++.||+|||+ .+++||||||+||+++.++.+||+|||+++......
T Consensus 91 ~~~~~~~-----~~l~~~~~~~~~~qi~~~L~~LH~---~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~----- 157 (282)
T cd06643 91 AVMLELE-----RPLTEPQIRVVCKQTLEALNYLHE---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI----- 157 (282)
T ss_pred HHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCcccEEEccCCCEEEccccccccccccc-----
Confidence 9886532 458999999999999999999999 899999999999999999999999999986542110
Q ss_pred cCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccC-----CCCCCchhhhHHHHHHHHHHHhCCCccccCCCC
Q 005102 568 QSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLK-----VVKPSQKWDIYSYGVILLEMITGRTAVVQVGSS 642 (714)
Q Consensus 568 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~~DVwS~Gvvl~elltG~~p~~~~~~~ 642 (714)
.......++..|+|||++. +..++.++|||||||++|||++|+.||.....
T Consensus 158 -----------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~- 213 (282)
T cd06643 158 -----------------------QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNP- 213 (282)
T ss_pred -----------------------cccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCH-
Confidence 0112234678899999984 45578899999999999999999999843211
Q ss_pred cchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 005102 643 EMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISD 704 (714)
Q Consensus 643 ~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 704 (714)
.+.+........ .....+ ......+.+++.+||+.||++|||+.++++
T Consensus 214 ----~~~~~~~~~~~~--~~~~~~--------~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 261 (282)
T cd06643 214 ----MRVLLKIAKSEP--PTLAQP--------SRWSSEFKDFLKKCLEKNVDARWTTTQLLQ 261 (282)
T ss_pred ----HHHHHHHhhcCC--CCCCCc--------cccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 111111111111 011111 011236789999999999999999999874
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=315.77 Aligned_cols=259 Identities=20% Similarity=0.294 Sum_probs=201.0
Q ss_pred cccccccCceEEEEEEECC-----CcEEEEEEeCCCC-chhHHHHHHHHHHHhccCCCCccceEEEEEe-CCceeEEEec
Q 005102 408 AFVLGKSGIGIVYKVVLED-----GHTLAVRRLGEGG-SQRFKEFQTEVEAIGKIRHSNIVTLRAYYWS-VDEKLLIYDY 480 (714)
Q Consensus 408 ~~~lG~G~~g~Vy~~~~~~-----g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~-~~~~~lV~e~ 480 (714)
.++||+|+||.||+|.+.+ +..|++|++.... ....+.+.+|+.++++++||||+++++++.. ....++++||
T Consensus 11 ~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~~ 90 (280)
T cd05043 11 SDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPPFVLYPY 90 (280)
T ss_pred eeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCCEEEEEc
Confidence 3589999999999999866 6889999987543 3345678899999999999999999999876 4678999999
Q ss_pred cCCCCHhhhhhCCCCC--CCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhh
Q 005102 481 IPNGSLATALHGKPGM--VSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLA 558 (714)
Q Consensus 481 ~~~gsL~~~l~~~~~~--~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~ 558 (714)
+++|+|.+++...... .....+++.++..++.|++.||+|||+ .+++||||||+||++++++.+||+|||+++.+
T Consensus 91 ~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~---~~i~H~di~p~nil~~~~~~~kl~d~g~~~~~ 167 (280)
T cd05043 91 MNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHK---RGVIHKDIAARNCVIDEELQVKITDNALSRDL 167 (280)
T ss_pred CCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccCHhhEEEcCCCcEEECCCCCcccc
Confidence 9999999998654211 011358999999999999999999999 89999999999999999999999999999754
Q ss_pred hccCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHh-CCCccc
Q 005102 559 NIAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMIT-GRTAVV 637 (714)
Q Consensus 559 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~ellt-G~~p~~ 637 (714)
..... ........++..|+|||++.+..++.++||||||+++||+++ |+.||.
T Consensus 168 ~~~~~--------------------------~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~ 221 (280)
T cd05043 168 FPMDY--------------------------HCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYV 221 (280)
T ss_pred cCCce--------------------------EEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcC
Confidence 32110 000111234567999999988889999999999999999999 999994
Q ss_pred cCCCCcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhhhhcc
Q 005102 638 QVGSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDALDRLIVS 712 (714)
Q Consensus 638 ~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~~ 712 (714)
.. ...++..++ ....... ... ....++.+++.+||..||++|||+.++++.|+.+...
T Consensus 222 ~~--~~~~~~~~~----~~~~~~~------~~~-----~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~ 279 (280)
T cd05043 222 EI--DPFEMAAYL----KDGYRLA------QPI-----NCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHAQ 279 (280)
T ss_pred cC--CHHHHHHHH----HcCCCCC------CCC-----cCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhc
Confidence 32 112222221 1111110 000 1123688999999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=317.92 Aligned_cols=261 Identities=23% Similarity=0.340 Sum_probs=195.4
Q ss_pred ccccccCceEEEEEEEC-----------------CCcEEEEEEeCCCC-chhHHHHHHHHHHHhccCCCCccceEEEEEe
Q 005102 409 FVLGKSGIGIVYKVVLE-----------------DGHTLAVRRLGEGG-SQRFKEFQTEVEAIGKIRHSNIVTLRAYYWS 470 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~-----------------~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~ 470 (714)
+.||+|+||.||++... ++..||+|++.... ....++|.+|++++++++|+||+++++++..
T Consensus 11 ~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~ 90 (296)
T cd05095 11 EKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCIT 90 (296)
T ss_pred eeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec
Confidence 47999999999998643 23478999997653 3344679999999999999999999999999
Q ss_pred CCceeEEEeccCCCCHhhhhhCCCCC-----CCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCC
Q 005102 471 VDEKLLIYDYIPNGSLATALHGKPGM-----VSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNM 545 (714)
Q Consensus 471 ~~~~~lV~e~~~~gsL~~~l~~~~~~-----~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~ 545 (714)
.+..++||||+++|+|.+++...... .....+++.++.+++.|++.||+|||+ .+++||||||+||++++++
T Consensus 91 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dlkp~Nili~~~~ 167 (296)
T cd05095 91 SDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSS---LNFVHRDLATRNCLVGKNY 167 (296)
T ss_pred CCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHH---CCeecccCChheEEEcCCC
Confidence 99999999999999999998754321 111347889999999999999999999 8999999999999999999
Q ss_pred CeEEcccchhhhhhccCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHH
Q 005102 546 EPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVI 625 (714)
Q Consensus 546 ~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvv 625 (714)
.+||+|||+++.+..... ........++..|+|||...++.++.++|||||||+
T Consensus 168 ~~~l~dfg~~~~~~~~~~--------------------------~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~ 221 (296)
T cd05095 168 TIKIADFGMSRNLYSGDY--------------------------YRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVT 221 (296)
T ss_pred CEEeccCcccccccCCcc--------------------------eeccCcCcCccccCCHHHHhcCCccchhhhhHHHHH
Confidence 999999999875432110 000111223466999999888889999999999999
Q ss_pred HHHHHh--CCCccccCCCCcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHH
Q 005102 626 LLEMIT--GRTAVVQVGSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHIS 703 (714)
Q Consensus 626 l~ellt--G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl 703 (714)
+|||++ |..||.... ..+............. .....+.. ......+.+++.+||+.||++|||+.+|.
T Consensus 222 l~el~~~~~~~p~~~~~--~~~~~~~~~~~~~~~~--~~~~~~~~------~~~~~~~~~li~~cl~~~p~~Rp~~~~i~ 291 (296)
T cd05095 222 LWEILTLCKEQPYSQLS--DEQVIENTGEFFRDQG--RQVYLPKP------ALCPDSLYKLMLSCWRRNAKERPSFQEIH 291 (296)
T ss_pred HHHHHHhCCCCCccccC--hHHHHHHHHHHHhhcc--ccccCCCC------CCCCHHHHHHHHHHcCCCcccCCCHHHHH
Confidence 999998 667774321 1111111111111110 00001100 01224688999999999999999999999
Q ss_pred HHHhh
Q 005102 704 DALDR 708 (714)
Q Consensus 704 ~~L~~ 708 (714)
+.|++
T Consensus 292 ~~l~~ 296 (296)
T cd05095 292 ATLLE 296 (296)
T ss_pred HHHhC
Confidence 99874
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=311.35 Aligned_cols=252 Identities=28% Similarity=0.404 Sum_probs=199.5
Q ss_pred cccccCceEEEEEEECC----CcEEEEEEeCCCCchh-HHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCC
Q 005102 410 VLGKSGIGIVYKVVLED----GHTLAVRRLGEGGSQR-FKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNG 484 (714)
Q Consensus 410 ~lG~G~~g~Vy~~~~~~----g~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~g 484 (714)
.||+|+||.||+|.... +..||+|.+....... .+.+.+|++.+.+++|+||+++++++......++||||++++
T Consensus 2 ~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 81 (262)
T cd00192 2 KLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEGG 81 (262)
T ss_pred ccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccCC
Confidence 69999999999999764 7899999998764433 578999999999999999999999999989999999999999
Q ss_pred CHhhhhhCCCCC---CCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhcc
Q 005102 485 SLATALHGKPGM---VSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIA 561 (714)
Q Consensus 485 sL~~~l~~~~~~---~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 561 (714)
+|.+++...... .....+++.++.+++.|++.||+|||+ ++++||||||+||++++++.+||+|||.++.....
T Consensus 82 ~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~ 158 (262)
T cd00192 82 DLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDD 158 (262)
T ss_pred cHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHc---CCcccCccCcceEEECCCCcEEEcccccccccccc
Confidence 999999765210 001458999999999999999999999 89999999999999999999999999999865432
Q ss_pred CCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHh-CCCccccCC
Q 005102 562 GGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMIT-GRTAVVQVG 640 (714)
Q Consensus 562 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~ellt-G~~p~~~~~ 640 (714)
.. ........++..|+|||.+....++.++||||+|+++|||++ |+.||....
T Consensus 159 ~~--------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~ 212 (262)
T cd00192 159 DY--------------------------YRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLS 212 (262)
T ss_pred cc--------------------------cccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCC
Confidence 11 011122334677999999988889999999999999999999 699985431
Q ss_pred CCcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHh
Q 005102 641 SSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDALD 707 (714)
Q Consensus 641 ~~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~ 707 (714)
..++ ...... ... ..... ....++.+++.+||+.+|++|||+.|+++.|+
T Consensus 213 --~~~~---~~~~~~-~~~------~~~~~-----~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 213 --NEEV---LEYLRK-GYR------LPKPE-----YCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred --HHHH---HHHHHc-CCC------CCCCc-----cCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 1112 211111 110 00111 11346889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=315.73 Aligned_cols=243 Identities=23% Similarity=0.346 Sum_probs=190.9
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeCCCC-chhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCCCH
Q 005102 409 FVLGKSGIGIVYKVVLE-DGHTLAVRRLGEGG-SQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGSL 486 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL 486 (714)
++||+|+||.||+|... +++.||+|.+.... ....+.+.+|++++++++||||+++++++...+..++||||+++++|
T Consensus 7 ~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l 86 (279)
T cd06619 7 EILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFMDGGSL 86 (279)
T ss_pred eeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecCCCCCh
Confidence 47999999999999864 58899999987542 33346789999999999999999999999999999999999999998
Q ss_pred hhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCCCC
Q 005102 487 ATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPT 566 (714)
Q Consensus 487 ~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 566 (714)
..+. .+++..+..++.|++.||+|||+ .+|+|+||||+||+++.++.+||+|||++......
T Consensus 87 ~~~~----------~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~----- 148 (279)
T cd06619 87 DVYR----------KIPEHVLGRIAVAVVKGLTYLWS---LKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS----- 148 (279)
T ss_pred HHhh----------cCCHHHHHHHHHHHHHHHHHHHH---CCEeeCCCCHHHEEECCCCCEEEeeCCcceecccc-----
Confidence 6542 36788899999999999999999 89999999999999999999999999998754211
Q ss_pred ccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCccccCCCCcch-
Q 005102 567 LQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGSSEMD- 645 (714)
Q Consensus 567 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~~~~~~~~~~- 645 (714)
......||..|+|||++.+..++.++||||||+++|||++|+.||.........
T Consensus 149 -------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~ 203 (279)
T cd06619 149 -------------------------IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSL 203 (279)
T ss_pred -------------------------cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhccccccc
Confidence 112235678899999999889999999999999999999999999543221111
Q ss_pred -hHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 005102 646 -LVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDA 705 (714)
Q Consensus 646 -l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 705 (714)
...+........ .+..... ....++.+++.+||+.||++||+++|+++.
T Consensus 204 ~~~~~~~~~~~~~-------~~~~~~~----~~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 204 MPLQLLQCIVDED-------PPVLPVG----QFSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred chHHHHHHHhccC-------CCCCCCC----cCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 111111111111 1111111 122357899999999999999999998753
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-37 Score=312.60 Aligned_cols=237 Identities=24% Similarity=0.374 Sum_probs=187.5
Q ss_pred cccccCceEEEEEEECCCc-----------EEEEEEeCCCCchhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEE
Q 005102 410 VLGKSGIGIVYKVVLEDGH-----------TLAVRRLGEGGSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIY 478 (714)
Q Consensus 410 ~lG~G~~g~Vy~~~~~~g~-----------~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 478 (714)
.||+|+||.||+|.+.+.. .|++|.+...... ...|.+|+.++++++||||+++++++.. +..++||
T Consensus 2 ~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~ 79 (259)
T cd05037 2 HLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMVE 79 (259)
T ss_pred cccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEEE
Confidence 6899999999999986533 5788877654433 5789999999999999999999999988 7889999
Q ss_pred eccCCCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCC-------CeEEcc
Q 005102 479 DYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNM-------EPHVSD 551 (714)
Q Consensus 479 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~-------~~kl~D 551 (714)
||+++|+|.+++.... ..+++..++.++.|++.||+|||+ ++|+||||||+||+++.++ .+||+|
T Consensus 80 e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~D 151 (259)
T cd05037 80 EYVKFGPLDVFLHREK-----NNVSLHWKLDVAKQLASALHYLED---KKLVHGNVCGKNILVARYGLNEGYVPFIKLSD 151 (259)
T ss_pred EcCCCCcHHHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHhh---CCeecccCccceEEEecCccccCCceeEEeCC
Confidence 9999999999997653 258899999999999999999999 8999999999999999887 799999
Q ss_pred cchhhhhhccCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCC--CCCchhhhHHHHHHHHHH
Q 005102 552 FGLARLANIAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVV--KPSQKWDIYSYGVILLEM 629 (714)
Q Consensus 552 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~s~~~DVwS~Gvvl~el 629 (714)
||+++..... ....++..|+|||++.+. .++.++|||||||++|||
T Consensus 152 fg~a~~~~~~--------------------------------~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l 199 (259)
T cd05037 152 PGIPITVLSR--------------------------------EERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEI 199 (259)
T ss_pred CCcccccccc--------------------------------cccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHH
Confidence 9998754210 111234569999999876 789999999999999999
Q ss_pred Hh-CCCccccCCCCcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHh
Q 005102 630 IT-GRTAVVQVGSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDALD 707 (714)
Q Consensus 630 lt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~ 707 (714)
++ |..||..... .....+.. ... ..+... ...+.+++.+||..+|++|||+.++++.|+
T Consensus 200 ~~~~~~p~~~~~~--~~~~~~~~----~~~---------~~~~~~----~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 200 CSNGEEPLSTLSS--SEKERFYQ----DQH---------RLPMPD----CAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred HhCCCCCcccCCc--hhHHHHHh----cCC---------CCCCCC----chHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 99 5667743321 11111111 110 000111 146889999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=309.92 Aligned_cols=246 Identities=22% Similarity=0.396 Sum_probs=195.9
Q ss_pred ccccccCceEEEEEEECCCcEEEEEEeCCCCchhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCCCHhh
Q 005102 409 FVLGKSGIGIVYKVVLEDGHTLAVRRLGEGGSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGSLAT 488 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL~~ 488 (714)
+.||+|+||.||++.+.++..+|+|.+..... ...+|.+|++++++++||||+++++++......++||||+++++|.+
T Consensus 10 ~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~ 88 (256)
T cd05112 10 QEIGSGQFGLVWLGYWLEKRKVAIKTIREGAM-SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEHGCLSD 88 (256)
T ss_pred eeecCcccceEEEEEEeCCCeEEEEECCCCCC-CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCCCCcHHH
Confidence 47999999999999987788999999875433 23678999999999999999999999999999999999999999999
Q ss_pred hhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCCCCcc
Q 005102 489 ALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQ 568 (714)
Q Consensus 489 ~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 568 (714)
++.... ..+++..+..++.|++.||+|||+ .+++||||||+||+++.++.+||+|||+++......
T Consensus 89 ~~~~~~-----~~~~~~~~~~~~~~l~~~l~~lH~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~------ 154 (256)
T cd05112 89 YLRAQR-----GKFSQETLLGMCLDVCEGMAYLES---SNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQ------ 154 (256)
T ss_pred HHHhCc-----cCCCHHHHHHHHHHHHHHHHHHHH---CCccccccccceEEEcCCCeEEECCCcceeecccCc------
Confidence 987553 347899999999999999999999 899999999999999999999999999987542110
Q ss_pred CCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHh-CCCccccCCCCcchhH
Q 005102 569 SNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMIT-GRTAVVQVGSSEMDLV 647 (714)
Q Consensus 569 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~ellt-G~~p~~~~~~~~~~l~ 647 (714)
........++..|+|||.+.+..++.++||||||+++|||++ |+.||.... ..
T Consensus 155 ---------------------~~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~-----~~ 208 (256)
T cd05112 155 ---------------------YTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRS-----NS 208 (256)
T ss_pred ---------------------ccccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCC-----HH
Confidence 000111223567999999998889999999999999999998 999984321 11
Q ss_pred HHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHh
Q 005102 648 NWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDALD 707 (714)
Q Consensus 648 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~ 707 (714)
...... .... ....+.. ....+.+++.+||+.+|++|||+.|+++.|.
T Consensus 209 ~~~~~~-~~~~---~~~~~~~--------~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 209 EVVETI-NAGF---RLYKPRL--------ASQSVYELMQHCWKERPEDRPSFSLLLHQLA 256 (256)
T ss_pred HHHHHH-hCCC---CCCCCCC--------CCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence 122111 1111 1111111 1236889999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=315.59 Aligned_cols=254 Identities=23% Similarity=0.328 Sum_probs=194.9
Q ss_pred ccccccCceEEEEEEECC------CcEEEEEEeCCCCc-hhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEecc
Q 005102 409 FVLGKSGIGIVYKVVLED------GHTLAVRRLGEGGS-QRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYI 481 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~~------g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~ 481 (714)
+.||+|+||.||+|.+.+ +..||+|.+..... .....|.+|+.++++++|+||+++++++.+.+..++||||+
T Consensus 12 ~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 91 (277)
T cd05036 12 RALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPRFILLELM 91 (277)
T ss_pred eECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCcEEEEecC
Confidence 479999999999999753 56899998875433 33457999999999999999999999999999999999999
Q ss_pred CCCCHhhhhhCCCCC-CCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCC---CeEEcccchhhh
Q 005102 482 PNGSLATALHGKPGM-VSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNM---EPHVSDFGLARL 557 (714)
Q Consensus 482 ~~gsL~~~l~~~~~~-~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~---~~kl~DFGla~~ 557 (714)
++++|.+++...... .....+++.++++++.||+.||+|||+ ++++||||||+||+++.++ .+||+|||+++.
T Consensus 92 ~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~nil~~~~~~~~~~kl~dfg~~~~ 168 (277)
T cd05036 92 AGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEE---NHFIHRDIAARNCLLTCKGPGRVAKIADFGMARD 168 (277)
T ss_pred CCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccchheEEEeccCCCcceEeccCccccc
Confidence 999999999765321 111358999999999999999999999 8999999999999998754 599999999986
Q ss_pred hhccCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHh-CCCcc
Q 005102 558 ANIAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMIT-GRTAV 636 (714)
Q Consensus 558 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~ellt-G~~p~ 636 (714)
...... .........+..|+|||++.+..++.++|||||||++|||++ |+.||
T Consensus 169 ~~~~~~--------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf 222 (277)
T cd05036 169 IYRASY--------------------------YRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPY 222 (277)
T ss_pred cCCccc--------------------------eecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCC
Confidence 521110 000111122456999999998899999999999999999997 99998
Q ss_pred ccCCCCcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhh
Q 005102 637 VQVGSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDALDR 708 (714)
Q Consensus 637 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~ 708 (714)
..... ..+ +........ +..... ....+.+++.+||+.+|++|||+.+|++.|++
T Consensus 223 ~~~~~--~~~---~~~~~~~~~-------~~~~~~-----~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~~ 277 (277)
T cd05036 223 PGRTN--QEV---MEFVTGGGR-------LDPPKG-----CPGPVYRIMTDCWQHTPEDRPNFATILERIQY 277 (277)
T ss_pred CCCCH--HHH---HHHHHcCCc-------CCCCCC-----CCHHHHHHHHHHcCCCcccCcCHHHHHHHhhC
Confidence 43221 111 211111111 001111 12368899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-37 Score=320.12 Aligned_cols=254 Identities=25% Similarity=0.400 Sum_probs=195.1
Q ss_pred ccccccCceEEEEEEECC-Cc--EEEEEEeCCCC-chhHHHHHHHHHHHhcc-CCCCccceEEEEEeCCceeEEEeccCC
Q 005102 409 FVLGKSGIGIVYKVVLED-GH--TLAVRRLGEGG-SQRFKEFQTEVEAIGKI-RHSNIVTLRAYYWSVDEKLLIYDYIPN 483 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~~-g~--~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~e~~~~ 483 (714)
+.||+|+||.||+|.+++ +. .+|+|.+.... ......+.+|++++.++ +||||+++++++...+..++||||+++
T Consensus 13 ~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 92 (303)
T cd05088 13 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 92 (303)
T ss_pred eeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEEEEeCCC
Confidence 479999999999999753 54 46888776543 33446788999999999 899999999999999999999999999
Q ss_pred CCHhhhhhCCCCC----------CCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccc
Q 005102 484 GSLATALHGKPGM----------VSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFG 553 (714)
Q Consensus 484 gsL~~~l~~~~~~----------~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFG 553 (714)
|+|.++++..... .....+++.+++.++.|++.||+|||+ ++|+||||||+|||+++++.+||+|||
T Consensus 93 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~gi~H~dlkp~Nili~~~~~~kl~dfg 169 (303)
T cd05088 93 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFG 169 (303)
T ss_pred CcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHh---CCccccccchheEEecCCCcEEeCccc
Confidence 9999999754311 011358899999999999999999999 899999999999999999999999999
Q ss_pred hhhhhhccCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHh-C
Q 005102 554 LARLANIAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMIT-G 632 (714)
Q Consensus 554 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~ellt-G 632 (714)
+++..... .......++..|+|||++.+..++.++|||||||++|||+| |
T Consensus 170 ~~~~~~~~-----------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g 220 (303)
T cd05088 170 LSRGQEVY-----------------------------VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLG 220 (303)
T ss_pred cCcccchh-----------------------------hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcC
Confidence 98632110 00111122456999999988889999999999999999998 9
Q ss_pred CCccccCCCCcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhhhhc
Q 005102 633 RTAVVQVGSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDALDRLIV 711 (714)
Q Consensus 633 ~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~ 711 (714)
..||..... .+..... .... ...... .....+.+++.+||+.+|++||++++++..|+++..
T Consensus 221 ~~p~~~~~~-----~~~~~~~-~~~~------~~~~~~-----~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~ 282 (303)
T cd05088 221 GTPYCGMTC-----AELYEKL-PQGY------RLEKPL-----NCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 282 (303)
T ss_pred CCCcccCCh-----HHHHHHH-hcCC------cCCCCC-----CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 999843221 1111111 1110 000000 112357899999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=323.65 Aligned_cols=259 Identities=24% Similarity=0.359 Sum_probs=199.8
Q ss_pred cccccccCceEEEEEEECC--------CcEEEEEEeCCCC-chhHHHHHHHHHHHhcc-CCCCccceEEEEEeCCceeEE
Q 005102 408 AFVLGKSGIGIVYKVVLED--------GHTLAVRRLGEGG-SQRFKEFQTEVEAIGKI-RHSNIVTLRAYYWSVDEKLLI 477 (714)
Q Consensus 408 ~~~lG~G~~g~Vy~~~~~~--------g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV 477 (714)
...||+|+||.||+|.... +..||+|.+.... ....+++.+|+++++++ +||||++++++|...+..++|
T Consensus 17 ~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv 96 (334)
T cd05100 17 GKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVL 96 (334)
T ss_pred cceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCCceEEE
Confidence 4589999999999997531 2478999887543 33456789999999999 799999999999999999999
Q ss_pred EeccCCCCHhhhhhCCCCC----------CCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCe
Q 005102 478 YDYIPNGSLATALHGKPGM----------VSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEP 547 (714)
Q Consensus 478 ~e~~~~gsL~~~l~~~~~~----------~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~ 547 (714)
|||+++|+|.+++...... .....+++.++++++.|++.||+|||+ ++|+||||||+||++++++.+
T Consensus 97 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~givH~dlkp~Nill~~~~~~ 173 (334)
T cd05100 97 VEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLAS---QKCIHRDLAARNVLVTEDNVM 173 (334)
T ss_pred EecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH---CCeeccccccceEEEcCCCcE
Confidence 9999999999998754210 112458899999999999999999999 899999999999999999999
Q ss_pred EEcccchhhhhhccCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHH
Q 005102 548 HVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILL 627 (714)
Q Consensus 548 kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~ 627 (714)
||+|||+++....... ........++..|+|||++.+..++.++||||||+++|
T Consensus 174 kL~Dfg~~~~~~~~~~--------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ 227 (334)
T cd05100 174 KIADFGLARDVHNIDY--------------------------YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLW 227 (334)
T ss_pred EECCcccceecccccc--------------------------cccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHH
Confidence 9999999875432110 00111122345699999999889999999999999999
Q ss_pred HHHh-CCCccccCCCCcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHH
Q 005102 628 EMIT-GRTAVVQVGSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDAL 706 (714)
Q Consensus 628 ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L 706 (714)
||++ |..||... ...++...... ... +.... ....++.+++.+||+.+|++|||+.|+++.|
T Consensus 228 el~~~g~~p~~~~-----~~~~~~~~~~~-~~~------~~~~~-----~~~~~l~~li~~cl~~~p~~Rps~~ell~~l 290 (334)
T cd05100 228 EIFTLGGSPYPGI-----PVEELFKLLKE-GHR------MDKPA-----NCTHELYMIMRECWHAVPSQRPTFKQLVEDL 290 (334)
T ss_pred HHHhcCCCCCCCC-----CHHHHHHHHHc-CCC------CCCCC-----CCCHHHHHHHHHHcccChhhCcCHHHHHHHH
Confidence 9999 88888432 22222222211 110 00111 1223688999999999999999999999999
Q ss_pred hhhhcc
Q 005102 707 DRLIVS 712 (714)
Q Consensus 707 ~~i~~~ 712 (714)
+++...
T Consensus 291 ~~~~~~ 296 (334)
T cd05100 291 DRVLTV 296 (334)
T ss_pred HHHhhh
Confidence 998743
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-37 Score=334.20 Aligned_cols=255 Identities=15% Similarity=0.169 Sum_probs=189.5
Q ss_pred ccccccCceEEEEEEECC-CcEEEEEEeCCCCchhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCCCHh
Q 005102 409 FVLGKSGIGIVYKVVLED-GHTLAVRRLGEGGSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGSLA 487 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL~ 487 (714)
..||+|+||.||++.+.. ++.||||.... ..+.+|++++++++|+|||++++++...+..++|||++. ++|.
T Consensus 175 ~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~~-~~L~ 247 (461)
T PHA03211 175 RALTPGSEGCVFESSHPDYPQRVVVKAGWY------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYR-SDLY 247 (461)
T ss_pred EEEccCCCeEEEEEEECCCCCEEEEecccc------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEccC-CCHH
Confidence 579999999999999865 78999996432 346789999999999999999999999999999999994 7999
Q ss_pred hhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCCCCc
Q 005102 488 TALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTL 567 (714)
Q Consensus 488 ~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 567 (714)
+++.... ..++|.+++.|+.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++.......
T Consensus 248 ~~l~~~~-----~~l~~~~~~~i~~qi~~aL~yLH~---~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~---- 315 (461)
T PHA03211 248 TYLGARL-----RPLGLAQVTAVARQLLSAIDYIHG---EGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWS---- 315 (461)
T ss_pred HHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHH---CCEEECcCCHHHEEECCCCCEEEcccCCceecccccc----
Confidence 8886543 358999999999999999999999 8999999999999999999999999999986532110
Q ss_pred cCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCccccCCCCc----
Q 005102 568 QSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGSSE---- 643 (714)
Q Consensus 568 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~~~~~~~~---- 643 (714)
........||..|+|||++.+..++.++|||||||++|||++|..|+.......
T Consensus 316 ----------------------~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~ 373 (461)
T PHA03211 316 ----------------------TPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRP 373 (461)
T ss_pred ----------------------cccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCC
Confidence 001123457899999999999999999999999999999999987764332111
Q ss_pred --chhHHHHHHHHhhcCCcccc----------------cCCCCCC-CCC-cHHHHHHHHHHHhHccCCCCCCCCCHHHHH
Q 005102 644 --MDLVNWMQLCIEEKKPLADV----------------LDPYLAP-DAD-KEEEIIAVLKIAMACVHSSPEKRPTMRHIS 703 (714)
Q Consensus 644 --~~l~~~~~~~~~~~~~~~~~----------------~d~~~~~-~~~-~~~~~~~l~~li~~Cl~~dP~~RPt~~evl 703 (714)
..+...++........+... ..+.... ... .......+.+|+.+||+.||.+|||+.|++
T Consensus 374 ~~~~l~~~i~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL 453 (461)
T PHA03211 374 YDAQILRIIRQAQVHVDEFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELL 453 (461)
T ss_pred cHHHHHHHHHhhccccccCCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHh
Confidence 11222221110000000000 0000000 000 001112577899999999999999999998
Q ss_pred H
Q 005102 704 D 704 (714)
Q Consensus 704 ~ 704 (714)
+
T Consensus 454 ~ 454 (461)
T PHA03211 454 R 454 (461)
T ss_pred h
Confidence 6
|
|
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-37 Score=330.01 Aligned_cols=257 Identities=20% Similarity=0.324 Sum_probs=189.9
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeCCC--CchhHHHHHHHHHHHhccCCCCccceEEEEEeCC-----ceeEEEec
Q 005102 409 FVLGKSGIGIVYKVVLE-DGHTLAVRRLGEG--GSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVD-----EKLLIYDY 480 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~-----~~~lV~e~ 480 (714)
+.||+|+||.||++... +|+.||||++... .....+.+.+|+++++.++||||+++++++...+ ..|+||||
T Consensus 6 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~ 85 (372)
T cd07853 6 RPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYVVTEL 85 (372)
T ss_pred ceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEEEEeec
Confidence 47999999999999974 6899999998753 2234467889999999999999999999998766 78999999
Q ss_pred cCCCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhc
Q 005102 481 IPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANI 560 (714)
Q Consensus 481 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 560 (714)
+. ++|.+.+... ..+++..+..++.||+.||+|||+ .+|+||||||+|||+++++.+||+|||+++....
T Consensus 86 ~~-~~l~~~~~~~------~~l~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~ 155 (372)
T cd07853 86 MQ-SDLHKIIVSP------QPLSSDHVKVFLYQILRGLKYLHS---AGILHRDIKPGNLLVNSNCVLKICDFGLARVEEP 155 (372)
T ss_pred cc-cCHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChHHEEECCCCCEEeccccceeeccc
Confidence 96 5888887654 458999999999999999999999 8999999999999999999999999999875432
Q ss_pred cCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCC-CCCchhhhHHHHHHHHHHHhCCCccccC
Q 005102 561 AGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVV-KPSQKWDIYSYGVILLEMITGRTAVVQV 639 (714)
Q Consensus 561 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DVwS~Gvvl~elltG~~p~~~~ 639 (714)
.. ........+|+.|+|||.+.+. .++.++|||||||++|||++|+.||...
T Consensus 156 ~~---------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 208 (372)
T cd07853 156 DE---------------------------SKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQ 208 (372)
T ss_pred Cc---------------------------cccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCC
Confidence 11 0011223457889999999774 4799999999999999999999999433
Q ss_pred CCCcchhHHHHHHHHhhcC---------Cccc-cc-CCCCCCCC-----CcHHHHHHHHHHHhHccCCCCCCCCCHHHHH
Q 005102 640 GSSEMDLVNWMQLCIEEKK---------PLAD-VL-DPYLAPDA-----DKEEEIIAVLKIAMACVHSSPEKRPTMRHIS 703 (714)
Q Consensus 640 ~~~~~~l~~~~~~~~~~~~---------~~~~-~~-d~~~~~~~-----~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl 703 (714)
.. .+....+........ .... +. .+...+.. .......++.+++.+||+.||++|||++|++
T Consensus 209 ~~--~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l 286 (372)
T cd07853 209 SP--IQQLDLITDLLGTPSLEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADAL 286 (372)
T ss_pred CH--HHHHHHHHHHcCCCCHHHHHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHh
Confidence 21 111111110000000 0000 00 00000000 0001133678999999999999999999998
Q ss_pred H
Q 005102 704 D 704 (714)
Q Consensus 704 ~ 704 (714)
+
T Consensus 287 ~ 287 (372)
T cd07853 287 A 287 (372)
T ss_pred c
Confidence 5
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=316.21 Aligned_cols=257 Identities=23% Similarity=0.330 Sum_probs=196.6
Q ss_pred ccccccCceEEEEEEECC------CcEEEEEEeCCCCc-hhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEecc
Q 005102 409 FVLGKSGIGIVYKVVLED------GHTLAVRRLGEGGS-QRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYI 481 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~~------g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~ 481 (714)
+.||+|+||.||+|..++ +..||+|.+..... .....+.+|+.++++++||||+++++++...+..++||||+
T Consensus 12 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 91 (288)
T cd05061 12 RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELM 91 (288)
T ss_pred eeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEeCC
Confidence 479999999999997542 45899999875532 23356889999999999999999999999999999999999
Q ss_pred CCCCHhhhhhCCCCC----CCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhh
Q 005102 482 PNGSLATALHGKPGM----VSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARL 557 (714)
Q Consensus 482 ~~gsL~~~l~~~~~~----~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 557 (714)
++|+|.+++...... ......++..+.+++.|++.||+|||+ ++|+||||||+||++++++.+||+|||+++.
T Consensus 92 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dikp~nili~~~~~~~L~Dfg~~~~ 168 (288)
T cd05061 92 AHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTRD 168 (288)
T ss_pred CCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCCcCCCCChheEEEcCCCcEEECcCCcccc
Confidence 999999999753211 011345778899999999999999999 8999999999999999999999999999875
Q ss_pred hhccCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHh-CCCcc
Q 005102 558 ANIAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMIT-GRTAV 636 (714)
Q Consensus 558 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~ellt-G~~p~ 636 (714)
...... ........++..|+|||.+.+..++.++|||||||++|||++ |..||
T Consensus 169 ~~~~~~--------------------------~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~ 222 (288)
T cd05061 169 IYETDY--------------------------YRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPY 222 (288)
T ss_pred cccccc--------------------------ccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCC
Confidence 432110 000111223566999999998899999999999999999999 78888
Q ss_pred ccCCCCcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhhhhc
Q 005102 637 VQVGSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDALDRLIV 711 (714)
Q Consensus 637 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~ 711 (714)
.... . .+.......... +.... .....+.+++.+||+.||++|||+.++++.|++...
T Consensus 223 ~~~~--~---~~~~~~~~~~~~-------~~~~~-----~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~ 280 (288)
T cd05061 223 QGLS--N---EQVLKFVMDGGY-------LDQPD-----NCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLH 280 (288)
T ss_pred CCCC--H---HHHHHHHHcCCC-------CCCCC-----CCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcC
Confidence 4321 1 122221111111 00111 112468899999999999999999999999998543
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=309.26 Aligned_cols=248 Identities=26% Similarity=0.375 Sum_probs=196.8
Q ss_pred cccccCceEEEEEEECCCcEEEEEEeCCCCch-hHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCCCHhh
Q 005102 410 VLGKSGIGIVYKVVLEDGHTLAVRRLGEGGSQ-RFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGSLAT 488 (714)
Q Consensus 410 ~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL~~ 488 (714)
.||+|+||.||++...+++.||+|.+...... ..+.+.+|++++++++|+||+++++++...+..++||||+++++|.+
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~ 81 (251)
T cd05041 2 KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLLT 81 (251)
T ss_pred ccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHHH
Confidence 69999999999999877999999998765443 45679999999999999999999999999999999999999999999
Q ss_pred hhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCCCCcc
Q 005102 489 ALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQ 568 (714)
Q Consensus 489 ~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 568 (714)
++.... ..+++..+..++.+++.||+|||+ ++++||||||+||+++.++.+||+|||+++.......
T Consensus 82 ~l~~~~-----~~~~~~~~~~~~~~~~~~l~~lH~---~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~----- 148 (251)
T cd05041 82 FLRKKK-----NRLTVKKLLQMSLDAAAGMEYLES---KNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIY----- 148 (251)
T ss_pred HHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHh---CCEehhhcCcceEEEcCCCcEEEeeccccccccCCcc-----
Confidence 997543 347889999999999999999999 8999999999999999999999999999875431100
Q ss_pred CCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHh-CCCccccCCCCcchhH
Q 005102 569 SNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMIT-GRTAVVQVGSSEMDLV 647 (714)
Q Consensus 569 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~ellt-G~~p~~~~~~~~~~l~ 647 (714)
........++..|+|||.+.+..++.++|||||||++|||+| |..||..... ...
T Consensus 149 ---------------------~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~--~~~- 204 (251)
T cd05041 149 ---------------------TVSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSN--QQT- 204 (251)
T ss_pred ---------------------eeccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCH--HHH-
Confidence 000011122456999999988899999999999999999999 8888843221 111
Q ss_pred HHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhh
Q 005102 648 NWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDALDR 708 (714)
Q Consensus 648 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~ 708 (714)
... ...... .... .....++.+++.+||..+|++|||+.|+++.|++
T Consensus 205 --~~~-~~~~~~------~~~~-----~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~~ 251 (251)
T cd05041 205 --RER-IESGYR------MPAP-----QLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQI 251 (251)
T ss_pred --HHH-HhcCCC------CCCC-----ccCCHHHHHHHHHHhccChhhCcCHHHHHHHhhC
Confidence 111 111100 0000 1123468899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=311.95 Aligned_cols=255 Identities=22% Similarity=0.317 Sum_probs=188.0
Q ss_pred cccccCceEEEEEEECC---CcEEEEEEeCCCCc-hhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCCC
Q 005102 410 VLGKSGIGIVYKVVLED---GHTLAVRRLGEGGS-QRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGS 485 (714)
Q Consensus 410 ~lG~G~~g~Vy~~~~~~---g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gs 485 (714)
.||+|+||.||+|...+ ...+|+|.+..... .....|.+|+++++.++||||+++++++...+..++||||+++|+
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD 81 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence 58999999999997543 35788888765432 334578899999999999999999999999999999999999999
Q ss_pred HhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCCC
Q 005102 486 LATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSP 565 (714)
Q Consensus 486 L~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 565 (714)
|.+++....... ....++...+.++.|++.||+|||+ ++|+||||||+||++++++.+||+|||+++.......
T Consensus 82 L~~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~-- 155 (269)
T cd05042 82 LKNYLRSNRGMV-AQMAQKDVLQRMACEVASGLLWLHQ---ADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDY-- 155 (269)
T ss_pred HHHHHHhccccc-cccccHHHHHHHHHHHHHHHHHHHh---cCEecccccHhheEecCCCcEEEeccccccccccchh--
Confidence 999997653211 1235678889999999999999999 8999999999999999999999999999864321100
Q ss_pred CccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccC-------CCCCCchhhhHHHHHHHHHHHh-CCCccc
Q 005102 566 TLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLK-------VVKPSQKWDIYSYGVILLEMIT-GRTAVV 637 (714)
Q Consensus 566 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~s~~~DVwS~Gvvl~ellt-G~~p~~ 637 (714)
........++..|+|||++. ...++.++|||||||++|||++ |..||.
T Consensus 156 ------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~ 211 (269)
T cd05042 156 ------------------------YITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYP 211 (269)
T ss_pred ------------------------eeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCC
Confidence 00112223456799999874 2356889999999999999999 777874
Q ss_pred cCCCCcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHh
Q 005102 638 QVGSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDALD 707 (714)
Q Consensus 638 ~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~ 707 (714)
.... .+ .......... ....++..... ....+.+++..|| .||++|||+++|++.|.
T Consensus 212 ~~~~--~~---~~~~~~~~~~--~~~~~~~~~~~-----~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 212 DLSD--EQ---VLKQVVREQD--IKLPKPQLDLK-----YSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred cCCH--HH---HHHHHhhccC--ccCCCCccccc-----CCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 3211 11 1111111111 11122222211 2235677888999 59999999999999873
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-37 Score=313.24 Aligned_cols=248 Identities=26% Similarity=0.433 Sum_probs=197.9
Q ss_pred ccccccCceEEEEEEECCCcEEEEEEeCCCCchhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCCCHhh
Q 005102 409 FVLGKSGIGIVYKVVLEDGHTLAVRRLGEGGSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGSLAT 488 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL~~ 488 (714)
+.||+|+||.||+|..++++.||||.+..... ..+++.+|+.++++++|+||+++++++......++||||+++++|.+
T Consensus 12 ~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~ 90 (261)
T cd05034 12 RKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTM-SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLD 90 (261)
T ss_pred eeeccCcceEEEEEEEcCCceEEEEEecCCcc-CHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEeccCCCCHHH
Confidence 47999999999999988888999999886433 34679999999999999999999999998889999999999999999
Q ss_pred hhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCCCCcc
Q 005102 489 ALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQ 568 (714)
Q Consensus 489 ~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 568 (714)
++....+ ..+++.++..++.|++.||+|||+ .+++|+||||+||++++++.+||+|||+++.......
T Consensus 91 ~i~~~~~----~~~~~~~~~~~~~~i~~al~~lh~---~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~----- 158 (261)
T cd05034 91 FLKSGEG----KKLRLPQLVDMAAQIAEGMAYLES---RNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEY----- 158 (261)
T ss_pred HHhcccc----CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcchheEEEcCCCCEEECccccceeccchhh-----
Confidence 9976532 358999999999999999999999 8999999999999999999999999999876532100
Q ss_pred CCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHh-CCCccccCCCCcchhH
Q 005102 569 SNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMIT-GRTAVVQVGSSEMDLV 647 (714)
Q Consensus 569 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~ellt-G~~p~~~~~~~~~~l~ 647 (714)
.......++..|+|||.+.+..++.++||||||+++|||+| |+.||.... ....
T Consensus 159 ----------------------~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~--~~~~- 213 (261)
T cd05034 159 ----------------------TAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMT--NREV- 213 (261)
T ss_pred ----------------------hhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCC--HHHH-
Confidence 00011112456999999998889999999999999999999 999984321 1111
Q ss_pred HHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhh
Q 005102 648 NWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDALDR 708 (714)
Q Consensus 648 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~ 708 (714)
....... .. ...... ....+.+++.+||..+|++||+++++.+.|+.
T Consensus 214 --~~~~~~~-~~------~~~~~~-----~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 214 --LEQVERG-YR------MPRPPN-----CPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred --HHHHHcC-CC------CCCCCC-----CCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 1111111 00 000001 12368899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=320.23 Aligned_cols=258 Identities=24% Similarity=0.374 Sum_probs=198.1
Q ss_pred cccccccCceEEEEEEEC--------CCcEEEEEEeCCCC-chhHHHHHHHHHHHhcc-CCCCccceEEEEEeCCceeEE
Q 005102 408 AFVLGKSGIGIVYKVVLE--------DGHTLAVRRLGEGG-SQRFKEFQTEVEAIGKI-RHSNIVTLRAYYWSVDEKLLI 477 (714)
Q Consensus 408 ~~~lG~G~~g~Vy~~~~~--------~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV 477 (714)
.+.||+|+||.||+|... ....||+|.++... ......+.+|+++++++ +||||+++++++...+..++|
T Consensus 17 ~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv 96 (314)
T cd05099 17 GKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEGPLYVI 96 (314)
T ss_pred eeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCCceEEE
Confidence 468999999999999752 24579999987643 23346788999999999 699999999999988899999
Q ss_pred EeccCCCCHhhhhhCCCCC----------CCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCe
Q 005102 478 YDYIPNGSLATALHGKPGM----------VSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEP 547 (714)
Q Consensus 478 ~e~~~~gsL~~~l~~~~~~----------~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~ 547 (714)
|||+++|+|.+++...... .....+++.++++++.|++.||+|||+ ++|+||||||+||++++++.+
T Consensus 97 ~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~---~gi~H~dlkp~Nill~~~~~~ 173 (314)
T cd05099 97 VEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLES---RRCIHRDLAARNVLVTEDNVM 173 (314)
T ss_pred EecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHH---CCeeeccccceeEEEcCCCcE
Confidence 9999999999999754210 112458999999999999999999999 899999999999999999999
Q ss_pred EEcccchhhhhhccCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHH
Q 005102 548 HVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILL 627 (714)
Q Consensus 548 kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~ 627 (714)
||+|||+++........ .......++..|+|||.+.+..++.++|||||||++|
T Consensus 174 kL~Dfg~~~~~~~~~~~--------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~ 227 (314)
T cd05099 174 KIADFGLARGVHDIDYY--------------------------KKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMW 227 (314)
T ss_pred EEccccccccccccccc--------------------------cccccCCCCccccCHHHHccCCcCccchhhHHHHHHH
Confidence 99999999865321100 0001112245699999998888999999999999999
Q ss_pred HHHh-CCCccccCCCCcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHH
Q 005102 628 EMIT-GRTAVVQVGSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDAL 706 (714)
Q Consensus 628 ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L 706 (714)
||++ |+.||.... ..++.+ .. ..... ..... ....++.+++.+||+.+|++|||+.|+++.|
T Consensus 228 el~~~g~~p~~~~~--~~~~~~---~~-~~~~~------~~~~~-----~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l 290 (314)
T cd05099 228 EIFTLGGSPYPGIP--VEELFK---LL-REGHR------MDKPS-----NCTHELYMLMRECWHAVPTQRPTFKQLVEAL 290 (314)
T ss_pred HHHhCCCCCCCCCC--HHHHHH---HH-HcCCC------CCCCC-----CCCHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence 9999 888884321 111221 11 11110 00111 1223677999999999999999999999999
Q ss_pred hhhhc
Q 005102 707 DRLIV 711 (714)
Q Consensus 707 ~~i~~ 711 (714)
+++..
T Consensus 291 ~~~~~ 295 (314)
T cd05099 291 DKVLA 295 (314)
T ss_pred HHHHH
Confidence 98864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=312.72 Aligned_cols=247 Identities=23% Similarity=0.338 Sum_probs=192.0
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeCCCCchhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCCCHh
Q 005102 409 FVLGKSGIGIVYKVVLE-DGHTLAVRRLGEGGSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGSLA 487 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL~ 487 (714)
..||+|+||.||+|.+. ++..||+|.+........+.+.+|++++++++|+||+++++++...+..++||||+++++|.
T Consensus 14 ~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 93 (268)
T cd06624 14 VVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLS 93 (268)
T ss_pred EEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecCCCCCHH
Confidence 47999999999999965 47889999988766666678999999999999999999999999999999999999999999
Q ss_pred hhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCC-CCCeEEcccchhhhhhccCCCCC
Q 005102 488 TALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGH-NMEPHVSDFGLARLANIAGGSPT 566 (714)
Q Consensus 488 ~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~-~~~~kl~DFGla~~~~~~~~~~~ 566 (714)
+++...... ...++..+..++.|++.||+|||+ ++|+||||||+||+++. ++.+||+|||++.......
T Consensus 94 ~~l~~~~~~---~~~~~~~~~~~~~qi~~al~~lH~---~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~---- 163 (268)
T cd06624 94 ALLRSKWGP---LKDNEQTIIFYTKQILEGLKYLHD---NQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGIN---- 163 (268)
T ss_pred HHHHHhccc---CCCcHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCeEEEecchhheecccCC----
Confidence 999754211 112788899999999999999999 89999999999999986 6789999999987542110
Q ss_pred ccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCC--CCchhhhHHHHHHHHHHHhCCCccccCCCCcc
Q 005102 567 LQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVK--PSQKWDIYSYGVILLEMITGRTAVVQVGSSEM 644 (714)
Q Consensus 567 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~s~~~DVwS~Gvvl~elltG~~p~~~~~~~~~ 644 (714)
.......++..|+|||++.+.. ++.++||||||+++|||++|+.||........
T Consensus 164 ------------------------~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~ 219 (268)
T cd06624 164 ------------------------PCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQA 219 (268)
T ss_pred ------------------------CccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhh
Confidence 0011223577899999986644 78999999999999999999999954322111
Q ss_pred hhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 005102 645 DLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISD 704 (714)
Q Consensus 645 ~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 704 (714)
..+...... ..+.+.. ....++.+++.+||+.+|++|||+.|+++
T Consensus 220 --~~~~~~~~~--------~~~~~~~-----~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 264 (268)
T cd06624 220 --AMFKVGMFK--------IHPEIPE-----SLSAEAKNFILRCFEPDPDKRASAHDLLQ 264 (268)
T ss_pred --hHhhhhhhc--------cCCCCCc-----ccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence 111100000 0111111 12235789999999999999999999875
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-37 Score=321.07 Aligned_cols=257 Identities=21% Similarity=0.300 Sum_probs=190.2
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeCCCCc-hhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCCCH
Q 005102 409 FVLGKSGIGIVYKVVLE-DGHTLAVRRLGEGGS-QRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGSL 486 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL 486 (714)
+.||+|+||.||+|+.+ +++.||+|+++.... .....+.+|++++++++||||+++++++...+..++||||+++ +|
T Consensus 12 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l 90 (309)
T cd07872 12 EKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYLDK-DL 90 (309)
T ss_pred EEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeCCCC-CH
Confidence 47999999999999976 478899999875432 2234678899999999999999999999999999999999975 88
Q ss_pred hhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCCCC
Q 005102 487 ATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPT 566 (714)
Q Consensus 487 ~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 566 (714)
.+++.... ..+++..+..++.|++.||+|||+ ++|+||||||+||++++++.+||+|||+++......
T Consensus 91 ~~~~~~~~-----~~~~~~~~~~~~~qi~~aL~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~---- 158 (309)
T cd07872 91 KQYMDDCG-----NIMSMHNVKIFLYQILRGLAYCHR---RKVLHRDLKPQNLLINERGELKLADFGLARAKSVPT---- 158 (309)
T ss_pred HHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECccccceecCCCc----
Confidence 88886543 347889999999999999999999 899999999999999999999999999987532110
Q ss_pred ccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCC-CCCCchhhhHHHHHHHHHHHhCCCccccCCCCcch
Q 005102 567 LQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKV-VKPSQKWDIYSYGVILLEMITGRTAVVQVGSSEMD 645 (714)
Q Consensus 567 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DVwS~Gvvl~elltG~~p~~~~~~~~~~ 645 (714)
.......+|+.|+|||.+.+ ..++.++|||||||++|||+||+.||..... .+
T Consensus 159 ------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~--~~ 212 (309)
T cd07872 159 ------------------------KTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTV--ED 212 (309)
T ss_pred ------------------------cccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh--HH
Confidence 01112345788999999865 4589999999999999999999999953322 11
Q ss_pred hHHHHHHHHhhcC--------C---cccccCCCCCCCC---CcHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 005102 646 LVNWMQLCIEEKK--------P---LADVLDPYLAPDA---DKEEEIIAVLKIAMACVHSSPEKRPTMRHISD 704 (714)
Q Consensus 646 l~~~~~~~~~~~~--------~---~~~~~d~~~~~~~---~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 704 (714)
....+........ . ....-.+...+.. .......++.+++.+||+.||++|||++|+++
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 285 (309)
T cd07872 213 ELHLIFRLLGTPTEETWPGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK 285 (309)
T ss_pred HHHHHHHHhCCCCHHHHhhhcchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence 1111111110000 0 0000000000000 00012235779999999999999999999886
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=330.66 Aligned_cols=246 Identities=22% Similarity=0.274 Sum_probs=189.1
Q ss_pred ccccccCceEEEEEEECC-CcEEEEEEeCCC---CchhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCC
Q 005102 409 FVLGKSGIGIVYKVVLED-GHTLAVRRLGEG---GSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNG 484 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~~-g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~g 484 (714)
+.||+|+||.||+++... ++.||+|.+.+. .....+.+.+|+.+++.++||||+++++++...+..++||||+++|
T Consensus 49 ~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~Ey~~gg 128 (370)
T cd05621 49 KVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGG 128 (370)
T ss_pred EEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEcCCCCC
Confidence 579999999999999864 789999998652 2223356889999999999999999999999999999999999999
Q ss_pred CHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCC
Q 005102 485 SLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGS 564 (714)
Q Consensus 485 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 564 (714)
+|.+++... .+++..+..++.||+.||+|||+ ++|+||||||+|||+++++.+||+|||+|+......
T Consensus 129 ~L~~~l~~~-------~~~~~~~~~~~~qil~aL~~LH~---~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~-- 196 (370)
T cd05621 129 DLVNLMSNY-------DVPEKWAKFYTAEVVLALDAIHS---MGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETG-- 196 (370)
T ss_pred cHHHHHHhc-------CCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEECCCCCEEEEecccceecccCC--
Confidence 999998643 37888999999999999999999 899999999999999999999999999997643211
Q ss_pred CCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCC----CCchhhhHHHHHHHHHHHhCCCccccCC
Q 005102 565 PTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVK----PSQKWDIYSYGVILLEMITGRTAVVQVG 640 (714)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~s~~~DVwS~Gvvl~elltG~~p~~~~~ 640 (714)
........||+.|+|||++.+.. ++.++||||+||++|||++|+.||....
T Consensus 197 -------------------------~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~ 251 (370)
T cd05621 197 -------------------------MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADS 251 (370)
T ss_pred -------------------------ceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCC
Confidence 01122345799999999986543 7889999999999999999999995321
Q ss_pred CCcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCC--CCCHHHHHHH
Q 005102 641 SSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEK--RPTMRHISDA 705 (714)
Q Consensus 641 ~~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~--RPt~~evl~~ 705 (714)
..............+ ...... .....+.+++..|+..++.+ |||++|+++.
T Consensus 252 -----~~~~~~~i~~~~~~~------~~p~~~---~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 252 -----LVGTYSKIMDHKNSL------NFPEDV---EISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred -----HHHHHHHHHhCCccc------CCCCcc---cCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 112222222211110 011111 11234668888999755543 8899998763
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=333.40 Aligned_cols=272 Identities=20% Similarity=0.243 Sum_probs=192.2
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeCCCC---chhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCC
Q 005102 409 FVLGKSGIGIVYKVVLE-DGHTLAVRRLGEGG---SQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNG 484 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~g 484 (714)
+.||+|+||.||+|+.. +++.||||++.+.. ......+.+|++++++++||||+++++.+.+.+..++||||+++|
T Consensus 7 ~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~~~~g 86 (376)
T cd05598 7 KTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGG 86 (376)
T ss_pred EEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEeCCCCC
Confidence 47999999999999975 48999999987532 223456889999999999999999999999999999999999999
Q ss_pred CHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCC
Q 005102 485 SLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGS 564 (714)
Q Consensus 485 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 564 (714)
+|.+++... ..+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+|+.+......
T Consensus 87 ~L~~~i~~~------~~~~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~ 157 (376)
T cd05598 87 DMMSLLIRL------GIFEEDLARFYIAELTCAIESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS 157 (376)
T ss_pred cHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHEEECCCCCEEEEeCCCCccccccccc
Confidence 999999765 357888999999999999999999 89999999999999999999999999998644211110
Q ss_pred CCccCCCCCCC---Cchhh------------hcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHH
Q 005102 565 PTLQSNRMPAE---KPQER------------QQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEM 629 (714)
Q Consensus 565 ~~~~~~~~~~~---~~~~~------------~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~el 629 (714)
........... .+... .................||+.|+|||++.+..++.++|||||||++|||
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyel 237 (376)
T cd05598 158 KYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEM 237 (376)
T ss_pred cccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeeh
Confidence 00000000000 00000 0000000001112245789999999999999999999999999999999
Q ss_pred HhCCCccccCCCCcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCC---CHHHHHH
Q 005102 630 ITGRTAVVQVGSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRP---TMRHISD 704 (714)
Q Consensus 630 ltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RP---t~~evl~ 704 (714)
++|+.||..... .+........... ...+. .. .....+.+++.+|+ .+|.+|+ |+.|+++
T Consensus 238 l~G~~Pf~~~~~-----~~~~~~i~~~~~~---~~~~~---~~---~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~ 300 (376)
T cd05598 238 LVGQPPFLADTP-----AETQLKVINWETT---LHIPS---QA---KLSREASDLILRLC-CGAEDRLGKNGADEIKA 300 (376)
T ss_pred hhCCCCCCCCCH-----HHHHHHHhccCcc---ccCCC---CC---CCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhC
Confidence 999999953321 1111111111100 00010 00 11224667777766 5999999 8888764
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-37 Score=332.18 Aligned_cols=221 Identities=22% Similarity=0.289 Sum_probs=169.8
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeCCCC---chhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCC
Q 005102 409 FVLGKSGIGIVYKVVLE-DGHTLAVRRLGEGG---SQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNG 484 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~g 484 (714)
+.||+|+||+||+|+.. +++.||+|++.... ......+.+|++++++++||||+++++++.+.+..++||||+++|
T Consensus 7 ~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E~~~gg 86 (382)
T cd05625 7 KTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGG 86 (382)
T ss_pred EEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEeCCCCC
Confidence 47999999999999975 48899999997642 223457889999999999999999999999999999999999999
Q ss_pred CHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCC
Q 005102 485 SLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGS 564 (714)
Q Consensus 485 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 564 (714)
+|.+++... ..+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++........
T Consensus 87 ~L~~~l~~~------~~~~e~~~~~~~~qi~~al~~lH~---~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~ 157 (382)
T cd05625 87 DMMSLLIRM------GIFPEDLARFYIAELTCAVESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS 157 (382)
T ss_pred cHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEEeECCCCccccccccc
Confidence 999998754 347889999999999999999999 89999999999999999999999999998644211110
Q ss_pred CCccCCCCCCCCch----------h---------hhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHH
Q 005102 565 PTLQSNRMPAEKPQ----------E---------RQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVI 625 (714)
Q Consensus 565 ~~~~~~~~~~~~~~----------~---------~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvv 625 (714)
.............. . ..................||+.|+|||++.+..++.++|||||||+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvi 237 (382)
T cd05625 158 KYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVI 237 (382)
T ss_pred cccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHH
Confidence 00000000000000 0 0000000000111234568999999999999999999999999999
Q ss_pred HHHHHhCCCcccc
Q 005102 626 LLEMITGRTAVVQ 638 (714)
Q Consensus 626 l~elltG~~p~~~ 638 (714)
+|||++|+.||..
T Consensus 238 l~elltG~~Pf~~ 250 (382)
T cd05625 238 LYEMLVGQPPFLA 250 (382)
T ss_pred HHHHHhCCCCCCC
Confidence 9999999999953
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=317.44 Aligned_cols=244 Identities=21% Similarity=0.336 Sum_probs=192.7
Q ss_pred cccccCceEEEEEEECC-CcEEEEEEeCCCCchhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCCCHhh
Q 005102 410 VLGKSGIGIVYKVVLED-GHTLAVRRLGEGGSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGSLAT 488 (714)
Q Consensus 410 ~lG~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL~~ 488 (714)
.||+|+||.||+|+... ++.||+|.+........+.+.+|++++++++||||+++++++...+..++||||+++++|..
T Consensus 19 ~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~ 98 (292)
T cd06644 19 ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDA 98 (292)
T ss_pred eecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecCCCCcHHH
Confidence 69999999999999865 89999999987766667789999999999999999999999999999999999999999998
Q ss_pred hhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCCCCcc
Q 005102 489 ALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQ 568 (714)
Q Consensus 489 ~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 568 (714)
++.... ..+++..+..++.|++.||+|||+ .+++||||||+||+++.++.+||+|||++......
T Consensus 99 ~~~~~~-----~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~------- 163 (292)
T cd06644 99 IMLELD-----RGLTEPQIQVICRQMLEALQYLHS---MKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKT------- 163 (292)
T ss_pred HHHhhc-----CCCCHHHHHHHHHHHHHHHHHHhc---CCeeecCCCcceEEEcCCCCEEEccCccceecccc-------
Confidence 876543 358999999999999999999999 89999999999999999999999999987643211
Q ss_pred CCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccC-----CCCCCchhhhHHHHHHHHHHHhCCCccccCCCCc
Q 005102 569 SNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLK-----VVKPSQKWDIYSYGVILLEMITGRTAVVQVGSSE 643 (714)
Q Consensus 569 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~~DVwS~Gvvl~elltG~~p~~~~~~~~ 643 (714)
........++..|+|||++. ...++.++|||||||++|||++|+.||.....
T Consensus 164 ---------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~-- 220 (292)
T cd06644 164 ---------------------LQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP-- 220 (292)
T ss_pred ---------------------ccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccH--
Confidence 00111223577899999984 34568899999999999999999999843211
Q ss_pred chhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 005102 644 MDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISD 704 (714)
Q Consensus 644 ~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 704 (714)
...+........ +.... .......+.+++.+||+.||++||+++++++
T Consensus 221 ---~~~~~~~~~~~~-------~~~~~---~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 268 (292)
T cd06644 221 ---MRVLLKIAKSEP-------PTLSQ---PSKWSMEFRDFLKTALDKHPETRPSAAQLLE 268 (292)
T ss_pred ---HHHHHHHhcCCC-------ccCCC---CcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 111111111110 11100 0112235789999999999999999999975
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=338.41 Aligned_cols=256 Identities=21% Similarity=0.322 Sum_probs=182.8
Q ss_pred cccccccCceEEEEEEEC-CCcEEEEEEeCCCCchhHHHHHHHHHHHhccCCCCccceEEEEEeC--------CceeEEE
Q 005102 408 AFVLGKSGIGIVYKVVLE-DGHTLAVRRLGEGGSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSV--------DEKLLIY 478 (714)
Q Consensus 408 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--------~~~~lV~ 478 (714)
.+.||+|+||.||+|... +++.||||++.... ....+|+.+|++++||||+++++++... ...++||
T Consensus 71 ~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l~lvm 146 (440)
T PTZ00036 71 GNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVM 146 (440)
T ss_pred eEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceEEEEEE
Confidence 357999999999999975 58899999886532 2345799999999999999999987542 1356899
Q ss_pred eccCCCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCC-CeEEcccchhhh
Q 005102 479 DYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNM-EPHVSDFGLARL 557 (714)
Q Consensus 479 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~-~~kl~DFGla~~ 557 (714)
||+++ +|.+++...... ...+++..+..++.||+.||+|||+ ++|+||||||+|||++.++ .+||+|||+|+.
T Consensus 147 E~~~~-~l~~~~~~~~~~--~~~l~~~~~~~~~~qi~~gL~yLH~---~~IiHrDLKp~NILl~~~~~~vkL~DFGla~~ 220 (440)
T PTZ00036 147 EFIPQ-TVHKYMKHYARN--NHALPLFLVKLYSYQLCRALAYIHS---KFICHRDLKPQNLLIDPNTHTLKLCDFGSAKN 220 (440)
T ss_pred ecCCc-cHHHHHHHHhhc--CCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCcCHHHEEEcCCCCceeeeccccchh
Confidence 99975 777766432111 1468999999999999999999999 8999999999999999664 799999999986
Q ss_pred hhccCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCC-CCCchhhhHHHHHHHHHHHhCCCcc
Q 005102 558 ANIAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVV-KPSQKWDIYSYGVILLEMITGRTAV 636 (714)
Q Consensus 558 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DVwS~Gvvl~elltG~~p~ 636 (714)
+.... ......||+.|+|||++.+. .++.++|||||||++|||+||+.||
T Consensus 221 ~~~~~-----------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf 271 (440)
T PTZ00036 221 LLAGQ-----------------------------RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIF 271 (440)
T ss_pred ccCCC-----------------------------CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCC
Confidence 53211 11123468889999998764 6899999999999999999999999
Q ss_pred ccCCCCcchhHHHHHHHHhhc---------CCcccccCCCCCCC-C---CcHHHHHHHHHHHhHccCCCCCCCCCHHHHH
Q 005102 637 VQVGSSEMDLVNWMQLCIEEK---------KPLADVLDPYLAPD-A---DKEEEIIAVLKIAMACVHSSPEKRPTMRHIS 703 (714)
Q Consensus 637 ~~~~~~~~~l~~~~~~~~~~~---------~~~~~~~d~~~~~~-~---~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl 703 (714)
...... ..+...++. .... ....++.-+..... . .......++.+++.+||..||.+|||+.|++
T Consensus 272 ~~~~~~-~~~~~i~~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l 349 (440)
T PTZ00036 272 SGQSSV-DQLVRIIQV-LGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEAL 349 (440)
T ss_pred CCCChH-HHHHHHHHH-hCCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHh
Confidence 532211 111111111 0000 00000000000000 0 0001224688999999999999999999987
Q ss_pred H
Q 005102 704 D 704 (714)
Q Consensus 704 ~ 704 (714)
+
T Consensus 350 ~ 350 (440)
T PTZ00036 350 A 350 (440)
T ss_pred C
Confidence 3
|
|
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=314.63 Aligned_cols=258 Identities=26% Similarity=0.385 Sum_probs=199.6
Q ss_pred ccccccCceEEEEEEEC-----CCcEEEEEEeCCCCch-hHHHHHHHHHHHhccCCCCccceEEEEEe--CCceeEEEec
Q 005102 409 FVLGKSGIGIVYKVVLE-----DGHTLAVRRLGEGGSQ-RFKEFQTEVEAIGKIRHSNIVTLRAYYWS--VDEKLLIYDY 480 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~-----~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~--~~~~~lV~e~ 480 (714)
+.||+|+||.||+|.+. ++..||||++...... ..+.|.+|++++++++||||+++++++.. ....++||||
T Consensus 10 ~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~ 89 (284)
T cd05038 10 KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLRLIMEY 89 (284)
T ss_pred eeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceEEEEec
Confidence 47999999999999864 3689999999866443 45789999999999999999999999887 5578999999
Q ss_pred cCCCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhc
Q 005102 481 IPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANI 560 (714)
Q Consensus 481 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 560 (714)
+++++|.+++.... ..+++..+..++.|++.||+|||+ .+++||||||+||+++.++.+||+|||++.....
T Consensus 90 ~~~~~l~~~l~~~~-----~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 161 (284)
T cd05038 90 LPSGSLRDYLQRHR-----DQINLKRLLLFSSQICKGMDYLGS---QRYIHRDLAARNILVESEDLVKISDFGLAKVLPE 161 (284)
T ss_pred CCCCCHHHHHHhCc-----cccCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHhEEEcCCCCEEEccccccccccc
Confidence 99999999997653 358999999999999999999999 8999999999999999999999999999986542
Q ss_pred cCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCccccCC
Q 005102 561 AGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVG 640 (714)
Q Consensus 561 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~~~~~ 640 (714)
.... ........++..|+|||.+.+..++.++||||||+++|||+||+.|+....
T Consensus 162 ~~~~-------------------------~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~ 216 (284)
T cd05038 162 DKDY-------------------------YYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPP 216 (284)
T ss_pred CCcc-------------------------eeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCccccc
Confidence 2110 000111223456999999988899999999999999999999999984432
Q ss_pred CCcch---------hHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhhhh
Q 005102 641 SSEMD---------LVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDALDRLI 710 (714)
Q Consensus 641 ~~~~~---------l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~ 710 (714)
..... ....+......... ... ......++.+++.+||+.+|++||||.||+++|+++.
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------~~~---~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i~ 284 (284)
T cd05038 217 AEFLRMIGIAQGQMIVTRLLELLKEGER--------LPR---PPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRLR 284 (284)
T ss_pred chhccccccccccccHHHHHHHHHcCCc--------CCC---CccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhcC
Confidence 22111 01111111111110 000 0112246889999999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=332.36 Aligned_cols=273 Identities=21% Similarity=0.260 Sum_probs=192.4
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeCCCC---chhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCC
Q 005102 409 FVLGKSGIGIVYKVVLE-DGHTLAVRRLGEGG---SQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNG 484 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~g 484 (714)
+.||+|+||+||++... +++.||||++.+.. ....+.+.+|++++++++||||+++++++.+.+..|+||||+++|
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~E~~~gg 86 (377)
T cd05629 7 KVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIMEFLPGG 86 (377)
T ss_pred EEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEEeCCCCC
Confidence 47999999999999875 58999999986532 233467889999999999999999999999999999999999999
Q ss_pred CHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCC
Q 005102 485 SLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGS 564 (714)
Q Consensus 485 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 564 (714)
+|.+++... ..+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++........
T Consensus 87 ~L~~~l~~~------~~~~~~~~~~~~~ql~~aL~~LH~---~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~ 157 (377)
T cd05629 87 DLMTMLIKY------DTFSEDVTRFYMAECVLAIEAVHK---LGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDS 157 (377)
T ss_pred cHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEECCCCCEEEeeccccccccccccc
Confidence 999999754 458899999999999999999999 89999999999999999999999999999744221100
Q ss_pred CCcc---CCCCCCCC----------------chhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHH
Q 005102 565 PTLQ---SNRMPAEK----------------PQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVI 625 (714)
Q Consensus 565 ~~~~---~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvv 625 (714)
.... ........ .....................||+.|+|||++.+..++.++|||||||+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvi 237 (377)
T cd05629 158 AYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAI 237 (377)
T ss_pred ccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecchh
Confidence 0000 00000000 0000000000000001113468999999999998899999999999999
Q ss_pred HHHHHhCCCccccCCCCcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCC---CCHHHH
Q 005102 626 LLEMITGRTAVVQVGSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKR---PTMRHI 702 (714)
Q Consensus 626 l~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~R---Pt~~ev 702 (714)
+|||+||+.||..... .+...........+ ...... .....+.+++.+|+. +|.+| +|+.|+
T Consensus 238 l~elltG~~Pf~~~~~-----~~~~~~i~~~~~~~------~~p~~~---~~s~~~~dli~~lL~-~~~~r~~r~~~~~~ 302 (377)
T cd05629 238 MFECLIGWPPFCSENS-----HETYRKIINWRETL------YFPDDI---HLSVEAEDLIRRLIT-NAENRLGRGGAHEI 302 (377)
T ss_pred hhhhhcCCCCCCCCCH-----HHHHHHHHccCCcc------CCCCCC---CCCHHHHHHHHHHhc-CHhhcCCCCCHHHH
Confidence 9999999999943221 11111111111100 011100 112357789999997 67765 599888
Q ss_pred HHH
Q 005102 703 SDA 705 (714)
Q Consensus 703 l~~ 705 (714)
++.
T Consensus 303 l~h 305 (377)
T cd05629 303 KSH 305 (377)
T ss_pred hcC
Confidence 753
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=316.42 Aligned_cols=246 Identities=22% Similarity=0.222 Sum_probs=191.4
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeCCCCc---hhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCC
Q 005102 409 FVLGKSGIGIVYKVVLE-DGHTLAVRRLGEGGS---QRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNG 484 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~g 484 (714)
+.||+|+||+||++... +++.||+|.+..... .....+.+|++++++++|+||+++++++...+..++||||++++
T Consensus 6 ~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 85 (285)
T cd05632 6 RVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTIMNGG 85 (285)
T ss_pred EEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEeccCc
Confidence 47999999999999875 588999999875422 22345788999999999999999999999999999999999999
Q ss_pred CHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCC
Q 005102 485 SLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGS 564 (714)
Q Consensus 485 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 564 (714)
+|.+++..... ..+++..+..++.|++.||.|||+ .+|+||||||+||++++++.+||+|||++......
T Consensus 86 ~L~~~~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~---~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~--- 155 (285)
T cd05632 86 DLKFHIYNMGN----PGFEEERALFYAAEILCGLEDLHR---ENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEG--- 155 (285)
T ss_pred cHHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCCHHHEEECCCCCEEEecCCcceecCCC---
Confidence 99988865422 358999999999999999999999 89999999999999999999999999988653211
Q ss_pred CCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCccccCCCCcc
Q 005102 565 PTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGSSEM 644 (714)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~~~~~~~~~ 644 (714)
.......|+..|+|||++.+..++.++|||||||++|||++|+.||...... .
T Consensus 156 --------------------------~~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~-~ 208 (285)
T cd05632 156 --------------------------ESIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEK-V 208 (285)
T ss_pred --------------------------CcccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHH-H
Confidence 0111234688899999999889999999999999999999999999532211 1
Q ss_pred hhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCC-----HHHHHH
Q 005102 645 DLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPT-----MRHISD 704 (714)
Q Consensus 645 ~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt-----~~evl~ 704 (714)
....+... ..... ...... ....+.+++.+||+.||++||+ +++++.
T Consensus 209 ~~~~~~~~-~~~~~-------~~~~~~-----~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05632 209 KREEVDRR-VLETE-------EVYSAK-----FSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR 260 (285)
T ss_pred HHHHHHHh-hhccc-------cccCcc-----CCHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence 11111111 11110 001111 1235778999999999999999 556554
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=315.97 Aligned_cols=254 Identities=24% Similarity=0.384 Sum_probs=196.3
Q ss_pred ccccccCceEEEEEEEC------CCcEEEEEEeCCCCc-hhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEecc
Q 005102 409 FVLGKSGIGIVYKVVLE------DGHTLAVRRLGEGGS-QRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYI 481 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~------~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~ 481 (714)
..||+|+||.||+|... ++..||+|.+..... ...++|.+|+.++++++||||+++++++...+..++||||+
T Consensus 11 ~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 90 (288)
T cd05050 11 RDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPMCLLFEYM 90 (288)
T ss_pred ccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCccEEEEecC
Confidence 47999999999999864 467899999876533 33467999999999999999999999999989999999999
Q ss_pred CCCCHhhhhhCCCCC----------------CCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCC
Q 005102 482 PNGSLATALHGKPGM----------------VSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNM 545 (714)
Q Consensus 482 ~~gsL~~~l~~~~~~----------------~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~ 545 (714)
++|+|.+++...... .....+++.+++.++.|++.||+|||+ ++++||||||+||++++++
T Consensus 91 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~---~~i~H~dl~p~nil~~~~~ 167 (288)
T cd05050 91 AYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSE---RKFVHRDLATRNCLVGENM 167 (288)
T ss_pred CCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---CCeecccccHhheEecCCC
Confidence 999999999743210 111357889999999999999999999 8999999999999999999
Q ss_pred CeEEcccchhhhhhccCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHH
Q 005102 546 EPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVI 625 (714)
Q Consensus 546 ~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvv 625 (714)
.+||+|||+++....... .........+..|+|||.+.+..++.++|||||||+
T Consensus 168 ~~~l~dfg~~~~~~~~~~--------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i 221 (288)
T cd05050 168 VVKIADFGLSRNIYSADY--------------------------YKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVV 221 (288)
T ss_pred ceEECccccceecccCcc--------------------------ccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHH
Confidence 999999999875432110 000111122456999999988899999999999999
Q ss_pred HHHHHh-CCCccccCCCCcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 005102 626 LLEMIT-GRTAVVQVGSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISD 704 (714)
Q Consensus 626 l~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 704 (714)
+|||++ |..||.... ..+...... .... . .... ....++.+++.+||+.||++|||+.|+++
T Consensus 222 l~el~~~~~~p~~~~~-----~~~~~~~~~-~~~~-~-----~~~~-----~~~~~l~~li~~~l~~~p~~Rpt~~el~~ 284 (288)
T cd05050 222 LWEIFSYGMQPYYGMA-----HEEVIYYVR-DGNV-L-----SCPD-----NCPLELYNLMRLCWSKLPSDRPSFASINR 284 (288)
T ss_pred HHHHHhCCCCCCCCCC-----HHHHHHHHh-cCCC-C-----CCCC-----CCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 999998 888884321 122222211 1110 0 0011 12246889999999999999999999999
Q ss_pred HHhh
Q 005102 705 ALDR 708 (714)
Q Consensus 705 ~L~~ 708 (714)
.|++
T Consensus 285 ~l~~ 288 (288)
T cd05050 285 ILQR 288 (288)
T ss_pred HhhC
Confidence 9874
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=326.70 Aligned_cols=255 Identities=21% Similarity=0.330 Sum_probs=186.9
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeCCC--CchhHHHHHHHHHHHhccCCCCccceEEEEEeCC------ceeEEEe
Q 005102 409 FVLGKSGIGIVYKVVLE-DGHTLAVRRLGEG--GSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVD------EKLLIYD 479 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~------~~~lV~e 479 (714)
+.||+|+||.||++... +|+.||||++... .......+.+|+.+++.++||||+++++++...+ ..|+|||
T Consensus 27 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e 106 (359)
T cd07876 27 KPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVME 106 (359)
T ss_pred EEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccceeEEEEe
Confidence 47999999999999975 4899999998754 2333467889999999999999999999986543 4699999
Q ss_pred ccCCCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhh
Q 005102 480 YIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLAN 559 (714)
Q Consensus 480 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~ 559 (714)
|+++ +|.+.++ ..+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||+++...
T Consensus 107 ~~~~-~l~~~~~--------~~~~~~~~~~~~~qi~~~L~~LH~---~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~ 174 (359)
T cd07876 107 LMDA-NLCQVIH--------MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAC 174 (359)
T ss_pred CCCc-CHHHHHh--------ccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEecCCCccccc
Confidence 9965 6776664 237888999999999999999999 899999999999999999999999999987432
Q ss_pred ccCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCccccC
Q 005102 560 IAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQV 639 (714)
Q Consensus 560 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~~~~ 639 (714)
.. .......||+.|+|||.+.+..++.++|||||||++|||+||+.||...
T Consensus 175 ~~-----------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~ 225 (359)
T cd07876 175 TN-----------------------------FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGT 225 (359)
T ss_pred cC-----------------------------ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCC
Confidence 11 0112234688899999999999999999999999999999999999533
Q ss_pred CCCcc-------------hhHHH----HHHHHhhcCCc-----ccccCCCCCCCC--CcHHHHHHHHHHHhHccCCCCCC
Q 005102 640 GSSEM-------------DLVNW----MQLCIEEKKPL-----ADVLDPYLAPDA--DKEEEIIAVLKIAMACVHSSPEK 695 (714)
Q Consensus 640 ~~~~~-------------~l~~~----~~~~~~~~~~~-----~~~~d~~~~~~~--~~~~~~~~l~~li~~Cl~~dP~~ 695 (714)
...+. ..... +.......... .+.......+.. ........+.+++.+||..||++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~ 305 (359)
T cd07876 226 DHIDQWNKVIEQLGTPSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDK 305 (359)
T ss_pred CHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCccc
Confidence 21100 00000 00000000000 000000000000 00012345789999999999999
Q ss_pred CCCHHHHHH
Q 005102 696 RPTMRHISD 704 (714)
Q Consensus 696 RPt~~evl~ 704 (714)
|||+.|+++
T Consensus 306 R~t~~e~l~ 314 (359)
T cd07876 306 RISVDEALR 314 (359)
T ss_pred CCCHHHHhc
Confidence 999999986
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=346.61 Aligned_cols=275 Identities=23% Similarity=0.260 Sum_probs=200.8
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeCCCC---chhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCC
Q 005102 409 FVLGKSGIGIVYKVVLE-DGHTLAVRRLGEGG---SQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNG 484 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~g 484 (714)
+.||+|+||.||+|+.. +|+.||+|++.... ....++|.+|++++++++||||+++++++.+.+..++||||+++|
T Consensus 8 ~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVMEY~eGG 87 (932)
T PRK13184 8 RLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTMPYIEGY 87 (932)
T ss_pred EEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEEEcCCCC
Confidence 47999999999999976 48999999997542 223467999999999999999999999999999999999999999
Q ss_pred CHhhhhhCCCCC-----CCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhh
Q 005102 485 SLATALHGKPGM-----VSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLAN 559 (714)
Q Consensus 485 sL~~~l~~~~~~-----~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~ 559 (714)
+|.+++...... .....+++..+++++.||++||+|||+ .+|+||||||+||+++.++.+||+|||+++...
T Consensus 88 SL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs---~GIIHRDLKPeNILLd~dg~vKLiDFGLAk~i~ 164 (932)
T PRK13184 88 TLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHS---KGVLHRDLKPDNILLGLFGEVVILDWGAAIFKK 164 (932)
T ss_pred CHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHH---CCccccCCchheEEEcCCCCEEEEecCcceecc
Confidence 999998642110 001346788899999999999999999 899999999999999999999999999998763
Q ss_pred ccCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCccccC
Q 005102 560 IAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQV 639 (714)
Q Consensus 560 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~~~~ 639 (714)
.............. ..............||+.|+|||++.+..++.++|||||||++|||+||+.||...
T Consensus 165 ~~~~~~~~l~~~~~----------~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~ 234 (932)
T PRK13184 165 LEEEDLLDIDVDER----------NICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRK 234 (932)
T ss_pred cccccccccccccc----------cccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCc
Confidence 21110000000000 00000011223356899999999999999999999999999999999999999432
Q ss_pred CCCcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCC-CHHHHHHHHhhhhc
Q 005102 640 GSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRP-TMRHISDALDRLIV 711 (714)
Q Consensus 640 ~~~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RP-t~~evl~~L~~i~~ 711 (714)
..... ... .. ..++.... ........+.+++.+||+.||++|| +++++++.|+....
T Consensus 235 ~~~ki-----~~~---~~-----i~~P~~~~--p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq 292 (932)
T PRK13184 235 KGRKI-----SYR---DV-----ILSPIEVA--PYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQ 292 (932)
T ss_pred chhhh-----hhh---hh-----ccChhhcc--ccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 11111 000 00 00110000 0011223578899999999999995 77888888887643
|
|
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=313.33 Aligned_cols=253 Identities=26% Similarity=0.380 Sum_probs=195.2
Q ss_pred cccccCceEEEEEEECC-------CcEEEEEEeCCCC-chhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEecc
Q 005102 410 VLGKSGIGIVYKVVLED-------GHTLAVRRLGEGG-SQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYI 481 (714)
Q Consensus 410 ~lG~G~~g~Vy~~~~~~-------g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~ 481 (714)
.||+|+||.||+|+..+ +..+|+|.+.... ......+.+|++++++++||||+++++++...+..++||||+
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (269)
T cd05044 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELM 81 (269)
T ss_pred ccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEecc
Confidence 68999999999998753 2579999886543 234567899999999999999999999999999999999999
Q ss_pred CCCCHhhhhhCCCCCC-CcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCC-----CeEEcccchh
Q 005102 482 PNGSLATALHGKPGMV-SFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNM-----EPHVSDFGLA 555 (714)
Q Consensus 482 ~~gsL~~~l~~~~~~~-~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~-----~~kl~DFGla 555 (714)
++|+|.+++....... ....+++.+++.++.|++.||+|||+ .+++|+||||+||+++.++ .+|++|||++
T Consensus 82 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~ 158 (269)
T cd05044 82 EGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQ---MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLA 158 (269)
T ss_pred CCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHh---CCcccCCCChheEEEecCCCCCCcceEECCcccc
Confidence 9999999997532110 11347899999999999999999999 8999999999999999877 8999999998
Q ss_pred hhhhccCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHh-CCC
Q 005102 556 RLANIAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMIT-GRT 634 (714)
Q Consensus 556 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~ellt-G~~ 634 (714)
+....... ........++..|+|||++.+..++.++|||||||++|||+| |+.
T Consensus 159 ~~~~~~~~--------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~ 212 (269)
T cd05044 159 RDIYKSDY--------------------------YRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQ 212 (269)
T ss_pred cccccccc--------------------------cccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCC
Confidence 75432110 000111223567999999999999999999999999999998 999
Q ss_pred ccccCCCCcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhh
Q 005102 635 AVVQVGSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDALDR 708 (714)
Q Consensus 635 p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~ 708 (714)
||.... ..+....+ ...... ... ......+.+++.+||..+|++||+++++++.|++
T Consensus 213 p~~~~~--~~~~~~~~----~~~~~~------~~~-----~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 213 PYPALN--NQEVLQHV----TAGGRL------QKP-----ENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred CCcccC--HHHHHHHH----hcCCcc------CCc-----ccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 984321 11111111 111100 000 1123467899999999999999999999999874
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=311.58 Aligned_cols=247 Identities=26% Similarity=0.476 Sum_probs=195.9
Q ss_pred ccccccCceEEEEEEECCCcEEEEEEeCCCCchhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCCCHhh
Q 005102 409 FVLGKSGIGIVYKVVLEDGHTLAVRRLGEGGSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGSLAT 488 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL~~ 488 (714)
+.||+|+||.||++...++..+|+|.+.... .....|.+|++++++++|+||+++++++.. ...+++|||+++|+|.+
T Consensus 12 ~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~~~~~L~~ 89 (260)
T cd05073 12 KKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFMAKGSLLD 89 (260)
T ss_pred eEecCccceEEEEEEecCCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeCCCCcHHH
Confidence 4799999999999998888889999887643 234678999999999999999999999877 77899999999999999
Q ss_pred hhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCCCCcc
Q 005102 489 ALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQ 568 (714)
Q Consensus 489 ~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 568 (714)
++..... ..+++.+++.++.|++.||+|||+ .+++||||||+||+++.++.+||+|||.++.......
T Consensus 90 ~~~~~~~----~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~----- 157 (260)
T cd05073 90 FLKSDEG----SKQPLPKLIDFSAQIAEGMAFIEQ---RNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEY----- 157 (260)
T ss_pred HHHhCCc----cccCHHHHHHHHHHHHHHHHHHHh---CCccccccCcceEEEcCCCcEEECCCcceeeccCCCc-----
Confidence 9976432 457899999999999999999999 8999999999999999999999999999875432110
Q ss_pred CCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHh-CCCccccCCCCcchhH
Q 005102 569 SNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMIT-GRTAVVQVGSSEMDLV 647 (714)
Q Consensus 569 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~ellt-G~~p~~~~~~~~~~l~ 647 (714)
.......++..|+|||++....++.++|||||||++||++| |+.||.... ..++.
T Consensus 158 ----------------------~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~--~~~~~ 213 (260)
T cd05073 158 ----------------------TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMS--NPEVI 213 (260)
T ss_pred ----------------------ccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCC--HHHHH
Confidence 00111223566999999988889999999999999999999 899984321 11122
Q ss_pred HHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhh
Q 005102 648 NWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDALDR 708 (714)
Q Consensus 648 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~ 708 (714)
.+. ...... + .. .....++.+++.+||+.+|++||++.++.+.|+.
T Consensus 214 ~~~----~~~~~~-----~-~~-----~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 214 RAL----ERGYRM-----P-RP-----ENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred HHH----hCCCCC-----C-Cc-----ccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 111 111110 0 00 1122368899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=318.71 Aligned_cols=257 Identities=23% Similarity=0.303 Sum_probs=193.6
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeCCCC-chhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCCCH
Q 005102 409 FVLGKSGIGIVYKVVLE-DGHTLAVRRLGEGG-SQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGSL 486 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL 486 (714)
+.||+|+||.||++... ++..+|+|.+.... .....++.+|++++++++||||+++++++...+..++||||+++++|
T Consensus 7 ~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey~~~~~L 86 (308)
T cd06615 7 GELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSL 86 (308)
T ss_pred eeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeeccCCCcH
Confidence 47999999999999975 47889999887543 23345688999999999999999999999999999999999999999
Q ss_pred hhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCCCC
Q 005102 487 ATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPT 566 (714)
Q Consensus 487 ~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 566 (714)
.++++.. ..+++..+..++.|++.||.|||+. .+++||||||+||++++++.+||+|||++......
T Consensus 87 ~~~l~~~------~~~~~~~~~~~~~~i~~~l~~lH~~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~----- 153 (308)
T cd06615 87 DQVLKKA------GRIPENILGKISIAVLRGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----- 153 (308)
T ss_pred HHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhh--CCEEECCCChHHEEEecCCcEEEccCCCccccccc-----
Confidence 9999755 4588999999999999999999972 38999999999999999999999999988654211
Q ss_pred ccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCccccCCCCcchh
Q 005102 567 LQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGSSEMDL 646 (714)
Q Consensus 567 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~~~~~~~~~~l 646 (714)
......++..|+|||.+.+..++.++|||||||++|||++|+.||.... ....
T Consensus 154 -------------------------~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~--~~~~ 206 (308)
T cd06615 154 -------------------------MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPD--AKEL 206 (308)
T ss_pred -------------------------ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcc--hhhH
Confidence 0112346778999999988889999999999999999999999984322 1111
Q ss_pred HHHHHHHHhhcCCc-------------------ccccCC---CCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 005102 647 VNWMQLCIEEKKPL-------------------ADVLDP---YLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISD 704 (714)
Q Consensus 647 ~~~~~~~~~~~~~~-------------------~~~~d~---~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 704 (714)
..+........... .+..+. ...+..........+.+++.+||..||++|||++|+++
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~ 286 (308)
T cd06615 207 EAMFGRPVSEGEAKESHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTK 286 (308)
T ss_pred HHhhcCccccccccCCcccccCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 11111000000000 000000 00000000012335889999999999999999999886
Q ss_pred H
Q 005102 705 A 705 (714)
Q Consensus 705 ~ 705 (714)
.
T Consensus 287 ~ 287 (308)
T cd06615 287 H 287 (308)
T ss_pred C
Confidence 4
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=327.97 Aligned_cols=248 Identities=25% Similarity=0.390 Sum_probs=200.6
Q ss_pred ccccccCceEEEEEEECC--C--cEEEEEEeCCCCch-hHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCC
Q 005102 409 FVLGKSGIGIVYKVVLED--G--HTLAVRRLGEGGSQ-RFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPN 483 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~~--g--~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~ 483 (714)
++||+|.||.|++|.|.. | ..||||.++..... ...+|.+|+.+|.+++|||++++||...+ ....||||.++.
T Consensus 116 e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ELapl 194 (1039)
T KOG0199|consen 116 ELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFELAPL 194 (1039)
T ss_pred HHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhhccc
Confidence 479999999999999864 4 46899999876544 56899999999999999999999999987 678999999999
Q ss_pred CCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCC
Q 005102 484 GSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGG 563 (714)
Q Consensus 484 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 563 (714)
|+|.+.|++... ..|.......++.|||.||.||.+ +++|||||..+|+|+-..-.+||+|||+.+.+...+.
T Consensus 195 GSLldrLrka~~----~~llv~~Lcdya~QiA~aM~YLes---krlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned 267 (1039)
T KOG0199|consen 195 GSLLDRLRKAKK----AILLVSRLCDYAMQIAKAMQYLES---KRLVHRDLAARNLLLASPRTVKICDFGLMRALGENED 267 (1039)
T ss_pred chHHHHHhhccc----cceeHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhhhheecccceeeeecccceeccCCCCc
Confidence 999999987322 457788889999999999999999 9999999999999999988999999999998876655
Q ss_pred CCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHh-CCCccccCCCC
Q 005102 564 SPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMIT-GRTAVVQVGSS 642 (714)
Q Consensus 564 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~ellt-G~~p~~~~~~~ 642 (714)
.+.+...+. -.+.|.|||.+...+++.++|||+|||++|||+| |..||... .
T Consensus 268 ~Yvm~p~rk-------------------------vPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~--~ 320 (1039)
T KOG0199|consen 268 MYVMAPQRK-------------------------VPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGC--R 320 (1039)
T ss_pred ceEecCCCc-------------------------CcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCC--C
Confidence 444332221 1345999999999999999999999999999999 78888432 2
Q ss_pred cchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHH
Q 005102 643 EMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDAL 706 (714)
Q Consensus 643 ~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L 706 (714)
..++.+.+ .++. ++. ..+.+.+.++++|..||..+|++|||+.+|.+.+
T Consensus 321 g~qIL~~i----D~~e--------rLp---RPk~csedIY~imk~cWah~paDRptFsair~~~ 369 (1039)
T KOG0199|consen 321 GIQILKNI----DAGE--------RLP---RPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDL 369 (1039)
T ss_pred HHHHHHhc----cccc--------cCC---CCCCChHHHHHHHHHhccCCccccccHHHHHHhH
Confidence 22222111 1111 111 1123566899999999999999999999997443
|
|
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-38 Score=324.90 Aligned_cols=244 Identities=20% Similarity=0.311 Sum_probs=198.3
Q ss_pred cccccCceEEEEEEECC-CcEEEEEEeCCCCchhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCCCHhh
Q 005102 410 VLGKSGIGIVYKVVLED-GHTLAVRRLGEGGSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGSLAT 488 (714)
Q Consensus 410 ~lG~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL~~ 488 (714)
.||.|+||.||+|..++ +-..|.|++........++|.-||+||..++||+||++++.|+..+.++++.|||.||-...
T Consensus 39 ELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~GGAVDa 118 (1187)
T KOG0579|consen 39 ELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCGGGAVDA 118 (1187)
T ss_pred hhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecCCchHhH
Confidence 48899999999999776 45567788887777788999999999999999999999999999999999999999999988
Q ss_pred hhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCCCCcc
Q 005102 489 ALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQ 568 (714)
Q Consensus 489 ~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 568 (714)
++-+-. ..|++.++..+++|++.||.|||+ ..|||||||+.|||++-+|.++|+|||.+.....
T Consensus 119 imlEL~-----r~LtE~QIqvvc~q~ldALn~LHs---~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~-------- 182 (1187)
T KOG0579|consen 119 IMLELG-----RVLTEDQIQVVCYQVLDALNWLHS---QNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKS-------- 182 (1187)
T ss_pred HHHHhc-----cccchHHHHHHHHHHHHHHHHHhh---cchhhhhccccceEEEecCcEeeecccccccchh--------
Confidence 776543 569999999999999999999999 9999999999999999999999999998753211
Q ss_pred CCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccC-----CCCCCchhhhHHHHHHHHHHHhCCCccccCCCCc
Q 005102 569 SNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLK-----VVKPSQKWDIYSYGVILLEMITGRTAVVQVGSSE 643 (714)
Q Consensus 569 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~~DVwS~Gvvl~elltG~~p~~~~~~~~ 643 (714)
......++.||++|||||+.. ..+|++++|||||||+|.||..+.+|....
T Consensus 183 --------------------t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhel---- 238 (1187)
T KOG0579|consen 183 --------------------TRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHEL---- 238 (1187)
T ss_pred --------------------HHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCcccc----
Confidence 123445678999999999874 578999999999999999999999987322
Q ss_pred chhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 005102 644 MDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISD 704 (714)
Q Consensus 644 ~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 704 (714)
.....+..+.+... |.+. .+......+.+++.+||.+||+.||+++++++
T Consensus 239 -npMRVllKiaKSeP-------PTLl---qPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~ 288 (1187)
T KOG0579|consen 239 -NPMRVLLKIAKSEP-------PTLL---QPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLK 288 (1187)
T ss_pred -chHHHHHHHhhcCC-------Cccc---CcchhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence 11222211111111 1111 12234457889999999999999999999875
|
|
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=316.14 Aligned_cols=246 Identities=23% Similarity=0.242 Sum_probs=192.2
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeCCCCc---hhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCC
Q 005102 409 FVLGKSGIGIVYKVVLE-DGHTLAVRRLGEGGS---QRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNG 484 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~g 484 (714)
++||+|+||.||++... +++.||||.+..... ...+.+.+|+.++++++|++|+++++.+...+..++||||+++|
T Consensus 6 ~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~g~ 85 (285)
T cd05630 6 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGG 85 (285)
T ss_pred EEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEecCCC
Confidence 47999999999999976 589999999875422 22345778999999999999999999999999999999999999
Q ss_pred CHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCC
Q 005102 485 SLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGS 564 (714)
Q Consensus 485 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 564 (714)
+|.+++..... ..+++.++..++.|++.||.|||+ .+|+||||||+||++++++.++|+|||++.......
T Consensus 86 ~L~~~l~~~~~----~~l~~~~~~~~~~qi~~~l~~lH~---~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~-- 156 (285)
T cd05630 86 DLKFHIYHMGE----AGFEEGRAVFYAAEICCGLEDLHQ---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ-- 156 (285)
T ss_pred cHHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCc--
Confidence 99998865432 358899999999999999999999 899999999999999999999999999986532110
Q ss_pred CCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCccccCCCCcc
Q 005102 565 PTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGSSEM 644 (714)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~~~~~~~~~ 644 (714)
......|+..|+|||++.+..++.++|||||||++|||++|+.||........
T Consensus 157 ---------------------------~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~ 209 (285)
T cd05630 157 ---------------------------TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIK 209 (285)
T ss_pred ---------------------------cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccch
Confidence 11123468889999999998999999999999999999999999953321110
Q ss_pred hhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCC-----HHHHHH
Q 005102 645 DLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPT-----MRHISD 704 (714)
Q Consensus 645 ~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt-----~~evl~ 704 (714)
. .......... . ...... ....+.+++.+||+.||++||| ++|+++
T Consensus 210 -~-~~~~~~~~~~---~----~~~~~~-----~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 210 -R-EEVERLVKEV---Q----EEYSEK-----FSPDARSLCKMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred -H-HHHHhhhhhh---h----hhcCcc-----CCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence 0 1111111110 0 011111 1225779999999999999999 778775
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=310.26 Aligned_cols=252 Identities=21% Similarity=0.340 Sum_probs=197.0
Q ss_pred cccccccCceEEEEEEECCC----cEEEEEEeCCCC-chhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccC
Q 005102 408 AFVLGKSGIGIVYKVVLEDG----HTLAVRRLGEGG-SQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIP 482 (714)
Q Consensus 408 ~~~lG~G~~g~Vy~~~~~~g----~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~ 482 (714)
.+.||+|+||.||+|.+.+. ..||||...... ....+.+.+|+.++++++||||+++++++.. +..++||||++
T Consensus 11 ~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv~e~~~ 89 (270)
T cd05056 11 GRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIVMELAP 89 (270)
T ss_pred eeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEEEEcCC
Confidence 35799999999999987542 468999887654 3445689999999999999999999999865 56789999999
Q ss_pred CCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccC
Q 005102 483 NGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAG 562 (714)
Q Consensus 483 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 562 (714)
+|+|.+++.... ..+++..+..++.|++.||+|||+ .+++||||||+||+++.++.+||+|||+++......
T Consensus 90 ~~~L~~~l~~~~-----~~~~~~~~~~~~~~l~~~l~~lH~---~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~ 161 (270)
T cd05056 90 LGELRSYLQVNK-----YSLDLASLILYSYQLSTALAYLES---KRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDES 161 (270)
T ss_pred CCcHHHHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccChheEEEecCCCeEEccCceeeeccccc
Confidence 999999997543 348999999999999999999999 899999999999999999999999999987653211
Q ss_pred CCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHh-CCCccccCCC
Q 005102 563 GSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMIT-GRTAVVQVGS 641 (714)
Q Consensus 563 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~ellt-G~~p~~~~~~ 641 (714)
. .......++..|+|||.+....++.++||||||+++|||++ |+.||.....
T Consensus 162 ~---------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~ 214 (270)
T cd05056 162 Y---------------------------YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKN 214 (270)
T ss_pred c---------------------------eecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCH
Confidence 0 00011123456999999988889999999999999999996 9999943321
Q ss_pred CcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhhhhcc
Q 005102 642 SEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDALDRLIVS 712 (714)
Q Consensus 642 ~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~~ 712 (714)
.+....+ ...... ..... ....+.+++.+||..+|++|||+.++++.|+++...
T Consensus 215 --~~~~~~~----~~~~~~------~~~~~-----~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~ 268 (270)
T cd05056 215 --NDVIGRI----ENGERL------PMPPN-----CPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQE 268 (270)
T ss_pred --HHHHHHH----HcCCcC------CCCCC-----CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 1111111 111110 01111 223688999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=309.60 Aligned_cols=248 Identities=21% Similarity=0.327 Sum_probs=193.9
Q ss_pred cccccccCceEEEEEEEC-CCcEEEEEEeCCCC-----chhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEecc
Q 005102 408 AFVLGKSGIGIVYKVVLE-DGHTLAVRRLGEGG-----SQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYI 481 (714)
Q Consensus 408 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~ 481 (714)
.+.||+|++|.||++... +++.||+|.+.... ....+.+.+|++++++++||||+++++++...+..++||||+
T Consensus 7 ~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 86 (263)
T cd06625 7 GKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSIFMEYM 86 (263)
T ss_pred cceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEEEEEEC
Confidence 358999999999999975 58999999986532 122357889999999999999999999999999999999999
Q ss_pred CCCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhcc
Q 005102 482 PNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIA 561 (714)
Q Consensus 482 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 561 (714)
++++|.+++... ..+++..+.+++.|++.||+|||+ .+|+||||||+||++++++.+||+|||+++.....
T Consensus 87 ~~~~l~~~~~~~------~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~ 157 (263)
T cd06625 87 PGGSVKDQLKAY------GALTETVTRKYTRQILEGVEYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTI 157 (263)
T ss_pred CCCcHHHHHHHh------CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeecccceecccc
Confidence 999999998754 357889999999999999999999 89999999999999999999999999998754321
Q ss_pred CCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCccccCCC
Q 005102 562 GGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGS 641 (714)
Q Consensus 562 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~~~~~~ 641 (714)
... ........++..|+|||.+.+..++.++||||||+++|||++|+.||.....
T Consensus 158 ~~~-------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~ 212 (263)
T cd06625 158 CSS-------------------------GTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEA 212 (263)
T ss_pred ccc-------------------------cccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccch
Confidence 000 0001123356789999999998899999999999999999999999843211
Q ss_pred CcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 005102 642 SEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDA 705 (714)
Q Consensus 642 ~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 705 (714)
... ......... .+.... .....+.+++.+||..+|++|||+.|+++.
T Consensus 213 ----~~~-~~~~~~~~~------~~~~~~-----~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 213 ----MAA-IFKIATQPT------NPQLPS-----HVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred ----HHH-HHHHhccCC------CCCCCc-----cCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 111 111111100 111111 122357899999999999999999999763
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=314.21 Aligned_cols=244 Identities=23% Similarity=0.358 Sum_probs=189.1
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeCCCCchhHHHHHHHHHHHhcc-CCCCccceEEEEEeC------CceeEEEec
Q 005102 409 FVLGKSGIGIVYKVVLE-DGHTLAVRRLGEGGSQRFKEFQTEVEAIGKI-RHSNIVTLRAYYWSV------DEKLLIYDY 480 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~------~~~~lV~e~ 480 (714)
+.||+|+||.||+|... +++.||+|++.... .....+.+|+.++.++ +||||+++++++... ...++||||
T Consensus 12 ~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~ 90 (272)
T cd06637 12 ELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEF 90 (272)
T ss_pred HheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEEEEEEEc
Confidence 36999999999999975 48899999987543 2346788999999999 799999999998753 357899999
Q ss_pred cCCCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhc
Q 005102 481 IPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANI 560 (714)
Q Consensus 481 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 560 (714)
+++|+|.+++..... ..+++..+..++.|++.||+|||+ ++|+||||||+||++++++.+||+|||+++....
T Consensus 91 ~~~~~L~~~l~~~~~----~~l~~~~~~~~~~qi~~~l~~LH~---~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~~~ 163 (272)
T cd06637 91 CGAGSVTDLIKNTKG----NTLKEEWIAYICREILRGLSHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDR 163 (272)
T ss_pred CCCCcHHHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHEEECCCCCEEEccCCCceeccc
Confidence 999999999876432 458899999999999999999999 8999999999999999999999999999875432
Q ss_pred cCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccC-----CCCCCchhhhHHHHHHHHHHHhCCCc
Q 005102 561 AGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLK-----VVKPSQKWDIYSYGVILLEMITGRTA 635 (714)
Q Consensus 561 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~~DVwS~Gvvl~elltG~~p 635 (714)
.. .......|+..|+|||++. +..++.++|||||||++|||++|+.|
T Consensus 164 ~~----------------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p 215 (272)
T cd06637 164 TV----------------------------GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPP 215 (272)
T ss_pred cc----------------------------ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCC
Confidence 10 1112334678899999986 34578899999999999999999999
Q ss_pred cccCCCCcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 005102 636 VVQVGSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISD 704 (714)
Q Consensus 636 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 704 (714)
|..... ...... .... . .+..... .....+.+++.+||..||.+|||+.++++
T Consensus 216 ~~~~~~----~~~~~~-~~~~--~-----~~~~~~~----~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 216 LCDMHP----MRALFL-IPRN--P-----APRLKSK----KWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred ccccCH----HHHHHH-HhcC--C-----CCCCCCC----CcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 943211 111111 0000 0 0111110 12236789999999999999999999875
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=317.60 Aligned_cols=243 Identities=20% Similarity=0.360 Sum_probs=194.7
Q ss_pred ccccccCceEEEEEEE-CCCcEEEEEEeCCCCchhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCCCHh
Q 005102 409 FVLGKSGIGIVYKVVL-EDGHTLAVRRLGEGGSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGSLA 487 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL~ 487 (714)
..||.|+||.||+|.. .+++.||+|.+........+.+.+|+.+++.++||||+++++++...+..++||||+++++|.
T Consensus 25 ~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 104 (296)
T cd06655 25 EKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLT 104 (296)
T ss_pred EEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEecCCCcHH
Confidence 4699999999999986 458999999997665555678899999999999999999999999999999999999999999
Q ss_pred hhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCCCCc
Q 005102 488 TALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTL 567 (714)
Q Consensus 488 ~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 567 (714)
+++... .+++.++..++.|++.||+|||+ .+++||||||+||++++++.+||+|||+++......
T Consensus 105 ~~~~~~-------~l~~~~~~~i~~~l~~al~~LH~---~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~----- 169 (296)
T cd06655 105 DVVTET-------CMDEAQIAAVCRECLQALEFLHA---NQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQ----- 169 (296)
T ss_pred HHHHhc-------CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEccCccchhccccc-----
Confidence 988643 48899999999999999999999 899999999999999999999999999987543211
Q ss_pred cCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCccccCCCCcchhH
Q 005102 568 QSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGSSEMDLV 647 (714)
Q Consensus 568 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~~~~~~~~~~l~ 647 (714)
.......++..|+|||.+.+..++.++|||||||++|||++|+.||..... .
T Consensus 170 -----------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~-----~ 221 (296)
T cd06655 170 -----------------------SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENP-----L 221 (296)
T ss_pred -----------------------ccCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-----H
Confidence 011123467789999999988899999999999999999999999943321 1
Q ss_pred HHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 005102 648 NWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISD 704 (714)
Q Consensus 648 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 704 (714)
........... .....+ ......+.+++.+||..||++|||+.+++.
T Consensus 222 ~~~~~~~~~~~--~~~~~~--------~~~~~~~~~li~~~l~~dp~~Rpt~~~il~ 268 (296)
T cd06655 222 RALYLIATNGT--PELQNP--------EKLSPIFRDFLNRCLEMDVEKRGSAKELLQ 268 (296)
T ss_pred HHHHHHHhcCC--cccCCc--------ccCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 11111111111 000011 112235778999999999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=309.60 Aligned_cols=243 Identities=23% Similarity=0.388 Sum_probs=194.8
Q ss_pred ccccccCceEEEEEEECC-CcEEEEEEeCCCCchhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCCCHh
Q 005102 409 FVLGKSGIGIVYKVVLED-GHTLAVRRLGEGGSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGSLA 487 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL~ 487 (714)
+.||+|+||.||+|...+ ++.+|+|.+..... .+++.+|++++++++||||+++++++......+++|||+++++|.
T Consensus 9 ~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~ 86 (256)
T cd06612 9 EKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCGAGSVS 86 (256)
T ss_pred hhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecCCCCcHH
Confidence 369999999999999876 78999999876533 578999999999999999999999999999999999999999999
Q ss_pred hhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCCCCc
Q 005102 488 TALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTL 567 (714)
Q Consensus 488 ~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 567 (714)
+++.... ..+++..+..++.|++.||.|||+ .+++||||+|+||++++++.+||+|||++........
T Consensus 87 ~~l~~~~-----~~l~~~~~~~~~~~l~~~l~~lh~---~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~---- 154 (256)
T cd06612 87 DIMKITN-----KTLTEEEIAAILYQTLKGLEYLHS---NKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA---- 154 (256)
T ss_pred HHHHhCc-----cCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEECCCCcEEEcccccchhcccCcc----
Confidence 9986543 458999999999999999999999 8999999999999999999999999999886532110
Q ss_pred cCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCccccCCCCcchhH
Q 005102 568 QSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGSSEMDLV 647 (714)
Q Consensus 568 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~~~~~~~~~~l~ 647 (714)
......++..|+|||++.+..++.++||||||+++|||++|+.||........
T Consensus 155 ------------------------~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~--- 207 (256)
T cd06612 155 ------------------------KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRA--- 207 (256)
T ss_pred ------------------------ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhh---
Confidence 11122356779999999988999999999999999999999999953321110
Q ss_pred HHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 005102 648 NWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISD 704 (714)
Q Consensus 648 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 704 (714)
+.. .... ..+... ........+.+++.+||+.||++|||+.|+++
T Consensus 208 --~~~-~~~~------~~~~~~---~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 208 --IFM-IPNK------PPPTLS---DPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred --hhh-hccC------CCCCCC---chhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 000 0000 001110 01112246889999999999999999999875
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=321.13 Aligned_cols=200 Identities=25% Similarity=0.378 Sum_probs=159.4
Q ss_pred cccccccCceEEEEEEECC---CcEEEEEEeCCCCchhHHHHHHHHHHHhccCCCCccceEEEEEe--CCceeEEEeccC
Q 005102 408 AFVLGKSGIGIVYKVVLED---GHTLAVRRLGEGGSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWS--VDEKLLIYDYIP 482 (714)
Q Consensus 408 ~~~lG~G~~g~Vy~~~~~~---g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~--~~~~~lV~e~~~ 482 (714)
+..||+|+||+||+|+.++ +..||+|.+..... ...+.+|++++++++||||+++++++.. ....++||||+.
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI--SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE 83 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCC--cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence 3579999999999999754 57899999876432 2467899999999999999999999864 456789999986
Q ss_pred CCCHhhhhhCCCC---CCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeee----CCCCCeEEcccchh
Q 005102 483 NGSLATALHGKPG---MVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILL----GHNMEPHVSDFGLA 555 (714)
Q Consensus 483 ~gsL~~~l~~~~~---~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl----~~~~~~kl~DFGla 555 (714)
+ +|.+++..... ......+++..+..++.|++.||+|||+ .+|+||||||+|||+ ++++.+||+|||++
T Consensus 84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07867 84 H-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred C-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHh---CCEEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence 4 88887753211 1111358899999999999999999999 899999999999999 56679999999999
Q ss_pred hhhhccCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCC-CCCchhhhHHHHHHHHHHHhCCC
Q 005102 556 RLANIAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVV-KPSQKWDIYSYGVILLEMITGRT 634 (714)
Q Consensus 556 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DVwS~Gvvl~elltG~~ 634 (714)
+........ ........||+.|+|||++.+. .++.++|||||||++|||+||+.
T Consensus 160 ~~~~~~~~~-------------------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~ 214 (317)
T cd07867 160 RLFNSPLKP-------------------------LADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEP 214 (317)
T ss_pred eccCCCccc-------------------------ccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCC
Confidence 865322100 0111234568889999998764 57999999999999999999999
Q ss_pred cccc
Q 005102 635 AVVQ 638 (714)
Q Consensus 635 p~~~ 638 (714)
||..
T Consensus 215 ~f~~ 218 (317)
T cd07867 215 IFHC 218 (317)
T ss_pred Cccc
Confidence 9953
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=316.85 Aligned_cols=243 Identities=21% Similarity=0.349 Sum_probs=194.4
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeCCCCchhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCCCHh
Q 005102 409 FVLGKSGIGIVYKVVLE-DGHTLAVRRLGEGGSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGSLA 487 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL~ 487 (714)
+.||+|+||.||++... +++.||+|.+........+.+.+|+.+++.++||||+++++++...+..++||||+++++|.
T Consensus 25 ~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 104 (297)
T cd06656 25 EKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT 104 (297)
T ss_pred eeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecccCCCCHH
Confidence 47999999999999964 68999999998765555677899999999999999999999999999999999999999999
Q ss_pred hhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCCCCc
Q 005102 488 TALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTL 567 (714)
Q Consensus 488 ~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 567 (714)
+++... .+++.++..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||++.......
T Consensus 105 ~~~~~~-------~~~~~~~~~~~~~l~~~L~~LH~---~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~----- 169 (297)
T cd06656 105 DVVTET-------CMDEGQIAAVCRECLQALDFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ----- 169 (297)
T ss_pred HHHHhC-------CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEECcCccceEccCCc-----
Confidence 998643 47889999999999999999999 899999999999999999999999999987543211
Q ss_pred cCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCccccCCCCcchhH
Q 005102 568 QSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGSSEMDLV 647 (714)
Q Consensus 568 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~~~~~~~~~~l~ 647 (714)
.......+++.|+|||.+.+..++.++|||||||++|+|++|+.||........ +
T Consensus 170 -----------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~-~- 224 (297)
T cd06656 170 -----------------------SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA-L- 224 (297)
T ss_pred -----------------------cCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchh-e-
Confidence 011123457789999999988899999999999999999999999943221110 0
Q ss_pred HHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 005102 648 NWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISD 704 (714)
Q Consensus 648 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 704 (714)
. ...... .+... ........+.+++.+||+.+|++||+++++++
T Consensus 225 --~-~~~~~~-------~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (297)
T cd06656 225 --Y-LIATNG-------TPELQ---NPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ 268 (297)
T ss_pred --e-eeccCC-------CCCCC---CccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0 000000 00000 01112235778999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=310.85 Aligned_cols=264 Identities=25% Similarity=0.318 Sum_probs=204.1
Q ss_pred cccccccCceEEEEEEECCCcEEEEEEeCCCCchhHHHHHHHHHHHhcc--CCCCccceEEEEEeCC----ceeEEEecc
Q 005102 408 AFVLGKSGIGIVYKVVLEDGHTLAVRRLGEGGSQRFKEFQTEVEAIGKI--RHSNIVTLRAYYWSVD----EKLLIYDYI 481 (714)
Q Consensus 408 ~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l--~H~niv~l~~~~~~~~----~~~lV~e~~ 481 (714)
.+.||+|.||+||+|.|+ |..||||++...++ +.+.+|.++...+ +|+||+.+++.-..++ ..+||.+|-
T Consensus 216 ~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~srdE---~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwLvTdYH 291 (513)
T KOG2052|consen 216 QEIIGKGRFGEVWRGRWR-GEDVAVKIFSSRDE---RSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWLVTDYH 291 (513)
T ss_pred EEEecCccccceeecccc-CCceEEEEecccch---hhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEEeeecc
Confidence 357999999999999997 89999999986544 4567787777654 9999999998765433 568999999
Q ss_pred CCCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhc-----CCCCCceecCCCCCCeeeCCCCCeEEcccchhh
Q 005102 482 PNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHE-----FSPKKYVHGDLKPSNILLGHNMEPHVSDFGLAR 556 (714)
Q Consensus 482 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~-----~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~ 556 (714)
+.|||+|+|... .++-...++++..+|.||+|||. ...+.|.|||||+.|||+..++.+.|+|+|+|.
T Consensus 292 e~GSL~DyL~r~-------tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv 364 (513)
T KOG2052|consen 292 EHGSLYDYLNRN-------TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 364 (513)
T ss_pred cCCcHHHHHhhc-------cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceeeE
Confidence 999999999764 48889999999999999999994 222479999999999999999999999999997
Q ss_pred hhhccCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCC----C-C-chhhhHHHHHHHHHHH
Q 005102 557 LANIAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVK----P-S-QKWDIYSYGVILLEMI 630 (714)
Q Consensus 557 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~-s-~~~DVwS~Gvvl~ell 630 (714)
...... .++.......+||-.|||||++.... + + ..+||||||.|+||++
T Consensus 365 ~h~~~t------------------------~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEia 420 (513)
T KOG2052|consen 365 RHDSDT------------------------DTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIA 420 (513)
T ss_pred EecccC------------------------CcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHH
Confidence 554321 11233445678899999999995422 1 2 3599999999999997
Q ss_pred hC----------CCccccCCCCcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHH
Q 005102 631 TG----------RTAVVQVGSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMR 700 (714)
Q Consensus 631 tG----------~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ 700 (714)
-+ +.||++.-..+....+.. ..+ -.+-+.|.++......+.+..+.++|+.||..+|..|-|+-
T Consensus 421 rRc~~ggi~eey~~Pyyd~Vp~DPs~eeMr-kVV-----Cv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltAL 494 (513)
T KOG2052|consen 421 RRCESGGIVEEYQLPYYDVVPSDPSFEEMR-KVV-----CVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTAL 494 (513)
T ss_pred HHhhcCCEehhhcCCcccCCCCCCCHHHHh-cce-----eecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHH
Confidence 63 357755444443332211 111 11223455555666677889999999999999999999999
Q ss_pred HHHHHHhhhhcc
Q 005102 701 HISDALDRLIVS 712 (714)
Q Consensus 701 evl~~L~~i~~~ 712 (714)
.+.+.|.++..+
T Consensus 495 riKKtl~~l~~~ 506 (513)
T KOG2052|consen 495 RIKKTLAKLSNS 506 (513)
T ss_pred HHHHHHHHHhcC
Confidence 999999988754
|
|
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=310.41 Aligned_cols=246 Identities=24% Similarity=0.310 Sum_probs=192.9
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeCCCCchhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCCCHh
Q 005102 409 FVLGKSGIGIVYKVVLE-DGHTLAVRRLGEGGSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGSLA 487 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL~ 487 (714)
+.||+|+||.||+|+.. +++.||+|.++.........+.+|+.+++.++||||+++++++...+..++||||+++++|.
T Consensus 15 ~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~ 94 (267)
T cd06645 15 QRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQ 94 (267)
T ss_pred HHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEeccCCCcHH
Confidence 36999999999999875 58899999987765555567889999999999999999999999999999999999999999
Q ss_pred hhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCCCCc
Q 005102 488 TALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTL 567 (714)
Q Consensus 488 ~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 567 (714)
+++... ..+++.++..++.|++.||+|||+ .+++|+||||+||+++.++.+||+|||++.......
T Consensus 95 ~~~~~~------~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~----- 160 (267)
T cd06645 95 DIYHVT------GPLSESQIAYVSRETLQGLYYLHS---KGKMHRDIKGANILLTDNGHVKLADFGVSAQITATI----- 160 (267)
T ss_pred HHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECcceeeeEccCcc-----
Confidence 998754 458899999999999999999999 899999999999999999999999999986542110
Q ss_pred cCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccC---CCCCCchhhhHHHHHHHHHHHhCCCccccCCCCcc
Q 005102 568 QSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLK---VVKPSQKWDIYSYGVILLEMITGRTAVVQVGSSEM 644 (714)
Q Consensus 568 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~~~DVwS~Gvvl~elltG~~p~~~~~~~~~ 644 (714)
.......|+..|+|||++. ...++.++|||||||++|||++|+.||........
T Consensus 161 -----------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~ 217 (267)
T cd06645 161 -----------------------AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA 217 (267)
T ss_pred -----------------------cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhh
Confidence 0112234678899999974 45688999999999999999999999853321110
Q ss_pred hhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 005102 645 DLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISD 704 (714)
Q Consensus 645 ~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 704 (714)
+......... .+...... .....+.+++.+||..+|++|||++++++
T Consensus 218 -----~~~~~~~~~~-----~~~~~~~~---~~~~~~~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 218 -----LFLMTKSNFQ-----PPKLKDKM---KWSNSFHHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred -----HHhhhccCCC-----CCcccccC---CCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence 0000111100 01111000 11235779999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=309.47 Aligned_cols=245 Identities=22% Similarity=0.336 Sum_probs=195.1
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeCCC-CchhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCCCH
Q 005102 409 FVLGKSGIGIVYKVVLE-DGHTLAVRRLGEG-GSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGSL 486 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL 486 (714)
+.||+|+||.||++... +++.+|+|.++.. .....+.+.+|+.++++++|+||+++++++...+..++||||+++|+|
T Consensus 6 ~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l 85 (255)
T cd08219 6 RVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDGGDL 85 (255)
T ss_pred EEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeCCCCcH
Confidence 47999999999999975 5889999998653 233456788999999999999999999999999999999999999999
Q ss_pred hhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCCCC
Q 005102 487 ATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPT 566 (714)
Q Consensus 487 ~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 566 (714)
.+++....+ ..+++..++.++.|++.||.|||+ ++|+|+||||+||++++++.++++|||.++......
T Consensus 86 ~~~~~~~~~----~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~---- 154 (255)
T cd08219 86 MQKIKLQRG----KLFPEDTILQWFVQMCLGVQHIHE---KRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPG---- 154 (255)
T ss_pred HHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCcceEEECCCCcEEEcccCcceeecccc----
Confidence 998865432 357899999999999999999999 899999999999999999999999999987543211
Q ss_pred ccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCccccCCCCcchh
Q 005102 567 LQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGSSEMDL 646 (714)
Q Consensus 567 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~~~~~~~~~~l 646 (714)
.......|+..|+|||++.+..++.++||||||+++|+|++|+.||... +.
T Consensus 155 ------------------------~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~-----~~ 205 (255)
T cd08219 155 ------------------------AYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQAN-----SW 205 (255)
T ss_pred ------------------------cccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCC-----CH
Confidence 0111234577899999999888999999999999999999999999432 11
Q ss_pred HHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 005102 647 VNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDA 705 (714)
Q Consensus 647 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 705 (714)
............ .+ ... .....+.+++.+||+.||++|||+.+++.+
T Consensus 206 ~~~~~~~~~~~~------~~-~~~-----~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 206 KNLILKVCQGSY------KP-LPS-----HYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred HHHHHHHhcCCC------CC-CCc-----ccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 111111111111 01 111 122357899999999999999999999865
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=322.25 Aligned_cols=202 Identities=23% Similarity=0.262 Sum_probs=163.5
Q ss_pred cccccc--CceEEEEEEEC-CCcEEEEEEeCCCC--chhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCC
Q 005102 409 FVLGKS--GIGIVYKVVLE-DGHTLAVRRLGEGG--SQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPN 483 (714)
Q Consensus 409 ~~lG~G--~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~ 483 (714)
.+||+| +|++||++..+ +|+.||+|++.... ....+.+.+|+++++.++||||+++++++...+..++||||+++
T Consensus 4 ~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~ 83 (327)
T cd08227 4 TVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAY 83 (327)
T ss_pred hhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEeccCC
Confidence 379999 68899999874 58999999997642 23345677899999999999999999999999999999999999
Q ss_pred CCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCC
Q 005102 484 GSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGG 563 (714)
Q Consensus 484 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 563 (714)
|+|.+++..... ..+++..+++++.|++.||+|||+ .+|+||||||+|||++.++.++++||+.+........
T Consensus 84 ~~l~~~~~~~~~----~~l~~~~~~~i~~qi~~~L~~LH~---~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~ 156 (327)
T cd08227 84 GSAKDLICTHFM----DGMSELAIAYILQGVLKALDYIHH---MGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQ 156 (327)
T ss_pred CcHHHHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCChhhEEEecCCcEEEcccchhhccccccc
Confidence 999999865422 348999999999999999999999 8999999999999999999999999987653321110
Q ss_pred CCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCC--CCCCchhhhHHHHHHHHHHHhCCCcccc
Q 005102 564 SPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKV--VKPSQKWDIYSYGVILLEMITGRTAVVQ 638 (714)
Q Consensus 564 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~~~DVwS~Gvvl~elltG~~p~~~ 638 (714)
... ..........++..|+|||++.+ ..++.++|||||||++|||++|+.||..
T Consensus 157 ~~~---------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 212 (327)
T cd08227 157 RLR---------------------VVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKD 212 (327)
T ss_pred ccc---------------------ccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence 000 00001112235677999999976 4589999999999999999999999954
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=325.34 Aligned_cols=186 Identities=23% Similarity=0.308 Sum_probs=158.5
Q ss_pred cccccccCceEEEEEEECC-CcEEEEEEeCCCCchhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCCCH
Q 005102 408 AFVLGKSGIGIVYKVVLED-GHTLAVRRLGEGGSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGSL 486 (714)
Q Consensus 408 ~~~lG~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL 486 (714)
.+.||+|+||.||+|+... ++.||+|..... ....|+.++++++||||+++++++...+..++||||+. ++|
T Consensus 71 ~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l 143 (357)
T PHA03209 71 IKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYS-SDL 143 (357)
T ss_pred EEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEccC-CcH
Confidence 3579999999999999864 678999975442 23569999999999999999999999999999999994 689
Q ss_pred hhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCCCC
Q 005102 487 ATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPT 566 (714)
Q Consensus 487 ~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 566 (714)
.+++.... ..+++..+++|+.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++.....
T Consensus 144 ~~~l~~~~-----~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~----- 210 (357)
T PHA03209 144 YTYLTKRS-----RPLPIDQALIIEKQILEGLRYLHA---QRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA----- 210 (357)
T ss_pred HHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEecCccccccccC-----
Confidence 98886543 458999999999999999999999 89999999999999999999999999998743211
Q ss_pred ccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCccc
Q 005102 567 LQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVV 637 (714)
Q Consensus 567 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~~ 637 (714)
.......||..|+|||++.+..++.++|||||||++|||+++..|+.
T Consensus 211 ------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f 257 (357)
T PHA03209 211 ------------------------PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIF 257 (357)
T ss_pred ------------------------cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccc
Confidence 01122347889999999999999999999999999999999766653
|
|
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=327.51 Aligned_cols=235 Identities=22% Similarity=0.237 Sum_probs=181.9
Q ss_pred ccccCceEEEEEEEC-CCcEEEEEEeCCCC---chhHHHHHHHHHHHhcc---CCCCccceEEEEEeCCceeEEEeccCC
Q 005102 411 LGKSGIGIVYKVVLE-DGHTLAVRRLGEGG---SQRFKEFQTEVEAIGKI---RHSNIVTLRAYYWSVDEKLLIYDYIPN 483 (714)
Q Consensus 411 lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l---~H~niv~l~~~~~~~~~~~lV~e~~~~ 483 (714)
||+|+||+||+|+.. +++.||||++.+.. ......+..|..++.+. +||||+++++++...+..++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 699999999999976 48999999986532 12233456677777665 699999999999999999999999999
Q ss_pred CCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCC
Q 005102 484 GSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGG 563 (714)
Q Consensus 484 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 563 (714)
|+|.+++... ..+++..+..++.||+.||+|||+ ++|+||||||+|||+++++.+||+|||+++......
T Consensus 81 g~L~~~l~~~------~~~~~~~~~~~~~qil~al~~LH~---~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~- 150 (330)
T cd05586 81 GELFWHLQKE------GRFSEDRAKFYIAELVLALEHLHK---YDIVYRDLKPENILLDATGHIALCDFGLSKANLTDN- 150 (330)
T ss_pred ChHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC-
Confidence 9999988754 458899999999999999999999 899999999999999999999999999987432110
Q ss_pred CCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCC-CCCchhhhHHHHHHHHHHHhCCCccccCCCC
Q 005102 564 SPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVV-KPSQKWDIYSYGVILLEMITGRTAVVQVGSS 642 (714)
Q Consensus 564 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DVwS~Gvvl~elltG~~p~~~~~~~ 642 (714)
.......||..|+|||++.+. .++.++|||||||++|||+||+.||....
T Consensus 151 ---------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~-- 201 (330)
T cd05586 151 ---------------------------KTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAED-- 201 (330)
T ss_pred ---------------------------CCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCC--
Confidence 111234578899999998764 47999999999999999999999994321
Q ss_pred cchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCH
Q 005102 643 EMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTM 699 (714)
Q Consensus 643 ~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~ 699 (714)
..+........... +... .....+.+++.+||+.||++||++
T Consensus 202 ---~~~~~~~i~~~~~~--------~~~~----~~~~~~~~li~~~L~~~P~~R~~~ 243 (330)
T cd05586 202 ---TQQMYRNIAFGKVR--------FPKN----VLSDEGRQFVKGLLNRNPQHRLGA 243 (330)
T ss_pred ---HHHHHHHHHcCCCC--------CCCc----cCCHHHHHHHHHHcCCCHHHCCCC
Confidence 11222221111111 1110 012356789999999999999954
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=308.18 Aligned_cols=251 Identities=27% Similarity=0.404 Sum_probs=195.5
Q ss_pred cccccccCceEEEEEEECCCcEEEEEEeCCCCc------hhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEecc
Q 005102 408 AFVLGKSGIGIVYKVVLEDGHTLAVRRLGEGGS------QRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYI 481 (714)
Q Consensus 408 ~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~ 481 (714)
...||+|+||+||+|...+++.+|+|.+..... .....+.+|++++++++|+||+++++++.+.+..++||||+
T Consensus 5 ~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 84 (265)
T cd06631 5 GEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIFMEFV 84 (265)
T ss_pred cceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEEEecC
Confidence 357999999999999988899999998875321 12356889999999999999999999999999999999999
Q ss_pred CCCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhcc
Q 005102 482 PNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIA 561 (714)
Q Consensus 482 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 561 (714)
++++|.+++... ..+++..+..++.|++.||+|||+ .+|+|+||||+||++++++.+||+|||+++.....
T Consensus 85 ~~~~L~~~l~~~------~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 155 (265)
T cd06631 85 PGGSISSILNRF------GPLPEPVFCKYTKQILDGVAYLHN---NCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWV 155 (265)
T ss_pred CCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcCHHhEEECCCCeEEeccchhhHhhhhc
Confidence 999999999754 357899999999999999999999 89999999999999999999999999998865321
Q ss_pred CCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCccccCCC
Q 005102 562 GGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGS 641 (714)
Q Consensus 562 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~~~~~~ 641 (714)
..... .........|+..|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus 156 ~~~~~----------------------~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~ 213 (265)
T cd06631 156 GLHGT----------------------HSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDR 213 (265)
T ss_pred ccccc----------------------ccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCCh
Confidence 11000 00011223468889999999988899999999999999999999999953211
Q ss_pred CcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 005102 642 SEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISD 704 (714)
Q Consensus 642 ~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 704 (714)
. .... ....... ..+..... ....+.+++.+||+.+|++|||+.++++
T Consensus 214 ~----~~~~-~~~~~~~-----~~~~~~~~-----~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 214 L----AAMF-YIGAHRG-----LMPRLPDS-----FSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred H----HHHH-HhhhccC-----CCCCCCCC-----CCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 1 1111 1111100 01111111 2235789999999999999999999874
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=311.07 Aligned_cols=252 Identities=27% Similarity=0.395 Sum_probs=197.8
Q ss_pred ccccccCceEEEEEEECC-C----cEEEEEEeCCCCc-hhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccC
Q 005102 409 FVLGKSGIGIVYKVVLED-G----HTLAVRRLGEGGS-QRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIP 482 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~~-g----~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~ 482 (714)
+.||+|+||.||+|.+++ | ..||+|.+..... .....+.+|+.++++++||||+++++++.. ...++||||++
T Consensus 13 ~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~ 91 (279)
T cd05057 13 KVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQLITQLMP 91 (279)
T ss_pred ceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEEEEecCC
Confidence 579999999999998753 3 2689998876543 334678999999999999999999999987 78899999999
Q ss_pred CCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccC
Q 005102 483 NGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAG 562 (714)
Q Consensus 483 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 562 (714)
+|+|.+++.... ..+++..+..++.|++.||+|||+ ++|+||||||+||++++++.+||+|||+++......
T Consensus 92 ~g~L~~~l~~~~-----~~~~~~~~~~~~~qi~~~l~~LH~---~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~~ 163 (279)
T cd05057 92 LGCLLDYVRNHK-----DNIGSQYLLNWCVQIAKGMSYLEE---KRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDE 163 (279)
T ss_pred CCcHHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHh---CCEEecccCcceEEEcCCCeEEECCCcccccccCcc
Confidence 999999997653 348999999999999999999999 899999999999999999999999999998654221
Q ss_pred CCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHh-CCCccccCCC
Q 005102 563 GSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMIT-GRTAVVQVGS 641 (714)
Q Consensus 563 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~ellt-G~~p~~~~~~ 641 (714)
.. .......++..|+|||.+....++.++||||||+++||+++ |+.||....
T Consensus 164 ~~--------------------------~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~- 216 (279)
T cd05057 164 KE--------------------------YHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIP- 216 (279)
T ss_pred cc--------------------------eecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCC-
Confidence 10 00111122456999999988889999999999999999999 999984321
Q ss_pred CcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhhhhcc
Q 005102 642 SEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDALDRLIVS 712 (714)
Q Consensus 642 ~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~~ 712 (714)
..++.+... ..... -.+ .. ....+.+++.+||..||.+|||+.++++.|+++...
T Consensus 217 ----~~~~~~~~~-~~~~~---~~~---~~-----~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~ 271 (279)
T cd05057 217 ----AVEIPDLLE-KGERL---PQP---PI-----CTIDVYMVLVKCWMIDAESRPTFKELINEFSKMARD 271 (279)
T ss_pred ----HHHHHHHHh-CCCCC---CCC---CC-----CCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhC
Confidence 112222111 11110 001 01 123578999999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=328.90 Aligned_cols=254 Identities=20% Similarity=0.255 Sum_probs=189.9
Q ss_pred ccccccCceEEEEEEECC---CcEEEEEEeCCCCchhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCCC
Q 005102 409 FVLGKSGIGIVYKVVLED---GHTLAVRRLGEGGSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGS 485 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~~---g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gs 485 (714)
..||+|+||.||++...+ +..||+|.+... +.+.+|++++++++||||+++++++...+..++||||+. ++
T Consensus 98 ~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~ 171 (392)
T PHA03207 98 SSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPKYK-CD 171 (392)
T ss_pred EeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEehhcC-CC
Confidence 479999999999998643 578999988653 235689999999999999999999999999999999995 68
Q ss_pred HhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCCC
Q 005102 486 LATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSP 565 (714)
Q Consensus 486 L~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 565 (714)
|.+++... ..+++.+++.|+.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++.......
T Consensus 172 l~~~l~~~------~~l~~~~~~~i~~ql~~aL~~LH~---~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~-- 240 (392)
T PHA03207 172 LFTYVDRS------GPLPLEQAITIQRRLLEALAYLHG---RGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPD-- 240 (392)
T ss_pred HHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEcCCCCEEEccCccccccCcccc--
Confidence 99888433 468999999999999999999999 8999999999999999999999999999975432110
Q ss_pred CccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCccccCCCCc--
Q 005102 566 TLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGSSE-- 643 (714)
Q Consensus 566 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~~~~~~~~-- 643 (714)
........||+.|+|||++.+..++.++|||||||++|||++|+.||.......
T Consensus 241 ------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~ 296 (392)
T PHA03207 241 ------------------------TPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSS 296 (392)
T ss_pred ------------------------cccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcH
Confidence 111223457899999999999999999999999999999999999995432211
Q ss_pred chhHHHHHHHHhhcC-Cccc-----------ccCCCCCCCCCc------HHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 005102 644 MDLVNWMQLCIEEKK-PLAD-----------VLDPYLAPDADK------EEEIIAVLKIAMACVHSSPEKRPTMRHISD 704 (714)
Q Consensus 644 ~~l~~~~~~~~~~~~-~~~~-----------~~d~~~~~~~~~------~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 704 (714)
..+..... ...... .+.. .......+.... ......+.+++.+||..||++|||+.|++.
T Consensus 297 ~~l~~i~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~ 374 (392)
T PHA03207 297 SQLRSIIR-CMQVHPLEFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILS 374 (392)
T ss_pred HHHHHHHH-HhccCccccCCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhh
Confidence 11111111 110000 0000 000000000000 011235778999999999999999999875
|
|
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=326.30 Aligned_cols=255 Identities=20% Similarity=0.289 Sum_probs=188.0
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeCCC--CchhHHHHHHHHHHHhccCCCCccceEEEEEeC------CceeEEEe
Q 005102 409 FVLGKSGIGIVYKVVLE-DGHTLAVRRLGEG--GSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSV------DEKLLIYD 479 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~------~~~~lV~e 479 (714)
+.||+|+||.||++... .++.||||++... .....+.+.+|+.+++.++||||+++++++... ...++|||
T Consensus 23 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e 102 (355)
T cd07874 23 KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVME 102 (355)
T ss_pred EEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccceeEEEhh
Confidence 47999999999999875 4889999999754 233346788999999999999999999988643 24689999
Q ss_pred ccCCCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhh
Q 005102 480 YIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLAN 559 (714)
Q Consensus 480 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~ 559 (714)
|+++ ++.+.+. ..+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++...
T Consensus 103 ~~~~-~l~~~~~--------~~l~~~~~~~~~~qi~~aL~~LH~---~givHrDikp~Nill~~~~~~kl~Dfg~~~~~~ 170 (355)
T cd07874 103 LMDA-NLCQVIQ--------MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 170 (355)
T ss_pred hhcc-cHHHHHh--------hcCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHHEEECCCCCEEEeeCcccccCC
Confidence 9965 7777664 237889999999999999999999 899999999999999999999999999997542
Q ss_pred ccCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCccccC
Q 005102 560 IAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQV 639 (714)
Q Consensus 560 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~~~~ 639 (714)
.. .......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 171 ~~-----------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 221 (355)
T cd07874 171 TS-----------------------------FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGR 221 (355)
T ss_pred Cc-----------------------------cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 11 0112234688899999999989999999999999999999999999432
Q ss_pred CCCcchhHHH------------------HHHHHhhcCCcccccCCCC------CCCC-CcHHHHHHHHHHHhHccCCCCC
Q 005102 640 GSSEMDLVNW------------------MQLCIEEKKPLADVLDPYL------APDA-DKEEEIIAVLKIAMACVHSSPE 694 (714)
Q Consensus 640 ~~~~~~l~~~------------------~~~~~~~~~~~~~~~d~~~------~~~~-~~~~~~~~l~~li~~Cl~~dP~ 694 (714)
...+ ..... +...............+.. .... ........+.+++.+||+.||+
T Consensus 222 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~ 300 (355)
T cd07874 222 DYID-QWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPA 300 (355)
T ss_pred CHHH-HHHHHHHHhCCCCHHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCch
Confidence 2110 00000 0001111000000000000 0000 0011234678999999999999
Q ss_pred CCCCHHHHHHH
Q 005102 695 KRPTMRHISDA 705 (714)
Q Consensus 695 ~RPt~~evl~~ 705 (714)
+|||+.|+++.
T Consensus 301 ~Rps~~ell~h 311 (355)
T cd07874 301 KRISVDEALQH 311 (355)
T ss_pred hcCCHHHHhcC
Confidence 99999999873
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-38 Score=335.12 Aligned_cols=258 Identities=24% Similarity=0.364 Sum_probs=208.8
Q ss_pred HHHHhccccccccCceEEEEEEE-CCC----cEEEEEEeCCC-CchhHHHHHHHHHHHhccCCCCccceEEEEEeCCcee
Q 005102 402 ELLKASAFVLGKSGIGIVYKVVL-EDG----HTLAVRRLGEG-GSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKL 475 (714)
Q Consensus 402 ~l~~~~~~~lG~G~~g~Vy~~~~-~~g----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 475 (714)
|.+....++||+|.||+||||.+ +.| -+||+|++... ..+..+++..|+-+|.+++|||+++++|+|.... ..
T Consensus 695 Etelkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~q 773 (1177)
T KOG1025|consen 695 ETELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQ 773 (1177)
T ss_pred hhhhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HH
Confidence 33334457899999999999986 333 57899998764 4445678999999999999999999999998765 88
Q ss_pred EEEeccCCCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchh
Q 005102 476 LIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLA 555 (714)
Q Consensus 476 lV~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla 555 (714)
||++||+.|+|.++++.++ ..+..+..+.|..|||+||.|||+ +++|||||.++|||+.+-..+||.|||+|
T Consensus 774 lvtq~mP~G~LlDyvr~hr-----~~igsq~lLnw~~QIAkgM~YLe~---qrlVHrdLaaRNVLVksP~hvkitdfgla 845 (1177)
T KOG1025|consen 774 LVTQLMPLGCLLDYVREHR-----DNIGSQDLLNWCYQIAKGMKYLEE---QRLVHRDLAARNVLVKSPNHVKITDFGLA 845 (1177)
T ss_pred HHHHhcccchHHHHHHHhh-----ccccHHHHHHHHHHHHHHHHHHHh---cchhhhhhhhhheeecCCCeEEEEecchh
Confidence 9999999999999999876 457788999999999999999999 99999999999999999999999999999
Q ss_pred hhhhccCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHh-CCC
Q 005102 556 RLANIAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMIT-GRT 634 (714)
Q Consensus 556 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~ellt-G~~ 634 (714)
+.+..++........++ .+-|||-|.+....|+.++|||||||++||++| |..
T Consensus 846 ~ll~~d~~ey~~~~gK~--------------------------pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~ 899 (1177)
T KOG1025|consen 846 KLLAPDEKEYSAPGGKV--------------------------PIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAK 899 (1177)
T ss_pred hccCccccccccccccc--------------------------CcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCC
Confidence 99877665544443333 234999999999999999999999999999999 999
Q ss_pred ccccCCCCcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhhhhc
Q 005102 635 AVVQVGSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDALDRLIV 711 (714)
Q Consensus 635 p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~ 711 (714)
|+......+ + ...++.+..+ -.| +-+...++.++.+||..|++.||+++++...+.++.+
T Consensus 900 Py~gi~~~e--I----~dlle~geRL---sqP--------piCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ar 959 (1177)
T KOG1025|consen 900 PYDGIPAEE--I----PDLLEKGERL---SQP--------PICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMAR 959 (1177)
T ss_pred ccCCCCHHH--h----hHHHhccccC---CCC--------CCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhc
Confidence 995443222 2 2222222211 111 2244578999999999999999999999999887654
|
|
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=314.47 Aligned_cols=252 Identities=25% Similarity=0.427 Sum_probs=195.1
Q ss_pred ccccccCceEEEEEEEC-CCc----EEEEEEeCCCCc-hhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccC
Q 005102 409 FVLGKSGIGIVYKVVLE-DGH----TLAVRRLGEGGS-QRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIP 482 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~-~g~----~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~ 482 (714)
+.||+|+||.||+|.+. +|. .||+|.+..... .....+.+|+.++++++||||+++++++... ..++++||++
T Consensus 13 ~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~v~e~~~ 91 (303)
T cd05110 13 KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQLVTQLMP 91 (303)
T ss_pred cccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-CceeeehhcC
Confidence 47999999999999864 343 578898876433 2234788999999999999999999998754 5679999999
Q ss_pred CCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccC
Q 005102 483 NGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAG 562 (714)
Q Consensus 483 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 562 (714)
+|+|.+++.... ..+++..+..++.|++.||+|||+ ++|+||||||+||++++++.+||+|||+++......
T Consensus 92 ~g~l~~~~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~~ 163 (303)
T cd05110 92 HGCLLDYVHEHK-----DNIGSQLLLNWCVQIAKGMMYLEE---RRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDE 163 (303)
T ss_pred CCCHHHHHHhcc-----cCCCHHHHHHHHHHHHHHHHHHhh---cCeeccccccceeeecCCCceEEccccccccccCcc
Confidence 999999987653 358899999999999999999999 899999999999999999999999999998653211
Q ss_pred CCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHh-CCCccccCCC
Q 005102 563 GSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMIT-GRTAVVQVGS 641 (714)
Q Consensus 563 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~ellt-G~~p~~~~~~ 641 (714)
.. .......++..|+|||++.+..++.++|||||||++|||++ |+.||....
T Consensus 164 ~~--------------------------~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~- 216 (303)
T cd05110 164 KE--------------------------YNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIP- 216 (303)
T ss_pred cc--------------------------cccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCC-
Confidence 00 01111233567999999998899999999999999999998 889984321
Q ss_pred CcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhhhhcc
Q 005102 642 SEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDALDRLIVS 712 (714)
Q Consensus 642 ~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~~ 712 (714)
......++ ....... .+ . .....+.+++.+||..+|++||+++++++.|+++...
T Consensus 217 -~~~~~~~~----~~~~~~~---~~---~-----~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~ 271 (303)
T cd05110 217 -TREIPDLL----EKGERLP---QP---P-----ICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARD 271 (303)
T ss_pred -HHHHHHHH----HCCCCCC---CC---C-----CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 11222222 1111110 00 1 1123678999999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=326.46 Aligned_cols=247 Identities=21% Similarity=0.263 Sum_probs=188.6
Q ss_pred cccccccCceEEEEEEECC-CcEEEEEEeCCC---CchhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCC
Q 005102 408 AFVLGKSGIGIVYKVVLED-GHTLAVRRLGEG---GSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPN 483 (714)
Q Consensus 408 ~~~lG~G~~g~Vy~~~~~~-g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~ 483 (714)
.+.||+|+||.||+++.+. ++.||+|++... .....+.+.+|+.+++.++||||+++++++...+..++||||+++
T Consensus 48 ~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~Ey~~g 127 (371)
T cd05622 48 VKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPG 127 (371)
T ss_pred EEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEcCCCC
Confidence 3579999999999999864 789999998652 222335678999999999999999999999999999999999999
Q ss_pred CCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCC
Q 005102 484 GSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGG 563 (714)
Q Consensus 484 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 563 (714)
|+|.+++... .+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++......
T Consensus 128 g~L~~~~~~~-------~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~~- 196 (371)
T cd05622 128 GDLVNLMSNY-------DVPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEG- 196 (371)
T ss_pred CcHHHHHHhc-------CCCHHHHHHHHHHHHHHHHHHHH---CCEEeCCCCHHHEEECCCCCEEEEeCCceeEcCcCC-
Confidence 9999998643 37888899999999999999999 999999999999999999999999999987643211
Q ss_pred CCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCC----CCchhhhHHHHHHHHHHHhCCCccccC
Q 005102 564 SPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVK----PSQKWDIYSYGVILLEMITGRTAVVQV 639 (714)
Q Consensus 564 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~s~~~DVwS~Gvvl~elltG~~p~~~~ 639 (714)
........||+.|+|||++.+.. ++.++|||||||++|||++|+.||...
T Consensus 197 --------------------------~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~ 250 (371)
T cd05622 197 --------------------------MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYAD 250 (371)
T ss_pred --------------------------cccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCC
Confidence 01122345799999999986543 789999999999999999999999432
Q ss_pred CCCcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCC--CCCHHHHHHH
Q 005102 640 GSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEK--RPTMRHISDA 705 (714)
Q Consensus 640 ~~~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~--RPt~~evl~~ 705 (714)
. .............. ... ... ......+.+++..|+..++.+ ||+++|+++.
T Consensus 251 ~-----~~~~~~~i~~~~~~-~~~-----~~~---~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h 304 (371)
T cd05622 251 S-----LVGTYSKIMNHKNS-LTF-----PDD---NDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 304 (371)
T ss_pred C-----HHHHHHHHHcCCCc-ccC-----CCc---CCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcC
Confidence 1 12222222221111 000 000 112235778999999844433 6788888763
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=316.38 Aligned_cols=244 Identities=22% Similarity=0.338 Sum_probs=194.7
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeCCCCchhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCCCHh
Q 005102 409 FVLGKSGIGIVYKVVLE-DGHTLAVRRLGEGGSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGSLA 487 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL~ 487 (714)
..||+|+||.||++... ++..||||++........+.+.+|+.++++++|+||+++++++...+..++||||+++++|.
T Consensus 28 ~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~ 107 (292)
T cd06658 28 IKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALT 107 (292)
T ss_pred hcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCcHH
Confidence 36999999999999875 58899999987765555677999999999999999999999999999999999999999999
Q ss_pred hhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCCCCc
Q 005102 488 TALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTL 567 (714)
Q Consensus 488 ~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 567 (714)
+++.. ..+++.++..++.||+.||+|||+ .+|+||||||+||++++++.+||+|||++.......
T Consensus 108 ~~~~~-------~~l~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~----- 172 (292)
T cd06658 108 DIVTH-------TRMNEEQIATVCLSVLRALSYLHN---QGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEV----- 172 (292)
T ss_pred HHHhc-------CCCCHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCEEEccCcchhhccccc-----
Confidence 98853 347899999999999999999999 899999999999999999999999999987543211
Q ss_pred cCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCccccCCCCcchhH
Q 005102 568 QSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGSSEMDLV 647 (714)
Q Consensus 568 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~~~~~~~~~~l~ 647 (714)
.......|+..|+|||.+.+..++.++||||||+++|||++|+.||..... .
T Consensus 173 -----------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~--~--- 224 (292)
T cd06658 173 -----------------------PKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPP--L--- 224 (292)
T ss_pred -----------------------ccCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--H---
Confidence 011123457889999999888899999999999999999999999953211 1
Q ss_pred HHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 005102 648 NWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDA 705 (714)
Q Consensus 648 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 705 (714)
..+..... ...+..... ......+.+++.+||..||++|||++|+++.
T Consensus 225 ~~~~~~~~-------~~~~~~~~~---~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 225 QAMRRIRD-------NLPPRVKDS---HKVSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred HHHHHHHh-------cCCCccccc---cccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 11111111 111111111 0122357789999999999999999999863
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=314.21 Aligned_cols=244 Identities=21% Similarity=0.340 Sum_probs=194.1
Q ss_pred cccccCceEEEEEEEC-CCcEEEEEEeCCCCchhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCCCHhh
Q 005102 410 VLGKSGIGIVYKVVLE-DGHTLAVRRLGEGGSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGSLAT 488 (714)
Q Consensus 410 ~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL~~ 488 (714)
.||+|+||.||++... ++..||+|.+........+.|.+|++++++++||||+++++++...+..++||||+++++|.+
T Consensus 12 ~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 91 (280)
T cd06611 12 ELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFCDGGALDS 91 (280)
T ss_pred HhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeeccCCCcHHH
Confidence 6999999999999975 589999999987666666789999999999999999999999999999999999999999999
Q ss_pred hhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCCCCcc
Q 005102 489 ALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQ 568 (714)
Q Consensus 489 ~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 568 (714)
++.... ..+++..+.+++.|++.||.|||+ .+|+|+||||+||+++.++.++|+|||++.......
T Consensus 92 ~~~~~~-----~~l~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~------ 157 (280)
T cd06611 92 IMLELE-----RGLTEPQIRYVCRQMLEALNFLHS---HKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTL------ 157 (280)
T ss_pred HHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEECCCCCEEEccCccchhhcccc------
Confidence 987543 358999999999999999999999 899999999999999999999999999886543210
Q ss_pred CCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccC-----CCCCCchhhhHHHHHHHHHHHhCCCccccCCCCc
Q 005102 569 SNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLK-----VVKPSQKWDIYSYGVILLEMITGRTAVVQVGSSE 643 (714)
Q Consensus 569 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~~DVwS~Gvvl~elltG~~p~~~~~~~~ 643 (714)
.......++..|+|||.+. ...++.++||||||+++|||++|+.||....
T Consensus 158 ----------------------~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~--- 212 (280)
T cd06611 158 ----------------------QKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELN--- 212 (280)
T ss_pred ----------------------cccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCC---
Confidence 0111234577899999974 3457889999999999999999999994321
Q ss_pred chhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 005102 644 MDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISD 704 (714)
Q Consensus 644 ~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 704 (714)
....+........ +.... .......+.+++.+||+.+|++||+++++++
T Consensus 213 --~~~~~~~~~~~~~-------~~~~~---~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (280)
T cd06611 213 --PMRVLLKILKSEP-------PTLDQ---PSKWSSSFNDFLKSCLVKDPDDRPTAAELLK 261 (280)
T ss_pred --HHHHHHHHhcCCC-------CCcCC---cccCCHHHHHHHHHHhccChhhCcCHHHHhc
Confidence 1111111111111 11100 0112235789999999999999999999875
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=304.71 Aligned_cols=247 Identities=25% Similarity=0.360 Sum_probs=196.8
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeCCCCchhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCCCHh
Q 005102 409 FVLGKSGIGIVYKVVLE-DGHTLAVRRLGEGGSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGSLA 487 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL~ 487 (714)
+.||+|+||.||+|... +++.+|+|.+........+.+.+|++++++++||||+++++++...+..+++|||+++++|.
T Consensus 9 ~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~~~~~l~ 88 (262)
T cd06613 9 QRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQ 88 (262)
T ss_pred EEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCCCCCcHH
Confidence 47999999999999975 47889999998765556678999999999999999999999999999999999999999999
Q ss_pred hhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCCCCc
Q 005102 488 TALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTL 567 (714)
Q Consensus 488 ~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 567 (714)
+++.... ..+++.++..++.|++.||+|||+ .+|+|+||||+||++++++.+||+|||++.......
T Consensus 89 ~~~~~~~-----~~l~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~----- 155 (262)
T cd06613 89 DIYQVTR-----GPLSELQIAYVCRETLKGLAYLHE---TGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATI----- 155 (262)
T ss_pred HHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHh---CCceecCCChhhEEECCCCCEEECccccchhhhhhh-----
Confidence 9987642 358899999999999999999999 899999999999999999999999999987653211
Q ss_pred cCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCC---CCCchhhhHHHHHHHHHHHhCCCccccCCCCcc
Q 005102 568 QSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVV---KPSQKWDIYSYGVILLEMITGRTAVVQVGSSEM 644 (714)
Q Consensus 568 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~s~~~DVwS~Gvvl~elltG~~p~~~~~~~~~ 644 (714)
.......++..|+|||.+.+. .++.++||||||+++|||+||+.||........
T Consensus 156 -----------------------~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~ 212 (262)
T cd06613 156 -----------------------AKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRA 212 (262)
T ss_pred -----------------------hccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 011123457789999999776 789999999999999999999999954321111
Q ss_pred hhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 005102 645 DLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISD 704 (714)
Q Consensus 645 ~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 704 (714)
........ ...+... ........+.+++.+||..+|.+|||+.+|+.
T Consensus 213 -----~~~~~~~~-----~~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 213 -----LFLISKSN-----FPPPKLK---DKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred -----HHHHHhcc-----CCCcccc---chhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 10111110 0001111 11223456889999999999999999999874
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=311.51 Aligned_cols=260 Identities=21% Similarity=0.287 Sum_probs=189.7
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeCCCC--chhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCCC
Q 005102 409 FVLGKSGIGIVYKVVLE-DGHTLAVRRLGEGG--SQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGS 485 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gs 485 (714)
+.||+|+||.||+|+.+ +++.||+|++.... ....+.+.+|+.++++++||||+++++++...+..++||||++ ++
T Consensus 6 ~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~-~~ 84 (285)
T cd07861 6 EKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEFLS-MD 84 (285)
T ss_pred eEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEecCC-CC
Confidence 46999999999999975 58999999987542 2234678899999999999999999999999999999999997 68
Q ss_pred HhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCCC
Q 005102 486 LATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSP 565 (714)
Q Consensus 486 L~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 565 (714)
|.+++...... ..+++..+..++.|++.||+|||+ .+|+||||||+||++++++.+||+|||+++......
T Consensus 85 l~~~~~~~~~~---~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~--- 155 (285)
T cd07861 85 LKKYLDSLPKG---QYMDAELVKSYLYQILQGILFCHS---RRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV--- 155 (285)
T ss_pred HHHHHhcCCCC---CcCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCCHHHEEEcCCCcEEECcccceeecCCCc---
Confidence 98888654321 458999999999999999999999 899999999999999999999999999987542110
Q ss_pred CccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCC-CCCchhhhHHHHHHHHHHHhCCCccccCCCCcc
Q 005102 566 TLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVV-KPSQKWDIYSYGVILLEMITGRTAVVQVGSSEM 644 (714)
Q Consensus 566 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DVwS~Gvvl~elltG~~p~~~~~~~~~ 644 (714)
.......+++.|+|||.+.+. .++.++|||||||++|||+||+.||...... .
T Consensus 156 -------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~-~ 209 (285)
T cd07861 156 -------------------------RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEI-D 209 (285)
T ss_pred -------------------------ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHH-H
Confidence 011122346789999988654 4789999999999999999999999432111 1
Q ss_pred hhHHHHHHHH-------hhcCC---cccccCCCCCCCC--CcHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 005102 645 DLVNWMQLCI-------EEKKP---LADVLDPYLAPDA--DKEEEIIAVLKIAMACVHSSPEKRPTMRHISD 704 (714)
Q Consensus 645 ~l~~~~~~~~-------~~~~~---~~~~~d~~~~~~~--~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 704 (714)
.......... ..... .....+....... .......++.+++.+||+.||++|||+.+|++
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 210 QLFRIFRILGTPTEDVWPGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred HHHHHHHHhCCCChhhhhcchhhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 1111100000 00000 0000000000000 00012235779999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=311.76 Aligned_cols=248 Identities=24% Similarity=0.363 Sum_probs=196.7
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeCCCC-chhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCCCH
Q 005102 409 FVLGKSGIGIVYKVVLE-DGHTLAVRRLGEGG-SQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGSL 486 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL 486 (714)
+.||+|+||+||++... +|+.||+|++.... ....+.+.+|+++++.++||||+++++++...+..++||||+++++|
T Consensus 11 ~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 90 (284)
T cd06620 11 SDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEFMDCGSL 90 (284)
T ss_pred HHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEecCCCCCH
Confidence 37999999999999975 48899999886543 33356789999999999999999999999999999999999999999
Q ss_pred hhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCCCC
Q 005102 487 ATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPT 566 (714)
Q Consensus 487 ~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 566 (714)
.+++... ..+++..+..++.+++.||.|||+. .+++||||||+||++++++.++|+|||++......
T Consensus 91 ~~~~~~~------~~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~----- 157 (284)
T cd06620 91 DRIYKKG------GPIPVEILGKIAVAVVEGLTYLYNV--HRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS----- 157 (284)
T ss_pred HHHHHhc------cCCCHHHHHHHHHHHHHHHHHHHHh--cCeeccCCCHHHEEECCCCcEEEccCCcccchhhh-----
Confidence 9988754 3588999999999999999999962 47999999999999999999999999988643211
Q ss_pred ccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCccccCCCCc---
Q 005102 567 LQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGSSE--- 643 (714)
Q Consensus 567 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~~~~~~~~--- 643 (714)
......|+..|+|||++.+..++.++|||||||++|||+||+.||......+
T Consensus 158 -------------------------~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~ 212 (284)
T cd06620 158 -------------------------IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQ 212 (284)
T ss_pred -------------------------ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhh
Confidence 0112346788999999988889999999999999999999999995432211
Q ss_pred ---chhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 005102 644 ---MDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDA 705 (714)
Q Consensus 644 ---~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 705 (714)
..+.+++........ +.+. .......+.+++.+||+.||++|||+.|+++.
T Consensus 213 ~~~~~~~~~~~~~~~~~~-------~~~~----~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~ 266 (284)
T cd06620 213 DDPMGILDLLQQIVQEPP-------PRLP----SSDFPEDLRDFVDACLLKDPTERPTPQQLCAM 266 (284)
T ss_pred hhhhHHHHHHHHHhhccC-------CCCC----chhcCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 112222222222111 1111 11123468899999999999999999999975
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=317.04 Aligned_cols=242 Identities=21% Similarity=0.337 Sum_probs=193.8
Q ss_pred cccccCceEEEEEEEC-CCcEEEEEEeCCCCchhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCCCHhh
Q 005102 410 VLGKSGIGIVYKVVLE-DGHTLAVRRLGEGGSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGSLAT 488 (714)
Q Consensus 410 ~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL~~ 488 (714)
.||+|+||.||++... +++.||+|.+........+.+.+|+.+++.++||||+++++++...+..++||||+++++|.+
T Consensus 28 ~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L~~ 107 (297)
T cd06659 28 KIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALTD 107 (297)
T ss_pred hcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCCHHH
Confidence 6999999999999875 589999999876555555778999999999999999999999999999999999999999999
Q ss_pred hhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCCCCcc
Q 005102 489 ALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQ 568 (714)
Q Consensus 489 ~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 568 (714)
++.. ..+++..+..++.|++.||+|||+ .+++||||||+||+++.++.+||+|||+++......
T Consensus 108 ~~~~-------~~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~------ 171 (297)
T cd06659 108 IVSQ-------TRLNEEQIATVCESVLQALCYLHS---QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV------ 171 (297)
T ss_pred HHhh-------cCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHeEEccCCcEEEeechhHhhccccc------
Confidence 8753 347899999999999999999999 899999999999999999999999999987543211
Q ss_pred CCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCccccCCCCcchhHH
Q 005102 569 SNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGSSEMDLVN 648 (714)
Q Consensus 569 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~~~~~~~~~~l~~ 648 (714)
.......|+..|+|||++.+..++.++|||||||++|||++|+.||..... . .
T Consensus 172 ----------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~--~---~ 224 (297)
T cd06659 172 ----------------------PKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSP--V---Q 224 (297)
T ss_pred ----------------------ccccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--H---H
Confidence 011223467889999999988899999999999999999999999953221 1 1
Q ss_pred HHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 005102 649 WMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISD 704 (714)
Q Consensus 649 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 704 (714)
.+........ +..... ......+.+++.+||+.+|++||+++++++
T Consensus 225 ~~~~~~~~~~-------~~~~~~---~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~ 270 (297)
T cd06659 225 AMKRLRDSPP-------PKLKNA---HKISPVLRDFLERMLTREPQERATAQELLD 270 (297)
T ss_pred HHHHHhccCC-------CCcccc---CCCCHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence 1111111110 000000 011235788999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=317.29 Aligned_cols=246 Identities=24% Similarity=0.371 Sum_probs=195.2
Q ss_pred ccccccCceEEEEEEECCCcEEEEEEeCC--CCchhHHHHHHHHHHHhccC-CCCccceEEEEEeCCceeEEEeccCCCC
Q 005102 409 FVLGKSGIGIVYKVVLEDGHTLAVRRLGE--GGSQRFKEFQTEVEAIGKIR-HSNIVTLRAYYWSVDEKLLIYDYIPNGS 485 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~~g~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lV~e~~~~gs 485 (714)
+.||+||.++||++...+.+.+|+|++.. .+.+....|.+|+..|.+++ |.+||++++|-..++..||||||= ..|
T Consensus 367 k~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE~G-d~D 445 (677)
T KOG0596|consen 367 KQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVMECG-DID 445 (677)
T ss_pred HhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEeecc-ccc
Confidence 37999999999999998889999998764 35566778999999999995 999999999999999999999986 459
Q ss_pred HhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCCC
Q 005102 486 LATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSP 565 (714)
Q Consensus 486 L~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 565 (714)
|..+|...... ...| .++.|..|++.|+.++|. .||||.||||+|+|+- .|.+||+|||+|..+..+.
T Consensus 446 L~kiL~k~~~~----~~~~-~lk~ywkqML~aV~~IH~---~gIVHSDLKPANFLlV-kG~LKLIDFGIA~aI~~DT--- 513 (677)
T KOG0596|consen 446 LNKILKKKKSI----DPDW-FLKFYWKQMLLAVKTIHQ---HGIVHSDLKPANFLLV-KGRLKLIDFGIANAIQPDT--- 513 (677)
T ss_pred HHHHHHhccCC----CchH-HHHHHHHHHHHHHHHHHH---hceeecCCCcccEEEE-eeeEEeeeechhcccCccc---
Confidence 99999877532 2334 788899999999999999 9999999999999985 5689999999998765332
Q ss_pred CccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCC-----------CCCchhhhHHHHHHHHHHHhCCC
Q 005102 566 TLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVV-----------KPSQKWDIYSYGVILLEMITGRT 634 (714)
Q Consensus 566 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~s~~~DVwS~Gvvl~elltG~~ 634 (714)
+.......+||+.||+||.+... +++.++||||+|||||+|+.|++
T Consensus 514 -----------------------TsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgkt 570 (677)
T KOG0596|consen 514 -----------------------TSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKT 570 (677)
T ss_pred -----------------------cceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCC
Confidence 13344567899999999998532 25789999999999999999999
Q ss_pred ccccCCCCcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 005102 635 AVVQVGSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISD 704 (714)
Q Consensus 635 p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 704 (714)
||.+ +...+. .+..+.||.-...+.......++.++|+.||.+||.+|||+.++++
T Consensus 571 Pf~~-------~~n~~a-------Kl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLq 626 (677)
T KOG0596|consen 571 PFGQ-------IINQIA-------KLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQ 626 (677)
T ss_pred chHH-------HHHHHH-------HHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhc
Confidence 9932 221111 1344445533222222222234889999999999999999999875
|
|
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=324.27 Aligned_cols=254 Identities=20% Similarity=0.291 Sum_probs=187.3
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeCCC--CchhHHHHHHHHHHHhccCCCCccceEEEEEeC------CceeEEEe
Q 005102 409 FVLGKSGIGIVYKVVLE-DGHTLAVRRLGEG--GSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSV------DEKLLIYD 479 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~------~~~~lV~e 479 (714)
+.||+|+||.||++... .++.||||++... .....+.+.+|+.+++.++||||+++++++... ...|+|||
T Consensus 30 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~~~~lv~e 109 (364)
T cd07875 30 KPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVME 109 (364)
T ss_pred EEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccCeEEEEEe
Confidence 47999999999999975 4889999999754 233346788999999999999999999987643 34699999
Q ss_pred ccCCCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhh
Q 005102 480 YIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLAN 559 (714)
Q Consensus 480 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~ 559 (714)
|+++ +|.+.+. ..+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||+++...
T Consensus 110 ~~~~-~l~~~~~--------~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~ 177 (364)
T cd07875 110 LMDA-NLCQVIQ--------MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 177 (364)
T ss_pred CCCC-CHHHHHH--------hcCCHHHHHHHHHHHHHHHHHHhh---CCeecCCCCHHHEEECCCCcEEEEeCCCccccC
Confidence 9965 7777774 237889999999999999999999 899999999999999999999999999997543
Q ss_pred ccCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCccccC
Q 005102 560 IAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQV 639 (714)
Q Consensus 560 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~~~~ 639 (714)
.. .......||..|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 178 ~~-----------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~ 228 (364)
T cd07875 178 TS-----------------------------FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGT 228 (364)
T ss_pred CC-----------------------------CcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCC
Confidence 11 0112234688899999999999999999999999999999999999432
Q ss_pred CCCcchhHHHHH------------------HHHhhcCCccc-----ccCCCCCC-CC-CcHHHHHHHHHHHhHccCCCCC
Q 005102 640 GSSEMDLVNWMQ------------------LCIEEKKPLAD-----VLDPYLAP-DA-DKEEEIIAVLKIAMACVHSSPE 694 (714)
Q Consensus 640 ~~~~~~l~~~~~------------------~~~~~~~~~~~-----~~d~~~~~-~~-~~~~~~~~l~~li~~Cl~~dP~ 694 (714)
... ..+...+. ........... .......+ .. ........+.+++.+|++.||+
T Consensus 229 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~ 307 (364)
T cd07875 229 DHI-DQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDAS 307 (364)
T ss_pred CHH-HHHHHHHHhcCCCCHHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcc
Confidence 211 00100000 00000000000 00000000 00 0001224678999999999999
Q ss_pred CCCCHHHHHH
Q 005102 695 KRPTMRHISD 704 (714)
Q Consensus 695 ~RPt~~evl~ 704 (714)
+|||+.|+++
T Consensus 308 ~R~t~~e~L~ 317 (364)
T cd07875 308 KRISVDEALQ 317 (364)
T ss_pred cCCCHHHHhc
Confidence 9999999976
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=312.16 Aligned_cols=257 Identities=23% Similarity=0.286 Sum_probs=186.5
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeCCCCc--hhHHHHHHHHHHHhcc---CCCCccceEEEEEeC-----CceeEE
Q 005102 409 FVLGKSGIGIVYKVVLE-DGHTLAVRRLGEGGS--QRFKEFQTEVEAIGKI---RHSNIVTLRAYYWSV-----DEKLLI 477 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~H~niv~l~~~~~~~-----~~~~lV 477 (714)
+.||+|+||+||+|+.. +++.||+|.++.... .....+.+|+++++++ +||||+++++++... ...++|
T Consensus 6 ~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~~~~lv 85 (288)
T cd07863 6 AEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRETKVTLV 85 (288)
T ss_pred eEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCceEEEE
Confidence 46999999999999976 589999999875421 2224566788877766 699999999998642 347899
Q ss_pred EeccCCCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhh
Q 005102 478 YDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARL 557 (714)
Q Consensus 478 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 557 (714)
|||++ ++|.+++..... ..+++..+..++.|++.||+|||+ .+|+||||||+||++++++.+||+|||+++.
T Consensus 86 ~e~~~-~~l~~~~~~~~~----~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dikp~Nili~~~~~~kl~dfg~~~~ 157 (288)
T cd07863 86 FEHVD-QDLRTYLDKVPP----PGLPAETIKDLMRQFLRGLDFLHA---NCIVHRDLKPENILVTSGGQVKLADFGLARI 157 (288)
T ss_pred Ecccc-cCHHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECccCcccc
Confidence 99997 489988875432 348999999999999999999999 8999999999999999999999999999876
Q ss_pred hhccCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCccc
Q 005102 558 ANIAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVV 637 (714)
Q Consensus 558 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~~ 637 (714)
..... ......||..|+|||++.+..++.++|||||||++|||++|++||.
T Consensus 158 ~~~~~-----------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~ 208 (288)
T cd07863 158 YSCQM-----------------------------ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFC 208 (288)
T ss_pred ccCcc-----------------------------cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcC
Confidence 53210 1112345788999999998899999999999999999999999984
Q ss_pred cCCCCcchhHHHHHHHHhhc--CCcc-------cccCCCCCCCC--CcHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 005102 638 QVGSSEMDLVNWMQLCIEEK--KPLA-------DVLDPYLAPDA--DKEEEIIAVLKIAMACVHSSPEKRPTMRHISD 704 (714)
Q Consensus 638 ~~~~~~~~l~~~~~~~~~~~--~~~~-------~~~d~~~~~~~--~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 704 (714)
..... ..+..... ..... .... ....+...... ........+.+++.+||+.||++|||+.|++.
T Consensus 209 ~~~~~-~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 209 GNSEA-DQLGKIFD-LIGLPPEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred CCCHH-HHHHHHHH-HhCCCChhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 32211 11111111 10000 0000 00000000000 00112345789999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=310.40 Aligned_cols=241 Identities=23% Similarity=0.371 Sum_probs=193.0
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeCCCC-chhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCCCH
Q 005102 409 FVLGKSGIGIVYKVVLE-DGHTLAVRRLGEGG-SQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGSL 486 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL 486 (714)
+.||+|+||.||+|.+. ++..||+|.+.... ....+.+.+|++++++++||||+++++++...+..++||||+++++|
T Consensus 10 ~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 89 (277)
T cd06642 10 ERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLGGGSA 89 (277)
T ss_pred HHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEccCCCcH
Confidence 36999999999999875 47899999987543 33446789999999999999999999999999999999999999999
Q ss_pred hhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCCCC
Q 005102 487 ATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPT 566 (714)
Q Consensus 487 ~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 566 (714)
.+++.. ..+++..+..++.|++.|+.|||+ ++++|+||+|+||++++++.+||+|||+++......
T Consensus 90 ~~~~~~-------~~~~~~~~~~~~~~i~~~l~~lH~---~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~---- 155 (277)
T cd06642 90 LDLLKP-------GPLEETYIATILREILKGLDYLHS---ERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ---- 155 (277)
T ss_pred HHHhhc-------CCCCHHHHHHHHHHHHHHHHHHhc---CCeeccCCChheEEEeCCCCEEEccccccccccCcc----
Confidence 998853 347899999999999999999999 899999999999999999999999999987543210
Q ss_pred ccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCccccCCCCcchh
Q 005102 567 LQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGSSEMDL 646 (714)
Q Consensus 567 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~~~~~~~~~~l 646 (714)
.......++..|+|||++.+..++.++|||||||++|||+||+.|+......
T Consensus 156 ------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~---- 207 (277)
T cd06642 156 ------------------------IKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPM---- 207 (277)
T ss_pred ------------------------hhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchh----
Confidence 0111234577899999999888999999999999999999999998432111
Q ss_pred HHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 005102 647 VNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISD 704 (714)
Q Consensus 647 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 704 (714)
..... .... ..+.... .....+.+++.+||+.+|++|||+.++++
T Consensus 208 -~~~~~-~~~~------~~~~~~~-----~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 252 (277)
T cd06642 208 -RVLFL-IPKN------SPPTLEG-----QYSKPFKEFVEACLNKDPRFRPTAKELLK 252 (277)
T ss_pred -hHHhh-hhcC------CCCCCCc-----ccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 11111 1111 1111111 12346889999999999999999999987
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=333.89 Aligned_cols=253 Identities=17% Similarity=0.232 Sum_probs=182.2
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeCCCCchhHHHHHHHHHHHhccCC------CCccceEEEEEeC-CceeEEEec
Q 005102 409 FVLGKSGIGIVYKVVLE-DGHTLAVRRLGEGGSQRFKEFQTEVEAIGKIRH------SNIVTLRAYYWSV-DEKLLIYDY 480 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H------~niv~l~~~~~~~-~~~~lV~e~ 480 (714)
+.||+|+||+||+|++. +++.||||+++.... ....+..|++++++++| .+++++++++... ++.++|||+
T Consensus 135 ~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~-~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~~~iv~~~ 213 (467)
T PTZ00284 135 SLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPK-YTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGHMCIVMPK 213 (467)
T ss_pred EEEEeccCEEEEEEEEcCCCeEEEEEEEecchh-hHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCceEEEEEec
Confidence 47999999999999975 478999999975322 22456677777777754 4588899988764 468899998
Q ss_pred cCCCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCC---------------
Q 005102 481 IPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNM--------------- 545 (714)
Q Consensus 481 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~--------------- 545 (714)
+ +++|.+++... ..+++..+..|+.||+.||+|||+. .+||||||||+|||++.++
T Consensus 214 ~-g~~l~~~l~~~------~~l~~~~~~~i~~qi~~aL~yLH~~--~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~~~ 284 (467)
T PTZ00284 214 Y-GPCLLDWIMKH------GPFSHRHLAQIIFQTGVALDYFHTE--LHLMHTDLKPENILMETSDTVVDPVTNRALPPDP 284 (467)
T ss_pred c-CCCHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHhc--CCeecCCCCHHHEEEecCCcccccccccccCCCC
Confidence 8 77899988754 4589999999999999999999971 3999999999999998765
Q ss_pred -CeEEcccchhhhhhccCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHH
Q 005102 546 -EPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGV 624 (714)
Q Consensus 546 -~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gv 624 (714)
.+||+|||.+.... .......||+.|+|||++.+..++.++|||||||
T Consensus 285 ~~vkl~DfG~~~~~~-------------------------------~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGv 333 (467)
T PTZ00284 285 CRVRICDLGGCCDER-------------------------------HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGC 333 (467)
T ss_pred ceEEECCCCccccCc-------------------------------cccccccCCccccCcHHhhcCCCCcHHHHHHHHH
Confidence 49999999875321 1122345789999999999999999999999999
Q ss_pred HHHHHHhCCCccccCCCCcchhHHHHHHHHhh-------cC---Cccccc------CCCCCCC----------CCcHHHH
Q 005102 625 ILLEMITGRTAVVQVGSSEMDLVNWMQLCIEE-------KK---PLADVL------DPYLAPD----------ADKEEEI 678 (714)
Q Consensus 625 vl~elltG~~p~~~~~~~~~~l~~~~~~~~~~-------~~---~~~~~~------d~~~~~~----------~~~~~~~ 678 (714)
++|||++|+.||.... ..+....+...... .. ...+++ .+...+. .......
T Consensus 334 il~elltG~~pf~~~~--~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 411 (467)
T PTZ00284 334 IIYELYTGKLLYDTHD--NLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRD 411 (467)
T ss_pred HHHHHHhCCCCCCCCC--hHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhch
Confidence 9999999999995322 11211111111000 00 000000 0000000 0000112
Q ss_pred HHHHHHHhHccCCCCCCCCCHHHHHH
Q 005102 679 IAVLKIAMACVHSSPEKRPTMRHISD 704 (714)
Q Consensus 679 ~~l~~li~~Cl~~dP~~RPt~~evl~ 704 (714)
..+.+|+.+||+.||++|||++|+++
T Consensus 412 ~~~~dli~~mL~~dP~~R~ta~e~L~ 437 (467)
T PTZ00284 412 DLLCDLIYGLLHYDRQKRLNARQMTT 437 (467)
T ss_pred HHHHHHHHHhCCcChhhCCCHHHHhc
Confidence 35789999999999999999999986
|
|
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=318.10 Aligned_cols=243 Identities=23% Similarity=0.295 Sum_probs=199.6
Q ss_pred ccccccCceEEEEEEECC-CcEEEEEEeCCCCc---hhHHHHHHHHHHHhccC-CCCccceEEEEEeCCceeEEEeccCC
Q 005102 409 FVLGKSGIGIVYKVVLED-GHTLAVRRLGEGGS---QRFKEFQTEVEAIGKIR-HSNIVTLRAYYWSVDEKLLIYDYIPN 483 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~~-g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lV~e~~~~ 483 (714)
..||+|.||.||+++.+. |+.+|+|.+.+... .....+.+|+++|+++. |||||.+++.|++....++|||++.+
T Consensus 41 ~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~lvmEL~~G 120 (382)
T KOG0032|consen 41 RELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYLVMELCEG 120 (382)
T ss_pred hhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEEEEEecCC
Confidence 479999999999999876 99999999987533 23468999999999998 99999999999999999999999999
Q ss_pred CCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCC----CCeEEcccchhhhhh
Q 005102 484 GSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHN----MEPHVSDFGLARLAN 559 (714)
Q Consensus 484 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~----~~~kl~DFGla~~~~ 559 (714)
|.|.+.+... . +++..+..++.|++.|++|||+ .+|+||||||+|+|+... +.+|++|||+|+...
T Consensus 121 GeLfd~i~~~------~-~sE~da~~~~~~il~av~~lH~---~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~ 190 (382)
T KOG0032|consen 121 GELFDRIVKK------H-YSERDAAGIIRQILEAVKYLHS---LGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIK 190 (382)
T ss_pred chHHHHHHHc------c-CCHHHHHHHHHHHHHHHHHHHh---CCceeccCCHHHeeeccccCCCCcEEEeeCCCceEcc
Confidence 9999998654 2 8899999999999999999999 899999999999999643 579999999998765
Q ss_pred ccCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCccccC
Q 005102 560 IAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQV 639 (714)
Q Consensus 560 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~~~~ 639 (714)
.. .......||++|+|||++....|+..+||||+||++|.|++|..||...
T Consensus 191 ~~-----------------------------~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~ 241 (382)
T KOG0032|consen 191 PG-----------------------------ERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGE 241 (382)
T ss_pred CC-----------------------------ceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCC
Confidence 31 1234567899999999999999999999999999999999999999543
Q ss_pred CCCcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 005102 640 GSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISD 704 (714)
Q Consensus 640 ~~~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 704 (714)
...... ........ ++-++.. ......+.+++..|+..||.+|+|+.++++
T Consensus 242 ~~~~~~-----~~i~~~~~---~f~~~~w------~~is~~akd~i~~ll~~dp~~R~ta~~~L~ 292 (382)
T KOG0032|consen 242 TEFEIF-----LAILRGDF---DFTSEPW------DDISESAKDFIRKLLEFDPRKRLTAAQALQ 292 (382)
T ss_pred ChhHHH-----HHHHcCCC---CCCCCCc------cccCHHHHHHHHHhcccCcccCCCHHHHhc
Confidence 322211 11222211 1112211 223446789999999999999999999987
|
|
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=315.82 Aligned_cols=257 Identities=22% Similarity=0.297 Sum_probs=190.4
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeCCCC-chhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCCCH
Q 005102 409 FVLGKSGIGIVYKVVLE-DGHTLAVRRLGEGG-SQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGSL 486 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL 486 (714)
..||+|+||.||+|+.+ +++.||+|.+.... ......+.+|++++++++||||+++++++...+..++||||++ ++|
T Consensus 12 ~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~~~-~~l 90 (301)
T cd07873 12 DKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLD-KDL 90 (301)
T ss_pred eEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEeccc-cCH
Confidence 46999999999999875 48899999987543 2233567889999999999999999999999999999999997 599
Q ss_pred hhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCCCC
Q 005102 487 ATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPT 566 (714)
Q Consensus 487 ~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 566 (714)
.+++.... ..+++..+..++.|++.||+|||+ .+|+||||||+||++++++.+||+|||+++......
T Consensus 91 ~~~l~~~~-----~~~~~~~~~~~~~qi~~aL~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~---- 158 (301)
T cd07873 91 KQYLDDCG-----NSINMHNVKLFLFQLLRGLNYCHR---RKVLHRDLKPQNLLINERGELKLADFGLARAKSIPT---- 158 (301)
T ss_pred HHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCC----
Confidence 99887543 357899999999999999999999 899999999999999999999999999987542111
Q ss_pred ccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCC-CCCchhhhHHHHHHHHHHHhCCCccccCCCCcch
Q 005102 567 LQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVV-KPSQKWDIYSYGVILLEMITGRTAVVQVGSSEMD 645 (714)
Q Consensus 567 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DVwS~Gvvl~elltG~~p~~~~~~~~~~ 645 (714)
.......+++.|+|||.+.+. .++.++|||||||++|||+||+.||..... .+
T Consensus 159 ------------------------~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~--~~ 212 (301)
T cd07873 159 ------------------------KTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTV--EE 212 (301)
T ss_pred ------------------------CcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCH--HH
Confidence 011122347789999998654 478899999999999999999999953321 11
Q ss_pred hHHHHHHHHhhcC--Cccccc---------CCCCCCCC---CcHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 005102 646 LVNWMQLCIEEKK--PLADVL---------DPYLAPDA---DKEEEIIAVLKIAMACVHSSPEKRPTMRHISD 704 (714)
Q Consensus 646 l~~~~~~~~~~~~--~~~~~~---------d~~~~~~~---~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 704 (714)
....+........ ....+. .+...... ........+.+++.+|++.||.+|||++|+++
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~ 285 (301)
T cd07873 213 QLHFIFRILGTPTEETWPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK 285 (301)
T ss_pred HHHHHHHHcCCCChhhchhhhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 1111111111000 000000 00000000 00011235779999999999999999999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=318.81 Aligned_cols=249 Identities=22% Similarity=0.288 Sum_probs=187.7
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeCCC---CchhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCC
Q 005102 409 FVLGKSGIGIVYKVVLE-DGHTLAVRRLGEG---GSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNG 484 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~g 484 (714)
+.||+|+||+||+++.. +++.||+|++.+. .....+.+.+|+.++..++|+||+++++++.+.+..++||||+++|
T Consensus 7 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~ 86 (331)
T cd05597 7 KVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVMDYYVGG 86 (331)
T ss_pred EEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEEecCCCC
Confidence 47999999999999976 4899999998752 2223456889999999999999999999999999999999999999
Q ss_pred CHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCC
Q 005102 485 SLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGS 564 (714)
Q Consensus 485 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 564 (714)
+|.+++.... ..+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++......
T Consensus 87 ~L~~~l~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-- 156 (331)
T cd05597 87 DLLTLLSKFE-----DRLPEDMARFYLAEMVLAIDSVHQ---LGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADG-- 156 (331)
T ss_pred cHHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHh---CCeEECCCCHHHEEECCCCCEEEEECCceeecCCCC--
Confidence 9999997532 358899999999999999999999 899999999999999999999999999986543211
Q ss_pred CCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCC-----CCCCchhhhHHHHHHHHHHHhCCCccccC
Q 005102 565 PTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKV-----VKPSQKWDIYSYGVILLEMITGRTAVVQV 639 (714)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~~~DVwS~Gvvl~elltG~~p~~~~ 639 (714)
........||+.|+|||++.. ..++.++|||||||++|||++|+.||...
T Consensus 157 -------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~ 211 (331)
T cd05597 157 -------------------------TVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAE 211 (331)
T ss_pred -------------------------CccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCC
Confidence 001112347889999999863 45788999999999999999999999432
Q ss_pred CCCcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCC--CCCCCHHHHHHH
Q 005102 640 GSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSP--EKRPTMRHISDA 705 (714)
Q Consensus 640 ~~~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP--~~RPt~~evl~~ 705 (714)
...+............ . +.+. .. .....+.+++.+|+..++ ..||+++++++.
T Consensus 212 -----~~~~~~~~i~~~~~~~-~-~~~~-~~-----~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 212 -----SLVETYGKIMNHKEHF-Q-FPPD-VT-----DVSEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred -----CHHHHHHHHHcCCCcc-c-CCCc-cC-----CCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 1222222222111100 0 0010 00 122356778888775433 347888888753
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-36 Score=304.64 Aligned_cols=242 Identities=28% Similarity=0.461 Sum_probs=191.4
Q ss_pred cccccccCceEEEEEEECCCcEEEEEEeCCCCchhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCCCHh
Q 005102 408 AFVLGKSGIGIVYKVVLEDGHTLAVRRLGEGGSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGSLA 487 (714)
Q Consensus 408 ~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL~ 487 (714)
.+.||+|+||.||++.. +++.||+|.++... ..+.+.+|+.++++++||||+++++++.. +..++||||+++++|.
T Consensus 11 ~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~~v~e~~~~~~L~ 86 (254)
T cd05083 11 GEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILH-NGLYIVMELMSKGNLV 86 (254)
T ss_pred eeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcC-CCcEEEEECCCCCCHH
Confidence 35799999999999986 57889999987543 23678999999999999999999999865 4579999999999999
Q ss_pred hhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCCCCc
Q 005102 488 TALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTL 567 (714)
Q Consensus 488 ~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 567 (714)
+++..... ..+++..+.+++.|++.||+|||+ .+++||||||+||+++.++.+||+|||+++......
T Consensus 87 ~~l~~~~~----~~~~~~~~~~~~~qi~~al~~lH~---~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~----- 154 (254)
T cd05083 87 NFLRTRGR----ALVSVIQLLQFSLDVAEGMEYLES---KKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV----- 154 (254)
T ss_pred HHHHhcCc----CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccCcceEEEcCCCcEEECCCccceeccccC-----
Confidence 99976532 358899999999999999999999 899999999999999999999999999987432110
Q ss_pred cCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHh-CCCccccCCCCcchh
Q 005102 568 QSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMIT-GRTAVVQVGSSEMDL 646 (714)
Q Consensus 568 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~ellt-G~~p~~~~~~~~~~l 646 (714)
.....+..|+|||.+.+..++.++|||||||++|||++ |+.||.... .
T Consensus 155 --------------------------~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~-----~ 203 (254)
T cd05083 155 --------------------------DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMS-----L 203 (254)
T ss_pred --------------------------CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCC-----H
Confidence 01112356999999988899999999999999999998 999984322 1
Q ss_pred HHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhh
Q 005102 647 VNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDALDR 708 (714)
Q Consensus 647 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~ 708 (714)
.+.... ....... ++ .. .....+.+++.+||+.+|++||+++++++.|++
T Consensus 204 ~~~~~~-~~~~~~~----~~--~~-----~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 204 KEVKEC-VEKGYRM----EP--PE-----GCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred HHHHHH-HhCCCCC----CC--CC-----cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 122211 1111110 00 11 123467899999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=305.32 Aligned_cols=248 Identities=23% Similarity=0.370 Sum_probs=193.9
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeCCCCch---------hHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEE
Q 005102 409 FVLGKSGIGIVYKVVLE-DGHTLAVRRLGEGGSQ---------RFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIY 478 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~---------~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 478 (714)
..||+|+||.||+|... +++.||+|.+...... ..+.+.+|++++++++||||+++++++...+..++||
T Consensus 6 ~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 85 (267)
T cd06628 6 ALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHLNIFL 85 (267)
T ss_pred ceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCccEEEE
Confidence 47999999999999875 4889999988654221 1256889999999999999999999999999999999
Q ss_pred eccCCCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhh
Q 005102 479 DYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLA 558 (714)
Q Consensus 479 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~ 558 (714)
||+++++|.+++... ..+++..+..++.|++.||+|||+ .+++||||||+||++++++.+||+|||.++..
T Consensus 86 e~~~~~~L~~~l~~~------~~l~~~~~~~~~~~l~~~l~~lH~---~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~ 156 (267)
T cd06628 86 EYVPGGSVAALLNNY------GAFEETLVRNFVRQILKGLNYLHN---RGIIHRDIKGANILVDNKGGIKISDFGISKKL 156 (267)
T ss_pred EecCCCCHHHHHHhc------cCccHHHHHHHHHHHHHHHHHHHh---cCcccccCCHHHEEEcCCCCEEecccCCCccc
Confidence 999999999999754 458889999999999999999999 89999999999999999999999999999865
Q ss_pred hccCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCcccc
Q 005102 559 NIAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQ 638 (714)
Q Consensus 559 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~~~ 638 (714)
......... ........|+..|+|||.+.+..++.++|||||||++|||++|+.||..
T Consensus 157 ~~~~~~~~~----------------------~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~ 214 (267)
T cd06628 157 EANSLSTKT----------------------NGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPD 214 (267)
T ss_pred ccccccCCc----------------------cccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCC
Confidence 421100000 0011123467789999999988899999999999999999999999953
Q ss_pred CCCCcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 005102 639 VGSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISD 704 (714)
Q Consensus 639 ~~~~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 704 (714)
... . .-+..... ...+..... ....+.+++.+||+.||.+||++.|+++
T Consensus 215 ~~~----~-~~~~~~~~-------~~~~~~~~~-----~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 215 CTQ----L-QAIFKIGE-------NASPEIPSN-----ISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred ccH----H-HHHHHHhc-------cCCCcCCcc-----cCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 211 1 11111001 111111111 2236789999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=306.61 Aligned_cols=255 Identities=26% Similarity=0.405 Sum_probs=193.6
Q ss_pred ccccccCceEEEEEEEC----CCcEEEEEEeCCC--CchhHHHHHHHHHHHhccCCCCccceEEEEEeCC------ceeE
Q 005102 409 FVLGKSGIGIVYKVVLE----DGHTLAVRRLGEG--GSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVD------EKLL 476 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~----~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~------~~~l 476 (714)
+.||+|+||.||+|.+. +++.||||++... .....+++.+|++++++++||||+++++++...+ ..++
T Consensus 5 ~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~ 84 (273)
T cd05074 5 RMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPIPMV 84 (273)
T ss_pred hcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcccceEE
Confidence 47999999999999864 3689999998764 2334567899999999999999999999886532 2378
Q ss_pred EEeccCCCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhh
Q 005102 477 IYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLAR 556 (714)
Q Consensus 477 V~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~ 556 (714)
++||+++|+|.+++...........+++..+++++.|++.||+|||+ .+|+||||||+||++++++.+||+|||+++
T Consensus 85 ~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~nili~~~~~~kl~dfg~~~ 161 (273)
T cd05074 85 ILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSS---KNFIHRDLAARNCMLNENMTVCVADFGLSK 161 (273)
T ss_pred EEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccchhhEEEcCCCCEEECcccccc
Confidence 99999999999887543211111357899999999999999999999 899999999999999999999999999988
Q ss_pred hhhccCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHh-CCCc
Q 005102 557 LANIAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMIT-GRTA 635 (714)
Q Consensus 557 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~ellt-G~~p 635 (714)
....... ........++..|++||.+....++.++||||||+++|||++ |+.|
T Consensus 162 ~~~~~~~--------------------------~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p 215 (273)
T cd05074 162 KIYSGDY--------------------------YRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTP 215 (273)
T ss_pred cccCCcc--------------------------eecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCC
Confidence 5432110 000111223456999999988889999999999999999999 8888
Q ss_pred cccCCCCcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhhh
Q 005102 636 VVQVGSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDALDRL 709 (714)
Q Consensus 636 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i 709 (714)
|... ...++..+.. ..... .... .....+.+++.+||+.+|++|||+.++++.|+++
T Consensus 216 ~~~~--~~~~~~~~~~----~~~~~------~~~~-----~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 216 YAGV--ENSEIYNYLI----KGNRL------KQPP-----DCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred CCCC--CHHHHHHHHH----cCCcC------CCCC-----CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 8422 1122222111 11110 0001 1223688999999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=308.58 Aligned_cols=248 Identities=27% Similarity=0.407 Sum_probs=194.6
Q ss_pred ccccccCceEEEEEEECC-CcEEEEEEeCCCCchhHH--HHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCCC
Q 005102 409 FVLGKSGIGIVYKVVLED-GHTLAVRRLGEGGSQRFK--EFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGS 485 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~--~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gs 485 (714)
+.||+|+||+||++.... ++.||+|++......... ...+|+.++++++||||+++++++......++||||+++++
T Consensus 5 ~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~~~~~ 84 (260)
T PF00069_consen 5 KKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYCPGGS 84 (260)
T ss_dssp EEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEETTEB
T ss_pred EEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccccccc
Confidence 479999999999999875 668999999887544322 34569999999999999999999999999999999999999
Q ss_pred HhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCCC
Q 005102 486 LATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSP 565 (714)
Q Consensus 486 L~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 565 (714)
|.+++... ..+++..+..++.|+++||+|||+ .+|+|+||||+||++++++.++|+|||.+......
T Consensus 85 L~~~l~~~------~~~~~~~~~~~~~qi~~~L~~Lh~---~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~---- 151 (260)
T PF00069_consen 85 LQDYLQKN------KPLSEEEILKIAYQILEALAYLHS---KGIVHRDIKPENILLDENGEVKLIDFGSSVKLSEN---- 151 (260)
T ss_dssp HHHHHHHH------SSBBHHHHHHHHHHHHHHHHHHHH---TTEEESSBSGGGEEESTTSEEEESSGTTTEESTST----
T ss_pred cccccccc------cccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccc----
Confidence 99999732 458999999999999999999999 89999999999999999999999999998753110
Q ss_pred CccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccC-CCCCCchhhhHHHHHHHHHHHhCCCccccCCCCcc
Q 005102 566 TLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLK-VVKPSQKWDIYSYGVILLEMITGRTAVVQVGSSEM 644 (714)
Q Consensus 566 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~s~~~DVwS~Gvvl~elltG~~p~~~~~~~~~ 644 (714)
........++..|+|||.+. +..++.++||||+|+++|+|++|+.||... ...
T Consensus 152 ------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~--~~~ 205 (260)
T PF00069_consen 152 ------------------------NENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEES--NSD 205 (260)
T ss_dssp ------------------------TSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTS--SHH
T ss_pred ------------------------ccccccccccccccccccccccccccccccccccccccccccccccccccc--cch
Confidence 11222344678899999998 788999999999999999999999999543 111
Q ss_pred hhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 005102 645 DLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISD 704 (714)
Q Consensus 645 ~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 704 (714)
+............. .. .... .......+.+++.+||+.||++|||+.++++
T Consensus 206 ~~~~~~~~~~~~~~--~~---~~~~----~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 206 DQLEIIEKILKRPL--PS---SSQQ----SREKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp HHHHHHHHHHHTHH--HH---HTTS----HTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred hhhhhhhhcccccc--cc---cccc----cchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 11122211111100 00 0000 0001247889999999999999999999875
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=303.06 Aligned_cols=245 Identities=20% Similarity=0.306 Sum_probs=196.5
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeCCC--CchhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCCC
Q 005102 409 FVLGKSGIGIVYKVVLE-DGHTLAVRRLGEG--GSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGS 485 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gs 485 (714)
++||+|+||.||.++.. +++.+++|.+... .....+++.+|++++++++|+||+++++++.+.+..++||||+++|+
T Consensus 6 ~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~~~~~~ 85 (256)
T cd08221 6 RVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGT 85 (256)
T ss_pred eEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEecCCCc
Confidence 47999999999999864 4889999998654 33445678999999999999999999999999999999999999999
Q ss_pred HhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCCC
Q 005102 486 LATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSP 565 (714)
Q Consensus 486 L~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 565 (714)
|.+++..... ..+++.++..++.|++.||+|||+ .+++|+||||+||++++++.+||+|||+++.......
T Consensus 86 L~~~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~-- 156 (256)
T cd08221 86 LYDKIVRQKG----QLFEEEMVLWYLFQIVSAVSYIHK---AGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS-- 156 (256)
T ss_pred HHHHHHhccc----cCCCHHHHHHHHHHHHHHHHHHHh---CCccccCCChHhEEEeCCCCEEECcCcceEEcccccc--
Confidence 9999976532 458899999999999999999999 8999999999999999999999999999875532110
Q ss_pred CccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCccccCCCCcch
Q 005102 566 TLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGSSEMD 645 (714)
Q Consensus 566 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~~~~~~~~~~ 645 (714)
......++..|+|||.+.+..++.++||||||+++|||++|+.||... .
T Consensus 157 --------------------------~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~-----~ 205 (256)
T cd08221 157 --------------------------MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDAT-----N 205 (256)
T ss_pred --------------------------cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCC-----C
Confidence 112234678899999998888999999999999999999999998432 1
Q ss_pred hHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 005102 646 LVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDA 705 (714)
Q Consensus 646 l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 705 (714)
..+.......... . +.. ......+.+++.+||..+|++||+++++++.
T Consensus 206 ~~~~~~~~~~~~~--~----~~~------~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~ 253 (256)
T cd08221 206 PLNLVVKIVQGNY--T----PVV------SVYSSELISLVHSLLQQDPEKRPTADEVLDQ 253 (256)
T ss_pred HHHHHHHHHcCCC--C----CCc------cccCHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence 1222222222111 1 100 1123368899999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-36 Score=308.26 Aligned_cols=242 Identities=21% Similarity=0.367 Sum_probs=194.4
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeCCCC-chhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCCCH
Q 005102 409 FVLGKSGIGIVYKVVLE-DGHTLAVRRLGEGG-SQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGSL 486 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL 486 (714)
..||.|+||.||+|... +++.||+|.+.... ......+.+|++++++++|+||+++++++......++|+||+++++|
T Consensus 7 ~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 86 (274)
T cd06609 7 ECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYCGGGSC 86 (274)
T ss_pred hhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEeeCCCcH
Confidence 36999999999999976 48899999987643 33446788999999999999999999999999999999999999999
Q ss_pred hhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCCCC
Q 005102 487 ATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPT 566 (714)
Q Consensus 487 ~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 566 (714)
.+++... .+++..+..++.|++.||.|||+ .+++||||+|+||++++++.++|+|||+++......
T Consensus 87 ~~~~~~~-------~~~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~---- 152 (274)
T cd06609 87 LDLLKPG-------KLDETYIAFILREVLLGLEYLHE---EGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM---- 152 (274)
T ss_pred HHHHhhc-------CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEcccccceeecccc----
Confidence 9998643 48899999999999999999999 899999999999999999999999999987654211
Q ss_pred ccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCccccCCCCcchh
Q 005102 567 LQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGSSEMDL 646 (714)
Q Consensus 567 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~~~~~~~~~~l 646 (714)
.......++..|+|||++.+..++.++||||||+++|||+||+.||.....
T Consensus 153 ------------------------~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~----- 203 (274)
T cd06609 153 ------------------------SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHP----- 203 (274)
T ss_pred ------------------------cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCch-----
Confidence 111223457789999999988899999999999999999999999943321
Q ss_pred HHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 005102 647 VNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISD 704 (714)
Q Consensus 647 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 704 (714)
........... .+..... .....+.+++.+||..+|++|||++++++
T Consensus 204 ~~~~~~~~~~~-------~~~~~~~----~~~~~~~~~l~~~l~~~p~~Rpt~~~il~ 250 (274)
T cd06609 204 MRVLFLIPKNN-------PPSLEGN----KFSKPFKDFVSLCLNKDPKERPSAKELLK 250 (274)
T ss_pred HHHHHHhhhcC-------CCCCccc----ccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 11111111111 1111111 02235789999999999999999999975
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=307.41 Aligned_cols=253 Identities=22% Similarity=0.325 Sum_probs=195.1
Q ss_pred cccccCceEEEEEEECC------CcEEEEEEeCCCCch-hHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccC
Q 005102 410 VLGKSGIGIVYKVVLED------GHTLAVRRLGEGGSQ-RFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIP 482 (714)
Q Consensus 410 ~lG~G~~g~Vy~~~~~~------g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~ 482 (714)
.||+|+||.||+|+.+. .+.||+|.+...... ..+.+.+|++++++++|+||+++++++...+..++||||++
T Consensus 12 ~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 91 (275)
T cd05046 12 TLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHYMILEYTD 91 (275)
T ss_pred eecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcceEEEEecC
Confidence 69999999999999642 467999988765443 45679999999999999999999999998889999999999
Q ss_pred CCCHhhhhhCCCCCC---CcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhh
Q 005102 483 NGSLATALHGKPGMV---SFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLAN 559 (714)
Q Consensus 483 ~gsL~~~l~~~~~~~---~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~ 559 (714)
+|+|.+++....... ....+++..+..++.|++.||+|||+ .+|+||||||+||++++++.++++|||+++...
T Consensus 92 ~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~---~~i~H~dlkp~Nili~~~~~~~l~~~~~~~~~~ 168 (275)
T cd05046 92 LGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSN---ARFVHRDLAARNCLVSSQREVKVSLLSLSKDVY 168 (275)
T ss_pred CCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhh---cCcccCcCccceEEEeCCCcEEEcccccccccC
Confidence 999999997653211 01258999999999999999999999 899999999999999999999999999986432
Q ss_pred ccCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHh-CCCcccc
Q 005102 560 IAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMIT-GRTAVVQ 638 (714)
Q Consensus 560 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~ellt-G~~p~~~ 638 (714)
... ........++..|+|||.+.+..++.++||||||+++|||++ |..||..
T Consensus 169 ~~~---------------------------~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~ 221 (275)
T cd05046 169 NSE---------------------------YYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYG 221 (275)
T ss_pred ccc---------------------------ccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccc
Confidence 110 001111223566999999988889999999999999999999 7888843
Q ss_pred CCCCcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhh
Q 005102 639 VGSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDALDR 708 (714)
Q Consensus 639 ~~~~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~ 708 (714)
.. ... .+.... ... .. ... .. .....+.+++.+||+.+|++|||+.|+++.|++
T Consensus 222 ~~--~~~---~~~~~~-~~~-~~-~~~---~~-----~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~~ 275 (275)
T cd05046 222 LS--DEE---VLNRLQ-AGK-LE-LPV---PE-----GCPSRLYKLMTRCWAVNPKDRPSFSELVSALGE 275 (275)
T ss_pred cc--hHH---HHHHHH-cCC-cC-CCC---CC-----CCCHHHHHHHHHHcCCCcccCCCHHHHHHHhcC
Confidence 21 111 111111 111 00 000 01 122368899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=302.78 Aligned_cols=244 Identities=26% Similarity=0.363 Sum_probs=192.7
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeCCCC--chhHHHHHHHHHHHhccCCCCccceEEEEEeC-CceeEEEeccCCC
Q 005102 409 FVLGKSGIGIVYKVVLE-DGHTLAVRRLGEGG--SQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSV-DEKLLIYDYIPNG 484 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~-~~~~lV~e~~~~g 484 (714)
+.||+|++|.||++..+ +++.||+|++.... ....+.+.+|++++++++|+|++++++.+... ...++||||++++
T Consensus 6 ~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~ 85 (257)
T cd08223 6 RVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGFCEGG 85 (257)
T ss_pred EEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEecccCCC
Confidence 47999999999999975 47899999987542 23445788999999999999999999987644 3578999999999
Q ss_pred CHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCC
Q 005102 485 SLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGS 564 (714)
Q Consensus 485 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 564 (714)
+|.+++..... ..+++.++..++.|++.||+|||+ .+++||||||+||++++++.++|+|||+++......
T Consensus 86 ~l~~~l~~~~~----~~l~~~~~~~~~~~l~~~l~~lH~---~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~-- 156 (257)
T cd08223 86 DLYHKLKEQKG----KLLPENQVVEWFVQIAMALQYLHE---KHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC-- 156 (257)
T ss_pred cHHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCchhEEEecCCcEEEecccceEEecccC--
Confidence 99999976432 458999999999999999999999 899999999999999999999999999987653211
Q ss_pred CCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCccccCCCCcc
Q 005102 565 PTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGSSEM 644 (714)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~~~~~~~~~ 644 (714)
.......+++.|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus 157 --------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~----- 205 (257)
T cd08223 157 --------------------------DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAK----- 205 (257)
T ss_pred --------------------------CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCC-----
Confidence 0111234577899999999989999999999999999999999998422
Q ss_pred hhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 005102 645 DLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISD 704 (714)
Q Consensus 645 ~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 704 (714)
+............. +... ......+.+++.+||+.||++|||+.++++
T Consensus 206 ~~~~~~~~~~~~~~-------~~~~-----~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 253 (257)
T cd08223 206 DMNSLVYRIIEGKL-------PPMP-----KDYSPELGELIATMLSKRPEKRPSVKSILR 253 (257)
T ss_pred CHHHHHHHHHhcCC-------CCCc-----cccCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 12222222222111 1111 112346889999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=312.67 Aligned_cols=258 Identities=20% Similarity=0.265 Sum_probs=189.8
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeCCCC--chhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCCC
Q 005102 409 FVLGKSGIGIVYKVVLE-DGHTLAVRRLGEGG--SQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGS 485 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gs 485 (714)
+.||+|+||.||+|+.. +|+.||+|++.... ......+.+|++++++++||||+++++++.+.+..++|+||++ ++
T Consensus 6 ~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~ 84 (284)
T cd07839 6 EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEYCD-QD 84 (284)
T ss_pred EEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEecCC-CC
Confidence 46999999999999986 58999999987532 2223467889999999999999999999999999999999996 58
Q ss_pred HhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCCC
Q 005102 486 LATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSP 565 (714)
Q Consensus 486 L~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 565 (714)
|.+++.... ..+++..++.++.||++||+|||+ .+|+||||||+||+++.++.+||+|||+++......
T Consensus 85 l~~~~~~~~-----~~~~~~~~~~~~~qi~~al~~LH~---~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~--- 153 (284)
T cd07839 85 LKKYFDSCN-----GDIDPEIVKSFMFQLLKGLAFCHS---HNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV--- 153 (284)
T ss_pred HHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEEcCCCcEEECccchhhccCCCC---
Confidence 888876543 358999999999999999999999 899999999999999999999999999987543211
Q ss_pred CccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCC-CCchhhhHHHHHHHHHHHhCCCccccCCCCcc
Q 005102 566 TLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVK-PSQKWDIYSYGVILLEMITGRTAVVQVGSSEM 644 (714)
Q Consensus 566 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s~~~DVwS~Gvvl~elltG~~p~~~~~~~~~ 644 (714)
.......++..|+|||.+.+.. ++.++|||||||++|||+||+.|+........
T Consensus 154 -------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~ 208 (284)
T cd07839 154 -------------------------RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD 208 (284)
T ss_pred -------------------------CCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHH
Confidence 0111223567899999987644 69999999999999999999999744322221
Q ss_pred hhHHHHHHHHhhcC-----CcccccCC----CCCCCCC----cHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 005102 645 DLVNWMQLCIEEKK-----PLADVLDP----YLAPDAD----KEEEIIAVLKIAMACVHSSPEKRPTMRHISD 704 (714)
Q Consensus 645 ~l~~~~~~~~~~~~-----~~~~~~d~----~~~~~~~----~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 704 (714)
.+ ........... ...+..+. ....... ......++.+++.+||+.||++|||++++++
T Consensus 209 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 209 QL-KRIFRLLGTPTEESWPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred HH-HHHHHHhCCCChHHhHHhhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 11 11111000000 00000000 0000000 0012346789999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-36 Score=341.49 Aligned_cols=248 Identities=20% Similarity=0.328 Sum_probs=188.5
Q ss_pred ccccccCceEEEEEEECC-CcEEEEEEeCCC--CchhHHHHHHHHHHHhccCCCCccceEEEEEeC--CceeEEEeccCC
Q 005102 409 FVLGKSGIGIVYKVVLED-GHTLAVRRLGEG--GSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSV--DEKLLIYDYIPN 483 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~~-g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~~lV~e~~~~ 483 (714)
..||+|+||+||+|.+.. +..||+|.+... .......|..|+.++++++|||||+++++|... +..|+||||+++
T Consensus 19 ~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~lyIVMEY~~g 98 (1021)
T PTZ00266 19 KKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDA 98 (1021)
T ss_pred EEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEEEEEeCCCC
Confidence 479999999999999765 778999988754 233346789999999999999999999988653 468999999999
Q ss_pred CCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCC----CCceecCCCCCCeeeCC----------------
Q 005102 484 GSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSP----KKYVHGDLKPSNILLGH---------------- 543 (714)
Q Consensus 484 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~----~~ivHrDlkp~NILl~~---------------- 543 (714)
|+|.++|...... ...+++..++.|+.||+.||+|||+..+ .+||||||||+|||++.
T Consensus 99 GSL~~lL~k~~~~--~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~~~n~n 176 (1021)
T PTZ00266 99 GDLSRNIQKCYKM--FGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLN 176 (1021)
T ss_pred CcHHHHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccccccccccC
Confidence 9999998753211 1458999999999999999999998321 35999999999999964
Q ss_pred -CCCeEEcccchhhhhhccCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCC--CCCCchhhhH
Q 005102 544 -NMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKV--VKPSQKWDIY 620 (714)
Q Consensus 544 -~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~~~DVw 620 (714)
...+||+|||+++..... .......||+.|+|||++.+ ..++.++|||
T Consensus 177 g~~iVKLsDFGlAr~l~~~-----------------------------s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVW 227 (1021)
T PTZ00266 177 GRPIAKIGDFGLSKNIGIE-----------------------------SMAHSCVGTPYYWSPELLLHETKSYDDKSDMW 227 (1021)
T ss_pred CCCceEEccCCcccccccc-----------------------------ccccccCCCccccCHHHHhccCCCCCchhHHH
Confidence 235899999999754321 01123457899999999854 4589999999
Q ss_pred HHHHHHHHHHhCCCccccCCCCcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHH
Q 005102 621 SYGVILLEMITGRTAVVQVGSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMR 700 (714)
Q Consensus 621 S~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ 700 (714)
|||||+|||+||+.||.... ....++.. +.... .+... .....+.+|+..||..+|++||++.
T Consensus 228 SLG~ILYELLTGk~PF~~~~----~~~qli~~-lk~~p--------~lpi~----~~S~eL~dLI~~~L~~dPeeRPSa~ 290 (1021)
T PTZ00266 228 ALGCIIYELCSGKTPFHKAN----NFSQLISE-LKRGP--------DLPIK----GKSKELNILIKNLLNLSAKERPSAL 290 (1021)
T ss_pred HHHHHHHHHHHCCCCCCcCC----cHHHHHHH-HhcCC--------CCCcC----CCCHHHHHHHHHHhcCChhHCcCHH
Confidence 99999999999999994321 11222211 11111 11100 1123688999999999999999999
Q ss_pred HHHH
Q 005102 701 HISD 704 (714)
Q Consensus 701 evl~ 704 (714)
|++.
T Consensus 291 QlL~ 294 (1021)
T PTZ00266 291 QCLG 294 (1021)
T ss_pred HHhc
Confidence 9983
|
|
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=325.33 Aligned_cols=221 Identities=22% Similarity=0.308 Sum_probs=170.9
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeCCCC---chhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCC
Q 005102 409 FVLGKSGIGIVYKVVLE-DGHTLAVRRLGEGG---SQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNG 484 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~g 484 (714)
+.||+|+||.||++..+ +++.||+|++.... ......+.+|+.++.+++||||+++++++.+.+..++||||+++|
T Consensus 7 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E~~~gg 86 (360)
T cd05627 7 KVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIMEFLPGG 86 (360)
T ss_pred EEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCCCCc
Confidence 47999999999999976 48999999997532 233457888999999999999999999999999999999999999
Q ss_pred CHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCC
Q 005102 485 SLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGS 564 (714)
Q Consensus 485 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 564 (714)
+|.+++... ..+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++........
T Consensus 87 ~L~~~l~~~------~~l~~~~~~~~~~qi~~~L~~lH~---~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~ 157 (360)
T cd05627 87 DMMTLLMKK------DTLSEEATQFYIAETVLAIDAIHQ---LGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRT 157 (360)
T ss_pred cHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeEccCCCHHHEEECCCCCEEEeeccCCccccccccc
Confidence 999999755 458899999999999999999999 99999999999999999999999999998765322110
Q ss_pred CCccCCC-C-CCC----Cc-hhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCccc
Q 005102 565 PTLQSNR-M-PAE----KP-QERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVV 637 (714)
Q Consensus 565 ~~~~~~~-~-~~~----~~-~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~~ 637 (714)
....... . +.. .. ....................||+.|+|||++.+..++.++|||||||++|||+||+.||.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~ 237 (360)
T cd05627 158 EFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFC 237 (360)
T ss_pred ccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCC
Confidence 0000000 0 000 00 000000000000111224568999999999999999999999999999999999999994
Q ss_pred c
Q 005102 638 Q 638 (714)
Q Consensus 638 ~ 638 (714)
.
T Consensus 238 ~ 238 (360)
T cd05627 238 S 238 (360)
T ss_pred C
Confidence 3
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=304.80 Aligned_cols=242 Identities=22% Similarity=0.356 Sum_probs=194.1
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeCCCC-chhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCCCH
Q 005102 409 FVLGKSGIGIVYKVVLE-DGHTLAVRRLGEGG-SQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGSL 486 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL 486 (714)
..||+|+||.||+|... ++..||+|.+.... ....+.+.+|++++++++||||+++++++...+..++||||+++|+|
T Consensus 10 ~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 89 (277)
T cd06640 10 ERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSA 89 (277)
T ss_pred hhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecCCCCcH
Confidence 36999999999999975 48899999987543 34456789999999999999999999999999999999999999999
Q ss_pred hhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCCCC
Q 005102 487 ATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPT 566 (714)
Q Consensus 487 ~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 566 (714)
.+++... ++++.++..++.|++.||+|||+ .+++|+||+|+||+++.++.++|+|||++.......
T Consensus 90 ~~~i~~~-------~l~~~~~~~~~~~l~~~l~~lh~---~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~---- 155 (277)
T cd06640 90 LDLLRAG-------PFDEFQIATMLKEILKGLDYLHS---EKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ---- 155 (277)
T ss_pred HHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHh---CCccCcCCChhhEEEcCCCCEEEcccccceeccCCc----
Confidence 9998642 47889999999999999999999 899999999999999999999999999987543211
Q ss_pred ccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCccccCCCCcchh
Q 005102 567 LQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGSSEMDL 646 (714)
Q Consensus 567 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~~~~~~~~~~l 646 (714)
.......++..|+|||++.+..++.++|||||||++|||+||+.||......
T Consensus 156 ------------------------~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~---- 207 (277)
T cd06640 156 ------------------------IKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPM---- 207 (277)
T ss_pred ------------------------cccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChH----
Confidence 0111223577899999998888999999999999999999999998432211
Q ss_pred HHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 005102 647 VNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDA 705 (714)
Q Consensus 647 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 705 (714)
...... .... .+.. .......+.+++.+||+.+|++||++.+++..
T Consensus 208 -~~~~~~-~~~~------~~~~-----~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 208 -RVLFLI-PKNN------PPTL-----TGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred -hHhhhh-hcCC------CCCC-----chhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 111100 0000 0111 12344568899999999999999999999654
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-36 Score=318.23 Aligned_cols=249 Identities=22% Similarity=0.272 Sum_probs=189.2
Q ss_pred ccccccCceEEEEEEECC-CcEEEEEEeCCC---CchhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCC
Q 005102 409 FVLGKSGIGIVYKVVLED-GHTLAVRRLGEG---GSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNG 484 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~~-g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~g 484 (714)
+.||+|+||+||+++.+. ++.+|+|++.+. .......+..|+.++..++|+||+++++++.+.+..++||||+++|
T Consensus 7 ~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ey~~~g 86 (332)
T cd05623 7 KVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMDYYVGG 86 (332)
T ss_pred EEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEEeccCCC
Confidence 479999999999999865 788999998653 1222345888999999999999999999999999999999999999
Q ss_pred CHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCC
Q 005102 485 SLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGS 564 (714)
Q Consensus 485 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 564 (714)
+|.+++.... ..+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++......
T Consensus 87 ~L~~~l~~~~-----~~l~~~~~~~~~~qi~~al~~lH~---~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~-- 156 (332)
T cd05623 87 DLLTLLSKFE-----DRLPEDMARFYLAEMVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG-- 156 (332)
T ss_pred cHHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEECCCCCEEEeecchheecccCC--
Confidence 9999997643 358899999999999999999999 899999999999999999999999999987542111
Q ss_pred CCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccC-----CCCCCchhhhHHHHHHHHHHHhCCCccccC
Q 005102 565 PTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLK-----VVKPSQKWDIYSYGVILLEMITGRTAVVQV 639 (714)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~~DVwS~Gvvl~elltG~~p~~~~ 639 (714)
........||+.|+|||++. ...++.++|||||||++|||++|+.||...
T Consensus 157 -------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~ 211 (332)
T cd05623 157 -------------------------TVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAE 211 (332)
T ss_pred -------------------------cceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCC
Confidence 01112345789999999986 346789999999999999999999999432
Q ss_pred CCCcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCC--CCCHHHHHHH
Q 005102 640 GSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEK--RPTMRHISDA 705 (714)
Q Consensus 640 ~~~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~--RPt~~evl~~ 705 (714)
+..+............ .-+... ......+.+++.+|+..++++ |++++|+++.
T Consensus 212 -----~~~~~~~~i~~~~~~~---~~p~~~-----~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 212 -----SLVETYGKIMNHKERF---QFPAQV-----TDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred -----CHHHHHHHHhCCCccc---cCCCcc-----ccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 2222222222221110 001000 112235778888888654444 6889888754
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=308.50 Aligned_cols=247 Identities=24% Similarity=0.379 Sum_probs=192.3
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeCCC-CchhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCCCH
Q 005102 409 FVLGKSGIGIVYKVVLE-DGHTLAVRRLGEG-GSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGSL 486 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL 486 (714)
+.||+|+||.||++... ++..||+|.+... .......+.+|++++++++||||+++++++...+..++||||+++++|
T Consensus 7 ~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~l 86 (286)
T cd06622 7 DELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYMDAGSL 86 (286)
T ss_pred hhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeecCCCCH
Confidence 37999999999999986 6899999988754 333446789999999999999999999999999999999999999999
Q ss_pred hhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCCCC
Q 005102 487 ATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPT 566 (714)
Q Consensus 487 ~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 566 (714)
..++..... ...+++..+..++.|++.||.|||+. .+|+||||||+||+++.++.+||+|||+++.....
T Consensus 87 ~~~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~----- 156 (286)
T cd06622 87 DKLYAGGVA---TEGIPEDVLRRITYAVVKGLKFLKEE--HNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS----- 156 (286)
T ss_pred HHHHHhccc---cCCCCHHHHHHHHHHHHHHHHHHHhc--CCEeeCCCCHHHEEECCCCCEEEeecCCcccccCC-----
Confidence 998875421 13689999999999999999999962 48999999999999999999999999998754211
Q ss_pred ccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCC------CCchhhhHHHHHHHHHHHhCCCccccCC
Q 005102 567 LQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVK------PSQKWDIYSYGVILLEMITGRTAVVQVG 640 (714)
Q Consensus 567 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~------~s~~~DVwS~Gvvl~elltG~~p~~~~~ 640 (714)
......++..|+|||.+.+.. ++.++|||||||++|||++|+.||....
T Consensus 157 -------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~ 211 (286)
T cd06622 157 -------------------------LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPET 211 (286)
T ss_pred -------------------------ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcc
Confidence 011223567799999985543 4889999999999999999999994321
Q ss_pred CCcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 005102 641 SSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISD 704 (714)
Q Consensus 641 ~~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 704 (714)
. ......+....... .+.... .....+.+++.+||+.+|++||+++++++
T Consensus 212 ~--~~~~~~~~~~~~~~-------~~~~~~-----~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 261 (286)
T cd06622 212 Y--ANIFAQLSAIVDGD-------PPTLPS-----GYSDDAQDFVAKCLNKIPNRRPTYAQLLE 261 (286)
T ss_pred h--hhHHHHHHHHhhcC-------CCCCCc-----ccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence 1 11111111111111 011111 12346789999999999999999999886
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=319.44 Aligned_cols=240 Identities=25% Similarity=0.393 Sum_probs=192.7
Q ss_pred ccccccCceEEEEEEECC-CcEEEEEEeC--C--CCchhHHHHHHHHHHHhccCCCCccceEEEEEeCCc--eeEEEecc
Q 005102 409 FVLGKSGIGIVYKVVLED-GHTLAVRRLG--E--GGSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDE--KLLIYDYI 481 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~~-g~~vavK~~~--~--~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~--~~lV~e~~ 481 (714)
.+||+|.|-+||||.+.. |..||=-.++ + ......++|..|+++|+.|+|||||++++++.+... .-+|+|.|
T Consensus 46 evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL~ 125 (632)
T KOG0584|consen 46 EVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITELF 125 (632)
T ss_pred hhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeecc
Confidence 379999999999999753 7777532222 1 133445789999999999999999999999987665 56889999
Q ss_pred CCCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCC-CCeEEcccchhhhhhc
Q 005102 482 PNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHN-MEPHVSDFGLARLANI 560 (714)
Q Consensus 482 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~-~~~kl~DFGla~~~~~ 560 (714)
..|+|..|+++. ++++...+++|++||++||.|||+..| +|||||||-.||+|+.+ |.+||+|.|+|.....
T Consensus 126 TSGtLr~Y~kk~------~~vn~kaik~W~RQILkGL~yLHs~~P-PIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~ 198 (632)
T KOG0584|consen 126 TSGTLREYRKKH------RRVNIKAIKSWCRQILKGLVYLHSQDP-PIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRK 198 (632)
T ss_pred cCCcHHHHHHHh------ccCCHHHHHHHHHHHHHHhhhhhcCCC-CccccccccceEEEcCCcCceeecchhHHHHhhc
Confidence 999999999877 457888999999999999999999886 99999999999999865 8999999999998753
Q ss_pred cCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCccccCC
Q 005102 561 AGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVG 640 (714)
Q Consensus 561 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~~~~~ 640 (714)
. ......|||-|||||++. ..|++.+||||||+.++||+|+.+||....
T Consensus 199 s------------------------------~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~ 247 (632)
T KOG0584|consen 199 S------------------------------HAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECT 247 (632)
T ss_pred c------------------------------ccceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhC
Confidence 2 223367899999999997 789999999999999999999999995432
Q ss_pred CCcchhHHHHHHHHhhcCC--cccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 005102 641 SSEMDLVNWMQLCIEEKKP--LADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISD 704 (714)
Q Consensus 641 ~~~~~l~~~~~~~~~~~~~--~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 704 (714)
. ..+.++......++ +..+-|| ++.+||.+|+.. .++|||+.|++.
T Consensus 248 n----~AQIYKKV~SGiKP~sl~kV~dP-------------evr~fIekCl~~-~~~R~sa~eLL~ 295 (632)
T KOG0584|consen 248 N----PAQIYKKVTSGIKPAALSKVKDP-------------EVREFIEKCLAT-KSERLSAKELLK 295 (632)
T ss_pred C----HHHHHHHHHcCCCHHHhhccCCH-------------HHHHHHHHHhcC-chhccCHHHHhh
Confidence 2 23333333333221 1122222 578999999999 999999999875
|
|
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-36 Score=318.67 Aligned_cols=250 Identities=21% Similarity=0.300 Sum_probs=185.0
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeCCCCc--hhHHHHHHHHHHHhccCCCCccceEEEEEeC------CceeEEEe
Q 005102 409 FVLGKSGIGIVYKVVLE-DGHTLAVRRLGEGGS--QRFKEFQTEVEAIGKIRHSNIVTLRAYYWSV------DEKLLIYD 479 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~------~~~~lV~e 479 (714)
..||+|+||.||+|... +++.||||++..... ...+.+.+|++++++++||||+++++++... ...++++|
T Consensus 21 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~ 100 (343)
T cd07878 21 TPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNEVYLVTN 100 (343)
T ss_pred eecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccCcEEEEee
Confidence 47999999999999975 578999999876422 2345678999999999999999999987543 34689999
Q ss_pred ccCCCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhh
Q 005102 480 YIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLAN 559 (714)
Q Consensus 480 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~ 559 (714)
++ +++|.+++.. ..+++..+..++.|++.||+|||+ ++|+||||||+||++++++.+||+|||+++...
T Consensus 101 ~~-~~~l~~~~~~-------~~l~~~~~~~i~~qi~~aL~~LH~---~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~ 169 (343)
T cd07878 101 LM-GADLNNIVKC-------QKLSDEHVQFLIYQLLRGLKYIHS---AGIIHRDLKPSNVAVNEDCELRILDFGLARQAD 169 (343)
T ss_pred cC-CCCHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHH---CCeecccCChhhEEECCCCCEEEcCCccceecC
Confidence 88 7799888753 348999999999999999999999 899999999999999999999999999987542
Q ss_pred ccCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCC-CCCCchhhhHHHHHHHHHHHhCCCcccc
Q 005102 560 IAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKV-VKPSQKWDIYSYGVILLEMITGRTAVVQ 638 (714)
Q Consensus 560 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DVwS~Gvvl~elltG~~p~~~ 638 (714)
.. .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||..
T Consensus 170 ~~-------------------------------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 218 (343)
T cd07878 170 DE-------------------------------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPG 218 (343)
T ss_pred CC-------------------------------cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCC
Confidence 11 112346888999999876 5689999999999999999999999943
Q ss_pred CCCCcchhHHHHHHHHhhcCCcccccC-----------CCCCCCCC--c----HHHHHHHHHHHhHccCCCCCCCCCHHH
Q 005102 639 VGSSEMDLVNWMQLCIEEKKPLADVLD-----------PYLAPDAD--K----EEEIIAVLKIAMACVHSSPEKRPTMRH 701 (714)
Q Consensus 639 ~~~~~~~l~~~~~~~~~~~~~~~~~~d-----------~~~~~~~~--~----~~~~~~l~~li~~Cl~~dP~~RPt~~e 701 (714)
... .+....+.... .....+... ..+..... . ......+.+++.+|++.||++|||++|
T Consensus 219 ~~~--~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~e 294 (343)
T cd07878 219 NDY--IDQLKRIMEVV--GTPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASE 294 (343)
T ss_pred CCH--HHHHHHHHHHh--CCCCHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHH
Confidence 211 11111110000 000000000 00000000 0 001124679999999999999999999
Q ss_pred HHH
Q 005102 702 ISD 704 (714)
Q Consensus 702 vl~ 704 (714)
+++
T Consensus 295 ll~ 297 (343)
T cd07878 295 ALA 297 (343)
T ss_pred Hhc
Confidence 985
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-36 Score=309.97 Aligned_cols=248 Identities=21% Similarity=0.293 Sum_probs=187.5
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeCCCCchhHHHHHHHHHHHhcc-CCCCccceEEEEEe-----CCceeEEEecc
Q 005102 409 FVLGKSGIGIVYKVVLE-DGHTLAVRRLGEGGSQRFKEFQTEVEAIGKI-RHSNIVTLRAYYWS-----VDEKLLIYDYI 481 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~-----~~~~~lV~e~~ 481 (714)
..||+|+||.||++... +++.+|+|++..... ...++.+|+.+++++ +||||+++++++.. .+..++||||+
T Consensus 24 ~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~-~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~ 102 (286)
T cd06638 24 ETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHD-IDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELC 102 (286)
T ss_pred eeeccCCCcEEEEEEECCCCceeEEEeeccccc-hHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeEEEEEeec
Confidence 36999999999999875 478999998865322 235688999999999 69999999998853 34679999999
Q ss_pred CCCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhcc
Q 005102 482 PNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIA 561 (714)
Q Consensus 482 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 561 (714)
++++|.+++...... ...+++..+..++.|++.||.|||+ .+|+||||||+||++++++.+||+|||+++.....
T Consensus 103 ~~~~L~~~l~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~ 177 (286)
T cd06638 103 NGGSVTDLVKGFLKR--GERMEEPIIAYILHEALMGLQHLHV---NKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTST 177 (286)
T ss_pred CCCCHHHHHHHhhcc--CccccHHHHHHHHHHHHHHHHHHHh---CCccccCCCHHhEEECCCCCEEEccCCceeecccC
Confidence 999999987642111 1458899999999999999999999 89999999999999999999999999998754321
Q ss_pred CCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCC-----CCCCchhhhHHHHHHHHHHHhCCCcc
Q 005102 562 GGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKV-----VKPSQKWDIYSYGVILLEMITGRTAV 636 (714)
Q Consensus 562 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~~~DVwS~Gvvl~elltG~~p~ 636 (714)
. .......|+..|+|||++.. ..++.++|||||||++|||++|+.||
T Consensus 178 ~----------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~ 229 (286)
T cd06638 178 R----------------------------LRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPL 229 (286)
T ss_pred C----------------------------CccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCC
Confidence 0 01122346788999999853 45788999999999999999999998
Q ss_pred ccCCCCcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 005102 637 VQVGSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDA 705 (714)
Q Consensus 637 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 705 (714)
...... .... .... .. .....++. .....+.+++.+||+.||++|||+.|+++.
T Consensus 230 ~~~~~~----~~~~-~~~~-~~-~~~~~~~~--------~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 283 (286)
T cd06638 230 ADLHPM----RALF-KIPR-NP-PPTLHQPE--------LWSNEFNDFIRKCLTKDYEKRPTVSDLLQH 283 (286)
T ss_pred CCCchh----HHHh-hccc-cC-CCcccCCC--------CcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence 432111 1111 0000 00 00111111 112358899999999999999999999864
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=305.87 Aligned_cols=257 Identities=20% Similarity=0.329 Sum_probs=191.7
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeCCCC--chhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCCC
Q 005102 409 FVLGKSGIGIVYKVVLE-DGHTLAVRRLGEGG--SQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGS 485 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gs 485 (714)
..||+|+||.||+|..+ +|+.||+|++.... ....+.+.+|++++++++||||+++++++...+..++||||+++++
T Consensus 7 ~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~ 86 (286)
T cd07847 7 SKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEYCDHTV 86 (286)
T ss_pred eeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEeccCccH
Confidence 46999999999999986 48999999986542 2233568899999999999999999999999999999999999988
Q ss_pred HhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCCC
Q 005102 486 LATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSP 565 (714)
Q Consensus 486 L~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 565 (714)
|..++... ..+++..++.++.|++.||+|||+ .+++||||||+||+++.++.+||+|||++........
T Consensus 87 l~~~~~~~------~~~~~~~~~~~~~ql~~~l~~LH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~-- 155 (286)
T cd07847 87 LNELEKNP------RGVPEHLIKKIIWQTLQAVNFCHK---HNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD-- 155 (286)
T ss_pred HHHHHhCC------CCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCChhhEEEcCCCcEEECccccceecCCCcc--
Confidence 88876543 358999999999999999999999 8999999999999999999999999999876532110
Q ss_pred CccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCC-CCCCchhhhHHHHHHHHHHHhCCCccccCCCCcc
Q 005102 566 TLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKV-VKPSQKWDIYSYGVILLEMITGRTAVVQVGSSEM 644 (714)
Q Consensus 566 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DVwS~Gvvl~elltG~~p~~~~~~~~~ 644 (714)
......++..|+|||.+.+ ..++.++||||||+++|||++|+.||......
T Consensus 156 --------------------------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~-- 207 (286)
T cd07847 156 --------------------------DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDV-- 207 (286)
T ss_pred --------------------------cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChH--
Confidence 0112234677999999876 45789999999999999999999999533221
Q ss_pred hhHHHHHHHHhhc-----------CCcccccCCCCCCCCCc----HHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 005102 645 DLVNWMQLCIEEK-----------KPLADVLDPYLAPDADK----EEEIIAVLKIAMACVHSSPEKRPTMRHISD 704 (714)
Q Consensus 645 ~l~~~~~~~~~~~-----------~~~~~~~d~~~~~~~~~----~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 704 (714)
+............ ........+........ ......+.+++.+||+.+|++|||+.|++.
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 208 DQLYLIRKTLGDLIPRHQQIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred HHHHHHHHHhCCCChHHhhhcccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 1111111111000 00000000110000000 011346789999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=304.61 Aligned_cols=251 Identities=24% Similarity=0.366 Sum_probs=193.7
Q ss_pred ccccccCceEEEEEEECC--CcEEEEEEeCCC----------CchhHHHHHHHHHHHhc-cCCCCccceEEEEEeCCcee
Q 005102 409 FVLGKSGIGIVYKVVLED--GHTLAVRRLGEG----------GSQRFKEFQTEVEAIGK-IRHSNIVTLRAYYWSVDEKL 475 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~~--g~~vavK~~~~~----------~~~~~~~~~~E~~~l~~-l~H~niv~l~~~~~~~~~~~ 475 (714)
+.||+|+||.||+|.++. ++.+|+|.+... ......++.+|+.++.+ ++||||+++++++...+..+
T Consensus 6 ~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~ 85 (269)
T cd08528 6 EHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLENDRLY 85 (269)
T ss_pred hhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEccCCeEE
Confidence 369999999999999865 688999987532 22234567789988875 79999999999999999999
Q ss_pred EEEeccCCCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchh
Q 005102 476 LIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLA 555 (714)
Q Consensus 476 lV~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla 555 (714)
+||||+++++|.+++...... ...+++..+++++.|++.||.|||+. .+++|+||||+||++++++.+||+|||++
T Consensus 86 lv~e~~~~~~l~~~l~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~--~~i~H~dl~~~nil~~~~~~~~l~dfg~~ 161 (269)
T cd08528 86 IVMDLIEGAPLGEHFNSLKEK--KQRFTEERIWNIFVQMVLALRYLHKE--KRIVHRDLTPNNIMLGEDDKVTITDFGLA 161 (269)
T ss_pred EEEecCCCCcHHHHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHhccC--CceeecCCCHHHEEECCCCcEEEecccce
Confidence 999999999999987532111 14588999999999999999999952 57999999999999999999999999998
Q ss_pred hhhhccCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCc
Q 005102 556 RLANIAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTA 635 (714)
Q Consensus 556 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p 635 (714)
....... ......|+..|+|||.+.+..++.++||||||+++|||++|+.|
T Consensus 162 ~~~~~~~-----------------------------~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p 212 (269)
T cd08528 162 KQKQPES-----------------------------KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPP 212 (269)
T ss_pred eeccccc-----------------------------ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCc
Confidence 7543210 11223457789999999988899999999999999999999999
Q ss_pred cccCCCCcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhh
Q 005102 636 VVQVGSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDALDR 708 (714)
Q Consensus 636 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~ 708 (714)
|... +............. .+... ......+.+++.+||+.||++||++.|+.+++++
T Consensus 213 ~~~~-----~~~~~~~~~~~~~~------~~~~~-----~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~~ 269 (269)
T cd08528 213 FYST-----NMLSLATKIVEAVY------EPLPE-----GMYSEDVTDVITSCLTPDAEARPDIIQVSAMISD 269 (269)
T ss_pred cccc-----CHHHHHHHHhhccC------CcCCc-----ccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhcC
Confidence 8432 11111211111111 01000 0122368899999999999999999999998863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=305.86 Aligned_cols=255 Identities=23% Similarity=0.300 Sum_probs=193.7
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeCCCCc-hhHHHHHHHHHHHhccCCCCccceEEEEEeC--CceeEEEeccCCC
Q 005102 409 FVLGKSGIGIVYKVVLE-DGHTLAVRRLGEGGS-QRFKEFQTEVEAIGKIRHSNIVTLRAYYWSV--DEKLLIYDYIPNG 484 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~~lV~e~~~~g 484 (714)
+.||.|++|.||++..+ +++.+|+|.+..... ....++.+|++++++++||||++++++|... +..++||||++++
T Consensus 7 ~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~ 86 (287)
T cd06621 7 SRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGG 86 (287)
T ss_pred EEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEEecCCC
Confidence 47999999999999985 488999999876433 3456789999999999999999999998654 3679999999999
Q ss_pred CHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCC
Q 005102 485 SLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGS 564 (714)
Q Consensus 485 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 564 (714)
+|.+++...... ...+++..+..++.|++.||+|||+ .+++|+||+|+||++++++.++|+|||++.......
T Consensus 87 ~L~~~l~~~~~~--~~~l~~~~~~~i~~~i~~~L~~lH~---~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~-- 159 (287)
T cd06621 87 SLDSIYKKVKKR--GGRIGEKVLGKIAESVLKGLSYLHS---RKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSL-- 159 (287)
T ss_pred CHHHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEecCCeEEEeeccccccccccc--
Confidence 999887532211 1458899999999999999999999 899999999999999999999999999986542110
Q ss_pred CCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCccccCCCCcc
Q 005102 565 PTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGSSEM 644 (714)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~~~~~~~~~ 644 (714)
.....++..|+|||.+.+..++.++||||||+++|||++|+.||........
T Consensus 160 ----------------------------~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~ 211 (287)
T cd06621 160 ----------------------------AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPL 211 (287)
T ss_pred ----------------------------cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCC
Confidence 0112346679999999988999999999999999999999999954422111
Q ss_pred hhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 005102 645 DLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISD 704 (714)
Q Consensus 645 ~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 704 (714)
...+.......... ... ....... ......+.+++.+||+.+|++|||+.|+++
T Consensus 212 ~~~~~~~~~~~~~~--~~~-~~~~~~~---~~~~~~~~~li~~~l~~~p~~Rpt~~eil~ 265 (287)
T cd06621 212 GPIELLSYIVNMPN--PEL-KDEPGNG---IKWSEEFKDFIKQCLEKDPTRRPTPWDMLE 265 (287)
T ss_pred ChHHHHHHHhcCCc--hhh-ccCCCCC---CchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence 12222211111110 111 1000000 112346889999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=318.79 Aligned_cols=248 Identities=22% Similarity=0.276 Sum_probs=188.9
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeCCC---CchhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCC
Q 005102 409 FVLGKSGIGIVYKVVLE-DGHTLAVRRLGEG---GSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNG 484 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~g 484 (714)
+.||+|+||+||+++.. +++.||+|.+.+. .......+.+|+.++..++|+||+++++++...+..|+||||+++|
T Consensus 7 ~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~Ey~~gg 86 (331)
T cd05624 7 KVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVMDYYVGG 86 (331)
T ss_pred EEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCCCCC
Confidence 47999999999999976 4789999998753 2223355888999999999999999999999999999999999999
Q ss_pred CHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCC
Q 005102 485 SLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGS 564 (714)
Q Consensus 485 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 564 (714)
+|.+++.... ..+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++......
T Consensus 87 ~L~~~l~~~~-----~~l~~~~~~~~~~qi~~~L~~lH~---~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~-- 156 (331)
T cd05624 87 DLLTLLSKFE-----DRLPEDMARFYIAEMVLAIHSIHQ---LHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDG-- 156 (331)
T ss_pred cHHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCchHHEEEcCCCCEEEEeccceeeccCCC--
Confidence 9999997642 358899999999999999999999 899999999999999999999999999987543211
Q ss_pred CCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCC-----CCCCchhhhHHHHHHHHHHHhCCCccccC
Q 005102 565 PTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKV-----VKPSQKWDIYSYGVILLEMITGRTAVVQV 639 (714)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~~~DVwS~Gvvl~elltG~~p~~~~ 639 (714)
........||+.|+|||++.+ ..++.++|||||||++|||++|+.||...
T Consensus 157 -------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~ 211 (331)
T cd05624 157 -------------------------TVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAE 211 (331)
T ss_pred -------------------------ceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCC
Confidence 011122457889999999875 46789999999999999999999999432
Q ss_pred CCCcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCC--CCCHHHHHH
Q 005102 640 GSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEK--RPTMRHISD 704 (714)
Q Consensus 640 ~~~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~--RPt~~evl~ 704 (714)
. ..+............ . +.+.. .....++.+++.+|+..++++ |++++++++
T Consensus 212 ~-----~~~~~~~i~~~~~~~-~-~p~~~------~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~ 265 (331)
T cd05624 212 S-----LVETYGKIMNHEERF-Q-FPSHI------TDVSEEAKDLIQRLICSRERRLGQNGIEDFKK 265 (331)
T ss_pred C-----HHHHHHHHHcCCCcc-c-CCCcc------ccCCHHHHHHHHHHccCchhhcCCCCHHHHhc
Confidence 1 112222222111100 0 00100 112336778999998865544 467877764
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=305.72 Aligned_cols=243 Identities=21% Similarity=0.321 Sum_probs=195.1
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeCCCCchhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCCCHh
Q 005102 409 FVLGKSGIGIVYKVVLE-DGHTLAVRRLGEGGSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGSLA 487 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL~ 487 (714)
..||+|++|.||++... +++.+|+|++........+.+.+|+.++++++||||+++++++...+..++|+||+++++|.
T Consensus 25 ~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~~~L~ 104 (285)
T cd06648 25 VKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALT 104 (285)
T ss_pred eEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCCCCHH
Confidence 48999999999999964 58899999987655555567899999999999999999999999999999999999999999
Q ss_pred hhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCCCCc
Q 005102 488 TALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTL 567 (714)
Q Consensus 488 ~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 567 (714)
+++... ++++.++..++.|++.||+|||+ .+|+||||||+||++++++.++|+|||.+.......
T Consensus 105 ~~~~~~-------~~~~~~~~~~~~ql~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~----- 169 (285)
T cd06648 105 DIVTHT-------RMNEEQIATVCLAVLKALSFLHA---QGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEV----- 169 (285)
T ss_pred HHHHhC-------CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCChhhEEEcCCCcEEEcccccchhhccCC-----
Confidence 998652 37889999999999999999999 899999999999999999999999999886542110
Q ss_pred cCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCccccCCCCcchhH
Q 005102 568 QSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGSSEMDLV 647 (714)
Q Consensus 568 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~~~~~~~~~~l~ 647 (714)
.......|+..|+|||.+.+..++.++|||||||++|||++|+.||.... ..
T Consensus 170 -----------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~-----~~ 221 (285)
T cd06648 170 -----------------------PRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEP-----PL 221 (285)
T ss_pred -----------------------cccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCC-----HH
Confidence 01112346788999999988889999999999999999999999984321 12
Q ss_pred HHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 005102 648 NWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISD 704 (714)
Q Consensus 648 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 704 (714)
..+........ +..... ......+.+++.+||+.+|++|||+.++++
T Consensus 222 ~~~~~~~~~~~-------~~~~~~---~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 222 QAMKRIRDNLP-------PKLKNL---HKVSPRLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred HHHHHHHhcCC-------CCCccc---ccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence 22222211111 111100 012236889999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=302.69 Aligned_cols=246 Identities=22% Similarity=0.334 Sum_probs=187.6
Q ss_pred cccccccCceEEEEEEEC-CCcEEEEEEeCCCC-----chhHHHHHHHHHHHhccCCCCccceEEEEEeC--CceeEEEe
Q 005102 408 AFVLGKSGIGIVYKVVLE-DGHTLAVRRLGEGG-----SQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSV--DEKLLIYD 479 (714)
Q Consensus 408 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~~lV~e 479 (714)
.+.||+|+||.||+|... ++..||+|++.... ....+.+.+|+.++++++||||+++++++... +..+++||
T Consensus 7 ~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l~~e 86 (266)
T cd06651 7 GKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTIFME 86 (266)
T ss_pred cceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEEEEEe
Confidence 357999999999999975 48999999886432 12345688999999999999999999998753 56789999
Q ss_pred ccCCCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhh
Q 005102 480 YIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLAN 559 (714)
Q Consensus 480 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~ 559 (714)
|+++++|.+++... ..+++..+..++.|++.||+|||+ .+|+||||||+||++++++.+||+|||+++...
T Consensus 87 ~~~~~~L~~~l~~~------~~l~~~~~~~~~~qi~~~l~~LH~---~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~ 157 (266)
T cd06651 87 YMPGGSVKDQLKAY------GALTESVTRKYTRQILEGMSYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQ 157 (266)
T ss_pred CCCCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEccCCCccccc
Confidence 99999999999754 347899999999999999999999 899999999999999999999999999987543
Q ss_pred ccCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCccccC
Q 005102 560 IAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQV 639 (714)
Q Consensus 560 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~~~~ 639 (714)
..... ........++..|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 158 ~~~~~-------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~ 212 (266)
T cd06651 158 TICMS-------------------------GTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEY 212 (266)
T ss_pred ccccc-------------------------CCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCcccc
Confidence 21000 00111233577899999999888999999999999999999999999432
Q ss_pred CCCcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 005102 640 GSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISD 704 (714)
Q Consensus 640 ~~~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 704 (714)
.. ...+....... ..+.... .....+.+++ +||..+|++||+++||++
T Consensus 213 ~~-----~~~~~~~~~~~------~~~~~~~-----~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 213 EA-----MAAIFKIATQP------TNPQLPS-----HISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred ch-----HHHHHHHhcCC------CCCCCch-----hcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 11 11111111110 1121111 1122455565 788899999999999974
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=308.60 Aligned_cols=263 Identities=16% Similarity=0.229 Sum_probs=197.0
Q ss_pred ccccccCceEEEEEEECC-CcEEEEEEeCCCCc---hhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCC
Q 005102 409 FVLGKSGIGIVYKVVLED-GHTLAVRRLGEGGS---QRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNG 484 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~~-g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~g 484 (714)
+.||+|+||.||++.... ++.||+|.+..... ...+.+.+|+++++.++||||+++++.+...+..++||||++++
T Consensus 7 ~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~ 86 (305)
T cd05609 7 KLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVMEYVEGG 86 (305)
T ss_pred eEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEecCCCC
Confidence 479999999999999764 78999999876532 23457889999999999999999999999999999999999999
Q ss_pred CHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCC
Q 005102 485 SLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGS 564 (714)
Q Consensus 485 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 564 (714)
+|.+++... ..+++..+..++.|++.||+|||+ .+++||||||+||++++++.+||+|||+++........
T Consensus 87 ~L~~~l~~~------~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~ 157 (305)
T cd05609 87 DCATLLKNI------GALPVDMARMYFAETVLALEYLHN---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTT 157 (305)
T ss_pred cHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCchHHEEECCCCCEEEeeCCCccccCcCccc
Confidence 999999654 358899999999999999999999 89999999999999999999999999998743211100
Q ss_pred CCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCccccCCCCcc
Q 005102 565 PTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGSSEM 644 (714)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~~~~~~~~~ 644 (714)
..... ..... ..........++..|+|||.+.+..++.++|||||||++|||++|+.||....
T Consensus 158 ~~~~~-~~~~~------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~---- 220 (305)
T cd05609 158 NLYEG-HIEKD------------TREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDT---- 220 (305)
T ss_pred ccccc-ccccc------------hhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC----
Confidence 00000 00000 00011112346778999999988889999999999999999999999995321
Q ss_pred hhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhh
Q 005102 645 DLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDALDR 708 (714)
Q Consensus 645 ~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~ 708 (714)
..++.......... .+.... .....+.+++.+||+.||++||++.++.+.|+.
T Consensus 221 -~~~~~~~~~~~~~~-----~~~~~~-----~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 221 -PEELFGQVISDDIE-----WPEGDE-----ALPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred -HHHHHHHHHhcccC-----CCCccc-----cCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 12222222221111 111111 122357899999999999999997777766654
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=310.11 Aligned_cols=258 Identities=22% Similarity=0.331 Sum_probs=188.5
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeCCCCc-hhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCCCH
Q 005102 409 FVLGKSGIGIVYKVVLE-DGHTLAVRRLGEGGS-QRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGSL 486 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL 486 (714)
..||+|+||.||+|..+ +++.||+|.+..... .....+.+|++++++++|+||+++++++...+..++||||+++ +|
T Consensus 11 ~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~-~L 89 (291)
T cd07844 11 DKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEYLDT-DL 89 (291)
T ss_pred EEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEecCCC-CH
Confidence 47999999999999976 589999999875432 2234577899999999999999999999999999999999974 99
Q ss_pred hhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCCCC
Q 005102 487 ATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPT 566 (714)
Q Consensus 487 ~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 566 (714)
.+++.... ..+++..++.++.|++.||.|||+ .+|+||||||+||++++++.+||+|||+++.......
T Consensus 90 ~~~~~~~~-----~~~~~~~~~~~~~ql~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~--- 158 (291)
T cd07844 90 KQYMDDCG-----GGLSMHNVRLFLFQLLRGLAYCHQ---RRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSK--- 158 (291)
T ss_pred HHHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHHh---CCeecccCCHHHEEEcCCCCEEECccccccccCCCCc---
Confidence 99887553 357899999999999999999999 8999999999999999999999999999864321100
Q ss_pred ccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCC-CCCCchhhhHHHHHHHHHHHhCCCccccCCCCcch
Q 005102 567 LQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKV-VKPSQKWDIYSYGVILLEMITGRTAVVQVGSSEMD 645 (714)
Q Consensus 567 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DVwS~Gvvl~elltG~~p~~~~~~~~~~ 645 (714)
......++..|+|||++.+ ..++.++||||+|+++|||++|+.||........
T Consensus 159 -------------------------~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~- 212 (291)
T cd07844 159 -------------------------TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVED- 212 (291)
T ss_pred -------------------------cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHH-
Confidence 0011124677999999865 4579999999999999999999999953321111
Q ss_pred hHHHHHHHHhhcC--------CcccccC---CCCC-----CCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 005102 646 LVNWMQLCIEEKK--------PLADVLD---PYLA-----PDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISD 704 (714)
Q Consensus 646 l~~~~~~~~~~~~--------~~~~~~d---~~~~-----~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 704 (714)
............. ....... +... ...........+.+++.+||+.+|++|||+.|+++
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 213 QLHKIFRVLGTPTEETWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred HHHHHHHhcCCCChhhhhhhhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 1111100000000 0000000 0000 00000011146779999999999999999999874
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=301.22 Aligned_cols=247 Identities=28% Similarity=0.420 Sum_probs=196.1
Q ss_pred ccccccCceEEEEEEECC-----CcEEEEEEeCCCCch-hHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccC
Q 005102 409 FVLGKSGIGIVYKVVLED-----GHTLAVRRLGEGGSQ-RFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIP 482 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~~-----g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~ 482 (714)
+.||+|+||.||++++.+ +..||+|++...... ..+.+..|++.+.+++|+||+++++++...+..+++|||++
T Consensus 5 ~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e~~~ 84 (258)
T smart00219 5 KKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVMEYME 84 (258)
T ss_pred ceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEeccC
Confidence 479999999999999864 388999999765443 45789999999999999999999999999999999999999
Q ss_pred CCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccC
Q 005102 483 NGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAG 562 (714)
Q Consensus 483 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 562 (714)
+++|.+++..... ..+++.++..++.|++.||+|||+ .+++||||||+||++++++.++|+|||+++......
T Consensus 85 ~~~l~~~~~~~~~----~~~~~~~~~~~~~ql~~~l~~lh~---~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 157 (258)
T smart00219 85 GGDLLDYLRKNRP----KELSLSDLLSFALQIARGMEYLES---KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD 157 (258)
T ss_pred CCCHHHHHHhhhh----ccCCHHHHHHHHHHHHHHHHHHhc---CCeeecccccceEEEccCCeEEEcccCCceeccccc
Confidence 9999999976532 128999999999999999999999 899999999999999999999999999987654321
Q ss_pred CCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHh-CCCccccCCC
Q 005102 563 GSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMIT-GRTAVVQVGS 641 (714)
Q Consensus 563 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~ellt-G~~p~~~~~~ 641 (714)
.. ......++..|+|||.+.+..++.++||||+|+++|||++ |+.||...
T Consensus 158 ~~---------------------------~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~-- 208 (258)
T smart00219 158 YY---------------------------KKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGM-- 208 (258)
T ss_pred cc---------------------------ccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC--
Confidence 00 0001124677999999988889999999999999999999 77887431
Q ss_pred CcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHH
Q 005102 642 SEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDAL 706 (714)
Q Consensus 642 ~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L 706 (714)
......+....... ..... ....++.+++.+||..||++|||+.|+++.|
T Consensus 209 ---~~~~~~~~~~~~~~-------~~~~~-----~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 209 ---SNEEVLEYLKKGYR-------LPKPE-----NCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred ---CHHHHHHHHhcCCC-------CCCCC-----cCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 11222222221111 00011 1234688999999999999999999998764
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=301.69 Aligned_cols=242 Identities=28% Similarity=0.392 Sum_probs=192.9
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeCCCC-----chhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccC
Q 005102 409 FVLGKSGIGIVYKVVLE-DGHTLAVRRLGEGG-----SQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIP 482 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~ 482 (714)
+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|++++++++|+||+++++++...+..++||||++
T Consensus 6 ~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~ 85 (258)
T cd06632 6 ELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFLELVP 85 (258)
T ss_pred ceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEEEEecC
Confidence 47999999999999986 68999999886543 2244678999999999999999999999999999999999999
Q ss_pred CCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccC
Q 005102 483 NGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAG 562 (714)
Q Consensus 483 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 562 (714)
+++|.+++... ..+++..+..++.|++.||+|||+ .+|+|+||+|+||+++.++.+||+|||++.......
T Consensus 86 ~~~L~~~~~~~------~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~ 156 (258)
T cd06632 86 GGSLAKLLKKY------GSFPEPVIRLYTRQILLGLEYLHD---RNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS 156 (258)
T ss_pred CCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEccCccceeccccc
Confidence 99999999754 358899999999999999999999 899999999999999999999999999987543211
Q ss_pred CCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCC-CCchhhhHHHHHHHHHHHhCCCccccCCC
Q 005102 563 GSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVK-PSQKWDIYSYGVILLEMITGRTAVVQVGS 641 (714)
Q Consensus 563 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s~~~DVwS~Gvvl~elltG~~p~~~~~~ 641 (714)
......++..|+|||.+.... ++.++|+||||+++|||++|+.||.....
T Consensus 157 -----------------------------~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~ 207 (258)
T cd06632 157 -----------------------------FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEG 207 (258)
T ss_pred -----------------------------cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcH
Confidence 011234577899999987766 89999999999999999999999943321
Q ss_pred CcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 005102 642 SEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISD 704 (714)
Q Consensus 642 ~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 704 (714)
......... .... +..... ....+.+++.+||+.+|++||++.+++.
T Consensus 208 -----~~~~~~~~~-~~~~-----~~~~~~-----~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 208 -----VAAVFKIGR-SKEL-----PPIPDH-----LSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred -----HHHHHHHHh-cccC-----CCcCCC-----cCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 111111111 0111 111111 1235778999999999999999999875
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=302.59 Aligned_cols=244 Identities=22% Similarity=0.348 Sum_probs=195.1
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeCCC--CchhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCCC
Q 005102 409 FVLGKSGIGIVYKVVLE-DGHTLAVRRLGEG--GSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGS 485 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gs 485 (714)
+.||+|+||.||++... +|+.||+|++... .....+++.+|++++++++||||+++++++...+..++||||+++++
T Consensus 6 ~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~ 85 (256)
T cd08218 6 KKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCEGGD 85 (256)
T ss_pred EEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEecCCCCc
Confidence 47999999999999875 5899999998653 23344678999999999999999999999999999999999999999
Q ss_pred HhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCCC
Q 005102 486 LATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSP 565 (714)
Q Consensus 486 L~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 565 (714)
|.+++..... ..+++.++.+++.|++.||+|||+ .+++|+||+|+||+++.++.++|+|||++.......
T Consensus 86 l~~~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~--- 155 (256)
T cd08218 86 LYKKINAQRG----VLFPEDQILDWFVQICLALKHVHD---RKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTV--- 155 (256)
T ss_pred HHHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEEeeccceeecCcch---
Confidence 9999875432 357899999999999999999999 899999999999999999999999999987543210
Q ss_pred CccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCccccCCCCcch
Q 005102 566 TLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGSSEMD 645 (714)
Q Consensus 566 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~~~~~~~~~~ 645 (714)
.......|+..|+|||++.+..++.++|||||||++|||++|+.||... +
T Consensus 156 -------------------------~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~-----~ 205 (256)
T cd08218 156 -------------------------ELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAG-----N 205 (256)
T ss_pred -------------------------hhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCC-----C
Confidence 0011223577899999999888999999999999999999999998432 1
Q ss_pred hHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 005102 646 LVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISD 704 (714)
Q Consensus 646 l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 704 (714)
..+.+........ +.... .....+.+++.+||+.+|++||++.+|++
T Consensus 206 ~~~~~~~~~~~~~-------~~~~~-----~~~~~~~~li~~~l~~~p~~Rp~~~~vl~ 252 (256)
T cd08218 206 MKNLVLKIIRGSY-------PPVSS-----HYSYDLRNLVSQLFKRNPRDRPSVNSILE 252 (256)
T ss_pred HHHHHHHHhcCCC-------CCCcc-----cCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 1222222221111 11111 12336889999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=308.65 Aligned_cols=244 Identities=22% Similarity=0.356 Sum_probs=194.3
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeCCCCchhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCCCHh
Q 005102 409 FVLGKSGIGIVYKVVLE-DGHTLAVRRLGEGGSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGSLA 487 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL~ 487 (714)
+.||+|+||.||++... +++.||+|.+........+.+.+|+.++++++||||+++++++...+..++|+||+++++|.
T Consensus 25 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 104 (293)
T cd06647 25 EKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLT 104 (293)
T ss_pred eEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecCCCCcHH
Confidence 47999999999999864 58899999987655555577899999999999999999999999999999999999999999
Q ss_pred hhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCCCCc
Q 005102 488 TALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTL 567 (714)
Q Consensus 488 ~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 567 (714)
+++... .+++.++..++.|++.||.|||+ ++++||||||+||+++.++.+||+|||++.......
T Consensus 105 ~~~~~~-------~l~~~~~~~i~~~l~~al~~LH~---~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~----- 169 (293)
T cd06647 105 DVVTET-------CMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ----- 169 (293)
T ss_pred HHHhhc-------CCCHHHHHHHHHHHHHHHHHHHh---CCEeeccCCHHHEEEcCCCCEEEccCcceecccccc-----
Confidence 998643 37889999999999999999999 899999999999999999999999999886543211
Q ss_pred cCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCccccCCCCcchhH
Q 005102 568 QSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGSSEMDLV 647 (714)
Q Consensus 568 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~~~~~~~~~~l~ 647 (714)
.......+++.|+|||.+.+..++.++|||||||++||+++|+.||........ +.
T Consensus 170 -----------------------~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~-~~ 225 (293)
T cd06647 170 -----------------------SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA-LY 225 (293)
T ss_pred -----------------------cccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhh-ee
Confidence 011123467789999999888899999999999999999999999943221110 00
Q ss_pred HHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 005102 648 NWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDA 705 (714)
Q Consensus 648 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 705 (714)
....... +... ........+.+++.+||+.+|++||++++++..
T Consensus 226 ----~~~~~~~-------~~~~---~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 226 ----LIATNGT-------PELQ---NPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred ----ehhcCCC-------CCCC---CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000000 0010 111123467899999999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=291.07 Aligned_cols=267 Identities=21% Similarity=0.301 Sum_probs=208.7
Q ss_pred CHHHHHHhccccccccCceEEEEEE-ECCCcEEEEEEeCCCCchhHHHHHHHHHHHhccC-CCCccceEEEEEeCCceeE
Q 005102 399 DLDELLKASAFVLGKSGIGIVYKVV-LEDGHTLAVRRLGEGGSQRFKEFQTEVEAIGKIR-HSNIVTLRAYYWSVDEKLL 476 (714)
Q Consensus 399 ~~~~l~~~~~~~lG~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~l 476 (714)
.++|+++-++++||+|.|+.|--++ ..+|.++|||++.+.....+.+..+|++++.+++ |+||++++++|++....||
T Consensus 74 ~F~d~YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYL 153 (463)
T KOG0607|consen 74 KFEDMYKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYL 153 (463)
T ss_pred hHHHHHHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEE
Confidence 4688888889999999999999887 6789999999999887677788999999999995 9999999999999999999
Q ss_pred EEeccCCCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCC---CeEEcccc
Q 005102 477 IYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNM---EPHVSDFG 553 (714)
Q Consensus 477 V~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~---~~kl~DFG 553 (714)
|||-|.+|.|..+++++ ..+++.++.++.++|+.||.|||. +||.||||||+|||..+.. -+||+||.
T Consensus 154 VfEKm~GGplLshI~~~------~~F~E~EAs~vvkdia~aLdFlH~---kgIAHRDlKPENiLC~~pn~vsPvKiCDfD 224 (463)
T KOG0607|consen 154 VFEKMRGGPLLSHIQKR------KHFNEREASRVVKDIASALDFLHT---KGIAHRDLKPENILCESPNKVSPVKICDFD 224 (463)
T ss_pred EEecccCchHHHHHHHh------hhccHHHHHHHHHHHHHHHHHHhh---cCcccccCCccceeecCCCCcCceeeeccc
Confidence 99999999999999877 458999999999999999999999 9999999999999997654 47999998
Q ss_pred hhhhhhccCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccC-----CCCCCchhhhHHHHHHHHH
Q 005102 554 LARLANIAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLK-----VVKPSQKWDIYSYGVILLE 628 (714)
Q Consensus 554 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~~DVwS~Gvvl~e 628 (714)
++.-...... .+...+....+.+|+..|||||+.. ...|+.+.|.||+|||+|-
T Consensus 225 LgSg~k~~~~---------------------~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYI 283 (463)
T KOG0607|consen 225 LGSGIKLNND---------------------CSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYI 283 (463)
T ss_pred cccccccCCC---------------------CCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHH
Confidence 8764322110 1111133445677888999999873 2358999999999999999
Q ss_pred HHhCCCccccCCCCc-----chh-----HHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCC
Q 005102 629 MITGRTAVVQVGSSE-----MDL-----VNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPT 698 (714)
Q Consensus 629 lltG~~p~~~~~~~~-----~~l-----~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt 698 (714)
|++|.+||...-..+ .+. ...+..+.+... -.++.+......+..+++...+..|+.+|-+
T Consensus 284 mLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFesIQEGkY---------eFPdkdWahIS~eakdlisnLlvrda~~rls 354 (463)
T KOG0607|consen 284 MLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKY---------EFPDKDWAHISSEAKDLISNLLVRDAKQRLS 354 (463)
T ss_pred HHhCCCCccCccCCcCCccCCCccHHHHHHHHHHHhccCC---------cCChhhhHHhhHHHHHHHHHHHhccHHhhhh
Confidence 999999994332211 111 111111111111 1122233345556778999999999999999
Q ss_pred HHHHHH
Q 005102 699 MRHISD 704 (714)
Q Consensus 699 ~~evl~ 704 (714)
+.+++.
T Consensus 355 a~~vln 360 (463)
T KOG0607|consen 355 AAQVLN 360 (463)
T ss_pred hhhccC
Confidence 988875
|
|
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=302.67 Aligned_cols=247 Identities=26% Similarity=0.377 Sum_probs=198.0
Q ss_pred cccccCceEEEEEEEC-CCcEEEEEEeCCCC-chhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCCCHh
Q 005102 410 VLGKSGIGIVYKVVLE-DGHTLAVRRLGEGG-SQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGSLA 487 (714)
Q Consensus 410 ~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL~ 487 (714)
.||+|+||.||++..+ +++.||+|++.... ....+++.+|++++++++||||+++++++...+..++|+||+++++|.
T Consensus 8 ~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 87 (265)
T cd06605 8 ELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYMDGGSLD 87 (265)
T ss_pred HhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEecCCCcHH
Confidence 6999999999999986 58999999987653 344567899999999999999999999999999999999999999999
Q ss_pred hhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCCCCc
Q 005102 488 TALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTL 567 (714)
Q Consensus 488 ~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 567 (714)
+++.... ..+++..+.+++.|++.||+|||+. .+++|+||||+||++++++.+||+|||.+.......
T Consensus 88 ~~~~~~~-----~~~~~~~~~~~~~~l~~~l~~lH~~--~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~----- 155 (265)
T cd06605 88 KILKEVQ-----GRIPERILGKIAVAVLKGLTYLHEK--HKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL----- 155 (265)
T ss_pred HHHHHcc-----CCCCHHHHHHHHHHHHHHHHHHcCC--CCeecCCCCHHHEEECCCCCEEEeecccchhhHHHH-----
Confidence 9997653 3588899999999999999999983 589999999999999999999999999987553211
Q ss_pred cCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCccccCCCCcchhH
Q 005102 568 QSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGSSEMDLV 647 (714)
Q Consensus 568 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~~~~~~~~~~l~ 647 (714)
.....++..|+|||.+.+..++.++||||||+++|+|++|+.||...........
T Consensus 156 -------------------------~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~ 210 (265)
T cd06605 156 -------------------------AKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIF 210 (265)
T ss_pred -------------------------hhcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHH
Confidence 0013456779999999988999999999999999999999999954432223333
Q ss_pred HHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 005102 648 NWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISD 704 (714)
Q Consensus 648 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 704 (714)
+.++....... +.... ......+.+++.+||..||++|||+.+++.
T Consensus 211 ~~~~~~~~~~~-------~~~~~----~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 256 (265)
T cd06605 211 ELLQYIVNEPP-------PRLPS----GKFSPDFQDFVNLCLIKDPRERPSYKELLE 256 (265)
T ss_pred HHHHHHhcCCC-------CCCCh----hhcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence 33333222211 11111 112346889999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=303.86 Aligned_cols=250 Identities=20% Similarity=0.324 Sum_probs=194.0
Q ss_pred ccccccCceEEEEEEE-CCCcEEEEEEeCCCC------chhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEecc
Q 005102 409 FVLGKSGIGIVYKVVL-EDGHTLAVRRLGEGG------SQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYI 481 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~ 481 (714)
+.||+|+||.||++.. .+++.||+|++.... ....+.+.+|++++++++|+||+++++++...+..++||||+
T Consensus 6 ~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~ 85 (268)
T cd06630 6 QQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLFVEWM 85 (268)
T ss_pred ceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEEEEecc
Confidence 5799999999999986 458999999987532 123467899999999999999999999999999999999999
Q ss_pred CCCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCC-CeEEcccchhhhhhc
Q 005102 482 PNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNM-EPHVSDFGLARLANI 560 (714)
Q Consensus 482 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~-~~kl~DFGla~~~~~ 560 (714)
++++|.+++... ..+++..+..++.|++.||+|||+ ++++|+||||+||+++.++ .+||+|||.+.....
T Consensus 86 ~~~~L~~~l~~~------~~~~~~~~~~~~~ql~~al~~LH~---~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~ 156 (268)
T cd06630 86 AGGSVSHLLSKY------GAFKEAVIINYTEQLLRGLSYLHE---NQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAA 156 (268)
T ss_pred CCCcHHHHHHHh------CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEEccccccccccc
Confidence 999999999754 458899999999999999999999 8999999999999998776 599999999876542
Q ss_pred cCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCccccCC
Q 005102 561 AGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVG 640 (714)
Q Consensus 561 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~~~~~ 640 (714)
..... ........++..|+|||.+.+..++.++||||+|+++|||++|+.||....
T Consensus 157 ~~~~~------------------------~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~ 212 (268)
T cd06630 157 KGTGA------------------------GEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEK 212 (268)
T ss_pred ccccC------------------------CccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCC
Confidence 21000 001122346778999999988889999999999999999999999994322
Q ss_pred CCcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 005102 641 SSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISD 704 (714)
Q Consensus 641 ~~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 704 (714)
.. ............. ..+... ......+.+++.+||..+|++|||+.++++
T Consensus 213 ~~--~~~~~~~~~~~~~------~~~~~~-----~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 213 HS--NHLALIFKIASAT------TAPSIP-----EHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred Cc--chHHHHHHHhccC------CCCCCc-----hhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 11 1111111111000 111111 122346889999999999999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=305.31 Aligned_cols=241 Identities=21% Similarity=0.224 Sum_probs=183.3
Q ss_pred cccccCceEEEEEEEC-CCcEEEEEEeCCCCc---hhHHHHHHHHHHHh---ccCCCCccceEEEEEeCCceeEEEeccC
Q 005102 410 VLGKSGIGIVYKVVLE-DGHTLAVRRLGEGGS---QRFKEFQTEVEAIG---KIRHSNIVTLRAYYWSVDEKLLIYDYIP 482 (714)
Q Consensus 410 ~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~E~~~l~---~l~H~niv~l~~~~~~~~~~~lV~e~~~ 482 (714)
+||+|+||.||++... +++.+|+|.+..... .....+.+|..++. ..+||||+.+++++...+..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999975 489999998865421 11233444544433 3479999999999999999999999999
Q ss_pred CCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccC
Q 005102 483 NGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAG 562 (714)
Q Consensus 483 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 562 (714)
+|+|.+++... ..+++..+..|+.|++.||+|||+ .+|+||||||+||++++++.+||+|||++......
T Consensus 81 ~~~L~~~i~~~------~~l~~~~~~~i~~qi~~al~~lH~---~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~- 150 (279)
T cd05633 81 GGDLHYHLSQH------GVFSEKEMRFYATEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK- 150 (279)
T ss_pred CCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCcCCCCCCHHHEEECCCCCEEEccCCcceecccc-
Confidence 99999988755 458999999999999999999999 89999999999999999999999999998643211
Q ss_pred CCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCC-CCCCchhhhHHHHHHHHHHHhCCCccccCCC
Q 005102 563 GSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKV-VKPSQKWDIYSYGVILLEMITGRTAVVQVGS 641 (714)
Q Consensus 563 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DVwS~Gvvl~elltG~~p~~~~~~ 641 (714)
......|+..|+|||.+.. ..++.++|||||||++|||++|+.||.....
T Consensus 151 -----------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 201 (279)
T cd05633 151 -----------------------------KPHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKT 201 (279)
T ss_pred -----------------------------CccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCC
Confidence 0112246888999999864 5589999999999999999999999954322
Q ss_pred CcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCC-----CHHHHHH
Q 005102 642 SEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRP-----TMRHISD 704 (714)
Q Consensus 642 ~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----t~~evl~ 704 (714)
.... ........ ....+... ...++.+++.+||+.||++|| |++|+++
T Consensus 202 ~~~~---~~~~~~~~-------~~~~~~~~-----~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~ 254 (279)
T cd05633 202 KDKH---EIDRMTLT-------VNVELPDS-----FSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKE 254 (279)
T ss_pred cCHH---HHHHHhhc-------CCcCCccc-----cCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHh
Confidence 2111 11111000 11111111 223678999999999999999 5888876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-36 Score=310.09 Aligned_cols=257 Identities=23% Similarity=0.359 Sum_probs=190.9
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeCCCCc--hhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCCC
Q 005102 409 FVLGKSGIGIVYKVVLE-DGHTLAVRRLGEGGS--QRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGS 485 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gs 485 (714)
+.||+|+||.||+|.++ +++.||+|++..... ...+.+.+|++++++++||||+++++++...+..++||||+++++
T Consensus 7 ~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 86 (286)
T cd07846 7 GLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFVDHTV 86 (286)
T ss_pred eeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEecCCccH
Confidence 47999999999999986 489999999865432 234578899999999999999999999999999999999999999
Q ss_pred HhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCCC
Q 005102 486 LATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSP 565 (714)
Q Consensus 486 L~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 565 (714)
|..+.... ..+++.+++.++.|++.||+|||+ .+++|+||+|+||++++++.+||+|||+++......
T Consensus 87 l~~~~~~~------~~~~~~~~~~~~~~i~~~l~~LH~---~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~--- 154 (286)
T cd07846 87 LDDLEKYP------NGLDESRVRKYLFQILRGIEFCHS---HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG--- 154 (286)
T ss_pred HHHHHhcc------CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc---
Confidence 88876543 348999999999999999999999 899999999999999999999999999987543211
Q ss_pred CccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCC-CCCCchhhhHHHHHHHHHHHhCCCccccCCCCcc
Q 005102 566 TLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKV-VKPSQKWDIYSYGVILLEMITGRTAVVQVGSSEM 644 (714)
Q Consensus 566 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DVwS~Gvvl~elltG~~p~~~~~~~~~ 644 (714)
.......++..|+|||++.+ ..++.++||||||+++|||++|+.||..... .
T Consensus 155 -------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~--~ 207 (286)
T cd07846 155 -------------------------EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSD--I 207 (286)
T ss_pred -------------------------cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCch--H
Confidence 01112335778999999875 4478899999999999999999988843211 1
Q ss_pred hhHHHHHHHHhh-----------cCCcccccCCCCCCCCC----cHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 005102 645 DLVNWMQLCIEE-----------KKPLADVLDPYLAPDAD----KEEEIIAVLKIAMACVHSSPEKRPTMRHISD 704 (714)
Q Consensus 645 ~l~~~~~~~~~~-----------~~~~~~~~d~~~~~~~~----~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 704 (714)
+...-....... .........+....... .......+.+++.+||+.+|++|||+.++++
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 208 DQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred HHHHHHHHHhCCCchhhHHHhccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 111100000000 00000000010000000 0012346889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=306.92 Aligned_cols=257 Identities=22% Similarity=0.309 Sum_probs=189.6
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeCCCC--chhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCCC
Q 005102 409 FVLGKSGIGIVYKVVLE-DGHTLAVRRLGEGG--SQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGS 485 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gs 485 (714)
..||+|++|.||+|+.+ +|+.||||++.... ....+.+.+|++++++++||||+++++++.+.+..++||||+. ++
T Consensus 6 ~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~-~~ 84 (284)
T cd07860 6 EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QD 84 (284)
T ss_pred eeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeeccc-cC
Confidence 46899999999999975 58999999987542 2223578899999999999999999999999999999999995 68
Q ss_pred HhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCCC
Q 005102 486 LATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSP 565 (714)
Q Consensus 486 L~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 565 (714)
|.+++..... ..+++..+..++.|++.||+|||+ .+++||||+|+||++++++.+||+|||+++......
T Consensus 85 l~~~~~~~~~----~~l~~~~~~~~~~~i~~~l~~lh~---~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~--- 154 (284)
T cd07860 85 LKKFMDASPL----SGIPLPLIKSYLFQLLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV--- 154 (284)
T ss_pred HHHHHHhCCC----CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEeeccchhhcccCc---
Confidence 9998875432 458999999999999999999999 899999999999999999999999999987543211
Q ss_pred CccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCC-CCchhhhHHHHHHHHHHHhCCCccccCCCCcc
Q 005102 566 TLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVK-PSQKWDIYSYGVILLEMITGRTAVVQVGSSEM 644 (714)
Q Consensus 566 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s~~~DVwS~Gvvl~elltG~~p~~~~~~~~~ 644 (714)
.......++..|+|||.+.+.. ++.++|||||||++|||+||+.||..... ..
T Consensus 155 -------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~-~~ 208 (284)
T cd07860 155 -------------------------RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSE-ID 208 (284)
T ss_pred -------------------------cccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCH-HH
Confidence 0111223467799999887644 58899999999999999999999953221 11
Q ss_pred hhHHHHHHHHhh--------------cCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 005102 645 DLVNWMQLCIEE--------------KKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISD 704 (714)
Q Consensus 645 ~l~~~~~~~~~~--------------~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 704 (714)
.........-.. ............... .......+.+++.+||+.||++|||++++++
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 209 QLFRIFRTLGTPDEVVWPGVTSLPDYKPSFPKWARQDFSKV--VPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred HHHHHHHHhCCCChhhhhhhhHHHHHHhhcccccccCHHHH--cccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence 111111100000 000000000000000 0011235678999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=302.90 Aligned_cols=249 Identities=25% Similarity=0.397 Sum_probs=191.1
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeCCCCc----------hhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEE
Q 005102 409 FVLGKSGIGIVYKVVLE-DGHTLAVRRLGEGGS----------QRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLI 477 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~----------~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV 477 (714)
+.||+|+||.||+|... +|+.||+|.++.... ...+.+.+|+.++++++||||+++++++...+..++|
T Consensus 7 ~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 86 (272)
T cd06629 7 ELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEEYLSIF 86 (272)
T ss_pred ceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCCceEEE
Confidence 57999999999999865 589999998864211 1124678899999999999999999999999999999
Q ss_pred EeccCCCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhh
Q 005102 478 YDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARL 557 (714)
Q Consensus 478 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 557 (714)
|||+++|+|.+++... ..+++..+..++.|++.||.|||+ .+++||||||+||++++++.+||+|||+++.
T Consensus 87 ~e~~~~~~L~~~l~~~------~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~ 157 (272)
T cd06629 87 LEYVPGGSIGSCLRTY------GRFEEQLVRFFTEQVLEGLAYLHS---KGILHRDLKADNLLVDADGICKISDFGISKK 157 (272)
T ss_pred EecCCCCcHHHHHhhc------cCCCHHHHHHHHHHHHHHHHHHhh---CCeeecCCChhhEEEcCCCeEEEeecccccc
Confidence 9999999999999765 358899999999999999999999 8999999999999999999999999999875
Q ss_pred hhccCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCC--CCchhhhHHHHHHHHHHHhCCCc
Q 005102 558 ANIAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVK--PSQKWDIYSYGVILLEMITGRTA 635 (714)
Q Consensus 558 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~s~~~DVwS~Gvvl~elltG~~p 635 (714)
...... ........|+..|+|||.+.... ++.++||||||+++||+++|+.|
T Consensus 158 ~~~~~~--------------------------~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p 211 (272)
T cd06629 158 SDDIYD--------------------------NDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRP 211 (272)
T ss_pred cccccc--------------------------ccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCC
Confidence 421100 00112234577899999987654 78999999999999999999999
Q ss_pred cccCCCCcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 005102 636 VVQVGSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISD 704 (714)
Q Consensus 636 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 704 (714)
|..... ...... ..... ....+...... .....+.+++.+||..+|++|||+++|++
T Consensus 212 ~~~~~~----~~~~~~-~~~~~--~~~~~~~~~~~-----~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (272)
T cd06629 212 WSDEEA----IAAMFK-LGNKR--SAPPIPPDVSM-----NLSPVALDFLNACFTINPDNRPTARELLQ 268 (272)
T ss_pred CcCcch----HHHHHH-hhccc--cCCcCCccccc-----cCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence 842211 111111 11010 01111111111 12346889999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=307.61 Aligned_cols=247 Identities=22% Similarity=0.328 Sum_probs=188.1
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeCCCCchhHHHHHHHHHHHhcc-CCCCccceEEEEEeC-----CceeEEEecc
Q 005102 409 FVLGKSGIGIVYKVVLE-DGHTLAVRRLGEGGSQRFKEFQTEVEAIGKI-RHSNIVTLRAYYWSV-----DEKLLIYDYI 481 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~-----~~~~lV~e~~ 481 (714)
..||+|+||.||++... +++.+|+|.+..... ....+.+|+.++.++ +|||++++++++... +..++||||+
T Consensus 28 ~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~-~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~~lv~ey~ 106 (291)
T cd06639 28 ETIGKGTYGKVYKVTNKKDGSLAAVKILDPISD-VDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELC 106 (291)
T ss_pred EEeecCCCeEEEEEEECCCCCEEEEEEeccccc-HHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCeeEEEEEEC
Confidence 47999999999999975 588999999875432 235678899999999 799999999998754 3579999999
Q ss_pred CCCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhcc
Q 005102 482 PNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIA 561 (714)
Q Consensus 482 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 561 (714)
++|+|.++++..... ...+++..++.++.|++.||+|||+ .+++||||||+||++++++.+||+|||+++.....
T Consensus 107 ~~~sL~~~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~nili~~~~~~kl~dfg~~~~~~~~ 181 (291)
T cd06639 107 NGGSVTELVKGLLIC--GQRLDEAMISYILYGALLGLQHLHN---NRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTST 181 (291)
T ss_pred CCCcHHHHHHHhhhc--CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEEcCCCCEEEeecccchhcccc
Confidence 999999988642111 1458999999999999999999999 89999999999999999999999999998764321
Q ss_pred CCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCC-----CCCchhhhHHHHHHHHHHHhCCCcc
Q 005102 562 GGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVV-----KPSQKWDIYSYGVILLEMITGRTAV 636 (714)
Q Consensus 562 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~s~~~DVwS~Gvvl~elltG~~p~ 636 (714)
.. ......|+..|+|||.+... .++.++|||||||++|||++|+.||
T Consensus 182 ~~----------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~ 233 (291)
T cd06639 182 RL----------------------------RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPL 233 (291)
T ss_pred cc----------------------------cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCC
Confidence 10 01123457789999998543 3689999999999999999999999
Q ss_pred ccCCCCcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 005102 637 VQVGSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISD 704 (714)
Q Consensus 637 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 704 (714)
..... ... +..... .. .....++ ......+.+++.+||+.+|++||++.|+++
T Consensus 234 ~~~~~----~~~-~~~~~~-~~-~~~~~~~--------~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 286 (291)
T cd06639 234 FDMHP----VKT-LFKIPR-NP-PPTLLHP--------EKWCRSFNHFISQCLIKDFEARPSVTHLLE 286 (291)
T ss_pred CCCcH----HHH-HHHHhc-CC-CCCCCcc--------cccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 43211 111 111111 10 1111111 112336889999999999999999999875
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=307.38 Aligned_cols=244 Identities=23% Similarity=0.333 Sum_probs=188.3
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeCCCCchhHHHHHHHHHHHhcc-CCCCccceEEEEEe------CCceeEEEec
Q 005102 409 FVLGKSGIGIVYKVVLE-DGHTLAVRRLGEGGSQRFKEFQTEVEAIGKI-RHSNIVTLRAYYWS------VDEKLLIYDY 480 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~------~~~~~lV~e~ 480 (714)
..||+|+||.||+|... +++.+|+|.+.... ....++..|+.+++++ +||||+++++++.. .+..++||||
T Consensus 22 ~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~ 100 (282)
T cd06636 22 EVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEF 100 (282)
T ss_pred eeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCEEEEEEEe
Confidence 37999999999999975 48899999886543 2335788999999999 69999999999863 3567999999
Q ss_pred cCCCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhc
Q 005102 481 IPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANI 560 (714)
Q Consensus 481 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 560 (714)
+++|+|.+++..... ..+++..+..++.|++.||+|||+ .+|+||||||+||++++++.++|+|||+++....
T Consensus 101 ~~~~~L~~~~~~~~~----~~~~~~~~~~~~~qi~~al~~LH~---~~ivH~dl~~~nili~~~~~~~l~dfg~~~~~~~ 173 (282)
T cd06636 101 CGAGSVTDLVKNTKG----NALKEDWIAYICREILRGLAHLHA---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDR 173 (282)
T ss_pred CCCCcHHHHHHHccC----CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEeeCcchhhhhc
Confidence 999999999875432 347888899999999999999999 8999999999999999999999999999875432
Q ss_pred cCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccC-----CCCCCchhhhHHHHHHHHHHHhCCCc
Q 005102 561 AGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLK-----VVKPSQKWDIYSYGVILLEMITGRTA 635 (714)
Q Consensus 561 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~~DVwS~Gvvl~elltG~~p 635 (714)
.. .......|+..|+|||.+. +..++.++|||||||++|||++|+.|
T Consensus 174 ~~----------------------------~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p 225 (282)
T cd06636 174 TV----------------------------GRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPP 225 (282)
T ss_pred cc----------------------------cCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCC
Confidence 11 0112234678899999985 34678899999999999999999999
Q ss_pred cccCCCCcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 005102 636 VVQVGSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISD 704 (714)
Q Consensus 636 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 704 (714)
|...... .... .. ... ..+... .......+.+++.+||+.||.+|||+.|+++
T Consensus 226 ~~~~~~~----~~~~-~~-~~~------~~~~~~----~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 226 LCDMHPM----RALF-LI-PRN------PPPKLK----SKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred ccccCHH----hhhh-hH-hhC------CCCCCc----ccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 9432211 1000 00 000 011111 1112346889999999999999999999874
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=298.63 Aligned_cols=243 Identities=21% Similarity=0.312 Sum_probs=192.8
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeCCC--CchhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCCC
Q 005102 409 FVLGKSGIGIVYKVVLE-DGHTLAVRRLGEG--GSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGS 485 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gs 485 (714)
+.||+|+||.||++... +++.+|+|.+... .....+.+.+|++++++++||||+++++.+...+..++||||+++++
T Consensus 6 ~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~ 85 (256)
T cd08220 6 RVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYAPGGT 85 (256)
T ss_pred EEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEecCCCCC
Confidence 47999999999999875 5889999998754 23345678999999999999999999999998899999999999999
Q ss_pred HhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCC-CCeEEcccchhhhhhccCCC
Q 005102 486 LATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHN-MEPHVSDFGLARLANIAGGS 564 (714)
Q Consensus 486 L~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~-~~~kl~DFGla~~~~~~~~~ 564 (714)
|.+++..... ..+++..+.+++.|++.||+|||+ ++++|+||||+||+++++ +.+||+|||+++......
T Consensus 86 L~~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lh~---~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~-- 156 (256)
T cd08220 86 LAEYIQKRCN----SLLDEDTILHFFVQILLALHHVHT---KLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS-- 156 (256)
T ss_pred HHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc--
Confidence 9999976532 358899999999999999999999 899999999999999865 468999999987653211
Q ss_pred CCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCccccCCCCcc
Q 005102 565 PTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGSSEM 644 (714)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~~~~~~~~~ 644 (714)
......++..|+|||.+.+..++.++||||||+++|+|++|+.||....
T Consensus 157 ---------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~---- 205 (256)
T cd08220 157 ---------------------------KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAAN---- 205 (256)
T ss_pred ---------------------------cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCc----
Confidence 1112335778999999998889999999999999999999999984321
Q ss_pred hhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 005102 645 DLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISD 704 (714)
Q Consensus 645 ~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 704 (714)
....+........ .. .... ....+.+++.+||+.+|++|||++|+++
T Consensus 206 -~~~~~~~~~~~~~--~~-----~~~~-----~~~~l~~li~~~l~~~p~~Rpt~~~ll~ 252 (256)
T cd08220 206 -LPALVLKIMSGTF--AP-----ISDR-----YSPDLRQLILSMLNLDPSKRPQLSQIMA 252 (256)
T ss_pred -hHHHHHHHHhcCC--CC-----CCCC-----cCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 1112211111111 11 1111 1235789999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=306.10 Aligned_cols=237 Identities=22% Similarity=0.288 Sum_probs=191.1
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeCCCC---chhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCC
Q 005102 409 FVLGKSGIGIVYKVVLE-DGHTLAVRRLGEGG---SQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNG 484 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~g 484 (714)
+.||+|+||.||++... +++.||+|++.... ....+.+.+|++++++++||||+++++++...+..++||||++++
T Consensus 7 ~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~ 86 (290)
T cd05580 7 KTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVMEYVPGG 86 (290)
T ss_pred EEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEEecCCCC
Confidence 47999999999999976 48999999987532 233467889999999999999999999999999999999999999
Q ss_pred CHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCC
Q 005102 485 SLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGS 564 (714)
Q Consensus 485 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 564 (714)
+|.+++... ..+++..+..++.|++.||+|||+ .+|+|+||+|+||++++++.+||+|||+++.....
T Consensus 87 ~L~~~~~~~------~~l~~~~~~~~~~qil~~l~~lH~---~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~--- 154 (290)
T cd05580 87 ELFSHLRKS------GRFPEPVARFYAAQVVLALEYLHS---LDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR--- 154 (290)
T ss_pred CHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC---
Confidence 999998765 458899999999999999999999 89999999999999999999999999998754311
Q ss_pred CCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCccccCCCCcc
Q 005102 565 PTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGSSEM 644 (714)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~~~~~~~~~ 644 (714)
.....+++.|+|||.+.+...+.++||||||+++|||++|+.||....
T Consensus 155 ----------------------------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~---- 202 (290)
T cd05580 155 ----------------------------TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDN---- 202 (290)
T ss_pred ----------------------------CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCC----
Confidence 112235778999999988888999999999999999999999994322
Q ss_pred hhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCC-----CHHHHH
Q 005102 645 DLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRP-----TMRHIS 703 (714)
Q Consensus 645 ~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----t~~evl 703 (714)
.....+....... .+.... ...+.+++.+||..||.+|| +++|++
T Consensus 203 -~~~~~~~~~~~~~--------~~~~~~-----~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~ 252 (290)
T cd05580 203 -PIQIYEKILEGKV--------RFPSFF-----SPDAKDLIRNLLQVDLTKRLGNLKNGVNDIK 252 (290)
T ss_pred -HHHHHHHHhcCCc--------cCCccC-----CHHHHHHHHHHccCCHHHccCcccCCHHHHH
Confidence 1111111111111 111111 23577999999999999998 666665
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=305.77 Aligned_cols=243 Identities=22% Similarity=0.337 Sum_probs=193.3
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeCCCCchhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCCCHh
Q 005102 409 FVLGKSGIGIVYKVVLE-DGHTLAVRRLGEGGSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGSLA 487 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL~ 487 (714)
..||+|+||.||++... +++.||||++........+.+.+|+.++++++|+||+++++++...+..++||||+++++|.
T Consensus 26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 105 (292)
T cd06657 26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT 105 (292)
T ss_pred HHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHH
Confidence 36999999999999875 58999999987655555677999999999999999999999999999999999999999999
Q ss_pred hhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCCCCc
Q 005102 488 TALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTL 567 (714)
Q Consensus 488 ~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 567 (714)
+++.. ..+++..+..++.|++.||+|||+ .+++|+||||+||++++++.++|+|||++.......
T Consensus 106 ~~~~~-------~~~~~~~~~~~~~ql~~~l~~lH~---~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~----- 170 (292)
T cd06657 106 DIVTH-------TRMNEEQIAAVCLAVLKALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV----- 170 (292)
T ss_pred HHHhc-------CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEcccccceeccccc-----
Confidence 98753 247899999999999999999999 899999999999999999999999999876442110
Q ss_pred cCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCccccCCCCcchhH
Q 005102 568 QSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGSSEMDLV 647 (714)
Q Consensus 568 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~~~~~~~~~~l~ 647 (714)
.......|+..|+|||.+.+..++.++||||||+++|||++|+.||... ...
T Consensus 171 -----------------------~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~--~~~--- 222 (292)
T cd06657 171 -----------------------PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE--PPL--- 222 (292)
T ss_pred -----------------------ccccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC--CHH---
Confidence 0112234678899999998888999999999999999999999998422 111
Q ss_pred HHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 005102 648 NWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISD 704 (714)
Q Consensus 648 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 704 (714)
+.+........ +..... ......+.+++.+||+.+|.+||++.++++
T Consensus 223 ~~~~~~~~~~~-------~~~~~~---~~~~~~l~~li~~~l~~~P~~R~~~~~ll~ 269 (292)
T cd06657 223 KAMKMIRDNLP-------PKLKNL---HKVSPSLKGFLDRLLVRDPAQRATAAELLK 269 (292)
T ss_pred HHHHHHHhhCC-------cccCCc---ccCCHHHHHHHHHHHhCCcccCcCHHHHhc
Confidence 11111111110 111000 011235778999999999999999999886
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=307.11 Aligned_cols=258 Identities=21% Similarity=0.294 Sum_probs=191.6
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeCCCCch-----hHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccC
Q 005102 409 FVLGKSGIGIVYKVVLE-DGHTLAVRRLGEGGSQ-----RFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIP 482 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~ 482 (714)
+.||+|+||.||+|... +++.||||++...... ....+..|++++++++|+||+++++++.+.+..++||||+
T Consensus 6 ~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~- 84 (298)
T cd07841 6 KKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLVFEFM- 84 (298)
T ss_pred eeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEEEccc-
Confidence 47999999999999975 5899999999765322 2345778999999999999999999999989999999999
Q ss_pred CCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccC
Q 005102 483 NGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAG 562 (714)
Q Consensus 483 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 562 (714)
+|+|.+++.... ..+++..+..++.||++||+|||+ .+|+|+||||+||+++.++.+||+|||+++......
T Consensus 85 ~~~L~~~i~~~~-----~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~ 156 (298)
T cd07841 85 ETDLEKVIKDKS-----IVLTPADIKSYMLMTLRGLEYLHS---NWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPN 156 (298)
T ss_pred CCCHHHHHhccC-----CCCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCChhhEEEcCCCCEEEccceeeeeccCCC
Confidence 899999997652 258999999999999999999999 899999999999999999999999999987653211
Q ss_pred CCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCC-CCCCchhhhHHHHHHHHHHHhCCCccccCCC
Q 005102 563 GSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKV-VKPSQKWDIYSYGVILLEMITGRTAVVQVGS 641 (714)
Q Consensus 563 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DVwS~Gvvl~elltG~~p~~~~~~ 641 (714)
. ......+++.|+|||.+.+ ..++.++|||||||++|||++|..||....
T Consensus 157 ~----------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~- 207 (298)
T cd07841 157 R----------------------------KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDS- 207 (298)
T ss_pred c----------------------------cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCc-
Confidence 0 0111234667999998854 457899999999999999999977774321
Q ss_pred CcchhHHHHHHHHhhc--------CCcccccCCCCCCCCC----cHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 005102 642 SEMDLVNWMQLCIEEK--------KPLADVLDPYLAPDAD----KEEEIIAVLKIAMACVHSSPEKRPTMRHISDA 705 (714)
Q Consensus 642 ~~~~l~~~~~~~~~~~--------~~~~~~~d~~~~~~~~----~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 705 (714)
+.+...-........ ................ .......+.+++.+||+.||++|||++|+++.
T Consensus 208 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 208 -DIDQLGKIFEALGTPTEENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred -cHHHHHHHHHHcCCCchhhhhhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 111111111000000 0000000000000000 01223568899999999999999999999873
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-35 Score=299.75 Aligned_cols=246 Identities=22% Similarity=0.299 Sum_probs=188.5
Q ss_pred cccccccCceEEEEEEECC-CcEEEEEEeCCCC-----chhHHHHHHHHHHHhccCCCCccceEEEEEeC--CceeEEEe
Q 005102 408 AFVLGKSGIGIVYKVVLED-GHTLAVRRLGEGG-----SQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSV--DEKLLIYD 479 (714)
Q Consensus 408 ~~~lG~G~~g~Vy~~~~~~-g~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~~lV~e 479 (714)
.+.||+|+||.||+|...+ +..||||.+.... ....+.+.+|++++++++||||+++++++.+. ...++|||
T Consensus 7 ~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~v~e 86 (265)
T cd06652 7 GKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLSIFME 86 (265)
T ss_pred eeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceEEEEEE
Confidence 3579999999999999754 8999999886421 12345788999999999999999999998764 45789999
Q ss_pred ccCCCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhh
Q 005102 480 YIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLAN 559 (714)
Q Consensus 480 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~ 559 (714)
|+++++|.+++... ..+++..+++++.|++.||+|||+ .+++|+||||+||+++.++.+||+|||+++...
T Consensus 87 ~~~~~~L~~~l~~~------~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~ 157 (265)
T cd06652 87 HMPGGSIKDQLKSY------GALTENVTRKYTRQILEGVSYLHS---NMIVHRDIKGANILRDSVGNVKLGDFGASKRLQ 157 (265)
T ss_pred ecCCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEecCCCCEEECcCccccccc
Confidence 99999999998754 347888999999999999999999 899999999999999999999999999987543
Q ss_pred ccCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCccccC
Q 005102 560 IAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQV 639 (714)
Q Consensus 560 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~~~~ 639 (714)
..... ........++..|+|||.+.+..++.++|||||||++|||++|+.||...
T Consensus 158 ~~~~~-------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~ 212 (265)
T cd06652 158 TICLS-------------------------GTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEF 212 (265)
T ss_pred ccccc-------------------------ccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCcc
Confidence 21000 00111234678899999998888999999999999999999999999432
Q ss_pred CCCcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 005102 640 GSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISD 704 (714)
Q Consensus 640 ~~~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 704 (714)
. .... ........ ..+... ......+.+++.+||. +|++||+++|+++
T Consensus 213 ~----~~~~-~~~~~~~~------~~~~~~-----~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~ 260 (265)
T cd06652 213 E----AMAA-IFKIATQP------TNPVLP-----PHVSDHCRDFLKRIFV-EAKLRPSADELLR 260 (265)
T ss_pred c----hHHH-HHHHhcCC------CCCCCc-----hhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence 1 1111 11111110 011111 1233467789999995 8999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-35 Score=306.12 Aligned_cols=239 Identities=23% Similarity=0.395 Sum_probs=188.2
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeCCCC---chhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCC
Q 005102 409 FVLGKSGIGIVYKVVLE-DGHTLAVRRLGEGG---SQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNG 484 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~g 484 (714)
+.||+|+||.||+|... +++.||+|++.... ....+++.+|++++++++||||+++++++...+..++||||+. |
T Consensus 21 ~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~-g 99 (307)
T cd06607 21 REIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVMEYCL-G 99 (307)
T ss_pred eeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEHHhhC-C
Confidence 47999999999999975 58999999986432 2334578899999999999999999999999999999999996 5
Q ss_pred CHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCC
Q 005102 485 SLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGS 564 (714)
Q Consensus 485 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 564 (714)
++.+++.... ..+++..+..++.|++.||.|||+ .+|+||||+|+||++++++.+||+|||+++.....
T Consensus 100 ~l~~~~~~~~-----~~l~~~~~~~~~~ql~~~L~~LH~---~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~--- 168 (307)
T cd06607 100 SASDILEVHK-----KPLQEVEIAAICHGALQGLAYLHS---HERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA--- 168 (307)
T ss_pred CHHHHHHHcc-----cCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcccEEECCCCCEEEeecCcceecCCC---
Confidence 7877775432 358999999999999999999999 89999999999999999999999999988653211
Q ss_pred CCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccC---CCCCCchhhhHHHHHHHHHHHhCCCccccCCC
Q 005102 565 PTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLK---VVKPSQKWDIYSYGVILLEMITGRTAVVQVGS 641 (714)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~~~DVwS~Gvvl~elltG~~p~~~~~~ 641 (714)
....++..|+|||++. ...++.++||||||+++|||+||+.||.....
T Consensus 169 -----------------------------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~ 219 (307)
T cd06607 169 -----------------------------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA 219 (307)
T ss_pred -----------------------------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccH
Confidence 1123567799999874 45688999999999999999999999843211
Q ss_pred CcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 005102 642 SEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISD 704 (714)
Q Consensus 642 ~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 704 (714)
....... .... .+.. ........+.+++.+||..||++||++.+++.
T Consensus 220 -----~~~~~~~-~~~~------~~~~----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 266 (307)
T cd06607 220 -----MSALYHI-AQND------SPTL----SSNDWSDYFRNFVDSCLQKIPQDRPSSEELLK 266 (307)
T ss_pred -----HHHHHHH-hcCC------CCCC----CchhhCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 1111111 1100 0111 11123446889999999999999999999976
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=309.16 Aligned_cols=273 Identities=23% Similarity=0.278 Sum_probs=198.4
Q ss_pred ccccccCceEEEEEEECC-CcEEEEEEeCCCCch---hHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCC
Q 005102 409 FVLGKSGIGIVYKVVLED-GHTLAVRRLGEGGSQ---RFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNG 484 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~g 484 (714)
+.||+|+||.||+|...+ ++.||+|.+...... ..+.+..|++++++++||||+++++++...+..++||||+.++
T Consensus 7 ~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 86 (316)
T cd05574 7 KLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMDYCPGG 86 (316)
T ss_pred eeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEEecCCC
Confidence 479999999999999865 899999999765322 3457889999999999999999999999999999999999999
Q ss_pred CHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCC
Q 005102 485 SLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGS 564 (714)
Q Consensus 485 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 564 (714)
+|.+++....+ ..+++..+..++.|++.||+|||+ .+++|+||||+||+++.++.++|+|||++.........
T Consensus 87 ~L~~~~~~~~~----~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~ 159 (316)
T cd05574 87 ELFRLLQRQPG----KCLSEEVARFYAAEVLLALEYLHL---LGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPP 159 (316)
T ss_pred CHHHHHHhCCC----CccCHHHHHHHHHHHHHHHHHHHH---CCeeccCCChHHeEEcCCCCEEEeecchhhcccccccc
Confidence 99999875432 458999999999999999999999 89999999999999999999999999998865432211
Q ss_pred CCccCCCCCCCC-chhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCccccCCCCc
Q 005102 565 PTLQSNRMPAEK-PQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGSSE 643 (714)
Q Consensus 565 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~~~~~~~~ 643 (714)
............ .....................||..|+|||++.+..++.++||||||+++|||++|+.||......
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~- 238 (316)
T cd05574 160 VSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRD- 238 (316)
T ss_pred cccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCchH-
Confidence 100000000000 000000000001111223446788999999999888999999999999999999999999533211
Q ss_pred chhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCC----HHHHHH
Q 005102 644 MDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPT----MRHISD 704 (714)
Q Consensus 644 ~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt----~~evl~ 704 (714)
............ .... ......+.+++.+||..||++||| ++|++.
T Consensus 239 ----~~~~~~~~~~~~--------~~~~---~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 239 ----ETFSNILKKEVT--------FPGS---PPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred ----HHHHHHhcCCcc--------CCCc---cccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence 111111111110 0000 012346889999999999999999 666554
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=299.02 Aligned_cols=241 Identities=23% Similarity=0.377 Sum_probs=192.8
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeCCCC-chhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCCCH
Q 005102 409 FVLGKSGIGIVYKVVLE-DGHTLAVRRLGEGG-SQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGSL 486 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL 486 (714)
..||+|+||.||+|... ++..||+|.+.... ....+.+.+|+.++++++||||+++++++...+..++||||+++++|
T Consensus 10 ~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l 89 (277)
T cd06641 10 EKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSA 89 (277)
T ss_pred eeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeCCCCcH
Confidence 36999999999999875 58899999986543 23346788999999999999999999999999999999999999999
Q ss_pred hhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCCCC
Q 005102 487 ATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPT 566 (714)
Q Consensus 487 ~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 566 (714)
.+++.. ..+++..+..++.|++.|+.|||+ .+++|+||||+||+++.++.++|+|||+++......
T Consensus 90 ~~~i~~-------~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~---- 155 (277)
T cd06641 90 LDLLEP-------GPLDETQIATILREILKGLDYLHS---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ---- 155 (277)
T ss_pred HHHHhc-------CCCCHHHHHHHHHHHHHHHHHHcc---CCeecCCCCHHhEEECCCCCEEEeecccceecccch----
Confidence 999863 247899999999999999999999 899999999999999999999999999987543210
Q ss_pred ccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCccccCCCCcchh
Q 005102 567 LQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGSSEMDL 646 (714)
Q Consensus 567 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~~~~~~~~~~l 646 (714)
.......++..|+|||.+.+..++.++|||||||++|||++|..||.....
T Consensus 156 ------------------------~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~----- 206 (277)
T cd06641 156 ------------------------IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHP----- 206 (277)
T ss_pred ------------------------hhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccch-----
Confidence 011123457789999999888899999999999999999999999843211
Q ss_pred HHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 005102 647 VNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISD 704 (714)
Q Consensus 647 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 704 (714)
....... .... .+.... .....+.+++.+||+.+|++||++.++++
T Consensus 207 ~~~~~~~-~~~~------~~~~~~-----~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 252 (277)
T cd06641 207 MKVLFLI-PKNN------PPTLEG-----NYSKPLKEFVEACLNKEPSFRPTAKELLK 252 (277)
T ss_pred HHHHHHH-hcCC------CCCCCc-----ccCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 1111111 1111 011111 12235789999999999999999999988
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=307.23 Aligned_cols=258 Identities=22% Similarity=0.365 Sum_probs=192.5
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeCCC--CchhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCCC
Q 005102 409 FVLGKSGIGIVYKVVLE-DGHTLAVRRLGEG--GSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGS 485 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gs 485 (714)
+.||+|+||.||+|..+ +++.||+|+++.. .....+.+.+|++++++++|+||+++++++...+..++||||++++.
T Consensus 7 ~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~~ 86 (288)
T cd07833 7 GVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYVERTL 86 (288)
T ss_pred EEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEecCCCCH
Confidence 47999999999999986 4889999998754 22334678999999999999999999999999999999999999877
Q ss_pred HhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCCC
Q 005102 486 LATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSP 565 (714)
Q Consensus 486 L~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 565 (714)
+..+.... ..+++.++..++.|++.||+|||+ .+++||||+|+||++++++.+||+|||+++.......
T Consensus 87 l~~~~~~~------~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~-- 155 (288)
T cd07833 87 LELLEASP------GGLPPDAVRSYIWQLLQAIAYCHS---HNIIHRDIKPENILVSESGVLKLCDFGFARALRARPA-- 155 (288)
T ss_pred HHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEEeeecccccCCCcc--
Confidence 76655433 348899999999999999999999 8999999999999999999999999999876542210
Q ss_pred CccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCC-CCCchhhhHHHHHHHHHHHhCCCccccCCCCcc
Q 005102 566 TLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVV-KPSQKWDIYSYGVILLEMITGRTAVVQVGSSEM 644 (714)
Q Consensus 566 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DVwS~Gvvl~elltG~~p~~~~~~~~~ 644 (714)
.......++..|+|||++.+. .++.++||||||+++|||++|+.||..... .
T Consensus 156 -------------------------~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~--~ 208 (288)
T cd07833 156 -------------------------SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSD--I 208 (288)
T ss_pred -------------------------ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCH--H
Confidence 011223457789999999887 789999999999999999999999843221 1
Q ss_pred hhHHHHHHHHhhcC-Ccccc--cCCCCC-----CCC--------CcHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 005102 645 DLVNWMQLCIEEKK-PLADV--LDPYLA-----PDA--------DKEEEIIAVLKIAMACVHSSPEKRPTMRHISD 704 (714)
Q Consensus 645 ~l~~~~~~~~~~~~-~~~~~--~d~~~~-----~~~--------~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 704 (714)
+............. ..... .++... ... .......++.+++.+||..+|++|||++++++
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 209 DQLYLIQKCLGPLPPSHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred HHHHHHHHHhCCCCHHHhhhcccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 11111111100000 00000 000000 000 00012456899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=302.99 Aligned_cols=242 Identities=25% Similarity=0.386 Sum_probs=191.1
Q ss_pred ccccccCceEEEEEEE-CCCcEEEEEEeCCC-CchhHHHHHHHHHHHhccC---CCCccceEEEEEeCCceeEEEeccCC
Q 005102 409 FVLGKSGIGIVYKVVL-EDGHTLAVRRLGEG-GSQRFKEFQTEVEAIGKIR---HSNIVTLRAYYWSVDEKLLIYDYIPN 483 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~---H~niv~l~~~~~~~~~~~lV~e~~~~ 483 (714)
+.||+|+||.||+|.+ .+++.||+|.+... .....+++.+|++++++++ |||++++++++......++||||+++
T Consensus 7 ~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~e~~~~ 86 (277)
T cd06917 7 ELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIMEYAEG 86 (277)
T ss_pred hheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEEecCCC
Confidence 3699999999999997 45899999998764 2334567889999999997 99999999999999999999999999
Q ss_pred CCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCC
Q 005102 484 GSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGG 563 (714)
Q Consensus 484 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 563 (714)
++|.+++... .+++..+..++.|++.||.|||+ .+|+|+||+|+||++++++.++|+|||++.......
T Consensus 87 ~~L~~~~~~~-------~l~~~~~~~i~~~i~~~l~~lh~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~- 155 (277)
T cd06917 87 GSVRTLMKAG-------PIAEKYISVIIREVLVALKYIHK---VGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNS- 155 (277)
T ss_pred CcHHHHHHcc-------CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCc-
Confidence 9999988543 48899999999999999999999 899999999999999999999999999987653221
Q ss_pred CCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCC-CCCchhhhHHHHHHHHHHHhCCCccccCCCC
Q 005102 564 SPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVV-KPSQKWDIYSYGVILLEMITGRTAVVQVGSS 642 (714)
Q Consensus 564 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DVwS~Gvvl~elltG~~p~~~~~~~ 642 (714)
.......|+..|+|||.+.++ .++.++|||||||++|||++|+.||....
T Consensus 156 ---------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~-- 206 (277)
T cd06917 156 ---------------------------SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVD-- 206 (277)
T ss_pred ---------------------------cccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCC--
Confidence 011223467789999998654 46899999999999999999999994321
Q ss_pred cchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 005102 643 EMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISD 704 (714)
Q Consensus 643 ~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 704 (714)
....... . .....+.+... .....+.+++.+||+.||++||++.|++.
T Consensus 207 ---~~~~~~~-~------~~~~~~~~~~~----~~~~~~~~~i~~~l~~~p~~R~~~~~il~ 254 (277)
T cd06917 207 ---AFRAMML-I------PKSKPPRLEDN----GYSKLLREFVAACLDEEPKERLSAEELLK 254 (277)
T ss_pred ---hhhhhhc-c------ccCCCCCCCcc----cCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence 1111110 0 00011111111 12346889999999999999999999965
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-35 Score=302.20 Aligned_cols=243 Identities=23% Similarity=0.266 Sum_probs=188.4
Q ss_pred ccccCceEEEEEEEC-CCcEEEEEEeCCCC---chhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCCCH
Q 005102 411 LGKSGIGIVYKVVLE-DGHTLAVRRLGEGG---SQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGSL 486 (714)
Q Consensus 411 lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL 486 (714)
||+|+||+||++... +|+.||+|.+.... ......+..|++++++++||||+++++++...+..|+||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 689999999999865 58999999986532 22234677899999999999999999999999999999999999999
Q ss_pred hhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCCCC
Q 005102 487 ATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPT 566 (714)
Q Consensus 487 ~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 566 (714)
.+++..... ..+++.++..++.|++.||.|||+ .+++||||+|+||++++++.+||+|||++.......
T Consensus 81 ~~~l~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~---~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~---- 149 (277)
T cd05577 81 KYHIYNVGE----PGFPEARAIFYAAQIICGLEHLHQ---RRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK---- 149 (277)
T ss_pred HHHHHHcCc----CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEccCcchhhhccCC----
Confidence 999876532 358999999999999999999999 899999999999999999999999999987643210
Q ss_pred ccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCccccCCCCcchh
Q 005102 567 LQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGSSEMDL 646 (714)
Q Consensus 567 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~~~~~~~~~~l 646 (714)
......++..|+|||++.+..++.++|||||||++|+|++|+.||....... ..
T Consensus 150 -------------------------~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~~ 203 (277)
T cd05577 150 -------------------------KIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKV-EK 203 (277)
T ss_pred -------------------------ccccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccc-cH
Confidence 0112234667999999988889999999999999999999999994332211 11
Q ss_pred HHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCC-----CHHHHH
Q 005102 647 VNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRP-----TMRHIS 703 (714)
Q Consensus 647 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----t~~evl 703 (714)
.......... ....... ....+.+++.+||+.||++|| ++.+++
T Consensus 204 ~~~~~~~~~~--------~~~~~~~-----~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll 252 (277)
T cd05577 204 EELKRRTLEM--------AVEYPDK-----FSPEAKDLCEALLQKDPEKRLGCRGGSADEVR 252 (277)
T ss_pred HHHHhccccc--------cccCCcc-----CCHHHHHHHHHHccCChhHccCCCcccHHHHH
Confidence 1111100000 0011111 123578999999999999999 555554
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-35 Score=298.98 Aligned_cols=242 Identities=21% Similarity=0.256 Sum_probs=192.8
Q ss_pred ccccCceEEEEEEECC-CcEEEEEEeCCCC---chhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCCCH
Q 005102 411 LGKSGIGIVYKVVLED-GHTLAVRRLGEGG---SQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGSL 486 (714)
Q Consensus 411 lG~G~~g~Vy~~~~~~-g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL 486 (714)
||+|+||.||+++... ++.||+|++.... ....+.+.+|++++++++||||+++++++...+..++||||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 6999999999999864 8999999987542 23346799999999999999999999999999999999999999999
Q ss_pred hhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCCCC
Q 005102 487 ATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPT 566 (714)
Q Consensus 487 ~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 566 (714)
.+++... ..+++..+..++.|++.||+|||+ ++++|+||||+||+++.++.+||+|||+++......
T Consensus 81 ~~~l~~~------~~l~~~~~~~~~~~i~~~l~~lH~---~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---- 147 (262)
T cd05572 81 WTILRDR------GLFDEYTARFYIACVVLAFEYLHN---RGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---- 147 (262)
T ss_pred HHHHhhc------CCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc----
Confidence 9999765 348899999999999999999999 899999999999999999999999999987653210
Q ss_pred ccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCccccCCCCcchh
Q 005102 567 LQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGSSEMDL 646 (714)
Q Consensus 567 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~~~~~~~~~~l 646 (714)
......++..|+|||.+.+..++.++||||||+++|||++|+.||.....+ .
T Consensus 148 -------------------------~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~ 199 (262)
T cd05572 148 -------------------------KTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDED---P 199 (262)
T ss_pred -------------------------ccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCC---H
Confidence 111224577799999998888999999999999999999999999543321 1
Q ss_pred HHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCC-----HHHHHH
Q 005102 647 VNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPT-----MRHISD 704 (714)
Q Consensus 647 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt-----~~evl~ 704 (714)
.+.......... ....+.. ....+.+++.+||..+|++||+ ++|+++
T Consensus 200 ~~~~~~~~~~~~------~~~~~~~-----~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 200 MEIYNDILKGNG------KLEFPNY-----IDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred HHHHHHHhccCC------CCCCCcc-----cCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 222222221110 0111111 1336889999999999999999 666654
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=319.40 Aligned_cols=266 Identities=26% Similarity=0.301 Sum_probs=198.6
Q ss_pred ccccccCceEEEEEEE-CCCcEEEEEEeCCCCc-hhHHHHHHHHHHHhccCCCCccceEEEEEeCC------ceeEEEec
Q 005102 409 FVLGKSGIGIVYKVVL-EDGHTLAVRRLGEGGS-QRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVD------EKLLIYDY 480 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~------~~~lV~e~ 480 (714)
+.||+|+||.||+|+. ++|+.||||.+++... ...+...+|+++|++++|+|||++++.-.+.. ...+||||
T Consensus 19 e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlvmEy 98 (732)
T KOG4250|consen 19 ERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLVMEY 98 (732)
T ss_pred hhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEEEee
Confidence 4799999999999995 5699999999988543 33466789999999999999999998865433 56899999
Q ss_pred cCCCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeee--CCCC--CeEEcccchhh
Q 005102 481 IPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILL--GHNM--EPHVSDFGLAR 556 (714)
Q Consensus 481 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl--~~~~--~~kl~DFGla~ 556 (714)
|.+|||...|.+.... ..|++.+.+.+..+++.||.|||+ ++|+||||||.||++ .++| .-||+|||.||
T Consensus 99 C~gGsL~~~L~~PEN~---~GLpE~e~l~lL~d~~~al~~LrE---n~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Ar 172 (732)
T KOG4250|consen 99 CSGGSLRKVLNSPENA---YGLPESEFLDLLSDLVSALRHLRE---NGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAAR 172 (732)
T ss_pred cCCCcHHHHhcCcccc---cCCCHHHHHHHHHHHHHHHHHHHH---cCceeccCCCCcEEEeecCCCceEEeeecccccc
Confidence 9999999999876543 569999999999999999999999 999999999999998 3334 46999999999
Q ss_pred hhhccCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCC-CCCCchhhhHHHHHHHHHHHhCCCc
Q 005102 557 LANIAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKV-VKPSQKWDIYSYGVILLEMITGRTA 635 (714)
Q Consensus 557 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DVwS~Gvvl~elltG~~p 635 (714)
.+++. ....+.+||..|.+||.+.. ..|+..+|.|||||++||.+||..|
T Consensus 173 el~d~-----------------------------s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lP 223 (732)
T KOG4250|consen 173 ELDDN-----------------------------SLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELP 223 (732)
T ss_pred cCCCC-----------------------------CeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCC
Confidence 77542 24556789999999999984 7889999999999999999999999
Q ss_pred cccCCCCcchhHHHHHHHHhhcC-CcccccCCCCC----------C-CCCcHHHHHHHHHHHhHccCCCCCCCC--CHHH
Q 005102 636 VVQVGSSEMDLVNWMQLCIEEKK-PLADVLDPYLA----------P-DADKEEEIIAVLKIAMACVHSSPEKRP--TMRH 701 (714)
Q Consensus 636 ~~~~~~~~~~l~~~~~~~~~~~~-~~~~~~d~~~~----------~-~~~~~~~~~~l~~li~~Cl~~dP~~RP--t~~e 701 (714)
|........ ..+.+......+. ...-..++... . ..-.......+-..+..+|..+|++|. .+.+
T Consensus 224 F~p~~~pk~-~~~~~~~~~tkkp~~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~ 302 (732)
T KOG4250|consen 224 FIPFGGPKN-NKEIMWHIITKKPSGVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDR 302 (732)
T ss_pred CCcCCCccc-cchhhhhhhccCCCceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcch
Confidence 954333221 1111111111111 11111111111 0 001123344566777788888999998 6666
Q ss_pred HHHHHhhhh
Q 005102 702 ISDALDRLI 710 (714)
Q Consensus 702 vl~~L~~i~ 710 (714)
....+..|+
T Consensus 303 ~Fa~~~dIL 311 (732)
T KOG4250|consen 303 FFAEVDDIL 311 (732)
T ss_pred HHHHHHHHH
Confidence 666665554
|
|
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=305.98 Aligned_cols=258 Identities=22% Similarity=0.296 Sum_probs=187.5
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeCCCCc-hhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCCCH
Q 005102 409 FVLGKSGIGIVYKVVLE-DGHTLAVRRLGEGGS-QRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGSL 486 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL 486 (714)
+.||+|+||.||+|... +|+.||+|++..... .....+.+|++++++++|+||+++++++...+..++||||+. +++
T Consensus 11 ~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~-~~l 89 (291)
T cd07870 11 EKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFEYMH-TDL 89 (291)
T ss_pred EEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEeccc-CCH
Confidence 47999999999999875 589999999875432 223467889999999999999999999999999999999995 688
Q ss_pred hhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCCCC
Q 005102 487 ATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPT 566 (714)
Q Consensus 487 ~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 566 (714)
.+++.... ..+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++......
T Consensus 90 ~~~~~~~~-----~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~---- 157 (291)
T cd07870 90 AQYMIQHP-----GGLHPYNVRLFMFQLLRGLAYIHG---QHILHRDLKPQNLLISYLGELKLADFGLARAKSIPS---- 157 (291)
T ss_pred HHHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHHEEEcCCCcEEEeccccccccCCCC----
Confidence 77765432 347788899999999999999999 899999999999999999999999999987532110
Q ss_pred ccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCC-CCCchhhhHHHHHHHHHHHhCCCccccCCCCcch
Q 005102 567 LQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVV-KPSQKWDIYSYGVILLEMITGRTAVVQVGSSEMD 645 (714)
Q Consensus 567 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DVwS~Gvvl~elltG~~p~~~~~~~~~~ 645 (714)
.......++..|+|||.+.+. .++.++|||||||++|||++|+.||.........
T Consensus 158 ------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~ 213 (291)
T cd07870 158 ------------------------QTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQ 213 (291)
T ss_pred ------------------------CCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHH
Confidence 001122347789999998754 4788999999999999999999999533221111
Q ss_pred hHHHHHHHHh-----------hcCC-cccccCCCCCCCC----CcHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 005102 646 LVNWMQLCIE-----------EKKP-LADVLDPYLAPDA----DKEEEIIAVLKIAMACVHSSPEKRPTMRHISD 704 (714)
Q Consensus 646 l~~~~~~~~~-----------~~~~-~~~~~d~~~~~~~----~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 704 (714)
+.+.+ .... .... ..+.......... ........+.+++.+|++.||++|||+.|++.
T Consensus 214 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 214 LEKIW-TVLGVPTEDTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred HHHHH-HHcCCCChhhhhhhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 11110 0000 0000 0000000000000 00011346779999999999999999999864
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=298.67 Aligned_cols=254 Identities=25% Similarity=0.411 Sum_probs=197.1
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeCCCC-chhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCCCH
Q 005102 409 FVLGKSGIGIVYKVVLE-DGHTLAVRRLGEGG-SQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGSL 486 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL 486 (714)
+.||.|+||+||+|... ++..+|+|++.... ....+.+.+|+++++.++|+||+++++.+...+..++||||+++++|
T Consensus 7 ~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~~l 86 (267)
T cd06610 7 EVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLSGGSL 86 (267)
T ss_pred eeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEeccCCCcH
Confidence 47999999999999965 57899999987543 23457899999999999999999999999999999999999999999
Q ss_pred hhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCCCC
Q 005102 487 ATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPT 566 (714)
Q Consensus 487 ~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 566 (714)
.+++...... ..+++..+..++.|++.||+|||+ .+++||||||+||++++++.+||+|||++..+.......
T Consensus 87 ~~~~~~~~~~---~~~~~~~~~~~~~ql~~al~~lh~---~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~~- 159 (267)
T cd06610 87 LDIMKSSYPR---GGLDEAIIATVLKEVLKGLEYLHS---NGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRT- 159 (267)
T ss_pred HHHHHHhccc---CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCcccc-
Confidence 9999754221 358899999999999999999999 899999999999999999999999999998764321100
Q ss_pred ccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCC-CCCchhhhHHHHHHHHHHHhCCCccccCCCCcch
Q 005102 567 LQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVV-KPSQKWDIYSYGVILLEMITGRTAVVQVGSSEMD 645 (714)
Q Consensus 567 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DVwS~Gvvl~elltG~~p~~~~~~~~~~ 645 (714)
........|+..|+|||++... .++.++|||||||++|||++|+.||.......
T Consensus 160 -----------------------~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~-- 214 (267)
T cd06610 160 -----------------------RKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMK-- 214 (267)
T ss_pred -----------------------ccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhh--
Confidence 0011233467889999998776 78999999999999999999999995332211
Q ss_pred hHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 005102 646 LVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISD 704 (714)
Q Consensus 646 l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 704 (714)
.+....... .+..............+.+++.+||..||++|||++++++
T Consensus 215 ---~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 215 ---VLMLTLQND-------PPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred ---hHHHHhcCC-------CCCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 111111111 0111111111122346789999999999999999999875
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=304.11 Aligned_cols=246 Identities=23% Similarity=0.320 Sum_probs=186.4
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeCCCC-chhHHHHHHHHHH-HhccCCCCccceEEEEEeCCceeEEEeccCCCC
Q 005102 409 FVLGKSGIGIVYKVVLE-DGHTLAVRRLGEGG-SQRFKEFQTEVEA-IGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGS 485 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~-l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gs 485 (714)
+.||+|+||.||++... +|+.||+|+++... .....++..|+.+ ++..+||||+++++++...+..++||||++ |+
T Consensus 7 ~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~-~~ 85 (283)
T cd06617 7 EELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICMEVMD-TS 85 (283)
T ss_pred EEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhhhhc-cc
Confidence 46999999999999976 58999999987653 2233456667765 566689999999999999999999999996 68
Q ss_pred HhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCC-CceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCC
Q 005102 486 LATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPK-KYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGS 564 (714)
Q Consensus 486 L~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~-~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 564 (714)
|.+++....... ..+++..+.+++.|++.||+|||+ + +++||||||+||++++++.+||+|||+++......
T Consensus 86 l~~~l~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~---~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~-- 158 (283)
T cd06617 86 LDKFYKKVYDKG--LTIPEDILGKIAVSIVKALEYLHS---KLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSV-- 158 (283)
T ss_pred HHHHHHHhccCC--CCCCHHHHHHHHHHHHHHHHHHhh---cCCeecCCCCHHHEEECCCCCEEEeeccccccccccc--
Confidence 888876432111 468999999999999999999998 6 89999999999999999999999999987542110
Q ss_pred CCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCC----CCCCchhhhHHHHHHHHHHHhCCCccccCC
Q 005102 565 PTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKV----VKPSQKWDIYSYGVILLEMITGRTAVVQVG 640 (714)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~s~~~DVwS~Gvvl~elltG~~p~~~~~ 640 (714)
......++..|+|||.+.+ ..++.++|||||||++|||++|+.||....
T Consensus 159 ---------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~ 211 (283)
T cd06617 159 ---------------------------AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWK 211 (283)
T ss_pred ---------------------------ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccc
Confidence 0111235778999998865 446889999999999999999999994322
Q ss_pred CCcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 005102 641 SSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISD 704 (714)
Q Consensus 641 ~~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 704 (714)
... +......... .+..... .....+.+++.+||..+|++|||+.++++
T Consensus 212 ~~~----~~~~~~~~~~-------~~~~~~~----~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 212 TPF----QQLKQVVEEP-------SPQLPAE----KFSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred cCH----HHHHHHHhcC-------CCCCCcc----ccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 111 1111111111 1111111 12236889999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=304.08 Aligned_cols=258 Identities=21% Similarity=0.323 Sum_probs=193.2
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeCCCC--chhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCCC
Q 005102 409 FVLGKSGIGIVYKVVLE-DGHTLAVRRLGEGG--SQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGS 485 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gs 485 (714)
..||+|+||.||+|.+. +|+.||+|++.... ....+.+.+|+.++++++||||+++++++...+..++||||+ +++
T Consensus 6 ~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~-~~~ 84 (286)
T cd07832 6 GRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEYM-PSD 84 (286)
T ss_pred eecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEeccc-CCC
Confidence 47999999999999975 58999999987653 233467899999999999999999999999999999999999 999
Q ss_pred HhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCCC
Q 005102 486 LATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSP 565 (714)
Q Consensus 486 L~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 565 (714)
|.+++.... ..+++.++..++.||+.||+|||+ .+++|+||||+||++++++.++|+|||+++.......
T Consensus 85 L~~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~-- 154 (286)
T cd07832 85 LSEVLRDEE-----RPLPEAQVKSYMRMLLKGVAYMHA---NGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEP-- 154 (286)
T ss_pred HHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC--
Confidence 999987543 458999999999999999999999 8999999999999999999999999999876532110
Q ss_pred CccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCC-CCchhhhHHHHHHHHHHHhCCCccccCCCCcc
Q 005102 566 TLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVK-PSQKWDIYSYGVILLEMITGRTAVVQVGSSEM 644 (714)
Q Consensus 566 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s~~~DVwS~Gvvl~elltG~~p~~~~~~~~~ 644 (714)
.......++..|+|||.+.+.. ++.++||||+|+++|||+||++||... .+.
T Consensus 155 -------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~--~~~ 207 (286)
T cd07832 155 -------------------------RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGE--NDI 207 (286)
T ss_pred -------------------------CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCC--CHH
Confidence 0111234678899999986544 689999999999999999997777322 111
Q ss_pred hhHHHHHHHHhhcC--------Cc---ccccCCCCCCCC---CcHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 005102 645 DLVNWMQLCIEEKK--------PL---ADVLDPYLAPDA---DKEEEIIAVLKIAMACVHSSPEKRPTMRHISD 704 (714)
Q Consensus 645 ~l~~~~~~~~~~~~--------~~---~~~~d~~~~~~~---~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 704 (714)
.............. .+ ..+..+...... ...+....+.+++.+||+.+|++|||+++++.
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~ 281 (286)
T cd07832 208 EQLAIVFRTLGTPNEETWPGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALR 281 (286)
T ss_pred HHHHHHHHHcCCCChHHHhhccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 11111111110000 00 000000000000 00012357889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-35 Score=302.81 Aligned_cols=248 Identities=21% Similarity=0.313 Sum_probs=188.1
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeCCCC-chhHHHHHHHHHHHhccC-CCCccceEEEEEeCCceeEEEeccCCCC
Q 005102 409 FVLGKSGIGIVYKVVLE-DGHTLAVRRLGEGG-SQRFKEFQTEVEAIGKIR-HSNIVTLRAYYWSVDEKLLIYDYIPNGS 485 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lV~e~~~~gs 485 (714)
..||+|+||.||++... +++.||+|.+.... ......+.+|+.++.++. |+||+++++++...+..+++|||+.. +
T Consensus 10 ~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~~~~-~ 88 (288)
T cd06616 10 GEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMELMDI-S 88 (288)
T ss_pred HHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEecccC-C
Confidence 47999999999999975 48999999987643 234567899999999996 99999999999998899999999864 6
Q ss_pred Hhhhh---hCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccC
Q 005102 486 LATAL---HGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAG 562 (714)
Q Consensus 486 L~~~l---~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 562 (714)
+.++. ..... ..+++..+.+++.|++.||+|||+. .+++||||||+||+++.++.+||+|||+++......
T Consensus 89 l~~l~~~~~~~~~----~~l~~~~~~~i~~~i~~~l~~lh~~--~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~ 162 (288)
T cd06616 89 LDKFYKYVYEVLK----SVIPEEILGKIAVATVKALNYLKEE--LKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSI 162 (288)
T ss_pred HHHHHHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHhhc--CCeeccCCCHHHEEEccCCcEEEeecchhHHhccCC
Confidence 55543 22211 4589999999999999999999972 389999999999999999999999999997653211
Q ss_pred CCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCC---CCCchhhhHHHHHHHHHHHhCCCccccC
Q 005102 563 GSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVV---KPSQKWDIYSYGVILLEMITGRTAVVQV 639 (714)
Q Consensus 563 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~s~~~DVwS~Gvvl~elltG~~p~~~~ 639 (714)
......|+..|+|||++.+. .++.++|||||||++|||++|+.||...
T Consensus 163 -----------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~ 213 (288)
T cd06616 163 -----------------------------AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKW 213 (288)
T ss_pred -----------------------------ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhc
Confidence 11122357789999999766 6899999999999999999999999432
Q ss_pred CCCcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 005102 640 GSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISD 704 (714)
Q Consensus 640 ~~~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 704 (714)
. ...+.+....... .+.+..... .....++.+++.+||+.||++|||+++|++
T Consensus 214 ~----~~~~~~~~~~~~~-------~~~~~~~~~-~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~ 266 (288)
T cd06616 214 N----SVFDQLTQVVKGD-------PPILSNSEE-REFSPSFVNFINLCLIKDESKRPKYKELLE 266 (288)
T ss_pred c----hHHHHHhhhcCCC-------CCcCCCcCC-CccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 2 1111111111111 111111110 123346889999999999999999999876
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=302.30 Aligned_cols=247 Identities=23% Similarity=0.335 Sum_probs=189.8
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeCCCCchhHHHHHHHHHHHhcc-CCCCccceEEEEEeCC------ceeEEEec
Q 005102 409 FVLGKSGIGIVYKVVLE-DGHTLAVRRLGEGGSQRFKEFQTEVEAIGKI-RHSNIVTLRAYYWSVD------EKLLIYDY 480 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~------~~~lV~e~ 480 (714)
+.||+|+||.||+|..+ +++.+++|++..... ..+.+.+|+++++++ +|+||+++++++.... ..++||||
T Consensus 12 ~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~ 90 (275)
T cd06608 12 EVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQLWLVMEL 90 (275)
T ss_pred eeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceEEEEEEEc
Confidence 47999999999999985 478999999876543 346789999999999 6999999999997654 37999999
Q ss_pred cCCCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhc
Q 005102 481 IPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANI 560 (714)
Q Consensus 481 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 560 (714)
+++++|.+++...... ...+++..+..++.|++.||+|||+ .+++|+||+|+||++++++.+||+|||++.....
T Consensus 91 ~~~~~L~~~~~~~~~~--~~~~~~~~~~~~~~ql~~al~~lH~---~~i~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~ 165 (275)
T cd06608 91 CGGGSVTDLVKGLRKK--GKRLKEEWIAYILRETLRGLAYLHE---NKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDS 165 (275)
T ss_pred CCCCcHHHHHHHHhhc--CCCCCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHHHEEEccCCeEEECCCccceeccc
Confidence 9999999988653211 1458899999999999999999999 8999999999999999999999999999875432
Q ss_pred cCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCC-----CCCCchhhhHHHHHHHHHHHhCCCc
Q 005102 561 AGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKV-----VKPSQKWDIYSYGVILLEMITGRTA 635 (714)
Q Consensus 561 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~~~DVwS~Gvvl~elltG~~p 635 (714)
.. .......|+..|+|||.+.. ..++.++|||||||++|||++|+.|
T Consensus 166 ~~----------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p 217 (275)
T cd06608 166 TL----------------------------GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPP 217 (275)
T ss_pred ch----------------------------hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCC
Confidence 11 11122346788999998753 3468899999999999999999999
Q ss_pred cccCCCCcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 005102 636 VVQVGSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISD 704 (714)
Q Consensus 636 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 704 (714)
|...... .......... .+... ........+.+++.+||..||++|||++|+++
T Consensus 218 ~~~~~~~-----~~~~~~~~~~-------~~~~~---~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 218 LCDMHPM-----RALFKIPRNP-------PPTLK---SPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred ccccchH-----HHHHHhhccC-------CCCCC---chhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 9432111 1111111110 01111 11123346889999999999999999999975
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=304.49 Aligned_cols=241 Identities=24% Similarity=0.240 Sum_probs=191.8
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeCCCCch---hHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCC
Q 005102 409 FVLGKSGIGIVYKVVLE-DGHTLAVRRLGEGGSQ---RFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNG 484 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~g 484 (714)
.+||+||||.||-++-+ +|+.+|.|++.+.... ...-..+|-.+|.+++.+.||.+--.|++.+..++|+..|.||
T Consensus 191 RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVLtlMNGG 270 (591)
T KOG0986|consen 191 RVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVLTLMNGG 270 (591)
T ss_pred EEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEEEeecCC
Confidence 58999999999999865 4999999998764322 2234678999999999999999998999999999999999999
Q ss_pred CHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCC
Q 005102 485 SLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGS 564 (714)
Q Consensus 485 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 564 (714)
||.-+|..... ..+++..++-++.+|+.||++||. .+||.|||||+|||+|++|+++|+|.|+|..+...
T Consensus 271 DLkfHiyn~g~----~gF~e~ra~FYAAEi~cGLehlH~---~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g--- 340 (591)
T KOG0986|consen 271 DLKFHIYNHGN----PGFDEQRARFYAAEIICGLEHLHR---RRIVYRDLKPENILLDDHGHVRISDLGLAVEIPEG--- 340 (591)
T ss_pred ceeEEeeccCC----CCCchHHHHHHHHHHHhhHHHHHh---cceeeccCChhheeeccCCCeEeeccceEEecCCC---
Confidence 99999876643 459999999999999999999999 99999999999999999999999999999866432
Q ss_pred CCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCccccCCCCcc
Q 005102 565 PTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGSSEM 644 (714)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~~~~~~~~~ 644 (714)
......+||.+|||||++..+.|+...|.||+||++|||+.|+.||.......
T Consensus 341 --------------------------~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKv- 393 (591)
T KOG0986|consen 341 --------------------------KPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKV- 393 (591)
T ss_pred --------------------------CccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhh-
Confidence 12334578999999999999999999999999999999999999995432211
Q ss_pred hhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCH
Q 005102 645 DLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTM 699 (714)
Q Consensus 645 ~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~ 699 (714)
.-.+.-++...+...+. +.-.++..++....|.+||++|...
T Consensus 394 k~eEvdrr~~~~~~ey~-------------~kFS~eakslc~~LL~Kdp~~RLGc 435 (591)
T KOG0986|consen 394 KREEVDRRTLEDPEEYS-------------DKFSEEAKSLCEGLLTKDPEKRLGC 435 (591)
T ss_pred hHHHHHHHHhcchhhcc-------------cccCHHHHHHHHHHHccCHHHhccC
Confidence 11111111111111111 1122356677788899999999643
|
|
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=302.33 Aligned_cols=240 Identities=22% Similarity=0.277 Sum_probs=197.6
Q ss_pred cccccCceEEEEEEEC-CCcEEEEEEeCCCCc--hhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCCCH
Q 005102 410 VLGKSGIGIVYKVVLE-DGHTLAVRRLGEGGS--QRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGSL 486 (714)
Q Consensus 410 ~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL 486 (714)
.||+|.|+.|-.|++- +|..||||++.+... .....+.+|++.|+-++|||||++|.+.......|||+|.=.+|+|
T Consensus 25 TlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLELGD~GDl 104 (864)
T KOG4717|consen 25 TLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILELGDGGDL 104 (864)
T ss_pred hhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEecCCchH
Confidence 6999999999999864 699999999987533 3345688899999999999999999999999999999999999999
Q ss_pred hhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeee-CCCCCeEEcccchhhhhhccCCCC
Q 005102 487 ATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILL-GHNMEPHVSDFGLARLANIAGGSP 565 (714)
Q Consensus 487 ~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl-~~~~~~kl~DFGla~~~~~~~~~~ 565 (714)
++++-.+. ..+.+..+.+++.||..|+.|+|. ..+|||||||+||.+ ..-|-+||.|||++-.+.+.
T Consensus 105 ~DyImKHe-----~Gl~E~La~kYF~QI~~AI~YCHq---LHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG---- 172 (864)
T KOG4717|consen 105 FDYIMKHE-----EGLNEDLAKKYFAQIVHAISYCHQ---LHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPG---- 172 (864)
T ss_pred HHHHHhhh-----ccccHHHHHHHHHHHHHHHHHHhh---hhhhcccCCcceeEEeeecCceEeeeccccccCCCc----
Confidence 99997765 458899999999999999999999 789999999999876 55688999999998655432
Q ss_pred CccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCC-chhhhHHHHHHHHHHHhCCCccccCCCCcc
Q 005102 566 TLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPS-QKWDIYSYGVILLEMITGRTAVVQVGSSEM 644 (714)
Q Consensus 566 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s-~~~DVwS~Gvvl~elltG~~p~~~~~~~~~ 644 (714)
....+..|+..|-|||++.|..|+ +++||||+|||||-|+.|+.||....+.+.
T Consensus 173 -------------------------~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSET 227 (864)
T KOG4717|consen 173 -------------------------KKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSET 227 (864)
T ss_pred -------------------------chhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhh
Confidence 234456778899999999999885 578999999999999999999954433221
Q ss_pred hhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 005102 645 DLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISD 704 (714)
Q Consensus 645 ~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 704 (714)
+..++|-...- +.....++.++|..||..||.+|.+.+||+.
T Consensus 228 ---------------LTmImDCKYtv---PshvS~eCrdLI~sMLvRdPkkRAslEeI~s 269 (864)
T KOG4717|consen 228 ---------------LTMIMDCKYTV---PSHVSKECRDLIQSMLVRDPKKRASLEEIVS 269 (864)
T ss_pred ---------------hhhhhcccccC---chhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence 22233322211 1234557899999999999999999999874
|
|
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-35 Score=303.50 Aligned_cols=243 Identities=24% Similarity=0.384 Sum_probs=194.7
Q ss_pred cccccCceEEEEEEEC-CCcEEEEEEeCCCCchhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCCCHhh
Q 005102 410 VLGKSGIGIVYKVVLE-DGHTLAVRRLGEGGSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGSLAT 488 (714)
Q Consensus 410 ~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL~~ 488 (714)
.||+|+||.||+|.+. ++..||+|++..... ..+.+.+|++.+++++|+||+++++++...+..++|+||+++++|.+
T Consensus 26 ~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 104 (286)
T cd06614 26 KIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTD 104 (286)
T ss_pred hccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEeccCCCcHHH
Confidence 6999999999999987 588999999976544 45678999999999999999999999999999999999999999999
Q ss_pred hhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCCCCcc
Q 005102 489 ALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQ 568 (714)
Q Consensus 489 ~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 568 (714)
++.... ..+++..+..++.|++.||+|||+ .+++|+||||+||+++.++.+||+|||++........
T Consensus 105 ~l~~~~-----~~l~~~~~~~i~~~i~~~L~~lH~---~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~----- 171 (286)
T cd06614 105 IITQNF-----VRMNEPQIAYVCREVLQGLEYLHS---QNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS----- 171 (286)
T ss_pred HHHHhc-----cCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCChhhEEEcCCCCEEECccchhhhhccchh-----
Confidence 998653 268999999999999999999999 8999999999999999999999999998865432110
Q ss_pred CCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCccccCCCCcchhHH
Q 005102 569 SNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGSSEMDLVN 648 (714)
Q Consensus 569 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~~~~~~~~~~l~~ 648 (714)
......++..|+|||.+.+..++.++|||||||++|||++|+.||..... ..
T Consensus 172 -----------------------~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~-----~~ 223 (286)
T cd06614 172 -----------------------KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPP-----LR 223 (286)
T ss_pred -----------------------hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCH-----HH
Confidence 01122356779999999888899999999999999999999999842211 11
Q ss_pred HHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 005102 649 WMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISD 704 (714)
Q Consensus 649 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 704 (714)
......... .....++ ......+.+++.+||+.+|.+|||+.++++
T Consensus 224 ~~~~~~~~~--~~~~~~~--------~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 269 (286)
T cd06614 224 ALFLITTKG--IPPLKNP--------EKWSPEFKDFLNKCLVKDPEKRPSAEELLQ 269 (286)
T ss_pred HHHHHHhcC--CCCCcch--------hhCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 111111111 1111110 112236889999999999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=297.60 Aligned_cols=242 Identities=19% Similarity=0.249 Sum_probs=185.8
Q ss_pred cccccCceEEEEEEEC-CCcEEEEEEeCCCCc---hhHHHHHHHHHHH-hccCCCCccceEEEEEeCCceeEEEeccCCC
Q 005102 410 VLGKSGIGIVYKVVLE-DGHTLAVRRLGEGGS---QRFKEFQTEVEAI-GKIRHSNIVTLRAYYWSVDEKLLIYDYIPNG 484 (714)
Q Consensus 410 ~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~E~~~l-~~l~H~niv~l~~~~~~~~~~~lV~e~~~~g 484 (714)
.||+|+||.||+|... +|+.||+|.+..... .....+..|..++ ...+|+|++++++++...+..++||||++++
T Consensus 3 ~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 82 (260)
T cd05611 3 PISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNGG 82 (260)
T ss_pred cCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCCC
Confidence 5899999999999975 489999999876432 1223445555554 4458999999999999999999999999999
Q ss_pred CHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCC
Q 005102 485 SLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGS 564 (714)
Q Consensus 485 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 564 (714)
+|.+++... ..+++..+.+++.|++.||.|||+ .+++||||+|+||++++++.+||+|||+++....
T Consensus 83 ~L~~~l~~~------~~~~~~~~~~i~~qi~~aL~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~---- 149 (260)
T cd05611 83 DCASLIKTL------GGLPEDWAKQYIAEVVLGVEDLHQ---RGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE---- 149 (260)
T ss_pred CHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCcEEEeecccceeccc----
Confidence 999999754 358899999999999999999999 8999999999999999999999999998864321
Q ss_pred CCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCccccCCCCcc
Q 005102 565 PTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGSSEM 644 (714)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~~~~~~~~~ 644 (714)
.....++..|+|||.+.+..++.++||||||+++|||+||..||.....
T Consensus 150 ----------------------------~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~--- 198 (260)
T cd05611 150 ----------------------------NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETP--- 198 (260)
T ss_pred ----------------------------cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCH---
Confidence 1112356779999999888899999999999999999999999943211
Q ss_pred hhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHH
Q 005102 645 DLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDAL 706 (714)
Q Consensus 645 ~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L 706 (714)
............... +... ......+.+++.+||..||++||++.++.+.|
T Consensus 199 --~~~~~~~~~~~~~~~----~~~~-----~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l 249 (260)
T cd05611 199 --DAVFDNILSRRINWP----EEVK-----EFCSPEAVDLINRLLCMDPAKRLGANGYQEIK 249 (260)
T ss_pred --HHHHHHHHhcccCCC----Cccc-----ccCCHHHHHHHHHHccCCHHHccCCCcHHHHH
Confidence 111111111111100 0010 01223688999999999999999886665544
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=296.27 Aligned_cols=249 Identities=25% Similarity=0.340 Sum_probs=194.6
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeCCCCc--hhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCCC
Q 005102 409 FVLGKSGIGIVYKVVLE-DGHTLAVRRLGEGGS--QRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGS 485 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gs 485 (714)
+.||+|+||.||+|... +++.||+|.+..... ...+.+.+|++++++++|+||+++++++...+..++|+||+++++
T Consensus 6 ~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~ 85 (264)
T cd06626 6 NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEYCSGGT 85 (264)
T ss_pred eEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEecCCCCc
Confidence 47999999999999975 589999999876544 256789999999999999999999999999999999999999999
Q ss_pred HhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCCC
Q 005102 486 LATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSP 565 (714)
Q Consensus 486 L~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 565 (714)
|.+++... ..+++..+..|+.|++.||+|||+ .+|+|+||+|+||++++++.+||+|||++..........
T Consensus 86 L~~~~~~~------~~~~~~~~~~i~~~i~~~l~~lh~---~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~ 156 (264)
T cd06626 86 LEELLEHG------RILDEHVIRVYTLQLLEGLAYLHS---HGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTM 156 (264)
T ss_pred HHHHHhhc------CCCChHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCcc
Confidence 99999754 347889999999999999999999 899999999999999999999999999987654321100
Q ss_pred CccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCC---CCchhhhHHHHHHHHHHHhCCCccccCCCC
Q 005102 566 TLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVK---PSQKWDIYSYGVILLEMITGRTAVVQVGSS 642 (714)
Q Consensus 566 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~s~~~DVwS~Gvvl~elltG~~p~~~~~~~ 642 (714)
........++..|+|||++.+.. ++.++||||||+++|||++|+.||......
T Consensus 157 ------------------------~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~ 212 (264)
T cd06626 157 ------------------------GEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNE 212 (264)
T ss_pred ------------------------cccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcch
Confidence 00011234567899999998766 899999999999999999999999432211
Q ss_pred cchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 005102 643 EMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISD 704 (714)
Q Consensus 643 ~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 704 (714)
...... .... ..+...... .....+.+++.+||+.+|++|||+.|++.
T Consensus 213 ----~~~~~~-~~~~------~~~~~~~~~---~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 213 ----FQIMFH-VGAG------HKPPIPDSL---QLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred ----HHHHHH-HhcC------CCCCCCccc---ccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 111111 0111 011111111 11335779999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-35 Score=298.79 Aligned_cols=244 Identities=22% Similarity=0.332 Sum_probs=193.4
Q ss_pred ccccccCceEEEEEEECC-CcEEEEEEeCCCC--chhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCCC
Q 005102 409 FVLGKSGIGIVYKVVLED-GHTLAVRRLGEGG--SQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGS 485 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~~-g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gs 485 (714)
+.||+|+||.||+|..+. |..||+|.+.... ....+.+.+|++++++++|+||+++++++...+..++||||+++++
T Consensus 6 ~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 85 (257)
T cd08225 6 KKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEYCDGGD 85 (257)
T ss_pred EEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEecCCCCc
Confidence 479999999999999864 8899999986542 2334578899999999999999999999999999999999999999
Q ss_pred HhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCC-CeEEcccchhhhhhccCCC
Q 005102 486 LATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNM-EPHVSDFGLARLANIAGGS 564 (714)
Q Consensus 486 L~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~-~~kl~DFGla~~~~~~~~~ 564 (714)
|.+++..... ..+++..+..++.|++.||+|||+ .+++|+||||+||++++++ .+||+|||.+.......
T Consensus 86 L~~~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lh~---~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~-- 156 (257)
T cd08225 86 LMKRINRQRG----VLFSEDQILSWFVQISLGLKHIHD---RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM-- 156 (257)
T ss_pred HHHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEEcCCCCeEEecccccchhccCCc--
Confidence 9999976432 357899999999999999999999 8999999999999999885 46999999887543211
Q ss_pred CCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCccccCCCCcc
Q 005102 565 PTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGSSEM 644 (714)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~~~~~~~~~ 644 (714)
.......|++.|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus 157 --------------------------~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~----- 205 (257)
T cd08225 157 --------------------------ELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGN----- 205 (257)
T ss_pred --------------------------ccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCc-----
Confidence 0111234677899999998888999999999999999999999998422
Q ss_pred hhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 005102 645 DLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISD 704 (714)
Q Consensus 645 ~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 704 (714)
...+++....... ..+ ..+. ....+.+++.+||..+|++|||+.|+++
T Consensus 206 ~~~~~~~~~~~~~------~~~-~~~~-----~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 253 (257)
T cd08225 206 NLHQLVLKICQGY------FAP-ISPN-----FSRDLRSLISQLFKVSPRDRPSITSILK 253 (257)
T ss_pred cHHHHHHHHhccc------CCC-CCCC-----CCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 1222222222111 111 1111 1235889999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=297.53 Aligned_cols=246 Identities=22% Similarity=0.340 Sum_probs=192.6
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeCCCC--chhHHHHHHHHHHHhccCCCCccceEEEEEe--CCceeEEEeccCC
Q 005102 409 FVLGKSGIGIVYKVVLE-DGHTLAVRRLGEGG--SQRFKEFQTEVEAIGKIRHSNIVTLRAYYWS--VDEKLLIYDYIPN 483 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~--~~~~~lV~e~~~~ 483 (714)
+.||.|+||.||++... +++.||+|.+.... ....+.+..|++++++++||||+++++++.. ....+++|||+++
T Consensus 6 ~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~e~~~~ 85 (265)
T cd08217 6 ETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVMEYCEG 85 (265)
T ss_pred eeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEehhccC
Confidence 47999999999999864 57899999987542 3334678899999999999999999998864 3457899999999
Q ss_pred CCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHh-----cCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhh
Q 005102 484 GSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLH-----EFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLA 558 (714)
Q Consensus 484 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH-----~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~ 558 (714)
++|.+++...... ...+++..++.++.|++.||+||| + .+++|+||||+||++++++.+||+|||+++..
T Consensus 86 ~~L~~~l~~~~~~--~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~---~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~ 160 (265)
T cd08217 86 GDLAQLIQKCKKE--RKYIEEEFIWRILTQLLLALYECHNRSDPG---NTVLHRDLKPANIFLDANNNVKLGDFGLAKIL 160 (265)
T ss_pred CCHHHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHhcCcccc---CcceecCCCHHHEEEecCCCEEEecccccccc
Confidence 9999998653211 146899999999999999999999 6 79999999999999999999999999998865
Q ss_pred hccCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCcccc
Q 005102 559 NIAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQ 638 (714)
Q Consensus 559 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~~~ 638 (714)
.... .......++..|+|||.+.+..++.++||||||+++|+|++|+.||..
T Consensus 161 ~~~~----------------------------~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~ 212 (265)
T cd08217 161 GHDS----------------------------SFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTA 212 (265)
T ss_pred cCCc----------------------------ccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccC
Confidence 3211 001123457789999999988899999999999999999999999943
Q ss_pred CCCCcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 005102 639 VGSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISD 704 (714)
Q Consensus 639 ~~~~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 704 (714)
.. .. ...+.. .... . +.+.. .....+.+++.+||+.+|++|||+.+|++
T Consensus 213 ~~--~~---~~~~~~-~~~~-~-----~~~~~-----~~~~~~~~l~~~~l~~~p~~Rp~~~~il~ 261 (265)
T cd08217 213 RN--QL---QLASKI-KEGK-F-----RRIPY-----RYSSELNEVIKSMLNVDPDKRPSTEELLQ 261 (265)
T ss_pred cC--HH---HHHHHH-hcCC-C-----CCCcc-----ccCHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 22 11 111111 1111 0 11111 12346889999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=286.67 Aligned_cols=198 Identities=25% Similarity=0.377 Sum_probs=163.4
Q ss_pred ccccccCceEEEEEEECC-----CcEEEEEEeCCCCc--hhHHHHHHHHHHHhccCCCCccceEEEEEe-CCceeEEEec
Q 005102 409 FVLGKSGIGIVYKVVLED-----GHTLAVRRLGEGGS--QRFKEFQTEVEAIGKIRHSNIVTLRAYYWS-VDEKLLIYDY 480 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~~-----g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~-~~~~~lV~e~ 480 (714)
..||+|+||.||+|..++ .+.+|+|+++.... .-.....+|+.+++.++||||+.+..++.+ +...++++||
T Consensus 30 g~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v~l~fdY 109 (438)
T KOG0666|consen 30 GKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKVWLLFDY 109 (438)
T ss_pred ceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceEEEEehh
Confidence 469999999999997543 23799999986522 122467899999999999999999999887 6678999999
Q ss_pred cCCCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCC----CCeEEcccchhh
Q 005102 481 IPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHN----MEPHVSDFGLAR 556 (714)
Q Consensus 481 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~----~~~kl~DFGla~ 556 (714)
.+. ||..+++-.+.... +.++...++.|+.||+.|+.|||+ +-|+||||||+|||+..+ |.+||+|||+|+
T Consensus 110 AEh-DL~~II~fHr~~~~-~~lp~~mvKsilwQil~Gv~YLH~---NWvlHRDLKPaNIlvmgdgperG~VKIaDlGlaR 184 (438)
T KOG0666|consen 110 AEH-DLWHIIKFHRASKA-KQLPRSMVKSILWQILDGVHYLHS---NWVLHRDLKPANILVMGDGPERGRVKIADLGLAR 184 (438)
T ss_pred hhh-hHHHHHHHhccchh-ccCCHHHHHHHHHHHHhhhHHHhh---hheeeccCCcceEEEeccCCccCeeEeecccHHH
Confidence 987 99999876543322 468889999999999999999999 899999999999999877 899999999999
Q ss_pred hhhccCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCC-CCchhhhHHHHHHHHHHHhCCCc
Q 005102 557 LANIAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVK-PSQKWDIYSYGVILLEMITGRTA 635 (714)
Q Consensus 557 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s~~~DVwS~Gvvl~elltG~~p 635 (714)
.+...-.. .......+-|.+|+|||.+.|.+ ||.+.||||.|||+.||+|-++.
T Consensus 185 ~~~~plkp-------------------------l~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~Pl 239 (438)
T KOG0666|consen 185 LFNNPLKP-------------------------LASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPL 239 (438)
T ss_pred Hhhccccc-------------------------cccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCcc
Confidence 88643211 11122333488999999999876 89999999999999999998877
Q ss_pred c
Q 005102 636 V 636 (714)
Q Consensus 636 ~ 636 (714)
|
T Consensus 240 F 240 (438)
T KOG0666|consen 240 F 240 (438)
T ss_pred c
Confidence 7
|
|
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=301.22 Aligned_cols=259 Identities=23% Similarity=0.300 Sum_probs=190.4
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeCCCC--chhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCCC
Q 005102 409 FVLGKSGIGIVYKVVLE-DGHTLAVRRLGEGG--SQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGS 485 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gs 485 (714)
+.||+|++|.||+|... +|..||+|++.... ......+.+|++++++++|||++++++++...+..++||||++ ++
T Consensus 5 ~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~~-~~ 83 (283)
T cd07835 5 EKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFLD-LD 83 (283)
T ss_pred eEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEeccC-cC
Confidence 47999999999999975 69999999987543 2223568899999999999999999999999999999999995 69
Q ss_pred HhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCCC
Q 005102 486 LATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSP 565 (714)
Q Consensus 486 L~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 565 (714)
|.+++..... ..+++..+.+++.|+++||+|||+ ++++||||+|+||++++++.+||+|||+++......
T Consensus 84 l~~~~~~~~~----~~~~~~~~~~~~~~i~~~L~~lH~---~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~--- 153 (283)
T cd07835 84 LKKYMDSSPL----TGLDPPLIKSYLYQLLQGIAYCHS---HRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPV--- 153 (283)
T ss_pred HHHHHhhCCC----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCc---
Confidence 9999876532 358999999999999999999999 899999999999999999999999999987543210
Q ss_pred CccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCC-CCCchhhhHHHHHHHHHHHhCCCccccCCCCcc
Q 005102 566 TLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVV-KPSQKWDIYSYGVILLEMITGRTAVVQVGSSEM 644 (714)
Q Consensus 566 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DVwS~Gvvl~elltG~~p~~~~~~~~~ 644 (714)
.......++..|+|||++.+. .++.++||||||+++|||++|+.||..... ..
T Consensus 154 -------------------------~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~-~~ 207 (283)
T cd07835 154 -------------------------RTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSE-ID 207 (283)
T ss_pred -------------------------cccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCH-HH
Confidence 001112346779999988664 478999999999999999999999953321 11
Q ss_pred hhHHHHHHHHhhc-------CCcccccC--CCCC-CC--CCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 005102 645 DLVNWMQLCIEEK-------KPLADVLD--PYLA-PD--ADKEEEIIAVLKIAMACVHSSPEKRPTMRHISD 704 (714)
Q Consensus 645 ~l~~~~~~~~~~~-------~~~~~~~d--~~~~-~~--~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 704 (714)
.+...++...... ..+.+... +... .. .........+.+++.+||+.||++|||++|+++
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 208 QLFRIFRTLGTPDEDVWPGVTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred HHHHHHHHhCCCChHHhhhhhhchhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 1111111000000 00000000 0000 00 000011236789999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-35 Score=304.62 Aligned_cols=257 Identities=22% Similarity=0.258 Sum_probs=189.0
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeCCCCc--hhHHHHHHHHHHHhccCCCCccceEEEEEeC--CceeEEEeccCC
Q 005102 409 FVLGKSGIGIVYKVVLE-DGHTLAVRRLGEGGS--QRFKEFQTEVEAIGKIRHSNIVTLRAYYWSV--DEKLLIYDYIPN 483 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~~lV~e~~~~ 483 (714)
+.||+|+||.||+|..+ +++.+|+|.++.... .....+.+|++++++++||||+++++++... +..++||||++
T Consensus 11 ~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv~e~~~- 89 (293)
T cd07843 11 NRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMVMEYVE- 89 (293)
T ss_pred hhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEEehhcC-
Confidence 47999999999999986 488999999975432 2234577899999999999999999999877 88999999997
Q ss_pred CCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCC
Q 005102 484 GSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGG 563 (714)
Q Consensus 484 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 563 (714)
++|.+++.... ..+++..+++++.|++.||+|||+ .+++|+||||+||++++++.+||+|||+++......
T Consensus 90 ~~L~~~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~---~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~- 160 (293)
T cd07843 90 HDLKSLMETMK-----QPFLQSEVKCLMLQLLSGVAHLHD---NWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPL- 160 (293)
T ss_pred cCHHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHHHEEECCCCcEEEeecCceeeccCCc-
Confidence 59999887643 358999999999999999999999 899999999999999999999999999987653211
Q ss_pred CCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCC-CCchhhhHHHHHHHHHHHhCCCccccCCCC
Q 005102 564 SPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVK-PSQKWDIYSYGVILLEMITGRTAVVQVGSS 642 (714)
Q Consensus 564 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s~~~DVwS~Gvvl~elltG~~p~~~~~~~ 642 (714)
.......++..|+|||.+.+.. ++.++||||||+++|||++|+.||.....
T Consensus 161 ---------------------------~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~- 212 (293)
T cd07843 161 ---------------------------KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSE- 212 (293)
T ss_pred ---------------------------cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCCh-
Confidence 0011223467799999987644 68999999999999999999999843221
Q ss_pred cchhHHHHHHHHhh---------------c-CCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 005102 643 EMDLVNWMQLCIEE---------------K-KPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISD 704 (714)
Q Consensus 643 ~~~l~~~~~~~~~~---------------~-~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 704 (714)
.+...-+...... . ..........+............+.+++.+||+.||++|||+.|++.
T Consensus 213 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 213 -IDQLNKIFKLLGTPTEKIWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred -HHHHHHHHHHhCCCchHHHHHhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 1111101000000 0 00000000000000000001345789999999999999999999875
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=302.98 Aligned_cols=241 Identities=23% Similarity=0.398 Sum_probs=189.4
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeCCCC---chhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCC
Q 005102 409 FVLGKSGIGIVYKVVLE-DGHTLAVRRLGEGG---SQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNG 484 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~g 484 (714)
+.||+|+||.||+++.. ++..||+|++.... ....+.+.+|++++++++|||++++++++...+..++||||++ |
T Consensus 31 ~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-g 109 (317)
T cd06635 31 REIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCL-G 109 (317)
T ss_pred heeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeCCC-C
Confidence 36999999999999975 58899999987532 2334578899999999999999999999999999999999996 5
Q ss_pred CHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCC
Q 005102 485 SLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGS 564 (714)
Q Consensus 485 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 564 (714)
+|.+.+.... ..+++.++..++.|++.||.|||+ ++|+||||+|+||+++.++.+||+|||++.....
T Consensus 110 ~l~~~~~~~~-----~~l~~~~~~~i~~~i~~~l~~lH~---~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~---- 177 (317)
T cd06635 110 SASDLLEVHK-----KPLQEVEIAAITHGALQGLAYLHS---HNMIHRDIKAGNILLTEPGQVKLADFGSASIASP---- 177 (317)
T ss_pred CHHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcccEEECCCCCEEEecCCCccccCC----
Confidence 8888775432 458999999999999999999999 8999999999999999999999999998764321
Q ss_pred CCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccC---CCCCCchhhhHHHHHHHHHHHhCCCccccCCC
Q 005102 565 PTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLK---VVKPSQKWDIYSYGVILLEMITGRTAVVQVGS 641 (714)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~~~DVwS~Gvvl~elltG~~p~~~~~~ 641 (714)
.....++..|+|||++. ...++.++|||||||++|||++|+.||.....
T Consensus 178 ----------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~ 229 (317)
T cd06635 178 ----------------------------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA 229 (317)
T ss_pred ----------------------------cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccH
Confidence 11123577899999974 45689999999999999999999999853211
Q ss_pred CcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHH
Q 005102 642 SEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDAL 706 (714)
Q Consensus 642 ~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L 706 (714)
............ +... .......+.+++.+||+.+|.+||++.++++.+
T Consensus 230 -----~~~~~~~~~~~~-------~~~~----~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~ 278 (317)
T cd06635 230 -----MSALYHIAQNES-------PTLQ----SNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHM 278 (317)
T ss_pred -----HHHHHHHHhccC-------CCCC----CccccHHHHHHHHHHccCCcccCcCHHHHHhCh
Confidence 111111111111 0000 111233578999999999999999999998754
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=298.42 Aligned_cols=241 Identities=21% Similarity=0.220 Sum_probs=183.8
Q ss_pred cccccCceEEEEEEEC-CCcEEEEEEeCCCCc---hhHHHHHHHHH---HHhccCCCCccceEEEEEeCCceeEEEeccC
Q 005102 410 VLGKSGIGIVYKVVLE-DGHTLAVRRLGEGGS---QRFKEFQTEVE---AIGKIRHSNIVTLRAYYWSVDEKLLIYDYIP 482 (714)
Q Consensus 410 ~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~E~~---~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~ 482 (714)
+||+|+||.||++... +++.||+|.+.+... .....+..|.. .++...||+|+++++++...+..++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 4899999999999875 488999999875421 11122344433 4445579999999999999999999999999
Q ss_pred CCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccC
Q 005102 483 NGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAG 562 (714)
Q Consensus 483 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 562 (714)
+|+|.+++... ..+++..++.++.|+++||+|||+ .+|+||||||+||++++++.+||+|||+++.....
T Consensus 81 g~~L~~~l~~~------~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~- 150 (278)
T cd05606 81 GGDLHYHLSQH------GVFSEAEMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK- 150 (278)
T ss_pred CCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCEEcCCCCHHHEEECCCCCEEEccCcCccccCcc-
Confidence 99999988654 458999999999999999999999 89999999999999999999999999998643211
Q ss_pred CCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCC-CCCchhhhHHHHHHHHHHHhCCCccccCCC
Q 005102 563 GSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVV-KPSQKWDIYSYGVILLEMITGRTAVVQVGS 641 (714)
Q Consensus 563 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DVwS~Gvvl~elltG~~p~~~~~~ 641 (714)
......|+..|+|||.+.++ .++.++||||+||++|||++|+.||.....
T Consensus 151 -----------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~ 201 (278)
T cd05606 151 -----------------------------KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKT 201 (278)
T ss_pred -----------------------------CCcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCc
Confidence 01122467889999999754 689999999999999999999999954322
Q ss_pred CcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCC-----CHHHHHH
Q 005102 642 SEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRP-----TMRHISD 704 (714)
Q Consensus 642 ~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----t~~evl~ 704 (714)
... ...... ... ..+..... ....+.+++.+|+..+|++|| ++.++++
T Consensus 202 ~~~--~~~~~~-~~~-------~~~~~~~~-----~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 254 (278)
T cd05606 202 KDK--HEIDRM-TLT-------MAVELPDS-----FSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 254 (278)
T ss_pred cch--HHHHHH-hhc-------cCCCCCCc-----CCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence 111 111110 000 11111111 123688999999999999999 9988875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-35 Score=298.70 Aligned_cols=252 Identities=23% Similarity=0.321 Sum_probs=194.8
Q ss_pred ccccCceEEEEEEECC-CcEEEEEEeCCCCc---hhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCCCH
Q 005102 411 LGKSGIGIVYKVVLED-GHTLAVRRLGEGGS---QRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGSL 486 (714)
Q Consensus 411 lG~G~~g~Vy~~~~~~-g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL 486 (714)
||+|+||.||+++..+ |+.+|+|.+..... ...+.+.+|++++++++||||+++++.+...+..++||||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 6899999999999875 89999999876533 3456788999999999999999999999999999999999999999
Q ss_pred hhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCCCC
Q 005102 487 ATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPT 566 (714)
Q Consensus 487 ~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 566 (714)
.+++... ..+++..+.+++.|++.||+|||+ .+++|+||+|+||++++++.+||+|||++..........
T Consensus 81 ~~~l~~~------~~~~~~~~~~i~~qi~~~L~~lH~---~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~- 150 (265)
T cd05579 81 ASLLENV------GSLDEDVARIYIAEIVLALEYLHS---NGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQIN- 150 (265)
T ss_pred HHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---cCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccc-
Confidence 9999754 358999999999999999999999 899999999999999999999999999987543211000
Q ss_pred ccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCccccCCCCcchh
Q 005102 567 LQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGSSEMDL 646 (714)
Q Consensus 567 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~~~~~~~~~~l 646 (714)
.. ..........++..|+|||.......+.++||||||+++|||++|+.||.... .
T Consensus 151 -----~~--------------~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~-----~ 206 (265)
T cd05579 151 -----LN--------------DDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGET-----P 206 (265)
T ss_pred -----cc--------------cccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC-----H
Confidence 00 00011122345678999999988889999999999999999999999994322 1
Q ss_pred HHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHh
Q 005102 647 VNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDALD 707 (714)
Q Consensus 647 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~ 707 (714)
.............. .... .....+.+++.+||+.+|++|||+.++.+.|+
T Consensus 207 ~~~~~~~~~~~~~~--------~~~~---~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~ 256 (265)
T cd05579 207 EEIFQNILNGKIEW--------PEDV---EVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN 256 (265)
T ss_pred HHHHHHHhcCCcCC--------Cccc---cCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence 12222211111100 0000 01346789999999999999999966666654
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=296.52 Aligned_cols=234 Identities=20% Similarity=0.258 Sum_probs=181.6
Q ss_pred ccccCceEEEEEEEC-CCcEEEEEEeCCCCchhHHHHHHHHHHHhcc-CCCCccceEEEEEeCCceeEEEeccCCCCHhh
Q 005102 411 LGKSGIGIVYKVVLE-DGHTLAVRRLGEGGSQRFKEFQTEVEAIGKI-RHSNIVTLRAYYWSVDEKLLIYDYIPNGSLAT 488 (714)
Q Consensus 411 lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~e~~~~gsL~~ 488 (714)
||+|+||.||++..+ ++..+|+|.+........ |+.....+ +||||+++++++...+..++||||+++|+|.+
T Consensus 24 lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~~ 98 (267)
T PHA03390 24 LIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFD 98 (267)
T ss_pred ecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEecCCeeEEEEEcCCCCcHHH
Confidence 699999999999975 578899999875422211 22222222 79999999999999999999999999999999
Q ss_pred hhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCC-CeEEcccchhhhhhccCCCCCc
Q 005102 489 ALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNM-EPHVSDFGLARLANIAGGSPTL 567 (714)
Q Consensus 489 ~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~-~~kl~DFGla~~~~~~~~~~~~ 567 (714)
++... ..+++.++..++.|+++||.|||+ .+++||||||+||+++.++ .++|+|||+++.....
T Consensus 99 ~l~~~------~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~------ 163 (267)
T PHA03390 99 LLKKE------GKLSEAEVKKIIRQLVEALNDLHK---HNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP------ 163 (267)
T ss_pred HHHhc------CCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEEeCCCCeEEEecCccceecCCC------
Confidence 99765 358999999999999999999999 8999999999999999998 9999999988754211
Q ss_pred cCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCccccCCCCcchhH
Q 005102 568 QSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGSSEMDLV 647 (714)
Q Consensus 568 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~~~~~~~~~~l~ 647 (714)
....++..|+|||++.+..++.++||||||+++|||++|+.||........+..
T Consensus 164 --------------------------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~ 217 (267)
T PHA03390 164 --------------------------SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLE 217 (267)
T ss_pred --------------------------ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHH
Confidence 112357789999999988899999999999999999999999964333332223
Q ss_pred HHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCC-HHHHHH
Q 005102 648 NWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPT-MRHISD 704 (714)
Q Consensus 648 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt-~~evl~ 704 (714)
.+.... .... ... ......+.+++.+||+.+|.+||+ ++|+++
T Consensus 218 ~~~~~~-~~~~--------~~~-----~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 218 SLLKRQ-QKKL--------PFI-----KNVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred HHHHhh-cccC--------Ccc-----cccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 332221 1100 000 112336889999999999999996 588763
|
|
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-34 Score=302.91 Aligned_cols=261 Identities=23% Similarity=0.280 Sum_probs=190.2
Q ss_pred ccccc--CceEEEEEEEC-CCcEEEEEEeCCCC--chhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCC
Q 005102 410 VLGKS--GIGIVYKVVLE-DGHTLAVRRLGEGG--SQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNG 484 (714)
Q Consensus 410 ~lG~G--~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~g 484 (714)
.||+| +||+||++++. +|+.||+|.+.... ....+.+.+|+.+++.++||||+++++++...+..++||||+.+|
T Consensus 5 ~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~~ 84 (328)
T cd08226 5 EIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYG 84 (328)
T ss_pred HhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccCC
Confidence 46666 89999999975 69999999987542 233467899999999999999999999999999999999999999
Q ss_pred CHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCC
Q 005102 485 SLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGS 564 (714)
Q Consensus 485 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 564 (714)
+|.+++..... ..+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+|++||+.+.........
T Consensus 85 ~l~~~l~~~~~----~~~~~~~~~~~~~qi~~aL~~lH~---~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~ 157 (328)
T cd08226 85 SANSLLKTYFP----EGMSEALIGNILFGALRGLNYLHQ---NGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQK 157 (328)
T ss_pred CHHHHHHhhcc----cCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcc
Confidence 99999876432 348899999999999999999999 89999999999999999999999999866433211100
Q ss_pred CCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCC--CCCchhhhHHHHHHHHHHHhCCCccccCCCC
Q 005102 565 PTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVV--KPSQKWDIYSYGVILLEMITGRTAVVQVGSS 642 (714)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~s~~~DVwS~Gvvl~elltG~~p~~~~~~~ 642 (714)
... .........++..|+|||++.+. .++.++|||||||++|||++|+.||......
T Consensus 158 ~~~---------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~ 216 (328)
T cd08226 158 AKV---------------------VYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRT 216 (328)
T ss_pred ccc---------------------cccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChH
Confidence 000 00001112235569999999764 4789999999999999999999999533211
Q ss_pred cchhHHHHHHHHhhcCC-------------------------cc----------cccCCCCCCCCCcHHHHHHHHHHHhH
Q 005102 643 EMDLVNWMQLCIEEKKP-------------------------LA----------DVLDPYLAPDADKEEEIIAVLKIAMA 687 (714)
Q Consensus 643 ~~~l~~~~~~~~~~~~~-------------------------~~----------~~~d~~~~~~~~~~~~~~~l~~li~~ 687 (714)
.. .... ...... .. ...+.... ..........+.+++.+
T Consensus 217 ~~-~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~ 290 (328)
T cd08226 217 QM-LLQK----LKGPPYSPLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLR-TPSSKTFSPAFQNLVEL 290 (328)
T ss_pred HH-HHHH----hcCCCCCCccccccchhhhhhccchhhhhcccccchhcccccccccccccc-chhhhhhhHHHHHHHHH
Confidence 11 1110 000000 00 00000000 01112345578999999
Q ss_pred ccCCCCCCCCCHHHHHH
Q 005102 688 CVHSSPEKRPTMRHISD 704 (714)
Q Consensus 688 Cl~~dP~~RPt~~evl~ 704 (714)
||+.||++|||++|+++
T Consensus 291 ~l~~dP~~Rpta~e~l~ 307 (328)
T cd08226 291 CLQQDPEKRPSASSLLS 307 (328)
T ss_pred HccCCcccCCCHHHHhh
Confidence 99999999999999974
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=280.10 Aligned_cols=254 Identities=23% Similarity=0.360 Sum_probs=195.5
Q ss_pred cCHHHHHHhccccccccCceEEEEEEECC-CcEEEEEEeCCC-CchhHHHHHHHHHHHhccC-CCCccceEEEEEeCCce
Q 005102 398 FDLDELLKASAFVLGKSGIGIVYKVVLED-GHTLAVRRLGEG-GSQRFKEFQTEVEAIGKIR-HSNIVTLRAYYWSVDEK 474 (714)
Q Consensus 398 ~~~~~l~~~~~~~lG~G~~g~Vy~~~~~~-g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~ 474 (714)
-++.|++.. ..||.|+.|.|++++++. |+.+|||.++.. .....+++...++++.+-+ .|+||+.+|||..+...
T Consensus 89 ~dindl~~l--~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV 166 (391)
T KOG0983|consen 89 ADINDLENL--GDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDV 166 (391)
T ss_pred cChHHhhhH--HhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchH
Confidence 355565543 259999999999999765 899999999875 4445677888888887775 89999999999999999
Q ss_pred eEEEeccCCCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccch
Q 005102 475 LLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGL 554 (714)
Q Consensus 475 ~lV~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGl 554 (714)
++.||.|.. -+..++.... +++++.-+-++...+.+||.||.+- ++|+|||+||+|||+|+.|++|++|||+
T Consensus 167 ~IcMelMs~-C~ekLlkrik-----~piPE~ilGk~tva~v~AL~YLKeK--H~viHRDvKPSNILlDe~GniKlCDFGI 238 (391)
T KOG0983|consen 167 FICMELMST-CAEKLLKRIK-----GPIPERILGKMTVAIVKALYYLKEK--HGVIHRDVKPSNILLDERGNIKLCDFGI 238 (391)
T ss_pred HHHHHHHHH-HHHHHHHHhc-----CCchHHhhhhhHHHHHHHHHHHHHh--cceeecccCccceEEccCCCEEeecccc
Confidence 999999954 5566665443 5688888889999999999999984 6899999999999999999999999999
Q ss_pred hhhhhccCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCC---CCCCchhhhHHHHHHHHHHHh
Q 005102 555 ARLANIAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKV---VKPSQKWDIYSYGVILLEMIT 631 (714)
Q Consensus 555 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~s~~~DVwS~Gvvl~ellt 631 (714)
+-.+-+. ...+...|.+.|||||-+.- .+|+.++|||||||+++||.|
T Consensus 239 sGrlvdS-----------------------------kAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaT 289 (391)
T KOG0983|consen 239 SGRLVDS-----------------------------KAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELAT 289 (391)
T ss_pred cceeecc-----------------------------cccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhc
Confidence 8765432 12233457888999999853 468999999999999999999
Q ss_pred CCCccccCCCCcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 005102 632 GRTAVVQVGSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISD 704 (714)
Q Consensus 632 G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 704 (714)
|+.||.....+ . +.+.....+.. |.+.+... -...+.+++..||.+|+.+||...++++
T Consensus 290 g~yPy~~c~td---F-e~ltkvln~eP-------P~L~~~~g---FSp~F~~fv~~CL~kd~r~RP~Y~~Ll~ 348 (391)
T KOG0983|consen 290 GQYPYKGCKTD---F-EVLTKVLNEEP-------PLLPGHMG---FSPDFQSFVKDCLTKDHRKRPKYNKLLE 348 (391)
T ss_pred ccCCCCCCCcc---H-HHHHHHHhcCC-------CCCCcccC---cCHHHHHHHHHHhhcCcccCcchHHHhc
Confidence 99999543222 1 22223333221 22222111 1235889999999999999999988765
|
|
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-35 Score=298.71 Aligned_cols=242 Identities=22% Similarity=0.263 Sum_probs=192.9
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeCCCC---chhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCC
Q 005102 409 FVLGKSGIGIVYKVVLE-DGHTLAVRRLGEGG---SQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNG 484 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~g 484 (714)
+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|++++++++||||+++++++...+..++||||++++
T Consensus 6 ~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 85 (258)
T cd05578 6 RVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVDLLLGG 85 (258)
T ss_pred EEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEeCCCCC
Confidence 47999999999999986 48999999997542 234578999999999999999999999999999999999999999
Q ss_pred CHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCC
Q 005102 485 SLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGS 564 (714)
Q Consensus 485 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 564 (714)
+|.+++... ..+++..+..++.|+++||.|||+ .+++|+||||+||++++++.++|+|||++.......
T Consensus 86 ~L~~~l~~~------~~l~~~~~~~~~~~i~~~l~~lh~---~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~-- 154 (258)
T cd05578 86 DLRYHLSQK------VKFSEEQVKFWICEIVLALEYLHS---KGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT-- 154 (258)
T ss_pred CHHHHHHhc------CCcCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeEEcCCCCEEEeecccccccCCCc--
Confidence 999998755 358899999999999999999999 899999999999999999999999999887543210
Q ss_pred CCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCccccCCCCcc
Q 005102 565 PTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGSSEM 644 (714)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~~~~~~~~~ 644 (714)
......|+..|+|||.+.+..++.++||||||+++|+|++|+.||......
T Consensus 155 ---------------------------~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-- 205 (258)
T cd05578 155 ---------------------------LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRT-- 205 (258)
T ss_pred ---------------------------cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCcc--
Confidence 111223567799999998888999999999999999999999999543321
Q ss_pred hhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCH--HHHH
Q 005102 645 DLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTM--RHIS 703 (714)
Q Consensus 645 ~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~--~evl 703 (714)
...++....... . +.... .....+.+++.+||+.||.+||++ +|++
T Consensus 206 -~~~~~~~~~~~~---~----~~~~~-----~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 206 -IRDQIRAKQETA---D----VLYPA-----TWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred -HHHHHHHHhccc---c----ccCcc-----cCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 111111111110 0 11111 122468899999999999999999 5544
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=293.94 Aligned_cols=248 Identities=27% Similarity=0.421 Sum_probs=198.2
Q ss_pred ccccccCceEEEEEEECC-CcEEEEEEeCCCCc-hhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCCCH
Q 005102 409 FVLGKSGIGIVYKVVLED-GHTLAVRRLGEGGS-QRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGSL 486 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~~-g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL 486 (714)
+.||+|++|.||+|...+ ++.||||++..... ...+.+.+|++.+.+++|+||+++++++...+..++||||+++++|
T Consensus 7 ~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 86 (264)
T cd06623 7 KVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYMDGGSL 86 (264)
T ss_pred eeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEecCCCcH
Confidence 479999999999999875 89999999987654 4457899999999999999999999999999999999999999999
Q ss_pred hhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCCCC
Q 005102 487 ATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPT 566 (714)
Q Consensus 487 ~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 566 (714)
.+++... ..+++..+.+++.|+++||+|||+. .+++||||+|+||+++.++.++|+|||++........
T Consensus 87 ~~~l~~~------~~l~~~~~~~~~~~l~~~l~~lh~~--~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~--- 155 (264)
T cd06623 87 ADLLKKV------GKIPEPVLAYIARQILKGLDYLHTK--RHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLD--- 155 (264)
T ss_pred HHHHHHc------CCCCHHHHHHHHHHHHHHHHHHhcc--CCCccCCCCHHHEEECCCCCEEEccCccceecccCCC---
Confidence 9999755 4589999999999999999999983 4899999999999999999999999999876532110
Q ss_pred ccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCccccCCCCcchh
Q 005102 567 LQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGSSEMDL 646 (714)
Q Consensus 567 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~~~~~~~~~~l 646 (714)
......++..|+|||.+.+..++.++||||||+++|||+||+.||..... ...
T Consensus 156 -------------------------~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~--~~~ 208 (264)
T cd06623 156 -------------------------QCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQ--PSF 208 (264)
T ss_pred -------------------------cccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccc--cCH
Confidence 01122356779999999988899999999999999999999999954332 111
Q ss_pred HHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 005102 647 VNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDA 705 (714)
Q Consensus 647 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 705 (714)
.+......... .+..... .....+.+++.+||..+|++|||+.++++.
T Consensus 209 ~~~~~~~~~~~-------~~~~~~~----~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 209 FELMQAICDGP-------PPSLPAE----EFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred HHHHHHHhcCC-------CCCCCcc----cCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 12121111111 1111111 023468899999999999999999999863
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=302.80 Aligned_cols=264 Identities=19% Similarity=0.243 Sum_probs=187.7
Q ss_pred ccccCceEEEEEEECCCcEEEEEEeCCC--CchhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCCCHhh
Q 005102 411 LGKSGIGIVYKVVLEDGHTLAVRRLGEG--GSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGSLAT 488 (714)
Q Consensus 411 lG~G~~g~Vy~~~~~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL~~ 488 (714)
+|.|+++.||++.. +++.||||++... .....+.+.+|++++++++|+||+++++++...+..+++|||+++|+|.+
T Consensus 10 ~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 88 (314)
T cd08216 10 FEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCED 88 (314)
T ss_pred hcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHH
Confidence 34445555555544 5899999998764 33445689999999999999999999999999999999999999999999
Q ss_pred hhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCCCCcc
Q 005102 489 ALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQ 568 (714)
Q Consensus 489 ~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 568 (714)
++..... ..+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||.+...........
T Consensus 89 ~l~~~~~----~~~~~~~~~~~~~~l~~~L~~LH~---~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~-- 159 (314)
T cd08216 89 LLKTHFP----EGLPELAIAFILKDVLNALDYIHS---KGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQR-- 159 (314)
T ss_pred HHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCcceEEEecCCceEEecCccceeecccccccc--
Confidence 9975432 348889999999999999999999 8999999999999999999999999998875432111000
Q ss_pred CCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCC--CCCCchhhhHHHHHHHHHHHhCCCccccCCCCcchh
Q 005102 569 SNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKV--VKPSQKWDIYSYGVILLEMITGRTAVVQVGSSEMDL 646 (714)
Q Consensus 569 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~~~DVwS~Gvvl~elltG~~p~~~~~~~~~~l 646 (714)
..........++..|+|||++.. ..++.++|||||||++|||++|+.||........ .
T Consensus 160 -------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~-~ 219 (314)
T cd08216 160 -------------------VVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQM-L 219 (314)
T ss_pred -------------------ccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHH-H
Confidence 00111123345678999999865 3578999999999999999999999954322111 1
Q ss_pred HHHHHHHHh----------hcCCccc----ccCCCCC---CCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 005102 647 VNWMQLCIE----------EKKPLAD----VLDPYLA---PDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISD 704 (714)
Q Consensus 647 ~~~~~~~~~----------~~~~~~~----~~d~~~~---~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 704 (714)
.+....... ....... ..++... ..........++.+++.+||..||++|||++++++
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~ 294 (314)
T cd08216 220 LEKVRGTVPCLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLN 294 (314)
T ss_pred HHHHhccCccccccCchhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhc
Confidence 111000000 0000000 0000000 00011122346889999999999999999999875
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=299.10 Aligned_cols=258 Identities=16% Similarity=0.171 Sum_probs=178.6
Q ss_pred ccccccCceEEEEEEECCC----cEEEEEEeCCCCchhH-----------HHHHHHHHHHhccCCCCccceEEEEEeCC-
Q 005102 409 FVLGKSGIGIVYKVVLEDG----HTLAVRRLGEGGSQRF-----------KEFQTEVEAIGKIRHSNIVTLRAYYWSVD- 472 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~~g----~~vavK~~~~~~~~~~-----------~~~~~E~~~l~~l~H~niv~l~~~~~~~~- 472 (714)
+.||+|+||.||+|...++ ..+|+|+......... .....+...+..++|+||+++++++....
T Consensus 18 ~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~ 97 (294)
T PHA02882 18 KLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGCGSFKRC 97 (294)
T ss_pred eEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEeeeEecC
Confidence 4799999999999997653 4556665432221110 11223445566778999999999776543
Q ss_pred ---ceeEEEeccCCCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEE
Q 005102 473 ---EKLLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHV 549 (714)
Q Consensus 473 ---~~~lV~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl 549 (714)
..++++|++.. ++.+.+... ...++..+..|+.|++.||+|||+ .+|+||||||+|||++.++.+||
T Consensus 98 ~~~~~~~~~~~~~~-~~~~~~~~~------~~~~~~~~~~i~~qi~~~l~~lH~---~~iiHrDiKp~Nill~~~~~~~l 167 (294)
T PHA02882 98 RMYYRFILLEKLVE-NTKEIFKRI------KCKNKKLIKNIMKDMLTTLEYIHE---HGISHGDIKPENIMVDGNNRGYI 167 (294)
T ss_pred CceEEEEEEehhcc-CHHHHHHhh------ccCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCcEEE
Confidence 34678887743 666666533 235788899999999999999999 89999999999999999999999
Q ss_pred cccchhhhhhccCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHH
Q 005102 550 SDFGLARLANIAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEM 629 (714)
Q Consensus 550 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~el 629 (714)
+|||+|+........... .........||+.|+|||+..+..++.++|||||||++|||
T Consensus 168 ~DFGla~~~~~~~~~~~~---------------------~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el 226 (294)
T PHA02882 168 IDYGIASHFIIHGKHIEY---------------------SKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKW 226 (294)
T ss_pred EEcCCceeeccCCccccc---------------------ccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHH
Confidence 999999866432111000 00112233579999999999999999999999999999999
Q ss_pred HhCCCccccCCCCcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHh
Q 005102 630 ITGRTAVVQVGSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDALD 707 (714)
Q Consensus 630 ltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~ 707 (714)
++|+.||........ +.......... .+..+.... ......+.+++..||..+|++||++.++.+.|+
T Consensus 227 ~~g~~P~~~~~~~~~-~~~~~~~~~~~-----~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~ 294 (294)
T PHA02882 227 AGIKLPWKGFGHNGN-LIHAAKCDFIK-----RLHEGKIKI----KNANKFIYDFIECVTKLSYEEKPDYDALIKIFD 294 (294)
T ss_pred HhCCCCCCccccchH-HHHHhHHHHHH-----Hhhhhhhcc----CCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence 999999954422221 11111100000 000010000 011246889999999999999999999998763
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=284.68 Aligned_cols=252 Identities=24% Similarity=0.316 Sum_probs=197.8
Q ss_pred HHHHhccccccccCceEEEEEEEC-CCcEEEEEEeCCCCchhHHHHHHHHHHHhcc-CCCCccceEEEEEe----CCcee
Q 005102 402 ELLKASAFVLGKSGIGIVYKVVLE-DGHTLAVRRLGEGGSQRFKEFQTEVEAIGKI-RHSNIVTLRAYYWS----VDEKL 475 (714)
Q Consensus 402 ~l~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~----~~~~~ 475 (714)
|-+..+.++||-|-.|.|-.+..+ +|+.+|+|++... ....+|++.--.. .|||||.++++|.. ...+.
T Consensus 61 edY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLL 135 (400)
T KOG0604|consen 61 EDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLL 135 (400)
T ss_pred hhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeE
Confidence 333445679999999999999875 5899999998754 3456788876666 69999999999874 34567
Q ss_pred EEEeccCCCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCC---CCCeEEccc
Q 005102 476 LIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGH---NMEPHVSDF 552 (714)
Q Consensus 476 lV~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~---~~~~kl~DF 552 (714)
+|||+|+||.|++.+.++.. ..+++.++-.|++||+.|+.|||+ ..|.||||||+|+|... |..+||+||
T Consensus 136 iVmE~meGGeLfsriq~~g~----~afTErea~eI~~qI~~Av~~lH~---~nIAHRDlKpENLLyt~t~~na~lKLtDf 208 (400)
T KOG0604|consen 136 IVMECMEGGELFSRIQDRGD----QAFTEREASEIMKQIGLAVRYLHS---MNIAHRDLKPENLLYTTTSPNAPLKLTDF 208 (400)
T ss_pred eeeecccchHHHHHHHHccc----ccchHHHHHHHHHHHHHHHHHHHh---cchhhccCChhheeeecCCCCcceEeccc
Confidence 99999999999999988754 569999999999999999999999 89999999999999964 567899999
Q ss_pred chhhhhhccCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhC
Q 005102 553 GLARLANIAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITG 632 (714)
Q Consensus 553 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG 632 (714)
|+|+.-... ....+...|++|.|||++...+|+...|+||+||++|-|+.|
T Consensus 209 GFAK~t~~~-----------------------------~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCG 259 (400)
T KOG0604|consen 209 GFAKETQEP-----------------------------GDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCG 259 (400)
T ss_pred ccccccCCC-----------------------------ccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcC
Confidence 999854321 122344569999999999999999999999999999999999
Q ss_pred CCccccCCCCcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 005102 633 RTAVVQVGSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISD 704 (714)
Q Consensus 633 ~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 704 (714)
.+||+.... ..+..-++..+..+. +-.+.+......+...++|+..|+.+|.+|.|++++++
T Consensus 260 yPPFYS~hg--~aispgMk~rI~~gq--------y~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~ 321 (400)
T KOG0604|consen 260 YPPFYSNHG--LAISPGMKRRIRTGQ--------YEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMD 321 (400)
T ss_pred CCcccccCC--ccCChhHHhHhhccC--------ccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhc
Confidence 999964433 222222322222221 11223333455667889999999999999999999875
|
|
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=297.47 Aligned_cols=255 Identities=18% Similarity=0.246 Sum_probs=187.7
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeCCCC-chhHHHHHHHHHHHhccC-CCCccceEEEEEeC--CceeEEEeccCC
Q 005102 409 FVLGKSGIGIVYKVVLE-DGHTLAVRRLGEGG-SQRFKEFQTEVEAIGKIR-HSNIVTLRAYYWSV--DEKLLIYDYIPN 483 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~--~~~~lV~e~~~~ 483 (714)
..||+|+||.||+|... +++.||+|+++... ........+|+.++.++. |+||+++++++.+. +..++||||++
T Consensus 5 ~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~~~- 83 (282)
T cd07831 5 GKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFELMD- 83 (282)
T ss_pred eeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEecCC-
Confidence 46999999999999975 58999999987642 222234567999999995 99999999999987 88999999996
Q ss_pred CCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCC
Q 005102 484 GSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGG 563 (714)
Q Consensus 484 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 563 (714)
|+|.+.+.... ..+++.++..++.|++.||+|||+ .+++||||||+||+++. +.+||+|||+++......
T Consensus 84 ~~l~~~l~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~---~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~- 153 (282)
T cd07831 84 MNLYELIKGRK-----RPLPEKRVKSYMYQLLKSLDHMHR---NGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKP- 153 (282)
T ss_pred ccHHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCceecccCHHHEEEcC-CCeEEEecccccccccCC-
Confidence 58888886543 358999999999999999999999 89999999999999999 999999999987653211
Q ss_pred CCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCC-CCCCchhhhHHHHHHHHHHHhCCCccccCCCC
Q 005102 564 SPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKV-VKPSQKWDIYSYGVILLEMITGRTAVVQVGSS 642 (714)
Q Consensus 564 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DVwS~Gvvl~elltG~~p~~~~~~~ 642 (714)
......++..|+|||.+.. ..++.++|||||||++|||++|+.||... +
T Consensus 154 ----------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~--~ 203 (282)
T cd07831 154 ----------------------------PYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGT--N 203 (282)
T ss_pred ----------------------------CcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCC--C
Confidence 0111235778999997654 55789999999999999999999999432 2
Q ss_pred cchhHHHHHHHHhhcCC-------cccccCCCCCCCC------CcHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 005102 643 EMDLVNWMQLCIEEKKP-------LADVLDPYLAPDA------DKEEEIIAVLKIAMACVHSSPEKRPTMRHISD 704 (714)
Q Consensus 643 ~~~l~~~~~~~~~~~~~-------~~~~~d~~~~~~~------~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 704 (714)
..+...+.......... .....+....... ........+.+++.+||+.+|++|||++++++
T Consensus 204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 278 (282)
T cd07831 204 ELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR 278 (282)
T ss_pred HHHHHHHHHHHcCCCCHHHHHhhcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence 22222222211110000 0000000000000 00123457899999999999999999999875
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-35 Score=329.26 Aligned_cols=271 Identities=26% Similarity=0.360 Sum_probs=208.2
Q ss_pred CccccCHHHHHHhccccccccCceEEEEEEECC--------CcEEEEEEeCCCC-chhHHHHHHHHHHHhcc-CCCCccc
Q 005102 394 TQVAFDLDELLKASAFVLGKSGIGIVYKVVLED--------GHTLAVRRLGEGG-SQRFKEFQTEVEAIGKI-RHSNIVT 463 (714)
Q Consensus 394 ~~~~~~~~~l~~~~~~~lG~G~~g~Vy~~~~~~--------g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~ 463 (714)
..+.+..+.+. ..+.+|+|.||.|++|.... ...||||.++... ....+.+..|+++|+.+ +|+||+.
T Consensus 289 ~~~e~~~~~l~--~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~ 366 (609)
T KOG0200|consen 289 PKWEIPRENLK--LGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVN 366 (609)
T ss_pred Cceeechhhcc--ccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhh
Confidence 34556666552 23489999999999998531 4579999998753 34567899999999999 6999999
Q ss_pred eEEEEEeCCceeEEEeccCCCCHhhhhhCCC---CCC-----CcC--CCCHHHHHHHHHHHHHHHHHHhcCCCCCceecC
Q 005102 464 LRAYYWSVDEKLLIYDYIPNGSLATALHGKP---GMV-----SFT--PVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGD 533 (714)
Q Consensus 464 l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~---~~~-----~~~--~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrD 533 (714)
++|+|...+..++|+||++.|+|.++++..+ ... ... .++..+.+.++.|||.|++||++ .++||||
T Consensus 367 llG~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~---~~~vHRD 443 (609)
T KOG0200|consen 367 LLGACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLAS---VPCVHRD 443 (609)
T ss_pred heeeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhh---CCccchh
Confidence 9999999999999999999999999998776 000 001 38899999999999999999999 8999999
Q ss_pred CCCCCeeeCCCCCeEEcccchhhhhhccCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCC
Q 005102 534 LKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKP 613 (714)
Q Consensus 534 lkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 613 (714)
|.++|||+.++..+||+|||+|+.......... ......-...|||||.+....|
T Consensus 444 LAaRNVLi~~~~~~kIaDFGlar~~~~~~~y~~-------------------------~~~~~~LP~kWmApEsl~~~~f 498 (609)
T KOG0200|consen 444 LAARNVLITKNKVIKIADFGLARDHYNKDYYRT-------------------------KSSAGTLPVKWMAPESLFDRVF 498 (609)
T ss_pred hhhhhEEecCCCEEEEccccceeccCCCCceEe-------------------------cCCCCccceeecCHHHhccCcc
Confidence 999999999999999999999986543221100 0000001234999999999999
Q ss_pred CchhhhHHHHHHHHHHHh-CCCccccCCCCcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCC
Q 005102 614 SQKWDIYSYGVILLEMIT-GRTAVVQVGSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSS 692 (714)
Q Consensus 614 s~~~DVwS~Gvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~d 692 (714)
+.|+|||||||+||||+| |..||..... ..++.+ .++.+..+ ..| ..+..+++++|+.||+.+
T Consensus 499 t~kSDVWSfGI~L~EifsLG~~PYp~~~~-~~~l~~----~l~~G~r~---~~P--------~~c~~eiY~iM~~CW~~~ 562 (609)
T KOG0200|consen 499 TSKSDVWSFGILLWEIFTLGGTPYPGIPP-TEELLE----FLKEGNRM---EQP--------EHCSDEIYDLMKSCWNAD 562 (609)
T ss_pred cccchhhHHHHHHHHHhhCCCCCCCCCCc-HHHHHH----HHhcCCCC---CCC--------CCCCHHHHHHHHHHhCCC
Confidence 999999999999999999 8889854211 122222 23333211 111 123447899999999999
Q ss_pred CCCCCCHHHHHHHHhhhh
Q 005102 693 PEKRPTMRHISDALDRLI 710 (714)
Q Consensus 693 P~~RPt~~evl~~L~~i~ 710 (714)
|++||++.++++.++...
T Consensus 563 p~~RP~F~~~~~~~~~~l 580 (609)
T KOG0200|consen 563 PEDRPTFSECVEFFEKHL 580 (609)
T ss_pred cccCCCHHHHHHHHHHHH
Confidence 999999999999999853
|
|
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=297.50 Aligned_cols=258 Identities=23% Similarity=0.326 Sum_probs=191.1
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeCCCCc-hhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCCCH
Q 005102 409 FVLGKSGIGIVYKVVLE-DGHTLAVRRLGEGGS-QRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGSL 486 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL 486 (714)
+.||+|++|.||+|+.. +|..||||++..... .....+.+|++++++++||||+++++++...+..++||||+++ +|
T Consensus 6 ~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l 84 (284)
T cd07836 6 EKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYMDK-DL 84 (284)
T ss_pred eeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecCCc-cH
Confidence 47999999999999986 589999999876532 2345678899999999999999999999999999999999985 89
Q ss_pred hhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCCCC
Q 005102 487 ATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPT 566 (714)
Q Consensus 487 ~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 566 (714)
.+++...... ..+++..+.+++.|++.||+|||+ .+++||||||+||++++++.+||+|||+++......
T Consensus 85 ~~~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~---~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~---- 154 (284)
T cd07836 85 KKYMDTHGVR---GALDPNTVKSFTYQLLKGIAFCHE---NRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPV---- 154 (284)
T ss_pred HHHHHhcCCC---CCcCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCc----
Confidence 8888654321 458999999999999999999999 899999999999999999999999999987543210
Q ss_pred ccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCC-CCCchhhhHHHHHHHHHHHhCCCccccCCCCcch
Q 005102 567 LQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVV-KPSQKWDIYSYGVILLEMITGRTAVVQVGSSEMD 645 (714)
Q Consensus 567 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DVwS~Gvvl~elltG~~p~~~~~~~~~~ 645 (714)
.......++..|+|||.+.+. .++.++|||||||++|||++|+.||...... ..
T Consensus 155 ------------------------~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~-~~ 209 (284)
T cd07836 155 ------------------------NTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNE-DQ 209 (284)
T ss_pred ------------------------cccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcH-HH
Confidence 011122346789999998654 4689999999999999999999998533211 11
Q ss_pred hHHHHHHHHhhc--------CCcccccCCCCCCCCC------cHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 005102 646 LVNWMQLCIEEK--------KPLADVLDPYLAPDAD------KEEEIIAVLKIAMACVHSSPEKRPTMRHISD 704 (714)
Q Consensus 646 l~~~~~~~~~~~--------~~~~~~~d~~~~~~~~------~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 704 (714)
...... ..... ...... ......... .......+.+++.+||+.||++||++.|+++
T Consensus 210 ~~~~~~-~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 210 LLKIFR-IMGTPTESTWPGISQLPEY-KPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred HHHHHH-HhCCCChhhHHHHhcCchh-cccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 111110 00000 000000 000000000 0112345789999999999999999999874
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=307.43 Aligned_cols=253 Identities=22% Similarity=0.323 Sum_probs=187.4
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeCCC--CchhHHHHHHHHHHHhccCCCCccceEEEEEeC------CceeEEEe
Q 005102 409 FVLGKSGIGIVYKVVLE-DGHTLAVRRLGEG--GSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSV------DEKLLIYD 479 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~------~~~~lV~e 479 (714)
..||+|+||.||+|... +++.||+|.+... .....+.+.+|+.++++++||||+++++++... ...++|||
T Consensus 22 ~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e 101 (353)
T cd07850 22 KPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVME 101 (353)
T ss_pred EEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccCcEEEEEe
Confidence 47999999999999975 5899999998653 233345678899999999999999999998643 35699999
Q ss_pred ccCCCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhh
Q 005102 480 YIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLAN 559 (714)
Q Consensus 480 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~ 559 (714)
|+. ++|.+.+.. .+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++...
T Consensus 102 ~~~-~~l~~~~~~--------~l~~~~~~~~~~ql~~aL~~LH~---~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~ 169 (353)
T cd07850 102 LMD-ANLCQVIQM--------DLDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 169 (353)
T ss_pred ccC-CCHHHHHhh--------cCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEccCccceeCC
Confidence 995 588887752 27888999999999999999999 899999999999999999999999999987543
Q ss_pred ccCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCccccC
Q 005102 560 IAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQV 639 (714)
Q Consensus 560 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~~~~ 639 (714)
... ......++..|+|||.+.+..++.++|||||||++|+|++|+.||...
T Consensus 170 ~~~-----------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~ 220 (353)
T cd07850 170 TSF-----------------------------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGT 220 (353)
T ss_pred CCC-----------------------------CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCC
Confidence 210 011223577899999999999999999999999999999999999432
Q ss_pred CCCcchhHHHH------------H-------HHHhhcC-----CcccccCCCCCCCCC---cHHHHHHHHHHHhHccCCC
Q 005102 640 GSSEMDLVNWM------------Q-------LCIEEKK-----PLADVLDPYLAPDAD---KEEEIIAVLKIAMACVHSS 692 (714)
Q Consensus 640 ~~~~~~l~~~~------------~-------~~~~~~~-----~~~~~~d~~~~~~~~---~~~~~~~l~~li~~Cl~~d 692 (714)
.. .+....+ . ....... .+.+.......+... .......+.+++.+||+.|
T Consensus 221 ~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 298 (353)
T cd07850 221 DH--IDQWNKIIEQLGTPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVID 298 (353)
T ss_pred CH--HHHHHHHHHhcCCCCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCC
Confidence 11 1100000 0 0000000 000111000000000 1123446789999999999
Q ss_pred CCCCCCHHHHHH
Q 005102 693 PEKRPTMRHISD 704 (714)
Q Consensus 693 P~~RPt~~evl~ 704 (714)
|++|||+.|+++
T Consensus 299 P~~R~t~~eiL~ 310 (353)
T cd07850 299 PEKRISVDDALQ 310 (353)
T ss_pred hhhCcCHHHHhc
Confidence 999999999985
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=308.42 Aligned_cols=239 Identities=22% Similarity=0.287 Sum_probs=196.1
Q ss_pred cccccCceEEEEEEEC-CCcEEEEEEeCCC--CchhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCCCH
Q 005102 410 VLGKSGIGIVYKVVLE-DGHTLAVRRLGEG--GSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGSL 486 (714)
Q Consensus 410 ~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL 486 (714)
.||+|.|+.|..+++. ++..||||.+.+. +......+.+|+++|+.++|||||+++.+.......|+||||+.+|.+
T Consensus 63 tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~eya~~ge~ 142 (596)
T KOG0586|consen 63 TIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVMEYASGGEL 142 (596)
T ss_pred eeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEEEeccCchh
Confidence 7999999999999975 4899999999875 333445589999999999999999999999999999999999999999
Q ss_pred hhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCCCC
Q 005102 487 ATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPT 566 (714)
Q Consensus 487 ~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 566 (714)
++++.... .+....+..++.|+.+|++|+|+ +.|||||||++|||++.++++||+|||++.++...
T Consensus 143 ~~yl~~~g------r~~e~~ar~~F~q~vsaveYcH~---k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~----- 208 (596)
T KOG0586|consen 143 FDYLVKHG------RMKEKEARAKFRQIVSAVEYCHS---KNIVHRDLKAENILLDENMNIKIADFGFSTFFDYG----- 208 (596)
T ss_pred HHHHHhcc------cchhhhhhhhhHHHHHHHHHHhh---cceeccccchhhcccccccceeeeccccceeeccc-----
Confidence 99998773 45668889999999999999999 99999999999999999999999999999887532
Q ss_pred ccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCC-CchhhhHHHHHHHHHHHhCCCccccCCCCcch
Q 005102 567 LQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKP-SQKWDIYSYGVILLEMITGRTAVVQVGSSEMD 645 (714)
Q Consensus 567 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~~DVwS~Gvvl~elltG~~p~~~~~~~~~~ 645 (714)
....+..|++.|.|||++.+.+| ++++|+||+|+++|-|+.|..||+.. .
T Consensus 209 ------------------------~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~-----~ 259 (596)
T KOG0586|consen 209 ------------------------LMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQ-----N 259 (596)
T ss_pred ------------------------ccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCc-----c
Confidence 23445678899999999998876 78999999999999999999999422 1
Q ss_pred hHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 005102 646 LVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISD 704 (714)
Q Consensus 646 l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 704 (714)
+.+.-.+++..+..+. +. ....+-+++++++..+|.+|++++++.+
T Consensus 260 lk~Lr~rvl~gk~rIp----------~~---ms~dce~lLrk~lvl~Pskr~~~dqim~ 305 (596)
T KOG0586|consen 260 LKELRPRVLRGKYRIP----------FY---MSCDCEDLLRKFLVLNPSKRGPCDQIMK 305 (596)
T ss_pred cccccchheeeeeccc----------ce---eechhHHHHHHhhccCccccCCHHHhhh
Confidence 2111112222211111 11 1114568999999999999999999865
|
|
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=306.64 Aligned_cols=270 Identities=21% Similarity=0.261 Sum_probs=192.4
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeCCCCchh--------------HHHHHHHHHHHhccCCCCccceEEEEEeCCc
Q 005102 409 FVLGKSGIGIVYKVVLE-DGHTLAVRRLGEGGSQR--------------FKEFQTEVEAIGKIRHSNIVTLRAYYWSVDE 473 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~--------------~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~ 473 (714)
..||+|+||.||+|... +++.||||++....... ...+.+|++++++++||||+++++++...+.
T Consensus 15 ~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 94 (335)
T PTZ00024 15 AHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVEGDF 94 (335)
T ss_pred hcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEEecCCc
Confidence 47999999999999975 58999999986542221 1247789999999999999999999999999
Q ss_pred eeEEEeccCCCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccc
Q 005102 474 KLLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFG 553 (714)
Q Consensus 474 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFG 553 (714)
.++||||+. |+|.+++... ..+++.....++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||
T Consensus 95 ~~lv~e~~~-~~l~~~l~~~------~~~~~~~~~~~~~ql~~aL~~LH~---~~i~H~dl~~~nill~~~~~~kl~dfg 164 (335)
T PTZ00024 95 INLVMDIMA-SDLKKVVDRK------IRLTESQVKCILLQILNGLNVLHK---WYFMHRDLSPANIFINSKGICKIADFG 164 (335)
T ss_pred EEEEEeccc-cCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHh---CCeecccccHHHeEECCCCCEEECCcc
Confidence 999999996 6999998654 458899999999999999999999 899999999999999999999999999
Q ss_pred hhhhhhccCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCC-CCCchhhhHHHHHHHHHHHhC
Q 005102 554 LARLANIAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVV-KPSQKWDIYSYGVILLEMITG 632 (714)
Q Consensus 554 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DVwS~Gvvl~elltG 632 (714)
+++................. ..........++..|+|||.+.+. .++.++|||||||++|||+||
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~--------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg 230 (335)
T PTZ00024 165 LARRYGYPPYSDTLSKDETM--------------QRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTG 230 (335)
T ss_pred ceeecccccccccccccccc--------------cccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhC
Confidence 99865422111100000000 001111223457789999998764 469999999999999999999
Q ss_pred CCccccCCCCcchhHHHHHHHHhhcCC--cccc-----cCCCCCCCCC-----cHHHHHHHHHHHhHccCCCCCCCCCHH
Q 005102 633 RTAVVQVGSSEMDLVNWMQLCIEEKKP--LADV-----LDPYLAPDAD-----KEEEIIAVLKIAMACVHSSPEKRPTMR 700 (714)
Q Consensus 633 ~~p~~~~~~~~~~l~~~~~~~~~~~~~--~~~~-----~d~~~~~~~~-----~~~~~~~l~~li~~Cl~~dP~~RPt~~ 700 (714)
+.||..... .+....+......... ..+. ..+....... .......+.+++.+||+.+|++|||++
T Consensus 231 ~~p~~~~~~--~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~ 308 (335)
T PTZ00024 231 KPLFPGENE--IDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAK 308 (335)
T ss_pred CCCCCCCCH--HHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHH
Confidence 999953321 1111111111111000 0000 0000000000 001234678999999999999999999
Q ss_pred HHHH
Q 005102 701 HISD 704 (714)
Q Consensus 701 evl~ 704 (714)
|++.
T Consensus 309 ~~l~ 312 (335)
T PTZ00024 309 EALK 312 (335)
T ss_pred HHhc
Confidence 9975
|
|
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=292.51 Aligned_cols=244 Identities=25% Similarity=0.392 Sum_probs=196.7
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeCCCCchhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCCCHh
Q 005102 409 FVLGKSGIGIVYKVVLE-DGHTLAVRRLGEGGSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGSLA 487 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL~ 487 (714)
+.||+|++|.||++... ++..+++|++........+.+.+|++.+++++|+||+++++++...+..++++||+++++|.
T Consensus 6 ~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~ 85 (253)
T cd05122 6 EKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSGGSLK 85 (253)
T ss_pred eeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCCCCcHH
Confidence 47999999999999986 58899999998766555678999999999999999999999999999999999999999999
Q ss_pred hhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCCCCc
Q 005102 488 TALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTL 567 (714)
Q Consensus 488 ~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 567 (714)
+++.... ..+++..+..++.|++.||+|||+ .+++||||+|+||++++++.++|+|||.+........
T Consensus 86 ~~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~---- 153 (253)
T cd05122 86 DLLKSTN-----QTLTESQIAYVCKELLKGLEYLHS---NGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA---- 153 (253)
T ss_pred HHHhhcC-----CCCCHHHHHHHHHHHHHHHHHhhc---CCEecCCCCHHHEEEccCCeEEEeecccccccccccc----
Confidence 9987653 358999999999999999999999 8999999999999999999999999999876532110
Q ss_pred cCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCccccCCCCcchhH
Q 005102 568 QSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGSSEMDLV 647 (714)
Q Consensus 568 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~~~~~~~~~~l~ 647 (714)
.....++..|+|||.+.+..++.++||||||+++|+|++|+.||..... .
T Consensus 154 -------------------------~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-----~ 203 (253)
T cd05122 154 -------------------------RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPP-----M 203 (253)
T ss_pred -------------------------ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCch-----H
Confidence 1223356779999999888899999999999999999999999843211 1
Q ss_pred HHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 005102 648 NWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISD 704 (714)
Q Consensus 648 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 704 (714)
......... .......+ . .....+.+++.+||+.||++|||+.|+++
T Consensus 204 ~~~~~~~~~--~~~~~~~~-----~---~~~~~~~~~i~~~l~~~p~~R~t~~~~l~ 250 (253)
T cd05122 204 KALFKIATN--GPPGLRNP-----E---KWSDEFKDFLKKCLQKNPEKRPTAEQLLK 250 (253)
T ss_pred HHHHHHHhc--CCCCcCcc-----c---ccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 111111111 11111111 0 01236889999999999999999999875
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=303.00 Aligned_cols=201 Identities=24% Similarity=0.356 Sum_probs=163.3
Q ss_pred ccccccCceEEEEEEECC---CcEEEEEEeCCCC---chhHHHHHHHHHHHhccCCCCccceEEEEEeC--CceeEEEec
Q 005102 409 FVLGKSGIGIVYKVVLED---GHTLAVRRLGEGG---SQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSV--DEKLLIYDY 480 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~~---g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~~lV~e~ 480 (714)
..||+|+||.||+|.... ++.||+|.+.... ....+.+.+|+.++++++||||+++++++... +..++||||
T Consensus 6 ~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~ 85 (316)
T cd07842 6 GCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVYLLFDY 85 (316)
T ss_pred EEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEEEEEeC
Confidence 469999999999999754 7899999998732 33346778899999999999999999999987 789999999
Q ss_pred cCCCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCC----CCCeEEcccchhh
Q 005102 481 IPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGH----NMEPHVSDFGLAR 556 (714)
Q Consensus 481 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~----~~~~kl~DFGla~ 556 (714)
+++ +|.+++....... ...+++..+..++.|++.||+|||+ .+|+||||||+||+++. ++.+||+|||+++
T Consensus 86 ~~~-~l~~~~~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~~ 160 (316)
T cd07842 86 AEH-DLWQIIKFHRQAK-RVSIPPSMVKSLLWQILNGVHYLHS---NWVLHRDLKPANILVMGEGPERGVVKIGDLGLAR 160 (316)
T ss_pred CCc-CHHHHHHhhccCC-CcCcCHHHHHHHHHHHHHHHHHHHh---CCEeeCCCCHHHEEEcCCCCccceEEECCCcccc
Confidence 975 7777765332211 1358899999999999999999999 89999999999999999 8999999999998
Q ss_pred hhhccCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCC-CCCchhhhHHHHHHHHHHHhCCCc
Q 005102 557 LANIAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVV-KPSQKWDIYSYGVILLEMITGRTA 635 (714)
Q Consensus 557 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DVwS~Gvvl~elltG~~p 635 (714)
........ ........++..|+|||.+.+. .++.++|||||||++|||++|+.|
T Consensus 161 ~~~~~~~~-------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~ 215 (316)
T cd07842 161 LFNAPLKP-------------------------LADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPI 215 (316)
T ss_pred ccCCCccc-------------------------ccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCC
Confidence 65422110 0111223457789999988764 579999999999999999999999
Q ss_pred cccC
Q 005102 636 VVQV 639 (714)
Q Consensus 636 ~~~~ 639 (714)
|...
T Consensus 216 ~~~~ 219 (316)
T cd07842 216 FKGR 219 (316)
T ss_pred CcCC
Confidence 9543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=299.54 Aligned_cols=256 Identities=23% Similarity=0.315 Sum_probs=187.0
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeCCCCc--hhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCCC
Q 005102 409 FVLGKSGIGIVYKVVLE-DGHTLAVRRLGEGGS--QRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGS 485 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gs 485 (714)
..||+|++|.||+|... +|+.||+|++..... ...+.+.+|++++++++||||+++++++...+..++||||++ ++
T Consensus 8 ~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~ 86 (294)
T PLN00009 8 EKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFEYLD-LD 86 (294)
T ss_pred EEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEeccc-cc
Confidence 47999999999999976 589999999865422 233578899999999999999999999999999999999996 58
Q ss_pred HhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCC-CCCeEEcccchhhhhhccCCC
Q 005102 486 LATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGH-NMEPHVSDFGLARLANIAGGS 564 (714)
Q Consensus 486 L~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~-~~~~kl~DFGla~~~~~~~~~ 564 (714)
|.+++..... ..+++..+..++.||+.||+|||+ ++++||||||+||++++ ++.+||+|||+++......
T Consensus 87 l~~~~~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~---~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~-- 157 (294)
T PLN00009 87 LKKHMDSSPD----FAKNPRLIKTYLYQILRGIAYCHS---HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV-- 157 (294)
T ss_pred HHHHHHhCCC----CCcCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCcceEEEECCCCEEEEcccccccccCCCc--
Confidence 8888765432 236788889999999999999999 89999999999999985 5679999999987543210
Q ss_pred CCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCC-CCCchhhhHHHHHHHHHHHhCCCccccCCCCc
Q 005102 565 PTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVV-KPSQKWDIYSYGVILLEMITGRTAVVQVGSSE 643 (714)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DVwS~Gvvl~elltG~~p~~~~~~~~ 643 (714)
.......+++.|+|||++.+. .++.++|||||||++|||+||+.||......
T Consensus 158 --------------------------~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~- 210 (294)
T PLN00009 158 --------------------------RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEI- 210 (294)
T ss_pred --------------------------cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-
Confidence 011122356789999998664 5789999999999999999999999532211
Q ss_pred chhHHHHHHHHhhcCCcccccC------------CCCCCCC---CcHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 005102 644 MDLVNWMQLCIEEKKPLADVLD------------PYLAPDA---DKEEEIIAVLKIAMACVHSSPEKRPTMRHISD 704 (714)
Q Consensus 644 ~~l~~~~~~~~~~~~~~~~~~d------------~~~~~~~---~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 704 (714)
. ...+.......+..+..+ +...... ........+.+++.+|++.+|++||++.++++
T Consensus 211 ~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~ 283 (294)
T PLN00009 211 D---ELFKIFRILGTPNEETWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE 283 (294)
T ss_pred H---HHHHHHHHhCCCChhhccccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1 111110000000000000 0000000 00011235789999999999999999999875
|
|
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=297.72 Aligned_cols=258 Identities=22% Similarity=0.299 Sum_probs=191.1
Q ss_pred ccccccCceEEEEEEECC-CcEEEEEEeCCCC--chhHHHHHHHHHHHhccCCCCccceEEEEEeC--CceeEEEeccCC
Q 005102 409 FVLGKSGIGIVYKVVLED-GHTLAVRRLGEGG--SQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSV--DEKLLIYDYIPN 483 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~~-g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~~lV~e~~~~ 483 (714)
+.||+|+||.||+|...+ ++.+|+|++.... ....+.+.+|++++++++|+|++++++++... +..++||||+++
T Consensus 5 ~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~ 84 (287)
T cd07840 5 AQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEYMDH 84 (287)
T ss_pred EEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEeccccc
Confidence 469999999999999864 8999999998753 33345788999999999999999999999887 789999999975
Q ss_pred CCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCC
Q 005102 484 GSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGG 563 (714)
Q Consensus 484 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 563 (714)
+|.+++.... ..+++..+..++.|++.||+|||+ .+++|+||||+||++++++.+||+|||++........
T Consensus 85 -~l~~~~~~~~-----~~~~~~~~~~i~~~i~~al~~LH~---~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~ 155 (287)
T cd07840 85 -DLTGLLDSPE-----VKFTESQIKCYMKQLLEGLQYLHS---NGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS 155 (287)
T ss_pred -cHHHHHhccC-----CCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCcHHHeEEcCCCCEEEccccceeeccCCCc
Confidence 8998886542 358999999999999999999999 8999999999999999999999999999876532210
Q ss_pred CCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCC-CCCCchhhhHHHHHHHHHHHhCCCccccCCCC
Q 005102 564 SPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKV-VKPSQKWDIYSYGVILLEMITGRTAVVQVGSS 642 (714)
Q Consensus 564 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DVwS~Gvvl~elltG~~p~~~~~~~ 642 (714)
.......++..|+|||.+.+ ..++.++||||||+++|||+||+.||.....
T Consensus 156 ---------------------------~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~- 207 (287)
T cd07840 156 ---------------------------ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTE- 207 (287)
T ss_pred ---------------------------ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCCh-
Confidence 01112234677999998765 4578999999999999999999999843221
Q ss_pred cchhHHHHHHHHhhc----C-Ccccc-----cCCCCCCCCC----cHH-HHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 005102 643 EMDLVNWMQLCIEEK----K-PLADV-----LDPYLAPDAD----KEE-EIIAVLKIAMACVHSSPEKRPTMRHISD 704 (714)
Q Consensus 643 ~~~l~~~~~~~~~~~----~-~~~~~-----~d~~~~~~~~----~~~-~~~~l~~li~~Cl~~dP~~RPt~~evl~ 704 (714)
......+....... + ..... ..+....... ... ....+.+++.+||..+|++||+++++++
T Consensus 208 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 208 -LEQLEKIFELCGSPTDENWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred -HHHHHHHHHHhCCCchhhccccccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 11111111110000 0 00000 0000000000 000 1456889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=283.90 Aligned_cols=263 Identities=22% Similarity=0.293 Sum_probs=197.9
Q ss_pred cccCHHHHHHhccccccccCceEEEEEEEC-CCcEEEEEEeCCCCc-hhHHHHHHHHHHHhcc-CCCCccceEEEEEeCC
Q 005102 396 VAFDLDELLKASAFVLGKSGIGIVYKVVLE-DGHTLAVRRLGEGGS-QRFKEFQTEVEAIGKI-RHSNIVTLRAYYWSVD 472 (714)
Q Consensus 396 ~~~~~~~l~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~ 472 (714)
..|+-++|+.. ..||.|.||+|+|-.++ .|+..|||+++.... ...+++..|.++..+- +.||||+++|.+...+
T Consensus 59 ~~F~~~~Lqdl--g~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EG 136 (361)
T KOG1006|consen 59 HTFTSDNLQDL--GEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEG 136 (361)
T ss_pred cccccchHHHH--HHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCC
Confidence 34555555543 25999999999998875 499999999987643 5667899999876665 6899999999999999
Q ss_pred ceeEEEeccCCCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEccc
Q 005102 473 EKLLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDF 552 (714)
Q Consensus 473 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DF 552 (714)
..++.||.|.- +|..+...- .......+++.-.-+|...+.+||.||.+. ..|||||+||+|||+|..|.+||+||
T Consensus 137 dcWiCMELMd~-SlDklYk~v-y~vq~~~ipE~Ilg~ItvatV~AL~yLK~~--lkiIHRDvKPSNILldr~G~vKLCDF 212 (361)
T KOG1006|consen 137 DCWICMELMDI-SLDKLYKRV-YSVQKSRIPENILGHITVATVDALDYLKEE--LKIIHRDVKPSNILLDRHGDVKLCDF 212 (361)
T ss_pred ceeeeHHHHhh-hHHHHHHHH-HHHHhccCcHhhhhheeeeehhHHHHHHHH--hhhhhccCChhheEEecCCCEeeecc
Confidence 99999999954 665543211 000114588888889999999999999875 57999999999999999999999999
Q ss_pred chhhhhhccCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCC--CCCCchhhhHHHHHHHHHHH
Q 005102 553 GLARLANIAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKV--VKPSQKWDIYSYGVILLEMI 630 (714)
Q Consensus 553 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~~~DVwS~Gvvl~ell 630 (714)
|.+-.+..+ ...+...|...|||||-+.. ..|+.++||||+|++|||+.
T Consensus 213 GIcGqLv~S-----------------------------iAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvA 263 (361)
T KOG1006|consen 213 GICGQLVDS-----------------------------IAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVA 263 (361)
T ss_pred cchHhHHHH-----------------------------HHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeee
Confidence 998766432 22334456788999999953 34899999999999999999
Q ss_pred hCCCccccCCCCcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 005102 631 TGRTAVVQVGSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISD 704 (714)
Q Consensus 631 tG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 704 (714)
||+.||... .++.+.+...+....+ .+..+....+....+..++..|+.+|-++||...++.+
T Consensus 264 tG~fPyr~w----~svfeql~~Vv~gdpp-------~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~ 326 (361)
T KOG1006|consen 264 TGNFPYRKW----DSVFEQLCQVVIGDPP-------ILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKK 326 (361)
T ss_pred cCCCCcchH----HHHHHHHHHHHcCCCC-------eecCcccccccCHHHHHHHHHHhhcccccCcchhhhhc
Confidence 999999433 2233444444333321 11112221223456889999999999999999988764
|
|
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=301.17 Aligned_cols=261 Identities=20% Similarity=0.265 Sum_probs=186.7
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeCCCC--chhHHHHHHHHHHHhccCCCCccceEEEEEeCCc--------eeEE
Q 005102 409 FVLGKSGIGIVYKVVLE-DGHTLAVRRLGEGG--SQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDE--------KLLI 477 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~--------~~lV 477 (714)
..||+|+||.||+|... +++.||||.+.... ......+.+|++++++++||||+++++++...+. .++|
T Consensus 18 ~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~lv 97 (310)
T cd07865 18 AKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLV 97 (310)
T ss_pred EEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCCceEEEE
Confidence 47999999999999976 58999999886542 2223456789999999999999999999876543 4999
Q ss_pred EeccCCCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhh
Q 005102 478 YDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARL 557 (714)
Q Consensus 478 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 557 (714)
|||+. ++|.+.+.... ..+++.++..++.|++.||+|||+ ++++|+||||+||++++++.+||+|||++..
T Consensus 98 ~e~~~-~~l~~~l~~~~-----~~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~ 168 (310)
T cd07865 98 FEFCE-HDLAGLLSNKN-----VKFTLSEIKKVMKMLLNGLYYIHR---NKILHRDMKAANILITKDGILKLADFGLARA 168 (310)
T ss_pred EcCCC-cCHHHHHHhcc-----cCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEECCCCcEEECcCCCccc
Confidence 99996 48888876542 358999999999999999999999 8999999999999999999999999999986
Q ss_pred hhccCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCC-CCchhhhHHHHHHHHHHHhCCCcc
Q 005102 558 ANIAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVK-PSQKWDIYSYGVILLEMITGRTAV 636 (714)
Q Consensus 558 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s~~~DVwS~Gvvl~elltG~~p~ 636 (714)
........ ........++..|+|||.+.+.. ++.++||||||+++|||+||+.||
T Consensus 169 ~~~~~~~~------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~ 224 (310)
T cd07865 169 FSLSKNSK------------------------PNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIM 224 (310)
T ss_pred ccCCcccC------------------------CCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCC
Confidence 54321100 00112234567899999886644 788999999999999999999998
Q ss_pred ccCCCCcchhHHHHHHHHhhcC-C-cc-----cccCC-CCCCCC--------CcHHHHHHHHHHHhHccCCCCCCCCCHH
Q 005102 637 VQVGSSEMDLVNWMQLCIEEKK-P-LA-----DVLDP-YLAPDA--------DKEEEIIAVLKIAMACVHSSPEKRPTMR 700 (714)
Q Consensus 637 ~~~~~~~~~l~~~~~~~~~~~~-~-~~-----~~~d~-~~~~~~--------~~~~~~~~l~~li~~Cl~~dP~~RPt~~ 700 (714)
.... .......+........ . .. +..+. ...... ........+.+++.+||..||++|||++
T Consensus 225 ~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~ 302 (310)
T cd07865 225 QGNT--EQHQLTLISQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDAD 302 (310)
T ss_pred CCCC--HHHHHHHHHHHhCCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHH
Confidence 4321 1111111111110000 0 00 00000 000000 0000123567999999999999999999
Q ss_pred HHHH
Q 005102 701 HISD 704 (714)
Q Consensus 701 evl~ 704 (714)
|+++
T Consensus 303 e~l~ 306 (310)
T cd07865 303 TALN 306 (310)
T ss_pred HHhc
Confidence 9874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=299.04 Aligned_cols=250 Identities=23% Similarity=0.255 Sum_probs=193.3
Q ss_pred ccccccCceEEEEEEEC----CCcEEEEEEeCCCC----chhHHHHHHHHHHHhcc-CCCCccceEEEEEeCCceeEEEe
Q 005102 409 FVLGKSGIGIVYKVVLE----DGHTLAVRRLGEGG----SQRFKEFQTEVEAIGKI-RHSNIVTLRAYYWSVDEKLLIYD 479 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~----~g~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~e 479 (714)
+.||+|+||.||+++.. ++..||||.+++.. ....+.+.+|++++.++ +||||+++++.+...+..++|||
T Consensus 6 ~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~e 85 (288)
T cd05583 6 RVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLHLILD 85 (288)
T ss_pred EEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEEEEEEe
Confidence 47999999999999853 47889999987532 22335688999999999 59999999999998889999999
Q ss_pred ccCCCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhh
Q 005102 480 YIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLAN 559 (714)
Q Consensus 480 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~ 559 (714)
|+++|+|.+++... ..+++..+..++.|+++||+|||+ .+++||||||+||++++++.++|+|||+++...
T Consensus 86 ~~~~~~L~~~~~~~------~~~~~~~~~~~~~ql~~~l~~lH~---~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 156 (288)
T cd05583 86 YVNGGELFTHLYQR------EHFTESEVRVYIAEIVLALDHLHQ---LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFL 156 (288)
T ss_pred cCCCCcHHHHHhhc------CCcCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEEECccccccc
Confidence 99999999998654 358899999999999999999999 899999999999999999999999999987543
Q ss_pred ccCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCC--CCchhhhHHHHHHHHHHHhCCCccc
Q 005102 560 IAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVK--PSQKWDIYSYGVILLEMITGRTAVV 637 (714)
Q Consensus 560 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~s~~~DVwS~Gvvl~elltG~~p~~ 637 (714)
.... .......|+..|+|||.+.+.. .+.++||||||+++|||++|+.||.
T Consensus 157 ~~~~---------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~ 209 (288)
T cd05583 157 AEEE---------------------------ERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFT 209 (288)
T ss_pred cccc---------------------------cccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcc
Confidence 2110 0011233577899999987665 7889999999999999999999994
Q ss_pred cCCCCcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhh
Q 005102 638 QVGSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDALDR 708 (714)
Q Consensus 638 ~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~ 708 (714)
.... .....++.+........ .... ....+.+++.+||+.||++|||+.++.+.|+-
T Consensus 210 ~~~~-~~~~~~~~~~~~~~~~~--------~~~~-----~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~ 266 (288)
T cd05583 210 VDGE-QNSQSEISRRILKSKPP--------FPKT-----MSAEARDFIQKLLEKDPKKRLGANGADEIKNH 266 (288)
T ss_pred cCcc-cchHHHHHHHHHccCCC--------CCcc-----cCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence 3221 11112222222221111 1111 12357789999999999999999988877764
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-34 Score=300.62 Aligned_cols=257 Identities=24% Similarity=0.324 Sum_probs=187.2
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeCCCCc--hhHHHHHHHHHHHhccCCCCccceEEEEEeC--CceeEEEeccCC
Q 005102 409 FVLGKSGIGIVYKVVLE-DGHTLAVRRLGEGGS--QRFKEFQTEVEAIGKIRHSNIVTLRAYYWSV--DEKLLIYDYIPN 483 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~~lV~e~~~~ 483 (714)
+.||+|+||.||+|... +|+.||+|+++.... .....+.+|++++++++|+||+++++++... +..++||||+.
T Consensus 13 ~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~- 91 (309)
T cd07845 13 NRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFLVMEYCE- 91 (309)
T ss_pred eeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEEEEecCC-
Confidence 47999999999999975 489999999875422 2223567899999999999999999998765 45799999996
Q ss_pred CCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCC
Q 005102 484 GSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGG 563 (714)
Q Consensus 484 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 563 (714)
++|.+++.... ..+++.++..++.|++.||+|||+ .+++||||||+||++++++.+||+|||+++.......
T Consensus 92 ~~l~~~l~~~~-----~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~~ 163 (309)
T cd07845 92 QDLASLLDNMP-----TPFSESQVKCLMLQLLRGLQYLHE---NFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAK 163 (309)
T ss_pred CCHHHHHHhcc-----cCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECccceeeecCCccC
Confidence 48988886543 458999999999999999999999 8999999999999999999999999999876532110
Q ss_pred CCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCC-CCCCchhhhHHHHHHHHHHHhCCCccccCCCC
Q 005102 564 SPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKV-VKPSQKWDIYSYGVILLEMITGRTAVVQVGSS 642 (714)
Q Consensus 564 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DVwS~Gvvl~elltG~~p~~~~~~~ 642 (714)
......++..|+|||.+.+ ..++.++||||+||++|||++|+.||....
T Consensus 164 ----------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~-- 213 (309)
T cd07845 164 ----------------------------PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKS-- 213 (309)
T ss_pred ----------------------------CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCC--
Confidence 0111223667999999865 457999999999999999999999995322
Q ss_pred cchhHHHHHHHHhhcC--Cccccc------CCCCCCCC--C----cHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 005102 643 EMDLVNWMQLCIEEKK--PLADVL------DPYLAPDA--D----KEEEIIAVLKIAMACVHSSPEKRPTMRHISD 704 (714)
Q Consensus 643 ~~~l~~~~~~~~~~~~--~~~~~~------d~~~~~~~--~----~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 704 (714)
..+....+........ ...... ........ . .......+.+++.+||+.||++|||++|++.
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~ 289 (309)
T cd07845 214 EIEQLDLIIQLLGTPNESIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE 289 (309)
T ss_pred HHHHHHHHHHhcCCCChhhchhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 2221111111110000 000000 00000000 0 0012345789999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=301.65 Aligned_cols=247 Identities=24% Similarity=0.379 Sum_probs=187.7
Q ss_pred cccccccCceEEEEEEECC-CcEEEEEEeCCCCc-hhHHHHHHHHHHHhccC-CCCccceEEEEEeCCceeEEEeccCCC
Q 005102 408 AFVLGKSGIGIVYKVVLED-GHTLAVRRLGEGGS-QRFKEFQTEVEAIGKIR-HSNIVTLRAYYWSVDEKLLIYDYIPNG 484 (714)
Q Consensus 408 ~~~lG~G~~g~Vy~~~~~~-g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lV~e~~~~g 484 (714)
.+.||+|+||.||+|.+.+ ++.||||.+..... .....+.+|+.++.+.. ||||+++++++......++||||+. +
T Consensus 20 ~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~-~ 98 (296)
T cd06618 20 LGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICMELMS-T 98 (296)
T ss_pred eeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEeeccC-c
Confidence 3589999999999999875 89999999976432 33456777888777775 9999999999999999999999985 4
Q ss_pred CHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCC
Q 005102 485 SLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGS 564 (714)
Q Consensus 485 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 564 (714)
++.+++.... ..+++..+.+++.|++.||+|||+. .+|+||||+|+||++++++.+||+|||++.......
T Consensus 99 ~l~~l~~~~~-----~~l~~~~~~~i~~~i~~~l~~lH~~--~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~-- 169 (296)
T cd06618 99 CLDKLLKRIQ-----GPIPEDILGKMTVAIVKALHYLKEK--HGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSK-- 169 (296)
T ss_pred CHHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhh--CCEecCCCcHHHEEEcCCCCEEECccccchhccCCC--
Confidence 7777765432 3589999999999999999999962 489999999999999999999999999987543211
Q ss_pred CCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCC----CCchhhhHHHHHHHHHHHhCCCccccCC
Q 005102 565 PTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVK----PSQKWDIYSYGVILLEMITGRTAVVQVG 640 (714)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~s~~~DVwS~Gvvl~elltG~~p~~~~~ 640 (714)
......++..|+|||.+.+.. ++.++||||||+++|||++|+.||....
T Consensus 170 ---------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~ 222 (296)
T cd06618 170 ---------------------------AKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCK 222 (296)
T ss_pred ---------------------------cccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcch
Confidence 011123467799999997654 7899999999999999999999994321
Q ss_pred CCcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 005102 641 SSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDA 705 (714)
Q Consensus 641 ~~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 705 (714)
.. .+.......... +...... ....++.+++.+||..||++||++.+++..
T Consensus 223 ~~----~~~~~~~~~~~~-------~~~~~~~---~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 223 TE----FEVLTKILQEEP-------PSLPPNE---GFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred hH----HHHHHHHhcCCC-------CCCCCCC---CCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 11 111211111111 1111000 123368899999999999999999999754
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=298.57 Aligned_cols=258 Identities=21% Similarity=0.258 Sum_probs=187.4
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeCCCC--chhHHHHHHHHHHHhccC-CCCccceEEEEEeCCc-----eeEEEe
Q 005102 409 FVLGKSGIGIVYKVVLE-DGHTLAVRRLGEGG--SQRFKEFQTEVEAIGKIR-HSNIVTLRAYYWSVDE-----KLLIYD 479 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~-----~~lV~e 479 (714)
+.||+|+||.||+|... +++.||+|++.... ......+.+|+.++++++ ||||+++++++...+. .|+|||
T Consensus 7 ~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~~lv~e 86 (295)
T cd07837 7 EKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSLYLVFE 86 (295)
T ss_pred eEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceEEEEee
Confidence 47999999999999976 58999999886542 223357888999999995 6999999999987665 799999
Q ss_pred ccCCCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCC-CCCeEEcccchhhhh
Q 005102 480 YIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGH-NMEPHVSDFGLARLA 558 (714)
Q Consensus 480 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~-~~~~kl~DFGla~~~ 558 (714)
|+++ +|.+++...... ....+++..+..++.||+.||+|||+ ++|+||||||+||+++. ++.+||+|||+++..
T Consensus 87 ~~~~-~l~~~~~~~~~~-~~~~~~~~~~~~~~~qi~~~L~~LH~---~~i~H~dl~~~nil~~~~~~~~kl~dfg~~~~~ 161 (295)
T cd07837 87 YLDS-DLKKFMDSNGRG-PGRPLPAKTIKSFMYQLLKGVAHCHK---HGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAF 161 (295)
T ss_pred ccCc-CHHHHHHHhccc-CCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChHHEEEecCCCeEEEeecccceec
Confidence 9985 898888654321 11458999999999999999999999 89999999999999998 889999999998754
Q ss_pred hccCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCC-CCCCchhhhHHHHHHHHHHHhCCCccc
Q 005102 559 NIAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKV-VKPSQKWDIYSYGVILLEMITGRTAVV 637 (714)
Q Consensus 559 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DVwS~Gvvl~elltG~~p~~ 637 (714)
..... ......+++.|+|||++.+ ..++.++||||||+++|||++|+.||.
T Consensus 162 ~~~~~----------------------------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~ 213 (295)
T cd07837 162 SIPVK----------------------------SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFP 213 (295)
T ss_pred CCCcc----------------------------ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCC
Confidence 22100 0111234677999998865 457999999999999999999999994
Q ss_pred cCCCCcchhHHHHHHHHhh-cCCcccccC-----------CCCCCCC---CcHHHHHHHHHHHhHccCCCCCCCCCHHHH
Q 005102 638 QVGSSEMDLVNWMQLCIEE-KKPLADVLD-----------PYLAPDA---DKEEEIIAVLKIAMACVHSSPEKRPTMRHI 702 (714)
Q Consensus 638 ~~~~~~~~l~~~~~~~~~~-~~~~~~~~d-----------~~~~~~~---~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev 702 (714)
.... ..... ..... ..+..+... +...+.. ..+....++.+++.+||+.||++|||++|+
T Consensus 214 ~~~~----~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~ei 288 (295)
T cd07837 214 GDSE----LQQLL-HIFKLLGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAA 288 (295)
T ss_pred CCCH----HHHHH-HHHHHhCCCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHH
Confidence 3211 11111 11110 000000000 0000000 001123468899999999999999999998
Q ss_pred HH
Q 005102 703 SD 704 (714)
Q Consensus 703 l~ 704 (714)
+.
T Consensus 289 l~ 290 (295)
T cd07837 289 LT 290 (295)
T ss_pred hc
Confidence 74
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-34 Score=289.33 Aligned_cols=242 Identities=25% Similarity=0.450 Sum_probs=195.0
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeCCCCc--hhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCCC
Q 005102 409 FVLGKSGIGIVYKVVLE-DGHTLAVRRLGEGGS--QRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGS 485 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gs 485 (714)
+.||+|++|.||++... +++.||+|.+..... ...+.+.+|++++++++|||++++++++...+..++||||+++++
T Consensus 6 ~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~ 85 (254)
T cd06627 6 DLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEYAENGS 85 (254)
T ss_pred eEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEecCCCCc
Confidence 47999999999999876 478999999987644 445689999999999999999999999999999999999999999
Q ss_pred HhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCCC
Q 005102 486 LATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSP 565 (714)
Q Consensus 486 L~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 565 (714)
|.+++... ..+++..+..++.|++.||.|||+ .+|+||||||+||+++.++.+||+|||++........
T Consensus 86 L~~~~~~~------~~l~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-- 154 (254)
T cd06627 86 LRQIIKKF------GPFPESLVAVYVYQVLQGLAYLHE---QGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK-- 154 (254)
T ss_pred HHHHHHhc------cCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCHHHEEECCCCCEEEeccccceecCCCcc--
Confidence 99998755 458999999999999999999999 8999999999999999999999999999986542211
Q ss_pred CccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCccccCCCCcch
Q 005102 566 TLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGSSEMD 645 (714)
Q Consensus 566 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~~~~~~~~~~ 645 (714)
......++..|+|||...+..++.++||||+|+++|+|++|+.||.... .
T Consensus 155 --------------------------~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~----~ 204 (254)
T cd06627 155 --------------------------DDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLN----P 204 (254)
T ss_pred --------------------------cccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCcc----H
Confidence 0112235777999999988888999999999999999999999985332 1
Q ss_pred hHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 005102 646 LVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISD 704 (714)
Q Consensus 646 l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 704 (714)
....... .... .+..... ....+.+++.+||..+|++|||+.+++.
T Consensus 205 ~~~~~~~-~~~~-------~~~~~~~-----~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 205 MAALFRI-VQDD-------HPPLPEG-----ISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred HHHHHHH-hccC-------CCCCCCC-----CCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 1111111 1110 0111111 1236789999999999999999999874
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-34 Score=296.79 Aligned_cols=246 Identities=23% Similarity=0.265 Sum_probs=189.0
Q ss_pred ccccccCceEEEEEEE----CCCcEEEEEEeCCCC----chhHHHHHHHHHHHhcc-CCCCccceEEEEEeCCceeEEEe
Q 005102 409 FVLGKSGIGIVYKVVL----EDGHTLAVRRLGEGG----SQRFKEFQTEVEAIGKI-RHSNIVTLRAYYWSVDEKLLIYD 479 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~----~~g~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~e 479 (714)
..||+|+||.||+++. .+|..||+|++.... ....+.+.+|++++.++ +|+||+++++++......++|||
T Consensus 6 ~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e 85 (290)
T cd05613 6 KVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLHLILD 85 (290)
T ss_pred eeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeEEEEEe
Confidence 4799999999999986 368999999987532 12335688999999999 59999999999998888999999
Q ss_pred ccCCCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhh
Q 005102 480 YIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLAN 559 (714)
Q Consensus 480 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~ 559 (714)
|+++++|.+++... ..+++..+..++.|++.||+|||+ .+++||||||+||++++++.+||+|||+++...
T Consensus 86 ~~~~~~L~~~l~~~------~~l~~~~~~~~~~qi~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~ 156 (290)
T cd05613 86 YINGGELFTHLSQR------ERFKEQEVQIYSGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFH 156 (290)
T ss_pred cCCCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeEECCCCCEEEeeCccceecc
Confidence 99999999998754 357889999999999999999999 899999999999999999999999999987543
Q ss_pred ccCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCC--CCCchhhhHHHHHHHHHHHhCCCccc
Q 005102 560 IAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVV--KPSQKWDIYSYGVILLEMITGRTAVV 637 (714)
Q Consensus 560 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~s~~~DVwS~Gvvl~elltG~~p~~ 637 (714)
.... .......|+..|+|||.+.+. .++.++||||||+++|||++|+.||.
T Consensus 157 ~~~~---------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~ 209 (290)
T cd05613 157 EDEV---------------------------ERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFT 209 (290)
T ss_pred cccc---------------------------cccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCC
Confidence 2110 011123467789999998753 46889999999999999999999984
Q ss_pred cCCCCcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCC-----CHHHHHH
Q 005102 638 QVGSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRP-----TMRHISD 704 (714)
Q Consensus 638 ~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----t~~evl~ 704 (714)
.... ......+.........+ .... ....+.+++.+||+.||++|| ++++++.
T Consensus 210 ~~~~-~~~~~~~~~~~~~~~~~--------~~~~-----~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~ 267 (290)
T cd05613 210 VDGE-KNSQAEISRRILKSEPP--------YPQE-----MSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK 267 (290)
T ss_pred cCCc-cccHHHHHHHhhccCCC--------CCcc-----CCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence 3211 11122222222111111 1111 123578999999999999997 5666554
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-34 Score=300.25 Aligned_cols=240 Identities=22% Similarity=0.374 Sum_probs=187.5
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeCCC---CchhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCC
Q 005102 409 FVLGKSGIGIVYKVVLE-DGHTLAVRRLGEG---GSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNG 484 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~g 484 (714)
+.||+|+||.||+|+.. ++..+|+|.+... .....+++.+|++++++++|+|++++++++...+..++||||+. |
T Consensus 21 ~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~ 99 (308)
T cd06634 21 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL-G 99 (308)
T ss_pred HheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEEccC-C
Confidence 36999999999999975 4789999998643 22334578899999999999999999999999999999999996 6
Q ss_pred CHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCC
Q 005102 485 SLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGS 564 (714)
Q Consensus 485 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 564 (714)
++.+.+.... ..+++.++..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||++......
T Consensus 100 ~l~~~~~~~~-----~~l~~~~~~~~~~~l~~~l~~LH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~--- 168 (308)
T cd06634 100 SASDLLEVHK-----KPLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA--- 168 (308)
T ss_pred CHHHHHHHcC-----CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHhEEECCCCcEEECCcccceeecCc---
Confidence 8888775432 358899999999999999999999 89999999999999999999999999988653211
Q ss_pred CCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccC---CCCCCchhhhHHHHHHHHHHHhCCCccccCCC
Q 005102 565 PTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLK---VVKPSQKWDIYSYGVILLEMITGRTAVVQVGS 641 (714)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~~~DVwS~Gvvl~elltG~~p~~~~~~ 641 (714)
....++..|+|||.+. ...++.++|||||||++|||++|+.||.....
T Consensus 169 -----------------------------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~ 219 (308)
T cd06634 169 -----------------------------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA 219 (308)
T ss_pred -----------------------------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccH
Confidence 1123567899999974 35678899999999999999999999843211
Q ss_pred CcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 005102 642 SEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDA 705 (714)
Q Consensus 642 ~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 705 (714)
............ +... .......+.+++.+||+.+|++||++++++..
T Consensus 220 -----~~~~~~~~~~~~-------~~~~----~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~ 267 (308)
T cd06634 220 -----MSALYHIAQNES-------PALQ----SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 267 (308)
T ss_pred -----HHHHHHHhhcCC-------CCcC----cccccHHHHHHHHHHhhCCcccCCCHHHHhhC
Confidence 111111111110 1111 11123457899999999999999999998764
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=306.01 Aligned_cols=259 Identities=21% Similarity=0.316 Sum_probs=187.9
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeCCCC-chhHHHHHHHHHHHhccCCCCccceEEEEEeC-----CceeEEEecc
Q 005102 409 FVLGKSGIGIVYKVVLE-DGHTLAVRRLGEGG-SQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSV-----DEKLLIYDYI 481 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~-----~~~~lV~e~~ 481 (714)
+.||+|+||.||+|... +|+.||||++.... ......+.+|+.++++++||||+++++++... ...++||||+
T Consensus 11 ~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~ 90 (336)
T cd07849 11 SYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVYIVQELM 90 (336)
T ss_pred EEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceEEEEehhc
Confidence 47999999999999865 58999999987532 23345688999999999999999999987654 3579999999
Q ss_pred CCCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhcc
Q 005102 482 PNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIA 561 (714)
Q Consensus 482 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 561 (714)
.+ +|.+++.. ..+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++.....
T Consensus 91 ~~-~l~~~~~~-------~~l~~~~~~~i~~ql~~aL~~LH~---~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~ 159 (336)
T cd07849 91 ET-DLYKLIKT-------QHLSNDHIQYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPE 159 (336)
T ss_pred cc-CHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEECCCCCEEECcccceeecccc
Confidence 64 88887753 348999999999999999999999 89999999999999999999999999998764321
Q ss_pred CCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCC-CCCCchhhhHHHHHHHHHHHhCCCccccCC
Q 005102 562 GGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKV-VKPSQKWDIYSYGVILLEMITGRTAVVQVG 640 (714)
Q Consensus 562 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DVwS~Gvvl~elltG~~p~~~~~ 640 (714)
... ........|+..|+|||.+.+ ..++.++|||||||++|||++|+.||....
T Consensus 160 ~~~-------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~ 214 (336)
T cd07849 160 HDH-------------------------TGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKD 214 (336)
T ss_pred ccc-------------------------cCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 100 001122356888999998754 468999999999999999999999994321
Q ss_pred CCcchhHHHHHHHHhhcC--CcccccCCC-------C--CCCCC----cHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 005102 641 SSEMDLVNWMQLCIEEKK--PLADVLDPY-------L--APDAD----KEEEIIAVLKIAMACVHSSPEKRPTMRHISDA 705 (714)
Q Consensus 641 ~~~~~l~~~~~~~~~~~~--~~~~~~d~~-------~--~~~~~----~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 705 (714)
.......+........ ....+.+.. . ..... ......++.+++.+||+.||++|||+.|+++.
T Consensus 215 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h 292 (336)
T cd07849 215 --YLHQLNLILGVLGTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH 292 (336)
T ss_pred --HHHHHHHHHHHcCCCCHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 1111111111110000 000000000 0 00000 00123468899999999999999999999875
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=297.05 Aligned_cols=239 Identities=21% Similarity=0.380 Sum_probs=187.1
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeCCCC---chhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCC
Q 005102 409 FVLGKSGIGIVYKVVLE-DGHTLAVRRLGEGG---SQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNG 484 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~g 484 (714)
+.||+|+||+||+|+.. +++.||+|++.... ....+.+.+|++++++++|||++++++++.+.+..++||||+. |
T Consensus 27 ~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~ 105 (313)
T cd06633 27 HEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCL-G 105 (313)
T ss_pred eeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEecCC-C
Confidence 46999999999999975 58899999987532 2334568899999999999999999999999999999999995 5
Q ss_pred CHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCC
Q 005102 485 SLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGS 564 (714)
Q Consensus 485 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 564 (714)
++.+++.... ..+++.++..++.|++.||+|||+ .+++|+||||+||++++++.+||+|||++.....
T Consensus 106 ~l~~~l~~~~-----~~l~~~~~~~~~~qi~~al~~LH~---~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~---- 173 (313)
T cd06633 106 SASDLLEVHK-----KPLQEVEIAAITHGALQGLAYLHS---HNMIHRDIKAGNILLTEPGQVKLADFGSASKSSP---- 173 (313)
T ss_pred CHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCChhhEEECCCCCEEEeecCCCcccCC----
Confidence 8888776443 458999999999999999999999 8999999999999999999999999998753210
Q ss_pred CCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccC---CCCCCchhhhHHHHHHHHHHHhCCCccccCCC
Q 005102 565 PTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLK---VVKPSQKWDIYSYGVILLEMITGRTAVVQVGS 641 (714)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~~~DVwS~Gvvl~elltG~~p~~~~~~ 641 (714)
.....|+..|+|||++. ...++.++|||||||++|||++|+.||.....
T Consensus 174 ----------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~ 225 (313)
T cd06633 174 ----------------------------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA 225 (313)
T ss_pred ----------------------------CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh
Confidence 11234577899999984 45688999999999999999999999843211
Q ss_pred CcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 005102 642 SEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISD 704 (714)
Q Consensus 642 ~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 704 (714)
...+........ .....+ .....+.+++.+||+.+|.+||++.+++.
T Consensus 226 -----~~~~~~~~~~~~--~~~~~~---------~~~~~l~~li~~~l~~~P~~Rp~~~~~l~ 272 (313)
T cd06633 226 -----MSALYHIAQNDS--PTLQSN---------EWTDSFRGFVDYCLQKIPQERPASAELLR 272 (313)
T ss_pred -----HHHHHHHHhcCC--CCCCcc---------ccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 111111111111 111110 11235788999999999999999999885
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=336.29 Aligned_cols=248 Identities=26% Similarity=0.331 Sum_probs=195.1
Q ss_pred cccccccCceEEEEEEEC-CCcEEEEEEeCCC--CchhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCC
Q 005102 408 AFVLGKSGIGIVYKVVLE-DGHTLAVRRLGEG--GSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNG 484 (714)
Q Consensus 408 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~g 484 (714)
+.+||.|.||.||-|... +|...|||-++.. .....+...+|+.++..++|||+|+++|+-...+..+|.||||++|
T Consensus 1240 g~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEyC~~G 1319 (1509)
T KOG4645|consen 1240 GNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEYCEGG 1319 (1509)
T ss_pred ccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHHhccC
Confidence 468999999999999854 5899999987654 3333466789999999999999999999999999999999999999
Q ss_pred CHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCC
Q 005102 485 SLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGS 564 (714)
Q Consensus 485 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 564 (714)
+|.+.+... +..++.....+..|++.|++|||+ .|||||||||+||+++.+|.+|++|||.|+.+.....
T Consensus 1320 sLa~ll~~g------ri~dE~vt~vyt~qll~gla~LH~---~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~- 1389 (1509)
T KOG4645|consen 1320 SLASLLEHG------RIEDEMVTRVYTKQLLEGLAYLHE---HGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQ- 1389 (1509)
T ss_pred cHHHHHHhc------chhhhhHHHHHHHHHHHHHHHHHh---cCceecCCCccceeeecCCcEEeecccceeEecCchh-
Confidence 999998755 336677778899999999999999 8999999999999999999999999999987643210
Q ss_pred CCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCC---CCchhhhHHHHHHHHHHHhCCCccccCCC
Q 005102 565 PTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVK---PSQKWDIYSYGVILLEMITGRTAVVQVGS 641 (714)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~s~~~DVwS~Gvvl~elltG~~p~~~~~~ 641 (714)
++........||+.|||||++.+.. -.-++||||+|||+.||+||+.||.+...
T Consensus 1390 -----------------------~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dn 1446 (1509)
T KOG4645|consen 1390 -----------------------TMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDN 1446 (1509)
T ss_pred -----------------------cCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccc
Confidence 0112223556899999999997644 45689999999999999999999965433
Q ss_pred CcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 005102 642 SEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISD 704 (714)
Q Consensus 642 ~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 704 (714)
+-. .+. .+..+. .|.++.. ...+-.+++.+|++.||++|.++.|+++
T Consensus 1447 e~a----IMy-~V~~gh------~Pq~P~~-----ls~~g~dFle~Cl~~dP~~Rw~~~qlle 1493 (1509)
T KOG4645|consen 1447 EWA----IMY-HVAAGH------KPQIPER-----LSSEGRDFLEHCLEQDPKMRWTASQLLE 1493 (1509)
T ss_pred hhH----HHh-HHhccC------CCCCchh-----hhHhHHHHHHHHHhcCchhhhHHHHHHH
Confidence 211 111 111111 1222211 3335678999999999999999987765
|
|
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=321.17 Aligned_cols=263 Identities=19% Similarity=0.184 Sum_probs=179.5
Q ss_pred ccccccCceEEEEEEECC--CcEEEEE------------------EeCCCCchhHHHHHHHHHHHhccCCCCccceEEEE
Q 005102 409 FVLGKSGIGIVYKVVLED--GHTLAVR------------------RLGEGGSQRFKEFQTEVEAIGKIRHSNIVTLRAYY 468 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~~--g~~vavK------------------~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~ 468 (714)
..||+|+||+||++..+. +...++| ++.. .......+.+|+++|++++||||+++++++
T Consensus 154 ~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~ 232 (501)
T PHA03210 154 DDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKA-GSRAAIQLENEILALGRLNHENILKIEEIL 232 (501)
T ss_pred eEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhc-chHHHHHHHHHHHHHHhCCCCCcCcEeEEE
Confidence 579999999999987643 2222222 1111 112335688999999999999999999999
Q ss_pred EeCCceeEEEeccCCCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeE
Q 005102 469 WSVDEKLLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPH 548 (714)
Q Consensus 469 ~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~k 548 (714)
...+..|+|+|++. ++|.+++....... .......++.+|+.|++.||+|||+ ++||||||||+|||++.++.+|
T Consensus 233 ~~~~~~~lv~e~~~-~~l~~~l~~~~~~~-~~~~~~~~~~~i~~ql~~aL~yLH~---~gIiHrDLKP~NILl~~~~~vk 307 (501)
T PHA03210 233 RSEANTYMITQKYD-FDLYSFMYDEAFDW-KDRPLLKQTRAIMKQLLCAVEYIHD---KKLIHRDIKLENIFLNCDGKIV 307 (501)
T ss_pred EECCeeEEEEeccc-cCHHHHHhhccccc-cccccHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEE
Confidence 99999999999985 57887775432110 1223456778899999999999999 8999999999999999999999
Q ss_pred EcccchhhhhhccCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHH
Q 005102 549 VSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLE 628 (714)
Q Consensus 549 l~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~e 628 (714)
|+|||+++.+.... ........||..|+|||++.+..++.++|||||||++||
T Consensus 308 L~DFGla~~~~~~~---------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~e 360 (501)
T PHA03210 308 LGDFGTAMPFEKER---------------------------EAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLD 360 (501)
T ss_pred EEeCCCceecCccc---------------------------ccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHH
Confidence 99999998653211 011123457899999999999999999999999999999
Q ss_pred HHhCCCccccCCC-C-cchhHHHHHHHHhhcCCc-------ccccCCC-CCCCC-CcH------HHHHHHHHHHhHccCC
Q 005102 629 MITGRTAVVQVGS-S-EMDLVNWMQLCIEEKKPL-------ADVLDPY-LAPDA-DKE------EEIIAVLKIAMACVHS 691 (714)
Q Consensus 629 lltG~~p~~~~~~-~-~~~l~~~~~~~~~~~~~~-------~~~~d~~-~~~~~-~~~------~~~~~l~~li~~Cl~~ 691 (714)
|++|..++..... . ...+.+.+.........+ .+.++.. ..... ... .....+.+++.+||+.
T Consensus 361 ll~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~ 440 (501)
T PHA03210 361 MLSHDFCPIGDGGGKPGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTF 440 (501)
T ss_pred HHHCCCCCccCCCCCHHHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhcc
Confidence 9998865432211 1 111211111100000000 0000000 00000 000 0112466789999999
Q ss_pred CCCCCCCHHHHHH
Q 005102 692 SPEKRPTMRHISD 704 (714)
Q Consensus 692 dP~~RPt~~evl~ 704 (714)
||.+|||+.|+++
T Consensus 441 DP~~Rpsa~elL~ 453 (501)
T PHA03210 441 DWHLRPGAAELLA 453 (501)
T ss_pred CcccCcCHHHHhh
Confidence 9999999999986
|
|
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=292.98 Aligned_cols=258 Identities=23% Similarity=0.294 Sum_probs=189.0
Q ss_pred ccccccCceEEEEEEECC-CcEEEEEEeCCCCc--hhHHHHHHHHHHHhcc---CCCCccceEEEEEeCCc-----eeEE
Q 005102 409 FVLGKSGIGIVYKVVLED-GHTLAVRRLGEGGS--QRFKEFQTEVEAIGKI---RHSNIVTLRAYYWSVDE-----KLLI 477 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~~-g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~H~niv~l~~~~~~~~~-----~~lV 477 (714)
+.||+|+||.||+|++++ ++.||+|++..... .....+.+|+.+++++ +||||+++++++...+. .+++
T Consensus 5 ~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~~l~ 84 (287)
T cd07838 5 AEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELKLTLV 84 (287)
T ss_pred EEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCceeEEE
Confidence 479999999999999875 89999999975322 2234566788877666 59999999999998776 8999
Q ss_pred EeccCCCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhh
Q 005102 478 YDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARL 557 (714)
Q Consensus 478 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 557 (714)
|||+. ++|.+++..... ..+++..++.++.|++.||+|||+ .+++|+||||+||++++++.+||+|||+++.
T Consensus 85 ~e~~~-~~l~~~l~~~~~----~~l~~~~~~~~~~~i~~al~~LH~---~~i~h~~l~~~nili~~~~~~~l~dfg~~~~ 156 (287)
T cd07838 85 FEHVD-QDLATYLSKCPK----PGLPPETIKDLMRQLLRGVDFLHS---HRIVHRDLKPQNILVTSDGQVKIADFGLARI 156 (287)
T ss_pred ehhcc-cCHHHHHHHccC----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCChhhEEEccCCCEEEeccCccee
Confidence 99996 489998875432 358999999999999999999999 8999999999999999999999999999876
Q ss_pred hhccCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCccc
Q 005102 558 ANIAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVV 637 (714)
Q Consensus 558 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~~ 637 (714)
..... ......++..|+|||.+.+..++.++|||||||++|||++|+.||.
T Consensus 157 ~~~~~-----------------------------~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~ 207 (287)
T cd07838 157 YSFEM-----------------------------ALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFR 207 (287)
T ss_pred ccCCc-----------------------------ccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCccc
Confidence 53211 0111234677999999998899999999999999999999998884
Q ss_pred cCCCCcchhHHHHHHHHh---hcCCccc-----ccCCCCCCCC--CcHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 005102 638 QVGSSEMDLVNWMQLCIE---EKKPLAD-----VLDPYLAPDA--DKEEEIIAVLKIAMACVHSSPEKRPTMRHISD 704 (714)
Q Consensus 638 ~~~~~~~~l~~~~~~~~~---~~~~~~~-----~~d~~~~~~~--~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 704 (714)
.... ...+..+...... ....... .......... ........+.+++.+||+.||++||+++|++.
T Consensus 208 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 208 GTSE-ADQLDKIFDVIGLPSEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred CCCh-HHHHHHHHHHcCCCChHhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 3221 1111111111000 0000000 0000000000 01123356789999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=288.49 Aligned_cols=246 Identities=24% Similarity=0.385 Sum_probs=196.3
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeCCCCc--hhHHHHHHHHHHHhccCCCCccceEEEEEeC--CceeEEEeccCC
Q 005102 409 FVLGKSGIGIVYKVVLE-DGHTLAVRRLGEGGS--QRFKEFQTEVEAIGKIRHSNIVTLRAYYWSV--DEKLLIYDYIPN 483 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~~lV~e~~~~ 483 (714)
+.||+|++|.||+|... +++.|++|++..... ...+.+.+|++++++++||||+++++.+... +..++||||+++
T Consensus 6 ~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~ 85 (260)
T cd06606 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLEYVSG 85 (260)
T ss_pred eEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEEEecCC
Confidence 47999999999999987 589999999876543 4457889999999999999999999999988 889999999999
Q ss_pred CCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCC
Q 005102 484 GSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGG 563 (714)
Q Consensus 484 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 563 (714)
++|.+++... ..+++..+..++.|++.||+|||+ .+++|+||+|+||++++++.+||+|||.+........
T Consensus 86 ~~L~~~~~~~------~~~~~~~~~~~~~~l~~~l~~lh~---~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 156 (260)
T cd06606 86 GSLSSLLKKF------GKLPEPVIRKYTRQILEGLAYLHS---NGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIET 156 (260)
T ss_pred CcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEcCCCCEEEcccccEEecccccc
Confidence 9999999765 358999999999999999999999 8999999999999999999999999999876543211
Q ss_pred CCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCccccCCCCc
Q 005102 564 SPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGSSE 643 (714)
Q Consensus 564 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~~~~~~~~ 643 (714)
. .......++..|+|||.+.+..++.++||||||+++|+|++|+.||.....
T Consensus 157 ~--------------------------~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-- 208 (260)
T cd06606 157 G--------------------------EGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGN-- 208 (260)
T ss_pred c--------------------------ccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc--
Confidence 0 011223456779999999888899999999999999999999999954331
Q ss_pred chhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 005102 644 MDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISD 704 (714)
Q Consensus 644 ~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 704 (714)
....+..... .... +.+.. .....+.+++.+|++.||++||++.|++.
T Consensus 209 --~~~~~~~~~~-~~~~-----~~~~~-----~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 209 --PMAALYKIGS-SGEP-----PEIPE-----HLSEEAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred --hHHHHHhccc-cCCC-----cCCCc-----ccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence 1111111100 0000 11111 11346889999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=321.31 Aligned_cols=266 Identities=23% Similarity=0.307 Sum_probs=185.5
Q ss_pred cCHHHHHHhccccccccCceEEEEEEEC-CCcEEEEEEeCCCC-chhHHHHHHHHHHHhccCCCCccceEEEEEe-----
Q 005102 398 FDLDELLKASAFVLGKSGIGIVYKVVLE-DGHTLAVRRLGEGG-SQRFKEFQTEVEAIGKIRHSNIVTLRAYYWS----- 470 (714)
Q Consensus 398 ~~~~~l~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~----- 470 (714)
-+++|+. +||+||||.||+++.+ ||+.+|||++.... ........+|+..+++++|||||+++..+.+
T Consensus 479 ~DFEEL~-----lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~ 553 (1351)
T KOG1035|consen 479 NDFEELE-----LLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAEL 553 (1351)
T ss_pred hhhHHHH-----HhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcc
Confidence 3455554 6999999999999975 79999999998753 3334568899999999999999988764300
Q ss_pred --------------------------------------------------C-----------------------------
Q 005102 471 --------------------------------------------------V----------------------------- 471 (714)
Q Consensus 471 --------------------------------------------------~----------------------------- 471 (714)
.
T Consensus 554 ~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~t 633 (1351)
T KOG1035|consen 554 TVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNT 633 (1351)
T ss_pred ccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccc
Confidence 0
Q ss_pred -----------------------------------CceeEEEeccCCCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHH
Q 005102 472 -----------------------------------DEKLLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAK 516 (714)
Q Consensus 472 -----------------------------------~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~ 516 (714)
-..||=||||+...+.++++.+... -.-....+++++|+.
T Consensus 634 S~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~-----~~~d~~wrLFreIlE 708 (1351)
T KOG1035|consen 634 SDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFN-----SQRDEAWRLFREILE 708 (1351)
T ss_pred cccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccc-----hhhHHHHHHHHHHHH
Confidence 0135678888887777777654211 024567899999999
Q ss_pred HHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCCCCccCCCCCCCCchhhhcccccceeecccCCC
Q 005102 517 GLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSS 596 (714)
Q Consensus 517 gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 596 (714)
||+|+|+ .|||||||||.||++|++..+||+|||+|+............. .+ .......-....+..
T Consensus 709 GLaYIH~---~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~--~~--------~~~~~g~~~~~~Ts~ 775 (1351)
T KOG1035|consen 709 GLAYIHD---QGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDL--SF--------STNRAGSNDGDLTSQ 775 (1351)
T ss_pred HHHHHHh---CceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhcc--Cc--------cccccCCCCcccccc
Confidence 9999999 8999999999999999999999999999987431100000000 00 000001112245677
Q ss_pred CCCccccCCcccCCC---CCCchhhhHHHHHHHHHHHhCCCccccCCCCcchhHHHHHHHHhhcCCcccccCCCCCCC--
Q 005102 597 NLGSYYQAPESLKVV---KPSQKWDIYSYGVILLEMITGRTAVVQVGSSEMDLVNWMQLCIEEKKPLADVLDPYLAPD-- 671 (714)
Q Consensus 597 ~gt~~y~aPE~~~~~---~~s~~~DVwS~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~-- 671 (714)
+||..|+|||++.+. +|+.|+|+||+|||++||+. ||. ..++-+..+.... ++.++..
T Consensus 776 VGTalYvAPEll~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~----TsMERa~iL~~LR----------~g~iP~~~~ 838 (1351)
T KOG1035|consen 776 VGTALYVAPELLSDTSSNKYNSKIDMYSLGIVLFEMLY---PFG----TSMERASILTNLR----------KGSIPEPAD 838 (1351)
T ss_pred cceeeeecHHHhcccccccccchhhhHHHHHHHHHHhc---cCC----chHHHHHHHHhcc----------cCCCCCCcc
Confidence 899999999999764 49999999999999999986 562 2233232222211 1112111
Q ss_pred CCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 005102 672 ADKEEEIIAVLKIAMACVHSSPEKRPTMRHISD 704 (714)
Q Consensus 672 ~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 704 (714)
+. .+....-.++|.++++.||.+||||.|++.
T Consensus 839 f~-~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 839 FF-DPEHPEEASLIRWLLSHDPSKRPTATELLN 870 (1351)
T ss_pred cc-cccchHHHHHHHHHhcCCCccCCCHHHHhh
Confidence 11 122334468999999999999999999975
|
|
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-34 Score=294.41 Aligned_cols=257 Identities=21% Similarity=0.305 Sum_probs=192.6
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeCCCCch--hHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCCC
Q 005102 409 FVLGKSGIGIVYKVVLE-DGHTLAVRRLGEGGSQ--RFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGS 485 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gs 485 (714)
..||+|++|.||+|... +++.+|+|++...... ....+.+|++++++++|+||+++++++...+..++||||+++ +
T Consensus 5 ~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~-~ 83 (283)
T cd05118 5 GKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFMDT-D 83 (283)
T ss_pred eeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEeccCC-C
Confidence 36999999999999975 5889999998765332 346788999999999999999999999999999999999975 8
Q ss_pred HhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCCC
Q 005102 486 LATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSP 565 (714)
Q Consensus 486 L~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 565 (714)
|.+++.... ..+++..+..++.|++.||+|||+ .+|+|+||||+||++++++.+||+|||.+.......
T Consensus 84 l~~~l~~~~-----~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~--- 152 (283)
T cd05118 84 LYKLIKDRQ-----RGLPESLIKSYLYQLLQGLAFCHS---HGILHRDLKPENLLINTEGVLKLADFGLARSFGSPV--- 152 (283)
T ss_pred HHHHHHhhc-----ccCCHHHHHHHHHHHHHHHHHHHH---CCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc---
Confidence 888887643 358999999999999999999999 899999999999999999999999999987653211
Q ss_pred CccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCC-CCCchhhhHHHHHHHHHHHhCCCccccCCCCcc
Q 005102 566 TLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVV-KPSQKWDIYSYGVILLEMITGRTAVVQVGSSEM 644 (714)
Q Consensus 566 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DVwS~Gvvl~elltG~~p~~~~~~~~~ 644 (714)
.......++..|+|||.+.+. .++.++||||||+++|+|+||+.||..... .
T Consensus 153 -------------------------~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~--~ 205 (283)
T cd05118 153 -------------------------RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSE--I 205 (283)
T ss_pred -------------------------ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCH--H
Confidence 001122356779999999776 689999999999999999999999843321 1
Q ss_pred hhHHHHHHHHhhcC--CcccccC---------CC--CCC-CCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 005102 645 DLVNWMQLCIEEKK--PLADVLD---------PY--LAP-DADKEEEIIAVLKIAMACVHSSPEKRPTMRHISD 704 (714)
Q Consensus 645 ~l~~~~~~~~~~~~--~~~~~~d---------~~--~~~-~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 704 (714)
+............. ......+ +. ... .........++.+++.+||+.||.+||++++++.
T Consensus 206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 206 DQLFKIFRTLGTPDPEVWPKFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred HHHHHHHHHcCCCchHhcccchhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 11111110000000 0000000 00 000 0001123457889999999999999999999875
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=288.44 Aligned_cols=246 Identities=22% Similarity=0.322 Sum_probs=188.6
Q ss_pred cccccccCceEEEEEEEC-CCcEEEEEEeCCC-----CchhHHHHHHHHHHHhccCCCCccceEEEEEeC--CceeEEEe
Q 005102 408 AFVLGKSGIGIVYKVVLE-DGHTLAVRRLGEG-----GSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSV--DEKLLIYD 479 (714)
Q Consensus 408 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~~lV~e 479 (714)
.+.||+|+||.||+|... +++.||+|.+... .......+.+|++++++++|+||+++++++.+. +..++|||
T Consensus 7 ~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~v~e 86 (264)
T cd06653 7 GKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLSIFVE 86 (264)
T ss_pred eeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEEEEEEE
Confidence 357999999999999975 4899999987532 123346788999999999999999999998764 35789999
Q ss_pred ccCCCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhh
Q 005102 480 YIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLAN 559 (714)
Q Consensus 480 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~ 559 (714)
|+++++|.+++... ..+++..+++++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||+++...
T Consensus 87 ~~~~~~L~~~~~~~------~~l~~~~~~~~~~~i~~al~~LH~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~ 157 (264)
T cd06653 87 YMPGGSIKDQLKAY------GALTENVTRRYTRQILQGVSYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRIQ 157 (264)
T ss_pred eCCCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEECccccccccc
Confidence 99999999998754 347889999999999999999999 899999999999999999999999999987543
Q ss_pred ccCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCccccC
Q 005102 560 IAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQV 639 (714)
Q Consensus 560 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~~~~ 639 (714)
..... ........++..|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 158 ~~~~~-------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 212 (264)
T cd06653 158 TICMS-------------------------GTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEY 212 (264)
T ss_pred ccccc-------------------------CccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCcc
Confidence 11000 00111234678899999999888999999999999999999999999432
Q ss_pred CCCcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 005102 640 GSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISD 704 (714)
Q Consensus 640 ~~~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 704 (714)
.. ... +....... ..+.++. .....+.+++.+||. +|.+|||+.+++.
T Consensus 213 ~~----~~~-~~~~~~~~------~~~~~p~-----~~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 213 EA----MAA-IFKIATQP------TKPMLPD-----GVSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred CH----HHH-HHHHHcCC------CCCCCCc-----ccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 11 111 11111110 0111111 122368899999999 5799999998764
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-35 Score=282.05 Aligned_cols=233 Identities=24% Similarity=0.293 Sum_probs=191.0
Q ss_pred cccccCceEEEEEEEC-CCcEEEEEEeCCCCc---hhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCCC
Q 005102 410 VLGKSGIGIVYKVVLE-DGHTLAVRRLGEGGS---QRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGS 485 (714)
Q Consensus 410 ~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gs 485 (714)
+||+|.||+|-.++-+ +|+.+|+|++++.-. .....-..|-++|+..+||.+..+.-.|+..++.|+||||+.+|.
T Consensus 175 vLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVMeyanGGe 254 (516)
T KOG0690|consen 175 VLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVMEYANGGE 254 (516)
T ss_pred HhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEEEEccCce
Confidence 7999999999999865 599999999988632 333455679999999999999999888999999999999999999
Q ss_pred HhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCCC
Q 005102 486 LATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSP 565 (714)
Q Consensus 486 L~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 565 (714)
|+-+|... +.+++...+-+...|..||.|||+ ++||.||||.+|.|+|.+|++||+|||+++.--
T Consensus 255 Lf~HLsre------r~FsE~RtRFYGaEIvsAL~YLHs---~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I------ 319 (516)
T KOG0690|consen 255 LFFHLSRE------RVFSEDRTRFYGAEIVSALGYLHS---RNIVYRDLKLENLLLDKDGHIKITDFGLCKEEI------ 319 (516)
T ss_pred Eeeehhhh------hcccchhhhhhhHHHHHHhhhhhh---CCeeeeechhhhheeccCCceEeeecccchhcc------
Confidence 99998765 458889999999999999999999 999999999999999999999999999998421
Q ss_pred CccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCccccCCCCcch
Q 005102 566 TLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGSSEMD 645 (714)
Q Consensus 566 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~~~~~~~~~~ 645 (714)
....+..+.+||+.|.|||++....|+.++|.|.+|||+|||+.|+.||+.... ..
T Consensus 320 ----------------------~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh--~k 375 (516)
T KOG0690|consen 320 ----------------------KYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDH--EK 375 (516)
T ss_pred ----------------------cccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccch--hH
Confidence 113455678899999999999999999999999999999999999999964322 22
Q ss_pred hHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCC
Q 005102 646 LVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRP 697 (714)
Q Consensus 646 l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RP 697 (714)
+. ..+..+...++.-+. .+...++...|.+||.+|.
T Consensus 376 LF---eLIl~ed~kFPr~ls-------------~eAktLLsGLL~kdP~kRL 411 (516)
T KOG0690|consen 376 LF---ELILMEDLKFPRTLS-------------PEAKTLLSGLLKKDPKKRL 411 (516)
T ss_pred HH---HHHHhhhccCCccCC-------------HHHHHHHHHHhhcChHhhc
Confidence 22 222222222221111 1455778899999999995
|
|
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-34 Score=303.76 Aligned_cols=258 Identities=20% Similarity=0.322 Sum_probs=189.4
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeCCCC--chhHHHHHHHHHHHhccCCCCccceEEEEEe----CCceeEEEecc
Q 005102 409 FVLGKSGIGIVYKVVLE-DGHTLAVRRLGEGG--SQRFKEFQTEVEAIGKIRHSNIVTLRAYYWS----VDEKLLIYDYI 481 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~----~~~~~lV~e~~ 481 (714)
+.||+|+||.||+|... +|+.||+|++.... ....+.+.+|+.++++++||||+++++++.. ....++||||+
T Consensus 11 ~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~ 90 (334)
T cd07855 11 ENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVYVVMDLM 90 (334)
T ss_pred eeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEEEEEehh
Confidence 47999999999999975 58999999987642 2334677889999999999999999998763 34679999999
Q ss_pred CCCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhcc
Q 005102 482 PNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIA 561 (714)
Q Consensus 482 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 561 (714)
. |+|.+++... ..+++..+..++.|++.||+|||+ ++|+||||||+||++++++.+||+|||+++.....
T Consensus 91 ~-~~l~~~~~~~------~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 160 (334)
T cd07855 91 E-SDLHHIIHSD------QPLTEEHIRYFLYQLLRGLKYIHS---ANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSS 160 (334)
T ss_pred h-hhHHHHhccC------CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEecccccceeeccc
Confidence 5 6999988654 458999999999999999999999 89999999999999999999999999998765322
Q ss_pred CCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCC-CCCCchhhhHHHHHHHHHHHhCCCccccCC
Q 005102 562 GGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKV-VKPSQKWDIYSYGVILLEMITGRTAVVQVG 640 (714)
Q Consensus 562 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DVwS~Gvvl~elltG~~p~~~~~ 640 (714)
... .........++..|+|||.+.+ ..++.++|||||||++|||++|+.||....
T Consensus 161 ~~~------------------------~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~ 216 (334)
T cd07855 161 PTE------------------------HKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKN 216 (334)
T ss_pred CcC------------------------CCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCC
Confidence 110 0111122346788999999865 458999999999999999999999994332
Q ss_pred CCcchhHHHHHHHHhhcCCcccc------------cCC-CCCCCCC----cHHHHHHHHHHHhHccCCCCCCCCCHHHHH
Q 005102 641 SSEMDLVNWMQLCIEEKKPLADV------------LDP-YLAPDAD----KEEEIIAVLKIAMACVHSSPEKRPTMRHIS 703 (714)
Q Consensus 641 ~~~~~l~~~~~~~~~~~~~~~~~------------~d~-~~~~~~~----~~~~~~~l~~li~~Cl~~dP~~RPt~~evl 703 (714)
.. .....+..... .+..+. .+. ....... .......+.+++.+||+.+|++|||+++++
T Consensus 217 ~~--~~~~~~~~~~g--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l 292 (334)
T cd07855 217 YV--HQLKLILSVLG--SPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQAL 292 (334)
T ss_pred hH--HHHHHHHHHhC--CChhHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHH
Confidence 11 11111111000 000000 000 0000000 011235688999999999999999999987
Q ss_pred H
Q 005102 704 D 704 (714)
Q Consensus 704 ~ 704 (714)
.
T Consensus 293 ~ 293 (334)
T cd07855 293 Q 293 (334)
T ss_pred h
Confidence 6
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-34 Score=295.02 Aligned_cols=257 Identities=26% Similarity=0.353 Sum_probs=189.7
Q ss_pred ccccccCceEEEEEEECC-CcEEEEEEeCCCCc-hhHHHHHHHHHHHhccC-CCCccceEEEEEeCCceeEEEeccCCCC
Q 005102 409 FVLGKSGIGIVYKVVLED-GHTLAVRRLGEGGS-QRFKEFQTEVEAIGKIR-HSNIVTLRAYYWSVDEKLLIYDYIPNGS 485 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~~-g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lV~e~~~~gs 485 (714)
+.||+|+||+||+|+..+ ++.||||++..... .......+|+..+++++ ||||+++++++...+..++||||+ +|+
T Consensus 5 ~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~ 83 (283)
T cd07830 5 KQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM-EGN 83 (283)
T ss_pred eeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC-CCC
Confidence 479999999999999864 78999999876432 22234567999999999 999999999999999999999999 889
Q ss_pred HhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCCC
Q 005102 486 LATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSP 565 (714)
Q Consensus 486 L~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 565 (714)
|.+++..... ..+++.++..++.|++.||.|||+ ++++|+||+|+||++++++.++|+|||+++......
T Consensus 84 l~~~~~~~~~----~~~~~~~~~~~~~~l~~~l~~Lh~---~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~--- 153 (283)
T cd07830 84 LYQLMKDRKG----KPFSESVIRSIIYQILQGLAHIHK---HGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP--- 153 (283)
T ss_pred HHHHHHhccc----ccCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEEcCCCCEEEeecccceeccCCC---
Confidence 9998876532 358999999999999999999999 899999999999999999999999999987543211
Q ss_pred CccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCC-CCCCchhhhHHHHHHHHHHHhCCCccccCCCCcc
Q 005102 566 TLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKV-VKPSQKWDIYSYGVILLEMITGRTAVVQVGSSEM 644 (714)
Q Consensus 566 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DVwS~Gvvl~elltG~~p~~~~~~~~~ 644 (714)
......++..|+|||++.. ..++.++||||||+++|||++|+.||......
T Consensus 154 --------------------------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~-- 205 (283)
T cd07830 154 --------------------------PYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEI-- 205 (283)
T ss_pred --------------------------CcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChH--
Confidence 0112335778999998854 45799999999999999999999998433211
Q ss_pred hhHHHHHHHHh--------hcCCcccccCCCCCCCCC------cHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 005102 645 DLVNWMQLCIE--------EKKPLADVLDPYLAPDAD------KEEEIIAVLKIAMACVHSSPEKRPTMRHISD 704 (714)
Q Consensus 645 ~l~~~~~~~~~--------~~~~~~~~~d~~~~~~~~------~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 704 (714)
+.......... +........+........ .......+.+++.+||+.||++|||++|++.
T Consensus 206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 279 (283)
T cd07830 206 DQLYKICSVLGTPTKQDWPEGYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ 279 (283)
T ss_pred HHHHHHHHhcCCCChhhhhhHhhhhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence 11110000000 000000000000000000 0011346889999999999999999999875
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=285.64 Aligned_cols=246 Identities=22% Similarity=0.351 Sum_probs=196.8
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeCCCCc--hhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCCC
Q 005102 409 FVLGKSGIGIVYKVVLE-DGHTLAVRRLGEGGS--QRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGS 485 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gs 485 (714)
+.||+|+||.||++... +++.||+|++..... ...+.+.+|++++++++|||++++++.+...+..++|+||+++++
T Consensus 6 ~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~~~~~~ 85 (258)
T cd08215 6 KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEYADGGD 85 (258)
T ss_pred eeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEecCCCc
Confidence 47999999999999976 589999999976533 445678999999999999999999999999999999999999999
Q ss_pred HhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCCC
Q 005102 486 LATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSP 565 (714)
Q Consensus 486 L~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 565 (714)
|.+++...... ...+++.++..++.+++.||.|||+ .+++|+||+|+||++++++.++|+|||.+.......
T Consensus 86 L~~~l~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lh~---~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~--- 157 (258)
T cd08215 86 LSQKIKKQKKE--GKPFPEEQILDWFVQLCLALKYLHS---RKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV--- 157 (258)
T ss_pred HHHHHHHhhcc--CCCcCHHHHHHHHHHHHHHHHHHHh---CCEecccCChHHeEEcCCCcEEECCccceeecccCc---
Confidence 99999764311 1468999999999999999999999 899999999999999999999999999987653211
Q ss_pred CccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCccccCCCCcch
Q 005102 566 TLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGSSEMD 645 (714)
Q Consensus 566 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~~~~~~~~~~ 645 (714)
.......|++.|+|||...+..++.++||||+|+++|+|++|+.||....
T Consensus 158 -------------------------~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~----- 207 (258)
T cd08215 158 -------------------------DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGEN----- 207 (258)
T ss_pred -------------------------ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCc-----
Confidence 01112245778999999988889999999999999999999999984322
Q ss_pred hHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 005102 646 LVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISD 704 (714)
Q Consensus 646 l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 704 (714)
..+.......... +.+... ....+.+++.+||..+|++|||+.++++
T Consensus 208 ~~~~~~~~~~~~~-------~~~~~~-----~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 254 (258)
T cd08215 208 LLELALKILKGQY-------PPIPSQ-----YSSELRNLVSSLLQKDPEERPSIAQILQ 254 (258)
T ss_pred HHHHHHHHhcCCC-------CCCCCC-----CCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 1222222211110 111111 2236889999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=288.54 Aligned_cols=244 Identities=24% Similarity=0.321 Sum_probs=194.4
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeCCCC--chhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCCC
Q 005102 409 FVLGKSGIGIVYKVVLE-DGHTLAVRRLGEGG--SQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGS 485 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gs 485 (714)
+.||+|+||.||++... +++.+|+|.+.... ......+.+|++++++++|+||+++++++......++||||+++++
T Consensus 6 ~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~ 85 (256)
T cd08530 6 KKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEYAPFGD 85 (256)
T ss_pred eeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehhcCCCC
Confidence 47999999999999865 58899999987542 2334578899999999999999999999999999999999999999
Q ss_pred HhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCCC
Q 005102 486 LATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSP 565 (714)
Q Consensus 486 L~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 565 (714)
|.+++...... ...+++..+..++.|++.||+|||+ .+++|+||+|+||++++++.+||+|||+++.....
T Consensus 86 L~~~~~~~~~~--~~~~~~~~~~~~~~~l~~al~~lh~---~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~---- 156 (256)
T cd08530 86 LSKAISKRKKK--RKLIPEQEIWRIFIQLLRGLQALHE---QKILHRDLKSANILLVANDLVKIGDLGISKVLKKN---- 156 (256)
T ss_pred HHHHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCcceEEEecCCcEEEeeccchhhhccC----
Confidence 99998653211 1458899999999999999999999 89999999999999999999999999999865421
Q ss_pred CccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCccccCCCCcch
Q 005102 566 TLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGSSEMD 645 (714)
Q Consensus 566 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~~~~~~~~~~ 645 (714)
......++..|+|||.+.+..++.++|+||||+++|||++|+.||....
T Consensus 157 --------------------------~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~----- 205 (256)
T cd08530 157 --------------------------MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARS----- 205 (256)
T ss_pred --------------------------CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-----
Confidence 0111235677999999998889999999999999999999999994322
Q ss_pred hHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 005102 646 LVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISD 704 (714)
Q Consensus 646 l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 704 (714)
..+......... .. ... ......+.+++.+||..+|++|||+.++++
T Consensus 206 ~~~~~~~~~~~~--~~-----~~~-----~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 252 (256)
T cd08530 206 MQDLRYKVQRGK--YP-----PIP-----PIYSQDLQNFIRSMLQVKPKLRPNCDKILA 252 (256)
T ss_pred HHHHHHHHhcCC--CC-----CCc-----hhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 111111111111 01 011 123346889999999999999999999875
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=287.03 Aligned_cols=236 Identities=25% Similarity=0.309 Sum_probs=189.9
Q ss_pred ccccCceEEEEEEECC-CcEEEEEEeCCCCc---hhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCCCH
Q 005102 411 LGKSGIGIVYKVVLED-GHTLAVRRLGEGGS---QRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGSL 486 (714)
Q Consensus 411 lG~G~~g~Vy~~~~~~-g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL 486 (714)
||+|+||.||++...+ ++.+|+|.+..... .....+..|++++++++||||+++++.+...+..++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 6999999999999864 89999999876532 2345789999999999999999999999999999999999999999
Q ss_pred hhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCCCC
Q 005102 487 ATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPT 566 (714)
Q Consensus 487 ~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 566 (714)
.+++... ..+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~l~~~------~~l~~~~~~~~~~qi~~~l~~lh~---~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~---- 147 (250)
T cd05123 81 FSHLSKE------GRFSEERARFYAAEIVLALEYLHS---LGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG---- 147 (250)
T ss_pred HHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcceEEEcCCCcEEEeecCcceecccCC----
Confidence 9999755 358899999999999999999999 899999999999999999999999999987643210
Q ss_pred ccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCccccCCCCcchh
Q 005102 567 LQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGSSEMDL 646 (714)
Q Consensus 567 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~~~~~~~~~~l 646 (714)
.......++..|+|||...+...+.++|+||||+++||+++|+.||.....
T Consensus 148 ------------------------~~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~----- 198 (250)
T cd05123 148 ------------------------SRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR----- 198 (250)
T ss_pred ------------------------CcccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH-----
Confidence 011223457779999999888899999999999999999999999943221
Q ss_pred HHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHH
Q 005102 647 VNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRH 701 (714)
Q Consensus 647 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~e 701 (714)
............. .... ....+.+++.+||..||++|||+.+
T Consensus 199 ~~~~~~~~~~~~~--------~~~~-----~~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 199 KEIYEKILKDPLR--------FPEF-----LSPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred HHHHHHHhcCCCC--------CCCC-----CCHHHHHHHHHHhcCCHhhCCCccc
Confidence 1222222211111 1111 1236789999999999999999954
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=295.03 Aligned_cols=258 Identities=23% Similarity=0.313 Sum_probs=187.8
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeCCCC--chhHHHHHHHHHHHhccCCCCccceEEEEEeCC----------cee
Q 005102 409 FVLGKSGIGIVYKVVLE-DGHTLAVRRLGEGG--SQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVD----------EKL 475 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~----------~~~ 475 (714)
..||+|+||.||+|..+ +|+.||+|+++... ......+.+|++++++++||||+++++++.+.. ..+
T Consensus 13 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~ 92 (302)
T cd07864 13 GQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFY 92 (302)
T ss_pred eeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhccccCCcEE
Confidence 47999999999999986 48899999987542 223356788999999999999999999987654 789
Q ss_pred EEEeccCCCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchh
Q 005102 476 LIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLA 555 (714)
Q Consensus 476 lV~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla 555 (714)
+||||+++ ++.+.+.... ..+++..+..++.|++.||+|||+ .+|+||||||+||++++++.+||+|||++
T Consensus 93 lv~e~~~~-~l~~~l~~~~-----~~~~~~~~~~i~~qi~~aL~~LH~---~~i~H~dl~p~nili~~~~~~kl~dfg~~ 163 (302)
T cd07864 93 LVFEYMDH-DLMGLLESGL-----VHFSEDHIKSFMKQLLEGLNYCHK---KNFLHRDIKCSNILLNNKGQIKLADFGLA 163 (302)
T ss_pred EEEcccCc-cHHHHHhcCC-----CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCcEEeCccccc
Confidence 99999976 7777776442 458999999999999999999999 89999999999999999999999999998
Q ss_pred hhhhccCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCC-CCCCchhhhHHHHHHHHHHHhCCC
Q 005102 556 RLANIAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKV-VKPSQKWDIYSYGVILLEMITGRT 634 (714)
Q Consensus 556 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DVwS~Gvvl~elltG~~ 634 (714)
+....... .......++..|+|||.+.+ ..++.++|||||||++|||++|+.
T Consensus 164 ~~~~~~~~---------------------------~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~ 216 (302)
T cd07864 164 RLYNSEES---------------------------RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKP 216 (302)
T ss_pred ccccCCcc---------------------------cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCC
Confidence 76542210 00111223567999998865 357899999999999999999999
Q ss_pred ccccCCCCcchhHHHHHHHHhhcCC--ccccc--------CCCCCCCC----CcHHHHHHHHHHHhHccCCCCCCCCCHH
Q 005102 635 AVVQVGSSEMDLVNWMQLCIEEKKP--LADVL--------DPYLAPDA----DKEEEIIAVLKIAMACVHSSPEKRPTMR 700 (714)
Q Consensus 635 p~~~~~~~~~~l~~~~~~~~~~~~~--~~~~~--------d~~~~~~~----~~~~~~~~l~~li~~Cl~~dP~~RPt~~ 700 (714)
||.... .......+........+ ...+. ++...... ........+.+++.+||+.||++|||++
T Consensus 217 ~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~ 294 (302)
T cd07864 217 IFQANQ--ELAQLELISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAE 294 (302)
T ss_pred CCCCCC--hHHHHHHHHHHhCCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHH
Confidence 994321 11111111111111000 00000 00000000 0001234688999999999999999999
Q ss_pred HHHH
Q 005102 701 HISD 704 (714)
Q Consensus 701 evl~ 704 (714)
+++.
T Consensus 295 ~il~ 298 (302)
T cd07864 295 EALN 298 (302)
T ss_pred HHhc
Confidence 9875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-34 Score=302.38 Aligned_cols=260 Identities=19% Similarity=0.301 Sum_probs=190.3
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeCCC--CchhHHHHHHHHHHHhccCCCCccceEEEEEeC-----CceeEEEec
Q 005102 409 FVLGKSGIGIVYKVVLE-DGHTLAVRRLGEG--GSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSV-----DEKLLIYDY 480 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~-----~~~~lV~e~ 480 (714)
..||+|+||.||+|+.. +++.||||.+... .......+.+|+.++++++|+||+++++++... ...++||||
T Consensus 11 ~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~lv~e~ 90 (337)
T cd07858 11 KPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDVYIVYEL 90 (337)
T ss_pred EEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcEEEEEeC
Confidence 47999999999999975 5899999998753 222345678899999999999999999988654 347999999
Q ss_pred cCCCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhc
Q 005102 481 IPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANI 560 (714)
Q Consensus 481 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 560 (714)
+. ++|.+++... ..+++..+..++.|++.||.|||+ ++++||||||+||+++.++.+||+|||+++....
T Consensus 91 ~~-~~L~~~~~~~------~~l~~~~~~~i~~qi~~aL~~LH~---~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~ 160 (337)
T cd07858 91 MD-TDLHQIIRSS------QTLSDDHCQYFLYQLLRGLKYIHS---ANVLHRDLKPSNLLLNANCDLKICDFGLARTTSE 160 (337)
T ss_pred CC-CCHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEECcCccccccCC
Confidence 95 6899888654 458999999999999999999999 8999999999999999999999999999876432
Q ss_pred cCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCC-CCCCchhhhHHHHHHHHHHHhCCCccccC
Q 005102 561 AGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKV-VKPSQKWDIYSYGVILLEMITGRTAVVQV 639 (714)
Q Consensus 561 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DVwS~Gvvl~elltG~~p~~~~ 639 (714)
.. .......++..|+|||.+.. ..++.++|||||||++|||++|+.||...
T Consensus 161 ~~----------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~ 212 (337)
T cd07858 161 KG----------------------------DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGK 212 (337)
T ss_pred Cc----------------------------ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCC
Confidence 11 00112235677999998864 46899999999999999999999999432
Q ss_pred CCCcchhHHHHHHHHhhcC----------C-------cccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHH
Q 005102 640 GSSEMDLVNWMQLCIEEKK----------P-------LADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHI 702 (714)
Q Consensus 640 ~~~~~~l~~~~~~~~~~~~----------~-------~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev 702 (714)
. ................ . .....++.... ........+.+++.+||+.+|++|||++|+
T Consensus 213 ~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~l~~~P~~Rps~~el 288 (337)
T cd07858 213 D--YVHQLKLITELLGSPSEEDLGFIRNEKARRYIRSLPYTPRQSFAR--LFPHANPLAIDLLEKMLVFDPSKRITVEEA 288 (337)
T ss_pred C--hHHHHHHHHHHhCCCChHHhhhcCchhhhHHHHhcCcccccCHHH--HcccCCHHHHHHHHHHhcCChhhccCHHHH
Confidence 1 1111111111000000 0 00000000000 001123467899999999999999999999
Q ss_pred HHH--Hhhhh
Q 005102 703 SDA--LDRLI 710 (714)
Q Consensus 703 l~~--L~~i~ 710 (714)
++- ++.+.
T Consensus 289 l~h~~~~~~~ 298 (337)
T cd07858 289 LAHPYLASLH 298 (337)
T ss_pred HcCcchhhhc
Confidence 875 55443
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=298.47 Aligned_cols=265 Identities=22% Similarity=0.323 Sum_probs=196.1
Q ss_pred ccccccCceEEEEEEECC-CcEEEEEEeCCCC--chhHHHHHHHHHHHhccCCCCccceEEEEEeCC-----ceeEEEec
Q 005102 409 FVLGKSGIGIVYKVVLED-GHTLAVRRLGEGG--SQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVD-----EKLLIYDY 480 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~~-g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~-----~~~lV~e~ 480 (714)
..||+|+||.||+|+..+ ++.||||++.... ....+.+.+|+++++.++||||+++++++...+ ..|+||||
T Consensus 6 ~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~ 85 (330)
T cd07834 6 KPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVYIVTEL 85 (330)
T ss_pred eeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceEEEecc
Confidence 479999999999999864 8999999987653 334567899999999999999999999988765 78999999
Q ss_pred cCCCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhc
Q 005102 481 IPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANI 560 (714)
Q Consensus 481 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 560 (714)
++ ++|.+++... ..+++..+..++.|++.||+|||+ .+|+||||||+||++++++.++|+|||++.....
T Consensus 86 ~~-~~l~~~l~~~------~~l~~~~~~~i~~~l~~~l~~LH~---~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~ 155 (330)
T cd07834 86 ME-TDLHKVIKSP------QPLTDDHIQYFLYQILRGLKYLHS---ANVIHRDLKPSNILVNSNCDLKICDFGLARGVDP 155 (330)
T ss_pred hh-hhHHHHHhCC------CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEcccCceEeecc
Confidence 97 5899988754 368999999999999999999999 8999999999999999999999999999986543
Q ss_pred cCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCC-CCCchhhhHHHHHHHHHHHhCCCccccC
Q 005102 561 AGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVV-KPSQKWDIYSYGVILLEMITGRTAVVQV 639 (714)
Q Consensus 561 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DVwS~Gvvl~elltG~~p~~~~ 639 (714)
.... ........++..|+|||.+.+. .++.++||||||+++|+|++|+.||...
T Consensus 156 ~~~~-------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~ 210 (330)
T cd07834 156 DEDE-------------------------KGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGR 210 (330)
T ss_pred cccc-------------------------cccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCC
Confidence 2100 0011223457789999999887 7899999999999999999999999433
Q ss_pred CCCcchhHHHHHHHHhhcC----------CcccccCCC-CCCCCC----cHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 005102 640 GSSEMDLVNWMQLCIEEKK----------PLADVLDPY-LAPDAD----KEEEIIAVLKIAMACVHSSPEKRPTMRHISD 704 (714)
Q Consensus 640 ~~~~~~l~~~~~~~~~~~~----------~~~~~~d~~-~~~~~~----~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 704 (714)
.. .+....+........ ...+.+... ...... .......+.+++.+||+.+|++|||+++++.
T Consensus 211 ~~--~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~ 288 (330)
T cd07834 211 DY--IDQLNLIVEVLGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALA 288 (330)
T ss_pred CH--HHHHHHHHHhcCCCChhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence 21 111111111100000 000000000 000000 0012346789999999999999999999987
Q ss_pred H--Hhhhh
Q 005102 705 A--LDRLI 710 (714)
Q Consensus 705 ~--L~~i~ 710 (714)
. ++++.
T Consensus 289 ~~~~~~~~ 296 (330)
T cd07834 289 HPYLAQLH 296 (330)
T ss_pred CccHHhhc
Confidence 3 55443
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=300.37 Aligned_cols=254 Identities=22% Similarity=0.336 Sum_probs=185.4
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeCCCC--chhHHHHHHHHHHHhccCCCCccceEEEEEeCC------ceeEEEe
Q 005102 409 FVLGKSGIGIVYKVVLE-DGHTLAVRRLGEGG--SQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVD------EKLLIYD 479 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~------~~~lV~e 479 (714)
..||+|+||.||+|... +|+.||||++.... ......+.+|++++++++||||+++++++.... ..++|+|
T Consensus 21 ~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e 100 (342)
T cd07879 21 KQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVMP 100 (342)
T ss_pred EEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCceEEEEec
Confidence 57999999999999975 58999999987532 222356889999999999999999999987543 4589999
Q ss_pred ccCCCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhh
Q 005102 480 YIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLAN 559 (714)
Q Consensus 480 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~ 559 (714)
|+.. +|..+.. ..+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++...
T Consensus 101 ~~~~-~l~~~~~--------~~~~~~~~~~~~~qi~~aL~~LH~---~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~ 168 (342)
T cd07879 101 YMQT-DLQKIMG--------HPLSEDKVQYLVYQMLCGLKYIHS---AGIIHRDLKPGNLAVNEDCELKILDFGLARHAD 168 (342)
T ss_pred cccc-CHHHHHc--------CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEeeCCCCcCCC
Confidence 9964 7776652 348899999999999999999999 899999999999999999999999999987432
Q ss_pred ccCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCC-CCCCchhhhHHHHHHHHHHHhCCCcccc
Q 005102 560 IAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKV-VKPSQKWDIYSYGVILLEMITGRTAVVQ 638 (714)
Q Consensus 560 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DVwS~Gvvl~elltG~~p~~~ 638 (714)
.. .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||..
T Consensus 169 ~~-------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~ 217 (342)
T cd07879 169 AE-------------------------------MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKG 217 (342)
T ss_pred CC-------------------------------CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCC
Confidence 10 112234677999999876 4689999999999999999999999943
Q ss_pred CCCCcchhHHHHHHHHhh-cCCc------------ccccC--CCCCC-CCC--cHHHHHHHHHHHhHccCCCCCCCCCHH
Q 005102 639 VGSSEMDLVNWMQLCIEE-KKPL------------ADVLD--PYLAP-DAD--KEEEIIAVLKIAMACVHSSPEKRPTMR 700 (714)
Q Consensus 639 ~~~~~~~l~~~~~~~~~~-~~~~------------~~~~d--~~~~~-~~~--~~~~~~~l~~li~~Cl~~dP~~RPt~~ 700 (714)
.. .... +...... +.+. ..... +.... ... .......+.+++.+||+.||++||+++
T Consensus 218 ~~--~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~ 292 (342)
T cd07879 218 KD--YLDQ---LTQILKVTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTAT 292 (342)
T ss_pred CC--HHHH---HHHHHHhcCCCCHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHH
Confidence 21 1111 1111110 0000 00000 00000 000 001123578999999999999999999
Q ss_pred HHHHH--Hhhhh
Q 005102 701 HISDA--LDRLI 710 (714)
Q Consensus 701 evl~~--L~~i~ 710 (714)
+++.. ++.+.
T Consensus 293 e~l~h~~f~~~~ 304 (342)
T cd07879 293 EALEHPYFDSFR 304 (342)
T ss_pred HHhcCcchhhcc
Confidence 99843 55543
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=294.94 Aligned_cols=268 Identities=21% Similarity=0.231 Sum_probs=187.5
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeCCCCc--hhHHHHHHHHHHHhccCCCCccceEEEEEeCC--------ceeEE
Q 005102 409 FVLGKSGIGIVYKVVLE-DGHTLAVRRLGEGGS--QRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVD--------EKLLI 477 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~--------~~~lV 477 (714)
..||+|+||.||+|... +++.||||++..... .....+.+|++++++++||||+++++++.... ..++|
T Consensus 14 ~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~lv 93 (311)
T cd07866 14 GKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMV 93 (311)
T ss_pred EEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheecccccccccCceEEEE
Confidence 47999999999999976 489999999865422 22346788999999999999999999876533 35899
Q ss_pred EeccCCCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhh
Q 005102 478 YDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARL 557 (714)
Q Consensus 478 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 557 (714)
|||+.. ++...+.... ..+++.++..++.|+++||+|||+ .+|+||||||+||++++++.+||+|||+++.
T Consensus 94 ~~~~~~-~l~~~~~~~~-----~~~~~~~~~~i~~~l~~al~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 164 (311)
T cd07866 94 TPYMDH-DLSGLLENPS-----VKLTESQIKCYMLQLLEGINYLHE---NHILHRDIKAANILIDNQGILKIADFGLARP 164 (311)
T ss_pred EecCCc-CHHHHHhccc-----cCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECcCccchh
Confidence 999965 7877776542 358999999999999999999999 8999999999999999999999999999986
Q ss_pred hhccCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCC-CCCchhhhHHHHHHHHHHHhCCCcc
Q 005102 558 ANIAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVV-KPSQKWDIYSYGVILLEMITGRTAV 636 (714)
Q Consensus 558 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DVwS~Gvvl~elltG~~p~ 636 (714)
............ ...........+++.|+|||.+.+. .++.++|||||||++|||++|+.||
T Consensus 165 ~~~~~~~~~~~~-----------------~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~ 227 (311)
T cd07866 165 YDGPPPNPKGGG-----------------GGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPIL 227 (311)
T ss_pred ccCCCcccccCC-----------------cccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCC
Confidence 543211100000 0001122334567889999988654 5799999999999999999999998
Q ss_pred ccCCCCcchhHHHHHHHHhh--------cCCcccccCCCCCCCCC--c----HHHHHHHHHHHhHccCCCCCCCCCHHHH
Q 005102 637 VQVGSSEMDLVNWMQLCIEE--------KKPLADVLDPYLAPDAD--K----EEEIIAVLKIAMACVHSSPEKRPTMRHI 702 (714)
Q Consensus 637 ~~~~~~~~~l~~~~~~~~~~--------~~~~~~~~d~~~~~~~~--~----~~~~~~l~~li~~Cl~~dP~~RPt~~ev 702 (714)
.... .......+...... ........+........ . ......+.+++.+||..||++|||+.|+
T Consensus 228 ~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~el 305 (311)
T cd07866 228 QGKS--DIDQLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDA 305 (311)
T ss_pred CCCC--HHHHHHHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHH
Confidence 4321 11111111110000 00000000000000000 0 0112467899999999999999999988
Q ss_pred HH
Q 005102 703 SD 704 (714)
Q Consensus 703 l~ 704 (714)
+.
T Consensus 306 l~ 307 (311)
T cd07866 306 LE 307 (311)
T ss_pred hc
Confidence 74
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=298.51 Aligned_cols=261 Identities=24% Similarity=0.319 Sum_probs=188.0
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeCCC--CchhHHHHHHHHHHHhcc-CCCCccceEEEEEeCC--ceeEEEeccC
Q 005102 409 FVLGKSGIGIVYKVVLE-DGHTLAVRRLGEG--GSQRFKEFQTEVEAIGKI-RHSNIVTLRAYYWSVD--EKLLIYDYIP 482 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~--~~~lV~e~~~ 482 (714)
+.||+|+||.||+|... +++.||+|++... .......+.+|+.+++++ +||||+++++++...+ ..++||||++
T Consensus 13 ~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~lv~e~~~ 92 (337)
T cd07852 13 QKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIYLVFEYME 92 (337)
T ss_pred HhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEEEEecccc
Confidence 47999999999999976 5889999988643 223345678899999999 9999999999987543 5799999997
Q ss_pred CCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccC
Q 005102 483 NGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAG 562 (714)
Q Consensus 483 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 562 (714)
++|..++... .+++..+..++.|++.||+|||+ .+|+||||||+||++++++.+||+|||+++......
T Consensus 93 -~~L~~~~~~~-------~~~~~~~~~i~~qi~~~L~~LH~---~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~ 161 (337)
T cd07852 93 -TDLHAVIRAN-------ILEDVHKRYIMYQLLKALKYIHS---GNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELE 161 (337)
T ss_pred -cCHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEEeeccchhcccccc
Confidence 5999888643 47889999999999999999999 899999999999999999999999999998654221
Q ss_pred CCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCC-CCCCchhhhHHHHHHHHHHHhCCCccccCCC
Q 005102 563 GSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKV-VKPSQKWDIYSYGVILLEMITGRTAVVQVGS 641 (714)
Q Consensus 563 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DVwS~Gvvl~elltG~~p~~~~~~ 641 (714)
... .........|+..|+|||.+.+ ..++.++||||||+++|||+||+.||.....
T Consensus 162 ~~~-----------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~ 218 (337)
T cd07852 162 ENP-----------------------ENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTST 218 (337)
T ss_pred ccc-----------------------cCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCCh
Confidence 100 0011122346888999998865 4578999999999999999999999843221
Q ss_pred CcchhHHHHHHHHhhc----------CCcccccC----CCCCCCC-CcHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 005102 642 SEMDLVNWMQLCIEEK----------KPLADVLD----PYLAPDA-DKEEEIIAVLKIAMACVHSSPEKRPTMRHISDA 705 (714)
Q Consensus 642 ~~~~l~~~~~~~~~~~----------~~~~~~~d----~~~~~~~-~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 705 (714)
. +....+....... ....++++ ....... .......++.+++.+||+.||++|||+.++++.
T Consensus 219 ~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 219 L--NQLEKIIEVIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred H--HHHHHHHHHhCCCCHHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 1 1111000000000 00000000 0000000 000123468899999999999999999999864
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=290.61 Aligned_cols=257 Identities=25% Similarity=0.352 Sum_probs=192.0
Q ss_pred ccccccCceEEEEEEECC-CcEEEEEEeCCCC--chhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCCC
Q 005102 409 FVLGKSGIGIVYKVVLED-GHTLAVRRLGEGG--SQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGS 485 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~~-g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gs 485 (714)
..||+|+||.||+|+..+ ++.||+|.+.... ....+.+..|++++++++|+||+++++++...+..++||||++ ++
T Consensus 5 ~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~-~~ 83 (282)
T cd07829 5 EKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYCD-MD 83 (282)
T ss_pred hcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCcC-cC
Confidence 369999999999999865 8999999998753 3334678899999999999999999999999999999999997 59
Q ss_pred HhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCCC
Q 005102 486 LATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSP 565 (714)
Q Consensus 486 L~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 565 (714)
|.+++.... ..+++..+.+++.|++.||+|||+ .+|+||||+|+||++++++.+||+|||+++.......
T Consensus 84 l~~~i~~~~-----~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~-- 153 (282)
T cd07829 84 LKKYLDKRP-----GPLSPNLIKSIMYQLLRGLAYCHS---HRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR-- 153 (282)
T ss_pred HHHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChheEEEcCCCCEEEecCCcccccCCCcc--
Confidence 999997653 358999999999999999999999 8999999999999999999999999999876532110
Q ss_pred CccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCC-CCCchhhhHHHHHHHHHHHhCCCccccCCCCcc
Q 005102 566 TLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVV-KPSQKWDIYSYGVILLEMITGRTAVVQVGSSEM 644 (714)
Q Consensus 566 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DVwS~Gvvl~elltG~~p~~~~~~~~~ 644 (714)
......++..|+|||.+.+. .++.++|||||||++|||++|+.||.... ..
T Consensus 154 --------------------------~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~--~~ 205 (282)
T cd07829 154 --------------------------TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDS--EI 205 (282)
T ss_pred --------------------------ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCcc--HH
Confidence 01112235679999998766 78999999999999999999999984321 11
Q ss_pred hhHHHHHHHHhhcCC-----cccc--cCCCCCC---CCC---cHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 005102 645 DLVNWMQLCIEEKKP-----LADV--LDPYLAP---DAD---KEEEIIAVLKIAMACVHSSPEKRPTMRHISD 704 (714)
Q Consensus 645 ~l~~~~~~~~~~~~~-----~~~~--~d~~~~~---~~~---~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 704 (714)
+....+......... .... .+..... ... .......+.+++.+||+.||++||++++++.
T Consensus 206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 206 DQLFKIFQILGTPTEESWPGVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred HHHHHHHHHhCCCcHHHHHhhcccccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 111111111000000 0000 0000000 000 0011346899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=290.61 Aligned_cols=261 Identities=20% Similarity=0.287 Sum_probs=196.1
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeCCC---CchhHHHHHHHHHHHhccC-CCCccceEEEEEeCCceeEEEeccCC
Q 005102 409 FVLGKSGIGIVYKVVLE-DGHTLAVRRLGEG---GSQRFKEFQTEVEAIGKIR-HSNIVTLRAYYWSVDEKLLIYDYIPN 483 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lV~e~~~~ 483 (714)
+.||+|+||.||+|... +++.||+|++... .....+.+.+|++++.+++ ||||+++++++...+..++||||+++
T Consensus 7 ~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 86 (280)
T cd05581 7 KIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVLEYAPN 86 (280)
T ss_pred eeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEEcCCCC
Confidence 47999999999999976 5899999998763 2233467889999999998 99999999999999999999999999
Q ss_pred CCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCC
Q 005102 484 GSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGG 563 (714)
Q Consensus 484 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 563 (714)
++|.+++... ..+++..+..|+.|++.||+|||+ .+++|+||||+||+++.++.++++|||++........
T Consensus 87 ~~L~~~l~~~------~~l~~~~~~~i~~ql~~~l~~Lh~---~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~ 157 (280)
T cd05581 87 GELLQYIRKY------GSLDEKCTRFYAAEILLALEYLHS---KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSS 157 (280)
T ss_pred CcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEecCCccccccCCccc
Confidence 9999999765 358999999999999999999999 8999999999999999999999999999986543221
Q ss_pred CCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCccccCCCCc
Q 005102 564 SPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGSSE 643 (714)
Q Consensus 564 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~~~~~~~~ 643 (714)
........... ...............++..|+|||...+..++.++||||||++++|+++|+.||.....
T Consensus 158 ~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-- 227 (280)
T cd05581 158 PESNKGDATNI--------DSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNE-- 227 (280)
T ss_pred cccCCCCCccc--------cccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccH--
Confidence 10000000000 00000001122334567889999999888899999999999999999999999953321
Q ss_pred chhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCH----HHHHH
Q 005102 644 MDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTM----RHISD 704 (714)
Q Consensus 644 ~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~----~evl~ 704 (714)
....+........+. .. ....+.+++.+||+.+|++|||+ +++++
T Consensus 228 ---~~~~~~~~~~~~~~~--------~~-----~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 228 ---YLTFQKILKLEYSFP--------PN-----FPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred ---HHHHHHHHhcCCCCC--------Cc-----cCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 111122211111111 11 12357899999999999999999 66653
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-33 Score=296.15 Aligned_cols=260 Identities=22% Similarity=0.272 Sum_probs=185.7
Q ss_pred ccccccCceEEEEEEECC---CcEEEEEEeCCC--CchhHHHHHHHHHHHhcc-CCCCccceEEEEEeC----CceeEEE
Q 005102 409 FVLGKSGIGIVYKVVLED---GHTLAVRRLGEG--GSQRFKEFQTEVEAIGKI-RHSNIVTLRAYYWSV----DEKLLIY 478 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~~---g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~----~~~~lV~ 478 (714)
+.||+|+||.||+++... +..||+|++... .....+.+.+|+++++++ +||||+++++++... ...++++
T Consensus 6 ~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~~ 85 (332)
T cd07857 6 KELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNELYLYE 85 (332)
T ss_pred EEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCcEEEEE
Confidence 479999999999999753 679999998753 222346788999999999 599999999976432 4568889
Q ss_pred eccCCCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhh
Q 005102 479 DYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLA 558 (714)
Q Consensus 479 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~ 558 (714)
||+. ++|.+++... ..+++..++.++.||+.||+|||+ .+|+||||||+||++++++.+||+|||+++..
T Consensus 86 e~~~-~~L~~~l~~~------~~~~~~~~~~~~~qi~~aL~~LH~---~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~ 155 (332)
T cd07857 86 ELME-ADLHQIIRSG------QPLTDAHFQSFIYQILCGLKYIHS---ANVLHRDLKPGNLLVNADCELKICDFGLARGF 155 (332)
T ss_pred eccc-CCHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHeEEcCCCCEEeCcCCCceec
Confidence 9985 6999988654 458999999999999999999999 89999999999999999999999999999765
Q ss_pred hccCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCC-CCCCchhhhHHHHHHHHHHHhCCCccc
Q 005102 559 NIAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKV-VKPSQKWDIYSYGVILLEMITGRTAVV 637 (714)
Q Consensus 559 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DVwS~Gvvl~elltG~~p~~ 637 (714)
....... ........||..|+|||.+.+ ..++.++|||||||++|+|++|+.||.
T Consensus 156 ~~~~~~~------------------------~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~ 211 (332)
T cd07857 156 SENPGEN------------------------AGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFK 211 (332)
T ss_pred ccccccc------------------------cccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCC
Confidence 3221100 011123456888999998765 468999999999999999999999984
Q ss_pred cCCCCcchhHHHHHHHHh------------hc-CCcccccCCCCCCCCC--cHHHHHHHHHHHhHccCCCCCCCCCHHHH
Q 005102 638 QVGSSEMDLVNWMQLCIE------------EK-KPLADVLDPYLAPDAD--KEEEIIAVLKIAMACVHSSPEKRPTMRHI 702 (714)
Q Consensus 638 ~~~~~~~~l~~~~~~~~~------------~~-~~~~~~~d~~~~~~~~--~~~~~~~l~~li~~Cl~~dP~~RPt~~ev 702 (714)
.... ......+..... .. ................ .......+.+++.+||+.||++|||+.++
T Consensus 212 ~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~l 289 (332)
T cd07857 212 GKDY--VDQLNQILQVLGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEA 289 (332)
T ss_pred CCCH--HHHHHHHHHHhCCCCHHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHH
Confidence 3221 111111110000 00 0000000000000000 00112468899999999999999999998
Q ss_pred HH
Q 005102 703 SD 704 (714)
Q Consensus 703 l~ 704 (714)
+.
T Consensus 290 l~ 291 (332)
T cd07857 290 LE 291 (332)
T ss_pred hc
Confidence 64
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-33 Score=296.77 Aligned_cols=248 Identities=20% Similarity=0.293 Sum_probs=184.3
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeCCCC--chhHHHHHHHHHHHhccCCCCccceEEEEEeCC------ceeEEEe
Q 005102 409 FVLGKSGIGIVYKVVLE-DGHTLAVRRLGEGG--SQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVD------EKLLIYD 479 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~------~~~lV~e 479 (714)
+.||+|+||.||++... +++.||||++.... ....+.+.+|++++++++||||+++++++.... ..++|||
T Consensus 21 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e 100 (343)
T cd07880 21 KQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMP 100 (343)
T ss_pred EEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccceEEEEEe
Confidence 47999999999999864 68999999986532 223456889999999999999999999987643 3589999
Q ss_pred ccCCCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhh
Q 005102 480 YIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLAN 559 (714)
Q Consensus 480 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~ 559 (714)
|+ +++|.+++.. ..+++..+..++.|++.||+|||+ .+|+||||||+||++++++.+||+|||+++...
T Consensus 101 ~~-~~~l~~~~~~-------~~l~~~~~~~i~~qi~~al~~LH~---~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~~ 169 (343)
T cd07880 101 FM-GTDLGKLMKH-------EKLSEDRIQFLVYQMLKGLKYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQTD 169 (343)
T ss_pred cC-CCCHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeecccccccc
Confidence 99 7799888753 348899999999999999999999 899999999999999999999999999987542
Q ss_pred ccCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCC-CCCCchhhhHHHHHHHHHHHhCCCcccc
Q 005102 560 IAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKV-VKPSQKWDIYSYGVILLEMITGRTAVVQ 638 (714)
Q Consensus 560 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DVwS~Gvvl~elltG~~p~~~ 638 (714)
.. .....+++.|+|||.+.+ ..++.++|||||||++|+|++|+.||..
T Consensus 170 ~~-------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~ 218 (343)
T cd07880 170 SE-------------------------------MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKG 218 (343)
T ss_pred cC-------------------------------ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 11 112234778999999875 4588999999999999999999999943
Q ss_pred CCCCcchhHHHHHHHHhhcCCcc-c------------ccC--CCCCC-CCC--cHHHHHHHHHHHhHccCCCCCCCCCHH
Q 005102 639 VGSSEMDLVNWMQLCIEEKKPLA-D------------VLD--PYLAP-DAD--KEEEIIAVLKIAMACVHSSPEKRPTMR 700 (714)
Q Consensus 639 ~~~~~~~l~~~~~~~~~~~~~~~-~------------~~d--~~~~~-~~~--~~~~~~~l~~li~~Cl~~dP~~RPt~~ 700 (714)
... ............... + ... +.... ... .......+.+++.+|++.||++|||+.
T Consensus 219 ~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~ 293 (343)
T cd07880 219 HDH-----LDQLMEIMKVTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAA 293 (343)
T ss_pred CCH-----HHHHHHHHHhcCCCCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHH
Confidence 211 111111111000000 0 000 00000 000 001223578999999999999999999
Q ss_pred HHH
Q 005102 701 HIS 703 (714)
Q Consensus 701 evl 703 (714)
+++
T Consensus 294 ~~l 296 (343)
T cd07880 294 EAL 296 (343)
T ss_pred HHh
Confidence 988
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=317.16 Aligned_cols=141 Identities=26% Similarity=0.384 Sum_probs=126.8
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeCCCC---chhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCC
Q 005102 409 FVLGKSGIGIVYKVVLE-DGHTLAVRRLGEGG---SQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNG 484 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~g 484 (714)
+.||+|+||.||+|++. +++.||||+++... ......+.+|+.+++.++||||+++++++...+..|+||||++++
T Consensus 10 ~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVmEy~~g~ 89 (669)
T cd05610 10 KPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVMEYLIGG 89 (669)
T ss_pred EEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEEeCCCCC
Confidence 47999999999999986 58999999997542 223467889999999999999999999999999999999999999
Q ss_pred CHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhh
Q 005102 485 SLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLA 558 (714)
Q Consensus 485 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~ 558 (714)
+|.+++... ..+++..+++|+.||+.||+|||. .+|+||||||+|||++.++.+||+|||+++..
T Consensus 90 ~L~~li~~~------~~l~~~~~~~i~~qil~aL~yLH~---~gIiHrDLKP~NILl~~~g~vkL~DFGls~~~ 154 (669)
T cd05610 90 DVKSLLHIY------GYFDEEMAVKYISEVALALDYLHR---HGIIHRDLKPDNMLISNEGHIKLTDFGLSKVT 154 (669)
T ss_pred CHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCccHHHEEEcCCCCEEEEeCCCCccc
Confidence 999999754 347889999999999999999999 89999999999999999999999999999753
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=274.78 Aligned_cols=260 Identities=22% Similarity=0.331 Sum_probs=189.6
Q ss_pred cccccCceEEEEEEECC-CcEEEEEEeCCC--CchhHHHHHHHHHHHhccCCCCccceEEEEEeC--------CceeEEE
Q 005102 410 VLGKSGIGIVYKVVLED-GHTLAVRRLGEG--GSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSV--------DEKLLIY 478 (714)
Q Consensus 410 ~lG~G~~g~Vy~~~~~~-g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--------~~~~lV~ 478 (714)
.||+|.||+||+|+.++ |+.||+|++-.. .........+|+++|..++|+|++.+++.|... ...|+||
T Consensus 24 kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~t~ylVf 103 (376)
T KOG0669|consen 24 KIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRATFYLVF 103 (376)
T ss_pred hcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccceeeeeH
Confidence 69999999999999765 788999876432 222234568999999999999999999988642 2479999
Q ss_pred eccCCCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhh
Q 005102 479 DYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLA 558 (714)
Q Consensus 479 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~ 558 (714)
++|+. +|.-+|.... .+++..++.+++.++..||.|+|. ..|+|||+||+|+||+.++.+||+|||+|+.+
T Consensus 104 ~~ceh-DLaGlLsn~~-----vr~sls~Ikk~Mk~Lm~GL~~iHr---~kilHRDmKaaNvLIt~dgilklADFGlar~f 174 (376)
T KOG0669|consen 104 DFCEH-DLAGLLSNRK-----VRFSLSEIKKVMKGLMNGLYYIHR---NKILHRDMKAANVLITKDGILKLADFGLARAF 174 (376)
T ss_pred HHhhh-hHHHHhcCcc-----ccccHHHHHHHHHHHHHHHHHHHH---hhHHhhcccHhhEEEcCCceEEeeccccccce
Confidence 99977 9999987553 568999999999999999999999 89999999999999999999999999999876
Q ss_pred hccCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCC-CCCchhhhHHHHHHHHHHHhCCCccc
Q 005102 559 NIAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVV-KPSQKWDIYSYGVILLEMITGRTAVV 637 (714)
Q Consensus 559 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DVwS~Gvvl~elltG~~p~~ 637 (714)
....... ....+..+-|.+|++||.+.|. .|+++.|||+.|||+.||+||.+.+.
T Consensus 175 s~~~n~~------------------------kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimq 230 (376)
T KOG0669|consen 175 STSKNVV------------------------KPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQ 230 (376)
T ss_pred ecccccC------------------------CCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCcccc
Confidence 5332110 1112344458899999999875 48999999999999999999988773
Q ss_pred cCCCCcchhHHHHHHHHh----hcC------Cccccc--CCCCCCCCC-cHHHHH------HHHHHHhHccCCCCCCCCC
Q 005102 638 QVGSSEMDLVNWMQLCIE----EKK------PLADVL--DPYLAPDAD-KEEEII------AVLKIAMACVHSSPEKRPT 698 (714)
Q Consensus 638 ~~~~~~~~l~~~~~~~~~----~~~------~~~~~~--d~~~~~~~~-~~~~~~------~l~~li~~Cl~~dP~~RPt 698 (714)
. +.+......+..... +-+ ++.+.+ .|....... .++... ..++++..++..||.+|++
T Consensus 231 g--nteqqql~~Is~LcGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ 308 (376)
T KOG0669|consen 231 G--NTEQQQLHLISQLCGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRID 308 (376)
T ss_pred C--ChHHHHHHHHHHHhccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcc
Confidence 2 222222222221111 000 001111 110000000 011111 5678999999999999999
Q ss_pred HHHHHH
Q 005102 699 MRHISD 704 (714)
Q Consensus 699 ~~evl~ 704 (714)
+.+++.
T Consensus 309 ad~aln 314 (376)
T KOG0669|consen 309 ADQALN 314 (376)
T ss_pred hHhhhc
Confidence 998874
|
|
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=298.35 Aligned_cols=258 Identities=21% Similarity=0.300 Sum_probs=184.7
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeCCCCchhHHHHHHHHHHHhccCCCCccceEEEEEeC--------------Cc
Q 005102 409 FVLGKSGIGIVYKVVLE-DGHTLAVRRLGEGGSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSV--------------DE 473 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--------------~~ 473 (714)
+.||+|+||.||+|... +|+.||+|++........+.+.+|++++++++||||+++++++... ..
T Consensus 11 ~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 90 (342)
T cd07854 11 RPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNS 90 (342)
T ss_pred EEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccccccccce
Confidence 47999999999999975 4899999998776655567789999999999999999999876543 34
Q ss_pred eeEEEeccCCCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeC-CCCCeEEccc
Q 005102 474 KLLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLG-HNMEPHVSDF 552 (714)
Q Consensus 474 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~-~~~~~kl~DF 552 (714)
.++||||++ ++|.+++.. ..+++..++.++.||+.||+|||+ .+|+||||||+||+++ +++.+|++||
T Consensus 91 ~~lv~e~~~-~~L~~~~~~-------~~l~~~~~~~~~~qi~~aL~~LH~---~givH~dikp~Nili~~~~~~~kl~df 159 (342)
T cd07854 91 VYIVQEYME-TDLANVLEQ-------GPLSEEHARLFMYQLLRGLKYIHS---ANVLHRDLKPANVFINTEDLVLKIGDF 159 (342)
T ss_pred EEEEeeccc-ccHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEcCCCceEEECCc
Confidence 689999997 599888753 248899999999999999999999 8999999999999997 4567899999
Q ss_pred chhhhhhccCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCC-CCCCchhhhHHHHHHHHHHHh
Q 005102 553 GLARLANIAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKV-VKPSQKWDIYSYGVILLEMIT 631 (714)
Q Consensus 553 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DVwS~Gvvl~ellt 631 (714)
|+++........ ........++..|+|||.+.+ ..++.++|||||||++|||++
T Consensus 160 g~~~~~~~~~~~-------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~ 214 (342)
T cd07854 160 GLARIVDPHYSH-------------------------KGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLT 214 (342)
T ss_pred ccceecCCcccc-------------------------ccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHh
Confidence 998754321100 000111235778999998754 557899999999999999999
Q ss_pred CCCccccCCCCcchhHHHHHHHHhhc-----C----CcccccC-CCCCCCCCc----HHHHHHHHHHHhHccCCCCCCCC
Q 005102 632 GRTAVVQVGSSEMDLVNWMQLCIEEK-----K----PLADVLD-PYLAPDADK----EEEIIAVLKIAMACVHSSPEKRP 697 (714)
Q Consensus 632 G~~p~~~~~~~~~~l~~~~~~~~~~~-----~----~~~~~~d-~~~~~~~~~----~~~~~~l~~li~~Cl~~dP~~RP 697 (714)
|+.||......+ ........ .... . ....... ......... .....++.+++.+||..||++||
T Consensus 215 g~~pf~~~~~~~-~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~ 292 (342)
T cd07854 215 GKPLFAGAHELE-QMQLILES-VPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRL 292 (342)
T ss_pred CCCCCCCCCHHH-HHHHHHHh-cCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhcc
Confidence 999994332111 00000000 0000 0 0000000 000000000 01223578999999999999999
Q ss_pred CHHHHHH
Q 005102 698 TMRHISD 704 (714)
Q Consensus 698 t~~evl~ 704 (714)
|++|++.
T Consensus 293 t~~ell~ 299 (342)
T cd07854 293 TAEEALM 299 (342)
T ss_pred CHHHHhC
Confidence 9999974
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-33 Score=285.54 Aligned_cols=245 Identities=24% Similarity=0.307 Sum_probs=187.0
Q ss_pred ccccccCceEEEEEEECC-CcEEEEEEeCCC-----CchhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccC
Q 005102 409 FVLGKSGIGIVYKVVLED-GHTLAVRRLGEG-----GSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIP 482 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~~-g~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~ 482 (714)
+.||+|+||.||++.... +..+++|.++.. ......++.+|+.++++++||||+++++++...+..++||||++
T Consensus 6 ~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 85 (260)
T cd08222 6 QRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCIITEYCE 85 (260)
T ss_pred eeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEEEEeCC
Confidence 479999999999998754 445666655432 22233467789999999999999999999998889999999999
Q ss_pred CCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccC
Q 005102 483 NGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAG 562 (714)
Q Consensus 483 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 562 (714)
+++|.+++...... ...+++.+++.++.|++.||.|||+ .+++|+||||+||++++ +.+||+|||+++......
T Consensus 86 ~~~l~~~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~~ 159 (260)
T cd08222 86 GRDLDCKLEELKHT--GKTLSENQVCEWFIQLLLGVHYMHQ---RRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGSC 159 (260)
T ss_pred CCCHHHHHHHHhhc--ccccCHHHHHHHHHHHHHHHHHHHH---cCccccCCChhheEeec-CCEeecccCceeecCCCc
Confidence 99999988642211 1468999999999999999999999 89999999999999975 569999999987653211
Q ss_pred CCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCccccCCCC
Q 005102 563 GSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGSS 642 (714)
Q Consensus 563 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~~~~~~~ 642 (714)
.......|+..|+|||.+.+..++.++||||||+++|+|++|..||...
T Consensus 160 ----------------------------~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~--- 208 (260)
T cd08222 160 ----------------------------DLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQ--- 208 (260)
T ss_pred ----------------------------ccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCc---
Confidence 0111233577899999998888899999999999999999999998421
Q ss_pred cchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 005102 643 EMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISD 704 (714)
Q Consensus 643 ~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 704 (714)
............. .+... ......+.+++.+||..+|++||++.|+++
T Consensus 209 --~~~~~~~~~~~~~-------~~~~~-----~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 209 --NFLSVVLRIVEGP-------TPSLP-----ETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred --cHHHHHHHHHcCC-------CCCCc-----chhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence 1122222211111 11111 122346889999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=291.81 Aligned_cols=253 Identities=22% Similarity=0.340 Sum_probs=185.8
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeCCC--CchhHHHHHHHHHHHhccCCCCccceEEEEEe-CCceeEEEeccCCC
Q 005102 409 FVLGKSGIGIVYKVVLE-DGHTLAVRRLGEG--GSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWS-VDEKLLIYDYIPNG 484 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~-~~~~~lV~e~~~~g 484 (714)
..||+|+||.||++... +++.||||++... .....+.+.+|++++++++||||+++++++.. .+..++||||+ ++
T Consensus 16 ~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~lv~e~~-~~ 94 (328)
T cd07856 16 QPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVTELL-GT 94 (328)
T ss_pred EeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEEEeehh-cc
Confidence 47999999999999865 6899999988653 22234678899999999999999999999876 55789999998 56
Q ss_pred CHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCC
Q 005102 485 SLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGS 564 (714)
Q Consensus 485 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 564 (714)
+|.+++... .+++..+..++.|++.||+|||+ .+|+||||||+||++++++.+||+|||+++.....
T Consensus 95 ~L~~~~~~~-------~~~~~~~~~~~~ql~~aL~~LH~---~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~--- 161 (328)
T cd07856 95 DLHRLLTSR-------PLEKQFIQYFLYQILRGLKYVHS---AGVVHRDLKPSNILINENCDLKICDFGLARIQDPQ--- 161 (328)
T ss_pred CHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEeECCCCCEEeCccccccccCCC---
Confidence 898888643 47888899999999999999999 89999999999999999999999999998743211
Q ss_pred CCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCC-CCCCchhhhHHHHHHHHHHHhCCCccccCCCCc
Q 005102 565 PTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKV-VKPSQKWDIYSYGVILLEMITGRTAVVQVGSSE 643 (714)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DVwS~Gvvl~elltG~~p~~~~~~~~ 643 (714)
.....++..|+|||.+.+ ..++.++||||||+++|||+||+.||.....
T Consensus 162 ----------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~-- 211 (328)
T cd07856 162 ----------------------------MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDH-- 211 (328)
T ss_pred ----------------------------cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCH--
Confidence 111234677999998865 5689999999999999999999999943221
Q ss_pred chhHHHHHHHHhhc----------CCcccccCCC-CCCCCCcH----HHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 005102 644 MDLVNWMQLCIEEK----------KPLADVLDPY-LAPDADKE----EEIIAVLKIAMACVHSSPEKRPTMRHISDA 705 (714)
Q Consensus 644 ~~l~~~~~~~~~~~----------~~~~~~~d~~-~~~~~~~~----~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 705 (714)
......+....... ....+..... ........ .....+.+++.+||+.+|++|||+++++..
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 212 VNQFSIITDLLGTPPDDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred HHHHHHHHHHhCCCCHHHHHhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 11111111000000 0000000000 00000000 122468899999999999999999998754
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-33 Score=280.86 Aligned_cols=220 Identities=21% Similarity=0.218 Sum_probs=174.5
Q ss_pred cCceEEEEEEEC-CCcEEEEEEeCCCCchhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCCCHhhhhhC
Q 005102 414 SGIGIVYKVVLE-DGHTLAVRRLGEGGSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGSLATALHG 492 (714)
Q Consensus 414 G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~ 492 (714)
|.||.||+++.. +++.||+|++.... .+.+|...+....||||+++++++...+..++||||+++|+|.+++..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 889999999975 58999999997643 234556666666799999999999999999999999999999999875
Q ss_pred CCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCCCCccCCCC
Q 005102 493 KPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRM 572 (714)
Q Consensus 493 ~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~ 572 (714)
. ..+++..+..++.|++.||+|||+ ++|+||||||+||++++++.++++|||.+......
T Consensus 79 ~------~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~----------- 138 (237)
T cd05576 79 F------LNIPEECVKRWAAEMVVALDALHR---EGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS----------- 138 (237)
T ss_pred h------cCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEEcCCCCEEEecccchhccccc-----------
Confidence 4 348999999999999999999999 89999999999999999999999999987654211
Q ss_pred CCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCccccCCCCcchhHHHHHH
Q 005102 573 PAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGSSEMDLVNWMQL 652 (714)
Q Consensus 573 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~ 652 (714)
.....++..|+|||...+..++.++||||+|+++|||++|+.|+.......
T Consensus 139 --------------------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~--------- 189 (237)
T cd05576 139 --------------------CDGEAVENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI--------- 189 (237)
T ss_pred --------------------cccCCcCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc---------
Confidence 111223566999999988889999999999999999999998873221100
Q ss_pred HHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHH
Q 005102 653 CIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMR 700 (714)
Q Consensus 653 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ 700 (714)
... ....++.. ....+.+++.+||+.||++|||+.
T Consensus 190 --~~~------~~~~~~~~-----~~~~~~~li~~~l~~dp~~R~~~~ 224 (237)
T cd05576 190 --NTH------TTLNIPEW-----VSEEARSLLQQLLQFNPTERLGAG 224 (237)
T ss_pred --ccc------cccCCccc-----CCHHHHHHHHHHccCCHHHhcCCC
Confidence 000 00011111 123578899999999999999973
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-33 Score=248.40 Aligned_cols=257 Identities=21% Similarity=0.282 Sum_probs=189.3
Q ss_pred cccccCceEEEEEEEC-CCcEEEEEEeCCCC--chhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCCCH
Q 005102 410 VLGKSGIGIVYKVVLE-DGHTLAVRRLGEGG--SQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGSL 486 (714)
Q Consensus 410 ~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL 486 (714)
.||+|.||+||+|+.+ +++.||+|+++..+ +.......+|+-+++.++|+|||++++....+....+|+|||.. +|
T Consensus 9 kigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~cdq-dl 87 (292)
T KOG0662|consen 9 KIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DL 87 (292)
T ss_pred hhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHHhhH-HH
Confidence 6999999999999965 48899999987643 22335678999999999999999999999999999999999954 89
Q ss_pred hhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCCCC
Q 005102 487 ATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPT 566 (714)
Q Consensus 487 ~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 566 (714)
..+...-. ..++.+..+.++.|+++||.|.|+ +.+.|||+||.|.||+.+|+.|++|||+|+.+....
T Consensus 88 kkyfdsln-----g~~d~~~~rsfmlqllrgl~fchs---hnvlhrdlkpqnllin~ngelkladfglarafgipv---- 155 (292)
T KOG0662|consen 88 KKYFDSLN-----GDLDPEIVRSFMLQLLRGLGFCHS---HNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPV---- 155 (292)
T ss_pred HHHHHhcC-----CcCCHHHHHHHHHHHHhhhhhhhh---hhhhhccCCcceEEeccCCcEEecccchhhhcCCce----
Confidence 98887665 358889999999999999999999 899999999999999999999999999999765321
Q ss_pred ccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCC-CCchhhhHHHHHHHHHHHh-CCCccccCCCCcc
Q 005102 567 LQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVK-PSQKWDIYSYGVILLEMIT-GRTAVVQVGSSEM 644 (714)
Q Consensus 567 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s~~~DVwS~Gvvl~ellt-G~~p~~~~~~~~~ 644 (714)
. -.+..+-|.+|++|.++.+.+ |++..|+||.||++.|+.. |++.|+ ...-+.
T Consensus 156 -----------------------r-cysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfp-g~dvdd 210 (292)
T KOG0662|consen 156 -----------------------R-CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFP-GNDVDD 210 (292)
T ss_pred -----------------------E-eeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCC-CCcHHH
Confidence 0 111223488999999998876 7999999999999999988 555553 222222
Q ss_pred hhHHHHHHHH---hhcC-CcccccCCCCCCCCC----cHHH----HHHHHHHHhHccCCCCCCCCCHHHHHH
Q 005102 645 DLVNWMQLCI---EEKK-PLADVLDPYLAPDAD----KEEE----IIAVLKIAMACVHSSPEKRPTMRHISD 704 (714)
Q Consensus 645 ~l~~~~~~~~---~~~~-~~~~~~d~~~~~~~~----~~~~----~~~l~~li~~Cl~~dP~~RPt~~evl~ 704 (714)
.+....+..- ++.+ .+...-|-..-+.+. ..+. ...=.+++++.+.-+|.+|.++++.++
T Consensus 211 qlkrif~~lg~p~ed~wps~t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq 282 (292)
T KOG0662|consen 211 QLKRIFRLLGTPTEDQWPSMTKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ 282 (292)
T ss_pred HHHHHHHHhCCCccccCCccccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence 2222221110 1111 111111111111111 1111 112357888888889999999988764
|
|
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=293.72 Aligned_cols=250 Identities=22% Similarity=0.299 Sum_probs=183.3
Q ss_pred ccccccCceEEEEEEE-CCCcEEEEEEeCCCC--chhHHHHHHHHHHHhccCCCCccceEEEEEeC------CceeEEEe
Q 005102 409 FVLGKSGIGIVYKVVL-EDGHTLAVRRLGEGG--SQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSV------DEKLLIYD 479 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~------~~~~lV~e 479 (714)
..||+|+||.||+|.. .+++.||+|++.... ....+.+.+|++++++++||||+++++++... ...+++++
T Consensus 23 ~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~~ 102 (345)
T cd07877 23 SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTH 102 (345)
T ss_pred EEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccccccccEEEEeh
Confidence 4699999999999986 468999999997542 22345688899999999999999999988643 34678888
Q ss_pred ccCCCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhh
Q 005102 480 YIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLAN 559 (714)
Q Consensus 480 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~ 559 (714)
++ +++|.+++.. ..+++..+..++.|+++||+|||+ .+|+||||||+||++++++.+||+|||+++...
T Consensus 103 ~~-~~~L~~~~~~-------~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~ 171 (345)
T cd07877 103 LM-GADLNNIVKC-------QKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTD 171 (345)
T ss_pred hc-ccCHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChHHEEEcCCCCEEEeccccccccc
Confidence 77 7899888753 248899999999999999999999 899999999999999999999999999987432
Q ss_pred ccCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCC-CCCCchhhhHHHHHHHHHHHhCCCcccc
Q 005102 560 IAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKV-VKPSQKWDIYSYGVILLEMITGRTAVVQ 638 (714)
Q Consensus 560 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DVwS~Gvvl~elltG~~p~~~ 638 (714)
.. .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||..
T Consensus 172 ~~-------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~ 220 (345)
T cd07877 172 DE-------------------------------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 220 (345)
T ss_pred cc-------------------------------ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 10 112245778999999866 4688999999999999999999999943
Q ss_pred CCCCcchhHHHHHHHHhhcCCcccccC--------------CCCCC-CCC--cHHHHHHHHHHHhHccCCCCCCCCCHHH
Q 005102 639 VGSSEMDLVNWMQLCIEEKKPLADVLD--------------PYLAP-DAD--KEEEIIAVLKIAMACVHSSPEKRPTMRH 701 (714)
Q Consensus 639 ~~~~~~~l~~~~~~~~~~~~~~~~~~d--------------~~~~~-~~~--~~~~~~~l~~li~~Cl~~dP~~RPt~~e 701 (714)
.... ..+.... ... ......+.. +.... ... .......+.+++.+|++.||.+|||+.+
T Consensus 221 ~~~~-~~~~~~~-~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e 296 (345)
T cd07877 221 TDHI-DQLKLIL-RLV--GTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQ 296 (345)
T ss_pred CCHH-HHHHHHH-HHh--CCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHH
Confidence 2211 1111110 000 000000000 00000 000 0001235789999999999999999999
Q ss_pred HHH
Q 005102 702 ISD 704 (714)
Q Consensus 702 vl~ 704 (714)
++.
T Consensus 297 ~l~ 299 (345)
T cd07877 297 ALA 299 (345)
T ss_pred Hhc
Confidence 875
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-33 Score=295.55 Aligned_cols=249 Identities=22% Similarity=0.316 Sum_probs=186.0
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeCCC--CchhHHHHHHHHHHHhccCCCCccceEEEEEeCCc------eeEEEe
Q 005102 409 FVLGKSGIGIVYKVVLE-DGHTLAVRRLGEG--GSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDE------KLLIYD 479 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~------~~lV~e 479 (714)
..||+|+||.||+|+.. +++.||||++... .....+.+.+|+.++++++||||+++++++...+. .++|+|
T Consensus 21 ~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e 100 (343)
T cd07851 21 SPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYLVTH 100 (343)
T ss_pred EEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccccEEEEEe
Confidence 47999999999999986 4789999998753 22234567889999999999999999998876554 899999
Q ss_pred ccCCCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhh
Q 005102 480 YIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLAN 559 (714)
Q Consensus 480 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~ 559 (714)
|+ +++|.+++.. ..+++..+..++.|+++||+|||+ .+|+||||||+||++++++.+||+|||++....
T Consensus 101 ~~-~~~L~~~~~~-------~~l~~~~~~~~~~ql~~aL~~LH~---~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~~ 169 (343)
T cd07851 101 LM-GADLNNIVKC-------QKLSDDHIQFLVYQILRGLKYIHS---AGIIHRDLKPSNIAVNEDCELKILDFGLARHTD 169 (343)
T ss_pred cC-CCCHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEcccccccccc
Confidence 99 6699998864 348999999999999999999999 899999999999999999999999999987542
Q ss_pred ccCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCC-CCCCchhhhHHHHHHHHHHHhCCCcccc
Q 005102 560 IAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKV-VKPSQKWDIYSYGVILLEMITGRTAVVQ 638 (714)
Q Consensus 560 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DVwS~Gvvl~elltG~~p~~~ 638 (714)
.. .....++..|+|||.+.+ ..++.++|||||||++|||+||+.||..
T Consensus 170 ~~-------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~ 218 (343)
T cd07851 170 DE-------------------------------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPG 218 (343)
T ss_pred cc-------------------------------ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence 11 112234677999999865 3678999999999999999999999943
Q ss_pred CCCCcchhHHHHHHHHhhcC-Cccccc------------C---CCCCCCCC--cHHHHHHHHHHHhHccCCCCCCCCCHH
Q 005102 639 VGSSEMDLVNWMQLCIEEKK-PLADVL------------D---PYLAPDAD--KEEEIIAVLKIAMACVHSSPEKRPTMR 700 (714)
Q Consensus 639 ~~~~~~~l~~~~~~~~~~~~-~~~~~~------------d---~~~~~~~~--~~~~~~~l~~li~~Cl~~dP~~RPt~~ 700 (714)
... . ..+........ +..++. . ........ ......++.+++.+||+.||++|||+.
T Consensus 219 ~~~--~---~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ 293 (343)
T cd07851 219 SDH--I---DQLKRIMNLVGTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAA 293 (343)
T ss_pred CCh--H---HHHHHHHHhcCCCCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHH
Confidence 221 1 11111111000 000000 0 00000000 001134688999999999999999999
Q ss_pred HHHH
Q 005102 701 HISD 704 (714)
Q Consensus 701 evl~ 704 (714)
+|+.
T Consensus 294 ell~ 297 (343)
T cd07851 294 EALA 297 (343)
T ss_pred HHhc
Confidence 9875
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-33 Score=274.76 Aligned_cols=257 Identities=18% Similarity=0.261 Sum_probs=200.4
Q ss_pred ccccccCceEEEEEEECC------CcEEEEEEeCCC-CchhHHHHHHHHHHHhccCCCCccceEEEEEeC-CceeEEEec
Q 005102 409 FVLGKSGIGIVYKVVLED------GHTLAVRRLGEG-GSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSV-DEKLLIYDY 480 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~~------g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~-~~~~lV~e~ 480 (714)
.++-+|.||+||+|.|++ .+.|-||.++.. +......+..|.-.+..+.|||+..+.+.+.+. ...+++|.+
T Consensus 290 ~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~P~V~y~~ 369 (563)
T KOG1024|consen 290 CLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYATPFVLYPA 369 (563)
T ss_pred hhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCcceEEEec
Confidence 467899999999997653 466788887765 334456788999999999999999999998764 567899999
Q ss_pred cCCCCHhhhhhCCCCCCC--cCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhh
Q 005102 481 IPNGSLATALHGKPGMVS--FTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLA 558 (714)
Q Consensus 481 ~~~gsL~~~l~~~~~~~~--~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~ 558 (714)
+.-|+|..+|...++... .+.++-.+.+.++.|++.|++|||. ++|||.||.++|.+||+..++||+|=.++|.+
T Consensus 370 ~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~---~~ViHkDiAaRNCvIdd~LqVkltDsaLSRDL 446 (563)
T KOG1024|consen 370 TGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHN---HGVIHKDIAARNCVIDDQLQVKLTDSALSRDL 446 (563)
T ss_pred cCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHh---cCcccchhhhhcceehhheeEEeccchhcccc
Confidence 999999999983332211 1456777889999999999999999 99999999999999999999999999999876
Q ss_pred hccCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHh-CCCccc
Q 005102 559 NIAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMIT-GRTAVV 637 (714)
Q Consensus 559 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~ellt-G~~p~~ 637 (714)
-+.+.+.-..+ .....-||+||.+....|+.++|||||||+||||+| |+.||.
T Consensus 447 FP~DYhcLGDn--------------------------EnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~Pya 500 (563)
T KOG1024|consen 447 FPGDYHCLGDN--------------------------ENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYA 500 (563)
T ss_pred CcccccccCCC--------------------------CCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCcc
Confidence 54432211111 111334999999999999999999999999999999 999995
Q ss_pred cCCCCcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhhhhc
Q 005102 638 QVGSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDALDRLIV 711 (714)
Q Consensus 638 ~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~ 711 (714)
+.+..+ +...++++..+.+ |. +++.++..+|.-||..+|++||+++|++..|.+...
T Consensus 501 eIDPfE------m~~ylkdGyRlaQ---P~--------NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~ 557 (563)
T KOG1024|consen 501 EIDPFE------MEHYLKDGYRLAQ---PF--------NCPDELFTVMACCWALLPEERPSFSQLVICLSEFHT 557 (563)
T ss_pred ccCHHH------HHHHHhccceecC---CC--------CCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHH
Confidence 443222 2233444443222 21 244579999999999999999999999999988653
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=280.91 Aligned_cols=234 Identities=22% Similarity=0.301 Sum_probs=187.2
Q ss_pred ccccccCceEEEEEEECC-CcEEEEEEeCCCCc---hhHHHHHHHHHHHhcc-CCCCccceEEEEEeCCceeEEEeccCC
Q 005102 409 FVLGKSGIGIVYKVVLED-GHTLAVRRLGEGGS---QRFKEFQTEVEAIGKI-RHSNIVTLRAYYWSVDEKLLIYDYIPN 483 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~~-g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~e~~~~ 483 (714)
.+||+|+||+|..+..+. .+.+|||++++... ...+--+.|-++|.-- +-|.+++++.+|++-+.+|+||||+.+
T Consensus 355 ~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFVMEyvnG 434 (683)
T KOG0696|consen 355 MVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFVMEYVNG 434 (683)
T ss_pred EEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeEEEEecC
Confidence 489999999999998765 57899999987522 2223345677777766 578999999999999999999999999
Q ss_pred CCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCC
Q 005102 484 GSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGG 563 (714)
Q Consensus 484 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 563 (714)
|+|..++++- .++.+..+.-+|.+||-||-|||+ ++||.||||..|||+|.+|++||+|||+++.--..
T Consensus 435 GDLMyhiQQ~------GkFKEp~AvFYAaEiaigLFFLh~---kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~~-- 503 (683)
T KOG0696|consen 435 GDLMYHIQQV------GKFKEPVAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIFD-- 503 (683)
T ss_pred chhhhHHHHh------cccCCchhhhhhHHHHHHhhhhhc---CCeeeeeccccceEeccCCceEeeecccccccccC--
Confidence 9999998765 457788899999999999999999 99999999999999999999999999999742111
Q ss_pred CCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCccccCCCCc
Q 005102 564 SPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGSSE 643 (714)
Q Consensus 564 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~~~~~~~~ 643 (714)
..++.+..||+.|+|||++..++|+..+|.|||||+||||+.|++||.. .++
T Consensus 504 --------------------------~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdG--eDE 555 (683)
T KOG0696|consen 504 --------------------------GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDG--EDE 555 (683)
T ss_pred --------------------------CcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCC--CCH
Confidence 3345677899999999999999999999999999999999999999942 222
Q ss_pred chhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCC
Q 005102 644 MDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRP 697 (714)
Q Consensus 644 ~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RP 697 (714)
.+..+.+.+..-..+. .-..+..++....+.+.|.+|.
T Consensus 556 ---~elF~aI~ehnvsyPK-------------slSkEAv~ickg~ltK~P~kRL 593 (683)
T KOG0696|consen 556 ---DELFQAIMEHNVSYPK-------------SLSKEAVAICKGLLTKHPGKRL 593 (683)
T ss_pred ---HHHHHHHHHccCcCcc-------------cccHHHHHHHHHHhhcCCcccc
Confidence 2333333333322111 1223566777788888999884
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=310.91 Aligned_cols=243 Identities=25% Similarity=0.291 Sum_probs=195.1
Q ss_pred cccccCceEEEEEEECC-CcEEEEEEeCCC---CchhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCCC
Q 005102 410 VLGKSGIGIVYKVVLED-GHTLAVRRLGEG---GSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGS 485 (714)
Q Consensus 410 ~lG~G~~g~Vy~~~~~~-g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gs 485 (714)
+||+|+||.|..++++. ++.||+|++.+- ......-|..|-++|..-+.+-|++++-.|.+..+.|+|||||+|||
T Consensus 82 vIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYlVMdY~pGGD 161 (1317)
T KOG0612|consen 82 VIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYLVMDYMPGGD 161 (1317)
T ss_pred HhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEEEEecccCch
Confidence 89999999999999865 889999999873 23344568999999999999999999999999999999999999999
Q ss_pred HhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCCC
Q 005102 486 LATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSP 565 (714)
Q Consensus 486 L~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 565 (714)
|-.++... .++++..++-|+..|.-||.-||+ .|+|||||||+|||||..|++||+|||.+-.++.++
T Consensus 162 lltLlSk~------~~~pE~~ArFY~aEiVlAldslH~---mgyVHRDiKPDNvLld~~GHikLADFGsClkm~~dG--- 229 (1317)
T KOG0612|consen 162 LLTLLSKF------DRLPEDWARFYTAEIVLALDSLHS---MGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDADG--- 229 (1317)
T ss_pred HHHHHhhc------CCChHHHHHHHHHHHHHHHHHHHh---ccceeccCCcceeEecccCcEeeccchhHHhcCCCC---
Confidence 99999765 358899999999999999999999 899999999999999999999999999887665332
Q ss_pred CccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccC----C-CCCCchhhhHHHHHHHHHHHhCCCccccCC
Q 005102 566 TLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLK----V-VKPSQKWDIYSYGVILLEMITGRTAVVQVG 640 (714)
Q Consensus 566 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~----~-~~~s~~~DVwS~Gvvl~elltG~~p~~~~~ 640 (714)
.......+|||.|++||+++ + +.|+..+|.||+||++|||+.|..||+.
T Consensus 230 ------------------------~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYa-- 283 (1317)
T KOG0612|consen 230 ------------------------TVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYA-- 283 (1317)
T ss_pred ------------------------cEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchH--
Confidence 34456778999999999995 3 5789999999999999999999999952
Q ss_pred CCcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCC---HHHHH
Q 005102 641 SSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPT---MRHIS 703 (714)
Q Consensus 641 ~~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt---~~evl 703 (714)
..+++-+..+...+..+ . ++.+. +...+..+||.+.+. +|+.|.. ++++.
T Consensus 284 ---dslveTY~KIm~hk~~l-~-----FP~~~---~VSeeakdLI~~ll~-~~e~RLgrngiedik 336 (1317)
T KOG0612|consen 284 ---DSLVETYGKIMNHKESL-S-----FPDET---DVSEEAKDLIEALLC-DREVRLGRNGIEDIK 336 (1317)
T ss_pred ---HHHHHHHHHHhchhhhc-C-----CCccc---ccCHHHHHHHHHHhc-ChhhhcccccHHHHH
Confidence 34555444444432211 0 11111 123356677776553 6888876 66654
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=283.23 Aligned_cols=255 Identities=25% Similarity=0.346 Sum_probs=190.7
Q ss_pred ccccccCceEEEEEEE-CCCcEEEEEEeCCCC-------chhHHHHHHHHHHHhccCCCCccceEEEEEe-CCceeEEEe
Q 005102 409 FVLGKSGIGIVYKVVL-EDGHTLAVRRLGEGG-------SQRFKEFQTEVEAIGKIRHSNIVTLRAYYWS-VDEKLLIYD 479 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~-------~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~-~~~~~lV~e 479 (714)
++||+|||++||+|.+ ...+.||||+-.... ....+...+|.+|-+.+.||.||++|+|+.- .+..|-|+|
T Consensus 469 hLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtdsFCTVLE 548 (775)
T KOG1151|consen 469 HLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDSFCTVLE 548 (775)
T ss_pred HHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccccceeeee
Confidence 4799999999999985 447889999754321 1123567899999999999999999999975 456789999
Q ss_pred ccCCCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeC---CCCCeEEcccchhh
Q 005102 480 YIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLG---HNMEPHVSDFGLAR 556 (714)
Q Consensus 480 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~---~~~~~kl~DFGla~ 556 (714)
||++.+|.-+|+.. ..+++.+++.|+.||..||.||.+-.| +|||-||||.|||+- ..|.+||.|||+++
T Consensus 549 YceGNDLDFYLKQh------klmSEKEARSIiMQiVnAL~YLNEikp-PIIHYDLKPgNILLv~GtacGeIKITDFGLSK 621 (775)
T KOG1151|consen 549 YCEGNDLDFYLKQH------KLMSEKEARSIIMQIVNALKYLNEIKP-PIIHYDLKPGNILLVNGTACGEIKITDFGLSK 621 (775)
T ss_pred ecCCCchhHHHHhh------hhhhHHHHHHHHHHHHHHHHHHhccCC-CeeeeccCCccEEEecCcccceeEeeecchhh
Confidence 99999999999877 458999999999999999999998765 899999999999994 35889999999999
Q ss_pred hhhccCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCC----CCCchhhhHHHHHHHHHHHhC
Q 005102 557 LANIAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVV----KPSQKWDIYSYGVILLEMITG 632 (714)
Q Consensus 557 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~s~~~DVwS~Gvvl~elltG 632 (714)
.++.+... +......+....||.+|.+||.+.-+ +++.|+||||.|||+|..+.|
T Consensus 622 IMdddSy~---------------------~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYG 680 (775)
T KOG1151|consen 622 IMDDDSYN---------------------SVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYG 680 (775)
T ss_pred hccCCccC---------------------cccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhcc
Confidence 98654211 01112334456789999999998644 468899999999999999999
Q ss_pred CCccccCCCCcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHH
Q 005102 633 RTAVVQVGSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHIS 703 (714)
Q Consensus 633 ~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl 703 (714)
+.||-.... ..++.+ +.. +...-.-.+++.+ ....+...+|++||.+.-++|....++.
T Consensus 681 rKPFGhnqs-QQdILq-------eNT-IlkAtEVqFP~KP---vVsseAkaFIRRCLaYRKeDR~DV~qLA 739 (775)
T KOG1151|consen 681 RKPFGHNQS-QQDILQ-------ENT-ILKATEVQFPPKP---VVSSEAKAFIRRCLAYRKEDRIDVQQLA 739 (775)
T ss_pred CCCCCCchh-HHHHHh-------hhc-hhcceeccCCCCC---ccCHHHHHHHHHHHHhhhhhhhhHHHHc
Confidence 999932211 111111 111 0000011111111 1223566899999999999998777664
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=289.70 Aligned_cols=253 Identities=23% Similarity=0.338 Sum_probs=196.3
Q ss_pred cCHHHHHHhc-cccccccCceEEEEEEEC-CCcEEEEEEeCCCC--chhHHHHHHHHHHHhccCCCCccceEEEEEeCCc
Q 005102 398 FDLDELLKAS-AFVLGKSGIGIVYKVVLE-DGHTLAVRRLGEGG--SQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDE 473 (714)
Q Consensus 398 ~~~~~l~~~~-~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~ 473 (714)
.++..+++.. .++||.|.||+||-|.++ +|+.||||++.+.. .....+..+|+.||..++||.||.+--.|++.+.
T Consensus 558 vd~stvYQif~devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~er 637 (888)
T KOG4236|consen 558 VDISTVYQIFADEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPER 637 (888)
T ss_pred hhHHHHHHhhhHhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCce
Confidence 3344444432 478999999999999975 69999999998752 2233678899999999999999999999999999
Q ss_pred eeEEEeccCCCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCC---CCeEEc
Q 005102 474 KLLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHN---MEPHVS 550 (714)
Q Consensus 474 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~---~~~kl~ 550 (714)
.++|||-+ +||..+++-.... .+|++...+-++.||+.||.|||. ++|+|+||||+|||+.+. -++||+
T Consensus 638 vFVVMEKl-~GDMLEMILSsEk----gRL~er~TkFlvtQIL~ALr~LH~---knIvHCDLKPENVLLas~~~FPQvKlC 709 (888)
T KOG4236|consen 638 VFVVMEKL-HGDMLEMILSSEK----GRLPERITKFLVTQILVALRYLHF---KNIVHCDLKPENVLLASASPFPQVKLC 709 (888)
T ss_pred EEEEehhh-cchHHHHHHHhhc----ccchHHHHHHHHHHHHHHHHHhhh---cceeeccCCchheeeccCCCCCceeec
Confidence 99999999 5677776644322 568888889999999999999999 999999999999999654 469999
Q ss_pred ccchhhhhhccCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHH
Q 005102 551 DFGLARLANIAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMI 630 (714)
Q Consensus 551 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~ell 630 (714)
|||+|+++.+. .-..+.+||+.|.|||+++...|...-|+||.|||+|--+
T Consensus 710 DFGfARiIgEk-----------------------------sFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsL 760 (888)
T KOG4236|consen 710 DFGFARIIGEK-----------------------------SFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSL 760 (888)
T ss_pred cccceeecchh-----------------------------hhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEe
Confidence 99999987532 1234567899999999999999999999999999999999
Q ss_pred hCCCccccCCCCcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHH
Q 005102 631 TGRTAVVQVGSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHIS 703 (714)
Q Consensus 631 tG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl 703 (714)
+|..||.+ +.++.+.++. ..++-| .....+.....+++|...|+..=++|-|.++.+
T Consensus 761 SGTFPFNE----dEdIndQIQN--------AaFMyP----p~PW~eis~~AidlIn~LLqVkm~kRysvdk~l 817 (888)
T KOG4236|consen 761 SGTFPFNE----DEDINDQIQN--------AAFMYP----PNPWSEISPEAIDLINNLLQVKMRKRYSVDKSL 817 (888)
T ss_pred cccccCCC----ccchhHHhhc--------cccccC----CCchhhcCHHHHHHHHHHHHHHHHHhcchHhhc
Confidence 99999932 2333332221 111111 111233444677888888888888888876654
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=3e-33 Score=278.24 Aligned_cols=251 Identities=22% Similarity=0.291 Sum_probs=193.0
Q ss_pred cccccCceEEEEEEECC-CcEEEEEEeCCCCchhHHHHHHHHHHHhccC-C-C----CccceEEEEEeCCceeEEEeccC
Q 005102 410 VLGKSGIGIVYKVVLED-GHTLAVRRLGEGGSQRFKEFQTEVEAIGKIR-H-S----NIVTLRAYYWSVDEKLLIYDYIP 482 (714)
Q Consensus 410 ~lG~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H-~----niv~l~~~~~~~~~~~lV~e~~~ 482 (714)
.+|+|+||.|-.+.++. +..||||+++.-... .+...-|++++.++. + | -+|.+.++|.-.++.|+|+|.+
T Consensus 96 ~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kY-reAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghiCivfell- 173 (415)
T KOG0671|consen 96 LLGEGTFGKVVECWDRETKEHVALKIIKNVDKY-REAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHICIVFELL- 173 (415)
T ss_pred hhcCCcccceEEEeecCCCceehHHHHHHHHHH-hhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCceEEEEecc-
Confidence 69999999999999754 789999999765433 356678999999994 2 3 3788888999999999999998
Q ss_pred CCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCC-------------------
Q 005102 483 NGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGH------------------- 543 (714)
Q Consensus 483 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~------------------- 543 (714)
|-|+++++..+.. .+++...++.|+.|++++++|||+ .+++|-||||+|||+-+
T Consensus 174 G~S~~dFlk~N~y----~~fpi~~ir~m~~QL~~sv~fLh~---~kl~HTDLKPENILfvss~~~~~~~~k~~~~~~r~~ 246 (415)
T KOG0671|consen 174 GLSTFDFLKENNY----IPFPIDHIRHMGYQLLESVAFLHD---LKLTHTDLKPENILFVSSEYFKTYNPKKKVCFIRPL 246 (415)
T ss_pred ChhHHHHhccCCc----cccchHHHHHHHHHHHHHHHHHHh---cceeecCCChheEEEeccceEEEeccCCccceeccC
Confidence 5699999987643 678999999999999999999999 89999999999999932
Q ss_pred -CCCeEEcccchhhhhhccCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHH
Q 005102 544 -NMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSY 622 (714)
Q Consensus 544 -~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~ 622 (714)
+..+||+|||.|++..... +..+.|..|+|||++.+-.++.++||||+
T Consensus 247 ks~~I~vIDFGsAtf~~e~h-------------------------------s~iVsTRHYRAPEViLgLGwS~pCDvWSi 295 (415)
T KOG0671|consen 247 KSTAIKVIDFGSATFDHEHH-------------------------------STIVSTRHYRAPEVILGLGWSQPCDVWSI 295 (415)
T ss_pred CCcceEEEecCCcceeccCc-------------------------------ceeeeccccCCchheeccCcCCccCceee
Confidence 2358999999998754321 22344788999999999999999999999
Q ss_pred HHHHHHHHhCCCccccCCCCcchhHHHHHHHHhhcCCcccccCCC-----------------CCC-------C-------
Q 005102 623 GVILLEMITGRTAVVQVGSSEMDLVNWMQLCIEEKKPLADVLDPY-----------------LAP-------D------- 671 (714)
Q Consensus 623 Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~-----------------~~~-------~------- 671 (714)
||||.|+.||...|....+. +....++.++.. .+ ..++... ... .
T Consensus 296 GCIL~ElytG~~LFqtHen~--EHLaMMerIlGp-~P-~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~ 371 (415)
T KOG0671|consen 296 GCILVELYTGETLFQTHENL--EHLAMMERILGP-IP-SRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKY 371 (415)
T ss_pred eeEEEEeeccceecccCCcH--HHHHHHHHhhCC-Cc-HHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHH
Confidence 99999999999999554322 222333332221 00 0110000 000 0
Q ss_pred -CCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 005102 672 -ADKEEEIIAVLKIAMACVHSSPEKRPTMRHISD 704 (714)
Q Consensus 672 -~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 704 (714)
.....+..++.+++.+||..||.+|+|+.|++.
T Consensus 372 ~~~~d~e~~~LfDLl~~mL~fDP~~RiTl~EAL~ 405 (415)
T KOG0671|consen 372 MLQDDLEHVQLFDLLRRMLEFDPARRITLREALS 405 (415)
T ss_pred hccCcHHHhHHHHHHHHHHccCccccccHHHHhc
Confidence 012356678999999999999999999999875
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.9e-32 Score=294.23 Aligned_cols=245 Identities=22% Similarity=0.336 Sum_probs=196.6
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeCCCCchhHHHHHHHHHHHhcc-CCCCccceEEEEEe-----CCceeEEEecc
Q 005102 409 FVLGKSGIGIVYKVVLE-DGHTLAVRRLGEGGSQRFKEFQTEVEAIGKI-RHSNIVTLRAYYWS-----VDEKLLIYDYI 481 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~-----~~~~~lV~e~~ 481 (714)
++||+|.+|.||+++.+ +|+.+|||+....... .++...|.++++.. .|||++.++|+|.. ++.++||||||
T Consensus 25 evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~-deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLWLVMEfC 103 (953)
T KOG0587|consen 25 EVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDE-EEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLWLVMEFC 103 (953)
T ss_pred EEEeeccceeEEEEeeeecCceeeeEeecCCccc-cHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEEEEeecc
Confidence 48999999999999964 5888899887664333 36778899999988 69999999999874 46789999999
Q ss_pred CCCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhcc
Q 005102 482 PNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIA 561 (714)
Q Consensus 482 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 561 (714)
.+|+..++++...+ .++.|..+..|++.+++||.|||. +.++|||+|-.|||++.++.+|+.|||++..++..
T Consensus 104 ~gGSVTDLVKn~~g----~rl~E~~IaYI~re~lrgl~HLH~---nkviHRDikG~NiLLT~e~~VKLvDFGvSaQldsT 176 (953)
T KOG0587|consen 104 GGGSVTDLVKNTKG----NRLKEEWIAYILREILRGLAHLHN---NKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDST 176 (953)
T ss_pred CCccHHHHHhhhcc----cchhhHHHHHHHHHHHHHHHHHhh---cceeeecccCceEEEeccCcEEEeeeeeeeeeecc
Confidence 99999999987764 579999999999999999999999 89999999999999999999999999998765421
Q ss_pred CCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCC-----CCCCchhhhHHHHHHHHHHHhCCCcc
Q 005102 562 GGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKV-----VKPSQKWDIYSYGVILLEMITGRTAV 636 (714)
Q Consensus 562 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~~~DVwS~Gvvl~elltG~~p~ 636 (714)
.....+..||++|||||++.. ..|+..+|+||+|++..||.-|.+|+
T Consensus 177 ----------------------------~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl 228 (953)
T KOG0587|consen 177 ----------------------------VGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPL 228 (953)
T ss_pred ----------------------------cccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCc
Confidence 234456778999999999853 34678999999999999999999999
Q ss_pred ccCCCCcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 005102 637 VQVGSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISD 704 (714)
Q Consensus 637 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 704 (714)
.+... ... .+...+. --|.+ .....-..++.++|..|+.+|-++||++.++++
T Consensus 229 ~DmHP-----mra---LF~IpRN----PPPkL---krp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~ 281 (953)
T KOG0587|consen 229 CDMHP-----MRA---LFLIPRN----PPPKL---KRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK 281 (953)
T ss_pred cCcch-----hhh---hccCCCC----CCccc---cchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence 54322 111 1111110 01111 123456778999999999999999999988764
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2e-32 Score=290.01 Aligned_cols=231 Identities=26% Similarity=0.330 Sum_probs=184.3
Q ss_pred cccccCceEEEEEEEC-CCcEEEEEEeCCCCchhHHHHHHHHHHHhcc-CCCCccceEEEEEeCCceeEEEeccCCCCHh
Q 005102 410 VLGKSGIGIVYKVVLE-DGHTLAVRRLGEGGSQRFKEFQTEVEAIGKI-RHSNIVTLRAYYWSVDEKLLIYDYIPNGSLA 487 (714)
Q Consensus 410 ~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~e~~~~gsL~ 487 (714)
.+|.|+|+.|-++.+. +++..+||++.+.. .+-.+|+.++.+. +||||+++.+.+.+..+.|+|||++.+|-+.
T Consensus 329 ~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~----~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~l~g~ell 404 (612)
T KOG0603|consen 329 ELGEGSFSAVKYCESSPTDQEPAVKIISKRA----DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMELLDGGELL 404 (612)
T ss_pred ccCCCCccceeeeeccccccchhheeccccc----cccccccchhhhhcCCCcceeecceecCCceeeeeehhccccHHH
Confidence 4999999999998865 48899999998762 2345688787777 6999999999999999999999999999888
Q ss_pred hhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeee-CCCCCeEEcccchhhhhhccCCCCC
Q 005102 488 TALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILL-GHNMEPHVSDFGLARLANIAGGSPT 566 (714)
Q Consensus 488 ~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl-~~~~~~kl~DFGla~~~~~~~~~~~ 566 (714)
+.+...+ ... .++..|+.+|+.|+.|||+ +|||||||||+|||+ ++.++++|+|||.++.....
T Consensus 405 ~ri~~~~------~~~-~e~~~w~~~lv~Av~~LH~---~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~----- 469 (612)
T KOG0603|consen 405 RRIRSKP------EFC-SEASQWAAELVSAVDYLHE---QGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS----- 469 (612)
T ss_pred HHHHhcc------hhH-HHHHHHHHHHHHHHHHHHh---cCeeecCCChhheeecCCCCcEEEEEechhhhCchh-----
Confidence 8776542 223 6788899999999999999 999999999999999 68999999999999876432
Q ss_pred ccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCccccCCCCcchh
Q 005102 567 LQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGSSEMDL 646 (714)
Q Consensus 567 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~~~~~~~~~~l 646 (714)
..+..-|..|.|||++....|++++|+||||++||||++|+.||.....+
T Consensus 470 --------------------------~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~---- 519 (612)
T KOG0603|consen 470 --------------------------CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG---- 519 (612)
T ss_pred --------------------------hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch----
Confidence 11122367799999999999999999999999999999999999544333
Q ss_pred HHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 005102 647 VNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISD 704 (714)
Q Consensus 647 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 704 (714)
.+...+ +.. +... ........+++.+||+.||.+||+|.++..
T Consensus 520 ~ei~~~-i~~---------~~~s-----~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~ 562 (612)
T KOG0603|consen 520 IEIHTR-IQM---------PKFS-----ECVSDEAKDLLQQLLQVDPALRLGADEIGA 562 (612)
T ss_pred HHHHHh-hcC---------Cccc-----cccCHHHHHHHHHhccCChhhCcChhhhcc
Confidence 111111 111 1111 123346789999999999999999999864
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-31 Score=269.12 Aligned_cols=238 Identities=26% Similarity=0.358 Sum_probs=190.2
Q ss_pred CceEEEEEEECC-CcEEEEEEeCCCCchh-HHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCCCHhhhhhC
Q 005102 415 GIGIVYKVVLED-GHTLAVRRLGEGGSQR-FKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGSLATALHG 492 (714)
Q Consensus 415 ~~g~Vy~~~~~~-g~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~ 492 (714)
+||.||+|...+ |+.+|+|++....... .+.+.+|++.+++++|+||+++++++......+++|||+++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 589999999875 8999999998765444 67899999999999999999999999999999999999999999999875
Q ss_pred CCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCCCCccCCCC
Q 005102 493 KPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRM 572 (714)
Q Consensus 493 ~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~ 572 (714)
.. .+++..+..++.++++++.|||+ .+++|+||+|+||++++++.++|+|||.+.......
T Consensus 81 ~~------~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---------- 141 (244)
T smart00220 81 RG------RLSEDEARFYARQILSALEYLHS---NGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---------- 141 (244)
T ss_pred cc------CCCHHHHHHHHHHHHHHHHHHHH---cCeecCCcCHHHeEECCCCcEEEccccceeeecccc----------
Confidence 42 37899999999999999999999 899999999999999999999999999987654221
Q ss_pred CCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCccccCCCCcchhHHHHHH
Q 005102 573 PAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGSSEMDLVNWMQL 652 (714)
Q Consensus 573 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~ 652 (714)
......++..|+|||.+.+..++.++||||||+++|+|++|+.||.... +.......
T Consensus 142 -------------------~~~~~~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~----~~~~~~~~ 198 (244)
T smart00220 142 -------------------LLTTFVGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDD----QLLELFKK 198 (244)
T ss_pred -------------------ccccccCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC----cHHHHHHH
Confidence 1122335677999999988889999999999999999999999984321 11111211
Q ss_pred HHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 005102 653 CIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISD 704 (714)
Q Consensus 653 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 704 (714)
........ ... . .....++.+++.+||..+|++||++.++++
T Consensus 199 ~~~~~~~~---~~~----~---~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 199 IGKPKPPF---PPP----E---WKISPEAKDLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HhccCCCC---ccc----c---ccCCHHHHHHHHHHccCCchhccCHHHHhh
Confidence 11111100 000 0 002236889999999999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-32 Score=248.44 Aligned_cols=208 Identities=24% Similarity=0.300 Sum_probs=165.2
Q ss_pred CHHHHHHhccccccccCceEEEEEEEC-CCcEEEEEEeCCC-CchhHHHHHHHHHHHhcc-CCCCccceEEEEEeCCcee
Q 005102 399 DLDELLKASAFVLGKSGIGIVYKVVLE-DGHTLAVRRLGEG-GSQRFKEFQTEVEAIGKI-RHSNIVTLRAYYWSVDEKL 475 (714)
Q Consensus 399 ~~~~l~~~~~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~ 475 (714)
..++|.. ...||+|+||.|-+-++. +|+..|+|+++.. ..+..++..+|+++..+. .+|.+|+++|.+......+
T Consensus 44 ~ad~L~~--i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvw 121 (282)
T KOG0984|consen 44 PADDLVG--IEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVW 121 (282)
T ss_pred chhhhhh--hhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEE
Confidence 3444443 446999999999888764 5999999999865 344556788899887665 7999999999999999999
Q ss_pred EEEeccCCCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchh
Q 005102 476 LIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLA 555 (714)
Q Consensus 476 lV~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla 555 (714)
+.||.|.. ||..+..+--... ..+++.-.-+||..|..||.|||+. ..+||||+||+||||+.+|++|+||||.+
T Consensus 122 IcME~M~t-Sldkfy~~v~~~g--~~ipE~vlGkIa~Svv~al~~L~~k--L~vIHRDvKPsNiLIn~~GqVKiCDFGIs 196 (282)
T KOG0984|consen 122 ICMELMDT-SLDKFYRKVLKKG--GTIPEDVLGKIAVSVVHALEFLHSK--LSVIHRDVKPSNILINYDGQVKICDFGIS 196 (282)
T ss_pred EeHHHhhh-hHHHHHHHHHhcC--CcCchHHhhHhHHHHHHHHHHHHHH--hhhhhccCCcceEEEccCCcEEEcccccc
Confidence 99999954 8877654321111 4688899999999999999999995 47999999999999999999999999998
Q ss_pred hhhhccCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCC----CCCCchhhhHHHHHHHHHHHh
Q 005102 556 RLANIAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKV----VKPSQKWDIYSYGVILLEMIT 631 (714)
Q Consensus 556 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~s~~~DVwS~Gvvl~ellt 631 (714)
-.+.++- ..+...|.-.|||||.+.. ..|+.|+||||+|+++.||.+
T Consensus 197 G~L~dSi-----------------------------Akt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~ 247 (282)
T KOG0984|consen 197 GYLVDSI-----------------------------AKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAI 247 (282)
T ss_pred eeehhhh-----------------------------HHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhh
Confidence 7764321 1112234566999999853 358999999999999999999
Q ss_pred CCCccccCCCC
Q 005102 632 GRTAVVQVGSS 642 (714)
Q Consensus 632 G~~p~~~~~~~ 642 (714)
++.||...+..
T Consensus 248 lr~PY~~w~tp 258 (282)
T KOG0984|consen 248 LRFPYESWGTP 258 (282)
T ss_pred ccccccccCCH
Confidence 99999655443
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.2e-32 Score=262.78 Aligned_cols=239 Identities=21% Similarity=0.311 Sum_probs=193.1
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeCCC---CchhHHHHHHHHHHHhcc-CCCCccceEEEEEeCCceeEEEeccCC
Q 005102 409 FVLGKSGIGIVYKVVLE-DGHTLAVRRLGEG---GSQRFKEFQTEVEAIGKI-RHSNIVTLRAYYWSVDEKLLIYDYIPN 483 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~e~~~~ 483 (714)
.+||+|+|++|..++++ +.+.+|+|++++. +....+-.+.|-.+..+. +||.+|.++.+|++....++|.||+++
T Consensus 256 ~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffvieyv~g 335 (593)
T KOG0695|consen 256 RVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFVIEYVNG 335 (593)
T ss_pred eeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEEEEEecC
Confidence 38999999999999975 4788999999874 334455678888888887 699999999999999999999999999
Q ss_pred CCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCC
Q 005102 484 GSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGG 563 (714)
Q Consensus 484 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 563 (714)
|+|.-+++.. ++++++.++-+..+|+-||.|||+ +|||.||||..|||+|..|++||.|+|+++.--.+
T Consensus 336 gdlmfhmqrq------rklpeeharfys~ei~lal~flh~---rgiiyrdlkldnvlldaeghikltdygmcke~l~~-- 404 (593)
T KOG0695|consen 336 GDLMFHMQRQ------RKLPEEHARFYSAEICLALNFLHE---RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGP-- 404 (593)
T ss_pred cceeeehhhh------hcCcHHHhhhhhHHHHHHHHHHhh---cCeeeeeccccceEEccCCceeecccchhhcCCCC--
Confidence 9998888766 569999999999999999999999 99999999999999999999999999999742111
Q ss_pred CCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCccccCC--C
Q 005102 564 SPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVG--S 641 (714)
Q Consensus 564 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~~~~~--~ 641 (714)
...+++..||+.|+|||++.+..|+..+|.|++||+++||+.|+.||...+ +
T Consensus 405 --------------------------gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n 458 (593)
T KOG0695|consen 405 --------------------------GDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDN 458 (593)
T ss_pred --------------------------CcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCC
Confidence 335567889999999999999999999999999999999999999995433 2
Q ss_pred CcchhHHHHHHHHhh-cCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCC
Q 005102 642 SEMDLVNWMQLCIEE-KKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRP 697 (714)
Q Consensus 642 ~~~~l~~~~~~~~~~-~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RP 697 (714)
.++.-..++-..+-+ ...++. . ...+...+++.-+.+||.+|.
T Consensus 459 ~d~ntedylfqvilekqiripr--------s-----lsvkas~vlkgflnkdp~erl 502 (593)
T KOG0695|consen 459 PDMNTEDYLFQVILEKQIRIPR--------S-----LSVKASHVLKGFLNKDPKERL 502 (593)
T ss_pred cccchhHHHHHHHhhhcccccc--------e-----eehhhHHHHHHhhcCCcHHhc
Confidence 333333333332222 211111 1 122455788889999999985
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=285.30 Aligned_cols=255 Identities=21% Similarity=0.293 Sum_probs=173.4
Q ss_pred cccccccCceEEEEEEE-----------------CCCcEEEEEEeCCCCchhHHH--------------HHHHHHHHhcc
Q 005102 408 AFVLGKSGIGIVYKVVL-----------------EDGHTLAVRRLGEGGSQRFKE--------------FQTEVEAIGKI 456 (714)
Q Consensus 408 ~~~lG~G~~g~Vy~~~~-----------------~~g~~vavK~~~~~~~~~~~~--------------~~~E~~~l~~l 456 (714)
.++||+|+||.||+|.+ .+++.||||++........++ +..|+..+.++
T Consensus 150 ~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~~~l~~l 229 (507)
T PLN03224 150 RDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEAYMCAKI 229 (507)
T ss_pred eeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHHHHHHHh
Confidence 35899999999999964 235789999987643332233 34477777777
Q ss_pred CCCCc-----cceEEEEEe--------CCceeEEEeccCCCCHhhhhhCCCCC------------------CCcCCCCHH
Q 005102 457 RHSNI-----VTLRAYYWS--------VDEKLLIYDYIPNGSLATALHGKPGM------------------VSFTPVPWS 505 (714)
Q Consensus 457 ~H~ni-----v~l~~~~~~--------~~~~~lV~e~~~~gsL~~~l~~~~~~------------------~~~~~l~~~ 505 (714)
+|.++ +++++||.. .+..++||||+++|+|.++++...+. .....++|.
T Consensus 230 ~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~~~~~~ 309 (507)
T PLN03224 230 KRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQDKRDIN 309 (507)
T ss_pred hcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcccccCCHH
Confidence 66554 677887753 35679999999999999999753210 011245788
Q ss_pred HHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCCCCccCCCCCCCCchhhhcccc
Q 005102 506 VRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQKSV 585 (714)
Q Consensus 506 ~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 585 (714)
.+..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++......
T Consensus 310 ~~~~i~~ql~~aL~~lH~---~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~----------------------- 363 (507)
T PLN03224 310 VIKGVMRQVLTGLRKLHR---IGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGI----------------------- 363 (507)
T ss_pred HHHHHHHHHHHHHHHHHH---CCeecCCCchHhEEECCCCcEEEEeCcCccccccCC-----------------------
Confidence 899999999999999999 899999999999999999999999999986542110
Q ss_pred cceeecccCCCCCCccccCCcccCCCCC----------------------CchhhhHHHHHHHHHHHhCCC-ccccCCCC
Q 005102 586 SLEVTTTNSSSNLGSYYQAPESLKVVKP----------------------SQKWDIYSYGVILLEMITGRT-AVVQVGSS 642 (714)
Q Consensus 586 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~----------------------s~~~DVwS~Gvvl~elltG~~-p~~~~~~~ 642 (714)
........+|+.|+|||.+..... ..+.||||+||++|||++|.. ||......
T Consensus 364 ----~~~~~~g~~tp~Y~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f 439 (507)
T PLN03224 364 ----NFNPLYGMLDPRYSPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLF 439 (507)
T ss_pred ----ccCccccCCCcceeChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhh
Confidence 001111223678999999854321 124799999999999999875 66321111
Q ss_pred c-------chhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCC---CCCCCHHHHHH
Q 005102 643 E-------MDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSP---EKRPTMRHISD 704 (714)
Q Consensus 643 ~-------~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP---~~RPt~~evl~ 704 (714)
. .++..|.. .... ..+-.. .........+++.+++..+| .+|+|++|+++
T Consensus 440 ~~~~~~~~~~~~~~r~--~~~~-----~~~~~~-----~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~ 499 (507)
T PLN03224 440 NTELRQYDNDLNRWRM--YKGQ-----KYDFSL-----LDRNKEAGWDLACKLITKRDQANRGRLSVGQALS 499 (507)
T ss_pred hhHHhhccchHHHHHh--hccc-----CCCccc-----ccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence 1 11111111 0000 001000 01123357789999999766 68999999875
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-32 Score=278.33 Aligned_cols=244 Identities=21% Similarity=0.272 Sum_probs=195.2
Q ss_pred CHHHHHHhccccccccCceEEEEEEECCCc-EEEEEEeCCC---CchhHHHHHHHHHHHhccCCCCccceEEEEEeCCce
Q 005102 399 DLDELLKASAFVLGKSGIGIVYKVVLEDGH-TLAVRRLGEG---GSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEK 474 (714)
Q Consensus 399 ~~~~l~~~~~~~lG~G~~g~Vy~~~~~~g~-~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~ 474 (714)
.+.++... -.||-|+||.|=.+..+... .+|+|.+++. +....+....|-++|...+.|.||++|-.|.+....
T Consensus 418 ~l~dl~~i--aTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyv 495 (732)
T KOG0614|consen 418 KLSDLKRI--ATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYV 495 (732)
T ss_pred chhhhhhh--hhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhh
Confidence 34444442 25999999999999876533 4888888764 334445678899999999999999999999999999
Q ss_pred eEEEeccCCCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccch
Q 005102 475 LLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGL 554 (714)
Q Consensus 475 ~lV~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGl 554 (714)
|++||-|-||.|+..|.++ ..++..+.+-++..+.+|++|||+ ++||.|||||+|.++|.+|-+||.|||+
T Consensus 496 YmLmEaClGGElWTiLrdR------g~Fdd~tarF~~acv~EAfeYLH~---k~iIYRDLKPENllLd~~Gy~KLVDFGF 566 (732)
T KOG0614|consen 496 YMLMEACLGGELWTILRDR------GSFDDYTARFYVACVLEAFEYLHR---KGIIYRDLKPENLLLDNRGYLKLVDFGF 566 (732)
T ss_pred hhhHHhhcCchhhhhhhhc------CCcccchhhhhHHHHHHHHHHHHh---cCceeccCChhheeeccCCceEEeehhh
Confidence 9999999999999999877 458888899999999999999999 9999999999999999999999999999
Q ss_pred hhhhhccCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCC
Q 005102 555 ARLANIAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRT 634 (714)
Q Consensus 555 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~ 634 (714)
|+.+... ..+.+..||+.|.|||++.....+.++|.||+|+++|||+||++
T Consensus 567 AKki~~g-----------------------------~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~p 617 (732)
T KOG0614|consen 567 AKKIGSG-----------------------------RKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSP 617 (732)
T ss_pred HHHhccC-----------------------------CceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCC
Confidence 9987542 34567789999999999999999999999999999999999999
Q ss_pred ccccCCCCcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCC
Q 005102 635 AVVQVGSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPT 698 (714)
Q Consensus 635 p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt 698 (714)
||... +.+...+ ..++.-. .+-=| ........+++++....+|.+|..
T Consensus 618 PFs~~--dpmktYn---~ILkGid---~i~~P--------r~I~k~a~~Lik~LCr~~P~ERLG 665 (732)
T KOG0614|consen 618 PFSGV--DPMKTYN---LILKGID---KIEFP--------RRITKTATDLIKKLCRDNPTERLG 665 (732)
T ss_pred CCCCC--chHHHHH---HHHhhhh---hhhcc--------cccchhHHHHHHHHHhcCcHhhhc
Confidence 99432 2222222 2222210 00001 112234668888999999999965
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.8e-31 Score=294.82 Aligned_cols=257 Identities=20% Similarity=0.244 Sum_probs=161.0
Q ss_pred cccccccCceEEEEEEECC-----CcEEEEEEeCCCCchhHHHHHHHHHHHhccCCCCccceEEE------EEeCCceeE
Q 005102 408 AFVLGKSGIGIVYKVVLED-----GHTLAVRRLGEGGSQRFKEFQTEVEAIGKIRHSNIVTLRAY------YWSVDEKLL 476 (714)
Q Consensus 408 ~~~lG~G~~g~Vy~~~~~~-----g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~------~~~~~~~~l 476 (714)
.+.||+|+||.||+|++.+ +..||||++...... +.+..| .+.+..+.+++.++.. +......++
T Consensus 137 ~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~L 212 (566)
T PLN03225 137 GKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLEPVSSKKEDEYWL 212 (566)
T ss_pred eEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhcccccccCCceEE
Confidence 3589999999999999854 689999998654322 111111 1122222222222211 234567899
Q ss_pred EEeccCCCCHhhhhhCCCCCCC--------------cCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeC
Q 005102 477 IYDYIPNGSLATALHGKPGMVS--------------FTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLG 542 (714)
Q Consensus 477 V~e~~~~gsL~~~l~~~~~~~~--------------~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~ 542 (714)
||||+.+++|.+++........ ........+..|+.|++.||+|||+ ++|+||||||+|||++
T Consensus 213 V~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~---~gIiHRDLKP~NILl~ 289 (566)
T PLN03225 213 VWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHS---TGIVHRDVKPQNIIFS 289 (566)
T ss_pred EEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHH---CCEEeCcCCHHHEEEe
Confidence 9999999999999875421000 0011234466899999999999999 8999999999999998
Q ss_pred C-CCCeEEcccchhhhhhccCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCC----------
Q 005102 543 H-NMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVV---------- 611 (714)
Q Consensus 543 ~-~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---------- 611 (714)
+ ++.+||+|||+|+.+.... ........+|+.|+|||.+...
T Consensus 290 ~~~~~~KL~DFGlA~~l~~~~---------------------------~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~ 342 (566)
T PLN03225 290 EGSGSFKIIDLGAAADLRVGI---------------------------NYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAP 342 (566)
T ss_pred CCCCcEEEEeCCCcccccccc---------------------------ccCCcccccCCCccChHHhhccCCCCCCcccc
Confidence 6 5799999999998653211 0111234567889999965322
Q ss_pred ------------CCCchhhhHHHHHHHHHHHhCCCccccCCCCcchhHHHHHHHHhhcCCcc---cccCCCCCCC----C
Q 005102 612 ------------KPSQKWDIYSYGVILLEMITGRTAVVQVGSSEMDLVNWMQLCIEEKKPLA---DVLDPYLAPD----A 672 (714)
Q Consensus 612 ------------~~s~~~DVwS~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~---~~~d~~~~~~----~ 672 (714)
.++.++|||||||++|||+++..++. .++..+............ ....+....+ .
T Consensus 343 ~~~~~sp~l~~~~~~~k~DVwSlGviL~el~~~~~~~~------~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 416 (566)
T PLN03225 343 VATALSPVLWQLNLPDRFDIYSAGLIFLQMAFPNLRSD------SNLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGF 416 (566)
T ss_pred ccccccchhccccCCCCcccHHHHHHHHHHHhCcCCCc------hHHHHHHHHHHhcCCcHHHHHHhhccccchhhhhhh
Confidence 23456799999999999999766542 112221111111111000 0111110000 0
Q ss_pred C-cHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 005102 673 D-KEEEIIAVLKIAMACVHSSPEKRPTMRHISD 704 (714)
Q Consensus 673 ~-~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 704 (714)
. .........+|+.+||+.||++|||++|+++
T Consensus 417 ~~~d~~~~~~~dLi~~mL~~dP~kR~ta~e~L~ 449 (566)
T PLN03225 417 EVLDLDGGAGWELLKSMMRFKGRQRISAKAALA 449 (566)
T ss_pred hhccccchHHHHHHHHHccCCcccCCCHHHHhC
Confidence 0 0001123568999999999999999999976
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=314.96 Aligned_cols=228 Identities=41% Similarity=0.683 Sum_probs=167.7
Q ss_pred CchhHHHHHHHHHHhccCCCCCCCCCCCCCCCCCCcccceEec-CCcEEEEEcCCCCccccCCccccCCCCCCEEEccCC
Q 005102 20 SLNGEGYALLSFKQSVHEDPEGSLSNWNSSDENPCSWNGITCK-EQRVVSVSIPKKKLLGFLPSALGSLTDLRHVNLRNN 98 (714)
Q Consensus 20 ~~~~~~~~l~~~~~~~~~~~~~~l~~w~~~~~~~c~w~gv~c~-~~~~~~l~l~~~~l~g~~p~~~~~l~~L~~L~L~~N 98 (714)
..+.|+.||++||+++ .+|.+.+.+|+.. .++|.|.||+|+ ..+|+.|+|++|+++|.+|+.|..+++|+.|+|++|
T Consensus 26 ~~~~~~~~l~~~~~~~-~~~~~~~~~w~~~-~~~c~w~gv~c~~~~~v~~L~L~~~~i~~~~~~~~~~l~~L~~L~Ls~n 103 (968)
T PLN00113 26 LHAEELELLLSFKSSI-NDPLKYLSNWNSS-ADVCLWQGITCNNSSRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNN 103 (968)
T ss_pred CCHHHHHHHHHHHHhC-CCCcccCCCCCCC-CCCCcCcceecCCCCcEEEEEecCCCccccCChHHhCCCCCCEEECCCC
Confidence 3568999999999998 4787889999754 578999999997 569999999999999999999999999999999999
Q ss_pred CCcccCChhhc-CCCCCCEEEcCCCcCcccCCcccCCCCCCCEEeccCccCCCCCCcccccccccceeecccCcCCCCCC
Q 005102 99 KFFGSLPLELL-EAQGLQSLVLYGNSFSGSVPNEIGKLKYLQILDLSQNFFNGSLPVSIVQCKRLKALDLSQNNFTGPLP 177 (714)
Q Consensus 99 ~l~~~~p~~~~-~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p 177 (714)
+++|.+|..+. .+++|++|+|++|.++|.+|. +.+++|+.|+|++|.+++.+|..+.++++|++|+|++|.+.+.+|
T Consensus 104 ~~~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~--~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p 181 (968)
T PLN00113 104 QLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPR--GSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIP 181 (968)
T ss_pred ccCCcCChHHhccCCCCCEEECcCCccccccCc--cccCCCCEEECcCCcccccCChHHhcCCCCCEEECccCcccccCC
Confidence 99999998866 788888888888888776664 345666666666666666666666666666666666666666666
Q ss_pred cccccCccccccccccCCcccccCCCCCCCCcccccccccccccCCcCcCccccCCCCcccccCcCCcCCCCCCCC
Q 005102 178 NGFGSGLVSLEKLNLSFNKFNGSIPSNTGNLSSLQGTVDFSHNLFSGSIPASLGNLPEKVYIDLTYNNLSGPIPQN 253 (714)
Q Consensus 178 ~~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~~ 253 (714)
..+. ++++|++|+|++|++++.+|..++++++|+ .|++++|++++.+|..++.+++|+.|++++|++++.+|..
T Consensus 182 ~~~~-~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~-~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~ 255 (968)
T PLN00113 182 NSLT-NLTSLEFLTLASNQLVGQIPRELGQMKSLK-WIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSS 255 (968)
T ss_pred hhhh-hCcCCCeeeccCCCCcCcCChHHcCcCCcc-EEECcCCccCCcCChhHhcCCCCCEEECcCceeccccChh
Confidence 5553 356666666666666666666666666665 6666666666666666666666666666666665555543
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5e-31 Score=275.27 Aligned_cols=223 Identities=22% Similarity=0.292 Sum_probs=175.1
Q ss_pred ccccccCceEEEEEEECC-CcEEEEEEeCCCCchh---HHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCC
Q 005102 409 FVLGKSGIGIVYKVVLED-GHTLAVRRLGEGGSQR---FKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNG 484 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~g 484 (714)
..||-|.||+|.++...| ...+|+|.+++.+.-. ......|-+||...+.+-||++|-.|.+.+.+|+||||++||
T Consensus 635 k~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMdYIPGG 714 (1034)
T KOG0608|consen 635 KTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGG 714 (1034)
T ss_pred eeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEeccCCc
Confidence 459999999999998655 6789999998764332 235678999999999999999999999999999999999999
Q ss_pred CHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCC
Q 005102 485 SLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGS 564 (714)
Q Consensus 485 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 564 (714)
|+..+|... .-+.+..++-++.++..|+++.|. .|+|||||||+|||||.+|++||.||||+.-+.....+
T Consensus 715 DmMSLLIrm------gIFeE~LARFYIAEltcAiesVHk---mGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHds 785 (1034)
T KOG0608|consen 715 DMMSLLIRM------GIFEEDLARFYIAELTCAIESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS 785 (1034)
T ss_pred cHHHHHHHh------ccCHHHHHHHHHHHHHHHHHHHHh---ccceecccCccceEEccCCceeeeeccccccceecccc
Confidence 999999766 458888999999999999999999 89999999999999999999999999999755433322
Q ss_pred CCccCCCCCCC---Cchhh-----------hcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHH
Q 005102 565 PTLQSNRMPAE---KPQER-----------QQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMI 630 (714)
Q Consensus 565 ~~~~~~~~~~~---~~~~~-----------~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~ell 630 (714)
..++....... .+... ..+.....-.......+||+.|+|||++....++..+|.||.|||||||+
T Consensus 786 kYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~ 865 (1034)
T KOG0608|consen 786 KYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEML 865 (1034)
T ss_pred ccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHh
Confidence 22221111100 00000 00000001122334678999999999999999999999999999999999
Q ss_pred hCCCccccCC
Q 005102 631 TGRTAVVQVG 640 (714)
Q Consensus 631 tG~~p~~~~~ 640 (714)
.|+.||....
T Consensus 866 ~g~~pf~~~t 875 (1034)
T KOG0608|consen 866 VGQPPFLADT 875 (1034)
T ss_pred hCCCCccCCC
Confidence 9999995443
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-31 Score=286.68 Aligned_cols=245 Identities=24% Similarity=0.323 Sum_probs=184.7
Q ss_pred cccccccCce-EEEEEEECCCcEEEEEEeCCCCchhHHHHHHHHHHHhcc-CCCCccceEEEEEeCCceeEEEeccCCCC
Q 005102 408 AFVLGKSGIG-IVYKVVLEDGHTLAVRRLGEGGSQRFKEFQTEVEAIGKI-RHSNIVTLRAYYWSVDEKLLIYDYIPNGS 485 (714)
Q Consensus 408 ~~~lG~G~~g-~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~e~~~~gs 485 (714)
.+++|.|..| .||+|.++ |+.||||++-.... .-.++||..|+.- +|||||++++.-.+.+..|+..|.|. .+
T Consensus 514 ~eilG~Gs~Gt~Vf~G~ye-~R~VAVKrll~e~~---~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~-~s 588 (903)
T KOG1027|consen 514 KEILGYGSNGTVVFRGVYE-GREVAVKRLLEEFF---DFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCA-CS 588 (903)
T ss_pred HHHcccCCCCcEEEEEeeC-CceehHHHHhhHhH---HHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhh-hh
Confidence 3578999887 68999995 89999999865432 3567899999988 59999999988888899999999995 59
Q ss_pred HhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCC---C--CCeEEcccchhhhhhc
Q 005102 486 LATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGH---N--MEPHVSDFGLARLANI 560 (714)
Q Consensus 486 L~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~---~--~~~kl~DFGla~~~~~ 560 (714)
|.+++....... ....-...+.+..|++.||+|||+ .+||||||||.||||+. + ..++|+|||+++.+..
T Consensus 589 L~dlie~~~~d~--~~~~~i~~~~~l~q~~~GlaHLHs---l~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~ 663 (903)
T KOG1027|consen 589 LQDLIESSGLDV--EMQSDIDPISVLSQIASGLAHLHS---LKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAG 663 (903)
T ss_pred HHHHHhccccch--hhcccccHHHHHHHHHHHHHHHHh---cccccccCCCceEEEEccCCCcceeEEecccccccccCC
Confidence 999998751111 111113457789999999999999 89999999999999975 3 5789999999997754
Q ss_pred cCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhC-CCccccC
Q 005102 561 AGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITG-RTAVVQV 639 (714)
Q Consensus 561 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG-~~p~~~~ 639 (714)
...+ -.......||.+|+|||++....-+.++||||+|||+|..++| ..||-+.
T Consensus 664 ~~sS-------------------------~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~ 718 (903)
T KOG1027|consen 664 GKSS-------------------------FSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDS 718 (903)
T ss_pred Ccch-------------------------hhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCch
Confidence 3221 1124566789999999999988888999999999999999995 8999332
Q ss_pred CCCcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 005102 640 GSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISD 704 (714)
Q Consensus 640 ~~~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 704 (714)
...+.. ++.....+..+ .+. .++ +..++|.+|++++|..||++.+|+.
T Consensus 719 ~~R~~N-------Il~~~~~L~~L-----~~~---~d~--eA~dLI~~ml~~dP~~RPsa~~VL~ 766 (903)
T KOG1027|consen 719 LERQAN-------ILTGNYTLVHL-----EPL---PDC--EAKDLISRMLNPDPQLRPSATDVLN 766 (903)
T ss_pred HHhhhh-------hhcCccceeee-----ccC---chH--HHHHHHHHhcCCCcccCCCHHHHhC
Confidence 211111 11122111111 111 111 5679999999999999999999973
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-30 Score=240.56 Aligned_cols=251 Identities=18% Similarity=0.250 Sum_probs=192.6
Q ss_pred cccccCceEEEEEEE-CCCcEEEEEEeCCCCchhHHHHHHHHHHHhccC-CCCccceEEEEEeCC--ceeEEEeccCCCC
Q 005102 410 VLGKSGIGIVYKVVL-EDGHTLAVRRLGEGGSQRFKEFQTEVEAIGKIR-HSNIVTLRAYYWSVD--EKLLIYDYIPNGS 485 (714)
Q Consensus 410 ~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~--~~~lV~e~~~~gs 485 (714)
.+|+|.|++||.|.. .+.+.++||+++... .+.+.+|+.+|..++ ||||+++++...+.. ...+|+||+.+.+
T Consensus 45 k~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk---kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiFE~v~n~D 121 (338)
T KOG0668|consen 45 KVGRGKYSEVFEGINITNNEKCVIKILKPVK---KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIFEYVNNTD 121 (338)
T ss_pred HHcCccHhhHhcccccCCCceEEEeeechHH---HHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHhhhhcccc
Confidence 699999999999984 457889999997643 356889999999997 999999999998754 4579999999988
Q ss_pred HhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCC-CCeEEcccchhhhhhccCCC
Q 005102 486 LATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHN-MEPHVSDFGLARLANIAGGS 564 (714)
Q Consensus 486 L~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~-~~~kl~DFGla~~~~~~~~~ 564 (714)
...+. ..++-..++.++.+++.||.|+|+ .||+|||+||.|++||.. -.++|+|+|+|-++.....
T Consensus 122 fk~ly---------~tl~d~dIryY~~elLkALdyCHS---~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~e- 188 (338)
T KOG0668|consen 122 FKQLY---------PTLTDYDIRYYIYELLKALDYCHS---MGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE- 188 (338)
T ss_pred HHHHh---------hhhchhhHHHHHHHHHHHHhHHHh---cCcccccCCcceeeechhhceeeeeecchHhhcCCCce-
Confidence 87765 457788899999999999999999 999999999999999864 5689999999998764321
Q ss_pred CCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCC-CCCCchhhhHHHHHHHHHHHhCCCccccCCCCc
Q 005102 565 PTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKV-VKPSQKWDIYSYGVILLEMITGRTAVVQVGSSE 643 (714)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DVwS~Gvvl~elltG~~p~~~~~~~~ 643 (714)
-...+.+++|.-||.+.. ..|+..-|+|||||++..|+..+.||+....+.
T Consensus 189 ----------------------------YnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~ 240 (338)
T KOG0668|consen 189 ----------------------------YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNY 240 (338)
T ss_pred ----------------------------eeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCH
Confidence 112234677999999965 458999999999999999999999998777776
Q ss_pred chhHHHHHHHHhhc-----CCcccccCCCCCC--------C-------CCcHHHHHHHHHHHhHccCCCCCCCCCHHHHH
Q 005102 644 MDLVNWMQLCIEEK-----KPLADVLDPYLAP--------D-------ADKEEEIIAVLKIAMACVHSSPEKRPTMRHIS 703 (714)
Q Consensus 644 ~~l~~~~~~~~~~~-----~~~~~~~d~~~~~--------~-------~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl 703 (714)
..++..++..-.+. ....-.+||.... . ....-...+.++++.+.|..|-.+|+|++|.+
T Consensus 241 DQLVkIakVLGt~el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam 320 (338)
T KOG0668|consen 241 DQLVKIAKVLGTDELYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAM 320 (338)
T ss_pred HHHHHHHHHhChHHHHHHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHh
Confidence 66666543211110 0000012221110 0 00111224678999999999999999999986
Q ss_pred H
Q 005102 704 D 704 (714)
Q Consensus 704 ~ 704 (714)
.
T Consensus 321 ~ 321 (338)
T KOG0668|consen 321 A 321 (338)
T ss_pred c
Confidence 4
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.6e-31 Score=249.21 Aligned_cols=192 Identities=24% Similarity=0.403 Sum_probs=159.1
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeCCC--CchhHHHHHHHHHHHhccCCCCccceEEEEEeC-----CceeEEEec
Q 005102 409 FVLGKSGIGIVYKVVLE-DGHTLAVRRLGEG--GSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSV-----DEKLLIYDY 480 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~-----~~~~lV~e~ 480 (714)
+.||.|.||.||.+.++ +|+.||.|++... +-...+++.+|++.|..++|.|++..++...-. ++.|+|+|.
T Consensus 59 RPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~TEL 138 (449)
T KOG0664|consen 59 RPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLTEL 138 (449)
T ss_pred CcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHHHH
Confidence 46999999999999974 6999999998753 333457899999999999999999998887643 356899999
Q ss_pred cCCCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhc
Q 005102 481 IPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANI 560 (714)
Q Consensus 481 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 560 (714)
|.. +|..++-.. +.++...++-+..||++||+|||+ .+|.||||||.|.|++.+..+||+|||+|+.-+.
T Consensus 139 mQS-DLHKIIVSP------Q~Ls~DHvKVFlYQILRGLKYLHs---A~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~ 208 (449)
T KOG0664|consen 139 MQS-DLHKIIVSP------QALTPDHVKVFVYQILRGLKYLHT---ANILHRDIKPGNLLVNSNCILKICDFGLARTWDQ 208 (449)
T ss_pred HHh-hhhheeccC------CCCCcchhhhhHHHHHhhhHHHhh---cchhhccCCCccEEeccCceEEecccccccccch
Confidence 955 888877654 568888899999999999999999 8999999999999999999999999999986543
Q ss_pred cCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCC-CCchhhhHHHHHHHHHHHhCCCccc
Q 005102 561 AGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVK-PSQKWDIYSYGVILLEMITGRTAVV 637 (714)
Q Consensus 561 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s~~~DVwS~Gvvl~elltG~~p~~ 637 (714)
.+ .+.++-+ +-|-+|+|||.+.|.+ |+.+.||||.|||+.|++.++-.|.
T Consensus 209 d~-------------------~~hMTqE--------VVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQ 259 (449)
T KOG0664|consen 209 RD-------------------RLNMTHE--------VVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQ 259 (449)
T ss_pred hh-------------------hhhhHHH--------HHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhh
Confidence 21 1111111 2266799999998865 8999999999999999998888773
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.7e-29 Score=242.79 Aligned_cols=249 Identities=21% Similarity=0.324 Sum_probs=182.1
Q ss_pred cccccCceEEEEEEEC-CCcEEEEEEeCCC--CchhHHHHHHHHHHHhccCCCCccceEEEEEeC------CceeEEEec
Q 005102 410 VLGKSGIGIVYKVVLE-DGHTLAVRRLGEG--GSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSV------DEKLLIYDY 480 (714)
Q Consensus 410 ~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~------~~~~lV~e~ 480 (714)
.+|.|.- .|..+.+. .++.||+|++... .....++..+|...+..++|+||++++.+|.-. .+.|+||||
T Consensus 24 p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~y~v~e~ 102 (369)
T KOG0665|consen 24 PIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEVYLVMEL 102 (369)
T ss_pred ccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhHHHHHHh
Confidence 4666665 45545432 4889999998654 233446788999999999999999999998643 356999999
Q ss_pred cCCCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhc
Q 005102 481 IPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANI 560 (714)
Q Consensus 481 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 560 (714)
|. ++|...++. .++-.+...|..|++.|++|||+ .+|+||||||+||++..+..+||.|||+|+..+.
T Consensus 103 m~-~nl~~vi~~--------elDH~tis~i~yq~~~~ik~lhs---~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~ 170 (369)
T KOG0665|consen 103 MD-ANLCQVILM--------ELDHETISYILYQMLCGIKHLHS---AGIIHRDLKPSNIVVNSDCTLKILDFGLARTEDT 170 (369)
T ss_pred hh-hHHHHHHHH--------hcchHHHHHHHHHHHHHHHHHHh---cceeecccCcccceecchhheeeccchhhcccCc
Confidence 95 599988872 36778899999999999999999 9999999999999999999999999999985321
Q ss_pred cCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCccccCC
Q 005102 561 AGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVG 640 (714)
Q Consensus 561 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~~~~~ 640 (714)
. ...+..+.|++|+|||++.+..+.+.+||||.||++.||++|+-.|.
T Consensus 171 ~-----------------------------~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~--- 218 (369)
T KOG0665|consen 171 D-----------------------------FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFP--- 218 (369)
T ss_pred c-----------------------------cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEec---
Confidence 1 12334456889999999999889999999999999999999998884
Q ss_pred CCcchhHHHHHHHHhhcC--------------------------Cccccc-CCCCCCCCC-cHHHHHHHHHHHhHccCCC
Q 005102 641 SSEMDLVNWMQLCIEEKK--------------------------PLADVL-DPYLAPDAD-KEEEIIAVLKIAMACVHSS 692 (714)
Q Consensus 641 ~~~~~l~~~~~~~~~~~~--------------------------~~~~~~-d~~~~~~~~-~~~~~~~l~~li~~Cl~~d 692 (714)
....+.+|-+....-+. .+.+.+ |........ .........+++.+||..|
T Consensus 219 -g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~ 297 (369)
T KOG0665|consen 219 -GKDHIDQWNKIIEQLGTPDPSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVID 297 (369)
T ss_pred -CchHHHHHHHHHHHhcCCCHHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccC
Confidence 12222333221111000 000000 111111100 1123345678999999999
Q ss_pred CCCCCCHHHHHH
Q 005102 693 PEKRPTMRHISD 704 (714)
Q Consensus 693 P~~RPt~~evl~ 704 (714)
|++|.+++++++
T Consensus 298 pe~Risv~daL~ 309 (369)
T KOG0665|consen 298 PEKRISVDDALR 309 (369)
T ss_pred hhhcccHHHHhc
Confidence 999999999875
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.7e-28 Score=237.49 Aligned_cols=210 Identities=32% Similarity=0.480 Sum_probs=180.5
Q ss_pred ccccCceEEEEEEECC-CcEEEEEEeCCCCch-hHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCCCHhh
Q 005102 411 LGKSGIGIVYKVVLED-GHTLAVRRLGEGGSQ-RFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGSLAT 488 (714)
Q Consensus 411 lG~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL~~ 488 (714)
||+|.+|.||++...+ ++.+++|++...... ..+.+.+|++.++.++|++|+++++++......+++|||+++++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 6899999999999865 899999999876442 34678999999999999999999999999899999999999999999
Q ss_pred hhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCC-CCCeEEcccchhhhhhccCCCCCc
Q 005102 489 ALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGH-NMEPHVSDFGLARLANIAGGSPTL 567 (714)
Q Consensus 489 ~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~-~~~~kl~DFGla~~~~~~~~~~~~ 567 (714)
++.... ..+++..+..++.+++++++|||+ .+++|+||+|.||+++. ++.++|+|||.+........
T Consensus 81 ~~~~~~-----~~~~~~~~~~~~~~l~~~l~~lh~---~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~---- 148 (215)
T cd00180 81 LLKENE-----GKLSEDEILRILLQILEGLEYLHS---NGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS---- 148 (215)
T ss_pred HHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc----
Confidence 987542 247899999999999999999999 89999999999999999 89999999999875532210
Q ss_pred cCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCC-CCCchhhhHHHHHHHHHHHhCCCccccCCCCcchh
Q 005102 568 QSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVV-KPSQKWDIYSYGVILLEMITGRTAVVQVGSSEMDL 646 (714)
Q Consensus 568 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DVwS~Gvvl~elltG~~p~~~~~~~~~~l 646 (714)
......+...|++||..... .++.++|+|++|+++++|
T Consensus 149 ------------------------~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l----------------- 187 (215)
T cd00180 149 ------------------------LLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL----------------- 187 (215)
T ss_pred ------------------------hhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH-----------------
Confidence 01112345679999999877 788999999999999999
Q ss_pred HHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 005102 647 VNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDA 705 (714)
Q Consensus 647 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 705 (714)
..+.+++.+|++.||++||+++++++.
T Consensus 188 --------------------------------~~~~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 188 --------------------------------PELKDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred --------------------------------HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence 257789999999999999999999864
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-29 Score=262.21 Aligned_cols=190 Identities=20% Similarity=0.253 Sum_probs=165.0
Q ss_pred ccccccCceEEEEEEECC-CcEEEEEEeCCCCch--------hHHHHHHHHHHHhccC---CCCccceEEEEEeCCceeE
Q 005102 409 FVLGKSGIGIVYKVVLED-GHTLAVRRLGEGGSQ--------RFKEFQTEVEAIGKIR---HSNIVTLRAYYWSVDEKLL 476 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~---H~niv~l~~~~~~~~~~~l 476 (714)
..+|+|+||.|+.|.++. ...|+||.+.+...- ..-..-.||+||..++ |+||++++++|++++..|+
T Consensus 567 q~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEddd~yyl 646 (772)
T KOG1152|consen 567 QPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDDDYYYL 646 (772)
T ss_pred eeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecCCeeEE
Confidence 579999999999999865 678999998774211 1123556999999997 9999999999999999999
Q ss_pred EEecc-CCCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchh
Q 005102 477 IYDYI-PNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLA 555 (714)
Q Consensus 477 V~e~~-~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla 555 (714)
+||-- ++-+|++++..+ ..+++.++..|++||+.|+++||+ .+|||||||-+||.+|.+|-+||+|||.|
T Consensus 647 ~te~hg~gIDLFd~IE~k------p~m~E~eAk~IFkQV~agi~hlh~---~~ivhrdikdenvivd~~g~~klidfgsa 717 (772)
T KOG1152|consen 647 ETEVHGEGIDLFDFIEFK------PRMDEPEAKLIFKQVVAGIKHLHD---QGIVHRDIKDENVIVDSNGFVKLIDFGSA 717 (772)
T ss_pred EecCCCCCcchhhhhhcc------CccchHHHHHHHHHHHhccccccc---cCceecccccccEEEecCCeEEEeeccch
Confidence 99854 567999999877 568999999999999999999999 89999999999999999999999999998
Q ss_pred hhhhccCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCC-CchhhhHHHHHHHHHHHhCCC
Q 005102 556 RLANIAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKP-SQKWDIYSYGVILLEMITGRT 634 (714)
Q Consensus 556 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~~DVwS~Gvvl~elltG~~ 634 (714)
.+.. .......+||.+|.|||++.|.+| +..-|||++|++||.++....
T Consensus 718 a~~k------------------------------sgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivyken 767 (772)
T KOG1152|consen 718 AYTK------------------------------SGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKEN 767 (772)
T ss_pred hhhc------------------------------CCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccC
Confidence 7653 234456788999999999999887 667899999999999999999
Q ss_pred ccc
Q 005102 635 AVV 637 (714)
Q Consensus 635 p~~ 637 (714)
||+
T Consensus 768 pyy 770 (772)
T KOG1152|consen 768 PYY 770 (772)
T ss_pred CCc
Confidence 985
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.2e-28 Score=249.75 Aligned_cols=126 Identities=20% Similarity=0.276 Sum_probs=107.2
Q ss_pred ccccccCceEEEEEEECC-CcEEEEEEeCCCCchhHHHHHHHHHHHhccC-----C---CCccceEEEEEe----CCcee
Q 005102 409 FVLGKSGIGIVYKVVLED-GHTLAVRRLGEGGSQRFKEFQTEVEAIGKIR-----H---SNIVTLRAYYWS----VDEKL 475 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----H---~niv~l~~~~~~----~~~~~ 475 (714)
..||-|.|++||++++.. .+.||+|+.+... ...+....||++|++++ | .+||+++++|.. +.+.|
T Consensus 84 rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAq-hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGpNG~HVC 162 (590)
T KOG1290|consen 84 RKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQ-HYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGPNGQHVC 162 (590)
T ss_pred EeccccccceeEEEeeccCCeEEEEEEEehhh-HHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCCCCcEEE
Confidence 479999999999999754 6789999887543 33467789999999994 3 379999999985 45889
Q ss_pred EEEeccCCCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeC
Q 005102 476 LIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLG 542 (714)
Q Consensus 476 lV~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~ 542 (714)
||+|++ |-+|..++..... +.++...+++|++||+.||.|||+. .+|||-||||+|||+.
T Consensus 163 MVfEvL-GdnLLklI~~s~Y----rGlpl~~VK~I~~qvL~GLdYLH~e--cgIIHTDlKPENvLl~ 222 (590)
T KOG1290|consen 163 MVFEVL-GDNLLKLIKYSNY----RGLPLSCVKEICRQVLTGLDYLHRE--CGIIHTDLKPENVLLC 222 (590)
T ss_pred EEehhh-hhHHHHHHHHhCC----CCCcHHHHHHHHHHHHHHHHHHHHh--cCccccCCCcceeeee
Confidence 999999 6699999987654 5699999999999999999999996 4899999999999993
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-29 Score=258.89 Aligned_cols=267 Identities=18% Similarity=0.221 Sum_probs=197.5
Q ss_pred cCHHHHHHhcc---ccccccCceEEEEEEECC-CcEEEEEEeCCCCchhHHHHHHHHHHHhccC------CCCccceEEE
Q 005102 398 FDLDELLKASA---FVLGKSGIGIVYKVVLED-GHTLAVRRLGEGGSQRFKEFQTEVEAIGKIR------HSNIVTLRAY 467 (714)
Q Consensus 398 ~~~~~l~~~~~---~~lG~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~------H~niv~l~~~ 467 (714)
..+.|++..-. -..|+|-|++|.+|.... |+.||||+++..... .+.=.+|+++|++|+ --|+++++-.
T Consensus 424 v~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M-~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~ 502 (752)
T KOG0670|consen 424 VRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVM-HKTGLKELEILKKLNDADPEDKFHCLRLFRH 502 (752)
T ss_pred EehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHH-hhhhhHHHHHHHHhhccCchhhhHHHHHHHH
Confidence 34445444322 347899999999999765 889999999876433 355678999999995 3489999999
Q ss_pred EEeCCceeEEEeccCCCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCC-CC
Q 005102 468 YWSVDEKLLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHN-ME 546 (714)
Q Consensus 468 ~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~-~~ 546 (714)
|...+++|||+|-+ .-+|.+.|+.-... -.|....+..++.|+.-||..|-. .+|+|.||||.|||+++. ..
T Consensus 503 F~hknHLClVFE~L-slNLRevLKKyG~n---vGL~ikaVRsYaqQLflALklLK~---c~vlHaDIKPDNiLVNE~k~i 575 (752)
T KOG0670|consen 503 FKHKNHLCLVFEPL-SLNLREVLKKYGRN---VGLHIKAVRSYAQQLFLALKLLKK---CGVLHADIKPDNILVNESKNI 575 (752)
T ss_pred hhhcceeEEEehhh-hchHHHHHHHhCcc---cceeehHHHHHHHHHHHHHHHHHh---cCeeecccCccceEeccCcce
Confidence 99999999999988 45999999865432 357788999999999999999999 799999999999999875 56
Q ss_pred eEEcccchhhhhhccCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHH
Q 005102 547 PHVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVIL 626 (714)
Q Consensus 547 ~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl 626 (714)
+||||||.|.+....+.. ...-+.+|+|||++.|.+|+...|+||.||+|
T Consensus 576 LKLCDfGSA~~~~eneit------------------------------PYLVSRFYRaPEIiLG~~yd~~iD~WSvgctL 625 (752)
T KOG0670|consen 576 LKLCDFGSASFASENEIT------------------------------PYLVSRFYRAPEIILGLPYDYPIDTWSVGCTL 625 (752)
T ss_pred eeeccCcccccccccccc------------------------------HHHHHHhccCcceeecCcccCCccceeeceee
Confidence 899999999876543211 11125679999999999999999999999999
Q ss_pred HHHHhCCCccccCCCCcchhHHHHHHH--------HhhcCCcccccCCC----------------------CCC------
Q 005102 627 LEMITGRTAVVQVGSSEMDLVNWMQLC--------IEEKKPLADVLDPY----------------------LAP------ 670 (714)
Q Consensus 627 ~elltG~~p~~~~~~~~~~l~~~~~~~--------~~~~~~~~~~~d~~----------------------~~~------ 670 (714)
|||.||+..|+...++. +..++..+ +..+.-..+-+|.. ..+
T Consensus 626 YElYtGkIlFpG~TNN~--MLrl~me~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s 703 (752)
T KOG0670|consen 626 YELYTGKILFPGRTNNQ--MLRLFMELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGS 703 (752)
T ss_pred EEeeccceecCCCCcHH--HHHHHHHhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHH
Confidence 99999999996544433 22222111 11000000000000 001
Q ss_pred --------CCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 005102 671 --------DADKEEEIIAVLKIAMACVHSSPEKRPTMRHISD 704 (714)
Q Consensus 671 --------~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 704 (714)
.........++.+|+..|+..||++|.|..+++.
T Consensus 704 ~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~nqAL~ 745 (752)
T KOG0670|consen 704 ELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITVNQALK 745 (752)
T ss_pred HHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCHHHHhc
Confidence 0112245667899999999999999999998764
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.9e-29 Score=265.96 Aligned_cols=245 Identities=23% Similarity=0.317 Sum_probs=196.0
Q ss_pred cccccCceEEEEEEEC-CCcEEEEEEeCCCCchhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCCCHhh
Q 005102 410 VLGKSGIGIVYKVVLE-DGHTLAVRRLGEGGSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGSLAT 488 (714)
Q Consensus 410 ~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL~~ 488 (714)
.+|.|+||.|||+++. .++..|||+++..-.....-.++|+-+++..+|||||.++|-|...+..++.|||+.+|+|.+
T Consensus 22 rvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEycgggslQd 101 (829)
T KOG0576|consen 22 RVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEYCGGGSLQD 101 (829)
T ss_pred eecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEecCCCcccc
Confidence 6999999999999975 589999999988766666778899999999999999999999999999999999999999999
Q ss_pred hhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCCCCcc
Q 005102 489 ALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQ 568 (714)
Q Consensus 489 ~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 568 (714)
..+.. .++++.++..+++..++||+|||+ .+-+|||||-.|||+++.+.+|++|||.+-.+...
T Consensus 102 iy~~T------gplselqiayvcRetl~gl~ylhs---~gk~hRdiKGanilltd~gDvklaDfgvsaqitat------- 165 (829)
T KOG0576|consen 102 IYHVT------GPLSELQIAYVCRETLQGLKYLHS---QGKIHRDIKGANILLTDEGDVKLADFGVSAQITAT------- 165 (829)
T ss_pred eeeec------ccchhHHHHHHHhhhhccchhhhc---CCcccccccccceeecccCceeecccCchhhhhhh-------
Confidence 88766 568899999999999999999999 89999999999999999999999999988654311
Q ss_pred CCCCCCCCchhhhcccccceeecccCCCCCCccccCCccc---CCCCCCchhhhHHHHHHHHHHHhCCCccccCCCCcch
Q 005102 569 SNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESL---KVVKPSQKWDIYSYGVILLEMITGRTAVVQVGSSEMD 645 (714)
Q Consensus 569 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~---~~~~~s~~~DVwS~Gvvl~elltG~~p~~~~~~~~~~ 645 (714)
......+.||++|||||+. ..+.|..++|||+.|++..|+-.-.+|.++..
T Consensus 166 ---------------------i~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlh----- 219 (829)
T KOG0576|consen 166 ---------------------IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLH----- 219 (829)
T ss_pred ---------------------hhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccc-----
Confidence 2234466789999999998 34568999999999999999988777753211
Q ss_pred hHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 005102 646 LVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISD 704 (714)
Q Consensus 646 l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 704 (714)
-.+.....-+.... .|.+... ..-...+.++++.|+-++|.+|||++.++.
T Consensus 220 pmr~l~LmTkS~~q-----pp~lkDk---~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 220 PMRALFLMTKSGFQ-----PPTLKDK---TKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred hHHHHHHhhccCCC-----CCcccCC---ccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 11111111111111 1112111 123346889999999999999999987654
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.2e-28 Score=232.33 Aligned_cols=254 Identities=18% Similarity=0.304 Sum_probs=185.4
Q ss_pred cCHHHHHHhccccccccCceEEEEEEECC-CcEEEEEEeCCCCchhHHHHHHHHHHHhcc-CCCCccceEEE-EEeCCce
Q 005102 398 FDLDELLKASAFVLGKSGIGIVYKVVLED-GHTLAVRRLGEGGSQRFKEFQTEVEAIGKI-RHSNIVTLRAY-YWSVDEK 474 (714)
Q Consensus 398 ~~~~~l~~~~~~~lG~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~-~~~~~~~ 474 (714)
++++|... ..+.+|+|.||.+-.++++. .+.+|+|-+..... ..++|.+|..---.+ .|.||+.-|+. |++.+..
T Consensus 20 v~l~d~y~-I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~t-t~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~Y 97 (378)
T KOG1345|consen 20 VDLEDVYT-INKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQT-TQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAY 97 (378)
T ss_pred cchhhhhh-HHHHhcccceeeEEeeeccCCceEEEeeccCcchh-hHHHHHHHhccceeeccchhhhHHHHHHhhcCceE
Confidence 34444433 23479999999999999876 67888888876533 357899998876666 58999988775 5566777
Q ss_pred eEEEeccCCCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeee-C-CCCCeEEccc
Q 005102 475 LLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILL-G-HNMEPHVSDF 552 (714)
Q Consensus 475 ~lV~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl-~-~~~~~kl~DF 552 (714)
.+++||++.|||.+-+... .+.+...++++.|++.|+.|||+ ..+||||||.+|||| + +...+||+||
T Consensus 98 vF~qE~aP~gdL~snv~~~-------GigE~~~K~v~~ql~SAi~fMHs---knlVHRdlK~eNiLif~~df~rvKlcDF 167 (378)
T KOG1345|consen 98 VFVQEFAPRGDLRSNVEAA-------GIGEANTKKVFAQLLSAIEFMHS---KNLVHRDLKAENILIFDADFYRVKLCDF 167 (378)
T ss_pred EEeeccCccchhhhhcCcc-------cccHHHHHHHHHHHHHHHHHhhc---cchhhcccccceEEEecCCccEEEeeec
Confidence 8999999999999988653 36778899999999999999999 999999999999999 3 3458999999
Q ss_pred chhhhhhccCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCC-----CCCchhhhHHHHHHHH
Q 005102 553 GLARLANIAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVV-----KPSQKWDIYSYGVILL 627 (714)
Q Consensus 553 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~s~~~DVwS~Gvvl~ 627 (714)
|+.+..+.. ......+-.|.|||..... ...+.+|||.||+++|
T Consensus 168 G~t~k~g~t-------------------------------V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f 216 (378)
T KOG1345|consen 168 GLTRKVGTT-------------------------------VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFF 216 (378)
T ss_pred ccccccCce-------------------------------ehhhhhhcccCCcHHHhhccccceEecccccchheeeeee
Confidence 998754211 1111124459999987532 3578899999999999
Q ss_pred HHHhCCCccccCCCCcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 005102 628 EMITGRTAVVQVGSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISD 704 (714)
Q Consensus 628 elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 704 (714)
.++||+.||......+....+|++-.-+....+++.+.+ + ...+.++.++-+..+|++|=...++.+
T Consensus 217 ~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~~P~~F~~-----f-----s~~a~r~Fkk~lt~~~~drcki~~~kk 283 (378)
T KOG1345|consen 217 YCLTGKFPWQKASIMDKPYWEWEQWLKRKNPALPKKFNP-----F-----SEKALRLFKKSLTPRFKDRCKIWTAKK 283 (378)
T ss_pred eeecCCCcchhhhccCchHHHHHHHhcccCccCchhhcc-----c-----CHHHHHHHHHhcCCcccccchhHHHHH
Confidence 999999999655555566666665433222222222211 1 224667777888999999944444443
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.6e-28 Score=248.11 Aligned_cols=283 Identities=19% Similarity=0.279 Sum_probs=198.0
Q ss_pred cccccccCceEEEEEEEC----CCcEEEEEEeCCCCchhHHHHHHHHHHHhccC-CCCccceEEEEEeCCceeEEEeccC
Q 005102 408 AFVLGKSGIGIVYKVVLE----DGHTLAVRRLGEGGSQRFKEFQTEVEAIGKIR-HSNIVTLRAYYWSVDEKLLIYDYIP 482 (714)
Q Consensus 408 ~~~lG~G~~g~Vy~~~~~----~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lV~e~~~ 482 (714)
.+.||+|+|++||++.+. ..+.||+|.+...+.. .....|++.|..+. +.||+++.+++..++...+|+||++
T Consensus 41 v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p--~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~ivlp~~~ 118 (418)
T KOG1167|consen 41 VNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSP--SRILNELEMLYRLGGSDNIIKLNGCFRNNDQVAIVLPYFE 118 (418)
T ss_pred hccccccchhhhhhhhHhhhccccceEeeeecccccCc--hHHHHHHHHHHHhccchhhhcchhhhccCCeeEEEecccC
Confidence 357999999999999854 3678999999876544 46889999999994 9999999999999999999999999
Q ss_pred CCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCC-CCeEEcccchhhhhhcc
Q 005102 483 NGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHN-MEPHVSDFGLARLANIA 561 (714)
Q Consensus 483 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~-~~~kl~DFGla~~~~~~ 561 (714)
.-+..+++. .++..++..+++.+..||+|+|. .|||||||||+|+|.+.. +.-.|.|||+|...+..
T Consensus 119 H~~f~~l~~---------~l~~~~i~~Yl~~ll~Al~~~h~---~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~ 186 (418)
T KOG1167|consen 119 HDRFRDLYR---------SLSLAEIRWYLRNLLKALAHLHK---NGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGY 186 (418)
T ss_pred ccCHHHHHh---------cCCHHHHHHHHHHHHHHhhhhhc---cCccccCCCccccccccccCCceEEechhHHHHHhh
Confidence 998888873 47788999999999999999999 999999999999999754 56789999999843321
Q ss_pred CCCCCccC----CCCC-CC------C-----chhhhcccccceeecccCCCCCCccccCCcccCC-CCCCchhhhHHHHH
Q 005102 562 GGSPTLQS----NRMP-AE------K-----PQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKV-VKPSQKWDIYSYGV 624 (714)
Q Consensus 562 ~~~~~~~~----~~~~-~~------~-----~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DVwS~Gv 624 (714)
........ ...+ .+ . .....................||+||+|||++.. ...++++||||.||
T Consensus 187 ~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GV 266 (418)
T KOG1167|consen 187 QQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGV 266 (418)
T ss_pred hhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeeccc
Confidence 10000000 0000 00 0 0000000001222334457789999999999965 44689999999999
Q ss_pred HHHHHHhCCCccccCCCCcchhHHHHHH--------HHh-hcC-Cccc---------c------cC-CCCCCCCC-----
Q 005102 625 ILLEMITGRTAVVQVGSSEMDLVNWMQL--------CIE-EKK-PLAD---------V------LD-PYLAPDAD----- 673 (714)
Q Consensus 625 vl~elltG~~p~~~~~~~~~~l~~~~~~--------~~~-~~~-~~~~---------~------~d-~~~~~~~~----- 673 (714)
|++-+++++.||.....+-..+.+.+.. +.. .+. .+.+ . ++ ..+....+
T Consensus 267 I~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~~ 346 (418)
T KOG1167|consen 267 ILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNTER 346 (418)
T ss_pred eeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccceee
Confidence 9999999999997766555444443211 000 000 0000 0 00 00000000
Q ss_pred ---cHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 005102 674 ---KEEEIIAVLKIAMACVHSSPEKRPTMRHISD 704 (714)
Q Consensus 674 ---~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 704 (714)
.+.....+++++.+|++.||.+|.|+++.++
T Consensus 347 ~~~~d~~~~~~~dlLdk~le~np~kRitAEeALk 380 (418)
T KOG1167|consen 347 EIGSDVFPALLLDLLDKCLELNPQKRITAEDALK 380 (418)
T ss_pred ccccccccHHHHHHHHHHccCChhhcccHHHHhc
Confidence 0111225789999999999999999999874
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-26 Score=232.13 Aligned_cols=194 Identities=31% Similarity=0.439 Sum_probs=166.9
Q ss_pred ccccccCceEEEEEEECC-CcEEEEEEeCCCCch-hHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCCCH
Q 005102 409 FVLGKSGIGIVYKVVLED-GHTLAVRRLGEGGSQ-RFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGSL 486 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL 486 (714)
+.||+|++|.||++...+ ++.+|+|.+...... ..+.+.+|++.+++++|+|++++++++......++++||+++++|
T Consensus 5 ~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L 84 (225)
T smart00221 5 KKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCEGGDL 84 (225)
T ss_pred eEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccCCCCH
Confidence 478999999999999876 899999999876554 567899999999999999999999999998999999999999999
Q ss_pred hhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCCCC
Q 005102 487 ATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPT 566 (714)
Q Consensus 487 ~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 566 (714)
.+++..... .+++..+..++.+++.++.|||+ .+++|+|++|+||+++.++.++|+|||.+........
T Consensus 85 ~~~~~~~~~-----~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~--- 153 (225)
T smart00221 85 FDYLRKKGG-----KLSEEEARFYLRQILEALEYLHS---LGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLA--- 153 (225)
T ss_pred HHHHHhccc-----CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCccc---
Confidence 999976521 17899999999999999999999 8999999999999999999999999999876542210
Q ss_pred ccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCccc-CCCCCCchhhhHHHHHHHHHHHhCCCccc
Q 005102 567 LQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESL-KVVKPSQKWDIYSYGVILLEMITGRTAVV 637 (714)
Q Consensus 567 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~s~~~DVwS~Gvvl~elltG~~p~~ 637 (714)
.......++..|++||.+ ....++.++|||+||++++||++|+.||.
T Consensus 154 ------------------------~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~ 201 (225)
T smart00221 154 ------------------------ALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFS 201 (225)
T ss_pred ------------------------ccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCcc
Confidence 011122345679999998 66678889999999999999999999994
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.93 E-value=8.1e-26 Score=217.22 Aligned_cols=169 Identities=21% Similarity=0.233 Sum_probs=126.0
Q ss_pred CCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCC
Q 005102 484 GSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGG 563 (714)
Q Consensus 484 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 563 (714)
|+|.++++... ..++|.++..|+.|++.||+|||+ .+ ||+|||+++++.+|+ ||+++.....
T Consensus 1 GsL~~~l~~~~-----~~l~~~~~~~i~~qi~~~L~~lH~---~~------kp~Nil~~~~~~~~~--fG~~~~~~~~-- 62 (176)
T smart00750 1 VSLADILEVRG-----RPLNEEEIWAVCLQCLRALRELHR---QA------KSGNILLTWDGLLKL--DGSVAFKTPE-- 62 (176)
T ss_pred CcHHHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHHh---cC------CcccEeEcCccceee--ccceEeeccc--
Confidence 68999997542 459999999999999999999999 55 999999999999999 9998754311
Q ss_pred CCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCccccCCCCc
Q 005102 564 SPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGSSE 643 (714)
Q Consensus 564 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~~~~~~~~ 643 (714)
...||+.|||||++.+..++.++|||||||++|||+||+.||.......
T Consensus 63 -------------------------------~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~ 111 (176)
T smart00750 63 -------------------------------QSRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELS 111 (176)
T ss_pred -------------------------------cCCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhc
Confidence 1136788999999999999999999999999999999999994332211
Q ss_pred chhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHH--HHHHHHHhHccCCCCCCCCCHHHHHHHHhhhhc
Q 005102 644 MDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEI--IAVLKIAMACVHSSPEKRPTMRHISDALDRLIV 711 (714)
Q Consensus 644 ~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~--~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~ 711 (714)
. ........... .++... ....... .++.+++.+||..||++|||+.|+++.+..+..
T Consensus 112 ~----~~~~~~~~~~~----~~~~~~--~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~ 171 (176)
T smart00750 112 A----ILEILLNGMPA----DDPRDR--SNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALFA 171 (176)
T ss_pred H----HHHHHHHHhcc----CCcccc--ccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHH
Confidence 1 12111111111 001000 0111122 258899999999999999999999998877643
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.1e-26 Score=271.73 Aligned_cols=223 Identities=15% Similarity=0.134 Sum_probs=141.2
Q ss_pred hccCC-CCccceEEEEE-------eCCceeEEEeccCCCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCC
Q 005102 454 GKIRH-SNIVTLRAYYW-------SVDEKLLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFS 525 (714)
Q Consensus 454 ~~l~H-~niv~l~~~~~-------~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~ 525 (714)
+.++| +||++++++|. ..+..+.+|||+ +++|.+++.... ..+++.+++.|+.||++||+|||+
T Consensus 27 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~-----~~~~~~~~~~i~~qi~~al~~lH~-- 98 (793)
T PLN00181 27 KSLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPD-----RSVDAFECFHVFRQIVEIVNAAHS-- 98 (793)
T ss_pred chhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhccc-----ccccHHHHHHHHHHHHHHHHHHHh--
Confidence 34556 68888888872 234567788988 569999997542 458999999999999999999999
Q ss_pred CCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCCC-CccC---CCCCCCCc---hhhhcccccceeecccCCCCC
Q 005102 526 PKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSP-TLQS---NRMPAEKP---QERQQKSVSLEVTTTNSSSNL 598 (714)
Q Consensus 526 ~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~-~~~~---~~~~~~~~---~~~~~~~~~~~~~~~~~~~~g 598 (714)
++|+||||||+|||++..+.+|++|||+++......... .... .+...... ....................|
T Consensus 99 -~gIvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g 177 (793)
T PLN00181 99 -QGIVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAME 177 (793)
T ss_pred -CCeeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCC
Confidence 899999999999999766666666665554321110000 0000 00000000 000000000000111123457
Q ss_pred CccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCccccCCCCcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHH
Q 005102 599 GSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEI 678 (714)
Q Consensus 599 t~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~ 678 (714)
|++|||||++.+..++.++|||||||+||||++|..|+.... ..+...... ...+... ...
T Consensus 178 t~~Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~-------~~~~~~~~~------~~~~~~~------~~~ 238 (793)
T PLN00181 178 MSWYTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS-------RTMSSLRHR------VLPPQIL------LNW 238 (793)
T ss_pred CcceEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH-------HHHHHHHHh------hcChhhh------hcC
Confidence 999999999999999999999999999999999988873210 111111000 0111110 112
Q ss_pred HHHHHHHhHccCCCCCCCCCHHHHHH
Q 005102 679 IAVLKIAMACVHSSPEKRPTMRHISD 704 (714)
Q Consensus 679 ~~l~~li~~Cl~~dP~~RPt~~evl~ 704 (714)
....+++.+||++||.+||||.|+++
T Consensus 239 ~~~~~~~~~~L~~~P~~Rps~~eil~ 264 (793)
T PLN00181 239 PKEASFCLWLLHPEPSCRPSMSELLQ 264 (793)
T ss_pred HHHHHHHHHhCCCChhhCcChHHHhh
Confidence 24567888999999999999999975
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.3e-26 Score=215.94 Aligned_cols=246 Identities=21% Similarity=0.368 Sum_probs=187.0
Q ss_pred cccccCceEEEEEEECCCcEEEEEEeCCCCc--hhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCCCHh
Q 005102 410 VLGKSGIGIVYKVVLEDGHTLAVRRLGEGGS--QRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGSLA 487 (714)
Q Consensus 410 ~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL~ 487 (714)
.|.+...|+.|+|+++ |..+++|++..... ...++|..|.-.|+-+.||||..++|.|....+..++..||+.|+|+
T Consensus 197 kl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gsly 275 (448)
T KOG0195|consen 197 KLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGSLY 275 (448)
T ss_pred hhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchHHH
Confidence 5788899999999996 66777888765432 22367999999999999999999999999999999999999999999
Q ss_pred hhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCCCCc
Q 005102 488 TALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTL 567 (714)
Q Consensus 488 ~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 567 (714)
..|++..+. -.+-.++++++.++|+|++|||+..| -|.---|.+..|++|++.+++|+= +-+++.-
T Consensus 276 nvlhe~t~v----vvd~sqav~faldiargmaflhslep-~ipr~~lns~hvmidedltarism-ad~kfsf-------- 341 (448)
T KOG0195|consen 276 NVLHEQTSV----VVDHSQAVRFALDIARGMAFLHSLEP-MIPRFYLNSKHVMIDEDLTARISM-ADTKFSF-------- 341 (448)
T ss_pred HHHhcCccE----EEecchHHHHHHHHHhhHHHHhhcch-hhhhhhcccceEEecchhhhheec-ccceeee--------
Confidence 999987543 36678899999999999999999754 344557889999999999988741 1111110
Q ss_pred cCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCC---chhhhHHHHHHHHHHHhCCCccccCCCCcc
Q 005102 568 QSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPS---QKWDIYSYGVILLEMITGRTAVVQVGSSEM 644 (714)
Q Consensus 568 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s---~~~DVwS~Gvvl~elltG~~p~~~~~~~~~ 644 (714)
........+.||+||.++..+.+ .++|+|||.+++||+.|+..||.+.+.-+.
T Consensus 342 ------------------------qe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmec 397 (448)
T KOG0195|consen 342 ------------------------QEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMEC 397 (448)
T ss_pred ------------------------eccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhh
Confidence 11111225679999999876543 478999999999999999999965543322
Q ss_pred hhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhhhh
Q 005102 645 DLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDALDRLI 710 (714)
Q Consensus 645 ~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~ 710 (714)
.. +. ..+-+.+.+++.. ...+.++|.-|+..||.+||.+..|+-.||++.
T Consensus 398 gm----ki-------aleglrv~ippgi-----s~hm~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 398 GM----KI-------ALEGLRVHIPPGI-----SRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred hh----hh-------hhccccccCCCCc-----cHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 11 11 1122233343332 235788999999999999999999999999875
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.7e-23 Score=217.22 Aligned_cols=133 Identities=24% Similarity=0.238 Sum_probs=107.6
Q ss_pred ccccccCceEEEEEEEC--CCcEEEEEEeCCC-----CchhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEecc
Q 005102 409 FVLGKSGIGIVYKVVLE--DGHTLAVRRLGEG-----GSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYI 481 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~--~g~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~ 481 (714)
+.||+|+||+||+|.++ +++.||||++... .....+.|.+|+++|++++|+|+++.+.. .+..++||||+
T Consensus 24 ~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---~~~~~LVmE~~ 100 (365)
T PRK09188 24 AVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---TGKDGLVRGWT 100 (365)
T ss_pred cEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---cCCcEEEEEcc
Confidence 47999999999999875 4778899987543 12234569999999999999999863322 25689999999
Q ss_pred CCCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCC-CCCCeeeCCCCCeEEcccchhhhhhc
Q 005102 482 PNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDL-KPSNILLGHNMEPHVSDFGLARLANI 560 (714)
Q Consensus 482 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDl-kp~NILl~~~~~~kl~DFGla~~~~~ 560 (714)
++++|... . . .. ...++.++++||+|||+ ++|+|||| ||+|||++.++.+||+|||+|+.+..
T Consensus 101 ~G~~L~~~-~-~--------~~---~~~~~~~i~~aL~~lH~---~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~~~ 164 (365)
T PRK09188 101 EGVPLHLA-R-P--------HG---DPAWFRSAHRALRDLHR---AGITHNDLAKPQNWLMGPDGEAAVIDFQLASVFRR 164 (365)
T ss_pred CCCCHHHh-C-c--------cc---hHHHHHHHHHHHHHHHH---CCCeeCCCCCcceEEEcCCCCEEEEECccceeccc
Confidence 99999632 1 1 00 14678899999999999 89999999 99999999999999999999997653
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=4.3e-21 Score=202.41 Aligned_cols=265 Identities=19% Similarity=0.205 Sum_probs=189.6
Q ss_pred ccccccCceEEEEEEECCC--cEEEEEEeCCCCchhHHHHHHHHHHHhccCC----CCccceEEEE-EeCCceeEEEecc
Q 005102 409 FVLGKSGIGIVYKVVLEDG--HTLAVRRLGEGGSQRFKEFQTEVEAIGKIRH----SNIVTLRAYY-WSVDEKLLIYDYI 481 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~~g--~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H----~niv~l~~~~-~~~~~~~lV~e~~ 481 (714)
..||+|+||.||.|..... ..+|+|............+..|+.++..+.+ +++..+++.. ......++||+.+
T Consensus 24 ~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~iVM~l~ 103 (322)
T KOG1164|consen 24 KKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFIVMSLL 103 (322)
T ss_pred eeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEEEEecc
Confidence 4799999999999997653 4788887766433322367889999998873 6899999998 4777889999988
Q ss_pred CCCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCC-----CCeEEcccchhh
Q 005102 482 PNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHN-----MEPHVSDFGLAR 556 (714)
Q Consensus 482 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~-----~~~kl~DFGla~ 556 (714)
+-+|.++...... ..++..+..+|+.|++.+|++||+ .|++||||||+|+++... ..+.|.|||+|+
T Consensus 104 -G~sL~dl~~~~~~----~~fs~~T~l~ia~q~l~~l~~lH~---~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar 175 (322)
T KOG1164|consen 104 -GPSLEDLRKRNPP----GRFSRKTVLRIAIQNLNALEDLHS---KGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLAR 175 (322)
T ss_pred -CccHHHHHHhCCC----CCcCHhHHHHHHHHHHHHHHHHHh---cCcccCCcCHHHeeecCCCCcccceEEEEecCCCc
Confidence 7799998765542 569999999999999999999999 999999999999999765 468999999998
Q ss_pred hhhccCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCcc
Q 005102 557 LANIAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAV 636 (714)
Q Consensus 557 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~ 636 (714)
........... .+. .........||..|.++....+...+.+.|+||++.++.|+..|..||
T Consensus 176 ~~~~~~~~~~~--~~~----------------~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW 237 (322)
T KOG1164|consen 176 RFKYVGDSGGN--LRP----------------PRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPW 237 (322)
T ss_pred cccccCCCCcc--ccc----------------CCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCC
Confidence 43221111000 000 011123456899999999999999999999999999999999999998
Q ss_pred ccCCCCcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhhhhcc
Q 005102 637 VQVGSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDALDRLIVS 712 (714)
Q Consensus 637 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~~ 712 (714)
........ .....+..... .... .. . .. ...+.++...+-..+..++|....+...|+.....
T Consensus 238 ~~~~~~~~-~~~~~~~~~~~------~~~~-~~-~-~~---~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~ 300 (322)
T KOG1164|consen 238 EALEMTDL-KSKFEKDPRKL------LTDR-FG-D-LK---PEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDS 300 (322)
T ss_pred ccccccch-HHHHHHHhhhh------cccc-cc-C-CC---hHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHh
Confidence 43322111 11111111111 0110 11 1 11 12345555555568999999999999998887554
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.2e-20 Score=199.35 Aligned_cols=262 Identities=27% Similarity=0.359 Sum_probs=191.8
Q ss_pred ccccccCceEEEEEEECCCcEEEEEEeCCCCch---hHHHHHHHHHHHhccCCC-CccceEEEEEeCCceeEEEeccCCC
Q 005102 409 FVLGKSGIGIVYKVVLEDGHTLAVRRLGEGGSQ---RFKEFQTEVEAIGKIRHS-NIVTLRAYYWSVDEKLLIYDYIPNG 484 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~H~-niv~l~~~~~~~~~~~lV~e~~~~g 484 (714)
..||.|+|+.||++... ..+++|.+...... ....|.+|+.+++.+.|+ +|+++.+++......+++++|+.++
T Consensus 6 ~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 83 (384)
T COG0515 6 RKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYVDGG 83 (384)
T ss_pred EeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEecCCCC
Confidence 46899999999999987 88999999875333 357899999999999988 7999999997777789999999999
Q ss_pred CHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCC-CeEEcccchhhhhhccCC
Q 005102 485 SLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNM-EPHVSDFGLARLANIAGG 563 (714)
Q Consensus 485 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~-~~kl~DFGla~~~~~~~~ 563 (714)
++.+++...... ..++......++.|++.++.|+|+ .+++|||+||+||+++... .++++|||.++.......
T Consensus 84 ~l~~~~~~~~~~---~~~~~~~~~~~~~~~~~~l~~~H~---~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~ 157 (384)
T COG0515 84 SLEDLLKKIGRK---GPLSESEALFILAQILSALEYLHS---KGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGS 157 (384)
T ss_pred cHHHHHHhcccc---cCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCc
Confidence 999777654211 257889999999999999999999 8999999999999999988 799999999985432211
Q ss_pred CCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCC---CCCCchhhhHHHHHHHHHHHhCCCccccCC
Q 005102 564 SPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKV---VKPSQKWDIYSYGVILLEMITGRTAVVQVG 640 (714)
Q Consensus 564 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~s~~~DVwS~Gvvl~elltG~~p~~~~~ 640 (714)
.... ........||..|+|||.+.+ ..++...|+||+|++++++++|..||....
T Consensus 158 ~~~~----------------------~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~ 215 (384)
T COG0515 158 TSSI----------------------PALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEK 215 (384)
T ss_pred cccc----------------------cccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC
Confidence 0000 012344567889999999987 578999999999999999999999974332
Q ss_pred CCcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 005102 641 SSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDA 705 (714)
Q Consensus 641 ~~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 705 (714)
.. ...............+ ........... ......+.+++..|+..+|..|.++.+....
T Consensus 216 ~~-~~~~~~~~~~~~~~~~---~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 216 NS-SATSQTLKIILELPTP---SLASPLSPSNP-ELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred cc-ccHHHHHHHHHhcCCc---ccccccCcccc-chhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 21 0011111111111111 00000000000 1123467789999999999999998876653
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.8e-22 Score=226.01 Aligned_cols=255 Identities=20% Similarity=0.210 Sum_probs=182.5
Q ss_pred ccccccccCceEEEEEEECC-CcEEEEEEeC----CCC-ch-hHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEe
Q 005102 407 SAFVLGKSGIGIVYKVVLED-GHTLAVRRLG----EGG-SQ-RFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYD 479 (714)
Q Consensus 407 ~~~~lG~G~~g~Vy~~~~~~-g~~vavK~~~----~~~-~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e 479 (714)
...++|.|.+|.|+.+.... ....+.|..+ ... .. ....+..|.-+-..++|||++..+..+.+....+-+||
T Consensus 322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE 401 (601)
T KOG0590|consen 322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSME 401 (601)
T ss_pred ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhh
Confidence 45689999999888776543 3334444333 111 11 11225668888888999999888877777666666699
Q ss_pred ccCCCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhh
Q 005102 480 YIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLAN 559 (714)
Q Consensus 480 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~ 559 (714)
|+++ ||+.++... ..++..++..++.|+..|++|+|+ .||.|||+|++|+++..++.+||+|||.+....
T Consensus 402 ~~~~-Dlf~~~~~~------~~~~~~e~~c~fKqL~~Gv~y~h~---~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~ 471 (601)
T KOG0590|consen 402 YCPY-DLFSLVMSN------GKLTPLEADCFFKQLLRGVKYLHS---MGLAHRDLKLENLLVTENGILKIIDFGAASVFR 471 (601)
T ss_pred cccH-HHHHHHhcc------cccchhhhhHHHHHHHHHHHHHHh---cCceeccCccccEEEecCCceEEeecCcceeec
Confidence 9999 999999765 347788899999999999999999 899999999999999999999999999987654
Q ss_pred ccCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCch-hhhHHHHHHHHHHHhCCCcccc
Q 005102 560 IAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQK-WDIYSYGVILLEMITGRTAVVQ 638 (714)
Q Consensus 560 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~-~DVwS~Gvvl~elltG~~p~~~ 638 (714)
.+.... ........|+..|+|||.+.+.+|++. .||||.||++..|++|+.||..
T Consensus 472 ~~~e~~------------------------~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~ 527 (601)
T KOG0590|consen 472 YPWEKN------------------------IHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKV 527 (601)
T ss_pred cCcchh------------------------hhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCcccc
Confidence 321100 123345567888999999999999775 7999999999999999999955
Q ss_pred CCCCcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 005102 639 VGSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISD 704 (714)
Q Consensus 639 ~~~~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 704 (714)
....+..... ... ..+. .....+..-......+...++.++++.||.+|.|+++|++
T Consensus 528 a~~~~~~~~~-------~~~-~~~~-~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 528 AKKSDNSFKT-------NNY-SDQR-NIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred ccccccchhh-------hcc-cccc-ccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 4443332100 000 0000 0000000001223445678999999999999999999985
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.3e-21 Score=189.11 Aligned_cols=139 Identities=14% Similarity=0.156 Sum_probs=109.1
Q ss_pred ccccccCceEEEEEEECCCcEEEEEEeCCCCch--h-------H-----------------HHHHHHHHHHhccCCCCcc
Q 005102 409 FVLGKSGIGIVYKVVLEDGHTLAVRRLGEGGSQ--R-------F-----------------KEFQTEVEAIGKIRHSNIV 462 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~--~-------~-----------------~~~~~E~~~l~~l~H~niv 462 (714)
..||+|+||.||+|..++|+.||||+++..... . . .....|++.+.++.|+++.
T Consensus 3 ~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v~ 82 (190)
T cd05147 3 GCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGIP 82 (190)
T ss_pred CccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCCC
Confidence 479999999999999889999999999764211 0 0 1223599999999888875
Q ss_pred ceEEEEEeCCceeEEEeccCCCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHH-hcCCCCCceecCCCCCCeee
Q 005102 463 TLRAYYWSVDEKLLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYL-HEFSPKKYVHGDLKPSNILL 541 (714)
Q Consensus 463 ~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~L-H~~~~~~ivHrDlkp~NILl 541 (714)
....+.. ...++||||++++++....... ..+++.+..+++.|++.+|.|+ |+ .+|+||||||+|||+
T Consensus 83 ~p~~~~~--~~~~iVmE~i~g~~l~~~~~~~------~~~~~~~~~~i~~qi~~~L~~l~H~---~giiHrDlkP~NIli 151 (190)
T cd05147 83 CPEPILL--KSHVLVMEFIGDDGWAAPRLKD------APLSESKARELYLQVIQIMRILYQD---CRLVHADLSEYNLLY 151 (190)
T ss_pred CCcEEEe--cCCEEEEEEeCCCCCcchhhhc------CCCCHHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEE
Confidence 4443322 2348999999987776543222 3578899999999999999999 68 899999999999999
Q ss_pred CCCCCeEEcccchhhhhh
Q 005102 542 GHNMEPHVSDFGLARLAN 559 (714)
Q Consensus 542 ~~~~~~kl~DFGla~~~~ 559 (714)
+ ++.++|+|||+|....
T Consensus 152 ~-~~~v~LiDFG~a~~~~ 168 (190)
T cd05147 152 H-DGKLYIIDVSQSVEHD 168 (190)
T ss_pred E-CCcEEEEEccccccCC
Confidence 8 4789999999997543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=5.9e-21 Score=203.75 Aligned_cols=218 Identities=26% Similarity=0.375 Sum_probs=163.2
Q ss_pred HhccCCCCccceEEEEEeCCceeEEEeccCCCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCc-ee
Q 005102 453 IGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKY-VH 531 (714)
Q Consensus 453 l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~i-vH 531 (714)
|+.+.|.|+.+++|.+.+....++|.+|++.|+|.+.+.... ..++|.-...++++|+.||+|+|. .+| .|
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~-----~~~d~~F~~s~~rdi~~Gl~ylh~---s~i~~h 72 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNED-----IKLDYFFILSFIRDISKGLAYLHN---SPIGYH 72 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccc-----cCccHHHHHHHHHHHHHHHHHHhc---Ccceee
Confidence 467899999999999999999999999999999999998743 569999999999999999999999 455 99
Q ss_pred cCCCCCCeeeCCCCCeEEcccchhhhhhccCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCC
Q 005102 532 GDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVV 611 (714)
Q Consensus 532 rDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 611 (714)
+.++++|.++|..+.+||+|||+........... ...+. .-..-|.|||.+.+.
T Consensus 73 g~l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~--------~~~~~------------------~~~~lw~aPellr~~ 126 (484)
T KOG1023|consen 73 GALKSSNCLVDSRWVLKLTDFGLNSLLEETAEPE--------AHHPI------------------RKALLWTAPELLRGA 126 (484)
T ss_pred eeeccccceeeeeEEEEechhhhccccccccccc--------ccchh------------------HHHHhccCHHHhccc
Confidence 9999999999999999999999987653200000 00000 012349999999763
Q ss_pred C-------CCchhhhHHHHHHHHHHHhCCCccccCCCCcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHH
Q 005102 612 K-------PSQKWDIYSYGVILLEMITGRTAVVQVGSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKI 684 (714)
Q Consensus 612 ~-------~s~~~DVwS~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l 684 (714)
. .+.++||||||++++|+++.+.||......... .+.+......+ .....|.+... .+...++..+
T Consensus 127 ~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~~~~~~~~~~-~eii~~~~~~~---~~~~rP~i~~~---~e~~~~l~~l 199 (484)
T KOG1023|consen 127 LSQSLESALTQKGDIYSFGIIMYEILFRSGPFDLRNLVEDP-DEIILRVKKGG---SNPFRPSIELL---NELPPELLLL 199 (484)
T ss_pred ccccccccccccCCeehHHHHHHHHHhccCccccccccCCh-HHHHHHHHhcC---CCCcCcchhhh---hhcchHHHHH
Confidence 2 467899999999999999999999654333332 22222222211 11122222211 1233368899
Q ss_pred HhHccCCCCCCCCCHHHHHHHHhhhhc
Q 005102 685 AMACVHSSPEKRPTMRHISDALDRLIV 711 (714)
Q Consensus 685 i~~Cl~~dP~~RPt~~evl~~L~~i~~ 711 (714)
+.+||..+|++||++++|...++.+..
T Consensus 200 ~~~cw~e~P~~rPs~~~i~~~~~~~~~ 226 (484)
T KOG1023|consen 200 VARCWEEIPEKRPSIEQIRSKLLTINK 226 (484)
T ss_pred HHHhcccChhhCccHHHHHhhhhhhcc
Confidence 999999999999999999999988765
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.1e-22 Score=180.96 Aligned_cols=166 Identities=28% Similarity=0.447 Sum_probs=146.6
Q ss_pred cccCCCCCCEEEccCCCCcccCChhhcCCCCCCEEEcCCCcCcccCCcccCCCCCCCEEeccCccCCCCCCccccccccc
Q 005102 83 ALGSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSGSVPNEIGKLKYLQILDLSQNFFNGSLPVSIVQCKRL 162 (714)
Q Consensus 83 ~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L 162 (714)
.+.++++.+.|.||+|+++ .+|+.+..+.+|+.|++++|+++ .+|..+++|+.|++|+++-|++. .+|..|+.++.|
T Consensus 28 gLf~~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~l 104 (264)
T KOG0617|consen 28 GLFNMSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPAL 104 (264)
T ss_pred cccchhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchh
Confidence 4567788888899999998 78888899999999999999998 89999999999999999999997 889999999999
Q ss_pred ceeecccCcCCC-CCCcccccCccccccccccCCcccccCCCCCCCCcccccccccccccCCcCcCccccCCCCcccccC
Q 005102 163 KALDLSQNNFTG-PLPNGFGSGLVSLEKLNLSFNKFNGSIPSNTGNLSSLQGTVDFSHNLFSGSIPASLGNLPEKVYIDL 241 (714)
Q Consensus 163 ~~L~l~~N~l~g-~~p~~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~~l~l~~N~l~g~~p~~~~~l~~L~~l~l 241 (714)
+.|||++|++.. .+|..|+ .++.|+.|+|++|.|. .+|..++++++|+ .|.+.+|.+- .+|.+++.+.+|+.|++
T Consensus 105 evldltynnl~e~~lpgnff-~m~tlralyl~dndfe-~lp~dvg~lt~lq-il~lrdndll-~lpkeig~lt~lrelhi 180 (264)
T KOG0617|consen 105 EVLDLTYNNLNENSLPGNFF-YMTTLRALYLGDNDFE-ILPPDVGKLTNLQ-ILSLRDNDLL-SLPKEIGDLTRLRELHI 180 (264)
T ss_pred hhhhccccccccccCCcchh-HHHHHHHHHhcCCCcc-cCChhhhhhccee-EEeeccCchh-hCcHHHHHHHHHHHHhc
Confidence 999999998875 5787775 5899999999999998 8999999999999 9999999887 78999999999999999
Q ss_pred cCCcCCCCCCCCcc
Q 005102 242 TYNNLSGPIPQNGA 255 (714)
Q Consensus 242 ~~N~l~~~~p~~~~ 255 (714)
++|+|+-.+|+...
T Consensus 181 qgnrl~vlppel~~ 194 (264)
T KOG0617|consen 181 QGNRLTVLPPELAN 194 (264)
T ss_pred ccceeeecChhhhh
Confidence 99999988887543
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=8.3e-21 Score=185.30 Aligned_cols=132 Identities=14% Similarity=0.208 Sum_probs=108.3
Q ss_pred cccccccCceEEEEEEECCCcEEEEEEeCCCCchhHH---------HHHHHHHHHhccCCCCccceEEEEEeC-------
Q 005102 408 AFVLGKSGIGIVYKVVLEDGHTLAVRRLGEGGSQRFK---------EFQTEVEAIGKIRHSNIVTLRAYYWSV------- 471 (714)
Q Consensus 408 ~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~---------~~~~E~~~l~~l~H~niv~l~~~~~~~------- 471 (714)
.+++|.|+||.||.+.. ++..+|||.++........ .+.+|++.+.+++|++|..+.+++...
T Consensus 36 ~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~~~~~~~ 114 (232)
T PRK10359 36 IKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAERKTLRY 114 (232)
T ss_pred EEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeecccccccc
Confidence 46899999999999766 5778999999765332222 268999999999999999999987643
Q ss_pred -CceeEEEeccCCCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEc
Q 005102 472 -DEKLLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVS 550 (714)
Q Consensus 472 -~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~ 550 (714)
+..++||||++|.+|.++.. ++. ....+++.+|..+|+ .+++|||+||+||++++++ ++|+
T Consensus 115 ~~~~~lvmEyi~G~tL~~~~~----------~~~----~~~~~i~~~l~~lH~---~gi~H~Dikp~Nili~~~g-i~li 176 (232)
T PRK10359 115 AHTYIMLIEYIEGVELNDMPE----------ISE----DVKAKIKASIESLHQ---HGMVSGDPHKGNFIVSKNG-LRII 176 (232)
T ss_pred cCCeEEEEEEECCccHHHhhh----------ccH----HHHHHHHHHHHHHHH---cCCccCCCChHHEEEeCCC-EEEE
Confidence 35789999999999988631 222 245699999999999 9999999999999999988 9999
Q ss_pred ccchhhhh
Q 005102 551 DFGLARLA 558 (714)
Q Consensus 551 DFGla~~~ 558 (714)
|||..+..
T Consensus 177 Dfg~~~~~ 184 (232)
T PRK10359 177 DLSGKRCT 184 (232)
T ss_pred ECCCcccc
Confidence 99987644
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=9.1e-20 Score=171.11 Aligned_cols=259 Identities=17% Similarity=0.211 Sum_probs=188.2
Q ss_pred ccccccCceEEEEEEE-CCCcEEEEEEeCCCCchhHHHHHHHHHHHhccCC-CCccceEEEEEeCCceeEEEeccCCCCH
Q 005102 409 FVLGKSGIGIVYKVVL-EDGHTLAVRRLGEGGSQRFKEFQTEVEAIGKIRH-SNIVTLRAYYWSVDEKLLIYDYIPNGSL 486 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H-~niv~l~~~~~~~~~~~lV~e~~~~gsL 486 (714)
..||.|+||.+|.|.. .+|..||||.-+.... ..+...|..+.+.++| ..|.++..|..+..+-.+|||.+ +-+|
T Consensus 21 rkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~--hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMdLL-GPsL 97 (341)
T KOG1163|consen 21 RKIGSGSFGDIYLGISITSGEEVAIKLESSKAK--HPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMDLL-GPSL 97 (341)
T ss_pred EeecCCchhheeeeeeccCCceEEEEeecccCC--CcchhHHHHHHHHhccCCCCchhhhhccccccceeeeecc-CccH
Confidence 4799999999999984 5699999998655432 2467789999999975 67888888888888999999988 7799
Q ss_pred hhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCC---CCeEEcccchhhhhhccCC
Q 005102 487 ATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHN---MEPHVSDFGLARLANIAGG 563 (714)
Q Consensus 487 ~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~---~~~kl~DFGla~~~~~~~~ 563 (714)
.+++.-.. +.++.++++-.+-|++.-++|+|. +++|||||||+|.|..-+ ..+.++|||+|+.+.+...
T Consensus 98 EdLfnfC~-----R~ftmkTvLMLaDQml~RiEyvH~---r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~t 169 (341)
T KOG1163|consen 98 EDLFNFCS-----RRFTMKTVLMLADQMLSRIEYVHL---RNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIRT 169 (341)
T ss_pred HHHHHHHh-----hhhhHHhHHHHHHHHHHHHHHHHh---hccccccCCccceeeccccccceEEEEeccchhhhccccc
Confidence 99987554 468899999999999999999999 999999999999999643 4688999999998765433
Q ss_pred CCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCccccCCCCc
Q 005102 564 SPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGSSE 643 (714)
Q Consensus 564 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~~~~~~~~ 643 (714)
...++ ........||..|.+--...+.+.+.+-|+-|+|.+|...--|..||.......
T Consensus 170 ~~HIp---------------------yre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~t 228 (341)
T KOG1163|consen 170 RQHIP---------------------YREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAAT 228 (341)
T ss_pred cccCc---------------------cccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhh
Confidence 22211 112234557888998888877788899999999999999999999994332211
Q ss_pred chhHHHHHHHHhhcC-CcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhhhh
Q 005102 644 MDLVNWMQLCIEEKK-PLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDALDRLI 710 (714)
Q Consensus 644 ~~l~~~~~~~~~~~~-~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~ 710 (714)
. .+-.....+.+- ...+.+ +..+ +.++.-.+.-|-..--++-|...-+.+.+.-+.
T Consensus 229 k--~QKyEkI~EkK~s~~ie~L----C~G~-----P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLf 285 (341)
T KOG1163|consen 229 K--KQKYEKISEKKMSTPIEVL----CKGF-----PAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILF 285 (341)
T ss_pred H--HHHHHHHHHhhcCCCHHHH----hCCC-----cHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHH
Confidence 1 111111111111 111111 1111 225666777787777778888777766665544
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=2.2e-19 Score=176.11 Aligned_cols=260 Identities=16% Similarity=0.198 Sum_probs=189.7
Q ss_pred cccccccCceEEEEEE-ECCCcEEEEEEeCCCCchhHHHHHHHHHHHhccC-CCCccceEEEEEeCCceeEEEeccCCCC
Q 005102 408 AFVLGKSGIGIVYKVV-LEDGHTLAVRRLGEGGSQRFKEFQTEVEAIGKIR-HSNIVTLRAYYWSVDEKLLIYDYIPNGS 485 (714)
Q Consensus 408 ~~~lG~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lV~e~~~~gs 485 (714)
+..||+|.||.++.|+ +-+++.||||.=...+. ..++..|.+..+.|. .++|..++-|..++-+-.||+|.+ +-+
T Consensus 33 GkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~--APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL-GPS 109 (449)
T KOG1165|consen 33 GKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSE--APQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL-GPS 109 (449)
T ss_pred ccccccCcceeeecccccccCceEEEEeccccCC--cchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh-CcC
Confidence 4589999999999998 45789999997554332 246778888888884 699999988888888889999998 779
Q ss_pred HhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCC-----CCeEEcccchhhhhhc
Q 005102 486 LATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHN-----MEPHVSDFGLARLANI 560 (714)
Q Consensus 486 L~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~-----~~~kl~DFGla~~~~~ 560 (714)
|.|+..-.. ++++.+++.-||.|++.-++|+|+ +.+|.|||||+|+||... ..+.++|||+|+.+.+
T Consensus 110 LEDLFD~Cg-----R~FSvKTV~miA~Qmi~rie~vH~---k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrD 181 (449)
T KOG1165|consen 110 LEDLFDLCG-----RRFSVKTVAMIAKQMITRIEYVHE---KDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRD 181 (449)
T ss_pred HHHHHHHhc-----CcccHHhHHHHHHHHHHHHHHHHh---cceeecccCccceeecCCCCCCCceEEEEeccchhhhcC
Confidence 999887654 569999999999999999999999 999999999999999643 3588999999999877
Q ss_pred cCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCccccCC
Q 005102 561 AGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVG 640 (714)
Q Consensus 561 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~~~~~ 640 (714)
......++.. ...+..||..||+--...+.+.+.+-|.=|+|-++...+-|..||....
T Consensus 182 p~TkqHIPYr---------------------E~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLK 240 (449)
T KOG1165|consen 182 PKTKQHIPYR---------------------EHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLK 240 (449)
T ss_pred ccccccCccc---------------------cccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCcccccc
Confidence 6544333221 1234457888999999999999999999999999999999999994432
Q ss_pred CCcchhHHHHHHHHhhcC--CcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhhhhc
Q 005102 641 SSEMDLVNWMQLCIEEKK--PLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDALDRLIV 711 (714)
Q Consensus 641 ~~~~~l~~~~~~~~~~~~--~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~ 711 (714)
.... .+-.+.+-+.++ ++.+. +.. .++++..-+..++ ..+-++-|..+-+...+..+++
T Consensus 241 A~tn--K~kYeKIGe~Kr~T~i~~L-----c~g--~P~efa~Yl~yvR---~L~F~E~PDYdylr~Lf~dvld 301 (449)
T KOG1165|consen 241 ADTN--KEKYEKIGETKRSTPIEVL-----CEG--FPEEFATYLRYVR---RLDFFETPDYDYLRKLFDDVLD 301 (449)
T ss_pred Ccch--HHHHHHhccccccCCHHHH-----Hhc--CHHHHHHHHHHHH---hcCcccCCCHHHHHHHHHHHHH
Confidence 2211 111111111111 01110 101 1233333344333 4566777888887777776654
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.82 E-value=6.4e-20 Score=178.10 Aligned_cols=139 Identities=18% Similarity=0.248 Sum_probs=110.8
Q ss_pred ccccccCceEEEEEEECCCcEEEEEEeCCCCch--h------------------------HHHHHHHHHHHhccCCCCcc
Q 005102 409 FVLGKSGIGIVYKVVLEDGHTLAVRRLGEGGSQ--R------------------------FKEFQTEVEAIGKIRHSNIV 462 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~--~------------------------~~~~~~E~~~l~~l~H~niv 462 (714)
..||+|+||.||+|...+|+.||||+++..... . ...+.+|.+.+.++.|+++.
T Consensus 3 ~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~ 82 (190)
T cd05145 3 GCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGVP 82 (190)
T ss_pred ceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCCC
Confidence 379999999999999888999999998764211 0 12246799999999999886
Q ss_pred ceEEEEEeCCceeEEEeccCCCCHhhh-hhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeee
Q 005102 463 TLRAYYWSVDEKLLIYDYIPNGSLATA-LHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILL 541 (714)
Q Consensus 463 ~l~~~~~~~~~~~lV~e~~~~gsL~~~-l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl 541 (714)
....+... ..++||||++++++... +.. ..++..+..+++.|++.++.++|+. .+|+||||||+||++
T Consensus 83 ~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~-------~~~~~~~~~~i~~~l~~~l~~lH~~--~givHrDlkP~NIll 151 (190)
T cd05145 83 VPEPILLK--KNVLVMEFIGDDGSPAPRLKD-------VPLEEEEAEELYEQVVEQMRRLYQE--AGLVHGDLSEYNILY 151 (190)
T ss_pred CceEEEec--CCEEEEEEecCCCchhhhhhh-------ccCCHHHHHHHHHHHHHHHHHHHHh--CCEecCCCChhhEEE
Confidence 55544433 35899999998755433 322 3467788999999999999999973 499999999999999
Q ss_pred CCCCCeEEcccchhhhhh
Q 005102 542 GHNMEPHVSDFGLARLAN 559 (714)
Q Consensus 542 ~~~~~~kl~DFGla~~~~ 559 (714)
+ ++.++|+|||+|+...
T Consensus 152 ~-~~~~~liDFG~a~~~~ 168 (190)
T cd05145 152 H-DGKPYIIDVSQAVELD 168 (190)
T ss_pred E-CCCEEEEEcccceecC
Confidence 9 7899999999998654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.4e-19 Score=172.75 Aligned_cols=194 Identities=18% Similarity=0.136 Sum_probs=137.4
Q ss_pred ccccccCceEEEEEEECCCcEEEEEEeCCCCchh----HHHHHHHHHHHhccC-CCCccceEEEEEeCCceeEEEeccCC
Q 005102 409 FVLGKSGIGIVYKVVLEDGHTLAVRRLGEGGSQR----FKEFQTEVEAIGKIR-HSNIVTLRAYYWSVDEKLLIYDYIPN 483 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~----~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lV~e~~~~ 483 (714)
..|++|+||+||.+.. .+..++.+.+....... ...|.+|+++|+++. |+++++++++ +..+++|||+.+
T Consensus 8 ~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI~G 82 (218)
T PRK12274 8 EPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYLAG 82 (218)
T ss_pred eeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeeecC
Confidence 4799999999997766 57788877776543311 125889999999995 5889999886 457999999999
Q ss_pred CCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCC-CCCCeeeCCCCCeEEcccchhhhhhccC
Q 005102 484 GSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDL-KPSNILLGHNMEPHVSDFGLARLANIAG 562 (714)
Q Consensus 484 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDl-kp~NILl~~~~~~kl~DFGla~~~~~~~ 562 (714)
.+|.+.+.. ....++.|++++|+++|+ .||+|||| ||+|||+++++.++|+|||+|.......
T Consensus 83 ~~L~~~~~~-------------~~~~~~~qi~~~L~~lH~---~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~ 146 (218)
T PRK12274 83 AAMYQRPPR-------------GDLAYFRAARRLLQQLHR---CGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRA 146 (218)
T ss_pred ccHHhhhhh-------------hhHHHHHHHHHHHHHHHH---CcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcc
Confidence 888654311 123578899999999999 99999999 7999999999999999999998543211
Q ss_pred CCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCC-CCC-chhhhHHHHHHHHHHHhCCCcccc
Q 005102 563 GSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVV-KPS-QKWDIYSYGVILLEMITGRTAVVQ 638 (714)
Q Consensus 563 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s-~~~DVwS~Gvvl~elltG~~p~~~ 638 (714)
... +.-...+....... ....++.|++|+...-. ..+ ...+.++-|.-+|.++||+.+...
T Consensus 147 ~~~--------------r~L~~rDl~~llk~-~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~ 209 (218)
T PRK12274 147 RWM--------------RLLAREDLRHLLKH-KRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWE 209 (218)
T ss_pred hHH--------------HHHHHHHHHHHHHH-HHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccc
Confidence 000 00000000000011 11246668888765332 334 567889999999999999988743
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=8.8e-21 Score=201.86 Aligned_cols=225 Identities=22% Similarity=0.249 Sum_probs=175.6
Q ss_pred cccccCceEEEEEEE----CCCcEEEEEEeCCCCch--hHHHHHHHHHHHhccC-CCCccceEEEEEeCCceeEEEeccC
Q 005102 410 VLGKSGIGIVYKVVL----EDGHTLAVRRLGEGGSQ--RFKEFQTEVEAIGKIR-HSNIVTLRAYYWSVDEKLLIYDYIP 482 (714)
Q Consensus 410 ~lG~G~~g~Vy~~~~----~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lV~e~~~ 482 (714)
++|+|.||.|+.++- ..|+.+|+|++++.... .......|..++..++ ||.+|++...++.....+++++|..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 379999999998653 23788899988764221 1124567888999997 9999999999999999999999999
Q ss_pred CCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccC
Q 005102 483 NGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAG 562 (714)
Q Consensus 483 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 562 (714)
+|+|...+... ..+++.....+...++-|++++|. .+|+|||+|++||+++.+|++|+.|||+++..-...
T Consensus 81 gg~lft~l~~~------~~f~~~~~~~~~aelaLald~lh~---l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~ 151 (612)
T KOG0603|consen 81 GGDLFTRLSKE------VMFDELDVAFYLAELALALDHLHK---LGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEK 151 (612)
T ss_pred cchhhhccccC------CchHHHHHHHHHHHHHHHHhhcch---hHHHHhcccccceeecccCccccCCchhhhHhHhhh
Confidence 99999988765 346777788889999999999999 899999999999999999999999999998753221
Q ss_pred CCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCccccCCCC
Q 005102 563 GSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGSS 642 (714)
Q Consensus 563 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~~~~~~~ 642 (714)
...||.-|||||+.. .....+|.||||++++||+||..||..
T Consensus 152 --------------------------------~~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~---- 193 (612)
T KOG0603|consen 152 --------------------------------IACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG---- 193 (612)
T ss_pred --------------------------------hcccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch----
Confidence 115688899999997 567899999999999999999999942
Q ss_pred cchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCH
Q 005102 643 EMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTM 699 (714)
Q Consensus 643 ~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~ 699 (714)
+.+..+.+....+. .+......+++..+...+|..|--.
T Consensus 194 -----~~~~~Il~~~~~~p-------------~~l~~~a~~~~~~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 194 -----DTMKRILKAELEMP-------------RELSAEARSLFRQLFKRNPENRLGA 232 (612)
T ss_pred -----HHHHHHhhhccCCc-------------hhhhHHHHHHHHHHHhhCHHHHhcc
Confidence 22333333222211 1223345677778888888888544
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.2e-21 Score=174.40 Aligned_cols=164 Identities=30% Similarity=0.478 Sum_probs=152.4
Q ss_pred CCcEEEEEcCCCCccccCCccccCCCCCCEEEccCCCCcccCChhhcCCCCCCEEEcCCCcCcccCCcccCCCCCCCEEe
Q 005102 63 EQRVVSVSIPKKKLLGFLPSALGSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSGSVPNEIGKLKYLQILD 142 (714)
Q Consensus 63 ~~~~~~l~l~~~~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ 142 (714)
...++.|.|++|+++- +|+.+..|.+|+.|++++|++. .+|..++.+++|+.|+++-|++. .+|..|+.++.|+.||
T Consensus 32 ~s~ITrLtLSHNKl~~-vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~levld 108 (264)
T KOG0617|consen 32 MSNITRLTLSHNKLTV-VPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEVLD 108 (264)
T ss_pred hhhhhhhhcccCceee-cCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhhhhh
Confidence 4578999999999984 6888999999999999999998 89999999999999999999998 9999999999999999
Q ss_pred ccCccCCC-CCCcccccccccceeecccCcCCCCCCcccccCccccccccccCCcccccCCCCCCCCccccccccccccc
Q 005102 143 LSQNFFNG-SLPVSIVQCKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLNLSFNKFNGSIPSNTGNLSSLQGTVDFSHNL 221 (714)
Q Consensus 143 Ls~N~l~g-~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~~l~l~~N~ 221 (714)
|++|+++. .+|..|..++.|+.|+|++|.|. .+|.+++ .|++|+.|.+.+|.+- ++|.+++.+..|. .|.+.+|.
T Consensus 109 ltynnl~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg-~lt~lqil~lrdndll-~lpkeig~lt~lr-elhiqgnr 184 (264)
T KOG0617|consen 109 LTYNNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVG-KLTNLQILSLRDNDLL-SLPKEIGDLTRLR-ELHIQGNR 184 (264)
T ss_pred ccccccccccCCcchhHHHHHHHHHhcCCCcc-cCChhhh-hhcceeEEeeccCchh-hCcHHHHHHHHHH-HHhcccce
Confidence 99999975 68999999999999999999997 8999996 5999999999999998 9999999999999 99999999
Q ss_pred CCcCcCccccCCC
Q 005102 222 FSGSIPASLGNLP 234 (714)
Q Consensus 222 l~g~~p~~~~~l~ 234 (714)
++ .+|.+++++.
T Consensus 185 l~-vlppel~~l~ 196 (264)
T KOG0617|consen 185 LT-VLPPELANLD 196 (264)
T ss_pred ee-ecChhhhhhh
Confidence 98 6777776643
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.7e-20 Score=208.70 Aligned_cols=252 Identities=18% Similarity=0.262 Sum_probs=173.8
Q ss_pred cccccccCceEEEEEEECCCcEEEEEEeCCCC-chhHHHHHHHHHH--HhccCCCCccceEEEEEeCCceeEEEeccCCC
Q 005102 408 AFVLGKSGIGIVYKVVLEDGHTLAVRRLGEGG-SQRFKEFQTEVEA--IGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNG 484 (714)
Q Consensus 408 ~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~-~~~~~~~~~E~~~--l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~g 484 (714)
.+.||.+.|=+|.+|++++|. |+||++-+.+ ......|.++++. ....+|||.+++.-.-......|||=+|+.+
T Consensus 28 ~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqyvkh- 105 (1431)
T KOG1240|consen 28 VENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQYVKH- 105 (1431)
T ss_pred ecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHHHhh-
Confidence 347999999999999999887 8999987664 3344455544444 4445899999987776666777899999965
Q ss_pred CHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCC
Q 005102 485 SLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGS 564 (714)
Q Consensus 485 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 564 (714)
+|+|.+..++ -+...+.+-|+.|++.||..+|. .+|+|+|||.+||||+.-.=+.|+||.--|...-.+..
T Consensus 106 nLyDRlSTRP------FL~~iEKkWiaFQLL~al~qcH~---~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDN 176 (1431)
T KOG1240|consen 106 NLYDRLSTRP------FLVLIEKKWIAFQLLKALSQCHK---LGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDN 176 (1431)
T ss_pred hhhhhhccch------HHHHHHHHHHHHHHHHHHHHHHH---cCccccccccceEEEeeechhhhhcccccCCccCCCCC
Confidence 9999997663 36777888999999999999999 89999999999999998888999999754432111110
Q ss_pred CCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCC----------CC-CCchhhhHHHHHHHHHHHh-C
Q 005102 565 PTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKV----------VK-PSQKWDIYSYGVILLEMIT-G 632 (714)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----------~~-~s~~~DVwS~Gvvl~ellt-G 632 (714)
+ .+.+ .-..+ ...-..|+|||-+.. .. .+++-||||+||++.||++ |
T Consensus 177 P-----------------adf~--fFFDT--SrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg 235 (1431)
T KOG1240|consen 177 P-----------------ADFT--FFFDT--SRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEG 235 (1431)
T ss_pred c-----------------ccce--EEEec--CCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcC
Confidence 0 0000 00011 111224999998743 11 5778999999999999998 6
Q ss_pred CCccccCCCCcchhHHHHHHH-HhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhhh
Q 005102 633 RTAVVQVGSSEMDLVNWMQLC-IEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDALDRL 709 (714)
Q Consensus 633 ~~p~~~~~~~~~~l~~~~~~~-~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i 709 (714)
++||.- -.+..+-... .....-+.++-|+ .+..++..|++.||++|-++++.++.-.++
T Consensus 236 ~PlF~L-----SQL~aYr~~~~~~~e~~Le~Ied~-------------~~Rnlil~Mi~rdPs~RlSAedyL~~yrG~ 295 (1431)
T KOG1240|consen 236 RPLFTL-----SQLLAYRSGNADDPEQLLEKIEDV-------------SLRNLILSMIQRDPSKRLSAEDYLQKYRGL 295 (1431)
T ss_pred CCcccH-----HHHHhHhccCccCHHHHHHhCcCc-------------cHHHHHHHHHccCchhccCHHHHHHhhhcc
Confidence 888821 1111111000 0000001111111 366899999999999999999999875543
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.80 E-value=3.8e-19 Score=173.43 Aligned_cols=136 Identities=21% Similarity=0.228 Sum_probs=107.0
Q ss_pred cccccccCceEEEEEEECCCcEEEEEEeCCCCchhHHHHHHHHHHHhcc-----CCCCccceEEEEEeCC---cee-EEE
Q 005102 408 AFVLGKSGIGIVYKVVLEDGHTLAVRRLGEGGSQRFKEFQTEVEAIGKI-----RHSNIVTLRAYYWSVD---EKL-LIY 478 (714)
Q Consensus 408 ~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-----~H~niv~l~~~~~~~~---~~~-lV~ 478 (714)
..+||+|+||.||. +++....+||++........+.+.+|+++++.+ .||||++++|++.+.. ..+ +|+
T Consensus 7 ~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I~ 84 (210)
T PRK10345 7 QSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVIA 84 (210)
T ss_pred cceecCCCceEEEE--CCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEEe
Confidence 45899999999996 443333479998776555567899999999999 5799999999998863 333 789
Q ss_pred ec--cCCCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHH-HHHhcCCCCCceecCCCCCCeeeCC----CCCeEEcc
Q 005102 479 DY--IPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGL-VYLHEFSPKKYVHGDLKPSNILLGH----NMEPHVSD 551 (714)
Q Consensus 479 e~--~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL-~~LH~~~~~~ivHrDlkp~NILl~~----~~~~kl~D 551 (714)
|| +++|+|.+++.+. .+++. ..++.+++.++ +|||+ .+|+||||||+|||++. +..++|+|
T Consensus 85 e~~G~~~~tL~~~l~~~-------~~~e~--~~~~~~~L~~l~~yLh~---~~IvhrDlKp~NILl~~~~~~~~~~~LiD 152 (210)
T PRK10345 85 DFDGKPSITLTEFAEQC-------RYEED--VAQLRQLLKKLKRYLLD---NRIVTMELKPQNILCQRISESEVIPVVCD 152 (210)
T ss_pred cCCCCcchhHHHHHHcc-------cccHh--HHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEeccCCCCCcEEEEE
Confidence 99 5579999999653 24444 35688888888 99999 99999999999999974 34799999
Q ss_pred -cchhhh
Q 005102 552 -FGLARL 557 (714)
Q Consensus 552 -FGla~~ 557 (714)
||...+
T Consensus 153 g~G~~~~ 159 (210)
T PRK10345 153 NIGESTF 159 (210)
T ss_pred CCCCcce
Confidence 554443
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=2.1e-20 Score=195.02 Aligned_cols=205 Identities=23% Similarity=0.226 Sum_probs=171.7
Q ss_pred EEcCCCCccccCCccccCCCCCCEEEccCCCCcccCChhhcCCCCCCEEEcCCCcCcccCCcccCCCCCCCEEeccCccC
Q 005102 69 VSIPKKKLLGFLPSALGSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSGSVPNEIGKLKYLQILDLSQNFF 148 (714)
Q Consensus 69 l~l~~~~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l 148 (714)
|.|++|++...-...|..+.++++|+|+.|++...-...+++|++|+.|+||+|.+.-.-++.+...++|++|+||+|++
T Consensus 250 lklqrN~I~kL~DG~Fy~l~kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i 329 (873)
T KOG4194|consen 250 LKLQRNDISKLDDGAFYGLEKMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRI 329 (873)
T ss_pred hhhhhcCcccccCcceeeecccceeecccchhhhhhcccccccchhhhhccchhhhheeecchhhhcccceeEecccccc
Confidence 34556666666666777888888888888888877777788899999999999999888888888889999999999999
Q ss_pred CCCCCcccccccccceeecccCcCCCCCCcccccCccccccccccCCcccccCCC---CCCCCcccccccccccccCCcC
Q 005102 149 NGSLPVSIVQCKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLNLSFNKFNGSIPS---NTGNLSSLQGTVDFSHNLFSGS 225 (714)
Q Consensus 149 ~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~l~~L~~L~l~~N~l~g~~p~---~~~~l~~L~~~l~l~~N~l~g~ 225 (714)
+..-+.+|..|..|++|+|++|+++ .+.+..+.++.+|++|||++|.+++.|.+ .|..|++|+ .|+|.+|+|...
T Consensus 330 ~~l~~~sf~~L~~Le~LnLs~Nsi~-~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~Lr-kL~l~gNqlk~I 407 (873)
T KOG4194|consen 330 TRLDEGSFRVLSQLEELNLSHNSID-HLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLR-KLRLTGNQLKSI 407 (873)
T ss_pred ccCChhHHHHHHHhhhhcccccchH-HHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhccchhhh-heeecCceeeec
Confidence 8766778888999999999999997 67766667899999999999999988875 455688888 999999999966
Q ss_pred cCccccCCCCcccccCcCCcCCCCCCCCccccCCCCcccccCCCCCCCCC
Q 005102 226 IPASLGNLPEKVYIDLTYNNLSGPIPQNGALMNRGPTAFIGNPRLCGPPL 275 (714)
Q Consensus 226 ~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~~~~~~~~~~~~n~~~~~~~~ 275 (714)
.-.+|..++.|+.|||.+|.+...-|..+.-+......+-....+|+|.+
T Consensus 408 ~krAfsgl~~LE~LdL~~NaiaSIq~nAFe~m~Lk~Lv~nSssflCDCql 457 (873)
T KOG4194|consen 408 PKRAFSGLEALEHLDLGDNAIASIQPNAFEPMELKELVMNSSSFLCDCQL 457 (873)
T ss_pred chhhhccCcccceecCCCCcceeecccccccchhhhhhhcccceEEeccH
Confidence 66899999999999999999999988888777666666767777888764
|
|
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.77 E-value=2.2e-20 Score=195.83 Aligned_cols=183 Identities=27% Similarity=0.401 Sum_probs=156.3
Q ss_pred CCcEEEEEcCCCCccccCCccccCCCCCCEEEccCCCCcccCChh-hcCCCCCCEEEcCCCcCcccCCcccCCCCCCCEE
Q 005102 63 EQRVVSVSIPKKKLLGFLPSALGSLTDLRHVNLRNNKFFGSLPLE-LLEAQGLQSLVLYGNSFSGSVPNEIGKLKYLQIL 141 (714)
Q Consensus 63 ~~~~~~l~l~~~~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~-~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L 141 (714)
...++.|+|++|+|.. .|..+..-+++-+|+||+|+|. +||.. |.+|+.|-+||||+|++. .+|+.+..|.+|+.|
T Consensus 102 l~dLt~lDLShNqL~E-vP~~LE~AKn~iVLNLS~N~Ie-tIPn~lfinLtDLLfLDLS~NrLe-~LPPQ~RRL~~LqtL 178 (1255)
T KOG0444|consen 102 LKDLTILDLSHNQLRE-VPTNLEYAKNSIVLNLSYNNIE-TIPNSLFINLTDLLFLDLSNNRLE-MLPPQIRRLSMLQTL 178 (1255)
T ss_pred cccceeeecchhhhhh-cchhhhhhcCcEEEEcccCccc-cCCchHHHhhHhHhhhccccchhh-hcCHHHHHHhhhhhh
Confidence 3578889999999884 6888888889999999999998 56655 568999999999999998 888888888888999
Q ss_pred eccCccCC-------------------------CCCCcccccccccceeecccCcCCCCCCcccccCccccccccccCCc
Q 005102 142 DLSQNFFN-------------------------GSLPVSIVQCKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLNLSFNK 196 (714)
Q Consensus 142 ~Ls~N~l~-------------------------g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~l~~L~~L~l~~N~ 196 (714)
+|++|.+. ..+|.++..|.+|..+|||.|++. .+|..+. .+.+|+.|+||+|+
T Consensus 179 ~Ls~NPL~hfQLrQLPsmtsL~vLhms~TqRTl~N~Ptsld~l~NL~dvDlS~N~Lp-~vPecly-~l~~LrrLNLS~N~ 256 (1255)
T KOG0444|consen 179 KLSNNPLNHFQLRQLPSMTSLSVLHMSNTQRTLDNIPTSLDDLHNLRDVDLSENNLP-IVPECLY-KLRNLRRLNLSGNK 256 (1255)
T ss_pred hcCCChhhHHHHhcCccchhhhhhhcccccchhhcCCCchhhhhhhhhccccccCCC-cchHHHh-hhhhhheeccCcCc
Confidence 99888765 247788888899999999999998 8899886 59999999999999
Q ss_pred ccccCCCCCCCCcccccccccccccCCcCcCccccCCCCcccccCcCCcCCC-CCCCC
Q 005102 197 FNGSIPSNTGNLSSLQGTVDFSHNLFSGSIPASLGNLPEKVYIDLTYNNLSG-PIPQN 253 (714)
Q Consensus 197 l~g~~p~~~~~l~~L~~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~-~~p~~ 253 (714)
|+ .+....+....|+ +|++|+|+++ .+|.+++.|+.|+.|.+.+|+|+- -+|+.
T Consensus 257 it-eL~~~~~~W~~lE-tLNlSrNQLt-~LP~avcKL~kL~kLy~n~NkL~FeGiPSG 311 (1255)
T KOG0444|consen 257 IT-ELNMTEGEWENLE-TLNLSRNQLT-VLPDAVCKLTKLTKLYANNNKLTFEGIPSG 311 (1255)
T ss_pred ee-eeeccHHHHhhhh-hhccccchhc-cchHHHhhhHHHHHHHhccCcccccCCccc
Confidence 98 7777777788888 9999999998 899999999999999999999872 24444
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.77 E-value=5.5e-18 Score=192.90 Aligned_cols=140 Identities=33% Similarity=0.528 Sum_probs=96.5
Q ss_pred CchhHHHHHHHHHHhccCCCCCCCCCCCCCCCCC--CcccceEecCCcEEEEEcCCCCccccCCccccCCCCCCEEEccC
Q 005102 20 SLNGEGYALLSFKQSVHEDPEGSLSNWNSSDENP--CSWNGITCKEQRVVSVSIPKKKLLGFLPSALGSLTDLRHVNLRN 97 (714)
Q Consensus 20 ~~~~~~~~l~~~~~~~~~~~~~~l~~w~~~~~~~--c~w~gv~c~~~~~~~l~l~~~~l~g~~p~~~~~l~~L~~L~L~~ 97 (714)
....|..||+++|+++. ++. ..+|++..+.| |.|.||.|..... + ....++.|+|++
T Consensus 369 t~~~~~~aL~~~k~~~~-~~~--~~~W~g~~C~p~~~~w~Gv~C~~~~~----------~--------~~~~v~~L~L~~ 427 (623)
T PLN03150 369 TLLEEVSALQTLKSSLG-LPL--RFGWNGDPCVPQQHPWSGADCQFDST----------K--------GKWFIDGLGLDN 427 (623)
T ss_pred cCchHHHHHHHHHHhcC-Ccc--cCCCCCCCCCCcccccccceeeccCC----------C--------CceEEEEEECCC
Confidence 45678999999999883 442 24897432111 2799999952110 0 011245666677
Q ss_pred CCCcccCChhhcCCCCCCEEEcCCCcCcccCCcccCCCCCCCEEeccCccCCCCCCcccccccccceeecccCcCCCCCC
Q 005102 98 NKFFGSLPLELLEAQGLQSLVLYGNSFSGSVPNEIGKLKYLQILDLSQNFFNGSLPVSIVQCKRLKALDLSQNNFTGPLP 177 (714)
Q Consensus 98 N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p 177 (714)
|.+.|.+|..+..+++|+.|+|++|.|+|.+|..++.+++|+.|+|++|+|+|.+|..+++|++|+.|+|++|+|+|.+|
T Consensus 428 n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~N~l~g~iP 507 (623)
T PLN03150 428 QGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVP 507 (623)
T ss_pred CCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcCCcccccCC
Confidence 77777777777777777777777777777777777777888888888888887777777777777777777777777776
Q ss_pred ccc
Q 005102 178 NGF 180 (714)
Q Consensus 178 ~~~ 180 (714)
..+
T Consensus 508 ~~l 510 (623)
T PLN03150 508 AAL 510 (623)
T ss_pred hHH
Confidence 654
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.76 E-value=6.1e-19 Score=177.37 Aligned_cols=230 Identities=19% Similarity=0.280 Sum_probs=143.6
Q ss_pred cccccccCceEEEEEEECC-CcEEEEEEeCCC---CchhHHHHHHHHHHHhccC----------CCCccceEEEEEe---
Q 005102 408 AFVLGKSGIGIVYKVVLED-GHTLAVRRLGEG---GSQRFKEFQTEVEAIGKIR----------HSNIVTLRAYYWS--- 470 (714)
Q Consensus 408 ~~~lG~G~~g~Vy~~~~~~-g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~----------H~niv~l~~~~~~--- 470 (714)
+..||.|+++.||.+++.+ |+.+|||++... .....+++.+|.-....+. |-.++--++...-
T Consensus 17 ~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~~~ 96 (288)
T PF14531_consen 17 GRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIPGK 96 (288)
T ss_dssp EEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEETTS
T ss_pred ccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEcCC
Confidence 3579999999999999875 899999987543 2334567777776555532 2233333333221
Q ss_pred ------CC--------ceeEEEeccCCCCHhhhhhC---CCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecC
Q 005102 471 ------VD--------EKLLIYDYIPNGSLATALHG---KPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGD 533 (714)
Q Consensus 471 ------~~--------~~~lV~e~~~~gsL~~~l~~---~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrD 533 (714)
.. ..+++|+-+ .+||.+++.. .... ...+....++.+..|+.+.+++||+ .|+||+|
T Consensus 97 ~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~--~~~l~~~arl~lT~Q~I~lvA~Lh~---~GlVHgd 170 (288)
T PF14531_consen 97 PPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQT--HSPLAFAARLSLTVQMIRLVANLHS---YGLVHGD 170 (288)
T ss_dssp -SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTT--SHHHHHHHHHHHHHHHHHHHHHHHH---TTEEEST
T ss_pred CcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccc--cchhHHHHHHHHHHHHHHHHHHHhh---cceEecc
Confidence 11 235778877 5588887642 1110 1234456677888999999999999 9999999
Q ss_pred CCCCCeeeCCCCCeEEcccchhhhhhccCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCC---
Q 005102 534 LKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKV--- 610 (714)
Q Consensus 534 lkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--- 610 (714)
|||+|++++++|.++|+||+......... .. ...+..|.+||....
T Consensus 171 i~~~nfll~~~G~v~Lg~F~~~~r~g~~~---------------------------~~----~~~~~~~~PPe~~~~~~~ 219 (288)
T PF14531_consen 171 IKPENFLLDQDGGVFLGDFSSLVRAGTRY---------------------------RC----SEFPVAFTPPELESCAGQ 219 (288)
T ss_dssp -SGGGEEE-TTS-EEE--GGGEEETTEEE---------------------------EG----GGS-TTTS-HHHHHHHTS
T ss_pred cceeeEEEcCCCCEEEcChHHHeecCcee---------------------------ec----cCCCcccCChhhhhhhcc
Confidence 99999999999999999998765432110 00 112356899997633
Q ss_pred -----CCCCchhhhHHHHHHHHHHHhCCCccccCCCCcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHH
Q 005102 611 -----VKPSQKWDIYSYGVILLEMITGRTAVVQVGSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIA 685 (714)
Q Consensus 611 -----~~~s~~~DVwS~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li 685 (714)
..++.+.|.|++|+++|.|+.|+.||......... .. .+. .+. +..+.+..+|
T Consensus 220 ~~~~~~~~t~~~DaW~LG~~ly~lWC~~lPf~~~~~~~~~---------------~~----~f~-~C~--~~Pe~v~~LI 277 (288)
T PF14531_consen 220 FGQNNAPYTFATDAWQLGITLYSLWCGRLPFGLSSPEADP---------------EW----DFS-RCR--DMPEPVQFLI 277 (288)
T ss_dssp CHHSEEEE-HHHHHHHHHHHHHHHHHSS-STCCCGGGSTS---------------GG----GGT-TSS-----HHHHHHH
T ss_pred cCcccceeeeccCHHHHHHHHHHHHHccCCCCCCCccccc---------------cc----cch-hcC--CcCHHHHHHH
Confidence 24789999999999999999999999432111110 00 111 111 3445688999
Q ss_pred hHccCCCCCCC
Q 005102 686 MACVHSSPEKR 696 (714)
Q Consensus 686 ~~Cl~~dP~~R 696 (714)
..+|++||++|
T Consensus 278 ~~lL~~~~~~R 288 (288)
T PF14531_consen 278 RGLLQRNPEDR 288 (288)
T ss_dssp HHHT-SSGGGS
T ss_pred HHHccCCcccC
Confidence 99999999988
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.74 E-value=9.6e-18 Score=167.78 Aligned_cols=137 Identities=16% Similarity=0.182 Sum_probs=107.1
Q ss_pred ccccccCceEEEEEE--ECCCcEEEEEEeCCCCch------------------------hHHHHHHHHHHHhccCCCC--
Q 005102 409 FVLGKSGIGIVYKVV--LEDGHTLAVRRLGEGGSQ------------------------RFKEFQTEVEAIGKIRHSN-- 460 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~--~~~g~~vavK~~~~~~~~------------------------~~~~~~~E~~~l~~l~H~n-- 460 (714)
+.||+|+||.||+|. ..+|+.||||+++..... ....+.+|++.+.++.+..
T Consensus 34 ~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~~~~i~ 113 (237)
T smart00090 34 GCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLYEAGVP 113 (237)
T ss_pred CeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHHhcCCC
Confidence 579999999999998 567999999998754210 0123678999999997633
Q ss_pred ccceEEEEEeCCceeEEEeccCCCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCC-ceecCCCCCCe
Q 005102 461 IVTLRAYYWSVDEKLLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKK-YVHGDLKPSNI 539 (714)
Q Consensus 461 iv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~-ivHrDlkp~NI 539 (714)
+.+++++ ...++||||+++++|....... ..+...+...++.|++.+++|||+ .+ |+||||||+||
T Consensus 114 ~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~------~~~~~~~~~~i~~qi~~~l~~LH~---~g~iiH~Dikp~NI 180 (237)
T smart00090 114 VPKPIAW----RRNVLVMEFIGGDGLPAPRLKD------VEPEEEEEFELYDDILEEMRKLYK---EGELVHGDLSEYNI 180 (237)
T ss_pred CCeeeEe----cCceEEEEEecCCccccccccc------CCcchHHHHHHHHHHHHHHHHHHh---cCCEEeCCCChhhE
Confidence 3344433 2458999999998887654222 234556678999999999999999 88 99999999999
Q ss_pred eeCCCCCeEEcccchhhhhh
Q 005102 540 LLGHNMEPHVSDFGLARLAN 559 (714)
Q Consensus 540 Ll~~~~~~kl~DFGla~~~~ 559 (714)
+++ ++.++|+|||.|....
T Consensus 181 li~-~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 181 LVH-DGKVVIIDVSQSVELD 199 (237)
T ss_pred EEE-CCCEEEEEChhhhccC
Confidence 999 8899999999988643
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.6e-17 Score=164.46 Aligned_cols=134 Identities=18% Similarity=0.304 Sum_probs=114.5
Q ss_pred ccccccCceEEEEEEECCCcEEEEEEeCCCCch--------hHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEec
Q 005102 409 FVLGKSGIGIVYKVVLEDGHTLAVRRLGEGGSQ--------RFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDY 480 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~ 480 (714)
+.||+|++|.||+|.+ +|..|++|+....... ....+.+|++++..++|++|.....++...+..++||||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 3689999999999998 6788999986543211 124578899999999999998888888788889999999
Q ss_pred cCCCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhh
Q 005102 481 IPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARL 557 (714)
Q Consensus 481 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 557 (714)
+++++|.+++... .+ .+..++.+++.+|.++|+ .+++|||++|+||+++ ++.++|+|||.++.
T Consensus 81 ~~G~~L~~~~~~~---------~~-~~~~i~~~i~~~l~~lH~---~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSN---------GM-EELELSREIGRLVGKLHS---AGIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhc---------cH-HHHHHHHHHHHHHHHHHh---CCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 9999999988533 12 788999999999999999 8999999999999999 78899999999875
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.1e-17 Score=167.59 Aligned_cols=202 Identities=20% Similarity=0.280 Sum_probs=139.2
Q ss_pred CCCCccceEEEEEe---------------------------CCceeEEEeccCCCCHhhhhhCCCCCCCcCCCCHHHHHH
Q 005102 457 RHSNIVTLRAYYWS---------------------------VDEKLLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVK 509 (714)
Q Consensus 457 ~H~niv~l~~~~~~---------------------------~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~ 509 (714)
+|||||++.++|.+ ....|+||.-++. +|.+++..+ ..+...+.-
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~-------~~s~r~~~~ 345 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTR-------HRSYRTGRV 345 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcC-------CCchHHHHH
Confidence 59999999887742 1235899988865 999998654 245556777
Q ss_pred HHHHHHHHHHHHhcCCCCCceecCCCCCCeee--CCCC--CeEEcccchhhhhhccCCCCCccCCCCCCCCchhhhcccc
Q 005102 510 IIKGIAKGLVYLHEFSPKKYVHGDLKPSNILL--GHNM--EPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQKSV 585 (714)
Q Consensus 510 i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl--~~~~--~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 585 (714)
|+.|+++|+.|||. ++|.|||+|++|||+ |+|+ .+.|+|||++-.-+.. + +
T Consensus 346 ~laQlLEav~hL~~---hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~h-G---------------------l 400 (598)
T KOG4158|consen 346 ILAQLLEAVTHLHK---HGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNH-G---------------------L 400 (598)
T ss_pred HHHHHHHHHHHHHH---ccchhhcccccceEEEecCCCCcEEEEcccceeeecccc-c---------------------c
Confidence 89999999999999 999999999999998 4444 3578999987532211 1 1
Q ss_pred cceeecccCCCCCCccccCCcccCCCC-----C-CchhhhHHHHHHHHHHHhCCCccccCCCCcchhHHHHHHHHhhcCC
Q 005102 586 SLEVTTTNSSSNLGSYYQAPESLKVVK-----P-SQKWDIYSYGVILLEMITGRTAVVQVGSSEMDLVNWMQLCIEEKKP 659 (714)
Q Consensus 586 ~~~~~~~~~~~~gt~~y~aPE~~~~~~-----~-s~~~DVwS~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~ 659 (714)
...........+|...-||||+....+ . -.|+|.|+.|.+.||+++...||+..+....+...+
T Consensus 401 qlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Y---------- 470 (598)
T KOG4158|consen 401 QLPYESDEVDLGGNAKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTY---------- 470 (598)
T ss_pred ccccccccccCCCcceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhh----------
Confidence 111122333455666789999985432 1 348999999999999999999997654433332221
Q ss_pred cccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHh
Q 005102 660 LADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDALD 707 (714)
Q Consensus 660 ~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~ 707 (714)
.+.--|.+... ...-+.+++...++.||++|++..-....|.
T Consensus 471 -qe~qLPalp~~-----vpp~~rqlV~~lL~r~pskRvsp~iAANvl~ 512 (598)
T KOG4158|consen 471 -QESQLPALPSR-----VPPVARQLVFDLLKRDPSKRVSPNIAANVLN 512 (598)
T ss_pred -hhhhCCCCccc-----CChHHHHHHHHHhcCCccccCCccHHHhHHH
Confidence 11111222221 1224678999999999999998776655553
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.72 E-value=3e-17 Score=187.24 Aligned_cols=242 Identities=14% Similarity=0.198 Sum_probs=170.8
Q ss_pred cccccccCceEEEEEEECCCcEEEEEEeCCCCchhHHHHHHHHHHHhccC---CCCccceEEEEEeCCceeEEEeccCCC
Q 005102 408 AFVLGKSGIGIVYKVVLEDGHTLAVRRLGEGGSQRFKEFQTEVEAIGKIR---HSNIVTLRAYYWSVDEKLLIYDYIPNG 484 (714)
Q Consensus 408 ~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---H~niv~l~~~~~~~~~~~lV~e~~~~g 484 (714)
...||+|+||+||+|...+|+.||+|+=+....-. |--=.+++.||+ -+.|+++...+.-.+.-++|+||.+.|
T Consensus 703 ~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WE---fYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~lv~ey~~~G 779 (974)
T KOG1166|consen 703 SKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWE---FYICLQVMERLKPQMLPSIMHISSAHVFQNASVLVSEYSPYG 779 (974)
T ss_pred EeeeccccceEEEEeecCCCcEEEEEeecCCCcee---eeehHHHHHhhchhhhcchHHHHHHHccCCcceeeeeccccc
Confidence 35799999999999999889999999877654322 111123344444 345666666666677889999999999
Q ss_pred CHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCC-------CCCeEEcccchhhh
Q 005102 485 SLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGH-------NMEPHVSDFGLARL 557 (714)
Q Consensus 485 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~-------~~~~kl~DFGla~~ 557 (714)
+|.+++... ..++|...+.++.|+++-+++||. .+|||+||||+|.||.. ...++|+|||.+--
T Consensus 780 tlld~~N~~------~~m~e~lv~~~~~qml~ive~lH~---~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~siD 850 (974)
T KOG1166|consen 780 TLLDLINTN------KVMDEYLVMFFSCQMLRIVEHLHA---MGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSID 850 (974)
T ss_pred cHHHhhccC------CCCCchhhhHHHHHHHHHHHHHHh---cceecccCCcceeEeecccCCCCcccceEEEeccccee
Confidence 999999844 458999999999999999999999 89999999999999942 34689999998754
Q ss_pred hhccCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCccc
Q 005102 558 ANIAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVV 637 (714)
Q Consensus 558 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~~ 637 (714)
+..=.. .+......+|-.+--+|+..|..+++++|-|.+..+++-|+.|++.=
T Consensus 851 m~lfp~--------------------------~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~q- 903 (974)
T KOG1166|consen 851 MKLFPD--------------------------GTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYME- 903 (974)
T ss_pred eeEcCC--------------------------CcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHHH-
Confidence 321000 12233344566688899999999999999999999999999997521
Q ss_pred cCCCCcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhhhh
Q 005102 638 QVGSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDALDRLI 710 (714)
Q Consensus 638 ~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~ 710 (714)
...+. ...++..++.. ...+ -..++....|..|-..=|...++...++++.
T Consensus 904 ----------------~~~g~--~~~~~~~~~Ry-~~~~---~W~~~F~~lLN~~~~~~p~l~~lr~~~~~~~ 954 (974)
T KOG1166|consen 904 ----------------VKNGS--SWMVKTNFPRY-WKRD---MWNKFFDLLLNPDCDTLPNLQELRTELEEVL 954 (974)
T ss_pred ----------------hcCCc--ceeccccchhh-hhHH---HHHHHHHHHhCcCcccchhHHHHHHHHHHHH
Confidence 11110 11112211111 1111 2345666666644444478888888887764
|
|
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.72 E-value=4.9e-19 Score=185.82 Aligned_cols=154 Identities=31% Similarity=0.467 Sum_probs=103.3
Q ss_pred CCcEEEEEcCCCCccccCCccccCCCCCCEEEccCCCCcccCChhhcCCCCCCEEEcCCCcCc-ccCCcccCCCCCCCEE
Q 005102 63 EQRVVSVSIPKKKLLGFLPSALGSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFS-GSVPNEIGKLKYLQIL 141 (714)
Q Consensus 63 ~~~~~~l~l~~~~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~-g~~p~~~~~l~~L~~L 141 (714)
..+++-|.|...+|. .+|..++.|.+|++|.+++|+|. .+-.++..|+.|+.+++..|++. .-+|..+-.|.-|++|
T Consensus 31 Mt~~~WLkLnrt~L~-~vPeEL~~lqkLEHLs~~HN~L~-~vhGELs~Lp~LRsv~~R~N~LKnsGiP~diF~l~dLt~l 108 (1255)
T KOG0444|consen 31 MTQMTWLKLNRTKLE-QVPEELSRLQKLEHLSMAHNQLI-SVHGELSDLPRLRSVIVRDNNLKNSGIPTDIFRLKDLTIL 108 (1255)
T ss_pred hhheeEEEechhhhh-hChHHHHHHhhhhhhhhhhhhhH-hhhhhhccchhhHHHhhhccccccCCCCchhcccccceee
Confidence 456777777777765 57889999999999999999886 44455555666666666666652 2456666666666666
Q ss_pred eccCccCCCCCCcccccccccceeecccCcCCCCCCcccccCccccccccccCCcccccCCCCCCCCccccccccccccc
Q 005102 142 DLSQNFFNGSLPVSIVQCKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLNLSFNKFNGSIPSNTGNLSSLQGTVDFSHNL 221 (714)
Q Consensus 142 ~Ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~~l~l~~N~ 221 (714)
|||+|+++ ..|..+..-+++-.|+||+|++. .||..++.+|+.|-.||||+|++. .+|+.+..|..|+ +|+|++|.
T Consensus 109 DLShNqL~-EvP~~LE~AKn~iVLNLS~N~Ie-tIPn~lfinLtDLLfLDLS~NrLe-~LPPQ~RRL~~Lq-tL~Ls~NP 184 (1255)
T KOG0444|consen 109 DLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIE-TIPNSLFINLTDLLFLDLSNNRLE-MLPPQIRRLSMLQ-TLKLSNNP 184 (1255)
T ss_pred ecchhhhh-hcchhhhhhcCcEEEEcccCccc-cCCchHHHhhHhHhhhccccchhh-hcCHHHHHHhhhh-hhhcCCCh
Confidence 66666665 66666666666666666666665 666666666666666666666666 5666666666666 66666664
Q ss_pred C
Q 005102 222 F 222 (714)
Q Consensus 222 l 222 (714)
+
T Consensus 185 L 185 (1255)
T KOG0444|consen 185 L 185 (1255)
T ss_pred h
Confidence 4
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.71 E-value=4.6e-17 Score=159.66 Aligned_cols=131 Identities=22% Similarity=0.348 Sum_probs=108.7
Q ss_pred cccccCceEEEEEEECCCcEEEEEEeCCCCc--------hhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEecc
Q 005102 410 VLGKSGIGIVYKVVLEDGHTLAVRRLGEGGS--------QRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYI 481 (714)
Q Consensus 410 ~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~ 481 (714)
+||+|+||.||+|.+ +|..|++|+...... ....++.+|++++..++|+++.....++...+..++||||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 489999999999996 578899998654211 11356788999999999988776666666777789999999
Q ss_pred CCCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhh
Q 005102 482 PNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLA 558 (714)
Q Consensus 482 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~ 558 (714)
++++|.+.+... . ..++.+++.+|.+||+ .+++|+|++|.||+++ ++.++++|||+++..
T Consensus 80 ~g~~l~~~~~~~------~-------~~~~~~i~~~l~~lH~---~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~~ 139 (199)
T TIGR03724 80 EGKPLKDVIEEG------N-------DELLREIGRLVGKLHK---AGIVHGDLTTSNIIVR-DDKLYLIDFGLGKYS 139 (199)
T ss_pred CCccHHHHHhhc------H-------HHHHHHHHHHHHHHHH---CCeecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence 999999887532 1 0789999999999999 8999999999999999 789999999998753
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.70 E-value=2.7e-18 Score=179.52 Aligned_cols=194 Identities=21% Similarity=0.195 Sum_probs=150.1
Q ss_pred CCcEEEEEcCCCCccccCCccccCCCCCCEEEccCCCCcccCChhhcCCCCCCEEEcCCCcCcccCCcccCCCCCCCEEe
Q 005102 63 EQRVVSVSIPKKKLLGFLPSALGSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSGSVPNEIGKLKYLQILD 142 (714)
Q Consensus 63 ~~~~~~l~l~~~~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ 142 (714)
.++++.|+|.+|.++..-.+++.-++.|++||||.|.|+.+--..|..-.+++.|+|++|+++..--..|.+|.+|..|.
T Consensus 124 sghl~~L~L~~N~I~sv~se~L~~l~alrslDLSrN~is~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~~lnsL~tlk 203 (873)
T KOG4194|consen 124 SGHLEKLDLRHNLISSVTSEELSALPALRSLDLSRNLISEIPKPSFPAKVNIKKLNLASNRITTLETGHFDSLNSLLTLK 203 (873)
T ss_pred ccceeEEeeeccccccccHHHHHhHhhhhhhhhhhchhhcccCCCCCCCCCceEEeeccccccccccccccccchheeee
Confidence 35789999999999888888888888888999988888844444455557788888888888765566677777888888
Q ss_pred ccCccCCCCCCcccccccccceeecccCcCCC-----------------------CCCcccccCccccccccccCCcccc
Q 005102 143 LSQNFFNGSLPVSIVQCKRLKALDLSQNNFTG-----------------------PLPNGFGSGLVSLEKLNLSFNKFNG 199 (714)
Q Consensus 143 Ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g-----------------------~~p~~~~~~l~~L~~L~l~~N~l~g 199 (714)
|+.|+++...+..|.+|++|+.|+|..|++.- .+-++.+-++.+++.|+|+.|+++.
T Consensus 204 LsrNrittLp~r~Fk~L~~L~~LdLnrN~irive~ltFqgL~Sl~nlklqrN~I~kL~DG~Fy~l~kme~l~L~~N~l~~ 283 (873)
T KOG4194|consen 204 LSRNRITTLPQRSFKRLPKLESLDLNRNRIRIVEGLTFQGLPSLQNLKLQRNDISKLDDGAFYGLEKMEHLNLETNRLQA 283 (873)
T ss_pred cccCcccccCHHHhhhcchhhhhhccccceeeehhhhhcCchhhhhhhhhhcCcccccCcceeeecccceeecccchhhh
Confidence 88888874444456667777777777776531 2233344457788888888888886
Q ss_pred cCCCCCCCCcccccccccccccCCcCcCccccCCCCcccccCcCCcCCCCCCCCcccc
Q 005102 200 SIPSNTGNLSSLQGTVDFSHNLFSGSIPASLGNLPEKVYIDLTYNNLSGPIPQNGALM 257 (714)
Q Consensus 200 ~~p~~~~~l~~L~~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~~~ 257 (714)
.-..++.+|++|+ .|+||+|.|....+++++..++|++|+|++|+++...+..+...
T Consensus 284 vn~g~lfgLt~L~-~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L 340 (873)
T KOG4194|consen 284 VNEGWLFGLTSLE-QLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVL 340 (873)
T ss_pred hhcccccccchhh-hhccchhhhheeecchhhhcccceeEeccccccccCChhHHHHH
Confidence 6667788899999 99999999999999999999999999999999998887765443
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.70 E-value=1.2e-18 Score=174.58 Aligned_cols=217 Identities=23% Similarity=0.263 Sum_probs=166.5
Q ss_pred cceEecC-----------CcEEEEEcCCCCccccCCccccCCCCCCEEEccCCCCcccCChhhcCCCCCCEEEcCC-CcC
Q 005102 57 NGITCKE-----------QRVVSVSIPKKKLLGFLPSALGSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYG-NSF 124 (714)
Q Consensus 57 ~gv~c~~-----------~~~~~l~l~~~~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~-N~l 124 (714)
.-|+|+. ...+.|+|..|+|+...|.+|+.+++|+.||||+|+|+-+-|.+|.++.+|..|-+.+ |+|
T Consensus 49 ~~VdCr~~GL~eVP~~LP~~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI 128 (498)
T KOG4237|consen 49 GIVDCRGKGLTEVPANLPPETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKI 128 (498)
T ss_pred ceEEccCCCcccCcccCCCcceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCch
Confidence 3488973 3567789999999999999999999999999999999999999999999998887776 999
Q ss_pred cccCCcccCCCCCCCEEeccCccCCCCCCcccccccccceeecccCcCCCCCCc--------------------------
Q 005102 125 SGSVPNEIGKLKYLQILDLSQNFFNGSLPVSIVQCKRLKALDLSQNNFTGPLPN-------------------------- 178 (714)
Q Consensus 125 ~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~-------------------------- 178 (714)
+...-..|++|.+|+.|.+.-|++.-.....|..+++|..|.+.+|.+. .++.
T Consensus 129 ~~l~k~~F~gL~slqrLllNan~i~Cir~~al~dL~~l~lLslyDn~~q-~i~~~tf~~l~~i~tlhlA~np~icdCnL~ 207 (498)
T KOG4237|consen 129 TDLPKGAFGGLSSLQRLLLNANHINCIRQDALRDLPSLSLLSLYDNKIQ-SICKGTFQGLAAIKTLHLAQNPFICDCNLP 207 (498)
T ss_pred hhhhhhHhhhHHHHHHHhcChhhhcchhHHHHHHhhhcchhcccchhhh-hhccccccchhccchHhhhcCccccccccc
Confidence 8433345666666666666666655444444444444444444444332 1111
Q ss_pred ------------------------------------------------------------ccccCccccccccccCCccc
Q 005102 179 ------------------------------------------------------------GFGSGLVSLEKLNLSFNKFN 198 (714)
Q Consensus 179 ------------------------------------------------------------~~~~~l~~L~~L~l~~N~l~ 198 (714)
..+..|++|++|+|++|+++
T Consensus 208 wla~~~a~~~ietsgarc~~p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~lnlsnN~i~ 287 (498)
T KOG4237|consen 208 WLADDLAMNPIETSGARCVSPYRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKLPNLRKLNLSNNKIT 287 (498)
T ss_pred hhhhHHhhchhhcccceecchHHHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcChHHHHhhcccceEeccCCCccc
Confidence 11234889999999999999
Q ss_pred ccCCCCCCCCcccccccccccccCCcCcCccccCCCCcccccCcCCcCCCCCCCCcccc-CCCCcccccCCCCCCCCC
Q 005102 199 GSIPSNTGNLSSLQGTVDFSHNLFSGSIPASLGNLPEKVYIDLTYNNLSGPIPQNGALM-NRGPTAFIGNPRLCGPPL 275 (714)
Q Consensus 199 g~~p~~~~~l~~L~~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~~~-~~~~~~~~~n~~~~~~~~ 275 (714)
+.-+.+|..+..++ .|.|..|+|.-.--..|..+.+|+.|+|.+|+++-.-|..+.-. ........+||+.|.+.+
T Consensus 288 ~i~~~aFe~~a~l~-eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~~Np~~CnC~l 364 (498)
T KOG4237|consen 288 RIEDGAFEGAAELQ-ELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNLLSNPFNCNCRL 364 (498)
T ss_pred hhhhhhhcchhhhh-hhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEecccccccceeeeeehccCcccCccch
Confidence 88889999999999 99999999987777889999999999999999998888776543 345666789999998754
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.70 E-value=1.1e-16 Score=156.72 Aligned_cols=133 Identities=17% Similarity=0.186 Sum_probs=106.1
Q ss_pred cccccccCceEEEEEEECCCcEEEEEEeCCCCch----------------------hHHHHHHHHHHHhccCCCC--ccc
Q 005102 408 AFVLGKSGIGIVYKVVLEDGHTLAVRRLGEGGSQ----------------------RFKEFQTEVEAIGKIRHSN--IVT 463 (714)
Q Consensus 408 ~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~----------------------~~~~~~~E~~~l~~l~H~n--iv~ 463 (714)
.+.||+|+||.||++..++|+.||||+++..... ....+.+|+.++.++.|++ +..
T Consensus 20 ~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~v~~ 99 (198)
T cd05144 20 GNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGFPVPK 99 (198)
T ss_pred CCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCCCCCc
Confidence 4579999999999999988999999987643210 0123678999999998874 444
Q ss_pred eEEEEEeCCceeEEEeccCCCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCC
Q 005102 464 LRAYYWSVDEKLLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGH 543 (714)
Q Consensus 464 l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~ 543 (714)
.++ ....++||||+++++|..+... .....++.+++.++.++|+ .+|+||||||+||++++
T Consensus 100 ~~~----~~~~~lv~e~~~g~~L~~~~~~------------~~~~~~~~~i~~~l~~lh~---~gi~H~Dl~p~Nill~~ 160 (198)
T cd05144 100 PID----WNRHAVVMEYIDGVELYRVRVL------------EDPEEVLDEILEEIVKAYK---HGIIHGDLSEFNILVDD 160 (198)
T ss_pred eee----cCCceEEEEEeCCcchhhcccc------------ccHHHHHHHHHHHHHHHHH---CCCCcCCCCcccEEEcC
Confidence 444 2456899999999998765421 2346788999999999999 89999999999999999
Q ss_pred CCCeEEcccchhhhhh
Q 005102 544 NMEPHVSDFGLARLAN 559 (714)
Q Consensus 544 ~~~~kl~DFGla~~~~ 559 (714)
++.++|+|||++....
T Consensus 161 ~~~~~liDfg~~~~~~ 176 (198)
T cd05144 161 DEKIYIIDWPQMVSTD 176 (198)
T ss_pred CCcEEEEECCccccCC
Confidence 9999999999986543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.1e-16 Score=180.48 Aligned_cols=132 Identities=21% Similarity=0.351 Sum_probs=109.1
Q ss_pred cccccccCceEEEEEEECCCcEEEEEE-eCCC-Cc------hhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEe
Q 005102 408 AFVLGKSGIGIVYKVVLEDGHTLAVRR-LGEG-GS------QRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYD 479 (714)
Q Consensus 408 ~~~lG~G~~g~Vy~~~~~~g~~vavK~-~~~~-~~------~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e 479 (714)
.+.||+|+||+||+|.+.+.. +++|+ +.+. .. ...+.+.+|++++.+++|++++....++...+..++|||
T Consensus 338 ~~~iG~G~~g~Vy~~~~~~~~-~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~E 416 (535)
T PRK09605 338 DHLIGKGAEADIKKGEYLGRD-AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKTIVME 416 (535)
T ss_pred cceeccCCcEEEEEEeecCcc-ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCEEEEE
Confidence 468999999999999986543 44443 2221 11 123568899999999999999998888888778899999
Q ss_pred ccCCCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhh
Q 005102 480 YIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLA 558 (714)
Q Consensus 480 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~ 558 (714)
|+++++|.+++. ....++.+++++|.|||+ .+++||||||+|||+ +++.++|+|||+++..
T Consensus 417 ~~~g~~L~~~l~--------------~~~~~~~~i~~~L~~lH~---~giiHrDlkp~NILl-~~~~~~liDFGla~~~ 477 (535)
T PRK09605 417 YIGGKDLKDVLE--------------GNPELVRKVGEIVAKLHK---AGIVHGDLTTSNFIV-RDDRLYLIDFGLGKYS 477 (535)
T ss_pred ecCCCcHHHHHH--------------HHHHHHHHHHHHHHHHHh---CCCccCCCChHHEEE-ECCcEEEEeCcccccC
Confidence 999999998874 356799999999999999 899999999999999 5779999999999864
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.69 E-value=3.5e-19 Score=178.55 Aligned_cols=191 Identities=28% Similarity=0.401 Sum_probs=122.3
Q ss_pred EEEEcCCCCccccCCccccCCCCCCEEEccCCCCcccCChhhcCCCCCCEEEcCCCcCcccCCcccCC------------
Q 005102 67 VSVSIPKKKLLGFLPSALGSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSGSVPNEIGK------------ 134 (714)
Q Consensus 67 ~~l~l~~~~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~------------ 134 (714)
+.++.++|++. .+|++++++.+|+.|+.++|.+. .+|+.++.+..|+.|+..+|+++ .+|+.+++
T Consensus 94 ~~l~vs~n~ls-~lp~~i~s~~~l~~l~~s~n~~~-el~~~i~~~~~l~dl~~~~N~i~-slp~~~~~~~~l~~l~~~~n 170 (565)
T KOG0472|consen 94 KSLNVSHNKLS-ELPEQIGSLISLVKLDCSSNELK-ELPDSIGRLLDLEDLDATNNQIS-SLPEDMVNLSKLSKLDLEGN 170 (565)
T ss_pred HHhhcccchHh-hccHHHhhhhhhhhhhcccccee-ecCchHHHHhhhhhhhccccccc-cCchHHHHHHHHHHhhcccc
Confidence 33555666655 35556666666666666666655 45555555555555555555554 44444443
Q ss_pred -----------CCCCCEEeccCccCCCCCCcccccccccceeecccCcCCCCCCcccccCccccccccccCCcccccCCC
Q 005102 135 -----------LKYLQILDLSQNFFNGSLPVSIVQCKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLNLSFNKFNGSIPS 203 (714)
Q Consensus 135 -----------l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~l~~L~~L~l~~N~l~g~~p~ 203 (714)
++.|++||...|-++ .+|+.++.+.+|..|+|..|++. .+| +|. ++..|++|+++.|.+. .+|.
T Consensus 171 ~l~~l~~~~i~m~~L~~ld~~~N~L~-tlP~~lg~l~~L~~LyL~~Nki~-~lP-ef~-gcs~L~Elh~g~N~i~-~lpa 245 (565)
T KOG0472|consen 171 KLKALPENHIAMKRLKHLDCNSNLLE-TLPPELGGLESLELLYLRRNKIR-FLP-EFP-GCSLLKELHVGENQIE-MLPA 245 (565)
T ss_pred chhhCCHHHHHHHHHHhcccchhhhh-cCChhhcchhhhHHHHhhhcccc-cCC-CCC-ccHHHHHHHhcccHHH-hhHH
Confidence 555555555555554 56666666666666666666665 555 342 3566666666666666 6665
Q ss_pred CCC-CCcccccccccccccCCcCcCccccCCCCcccccCcCCcCCCCCCCCccccCCCCcccccCC
Q 005102 204 NTG-NLSSLQGTVDFSHNLFSGSIPASLGNLPEKVYIDLTYNNLSGPIPQNGALMNRGPTAFIGNP 268 (714)
Q Consensus 204 ~~~-~l~~L~~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~~~~~~~~~~~~n~ 268 (714)
+.+ ++.++. .+||++|++. .+|..++.+.+|.+||+|+|.+++.++..+.. ........|||
T Consensus 246 e~~~~L~~l~-vLDLRdNklk-e~Pde~clLrsL~rLDlSNN~is~Lp~sLgnl-hL~~L~leGNP 308 (565)
T KOG0472|consen 246 EHLKHLNSLL-VLDLRDNKLK-EVPDEICLLRSLERLDLSNNDISSLPYSLGNL-HLKFLALEGNP 308 (565)
T ss_pred HHhcccccce-eeeccccccc-cCchHHHHhhhhhhhcccCCccccCCcccccc-eeeehhhcCCc
Confidence 555 677777 8888888887 78888888888999999999999888776654 44455566775
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.68 E-value=1.1e-17 Score=175.09 Aligned_cols=179 Identities=24% Similarity=0.360 Sum_probs=129.6
Q ss_pred ceeEEEeccCCCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEccc
Q 005102 473 EKLLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDF 552 (714)
Q Consensus 473 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DF 552 (714)
..|+.|+++...+|.+|+..++.. ...++...+.++.|++.|++| ++.+|||+||.||+...+..+||.||
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~---e~~s~s~~~~~~~q~~~~~~y------k~~ihrdlkp~nif~~~d~q~kIgDF 400 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTG---EERSLSLMLDIFKQIAPAVEY------KGLIHRDLKPSNIFFSDDDQLKIGDF 400 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcc---cccchhHHHHHHHhhccchhh------ccchhhhccccccccccchhhhhhhh
Confidence 578999999999999999755432 457888999999999999999 38999999999999999999999999
Q ss_pred chhhhhhccCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHh-
Q 005102 553 GLARLANIAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMIT- 631 (714)
Q Consensus 553 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~ellt- 631 (714)
|+.......... .......+...||..||+||.+.+..|+.|+||||+|++++|+++
T Consensus 401 gl~ts~~~~~~~----------------------~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~ 458 (516)
T KOG1033|consen 401 GLVTSQDKDETV----------------------APAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQ 458 (516)
T ss_pred hheeecccCCcc----------------------cchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHH
Confidence 998755432200 001223445678999999999999999999999999999999998
Q ss_pred CCCccccCCCCcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHH
Q 005102 632 GRTAVVQVGSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHI 702 (714)
Q Consensus 632 G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev 702 (714)
=..++.. . ..+.++-|..+++... ..-..-+.++.+++...|.+||++.++
T Consensus 459 f~T~~er--------~----------~t~~d~r~g~ip~~~~--~d~p~e~~ll~~lls~~p~~RP~~~~~ 509 (516)
T KOG1033|consen 459 FSTQFER--------I----------ATLTDIRDGIIPPEFL--QDYPEEYTLLQQLLSPSPEERPSAIEV 509 (516)
T ss_pred hccHHHH--------H----------HhhhhhhcCCCChHHh--hcCcHHHHHHHHhcCCCcccCchHHHH
Confidence 2222210 0 0112222222221110 011123578889999999999955443
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.68 E-value=9.3e-17 Score=179.39 Aligned_cols=215 Identities=20% Similarity=0.268 Sum_probs=139.1
Q ss_pred ccccccCceEEEEEEECC-CcEEEEEEeCCCCchhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCCCHh
Q 005102 409 FVLGKSGIGIVYKVVLED-GHTLAVRRLGEGGSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGSLA 487 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL~ 487 (714)
+.|..|+||.||.++++. .+.+|+ ++.+.... .+- ++.....|.+| ||-.
T Consensus 89 klisngAygavylvrh~~trqrfa~-kiNkq~li-----lRn--ilt~a~npfvv---------------------gDc~ 139 (1205)
T KOG0606|consen 89 KLISNGAYGAVYLVRHKETRQRFAM-KINKQNLI-----LRN--ILTFAGNPFVV---------------------GDCA 139 (1205)
T ss_pred EeeccCCCCceeeeeccccccchhh-cccccchh-----hhc--cccccCCccee---------------------chhh
Confidence 478999999999999875 677888 44332211 110 23233333333 4555
Q ss_pred hhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCCCCc
Q 005102 488 TALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTL 567 (714)
Q Consensus 488 ~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 567 (714)
..++.. ..++.. .+.+++|||+ .+|+|||+||+|.+|+.-|++|+.|||+++.--..-..
T Consensus 140 tllk~~------g~lPvd--------mvla~Eylh~---ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~at--- 199 (1205)
T KOG0606|consen 140 TLLKNI------GPLPVD--------MVLAVEYLHS---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLAT--- 199 (1205)
T ss_pred hhcccC------CCCcch--------hhHHhHhhcc---CCeecCCCCCCcceeeecccccccchhhhhhhhhhccc---
Confidence 555433 223222 2788999999 89999999999999999999999999999864321110
Q ss_pred cCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCccccCCCCcchhH
Q 005102 568 QSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGSSEMDLV 647 (714)
Q Consensus 568 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~~~~~~~~~~l~ 647 (714)
+.. .................||+.|+|||++....|+..+|.|++|+|+||.+.|+.||+.. ...++.
T Consensus 200 --nl~--------eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGd--tpeelf 267 (1205)
T KOG0606|consen 200 --NLK--------EGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGD--TPEELF 267 (1205)
T ss_pred --hhh--------hcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCC--CHHHHH
Confidence 000 00000111122334557899999999999999999999999999999999999999532 222222
Q ss_pred HHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCC
Q 005102 648 NWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRP 697 (714)
Q Consensus 648 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RP 697 (714)
. ..+.+.....+- |... ..+..+++.+.|+.+|..|-
T Consensus 268 g---~visd~i~wpE~-dea~---------p~Ea~dli~~LL~qnp~~Rl 304 (1205)
T KOG0606|consen 268 G---QVISDDIEWPEE-DEAL---------PPEAQDLIEQLLRQNPLCRL 304 (1205)
T ss_pred h---hhhhhhcccccc-CcCC---------CHHHHHHHHHHHHhChHhhc
Confidence 2 222222222222 2222 22567888999999999994
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.63 E-value=5.1e-18 Score=170.28 Aligned_cols=174 Identities=31% Similarity=0.448 Sum_probs=157.9
Q ss_pred cEEEEEcCCCCccccCCccccCCCCCCEEEccCCCCcccCChhhcCCCCCCEEEcCCCcCcccCCcccCCCCCCCEEecc
Q 005102 65 RVVSVSIPKKKLLGFLPSALGSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSGSVPNEIGKLKYLQILDLS 144 (714)
Q Consensus 65 ~~~~l~l~~~~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls 144 (714)
.+..++..+|+++ .+|++++++.+|..|++.+|++. .+|+..-+++.|+.||...|-++ .+|++++.|.+|.-|+|.
T Consensus 138 ~l~dl~~~~N~i~-slp~~~~~~~~l~~l~~~~n~l~-~l~~~~i~m~~L~~ld~~~N~L~-tlP~~lg~l~~L~~LyL~ 214 (565)
T KOG0472|consen 138 DLEDLDATNNQIS-SLPEDMVNLSKLSKLDLEGNKLK-ALPENHIAMKRLKHLDCNSNLLE-TLPPELGGLESLELLYLR 214 (565)
T ss_pred hhhhhhccccccc-cCchHHHHHHHHHHhhccccchh-hCCHHHHHHHHHHhcccchhhhh-cCChhhcchhhhHHHHhh
Confidence 3444566778877 47888999999999999999998 55555555999999999999997 999999999999999999
Q ss_pred CccCCCCCCcccccccccceeecccCcCCCCCCcccccCccccccccccCCcccccCCCCCCCCcccccccccccccCCc
Q 005102 145 QNFFNGSLPVSIVQCKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLNLSFNKFNGSIPSNTGNLSSLQGTVDFSHNLFSG 224 (714)
Q Consensus 145 ~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~~l~l~~N~l~g 224 (714)
.|++. .+| +|.+|+.|++|+++.|.+. .+|.+....|.+|..|||.+|+++ ..|.++.-+++|. ++|+|+|.++
T Consensus 215 ~Nki~-~lP-ef~gcs~L~Elh~g~N~i~-~lpae~~~~L~~l~vLDLRdNklk-e~Pde~clLrsL~-rLDlSNN~is- 288 (565)
T KOG0472|consen 215 RNKIR-FLP-EFPGCSLLKELHVGENQIE-MLPAEHLKHLNSLLVLDLRDNKLK-EVPDEICLLRSLE-RLDLSNNDIS- 288 (565)
T ss_pred hcccc-cCC-CCCccHHHHHHHhcccHHH-hhHHHHhcccccceeeeccccccc-cCchHHHHhhhhh-hhcccCCccc-
Confidence 99998 788 8999999999999999997 899999888999999999999999 9999999999999 9999999999
Q ss_pred CcCccccCCCCcccccCcCCcCCC
Q 005102 225 SIPASLGNLPEKVYIDLTYNNLSG 248 (714)
Q Consensus 225 ~~p~~~~~l~~L~~l~l~~N~l~~ 248 (714)
.+|.+++++ +|+.|-+.+|.+..
T Consensus 289 ~Lp~sLgnl-hL~~L~leGNPlrT 311 (565)
T KOG0472|consen 289 SLPYSLGNL-HLKFLALEGNPLRT 311 (565)
T ss_pred cCCcccccc-eeeehhhcCCchHH
Confidence 688899999 99999999999873
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.62 E-value=3.7e-15 Score=149.43 Aligned_cols=137 Identities=20% Similarity=0.258 Sum_probs=107.8
Q ss_pred hcccccc-ccCceEEEEEEECCCcEEEEEEeCCCC-------------chhHHHHHHHHHHHhccCCCCc--cceEEEEE
Q 005102 406 ASAFVLG-KSGIGIVYKVVLEDGHTLAVRRLGEGG-------------SQRFKEFQTEVEAIGKIRHSNI--VTLRAYYW 469 (714)
Q Consensus 406 ~~~~~lG-~G~~g~Vy~~~~~~g~~vavK~~~~~~-------------~~~~~~~~~E~~~l~~l~H~ni--v~l~~~~~ 469 (714)
....+|| .||.|+||++... +..+|||++.... ......+.+|++++.+++|++| ++.+++..
T Consensus 34 ~~~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~ 112 (239)
T PRK01723 34 QQARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARV 112 (239)
T ss_pred hcCceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeee
Confidence 4456898 8999999999885 7789999885421 1223568899999999998875 67777654
Q ss_pred eCC----ceeEEEeccCC-CCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCC
Q 005102 470 SVD----EKLLIYDYIPN-GSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHN 544 (714)
Q Consensus 470 ~~~----~~~lV~e~~~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~ 544 (714)
... ..++||||+++ .+|.+++... .++.. .+.+++.+|.+||+ .||+||||||+|||++.+
T Consensus 113 ~~~~~~~~~~lV~e~l~G~~~L~~~l~~~-------~l~~~----~~~~i~~~l~~lH~---~GI~HrDlkp~NILv~~~ 178 (239)
T PRK01723 113 VRHGLFYRADILIERIEGARDLVALLQEA-------PLSEE----QWQAIGQLIARFHD---AGVYHADLNAHNILLDPD 178 (239)
T ss_pred eecCcceeeeEEEEecCCCCCHHHHHhcC-------CCCHH----HHHHHHHHHHHHHH---CCCCCCCCCchhEEEcCC
Confidence 432 23599999997 6999887542 23333 36789999999999 999999999999999998
Q ss_pred CCeEEcccchhhh
Q 005102 545 MEPHVSDFGLARL 557 (714)
Q Consensus 545 ~~~kl~DFGla~~ 557 (714)
+.++|+|||.++.
T Consensus 179 ~~v~LIDfg~~~~ 191 (239)
T PRK01723 179 GKFWLIDFDRGEL 191 (239)
T ss_pred CCEEEEECCCccc
Confidence 8999999998875
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.60 E-value=5.2e-15 Score=137.73 Aligned_cols=134 Identities=19% Similarity=0.181 Sum_probs=113.5
Q ss_pred ccccccCceEEEEEEECCCcEEEEEEeCCCCchhHHHHHHHHHHHhccCC--CCccceEEEEEeCCceeEEEeccCCCCH
Q 005102 409 FVLGKSGIGIVYKVVLEDGHTLAVRRLGEGGSQRFKEFQTEVEAIGKIRH--SNIVTLRAYYWSVDEKLLIYDYIPNGSL 486 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H--~niv~l~~~~~~~~~~~lV~e~~~~gsL 486 (714)
+.||+|.++.||++...+ ..+++|....... ...+.+|+..+..++| .+++++++++...+..+++|||++++.+
T Consensus 4 ~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~~ 80 (155)
T cd05120 4 KLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGETL 80 (155)
T ss_pred eecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCeec
Confidence 368999999999999864 7899999876543 4678999999999976 5899999988888889999999988766
Q ss_pred hhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhh
Q 005102 487 ATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLA 558 (714)
Q Consensus 487 ~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~ 558 (714)
..+ +......++.+++++++++|.....+++|+|++|+||++++.+.++++|||.++..
T Consensus 81 ~~~-------------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~~ 139 (155)
T cd05120 81 DEV-------------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYG 139 (155)
T ss_pred ccC-------------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccCC
Confidence 542 44567888999999999999854347999999999999999899999999998753
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.60 E-value=8.1e-17 Score=177.29 Aligned_cols=200 Identities=33% Similarity=0.428 Sum_probs=150.4
Q ss_pred CCcEEEEEcCCCCccccCCccccCCCCCCEEEccCCCCcccCChhhcCCCCCCEEEcCCCcCcccCCcccCCCCCCCEEe
Q 005102 63 EQRVVSVSIPKKKLLGFLPSALGSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSGSVPNEIGKLKYLQILD 142 (714)
Q Consensus 63 ~~~~~~l~l~~~~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ 142 (714)
...++.+++++|++++ +|+.++.+.+|+.|+..+|+|+ .+|..+...++|+.|.+..|.++ .+|+.+..++.|+.|+
T Consensus 240 p~nl~~~dis~n~l~~-lp~wi~~~~nle~l~~n~N~l~-~lp~ri~~~~~L~~l~~~~nel~-yip~~le~~~sL~tLd 316 (1081)
T KOG0618|consen 240 PLNLQYLDISHNNLSN-LPEWIGACANLEALNANHNRLV-ALPLRISRITSLVSLSAAYNELE-YIPPFLEGLKSLRTLD 316 (1081)
T ss_pred cccceeeecchhhhhc-chHHHHhcccceEecccchhHH-hhHHHHhhhhhHHHHHhhhhhhh-hCCCcccccceeeeee
Confidence 3567778888888886 4588888888888888888885 56666555555555555555555 5555555555555555
Q ss_pred ccCccCC-------------------------------------------------CCCCcccccccccceeecccCcCC
Q 005102 143 LSQNFFN-------------------------------------------------GSLPVSIVQCKRLKALDLSQNNFT 173 (714)
Q Consensus 143 Ls~N~l~-------------------------------------------------g~~p~~~~~l~~L~~L~l~~N~l~ 173 (714)
|..|+|. ...-+.+.+...|+.|+|++|+|.
T Consensus 317 L~~N~L~~lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~ 396 (1081)
T KOG0618|consen 317 LQSNNLPSLPDNFLAVLNASLNTLNVSSNKLSTLPSYEENNHAALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRLN 396 (1081)
T ss_pred ehhccccccchHHHhhhhHHHHHHhhhhccccccccccchhhHHHHHHHHhcCcccccchhhhccccceeeeeecccccc
Confidence 5555554 333333445568899999999997
Q ss_pred CCCCcccccCccccccccccCCcccccCCCCCCCCcccccccccccccCCcCcCccccCCCCcccccCcCCcCCC-CCCC
Q 005102 174 GPLPNGFGSGLVSLEKLNLSFNKFNGSIPSNTGNLSSLQGTVDFSHNLFSGSIPASLGNLPEKVYIDLTYNNLSG-PIPQ 252 (714)
Q Consensus 174 g~~p~~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~-~~p~ 252 (714)
.+|.....++..|+.|+||+|+|+ .+|..+.++..|+ +|....|+|. .+| ++..+++|+.+|+|.|+|+- .+|.
T Consensus 397 -~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~-tL~ahsN~l~-~fP-e~~~l~qL~~lDlS~N~L~~~~l~~ 471 (1081)
T KOG0618|consen 397 -SFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLH-TLRAHSNQLL-SFP-ELAQLPQLKVLDLSCNNLSEVTLPE 471 (1081)
T ss_pred -cCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhH-HHhhcCCcee-ech-hhhhcCcceEEecccchhhhhhhhh
Confidence 899888888999999999999999 9999999999999 9999999998 788 99999999999999999984 4444
Q ss_pred CccccCCCCcccccCCCC
Q 005102 253 NGALMNRGPTAFIGNPRL 270 (714)
Q Consensus 253 ~~~~~~~~~~~~~~n~~~ 270 (714)
...-.+.....+.||.++
T Consensus 472 ~~p~p~LkyLdlSGN~~l 489 (1081)
T KOG0618|consen 472 ALPSPNLKYLDLSGNTRL 489 (1081)
T ss_pred hCCCcccceeeccCCccc
Confidence 433344455677788753
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.59 E-value=4.3e-15 Score=144.11 Aligned_cols=136 Identities=18% Similarity=0.231 Sum_probs=99.2
Q ss_pred ccccccCceEEEEEEECCCcEEEEEEeCCCCch--hHHH----------------------HHHHHHHHhccCCCC--cc
Q 005102 409 FVLGKSGIGIVYKVVLEDGHTLAVRRLGEGGSQ--RFKE----------------------FQTEVEAIGKIRHSN--IV 462 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~--~~~~----------------------~~~E~~~l~~l~H~n--iv 462 (714)
+.||+|+||.||+|...+|+.||||+++..... .... ...|.+.+.++.+.. +.
T Consensus 3 ~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~ 82 (187)
T cd05119 3 GPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPVP 82 (187)
T ss_pred cccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCCC
Confidence 479999999999999888999999998753211 1111 135666677765443 44
Q ss_pred ceEEEEEeCCceeEEEeccCCCCHhhh-hhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeee
Q 005102 463 TLRAYYWSVDEKLLIYDYIPNGSLATA-LHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILL 541 (714)
Q Consensus 463 ~l~~~~~~~~~~~lV~e~~~~gsL~~~-l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl 541 (714)
+.+++ ...++||||++++.+... +... . .. .+..+++.+++.++.++|.. .+|+||||||+||++
T Consensus 83 ~~~~~----~~~~lv~e~~~g~~~~~~~l~~~------~-~~-~~~~~~~~~~~~~l~~lh~~--~~ivH~Dl~p~Nili 148 (187)
T cd05119 83 KPIDL----NRHVLVMEFIGGDGIPAPRLKDV------R-LL-EDPEELYDQILELMRKLYRE--AGLVHGDLSEYNILV 148 (187)
T ss_pred ceEec----CCCEEEEEEeCCCCccChhhhhh------h-hc-ccHHHHHHHHHHHHHHHhhc--cCcCcCCCChhhEEE
Confidence 44443 346899999998654321 1111 0 11 56788999999999999973 589999999999999
Q ss_pred CCCCCeEEcccchhhhhh
Q 005102 542 GHNMEPHVSDFGLARLAN 559 (714)
Q Consensus 542 ~~~~~~kl~DFGla~~~~ 559 (714)
+ ++.++++|||.+....
T Consensus 149 ~-~~~~~liDfg~a~~~~ 165 (187)
T cd05119 149 D-DGKVYIIDVPQAVEID 165 (187)
T ss_pred E-CCcEEEEECccccccc
Confidence 9 8899999999997543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.57 E-value=2.4e-16 Score=176.91 Aligned_cols=248 Identities=23% Similarity=0.268 Sum_probs=182.2
Q ss_pred cccccCceEEEEEEECC--CcEEEEEEeCCCC--chhHHHHHHHHHHHhccC-CCCccceEEEEEeCCceeEEEeccCCC
Q 005102 410 VLGKSGIGIVYKVVLED--GHTLAVRRLGEGG--SQRFKEFQTEVEAIGKIR-HSNIVTLRAYYWSVDEKLLIYDYIPNG 484 (714)
Q Consensus 410 ~lG~G~~g~Vy~~~~~~--g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lV~e~~~~g 484 (714)
.||+|.|+.|-...... ...+|+|.+.... ....+....|..+-+.+. |+|++++++.....+..+++++|..++
T Consensus 27 ~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~~~s~g~ 106 (601)
T KOG0590|consen 27 SIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSLSYSDGG 106 (601)
T ss_pred cccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccccCccccc
Confidence 48999999998877643 4566777665543 222344556888888886 999999999999999999999999999
Q ss_pred CHhhhh-hCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHh-cCCCCCceecCCCCCCeeeCCCC-CeEEcccchhhhhhcc
Q 005102 485 SLATAL-HGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLH-EFSPKKYVHGDLKPSNILLGHNM-EPHVSDFGLARLANIA 561 (714)
Q Consensus 485 sL~~~l-~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH-~~~~~~ivHrDlkp~NILl~~~~-~~kl~DFGla~~~~~~ 561 (714)
++.+.+ +... ...+......+..|+..++.|+| . .++.|||+||+|.+++..+ ..|++|||+|..+...
T Consensus 107 ~~f~~i~~~~~-----~~~~~~~~~~~~~ql~s~l~~~H~~---~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~~ 178 (601)
T KOG0590|consen 107 SLFSKISHPDS-----TGTSSSSASRYLPQLNSGLSYLHPE---NGVTHRDIKPSNSLLDESGSALKIADFGLATAYRNK 178 (601)
T ss_pred ccccccccCCc-----cCCCCcchhhhhhhhccCccccCcc---cccccCCCCCccchhccCCCcccCCCchhhcccccc
Confidence 999888 3331 23566678889999999999999 7 8999999999999999999 9999999999876541
Q ss_pred CCCCCccCCCCCCCCchhhhcccccceeecccCCCCC-CccccCCcccCCC-CCCchhhhHHHHHHHHHHHhCCCccccC
Q 005102 562 GGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNL-GSYYQAPESLKVV-KPSQKWDIYSYGVILLEMITGRTAVVQV 639 (714)
Q Consensus 562 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g-t~~y~aPE~~~~~-~~s~~~DVwS~Gvvl~elltG~~p~~~~ 639 (714)
.+. ........| ++.|+|||...+. ...+..|+||.|+++.-+++|..|+...
T Consensus 179 ~g~-------------------------~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~ 233 (601)
T KOG0590|consen 179 NGA-------------------------ERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFP 233 (601)
T ss_pred CCc-------------------------ceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccc
Confidence 111 111223334 8889999999874 4577899999999999999999999655
Q ss_pred CCCcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHH
Q 005102 640 GSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHIS 703 (714)
Q Consensus 640 ~~~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl 703 (714)
.........|......... .+ .........++..+++..+|+.|.+.+++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~------~~-------~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~ 284 (601)
T KOG0590|consen 234 SRKDGRYSSWKSNKGRFTQ------LP-------WNSISDQAHDLLHKILKENPSNRLSIEELK 284 (601)
T ss_pred ccccccceeeccccccccc------Cc-------cccCChhhhhcccccccCCchhcccccccc
Confidence 5544444444322100000 00 001112456788889989999999987764
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.53 E-value=2.9e-14 Score=163.11 Aligned_cols=141 Identities=23% Similarity=0.377 Sum_probs=76.4
Q ss_pred CCcEEEEEcCCCCccccCCccccCCCCCCEEEccCCCCcccCChhhcCCCCCCEEEcCCCcCcccCCcccCCCCCCCEEe
Q 005102 63 EQRVVSVSIPKKKLLGFLPSALGSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSGSVPNEIGKLKYLQILD 142 (714)
Q Consensus 63 ~~~~~~l~l~~~~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ 142 (714)
..+.+.|+|.+++++. +|..+. ++|+.|+|++|+|+ .+|..+. .+|+.|+|++|.|+ .+|..+. .+|+.|+
T Consensus 177 ~~~~~~L~L~~~~Lts-LP~~Ip--~~L~~L~Ls~N~Lt-sLP~~l~--~nL~~L~Ls~N~Lt-sLP~~l~--~~L~~L~ 247 (754)
T PRK15370 177 KNNKTELRLKILGLTT-IPACIP--EQITTLILDNNELK-SLPENLQ--GNIKTLYANSNQLT-SIPATLP--DTIQEME 247 (754)
T ss_pred ccCceEEEeCCCCcCc-CCcccc--cCCcEEEecCCCCC-cCChhhc--cCCCEEECCCCccc-cCChhhh--ccccEEE
Confidence 3456777777777774 455442 46777777777776 4555443 36667777766666 4555432 3455566
Q ss_pred ccCccCCCCCCcccccccccceeecccCcCCCCCCcccccCccccccccccCCcccccCCCCCCCCcccccccccccccC
Q 005102 143 LSQNFFNGSLPVSIVQCKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLNLSFNKFNGSIPSNTGNLSSLQGTVDFSHNLF 222 (714)
Q Consensus 143 Ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~~l~l~~N~l 222 (714)
|++|++. .+|..+. ++|+.|+|++|+|+ .+|..+. .+|+.|+|++|+|+ .+|..+. ++|+ .|++++|.+
T Consensus 248 Ls~N~L~-~LP~~l~--s~L~~L~Ls~N~L~-~LP~~l~---~sL~~L~Ls~N~Lt-~LP~~lp--~sL~-~L~Ls~N~L 316 (754)
T PRK15370 248 LSINRIT-ELPERLP--SALQSLDLFHNKIS-CLPENLP---EELRYLSVYDNSIR-TLPAHLP--SGIT-HLNVQSNSL 316 (754)
T ss_pred CcCCccC-cCChhHh--CCCCEEECcCCccC-ccccccC---CCCcEEECCCCccc-cCcccch--hhHH-HHHhcCCcc
Confidence 6666555 4554443 34555555555555 3454432 34555555555555 3443322 2333 444444444
Q ss_pred C
Q 005102 223 S 223 (714)
Q Consensus 223 ~ 223 (714)
+
T Consensus 317 t 317 (754)
T PRK15370 317 T 317 (754)
T ss_pred c
Confidence 4
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.53 E-value=1.8e-14 Score=163.76 Aligned_cols=93 Identities=29% Similarity=0.303 Sum_probs=48.3
Q ss_pred CCCEEeccCccCCCCCCcccccccccceeecccCcCCCCCCcccccCccccccccccCCcccccCCCCCCCCcccccccc
Q 005102 137 YLQILDLSQNFFNGSLPVSIVQCKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLNLSFNKFNGSIPSNTGNLSSLQGTVD 216 (714)
Q Consensus 137 ~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~~l~ 216 (714)
+|+.|+|++|+|+ .+|... .+|+.|++++|+|+ .+|.. ..+|+.|+|++|+|+ .+|... ++|. .|+
T Consensus 343 ~Lq~LdLS~N~Ls-~LP~lp---~~L~~L~Ls~N~L~-~LP~l----~~~L~~LdLs~N~Lt-~LP~l~---s~L~-~Ld 408 (788)
T PRK15387 343 GLQELSVSDNQLA-SLPTLP---SELYKLWAYNNRLT-SLPAL----PSGLKELIVSGNRLT-SLPVLP---SELK-ELM 408 (788)
T ss_pred ccceEecCCCccC-CCCCCC---cccceehhhccccc-cCccc----ccccceEEecCCccc-CCCCcc---cCCC-EEE
Confidence 6777777777777 455432 34555556666555 34432 234555566666555 344322 2344 555
Q ss_pred cccccCCcCcCccccCCCCcccccCcCCcCC
Q 005102 217 FSHNLFSGSIPASLGNLPEKVYIDLTYNNLS 247 (714)
Q Consensus 217 l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~ 247 (714)
+++|+|++ +|... .+|+.|++++|+|+
T Consensus 409 LS~N~Lss-IP~l~---~~L~~L~Ls~NqLt 435 (788)
T PRK15387 409 VSGNRLTS-LPMLP---SGLLSLSVYRNQLT 435 (788)
T ss_pred ccCCcCCC-CCcch---hhhhhhhhccCccc
Confidence 55555552 34321 23445555555555
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.52 E-value=2.8e-14 Score=163.36 Aligned_cols=162 Identities=25% Similarity=0.441 Sum_probs=113.5
Q ss_pred CcEEEEEcCCCCccccCCccccCCCCCCEEEccCCCCcccCChhhcCCCCCCEEEcCCCcCcccCCcccCCCCCCCEEec
Q 005102 64 QRVVSVSIPKKKLLGFLPSALGSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSGSVPNEIGKLKYLQILDL 143 (714)
Q Consensus 64 ~~~~~l~l~~~~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L 143 (714)
..++.|+|++|+|+. +|..+. ++|++|+|++|+|+ .+|..+. .+|+.|+|++|.++ .+|..+. .+|+.|+|
T Consensus 199 ~~L~~L~Ls~N~Lts-LP~~l~--~nL~~L~Ls~N~Lt-sLP~~l~--~~L~~L~Ls~N~L~-~LP~~l~--s~L~~L~L 269 (754)
T PRK15370 199 EQITTLILDNNELKS-LPENLQ--GNIKTLYANSNQLT-SIPATLP--DTIQEMELSINRIT-ELPERLP--SALQSLDL 269 (754)
T ss_pred cCCcEEEecCCCCCc-CChhhc--cCCCEEECCCCccc-cCChhhh--ccccEEECcCCccC-cCChhHh--CCCCEEEC
Confidence 467889999999885 566554 58899999999888 5676553 36888888888887 6777664 57888888
Q ss_pred cCccCCCCCCcccccccccceeecccCcCCCCCCcccccCccccccccccCCcccccCCCCCCCCcccccccccccccCC
Q 005102 144 SQNFFNGSLPVSIVQCKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLNLSFNKFNGSIPSNTGNLSSLQGTVDFSHNLFS 223 (714)
Q Consensus 144 s~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~~l~l~~N~l~ 223 (714)
++|+|+ .+|..+. .+|+.|+|++|+|+ .+|..+. .+|+.|++++|+|+ .+|..+. ++|+ .|++++|.|+
T Consensus 270 s~N~L~-~LP~~l~--~sL~~L~Ls~N~Lt-~LP~~lp---~sL~~L~Ls~N~Lt-~LP~~l~--~sL~-~L~Ls~N~Lt 338 (754)
T PRK15370 270 FHNKIS-CLPENLP--EELRYLSVYDNSIR-TLPAHLP---SGITHLNVQSNSLT-ALPETLP--PGLK-TLEAGENALT 338 (754)
T ss_pred cCCccC-ccccccC--CCCcEEECCCCccc-cCcccch---hhHHHHHhcCCccc-cCCcccc--ccce-eccccCCccc
Confidence 888887 5777664 47888888888887 4665542 46777777777776 4554432 4555 6666777666
Q ss_pred cCcCccccCCCCcccccCcCCcCCC
Q 005102 224 GSIPASLGNLPEKVYIDLTYNNLSG 248 (714)
Q Consensus 224 g~~p~~~~~l~~L~~l~l~~N~l~~ 248 (714)
+ +|..+. ++|+.|++++|+|+.
T Consensus 339 ~-LP~~l~--~sL~~L~Ls~N~L~~ 360 (754)
T PRK15370 339 S-LPASLP--PELQVLDVSKNQITV 360 (754)
T ss_pred c-CChhhc--CcccEEECCCCCCCc
Confidence 3 555443 466666666666663
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.51 E-value=3.4e-16 Score=163.87 Aligned_cols=178 Identities=28% Similarity=0.406 Sum_probs=157.1
Q ss_pred cEEEEEcCCCCccccCCccccCCCCCCEEEccCCCCcccCChhhcCCCCCCEEEcCCCcCcccCCcccCCCCCCCEEecc
Q 005102 65 RVVSVSIPKKKLLGFLPSALGSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSGSVPNEIGKLKYLQILDLS 144 (714)
Q Consensus 65 ~~~~l~l~~~~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls 144 (714)
..+..+|+.|++. .+|..+..+..|+.|.|..|.+. .+|..++++..|++|||+.|+++ .+|..++.|+ |+.|-++
T Consensus 76 dt~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~lp-Lkvli~s 151 (722)
T KOG0532|consen 76 DTVFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLS-HLPDGLCDLP-LKVLIVS 151 (722)
T ss_pred chhhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhh-cCChhhhcCc-ceeEEEe
Confidence 3455678888877 57888888999999999999997 89999999999999999999998 8999998887 9999999
Q ss_pred CccCCCCCCcccccccccceeecccCcCCCCCCcccccCccccccccccCCcccccCCCCCCCCcccccccccccccCCc
Q 005102 145 QNFFNGSLPVSIVQCKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLNLSFNKFNGSIPSNTGNLSSLQGTVDFSHNLFSG 224 (714)
Q Consensus 145 ~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~~l~l~~N~l~g 224 (714)
+|+++ .+|..++.+..|..||.+.|++. .+|..++ +|.+|+.|++..|++. .+|.++..| .|. .||+|+|+++
T Consensus 152 NNkl~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~-~l~slr~l~vrRn~l~-~lp~El~~L-pLi-~lDfScNkis- 224 (722)
T KOG0532|consen 152 NNKLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLG-YLTSLRDLNVRRNHLE-DLPEELCSL-PLI-RLDFSCNKIS- 224 (722)
T ss_pred cCccc-cCCcccccchhHHHhhhhhhhhh-hchHHhh-hHHHHHHHHHhhhhhh-hCCHHHhCC-cee-eeecccCcee-
Confidence 99997 89999998899999999999998 7888885 6999999999999998 788888855 466 8999999998
Q ss_pred CcCccccCCCCcccccCcCCcCCCCCCCC
Q 005102 225 SIPASLGNLPEKVYIDLTYNNLSGPIPQN 253 (714)
Q Consensus 225 ~~p~~~~~l~~L~~l~l~~N~l~~~~p~~ 253 (714)
.+|-.|.+|.+|++|-|.+|.|..++.+.
T Consensus 225 ~iPv~fr~m~~Lq~l~LenNPLqSPPAqI 253 (722)
T KOG0532|consen 225 YLPVDFRKMRHLQVLQLENNPLQSPPAQI 253 (722)
T ss_pred ecchhhhhhhhheeeeeccCCCCCChHHH
Confidence 89999999999999999999999776543
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.50 E-value=1.1e-13 Score=157.41 Aligned_cols=159 Identities=28% Similarity=0.384 Sum_probs=86.4
Q ss_pred cEEEEEcCCCCccccCCccccCCCCCCEEEccCCCCcccCChhhcCCCCCCEEEcCCCcCcc------------------
Q 005102 65 RVVSVSIPKKKLLGFLPSALGSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSG------------------ 126 (714)
Q Consensus 65 ~~~~l~l~~~~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g------------------ 126 (714)
.++.|++.+|+|+. +|. .+++|++|+|++|+|+ .+|.. .++|+.|+|++|.|+.
T Consensus 223 ~L~~L~L~~N~Lt~-LP~---lp~~Lk~LdLs~N~Lt-sLP~l---p~sL~~L~Ls~N~L~~Lp~lp~~L~~L~Ls~N~L 294 (788)
T PRK15387 223 HITTLVIPDNNLTS-LPA---LPPELRTLEVSGNQLT-SLPVL---PPGLLELSIFSNPLTHLPALPSGLCKLWIFGNQL 294 (788)
T ss_pred CCCEEEccCCcCCC-CCC---CCCCCcEEEecCCccC-cccCc---ccccceeeccCCchhhhhhchhhcCEEECcCCcc
Confidence 57778888888885 554 2578888999988888 34532 2344444444444431
Q ss_pred -cCCcccCCCCCCCEEeccCccCCCCCCcccccc-----------------cccceeecccCcCCCCCCcccccCccccc
Q 005102 127 -SVPNEIGKLKYLQILDLSQNFFNGSLPVSIVQC-----------------KRLKALDLSQNNFTGPLPNGFGSGLVSLE 188 (714)
Q Consensus 127 -~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l-----------------~~L~~L~l~~N~l~g~~p~~~~~~l~~L~ 188 (714)
.+|. .+++|+.|+|++|+|++ +|.....+ .+|+.|+|++|+|+ .+|.. ..+|+
T Consensus 295 t~LP~---~p~~L~~LdLS~N~L~~-Lp~lp~~L~~L~Ls~N~L~~LP~lp~~Lq~LdLS~N~Ls-~LP~l----p~~L~ 365 (788)
T PRK15387 295 TSLPV---LPPGLQELSVSDNQLAS-LPALPSELCKLWAYNNQLTSLPTLPSGLQELSVSDNQLA-SLPTL----PSELY 365 (788)
T ss_pred ccccc---cccccceeECCCCcccc-CCCCcccccccccccCccccccccccccceEecCCCccC-CCCCC----Ccccc
Confidence 2332 12567777777777763 33311110 13444444444444 23331 12444
Q ss_pred cccccCCcccccCCCCCCCCcccccccccccccCCcCcCccccCCCCcccccCcCCcCCCC
Q 005102 189 KLNLSFNKFNGSIPSNTGNLSSLQGTVDFSHNLFSGSIPASLGNLPEKVYIDLTYNNLSGP 249 (714)
Q Consensus 189 ~L~l~~N~l~g~~p~~~~~l~~L~~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~ 249 (714)
.|++++|+|+ .+|... .+|+ .|++++|+|++ +|.. .++|+.|++++|+|++.
T Consensus 366 ~L~Ls~N~L~-~LP~l~---~~L~-~LdLs~N~Lt~-LP~l---~s~L~~LdLS~N~LssI 417 (788)
T PRK15387 366 KLWAYNNRLT-SLPALP---SGLK-ELIVSGNRLTS-LPVL---PSELKELMVSGNRLTSL 417 (788)
T ss_pred eehhhccccc-cCcccc---cccc-eEEecCCcccC-CCCc---ccCCCEEEccCCcCCCC
Confidence 4455555554 344322 3455 66677777763 4432 24567777777777753
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.47 E-value=1e-13 Score=151.10 Aligned_cols=140 Identities=21% Similarity=0.320 Sum_probs=101.8
Q ss_pred ccccccCceEEEEEEECCCcEEEEEEeCCCCchhH----------------------------------------HHHHH
Q 005102 409 FVLGKSGIGIVYKVVLEDGHTLAVRRLGEGGSQRF----------------------------------------KEFQT 448 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~----------------------------------------~~~~~ 448 (714)
+.||.|++|.||+|++++|+.||||+.+.+..... -+|.+
T Consensus 123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~ 202 (437)
T TIGR01982 123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR 202 (437)
T ss_pred cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence 57999999999999999999999999876421110 12556
Q ss_pred HHHHHhccC----CCCccceEEEEE-eCCceeEEEeccCCCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHH-HHHHHh
Q 005102 449 EVEAIGKIR----HSNIVTLRAYYW-SVDEKLLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAK-GLVYLH 522 (714)
Q Consensus 449 E~~~l~~l~----H~niv~l~~~~~-~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~-gL~~LH 522 (714)
|.+.+.+++ |.+-+.+-..+. .....++||||+++++|.++..... ... .+.+++..++. .+..+|
T Consensus 203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~-----~~~---~~~~ia~~~~~~~l~ql~ 274 (437)
T TIGR01982 203 EAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDE-----AGL---DRKALAENLARSFLNQVL 274 (437)
T ss_pred HHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHh-----cCC---CHHHHHHHHHHHHHHHHH
Confidence 666666653 332333333332 2346799999999999988764321 112 24556776666 467889
Q ss_pred cCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhh
Q 005102 523 EFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLAN 559 (714)
Q Consensus 523 ~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~ 559 (714)
. .|++|+|+||.||++++++.++++|||++..+.
T Consensus 275 ~---~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 275 R---DGFFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred h---CCceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 8 899999999999999999999999999997664
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.47 E-value=1.8e-15 Score=158.58 Aligned_cols=179 Identities=34% Similarity=0.512 Sum_probs=158.9
Q ss_pred cCCCCCCEEEccCCCCcccCChhhcCCCCCCEEEcCCCcCcccCCcccCCCCCCCEEeccCccCCCCCCcccccccccce
Q 005102 85 GSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSGSVPNEIGKLKYLQILDLSQNFFNGSLPVSIVQCKRLKA 164 (714)
Q Consensus 85 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~ 164 (714)
-.|+.-...||+.|++. .+|.++..+..|+.|.|+.|.+. .+|..+++|..|++|||+.|+++ .+|..+..|+ |+.
T Consensus 72 ~~ltdt~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~lp-Lkv 147 (722)
T KOG0532|consen 72 YDLTDTVFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLS-HLPDGLCDLP-LKV 147 (722)
T ss_pred ccccchhhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhh-cCChhhhcCc-cee
Confidence 35666778999999998 89999999999999999999998 99999999999999999999998 8999998887 999
Q ss_pred eecccCcCCCCCCcccccCccccccccccCCcccccCCCCCCCCcccccccccccccCCcCcCccccCCCCcccccCcCC
Q 005102 165 LDLSQNNFTGPLPNGFGSGLVSLEKLNLSFNKFNGSIPSNTGNLSSLQGTVDFSHNLFSGSIPASLGNLPEKVYIDLTYN 244 (714)
Q Consensus 165 L~l~~N~l~g~~p~~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N 244 (714)
|.+++|+++ .+|..++ .+..|..|+.+.|.+. .+|+.++.+.+|+ .+.++.|++. .+|.+++.|+ |..||+|.|
T Consensus 148 li~sNNkl~-~lp~~ig-~~~tl~~ld~s~nei~-slpsql~~l~slr-~l~vrRn~l~-~lp~El~~Lp-Li~lDfScN 221 (722)
T KOG0532|consen 148 LIVSNNKLT-SLPEEIG-LLPTLAHLDVSKNEIQ-SLPSQLGYLTSLR-DLNVRRNHLE-DLPEELCSLP-LIRLDFSCN 221 (722)
T ss_pred EEEecCccc-cCCcccc-cchhHHHhhhhhhhhh-hchHHhhhHHHHH-HHHHhhhhhh-hCCHHHhCCc-eeeeecccC
Confidence 999999998 8999997 7999999999999999 9999999999999 9999999998 7899999776 889999999
Q ss_pred cCCCCCCCCccccCCCCcccccCCCCCCCC
Q 005102 245 NLSGPIPQNGALMNRGPTAFIGNPRLCGPP 274 (714)
Q Consensus 245 ~l~~~~p~~~~~~~~~~~~~~~n~~~~~~~ 274 (714)
+++ .+|-.+..|.......+.|+.+..+|
T Consensus 222 kis-~iPv~fr~m~~Lq~l~LenNPLqSPP 250 (722)
T KOG0532|consen 222 KIS-YLPVDFRKMRHLQVLQLENNPLQSPP 250 (722)
T ss_pred cee-ecchhhhhhhhheeeeeccCCCCCCh
Confidence 999 55666666665666666776666554
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.44 E-value=7.3e-13 Score=161.90 Aligned_cols=182 Identities=26% Similarity=0.268 Sum_probs=122.9
Q ss_pred CcEEEEEcCCCCccccCCccccCCCCCCEEEccCCCCcccCChhhcCCCCCCEEEcCCCcCcccCCcccCCCCCCCEEec
Q 005102 64 QRVVSVSIPKKKLLGFLPSALGSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSGSVPNEIGKLKYLQILDL 143 (714)
Q Consensus 64 ~~~~~l~l~~~~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L 143 (714)
.+++.|+|.++++. .++..+..+++|+.|+|++|...+.+| .+..+++|+.|+|++|.....+|..++++++|+.|+|
T Consensus 611 ~~L~~L~L~~s~l~-~L~~~~~~l~~Lk~L~Ls~~~~l~~ip-~ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L 688 (1153)
T PLN03210 611 ENLVKLQMQGSKLE-KLWDGVHSLTGLRNIDLRGSKNLKEIP-DLSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDM 688 (1153)
T ss_pred cCCcEEECcCcccc-ccccccccCCCCCEEECCCCCCcCcCC-ccccCCcccEEEecCCCCccccchhhhccCCCCEEeC
Confidence 46677777777765 356667777778888887765545566 3667777888888777666677777777788888888
Q ss_pred cCccCCCCCCcccccccccceeecccCcCCCCCCcccccCccccccccccCCcccccCCCCCC-----------------
Q 005102 144 SQNFFNGSLPVSIVQCKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLNLSFNKFNGSIPSNTG----------------- 206 (714)
Q Consensus 144 s~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~l~~L~~L~l~~N~l~g~~p~~~~----------------- 206 (714)
++|...+.+|..+ ++++|+.|+|++|...+.+|.. ..+|+.|+|++|.+. .+|..+.
T Consensus 689 ~~c~~L~~Lp~~i-~l~sL~~L~Lsgc~~L~~~p~~----~~nL~~L~L~~n~i~-~lP~~~~l~~L~~L~l~~~~~~~l 762 (1153)
T PLN03210 689 SRCENLEILPTGI-NLKSLYRLNLSGCSRLKSFPDI----STNISWLDLDETAIE-EFPSNLRLENLDELILCEMKSEKL 762 (1153)
T ss_pred CCCCCcCccCCcC-CCCCCCEEeCCCCCCccccccc----cCCcCeeecCCCccc-cccccccccccccccccccchhhc
Confidence 7765445677655 6677777777776555455532 346666777777665 5554321
Q ss_pred -------------CCcccccccccccccCCcCcCccccCCCCcccccCcCCcCCCCCCCCc
Q 005102 207 -------------NLSSLQGTVDFSHNLFSGSIPASLGNLPEKVYIDLTYNNLSGPIPQNG 254 (714)
Q Consensus 207 -------------~l~~L~~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~ 254 (714)
..++|+ .|++++|...+.+|.+++++++|+.|++++|+.-+.+|...
T Consensus 763 ~~~~~~l~~~~~~~~~sL~-~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~~ 822 (1153)
T PLN03210 763 WERVQPLTPLMTMLSPSLT-RLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPTGI 822 (1153)
T ss_pred cccccccchhhhhccccch-heeCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeCCCC
Confidence 123555 67777777777788888888888888888865444555543
|
syringae 6; Provisional |
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.43 E-value=7.4e-13 Score=161.86 Aligned_cols=182 Identities=23% Similarity=0.289 Sum_probs=102.7
Q ss_pred ccceEecCCcEEEEEcCCCCccccCCccccCCCCCCEEEccCCCCcccCChhhcCCCCCCEEEcCCCcCcccCCcccCCC
Q 005102 56 WNGITCKEQRVVSVSIPKKKLLGFLPSALGSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSGSVPNEIGKL 135 (714)
Q Consensus 56 w~gv~c~~~~~~~l~l~~~~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l 135 (714)
|.|+.+ ..+++.|+|+++...+.+|. ++.+++|+.|+|++|.....+|..+..+++|+.|+|++|..-+.+|..+ ++
T Consensus 627 ~~~~~~-l~~Lk~L~Ls~~~~l~~ip~-ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~~i-~l 703 (1153)
T PLN03210 627 WDGVHS-LTGLRNIDLRGSKNLKEIPD-LSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMSRCENLEILPTGI-NL 703 (1153)
T ss_pred cccccc-CCCCCEEECCCCCCcCcCCc-cccCCcccEEEecCCCCccccchhhhccCCCCEEeCCCCCCcCccCCcC-CC
Confidence 566533 34677777777665556663 6677777777777766555677777777777777777654444555543 34
Q ss_pred CCCCEEeccC---------------------ccCCCCCCccc------------------------------ccccccce
Q 005102 136 KYLQILDLSQ---------------------NFFNGSLPVSI------------------------------VQCKRLKA 164 (714)
Q Consensus 136 ~~L~~L~Ls~---------------------N~l~g~~p~~~------------------------------~~l~~L~~ 164 (714)
++|+.|+|++ |.+. .+|..+ ...++|+.
T Consensus 704 ~sL~~L~Lsgc~~L~~~p~~~~nL~~L~L~~n~i~-~lP~~~~l~~L~~L~l~~~~~~~l~~~~~~l~~~~~~~~~sL~~ 782 (1153)
T PLN03210 704 KSLYRLNLSGCSRLKSFPDISTNISWLDLDETAIE-EFPSNLRLENLDELILCEMKSEKLWERVQPLTPLMTMLSPSLTR 782 (1153)
T ss_pred CCCCEEeCCCCCCccccccccCCcCeeecCCCccc-cccccccccccccccccccchhhccccccccchhhhhccccchh
Confidence 4444444443 3332 233221 01135666
Q ss_pred eecccCcCCCCCCcccccCccccccccccCCcccccCCCCCCCCcccccccccccccCCcCcCccccCCCCcccccCcCC
Q 005102 165 LDLSQNNFTGPLPNGFGSGLVSLEKLNLSFNKFNGSIPSNTGNLSSLQGTVDFSHNLFSGSIPASLGNLPEKVYIDLTYN 244 (714)
Q Consensus 165 L~l~~N~l~g~~p~~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N 244 (714)
|+|++|...+.+|..+. ++++|+.|+|++|...+.+|..+ ++++|+ .|++++|.....+|.. .++|+.|++++|
T Consensus 783 L~Ls~n~~l~~lP~si~-~L~~L~~L~Ls~C~~L~~LP~~~-~L~sL~-~L~Ls~c~~L~~~p~~---~~nL~~L~Ls~n 856 (1153)
T PLN03210 783 LFLSDIPSLVELPSSIQ-NLHKLEHLEIENCINLETLPTGI-NLESLE-SLDLSGCSRLRTFPDI---STNISDLNLSRT 856 (1153)
T ss_pred eeCCCCCCccccChhhh-CCCCCCEEECCCCCCcCeeCCCC-CccccC-EEECCCCCcccccccc---ccccCEeECCCC
Confidence 67777766666777664 47777777777765444666554 455555 5555554333333322 123444444444
Q ss_pred cCC
Q 005102 245 NLS 247 (714)
Q Consensus 245 ~l~ 247 (714)
.++
T Consensus 857 ~i~ 859 (1153)
T PLN03210 857 GIE 859 (1153)
T ss_pred CCc
Confidence 444
|
syringae 6; Provisional |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.41 E-value=2.7e-13 Score=133.54 Aligned_cols=207 Identities=21% Similarity=0.308 Sum_probs=137.8
Q ss_pred HHHhccCCCCccceEEEEEeC-----CceeEEEeccCCCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCC
Q 005102 451 EAIGKIRHSNIVTLRAYYWSV-----DEKLLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFS 525 (714)
Q Consensus 451 ~~l~~l~H~niv~l~~~~~~~-----~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~ 525 (714)
.-+-++.|.|||+++.|+.+. ....++.|||+.|++.++|++..... ..+....-.+|+-||..||.|||++.
T Consensus 119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~--~a~~~~~wkkw~tqIlsal~yLhs~~ 196 (458)
T KOG1266|consen 119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQ--KALFQKAWKKWCTQILSALSYLHSCD 196 (458)
T ss_pred HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhh--hhhhHHHHHHHHHHHHhhhhhhhccC
Confidence 445566799999999998653 34578999999999999998654322 45777788899999999999999987
Q ss_pred CCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCC
Q 005102 526 PKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAP 605 (714)
Q Consensus 526 ~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP 605 (714)
| +|+|+++.-+-|++..++-+|+.--- -.... +... ...........+-++|.||
T Consensus 197 P-piihgnlTc~tifiq~ngLIkig~~a-p~s~h-----~s~~------------------~~~~~Ek~~~~~~~g~~a~ 251 (458)
T KOG1266|consen 197 P-PIIHGNLTCDTIFIQHNGLIKIGSVA-PDSTH-----PSVN------------------STREAEKSVNTSLPGFSAP 251 (458)
T ss_pred C-ccccCCcchhheeecCCceEEecccC-ccccc-----hhhh------------------hhhHhhhhccccCCccccC
Confidence 6 89999999999999988888864211 10000 0000 0001111222345679999
Q ss_pred cccCCCCCCchhhhHHHHHHHHHHHhCCCccccCCCCcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHH
Q 005102 606 ESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIA 685 (714)
Q Consensus 606 E~~~~~~~s~~~DVwS~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li 685 (714)
|+-.....+.++|||+||...+||..+..--... .......+-... .....-++. =.+++
T Consensus 252 ~sg~~tn~~~a~dIy~fgmcAlemailEiq~tns-eS~~~~ee~ia~------~i~~len~l-------------qr~~i 311 (458)
T KOG1266|consen 252 ESGTTTNTTGASDIYKFGMCALEMAILEIQSTNS-ESKVEVEENIAN------VIIGLENGL-------------QRGSI 311 (458)
T ss_pred CcCcccccccchhhhhhhHHHHHHHHheeccCCC-cceeehhhhhhh------heeeccCcc-------------ccCcC
Confidence 9987777888999999999999998876422111 111100000000 000000111 12567
Q ss_pred hHccCCCCCCCCCHHHHHH
Q 005102 686 MACVHSSPEKRPTMRHISD 704 (714)
Q Consensus 686 ~~Cl~~dP~~RPt~~evl~ 704 (714)
..|++..|..||+|++++.
T Consensus 312 ~kcl~~eP~~rp~ar~llf 330 (458)
T KOG1266|consen 312 TKCLEGEPNGRPDARLLLF 330 (458)
T ss_pred cccccCCCCCCcchhhhhc
Confidence 7999999999999998764
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.38 E-value=2.4e-14 Score=158.02 Aligned_cols=172 Identities=34% Similarity=0.488 Sum_probs=139.9
Q ss_pred cEEEEEcCCCCccccCCccccCCCCCCEEEccCCCCcccCChhhcC--------------------------CCCCCEEE
Q 005102 65 RVVSVSIPKKKLLGFLPSALGSLTDLRHVNLRNNKFFGSLPLELLE--------------------------AQGLQSLV 118 (714)
Q Consensus 65 ~~~~l~l~~~~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~--------------------------l~~L~~L~ 118 (714)
.++.|.+..|.+. .+|+.+..+++|++|+|..|+|. .+|..+.. ...|+.|+
T Consensus 288 ~L~~l~~~~nel~-yip~~le~~~sL~tLdL~~N~L~-~lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq~Ly 365 (1081)
T KOG0618|consen 288 SLVSLSAAYNELE-YIPPFLEGLKSLRTLDLQSNNLP-SLPDNFLAVLNASLNTLNVSSNKLSTLPSYEENNHAALQELY 365 (1081)
T ss_pred hHHHHHhhhhhhh-hCCCcccccceeeeeeehhcccc-ccchHHHhhhhHHHHHHhhhhccccccccccchhhHHHHHHH
Confidence 4445566667765 46777777888888888888886 44433221 13478889
Q ss_pred cCCCcCcccCCcccCCCCCCCEEeccCccCCCCCCcc-cccccccceeecccCcCCCCCCcccccCccccccccccCCcc
Q 005102 119 LYGNSFSGSVPNEIGKLKYLQILDLSQNFFNGSLPVS-IVQCKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLNLSFNKF 197 (714)
Q Consensus 119 L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~-~~~l~~L~~L~l~~N~l~g~~p~~~~~~l~~L~~L~l~~N~l 197 (714)
|.+|.|+...-+.|.+...|++|+|++|+|. .+|++ +.++..|++|+||+|+|+ .+|..+. .+..|++|...+|++
T Consensus 366 lanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~-~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva-~~~~L~tL~ahsN~l 442 (1081)
T KOG0618|consen 366 LANNHLTDSCFPVLVNFKHLKVLHLSYNRLN-SFPASKLRKLEELEELNLSGNKLT-TLPDTVA-NLGRLHTLRAHSNQL 442 (1081)
T ss_pred HhcCcccccchhhhccccceeeeeecccccc-cCCHHHHhchHHhHHHhcccchhh-hhhHHHH-hhhhhHHHhhcCCce
Confidence 9999999888888999999999999999997 77764 678999999999999998 8998884 699999999999999
Q ss_pred cccCCCCCCCCcccccccccccccCCcC-cCccccCCCCcccccCcCCc
Q 005102 198 NGSIPSNTGNLSSLQGTVDFSHNLFSGS-IPASLGNLPEKVYIDLTYNN 245 (714)
Q Consensus 198 ~g~~p~~~~~l~~L~~~l~l~~N~l~g~-~p~~~~~l~~L~~l~l~~N~ 245 (714)
. ..| .+.++++|+ .+|++.|+|+-. +|... .-++|++||+++|.
T Consensus 443 ~-~fP-e~~~l~qL~-~lDlS~N~L~~~~l~~~~-p~p~LkyLdlSGN~ 487 (1081)
T KOG0618|consen 443 L-SFP-ELAQLPQLK-VLDLSCNNLSEVTLPEAL-PSPNLKYLDLSGNT 487 (1081)
T ss_pred e-ech-hhhhcCcce-EEecccchhhhhhhhhhC-CCcccceeeccCCc
Confidence 9 888 899999999 999999999844 44333 33899999999998
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.36 E-value=4.4e-14 Score=149.35 Aligned_cols=186 Identities=24% Similarity=0.232 Sum_probs=113.5
Q ss_pred CCcEEEEEcCCCCccccCCccccCCCC---CCEEEccCCCCcc----cCChhhcCC-CCCCEEEcCCCcCccc----CCc
Q 005102 63 EQRVVSVSIPKKKLLGFLPSALGSLTD---LRHVNLRNNKFFG----SLPLELLEA-QGLQSLVLYGNSFSGS----VPN 130 (714)
Q Consensus 63 ~~~~~~l~l~~~~l~g~~p~~~~~l~~---L~~L~L~~N~l~~----~~p~~~~~l-~~L~~L~L~~N~l~g~----~p~ 130 (714)
..+++.|+|++|.+.+..+..+..+.+ |++|++++|++++ .+...+..+ ++|+.|+|++|.+++. ++.
T Consensus 80 ~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~ 159 (319)
T cd00116 80 GCGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAK 159 (319)
T ss_pred cCceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHHHH
Confidence 347777777777777666655555555 7777777777762 233344555 6777777777777632 333
Q ss_pred ccCCCCCCCEEeccCccCCCC----CCcccccccccceeecccCcCCCCCCccc---ccCccccccccccCCcccccCCC
Q 005102 131 EIGKLKYLQILDLSQNFFNGS----LPVSIVQCKRLKALDLSQNNFTGPLPNGF---GSGLVSLEKLNLSFNKFNGSIPS 203 (714)
Q Consensus 131 ~~~~l~~L~~L~Ls~N~l~g~----~p~~~~~l~~L~~L~l~~N~l~g~~p~~~---~~~l~~L~~L~l~~N~l~g~~p~ 203 (714)
.+..+.+|+.|+|++|.+++. ++..+..+++|++|+|++|.+++.-...+ ...+++|+.|++++|.+++....
T Consensus 160 ~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~~~L~~L~ls~n~l~~~~~~ 239 (319)
T cd00116 160 ALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTDAGAA 239 (319)
T ss_pred HHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHHHHHHHhcccCCCCEEecCCCcCchHHHH
Confidence 455666777777777777642 33344455677777777777753222111 12356777777777777642221
Q ss_pred CCC-----CCcccccccccccccCC----cCcCccccCCCCcccccCcCCcCCCC
Q 005102 204 NTG-----NLSSLQGTVDFSHNLFS----GSIPASLGNLPEKVYIDLTYNNLSGP 249 (714)
Q Consensus 204 ~~~-----~l~~L~~~l~l~~N~l~----g~~p~~~~~l~~L~~l~l~~N~l~~~ 249 (714)
.+. ....|+ .+++++|.++ ..+...+..+++|+++++++|.++..
T Consensus 240 ~l~~~~~~~~~~L~-~L~l~~n~i~~~~~~~l~~~~~~~~~L~~l~l~~N~l~~~ 293 (319)
T cd00116 240 ALASALLSPNISLL-TLSLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKFGEE 293 (319)
T ss_pred HHHHHHhccCCCce-EEEccCCCCCcHHHHHHHHHHhcCCCccEEECCCCCCcHH
Confidence 111 125666 7777777776 23344556667777777777777743
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.33 E-value=2.2e-12 Score=138.42 Aligned_cols=248 Identities=22% Similarity=0.227 Sum_probs=173.0
Q ss_pred ccccccc--cCceEEEEEEE---CCCcEEEEEEeCCC--CchhHHHHHHHHHHHhccC-CCCccceEEEEEeCCceeEEE
Q 005102 407 SAFVLGK--SGIGIVYKVVL---EDGHTLAVRRLGEG--GSQRFKEFQTEVEAIGKIR-HSNIVTLRAYYWSVDEKLLIY 478 (714)
Q Consensus 407 ~~~~lG~--G~~g~Vy~~~~---~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lV~ 478 (714)
...-+|. |.+|.||.+.. +++..+|+|+-+.. .......=.+|+.-.++++ |+|.++.+..+...+..++-+
T Consensus 118 ~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lfiqt 197 (524)
T KOG0601|consen 118 ISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILFIQT 197 (524)
T ss_pred cccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcceeee
Confidence 3456888 99999999886 45889999984432 1122233356777777774 999999888888999999999
Q ss_pred eccCCCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHH----HHHHHhcCCCCCceecCCCCCCeeeCCC-CCeEEcccc
Q 005102 479 DYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAK----GLVYLHEFSPKKYVHGDLKPSNILLGHN-MEPHVSDFG 553 (714)
Q Consensus 479 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~----gL~~LH~~~~~~ivHrDlkp~NILl~~~-~~~kl~DFG 553 (714)
|++. .+|.++-+... .-++......+..+... ||.++|+ ..++|-|+||+||++..+ ...++.|||
T Consensus 198 E~~~-~sl~~~~~~~~-----~~~p~~~l~~~~~~~~~~~~~al~~~hs---~~~~~~~~kp~~i~~~~~~~s~~~~df~ 268 (524)
T KOG0601|consen 198 ELCG-ESLQSYCHTPC-----NFLPDNLLWNSLRDWLSRDVTALSHLHS---NNIVHDDLKPANIFTTSDWTSCKLTDFG 268 (524)
T ss_pred cccc-chhHHhhhccc-----ccCCchhhhhHHhhhhhcccccccccCC---CcccccccchhheecccccceeecCCcc
Confidence 9884 68888876553 23666777778888888 9999999 899999999999999999 889999999
Q ss_pred hhhhhhccCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCC
Q 005102 554 LARLANIAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGR 633 (714)
Q Consensus 554 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~ 633 (714)
+...+....-.... .......|..-|++||... +.++...|||++|.++.|-.++.
T Consensus 269 ~v~~i~~~~~~~~~-----------------------~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~ 324 (524)
T KOG0601|consen 269 LVSKISDGNFSSVF-----------------------KVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGS 324 (524)
T ss_pred eeEEccCCccccce-----------------------eeeecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhc
Confidence 98876543211110 0011223455699999986 46789999999999999999987
Q ss_pred CccccCCCCcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 005102 634 TAVVQVGSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISD 704 (714)
Q Consensus 634 ~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 704 (714)
.+....... .|.+ +.... +..++ ......++...+..+++.+|-.|++++.+.+
T Consensus 325 ~~~~~g~~~-----~W~~--------~r~~~---ip~e~-~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 325 HLPSVGKNS-----SWSQ--------LRQGY---IPLEF-CEGGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred ccccCCCCC-----Cccc--------ccccc---Cchhh-hcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 766322111 1111 11111 11110 0111223445888999999999998876643
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.32 E-value=8.7e-14 Score=147.08 Aligned_cols=180 Identities=21% Similarity=0.262 Sum_probs=89.4
Q ss_pred EEEEEcCCCCcc------ccCCccccCCCCCCEEEccCCCCcccCChhhcCCCC---CCEEEcCCCcCcc----cCCccc
Q 005102 66 VVSVSIPKKKLL------GFLPSALGSLTDLRHVNLRNNKFFGSLPLELLEAQG---LQSLVLYGNSFSG----SVPNEI 132 (714)
Q Consensus 66 ~~~l~l~~~~l~------g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~---L~~L~L~~N~l~g----~~p~~~ 132 (714)
++.+++.++.+. ..++..+..+++|+.|+|++|.+.+..+..+..+.+ |+.|++++|++++ .+...+
T Consensus 53 l~~l~l~~~~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l 132 (319)
T cd00116 53 LKELCLSLNETGRIPRGLQSLLQGLTKGCGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGL 132 (319)
T ss_pred ceEEeccccccCCcchHHHHHHHHHHhcCceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHHHHH
Confidence 555555555544 223344555566666666666665444444444443 6666666666552 222334
Q ss_pred CCC-CCCCEEeccCccCCCC----CCcccccccccceeecccCcCCCC----CCcccccCccccccccccCCccccc---
Q 005102 133 GKL-KYLQILDLSQNFFNGS----LPVSIVQCKRLKALDLSQNNFTGP----LPNGFGSGLVSLEKLNLSFNKFNGS--- 200 (714)
Q Consensus 133 ~~l-~~L~~L~Ls~N~l~g~----~p~~~~~l~~L~~L~l~~N~l~g~----~p~~~~~~l~~L~~L~l~~N~l~g~--- 200 (714)
..+ ++|+.|+|++|.+++. ++..+..+.+|+.|+|++|.+++. ++..+. .+++|+.|+|++|.+++.
T Consensus 133 ~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~-~~~~L~~L~L~~n~i~~~~~~ 211 (319)
T cd00116 133 KDLPPALEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLK-ANCNLEVLDLNNNGLTDEGAS 211 (319)
T ss_pred HhCCCCceEEEcCCCcCCchHHHHHHHHHHhCCCcCEEECcCCCCchHHHHHHHHHHH-hCCCCCEEeccCCccChHHHH
Confidence 444 5666666666666532 222334445566666666666532 111111 233566666666655422
Q ss_pred -CCCCCCCCcccccccccccccCCcCcCcccc-----CCCCcccccCcCCcCC
Q 005102 201 -IPSNTGNLSSLQGTVDFSHNLFSGSIPASLG-----NLPEKVYIDLTYNNLS 247 (714)
Q Consensus 201 -~p~~~~~l~~L~~~l~l~~N~l~g~~p~~~~-----~l~~L~~l~l~~N~l~ 247 (714)
++..+.++++|+ .|++++|.+++.....+. ..+.|+.|++++|.++
T Consensus 212 ~l~~~~~~~~~L~-~L~ls~n~l~~~~~~~l~~~~~~~~~~L~~L~l~~n~i~ 263 (319)
T cd00116 212 ALAETLASLKSLE-VLNLGDNNLTDAGAAALASALLSPNISLLTLSLSCNDIT 263 (319)
T ss_pred HHHHHhcccCCCC-EEecCCCcCchHHHHHHHHHHhccCCCceEEEccCCCCC
Confidence 233344455555 666666665542222221 1245666666666554
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.31 E-value=4.7e-12 Score=139.53 Aligned_cols=142 Identities=16% Similarity=0.241 Sum_probs=94.7
Q ss_pred ccccccCceEEEEEEECC-CcEEEEEEeCCCCchh----------------------------------H------HHHH
Q 005102 409 FVLGKSGIGIVYKVVLED-GHTLAVRRLGEGGSQR----------------------------------F------KEFQ 447 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~----------------------------------~------~~~~ 447 (714)
+.||.|++|.||+|++++ |+.||||+.+++-... . -+|.
T Consensus 125 ~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ElD~~ 204 (537)
T PRK04750 125 KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHDELDLM 204 (537)
T ss_pred hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHHhhCHH
Confidence 479999999999999988 9999999997642110 0 1245
Q ss_pred HHHHHHhccC----CCCccceEEEEEe-CCceeEEEeccCCCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHh
Q 005102 448 TEVEAIGKIR----HSNIVTLRAYYWS-VDEKLLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLH 522 (714)
Q Consensus 448 ~E~~~l~~l~----H~niv~l~~~~~~-~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH 522 (714)
+|+..+.+++ +...+.+-.++.+ ....++||||++|+.+.++-.-.....+...+.......++.|+ +
T Consensus 205 ~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi-------f 277 (537)
T PRK04750 205 REAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV-------F 277 (537)
T ss_pred HHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH-------H
Confidence 5665555553 4444554455543 45678999999999998742211100000122222233333333 3
Q ss_pred cCCCCCceecCCCCCCeeeCCCC----CeEEcccchhhhhhc
Q 005102 523 EFSPKKYVHGDLKPSNILLGHNM----EPHVSDFGLARLANI 560 (714)
Q Consensus 523 ~~~~~~ivHrDlkp~NILl~~~~----~~kl~DFGla~~~~~ 560 (714)
. .|++|+|+||.||+++.++ .++++|||++..++.
T Consensus 278 ~---~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 278 R---DGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred h---CCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 4 6999999999999999888 999999999876643
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.30 E-value=1.3e-11 Score=117.42 Aligned_cols=129 Identities=24% Similarity=0.250 Sum_probs=96.1
Q ss_pred cccccCceEEEEEEECCCcEEEEEEeCCCCchhHHHHHHHHHHHhccCCCCcc-ceEEEEEeCCceeEEEeccCCCCHhh
Q 005102 410 VLGKSGIGIVYKVVLEDGHTLAVRRLGEGGSQRFKEFQTEVEAIGKIRHSNIV-TLRAYYWSVDEKLLIYDYIPNGSLAT 488 (714)
Q Consensus 410 ~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv-~l~~~~~~~~~~~lV~e~~~~gsL~~ 488 (714)
.++.|.++.||++... +..|++|........ ...+.+|+++++.+.+.+++ +++++. ....++||||+++.++.+
T Consensus 5 ~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~~-~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l~~ 80 (170)
T cd05151 5 PLKGGMTNKNYRVEVA-NKKYVVRIPGNGTEL-LINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSELLT 80 (170)
T ss_pred ecCCcccCceEEEEEC-CeEEEEEeCCCCccc-ccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCcccc
Confidence 5788999999999975 778999987654321 23567899999998765554 444443 334689999999987754
Q ss_pred hhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCC--CCCceecCCCCCCeeeCCCCCeEEcccchhhh
Q 005102 489 ALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFS--PKKYVHGDLKPSNILLGHNMEPHVSDFGLARL 557 (714)
Q Consensus 489 ~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~--~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 557 (714)
. . .....++.+++++|+.||... +.+++|+|++|.||+++ ++.++++|||.+..
T Consensus 81 ~---~-----------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 81 E---D-----------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred c---c-----------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 2 0 012345788999999999932 12359999999999999 56899999998864
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.29 E-value=2.3e-12 Score=140.41 Aligned_cols=178 Identities=37% Similarity=0.531 Sum_probs=88.9
Q ss_pred cEEEEEcCCCCccccCCccccCCC-CCCEEEccCCCCcccCChhhcCCCCCCEEEcCCCcCcccCCcccCCCCCCCEEec
Q 005102 65 RVVSVSIPKKKLLGFLPSALGSLT-DLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSGSVPNEIGKLKYLQILDL 143 (714)
Q Consensus 65 ~~~~l~l~~~~l~g~~p~~~~~l~-~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L 143 (714)
.++.+++.+|.++. +|+....++ +|+.|++++|.+. .+|..+..+++|+.|++++|+++ .+|...+.+++|+.|++
T Consensus 117 ~l~~L~l~~n~i~~-i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N~l~-~l~~~~~~~~~L~~L~l 193 (394)
T COG4886 117 NLTSLDLDNNNITD-IPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDL 193 (394)
T ss_pred ceeEEecCCccccc-Cccccccchhhcccccccccchh-hhhhhhhccccccccccCCchhh-hhhhhhhhhhhhhheec
Confidence 34445555555443 333344442 5555555555554 34444555555555555555555 44444445555555555
Q ss_pred cCccCCCCCCcccccccccceeecccCcCCCCCCcccccCccccccccccCCcccccCCCCCCCCcccccccccccccCC
Q 005102 144 SQNFFNGSLPVSIVQCKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLNLSFNKFNGSIPSNTGNLSSLQGTVDFSHNLFS 223 (714)
Q Consensus 144 s~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~~l~l~~N~l~ 223 (714)
++|+++ .+|..+..+..|++|.+++|++. .++..+ ..+.++..|.+++|++. .++..+++++.++ .+++++|+++
T Consensus 194 s~N~i~-~l~~~~~~~~~L~~l~~~~N~~~-~~~~~~-~~~~~l~~l~l~~n~~~-~~~~~~~~l~~l~-~L~~s~n~i~ 268 (394)
T COG4886 194 SGNKIS-DLPPEIELLSALEELDLSNNSII-ELLSSL-SNLKNLSGLELSNNKLE-DLPESIGNLSNLE-TLDLSNNQIS 268 (394)
T ss_pred cCCccc-cCchhhhhhhhhhhhhhcCCcce-ecchhh-hhcccccccccCCceee-eccchhccccccc-eecccccccc
Confidence 555554 45544444444555555555322 233333 23455555555555554 3344555555555 5555555555
Q ss_pred cCcCccccCCCCcccccCcCCcCCCCCCC
Q 005102 224 GSIPASLGNLPEKVYIDLTYNNLSGPIPQ 252 (714)
Q Consensus 224 g~~p~~~~~l~~L~~l~l~~N~l~~~~p~ 252 (714)
.++. ++.+.+++.|++++|.+...+|.
T Consensus 269 -~i~~-~~~~~~l~~L~~s~n~~~~~~~~ 295 (394)
T COG4886 269 -SISS-LGSLTNLRELDLSGNSLSNALPL 295 (394)
T ss_pred -cccc-ccccCccCEEeccCccccccchh
Confidence 2232 55555555555555555555443
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.24 E-value=2e-13 Score=137.45 Aligned_cols=184 Identities=24% Similarity=0.267 Sum_probs=138.4
Q ss_pred CCcEEEEEcCCCCccccCCccccCCCCCCEEEccC-CCCcccCChhhcCCCCCCEEEcCCCcCcc---------------
Q 005102 63 EQRVVSVSIPKKKLLGFLPSALGSLTDLRHVNLRN-NKFFGSLPLELLEAQGLQSLVLYGNSFSG--------------- 126 (714)
Q Consensus 63 ~~~~~~l~l~~~~l~g~~p~~~~~l~~L~~L~L~~-N~l~~~~p~~~~~l~~L~~L~L~~N~l~g--------------- 126 (714)
-.++..|||++|+|+-+-|.+|.+|.+|..|-+-+ |+|+......|.+|.+|+.|.+.-|++.-
T Consensus 90 l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~~l~k~~F~gL~slqrLllNan~i~Cir~~al~dL~~l~lL 169 (498)
T KOG4237|consen 90 LHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKITDLPKGAFGGLSSLQRLLLNANHINCIRQDALRDLPSLSLL 169 (498)
T ss_pred hhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchhhhhhhHhhhHHHHHHHhcChhhhcchhHHHHHHhhhcchh
Confidence 45889999999999999999999999987765554 89985544456666555555554444442
Q ss_pred --------cCCc-ccCCCCCCCEEeccCccCC------------------------------------------------
Q 005102 127 --------SVPN-EIGKLKYLQILDLSQNFFN------------------------------------------------ 149 (714)
Q Consensus 127 --------~~p~-~~~~l~~L~~L~Ls~N~l~------------------------------------------------ 149 (714)
.++. .|..+.+++.+.+..|.+-
T Consensus 170 slyDn~~q~i~~~tf~~l~~i~tlhlA~np~icdCnL~wla~~~a~~~ietsgarc~~p~rl~~~Ri~q~~a~kf~c~~e 249 (498)
T KOG4237|consen 170 SLYDNKIQSICKGTFQGLAAIKTLHLAQNPFICDCNLPWLADDLAMNPIETSGARCVSPYRLYYKRINQEDARKFLCSLE 249 (498)
T ss_pred cccchhhhhhccccccchhccchHhhhcCccccccccchhhhHHhhchhhcccceecchHHHHHHHhcccchhhhhhhHH
Confidence 3333 4555555555555555421
Q ss_pred -------------CCCC-cccccccccceeecccCcCCCCCCcccccCccccccccccCCcccccCCCCCCCCccccccc
Q 005102 150 -------------GSLP-VSIVQCKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLNLSFNKFNGSIPSNTGNLSSLQGTV 215 (714)
Q Consensus 150 -------------g~~p-~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~~l 215 (714)
+..| ..|..|++|+.|+|++|++++ |-+..+.++..|+.|.|..|+|.-.-...|.+++.|. .|
T Consensus 250 sl~s~~~~~d~~d~~cP~~cf~~L~~L~~lnlsnN~i~~-i~~~aFe~~a~l~eL~L~~N~l~~v~~~~f~~ls~L~-tL 327 (498)
T KOG4237|consen 250 SLPSRLSSEDFPDSICPAKCFKKLPNLRKLNLSNNKITR-IEDGAFEGAAELQELYLTRNKLEFVSSGMFQGLSGLK-TL 327 (498)
T ss_pred hHHHhhccccCcCCcChHHHHhhcccceEeccCCCccch-hhhhhhcchhhhhhhhcCcchHHHHHHHhhhccccce-ee
Confidence 1111 124457789999999999994 5555557899999999999999855557788999999 99
Q ss_pred ccccccCCcCcCccccCCCCcccccCcCCcCCC
Q 005102 216 DFSHNLFSGSIPASLGNLPEKVYIDLTYNNLSG 248 (714)
Q Consensus 216 ~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~ 248 (714)
+|.+|+|+..-|.+|..+.+|..|++-.|.+.-
T Consensus 328 ~L~~N~it~~~~~aF~~~~~l~~l~l~~Np~~C 360 (498)
T KOG4237|consen 328 SLYDNQITTVAPGAFQTLFSLSTLNLLSNPFNC 360 (498)
T ss_pred eecCCeeEEEecccccccceeeeeehccCcccC
Confidence 999999999999999999999999999998863
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.22 E-value=1.1e-10 Score=111.85 Aligned_cols=135 Identities=12% Similarity=0.125 Sum_probs=98.9
Q ss_pred cccccCceEEEEEEECC-------CcEEEEEEeCCC-------------C---------chhHHHH----HHHHHHHhcc
Q 005102 410 VLGKSGIGIVYKVVLED-------GHTLAVRRLGEG-------------G---------SQRFKEF----QTEVEAIGKI 456 (714)
Q Consensus 410 ~lG~G~~g~Vy~~~~~~-------g~~vavK~~~~~-------------~---------~~~~~~~----~~E~~~l~~l 456 (714)
.||.|--+.||.|...+ +..+|||+.+.. + ....+.+ .+|.+.|+++
T Consensus 4 ~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~rl 83 (197)
T cd05146 4 CISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKRM 83 (197)
T ss_pred ccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHHH
Confidence 68999999999998653 479999987531 0 0112223 3899999999
Q ss_pred CC--CCccceEEEEEeCCceeEEEeccCCCCHhh-hhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHH-hcCCCCCceec
Q 005102 457 RH--SNIVTLRAYYWSVDEKLLIYDYIPNGSLAT-ALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYL-HEFSPKKYVHG 532 (714)
Q Consensus 457 ~H--~niv~l~~~~~~~~~~~lV~e~~~~gsL~~-~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~L-H~~~~~~ivHr 532 (714)
.. -++..++++ ..-++||||+.++.+.. .+.+ ..++..+...+..+++.+|..| |. .+|||+
T Consensus 84 ~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd-------~~~~~~~~~~i~~~i~~~l~~l~H~---~glVHG 149 (197)
T cd05146 84 QKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD-------AKLNDEEMKNAYYQVLSMMKQLYKE---CNLVHA 149 (197)
T ss_pred HHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc-------cccCHHHHHHHHHHHHHHHHHHHHh---CCeecC
Confidence 53 456666654 56789999997654422 2221 1244556678889999999999 88 899999
Q ss_pred CCCCCCeeeCCCCCeEEcccchhhhhh
Q 005102 533 DLKPSNILLGHNMEPHVSDFGLARLAN 559 (714)
Q Consensus 533 Dlkp~NILl~~~~~~kl~DFGla~~~~ 559 (714)
||++.||+++ ++.+.|+|||.|...+
T Consensus 150 DLs~~NIL~~-~~~v~iIDF~qav~~~ 175 (197)
T cd05146 150 DLSEYNMLWH-DGKVWFIDVSQSVEPT 175 (197)
T ss_pred CCCHHHEEEE-CCcEEEEECCCceeCC
Confidence 9999999997 4679999999886543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.19 E-value=1.8e-11 Score=133.49 Aligned_cols=204 Identities=30% Similarity=0.380 Sum_probs=162.3
Q ss_pred CcccceEecCCcEE---EEEcCCCCccccCCccccCCCCCCEEEccCCCCcccCChhhcCCC-CCCEEEcCCCcCcccCC
Q 005102 54 CSWNGITCKEQRVV---SVSIPKKKLLGFLPSALGSLTDLRHVNLRNNKFFGSLPLELLEAQ-GLQSLVLYGNSFSGSVP 129 (714)
Q Consensus 54 c~w~gv~c~~~~~~---~l~l~~~~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~-~L~~L~L~~N~l~g~~p 129 (714)
+.+.+..+...... .+++..+.+...+ ..+..++.++.|++.+|.++ .+|.....+. +|+.|++++|.+. .+|
T Consensus 80 ~~~l~~~~~~~~~~~~~~l~~~~~~~~~~~-~~~~~~~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~ 156 (394)
T COG4886 80 ISSLDGSENLLNLLPLPSLDLNLNRLRSNI-SELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLP 156 (394)
T ss_pred cccccccccccCCCCCceeeccccccccCc-hhhhcccceeEEecCCcccc-cCccccccchhhcccccccccchh-hhh
Confidence 45555556544444 4777777775433 35667789999999999999 6777777775 9999999999998 888
Q ss_pred cccCCCCCCCEEeccCccCCCCCCcccccccccceeecccCcCCCCCCcccccCccccccccccCCcccccCCCCCCCCc
Q 005102 130 NEIGKLKYLQILDLSQNFFNGSLPVSIVQCKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLNLSFNKFNGSIPSNTGNLS 209 (714)
Q Consensus 130 ~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~ 209 (714)
..+..+++|+.|++++|+++ .+|.....+++|+.|++++|+++ .+|.... .+..|++|.+++|++. .++..+.++.
T Consensus 157 ~~~~~l~~L~~L~l~~N~l~-~l~~~~~~~~~L~~L~ls~N~i~-~l~~~~~-~~~~L~~l~~~~N~~~-~~~~~~~~~~ 232 (394)
T COG4886 157 SPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIE-LLSALEELDLSNNSII-ELLSSLSNLK 232 (394)
T ss_pred hhhhccccccccccCCchhh-hhhhhhhhhhhhhheeccCCccc-cCchhhh-hhhhhhhhhhcCCcce-ecchhhhhcc
Confidence 88999999999999999998 78887778899999999999998 7888642 2556999999999755 6788888999
Q ss_pred ccccccccccccCCcCcCccccCCCCcccccCcCCcCCCCCCCCccccCCCCcccccC
Q 005102 210 SLQGTVDFSHNLFSGSIPASLGNLPEKVYIDLTYNNLSGPIPQNGALMNRGPTAFIGN 267 (714)
Q Consensus 210 ~L~~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~~~~~~~~~~~~n 267 (714)
.+. .+.+.+|++. .++..++.++++++|++++|+++...+ ...........+.+|
T Consensus 233 ~l~-~l~l~~n~~~-~~~~~~~~l~~l~~L~~s~n~i~~i~~-~~~~~~l~~L~~s~n 287 (394)
T COG4886 233 NLS-GLELSNNKLE-DLPESIGNLSNLETLDLSNNQISSISS-LGSLTNLRELDLSGN 287 (394)
T ss_pred ccc-ccccCCceee-eccchhccccccceecccccccccccc-ccccCccCEEeccCc
Confidence 998 8889999987 458889999999999999999997655 333333333333344
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.18 E-value=2.4e-11 Score=138.66 Aligned_cols=94 Identities=38% Similarity=0.620 Sum_probs=89.3
Q ss_pred CCCEEEcCCCcCcccCCcccCCCCCCCEEeccCccCCCCCCcccccccccceeecccCcCCCCCCcccccCccccccccc
Q 005102 113 GLQSLVLYGNSFSGSVPNEIGKLKYLQILDLSQNFFNGSLPVSIVQCKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLNL 192 (714)
Q Consensus 113 ~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~l~~L~~L~l 192 (714)
.++.|+|++|.++|.+|..++.|++|+.|+|++|+|+|.+|..+..+++|+.|+|++|+|+|.+|..+. .+++|+.|+|
T Consensus 419 ~v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~-~L~~L~~L~L 497 (623)
T PLN03150 419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLG-QLTSLRILNL 497 (623)
T ss_pred EEEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHh-cCCCCCEEEC
Confidence 378999999999999999999999999999999999999999999999999999999999999999885 6999999999
Q ss_pred cCCcccccCCCCCCC
Q 005102 193 SFNKFNGSIPSNTGN 207 (714)
Q Consensus 193 ~~N~l~g~~p~~~~~ 207 (714)
++|+|+|.+|..++.
T Consensus 498 s~N~l~g~iP~~l~~ 512 (623)
T PLN03150 498 NGNSLSGRVPAALGG 512 (623)
T ss_pred cCCcccccCChHHhh
Confidence 999999999988764
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.16 E-value=2.2e-10 Score=114.18 Aligned_cols=141 Identities=19% Similarity=0.252 Sum_probs=110.6
Q ss_pred cccccCceEEEEEEECCCcEEEEEEeCCCCc-hhHHHHHHHHHHHhccCCC--CccceEEEEEeCC---ceeEEEeccCC
Q 005102 410 VLGKSGIGIVYKVVLEDGHTLAVRRLGEGGS-QRFKEFQTEVEAIGKIRHS--NIVTLRAYYWSVD---EKLLIYDYIPN 483 (714)
Q Consensus 410 ~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~--niv~l~~~~~~~~---~~~lV~e~~~~ 483 (714)
.|+.|.++.||++...+|..+++|....... ....++.+|+++++.+++. .+.+++.+..... ..++||||+++
T Consensus 5 ~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~G 84 (223)
T cd05154 5 QLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVDG 84 (223)
T ss_pred ecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeCC
Confidence 5899999999999987778999999876432 1335788999999999763 4577777776542 56899999999
Q ss_pred CCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCC--------------------------------------
Q 005102 484 GSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFS-------------------------------------- 525 (714)
Q Consensus 484 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~-------------------------------------- 525 (714)
.++.+.+.. ..++..++..++.+++++|.+||+..
T Consensus 85 ~~l~~~~~~-------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (223)
T cd05154 85 RVLRDRLLR-------PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAM 157 (223)
T ss_pred EecCCCCCC-------CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHH
Confidence 888775431 13677788889999999999998521
Q ss_pred ---------------CCCceecCCCCCCeeeCC--CCCeEEcccchhhh
Q 005102 526 ---------------PKKYVHGDLKPSNILLGH--NMEPHVSDFGLARL 557 (714)
Q Consensus 526 ---------------~~~ivHrDlkp~NILl~~--~~~~kl~DFGla~~ 557 (714)
+..++|+|+.+.||++++ ++.+.|+||+.+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 158 ERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 245799999999999998 56689999998864
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.15 E-value=1.6e-11 Score=138.09 Aligned_cols=267 Identities=18% Similarity=0.217 Sum_probs=162.9
Q ss_pred cccccCceEEEEEEECC-CcEEEEEEeCCCC---chhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCCC
Q 005102 410 VLGKSGIGIVYKVVLED-GHTLAVRRLGEGG---SQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGS 485 (714)
Q Consensus 410 ~lG~G~~g~Vy~~~~~~-g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gs 485 (714)
-+-+|.++.++-+.-.. |+..++|...... ..+.+....+-.++-..+||-++....-+......+||++|+.+++
T Consensus 811 p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~~~~~~~~~ 890 (1205)
T KOG0606|consen 811 PSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLVGHYLNGGD 890 (1205)
T ss_pred cccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchhhHHhccCC
Confidence 56678888888776433 5455555443321 1112222333344444455666655444445667899999999999
Q ss_pred HhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCCC
Q 005102 486 LATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSP 565 (714)
Q Consensus 486 L~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 565 (714)
|...|+... ..+..-.......+..+++|||. ..+.|||++|.|+++..+++.+++|||............
T Consensus 891 ~~Skl~~~~------~~saepaRs~i~~~vqs~e~L~s---~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~~ 961 (1205)
T KOG0606|consen 891 LPSKLHNSG------CLSAEPARSPILERVQSLESLHS---SLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPPTT 961 (1205)
T ss_pred chhhhhcCC------CcccccccchhHHHHhhhhcccc---chhhcccccccchhhcccCCcccCccccccccccccCcC
Confidence 999998764 24444556677778899999999 679999999999999999999999999554332210000
Q ss_pred Cc--cCCC-CCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCccccCCCC
Q 005102 566 TL--QSNR-MPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGSS 642 (714)
Q Consensus 566 ~~--~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~~~~~~~ 642 (714)
.. .... .+.......+....+..-........||+.|.|||...+......+|.|++|++++|.++|..||......
T Consensus 962 ~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na~tpq 1041 (1205)
T KOG0606|consen 962 DLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNAETPQ 1041 (1205)
T ss_pred CcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCCcchh
Confidence 00 0000 00000000000001111112245567899999999999999999999999999999999999999433221
Q ss_pred cchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHH
Q 005102 643 EMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMR 700 (714)
Q Consensus 643 ~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ 700 (714)
.. + ..+....+....-..+......+++...+..+|.+|-.|.
T Consensus 1042 ~~-----f----------~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1042 QI-----F----------ENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred hh-----h----------hccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 10 1 1111111111111122233456777788888999997664
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.15 E-value=7.5e-10 Score=120.05 Aligned_cols=167 Identities=19% Similarity=0.232 Sum_probs=122.3
Q ss_pred ECCCcEEEEEEeCCCCchhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCCCHhhhhhCCCCCCCcCCCC
Q 005102 424 LEDGHTLAVRRLGEGGSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGSLATALHGKPGMVSFTPVP 503 (714)
Q Consensus 424 ~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~l~ 503 (714)
..++.+|.|...+...........+-++.|+.+|||||+++++.+...+..|+|+|-+. -|..++.+ +.
T Consensus 34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~---------l~ 102 (690)
T KOG1243|consen 34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE---------LG 102 (690)
T ss_pred eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH---------hH
Confidence 34578888887766544333456778889999999999999999999999999999874 45666643 33
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCCCCccCCCCCCCCchhhhcc
Q 005102 504 WSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQK 583 (714)
Q Consensus 504 ~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 583 (714)
.....-.+.||+.||.|||+. .+++|++|.-+-|++++.|+.||++|-++........ +.+
T Consensus 103 ~~~v~~Gl~qIl~AL~FL~~d--~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~---------~~~-------- 163 (690)
T KOG1243|consen 103 KEEVCLGLFQILAALSFLNDD--CNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA---------PAK-------- 163 (690)
T ss_pred HHHHHHHHHHHHHHHHHHhcc--CCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc---------ccc--------
Confidence 455667889999999999864 5899999999999999999999999988754321110 000
Q ss_pred cccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCC
Q 005102 584 SVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGR 633 (714)
Q Consensus 584 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~ 633 (714)
...---.|..|+.+.... -..|.|-||++++|++.|.
T Consensus 164 -----------~~~~~~s~~~P~~~~~s~--~s~D~~~Lg~li~el~ng~ 200 (690)
T KOG1243|consen 164 -----------SLYLIESFDDPEEIDPSE--WSIDSWGLGCLIEELFNGS 200 (690)
T ss_pred -----------cchhhhcccChhhcCccc--cchhhhhHHHHHHHHhCcc
Confidence 000001266676553222 3469999999999999993
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.10 E-value=5.7e-11 Score=127.62 Aligned_cols=240 Identities=20% Similarity=0.230 Sum_probs=167.0
Q ss_pred cccccCceEEEEEEEC--CCcEEEEEEeCCCCchhHH--HHHHHHHHHhcc-CCCCccceEEEEEeCCceeEEEeccCCC
Q 005102 410 VLGKSGIGIVYKVVLE--DGHTLAVRRLGEGGSQRFK--EFQTEVEAIGKI-RHSNIVTLRAYYWSVDEKLLIYDYIPNG 484 (714)
Q Consensus 410 ~lG~G~~g~Vy~~~~~--~g~~vavK~~~~~~~~~~~--~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~e~~~~g 484 (714)
.||.|.|+.||++..+ ++..+++|.+.+....... .-..|+-+...+ .|.+++..+..+......|+--||++++
T Consensus 272 ~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip~e~~~~~ 351 (524)
T KOG0601|consen 272 KISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYIPLEFCEGG 351 (524)
T ss_pred EccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccCchhhhcCc
Confidence 5999999999998754 5789999988775333222 224566666666 5888888877777777888999999999
Q ss_pred CHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCC-CCeEEcccchhhhhhccCC
Q 005102 485 SLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHN-MEPHVSDFGLARLANIAGG 563 (714)
Q Consensus 485 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~-~~~kl~DFGla~~~~~~~~ 563 (714)
++.....-. ..++...++++..|++.++.++|+ ..++|+|+||+||++..+ +..++.|||++.-+.....
T Consensus 352 s~~l~~~~~------~~~d~~~~~~~~~q~~~~l~~i~s---~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~~~ 422 (524)
T KOG0601|consen 352 SSSLRSVTS------QMLDEDPRLRLTAQILTALNVIHS---KLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFSSG 422 (524)
T ss_pred chhhhhHHH------HhcCcchhhhhHHHHHhccccccc---hhhhcccccccceeeccchhhhhccccccccccceecc
Confidence 887765222 457778899999999999999999 899999999999999886 7889999998863211100
Q ss_pred CCCccCCCCCCCCchhhhcccccceeecccCCCCCCccc-cCCcccCCCCCCchhhhHHHHHHHHHHHhCCCccccCCCC
Q 005102 564 SPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYY-QAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGSS 642 (714)
Q Consensus 564 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y-~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~~~~~~~ 642 (714)
....++..| .+++......+..++|+||||..+.|.+++..--. ..
T Consensus 423 ------------------------------~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~-~~-- 469 (524)
T KOG0601|consen 423 ------------------------------VFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSE-SG-- 469 (524)
T ss_pred ------------------------------cccccccccccchhhccccccccccccccccccccccccCcccCc-cc--
Confidence 001112334 35666666778899999999999999999875331 11
Q ss_pred cchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhhh
Q 005102 643 EMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDALDRL 709 (714)
Q Consensus 643 ~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i 709 (714)
.+|.. +..-.-+.... ....+..+...+...++..||.+.++....+..
T Consensus 470 ----~~~~~--------i~~~~~p~~~~------~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~ 518 (524)
T KOG0601|consen 470 ----VQSLT--------IRSGDTPNLPG------LKLQLQVLLKVMINPDRKRRPSAVELSLHSEFY 518 (524)
T ss_pred ----cccee--------eecccccCCCc------hHHhhhhhhhhhcCCccccchhhhhhcccchhh
Confidence 11110 11111111111 113456677788899999999998877655443
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.09 E-value=8.7e-10 Score=101.71 Aligned_cols=131 Identities=24% Similarity=0.370 Sum_probs=100.8
Q ss_pred cccccCceEEEEEEECCCcEEEEEEe-CCC-C------chhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEecc
Q 005102 410 VLGKSGIGIVYKVVLEDGHTLAVRRL-GEG-G------SQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYI 481 (714)
Q Consensus 410 ~lG~G~~g~Vy~~~~~~g~~vavK~~-~~~-~------~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~ 481 (714)
++++|+-+.+|.+.+. |..+++|.- ++. . .-...+..+|+.++.+++--.|...+=|..+.+...++|||+
T Consensus 3 ~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I 81 (204)
T COG3642 3 LIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYI 81 (204)
T ss_pred hhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEe
Confidence 5789999999999875 444556643 222 1 112345778999999997666666666667788889999999
Q ss_pred CCCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhh
Q 005102 482 PNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLA 558 (714)
Q Consensus 482 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~ 558 (714)
++-.|.+.+... ...++..+-.-+.-||. .+|+|+||.++||++..+. +.++|||++.+-
T Consensus 82 ~G~~lkd~l~~~-------------~~~~~r~vG~~vg~lH~---~givHGDLTtsNiIl~~~~-i~~IDfGLg~~s 141 (204)
T COG3642 82 EGELLKDALEEA-------------RPDLLREVGRLVGKLHK---AGIVHGDLTTSNIILSGGR-IYFIDFGLGEFS 141 (204)
T ss_pred CChhHHHHHHhc-------------chHHHHHHHHHHHHHHh---cCeecCCCccceEEEeCCc-EEEEECCccccc
Confidence 998888888643 24566677777888999 9999999999999998764 999999999853
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.06 E-value=2.1e-11 Score=118.66 Aligned_cols=138 Identities=29% Similarity=0.330 Sum_probs=95.6
Q ss_pred hhhcCCCCCCEEEcCCCcCcccCCcccCCCCCCCEEeccCccCCCCCCcccccccccceeecccCcCCCCCCcccccCcc
Q 005102 106 LELLEAQGLQSLVLYGNSFSGSVPNEIGKLKYLQILDLSQNFFNGSLPVSIVQCKRLKALDLSQNNFTGPLPNGFGSGLV 185 (714)
Q Consensus 106 ~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~l~ 185 (714)
..+...+.|+.||||+|.++ .+.....-++.++.|++|+|.+. .+ +++..+.+|+.||||+|.++ .+- ++...|-
T Consensus 278 ~~~dTWq~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~-~v-~nLa~L~~L~~LDLS~N~Ls-~~~-Gwh~KLG 352 (490)
T KOG1259|consen 278 VSADTWQELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIR-TV-QNLAELPQLQLLDLSGNLLA-ECV-GWHLKLG 352 (490)
T ss_pred EecchHhhhhhccccccchh-hhhhhhhhccceeEEecccccee-ee-hhhhhcccceEeecccchhH-hhh-hhHhhhc
Confidence 33344456777777777776 66666666677778888887776 22 34667777788888887776 222 2334566
Q ss_pred ccccccccCCcccccCCCCCCCCcccccccccccccCCcC-cCccccCCCCcccccCcCCcCCCCCC
Q 005102 186 SLEKLNLSFNKFNGSIPSNTGNLSSLQGTVDFSHNLFSGS-IPASLGNLPEKVYIDLTYNNLSGPIP 251 (714)
Q Consensus 186 ~L~~L~l~~N~l~g~~p~~~~~l~~L~~~l~l~~N~l~g~-~p~~~~~l~~L~~l~l~~N~l~~~~p 251 (714)
++++|.|+.|.+. .+ +.++.+-+|. .||+++|+|... --..+++||-|+.+.|.+|.+.+.+.
T Consensus 353 NIKtL~La~N~iE-~L-SGL~KLYSLv-nLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~~vd 416 (490)
T KOG1259|consen 353 NIKTLKLAQNKIE-TL-SGLRKLYSLV-NLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAGSVD 416 (490)
T ss_pred CEeeeehhhhhHh-hh-hhhHhhhhhe-eccccccchhhHHHhcccccccHHHHHhhcCCCccccch
Confidence 7788888888776 22 3566677777 788888887632 12468899999999999999987764
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.01 E-value=4.7e-09 Score=106.48 Aligned_cols=150 Identities=17% Similarity=0.157 Sum_probs=107.2
Q ss_pred HHHHHHhccccccccCceEEEEEEECCCcEEEEEEeCCCCchh-H----------HHHHHHHHHHhccCCCCc--cceEE
Q 005102 400 LDELLKASAFVLGKSGIGIVYKVVLEDGHTLAVRRLGEGGSQR-F----------KEFQTEVEAIGKIRHSNI--VTLRA 466 (714)
Q Consensus 400 ~~~l~~~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~-~----------~~~~~E~~~l~~l~H~ni--v~l~~ 466 (714)
++.+.....+++-.-....|+++.+ +|+.|.||+........ . ..+.+|...+.++...+| .++++
T Consensus 19 f~~~~~~~~e~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa 97 (268)
T PRK15123 19 FEEVKTLQGEVFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVA 97 (268)
T ss_pred HHHHHhcCCcEEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeE
Confidence 3444433345566555566888777 57899999875443211 1 147899999988854443 34566
Q ss_pred EEEe-----CCceeEEEeccCCC-CHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCee
Q 005102 467 YYWS-----VDEKLLIYDYIPNG-SLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNIL 540 (714)
Q Consensus 467 ~~~~-----~~~~~lV~e~~~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NIL 540 (714)
|... ....++|||++++. +|.+++..... ...+...+..++.+++..+.-||. .||+|+|++++|||
T Consensus 98 ~~e~~~~~~~~~s~LVte~l~~~~sL~~~~~~~~~----~~~~~~~~~~ll~~la~~i~~LH~---~Gi~HgDL~~~NiL 170 (268)
T PRK15123 98 FGERGSNPATRTSFIITEDLAPTISLEDYCADWAT----NPPDPRLKRMLIKRVATMVRDMHA---AGINHRDCYICHFL 170 (268)
T ss_pred EEEecCCCccceeEEEEeeCCCCccHHHHHHhhcc----cCCCHHHHHHHHHHHHHHHHHHHH---CcCccCCCChhhEE
Confidence 6643 23468999999876 79888753211 234556778999999999999999 99999999999999
Q ss_pred eCC-------CCCeEEcccchhhh
Q 005102 541 LGH-------NMEPHVSDFGLARL 557 (714)
Q Consensus 541 l~~-------~~~~kl~DFGla~~ 557 (714)
++. +..+.++||+.++.
T Consensus 171 l~~~~~~~~~~~~~~LIDl~r~~~ 194 (268)
T PRK15123 171 LHLPFPGREEDLKLSVIDLHRAQI 194 (268)
T ss_pred EeccccCCCCCceEEEEECCcccc
Confidence 975 46789999998753
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.01 E-value=1.1e-10 Score=109.64 Aligned_cols=109 Identities=28% Similarity=0.307 Sum_probs=28.5
Q ss_pred ccCCCCCCEEEccCCCCcccCChhhc-CCCCCCEEEcCCCcCcccCCcccCCCCCCCEEeccCccCCCCCCccc-ccccc
Q 005102 84 LGSLTDLRHVNLRNNKFFGSLPLELL-EAQGLQSLVLYGNSFSGSVPNEIGKLKYLQILDLSQNFFNGSLPVSI-VQCKR 161 (714)
Q Consensus 84 ~~~l~~L~~L~L~~N~l~~~~p~~~~-~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~-~~l~~ 161 (714)
+.+...++.|+|++|.|+. +. .+. .+.+|+.|+|++|.++ .++ .+..+++|+.|+|++|+++ .+...+ ..+++
T Consensus 15 ~~n~~~~~~L~L~~n~I~~-Ie-~L~~~l~~L~~L~Ls~N~I~-~l~-~l~~L~~L~~L~L~~N~I~-~i~~~l~~~lp~ 89 (175)
T PF14580_consen 15 YNNPVKLRELNLRGNQIST-IE-NLGATLDKLEVLDLSNNQIT-KLE-GLPGLPRLKTLDLSNNRIS-SISEGLDKNLPN 89 (175)
T ss_dssp -----------------------S--TT-TT--EEE-TTS--S---T-T----TT--EEE--SS----S-CHHHHHH-TT
T ss_pred ccccccccccccccccccc-cc-chhhhhcCCCEEECCCCCCc-ccc-CccChhhhhhcccCCCCCC-ccccchHHhCCc
Confidence 4455567777777777762 32 344 4667777777777776 333 4666777777777777776 444444 34667
Q ss_pred cceeecccCcCCCCCCc-ccccCccccccccccCCccc
Q 005102 162 LKALDLSQNNFTGPLPN-GFGSGLVSLEKLNLSFNKFN 198 (714)
Q Consensus 162 L~~L~l~~N~l~g~~p~-~~~~~l~~L~~L~l~~N~l~ 198 (714)
|+.|+|++|++.. +-. .....+++|+.|+|.+|.++
T Consensus 90 L~~L~L~~N~I~~-l~~l~~L~~l~~L~~L~L~~NPv~ 126 (175)
T PF14580_consen 90 LQELYLSNNKISD-LNELEPLSSLPKLRVLSLEGNPVC 126 (175)
T ss_dssp --EEE-TTS---S-CCCCGGGGG-TT--EEE-TT-GGG
T ss_pred CCEEECcCCcCCC-hHHhHHHHcCCCcceeeccCCccc
Confidence 7777777777652 111 01123444555555555443
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.96 E-value=4.5e-09 Score=100.46 Aligned_cols=124 Identities=22% Similarity=0.315 Sum_probs=83.6
Q ss_pred EEEEEEECCCcEEEEEEeCCCCc--------------------------hhHHHHHHHHHHHhccCCC--CccceEEEEE
Q 005102 418 IVYKVVLEDGHTLAVRRLGEGGS--------------------------QRFKEFQTEVEAIGKIRHS--NIVTLRAYYW 469 (714)
Q Consensus 418 ~Vy~~~~~~g~~vavK~~~~~~~--------------------------~~~~~~~~E~~~l~~l~H~--niv~l~~~~~ 469 (714)
.||.|...+|..+|||+.+.... .......+|.+.|.++..- ++.+++++.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 48999999999999998754200 0123467899999999765 466666542
Q ss_pred eCCceeEEEeccC--CCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHH-HhcCCCCCceecCCCCCCeeeCCCCC
Q 005102 470 SVDEKLLIYDYIP--NGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVY-LHEFSPKKYVHGDLKPSNILLGHNME 546 (714)
Q Consensus 470 ~~~~~~lV~e~~~--~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~-LH~~~~~~ivHrDlkp~NILl~~~~~ 546 (714)
.-++||||++ +..+..+.... ++......++.+++..+.. +|. .||+|+||.+.||+++++ .
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~~~~--------~~~~~~~~~~~~il~~~~~~~~~---~givHGDLs~~NIlv~~~-~ 144 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLKDVD--------LSPEEPKELLEEILEEIIKMLHK---AGIVHGDLSEYNILVDDG-K 144 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHHHCG--------GGGSTHHHHHHHHHHHHHHHHHC---TTEEESS-STTSEEEETT-C
T ss_pred ---CCEEEEEecCCCccchhhHHhcc--------ccchhHHHHHHHHHHHHHHHHHh---cCceecCCChhhEEeecc-e
Confidence 4579999998 54444433211 2234466778888886666 468 899999999999999988 8
Q ss_pred eEEcccchhhh
Q 005102 547 PHVSDFGLARL 557 (714)
Q Consensus 547 ~kl~DFGla~~ 557 (714)
+.++|||.+..
T Consensus 145 ~~iIDf~qav~ 155 (188)
T PF01163_consen 145 VYIIDFGQAVD 155 (188)
T ss_dssp EEE--GTTEEE
T ss_pred EEEEecCccee
Confidence 99999998764
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.96 E-value=5.4e-09 Score=95.90 Aligned_cols=140 Identities=19% Similarity=0.252 Sum_probs=103.2
Q ss_pred cccccCceEEEEEEECCCcEEEEEEe-CCCC-------chhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEecc
Q 005102 410 VLGKSGIGIVYKVVLEDGHTLAVRRL-GEGG-------SQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYI 481 (714)
Q Consensus 410 ~lG~G~~g~Vy~~~~~~g~~vavK~~-~~~~-------~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~ 481 (714)
++-+|+-+.|+++.+. |+...||.- .+.- .-..++..+|++.+.+++--.|....=++.+...-.++|||+
T Consensus 14 likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME~~ 92 (229)
T KOG3087|consen 14 LIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYMEFI 92 (229)
T ss_pred eeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEEec
Confidence 6889999999999995 777667643 2221 112356788999999997666666556676777788999999
Q ss_pred CC-CCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCC---CeEEcccchhhh
Q 005102 482 PN-GSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNM---EPHVSDFGLARL 557 (714)
Q Consensus 482 ~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~---~~kl~DFGla~~ 557 (714)
++ -++.+++..... ...........+..|-+.+.-||. .+|+|+||..+||++..++ .+.++|||++..
T Consensus 93 ~g~~~vk~~i~~~~~----~~~~d~~~~~~~~~iG~~igklH~---ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 93 DGASTVKDFILSTME----DESEDEGLAELARRIGELIGKLHD---NDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred cchhHHHHHHHHHcc----CcccchhHHHHHHHHHHHHHHhhh---CCeecccccccceEEecCCCcCceEEEeecchhc
Confidence 66 377777754421 112222236788889999999999 9999999999999997654 458999999864
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=98.93 E-value=9.2e-10 Score=103.42 Aligned_cols=125 Identities=30% Similarity=0.427 Sum_probs=43.6
Q ss_pred cCCCCCCEEEcCCCcCcccCCcccC-CCCCCCEEeccCccCCCCCCcccccccccceeecccCcCCCCCCcccccCcccc
Q 005102 109 LEAQGLQSLVLYGNSFSGSVPNEIG-KLKYLQILDLSQNFFNGSLPVSIVQCKRLKALDLSQNNFTGPLPNGFGSGLVSL 187 (714)
Q Consensus 109 ~~l~~L~~L~L~~N~l~g~~p~~~~-~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~l~~L 187 (714)
.+..+++.|+|.+|.|+ .+ +.++ .+.+|+.|||++|.++ .++ .+..+++|++|++++|+++ .++..+...+++|
T Consensus 16 ~n~~~~~~L~L~~n~I~-~I-e~L~~~l~~L~~L~Ls~N~I~-~l~-~l~~L~~L~~L~L~~N~I~-~i~~~l~~~lp~L 90 (175)
T PF14580_consen 16 NNPVKLRELNLRGNQIS-TI-ENLGATLDKLEVLDLSNNQIT-KLE-GLPGLPRLKTLDLSNNRIS-SISEGLDKNLPNL 90 (175)
T ss_dssp ----------------------S--TT-TT--EEE-TTS--S---T-T----TT--EEE--SS----S-CHHHHHH-TT-
T ss_pred ccccccccccccccccc-cc-cchhhhhcCCCEEECCCCCCc-ccc-CccChhhhhhcccCCCCCC-ccccchHHhCCcC
Confidence 34456788888888886 34 3455 5778888888888887 443 4667788888888888887 4554443347788
Q ss_pred ccccccCCcccccCC-CCCCCCcccccccccccccCCcCcCc----cccCCCCccccc
Q 005102 188 EKLNLSFNKFNGSIP-SNTGNLSSLQGTVDFSHNLFSGSIPA----SLGNLPEKVYID 240 (714)
Q Consensus 188 ~~L~l~~N~l~g~~p-~~~~~l~~L~~~l~l~~N~l~g~~p~----~~~~l~~L~~l~ 240 (714)
+.|+|++|+|...-- ..+..+++|+ .|++.+|+++.. +. .+..+|+|+.||
T Consensus 91 ~~L~L~~N~I~~l~~l~~L~~l~~L~-~L~L~~NPv~~~-~~YR~~vi~~lP~Lk~LD 146 (175)
T PF14580_consen 91 QELYLSNNKISDLNELEPLSSLPKLR-VLSLEGNPVCEK-KNYRLFVIYKLPSLKVLD 146 (175)
T ss_dssp -EEE-TTS---SCCCCGGGGG-TT---EEE-TT-GGGGS-TTHHHHHHHH-TT-SEET
T ss_pred CEEECcCCcCCChHHhHHHHcCCCcc-eeeccCCcccch-hhHHHHHHHHcChhheeC
Confidence 888888888863211 3344566777 788888887633 22 345677777776
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.89 E-value=1.7e-10 Score=112.52 Aligned_cols=115 Identities=27% Similarity=0.315 Sum_probs=74.6
Q ss_pred cccCCcccCCCCCCCEEeccCccCCCCCCcccccccccceeecccCcCCCCCCcccccCccccccccccCCcccccCCCC
Q 005102 125 SGSVPNEIGKLKYLQILDLSQNFFNGSLPVSIVQCKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLNLSFNKFNGSIPSN 204 (714)
Q Consensus 125 ~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~l~~L~~L~l~~N~l~g~~p~~ 204 (714)
+|.+-..+...+.|+.||||+|.++ .+..+..-++.++.|++|+|.+. .+-. + ..|++|+.||||+|.++ .+-.+
T Consensus 273 ~G~~~~~~dTWq~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~-~v~n-L-a~L~~L~~LDLS~N~Ls-~~~Gw 347 (490)
T KOG1259|consen 273 NGSALVSADTWQELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIR-TVQN-L-AELPQLQLLDLSGNLLA-ECVGW 347 (490)
T ss_pred CCceEEecchHhhhhhccccccchh-hhhhhhhhccceeEEecccccee-eehh-h-hhcccceEeecccchhH-hhhhh
Confidence 3444445555567777777777776 66666666777777777777776 3332 3 23677777777777776 44444
Q ss_pred CCCCcccccccccccccCCcCcCccccCCCCcccccCcCCcCC
Q 005102 205 TGNLSSLQGTVDFSHNLFSGSIPASLGNLPEKVYIDLTYNNLS 247 (714)
Q Consensus 205 ~~~l~~L~~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~ 247 (714)
-..+-+.. +|.|+.|.+.. -..++.|-+|.+||+++|++.
T Consensus 348 h~KLGNIK-tL~La~N~iE~--LSGL~KLYSLvnLDl~~N~Ie 387 (490)
T KOG1259|consen 348 HLKLGNIK-TLKLAQNKIET--LSGLRKLYSLVNLDLSSNQIE 387 (490)
T ss_pred HhhhcCEe-eeehhhhhHhh--hhhhHhhhhheeccccccchh
Confidence 44455555 67777777642 123556667777777777775
|
|
| >PF08263 LRRNT_2: Leucine rich repeat N-terminal domain; InterPro: IPR013210 Leucine-rich repeats (LRR) consist of 2-45 motifs of 20-30 amino acids in length that generally folds into an arc or horseshoe shape [] | Back alignment and domain information |
|---|
Probab=98.87 E-value=2.5e-09 Score=75.62 Aligned_cols=41 Identities=54% Similarity=1.148 Sum_probs=31.4
Q ss_pred hhHHHHHHHHHHhccCCCCCCCCCCCCCC-CCCCcccceEec
Q 005102 22 NGEGYALLSFKQSVHEDPEGSLSNWNSSD-ENPCSWNGITCK 62 (714)
Q Consensus 22 ~~~~~~l~~~~~~~~~~~~~~l~~w~~~~-~~~c~w~gv~c~ 62 (714)
+.|++||++||+++..+|.+.+.+|+.+. .+||+|.||+|+
T Consensus 2 ~~d~~aLl~~k~~l~~~~~~~l~~W~~~~~~~~C~W~GV~Cd 43 (43)
T PF08263_consen 2 NQDRQALLAFKKSLNNDPSGVLSSWNPSSDSDPCSWSGVTCD 43 (43)
T ss_dssp HHHHHHHHHHHHCTT-SC-CCCTT--TT--S-CCCSTTEEE-
T ss_pred cHHHHHHHHHHHhcccccCcccccCCCcCCCCCeeeccEEeC
Confidence 57999999999999777888999999774 799999999995
|
LRRs occur in proteins ranging from viruses to eukaryotes, and appear to provide a structural framework for the formation of protein-protein interactions [, ].Proteins containing LRRs include tyrosine kinase receptors, cell-adhesion molecules, virulence factors, and extracellular matrix-binding glycoproteins, and are involved in a variety of biological processes, including signal transduction, cell adhesion, DNA repair, recombination, transcription, RNA processing, disease resistance, apoptosis, and the immune response []. Sequence analyses of LRR proteins suggested the existence of several different subfamilies of LRRs. The significance of this classification is that repeats from different subfamilies never occur simultaneously and have most probably evolved independently. It is, however, now clear that all major classes of LRR have curved horseshoe structures with a parallel beta sheet on the concave side and mostly helical elements on the convex side. At least six families of LRR proteins, characterised by different lengths and consensus sequences of the repeats, have been identified. Eleven-residue segments of the LRRs (LxxLxLxxN/CxL), corresponding to the beta-strand and adjacent loop regions, are conserved in LRR proteins, whereas the remaining parts of the repeats (herein termed variable) may be very different. Despite the differences, each of the variable parts contains two half-turns at both ends and a "linear" segment (as the chain follows a linear path overall), usually formed by a helix, in the middle. The concave face and the adjacent loops are the most common protein interaction surfaces on LRR proteins. 3D structure of some LRR proteins-ligand complexes show that the concave surface of LRR domain is ideal for interaction with alpha-helix, thus supporting earlier conclusions that the elongated and curved LRR structure provides an outstanding framework for achieving diverse protein-protein interactions []. Molecular modeling suggests that the conserved pattern LxxLxL, which is shorter than the previously proposed LxxLxLxxN/CxL is sufficient to impart the characteristic horseshoe curvature to proteins with 20- to 30-residue repeats []. This domain is often found at the N terminus of tandem leucine rich repeats.; PDB: 3RGZ_A 3RJ0_A 3RIZ_A 3RGX_A 1OGQ_A. |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.83 E-value=9.6e-08 Score=100.69 Aligned_cols=171 Identities=25% Similarity=0.349 Sum_probs=127.5
Q ss_pred eEEEEEEE-CCCcEEEEEEeCCCCchhHHHHHHHHHHHhccCCCCccceEEEEEe----CCceeEEEeccCC-CCHhhhh
Q 005102 417 GIVYKVVL-EDGHTLAVRRLGEGGSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWS----VDEKLLIYDYIPN-GSLATAL 490 (714)
Q Consensus 417 g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~----~~~~~lV~e~~~~-gsL~~~l 490 (714)
.+.||+.. .||..|++|++.............-++.++++.|+|+|++.+++.. +...++||+|.++ ++|.++.
T Consensus 290 ~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~~ 369 (655)
T KOG3741|consen 290 ITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDLY 369 (655)
T ss_pred ceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHHH
Confidence 57899985 4799999999944333222233456889999999999999998863 3467899999986 6777765
Q ss_pred hCCCCCC---------CcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhcc
Q 005102 491 HGKPGMV---------SFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIA 561 (714)
Q Consensus 491 ~~~~~~~---------~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 561 (714)
....... .....++...+.++.|+..||.++|+ .|+.-+-|.+.+|+++.+.+++|+..|....+..+
T Consensus 370 F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHs---sGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d 446 (655)
T KOG3741|consen 370 FANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHS---SGLACKTLDLKKILVTGKMRIRISGCGIMDVLQED 446 (655)
T ss_pred ccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHh---cCceeecccHhHeEeeCcceEEEecccceeeecCC
Confidence 4322111 11357788999999999999999999 89999999999999999999999988876554322
Q ss_pred CCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCc
Q 005102 562 GGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTA 635 (714)
Q Consensus 562 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p 635 (714)
.. |-+. --.+-|.-.||.+++-|.||..-
T Consensus 447 ~~------------------------------------------~~le---~~Qq~D~~~lG~ll~aLAt~~~n 475 (655)
T KOG3741|consen 447 PT------------------------------------------EPLE---SQQQNDLRDLGLLLLALATGTEN 475 (655)
T ss_pred CC------------------------------------------cchh---HHhhhhHHHHHHHHHHHhhcccc
Confidence 10 1111 12367888999999999999643
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.79 E-value=3.9e-08 Score=96.34 Aligned_cols=135 Identities=21% Similarity=0.208 Sum_probs=97.9
Q ss_pred hccccccccCceEEEEEEECCCcEEEEEEeCCCCc----------------------hhHHHHHHHHHHHhccCCC--Cc
Q 005102 406 ASAFVLGKSGIGIVYKVVLEDGHTLAVRRLGEGGS----------------------QRFKEFQTEVEAIGKIRHS--NI 461 (714)
Q Consensus 406 ~~~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~----------------------~~~~~~~~E~~~l~~l~H~--ni 461 (714)
+.++.||-|--+.||.|..+.|.++|||.=+.+.. ......++|.++|.++.-. .+
T Consensus 94 ~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~V 173 (304)
T COG0478 94 AIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVKV 173 (304)
T ss_pred hhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCCC
Confidence 44678999999999999999999999996433211 1134578899999999654 66
Q ss_pred cceEEEEEeCCceeEEEeccCCCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeee
Q 005102 462 VTLRAYYWSVDEKLLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILL 541 (714)
Q Consensus 462 v~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl 541 (714)
.+.+++ +...+||||+++-.|...- ++....-.|+..|+.-+.-+-. .||||+|+.+-||++
T Consensus 174 P~P~~~----nRHaVvMe~ieG~eL~~~r-----------~~~en~~~il~~il~~~~~~~~---~GiVHGDlSefNIlV 235 (304)
T COG0478 174 PKPIAW----NRHAVVMEYIEGVELYRLR-----------LDVENPDEILDKILEEVRKAYR---RGIVHGDLSEFNILV 235 (304)
T ss_pred CCcccc----ccceeeeehcccceeeccc-----------CcccCHHHHHHHHHHHHHHHHH---cCccccCCchheEEE
Confidence 666654 4568999999886554421 1222334444555554444445 699999999999999
Q ss_pred CCCCCeEEcccchhhhh
Q 005102 542 GHNMEPHVSDFGLARLA 558 (714)
Q Consensus 542 ~~~~~~kl~DFGla~~~ 558 (714)
+++|.+.++||--+...
T Consensus 236 ~~dg~~~vIDwPQ~v~~ 252 (304)
T COG0478 236 TEDGDIVVIDWPQAVPI 252 (304)
T ss_pred ecCCCEEEEeCcccccC
Confidence 99999999999766543
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=98.75 E-value=1.8e-09 Score=110.80 Aligned_cols=177 Identities=20% Similarity=0.249 Sum_probs=126.6
Q ss_pred cEEEEEcCCCCccccCC--ccccCCCCCCEEEccCCCCcccCCh--hhcCCCCCCEEEcCCCcCcccCCccc-CCCCCCC
Q 005102 65 RVVSVSIPKKKLLGFLP--SALGSLTDLRHVNLRNNKFFGSLPL--ELLEAQGLQSLVLYGNSFSGSVPNEI-GKLKYLQ 139 (714)
Q Consensus 65 ~~~~l~l~~~~l~g~~p--~~~~~l~~L~~L~L~~N~l~~~~p~--~~~~l~~L~~L~L~~N~l~g~~p~~~-~~l~~L~ 139 (714)
++..+.|.+.... ..+ .....+++++.||||.|-|....|- -...|++|+.|+|+.|++.-...... ..++.|+
T Consensus 122 kL~~IsLdn~~V~-~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l~~lK 200 (505)
T KOG3207|consen 122 KLREISLDNYRVE-DAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLLSHLK 200 (505)
T ss_pred hhhheeecCcccc-ccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhhhhhh
Confidence 5555566554433 222 3567889999999999998754442 24578999999999999963333322 2568999
Q ss_pred EEeccCccCCCC-CCcccccccccceeecccCcCCC--CCCcccccCccccccccccCCcccccCC--CCCCCCcccccc
Q 005102 140 ILDLSQNFFNGS-LPVSIVQCKRLKALDLSQNNFTG--PLPNGFGSGLVSLEKLNLSFNKFNGSIP--SNTGNLSSLQGT 214 (714)
Q Consensus 140 ~L~Ls~N~l~g~-~p~~~~~l~~L~~L~l~~N~l~g--~~p~~~~~~l~~L~~L~l~~N~l~g~~p--~~~~~l~~L~~~ 214 (714)
.|.|+.+.|+-. +-..+..+++|+.|+|..|...+ ..+. ..+..|+.|||++|++- ..+ ...+.++.|. .
T Consensus 201 ~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~---~i~~~L~~LdLs~N~li-~~~~~~~~~~l~~L~-~ 275 (505)
T KOG3207|consen 201 QLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATST---KILQTLQELDLSNNNLI-DFDQGYKVGTLPGLN-Q 275 (505)
T ss_pred eEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchh---hhhhHHhhccccCCccc-ccccccccccccchh-h
Confidence 999999999832 11234567899999999995322 2222 23678999999999987 444 5667888888 8
Q ss_pred cccccccCCcC-cCcc-----ccCCCCcccccCcCCcCC
Q 005102 215 VDFSHNLFSGS-IPAS-----LGNLPEKVYIDLTYNNLS 247 (714)
Q Consensus 215 l~l~~N~l~g~-~p~~-----~~~l~~L~~l~l~~N~l~ 247 (714)
|+++.+.++.. +|+. ...+++|++|+++.|++.
T Consensus 276 Lnls~tgi~si~~~d~~s~~kt~~f~kL~~L~i~~N~I~ 314 (505)
T KOG3207|consen 276 LNLSSTGIASIAEPDVESLDKTHTFPKLEYLNISENNIR 314 (505)
T ss_pred hhccccCcchhcCCCccchhhhcccccceeeecccCccc
Confidence 88888888643 3433 467899999999999986
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.72 E-value=7.6e-09 Score=79.85 Aligned_cols=58 Identities=36% Similarity=0.468 Sum_probs=24.0
Q ss_pred CCEEEcCCCcCcccCCcccCCCCCCCEEeccCccCCCCCCcccccccccceeecccCc
Q 005102 114 LQSLVLYGNSFSGSVPNEIGKLKYLQILDLSQNFFNGSLPVSIVQCKRLKALDLSQNN 171 (714)
Q Consensus 114 L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~N~ 171 (714)
|++|+|++|+++...+..|.++++|++|++++|+++...|..|..+++|++|++++|+
T Consensus 3 L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~ 60 (61)
T PF13855_consen 3 LESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNN 60 (61)
T ss_dssp ESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSS
T ss_pred CcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCc
Confidence 3444444444442222334444444444444444443333344444444444444443
|
... |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.72 E-value=5e-07 Score=92.94 Aligned_cols=263 Identities=14% Similarity=0.138 Sum_probs=153.1
Q ss_pred ccccccCceEEEEEEECCCcEEEEEEeCCCCchhHHHHHHHHHHHhcc-CCCCccceEEE----EE--eCC-ceeEEEec
Q 005102 409 FVLGKSGIGIVYKVVLEDGHTLAVRRLGEGGSQRFKEFQTEVEAIGKI-RHSNIVTLRAY----YW--SVD-EKLLIYDY 480 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~----~~--~~~-~~~lV~e~ 480 (714)
.-||+|+-+.+|-.--- +.. +.|++...-.... .+.++.|... .||-+..-+.+ .+ ..+ ..-+.|..
T Consensus 17 r~LgqGgea~ly~l~e~-~d~-VAKIYh~Pppa~~---aqk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflmP~ 91 (637)
T COG4248 17 RPLGQGGEADLYTLGEV-RDQ-VAKIYHAPPPAAQ---AQKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLMPK 91 (637)
T ss_pred ccccCCccceeeecchh-hch-hheeecCCCchHH---HHHHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEeccc
Confidence 46999999999965322 112 4566665433221 1223344444 56644331111 11 112 24577777
Q ss_pred cCCC-CHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhh
Q 005102 481 IPNG-SLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLAN 559 (714)
Q Consensus 481 ~~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~ 559 (714)
+++. -...++.....+.++....|.-.++.++.+|.+.+-||+ .|.+-+|+.++|+|+.+++.+.|.|=..-....
T Consensus 92 v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~---~Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi~~ 168 (637)
T COG4248 92 VSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHE---HGHVVGDVNQNSFLVSDDSKVVLVDSDSFQINA 168 (637)
T ss_pred CCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHh---cCCcccccCccceeeecCceEEEEcccceeecc
Confidence 7653 222233322223344678899999999999999999999 899999999999999999999998732111100
Q ss_pred ccCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccC-----CCCCCchhhhHHHHHHHHHHHhC-C
Q 005102 560 IAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLK-----VVKPSQKWDIYSYGVILLEMITG-R 633 (714)
Q Consensus 560 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~~DVwS~Gvvl~elltG-~ 633 (714)
. .......+|...|.+||.-. +..-+...|-|.+||++++++.| +
T Consensus 169 -n----------------------------g~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggr 219 (637)
T COG4248 169 -N----------------------------GTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGR 219 (637)
T ss_pred -C----------------------------CceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCC
Confidence 0 12233456677899999764 33457789999999999999986 9
Q ss_pred CccccCC---CCcchhH-HHHHHHHhhcCCcccccCCCCCC--CCCcHHHHHHHHHHHhHccCC--CCCCCCCHHHHHHH
Q 005102 634 TAVVQVG---SSEMDLV-NWMQLCIEEKKPLADVLDPYLAP--DADKEEEIIAVLKIAMACVHS--SPEKRPTMRHISDA 705 (714)
Q Consensus 634 ~p~~~~~---~~~~~l~-~~~~~~~~~~~~~~~~~d~~~~~--~~~~~~~~~~l~~li~~Cl~~--dP~~RPt~~evl~~ 705 (714)
+||.... .....+. ......+.... +.-.+.... ......-...+..+..+|+.. ++.-|||++.-+..
T Consensus 220 HPysGI~~~~~ap~p~E~~Ia~g~f~ya~---~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aA 296 (637)
T COG4248 220 HPYSGIPLISDAPNPLETDIAHGRFAYAS---DQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAA 296 (637)
T ss_pred CCCCcccccCCCCCcchhhhhcceeeech---hccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Confidence 9994321 1111111 11111010000 000011111 111112223455666788765 35689999999988
Q ss_pred Hhhhhc
Q 005102 706 LDRLIV 711 (714)
Q Consensus 706 L~~i~~ 711 (714)
|.++..
T Consensus 297 l~al~~ 302 (637)
T COG4248 297 LDALRQ 302 (637)
T ss_pred HHHHHH
Confidence 877653
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.72 E-value=8.3e-09 Score=79.63 Aligned_cols=61 Identities=30% Similarity=0.419 Sum_probs=48.6
Q ss_pred CCCCEEEccCCCCcccCChhhcCCCCCCEEEcCCCcCcccCCcccCCCCCCCEEeccCccC
Q 005102 88 TDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSGSVPNEIGKLKYLQILDLSQNFF 148 (714)
Q Consensus 88 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l 148 (714)
++|++|+|++|+|+...+..|..+++|++|+|++|.++...|..|.++++|+.|++++|+|
T Consensus 1 p~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 1 PNLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TTESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred CcCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 4678888888888866566777888888888888888877777788888888888888875
|
... |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.65 E-value=7e-08 Score=105.96 Aligned_cols=150 Identities=21% Similarity=0.346 Sum_probs=99.1
Q ss_pred CHHHHHHhcc-ccccccCceEEEEEEECCCcEEEEEEeCCCCchh-----------------------------------
Q 005102 399 DLDELLKASA-FVLGKSGIGIVYKVVLEDGHTLAVRRLGEGGSQR----------------------------------- 442 (714)
Q Consensus 399 ~~~~l~~~~~-~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~----------------------------------- 442 (714)
..+|+....+ +.|+.++-|.||+|++++|+.||||+.+.+-...
T Consensus 120 ~iee~F~eF~~~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~ 199 (517)
T COG0661 120 PIEELFSEFEPEPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFE 199 (517)
T ss_pred CHHHHHHHcCCCchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHH
Confidence 3455555444 6799999999999999999999999876531110
Q ss_pred -----HHHHHHHHHHHhccC----CCCccceEEEEEe-CCceeEEEeccCCCCHhhhhhCCCCCCCcCCCCHHHHHHHHH
Q 005102 443 -----FKEFQTEVEAIGKIR----HSNIVTLRAYYWS-VDEKLLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIK 512 (714)
Q Consensus 443 -----~~~~~~E~~~l~~l~----H~niv~l~~~~~~-~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~ 512 (714)
.-++.+|..-+.+++ +.-=+.+=..|++ .....|+|||++|-.+.+...-.. ...+ +..++.
T Consensus 200 ~~l~~ElDy~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~-----~g~d---~k~ia~ 271 (517)
T COG0661 200 KRLREELDYRREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS-----AGID---RKELAE 271 (517)
T ss_pred HHHHHHhCHHHHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh-----cCCC---HHHHHH
Confidence 012556666666663 2222333334433 467789999999988888742221 1133 233333
Q ss_pred HHHHH-HHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhh
Q 005102 513 GIAKG-LVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLAN 559 (714)
Q Consensus 513 ~ia~g-L~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~ 559 (714)
.++++ +..+-. .|++|.|..|.||+++.++++.+.|||+...++
T Consensus 272 ~~~~~f~~q~~~---dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~ 316 (517)
T COG0661 272 LLVRAFLRQLLR---DGFFHADPHPGNILVRSDGRIVLLDFGIVGRLD 316 (517)
T ss_pred HHHHHHHHHHHh---cCccccCCCccceEEecCCcEEEEcCcceecCC
Confidence 33332 222222 489999999999999999999999999987654
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=98.65 E-value=6.6e-09 Score=106.81 Aligned_cols=161 Identities=23% Similarity=0.211 Sum_probs=98.6
Q ss_pred cCCCCCCEEEccCCCCcccCC--hhhcCCCCCCEEEcCCCcCcccCC--cccCCCCCCCEEeccCccCCCCCCcc-cccc
Q 005102 85 GSLTDLRHVNLRNNKFFGSLP--LELLEAQGLQSLVLYGNSFSGSVP--NEIGKLKYLQILDLSQNFFNGSLPVS-IVQC 159 (714)
Q Consensus 85 ~~l~~L~~L~L~~N~l~~~~p--~~~~~l~~L~~L~L~~N~l~g~~p--~~~~~l~~L~~L~Ls~N~l~g~~p~~-~~~l 159 (714)
.++++|+...|.+.... ..+ .....+++++.||||.|-|+...| .....|++|+.|+|+.|+|.-..-.. -..+
T Consensus 118 sn~kkL~~IsLdn~~V~-~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l 196 (505)
T KOG3207|consen 118 SNLKKLREISLDNYRVE-DAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLL 196 (505)
T ss_pred hhHHhhhheeecCcccc-ccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhh
Confidence 46677777777776664 222 245567778888888887764333 23456778888888888876322211 1245
Q ss_pred cccceeecccCcCCCCCCcccccCccccccccccCCcccccCCCCCCCCcccccccccccccCCcCcC--ccccCCCCcc
Q 005102 160 KRLKALDLSQNNFTGPLPNGFGSGLVSLEKLNLSFNKFNGSIPSNTGNLSSLQGTVDFSHNLFSGSIP--ASLGNLPEKV 237 (714)
Q Consensus 160 ~~L~~L~l~~N~l~g~~p~~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~~l~l~~N~l~g~~p--~~~~~l~~L~ 237 (714)
+.|+.|.|+++.|+-.--..+...+++|+.|+|..|...+.-......+..|+ .|||++|++- ..+ ...+.+|.|.
T Consensus 197 ~~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~-~LdLs~N~li-~~~~~~~~~~l~~L~ 274 (505)
T KOG3207|consen 197 SHLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQ-ELDLSNNNLI-DFDQGYKVGTLPGLN 274 (505)
T ss_pred hhhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHh-hccccCCccc-ccccccccccccchh
Confidence 67777777777776211111112357778888888753323333444456676 7788777775 333 4466777777
Q ss_pred cccCcCCcCCC
Q 005102 238 YIDLTYNNLSG 248 (714)
Q Consensus 238 ~l~l~~N~l~~ 248 (714)
.|+++.+.++.
T Consensus 275 ~Lnls~tgi~s 285 (505)
T KOG3207|consen 275 QLNLSSTGIAS 285 (505)
T ss_pred hhhccccCcch
Confidence 77777777764
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.59 E-value=3.6e-07 Score=89.72 Aligned_cols=106 Identities=24% Similarity=0.313 Sum_probs=84.0
Q ss_pred HHHHHHHHHHhccCCC--CccceEEEEEeCC----ceeEEEeccCCC-CHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHH
Q 005102 444 KEFQTEVEAIGKIRHS--NIVTLRAYYWSVD----EKLLIYDYIPNG-SLATALHGKPGMVSFTPVPWSVRVKIIKGIAK 516 (714)
Q Consensus 444 ~~~~~E~~~l~~l~H~--niv~l~~~~~~~~----~~~lV~e~~~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~ 516 (714)
..+.+|...+.++... .+.+.+++..... ..++|+|++++. +|.+++.... ..+......++.+++.
T Consensus 56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~------~~~~~~~~~ll~~l~~ 129 (206)
T PF06293_consen 56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWE------QLDPSQRRELLRALAR 129 (206)
T ss_pred hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhc------ccchhhHHHHHHHHHH
Confidence 4678899888888543 3556677766532 348999999874 7999887532 2455678889999999
Q ss_pred HHHHHhcCCCCCceecCCCCCCeeeCCCC---CeEEcccchhhhh
Q 005102 517 GLVYLHEFSPKKYVHGDLKPSNILLGHNM---EPHVSDFGLARLA 558 (714)
Q Consensus 517 gL~~LH~~~~~~ivHrDlkp~NILl~~~~---~~kl~DFGla~~~ 558 (714)
.++-||+ .||+|+|+++.|||++.+. .+.++||+-++..
T Consensus 130 ~i~~lH~---~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 130 LIAKLHD---AGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HHHHHHH---CcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 9999999 9999999999999999886 8999999987753
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.58 E-value=1.1e-06 Score=84.62 Aligned_cols=138 Identities=18% Similarity=0.158 Sum_probs=102.9
Q ss_pred ccccCceEEEEEEECCCcEEEEEEeCCCC------chhHHHHHHHHHHHhccCCC--CccceEEEEE-eC----CceeEE
Q 005102 411 LGKSGIGIVYKVVLEDGHTLAVRRLGEGG------SQRFKEFQTEVEAIGKIRHS--NIVTLRAYYW-SV----DEKLLI 477 (714)
Q Consensus 411 lG~G~~g~Vy~~~~~~g~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~H~--niv~l~~~~~-~~----~~~~lV 477 (714)
-|+||.+-|++..+. |+.+-+|+-...- ......|.+|...+.++... .+.+++ ++. .. ...+||
T Consensus 26 ~~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV 103 (216)
T PRK09902 26 YRRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV 103 (216)
T ss_pred cCCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence 478999999998875 5578899865321 22346899999999999532 244444 332 11 235799
Q ss_pred EeccCC-CCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCC--eEEcccch
Q 005102 478 YDYIPN-GSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNME--PHVSDFGL 554 (714)
Q Consensus 478 ~e~~~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~--~kl~DFGl 554 (714)
+|-+.+ -+|.+++.+..- .+.+...+..+..+++..++-||+ .|+.|+|+-+.||+++.++. ++++||--
T Consensus 104 Te~L~g~~~L~~~l~~~~~----~~~~~~~k~~il~~va~~ia~LH~---~Gv~Hgdly~khIll~~~g~~~v~lIDlEk 176 (216)
T PRK09902 104 TEDMAGFISIADWYAQHAV----SPYSDEVRQAMLKAVALAFKKMHS---VNRQHGCCYVRHIYVKTEGKAEAGFLDLEK 176 (216)
T ss_pred EEeCCCCccHHHHHhcCCc----CCcchHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHhheeecCCCCeeEEEEEhhc
Confidence 997753 588888865421 345677788999999999999999 99999999999999986666 99999976
Q ss_pred hhh
Q 005102 555 ARL 557 (714)
Q Consensus 555 a~~ 557 (714)
++.
T Consensus 177 ~r~ 179 (216)
T PRK09902 177 SRR 179 (216)
T ss_pred cch
Confidence 553
|
|
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.53 E-value=7.5e-09 Score=89.91 Aligned_cols=88 Identities=26% Similarity=0.353 Sum_probs=50.3
Q ss_pred CCCCEEEccCCCCcccCChhhcCC-CCCCEEEcCCCcCcccCCcccCCCCCCCEEeccCccCCCCCCcccccccccceee
Q 005102 88 TDLRHVNLRNNKFFGSLPLELLEA-QGLQSLVLYGNSFSGSVPNEIGKLKYLQILDLSQNFFNGSLPVSIVQCKRLKALD 166 (714)
Q Consensus 88 ~~L~~L~L~~N~l~~~~p~~~~~l-~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~ 166 (714)
.+|+..+|++|.|. .+|..|... +.++.|+|++|.++ .+|.++..++.|+.|+++.|.|. ..|.-+..|.+|..|+
T Consensus 53 ~el~~i~ls~N~fk-~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~lNl~~N~l~-~~p~vi~~L~~l~~Ld 129 (177)
T KOG4579|consen 53 YELTKISLSDNGFK-KFPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRSLNLRFNPLN-AEPRVIAPLIKLDMLD 129 (177)
T ss_pred ceEEEEecccchhh-hCCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhhcccccCccc-cchHHHHHHHhHHHhc
Confidence 34444566666665 344444332 35666666666665 56666666666666666666665 5555555566666666
Q ss_pred cccCcCCCCCCcc
Q 005102 167 LSQNNFTGPLPNG 179 (714)
Q Consensus 167 l~~N~l~g~~p~~ 179 (714)
..+|.+. +||.+
T Consensus 130 s~~na~~-eid~d 141 (177)
T KOG4579|consen 130 SPENARA-EIDVD 141 (177)
T ss_pred CCCCccc-cCcHH
Confidence 6666554 45544
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.53 E-value=3.8e-08 Score=107.60 Aligned_cols=173 Identities=28% Similarity=0.284 Sum_probs=100.0
Q ss_pred CcEEEEEcCCCCccccCCccccCCCCCCEEEccCCCCcccCChhhcCCCCCCEEEcCCCcCcccCCcccCCCCCCCEEec
Q 005102 64 QRVVSVSIPKKKLLGFLPSALGSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSGSVPNEIGKLKYLQILDL 143 (714)
Q Consensus 64 ~~~~~l~l~~~~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L 143 (714)
..+..+++..|+|.+... .+..+++|++|+|++|.|+...+ +..++.|+.|++++|.++ . ...+..+++|+.+++
T Consensus 95 ~~l~~l~l~~n~i~~i~~-~l~~~~~L~~L~ls~N~I~~i~~--l~~l~~L~~L~l~~N~i~-~-~~~~~~l~~L~~l~l 169 (414)
T KOG0531|consen 95 KSLEALDLYDNKIEKIEN-LLSSLVNLQVLDLSFNKITKLEG--LSTLTLLKELNLSGNLIS-D-ISGLESLKSLKLLDL 169 (414)
T ss_pred cceeeeeccccchhhccc-chhhhhcchheeccccccccccc--hhhccchhhheeccCcch-h-ccCCccchhhhcccC
Confidence 456666777777665432 25566777777777777764333 334455777777777775 2 223444677777777
Q ss_pred cCccCCCCCCcc-cccccccceeecccCcCCCCCCcccccCccccccccccCCcccccCCCCCCCCcc--cccccccccc
Q 005102 144 SQNFFNGSLPVS-IVQCKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLNLSFNKFNGSIPSNTGNLSS--LQGTVDFSHN 220 (714)
Q Consensus 144 s~N~l~g~~p~~-~~~l~~L~~L~l~~N~l~g~~p~~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~--L~~~l~l~~N 220 (714)
++|.+.. +... ...+.+|+.+++.+|.+. .+. .+ ..+..+..+++..|+++-.-+ +..+.. |+ .+++++|
T Consensus 170 ~~n~i~~-ie~~~~~~~~~l~~l~l~~n~i~-~i~-~~-~~~~~l~~~~l~~n~i~~~~~--l~~~~~~~L~-~l~l~~n 242 (414)
T KOG0531|consen 170 SYNRIVD-IENDELSELISLEELDLGGNSIR-EIE-GL-DLLKKLVLLSLLDNKISKLEG--LNELVMLHLR-ELYLSGN 242 (414)
T ss_pred Ccchhhh-hhhhhhhhccchHHHhccCCchh-ccc-ch-HHHHHHHHhhcccccceeccC--cccchhHHHH-HHhcccC
Confidence 7777763 3222 355666777777777665 221 11 124455555677777662111 111122 55 6777777
Q ss_pred cCCcCcCccccCCCCcccccCcCCcCCCC
Q 005102 221 LFSGSIPASLGNLPEKVYIDLTYNNLSGP 249 (714)
Q Consensus 221 ~l~g~~p~~~~~l~~L~~l~l~~N~l~~~ 249 (714)
.+. .++..+..+.++..|++.+|+++..
T Consensus 243 ~i~-~~~~~~~~~~~l~~l~~~~n~~~~~ 270 (414)
T KOG0531|consen 243 RIS-RSPEGLENLKNLPVLDLSSNRISNL 270 (414)
T ss_pred ccc-cccccccccccccccchhhcccccc
Confidence 776 3335566677777777777777643
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.42 E-value=1e-07 Score=104.23 Aligned_cols=158 Identities=18% Similarity=0.235 Sum_probs=98.4
Q ss_pred HHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCCCCccCCCCCCCCchhhhcccccceeec
Q 005102 512 KGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQKSVSLEVTT 591 (714)
Q Consensus 512 ~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 591 (714)
.+++.|+.|+|.. .++||++|.|++|.++..+..||+.|+.+.........+ ......+
T Consensus 106 ~~v~dgl~flh~s--Ak~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p-~~~yd~~------------------ 164 (700)
T KOG2137|consen 106 GNVADGLAFLHRS--AKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYP-FSEYDPP------------------ 164 (700)
T ss_pred hcccchhhhhccC--cceeecccchhheeeccCcceeeccchhhhccCCCCccc-cccCCCC------------------
Confidence 3455999999985 689999999999999999999999999876544321111 0000000
Q ss_pred ccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCccccCCCCcchhHHHHHHHHhhcCCcccccCCCCCCC
Q 005102 592 TNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGSSEMDLVNWMQLCIEEKKPLADVLDPYLAPD 671 (714)
Q Consensus 592 ~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~ 671 (714)
...-..-...|.|||++.+...+.++|+||+||++|.+..|..+......... . +.......+ .....
T Consensus 165 lp~~~~~~~~f~apE~~~~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~-~--~~~~~~~~~--------~~~~~- 232 (700)
T KOG2137|consen 165 LPLLLQPHLNFLAPEYLLGTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLL-S--YSFSRNLLN--------AGAFG- 232 (700)
T ss_pred CChhhccCcccccchhhccccccccccceeeeeEEEEEecCCcchhhccCCcc-h--hhhhhcccc--------ccccc-
Confidence 00011113459999999988889999999999999999954444322221111 0 000000000 00000
Q ss_pred CCcHHHHHHHHHHHhHccCCCCCCCCCHHHHH
Q 005102 672 ADKEEEIIAVLKIAMACVHSSPEKRPTMRHIS 703 (714)
Q Consensus 672 ~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl 703 (714)
...+...++.+=+.+.+..++..||++.++.
T Consensus 233 -~s~~~p~el~~~l~k~l~~~~~~rp~~~~l~ 263 (700)
T KOG2137|consen 233 -YSNNLPSELRESLKKLLNGDSAVRPTLDLLL 263 (700)
T ss_pred -ccccCcHHHHHHHHHHhcCCcccCcchhhhh
Confidence 0012233677778889999999999776654
|
|
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.41 E-value=9.2e-09 Score=111.51 Aligned_cols=169 Identities=25% Similarity=0.274 Sum_probs=116.3
Q ss_pred EEcCCCCccccCCccccCCCCCCEEEccCCCCcc---cCC-------------------------hhhcC---CCCCCEE
Q 005102 69 VSIPKKKLLGFLPSALGSLTDLRHVNLRNNKFFG---SLP-------------------------LELLE---AQGLQSL 117 (714)
Q Consensus 69 l~l~~~~l~g~~p~~~~~l~~L~~L~L~~N~l~~---~~p-------------------------~~~~~---l~~L~~L 117 (714)
+..++-.-+| |-.|..+.+|++|.|.+..|.- ..+ ..+.+ .-.|.+.
T Consensus 92 ~~~pa~~pt~--pi~ifpF~sLr~LElrg~~L~~~~GL~~lr~qLe~LIC~~Sl~Al~~v~ascggd~~ns~~Wn~L~~a 169 (1096)
T KOG1859|consen 92 LPSPARDPTE--PISIFPFRSLRVLELRGCDLSTAKGLQELRHQLEKLICHNSLDALRHVFASCGGDISNSPVWNKLATA 169 (1096)
T ss_pred cccCCCCCCC--CceeccccceeeEEecCcchhhhhhhHHHHHhhhhhhhhccHHHHHHHHHHhccccccchhhhhHhhh
Confidence 4444555554 5678889999999999988752 111 00110 1236677
Q ss_pred EcCCCcCcccCCcccCCCCCCCEEeccCccCCCCCCcccccccccceeecccCcCCCCCCcccccCccccccccccCCcc
Q 005102 118 VLYGNSFSGSVPNEIGKLKYLQILDLSQNFFNGSLPVSIVQCKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLNLSFNKF 197 (714)
Q Consensus 118 ~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~l~~L~~L~l~~N~l 197 (714)
+.++|+|. .+...+.-++.|+.|||++|+|+. . +.+..|..|++|||++|.+. .+|.--..++ .|..|+|++|-+
T Consensus 170 ~fsyN~L~-~mD~SLqll~ale~LnLshNk~~~-v-~~Lr~l~~LkhLDlsyN~L~-~vp~l~~~gc-~L~~L~lrnN~l 244 (1096)
T KOG1859|consen 170 SFSYNRLV-LMDESLQLLPALESLNLSHNKFTK-V-DNLRRLPKLKHLDLSYNCLR-HVPQLSMVGC-KLQLLNLRNNAL 244 (1096)
T ss_pred hcchhhHH-hHHHHHHHHHHhhhhccchhhhhh-h-HHHHhcccccccccccchhc-cccccchhhh-hheeeeecccHH
Confidence 77888887 667777778888899999998873 2 37778888889999999887 5664322233 388888888888
Q ss_pred cccCCCCCCCCcccccccccccccCCcCcC-ccccCCCCcccccCcCCcCC
Q 005102 198 NGSIPSNTGNLSSLQGTVDFSHNLFSGSIP-ASLGNLPEKVYIDLTYNNLS 247 (714)
Q Consensus 198 ~g~~p~~~~~l~~L~~~l~l~~N~l~g~~p-~~~~~l~~L~~l~l~~N~l~ 247 (714)
+ .+ ..+.+|++|+ .||++.|.|++--- .-+..|..|+.|.|.+|.+-
T Consensus 245 ~-tL-~gie~LksL~-~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~ 292 (1096)
T KOG1859|consen 245 T-TL-RGIENLKSLY-GLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLC 292 (1096)
T ss_pred H-hh-hhHHhhhhhh-ccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccc
Confidence 7 33 2566788888 88888888775421 22456677888888888875
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.36 E-value=4.9e-06 Score=82.76 Aligned_cols=139 Identities=17% Similarity=0.172 Sum_probs=85.6
Q ss_pred ccccccCceEEEEEEECCCcEEEEEEeCCCCchhHHHHHHHHHHHhccCCCC--ccceEEEEEeCCceeEEEeccCCCC-
Q 005102 409 FVLGKSGIGIVYKVVLEDGHTLAVRRLGEGGSQRFKEFQTEVEAIGKIRHSN--IVTLRAYYWSVDEKLLIYDYIPNGS- 485 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n--iv~l~~~~~~~~~~~lV~e~~~~gs- 485 (714)
..||+|..+.||+. .|..+++|...... ......+|.++++.+..-. +.+.+++....+...+|||+++|.+
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~ 81 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS 81 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence 36899999999984 25567888877543 2245688999999986443 4677888777777889999998863
Q ss_pred Hhhhh---------------------hCCCCCCCcCCCCHHHHH-HHHH----------HHHH-HHHHHhcC-CCCCcee
Q 005102 486 LATAL---------------------HGKPGMVSFTPVPWSVRV-KIIK----------GIAK-GLVYLHEF-SPKKYVH 531 (714)
Q Consensus 486 L~~~l---------------------~~~~~~~~~~~l~~~~~~-~i~~----------~ia~-gL~~LH~~-~~~~ivH 531 (714)
+...+ |.-.. ...+..... ++.. .+.. ...+|... .+..++|
T Consensus 82 ~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~----~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~H 157 (226)
T TIGR02172 82 FSRIISDNPSRLEEIAKIFAEMAKKLHSTKC----DTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLH 157 (226)
T ss_pred hhhhhcCCHHHHHHHHHHHHHHHHHHhCCCC----CCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEe
Confidence 21111 11100 001111100 0000 0001 12222211 1135789
Q ss_pred cCCCCCCeeeCCCCCeEEcccchhhh
Q 005102 532 GDLKPSNILLGHNMEPHVSDFGLARL 557 (714)
Q Consensus 532 rDlkp~NILl~~~~~~kl~DFGla~~ 557 (714)
+|+.|.||++++++ +.|+||+.+..
T Consensus 158 gD~~~~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 158 GDFQIGNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred cCCCCCcEEEcCCC-cEEEechhcCc
Confidence 99999999999888 99999998764
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.35 E-value=6.4e-08 Score=84.21 Aligned_cols=139 Identities=19% Similarity=0.292 Sum_probs=106.4
Q ss_pred CCCEEEccCCCCcccCChhhc---CCCCCCEEEcCCCcCcccCCcccCC-CCCCCEEeccCccCCCCCCcccccccccce
Q 005102 89 DLRHVNLRNNKFFGSLPLELL---EAQGLQSLVLYGNSFSGSVPNEIGK-LKYLQILDLSQNFFNGSLPVSIVQCKRLKA 164 (714)
Q Consensus 89 ~L~~L~L~~N~l~~~~p~~~~---~l~~L~~L~L~~N~l~g~~p~~~~~-l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~ 164 (714)
.+..++|++++|. .++.... ....|+..+|++|.|. .+|+.|.. .+.++.|+|++|.++ .+|.++..++.|+.
T Consensus 28 E~h~ldLssc~lm-~i~davy~l~~~~el~~i~ls~N~fk-~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~ 104 (177)
T KOG4579|consen 28 ELHFLDLSSCQLM-YIADAVYMLSKGYELTKISLSDNGFK-KFPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRS 104 (177)
T ss_pred Hhhhcccccchhh-HHHHHHHHHhCCceEEEEecccchhh-hCCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhh
Confidence 4566788888775 4555544 4456777899999998 66666654 468999999999998 89999999999999
Q ss_pred eecccCcCCCCCCcccccCccccccccccCCcccccCCCCCCCCcccccccccccccCCcCcCccccCCC
Q 005102 165 LDLSQNNFTGPLPNGFGSGLVSLEKLNLSFNKFNGSIPSNTGNLSSLQGTVDFSHNLFSGSIPASLGNLP 234 (714)
Q Consensus 165 L~l~~N~l~g~~p~~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~~l~l~~N~l~g~~p~~~~~l~ 234 (714)
|+++.|.|. ..|.-+.. |.+|-.|+..+|.+. .||-.+. .+++....++.++.+.+.-+.-+..++
T Consensus 105 lNl~~N~l~-~~p~vi~~-L~~l~~Lds~~na~~-eid~dl~-~s~~~al~~lgnepl~~~~~~klqa~k 170 (177)
T KOG4579|consen 105 LNLRFNPLN-AEPRVIAP-LIKLDMLDSPENARA-EIDVDLF-YSSLPALIKLGNEPLGDETKKKLQALK 170 (177)
T ss_pred cccccCccc-cchHHHHH-HHhHHHhcCCCCccc-cCcHHHh-ccccHHHHHhcCCcccccCcccccccC
Confidence 999999998 66766654 889999999999887 7776533 455555778888889887776554443
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.32 E-value=1.1e-07 Score=104.09 Aligned_cols=127 Identities=32% Similarity=0.433 Sum_probs=53.1
Q ss_pred CCCCCEEEccCCCCcccCChhhcCCCCCCEEEcCCCcCcccCCcccCCCCCCCEEeccCccCCCCCCcccccccccceee
Q 005102 87 LTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSGSVPNEIGKLKYLQILDLSQNFFNGSLPVSIVQCKRLKALD 166 (714)
Q Consensus 87 l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~ 166 (714)
+..++.+++..|.+.. +-..+..+++|+.|+|.+|.|. .+...+..+++|++|+|++|+|+... .+..++.|+.|+
T Consensus 71 l~~l~~l~l~~n~i~~-~~~~l~~~~~l~~l~l~~n~i~-~i~~~l~~~~~L~~L~ls~N~I~~i~--~l~~l~~L~~L~ 146 (414)
T KOG0531|consen 71 LTSLKELNLRQNLIAK-ILNHLSKLKSLEALDLYDNKIE-KIENLLSSLVNLQVLDLSFNKITKLE--GLSTLTLLKELN 146 (414)
T ss_pred hHhHHhhccchhhhhh-hhcccccccceeeeeccccchh-hcccchhhhhcchheecccccccccc--chhhccchhhhe
Confidence 3344444444444431 2222344444555555555554 22222444455555555555554221 233334455555
Q ss_pred cccCcCCCCCCcccccCccccccccccCCcccccCCCC-CCCCcccccccccccccC
Q 005102 167 LSQNNFTGPLPNGFGSGLVSLEKLNLSFNKFNGSIPSN-TGNLSSLQGTVDFSHNLF 222 (714)
Q Consensus 167 l~~N~l~g~~p~~~~~~l~~L~~L~l~~N~l~g~~p~~-~~~l~~L~~~l~l~~N~l 222 (714)
+++|.++ .+.. + ..+.+|+.+++++|++. .++.. ...+..+. .+++.+|.+
T Consensus 147 l~~N~i~-~~~~-~-~~l~~L~~l~l~~n~i~-~ie~~~~~~~~~l~-~l~l~~n~i 198 (414)
T KOG0531|consen 147 LSGNLIS-DISG-L-ESLKSLKLLDLSYNRIV-DIENDELSELISLE-ELDLGGNSI 198 (414)
T ss_pred eccCcch-hccC-C-ccchhhhcccCCcchhh-hhhhhhhhhccchH-HHhccCCch
Confidence 5555544 2221 1 11444555555555544 22221 23334444 444444444
|
|
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.29 E-value=1.9e-08 Score=109.16 Aligned_cols=128 Identities=29% Similarity=0.223 Sum_probs=87.0
Q ss_pred cEEEEEcCCCCccccCCccccCCCCCCEEEccCCCCcccCChhhcCCCCCCEEEcCCCcCcccCCcccCCCCCCCEEecc
Q 005102 65 RVVSVSIPKKKLLGFLPSALGSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSGSVPNEIGKLKYLQILDLS 144 (714)
Q Consensus 65 ~~~~l~l~~~~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls 144 (714)
.+..++.+.|.|.- +..++.-++.|+.|||++|++...- .+..++.|+.|||++|+|. .+|..=..--.|+.|.|+
T Consensus 165 ~L~~a~fsyN~L~~-mD~SLqll~ale~LnLshNk~~~v~--~Lr~l~~LkhLDlsyN~L~-~vp~l~~~gc~L~~L~lr 240 (1096)
T KOG1859|consen 165 KLATASFSYNRLVL-MDESLQLLPALESLNLSHNKFTKVD--NLRRLPKLKHLDLSYNCLR-HVPQLSMVGCKLQLLNLR 240 (1096)
T ss_pred hHhhhhcchhhHHh-HHHHHHHHHHhhhhccchhhhhhhH--HHHhcccccccccccchhc-cccccchhhhhheeeeec
Confidence 34445556666653 4556777788888888888887322 6677888888888888887 565431111348888888
Q ss_pred CccCCCCCCcccccccccceeecccCcCCCCCCcccccCccccccccccCCccc
Q 005102 145 QNFFNGSLPVSIVQCKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLNLSFNKFN 198 (714)
Q Consensus 145 ~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~l~~L~~L~l~~N~l~ 198 (714)
+|.++ .+ ..+.+|.+|+.|||++|-|.+.---.+...|..|+.|+|.+|.+-
T Consensus 241 nN~l~-tL-~gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~ 292 (1096)
T KOG1859|consen 241 NNALT-TL-RGIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLC 292 (1096)
T ss_pred ccHHH-hh-hhHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccc
Confidence 88887 33 356788888888888888775322222234678888888888775
|
|
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.19 E-value=1.2e-07 Score=95.23 Aligned_cols=181 Identities=21% Similarity=0.235 Sum_probs=108.7
Q ss_pred cEEEEEcCCCCccccCCcc----ccCCCCCCEEEccCCCCccc----CCh---------hhcCCCCCCEEEcCCCcCccc
Q 005102 65 RVVSVSIPKKKLLGFLPSA----LGSLTDLRHVNLRNNKFFGS----LPL---------ELLEAQGLQSLVLYGNSFSGS 127 (714)
Q Consensus 65 ~~~~l~l~~~~l~g~~p~~----~~~l~~L~~L~L~~N~l~~~----~p~---------~~~~l~~L~~L~L~~N~l~g~ 127 (714)
+++.|+|+.|-+.-.-++. +.+.+.|++|.|.||.+... +.. ....-+.|+++..+.|++...
T Consensus 93 ~L~~ldLSDNA~G~~g~~~l~~ll~s~~~L~eL~L~N~Glg~~ag~~l~~al~~l~~~kk~~~~~~Lrv~i~~rNrlen~ 172 (382)
T KOG1909|consen 93 KLQKLDLSDNAFGPKGIRGLEELLSSCTDLEELYLNNCGLGPEAGGRLGRALFELAVNKKAASKPKLRVFICGRNRLENG 172 (382)
T ss_pred ceeEeeccccccCccchHHHHHHHHhccCHHHHhhhcCCCChhHHHHHHHHHHHHHHHhccCCCcceEEEEeeccccccc
Confidence 7778888888776554433 34567788888888877521 111 122335678888888887532
Q ss_pred C----CcccCCCCCCCEEeccCccCCCC----CCcccccccccceeecccCcCCCC----CCcccccCccccccccccCC
Q 005102 128 V----PNEIGKLKYLQILDLSQNFFNGS----LPVSIVQCKRLKALDLSQNNFTGP----LPNGFGSGLVSLEKLNLSFN 195 (714)
Q Consensus 128 ~----p~~~~~l~~L~~L~Ls~N~l~g~----~p~~~~~l~~L~~L~l~~N~l~g~----~p~~~~~~l~~L~~L~l~~N 195 (714)
- ...|...+.|+.+.++.|.+... +-..+..|++|+.|||.+|-|+-. +...+ ..+++|+.|+++++
T Consensus 173 ga~~~A~~~~~~~~leevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~~LakaL-~s~~~L~El~l~dc 251 (382)
T KOG1909|consen 173 GATALAEAFQSHPTLEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSVALAKAL-SSWPHLRELNLGDC 251 (382)
T ss_pred cHHHHHHHHHhccccceEEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHHHHHHHh-cccchheeeccccc
Confidence 1 12355567788888888877521 122456678888888888877632 11222 23667778888877
Q ss_pred cccccCCC----CC-CCCcccccccccccccCCc----CcCccccCCCCcccccCcCCcCC
Q 005102 196 KFNGSIPS----NT-GNLSSLQGTVDFSHNLFSG----SIPASLGNLPEKVYIDLTYNNLS 247 (714)
Q Consensus 196 ~l~g~~p~----~~-~~l~~L~~~l~l~~N~l~g----~~p~~~~~l~~L~~l~l~~N~l~ 247 (714)
.+...=.. .+ ...++|+ .+.+.+|.++. .+-..+...|.|..|+|++|.|.
T Consensus 252 ll~~~Ga~a~~~al~~~~p~L~-vl~l~gNeIt~da~~~la~~~~ek~dL~kLnLngN~l~ 311 (382)
T KOG1909|consen 252 LLENEGAIAFVDALKESAPSLE-VLELAGNEITRDAALALAACMAEKPDLEKLNLNGNRLG 311 (382)
T ss_pred ccccccHHHHHHHHhccCCCCc-eeccCcchhHHHHHHHHHHHHhcchhhHHhcCCccccc
Confidence 77522111 11 1134566 77777777762 23334556777777777777773
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.18 E-value=8.9e-06 Score=89.19 Aligned_cols=148 Identities=16% Similarity=0.286 Sum_probs=94.3
Q ss_pred HHHHHHhc-cccccccCceEEEEEEECCCcEEEEEEeCCCCch-------------------------------------
Q 005102 400 LDELLKAS-AFVLGKSGIGIVYKVVLEDGHTLAVRRLGEGGSQ------------------------------------- 441 (714)
Q Consensus 400 ~~~l~~~~-~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~------------------------------------- 441 (714)
++++.... .+.||.-+.|.||+|++++|+.||||+-+.+-..
T Consensus 157 ie~if~~f~~~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~ 236 (538)
T KOG1235|consen 157 IEDIFSEFDEEPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLP 236 (538)
T ss_pred HHHHHHhcCcchhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhH
Confidence 34444433 2679999999999999999999999986553111
Q ss_pred hHHHHHHHHHHHhcc----CCCC---ccceEEEEEe-CCceeEEEeccCCCCHhhhhhCCCCCCCcCCCCHHHHHHHHHH
Q 005102 442 RFKEFQTEVEAIGKI----RHSN---IVTLRAYYWS-VDEKLLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKG 513 (714)
Q Consensus 442 ~~~~~~~E~~~l~~l----~H~n---iv~l~~~~~~-~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ 513 (714)
..-+|.+|.+-..++ .|-+ =|.+=.++++ .....|+||||+|.-+.+.-.-.. ..++...+. ..
T Consensus 237 ~ELDF~~EA~Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i~~-----~gi~~~~i~---~~ 308 (538)
T KOG1235|consen 237 QELDFTKEAKNAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAIDK-----RGISPHDIL---NK 308 (538)
T ss_pred hhcchHHHHHhHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHHHH-----cCCCHHHHH---HH
Confidence 001355666655554 3444 1222233333 346799999999987766532221 234444333 33
Q ss_pred HHHHHHH--HhcCCCCCceecCCCCCCeeeCC----CCCeEEcccchhhhhh
Q 005102 514 IAKGLVY--LHEFSPKKYVHGDLKPSNILLGH----NMEPHVSDFGLARLAN 559 (714)
Q Consensus 514 ia~gL~~--LH~~~~~~ivHrDlkp~NILl~~----~~~~kl~DFGla~~~~ 559 (714)
+.++... ++ .|++|+|=.|.||+++. ++++.+-|||+...+.
T Consensus 309 l~~~~~~qIf~----~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is 356 (538)
T KOG1235|consen 309 LVEAYLEQIFK----TGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS 356 (538)
T ss_pred HHHHHHHHHHh----cCCccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence 3332221 22 48999999999999984 6789999999987654
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 714 | ||||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 3e-39 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 3e-39 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 5e-28 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 7e-28 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 7e-28 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 1e-26 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 2e-26 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 1e-25 | ||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 3e-18 | ||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 3e-18 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 1e-16 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 2e-16 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 4e-15 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 5e-15 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 1e-14 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 2e-14 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 2e-14 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 3e-14 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 3e-14 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 4e-14 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 7e-14 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 8e-14 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 8e-14 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 8e-14 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 8e-14 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 8e-14 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 9e-14 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 9e-14 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 9e-14 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 9e-14 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 1e-13 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 1e-13 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 1e-13 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 1e-13 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 1e-13 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 1e-13 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 1e-13 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 2e-13 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 3e-13 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-13 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 4e-13 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 4e-13 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 4e-13 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 4e-13 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 5e-13 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 5e-13 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 5e-13 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 5e-13 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 7e-13 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 7e-13 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 7e-13 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 8e-13 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 8e-13 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 8e-13 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 8e-13 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 8e-13 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 8e-13 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 8e-13 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 9e-13 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 9e-13 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 9e-13 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 9e-13 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 9e-13 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 9e-13 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 1e-12 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 1e-12 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 1e-12 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-12 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 1e-12 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 1e-12 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 1e-12 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 2e-12 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 2e-12 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 2e-12 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-12 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 2e-12 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-12 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 3e-12 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 3e-12 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 5e-12 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 6e-12 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 8e-12 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 9e-12 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 1e-11 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 1e-11 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 1e-11 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 1e-11 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 1e-11 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 2e-11 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 2e-11 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 2e-11 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 2e-11 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 2e-11 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 2e-11 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 3e-11 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 3e-11 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 3e-11 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 5e-11 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 6e-11 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 8e-11 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 9e-11 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 1e-10 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 1e-10 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 1e-10 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 1e-10 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 1e-10 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 1e-10 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 1e-10 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 1e-10 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 1e-10 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-10 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 2e-10 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-10 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 2e-10 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 2e-10 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 2e-10 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 2e-10 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 2e-10 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 2e-10 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 2e-10 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 2e-10 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 2e-10 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 3e-10 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 3e-10 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 7e-10 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 1e-09 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 1e-09 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 1e-09 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 1e-09 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 1e-09 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 2e-09 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 2e-09 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 2e-09 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 2e-09 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 2e-09 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 2e-09 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 2e-09 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 2e-09 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-09 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 2e-09 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 3e-09 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 4e-09 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 4e-09 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 5e-09 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 5e-09 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-09 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 5e-09 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 6e-09 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 6e-09 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-09 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 6e-09 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 6e-09 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 6e-09 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 6e-09 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 7e-09 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 8e-09 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 8e-09 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 9e-09 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 9e-09 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 1e-08 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 1e-08 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-08 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 1e-08 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-08 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 1e-08 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 1e-08 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 2e-08 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-08 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-08 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 2e-08 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 2e-08 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 2e-08 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 2e-08 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 2e-08 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 3e-08 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-08 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-08 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-08 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-08 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 4e-08 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 4e-08 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 4e-08 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 4e-08 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 5e-08 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 5e-08 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 5e-08 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 5e-08 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 5e-08 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 5e-08 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 5e-08 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-08 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 5e-08 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-08 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 6e-08 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 6e-08 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-08 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 6e-08 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 7e-08 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 7e-08 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 7e-08 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 7e-08 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 7e-08 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 7e-08 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 7e-08 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 7e-08 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 8e-08 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 8e-08 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 8e-08 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 8e-08 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 9e-08 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-07 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 1e-07 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 1e-07 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-07 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 1e-07 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-07 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 1e-07 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 1e-07 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-07 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 1e-07 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 1e-07 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 1e-07 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 1e-07 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 1e-07 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 2e-07 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 2e-07 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 2e-07 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 2e-07 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-07 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 2e-07 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 2e-07 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 2e-07 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 2e-07 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 2e-07 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 2e-07 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 3e-07 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 3e-07 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 3e-07 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 3e-07 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 3e-07 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 3e-07 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 3e-07 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 3e-07 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 3e-07 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 3e-07 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 3e-07 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 3e-07 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 3e-07 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 3e-07 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 3e-07 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 3e-07 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 3e-07 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 4e-07 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 4e-07 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 4e-07 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 4e-07 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 4e-07 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 4e-07 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 4e-07 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 4e-07 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 4e-07 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 4e-07 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 4e-07 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 4e-07 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 4e-07 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 5e-07 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 5e-07 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 5e-07 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 5e-07 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 5e-07 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 5e-07 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 5e-07 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 5e-07 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 5e-07 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 5e-07 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 5e-07 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 5e-07 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 5e-07 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 6e-07 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 6e-07 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 6e-07 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 6e-07 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 6e-07 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 6e-07 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 6e-07 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 6e-07 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 6e-07 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 6e-07 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 6e-07 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 6e-07 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 6e-07 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 6e-07 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 7e-07 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 7e-07 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 7e-07 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 7e-07 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 7e-07 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 7e-07 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 7e-07 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 7e-07 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 7e-07 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 7e-07 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 8e-07 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 8e-07 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 9e-07 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 9e-07 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 9e-07 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 9e-07 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 9e-07 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 9e-07 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 1e-06 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 1e-06 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 1e-06 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 1e-06 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 1e-06 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 1e-06 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-06 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 1e-06 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-06 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 1e-06 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 1e-06 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 1e-06 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-06 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-06 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-06 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 2e-06 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-06 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 2e-06 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 2e-06 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 2e-06 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 2e-06 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 2e-06 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 2e-06 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 2e-06 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 2e-06 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 2e-06 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 2e-06 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 2e-06 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 2e-06 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 2e-06 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 2e-06 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 2e-06 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 2e-06 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 2e-06 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 3e-06 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 3e-06 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 3e-06 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 3e-06 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 3e-06 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 3e-06 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 3e-06 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 3e-06 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-06 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 4e-06 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 4e-06 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 4e-06 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 4e-06 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 4e-06 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 4e-06 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 4e-06 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 4e-06 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 4e-06 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 4e-06 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 4e-06 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 4e-06 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 5e-06 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 5e-06 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 5e-06 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 5e-06 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 5e-06 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 5e-06 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 5e-06 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 5e-06 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 5e-06 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 5e-06 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 5e-06 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 5e-06 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 5e-06 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 5e-06 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 6e-06 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 6e-06 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 6e-06 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 6e-06 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 7e-06 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 7e-06 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 7e-06 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 7e-06 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 7e-06 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 7e-06 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 7e-06 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 8e-06 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 8e-06 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 8e-06 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 8e-06 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 8e-06 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 8e-06 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 8e-06 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 8e-06 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 8e-06 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 8e-06 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 8e-06 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 8e-06 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 9e-06 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 9e-06 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 9e-06 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 9e-06 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 9e-06 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 9e-06 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 9e-06 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 9e-06 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 9e-06 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 9e-06 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 9e-06 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 9e-06 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 9e-06 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 9e-06 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 9e-06 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 9e-06 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 9e-06 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 9e-06 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 9e-06 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 1e-05 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 1e-05 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 1e-05 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 1e-05 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 1e-05 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 1e-05 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-05 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 1e-05 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-05 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 1e-05 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 1e-05 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 1e-05 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 1e-05 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 1e-05 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 1e-05 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 1e-05 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 1e-05 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 1e-05 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 1e-05 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 1e-05 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 1e-05 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 1e-05 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 1e-05 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-05 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-05 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 1e-05 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-05 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 1e-05 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 1e-05 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 1e-05 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 1e-05 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 1e-05 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-05 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 1e-05 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 1e-05 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 1e-05 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 1e-05 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 1e-05 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 1e-05 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 1e-05 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 1e-05 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 1e-05 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 1e-05 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 1e-05 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 1e-05 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 1e-05 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 1e-05 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 1e-05 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 1e-05 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 1e-05 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 1e-05 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 1e-05 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 1e-05 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 2e-05 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 2e-05 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 2e-05 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 2e-05 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 2e-05 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 2e-05 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 2e-05 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 2e-05 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 2e-05 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 2e-05 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 2e-05 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-05 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 2e-05 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 2e-05 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 2e-05 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 2e-05 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 2e-05 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 2e-05 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 2e-05 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 2e-05 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 2e-05 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 2e-05 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 2e-05 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 2e-05 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 2e-05 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-05 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 2e-05 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 2e-05 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 2e-05 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 2e-05 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 2e-05 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 2e-05 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-05 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 2e-05 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 2e-05 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 2e-05 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-05 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 2e-05 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-05 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 2e-05 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-05 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-05 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 3e-05 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 3e-05 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 3e-05 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 3e-05 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 3e-05 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 3e-05 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 3e-05 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 3e-05 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 3e-05 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 3e-05 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 3e-05 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 4e-05 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-05 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-05 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 4e-05 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 4e-05 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 4e-05 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 4e-05 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 4e-05 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 4e-05 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 4e-05 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-05 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-05 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 4e-05 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 4e-05 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 4e-05 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 4e-05 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 5e-05 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 5e-05 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 5e-05 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-05 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 6e-05 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 6e-05 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 6e-05 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-05 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 6e-05 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 6e-05 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 6e-05 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 6e-05 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 6e-05 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 6e-05 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 6e-05 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-05 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 7e-05 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-05 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 7e-05 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 7e-05 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 7e-05 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 7e-05 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 8e-05 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 8e-05 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 8e-05 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 8e-05 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 8e-05 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-05 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 8e-05 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 8e-05 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-05 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-05 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 8e-05 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 9e-05 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 9e-05 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 9e-05 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 1e-04 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 1e-04 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-04 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 1e-04 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 1e-04 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 1e-04 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 1e-04 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 1e-04 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 1e-04 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 1e-04 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 1e-04 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 1e-04 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 1e-04 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 1e-04 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 1e-04 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 2e-04 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 2e-04 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 2e-04 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-04 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 2e-04 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 2e-04 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 2e-04 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-04 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 2e-04 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 2e-04 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 2e-04 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 2e-04 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 2e-04 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 2e-04 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 2e-04 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 2e-04 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 2e-04 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 2e-04 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-04 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 2e-04 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 3e-04 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 3e-04 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 3e-04 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 3e-04 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 3e-04 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 3e-04 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 3e-04 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 3e-04 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 3e-04 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 3e-04 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 3e-04 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 4e-04 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 4e-04 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 4e-04 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 4e-04 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 4e-04 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 4e-04 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 4e-04 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 4e-04 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 4e-04 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 4e-04 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 4e-04 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 4e-04 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 4e-04 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 4e-04 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 4e-04 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 4e-04 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 4e-04 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 5e-04 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 5e-04 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 5e-04 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 5e-04 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 5e-04 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 5e-04 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 5e-04 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 6e-04 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 6e-04 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 6e-04 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 6e-04 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 6e-04 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 6e-04 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 6e-04 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 6e-04 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 6e-04 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 7e-04 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 7e-04 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 7e-04 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 7e-04 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 7e-04 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 7e-04 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-04 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 8e-04 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 8e-04 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 8e-04 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 8e-04 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 8e-04 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 8e-04 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-04 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-04 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 9e-04 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 9e-04 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 9e-04 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 9e-04 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 9e-04 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 9e-04 |
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 272 bits (698), Expect = 9e-86
Identities = 112/319 (35%), Positives = 170/319 (53%), Gaps = 40/319 (12%)
Query: 398 FDLDELLKA-----SAFVLGKSGIGIVYKVVLEDGHTLAVRRLGEGGSQRFK-EFQTEVE 451
F L EL A + +LG+ G G VYK L DG +AV+RL E +Q + +FQTEVE
Sbjct: 20 FSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVE 79
Query: 452 AIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKII 511
I H N++ LR + + E+LL+Y Y+ NGS+A+ L +P S P+ W R +I
Sbjct: 80 MISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPE--SQPPLDWPKRQRIA 137
Query: 512 KGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNR 571
G A+GL YLH+ K +H D+K +NILL E V DFGLA+L
Sbjct: 138 LGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM------------- 184
Query: 572 MPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMIT 631
+ + V+ V T +G + APE L K S+K D++ YGV+LLE+IT
Sbjct: 185 -------DYKDTHVTTAVRGT-----IG--HIAPEYLSTGKSSEKTDVFGYGVMLLELIT 230
Query: 632 GRTAV---VQVGSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMAC 688
G+ A ++ L++W++ ++EKK L ++D L + +EE+ ++++A+ C
Sbjct: 231 GQRAFDLARLANDDDVMLLDWVKGLLKEKK-LEALVDVDLQGNYK-DEEVEQLIQVALLC 288
Query: 689 VHSSPEKRPTMRHISDALD 707
SSP +RP M + L+
Sbjct: 289 TQSSPMERPKMSEVVRMLE 307
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 254 bits (652), Expect = 3e-79
Identities = 94/316 (29%), Positives = 147/316 (46%), Gaps = 41/316 (12%)
Query: 398 FDLDELLKA-----SAFVLGKSGIGIVYKVVLEDGHTLAVRRLGEGGSQRFKEFQTEVEA 452
L +L +A F++G G VYK VL DG +A++R SQ +EF+TE+E
Sbjct: 29 VPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIET 88
Query: 453 IGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIK 512
+ RH ++V+L + +E +LIY Y+ NG+L L+G + W R++I
Sbjct: 89 LSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDL--PTMSMSWEQRLEICI 146
Query: 513 GIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRM 572
G A+GL YLH + +H D+K NILL N P ++DFG+++ +
Sbjct: 147 GAARGLHYLHT---RAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQT-------- 195
Query: 573 PAEKPQERQQKSVSLEVTTTNSSSNLGSY-YQAPESLKVVKPSQKWDIYSYGVILLEMIT 631
+S V G+ Y PE + ++K D+YS+GV+L E++
Sbjct: 196 -----------HLSTVV--------KGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLC 236
Query: 632 GRTAVVQVGSSEMD-LVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVH 690
R+A+VQ EM L W + L ++DP LA E + A+ C+
Sbjct: 237 ARSAIVQSLPREMVNLAEWAVESHNNGQ-LEQIVDPNLADKIRP-ESLRKFGDTAVKCLA 294
Query: 691 SSPEKRPTMRHISDAL 706
S E RP+M + L
Sbjct: 295 LSSEDRPSMGDVLWKL 310
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 254 bits (651), Expect = 4e-79
Identities = 100/346 (28%), Positives = 162/346 (46%), Gaps = 57/346 (16%)
Query: 385 EQYDLVPLDTQV-AFDLDELLKA-----------SAFVLGKSGIGIVYKVVLEDGHTLAV 432
E L DT+ +F EL +G+ G G+VYK + + T+AV
Sbjct: 1 ENKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAV 59
Query: 433 RRLGEG----GSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGSLAT 488
++L + ++F E++ + K +H N+V L + D+ L+Y Y+PNGSL
Sbjct: 60 KKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLD 119
Query: 489 ALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPH 548
L G P+ W +R KI +G A G+ +LHE ++H D+K +NILL
Sbjct: 120 RLSCLDGT---PPLSWHMRCKIAQGAANGINFLHE---NHHIHRDIKSANILLDEAFTAK 173
Query: 549 VSDFGLARLANIAGGSPTLQSNR-MPAEKPQERQQKSVSLEVTTTNSSSNLGSY-YQAPE 606
+SDFGLAR + + T+ ++R + G+ Y APE
Sbjct: 174 ISDFGLARAS--EKFAQTVMTSRIV--------------------------GTTAYMAPE 205
Query: 607 SLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGSSEMDLVNWMQLCIEEKKPLADVLDP 666
+L+ + + K DIYS+GV+LLE+ITG A V L++ + +E+K + D +D
Sbjct: 206 ALR-GEITPKSDIYSFGVVLLEIITGLPA-VDEHREPQLLLDIKEEIEDEEKTIEDYIDK 263
Query: 667 YLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDALDRLIVS 712
+ DAD + A+ +A C+H KRP ++ + L + S
Sbjct: 264 KMN-DAD-STSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTAS 307
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 236 bits (604), Expect = 3e-72
Identities = 72/314 (22%), Positives = 121/314 (38%), Gaps = 64/314 (20%)
Query: 24 EGYALLSFKQSVHEDPEGSLSNWN-SSDENPCSWNGITC----KEQRVVSV--------- 69
+ ALL K+ + +LS+W ++D +W G+ C + RV ++
Sbjct: 7 DKQALLQIKKDLGNPT--TLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPK 64
Query: 70 ---------------------------SIPKK---------------KLLGFLPSALGSL 87
IP + G +P L +
Sbjct: 65 PYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQI 124
Query: 88 TDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSGSVPNEIGKLKYL-QILDLSQN 146
L ++ N G+LP + L + GN SG++P+ G L + +S+N
Sbjct: 125 KTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRN 184
Query: 147 FFNGSLPVSIVQCKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLNLSFNKFNGSIPSNTG 206
G +P + L +DLS+N G FGS + +K++L+ N + G
Sbjct: 185 RLTGKIPPTFANLN-LAFVDLSRNMLEGDASVLFGS-DKNTQKIHLAKNSLAFDLGK-VG 241
Query: 207 NLSSLQGTVDFSHNLFSGSIPASLGNLPEKVYIDLTYNNLSGPIPQNGALMNRGPTAFIG 266
+L +D +N G++P L L +++++NNL G IPQ G L +A+
Sbjct: 242 LSKNLN-GLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYAN 300
Query: 267 NPRLCGPPLKNPCS 280
N LCG PL C+
Sbjct: 301 NKCLCGSPLP-ACT 313
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 214 bits (547), Expect = 7e-60
Identities = 65/236 (27%), Positives = 97/236 (41%), Gaps = 24/236 (10%)
Query: 75 KLLGFLPSALGSLTDLRHVNLRNNKFFGSLPLELLEAQGLQS------------------ 116
G +P+ LG L ++L N F G++P + + G +
Sbjct: 525 SFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMK 584
Query: 117 ----LVLYGNSFSGSVPNEIGKLKYLQILDLSQNFFNGSLPVSIVQCKRLKALDLSQNNF 172
F G ++ +L +++ + G + + LD+S N
Sbjct: 585 KECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNML 644
Query: 173 TGPLPNGFGSGLVSLEKLNLSFNKFNGSIPSNTGNLSSLQGTVDFSHNLFSGSIPASLGN 232
+G +P GS + L LNL N +GSIP G+L L +D S N G IP ++
Sbjct: 645 SGYIPKEIGS-MPYLFILNLGHNDISGSIPDEVGDLRGLN-ILDLSSNKLDGRIPQAMSA 702
Query: 233 LPEKVYIDLTYNNLSGPIPQNGALMNRGPTAFIGNPRLCGPPLKNPCSSDVPGASS 288
L IDL+ NNLSGPIP+ G P F+ NP LCG PL S+ G +
Sbjct: 703 LTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCGYPLPRCDPSNADGYAH 758
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 197 bits (503), Expect = 7e-54
Identities = 69/237 (29%), Positives = 108/237 (45%), Gaps = 33/237 (13%)
Query: 20 SLNGEGYALLSFKQSVHEDPEGSLSNWNSSDENPCSWNGITCKEQRVVSVSIPKKKLLGF 79
SL E + L+SFK + + L +W+S+ +NPC+++G+TC++ +V S+
Sbjct: 9 SLYREIHQLISFKDVL--PDKNLLPDWSSN-KNPCTFDGVTCRDDKVTSI---------- 55
Query: 80 LPSALGSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSGSVPNEIGKLKYLQ 139
DL L N F ++ LL GL+SL L + +GSV L
Sbjct: 56 ---------DLSSKPL--NVGFSAVSSSLLSLTGLESLFLSNSHINGSVS-GFKCSASLT 103
Query: 140 ILDLSQNFFNGSLP--VSIVQCKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLNLSFNKF 197
LDLS+N +G + S+ C LK L++S N P G L SLE L+LS N
Sbjct: 104 SLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSI 163
Query: 198 NGSIPSN---TGNLSSLQGTVDFSHNLFSGSIPASLGNLPEKVYIDLTYNNLSGPIP 251
+G+ + L+ + S N SG + + ++D++ NN S IP
Sbjct: 164 SGANVVGWVLSDGCGELK-HLAISGNKISGDVD--VSRCVNLEFLDVSSNNFSTGIP 217
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 192 bits (490), Expect = 4e-52
Identities = 61/179 (34%), Positives = 92/179 (51%), Gaps = 4/179 (2%)
Query: 75 KLLGFLPSALG--SLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSGSVPNEI 132
G + L L+ + L+NN F G +P L L SL L N SG++P+ +
Sbjct: 379 NFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSL 438
Query: 133 GKLKYLQILDLSQNFFNGSLPVSIVQCKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLNL 192
G L L+ L L N G +P ++ K L+ L L N+ TG +P+G + +L ++L
Sbjct: 439 GSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSN-CTNLNWISL 497
Query: 193 SFNKFNGSIPSNTGNLSSLQGTVDFSHNLFSGSIPASLGNLPEKVYIDLTYNNLSGPIP 251
S N+ G IP G L +L + S+N FSG+IPA LG+ +++DL N +G IP
Sbjct: 498 SNNRLTGEIPKWIGRLENLA-ILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIP 555
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 186 bits (475), Expect = 4e-50
Identities = 68/180 (37%), Positives = 100/180 (55%), Gaps = 5/180 (2%)
Query: 75 KLLGFLPSALGSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSGSVPNEI-G 133
KL G A+ + T+L+ +N+ +N+F G +P L + LQ L L N F+G +P+ + G
Sbjct: 234 KLSGDFSRAISTCTELKLLNISSNQFVGPIPPLPL--KSLQYLSLAENKFTGEIPDFLSG 291
Query: 134 KLKYLQILDLSQNFFNGSLPVSIVQCKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLNLS 193
L LDLS N F G++P C L++L LS NNF+G LP + L+ L+LS
Sbjct: 292 ACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLS 351
Query: 194 FNKFNGSIPSNTGNLSSLQGTVDFSHNLFSGSIPASLGNLPEK--VYIDLTYNNLSGPIP 251
FN+F+G +P + NLS+ T+D S N FSG I +L P+ + L N +G IP
Sbjct: 352 FNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIP 411
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 186 bits (475), Expect = 4e-50
Identities = 55/177 (31%), Positives = 87/177 (49%), Gaps = 6/177 (3%)
Query: 75 KLLGFLPSALGSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSGSVPNEIGK 134
G +P L + ++L ++L N G++P L L+ L L+ N G +P E+
Sbjct: 405 GFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMY 464
Query: 135 LKYLQILDLSQNFFNGSLPVSIVQCKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLNLSF 194
+K L+ L L N G +P + C L + LS N TG +P G L +L L LS
Sbjct: 465 VKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGR-LENLAILKLSN 523
Query: 195 NKFNGSIPSNTGNLSSLQGTVDFSHNLFSGSIPASLGNLPEKVYIDLTYNNLSGPIP 251
N F+G+IP+ G+ SL +D + NLF+G+IPA++ + N ++G
Sbjct: 524 NSFSGNIPAELGDCRSLI-WLDLNTNLFNGTIPAAMFKQSG----KIAANFIAGKRY 575
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 184 bits (470), Expect = 2e-49
Identities = 70/183 (38%), Positives = 100/183 (54%), Gaps = 5/183 (2%)
Query: 75 KLLGFLPSAL-GSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSGSVPNE-I 132
K G +P L G+ L ++L N F+G++P L+SL L N+FSG +P + +
Sbjct: 280 KFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTL 339
Query: 133 GKLKYLQILDLSQNFFNGSLPVSIVQCK-RLKALDLSQNNFTGPLPNGFGSG-LVSLEKL 190
K++ L++LDLS N F+G LP S+ L LDLS NNF+GP+ +L++L
Sbjct: 340 LKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQEL 399
Query: 191 NLSFNKFNGSIPSNTGNLSSLQGTVDFSHNLFSGSIPASLGNLPEKVYIDLTYNNLSGPI 250
L N F G IP N S L ++ S N SG+IP+SLG+L + + L N L G I
Sbjct: 400 YLQNNGFTGKIPPTLSNCSELV-SLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEI 458
Query: 251 PQN 253
PQ
Sbjct: 459 PQE 461
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 183 bits (467), Expect = 5e-49
Identities = 70/183 (38%), Positives = 101/183 (55%), Gaps = 7/183 (3%)
Query: 75 KLLGFLPSALGSLTDLRHVNLRNNKFFGSLPLELLEA-QGLQSLVLYGNSFSGSVPNEIG 133
+ +G +P L L++++L NKF G +P L A L L L GN F G+VP G
Sbjct: 258 QFVGPIPPL--PLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFG 315
Query: 134 KLKYLQILDLSQNFFNGSLPV-SIVQCKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLNL 192
L+ L LS N F+G LP+ ++++ + LK LDLS N F+G LP + SL L+L
Sbjct: 316 SCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDL 375
Query: 193 SFNKFNGSIPSNTGN--LSSLQGTVDFSHNLFSGSIPASLGNLPEKVYIDLTYNNLSGPI 250
S N F+G I N ++LQ + +N F+G IP +L N E V + L++N LSG I
Sbjct: 376 SSNNFSGPILPNLCQNPKNTLQ-ELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTI 434
Query: 251 PQN 253
P +
Sbjct: 435 PSS 437
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 182 bits (465), Expect = 8e-49
Identities = 57/183 (31%), Positives = 88/183 (48%), Gaps = 11/183 (6%)
Query: 75 KLLGFLPSAL---GSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSGSVPNE 131
+ G +L+H+ + NK G + + L+ L + N+FS +P
Sbjct: 162 SISGANVVGWVLSDGCGELKHLAISGNKISGDVDVSRC--VNLEFLDVSSNNFSTGIP-F 218
Query: 132 IGKLKYLQILDLSQNFFNGSLPVSIVQCKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLN 191
+G LQ LD+S N +G +I C LK L++S N F GP+P L SL+ L+
Sbjct: 219 LGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPP---LPLKSLQYLS 275
Query: 192 LSFNKFNGSIPSN-TGNLSSLQGTVDFSHNLFSGSIPASLGNLPEKVYIDLTYNNLSGPI 250
L+ NKF G IP +G +L +D S N F G++P G+ + L+ NN SG +
Sbjct: 276 LAENKFTGEIPDFLSGACDTLT-GLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGEL 334
Query: 251 PQN 253
P +
Sbjct: 335 PMD 337
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 182 bits (463), Expect = 1e-48
Identities = 60/182 (32%), Positives = 87/182 (47%), Gaps = 6/182 (3%)
Query: 75 KLLGFLP-SALGSLTDLRHVNLRNNKFFGSLPLELLEAQG-LQSLVLYGNSFSGSVPNEI 132
G LP L + L+ ++L N+F G LP L L +L L N+FSG + +
Sbjct: 329 NFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNL 388
Query: 133 GK--LKYLQILDLSQNFFNGSLPVSIVQCKRLKALDLSQNNFTGPLPNGFGSGLVSLEKL 190
+ LQ L L N F G +P ++ C L +L LS N +G +P+ GS L L L
Sbjct: 389 CQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGS-LSKLRDL 447
Query: 191 NLSFNKFNGSIPSNTGNLSSLQGTVDFSHNLFSGSIPASLGNLPEKVYIDLTYNNLSGPI 250
L N G IP + +L+ T+ N +G IP+ L N +I L+ N L+G I
Sbjct: 448 KLWLNMLEGEIPQELMYVKTLE-TLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEI 506
Query: 251 PQ 252
P+
Sbjct: 507 PK 508
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 177 bits (451), Expect = 5e-47
Identities = 51/199 (25%), Positives = 84/199 (42%), Gaps = 22/199 (11%)
Query: 75 KLLGFLPSALGSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSGSVPNEIGK 134
L G +P L + L + L N G +P L L + L N +G +P IG+
Sbjct: 453 MLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGR 512
Query: 135 LKYLQILDLSQNFFNGSLPVSIVQCKRLKALDLSQNNFTGPLPNGFG------------- 181
L+ L IL LS N F+G++P + C+ L LDL+ N F G +P
Sbjct: 513 LENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAG 572
Query: 182 ------SGLVSLEKLNLSFN--KFNGSIPSNTGNLSSLQGTVDFSHNLFSGSIPASLGNL 233
++ + + N +F G LS+ + + ++ G + N
Sbjct: 573 KRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRN-PCNITSRVYGGHTSPTFDNN 631
Query: 234 PEKVYIDLTYNNLSGPIPQ 252
+++D++YN LSG IP+
Sbjct: 632 GSMMFLDMSYNMLSGYIPK 650
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 64.5 bits (158), Expect = 8e-11
Identities = 16/75 (21%), Positives = 38/75 (50%), Gaps = 2/75 (2%)
Query: 184 LVSLEKLNLSFNKFNGSIPSNTGNLSSLQGTVDFSHNLFSGSIPASLGNLPEKVYIDLTY 243
+ S++ + N ++ S+ +L+ L+ ++ S++ +GS+ +DL+
Sbjct: 52 VTSIDLSSKPLNVGFSAVSSSLLSLTGLE-SLFLSNSHINGSVS-GFKCSASLTSLDLSR 109
Query: 244 NNLSGPIPQNGALMN 258
N+LSGP+ +L +
Sbjct: 110 NSLSGPVTTLTSLGS 124
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 42.6 bits (101), Expect = 5e-04
Identities = 7/55 (12%), Positives = 24/55 (43%), Gaps = 1/55 (1%)
Query: 204 NTGNLSSLQGTVDFSHNLFSGSIPASLGNLPEKVYIDLTYNNLSGPIPQNGALMN 258
++S+ + N+ ++ +SL +L + L+ ++++G + +
Sbjct: 48 RDDKVTSIDLS-SKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVSGFKCSAS 101
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 190 bits (485), Expect = 4e-55
Identities = 65/345 (18%), Positives = 120/345 (34%), Gaps = 65/345 (18%)
Query: 398 FDLDELLKAS-----AFVLGKSGIGIVYKVVLEDGHTLAVRRLGEGGSQRFKEFQTEVEA 452
+ L S V + G V+K L +AV+ Q + + + EV +
Sbjct: 14 LGTENLYFQSMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIFPIQDKQSW-QNEYEVYS 71
Query: 453 IGKIRHSNIVTLRAY----YWSVDEKLLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRV 508
+ ++H NI+ + LI + GSL+ L V W+
Sbjct: 72 LPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANV-------VSWNELC 124
Query: 509 KIIKGIAKGLVYLHEFSPK-------KYVHGDLKPSNILLGHNMEPHVSDFGLARLANIA 561
I + +A+GL YLHE P H D+K N+LL +N+ ++DFGLA
Sbjct: 125 HIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAG 184
Query: 562 GGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSY-YQAPESL-----KVVKPSQ 615
+ ++ +G+ Y APE L
Sbjct: 185 K---------------------------SAGDTHGQVGTRRYMAPEVLEGAINFQRDAFL 217
Query: 616 KWDIYSYGVILLEMITGRTAVVQVGSSEM----DLVNWMQLCIEEKKPLADV--LDPYLA 669
+ D+Y+ G++L E+ + TA M + + +E+ + + P L
Sbjct: 218 RIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEI-GQHPSLEDMQEVVVHKKKRPVLR 276
Query: 670 PDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDALDRLIVSSD 714
K + + + C E R + + + + ++ ++
Sbjct: 277 DYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRLTN 321
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 160 bits (407), Expect = 4e-44
Identities = 67/333 (20%), Positives = 111/333 (33%), Gaps = 59/333 (17%)
Query: 410 VLGKSGIGIVYKVVLEDGHTLAVRRLGEGGSQRFKEFQTEVEAIGKIRHSNIVTL----- 464
++G+ G VYK L D +AV+ Q F + + + H NI
Sbjct: 20 LIGRGRYGAVYKGSL-DERPVAVKVFSFANRQNFINE-KNIYRVPLMEHDNIARFIVGDE 77
Query: 465 RAYYWSVDEKLLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEF 524
R E LL+ +Y PNGSL L W ++ + +GL YLH
Sbjct: 78 RVTADGRMEYLLVMEYYPNGSLXKYLSLHT-------SDWVSSCRLAHSVTRGLAYLHTE 130
Query: 525 SPK------KYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQ 578
P+ H DL N+L+ ++ +SDFGL+
Sbjct: 131 LPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMR--------------------- 169
Query: 579 ERQQKSVSLEVTTTNSSSNLGSY-YQAPESLK-------VVKPSQKWDIYSYGVILLEMI 630
+ V + S +G+ Y APE L+ ++ D+Y+ G+I E+
Sbjct: 170 LTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIF 229
Query: 631 TGRTAVVQVGSSE------MDLVNWMQLCIEEKKPLADV--LDPYLAPDADKEEEIIAVL 682
T + S V E+ + L P + + L
Sbjct: 230 MRCTDLFPGESVPEYQMAFQTEV-GNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSL 288
Query: 683 -KIAMACVHSSPEKRPTMRHISDALDRLIVSSD 714
+ C E R T + + + L++ +
Sbjct: 289 KETIEDCWDQDAEARLTAQXAEERMAELMMIWE 321
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 6e-43
Identities = 79/305 (25%), Positives = 119/305 (39%), Gaps = 40/305 (13%)
Query: 410 VLGKSGIGIVYKVVL-EDGHTLAVRRLGEGGSQRFKEFQTEVEAIGKIRHSNIVTLRAYY 468
VLGK G KV E G + ++ L + + F EV+ + + H N++
Sbjct: 17 VLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVL 76
Query: 469 WSVDEKLLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKK 528
+ I +YI G+L + PWS RV K IA G+ YLH
Sbjct: 77 YKDKRLNFITEYIKGGTLRGIIKSMDS-----QYPWSQRVSFAKDIASGMAYLHS---MN 128
Query: 529 YVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQKSVSLE 588
+H DL N L+ N V+DFGLARL T +KP +++ +V
Sbjct: 129 IIHRDLNSHNCLVRENKNVVVADFGLARLMV---DEKTQPEGLRSLKKPDRKKRYTVV-- 183
Query: 589 VTTTNSSSNLGSYY-QAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGSSEMDLV 647
G+ Y APE + +K D++S+G++L E+I A MD
Sbjct: 184 ----------GNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMD-- 231
Query: 648 NWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDALD 707
L + LD Y P+ + I + C PEKRP+ + L+
Sbjct: 232 --FGLNVRGF------LDRYCPPNCPP-----SFFPITVRCCDLDPEKRPSFVKLEHWLE 278
Query: 708 RLIVS 712
L +
Sbjct: 279 TLRMH 283
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 150 bits (382), Expect = 6e-41
Identities = 73/317 (23%), Positives = 121/317 (38%), Gaps = 61/317 (19%)
Query: 399 DLDELLKASAFVLGKSGIGIVYKVVLEDGHTLAVRRLGEGGSQRFKEFQTEVEAIGKIRH 458
D E+ V+G+ G+V K +A++++ K F E+ + ++ H
Sbjct: 6 DYKEIEVEE--VVGRGAFGVVCKAKW-RAKDVAIKQIESE--SERKAFIVELRQLSRVNH 60
Query: 459 SNIVTLRAYYWSVDEKLLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGL 518
NIV L ++ L+ +Y GSL LHG + +T + + ++G+
Sbjct: 61 PNIVKLYGA--CLNPVCLVMEYAEGGSLYNVLHGAEPLPYYT---AAHAMSWCLQCSQGV 115
Query: 519 VYLHEFSPKKYVHGDLKPSNILLGHNME-PHVSDFGLARLANIAGGSPTLQSNRMPAEKP 577
YLH PK +H DLKP N+LL + DFG A
Sbjct: 116 AYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQ------------------ 157
Query: 578 QERQQKSVSLEVTTTNSSSNLGSY-YQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAV 636
T+ ++N GS + APE + S+K D++S+G+IL E+IT R
Sbjct: 158 --------------THMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPF 203
Query: 637 VQVGSSEMDLVNWMQLCIEEKKP-LADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEK 695
++G + M +P L L + + C P +
Sbjct: 204 DEIGGPAFRI---MWAVHNGTRPPLIKNLPKPIE-------------SLMTRCWSKDPSQ 247
Query: 696 RPTMRHISDALDRLIVS 712
RP+M I + L+
Sbjct: 248 RPSMEEIVKIMTHLMRY 264
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 143 bits (364), Expect = 7e-39
Identities = 76/315 (24%), Positives = 120/315 (38%), Gaps = 72/315 (22%)
Query: 410 VLGKSGIGIVYKVVLEDGHTLAVRRLGEGG----SQRFKEFQTEVEAIGKIRHSNIVTLR 465
++G G G VY+ G +AV+ SQ + + E + ++H NI+ LR
Sbjct: 14 IIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALR 72
Query: 466 AYYWSVDEKLLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFS 525
L+ ++ G L L GK +P + V IA+G+ YLH+ +
Sbjct: 73 GVCLKEPNLCLVMEFARGGPLNRVLSGKR-------IPPDILVNWAVQIARGMNYLHDEA 125
Query: 526 PKKYVHGDLKPSNILLGHNMEPH--------VSDFGLARLANIAGGSPTLQSNRMPAEKP 577
+H DLK SNIL+ +E ++DFGLAR
Sbjct: 126 IVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR--------------------- 164
Query: 578 QERQQKSVSLEVTTTNSSSNLGSY-YQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAV 636
E T S G+Y + APE ++ S+ D++SYGV+L E++TG
Sbjct: 165 ----------EWHRTTKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTG---- 210
Query: 637 VQVGSSEMDLVNWMQLCIEEKK--PLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPE 694
+V +D + K P+ A K+ C + P
Sbjct: 211 -EVPFRGIDGLAVAYGVAMNKLALPIPSTCPEPFA-------------KLMEDCWNPDPH 256
Query: 695 KRPTMRHISDALDRL 709
RP+ +I D L +
Sbjct: 257 SRPSFTNILDQLTTI 271
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 1e-37
Identities = 75/318 (23%), Positives = 132/318 (41%), Gaps = 74/318 (23%)
Query: 410 VLGKSGIGIVYKVV-LEDGHTLAVRRLGEGGSQ-------RFKEFQTEVEAIGKIRHSNI 461
+GK G G+V+K ++D +A++ L G S+ +F+EFQ EV + + H NI
Sbjct: 26 QIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNI 85
Query: 462 VTLRAYYWSVDEKLLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYL 521
V L + ++ +++P G L L K P+ WSV+++++ IA G+ Y+
Sbjct: 86 VKLYGLMH--NPPRMVMEFVPCGDLYHRLLDKA-----HPIKWSVKLRLMLDIALGIEYM 138
Query: 522 HEFSPKKYVHGDLKPSNILL-----GHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEK 576
+P VH DL+ NI L + V+DFGL++
Sbjct: 139 QNQNP-PIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ-------------------- 177
Query: 577 PQERQQKSVSLEVTTTNSSSNLGSY-YQAPESLKVVKP--SQKWDIYSYGVILLEMITGR 633
+ + S LG++ + APE++ + ++K D YS+ +IL ++TG
Sbjct: 178 ------------QSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGE 225
Query: 634 TAVVQVGSSEMDLVNWMQLCIEEKK--PLADVLDPYLAPDADKEEEIIAVLKIAMACVHS 691
+ ++ +N + EE + + P L + C
Sbjct: 226 GPFDEYSYGKIKFINMI---REEGLRPTIPEDCPPRLR-------------NVIELCWSG 269
Query: 692 SPEKRPTMRHISDALDRL 709
P+KRP +I L L
Sbjct: 270 DPKKRPHFSYIVKELSEL 287
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 1e-37
Identities = 33/210 (15%), Positives = 73/210 (34%), Gaps = 32/210 (15%)
Query: 77 LGFLPSALGSLTDLRHVNLRNNKFFGSLPLELLEA-------------------QGLQSL 117
+ F+ A+ LT LR + N+ F E E + L +
Sbjct: 195 ITFVSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDV 254
Query: 118 VLYGNSFSGSVPNEIGKLKYLQILDLSQNFF--------NGSLPVSIVQCKRLKALDLSQ 169
+Y +P + L +Q+++++ N + ++++ + +
Sbjct: 255 EVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGY 314
Query: 170 NNF-TGPLPNGFGSGLVSLEKLNLSFNKFNGSIPSNTGNLSSLQGTVDFSHNLFSGSIPA 228
NN T P+ + L L +N+ G +P+ G+ L +++ ++N +
Sbjct: 315 NNLKTFPVETSLQK-MKKLGMLECLYNQLEGKLPA-FGSEIKLA-SLNLAYNQITEIPAN 371
Query: 229 SLGNLPEKVYIDLTYNNLSGPIPQNGALMN 258
G + + +N L IP +
Sbjct: 372 FCGFTEQVENLSFAHNKLKY-IPNIFDAKS 400
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 2e-34
Identities = 37/190 (19%), Positives = 67/190 (35%), Gaps = 15/190 (7%)
Query: 75 KLLGFLPSALGSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSF--------SG 126
+ +L DL V + N LP L +Q + + N
Sbjct: 236 QQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDW 295
Query: 127 SVPNEIGKLKYLQILDLSQN-FFNGSLPVSIVQCKRLKALDLSQNNFTGPLPNGFGSGLV 185
+ + +QI+ + N + S+ + K+L L+ N G FG +
Sbjct: 296 QALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEG-KLPAFG-SEI 353
Query: 186 SLEKLNLSFNKFNGSIPSNTGNLSSLQGTVDFSHNLFSGSIPASL--GNLPEKVYIDLTY 243
L LNL++N+ + G ++ + F+HN IP ++ ID +Y
Sbjct: 354 KLASLNLAYNQITEIPANFCGFTEQVE-NLSFAHNKLK-YIPNIFDAKSVSVMSAIDFSY 411
Query: 244 NNLSGPIPQN 253
N + +N
Sbjct: 412 NEIGSVDGKN 421
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 1e-31
Identities = 31/195 (15%), Positives = 68/195 (34%), Gaps = 15/195 (7%)
Query: 69 VSIPKKKLLGFLPSALGSLTDLRHVNLRNNKFF-GSLPLELLEAQGLQSLVLYGNSFSGS 127
+S + K + ++ + + N + L + + L L N G
Sbjct: 286 ISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEG- 344
Query: 128 VPNEIGKLKYLQILDLSQNFFNGSLPVSIVQ-CKRLKALDLSQNNFTGPLPNGFGSG-LV 185
G L L+L+ N +P + ++++ L + N +PN F + +
Sbjct: 345 KLPAFGSEIKLASLNLAYNQITE-IPANFCGFTEQVENLSFAHNKLKY-IPNIFDAKSVS 402
Query: 186 SLEKLNLSFNKFNG-------SIPSNTGNLSSLQGTVDFSHNLFSGSIPASLGNLPEKVY 238
+ ++ S+N+ + ++ +++ S+N S
Sbjct: 403 VMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVS-SINLSNNQISKFPKELFSTGSPLSS 461
Query: 239 IDLTYNNLSGPIPQN 253
I+L N L+ IP+N
Sbjct: 462 INLMGNMLTE-IPKN 475
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 2e-30
Identities = 31/195 (15%), Positives = 57/195 (29%), Gaps = 27/195 (13%)
Query: 81 PSALGSLTDLRHVNLRNNKFFGSLP--LELLEAQGLQSLVLYGNSFSG-------SVPNE 131
+ G + +++ +NK +P + + ++ N +
Sbjct: 370 ANFCGFTEQVENLSFAHNKL-KYIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPT 428
Query: 132 IGKLKYLQILDLSQNFFNGSLPVSIVQCKRLKALDLSQNNFTG-------PLPNGFGSGL 184
K + ++LS N + L +++L N T F +
Sbjct: 429 PFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKN-T 487
Query: 185 VSLEKLNLSFNKFNGSIPS-NTGNLSSLQGTVDFSHNLFSGSIPASLGNLPE------KV 237
L ++L FNK L L +D S+N FS P N +
Sbjct: 488 YLLTSIDLRFNKLTKLSDDFRATTLPYLV-GIDLSYNSFSK-FPTQPLNSSTLKGFGIRN 545
Query: 238 YIDLTYNNLSGPIPQ 252
D N P+
Sbjct: 546 QRDAQGNRTLREWPE 560
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 1e-29
Identities = 33/188 (17%), Positives = 55/188 (29%), Gaps = 22/188 (11%)
Query: 75 KLLGFLPSALGSLTDLRHVNLRNNKF-------FGSLPLELLEAQGLQSLVLYGNSFSGS 127
++ F + + L +NL N L S+ L N +
Sbjct: 444 QISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLT-K 502
Query: 128 VPNEI--GKLKYLQILDLSQNFFNGSLPVSIVQCKRLKAL------DLSQNNFTGPLPNG 179
+ ++ L YL +DLS N F+ P + LK D N P G
Sbjct: 503 LSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEG 561
Query: 180 FGSGLVSLEKLNLSFNKFNGSIPSNTGNLSSLQGTVDFSHNLFSGSIPASLGNLPEKVYI 239
SL +L + N + ++ +D N + + E
Sbjct: 562 ITL-CPSLTQLQIGSNDIR-KVNEKI--TPNIS-VLDIKDNPNISIDLSYVCPYIEAGMY 616
Query: 240 DLTYNNLS 247
L Y+
Sbjct: 617 MLFYDKTQ 624
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 1e-29
Identities = 32/192 (16%), Positives = 51/192 (26%), Gaps = 22/192 (11%)
Query: 75 KLLGFLPSALGSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSG-------S 127
K L ++ +NL NN+ L S+ L GN +
Sbjct: 420 KNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKD 479
Query: 128 VPNEIGKLKYLQILDLSQNFFNGSLPVSIV--QCKRLKALDLSQNNFTGPLPNGFGSGLV 185
L +DL N L L +DLS N+F+ P +
Sbjct: 480 ENENFKNTYLLTSIDLRFNKLT-KLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLN-SS 536
Query: 186 SLEKL------NLSFNKFNGSIPSNTGNLSSLQGTVDFSHNLFSGSIPASLGNLPEKVYI 239
+L+ + N+ P SL + N N+ +
Sbjct: 537 TLKGFGIRNQRDAQGNRTLREWPEGITLCPSLT-QLQIGSNDIRKVNEKITPNI---SVL 592
Query: 240 DLTYNNLSGPIP 251
D+ N
Sbjct: 593 DIKDNPNISIDL 604
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 9e-28
Identities = 29/258 (11%), Positives = 65/258 (25%), Gaps = 62/258 (24%)
Query: 1 MCFWVVLFLVLCNFNGFVDSLNGEGYALLSFKQSVHEDPEGSLSNWNSSDENPCSWNGIT 60
+ W V N NG V L+ L G +
Sbjct: 66 LDMWGAQPGVSLNSNGRVTGLS--------------------LEG-----------FGAS 94
Query: 61 CKEQRVVSVSIPKKKLLGFLPSALGSLTDLRHVNLRNNKFFG----SLPLELLEAQGLQS 116
G +P A+G LT+L + L ++ P + +
Sbjct: 95 -----------------GRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQ 137
Query: 117 LVLYGNSFSGSVPNEIGKLKYLQI--LDLSQNFFNGSLPVSIVQCKRLKALDLSQNNFTG 174
+ + + + + + ++ + S+ S + + NN T
Sbjct: 138 KQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITF 197
Query: 175 PLPNGFGSGLVSLEKLNLSFNKFNGSIPSNTGNLSSLQGTVDFSHNLFSGSIPASLGNLP 234
+ L L + + + F + + + + NL
Sbjct: 198 -VSKAVMR-LTKLRQFYMGNSPFVAENICEAWENENSE------YAQQYKTEDLKWDNLK 249
Query: 235 EKVYIDLTYNNLSGPIPQ 252
+ +++ +P
Sbjct: 250 DLTDVEVYNCPNLTKLPT 267
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 3e-25
Identities = 28/244 (11%), Positives = 65/244 (26%), Gaps = 31/244 (12%)
Query: 20 SLNGEGYALLSFKQSVHEDPEGSLSNWNSSDENPCSWNGITCKEQRVVSVSIPKKKLLGF 79
+ + LS +D W++ + S G
Sbjct: 13 TDDAIVPIKLSRTAEYIKDYLALKEIWDALNGKNWSQQGFGT------------------ 54
Query: 80 LPSALGSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSGSVPNEIGKLKYLQ 139
+ + +++ + + L + L L G SG VP+ IG+L L+
Sbjct: 55 --QPGANWNFNKELDM----WGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLTELE 108
Query: 140 ILDLSQNFFNG----SLPVSIVQCKRLKALDLSQNNFTGPLPNGFGSG-LVSLEKLNLSF 194
+L L + P I + + ++ + L K ++
Sbjct: 109 VLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINS 168
Query: 195 NKFNGSIPSNTGNLSSLQGTVDFSHNLFSGSIPASLGNLPEKVYIDLTYNNLSGPIPQNG 254
+ SI ++ + N + + ++ L + + +
Sbjct: 169 DPQQKSIKKSSRITLKDT-QIGQLSNNIT-FVSKAVMRLTKLRQFYMGNSPFVAENICEA 226
Query: 255 ALMN 258
Sbjct: 227 WENE 230
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 3e-23
Identities = 30/159 (18%), Positives = 46/159 (28%), Gaps = 16/159 (10%)
Query: 70 SIPKKKLLGFLPSALGSLTDLRHVNLRNNKFFGSLPLELLEA--QGLQSLVLYGNSFSGS 127
IPK L + L ++LR NK L + L + L NSFS
Sbjct: 471 EIPKNSLKD-ENENFKNTYLLTSIDLRFNKL-TKLSDDFRATTLPYLVGIDLSYNSFSK- 527
Query: 128 VPNEIGKLKYLQIL------DLSQNFFNGSLPVSIVQCKRLKALDLSQNNFTGPLPNGFG 181
P + L+ D N P I C L L + N+ +
Sbjct: 528 FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIRK-VNEKI- 585
Query: 182 SGLVSLEKLNLSFNKFNGSIPSNTGNLSSLQGTVDFSHN 220
++ L++ N S G ++
Sbjct: 586 --TPNISVLDIKDNPNISIDLSYVCPYIEA-GMYMLFYD 621
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 4e-37
Identities = 82/316 (25%), Positives = 123/316 (38%), Gaps = 71/316 (22%)
Query: 410 VLGKSGIGIVYKVVLEDGHTLAVRRLGEGG--SQRFKEFQTEVEAIGKIRHSNIVTLRAY 467
+G G V++ G +AV+ L E ++R EF EV + ++RH NIV
Sbjct: 44 KIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGA 102
Query: 468 YWSVDEKLLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPK 527
++ +Y+ GSL LH + + R+ + +AKG+ YLH +P
Sbjct: 103 VTQPPNLSIVTEYLSRGSLYRLLHKSG---AREQLDERRRLSMAYDVAKGMNYLHNRNPP 159
Query: 528 KYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQKSVSL 587
VH +LK N+L+ V DFGL+RL
Sbjct: 160 -IVHRNLKSPNLLVDKKYTVKVCDFGLSRL-----------------------------K 189
Query: 588 EVTTTNSSSNLGSY-YQAPESLKVVKPSQKWDIYSYGVILLEMITGRT---------AVV 637
T +S S G+ + APE L+ ++K D+YS+GVIL E+ T + V
Sbjct: 190 ASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVA 249
Query: 638 QVGSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRP 697
VG L + L+P +A I C + P KRP
Sbjct: 250 AVGFKCKRL------------EIPRNLNPQVA-------------AIIEGCWTNEPWKRP 284
Query: 698 TMRHISDALDRLIVSS 713
+ I D L LI S+
Sbjct: 285 SFATIMDLLRPLIKSA 300
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 6e-37
Identities = 39/219 (17%), Positives = 73/219 (33%), Gaps = 7/219 (3%)
Query: 39 PEGSLSNWNSSDENPCSWNGITCKEQ----RVVSVSIPKKKLLGFLPSALGSLTDLRHVN 94
P L + + + +S G + T L++++
Sbjct: 320 PTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLD 379
Query: 95 LRNNKFFGSLPLELLEAQGLQSLVLYGNSFSGSVPNEI-GKLKYLQILDLSQNFFNGSLP 153
L N + L + L+ L ++ + L+ L LD+S +
Sbjct: 380 LSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFN 438
Query: 154 VSIVQCKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLNLSFNKFNGSIPSNTGNLSSLQG 213
L+ L ++ N+F + L +L L+LS + P+ +LSSLQ
Sbjct: 439 GIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQ- 497
Query: 214 TVDFSHNLFSGSIPASLGNLPEKVYIDLTYNNLSGPIPQ 252
++ SHN F L +D + N++ Q
Sbjct: 498 VLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQ 536
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 1e-34
Identities = 41/175 (23%), Positives = 69/175 (39%), Gaps = 5/175 (2%)
Query: 80 LPSALGSLTDLRHVNLRNNKFFGSLPLELL-EAQGLQSLVLYGNSFSGSVPNEIGKLKYL 138
+ S L L H++ +++ + + L L + + L L
Sbjct: 388 MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSL 447
Query: 139 QILDLSQNFFNGSL-PVSIVQCKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLNLSFNKF 197
++L ++ N F + P + + L LDLSQ P F L SL+ LN+S N F
Sbjct: 448 EVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFN-SLSSLQVLNMSHNNF 506
Query: 198 NGSIPSNTGNLSSLQGTVDFSHNLFSGSIPASLGNLPEK-VYIDLTYNNLSGPIP 251
L+SLQ +D+S N S L + P +++LT N+ +
Sbjct: 507 FSLDTFPYKCLNSLQ-VLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCE 560
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 1e-33
Identities = 38/183 (20%), Positives = 63/183 (34%), Gaps = 6/183 (3%)
Query: 75 KLLGFLPSALGSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSGSVPNEIGK 134
L + S +L+ ++L + L +L+L GN
Sbjct: 39 PLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSG 98
Query: 135 LKYLQILDLSQNFFNGSLPVSIVQCKRLKALDLSQNNFTG-PLPNGFGSGLVSLEKLNLS 193
L LQ L + I K LK L+++ N LP F L +LE L+LS
Sbjct: 99 LSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFS-NLTNLEHLDLS 157
Query: 194 FNKFNGSIPSNTGNLSSLQG---TVDFSHNLFSGSIPASLGNLPEKVYIDLTYNNLSGPI 250
NK ++ L + ++D S N + P + + + L N S +
Sbjct: 158 SNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEI-RLHKLTLRNNFDSLNV 216
Query: 251 PQN 253
+
Sbjct: 217 MKT 219
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 1e-28
Identities = 29/163 (17%), Positives = 50/163 (30%), Gaps = 4/163 (2%)
Query: 75 KLLGFLPSALGSLTDLRHVNLRNNKFFGSLPLELLEA-QGLQSLVLYGNSFSGSVPNEIG 133
L+ L + + N F + ++ + L L L P
Sbjct: 432 HTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFN 491
Query: 134 KLKYLQILDLSQNFFNGSLPVSIVQCKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLNLS 193
L LQ+L++S N F L+ LD S N+ SL LNL+
Sbjct: 492 SLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLT 551
Query: 194 FNKFNGSIPSNT--GNLSSLQGTVDFSHNLFSGSIPASLGNLP 234
N F + + + + + + P+ +P
Sbjct: 552 QNDFACTCEHQSFLQWIKDQRQLL-VEVERMECATPSDKQGMP 593
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 2e-26
Identities = 36/190 (18%), Positives = 57/190 (30%), Gaps = 14/190 (7%)
Query: 75 KLLGFLPSALGSLTDLRHVNLRNNKF-FGSLPLELLEAQGLQSLVLYGNSFSGSVPNEIG 133
L +G L L+ +N+ +N LP L+ L L N ++
Sbjct: 111 NLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLR 170
Query: 134 KLKYLQI----LDLSQNFFNGSLPVSIVQCKRLKALDLSQNNFTGPLPNGFGSGLVSLEK 189
L + + LDLS N N + + RL L L N + + GL LE
Sbjct: 171 VLHQMPLLNLSLDLSLNPMNF-IQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEV 229
Query: 190 LNLSFNKFNGSIPSNTGNLSSLQG--TVDFSHN------LFSGSIPASLGNLPEKVYIDL 241
L +F + S+L+G + + I L L
Sbjct: 230 HRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSL 289
Query: 242 TYNNLSGPIP 251
+
Sbjct: 290 VSVTIERVKD 299
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 5e-22
Identities = 36/206 (17%), Positives = 66/206 (32%), Gaps = 33/206 (16%)
Query: 77 LGFLPSALGSLTDLRHVNLRNNKFFGSLPLELLEA---QGLQSLVL------YGNSFSGS 127
L + + + L L L +F LE + +GL +L + Y + +
Sbjct: 214 LNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDD 273
Query: 128 VPNEIGKLKYLQILDLSQNFFNGSLPVSIVQCKRLKALDLSQNNFTGPLPNGFGS----- 182
+ + L + L S + L+L F S
Sbjct: 274 IIDLFNCLTNVSSFSLVSVTIERVKDFS--YNFGWQHLELVNCKFGQFPTLKLKSLKRLT 331
Query: 183 -------------GLVSLEKLNLSFNKFN--GSIPSNTGNLSSLQGTVDFSHNLFSGSIP 227
L SLE L+LS N + G + +SL+ +D S N +
Sbjct: 332 FTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLK-YLDLSFNGVIT-MS 389
Query: 228 ASLGNLPEKVYIDLTYNNLSGPIPQN 253
++ L + ++D ++NL +
Sbjct: 390 SNFLGLEQLEHLDFQHSNLKQMSEFS 415
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 93.6 bits (233), Expect = 4e-20
Identities = 36/212 (16%), Positives = 63/212 (29%), Gaps = 30/212 (14%)
Query: 75 KLLGFLPSALGSLTDLRHVNLRNNKFFGSLPLELLEA-QGLQSLVLYGNSFSGSV----- 128
+ P A + L + LRNN ++ ++ GL+ L F
Sbjct: 188 PMNFIQPGAFKEIR-LHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKF 246
Query: 129 -PNEIGKLKYLQILDLSQNFFNGS---LPVSIVQCKRLKALDLSQNNFTGPLPNGFGSGL 184
+ + L L I + + + + + + L + G
Sbjct: 247 DKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGW 306
Query: 185 VSLEKLNLSFNKF----------------NGSIPSNTGNLSSLQGTVDFSHN--LFSGSI 226
LE +N F +F G + +L SL+ +D S N F G
Sbjct: 307 QHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLE-FLDLSRNGLSFKGCC 365
Query: 227 PASLGNLPEKVYIDLTYNNLSGPIPQNGALMN 258
S Y+DL++N + L
Sbjct: 366 SQSDFGTTSLKYLDLSFNGVITMSSNFLGLEQ 397
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 1e-35
Identities = 68/320 (21%), Positives = 116/320 (36%), Gaps = 84/320 (26%)
Query: 411 LGKSGIGIVYKVVLEDGH---TLAVRRLGEGG--SQRFKEFQTEVEAIGKIRHSNIVTLR 465
+G G VYK G +AV+ L Q+ + F+ EV + K RH NI+
Sbjct: 32 IGSGSFGTVYK-----GKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 86
Query: 466 AYYWSVDEKL-LIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEF 524
Y S +L ++ + SL LH + I + A+G+ YLH
Sbjct: 87 GY--STAPQLAIVTQWCEGSSLYHHLHASET-----KFEMKKLIDIARQTARGMDYLHA- 138
Query: 525 SPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQKS 584
K +H DLK +NI L + + DFGLA S S++
Sbjct: 139 --KSIIHRDLKSNNIFLHEDNTVKIGDFGLATE-----KSRWSGSHQFEQLS-------- 183
Query: 585 VSLEVTTTNSSSNLGSY-YQAPESLKVVKP---SQKWDIYSYGVILLEMITGRT------ 634
GS + APE +++ S + D+Y++G++L E++TG+
Sbjct: 184 --------------GSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNIN 229
Query: 635 ----AVVQVGSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVH 690
+ VG + P + + K + ++ C+
Sbjct: 230 NRDQIIEMVGRGSL-------------SPDL----SKVRSNCPKR-----MKRLMAECLK 267
Query: 691 SSPEKRPTMRHISDALDRLI 710
++RP+ I ++ L
Sbjct: 268 KKRDERPSFPRILAEIEELA 287
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 7e-35
Identities = 68/327 (20%), Positives = 107/327 (32%), Gaps = 58/327 (17%)
Query: 410 VLGKSGIGIVYKVVLEDGHTLAVRRLGEGGSQRFKEFQTEVE--AIGKIRHSNIVTLRAY 467
+GK G V+ G +AV+ + + E E +RH NI+ A
Sbjct: 44 QIGKGRYGEVWMGKW-RGEKVAVKVFF---TTEEASWFRETEIYQTVLMRHENILGFIAA 99
Query: 468 ----YWSVDEKLLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHE 523
S + LI DY NGSL L + +K+ GL +LH
Sbjct: 100 DIKGTGSWTQLYLITDYHENGSLYDYLKSTT-------LDAKSMLKLAYSSVSGLCHLHT 152
Query: 524 FSPKKY-----VHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQ 578
H DLK NIL+ N ++D GLA + N
Sbjct: 153 EIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPN-------- 204
Query: 579 ERQQKSVSLEVTTTNSSSNLGSY-YQAPESLK-----VVKPS-QKWDIYSYGVILLEMIT 631
+ +G+ Y PE L S D+YS+G+IL E+
Sbjct: 205 -----------------TRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVAR 247
Query: 632 GRTAVVQVGSSEM--DLVNWMQLCIEEKKPLA--DVLDPYLAPDADKEEEIIAVLKIAMA 687
+ V ++ + E+ + + L P +E + + K+
Sbjct: 248 RCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTE 307
Query: 688 CVHSSPEKRPTMRHISDALDRLIVSSD 714
C +P R T + L ++ S D
Sbjct: 308 CWAHNPASRLTALRVKKTLAKMSESQD 334
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 9e-35
Identities = 62/324 (19%), Positives = 109/324 (33%), Gaps = 87/324 (26%)
Query: 410 VLGKSGIGIVYKVVLEDGH---TLAVRRLGEGG--SQRFKEFQTEVEAIGKIRHSNIVTL 464
++GK G VY G +A+R + + K F+ EV A + RH N+V
Sbjct: 40 LIGKGRFGQVYH-----GRWHGEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLF 94
Query: 465 RAYYWSVDEKLLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEF 524
S +I +L + + + + +I + I KG+ YLH
Sbjct: 95 MGACMSPPHLAIITSLCKGRTLYSVVRDAK-----IVLDVNKTRQIAQEIVKGMGYLHA- 148
Query: 525 SPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQKS 584
K +H DLK N+ N + ++DFGL + + +++ +
Sbjct: 149 --KGILHKDLKSKNVFY-DNGKVVITDFGLFSI--SGVLQAGRREDKLRIQN-------- 195
Query: 585 VSLEVTTTNSSSNLGSY-YQAPESLKVVKP---------SQKWDIYSYGVILLEMITGRT 634
G + APE ++ + P S+ D+++ G I E+
Sbjct: 196 --------------GWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREW 241
Query: 635 ---------AVVQVGSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIA 685
+ Q+G+ KP L + I
Sbjct: 242 PFKTQPAEAIIWQMGTG--------------MKPN---LSQIGMGK--------EISDIL 276
Query: 686 MACVHSSPEKRPTMRHISDALDRL 709
+ C E+RPT + D L++L
Sbjct: 277 LFCWAFEQEERPTFTKLMDMLEKL 300
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 6e-34
Identities = 66/327 (20%), Positives = 112/327 (34%), Gaps = 58/327 (17%)
Query: 410 VLGKSGIGIVYKVVLEDGHTLAVRRLGEGGSQRFKEFQTEVE--AIGKIRHSNIVTLRAY 467
+GK G V++ G +AV+ S+ + + E E +RH NI+ A
Sbjct: 49 SIGKGRFGEVWRGKW-RGEEVAVKIFS---SREERSWFREAEIYQTVMLRHENILGFIAA 104
Query: 468 YWSVDEK----LLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHE 523
+ L+ DY +GSL L+ V +K+ A GL +LH
Sbjct: 105 DNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT-------VTVEGMIKLALSTASGLAHLHM 157
Query: 524 FSPKKY-----VHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQ 578
H DLK NIL+ N ++D GLA
Sbjct: 158 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR--------------------- 196
Query: 579 ERQQKSVSLEVTTTNSSSNLGSY-YQAPESL------KVVKPSQKWDIYSYGVILLEMIT 631
+ + + +G+ Y APE L K + ++ DIY+ G++ E+
Sbjct: 197 ----HDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIAR 252
Query: 632 GRTAVVQVGSSEM--DLVNWMQLCIEEKKPLA--DVLDPYLAPDADKEEEIIAVLKIAMA 687
+ ++ + +EE + + L P + E + + KI
Sbjct: 253 RCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRE 312
Query: 688 CVHSSPEKRPTMRHISDALDRLIVSSD 714
C +++ R T I L +L
Sbjct: 313 CWYANGAARLTALRIKKTLSQLSQQEG 339
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 6e-34
Identities = 52/310 (16%), Positives = 111/310 (35%), Gaps = 68/310 (21%)
Query: 410 VLGKSGIGIVYKVVLEDGHTLAVRRL--GEGGSQRFKEFQTEVEAIGKIRHSNIVTLRAY 467
L ++ G ++K G+ + V+ L + +++ ++F E + H N++ +
Sbjct: 17 KLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGA 75
Query: 468 YWSVDEKLL--IYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFS 525
S I ++P GSL LH V S VK +A+G+ +LH
Sbjct: 76 CQSPPAPHPTLITHWMPYGSLYNVLHEGTNF----VVDQSQAVKFALDMARGMAFLHTLE 131
Query: 526 PKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQKSV 585
P L ++++ +M +S +
Sbjct: 132 PL-IPRHALNSRSVMIDEDMTARISMADVKF----------------------------- 161
Query: 586 SLEVTTTNSSSNLGSY-YQAPESLK---VVKPSQKWDIYSYGVILLEMITGRTAVVQVGS 641
+ S + + + APE+L+ + D++S+ V+L E++T +V
Sbjct: 162 -----SFQSPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTR-----EVPF 211
Query: 642 SEMDLVNWMQLCIEEKK--PLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTM 699
+++ + E + + P+++ K+ C++ P KRP
Sbjct: 212 ADLSNMEIGMKVALEGLRPTIPPGISPHVS-------------KLMKICMNEDPAKRPKF 258
Query: 700 RHISDALDRL 709
I L+++
Sbjct: 259 DMIVPILEKM 268
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 1e-33
Identities = 67/324 (20%), Positives = 114/324 (35%), Gaps = 62/324 (19%)
Query: 410 VLGKSGIGIVYKVVLEDGHTLAVRRLGEGGSQRFKEFQTEVE--AIGKIRHSNIVTLRAY 467
+GK G V++ G +AV+ S+ K + E E +RH NI+ A
Sbjct: 15 CVGKGRYGEVWRGSW-QGENVAVKIFS---SRDEKSWFRETELYNTVMLRHENILGFIAS 70
Query: 468 YWSVDEK----LLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHE 523
+ LI Y GSL L + ++I+ IA GL +LH
Sbjct: 71 DMTSRHSSTQLWLITHYHEMGSLYDYLQLTT-------LDTVSCLRIVLSIASGLAHLHI 123
Query: 524 FSPKKY-----VHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQ 578
H DLK NIL+ N + ++D GLA +
Sbjct: 124 EIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVM--------------------- 162
Query: 579 ERQQKSVSLEVTTTNSSSNLGSY-YQAPESLK------VVKPSQKWDIYSYGVILLEMIT 631
S S ++ +G+ Y APE L ++ DI+++G++L E+
Sbjct: 163 ----HSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVAR 218
Query: 632 GRTAVVQVGSSEM--DLVNWMQLCIEEKKPLADVLD----PYLAPDADKEEEIIAVLKIA 685
+ V + V E+ + + V P + + + ++ K+
Sbjct: 219 RMVSNGIVEDYKPPFYDVVPNDPSFEDMRKV--VCVDQQRPNIPNRWFSDPTLTSLAKLM 276
Query: 686 MACVHSSPEKRPTMRHISDALDRL 709
C + +P R T I L ++
Sbjct: 277 KECWYQNPSARLTALRIKKTLTKI 300
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 2e-32
Identities = 41/181 (22%), Positives = 64/181 (35%), Gaps = 10/181 (5%)
Query: 81 PSALGSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSG--SVPNEIGKLKYL 138
L ++ + L NK+ LQ L+L + S P+ L+ L
Sbjct: 423 GQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNL 482
Query: 139 QILDLSQNFFNGSLPVSIVQCKRLKALDLSQNNFT-------GPLPNGFGSGLVSLEKLN 191
ILDLS N + ++L+ LDL NN P F GL L LN
Sbjct: 483 TILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILN 542
Query: 192 LSFNKFNGSIPSNTGNLSSLQGTVDFSHNLFSGSIPASLGNLPEKVYIDLTYNNLSGPIP 251
L N F+ +L L+ +D N + + N ++L N ++
Sbjct: 543 LESNGFDEIPVEVFKDLFELK-IIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEK 601
Query: 252 Q 252
+
Sbjct: 602 K 602
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 6e-32
Identities = 41/175 (23%), Positives = 61/175 (34%), Gaps = 5/175 (2%)
Query: 81 PSALGSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSGSVPNEIGKLKYLQI 140
P L L+ +NL++N+ L L L NS N K K L
Sbjct: 66 PELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLIT 125
Query: 141 LDLSQNFFNGSLPVSIVQCKRLKALDLSQNNFTGPLPNGFGS-GLVSLEKLNLSFNKFNG 199
LDLS N + + + VQ + L+ L LS N SL+KL LS N+
Sbjct: 126 LDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKE 185
Query: 200 SIPSNTGNLSSLQGTVDFSHNLFSGSIPASLG---NLPEKVYIDLTYNNLSGPIP 251
P + L + ++ S+ L + L+ + LS
Sbjct: 186 FSPGCFHAIGRLF-GLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSN 239
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 9e-32
Identities = 41/211 (19%), Positives = 64/211 (30%), Gaps = 18/211 (8%)
Query: 54 CSWNGITCKEQRVVSVSIPKK---------KLLGFLPSALGSLTDLRHVNLRNNKFFGSL 104
CS +T V +P +L + + L +++ N
Sbjct: 11 CSHLKLT-----QVPDDLPTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLE 65
Query: 105 PLELLEAQGLQSLVLYGNSFSGSVPNEIGKLKYLQILDLSQNFFNGSLPVSIVQCKRLKA 164
P + L+ L L N S L L L N V+ K L
Sbjct: 66 PELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLIT 125
Query: 165 LDLSQNNFTGPLPNGFGSGLVSLEKLNLSFNKFNGSIPS--NTGNLSSLQGTVDFSHNLF 222
LDLS N + L +L++L LS NK + SSL+ ++ S N
Sbjct: 126 LDLSHNGLSSTKLGTQV-QLENLQELLLSNNKIQALKSEELDIFANSSLK-KLELSSNQI 183
Query: 223 SGSIPASLGNLPEKVYIDLTYNNLSGPIPQN 253
P + + L L + +
Sbjct: 184 KEFSPGCFHAIGRLFGLFLNNVQLGPSLTEK 214
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 2e-30
Identities = 41/198 (20%), Positives = 70/198 (35%), Gaps = 16/198 (8%)
Query: 75 KLLGFLPSALGSLTDLRHVNLRNNKFFGSLPLELLEAQG---LQSLVLYGNSFSGSVPNE 131
++ F P ++ L + L N + SL +L +++L L + S +
Sbjct: 182 QIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTT 241
Query: 132 IGKLKY--LQILDLSQNFFNGSLPVSIVQCKRLKALDLSQNNFTGPLPNGFGSGLVSLEK 189
LK+ L +LDLS N N S +L+ L NN + GL ++
Sbjct: 242 FLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSL-HGLFNVRY 300
Query: 190 LNLSFNKFNGSIPSNT---------GNLSSLQGTVDFSHNLFSGSIPASLGNLPEKVYID 240
LNL + SI + L L+ ++ N G L Y+
Sbjct: 301 LNLKRSFTKQSISLASLPKIDDFSFQWLKCLE-HLNMEDNDIPGIKSNMFTGLINLKYLS 359
Query: 241 LTYNNLSGPIPQNGALMN 258
L+ + S N ++
Sbjct: 360 LSNSFTSLRTLTNETFVS 377
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 2e-30
Identities = 39/210 (18%), Positives = 73/210 (34%), Gaps = 24/210 (11%)
Query: 75 KLLGFLPSALGSLTDLRHVNLRNNKFFGSL---------PLELLEAQGLQSLVLYGNSFS 125
+ +L L ++R++NL+ + S+ + L+ L + N
Sbjct: 283 NIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIP 342
Query: 126 GSVPNEIGKLKYLQILDLSQNFFNGSLPVSIV----QCKRLKALDLSQNNFTGPLPNGFG 181
G N L L+ L LS +F + + L L+L++N + + F
Sbjct: 343 GIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAF- 401
Query: 182 SGLVSLEKLNLSFNKFNGSIPSNT-GNLSSLQGTVDFSHNLFSGSIPASLGNLPEKVYID 240
S L LE L+L N+ + L ++ + S+N + S +P +
Sbjct: 402 SWLGHLEVLDLGLNEIGQELTGQEWRGLENIF-EIYLSYNKYLQLTRNSFALVPSLQRLM 460
Query: 241 LTYNNLSGPIPQNGALMNRGPTAFIGNPRL 270
L L ++ P+ F L
Sbjct: 461 LRRVALKN--------VDSSPSPFQPLRNL 482
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 3e-30
Identities = 40/195 (20%), Positives = 66/195 (33%), Gaps = 13/195 (6%)
Query: 75 KLLGFLPSALGSLTDLRHVNLRNNKF--FGSLPLELLEAQGLQSLVLYGNSFSGSVPNEI 132
K L ++ + L+ + LR S P + L L L N+ + + +
Sbjct: 441 KYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDML 500
Query: 133 GKLKYLQILDLSQN--------FFNGSLPVSIVQCKRLKALDLSQNNFTGPLPNGFGSGL 184
L+ L+ILDL N G + L L+L N F F L
Sbjct: 501 EGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFK-DL 559
Query: 185 VSLEKLNLSFNKFNGSIPSNTGNLSSLQGTVDFSHNLFSGSIPASLGNLPEK-VYIDLTY 243
L+ ++L N N S N SL+ +++ NL + G +D+ +
Sbjct: 560 FELKIIDLGLNNLNTLPASVFNNQVSLK-SLNLQKNLITSVEKKVFGPAFRNLTELDMRF 618
Query: 244 NNLSGPIPQNGALMN 258
N +N
Sbjct: 619 NPFDCTCESIAWFVN 633
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 3e-29
Identities = 31/171 (18%), Positives = 56/171 (32%), Gaps = 5/171 (2%)
Query: 88 TDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSGSVPNEIGKLKYLQILDLSQNF 147
+ + K +P +L + L L N + L LD+ N
Sbjct: 4 VSHEVADCSHLKLT-QVPDDLPT--NITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNT 60
Query: 148 FNGSLPVSIVQCKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLNLSFNKFNGSIPSNTGN 207
+ P + LK L+L N + F + +L +L+L N +
Sbjct: 61 ISKLEPELCQKLPMLKVLNLQHNELSQLSDKTF-AFCTNLTELHLMSNSIQKIKNNPFVK 119
Query: 208 LSSLQGTVDFSHNLFSGSIPASLGNLPEKVYIDLTYNNLSGPIPQNGALMN 258
+L T+D SHN S + + L + L+ N + + +
Sbjct: 120 QKNLI-TLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFA 169
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 6e-28
Identities = 38/211 (18%), Positives = 74/211 (35%), Gaps = 26/211 (12%)
Query: 75 KLLGFLPSALGSL--TDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSGSVPNEI 132
+L + L T+L ++L N L+ L N+ + +
Sbjct: 233 QLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSL 292
Query: 133 GKLKYLQILDLSQNFFNGSL---------PVSIVQCKRLKALDLSQNNFTGPLPNGFGSG 183
L ++ L+L ++F S+ S K L+ L++ N+ G N F +G
Sbjct: 293 HGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMF-TG 351
Query: 184 LVSLEKLNLSFNKFNGSIPSNTG----NLSSLQGTVDFSHNLFSGSIPASLGNLPEKVYI 239
L++L+ L+LS + + +N S L ++ + N S + L +
Sbjct: 352 LINLKYLSLSNSFTSLRTLTNETFVSLAHSPLH-ILNLTKNKISKIESDAFSWLGHLEVL 410
Query: 240 DLTYNNLSGPIPQNGALMNRGPTAFIGNPRL 270
DL N + + + G +
Sbjct: 411 DLGLNEIGQELT---------GQEWRGLENI 432
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 1e-27
Identities = 40/191 (20%), Positives = 67/191 (35%), Gaps = 7/191 (3%)
Query: 68 SVSIPKKKLLGFLPSALGSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSGS 127
SI L + L L H+N+ +N G L+ L L + S
Sbjct: 309 KQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLR 368
Query: 128 VPNEIG----KLKYLQILDLSQNFFNGSLPVSIVQCKRLKALDLSQNNFTGPLPNGFGSG 183
L IL+L++N + + L+ LDL N L G
Sbjct: 369 TLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRG 428
Query: 184 LVSLEKLNLSFNKFNGSIPSNTGNLSSLQGTVDFSHNLFSG--SIPASLGNLPEKVYIDL 241
L ++ ++ LS+NK+ ++ + SLQ + S P+ L +DL
Sbjct: 429 LENIFEIYLSYNKYLQLTRNSFALVPSLQ-RLMLRRVALKNVDSSPSPFQPLRNLTILDL 487
Query: 242 TYNNLSGPIPQ 252
+ NN++
Sbjct: 488 SNNNIANINDD 498
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 2e-25
Identities = 35/195 (17%), Positives = 69/195 (35%), Gaps = 18/195 (9%)
Query: 75 KLLGFLPSALG---SLTDLRHVNLRNNKFFGSLP--LELLEAQGLQSLVLYGNSFSGSVP 129
+L L L + T +R+++L N++ + L+ L L L N+ +
Sbjct: 206 QLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGN 265
Query: 130 NEIGKLKYLQILDLSQNFFNGSLPVSIVQCKRLKALDLSQNNFTGPL--------PNGFG 181
+ L L+ L N S+ ++ L+L ++ + +
Sbjct: 266 DSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSF 325
Query: 182 SGLVSLEKLNLSFNKFNGSIPSNTGNLSSLQGTVDFSHNLFSGS--IPASLGNLPEK--V 237
L LE LN+ N G + L +L+ + S++ S + +L
Sbjct: 326 QWLKCLEHLNMEDNDIPGIKSNMFTGLINLK-YLSLSNSFTSLRTLTNETFVSLAHSPLH 384
Query: 238 YIDLTYNNLSGPIPQ 252
++LT N +S
Sbjct: 385 ILNLTKNKISKIESD 399
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 8e-23
Identities = 37/172 (21%), Positives = 59/172 (34%), Gaps = 13/172 (7%)
Query: 75 KLLGFLPSALGSLTDLRHVNLRNNK--------FFGSLPLELLEAQGLQSLVLYGNSFSG 126
+ L L L ++L++N G L L L L N F
Sbjct: 491 NIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDE 550
Query: 127 SVPNEIGKLKYLQILDLSQNFFNGSLPVSIVQCKRLKALDLSQNNFTGPLPNGFGSGLVS 186
L L+I+DL N N LK+L+L +N T FG +
Sbjct: 551 IPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRN 610
Query: 187 LEKLNLSFNKFNGSIPSNTGNLSSLQGT----VDFSHNLFSGSIPASLGNLP 234
L +L++ FN F+ + S ++ + T + S + + P P
Sbjct: 611 LTELDMRFNPFDCTCESIAWFVNWINETHTNIPELSSHYLCNT-PPHYHGFP 661
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 8e-32
Identities = 48/290 (16%), Positives = 86/290 (29%), Gaps = 52/290 (17%)
Query: 24 EGYALLSFKQ----------SVHEDPEGSLSNWNSSDENPCSWNGITC----KEQRVVSV 69
+ AL + + S + NWN + E W RV +
Sbjct: 270 DYKALKAIWEALDGKNWRYYSGTINNTIHSLNWNFNKE-LDMWGDQPGVDLDNNGRVTGL 328
Query: 70 SIPKKKLLGFLPSALGSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSGSVP 129
S+ G +P A+G LT+L+ ++ + S L E +
Sbjct: 329 SLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYK 388
Query: 130 NEIGK-LKYLQILDLSQNFFNG----------------------------SLPVSIVQCK 160
+ L + DL Q+ N + +I +
Sbjct: 389 KMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRITFISKAIQRLT 448
Query: 161 RLKALDLSQNNFTGPLPNGFGSGLVSLEKLNLSFNKFNGSIPSNTGNLSSLQGTVDFSHN 220
+L+ + + + FT V E N + K + + NL L V+ +
Sbjct: 449 KLQIIYFANSPFTYDNI------AVDWEDANSDYAKQYENEELSWSNLKDLT-DVELYNC 501
Query: 221 LFSGSIPASLGNLPEKVYIDLTYNNLSGPIPQNGALMNRGPTAFIGNPRL 270
+P L +LPE +++ N Q A R P++
Sbjct: 502 PNMTQLPDFLYDLPELQSLNIACNRGIS-AAQLKADWTRLADDEDTGPKI 550
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 5e-31
Identities = 33/197 (16%), Positives = 64/197 (32%), Gaps = 23/197 (11%)
Query: 77 LGFLPSA--LGSLTDLRHVNLRNNKFFGSLPLELLEAQG------LQSLVLYGNSFSGSV 128
L ++P+ S+ + V+ NK GS + + ++ L N
Sbjct: 631 LKYIPNIFNAKSVYVMGSVDFSYNKI-GSEGRNISCSMDDYKGINASTVTLSYNEIQKFP 689
Query: 129 PNEIGKLKYLQILDLSQNFF-------NGSLPVSIVQCKRLKALDLSQNNFTGPLPNGFG 181
+ + LS N + L +DL N T +
Sbjct: 690 TELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKLTSLSDDFRA 749
Query: 182 SGLVSLEKLNLSFNKFNGSIPSNTGNLSSLQ-----GTVDFSHNLFSGSIPASLGNLPEK 236
+ L L +++S+N F+ S P+ N S L+ D N P + P
Sbjct: 750 TTLPYLSNMDVSYNCFS-SFPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSL 808
Query: 237 VYIDLTYNNLSGPIPQN 253
+ + + N++ + +
Sbjct: 809 IQLQIGSNDIRK-VDEK 824
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 3e-30
Identities = 29/188 (15%), Positives = 62/188 (32%), Gaps = 20/188 (10%)
Query: 76 LLGFLPSALGSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSGSVPNEIGKL 135
+ F+ A+ LT L+ + N+ F + + + + L
Sbjct: 436 RITFISKAIQRLTKLQIIYFANSPF-TYDNIAVD----WEDANSDYAKQYENEELSWSNL 490
Query: 136 KYLQILDLSQNFFNGSLPVSIVQCKRLKALDLSQNNFTGP---------LPNGFGSGLVS 186
K L ++L LP + L++L+++ N L +
Sbjct: 491 KDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDED-TGPK 549
Query: 187 LEKLNLSFNKFNGSIPSNT-GNLSSLQGTVDFSHNLFSGSIPASLGNLPEKVYIDLTYNN 245
++ + +N S + + L +D HN + + G + + L YN
Sbjct: 550 IQIFYMGYNNLEEFPASASLQKMVKLG-LLDCVHNKVR-HLE-AFGTNVKLTDLKLDYNQ 606
Query: 246 LSGPIPQN 253
+ IP++
Sbjct: 607 IEE-IPED 613
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 2e-29
Identities = 44/198 (22%), Positives = 69/198 (34%), Gaps = 21/198 (10%)
Query: 75 KLLGFLPSALGSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSG-------- 126
K + +L DL V L N LP L + LQSL + N
Sbjct: 478 KQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADW 537
Query: 127 -SVPNEIGKLKYLQILDLSQNFFNGSLPVS--IVQCKRLKALDLSQNNFTGPLPNGFGSG 183
+ ++ +QI + N P S + + +L LD N L FG
Sbjct: 538 TRLADDEDTGPKIQIFYMGYNNLE-EFPASASLQKMVKLGLLDCVHNKVRH-LEA-FG-T 593
Query: 184 LVSLEKLNLSFNKFNGSIPSNTG-NLSSLQGTVDFSHNLFSGSIP--ASLGNLPEKVYID 240
V L L L +N+ IP + ++ + FSHN IP + ++ +D
Sbjct: 594 NVKLTDLKLDYNQIE-EIPEDFCAFTDQVE-GLGFSHNKLK-YIPNIFNAKSVYVMGSVD 650
Query: 241 LTYNNLSGPIPQNGALMN 258
+YN + M+
Sbjct: 651 FSYNKIGSEGRNISCSMD 668
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 116 bits (291), Expect = 7e-27
Identities = 34/189 (17%), Positives = 63/189 (33%), Gaps = 24/189 (12%)
Query: 75 KLLGFLPSALGSLTDLRHVNLRNNKF-------FGSLPLELLEAQGLQSLVLYGNSFSGS 127
++ F + + + + L NN L ++ L N + S
Sbjct: 684 EIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKLT-S 742
Query: 128 VPNEI--GKLKYLQILDLSQNFFNGSLPVSIVQCKRLKALDLSQ------NNFTGPLPNG 179
+ ++ L YL +D+S N F+ S P + +LKA + N P G
Sbjct: 743 LSDDFRATTLPYLSNMDVSYNCFS-SFPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTG 801
Query: 180 FGSGLVSLEKLNLSFNKFNGSIPSNTGNLSSLQGTVDFSHN-LFSGSIPASLGNLPEKVY 238
+ SL +L + N + L +D + N S + + + +Y
Sbjct: 802 ITT-CPSLIQLQIGSNDIR-KVDEKL--TPQLY-ILDIADNPNISIDVTSVCPYIEAGMY 856
Query: 239 IDLTYNNLS 247
L Y+
Sbjct: 857 -VLLYDKTQ 864
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 3e-26
Identities = 30/201 (14%), Positives = 56/201 (27%), Gaps = 14/201 (6%)
Query: 77 LGFLPSALGSLTDLRHVNLRNNKFFGSLPLE--LLEAQGLQSLVLYGNSFSGSVPNEIGK 134
L + ++ + N P L + L L N G
Sbjct: 537 WTRLADDEDTGPKIQIFYMGYNNL-EEFPASASLQKMVKLGLLDCVHNKVR--HLEAFGT 593
Query: 135 LKYLQILDLSQNFFNGSLPVSIVQ-CKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLNLS 193
L L L N +P +++ L S N + + ++ S
Sbjct: 594 NVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLKYIPNIFNAKSVYVMGSVDFS 652
Query: 194 FNKFNGSIPSNTGNLSSLQGT----VDFSHNLFSGSIPASLGNLPEKVYIDLTYNNLSGP 249
+NK + + ++ +G V S+N I L+ N ++
Sbjct: 653 YNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTS- 711
Query: 250 IPQNGALMNRGPTAFIGNPRL 270
IP+N + + L
Sbjct: 712 IPEN--SLKPKDGNYKNTYLL 730
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 6e-30
Identities = 43/183 (23%), Positives = 75/183 (40%), Gaps = 14/183 (7%)
Query: 80 LPSALGSLTDLRHVNLRNNKFFGSLP---------LELLEAQGLQSLVLYGNSFSGSVPN 130
LP+++ SL LR +++R LP E LQSL L S+P
Sbjct: 142 LPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPA 200
Query: 131 EIGKLKYLQILDLSQNFFNGSLPVSIVQCKRLKALDLSQNNFTGPLPNGFGSGLVSLEKL 190
I L+ L+ L + + + +L +I +L+ LDL P FG L++L
Sbjct: 201 SIANLQNLKSLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTALRNYPPIFGG-RAPLKRL 258
Query: 191 NLSFNKFNGSIPSNTGNLSSLQGTVDFSHNLFSGSIPASLGNLPEKVYIDLTYNNLSGPI 250
L ++P + L+ L+ +D + +P+ + LP I + +L +
Sbjct: 259 ILKDCSNLLTLPLDIHRLTQLE-KLDLRGCVNLSRLPSLIAQLPANCIILV-PPHLQAQL 316
Query: 251 PQN 253
Q+
Sbjct: 317 DQH 319
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 6e-28
Identities = 31/178 (17%), Positives = 60/178 (33%), Gaps = 15/178 (8%)
Query: 77 LGFLPSALGSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSGSVPNEIGKLK 136
L P L+ L+H+ + LP + + GL++L L N ++P I L
Sbjct: 93 LPQFPDQAFRLSHLQHMTIDAAGL-MELPDTMQQFAGLETLTLARNPLR-ALPASIASLN 150
Query: 137 YLQILDLSQN---------FFNGSLPVSIVQCKRLKALDLSQNNFTGPLPNGFGSGLVSL 187
L+ L + + L++L L LP + L +L
Sbjct: 151 RLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIRS-LPASIAN-LQNL 208
Query: 188 EKLNLSFNKFNGSIPSNTGNLSSLQGTVDFSHNLFSGSIPASLGNLPEKVYIDLTYNN 245
+ L + + + ++ +L L+ +D + P G + L +
Sbjct: 209 KSLKIRNSPLS-ALGPAIHHLPKLE-ELDLRGCTALRNYPPIFGGRAPLKRLILKDCS 264
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 6e-24
Identities = 37/168 (22%), Positives = 58/168 (34%), Gaps = 7/168 (4%)
Query: 70 SIPKKKLLGFLPSALGSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSGSVP 129
+P+ L +L+ + L SLP + Q L+SL + + S ++
Sbjct: 165 ELPEPLASTDASGEHQGLVNLQSLRLEWTGI-RSLPASIANLQNLKSLKIRNSPLS-ALG 222
Query: 130 NEIGKLKYLQILDLSQNFFNGSLPVSIVQCKRLKALDLSQNNFTGPLPNGFGSGLVSLEK 189
I L L+ LDL + P LK L L + LP L LEK
Sbjct: 223 PAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHR-LTQLEK 281
Query: 190 LNLSFNKFNGSIPSNTGNLSSLQGTVDFSHNLFSGSI---PASLGNLP 234
L+L +PS L + + +L + P + P
Sbjct: 282 LDLRGCVNLSRLPSLIAQLPANC-IILVPPHLQAQLDQHRPVARPAEP 328
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 1e-16
Identities = 21/179 (11%), Positives = 50/179 (27%), Gaps = 12/179 (6%)
Query: 77 LGFLPSALGSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSGSVPNEIGKLK 136
+G + ++ + + L Q + S
Sbjct: 1 MGSSHHHHHHSSGRENLYFQGSTALRPYHDVL---SQWQRHYNADRNRWHS-AWRQANSN 56
Query: 137 YLQILDLSQNFFNGSLPVSIVQCKR--LKALDLSQNNFTGPLPNGFGSGLVSLEKLNLSF 194
QI + + + + AL+L P+ L L+ + +
Sbjct: 57 NPQIETRTGRALK-ATADLLEDATQPGRVALELRSVPLPQ-FPDQAFR-LSHLQHMTIDA 113
Query: 195 NKFNGSIPSNTGNLSSLQGTVDFSHNLFSGSIPASLGNLPEKVYIDLTYNNLSGPIPQN 253
+P + L+ T+ + N ++PAS+ +L + + +P+
Sbjct: 114 AGLM-ELPDTMQQFAGLE-TLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEP 169
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 8e-27
Identities = 46/200 (23%), Positives = 71/200 (35%), Gaps = 15/200 (7%)
Query: 75 KLLGFLPSALGSLTD--LRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSGSVPNEI 132
P+ L + + +NL+ + FF GLQ L L S +P+ +
Sbjct: 239 DDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGL 297
Query: 133 GKLKYLQILDLSQNFFNGSLPVSIVQCKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLNL 192
L L+ L LS N F +S L L + N L G L +L +L+L
Sbjct: 298 VGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDL 357
Query: 193 SFNKFNGSIPSNT--GNLSSLQGTVDFSHNLFSGSIPASLGNLPEKVYIDLTYNNLSGPI 250
S + S N NLS LQ +++ S+N + P+ +DL + L
Sbjct: 358 SHDDIETSDCCNLQLRNLSHLQ-SLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKD 416
Query: 251 PQNGALMNRGPTAFIGNPRL 270
+ F L
Sbjct: 417 A---------QSPFQNLHLL 427
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 2e-26
Identities = 42/181 (23%), Positives = 69/181 (38%), Gaps = 5/181 (2%)
Query: 75 KLLGFLPSALGSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSGSVPNEI-G 133
+ L +L+ L+ +NL N+ E L+ L L
Sbjct: 363 ETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQ 422
Query: 134 KLKYLQILDLSQNFFNGSLPVSIVQCKRLKALDLSQNNFTG--PLPNGFGSGLVSLEKLN 191
L L++L+LS + + S L+ L+L N+F L LE L
Sbjct: 423 NLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILV 482
Query: 192 LSFNKFNGSIPSNTGNLSSLQGTVDFSHNLFSGSIPASLGNLPEKVYIDLTYNNLSGPIP 251
LSF + +L + VD SHN + S +L +L +Y++L N++S +P
Sbjct: 483 LSFCDLSSIDQHAFTSLKMMN-HVDLSHNRLTSSSIEALSHLK-GIYLNLASNHISIILP 540
Query: 252 Q 252
Sbjct: 541 S 541
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 1e-25
Identities = 41/183 (22%), Positives = 69/183 (37%), Gaps = 7/183 (3%)
Query: 75 KLLGFLPSALGSLTDLRHVNLRNNKFFGSLPLELLEA-QGLQSLVLYGN--SFSGSVPNE 131
K + + L H++++ N L LE + L+ L L + S +
Sbjct: 312 KFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQ 371
Query: 132 IGKLKYLQILDLSQNFFNGSLPVSIVQCKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLN 191
+ L +LQ L+LS N + +C +L+ LDL+ L L+ LN
Sbjct: 372 LRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLN 431
Query: 192 LSFNKFNGSIPSNTGNLSSLQGTVDFSHNLFSGSI---PASLGNLPEKVYIDLTYNNLSG 248
LS + + S L +LQ ++ N F SL L + L++ +LS
Sbjct: 432 LSHSLLDISSEQLFDGLPALQ-HLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSS 490
Query: 249 PIP 251
Sbjct: 491 IDQ 493
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 1e-24
Identities = 43/184 (23%), Positives = 67/184 (36%), Gaps = 8/184 (4%)
Query: 74 KKLLGFLPSALGSLTDLRHVNLRNNK--FFGSLPLELLEAQGLQSLVLYGNSFSGSVPNE 131
K L L +L +LR ++L ++ L+L LQSL L N
Sbjct: 336 TKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEA 395
Query: 132 IGKLKYLQILDLSQNFFNGSLPVSI-VQCKRLKALDLSQNNFTGPLPNGFGSGLVSLEKL 190
+ L++LDL+ S LK L+LS + GL +L+ L
Sbjct: 396 FKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDI-SSEQLFDGLPALQHL 454
Query: 191 NLSFNKFNGSIPSNTG---NLSSLQGTVDFSHNLFSGSIPASLGNLPEKVYIDLTYNNLS 247
NL N F T L L+ + S S + +L ++DL++N L+
Sbjct: 455 NLQGNHFPKGNIQKTNSLQTLGRLE-ILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLT 513
Query: 248 GPIP 251
Sbjct: 514 SSSI 517
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 3e-24
Identities = 28/171 (16%), Positives = 49/171 (28%), Gaps = 6/171 (3%)
Query: 80 LPSALGSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSGSVPNEIGKLKYLQ 139
+P L + N L L L + L
Sbjct: 27 IPGTL--PNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLD 84
Query: 140 ILDLSQNFFNGSLPVSIVQCKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLNLSFNKFNG 199
L L+ N ++ K LK L Q + +LE L L N +
Sbjct: 85 TLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLH-NQKTLESLYLGSNHISS 143
Query: 200 SIPSNTGNLSSLQGTVDFSHNLFSGSIPASLGNLPE--KVYIDLTYNNLSG 248
L+ +DF +N + +L + + ++L N+++G
Sbjct: 144 IKLPKGFPTEKLK-VLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAG 193
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 5e-23
Identities = 24/171 (14%), Positives = 49/171 (28%), Gaps = 5/171 (2%)
Query: 81 PSALGSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSGSVPNEIGKLKYLQI 140
L + L + L +N + + L+ L N+ ++ L+
Sbjct: 122 FIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATN 181
Query: 141 --LDLSQNFFNGSLPVSIVQCKRLKALDLSQNNFTGPLPNGF-GSGLVSLEKLNLSFNKF 197
L+L+ N + ++L+ + G S + SL
Sbjct: 182 LSLNLNGNDIA-GIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDD 240
Query: 198 NGSIPSNTGNLSSLQGTV-DFSHNLFSGSIPASLGNLPEKVYIDLTYNNLS 247
P+ L + + + F + +DLT +LS
Sbjct: 241 EDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS 291
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 2e-22
Identities = 31/181 (17%), Positives = 49/181 (27%), Gaps = 7/181 (3%)
Query: 75 KLLGFLPSALGSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSGSVPNEIGK 134
++ S L + L N L + L+ L S +
Sbjct: 68 QIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHN 127
Query: 135 LKYLQILDLSQNFFNGSLPVSIVQCKRLKALDLSQNNFTGPLPNGFGSGLVSLE--KLNL 192
K L+ L L N + ++LK LD N S L LNL
Sbjct: 128 QKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDM-SSLQQATNLSLNL 186
Query: 193 SFNKFNGSIPSNTGNLSSLQGTVDFSHNLFSGSIPASLGN--LPEKVYIDLTYNNLSGPI 250
+ N I + + Q +++F I L N + +
Sbjct: 187 NGNDI-AGIEPGAFDSAVFQ-SLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDIS 244
Query: 251 P 251
P
Sbjct: 245 P 245
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 98.2 bits (245), Expect = 2e-21
Identities = 26/162 (16%), Positives = 45/162 (27%), Gaps = 5/162 (3%)
Query: 91 RHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSGSVPNEIGKLKYLQILDLSQNFFNG 150
+ N N +P L + L N +L L LDL++
Sbjct: 15 KTYNCENLGLN-EIPGTLPN--STECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYW 71
Query: 151 SLPVSIVQCKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLNLSFNKFNGSIPSNTGNLSS 210
+ RL L L+ N SG +L+ L + N +
Sbjct: 72 IHEDTFQSQHRLDTLVLTANPLIFMAETAL-SGPKALKHLFFIQTGISSIDFIPLHNQKT 130
Query: 211 LQGTVDFSHNLFSGSIPASLGNLPEKVYIDLTYNNLSGPIPQ 252
L+ ++ N S + +D N + +
Sbjct: 131 LE-SLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKE 171
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 2e-18
Identities = 40/172 (23%), Positives = 61/172 (35%), Gaps = 10/172 (5%)
Query: 81 PSALGSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSG---SVPNEIGKLKY 137
S +L L+ +NL ++ S LQ L L GN F N + L
Sbjct: 418 QSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGR 477
Query: 138 LQILDLSQNFFNGSLPVSIVQCKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLNLSFNKF 197
L+IL LS + + K + +DLS N T S L + LNL+ N
Sbjct: 478 LEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTS-SSIEALSHLKGIY-LNLASNHI 535
Query: 198 NGSIPSNTGNLSSLQGTVDFSHNLFSGSIPASLGNLPEKVYIDLTYNNLSGP 249
+ +PS LS + T++ N + N+ + L
Sbjct: 536 SIILPSLLPILSQQR-TINLRQNPLDCTC----SNIYFLEWYKENMQKLEDT 582
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 2e-09
Identities = 18/101 (17%), Positives = 36/101 (35%), Gaps = 1/101 (0%)
Query: 74 KKLLGFLPSALGSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSGSVPNEIG 133
K ++L +L L + L + + + L N + S +
Sbjct: 462 PKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALS 521
Query: 134 KLKYLQILDLSQNFFNGSLPVSIVQCKRLKALDLSQNNFTG 174
LK + L+L+ N + LP + + + ++L QN
Sbjct: 522 HLKGIY-LNLASNHISIILPSLLPILSQQRTINLRQNPLDC 561
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 9e-27
Identities = 34/173 (19%), Positives = 63/173 (36%), Gaps = 4/173 (2%)
Query: 77 LGFLPSALGSLTDLRHVNLRNNKFFGSLPLELLEA-QGLQSLVLYGNSFSGSVPNEIGKL 135
+ + L +L+H++ +++ + + L L + + L
Sbjct: 388 AIIMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGL 447
Query: 136 KYLQILDLSQNFFNGSLPVSIVQ-CKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLNLSF 194
L L ++ N F + ++ L LDLS+ + G L L+ LN+S
Sbjct: 448 TSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQ-ISWGVFDTLHRLQLLNMSH 506
Query: 195 NKFNGSIPSNTGNLSSLQGTVDFSHNLFSGSIPASLGNLPEKVYIDLTYNNLS 247
N S+ L SL T+D S N S + +LT N+++
Sbjct: 507 NNLLFLDSSHYNQLYSLS-TLDCSFNRIETSKGILQHFPKSLAFFNLTNNSVA 558
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 1e-26
Identities = 30/175 (17%), Positives = 55/175 (31%), Gaps = 3/175 (1%)
Query: 86 SLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSGSVPNE-IGKLKYLQILDLS 144
LRH++L N + + + LQ L ++ L+ L LD+S
Sbjct: 374 GTNSLRHLDLSFNGAI-IMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDIS 432
Query: 145 QNFFNGSLPVSIVQCKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLNLSFNKFNGSIPSN 204
+ L L ++ N+F + + +L L+LS +
Sbjct: 433 YTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGV 492
Query: 205 TGNLSSLQGTVDFSHNLFSGSIPASLGNLPEKVYIDLTYNNLSGPIPQNGALMNR 259
L LQ ++ SHN + L +D ++N +
Sbjct: 493 FDTLHRLQ-LLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKS 546
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 3e-26
Identities = 33/182 (18%), Positives = 60/182 (32%), Gaps = 4/182 (2%)
Query: 75 KLLGFLPSALGSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSGSVPNEIGK 134
L + + ++L+ ++L + L +L+L GN P
Sbjct: 43 PLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSG 102
Query: 135 LKYLQILDLSQNFFNGSLPVSIVQCKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLNLSF 194
L L+ L + I Q LK L+++ N + S L +L ++LS+
Sbjct: 103 LTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSY 162
Query: 195 NKFNGSIPSNTGNLSSLQG---TVDFSHNLFSGSIPASLGNLPEKVYIDLTYNNLSGPIP 251
N ++ L ++D S N I + + L N S I
Sbjct: 163 NYIQTITVNDLQFLRENPQVNLSLDMSLNPID-FIQDQAFQGIKLHELTLRGNFNSSNIM 221
Query: 252 QN 253
+
Sbjct: 222 KT 223
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 1e-21
Identities = 31/185 (16%), Positives = 54/185 (29%), Gaps = 13/185 (7%)
Query: 75 KLLGFLPSALGSLTDLRHVNLRNNKFFG-SLPLELLEAQGLQSLVLYGNSFSGSVPNEIG 133
KL +G L L+ +N+ +N LP L + L N N++
Sbjct: 115 KLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQ 174
Query: 134 KLKYLQI----LDLSQNFFNGSLPVSIVQCKRLKALDLSQNNFTGPLPNGFGSGLVSLEK 189
L+ LD+S N + + Q +L L L N + + L L
Sbjct: 175 FLRENPQVNLSLDMSLNPID-FIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHV 233
Query: 190 LNLSFNKFNGSIPSNTGNLSSLQG-------TVDFSHNLFSGSIPASLGNLPEKVYIDLT 242
L +F S ++G ++ L + L
Sbjct: 234 HRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLA 293
Query: 243 YNNLS 247
++
Sbjct: 294 GVSIK 298
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 2e-19
Identities = 27/141 (19%), Positives = 38/141 (26%), Gaps = 3/141 (2%)
Query: 75 KLLGFLPSALGSLTDLRHVNLRNNKFFGSLPLELLE-AQGLQSLVLYGNSFSGSVPNEIG 133
LT L + + N F + + L L L
Sbjct: 435 NTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFD 494
Query: 134 KLKYLQILDLSQNFFNGSLPVSIVQCKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLNLS 193
L LQ+L++S N Q L LD S N SL NL+
Sbjct: 495 TLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIET-SKGILQHFPKSLAFFNLT 553
Query: 194 FNKFNGSIPSNTGNLSSLQGT 214
N I + L ++
Sbjct: 554 NNSVA-CICEHQKFLQWVKEQ 573
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 3e-18
Identities = 37/208 (17%), Positives = 71/208 (34%), Gaps = 35/208 (16%)
Query: 80 LPSALGSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLV--------LYGNSFSGSVPNE 131
+ + L +L L L +F LE+ E ++ L L + +
Sbjct: 221 MKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVK 280
Query: 132 IGKLKYLQILDLSQN--------FFNGSL-----------PVSIVQCKRLKALDLSQNNF 172
L + + L+ + + LK+L L+ N
Sbjct: 281 FHCLANVSAMSLAGVSIKYLEDVPKHFKWQSLSIIRCQLKQFPTLDLPFLKSLTLTMNKG 340
Query: 173 TGPLPNGFGSGLVSLEKLNLSFNKFNGSIPSNTGNL--SSLQGTVDFSHNLFSGSIPASL 230
+ L SL L+LS N + S + +L +SL+ +D S N + A+
Sbjct: 341 SISFKK---VALPSLSYLDLSRNALSFSGCCSYSDLGTNSLR-HLDLSFNGAI-IMSANF 395
Query: 231 GNLPEKVYIDLTYNNLSGPIPQNGALMN 258
L E ++D ++ L + + A ++
Sbjct: 396 MGLEELQHLDFQHSTLKR-VTEFSAFLS 422
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 9e-18
Identities = 33/185 (17%), Positives = 59/185 (31%), Gaps = 18/185 (9%)
Query: 77 LGFLPSALGSLTDLRHVNLRNNKFFGSLPLELLEA-QGLQSLVLYGNSFSGSV------P 129
+ F+ L + LR N ++ L+ GL L F P
Sbjct: 193 IDFIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEP 252
Query: 130 NEIGKLKYLQI--LDLSQNFFNGSLPVSIVQCKRLKALDLSQNNFTGPLPNGFGSGLVSL 187
+ + L + I L+ V + A+ L+ +
Sbjct: 253 SIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKYLEDVPKHF---KW 309
Query: 188 EKLNLSFNKFNGSIPSNTGNLSSLQGTVDFSHNLFSGSIPASLGNLPEKVYIDLTYNNLS 247
+ L++ + P+ +L L+ ++ + N GSI LP Y+DL+ N LS
Sbjct: 310 QSLSIIRCQLK-QFPTL--DLPFLK-SLTLTMN--KGSISFKKVALPSLSYLDLSRNALS 363
Query: 248 GPIPQ 252
Sbjct: 364 FSGCC 368
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 2e-26
Identities = 68/308 (22%), Positives = 115/308 (37%), Gaps = 57/308 (18%)
Query: 410 VLGKSGIGIVYKVV-LEDGHTLAVRRLGEGGSQRFKE-FQTEVEAIGKIRHSNIVTLRAY 467
LG+ G G+V++ D A++R+ + +E EV+A+ K+ H IV
Sbjct: 12 CLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNA 71
Query: 468 Y-------WSVDEKLLIYDYI-----PNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIA 515
+ +Y YI +L ++G+ + SV + I IA
Sbjct: 72 WLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTI---EERERSVCLHIFLQIA 128
Query: 516 KGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAE 575
+ + +LH K +H DLKPSNI + V DFGL +
Sbjct: 129 EAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMD---------------- 169
Query: 576 KPQERQQKSVSLEVTTTNSSSNLGS-YYQAPESLKVVKPSQKWDIYSYGVILLEMITGRT 634
E +Q ++ + +G+ Y +PE + S K DI+S G+IL E++ +
Sbjct: 170 -QDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFS 228
Query: 635 AVVQVGSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPE 694
+M+ V + K P P E ++ + SP
Sbjct: 229 T-------QMERVRTLTDVRNLKFP------PLFTQKYPCEYVMVQ------DMLSPSPM 269
Query: 695 KRPTMRHI 702
+RP +I
Sbjct: 270 ERPEAINI 277
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 1e-25
Identities = 59/234 (25%), Positives = 91/234 (38%), Gaps = 32/234 (13%)
Query: 410 VLGKSGIGIVYKVV-LEDGHTLAVRRLGEGGSQRFKEFQTEVEAIGKIRHSNIVTLRAYY 468
LG+ G V V L DGH A++R+ Q +E Q E + H NI+ L AY
Sbjct: 36 KLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYC 95
Query: 469 W----SVDEKLLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEF 524
+ E L+ + G+L + + + + ++ GI +GL +H
Sbjct: 96 LRERGAKHEAWLLLPFFKRGTLWNEI--ERLKDKGNFLTEDQILWLLLGICRGLEAIHA- 152
Query: 525 SPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQKS 584
K Y H DLKP+NILLG +P + D G A + E ++
Sbjct: 153 --KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQA------------CIHVEGSRQALTLQ 198
Query: 585 VSLEVTTTNSSSNLGSYYQAPESLKV---VKPSQKWDIYSYGVILLEMITGRTA 635
T Y+APE V ++ D++S G +L M+ G
Sbjct: 199 DWAAQRCT-------ISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGP 245
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 9e-25
Identities = 73/318 (22%), Positives = 120/318 (37%), Gaps = 78/318 (24%)
Query: 410 VLGKSGIGIVYKVVLEDGHTLAVRRLGEGGSQRFKEFQTEVEAIGKIRHSNIVTLRAYYW 469
LG+ G V+ +A++ L G + F E + + K+RH +V L Y
Sbjct: 191 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQL---YA 246
Query: 470 SVDEK--LLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPK 527
V E+ ++ +Y+ GSL L G+ G + V + IA G+ Y+
Sbjct: 247 VVSEEPIYIVTEYMSKGSLLDFLKGETGKY----LRLPQLVDMAAQIASGMAYVER---M 299
Query: 528 KYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQKSVSL 587
YVH DL+ +NIL+G N+ V+DFGLARL
Sbjct: 300 NYVHRDLRAANILVGENLVCKVADFGLARLIED--------------------------- 332
Query: 588 EVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMIT-GRTAVVQVGSSEMDL 646
T + + APE+ + + K D++S+G++L E+ T GR
Sbjct: 333 NEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPY---------- 382
Query: 647 VNWMQLCIEEKKPLADVLD----------PYLAPDADKEEEIIAVLKIAMACVHSSPEKR 696
+VLD P P+ ++ + C PE+R
Sbjct: 383 ---------PGMVNREVLDQVERGYRMPCPPECPE--------SLHDLMCQCWRKEPEER 425
Query: 697 PTMRHISDALDRLIVSSD 714
PT ++ L+ S++
Sbjct: 426 PTFEYLQAFLEDYFTSTE 443
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 1e-24
Identities = 74/335 (22%), Positives = 120/335 (35%), Gaps = 88/335 (26%)
Query: 410 VLGKSGIGIVYKVVL-----EDGHTLAVRRLGEGGSQRFKEFQTEVEAIGKIRHSNIVTL 464
LGK G V G +AV++L G + ++FQ E++ + + IV
Sbjct: 30 QLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKY 89
Query: 465 RAYYWSVDEK--LLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLH 522
R + + L+ +Y+P+G L L + + + + I KG+ YL
Sbjct: 90 RGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRL-----LLYSSQICKGMEYLG 144
Query: 523 EFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQ 582
++ VH DL NIL+ ++DFGLA+L +P +K
Sbjct: 145 S---RRCVHRDLAARNILVESEAHVKIADFGLAKL--------------LPLDK------ 181
Query: 583 KSVSLEVTTTNSSSNLGSYYQ------------APESLKVVKPSQKWDIYSYGVILLEMI 630
YY APESL S++ D++S+GV+L E+
Sbjct: 182 -----------------DYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELF 224
Query: 631 T-GRTAVVQVGSSEMDLVNWMQLCIEEKKPLADVLD----------PYLAPDADKEEEII 679
T + S M C + L+ +L+ P P
Sbjct: 225 TYCDKS-----CSPSAEFLRMMGCERDVPALSRLLELLEEGQRLPAPPACPA-------- 271
Query: 680 AVLKIAMACVHSSPEKRPTMRHISDALDRLIVSSD 714
V ++ C SP+ RP+ + LD L S
Sbjct: 272 EVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSR 306
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 2e-24
Identities = 60/300 (20%), Positives = 111/300 (37%), Gaps = 67/300 (22%)
Query: 410 VLGKSGIGIVYKVV-LEDGHTLAVR--RLGEGGSQRFKEFQTEVEAIGKIRHSNIVTLRA 466
+G+ VYK + E +A + + + F+ E E + ++H NIV
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92
Query: 467 YYWSVDEK---LLIY-DYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLH 522
+ S + +++ + + +G+L T L F + V + I KGL +LH
Sbjct: 93 SWESTVKGKKCIVLVTELMTSGTLKTYLK------RFKVMKIKVLRSWCRQILKGLQFLH 146
Query: 523 EFSPKKYVHGDLKPSNILL-GHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQ 581
+P +H DLK NI + G + D GLA L
Sbjct: 147 TRTP-PIIHRDLKCDNIFITGPTGSVKIGDLGLATL------------------------ 181
Query: 582 QKSVSLEVTTTNSSSNLGS-YYQAPESLKVVKP--SQKWDIYSYGVILLEMITGRTAVVQ 638
+ + + +G+ + APE + + + D+Y++G+ +LEM T
Sbjct: 182 -------KRASFAKAVIGTPEFMAPE---MYEEKYDESVDVYAFGMCMLEMATSEYP--- 228
Query: 639 VGSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPT 698
S + + KP + D P+ +EII C+ + ++R +
Sbjct: 229 -YSECQNAAQIYRRVTSGVKPAS--FDKVAIPEV---KEII------EGCIRQNKDERYS 276
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 63/303 (20%), Positives = 117/303 (38%), Gaps = 63/303 (20%)
Query: 410 VLGKSGIGIVYKVV-LEDGHTLAVR--RLGEGGSQRFKEF-QTEVEAIGKIRHSNIVTLR 465
+G+ VY+ L DG +A++ ++ + + + E++ + ++ H N++
Sbjct: 39 KIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVI--- 95
Query: 466 AYY--WSVDEKLLIY-DYIPNGSLATAL--HGKPGMVSFTPVPWSVRVKIIKGIAKGLVY 520
YY + D +L I + G L+ + K +P K + L +
Sbjct: 96 KYYASFIEDNELNIVLELADAGDLSRMIKHFKKQK----RLIPERTVWKYFVQLCSALEH 151
Query: 521 LHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQER 580
+H ++ +H D+KP+N+ + + D GL R
Sbjct: 152 MHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRF----------------------- 185
Query: 581 QQKSVSLEVTTTNSSSNLGS-YYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQV 639
TT + S +G+ YY +PE + + K DI+S G +L EM ++
Sbjct: 186 ------FSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPF--- 236
Query: 640 GSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTM 699
D +N LC KK P P EE+ ++ C++ PEKRP +
Sbjct: 237 ---YGDKMNLYSLC---KKIEQCDYPPL--PSDHYSEELRQLVN---MCINPDPEKRPDV 285
Query: 700 RHI 702
++
Sbjct: 286 TYV 288
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 3e-24
Identities = 66/310 (21%), Positives = 115/310 (37%), Gaps = 58/310 (18%)
Query: 410 VLGKSGIGIVYKVV-LEDGHTLAVRRLGEGGSQRFKEFQTEVEAIGKIRHSNIVTLRAYY 468
VLG+ G V K D A++++ + +EV + + H +V A +
Sbjct: 13 VLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKL-STILSEVMLLASLNHQYVVRYYAAW 71
Query: 469 ----------WSVDEKLLIY---DYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIA 515
+V +K ++ +Y NG+L +H + ++ + I
Sbjct: 72 LERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEY-----WRLFRQIL 126
Query: 516 KGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAE 575
+ L Y+H + +H DLKP NI + + + DFGLA+ +
Sbjct: 127 EALSYIHS---QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVH---------------R 168
Query: 576 KPQERQQKSVSLEVTTTNSSSNLGS-YYQAPESLKVVKPS--QKWDIYSYGVILLEMITG 632
+ S +L ++ N +S +G+ Y A E L +K D+YS G+I EMI
Sbjct: 169 SLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLD-GTGHYNEKIDMYSLGIIFFEMIYP 227
Query: 633 RTAVVQVGSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSS 692
S+ M+ VN ++ D ++II +
Sbjct: 228 F-------STGMERVNILKKLRSVSIEFPPDFDDNKMKVE---KKIIR------LLIDHD 271
Query: 693 PEKRPTMRHI 702
P KRP R +
Sbjct: 272 PNKRPGARTL 281
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 6e-24
Identities = 73/318 (22%), Positives = 120/318 (37%), Gaps = 78/318 (24%)
Query: 410 VLGKSGIGIVYKVVLEDGHTLAVRRLGEGGSQRFKEFQTEVEAIGKIRHSNIVTLRAYYW 469
LG+ G V+ +A++ L G + F E + + K+RH +V L Y
Sbjct: 274 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQL---YA 329
Query: 470 SVDEK--LLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPK 527
V E+ ++ +Y+ GSL L G+ G + V + IA G+ Y+
Sbjct: 330 VVSEEPIYIVTEYMSKGSLLDFLKGETGKY----LRLPQLVDMAAQIASGMAYVER---M 382
Query: 528 KYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQKSVSL 587
YVH DL+ +NIL+G N+ V+DFGLARL
Sbjct: 383 NYVHRDLRAANILVGENLVCKVADFGLARLIED--------------------------- 415
Query: 588 EVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMIT-GRTAVVQVGSSEMDL 646
T + + APE+ + + K D++S+G++L E+ T GR
Sbjct: 416 NEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPY---------- 465
Query: 647 VNWMQLCIEEKKPLADVLD----------PYLAPDADKEEEIIAVLKIAMACVHSSPEKR 696
+VLD P P+ ++ + C PE+R
Sbjct: 466 ---------PGMVNREVLDQVERGYRMPCPPECPE--------SLHDLMCQCWRKEPEER 508
Query: 697 PTMRHISDALDRLIVSSD 714
PT ++ L+ S++
Sbjct: 509 PTFEYLQAFLEDYFTSTE 526
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 8e-24
Identities = 29/173 (16%), Positives = 56/173 (32%), Gaps = 10/173 (5%)
Query: 82 SALGSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSGSVPNEIGKLKYLQIL 141
L + ++ NN + QG +++ L N + + G +Q L
Sbjct: 93 QELLVGPSIETLHAANNNI-SRVSCSRG--QGKKNIYLANNKITMLRDLDEGCRSRVQYL 149
Query: 142 DLSQNFFNG-SLPVSIVQCKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLNLSFNKFNGS 200
DL N + + L+ L+L N + L+ L+LS NK
Sbjct: 150 DLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYD-VKGQ--VVFAKLKTLDLSSNKLA-F 205
Query: 201 IPSNTGNLSSLQGTVDFSHNLFSGSIPASLGNLPEKVYIDLTYNNLSGPIPQN 253
+ + + + + +N I +L + DL N ++
Sbjct: 206 MGPEFQSAAGVT-WISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRD 256
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 93.8 bits (233), Expect = 3e-20
Identities = 38/190 (20%), Positives = 64/190 (33%), Gaps = 24/190 (12%)
Query: 75 KLLGFLPSALGSLTDLRHVNLRNNKF-----FGSLP-LELLEAQG-----------LQSL 117
L + L T L +NL +N SL L L+ +++L
Sbjct: 45 PLSQISAADLAPFTKLELLNLSSNVLYETLDLESLSTLRTLDLNNNYVQELLVGPSIETL 104
Query: 118 VLYGNSFSGSVPNEIGKLKYLQILDLSQNFFNGSLPVSIVQCKRLKALDLSQNNFTGPLP 177
N+ S V G+ + + L+ N + R++ LDL N
Sbjct: 105 HAANNNIS-RVSCSRGQG--KKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNF 161
Query: 178 NGFGSGLVSLEKLNLSFNKFNGSIPSNTGNLSSLQGTVDFSHNLFSGSIPASLGNLPEKV 237
+ +LE LNL +N + + L+ T+D S N + + +
Sbjct: 162 AELAASSDTLEHLNLQYNFIY-DVKGQV-VFAKLK-TLDLSSNKLA-FMGPEFQSAAGVT 217
Query: 238 YIDLTYNNLS 247
+I L N L
Sbjct: 218 WISLRNNKLV 227
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 89.1 bits (221), Expect = 8e-19
Identities = 28/170 (16%), Positives = 59/170 (34%), Gaps = 16/170 (9%)
Query: 80 LPSALGSLTDLRHVNLRNNKFFGSLPLELLEA-QGLQSLVLYGNSFSGSVPNEIGKLKYL 138
+ + + + ++ L ++ ++ L L GN S ++ L
Sbjct: 2 IHEIKQNGNRYKIEKVTDSS-LKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 139 QILDLSQNFFNGSLPVSIVQCKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLNLSFNKFN 198
++L+LS N + L+ LDL+ N L S+E L+ + N +
Sbjct: 61 ELLNLSSNVLY-ETL-DLESLSTLRTLDLNNNYVQE-LLV-----GPSIETLHAANNNIS 112
Query: 199 GSIPSNTG-NLSSLQGTVDFSHNLFSGSIPASLGNLPEKVYIDLTYNNLS 247
+ + G ++ ++N + G Y+DL N +
Sbjct: 113 -RVSCSRGQGKKNI----YLANNKITMLRDLDEGCRSRVQYLDLKLNEID 157
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 86.8 bits (215), Expect = 5e-18
Identities = 32/175 (18%), Positives = 63/175 (36%), Gaps = 15/175 (8%)
Query: 75 KLLGFLPSALGSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSGSVPNEIGK 134
L L S S +++ ++L N +L L+ L L N ++
Sbjct: 21 SLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYE--TLDLES 78
Query: 135 LKYLQILDLSQNFFNGSLPVSIVQCKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLNLSF 194
L L+ LDL+ N+ ++ ++ L + NN + + S + + L+
Sbjct: 79 LSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNISR-VS---CSRGQGKKNIYLAN 129
Query: 195 NKFNGSIPSNT-GNLSSLQGTVDFSHNLFSG-SIPASLGNLPEKVYIDLTYNNLS 247
NK + G S +Q +D N + + +++L YN +
Sbjct: 130 NKIT-MLRDLDEGCRSRVQ-YLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY 182
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 80.3 bits (198), Expect = 6e-16
Identities = 29/175 (16%), Positives = 56/175 (32%), Gaps = 8/175 (4%)
Query: 77 LGFLPSALGSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSGSVPNEIGKLK 136
L F+ S + ++LRNNK + L +Q L+ L GN F K
Sbjct: 203 LAFMGPEFQSAAGVTWISLRNNKL-VLIEKALRFSQNLEHFDLRGNGFH-CGTLRDFFSK 260
Query: 137 YLQILDLSQNFFNGSLPVSIVQCKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLNLSFNK 196
++ +++ + +C LP F L++L++ +
Sbjct: 261 NQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCE-DLPAPFADRLIALKRKEHALLS 319
Query: 197 FNGS----IPSNTGNLSSLQGTVDFSHNLFSGSIPASLGNLPEKVYIDLTYNNLS 247
GS + N + + +D + I K+ ++ L
Sbjct: 320 GQGSETERLECERENQARQR-EIDALKEQYRTVIDQVTLRKQAKITLEQKKKALD 373
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 71.0 bits (174), Expect = 5e-13
Identities = 21/167 (12%), Positives = 45/167 (26%), Gaps = 3/167 (1%)
Query: 82 SALGSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSGSVPNEIGKLKYLQIL 141
L+ ++L +NK + E A G+ + L N + + + L+
Sbjct: 185 KGQVVFAKLKTLDLSSNKL-AFMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHF 242
Query: 142 DLSQNFFN-GSLPVSIVQCKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLNLSFNKFNGS 200
DL N F+ G+L + +R++ + +
Sbjct: 243 DLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAP 302
Query: 201 IPSNTGNLSSLQGTVDFSHNLFSGSIPASLGNLPEKVYIDLTYNNLS 247
L + + + + N + ID
Sbjct: 303 FADRLIALKRKEHALLSGQGSETERLECERENQARQREIDALKEQYR 349
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 69.1 bits (169), Expect = 2e-12
Identities = 25/191 (13%), Positives = 53/191 (27%), Gaps = 28/191 (14%)
Query: 81 PSALGSLTDLRHVNLRNNK--------FFGSLP-LELLEAQG--------------LQSL 117
G + +++++L+ N+ S LE L Q L++L
Sbjct: 137 DLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDVKGQVVFAKLKTL 196
Query: 118 VLYGNSFSGSVPNEIGKLKYLQILDLSQNFFNGSLPVSIVQCKRLKALDLSQNNFTGPLP 177
L N + + E + + L N + ++ + L+ DL N F
Sbjct: 197 DLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTL 254
Query: 178 NGFGSGLVSLEKLNLSFNKFNGSIPSNTGNLSSLQGTVDFSHNLFSGSIPASLGNLPEKV 237
F S ++ + K + ++ + L
Sbjct: 255 RDFFSKNQRVQTVAKQTVK---KLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALK 311
Query: 238 YIDLTYNNLSG 248
+ + G
Sbjct: 312 RKEHALLSGQG 322
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 62.2 bits (151), Expect = 3e-10
Identities = 17/168 (10%), Positives = 39/168 (23%), Gaps = 30/168 (17%)
Query: 77 LGFLPSALGSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSGSVPNEIGKLK 136
L + AL +L H +LR N F L ++ + + + +
Sbjct: 226 LVLIEKALRFSQNLEHFDLRGNGF-HCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECT 284
Query: 137 YLQILDLSQNFFN----------------------------GSLPVSIVQCKRLKALDLS 168
+ L R + +D
Sbjct: 285 VPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQARQREIDAL 344
Query: 169 QNNFTGPLPNGFGSGLVSLEKLNLSFNKFNGSIPSNTGNLSSLQGTVD 216
+ + + + + L + + + + L GT+
Sbjct: 345 KEQYRT-VIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAELDGTLQ 391
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 2e-23
Identities = 64/318 (20%), Positives = 122/318 (38%), Gaps = 78/318 (24%)
Query: 410 VLGKSGIGIVYKVVLEDGHTLAVRRLGEGGSQRFKEFQTEVEAIGKIRHSNIVTLRAYYW 469
LG G V+ +AV+ + G + F E + ++H +V L +
Sbjct: 195 KLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSV-EAFLAEANVMKTLQHDKLVKL---HA 250
Query: 470 SVDEK--LLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPK 527
V ++ +I +++ GSL L G + P + IA+G+ ++ + +
Sbjct: 251 VVTKEPIYIITEFMAKGSLLDFLKSDEG----SKQPLPKLIDFSAQIAEGMAFIEQ---R 303
Query: 528 KYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQKSVSL 587
Y+H DL+ +NIL+ ++ ++DFGLAR+ +
Sbjct: 304 NYIHRDLRAANILVSASLVCKIADFGLARV---------------------------IED 336
Query: 588 EVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMIT-GRTAVVQVGSSEMDL 646
T + + APE++ + K D++S+G++L+E++T GR + M
Sbjct: 337 NEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGR-----IPYPGM-- 389
Query: 647 VNWMQLCIEEKKPLADVLD----------PYLAPDADKEEEIIAVLKIAMACVHSSPEKR 696
+V+ P P+ + I M C + PE+R
Sbjct: 390 ------------SNPEVIRALERGYRMPRPENCPE--------ELYNIMMRCWKNRPEER 429
Query: 697 PTMRHISDALDRLIVSSD 714
PT +I LD +++
Sbjct: 430 PTFEYIQSVLDDFYTATE 447
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 4e-23
Identities = 63/298 (21%), Positives = 109/298 (36%), Gaps = 51/298 (17%)
Query: 410 VLGKSGIGIVYKVV-LEDGHTLAVRR--LGEGGSQRFKEFQTEVEAIGKI-RHSNIVTLR 465
+G G V+K V DG A++R GS + EV A + +HS++V
Sbjct: 18 KIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVV--- 74
Query: 466 AYY--WSVDEKLLIY-DYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLH 522
Y+ W+ D+ +LI +Y GSLA A+ + + ++ + +GL Y+H
Sbjct: 75 RYFSAWAEDDHMLIQNEYCNGGSLADAI--SENYRIMSYFKEAELKDLLLQVGRGLRYIH 132
Query: 523 EFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQ 582
VH D+KPSNI + + A+ G SN++ +
Sbjct: 133 S---MSLVHMDIKPSNIFISRT--------SIPNAASEEGDEDDWASNKVMF------KI 175
Query: 583 KSVSLEVTTTNSSSNLGS-YYQAPESLKVVKP-SQKWDIYSYGVILLEMITGRTAVVQVG 640
+ ++ G + A E L+ K DI++ + ++
Sbjct: 176 GDLGHVTRISSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPL----- 230
Query: 641 SSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPT 698
D W ++ + VL E +LK +H PE+RP+
Sbjct: 231 PRNGDQ--WHEIRQGRLPRIPQVLSQ----------EFTELLK---VMIHPDPERRPS 273
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 5e-23
Identities = 68/330 (20%), Positives = 128/330 (38%), Gaps = 85/330 (25%)
Query: 410 VLGKSGIGIVYKVVLE-----DGHTLAVRRLGEGGSQRFKEFQTEVEAIGKIRHSNIVTL 464
LGK G V + G +AV++L + ++F+ E+E + ++H NIV
Sbjct: 17 QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 76
Query: 465 RAYYWSVDEK--LLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLH 522
+ +S + LI +Y+P GSL L + + ++ I KG+ YL
Sbjct: 77 KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL-----LQYTSQICKGMEYLG 131
Query: 523 EFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQ 582
K+Y+H DL NIL+ + + DFGL ++ +P +K
Sbjct: 132 T---KRYIHRDLATRNILVENENRVKIGDFGLTKV--------------LPQDK------ 168
Query: 583 KSVSLEVTTTNSSSNLGSYYQ------------APESLKVVKPSQKWDIYSYGVILLEMI 630
+++ APESL K S D++S+GV+L E+
Sbjct: 169 -----------------EFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELF 211
Query: 631 TGRTAVVQVGSSEMDLVNWMQLCIEEKKPLADVLD----------PYLAPDADKEEEIIA 680
T + S + + + + + + +++ P PD
Sbjct: 212 TYIE---KSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPD--------E 260
Query: 681 VLKIAMACVHSSPEKRPTMRHISDALDRLI 710
+ I C +++ +RP+ R ++ +D++
Sbjct: 261 IYMIMTECWNNNVNQRPSFRDLALRVDQIR 290
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 1e-22
Identities = 60/311 (19%), Positives = 112/311 (36%), Gaps = 81/311 (26%)
Query: 410 VLGKSGIGIVYKVV-LEDGHTLAVRRLGEGGSQRFKEFQTEVEAIGKIRHSNIVTLRAYY 468
++G G G V+K DG T ++R+ ++ + EV+A+ K+ H NIV +
Sbjct: 18 LIGSGGFGQVFKAKHRIDGKTYVIKRV----KYNNEKAEREVKALAKLDHVNIVHYNGCW 73
Query: 469 ---------------WSVDEKLLIY-DYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIK 512
S + L I ++ G+L + + G + + +++ +
Sbjct: 74 DGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRG----EKLDKVLALELFE 129
Query: 513 GIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRM 572
I KG+ Y+H KK ++ DLKPSNI L + + DFGL
Sbjct: 130 QITKGVDYIHS---KKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLK------------- 173
Query: 573 PAEKPQERQQKSVSLEVTTTNSSSNLGS-YYQAPESLKVVKPSQKWDIYSYGVILLEMIT 631
+ + G+ Y +PE + ++ D+Y+ G+IL E++
Sbjct: 174 -----------------NDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLH 216
Query: 632 GRTAVVQVGSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHS 691
V + + + ++D+ D ++ +
Sbjct: 217 -------VCDTAFETSKFFTDLR--DGIISDIFDKKEK-------TLLQ------KLLSK 254
Query: 692 SPEKRPTMRHI 702
PE RP I
Sbjct: 255 KPEDRPNTSEI 265
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 2e-22
Identities = 70/334 (20%), Positives = 128/334 (38%), Gaps = 85/334 (25%)
Query: 410 VLGKSGIGIVYKVVLE-----DGHTLAVRRLGEGGSQRFKEFQTEVEAIGKIRHSNIVTL 464
LGK G V + G +AV++L + ++F+ E+E + ++H NIV
Sbjct: 48 QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 107
Query: 465 RAYYWSVDEK--LLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLH 522
+ +S + LI +Y+P GSL L + + ++ I KG+ YL
Sbjct: 108 KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL-----LQYTSQICKGMEYLG 162
Query: 523 EFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQ 582
K+Y+H DL NIL+ + + DFGL ++ +P +K
Sbjct: 163 T---KRYIHRDLATRNILVENENRVKIGDFGLTKV--------------LPQDK------ 199
Query: 583 KSVSLEVTTTNSSSNLGSYYQ------------APESLKVVKPSQKWDIYSYGVILLEMI 630
YY+ APESL K S D++S+GV+L E+
Sbjct: 200 -----------------EYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELF 242
Query: 631 TGRTAVVQVGSSEMDLVNWMQLCIEEKKPLADVLD----------PYLAPDADKEEEIIA 680
T + S + + + + + + +++ P PD
Sbjct: 243 TYIE---KSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPD--------E 291
Query: 681 VLKIAMACVHSSPEKRPTMRHISDALDRLIVSSD 714
+ I C +++ +RP+ R ++ +D++
Sbjct: 292 IYMIMTECWNNNVNQRPSFRDLALRVDQIRDQMA 325
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 3e-22
Identities = 62/236 (26%), Positives = 97/236 (41%), Gaps = 54/236 (22%)
Query: 410 VLGKSGIGIVYKVV-LEDGHTLAVRRLGEGGSQRFKEFQTEVEAIGKIRHSNIVTLRAYY 468
VLGK GIVY L + +A++ + E S+ + E+ ++H NIV Y
Sbjct: 29 VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQ---YL 85
Query: 469 WSV--DEKLLIY-DYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFS 525
S + + I+ + +P GSL+ L K G + K I +GL YLH+
Sbjct: 86 GSFSENGFIKIFMEQVPGGSLSALLRSKWGPL---KDNEQTIGFYTKQILEGLKYLHD-- 140
Query: 526 PKKYVHGDLKPSNILLG-HNMEPHVSDFGLA-RLANIAGGSPTLQSNRMPAEKPQERQQK 583
+ VH D+K N+L+ ++ +SDFG + RLA I + T
Sbjct: 141 -NQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFT--------------- 184
Query: 584 SVSLEVTTTNSSSNLGS-YYQAPESLKVVKPSQ-----KWDIYSYGVILLEMITGR 633
G+ Y APE ++ DI+S G ++EM TG+
Sbjct: 185 ---------------GTLQYMAPE---IIDKGPRGYGKAADIWSLGCTIIEMATGK 222
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 3e-22
Identities = 61/312 (19%), Positives = 105/312 (33%), Gaps = 70/312 (22%)
Query: 410 VLGKSGIGIVYKVVLEDGHTL-AVRRLGEGGSQR-FKEFQTEVEAIGKIRHSNIVTLRAY 467
+G+ G V+ L +TL AV+ E +F E + + H NIV L
Sbjct: 121 QIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 180
Query: 468 YWSVDEKLLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPK 527
++ + + G T L + + ++++ A G+ YL K
Sbjct: 181 CTQKQPIYIVMELVQGGDFLTFLRTEGA-----RLRVKTLLQMVGDAAAGMEYLES---K 232
Query: 528 KYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQKSVSL 587
+H DL N L+ +SDFG++R + +
Sbjct: 233 CCIHRDLAARNCLVTEKNVLKISDFGMSREEA---------------DGVYAASGGLRQV 277
Query: 588 EVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMIT-GRT-----AVVQVGS 641
V T APE+L + S + D++S+G++L E + G + + Q
Sbjct: 278 PVKWT-----------APEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQT-- 324
Query: 642 SEMDLVN---WMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPT 698
+ V + P L PD AV ++ C P +RP+
Sbjct: 325 --REFVEKGGRLPC-------------PELCPD--------AVFRLMEQCWAYEPGQRPS 361
Query: 699 MRHISDALDRLI 710
I L +
Sbjct: 362 FSTIYQELQSIR 373
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 99.8 bits (249), Expect = 3e-22
Identities = 70/317 (22%), Positives = 116/317 (36%), Gaps = 74/317 (23%)
Query: 410 VLGKSGIGIVYKVVLEDGHTL-AVRRLGEGGSQRFKEFQTEVEAIGKIRHSNIVTLRAYY 468
LG G VY+ V + AV+ L E + +EF E + +I+H N+V L
Sbjct: 227 KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQLLGVC 285
Query: 469 WSVDEKLLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKK 528
+I +++ G+L L V V + + I+ + YL + K
Sbjct: 286 TREPPFYIITEFMTYGNLLDYLRECNR----QEVSAVVLLYMATQISSAMEYLEK---KN 338
Query: 529 YVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQKSVSLE 588
++H +L N L+G N V+DFGL+RL +
Sbjct: 339 FIHRNLAARNCLVGENHLVKVADFGLSRLMTG---------------------------D 371
Query: 589 VTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMIT-GRTAVVQVGSSEMDLV 647
T ++ + + APESL K S K D++++GV+L E+ T G +
Sbjct: 372 TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY----------- 420
Query: 648 NWMQLCIEEKKPLADVLD----------PYLAPDADKEEEIIAVLKIAMACVHSSPEKRP 697
L+ V + P P+ V ++ AC +P RP
Sbjct: 421 --------PGIDLSQVYELLEKDYRMERPEGCPE--------KVYELMRACWQWNPSDRP 464
Query: 698 TMRHISDALDRLIVSSD 714
+ I A + + S
Sbjct: 465 SFAEIHQAFETMFQESS 481
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 4e-22
Identities = 32/174 (18%), Positives = 60/174 (34%), Gaps = 7/174 (4%)
Query: 77 LGFLPSALGSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSGSVPNEI--GK 134
G + T L++++L N ++ L + L+ L ++ +
Sbjct: 362 KGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLK-QMSEFSVFLS 419
Query: 135 LKYLQILDLSQNFFNGSLPVSIVQCKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLNLSF 194
L+ L LD+S + L+ L ++ N+F + L +L L+LS
Sbjct: 420 LRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQ 479
Query: 195 NKFNGSIPSNT-GNLSSLQGTVDFSHNLFSGSIPASLGNLPEKVYIDLTYNNLS 247
+ + +LSSLQ ++ + N L I L N
Sbjct: 480 CQLE-QLSPTAFNSLSSLQ-VLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWD 531
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 92.5 bits (230), Expect = 1e-19
Identities = 38/178 (21%), Positives = 65/178 (36%), Gaps = 8/178 (4%)
Query: 81 PSALGSLTDLRHVNLRNNKFFGSLPLELLEA-QGLQSLVLYGNSFSGSVPNEIGKLKYLQ 139
+ S +L+ ++L + ++ ++ L +L+L GN L LQ
Sbjct: 45 SYSFFSFPELQVLDLSRCEI-QTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQ 103
Query: 140 ILDLSQNFFNGSLPVSIVQCKRLKALDLSQNNFT-GPLPNGFGSGLVSLEKLNLSFNKFN 198
L + I K LK L+++ N LP F S L +LE L+LS NK
Sbjct: 104 KLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYF-SNLTNLEHLDLSSNKIQ 162
Query: 199 GSIPSNTGNLSSLQG---TVDFSHNLFSGSIPASLGNLPEKVYIDLTYNNLSGPIPQN 253
++ L + ++D S N + I + L N S + +
Sbjct: 163 SIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKEIRLHKLTLRNNFDSLNVMKT 219
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 84.8 bits (210), Expect = 3e-17
Identities = 38/158 (24%), Positives = 61/158 (38%), Gaps = 8/158 (5%)
Query: 92 HVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSGSVPNEIGKLKYLQILDLSQNFFNGS 151
F+ +P L ++L L N LQ+LDLS+
Sbjct: 11 TYQCMELNFY-KIPDNLPF--STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTI 67
Query: 152 LPVSIVQCKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLNLSFNKFNGSIPSNT-GNLSS 210
+ L L L+ N L G SGL SL+KL S+ + G+L +
Sbjct: 68 EDGAYQSLSHLSTLILTGNPIQS-LALGAFSGLSSLQKLVAVETNLA-SLENFPIGHLKT 125
Query: 211 LQGTVDFSHN-LFSGSIPASLGNLPEKVYIDLTYNNLS 247
L+ ++ +HN + S +P NL ++DL+ N +
Sbjct: 126 LK-ELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQ 162
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 82.1 bits (203), Expect = 2e-16
Identities = 39/196 (19%), Positives = 68/196 (34%), Gaps = 27/196 (13%)
Query: 80 LPSALGSLTDLRHVNLRNNK--------FFGSLP-LELL----------EAQGLQSLVLY 120
+ LT++ +L + + LEL+ + + L+ L
Sbjct: 274 IIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFT 333
Query: 121 GNSFSGSVPNEIGKLKYLQILDLSQNFFN--GSLPVSIVQCKRLKALDLSQNNFTGPLPN 178
N + +E+ L L+ LDLS+N + G S LK LDLS N + +
Sbjct: 334 SNKGG-NAFSEVD-LPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSS 390
Query: 179 GFGSGLVSLEKLNLSFNKFNGSIPSNT-GNLSSLQGTVDFSHNLFSGSIPASLGNLPEKV 237
F GL LE L+ + + +L +L +D SH + L
Sbjct: 391 NF-LGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLI-YLDISHTHTRVAFNGIFNGLSSLE 448
Query: 238 YIDLTYNNLSGPIPQN 253
+ + N+ +
Sbjct: 449 VLKMAGNSFQENFLPD 464
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 4e-16
Identities = 35/186 (18%), Positives = 57/186 (30%), Gaps = 14/186 (7%)
Query: 75 KLLGFLPSALGSLTDLRHVNLRNNKF-FGSLPLELLEAQGLQSLVLYGNSFSGSVPNEIG 133
L +G L L+ +N+ +N LP L+ L L N ++
Sbjct: 111 NLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLR 170
Query: 134 KLKYLQI----LDLSQNFFNGSLPVSIVQCKRLKALDLSQNNFTGPLPNGFGSGLVSLEK 189
L + + LDLS N N + + RL L L N + + GL LE
Sbjct: 171 VLHQMPLLNLSLDLSLNPMN-FIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEV 229
Query: 190 LNLSFNKFNG-----SIPSNT-GNLSSLQGTV-DFSH-NLFSGSIPASLGNLPEKVYIDL 241
L +F + L +L ++ + + I L L
Sbjct: 230 HRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSL 289
Query: 242 TYNNLS 247
+
Sbjct: 290 VSVTIE 295
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 5e-15
Identities = 38/189 (20%), Positives = 67/189 (35%), Gaps = 16/189 (8%)
Query: 75 KLLGFLPSALGSLTDLRHVNLRNNK---FFGSLPLELLEAQGLQSLVLYGNSFSGSVPNE 131
L F SAL L +L R + + + S L + V +
Sbjct: 242 NLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIE-RVKDF 300
Query: 132 IGKLKYLQILDLSQNFFNGSLPVSIVQCKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLN 191
Q L+L F ++ K LK L + N L SLE L+
Sbjct: 301 SYNFG-WQHLELVNCKFGQ---FPTLKLKSLKRLTFTSNKGGNAFS---EVDLPSLEFLD 353
Query: 192 LSFNKFN--GSIPSNTGNLSSLQGTVDFSHNLFSGSIPASLGNLPEKVYIDLTYNNLSGP 249
LS N + G + +SL+ +D S N ++ ++ L + ++D ++NL
Sbjct: 354 LSRNGLSFKGCCSQSDFGTTSLK-YLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQ- 410
Query: 250 IPQNGALMN 258
+ + ++
Sbjct: 411 MSEFSVFLS 419
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 6e-15
Identities = 32/126 (25%), Positives = 56/126 (44%), Gaps = 6/126 (4%)
Query: 81 PSALGSLTDLRHVNLRNNKFFGSLPLELLEA-QGLQSLVLYGNSFSGSVPNEI-GKLKYL 138
S SL +L ++++ + + L+ L + GNSF + +I +L+ L
Sbjct: 414 FSVFLSLRNLIYLDISHTHT-RVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNL 472
Query: 139 QILDLSQNFFNGSLPVSI-VQCKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLNLSFNKF 197
LDLSQ L + L+ L+++ N +P+G L SL+K+ L N +
Sbjct: 473 TFLDLSQCQLE-QLSPTAFNSLSSLQVLNMASNQLKS-VPDGIFDRLTSLQKIWLHTNPW 530
Query: 198 NGSIPS 203
+ S P
Sbjct: 531 DCSCPR 536
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 74.4 bits (183), Expect = 5e-14
Identities = 33/214 (15%), Positives = 63/214 (29%), Gaps = 20/214 (9%)
Query: 75 KLLGFLPSALGSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSF-SGSVPNEIG 133
+ A L+ L+ + + + L+ L + N S +P
Sbjct: 87 PIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFS 146
Query: 134 KLKYLQILDLSQNFFNGSLPVSIVQCKRLKA----LDLSQNNFTGPLPNGFGSGLVSLEK 189
L L+ LDLS N + ++ LDLS N + G + L K
Sbjct: 147 NLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNF-IQPGAFKEI-RLHK 204
Query: 190 LNLSFNKFNGSIPSNT-GNLSSLQ-----GTVDFSHNLFSGSIPASLGNLPEKVYIDLTY 243
L L N + ++ L+ L+ + ++L L + +
Sbjct: 205 LTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLC---NLTIEE 261
Query: 244 NNLSGPIPQNGALMNRGPTAFIGNPRLCGPPLKN 277
L+ ++ F + L +
Sbjct: 262 FRLA----YLDYYLDDIIDLFNCLTNVSSFSLVS 291
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 97.1 bits (242), Expect = 5e-22
Identities = 61/298 (20%), Positives = 109/298 (36%), Gaps = 59/298 (19%)
Query: 410 VLGKSGIGIVYKVV-LEDGHTLAVR--RLGEGGSQRFKEFQTEVEAIGKIRHSNIVTLRA 466
+G+ G V EDG ++ + S+ +E + EV + ++H NIV R
Sbjct: 31 KIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRE 90
Query: 467 YYWSVDEKLLIY-DYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFS 525
+ + L I DY G L ++ + G + I L ++H+
Sbjct: 91 S-FEENGSLYIVMDYCEGGDLFKRINAQKG----VLFQEDQILDWFVQICLALKHVHD-- 143
Query: 526 PKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQKSV 585
+K +H D+K NI L + + DFG+AR+
Sbjct: 144 -RKILHRDIKSQNIFLTKDGTVQLGDFGIARV---------------------------- 174
Query: 586 SLEVTTTNSSSNLGS-YYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGSSEM 644
L T + + +G+ YY +PE + + K DI++ G +L E+ T + A S
Sbjct: 175 -LNSTVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAF--EAGSMK 231
Query: 645 DLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHI 702
+LV ++ P++ L + +P RP++ I
Sbjct: 232 NLVL--KIISGSFPPVSLHYSYDLR-------------SLVSQLFKRNPRDRPSVNSI 274
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 96.7 bits (241), Expect = 6e-22
Identities = 50/241 (20%), Positives = 90/241 (37%), Gaps = 54/241 (22%)
Query: 410 VLGKSGIGIVYKVVLEDGHTLAVRR--LGEGGSQRFKEFQTEVEAIGKIRH--SNIVTLR 465
+G G V++V+ E A++ L E +Q ++ E+ + K++ I+ L
Sbjct: 16 QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 75
Query: 466 AYYWSVDEKLLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFS 525
Y + ++ + N L + L + R K + + + +H+
Sbjct: 76 DYEITDQYIYMVMEC-GNIDLNSWL------KKKKSIDPWERKSYWKNMLEAVHTIHQ-- 126
Query: 526 PKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQKSV 585
VH DLKP+N L+ + + DFG+A +
Sbjct: 127 -HGIVHSDLKPANFLI-VDGMLKLIDFGIA---------------------------NQM 157
Query: 586 SLEVTTTNSSSNLGS-YYQAPESLK-----------VVKPSQKWDIYSYGVILLEMITGR 633
+ T+ S +G+ Y PE++K K S K D++S G IL M G+
Sbjct: 158 QPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 217
Query: 634 T 634
T
Sbjct: 218 T 218
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 98.9 bits (246), Expect = 1e-21
Identities = 51/295 (17%), Positives = 95/295 (32%), Gaps = 41/295 (13%)
Query: 10 VLCNFNGFVDSLNGEGYALLSFKQSVHEDPEGSLSNWNSSDENPCSWNGITCKEQRVVSV 69
++ D + + ++V E ++ ++ + ++ +
Sbjct: 25 TYADYFSAWDKWEKQALPGENRNEAVSLLKECLINQFSELQ---LNRLNLS-----SLPD 76
Query: 70 SIPK--KKL------LGFLPSALGSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYG 121
++P L L LP SL L + +N+ +LP L+ L +
Sbjct: 77 NLPPQITVLEITQNALISLPELPASLEYL---DACDNRL-STLPELP---ASLKHLDVDN 129
Query: 122 NSFSGSVPNEIGKLKYLQILDLSQNFFNGSLPVSIVQCKRLKALDLSQNNFTGPLPNGFG 181
N + +P L+Y+ + N LP L+ L + N T LP
Sbjct: 130 NQLT-MLPELPALLEYI---NADNNQLT-MLPELP---TSLEVLSVRNNQLTF-LP---- 176
Query: 182 SGLVSLEKLNLSFNKFNGSIPSNTGNLSSLQGTV---DFSHNLFSGSIPASLGNLPEKVY 238
SLE L++S N S+P+ + T N + IP ++ +L
Sbjct: 177 ELPESLEALDVSTNLLE-SLPAVPVRNHHSEETEIFFRCRENRIT-HIPENILSLDPTCT 234
Query: 239 IDLTYNNLSGPIPQNGALMNRGPTAFIGNPRLCGPPLKNPCSSDVPGASSPASYP 293
I L N LS I ++ + P + + A +P
Sbjct: 235 IILEDNPLSSRIRESLSQQTAQPDYHGPRIYFSMSDGQQNTLHRPLADAVTAWFP 289
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 55.0 bits (132), Expect = 6e-08
Identities = 29/164 (17%), Positives = 45/164 (27%), Gaps = 10/164 (6%)
Query: 77 LGFLPSALGSLTDLRHVNLRNNKFFGSLPLELLEAQGLQS----LVLYGNSFSGSVPNEI 132
L FLP SL L ++ N SLP + + N + +P I
Sbjct: 172 LTFLPELPESLEAL---DVSTNLL-ESLPAVPVRNHHSEETEIFFRCRENRIT-HIPENI 226
Query: 133 GKLKYLQILDLSQNFFNGSLPVSIVQCKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLNL 192
L + L N + + S+ Q + F+ + +
Sbjct: 227 LSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYFSMSDGQQNTLHRPLADAVTA 286
Query: 193 SFNKFNGSIPSNT-GNLSSLQGTVDFSHNLFSGSIPASLGNLPE 235
F + S S + FS L S S N
Sbjct: 287 WFPENKQSDVSQIWHAFEHEEHANTFSAFLDRLSDTVSARNTSG 330
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 96.1 bits (240), Expect = 1e-21
Identities = 37/170 (21%), Positives = 68/170 (40%), Gaps = 12/170 (7%)
Query: 82 SALGSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSGSVPNEIGKLKYLQIL 141
+ + +LTDL ++L N+ PL L + L Y N + P + + L L
Sbjct: 171 TPIANLTDLYSLSLNYNQIEDISPLASLTS--LHYFTAYVNQITDITP--VANMTRLNSL 226
Query: 142 DLSQNFFNGSLPVSIVQCKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLNLSFNKFNGSI 201
+ N P++ +L L++ N + N L L+ LN+ N+ +
Sbjct: 227 KIGNNKITDLSPLA--NLSQLTWLEIGTNQISDI--NAVKD-LTKLKMLNVGSNQISD-- 279
Query: 202 PSNTGNLSSLQGTVDFSHNLFSGSIPASLGNLPEKVYIDLTYNNLSGPIP 251
S NLS L ++ ++N +G L + L+ N+++ P
Sbjct: 280 ISVLNNLSQLN-SLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP 328
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 95.3 bits (238), Expect = 2e-21
Identities = 37/168 (22%), Positives = 64/168 (38%), Gaps = 16/168 (9%)
Query: 82 SALGSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSGSVPNEIGKLKYLQIL 141
S L SLT L + N+ P+ + L SL + N + P + L L L
Sbjct: 193 SPLASLTSLHYFTAYVNQITDITPVANM--TRLNSLKIGNNKITDLSP--LANLSQLTWL 248
Query: 142 DLSQNFFNGSLPVSIVQCKRLKALDLSQNNFTG--PLPNGFGSGLVSLEKLNLSFNKFNG 199
++ N + + ++ +LK L++ N + L + L L L L+ N+
Sbjct: 249 EIGTNQIS-DIN-AVKDLTKLKMLNVGSNQISDISVL-----NNLSQLNSLFLNNNQLGN 301
Query: 200 SIPSNTGNLSSLQGTVDFSHNLFSGSIPASLGNLPEKVYIDLTYNNLS 247
G L++L T+ S N + P L +L + D +
Sbjct: 302 EDMEVIGGLTNLT-TLFLSQNHITDIRP--LASLSKMDSADFANQVIK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 93.0 bits (232), Expect = 1e-20
Identities = 34/170 (20%), Positives = 69/170 (40%), Gaps = 13/170 (7%)
Query: 82 SALGSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSGSVPNEIGKLKYLQIL 141
+ LT+L ++NL N+ PL L L +L + N + + + L L+ L
Sbjct: 60 QGIEYLTNLEYLNLNGNQITDISPLSNLVK--LTNLYIGTNKITD--ISALQNLTNLREL 115
Query: 142 DLSQNFFNGSLPVSIVQCKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLNLSFNKFNGSI 201
L+++ + P++ ++ +L+L N+ + + L L ++ +K
Sbjct: 116 YLNEDNISDISPLA--NLTKMYSLNLGANHNLS-DLSPLS-NMTGLNYLTVTESKVKDVT 171
Query: 202 PSNTGNLSSLQGTVDFSHNLFSGSIPASLGNLPEKVYIDLTYNNLSGPIP 251
P NL+ L ++ ++N P L +L Y N ++ P
Sbjct: 172 P--IANLTDLY-SLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITP 216
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 91.8 bits (229), Expect = 3e-20
Identities = 39/171 (22%), Positives = 69/171 (40%), Gaps = 17/171 (9%)
Query: 81 PSALGSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSGSVPNEIGKLKYLQI 140
SAL +LT+LR + L + PL L + SL L N S + + + L
Sbjct: 103 ISALQNLTNLRELYLNEDNISDISPLANLTK--MYSLNLGANHNL-SDLSPLSNMTGLNY 159
Query: 141 LDLSQNFFNGSLPVSIVQCKRLKALDLSQNNFTG--PLPNGFGSGLVSLEKLNLSFNKFN 198
L ++++ P++ L +L L+ N PL + L SL N+
Sbjct: 160 LTVTESKVKDVTPIA--NLTDLYSLSLNYNQIEDISPL-----ASLTSLHYFTAYVNQIT 212
Query: 199 GSIPSNTGNLSSLQGTVDFSHNLFSGSIPASLGNLPEKVYIDLTYNNLSGP 249
P N++ L ++ +N + P L NL + ++++ N +S
Sbjct: 213 DITPV--ANMTRLN-SLKIGNNKITDLSP--LANLSQLTWLEIGTNQISDI 258
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 77.6 bits (192), Expect = 2e-15
Identities = 37/172 (21%), Positives = 63/172 (36%), Gaps = 17/172 (9%)
Query: 87 LTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSGSVPNEIGKLKYLQILDLSQN 146
L + N+ F P L VL S + V +L+ + L ++
Sbjct: 2 AATLATLPAPINQIF---PDADLAE--GIRAVLQKASVTDVVT--QEELESITKLVVAGE 54
Query: 147 FFNGSLPVSIVQCKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLNLSFNKFNGSIPSNTG 206
S+ I L+ L+L+ N T P S LV L L + NK + S
Sbjct: 55 KVA-SIQ-GIEYLTNLEYLNLNGNQITDISPL---SNLVKLTNLYIGTNKI--TDISALQ 107
Query: 207 NLSSLQGTVDFSHNLFSGSIPASLGNLPEKVYIDLTYNNLSGPIPQNGALMN 258
NL++L+ + + + S P L NL + ++L N+ + +
Sbjct: 108 NLTNLR-ELYLNEDNISDISP--LANLTKMYSLNLGANHNLSDLSPLSNMTG 156
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 46.4 bits (111), Expect = 2e-05
Identities = 14/66 (21%), Positives = 24/66 (36%), Gaps = 2/66 (3%)
Query: 81 PSALGSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSGSVPNEIGKLKYLQI 140
S L +L+ L + L NN+ + L +L L N + P + L +
Sbjct: 280 ISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDS 337
Query: 141 LDLSQN 146
D +
Sbjct: 338 ADFANQ 343
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 96.4 bits (240), Expect = 2e-21
Identities = 51/241 (21%), Positives = 91/241 (37%), Gaps = 54/241 (22%)
Query: 410 VLGKSGIGIVYKVVLEDGHTLAVRR--LGEGGSQRFKEFQTEVEAIGKIRH--SNIVTLR 465
+G G V++V+ E A++ L E +Q ++ E+ + K++ I+ L
Sbjct: 63 QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 122
Query: 466 AYYWSVDEKLLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFS 525
Y + D+ + + N L + L + R K + + + +H+
Sbjct: 123 DYEIT-DQYIYMVMECGNIDLNSWL------KKKKSIDPWERKSYWKNMLEAVHTIHQ-- 173
Query: 526 PKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQKSV 585
VH DLKP+N L+ + + DFG+A +
Sbjct: 174 -HGIVHSDLKPANFLI-VDGMLKLIDFGIA---------------------------NQM 204
Query: 586 SLEVTTTNSSSNLGS-YYQAPESLK-----------VVKPSQKWDIYSYGVILLEMITGR 633
+ T+ S +G+ Y PE++K K S K D++S G IL M G+
Sbjct: 205 QPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 264
Query: 634 T 634
T
Sbjct: 265 T 265
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 2e-21
Identities = 62/332 (18%), Positives = 112/332 (33%), Gaps = 89/332 (26%)
Query: 410 VLGKSGIGIVYKVVLE-----DGHTLAVRRLGEG-GSQRFKEFQTEVEAIGKIRHSNIVT 463
LG+ G V + G +AV+ L G + + E+E + + H NIV
Sbjct: 28 DLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVK 87
Query: 464 LRA--YYWSVDEKLLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYL 521
+ + LI +++P+GSL L ++ +K I KG+ YL
Sbjct: 88 YKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQ-----LKYAVQICKGMDYL 142
Query: 522 HEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQ 581
++YVH DL N+L+ + + DFGL + + +K
Sbjct: 143 GS---RQYVHRDLAARNVLVESEHQVKIGDFGLTKA--------------IETDK----- 180
Query: 582 QKSVSLEVTTTNSSSNLGSYYQ------------APESLKVVKPSQKWDIYSYGVILLEM 629
YY APE L K D++S+GV L E+
Sbjct: 181 ------------------EYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHEL 222
Query: 630 IT-GRTAVVQVGSSEMDLVNWMQLCIEEKKPLADVLD----------PYLAPDADKEEEI 678
+T + + + + + +++ P PD
Sbjct: 223 LTYCDSDSSPMALFLKMIGPT-----HGQMTVTRLVNTLKEGKRLPCPPNCPD------- 270
Query: 679 IAVLKIAMACVHSSPEKRPTMRHISDALDRLI 710
V ++ C P R + +++ + + L+
Sbjct: 271 -EVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 93.4 bits (233), Expect = 2e-21
Identities = 60/312 (19%), Positives = 115/312 (36%), Gaps = 74/312 (23%)
Query: 410 VLGKSGIGIVYKVVLEDGHTLAVRRLGEGGSQRFKEFQTEVEAIGKIRHSNIVTLRAYYW 469
+G G+V+ + +A++ + EG ++F E E + K+ H +V L
Sbjct: 15 EIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE-EDFIEEAEVMMKLSHPKLVQLYGVCL 73
Query: 470 SVDEKLLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKY 529
L+ +++ +G L+ L + G+ + + + + + +G+ YL E
Sbjct: 74 EQAPICLVTEFMEHGCLSDYLRTQRGLFAAETL-----LGMCLDVCEGMAYLEE---ACV 125
Query: 530 VHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQKSVSLEV 589
+H DL N L+G N VSDFG+ R V +
Sbjct: 126 IHRDLAARNCLVGENQVIKVSDFGMTRF---------------------------VLDDQ 158
Query: 590 TTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMIT-GRTAVVQVGSSEMDLVN 648
T+++ + + +PE + S K D++S+GV++ E+ + G+
Sbjct: 159 YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPY------------ 206
Query: 649 WMQLCIEEKKPLADVLD----------PYLAPDADKEEEIIAVLKIAMACVHSSPEKRPT 698
E + ++V++ P LA V +I C PE RP
Sbjct: 207 -------ENRSNSEVVEDISTGFRLYKPRLAST--------HVYQIMNHCWRERPEDRPA 251
Query: 699 MRHISDALDRLI 710
+ L +
Sbjct: 252 FSRLLRQLAEIA 263
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 94.6 bits (235), Expect = 3e-21
Identities = 46/238 (19%), Positives = 78/238 (32%), Gaps = 44/238 (18%)
Query: 467 YYWSVDEKLLI-YDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFS 525
S L I +L ++ + V + I IA+ + +LH
Sbjct: 128 QPSSPKVYLYIQMQLCRKENLKDWMNRRCS---LEDREHGVCLHIFIQIAEAVEFLHS-- 182
Query: 526 PKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQKSV 585
K +H DLKPSNI + V DFGL + E +Q +
Sbjct: 183 -KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQ-----------------DEEEQTVL 224
Query: 586 SLEVTTTNSSSNLGS-YYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGSSEM 644
+ + +G+ Y +PE + S K DI+S G+IL E++ + E
Sbjct: 225 TPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFST-----QMER 279
Query: 645 DLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHI 702
+ + + +E ++ + SP +RP I
Sbjct: 280 VRI-ITDVR---NLKFPLLFTQKY----PQEHMMVQ------DMLSPSPTERPEATDI 323
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 93.8 bits (234), Expect = 3e-21
Identities = 52/232 (22%), Positives = 93/232 (40%), Gaps = 50/232 (21%)
Query: 411 LGKSGIGIVYK---VVLEDGHTLAVR--RLGEGGSQRFKE-FQTEVEAIGKIRHSNIVTL 464
LG G+ VY +L +A++ + + + F+ EV ++ H NIV++
Sbjct: 19 LGGGGMSTVYLAEDTIL--NIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSM 76
Query: 465 RAYYWSVDEKL--LIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLH 522
++ L+ +YI +L+ + P+ + I G+ + H
Sbjct: 77 --IDVDEEDDCYYLVMEYIEGPTLSEYIESH------GPLSVDTAINFTNQILDGIKHAH 128
Query: 523 EFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQ 582
+ + VH D+KP NIL+ N + DFG+A+ +
Sbjct: 129 D---MRIVHRDIKPQNILIDSNKTLKIFDFGIAKALS----------------------- 162
Query: 583 KSVSLEVTTTNSSSNLGS-YYQAPESLKVVKPSQKWDIYSYGVILLEMITGR 633
E + T ++ LG+ Y +PE K + DIYS G++L EM+ G
Sbjct: 163 -----ETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGE 209
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 3e-21
Identities = 50/241 (20%), Positives = 90/241 (37%), Gaps = 54/241 (22%)
Query: 410 VLGKSGIGIVYKVVLEDGHTLAVRR--LGEGGSQRFKEFQTEVEAIGKIRH--SNIVTLR 465
+G G V++V+ E A++ L E +Q ++ E+ + K++ I+ L
Sbjct: 35 QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 94
Query: 466 AYYWSVDEKLLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFS 525
Y + ++ + N L + L + R K + + + +H+
Sbjct: 95 DYEITDQYIYMVMEC-GNIDLNSWL------KKKKSIDPWERKSYWKNMLEAVHTIHQ-- 145
Query: 526 PKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQKSV 585
VH DLKP+N L+ + + DFG+A +
Sbjct: 146 -HGIVHSDLKPANFLI-VDGMLKLIDFGIA---------------------------NQM 176
Query: 586 SLEVTTTNSSSNLGS-YYQAPESLK-----------VVKPSQKWDIYSYGVILLEMITGR 633
+ T+ S +G+ Y PE++K K S K D++S G IL M G+
Sbjct: 177 QPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 236
Query: 634 T 634
T
Sbjct: 237 T 237
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 7e-21
Identities = 38/190 (20%), Positives = 63/190 (33%), Gaps = 24/190 (12%)
Query: 75 KLLGFLPSALGSLTDLRHVNLRNNKF-----FGSLP-LELL-----------EAQGLQSL 117
L + L T L +NL +N SL L L +++L
Sbjct: 45 PLSQISAADLAPFTKLELLNLSSNVLYETLDLESLSTLRTLDLNNNYVQELLVGPSIETL 104
Query: 118 VLYGNSFSGSVPNEIGKLKYLQILDLSQNFFNGSLPVSIVQCKRLKALDLSQNNFTGPLP 177
N+ S V G+ + + L+ N + R++ LDL N
Sbjct: 105 HAANNNIS-RVSCSRGQG--KKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNF 161
Query: 178 NGFGSGLVSLEKLNLSFNKFNGSIPSNTGNLSSLQGTVDFSHNLFSGSIPASLGNLPEKV 237
+ +LE LNL +N + + L+ T+D S N + + +
Sbjct: 162 AELAASSDTLEHLNLQYNFIY-DVKGQV-VFAKLK-TLDLSSNKLA-FMGPEFQSAAGVT 217
Query: 238 YIDLTYNNLS 247
+I L N L
Sbjct: 218 WISLRNNKLV 227
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 5e-20
Identities = 28/170 (16%), Positives = 59/170 (34%), Gaps = 16/170 (9%)
Query: 80 LPSALGSLTDLRHVNLRNNKFFGSLPLELLEA-QGLQSLVLYGNSFSGSVPNEIGKLKYL 138
+ + + + ++ L ++ ++ L L GN S ++ L
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSL-KQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 139 QILDLSQNFFNGSLPVSIVQCKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLNLSFNKFN 198
++L+LS N + L+ LDL+ N L S+E L+ + N +
Sbjct: 61 ELLNLSSNVLY-ETL-DLESLSTLRTLDLNNNYVQE-LLV-----GPSIETLHAANNNIS 112
Query: 199 GSIPSNTG-NLSSLQGTVDFSHNLFSGSIPASLGNLPEKVYIDLTYNNLS 247
+ + G ++ ++N + G Y+DL N +
Sbjct: 113 -RVSCSRGQGKKNI----YLANNKITMLRDLDEGCRSRVQYLDLKLNEID 157
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 2e-18
Identities = 32/175 (18%), Positives = 65/175 (37%), Gaps = 15/175 (8%)
Query: 75 KLLGFLPSALGSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSGSVPNEIGK 134
L L S S +++ ++L N +L L+ L L N ++
Sbjct: 21 SLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLY-ETL-DLES 78
Query: 135 LKYLQILDLSQNFFNGSLPVSIVQCKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLNLSF 194
L L+ LDL+ N+ ++ ++ L + NN + + G + + L+
Sbjct: 79 LSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNISR-VSCSRGQ---GKKNIYLAN 129
Query: 195 NKFNGSIPSNT-GNLSSLQGTVDFSHN-LFSGSIPASLGNLPEKVYIDLTYNNLS 247
NK + G S +Q +D N + + + + +++L YN +
Sbjct: 130 NKIT-MLRDLDEGCRSRVQ-YLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY 182
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 3e-11
Identities = 23/139 (16%), Positives = 45/139 (32%), Gaps = 25/139 (17%)
Query: 81 PSALGSLTDLRHVNLRNNK--------FFGSLP-LELLEAQG--------------LQSL 117
G + +++++L+ N+ S LE L Q L++L
Sbjct: 137 DLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDVKGQVVFAKLKTL 196
Query: 118 VLYGNSFSGSVPNEIGKLKYLQILDLSQNFFNGSLPVSIVQCKRLKALDLSQNNFTGPLP 177
L N + + E + + L N + ++ + L+ DL N F
Sbjct: 197 DLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTL 254
Query: 178 NGFGSGLVSLEKLNLSFNK 196
F S ++ + K
Sbjct: 255 RDFFSKNQRVQTVAKQTVK 273
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 3e-09
Identities = 23/117 (19%), Positives = 40/117 (34%), Gaps = 3/117 (2%)
Query: 77 LGFLPSALGSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSGSVPNEIGKLK 136
L F+ S + ++LRNNK + L +Q L+ L GN F K
Sbjct: 203 LAFMGPEFQSAAGVTWISLRNNK-LVLIEKALRFSQNLEHFDLRGNGFH-CGTLRDFFSK 260
Query: 137 YLQILDLSQNFFNGSLPVSIVQCKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLNLS 193
++ +++ L + + L LP F L++L +
Sbjct: 261 NQRVQTVAKQTVK-KLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALGHHHHH 316
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 1e-20
Identities = 61/312 (19%), Positives = 111/312 (35%), Gaps = 74/312 (23%)
Query: 410 VLGKSGIGIVYKVVLEDGHTLAVRRLGEGGSQRFKEFQTEVEAIGKIRHSNIVTLRAYYW 469
LG G+V + +A++ + EG EF E + + + H +V L
Sbjct: 31 ELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE-DEFIEEAKVMMNLSHEKLVQLYGVCT 89
Query: 470 SVDEKLLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKY 529
+I +Y+ NG L L +++ K + + + YL K++
Sbjct: 90 KQRPIFIITEYMANGCLLNYLREMRHRFQTQ-----QLLEMCKDVCEAMEYLES---KQF 141
Query: 530 VHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQKSVSLEV 589
+H DL N L+ VSDFGL+R V +
Sbjct: 142 LHRDLAARNCLVNDQGVVKVSDFGLSRY---------------------------VLDDE 174
Query: 590 TTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMIT-GRTAVVQVGSSEMDLVN 648
T++ S + PE L K S K DI+++GV++ E+ + G+
Sbjct: 175 YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPY------------ 222
Query: 649 WMQLCIEEKKPLADVLD----------PYLAPDADKEEEIIAVLKIAMACVHSSPEKRPT 698
E+ ++ + P+LA + V I +C H ++RPT
Sbjct: 223 -------ERFTNSETAEHIAQGLRLYRPHLASE--------KVYTIMYSCWHEKADERPT 267
Query: 699 MRHISDALDRLI 710
+ + + ++
Sbjct: 268 FKILLSNILDVM 279
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 1e-20
Identities = 69/315 (21%), Positives = 116/315 (36%), Gaps = 84/315 (26%)
Query: 410 VLGKSGIGIVYKVVLEDGHTLAVRRLGEGGSQRFKEFQTEVEAIGKIRHSNIVTLRAYYW 469
+GK G V G+ +AV+ + + + F E + ++RHSN+V L
Sbjct: 200 TIGKGEFGDVMLGDYR-GNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLG--- 253
Query: 470 SV--DEKLLIY---DYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEF 524
V +EK +Y +Y+ GSL L + + + +K + + + YL
Sbjct: 254 -VIVEEKGGLYIVTEYMAKGSLVDYLRSRGR----SVLGGDCLLKFSLDVCEAMEYLEG- 307
Query: 525 SPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQKS 584
+VH DL N+L+ + VSDFGL +
Sbjct: 308 --NNFVHRDLAARNVLVSEDNVAKVSDFGLTK---------------------------- 337
Query: 585 VSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMIT-GRT-----AVVQ 638
E ++T + L + APE+L+ K S K D++S+G++L E+ + GR +
Sbjct: 338 ---EASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD 394
Query: 639 VGSSEMDLVN---WMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEK 695
V + V M P P AV + C H
Sbjct: 395 V----VPRVEKGYKMDA-------------PDGCPP--------AVYDVMKNCWHLDAAT 429
Query: 696 RPTMRHISDALDRLI 710
RPT + + L+ +
Sbjct: 430 RPTFLQLREQLEHIR 444
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 1e-20
Identities = 61/301 (20%), Positives = 112/301 (37%), Gaps = 56/301 (18%)
Query: 410 VLGKSGIGIVYKVV-LEDGHTLAVRRLGEGG-SQRFKEF-QTEVEAIGKIRHSNIVTLR- 465
+G G K+ DG L + L G ++ K+ +EV + +++H NIV
Sbjct: 13 TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 72
Query: 466 AYYWSVDEKLLIY-DYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEF 524
+ L I +Y G LA+ + G + ++++ + L H
Sbjct: 73 RIIDRTNTTLYIVMEYCEGGDLASVI--TKGTKERQYLDEEFVLRVMTQLTLALKECHRR 130
Query: 525 SPKKY--VHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQ 582
S + +H DLKP+N+ L + DFGLAR+
Sbjct: 131 SDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI------------------------- 165
Query: 583 KSVSLEVTTTNSSSNLGS-YYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGS 641
L T+ + + +G+ YY +PE + + ++K DI+S G +L E+
Sbjct: 166 ----LNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPF--TAF 219
Query: 642 SEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRH 701
S+ +L ++ + + + L EII ++ RP++
Sbjct: 220 SQKELAG--KIREGKFRRIPYRYSDEL-------NEIIT------RMLNLKDYHRPSVEE 264
Query: 702 I 702
I
Sbjct: 265 I 265
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 93.2 bits (231), Expect = 1e-20
Identities = 33/329 (10%), Positives = 67/329 (20%), Gaps = 81/329 (24%)
Query: 410 VLGKSGIGIVYKVV-LEDGHTLAV---RRLGEGGSQRFKEFQTEVEAIGKIRHSNIVTLR 465
L +V+ V +E A+ E + A ++ + R
Sbjct: 69 PLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEAR 128
Query: 466 AYY--------------------------WSVDEKLLIYDYIPNGSLATALHGKPGMVSF 499
++V LL+ + L + F
Sbjct: 129 DRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPA-ASVDLELLFSTLDFVYVF 187
Query: 500 -TPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLA 558
+ + + L K VHG P N+ + + + D
Sbjct: 188 RGDEGILALHILTAQLIRLAANLQS---KGLVHGHFTPDNLFIMPDGRLMLGDVSALWKV 244
Query: 559 NIAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESL--KVVKPSQK 616
+ + Y E L +
Sbjct: 245 G------------------------TRGPASSVP-------VTYAPREFLNASTATFTHA 273
Query: 617 WDIYSYGVILLEMITGRTAVVQVGSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEE 676
+ + G+ + + V L + LA L +
Sbjct: 274 LNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFV---K 330
Query: 677 EIIAVLKIAMACVHSSPEKRPT----MRH 701
+I ++ +R M
Sbjct: 331 TLI------GRFLNFDRRRRLLPLEAMET 353
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 1e-20
Identities = 62/323 (19%), Positives = 112/323 (34%), Gaps = 67/323 (20%)
Query: 410 VLGKSGIGIVYKVVLED-----GHTLAVRRLGEG-GSQRFKEFQTEVEAIGKIRHSNIVT 463
LG+ G V + G +AV+ L G Q ++ E++ + + H +I+
Sbjct: 38 DLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIK 97
Query: 464 LRAYYWSVDEK--LLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYL 521
+ L+ +Y+P GSL L + + + + I +G+ YL
Sbjct: 98 YKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHS-------IGLAQLLLFAQQICEGMAYL 150
Query: 522 HEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQ 581
H + Y+H DL N+LL ++ + DFGLA+ +P R
Sbjct: 151 HA---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKA--------------VPEGHEYYRV 193
Query: 582 QKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMIT-GRTAVVQVG 640
++ V APE LK K D++S+GV L E++T ++
Sbjct: 194 REDGDSPVFWY-----------APECLKEYKFYYASDVWSFGVTLYELLTHCDSS----- 237
Query: 641 SSEMDLVNWMQLCIEEKKPLADVLD----------PYLAPDADKEEEIIAVLKIAMACVH 690
S + + + + + + P P V + C
Sbjct: 238 QSPPTKFLELIGIAQGQMTVLRLTELLERGERLPRPDKCPA--------EVYHLMKNCWE 289
Query: 691 SSPEKRPTMRHISDALDRLIVSS 713
+ RPT ++ L +
Sbjct: 290 TEASFRPTFENLIPILKTVHEKY 312
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 91.1 bits (227), Expect = 2e-20
Identities = 64/318 (20%), Positives = 119/318 (37%), Gaps = 78/318 (24%)
Query: 410 VLGKSGIGIVYKVVLEDGHTLAVRRLGEGGSQRFKEFQTEVEAIGKIRHSNIVTLRAYYW 469
LG G V+ +AV+ L +G F E + +++H +V L Y
Sbjct: 20 RLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP-DAFLAEANLMKQLQHQRLVRL---YA 75
Query: 470 SVDEK--LLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPK 527
V ++ +I +Y+ NGSL L G + + + + IA+G+ ++ E +
Sbjct: 76 VVTQEPIYIITEYMENGSLVDFLKTPSG----IKLTINKLLDMAAQIAEGMAFIEE---R 128
Query: 528 KYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQKSVSL 587
Y+H DL+ +NIL+ + ++DFGLARL +
Sbjct: 129 NYIHRDLRAANILVSDTLSCKIADFGLARL---------------------------IED 161
Query: 588 EVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMIT-GRTAVVQVGSSEMDL 646
T + + APE++ + K D++S+G++L E++T GR
Sbjct: 162 NEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPY---------- 211
Query: 647 VNWMQLCIEEKKPLADVLD----------PYLAPDADKEEEIIAVLKIAMACVHSSPEKR 696
+V+ P P+ + ++ C PE R
Sbjct: 212 ---------PGMTNPEVIQNLERGYRMVRPDNCPE--------ELYQLMRLCWKERPEDR 254
Query: 697 PTMRHISDALDRLIVSSD 714
PT ++ L+ +++
Sbjct: 255 PTFDYLRSVLEDFFTATE 272
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 3e-20
Identities = 51/235 (21%), Positives = 88/235 (37%), Gaps = 52/235 (22%)
Query: 410 VLGKSGIGIVYK---VVLEDGHTLAVRRLGE--GGSQRFKE-FQTEVEAIGKIRHSNIVT 463
++G+ G+G VY+ V +A++ + E F+ Q E G+++ ++V
Sbjct: 41 LVGRGGMGDVYEAEDTVR--ERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVP 98
Query: 464 LRAYYWSVDEKLLIY---DYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVY 520
+ + + + L Y I LA L P+ V I++ I L
Sbjct: 99 I--HDFGEIDGQL-YVDMRLINGVDLAAMLR------RQGPLAPPRAVAIVRQIGSALDA 149
Query: 521 LHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQER 580
H H D+KP NIL+ + ++ DFG+A A L
Sbjct: 150 AHA---AGATHRDVKPENILVSADDFAYLVDFGIAS----ATTDEKL------------- 189
Query: 581 QQKSVSLEVTTTNSSSNLGSY-YQAPESLKVVKPSQKWDIYSYGVILLEMITGRT 634
T ++ +G+ Y APE + + DIY+ +L E +TG
Sbjct: 190 ---------TQLGNT--VGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSP 233
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 91.7 bits (228), Expect = 3e-20
Identities = 66/312 (21%), Positives = 108/312 (34%), Gaps = 52/312 (16%)
Query: 410 VLGKSGIGIVYKVV-LEDGHTLAVRRLGEGGSQRFKEFQTEVEAIGKIR-HSNIVTLRAY 467
VL + G VY+ + G A++RL ++ + EV + K+ H NIV +
Sbjct: 35 VLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSA 94
Query: 468 YWSVDEK-------LLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVY 520
E+ L+ + G L L + +KI + + +
Sbjct: 95 ASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSC---DTVLKIFYQTCRAVQH 151
Query: 521 LHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQER 580
+H P +H DLK N+LL + + DFG A T+ + Q R
Sbjct: 152 MHRQKPP-IIHRDLKVENLLLSNQGTIKLCDFGSAT---------TISHYPDYSWSAQRR 201
Query: 581 QQKSVSLEVTTTNSSSNLGSYYQAPE--SLKVVKP-SQKWDIYSYGVILLEMITGRTAVV 637
+ TT Y+ PE L P +K DI++ G IL + +
Sbjct: 202 ALVEEEITRNTT-------PMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHP-- 252
Query: 638 QVGSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRP 697
E+ L V Y P D + + L AM V+ PE+R
Sbjct: 253 ----------------FEDGAKLRIVNGKYSIPPHDTQYTVFHSLIRAMLQVN--PEERL 294
Query: 698 TMRHISDALDRL 709
++ + L +
Sbjct: 295 SIAEVVHQLQEI 306
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 3e-20
Identities = 39/171 (22%), Positives = 57/171 (33%), Gaps = 23/171 (13%)
Query: 77 LGFLPSALGSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSGSVPNEIGKLK 136
L LP SL L N LP L+ L + N +P E+
Sbjct: 103 LTELPELPQSLKSLLVDNNNLKA-LSDLP------PLLEYLGVSNNQLE-KLP-ELQNSS 153
Query: 137 YLQILDLSQNFFNGSLPVSIVQCKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLNLSFNK 196
+L+I+D+ N LP L+ + N LP + L L + N
Sbjct: 154 FLKIIDVDNNSLK-KLPDLPPS---LEFIAAGNNQLEE-LPE-LQN-LPFLTAIYADNNS 206
Query: 197 FNGSIPSNTGNLSSLQGTVDFSHNLFSGSIPASLGNLPEKVYIDLTYNNLS 247
+P +L S+ +N+ +P L NLP I N L
Sbjct: 207 LK-KLPDLPLSLESI----VAGNNILE-ELP-ELQNLPFLTTIYADNNLLK 250
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 4e-18
Identities = 43/187 (22%), Positives = 66/187 (35%), Gaps = 37/187 (19%)
Query: 77 LGFLPSALGSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSGSVPNEIGKLK 136
L LP L +L L + NN LP L+S+V N E+ L
Sbjct: 185 LEELPE-LQNLPFLTAIYADNNSL-KKLPDLP---LSLESIVAGNNILE--ELPELQNLP 237
Query: 137 YLQILDLSQNFFNGSLPVSIVQCKRLKALDLSQNNFTGPLPNGFGS-------------- 182
+L + N +LP L+AL++ N T LP S
Sbjct: 238 FLTTIYADNNLLK-TLPDLPPS---LEALNVRDNYLTD-LPELPQSLTFLDVSENIFSGL 292
Query: 183 --GLVSLEKLNLSFNKFNGSIPSNTGNLSSLQGTVDFSHNLFSGSIPASLGNLPEKVYID 240
+L LN S N+ S+ +L L + S+N +PA L +
Sbjct: 293 SELPPNLYYLNASSNEIR-SLCDLPPSLEEL----NVSNNKLI-ELPALPPRL---ERLI 343
Query: 241 LTYNNLS 247
++N+L+
Sbjct: 344 ASFNHLA 350
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 2e-16
Identities = 38/208 (18%), Positives = 68/208 (32%), Gaps = 41/208 (19%)
Query: 79 FLPSALGSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSGSVPNEIGKLKYL 138
F+ S T L+ ++ +P+E + + + + P G+ + +
Sbjct: 2 FINPRNVSNTFLQEPLRHSSNL-TEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREM 60
Query: 139 QI-------------LDLSQNFFNGSLPVSIVQCKRLKALDLSQNNFTGPLPNGFGSGLV 185
+ L+L+ + SLP L++L S N+ T LP S L
Sbjct: 61 AVSRLRDCLDRQAHELELNNLGLS-SLPELP---PHLESLVASCNSLT-ELPELPQS-LK 114
Query: 186 SLEKLNLSFNKFNGSIPSNT---------------GNLSSLQGTVDFSHNLFSGSIPASL 230
SL N + + P N S L+ +D +N +P
Sbjct: 115 SLLVDNNNLKALSDLPPLLEYLGVSNNQLEKLPELQNSSFLK-IIDVDNNSLK-KLPDLP 172
Query: 231 GNLPEKVYIDLTYNNLSGPIPQNGALMN 258
+L +I N L +P+ L
Sbjct: 173 PSL---EFIAAGNNQLEE-LPELQNLPF 196
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 1e-14
Identities = 32/185 (17%), Positives = 54/185 (29%), Gaps = 36/185 (19%)
Query: 80 LPSALGSLTDLRHVNLRNNKFFGSLP----LELLEAQ---------GLQSLVLYGNSFSG 126
LP SLT L + P L + L+ L + N
Sbjct: 272 LPELPQSLTFLDVSENIFSGLSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI- 330
Query: 127 SVPNEIGKLKYLQILDLSQNFFNGSLPVSIVQCKRLKALDLSQNNFTGPLPNGFGSGLVS 186
+P + L+ L S N +P + LK L + N P+ S
Sbjct: 331 ELPALPPR---LERLIASFNHLA-EVPELP---QNLKQLHVEYNPLRE-FPDIPE----S 378
Query: 187 LEKLNLSFNKFNGSIPSNTGNLSSLQGTVDFSHNLFSGSIPASLGNLPEKVYIDLTYNNL 246
+E L ++ + +P NL L N P ++ + + + +
Sbjct: 379 VEDLRMN-SHLA-EVPELPQNLKQL----HVETNPLR-EFPDIPESVED---LRMNSERV 428
Query: 247 SGPIP 251
P
Sbjct: 429 VDPYE 433
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 2e-12
Identities = 31/160 (19%), Positives = 46/160 (28%), Gaps = 34/160 (21%)
Query: 80 LPSALGSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSGSVPNEIGKLKYLQ 139
L SL +L N+ NNK LP L+ L+ N + VP LK L
Sbjct: 312 LCDLPPSLEEL---NVSNNKL-IELPALP---PRLERLIASFNHLA-EVPELPQNLKQL- 362
Query: 140 ILDLSQNFFNGSLPVSIVQ----------------CKRLKALDLSQNNFTGPLPNGFGSG 183
+ N P + LK L + N P+ S
Sbjct: 363 --HVEYNPLR-EFPDIPESVEDLRMNSHLAEVPELPQNLKQLHVETNPLRE-FPDIPES- 417
Query: 184 LVSLEKLNLSFNKFNGSIPSNTGNLSSLQGTVDFSHNLFS 223
+E L ++ + L+ F H+
Sbjct: 418 ---VEDLRMNSERVVDPYEFAHETTDKLE-DDVFEHHHHH 453
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 3e-20
Identities = 49/178 (27%), Positives = 70/178 (39%), Gaps = 14/178 (7%)
Query: 81 PSALGSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSGSVPNEIGKLKYLQI 140
L SLT+L ++L NN+ PL L L L L N S P + L L
Sbjct: 236 IGTLASLTNLTDLDLANNQISNLAPLSGL--TKLTELKLGANQISNISP--LAGLTALTN 291
Query: 141 LDLSQNFFNGSLPVSIVQCKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLNLSFNKFNGS 200
L+L++N P I K L L L NN + P S L L++L NK +
Sbjct: 292 LELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP---VSSLTKLQRLFFYNNKVSD- 345
Query: 201 IPSNTGNLSSLQGTVDFSHNLFSGSIPASLGNLPEKVYIDLTYNNLSGPIPQNGALMN 258
S+ NL+++ + HN S P L NL + L + A ++
Sbjct: 346 -VSSLANLTNIN-WLSAGHNQISDLTP--LANLTRITQLGLNDQAWTNAPVNYKANVS 399
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 2e-19
Identities = 41/171 (23%), Positives = 63/171 (36%), Gaps = 15/171 (8%)
Query: 81 PSALGSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSGSVPNEIGKLKYLQI 140
SAL LT L+ ++ N PL L L+ L + N S + + KL L+
Sbjct: 149 ISALSGLTSLQQLSFGNQVT-DLKPLANL--TTLERLDISSNKVSD--ISVLAKLTNLES 203
Query: 141 LDLSQNFFNGSLPVSIVQCKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLNLSFNKFNGS 200
L + N + P+ L L L+ N + L +L L+L+ N+ +
Sbjct: 204 LIATNNQISDITPLG--ILTNLDELSLNGNQLKDI--GTL-ASLTNLTDLDLANNQISNL 258
Query: 201 IPSNTGNLSSLQGTVDFSHNLFSGSIPASLGNLPEKVYIDLTYNNLSGPIP 251
P L+ L + N S P L L ++L N L P
Sbjct: 259 AP--LSGLTKLT-ELKLGANQISNISP--LAGLTALTNLELNENQLEDISP 304
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 3e-18
Identities = 28/170 (16%), Positives = 55/170 (32%), Gaps = 15/170 (8%)
Query: 82 SALGSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSGSVPNEIGKLKYLQIL 141
+L + L ++ L+ + +L + + L L +
Sbjct: 18 FTDTALAEKMKTVLGKTNVTDTVSQTDLD--QVTTLQADRLGIKS--IDGVEYLNNLTQI 73
Query: 142 DLSQNFFNGSLPVSIVQCKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLNLSFNKFNGSI 201
+ S N P+ +L + ++ N P L +L L L N+
Sbjct: 74 NFSNNQLTDITPLK--NLTKLVDILMNNNQIADITPLA---NLTNLTGLTLFNNQITDID 128
Query: 202 PSNTGNLSSLQGTVDFSHNLFSGSIPASLGNLPEKVYIDLTYNNLSGPIP 251
P NL++L ++ S N S ++L L + N ++ P
Sbjct: 129 PL--KNLTNLN-RLELSSNTISD--ISALSGLTSLQQLSF-GNQVTDLKP 172
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 3e-18
Identities = 47/170 (27%), Positives = 70/170 (41%), Gaps = 14/170 (8%)
Query: 82 SALGSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSGSVPNEIGKLKYLQIL 141
+ LG LT+L ++L N+ L L L L L N S P + L L L
Sbjct: 215 TPLGILTNLDELSLNGNQLKDIGTLASLTN--LTDLDLANNQISNLAP--LSGLTKLTEL 270
Query: 142 DLSQNFFNGSLPVSIVQCKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLNLSFNKFNGSI 201
L N + P++ L L+L++N P S L +L L L FN +
Sbjct: 271 KLGANQISNISPLA--GLTALTNLELNENQLEDISP---ISNLKNLTYLTLYFNNISDIS 325
Query: 202 PSNTGNLSSLQGTVDFSHNLFSGSIPASLGNLPEKVYIDLTYNNLSGPIP 251
P +L+ LQ + F +N S +SL NL ++ +N +S P
Sbjct: 326 P--VSSLTKLQ-RLFFYNNKVSD--VSSLANLTNINWLSAGHNQISDLTP 370
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 3e-18
Identities = 45/189 (23%), Positives = 72/189 (38%), Gaps = 29/189 (15%)
Query: 81 PSALGSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSGSVPNEIGKLKYLQI 140
+ L +L +N NN+ PL+ L L +++ N + P + L L
Sbjct: 61 IDGVEYLNNLTQINFSNNQLTDITPLKNLTK--LVDILMNNNQIADITP--LANLTNLTG 116
Query: 141 LDLSQNFFNGSLPVSIVQCKRLKALDLSQNNFTGP-----LPN----GFG---------S 182
L L N P + L L+LS N + L + FG +
Sbjct: 117 LTLFNNQITDIDP--LKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLA 174
Query: 183 GLVSLEKLNLSFNKFNGSIPSNTGNLSSLQGTVDFSHNLFSGSIPASLGNLPEKVYIDLT 242
L +LE+L++S NK S S L++L+ ++ ++N S P LG L + L
Sbjct: 175 NLTTLERLDISSNKV--SDISVLAKLTNLE-SLIATNNQISDITP--LGILTNLDELSLN 229
Query: 243 YNNLSGPIP 251
N L
Sbjct: 230 GNQLKDIGT 238
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 4e-18
Identities = 38/192 (19%), Positives = 63/192 (32%), Gaps = 29/192 (15%)
Query: 82 SALGSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSGSVPNEIGKLKYLQIL 141
S L LT L ++ L N+ P+ L + L L LY N+ S P + L LQ L
Sbjct: 281 SPLAGLTALTNLELNENQLEDISPISNL--KNLTYLTLYFNNISDISP--VSSLTKLQRL 336
Query: 142 DLSQNFFNGSLPVSIVQCKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLNLSFNKFNGSI 201
N + S+ + L N + P L + +L L+ + +
Sbjct: 337 FFYNNKVSD--VSSLANLTNINWLSAGHNQISDLTPLA---NLTRITQLGLNDQAWTNAP 391
Query: 202 PSNTGNLSSLQGTVDFSHNLFSGSIPASLGNL-------------PEKVY-------IDL 241
+ N+S + + L + + + G+ E Y I
Sbjct: 392 VNYKANVSIPNTVKNVTGALIAPATISDGGSYTEPDITWNLPSYTNEVSYTFSQPVTIGK 451
Query: 242 TYNNLSGPIPQN 253
SG + Q
Sbjct: 452 GTTTFSGTVTQP 463
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 2e-15
Identities = 28/162 (17%), Positives = 52/162 (32%), Gaps = 18/162 (11%)
Query: 95 LRNNKFFGSLPLELLEAQGLQSLVLYGNSFSGSVPNEIGKLKYLQILDLSQNFFNGSLPV 154
++ L VL + + +V L + L +
Sbjct: 9 TQDTPINQIFTDTALAE--KMKTVLGKTNVTDTVS--QTDLDQVTTLQADRL--GIKSID 62
Query: 155 SIVQCKRLKALDLSQNNFTG--PLPNGFGSGLVSLEKLNLSFNKFNGSIPSNTGNLSSLQ 212
+ L ++ S N T PL L L + ++ N+ P NL++L
Sbjct: 63 GVEYLNNLTQINFSNNQLTDITPL-----KNLTKLVDILMNNNQIADITP--LANLTNLT 115
Query: 213 GTVDFSHNLFSGSIPASLGNLPEKVYIDLTYNNLSGPIPQNG 254
+ +N + P L NL ++L+ N +S +G
Sbjct: 116 -GLTLFNNQITDIDP--LKNLTNLNRLELSSNTISDISALSG 154
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 4e-07
Identities = 19/123 (15%), Positives = 44/123 (35%), Gaps = 8/123 (6%)
Query: 81 PSALGSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSGSVPNEIGKLKYLQI 140
S+L +LT++ ++ +N+ PL L + L L +++ + P + I
Sbjct: 346 VSSLANLTNINWLSAGHNQISDLTPLANLTR--ITQLGLNDQAWT-NAPVNYKAN--VSI 400
Query: 141 LDLSQNFFNG-SLPVSIVQCKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLNLSFNKFNG 199
+ +N P +I D++ N + + + F+G
Sbjct: 401 PNTVKNVTGALIAPATISDGGSYTEPDITWNLPSYTNEVSYTFSQ--PVTIGKGTTTFSG 458
Query: 200 SIP 202
++
Sbjct: 459 TVT 461
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 90.3 bits (225), Expect = 4e-20
Identities = 69/319 (21%), Positives = 118/319 (36%), Gaps = 88/319 (27%)
Query: 410 VLGKSGIGIVYKVVLEDGHTLAVRRLGEGGSQRFKEFQTEVEAIGKIRHSNIVTLRAYYW 469
+GK G V G+ +AV+ + + + F E + ++RHSN+V L
Sbjct: 28 TIGKGEFGDVMLGDYR-GNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLG--- 81
Query: 470 SV--DEKLLIY---DYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEF 524
V +EK +Y +Y+ GSL L + + + +K + + + YL
Sbjct: 82 -VIVEEKGGLYIVTEYMAKGSLVDYLRSRGR----SVLGGDCLLKFSLDVCEAMEYL--- 133
Query: 525 SPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQKS 584
+VH DL N+L+ + VSDFGL +
Sbjct: 134 EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTK---------------------------- 165
Query: 585 VSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMIT-GRTAVVQVGSSE 643
E ++T + L + APE+L+ K S K D++S+G++L E+ + GR
Sbjct: 166 ---EASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPY------- 215
Query: 644 MDLVNWMQLCIEEKKPLADVLD----------PYLAPDADKEEEIIAVLKIAMACVHSSP 693
+ PL DV+ P P AV ++ C H
Sbjct: 216 ------------PRIPLKDVVPRVEKGYKMDAPDGCPP--------AVYEVMKNCWHLDA 255
Query: 694 EKRPTMRHISDALDRLIVS 712
RP+ + + L+ +
Sbjct: 256 AMRPSFLQLREQLEHIKTH 274
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 5e-20
Identities = 59/311 (18%), Positives = 116/311 (37%), Gaps = 74/311 (23%)
Query: 410 VLGKSGIGIVYKVVLEDGHTLAVRRLGEGGSQRFKEFQTEVEAIGKIRHSNIVTLRAYYW 469
LG G+V + + +AV+ + EG EF E + + K+ H +V
Sbjct: 15 ELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSE-DEFFQEAQTMMKLSHPKLVKFYGVCS 73
Query: 470 SVDEKLLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKY 529
++ +YI NG L L + + +++ + +G+ +L ++
Sbjct: 74 KEYPIYIVTEYISNGCLLNYLRSHGKGLEPS-----QLLEMCYDVCEGMAFLES---HQF 125
Query: 530 VHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQKSVSLEV 589
+H DL N L+ ++ VSDFG+ R V +
Sbjct: 126 IHRDLAARNCLVDRDLCVKVSDFGMTRY---------------------------VLDDQ 158
Query: 590 TTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMIT-GRTAVVQVGSSEMDLVN 648
++ + + APE K S K D++++G+++ E+ + G+
Sbjct: 159 YVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPY------------ 206
Query: 649 WMQLCIEEKKPLADVLD----------PYLAPDADKEEEIIAVLKIAMACVHSSPEKRPT 698
+ ++V+ P+LA D + +I +C H PEKRPT
Sbjct: 207 -------DLYTNSEVVLKVSQGHRLYRPHLASD--------TIYQIMYSCWHELPEKRPT 251
Query: 699 MRHISDALDRL 709
+ + +++ L
Sbjct: 252 FQQLLSSIEPL 262
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 93.4 bits (232), Expect = 5e-20
Identities = 49/177 (27%), Positives = 69/177 (38%), Gaps = 26/177 (14%)
Query: 77 LGFLPSALGSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSGSVPNEIGKLK 136
L LP+ L L NN+ SLP+ GLQ L + N + S+P +L
Sbjct: 153 LASLPALPSELCKL---WAYNNQL-TSLPMLP---SGLQELSVSDNQLA-SLPTLPSELY 204
Query: 137 YLQILDLSQNFFNGSLPVSIVQCKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLNLSFNK 196
L + SLP LK L +S N T LP L++L +S N+
Sbjct: 205 KLWAYNNRLT----SLPALPSG---LKELIVSGNRLTS-LPVLPSE----LKELMVSGNR 252
Query: 197 FNGSIPSNTGNLSSLQGTVDFSHNLFSGSIPASLGNLPEKVYIDLTYNNLSGPIPQN 253
S+P L SL N + +P SL +L + ++L N LS Q
Sbjct: 253 LT-SLPMLPSGLLSL----SVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQA 303
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 91.9 bits (228), Expect = 2e-19
Identities = 34/161 (21%), Positives = 56/161 (34%), Gaps = 25/161 (15%)
Query: 87 LTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSGSVPNEIGKLKYLQILDLSQN 146
+N+ + +LP L + +LV+ N+ + S+P +L+ L ++S N
Sbjct: 39 NNGNAVLNVGESGL-TTLPDCLP--AHITTLVIPDNNLT-SLPALPPELRTL---EVSGN 91
Query: 147 FFNGSLPVSIVQCKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLNLSFNKFNGSIPSNTG 206
SLPV L + L KL + N+ S+P
Sbjct: 92 QLT-SLPVLPPGLLELSIFSNPLTHLPALPSG--------LCKLWIFGNQLT-SLPVLPP 141
Query: 207 NLSSLQGTVDFSHNLFSGSIPASLGNLPEKVYIDLTYNNLS 247
L L S N + S+PA L + N L+
Sbjct: 142 GLQEL----SVSDNQLA-SLPALPSEL---CKLWAYNNQLT 174
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 89.2 bits (221), Expect = 1e-18
Identities = 44/187 (23%), Positives = 69/187 (36%), Gaps = 41/187 (21%)
Query: 77 LGFLPSALGSLTDLRHVNLRNNKF------FGSLP-LELLEAQ---------GLQSLVLY 120
L LP+ L L + N+ L L + GL L ++
Sbjct: 73 LTSLPALPPELRTL---EVSGNQLTSLPVLPPGLLELSIFSNPLTHLPALPSGLCKLWIF 129
Query: 121 GNSFSGSVPNEIGKLKYLQILDLSQNFFNGSLPVSIVQCKRLKALDLSQNNFTGPLPNGF 180
GN + S+P L+ L +S N SLP + L L N T LP
Sbjct: 130 GNQLT-SLPVLPPGLQE---LSVSDNQLA-SLPALPSE---LCKLWAYNNQLTS-LPMLP 180
Query: 181 GSGLVSLEKLNLSFNKFNGSIPSNTGNLSSLQGTVDFSHNLFSGSIPASLGNLPEKVYID 240
L++L++S N+ S+P+ L L +N + S+PA L E +
Sbjct: 181 S----GLQELSVSDNQLA-SLPTLPSELYKL----WAYNNRLT-SLPALPSGLKE---LI 227
Query: 241 LTYNNLS 247
++ N L+
Sbjct: 228 VSGNRLT 234
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 69.9 bits (171), Expect = 1e-12
Identities = 27/136 (19%), Positives = 50/136 (36%), Gaps = 13/136 (9%)
Query: 77 LGFLPSALGSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSGSVPNEIGKLK 136
L LP+ L +L + N+ SLP+ L+ L++ GN + S+P L
Sbjct: 213 LTSLPALPSGLKEL---IVSGNRL-TSLPVLP---SELKELMVSGNRLT-SLPMLPSGL- 263
Query: 137 YLQILDLSQNFFNGSLPVSIVQCKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLNLSFNK 196
L + +N LP S++ ++L N + + S + +
Sbjct: 264 --LSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLS-ERTLQALREITSAPGYSGPIIR 319
Query: 197 FNGSIPSNTGNLSSLQ 212
F+ + S +L
Sbjct: 320 FDMAGASAPRETRALH 335
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 93.8 bits (233), Expect = 5e-20
Identities = 41/234 (17%), Positives = 78/234 (33%), Gaps = 57/234 (24%)
Query: 410 VLGKSGIGIVYK---VVLEDGHTLAVRRLGEGGSQRFKE-FQTEVEAIGKIRHSNIVTLR 465
+ G+G +Y + +G + ++ L G + E + + ++ H +IV +
Sbjct: 87 CIAHGGLGWIYLALDRNV-NGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIF 145
Query: 466 AY--YWSVDEKLLIY---DYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVY 520
+ + + Y +Y+ SL + +P + + + I L Y
Sbjct: 146 NFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ--------KLPVAEAIAYLLEILPALSY 197
Query: 521 LHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQER 580
LH V+ DLKP NI+L + + D G
Sbjct: 198 LHS---IGLVYNDLKPENIMLTEE-QLKLIDLGAVS------------------------ 229
Query: 581 QQKSVSLEVTTTNSSSNLGS-YYQAPESLKVVKPSQKWDIYSYGVILLEMITGR 633
+ G+ +QAPE ++ P+ DIY+ G L +
Sbjct: 230 ---------RINSFGYLYGTPGFQAPEIVR-TGPTVATDIYTVGRTLAALTLDL 273
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 90.3 bits (224), Expect = 5e-20
Identities = 36/172 (20%), Positives = 53/172 (30%), Gaps = 15/172 (8%)
Query: 86 SLTDLRHVNLRNNKFFGSLPLELLEA-QGLQSLVLYGNSFSGSVPNEI----GKLKYLQI 140
L+ +++ + E + L +L L N G K LQ+
Sbjct: 147 LKPGLKVLSIAQAHSL-NFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQV 205
Query: 141 LDLSQNFFN---GSLPVSIVQCKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLNLSFNKF 197
L L G +L+ LDLS N+ L LNLSF
Sbjct: 206 LALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGL 265
Query: 198 NGSIPSNTGNLSSLQGTVDFSHNLFSGSIPASLGNLPEKVYIDLTYNNLSGP 249
+P + L +D S+N P S LP+ + L N
Sbjct: 266 K-QVPKGL--PAKLS-VLDLSYNRLD-RNP-SPDELPQVGNLSLKGNPFLDS 311
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 87.6 bits (217), Expect = 5e-19
Identities = 41/192 (21%), Positives = 66/192 (34%), Gaps = 15/192 (7%)
Query: 42 SLSNWNSSDENPCSWNGITCKEQRVVSVSIPKKKLLGFLPSALGSLTDLRHVNLRNNKFF 101
+L N + + + + + +SI + L F + L ++L +N
Sbjct: 127 NLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPEL 186
Query: 102 GSLPLELLEAQG----LQSLVLYGN---SFSGSVPNEIGKLKYLQILDLSQNFFNGSLPV 154
G L LQ L L + SG LQ LDLS N +
Sbjct: 187 GERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGA 246
Query: 155 SI-VQCKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLNLSFNKFNGSIPSNTGNLSSLQG 213
+L +L+LS +P G + L L+LS+N+ + PS L +
Sbjct: 247 PSCDWPSQLNSLNLSFTGLKQ-VPKGLPA---KLSVLDLSYNRLD-RNPSPDE-LPQVG- 299
Query: 214 TVDFSHNLFSGS 225
+ N F S
Sbjct: 300 NLSLKGNPFLDS 311
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 66.5 bits (162), Expect = 6e-12
Identities = 30/209 (14%), Positives = 61/209 (29%), Gaps = 43/209 (20%)
Query: 84 LGSLTDLRHVNLRNNKFFGSLP-LELLEAQGLQSLVLYGNSFSGSVPNEIGKL---KYLQ 139
G L ++ R + +++++ L+ L + + ++ LQ
Sbjct: 39 YGGGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQ 98
Query: 140 ILDLSQNFFNGSLPVSIVQC------------------------------KRLKALDLSQ 169
L L G+ P +++ LK L ++Q
Sbjct: 99 ELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQ 158
Query: 170 NNFTGPLPNGFGSGLVSLEKLNLSFNKFNGSIPSNT----GNLSSLQGTVDFSHNLF--- 222
+ +L L+LS N G + +LQ + +
Sbjct: 159 AHSLN-FSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQ-VLALRNAGMETP 216
Query: 223 SGSIPASLGNLPEKVYIDLTYNNLSGPIP 251
SG A + +DL++N+L
Sbjct: 217 SGVCSALAAARVQLQGLDLSHNSLRDAAG 245
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 90.6 bits (225), Expect = 7e-20
Identities = 48/230 (20%), Positives = 86/230 (37%), Gaps = 49/230 (21%)
Query: 411 LGKSGIGIVYKVV-LEDGHTLAVRRLGEGGSQRFKEFQTEVEAIGKIRHSNIVTLRAYYW 469
+G+ G V+++ + G AV+++ + E+ A + IV Y
Sbjct: 66 VGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR-----VEELVACAGLSSPRIVP---LYG 117
Query: 470 SV--DEKLLIY-DYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSP 526
+V + I+ + + GSL + +P + + +GL YLH
Sbjct: 118 AVREGPWVNIFMELLEGGSLGQLIK------QMGCLPEDRALYYLGQALEGLEYLHT--- 168
Query: 527 KKYVHGDLKPSNILLGHN-MEPHVSDFGLA-RLANIAGGSPTLQSNRMPAEKPQERQQKS 584
++ +HGD+K N+LL + + DFG A L G L + +P
Sbjct: 169 RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIP----------- 217
Query: 585 VSLEVTTTNSSSNLGS-YYQAPESLKVVKPSQKWDIYSYGVILLEMITGR 633
G+ + APE + K DI+S ++L M+ G
Sbjct: 218 --------------GTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGC 253
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 8e-20
Identities = 71/317 (22%), Positives = 117/317 (36%), Gaps = 74/317 (23%)
Query: 410 VLGKSGIGIVYKVVLEDGHTL-AVRRLGEGGSQRFKEFQTEVEAIGKIRHSNIVTLRAYY 468
LG G VY+ V + AV+ L E + +EF E + +I+H N+V L
Sbjct: 20 KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQLLGVC 78
Query: 469 WSVDEKLLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKK 528
+I +++ G+L L V V + + I+ + YL K
Sbjct: 79 TREPPFYIITEFMTYGNLLDYLRECNR----QEVSAVVLLYMATQISSAMEYL---EKKN 131
Query: 529 YVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQKSVSLE 588
++H DL N L+G N V+DFGL+RL ++ +
Sbjct: 132 FIHRDLAARNCLVGENHLVKVADFGLSRL---------------------------MTGD 164
Query: 589 VTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMIT-GRTAVVQVGSSEMDLV 647
T ++ + + APESL K S K D++++GV+L E+ T G +
Sbjct: 165 TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY----------- 213
Query: 648 NWMQLCIEEKKPLADVLD----------PYLAPDADKEEEIIAVLKIAMACVHSSPEKRP 697
L+ V + P P+ V ++ AC +P RP
Sbjct: 214 --------PGIDLSQVYELLEKDYRMERPEGCPE--------KVYELMRACWQWNPSDRP 257
Query: 698 TMRHISDALDRLIVSSD 714
+ I A + + S
Sbjct: 258 SFAEIHQAFETMFQESS 274
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 90.2 bits (224), Expect = 1e-19
Identities = 50/223 (22%), Positives = 79/223 (35%), Gaps = 39/223 (17%)
Query: 418 IVYKVVLEDGHTLAVRRLGEGGSQRFKE-FQTEVEAIGKIRHSNIVTLRAYYWSVDEKLL 476
K +LE + + + F+ E++ I I++ +T + DE +
Sbjct: 61 KYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGIITNYDEVYI 120
Query: 477 IYDYIPNGSLATAL--HGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDL 534
IY+Y+ N S+ +P V IIK + Y+H + K H D+
Sbjct: 121 IYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIH--NEKNICHRDV 178
Query: 535 KPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNS 594
KPSNIL+ N +SDFG S M +K + +
Sbjct: 179 KPSNILMDKNGRVKLSDFGE--------------SEYMVDKK------------IKGS-- 210
Query: 595 SSNLGSY-YQAPESLKVVKP--SQKWDIYSYGVILLEMITGRT 634
G+Y + PE K DI+S G+ L M
Sbjct: 211 ---RGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVV 250
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 1e-19
Identities = 32/164 (19%), Positives = 61/164 (37%), Gaps = 14/164 (8%)
Query: 84 LGSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSGSVPNEIGKLKYLQILDL 143
L + L H N+ N +L + + ++ L NS + V + L IL L
Sbjct: 182 LSLIPSLFHANVSYNLL-STLAIPI----AVEELDASHNSIN-VVRGPV--NVELTILKL 233
Query: 144 SQNFFNGSLPVSIVQCKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLNLSFNKFNGSIPS 203
N ++ L +DLS N + + LE+L +S N+ ++
Sbjct: 234 QHNNLT-DTA-WLLNYPGLVEVDLSYNELEK-IMYHPFVKMQRLERLYISNNRLV-ALNL 289
Query: 204 NTGNLSSLQGTVDFSHNLFSGSIPASLGNLPEKVYIDLTYNNLS 247
+ +L+ +D SHN + + + L +N++
Sbjct: 290 YGQPIPTLK-VLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV 331
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 1e-18
Identities = 27/179 (15%), Positives = 57/179 (31%), Gaps = 8/179 (4%)
Query: 72 PKKKLLGFLPSALGSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSGSVPNE 131
P++ + S L V++ E + + + ++ +P
Sbjct: 5 PRQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAA 63
Query: 132 I-GKLKYLQILDLSQNFFNGSLPVSIVQCKRLKALDLSQNNFTGPLPNGFGSGLVSLEKL 190
+ + +++L+L+ + ++ L + N LP + L L
Sbjct: 64 LLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRY-LPPHVFQNVPLLTVL 122
Query: 191 NLSFNKFNGSIPSNT-GNLSSLQGTVDFSHNLFSGSIPAS-LGNLPEKVYIDLTYNNLS 247
L N + S+P N L T+ S+N I + L+ N L+
Sbjct: 123 VLERNDLS-SLPRGIFHNTPKLT-TLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRLT 178
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 4e-17
Identities = 36/170 (21%), Positives = 68/170 (40%), Gaps = 16/170 (9%)
Query: 81 PSALGSLTDLRHVNLRNNKFFGSLPLELLEAQG-LQSLVLYGNSFSGSVPNEI-GKLKYL 138
+ L S + +NL + + + +Q L + N+ +P + + L
Sbjct: 62 AALLDSFRQVELLNLNDLQI-EEIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLL 119
Query: 139 QILDLSQNFFNGSLPVSI-VQCKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLNLSFNKF 197
+L L +N + SLP I +L L +S NN + + SL+ L LS N+
Sbjct: 120 TVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLER-IEDDTFQATTSLQNLQLSSNRL 177
Query: 198 NGSIPSNTGNLSSLQGTVDFSHNLFSGSIPASLGNLPEKVYIDLTYNNLS 247
+ + SL + S+NL S +L +D ++N+++
Sbjct: 178 T-HVDL--SLIPSLF-HANVSYNLLS-----TLAIPIAVEELDASHNSIN 218
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 4e-13
Identities = 31/142 (21%), Positives = 52/142 (36%), Gaps = 21/142 (14%)
Query: 85 GSLTDLRHVNLRNNKF-----FGSLPLELLEAQGLQSLVLYGNSFSGSVPNEI-GKLKYL 138
+L + L++N + P GL + L N + K++ L
Sbjct: 223 PVNVELTILKLQHNNLTDTAWLLNYP-------GLVEVDLSYNELE-KIMYHPFVKMQRL 274
Query: 139 QILDLSQNFFNGSLPVSIVQCKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLNLSFNKFN 198
+ L +S N +L + LK LDLS N+ + LE L L N
Sbjct: 275 ERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLLH-VERNQP-QFDRLENLYLDHNSIV 331
Query: 199 GSIPSNTGNLSSLQGTVDFSHN 220
++ +T +L+ + SHN
Sbjct: 332 -TLKLST--HHTLK-NLTLSHN 349
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 1e-12
Identities = 27/119 (22%), Positives = 47/119 (39%), Gaps = 8/119 (6%)
Query: 81 PSALGSLTDLRHVNLRNNKFFGSLPLELLE-AQGLQSLVLYGNSFSGSVPNEIGKLKYLQ 139
+ L + L V+L N+ + Q L+ L + N ++ + L+
Sbjct: 241 TAWLLNYPGLVEVDLSYNE-LEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLK 298
Query: 140 ILDLSQNFFNGSLPVSIVQCKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLNLSFNKFN 198
+LDLS N + + Q RL+ L L N+ L +L+ L LS N ++
Sbjct: 299 VLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLKLS---THHTLKNLTLSHNDWD 352
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 2e-08
Identities = 24/127 (18%), Positives = 43/127 (33%), Gaps = 8/127 (6%)
Query: 81 PSALGSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSGSVPNEIGKLKYLQI 140
+ L + + NN+ +L L L+ L L N V + L+
Sbjct: 265 YHPFVKMQRLERLYISNNR-LVALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLEN 322
Query: 141 LDLSQNFFNGSLPVSIVQCKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLNLSFNKFNGS 200
L L N +L +S LK L LS N++ N + ++ + + +
Sbjct: 323 LYLDHNSIV-TLKLST--HHTLKNLTLSHNDWD---CNSLRALFRNVARPAVDDADQHCK 376
Query: 201 IPSNTGN 207
I +
Sbjct: 377 IDYQLEH 383
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 1e-04
Identities = 17/108 (15%), Positives = 40/108 (37%), Gaps = 6/108 (5%)
Query: 77 LGFLPSALGSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSGSVPNEIGKLK 136
L L + L+ ++L +N + + L++L L NS ++ +
Sbjct: 284 LVALNLYGQPIPTLKVLDLSHNH-LLHVERNQPQFDRLENLYLDHNSIV-TLK--LSTHH 339
Query: 137 YLQILDLSQNFFNGSLPVSIVQCKRLKALDLSQNNFTGPLPNGFGSGL 184
L+ L LS N ++ + ++ + + + + + GL
Sbjct: 340 TLKNLTLSHNDWDCNSLRALFR--NVARPAVDDADQHCKIDYQLEHGL 385
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 89.4 bits (222), Expect = 1e-19
Identities = 51/241 (21%), Positives = 88/241 (36%), Gaps = 53/241 (21%)
Query: 410 VLGKSGIGIVYKVV-LEDGHTLAVRRLGEGGSQRFKE-FQTEVEAIGKIRHSNIVTLRAY 467
+LG+ V++ + G A++ R + E E + K+ H NIV L A
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75
Query: 468 YWSVDEKL--LIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFS 525
+ LI ++ P GSL T L +P + +P S + +++ + G+ +L E
Sbjct: 76 EEETTTRHKVLIMEFCPCGSLYTVLE-EPS--NAYGLPESEFLIVLRDVVGGMNHLRE-- 130
Query: 526 PKKYVHGDLKPSNILLGHNMEPH----VSDFGLARLANIAGGSPTLQSNRMPAEKPQERQ 581
VH ++KP NI+ + ++DFG AR L+ +
Sbjct: 131 -NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR---------ELEDDEQ--------- 171
Query: 582 QKSVSLEVTTTNSSSNLGS-YYQAPESLKVVKPSQKW--------DIYSYGVILLEMITG 632
S G+ Y P+ + + D++S GV TG
Sbjct: 172 ------------FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATG 219
Query: 633 R 633
Sbjct: 220 S 220
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 2e-19
Identities = 59/332 (17%), Positives = 105/332 (31%), Gaps = 99/332 (29%)
Query: 410 VLGKSGIGIVYKVVLEDGH-----TLAVRRLGEGGSQR-FKEFQTEVEAIGKIRHSNIVT 463
VLG G VYK + +A++ L E S + KE E + + + ++
Sbjct: 22 VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 81
Query: 464 LRAYYWSV---DEKLLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVY 520
L + LI +P G L + + + + IAKG+ Y
Sbjct: 82 LLG----ICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYL-----LNWCVQIAKGMNY 132
Query: 521 LHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSN--RMPAEKPQ 578
L + ++ VH DL N+L+ ++DFGLA+L + + ++P
Sbjct: 133 LED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKL--LGAEEKEYHAEGGKVP----- 182
Query: 579 ERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMIT-GRTAVV 637
+ A ES+ + + D++SYGV + E++T G
Sbjct: 183 ----------IKWM-----------ALESILHRIYTHQSDVWSYGVTVWELMTFGS---- 217
Query: 638 QVGSSEMDLVNWMQLCIEEKKP-----LADVLD----------PYLAPDADKEEEIIAVL 682
KP +++ P + V
Sbjct: 218 --------------------KPYDGIPASEISSILEKGERLPQPPICTI--------DVY 249
Query: 683 KIAMACVHSSPEKRPTMRHISDALDRLIVSSD 714
I C + RP R + ++
Sbjct: 250 MIMRKCWMIDADSRPKFRELIIEFSKMARDPQ 281
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 4e-19
Identities = 62/299 (20%), Positives = 92/299 (30%), Gaps = 66/299 (22%)
Query: 410 VLGKSGIGIVYKVV-LEDGHTLAVR--RLGEGGSQRFKEFQTEVEAIGKI-RHSNIVTLR 465
LG G V+KV EDG AV+ G + EV + K+ +H V L
Sbjct: 64 RLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLE 123
Query: 466 AYYWSVDEKLLIY-DYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEF 524
W L + + SL G +P + ++ L +LH
Sbjct: 124 -QAWEEGGILYLQTELC-GPSLQQHCE-AWG----ASLPEAQVWGYLRDTLLALAHLHS- 175
Query: 525 SPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQKS 584
+ VH D+KP+NI LG + DFGL
Sbjct: 176 --QGLVHLDVKPANIFLGPRGRCKLGDFGLLVELG------------------------- 208
Query: 585 VSLEVTTTNSSSNLGS-YYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGSSE 643
T G Y APE L+ D++S G+ +LE+
Sbjct: 209 -----TAGAGEVQEGDPRYMAPELLQ-GSYGTAADVFSLGLTILEVACNMELPHG----- 257
Query: 644 MDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHI 702
W QL + L L+ + +VL + P+ R T +
Sbjct: 258 --GEGWQQLR---QGYLPPEFTAGLSSEL------RSVLV---MMLEPDPKLRATAEAL 302
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 4e-19
Identities = 70/326 (21%), Positives = 121/326 (37%), Gaps = 86/326 (26%)
Query: 410 VLGKSGIGIVYKVVLEDGH----TLAVRRLGEGGSQRFK-EFQTEVEAIGKIRHSNIVTL 464
++G G V L +A++ L G ++R + +F +E +G+ H NI+ L
Sbjct: 56 IIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRL 115
Query: 465 RAYYWSVDEKLLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEF 524
+++ +Y+ NGSL T L G + V +++G+ G+ YL +
Sbjct: 116 EGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTI-----MQLVGMLRGVGAGMRYLSD- 169
Query: 525 SPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQKS 584
YVH DL N+L+ N+ VSDFGL+R+ + +
Sbjct: 170 --LGYVHRDLAARNVLVDSNLVCKVSDFGLSRV--------------LEDDPDAAYTTTG 213
Query: 585 VSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMIT-GRTAVVQVGSSE 643
+ + T APE++ S D++S+GV++ E++ G
Sbjct: 214 GKIPIRWT-----------APEAIAFRTFSSASDVWSFGVVMWEVLAYGE---------- 252
Query: 644 MDLVNWMQLCIEEKKP-----LADVLD----------PYLAPDADKEEEIIAVLKIAMAC 688
+P DV+ P P A+ ++ + C
Sbjct: 253 --------------RPYWNMTNRDVISSVEEGYRLPAPMGCPH--------ALHQLMLDC 290
Query: 689 VHSSPEKRPTMRHISDALDRLIVSSD 714
H +RP I LD LI S +
Sbjct: 291 WHKDRAQRPRFSQIVSVLDALIRSPE 316
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 89.4 bits (222), Expect = 4e-19
Identities = 59/302 (19%), Positives = 99/302 (32%), Gaps = 60/302 (19%)
Query: 410 VLGKSGIGIVYKVVLEDGHTLAVRRLGEGGSQRFKEFQTEVEAIGKI-RHSNIVTLRAYY 468
VLG G + + D +AV+R+ + F EV+ + + H N++
Sbjct: 31 VLGHGAEGTIVYRGMFDNRDVAVKRIL---PECFSFADREVQLLRESDEHPNVIRYFCTE 87
Query: 469 WSVDEKLLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKK 528
+ + + +L + K + +++ GL +LH
Sbjct: 88 KDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLEP-----ITLLQQTTSGLAHLHS---LN 138
Query: 529 YVHGDLKPSNILL-----GHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQK 583
VH DLKP NIL+ ++ +SDFGL + +
Sbjct: 139 IVHRDLKPHNILISMPNAHGKIKAMISDFGLCK----------------------KLAVG 176
Query: 584 SVSLEVTTTNSSSNLGSYYQAPESLKVV---KPSQKWDIYSYGVILLEMITGRTAVVQVG 640
S + + + APE L P+ DI+S G + +I+ G
Sbjct: 177 RHSFSRRSGVPGT---EGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISE-------G 226
Query: 641 SSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMR 700
S Q I D L P D E I + P+KRP+ +
Sbjct: 227 SHPFGKSLQRQANILLGACSLDCLHPEKHEDVIARELI-------EKMIAMDPQKRPSAK 279
Query: 701 HI 702
H+
Sbjct: 280 HV 281
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 88.5 bits (219), Expect = 6e-19
Identities = 30/241 (12%), Positives = 71/241 (29%), Gaps = 47/241 (19%)
Query: 410 VLGKSGIGIVYKVV------LEDGHTLAVRRLGEGGSQRFKEFQTEVEAIGKIRHSNIVT 463
+LG+ VY+ ++ ++ F +E + +
Sbjct: 72 LLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMK 131
Query: 464 LRAYYWSVDEKLLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHE 523
+ + + +L+ + G+L A++ +P + + + + +H+
Sbjct: 132 FYSAHLFQNGSVLVGELYSYGTLLNAIN-LYKNTPEKVMPQGLVISFAMRMLYMIEQVHD 190
Query: 524 FSPKKYVHGDLKPSNILLGHNMEPH-----------VSDFGLARLANIAGGSPTLQSNRM 572
+ +HGD+KP N +LG+ + D G + + +
Sbjct: 191 ---CEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKC- 246
Query: 573 PAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITG 632
T S +Q E L + + D + + M+ G
Sbjct: 247 -----------------ET--------SGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFG 281
Query: 633 R 633
Sbjct: 282 T 282
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 7e-19
Identities = 70/311 (22%), Positives = 125/311 (40%), Gaps = 56/311 (18%)
Query: 410 VLGKSGIGIVYKVVL----EDGHTLAVRRLGEGGSQR-FKEFQTEVEAIGKIRHSNIVTL 464
V+G G V L + ++A++ L G +++ ++F E +G+ H NI+ L
Sbjct: 52 VVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRL 111
Query: 465 RAYYWSVDEKLLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEF 524
+++ +Y+ NGSL + L + V +++GIA G+ YL +
Sbjct: 112 EGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFT-----VIQLVGMLRGIASGMKYLSD- 165
Query: 525 SPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQKS 584
YVH DL NIL+ N+ VSDFGL R+ + + +
Sbjct: 166 --MGYVHRDLAARNILINSNLVCKVSDFGLGRV--------------LEDDPEAAYTTRG 209
Query: 585 VSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMIT-GRTAVVQVGSSE 643
+ + T +PE++ K + D++SYG++L E+++ G S
Sbjct: 210 GKIPIRWT-----------SPEAIAYRKFTSASDVWSYGIVLWEVMSYGE--RPYWEMSN 256
Query: 644 MDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHIS 703
D++ ++E L P P A+ ++ + C RP I
Sbjct: 257 QDVIK----AVDEGYRLP---PPMDCPA--------ALYQLMLDCWQKDRNNRPKFEQIV 301
Query: 704 DALDRLIVSSD 714
LD+LI +
Sbjct: 302 SILDKLIRNPG 312
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 89.0 bits (221), Expect = 1e-18
Identities = 35/190 (18%), Positives = 66/190 (34%), Gaps = 7/190 (3%)
Query: 59 ITCKEQRVVSVSIPKKKLLGFLPSALGSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLV 118
++C V + +PS L ++ ++L NK +L LQ L+
Sbjct: 2 LSCDASGVCDGR---SRSFTSIPSGL--TAAMKSLDLSFNKITYIGHGDLRACANLQVLI 56
Query: 119 LYGNSFSGSVPNEIGKLKYLQILDLSQNFFNGSLPVSIVQCKRLKALDLSQNNFTGPLPN 178
L + + + L L+ LDLS N + LK L+L N +
Sbjct: 57 LKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVT 116
Query: 179 GFGSGLVSLEKLNLSFNKFNGSIPSNT-GNLSSLQGTVDFSHNLFSGSIPASLGNLPEKV 237
L +L+ L + + I L+SL ++ SL ++ +
Sbjct: 117 SLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLN-ELEIKALSLRNYQSQSLKSIRDIH 175
Query: 238 YIDLTYNNLS 247
++ L + +
Sbjct: 176 HLTLHLSESA 185
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 9e-18
Identities = 38/168 (22%), Positives = 61/168 (36%), Gaps = 14/168 (8%)
Query: 81 PSALGSLTDLRHVNLRNNKF--FGSLPLELLEAQGLQSLVLYGNSFSGSVPNEIGKLKYL 138
+ G+ L+ + L N LL + L SL + N+F +P+ + +
Sbjct: 354 SACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKM 412
Query: 139 QILDLSQNFFNGSLPVSIVQCKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLNLSFNKFN 198
+ L+LS + I Q L+ LD+S NN F L L++L +S NK
Sbjct: 413 RFLNLSSTGIR-VVKTCIPQ--TLEVLDVSNNNLDS-----FSLFLPRLQELYISRNKLK 464
Query: 199 GSIPSNTGNLSSLQGTVDFSHNLFSGSIPASLGNLPEKVYIDLTYNNL 246
++P + L + S N L I L N
Sbjct: 465 -TLPDAS-LFPVLL-VMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPW 509
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 85.9 bits (213), Expect = 1e-17
Identities = 29/182 (15%), Positives = 59/182 (32%), Gaps = 9/182 (4%)
Query: 70 SIPKKKLLGFLPSALGSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSGSVP 129
+ +R +++ F L + ++ + + +
Sbjct: 268 DFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPC 327
Query: 130 NEIGKLKYLQILDLSQNFFNGSL---PVSIVQCKRLKALDLSQNNFTG-PLPNGFGSGLV 185
+ LK L+ LDLS+N L+ L LSQN+ L
Sbjct: 328 SFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLK 387
Query: 186 SLEKLNLSFNKFNGSIPSNTGNLSSLQGTVDFSHNLFSGSIPASLGNLPEKVYIDLTYNN 245
+L L++S N F+ +P + ++ ++ S + +D++ NN
Sbjct: 388 NLTSLDISRNTFH-PMPDSCQWPEKMR-FLNLSSTGIR-VVKT--CIPQTLEVLDVSNNN 442
Query: 246 LS 247
L
Sbjct: 443 LD 444
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 74.4 bits (183), Expect = 5e-14
Identities = 30/147 (20%), Positives = 58/147 (39%), Gaps = 14/147 (9%)
Query: 77 LGFLPSALGSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSGSVPNEIGKLK 136
+ L +L +L +++ N F +P + ++ L L V I +
Sbjct: 376 MQKTGEILLTLKNLTSLDISRNTF-HPMPDSCQWPEKMRFLNLSSTGIR-VVKTCI--PQ 431
Query: 137 YLQILDLSQNFFNGSLPVSIVQCKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLNLSFNK 196
L++LD+S N + S + + + L+ L +S+N L + +S N+
Sbjct: 432 TLEVLDVSNNNLD-SFSLFLPR---LQELYISRNKLKTLPDASL---FPVLLVMKISRNQ 484
Query: 197 FNGSIPSNT-GNLSSLQGTVDFSHNLF 222
S+P L+SLQ + N +
Sbjct: 485 LK-SVPDGIFDRLTSLQ-KIWLHTNPW 509
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 74.0 bits (182), Expect = 7e-14
Identities = 34/219 (15%), Positives = 70/219 (31%), Gaps = 49/219 (22%)
Query: 75 KLLGFLPSALGSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSG-------- 126
L + +L S+ D+ H+ L ++ L + ++ L L + +
Sbjct: 159 SLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPV 218
Query: 127 --------------------------SVPNEIGKLKYLQILDLSQNFFNGSLPVSI---- 156
+ I +L ++ D + N P
Sbjct: 219 DEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVS 278
Query: 157 ----VQCKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLNLSFNKFNGSIPSNTG-NLSSL 211
V+ ++ L + Q + S L ++++ + +K +P + +L SL
Sbjct: 279 ELGKVETVTIRRLHIPQFYLF-YDLSTVYSLLEKVKRITVENSKVF-LVPCSFSQHLKSL 336
Query: 212 QGTVDFSHNLFSGSI---PASLGNLPEKVYIDLTYNNLS 247
+ +D S NL A G P + L+ N+L
Sbjct: 337 E-FLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLR 374
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 71.3 bits (175), Expect = 5e-13
Identities = 32/137 (23%), Positives = 55/137 (40%), Gaps = 8/137 (5%)
Query: 119 LYGNSFSGSVPNEIGKLKYLQILDLSQNFFNGSLPVSIVQCKRLKALDLSQNNFTGPLPN 178
SF+ S+P+ + ++ LDLS N + C L+ L L + +
Sbjct: 12 GRSRSFT-SIPSGL--TAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINT-IEG 67
Query: 179 GFGSGLVSLEKLNLSFNKFNGSIPSNT-GNLSSLQGTVDFSHNLFSG-SIPASLGNLPEK 236
L SLE L+LS N + S+ S+ G LSSL+ ++ N + + + NL
Sbjct: 68 DAFYSLGSLEHLDLSDNHLS-SLSSSWFGPLSSLK-YLNLMGNPYQTLGVTSLFPNLTNL 125
Query: 237 VYIDLTYNNLSGPIPQN 253
+ + I +
Sbjct: 126 QTLRIGNVETFSEIRRI 142
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 69.4 bits (170), Expect = 2e-12
Identities = 27/122 (22%), Positives = 47/122 (38%), Gaps = 10/122 (8%)
Query: 77 LGFLPSALGSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSGSVPNEIGKLK 136
+P + +R +NL + + + Q L+ L + N+ S L
Sbjct: 399 FHPMPDSCQWPEKMRFLNLSSTGI-RVVKTCIP--QTLEVLDVSNNNLD-SFSLF---LP 451
Query: 137 YLQILDLSQNFFNGSLPVSIVQCKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLNLSFNK 196
LQ L +S+N +LP L + +S+N F L SL+K+ L N
Sbjct: 452 RLQELYISRNKLK-TLP-DASLFPVLLVMKISRNQLKSVPDGIFDR-LTSLQKIWLHTNP 508
Query: 197 FN 198
++
Sbjct: 509 WD 510
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 3e-10
Identities = 24/209 (11%), Positives = 54/209 (25%), Gaps = 41/209 (19%)
Query: 80 LPSALGSLTDLRHVNLRNNKFFGSLPLELLEA-QGLQSLVLYGNSFSGSVPNEIGKLKYL 138
+ S +LT+L+ + + N + F + L L + S + ++ +
Sbjct: 115 VTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDI 174
Query: 139 QILDLSQNFFNGSLPVSIVQCKRLKALDLSQNNFTGPLPNGFGSG--------------- 183
L L + L + ++ L+L N +
Sbjct: 175 HHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSV 234
Query: 184 ------------------LVSLEKLNLSFNKFNGSIPSNTGNLSSLQG-------TVDFS 218
L +E + + N PS + +S L +
Sbjct: 235 LTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIP 294
Query: 219 HNLFSGSIPASLGNLPEKVYIDLTYNNLS 247
+ L + I + + +
Sbjct: 295 QFYLFYDLSTVYSLLEKVKRITVENSKVF 323
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 85.7 bits (213), Expect = 1e-18
Identities = 52/229 (22%), Positives = 89/229 (38%), Gaps = 44/229 (19%)
Query: 411 LGKSGIGIVYKVV-LEDGHTLAV-----RRLGEGGSQRFKEFQTEVEAIGKIRHSNIVTL 464
LGK VY+ + G +A+ + + + G + Q EV+ +++H +I+ L
Sbjct: 19 LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMV--QRVQNEVKIHCQLKHPSILEL 76
Query: 465 RAYYWSVDEKLLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEF 524
Y+ + L+ + NG + L + S R + I G++YLH
Sbjct: 77 YNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFS----ENEAR-HFMHQIITGMLYLHS- 130
Query: 525 SPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQKS 584
+H DL SN+LL NM ++DFGLA + P E+
Sbjct: 131 --HGILHRDLTLSNLLLTRNMNIKIADFGLATQ----------------LKMPHEKHY-- 170
Query: 585 VSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGR 633
T + N Y +PE + D++S G + ++ GR
Sbjct: 171 ------TLCGTPN----YISPEIATRSAHGLESDVWSLGCMFYTLLIGR 209
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 86.8 bits (215), Expect = 2e-18
Identities = 74/333 (22%), Positives = 127/333 (38%), Gaps = 61/333 (18%)
Query: 373 RKDESETLSENVEQYDLVPLDTQVAFDLDELLKASAFVLGKSGIGIVYKVVL-EDGHTLA 431
RK L++ + +L D D +++ + LG G+V+KV G +A
Sbjct: 14 RKRLEAFLTQKQKVGEL-KDD-----DFEKISE-----LGAGNGGVVFKVSHKPSGLVMA 62
Query: 432 VRRL-GEGGSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWS--VDEKLLIY-DYIPNGSLA 487
+ + E + E++ + + IV +Y + D ++ I +++ GSL
Sbjct: 63 RKLIHLEIKPAIRNQIIRELQVLHECNSPYIVG---FYGAFYSDGEISICMEHMDGGSLD 119
Query: 488 TALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEP 547
L K G +P + K+ + KGL YL K +H D+KPSNIL+ E
Sbjct: 120 QVLK-KAG-----RIPEQILGKVSIAVIKGLTYLR--EKHKIMHRDVKPSNILVNSRGEI 171
Query: 548 HVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLG-SYYQAPE 606
+ DFG VS ++ + ++S +G Y +PE
Sbjct: 172 KLCDFG-------------------------------VSGQLIDSMANSFVGTRSYMSPE 200
Query: 607 SLKVVKPSQKWDIYSYGVILLEMITGR--TAVVQVGSSEMDLVNWMQLCIEEKKPLADVL 664
L+ S + DI+S G+ L+EM GR E+ ++ E P
Sbjct: 201 RLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTP 260
Query: 665 DPYLAPDADKEEEIIAVLKIAMACVHSSPEKRP 697
L +A+ ++ V+ P K P
Sbjct: 261 GRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLP 293
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 88.8 bits (220), Expect = 2e-18
Identities = 68/351 (19%), Positives = 122/351 (34%), Gaps = 60/351 (17%)
Query: 371 CFRKDESETLSENVEQYDLVPLDTQVAFDLDELLKASAFVLGKSGIGIVYKVVL--EDGH 428
R +T D L + F + L + LG G V + V
Sbjct: 304 KPRPMPMDTSVFESPFSDPEELKDKKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQ 363
Query: 429 TL-AVRRLGEGGSQRFK-EFQTEVEAIGKIRHSNIVTLRAYYWSVDEK--LLIYDYIPNG 484
A++ L +G + E E + + ++ + IV L + +L+ + G
Sbjct: 364 IDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGV---CQAEALMLVMEMAGGG 420
Query: 485 SLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHN 544
L L GK + P S +++ ++ G+ YL E K +VH +L N+LL +
Sbjct: 421 PLHKFLVGKREEI-----PVSNVAELLHQVSMGMKYLEE---KNFVHRNLAARNVLLVNR 472
Query: 545 MEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQA 604
+SDFGL++ + A+ + + + A
Sbjct: 473 HYAKISDFGLSKA--------------LGADDSYYTARSAGKWPLKWY-----------A 507
Query: 605 PESLKVVKPSQKWDIYSYGVILLEMIT-GRTAVVQVGSSEMDLVNWMQLCIEEKKPLADV 663
PE + K S + D++SYGV + E ++ G+ ++ E+ M IE+ K +
Sbjct: 508 PECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEV-----MAF-IEQGKRME-- 559
Query: 664 LDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDALDRLIVSSD 714
P P + + C E RP + + S
Sbjct: 560 -CPPECPP--------ELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLA 601
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 85.7 bits (213), Expect = 2e-18
Identities = 73/340 (21%), Positives = 130/340 (38%), Gaps = 103/340 (30%)
Query: 411 LGKSGIGIVYK-----VVLEDGHTL-AVRRLGEGGSQRFKEFQTEVEAIGKIRHSNIVTL 464
LG+ G V+ + L AV+ L + K+FQ E E + ++H +IV
Sbjct: 23 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 82
Query: 465 RAYYWSVDEK--LLIYDYIPNGSLATAL--HGKPGMVSFTPVPWSVR--------VKIIK 512
D +++++Y+ +G L L HG M+ P + + I
Sbjct: 83 YGV--CGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIAS 140
Query: 513 GIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRM 572
IA G+VYL + + +VH DL N L+G N+ + DFG++R
Sbjct: 141 QIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSR---------------- 181
Query: 573 PAEKPQERQQKSVSLEVTTTNSSSNLGSYYQ------------APESLKVVKPSQKWDIY 620
+V +T+ YY+ PES+ K + + D++
Sbjct: 182 ---------------DVYSTD-------YYRVGGHTMLPIRWMPPESIMYRKFTTESDVW 219
Query: 621 SYGVILLEMIT-GRT-----AVVQVGSSEMDLVNWMQLCIEEKKPLADVLD-PYLAPDAD 673
S+GVIL E+ T G+ + +V ++ + + VL+ P + P
Sbjct: 220 SFGVILWEIFTYGKQPWFQLSNTEV----IECITQGR-----------VLERPRVCPK-- 262
Query: 674 KEEEIIAVLKIAMACVHSSPEKRPTMRHISDALDRLIVSS 713
V + + C P++R ++ I L L ++
Sbjct: 263 ------EVYDVMLGCWQREPQQRLNIKEIYKILHALGKAT 296
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 88.4 bits (219), Expect = 2e-18
Identities = 27/180 (15%), Positives = 57/180 (31%), Gaps = 8/180 (4%)
Query: 71 IPKKKLLGFLPSALGSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSGSVPN 130
P++ + S L V++ E + + + ++ +P
Sbjct: 10 KPRQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPA 68
Query: 131 EI-GKLKYLQILDLSQNFFNGSLPVSIVQCKRLKALDLSQNNFTGPLPNGFGSGLVSLEK 189
+ + +++L+L+ + ++ L + N LP + L
Sbjct: 69 ALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRY-LPPHVFQNVPLLTV 127
Query: 190 LNLSFNKFNGSIPSNT-GNLSSLQGTVDFSHNLFSGSIPAS-LGNLPEKVYIDLTYNNLS 247
L L N + S+P N L T+ S+N I + L+ N L+
Sbjct: 128 LVLERNDLS-SLPRGIFHNTPKLT-TLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRLT 184
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 87.3 bits (216), Expect = 4e-18
Identities = 33/168 (19%), Positives = 65/168 (38%), Gaps = 18/168 (10%)
Query: 81 PSALGSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSGSVPNEIGKLKYLQI 140
+ T L+++ L +N+ + L L+ L + N S + ++
Sbjct: 164 DDTFQATTSLQNLQLSSNRL-THVDLSLI--PSLFHANVSYNLLS-----TLAIPIAVEE 215
Query: 141 LDLSQNFFNGSLPVSIVQCKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLNLSFNKFNGS 200
LD S N N + + L L L NN T + L +++LS+N+
Sbjct: 216 LDASHNSIN-VVRGPV--NVELTILKLQHNNLT---DTAWLLNYPGLVEVDLSYNELE-K 268
Query: 201 IPSNT-GNLSSLQGTVDFSHNLFSGSIPASLGNLPEKVYIDLTYNNLS 247
I + + L+ + S+N ++ +P +DL++N+L
Sbjct: 269 IMYHPFVKMQRLE-RLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL 314
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 76.9 bits (189), Expect = 8e-15
Identities = 47/209 (22%), Positives = 69/209 (33%), Gaps = 39/209 (18%)
Query: 81 PSALGSLTDLRHVNLRNNKFFGSLPLELLE-AQGLQSLVLYGNSFSGSVPNEI-GKLKYL 138
A ++ + + N LP + + L LVL N S S+P I L
Sbjct: 92 TYAFAYAHTIQKLYMGFNAI-RYLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKL 149
Query: 139 QILDLSQNFFNGSLPVSIVQ-CKRLKALDLSQNNFTGPLPNGFGS--------------- 182
L +S N + Q L+ L LS N T + S
Sbjct: 150 TTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRLTHVDLSLIPSLFHANVSYNLLSTLA 208
Query: 183 GLVSLEKLNLSFNKFNGSIPSNT-GNLSSLQGTVDFSHNLFSGSIPASLGNLPEKVYIDL 241
+++E+L+ S N N + L+ L HN + L N P V +DL
Sbjct: 209 IPIAVEELDASHNSIN-VVRGPVNVELTIL----KLQHNNLT-DTAW-LLNYPGLVEVDL 261
Query: 242 TYNNLSGPIPQNGALMNRGPTAFIGNPRL 270
+YN L I F+ RL
Sbjct: 262 SYNELEK-IM---------YHPFVKMQRL 280
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 69.6 bits (170), Expect = 2e-12
Identities = 31/142 (21%), Positives = 52/142 (36%), Gaps = 21/142 (14%)
Query: 85 GSLTDLRHVNLRNNKF-----FGSLPLELLEAQGLQSLVLYGNSFSGSVPNEI-GKLKYL 138
+L + L++N + P GL + L N + K++ L
Sbjct: 229 PVNVELTILKLQHNNLTDTAWLLNYP-------GLVEVDLSYNELE-KIMYHPFVKMQRL 280
Query: 139 QILDLSQNFFNGSLPVSIVQCKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLNLSFNKFN 198
+ L +S N +L + LK LDLS N+ + LE L L N
Sbjct: 281 ERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLLH-VERNQ-PQFDRLENLYLDHNSIV 337
Query: 199 GSIPSNTGNLSSLQGTVDFSHN 220
++ +T +L+ + SHN
Sbjct: 338 -TLKLST--HHTLK-NLTLSHN 355
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 69.2 bits (169), Expect = 2e-12
Identities = 28/184 (15%), Positives = 62/184 (33%), Gaps = 18/184 (9%)
Query: 90 LRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSGSVPNEIGKLKYLQILDLSQNFFN 149
R+ + + L + + + E L +I+ +
Sbjct: 5 QRYNVKPRQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR 64
Query: 150 GSLPVSIVQ-CKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLNLSFNKFNGSIPSNT-GN 207
LP +++ ++++ L+L+ + + +++KL + FN +P + N
Sbjct: 65 -KLPAALLDSFRQVELLNLNDLQIEE-IDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQN 121
Query: 208 LSSLQGTVDFSHNLFSGSIPASL-GNLPEKVYIDLTYNNLSGPIPQNGALMNRGPTAFIG 266
+ L + N S S+P + N P+ + ++ NNL I F
Sbjct: 122 VPLLT-VLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLER-IE---------DDTFQA 169
Query: 267 NPRL 270
L
Sbjct: 170 TTSL 173
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 56.5 bits (136), Expect = 2e-08
Identities = 24/127 (18%), Positives = 43/127 (33%), Gaps = 8/127 (6%)
Query: 81 PSALGSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSGSVPNEIGKLKYLQI 140
+ L + + NN+ +L L L+ L L N V + L+
Sbjct: 271 YHPFVKMQRLERLYISNNR-LVALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLEN 328
Query: 141 LDLSQNFFNGSLPVSIVQCKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLNLSFNKFNGS 200
L L N +L +S LK L LS N++ N + ++ + + +
Sbjct: 329 LYLDHNSIV-TLKLST--HHTLKNLTLSHNDWD---CNSLRALFRNVARPAVDDADQHCK 382
Query: 201 IPSNTGN 207
I +
Sbjct: 383 IDYQLEH 389
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 87.2 bits (216), Expect = 2e-18
Identities = 51/241 (21%), Positives = 88/241 (36%), Gaps = 53/241 (21%)
Query: 410 VLGKSGIGIVYKVV-LEDGHTLAVRRLGEGGSQRFKE-FQTEVEAIGKIRHSNIVTLRAY 467
+LG+ V++ + G A++ R + E E + K+ H NIV L A
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75
Query: 468 YWSVDEKL--LIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFS 525
+ LI ++ P GSL T L +P + +P S + +++ + G+ +L E
Sbjct: 76 EEETTTRHKVLIMEFCPCGSLYTVLE-EPS--NAYGLPESEFLIVLRDVVGGMNHLRE-- 130
Query: 526 PKKYVHGDLKPSNILLGHNMEPH----VSDFGLARLANIAGGSPTLQSNRMPAEKPQERQ 581
VH ++KP NI+ + ++DFG AR L+ +
Sbjct: 131 -NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR---------ELEDDEQ--------- 171
Query: 582 QKSVSLEVTTTNSSSNLGS-YYQAPESLKVVKPSQKW--------DIYSYGVILLEMITG 632
S G+ Y P+ + + D++S GV TG
Sbjct: 172 ------------FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATG 219
Query: 633 R 633
Sbjct: 220 S 220
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 2e-18
Identities = 78/328 (23%), Positives = 129/328 (39%), Gaps = 89/328 (27%)
Query: 410 VLGKSGIGIVYKVVLEDGHTL-----AVRRLGEGGSQRFK-EFQTEVEAIGKIRHSNIVT 463
V+G G VYK +L+ A++ L G +++ + +F E +G+ H NI+
Sbjct: 51 VIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIR 110
Query: 464 LRAYYWSVDEKLLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHE 523
L ++I +Y+ NG+L L K G S + V +++GIA G+ YL
Sbjct: 111 LEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQL-----VGMLRGIAAGMKYLAN 165
Query: 524 FSPKKYVHGDLKPSNILLGHNMEPHVSDFGLAR-LANIAGGSPTLQSNRMPAEKPQERQQ 582
YVH DL NIL+ N+ VSDFGL+R L + + T ++P
Sbjct: 166 ---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIP--------- 213
Query: 583 KSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMIT-GRTAVVQVGS 641
+ T APE++ K + D++S+G+++ E++T G
Sbjct: 214 ------IRWT-----------APEAISYRKFTSASDVWSFGIVMWEVMTYGE-------- 248
Query: 642 SEMDLVNWMQLCIEEKKP-----LADVLD----------PYLAPDADKEEEIIAVLKIAM 686
+P +V+ P P A+ ++ M
Sbjct: 249 ----------------RPYWELSNHEVMKAINDGFRLPTPMDCPS--------AIYQLMM 284
Query: 687 ACVHSSPEKRPTMRHISDALDRLIVSSD 714
C +RP I LD+LI + D
Sbjct: 285 QCWQQERARRPKFADIVSILDKLIRAPD 312
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 2e-18
Identities = 62/341 (18%), Positives = 113/341 (33%), Gaps = 95/341 (27%)
Query: 399 DLDELLKASAFVLGKSGIG-----IVYKVVLEDGH---TLAVRRLGEGGSQR-FKEFQTE 449
D LK ++ +G V + V +A++ L +G + +E E
Sbjct: 1 DKKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMRE 60
Query: 450 VEAIGKIRHSNIVTLRAYYWSVDEK--LLIYDYIPNGSLATALHGKPGMVSFTPVPWSVR 507
+ + ++ + IV L + +L+ + G L L GK + P S
Sbjct: 61 AQIMHQLDNPYIVRLIGV---CQAEALMLVMEMAGGGPLHKFLVGKREEI-----PVSNV 112
Query: 508 VKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTL 567
+++ ++ G+ YL E K +VH DL N+LL + +SDFGL++
Sbjct: 113 AELLHQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKA---------- 159
Query: 568 QSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILL 627
+ A+ + + + APE + K S + D++SYGV +
Sbjct: 160 ----LGADDSYYTARSAGKWPLKWY-----------APECINFRKFSSRSDVWSYGVTMW 204
Query: 628 EMIT-GRTAVVQVGSSEMDLVNWMQLCIEEKKP-----LADVLD----------PYLAPD 671
E ++ G+ KP +V+ P P
Sbjct: 205 EALSYGQ------------------------KPYKKMKGPEVMAFIEQGKRMECPPECPP 240
Query: 672 ADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDALDRLIVS 712
+ + C E RP + + S
Sbjct: 241 --------ELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 273
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 84.9 bits (211), Expect = 3e-18
Identities = 49/230 (21%), Positives = 80/230 (34%), Gaps = 47/230 (20%)
Query: 411 LGKSGIGIVYKVV-LEDGHTLAV----RRLGEGGSQRFKEFQTEVEAIGKIRHSNIVTLR 465
LGK G +++ + A + L QR K E+ + H ++V
Sbjct: 23 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREK-MSMEISIHRSLAHQHVVGFH 81
Query: 466 AYYWSVDEKLLIYDYIPNGSLATAL--HGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHE 523
++ D ++ + SL T R ++ I G YLH
Sbjct: 82 GFFEDNDFVFVVLELCRRRSLLELHKRRKA-----LTE--PEAR-YYLRQIVLGCQYLHR 133
Query: 524 FSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQK 583
+ +H DLK N+ L ++E + DFGLA E ER+
Sbjct: 134 ---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATK----------------VEYDGERK-- 172
Query: 584 SVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGR 633
+ N Y APE L S + D++S G I+ ++ G+
Sbjct: 173 ------KVLCGTPN----YIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGK 212
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 3e-18
Identities = 46/234 (19%), Positives = 89/234 (38%), Gaps = 48/234 (20%)
Query: 411 LGKSGIGIVYK---VVLEDGHTLAVR--RLGEGGSQRFKE-FQTEVEAIGKIRHSNIVTL 464
LG G+ V+ + +AV+ R F F+ E + + H IV +
Sbjct: 20 LGFGGMSEVHLARDLRD--HRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAV 77
Query: 465 RAYYWSVDEKLLIY----DYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVY 520
+ + +Y+ +L +H + P+ +++I + L +
Sbjct: 78 YDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTE------GPMTPKRAIEVIADACQALNF 131
Query: 521 LHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQER 580
H+ +H D+KP+NI++ V DFG+AR +G
Sbjct: 132 SHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSG------------------ 170
Query: 581 QQKSVSLEVTTTNSSSNLGS-YYQAPESLKVVKPSQKWDIYSYGVILLEMITGR 633
+ T +++ +G+ Y +PE + + D+YS G +L E++TG
Sbjct: 171 --------NSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE 216
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 3e-18
Identities = 67/339 (19%), Positives = 122/339 (35%), Gaps = 98/339 (28%)
Query: 410 VLGKSGIGIVYK-----VVLEDGHTL-AVRRLGEGGSQRFKEFQTEVEAIGKIRHSNIVT 463
LG+ G V+ ++ E L AV+ L E ++FQ E E + ++H +IV
Sbjct: 48 ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVR 107
Query: 464 LRAYYWSVDEKLLIYDYIPNGSLATAL-------HGKPGMVSFTPVPWSVR--VKIIKGI 514
L++++Y+ +G L L G P P + + + +
Sbjct: 108 FFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQV 167
Query: 515 AKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPA 574
A G+VYL +VH DL N L+G + + DFG++R
Sbjct: 168 AAGMVYLAG---LHFVHRDLATRNCLVGQGLVVKIGDFGMSR------------------ 206
Query: 575 EKPQERQQKSVSLEVTTTNSSSNLGSYYQ------------APESLKVVKPSQKWDIYSY 622
++ +T+ YY+ PES+ K + + D++S+
Sbjct: 207 -------------DIYSTD-------YYRVGGRTMLPIRWMPPESILYRKFTTESDVWSF 246
Query: 623 GVILLEMIT-GRT-----AVVQVGSSEMDLVNWMQLCIEEKKPLADVLD-PYLAPDADKE 675
GV+L E+ T G+ + + +D + + L+ P P
Sbjct: 247 GVVLWEIFTYGKQPWYQLSNTEA----IDCITQGR-----------ELERPRACPP---- 287
Query: 676 EEIIAVLKIAMACVHSSPEKRPTMRHISDALDRLIVSSD 714
V I C P++R +++ + L L +
Sbjct: 288 ----EVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPP 322
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 3e-18
Identities = 49/230 (21%), Positives = 81/230 (35%), Gaps = 47/230 (20%)
Query: 411 LGKSGIGIVYKVV-LEDGHTLAV----RRLGEGGSQRFKEFQTEVEAIGKIRHSNIVTLR 465
LGK G +++ + A + L QR K E+ + H ++V
Sbjct: 49 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREK-MSMEISIHRSLAHQHVVGFH 107
Query: 466 AYYWSVDEKLLIYDYIPNGSLATAL--HGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHE 523
++ D ++ + SL T R ++ I G YLH
Sbjct: 108 GFFEDNDFVFVVLELCRRRSLLELHKRRKA-----LTE--PEAR-YYLRQIVLGCQYLHR 159
Query: 524 FSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQK 583
+ +H DLK N+ L ++E + DFGLA E ER++
Sbjct: 160 ---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATK----------------VEYDGERKK- 199
Query: 584 SVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGR 633
+ N Y APE L S + D++S G I+ ++ G+
Sbjct: 200 -------VLCGTPN----YIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGK 238
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 3e-18
Identities = 68/330 (20%), Positives = 113/330 (34%), Gaps = 95/330 (28%)
Query: 410 VLGKSGIGIVYKVVLEDGH-----TLAVRRLGEG-GSQRFKEFQTEVEAIGKIRHSNIVT 463
VLG G V+K V + ++ + + G Q F+ + AIG + H++IV
Sbjct: 20 VLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVR 79
Query: 464 LRAYYWSV---DEKLLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVY 520
L + L+ Y+P GSL + G + + + IAKG+ Y
Sbjct: 80 LLG----LCPGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLL-----LNWGVQIAKGMYY 130
Query: 521 LHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQER 580
L E VH +L N+LL + V+DFG+A L + P +
Sbjct: 131 LEE---HGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIK----- 182
Query: 581 QQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMIT-GRTAVVQV 639
+ A ES+ K + + D++SYGV + E++T G
Sbjct: 183 ---------------------WMALESIHFGKYTHQSDVWSYGVTVWELMTFGA------ 215
Query: 640 GSSEMDLVNWMQLCIEEKKP-----LADVLD----------PYLAPDADKEEEIIAVLKI 684
+P LA+V D P + V +
Sbjct: 216 ------------------EPYAGLRLAEVPDLLEKGERLAQPQICTI--------DVYMV 249
Query: 685 AMACVHSSPEKRPTMRHISDALDRLIVSSD 714
+ C RPT + +++ R+
Sbjct: 250 MVKCWMIDENIRPTFKELANEFTRMARDPP 279
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 87.0 bits (215), Expect = 6e-18
Identities = 54/236 (22%), Positives = 94/236 (39%), Gaps = 48/236 (20%)
Query: 410 VLGKSGIGIVYKVV-LEDGHTLAVRRLGEGGSQRFKE-FQTEVEAIGKIRHSNIVTLRAY 467
LG G G V + + + G +A+++ + S + +E + E++ + K+ H N+V+ R
Sbjct: 21 RLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREV 80
Query: 468 Y------WSVDEKLLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYL 521
D LL +Y G L L+ + + + ++ I+ L YL
Sbjct: 81 PDGLQKLAPNDLPLLAMEYCEGGDLRKYLN-QFE--NCCGLKEGPIRTLLSDISSALRYL 137
Query: 522 HEFSPKKYVHGDLKPSNILLGHNMEPH---VSDFGLARLANIAGGSPTLQSNRMPAEKPQ 578
HE + +H DLKP NI+L + + D G A+ L +
Sbjct: 138 HE---NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAK---------ELDQGEL------ 179
Query: 579 ERQQKSVSLEVTTTNSSSNLGS-YYQAPESLKVVKPSQKWDIYSYGVILLEMITGR 633
+ +G+ Y APE L+ K + D +S+G + E ITG
Sbjct: 180 ---------------CTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGF 220
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 7e-18
Identities = 61/317 (19%), Positives = 112/317 (35%), Gaps = 69/317 (21%)
Query: 410 VLGKSGIGIVYKVVLEDGH-----TLAVRRLGEGGSQR-FKEFQTEVEAIGKIRHSNIVT 463
VLG G VYK + +A++ L E S + KE E + + + ++
Sbjct: 22 VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 81
Query: 464 LRAYYWSV---DEKLLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVY 520
L + LI +P G L + + + + IAKG+ Y
Sbjct: 82 LLG----ICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYL-----LNWCVQIAKGMNY 132
Query: 521 LHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSN--RMPAEKPQ 578
L + ++ VH DL N+L+ ++DFGLA+L + + ++P
Sbjct: 133 LED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKL--LGAEEKEYHAEGGKVP----- 182
Query: 579 ERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMIT-GRTAVV 637
+ A ES+ + + D++SYGV + E++T G
Sbjct: 183 ----------IKWM-----------ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 221
Query: 638 QVGSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRP 697
+ +SE+ + +E+ + L P + V I + C + RP
Sbjct: 222 GIPASEI-----SSI-LEKGERLP---QPPICTI--------DVYMIMVKCWMIDADSRP 264
Query: 698 TMRHISDALDRLIVSSD 714
R + ++
Sbjct: 265 KFRELIIEFSKMARDPQ 281
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 8e-18
Identities = 69/326 (21%), Positives = 104/326 (31%), Gaps = 94/326 (28%)
Query: 410 VLGKSGIGIVYKVVL--EDGHTL--AVRRLGEG---GSQRFKEFQTEVEAIGKIRHSNIV 462
LG G+V + G T+ AV+ L + +F EV A+ + H N++
Sbjct: 25 KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 84
Query: 463 TLRAYYWSVDEK--LLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVY 520
L Y V ++ + P GSL L G + +A+G+ Y
Sbjct: 85 RL---YGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLL-----GTLSRYAVQVAEGMGY 136
Query: 521 LHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQER 580
L K+++H DL N+LL + DFGL R +P
Sbjct: 137 LES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRA--------------LPQNDDHYV 179
Query: 581 QQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMIT-GRTAVVQV 639
Q+ + APESLK S D + +GV L EM T G+
Sbjct: 180 MQEHRKVPFAWC-----------APESLKTRTFSHASDTWMFGVTLWEMFTYGQ------ 222
Query: 640 GSSEMDLVNWMQLCIEEKKP-----LADVLD-----------PYLAPDADKEEEIIAVLK 683
+P + +L P P +
Sbjct: 223 ------------------EPWIGLNGSQILHKIDKEGERLPRPEDCPQ--------DIYN 256
Query: 684 IAMACVHSSPEKRPTMRHISDALDRL 709
+ + C PE RPT + D L
Sbjct: 257 VMVQCWAHKPEDRPTFVALRDFLLEA 282
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 8e-18
Identities = 68/327 (20%), Positives = 114/327 (34%), Gaps = 88/327 (26%)
Query: 410 VLGKSGIGIVYKVVLEDG----HTLAVRRLGEGGSQR-FKEFQTEVEAIGKIRHSNIVTL 464
V+G+ G VY L D AV+ L +F TE + H N+++L
Sbjct: 32 VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 91
Query: 465 RAYYWSVDEKLL-IYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHE 523
+ L + Y+ +G L + + + + + +AKG+ YL
Sbjct: 92 LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL-----IGFGLQVAKGMKYLAS 146
Query: 524 FSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQK 583
KK+VH DL N +L V+DFGLAR ++ N+ A+ P
Sbjct: 147 ---KKFVHRDLAARNCMLDEKFTVKVADFGLAR--DMYDKEYYSVHNKTGAKLP------ 195
Query: 584 SVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMIT-GRTAVVQVGSS 642
V A ESL+ K + K D++S+GV+L E++T G
Sbjct: 196 -----VKWM-----------ALESLQTQKFTTKSDVWSFGVLLWELMTRGAP-------- 231
Query: 643 EMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLK----------------IAM 686
PY PD + + + +L+ + +
Sbjct: 232 -----------------------PY--PDVNTFDITVYLLQGRRLLQPEYCPDPLYEVML 266
Query: 687 ACVHSSPEKRPTMRHISDALDRLIVSS 713
C H E RP+ + + + +
Sbjct: 267 KCWHPKAEMRPSFSELVSRISAIFSTF 293
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 8e-18
Identities = 67/364 (18%), Positives = 122/364 (33%), Gaps = 97/364 (26%)
Query: 374 KDESETLSENVEQYDLVPLDTQVAFDLDELLKASAFVLGKSGIGIVYKVVLEDGH----T 429
+D L V+ L+P + +V D ++ F G+VY D
Sbjct: 1 RDLDSALLAEVKDV-LIPHE-RVVTHSDRVIGKGHF-------GVVYHGEYIDQAQNRIQ 51
Query: 430 LAVRRLGEGGSQR-FKEFQTEVEAIGKIRHSNIVTLRAYYWSVDE-KLLIYDYIPNGSLA 487
A++ L + + F E + + H N++ L + ++ Y+ +G L
Sbjct: 52 CAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLL 111
Query: 488 TALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEP 547
+ + + + +A+G+ YL + +K+VH DL N +L +
Sbjct: 112 QFIRSPQRNPTVKDL-----ISFGLQVARGMEYL---AEQKFVHRDLAARNCMLDESFTV 163
Query: 548 HVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPES 607
V+DFGLAR I A P V T A ES
Sbjct: 164 KVADFGLARD--ILDREYYSVQQHRHARLP-----------VKWT-----------ALES 199
Query: 608 LKVVKPSQKWDIYSYGVILLEMIT-GRTAVVQVGSSEMDLVNWMQLCIEEKKPLADVLDP 666
L+ + + K D++S+GV+L E++T G P
Sbjct: 200 LQTYRFTTKSDVWSFGVLLWELLTRGAP-------------------------------P 228
Query: 667 YLAPDADKEEEIIAVLK----------------IAMACVHSSPEKRPTMRHISDALDRLI 710
Y D + + + + C + P RPT R + +++++
Sbjct: 229 Y--RHIDPFDLTHFLAQGRRLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIV 286
Query: 711 VSSD 714
+
Sbjct: 287 SALL 290
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 86.8 bits (215), Expect = 1e-17
Identities = 36/216 (16%), Positives = 64/216 (29%), Gaps = 12/216 (5%)
Query: 81 PSALGSLTDLRHVNLRNNKFFGSLPLELLEAQG-LQSLVLYGNSFSGSVPNEIGKLKYLQ 139
S+ L L+ + L + ++ E L+ L L + P+ L +L
Sbjct: 41 ASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLF 100
Query: 140 ILDLSQNFFNGSL--PVSIVQCKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLNLSFNKF 197
L L + ++ K L LDLS+N + L SL+ ++ S N+
Sbjct: 101 ELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQI 160
Query: 198 NGSIPSNTGNLSSLQ-GTVDFSHNLFSGSIPASLGNLPEKV------YIDLTYNNLSGPI 250
L + N + G +D++ N + I
Sbjct: 161 FLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDI 220
Query: 251 PQN--GALMNRGPTAFIGNPRLCGPPLKNPCSSDVP 284
N A+ + I + G D
Sbjct: 221 TGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPD 256
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 85.6 bits (212), Expect = 2e-17
Identities = 39/199 (19%), Positives = 63/199 (31%), Gaps = 14/199 (7%)
Query: 51 ENPCSWNGITCKEQRVVSVSIPKKKLLGFLPSALGSLTDLRHVNLRNNKF--FGSLPLEL 108
S NG T S +I K + +L + +
Sbjct: 208 ILDVSGNGWTVDITGNFSNAISKSQAF-----SLILAHHIMGAGFGFHNIKDPDQNTFAG 262
Query: 109 LEAQGLQSLVLYGNSFSGSVPNEIGKLKYLQILDLSQNFFNGSLPVSIVQCKRLKALDLS 168
L ++ L L LK L++L+L+ N N + L+ L+LS
Sbjct: 263 LARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLS 322
Query: 169 QNNFTGPLPNGFGSGLVSLEKLNLSFNKFNGSIPSNTGNLSSLQGTVDFSHNLFSGSIPA 228
N L + GL + ++L N L LQ T+D N +
Sbjct: 323 YNLLGE-LYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQ-TLDLRDNALT----- 375
Query: 229 SLGNLPEKVYIDLTYNNLS 247
++ +P I L+ N L
Sbjct: 376 TIHFIPSIPDIFLSGNKLV 394
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 81.4 bits (201), Expect = 4e-16
Identities = 38/163 (23%), Positives = 61/163 (37%), Gaps = 10/163 (6%)
Query: 89 DLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSGSVPNEIGKLKYLQILDLSQNFF 148
D R R +P L + L+L N + L+ LQ+L+L +
Sbjct: 5 DGRIAFYRFCNLT-QVPQVL---NTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYT 60
Query: 149 NGSLPVSIVQ-CKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLNLSFNKF-NGSIPSNT- 205
++ + L+ LDL + P+ F GL L +L L F + +
Sbjct: 61 PLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAF-QGLFHLFELRLYFCGLSDAVLKDGYF 119
Query: 206 GNLSSLQGTVDFSHN-LFSGSIPASLGNLPEKVYIDLTYNNLS 247
NL +L +D S N + S + S G L ID + N +
Sbjct: 120 RNLKALT-RLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIF 161
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 81.4 bits (201), Expect = 4e-16
Identities = 46/213 (21%), Positives = 79/213 (37%), Gaps = 34/213 (15%)
Query: 80 LPSALGSLTDLRHVNLRNNKFFGSLP--LELLEAQGLQSLVLYGNSFSGSVPNEIGKL-- 135
L + G L L+ ++ +N+ F LE L+ + L L NS V + GK
Sbjct: 140 LHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMN 199
Query: 136 ----KYLQILDLSQNFFN------------GSLPVSIVQCKRLKALDLSQNNFTGPLPNG 179
L+ILD+S N + S S++ + +N P N
Sbjct: 200 PFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNT 259
Query: 180 F-GSGLVSLEKLNLSFNKFNGSIPSNT-GNLSSLQGTVDFSHNLFSGSIPASLGNLPEKV 237
F G S+ L+LS S+ S L L+ ++ ++N + + L
Sbjct: 260 FAGLARSSVRHLDLSHGFVF-SLNSRVFETLKDLK-VLNLAYNKINKIADEAFYGLDNLQ 317
Query: 238 YIDLTYNNLSGPIPQNGALMNRGPTAFIGNPRL 270
++L+YN L + + F G P++
Sbjct: 318 VLNLSYNLLGE-LYSS---------NFYGLPKV 340
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 81.0 bits (200), Expect = 6e-16
Identities = 35/173 (20%), Positives = 63/173 (36%), Gaps = 16/173 (9%)
Query: 81 PSALGSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSGSVPNEIGKLKYLQI 140
L L+ ++LR+N + + + L GN + +
Sbjct: 355 DQTFKFLEKLQTLDLRDNAL-----TTIHFIPSIPDIFLSGNKLVTLPKINL----TANL 405
Query: 141 LDLSQNFFNG-SLPVSIVQCKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLNLSFNKFNG 199
+ LS+N + +++ L+ L L+QN F+ + S SLE+L L N
Sbjct: 406 IHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQL 465
Query: 200 ----SIPSNT-GNLSSLQGTVDFSHNLFSGSIPASLGNLPEKVYIDLTYNNLS 247
+ + LS LQ + +HN + P +L + L N L+
Sbjct: 466 AWETELCWDVFEGLSHLQ-VLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLT 517
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 79.8 bits (197), Expect = 2e-15
Identities = 36/174 (20%), Positives = 57/174 (32%), Gaps = 12/174 (6%)
Query: 75 KLLGFLPSALGSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSGSVPNEIGK 134
+ +L DL+ +NL NK LQ L L N +
Sbjct: 277 FVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYG 336
Query: 135 LKYLQILDLSQNFFNGSLPVSIVQCKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLNLSF 194
L + +DL +N + ++L+ LDL N T + S+ + LS
Sbjct: 337 LPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALTTI------HFIPSIPDIFLSG 390
Query: 195 NKFNGSIPSNTGNLSSLQGTVDFSHNLFSG-SIPASLGNLPEKVYIDLTYNNLS 247
NK ++P + + S N I L +P + L N S
Sbjct: 391 NKLV-TLPKINLTANLI----HLSENRLENLDILYFLLRVPHLQILILNQNRFS 439
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 72.1 bits (177), Expect = 3e-13
Identities = 22/127 (17%), Positives = 43/127 (33%), Gaps = 6/127 (4%)
Query: 135 LKYLQILDLSQNFFNGSLPVSIVQCKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLNLSF 194
L + L LS N+ S ++L+ L+L + L +L L+L
Sbjct: 23 LNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGS 82
Query: 195 NKFNGSIPSNT-GNLSSLQGTVDFSHNLFSGSI--PASLGNLPEKVYIDLTYNNLSGPIP 251
+K + + L L + S ++ NL +DL+ N + +
Sbjct: 83 SKIY-FLHPDAFQGLFHLF-ELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRS-LY 139
Query: 252 QNGALMN 258
+ +
Sbjct: 140 LHPSFGK 146
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 72.1 bits (177), Expect = 3e-13
Identities = 39/203 (19%), Positives = 65/203 (32%), Gaps = 37/203 (18%)
Query: 75 KLLGFLPSALGSLTDLRHVNLRNNK---------FFGSLPLELLEAQGLQSLVLYGNSFS 125
K+ P A L L + L +F +L L L L N
Sbjct: 84 KIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLK-------ALTRLDLSKNQIR 136
Query: 126 G-SVPNEIGKLKYLQILDLSQNFFNGSLPVSI--VQCKRLKALDLSQNNFTGPLPNGFGS 182
+ GKL L+ +D S N + +Q K L L+ N+ + +G
Sbjct: 137 SLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGK 196
Query: 183 GL-----VSLEKLNLSFNKFNGSIPSNTGN-LSSLQ----------GTVDFSHNLFSGSI 226
+ + LE L++S N + I N N +S Q F +
Sbjct: 197 CMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPD 256
Query: 227 PASLGNLPEK--VYIDLTYNNLS 247
+ L ++DL++ +
Sbjct: 257 QNTFAGLARSSVRHLDLSHGFVF 279
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 64.1 bits (156), Expect = 1e-10
Identities = 40/154 (25%), Positives = 64/154 (41%), Gaps = 17/154 (11%)
Query: 84 LGSLTDLRHVNLRNNKFFGSLPLELLEA--QGLQSLVLYGNSFSGSVPNEI-----GKLK 136
L + L+ + L N+F S + + L+ L L N + E+ L
Sbjct: 422 LLRVPHLQILILNQNRF-SSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLS 480
Query: 137 YLQILDLSQNFFNGSLPVSIVQC-KRLKALDLSQNNFTGPLPNGFGSGLVSLEKLNLSFN 195
+LQ+L L+ N+ N SLP + L+ L L+ N T L + +LE L++S N
Sbjct: 481 HLQVLYLNHNYLN-SLPPGVFSHLTALRGLSLNSNRLTV-LSHNDLPA--NLEILDISRN 536
Query: 196 KFNGSIPSNTGNLSSLQGTVDFSHNLFSGSIPAS 229
+ P +LS +D +HN F S
Sbjct: 537 QLLAPNPDVFVSLS----VLDITHNKFICECELS 566
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 44.4 bits (105), Expect = 1e-04
Identities = 31/128 (24%), Positives = 47/128 (36%), Gaps = 30/128 (23%)
Query: 78 GFLPSALGSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSGSVPNEIGKLKY 137
L+ L+ + L +N SLP FS L
Sbjct: 470 ELCWDVFEGLSHLQVLYLNHNYLN-SLP---------------PGVFSH--------LTA 505
Query: 138 LQILDLSQNFFNGSLPVSIVQCKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLNLSFNKF 197
L+ L L+ N L + + L+ LD+S+N P P+ F VSL L+++ NKF
Sbjct: 506 LRGLSLNSNRLT-VLSHNDLP-ANLEILDISRNQLLAPNPDVF----VSLSVLDITHNKF 559
Query: 198 NGSIPSNT 205
+T
Sbjct: 560 ICECELST 567
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 82.6 bits (205), Expect = 1e-17
Identities = 57/339 (16%), Positives = 103/339 (30%), Gaps = 115/339 (33%)
Query: 410 VLGKSGIGIVYKVVLEDGHTL----AVRRLGEGGSQRFK-EFQTEVEAIGKIRHSNIVTL 464
+LG+ G VY+ V + AV+ + + K +F +E + + H +IV L
Sbjct: 19 ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKL 78
Query: 465 RAYYWSVDEK--LLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLH 522
++E+ +I + P G L L + + V I K + YL
Sbjct: 79 IGI---IEEEPTWIIMELYPYGELGHYLERNKNSLKVLTL-----VLYSLQICKAMAYLE 130
Query: 523 EFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQ 582
VH D+ NIL+ + DFGL+R ++
Sbjct: 131 S---INCVHRDIAVRNILVASPECVKLGDFGLSRY---------IEDE------------ 166
Query: 583 KSVSLEVTTTNSSSNLGSYYQ-----------APESLKVVKPSQKWDIYSYGVILLEMIT 631
YY+ +PES+ + + D++ + V + E+++
Sbjct: 167 -----------------DYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILS 209
Query: 632 -GRTAVVQVGSSEMDLVNWMQLCIEEKKP-----LADVLD----------PYLAPDADKE 675
G+ +P DV+ P L P
Sbjct: 210 FGK------------------------QPFFWLENKDVIGVLEKGDRLPKPDLCPP---- 241
Query: 676 EEIIAVLKIAMACVHSSPEKRPTMRHISDALDRLIVSSD 714
+ + C P RP + +L +
Sbjct: 242 ----VLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQMEK 276
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 1e-17
Identities = 53/335 (15%), Positives = 104/335 (31%), Gaps = 115/335 (34%)
Query: 410 VLGKSGIGIVYKVVLEDGH----TLAVRRLGEGGSQRFK-EFQTEVEAIGKIRHSNIVTL 464
+G+ G V++ + +A++ S + +F E + + H +IV L
Sbjct: 22 CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 81
Query: 465 RAYYWSVDEK--LLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLH 522
+ E +I + G L + L + + + + ++ L YL
Sbjct: 82 IGV---ITENPVWIIMELCTLGELRSFLQVRKYSLDLASL-----ILYAYQLSTALAYLE 133
Query: 523 EFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQ 582
K++VH D+ N+L+ N + DFGL+R ++ +
Sbjct: 134 S---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRY---------MEDS------------ 169
Query: 583 KSVSLEVTTTNSSSNLGSYYQ-----------APESLKVVKPSQKWDIYSYGVILLEMIT 631
+YY+ APES+ + + D++ +GV + E++
Sbjct: 170 -----------------TYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILM 212
Query: 632 -GRTAVVQVGSSEMDLVNWMQLCIEEKKP-----LADVLD----------PYLAPDADKE 675
G KP DV+ P P
Sbjct: 213 HGV------------------------KPFQGVKNNDVIGRIENGERLPMPPNCPP---- 244
Query: 676 EEIIAVLKIAMACVHSSPEKRPTMRHISDALDRLI 710
+ + C P +RP + L ++
Sbjct: 245 ----TLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 275
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 1e-17
Identities = 66/354 (18%), Positives = 107/354 (30%), Gaps = 124/354 (35%)
Query: 410 VLGKSGIGIVYK-----VVLEDGHTL-AVRRLGEGGSQR-FKEFQTEVEAIGKI-RHSNI 461
LG G V + ++ D AV+ L + +E++ + + H NI
Sbjct: 30 TLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNI 89
Query: 462 VTLRAYYWSVDEKLLIYDYIPNGSL----------ATALHGKPGMVSFTPVPWSVR--VK 509
V L L+I +Y G L P ++ + + +
Sbjct: 90 VNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLS 149
Query: 510 IIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQS 569
+AKG+ +L + K +H DL NILL H + DFGLAR
Sbjct: 150 FSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDI----------- 195
Query: 570 NRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQ------------APESLKVVKPSQKW 617
S Y APES+ + +
Sbjct: 196 ---------------------------KNDSNYVVKGNARLPVKWMAPESIFNCVYTFES 228
Query: 618 DIYSYGVILLEMIT-GRTAVVQVGSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEE 676
D++SYG+ L E+ + G + PY P +
Sbjct: 229 DVWSYGIFLWELFSLGSS-------------------------------PY--PGMPVDS 255
Query: 677 EIIAVLK-----------------IAMACVHSSPEKRPTMRHISDALDRLIVSS 713
+ ++K I C + P KRPT + I +++ I S
Sbjct: 256 KFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISES 309
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 2e-17
Identities = 46/313 (14%), Positives = 91/313 (29%), Gaps = 109/313 (34%)
Query: 431 AVRRLGEGGSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGSLATAL 490
++ L + + F + K+ H ++V DE +L+ +++ GSL T L
Sbjct: 44 LLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYL 103
Query: 491 HGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPH-- 548
++ ++++ K +A + +L E +HG++ NILL +
Sbjct: 104 KKNKNCINI-----LWKLEVAKQLAAAMHFLEE---NTLIHGNVCAKNILLIREEDRKTG 155
Query: 549 ------VSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYY 602
+SD G++ +
Sbjct: 156 NPPFIKLSDPGISIT---------VLPK-----------------------------DIL 177
Query: 603 Q------APESLKVVKP-SQKWDIYSYGVILLEMIT-GRTAVVQVGSSEMDLVNWMQLCI 654
Q PE ++ K + D +S+G L E+ + G
Sbjct: 178 QERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDK-------------------- 217
Query: 655 EEKKPLADVLDPYLAPDADKEEEIIAVLK--------------IAMACVHSSPEKRPTMR 700
P D + ++ + C+ P+ RP+ R
Sbjct: 218 -----------PL--SALDSQRKLQFYEDRHQLPAPKAAELANLINNCMDYEPDHRPSFR 264
Query: 701 HISDALDRLIVSS 713
I L+ L
Sbjct: 265 AIIRDLNSLFTPD 277
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 84.0 bits (207), Expect = 2e-17
Identities = 37/303 (12%), Positives = 76/303 (25%), Gaps = 71/303 (23%)
Query: 410 VLGKSGIGIVYKVV-LEDGHTLAV---RRLGEGGSQRFKEFQTEVEAIGKIRH------- 458
VLG+ + E G + V S K+ + EV + +R
Sbjct: 85 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 144
Query: 459 ---------SNIVTLRAYYWSVDEKLLIYDY----------IPNGSLATALHGKPGMVSF 499
++V + +L D +L T S
Sbjct: 145 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 204
Query: 500 T-PVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLA 558
+ R+++ + + L LH VH L+P +I+L ++ F
Sbjct: 205 HKSLVHHARLQLTLQVIRLLASLHH---YGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRD 261
Query: 559 NIAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGS-YYQAPESLKVVKPSQKW 617
+ A L +
Sbjct: 262 G----------------------------ASAVSPIGRGFAPPETTAERMLPFGQHHPTL 293
Query: 618 -----DIYSYGVILLEMITGRTAVVQVGSSEMDLVNW-MQLCIEEKKPLADVLDPYLAPD 671
D ++ G+ + + + + W + C +P+ +L+ +L
Sbjct: 294 MTFAFDTWTLGLAIYWIWCADLPN--TDDAALGGSEWIFRSCKNIPQPVRALLEGFLRYP 351
Query: 672 ADK 674
+
Sbjct: 352 KED 354
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 2e-17
Identities = 45/184 (24%), Positives = 75/184 (40%), Gaps = 25/184 (13%)
Query: 77 LGFLPSALGSLTDLRHVNLRNNK--------FFGSLPLELLEAQGLQSLVLYGNSFSGSV 128
+ + S L L H++ +++ F SL L L +
Sbjct: 90 VITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLR-------NLIYLDISHTHTR-VA 141
Query: 129 PNEI-GKLKYLQILDLSQNFFNGSLPVSI-VQCKRLKALDLSQNNFTGPLPNGFGSGLVS 186
N I L L++L ++ N F + I + + L LDLSQ L + L S
Sbjct: 142 FNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQ-LSPTAFNSLSS 200
Query: 187 LEKLNLSFNKFNGSIPSNT-GNLSSLQGTVDFSHNLFSGSIPAS-LGNLPEK-VYIDLTY 243
L+ LN+S N F S+ + L+SLQ +D+S N + L + P +++LT
Sbjct: 201 LQVLNMSHNNFF-SLDTFPYKCLNSLQ-VLDYSLNHIM-TSKKQELQHFPSSLAFLNLTQ 257
Query: 244 NNLS 247
N+ +
Sbjct: 258 NDFA 261
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 3e-17
Identities = 34/170 (20%), Positives = 64/170 (37%), Gaps = 7/170 (4%)
Query: 81 PSALGSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSGSVPNEI-GKLKYLQ 139
+ T L++++L N ++ L + L+ L ++ + L+ L
Sbjct: 71 SQSDFGTTSLKYLDLSFNGV-ITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLI 129
Query: 140 ILDLSQNFFNGSLPVSIVQ-CKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLNLSFNKFN 198
LD+S I L+ L ++ N+F + L +L L+LS +
Sbjct: 130 YLDISHTHTR-VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE 188
Query: 199 GSIPSNT-GNLSSLQGTVDFSHNLFSGSIPASLGNLPEKVYIDLTYNNLS 247
+ +LSSLQ ++ SHN F L +D + N++
Sbjct: 189 -QLSPTAFNSLSSLQ-VLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIM 236
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 8e-17
Identities = 37/185 (20%), Positives = 64/185 (34%), Gaps = 24/185 (12%)
Query: 80 LPSALGSLTDLRHVNLRNNKF-------FGSLPLELLEAQGLQSLVLYGN--SFSGSVPN 130
+P+ + + + L +NK F L L L L N SF G
Sbjct: 22 VPTGI--PSSATRLELESNKLQSLPHGVFDKLT-------QLTKLSLSSNGLSFKGCCSQ 72
Query: 131 EIGKLKYLQILDLSQNFFNGSLPVSIVQCKRLKALDLSQNNFTGPLPNGFGSGLVSLEKL 190
L+ LDLS N ++ + + ++L+ LD +N L +L L
Sbjct: 73 SDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYL 131
Query: 191 NLSFNKFNGSIPSNT-GNLSSLQGTVDFSHNLFSGSIPA-SLGNLPEKVYIDLTYNNLSG 248
++S + LSSL+ + + N F + L ++DL+ L
Sbjct: 132 DISHTHTR-VAFNGIFNGLSSLE-VLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQ 189
Query: 249 PIPQN 253
+
Sbjct: 190 -LSPT 193
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 1e-13
Identities = 35/169 (20%), Positives = 53/169 (31%), Gaps = 11/169 (6%)
Query: 89 DLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSGSVPNEIGKLKYLQILDLSQNF- 147
+ + S+P + L L N KL L L LS N
Sbjct: 8 SGTEIRCNSKGL-TSVPTGIPS--SATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGL 64
Query: 148 -FNGSLPVSIVQCKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLNLSFNKFNGSIPSNT- 205
F G S LK LDLS N + + F GL LE L+ + + +
Sbjct: 65 SFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNF-LGLEQLEHLDFQHSNLK-QMSEFSV 121
Query: 206 -GNLSSLQGTVDFSHNLFSGSIPASLGNLPEKVYIDLTYNNLSGPIPQN 253
+L +L +D SH + L + + N+ +
Sbjct: 122 FLSLRNLI-YLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPD 169
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 3e-17
Identities = 65/330 (19%), Positives = 106/330 (32%), Gaps = 84/330 (25%)
Query: 410 VLGKSGIGIVYKVVL------EDGHTLAVRRLGEGGSQR-FKEFQTEVEAIGKIRHSNIV 462
LG G VY+ + +AV+ L E S++ +F E I K H NIV
Sbjct: 37 GLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIV 96
Query: 463 TLRAYYWSVDEKLLIYDYIPNGSLATAL-HGKPGMVSFTPVPWSVRVKIIKGIAKGLVYL 521
+ ++ + + G L + L +P + + + + + IA G YL
Sbjct: 97 RCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 156
Query: 522 HEFSPKKYVHGDLKPSNILLGHNMEPHV---SDFGLARLANIAGGSPTLQSNRMPAEKPQ 578
++H D+ N LL V DFG+AR +I
Sbjct: 157 ---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR--DI------------------ 193
Query: 579 ERQQKSVSLEVTTTNSSSNLGSYYQ------------APESLKVVKPSQKWDIYSYGVIL 626
SYY+ PE+ + K D +S+GV+L
Sbjct: 194 ------------------YRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLL 235
Query: 627 LEMIT-GRTAVVQVGSSEMDLVNWMQLCIEEKKPLADVLD-PYLAPDADKEEEIIAVLKI 684
E+ + G S +++ + +D P P V +I
Sbjct: 236 WEIFSLGYMPY--PSKSNQEVLE----FVTSGG----RMDPPKNCPG--------PVYRI 277
Query: 685 AMACVHSSPEKRPTMRHISDALDRLIVSSD 714
C PE RP I + ++ D
Sbjct: 278 MTQCWQHQPEDRPNFAIILERIEYCTQDPD 307
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 4e-17
Identities = 63/330 (19%), Positives = 105/330 (31%), Gaps = 84/330 (25%)
Query: 410 VLGKSGIGIVYKVVL------EDGHTLAVRRLGEGGSQR-FKEFQTEVEAIGKIRHSNIV 462
LG G VY+ + +AV+ L E S++ +F E I K H NIV
Sbjct: 78 GLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIV 137
Query: 463 TLRAYYWSVDEKLLIYDYIPNGSLATAL-HGKPGMVSFTPVPWSVRVKIIKGIAKGLVYL 521
+ ++ + + G L + L +P + + + + + IA G YL
Sbjct: 138 RCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 197
Query: 522 HEFSPKKYVHGDLKPSNILLGHNMEPHV---SDFGLARLANIAGGSPTLQSNRMPAEKPQ 578
++H D+ N LL V DFG+AR
Sbjct: 198 ---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR---------------------- 232
Query: 579 ERQQKSVSLEVTTTNSSSNLGSYYQ------------APESLKVVKPSQKWDIYSYGVIL 626
++ YY+ PE+ + K D +S+GV+L
Sbjct: 233 ---------DIYRA-------GYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLL 276
Query: 627 LEMIT-GRTAVVQVGSSEMDLVNWMQLCIEEKKPLADVLD-PYLAPDADKEEEIIAVLKI 684
E+ + G S +++ + +D P P V +I
Sbjct: 277 WEIFSLGYMPY--PSKSNQEVLE----FVTSGG----RMDPPKNCPG--------PVYRI 318
Query: 685 AMACVHSSPEKRPTMRHISDALDRLIVSSD 714
C PE RP I + ++ D
Sbjct: 319 MTQCWQHQPEDRPNFAIILERIEYCTQDPD 348
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 7e-17
Identities = 67/331 (20%), Positives = 117/331 (35%), Gaps = 94/331 (28%)
Query: 410 VLGKSGIGIVYK-----VVLEDGHTL-AVRRLGEGGSQR-FKEFQTEVEAIGKIRHSNIV 462
LG+ G+VY+ VV ++ T A++ + E S R EF E + + ++V
Sbjct: 32 ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 91
Query: 463 TLRAYYWSVDEKLLIYDYIPNGSLATAL--HGKPGMVSFTPVPWSVR--VKIIKGIAKGL 518
L L+I + + G L + L + P S+ +++ IA G+
Sbjct: 92 RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGM 151
Query: 519 VYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQ 578
YL+ K+VH DL N ++ + + DFG+ R +I
Sbjct: 152 AYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTR--DI------------------ 188
Query: 579 ERQQKSVSLEVTTTNSSSNLGSYYQ------------APESLKVVKPSQKWDIYSYGVIL 626
YY+ +PESLK + D++S+GV+L
Sbjct: 189 ------------------YETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVL 230
Query: 627 LEMIT-GRT-----AVVQVGSSEMDLVNWMQLCIEEKKPLADVLD-PYLAPDADKEEEII 679
E+ T + QV + E +LD P PD
Sbjct: 231 WEIATLAEQPYQGLSNEQVLR-----------FVMEGG----LLDKPDNCPD-------- 267
Query: 680 AVLKIAMACVHSSPEKRPTMRHISDALDRLI 710
+ ++ C +P+ RP+ I ++ +
Sbjct: 268 MLFELMRMCWQYNPKMRPSFLEIISSIKEEM 298
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 7e-17
Identities = 39/194 (20%), Positives = 70/194 (36%), Gaps = 20/194 (10%)
Query: 81 PSALGSLTDLRHVNLRNNKFFGSLPLELLEA-QGLQSLVLYGNSFSGSVPNEI-GKLKYL 138
P A +L +LR + LR+N+ +PL + L L + N + + + L L
Sbjct: 73 PGAFNNLFNLRTLGLRSNR-LKLIPLGVFTGLSNLTKLDISENKIV-ILLDYMFQDLYNL 130
Query: 139 QILDLSQNFFNGSLPVSI-VQCKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLNLSFNKF 197
+ L++ N + L+ L L + N T S L L L L
Sbjct: 131 KSLEVGDNDLV-YISHRAFSGLNSLEQLTLEKCNLTSIPTEAL-SHLHGLIVLRLRHLNI 188
Query: 198 NGSIPSNT-GNLSSLQGTVDFSHNLFSGSIPASLGNLPEKVYIDLTYNNLSGPIPQNGAL 256
N +I + L L+ ++ SH + ++ + + +T+ NL+ +P
Sbjct: 189 N-AIRDYSFKRLYRLK-VLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTA-VPYL--- 242
Query: 257 MNRGPTAFIGNPRL 270
A L
Sbjct: 243 ------AVRHLVYL 250
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 4e-16
Identities = 38/177 (21%), Positives = 65/177 (36%), Gaps = 10/177 (5%)
Query: 81 PSALGSLTDLRHVNLRNNKFFGSLPLELLEAQG-LQSLVLYGNSFSGSVPNEI-GKLKYL 138
S L + L N ++ L++L L N +P + L L
Sbjct: 49 QDEFASFPHLEELELNENI-VSAVEPGAFNNLFNLRTLGLRSNRLK-LIPLGVFTGLSNL 106
Query: 139 QILDLSQNFFNGSLPVSIVQ-CKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLNLSFNKF 197
LD+S+N L + Q LK+L++ N+ + + SGL SLE+L L
Sbjct: 107 TKLDISENKIV-ILLDYMFQDLYNLKSLEVGDNDLVY-ISHRAFSGLNSLEQLTLEKCNL 164
Query: 198 NGSIPSNT-GNLSSLQGTVDFSHNLFSGSIPASLGNLPEKVYIDLTYNNLSGPIPQN 253
SIP+ +L L + H + S L +++++ + N
Sbjct: 165 T-SIPTEALSHLHGLI-VLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPN 219
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 4e-16
Identities = 38/193 (19%), Positives = 71/193 (36%), Gaps = 18/193 (9%)
Query: 81 PSALGSLTDLRHVNLRNNKFFGSLPLELLEA-QGLQSLVLYGNSFSGSVPNEIGKLKYLQ 139
A L L + L S+P E L GL L L + + +L L+
Sbjct: 145 HRAFSGLNSLEQLTLEKCNL-TSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLK 203
Query: 140 ILDLSQNFFNGSLPVSIVQCKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLNLSFNKFNG 199
+L++S + ++ + + L +L ++ N T +P LV L LNLS+N +
Sbjct: 204 VLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTA-VPYLAVRHLVYLRFLNLSYNPIS- 261
Query: 200 SIPSNT-GNLSSLQGTVDFSHNLFSGSIPA-SLGNLPEKVYIDLTYNNLSGPIPQNGALM 257
+I + L LQ + + + + L ++++ N L+ +
Sbjct: 262 TIEGSMLHELLRLQ-EIQLVGGQLA-VVEPYAFRGLNYLRVLNVSGNQLTT-LE------ 312
Query: 258 NRGPTAFIGNPRL 270
+ F L
Sbjct: 313 ---ESVFHSVGNL 322
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 1e-13
Identities = 38/185 (20%), Positives = 67/185 (36%), Gaps = 21/185 (11%)
Query: 89 DLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSGSVPNEIGKLKYLQILDLSQNFF 148
R V +F ++P + + L L N +E +L+ L+L++N
Sbjct: 12 QDRAVLCHRKRFV-AVPEGIPT--ETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIV 68
Query: 149 NGSLPVSIVQ-CKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLNLSFNKFNGSIPSNT-G 206
++ L+ L L N +P G +GL +L KL++S NK +
Sbjct: 69 -SAVEPGAFNNLFNLRTLGLRSNRLKL-IPLGVFTGLSNLTKLDISENKIV-ILLDYMFQ 125
Query: 207 NLSSLQGTVDFSHNLFSGSIPA-SLGNLPEKVYIDLTYNNLSGPIPQNGALMNRGPTAFI 265
+L +L+ +++ N I + L + L NL+ IP A
Sbjct: 126 DLYNLK-SLEVGDNDLV-YISHRAFSGLNSLEQLTLEKCNLTS-IP---------TEALS 173
Query: 266 GNPRL 270
L
Sbjct: 174 HLHGL 178
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 56.3 bits (136), Expect = 2e-08
Identities = 26/142 (18%), Positives = 48/142 (33%), Gaps = 25/142 (17%)
Query: 81 PSALGSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSGSVPNE-IGKLKYLQ 139
+ L L+ + + + + ++ L L SL + + + +VP + L YL+
Sbjct: 193 DYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLT-AVPYLAVRHLVYLR 251
Query: 140 ILDLSQNFFNGSLPVSIVQCKRLKALDLSQNN--------FTG---------------PL 176
L+LS N + + + RL+ + L F G L
Sbjct: 252 FLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTL 311
Query: 177 PNGFGSGLVSLEKLNLSFNKFN 198
+ +LE L L N
Sbjct: 312 EESVFHSVGNLETLILDSNPLA 333
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 83.8 bits (207), Expect = 8e-17
Identities = 64/438 (14%), Positives = 127/438 (28%), Gaps = 105/438 (23%)
Query: 308 GGKREKGRGLSKSAIVAIIVSDVI-GICLV--GLLFSYCYSR----VCGFGEGKDENCYA 360
G E + S +A ++D+I G C + G S+
Sbjct: 291 AGAPEPLTVTAPSLTIAENMADLIDGYCRLVNGATQSFIIRPQKEGERALPSIPKLANNE 350
Query: 361 KGGKGRKECLCFRKDESETLSENVEQYDLVPLDTQVAFDLDELLKASAFVLGKSGIGIVY 420
K G D+ + + + Y + P + + +G+ G V+
Sbjct: 351 KQGVRSHTVSVSETDDYAEIIDEEDTYTM-PSTRDYEIQRERIELGR--CIGEGQFGDVH 407
Query: 421 KVVLEDGH----TLAVRRLGEGGSQRFK-EFQTEVEAIGKIRHSNIVTLRAYYWSVDEK- 474
+ + +A++ S + +F E + + H +IV L + E
Sbjct: 408 QGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGV---ITENP 464
Query: 475 -LLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGD 533
+I + G L + L + + + + ++ L YL K++VH D
Sbjct: 465 VWIIMELCTLGELRSFLQVRKFSLDLASL-----ILYAYQLSTALAYLES---KRFVHRD 516
Query: 534 LKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTN 593
+ N+L+ N + DFGL+R +
Sbjct: 517 IAARNVLVSSNDCVKLGDFGLSRY---------------------------MEDSTYYKA 549
Query: 594 SSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMIT-GRTAVVQVGSSEMDLVNWMQL 652
S L + APES+ + + D++ +GV + E++ G
Sbjct: 550 SKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVK------------------ 591
Query: 653 CIEEKKPLADVLDPYLAPDADKEEEIIAVLK----------------IAMACVHSSPEKR 696
P+ + I + + C P +R
Sbjct: 592 -------------PF--QGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRR 636
Query: 697 PTMRHISDALDRLIVSSD 714
P + L ++
Sbjct: 637 PRFTELKAQLSTILEEEK 654
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 81.7 bits (202), Expect = 1e-16
Identities = 64/338 (18%), Positives = 108/338 (31%), Gaps = 110/338 (32%)
Query: 410 VLGKSGIGIVYKVVLEDGH----TLAVRRLGEGGSQR-FKEFQTEVEAIGKIRHSNIVTL 464
V+G+ G VY L D AV+ L +F TE + H N+++L
Sbjct: 96 VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 155
Query: 465 RAYYWSVDEKLL-IYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHE 523
+ L + Y+ +G L + + + + + +AKG+ +L
Sbjct: 156 LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL-----IGFGLQVAKGMKFLAS 210
Query: 524 FSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQK 583
KK+VH DL N +L V+DFGLAR
Sbjct: 211 ---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMY------------------------ 243
Query: 584 SVSLEVTTTNSSSNLGSYYQ-----------APESLKVVKPSQKWDIYSYGVILLEMIT- 631
S + A ESL+ K + K D++S+GV+L E++T
Sbjct: 244 -----------DKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTR 292
Query: 632 GRTAVVQVGSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLK-------- 683
G PY PD + + + +L+
Sbjct: 293 GAP-------------------------------PY--PDVNTFDITVYLLQGRRLLQPE 319
Query: 684 --------IAMACVHSSPEKRPTMRHISDALDRLIVSS 713
+ + C H E RP+ + + + +
Sbjct: 320 YCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 357
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 1e-16
Identities = 59/346 (17%), Positives = 113/346 (32%), Gaps = 115/346 (33%)
Query: 410 VLGKSGIGIVYKVVLEDG----HTLAVRRLGEGGS--QRFKEFQTEVEAIGKIRHSNIVT 463
+LGK G V + L+ +AV+ L +EF E + + H ++
Sbjct: 30 MLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAK 89
Query: 464 L------RAYYWSVDEKLLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKG 517
L + ++I ++ +G L L + +P V+ + IA G
Sbjct: 90 LVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACG 149
Query: 518 LVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKP 577
+ YL S + ++H DL N +L +M V+DFGL+R
Sbjct: 150 MEYL---SSRNFIHRDLAARNCMLAEDMTVCVADFGLSR--------------------- 185
Query: 578 QERQQKSVSLEVTTTNSSSNLGSYYQ------------APESLKVVKPSQKWDIYSYGVI 625
++ + + YY+ A ESL + D++++GV
Sbjct: 186 ----------KIYSGD-------YYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVT 228
Query: 626 LLEMIT-GRTAVVQVGSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLK- 683
+ E++T G+T PY + E ++
Sbjct: 229 MWEIMTRGQT-------------------------------PY--AGIENAEIYNYLIGG 255
Query: 684 ---------------IAMACVHSSPEKRPTMRHISDALDRLIVSSD 714
+ C + P++RP+ + L+ ++
Sbjct: 256 NRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLS 301
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 1e-16
Identities = 67/341 (19%), Positives = 113/341 (33%), Gaps = 114/341 (33%)
Query: 410 VLGKSGIGIVYKVVLEDG----HTLAVRRLGEGGS--QRFKEFQTEVEAIGKIRHSNIVT 463
+LG+ G V + L+ +AV+ + S + +EF +E + H N++
Sbjct: 41 ILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIR 100
Query: 464 L-----RAYYWSVDEKLLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGL 518
L + + ++I ++ G L T L +P +K + IA G+
Sbjct: 101 LLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGM 160
Query: 519 VYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQ 578
YL S + ++H DL N +L +M V+DFGL++ I
Sbjct: 161 EYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSK--KIYS---------------- 199
Query: 579 ERQQKSVSLEVTTTNSSSNLGSYYQ------------APESLKVVKPSQKWDIYSYGVIL 626
G YY+ A ESL + K D++++GV +
Sbjct: 200 --------------------GDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTM 239
Query: 627 LEMIT-GRTAVVQVGSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLK-- 683
E+ T G T PY P E +L
Sbjct: 240 WEIATRGMT-------------------------------PY--PGVQNHEMYDYLLHGH 266
Query: 684 --------------IAMACVHSSPEKRPTMRHISDALDRLI 710
I +C + P RPT + L++L+
Sbjct: 267 RLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLL 307
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 81.5 bits (201), Expect = 1e-16
Identities = 47/234 (20%), Positives = 80/234 (34%), Gaps = 47/234 (20%)
Query: 412 GKSGIGIVYKVV-LEDGHTLAVRR--LGEGGSQRFKEFQTEVEAIGKIRHSNIVTLRAYY 468
G + V G + VRR L ++ Q E+ H NIV Y
Sbjct: 36 GFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVP---YR 92
Query: 469 WS--VDEKL-LIYDYIPNGSLATAL-HGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEF 524
+ D +L ++ ++ GS + + I++G+ K L Y+H
Sbjct: 93 ATFIADNELWVVTSFMAYGSAKDLICTHFMD-----GMNELAIAYILQGVLKALDYIHH- 146
Query: 525 SPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQKS 584
YVH +K S+IL+ + + ++S S Q+
Sbjct: 147 --MGYVHRSVKASHILISVDGKVYLSGLRSN-------LSMI------------SHGQRQ 185
Query: 585 VSLEVTTTNSSSNLGSYYQAPESLKVVKPS-----QKWDIYSYGVILLEMITGR 633
+ S L + +PE V++ + K DIYS G+ E+ G
Sbjct: 186 RVVHDFPKYSVKVL--PWLSPE---VLQQNLQGYDAKSDIYSVGITACELANGH 234
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 2e-16
Identities = 40/171 (23%), Positives = 62/171 (36%), Gaps = 11/171 (6%)
Query: 81 PSALGSLTDLRHVNLRNNKFFGSLPLELLEA-QGLQSLVLYGNSFSGSVPNEI-GKLKYL 138
+A L L ++L +N S+ L +L L + + L L
Sbjct: 73 AAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAAL 131
Query: 139 QILDLSQNFFNGSLPVSIVQ-CKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLNLSFNKF 197
Q L L N +LP + L L L N + +P GL SL++L L N+
Sbjct: 132 QYLYLQDNALQ-ALPDDTFRDLGNLTHLFLHGNRISS-VPERAFRGLHSLDRLLLHQNRV 189
Query: 198 NGSIPSNT-GNLSSLQGTVDFSHNLFSGSIPAS-LGNLPEKVYIDLTYNNL 246
+ + +L L T+ N S ++P L L Y+ L N
Sbjct: 190 A-HVHPHAFRDLGRLM-TLYLFANNLS-ALPTEALAPLRALQYLRLNDNPW 237
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 5e-16
Identities = 49/221 (22%), Positives = 79/221 (35%), Gaps = 34/221 (15%)
Query: 60 TCKEQRVVSVSIPKKKLLGFLPSALGSLTDLRHVNLRNNKF-------FGSLPLELLEAQ 112
C + V+ S P++ L +P + + + L N+ F +
Sbjct: 7 VCYNEPKVTTSCPQQGLQ-AVPVGI--PAASQRIFLHGNRISHVPAASFRACR------- 56
Query: 113 GLQSLVLYGNSFSGSVPNEIGKLKYLQILDLSQNFFNGSLPVSI-VQCKRLKALDLSQNN 171
L L L+ N + L L+ LDLS N S+ + RL L L +
Sbjct: 57 NLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCG 116
Query: 172 FTGPLPNGFGSGLVSLEKLNLSFNKFNGSIPSNT-GNLSSLQGTVDFSHNLFSGSIPA-S 229
L G GL +L+ L L N ++P +T +L +L + N S S+P +
Sbjct: 117 LQE-LGPGLFRGLAALQYLYLQDNALQ-ALPDDTFRDLGNLT-HLFLHGNRIS-SVPERA 172
Query: 230 LGNLPEKVYIDLTYNNLSGPIPQNGALMNRGPTAFIGNPRL 270
L + L N ++ + P AF RL
Sbjct: 173 FRGLHSLDRLLLHQNRVAH-VH---------PHAFRDLGRL 203
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 2e-16
Identities = 69/339 (20%), Positives = 116/339 (34%), Gaps = 101/339 (29%)
Query: 410 VLGKSGIGIVYKVVLEDG---HTLAVRRLGEGGSQR-FKEFQTEVEAIGKI-RHSNIVTL 464
V+G+ G V K ++ A++R+ E S+ ++F E+E + K+ H NI+ L
Sbjct: 32 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 91
Query: 465 RAYYWSVDEK--LLIYDYIPNGSLATAL--HGKPGMVSFTPVPWSVR--------VKIIK 512
L +Y P+G+L L + S +
Sbjct: 92 LG--ACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 149
Query: 513 GIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRM 572
+A+G+ YL S K+++H DL NIL+G N ++DFGL+R
Sbjct: 150 DVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR---------------- 190
Query: 573 PAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMIT- 631
EV + L + A ESL + D++SYGV+L E+++
Sbjct: 191 -------------GQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSL 237
Query: 632 GRTAVVQVGSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLK-------- 683
G T PY E + +
Sbjct: 238 GGT-------------------------------PY--CGMTCAELYEKLPQGYRLEKPL 264
Query: 684 --------IAMACVHSSPEKRPTMRHISDALDRLIVSSD 714
+ C P +RP+ I +L+R++
Sbjct: 265 NCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 303
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 3e-16
Identities = 58/338 (17%), Positives = 102/338 (30%), Gaps = 116/338 (34%)
Query: 410 VLGKSGIGIVYKVVLEDGHTL---AVRRLGEGGS--QRFKEFQTEVEAIGKIRHSNIVTL 464
LG G V K + + AV+ L + E E + ++ + IV +
Sbjct: 24 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 83
Query: 465 RAYYWSVDEK--LLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLH 522
+ + +L+ + G L L V ++++ ++ G+ YL
Sbjct: 84 ---IGICEAESWMLVMEMAELGPLNKYLQQNR------HVKDKNIIELVHQVSMGMKYLE 134
Query: 523 EFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQ 582
E +VH DL N+LL +SDFGL++ + A++
Sbjct: 135 E---SNFVHRDLAARNVLLVTQHYAKISDFGLSKA--------------LRADE------ 171
Query: 583 KSVSLEVTTTNSSSNLGSYYQ------------APESLKVVKPSQKWDIYSYGVILLEMI 630
+YY+ APE + K S K D++S+GV++ E
Sbjct: 172 -----------------NYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAF 214
Query: 631 T-GRTAVVQVGSSEMDLVNWMQLCIEEKKP-----LADVLD----------PYLAPDADK 674
+ G+ KP ++V P P
Sbjct: 215 SYGQ------------------------KPYRGMKGSEVTAMLEKGERMGCPAGCPR--- 247
Query: 675 EEEIIAVLKIAMACVHSSPEKRPTMRHISDALDRLIVS 712
+ + C E RP + L
Sbjct: 248 -----EMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 280
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 3e-16
Identities = 68/353 (19%), Positives = 114/353 (32%), Gaps = 123/353 (34%)
Query: 410 VLGKSGIGIVYK------VVLEDGHTLAVRRLGEGGSQR-FKEFQTEVEAIGKI-RHSNI 461
LG+ G V + T+AV+ L EG + + +E++ + I H N+
Sbjct: 34 PLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNV 93
Query: 462 VTLRAYYWSVDEKL-LIYDYIPNGSLATAL-HGKPGMVSFTPVPWSVRVKIIKG------ 513
V L L +I ++ G+L+T L + V + P + +
Sbjct: 94 VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICY 153
Query: 514 ---IAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSN 570
+AKG+ +L + +K +H DL NILL + DFGLAR
Sbjct: 154 SFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDI------------ 198
Query: 571 RMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQ------------APESLKVVKPSQKWD 618
Y APE++ + + D
Sbjct: 199 --------------------------YKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSD 232
Query: 619 IYSYGVILLEMIT-GRTAVVQVGSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEE 677
++S+GV+L E+ + G + PY P +EE
Sbjct: 233 VWSFGVLLWEIFSLGAS-------------------------------PY--PGVKIDEE 259
Query: 678 IIAVLK-----------------IAMACVHSSPEKRPTMRHISDALDRLIVSS 713
LK + C H P +RPT + + L L+ ++
Sbjct: 260 FCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 312
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 4e-16
Identities = 55/236 (23%), Positives = 93/236 (39%), Gaps = 45/236 (19%)
Query: 410 VLGKSGIGIVYKVV-LEDGHTLAVRRLG-EGGSQRFKEFQTEVEAIGKIRHSNIVTLRAY 467
V+G +V +A++R+ E E E++A+ + H NIV+ Y
Sbjct: 22 VIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVS---Y 78
Query: 468 YWS--VDEKL-LIYDYIPNGSLATALHGKPGMVSFTPVPWSVRV--KIIKGIAKGLVYLH 522
Y S V ++L L+ + GS+ + I++ + +GL YLH
Sbjct: 79 YTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLH 138
Query: 523 EFSPKKYVHGDLKPSNILLGHNMEPHVSDFGL-ARLANIAGGSPTLQSNRMPAEKPQERQ 581
+ +H D+K NILLG + ++DFG+ A LA +
Sbjct: 139 K---NGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTF--------- 186
Query: 582 QKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQ----KWDIYSYGVILLEMITGR 633
V T + APE V++ + K DI+S+G+ +E+ TG
Sbjct: 187 -------VGT--------PCWMAPE---VMEQVRGYDFKADIWSFGITAIELATGA 224
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 7e-16
Identities = 35/190 (18%), Positives = 65/190 (34%), Gaps = 30/190 (15%)
Query: 81 PSALGSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSGSVPNEI-GKLKYLQ 139
A L L+ + + N +P L L L ++ N VP + L+ +
Sbjct: 95 EKAFSPLRKLQKLYISKNHL-VEIPPNLP--SSLVELRIHDNRIR-KVPKGVFSGLRNMN 150
Query: 140 ILDLSQN-FFNGSLPVSIVQCKRLKALDLSQNNFTGPLPNGFGS---------------- 182
+++ N N +L L +S+ TG + +
Sbjct: 151 CIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLTGIPKDLPETLNELHLDHNKIQAIEL 210
Query: 183 ----GLVSLEKLNLSFNKFNGSIPSNT-GNLSSLQGTVDFSHNLFSGSIPASLGNLPEKV 237
L +L L N+ I + + L +L+ + +N S +PA L +L
Sbjct: 211 EDLLRYSKLYRLGLGHNQIR-MIENGSLSFLPTLR-ELHLDNNKLS-RVPAGLPDLKLLQ 267
Query: 238 YIDLTYNNLS 247
+ L NN++
Sbjct: 268 VVYLHTNNIT 277
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 3e-14
Identities = 41/192 (21%), Positives = 61/192 (31%), Gaps = 33/192 (17%)
Query: 81 PSALGSLTDLRHVNLRNNKF-------FGSLP-----------LELLEA---QGLQSLVL 119
L L + L NNK F L L + L L +
Sbjct: 71 KDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNHLVEIPPNLPSSLVELRI 130
Query: 120 YGNSFSGSVPNEI-GKLKYLQILDLSQN-FFNGSLPVSIVQCKRLKALDLSQNNFTGPLP 177
+ N VP + L+ + +++ N N +L L +S+ TG
Sbjct: 131 HDNRIR-KVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLTGIPK 189
Query: 178 NGFGSGLVSLEKLNLSFNKFNGSIPSNT-GNLSSLQGTVDFSHNLFSGSIPA-SLGNLPE 235
+ +L +L+L NK +I S L + HN I SL LP
Sbjct: 190 DLPE----TLNELHLDHNKIQ-AIELEDLLRYSKLY-RLGLGHNQIR-MIENGSLSFLPT 242
Query: 236 KVYIDLTYNNLS 247
+ L N LS
Sbjct: 243 LRELHLDNNKLS 254
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 2e-09
Identities = 29/145 (20%), Positives = 49/145 (33%), Gaps = 13/145 (8%)
Query: 85 GSLTDLRHVNLRNNKFFGSLPLELLEA-QGLQSLVLYGNSFSGSVPNEIGKLKYLQILDL 143
L ++L +NK ++ LE L L L L N + L L+ L L
Sbjct: 190 DLPETLNELHLDHNKI-QAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHL 248
Query: 144 SQNFFNGSLPVSIVQCKRLKALDLSQNNFTGPLPNG------FGSGLVSLEKLNLSFNKF 197
N + +P + K L+ + L NN T + FG ++L N
Sbjct: 249 DNNKLS-RVPAGLPDLKLLQVVYLHTNNITK-VGVNDFCPVGFGVKRAYYNGISLFNNPV 306
Query: 198 -NGSIPSNT-GNLSSLQGTVDFSHN 220
+ T ++ + F +
Sbjct: 307 PYWEVQPATFRCVTDRL-AIQFGNY 330
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 2e-09
Identities = 32/167 (19%), Positives = 67/167 (40%), Gaps = 12/167 (7%)
Query: 89 DLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSGSVPNEIGKLKYLQILDLSQNFF 148
LR V + ++P E+ + L L N S ++ L++L L L N
Sbjct: 34 HLRVVQCSDLGL-KAVPKEI--SPDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKI 90
Query: 149 NGSLPVSIVQCKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLNLSFNKFNGSIPSNT-GN 207
+ + ++L+ L +S+N+ +P SL +L + N+ +P
Sbjct: 91 SKIHEKAFSPLRKLQKLYISKNHLVE-IPPNL---PSSLVELRIHDNRIR-KVPKGVFSG 145
Query: 208 LSSLQGTVDFSHN-LFSGSIPASLGNLPEKVYIDLTYNNLSGPIPQN 253
L ++ ++ N L + + + Y+ ++ L+G IP++
Sbjct: 146 LRNMN-CIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLTG-IPKD 190
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 7e-16
Identities = 65/347 (18%), Positives = 103/347 (29%), Gaps = 120/347 (34%)
Query: 410 VLGKSGIGIVYK-----VVLEDGHTL-AVRRLGEGGSQR-FKEFQTEVEAIGKI-RHSNI 461
LG G V + + ED AV+ L + +E++ + + +H NI
Sbjct: 53 TLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENI 112
Query: 462 VTLRAYYWSVDEKLLIYDYIPNGSLATALHGKPGMVSFTPVPWSVR--------VKIIKG 513
V L L+I +Y G L L K ++ P +
Sbjct: 113 VNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQ 172
Query: 514 IAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMP 573
+A+G+ +L K +H D+ N+LL + + DFGLAR +I
Sbjct: 173 VAQGMAFLAS---KNCIHRDVAARNVLLTNGHVAKIGDFGLAR--DI------------- 214
Query: 574 AEKPQERQQKSVSLEVTTTNSSSNLGSYYQ------------APESLKVVKPSQKWDIYS 621
S Y APES+ + + D++S
Sbjct: 215 -----------------------MNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWS 251
Query: 622 YGVILLEMIT-GRTAVVQVGSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIA 680
YG++L E+ + G PY P +
Sbjct: 252 YGILLWEIFSLGLN-------------------------------PY--PGILVNSKFYK 278
Query: 681 VLK-----------------IAMACVHSSPEKRPTMRHISDALDRLI 710
++K I AC P RPT + I L
Sbjct: 279 LVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQA 325
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 8e-16
Identities = 55/231 (23%), Positives = 88/231 (38%), Gaps = 47/231 (20%)
Query: 410 VLGKSGIGIVYKVV-LEDGHTLAV-----RRLGEGGSQRFKEFQTEVEAIGKIRHSNIVT 463
LGK G VY + LA+ +L + G + + + EVE +RH NI+
Sbjct: 16 PLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE--HQLRREVEIQSHLRHPNILR 73
Query: 464 LRAYYWSVDEKLLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHE 523
L Y+ LI +Y P G++ L + I +A L Y H
Sbjct: 74 LYGYFHDATRVYLILEYAPLGTVYREL------QKLSKFDEQRTATYITELANALSYCHS 127
Query: 524 FSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQK 583
K+ +H D+KP N+LLG E ++DFG + P R+
Sbjct: 128 ---KRVIHRDIKPENLLLGSAGELKIADFGWS------------------VHAPSSRRT- 165
Query: 584 SVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRT 634
+ + Y PE ++ +K D++S GV+ E + G+
Sbjct: 166 -------DLCGTLD----YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKP 205
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 78.9 bits (194), Expect = 8e-16
Identities = 33/268 (12%), Positives = 69/268 (25%), Gaps = 79/268 (29%)
Query: 410 VLGKSGIGIVYKVV-LEDGHTLAV---RRLGEGGSQRFKEFQTEVEAIGKIR-------- 457
VLG+ + E G + V S K+ + EV + +R
Sbjct: 80 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 139
Query: 458 -----------------HSNIVTLRAYY--WSVDEKLLIYDYIPNGSLATALHGKPGMVS 498
++ +R V + +Y +L T S
Sbjct: 140 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLY-PRMQSNLQTFGEVLLSHSS 198
Query: 499 F-TPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARL 557
+ R+++ + + L LH VH L+P +I+L ++ F
Sbjct: 199 THKSLVHHARLQLTLQVIRLLASLHH---YGLVHTYLRPVDIVLDQRGGVFLTGFEHLVR 255
Query: 558 ANIAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKP---- 613
S++ ++ PE
Sbjct: 256 DG--------------------------------ARVVSSVSRGFEPPELEARRATISYH 283
Query: 614 -------SQKWDIYSYGVILLEMITGRT 634
+ +D ++ G+++ +
Sbjct: 284 RDRRTLMTFSFDAWALGLVIYWIWCADL 311
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 8e-16
Identities = 65/362 (17%), Positives = 107/362 (29%), Gaps = 133/362 (36%)
Query: 410 VLGKSGIGIVYK------VVLEDGHTLAVRRLGEGGSQR-FKEFQTEVEAIGKI-RHSNI 461
VLG G V +AV+ L E + +E++ + ++ H NI
Sbjct: 52 VLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENI 111
Query: 462 VTLRAYYWSVDEK--LLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKG------ 513
V L LI++Y G L L K S + + + ++ +
Sbjct: 112 VNL--LGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVL 169
Query: 514 -----------IAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAG 562
+AKG+ +L K VH DL N+L+ H + DFGLAR
Sbjct: 170 TFEDLLCFAYQVAKGMEFL---EFKSCVHRDLAARNVLVTHGKVVKICDFGLARDI---- 222
Query: 563 GSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQ------------APESLKV 610
S Y APESL
Sbjct: 223 ----------------------------------MSDSNYVVRGNARLPVKWMAPESLFE 248
Query: 611 VKPSQKWDIYSYGVILLEMIT-GRTAVVQVGSSEMDLVNWMQLCIEEKKPLADVLDPYLA 669
+ K D++SYG++L E+ + G PY
Sbjct: 249 GIYTIKSDVWSYGILLWEIFSLGVN-------------------------------PY-- 275
Query: 670 PDADKEEEIIAVLK-----------------IAMACVHSSPEKRPTMRHISDALDRLIVS 712
P + +++ I +C KRP+ +++ L +
Sbjct: 276 PGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLAD 335
Query: 713 SD 714
++
Sbjct: 336 AE 337
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 1e-15
Identities = 39/191 (20%), Positives = 72/191 (37%), Gaps = 31/191 (16%)
Query: 81 PSALGSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSGSVPNEI-GKLKYLQ 139
P A L L + L N+ LP ++ + LQ L ++ N + V + L +
Sbjct: 93 PGAFAPLVKLERLYLSKNQL-KELPEKMP--KTLQELRVHENEIT-KVRKSVFNGLNQMI 148
Query: 140 ILDLSQN-FFNGSLPVSI-VQCKRLKALDLSQNNFTGPLPNGFGS--------------- 182
+++L N + + K+L + ++ N T S
Sbjct: 149 VVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQGLPPSLTELHLDGNKITKVD 208
Query: 183 -----GLVSLEKLNLSFNKFNGSIPSNT-GNLSSLQGTVDFSHNLFSGSIPASLGNLPEK 236
GL +L KL LSFN + ++ + + N L+ + ++N +P L +
Sbjct: 209 AASLKGLNNLAKLGLSFNSIS-AVDNGSLANTPHLR-ELHLNNNKLV-KVPGGLADHKYI 265
Query: 237 VYIDLTYNNLS 247
+ L NN+S
Sbjct: 266 QVVYLHNNNIS 276
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 2e-14
Identities = 41/188 (21%), Positives = 72/188 (38%), Gaps = 28/188 (14%)
Query: 81 PSALGSLTDLRHVNLRNNKF-------FGSLPLELLEAQGLQSLVLYGNSFSGSVPNEIG 133
+L +L + L NNK F L L+ L L N +P ++
Sbjct: 69 DGDFKNLKNLHTLILINNKISKISPGAFAPLV-------KLERLYLSKNQLK-ELPEKM- 119
Query: 134 KLKYLQILDLSQNFFNGSLPVSI-VQCKRLKALDLSQNNFT-GPLPNGFGSGLVSLEKLN 191
K LQ L + +N + S+ ++ ++L N + NG G+ L +
Sbjct: 120 -PKTLQELRVHENEIT-KVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIR 177
Query: 192 LSFNKFNGSIPSNTGNLSSLQGTVDFSHNLFSGSIPA-SLGNLPEKVYIDLTYNNLSGPI 250
++ +IP SL + N + + A SL L + L++N++S +
Sbjct: 178 IADTNIT-TIPQGL--PPSLT-ELHLDGNKIT-KVDAASLKGLNNLAKLGLSFNSISA-V 231
Query: 251 PQNGALMN 258
NG+L N
Sbjct: 232 D-NGSLAN 238
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 7e-13
Identities = 31/148 (20%), Positives = 51/148 (34%), Gaps = 14/148 (9%)
Query: 81 PSALGSLTDLRHVNLRNNKFFGSLPLELLEA-QGLQSLVLYGNSFSGSVPNEIGKLKYLQ 139
SLT+L L NK + L+ L L L NS S + +L+
Sbjct: 188 QGLPPSLTELH---LDGNKI-TKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLR 243
Query: 140 ILDLSQNFFNGSLPVSIVQCKRLKALDLSQNNFT-----GPLPNGFGSGLVSLEKLNLSF 194
L L+ N +P + K ++ + L NN + P G+ + S ++L
Sbjct: 244 ELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFS 302
Query: 195 NKFN-GSIPSNT-GNLSSLQGTVDFSHN 220
N I +T + V +
Sbjct: 303 NPVQYWEIQPSTFRCVYVRA-AVQLGNY 329
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 2e-10
Identities = 37/168 (22%), Positives = 63/168 (37%), Gaps = 13/168 (7%)
Query: 89 DLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSGSVPNEIGKLKYLQILDLSQNFF 148
LR V + +P +L L L N + + LK L L L N
Sbjct: 32 HLRVVQCSDLGL-EKVPKDLPP--DTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKI 88
Query: 149 NGSLPVSIVQCKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLNLSFNKFNGSIPSNT-GN 207
+ P + +L+ L LS+N LP +L++L + N+ + +
Sbjct: 89 SKISPGAFAPLVKLERLYLSKNQLKE-LPEKM---PKTLQELRVHENEIT-KVRKSVFNG 143
Query: 208 LSSLQGTVDFSHN-LFSGSIPA-SLGNLPEKVYIDLTYNNLSGPIPQN 253
L+ + V+ N L S I + + + YI + N++ IPQ
Sbjct: 144 LNQMI-VVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITT-IPQG 189
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 1e-15
Identities = 69/350 (19%), Positives = 118/350 (33%), Gaps = 112/350 (32%)
Query: 410 VLGKSGIGIVYK-----VVLEDGHTL-AVRRLGEGGSQR-FKEFQTEVEAIGKIRHSNIV 462
LG+ G V K + G+T AV+ L E S ++ +E + ++ H +++
Sbjct: 30 TLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVI 89
Query: 463 TLRAYYWSVDEKLLIYDYIPNGSLATAL--HGKPGMVSFTPVPWSVRVKIIKG------- 513
L LLI +Y GSL L K G +
Sbjct: 90 KLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTM 149
Query: 514 ---------IAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGS 564
I++G+ YL + K VH DL NIL+ + +SDFGL+R ++
Sbjct: 150 GDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSR--DV---- 200
Query: 565 PTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQ------------APESLKVVK 612
Y A ESL
Sbjct: 201 --------------------------------YEEDSYVKRSQGRIPVKWMAIESLFDHI 228
Query: 613 PSQKWDIYSYGVILLEMIT-GRT-----AVVQVGSSEMDLV---NWMQLCIEEKKPLADV 663
+ + D++S+GV+L E++T G ++ +L+ + M E+
Sbjct: 229 YTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERL----FNLLKTGHRM-----ER------ 273
Query: 664 LDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDALDRLIVSS 713
P + + ++ + C P+KRP IS L++++V
Sbjct: 274 --PDNCSE--------EMYRLMLQCWKQEPDKRPVFADISKDLEKMMVKR 313
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 77.9 bits (192), Expect = 1e-15
Identities = 50/269 (18%), Positives = 83/269 (30%), Gaps = 73/269 (27%)
Query: 410 VLGKSGIGIVYKVV-LEDGHTLAV-----RRLGEGGSQRFKEFQTEVEAIGKIRHSNIVT 463
+G+ G+V + + A+ ++ + + + +TEV + K+ H NI
Sbjct: 33 AIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIAR 92
Query: 464 LRAYYWSVDEKLLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRV--------------- 508
L Y L+ + G L L+ + V+
Sbjct: 93 LYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAING 152
Query: 509 -------------------KIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHV 549
I++ I L YLH + H D+KP N L N +
Sbjct: 153 SIHGFRESLDFVQREKLISNIMRQIFSALHYLHN---QGICHRDIKPENFLFSTNKSFEI 209
Query: 550 --SDFGLARLANIAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGS-YYQAPE 606
DFGL++ E + G+ Y+ APE
Sbjct: 210 KLVDFGLSK--------------EFYKLNNGEYYGMTTKA-----------GTPYFVAPE 244
Query: 607 SLKVVKPS--QKWDIYSYGVILLEMITGR 633
L S K D +S GV+L ++ G
Sbjct: 245 VLNTTNESYGPKCDAWSAGVLLHLLLMGA 273
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 2e-15
Identities = 55/229 (24%), Positives = 80/229 (34%), Gaps = 51/229 (22%)
Query: 410 VLGKSGIGIVYKVV-LEDGHTLAV-----RRLGEGGSQRFKE-FQTEVEAIGKIRHSNIV 462
LG IV K G A R+ +E + EV + ++ H N++
Sbjct: 19 ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVI 78
Query: 463 TLRAYYWSVDEKLLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLH 522
TL Y + + +LI + + G L L K S + IK I G+ YLH
Sbjct: 79 TLHDVYENRTDVVLILELVSGGELFDFLAQK---ESLSE---EEATSFIKQILDGVNYLH 132
Query: 523 EFSPKKYVHGDLKPSNILLGHNMEPH----VSDFGLARLANIAGGSPTLQSNRMPAEKPQ 578
KK H DLKP NI+L P + DFGLA +
Sbjct: 133 T---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE-----------------IEDG 172
Query: 579 ERQQKSVSLEVTTTNSSSNLGS-YYQAPESLKVVKPSQKWDIYSYGVIL 626
+ G+ + APE + + D++S GVI
Sbjct: 173 VEFKNIF-------------GTPEFVAPEIVNYEPLGLEADMWSIGVIT 208
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 2e-15
Identities = 56/229 (24%), Positives = 80/229 (34%), Gaps = 51/229 (22%)
Query: 410 VLGKSGIGIVYKVV-LEDGHTLAV-----RRLGEGGSQRFKE-FQTEVEAIGKIRHSNIV 462
LG IV K G A R+ +E + EV + ++ H NI+
Sbjct: 19 ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNII 78
Query: 463 TLRAYYWSVDEKLLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLH 522
TL Y + + +LI + + G L L K S + IK I G+ YLH
Sbjct: 79 TLHDVYENRTDVVLILELVSGGELFDFLAQK---ESLSE---EEATSFIKQILDGVNYLH 132
Query: 523 EFSPKKYVHGDLKPSNILLGHNMEPH----VSDFGLARLANIAGGSPTLQSNRMPAEKPQ 578
KK H DLKP NI+L P + DFGLA +
Sbjct: 133 T---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE-----------------IEDG 172
Query: 579 ERQQKSVSLEVTTTNSSSNLGS-YYQAPESLKVVKPSQKWDIYSYGVIL 626
+ G+ + APE + + D++S GVI
Sbjct: 173 VEFKNIF-------------GTPEFVAPEIVNYEPLGLEADMWSIGVIT 208
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 75.7 bits (187), Expect = 3e-15
Identities = 53/241 (21%), Positives = 97/241 (40%), Gaps = 55/241 (22%)
Query: 402 ELLKASAFVLGKSGIGIVYKVV-LEDGHTLAV-----RRLGEGGSQRFKEFQTEVEAIGK 455
++ + LGK G VY ++ +A+ +L + G + + + E+E
Sbjct: 17 DIGR----PLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVE--HQLRREIEIQSH 70
Query: 456 IRHSNIVTLRAYYWSVDEKLLIYDYIPNGSLATAL--HGKPGMVSFTPVPWSVRVKIIKG 513
+RH NI+ + Y+ L+ ++ P G L L HG+ F ++
Sbjct: 71 LRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGR-----FDE---QRSATFMEE 122
Query: 514 IAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMP 573
+A L Y HE +K +H D+KP N+L+G+ E ++DFG +
Sbjct: 123 LADALHYCHE---RKVIHRDIKPENLLMGYKGELKIADFGWS------------------ 161
Query: 574 AEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGR 633
P R++ T + + Y PE ++ +K D++ GV+ E + G
Sbjct: 162 VHAPSLRRR--------TMCGTLD----YLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGM 209
Query: 634 T 634
Sbjct: 210 P 210
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 77.5 bits (191), Expect = 3e-15
Identities = 46/247 (18%), Positives = 83/247 (33%), Gaps = 57/247 (23%)
Query: 410 VLGKSGIGIVYKVVLEDGHTLAVRRLGEGGSQRFKEFQTEVEAIGKI-RHSNIVTLRAYY 468
+LG G V G +AV+R+ E++ + + H N++
Sbjct: 22 ILGYGSSGTVVFQGSFQGRPVAVKRML---IDFCDIALMEIKLLTESDDHPNVIRYYCSE 78
Query: 469 WSVDEKLLIYDYIPNGSLATALHGKPGMVSFTPVPWSVR--VKIIKGIAKGLVYLHEFSP 526
+ + + N +L + K + + +++ IA G+ +LH
Sbjct: 79 TTDRFLYIALELC-NLNLQDLVESK-NVSDENLKLQKEYNPISLLRQIASGVAHLHS--- 133
Query: 527 KKYVHGDLKPSNILLGHNMEPH-------------VSDFGLARLANIAGGSPTLQSNRMP 573
K +H DLKP NIL+ + +SDFGL
Sbjct: 134 LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLC------------------ 175
Query: 574 AEKPQERQQKSVSLEVTTTNSSSNLGS-YYQAPESLKVVKPSQKW-------DIYSYGVI 625
K + Q S + G+ ++APE L+ Q DI+S G +
Sbjct: 176 --KKLDSGQSSFRTNLNNP-----SGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCV 228
Query: 626 LLEMITG 632
+++
Sbjct: 229 FYYILSK 235
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 4e-15
Identities = 73/387 (18%), Positives = 131/387 (33%), Gaps = 112/387 (28%)
Query: 370 LCFRKDESETLSENVEQYDLVPLDTQVAFDLDEL-LKASAFVLGKSGIGIVYKVVL---- 424
+ + V +Y+L P D + D L L LG+ G V
Sbjct: 39 PTTENLYFQGMLAGVSEYEL-PEDPRWELPRDRLVLGK---PLGEGAFGQVVLAEAIGLD 94
Query: 425 ----EDGHTLAVRRLGEGGSQR-FKEFQTEVEAIGKI-RHSNIVTLRAYYWSVDEKLLIY 478
+AV+ L +++ + +E+E + I +H NI+ L +I
Sbjct: 95 KDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIV 154
Query: 479 DYIPNGSL----------ATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKK 528
+Y G+L P + V +A+G+ YL + KK
Sbjct: 155 EYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYL---ASKK 211
Query: 529 YVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQKSVSLE 588
+H DL N+L+ + ++DFGLAR
Sbjct: 212 CIHRDLAARNVLVTEDNVMKIADFGLARDI------------------------------ 241
Query: 589 VTTTNSSSNLGSYYQ------------APESLKVVKPSQKWDIYSYGVILLEMIT-GRT- 634
+ YY+ APE+L + + D++S+GV+L E+ T G +
Sbjct: 242 --------HHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP 293
Query: 635 ----AVVQVGSSEMDLV---NWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMA 687
V ++ L+ + M +K P + + +
Sbjct: 294 YPGVPVEEL----FKLLKEGHRM-----DK--------PSNCTN--------ELYMMMRD 328
Query: 688 CVHSSPEKRPTMRHISDALDRLIVSSD 714
C H+ P +RPT + + + LDR++ +
Sbjct: 329 CWHAVPSQRPTFKQLVEDLDRIVALTS 355
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 4e-15
Identities = 42/229 (18%), Positives = 80/229 (34%), Gaps = 48/229 (20%)
Query: 410 VLGKSGIGIVYKVV-LEDGHTLAV-----RRLGEGGSQRFKEFQTEVEAIGKIRHSNIVT 463
V+GK +V + + E G AV + ++ + E ++H +IV
Sbjct: 31 VIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVE 90
Query: 464 LRAYYWSVDEKLLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRV--KIIKGIAKGLVYL 521
L Y S ++++++ L + + + +S V ++ I + L Y
Sbjct: 91 LLETYSSDGMLYMVFEFMDGADLCFEIVKR----ADAGFVYSEAVASHYMRQILEALRYC 146
Query: 522 HEFSPKKYVHGDLKPSNILLGHNMEPH---VSDFGLARLANIAGGSPTLQSNRMPAEKPQ 578
H+ +H D+KP +LL + FG+A +
Sbjct: 147 HD---NNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQ----------------LGESG 187
Query: 579 ERQQKSVSLEVTTTNSSSNLGS-YYQAPESLKVVKPSQKWDIYSYGVIL 626
V G+ ++ APE +K + D++ GVIL
Sbjct: 188 LVAGGRV-------------GTPHFMAPEVVKREPYGKPVDVWGCGVIL 223
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 4e-15
Identities = 61/271 (22%), Positives = 105/271 (38%), Gaps = 71/271 (26%)
Query: 376 ESETLSENVEQYDLVPLDTQVAFDLDELLKASAFVLGKSGIGIVYKVV-LEDGHTLAVRR 434
+ + + D + F E +GK G V+K + +A++
Sbjct: 2 AHSPVQSGLPGMQNLKADPEELFTKLE-------KIGKGSFGEVFKGIDNRTQKVVAIKI 54
Query: 435 LG-EGGSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWS--VDEKL-LIYDYIPNGSLATAL 490
+ E ++ Q E+ + + + YY S D KL +I +Y+ GS L
Sbjct: 55 IDLEEAEDEIEDIQQEITVLSQCDSPYVTK---YYGSYLKDTKLWIIMEYLGGGSALDLL 111
Query: 491 HGKP---GMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEP 547
P ++ I++ I KGL YLH +K +H D+K +N+LL + E
Sbjct: 112 EPGPLDETQIAT----------ILREILKGLDYLHS---EKKIHRDIKAANVLLSEHGEV 158
Query: 548 HVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSN--LGS-YYQA 604
++DFG V+ ++T T N +G+ ++ A
Sbjct: 159 KLADFG-------------------------------VAGQLTDTQIKRNTFVGTPFWMA 187
Query: 605 PESLKVVKPSQ---KWDIYSYGVILLEMITG 632
PE V+K S K DI+S G+ +E+ G
Sbjct: 188 PE---VIKQSAYDSKADIWSLGITAIELARG 215
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 5e-15
Identities = 28/162 (17%), Positives = 61/162 (37%), Gaps = 10/162 (6%)
Query: 86 SLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSGSVPNEIGKLKYLQILDLSQ 145
+ + L + + + + L + L + + + I ++ L ++
Sbjct: 21 TFKAYLNGLLGQSS---TANITEAQMNSLTYITLANINVT-DLTG-IEYAHNIKDLTINN 75
Query: 146 NFFNGSLPVSIVQCKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLNLSFNKFNGSIPSNT 205
P+S L+ L + + T SGL SL L++S + + SI +
Sbjct: 76 IHATNYNPIS--GLSNLERLRIMGKDVTSDKIPNL-SGLTSLTLLDISHSAHDDSILTKI 132
Query: 206 GNLSSLQGTVDFSHNLFSGSIPASLGNLPEKVYIDLTYNNLS 247
L + ++D S+N I L LPE +++ ++ +
Sbjct: 133 NTLPKVN-SIDLSYNGAITDIMP-LKTLPELKSLNIQFDGVH 172
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 1e-14
Identities = 26/146 (17%), Positives = 53/146 (36%), Gaps = 13/146 (8%)
Query: 82 SALGSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSGSVPNEIGKLKYLQIL 141
+ + +++ + + N P+ L L+ L + G + + L L +L
Sbjct: 60 TGIEYAHNIKDLTINNIHATNYNPISGLSN--LERLRIMGKDVTSDKIPNLSGLTSLTLL 117
Query: 142 DLSQNFFNGSLPVSIVQCKRLKALDLSQNNFTG---PLPNGFGSGLVSLEKLNLSFNKFN 198
D+S + + S+ I ++ ++DLS N PL L L+ LN+ F+ +
Sbjct: 118 DISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIMPL-----KTLPELKSLNIQFDGVH 172
Query: 199 GSIPSNTGNLSSLQGTVDFSHNLFSG 224
+ L + G
Sbjct: 173 -DY-RGIEDFPKLN-QLYAFSQTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 1e-07
Identities = 16/121 (13%), Positives = 39/121 (32%), Gaps = 13/121 (10%)
Query: 135 LKYLQILDLSQNFFNGSLPVSIVQCKRLKALDLSQNNFTG--PLPNGFGSGLVSLEKLNL 192
K L Q+ + ++ Q L + L+ N T + +++ L +
Sbjct: 22 FKAYLNGLLGQS---STANITEAQMNSLTYITLANINVTDLTGI-----EYAHNIKDLTI 73
Query: 193 SFNKFNGSIPSNTGNLSSLQGTVDFSHNLFSGSIPASLGNLPEKVYIDLTYNNLSGPIPQ 252
+ + LS+L+ + + +L L +D++++ I
Sbjct: 74 NNIHATNY--NPISGLSNLE-RLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILT 130
Query: 253 N 253
Sbjct: 131 K 131
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 48.0 bits (115), Expect = 2e-06
Identities = 14/100 (14%), Positives = 34/100 (34%), Gaps = 3/100 (3%)
Query: 75 KLLGFLPSALGSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSGSVPNEIGK 134
+ L LT L +++ ++ S+ ++ + S+ L N + +
Sbjct: 99 DVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIMP-LKT 157
Query: 135 LKYLQILDLSQNFFNGSLPVSIVQCKRLKALDLSQNNFTG 174
L L+ L++ + + + +L L G
Sbjct: 158 LPELKSLNIQFDGVHDYRGIE--DFPKLNQLYAFSQTIGG 195
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 5e-15
Identities = 66/345 (19%), Positives = 123/345 (35%), Gaps = 107/345 (31%)
Query: 410 VLGKSGIGIVYKVVL--------EDGHTLAVRRLGEGGSQR-FKEFQTEVEAIGKI-RHS 459
LG+ G V ++ T+AV+ L + +++ + +E+E + I +H
Sbjct: 42 PLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHK 101
Query: 460 NIVTLRAYYWSVDEKLLIYDYIPNGSL----------ATALHGKPGMVSFTPVPWSVRVK 509
NI+ L +I +Y G+L V + + V
Sbjct: 102 NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS 161
Query: 510 IIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQS 569
+A+G+ YL + +K +H DL N+L+ N ++DFGLAR
Sbjct: 162 CTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDI----------- 207
Query: 570 NRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQ------------APESLKVVKPSQKW 617
N YY+ APE+L + +
Sbjct: 208 ---------------------------NNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQS 240
Query: 618 DIYSYGVILLEMIT-GRT-----AVVQVGSSEMDLV---NWMQLCIEEKKPLADVLDPYL 668
D++S+GV++ E+ T G + V ++ L+ + M +K P
Sbjct: 241 DVWSFGVLMWEIFTLGGSPYPGIPVEEL----FKLLKEGHRM-----DK--------PAN 283
Query: 669 APDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDALDRLIVSS 713
+ + + C H+ P +RPT + + + LDR++ +
Sbjct: 284 CTN--------ELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLT 320
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 77.2 bits (190), Expect = 6e-15
Identities = 46/221 (20%), Positives = 87/221 (39%), Gaps = 42/221 (19%)
Query: 410 VLGKSGIGIVYKVV-LEDGHTLAVRRLGEGGSQRFKEFQTEVEAIGKIRHSNIVTLRAYY 468
LG G+V++V G+ A + + + + E++ + +RH +V L +
Sbjct: 164 ELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF 223
Query: 469 WSVDEKLLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKK 528
+E ++IY+++ G L + + +S V+ ++ + KGL ++HE
Sbjct: 224 EDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEA-----VEYMRQVCKGLCHMHE---NN 275
Query: 529 YVHGDLKPSNILLGHNMEPHV--SDFGLARLANIAGGSPTLQSNRMPAEKPQERQQKSVS 586
YVH DLKP NI+ + DFGL P++ + +
Sbjct: 276 YVHLDLKPENIMFTTKRSNELKLIDFGLTAH-----------------LDPKQSVKVTT- 317
Query: 587 LEVTTTNSSSNLGS-YYQAPESLKVVKPSQKWDIYSYGVIL 626
G+ + APE + D++S GV+
Sbjct: 318 ------------GTAEFAAPEVAEGKPVGYYTDMWSVGVLS 346
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 76.7 bits (189), Expect = 7e-15
Identities = 45/200 (22%), Positives = 67/200 (33%), Gaps = 33/200 (16%)
Query: 81 PSALGSLTDLRHVNLRNNKF-------FGSLPLELLEAQGLQSLVLYGNSFSGSVPNEI- 132
L L + L N F L L +L L+ N + +P+
Sbjct: 92 ADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLA-------SLNTLELFDNWLT-VIPSGAF 143
Query: 133 GKLKYLQILDLSQNFFNGSLPVSI-VQCKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLN 191
L L+ L L N S+P + L LDL + + G GL +L+ LN
Sbjct: 144 EYLSKLRELWLRNNPIE-SIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLN 202
Query: 192 LSFNKFNGSIPSNTGNLSSLQGTVDFSHNLFSGSIPA-SLGNLPEKVYIDLTYNNLSGPI 250
L +P+ T L L+ ++ S N F I S L + + + +S I
Sbjct: 203 LGMCNIK-DMPNLT-PLVGLE-ELEMSGNHFP-EIRPGSFHGLSSLKKLWVMNSQVSL-I 257
Query: 251 PQNGALMNRGPTAFIGNPRL 270
AF G L
Sbjct: 258 E---------RNAFDGLASL 268
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 72.5 bits (178), Expect = 2e-13
Identities = 46/177 (25%), Positives = 73/177 (41%), Gaps = 12/177 (6%)
Query: 81 PSALGSLTDLRHVNLRNNKFFGSLPLELLEA-QGLQSLVLYGNSFSGSVPNEI-GKLKYL 138
A L L + L +N +P E L+ L L N S+P+ ++ L
Sbjct: 116 VGAFNGLASLNTLELFDNWL-TVIPSGAFEYLSKLRELWLRNNPIE-SIPSYAFNRVPSL 173
Query: 139 QILDLSQNFFNGSLPVSIVQ-CKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLNLSFNKF 197
LDL + + + LK L+L N +PN + LV LE+L +S N F
Sbjct: 174 MRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKD-MPNL--TPLVGLEELEMSGNHF 230
Query: 198 NGSIPSNT-GNLSSLQGTVDFSHNLFSGSIPASLGNLPEKVYIDLTYNNLSGPIPQN 253
I + LSSL+ + ++ S + L V ++L +NNLS +P +
Sbjct: 231 P-EIRPGSFHGLSSLK-KLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSS-LPHD 284
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 2e-11
Identities = 36/142 (25%), Positives = 56/142 (39%), Gaps = 7/142 (4%)
Query: 81 PSALGSLTDLRHVNLRNNKFFGSLPLELLEA-QGLQSLVLYGNSFSGSVPNEIGKLKYLQ 139
A + L ++L K + E L+ L L + +P + L L+
Sbjct: 164 SYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIK-DMP-NLTPLVGLE 221
Query: 140 ILDLSQNFFNGSLPVSIVQCKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLNLSFNKFNG 199
L++S N F P S LK L + + + N F GL SL +LNL+ N +
Sbjct: 222 ELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAF-DGLASLVELNLAHNNLS- 279
Query: 200 SIPSNT-GNLSSLQGTVDFSHN 220
S+P + L L + HN
Sbjct: 280 SLPHDLFTPLRYLV-ELHLHHN 300
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 3e-11
Identities = 34/161 (21%), Positives = 54/161 (33%), Gaps = 8/161 (4%)
Query: 89 DLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSGSVPNEIGKLKYLQILDLSQNFF 148
V +P + + L L N+ + L +L++L L +N
Sbjct: 55 QFSKVVCTRRGLS-EVPQGIPS--NTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSI 111
Query: 149 NGSLPVSIVQCKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLNLSFNKFNGSIPSNT-GN 207
+ L L+L N T +P+G L L +L L N SIPS
Sbjct: 112 RQIEVGAFNGLASLNTLELFDNWLTV-IPSGAFEYLSKLRELWLRNNPIE-SIPSYAFNR 169
Query: 208 LSSLQGTVDFSHNLFSGSIPA-SLGNLPEKVYIDLTYNNLS 247
+ SL +D I + L Y++L N+
Sbjct: 170 VPSLM-RLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIK 209
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 7e-15
Identities = 58/253 (22%), Positives = 92/253 (36%), Gaps = 74/253 (29%)
Query: 410 VLGKSGIGIVYKVVL------EDGHTLAVRRLGEGGSQRFK-EFQTEVEAIGKIRHSNIV 462
LG+ G VYK L E +A++ L + + EF+ E +++H N+V
Sbjct: 16 ELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVV 75
Query: 463 TLRAYYWSVDEK--LLIYDYIPNGSLATAL--HGKPGMVSFTPVPWSVR--------VKI 510
L ++ +I+ Y +G L L V T +V+ V +
Sbjct: 76 CLLGV--VTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHL 133
Query: 511 IKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSN 570
+ IA G+ YL S VH DL N+L+ + +SD GL R + +
Sbjct: 134 VAQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFRE---------VYAA 181
Query: 571 RMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQ------------APESLKVVKPSQKWD 618
YY+ APE++ K S D
Sbjct: 182 -----------------------------DYYKLLGNSLLPIRWMAPEAIMYGKFSIDSD 212
Query: 619 IYSYGVILLEMIT 631
I+SYGV+L E+ +
Sbjct: 213 IWSYGVVLWEVFS 225
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 76.3 bits (188), Expect = 8e-15
Identities = 34/164 (20%), Positives = 60/164 (36%), Gaps = 19/164 (11%)
Query: 84 LGSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSGSVPNEIGKLKYLQILDL 143
L T+L ++ +NK +L + L L L N + + + + L L+
Sbjct: 81 LSQNTNLTYLACDSNKL-TNLDVTPLTK--LTYLNCDTNKLT-KLD--VSQNPLLTYLNC 134
Query: 144 SQNFFNGSLPVSIVQCKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLNLSFNKFNGSIPS 203
++N + VS +L LD N L + L L+ SFNK S
Sbjct: 135 ARNTLT-EIDVS--HNTQLTELDCHLNKKITKLDV---TPQTQLTTLDCSFNKITELDVS 188
Query: 204 NTGNLSSLQGTVDFSHNLFSGSIPASLGNLPEKVYIDLTYNNLS 247
L+ L + N + + L + ++D + N L+
Sbjct: 189 QNKLLNRL----NCDTNNIT-KLD--LNQNIQLTFLDCSSNKLT 225
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 2e-12
Identities = 33/176 (18%), Positives = 56/176 (31%), Gaps = 23/176 (13%)
Query: 84 LGSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSGSVPNEIGKLKYLQILDL 143
+ T L ++ NK L + L +L N + ++ + K L L+
Sbjct: 144 VSHNTQLTELDCHLNKKITKLDVTPQTQ--LTTLDCSFNKITEL---DVSQNKLLNRLNC 198
Query: 144 SQNFFNGSLPVSIVQCKRLKALDLSQNNFTG-PLPNGFGSGLVSLEKLNLSFNKFNGSIP 202
N L ++ Q +L LD S N T + + L L + S N +
Sbjct: 199 DTNNIT-KLDLN--QNIQLTFLDCSSNKLTEIDV-----TPLTQLTYFDCSVNPLT-ELD 249
Query: 203 SNTGNLSSLQGTVDFSHNLFSGSIPASLGNLPEKVYIDLTYNNL--SGPIPQNGAL 256
+ LS L T+ I L + + +Y + N L
Sbjct: 250 VS--TLSKLT-TLHCIQTDLL-EID--LTHNTQLIYFQAEGCRKIKELDVTHNTQL 299
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 67.8 bits (166), Expect = 5e-12
Identities = 24/164 (14%), Positives = 44/164 (26%), Gaps = 18/164 (10%)
Query: 84 LGSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSGSVPNEIGKLKYLQILDL 143
+ LT L + + N L + L L +L ++ L
Sbjct: 229 VTPLTQLTYFDCSVNPL-TELDVSTLSK--LTTLHCIQTDLLE---IDLTHNTQLIYFQA 282
Query: 144 SQNFFNGSLPVSIVQCKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLNLSFNKFNGSIPS 203
L V+ +L LD T L S L L L+ + +
Sbjct: 283 EGCRKIKELDVT--HNTQLYLLDCQAAGIT-ELDL---SQNPKLVYLYLNNTELT-ELDV 335
Query: 204 NTGNLSSLQGTVDFSHNLFSGSIPASLGNLPEKVYIDLTYNNLS 247
+ + L+ ++ + S+G +P
Sbjct: 336 --SHNTKLK-SLSCVNAHIQ-DFS-SVGKIPALNNNFEAEGQTI 374
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 1e-11
Identities = 31/162 (19%), Positives = 52/162 (32%), Gaps = 16/162 (9%)
Query: 90 LRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSGSVPNEIGKLKYLQILDLSQNFFN 149
+ + + + L SL + +S + + I KL L L + N
Sbjct: 20 FASEVAAAFEMQATDTISEEQLATLTSLDCHNSSIT-DMT-GIEKLTGLTKLICTSNNIT 77
Query: 150 GSLPVSIVQCKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLNLSFNKFNGSIPSNTGNLS 209
+L +S Q L L N T L + L L LN NK S L+
Sbjct: 78 -TLDLS--QNTNLTYLACDSNKLTN-LD---VTPLTKLTYLNCDTNKLTKLDVSQNPLLT 130
Query: 210 SLQGTVDFSHNLFSGSIPASLGNLPEKVYIDLTYNNLSGPIP 251
L + + N + I + + + +D N +
Sbjct: 131 YL----NCARNTLT-EID--VSHNTQLTELDCHLNKKITKLD 165
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 1e-07
Identities = 22/165 (13%), Positives = 47/165 (28%), Gaps = 31/165 (18%)
Query: 84 LGSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSGSVPNEIGKLKYLQILDL 143
+ T L ++ + L L L L L + + + L+ L
Sbjct: 293 VTHNTQLYLLDCQAAGI-TELDLSQN--PKLVYLYLNNTELT-ELD--VSHNTKLKSLSC 346
Query: 144 SQNFFNGSLPVSIVQCKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLNLSFNKFNGSIPS 203
S+ + L ++ ++ K L+ N ++
Sbjct: 347 VNAHIQ-DFS-SVGKIPALNNNFEAEGQTI------------TMPKETLTNNSLTIAVSP 392
Query: 204 NTGNLSSLQGTVDFSHNLFSGSIPASLGNLPEKVYIDLTYNNLSG 248
+ +D N +I G + ++ +T+ NLS
Sbjct: 393 D---------LLDQFGNPM--NIEPGDGGVYDQATNTITWENLST 426
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 8e-07
Identities = 22/128 (17%), Positives = 45/128 (35%), Gaps = 11/128 (8%)
Query: 130 NEIGKLKYLQILDLSQNFFNGSLPVSIVQCKRLKALDLSQNNFTGPLPNGFGSGLVSLEK 189
N+ + + +S Q L +LD ++ T + G L L K
Sbjct: 12 NDWFPDDNFASEVAAAFEMQATDTISEEQLATLTSLDCHNSSITD-MT-GI-EKLTGLTK 68
Query: 190 LNLSFNKFNGSIPSNTGNLSSLQGTVDFSHNLFSGSIPASLGNLPEKVYIDLTYNNLSG- 248
L + N ++ ++L + N + ++ + L + Y++ N L+
Sbjct: 69 LICTSNNIT-TLD--LSQNTNLT-YLACDSNKLT-NLD--VTPLTKLTYLNCDTNKLTKL 121
Query: 249 PIPQNGAL 256
+ QN L
Sbjct: 122 DVSQNPLL 129
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 76.3 bits (188), Expect = 9e-15
Identities = 44/194 (22%), Positives = 70/194 (36%), Gaps = 21/194 (10%)
Query: 81 PSALGSLTDLRHVNLRNNKFFGSLPLELLEA-QGLQSLVLYGNSFSGSVPNEI-GKLKYL 138
++ L L + L N ++ + L +L L+ N + ++PN L L
Sbjct: 81 VNSFKHLRHLEILQLSRNHI-RTIEIGAFNGLANLNTLELFDNRLT-TIPNGAFVYLSKL 138
Query: 139 QILDLSQNFFNGSLPVSI-VQCKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLNLSFNKF 197
+ L L N S+P + L+ LDL + + G GL +L LNL+
Sbjct: 139 KELWLRNNPIE-SIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNL 197
Query: 198 NGSIPSNTGNLSSLQGTVDFSHNLFSGSIPA-SLGNLPEKVYIDLTYNNLSGPIPQNGAL 256
IP+ T L L +D S N S +I S L + + + + I
Sbjct: 198 R-EIPNLT-PLIKLD-ELDLSGNHLS-AIRPGSFQGLMHLQKLWMIQSQIQV-IE----- 247
Query: 257 MNRGPTAFIGNPRL 270
AF L
Sbjct: 248 ----RNAFDNLQSL 257
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 5e-13
Identities = 44/195 (22%), Positives = 79/195 (40%), Gaps = 23/195 (11%)
Query: 81 PSALGSLTDLRHVNLRNNKFFGSLPLELLEA-QGLQSLVLYGNSFSGSVPNEI-GKLKYL 138
A L +L + L +N+ ++P L+ L L N S+P+ ++ L
Sbjct: 105 IGAFNGLANLNTLELFDNRL-TTIPNGAFVYLSKLKELWLRNNPIE-SIPSYAFNRIPSL 162
Query: 139 QILDLSQNFFNGSLPVSIVQ-CKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLNLSFNKF 197
+ LDL + + + L+ L+L+ N +PN + L+ L++L+LS N
Sbjct: 163 RRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLRE-IPN-L-TPLIKLDELDLSGNHL 219
Query: 198 NGSIPSNT-GNLSSLQGTVDFSHNLFSGSIPA-SLGNLPEKVYIDLTYNNLSGPIPQNGA 255
+ +I + L LQ + + I + NL V I+L +NNL+ +P +
Sbjct: 220 S-AIRPGSFQGLMHLQ-KLWMIQSQIQ-VIERNAFDNLQSLVEINLAHNNLTL-LPHD-- 273
Query: 256 LMNRGPTAFIGNPRL 270
F L
Sbjct: 274 -------LFTPLHHL 281
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 66.3 bits (162), Expect = 1e-11
Identities = 39/161 (24%), Positives = 57/161 (35%), Gaps = 8/161 (4%)
Query: 89 DLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSGSVPNEIGKLKYLQILDLSQNFF 148
V +P + + L L+ N N L++L+IL LS+N
Sbjct: 44 QFSKVICVRKNL-REVPDGIST--NTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHI 100
Query: 149 NGSLPVSIVQCKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLNLSFNKFNGSIPSNT-GN 207
+ L L+L N T +PNG L L++L L N SIPS
Sbjct: 101 RTIEIGAFNGLANLNTLELFDNRLTT-IPNGAFVYLSKLKELWLRNNPIE-SIPSYAFNR 158
Query: 208 LSSLQGTVDFSHNLFSGSIPA-SLGNLPEKVYIDLTYNNLS 247
+ SL+ S I + L Y++L NL
Sbjct: 159 IPSLRRLDLGELKRLS-YISEGAFEGLSNLRYLNLAMCNLR 198
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 65.9 bits (161), Expect = 1e-11
Identities = 35/142 (24%), Positives = 54/142 (38%), Gaps = 7/142 (4%)
Query: 81 PSALGSLTDLRHVNLRNNKFFGSLPLELLEA-QGLQSLVLYGNSFSGSVPNEIGKLKYLQ 139
A + LR ++L K + E L+ L L + +P + L L
Sbjct: 153 SYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIP-NLTPLIKLD 210
Query: 140 ILDLSQNFFNGSLPVSIVQCKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLNLSFNKFNG 199
LDLS N + P S L+ L + Q+ N F L SL ++NL+ N
Sbjct: 211 ELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAF-DNLQSLVEINLAHNNLT- 268
Query: 200 SIPSNT-GNLSSLQGTVDFSHN 220
+P + L L+ + HN
Sbjct: 269 LLPHDLFTPLHHLE-RIHLHHN 289
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 1e-14
Identities = 65/344 (18%), Positives = 119/344 (34%), Gaps = 111/344 (32%)
Query: 405 KASAFVLGKSGIGIVYKVVLEDGHTLAVRRLGEGGSQR-FKEFQTEVEAIGKI-RHSNIV 462
A A + K V AV+ L + +++ + +E+E + I +H NI+
Sbjct: 99 MAEAVGIDKDKPKEAVTV--------AVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNII 150
Query: 463 TLRAYYWSVDEK--LLIYDYIPNGSL----------ATALHGKPGMVSFTPVPWSVRVKI 510
L + +I +Y G+L V + + V
Sbjct: 151 NL--LGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 208
Query: 511 IKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSN 570
+A+G+ YL +K +H DL N+L+ N ++DFGLAR
Sbjct: 209 TYQLARGMEYLAS---QKCIHRDLAARNVLVTENNVMKIADFGLARDI------------ 253
Query: 571 RMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQ------------APESLKVVKPSQKWD 618
N YY+ APE+L + + D
Sbjct: 254 --------------------------NNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSD 287
Query: 619 IYSYGVILLEMIT-GRT-----AVVQVGSSEMDLV---NWMQLCIEEKKPLADVLDPYLA 669
++S+GV++ E+ T G + V ++ L+ + M +K P
Sbjct: 288 VWSFGVLMWEIFTLGGSPYPGIPVEEL----FKLLKEGHRM-----DK--------PANC 330
Query: 670 PDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDALDRLIVSS 713
+ + + C H+ P +RPT + + + LDR++ +
Sbjct: 331 TN--------ELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLT 366
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 74.1 bits (183), Expect = 1e-14
Identities = 57/229 (24%), Positives = 84/229 (36%), Gaps = 51/229 (22%)
Query: 410 VLGKSGIGIVYKVV-LEDGHTLAV-----RRLGEGGSQRFKE-FQTEVEAIGKIRHSNIV 462
LG IV K G A RRL +E + EV + +IRH NI+
Sbjct: 12 ELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNII 71
Query: 463 TLRAYYWSVDEKLLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLH 522
TL + + + +LI + + G L L K S T + +K I G+ YLH
Sbjct: 72 TLHDIFENKTDVVLILELVSGGELFDFLAEK---ESLTE---DEATQFLKQILDGVHYLH 125
Query: 523 EFSPKKYVHGDLKPSNILLGHNMEPH----VSDFGLARLANIAGGSPTLQSNRMPAEKPQ 578
K+ H DLKP NI+L P+ + DFG+A +
Sbjct: 126 S---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHK-----------------IEAG 165
Query: 579 ERQQKSVSLEVTTTNSSSNLGS-YYQAPESLKVVKPSQKWDIYSYGVIL 626
+ G+ + APE + + D++S GVI
Sbjct: 166 NEFKNIF-------------GTPEFVAPEIVNYEPLGLEADMWSIGVIT 201
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 3e-14
Identities = 52/232 (22%), Positives = 89/232 (38%), Gaps = 50/232 (21%)
Query: 410 VLGKSGIGIVYKVV-LEDGHTLAV----RRLGEGGSQRFKEFQTEVEAIGKIR-HSNIVT 463
VLG+ V + L AV ++ G S+ EVE + + + H N++
Sbjct: 20 VLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSR----VFREVEMLYQCQGHRNVLE 75
Query: 464 LRAYYWSVDEKLLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHE 523
L ++ D L+++ + GS+ + +H + F + S +++ +A L +LH
Sbjct: 76 LIEFFEEEDRFYLVFEKMRGGSILSHIHKR---RHFNELEAS---VVVQDVASALDFLHN 129
Query: 524 FSPKKYVHGDLKPSNILLGHNMEPH---VSDFGLARLANIAGGSPTLQSNRMPAEKPQER 580
K H DLKP NIL H + + DF L + G + + +
Sbjct: 130 ---KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPEL-------- 178
Query: 581 QQKSVSLEVTTTNSSSNLGS-YYQAPESLKVVKPSQKW-----DIYSYGVIL 626
+ GS Y APE ++ D++S GVIL
Sbjct: 179 --------------LTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVIL 216
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 3e-14
Identities = 51/239 (21%), Positives = 89/239 (37%), Gaps = 56/239 (23%)
Query: 410 VLGKSGIGIVYKVV-LEDGHTLAVRRL-GEGGSQRFKEFQTEVEAIGK-IRHSNIVTLRA 466
+G+ G V K+V G +AV+R+ + K+ +++ + + IV
Sbjct: 29 EIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQ--- 85
Query: 467 YYWS--VDEKLLIY-DYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHE 523
+Y + + I + + + S V +P + KI K L +L
Sbjct: 86 FYGALFREGDCWICMELM-STSFDKFYK-YVYSVLDDVIPEEILGKITLATVKALNHLK- 142
Query: 524 FSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQK 583
K +H D+KPSNILL + + DFG
Sbjct: 143 -ENLKIIHRDIKPSNILLDRSGNIKLCDFG------------------------------ 171
Query: 584 SVSLEVTTTNSSSN-LG-SYYQAPESLKVVKPSQ-------KWDIYSYGVILLEMITGR 633
+S ++ + + + G Y APE + PS + D++S G+ L E+ TGR
Sbjct: 172 -ISGQLVDSIAKTRDAGCRPYMAPE---RIDPSASRQGYDVRSDVWSLGITLYELATGR 226
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 3e-14
Identities = 52/275 (18%), Positives = 98/275 (35%), Gaps = 66/275 (24%)
Query: 372 FRKDESETLSENVEQYDLVPLDTQVAFDLDELLKASAFVLGKSGIGIVYKVV-LEDGHTL 430
++ L+ ++Y D + +G G V+K+ + GH +
Sbjct: 5 SSGKQTGYLTIGGQRYQAEIND----LENLG-------EMGSGTCGQVWKMRFRKTGHVI 53
Query: 431 AVRRL-GEGGSQRFKEFQTEVEAIGK-IRHSNIVTLRAYYWS--VDEKLLIY-DYIPNGS 485
AV+++ G + K +++ + K IV + + + + I + +
Sbjct: 54 AVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQ---CFGTFITNTDVFIAMELM-GTC 109
Query: 486 LATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNM 545
G P+P + K+ I K L YL +H D+KPSNILL
Sbjct: 110 AEKLKKRMQG-----PIPERILGKMTVAIVKALYYLK--EKHGVIHRDVKPSNILLDERG 162
Query: 546 EPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSN-LG-SYYQ 603
+ + DFG +S + + G + Y
Sbjct: 163 QIKLCDFG-------------------------------ISGRLVDDKAKDRSAGCAAYM 191
Query: 604 APESLKVVKPSQ-----KWDIYSYGVILLEMITGR 633
APE + P++ + D++S G+ L+E+ TG+
Sbjct: 192 APERIDPPDPTKPDYDIRADVWSLGISLVELATGQ 226
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 4e-14
Identities = 54/229 (23%), Positives = 80/229 (34%), Gaps = 51/229 (22%)
Query: 410 VLGKSGIGIVYKVV-LEDGHTLAV-----RRLGEGGSQRFKE-FQTEVEAIGKIRHSNIV 462
LG +V K G A RR +E + EV + +I+H N++
Sbjct: 18 ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 463 TLRAYYWSVDEKLLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLH 522
TL Y + + +LI + + G L L K S T + +K I G+ YLH
Sbjct: 78 TLHEVYENKTDVILILELVAGGELFDFLAEK---ESLTE---EEATEFLKQILNGVYYLH 131
Query: 523 EFSPKKYVHGDLKPSNILLGHNMEPH----VSDFGLARLANIAGGSPTLQSNRMPAEKPQ 578
+ H DLKP NI+L P + DFGLA
Sbjct: 132 S---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK-----------------IDFG 171
Query: 579 ERQQKSVSLEVTTTNSSSNLGS-YYQAPESLKVVKPSQKWDIYSYGVIL 626
+ G+ + APE + + D++S GVI
Sbjct: 172 NEFKNIF-------------GTPEFVAPEIVNYEPLGLEADMWSIGVIT 207
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 4e-14
Identities = 61/300 (20%), Positives = 90/300 (30%), Gaps = 55/300 (18%)
Query: 39 PEGSLSNWNSSDENPCSWNGITCKEQRVVSVSIP---------KKKLLGFLPSALGSLTD 89
P +S S E C +T + +P + L F + L T
Sbjct: 2 PICEVSKVASHLEVNCDKRNLT-----ALPPDLPKDTTILHLSENLLYTFSLATLMPYTR 56
Query: 90 LRHVNLRNNKF-----FGSLPLELLEAQGLQSLVLYGNSFSGSVPNEIGKLKYLQILDLS 144
L +NL + G+LP L +L L N S+P L L +LD+S
Sbjct: 57 LTQLNLDRAELTKLQVDGTLP-------VLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVS 108
Query: 145 QNFFNGSLPVSI-VQCKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLNLSFNKFNGSIPS 203
N SLP+ L+ L L N LP G + LEKL+L+ N +P+
Sbjct: 109 FNRLT-SLPLGALRGLGELQELYLKGNELKT-LPPGLLTPTPKLEKLSLANNNLT-ELPA 165
Query: 204 NT-GNLSSLQGTVDFSHNLFSGSIPASLGNLPEKVYIDLTYNN----------LSGPIPQ 252
L +L T+ N +IP + L + N +
Sbjct: 166 GLLNGLENLD-TLLLQENSLY-TIPKGFFGSHLLPFAFL-HGNPWLCNCEILYFRRWLQD 222
Query: 253 NGALMNRGPTAFIGNPRLCGP-------PLKNP-CSSDVPGASSPASYPFLP--NNYPPE 302
N + K P G + + YP E
Sbjct: 223 NAENVYVWKQGVDVKAMTSNVASVQCDNSDKFPVYKYPGKGCPTLGDEGDTDLYDYYPEE 282
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 4e-14
Identities = 73/351 (20%), Positives = 123/351 (35%), Gaps = 112/351 (31%)
Query: 410 VLGKSGIGIVYK-----VVLEDGHTL-AVRRLGEGGSQR-FKEFQTEVEAIGKIRHSNIV 462
+G+ G V++ ++ + T+ AV+ L E S +FQ E + + + NIV
Sbjct: 54 DIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIV 113
Query: 463 TLRAYYWSVDEK--LLIYDYIPNGSLATAL--HGKPGMVSFTPVPWSVR----------- 507
L K L+++Y+ G L L + S + S R
Sbjct: 114 KLLGV--CAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPL 171
Query: 508 -----VKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAG 562
+ I + +A G+ YL E +K+VH DL N L+G NM ++DFGL+R NI
Sbjct: 172 SCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVVKIADFGLSR--NIYS 226
Query: 563 GSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQ------------APESLKV 610
YY+ PES+
Sbjct: 227 ------------------------------------ADYYKADGNDAIPIRWMPPESIFY 250
Query: 611 VKPSQKWDIYSYGVILLEMIT-GRT-----AVVQVGSSEMDLVNWMQLCIEEKKPLADVL 664
+ + + D+++YGV+L E+ + G A +V + V + +L
Sbjct: 251 NRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEV----IYYV-------RDGN----IL 295
Query: 665 D-PYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDALDRLIVSSD 714
P P + + C P RP+ I L R+ ++
Sbjct: 296 ACPENCPL--------ELYNLMRLCWSKLPADRPSFCSIHRILQRMCERAE 338
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 73.6 bits (181), Expect = 4e-14
Identities = 50/221 (22%), Positives = 94/221 (42%), Gaps = 42/221 (19%)
Query: 410 VLGKSGIGIVYKVV-LEDGHTLAVRRLGEGGSQRFKEFQTEVEAIGKIRHSNIVTLRAYY 468
+LG G V+K G LA + + G + +E + E+ + ++ H+N++ L +
Sbjct: 96 ILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAF 155
Query: 469 WSVDEKLLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKK 528
S ++ +L+ +Y+ G L + + ++ + +K I +G+ ++H+
Sbjct: 156 ESKNDIVLVMEYVDGGELFDRIIDESYNLTELDT-----ILFMKQICEGIRHMHQ---MY 207
Query: 529 YVHGDLKPSNILLGHNMEPHV--SDFGLARLANIAGGSPTLQSNRMPAEKPQERQQKSVS 586
+H DLKP NIL + + DFGLAR KP+E+ + +
Sbjct: 208 ILHLDLKPENILCVNRDAKQIKIIDFGLARR-----------------YKPREKLKVNF- 249
Query: 587 LEVTTTNSSSNLGS-YYQAPESLKVVKPSQKWDIYSYGVIL 626
G+ + APE + S D++S GVI
Sbjct: 250 ------------GTPEFLAPEVVNYDFVSFPTDMWSVGVIA 278
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 5e-14
Identities = 50/242 (20%), Positives = 96/242 (39%), Gaps = 60/242 (24%)
Query: 410 VLGKSGIGIVYK-VVLEDGHTLAVRRLGEGGSQRFK--EFQTEVEAIGKIRHSNIVTLRA 466
+ G+ G V G ++A++++ + RF+ E Q ++ + + H NIV L++
Sbjct: 30 MAGQGTFGTVQLGKEKSTGMSVAIKKVIQ--DPRFRNRELQ-IMQDLAVLHHPNIVQLQS 86
Query: 467 YYWSVDEK-------LLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKG----IA 515
Y++++ E+ ++ +Y+P LH ++ + +IK +
Sbjct: 87 YFYTLGERDRRDIYLNVVMEYVP-----DTLHRC--CRNYYRRQVAPPPILIKVFLFQLI 139
Query: 516 KGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHV---SDFGLARLANIAGGSPTLQSNRM 572
+ + LH S H D+KP N+L+ N DFG A+ +
Sbjct: 140 RSIGCLHLPS-VNVCHRDIKPHNVLV--NEADGTLKLCDFGSAKKLS------------- 183
Query: 573 PAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPES-LKVVKPSQKWDIYSYGVILLEMIT 631
+ +V+ + + YY+APE + DI+S G I EM+
Sbjct: 184 -------PSEPNVA-YICSR--------YYRAPELIFGNQHYTTAVDIWSVGCIFAEMML 227
Query: 632 GR 633
G
Sbjct: 228 GE 229
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 74.0 bits (182), Expect = 5e-14
Identities = 53/235 (22%), Positives = 89/235 (37%), Gaps = 54/235 (22%)
Query: 410 VLGKSGIGIVYKVV-LEDGHTLAV---RRLGEGGSQRFKEFQTEVEAIGKIRHSNIVTLR 465
VLGK G V G AV + + EV+ + ++ H NI+ L
Sbjct: 33 VLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLY 92
Query: 466 AYYWSVDEKLLIYDYIPNGSLATALHGKPGMVSFTPVPWSVR--VKIIKGIAKGLVYLHE 523
++ L+ + G L + + +S +II+ + G+ Y+H+
Sbjct: 93 EFFEDKGYFYLVGEVYTGGELFDEIISRK--------RFSEVDAARIIRQVLSGITYMHK 144
Query: 524 FSPKKYVHGDLKPSNILL---GHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQER 580
K VH DLKP N+LL + + DFGL+ + ++
Sbjct: 145 ---NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTH-----------------FEASKK 184
Query: 581 QQKSVSLEVTTTNSSSNLGS-YYQAPESLKVVKP-SQKWDIYSYGVILLEMITGR 633
+ + G+ YY APE L +K D++S GVIL +++G
Sbjct: 185 MKDKI-------------GTAYYIAPEVLH--GTYDEKCDVWSTGVILYILLSGC 224
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 6e-14
Identities = 41/221 (18%), Positives = 78/221 (35%), Gaps = 42/221 (19%)
Query: 410 VLGKSGIGIVYKVV-LEDGHTLAVRRLGEGGSQRFKEFQTEVEAIGKIRHSNIVTLRAYY 468
LG G+V++ V G + + + E+ + ++ H ++ L +
Sbjct: 58 ELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF 117
Query: 469 WSVDEKLLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKK 528
E +LI +++ G L + + +S V + ++ +GL ++HE
Sbjct: 118 EDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEV-----INYMRQACEGLKHMHE---HS 169
Query: 529 YVHGDLKPSNILLGHNMEPHV--SDFGLARLANIAGGSPTLQSNRMPAEKPQERQQKSVS 586
VH D+KP NI+ V DFGLA P E + +
Sbjct: 170 IVHLDIKPENIMCETKKASSVKIIDFGLATKL-----------------NPDEIVKVTT- 211
Query: 587 LEVTTTNSSSNLGS-YYQAPESLKVVKPSQKWDIYSYGVIL 626
+ + APE + D+++ GV+
Sbjct: 212 ------------ATAEFAAPEIVDREPVGFYTDMWAIGVLG 240
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 73.6 bits (181), Expect = 6e-14
Identities = 35/181 (19%), Positives = 58/181 (32%), Gaps = 16/181 (8%)
Query: 81 PSALGSLTDLRHVNLRNNKFFGSLPLELLEAQG-LQSLVLYGNSFSGSVPNEI-GKLKYL 138
++ L DL+ + + + L L L N F + L L
Sbjct: 47 ETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFL-QLETGAFNGLANL 105
Query: 139 QILDLSQNFFNGS-LPVSIVQC-KRLKALDLSQNNFTGPLPNGFGSGLVSLEKLNLSFNK 196
++L L+Q +G+ L + + L+ L L NN P F + L+L+FNK
Sbjct: 106 EVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNK 165
Query: 197 FNGSIPSNT-GNLSSLQGTV---------DFSHNLFSGSIPASLGNLPEKVYIDLTYNNL 246
SI N T+ D + + +DL+ N
Sbjct: 166 VK-SICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGF 224
Query: 247 S 247
Sbjct: 225 K 225
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 73.6 bits (181), Expect = 7e-14
Identities = 43/200 (21%), Positives = 71/200 (35%), Gaps = 20/200 (10%)
Query: 55 SWNGITCKEQRVVSVSIPKKKL----LGFLPSALGSLTDLRHVNLRNNKFFGSLPLELLE 110
S NG + +I K+ L + S + N F G LE
Sbjct: 220 SGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTFKG------LE 273
Query: 111 AQGLQSLVLYGNSFSGSVPNEI-GKLKYLQILDLSQNFFNGSLPVSI-VQCKRLKALDLS 168
A G+++ L + ++ + L+ L L+QN N + + L L+LS
Sbjct: 274 ASGVKTCDLSKSKIF-ALLKSVFSHFTDLEQLTLAQNEIN-KIDDNAFWGLTHLLKLNLS 331
Query: 169 QNNFTGPLPNGFGSGLVSLEKLNLSFNKFNGSIPSNT-GNLSSLQGTVDFSHNLFSGSIP 227
QN + + L LE L+LS+N ++ + L +L+ + N S+P
Sbjct: 332 QNFLGS-IDSRMFENLDKLEVLDLSYNHI-RALGDQSFLGLPNLK-ELALDTNQLK-SVP 387
Query: 228 AS-LGNLPEKVYIDLTYNNL 246
L I L N
Sbjct: 388 DGIFDRLTSLQKIWLHTNPW 407
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 64.8 bits (158), Expect = 4e-11
Identities = 32/141 (22%), Positives = 55/141 (39%), Gaps = 12/141 (8%)
Query: 114 LQSLVLYGNSFSGSVPNEIGKLKYLQILDLSQNFFNGSLPVSI-VQCKRLKALDLSQNNF 172
+ + L NS + +L+ LQ L + Q + + L L L N F
Sbjct: 32 VNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQF 91
Query: 173 TGPLPNGFGSGLVSLEKLNLSFNKFNGS-IPSNT-GNLSSLQGTVDFSHN----LFSGSI 226
L G +GL +LE L L+ +G+ + N L+SL+ + N + S
Sbjct: 92 LQ-LETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLE-MLVLRDNNIKKIQPASF 149
Query: 227 PASLGNLPEKVYIDLTYNNLS 247
++ +DLT+N +
Sbjct: 150 FLNMRRF---HVLDLTFNKVK 167
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 60.5 bits (147), Expect = 8e-10
Identities = 42/171 (24%), Positives = 66/171 (38%), Gaps = 21/171 (12%)
Query: 37 EDPEGSLSNWNSSDENPCSWNGITCKEQRVVSVSIPKKKLLGFLPSALGSLTDLRHVNLR 96
+ S + N D + ++ G+ + +S K K+ L S TDL + L
Sbjct: 250 YNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLS--KSKIFALLKSVFSHFTDLEQLTLA 307
Query: 97 NNKF-------FGSLPLELLEAQGLQSLVLYGNSFSGSVPNEI-GKLKYLQILDLSQNFF 148
N+ F L L L L N S+ + + L L++LDLS N
Sbjct: 308 QNEINKIDDNAFWGLT-------HLLKLNLSQNFLG-SIDSRMFENLDKLEVLDLSYNHI 359
Query: 149 NGSLPVSI-VQCKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLNLSFNKFN 198
+L + LK L L N +P+G L SL+K+ L N ++
Sbjct: 360 -RALGDQSFLGLPNLKELALDTNQLKS-VPDGIFDRLTSLQKIWLHTNPWD 408
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 59.8 bits (145), Expect = 1e-09
Identities = 31/201 (15%), Positives = 63/201 (31%), Gaps = 44/201 (21%)
Query: 81 PSALGSLTDLRHVNLRNNK--------FFGSLPLELLEAQGLQSLVLYGNSFSGSVPNEI 132
+ LT L + LR+N FF ++ L L N S+ E
Sbjct: 122 GNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMR-------RFHVLDLTFNKVK-SICEED 173
Query: 133 -----------GKLKYLQILDLSQNFFNGSLPVSIVQCKRLKALDLSQNNFTGPLPNGFG 181
+L + + D+++ + + + + LDLS N F + F
Sbjct: 174 LLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFF 233
Query: 182 SGLVSLEKLNLSFNKFNGSIPSNTGN--------------LSSLQGTVDFSHNLFSGSIP 227
+ + +L + S S ++ T D S + ++
Sbjct: 234 DAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVK-TCDLSKSKIF-ALL 291
Query: 228 ASL-GNLPEKVYIDLTYNNLS 247
S+ + + + L N ++
Sbjct: 292 KSVFSHFTDLEQLTLAQNEIN 312
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 7e-14
Identities = 49/229 (21%), Positives = 92/229 (40%), Gaps = 51/229 (22%)
Query: 411 LGKSGIGIVYKVV-LEDGHTLAVRRLGEGGSQRFKEFQTEVEAIGKIRHSNIVTLRAYYW 469
+G+ GIV G +AV+ + QR + EV + +H N+V Y
Sbjct: 53 IGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVE---MYK 109
Query: 470 S--VDEKL-LIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSP 526
S V E+L ++ +++ G+L +VS + + + + + L YLH
Sbjct: 110 SYLVGEELWVLMEFLQGGALTD-------IVSQVRLNEEQIATVCEAVLQALAYLHA--- 159
Query: 527 KKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQKSVS 586
+ +H D+K +ILL + +SDFG
Sbjct: 160 QGVIHRDIKSDSILLTLDGRVKLSDFG-------------------------------FC 188
Query: 587 LEVTTTNSSSN--LGS-YYQAPESLKVVKPSQKWDIYSYGVILLEMITG 632
+++ +G+ Y+ APE + + + DI+S G++++EM+ G
Sbjct: 189 AQISKDVPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDG 237
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 73.6 bits (181), Expect = 7e-14
Identities = 51/237 (21%), Positives = 88/237 (37%), Gaps = 59/237 (24%)
Query: 410 VLGKSGIGIVYKVV-LEDGHTLAV-----RRLGEGGSQRFKEFQTEVEAIGKIRHSNIVT 463
LG G V A+ + + + EV + + H NI+
Sbjct: 44 KLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLL---EEVAVLKLLDHPNIMK 100
Query: 464 LRAYYWSVDEKLLIYDYIPNGSLATALHGKPGMVSFTPVPWSVR--VKIIKGIAKGLVYL 521
L ++ L+ + G L + + + ++ IIK + G+ YL
Sbjct: 101 LYDFFEDKRNYYLVMECYKGGELFDEIIHR--------MKFNEVDAAVIIKQVLSGVTYL 152
Query: 522 HEFSPKKYVHGDLKPSNILL---GHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQ 578
H+ VH DLKP N+LL + + DFGL+ + + Q
Sbjct: 153 HK---HNIVHRDLKPENLLLESKEKDALIKIVDFGLSAV-----------------FENQ 192
Query: 579 ERQQKSVSLEVTTTNSSSNLGS-YYQAPESLKVVKP-SQKWDIYSYGVILLEMITGR 633
++ ++ + G+ YY APE L+ K +K D++S GVIL ++ G
Sbjct: 193 KKMKERL-------------GTAYYIAPEVLR--KKYDEKCDVWSIGVILFILLAGY 234
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 1e-13
Identities = 50/232 (21%), Positives = 95/232 (40%), Gaps = 57/232 (24%)
Query: 411 LGKSGIGIVYKVV-LEDGHTLAVRRLGEGGSQRFKEFQTEVEAIGKIRHSNIVTLRAYYW 469
+G+ G VY + + G +A+R++ + + E+ + + ++ NIV Y
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN---YLD 84
Query: 470 S--VDEKL-LIYDYIPNGSLATALHGKP---GMVSFTPVPWSVRVKIIKGIAKGLVYLHE 523
S V ++L ++ +Y+ GSL + G ++ + + + L +LH
Sbjct: 85 SYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAA----------VCRECLQALEFLHS 134
Query: 524 FSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQK 583
+ +H D+K NILLG + ++DFG
Sbjct: 135 ---NQVIHRDIKSDNILLGMDGSVKLTDFG------------------------------ 161
Query: 584 SVSLEVTTTNSSSN--LGS-YYQAPESLKVVKPSQKWDIYSYGVILLEMITG 632
++T S + +G+ Y+ APE + K DI+S G++ +EMI G
Sbjct: 162 -FCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEG 212
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 1e-13
Identities = 52/232 (22%), Positives = 96/232 (41%), Gaps = 57/232 (24%)
Query: 411 LGKSGIGIVYKVV-LEDGHTLAVRRLGEGGSQRFKEFQTEVEAIGKIRHSNIVTLRAYYW 469
LG+ G VYK + E G +A++++ +E E+ + + ++V YY
Sbjct: 37 LGEGSYGSVYKAIHKETGQIVAIKQVPV--ESDLQEIIKEISIMQQCDSPHVVK---YYG 91
Query: 470 S--VDEKL-LIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSP 526
S + L ++ +Y GS++ + + ++ + I++ KGL YLH
Sbjct: 92 SYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIAT-----ILQSTLKGLEYLHF--- 143
Query: 527 KKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQKSVS 586
+ +H D+K NILL ++DFG V+
Sbjct: 144 MRKIHRDIKAGNILLNTEGHAKLADFG-------------------------------VA 172
Query: 587 LEVTTTNSSSN--LGS-YYQAPESLKVVKPSQ---KWDIYSYGVILLEMITG 632
++T T + N +G+ ++ APE V++ DI+S G+ +EM G
Sbjct: 173 GQLTDTMAKRNTVIGTPFWMAPE---VIQEIGYNCVADIWSLGITAIEMAEG 221
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 1e-13
Identities = 50/245 (20%), Positives = 83/245 (33%), Gaps = 64/245 (26%)
Query: 410 VLGKSGIGIVYKVV-LEDGHTLAV-------------RRLGEGGSQRFKEFQTEVEAIGK 455
LG G V A+ + + +E E+ +
Sbjct: 43 KLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKS 102
Query: 456 IRHSNIVTLRAYYWSVDEKLLIYDYIPNGSLATALHGKPGMVSFTPVPWSVR--VKIIKG 513
+ H NI+ L + L+ ++ G L + + + I+K
Sbjct: 103 LDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRH--------KFDECDAANIMKQ 154
Query: 514 IAKGLVYLHEFSPKKYVHGDLKPSNILL---GHNMEPHVSDFGLARLANIAGGSPTLQSN 570
I G+ YLH+ VH D+KP NILL + + DFGL+
Sbjct: 155 ILSGICYLHK---HNIVHRDIKPENILLENKNSLLNIKIVDFGLSSF------------- 198
Query: 571 RMPAEKPQERQQKSVSLEVTTTNSSSNLGS-YYQAPESLKVVKP-SQKWDIYSYGVILLE 628
+ + + G+ YY APE LK K ++K D++S GVI+
Sbjct: 199 ----FSKDYKLRDRL-------------GTAYYIAPEVLK--KKYNEKCDVWSCGVIMYI 239
Query: 629 MITGR 633
++ G
Sbjct: 240 LLCGY 244
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 70.7 bits (174), Expect = 2e-13
Identities = 41/221 (18%), Positives = 80/221 (36%), Gaps = 43/221 (19%)
Query: 410 VLGKSGIGIVYKVV-LEDGHTLAVRRLGEGGSQRFKEFQTEVEAIGKIRHSNIVTLRAYY 468
LG+ GIV++ V T + + G+ + + E+ + RH NI+ L +
Sbjct: 12 DLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQ-VLVKKEISILNIARHRNILHLHESF 70
Query: 469 WSVDEKLLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKK 528
S++E ++I+++I + ++ V + + + L +LH
Sbjct: 71 ESMEELVMIFEFISGLDIFERINTS--AFELNE---REIVSYVHQVCEALQFLHS---HN 122
Query: 529 YVHGDLKPSNILLGHNMEPHV--SDFGLARLANIAGGSPTLQSNRMPAEKPQERQQKSVS 586
H D++P NI+ + +FG AR KP + +
Sbjct: 123 IGHFDIRPENIIYQTRRSSTIKIIEFGQARQ-----------------LKPGDNFRLLF- 164
Query: 587 LEVTTTNSSSNLGS-YYQAPESLKVVKPSQKWDIYSYGVIL 626
+ Y APE + S D++S G ++
Sbjct: 165 ------------TAPEYYAPEVHQHDVVSTATDMWSLGTLV 193
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 3e-13
Identities = 54/237 (22%), Positives = 87/237 (36%), Gaps = 59/237 (24%)
Query: 410 VLGKSGIGIVYKVV-LEDGHTLAV-----RRLGEGGSQRFKEFQTEVEAIGKIRHSNIVT 463
+LGK G V K AV ++ EVE + K+ H NI+
Sbjct: 29 MLGKGSFGEVLKCKDRITQQEYAVKVINKASAK---NKDTSTILREVELLKKLDHPNIMK 85
Query: 464 LRAYYWSVDEKLLIYDYIPNGSLATALHGKPGMVSFTPVPWSVR--VKIIKGIAKGLVYL 521
L ++ + G L + + +S +IIK + G+ Y+
Sbjct: 86 LFEILEDSSSFYIVGELYTGGELFDEIIKR--------KRFSEHDAARIIKQVFSGITYM 137
Query: 522 HEFSPKKYVHGDLKPSNILL---GHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQ 578
H+ VH DLKP NILL + + + DFGL+ +
Sbjct: 138 HK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTC-----------------FQQN 177
Query: 579 ERQQKSVSLEVTTTNSSSNLGS-YYQAPESLKVVKP-SQKWDIYSYGVILLEMITGR 633
+ + + G+ YY APE L+ +K D++S GVIL +++G
Sbjct: 178 TKMKDRI-------------GTAYYIAPEVLR--GTYDEKCDVWSAGVILYILLSGT 219
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 3e-13
Identities = 50/236 (21%), Positives = 88/236 (37%), Gaps = 51/236 (21%)
Query: 410 VLGKSGIGIVYKVV-LEDGHTLAVRRL-GEGGSQRFKEFQTEVEAIGK-IRHSNIVTLRA 466
LG+ G+V K+ + G +AV+R+ SQ K +++ + + VT
Sbjct: 14 ELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYG 73
Query: 467 YYWSVDEKLLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSP 526
+ + + + + + SL K + +P + KI I K L +LH S
Sbjct: 74 ALFREGDVWICMELM-DTSLDKFY--KQVIDKGQTIPEDILGKIAVSIVKALEHLH--SK 128
Query: 527 KKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQKSVS 586
+H D+KPSN+L+ + + DFG +S
Sbjct: 129 LSVIHRDVKPSNVLINALGQVKMCDFG-------------------------------IS 157
Query: 587 LEVTTTNS-SSNLG-SYYQAPESLKVVKPSQ-------KWDIYSYGVILLEMITGR 633
+ + + G Y APE + P K DI+S G+ ++E+ R
Sbjct: 158 GYLVDDVAKDIDAGCKPYMAPE---RINPELNQKGYSVKSDIWSLGITMIELAILR 210
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 69.5 bits (171), Expect = 4e-13
Identities = 51/227 (22%), Positives = 83/227 (36%), Gaps = 52/227 (22%)
Query: 410 VLGKSGIGIVYKVV-LEDGHTLAV-----RRLGEGGSQRFKEFQTEVEAIGKIRHSNIVT 463
LGK +V + V G A ++L ++ F++ + E K++H NIV
Sbjct: 13 ELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLS---ARDFQKLEREARICRKLQHPNIVR 69
Query: 464 LRAYYWSVDEKLLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHE 523
L L++D + G L + + ++ + I+ I + + Y H
Sbjct: 70 LHDSIQEESFHYLVFDLVTGGELFEDIVAR---EFYSE---ADASHCIQQILESIAYCHS 123
Query: 524 FSPKKYVHGDLKPSNILLGHNMEPH---VSDFGLARLANIAGGSPTLQSNRMPAEKPQER 580
VH +LKP N+LL + ++DFGLA E
Sbjct: 124 ---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV-----------------NDSEA 163
Query: 581 QQKSVSLEVTTTNSSSNLGS-YYQAPESLKVVKPSQKWDIYSYGVIL 626
G+ Y +PE LK S+ DI++ GVIL
Sbjct: 164 WHGFA-------------GTPGYLSPEVLKKDPYSKPVDIWACGVIL 197
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 4e-13
Identities = 45/181 (24%), Positives = 66/181 (36%), Gaps = 26/181 (14%)
Query: 81 PSALGSLTDLRHVNLRNNKF-------FGSLPLELLEAQGLQSLVLYGNSFSGSVPNEI- 132
+ S +L+ ++L + + SL L +L+L GN S+
Sbjct: 45 SYSFFSFPELQVLDLSRCEIQTIEDGAYQSLS-------HLSTLILTGNPIQ-SLALGAF 96
Query: 133 GKLKYLQILDLSQNFFNGSLP-VSIVQCKRLKALDLSQNNFTG-PLPNGFGSGLVSLEKL 190
L LQ L + SL I K LK L+++ N LP F S L +LE L
Sbjct: 97 SGLSSLQKLVAVETNLA-SLENFPIGHLKTLKELNVAHNLIQSFKLPEYF-SNLTNLEHL 154
Query: 191 NLSFNKFNGSIPSNT----GNLSSLQGTVDFSHNLFSGSIPASLGNLPEKVYIDLTYNNL 246
+LS NK SI + L ++D S N + I + L N L
Sbjct: 155 DLSSNKIQ-SIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKEIRLKELALDTNQL 212
Query: 247 S 247
Sbjct: 213 K 213
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 4e-10
Identities = 36/141 (25%), Positives = 58/141 (41%), Gaps = 15/141 (10%)
Query: 114 LQSLVLYGNSFSGSVPNEIGKLKYLQILDLSQNFFNGSLPVSI-VQCKRLKALDLSQNNF 172
++L L N LQ+LDLS+ ++ L L L+ N
Sbjct: 30 TKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGNPI 88
Query: 173 TGPLPNGFGSGLVSLEKLNLSFNKFNGSIPSNT-GNLSSLQGTVDFSHNLFSGSIP---- 227
L G SGL SL+KL S+ + G+L +L+ ++ +HNL S
Sbjct: 89 QS-LALGAFSGLSSLQKLVAVETNLA-SLENFPIGHLKTLK-ELNVAHNLIQ-SFKLPEY 144
Query: 228 -ASLGNLPEKVYIDLTYNNLS 247
++L NL ++DL+ N +
Sbjct: 145 FSNLTNL---EHLDLSSNKIQ 162
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 54.2 bits (131), Expect = 4e-08
Identities = 34/130 (26%), Positives = 52/130 (40%), Gaps = 24/130 (18%)
Query: 80 LPS-ALGSLTDLRHVNLRNNKF--------FGSLPLELLEAQGLQSLVLYGNSFSGSVPN 130
L + +G L L+ +N+ +N F +L L+ L L N S+
Sbjct: 115 LENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLT-------NLEHLDLSSNKIQ-SIYC 166
Query: 131 EI----GKLKYLQI-LDLSQNFFNGSLPVSIVQCKRLKALDLSQNNFTGPLPNGFGSGLV 185
++ L + LDLS N N + + RLK L L N +P+G L
Sbjct: 167 TDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKEIRLKELALDTNQLKS-VPDGIFDRLT 224
Query: 186 SLEKLNLSFN 195
SL+K+ L N
Sbjct: 225 SLQKIWLHTN 234
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 5e-13
Identities = 53/228 (23%), Positives = 82/228 (35%), Gaps = 55/228 (24%)
Query: 410 VLGKSGIGIVYKVV-LEDGHTLAV-----RRLGEGGSQRFKEFQTEVEAIGKIRHSNIVT 463
+LGK G V K AV ++ EVE + K+ H NI+
Sbjct: 29 MLGKGSFGEVLKCKDRITQQEYAVKVINKASAK---NKDTSTILREVELLKKLDHPNIMK 85
Query: 464 LRAYYWSVDEKLLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHE 523
L ++ + G L + + F+ +IIK + G+ Y+H+
Sbjct: 86 LFEILEDSSSFYIVGELYTGGELFDEIIKR---KRFSE---HDAARIIKQVFSGITYMHK 139
Query: 524 FSPKKYVHGDLKPSNILLGHNMEPH---VSDFGLARLANIAGGSPTLQSNRMPAEKPQER 580
VH DLKP NILL + + DFGL+ + +
Sbjct: 140 ---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF-----------------QQNTK 179
Query: 581 QQKSVSLEVTTTNSSSNLGS-YYQAPESLKVVKP-SQKWDIYSYGVIL 626
+ + G+ YY APE L+ +K D++S GVIL
Sbjct: 180 MKDRI-------------GTAYYIAPEVLR--GTYDEKCDVWSAGVIL 212
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 6e-13
Identities = 48/235 (20%), Positives = 86/235 (36%), Gaps = 54/235 (22%)
Query: 410 VLGKSGIGIVYKVV-LEDGHTLAVRRLGEGGSQRFKEFQTEVEAIGKIRHSNIVTLRAYY 468
LG G VYK E G A + + + +++ E+E + H IV
Sbjct: 26 ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVK---LL 82
Query: 469 WS--VDEKL-LIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFS 525
+ D KL ++ ++ P G++ + + + + + + L +LH
Sbjct: 83 GAYYHDGKLWIMIEFCPGGAVDAIMLELDR-----GLTEPQIQVVCRQMLEALNFLHS-- 135
Query: 526 PKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQKSV 585
K+ +H DLK N+L+ + ++DFG V
Sbjct: 136 -KRIIHRDLKAGNVLMTLEGDIRLADFG-------------------------------V 163
Query: 586 SLEVTTTNSSSN--LGS-YYQAPESLKVVKPSQ-----KWDIYSYGVILLEMITG 632
S + T + +G+ Y+ APE + K DI+S G+ L+EM
Sbjct: 164 SAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQI 218
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 68.8 bits (169), Expect = 7e-13
Identities = 46/230 (20%), Positives = 80/230 (34%), Gaps = 56/230 (24%)
Query: 410 VLGKSGIGIVYKVV-LEDGHTLAV----RRLGEGGSQRFKEFQTEVEAIGKIRHSNIVTL 464
LG G V+ V G + + + ++ + E+E + + H NI+ +
Sbjct: 29 KLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIE---AEIEVLKSLDHPNIIKI 85
Query: 465 RAYYWSVDEKLLIYDYIPNGSL---ATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYL 521
+ ++ + G L + + + + +++K + L Y
Sbjct: 86 FEVFEDYHNMYIVMETCEGGELLERIVSAQARGK--ALSE---GYVAELMKQMMNALAYF 140
Query: 522 HEFSPKKYVHGDLKPSNILL---GHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQ 578
H + VH DLKP NIL + + DFGLA L K
Sbjct: 141 HS---QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELF-----------------KSD 180
Query: 579 ERQQKSVSLEVTTTNSSSNLGS-YYQAPESLKVVKP-SQKWDIYSYGVIL 626
E + G+ Y APE K + + K DI+S GV++
Sbjct: 181 EHSTNAA-------------GTALYMAPEVFK--RDVTFKCDIWSAGVVM 215
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 68.8 bits (169), Expect = 8e-13
Identities = 52/235 (22%), Positives = 90/235 (38%), Gaps = 57/235 (24%)
Query: 410 VLGKSGIGIVYKVV-LEDGHTLAV-----RRLGEGGSQRFKE----FQTEVEAIGKI-RH 458
+LG+ +V + + AV G ++ +E EV+ + K+ H
Sbjct: 24 ILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGH 83
Query: 459 SNIVTLRAYYWSVDEKLLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGL 518
NI+ L+ Y + L++D + G L L K V+ + KI++ + + +
Sbjct: 84 PNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEK---VTLSEKETR---KIMRALLEVI 137
Query: 519 VYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQ 578
LH+ VH DLKP NILL +M ++DFG + P
Sbjct: 138 CALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQ-----------------LDPG 177
Query: 579 ERQQKSVSLEVTTTNSSSNLGS-YYQAPESLKVVKPSQKW------DIYSYGVIL 626
E+ ++ G+ Y APE ++ D++S GVI+
Sbjct: 178 EKLREVC-------------GTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIM 219
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 8e-13
Identities = 46/224 (20%), Positives = 81/224 (36%), Gaps = 49/224 (21%)
Query: 410 VLGKSGIGIVYKVV-LEDGHTLAVRRLGEGGSQRFKEFQTEVEAIGK-IRHSNIVTLRAY 467
+G + + + AV+ + + ++ E+E + + +H NI+TL+
Sbjct: 29 DIGVGSYSVCKRCIHKATNMEFAVKII----DKSKRDPTEEIEILLRYGQHPNIITLKDV 84
Query: 468 YWSVDEKLLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPK 527
Y ++ + + G L + + F+ S ++ I K + YLH +
Sbjct: 85 YDDGKYVYVVTELMKGGELLDKILRQ---KFFSEREAS---AVLFTITKTVEYLHA---Q 135
Query: 528 KYVHGDLKPSNILLGHNMEPH----VSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQK 583
VH DLKPSNIL + DFG A+ + + L
Sbjct: 136 GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQ--LRAENGLL---------------- 177
Query: 584 SVSLEVTTTNSSSNLGS-YYQAPESLKVVKPSQKWDIYSYGVIL 626
T + + APE L+ DI+S GV+L
Sbjct: 178 ------MTP-----CYTANFVAPEVLERQGYDAACDIWSLGVLL 210
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 68.3 bits (168), Expect = 1e-12
Identities = 53/200 (26%), Positives = 82/200 (41%), Gaps = 43/200 (21%)
Query: 449 EVEAIGKIRHSNIVTLRAYYWSVDEKL-LIYDYIPNGSLATALHGKPGMVSFTPVPWSVR 507
E+ + +++H NIV L S D+KL L++++ L G P
Sbjct: 51 EICLLKELKHKNIVRLHDVLHS-DKKLTLVFEFCDQ-DLKKYFDSCNG--DLDPE----I 102
Query: 508 VK-IIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPT 566
VK + + KGL + H + +H DLKP N+L+ N E +++FGLAR A G P
Sbjct: 103 VKSFLFQLLKGLGFCHS---RNVLHRDLKPQNLLINRNGELKLANFGLAR----AFGIPV 155
Query: 567 LQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKP-SQKWDIYSYGVI 625
+ S EV T +Y+ P+ L K S D++S G I
Sbjct: 156 ----------------RCYSAEVVTL--------WYRPPDVLFGAKLYSTSIDMWSAGCI 191
Query: 626 LLEMITGRTAVVQVGSSEMD 645
E+ + G+ D
Sbjct: 192 FAELANAGRPLFP-GNDVDD 210
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 69.9 bits (171), Expect = 1e-12
Identities = 31/189 (16%), Positives = 57/189 (30%), Gaps = 14/189 (7%)
Query: 68 SVSIPKKKLLGFLPSALGSLTDLRHVNLRNNKFFGSLPLELLEAQG-----LQSLVLYGN 122
++ + L L T + + ++ N K G L + G L + +
Sbjct: 229 NIETTWNSFIRIL--QLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSD 286
Query: 123 SFSGSVPNEIGKLKYLQILDLSQNFFNGSLPVSIVQCKRLKALDLSQNNFTGPLPNGFGS 182
F + I + + + + + LD S N T
Sbjct: 287 VFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTD-TVFENCG 345
Query: 183 GLVSLEKLNLSFNKFNGSIPSNTG---NLSSLQGTVDFSHNLFSGSIPASL-GNLPEKVY 238
L LE L L N+ + + SLQ +D S N S +
Sbjct: 346 HLTELETLILQMNQLK-ELSKIAEMTTQMKSLQ-QLDISQNSVSYDEKKGDCSWTKSLLS 403
Query: 239 IDLTYNNLS 247
++++ N L+
Sbjct: 404 LNMSSNILT 412
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 69.5 bits (170), Expect = 1e-12
Identities = 38/166 (22%), Positives = 59/166 (35%), Gaps = 12/166 (7%)
Query: 86 SLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSGSVPNEIGKLKYLQILDLSQ 145
S ++++ + + L + L N + +V G L L+ L L
Sbjct: 300 SNMNIKNFTVSGTRMVHMLCPSKISP--FLHLDFSNNLLTDTVFENCGHLTELETLILQM 357
Query: 146 NFFNGSLPVSI---VQCKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLNLSFNKFNGSIP 202
N L Q K L+ LD+SQN+ + G S SL LN+S N +I
Sbjct: 358 NQLK-ELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIF 416
Query: 203 SN-TGNLSSLQGTVDFSHNLFSGSIPASLGNLPEKVYIDLTYNNLS 247
+ L D N SIP + L +++ N L
Sbjct: 417 RCLPPRIKVL----DLHSNKIK-SIPKQVVKLEALQELNVASNQLK 457
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 64.1 bits (156), Expect = 7e-11
Identities = 35/172 (20%), Positives = 57/172 (33%), Gaps = 6/172 (3%)
Query: 88 TDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSGSVPNEIGKLKYLQILDLSQNF 147
+N+ N ++L L+ L++ N + + L+ LDLS N
Sbjct: 21 QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNK 80
Query: 148 FNGSLPVSIVQCKRLKALDLSQNNFTG-PLPNGFGSGLVSLEKLNLSFNKFNGSIPSNTG 206
+ LK LDLS N F P+ FG+ + L+ L LS S
Sbjct: 81 LV-KISCH--PTVNLKHLDLSFNAFDALPICKEFGN-MSQLKFLGLSTTHLEKSSVLPIA 136
Query: 207 NLSSLQGTVDFSHNLFSGSIPASLGNL-PEKVYIDLTYNNLSGPIPQNGALM 257
+L+ + + P L + E ++I N I
Sbjct: 137 HLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKT 188
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 63.7 bits (155), Expect = 1e-10
Identities = 34/207 (16%), Positives = 66/207 (31%), Gaps = 9/207 (4%)
Query: 45 NWNSSDENPCSWNGITCKEQRVVSVSIPKKKLLGFLPSALGSLTDLRHVNLRNNKFFGSL 104
WNS T + +V + + + SL L + ++ F
Sbjct: 233 TWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQ 292
Query: 105 PLELLEAQGLQSLVLYGNSFSGSVPNEIGKLKYLQILDLSQNFFNGSLPVSIVQCKRLKA 164
+ + K+ LD S N ++ + L+
Sbjct: 293 SYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELET 352
Query: 165 LDLSQNNFTGPLPNGFG--SGLVSLEKLNLSFNKFNGSIPSNT-GNLSSLQGTVDFSHNL 221
L L N L + + SL++L++S N + SL +++ S N+
Sbjct: 353 LILQMNQLKE-LSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLL-SLNMSSNI 410
Query: 222 FSGSIPASLGNLPEKV-YIDLTYNNLS 247
+ +I LP ++ +DL N +
Sbjct: 411 LTDTIF---RCLPPRIKVLDLHSNKIK 434
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 63.0 bits (153), Expect = 2e-10
Identities = 29/218 (13%), Positives = 64/218 (29%), Gaps = 10/218 (4%)
Query: 42 SLSNWNSSDENPCSWNGITCKEQRVVSVSIPKKKLLGFLPSALGSLTDLRHVNLRNNKFF 101
+ + + + I C + L + S L ++ N F
Sbjct: 180 FILDVSVKTVANLELSNIKCVLEDNKCSYFLSI-LAKLQTNPKLSNLTLNNIETTWNSFI 238
Query: 102 GSLPLEL---LEAQGLQSLVLYGNSFSGSVPNEIGKLKYLQILDLSQNFFNGSLPVSIVQ 158
L L + + ++ L G LK L I + + F
Sbjct: 239 RILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEI 298
Query: 159 CKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLNLSFNKFNGSIPSNTGNLSSLQGTVDFS 218
+ + + + + S + L+ S N ++ N G+L+ L+ T+
Sbjct: 299 FSNMNIKNFTVSGTRM-VHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELE-TLILQ 356
Query: 219 HNLFSGSIPASLG---NLPEKVYIDLTYNNLSGPIPQN 253
N + + +D++ N++S +
Sbjct: 357 MNQLK-ELSKIAEMTTQMKSLQQLDISQNSVSYDEKKG 393
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 61.8 bits (150), Expect = 4e-10
Identities = 26/125 (20%), Positives = 55/125 (44%), Gaps = 5/125 (4%)
Query: 75 KLLGFLPSALGSLTDLRHVNLRNNKFFGSLPLELLE-AQGLQSLVLYGNSFSGSVPNEIG 133
K L + + L+ +++ N + L SL + N + ++ +
Sbjct: 361 KELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLP 420
Query: 134 KLKYLQILDLSQNFFNGSLPVSIVQCKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLNLS 193
+++LDL N S+P +V+ + L+ L+++ N +P+G L SL+K+ L
Sbjct: 421 PR--IKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLKS-VPDGIFDRLTSLQKIWLH 476
Query: 194 FNKFN 198
N ++
Sbjct: 477 TNPWD 481
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 61.4 bits (149), Expect = 6e-10
Identities = 34/155 (21%), Positives = 60/155 (38%), Gaps = 11/155 (7%)
Query: 119 LYGNSFSGSVPNEIGKLKYLQILDLSQNFFNGSLPVSIVQCKRLKALDLSQNNFTGPLPN 178
N VP ++ + IL++SQN+ + I+ +L+ L +S N L
Sbjct: 7 RSKNGLI-HVPKDLSQ--KTTILNISQNYISELWTSDILSLSKLRILIISHNRIQY-LDI 62
Query: 179 GFGSGLVSLEKLNLSFNKFNGSIPSNTGNLSSLQGTVDFSHNLFSGSIP--ASLGNLPEK 236
LE L+LS NK I + +L+ +D S N F ++P GN+ +
Sbjct: 63 SVFKFNQELEYLDLSHNKLV-KISCH--PTVNLK-HLDLSFNAFD-ALPICKEFGNMSQL 117
Query: 237 VYIDLTYNNLSGPIPQNGALMNRGPTAFIGNPRLC 271
++ L+ +L A +N +
Sbjct: 118 KFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYG 152
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 52.2 bits (125), Expect = 4e-07
Identities = 32/173 (18%), Positives = 53/173 (30%), Gaps = 9/173 (5%)
Query: 81 PSALGSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSF-SGSVPNEIGKLKYLQ 139
S +L +++L +NK + L+ L L N+F + + E G + L+
Sbjct: 62 ISVFKFNQELEYLDLSHNKL-VKISCHPT--VNLKHLDLSFNAFDALPICKEFGNMSQLK 118
Query: 140 ILDLSQNFFNGSLPVSIVQCKRLKALDLSQNNFT-----GPLPNGFGSGLVSLEKLNLSF 194
L LS S + I K L + + L + L + N F
Sbjct: 119 FLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEF 178
Query: 195 NKFNGSIPSNTGNLSSLQGTVDFSHNLFSGSIPASLGNLPEKVYIDLTYNNLS 247
+ NL N S + +LT NN+
Sbjct: 179 HFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIE 231
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 68.4 bits (168), Expect = 1e-12
Identities = 46/228 (20%), Positives = 82/228 (35%), Gaps = 51/228 (22%)
Query: 410 VLGKSGIGIVYKVV-LEDGHTLAV-----RRLGEGGSQRFKEFQTEVEAIGKIRHS-NIV 462
LG+ +V + + G A RR G+ E+ + + ++
Sbjct: 36 ELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILH---EIAVLELAKSCPRVI 92
Query: 463 TLRAYYWSVDEKLLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLH 522
L Y + E +LI +Y G + + + + + +++IK I +G+ YLH
Sbjct: 93 NLHEVYENTSEIILILEYAAGGEIFSLCLPE-LAEMVSE---NDVIRLIKQILEGVYYLH 148
Query: 523 EFSPKKYVHGDLKPSNILLGHNMEPH---VSDFGLARLANIAGGSPTLQSNRMPAEKPQE 579
+ VH DLKP NILL + DFG++R
Sbjct: 149 Q---NNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRK-----------------IGHAC 188
Query: 580 RQQKSVSLEVTTTNSSSNLGS-YYQAPESLKVVKPSQKWDIYSYGVIL 626
++ + G+ Y APE L + D+++ G+I
Sbjct: 189 ELREIM-------------GTPEYLAPEILNYDPITTATDMWNIGIIA 223
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 68.0 bits (167), Expect = 2e-12
Identities = 56/223 (25%), Positives = 87/223 (39%), Gaps = 47/223 (21%)
Query: 410 VLGKSGIGIVYKVV-LEDGHTLAVRRLGEGGSQRFKEFQTEVEAIGKIRHSNIVTLRAYY 468
VLG V+ V G A++ + + + R + E+ + KI+H NIVTL Y
Sbjct: 16 VLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIY 75
Query: 469 WSVDEKLLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKK 528
S L+ + G L + + +T +I+ + + YLHE
Sbjct: 76 ESTTHYYLVMQLVSGGELFDRILER---GVYTE---KDASLVIQQVLSAVKYLHE---NG 126
Query: 529 YVHGDLKPSNILLGHNMEPH----VSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQKS 584
VH DLKP N+L E + ++DFGL+++ Q+ M
Sbjct: 127 IVHRDLKPENLLY-LTPEENSKIMITDFGLSKM---------EQNGIM------------ 164
Query: 585 VSLEVTTTNSSSNLGS-YYQAPESLKVVKPSQKWDIYSYGVIL 626
+T G+ Y APE L S+ D +S GVI
Sbjct: 165 -----STA-----CGTPGYVAPEVLAQKPYSKAVDCWSIGVIT 197
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 2e-12
Identities = 51/227 (22%), Positives = 80/227 (35%), Gaps = 52/227 (22%)
Query: 410 VLGKSGIGIVYKVV-LEDGHTLAV-----RRLGEGGSQRFKEFQTEVEAIGKIRHSNIVT 463
LGK +V + V G A ++L Q+ + E K++H NIV
Sbjct: 36 ELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLE---REARICRKLQHPNIVR 92
Query: 464 LRAYYWSVDEKLLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHE 523
L L++D + G L + + ++ + I+ I + + Y H
Sbjct: 93 LHDSIQEESFHYLVFDLVTGGELFEDIVAR---EFYSE---ADASHCIQQILESIAYCHS 146
Query: 524 FSPKKYVHGDLKPSNILLGHNMEPH---VSDFGLARLANIAGGSPTLQSNRMPAEKPQER 580
VH +LKP N+LL + ++DFGLA E
Sbjct: 147 ---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV-----------------NDSEA 186
Query: 581 QQKSVSLEVTTTNSSSNLGS-YYQAPESLKVVKPSQKWDIYSYGVIL 626
G+ Y +PE LK S+ DI++ GVIL
Sbjct: 187 WHGFA-------------GTPGYLSPEVLKKDPYSKPVDIWACGVIL 220
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 67.6 bits (166), Expect = 2e-12
Identities = 52/206 (25%), Positives = 90/206 (43%), Gaps = 51/206 (24%)
Query: 449 EVEAIGKIRHSNIVTLRAYYWSVDEKL-LIYDYIPNGSLATALHGKPGMVSFTPVPWSVR 507
E+ + +++H NIV L + + KL L+++++ N L + + + + ++
Sbjct: 53 EISLMKELKHENIVRLYDVIHT-ENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLV 110
Query: 508 VKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTL 567
+ +GL + HE K +H DLKP N+L+ + + DFGLAR A G P
Sbjct: 111 KYFQWQLLQGLAFCHE---NKILHRDLKPQNLLINKRGQLKLGDFGLAR----AFGIPV- 162
Query: 568 QSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPE--------SLKVVKPSQKWDI 619
+ S EV T +Y+AP+ S + DI
Sbjct: 163 ---------------NTFSSEVVTL--------WYRAPDVLMGSRTYSTSI-------DI 192
Query: 620 YSYGVILLEMITGRTAVVQVGSSEMD 645
+S G IL EMITG+ + G+++ +
Sbjct: 193 WSCGCILAEMITGK-PLFP-GTNDEE 216
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 3e-12
Identities = 54/239 (22%), Positives = 96/239 (40%), Gaps = 55/239 (23%)
Query: 410 VLGKSGIGIVYKVV-LEDGHTLAVRRLGEGGSQRFKEFQTEVEAIGKI-RHSNIVT---- 463
++G G VYK ++ G A++ + + +E + E+ + K H NI T
Sbjct: 31 LVGNGTYGQVYKGRHVKTGQLAAIKVM-DVTGDEEEEIKQEINMLKKYSHHRNIATYYGA 89
Query: 464 -LRAYYWSVDEKL-LIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYL 521
++ +D++L L+ ++ GS+ + G + I + I +GL +L
Sbjct: 90 FIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKG----NTLKEEWIAYICREILRGLSHL 145
Query: 522 HEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQ 581
H+ K +H D+K N+LL N E + DFG
Sbjct: 146 HQ---HKVIHRDIKGQNVLLTENAEVKLVDFG---------------------------- 174
Query: 582 QKSVSLEVTTTNSSSN--LGS-YYQAPESLKVVKPSQ-----KWDIYSYGVILLEMITG 632
VS ++ T N +G+ Y+ APE + + K D++S G+ +EM G
Sbjct: 175 ---VSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEG 230
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 67.9 bits (166), Expect = 3e-12
Identities = 51/238 (21%), Positives = 87/238 (36%), Gaps = 60/238 (25%)
Query: 417 GIVYKVVLEDGHTLAVRRLGEGGSQRFKEFQTEVEAIGKI------RHSNIVTLR-AYYW 469
G VYK +DG L ++ + + A +I +H N+++L+ +
Sbjct: 35 GHVYKAKRKDGKDDKDYAL-----KQIEGTGISMSACREIALLRELKHPNVISLQKVFLS 89
Query: 470 SVDEKL-LIYDYIPN--GSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSP 526
D K+ L++DY + + +P + ++ I G+ YLH
Sbjct: 90 HADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA--- 146
Query: 527 KKYVHGDLKPSNILLGHNMEPH----VSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQ 582
+H DLKP+NIL+ ++D G AR SP +
Sbjct: 147 NWVLHRDLKPANILVMGEGPERGRVKIADMGFAR----LFNSPL-------------KPL 189
Query: 583 KSVSLEVTTTNSSSNLGSYYQAPESL-------KVVKPSQKWDIYSYGVILLEMITGR 633
+ V T +Y+APE L K + DI++ G I E++T
Sbjct: 190 ADLDPVVVTF--------WYRAPELLLGARHYTKAI------DIWAIGCIFAELLTSE 233
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 67.5 bits (165), Expect = 3e-12
Identities = 28/183 (15%), Positives = 56/183 (30%), Gaps = 14/183 (7%)
Query: 81 PSALGSLTDLRHVNLRNNKFFGSLPLELLEAQG-LQSLVLYGNSFSGSVPNEI-GKLKYL 138
S L+ L +NL N + L LQ L + + + L +L
Sbjct: 117 SSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFL 176
Query: 139 QILDLSQNFFNGSLPVSIVQCKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLNLSFNKFN 198
+ L++ + P S+ + + L L L F S+E L L +
Sbjct: 177 EELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHIL-LLEIFVDVTSSVECLELRDTDLD 235
Query: 199 G----SIPSNT----GNLSSLQGTVDFSHNLFSGSIPASLGNLPEKVYIDLTYNNLSGPI 250
+ + + + V + + L + + ++ + N L +
Sbjct: 236 TFHFSELSTGETNSLIKKFTFR-NVKITDESLF-QVMKLLNQISGLLELEFSRNQLKS-V 292
Query: 251 PQN 253
P
Sbjct: 293 PDG 295
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 67.5 bits (165), Expect = 3e-12
Identities = 45/217 (20%), Positives = 75/217 (34%), Gaps = 32/217 (14%)
Query: 42 SLSNWNSSDENPCSWNGITCKEQRVVSVSIPKKKLLGFLPSALGSLTDLRHVNLRNNKF- 100
SLS SS++ S C + S L +PS L ++ ++L NN+
Sbjct: 16 SLSKEESSNQASLS-----CDRNGICKGS---SGSLNSIPSGL--TEAVKSLDLSNNRIT 65
Query: 101 ------FGSLPLELLEAQGLQSLVLYGNSFSGSVPNEI-GKLKYLQILDLSQNFFNGSLP 153
LQ+LVL N + ++ + L L+ LDLS N+ +L
Sbjct: 66 YISNSDLQRCV-------NLQALVLTSNGIN-TIEEDSFSSLGSLEHLDLSYNYL-SNLS 116
Query: 154 VSI-VQCKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLNLSFNKFNGSIPSNT-GNLSSL 211
S L L+L N + S L L+ L + I L+ L
Sbjct: 117 SSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFL 176
Query: 212 QGTVDFSHNLFSGSIPA-SLGNLPEKVYIDLTYNNLS 247
+ ++ + S SL ++ ++ L
Sbjct: 177 E-ELEIDASDLQ-SYEPKSLKSIQNVSHLILHMKQHI 211
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 59.4 bits (144), Expect = 1e-09
Identities = 25/126 (19%), Positives = 50/126 (39%), Gaps = 10/126 (7%)
Query: 81 PSALGSLTDLRHVNLRNNK-------FFGSLP-LELLEAQGLQSLVLYGNSFSGSVPNEI 132
P +L S+ ++ H+ L + F +E LE + + + S N +
Sbjct: 191 PKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSL 250
Query: 133 GKLKYLQILDLSQNFFNGSLPVSIVQCKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLNL 192
K + + ++ + + Q L L+ S+N +P+G L SL+K+ L
Sbjct: 251 IKKFTFRNVKITDESLF-QVMKLLNQISGLLELEFSRNQLKS-VPDGIFDRLTSLQKIWL 308
Query: 193 SFNKFN 198
N ++
Sbjct: 309 HTNPWD 314
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 4e-12
Identities = 30/204 (14%), Positives = 61/204 (29%), Gaps = 24/204 (11%)
Query: 60 TCKEQRVVSVSIPKKKLLGFLPSALGSLTDLRHVNLRNNKF-------FGSLPLELLEAQ 112
C ++ V+ K + +PS S L L F +LP
Sbjct: 9 ECHQEEDFRVT---CKDIQRIPSLPPSTQTL---KLIETHLRTIPSHAFSNLP------- 55
Query: 113 GLQSLVLYGNSFSGSVPNEI-GKLKYLQILDLSQNFFNGSLPVSI-VQCKRLKALDLSQN 170
+ + + + + + L + +++ + + LK L +
Sbjct: 56 NISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNT 115
Query: 171 NFTGPLPNGFGSGLVSLEKLNLSFNKFNGSIPSNT-GNLSSLQGTVDFSHNLFSGSIPAS 229
L ++ N + SIP N L + T+ +N F+ S+
Sbjct: 116 GLKMFPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGY 174
Query: 230 LGNLPEKVYIDLTYNNLSGPIPQN 253
N + + L N I ++
Sbjct: 175 AFNGTKLDAVYLNKNKYLTVIDKD 198
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 5e-09
Identities = 30/155 (19%), Positives = 53/155 (34%), Gaps = 26/155 (16%)
Query: 81 PSALGSLTDLRHVNLRNNK--------FFGSLPLELLEAQGLQSLVLYGNSFSGSVPNEI 132
P AL L L+ + + N S + L + N + S+P
Sbjct: 98 PDALKELPLLKFLGIFNTGLKMFPDLTKVYSTDI-------FFILEITDNPYMTSIPVNA 150
Query: 133 --GKLKYLQILDLSQNFFNGSLPVSIVQCKRLKALDLSQNNFTGPLPNGFGSGLVS-LEK 189
G L L N F S+ +L A+ L++N + + G+ S
Sbjct: 151 FQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSL 209
Query: 190 LNLSFNKFNGSIPSNT-GNLSSLQGTVDFSHNLFS 223
L++S ++PS +L L + N ++
Sbjct: 210 LDVSQTSVT-ALPSKGLEHLKELI-----ARNTWT 238
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 66.1 bits (162), Expect = 5e-12
Identities = 46/223 (20%), Positives = 80/223 (35%), Gaps = 47/223 (21%)
Query: 410 VLGKSGIGIVYKVV-LEDGHTLAVRRLGEGGSQRFKEFQTEVEAIGKIRHSNIVTLRAYY 468
+G+ G V V A +++ + + F+ E+E + + H NI+ L +
Sbjct: 16 TIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETF 75
Query: 469 WSVDEKLLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKK 528
+ L+ + G L + K F S +I+K + + Y H+
Sbjct: 76 EDNTDIYLVMELCTGGELFERVVHK---RVFRE---SDAARIMKDVLSAVAYCHK---LN 126
Query: 529 YVHGDLKPSNILLGH---NMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQKSV 585
H DLKP N L + + DFGLA KP + + V
Sbjct: 127 VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARF-----------------KPGKMMRTKV 169
Query: 586 SLEVTTTNSSSNLGS-YYQAPESLKVVKP-SQKWDIYSYGVIL 626
G+ YY +P+ L+ + D +S GV++
Sbjct: 170 -------------GTPYYVSPQVLE--GLYGPECDEWSAGVMM 197
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 6e-12
Identities = 56/231 (24%), Positives = 103/231 (44%), Gaps = 58/231 (25%)
Query: 417 GIVYK-VVLEDGHTLAVRRLGEGGSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKL 475
G+VY+ + + G +A++++ + +RFK E++ + K+ H NIV LR +++S EK
Sbjct: 68 GVVYQAKLCDSGELVAIKKVLQD--KRFK--NRELQIMRKLDHCNIVRLRYFFYSSGEKK 123
Query: 476 ------LIYDYIPNGSLATALHG--KPGMVSFTPVPWSVRVK-IIKGIAKGLVYLHEFSP 526
L+ DY+P ++ + + +P + VK + + + L Y+H F
Sbjct: 124 DEVYLNLVLDYVP-----ETVYRVARHYSRAKQTLP-VIYVKLYMYQLFRSLAYIHSF-- 175
Query: 527 KKYVHGDLKPSNILLGHNMEPHV---SDFGLARLANIAGGSPTLQSNRMPAEKPQERQQK 583
H D+KP N+LL + + V DFG A+ R +
Sbjct: 176 -GICHRDIKPQNLLL--DPDTAVLKLCDFGSAKQLV--------------------RGEP 212
Query: 584 SVSLEVTTTNSSSNLGSYYQAPES-LKVVKPSQKWDIYSYGVILLEMITGR 633
+VS + + YY+APE + D++S G +L E++ G+
Sbjct: 213 NVS-YICS--------RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 254
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 8e-12
Identities = 53/232 (22%), Positives = 86/232 (37%), Gaps = 49/232 (21%)
Query: 410 VLGKSGIGIVYKVV-LEDGHTLAVRRLGEGGSQRFKE-FQTEVEAIGKIR-HSNIVTLRA 466
LG+ I K V + AV+ + S+R + Q E+ A+ H NIV L
Sbjct: 18 PLGEGSFSICRKCVHKKSNQAFAVKII----SKRMEANTQKEITALKLCEGHPNIVKLHE 73
Query: 467 YYWSVDEKLLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSP 526
+ L+ + + G L + K F+ S I++ + + ++H+
Sbjct: 74 VFHDQLHTFLVMELLNGGELFERIKKK---KHFSETEAS---YIMRKLVSAVSHMHD--- 124
Query: 527 KKYVHGDLKPSNILLGHNMEPH---VSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQK 583
VH DLKP N+L + + DFG ARL
Sbjct: 125 VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ-------------------- 164
Query: 584 SVSLEVTTTNSSSNLGS-YYQAPESLKVVKPSQKWDIYSYGVILLEMITGRT 634
+ T + +Y APE L + D++S GVIL M++G+
Sbjct: 165 ----PLKTP-----CFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQV 207
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 8e-12
Identities = 48/227 (21%), Positives = 84/227 (37%), Gaps = 51/227 (22%)
Query: 410 VLGKSGIGIVYKVV-LEDGHTLAV-----RRLGEGGSQRFKEFQTEVEAIGKIRHSNIVT 463
LGK +V + V + G A ++L Q+ + E ++H NIV
Sbjct: 18 ELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLE---REARICRLLKHPNIVR 74
Query: 464 LRAYYWSVDEKLLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHE 523
L LI+D + G L + + ++ + I+ I + +++ H+
Sbjct: 75 LHDSISEEGHHYLIFDLVTGGELFEDIVAR---EYYSE---ADASHCIQQILEAVLHCHQ 128
Query: 524 FSPKKYVHGDLKPSNILLGHNMEPH---VSDFGLARLANIAGGSPTLQSNRMPAEKPQER 580
VH +LKP N+LL ++ ++DFGLA E Q+
Sbjct: 129 ---MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIE----------------VEGEQQA 169
Query: 581 QQKSVSLEVTTTNSSSNLGS-YYQAPESLKVVKPSQKWDIYSYGVIL 626
G+ Y +PE L+ + D+++ GVIL
Sbjct: 170 WFGFA-------------GTPGYLSPEVLRKDPYGKPVDLWACGVIL 203
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 66.5 bits (162), Expect = 8e-12
Identities = 46/217 (21%), Positives = 77/217 (35%), Gaps = 78/217 (35%)
Query: 514 IAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMP 573
+AKG+ +L + +K +H DL NILL + DFGLAR
Sbjct: 202 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIY-------------- 244
Query: 574 AEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGR 633
+ P ++ L + APE++ + + D++S+GV+L E+ +
Sbjct: 245 -KDPDYVRKGDARLPLKWM-----------APETIFDRVYTIQSDVWSFGVLLWEIFS-- 290
Query: 634 TAVVQVGSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLK---------- 683
+G+S PY P +EE LK
Sbjct: 291 -----LGAS-----------------------PY--PGVKIDEEFCRRLKEGTRMRAPDY 320
Query: 684 -------IAMACVHSSPEKRPTMRHISDALDRLIVSS 713
+ C H P +RPT + + L L+ ++
Sbjct: 321 TTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 357
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 66.3 bits (162), Expect = 9e-12
Identities = 57/234 (24%), Positives = 91/234 (38%), Gaps = 56/234 (23%)
Query: 410 VLGKSGIGIVYKVV-LEDGHTLAV--------RRLGEGGSQRFKEFQTEVEAIGKIR-HS 459
V+G+ +V + V GH AV R E + + + E + ++ H
Sbjct: 101 VIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHP 160
Query: 460 NIVTLRAYYWSVDEKLLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLV 519
+I+TL Y S L++D + G L L K V+ + I++ + + +
Sbjct: 161 HIITLIDSYESSSFMFLVFDLMRKGELFDYLTEK---VALSEKETR---SIMRSLLEAVS 214
Query: 520 YLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQE 579
+LH VH DLKP NILL NM+ +SDFG + +P E
Sbjct: 215 FLHA---NNIVHRDLKPENILLDDNMQIRLSDFGFSCH-----------------LEPGE 254
Query: 580 RQQKSVSLEVTTTNSSSNLGS-YYQAPESLKVVKPSQKW------DIYSYGVIL 626
+ ++ G+ Y APE LK D+++ GVIL
Sbjct: 255 KLRELC-------------GTPGYLAPEILKCSMDETHPGYGKEVDLWACGVIL 295
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 1e-11
Identities = 48/240 (20%), Positives = 86/240 (35%), Gaps = 58/240 (24%)
Query: 410 VLGKSGIGIVYKVV-LEDGHTLAV-----RRLGEGGSQRFKE---FQTEVEAIGKIRHSN 460
LG G V + +A+ R+ G ++ +TE+E + K+ H
Sbjct: 142 TLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPC 201
Query: 461 IVTLRAYYWSVDEKL-LIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLV 519
I+ ++ ++ E ++ + + G L + V + + + +
Sbjct: 202 IIKIKNFF--DAEDYYIVLELMEGGELFDKV------VGNKRLKEATCKLYFYQMLLAVQ 253
Query: 520 YLHEFSPKKYVHGDLKPSNILLGHNMEPH---VSDFGLARLANIAGGSPTLQSNRMPAEK 576
YLHE +H DLKP N+LL E ++DFG +++
Sbjct: 254 YLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG----------------- 293
Query: 577 PQERQQKSVSLEVTTTNSSSNLGS-YYQAPESLKVVKP---SQKWDIYSYGVILLEMITG 632
+ T G+ Y APE L V ++ D +S GVIL ++G
Sbjct: 294 ---------ETSLMRT----LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 340
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 1e-11
Identities = 47/232 (20%), Positives = 99/232 (42%), Gaps = 61/232 (26%)
Query: 417 GIVYKVVLEDGHTLAVRRLGEGGSQRFKEFQT-EVEAIGKIRHSNIVTLRAYYWSVDEKL 475
G+V++ L + +A++++ + K F+ E++ + ++H N+V L+A+++S +K
Sbjct: 54 GVVFQAKLVESDEVAIKKV-----LQDKRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKK 108
Query: 476 ------LIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKG----IAKGLVYLHEFS 525
L+ +Y+P ++ + + ++ + +IK + + L Y+H
Sbjct: 109 DEVFLNLVLEYVP-----ETVY--RASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSI- 160
Query: 526 PKKYVHGDLKPSNILLGHNMEPHV---SDFGLARLANIAGGSPTLQSNRMPAEKPQERQQ 582
H D+KP N+LL + V DFG A+ +
Sbjct: 161 --GICHRDIKPQNLLL--DPPSGVLKLIDFGSAK--------------------ILIAGE 196
Query: 583 KSVSLEVTTTNSSSNLGSYYQAPES-LKVVKPSQKWDIYSYGVILLEMITGR 633
+VS + + YY+APE + DI+S G ++ E++ G+
Sbjct: 197 PNVS-YICS--------RYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQ 239
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 66.0 bits (161), Expect = 1e-11
Identities = 29/180 (16%), Positives = 52/180 (28%), Gaps = 11/180 (6%)
Query: 81 PSALGSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSL----VLYGNSFSGSVPNEI-GKL 135
A DL + + N + ++ L L + N+ + E L
Sbjct: 47 KGAFSGFGDLEKIEISQNDVLEVIEADVF--SNLPKLHEIRIEKANNLL-YINPEAFQNL 103
Query: 136 KYLQILDLSQNFFNGSLPVSIVQCKRLKALDLSQNNFTGPLPNG-FGSGLVSLEKLNLSF 194
LQ L +S V + + LD+ N + F L L+
Sbjct: 104 PNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNK 163
Query: 195 NKFNGSIPSNTGNLSSLQGTVDFSHNLFSGSIPASLGNLPEKVYIDLTYNNLSGPIPQNG 254
N I ++ N + L +N V +D++ + +P G
Sbjct: 164 NGIQ-EIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIH-SLPSYG 221
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 62.5 bits (152), Expect = 1e-10
Identities = 24/161 (14%), Positives = 51/161 (31%), Gaps = 9/161 (5%)
Query: 91 RHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSGSVPNEIGKLKYLQILDLSQNFFNG 150
R + +K +P +L + L L+ +++SQN
Sbjct: 12 RVFLCQESKV-TEIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLE 68
Query: 151 SLPVSI-VQCKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLNLSFNKFNGSIPSNT-GNL 208
+ + +L + + + N + L +L+ L +S +P +
Sbjct: 69 VIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIK-HLPDVHKIHS 127
Query: 209 SSLQGTVDFSHNLFSGSIPA-SLGNLPEK-VYIDLTYNNLS 247
+D N+ +I S L + V + L N +
Sbjct: 128 LQKV-LLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ 167
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 52.1 bits (125), Expect = 3e-07
Identities = 22/141 (15%), Positives = 50/141 (35%), Gaps = 7/141 (4%)
Query: 115 QSLVLYGNSFSGSVPNEIGKLKYLQILDLSQNFFNGSLPVSIVQCKRLKALDLSQNNFTG 174
+ + + + +P+++ + L + L+ +++SQN+
Sbjct: 12 RVFLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLE 68
Query: 175 PLPNGFGSGLVSLEKLNLSFNKFNGSIPSNT-GNLSSLQGTVDFSHNLFSGSIPA-SLGN 232
+ S L L ++ + I NL +LQ + S+ +P +
Sbjct: 69 VIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQ-YLLISNTGIK-HLPDVHKIH 126
Query: 233 LPEKVYIDLTYNNLSGPIPQN 253
+KV +D+ N I +N
Sbjct: 127 SLQKVLLDIQDNINIHTIERN 147
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 1e-11
Identities = 44/175 (25%), Positives = 69/175 (39%), Gaps = 24/175 (13%)
Query: 81 PSALGSLTDLRHVNLRNNKF-------FGSLPLELLEAQGLQSLVLYGNSFSGSVPNEI- 132
A LT LR + L +NK F L L++L + N ++P +
Sbjct: 54 SKAFHRLTKLRLLYLNDNKLQTLPAGIFKELK-------NLETLWVTDNKLQ-ALPIGVF 105
Query: 133 GKLKYLQILDLSQNFFNGSLPVSI-VQCKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLN 191
+L L L L +N SLP + +L L L N LP G L SL++L
Sbjct: 106 DQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYLSLGYNELQS-LPKGVFDKLTSLKELR 163
Query: 192 LSFNKFNGSIPSNT-GNLSSLQGTVDFSHNLFSGSIPA-SLGNLPEKVYIDLTYN 244
L N+ +P L+ L+ T+ +N +P + +L + + L N
Sbjct: 164 LYNNQLK-RVPEGAFDKLTELK-TLKLDNNQLK-RVPEGAFDSLEKLKMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 5e-09
Identities = 37/140 (26%), Positives = 58/140 (41%), Gaps = 14/140 (10%)
Query: 114 LQSLVLYGNSFSGSVPNEIGKLKYLQILDLSQNFFNGSLPVSI-VQCKRLKALDLSQNNF 172
+ L L N S +L L++L L+ N +LP I + K L+ L ++ N
Sbjct: 39 TKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKELKNLETLWVTDNKL 97
Query: 173 TGPLPNGFGSGLVSLEKLNLSFNKFNGSIPSNT-GNLSSLQGTVDFSHNLFSGSIPA--- 228
LP G LV+L +L L N+ S+P +L+ L + +N S+P
Sbjct: 98 QA-LPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLT-YLSLGYNELQ-SLPKGVF 153
Query: 229 -SLGNLPEKVYIDLTYNNLS 247
L +L + L N L
Sbjct: 154 DKLTSL---KELRLYNNQLK 170
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 2e-08
Identities = 39/149 (26%), Positives = 59/149 (39%), Gaps = 11/149 (7%)
Query: 77 LGFLPS-ALGSLTDLRHVNLRNNKFFGSLPLELLEA-QGLQSLVLYGNSFSGSVPNEI-G 133
L LP+ L +L + + +NK +LP+ + + L L L N S+P +
Sbjct: 73 LQTLPAGIFKELKNLETLWVTDNKL-QALPIGVFDQLVNLAELRLDRNQLK-SLPPRVFD 130
Query: 134 KLKYLQILDLSQNFFNGSLPVSI-VQCKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLNL 192
L L L L N SLP + + LK L L N +P G L L+ L L
Sbjct: 131 SLTKLTYLSLGYNELQ-SLPKGVFDKLTSLKELRLYNNQLKR-VPEGAFDKLTELKTLKL 188
Query: 193 SFNKFNGSIPSNT-GNLSSLQGTVDFSHN 220
N+ +P +L L+ + N
Sbjct: 189 DNNQLK-RVPEGAFDSLEKLK-MLQLQEN 215
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 1e-11
Identities = 48/227 (21%), Positives = 84/227 (37%), Gaps = 53/227 (23%)
Query: 410 VLGKSGIGIVYKVV-LEDGHTLAVRRLGEGGSQRFKEFQTEVEAIGKI-RHSNIVTLRAY 467
VLG G V + G A++ L + + EV+ + +IV +
Sbjct: 36 VLGLGVNGKVLECFHRRTGQKCALKLL-----YDSPKARQEVDHHWQASGGPHIVCILDV 90
Query: 468 YWSVDEK----LLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHE 523
Y ++ L+I + + G L + + + G +FT + +I++ I + +LH
Sbjct: 91 YENMHHGKRCLLIIMECMEGGELFSRIQER-GDQAFTEREAA---EIMRDIGTAIQFLHS 146
Query: 524 FSPKKYVHGDLKPSNILLGHNMEPH---VSDFGLARLANIAGGSPTLQSNRMPAEKPQER 580
H D+KP N+L + ++DFG A+
Sbjct: 147 ---HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAK------------------------ 179
Query: 581 QQKSVSLEVTTTNSSSNLGS-YYQAPESLKVVKPSQKWDIYSYGVIL 626
E T + + YY APE L K + D++S GVI+
Sbjct: 180 -------ETTQNALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 219
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 2e-11
Identities = 36/168 (21%), Positives = 62/168 (36%), Gaps = 18/168 (10%)
Query: 82 SALGSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSGSVPNEIGKLKYLQIL 141
+ L +LT + + L N + L Q +++L L + P + L LQ+L
Sbjct: 79 APLKNLTKITELELSGNPLKNVSAIAGL--QSIKTLDLTSTQITDVTP--LAGLSNLQVL 134
Query: 142 DLSQNFFNGSLPVSIVQCKRLKALDLSQNNFTG--PLPNGFGSGLVSLEKLNLSFNKFNG 199
L N ++ + L+ L + + PL + L L L NK +
Sbjct: 135 YLDLNQIT-NIS-PLAGLTNLQYLSIGNAQVSDLTPL-----ANLSKLTTLKADDNKIS- 186
Query: 200 SIPSNTGNLSSLQGTVDFSHNLFSGSIPASLGNLPEKVYIDLTYNNLS 247
I S +L +L V +N S + L N + LT ++
Sbjct: 187 DI-SPLASLPNLI-EVHLKNNQIS-DVSP-LANTSNLFIVTLTNQTIT 230
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 2e-11
Identities = 30/168 (17%), Positives = 64/168 (38%), Gaps = 18/168 (10%)
Query: 82 SALGSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSGSVPNEIGKLKYLQIL 141
+L + + + ++ L+ G+ +L +G + ++ + L L L
Sbjct: 13 FPDPALANAIKIAAGKSNVTDTVTQADLD--GITTLSAFGTGVT-TIEG-VQYLNNLIGL 68
Query: 142 DLSQNFFNGSLPVSIVQCKRLKALDLSQNNFT--GPLPNGFGSGLVSLEKLNLSFNKFNG 199
+L N L + ++ L+LS N + +GL S++ L+L+ +
Sbjct: 69 ELKDNQIT-DLA-PLKNLTKITELELSGNPLKNVSAI-----AGLQSIKTLDLTSTQITD 121
Query: 200 SIPSNTGNLSSLQGTVDFSHNLFSGSIPASLGNLPEKVYIDLTYNNLS 247
+ LS+LQ + N + +I L L Y+ + +S
Sbjct: 122 --VTPLAGLSNLQ-VLYLDLNQIT-NISP-LAGLTNLQYLSIGNAQVS 164
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 5e-07
Identities = 27/137 (19%), Positives = 50/137 (36%), Gaps = 6/137 (4%)
Query: 82 SALGSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSGSVPNEIGKLKYLQIL 141
S L LT+L+++++ N + PL L L +L N S + + L L +
Sbjct: 145 SPLAGLTNLQYLSIGNAQVSDLTPLANL--SKLTTLKADDNKIS-DISP-LASLPNLIEV 200
Query: 142 DLSQNFFNGSLPVSIVQCKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLNLSFNKFNGSI 201
L N + P++ L + L+ T + +V S +
Sbjct: 201 HLKNNQISDVSPLA--NTSNLFIVTLTNQTITNQPVFYNNNLVVPNVVKGPSGAPIAPAT 258
Query: 202 PSNTGNLSSLQGTVDFS 218
S+ G +S T + +
Sbjct: 259 ISDNGTYASPNLTWNLT 275
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 2e-11
Identities = 40/194 (20%), Positives = 75/194 (38%), Gaps = 51/194 (26%)
Query: 449 EVEAIGKIRHSNIVTLRAYY--WSVDEKLLIY---DYIPNGSLATALHGKPGMVSFTPVP 503
E+ + K+ H N+V L + +Y + + G + + + P+
Sbjct: 86 EIAILKKLDHPNVVKL---VEVLDDPNEDHLYMVFELVNQGPVME-------VPTLKPLS 135
Query: 504 WSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGG 563
+ + KG+ YLH K +H D+KPSN+L+G + ++DFG++
Sbjct: 136 EDQARFYFQDLIKGIEYLHYQ---KIIHRDIKPSNLLVGEDGHIKIADFGVSNE------ 186
Query: 564 SPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGS-YYQAPESLKVVKPS---QKWDI 619
+ S +L T G+ + APESL + + D+
Sbjct: 187 -----------------FKGSDALLSNTV------GTPAFMAPESLSETRKIFSGKALDV 223
Query: 620 YSYGVILLEMITGR 633
++ GV L + G+
Sbjct: 224 WAMGVTLYCFVFGQ 237
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 64.5 bits (158), Expect = 2e-11
Identities = 53/194 (27%), Positives = 84/194 (43%), Gaps = 44/194 (22%)
Query: 455 KIRHSNIVTLRAYYWSVDEKL-LIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVK-IIK 512
+++HSNIV L + ++L L+++++ L L G V K +
Sbjct: 56 ELKHSNIVKLYDVIHT-KKRLVLVFEHLDQ-DLKKLLDVCEG--GLESV----TAKSFLL 107
Query: 513 GIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRM 572
+ G+ Y H+ ++ +H DLKP N+L+ E ++DFGLAR A G P
Sbjct: 108 QLLNGIAYCHD---RRVLHRDLKPQNLLINREGELKIADFGLAR----AFGIPV------ 154
Query: 573 PAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKP-SQKWDIYSYGVILLEMIT 631
+ + E+ T +Y+AP+ L K S DI+S G I EM+
Sbjct: 155 ----------RKYTHEIVTL--------WYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVN 196
Query: 632 GRTAVVQVGSSEMD 645
G + G SE D
Sbjct: 197 GT-PLFP-GVSEAD 208
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 2e-11
Identities = 48/222 (21%), Positives = 86/222 (38%), Gaps = 46/222 (20%)
Query: 410 VLGKSGIGIVYKVV-LEDGHTLAVRRLGEGGSQRFKEFQTEVEAIGKIRHSNIVTLRAYY 468
LG+ IVY+ A++ L + + K +TE+ + ++ H NI+ L+ +
Sbjct: 60 ELGRGATSIVYRCKQKGTQKPYALKVLKK--TVDKKIVRTEIGVLLRLSHPNIIKLKEIF 117
Query: 469 WSVDEKLLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKK 528
+ E L+ + + G L + K ++ +K I + + YLHE
Sbjct: 118 ETPTEISLVLELVTGGELFDRIVEK---GYYSE---RDAADAVKQILEAVAYLHE---NG 168
Query: 529 YVHGDLKPSNILLGHNMEPH---VSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQKSV 585
VH DLKP N+L ++DFGL+++ + Q +
Sbjct: 169 IVHRDLKPENLLYATPAPDAPLKIADFGLSKI-----------------VEHQVLMKTVC 211
Query: 586 SLEVTTTNSSSNLGS-YYQAPESLKVVKPSQKWDIYSYGVIL 626
G+ Y APE L+ + D++S G+I
Sbjct: 212 -------------GTPGYCAPEILRGCAYGPEVDMWSVGIIT 240
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 64.5 bits (158), Expect = 2e-11
Identities = 52/200 (26%), Positives = 88/200 (44%), Gaps = 44/200 (22%)
Query: 449 EVEAIGKIRHSNIVTLRAYYWSVDEKL-LIYDYIPNGSLATALHGKPGMVSFTPVPWSVR 507
E+ + ++ H NIV+L S + L L+++++ L L +
Sbjct: 69 EISLLKELHHPNIVSLIDVIHS-ERCLTLVFEFMEK-DLKKVLDENKT--GLQDS----Q 120
Query: 508 VK-IIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPT 566
+K + + +G+ + H+ + +H DLKP N+L+ + ++DFGLAR A G P
Sbjct: 121 IKIYLYQLLRGVAHCHQ---HRILHRDLKPQNLLINSDGALKLADFGLAR----AFGIPV 173
Query: 567 LQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKP-SQKWDIYSYGVI 625
+S + EV T +Y+AP+ L K S DI+S G I
Sbjct: 174 ----------------RSYTHEVVTL--------WYRAPDVLMGSKKYSTSVDIWSIGCI 209
Query: 626 LLEMITGRTAVVQVGSSEMD 645
EMITG+ + G ++ D
Sbjct: 210 FAEMITGK-PLFP-GVTDDD 227
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 2e-11
Identities = 50/251 (19%), Positives = 82/251 (32%), Gaps = 79/251 (31%)
Query: 410 VLGKSGIGIVYKVV-LEDGHTLAV-----RRLGEGGSQRFKEFQTEVEAIGKIRHSNIVT 463
+LG+ G V +V+ E AV ++L + + E++ + ++RH N++
Sbjct: 12 LLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEAN-VKKEIQLLRRLRHKNVIQ 70
Query: 464 LRAYY--WSVDEKLLIY--------------DYIPNGSLATALHGKPGMVSFTPVPWSVR 507
L +EK +Y D +P
Sbjct: 71 L---VDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFP---------------VCQAH 112
Query: 508 VK---IIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGS 564
+I G+ YLH + VH D+KP N+LL +S G+A +
Sbjct: 113 GYFCQLIDGLE----YLHS---QGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAAD 165
Query: 565 PTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKP--SQKWDIYSY 622
T + T+ S +Q PE + K DI+S
Sbjct: 166 DTCR----------------------TSQGSPA----FQPPEIANGLDTFSGFKVDIWSA 199
Query: 623 GVILLEMITGR 633
GV L + TG
Sbjct: 200 GVTLYNITTGL 210
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 63.8 bits (156), Expect = 4e-11
Identities = 45/236 (19%), Positives = 81/236 (34%), Gaps = 62/236 (26%)
Query: 410 VLGKSGIGIVYKVV-LEDGHTLAV-----RRLGEGGSQRFKE---FQTEVEAIGKIRHSN 460
LG G V + +A+ R+ G ++ +TE+E + K+ H
Sbjct: 17 TLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPC 76
Query: 461 IVTLRAYYWSVDEKL-LIYDYIPNGSL--ATALHGKPGMVSFTPVPWSVRVKIIKGIAKG 517
I+ ++ ++ E ++ + + G L + + + +
Sbjct: 77 IIKIKNFF--DAEDYYIVLELMEGGELFDKVVGNKR-----LKE---ATCKLYFYQMLLA 126
Query: 518 LVYLHEFSPKKYVHGDLKPSNILLGHNMEPH---VSDFGLARLANIAGGSPTLQSNRMPA 574
+ YLHE +H DLKP N+LL E ++DFG +++
Sbjct: 127 VQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI----------------- 166
Query: 575 EKPQERQQKSVSLEVTTTNSSSNLGS-YYQAPESLKVVKP---SQKWDIYSYGVIL 626
+ G+ Y APE L V ++ D +S GVIL
Sbjct: 167 LGETSLMRTLC-------------GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 209
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 63.6 bits (155), Expect = 7e-11
Identities = 49/227 (21%), Positives = 81/227 (35%), Gaps = 52/227 (22%)
Query: 410 VLGKSGIGIVYKVV-LEDGHTLAVRRLGEGGSQRFKEFQTEVEAIGKI-RHSNIVTLRAY 467
VLG G V ++ A++ L Q + + EVE + + +IV +
Sbjct: 69 VLGLGINGKVLQIFNKRTQEKFALKML-----QDCPKARREVELHWRASQCPHIVRIVDV 123
Query: 468 Y----WSVDEKLLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHE 523
Y L++ + + G L + + + G +FT S +I+K I + + YLH
Sbjct: 124 YENLYAGRKCLLIVMECLDGGELFSRIQDR-GDQAFTEREAS---EIMKSIGEAIQYLHS 179
Query: 524 FSPKKYVHGDLKPSNILLGHNMEPH---VSDFGLARLANIAGGSPTLQSNRMPAEKPQER 580
H D+KP N+L ++DFG A+
Sbjct: 180 ---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE-----------------TTSHNS 219
Query: 581 QQKSVSLEVTTTNSSSNLGS-YYQAPESLKVVKPSQKWDIYSYGVIL 626
+ YY APE L K + D++S GVI+
Sbjct: 220 LTTPC-------------YTPYYVAPEVLGPEKYDKSCDMWSLGVIM 253
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 63.0 bits (154), Expect = 7e-11
Identities = 53/194 (27%), Positives = 83/194 (42%), Gaps = 44/194 (22%)
Query: 455 KIRHSNIVTLRAYYWSVDEKL-LIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVK-IIK 512
++H+NIVTL + ++ L L+++Y+ L L + VK +
Sbjct: 56 DLKHANIVTLHDIIHT-EKSLTLVFEYLDK-DLKQYLDDCGNI--INMH----NVKLFLF 107
Query: 513 GIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRM 572
+ +GL Y H +K +H DLKP N+L+ E ++DFGLAR A PT
Sbjct: 108 QLLRGLAYCHR---QKVLHRDLKPQNLLINERGELKLADFGLAR----AKSIPT------ 154
Query: 573 PAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKP-SQKWDIYSYGVILLEMIT 631
K+ EV T +Y+ P+ L S + D++ G I EM T
Sbjct: 155 ----------KTYDNEVVTL--------WYRPPDILLGSTDYSTQIDMWGVGCIFYEMAT 196
Query: 632 GRTAVVQVGSSEMD 645
GR + GS+ +
Sbjct: 197 GR-PLFP-GSTVEE 208
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 62.1 bits (151), Expect = 1e-10
Identities = 32/314 (10%), Positives = 67/314 (21%), Gaps = 92/314 (29%)
Query: 410 VLGKSGIGIVYK---VVLEDGHTLAVR--RLGEGGSQRFKE-FQTEVEAIGKIRHSNIVT 463
G ++ L +A+ + + + +I +
Sbjct: 38 FHGGVPPLQFWQALDTAL--DRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVAR 95
Query: 464 LRAYYWSVDEKLLIY---DYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVY 520
+ V + ++I GSL P ++R ++ +A
Sbjct: 96 V---LDVVHTRAGGLVVAEWIRGGSLQEVADTSP------SPVGAIR--AMQSLAAAADA 144
Query: 521 LHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQER 580
H PS + VS G LA A
Sbjct: 145 AHR---AGVALSIDHPSRVR--------VSIDGDVVLAYPATMPDA-------------- 179
Query: 581 QQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVG 640
P+ DI G L ++ R +
Sbjct: 180 -----------------------NPQD----------DIRGIGASLYALLVNRWPL--PE 204
Query: 641 SSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMR 700
+ + + + +D + +A V R
Sbjct: 205 AGVRSGLAPAERDTAGQPIEPADIDRDIPFQIS---------AVAARSVQGDGGIRSAS- 254
Query: 701 HISDALDRLIVSSD 714
+ + + + +D
Sbjct: 255 TLLNLMQQATAVAD 268
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 1e-10
Identities = 48/234 (20%), Positives = 88/234 (37%), Gaps = 56/234 (23%)
Query: 410 VLGKSGIGIVYKVV-LEDGHTLAVRRL---GEGGSQRFKEFQTEVEAIGKIRHSNIVTLR 465
+G G VY + + +A++++ G+ ++++++ EV + K+RH N +
Sbjct: 61 EIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTI--- 117
Query: 466 AYYWS--VDEKL-LIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLH 522
Y + L+ +Y GS + L V + + G +GL YLH
Sbjct: 118 QYRGCYLREHTAWLVMEYCL-GSASDLLEVHKK--PLQEVEIAA---VTHGALQGLAYLH 171
Query: 523 EFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQ 582
+H D+K NILL + DFG
Sbjct: 172 S---HNMIHRDVKAGNILLSEPGLVKLGDFG----------------------------- 199
Query: 583 KSVSLEVTTTNSSSNLGS-YYQAPESLKVVKPSQ---KWDIYSYGVILLEMITG 632
+ + NS +G+ Y+ APE + + Q K D++S G+ +E+
Sbjct: 200 --SASIMAPANSF--VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAER 249
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 63.2 bits (153), Expect = 1e-10
Identities = 29/157 (18%), Positives = 57/157 (36%), Gaps = 20/157 (12%)
Query: 75 KLLGFLPSALGSLTDLRHVN--------LRNNKFFGSLPLELLEAQGLQSLVLYGNSFSG 126
L + L + L+ V+ +KF + +E ++ L L +
Sbjct: 396 DPLLYEKETLQYFSTLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLT- 454
Query: 127 SVPNEIGKLKYLQILDLSQNFFNGSLPVSIVQCKRLKALDLSQNNFT--GPLPNGFGSGL 184
+ + + +L + LDLS N +LP ++ + L+ L S N + N L
Sbjct: 455 VLCH-LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALENVDGVAN-----L 507
Query: 185 VSLEKLNLSFNKFNG-SIPSNTGNLSSLQGTVDFSHN 220
L++L L N+ + + L ++ N
Sbjct: 508 PRLQELLLCNNRLQQSAAIQPLVSCPRLV-LLNLQGN 543
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 55.9 bits (134), Expect = 3e-08
Identities = 25/94 (26%), Positives = 39/94 (41%), Gaps = 6/94 (6%)
Query: 82 SALGSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSGSVPNEIGKLKYLQIL 141
L L + H++L +N+ +LP L + L+ L N+ +V + L LQ L
Sbjct: 457 CHLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVDG-VANLPRLQEL 513
Query: 142 DLSQNFFNGSLP--VSIVQCKRLKALDLSQNNFT 173
L N +V C RL L+L N+
Sbjct: 514 LLCNNRLQ-QSAAIQPLVSCPRLVLLNLQGNSLC 546
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 53.2 bits (127), Expect = 2e-07
Identities = 29/132 (21%), Positives = 46/132 (34%), Gaps = 7/132 (5%)
Query: 65 RVVSVSIPKKKLLGFLPSALGSLTDLRHVNLRNNKFFGSLP-LELLEAQGLQSLVLYGNS 123
R + + K L D+R ++L + L LE L + L L N
Sbjct: 418 RAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDL-TVLCHLEQL--LLVTHLDLSHNR 474
Query: 124 FSGSVPNEIGKLKYLQILDLSQNFFNGSLPVSIVQCKRLKALDLSQNNFTGPLPNGFGSG 183
++P + L+ L++L S N ++ + RL+ L L N
Sbjct: 475 LR-ALPPALAALRCLEVLQASDNALE-NVD-GVANLPRLQELLLCNNRLQQSAAIQPLVS 531
Query: 184 LVSLEKLNLSFN 195
L LNL N
Sbjct: 532 CPRLVLLNLQGN 543
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 44.7 bits (105), Expect = 1e-04
Identities = 26/179 (14%), Positives = 53/179 (29%), Gaps = 48/179 (26%)
Query: 77 LGFLPSALGSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSGSVPNEIGKLK 136
L S L S +L+ + N ++ L + L +
Sbjct: 361 STVLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYE-----------KETLQYFS 409
Query: 137 YLQILD--------LSQNFFNGSLPVSIVQCKRLKALDLSQNNFTGPLPNGFGSGLVSLE 188
L+ +D ++ F V ++ ++ L L+ + T L + L+ +
Sbjct: 410 TLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLTV-LCHL--EQLLLVT 466
Query: 189 KLNLSFNKFNGSIPSNTGNLSSLQGTVDFSHNLFSGSIPASLGNLPEKVYIDLTYNNLS 247
L+LS N+ ++P +L L + + N L
Sbjct: 467 HLDLSHNRLR--------------------------ALPPALAALRCLEVLQASDNALE 499
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 2e-10
Identities = 34/122 (27%), Positives = 53/122 (43%), Gaps = 13/122 (10%)
Query: 514 IAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMP 573
+ K + YLH +H D+KPSNILL V+DFGL+R +
Sbjct: 118 LIKVIKYLHS---GGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSIN 174
Query: 574 AEKPQERQQKSVSLE-VTTTNSSSNLGSYYQAPES-LKVVKPSQKWDIYSYGVILLEMIT 631
+ + + V T +Y+APE L K ++ D++S G IL E++
Sbjct: 175 ENTENFDDDQPILTDYVAT--------RWYRAPEILLGSTKYTKGIDMWSLGCILGEILC 226
Query: 632 GR 633
G+
Sbjct: 227 GK 228
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 61.8 bits (151), Expect = 2e-10
Identities = 48/195 (24%), Positives = 79/195 (40%), Gaps = 46/195 (23%)
Query: 457 RHSNIVTLR----AYYWSVDEKL-LIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVK-I 510
H N+V L + KL L+++++ L T L P +K +
Sbjct: 72 EHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPE-PGVPTE----TIKDM 125
Query: 511 IKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSN 570
+ + +GL +LH + VH DLKP NIL+ + + ++DFGLAR ++
Sbjct: 126 MFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLAR----IYSFQMALTS 178
Query: 571 RMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMI 630
V T +Y+APE L + D++S G I EM
Sbjct: 179 -----------------VVVTL--------WYRAPEVLLQSSYATPVDLWSVGCIFAEMF 213
Query: 631 TGRTAVVQVGSSEMD 645
+ + + GSS++D
Sbjct: 214 RRK-PLFR-GSSDVD 226
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 61.5 bits (150), Expect = 3e-10
Identities = 45/205 (21%), Positives = 83/205 (40%), Gaps = 54/205 (26%)
Query: 449 EVEAIGKIRHSNIVTLRAYYWSVDEKL-LIYDYIPNGSLATALHGKPGMVSFTPVPWSVR 507
E++ + ++RH N+V L ++ L+++++ + ++ L P + + V
Sbjct: 74 EIKLLKQLRHENLVNLLEVCKK-KKRWYLVFEFVDH-TILDDLELFPN-----GLDYQVV 126
Query: 508 VKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTL 567
K + I G+ + H +H D+KP NIL+ + + DFG AR +P
Sbjct: 127 QKYLFQIINGIGFCHS---HNIIHRDIKPENILVSQSGVVKLCDFGFAR----TLAAPG- 178
Query: 568 QSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESL-------KVVKPSQKWDIY 620
+ EV T +Y+APE L K V D++
Sbjct: 179 ---------------EVYDDEVATR--------WYRAPELLVGDVKYGKAV------DVW 209
Query: 621 SYGVILLEMITGRTAVVQVGSSEMD 645
+ G ++ EM G + G S++D
Sbjct: 210 AIGCLVTEMFMGE-PLFP-GDSDID 232
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 62.4 bits (151), Expect = 3e-10
Identities = 32/168 (19%), Positives = 60/168 (35%), Gaps = 18/168 (10%)
Query: 82 SALGSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSGSVPNEIGKLKYLQIL 141
+ + NL+ ++ L + + ++ + SV I L + L
Sbjct: 15 FPDDAFAETIKDNLKKKSVTDAVTQNELNS--IDQIIANNSDIK-SVQG-IQYLPNVTKL 70
Query: 142 DLSQNFFNGSLPVSIVQCKRLKALDLSQNNFT--GPLPNGFGSGLVSLEKLNLSFNKFNG 199
L+ N P++ K L L L +N L L L+ L+L N +
Sbjct: 71 FLNGNKLTDIKPLT--NLKNLGWLFLDENKIKDLSSL-----KDLKKLKSLSLEHNGIS- 122
Query: 200 SIPSNTGNLSSLQGTVDFSHNLFSGSIPASLGNLPEKVYIDLTYNNLS 247
I + +L L+ ++ +N + I L L + + L N +S
Sbjct: 123 DI-NGLVHLPQLE-SLYLGNNKIT-DIT-VLSRLTKLDTLSLEDNQIS 166
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 52.8 bits (126), Expect = 3e-07
Identities = 31/133 (23%), Positives = 55/133 (41%), Gaps = 13/133 (9%)
Query: 82 SALGSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSGSVPNEIGKLKYLQIL 141
S+L L L+ ++L +N L L L+SL L N + + + +L L L
Sbjct: 103 SSLKDLKKLKSLSLEHNGISDINGLVHL--PQLESLYLGNNKIT-DITV-LSRLTKLDTL 158
Query: 142 DLSQNFFNGSLPVSIVQCKRLKALDLSQNNFT--GPLPNGFGSGLVSLEKLNLSFNKFNG 199
L N + + + +L+ L LS+N+ + L +GL +L+ L L +
Sbjct: 159 SLEDNQIS-DIV-PLAGLTKLQNLYLSKNHISDLRAL-----AGLKNLDVLELFSQECLN 211
Query: 200 SIPSNTGNLSSLQ 212
++ NL
Sbjct: 212 KPINHQSNLVVPN 224
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 48.9 bits (116), Expect = 4e-06
Identities = 20/136 (14%), Positives = 47/136 (34%), Gaps = 16/136 (11%)
Query: 114 LQSLVLYGNSFSGSVPNEIGKLKYLQILDLSQNFFNGSLPVSIVQCKRLKALDLSQNNFT 173
+ + P++ +L + + + V+ + + + + ++
Sbjct: 1 MGETITVSTPIKQIFPDD--AFAETIKDNLKKK--SVTDAVTQNELNSIDQIIANNSDIK 56
Query: 174 --GPLPNGFGSGLVSLEKLNLSFNKFNGSIPSNTGNLSSLQGTVDFSHNLFSGSIPASLG 231
+ L ++ KL L+ NK I NL +L + N + SL
Sbjct: 57 SVQGI-----QYLPNVTKLFLNGNKLT-DI-KPLTNLKNLG-WLFLDENKIK-DLS-SLK 106
Query: 232 NLPEKVYIDLTYNNLS 247
+L + + L +N +S
Sbjct: 107 DLKKLKSLSLEHNGIS 122
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 42.0 bits (98), Expect = 6e-04
Identities = 30/157 (19%), Positives = 52/157 (33%), Gaps = 9/157 (5%)
Query: 82 SALGSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSGSVPNEIGKLKYLQIL 141
+ L LT L ++L +N+ +PL L LQ+L L N S + LK L +L
Sbjct: 147 TVLSRLTKLDTLSLEDNQISDIVPLAGLTK--LQNLYLSKNHI--SDLRALAGLKNLDVL 202
Query: 142 DLSQNFFNGSLPVSIVQCKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLNLSFNKFNGSI 201
+L + + + P S EK N+ ++
Sbjct: 203 ELFSQECLNKPINHQSNLVVPNTVKNTDGSLVTPEII---SDDGDYEKPNVKWH--LPEF 257
Query: 202 PSNTGNLSSLQGTVDFSHNLFSGSIPASLGNLPEKVY 238
+ + T+ + F G + L + Y
Sbjct: 258 TNEVSFIFYQPVTIGKAKARFHGRVTQPLKEVYTVSY 294
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 61.0 bits (149), Expect = 3e-10
Identities = 47/195 (24%), Positives = 73/195 (37%), Gaps = 46/195 (23%)
Query: 457 RHSNIVTLR----AYYWSVDEKL-LIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVK-I 510
H N+V L + K+ L+++++ L T L P +K +
Sbjct: 72 EHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPP-PGLPAE----TIKDL 125
Query: 511 IKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSN 570
++ +GL +LH VH DLKP NIL+ ++DFGLAR +
Sbjct: 126 MRQFLRGLDFLHA---NCIVHRDLKPENILVTSGGTVKLADFGLAR----IYSYQMALTP 178
Query: 571 RMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMI 630
V T +Y+APE L + D++S G I EM
Sbjct: 179 -----------------VVVTL--------WYRAPEVLLQSTYATPVDMWSVGCIFAEMF 213
Query: 631 TGRTAVVQVGSSEMD 645
+ + G+SE D
Sbjct: 214 RRK-PLFC-GNSEAD 226
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 61.7 bits (150), Expect = 3e-10
Identities = 43/267 (16%), Positives = 90/267 (33%), Gaps = 84/267 (31%)
Query: 410 VLGKSGIGIVYK-VVLEDGHTLAVRRLGEGGSQRFKEFQT---EVEAIGKIRHSNIVTLR 465
LG GIV + +E G A++++ ++ + E++ + + H NI+ L
Sbjct: 14 TLGTGSFGIVCEVFDIESGKRFALKKV-------LQDPRYKNRELDIMKVLDHVNIIKLV 66
Query: 466 AYYWSVDEKLLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRV----------------K 509
Y+++ ++ P+ V + K
Sbjct: 67 DYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHK 126
Query: 510 IIKG-------------------IAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHV- 549
++K + + + ++H H D+KP N+L+ N + +
Sbjct: 127 VLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLG---ICHRDIKPQNLLV--NSKDNTL 181
Query: 550 --SDFGLARLANIAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPE- 606
DFG A+ + SV+ + + +Y+APE
Sbjct: 182 KLCDFGSAKKLI--------------------PSEPSVA-YICSR--------FYRAPEL 212
Query: 607 SLKVVKPSQKWDIYSYGVILLEMITGR 633
L + + D++S G + E+I G+
Sbjct: 213 MLGATEYTPSIDLWSIGCVFGELILGK 239
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 61.7 bits (150), Expect = 3e-10
Identities = 34/125 (27%), Positives = 51/125 (40%), Gaps = 14/125 (11%)
Query: 514 IAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMP 573
+ G ++HE +H DLKP+N LL + V DFGLAR N + +
Sbjct: 138 LLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEEN 194
Query: 574 AEKPQERQQKSVSL--EVTTTNSSSNLGSYYQAPE-SLKVVKPSQKWDIYSYGVILLEMI 630
E + L V T +Y+APE L ++ DI+S G I E++
Sbjct: 195 EEPGPHNKNLKKQLTSHVVT--------RWYRAPELILLQENYTKSIDIWSTGCIFAELL 246
Query: 631 TGRTA 635
+
Sbjct: 247 NMLQS 251
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 60.7 bits (148), Expect = 4e-10
Identities = 41/205 (20%), Positives = 79/205 (38%), Gaps = 54/205 (26%)
Query: 449 EVEAIGKIRHSNIVTLRAYYWSVDEKL-LIYDYIPNGSLATALHGKPGMVSFTPVPWSVR 507
E+ + +++H N+V L + +L L+++Y + ++ L V V+
Sbjct: 52 EIRMLKQLKHPNLVNLLEVFRR-KRRLHLVFEYCDH-TVLHELDRYQRGVP----EHLVK 105
Query: 508 VKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTL 567
I + + + H+ +H D+KP NIL+ + + DFG AR P+
Sbjct: 106 -SITWQTLQAVNFCHK---HNCIHRDVKPENILITKHSVIKLCDFGFAR----LLTGPS- 156
Query: 568 QSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESL-------KVVKPSQKWDIY 620
EV T +Y++PE L V D++
Sbjct: 157 ---------------DYYDDEVATR--------WYRSPELLVGDTQYGPPV------DVW 187
Query: 621 SYGVILLEMITGRTAVVQVGSSEMD 645
+ G + E+++G + G S++D
Sbjct: 188 AIGCVFAELLSGV-PLWP-GKSDVD 210
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 61.1 bits (149), Expect = 4e-10
Identities = 47/198 (23%), Positives = 78/198 (39%), Gaps = 48/198 (24%)
Query: 455 KIRHSNIVTLRAYYWSVDEKLLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVK-IIKG 513
+++H NI+ L++ LI++Y N L + P + +K +
Sbjct: 89 ELQHRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNPDVSMRV-------IKSFLYQ 140
Query: 514 IAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPH-----VSDFGLARLANIAGGSPTLQ 568
+ G+ + H ++ +H DLKP N+LL + + DFGLAR A G P
Sbjct: 141 LINGVNFCHS---RRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLAR----AFGIPI-- 191
Query: 569 SNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKP-SQKWDIYSYGVILL 627
+ + E+ T +Y+ PE L + S DI+S I
Sbjct: 192 --------------RQFTHEIITL--------WYRPPEILLGSRHYSTSVDIWSIACIWA 229
Query: 628 EMITGRTAVVQVGSSEMD 645
EM+ + G SE+D
Sbjct: 230 EMLMKT-PLFP-GDSEID 245
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 1e-09
Identities = 45/191 (23%), Positives = 69/191 (36%), Gaps = 45/191 (23%)
Query: 447 QTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGSLATAL--HGKPGMVSFTPVPW 504
EV + + H NIV L + LI +Y G + L HG+ +
Sbjct: 62 FREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGR--------MKE 113
Query: 505 SVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGS 564
+ I + Y H+ K+ VH DLK N+LL +M ++DFG
Sbjct: 114 KEARSKFRQIVSAVQYCHQ---KRIVHRDLKAENLLLDADMNIKIADFGF---------- 160
Query: 565 PTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGS-YYQAPESLKVVK-PSQKWDIYSY 622
SN + G+ Y APE + K + D++S
Sbjct: 161 ----SNEF---TVGGKLDAFC-------------GAPPYAAPELFQGKKYDGPEVDVWSL 200
Query: 623 GVILLEMITGR 633
GVIL +++G
Sbjct: 201 GVILYTLVSGS 211
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 60.2 bits (146), Expect = 1e-09
Identities = 38/260 (14%), Positives = 84/260 (32%), Gaps = 78/260 (30%)
Query: 410 VLGKSGIGIVYKVV-LEDGHTLAVRRLGEGGSQRFKEFQTEVEAIGKIR---------HS 459
++G G V + + +A++++ + F+ ++ +R H
Sbjct: 60 LIGTGSYGHVCEAYDKLEKRVVAIKKI-------LRVFEDLIDCKRILREIAILNRLNHD 112
Query: 460 NIVTL----RAYYWSVDEKL-LIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKG- 513
++V + ++L ++ + + K+ +
Sbjct: 113 HVVKVLDIVIPKDVEKFDELYVVLEI-----ADSDFK-----------------KLFRTP 150
Query: 514 --------------IAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLAN 559
+ G+ Y+H +H DLKP+N L+ + V DFGLAR +
Sbjct: 151 VYLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLARTVD 207
Query: 560 IAGGSPTLQSNRMPAEKPQERQQKSVSL-------EVTTTNSSSNLGSYYQAPESLKVVK 612
+ + V T +Y+APE + + +
Sbjct: 208 YPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVT--------RWYRAPELILLQE 259
Query: 613 P-SQKWDIYSYGVILLEMIT 631
++ D++S G I E++
Sbjct: 260 NYTEAIDVWSIGCIFAELLN 279
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 1e-09
Identities = 46/208 (22%), Positives = 83/208 (39%), Gaps = 60/208 (28%)
Query: 455 KIRHSNIVTLR-------AYYWSVDEKL-LIYDYIPNGSLATALHGKPGMVSFTPVPWSV 506
++H N+V L + Y + L++D+ + LA L V FT
Sbjct: 72 LLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVL--VKFTLS---- 124
Query: 507 RVK-IIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSP 565
+K +++ + GL Y+H K +H D+K +N+L+ + ++DFGLAR ++
Sbjct: 125 EIKRVMQMLLNGLYYIHR---NKILHRDMKAANVLITRDGVLKLADFGLARAFSL----- 176
Query: 566 TLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESL--------KVVKPSQKW 617
+ Q + V T +Y+ PE L +
Sbjct: 177 -----------AKNSQPNRYTNRVVTL--------WYRPPELLLGERDYGPPI------- 210
Query: 618 DIYSYGVILLEMITGRTAVVQVGSSEMD 645
D++ G I+ EM T ++Q G++E
Sbjct: 211 DLWGAGCIMAEMWTRS-PIMQ-GNTEQH 236
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 59.1 bits (144), Expect = 1e-09
Identities = 48/207 (23%), Positives = 88/207 (42%), Gaps = 58/207 (28%)
Query: 449 EVEAIGKIRHSNIVTLRAYYWSVDEKL-LIYDYIPNGSLATALHGKPGMVSFTPVPWSVR 507
E++ + ++ H NI+ L + + L++D++ L + + TP
Sbjct: 62 EIKLLQELSHPNIIGLLDAFGH-KSNISLVFDFMET-DLEVIIKDNSLV--LTPS----H 113
Query: 508 VK-IIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPT 566
+K + +GL YLH+ +H DLKP+N+LL N ++DFGLA+ + GSP
Sbjct: 114 IKAYMLMTLQGLEYLHQ---HWILHRDLKPNNLLLDENGVLKLADFGLAK----SFGSPN 166
Query: 567 LQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPE--------SLKVVKPSQKWD 618
++ + +V T +Y+APE + V D
Sbjct: 167 ----------------RAYTHQVVTR--------WYRAPELLFGARMYGVGV-------D 195
Query: 619 IYSYGVILLEMITGRTAVVQVGSSEMD 645
+++ G IL E++ + G S++D
Sbjct: 196 MWAVGCILAELLLRV-PFLP-GDSDLD 220
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 1e-09
Identities = 50/240 (20%), Positives = 81/240 (33%), Gaps = 51/240 (21%)
Query: 410 VLGKSGIGIVYKVVLEDGHTLAVRRLGEGGSQRFKE--FQTEVEAIGKIR---------H 458
+ G V V +G +A++R+ S +R H
Sbjct: 29 FISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHH 88
Query: 459 SNIVTLRAYYWSVDEKLLIYDYIPNGSLATALHG--KPGMVSFTPVPWSVRVK-IIKGIA 515
NI+ LR + +E + Y+ + T L + +P ++ + I
Sbjct: 89 PNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQ----HIQYFMYHIL 144
Query: 516 KGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAE 575
GL LHE VH DL P NILL N + + DF LAR
Sbjct: 145 LGLHVLHE---AGVVHRDLHPGNILLADNNDITICDFNLAREDT--------ADANKTH- 192
Query: 576 KPQERQQKSVSLEVTTTNSSSNLGSYYQAPES-LKVVKPSQKWDIYSYGVILLEMITGRT 634
VT +Y+APE ++ ++ D++S G ++ EM +
Sbjct: 193 ------------YVTH--------RWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKA 232
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 2e-09
Identities = 34/121 (28%), Positives = 50/121 (41%), Gaps = 32/121 (26%)
Query: 514 IAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMP 573
+ G+ +LH +H DLKPSNI++ + + DFGLAR A
Sbjct: 136 MLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG-------------- 178
Query: 574 AEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGR 633
++ V T YY+APE + + + DI+S G I+ EMI G
Sbjct: 179 -------TSFMMTPYVVT--------RYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223
Query: 634 T 634
Sbjct: 224 V 224
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 2e-09
Identities = 37/188 (19%), Positives = 64/188 (34%), Gaps = 36/188 (19%)
Query: 82 SALGSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSGSVPNEIGKLKYLQIL 141
+ + + NL+ ++ L + + ++ + SV I L + L
Sbjct: 18 FSDDAFAETIKDNLKKKSVTDAVTQNELNS--IDQIIANNSDIK-SVQG-IQYLPNVTKL 73
Query: 142 DLSQN-----FFNGSLP---------------VSIVQCKRLKALDLSQNNFT--GPLPNG 179
L+ N +L S+ K+LK+L L N + L
Sbjct: 74 FLNGNKLTDIKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDINGL--- 130
Query: 180 FGSGLVSLEKLNLSFNKFNGSIPSNTGNLSSLQGTVDFSHNLFSGSIPASLGNLPEKVYI 239
L LE L L NK + + L+ L T+ N S I L L + +
Sbjct: 131 --VHLPQLESLYLGNNKI--TDITVLSRLTKLD-TLSLEDNQIS-DIV-PLAGLTKLQNL 183
Query: 240 DLTYNNLS 247
L+ N++S
Sbjct: 184 YLSKNHIS 191
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 6e-09
Identities = 41/168 (24%), Positives = 65/168 (38%), Gaps = 18/168 (10%)
Query: 82 SALGSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSGSVPNEIGKLKYLQIL 141
+ L ++ + L NK PL L+ L L L N + + + LK L+ L
Sbjct: 62 QGIQYLPNVTKLFLNGNKLTDIKPLANLKN--LGWLFLDENKVK-DLSS-LKDLKKLKSL 117
Query: 142 DLSQNFFNGSLPVSIVQCKRLKALDLSQNNFTG--PLPNGFGSGLVSLEKLNLSFNKFNG 199
L N + + +V +L++L L N T L S L L+ L+L N+ +
Sbjct: 118 SLEHNGIS-DIN-GLVHLPQLESLYLGNNKITDITVL-----SRLTKLDTLSLEDNQIS- 169
Query: 200 SIPSNTGNLSSLQGTVDFSHNLFSGSIPASLGNLPEKVYIDLTYNNLS 247
I L+ LQ + S N S + A L L ++L
Sbjct: 170 DI-VPLAGLTKLQ-NLYLSKNHIS-DLRA-LAGLKNLDVLELFSQECL 213
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 58.8 bits (143), Expect = 2e-09
Identities = 36/121 (29%), Positives = 50/121 (41%), Gaps = 22/121 (18%)
Query: 514 IAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMP 573
+ + LH +H DLKPSN+L+ N + V DFGLAR+
Sbjct: 121 TLRAVKVLHG---SNVIHRDLKPSNLLINSNCDLKVCDFGLARII----------DESAA 167
Query: 574 AEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPE-SLKVVKPSQKWDIYSYGVILLEMITG 632
QQ + V T +Y+APE L K S+ D++S G IL E+
Sbjct: 168 DNSEPTGQQSGMVEFVAT--------RWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLR 219
Query: 633 R 633
R
Sbjct: 220 R 220
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 58.7 bits (142), Expect = 2e-09
Identities = 38/172 (22%), Positives = 61/172 (35%), Gaps = 26/172 (15%)
Query: 88 TDLRHVNLRNNK--------FFGSLPLELLEAQGLQSLVLYGNSFSGSVPNEI-GKLKYL 138
+ ++L +N L L SL+L N + + +E + L
Sbjct: 39 SYTALLDLSHNNLSRLRAEWTPTRLT-------NLHSLLLSHNHLN-FISSEAFVPVPNL 90
Query: 139 QILDLSQNFFNGSLPVSIVQ-CKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLNLSFNKF 197
+ LDLS N + +L + + L+ L L N+ + + L+KL LS N+
Sbjct: 91 RYLDLSSNHLH-TLDEFLFSDLQALEVLLLYNNHIVV-VDRNAFEDMAQLQKLYLSQNQI 148
Query: 198 NGSIPSNT----GNLSSLQGTVDFSHNLFSGSIPASLGNLPEKVYIDLTYNN 245
+ P L L +D S N L LP V L +N
Sbjct: 149 S-RFPVELIKDGNKLPKLM-LLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHN 198
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 45.6 bits (108), Expect = 4e-05
Identities = 22/85 (25%), Positives = 35/85 (41%), Gaps = 5/85 (5%)
Query: 165 LDLSQNNFTGPLPNGFGSGLVSLEKLNLSFNKFNGSIPSNT-GNLSSLQGTVDFSHNLFS 223
LDLS NN + + L +L L LS N N I S + +L+ +D S N
Sbjct: 44 LDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPVPNLR-YLDLSSNHLH 101
Query: 224 GSIPA-SLGNLPEKVYIDLTYNNLS 247
++ +L + L N++
Sbjct: 102 -TLDEFLFSDLQALEVLLLYNNHIV 125
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 58.4 bits (142), Expect = 3e-09
Identities = 38/122 (31%), Positives = 55/122 (45%), Gaps = 29/122 (23%)
Query: 514 IAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMP 573
I +GL Y+H +H DLKPSN+LL + + DFGLAR+A+
Sbjct: 137 ILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVAD-------------- 179
Query: 574 AEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPE-SLKVVKPSQKWDIYSYGVILLEMITG 632
P ++ V T +Y+APE L ++ DI+S G IL EM++
Sbjct: 180 ---PDHDHTGFLTEYVAT--------RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN 228
Query: 633 RT 634
R
Sbjct: 229 RP 230
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 3e-09
Identities = 32/166 (19%), Positives = 60/166 (36%), Gaps = 15/166 (9%)
Query: 82 SALGSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSGSVPNEIGKLKYLQIL 141
L + NL + + L +Q+ ++ S+ + L+ L
Sbjct: 13 FPDPGLANAVKQNLGKQSVTDLVSQKELSG--VQNFNGDNSNIQ-SLAG-MQFFTNLKEL 68
Query: 142 DLSQNFFNGSLPVSIVQCKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLNLSFNKFNGSI 201
LS N S + +L+ L +++N N G L +L L N+
Sbjct: 69 HLSHN--QISDLSPLKDLTKLEELSVNRNRLK----NLNGIPSACLSRLFLDNNEL--RD 120
Query: 202 PSNTGNLSSLQGTVDFSHNLFSGSIPASLGNLPEKVYIDLTYNNLS 247
+ +L +L+ + +N SI LG L + +DL N ++
Sbjct: 121 TDSLIHLKNLE-ILSIRNNKLK-SIV-MLGFLSKLEVLDLHGNEIT 163
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 2e-07
Identities = 35/168 (20%), Positives = 57/168 (33%), Gaps = 17/168 (10%)
Query: 82 SALGSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSGSVPNEIGKLKYLQIL 141
S L LT L +++ N+ L + + L L L N + + LK L+IL
Sbjct: 79 SPLKDLTKLEELSVNRNRL---KNLNGIPSACLSRLFLDNNELR-DTDS-LIHLKNLEIL 133
Query: 142 DLSQNFFNGSLPVSIVQCKRLKALDLSQNNFT--GPLPNGFGSGLVSLEKLNLSFNKFNG 199
+ N S+ + +L+ LDL N T G L + L + ++L+ K
Sbjct: 134 SIRNNKLK-SIV-MLGFLSKLEVLDLHGNEITNTGGL-----TRLKKVNWIDLTGQKCVN 186
Query: 200 SIPSNTGNLSSLQGTVDFSHNLFSGSIPASLGNLPEKVYIDLTYNNLS 247
L D S P + N V + +
Sbjct: 187 EPVKYQPELYITNTVKDPDGRWIS---PYYISNGGSYVDGCVLWELPV 231
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 59.1 bits (143), Expect = 3e-09
Identities = 29/169 (17%), Positives = 52/169 (30%), Gaps = 10/169 (5%)
Query: 87 LTDLRHVNLRNNKFFGSLPLELLEAQG-----LQSLVLYGNSFSGSVPNEIGKLKYLQIL 141
+ ++N+ N + E L + F S + I
Sbjct: 275 PRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIK 334
Query: 142 DLSQNFFNGSLPVSIVQCKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLNLSFNKFNGSI 201
LS + V L+ +QN FT + G + L L+ L L N +
Sbjct: 335 MLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCST-LKRLQTLILQRNGLK-NF 392
Query: 202 PSNTGNLSSLQ--GTVDFSHNLFSGSIPASLGNLPEK-VYIDLTYNNLS 247
++ T+D S N + E + ++L+ N L+
Sbjct: 393 FKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLT 441
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 56.8 bits (137), Expect = 2e-08
Identities = 38/139 (27%), Positives = 61/139 (43%), Gaps = 11/139 (7%)
Query: 114 LQSLVLYGNSFSGSVPNEIGKLKYLQILDLSQNFFNGSLPVSI-VQCKRLKALDLSQNNF 172
++L L NS S +I L L++L LS N SL + + + L+ LD+S N
Sbjct: 54 TKALSLSQNSISELRMPDISFLSELRVLRLSHNRIR-SLDFHVFLFNQDLEYLDVSHNRL 112
Query: 173 TGPLPNGFGSGLVSLEKLNLSFNKFNGSIPSNT--GNLSSLQGTVDFSHNLFSGSIPASL 230
+ + SL L+LSFN F+ +P GNL+ L + S F +
Sbjct: 113 QN-ISCC---PMASLRHLDLSFNDFD-VLPVCKEFGNLTKLT-FLGLSAAKFRQLDLLPV 166
Query: 231 GNLPEK-VYIDLTYNNLSG 248
+L + +DL ++ G
Sbjct: 167 AHLHLSCILLDLVSYHIKG 185
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 55.6 bits (134), Expect = 3e-08
Identities = 25/115 (21%), Positives = 51/115 (44%), Gaps = 5/115 (4%)
Query: 84 LGSLTDLRHVNLRNNKF-FGSLPLELLEAQGLQSLVLYGNSFSGSVPNEIGKLKYLQILD 142
+++ L +++ N + A+ + L L N +GSV + +++LD
Sbjct: 399 TKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLPPK--VKVLD 456
Query: 143 LSQNFFNGSLPVSIVQCKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLNLSFNKF 197
L N S+P + + L+ L+++ N +P+G L SL+ + L N +
Sbjct: 457 LHNNRIM-SIPKDVTHLQALQELNVASNQLKS-VPDGVFDRLTSLQYIWLHDNPW 509
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 55.6 bits (134), Expect = 4e-08
Identities = 38/178 (21%), Positives = 60/178 (33%), Gaps = 21/178 (11%)
Query: 88 TDLRHVNLRNNKF-------FGSLPLELLEAQGLQSLVLYGNSFSGSVPNEI-GKLKYLQ 139
+ ++L N L L+ L L N S+ + + L+
Sbjct: 52 PRTKALSLSQNSISELRMPDISFLS-------ELRVLRLSHNRIR-SLDFHVFLFNQDLE 103
Query: 140 ILDLSQNFFNGSLPVSIVQCKRLKALDLSQNNFTG-PLPNGFGSGLVSLEKLNLSFNKFN 198
LD+S N ++ + L+ LDLS N+F P+ FG L L L LS KF
Sbjct: 104 YLDVSHNRL-QNISCCPM--ASLRHLDLSFNDFDVLPVCKEFG-NLTKLTFLGLSAAKFR 159
Query: 199 GSIPSNTGNLSSLQGTVDFSHNLFSGSIPASLGNLPEKVYIDLTYNNLSGPIPQNGAL 256
+L +D G SL V + + N + N ++
Sbjct: 160 QLDLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSV 217
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 54.9 bits (132), Expect = 7e-08
Identities = 36/183 (19%), Positives = 62/183 (33%), Gaps = 21/183 (11%)
Query: 81 PSALGSLTDLRHVNLRNNKF-------FGSLPLELLEAQGLQSLVLYGNSFSGSVPNEIG 133
+ L++LR + L +N+ F L+ L + N ++
Sbjct: 69 MPDISFLSELRVLRLSHNRIRSLDFHVFLFNQD-------LEYLDVSHNRLQ-NIS--CC 118
Query: 134 KLKYLQILDLSQNFFNGSLPVSIV--QCKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLN 191
+ L+ LDLS N F+ LPV +L L LS F +S L+
Sbjct: 119 PMASLRHLDLSFNDFD-VLPVCKEFGNLTKLTFLGLSAAKFRQLDLLPVAHLHLSCILLD 177
Query: 192 LSFNKFNGSIPSNTGNLSSLQGTVDFSHN-LFSGSIPASLGNLPEKVYIDLTYNNLSGPI 250
L G + ++ + F N LFS + S+ L ++ N+ +
Sbjct: 178 LVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQR 237
Query: 251 PQN 253
Sbjct: 238 LMT 240
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 53.7 bits (129), Expect = 1e-07
Identities = 36/187 (19%), Positives = 68/187 (36%), Gaps = 9/187 (4%)
Query: 65 RVVSVSIPKKKLLGFLPSALGSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSF 124
+ +++I ++ + +L L +++N F S + +L +
Sbjct: 282 NIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDT 341
Query: 125 SGSVPNEIGKLKYLQILDLSQNFFNGSLPVSIVQCKRLKALDLSQNNFTGPLPNGFG--S 182
L+ +QN F S+ KRL+ L L +N
Sbjct: 342 PFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKN-FFKVALMTK 400
Query: 183 GLVSLEKLNLSFNKF-NGSIPSNTGNLSSLQGTVDFSHNLFSGSIPASLGNLPEKV-YID 240
+ SLE L++S N + + S+ ++ S N+ +GS+ LP KV +D
Sbjct: 401 NMSSLETLDVSLNSLNSHAYDRTCAWAESIL-VLNLSSNMLTGSVFRC---LPPKVKVLD 456
Query: 241 LTYNNLS 247
L N +
Sbjct: 457 LHNNRIM 463
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 4e-09
Identities = 38/122 (31%), Positives = 55/122 (45%), Gaps = 35/122 (28%)
Query: 514 IAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMP 573
I +GL Y+H +H DLKPSN+ + + E + DFGLAR ++ M
Sbjct: 141 ILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHT----------ADEMT 187
Query: 574 AEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPES-LKVVKPSQKWDIYSYGVILLEMITG 632
V T +Y+APE L + +Q DI+S G I+ E++TG
Sbjct: 188 G-------------YVAT--------RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 226
Query: 633 RT 634
RT
Sbjct: 227 RT 228
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 4e-09
Identities = 39/122 (31%), Positives = 55/122 (45%), Gaps = 35/122 (28%)
Query: 514 IAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMP 573
+ KGL Y+H +H DLKP N+ + + E + DFGLAR A + M
Sbjct: 137 MLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQA----------DSEMT 183
Query: 574 AEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPE-SLKVVKPSQKWDIYSYGVILLEMITG 632
V T +Y+APE L ++ +Q DI+S G I+ EMITG
Sbjct: 184 G-------------YVVT--------RWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITG 222
Query: 633 RT 634
+T
Sbjct: 223 KT 224
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 58.3 bits (141), Expect = 4e-09
Identities = 33/121 (27%), Positives = 51/121 (42%), Gaps = 32/121 (26%)
Query: 514 IAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMP 573
+ G+ +LH +H DLKPSNI++ + + DFGLAR T ++ M
Sbjct: 173 MLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR---------TAGTSFMM 220
Query: 574 AEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGR 633
V T YY+APE + + + DI+S G I+ EM+ +
Sbjct: 221 TP------------YVVT--------RYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260
Query: 634 T 634
Sbjct: 261 I 261
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 57.9 bits (140), Expect = 6e-09
Identities = 59/240 (24%), Positives = 89/240 (37%), Gaps = 52/240 (21%)
Query: 402 ELLKASAFVLGKSGIGIVYKVVLED-GHTLAVRRLGEGGSQRFKEFQ---TEVEAIGKIR 457
+ VLGK G G V + G A ++L + ++ K E + + K+
Sbjct: 187 RQYR----VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVN 242
Query: 458 HSNIVTLRAYYWSVDEKLLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKI-IKGIAK 516
+V+L Y + D L+ + G L ++ G F R I
Sbjct: 243 SRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIY-HMGQAGFPEA----RAVFYAAEICC 297
Query: 517 GLVYLHEFSPKKYVHGDLKPSNILL---GHNMEPHVSDFGLARLANIAGGSPTLQSNRMP 573
GL LH ++ V+ DLKP NILL GH +SD GLA ++ G
Sbjct: 298 GLEDLHR---ERIVYRDLKPENILLDDHGHIR---ISDLGLAV--HVPEGQTIKGR---- 345
Query: 574 AEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGR 633
V T Y APE +K + + D ++ G +L EMI G+
Sbjct: 346 ---------------VGTVG--------YMAPEVVKNERYTFSPDWWALGCLLYEMIAGQ 382
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 7e-09
Identities = 39/122 (31%), Positives = 55/122 (45%), Gaps = 35/122 (28%)
Query: 514 IAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMP 573
+ KGL Y+H VH DLKP N+ + + E + DFGLAR A+ M
Sbjct: 135 MLKGLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFGLARHAD----------AEM- 180
Query: 574 AEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPES-LKVVKPSQKWDIYSYGVILLEMITG 632
+ V T +Y+APE L + +Q DI+S G I+ EM+TG
Sbjct: 181 ------------TGYVVT--------RWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTG 220
Query: 633 RT 634
+T
Sbjct: 221 KT 222
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 56.5 bits (137), Expect = 8e-09
Identities = 30/123 (24%), Positives = 55/123 (44%), Gaps = 30/123 (24%)
Query: 514 IAKGLVYLHEFSPKKYVHGDLKPSNILL-GHNMEPHVSDFGLARLANIAGGSPTLQSNRM 572
+ +GL Y+H +H DLKP+N+ + ++ + DFGLAR+ +
Sbjct: 129 LLRGLKYIHS---ANVLHRDLKPANLFINTEDLVLKIGDFGLARIMD------------- 172
Query: 573 PAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPE-SLKVVKPSQKWDIYSYGVILLEMIT 631
P + +S + T +Y++P L ++ D+++ G I EM+T
Sbjct: 173 ----PHYSHKGHLSEGLVTK--------WYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLT 220
Query: 632 GRT 634
G+T
Sbjct: 221 GKT 223
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 57.1 bits (138), Expect = 1e-08
Identities = 62/284 (21%), Positives = 105/284 (36%), Gaps = 61/284 (21%)
Query: 368 ECLCFRKDESETLSENVEQY-DLVPLDTQVAFDLD--ELLKASAFVLGKSGIGIVYKVVL 424
EC + + E +E Q+ + E+LK V+G+ G V V L
Sbjct: 40 ECNNSPLRREKNILEYLEWAKPFTSKVKQMRLHREDFEILK----VIGRGAFGEVAVVKL 95
Query: 425 ED-GHTLAVRRLGEGGSQRFKE---FQTEVEAIGKIRHSNIVTLRAYYWSVDEKL-LIYD 479
++ A++ L + + E F+ E + + I TL Y + D L L+ D
Sbjct: 96 KNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLH-YAFQDDNNLYLVMD 154
Query: 480 YIPNGSLATALHGKPGMVSFTPVPWSVRVKI-IKGIAKGLVYLHEFSPKKYVHGDLKPSN 538
Y G L T L + + + + + +H+ YVH D+KP N
Sbjct: 155 YYVGGDLLTLLSKFEDRLP------EEMARFYLAEMVIAIDSVHQ---LHYVHRDIKPDN 205
Query: 539 ILL---GHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSS 595
IL+ GH ++DFG + ++ +S V T +
Sbjct: 206 ILMDMNGHIR---LADFGSC------------------LKLMEDGTVQSSVA-VGTPD-- 241
Query: 596 SNLGSYYQAPESLKVVKPSQKW-----DIYSYGVILLEMITGRT 634
Y +PE L+ ++ + D +S GV + EM+ G T
Sbjct: 242 ------YISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGET 279
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 2e-08
Identities = 37/155 (23%), Positives = 63/155 (40%), Gaps = 21/155 (13%)
Query: 410 VLGKSGIGIVYKVV-LEDGHTLAVRRLGEGGSQRFKEFQTEVEAIGKI-RHSNIVTLRAY 467
VLG G V ++ A++ L Q + + EVE + + +IV +
Sbjct: 25 VLGLGINGKVLQIFNKRTQEKFALKML-----QDCPKARREVELHWRASQCPHIVRIVDV 79
Query: 468 Y----WSVDEKLLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHE 523
Y L++ + + G L + + + G +FT S +I+K I + + YLH
Sbjct: 80 YENLYAGRKCLLIVMECLDGGELFSRIQDR-GDQAFTEREAS---EIMKSIGEAIQYLHS 135
Query: 524 FSPKKYVHGDLKPSNILLGHNMEPH---VSDFGLA 555
H D+KP N+L ++DFG A
Sbjct: 136 ---INIAHRDVKPENLLYTSKRPNAILKLTDFGFA 167
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 4e-08
Identities = 29/132 (21%), Positives = 48/132 (36%), Gaps = 35/132 (26%)
Query: 516 KGLVYLHEFSPKKYVHGDLKPSNILLGH-NMEPHVSDFGLARLANIAGGSPTLQSNRMPA 574
K L Y H +H D+KP N+++ H + + + D+GLA P + N
Sbjct: 141 KALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAE-----FYHPGQEYN---- 188
Query: 575 EKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKP-SQKWDIYSYGVILLEMITGR 633
+ V + Y++ PE L + D++S G +L MI +
Sbjct: 189 ------------VRVAS--------RYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRK 228
Query: 634 TAVVQVGSSEMD 645
G D
Sbjct: 229 EPFFH-GHDNYD 239
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 54.1 bits (131), Expect = 4e-08
Identities = 43/196 (21%), Positives = 73/196 (37%), Gaps = 55/196 (28%)
Query: 447 QTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGSLATAL--HGKPGMVSFTPVPW 504
+ E++ + RH +I+ L + + ++ +Y+ G L + HG+ V
Sbjct: 59 KREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGR--------VEE 110
Query: 505 SVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAG-- 562
++ + I + Y H VH DLKP N+LL +M ++DFGL+ + +
Sbjct: 111 MEARRLFQQILSAVDYCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFL 167
Query: 563 ----GSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVK-PSQKW 617
GSP Y APE + +
Sbjct: 168 RTSCGSPN-----------------------------------YAAPEVISGRLYAGPEV 192
Query: 618 DIYSYGVILLEMITGR 633
DI+S GVIL ++ G
Sbjct: 193 DIWSCGVILYALLCGT 208
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 4e-08
Identities = 32/133 (24%), Positives = 48/133 (36%), Gaps = 7/133 (5%)
Query: 115 QSLVLYGNSFSGSVPNEIGKLKYLQILDLSQNFFNGSLPVSI-VQCKRLKALDLSQNNFT 173
+ L N+ P K L+ +DLS N + L + L +L L N T
Sbjct: 35 TEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGNKIT 93
Query: 174 GPLPNGFGSGLVSLEKLNLSFNKFNGSIPSNT-GNLSSLQGTVDFSHNLFSGSIPASLGN 232
LP GL SL+ L L+ NK N + + +L +L + N +
Sbjct: 94 E-LPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHNLN-LLSLYDNKLQTIAKGTFSP 150
Query: 233 LPEKVYIDLTYNN 245
L + L N
Sbjct: 151 LRAIQTMHL-AQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 1e-07
Identities = 36/121 (29%), Positives = 53/121 (43%), Gaps = 7/121 (5%)
Query: 81 PSALGSLTDLRHVNLRNNKFFGSLPLELLEAQG-LQSLVLYGNSFSGSVPNEI-GKLKYL 138
P A LR ++L NN+ L + + L SLVLYGN + +P + L L
Sbjct: 49 PGAFSPYKKLRRIDLSNNQ-ISELAPDAFQGLRSLNSLVLYGNKIT-ELPKSLFEGLFSL 106
Query: 139 QILDLSQNFFNGSLPVSI-VQCKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLNLSFNKF 197
Q+L L+ N N L V L L L N + G S L +++ ++L+ N F
Sbjct: 107 QLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDNKLQT-IAKGTFSPLRAIQTMHLAQNPF 164
Query: 198 N 198
Sbjct: 165 I 165
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 54.9 bits (132), Expect = 5e-08
Identities = 32/152 (21%), Positives = 50/152 (32%), Gaps = 20/152 (13%)
Query: 501 PVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANI 560
+P KII+ + +GL YLH + + +H D+KP NILL N + A
Sbjct: 142 GLPLPCVKKIIQQVLQGLDYLH--TKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQR 199
Query: 561 AGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSY------------------Y 602
+G P S A + + Y
Sbjct: 200 SGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQY 259
Query: 603 QAPESLKVVKPSQKWDIYSYGVILLEMITGRT 634
++ E L + DI+S + E+ TG
Sbjct: 260 RSLEVLIGSGYNTPADIWSTACMAFELATGDY 291
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 6e-08
Identities = 35/197 (17%), Positives = 64/197 (32%), Gaps = 33/197 (16%)
Query: 80 LPSALGSLTDLRHVNLRNNKFFGSLPLELLEA-----QGLQSLVLYGNSFS----GSVPN 130
+ SAL L +NLR+N+ +L+ +Q L L + G + +
Sbjct: 48 ISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSS 107
Query: 131 EIGKLKYLQILDLSQNFFNGSLPVSIVQ-----CKRLKALDLSQNNFTGPLPNGFGSGLV 185
+ L LQ L LS N + + + RL+ L L + + S L
Sbjct: 108 TLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLR 167
Query: 186 ---SLEKLNLSFNKFNGS--------IPSNTGNLSSLQGTVDFSHNLFS----GSIPASL 230
++L +S N N + + + L +L + + +
Sbjct: 168 AKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEAL----KLESCGVTSDNCRDLCGIV 223
Query: 231 GNLPEKVYIDLTYNNLS 247
+ + L N L
Sbjct: 224 ASKASLRELALGSNKLG 240
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 5e-06
Identities = 30/136 (22%), Positives = 48/136 (35%), Gaps = 17/136 (12%)
Query: 79 FLPSALGSLTDLRHVNLRNNKFFGSLPLELLEAQ-----GLQSLVLYGNSFSGSVPNEIG 133
L S L +L L+ ++L +N + L E L+ L L S S + +
Sbjct: 104 VLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLA 163
Query: 134 KL----KYLQILDLSQNFFNGS----LPVSIVQCK-RLKALDLSQNNFTGPLPNGFGSGL 184
+ + L +S N N + L + +L+AL L T +
Sbjct: 164 SVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIV 223
Query: 185 ---VSLEKLNLSFNKF 197
SL +L L NK
Sbjct: 224 ASKASLRELALGSNKL 239
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 7e-05
Identities = 29/185 (15%), Positives = 64/185 (34%), Gaps = 29/185 (15%)
Query: 88 TDLRHVNLRNNKFFGSLPLELLEA-QGLQSLVLYGNSFS----GSVPNEIGKLKYLQILD 142
D++ ++++ + + ELL Q Q + L + + + + L L+
Sbjct: 3 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 62
Query: 143 LSQNFFNGSLPVSIVQC-----KRLKALDLSQNNFTGPLPNGFGSGLVS---LEKLNLSF 194
L N ++Q +++ L L TG S L + L++L+LS
Sbjct: 63 LRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSD 122
Query: 195 NKFNGS--------IPSNTGNLSSLQGTVDFSHNLFS----GSIPASLGNLPEKVYIDLT 242
N + + L L + S + + L P+ + ++
Sbjct: 123 NLLGDAGLQLLCEGLLDPQCRLEKL----QLEYCSLSAASCEPLASVLRAKPDFKELTVS 178
Query: 243 YNNLS 247
N+++
Sbjct: 179 NNDIN 183
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 54.2 bits (131), Expect = 6e-08
Identities = 51/198 (25%), Positives = 76/198 (38%), Gaps = 57/198 (28%)
Query: 448 TEVEAIGKIRHSNIVTLRAYYWSVDEKL-LIYDYIPNGSLATALHGKPGMVSFTPVPWSV 506
E + + ++ H V L + + DEKL Y NG L + K G SF
Sbjct: 79 RERDVMSRLDHPFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIR-KIG--SFDET---- 130
Query: 507 RVKI-IKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHV--SDFGLARLANIAGG 563
+ I L YLH K +H DLKP NILL +M H+ +DFG A
Sbjct: 131 CTRFYTAEIVSALEYLHG---KGIIHRDLKPENILLNEDM--HIQITDFGTA-------- 177
Query: 564 SPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGS-YYQAPESL------KVVKPSQK 616
K +S E ++S +G+ Y +PE L K
Sbjct: 178 -------------------KVLSPESKQARANSFVGTAQYVSPELLTEKSACKSS----- 213
Query: 617 WDIYSYGVILLEMITGRT 634
D+++ G I+ +++ G
Sbjct: 214 -DLWALGCIIYQLVAGLP 230
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 6e-08
Identities = 32/100 (32%), Positives = 46/100 (46%), Gaps = 6/100 (6%)
Query: 115 QSLVLYGNSFSGSVPNEIGKLKYLQILDLSQNFFNGSLPVSIV-QCKRLKALDLSQNNFT 173
L L GN F+ VP E+ K+L ++DLS N + +L +L L LS N
Sbjct: 34 TELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRIS-TLSNQSFSNMTQLLTLILSYNRLR 91
Query: 174 GPLPNGFGSGLVSLEKLNLSFNKFNGSIPSNT-GNLSSLQ 212
+P GL SL L+L N + +P +LS+L
Sbjct: 92 C-IPPRTFDGLKSLRLLSLHGNDIS-VVPEGAFNDLSALS 129
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 7e-08
Identities = 41/169 (24%), Positives = 63/169 (37%), Gaps = 23/169 (13%)
Query: 115 QSLVLYGNSFSGSVPNEIGKLKYLQILDLSQNFFNGSLPVSIV-QCKRLKALDLSQNNFT 173
Q L L+ N + P L L+ L L N +LPV + +L LDL N T
Sbjct: 43 QILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFDSLTQLTVLDLGTNQLT 101
Query: 174 GPLPNG-FGSGLVSLEKLNLSFNKFNGSIPSNTGNLSSLQGTVDFSHNLFSGSIPA--SL 230
LP+ F LV L++L + NK +P L+ L + L S A L
Sbjct: 102 V-LPSAVFDR-LVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRL 158
Query: 231 GNLPEKVYIDLTYNN-----------LSGPIPQNGALMNRGPTAFIGNP 268
+L + L + N L + + ++ R + +P
Sbjct: 159 SSL---THAYL-FGNPWDCECRDIMYLRNWVADHTSIAMRWDGKAVNDP 203
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 42.8 bits (101), Expect = 1e-04
Identities = 42/158 (26%), Positives = 66/158 (41%), Gaps = 23/158 (14%)
Query: 54 CSWNGITCKEQRVVSV--SIP---------KKKLLGFLPSALGSLTDLRHVNLRNNKFFG 102
CS + C+ +R SV IP ++ P SL +L+ + L +N+ G
Sbjct: 19 CSGTTVDCRSKRHASVPAGIPTNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQ-LG 77
Query: 103 SLPL----ELLEAQGLQSLVLYGNSFSGSVPNEI-GKLKYLQILDLSQNFFNGSLPVSIV 157
+LP+ L + L L L N + +P+ + +L +L+ L + N LP I
Sbjct: 78 ALPVGVFDSLTQ---LTVLDLGTNQLT-VLPSAVFDRLVHLKELFMCCNKLT-ELPRGIE 132
Query: 158 QCKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLNLSFN 195
+ L L L QN +P+G L SL L N
Sbjct: 133 RLTHLTHLALDQNQLKS-IPHGAFDRLSSLTHAYLFGN 169
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 53.7 bits (130), Expect = 8e-08
Identities = 68/253 (26%), Positives = 101/253 (39%), Gaps = 77/253 (30%)
Query: 402 ELLKASAFVLGKSGIGIVYKVVLEDGHTLAVRRLGEGGSQRF-------KEF---QTEVE 451
ELLK VLG+ G KV L V+++ +++ K + V
Sbjct: 27 ELLK----VLGQGSFG---KVFL-------VKKISGSDARQLYAMKVLKKATLKVRDRVR 72
Query: 452 AIG------KIRHSNIVTLRAYYWSVDEKL-LIYDYIPNGSLATALHGKPGMVSFTPVPW 504
++ H IV L Y + + KL LI D++ G L T L K M FT
Sbjct: 73 TKMERDILVEVNHPFIVKLH-YAFQTEGKLYLILDFLRGGDLFTRLS-KEVM--FTEE-- 126
Query: 505 SVRVKI-IKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHV--SDFGLARLANIA 561
VK + +A L +LH ++ DLKP NILL + E H+ +DFGL++ +I
Sbjct: 127 --DVKFYLAELALALDHLHS---LGIIYRDLKPENILL--DEEGHIKLTDFGLSKE-SID 178
Query: 562 GGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSY-YQAPESLKVVKPSQKWDIY 620
S G+ Y APE + +Q D +
Sbjct: 179 HEKKA----------------------------YSFCGTVEYMAPEVVNRRGHTQSADWW 210
Query: 621 SYGVILLEMITGR 633
S+GV++ EM+TG
Sbjct: 211 SFGVLMFEMLTGT 223
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 54.0 bits (130), Expect = 9e-08
Identities = 39/161 (24%), Positives = 58/161 (36%), Gaps = 42/161 (26%)
Query: 498 SFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPH--VSDFGLA 555
F + K I + L LH+ + +H DLKP NILL V DFG +
Sbjct: 193 KFQGFSLPLVRKFAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVIDFGSS 249
Query: 556 RLANIAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQ 615
+ +QS R +Y+APE + +
Sbjct: 250 CYEHQR-VYTYIQS-R-----------------------------FYRAPEVILGARYGM 278
Query: 616 KWDIYSYGVILLEMITGRTAVVQVGSSEMDLVNWMQLCIEE 656
D++S G IL E++TG + G E D + C+ E
Sbjct: 279 PIDMWSLGCILAELLTGY--PLLPGEDEGDQLA----CMIE 313
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 53.6 bits (129), Expect = 1e-07
Identities = 41/251 (16%), Positives = 77/251 (30%), Gaps = 83/251 (33%)
Query: 411 LGKSGIGIVYKVV-LEDGHTLAV-----RRLGEGGSQRFKEFQT---EVEAIGKIRHSNI 461
LG G V+ V E + V ++ E + E+ + ++ H+NI
Sbjct: 32 LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91
Query: 462 VTL------RAYYWSVDEKLL----IYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKII 511
+ + + ++ V EK ++ +I H + + + I
Sbjct: 92 IKVLDIFENQGFFQLVMEKHGSGLDLFAFI-------DRHPR--------LDEPLASYIF 136
Query: 512 KGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAG------GSP 565
+ + + YL K +H D+K NI++ + + DFG A G+
Sbjct: 137 RQLVSAVGYLRL---KDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFCGTI 193
Query: 566 TLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVK---PSQKWDIYSY 622
Y APE L P +++S
Sbjct: 194 E-----------------------------------YCAPEVLMGNPYRGPEL--EMWSL 216
Query: 623 GVILLEMITGR 633
GV L ++
Sbjct: 217 GVTLYTLVFEE 227
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 1e-07
Identities = 45/136 (33%), Positives = 62/136 (45%), Gaps = 19/136 (13%)
Query: 86 SLTDLRHVNLRNNKFFGSLPLELLEA-QGLQSLVLYGNSFSGSVPNEI-GKLKYLQILDL 143
LT+L ++ L N+ SLP + + L+ LVL N S+P+ + KL L L+L
Sbjct: 83 ELTNLTYLILTGNQ-LQSLPNGVFDKLTNLKELVLVENQLQ-SLPDGVFDKLTNLTYLNL 140
Query: 144 SQNFFNGSLPV----SIVQCKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLNLSFNKFNG 199
+ N SLP + L LDLS N LP G L L+ L L N+
Sbjct: 141 AHNQLQ-SLPKGVFDKLTN---LTELDLSYNQLQS-LPEGVFDKLTQLKDLRLYQNQLK- 194
Query: 200 SIPSNTG---NLSSLQ 212
S+P G L+SLQ
Sbjct: 195 SVPD--GVFDRLTSLQ 208
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 53.6 bits (129), Expect = 1e-07
Identities = 44/193 (22%), Positives = 75/193 (38%), Gaps = 53/193 (27%)
Query: 449 EVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGSLATAL--HGKPGMVSFTPVPWSV 506
E++ + RH +I+ L + + ++ +Y+ G L + +G+ +
Sbjct: 66 EIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGR--------LDEKE 117
Query: 507 RVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAG---- 562
++ + I G+ Y H VH DLKP N+LL +M ++DFGL+ + +
Sbjct: 118 SRRLFQQILSGVDYCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRT 174
Query: 563 --GSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIY 620
GSP + EV + G Y PE DI+
Sbjct: 175 SCGSPNY-----------------AAPEVIS-------GRLYAGPEV----------DIW 200
Query: 621 SYGVILLEMITGR 633
S GVIL ++ G
Sbjct: 201 SSGVILYALLCGT 213
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 52.6 bits (127), Expect = 2e-07
Identities = 44/189 (23%), Positives = 66/189 (34%), Gaps = 42/189 (22%)
Query: 449 EVEAIGKIRHSNIVTLRAYYWSVDEKLLIY---DYIPNGSLATALHGKPGMVSFTPVPWS 505
E+ + H N+V Y E + Y +Y G L + GM P
Sbjct: 55 EICINKMLNHENVVKF---YGHRREGNIQYLFLEYCSGGELFDRIEPDIGM------PEP 105
Query: 506 VRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSP 565
+ + G+VYLH H D+KP N+LL +SDFGLA +
Sbjct: 106 DAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER 162
Query: 566 TLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVK-PSQKWDIYSYGV 624
L + Y APE LK + ++ D++S G+
Sbjct: 163 LLN----------------------KMCGTLP----YVAPELLKRREFHAEPVDVWSCGI 196
Query: 625 ILLEMITGR 633
+L M+ G
Sbjct: 197 VLTAMLAGE 205
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 2e-07
Identities = 42/205 (20%), Positives = 67/205 (32%), Gaps = 74/205 (36%)
Query: 447 QTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIY-----------DYIPNGSLATALHGKPG 495
+ E+ + +RH +I+ L Y + I DYI +
Sbjct: 57 EREISYLKLLRHPHIIKL---YDVITTPTDIVMVIEYAGGELFDYI-------VEKKR-- 104
Query: 496 MVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLA 555
+ + + I + Y H K VH DLKP N+LL N+ ++DFGL+
Sbjct: 105 ------MTEDEGRRFFQQIICAIEYCHR---HKIVHRDLKPENLLLDDNLNVKIADFGLS 155
Query: 556 RLANIAG------GSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLK 609
+ GSP Y APE +
Sbjct: 156 NIMTDGNFLKTSCGSPN-----------------------------------YAAPEVIN 180
Query: 610 VVK-PSQKWDIYSYGVILLEMITGR 633
+ D++S G++L M+ GR
Sbjct: 181 GKLYAGPEVDVWSCGIVLYVMLVGR 205
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 53.2 bits (128), Expect = 2e-07
Identities = 54/240 (22%), Positives = 90/240 (37%), Gaps = 49/240 (20%)
Query: 402 ELLKASAFVLGKSGIGIVYKVVLED-GHTLAVRRLGEGGSQRFKEFQ---TEVEAIGKIR 457
+ VLG+ G G V+ ++ G A ++L + ++ K +Q E + + K+
Sbjct: 188 LDFR----VLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVH 243
Query: 458 HSNIVTLRAYYWSVDEKLLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKI-IKGIAK 516
IV+L + + + L+ + G + ++ P R I
Sbjct: 244 SRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEP---RAIFYTAQIVS 300
Query: 517 GLVYLHEFSPKKYVHGDLKPSNILL---GHNMEPHVSDFGLARLANIAGGSPTLQSNRMP 573
GL +LH+ + ++ DLKP N+LL G+ +SD GLA AG + T
Sbjct: 301 GLEHLHQ---RNIIYRDLKPENVLLDDDGNVR---ISDLGLAVE-LKAGQTKT------- 346
Query: 574 AEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGR 633
T + APE L + D ++ GV L EMI R
Sbjct: 347 ------------KGYAGTPG--------FMAPELLLGEEYDFSVDYFALGVTLYEMIAAR 386
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 3e-07
Identities = 58/262 (22%), Positives = 97/262 (37%), Gaps = 67/262 (25%)
Query: 390 VPLDTQVAFDLD--ELLKASAFVLGKSGIGIVYKVVLED-GHTLAVRRLGEGGSQRFKEF 446
D + D E+L+ +GK G V V D A++ + + E
Sbjct: 4 PVFDENEDVNFDHFEILR----AIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEV 59
Query: 447 Q---TEVEAIGKIRHSNIVTLRAYYWSVDEKL-LIYDYIPNGSLATALHGKPGMVSFTPV 502
+ E++ + + H +V L Y + +E + ++ D + G L L + F
Sbjct: 60 RNVFKELQIMQGLEHPFLVNLW-YSFQDEEDMFMVVDLLLGGDLRYHL-QQNVH--FK-- 113
Query: 503 PWSVRVKI-IKGIAKGLVYLHEFSPKKYVHGDLKPSNILL---GHNMEPHVSDFGLARLA 558
VK+ I + L YL ++ +H D+KP NILL GH H++DF +A
Sbjct: 114 --EETVKLFICELVMALDYLQN---QRIIHRDMKPDNILLDEHGH---VHITDFNIAA-- 163
Query: 559 NIAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKW- 617
P+E Q +++ T Y APE + +
Sbjct: 164 ----------------MLPRETQITTMA---GTKP--------YMAPE---MFSSRKGAG 193
Query: 618 -----DIYSYGVILLEMITGRT 634
D +S GV E++ GR
Sbjct: 194 YSFAVDWWSLGVTAYELLRGRR 215
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 4e-07
Identities = 55/249 (22%), Positives = 87/249 (34%), Gaps = 60/249 (24%)
Query: 402 ELLKASAFVLGKSGIGIVYKVVLED-GHTLAVRRLGEGGSQRFKE---FQTEVEAIGKIR 457
E+LK V+G+ V V ++ G A++ + + + E F+ E + +
Sbjct: 64 EILK----VIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGD 119
Query: 458 HSNIVTLRAYYWSVDEKL-LIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKI-IKGIA 515
I L + + + L L+ +Y G L T L K G + + I
Sbjct: 120 RRWITQLH-FAFQDENYLYLVMEYYVGGDLLTLLS-KFGER-IPAE----MARFYLAEIV 172
Query: 516 KGLVYLHEFSPKKYVHGDLKPSNILL---GHNMEPHVSDFGLARLANIAGGSPTLQSNRM 572
+ +H YVH D+KP NILL GH ++DFG G +
Sbjct: 173 MAIDSVHR---LGYVHRDIKPDNILLDRCGHIR---LADFGSCLKLRADGTVRS------ 220
Query: 573 PAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIY-------SYGVI 625
+ V T + Y +PE L+ V Y + GV
Sbjct: 221 -------------LVAVGTPD--------YLSPEILQAVGGGPGTGSYGPECDWWALGVF 259
Query: 626 LLEMITGRT 634
EM G+T
Sbjct: 260 AYEMFYGQT 268
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 52.2 bits (125), Expect = 5e-07
Identities = 62/312 (19%), Positives = 101/312 (32%), Gaps = 95/312 (30%)
Query: 350 FGEGKDENCYAKGGKGRKECLCFRKDESETLSENVEQYDLVPLDTQVAFDLDELLKASAF 409
F +E C G ++ + K +NVE + ++ F + +
Sbjct: 146 FQPYIEEICQNLRGDVFQKFIESDKFTRFCQWKNVELNIHLTMND---F---SVHR---- 195
Query: 410 VLGKSGIGIVYKV------------VL---------EDGHTLAVRRLGEGGSQRFKEFQT 448
++G+ G G VY L + L R +
Sbjct: 196 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIM------------- 242
Query: 449 EVEAIGKIRHSNIVTLRAYYWSVDEKL-LIYDYIPNGSLATALHGKPGMVSFTPVPWSVR 507
+ + IV + +Y + +KL I D + G L L F+
Sbjct: 243 -LSLVSTGDCPFIVCM-SYAFHTPDKLSFILDLMNGGDLHYHLSQ---HGVFSEA----D 293
Query: 508 VKI-IKGIAKGLVYLHEFSPKKYVHGDLKPSNILL---GHNMEPHVSDFGLARLANIAGG 563
++ I GL ++H + V+ DLKP+NILL GH +SD GLA
Sbjct: 294 MRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVR---ISDLGLAC------- 340
Query: 564 SPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKP-SQKWDIYSY 622
+KP V T Y APE L+ D +S
Sbjct: 341 -------DFSKKKPHAS--------VGTHG--------YMAPEVLQKGVAYDSSADWFSL 377
Query: 623 GVILLEMITGRT 634
G +L +++ G +
Sbjct: 378 GCMLFKLLRGHS 389
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 5e-07
Identities = 33/146 (22%), Positives = 49/146 (33%), Gaps = 27/146 (18%)
Query: 498 SFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARL 557
++ I K L YL + H DLKP NILL
Sbjct: 130 NYNGFHIEDIKLYCIEILKALNYLRKM---SLTHTDLKPENILLDDPYFEKS-------- 178
Query: 558 ANIAGGSPTLQSNRMPAEKPQERQQKSVSLEV----TTTNSSSNLGSY-----YQAPESL 608
+K Q + KS +++ T S GS Y+APE +
Sbjct: 179 -------LITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYHGSIINTRQYRAPEVI 231
Query: 609 KVVKPSQKWDIYSYGVILLEMITGRT 634
+ D++S+G +L E+ TG
Sbjct: 232 LNLGWDVSSDMWSFGCVLAELYTGSL 257
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 51.0 bits (123), Expect = 6e-07
Identities = 64/255 (25%), Positives = 100/255 (39%), Gaps = 79/255 (30%)
Query: 402 ELLKASAFVLGKSGIGIVYKVVLEDGHTLAVRRLGEGGSQRF-------KEF-------- 446
ELL+ VLGK G G KV VR++ + + K
Sbjct: 20 ELLR----VLGKGGYG---KVFQ-------VRKVTGANTGKIFAMKVLKKAMIVRNAKDT 65
Query: 447 ---QTEVEAIGKIRHSNIVTLRAYYWSVDEKL-LIYDYIPNGSLATALHGKPGMVSFTPV 502
+ E + +++H IV L Y + KL LI +Y+ G L L + G+ F
Sbjct: 66 AHTKAERNILEEVKHPFIVDLI-YAFQTGGKLYLILEYLSGGELFMQLE-REGI--FMED 121
Query: 503 PWSVRVKI-IKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHV--SDFGLARLAN 559
+ I+ L +LH+ K ++ DLKP NI+L N + HV +DFGL + +
Sbjct: 122 ----TACFYLAEISMALGHLHQ---KGIIYRDLKPENIML--NHQGHVKLTDFGLCKE-S 171
Query: 560 IAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSY-YQAPESLKVVKPSQKWD 618
I G+ T + G+ Y APE L ++ D
Sbjct: 172 IHDGTVT----------------------------HTFCGTIEYMAPEILMRSGHNRAVD 203
Query: 619 IYSYGVILLEMITGR 633
+S G ++ +M+TG
Sbjct: 204 WWSLGALMYDMLTGA 218
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 50.9 bits (122), Expect = 7e-07
Identities = 29/137 (21%), Positives = 50/137 (36%), Gaps = 43/137 (31%)
Query: 508 VKIIKGIAK----GLVYLHEFSPKKYVHGDLKPSNILLGHNMEPH------VSDFGLARL 557
+ +K I+K GL Y+H +H D+KP N+L+ P ++D G A
Sbjct: 130 LIYVKQISKQLLLGLDYMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACW 187
Query: 558 ANIAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKW 617
+ + ++Q+ Y++PE L
Sbjct: 188 YD-EHYTNSIQTR------------------------------EYRSPEVLLGAPWGCGA 216
Query: 618 DIYSYGVILLEMITGRT 634
DI+S ++ E+ITG
Sbjct: 217 DIWSTACLIFELITGDF 233
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 7e-07
Identities = 44/190 (23%), Positives = 67/190 (35%), Gaps = 44/190 (23%)
Query: 449 EVEAIGKIRHSNIVTLRAYYWSVDEKLLIY---DYIPNGSLATALHGKPGMVSFTPVPWS 505
E+ + H N+V Y E + Y +Y G L + GM P
Sbjct: 55 EICINKMLNHENVVKF---YGHRREGNIQYLFLEYCSGGELFDRIEPDIGM------PEP 105
Query: 506 VRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSP 565
+ + G+VYLH H D+KP N+LL +SDFGL
Sbjct: 106 DAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGL----------- 151
Query: 566 TLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGS-YYQAPESLKVVK-PSQKWDIYSYG 623
+ + K G+ Y APE LK + ++ D++S G
Sbjct: 152 ---ATVFRYNNRERLLNKMC-------------GTLPYVAPELLKRREFHAEPVDVWSCG 195
Query: 624 VILLEMITGR 633
++L M+ G
Sbjct: 196 IVLTAMLAGE 205
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 50.5 bits (121), Expect = 1e-06
Identities = 58/268 (21%), Positives = 99/268 (36%), Gaps = 50/268 (18%)
Query: 374 KDESETLSENVEQYDLVPLDTQVAFDLD--ELLKASAFVLGKSGIGIVYKVVLEDGHTL- 430
+ S + + E+ ++ + ++ E LK +LGK G V V +
Sbjct: 121 RSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLK----LLGKGTFGKVILVKEKATGRYY 176
Query: 431 AVRRLGEGGSQRFKEF---QTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGSLA 487
A++ L + E TE + RH + L+ + + D + +Y G L
Sbjct: 177 AMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELF 236
Query: 488 TALHGKPGMVSFTPVPWSVRVKIIKG-IAKGLVYLHEFSPKKYVHGDLKPSNILLGHNME 546
L + + F+ R + I L YLH S K V+ DLK N++L +
Sbjct: 237 FHLS-RERV--FSED----RARFYGAEIVSALDYLH--SEKNVVYRDLKLENLMLDKDGH 287
Query: 547 PHVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSY-YQAP 605
++DFGL + I G+ + G+ Y AP
Sbjct: 288 IKITDFGLCKE-GIKDGATM----------------------------KTFCGTPEYLAP 318
Query: 606 ESLKVVKPSQKWDIYSYGVILLEMITGR 633
E L+ + D + GV++ EM+ GR
Sbjct: 319 EVLEDNDYGRAVDWWGLGVVMYEMMCGR 346
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 1e-06
Identities = 32/146 (21%), Positives = 54/146 (36%), Gaps = 33/146 (22%)
Query: 498 SFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARL 557
+F P P + + L +LHE + H DLKP NIL +
Sbjct: 116 NFQPYPLPHVRHMAYQLCHALRFLHEN---QLTHTDLKPENILFVN-------------- 158
Query: 558 ANIAGGSPTLQSNRMPAEKPQERQQKSVSLEV----TTTNSSSNLGSY-----YQAPESL 608
++ + +E+ K+ S+ V + T + + Y+ PE +
Sbjct: 159 -------SEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEHHTTIVATRHYRPPEVI 211
Query: 609 KVVKPSQKWDIYSYGVILLEMITGRT 634
+ +Q D++S G IL E G T
Sbjct: 212 LELGWAQPCDVWSIGCILFEYYRGFT 237
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 2e-06
Identities = 53/253 (20%), Positives = 87/253 (34%), Gaps = 73/253 (28%)
Query: 402 ELLKASAFVLGKSGIGIVYKVVLED-GHTLAVRRLGEGGSQRFKE---FQTEVEAIGKIR 457
E++K V+G+ G V V + A++ L + + + F E + +
Sbjct: 72 EVVK----VIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFAN 127
Query: 458 HSNIVTLRAYYWSVDEKL-LIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAK 516
+V L Y + D L ++ +Y+P G L + + + A+
Sbjct: 128 SPWVVQLF-YAFQDDRYLYMVMEYMPGGDLVNLMS---------------NYDVPEKWAR 171
Query: 517 --------GLVYLHEFSPKKYVHGDLKPSNILL---GHNMEPHVSDFGLARLANIAGGSP 565
L +H ++H D+KP N+LL GH ++DFG N G
Sbjct: 172 FYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLK---LADFGTCMKMNKEGMVR 225
Query: 566 TLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKW----DIYS 621
V T + Y +PE LK + D +S
Sbjct: 226 C-------------------DTAVGTPD--------YISPEVLKSQGGDGYYGRECDWWS 258
Query: 622 YGVILLEMITGRT 634
GV L EM+ G T
Sbjct: 259 VGVFLYEMLVGDT 271
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 2e-06
Identities = 39/160 (24%), Positives = 62/160 (38%), Gaps = 19/160 (11%)
Query: 54 CSWNGITCKEQRVVSV--SIPK--KKL------LGFLPS--ALGSLTDLRHVNLRNNKFF 101
C + C Q++ + IP+ +L L + L LR +N NNK
Sbjct: 11 CEGTTVDCSNQKLNKIPEHIPQYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKI- 69
Query: 102 GSLPLELLE-AQGLQSLVLYGNSFSGSVPNEI-GKLKYLQILDLSQNFFNGSLPVSI-VQ 158
+ E A G+ ++L N +V +++ L+ L+ L L N + +
Sbjct: 70 TDIEEGAFEGASGVNEILLTSNRLE-NVQHKMFKGLESLKTLMLRSNRIT-CVGNDSFIG 127
Query: 159 CKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLNLSFNKFN 198
++ L L N T + G L SL LNL N FN
Sbjct: 128 LSSVRLLSLYDNQIT-TVAPGAFDTLHSLSTLNLLANPFN 166
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 2e-06
Identities = 21/92 (22%), Positives = 31/92 (33%), Gaps = 8/92 (8%)
Query: 107 ELLEAQGLQSLVLYGNSFSGSVPNEIGKLKYLQILDLSQNFFN--GSLPVSIVQCKRLKA 164
+ A + L L G + N L +D S N P +RLK
Sbjct: 14 QYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKLDGFP----LLRRLKT 68
Query: 165 LDLSQNNFTGPLPNGFGSGLVSLEKLNLSFNK 196
L ++ N + G L L +L L+ N
Sbjct: 69 LLVNNNRICR-IGEGLDQALPDLTELILTNNS 99
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 2e-05
Identities = 19/108 (17%), Positives = 38/108 (35%), Gaps = 7/108 (6%)
Query: 140 ILDLSQNFFNGSLPVSIVQCKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLNLSFNKFNG 199
++ L+ + R + LDL + G+ L + ++ S N+
Sbjct: 1 MVKLTAELIEQAA--QYTNAVRDRELDLRGYKIP--VIENLGATLDQFDAIDFSDNEIR- 55
Query: 200 SIPSNTGNLSSLQGTVDFSHNLFSGSIPASLGNLPEKVYIDLTYNNLS 247
+ L L+ T+ ++N LP+ + LT N+L
Sbjct: 56 KL-DGFPLLRRLK-TLLVNNNRICRIGEGLDQALPDLTELILTNNSLV 101
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 3e-04
Identities = 23/119 (19%), Positives = 38/119 (31%), Gaps = 17/119 (14%)
Query: 84 LGSLTDLRHVNLRNNKFFGSLPLELLEA--QGLQSLVLYGNSFSGSVPNEIGKLKYLQIL 141
+ R ++LR K +E L A ++ N + L+ L+ L
Sbjct: 15 YTNAVRDRELDLRGYK---IPVIENLGATLDQFDAIDFSDNEIR-KLDG-FPLLRRLKTL 69
Query: 142 DLSQNFFNGSLPVSIVQCKRLKALDLSQNNFT-----GPLPNGFGSGLVSLEKLNLSFN 195
++ N L L L+ N+ PL + L SL L + N
Sbjct: 70 LVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPL-----ASLKSLTYLCILRN 123
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 49.0 bits (116), Expect = 3e-06
Identities = 23/116 (19%), Positives = 37/116 (31%), Gaps = 7/116 (6%)
Query: 60 TCKEQRVVSVSIPKKKLLGFLPSALGSLTDLRHVNLRNNKFFGSLPLELLEA-QGLQSLV 118
+ + + L +L + + N + L L L L++L
Sbjct: 6 CPHGSSGLRCT---RDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLT 62
Query: 119 LYGNSFSGSVPNEI-GKLKYLQILDLSQNFFNGSLPVSIVQCKRLKALDLSQNNFT 173
+ + V + L L+LS N SL VQ L+ L LS N
Sbjct: 63 IVKSGLR-FVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLH 116
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 43.6 bits (102), Expect = 1e-04
Identities = 11/91 (12%), Positives = 29/91 (31%), Gaps = 6/91 (6%)
Query: 159 CKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLNLSFNKFNGSIPSNT-GNLSSLQGTVDF 217
L +++ L + G +L +L + + + L L+ +
Sbjct: 7 PHGSSGLRCTRDGALDSLHH-L-PGAENLTELYIENQQHLQHLELRDLRGLGELR-NLTI 63
Query: 218 SHNLFSGSIPA-SLGNLPEKVYIDLTYNNLS 247
+ + + P ++L++N L
Sbjct: 64 VKSGLR-FVAPDAFHFTPRLSRLNLSFNALE 93
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 42.4 bits (99), Expect = 3e-04
Identities = 11/85 (12%), Positives = 22/85 (25%), Gaps = 3/85 (3%)
Query: 151 SLPVSIVQCKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLNLSFNKFNGSIPSNT-GNLS 209
+ + L L + L GL L L + + + +
Sbjct: 22 DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAPDAFHFTP 80
Query: 210 SLQGTVDFSHNLFSGSIPASLGNLP 234
L ++ S N ++ L
Sbjct: 81 RLS-RLNLSFNALESLSWKTVQGLS 104
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 4e-06
Identities = 37/125 (29%), Positives = 53/125 (42%), Gaps = 41/125 (32%)
Query: 514 IAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHV--SDFGLARLANIAGGSPTLQSNR 571
I GL +LH K V+ DLK NILL + H+ +DFG+ + N+ G + T
Sbjct: 127 IILGLQFLHS---KGIVYRDLKLDNILLDK--DGHIKIADFGMCKE-NMLGDAKT----- 175
Query: 572 MPAEKPQERQQKSVSLEVT---TTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLE 628
T T + Y APE L K + D +S+GV+L E
Sbjct: 176 -----------------NTFCGTPD--------YIAPEILLGQKYNHSVDWWSFGVLLYE 210
Query: 629 MITGR 633
M+ G+
Sbjct: 211 MLIGQ 215
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 4e-06
Identities = 39/210 (18%), Positives = 64/210 (30%), Gaps = 44/210 (20%)
Query: 77 LGFLPSALGSLTDLRHVNLRNNKF--FGSLPLE--LLEAQGLQSLVLYGNSFS------- 125
L L AL L V L +N F PL L + L+ L L+ N
Sbjct: 83 LRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKI 142
Query: 126 ------GSVPNEIGKLKYLQILDLSQNFFNG----SLPVSIVQCKRLKALDLSQNNFTGP 175
+V + L+ + +N + + L + + QN
Sbjct: 143 ARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPE 202
Query: 176 -LPNGFGSGLV---SLEKLNLSFNKFN--------GSIPSNTGNLSSLQGTVDFSHNLFS 223
+ + GL L+ L+L N F ++ S NL L + L S
Sbjct: 203 GIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWP-NLREL----GLNDCLLS 257
Query: 224 G----SIPASLGNLPEK--VYIDLTYNNLS 247
++ + L + L YN +
Sbjct: 258 ARGAAAVVDAFSKLENIGLQTLRLQYNEIE 287
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 47.8 bits (114), Expect = 7e-06
Identities = 34/184 (18%), Positives = 58/184 (31%), Gaps = 34/184 (18%)
Query: 84 LGSLTDLRHVNLRNNKF----FGSLPLELLEAQGLQSLVLYGNSFSGSVPNEIGKL---- 135
+ + + +L+ + S+ LLE ++ +VL GN+ + +
Sbjct: 1 MARFS-IEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASK 59
Query: 136 KYLQILDLSQNFFN----------GSLPVSIVQCKRLKALDLSQNNFTGPLPNGFGSGL- 184
K L+I + S F L ++++C +L + LS N F L
Sbjct: 60 KDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLS 119
Query: 185 --VSLEKLNLSFNKFNGSIPSNTGNLSSLQGTVDFSHNLFSGSIPASLGNLPEKVYIDLT 242
LE L L N Q + L ++ N P I
Sbjct: 120 KHTPLEHLYLHNNGL------------GPQAGAKIARALQELAVNKKAKNAPPLRSIICG 167
Query: 243 YNNL 246
N L
Sbjct: 168 RNRL 171
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 45.5 bits (108), Expect = 4e-05
Identities = 30/210 (14%), Positives = 56/210 (26%), Gaps = 50/210 (23%)
Query: 82 SALGSLTDLRHVNLRNNKFFGSLPLE-----------LLEAQGLQSLVLYGNSFSGSVPN 130
+ S DL + F G + E LL+ L ++ L N+F +
Sbjct: 54 ENIASKKDLEIAEFSDI-FTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQE 112
Query: 131 EIGKL----KYLQILDLSQN-------------FFNGSLPVSIVQCKRLKALDLSQNNFT 173
+ L+ L L N ++ L+++ +N
Sbjct: 113 PLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLE 172
Query: 174 GPLPNGFGSGLV---SLEKLNLSFNKFN---------GSIPSNTGNLSSLQGTVDFSHNL 221
+ L + + N + L L D N
Sbjct: 173 NGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQ-ELKVL----DLQDNT 227
Query: 222 FSG----SIPASLGNLPEKVYIDLTYNNLS 247
F+ ++ +L + P + L LS
Sbjct: 228 FTHLGSSALAIALKSWPNLRELGLNDCLLS 257
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 41.6 bits (98), Expect = 6e-04
Identities = 29/135 (21%), Positives = 44/135 (32%), Gaps = 19/135 (14%)
Query: 82 SALGSLTDLRHVNLRNNKF--FGSLPL--ELLEA-QGLQSLVLYGNSFSGSVPNEIGK-- 134
S L V + N G L E L Q L+ L L N+F+ + +
Sbjct: 181 KTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIAL 240
Query: 135 --LKYLQILDLSQNFF--NGSLPVS----IVQCKRLKALDLSQNNFTGP----LPNGFGS 182
L+ L L+ G+ V ++ L+ L L N L
Sbjct: 241 KSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDE 300
Query: 183 GLVSLEKLNLSFNKF 197
+ L L L+ N+F
Sbjct: 301 KMPDLLFLELNGNRF 315
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 7e-06
Identities = 37/147 (25%), Positives = 53/147 (36%), Gaps = 35/147 (23%)
Query: 498 SFTPVPWS-VRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLAR 556
F P +R K+ I K + +LH K H DLKP NIL
Sbjct: 111 GFLPFRLDHIR-KMAYQICKSVNFLHSN---KLTHTDLKPENILFVQ------------- 153
Query: 557 LANIAGGSPTLQSNRMPAEKPQERQQKSVSLEV----TTTNSSSNLGSY-----YQAPES 607
P K ER + ++V + T + + Y+APE
Sbjct: 154 --------SDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEHHSTLVSTRHYRAPEV 205
Query: 608 LKVVKPSQKWDIYSYGVILLEMITGRT 634
+ + SQ D++S G IL+E G T
Sbjct: 206 ILALGWSQPCDVWSIGCILIEYYLGFT 232
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 9e-06
Identities = 28/111 (25%), Positives = 49/111 (44%), Gaps = 3/111 (2%)
Query: 86 SLTDLRHVNLRNNKFFGSLPLELLEA-QGLQSLVLYGNSFSGSVPNEIGKLKYLQILDLS 144
+ +D++ + L N++ L + + L+ L + S+ N + KL L+ L+LS
Sbjct: 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SIAN-LPKLNKLKKLELS 72
Query: 145 QNFFNGSLPVSIVQCKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLNLSFN 195
N +G L V +C L L+LS N L +L+ L+L
Sbjct: 73 DNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 40.8 bits (96), Expect = 2e-04
Identities = 23/93 (24%), Positives = 34/93 (36%), Gaps = 16/93 (17%)
Query: 84 LGSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSG-SVPNEIGKLKYLQILD 142
L L L+ + L +N+ G L + + L L L GN S + KL+ L+ LD
Sbjct: 60 LPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLD 119
Query: 143 LSQNFFNGSLPVS---------IVQCKRLKALD 166
L V+ +L LD
Sbjct: 120 LFNC------EVTNLNDYRENVFKLLPQLTYLD 146
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 39.3 bits (92), Expect = 9e-04
Identities = 19/89 (21%), Positives = 33/89 (37%), Gaps = 3/89 (3%)
Query: 159 CKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLNLSFNKFNGSIPSNTGNLSSLQGTVDFS 218
+K L L + G LE L+ SI +N L+ L+ ++ S
Sbjct: 16 PSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SI-ANLPKLNKLK-KLELS 72
Query: 219 HNLFSGSIPASLGNLPEKVYIDLTYNNLS 247
N SG + P +++L+ N +
Sbjct: 73 DNRVSGGLEVLAEKCPNLTHLNLSGNKIK 101
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 1e-05
Identities = 12/39 (30%), Positives = 20/39 (51%), Gaps = 5/39 (12%)
Query: 520 YLHEFSPKKYVHGDLKPSNILLGHNMEPHV--SDFGLAR 556
+LHE +YVHG++ NI + + V + +G A
Sbjct: 174 FLHE---NEYVHGNVTAENIFVDPEDQSQVTLAGYGFAF 209
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 1e-05
Identities = 39/161 (24%), Positives = 62/161 (38%), Gaps = 40/161 (24%)
Query: 498 SFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPH--VSDFGLA 555
+F V ++ K + + L++L +H DLKP NILL + + DF
Sbjct: 150 NFRGVSLNLTRKFAQQMCTALLFLATPELS-IIHCDLKPENILLCNPKRSAIKIVDF--- 205
Query: 556 RLANIAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQ 615
GS R + S +Y++PE L +
Sbjct: 206 -------GSSCQLGQR-----------------IYQYIQS----RFYRSPEVLLGMPYDL 237
Query: 616 KWDIYSYGVILLEMITGRTAVVQVGSSEMDLVNWMQLCIEE 656
D++S G IL+EM TG + G++E+D +N I E
Sbjct: 238 AIDMWSLGCILVEMHTGE--PLFSGANEVDQMN----KIVE 272
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 1e-05
Identities = 37/125 (29%), Positives = 46/125 (36%), Gaps = 41/125 (32%)
Query: 514 IAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHV--SDFGLARLANIAGGSPTLQSNR 571
IA L YLH V+ DLKP NILL + H+ +DFGL + NI S T
Sbjct: 148 IASALGYLHS---LNIVYRDLKPENILLDS--QGHIVLTDFGLCKE-NIEHNSTT----- 196
Query: 572 MPAEKPQERQQKSVSLEVT---TTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLE 628
T T Y APE L + D + G +L E
Sbjct: 197 -----------------STFCGTPE--------YLAPEVLHKQPYDRTVDWWCLGAVLYE 231
Query: 629 MITGR 633
M+ G
Sbjct: 232 MLYGL 236
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 2e-05
Identities = 67/258 (25%), Positives = 100/258 (38%), Gaps = 81/258 (31%)
Query: 402 ELLKASAFVLGKSGIGIVYKVVLEDGHTLAVRRLGEGGSQRF-------KEF-------- 446
ELLK VLG G KV L VR++ + + K
Sbjct: 57 ELLK----VLGTGAYG---KVFL-------VRKISGHDTGKLYAMKVLKKATIVQKAKTT 102
Query: 447 ---QTEVEAIGKIRHSN-IVTLRAYYWSVDEKL-LIYDYIPNGSLATALHGKPGMVSFTP 501
+TE + + IR S +VTL Y + + KL LI DYI G L T L + FT
Sbjct: 103 EHTRTERQVLEHIRQSPFLVTLH-YAFQTETKLHLILDYINGGELFTHLS-QRER--FTE 158
Query: 502 VPWSVRVKI-IKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHV--SDFGLARLA 558
V+I + I L +LH+ ++ D+K NILL + HV +DFGL++
Sbjct: 159 H----EVQIYVGEIVLALEHLHK---LGIIYRDIKLENILL--DSNGHVVLTDFGLSKE- 208
Query: 559 NIAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSY-YQAPESLKVVKP--SQ 615
V+ E G+ Y AP+ ++ +
Sbjct: 209 -------------------------FVADETERAYDF--CGTIEYMAPDIVRGGDSGHDK 241
Query: 616 KWDIYSYGVILLEMITGR 633
D +S GV++ E++TG
Sbjct: 242 AVDWWSLGVLMYELLTGA 259
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 2e-05
Identities = 17/39 (43%), Positives = 26/39 (66%), Gaps = 5/39 (12%)
Query: 520 YLHEFSPKKYVHGDLKPSNILLGHNMEPHV--SDFGLAR 556
Y+HE +YVHGD+K +N+LLG+ V +D+GL+
Sbjct: 166 YIHE---NEYVHGDIKAANLLLGYKNPDQVYLADYGLSY 201
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 46.7 bits (111), Expect = 2e-05
Identities = 18/39 (46%), Positives = 24/39 (61%), Gaps = 5/39 (12%)
Query: 520 YLHEFSPKKYVHGDLKPSNILLGHNMEPHV--SDFGLAR 556
Y+HE +YVHGD+K SN+LL + V D+GLA
Sbjct: 167 YIHE---HEYVHGDIKASNLLLNYKNPDQVYLVDYGLAY 202
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 46.1 bits (110), Expect = 3e-05
Identities = 31/125 (24%), Positives = 49/125 (39%), Gaps = 41/125 (32%)
Query: 514 IAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHV--SDFGLARLANIAGGSPTLQSNR 571
I L YLH + V+ D+K N++L + + H+ +DFGL + I+ G+
Sbjct: 114 IVSALEYLHS---RDVVYRDIKLENLML--DKDGHIKITDFGLCKE-GISDGATM----- 162
Query: 572 MPAEKPQERQQKSVSLEVT---TTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLE 628
T T Y APE L+ + D + GV++ E
Sbjct: 163 -----------------KTFCGTPE--------YLAPEVLEDNDYGRAVDWWGLGVVMYE 197
Query: 629 MITGR 633
M+ GR
Sbjct: 198 MMCGR 202
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 45.7 bits (109), Expect = 3e-05
Identities = 33/125 (26%), Positives = 52/125 (41%), Gaps = 41/125 (32%)
Query: 514 IAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHV--SDFGLARLANIAGGSPTLQSNR 571
IA GL +L K ++ DLK N++L + E H+ +DFG+ + NI G T
Sbjct: 130 IAIGLFFLQS---KGIIYRDLKLDNVML--DSEGHIKIADFGMCKE-NIWDGVTT----- 178
Query: 572 MPAEKPQERQQKSVSLEVT---TTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLE 628
T T + Y APE + + D +++GV+L E
Sbjct: 179 -----------------KTFCGTPD--------YIAPEIIAYQPYGKSVDWWAFGVLLYE 213
Query: 629 MITGR 633
M+ G+
Sbjct: 214 MLAGQ 218
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 3e-05
Identities = 37/138 (26%), Positives = 52/138 (37%), Gaps = 14/138 (10%)
Query: 115 QSLVLYGNSFSGSVPNEIGKLKYLQILDLSQNFFNGSLPVSIVQC-KRLKALDLSQNNFT 173
+ L L + L L L+L N +L + L L L+ N
Sbjct: 38 EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQL-QTLSAGVFDDLTELGTLGLANNQLA 96
Query: 174 GPLPNGFGSGLVSLEKLNLSFNKFNGSIPSNT-GNLSSLQGTVDFSHNLFSGSIPA---- 228
LP G L L+KL L N+ S+PS L+ L+ + + N SIPA
Sbjct: 97 S-LPLGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRLTKLK-ELRLNTNQLQ-SIPAGAFD 152
Query: 229 SLGNLPEKVYIDLTYNNL 246
L NL + L+ N L
Sbjct: 153 KLTNL---QTLSLSTNQL 167
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 4e-05
Identities = 31/178 (17%), Positives = 54/178 (30%), Gaps = 48/178 (26%)
Query: 80 LPSALGSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSGSVPNEIGKLKYLQ 139
+ + L +L +H+ L N +E + L ++ L+
Sbjct: 40 MDATLSTLKACKHLALSTNN------IEKIS--SLS------------------GMENLR 73
Query: 140 ILDLSQNFFNGSLPVSIVQCKRLKALDLSQNNFT--GPLPNGFGSGLVSLEKLNLSFNKF 197
IL L +N + L+ L +S N + LV+L L +S NK
Sbjct: 74 ILSLGRNLIK-KIENLDAVADTLEELWISYNQIASLSGI-----EKLVNLRVLYMSNNKI 127
Query: 198 N--GSIPSNTGNLSSLQGTVDFSHNLFSGSIPAS----------LGNLPEKVYIDLTY 243
G I L L+ + + N + + LP +D
Sbjct: 128 TNWGEI-DKLAALDKLE-DLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLDGMP 183
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 41.6 bits (98), Expect = 3e-04
Identities = 22/120 (18%), Positives = 46/120 (38%), Gaps = 12/120 (10%)
Query: 131 EIGKLKYLQILDLSQNFFN-GSLPVSIVQCKRLKALDLSQNNFT--GPLPNGFGSGLVSL 187
+ + ++L + ++ K K L LS NN L SG+ +L
Sbjct: 18 KSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEKISSL-----SGMENL 72
Query: 188 EKLNLSFNKFNGSIPSNTGNLSSLQGTVDFSHNLFSGSIPASLGNLPEKVYIDLTYNNLS 247
L+L N I + +L+ + S+N + S+ + + L + ++ N ++
Sbjct: 73 RILSLGRNLIK-KIENLDAVADTLE-ELWISYNQIA-SL-SGIEKLVNLRVLYMSNNKIT 128
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 45.3 bits (108), Expect = 5e-05
Identities = 39/167 (23%), Positives = 65/167 (38%), Gaps = 47/167 (28%)
Query: 514 IAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHV--SDFGLARLANIAGGSPTLQSNR 571
I+ L YLHE + ++ DLK N+LL E H+ +D+G+ + + G T
Sbjct: 119 ISLALNYLHE---RGIIYRDLKLDNVLLDS--EGHIKLTDYGMCKE-GLRPGDTT----- 167
Query: 572 MPAEKPQERQQKSVSLEVT---TTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLE 628
T T N Y APE L+ D ++ GV++ E
Sbjct: 168 -----------------STFCGTPN--------YIAPEILRGEDYGFSVDWWALGVLMFE 202
Query: 629 MITGR---TAVVQVGSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDA 672
M+ GR V + + + +++ I EK+ + L+ A
Sbjct: 203 MMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI---RIPRSLSVKA 246
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 5e-05
Identities = 28/133 (21%), Positives = 45/133 (33%), Gaps = 51/133 (38%)
Query: 510 IIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPH--VSDFGLARLANIAG----- 562
++ G++ Y H + H DLK N LL + P + DFG ++ + +
Sbjct: 125 LLSGVS----YCHS---MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST 177
Query: 563 -GSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVK-PSQKWDIY 620
G+P Y APE L + + D++
Sbjct: 178 VGTPA-----------------------------------YIAPEVLLRQEYDGKIADVW 202
Query: 621 SYGVILLEMITGR 633
S GV L M+ G
Sbjct: 203 SCGVTLYVMLVGA 215
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 45.8 bits (108), Expect = 5e-05
Identities = 61/293 (20%), Positives = 106/293 (36%), Gaps = 58/293 (19%)
Query: 352 EGKDENCYAKGGKGRKECLCFRKDESETLSENVEQYDLVPLDTQVAFDLDELLKASAFVL 411
EG + N + R + K E + + ++D ++ L VL
Sbjct: 294 EGSEGNEELRQKFERAKIGQGTKAPEEKTANTISKFDNNGNRDRMKLTDFNFLM----VL 349
Query: 412 GKSGIGIVYKVVLEDGHTL-AVRRLGEGGSQRFKEFQ-TEVEA---IGKIRHSNIVTLRA 466
GK G V + L AV+ L + + + + T VE + + L +
Sbjct: 350 GKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHS 409
Query: 467 YYWSVDEKLLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKG-IAKGLVYLHEFS 525
+ ++D + +Y+ G L + + G F IA GL +L
Sbjct: 410 CFQTMDRLYFVMEYVNGGDLMYHIQ-QVGR--FK----EPHAVFYAAEIAIGLFFLQS-- 460
Query: 526 PKKYVHGDLKPSNILLGHNMEPHV--SDFGLARLANIAGGSPTLQSNRMPAEKPQERQQK 583
K ++ DLK N++L + E H+ +DFG+ + NI G T
Sbjct: 461 -KGIIYRDLKLDNVML--DSEGHIKIADFGMCKE-NIWDGVTT----------------- 499
Query: 584 SVSLEVT---TTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGR 633
T T + Y APE + + D +++GV+L EM+ G+
Sbjct: 500 -----KTFCGTPD--------YIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 539
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594 | Back alignment and structure |
|---|
Score = 45.7 bits (108), Expect = 5e-05
Identities = 23/139 (16%), Positives = 39/139 (28%), Gaps = 6/139 (4%)
Query: 80 LPSALGSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYG------NSFSGSVPNEIG 133
L + +L+ + L L L A L+ L G + +
Sbjct: 203 LERLVTRCPNLKSLKLNRAVPLEKLATLLQRAPQLEELGTGGYTAEVRPDVYSGLSVALS 262
Query: 134 KLKYLQILDLSQNFFNGSLPVSIVQCKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLNLS 193
K L+ L + LP C RL L+LS L++L +
Sbjct: 263 GCKELRCLSGFWDAVPAYLPAVYSVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVL 322
Query: 194 FNKFNGSIPSNTGNLSSLQ 212
+ + L+
Sbjct: 323 DYIEDAGLEVLASTCKDLR 341
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 43.6 bits (103), Expect = 5e-05
Identities = 29/111 (26%), Positives = 42/111 (37%), Gaps = 3/111 (2%)
Query: 86 SLTDLRHVNLRNNKFFGSLPLELLEA-QGLQSLVLYGNSFSGSVPNEIGKLKYLQILDLS 144
+ +R + L N K L L+ L L SV N + KL L+ L+LS
Sbjct: 22 TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-SVSN-LPKLPKLKKLELS 79
Query: 145 QNFFNGSLPVSIVQCKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLNLSFN 195
+N G L + + L L+LS N L L+ L+L
Sbjct: 80 ENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNC 130
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 1e-04
Identities = 21/86 (24%), Positives = 35/86 (40%), Gaps = 3/86 (3%)
Query: 162 LKALDLSQNNFTGPLPNGFGSGLVSLEKLNLSFNKFNGSIPSNTGNLSSLQGTVDFSHNL 221
++ L L G + V+LE L+L S+ SN L L+ ++ S N
Sbjct: 26 VRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-SV-SNLPKLPKLK-KLELSENR 82
Query: 222 FSGSIPASLGNLPEKVYIDLTYNNLS 247
G + LP +++L+ N L
Sbjct: 83 IFGGLDMLAEKLPNLTHLNLSGNKLK 108
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 41.3 bits (97), Expect = 3e-04
Identities = 24/93 (25%), Positives = 34/93 (36%), Gaps = 16/93 (17%)
Query: 84 LGSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSG-SVPNEIGKLKYLQILD 142
L L L+ + L N+ FG L + + L L L GN S + KL+ L+ LD
Sbjct: 67 LPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLD 126
Query: 143 LSQNFFNGSLPVS---------IVQCKRLKALD 166
L V+ +L LD
Sbjct: 127 LFNC------EVTNLNDYRESVFKLLPQLTYLD 153
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 5e-05
Identities = 39/167 (23%), Positives = 66/167 (39%), Gaps = 47/167 (28%)
Query: 514 IAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHV--SDFGLARLANIAGGSPTLQSNR 571
I+ L YLHE + ++ DLK N+LL + E H+ +D+G+ + + G T
Sbjct: 162 ISLALNYLHE---RGIIYRDLKLDNVLL--DSEGHIKLTDYGMCKE-GLRPGDTT----- 210
Query: 572 MPAEKPQERQQKSVSLEVT---TTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLE 628
T T N Y APE L+ D ++ GV++ E
Sbjct: 211 -----------------STFCGTPN--------YIAPEILRGEDYGFSVDWWALGVLMFE 245
Query: 629 MITGR---TAVVQVGSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDA 672
M+ GR V + + + +++ I EK+ + L+ A
Sbjct: 246 MMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI---RIPRSLSVKA 289
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 7e-05
Identities = 23/101 (22%), Positives = 43/101 (42%), Gaps = 6/101 (5%)
Query: 115 QSLVLYGNSFSGSVPNEI-GKLKYLQILDLSQNFFNGSLPVSIV-QCKRLKALDLSQNNF 172
L+L N + + G+L +L L+L +N + + ++ L L +N
Sbjct: 32 TELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLT-GIEPNAFEGASHIQELQLGENKI 90
Query: 173 TGPLPNGFGSGLVSLEKLNLSFNKFNGSIPSNT-GNLSSLQ 212
+ N GL L+ LNL N+ + + + +L+SL
Sbjct: 91 KE-ISNKMFLGLHQLKTLNLYDNQIS-CVMPGSFEHLNSLT 129
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 44.1 bits (105), Expect = 1e-04
Identities = 33/125 (26%), Positives = 50/125 (40%), Gaps = 41/125 (32%)
Query: 514 IAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHV--SDFGLARLANIAGGSPTLQSNR 571
I L++LH+ K ++ DLK N+LL + E H +DFG+ + I G T
Sbjct: 133 IISALMFLHD---KGIIYRDLKLDNVLL--DHEGHCKLADFGMCKE-GICNGVTT----- 181
Query: 572 MPAEKPQERQQKSVSLEVT---TTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLE 628
T T + Y APE L+ + D ++ GV+L E
Sbjct: 182 -----------------ATFCGTPD--------YIAPEILQEMLYGPAVDWWAMGVLLYE 216
Query: 629 MITGR 633
M+ G
Sbjct: 217 MLCGH 221
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 1e-04
Identities = 41/247 (16%), Positives = 80/247 (32%), Gaps = 73/247 (29%)
Query: 410 VLGKSGIGIVYKVV-LEDGHTLAV-----RRLGEGGSQRFKE-FQTEVEAIGKIRHS--N 460
+LG G G VY + + D +A+ R+ + G EV + K+
Sbjct: 50 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 109
Query: 461 IVTLRAYYWSVDEKLLI----------YDYIPNGSLATALHGKPGMVSFTPVPWSVRVKI 510
++ L ++ D +LI +D+I G + +
Sbjct: 110 VIRLLDWFERPDSFVLILERPEPVQDLFDFI-------TERGA--------LQEELARSF 154
Query: 511 IKGIAKGLVYLHEFSPKKYVHGDLKPSNILL-GHNMEPHVSDFGLARLANIAGGSPTLQS 569
+ + + + H +H D+K NIL+ + E + DFG
Sbjct: 155 FWQVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGS--------------G 197
Query: 570 NRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVK---PSQKWDIYSYGVIL 626
+ T + + Y PE ++ + S ++S G++L
Sbjct: 198 ALLKDTV------------YTDFDGTRV----YSPPEWIRYHRYHGRSA--AVWSLGILL 239
Query: 627 LEMITGR 633
+M+ G
Sbjct: 240 YDMVCGD 246
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 44.2 bits (103), Expect = 1e-04
Identities = 19/136 (13%), Positives = 47/136 (34%), Gaps = 19/136 (13%)
Query: 80 LPSALGSLTDLRHVNLRNNKFFGSLPLELLEAQ--GLQSLVLYGNSFSGSVPNEI----- 132
L +L+ + + + S+ ++L + L+ LVLY ++
Sbjct: 185 LSIGKKPRPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRP 244
Query: 133 ----GKLKYLQILDLSQNFFNGSLPVSIVQC---KRLKALDLSQNNFTG----PLPNGFG 181
+ L+ L + + ++ +L+ +D+S T L +
Sbjct: 245 LFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVD 304
Query: 182 SGLVSLEKLNLSFNKF 197
+ L+ +N+ +N
Sbjct: 305 K-IKHLKFINMKYNYL 319
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A Length = 336 | Back alignment and structure |
|---|
Score = 43.7 bits (103), Expect = 1e-04
Identities = 38/158 (24%), Positives = 63/158 (39%), Gaps = 9/158 (5%)
Query: 44 SNWNSSDENPCSWNGITCK---EQRVVSVSIPKKKLLGFLPSALGSLTDLRHVNLRNNKF 100
S W + D + + Q V++ P+ + L ++H++L N+
Sbjct: 47 SLWQTLDLTGKNLHPDVTGRLLSQGVIAFRCPRSFMDQPLAEHFSPFR-VQHMDLSNSVI 105
Query: 101 FGSLPLELLEA-QGLQSLVLYGNSFSGSVPNEIGKLKYLQILDLS--QNFFNGSLPVSIV 157
S +L LQ+L L G S + N + K L L+LS F +L +
Sbjct: 106 EVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLS 165
Query: 158 QCKRLKALDLSQ-NNFT-GPLPNGFGSGLVSLEKLNLS 193
C RL L+LS +FT + ++ +LNLS
Sbjct: 166 SCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLS 203
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 1e-04
Identities = 28/90 (31%), Positives = 37/90 (41%), Gaps = 4/90 (4%)
Query: 115 QSLVLYGNSFSGSVPNEIGKLKYLQILDLSQNFFNGSLPVSIV-QCKRLKALDLSQNNFT 173
L L NS +L L L L N SLP + + L L+LS N
Sbjct: 31 TYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ-SLPNGVFNKLTSLTYLNLSTNQLQ 89
Query: 174 GPLPNGFGSGLVSLEKLNLSFNKFNGSIPS 203
LPNG L L++L L+ N+ S+P
Sbjct: 90 S-LPNGVFDKLTQLKELALNTNQLQ-SLPD 117
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 44.1 bits (103), Expect = 2e-04
Identities = 24/199 (12%), Positives = 54/199 (27%), Gaps = 47/199 (23%)
Query: 7 LFLVLCNFNG-----FVDSLNGEGYALLSFK-QSVHEDPEGSLSNWNSSDENPCSWNGIT 60
LF L + FV+ + Y L ++ P + + +N
Sbjct: 67 LFWTLLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDR--LYNDN- 123
Query: 61 CKEQRVVSVSIPKKKLLGFLPSALGSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLY 120
Q ++ + + ++ LR LLE + +++++
Sbjct: 124 ---QVFAKYNVSRLQP---------------YLKLRQA---------LLELRPAKNVLID 156
Query: 121 GNSFSGSVPNEIGK----LKYLQILDLSQNFFNGSLPVSIVQCKRLKALDLSQNNFTGPL 176
G GS GK L + +++ C + + +
Sbjct: 157 G--VLGS-----GKTWVALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQI 209
Query: 177 PNGFGSGLVSLEKLNLSFN 195
+ S + L +
Sbjct: 210 DPNWTSRSDHSSNIKLRIH 228
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 42.8 bits (101), Expect = 3e-04
Identities = 40/198 (20%), Positives = 73/198 (36%), Gaps = 36/198 (18%)
Query: 82 SALGSLTDLRHVNLRNNKFFGSLPLELLEA-----QGLQSLVLYGNSFSGSVPNEIGKL- 135
+ ++L N + +EL++A + SL L GNS +E+ ++
Sbjct: 16 EFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQIL 75
Query: 136 ----KYLQILDLSQNFFNGSLPVSIVQ-----CKRLKALDLSQNNFTG----PLPNGFGS 182
+ L+LS NF + +V+ + LDL N+F+ F +
Sbjct: 76 AAIPANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSN 135
Query: 183 GLVSLEKLNLSFNKFN--------GSIPSNTGNLSSLQGTVDFSHNLFS----GSIPASL 230
S+ LNL N + + N++SL + N + + L
Sbjct: 136 LPASITSLNLRGNDLGIKSSDELIQILAAIPANVNSL----NLRGNNLASKNCAELAKFL 191
Query: 231 GNLPEKV-YIDLTYNNLS 247
++P V +DL+ N L
Sbjct: 192 ASIPASVTSLDLSANLLG 209
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 3e-04
Identities = 14/42 (33%), Positives = 21/42 (50%), Gaps = 8/42 (19%)
Query: 520 YLHEFSPKKYVHGDLKPSNILLGHNMEP-----HVSDFGLAR 556
Y+H K ++ D+KP N L+G H+ DF LA+
Sbjct: 120 YVHS---KNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 41.1 bits (97), Expect = 4e-04
Identities = 33/100 (33%), Positives = 42/100 (42%), Gaps = 5/100 (5%)
Query: 115 QSLVLYGNSFSGSVPNEIGKLKYLQILDLSQNFFNGSLPVSIV-QCKRLKALDLSQNNFT 173
L L N KL L L LSQN SLP + + +L L L +N
Sbjct: 31 TRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQ-SLPDGVFDKLTKLTILYLHENKLQ 89
Query: 174 GPLPNGFGSGLVSLEKLNLSFNKFNGSIPSNT-GNLSSLQ 212
LPNG L L++L L N+ S+P L+SLQ
Sbjct: 90 S-LPNGVFDKLTQLKELALDTNQLK-SVPDGIFDRLTSLQ 127
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 5e-04
Identities = 21/124 (16%), Positives = 39/124 (31%), Gaps = 39/124 (31%)
Query: 514 IAKGLVYLHEFSPKKYVHGDLKPSNILL-GHNMEPHVSDFGLARLANIAGGSPTLQSNRM 572
+ + + H + VH D+K NIL+ + DFG + P
Sbjct: 148 VVAAIQHCHS---RGVVHRDIKDENILIDLRRGCAKLIDFG---SGALLHDEP------- 194
Query: 573 PAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVK---PSQKWDIYSYGVILLEM 629
T + + Y PE + + ++S G++L +M
Sbjct: 195 ----------------YTDFDGTRV----YSPPEWISRHQYHALPA--TVWSLGILLYDM 232
Query: 630 ITGR 633
+ G
Sbjct: 233 VCGD 236
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 714 | |||
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 99.97 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.97 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 99.97 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 99.97 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 99.97 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.96 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.93 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.93 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.92 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.92 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.92 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.91 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.91 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 99.9 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.9 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.9 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.9 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 99.89 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.89 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.89 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.89 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 99.89 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 99.89 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.88 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.88 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.88 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.88 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 99.88 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.88 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 99.87 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 99.87 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 99.87 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 99.87 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.87 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.87 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 99.87 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 99.87 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.87 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 99.86 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 99.86 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.86 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 99.86 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.86 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.86 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.86 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.86 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 99.85 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 99.85 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 99.85 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 99.85 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 99.84 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 99.84 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 99.84 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 99.84 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.84 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.84 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 99.84 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.83 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 99.83 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 99.83 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.83 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.83 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 99.82 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.82 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.82 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.82 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.82 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 99.81 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 99.81 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.81 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.81 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.81 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 99.81 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.81 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.81 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.8 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.8 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.79 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.79 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.79 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.79 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.79 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.79 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 99.79 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.79 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.78 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.77 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.77 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.77 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 99.76 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 99.75 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 99.75 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.75 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 99.75 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.75 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 99.74 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.74 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.74 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 99.73 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 99.73 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.73 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.73 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.72 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.71 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.71 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 99.71 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.71 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.7 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 99.7 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.69 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.69 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.69 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.69 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.69 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.67 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.67 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.67 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.67 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.66 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.66 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.64 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.63 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.62 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.62 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.62 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.62 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.61 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.58 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.56 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.55 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 99.54 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.53 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.52 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 99.51 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.51 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.48 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.46 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.46 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.46 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.3 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 99.3 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.23 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 99.22 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 99.19 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 99.18 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 99.16 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.16 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 99.12 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.0 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 98.94 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.89 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 98.87 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.86 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 98.86 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 98.84 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 98.82 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 98.62 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.61 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.51 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.47 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.43 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.38 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.35 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.29 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.27 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.26 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.9 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.87 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.61 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.58 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.54 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 97.44 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 97.43 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 97.39 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 97.28 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.27 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 97.19 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 97.18 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.14 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.1 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.05 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.05 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 97.02 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 97.01 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.98 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.97 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 96.92 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 96.83 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 96.8 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.71 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 96.69 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.63 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.3 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 95.87 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 95.25 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 90.39 | |
| 2k1k_A | 38 | Ephrin type-A receptor 1; EPHA1, receptor tyrosine | 89.26 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 88.53 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 84.06 |
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-54 Score=453.22 Aligned_cols=258 Identities=23% Similarity=0.375 Sum_probs=204.5
Q ss_pred ccccccCceEEEEEEEC------CCcEEEEEEeCCCCchhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccC
Q 005102 409 FVLGKSGIGIVYKVVLE------DGHTLAVRRLGEGGSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIP 482 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~ 482 (714)
+.||+|+||+||+|+++ +++.||||+++.......++|.+|+++|++++|||||+++|+|.+.+..++|||||+
T Consensus 47 ~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~Ey~~ 126 (329)
T 4aoj_A 47 WELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMR 126 (329)
T ss_dssp EEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred EEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCC
Confidence 47999999999999875 478999999988777777889999999999999999999999999999999999999
Q ss_pred CCCHhhhhhCCCCC---------CCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccc
Q 005102 483 NGSLATALHGKPGM---------VSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFG 553 (714)
Q Consensus 483 ~gsL~~~l~~~~~~---------~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFG 553 (714)
+|+|.++++..... ....+++|.++++|+.|||+||+|||+ ++||||||||+|||+++++++||+|||
T Consensus 127 ~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDLKp~NILl~~~~~~Ki~DFG 203 (329)
T 4aoj_A 127 HGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAG---LHFVHRDLATRNCLVGQGLVVKIGDFG 203 (329)
T ss_dssp TCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTTEEEECCCC
T ss_pred CCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhc---CCeecccccHhhEEECCCCcEEEcccc
Confidence 99999999765321 112469999999999999999999999 899999999999999999999999999
Q ss_pred hhhhhhccCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHh-C
Q 005102 554 LARLANIAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMIT-G 632 (714)
Q Consensus 554 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~ellt-G 632 (714)
+|+....... ........||+.|||||++.+..++.++|||||||++|||+| |
T Consensus 204 la~~~~~~~~--------------------------~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G 257 (329)
T 4aoj_A 204 MSRDIYSTDY--------------------------YRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYG 257 (329)
T ss_dssp ------------------------------------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTS
T ss_pred cceeccCCCc--------------------------ceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCC
Confidence 9986543211 112234568999999999999999999999999999999999 8
Q ss_pred CCccccCCCCcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhhhhcc
Q 005102 633 RTAVVQVGSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDALDRLIVS 712 (714)
Q Consensus 633 ~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~~ 712 (714)
+.||.... .. +.+........ +..+.. ...++.+|+.+||+.||++||||+||++.|+++...
T Consensus 258 ~~Pf~~~~--~~---~~~~~i~~g~~-------~~~p~~-----~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~ 320 (329)
T 4aoj_A 258 KQPWYQLS--NT---EAIDCITQGRE-------LERPRA-----CPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA 320 (329)
T ss_dssp CCTTCSSC--HH---HHHHHHHHTCC-------CCCCTT-----CCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred CCCCCCCC--HH---HHHHHHHcCCC-------CCCccc-----ccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhC
Confidence 99995432 22 22222222211 111111 223688999999999999999999999999998754
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-55 Score=450.98 Aligned_cols=259 Identities=24% Similarity=0.367 Sum_probs=208.6
Q ss_pred cccccccCceEEEEEEEC------CCcEEEEEEeCCCCchhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEecc
Q 005102 408 AFVLGKSGIGIVYKVVLE------DGHTLAVRRLGEGGSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYI 481 (714)
Q Consensus 408 ~~~lG~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~ 481 (714)
.+.||+|+||+||+|++. ++..||||+++.......++|.+|+++|++++|||||+++|+|.+.+..++|||||
T Consensus 18 ~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~Ey~ 97 (299)
T 4asz_A 18 KRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYM 97 (299)
T ss_dssp EEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred eeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEEEcC
Confidence 357999999999999874 47889999998877666788999999999999999999999999999999999999
Q ss_pred CCCCHhhhhhCCCC-------CCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccch
Q 005102 482 PNGSLATALHGKPG-------MVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGL 554 (714)
Q Consensus 482 ~~gsL~~~l~~~~~-------~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGl 554 (714)
++|+|.++|+.... ......++|.++++|+.|||+||+|||+ ++||||||||+|||+++++++||+|||+
T Consensus 98 ~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDlKp~NILl~~~~~~Ki~DFGl 174 (299)
T 4asz_A 98 KHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLAS---QHFVHRDLATRNCLVGENLLVKIGDFGM 174 (299)
T ss_dssp TTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCSC
T ss_pred CCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCccCHhhEEECCCCcEEECCccc
Confidence 99999999975420 1112469999999999999999999999 8999999999999999999999999999
Q ss_pred hhhhhccCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHh-CC
Q 005102 555 ARLANIAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMIT-GR 633 (714)
Q Consensus 555 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~ellt-G~ 633 (714)
|+....... ........||+.|||||++.+..|+.++|||||||++|||+| |+
T Consensus 175 a~~~~~~~~--------------------------~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~ 228 (299)
T 4asz_A 175 SRDVYSTDY--------------------------YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGK 228 (299)
T ss_dssp HHHHTGGGC--------------------------EEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTC
T ss_pred ceecCCCCc--------------------------eeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCC
Confidence 987643211 112223457889999999999999999999999999999999 89
Q ss_pred CccccCCCCcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhhhhcc
Q 005102 634 TAVVQVGSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDALDRLIVS 712 (714)
Q Consensus 634 ~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~~ 712 (714)
.||.... .. +.+........ +..+.. ...++.+++.+||+.||++||||+||++.|+++..+
T Consensus 229 ~Pf~~~~--~~---~~~~~i~~~~~-------~~~p~~-----~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~ 290 (299)
T 4asz_A 229 QPWYQLS--NN---EVIECITQGRV-------LQRPRT-----CPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKA 290 (299)
T ss_dssp CTTTTSC--HH---HHHHHHHHTCC-------CCCCTT-----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCCCC--HH---HHHHHHHcCCC-------CCCCcc-----chHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence 9995432 22 22222222211 111111 223688999999999999999999999999998654
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-54 Score=449.57 Aligned_cols=257 Identities=26% Similarity=0.345 Sum_probs=206.5
Q ss_pred ccccccCceEEEEEEEC------CCcEEEEEEeCCCC-chhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEecc
Q 005102 409 FVLGKSGIGIVYKVVLE------DGHTLAVRRLGEGG-SQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYI 481 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~------~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~ 481 (714)
+.||+|+||+||+|++. +++.||||+++... ....++|.+|+.+|++++|||||+++|+|.+.+..++|||||
T Consensus 32 ~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~lV~Ey~ 111 (308)
T 4gt4_A 32 EELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYC 111 (308)
T ss_dssp EEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred eEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEEEEEcC
Confidence 47999999999999973 46899999997653 334578999999999999999999999999999999999999
Q ss_pred CCCCHhhhhhCCCCC----------CCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcc
Q 005102 482 PNGSLATALHGKPGM----------VSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSD 551 (714)
Q Consensus 482 ~~gsL~~~l~~~~~~----------~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~D 551 (714)
++|||.++|...... .....++|.++++|+.|||+||+|||+ ++||||||||+|||+++++++||+|
T Consensus 112 ~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDLK~~NILl~~~~~~Ki~D 188 (308)
T 4gt4_A 112 SHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSS---HHVVHKDLATRNVLVYDKLNVKISD 188 (308)
T ss_dssp SSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECC
T ss_pred CCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh---CCCCCCCccccceEECCCCCEEECC
Confidence 999999999754311 112468999999999999999999999 8999999999999999999999999
Q ss_pred cchhhhhhccCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHh
Q 005102 552 FGLARLANIAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMIT 631 (714)
Q Consensus 552 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~ellt 631 (714)
||+|+....... ........||+.|||||++.++.|+.++|||||||++|||+|
T Consensus 189 FGlar~~~~~~~--------------------------~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t 242 (308)
T 4gt4_A 189 LGLFREVYAADY--------------------------YKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 242 (308)
T ss_dssp SCCBCGGGGGGC--------------------------BCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHT
T ss_pred cccceeccCCCc--------------------------eeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHh
Confidence 999987643211 112334567999999999999999999999999999999999
Q ss_pred -CCCccccCCCCcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhhhh
Q 005102 632 -GRTAVVQVGSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDALDRLI 710 (714)
Q Consensus 632 -G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~ 710 (714)
|+.||.... ..++. .... .+... + .+. .+...+.+++.+||+.||++||||+||++.|++..
T Consensus 243 ~g~~Pf~~~~--~~~~~---~~i~-~~~~~-----~-~p~-----~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~~ 305 (308)
T 4gt4_A 243 YGLQPYCGYS--NQDVV---EMIR-NRQVL-----P-CPD-----DCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAWG 305 (308)
T ss_dssp TTCCTTTTCC--HHHHH---HHHH-TTCCC-----C-CCT-----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred CCCCCCCCCC--HHHHH---HHHH-cCCCC-----C-Ccc-----cchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhcc
Confidence 899995332 22222 2222 22111 1 111 12346889999999999999999999999999864
Q ss_pred c
Q 005102 711 V 711 (714)
Q Consensus 711 ~ 711 (714)
.
T Consensus 306 n 306 (308)
T 4gt4_A 306 N 306 (308)
T ss_dssp C
T ss_pred C
Confidence 3
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-54 Score=443.52 Aligned_cols=256 Identities=26% Similarity=0.418 Sum_probs=199.7
Q ss_pred cccccccCceEEEEEEECCCcEEEEEEeCCC--CchhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCCC
Q 005102 408 AFVLGKSGIGIVYKVVLEDGHTLAVRRLGEG--GSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGS 485 (714)
Q Consensus 408 ~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gs 485 (714)
.+.||+|+||+||+|++++ .||||+++.. .....+.|.+|+++|++++|||||+++|++. .+..++|||||++|+
T Consensus 41 ~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~-~~~~~iVmEy~~gGs 117 (307)
T 3omv_A 41 STRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMT-KDNLAIVTQWCEGSS 117 (307)
T ss_dssp EEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEEECCSSCB
T ss_pred eeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE-CCeEEEEEEcCCCCC
Confidence 3579999999999999753 6999998754 3344578999999999999999999999885 467899999999999
Q ss_pred HhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCCC
Q 005102 486 LATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSP 565 (714)
Q Consensus 486 L~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 565 (714)
|.++|+... .+++|.++++|+.|||+||+|||+ ++||||||||+|||+++++++||+|||+|+.......
T Consensus 118 L~~~l~~~~-----~~l~~~~~~~i~~qia~gL~yLH~---~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~-- 187 (307)
T 3omv_A 118 LYKHLHVQE-----TKFQMFQLIDIARQTAQGMDYLHA---KNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSG-- 187 (307)
T ss_dssp HHHHHHTSC-----CCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCCSSSEEEETTEEEEECCCSSCBC--------
T ss_pred HHHHHhhcC-----CCCCHHHHHHHHHHHHHHHHHHHH---CCccCCccCHHHEEECCCCcEEEeeccCceecccCCc--
Confidence 999997654 459999999999999999999999 8999999999999999999999999999986542211
Q ss_pred CccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCC---CCCCchhhhHHHHHHHHHHHhCCCccccCCCC
Q 005102 566 TLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKV---VKPSQKWDIYSYGVILLEMITGRTAVVQVGSS 642 (714)
Q Consensus 566 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~s~~~DVwS~Gvvl~elltG~~p~~~~~~~ 642 (714)
........||+.|||||++.+ .+|+.++|||||||++|||+||+.||.....
T Consensus 188 ------------------------~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~- 242 (307)
T 3omv_A 188 ------------------------SQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINN- 242 (307)
T ss_dssp ------------------------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCC-
T ss_pred ------------------------ceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCCh-
Confidence 112334568999999999853 4689999999999999999999999953321
Q ss_pred cchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhhhhcc
Q 005102 643 EMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDALDRLIVS 712 (714)
Q Consensus 643 ~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~~ 712 (714)
. ..+...+..... .|...... ......+.+++.+||+.||++||||+||++.|+.+..+
T Consensus 243 -~---~~~~~~~~~~~~-----~p~~~~~~--~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~ 301 (307)
T 3omv_A 243 -R---DQIIFMVGRGYA-----SPDLSKLY--KNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHS 301 (307)
T ss_dssp -H---HHHHHHHHTTCC-----CCCSTTSC--TTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTT
T ss_pred -H---HHHHHHHhcCCC-----CCCccccc--ccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcc
Confidence 1 112222222211 11111100 11234688999999999999999999999999988654
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-53 Score=438.50 Aligned_cols=267 Identities=24% Similarity=0.251 Sum_probs=200.5
Q ss_pred ccccccCceEEEEEEECCCcEEEEEEeCCCCchhHHHHHHHHHHHhccCCCCccceEEEEEeCC----ceeEEEeccCCC
Q 005102 409 FVLGKSGIGIVYKVVLEDGHTLAVRRLGEGGSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVD----EKLLIYDYIPNG 484 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~----~~~lV~e~~~~g 484 (714)
+.||+|+||+||+|++ +|+.||||++...... ...++.|+..+.+++|||||+++|+|...+ ..|+|||||++|
T Consensus 9 ~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~~-~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~Ey~~~g 86 (303)
T 3hmm_A 9 ESIGKGRFGEVWRGKW-RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHG 86 (303)
T ss_dssp EEEEECSSSEEEEEEE-TTEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTC
T ss_pred EEEeeCCCeEEEEEEE-CCEEEEEEEECccchh-hHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEecCCCCC
Confidence 5799999999999998 5899999999764322 223445667778899999999999998754 469999999999
Q ss_pred CHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCC-----CCCceecCCCCCCeeeCCCCCeEEcccchhhhhh
Q 005102 485 SLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFS-----PKKYVHGDLKPSNILLGHNMEPHVSDFGLARLAN 559 (714)
Q Consensus 485 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~-----~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~ 559 (714)
+|.++++.. .++|..+.+|+.|+|+||+|||+.. .++||||||||+|||+|+++++||+|||+|+...
T Consensus 87 sL~~~l~~~-------~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~ 159 (303)
T 3hmm_A 87 SLFDYLNRY-------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHD 159 (303)
T ss_dssp BHHHHHHHC-------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEEE
T ss_pred cHHHHHHhC-------CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCcccc
Confidence 999999753 4899999999999999999999821 1389999999999999999999999999998754
Q ss_pred ccCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCC------CCCchhhhHHHHHHHHHHHhCC
Q 005102 560 IAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVV------KPSQKWDIYSYGVILLEMITGR 633 (714)
Q Consensus 560 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~s~~~DVwS~Gvvl~elltG~ 633 (714)
.... ..........||+.|||||++.+. .++.++|||||||++|||+||+
T Consensus 160 ~~~~------------------------~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~ 215 (303)
T 3hmm_A 160 SATD------------------------TIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRC 215 (303)
T ss_dssp TTTT------------------------EESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTB
T ss_pred CCCC------------------------ceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCC
Confidence 3211 011223345789999999999764 3678999999999999999998
Q ss_pred CccccCCCCcc---------hhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 005102 634 TAVVQVGSSEM---------DLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISD 704 (714)
Q Consensus 634 ~p~~~~~~~~~---------~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 704 (714)
.||........ ...+.+...... +..+|.++......+....+.+++.+||+.||++||||+||++
T Consensus 216 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~-----~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~ 290 (303)
T 3hmm_A 216 SIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCE-----QKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 290 (303)
T ss_dssp CBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTT-----SCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHH
T ss_pred CCCCccccccccchhcccccchHHHHHHHHhc-----ccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHH
Confidence 87732221111 011112111111 1223433333333456678899999999999999999999999
Q ss_pred HHhhhhccC
Q 005102 705 ALDRLIVSS 713 (714)
Q Consensus 705 ~L~~i~~~~ 713 (714)
.|+++....
T Consensus 291 ~L~~l~~~~ 299 (303)
T 3hmm_A 291 TLSQLSQQE 299 (303)
T ss_dssp HHHHHHHC-
T ss_pred HHHHHHHHc
Confidence 999987654
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-52 Score=435.82 Aligned_cols=251 Identities=20% Similarity=0.230 Sum_probs=201.2
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeCCCCchhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCCCHh
Q 005102 409 FVLGKSGIGIVYKVVLE-DGHTLAVRRLGEGGSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGSLA 487 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL~ 487 (714)
+.||+|+||+||+|+++ +|+.||||+++.... +.+|+.+|++++|||||++++++.+.+..|+|||||++|+|.
T Consensus 64 ~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L~ 138 (336)
T 4g3f_A 64 PRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLG 138 (336)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCCTTCBHH
T ss_pred cEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCCCcHH
Confidence 47999999999999986 489999999976432 247999999999999999999999999999999999999999
Q ss_pred hhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCC-CeEEcccchhhhhhccCCCCC
Q 005102 488 TALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNM-EPHVSDFGLARLANIAGGSPT 566 (714)
Q Consensus 488 ~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~-~~kl~DFGla~~~~~~~~~~~ 566 (714)
++++.. ..+++.++..|+.||+.||+|||+ ++||||||||+|||++.++ ++||+|||+|+.+.......
T Consensus 139 ~~l~~~------~~l~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~- 208 (336)
T 4g3f_A 139 QLIKQM------GCLPEDRALYYLGQALEGLEYLHT---RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGK- 208 (336)
T ss_dssp HHHHHH------SSCCHHHHHHHHHHHHHHHHHHHT---TTEECSCCCGGGEEECTTSCCEEECCCTTCEEC--------
T ss_pred HHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCccc-
Confidence 999765 469999999999999999999999 9999999999999999987 69999999998764321100
Q ss_pred ccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCccccCCCCcchh
Q 005102 567 LQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGSSEMDL 646 (714)
Q Consensus 567 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~~~~~~~~~~l 646 (714)
.........||+.|||||++.+..|+.++|||||||++|||+||+.||....... +
T Consensus 209 ----------------------~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~--~ 264 (336)
T 4g3f_A 209 ----------------------SLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGP--L 264 (336)
T ss_dssp ---------------------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSC--C
T ss_pred ----------------------ceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHH--H
Confidence 0112334578999999999999999999999999999999999999995433222 2
Q ss_pred HHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhhhhc
Q 005102 647 VNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDALDRLIV 711 (714)
Q Consensus 647 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~ 711 (714)
. ........+..+ +.+.. ...+.+++.+||+.||++|||++|+++.|.....
T Consensus 265 ~---~~i~~~~~~~~~-----~~~~~-----s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~ 316 (336)
T 4g3f_A 265 C---LKIASEPPPIRE-----IPPSC-----APLTAQAIQEGLRKEPVHRASAMELRRKVGKALQ 316 (336)
T ss_dssp H---HHHHHSCCGGGG-----SCTTS-----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred H---HHHHcCCCCchh-----cCccC-----CHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence 2 122222221111 11111 2357899999999999999999999999887653
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-52 Score=440.00 Aligned_cols=243 Identities=21% Similarity=0.337 Sum_probs=201.1
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeCCCCchhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCCCHh
Q 005102 409 FVLGKSGIGIVYKVVLE-DGHTLAVRRLGEGGSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGSLA 487 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL~ 487 (714)
+.||+|+||+||+|+++ +|+.||||++........+.+.+|+++|++++|||||+++++|.+.+..|||||||++|+|.
T Consensus 80 ~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L~ 159 (346)
T 4fih_A 80 IKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT 159 (346)
T ss_dssp EEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCCTTEEHH
T ss_pred EEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCCCCCcHH
Confidence 46999999999999986 59999999997665555567899999999999999999999999999999999999999999
Q ss_pred hhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCCCCc
Q 005102 488 TALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTL 567 (714)
Q Consensus 488 ~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 567 (714)
+++... .+++.++..|+.||+.||+|||+ ++||||||||+|||++.++++||+|||+|+.+...
T Consensus 160 ~~l~~~-------~l~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~------ 223 (346)
T 4fih_A 160 DIVTHT-------RMNEEQIAAVCLAVLQALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE------ 223 (346)
T ss_dssp HHHHHS-------CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSS------
T ss_pred HHHHcC-------CCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEECCCCCEEEecCcCceecCCC------
Confidence 999643 48999999999999999999999 99999999999999999999999999999865321
Q ss_pred cCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCccccCCCCcchhH
Q 005102 568 QSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGSSEMDLV 647 (714)
Q Consensus 568 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~~~~~~~~~~l~ 647 (714)
........||+.|||||++.+..|+.++|||||||++|||++|+.||... .. .
T Consensus 224 ----------------------~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~--~~---~ 276 (346)
T 4fih_A 224 ----------------------VPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE--PP---L 276 (346)
T ss_dssp ----------------------SCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTS--CH---H
T ss_pred ----------------------CCcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc--CH---H
Confidence 11234567899999999999999999999999999999999999999432 12 2
Q ss_pred HHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 005102 648 NWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISD 704 (714)
Q Consensus 648 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 704 (714)
+.+........ +.... ......++.+|+.+||+.||++|||++|+++
T Consensus 277 ~~~~~i~~~~~-------~~~~~---~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~ 323 (346)
T 4fih_A 277 KAMKMIRDNLP-------PRLKN---LHKVSPSLKGFLDRLLVRDPAQRATAAELLK 323 (346)
T ss_dssp HHHHHHHHSSC-------CCCSC---GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred HHHHHHHcCCC-------CCCCc---cccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 22222222211 11110 1112236789999999999999999999875
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-52 Score=438.00 Aligned_cols=244 Identities=22% Similarity=0.337 Sum_probs=195.6
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeCCC--CchhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCCC
Q 005102 409 FVLGKSGIGIVYKVVLE-DGHTLAVRRLGEG--GSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGS 485 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gs 485 (714)
+.||+|+||+||+|++. +|+.||||++... .....+.|.+|+++|++++|||||++++++.+.+..|+|||||++|+
T Consensus 30 ~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmEy~~gg~ 109 (350)
T 4b9d_A 30 QKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGD 109 (350)
T ss_dssp EEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCB
T ss_pred EEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEeCCCCCc
Confidence 47999999999999975 5999999999764 33345689999999999999999999999999999999999999999
Q ss_pred HhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCCC
Q 005102 486 LATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSP 565 (714)
Q Consensus 486 L~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 565 (714)
|.+++....+ ..+++.+++.|+.||+.||+|||+ ++||||||||+|||+++++.+||+|||+|+.....
T Consensus 110 L~~~i~~~~~----~~~~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~---- 178 (350)
T 4b9d_A 110 LFKRINAQKG----VLFQEDQILDWFVQICLALKHVHD---RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST---- 178 (350)
T ss_dssp HHHHHHHTTT----CCCCHHHHHHHHHHHHHHHHHHHH---TTCEETTCCGGGEEECTTCCEEECSTTEESCCCHH----
T ss_pred HHHHHHHcCC----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHHHEEECCCCCEEEcccccceeecCC----
Confidence 9999975532 357899999999999999999999 99999999999999999999999999999865321
Q ss_pred CccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCccccCCCCcch
Q 005102 566 TLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGSSEMD 645 (714)
Q Consensus 566 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~~~~~~~~~~ 645 (714)
........||+.|||||++.+..|+.++|||||||++|||+||+.||... .
T Consensus 179 ------------------------~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~-----~ 229 (350)
T 4b9d_A 179 ------------------------VELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAG-----S 229 (350)
T ss_dssp ------------------------HHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCS-----S
T ss_pred ------------------------cccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc-----C
Confidence 01112345899999999999999999999999999999999999999432 2
Q ss_pred hHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 005102 646 LVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISD 704 (714)
Q Consensus 646 l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 704 (714)
..+.+........+ ..... ...++.+|+.+||+.||++|||++|+++
T Consensus 230 ~~~~~~~i~~~~~~-------~~~~~-----~s~~~~~li~~~L~~dP~~R~s~~e~l~ 276 (350)
T 4b9d_A 230 MKNLVLKIISGSFP-------PVSLH-----YSYDLRSLVSQLFKRNPRDRPSVNSILE 276 (350)
T ss_dssp HHHHHHHHHHTCCC-------CCCTT-----SCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHHHHHHcCCCC-------CCCcc-----CCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 23333333333221 11111 1235789999999999999999999975
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-52 Score=429.51 Aligned_cols=241 Identities=22% Similarity=0.330 Sum_probs=192.0
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeCCC--CchhHHHHHHHHHHHhccCCCCccceEEEEEe----CCceeEEEecc
Q 005102 409 FVLGKSGIGIVYKVVLE-DGHTLAVRRLGEG--GSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWS----VDEKLLIYDYI 481 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~----~~~~~lV~e~~ 481 (714)
+.||+|+||+||+|.+. ++..||||++... .....+.|.+|+++|++++|||||+++++|.+ .+..|+|||||
T Consensus 32 ~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvmEy~ 111 (290)
T 3fpq_A 32 IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELM 111 (290)
T ss_dssp EEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEEECC
T ss_pred eEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEEeCC
Confidence 36999999999999986 4899999999754 33345679999999999999999999999875 34579999999
Q ss_pred CCCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCC--ceecCCCCCCeeeCC-CCCeEEcccchhhhh
Q 005102 482 PNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKK--YVHGDLKPSNILLGH-NMEPHVSDFGLARLA 558 (714)
Q Consensus 482 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~--ivHrDlkp~NILl~~-~~~~kl~DFGla~~~ 558 (714)
++|+|.+++... ..+++..+..|+.||+.||+|||+ ++ ||||||||+|||++. ++.+||+|||+|+..
T Consensus 112 ~gg~L~~~l~~~------~~l~~~~~~~~~~qi~~aL~ylH~---~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~ 182 (290)
T 3fpq_A 112 TSGTLKTYLKRF------KVMKIKVLRSWCRQILKGLQFLHT---RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK 182 (290)
T ss_dssp CSCBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHT---SSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred CCCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCCCEEecccChhheeEECCCCCEEEEeCcCCEeC
Confidence 999999999765 468999999999999999999999 66 999999999999984 799999999999853
Q ss_pred hccCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCcccc
Q 005102 559 NIAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQ 638 (714)
Q Consensus 559 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~~~ 638 (714)
.. .......||+.|||||++.+ +|+.++|||||||++|||+||+.||..
T Consensus 183 ~~------------------------------~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~ 231 (290)
T 3fpq_A 183 RA------------------------------SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSE 231 (290)
T ss_dssp CT------------------------------TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred CC------------------------------CccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 21 11223568999999999864 699999999999999999999999953
Q ss_pred CCCCcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 005102 639 VGSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISD 704 (714)
Q Consensus 639 ~~~~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 704 (714)
... ....... +..... ....++ . ...++.+++.+||+.||++|||++|+++
T Consensus 232 ~~~----~~~~~~~-i~~~~~-~~~~~~----~-----~~~~~~~li~~~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 232 CQN----AAQIYRR-VTSGVK-PASFDK----V-----AIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp CSS----HHHHHHH-HTTTCC-CGGGGG----C-----CCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCc----HHHHHHH-HHcCCC-CCCCCc----c-----CCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 221 1122222 222111 111111 1 1125789999999999999999999875
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-52 Score=429.54 Aligned_cols=243 Identities=19% Similarity=0.238 Sum_probs=201.9
Q ss_pred cccccccCceEEEEEEEC-CCcEEEEEEeCCC---CchhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCC
Q 005102 408 AFVLGKSGIGIVYKVVLE-DGHTLAVRRLGEG---GSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPN 483 (714)
Q Consensus 408 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~ 483 (714)
.+.||+|+||+||+|+++ +|+.||||++.+. .....+.+.+|+++|++++|||||++++++.+.+..|+||||+++
T Consensus 37 ~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivmEy~~g 116 (311)
T 4aw0_A 37 GKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKN 116 (311)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCTT
T ss_pred EEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecCCC
Confidence 358999999999999975 5899999999753 233457899999999999999999999999999999999999999
Q ss_pred CCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCC
Q 005102 484 GSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGG 563 (714)
Q Consensus 484 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 563 (714)
|+|.+++... ..+++.++..|+.||+.||+|||+ ++|+||||||+|||+++++.+||+|||+|+.+.....
T Consensus 117 G~L~~~i~~~------~~l~e~~~~~~~~qi~~al~ylH~---~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~ 187 (311)
T 4aw0_A 117 GELLKYIRKI------GSFDETCTRFYTAEIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK 187 (311)
T ss_dssp EEHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTT
T ss_pred CCHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCC
Confidence 9999999765 469999999999999999999999 9999999999999999999999999999987642211
Q ss_pred CCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCccccCCCCc
Q 005102 564 SPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGSSE 643 (714)
Q Consensus 564 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~~~~~~~~ 643 (714)
.....+..||+.|||||++.+..|+.++||||+||++|||+||+.||...
T Consensus 188 --------------------------~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~---- 237 (311)
T 4aw0_A 188 --------------------------QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAG---- 237 (311)
T ss_dssp --------------------------CCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCS----
T ss_pred --------------------------cccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC----
Confidence 12234567999999999999999999999999999999999999999432
Q ss_pred chhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHH
Q 005102 644 MDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHIS 703 (714)
Q Consensus 644 ~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl 703 (714)
+..+.+.........+ +... ..++.+++.+||+.||++|||++|++
T Consensus 238 -~~~~~~~~i~~~~~~~--------p~~~-----s~~~~dli~~lL~~dp~~R~t~~e~~ 283 (311)
T 4aw0_A 238 -NEGLIFAKIIKLEYDF--------PEKF-----FPKARDLVEKLLVLDATKRLGCEEME 283 (311)
T ss_dssp -SHHHHHHHHHHTCCCC--------CTTC-----CHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred -CHHHHHHHHHcCCCCC--------Cccc-----CHHHHHHHHHHccCCHhHCcChHHHc
Confidence 2223333333333221 1111 12578999999999999999999863
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-51 Score=416.74 Aligned_cols=239 Identities=21% Similarity=0.289 Sum_probs=186.9
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeCCCC---chhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCC
Q 005102 409 FVLGKSGIGIVYKVVLE-DGHTLAVRRLGEGG---SQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNG 484 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~g 484 (714)
+.||+|+||+||+|+.. +|+.||||++.+.. ....+.+.+|+++|++++|||||++++++.+.+..|+||||+ +|
T Consensus 19 ~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~-~g 97 (275)
T 3hyh_A 19 KTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYA-GN 97 (275)
T ss_dssp EEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECC-CE
T ss_pred EEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEEeCC-CC
Confidence 47999999999999975 59999999997642 233567999999999999999999999999999999999999 68
Q ss_pred CHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCC
Q 005102 485 SLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGS 564 (714)
Q Consensus 485 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 564 (714)
+|.+++... ..+++.++..|+.||+.||+|||+ ++|+||||||+|||+++++++||+|||+|+.....
T Consensus 98 ~L~~~l~~~------~~l~e~~~~~~~~qi~~al~ylH~---~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~--- 165 (275)
T 3hyh_A 98 ELFDYIVQR------DKMSEQEARRFFQQIISAVEYCHR---HKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG--- 165 (275)
T ss_dssp EHHHHHHHS------CSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCTTTEEECTTCCEEECCSSCC---------
T ss_pred CHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCChHHeEECCCCCEEEeecCCCeecCCC---
Confidence 999999765 469999999999999999999999 99999999999999999999999999999865321
Q ss_pred CCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCC-CchhhhHHHHHHHHHHHhCCCccccCCCCc
Q 005102 565 PTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKP-SQKWDIYSYGVILLEMITGRTAVVQVGSSE 643 (714)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~~DVwS~Gvvl~elltG~~p~~~~~~~~ 643 (714)
....+..||+.|||||++.+..+ +.++||||+||++|||+||+.||...
T Consensus 166 --------------------------~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~---- 215 (275)
T 3hyh_A 166 --------------------------NFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDE---- 215 (275)
T ss_dssp -----------------------------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCS----
T ss_pred --------------------------CccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCC----
Confidence 11224568999999999998876 58999999999999999999999432
Q ss_pred chhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 005102 644 MDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISD 704 (714)
Q Consensus 644 ~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 704 (714)
......+........+. ... ..++.+++.+||+.||++|||++|+++
T Consensus 216 -~~~~~~~~i~~~~~~~p--------~~~-----s~~~~~li~~~L~~dP~~R~s~~eil~ 262 (275)
T 3hyh_A 216 -SIPVLFKNISNGVYTLP--------KFL-----SPGAAGLIKRMLIVNPLNRISIHEIMQ 262 (275)
T ss_dssp -SHHHHHHHHHHTCCCCC--------TTS-----CHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred -CHHHHHHHHHcCCCCCC--------CCC-----CHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 22233333333322211 111 125789999999999999999999976
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-51 Score=439.22 Aligned_cols=243 Identities=21% Similarity=0.333 Sum_probs=201.3
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeCCCCchhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCCCHh
Q 005102 409 FVLGKSGIGIVYKVVLE-DGHTLAVRRLGEGGSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGSLA 487 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL~ 487 (714)
+.||+|+||.||+|+++ +|+.||||++........+.+.+|+++|++++|||||+++++|.+.+..|||||||++|+|.
T Consensus 157 ~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~~gG~L~ 236 (423)
T 4fie_A 157 IKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT 236 (423)
T ss_dssp EEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEHH
T ss_pred eEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCCCCCcHH
Confidence 47999999999999986 59999999998765555677899999999999999999999999999999999999999999
Q ss_pred hhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCCCCc
Q 005102 488 TALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTL 567 (714)
Q Consensus 488 ~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 567 (714)
+++... .+++.++..|+.||+.||+|||+ ++||||||||+|||++.++.+||+|||+|+.+...
T Consensus 237 ~~i~~~-------~l~e~~~~~~~~qil~aL~ylH~---~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~------ 300 (423)
T 4fie_A 237 DIVTHT-------RMNEEQIAAVCLAVLQALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE------ 300 (423)
T ss_dssp HHHHHS-------CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSTTTEEECTTCCEEECCCTTCEECCSS------
T ss_pred HHHhcc-------CCCHHHHHHHHHHHHHHHHHHHH---CCeecccCCHHHEEEcCCCCEEEecCccceECCCC------
Confidence 999643 48999999999999999999999 99999999999999999999999999999865322
Q ss_pred cCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCccccCCCCcchhH
Q 005102 568 QSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGSSEMDLV 647 (714)
Q Consensus 568 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~~~~~~~~~~l~ 647 (714)
.......+||+.|||||++.+..|+.++|||||||++|||++|+.||... .. .
T Consensus 301 ----------------------~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~--~~---~ 353 (423)
T 4fie_A 301 ----------------------VPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE--PP---L 353 (423)
T ss_dssp ----------------------CCCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTS--CH---H
T ss_pred ----------------------CccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc--CH---H
Confidence 11223456899999999999999999999999999999999999999432 12 2
Q ss_pred HHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 005102 648 NWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISD 704 (714)
Q Consensus 648 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 704 (714)
+.+........ +.+.... .....+.+|+.+||+.||++|||++|+++
T Consensus 354 ~~~~~i~~~~~-------~~~~~~~---~~s~~~~dli~~~L~~dP~~R~ta~ell~ 400 (423)
T 4fie_A 354 KAMKMIRDNLP-------PRLKNLH---KVSPSLKGFLDRLLVRDPAQRATAAELLK 400 (423)
T ss_dssp HHHHHHHHSCC-------CCCSCTT---SSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred HHHHHHHcCCC-------CCCcccc---cCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 22222222211 1111110 11236789999999999999999999875
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-51 Score=434.27 Aligned_cols=260 Identities=24% Similarity=0.324 Sum_probs=205.7
Q ss_pred cccccccCceEEEEEEECC------CcEEEEEEeCCCCc-hhHHHHHHHHHHHhccCC-CCccceEEEEEeC-CceeEEE
Q 005102 408 AFVLGKSGIGIVYKVVLED------GHTLAVRRLGEGGS-QRFKEFQTEVEAIGKIRH-SNIVTLRAYYWSV-DEKLLIY 478 (714)
Q Consensus 408 ~~~lG~G~~g~Vy~~~~~~------g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H-~niv~l~~~~~~~-~~~~lV~ 478 (714)
.+.||+|+||+||+|.+.. ++.||||++..... ...+.|.+|+++|++++| ||||+++|+|... +..++||
T Consensus 69 ~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~~~~~iV~ 148 (353)
T 4ase_A 69 GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIV 148 (353)
T ss_dssp EEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSCCEEEE
T ss_pred eeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecCCEEEEEE
Confidence 4589999999999998653 36899999987543 345679999999999965 8999999999764 5689999
Q ss_pred eccCCCCHhhhhhCCCCC----------CCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeE
Q 005102 479 DYIPNGSLATALHGKPGM----------VSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPH 548 (714)
Q Consensus 479 e~~~~gsL~~~l~~~~~~----------~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~k 548 (714)
|||++|+|.++|+..... .....++|.+++.|+.|||+||+|||+ ++||||||||+|||+++++++|
T Consensus 149 Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~---~~iiHRDLK~~NILl~~~~~vK 225 (353)
T 4ase_A 149 EFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVK 225 (353)
T ss_dssp ECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEE
T ss_pred EcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhh---CCeecCccCccceeeCCCCCEE
Confidence 999999999999754210 112458999999999999999999999 8999999999999999999999
Q ss_pred EcccchhhhhhccCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHH
Q 005102 549 VSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLE 628 (714)
Q Consensus 549 l~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~e 628 (714)
|+|||+|+.+..... ........||+.|||||++.+..|+.++|||||||++||
T Consensus 226 i~DFGlar~~~~~~~--------------------------~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~E 279 (353)
T 4ase_A 226 ICDFGLARDIYKDPD--------------------------YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWE 279 (353)
T ss_dssp ECCCGGGSCTTTCTT--------------------------SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHH
T ss_pred ECcchhhhhcccCCC--------------------------ceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHH
Confidence 999999986542211 112233457889999999999999999999999999999
Q ss_pred HHh-CCCccccCCCCcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHh
Q 005102 629 MIT-GRTAVVQVGSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDALD 707 (714)
Q Consensus 629 llt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~ 707 (714)
|+| |+.||....... .+...+..+.. +..+.. ...++.+++.+||+.||++||||+||++.|+
T Consensus 280 l~t~G~~Pf~~~~~~~-----~~~~~i~~g~~------~~~p~~-----~~~~~~~li~~c~~~dP~~RPt~~eil~~L~ 343 (353)
T 4ase_A 280 IFSLGASPYPGVKIDE-----EFCRRLKEGTR------MRAPDY-----TTPEMYQTMLDCWHGEPSQRPTFSELVEHLG 343 (353)
T ss_dssp HTTTSCCSSTTCCCSH-----HHHHHHHHTCC------CCCCTT-----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHhCCCCCCCCCCHHH-----HHHHHHHcCCC------CCCCcc-----CCHHHHHHHHHHcCcChhHCcCHHHHHHHHH
Confidence 998 999995432221 12222223221 111111 1236889999999999999999999999999
Q ss_pred hhhcc
Q 005102 708 RLIVS 712 (714)
Q Consensus 708 ~i~~~ 712 (714)
+++.+
T Consensus 344 ~llq~ 348 (353)
T 4ase_A 344 NLLQA 348 (353)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 98754
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-51 Score=422.79 Aligned_cols=236 Identities=23% Similarity=0.255 Sum_probs=188.2
Q ss_pred ccccccCceEEEEEEEC----CCcEEEEEEeCCCC--chhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccC
Q 005102 409 FVLGKSGIGIVYKVVLE----DGHTLAVRRLGEGG--SQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIP 482 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~----~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~ 482 (714)
+.||+|+||+||+|+.. +++.||||++++.. ......+.+|+++|++++|||||++++++.+.+..|+|||||+
T Consensus 30 ~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmEy~~ 109 (304)
T 3ubd_A 30 KVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLR 109 (304)
T ss_dssp EEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEEEECCCT
T ss_pred EEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEEEcCC
Confidence 47999999999999863 37899999997642 2223468899999999999999999999999999999999999
Q ss_pred CCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccC
Q 005102 483 NGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAG 562 (714)
Q Consensus 483 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 562 (714)
+|+|.+++... ..+++.++..|+.||+.||+|||+ ++|+||||||+|||+++++++||+|||+|+.....
T Consensus 110 gg~L~~~l~~~------~~l~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~- 179 (304)
T 3ubd_A 110 GGDLFTRLSKE------VMFTEEDVKFYLAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDH- 179 (304)
T ss_dssp TCEEHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCCGGGEEECTTSCEEEESSEEEEC-----
T ss_pred CCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHHHeEEcCCCCEEecccccceeccCC-
Confidence 99999999765 458999999999999999999999 99999999999999999999999999999854321
Q ss_pred CCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCccccCCCC
Q 005102 563 GSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGSS 642 (714)
Q Consensus 563 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~~~~~~~ 642 (714)
........||+.|||||++.+..|+.++||||+||++|||+||+.||...
T Consensus 180 ---------------------------~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~--- 229 (304)
T 3ubd_A 180 ---------------------------EKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGK--- 229 (304)
T ss_dssp ----------------------------CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCS---
T ss_pred ---------------------------CccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCc---
Confidence 11233467899999999999999999999999999999999999999432
Q ss_pred cchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCH
Q 005102 643 EMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTM 699 (714)
Q Consensus 643 ~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~ 699 (714)
+..+.+.........+. ... ..++.+++.+||+.||++|||+
T Consensus 230 --~~~~~~~~i~~~~~~~p--------~~~-----s~~~~~li~~~L~~dP~~R~ta 271 (304)
T 3ubd_A 230 --DRKETMTMILKAKLGMP--------QFL-----SPEAQSLLRMLFKRNPANRLGA 271 (304)
T ss_dssp --SHHHHHHHHHHCCCCCC--------TTS-----CHHHHHHHHHHTCSSGGGSTTC
T ss_pred --CHHHHHHHHHcCCCCCC--------CcC-----CHHHHHHHHHHcccCHHHCCCC
Confidence 22233333333322211 111 2357899999999999999985
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-49 Score=408.00 Aligned_cols=255 Identities=23% Similarity=0.332 Sum_probs=185.1
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeCCCCc-hhHHHHHHHHHHHhccCCCCccceEEEEEeCC------------ce
Q 005102 409 FVLGKSGIGIVYKVVLE-DGHTLAVRRLGEGGS-QRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVD------------EK 474 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~------------~~ 474 (714)
+.||+|+||+||+|+++ +|+.||||+++.... ...+.+.+|+++|++++|||||++++++.+.+ ..
T Consensus 11 ~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~~~~~~l 90 (299)
T 4g31_A 11 QCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYL 90 (299)
T ss_dssp EEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC----------CEEE
T ss_pred eEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccccCCCcEE
Confidence 57999999999999975 589999999976543 34567999999999999999999999987654 36
Q ss_pred eEEEeccCCCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccch
Q 005102 475 LLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGL 554 (714)
Q Consensus 475 ~lV~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGl 554 (714)
|+|||||++|+|.+++...... ...++..++.|+.||+.||+|||+ ++||||||||+|||++.++.+||+|||+
T Consensus 91 ~ivmE~~~gg~L~~~l~~~~~~---~~~~~~~~~~i~~qi~~al~ylH~---~~IiHRDlKp~NILl~~~~~vKl~DFGl 164 (299)
T 4g31_A 91 YIQMQLCRKENLKDWMNGRCTI---EERERSVCLHIFLQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGL 164 (299)
T ss_dssp EEEEECCCSCCHHHHHHTCCSG---GGSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCCCC
T ss_pred EEEEecCCCCcHHHHHHhcCCC---ChhHHHHHHHHHHHHHHHHHHHHH---CcCccccCcHHHeEECCCCcEEEccCcc
Confidence 8999999999999999865321 345677889999999999999999 9999999999999999999999999999
Q ss_pred hhhhhccCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCC
Q 005102 555 ARLANIAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRT 634 (714)
Q Consensus 555 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~ 634 (714)
|+............. ............||+.|||||++.+..|+.++|||||||++|||++
T Consensus 165 a~~~~~~~~~~~~~~----------------~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~--- 225 (299)
T 4g31_A 165 VTAMDQDEEEQTVLT----------------PMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY--- 225 (299)
T ss_dssp C------------------------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---
T ss_pred ceecCCCcccccccc----------------ccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---
Confidence 997754321110000 0001122345679999999999999999999999999999999996
Q ss_pred ccccCCCCcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 005102 635 AVVQVGSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISD 704 (714)
Q Consensus 635 p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 704 (714)
||.. ..+....+....... .. .........+.+++.+||+.||++|||+.|+++
T Consensus 226 Pf~~----~~~~~~~~~~~~~~~--~p----------~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 279 (299)
T 4g31_A 226 PFST----QMERVRTLTDVRNLK--FP----------PLFTQKYPCEYVMVQDMLSPSPMERPEAINIIE 279 (299)
T ss_dssp CCSS----HHHHHHHHHHHHTTC--CC----------HHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCCC----ccHHHHHHHHHhcCC--CC----------CCCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 7731 111112121111111 00 011223345678999999999999999999976
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=405.45 Aligned_cols=258 Identities=21% Similarity=0.337 Sum_probs=194.6
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeCCCC--chhHHHHHHHHHHHhccCCCCccceEEEEEeC------CceeEEEe
Q 005102 409 FVLGKSGIGIVYKVVLE-DGHTLAVRRLGEGG--SQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSV------DEKLLIYD 479 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~------~~~~lV~e 479 (714)
+.||+|+||+||+|+++ +|+.||||+++... ....+.+.+|+++|++++|||||++++++... +..|+|||
T Consensus 60 ~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~~~ivmE 139 (398)
T 4b99_A 60 ETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKSVYVVLD 139 (398)
T ss_dssp EEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCCEEEEEE
T ss_pred EEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCEEEEEEe
Confidence 47999999999999985 59999999997643 23346788999999999999999999998643 56899999
Q ss_pred ccCCCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhh
Q 005102 480 YIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLAN 559 (714)
Q Consensus 480 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~ 559 (714)
||+ |+|.+++... ..+++..+..|+.||+.||+|||+ ++||||||||+|||++.++.+||+|||+|+.+.
T Consensus 140 ~~~-g~L~~~i~~~------~~l~~~~~~~~~~qil~al~ylH~---~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~ 209 (398)
T 4b99_A 140 LME-SDLHQIIHSS------QPLTLEHVRYFLYQLLRGLKYMHS---AQVIHRDLKPSNLLVNENCELKIGDFGMARGLC 209 (398)
T ss_dssp CCS-EEHHHHHTSS------SCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTCCEEECCCTTCBCC-
T ss_pred CCC-CCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CcCcCCCcCccccccCCCCCEEEeecceeeecc
Confidence 995 7899999765 569999999999999999999999 999999999999999999999999999998653
Q ss_pred ccCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCC-CCCchhhhHHHHHHHHHHHhCCCcccc
Q 005102 560 IAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVV-KPSQKWDIYSYGVILLEMITGRTAVVQ 638 (714)
Q Consensus 560 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DVwS~Gvvl~elltG~~p~~~ 638 (714)
..... .........||+.|||||++.+. .++.++||||+||++|||++|+.||..
T Consensus 210 ~~~~~------------------------~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g 265 (398)
T 4b99_A 210 TSPAE------------------------HQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPG 265 (398)
T ss_dssp ------------------------------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCC
T ss_pred cCccc------------------------cccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCC
Confidence 22100 01223456789999999998875 469999999999999999999999943
Q ss_pred CCCCcchhHHHHHHHHhhcCCcccccCC-----------CCCCC--CCcH----HHHHHHHHHHhHccCCCCCCCCCHHH
Q 005102 639 VGSSEMDLVNWMQLCIEEKKPLADVLDP-----------YLAPD--ADKE----EEIIAVLKIAMACVHSSPEKRPTMRH 701 (714)
Q Consensus 639 ~~~~~~~l~~~~~~~~~~~~~~~~~~d~-----------~~~~~--~~~~----~~~~~l~~li~~Cl~~dP~~RPt~~e 701 (714)
. +..+....+...... +....... .+... .... ....++.+|+.+||..||++|||++|
T Consensus 266 ~--~~~~~l~~I~~~~g~--p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e 341 (398)
T 4b99_A 266 K--NYVHQLQLIMMVLGT--PSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAA 341 (398)
T ss_dssp S--SHHHHHHHHHHHHCC--CCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred C--CHHHHHHHHHHhcCC--CChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHH
Confidence 2 222222222111111 00000000 00000 0000 01235789999999999999999999
Q ss_pred HHH
Q 005102 702 ISD 704 (714)
Q Consensus 702 vl~ 704 (714)
+++
T Consensus 342 ~L~ 344 (398)
T 4b99_A 342 ALR 344 (398)
T ss_dssp HTT
T ss_pred Hhc
Confidence 875
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-47 Score=403.30 Aligned_cols=218 Identities=19% Similarity=0.274 Sum_probs=165.5
Q ss_pred ccccccCceEEEEEEEC----CCcEEEEEEeCCCCchhHHHHHHHHHHHhcc-CCCCccceEEEEEeCCceeEEEeccCC
Q 005102 409 FVLGKSGIGIVYKVVLE----DGHTLAVRRLGEGGSQRFKEFQTEVEAIGKI-RHSNIVTLRAYYWSVDEKLLIYDYIPN 483 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~----~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~e~~~~ 483 (714)
+.||+|+||+||+|+.+ +++.||||++..... ..++.+|+++|+++ +|||||++++++.+.++.|+||||+++
T Consensus 27 ~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~--~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~lvmE~~~g 104 (361)
T 4f9c_A 27 DKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSH--PIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVIAMPYLEH 104 (361)
T ss_dssp EEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSC--HHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEEEEECCCC
T ss_pred EEEecccCcEEEEEEEcccCCCCCEEEEEEEccccC--HHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEEEEeCCCc
Confidence 57999999999999864 468999999876543 35688999999998 699999999999999999999999999
Q ss_pred CCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCC-CCeEEcccchhhhhhccC
Q 005102 484 GSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHN-MEPHVSDFGLARLANIAG 562 (714)
Q Consensus 484 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~-~~~kl~DFGla~~~~~~~ 562 (714)
|+|.+++. .+++.+++.|+.|++.||+|||+ ++|+||||||+|||++.+ +.+||+|||+|+......
T Consensus 105 ~~L~~~~~---------~l~~~~~~~~~~qll~al~ylH~---~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~~ 172 (361)
T 4f9c_A 105 ESFLDILN---------SLSFQEVREYMLNLFKALKRIHQ---FGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTK 172 (361)
T ss_dssp CCHHHHHT---------TCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEEECCCTTCEECTTCS
T ss_pred ccHHHHHc---------CCCHHHHHHHHHHHHHHHHHHHH---CCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCcc
Confidence 99999983 48899999999999999999999 999999999999999876 799999999998654322
Q ss_pred CCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCC-CCCchhhhHHHHHHHHHHHhCCCccccCC
Q 005102 563 GSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVV-KPSQKWDIYSYGVILLEMITGRTAVVQVG 640 (714)
Q Consensus 563 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DVwS~Gvvl~elltG~~p~~~~~ 640 (714)
.....................+.............||++|||||++.+. .++.++||||+||++|||+||+.||....
T Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~~ 251 (361)
T 4f9c_A 173 IELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKAS 251 (361)
T ss_dssp CGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCCS
T ss_pred ccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCCC
Confidence 1100000000000000000000001112233456799999999999876 48999999999999999999999996543
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-45 Score=411.38 Aligned_cols=242 Identities=21% Similarity=0.235 Sum_probs=192.8
Q ss_pred cccccccCceEEEEEEEC-CCcEEEEEEeCCCC---chh---HHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEec
Q 005102 408 AFVLGKSGIGIVYKVVLE-DGHTLAVRRLGEGG---SQR---FKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDY 480 (714)
Q Consensus 408 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~---~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~ 480 (714)
.++||+|+||+||+|+.+ +|+.||||++.+.. ... ......++.+++.++|||||+++++|.+.+..|+||||
T Consensus 194 ~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~lylVmEy 273 (689)
T 3v5w_A 194 HRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDL 273 (689)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEEECC
T ss_pred EEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEEEEEec
Confidence 358999999999999986 49999999996531 111 22233456778888999999999999999999999999
Q ss_pred cCCCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhc
Q 005102 481 IPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANI 560 (714)
Q Consensus 481 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 560 (714)
|++|+|.++|... ..+++..++.|+.||+.||+|||+ ++||||||||+|||++.+|++||+|||+|+....
T Consensus 274 ~~GGdL~~~l~~~------~~l~E~~a~~y~~qIl~aL~yLH~---~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~~ 344 (689)
T 3v5w_A 274 MNGGDLHYHLSQH------GVFSEADMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSK 344 (689)
T ss_dssp CCSCBHHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred CCCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCchHHeEEeCCCCEEecccceeeecCC
Confidence 9999999999765 459999999999999999999999 9999999999999999999999999999986532
Q ss_pred cCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCC-CCCCchhhhHHHHHHHHHHHhCCCccccC
Q 005102 561 AGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKV-VKPSQKWDIYSYGVILLEMITGRTAVVQV 639 (714)
Q Consensus 561 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DVwS~Gvvl~elltG~~p~~~~ 639 (714)
. ...+..||+.|||||++.. ..|+.++||||+||++|||++|+.||...
T Consensus 345 ~------------------------------~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~ 394 (689)
T 3v5w_A 345 K------------------------------KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQH 394 (689)
T ss_dssp C------------------------------CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGG
T ss_pred C------------------------------CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 1 1234579999999999964 57999999999999999999999999543
Q ss_pred CCCcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCC-----HHHHH
Q 005102 640 GSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPT-----MRHIS 703 (714)
Q Consensus 640 ~~~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt-----~~evl 703 (714)
... +.....+........+ +... ..++.+|+.+||+.||++|++ ++||+
T Consensus 395 ~~~--~~~~i~~~i~~~~~~~--------p~~~-----S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~ 448 (689)
T 3v5w_A 395 KTK--DKHEIDRMTLTMAVEL--------PDSF-----SPELRSLLEGLLQRDVNRRLGCLGRGAQEVK 448 (689)
T ss_dssp GCC--CHHHHHHHHHHCCCCC--------CTTS-----CHHHHHHHHHHTCSCGGGCTTCSSSTHHHHT
T ss_pred ChH--HHHHHHHhhcCCCCCC--------CccC-----CHHHHHHHHHHccCCHhHCCCCCCCCHHHHh
Confidence 222 2223233333322211 1111 125789999999999999998 56664
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-45 Score=413.65 Aligned_cols=246 Identities=20% Similarity=0.295 Sum_probs=201.6
Q ss_pred cccccccCceEEEEEEEC-CCcEEEEEEeCCCCchhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCCCH
Q 005102 408 AFVLGKSGIGIVYKVVLE-DGHTLAVRRLGEGGSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGSL 486 (714)
Q Consensus 408 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL 486 (714)
.+.||+|+||+||+|+.+ +|+.||||++........+.+.+|+++|++++|||||+++++|.+.+..|+|||||++|+|
T Consensus 162 ~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~~gg~L 241 (573)
T 3uto_A 162 HEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGEL 241 (573)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECCCCCBH
T ss_pred EEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeecCCCcH
Confidence 357999999999999986 5999999999877666667899999999999999999999999999999999999999999
Q ss_pred hhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCC--CCeEEcccchhhhhhccCCC
Q 005102 487 ATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHN--MEPHVSDFGLARLANIAGGS 564 (714)
Q Consensus 487 ~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~--~~~kl~DFGla~~~~~~~~~ 564 (714)
.+++.... ..+++.++..|+.||+.||+|||+ ++|+||||||+|||++.+ +.+||+|||+|+.+....
T Consensus 242 ~~~i~~~~-----~~l~e~~~~~~~~qi~~al~ylH~---~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~-- 311 (573)
T 3uto_A 242 FEKVADEH-----NKMSEDEAVEYMRQVCKGLCHMHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ-- 311 (573)
T ss_dssp HHHHTCTT-----SCEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTS--
T ss_pred HHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCChhhccccCCCCCCEEEeeccceeEccCCC--
Confidence 99997543 458999999999999999999999 999999999999999854 899999999998754211
Q ss_pred CCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCccccCCCCcc
Q 005102 565 PTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGSSEM 644 (714)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~~~~~~~~~ 644 (714)
......||+.|||||++.+..|+.++||||+||++|||++|+.||... ..
T Consensus 312 ---------------------------~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~--~~- 361 (573)
T 3uto_A 312 ---------------------------SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGE--ND- 361 (573)
T ss_dssp ---------------------------EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCS--SH-
T ss_pred ---------------------------ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc--CH-
Confidence 112346899999999999999999999999999999999999999432 11
Q ss_pred hhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 005102 645 DLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISD 704 (714)
Q Consensus 645 ~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 704 (714)
.+.+.........+... .... ....+.+|+.+||+.||++|||++|+++
T Consensus 362 --~~~~~~i~~~~~~~~~~----~~~~-----~s~~~~dli~~~L~~dp~~R~t~~e~l~ 410 (573)
T 3uto_A 362 --DETLRNVKSCDWNMDDS----AFSG-----ISEDGKDFIRKLLLADPNTRMTIHQALE 410 (573)
T ss_dssp --HHHHHHHHTTCCCCCSG----GGTT-----SCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred --HHHHHHHHhCCCCCCcc----cccC-----CCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 22222222222211111 0011 1235789999999999999999999876
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-44 Score=380.30 Aligned_cols=272 Identities=32% Similarity=0.529 Sum_probs=223.0
Q ss_pred ccccccCceEEEEEEECCCcEEEEEEeCCCCchhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCCCHhh
Q 005102 409 FVLGKSGIGIVYKVVLEDGHTLAVRRLGEGGSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGSLAT 488 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL~~ 488 (714)
+.||+|+||.||+|++++++.||||++........+.+.+|++++++++||||+++++++...+..++||||+++|+|.+
T Consensus 45 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~ 124 (321)
T 2qkw_B 45 FLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKR 124 (321)
T ss_dssp CCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEEEECCTTCBTGG
T ss_pred ceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEEcCCCCcHHH
Confidence 47999999999999998899999999987766667889999999999999999999999999999999999999999999
Q ss_pred hhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCCCCcc
Q 005102 489 ALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQ 568 (714)
Q Consensus 489 ~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 568 (714)
++...... ...++|.++.+++.|++.||+|||+ ++|+||||||+||++++++.+||+|||+++.......
T Consensus 125 ~l~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~----- 194 (321)
T 2qkw_B 125 HLYGSDLP--TMSMSWEQRLEICIGAARGLHYLHT---RAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQ----- 194 (321)
T ss_dssp GSSSSCCC--SCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCSTTEEECTTCCEEECCCTTCEECSSSSC-----
T ss_pred HHhccCCC--ccccCHHHHHHHHHHHHHHHHHhcC---CCeecCCCCHHHEEECCCCCEEEeecccccccccccc-----
Confidence 99765321 1458999999999999999999999 8999999999999999999999999999875432110
Q ss_pred CCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCccccCCCC-cchhH
Q 005102 569 SNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGSS-EMDLV 647 (714)
Q Consensus 569 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~~~~~~~-~~~l~ 647 (714)
........||+.|+|||++.+..++.++||||||+++|||+||+.||...... .....
T Consensus 195 ---------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~ 253 (321)
T 2qkw_B 195 ---------------------THLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLA 253 (321)
T ss_dssp ---------------------CCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHH
T ss_pred ---------------------cccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHH
Confidence 01112234688899999998889999999999999999999999999543332 23344
Q ss_pred HHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhhhhccC
Q 005102 648 NWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDALDRLIVSS 713 (714)
Q Consensus 648 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~~~ 713 (714)
.|....... ..+.+.+++...... .......+.+++.+||+.||++|||++|+++.|+.+.+..
T Consensus 254 ~~~~~~~~~-~~~~~~~~~~~~~~~-~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~~ 317 (321)
T 2qkw_B 254 EWAVESHNN-GQLEQIVDPNLADKI-RPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQ 317 (321)
T ss_dssp HHTHHHHTT-TCCCSSSSSSCTTCS-CHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred HHhhhcccc-ccHHHhcChhhcccc-CHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhcc
Confidence 554433322 234555565554333 3457778999999999999999999999999999987543
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-44 Score=378.39 Aligned_cols=283 Identities=39% Similarity=0.620 Sum_probs=223.5
Q ss_pred cccCHHHHHHhc-----cccccccCceEEEEEEECCCcEEEEEEeCCCCch-hHHHHHHHHHHHhccCCCCccceEEEEE
Q 005102 396 VAFDLDELLKAS-----AFVLGKSGIGIVYKVVLEDGHTLAVRRLGEGGSQ-RFKEFQTEVEAIGKIRHSNIVTLRAYYW 469 (714)
Q Consensus 396 ~~~~~~~l~~~~-----~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~ 469 (714)
..|++.++.... .+.||+|+||.||+|+..+|+.||||++...... ....+.+|++++++++||||+++++++.
T Consensus 18 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 97 (326)
T 3uim_A 18 KRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCM 97 (326)
T ss_dssp EECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEEC
T ss_pred ceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEEe
Confidence 456666666544 3579999999999999888999999999765322 2236899999999999999999999999
Q ss_pred eCCceeEEEeccCCCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEE
Q 005102 470 SVDEKLLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHV 549 (714)
Q Consensus 470 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl 549 (714)
..+..++||||+++|+|.+++....... ..+++..+..|+.|++.||+|||+.+..+|+||||||+|||+++++.+||
T Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl 175 (326)
T 3uim_A 98 TPTERLLVYPYMANGSVASCLRERPESQ--PPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVV 175 (326)
T ss_dssp CSSCCEEEEECCTTCBHHHHHHCCSTTC--CCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEE
T ss_pred cCCceEEEEEeccCCCHHHHHHhccccC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEe
Confidence 9999999999999999999998764321 45999999999999999999999922229999999999999999999999
Q ss_pred cccchhhhhhccCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHH
Q 005102 550 SDFGLARLANIAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEM 629 (714)
Q Consensus 550 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~el 629 (714)
+|||+++...... ........||+.|+|||++.+..++.++|||||||++|||
T Consensus 176 ~Dfg~~~~~~~~~---------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l 228 (326)
T 3uim_A 176 GDFGLAKLMDYKD---------------------------THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLEL 228 (326)
T ss_dssp CCCSSCEECCSSS---------------------------SCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHH
T ss_pred ccCccccccCccc---------------------------ccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHH
Confidence 9999998653221 1112234579999999999888899999999999999999
Q ss_pred HhCCCcccc---CCCCcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHH
Q 005102 630 ITGRTAVVQ---VGSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDAL 706 (714)
Q Consensus 630 ltG~~p~~~---~~~~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L 706 (714)
+||+.||.. ..........|+....... ......+....... .......+.+++.+||+.||++|||++||++.|
T Consensus 229 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~-~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L 306 (326)
T 3uim_A 229 ITGQRAFDLARLANDDDVMLLDWVKGLLKEK-KLEALVDVDLQGNY-KDEEVEQLIQVALLCTQSSPMERPKMSEVVRML 306 (326)
T ss_dssp HHCCCSBCHHHHTTTSCSBHHHHHTTTTSSC-CSTTSSCTTCTTSC-CHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHH
T ss_pred HhCCCcccccccccccchhHHHHHHHHhhch-hhhhhcChhhcccc-CHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHh
Confidence 999999942 2223334455554333322 23444555444333 355778899999999999999999999999999
Q ss_pred hhh
Q 005102 707 DRL 709 (714)
Q Consensus 707 ~~i 709 (714)
++.
T Consensus 307 ~~~ 309 (326)
T 3uim_A 307 EGD 309 (326)
T ss_dssp HTS
T ss_pred cCc
Confidence 864
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=372.30 Aligned_cols=267 Identities=27% Similarity=0.410 Sum_probs=208.2
Q ss_pred cccccccCceEEEEEEEC-CCcEEEEEEeCCCCchhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCCCH
Q 005102 408 AFVLGKSGIGIVYKVVLE-DGHTLAVRRLGEGGSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGSL 486 (714)
Q Consensus 408 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL 486 (714)
.+.||+|+||+||+|.+. +++.||+|++........+.|.+|++++++++||||+++++++.+.+..++||||+++|+|
T Consensus 15 ~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L 94 (310)
T 3s95_A 15 GEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTL 94 (310)
T ss_dssp EEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCTTCBH
T ss_pred cceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEecCCCcH
Confidence 358999999999999986 4899999999877767778899999999999999999999999999999999999999999
Q ss_pred hhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCCCC
Q 005102 487 ATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPT 566 (714)
Q Consensus 487 ~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 566 (714)
.+++.... ..+++.++..|+.|++.||+|||+ .+|+||||||+||++++++.+||+|||+++..........
T Consensus 95 ~~~l~~~~-----~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 166 (310)
T 3s95_A 95 RGIIKSMD-----SQYPWSQRVSFAKDIASGMAYLHS---MNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPE 166 (310)
T ss_dssp HHHHHHCC-----TTSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEECTTSCEEECCCTTCEECC-------
T ss_pred HHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCCcCeEEECCCCCEEEeecccceeccccccccc
Confidence 99998643 458999999999999999999999 8999999999999999999999999999987643221100
Q ss_pred ccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCccccCCCCcchh
Q 005102 567 LQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGSSEMDL 646 (714)
Q Consensus 567 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~~~~~~~~~~l 646 (714)
.. ...............||+.|+|||++.+..++.++||||||+++|||++|..|+..........
T Consensus 167 ~~--------------~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~ 232 (310)
T 3s95_A 167 GL--------------RSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDF 232 (310)
T ss_dssp ---------------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTS
T ss_pred cc--------------ccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHH
Confidence 00 0000001112235578999999999999999999999999999999999999985433322211
Q ss_pred HHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhhhhc
Q 005102 647 VNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDALDRLIV 711 (714)
Q Consensus 647 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~ 711 (714)
........... ..... ...+.+++.+||+.||++|||++++++.|+++..
T Consensus 233 ~~~~~~~~~~~----------~~~~~-----~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~ 282 (310)
T 3s95_A 233 GLNVRGFLDRY----------CPPNC-----PPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRM 282 (310)
T ss_dssp SBCHHHHHHHT----------CCTTC-----CTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hhhhhcccccc----------CCCCC-----CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 11111111111 11111 1247899999999999999999999999998864
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-44 Score=375.70 Aligned_cols=260 Identities=23% Similarity=0.303 Sum_probs=202.8
Q ss_pred ccccccCceEEEEEEECCCcEEEEEEeCCCCchhHHHHHHHHHHHhccCCCCccceEEEEEeCCc----eeEEEeccCCC
Q 005102 409 FVLGKSGIGIVYKVVLEDGHTLAVRRLGEGGSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDE----KLLIYDYIPNG 484 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~----~~lV~e~~~~g 484 (714)
+.||+|+||+||+|++. ++.||||++..... ....+.+|+.++++++||||+++++++..... .++||||+++|
T Consensus 30 ~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~e~~~~g 107 (322)
T 3soc_A 30 EVKARGRFGCVWKAQLL-NEYVAVKIFPIQDK-QSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKG 107 (322)
T ss_dssp EEEECSTTCEEEEEEET-TEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTC
T ss_pred heecccCceEEEEEEEC-CCEEEEEEeecCch-HHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEEEecCCCC
Confidence 47999999999999986 79999999976433 23456779999999999999999999987543 69999999999
Q ss_pred CHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCC----------CceecCCCCCCeeeCCCCCeEEcccch
Q 005102 485 SLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPK----------KYVHGDLKPSNILLGHNMEPHVSDFGL 554 (714)
Q Consensus 485 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~----------~ivHrDlkp~NILl~~~~~~kl~DFGl 554 (714)
+|.+++... .+++..+..|+.|++.||+|||+ . +|+||||||+|||++.++.+||+|||+
T Consensus 108 ~L~~~l~~~-------~~~~~~~~~i~~qi~~al~~LH~---~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg~ 177 (322)
T 3soc_A 108 SLSDFLKAN-------VVSWNELCHIAETMARGLAYLHE---DIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGL 177 (322)
T ss_dssp BHHHHHHHC-------CBCHHHHHHHHHHHHHHHHHHTC---CEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred CHHHHHHhc-------CCCHHHHHHHHHHHHHHHHHHHh---hccccccccCCCEEeCCCChHhEEECCCCeEEEccCCc
Confidence 999999753 48999999999999999999999 7 999999999999999999999999999
Q ss_pred hhhhhccCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCC-----CCCchhhhHHHHHHHHHH
Q 005102 555 ARLANIAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVV-----KPSQKWDIYSYGVILLEM 629 (714)
Q Consensus 555 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~s~~~DVwS~Gvvl~el 629 (714)
++....... ........||+.|+|||++.+. .++.++|||||||++|||
T Consensus 178 a~~~~~~~~--------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el 231 (322)
T 3soc_A 178 ALKFEAGKS--------------------------AGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWEL 231 (322)
T ss_dssp CEEECTTSC--------------------------CCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred ccccccccC--------------------------ccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHH
Confidence 986543211 1112334679999999999863 456789999999999999
Q ss_pred HhCCCccccCCCCcch-----------hHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCC
Q 005102 630 ITGRTAVVQVGSSEMD-----------LVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPT 698 (714)
Q Consensus 630 ltG~~p~~~~~~~~~~-----------l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt 698 (714)
+||+.||......... ...+... ... ....+.............++.+++.+||+.||++|||
T Consensus 232 ~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~-----~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps 305 (322)
T 3soc_A 232 ASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEV-VVH-----KKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLS 305 (322)
T ss_dssp HTTBTTSSSCCCCCCCTTHHHHCSSCCHHHHHHH-HTT-----SCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCC
T ss_pred HhCCCCCCCCcchhccchhhhhccCCchhhhhhh-hhc-----ccCCCCccccccccchHHHHHHHHHHHccCChhhCcC
Confidence 9999999543322111 1111111 111 1112222222222345667999999999999999999
Q ss_pred HHHHHHHHhhhhcc
Q 005102 699 MRHISDALDRLIVS 712 (714)
Q Consensus 699 ~~evl~~L~~i~~~ 712 (714)
++||++.|+++.+.
T Consensus 306 ~~ell~~L~~l~~~ 319 (322)
T 3soc_A 306 AGCVGERITQMQRL 319 (322)
T ss_dssp HHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHH
Confidence 99999999998764
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=363.01 Aligned_cols=280 Identities=33% Similarity=0.553 Sum_probs=222.7
Q ss_pred cccCHHHHHHhcc-----------ccccccCceEEEEEEECCCcEEEEEEeCCC----CchhHHHHHHHHHHHhccCCCC
Q 005102 396 VAFDLDELLKASA-----------FVLGKSGIGIVYKVVLEDGHTLAVRRLGEG----GSQRFKEFQTEVEAIGKIRHSN 460 (714)
Q Consensus 396 ~~~~~~~l~~~~~-----------~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~H~n 460 (714)
..|+++++.+++. +.||+|+||.||+|.. +++.||||++... .....+.+.+|++++++++|||
T Consensus 13 ~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ 91 (307)
T 2nru_A 13 HSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHEN 91 (307)
T ss_dssp EECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTT
T ss_pred CcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCC
Confidence 4567777777653 5799999999999997 5889999998753 2234567999999999999999
Q ss_pred ccceEEEEEeCCceeEEEeccCCCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCee
Q 005102 461 IVTLRAYYWSVDEKLLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNIL 540 (714)
Q Consensus 461 iv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NIL 540 (714)
|+++++++...+..++||||+++|+|.+++...... ..+++..+.+++.|++.||+|||+ .+|+||||||+||+
T Consensus 92 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dlkp~Nil 165 (307)
T 2nru_A 92 LVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGT---PPLSWHMRCKIAQGAANGINFLHE---NHHIHRDIKSANIL 165 (307)
T ss_dssp BCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGC---CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEE
T ss_pred eEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCC---CCCCHHHHHHHHHHHHHHHHHHhc---CCeecCCCCHHHEE
Confidence 999999999999999999999999999999754321 458999999999999999999999 89999999999999
Q ss_pred eCCCCCeEEcccchhhhhhccCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhH
Q 005102 541 LGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIY 620 (714)
Q Consensus 541 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVw 620 (714)
+++++.+||+|||+++....... ........||+.|+|||.+.+ .++.++|||
T Consensus 166 i~~~~~~kl~Dfg~~~~~~~~~~--------------------------~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~ 218 (307)
T 2nru_A 166 LDEAFTAKISDFGLARASEKFAQ--------------------------TVMTSRIVGTTAYMAPEALRG-EITPKSDIY 218 (307)
T ss_dssp ECTTCCEEECCCTTCEECCSCSS--------------------------CEECSSCCSCGGGCCHHHHTT-EECTHHHHH
T ss_pred EcCCCcEEEeecccccccccccc--------------------------cccccccCCCcCcCChHHhcC-CCCccchhH
Confidence 99999999999999876432110 111223457899999998865 589999999
Q ss_pred HHHHHHHHHHhCCCccccCCCCcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHH
Q 005102 621 SYGVILLEMITGRTAVVQVGSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMR 700 (714)
Q Consensus 621 S~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ 700 (714)
|||+++|||++|+.||...... ..+..+..........+.+.+++.+.. ........+.+++.+||+.||++|||++
T Consensus 219 slG~il~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~cl~~~p~~Rps~~ 295 (307)
T 2nru_A 219 SFGVVLLEIITGLPAVDEHREP-QLLLDIKEEIEDEEKTIEDYIDKKMND--ADSTSVEAMYSVASQCLHEKKNKRPDIK 295 (307)
T ss_dssp HHHHHHHHHHHCCCSBCTTBSS-SBTTHHHHHHHTTSCCHHHHSCSSCSC--CCHHHHHHHHHHHHHHTCSSTTTSCCHH
T ss_pred HHHHHHHHHHHCCCCcccCcch-HHHHHHHHHhhhhhhhhhhhccccccc--cchHHHHHHHHHHHHHcCCCcccCcCHH
Confidence 9999999999999999543322 223334443333444445555554432 2345667899999999999999999999
Q ss_pred HHHHHHhhhhcc
Q 005102 701 HISDALDRLIVS 712 (714)
Q Consensus 701 evl~~L~~i~~~ 712 (714)
++++.|+++..+
T Consensus 296 ~l~~~L~~l~~s 307 (307)
T 2nru_A 296 KVQQLLQEMTAS 307 (307)
T ss_dssp HHHHHHHHHC--
T ss_pred HHHHHHHHHhcC
Confidence 999999998754
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-43 Score=365.31 Aligned_cols=254 Identities=29% Similarity=0.389 Sum_probs=197.4
Q ss_pred cccccccCceEEEEEEECCCcEEEEEEeCCCC--chhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCCC
Q 005102 408 AFVLGKSGIGIVYKVVLEDGHTLAVRRLGEGG--SQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGS 485 (714)
Q Consensus 408 ~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gs 485 (714)
.+.||+|+||+||+|++ +|+.||||++.... ....+.+.+|++++++++||||+++++++...+..++||||+++|+
T Consensus 42 ~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~ 120 (309)
T 3p86_A 42 KEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGS 120 (309)
T ss_dssp EEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEEECCTTCB
T ss_pred eeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEEecCCCCc
Confidence 35799999999999988 58899999997653 3344679999999999999999999999999999999999999999
Q ss_pred HhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCC--ceecCCCCCCeeeCCCCCeEEcccchhhhhhccCC
Q 005102 486 LATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKK--YVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGG 563 (714)
Q Consensus 486 L~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~--ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 563 (714)
|.+++...... ..+++..+..++.|++.||+|||+ .+ |+||||||+||+++.++.+||+|||+++.....
T Consensus 121 L~~~l~~~~~~---~~~~~~~~~~i~~qi~~aL~~LH~---~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~-- 192 (309)
T 3p86_A 121 LYRLLHKSGAR---EQLDERRRLSMAYDVAKGMNYLHN---RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKAST-- 192 (309)
T ss_dssp HHHHHHSTTHH---HHSCHHHHHHHHHHHHHHHHHHHT---SSSCCCCTTCCGGGEEECTTCCEEECCCC----------
T ss_pred HHHHHhhcCCC---CCCCHHHHHHHHHHHHHHHHHHHc---CCCCEECCCCChhhEEEeCCCcEEECCCCCCcccccc--
Confidence 99999865311 248999999999999999999999 78 999999999999999999999999999754321
Q ss_pred CCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCccccCCCCc
Q 005102 564 SPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGSSE 643 (714)
Q Consensus 564 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~~~~~~~~ 643 (714)
........||+.|+|||++.+..++.++|||||||++|||+||+.||.... .
T Consensus 193 --------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~--~ 244 (309)
T 3p86_A 193 --------------------------FLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLN--P 244 (309)
T ss_dssp -----------------------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSC--H
T ss_pred --------------------------ccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--H
Confidence 111223457889999999999999999999999999999999999994321 1
Q ss_pred chhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhhhhcc
Q 005102 644 MDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDALDRLIVS 712 (714)
Q Consensus 644 ~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~~ 712 (714)
. +.......... ....... ...++.+++.+||+.||++|||++++++.|+++..+
T Consensus 245 ~---~~~~~~~~~~~------~~~~~~~-----~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~ 299 (309)
T 3p86_A 245 A---QVVAAVGFKCK------RLEIPRN-----LNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKS 299 (309)
T ss_dssp H---HHHHHHHHSCC------CCCCCTT-----SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-
T ss_pred H---HHHHHHHhcCC------CCCCCcc-----CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 1 11111111111 0111111 123588999999999999999999999999998754
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-43 Score=368.53 Aligned_cols=240 Identities=22% Similarity=0.287 Sum_probs=197.9
Q ss_pred ccccccCceEEEEEEE-CCCcEEEEEEeCCC--CchhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCCC
Q 005102 409 FVLGKSGIGIVYKVVL-EDGHTLAVRRLGEG--GSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGS 485 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gs 485 (714)
+.||+|+||.||+|++ .+|+.||||++... .....+.+.+|++++++++||||+++++++...+..++||||+++|+
T Consensus 21 ~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~~~ 100 (328)
T 3fe3_A 21 KTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGE 100 (328)
T ss_dssp EEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTTCB
T ss_pred EEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEECCCCCc
Confidence 4799999999999998 46999999999764 33445678899999999999999999999999999999999999999
Q ss_pred HhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCCC
Q 005102 486 LATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSP 565 (714)
Q Consensus 486 L~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 565 (714)
|.+++... ..+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++.....
T Consensus 101 L~~~l~~~------~~l~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~---- 167 (328)
T 3fe3_A 101 VFDYLVAH------GRMKEKEARSKFRQIVSAVQYCHQ---KRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVG---- 167 (328)
T ss_dssp HHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSS----
T ss_pred HHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCEeccCCCHHHEEEcCCCCEEEeeccCceecCCC----
Confidence 99999765 458999999999999999999999 89999999999999999999999999999765321
Q ss_pred CccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCC-chhhhHHHHHHHHHHHhCCCccccCCCCcc
Q 005102 566 TLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPS-QKWDIYSYGVILLEMITGRTAVVQVGSSEM 644 (714)
Q Consensus 566 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s-~~~DVwS~Gvvl~elltG~~p~~~~~~~~~ 644 (714)
.......||+.|+|||++.+..++ .++||||+||++|||++|+.||...
T Consensus 168 -------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~----- 217 (328)
T 3fe3_A 168 -------------------------GKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQ----- 217 (328)
T ss_dssp -------------------------CGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCS-----
T ss_pred -------------------------CccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCC-----
Confidence 112334579999999999888765 8999999999999999999999432
Q ss_pred hhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 005102 645 DLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISD 704 (714)
Q Consensus 645 ~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 704 (714)
+................ .. ....+.+++.+||..||++|||++|+++
T Consensus 218 ~~~~~~~~i~~~~~~~p--------~~-----~s~~~~~li~~~L~~dP~~R~t~~eil~ 264 (328)
T 3fe3_A 218 NLKELRERVLRGKYRIP--------FY-----MSTDCENLLKRFLVLNPIKRGTLEQIMK 264 (328)
T ss_dssp SHHHHHHHHHHCCCCCC--------TT-----SCHHHHHHHHHHCCSSTTTSCCHHHHTT
T ss_pred CHHHHHHHHHhCCCCCC--------CC-----CCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 22233333333222111 11 1225779999999999999999999875
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-43 Score=368.64 Aligned_cols=255 Identities=25% Similarity=0.402 Sum_probs=203.5
Q ss_pred ccccccCceEEEEEEEC----CCcEEEEEEeCCC-CchhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCC
Q 005102 409 FVLGKSGIGIVYKVVLE----DGHTLAVRRLGEG-GSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPN 483 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~----~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~ 483 (714)
+.||+|+||.||+|.+. .+..||||++... .....+.|.+|++++++++||||+++++++...+..++||||+++
T Consensus 55 ~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 134 (325)
T 3kul_A 55 KIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMEN 134 (325)
T ss_dssp EEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEEEEECCTT
T ss_pred eEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEEEeeCCCC
Confidence 58999999999999985 3456999999875 334456799999999999999999999999999999999999999
Q ss_pred CCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCC
Q 005102 484 GSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGG 563 (714)
Q Consensus 484 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 563 (714)
|+|.+++.... ..+++.++..|+.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++.......
T Consensus 135 ~~L~~~l~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 206 (325)
T 3kul_A 135 GSLDTFLRTHD-----GQFTIMQLVGMLRGVGAGMRYLSD---LGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPD 206 (325)
T ss_dssp CBHHHHHHTTT-----TCSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCSSCEECC----
T ss_pred CcHHHHHHhcc-----cCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCcceEEECCCCCEEECCCCcccccccCcc
Confidence 99999997653 458999999999999999999999 8999999999999999999999999999986543211
Q ss_pred CCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHh-CCCccccCCCC
Q 005102 564 SPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMIT-GRTAVVQVGSS 642 (714)
Q Consensus 564 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~ellt-G~~p~~~~~~~ 642 (714)
. ........+|+.|+|||++.+..++.++|||||||++|||++ |+.||.....
T Consensus 207 ~-------------------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~- 260 (325)
T 3kul_A 207 A-------------------------AYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTN- 260 (325)
T ss_dssp C-------------------------CEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCH-
T ss_pred c-------------------------eeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCH-
Confidence 0 111223345778999999988899999999999999999999 9999943321
Q ss_pred cchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhhhhccC
Q 005102 643 EMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDALDRLIVSS 713 (714)
Q Consensus 643 ~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~~~ 713 (714)
. ........ ... ...... ....+.+++.+||+.||++|||++||++.|+++....
T Consensus 261 -~---~~~~~~~~-~~~------~~~~~~-----~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~ 315 (325)
T 3kul_A 261 -R---DVISSVEE-GYR------LPAPMG-----CPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSP 315 (325)
T ss_dssp -H---HHHHHHHT-TCC------CCCCTT-----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSC
T ss_pred -H---HHHHHHHc-CCC------CCCCCC-----cCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCc
Confidence 1 11221111 111 111111 2236889999999999999999999999999987653
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=372.52 Aligned_cols=258 Identities=25% Similarity=0.386 Sum_probs=204.8
Q ss_pred cccccccCceEEEEEEEC--------CCcEEEEEEeCCCCc-hhHHHHHHHHHHHhcc-CCCCccceEEEEEeCCceeEE
Q 005102 408 AFVLGKSGIGIVYKVVLE--------DGHTLAVRRLGEGGS-QRFKEFQTEVEAIGKI-RHSNIVTLRAYYWSVDEKLLI 477 (714)
Q Consensus 408 ~~~lG~G~~g~Vy~~~~~--------~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV 477 (714)
.+.||+|+||.||+|++. ++..||||+++.... ...+.+.+|+++++++ +||||+++++++...+..|+|
T Consensus 86 ~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv 165 (370)
T 2psq_A 86 GKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVI 165 (370)
T ss_dssp EEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSSSSCEEE
T ss_pred eeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccCCCEEEE
Confidence 357999999999999863 356799999986533 3456799999999999 899999999999999999999
Q ss_pred EeccCCCCHhhhhhCCCCC----------CCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCe
Q 005102 478 YDYIPNGSLATALHGKPGM----------VSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEP 547 (714)
Q Consensus 478 ~e~~~~gsL~~~l~~~~~~----------~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~ 547 (714)
|||+++|+|.+++...... .....+++.+++.++.||+.||+|||+ ++|+||||||+|||++.++.+
T Consensus 166 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~ 242 (370)
T 2psq_A 166 VEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS---QKCIHRDLAARNVLVTENNVM 242 (370)
T ss_dssp EECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCE
T ss_pred EEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCeeccccchhhEEECCCCCE
Confidence 9999999999999764310 112358999999999999999999999 899999999999999999999
Q ss_pred EEcccchhhhhhccCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHH
Q 005102 548 HVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILL 627 (714)
Q Consensus 548 kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~ 627 (714)
||+|||+++....... ........+|+.|+|||++.+..++.++|||||||++|
T Consensus 243 kl~DFG~a~~~~~~~~--------------------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ 296 (370)
T 2psq_A 243 KIADFGLARDINNIDY--------------------------YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMW 296 (370)
T ss_dssp EECCCSSCEETTCCCT--------------------------TCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHH
T ss_pred EEccccCCcccCcccc--------------------------eecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHH
Confidence 9999999986542211 01122334578899999999999999999999999999
Q ss_pred HHHh-CCCccccCCCCcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHH
Q 005102 628 EMIT-GRTAVVQVGSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDAL 706 (714)
Q Consensus 628 ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L 706 (714)
||+| |+.||..... .++.. . +..... +..... ....+.+++.+||+.||++|||++|+++.|
T Consensus 297 ellt~g~~p~~~~~~--~~~~~---~-~~~~~~------~~~~~~-----~~~~l~~li~~~l~~dP~~Rpt~~ell~~L 359 (370)
T 2psq_A 297 EIFTLGGSPYPGIPV--EELFK---L-LKEGHR------MDKPAN-----CTNELYMMMRDCWHAVPSQRPTFKQLVEDL 359 (370)
T ss_dssp HHHTTSCCSSTTCCG--GGHHH---H-HHTTCC------CCCCTT-----SCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHcCCCCCCCCCCH--HHHHH---H-HhcCCC------CCCCCC-----CCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 9999 9999954321 22221 1 111111 111111 223688999999999999999999999999
Q ss_pred hhhhc
Q 005102 707 DRLIV 711 (714)
Q Consensus 707 ~~i~~ 711 (714)
+++..
T Consensus 360 ~~il~ 364 (370)
T 2psq_A 360 DRILT 364 (370)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 99864
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-42 Score=364.38 Aligned_cols=243 Identities=21% Similarity=0.324 Sum_probs=200.0
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeCCCCchhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCCCHh
Q 005102 409 FVLGKSGIGIVYKVVLE-DGHTLAVRRLGEGGSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGSLA 487 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL~ 487 (714)
+.||+|+||.||+|+.. +|+.||||++........+.+.+|+.++++++||||+++++++...+..++||||+++|+|.
T Consensus 51 ~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~ 130 (321)
T 2c30_A 51 VKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALT 130 (321)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECCCCSCBHH
T ss_pred EEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEecCCCCCHH
Confidence 47999999999999987 69999999998776666788999999999999999999999999999999999999999999
Q ss_pred hhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCCCCc
Q 005102 488 TALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTL 567 (714)
Q Consensus 488 ~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 567 (714)
+++... .+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++......
T Consensus 131 ~~l~~~-------~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~----- 195 (321)
T 2c30_A 131 DIVSQV-------RLNEEQIATVCEAVLQALAYLHA---QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV----- 195 (321)
T ss_dssp HHHTTC-------CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSS-----
T ss_pred HHHHhc-------CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCcEEEeeeeeeeecccCc-----
Confidence 998643 48999999999999999999999 899999999999999999999999999987643211
Q ss_pred cCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCccccCCCCcchhH
Q 005102 568 QSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGSSEMDLV 647 (714)
Q Consensus 568 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~~~~~~~~~~l~ 647 (714)
.......||+.|+|||++.+..++.++||||||+++|||++|+.||.... . .
T Consensus 196 -----------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~--~---~ 247 (321)
T 2c30_A 196 -----------------------PKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDS--P---V 247 (321)
T ss_dssp -----------------------CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC--H---H
T ss_pred -----------------------cccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--H---H
Confidence 11223457899999999999999999999999999999999999994321 1 1
Q ss_pred HHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 005102 648 NWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISD 704 (714)
Q Consensus 648 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 704 (714)
..+........ +.... .......+.+++.+||+.||++|||++|+++
T Consensus 248 ~~~~~~~~~~~-------~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 294 (321)
T 2c30_A 248 QAMKRLRDSPP-------PKLKN---SHKVSPVLRDFLERMLVRDPQERATAQELLD 294 (321)
T ss_dssp HHHHHHHHSSC-------CCCTT---GGGSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHHHHHhcCCC-------CCcCc---cccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 22222222111 11111 0112235789999999999999999999986
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=354.71 Aligned_cols=251 Identities=22% Similarity=0.357 Sum_probs=205.8
Q ss_pred ccccccCceEEEEEEECCCcEEEEEEeCCCCchhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCCCHhh
Q 005102 409 FVLGKSGIGIVYKVVLEDGHTLAVRRLGEGGSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGSLAT 488 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL~~ 488 (714)
+.||+|+||.||+|.+.+++.||+|++...... .+++.+|++++++++||||+++++++.+.+..++||||+++|+|.+
T Consensus 16 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~-~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 94 (269)
T 4hcu_A 16 QEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS-EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSD 94 (269)
T ss_dssp EEEEECSSCEEEEEEETTTEEEEEEEECTTSBC-HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHH
T ss_pred heecCCCccEEEEEEecCCCeEEEEEecccccC-HHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCCCCcHHH
Confidence 479999999999999988999999999875433 3679999999999999999999999999999999999999999999
Q ss_pred hhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCCCCcc
Q 005102 489 ALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQ 568 (714)
Q Consensus 489 ~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 568 (714)
++.... ..+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++......
T Consensus 95 ~l~~~~-----~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~------ 160 (269)
T 4hcu_A 95 YLRTQR-----GLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ------ 160 (269)
T ss_dssp HHHTTT-----TCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHH------
T ss_pred HHHhcC-----cccCHHHHHHHHHHHHHHHHHHHh---CCeecCCcchheEEEcCCCCEEeccccccccccccc------
Confidence 997654 458999999999999999999999 899999999999999999999999999998653210
Q ss_pred CCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHh-CCCccccCCCCcchhH
Q 005102 569 SNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMIT-GRTAVVQVGSSEMDLV 647 (714)
Q Consensus 569 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~ellt-G~~p~~~~~~~~~~l~ 647 (714)
........+|+.|+|||.+.+..++.++||||||+++|||++ |+.||.... ..
T Consensus 161 ---------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~-----~~ 214 (269)
T 4hcu_A 161 ---------------------YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS-----NS 214 (269)
T ss_dssp ---------------------HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC-----HH
T ss_pred ---------------------cccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCC-----HH
Confidence 112223345778999999998899999999999999999999 999994321 11
Q ss_pred HHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhhhhcc
Q 005102 648 NWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDALDRLIVS 712 (714)
Q Consensus 648 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~~ 712 (714)
+.......... +..... ....+.+++.+||+.||++|||++|+++.|+++..+
T Consensus 215 ~~~~~~~~~~~-------~~~~~~-----~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~~ 267 (269)
T 4hcu_A 215 EVVEDISTGFR-------LYKPRL-----ASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 267 (269)
T ss_dssp HHHHHHHTTCC-------CCCCTT-----SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHHHHHhcCcc-------CCCCCc-----CCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHHc
Confidence 22222111111 111111 123588999999999999999999999999998764
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=361.85 Aligned_cols=243 Identities=22% Similarity=0.358 Sum_probs=198.8
Q ss_pred ccccccCceEEEEEEE-CCCcEEEEEEeCCCCchhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCCCHh
Q 005102 409 FVLGKSGIGIVYKVVL-EDGHTLAVRRLGEGGSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGSLA 487 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL~ 487 (714)
+.||+|+||+||+|.. .+++.||||++........+.+.+|+.++++++||||+++++++...+..++||||+++|+|.
T Consensus 26 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 105 (297)
T 3fxz_A 26 EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT 105 (297)
T ss_dssp EEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHH
T ss_pred eeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEECCCCCCHH
Confidence 4799999999999996 458999999997765556678999999999999999999999999999999999999999999
Q ss_pred hhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCCCCc
Q 005102 488 TALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTL 567 (714)
Q Consensus 488 ~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 567 (714)
+++... .+++.++..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++......
T Consensus 106 ~~~~~~-------~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~----- 170 (297)
T 3fxz_A 106 DVVTET-------CMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ----- 170 (297)
T ss_dssp HHHHHS-------CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT-----
T ss_pred HHHhhc-------CCCHHHHHHHHHHHHHHHHHHHh---CCceeCCCCHHHEEECCCCCEEEeeCCCceecCCcc-----
Confidence 999753 48899999999999999999999 899999999999999999999999999987653211
Q ss_pred cCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCccccCCCCcchhH
Q 005102 568 QSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGSSEMDLV 647 (714)
Q Consensus 568 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~~~~~~~~~~l~ 647 (714)
.......||+.|+|||++.+..++.++|||||||++|||+||+.||..... .
T Consensus 171 -----------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-----~ 222 (297)
T 3fxz_A 171 -----------------------SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP-----L 222 (297)
T ss_dssp -----------------------CCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-----H
T ss_pred -----------------------cccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH-----H
Confidence 112334579999999999999999999999999999999999999943211 1
Q ss_pred HHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 005102 648 NWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISD 704 (714)
Q Consensus 648 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 704 (714)
............ .... .......+.+++.+||+.||++|||++|+++
T Consensus 223 ~~~~~~~~~~~~--~~~~--------~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 269 (297)
T 3fxz_A 223 RALYLIATNGTP--ELQN--------PEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ 269 (297)
T ss_dssp HHHHHHHHHCSC--CCSC--------GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred HHHHHHHhCCCC--CCCC--------ccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 111111222111 0000 1112235789999999999999999999975
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=361.55 Aligned_cols=257 Identities=24% Similarity=0.344 Sum_probs=198.1
Q ss_pred ccccccCceEEEEEEECCCcEEEEEEeCCCCchhHHHHHHHHHHHhc--cCCCCccceEEEEEeC----CceeEEEeccC
Q 005102 409 FVLGKSGIGIVYKVVLEDGHTLAVRRLGEGGSQRFKEFQTEVEAIGK--IRHSNIVTLRAYYWSV----DEKLLIYDYIP 482 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~H~niv~l~~~~~~~----~~~~lV~e~~~ 482 (714)
+.||+|+||+||+|++ +++.||||++.... .+.+.+|.+++.. ++||||+++++++... ...++||||++
T Consensus 14 ~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~---~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~lv~e~~~ 89 (301)
T 3q4u_A 14 ECVGKGRYGEVWRGSW-QGENVAVKIFSSRD---EKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHE 89 (301)
T ss_dssp EEEEECSSEEEEEEEE-TTEEEEEEEECGGG---HHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEEEECCCT
T ss_pred EeeccCCCcEEEEEEE-CCEEEEEEEecccc---chhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEEehhhcc
Confidence 4799999999999998 68999999997542 3456667766665 7999999999997653 45789999999
Q ss_pred CCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHh--------cCCCCCceecCCCCCCeeeCCCCCeEEcccch
Q 005102 483 NGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLH--------EFSPKKYVHGDLKPSNILLGHNMEPHVSDFGL 554 (714)
Q Consensus 483 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH--------~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGl 554 (714)
+|+|.++++. ..+++..+.+|+.|++.||+||| + ++|+||||||+|||++.++.+||+|||+
T Consensus 90 ~g~L~~~l~~-------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~---~~ivH~Dlkp~Nill~~~~~~kl~Dfg~ 159 (301)
T 3q4u_A 90 MGSLYDYLQL-------TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGK---PAIAHRDLKSKNILVKKNGQCCIADLGL 159 (301)
T ss_dssp TCBHHHHHTT-------CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCB---CEEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred CCCHHHHHhh-------cccCHHHHHHHHHHHHHHHHHHHHhhhhccCC---CCeecCCCChHhEEEcCCCCEEEeeCCC
Confidence 9999999953 35899999999999999999999 7 8999999999999999999999999999
Q ss_pred hhhhhccCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCC------CCCchhhhHHHHHHHHH
Q 005102 555 ARLANIAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVV------KPSQKWDIYSYGVILLE 628 (714)
Q Consensus 555 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~s~~~DVwS~Gvvl~e 628 (714)
++....... ..........||+.|+|||++.+. .++.++|||||||++||
T Consensus 160 a~~~~~~~~------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~e 215 (301)
T 3q4u_A 160 AVMHSQSTN------------------------QLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWE 215 (301)
T ss_dssp CEEEETTTT------------------------EEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHH
T ss_pred eeecccccc------------------------cccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHH
Confidence 976542211 001122334689999999999876 45579999999999999
Q ss_pred HHhC----------CCccccCCCCcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCC
Q 005102 629 MITG----------RTAVVQVGSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPT 698 (714)
Q Consensus 629 lltG----------~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt 698 (714)
|+|| +.||................ ..... ..+..............+.+++.+||+.||++|||
T Consensus 216 l~tg~~~~~~~~~~~~pf~~~~~~~~~~~~~~~~-~~~~~-----~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps 289 (301)
T 3q4u_A 216 VARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKV-VCVDQ-----QRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLT 289 (301)
T ss_dssp HHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHH-HTTSC-----CCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCC
T ss_pred HHhhhcCccccccccccccccCCCCcchhhhhHH-HhccC-----CCCCCChhhccCccHHHHHHHHHHHhhcChhhCCC
Confidence 9999 88885543333332222221 11111 11222211122345678999999999999999999
Q ss_pred HHHHHHHHhhh
Q 005102 699 MRHISDALDRL 709 (714)
Q Consensus 699 ~~evl~~L~~i 709 (714)
++||++.|++|
T Consensus 290 ~~~i~~~L~~i 300 (301)
T 3q4u_A 290 ALRIKKTLTKI 300 (301)
T ss_dssp HHHHHHHHHHH
T ss_pred HHHHHHHHhcc
Confidence 99999999986
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=374.33 Aligned_cols=255 Identities=26% Similarity=0.453 Sum_probs=194.0
Q ss_pred cccccccCceEEEEEEEC----CCcEEEEEEeCCCC-chhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccC
Q 005102 408 AFVLGKSGIGIVYKVVLE----DGHTLAVRRLGEGG-SQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIP 482 (714)
Q Consensus 408 ~~~lG~G~~g~Vy~~~~~----~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~ 482 (714)
.+.||+|+||.||+|++. ++..||||+++... ....+.|.+|++++++++||||+++++++...+..++||||++
T Consensus 50 ~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 129 (373)
T 2qol_A 50 DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYME 129 (373)
T ss_dssp CEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred eeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEEEeCCC
Confidence 358999999999999875 47789999998653 3445679999999999999999999999999999999999999
Q ss_pred CCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccC
Q 005102 483 NGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAG 562 (714)
Q Consensus 483 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 562 (714)
+|+|.++++... ..+++.++..|+.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++......
T Consensus 130 ~~sL~~~l~~~~-----~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 201 (373)
T 2qol_A 130 NGSLDSFLRKHD-----AQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDP 201 (373)
T ss_dssp TCBHHHHHHTTT-----TCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred CCcHHHHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCcceEEEcCCCCEEECcCccccccccCC
Confidence 999999998653 458999999999999999999999 899999999999999999999999999998764321
Q ss_pred CCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHh-CCCccccCCC
Q 005102 563 GSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMIT-GRTAVVQVGS 641 (714)
Q Consensus 563 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~ellt-G~~p~~~~~~ 641 (714)
.. ........++..|+|||++.+..++.++|||||||++|||++ |+.||....
T Consensus 202 ~~-------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~- 255 (373)
T 2qol_A 202 EA-------------------------AYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMS- 255 (373)
T ss_dssp -------------------------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCC-
T ss_pred cc-------------------------ceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCC-
Confidence 10 001112234677999999998999999999999999999998 999995332
Q ss_pred CcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhhhhcc
Q 005102 642 SEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDALDRLIVS 712 (714)
Q Consensus 642 ~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~~ 712 (714)
.. +..... ...... + ... .....+.+++.+||+.||++|||+++|++.|+++...
T Consensus 256 -~~---~~~~~i-~~~~~~-----~-~~~-----~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~ 310 (373)
T 2qol_A 256 -NQ---DVIKAV-DEGYRL-----P-PPM-----DCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN 310 (373)
T ss_dssp -HH---HHHHHH-HTTEEC-----C-CCT-----TCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred -HH---HHHHHH-HcCCCC-----C-CCc-----cccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhC
Confidence 11 112111 111100 0 011 1223688999999999999999999999999998653
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=361.78 Aligned_cols=260 Identities=24% Similarity=0.378 Sum_probs=201.6
Q ss_pred ccccccCceEEEEEEE-----CCCcEEEEEEeCCCCchhHHHHHHHHHHHhccCCCCccceEEEEEeC--CceeEEEecc
Q 005102 409 FVLGKSGIGIVYKVVL-----EDGHTLAVRRLGEGGSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSV--DEKLLIYDYI 481 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~-----~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~~lV~e~~ 481 (714)
+.||+|+||+||+|++ .+++.||||++........+.+.+|++++++++||||+++++++... ...++||||+
T Consensus 16 ~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~ 95 (295)
T 3ugc_A 16 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYL 95 (295)
T ss_dssp EEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSCEEEEECC
T ss_pred heeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCceEEEEEeC
Confidence 4799999999999985 25889999999887766678899999999999999999999998653 5689999999
Q ss_pred CCCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhcc
Q 005102 482 PNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIA 561 (714)
Q Consensus 482 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 561 (714)
++|+|.+++.... ..+++.++..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++.....
T Consensus 96 ~~~~L~~~l~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 167 (295)
T 3ugc_A 96 PYGSLRDYLQKHK-----ERIDHIKLLQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQD 167 (295)
T ss_dssp TTCBHHHHHHHCG-----GGCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCCCSCC-----
T ss_pred CCCCHHHHHHhcc-----cccCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHhhEEEcCCCeEEEccCcccccccCC
Confidence 9999999997653 358999999999999999999999 89999999999999999999999999999865432
Q ss_pred CCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCccccCCC
Q 005102 562 GGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGS 641 (714)
Q Consensus 562 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~~~~~~ 641 (714)
... ........++..|+|||.+.+..++.++||||||+++|||+||..|+.....
T Consensus 168 ~~~-------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~ 222 (295)
T 3ugc_A 168 KEF-------------------------FKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPA 222 (295)
T ss_dssp ---------------------------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHH
T ss_pred cce-------------------------eeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChH
Confidence 110 1112233457789999999989999999999999999999999998832110
Q ss_pred ----------CcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhhhhc
Q 005102 642 ----------SEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDALDRLIV 711 (714)
Q Consensus 642 ----------~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~ 711 (714)
........+......... ..... ....++.+++.+||+.||++|||++|+++.|+++..
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~-----~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~ 291 (295)
T 3ugc_A 223 EFMRMIGNDKQGQMIVFHLIELLKNNGR------LPRPD-----GCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD 291 (295)
T ss_dssp HHHHHHCTTCCTHHHHHHHHHHHHTTCC------CCCCT-----TCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHhhhcCccccchhHHHHHHHHhccCc------CCCCc-----CcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHH
Confidence 000011111111111111 01111 122368899999999999999999999999999876
Q ss_pred c
Q 005102 712 S 712 (714)
Q Consensus 712 ~ 712 (714)
.
T Consensus 292 ~ 292 (295)
T 3ugc_A 292 N 292 (295)
T ss_dssp C
T ss_pred h
Confidence 4
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-42 Score=362.97 Aligned_cols=241 Identities=21% Similarity=0.269 Sum_probs=197.2
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeCCC---CchhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCC
Q 005102 409 FVLGKSGIGIVYKVVLE-DGHTLAVRRLGEG---GSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNG 484 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~g 484 (714)
+.||+|+||+||+|+.+ +|+.||||++++. .......+.+|++++++++||||+++++++...+..++||||+++|
T Consensus 11 ~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~E~~~gg 90 (337)
T 1o6l_A 11 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 90 (337)
T ss_dssp EEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEECCTTC
T ss_pred EEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEEeCCCCC
Confidence 47999999999999986 5899999999754 2234567889999999999999999999999999999999999999
Q ss_pred CHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCC
Q 005102 485 SLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGS 564 (714)
Q Consensus 485 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 564 (714)
+|.+++... ..+++..+..++.||+.||+|||+ ++|+||||||+|||++.++++||+|||+++.....
T Consensus 91 ~L~~~l~~~------~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~--- 158 (337)
T 1o6l_A 91 ELFFHLSRE------RVFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD--- 158 (337)
T ss_dssp BHHHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT---
T ss_pred cHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCcCCHHHEEECCCCCEEEeeccchhhcccC---
Confidence 999999754 458999999999999999999999 89999999999999999999999999998753211
Q ss_pred CCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCccccCCCCcc
Q 005102 565 PTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGSSEM 644 (714)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~~~~~~~~~ 644 (714)
........||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 159 -------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~---- 209 (337)
T 1o6l_A 159 -------------------------GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD---- 209 (337)
T ss_dssp -------------------------TCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSS----
T ss_pred -------------------------CCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCC----
Confidence 011223457899999999999999999999999999999999999995321
Q ss_pred hhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCC-----CHHHHHH
Q 005102 645 DLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRP-----TMRHISD 704 (714)
Q Consensus 645 ~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----t~~evl~ 704 (714)
.............. .+... ..++.+++.+||+.||++|| +++|+++
T Consensus 210 -~~~~~~~i~~~~~~--------~p~~~-----s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~ 260 (337)
T 1o6l_A 210 -HERLFELILMEEIR--------FPRTL-----SPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp -HHHHHHHHHHCCCC--------CCTTS-----CHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred -HHHHHHHHHcCCCC--------CCCCC-----CHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHc
Confidence 12222222222211 11111 23578999999999999999 8888864
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=382.11 Aligned_cols=253 Identities=24% Similarity=0.432 Sum_probs=204.8
Q ss_pred cccccccCceEEEEEEECCCcEEEEEEeCCCCchhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCCCHh
Q 005102 408 AFVLGKSGIGIVYKVVLEDGHTLAVRRLGEGGSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGSLA 487 (714)
Q Consensus 408 ~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL~ 487 (714)
.+.||+|+||.||+|.+.++..||||+++.... ..+.|.+|+++|++++||||+++++++. .+..++||||+++|+|.
T Consensus 193 ~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~~~~g~L~ 270 (454)
T 1qcf_A 193 EKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSM-SVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEFMAKGSLL 270 (454)
T ss_dssp EEEEECCSSEEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECCCTTCBHH
T ss_pred EEEcccCCceEEEEEEECCccEEEEEEecCCCc-cHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEeecCCCcHH
Confidence 357999999999999998899999999987543 4578999999999999999999999986 66789999999999999
Q ss_pred hhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCCCCc
Q 005102 488 TALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTL 567 (714)
Q Consensus 488 ~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 567 (714)
++++.... ..+++..+.+++.||+.||+|||+ ++|+||||||+|||+++++.+||+|||+++......
T Consensus 271 ~~l~~~~~----~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~----- 338 (454)
T 1qcf_A 271 DFLKSDEG----SKQPLPKLIDFSAQIAEGMAFIEQ---RNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE----- 338 (454)
T ss_dssp HHHHSHHH----HTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHH-----
T ss_pred HHHHhccC----CCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCc-----
Confidence 99975421 358899999999999999999999 899999999999999999999999999998653210
Q ss_pred cCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHh-CCCccccCCCCcchh
Q 005102 568 QSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMIT-GRTAVVQVGSSEMDL 646 (714)
Q Consensus 568 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~ellt-G~~p~~~~~~~~~~l 646 (714)
........+|..|+|||++.+..++.++|||||||++|||+| |+.||.... ..
T Consensus 339 ----------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~--~~-- 392 (454)
T 1qcf_A 339 ----------------------YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMS--NP-- 392 (454)
T ss_dssp ----------------------HHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC--HH--
T ss_pred ----------------------eeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCC--HH--
Confidence 111122335678999999998899999999999999999999 999995322 11
Q ss_pred HHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhhhhccC
Q 005102 647 VNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDALDRLIVSS 713 (714)
Q Consensus 647 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~~~ 713 (714)
+....... .... .... .....+.+++.+||+.||++|||+++|++.|+++..+.
T Consensus 393 -~~~~~i~~-~~~~------~~~~-----~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~~ 446 (454)
T 1qcf_A 393 -EVIRALER-GYRM------PRPE-----NCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTAT 446 (454)
T ss_dssp -HHHHHHHH-TCCC------CCCT-----TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSSS
T ss_pred -HHHHHHHc-CCCC------CCCC-----CCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhcc
Confidence 22222211 1111 0111 12236889999999999999999999999999987653
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-42 Score=356.20 Aligned_cols=255 Identities=23% Similarity=0.336 Sum_probs=200.4
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeCCC---CchhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCC
Q 005102 409 FVLGKSGIGIVYKVVLE-DGHTLAVRRLGEG---GSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNG 484 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~g 484 (714)
+.||+|+||.||+|++. +++.||+|++... .....+.+.+|+.++++++||||+++++++...+..++||||+++|
T Consensus 17 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~g~ 96 (294)
T 4eqm_A 17 DKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGP 96 (294)
T ss_dssp EEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEEEECCCSC
T ss_pred EEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEEEeCCCCC
Confidence 47999999999999975 5899999998553 2334567999999999999999999999999999999999999999
Q ss_pred CHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCC
Q 005102 485 SLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGS 564 (714)
Q Consensus 485 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 564 (714)
+|.+++... ..+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++......
T Consensus 97 ~L~~~l~~~------~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-- 165 (294)
T 4eqm_A 97 TLSEYIESH------GPLSVDTAINFTNQILDGIKHAHD---MRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETS-- 165 (294)
T ss_dssp BHHHHHHHH------CSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCSSSTTC------
T ss_pred CHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEEeCCCcccccccc--
Confidence 999999755 458999999999999999999999 899999999999999999999999999998653211
Q ss_pred CCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCccccCCCCcc
Q 005102 565 PTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGSSEM 644 (714)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~~~~~~~~~ 644 (714)
........||+.|+|||.+.+..++.++||||||+++|||+||+.||.....
T Consensus 166 -------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~--- 217 (294)
T 4eqm_A 166 -------------------------LTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETA--- 217 (294)
T ss_dssp ----------------------------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCH---
T ss_pred -------------------------ccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh---
Confidence 1112234578999999999999999999999999999999999999943221
Q ss_pred hhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCC-CHHHHHHHHhhhhcc
Q 005102 645 DLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRP-TMRHISDALDRLIVS 712 (714)
Q Consensus 645 ~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RP-t~~evl~~L~~i~~~ 712 (714)
............+ .. ....... ....+.+++.+||+.||++|| +++++.+.|+++...
T Consensus 218 --~~~~~~~~~~~~~--~~-~~~~~~~-----~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~ 276 (294)
T 4eqm_A 218 --VSIAIKHIQDSVP--NV-TTDVRKD-----IPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHE 276 (294)
T ss_dssp --HHHHHHHHSSCCC--CH-HHHSCTT-----SCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSS
T ss_pred --HHHHHHHhhccCC--Cc-chhcccC-----CCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhh
Confidence 1111111211111 00 0001111 123688999999999999998 999999999987653
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-42 Score=351.30 Aligned_cols=251 Identities=22% Similarity=0.372 Sum_probs=204.4
Q ss_pred ccccccCceEEEEEEECCCcEEEEEEeCCCCchhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCCCHhh
Q 005102 409 FVLGKSGIGIVYKVVLEDGHTLAVRRLGEGGSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGSLAT 488 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL~~ 488 (714)
+.||+|+||.||+|.++++..||||++...... .+++.+|++++++++||||+++++++...+..++||||+++++|.+
T Consensus 14 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~-~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 92 (268)
T 3sxs_A 14 KELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMS-EDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLN 92 (268)
T ss_dssp EEEEEETTEEEEEEEETTTEEEEEEEECBTTBC-HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHH
T ss_pred eeeccCCCceEEEEEecCceeEEEEEeccCCCc-HHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEccCCCcHHH
Confidence 479999999999999998889999999875433 3679999999999999999999999999999999999999999999
Q ss_pred hhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCCCCcc
Q 005102 489 ALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQ 568 (714)
Q Consensus 489 ~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 568 (714)
++.... ..+++.++..|+.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++......
T Consensus 93 ~l~~~~-----~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~------ 158 (268)
T 3sxs_A 93 YLRSHG-----KGLEPSQLLEMCYDVCEGMAFLES---HQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ------ 158 (268)
T ss_dssp HHHHHG-----GGCCHHHHHHHHHHHHHHHHHHHH---TTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTC------
T ss_pred HHHHcC-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCcCcceEEECCCCCEEEccCccceecchhh------
Confidence 997542 358999999999999999999999 899999999999999999999999999997653211
Q ss_pred CCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHh-CCCccccCCCCcchhH
Q 005102 569 SNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMIT-GRTAVVQVGSSEMDLV 647 (714)
Q Consensus 569 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~ellt-G~~p~~~~~~~~~~l~ 647 (714)
........+|+.|+|||.+.+..++.++||||||+++|||+| |+.||..... .
T Consensus 159 ---------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~-----~ 212 (268)
T 3sxs_A 159 ---------------------YVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTN-----S 212 (268)
T ss_dssp ---------------------EEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCH-----H
T ss_pred ---------------------hhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccCh-----H
Confidence 112223345778999999988889999999999999999999 9999943221 1
Q ss_pred HHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhhhhcc
Q 005102 648 NWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDALDRLIVS 712 (714)
Q Consensus 648 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~~ 712 (714)
........... ...+. . ....+.+++.+||+.||++|||++|+++.|+++...
T Consensus 213 ~~~~~~~~~~~----~~~~~----~----~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (268)
T 3sxs_A 213 EVVLKVSQGHR----LYRPH----L----ASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREK 265 (268)
T ss_dssp HHHHHHHTTCC----CCCCT----T----SCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC-
T ss_pred HHHHHHHcCCC----CCCCC----c----ChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhc
Confidence 11111111111 01111 1 123588999999999999999999999999998764
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-43 Score=375.66 Aligned_cols=254 Identities=21% Similarity=0.314 Sum_probs=202.8
Q ss_pred cccccccCceEEEEEEEC-CCcEEEEEEeCCCCc-hhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCCC
Q 005102 408 AFVLGKSGIGIVYKVVLE-DGHTLAVRRLGEGGS-QRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGS 485 (714)
Q Consensus 408 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gs 485 (714)
.+.||+|+||.||+|.+. +++.||||+++.... ...+.|.+|+++|++++||||+++++++...+..++||||+++|+
T Consensus 119 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~ 198 (377)
T 3cbl_A 119 GEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGD 198 (377)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTCB
T ss_pred eeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEEcCCCCC
Confidence 357999999999999987 689999999986533 334568899999999999999999999999999999999999999
Q ss_pred HhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCCC
Q 005102 486 LATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSP 565 (714)
Q Consensus 486 L~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 565 (714)
|.+++.... ..+++..+..++.|++.||+|||+ ++|+||||||+|||+++++.+||+|||+++......
T Consensus 199 L~~~l~~~~-----~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~--- 267 (377)
T 3cbl_A 199 FLTFLRTEG-----ARLRVKTLLQMVGDAAAGMEYLES---KCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGV--- 267 (377)
T ss_dssp HHHHHHHHG-----GGCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCGGGCEECTTSE---
T ss_pred HHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHH---CCcCCcccCHHHEEEcCCCcEEECcCCCceecCCCc---
Confidence 999997542 358999999999999999999999 899999999999999999999999999997532110
Q ss_pred CccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHh-CCCccccCCCCcc
Q 005102 566 TLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMIT-GRTAVVQVGSSEM 644 (714)
Q Consensus 566 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~ellt-G~~p~~~~~~~~~ 644 (714)
.........++..|+|||.+.+..++.++|||||||++|||+| |+.||..... .
T Consensus 268 -----------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~--~ 322 (377)
T 3cbl_A 268 -----------------------YAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSN--Q 322 (377)
T ss_dssp -----------------------EECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCH--H
T ss_pred -----------------------eeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH--H
Confidence 0111111223567999999988889999999999999999999 9999953321 1
Q ss_pred hhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhhhhcc
Q 005102 645 DLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDALDRLIVS 712 (714)
Q Consensus 645 ~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~~ 712 (714)
.... .+...... ..... ....+.+++.+||+.||++|||++++++.|+++...
T Consensus 323 ~~~~----~~~~~~~~------~~~~~-----~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~ 375 (377)
T 3cbl_A 323 QTRE----FVEKGGRL------PCPEL-----CPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKR 375 (377)
T ss_dssp HHHH----HHHTTCCC------CCCTT-----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHH----HHHcCCCC------CCCCC-----CCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHhh
Confidence 1111 11221110 01111 123688999999999999999999999999998753
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=362.88 Aligned_cols=244 Identities=23% Similarity=0.266 Sum_probs=197.4
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeCCCCch------hHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEecc
Q 005102 409 FVLGKSGIGIVYKVVLE-DGHTLAVRRLGEGGSQ------RFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYI 481 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~ 481 (714)
+.||+|+||.||+|+.+ +|+.||||++...... ..+.+.+|++++++++||||+++++++.+.+..++||||+
T Consensus 18 ~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e~~ 97 (361)
T 2yab_A 18 EELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVVLILELV 97 (361)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred eEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEEEEEEEcC
Confidence 57999999999999986 4899999999764321 3468999999999999999999999999999999999999
Q ss_pred CCCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCC----CeEEcccchhhh
Q 005102 482 PNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNM----EPHVSDFGLARL 557 (714)
Q Consensus 482 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~----~~kl~DFGla~~ 557 (714)
++|+|.+++... ..+++..+..++.||+.||+|||+ .+|+||||||+|||+++++ .+||+|||+++.
T Consensus 98 ~gg~L~~~l~~~------~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~ 168 (361)
T 2yab_A 98 SGGELFDFLAQK------ESLSEEEATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE 168 (361)
T ss_dssp CSCBHHHHHTTC------SCCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCTTSSSCCEEECCCSSCEE
T ss_pred CCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEeCCCCCccCEEEEecCCceE
Confidence 999999999754 458999999999999999999999 8999999999999998877 799999999986
Q ss_pred hhccCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCccc
Q 005102 558 ANIAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVV 637 (714)
Q Consensus 558 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~~ 637 (714)
..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus 169 ~~~~~-----------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~ 219 (361)
T 2yab_A 169 IEDGV-----------------------------EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL 219 (361)
T ss_dssp CCTTC-----------------------------CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSC
T ss_pred cCCCC-----------------------------ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCC
Confidence 53211 1223457999999999999899999999999999999999999994
Q ss_pred cCCCCcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 005102 638 QVGSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISD 704 (714)
Q Consensus 638 ~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 704 (714)
.. .. .+...........+.... .. .....+.+++.+||..||++|||++|+++
T Consensus 220 ~~--~~---~~~~~~i~~~~~~~~~~~----~~-----~~s~~~~~li~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 220 GD--TK---QETLANITAVSYDFDEEF----FS-----QTSELAKDFIRKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp CS--SH---HHHHHHHHTTCCCCCHHH----HT-----TSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CC--CH---HHHHHHHHhcCCCCCchh----cc-----CCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 32 11 122222222211111000 00 11235789999999999999999999874
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=351.46 Aligned_cols=251 Identities=23% Similarity=0.337 Sum_probs=202.3
Q ss_pred ccccccCceEEEEEEECCCcEEEEEEeCCCCchhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCCCHhh
Q 005102 409 FVLGKSGIGIVYKVVLEDGHTLAVRRLGEGGSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGSLAT 488 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL~~ 488 (714)
+.||+|+||.||++.+.++..||||++...... .+++.+|++++++++||||+++++++...+..++||||+++|+|.+
T Consensus 30 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~-~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 108 (283)
T 3gen_A 30 KELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS-EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLN 108 (283)
T ss_dssp EECC---CEEEEEEEETTTEEEEEEEECTTSBC-HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCCTTCBHHH
T ss_pred hhcCCCCCceEEEEEEcCCCeEEEEEecCCCCC-HHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEeccCCCcHHH
Confidence 479999999999999998899999999875433 3679999999999999999999999999999999999999999999
Q ss_pred hhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCCCCcc
Q 005102 489 ALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQ 568 (714)
Q Consensus 489 ~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 568 (714)
++.... ..+++.++..|+.|++.||+|||+ ++|+||||||+||++++++.+||+|||+++......
T Consensus 109 ~l~~~~-----~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~------ 174 (283)
T 3gen_A 109 YLREMR-----HRFQTQQLLEMCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE------ 174 (283)
T ss_dssp HHHCGG-----GCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHH------
T ss_pred HHHHhc-----cCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCCccceEEEcCCCCEEEccccccccccccc------
Confidence 997643 458999999999999999999999 899999999999999999999999999998653210
Q ss_pred CCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHh-CCCccccCCCCcchhH
Q 005102 569 SNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMIT-GRTAVVQVGSSEMDLV 647 (714)
Q Consensus 569 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~ellt-G~~p~~~~~~~~~~l~ 647 (714)
........+|+.|+|||.+.+..++.++||||||+++|||+| |+.||..... .
T Consensus 175 ---------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~-----~ 228 (283)
T 3gen_A 175 ---------------------YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN-----S 228 (283)
T ss_dssp ---------------------HHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCH-----H
T ss_pred ---------------------cccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccCh-----h
Confidence 111223345778999999998899999999999999999999 9999943221 1
Q ss_pred HHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhhhhcc
Q 005102 648 NWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDALDRLIVS 712 (714)
Q Consensus 648 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~~ 712 (714)
........... ...... ....+.+++.+||+.||++|||++|+++.|+++...
T Consensus 229 ~~~~~~~~~~~-------~~~~~~-----~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~ 281 (283)
T 3gen_A 229 ETAEHIAQGLR-------LYRPHL-----ASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDE 281 (283)
T ss_dssp HHHHHHHTTCC-------CCCCTT-----CCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHhcccC-------CCCCCc-----CCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhhc
Confidence 11111111111 111111 123688999999999999999999999999998753
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=365.94 Aligned_cols=267 Identities=17% Similarity=0.218 Sum_probs=202.6
Q ss_pred ccccccCceEEEEEEECC------CcEEEEEEeCCCCchhH-----------HHHHHHHHHHhccCCCCccceEEEEEeC
Q 005102 409 FVLGKSGIGIVYKVVLED------GHTLAVRRLGEGGSQRF-----------KEFQTEVEAIGKIRHSNIVTLRAYYWSV 471 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~~------g~~vavK~~~~~~~~~~-----------~~~~~E~~~l~~l~H~niv~l~~~~~~~ 471 (714)
+.||+|+||.||+|.+.+ ++.||||++........ ..+..|+..+..++||||+++++++...
T Consensus 41 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~ 120 (364)
T 3op5_A 41 LPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGSGLHD 120 (364)
T ss_dssp EECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCEEEEEEEE
T ss_pred EEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeEEeeeeec
Confidence 479999999999999865 47899999876542111 2244566778888999999999999865
Q ss_pred ----CceeEEEeccCCCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeC--CCC
Q 005102 472 ----DEKLLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLG--HNM 545 (714)
Q Consensus 472 ----~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~--~~~ 545 (714)
...++||||+ +++|.+++.... ..+++..++.|+.||+.||+|||+ .+|+||||||+|||++ .++
T Consensus 121 ~~~~~~~~lv~e~~-g~~L~~~~~~~~-----~~l~~~~~~~i~~qi~~~l~~lH~---~~iiHrDlkp~Nill~~~~~~ 191 (364)
T 3op5_A 121 KNGKSYRFMIMDRF-GSDLQKIYEANA-----KRFSRKTVLQLSLRILDILEYIHE---HEYVHGDIKASNLLLNYKNPD 191 (364)
T ss_dssp ETTEEEEEEEEECE-EEEHHHHHHHTT-----SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEESSCTT
T ss_pred cCCcceEEEEEeCC-CCCHHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeEEecCCHHHEEEecCCCC
Confidence 4479999999 999999997653 459999999999999999999999 8999999999999999 889
Q ss_pred CeEEcccchhhhhhccCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHH
Q 005102 546 EPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVI 625 (714)
Q Consensus 546 ~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvv 625 (714)
.+||+|||+++.+......... .........||+.|+|||++.+..++.++|||||||+
T Consensus 192 ~~kl~DFG~a~~~~~~~~~~~~---------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~ 250 (364)
T 3op5_A 192 QVYLVDYGLAYRYCPEGVHKAY---------------------AADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYC 250 (364)
T ss_dssp CEEECCCTTCEESSGGGCCCCS---------------------SCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHH
T ss_pred eEEEEECCcceecccCCccccc---------------------ccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHH
Confidence 9999999999876533211000 0111234458999999999999999999999999999
Q ss_pred HHHHHhCCCccccCCCCcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 005102 626 LLEMITGRTAVVQVGSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDA 705 (714)
Q Consensus 626 l~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 705 (714)
+|||+||+.||...... ............. .+.++.++.+.... ...++.+++..||+.||++||++++|++.
T Consensus 251 l~el~~g~~Pf~~~~~~-~~~~~~~~~~~~~--~~~~~~~~~~~~~~----~~~~~~~li~~cl~~~p~~RP~~~~l~~~ 323 (364)
T 3op5_A 251 MIQWLTGHLPWEDNLKD-PKYVRDSKIRYRE--NIASLMDKCFPAAN----APGEIAKYMETVKLLDYTEKPLYENLRDI 323 (364)
T ss_dssp HHHHHHSCCTTGGGTTC-HHHHHHHHHHHHH--CHHHHHHHHSCTTC----CCHHHHHHHHHHHTCCTTCCCCHHHHHHH
T ss_pred HHHHHhCCCCccccccC-HHHHHHHHHHhhh--hHHHHHHHhccccc----CHHHHHHHHHHHhcCCCCCCCCHHHHHHH
Confidence 99999999999643222 2222222222211 23333333322111 12368899999999999999999999999
Q ss_pred Hhhhhcc
Q 005102 706 LDRLIVS 712 (714)
Q Consensus 706 L~~i~~~ 712 (714)
|+++...
T Consensus 324 l~~~~~~ 330 (364)
T 3op5_A 324 LLQGLKA 330 (364)
T ss_dssp HHHHHHH
T ss_pred HHHHHHH
Confidence 9998754
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=365.36 Aligned_cols=245 Identities=20% Similarity=0.259 Sum_probs=195.0
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeCCCCchhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCCCHh
Q 005102 409 FVLGKSGIGIVYKVVLE-DGHTLAVRRLGEGGSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGSLA 487 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL~ 487 (714)
+.||+|+||.||+|... +|+.||+|++........+.+.+|++++++++||||+++++++...+..++||||+++|+|.
T Consensus 95 ~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L~ 174 (373)
T 2x4f_A 95 EILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELF 174 (373)
T ss_dssp EECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEEH
T ss_pred eEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcHH
Confidence 47999999999999975 58999999998876666678999999999999999999999999999999999999999999
Q ss_pred hhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeee--CCCCCeEEcccchhhhhhccCCCC
Q 005102 488 TALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILL--GHNMEPHVSDFGLARLANIAGGSP 565 (714)
Q Consensus 488 ~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl--~~~~~~kl~DFGla~~~~~~~~~~ 565 (714)
+++.... ..+++..+..++.||+.||+|||+ .+|+||||||+|||+ ++++.+||+|||+++......
T Consensus 175 ~~l~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~--- 243 (373)
T 2x4f_A 175 DRIIDES-----YNLTELDTILFMKQICEGIRHMHQ---MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE--- 243 (373)
T ss_dssp HHHHHTG-----GGCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC---
T ss_pred HHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc---
Confidence 9886543 458999999999999999999999 899999999999999 677899999999998653211
Q ss_pred CccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCccccCCCCcch
Q 005102 566 TLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGSSEMD 645 (714)
Q Consensus 566 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~~~~~~~~~~ 645 (714)
......||+.|+|||++.+..++.++|||||||++|||++|+.||.... .
T Consensus 244 --------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~--~-- 293 (373)
T 2x4f_A 244 --------------------------KLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDN--D-- 293 (373)
T ss_dssp --------------------------BCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSS--H--
T ss_pred --------------------------ccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCC--H--
Confidence 1123357899999999998899999999999999999999999994321 1
Q ss_pred hHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 005102 646 LVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISD 704 (714)
Q Consensus 646 l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 704 (714)
.+.+............ ... . ....++.+++.+||+.||++|||++|+++
T Consensus 294 -~~~~~~i~~~~~~~~~---~~~-~-----~~~~~~~~li~~~L~~dp~~Rps~~e~l~ 342 (373)
T 2x4f_A 294 -AETLNNILACRWDLED---EEF-Q-----DISEEAKEFISKLLIKEKSWRISASEALK 342 (373)
T ss_dssp -HHHHHHHHHTCCCSCS---GGG-T-----TSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred -HHHHHHHHhccCCCCh---hhh-c-----cCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 1222222222221110 000 0 11236889999999999999999999986
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-41 Score=356.47 Aligned_cols=245 Identities=22% Similarity=0.284 Sum_probs=197.5
Q ss_pred cccccccCceEEEEEEEC-CCcEEEEEEeCCCCc------hhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEec
Q 005102 408 AFVLGKSGIGIVYKVVLE-DGHTLAVRRLGEGGS------QRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDY 480 (714)
Q Consensus 408 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~ 480 (714)
.+.||+|+||.||+|... +|+.||||++..... ...+.+.+|++++++++||||+++++++...+..++||||
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 95 (326)
T 2y0a_A 16 GEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILEL 95 (326)
T ss_dssp EEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred ceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEEc
Confidence 457999999999999986 489999999876422 1357899999999999999999999999999999999999
Q ss_pred cCCCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCC----CeEEcccchhh
Q 005102 481 IPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNM----EPHVSDFGLAR 556 (714)
Q Consensus 481 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~----~~kl~DFGla~ 556 (714)
+++|+|.+++... ..+++..+..++.|++.||+|||+ .+|+||||||+|||+++++ .+||+|||+++
T Consensus 96 ~~~~~L~~~l~~~------~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~ 166 (326)
T 2y0a_A 96 VAGGELFDFLAEK------ESLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 166 (326)
T ss_dssp CCSCBHHHHHTTS------SCCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred CCCCCHHHHHHhc------CCcCHHHHHHHHHHHHHHHHHHHH---CCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCe
Confidence 9999999999754 458999999999999999999999 8999999999999999887 79999999998
Q ss_pred hhhccCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCcc
Q 005102 557 LANIAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAV 636 (714)
Q Consensus 557 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~ 636 (714)
...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||
T Consensus 167 ~~~~~~-----------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf 217 (326)
T 2y0a_A 167 KIDFGN-----------------------------EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 217 (326)
T ss_dssp ECCTTS-----------------------------CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSS
T ss_pred ECCCCC-----------------------------ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCC
Confidence 653211 112345789999999999899999999999999999999999999
Q ss_pred ccCCCCcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 005102 637 VQVGSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISD 704 (714)
Q Consensus 637 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 704 (714)
.... . .+.................+ .....+.+++.+||+.||++|||++|+++
T Consensus 218 ~~~~--~---~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 271 (326)
T 2y0a_A 218 LGDT--K---QETLANVSAVNYEFEDEYFS---------NTSALAKDFIRRLLVKDPKKRMTIQDSLQ 271 (326)
T ss_dssp CCSS--H---HHHHHHHHHTCCCCCHHHHT---------TSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred CCCC--H---HHHHHHHHhcCCCcCccccc---------cCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 4321 1 11222222211111100000 11235789999999999999999999986
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-42 Score=366.72 Aligned_cols=257 Identities=23% Similarity=0.298 Sum_probs=202.6
Q ss_pred ccccccCceEEEEEEEC------CCcEEEEEEeCCC-CchhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEecc
Q 005102 409 FVLGKSGIGIVYKVVLE------DGHTLAVRRLGEG-GSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYI 481 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~------~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~ 481 (714)
+.||+|+||+||+|++. +++.||||++... ......++.+|+.++++++||||+++++++...+..++||||+
T Consensus 77 ~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~ 156 (367)
T 3l9p_A 77 RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELM 156 (367)
T ss_dssp EECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred eEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCEEEEEeC
Confidence 47999999999999953 3678999999764 3344567899999999999999999999999999999999999
Q ss_pred CCCCHhhhhhCCCCC-CCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCC---CeEEcccchhhh
Q 005102 482 PNGSLATALHGKPGM-VSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNM---EPHVSDFGLARL 557 (714)
Q Consensus 482 ~~gsL~~~l~~~~~~-~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~---~~kl~DFGla~~ 557 (714)
++|+|.+++...... .....+++.+++.|+.||+.||+|||+ ++|+||||||+|||++.++ .+||+|||+++.
T Consensus 157 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~~~~kL~DFG~a~~ 233 (367)
T 3l9p_A 157 AGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE---NHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARD 233 (367)
T ss_dssp TTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESCSSTTCCEEECCCHHHHH
T ss_pred CCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChhhEEEecCCCCceEEECCCccccc
Confidence 999999999754321 111358999999999999999999999 8999999999999999554 599999999987
Q ss_pred hhccCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHh-CCCcc
Q 005102 558 ANIAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMIT-GRTAV 636 (714)
Q Consensus 558 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~ellt-G~~p~ 636 (714)
...... ........||+.|+|||++.+..++.++|||||||++|||+| |+.||
T Consensus 234 ~~~~~~--------------------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf 287 (367)
T 3l9p_A 234 IYRAGY--------------------------YRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPY 287 (367)
T ss_dssp HHHHSS--------------------------CTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred cccccc--------------------------cccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 643321 111122345788999999998899999999999999999998 99999
Q ss_pred ccCCCCcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhhhhc
Q 005102 637 VQVGSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDALDRLIV 711 (714)
Q Consensus 637 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~ 711 (714)
.... .. +.......... +..... ....+.+++.+||+.||++|||+++|++.|+.+..
T Consensus 288 ~~~~--~~---~~~~~i~~~~~-------~~~~~~-----~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~ 345 (367)
T 3l9p_A 288 PSKS--NQ---EVLEFVTSGGR-------MDPPKN-----CPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ 345 (367)
T ss_dssp TTCC--HH---HHHHHHHTTCC-------CCCCTT-----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCC--HH---HHHHHHHcCCC-------CCCCcc-----CCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhh
Confidence 4321 11 22222222111 001111 12358899999999999999999999999998764
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=358.01 Aligned_cols=244 Identities=18% Similarity=0.243 Sum_probs=197.2
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeCCCCchhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCCCHh
Q 005102 409 FVLGKSGIGIVYKVVLE-DGHTLAVRRLGEGGSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGSLA 487 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL~ 487 (714)
+.||+|+||.||+|... +++.||+|.+.... .....+.+|++++++++||||+++++++.+.+..++||||+++|+|.
T Consensus 11 ~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~g~~L~ 89 (321)
T 1tki_A 11 EDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDIF 89 (321)
T ss_dssp EEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCCCBHH
T ss_pred eEEecCCCeEEEEEEECCCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEeCCCCCHH
Confidence 47999999999999986 48899999987643 33467899999999999999999999999999999999999999999
Q ss_pred hhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCC--CCCeEEcccchhhhhhccCCCC
Q 005102 488 TALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGH--NMEPHVSDFGLARLANIAGGSP 565 (714)
Q Consensus 488 ~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~--~~~~kl~DFGla~~~~~~~~~~ 565 (714)
+++.... ..+++.++..++.|++.||+|||+ .+|+||||||+|||++. ++.+||+|||+++......
T Consensus 90 ~~l~~~~-----~~~~~~~~~~i~~qi~~al~~lH~---~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~--- 158 (321)
T 1tki_A 90 ERINTSA-----FELNEREIVSYVHQVCEALQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD--- 158 (321)
T ss_dssp HHHTSSS-----CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC---
T ss_pred HHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHH---CCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCC---
Confidence 9997653 358999999999999999999999 89999999999999987 7899999999998653211
Q ss_pred CccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCccccCCCCcch
Q 005102 566 TLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGSSEMD 645 (714)
Q Consensus 566 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~~~~~~~~~~ 645 (714)
......||+.|+|||++.+..++.++|||||||++|||++|+.||.... .
T Consensus 159 --------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~--~-- 208 (321)
T 1tki_A 159 --------------------------NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAET--N-- 208 (321)
T ss_dssp --------------------------EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSS--H--
T ss_pred --------------------------ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCC--H--
Confidence 0112346889999999998889999999999999999999999994321 1
Q ss_pred hHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 005102 646 LVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISD 704 (714)
Q Consensus 646 l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 704 (714)
.+.+..............-+ ....++.+++.+||..||++|||++|+++
T Consensus 209 -~~~~~~i~~~~~~~~~~~~~---------~~s~~~~~li~~~L~~dp~~Rpt~~e~l~ 257 (321)
T 1tki_A 209 -QQIIENIMNAEYTFDEEAFK---------EISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp -HHHHHHHHHTCCCCCHHHHT---------TSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred -HHHHHHHHcCCCCCChhhhc---------cCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 22222222222211100000 11236789999999999999999999986
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-41 Score=352.52 Aligned_cols=266 Identities=21% Similarity=0.234 Sum_probs=206.7
Q ss_pred ccccccCceEEEEEEECC-CcEEEEEEeCCCC-chhHHHHHHHHHHHhccCCCCccceEEEEEeCC--ceeEEEeccCCC
Q 005102 409 FVLGKSGIGIVYKVVLED-GHTLAVRRLGEGG-SQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVD--EKLLIYDYIPNG 484 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~~-g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~--~~~lV~e~~~~g 484 (714)
+.||+|+||+||+|++.. ++.||||++.... ....+.+.+|++++++++||||+++++++...+ ..++||||+++|
T Consensus 15 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~ 94 (319)
T 4euu_A 15 DILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCG 94 (319)
T ss_dssp EEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEEECCTTC
T ss_pred EEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEEeCCCCC
Confidence 479999999999999865 8999999997643 234567889999999999999999999998765 679999999999
Q ss_pred CHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeee----CCCCCeEEcccchhhhhhc
Q 005102 485 SLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILL----GHNMEPHVSDFGLARLANI 560 (714)
Q Consensus 485 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl----~~~~~~kl~DFGla~~~~~ 560 (714)
+|.+++...... ..+++.++..|+.|++.||+|||+ .+|+||||||+|||+ +.++.+||+|||+++....
T Consensus 95 ~L~~~l~~~~~~---~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~~~ 168 (319)
T 4euu_A 95 SLYTVLEEPSNA---YGLPESEFLIVLRDVVGGMNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELED 168 (319)
T ss_dssp BHHHHHHSGGGT---TCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEECTTSCEEEEECCCTTCEECCT
T ss_pred CHHHHHHHhccc---cCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEEeccCCCCceEEEccCCCceecCC
Confidence 999999865321 348999999999999999999999 899999999999999 8888899999999986532
Q ss_pred cCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccC--------CCCCCchhhhHHHHHHHHHHHhC
Q 005102 561 AGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLK--------VVKPSQKWDIYSYGVILLEMITG 632 (714)
Q Consensus 561 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~s~~~DVwS~Gvvl~elltG 632 (714)
.. ......||+.|+|||++. +..++.++|||||||++|||+||
T Consensus 169 ~~-----------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g 219 (319)
T 4euu_A 169 DE-----------------------------QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATG 219 (319)
T ss_dssp TC-----------------------------CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHS
T ss_pred CC-----------------------------ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhC
Confidence 11 112345789999999985 56789999999999999999999
Q ss_pred CCccccCCCCcchhHHHHHHHHhhcCC--cccc---------cCCCCCC-CCCcHHHHHHHHHHHhHccCCCCCCCCCHH
Q 005102 633 RTAVVQVGSSEMDLVNWMQLCIEEKKP--LADV---------LDPYLAP-DADKEEEIIAVLKIAMACVHSSPEKRPTMR 700 (714)
Q Consensus 633 ~~p~~~~~~~~~~l~~~~~~~~~~~~~--~~~~---------~d~~~~~-~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ 700 (714)
+.||....... ...+.+......... ...+ ..+.... ..........+.+++.+||+.||++|||++
T Consensus 220 ~~pf~~~~~~~-~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ 298 (319)
T 4euu_A 220 SLPFRPFEGPR-RNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFD 298 (319)
T ss_dssp SCSEECTTCGG-GCHHHHHHHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHH
T ss_pred CCCCCCCCccc-hhHHHHHHHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHH
Confidence 99996433322 223333333332211 0000 0001111 112345566788999999999999999999
Q ss_pred HHHHHHhhhh
Q 005102 701 HISDALDRLI 710 (714)
Q Consensus 701 evl~~L~~i~ 710 (714)
|+++...+..
T Consensus 299 ell~h~~d~~ 308 (319)
T 4euu_A 299 QFFAETSDIL 308 (319)
T ss_dssp HHHHHHHHHT
T ss_pred HhhhccHHHh
Confidence 9999887643
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-42 Score=365.48 Aligned_cols=236 Identities=20% Similarity=0.259 Sum_probs=190.5
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeCCC---CchhHHHHHHHHHHHhcc-CCCCccceEEEEEeCCceeEEEeccCC
Q 005102 409 FVLGKSGIGIVYKVVLE-DGHTLAVRRLGEG---GSQRFKEFQTEVEAIGKI-RHSNIVTLRAYYWSVDEKLLIYDYIPN 483 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~e~~~~ 483 (714)
+.||+|+||+||+|+.+ +|+.||||++++. .....+.+.+|.++++.+ +||||+++++++.+.+..|+||||+++
T Consensus 29 ~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lv~E~~~g 108 (353)
T 3txo_A 29 RVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNG 108 (353)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEECCCS
T ss_pred EEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEEEEeCCCC
Confidence 47999999999999986 4899999999764 223346688999999988 699999999999999999999999999
Q ss_pred CCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCC
Q 005102 484 GSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGG 563 (714)
Q Consensus 484 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 563 (714)
|+|.+++... ..+++..++.|+.||+.||+|||+ ++|+||||||+|||++.++++||+|||+|+.....
T Consensus 109 g~L~~~l~~~------~~~~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~-- 177 (353)
T 3txo_A 109 GDLMFHIQKS------RRFDEARARFYAAEIISALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICN-- 177 (353)
T ss_dssp CBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC---
T ss_pred CcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCCcccCCCHHHEEECCCCCEEEccccceeecccC--
Confidence 9999999765 458999999999999999999999 89999999999999999999999999999743211
Q ss_pred CCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCccccCCCCc
Q 005102 564 SPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGSSE 643 (714)
Q Consensus 564 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~~~~~~~~ 643 (714)
........||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 178 --------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~---- 227 (353)
T 3txo_A 178 --------------------------GVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAE---- 227 (353)
T ss_dssp ----------------------------------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCS----
T ss_pred --------------------------CccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCC----
Confidence 11223456899999999998888999999999999999999999999432
Q ss_pred chhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCH
Q 005102 644 MDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTM 699 (714)
Q Consensus 644 ~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~ 699 (714)
+..+............. .. ....+.+++.+||+.||++||++
T Consensus 228 -~~~~~~~~i~~~~~~~p--------~~-----~~~~~~~li~~lL~~dP~~R~~~ 269 (353)
T 3txo_A 228 -NEDDLFEAILNDEVVYP--------TW-----LHEDATGILKSFMTKNPTMRLGS 269 (353)
T ss_dssp -SHHHHHHHHHHCCCCCC--------TT-----SCHHHHHHHHHHTCSSGGGSTTS
T ss_pred -CHHHHHHHHHcCCCCCC--------CC-----CCHHHHHHHHHHhhhCHHHccCC
Confidence 12222333333222111 11 11257899999999999999998
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-41 Score=352.64 Aligned_cols=257 Identities=23% Similarity=0.316 Sum_probs=194.7
Q ss_pred ccccccCceEEEEEEECCCcEEEEEEeCCCC--chhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCCCH
Q 005102 409 FVLGKSGIGIVYKVVLEDGHTLAVRRLGEGG--SQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGSL 486 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL 486 (714)
+.||+|+||+||+|++.+|+.||+|++.... ....+.+.+|++++++++||||+++++++.+.+..++||||++ |+|
T Consensus 27 ~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~-~~l 105 (311)
T 3niz_A 27 EKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEFME-KDL 105 (311)
T ss_dssp EEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEECCS-EEH
T ss_pred hhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEcCCC-CCH
Confidence 4799999999999999889999999997542 2234678999999999999999999999999999999999997 488
Q ss_pred hhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCCCC
Q 005102 487 ATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPT 566 (714)
Q Consensus 487 ~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 566 (714)
.+.+.... ..+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++......
T Consensus 106 ~~~~~~~~-----~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~---- 173 (311)
T 3niz_A 106 KKVLDENK-----TGLQDSQIKIYLYQLLRGVAHCHQ---HRILHRDLKPQNLLINSDGALKLADFGLARAFGIPV---- 173 (311)
T ss_dssp HHHHHTCT-----TCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEETTSCC----
T ss_pred HHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCchHhEEECCCCCEEEccCcCceecCCCc----
Confidence 88887653 458999999999999999999999 899999999999999999999999999998653211
Q ss_pred ccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCC-CCCCchhhhHHHHHHHHHHHhCCCccccCCCCcch
Q 005102 567 LQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKV-VKPSQKWDIYSYGVILLEMITGRTAVVQVGSSEMD 645 (714)
Q Consensus 567 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DVwS~Gvvl~elltG~~p~~~~~~~~~~ 645 (714)
.......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...... +
T Consensus 174 ------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--~ 227 (311)
T 3niz_A 174 ------------------------RSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDD--D 227 (311)
T ss_dssp ------------------------C---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTT--T
T ss_pred ------------------------ccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChH--H
Confidence 11223456889999999876 56899999999999999999999999543322 2
Q ss_pred hHHHHHHHHhhcCC--cccc------cCCCCC--CCCCc----HHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 005102 646 LVNWMQLCIEEKKP--LADV------LDPYLA--PDADK----EEEIIAVLKIAMACVHSSPEKRPTMRHISD 704 (714)
Q Consensus 646 l~~~~~~~~~~~~~--~~~~------~d~~~~--~~~~~----~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 704 (714)
....+........+ .... .+.... ..... .....++.+++.+||+.||++|||++|+++
T Consensus 228 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 300 (311)
T 3niz_A 228 QLPKIFSILGTPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN 300 (311)
T ss_dssp HHHHHHHHHCCCCTTTSGGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred HHHHHHHHHCCCChHHhhhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 22222222111100 0000 000000 00000 011236789999999999999999999986
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-42 Score=382.85 Aligned_cols=253 Identities=26% Similarity=0.380 Sum_probs=206.0
Q ss_pred cccccccCceEEEEEEECC-CcEEEEEEeCCCCchhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCCCH
Q 005102 408 AFVLGKSGIGIVYKVVLED-GHTLAVRRLGEGGSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGSL 486 (714)
Q Consensus 408 ~~~lG~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL 486 (714)
.+.||+|+||.||+|.++. +..||||+++.... ..++|.+|+++|++++||||++++++|...+..++||||+++|+|
T Consensus 225 ~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~~~~g~L 303 (495)
T 1opk_A 225 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNL 303 (495)
T ss_dssp EEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBH
T ss_pred eeEecCCCCeEEEEEEEcCCCeEEEEEEecCccc-chHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEccCCCCH
Confidence 3579999999999999875 88999999986543 357899999999999999999999999999999999999999999
Q ss_pred hhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCCCC
Q 005102 487 ATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPT 566 (714)
Q Consensus 487 ~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 566 (714)
.+++..... ..+++..++.|+.||+.||+|||+ ++|+||||||+|||+++++.+||+|||+++......
T Consensus 304 ~~~l~~~~~----~~~~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~---- 372 (495)
T 1opk_A 304 LDYLRECNR----QEVSAVVLLYMATQISSAMEYLEK---KNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDT---- 372 (495)
T ss_dssp HHHHHHSCT----TTSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECGGGCEEECCTTCEECCTTCC----
T ss_pred HHHHHhcCc----CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChhhEEECCCCcEEEeecccceeccCCc----
Confidence 999976432 458999999999999999999999 899999999999999999999999999998653210
Q ss_pred ccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHh-CCCccccCCCCcch
Q 005102 567 LQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMIT-GRTAVVQVGSSEMD 645 (714)
Q Consensus 567 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~ellt-G~~p~~~~~~~~~~ 645 (714)
........++..|+|||++.+..++.++|||||||++|||+| |+.||..... ..
T Consensus 373 -----------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~--~~ 427 (495)
T 1opk_A 373 -----------------------YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL--SQ 427 (495)
T ss_dssp -----------------------EECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCG--GG
T ss_pred -----------------------eeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCH--HH
Confidence 111223345678999999988889999999999999999999 9999954322 22
Q ss_pred hHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhhhhcc
Q 005102 646 LVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDALDRLIVS 712 (714)
Q Consensus 646 l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~~ 712 (714)
+.+. +..... ..... .....+.+++.+||+.||++|||+++|++.|+++...
T Consensus 428 ~~~~----~~~~~~------~~~~~-----~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~~ 479 (495)
T 1opk_A 428 VYEL----LEKDYR------MERPE-----GCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 479 (495)
T ss_dssp HHHH----HHTTCC------CCCCT-----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCSS
T ss_pred HHHH----HHcCCC------CCCCC-----CCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHhc
Confidence 2221 111111 11111 1223688999999999999999999999999998654
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-41 Score=347.90 Aligned_cols=246 Identities=30% Similarity=0.487 Sum_probs=195.1
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeCCCCchh-------HHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEec
Q 005102 409 FVLGKSGIGIVYKVVLE-DGHTLAVRRLGEGGSQR-------FKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDY 480 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~-------~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~ 480 (714)
+.||+|+||.||+|++. +++.||||++....... .+.+.+|++++++++||||+++++++.+. .++||||
T Consensus 25 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~lv~e~ 102 (287)
T 4f0f_A 25 KQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNP--PRMVMEF 102 (287)
T ss_dssp EECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTT--TEEEEEC
T ss_pred hccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCC--CeEEEEe
Confidence 47999999999999985 68999999987543221 16789999999999999999999998654 3799999
Q ss_pred cCCCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCC--ceecCCCCCCeeeCCCCC-----eEEcccc
Q 005102 481 IPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKK--YVHGDLKPSNILLGHNME-----PHVSDFG 553 (714)
Q Consensus 481 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~--ivHrDlkp~NILl~~~~~-----~kl~DFG 553 (714)
+++|+|.+.+.... ..+++..+..++.|++.||+|||+ .+ |+||||||+||+++.++. +||+|||
T Consensus 103 ~~~~~L~~~l~~~~-----~~~~~~~~~~~~~~l~~~l~~lH~---~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Dfg 174 (287)
T 4f0f_A 103 VPCGDLYHRLLDKA-----HPIKWSVKLRLMLDIALGIEYMQN---QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFG 174 (287)
T ss_dssp CTTCBHHHHHHCTT-----SCCCHHHHHHHHHHHHHHHHHHHT---SSSCCBCSCCSGGGEEESCCCTTCSCCEEECCCT
T ss_pred cCCCCHHHHHhccc-----CCccHHHHHHHHHHHHHHHHHHHh---CCCCeecCCCCcceEEEeccCCCCceeEEeCCCC
Confidence 99999999887653 468999999999999999999999 78 999999999999988776 9999999
Q ss_pred hhhhhhccCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCccc--CCCCCCchhhhHHHHHHHHHHHh
Q 005102 554 LARLANIAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESL--KVVKPSQKWDIYSYGVILLEMIT 631 (714)
Q Consensus 554 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~s~~~DVwS~Gvvl~ellt 631 (714)
+++.... ......||+.|+|||.+ ....++.++|||||||++|||++
T Consensus 175 ~~~~~~~-------------------------------~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~ 223 (287)
T 4f0f_A 175 LSQQSVH-------------------------------SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILT 223 (287)
T ss_dssp TCBCCSS-------------------------------CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHH
T ss_pred ccccccc-------------------------------cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHc
Confidence 9874221 11234578899999998 34557899999999999999999
Q ss_pred CCCccccCCCCcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhhh
Q 005102 632 GRTAVVQVGSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDALDRL 709 (714)
Q Consensus 632 G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i 709 (714)
|+.||.......... ......... .+..... ....+.+++.+||+.||++|||++|+++.|+++
T Consensus 224 g~~pf~~~~~~~~~~---~~~~~~~~~------~~~~~~~-----~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 224 GEGPFDEYSYGKIKF---INMIREEGL------RPTIPED-----CPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp SSCTTTTCCCCHHHH---HHHHHHSCC------CCCCCTT-----SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred CCCCCccccccHHHH---HHHHhccCC------CCCCCcc-----cCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 999995443332211 211112111 1112111 123688999999999999999999999999875
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-41 Score=360.78 Aligned_cols=245 Identities=22% Similarity=0.295 Sum_probs=197.1
Q ss_pred cccccccCceEEEEEEEC-CCcEEEEEEeCCCC--chhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCC
Q 005102 408 AFVLGKSGIGIVYKVVLE-DGHTLAVRRLGEGG--SQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNG 484 (714)
Q Consensus 408 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~g 484 (714)
.+.||+|+||.||+|..+ +|+.||+|++.... ....+.+.+|++++++++||||+++++++.+.+..++||||+++|
T Consensus 34 ~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~e~~~gg 113 (362)
T 2bdw_A 34 KEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGG 113 (362)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSC
T ss_pred eeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecCCCC
Confidence 457999999999999986 48999999997643 334567899999999999999999999999999999999999999
Q ss_pred CHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCC---CCeEEcccchhhhhhcc
Q 005102 485 SLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHN---MEPHVSDFGLARLANIA 561 (714)
Q Consensus 485 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~---~~~kl~DFGla~~~~~~ 561 (714)
+|.+++... ..+++..+..++.||+.||+|||+ .+|+||||||+|||++.+ +.+||+|||+++.....
T Consensus 114 ~L~~~l~~~------~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~ 184 (362)
T 2bdw_A 114 ELFEDIVAR------EFYSEADASHCIQQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS 184 (362)
T ss_dssp BHHHHHTTC------SCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTC
T ss_pred CHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCchHHEEEecCCCCCCEEEeecCcceEecCC
Confidence 999998755 458999999999999999999999 899999999999999865 45999999999754321
Q ss_pred CCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCccccCCC
Q 005102 562 GGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGS 641 (714)
Q Consensus 562 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~~~~~~ 641 (714)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 185 -----------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~- 234 (362)
T 2bdw_A 185 -----------------------------EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED- 234 (362)
T ss_dssp -----------------------------CSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS-
T ss_pred -----------------------------cccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCC-
Confidence 11123457899999999999899999999999999999999999994321
Q ss_pred CcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 005102 642 SEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISD 704 (714)
Q Consensus 642 ~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 704 (714)
................ .+ ........+.+++.+||+.||++|||+.|+++
T Consensus 235 ----~~~~~~~i~~~~~~~~---~~------~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 284 (362)
T 2bdw_A 235 ----QHRLYAQIKAGAYDYP---SP------EWDTVTPEAKSLIDSMLTVNPKKRITADQALK 284 (362)
T ss_dssp ----HHHHHHHHHHTCCCCC---TT------GGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred ----HHHHHHHHHhCCCCCC---cc------cccCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 1222222222221110 00 00112236789999999999999999999875
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-41 Score=354.35 Aligned_cols=238 Identities=21% Similarity=0.306 Sum_probs=196.7
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeCCCC---chhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCC
Q 005102 409 FVLGKSGIGIVYKVVLE-DGHTLAVRRLGEGG---SQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNG 484 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~g 484 (714)
+.||+|+||+||+|+.+ +|+.||+|++.+.. ....+.+.+|+.+++.++||||+++++++.+.+..++||||+++|
T Consensus 12 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~e~~~gg 91 (318)
T 1fot_A 12 RTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGG 91 (318)
T ss_dssp EEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECCCCSC
T ss_pred EEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEEeCCCCC
Confidence 47999999999999986 58999999997542 233467889999999999999999999999999999999999999
Q ss_pred CHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCC
Q 005102 485 SLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGS 564 (714)
Q Consensus 485 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 564 (714)
+|.+++... ..+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++....
T Consensus 92 ~L~~~l~~~------~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~---- 158 (318)
T 1fot_A 92 ELFSLLRKS------QRFPNPVAKFYAAEVCLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD---- 158 (318)
T ss_dssp BHHHHHHHT------SSCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTSCEEECCCSSCEECSS----
T ss_pred CHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChheEEEcCCCCEEEeecCcceecCC----
Confidence 999999765 458999999999999999999999 8999999999999999999999999999975421
Q ss_pred CCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCccccCCCCcc
Q 005102 565 PTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGSSEM 644 (714)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~~~~~~~~~ 644 (714)
......||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 159 ---------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~---- 207 (318)
T 1fot_A 159 ---------------------------VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSN---- 207 (318)
T ss_dssp ---------------------------CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS----
T ss_pred ---------------------------ccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC----
Confidence 1123457899999999999999999999999999999999999995321
Q ss_pred hhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCC-----CHHHHHH
Q 005102 645 DLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRP-----TMRHISD 704 (714)
Q Consensus 645 ~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----t~~evl~ 704 (714)
.............. ..... ...+.+++.+||..||++|| +++|+++
T Consensus 208 -~~~~~~~i~~~~~~--------~p~~~-----~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~ 258 (318)
T 1fot_A 208 -TMKTYEKILNAELR--------FPPFF-----NEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 258 (318)
T ss_dssp -HHHHHHHHHHCCCC--------CCTTS-----CHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred -HHHHHHHHHhCCCC--------CCCCC-----CHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence 12222333332211 11111 12578999999999999999 8888763
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=365.98 Aligned_cols=241 Identities=22% Similarity=0.330 Sum_probs=191.9
Q ss_pred ccccccCceEEEEEEECC-CcEEEEEEeCCCC---chhHHHHHHHHHHHhcc-CCCCccceEEEEEeCCceeEEEeccCC
Q 005102 409 FVLGKSGIGIVYKVVLED-GHTLAVRRLGEGG---SQRFKEFQTEVEAIGKI-RHSNIVTLRAYYWSVDEKLLIYDYIPN 483 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~~-g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~e~~~~ 483 (714)
++||+|+||+||+|+.+. ++.||||++++.. ....+.+.+|..++.++ +||||+++++++.+.+..++||||+++
T Consensus 58 ~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lV~E~~~g 137 (396)
T 4dc2_A 58 RVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 137 (396)
T ss_dssp EEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTT
T ss_pred EEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEEEEEcCCC
Confidence 589999999999999865 7899999997642 22234578999999887 899999999999999999999999999
Q ss_pred CCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCC
Q 005102 484 GSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGG 563 (714)
Q Consensus 484 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 563 (714)
|+|.+++... ..+++..++.++.||+.||+|||+ ++|+||||||+|||++.++++||+|||+|+.....
T Consensus 138 g~L~~~l~~~------~~l~~~~~~~~~~qi~~aL~~LH~---~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~-- 206 (396)
T 4dc2_A 138 GDLMFHMQRQ------RKLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP-- 206 (396)
T ss_dssp CBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT--
T ss_pred CcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCEEeccCCHHHEEECCCCCEEEeecceeeecccC--
Confidence 9999999764 458999999999999999999999 89999999999999999999999999999742211
Q ss_pred CCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCccccCCCCc
Q 005102 564 SPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGSSE 643 (714)
Q Consensus 564 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~~~~~~~~ 643 (714)
........||+.|+|||++.+..++.++|||||||++|||++|+.||......+
T Consensus 207 --------------------------~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~ 260 (396)
T 4dc2_A 207 --------------------------GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSD 260 (396)
T ss_dssp --------------------------TCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC--
T ss_pred --------------------------CCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccccc
Confidence 112334568999999999999999999999999999999999999995332211
Q ss_pred ---chhHHHH-HHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCH
Q 005102 644 ---MDLVNWM-QLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTM 699 (714)
Q Consensus 644 ---~~l~~~~-~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~ 699 (714)
......+ +........ ++... ...+.+++.+||+.||++||++
T Consensus 261 ~~~~~~~~~~~~~i~~~~~~--------~p~~~-----s~~~~~li~~lL~~dP~~R~~~ 307 (396)
T 4dc2_A 261 NPDQNTEDYLFQVILEKQIR--------IPRSL-----SVKAASVLKSFLNKDPKERLGC 307 (396)
T ss_dssp ----CCHHHHHHHHHHCCCC--------CCTTS-----CHHHHHHHHHHTCSCTTTSTTC
T ss_pred ccchhhHHHHHHHHhccccC--------CCCcC-----CHHHHHHHHHHhcCCHhHcCCC
Confidence 1111222 222222211 11111 2257899999999999999996
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-42 Score=361.10 Aligned_cols=251 Identities=24% Similarity=0.363 Sum_probs=195.1
Q ss_pred ccccccCceEEEEEEECC-Cc----EEEEEEeCCC-CchhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccC
Q 005102 409 FVLGKSGIGIVYKVVLED-GH----TLAVRRLGEG-GSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIP 482 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~~-g~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~ 482 (714)
+.||+|+||+||+|++.. ++ .||+|.+... .....+.|.+|+.++++++||||++++++|... ..++||||++
T Consensus 21 ~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~v~e~~~ 99 (327)
T 3poz_A 21 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQLMP 99 (327)
T ss_dssp EEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS-SEEEEEECCT
T ss_pred eEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC-CeEEEEEecC
Confidence 579999999999999753 44 4688888654 234457899999999999999999999999875 4789999999
Q ss_pred CCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccC
Q 005102 483 NGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAG 562 (714)
Q Consensus 483 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 562 (714)
+|+|.+++.... ..+++..++.|+.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++......
T Consensus 100 ~g~L~~~l~~~~-----~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~ 171 (327)
T 3poz_A 100 FGCLLDYVREHK-----DNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 171 (327)
T ss_dssp TCBHHHHHHHST-----TSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCTTHHHHHTTTC
T ss_pred CCcHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCChheEEECCCCCEEEccCcceeEccCCc
Confidence 999999997653 458999999999999999999999 899999999999999999999999999998765322
Q ss_pred CCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHh-CCCccccCCC
Q 005102 563 GSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMIT-GRTAVVQVGS 641 (714)
Q Consensus 563 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~ellt-G~~p~~~~~~ 641 (714)
. ........+|..|+|||++.+..++.++|||||||++|||+| |+.||.....
T Consensus 172 ~--------------------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~ 225 (327)
T 3poz_A 172 K--------------------------EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA 225 (327)
T ss_dssp C---------------------------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCG
T ss_pred c--------------------------cccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCH
Confidence 1 111223345778999999999999999999999999999999 9999953322
Q ss_pred CcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhhhhc
Q 005102 642 SEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDALDRLIV 711 (714)
Q Consensus 642 ~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~ 711 (714)
..+... ....... .... .....+.+++.+||+.||++|||++|+++.|+++..
T Consensus 226 --~~~~~~----~~~~~~~------~~~~-----~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~ 278 (327)
T 3poz_A 226 --SEISSI----LEKGERL------PQPP-----ICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp --GGHHHH----HHTTCCC------CCCT-----TBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHT
T ss_pred --HHHHHH----HHcCCCC------CCCc-----cCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 222221 1111110 0111 122368899999999999999999999999998754
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=359.31 Aligned_cols=246 Identities=24% Similarity=0.319 Sum_probs=195.6
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeCCCCc-hhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCCCH
Q 005102 409 FVLGKSGIGIVYKVVLE-DGHTLAVRRLGEGGS-QRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGSL 486 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL 486 (714)
+.||+|+||+||+|++. +++.||||++..... ...+.+.+|+.+++.++||||+++++++...+..++||||+++|+|
T Consensus 13 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L 92 (323)
T 3tki_A 13 QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGEL 92 (323)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCTTEEG
T ss_pred eEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEcCCCCcH
Confidence 47999999999999986 689999999865432 2335688999999999999999999999999999999999999999
Q ss_pred hhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCCCC
Q 005102 487 ATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPT 566 (714)
Q Consensus 487 ~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 566 (714)
.+++... ..+++.++..|+.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++.......
T Consensus 93 ~~~l~~~------~~~~~~~~~~i~~qi~~aL~~LH~---~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~--- 160 (323)
T 3tki_A 93 FDRIEPD------IGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR--- 160 (323)
T ss_dssp GGGSBTT------TBCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTE---
T ss_pred HHHHhhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCccccccchHHEEEeCCCCEEEEEeeccceeccCCc---
Confidence 9999755 458999999999999999999999 8999999999999999999999999999986532210
Q ss_pred ccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCC-CchhhhHHHHHHHHHHHhCCCccccCCCCcch
Q 005102 567 LQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKP-SQKWDIYSYGVILLEMITGRTAVVQVGSSEMD 645 (714)
Q Consensus 567 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~~DVwS~Gvvl~elltG~~p~~~~~~~~~~ 645 (714)
........||+.|+|||++.+..+ +.++|||||||++|||++|+.||.........
T Consensus 161 -----------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~ 217 (323)
T 3tki_A 161 -----------------------ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE 217 (323)
T ss_dssp -----------------------ECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHH
T ss_pred -----------------------ccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHH
Confidence 112234567999999999987765 78999999999999999999999654333222
Q ss_pred hHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 005102 646 LVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISD 704 (714)
Q Consensus 646 l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 704 (714)
...+. ..... ..+ .......+.+++.+||+.||++|||++|+++
T Consensus 218 ~~~~~----~~~~~----~~~-------~~~~~~~~~~li~~~L~~dP~~R~t~~eil~ 261 (323)
T 3tki_A 218 YSDWK----EKKTY----LNP-------WKKIDSAPLALLHKILVENPSARITIPDIKK 261 (323)
T ss_dssp HHHHH----TTCTT----STT-------GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred HHHHh----ccccc----CCc-------cccCCHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 22211 11110 000 0112235779999999999999999999875
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=374.57 Aligned_cols=247 Identities=25% Similarity=0.400 Sum_probs=200.7
Q ss_pred cccccccCceEEEEEEECCCcEEEEEEeCCCCchhHHHHHHHHHHHhccCCCCccceEEEEEeCC-ceeEEEeccCCCCH
Q 005102 408 AFVLGKSGIGIVYKVVLEDGHTLAVRRLGEGGSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVD-EKLLIYDYIPNGSL 486 (714)
Q Consensus 408 ~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~-~~~lV~e~~~~gsL 486 (714)
.+.||+|+||.||+|.+. |+.||||+++... ..+.|.+|+++|++++||||+++++++...+ ..++||||+++|+|
T Consensus 198 ~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~~~g~L 274 (450)
T 1k9a_A 198 LQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSL 274 (450)
T ss_dssp EEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEECCTTCBH
T ss_pred EeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEecCCCcH
Confidence 357999999999999986 7899999998654 3468999999999999999999999987765 78999999999999
Q ss_pred hhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCCCC
Q 005102 487 ATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPT 566 (714)
Q Consensus 487 ~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 566 (714)
.+++..... ..+++..++.++.||+.||+|||+ ++|+||||||+|||+++++.+||+|||+++.....
T Consensus 275 ~~~l~~~~~----~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~----- 342 (450)
T 1k9a_A 275 VDYLRSRGR----SVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST----- 342 (450)
T ss_dssp HHHHHHHCT----TTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTSCEEECCCTTCEECC-------
T ss_pred HHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHhhEEECCCCCEEEeeCCCccccccc-----
Confidence 999976532 347899999999999999999999 89999999999999999999999999998743210
Q ss_pred ccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHh-CCCccccCCCCcch
Q 005102 567 LQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMIT-GRTAVVQVGSSEMD 645 (714)
Q Consensus 567 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~ellt-G~~p~~~~~~~~~~ 645 (714)
.....++..|+|||.+.+..++.++|||||||++|||+| |+.||...... +
T Consensus 343 --------------------------~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~--~ 394 (450)
T 1k9a_A 343 --------------------------QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK--D 394 (450)
T ss_dssp ------------------------------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTT--T
T ss_pred --------------------------ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH--H
Confidence 011234677999999999999999999999999999999 99999543322 2
Q ss_pred hHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhhhhcc
Q 005102 646 LVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDALDRLIVS 712 (714)
Q Consensus 646 l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~~ 712 (714)
... . +..+.. ...... ....+.+++.+||+.||++|||++++++.|+++...
T Consensus 395 ~~~---~-i~~~~~------~~~p~~-----~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~ 446 (450)
T 1k9a_A 395 VVP---R-VEKGYK------MDAPDG-----CPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTH 446 (450)
T ss_dssp HHH---H-HHTTCC------CCCCTT-----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred HHH---H-HHcCCC------CCCCCc-----CCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHh
Confidence 222 1 111111 111111 223688999999999999999999999999998764
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-41 Score=358.60 Aligned_cols=258 Identities=23% Similarity=0.364 Sum_probs=204.0
Q ss_pred ccccccCceEEEEEEEC------CCcEEEEEEeCCCCc-hhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEecc
Q 005102 409 FVLGKSGIGIVYKVVLE------DGHTLAVRRLGEGGS-QRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYI 481 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~------~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~ 481 (714)
+.||+|+||.||+|++. +++.||||+++.... ...+.+.+|++++++++||||+++++++...+..++||||+
T Consensus 53 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 132 (343)
T 1luf_A 53 RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYM 132 (343)
T ss_dssp EEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred eeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCceEEEEecC
Confidence 57999999999999985 348999999986533 33567999999999999999999999999999999999999
Q ss_pred CCCCHhhhhhCCCCCC------------------CcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCC
Q 005102 482 PNGSLATALHGKPGMV------------------SFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGH 543 (714)
Q Consensus 482 ~~gsL~~~l~~~~~~~------------------~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~ 543 (714)
++|+|.+++....... ....+++.+++.|+.||+.||+|||+ ++|+||||||+||++++
T Consensus 133 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIl~~~ 209 (343)
T 1luf_A 133 AYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVGE 209 (343)
T ss_dssp TTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECG
T ss_pred CCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCcceEEECC
Confidence 9999999997642110 01468999999999999999999999 89999999999999999
Q ss_pred CCCeEEcccchhhhhhccCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHH
Q 005102 544 NMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYG 623 (714)
Q Consensus 544 ~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~G 623 (714)
++.+||+|||+++....... ........+|+.|+|||.+.+..++.++||||||
T Consensus 210 ~~~~kl~Dfg~~~~~~~~~~--------------------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG 263 (343)
T 1luf_A 210 NMVVKIADFGLSRNIYSADY--------------------------YKADGNDAIPIRWMPPESIFYNRYTTESDVWAYG 263 (343)
T ss_dssp GGCEEECCCSCHHHHTGGGC--------------------------BC----CCBCGGGCCHHHHHHCCCCHHHHHHHHH
T ss_pred CCeEEEeecCCCcccccCcc--------------------------ccccCCCcccceecChhhhccCCcCcccccHHHH
Confidence 99999999999987643211 1112233467889999999888999999999999
Q ss_pred HHHHHHHh-CCCccccCCCCcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHH
Q 005102 624 VILLEMIT-GRTAVVQVGSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHI 702 (714)
Q Consensus 624 vvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev 702 (714)
+++|||+| |+.||.... ..+.......... +..... ....+.+++.+||+.||++|||++++
T Consensus 264 ~il~el~t~g~~p~~~~~-----~~~~~~~~~~~~~-------~~~~~~-----~~~~l~~li~~~l~~~p~~Rps~~~~ 326 (343)
T 1luf_A 264 VVLWEIFSYGLQPYYGMA-----HEEVIYYVRDGNI-------LACPEN-----CPLELYNLMRLCWSKLPADRPSFCSI 326 (343)
T ss_dssp HHHHHHHTTTCCTTTTSC-----HHHHHHHHHTTCC-------CCCCTT-----CCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred HHHHHHHhcCCCcCCCCC-----hHHHHHHHhCCCc-------CCCCCC-----CCHHHHHHHHHHcccCcccCCCHHHH
Confidence 99999999 999994321 1122222111111 011111 12368899999999999999999999
Q ss_pred HHHHhhhhcc
Q 005102 703 SDALDRLIVS 712 (714)
Q Consensus 703 l~~L~~i~~~ 712 (714)
++.|+++...
T Consensus 327 ~~~L~~~~~~ 336 (343)
T 1luf_A 327 HRILQRMCER 336 (343)
T ss_dssp HHHHHHTTC-
T ss_pred HHHHHHHHhh
Confidence 9999998754
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-41 Score=349.54 Aligned_cols=260 Identities=14% Similarity=0.153 Sum_probs=204.1
Q ss_pred ccccccCceEEEEEEE-CCCcEEEEEEeCCCCchhHHHHHHHHHHHhcc-CCCCccceEEEEEeCCceeEEEeccCCCCH
Q 005102 409 FVLGKSGIGIVYKVVL-EDGHTLAVRRLGEGGSQRFKEFQTEVEAIGKI-RHSNIVTLRAYYWSVDEKLLIYDYIPNGSL 486 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~e~~~~gsL 486 (714)
+.||+|+||.||+|.. .+|+.||||++...... +.+.+|+++++++ +|+|++++++++......++||||+ +++|
T Consensus 16 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L 92 (298)
T 1csn_A 16 RRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-GPSL 92 (298)
T ss_dssp EEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS--CCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-CCBH
T ss_pred EEEeecCCEEEEEEEECCCCcEEEEEEeccCCcc--HHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEec-CCCH
Confidence 4799999999999997 46899999998654322 4578899999999 7999999999999999999999999 9999
Q ss_pred hhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCC-----eEEcccchhhhhhcc
Q 005102 487 ATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNME-----PHVSDFGLARLANIA 561 (714)
Q Consensus 487 ~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~-----~kl~DFGla~~~~~~ 561 (714)
.+++.... ..+++..+.+|+.|++.||+|||+ ++|+||||||+||+++.++. +||+|||+++.....
T Consensus 93 ~~~l~~~~-----~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~ 164 (298)
T 1csn_A 93 EDLLDLCG-----RKFSVKTVAMAAKQMLARVQSIHE---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDP 164 (298)
T ss_dssp HHHHHHTT-----TCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCT
T ss_pred HHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEeccCCCCCCCeEEEEECccccccccc
Confidence 99997653 358999999999999999999999 89999999999999987776 999999999876432
Q ss_pred CCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCccccCCC
Q 005102 562 GGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGS 641 (714)
Q Consensus 562 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~~~~~~ 641 (714)
....... ........||+.|+|||.+.+..++.++||||||+++|||++|+.||.....
T Consensus 165 ~~~~~~~---------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~ 223 (298)
T 1csn_A 165 VTKQHIP---------------------YREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKA 223 (298)
T ss_dssp TTCCBCC---------------------CCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCS
T ss_pred ccccccc---------------------ccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhc
Confidence 2110000 1123345679999999999999999999999999999999999999954332
Q ss_pred CcchhHHHHHHHHhhc--CCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhhhhcc
Q 005102 642 SEMDLVNWMQLCIEEK--KPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDALDRLIVS 712 (714)
Q Consensus 642 ~~~~l~~~~~~~~~~~--~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~~ 712 (714)
... ........... ....+. .+. ....+.+++.+||+.||++|||+++|++.|+++...
T Consensus 224 ~~~--~~~~~~~~~~~~~~~~~~~-~~~---------~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~ 284 (298)
T 1csn_A 224 ATN--KQKYERIGEKKQSTPLREL-CAG---------FPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLER 284 (298)
T ss_dssp CCH--HHHHHHHHHHHHHSCHHHH-TTT---------SCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHH
T ss_pred ccc--HHHHHHHHhhccCccHHHH-Hhh---------CcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHh
Confidence 211 11111111111 111111 111 123688999999999999999999999999998754
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-41 Score=357.58 Aligned_cols=260 Identities=13% Similarity=0.106 Sum_probs=204.4
Q ss_pred ccccccCceEEEEEEE-CCCcEEEEEEeCCCCchhHHHHHHHHHHHhcc-CCCCccceEEEEEeCCceeEEEeccCCCCH
Q 005102 409 FVLGKSGIGIVYKVVL-EDGHTLAVRRLGEGGSQRFKEFQTEVEAIGKI-RHSNIVTLRAYYWSVDEKLLIYDYIPNGSL 486 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~e~~~~gsL 486 (714)
+.||+|+||+||+|+. .+|+.||||++...... +.+.+|+++++++ +||||+++++++...+..++||||+ +++|
T Consensus 15 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~L 91 (330)
T 2izr_A 15 KKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA--PQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELL-GPSL 91 (330)
T ss_dssp EECCC-CTTSEEEEEETTTTEEEEEEEEETTCSS--CCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEECC-CCBH
T ss_pred EEeeccCCceEEEEEECCCCcEEEEEEeccccch--HHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEeC-CCCH
Confidence 4799999999999997 46899999998764332 4688999999999 9999999999999999999999999 9999
Q ss_pred hhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCC-----eEEcccchhhhhhcc
Q 005102 487 ATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNME-----PHVSDFGLARLANIA 561 (714)
Q Consensus 487 ~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~-----~kl~DFGla~~~~~~ 561 (714)
.+++.... ..+++..+..|+.|++.||+|||+ .+|+||||||+|||++.++. +||+|||+++.....
T Consensus 92 ~~~~~~~~-----~~~~~~~~~~i~~qi~~~l~~LH~---~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~~ 163 (330)
T 2izr_A 92 EDLFDLCD-----RTFSLKTVLMIAIQLISRMEYVHS---KNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDP 163 (330)
T ss_dssp HHHHHHTT-----TCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBCT
T ss_pred HHHHHHcC-----CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeeeccCCCCCCceEEEEEcccceeeecC
Confidence 99997642 458999999999999999999999 89999999999999998887 999999999865432
Q ss_pred CCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCccccCCC
Q 005102 562 GGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGS 641 (714)
Q Consensus 562 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~~~~~~ 641 (714)
...... .........||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus 164 ~~~~~~---------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~ 222 (330)
T 2izr_A 164 ETKKHI---------------------PYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKA 222 (330)
T ss_dssp TTCCBC---------------------CCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCC
T ss_pred CCCccc---------------------cccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCcccccc
Confidence 211000 01122345689999999999999999999999999999999999999954432
Q ss_pred CcchhHHHHHHHHhhcCCc-ccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhhhhcc
Q 005102 642 SEMDLVNWMQLCIEEKKPL-ADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDALDRLIVS 712 (714)
Q Consensus 642 ~~~~l~~~~~~~~~~~~~~-~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~~ 712 (714)
.+..+.+.......... .+.... . .. ++.+++..||+.||.+||++++|.+.|+++...
T Consensus 223 --~~~~~~~~~i~~~~~~~~~~~~~~----~-----~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~ 282 (330)
T 2izr_A 223 --DTLKERYQKIGDTKRATPIEVLCE----N-----FP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDR 282 (330)
T ss_dssp --SSHHHHHHHHHHHHHHSCHHHHTT----T-----CH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHH
T ss_pred --ccHHHHHHHHHhhhccCCHHHHhc----c-----Ch-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHH
Confidence 22222222222111100 010000 0 11 688999999999999999999999999987643
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-41 Score=368.02 Aligned_cols=246 Identities=20% Similarity=0.231 Sum_probs=196.7
Q ss_pred cccccccCceEEEEEEEC-CCcEEEEEEeCCCCc--hhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCC
Q 005102 408 AFVLGKSGIGIVYKVVLE-DGHTLAVRRLGEGGS--QRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNG 484 (714)
Q Consensus 408 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~g 484 (714)
.+.||+|+||.||+|... +|+.||+|++..... ...+.+.+|++++++++||||+++++++.+.+..++||||+++|
T Consensus 16 ~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg 95 (444)
T 3soa_A 16 FEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGG 95 (444)
T ss_dssp EEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEECCCBCC
T ss_pred EEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEEEeCCCC
Confidence 357999999999999875 589999999976532 33467899999999999999999999999999999999999999
Q ss_pred CHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeC---CCCCeEEcccchhhhhhcc
Q 005102 485 SLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLG---HNMEPHVSDFGLARLANIA 561 (714)
Q Consensus 485 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~---~~~~~kl~DFGla~~~~~~ 561 (714)
+|.+.+... ..+++..+..++.||+.||+|||+ .+|+||||||+|||++ +++.+||+|||+++.....
T Consensus 96 ~L~~~i~~~------~~~~e~~~~~i~~qil~aL~~lH~---~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~ 166 (444)
T 3soa_A 96 ELFEDIVAR------EYYSEADASHCIQQILEAVLHCHQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGE 166 (444)
T ss_dssp BHHHHHHHC------SCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTT
T ss_pred CHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEeccCCCCcEEEccCceeEEecCC
Confidence 999998765 458999999999999999999999 8999999999999998 4678999999999754321
Q ss_pred CCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCccccCCC
Q 005102 562 GGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGS 641 (714)
Q Consensus 562 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~~~~~~ 641 (714)
. .......||+.|+|||++.+..++.++||||+||++|||++|+.||...
T Consensus 167 ~----------------------------~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~-- 216 (444)
T 3soa_A 167 Q----------------------------QAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDE-- 216 (444)
T ss_dssp C----------------------------CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCS--
T ss_pred C----------------------------ceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCc--
Confidence 1 1122346899999999999989999999999999999999999999432
Q ss_pred CcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 005102 642 SEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISD 704 (714)
Q Consensus 642 ~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 704 (714)
. ............... ..+... .....+.+++.+||+.||++|||++|+++
T Consensus 217 ~---~~~~~~~i~~~~~~~---~~~~~~------~~s~~~~~li~~~L~~dP~~Rpta~e~L~ 267 (444)
T 3soa_A 217 D---QHRLYQQIKAGAYDF---PSPEWD------TVTPEAKDLINKMLTINPSKRITAAEALK 267 (444)
T ss_dssp S---HHHHHHHHHHTCCCC---CTTTTT------TSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred c---HHHHHHHHHhCCCCC---Cccccc------cCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 1 122222222222111 111110 11236789999999999999999999976
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-41 Score=344.49 Aligned_cols=251 Identities=22% Similarity=0.347 Sum_probs=205.0
Q ss_pred ccccccCceEEEEEEECCCcEEEEEEeCCCCchhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCCCHhh
Q 005102 409 FVLGKSGIGIVYKVVLEDGHTLAVRRLGEGGSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGSLAT 488 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL~~ 488 (714)
+.||+|+||.||+|.+.+++.||+|++...... .+.+.+|++++++++||||+++++++...+..++||||+++++|.+
T Consensus 14 ~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 92 (267)
T 3t9t_A 14 QEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS-EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSD 92 (267)
T ss_dssp EEEEEETTEEEEEEEETTTEEEEEEEECTTTBC-HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCTTCBHHH
T ss_pred eEecCCCceeEEEEEecCCCeEEEEEccccCCC-HHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCCCCcHHH
Confidence 479999999999999988999999999876443 3679999999999999999999999999999999999999999999
Q ss_pred hhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCCCCcc
Q 005102 489 ALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQ 568 (714)
Q Consensus 489 ~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 568 (714)
++.... ..+++..+..++.|++.||+|||+ .+|+||||||+||++++++.+||+|||+++......
T Consensus 93 ~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~------ 158 (267)
T 3t9t_A 93 YLRTQR-----GLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ------ 158 (267)
T ss_dssp HHHHTT-----TCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHH------
T ss_pred HHhhCc-----ccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCchheEEECCCCCEEEccccccccccccc------
Confidence 997653 358899999999999999999999 899999999999999999999999999998643210
Q ss_pred CCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHh-CCCccccCCCCcchhH
Q 005102 569 SNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMIT-GRTAVVQVGSSEMDLV 647 (714)
Q Consensus 569 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~ellt-G~~p~~~~~~~~~~l~ 647 (714)
........++..|+|||.+.+..++.++||||||+++|||++ |+.||.... ..
T Consensus 159 ---------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~-----~~ 212 (267)
T 3t9t_A 159 ---------------------YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS-----NS 212 (267)
T ss_dssp ---------------------HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC-----HH
T ss_pred ---------------------ccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCC-----HH
Confidence 111223345778999999988889999999999999999999 899984321 11
Q ss_pred HHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhhhhcc
Q 005102 648 NWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDALDRLIVS 712 (714)
Q Consensus 648 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~~ 712 (714)
+.......... +..... ....+.+++.+||+.||++|||++++++.|+++..+
T Consensus 213 ~~~~~i~~~~~-------~~~~~~-----~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (267)
T 3t9t_A 213 EVVEDISTGFR-------LYKPRL-----ASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 265 (267)
T ss_dssp HHHHHHHTTCC-------CCCCTT-----SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHHHHHhcCCc-------CCCCcc-----CcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 22222211111 111111 123678999999999999999999999999998764
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-41 Score=355.17 Aligned_cols=263 Identities=25% Similarity=0.281 Sum_probs=199.9
Q ss_pred cccccccCceEEEEEEECCCcEEEEEEeCCCCchhHHHHHHHHHHHhcc--CCCCccceEEEEEeC----CceeEEEecc
Q 005102 408 AFVLGKSGIGIVYKVVLEDGHTLAVRRLGEGGSQRFKEFQTEVEAIGKI--RHSNIVTLRAYYWSV----DEKLLIYDYI 481 (714)
Q Consensus 408 ~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l--~H~niv~l~~~~~~~----~~~~lV~e~~ 481 (714)
.+.||+|+||.||+|++. ++.||||++.... ...+.+|.+++..+ +||||+++++++... ...++||||+
T Consensus 42 ~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~ 117 (337)
T 3mdy_A 42 VKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTE---EASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYH 117 (337)
T ss_dssp EEEEEEETTEEEEEEEET-TEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEEEEEECCC
T ss_pred EeEeecCCCeEEEEEEEC-CceEEEEEEeccc---cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCceEEEEecc
Confidence 458999999999999986 8999999986532 24455666666555 899999999999887 6789999999
Q ss_pred CCCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCC--------CceecCCCCCCeeeCCCCCeEEcccc
Q 005102 482 PNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPK--------KYVHGDLKPSNILLGHNMEPHVSDFG 553 (714)
Q Consensus 482 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~--------~ivHrDlkp~NILl~~~~~~kl~DFG 553 (714)
++|+|.++++.. .+++..+..++.|++.||+|||+ . +|+||||||+|||++.++.+||+|||
T Consensus 118 ~~g~L~~~l~~~-------~~~~~~~~~i~~~i~~~l~~lH~---~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg 187 (337)
T 3mdy_A 118 ENGSLYDYLKST-------TLDAKSMLKLAYSSVSGLCHLHT---EIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLG 187 (337)
T ss_dssp TTCBHHHHHHHC-------CBCHHHHHHHHHHHHHHHHHHHS---CBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCT
T ss_pred CCCcHHHHhhcc-------CCCHHHHHHHHHHHHHHHHHHHH---hhhhhccCCCEEecccchHHEEECCCCCEEEEeCC
Confidence 999999999643 48999999999999999999998 6 99999999999999999999999999
Q ss_pred hhhhhhccCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCch------hhhHHHHHHHH
Q 005102 554 LARLANIAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQK------WDIYSYGVILL 627 (714)
Q Consensus 554 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~------~DVwS~Gvvl~ 627 (714)
+++........ .........||+.|+|||++.+...+.+ +|||||||++|
T Consensus 188 ~a~~~~~~~~~------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~ 243 (337)
T 3mdy_A 188 LAVKFISDTNE------------------------VDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILW 243 (337)
T ss_dssp TCEECC---------------------------------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHH
T ss_pred Cceeecccccc------------------------ccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHH
Confidence 99765322110 0111234467999999999987766654 99999999999
Q ss_pred HHHhC----------CCccccCCCCcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCC
Q 005102 628 EMITG----------RTAVVQVGSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRP 697 (714)
Q Consensus 628 elltG----------~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RP 697 (714)
||+|| +.||............. ....... ...+.............++.+++.+||+.||++||
T Consensus 244 el~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~-~~~~~~~-----~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp 317 (337)
T 3mdy_A 244 EVARRCVSGGIVEEYQLPYHDLVPSDPSYEDM-REIVCIK-----KLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRL 317 (337)
T ss_dssp HHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHH-HHHHTTS-----CCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSC
T ss_pred HHHhccCcccccccccccHhhhcCCCCchhhh-HHHHhhh-----ccCccccccchhhHHHHHHHHHHHHhhhhChhhCC
Confidence 99999 66664332222222221 1111111 11222222222335677899999999999999999
Q ss_pred CHHHHHHHHhhhhccCC
Q 005102 698 TMRHISDALDRLIVSSD 714 (714)
Q Consensus 698 t~~evl~~L~~i~~~~~ 714 (714)
|++||++.|+++..+.+
T Consensus 318 s~~ell~~L~~l~~~~~ 334 (337)
T 3mdy_A 318 TALRVKKTLAKMSESQD 334 (337)
T ss_dssp CHHHHHHHHHHHHHTTT
T ss_pred CHHHHHHHHHHHHhhcc
Confidence 99999999999987653
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-42 Score=365.53 Aligned_cols=260 Identities=24% Similarity=0.324 Sum_probs=202.9
Q ss_pred cccccccCceEEEEEEEC------CCcEEEEEEeCCCCc-hhHHHHHHHHHHHhcc-CCCCccceEEEEEeCCc-eeEEE
Q 005102 408 AFVLGKSGIGIVYKVVLE------DGHTLAVRRLGEGGS-QRFKEFQTEVEAIGKI-RHSNIVTLRAYYWSVDE-KLLIY 478 (714)
Q Consensus 408 ~~~lG~G~~g~Vy~~~~~------~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~-~~lV~ 478 (714)
.+.||+|+||.||+|++. +++.||||++..... ...+.+.+|++++.++ +||||+++++++...+. .++||
T Consensus 27 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~~iv~ 106 (359)
T 3vhe_A 27 GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIV 106 (359)
T ss_dssp EEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCCEEEE
T ss_pred ceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecCCCceEEEE
Confidence 357999999999999842 368999999987533 3446799999999999 79999999999987654 89999
Q ss_pred eccCCCCHhhhhhCCCCCC------------------------------------------------------------C
Q 005102 479 DYIPNGSLATALHGKPGMV------------------------------------------------------------S 498 (714)
Q Consensus 479 e~~~~gsL~~~l~~~~~~~------------------------------------------------------------~ 498 (714)
||+++|+|.++++...... .
T Consensus 107 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 186 (359)
T 3vhe_A 107 EFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLY 186 (359)
T ss_dssp ECCTTEEHHHHHHTTTTSBCSCC------------------------------------------------------CTT
T ss_pred EecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhhcccccchh
Confidence 9999999999998653210 0
Q ss_pred cCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCCCCccCCCCCCCCch
Q 005102 499 FTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQ 578 (714)
Q Consensus 499 ~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~ 578 (714)
...+++..+..|+.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++.......
T Consensus 187 ~~~l~~~~~~~~~~ql~~aL~~LH~---~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~--------------- 248 (359)
T 3vhe_A 187 KDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD--------------- 248 (359)
T ss_dssp TTCBCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTT---------------
T ss_pred ccccCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEEcCCCcEEEEeccceeeeccccc---------------
Confidence 1228999999999999999999999 8999999999999999999999999999986532211
Q ss_pred hhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHh-CCCccccCCCCcchhHHHHHHHHhhc
Q 005102 579 ERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMIT-GRTAVVQVGSSEMDLVNWMQLCIEEK 657 (714)
Q Consensus 579 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~ 657 (714)
........||+.|+|||++.+..++.++|||||||++|||+| |+.||......+ .+.......
T Consensus 249 -----------~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~-----~~~~~~~~~ 312 (359)
T 3vhe_A 249 -----------YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE-----EFCRRLKEG 312 (359)
T ss_dssp -----------CEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH-----HHHHHHHHT
T ss_pred -----------chhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhH-----HHHHHHHcC
Confidence 111223446788999999998999999999999999999999 999995432221 111222222
Q ss_pred CCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhhhhcc
Q 005102 658 KPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDALDRLIVS 712 (714)
Q Consensus 658 ~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~~ 712 (714)
.. ...... ...++.+++.+||+.||++|||++|+++.|+++..+
T Consensus 313 ~~------~~~~~~-----~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~ 356 (359)
T 3vhe_A 313 TR------MRAPDY-----TTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 356 (359)
T ss_dssp CC------CCCCTT-----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CC------CCCCCC-----CCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHH
Confidence 11 111111 123588999999999999999999999999998753
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-42 Score=376.59 Aligned_cols=253 Identities=27% Similarity=0.429 Sum_probs=199.8
Q ss_pred cccccccCceEEEEEEECCCcEEEEEEeCCCCchhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCCCHh
Q 005102 408 AFVLGKSGIGIVYKVVLEDGHTLAVRRLGEGGSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGSLA 487 (714)
Q Consensus 408 ~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL~ 487 (714)
.+.||+|+||.||+|.+.++..||||+++.... ..+.|.+|+++|++++||||+++++++.. +..++||||+++|+|.
T Consensus 189 ~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~~~gsL~ 266 (452)
T 1fmk_A 189 EVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLL 266 (452)
T ss_dssp EEEEEECSSCEEEEEEETTTEEEEEEECCTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTCBHH
T ss_pred eeeecCCCCeEEEEEEECCCceEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehhhcCCCHH
Confidence 357999999999999998888999999986543 34789999999999999999999999866 6789999999999999
Q ss_pred hhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCCCCc
Q 005102 488 TALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTL 567 (714)
Q Consensus 488 ~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 567 (714)
+++....+ ..+++.++..|+.|++.||+|||+ ++|+||||||+|||+++++.+||+|||+++......
T Consensus 267 ~~l~~~~~----~~~~~~~~~~i~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~----- 334 (452)
T 1fmk_A 267 DFLKGETG----KYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE----- 334 (452)
T ss_dssp HHHSHHHH----TTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCTTC-----------
T ss_pred HHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChhhEEECCCCCEEECCCccceecCCCc-----
Confidence 99964321 348999999999999999999999 899999999999999999999999999998654211
Q ss_pred cCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHh-CCCccccCCCCcchh
Q 005102 568 QSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMIT-GRTAVVQVGSSEMDL 646 (714)
Q Consensus 568 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~ellt-G~~p~~~~~~~~~~l 646 (714)
........++..|+|||.+.+..++.++|||||||++|||+| |+.||.... .
T Consensus 335 ----------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~--~--- 387 (452)
T 1fmk_A 335 ----------------------YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV--N--- 387 (452)
T ss_dssp ------------------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC--H---
T ss_pred ----------------------eecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCC--H---
Confidence 011122335678999999998899999999999999999999 999994321 1
Q ss_pred HHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhhhhccC
Q 005102 647 VNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDALDRLIVSS 713 (714)
Q Consensus 647 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~~~ 713 (714)
.+..... ..... ..... .....+.+++.+||+.||++|||++++++.|+++..+.
T Consensus 388 ~~~~~~i-~~~~~------~~~~~-----~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~ 442 (452)
T 1fmk_A 388 REVLDQV-ERGYR------MPCPP-----ECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 442 (452)
T ss_dssp HHHHHHH-HTTCC------CCCCT-----TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred HHHHHHH-HcCCC------CCCCC-----CCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccC
Confidence 1222221 11111 11111 12236889999999999999999999999999987654
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-41 Score=362.87 Aligned_cols=258 Identities=24% Similarity=0.348 Sum_probs=204.7
Q ss_pred ccccccCceEEEEEEEC--------CCcEEEEEEeCCCC-chhHHHHHHHHHHHhcc-CCCCccceEEEEEeCCceeEEE
Q 005102 409 FVLGKSGIGIVYKVVLE--------DGHTLAVRRLGEGG-SQRFKEFQTEVEAIGKI-RHSNIVTLRAYYWSVDEKLLIY 478 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~--------~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~ 478 (714)
+.||+|+||.||+|++. ++..||||++.... ....+.+.+|+++++++ +||||+++++++...+..++||
T Consensus 75 ~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~ 154 (382)
T 3tt0_A 75 KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIV 154 (382)
T ss_dssp EEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred eEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccCCceEEEE
Confidence 57999999999999863 24679999998653 33456799999999999 8999999999999999999999
Q ss_pred eccCCCCHhhhhhCCCCC----------CCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeE
Q 005102 479 DYIPNGSLATALHGKPGM----------VSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPH 548 (714)
Q Consensus 479 e~~~~gsL~~~l~~~~~~----------~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~k 548 (714)
||+++|+|.+++...... .....+++.++++|+.|++.||+|||+ .+|+||||||+|||+++++.+|
T Consensus 155 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~k 231 (382)
T 3tt0_A 155 EYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMK 231 (382)
T ss_dssp ECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEE
T ss_pred EecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCcceEEEcCCCcEE
Confidence 999999999999765311 011358999999999999999999999 8999999999999999999999
Q ss_pred EcccchhhhhhccCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHH
Q 005102 549 VSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLE 628 (714)
Q Consensus 549 l~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~e 628 (714)
|+|||+++....... ........+|+.|+|||++.+..++.++|||||||++||
T Consensus 232 L~DFG~a~~~~~~~~--------------------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~e 285 (382)
T 3tt0_A 232 IADFGLARDIHHIDY--------------------------YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWE 285 (382)
T ss_dssp ECSCSCCCCSSCCCT--------------------------TCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHH
T ss_pred EcccCcccccccccc--------------------------cccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHH
Confidence 999999986532211 011223345788999999999999999999999999999
Q ss_pred HHh-CCCccccCCCCcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHh
Q 005102 629 MIT-GRTAVVQVGSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDALD 707 (714)
Q Consensus 629 llt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~ 707 (714)
|+| |+.||.... ..+.......... +..... ...++.+++.+||+.||++|||++||++.|+
T Consensus 286 llt~g~~p~~~~~-----~~~~~~~~~~~~~-------~~~~~~-----~~~~l~~li~~~l~~dP~~Rps~~ell~~L~ 348 (382)
T 3tt0_A 286 IFTLGGSPYPGVP-----VEELFKLLKEGHR-------MDKPSN-----CTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 348 (382)
T ss_dssp HHTTSCCSSTTCC-----HHHHHHHHHTTCC-------CCCCSS-----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHhCCCCCCCCCC-----HHHHHHHHHcCCC-------CCCCcc-----CCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 999 999994321 1222222211111 111111 1236889999999999999999999999999
Q ss_pred hhhcc
Q 005102 708 RLIVS 712 (714)
Q Consensus 708 ~i~~~ 712 (714)
++...
T Consensus 349 ~~~~~ 353 (382)
T 3tt0_A 349 RIVAL 353 (382)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 98643
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-41 Score=361.55 Aligned_cols=242 Identities=19% Similarity=0.282 Sum_probs=195.6
Q ss_pred ccccccCceEEEEEEECC-CcEEEEEEeCCCC---chhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCC
Q 005102 409 FVLGKSGIGIVYKVVLED-GHTLAVRRLGEGG---SQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNG 484 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~~-g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~g 484 (714)
+.||+|+||.||+|.... ++.||+|++.... ....+.+.+|++++++++||||+++++++.+.+..|+||||+++|
T Consensus 21 ~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~~~gg 100 (384)
T 4fr4_A 21 RAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGG 100 (384)
T ss_dssp EEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCTTE
T ss_pred EEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEecCCCC
Confidence 479999999999999865 8899999987532 233567889999999999999999999999999999999999999
Q ss_pred CHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCC
Q 005102 485 SLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGS 564 (714)
Q Consensus 485 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 564 (714)
+|.+++... ..+++..+..|+.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++.....
T Consensus 101 ~L~~~l~~~------~~l~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~--- 168 (384)
T 4fr4_A 101 DLRYHLQQN------VHFKEETVKLFICELVMALDYLQN---QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE--- 168 (384)
T ss_dssp EHHHHHHTT------CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT---
T ss_pred cHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCcHHHeEECCCCCEEEeccceeeeccCC---
Confidence 999999865 458999999999999999999999 89999999999999999999999999999864321
Q ss_pred CCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCC---CCCCchhhhHHHHHHHHHHHhCCCccccCCC
Q 005102 565 PTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKV---VKPSQKWDIYSYGVILLEMITGRTAVVQVGS 641 (714)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~s~~~DVwS~Gvvl~elltG~~p~~~~~~ 641 (714)
.......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.....
T Consensus 169 --------------------------~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~ 222 (384)
T 4fr4_A 169 --------------------------TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSS 222 (384)
T ss_dssp --------------------------CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTT
T ss_pred --------------------------CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCC
Confidence 12234568999999999964 4589999999999999999999999954322
Q ss_pred CcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCC-HHHHH
Q 005102 642 SEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPT-MRHIS 703 (714)
Q Consensus 642 ~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt-~~evl 703 (714)
. .....+......... ..... ...+.+++.+||+.||++||+ ++++.
T Consensus 223 ~--~~~~~~~~~~~~~~~--------~p~~~-----s~~~~~li~~lL~~dP~~R~s~~~~l~ 270 (384)
T 4fr4_A 223 T--SSKEIVHTFETTVVT--------YPSAW-----SQEMVSLLKKLLEPNPDQRFSQLSDVQ 270 (384)
T ss_dssp S--CHHHHHHHHHHCCCC--------CCTTS-----CHHHHHHHHHHSCSSGGGSCCSHHHHH
T ss_pred c--cHHHHHHHHhhcccC--------CCCcC-----CHHHHHHHHHHhcCCHhHhcccHHHHH
Confidence 2 222222222222111 11111 236889999999999999998 66654
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-41 Score=352.03 Aligned_cols=249 Identities=26% Similarity=0.437 Sum_probs=195.0
Q ss_pred ccccccCceEEEEEEECCCcEEEEEEeCCCCchhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCCCHhh
Q 005102 409 FVLGKSGIGIVYKVVLEDGHTLAVRRLGEGGSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGSLAT 488 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL~~ 488 (714)
+.||+|+||.||+|++. ++.||||++... ...+.|.+|++++++++||||+++++++. +..++||||+++|+|.+
T Consensus 14 ~~lg~G~~g~V~~~~~~-~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~~~~~~L~~ 88 (307)
T 2eva_A 14 EVVGRGAFGVVCKAKWR-AKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYAEGGSLYN 88 (307)
T ss_dssp EEEECCSSSEEEEEEET-TEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEECCTTCBHHH
T ss_pred eEeecCCCceEEEEEEC-CeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEcCCCCCHHH
Confidence 57999999999999985 789999999754 33478999999999999999999999876 45899999999999999
Q ss_pred hhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCC-eEEcccchhhhhhccCCCCCc
Q 005102 489 ALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNME-PHVSDFGLARLANIAGGSPTL 567 (714)
Q Consensus 489 ~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~-~kl~DFGla~~~~~~~~~~~~ 567 (714)
++...... ..+++..+++++.|+++||+|||+..+++|+||||||+||+++.++. +||+|||+++.....
T Consensus 89 ~l~~~~~~---~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~------ 159 (307)
T 2eva_A 89 VLHGAEPL---PYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH------ 159 (307)
T ss_dssp HHHCSSSE---ECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC-------------
T ss_pred HHhccCCC---CccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc------
Confidence 99865321 34788999999999999999999965568999999999999998886 799999998754211
Q ss_pred cCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCccccCCCCcchhH
Q 005102 568 QSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGSSEMDLV 647 (714)
Q Consensus 568 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~~~~~~~~~~l~ 647 (714)
.....||+.|+|||++.+..++.++||||||+++|||+||+.||........
T Consensus 160 -------------------------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~--- 211 (307)
T 2eva_A 160 -------------------------MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAF--- 211 (307)
T ss_dssp ------------------------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHH---
T ss_pred -------------------------cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHH---
Confidence 1123468899999999999999999999999999999999999954433221
Q ss_pred HHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhhhhc
Q 005102 648 NWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDALDRLIV 711 (714)
Q Consensus 648 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~ 711 (714)
........... +..... ....+.+++.+||+.||++|||++++++.|+.+..
T Consensus 212 ~~~~~~~~~~~-------~~~~~~-----~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 263 (307)
T 2eva_A 212 RIMWAVHNGTR-------PPLIKN-----LPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMR 263 (307)
T ss_dssp HHHHHHHTTCC-------CCCBTT-----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGG
T ss_pred HHHHHHhcCCC-------CCcccc-----cCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHH
Confidence 11111111111 111111 12357899999999999999999999999998864
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-41 Score=357.21 Aligned_cols=242 Identities=22% Similarity=0.311 Sum_probs=192.8
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeCCCC---chhHHHHHHHHHHHhcc-CCCCccceEEEEEeCCceeEEEeccCC
Q 005102 409 FVLGKSGIGIVYKVVLE-DGHTLAVRRLGEGG---SQRFKEFQTEVEAIGKI-RHSNIVTLRAYYWSVDEKLLIYDYIPN 483 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~e~~~~ 483 (714)
+.||+|+||.||+|+.+ +++.||||++.+.. ....+.+.+|+.++.++ +||||+++++++.+.+..|+||||+++
T Consensus 15 ~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~e~~~g 94 (345)
T 3a8x_A 15 RVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 94 (345)
T ss_dssp EEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred EEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEEEeCCCC
Confidence 47999999999999986 48999999997642 23345688999999988 899999999999999999999999999
Q ss_pred CCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCC
Q 005102 484 GSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGG 563 (714)
Q Consensus 484 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 563 (714)
|+|.+++... ..+++..++.++.||+.||+|||+ ++|+||||||+|||++.++++||+|||+++.....
T Consensus 95 g~L~~~l~~~------~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~-- 163 (345)
T 3a8x_A 95 GDLMFHMQRQ------RKLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP-- 163 (345)
T ss_dssp CBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCT--
T ss_pred CcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCHHHEEECCCCCEEEEeccccccccCC--
Confidence 9999999754 458999999999999999999999 89999999999999999999999999999743211
Q ss_pred CCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCccccCCCCc
Q 005102 564 SPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGSSE 643 (714)
Q Consensus 564 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~~~~~~~~ 643 (714)
........||+.|+|||++.+..++.++|||||||++|||++|+.||...+...
T Consensus 164 --------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~ 217 (345)
T 3a8x_A 164 --------------------------GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSD 217 (345)
T ss_dssp --------------------------TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC--
T ss_pred --------------------------CCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCccccc
Confidence 111234568999999999999999999999999999999999999995432211
Q ss_pred c---hhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCH
Q 005102 644 M---DLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTM 699 (714)
Q Consensus 644 ~---~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~ 699 (714)
. .....+........ ..++... ...+.+++.+||+.||++||++
T Consensus 218 ~~~~~~~~~~~~~i~~~~-------~~~p~~~-----s~~~~~li~~lL~~dP~~R~~~ 264 (345)
T 3a8x_A 218 NPDQNTEDYLFQVILEKQ-------IRIPRSL-----SVKAASVLKSFLNKDPKERLGC 264 (345)
T ss_dssp -----CHHHHHHHHHHCC-------CCCCTTS-----CHHHHHHHHHHTCSSTTTSTTC
T ss_pred ccccccHHHHHHHHHcCC-------CCCCCCC-----CHHHHHHHHHHhcCCHhHCCCC
Confidence 1 11112222221111 1111111 2357899999999999999996
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-41 Score=362.22 Aligned_cols=245 Identities=18% Similarity=0.263 Sum_probs=198.5
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeCCCCchhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCCCHh
Q 005102 409 FVLGKSGIGIVYKVVLE-DGHTLAVRRLGEGGSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGSLA 487 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL~ 487 (714)
+.||+|+||.||+|... +|+.||+|++..........+.+|++++++++||||+++++++.+.+..++||||+++|+|.
T Consensus 57 ~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~~~gg~L~ 136 (387)
T 1kob_A 57 EELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELF 136 (387)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCCCCBHH
T ss_pred EEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEcCCCCcHH
Confidence 57999999999999986 58999999998766555678999999999999999999999999999999999999999999
Q ss_pred hhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCC--CCCeEEcccchhhhhhccCCCC
Q 005102 488 TALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGH--NMEPHVSDFGLARLANIAGGSP 565 (714)
Q Consensus 488 ~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~--~~~~kl~DFGla~~~~~~~~~~ 565 (714)
+++.... ..+++..+..++.||+.||+|||+ .+|+||||||+|||++. ++.+||+|||+++......
T Consensus 137 ~~l~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~--- 205 (387)
T 1kob_A 137 DRIAAED-----YKMSEAEVINYMRQACEGLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE--- 205 (387)
T ss_dssp HHTTCTT-----CCBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS---
T ss_pred HHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccchHHeEEecCCCCceEEEecccceecCCCc---
Confidence 9997553 358999999999999999999999 89999999999999974 5789999999998653211
Q ss_pred CccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCccccCCCCcch
Q 005102 566 TLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGSSEMD 645 (714)
Q Consensus 566 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~~~~~~~~~~ 645 (714)
......||+.|+|||++.+..++.++|||||||++|||++|+.||... ..
T Consensus 206 --------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~--~~-- 255 (387)
T 1kob_A 206 --------------------------IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGE--DD-- 255 (387)
T ss_dssp --------------------------CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCS--SH--
T ss_pred --------------------------ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCC--CH--
Confidence 011224689999999999999999999999999999999999999432 11
Q ss_pred hHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 005102 646 LVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISD 704 (714)
Q Consensus 646 l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 704 (714)
.+.+.......... ++..... ...++.+++.+||+.||++|||++|+++
T Consensus 256 -~~~~~~i~~~~~~~----~~~~~~~-----~s~~~~~li~~~L~~dP~~Rpt~~ell~ 304 (387)
T 1kob_A 256 -LETLQNVKRCDWEF----DEDAFSS-----VSPEAKDFIKNLLQKEPRKRLTVHDALE 304 (387)
T ss_dssp -HHHHHHHHHCCCCC----CSSTTTT-----SCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred -HHHHHHHHhCCCCC----Ccccccc-----CCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence 22222222222111 1111111 1236789999999999999999999976
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-41 Score=344.16 Aligned_cols=246 Identities=21% Similarity=0.333 Sum_probs=198.4
Q ss_pred ccccccCceEEEEEEECCCcEEEEEEeCCCC--chhHHHHHHHHHHHhccCCCCccceEEEEEeC--CceeEEEeccCCC
Q 005102 409 FVLGKSGIGIVYKVVLEDGHTLAVRRLGEGG--SQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSV--DEKLLIYDYIPNG 484 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~~lV~e~~~~g 484 (714)
+.||+|+||.||+|++. ++.||||++.... ....+.|.+|++++++++||||+++++++... +..++||||+++|
T Consensus 16 ~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~ 94 (271)
T 3kmu_A 16 TKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYG 94 (271)
T ss_dssp EEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEEECCTTC
T ss_pred HHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeeecccCCC
Confidence 47999999999999995 8899999998653 33456799999999999999999999999877 7789999999999
Q ss_pred CHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCC--ceecCCCCCCeeeCCCCCeEEcccchhhhhhccC
Q 005102 485 SLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKK--YVHGDLKPSNILLGHNMEPHVSDFGLARLANIAG 562 (714)
Q Consensus 485 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~--ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 562 (714)
+|.+++..... ..+++..+..|+.|++.||+|||+ .+ |+||||||+||++++++.++|+|||++....
T Consensus 95 ~L~~~l~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~---~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~--- 164 (271)
T 3kmu_A 95 SLYNVLHEGTN----FVVDQSQAVKFALDMARGMAFLHT---LEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQ--- 164 (271)
T ss_dssp BHHHHHHSCSS----CCCCHHHHHHHHHHHHHHHHHHTT---SSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTS---
T ss_pred cHHHHHhhccc----CCCCHHHHHHHHHHHHHHHHHHhc---CCCceecCCCccceEEEcCCcceeEEeccceeeec---
Confidence 99999987532 358999999999999999999999 77 9999999999999999999999998765321
Q ss_pred CCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCc---hhhhHHHHHHHHHHHhCCCccccC
Q 005102 563 GSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQ---KWDIYSYGVILLEMITGRTAVVQV 639 (714)
Q Consensus 563 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~---~~DVwS~Gvvl~elltG~~p~~~~ 639 (714)
.....||+.|+|||.+.+..++. ++||||||+++|||+||+.||...
T Consensus 165 ------------------------------~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~ 214 (271)
T 3kmu_A 165 ------------------------------SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADL 214 (271)
T ss_dssp ------------------------------CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTS
T ss_pred ------------------------------ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCcccc
Confidence 11234588899999998765444 899999999999999999999533
Q ss_pred CCCcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhhhhc
Q 005102 640 GSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDALDRLIV 711 (714)
Q Consensus 640 ~~~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~ 711 (714)
.. ............ .+...... ...+.+++.+||+.||++|||++|+++.|+++..
T Consensus 215 ~~-----~~~~~~~~~~~~------~~~~~~~~-----~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~ 270 (271)
T 3kmu_A 215 SN-----MEIGMKVALEGL------RPTIPPGI-----SPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270 (271)
T ss_dssp CH-----HHHHHHHHHSCC------CCCCCTTC-----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred Ch-----HHHHHHHHhcCC------CCCCCCCC-----CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 21 111222222211 11121111 2358899999999999999999999999999865
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=361.01 Aligned_cols=240 Identities=21% Similarity=0.282 Sum_probs=195.1
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeCCCC---chhHHHHHHHHHHHhcc-CCCCccceEEEEEeCCceeEEEeccCC
Q 005102 409 FVLGKSGIGIVYKVVLE-DGHTLAVRRLGEGG---SQRFKEFQTEVEAIGKI-RHSNIVTLRAYYWSVDEKLLIYDYIPN 483 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~e~~~~ 483 (714)
+.||+|+||.||+|+++ +|+.||||++++.. ....+.+..|.+++..+ +||||+++++++.+.+..|+||||+++
T Consensus 23 ~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~lv~E~~~g 102 (345)
T 1xjd_A 23 KMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNG 102 (345)
T ss_dssp EEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTT
T ss_pred EEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEEEEEeCCCC
Confidence 57999999999999986 48999999997642 23346688899999987 899999999999999999999999999
Q ss_pred CCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCC
Q 005102 484 GSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGG 563 (714)
Q Consensus 484 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 563 (714)
|+|.+++... ..+++..+..++.||+.||+|||+ ++|+||||||+|||++.++++||+|||+++.....
T Consensus 103 g~L~~~l~~~------~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~-- 171 (345)
T 1xjd_A 103 GDLMYHIQSC------HKFDLSRATFYAAEIILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG-- 171 (345)
T ss_dssp CBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT--
T ss_pred CcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCChhhEEECCCCCEEEeEChhhhhcccC--
Confidence 9999999754 458999999999999999999999 89999999999999999999999999998743211
Q ss_pred CCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCccccCCCCc
Q 005102 564 SPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGSSE 643 (714)
Q Consensus 564 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~~~~~~~~ 643 (714)
........||+.|+|||++.+..++.++|||||||++|||++|+.||... ..
T Consensus 172 --------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~--~~ 223 (345)
T 1xjd_A 172 --------------------------DAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQ--DE 223 (345)
T ss_dssp --------------------------TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS--SH
T ss_pred --------------------------CCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCC--CH
Confidence 01123456899999999999999999999999999999999999999432 11
Q ss_pred chhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHH-HHH
Q 005102 644 MDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMR-HIS 703 (714)
Q Consensus 644 ~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~-evl 703 (714)
.+........... ..... ...+.+++.+||..||++||++. |++
T Consensus 224 ---~~~~~~i~~~~~~--------~p~~~-----s~~~~~li~~lL~~dp~~R~~~~~~i~ 268 (345)
T 1xjd_A 224 ---EELFHSIRMDNPF--------YPRWL-----EKEAKDLLVKLFVREPEKRLGVRGDIR 268 (345)
T ss_dssp ---HHHHHHHHHCCCC--------CCTTS-----CHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred ---HHHHHHHHhCCCC--------CCccc-----CHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence 2222222222211 11111 23578999999999999999997 553
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-41 Score=354.37 Aligned_cols=241 Identities=23% Similarity=0.292 Sum_probs=187.5
Q ss_pred ccccccCceEEEEEEE----CCCcEEEEEEeCCCC----chhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEec
Q 005102 409 FVLGKSGIGIVYKVVL----EDGHTLAVRRLGEGG----SQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDY 480 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~----~~g~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~ 480 (714)
+.||+|+||.||+|+. .+|+.||+|++.+.. ......+.+|++++++++||||+++++++...+..++||||
T Consensus 23 ~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 102 (327)
T 3a62_A 23 RVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKLYLILEY 102 (327)
T ss_dssp EEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred EEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCEEEEEEeC
Confidence 4799999999999997 468999999998642 22345688999999999999999999999999999999999
Q ss_pred cCCCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhc
Q 005102 481 IPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANI 560 (714)
Q Consensus 481 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 560 (714)
+++|+|.+++... ..+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++....
T Consensus 103 ~~~~~L~~~l~~~------~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 173 (327)
T 3a62_A 103 LSGGELFMQLERE------GIFMEDTACFYLAEISMALGHLHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIH 173 (327)
T ss_dssp CTTEEHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCTTTEEECTTSCEEECCCSCC-----
T ss_pred CCCCcHHHHHHhC------CCCCHHHHHHHHHHHHHHHHHHHh---CCEEcccCCHHHeEECCCCcEEEEeCCccccccc
Confidence 9999999999754 458899999999999999999999 8999999999999999999999999999875322
Q ss_pred cCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCccccCC
Q 005102 561 AGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVG 640 (714)
Q Consensus 561 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~~~~~ 640 (714)
. ........||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 174 ~----------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 225 (327)
T 3a62_A 174 D----------------------------GTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGEN 225 (327)
T ss_dssp ---------------------------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred C----------------------------CccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCC
Confidence 1 111223457899999999999899999999999999999999999994321
Q ss_pred CCcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCC-----CHHHHHH
Q 005102 641 SSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRP-----TMRHISD 704 (714)
Q Consensus 641 ~~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----t~~evl~ 704 (714)
....+.........+ .... ...+.+++.+||+.||++|| +++|+++
T Consensus 226 -----~~~~~~~i~~~~~~~--------p~~~-----~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~ 276 (327)
T 3a62_A 226 -----RKKTIDKILKCKLNL--------PPYL-----TQEARDLLKKLLKRNAASRLGAGPGDAGEVQA 276 (327)
T ss_dssp -----HHHHHHHHHHTCCCC--------CTTS-----CHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred -----HHHHHHHHHhCCCCC--------CCCC-----CHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence 122222333322111 1111 23578999999999999999 6667654
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=353.10 Aligned_cols=247 Identities=21% Similarity=0.322 Sum_probs=197.1
Q ss_pred ccccccCceEEEEEEECC-C-------cEEEEEEeCCCCchhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEec
Q 005102 409 FVLGKSGIGIVYKVVLED-G-------HTLAVRRLGEGGSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDY 480 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~~-g-------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~ 480 (714)
+.||+|+||.||+|+... + ..||+|++........+.+.+|++++++++||||+++++++...+..++||||
T Consensus 14 ~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 93 (289)
T 4fvq_A 14 ESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDENILVQEF 93 (289)
T ss_dssp EEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred eeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCCCEEEEEC
Confidence 479999999999998754 3 57999999877666678899999999999999999999999999999999999
Q ss_pred cCCCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCC--------eEEccc
Q 005102 481 IPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNME--------PHVSDF 552 (714)
Q Consensus 481 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~--------~kl~DF 552 (714)
+++|+|.+++.... ..+++..+..|+.|++.||+|||+ ++|+||||||+|||++.++. +||+||
T Consensus 94 ~~~~~L~~~l~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~Df 165 (289)
T 4fvq_A 94 VKFGSLDTYLKKNK-----NCINILWKLEVAKQLAAAMHFLEE---NTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDP 165 (289)
T ss_dssp CTTCBHHHHHHHTG-----GGCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEEECCBGGGTBCCEEEECCC
T ss_pred CCCCCHHHHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHhh---CCeECCCcCcceEEEecCCcccccccceeeeccC
Confidence 99999999997653 348999999999999999999999 89999999999999998887 999999
Q ss_pred chhhhhhccCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCC-CCCCchhhhHHHHHHHHHHHh
Q 005102 553 GLARLANIAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKV-VKPSQKWDIYSYGVILLEMIT 631 (714)
Q Consensus 553 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DVwS~Gvvl~ellt 631 (714)
|+++..... ....||+.|+|||.+.+ ..++.++||||||+++|||++
T Consensus 166 g~~~~~~~~--------------------------------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~ 213 (289)
T 4fvq_A 166 GISITVLPK--------------------------------DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICS 213 (289)
T ss_dssp CSCTTTSCH--------------------------------HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHT
T ss_pred cccccccCc--------------------------------cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHc
Confidence 998654211 01124677999999987 678999999999999999999
Q ss_pred CCCccccCCCCcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhhhhc
Q 005102 632 GRTAVVQVGSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDALDRLIV 711 (714)
Q Consensus 632 G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~ 711 (714)
|..|+...... ..... ......... ... ...+.+++.+||+.||++|||++|+++.|+++..
T Consensus 214 g~~~~~~~~~~----~~~~~-~~~~~~~~~--------~~~-----~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~ 275 (289)
T 4fvq_A 214 GGDKPLSALDS----QRKLQ-FYEDRHQLP--------APK-----AAELANLINNCMDYEPDHRPSFRAIIRDLNSLFT 275 (289)
T ss_dssp TTCCTTTTSCH----HHHHH-HHHTTCCCC--------CCS-----SCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC-
T ss_pred CCCCCccccch----HHHHH-HhhccCCCC--------CCC-----CHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 66555322111 11111 111111111 111 1147789999999999999999999999999987
Q ss_pred cC
Q 005102 712 SS 713 (714)
Q Consensus 712 ~~ 713 (714)
+.
T Consensus 276 p~ 277 (289)
T 4fvq_A 276 PD 277 (289)
T ss_dssp --
T ss_pred CC
Confidence 64
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-41 Score=359.96 Aligned_cols=249 Identities=18% Similarity=0.262 Sum_probs=195.6
Q ss_pred cccccccCceEEEEEEEC-CCcEEEEEEeCCC-----CchhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEecc
Q 005102 408 AFVLGKSGIGIVYKVVLE-DGHTLAVRRLGEG-----GSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYI 481 (714)
Q Consensus 408 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~ 481 (714)
.+.||+|+||.||+|..+ +|+.||||++... .....+.+.+|++++++++||||+++++++...+..++||||+
T Consensus 29 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~ 108 (351)
T 3c0i_A 29 CEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFM 108 (351)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred eeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEeCC
Confidence 458999999999999975 5899999998642 1223578999999999999999999999999999999999999
Q ss_pred CCCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCC---eEEcccchhhhh
Q 005102 482 PNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNME---PHVSDFGLARLA 558 (714)
Q Consensus 482 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~---~kl~DFGla~~~ 558 (714)
++|+|.+.+...... ...+++..+..++.||+.||+|||+ ++|+||||||+|||++.++. +||+|||+++..
T Consensus 109 ~g~~L~~~l~~~~~~--~~~~~~~~~~~i~~qi~~al~~lH~---~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~~ 183 (351)
T 3c0i_A 109 DGADLCFEIVKRADA--GFVYSEAVASHYMRQILEALRYCHD---NNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQL 183 (351)
T ss_dssp SSCBHHHHHHHHHHT--TCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECSSSTTCCEEECCCTTCEEC
T ss_pred CCCCHHHHHHHhccc--CCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCChHHeEEecCCCCCcEEEecCcceeEe
Confidence 999998887543211 0348999999999999999999999 89999999999999986654 999999999765
Q ss_pred hccCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCcccc
Q 005102 559 NIAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQ 638 (714)
Q Consensus 559 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~~~ 638 (714)
.... .......||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 184 ~~~~----------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~ 235 (351)
T 3c0i_A 184 GESG----------------------------LVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYG 235 (351)
T ss_dssp CTTS----------------------------CBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCS
T ss_pred cCCC----------------------------eeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCC
Confidence 3211 112234579999999999999999999999999999999999999953
Q ss_pred CCCCcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 005102 639 VGSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISD 704 (714)
Q Consensus 639 ~~~~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 704 (714)
. .. ................. .. .....+.+++.+||+.||++|||+.|+++
T Consensus 236 ~---~~---~~~~~i~~~~~~~~~~~----~~-----~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 236 T---KE---RLFEGIIKGKYKMNPRQ----WS-----HISESAKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp S---HH---HHHHHHHHTCCCCCHHH----HT-----TSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred c---HH---HHHHHHHcCCCCCCccc----cc-----cCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 2 11 12222222221110000 00 11236789999999999999999999975
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-41 Score=347.31 Aligned_cols=257 Identities=23% Similarity=0.327 Sum_probs=193.5
Q ss_pred ccccccCceEEEEEEECCCcEEEEEEeCCCCc--hhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCCCH
Q 005102 409 FVLGKSGIGIVYKVVLEDGHTLAVRRLGEGGS--QRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGSL 486 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL 486 (714)
+.||+|+||.||+|+..+|+.||||++..... ...+.+.+|++++++++||||+++++++...+..++||||+++ +|
T Consensus 8 ~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l 86 (288)
T 1ob3_A 8 EKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQ-DL 86 (288)
T ss_dssp EEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCSE-EH
T ss_pred hhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEecCC-CH
Confidence 47999999999999998899999999976432 2236788999999999999999999999999999999999975 99
Q ss_pred hhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCCCC
Q 005102 487 ATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPT 566 (714)
Q Consensus 487 ~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 566 (714)
.+++.... ..+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||+++......
T Consensus 87 ~~~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~---- 154 (288)
T 1ob3_A 87 KKLLDVCE-----GGLESVTAKSFLLQLLNGIAYCHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPV---- 154 (288)
T ss_dssp HHHHHTST-----TCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC------
T ss_pred HHHHHhcc-----cCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEEeECccccccCccc----
Confidence 99987653 458999999999999999999999 899999999999999999999999999998653211
Q ss_pred ccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCC-CCCchhhhHHHHHHHHHHHhCCCccccCCCCcch
Q 005102 567 LQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVV-KPSQKWDIYSYGVILLEMITGRTAVVQVGSSEMD 645 (714)
Q Consensus 567 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DVwS~Gvvl~elltG~~p~~~~~~~~~~ 645 (714)
.......||+.|+|||++.+. .++.++|||||||++|||+||+.||.... ..+
T Consensus 155 ------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~--~~~ 208 (288)
T 1ob3_A 155 ------------------------RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVS--EAD 208 (288)
T ss_dssp -------------------------------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSS--HHH
T ss_pred ------------------------cccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC--HHH
Confidence 111223468899999999764 58999999999999999999999995332 111
Q ss_pred hHHHHHHHHhhcC--Cccc-----ccCCCCCCCC------CcHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 005102 646 LVNWMQLCIEEKK--PLAD-----VLDPYLAPDA------DKEEEIIAVLKIAMACVHSSPEKRPTMRHISD 704 (714)
Q Consensus 646 l~~~~~~~~~~~~--~~~~-----~~d~~~~~~~------~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 704 (714)
....+........ .... ..++...... ........+.+++.+||+.||++|||++|+++
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 280 (288)
T 1ob3_A 209 QLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (288)
T ss_dssp HHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHHHHHHCCCChhhchhhhcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 1111111111100 0000 0111110000 00012236789999999999999999999875
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-41 Score=352.28 Aligned_cols=259 Identities=25% Similarity=0.362 Sum_probs=205.0
Q ss_pred cccccccCceEEEEEEE------CCCcEEEEEEeCCCC-chhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEec
Q 005102 408 AFVLGKSGIGIVYKVVL------EDGHTLAVRRLGEGG-SQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDY 480 (714)
Q Consensus 408 ~~~lG~G~~g~Vy~~~~------~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~ 480 (714)
.+.||+|+||.||+|.. .++..||||++.... ....+.+.+|++++++++||||+++++++...+..++||||
T Consensus 28 ~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 107 (314)
T 2ivs_A 28 GKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEY 107 (314)
T ss_dssp EEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred eeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCceEEEEee
Confidence 35799999999999986 235899999998653 34457799999999999999999999999999999999999
Q ss_pred cCCCCHhhhhhCCCCCC------------------CcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeC
Q 005102 481 IPNGSLATALHGKPGMV------------------SFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLG 542 (714)
Q Consensus 481 ~~~gsL~~~l~~~~~~~------------------~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~ 542 (714)
+++|+|.+++....... ....+++.++.+++.|++.||+|||+ ++|+||||||+||+++
T Consensus 108 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dikp~NIli~ 184 (314)
T 2ivs_A 108 AKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAE---MKLVHRDLAARNILVA 184 (314)
T ss_dssp CTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEE
T ss_pred cCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHH---CCCcccccchheEEEc
Confidence 99999999997643210 01348999999999999999999999 8999999999999999
Q ss_pred CCCCeEEcccchhhhhhccCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHH
Q 005102 543 HNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSY 622 (714)
Q Consensus 543 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~ 622 (714)
+++.+||+|||+++....... ........+|+.|+|||.+.+..++.++|||||
T Consensus 185 ~~~~~kl~Dfg~~~~~~~~~~--------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 238 (314)
T 2ivs_A 185 EGRKMKISDFGLSRDVYEEDS--------------------------YVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSF 238 (314)
T ss_dssp TTTEEEECCCTTCEECTTTSC--------------------------EECSSCCCSCGGGCCHHHHHHCEECHHHHHHHH
T ss_pred CCCCEEEcccccccccccccc--------------------------ceeccCCCCcccccChhhhcCCCcCchhhHHHH
Confidence 999999999999976532210 112223445788999999988889999999999
Q ss_pred HHHHHHHHh-CCCccccCCCCcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHH
Q 005102 623 GVILLEMIT-GRTAVVQVGSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRH 701 (714)
Q Consensus 623 Gvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~e 701 (714)
|+++|||+| |+.||..... ..+... ...... +..... ....+.+++.+||+.||++|||++|
T Consensus 239 G~il~el~t~g~~p~~~~~~--~~~~~~----~~~~~~------~~~~~~-----~~~~~~~li~~~l~~dp~~Rps~~~ 301 (314)
T 2ivs_A 239 GVLLWEIVTLGGNPYPGIPP--ERLFNL----LKTGHR------MERPDN-----CSEEMYRLMLQCWKQEPDKRPVFAD 301 (314)
T ss_dssp HHHHHHHHTTSCCSSTTCCG--GGHHHH----HHTTCC------CCCCTT-----CCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred HHHHHHHHhCCCCCCCCCCH--HHHHHH----hhcCCc------CCCCcc-----CCHHHHHHHHHHccCChhhCcCHHH
Confidence 999999999 9999953322 222221 111110 111111 1236889999999999999999999
Q ss_pred HHHHHhhhhcc
Q 005102 702 ISDALDRLIVS 712 (714)
Q Consensus 702 vl~~L~~i~~~ 712 (714)
+++.|+++...
T Consensus 302 l~~~l~~~~~~ 312 (314)
T 2ivs_A 302 ISKDLEKMMVK 312 (314)
T ss_dssp HHHHHHHHHHT
T ss_pred HHHHHHHHHhh
Confidence 99999998653
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-41 Score=349.42 Aligned_cols=258 Identities=19% Similarity=0.260 Sum_probs=194.0
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeCCCC--chhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCCC
Q 005102 409 FVLGKSGIGIVYKVVLE-DGHTLAVRRLGEGG--SQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGS 485 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gs 485 (714)
+.||+|+||+||+|+.. +++.||||++.... ....+.+.+|++++++++||||+++++++.+.+..++||||+++ +
T Consensus 8 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~ 86 (292)
T 3o0g_A 8 EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-D 86 (292)
T ss_dssp EEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSE-E
T ss_pred eEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEecCCC-C
Confidence 47999999999999986 48999999997543 33346788999999999999999999999999999999999975 6
Q ss_pred HhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCCC
Q 005102 486 LATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSP 565 (714)
Q Consensus 486 L~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 565 (714)
+.+.+.... ..+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++.....
T Consensus 87 l~~~~~~~~-----~~l~~~~~~~~~~ql~~~l~~lH~---~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~---- 154 (292)
T 3o0g_A 87 LKKYFDSCN-----GDLDPEIVKSFLFQLLKGLGFCHS---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIP---- 154 (292)
T ss_dssp HHHHHHHTT-----TCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECCSC----
T ss_pred HHHHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeecccceecCCc----
Confidence 666665432 458999999999999999999999 89999999999999999999999999999765321
Q ss_pred CccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCC-CCchhhhHHHHHHHHHHHhCCCccccCCCCcc
Q 005102 566 TLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVK-PSQKWDIYSYGVILLEMITGRTAVVQVGSSEM 644 (714)
Q Consensus 566 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s~~~DVwS~Gvvl~elltG~~p~~~~~~~~~ 644 (714)
........||+.|+|||++.+.. ++.++|||||||++|||++|..||........
T Consensus 155 ------------------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~ 210 (292)
T 3o0g_A 155 ------------------------VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD 210 (292)
T ss_dssp ------------------------CSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHH
T ss_pred ------------------------cccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHH
Confidence 11123345688999999998766 79999999999999999999999754332222
Q ss_pred hhHHHHHHHHhhcC-----CcccccCCC----CC---C-CCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 005102 645 DLVNWMQLCIEEKK-----PLADVLDPY----LA---P-DADKEEEIIAVLKIAMACVHSSPEKRPTMRHISD 704 (714)
Q Consensus 645 ~l~~~~~~~~~~~~-----~~~~~~d~~----~~---~-~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 704 (714)
.+.... ....... ......+.. .. . ..........+.+++.+||+.||++|||++|+++
T Consensus 211 ~~~~i~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 282 (292)
T 3o0g_A 211 QLKRIF-RLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp HHHHHH-HHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHHH-HHhCCCChhhhhhhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence 222111 1111100 000000000 00 0 0000112346789999999999999999999875
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=357.28 Aligned_cols=259 Identities=23% Similarity=0.374 Sum_probs=191.2
Q ss_pred cccccccCceEEEEEEECCC----cEEEEEEeCCC--CchhHHHHHHHHHHHhccCCCCccceEEEEEeCCce------e
Q 005102 408 AFVLGKSGIGIVYKVVLEDG----HTLAVRRLGEG--GSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEK------L 475 (714)
Q Consensus 408 ~~~lG~G~~g~Vy~~~~~~g----~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~------~ 475 (714)
.+.||+|+||.||+|++... ..||||++... .....+.+.+|++++++++||||+++++++...+.. +
T Consensus 28 ~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 107 (323)
T 3qup_A 28 GRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPM 107 (323)
T ss_dssp EEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-------CEE
T ss_pred eceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccccCCCccE
Confidence 35899999999999997643 27999999765 344567899999999999999999999999876655 9
Q ss_pred EEEeccCCCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchh
Q 005102 476 LIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLA 555 (714)
Q Consensus 476 lV~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla 555 (714)
+||||+++|+|.+++...........+++.++.+|+.|++.||+|||+ .+|+||||||+|||+++++.+||+|||++
T Consensus 108 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~---~~ivH~Dikp~NIli~~~~~~kl~Dfg~a 184 (323)
T 3qup_A 108 VILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSS---RNFIHRDLAARNCMLAEDMTVCVADFGLS 184 (323)
T ss_dssp EEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTSCEEECCCCC-
T ss_pred EEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHc---CCcccCCCCcceEEEcCCCCEEEeecccc
Confidence 999999999999998643221111358999999999999999999999 89999999999999999999999999999
Q ss_pred hhhhccCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHh-CCC
Q 005102 556 RLANIAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMIT-GRT 634 (714)
Q Consensus 556 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~ellt-G~~ 634 (714)
+....... ........+++.|+|||.+.+..++.++|||||||++|||++ |+.
T Consensus 185 ~~~~~~~~--------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~ 238 (323)
T 3qup_A 185 RKIYSGDY--------------------------YRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQT 238 (323)
T ss_dssp ------------------------------------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCC
T ss_pred cccccccc--------------------------ccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCC
Confidence 86543211 011122335778999999998899999999999999999999 899
Q ss_pred ccccCCCCcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhhhhcc
Q 005102 635 AVVQVGSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDALDRLIVS 712 (714)
Q Consensus 635 p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~~ 712 (714)
||..... .+.. ........ ...... ....+.+++.+||+.||++|||+.++++.|+++...
T Consensus 239 p~~~~~~--~~~~---~~~~~~~~-------~~~~~~-----~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~ 299 (323)
T 3qup_A 239 PYAGIEN--AEIY---NYLIGGNR-------LKQPPE-----CMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGH 299 (323)
T ss_dssp TTTTCCG--GGHH---HHHHTTCC-------CCCCTT-----CCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred CccccCh--HHHH---HHHhcCCC-------CCCCCc-----cCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 9854322 2221 11111111 011111 223688999999999999999999999999998653
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-41 Score=345.83 Aligned_cols=244 Identities=27% Similarity=0.434 Sum_probs=187.6
Q ss_pred ccccccCceEEEEEEECCCcEEEEEEeCCCCc----hhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCC
Q 005102 409 FVLGKSGIGIVYKVVLEDGHTLAVRRLGEGGS----QRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNG 484 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~----~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~g 484 (714)
+.||+|+||.||+|.+. ++.||||++..... ...+.+.+|++++++++||||+++++++...+..++||||++++
T Consensus 13 ~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 91 (271)
T 3dtc_A 13 EIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGG 91 (271)
T ss_dssp EEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEEECCTTE
T ss_pred eeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEEEcCCCC
Confidence 57999999999999985 89999999876422 23467899999999999999999999999999999999999999
Q ss_pred CHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCC---ceecCCCCCCeeeCC--------CCCeEEcccc
Q 005102 485 SLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKK---YVHGDLKPSNILLGH--------NMEPHVSDFG 553 (714)
Q Consensus 485 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~---ivHrDlkp~NILl~~--------~~~~kl~DFG 553 (714)
+|.+++.. ..+++..+..++.|++.||+|||+ .+ |+||||||+||+++. ++.+||+|||
T Consensus 92 ~L~~~~~~-------~~~~~~~~~~i~~~l~~~l~~lH~---~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg 161 (271)
T 3dtc_A 92 PLNRVLSG-------KRIPPDILVNWAVQIARGMNYLHD---EAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFG 161 (271)
T ss_dssp EHHHHHTS-------SCCCHHHHHHHHHHHHHHHHHHHH---SSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCC
T ss_pred CHHHHhhc-------CCCCHHHHHHHHHHHHHHHHHHHh---CCCCceeecCCchHHEEEecccccccccCcceEEccCC
Confidence 99999853 358999999999999999999999 67 999999999999986 6789999999
Q ss_pred hhhhhhccCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCC
Q 005102 554 LARLANIAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGR 633 (714)
Q Consensus 554 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~ 633 (714)
+++..... ......||+.|+|||.+.+..++.++||||||+++|||++|+
T Consensus 162 ~~~~~~~~------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~ 211 (271)
T 3dtc_A 162 LAREWHRT------------------------------TKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGE 211 (271)
T ss_dssp C-------------------------------------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCC
T ss_pred cccccccc------------------------------cccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCC
Confidence 99754321 111234688999999999889999999999999999999999
Q ss_pred CccccCCCCcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhhh
Q 005102 634 TAVVQVGSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDALDRL 709 (714)
Q Consensus 634 ~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i 709 (714)
.||..... . ........... ....... ....+.+++.+||+.||++|||++|+++.|++|
T Consensus 212 ~p~~~~~~--~---~~~~~~~~~~~------~~~~~~~-----~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 212 VPFRGIDG--L---AVAYGVAMNKL------ALPIPST-----CPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp CTTTTSCH--H---HHHHHHHTSCC------CCCCCTT-----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred CCCCCCCH--H---HHHHhhhcCCC------CCCCCcc-----cCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 99953221 1 11111111111 0111111 123688999999999999999999999999875
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-41 Score=357.71 Aligned_cols=238 Identities=18% Similarity=0.217 Sum_probs=196.2
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeCCCC---chhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCC
Q 005102 409 FVLGKSGIGIVYKVVLE-DGHTLAVRRLGEGG---SQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNG 484 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~g 484 (714)
+.||+|+||.||+|+.. +|+.||||++.+.. ....+.+.+|++++++++||||+++++++.+.+..|+||||+++|
T Consensus 47 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~gg 126 (350)
T 1rdq_E 47 KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGG 126 (350)
T ss_dssp EEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTC
T ss_pred EEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEcCCCCC
Confidence 47999999999999986 58999999987542 233567889999999999999999999999999999999999999
Q ss_pred CHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCC
Q 005102 485 SLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGS 564 (714)
Q Consensus 485 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 564 (714)
+|.+++... ..+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++....
T Consensus 127 ~L~~~l~~~------~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~---- 193 (350)
T 1rdq_E 127 EMFSHLRRI------GRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG---- 193 (350)
T ss_dssp BHHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECSS----
T ss_pred cHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCccceEEECCCCCEEEcccccceeccC----
Confidence 999999754 358999999999999999999999 8999999999999999999999999999975421
Q ss_pred CCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCccccCCCCcc
Q 005102 565 PTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGSSEM 644 (714)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~~~~~~~~~ 644 (714)
......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 194 ---------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~----- 241 (350)
T 1rdq_E 194 ---------------------------RTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFAD----- 241 (350)
T ss_dssp ---------------------------CBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS-----
T ss_pred ---------------------------CcccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCC-----
Confidence 112335789999999999999999999999999999999999999532
Q ss_pred hhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCC-----HHHHHH
Q 005102 645 DLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPT-----MRHISD 704 (714)
Q Consensus 645 ~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt-----~~evl~ 704 (714)
...+........... .+... ...+.+++.+||+.||++||+ ++|+++
T Consensus 242 ~~~~~~~~i~~~~~~--------~p~~~-----~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~ 293 (350)
T 1rdq_E 242 QPIQIYEKIVSGKVR--------FPSHF-----SSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp SHHHHHHHHHHCCCC--------CCTTC-----CHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred CHHHHHHHHHcCCCC--------CCCCC-----CHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence 122223333222211 11111 235789999999999999998 777754
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-41 Score=357.64 Aligned_cols=236 Identities=21% Similarity=0.274 Sum_probs=193.0
Q ss_pred ccccccCceEEEEEEECC-CcEEEEEEeCCC---CchhHHHHHHHHHHHhcc-CCCCccceEEEEEeCCceeEEEeccCC
Q 005102 409 FVLGKSGIGIVYKVVLED-GHTLAVRRLGEG---GSQRFKEFQTEVEAIGKI-RHSNIVTLRAYYWSVDEKLLIYDYIPN 483 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~~-g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~e~~~~ 483 (714)
+.||+|+||+||+|+.+. |+.||||++.+. .....+.+.+|..++..+ +||||+++++++.+.+..|+||||+++
T Consensus 26 ~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~E~~~g 105 (353)
T 2i0e_A 26 MVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNG 105 (353)
T ss_dssp EEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEEEEECCCS
T ss_pred EEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEEEEeCCCC
Confidence 479999999999999875 789999999764 223346788999999998 799999999999999999999999999
Q ss_pred CCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCC
Q 005102 484 GSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGG 563 (714)
Q Consensus 484 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 563 (714)
|+|.+++... ..+++..++.++.||+.||+|||+ ++|+||||||+|||++.++++||+|||+++.....
T Consensus 106 g~L~~~l~~~------~~~~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~-- 174 (353)
T 2i0e_A 106 GDLMYHIQQV------GRFKEPHAVFYAAEIAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWD-- 174 (353)
T ss_dssp CBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT--
T ss_pred CcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCEEeccCCHHHEEEcCCCcEEEEeCCcccccccC--
Confidence 9999999754 458999999999999999999999 89999999999999999999999999999743211
Q ss_pred CCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCccccCCCCc
Q 005102 564 SPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGSSE 643 (714)
Q Consensus 564 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~~~~~~~~ 643 (714)
........||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 175 --------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~---- 224 (353)
T 2i0e_A 175 --------------------------GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGE---- 224 (353)
T ss_dssp --------------------------TCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCS----
T ss_pred --------------------------CcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCC----
Confidence 11223456899999999999999999999999999999999999999432
Q ss_pred chhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCH
Q 005102 644 MDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTM 699 (714)
Q Consensus 644 ~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~ 699 (714)
+..+..+........+ +... ..++.+++.+||..||++||++
T Consensus 225 -~~~~~~~~i~~~~~~~--------p~~~-----s~~~~~li~~lL~~dP~~R~~~ 266 (353)
T 2i0e_A 225 -DEDELFQSIMEHNVAY--------PKSM-----SKEAVAICKGLMTKHPGKRLGC 266 (353)
T ss_dssp -SHHHHHHHHHHCCCCC--------CTTS-----CHHHHHHHHHHTCSCTTSCTTC
T ss_pred -CHHHHHHHHHhCCCCC--------CCCC-----CHHHHHHHHHHhhcCHHHcCCC
Confidence 1222333333322211 1111 2357899999999999999964
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-41 Score=346.10 Aligned_cols=251 Identities=19% Similarity=0.320 Sum_probs=191.4
Q ss_pred cccccccCceEEEEEEECC----CcEEEEEEeCCCC-chhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccC
Q 005102 408 AFVLGKSGIGIVYKVVLED----GHTLAVRRLGEGG-SQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIP 482 (714)
Q Consensus 408 ~~~lG~G~~g~Vy~~~~~~----g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~ 482 (714)
.+.||+|+||.||+|.+.. +..||+|++.... ....+.+.+|+.++++++||||+++++++ ..+..++||||++
T Consensus 20 ~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e~~~ 98 (281)
T 1mp8_A 20 GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI-TENPVWIIMELCT 98 (281)
T ss_dssp EEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-CSSSCEEEEECCT
T ss_pred EeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEE-ccCccEEEEecCC
Confidence 3579999999999999753 4579999987643 33456799999999999999999999998 4567899999999
Q ss_pred CCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccC
Q 005102 483 NGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAG 562 (714)
Q Consensus 483 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 562 (714)
+|+|.+++.... ..+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++......
T Consensus 99 ~~~L~~~l~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 170 (281)
T 1mp8_A 99 LGELRSFLQVRK-----YSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST 170 (281)
T ss_dssp TEEHHHHHHHTT-----TTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECC-----------
T ss_pred CCCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHh---CCeecccccHHHEEECCCCCEEECccccccccCccc
Confidence 999999997553 358999999999999999999999 899999999999999999999999999998654221
Q ss_pred CCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHh-CCCccccCCC
Q 005102 563 GSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMIT-GRTAVVQVGS 641 (714)
Q Consensus 563 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~ellt-G~~p~~~~~~ 641 (714)
. .......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||.....
T Consensus 171 ~---------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~ 223 (281)
T 1mp8_A 171 Y---------------------------YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN 223 (281)
T ss_dssp -----------------------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCG
T ss_pred c---------------------------cccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCH
Confidence 0 01122335678999999988899999999999999999997 9999954322
Q ss_pred CcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhhhhc
Q 005102 642 SEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDALDRLIV 711 (714)
Q Consensus 642 ~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~ 711 (714)
.+.... ...... ...... ....+.+++.+||+.||++|||+.|+++.|+++..
T Consensus 224 --~~~~~~---i~~~~~-------~~~~~~-----~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 276 (281)
T 1mp8_A 224 --NDVIGR---IENGER-------LPMPPN-----CPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 276 (281)
T ss_dssp --GGHHHH---HHTTCC-------CCCCTT-----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --HHHHHH---HHcCCC-------CCCCCC-----CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 222221 111111 011111 12368899999999999999999999999999864
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-41 Score=356.01 Aligned_cols=237 Identities=21% Similarity=0.303 Sum_probs=192.5
Q ss_pred ccccccCceEEEEEEE-CCCcEEEEEEeCCCC---chhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCC
Q 005102 409 FVLGKSGIGIVYKVVL-EDGHTLAVRRLGEGG---SQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNG 484 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~g 484 (714)
+.||+|+||.||+|.+ .+++.||||++.... ....+.+.+|+++++.++||||+++++++...+..++||||+ +|
T Consensus 15 ~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~-~g 93 (336)
T 3h4j_B 15 ETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVIEYA-GG 93 (336)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCC-CE
T ss_pred EEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEECC-CC
Confidence 4799999999999997 468999999986531 122357899999999999999999999999999999999999 78
Q ss_pred CHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCC
Q 005102 485 SLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGS 564 (714)
Q Consensus 485 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 564 (714)
+|.+++... ..+++.++..++.|++.||+|||+ .+|+||||||+|||+++++.+||+|||+++.....
T Consensus 94 ~l~~~l~~~------~~l~~~~~~~i~~qi~~aL~~LH~---~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~--- 161 (336)
T 3h4j_B 94 ELFDYIVEK------KRMTEDEGRRFFQQIICAIEYCHR---HKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG--- 161 (336)
T ss_dssp EHHHHHHHH------CSCCHHHHHHHHHHHHHHHHHHHH---HTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTS---
T ss_pred cHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCchhhEEEcCCCCEEEEEeccceeccCC---
Confidence 999988755 458999999999999999999999 89999999999999999999999999999765321
Q ss_pred CCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCC-CchhhhHHHHHHHHHHHhCCCccccCCCCc
Q 005102 565 PTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKP-SQKWDIYSYGVILLEMITGRTAVVQVGSSE 643 (714)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~~DVwS~Gvvl~elltG~~p~~~~~~~~ 643 (714)
.......||+.|+|||++.+..+ ++++|||||||++|||++|+.||.......
T Consensus 162 --------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~ 215 (336)
T 3h4j_B 162 --------------------------NFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPN 215 (336)
T ss_dssp --------------------------BTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTT
T ss_pred --------------------------cccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHH
Confidence 11223457899999999988776 789999999999999999999995432211
Q ss_pred chhHHHHHHHHhhcCCcccccCC--CCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 005102 644 MDLVNWMQLCIEEKKPLADVLDP--YLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISD 704 (714)
Q Consensus 644 ~~l~~~~~~~~~~~~~~~~~~d~--~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 704 (714)
. ...+... ..+.. ....+.+++.+||+.||.+|||++|+++
T Consensus 216 ~---------------~~~i~~~~~~~p~~-----~s~~~~~li~~~L~~dP~~Rpt~~eil~ 258 (336)
T 3h4j_B 216 L---------------FKKVNSCVYVMPDF-----LSPGAQSLIRRMIVADPMQRITIQEIRR 258 (336)
T ss_dssp C---------------BCCCCSSCCCCCTT-----SCHHHHHHHHTTSCSSGGGSCCHHHHTT
T ss_pred H---------------HHHHHcCCCCCccc-----CCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 1 0011110 11111 1235789999999999999999999875
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-41 Score=352.63 Aligned_cols=262 Identities=22% Similarity=0.315 Sum_probs=188.5
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeCCCC-chhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCCCH
Q 005102 409 FVLGKSGIGIVYKVVLE-DGHTLAVRRLGEGG-SQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGSL 486 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL 486 (714)
+.||+|+||.||+|..+ +|+.||||++.... ....+.+.+|++++++++||||+++++++...+..++||||++ |+|
T Consensus 11 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~-~~L 89 (317)
T 2pmi_A 11 EKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFEFMD-NDL 89 (317)
T ss_dssp --------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEECCC-CBH
T ss_pred eEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEEecC-CCH
Confidence 37999999999999975 58999999987543 2234678899999999999999999999999999999999997 699
Q ss_pred hhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCCCC
Q 005102 487 ATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPT 566 (714)
Q Consensus 487 ~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 566 (714)
.+++...........+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++......
T Consensus 90 ~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~---- 162 (317)
T 2pmi_A 90 KKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHE---NKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPV---- 162 (317)
T ss_dssp HHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCSSCEETTSCC----
T ss_pred HHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCChHHeEEcCCCCEEECcCccceecCCCc----
Confidence 9988643211112458999999999999999999999 899999999999999999999999999997653211
Q ss_pred ccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCC-CCCchhhhHHHHHHHHHHHhCCCccccCCCCcch
Q 005102 567 LQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVV-KPSQKWDIYSYGVILLEMITGRTAVVQVGSSEMD 645 (714)
Q Consensus 567 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DVwS~Gvvl~elltG~~p~~~~~~~~~~ 645 (714)
.......||+.|+|||++.+. .++.++|||||||++|||+||+.||... ...+
T Consensus 163 ------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~--~~~~ 216 (317)
T 2pmi_A 163 ------------------------NTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGT--NDEE 216 (317)
T ss_dssp ------------------------CCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCS--SHHH
T ss_pred ------------------------ccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC--ChHH
Confidence 112234568899999999764 5899999999999999999999999532 2222
Q ss_pred hHHHHHHHHhhcC-Cc-cc-----ccCCCCCCC--CCcH---------HHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 005102 646 LVNWMQLCIEEKK-PL-AD-----VLDPYLAPD--ADKE---------EEIIAVLKIAMACVHSSPEKRPTMRHISD 704 (714)
Q Consensus 646 l~~~~~~~~~~~~-~~-~~-----~~d~~~~~~--~~~~---------~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 704 (714)
....+........ .. .. ...+..... .... .....+.+++.+||+.||++|||++|+++
T Consensus 217 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~ 293 (317)
T 2pmi_A 217 QLKLIFDIMGTPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH 293 (317)
T ss_dssp HHHHHHHHHCSCCTTTCGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred HHHHHHHHhCCCChhHhhhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence 2222221111100 00 00 000000000 0000 11236889999999999999999999875
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-41 Score=359.57 Aligned_cols=243 Identities=22% Similarity=0.314 Sum_probs=182.9
Q ss_pred ccccccCceEEEEEEECC-CcEEEEEEeCCCCchhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCCCHh
Q 005102 409 FVLGKSGIGIVYKVVLED-GHTLAVRRLGEGGSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGSLA 487 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL~ 487 (714)
+.||+|+||.||+|++.. ++.||||++.... ..+.+.+|++++++++||||+++++++...+..++||||+++|+|.
T Consensus 59 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~ 136 (349)
T 2w4o_A 59 SELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELF 136 (349)
T ss_dssp EEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHH
T ss_pred eEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEeCCCCCHH
Confidence 479999999999999874 7899999997643 2356889999999999999999999999999999999999999999
Q ss_pred hhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCC---CCCeEEcccchhhhhhccCCC
Q 005102 488 TALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGH---NMEPHVSDFGLARLANIAGGS 564 (714)
Q Consensus 488 ~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~---~~~~kl~DFGla~~~~~~~~~ 564 (714)
+++... ..+++.++..++.|++.||+|||+ .+|+||||||+|||++. ++.+||+|||+++.....
T Consensus 137 ~~l~~~------~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~--- 204 (349)
T 2w4o_A 137 DRIVEK------GYYSERDAADAVKQILEAVAYLHE---NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQ--- 204 (349)
T ss_dssp HHHTTC------SSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEESSSSTTCCEEECCCC-----------
T ss_pred HHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCcccEEEecCCCCCCEEEccCccccccCcc---
Confidence 999765 458999999999999999999999 89999999999999975 889999999999865321
Q ss_pred CCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCccccCCCCcc
Q 005102 565 PTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGSSEM 644 (714)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~~~~~~~~~ 644 (714)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||.......
T Consensus 205 --------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~- 257 (349)
T 2w4o_A 205 --------------------------VLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQ- 257 (349)
T ss_dssp ----------------------------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHH-
T ss_pred --------------------------cccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccH-
Confidence 01123457899999999999999999999999999999999999995432211
Q ss_pred hhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 005102 645 DLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISD 704 (714)
Q Consensus 645 ~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 704 (714)
............ ...+.. . .....+.+++.+||+.||++|||+.|+++
T Consensus 258 ---~~~~~i~~~~~~---~~~~~~-~-----~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 305 (349)
T 2w4o_A 258 ---FMFRRILNCEYY---FISPWW-D-----EVSLNAKDLVRKLIVLDPKKRLTTFQALQ 305 (349)
T ss_dssp ---HHHHHHHTTCCC---CCTTTT-T-----TSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ---HHHHHHHhCCCc---cCCchh-h-----hCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 111222222111 111111 1 12236789999999999999999999876
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=352.26 Aligned_cols=255 Identities=22% Similarity=0.320 Sum_probs=194.0
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeCCCC-chhHHHHHHHHHHHhccCCCCccceEEEEEeCCc-------------
Q 005102 409 FVLGKSGIGIVYKVVLE-DGHTLAVRRLGEGG-SQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDE------------- 473 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~------------- 473 (714)
+.||+|+||.||+|+++ +|+.||||++.... ....+.+.+|++++++++||||+++++++.+.+.
T Consensus 12 ~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~~~~~~ 91 (332)
T 3qd2_B 12 QCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEMDEIWLK 91 (332)
T ss_dssp EEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHHHC----
T ss_pred eEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhhhhhhhc
Confidence 57999999999999987 69999999997543 3345789999999999999999999999866432
Q ss_pred --------------------------------------------eeEEEeccCCCCHhhhhhCCCCCCCcCCCCHHHHHH
Q 005102 474 --------------------------------------------KLLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVK 509 (714)
Q Consensus 474 --------------------------------------------~~lV~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~ 509 (714)
.++||||+++|+|.+++...... ...++..+++
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~---~~~~~~~~~~ 168 (332)
T 3qd2_B 92 DESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSL---EDREHGVCLH 168 (332)
T ss_dssp ----------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSG---GGSCHHHHHH
T ss_pred cccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCc---cchhhHHHHH
Confidence 78999999999999999876432 4567788999
Q ss_pred HHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCCCCccCCCCCCCCchhhhccccccee
Q 005102 510 IIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQKSVSLEV 589 (714)
Q Consensus 510 i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 589 (714)
|+.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++............. ....
T Consensus 169 i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~----------------~~~~ 229 (332)
T 3qd2_B 169 IFIQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLT----------------PMPA 229 (332)
T ss_dssp HHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC----------------------------
T ss_pred HHHHHHHHHHHHHh---CCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccc----------------cccc
Confidence 99999999999999 8999999999999999999999999999987653321100000 0000
Q ss_pred ecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCccccCCCCcchhHHHHHHHHhhcCCcccccCCCCC
Q 005102 590 TTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGSSEMDLVNWMQLCIEEKKPLADVLDPYLA 669 (714)
Q Consensus 590 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~~~ 669 (714)
........||+.|+|||++.+..++.++|||||||++|||++|..|+.. ............ ..
T Consensus 230 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~-------~~~~~~~~~~~~--~~-------- 292 (332)
T 3qd2_B 230 YATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME-------RVRIITDVRNLK--FP-------- 292 (332)
T ss_dssp --CCCSCC-CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH-------HHHHHHHHHTTC--CC--------
T ss_pred cccccccCCCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH-------HHHHHHHhhccC--CC--------
Confidence 1223445689999999999999999999999999999999999877621 111111111110 00
Q ss_pred CCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 005102 670 PDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISD 704 (714)
Q Consensus 670 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 704 (714)
.........+.+++.+||+.||++|||++|+++
T Consensus 293 --~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 325 (332)
T 3qd2_B 293 --LLFTQKYPQEHMMVQDMLSPSPTERPEATDIIE 325 (332)
T ss_dssp --HHHHHHCHHHHHHHHHHHCSSGGGSCCHHHHHH
T ss_pred --cccccCChhHHHHHHHHccCCCCcCCCHHHHhh
Confidence 011223346789999999999999999999986
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-41 Score=356.11 Aligned_cols=246 Identities=23% Similarity=0.313 Sum_probs=178.3
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeCCCCchhHHHHHHHHHHHhccC-CCCccceEEEEEeCCceeEEEeccCCCCH
Q 005102 409 FVLGKSGIGIVYKVVLE-DGHTLAVRRLGEGGSQRFKEFQTEVEAIGKIR-HSNIVTLRAYYWSVDEKLLIYDYIPNGSL 486 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lV~e~~~~gsL 486 (714)
+.||+|+||.||+|.+. +++.||||++... ....+.+|+.++++++ ||||+++++++.+.+..++||||+++|+|
T Consensus 17 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~L 93 (325)
T 3kn6_A 17 KPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGEL 93 (325)
T ss_dssp CCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBH
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCcH
Confidence 57999999999999986 5899999999653 3357789999999997 99999999999999999999999999999
Q ss_pred hhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCC---CeEEcccchhhhhhccCC
Q 005102 487 ATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNM---EPHVSDFGLARLANIAGG 563 (714)
Q Consensus 487 ~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~---~~kl~DFGla~~~~~~~~ 563 (714)
.+++... ..+++.++..|+.|++.||+|||+ ++|+||||||+|||++.++ .+||+|||+++......
T Consensus 94 ~~~l~~~------~~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~- 163 (325)
T 3kn6_A 94 FERIKKK------KHFSETEASYIMRKLVSAVSHMHD---VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDN- 163 (325)
T ss_dssp HHHHHHC------SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC---
T ss_pred HHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCC-
Confidence 9999765 458999999999999999999999 8999999999999997665 89999999997543211
Q ss_pred CCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCccccCCCC-
Q 005102 564 SPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGSS- 642 (714)
Q Consensus 564 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~~~~~~~- 642 (714)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||......
T Consensus 164 ---------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~ 216 (325)
T 3kn6_A 164 ---------------------------QPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSL 216 (325)
T ss_dssp -----------------------------------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC------
T ss_pred ---------------------------CcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCcccc
Confidence 1122334688999999999999999999999999999999999999543221
Q ss_pred -cchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHH
Q 005102 643 -EMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHIS 703 (714)
Q Consensus 643 -~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl 703 (714)
.....+.+.......... . .........++.+++.+||+.||++|||++|++
T Consensus 217 ~~~~~~~~~~~i~~~~~~~--------~-~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell 269 (325)
T 3kn6_A 217 TCTSAVEIMKKIKKGDFSF--------E-GEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLR 269 (325)
T ss_dssp -CCCHHHHHHHHTTTCCCC--------C-SHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTST
T ss_pred ccccHHHHHHHHHcCCCCC--------C-cccccCCCHHHHHHHHHHCCCChhHCCCHHHHh
Confidence 111222222221111100 0 000011234688999999999999999999886
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-41 Score=359.95 Aligned_cols=256 Identities=25% Similarity=0.394 Sum_probs=192.5
Q ss_pred cccccccCceEEEEEEECC----CcEEEEEEeCCC-CchhHHHHHHHHHHHhccCCCCccceEEEEEe-CCceeEEEecc
Q 005102 408 AFVLGKSGIGIVYKVVLED----GHTLAVRRLGEG-GSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWS-VDEKLLIYDYI 481 (714)
Q Consensus 408 ~~~lG~G~~g~Vy~~~~~~----g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~-~~~~~lV~e~~ 481 (714)
.+.||+|+||.||+|.+.+ +..||||.+... .....++|.+|+.++++++||||+++++++.. .+..++||||+
T Consensus 94 ~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv~e~~ 173 (373)
T 3c1x_A 94 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 173 (373)
T ss_dssp EEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEEEECC
T ss_pred CcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEEEECC
Confidence 3579999999999998642 246899998764 33456789999999999999999999999765 45789999999
Q ss_pred CCCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhcc
Q 005102 482 PNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIA 561 (714)
Q Consensus 482 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 561 (714)
++|+|.+++.... ..+++.++..++.||+.||+|||+ ++|+||||||+|||+++++.+||+|||+++.....
T Consensus 174 ~~g~L~~~l~~~~-----~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~ 245 (373)
T 3c1x_A 174 KHGDLRNFIRNET-----HNPTVKDLIGFGLQVAKGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 245 (373)
T ss_dssp TTCBHHHHHHCTT-----CCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred CCCCHHHHHhhcc-----cCCCHHHHHHHHHHHHHHHHHHHH---CCEecCccchheEEECCCCCEEEeecccccccccc
Confidence 9999999997653 358899999999999999999999 89999999999999999999999999999865322
Q ss_pred CCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHh-CCCccccCC
Q 005102 562 GGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMIT-GRTAVVQVG 640 (714)
Q Consensus 562 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~ellt-G~~p~~~~~ 640 (714)
.... ........+|+.|+|||.+.+..++.++|||||||++|||+| |..||....
T Consensus 246 ~~~~------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~ 301 (373)
T 3c1x_A 246 EFDS------------------------VHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN 301 (373)
T ss_dssp ------------------------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSC
T ss_pred cccc------------------------ccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCC
Confidence 1000 111223345778999999999999999999999999999999 666774332
Q ss_pred CCcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhhhhcc
Q 005102 641 SSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDALDRLIVS 712 (714)
Q Consensus 641 ~~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~~ 712 (714)
.. +....+ ..... ...+ .. ....+.+++.+||+.||++|||++|+++.|+++...
T Consensus 302 ~~--~~~~~~---~~~~~----~~~p---~~-----~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~ 356 (373)
T 3c1x_A 302 TF--DITVYL---LQGRR----LLQP---EY-----CPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 356 (373)
T ss_dssp SS--CHHHHH---HTTCC----CCCC---TT-----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred HH--HHHHHH---HcCCC----CCCC---CC-----CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 22 222211 11111 0111 11 123688999999999999999999999999998754
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-41 Score=351.16 Aligned_cols=258 Identities=24% Similarity=0.376 Sum_probs=200.5
Q ss_pred ccccccCceEEEEEEE-----CCCcEEEEEEeCCC-CchhHHHHHHHHHHHhccCCCCccceEEEEEeC--CceeEEEec
Q 005102 409 FVLGKSGIGIVYKVVL-----EDGHTLAVRRLGEG-GSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSV--DEKLLIYDY 480 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~-----~~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~~lV~e~ 480 (714)
+.||+|+||.||+|++ .+++.||||++... .....+.+.+|++++++++||||+++++++... +..++||||
T Consensus 27 ~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~ 106 (302)
T 4e5w_A 27 RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEF 106 (302)
T ss_dssp EEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCEEEEEEC
T ss_pred hccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceEEEEEEe
Confidence 5799999999999984 35899999999854 333457899999999999999999999999876 668999999
Q ss_pred cCCCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhc
Q 005102 481 IPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANI 560 (714)
Q Consensus 481 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 560 (714)
+++|+|.+++.... ..+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||+++....
T Consensus 107 ~~~~~L~~~l~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 178 (302)
T 4e5w_A 107 LPSGSLKEYLPKNK-----NKINLKQQLKYAVQICKGMDYLGS---RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIET 178 (302)
T ss_dssp CTTCBHHHHHHHHT-----TTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCCTTCEECCT
T ss_pred CCCCcHHHHHHhcc-----ccCCHHHHHHHHHHHHHHHHHhhc---CCcccCCCchheEEEcCCCCEEECcccccccccC
Confidence 99999999996543 458999999999999999999999 8999999999999999999999999999986543
Q ss_pred cCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCccccCC
Q 005102 561 AGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVG 640 (714)
Q Consensus 561 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~~~~~ 640 (714)
... .........||..|+|||.+.+..++.++||||||+++|||+||+.|+....
T Consensus 179 ~~~-------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 233 (302)
T 4e5w_A 179 DKE-------------------------YYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPM 233 (302)
T ss_dssp TCC-------------------------EEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHH
T ss_pred CCc-------------------------ceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchh
Confidence 211 0122334457888999999988889999999999999999999999873210
Q ss_pred ----------CCcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhhhh
Q 005102 641 ----------SSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDALDRLI 710 (714)
Q Consensus 641 ----------~~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~ 710 (714)
.......... ........ ...... ....+.+++.+||+.||++|||++|+++.|++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~------~~~~~~-----~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 234 ALFLKMIGPTHGQMTVTRLV-NTLKEGKR------LPCPPN-----CPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp HHHHHHHCSCCGGGHHHHHH-HHHHTTCC------CCCCTT-----CCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred hHHhhccCCcccccCHHHHH-HHHhccCC------CCCCCC-----CCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 0111111111 11111110 111111 2236889999999999999999999999999986
Q ss_pred c
Q 005102 711 V 711 (714)
Q Consensus 711 ~ 711 (714)
.
T Consensus 302 ~ 302 (302)
T 4e5w_A 302 K 302 (302)
T ss_dssp C
T ss_pred C
Confidence 3
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=346.68 Aligned_cols=242 Identities=21% Similarity=0.332 Sum_probs=187.3
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeCCCCch--------------------------hHHHHHHHHHHHhccCCCCc
Q 005102 409 FVLGKSGIGIVYKVVLE-DGHTLAVRRLGEGGSQ--------------------------RFKEFQTEVEAIGKIRHSNI 461 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~--------------------------~~~~~~~E~~~l~~l~H~ni 461 (714)
+.||+|+||.||+|+.. +++.||||++...... ..+.+.+|++++++++||||
T Consensus 19 ~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i 98 (298)
T 2zv2_A 19 DEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKKLDHPNV 98 (298)
T ss_dssp EEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHTCCCTTB
T ss_pred eEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHhCCCCCC
Confidence 47999999999999975 5889999998754211 13468899999999999999
Q ss_pred cceEEEEEe--CCceeEEEeccCCCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCe
Q 005102 462 VTLRAYYWS--VDEKLLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNI 539 (714)
Q Consensus 462 v~l~~~~~~--~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NI 539 (714)
+++++++.. .+..++||||+++|+|.+++.. ..+++.++..++.|++.||+|||+ .+|+||||||+||
T Consensus 99 v~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~-------~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Ni 168 (298)
T 2zv2_A 99 VKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL-------KPLSEDQARFYFQDLIKGIEYLHY---QKIIHRDIKPSNL 168 (298)
T ss_dssp CCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS-------SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGE
T ss_pred CeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc-------CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHE
Confidence 999999986 5678999999999999886532 458999999999999999999999 8999999999999
Q ss_pred eeCCCCCeEEcccchhhhhhccCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCC---CCch
Q 005102 540 LLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVK---PSQK 616 (714)
Q Consensus 540 Ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~s~~ 616 (714)
|++.++.+||+|||+++...... .......||+.|+|||.+.+.. ++.+
T Consensus 169 l~~~~~~~kl~Dfg~~~~~~~~~----------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~ 220 (298)
T 2zv2_A 169 LVGEDGHIKIADFGVSNEFKGSD----------------------------ALLSNTVGTPAFMAPESLSETRKIFSGKA 220 (298)
T ss_dssp EECTTSCEEECCCTTCEECSSSS----------------------------CEECCCCSCGGGCCGGGCCTTCCCEESHH
T ss_pred EECCCCCEEEecCCCcccccccc----------------------------ccccCCcCCccccChhhhccCCCCCCCch
Confidence 99999999999999997643211 0112345789999999997765 3789
Q ss_pred hhhHHHHHHHHHHHhCCCccccCCCCcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCC
Q 005102 617 WDIYSYGVILLEMITGRTAVVQVGSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKR 696 (714)
Q Consensus 617 ~DVwS~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~R 696 (714)
+|||||||++|||++|+.||... ....+........... +. ... ....+.+++.+||+.||++|
T Consensus 221 ~Di~slG~~l~~l~~g~~pf~~~-----~~~~~~~~~~~~~~~~-----~~-~~~-----~~~~l~~li~~~l~~dp~~R 284 (298)
T 2zv2_A 221 LDVWAMGVTLYCFVFGQCPFMDE-----RIMCLHSKIKSQALEF-----PD-QPD-----IAEDLKDLITRMLDKNPESR 284 (298)
T ss_dssp HHHHHHHHHHHHHHHSSCSSCCS-----SHHHHHHHHHHCCCCC-----CS-SSC-----CCHHHHHHHHHHTCSCTTTS
T ss_pred hhhHhHHHHHHHHHHCCCCCCCc-----cHHHHHHHHhcccCCC-----CC-ccc-----cCHHHHHHHHHHhhcChhhC
Confidence 99999999999999999999432 1222222222211110 10 011 12358899999999999999
Q ss_pred CCHHHHHH
Q 005102 697 PTMRHISD 704 (714)
Q Consensus 697 Pt~~evl~ 704 (714)
||++|+++
T Consensus 285 ~s~~e~l~ 292 (298)
T 2zv2_A 285 IVVPEIKL 292 (298)
T ss_dssp CCHHHHTT
T ss_pred CCHHHHhc
Confidence 99999864
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-41 Score=353.03 Aligned_cols=260 Identities=24% Similarity=0.335 Sum_probs=205.4
Q ss_pred cccccccCceEEEEEEE------CCCcEEEEEEeCCCCc-hhHHHHHHHHHHHhcc-CCCCccceEEEEEeCCceeEEEe
Q 005102 408 AFVLGKSGIGIVYKVVL------EDGHTLAVRRLGEGGS-QRFKEFQTEVEAIGKI-RHSNIVTLRAYYWSVDEKLLIYD 479 (714)
Q Consensus 408 ~~~lG~G~~g~Vy~~~~------~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~e 479 (714)
.+.||+|+||.||+|++ .+++.||||++..... ...+.+.+|+++++++ +||||+++++++...+..++|||
T Consensus 28 ~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e 107 (313)
T 1t46_A 28 GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITE 107 (313)
T ss_dssp EEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred HHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCCcEEEEe
Confidence 35799999999999985 2468999999986543 3457799999999999 99999999999999999999999
Q ss_pred ccCCCCHhhhhhCCCCC------------CCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCe
Q 005102 480 YIPNGSLATALHGKPGM------------VSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEP 547 (714)
Q Consensus 480 ~~~~gsL~~~l~~~~~~------------~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~ 547 (714)
|+++|+|.+++...... .....+++..+.+++.|++.||+|||+ .+|+||||||+||++++++.+
T Consensus 108 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~ 184 (313)
T 1t46_A 108 YCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRIT 184 (313)
T ss_dssp CCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEETTTEE
T ss_pred cCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCccceEEEcCCCCE
Confidence 99999999999765321 001258999999999999999999999 899999999999999999999
Q ss_pred EEcccchhhhhhccCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHH
Q 005102 548 HVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILL 627 (714)
Q Consensus 548 kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~ 627 (714)
||+|||+++....... ........+|+.|+|||.+.+..++.++||||||+++|
T Consensus 185 kl~Dfg~~~~~~~~~~--------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ 238 (313)
T 1t46_A 185 KICDFGLARDIKNDSN--------------------------YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLW 238 (313)
T ss_dssp EECCCGGGSCTTSCTT--------------------------SEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHH
T ss_pred EEcccccccccccccc--------------------------ceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHH
Confidence 9999999986543211 01122234577899999998889999999999999999
Q ss_pred HHHh-CCCccccCCCCcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHH
Q 005102 628 EMIT-GRTAVVQVGSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDAL 706 (714)
Q Consensus 628 ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L 706 (714)
||+| |+.||....... . +......... +..... ....+.+++.+||+.||++|||++|+++.|
T Consensus 239 ellt~g~~p~~~~~~~~-~----~~~~~~~~~~------~~~~~~-----~~~~l~~li~~~l~~dp~~Rps~~ell~~L 302 (313)
T 1t46_A 239 ELFSLGSSPYPGMPVDS-K----FYKMIKEGFR------MLSPEH-----APAEMYDIMKTCWDADPLKRPTFKQIVQLI 302 (313)
T ss_dssp HHHTTTCCSSTTCCSSH-H----HHHHHHHTCC------CCCCTT-----SCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHhCCCCCCCcccchh-H----HHHHhccCCC------CCCccc-----CCHHHHHHHHHHcCCCchhCcCHHHHHHHH
Confidence 9999 999995432221 1 1111222111 111111 123688999999999999999999999999
Q ss_pred hhhhcc
Q 005102 707 DRLIVS 712 (714)
Q Consensus 707 ~~i~~~ 712 (714)
+++...
T Consensus 303 ~~~~~~ 308 (313)
T 1t46_A 303 EKQISE 308 (313)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 998754
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-41 Score=353.55 Aligned_cols=254 Identities=21% Similarity=0.294 Sum_probs=191.3
Q ss_pred ccccccCceEEEEEEE-CCCcEEEEEEeCCCC---chhHHHHHHHHHHHhccCCCCccceEEEEEeCCce----eEEEec
Q 005102 409 FVLGKSGIGIVYKVVL-EDGHTLAVRRLGEGG---SQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEK----LLIYDY 480 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~----~lV~e~ 480 (714)
+.||+|+||.||+|++ .+++.||||++.... ....+.+.+|++++++++||||+++++++...+.. ++||||
T Consensus 18 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~lv~e~ 97 (311)
T 3ork_A 18 EILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEY 97 (311)
T ss_dssp EEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEEEEEEEEC
T ss_pred EEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcccEEEEec
Confidence 4799999999999997 468999999997653 23346789999999999999999999998876544 999999
Q ss_pred cCCCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhc
Q 005102 481 IPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANI 560 (714)
Q Consensus 481 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 560 (714)
+++|+|.+++... ..+++.++..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++....
T Consensus 98 ~~g~~L~~~l~~~------~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~ 168 (311)
T 3ork_A 98 VDGVTLRDIVHTE------GPMTPKRAIEVIADACQALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIAD 168 (311)
T ss_dssp CCEEEHHHHHHHH------CSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEETTSCEEECCCSCC-----
T ss_pred CCCCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCCCcCCCCHHHEEEcCCCCEEEeeccCcccccc
Confidence 9999999999754 458999999999999999999999 8999999999999999999999999999986543
Q ss_pred cCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCccccCC
Q 005102 561 AGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVG 640 (714)
Q Consensus 561 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~~~~~ 640 (714)
.... ........||+.|+|||++.+..++.++||||||+++|||+||+.||....
T Consensus 169 ~~~~-------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~ 223 (311)
T 3ork_A 169 SGNS-------------------------VTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDS 223 (311)
T ss_dssp --------------------------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred cccc-------------------------cccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC
Confidence 2110 112223457899999999999999999999999999999999999994321
Q ss_pred CCcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHH-HHHHHhhhh
Q 005102 641 SSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRH-ISDALDRLI 710 (714)
Q Consensus 641 ~~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~e-vl~~L~~i~ 710 (714)
....................+. ....+.+++.+||+.||++||++.+ +...|.++.
T Consensus 224 -----~~~~~~~~~~~~~~~~~~~~~~---------~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~ 280 (311)
T 3ork_A 224 -----PVSVAYQHVREDPIPPSARHEG---------LSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 280 (311)
T ss_dssp -----HHHHHHHHHHCCCCCHHHHSTT---------CCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred -----hHHHHHHHhcCCCCCcccccCC---------CCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHh
Confidence 1122222222221111111111 1235789999999999999996554 555665543
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-41 Score=359.78 Aligned_cols=260 Identities=24% Similarity=0.306 Sum_probs=201.4
Q ss_pred cccccccCceEEEEEEEC------CCcEEEEEEeCCCC-chhHHHHHHHHHHHhcc-CCCCccceEEEEEeCCceeEEEe
Q 005102 408 AFVLGKSGIGIVYKVVLE------DGHTLAVRRLGEGG-SQRFKEFQTEVEAIGKI-RHSNIVTLRAYYWSVDEKLLIYD 479 (714)
Q Consensus 408 ~~~lG~G~~g~Vy~~~~~------~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~e 479 (714)
.+.||+|+||.||+|.+. ++..||||++.... ....+.+.+|+++++++ +||||+++++++...+..++|||
T Consensus 50 ~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e 129 (344)
T 1rjb_A 50 GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFE 129 (344)
T ss_dssp EEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred eeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCCccEEEEe
Confidence 458999999999999962 35689999997642 23346799999999999 89999999999999999999999
Q ss_pred ccCCCCHhhhhhCCCCCC-----------------CcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeC
Q 005102 480 YIPNGSLATALHGKPGMV-----------------SFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLG 542 (714)
Q Consensus 480 ~~~~gsL~~~l~~~~~~~-----------------~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~ 542 (714)
|+++|+|.+++....... ....+++..+..++.|++.||+|||+ .+|+||||||+||+++
T Consensus 130 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIll~ 206 (344)
T 1rjb_A 130 YCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVT 206 (344)
T ss_dssp CCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH---TTEEETTCSGGGEEEE
T ss_pred cCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChhhEEEc
Confidence 999999999998654210 01247999999999999999999999 8999999999999999
Q ss_pred CCCCeEEcccchhhhhhccCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHH
Q 005102 543 HNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSY 622 (714)
Q Consensus 543 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~ 622 (714)
.++.+||+|||+++....... ........||+.|+|||.+.+..++.++|||||
T Consensus 207 ~~~~~kL~Dfg~~~~~~~~~~--------------------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~sl 260 (344)
T 1rjb_A 207 HGKVVKICDFGLARDIMSDSN--------------------------YVVRGNARLPVKWMAPESLFEGIYTIKSDVWSY 260 (344)
T ss_dssp TTTEEEECCCGGGSCGGGCTT--------------------------SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHH
T ss_pred CCCcEEeCCCccCcccccCcc--------------------------ceeccCccCccCccCHHHhccCCCChhHhHHHH
Confidence 999999999999986543211 011122335778999999988899999999999
Q ss_pred HHHHHHHHh-CCCccccCCCCcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHH
Q 005102 623 GVILLEMIT-GRTAVVQVGSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRH 701 (714)
Q Consensus 623 Gvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~e 701 (714)
||++|||+| |+.||....... .. ......... +..... ....+.+++.+||+.||++|||++|
T Consensus 261 G~il~el~t~g~~p~~~~~~~~-~~----~~~~~~~~~------~~~~~~-----~~~~l~~li~~~l~~dp~~Rps~~~ 324 (344)
T 1rjb_A 261 GILLWEIFSLGVNPYPGIPVDA-NF----YKLIQNGFK------MDQPFY-----ATEEIYIIMQSCWAFDSRKRPSFPN 324 (344)
T ss_dssp HHHHHHHTTTSCCSSTTCCCSH-HH----HHHHHTTCC------CCCCTT-----CCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred HHHHHHHHcCCCCCcccCCcHH-HH----HHHHhcCCC------CCCCCC-----CCHHHHHHHHHHcCCCchhCcCHHH
Confidence 999999998 999995432221 11 112222111 111111 1236889999999999999999999
Q ss_pred HHHHHhhhhcc
Q 005102 702 ISDALDRLIVS 712 (714)
Q Consensus 702 vl~~L~~i~~~ 712 (714)
+++.|+.+...
T Consensus 325 l~~~l~~~~~~ 335 (344)
T 1rjb_A 325 LTSFLGCQLAD 335 (344)
T ss_dssp HHHHHHHHC--
T ss_pred HHHHHHHHHHH
Confidence 99999998754
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=380.79 Aligned_cols=251 Identities=24% Similarity=0.369 Sum_probs=198.8
Q ss_pred cccccCceEEEEEEEC---CCcEEEEEEeCCCC-chhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCCC
Q 005102 410 VLGKSGIGIVYKVVLE---DGHTLAVRRLGEGG-SQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGS 485 (714)
Q Consensus 410 ~lG~G~~g~Vy~~~~~---~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gs 485 (714)
.||+|+||.||+|.++ ++..||||+++... ....++|.+|+++|++++|||||++++++.. +..++||||+++|+
T Consensus 343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~ 421 (613)
T 2ozo_A 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP 421 (613)
T ss_dssp EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCB
T ss_pred EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCc
Confidence 6999999999999874 46789999998753 3456789999999999999999999999976 57899999999999
Q ss_pred HhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCCC
Q 005102 486 LATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSP 565 (714)
Q Consensus 486 L~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 565 (714)
|.+++.... ..+++..+..|+.||+.||+|||+ ++|+||||||+|||+++++.+||+|||+++........
T Consensus 422 L~~~l~~~~-----~~l~~~~~~~i~~qi~~~L~~LH~---~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~- 492 (613)
T 2ozo_A 422 LHKFLVGKR-----EEIPVSNVAELLHQVSMGMKYLEE---KNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSY- 492 (613)
T ss_dssp HHHHHTTCT-----TTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC------
T ss_pred HHHHHhhcc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCce-
Confidence 999997653 458999999999999999999999 89999999999999999999999999999865322110
Q ss_pred CccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHh-CCCccccCCCCcc
Q 005102 566 TLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMIT-GRTAVVQVGSSEM 644 (714)
Q Consensus 566 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~ellt-G~~p~~~~~~~~~ 644 (714)
........+|+.|+|||++.+..++.++|||||||++|||+| |+.||..... .
T Consensus 493 ------------------------~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~--~ 546 (613)
T 2ozo_A 493 ------------------------YTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG--P 546 (613)
T ss_dssp ---------------------------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCS--H
T ss_pred ------------------------eeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCH--H
Confidence 011112234678999999998899999999999999999998 9999954322 2
Q ss_pred hhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhhhhc
Q 005102 645 DLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDALDRLIV 711 (714)
Q Consensus 645 ~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~ 711 (714)
++.. . +..+.. ...... ....+.++|.+||+.||++|||+++|++.|+.+..
T Consensus 547 ~~~~---~-i~~~~~------~~~p~~-----~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~ 598 (613)
T 2ozo_A 547 EVMA---F-IEQGKR------MECPPE-----CPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY 598 (613)
T ss_dssp HHHH---H-HHTTCC------CCCCTT-----CCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred HHHH---H-HHcCCC------CCCCCc-----CCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence 2222 1 112111 111111 22368899999999999999999999999998754
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-41 Score=352.89 Aligned_cols=251 Identities=25% Similarity=0.379 Sum_probs=195.9
Q ss_pred ccccccCceEEEEEEECC-CcE----EEEEEeCCCC-chhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccC
Q 005102 409 FVLGKSGIGIVYKVVLED-GHT----LAVRRLGEGG-SQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIP 482 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~~-g~~----vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~ 482 (714)
+.||+|+||.||+|++.. ++. ||+|.+.... ....+.+.+|+.++++++||||+++++++. .+..++||||++
T Consensus 19 ~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~ 97 (325)
T 3kex_A 19 KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQLVTQYLP 97 (325)
T ss_dssp EEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEEEEECCT
T ss_pred eeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEEEEEeCC
Confidence 479999999999999753 443 8888876542 233356788999999999999999999985 567899999999
Q ss_pred CCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccC
Q 005102 483 NGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAG 562 (714)
Q Consensus 483 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 562 (714)
+|+|.+++.... ..+++..+..|+.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++......
T Consensus 98 ~~~L~~~l~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~ 169 (325)
T 3kex_A 98 LGSLLDHVRQHR-----GALGPQLLLNWGVQIAKGMYYLEE---HGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDD 169 (325)
T ss_dssp TCBSHHHHHSSG-----GGSCTTHHHHHHHHHHHHHHHHHH---TTCCCSCCSSTTEEESSSSCEEECSCSGGGGSCCCT
T ss_pred CCCHHHHHHHcc-----ccCCHHHHHHHHHHHHHHHHHHHh---CCCCCCccchheEEECCCCeEEECCCCcccccCccc
Confidence 999999997653 458899999999999999999999 899999999999999999999999999998764321
Q ss_pred CCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHh-CCCccccCCC
Q 005102 563 GSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMIT-GRTAVVQVGS 641 (714)
Q Consensus 563 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~ellt-G~~p~~~~~~ 641 (714)
. ........||..|+|||++.+..++.++|||||||++|||+| |+.||.....
T Consensus 170 ~--------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~ 223 (325)
T 3kex_A 170 K--------------------------QLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRL 223 (325)
T ss_dssp T--------------------------CCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCT
T ss_pred c--------------------------cccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCH
Confidence 1 111223456778999999998899999999999999999999 9999954322
Q ss_pred CcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhhhhc
Q 005102 642 SEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDALDRLIV 711 (714)
Q Consensus 642 ~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~ 711 (714)
..+... ...... ...+.. ....+.+++.+||+.||++|||++|+++.|+++..
T Consensus 224 --~~~~~~----~~~~~~---~~~~~~--------~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~ 276 (325)
T 3kex_A 224 --AEVPDL----LEKGER---LAQPQI--------CTIDVYMVMVKCWMIDENIRPTFKELANEFTRMAR 276 (325)
T ss_dssp --THHHHH----HHTTCB---CCCCTT--------BCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTT
T ss_pred --HHHHHH----HHcCCC---CCCCCc--------CcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 122211 111111 001111 11146789999999999999999999999998754
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=345.63 Aligned_cols=254 Identities=24% Similarity=0.398 Sum_probs=190.2
Q ss_pred ccccccCceEEEEEEECCCcEEEEEEeCCCC--chhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCCCH
Q 005102 409 FVLGKSGIGIVYKVVLEDGHTLAVRRLGEGG--SQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGSL 486 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL 486 (714)
+.||+|+||.||+|++. ..||||+++... ....+.|.+|++++++++||||+++++++ ..+..++||||+++++|
T Consensus 30 ~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e~~~~~~L 106 (289)
T 3og7_A 30 QRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQWCEGSSL 106 (289)
T ss_dssp EEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEECCCEEEH
T ss_pred eEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEEecCCCcH
Confidence 47999999999999875 369999997653 33456799999999999999999999965 55678999999999999
Q ss_pred hhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCCCC
Q 005102 487 ATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPT 566 (714)
Q Consensus 487 ~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 566 (714)
.+++.... ..+++.++.+|+.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++.......
T Consensus 107 ~~~l~~~~-----~~~~~~~~~~i~~qi~~~L~~lH~---~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--- 175 (289)
T 3og7_A 107 YHHLHASE-----TKFEMKKLIDIARQTARGMDYLHA---KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSG--- 175 (289)
T ss_dssp HHHHTTC--------CCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTTEEEECCCC-------------
T ss_pred HHHHhhcc-----CCCCHHHHHHHHHHHHHHHHHHHh---CCcccccCccceEEECCCCCEEEccceeccccccccc---
Confidence 99997553 458999999999999999999999 8999999999999999999999999999976532111
Q ss_pred ccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccC---CCCCCchhhhHHHHHHHHHHHhCCCccccCCCCc
Q 005102 567 LQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLK---VVKPSQKWDIYSYGVILLEMITGRTAVVQVGSSE 643 (714)
Q Consensus 567 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~~~DVwS~Gvvl~elltG~~p~~~~~~~~ 643 (714)
........||+.|+|||.+. +..++.++||||||+++|||++|+.||......+
T Consensus 176 -----------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~ 232 (289)
T 3og7_A 176 -----------------------SHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD 232 (289)
T ss_dssp -------------------------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHH
T ss_pred -----------------------cccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHH
Confidence 11122345788999999986 5678999999999999999999999995432211
Q ss_pred chhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhhhhc
Q 005102 644 MDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDALDRLIV 711 (714)
Q Consensus 644 ~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~ 711 (714)
. +......... ..... .... .....+.+++.+||+.||++|||++|+++.|+++.+
T Consensus 233 -~----~~~~~~~~~~-~~~~~-~~~~-----~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~ 288 (289)
T 3og7_A 233 -Q----IIEMVGRGSL-SPDLS-KVRS-----NCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288 (289)
T ss_dssp -H----HHHHHHHTSC-CCCTT-SSCT-----TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred -H----HHHHhccccc-Ccchh-hccc-----cCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence 1 1111222111 10000 0111 122468899999999999999999999999999864
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-40 Score=346.17 Aligned_cols=253 Identities=23% Similarity=0.297 Sum_probs=194.7
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeCCCCc---hhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCC
Q 005102 409 FVLGKSGIGIVYKVVLE-DGHTLAVRRLGEGGS---QRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNG 484 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~g 484 (714)
+.||+|+||.||+|... +++.||||++..... ...+.+.+|+.++++++||||+++++++...+..++||||++++
T Consensus 40 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~ 119 (309)
T 2h34_A 40 RLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVDMRLINGV 119 (309)
T ss_dssp EEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCCCE
T ss_pred EEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEEEEecCCC
Confidence 47999999999999986 588999999976422 23467899999999999999999999999999999999999999
Q ss_pred CHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCC
Q 005102 485 SLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGS 564 (714)
Q Consensus 485 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 564 (714)
+|.+++... ..+++.++..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++......
T Consensus 120 ~L~~~l~~~------~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~-- 188 (309)
T 2h34_A 120 DLAAMLRRQ------GPLAPPRAVAIVRQIGSALDAAHA---AGATHRDVKPENILVSADDFAYLVDFGIASATTDEK-- 188 (309)
T ss_dssp EHHHHHHHH------CSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECSCCC----------
T ss_pred CHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CcCCcCCCChHHEEEcCCCCEEEecCccCccccccc--
Confidence 999999754 458999999999999999999999 899999999999999999999999999987653211
Q ss_pred CCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCccccCCCCcc
Q 005102 565 PTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGSSEM 644 (714)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~~~~~~~~~ 644 (714)
........||+.|+|||.+.+..++.++||||||+++|||++|+.||....
T Consensus 189 -------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~---- 239 (309)
T 2h34_A 189 -------------------------LTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQ---- 239 (309)
T ss_dssp ---------------------------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCH----
T ss_pred -------------------------cccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCch----
Confidence 011223357889999999999899999999999999999999999994321
Q ss_pred hhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCC-CHHHHHHHHhhhhcc
Q 005102 645 DLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRP-TMRHISDALDRLIVS 712 (714)
Q Consensus 645 ~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RP-t~~evl~~L~~i~~~ 712 (714)
. ..+...............+.. ...+.+++.+||+.||++|| |++++++.|+++...
T Consensus 240 -~-~~~~~~~~~~~~~~~~~~~~~---------~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~ 297 (309)
T 2h34_A 240 -L-SVMGAHINQAIPRPSTVRPGI---------PVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALAT 297 (309)
T ss_dssp -H-HHHHHHHHSCCCCGGGTSTTC---------CTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC-
T ss_pred -H-HHHHHHhccCCCCccccCCCC---------CHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHh
Confidence 1 122222222221111111111 12578999999999999999 999999999987654
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=353.09 Aligned_cols=254 Identities=29% Similarity=0.450 Sum_probs=197.3
Q ss_pred ccccccCceEEEEEEECC-----CcEEEEEEeCCCC-chhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccC
Q 005102 409 FVLGKSGIGIVYKVVLED-----GHTLAVRRLGEGG-SQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIP 482 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~~-----g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~ 482 (714)
+.||+|+||.||+|.+.. +..||||++.... ......+.+|++++++++||||+++++++...+..++||||++
T Consensus 50 ~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 129 (333)
T 1mqb_A 50 KVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYME 129 (333)
T ss_dssp EEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred cEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEEEEeCCC
Confidence 579999999999998753 2469999998653 3344679999999999999999999999999999999999999
Q ss_pred CCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccC
Q 005102 483 NGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAG 562 (714)
Q Consensus 483 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 562 (714)
+|+|.+++.... ..+++.++..++.|++.||+|||+ .+|+||||||+||++++++.+||+|||+++......
T Consensus 130 ~~~L~~~l~~~~-----~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 201 (333)
T 1mqb_A 130 NGALDKFLREKD-----GEFSVLQLVGMLRGIAAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP 201 (333)
T ss_dssp TEEHHHHHHHTT-----TCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCCCC--------
T ss_pred CCcHHHHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChheEEECCCCcEEECCCCcchhhcccc
Confidence 999999997653 458999999999999999999999 899999999999999999999999999998654321
Q ss_pred CCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHh-CCCccccCCC
Q 005102 563 GSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMIT-GRTAVVQVGS 641 (714)
Q Consensus 563 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~ellt-G~~p~~~~~~ 641 (714)
.. ........+|..|+|||.+.+..++.++||||||+++|||++ |+.||.....
T Consensus 202 ~~-------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~ 256 (333)
T 1mqb_A 202 EA-------------------------TYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN 256 (333)
T ss_dssp ----------------------------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH
T ss_pred cc-------------------------ccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCH
Confidence 00 011122335778999999998899999999999999999999 9999943221
Q ss_pred CcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhhhhcc
Q 005102 642 SEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDALDRLIVS 712 (714)
Q Consensus 642 ~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~~ 712 (714)
.+.+.... ..... ..... ....+.+++.+||+.||++||+++++++.|+++...
T Consensus 257 -----~~~~~~~~-~~~~~------~~~~~-----~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~ 310 (333)
T 1mqb_A 257 -----HEVMKAIN-DGFRL------PTPMD-----CPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 310 (333)
T ss_dssp -----HHHHHHHH-TTCCC------CCCTT-----CBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred -----HHHHHHHH-CCCcC------CCccc-----CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 11222211 11110 01111 223688999999999999999999999999998654
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=344.55 Aligned_cols=253 Identities=24% Similarity=0.371 Sum_probs=203.0
Q ss_pred ccccccCceEEEEEEEC---CCcEEEEEEeCCCC-chhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCC
Q 005102 409 FVLGKSGIGIVYKVVLE---DGHTLAVRRLGEGG-SQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNG 484 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~---~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~g 484 (714)
..||+|+||.||+|.+. ++..||||++.... ....+.+.+|++++++++||||+++++++ ..+..++||||++++
T Consensus 16 ~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e~~~~~ 94 (287)
T 1u59_A 16 IELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGG 94 (287)
T ss_dssp EEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEEEECCTTE
T ss_pred ccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEEEEeCCCC
Confidence 37999999999999864 57889999998753 34457799999999999999999999999 556789999999999
Q ss_pred CHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCC
Q 005102 485 SLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGS 564 (714)
Q Consensus 485 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 564 (714)
+|.+++.... ..+++..+..++.|++.||+|||+ .+|+||||||+||++++++.+||+|||+++.......
T Consensus 95 ~L~~~l~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~- 165 (287)
T 1u59_A 95 PLHKFLVGKR-----EEIPVSNVAELLHQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDS- 165 (287)
T ss_dssp EHHHHHTTCT-----TTSCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSC-
T ss_pred CHHHHHHhCC-----ccCCHHHHHHHHHHHHHHHHHHHH---CCEeeCCCchheEEEcCCCCEEECcccceeeeccCcc-
Confidence 9999997543 458999999999999999999999 8999999999999999999999999999986542211
Q ss_pred CCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHh-CCCccccCCCCc
Q 005102 565 PTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMIT-GRTAVVQVGSSE 643 (714)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~ellt-G~~p~~~~~~~~ 643 (714)
.........+|+.|+|||.+.+..++.++||||||+++|||+| |+.||.....
T Consensus 166 ------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~-- 219 (287)
T 1u59_A 166 ------------------------YYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG-- 219 (287)
T ss_dssp ------------------------EECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT--
T ss_pred ------------------------eeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH--
Confidence 0111223345788999999988889999999999999999999 9999954322
Q ss_pred chhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhhhhcc
Q 005102 644 MDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDALDRLIVS 712 (714)
Q Consensus 644 ~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~~ 712 (714)
.++ ......... +..... ....+.+++.+||+.||++|||++++++.|+++..+
T Consensus 220 ~~~---~~~i~~~~~-------~~~~~~-----~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 273 (287)
T 1u59_A 220 PEV---MAFIEQGKR-------MECPPE-----CPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 273 (287)
T ss_dssp HHH---HHHHHTTCC-------CCCCTT-----CCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHH---HHHHhcCCc-------CCCCCC-----cCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 112 211111111 111111 223688999999999999999999999999998654
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-41 Score=358.68 Aligned_cols=243 Identities=23% Similarity=0.261 Sum_probs=187.9
Q ss_pred ccccccCceEEEEEEECC-CcEEEEEEeCCCCc---hhHHHHHHHHHH-HhccCCCCccceEEEEEeCCceeEEEeccCC
Q 005102 409 FVLGKSGIGIVYKVVLED-GHTLAVRRLGEGGS---QRFKEFQTEVEA-IGKIRHSNIVTLRAYYWSVDEKLLIYDYIPN 483 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~~-g~~vavK~~~~~~~---~~~~~~~~E~~~-l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~ 483 (714)
+.||+|+||+||+|+.+. ++.||||++.+... .....+.+|..+ ++.++||||+++++++.+.+..|+||||+++
T Consensus 44 ~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv~E~~~g 123 (373)
T 2r5t_A 44 KVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 123 (373)
T ss_dssp EEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEEEEECCCS
T ss_pred EEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEEEeCCCC
Confidence 479999999999999864 88999999976432 233456778777 5778999999999999999999999999999
Q ss_pred CCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCC
Q 005102 484 GSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGG 563 (714)
Q Consensus 484 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 563 (714)
|+|.+++... ..+++..++.++.||+.||+|||+ ++|+||||||+|||++.++++||+|||+++.....
T Consensus 124 g~L~~~l~~~------~~~~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~-- 192 (373)
T 2r5t_A 124 GELFYHLQRE------RCFLEPRARFYAAEIASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEH-- 192 (373)
T ss_dssp CBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCC--
T ss_pred CcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCHHHEEECCCCCEEEeeCccccccccC--
Confidence 9999999754 458899999999999999999999 89999999999999999999999999999853211
Q ss_pred CCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCccccCCCCc
Q 005102 564 SPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGSSE 643 (714)
Q Consensus 564 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~~~~~~~~ 643 (714)
........||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 193 --------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~---- 242 (373)
T 2r5t_A 193 --------------------------NSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSR---- 242 (373)
T ss_dssp --------------------------CCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCS----
T ss_pred --------------------------CCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCC----
Confidence 11223446799999999999999999999999999999999999999432
Q ss_pred chhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHH
Q 005102 644 MDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDAL 706 (714)
Q Consensus 644 ~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L 706 (714)
+..+........... ..... ...+.+++.+||+.||++||++.+.++.+
T Consensus 243 -~~~~~~~~i~~~~~~--------~~~~~-----~~~~~~li~~lL~~dp~~R~~~~~~~~~i 291 (373)
T 2r5t_A 243 -NTAEMYDNILNKPLQ--------LKPNI-----TNSARHLLEGLLQKDRTKRLGAKDDFMEI 291 (373)
T ss_dssp -BHHHHHHHHHHSCCC--------CCSSS-----CHHHHHHHHHHTCSSGGGSTTTTTTHHHH
T ss_pred -CHHHHHHHHHhcccC--------CCCCC-----CHHHHHHHHHHcccCHHhCCCCCCCHHHH
Confidence 122223333332211 11111 12578999999999999999986544433
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=356.15 Aligned_cols=245 Identities=20% Similarity=0.265 Sum_probs=189.3
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeCCCCchhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCCCHh
Q 005102 409 FVLGKSGIGIVYKVVLE-DGHTLAVRRLGEGGSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGSLA 487 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL~ 487 (714)
+.||+|+||.||+++.. +++.||||++....... +.+.+|+.++++++||||+++++++...+..++||||+++|+|.
T Consensus 26 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~ 104 (361)
T 3uc3_A 26 KDIGSGNFGVARLMRDKLTKELVAVKYIERGAAID-ENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELY 104 (361)
T ss_dssp EEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSC-HHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHH
T ss_pred EEeccCCCEEEEEEEECCCCcEEEEEEEecCcccc-HHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEeCCCCCHH
Confidence 47999999999999986 58999999997654332 67889999999999999999999999999999999999999999
Q ss_pred hhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCC--eEEcccchhhhhhccCCCC
Q 005102 488 TALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNME--PHVSDFGLARLANIAGGSP 565 (714)
Q Consensus 488 ~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~--~kl~DFGla~~~~~~~~~~ 565 (714)
+++... ..+++..+..++.|++.||+|||+ ++|+||||||+|||++.++. +||+|||+++.....
T Consensus 105 ~~l~~~------~~~~~~~~~~i~~ql~~~L~~LH~---~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~---- 171 (361)
T 3uc3_A 105 ERICNA------GRFSEDEARFFFQQLLSGVSYCHS---MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH---- 171 (361)
T ss_dssp HHHHHH------SSCCHHHHHHHHHHHHHHHHHHHH---TTCCSCCCCGGGEEECSSSSCCEEECCCCCC----------
T ss_pred HHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCCCCceEEEeecCcccccccc----
Confidence 998754 458999999999999999999999 89999999999999987765 999999998743211
Q ss_pred CccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCch-hhhHHHHHHHHHHHhCCCccccCCCCcc
Q 005102 566 TLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQK-WDIYSYGVILLEMITGRTAVVQVGSSEM 644 (714)
Q Consensus 566 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~-~DVwS~Gvvl~elltG~~p~~~~~~~~~ 644 (714)
.......||+.|+|||++.+..++.+ +|||||||++|||++|+.||...... .
T Consensus 172 -------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~-~ 225 (361)
T 3uc3_A 172 -------------------------SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP-R 225 (361)
T ss_dssp ----------------------------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----C-C
T ss_pred -------------------------CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccH-H
Confidence 11223357899999999988887665 89999999999999999999543322 2
Q ss_pred hhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 005102 645 DLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISD 704 (714)
Q Consensus 645 ~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 704 (714)
.....++.......... .... ....+.+++.+||+.||++|||++|+++
T Consensus 226 ~~~~~~~~~~~~~~~~~--------~~~~---~s~~~~~li~~~L~~dP~~Rps~~ell~ 274 (361)
T 3uc3_A 226 DYRKTIQRILSVKYSIP--------DDIR---ISPECCHLISRIFVADPATRISIPEIKT 274 (361)
T ss_dssp CHHHHHHHHHTTCCCCC--------TTSC---CCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred HHHHHHHHHhcCCCCCC--------CcCC---CCHHHHHHHHHHccCChhHCcCHHHHHh
Confidence 23333333332221111 0000 1235789999999999999999999975
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-41 Score=345.23 Aligned_cols=251 Identities=24% Similarity=0.402 Sum_probs=201.8
Q ss_pred ccccccCceEEEEEEECCCcEEEEEEeCCCCchhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCCCHhh
Q 005102 409 FVLGKSGIGIVYKVVLEDGHTLAVRRLGEGGSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGSLAT 488 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL~~ 488 (714)
+.||+|+||.||+|...++..||||++..... ..+.+.+|++++++++||||+++++++. .+..++||||+++++|.+
T Consensus 19 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~~~L~~ 96 (279)
T 1qpc_A 19 ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM-SPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYMENGSLVD 96 (279)
T ss_dssp EEEEEETTEEEEEEEETTTEEEEEEEECTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECCTTCBHHH
T ss_pred eeecCCCCeEEEEEEEcCCcEEEEEEecCCcc-cHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEEecCCCCCHHH
Confidence 47999999999999998888999999976543 3478999999999999999999999986 456899999999999999
Q ss_pred hhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCCCCcc
Q 005102 489 ALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQ 568 (714)
Q Consensus 489 ~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 568 (714)
++..... ..+++..+.+++.|++.||+|||+ .+|+||||||+||++++++.+||+|||+++......
T Consensus 97 ~l~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~------ 163 (279)
T 1qpc_A 97 FLKTPSG----IKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE------ 163 (279)
T ss_dssp HTTSHHH----HTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSC------
T ss_pred HHhcCCC----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHhhEEEcCCCCEEECCCcccccccCcc------
Confidence 9965421 258999999999999999999999 899999999999999999999999999998653211
Q ss_pred CCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHh-CCCccccCCCCcchhH
Q 005102 569 SNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMIT-GRTAVVQVGSSEMDLV 647 (714)
Q Consensus 569 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~ellt-G~~p~~~~~~~~~~l~ 647 (714)
........++..|+|||.+.+..++.++||||||+++|||++ |+.||.... . .
T Consensus 164 ---------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~--~---~ 217 (279)
T 1qpc_A 164 ---------------------YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT--N---P 217 (279)
T ss_dssp ---------------------EECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCC--H---H
T ss_pred ---------------------cccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccC--H---H
Confidence 111223345778999999988889999999999999999999 899984321 1 1
Q ss_pred HHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhhhhcc
Q 005102 648 NWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDALDRLIVS 712 (714)
Q Consensus 648 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~~ 712 (714)
+....... .. .+..... ....+.+++.+||+.||++|||++++++.|+++...
T Consensus 218 ~~~~~~~~-~~------~~~~~~~-----~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 270 (279)
T 1qpc_A 218 EVIQNLER-GY------RMVRPDN-----CPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270 (279)
T ss_dssp HHHHHHHT-TC------CCCCCTT-----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHhc-cc------CCCCccc-----ccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHh
Confidence 12222111 11 0111111 123688999999999999999999999999998754
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=350.80 Aligned_cols=258 Identities=24% Similarity=0.381 Sum_probs=203.2
Q ss_pred cccccccCceEEEEEEEC--------CCcEEEEEEeCCCC-chhHHHHHHHHHHHhcc-CCCCccceEEEEEeCCceeEE
Q 005102 408 AFVLGKSGIGIVYKVVLE--------DGHTLAVRRLGEGG-SQRFKEFQTEVEAIGKI-RHSNIVTLRAYYWSVDEKLLI 477 (714)
Q Consensus 408 ~~~lG~G~~g~Vy~~~~~--------~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV 477 (714)
.+.||+|+||.||+|.+. ++..||||++.... ....+.+.+|+++++++ +||||+++++++...+..++|
T Consensus 40 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 119 (334)
T 2pvf_A 40 GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVI 119 (334)
T ss_dssp EEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCCEEE
T ss_pred eeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccCCceEEE
Confidence 357999999999999873 46789999998653 33456799999999999 899999999999999999999
Q ss_pred EeccCCCCHhhhhhCCCCC----------CCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCe
Q 005102 478 YDYIPNGSLATALHGKPGM----------VSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEP 547 (714)
Q Consensus 478 ~e~~~~gsL~~~l~~~~~~----------~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~ 547 (714)
|||+++|+|.+++...... .....+++.++.+++.|++.||+|||+ .+|+||||||+||+++.++.+
T Consensus 120 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~ 196 (334)
T 2pvf_A 120 VEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS---QKCIHRDLAARNVLVTENNVM 196 (334)
T ss_dssp EECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCE
T ss_pred EECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCccceEEEcCCCCE
Confidence 9999999999999865321 011348999999999999999999999 899999999999999999999
Q ss_pred EEcccchhhhhhccCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHH
Q 005102 548 HVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILL 627 (714)
Q Consensus 548 kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~ 627 (714)
||+|||+++....... ........+|+.|+|||++.+..++.++||||||+++|
T Consensus 197 kL~Dfg~~~~~~~~~~--------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ 250 (334)
T 2pvf_A 197 KIADFGLARDINNIDY--------------------------YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMW 250 (334)
T ss_dssp EECCCTTCEECTTTSS--------------------------EECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHH
T ss_pred EEcccccccccccccc--------------------------ccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHH
Confidence 9999999976532110 11122334578899999998888999999999999999
Q ss_pred HHHh-CCCccccCCCCcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHH
Q 005102 628 EMIT-GRTAVVQVGSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDAL 706 (714)
Q Consensus 628 ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L 706 (714)
||+| |+.||.... ..+.......... +..... ....+.+++.+||+.||++|||++|+++.|
T Consensus 251 ellt~g~~p~~~~~-----~~~~~~~~~~~~~-------~~~~~~-----~~~~l~~li~~~l~~dp~~Rps~~ell~~L 313 (334)
T 2pvf_A 251 EIFTLGGSPYPGIP-----VEELFKLLKEGHR-------MDKPAN-----CTNELYMMMRDCWHAVPSQRPTFKQLVEDL 313 (334)
T ss_dssp HHHTTSCCSSTTCC-----HHHHHHHHHHTCC-------CCCCTT-----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHhCCCCCcCcCC-----HHHHHHHHhcCCC-------CCCCcc-----CCHHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence 9999 999994321 1222222212111 111111 123688999999999999999999999999
Q ss_pred hhhhc
Q 005102 707 DRLIV 711 (714)
Q Consensus 707 ~~i~~ 711 (714)
+++..
T Consensus 314 ~~l~~ 318 (334)
T 2pvf_A 314 DRILT 318 (334)
T ss_dssp HHHHH
T ss_pred HHHHh
Confidence 99864
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=353.20 Aligned_cols=262 Identities=24% Similarity=0.299 Sum_probs=204.9
Q ss_pred cccccccCceEEEEEEECCCcEEEEEEeCCCCchhHHHHHHHHHHHhc--cCCCCccceEEEEEeCC----ceeEEEecc
Q 005102 408 AFVLGKSGIGIVYKVVLEDGHTLAVRRLGEGGSQRFKEFQTEVEAIGK--IRHSNIVTLRAYYWSVD----EKLLIYDYI 481 (714)
Q Consensus 408 ~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~H~niv~l~~~~~~~~----~~~lV~e~~ 481 (714)
.+.||+|+||.||+|++ +|+.||||++... ....+.+|++++.. ++||||+++++++...+ ..++||||+
T Consensus 47 ~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~lv~e~~ 122 (342)
T 1b6c_B 47 QESIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYH 122 (342)
T ss_dssp EEEEEEETTEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCEEEEECCC
T ss_pred EeeecCCCCcEEEEEEE-cCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccceeEEEEeec
Confidence 45899999999999998 4899999999653 23567889888887 78999999999998776 789999999
Q ss_pred CCCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHh--------cCCCCCceecCCCCCCeeeCCCCCeEEcccc
Q 005102 482 PNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLH--------EFSPKKYVHGDLKPSNILLGHNMEPHVSDFG 553 (714)
Q Consensus 482 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH--------~~~~~~ivHrDlkp~NILl~~~~~~kl~DFG 553 (714)
++|+|.+++... .+++.++.+++.|++.||+||| + .+|+||||||+|||++.++.+||+|||
T Consensus 123 ~~g~L~~~l~~~-------~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~---~~ivH~Dlkp~NIll~~~~~~kL~Dfg 192 (342)
T 1b6c_B 123 EHGSLFDYLNRY-------TVTVEGMIKLALSTASGLAHLHMEIVGTQGK---PAIAHRDLKSKNILVKKNGTCCIADLG 192 (342)
T ss_dssp TTCBHHHHHHHC-------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCB---CEEECSCCSGGGEEECTTSCEEECCCT
T ss_pred CCCcHHHHHhcc-------CccHHHHHHHHHHHHHHHHHHHHHHhhhccc---CCeeeCCCCHHHEEECCCCCEEEEECC
Confidence 999999999643 4899999999999999999999 7 899999999999999999999999999
Q ss_pred hhhhhhccCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCC------CCchhhhHHHHHHHH
Q 005102 554 LARLANIAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVK------PSQKWDIYSYGVILL 627 (714)
Q Consensus 554 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~------~s~~~DVwS~Gvvl~ 627 (714)
+++....... ..........||+.|+|||.+.+.. ++.++|||||||++|
T Consensus 193 ~~~~~~~~~~------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ 248 (342)
T 1b6c_B 193 LAVRHDSATD------------------------TIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFW 248 (342)
T ss_dssp TCEEEETTTT------------------------EEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHH
T ss_pred Cceecccccc------------------------ccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHH
Confidence 9976542210 0011233456799999999997652 347899999999999
Q ss_pred HHHhC----------CCccccCCCCcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCC
Q 005102 628 EMITG----------RTAVVQVGSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRP 697 (714)
Q Consensus 628 elltG----------~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RP 697 (714)
||+|| +.||............+....... ...+.........+....+.+++.+||+.||++||
T Consensus 249 el~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp 322 (342)
T 1b6c_B 249 EIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQ------KLRPNIPNRWQSCEALRVMAKIMRECWYANGAARL 322 (342)
T ss_dssp HHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTS------CCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSC
T ss_pred HHHhccCcCCcccccccCccccCcCcccHHHHHHHHHHH------HhCCCCcccccchhHHHHHHHHHHHHhccChhhCC
Confidence 99999 778854433333333333222111 11222222222235667899999999999999999
Q ss_pred CHHHHHHHHhhhhccC
Q 005102 698 TMRHISDALDRLIVSS 713 (714)
Q Consensus 698 t~~evl~~L~~i~~~~ 713 (714)
|++||++.|+++....
T Consensus 323 s~~~i~~~L~~i~~~~ 338 (342)
T 1b6c_B 323 TALRIKKTLSQLSQQE 338 (342)
T ss_dssp CHHHHHHHHHHHHHTT
T ss_pred CHHHHHHHHHHHHHHh
Confidence 9999999999987653
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=361.70 Aligned_cols=267 Identities=21% Similarity=0.225 Sum_probs=207.0
Q ss_pred ccccccCceEEEEEEECC-CcEEEEEEeCCCC-chhHHHHHHHHHHHhccCCCCccceEEEEEeCC--ceeEEEeccCCC
Q 005102 409 FVLGKSGIGIVYKVVLED-GHTLAVRRLGEGG-SQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVD--EKLLIYDYIPNG 484 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~~-g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~--~~~lV~e~~~~g 484 (714)
+.||+|+||.||+|++.. |+.||||++.... ....+.+.+|++++++++||||+++++++...+ ..++||||+++|
T Consensus 15 ~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~e~~~~g 94 (396)
T 4eut_A 15 DILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCG 94 (396)
T ss_dssp EEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEECCCTTE
T ss_pred EEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEEecCCCC
Confidence 479999999999999865 8999999997643 233567889999999999999999999998765 679999999999
Q ss_pred CHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeee----CCCCCeEEcccchhhhhhc
Q 005102 485 SLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILL----GHNMEPHVSDFGLARLANI 560 (714)
Q Consensus 485 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl----~~~~~~kl~DFGla~~~~~ 560 (714)
+|.+++...... ..+++..++.|+.|++.||+|||+ .+|+||||||+|||+ +.++.+||+|||+++....
T Consensus 95 ~L~~~l~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~~~ 168 (396)
T 4eut_A 95 SLYTVLEEPSNA---YGLPESEFLIVLRDVVGGMNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELED 168 (396)
T ss_dssp EHHHHTTSGGGT---TCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEEECTTSCEEEEECCGGGCEECCC
T ss_pred CHHHHHHhhhcc---cCCCHHHHHHHHHHHHHHHHHHHH---CCEEECCcCHHHEEEeecCCCceeEEEecCCCceEccC
Confidence 999999765321 338999999999999999999999 899999999999999 7888899999999986532
Q ss_pred cCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCC--------CCCCchhhhHHHHHHHHHHHhC
Q 005102 561 AGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKV--------VKPSQKWDIYSYGVILLEMITG 632 (714)
Q Consensus 561 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~s~~~DVwS~Gvvl~elltG 632 (714)
. .......||+.|+|||++.+ ..++.++|||||||++|||+||
T Consensus 169 ~-----------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg 219 (396)
T 4eut_A 169 D-----------------------------EQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATG 219 (396)
T ss_dssp G-----------------------------GGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHS
T ss_pred C-----------------------------CccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHC
Confidence 1 11223457899999999864 4578899999999999999999
Q ss_pred CCccccCCCCcchhHHHHHHHHhhcCC-c-ccc---------cCCCCCC-CCCcHHHHHHHHHHHhHccCCCCCCCCCHH
Q 005102 633 RTAVVQVGSSEMDLVNWMQLCIEEKKP-L-ADV---------LDPYLAP-DADKEEEIIAVLKIAMACVHSSPEKRPTMR 700 (714)
Q Consensus 633 ~~p~~~~~~~~~~l~~~~~~~~~~~~~-~-~~~---------~d~~~~~-~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ 700 (714)
+.||........ ..+.+......... . ... ....... ..-.......+.+++.+||+.||++|||++
T Consensus 220 ~~Pf~~~~~~~~-~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~ 298 (396)
T 4eut_A 220 SLPFRPFEGPRR-NKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFD 298 (396)
T ss_dssp SCSEECTTCTTT-CHHHHHHHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHH
T ss_pred CCCCCCCCcccc-hHHHHHHHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHH
Confidence 999964333222 22333333332211 0 000 0001111 111245666788999999999999999999
Q ss_pred HHHHHHhhhhc
Q 005102 701 HISDALDRLIV 711 (714)
Q Consensus 701 evl~~L~~i~~ 711 (714)
|+++.+++++.
T Consensus 299 e~l~~l~~il~ 309 (396)
T 4eut_A 299 QFFAETSDILH 309 (396)
T ss_dssp HHHHHHHHHHT
T ss_pred HHHHHHHHHhh
Confidence 99999998864
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=366.96 Aligned_cols=240 Identities=23% Similarity=0.324 Sum_probs=196.6
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeCCCC---chhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCC
Q 005102 409 FVLGKSGIGIVYKVVLE-DGHTLAVRRLGEGG---SQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNG 484 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~g 484 (714)
+.||+|+||.||+|++. +|+.||||++.... ....+.+.+|+++++.++||||+++++++...+..++||||+++|
T Consensus 22 ~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~~gg 101 (476)
T 2y94_A 22 DTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGG 101 (476)
T ss_dssp EEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCSSE
T ss_pred EEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCCCCC
Confidence 47999999999999986 69999999997532 223467899999999999999999999999999999999999999
Q ss_pred CHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCC
Q 005102 485 SLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGS 564 (714)
Q Consensus 485 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 564 (714)
+|.+++... ..+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++......
T Consensus 102 ~L~~~l~~~------~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~-- 170 (476)
T 2y94_A 102 ELFDYICKN------GRLDEKESRRLFQQILSGVDYCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE-- 170 (476)
T ss_dssp EHHHHTTSS------SSCCHHHHHHHHHHHHHHHHHHHT---TTEECSCCSGGGEEECTTCCEEECCCSSCEECCTTC--
T ss_pred cHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCCCcccccHHHEEEecCCCeEEEeccchhhccccc--
Confidence 999999754 458999999999999999999999 899999999999999999999999999997643210
Q ss_pred CCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCC-CchhhhHHHHHHHHHHHhCCCccccCCCCc
Q 005102 565 PTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKP-SQKWDIYSYGVILLEMITGRTAVVQVGSSE 643 (714)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~~DVwS~Gvvl~elltG~~p~~~~~~~~ 643 (714)
......||+.|+|||++.+..+ +.++|||||||++|||++|+.||....
T Consensus 171 ---------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~--- 220 (476)
T 2y94_A 171 ---------------------------FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDH--- 220 (476)
T ss_dssp ---------------------------CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSS---
T ss_pred ---------------------------cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCC---
Confidence 1123457899999999988765 789999999999999999999995322
Q ss_pred chhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 005102 644 MDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISD 704 (714)
Q Consensus 644 ~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 704 (714)
.............. .... ....+.+++.+||+.||++|||++|+++
T Consensus 221 --~~~~~~~i~~~~~~--------~p~~-----~s~~~~~Li~~~L~~dP~~Rpt~~eil~ 266 (476)
T 2y94_A 221 --VPTLFKKICDGIFY--------TPQY-----LNPSVISLLKHMLQVDPMKRATIKDIRE 266 (476)
T ss_dssp --SHHHHHHHHTTCCC--------CCTT-----CCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred --HHHHHHHHhcCCcC--------CCcc-----CCHHHHHHHHHHcCCCchhCcCHHHHHh
Confidence 12222222222111 0111 1125789999999999999999999986
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-41 Score=380.10 Aligned_cols=253 Identities=27% Similarity=0.436 Sum_probs=203.7
Q ss_pred cccccccCceEEEEEEECCCcEEEEEEeCCCCchhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCCCHh
Q 005102 408 AFVLGKSGIGIVYKVVLEDGHTLAVRRLGEGGSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGSLA 487 (714)
Q Consensus 408 ~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL~ 487 (714)
.+.||+|+||.||+|.+.++..||||+++.... ..++|.+|+++|++++||||+++++++.. +..++||||+++|+|.
T Consensus 272 ~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~~~~gsL~ 349 (535)
T 2h8h_A 272 EVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLL 349 (535)
T ss_dssp EEEEEECSSEEEEEEEETTTEEEEEEEECTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTEEHH
T ss_pred heecccCCCeEEEEEEECCCceEEEEEeCCCCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeehhcCCcHH
Confidence 357999999999999998888999999987543 34789999999999999999999999866 6789999999999999
Q ss_pred hhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCCCCc
Q 005102 488 TALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTL 567 (714)
Q Consensus 488 ~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 567 (714)
+++....+ ..+++.+++.|+.||+.||+|||+ ++|+||||||+|||+++++.+||+|||+++......
T Consensus 350 ~~l~~~~~----~~l~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~----- 417 (535)
T 2h8h_A 350 DFLKGETG----KYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE----- 417 (535)
T ss_dssp HHHSHHHH----TTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHH-----
T ss_pred HHHhhcCC----CCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHhhEEEcCCCcEEEcccccceecCCCc-----
Confidence 99964321 348999999999999999999999 899999999999999999999999999998653210
Q ss_pred cCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHh-CCCccccCCCCcchh
Q 005102 568 QSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMIT-GRTAVVQVGSSEMDL 646 (714)
Q Consensus 568 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~ellt-G~~p~~~~~~~~~~l 646 (714)
........++..|+|||++.+..++.++|||||||++|||+| |+.||.... .
T Consensus 418 ----------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~--~--- 470 (535)
T 2h8h_A 418 ----------------------YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV--N--- 470 (535)
T ss_dssp ----------------------HHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCC--H---
T ss_pred ----------------------eecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC--H---
Confidence 111222345678999999998899999999999999999999 999994321 1
Q ss_pred HHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhhhhccC
Q 005102 647 VNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDALDRLIVSS 713 (714)
Q Consensus 647 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~~~ 713 (714)
.+.+... .....+ .... .....+.++|.+||+.||++|||+++|++.|+++..+.
T Consensus 471 ~~~~~~i-~~~~~~------~~~~-----~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~ 525 (535)
T 2h8h_A 471 REVLDQV-ERGYRM------PCPP-----ECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 525 (535)
T ss_dssp HHHHHHH-HTTCCC------CCCT-----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCC
T ss_pred HHHHHHH-HcCCCC------CCCC-----CCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhcc
Confidence 1222221 111110 0111 12236889999999999999999999999999987654
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=344.68 Aligned_cols=257 Identities=23% Similarity=0.337 Sum_probs=201.9
Q ss_pred cccccccCceEEEEEEECC----CcEEEEEEeCCCCc-hhHHHHHHHHHHHhccCCCCccceEEEEEeCCce-eEEEecc
Q 005102 408 AFVLGKSGIGIVYKVVLED----GHTLAVRRLGEGGS-QRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEK-LLIYDYI 481 (714)
Q Consensus 408 ~~~lG~G~~g~Vy~~~~~~----g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~-~lV~e~~ 481 (714)
.++||+|+||+||+|.+.+ +..||+|++..... ...+.+.+|++++++++||||+++++++...+.. ++||||+
T Consensus 26 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~~ 105 (298)
T 3pls_A 26 DRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYM 105 (298)
T ss_dssp EEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEECCC
T ss_pred CceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEEEecc
Confidence 4689999999999998643 23799999986533 4457899999999999999999999999876655 9999999
Q ss_pred CCCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhcc
Q 005102 482 PNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIA 561 (714)
Q Consensus 482 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 561 (714)
.+|+|.+++.... ..+++..+..|+.|++.||+|||+ .+|+||||||+||++++++.+||+|||+++.....
T Consensus 106 ~~~~L~~~~~~~~-----~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 177 (298)
T 3pls_A 106 CHGDLLQFIRSPQ-----RNPTVKDLISFGLQVARGMEYLAE---QKFVHRDLAARNCMLDESFTVKVADFGLARDILDR 177 (298)
T ss_dssp TTCBHHHHHHCTT-----CCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTG
T ss_pred cCCCHHHHHhccc-----cCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEcCCCcEEeCcCCCcccccCC
Confidence 9999999998643 458899999999999999999999 89999999999999999999999999999765322
Q ss_pred CCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCccccCCC
Q 005102 562 GGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGS 641 (714)
Q Consensus 562 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~~~~~~ 641 (714)
... .........+|+.|+|||.+.+..++.++||||||+++|||++|..|+.....
T Consensus 178 ~~~------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~ 233 (298)
T 3pls_A 178 EYY------------------------SVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHID 233 (298)
T ss_dssp GGG------------------------CSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC
T ss_pred ccc------------------------ccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCC
Confidence 100 01122334568889999999999999999999999999999997666533222
Q ss_pred CcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhhhhcc
Q 005102 642 SEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDALDRLIVS 712 (714)
Q Consensus 642 ~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~~ 712 (714)
..++...+ ..... ...... ....+.+++.+||+.||++|||++++++.|+++...
T Consensus 234 -~~~~~~~~----~~~~~------~~~~~~-----~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~ 288 (298)
T 3pls_A 234 -PFDLTHFL----AQGRR------LPQPEY-----CPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSA 288 (298)
T ss_dssp -GGGHHHHH----HTTCC------CCCCTT-----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -HHHHHHHh----hcCCC------CCCCcc-----chHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 22222211 11111 001111 123688999999999999999999999999998654
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-41 Score=356.17 Aligned_cols=260 Identities=25% Similarity=0.383 Sum_probs=203.6
Q ss_pred ccccccCceEEEEEEE-----CCCcEEEEEEeCCCCchhHHHHHHHHHHHhccCCCCccceEEEEEe--CCceeEEEecc
Q 005102 409 FVLGKSGIGIVYKVVL-----EDGHTLAVRRLGEGGSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWS--VDEKLLIYDYI 481 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~-----~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~--~~~~~lV~e~~ 481 (714)
+.||+|+||.||+|++ .+++.||||++........+.+.+|++++++++||||+++++++.. .+..++||||+
T Consensus 29 ~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~ 108 (327)
T 3lxl_A 29 SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYL 108 (327)
T ss_dssp EEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEEEEEECC
T ss_pred hhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEEEEEeec
Confidence 4799999999999985 3588999999988776667789999999999999999999999874 45688999999
Q ss_pred CCCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhcc
Q 005102 482 PNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIA 561 (714)
Q Consensus 482 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 561 (714)
++|+|.+++.... ..+++..+..|+.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++.....
T Consensus 109 ~~~~L~~~l~~~~-----~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~ 180 (327)
T 3lxl_A 109 PSGCLRDFLQRHR-----ARLDASRLLLYSSQICKGMEYLGS---RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLD 180 (327)
T ss_dssp TTCBHHHHHHHHG-----GGCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCGGGCEECCTT
T ss_pred CCCCHHHHHHhcc-----cCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCChhhEEECCCCCEEEcccccceecccC
Confidence 9999999997542 358999999999999999999999 89999999999999999999999999999865322
Q ss_pred CCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCccccCCC
Q 005102 562 GGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGS 641 (714)
Q Consensus 562 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~~~~~~ 641 (714)
.. .........||..|+|||.+.+..++.++||||||+++|||++|+.||.....
T Consensus 181 ~~-------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~ 235 (327)
T 3lxl_A 181 KD-------------------------YYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSA 235 (327)
T ss_dssp CS-------------------------EEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHH
T ss_pred Cc-------------------------cceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccc
Confidence 11 01122334578889999999888899999999999999999999999843211
Q ss_pred Cc---------chhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhhhhcc
Q 005102 642 SE---------MDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDALDRLIVS 712 (714)
Q Consensus 642 ~~---------~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~~ 712 (714)
.. ......+........ ...... .....+.+++.+||+.||++|||++|+++.|+++...
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~-----~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~ 304 (327)
T 3lxl_A 236 EFLRMMGCERDVPALSRLLELLEEGQ------RLPAPP-----ACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSG 304 (327)
T ss_dssp HHHHHCC----CCHHHHHHHHHHTTC------CCCCCT-----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC---
T ss_pred hhhhhcccccccccHHHHHHHhhccc------CCCCCC-----cccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhh
Confidence 00 000011111111111 011111 1223688999999999999999999999999988643
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-41 Score=355.95 Aligned_cols=265 Identities=15% Similarity=0.191 Sum_probs=196.5
Q ss_pred ccccccCceEEEEEEEC----CCcEEEEEEeCCCCch-----------hHHHHHHHHHHHhccCCCCccceEEEEEe---
Q 005102 409 FVLGKSGIGIVYKVVLE----DGHTLAVRRLGEGGSQ-----------RFKEFQTEVEAIGKIRHSNIVTLRAYYWS--- 470 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~----~g~~vavK~~~~~~~~-----------~~~~~~~E~~~l~~l~H~niv~l~~~~~~--- 470 (714)
+.||+|+||.||+|.+. ++..||||++...... ....+.+|+..++.++||||+++++++..
T Consensus 43 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~~~~~~~ 122 (345)
T 2v62_A 43 KKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGSGLTEFK 122 (345)
T ss_dssp EEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEEEEEESS
T ss_pred eeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecccccccC
Confidence 47999999999999986 5789999998765322 11346788999999999999999999988
Q ss_pred -CCceeEEEeccCCCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCC--Ce
Q 005102 471 -VDEKLLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNM--EP 547 (714)
Q Consensus 471 -~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~--~~ 547 (714)
....++||||+ +++|.+++... ..+++.++++|+.||+.||+|||+ .+|+||||||+|||++.++ .+
T Consensus 123 ~~~~~~lv~e~~-~~~L~~~l~~~------~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~~~ 192 (345)
T 2v62_A 123 GRSYRFMVMERL-GIDLQKISGQN------GTFKKSTVLQLGIRMLDVLEYIHE---NEYVHGDIKAANLLLGYKNPDQV 192 (345)
T ss_dssp SCEEEEEEEECE-EEEHHHHCBGG------GBCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEESSSTTSE
T ss_pred CCcEEEEEEecc-CCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCcCHHHEEEccCCCCcE
Confidence 67889999999 99999999755 368999999999999999999999 8999999999999998877 99
Q ss_pred EEcccchhhhhhccCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHH
Q 005102 548 HVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILL 627 (714)
Q Consensus 548 kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~ 627 (714)
||+|||+++.+......... .........||+.|+|||++.+..++.++|||||||++|
T Consensus 193 kL~Dfg~a~~~~~~~~~~~~---------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ 251 (345)
T 2v62_A 193 YLADYGLSYRYCPNGNHKQY---------------------QENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCML 251 (345)
T ss_dssp EECCCTTCEESSGGGCCCCC---------------------CCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHH
T ss_pred EEEeCCCceecccccccccc---------------------hhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHH
Confidence 99999999876432211000 011123456789999999999989999999999999999
Q ss_pred HHHhCCCccccCCCCcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHh
Q 005102 628 EMITGRTAVVQVGSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDALD 707 (714)
Q Consensus 628 elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~ 707 (714)
||+||+.||.................... +........... ....++.+++.+||+.||++|||+++|++.|+
T Consensus 252 ell~g~~pf~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~----~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~ 324 (345)
T 2v62_A 252 RWLCGKLPWEQNLKDPVAVQTAKTNLLDE---LPQSVLKWAPSG----SSCCEIAQFLVCAHSLAYDEKPNYQALKKILN 324 (345)
T ss_dssp HHHHSSCTTGGGTTCHHHHHHHHHHHHHT---TTHHHHHHSCTT----SCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHC
T ss_pred HHHhCCCCccccccccHHHHHHHHhhccc---ccHHHHhhcccc----ccHHHHHHHHHHHhhcCcccCCCHHHHHHHHh
Confidence 99999999954333222222222111111 111111100000 11236889999999999999999999999999
Q ss_pred hhhc
Q 005102 708 RLIV 711 (714)
Q Consensus 708 ~i~~ 711 (714)
++..
T Consensus 325 ~~~~ 328 (345)
T 2v62_A 325 PHGI 328 (345)
T ss_dssp TTCC
T ss_pred ccCC
Confidence 8653
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=356.51 Aligned_cols=257 Identities=22% Similarity=0.343 Sum_probs=200.5
Q ss_pred ccccccCceEEEEEEEC-----CCcEEEEEEeCCCC-chhHHHHHHHHHHHhccCCCCccceEEEEEeC--CceeEEEec
Q 005102 409 FVLGKSGIGIVYKVVLE-----DGHTLAVRRLGEGG-SQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSV--DEKLLIYDY 480 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~-----~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~~lV~e~ 480 (714)
+.||+|+||+||++.+. +++.||||++.... ....+.+.+|++++++++||||+++++++... ...++||||
T Consensus 37 ~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~ 116 (318)
T 3lxp_A 37 RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEY 116 (318)
T ss_dssp EEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEEEECC
T ss_pred heecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEEEEec
Confidence 47999999999998753 58899999998753 33456799999999999999999999999874 567899999
Q ss_pred cCCCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhc
Q 005102 481 IPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANI 560 (714)
Q Consensus 481 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 560 (714)
+++|+|.+++... .+++..+..|+.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++....
T Consensus 117 ~~~~~L~~~l~~~-------~~~~~~~~~i~~~l~~~l~~LH~---~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 186 (318)
T 3lxp_A 117 VPLGSLRDYLPRH-------SIGLAQLLLFAQQICEGMAYLHA---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE 186 (318)
T ss_dssp CTTCBHHHHGGGS-------CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCGGGCEECCT
T ss_pred ccCCcHHHHHhhC-------CCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCchheEEEcCCCCEEECCccccccccc
Confidence 9999999999654 38999999999999999999999 8999999999999999999999999999986542
Q ss_pred cCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCccccCC
Q 005102 561 AGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVG 640 (714)
Q Consensus 561 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~~~~~ 640 (714)
... .........+|..|+|||.+.+..++.++||||||+++|||+||+.||....
T Consensus 187 ~~~-------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~ 241 (318)
T 3lxp_A 187 GHE-------------------------YYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPP 241 (318)
T ss_dssp TCS-------------------------EEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHH
T ss_pred ccc-------------------------ccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccc
Confidence 210 0112233456888999999998889999999999999999999999984321
Q ss_pred CCcch---------hHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhhhhc
Q 005102 641 SSEMD---------LVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDALDRLIV 711 (714)
Q Consensus 641 ~~~~~---------l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~ 711 (714)
..... -...+........ ...... .....+.+++.+||+.||++|||++|+++.|+++..
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~-----~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~ 310 (318)
T 3lxp_A 242 TKFLELIGIAQGQMTVLRLTELLERGE------RLPRPD-----KCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHE 310 (318)
T ss_dssp HHHHHHHCSCCHHHHHHHHHHHHHTTC------CCCCCT-----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hhhhhhhcccccchhHHHHHHHHhccc------CCCCCc-----cccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHH
Confidence 11000 0000111111111 011111 122368899999999999999999999999999864
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-41 Score=357.25 Aligned_cols=263 Identities=16% Similarity=0.208 Sum_probs=203.6
Q ss_pred ccccccCceEEEEEEECC---------CcEEEEEEeCCCCchhHHHHHHHHHHHhccCCCCccc---------------e
Q 005102 409 FVLGKSGIGIVYKVVLED---------GHTLAVRRLGEGGSQRFKEFQTEVEAIGKIRHSNIVT---------------L 464 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~~---------g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~---------------l 464 (714)
+.||+|+||.||+|+... ++.||||++... +.+.+|++++++++||||++ +
T Consensus 48 ~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~i~~~ 122 (352)
T 2jii_A 48 SFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAIPTC 122 (352)
T ss_dssp EEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCTTCSCCCC
T ss_pred EEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCCccCccch
Confidence 479999999999999864 789999998754 35789999999999999988 6
Q ss_pred EEEEEe-CCceeEEEeccCCCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCC
Q 005102 465 RAYYWS-VDEKLLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGH 543 (714)
Q Consensus 465 ~~~~~~-~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~ 543 (714)
++++.. .+..++||||+ +++|.+++..... ..+++.++..|+.||+.||+|||+ .+|+||||||+|||++.
T Consensus 123 ~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~----~~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dikp~NIl~~~ 194 (352)
T 2jii_A 123 MGFGVHQDKYRFLVLPSL-GRSLQSALDVSPK----HVLSERSVLQVACRLLDALEFLHE---NEYVHGNVTAENIFVDP 194 (352)
T ss_dssp CEEEEETTTEEEEEEECC-CEEHHHHHHHSGG----GCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCCGGGEEEET
T ss_pred hhccccCCcEEEEEecCC-CcCHHHHHHhCCc----CCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCCHHHEEEcC
Confidence 788876 67789999999 9999999986521 459999999999999999999999 89999999999999999
Q ss_pred CC--CeEEcccchhhhhhccCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHH
Q 005102 544 NM--EPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYS 621 (714)
Q Consensus 544 ~~--~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS 621 (714)
++ .+||+|||+++........... .........||+.|+|||++.+..++.++||||
T Consensus 195 ~~~~~~kl~Dfg~a~~~~~~~~~~~~---------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s 253 (352)
T 2jii_A 195 EDQSQVTLAGYGFAFRYCPSGKHVAY---------------------VEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQS 253 (352)
T ss_dssp TEEEEEEECCGGGCBCSSGGGCCCCC---------------------CTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHH
T ss_pred CCCceEEEecCcceeeccCCCccccc---------------------cccccccccCCccccCHHHHccCCCCchhhHHH
Confidence 98 8999999999876432211000 011223346789999999999999999999999
Q ss_pred HHHHHHHHHhCCCccccCCCCcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHH
Q 005102 622 YGVILLEMITGRTAVVQVGSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRH 701 (714)
Q Consensus 622 ~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~e 701 (714)
|||++|||++|+.||.........+........... ....+...... .....+.+++.+||+.||++|||+++
T Consensus 254 lG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~----~~~~~l~~li~~~l~~dp~~Rps~~~ 326 (352)
T 2jii_A 254 LGYCMLKWLYGFLPWTNCLPNTEDIMKQKQKFVDKP---GPFVGPCGHWI----RPSETLQKYLKVVMALTYEEKPPYAM 326 (352)
T ss_dssp HHHHHHHHHHSCCTTGGGTTCHHHHHHHHHHHHHSC---CCEECTTSCEE----CCCHHHHHHHHHHHTCCTTCCCCHHH
T ss_pred HHHHHHHHHhCCCCcccCCcCHHHHHHHHHhccCCh---hhhhhhccccC----CCcHHHHHHHHHHHhCChhhCCCHHH
Confidence 999999999999999654433333333332222221 12222111100 01236889999999999999999999
Q ss_pred HHHHHhhhhcc
Q 005102 702 ISDALDRLIVS 712 (714)
Q Consensus 702 vl~~L~~i~~~ 712 (714)
+++.|+++...
T Consensus 327 l~~~L~~~~~~ 337 (352)
T 2jii_A 327 LRNNLEALLQD 337 (352)
T ss_dssp HHHHHHHHHHH
T ss_pred HHHHHHHHHHh
Confidence 99999998754
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-40 Score=344.16 Aligned_cols=256 Identities=25% Similarity=0.372 Sum_probs=197.7
Q ss_pred cccccccCceEEEEEEECC----CcEEEEEEeCCCC-chhHHHHHHHHHHHhccCCCCccceEEEEEe-CCceeEEEecc
Q 005102 408 AFVLGKSGIGIVYKVVLED----GHTLAVRRLGEGG-SQRFKEFQTEVEAIGKIRHSNIVTLRAYYWS-VDEKLLIYDYI 481 (714)
Q Consensus 408 ~~~lG~G~~g~Vy~~~~~~----g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~-~~~~~lV~e~~ 481 (714)
.+.||+|+||.||+|++.+ ...||+|.+.... ....+.+.+|+.++++++||||+++++++.. .+..++||||+
T Consensus 30 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~~ 109 (298)
T 3f66_A 30 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 109 (298)
T ss_dssp EEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEEECC
T ss_pred cceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEEEEeCC
Confidence 3589999999999999653 2368999988643 3445779999999999999999999999754 55789999999
Q ss_pred CCCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhcc
Q 005102 482 PNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIA 561 (714)
Q Consensus 482 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 561 (714)
++|+|.+++.... ..+++..+..|+.|++.||+|||+ ++|+||||||+||++++++.+||+|||+++.....
T Consensus 110 ~~~~L~~~l~~~~-----~~~~~~~~~~i~~ql~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~ 181 (298)
T 3f66_A 110 KHGDLRNFIRNET-----HNPTVKDLIGFGLQVAKGMKYLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 181 (298)
T ss_dssp TTCBHHHHHHCTT-----CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSCG
T ss_pred CCCCHHHHHHhcc-----cCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCchheEEECCCCCEEECccccccccccc
Confidence 9999999997643 458899999999999999999999 89999999999999999999999999999865322
Q ss_pred CCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCC-CccccCC
Q 005102 562 GGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGR-TAVVQVG 640 (714)
Q Consensus 562 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~-~p~~~~~ 640 (714)
... .........+|+.|+|||.+.+..++.++||||||+++|||++|. +||....
T Consensus 182 ~~~------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~ 237 (298)
T 3f66_A 182 EYY------------------------SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN 237 (298)
T ss_dssp GGC------------------------BC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSC
T ss_pred chh------------------------ccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCC
Confidence 100 011223345678899999999889999999999999999999955 4553222
Q ss_pred CCcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhhhhcc
Q 005102 641 SSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDALDRLIVS 712 (714)
Q Consensus 641 ~~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~~ 712 (714)
. .+... ........ ..+ .. ....+.+++.+||+.||++|||++|+++.|+++...
T Consensus 238 ~--~~~~~---~~~~~~~~----~~~---~~-----~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~ 292 (298)
T 3f66_A 238 T--FDITV---YLLQGRRL----LQP---EY-----CPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 292 (298)
T ss_dssp T--TTHHH---HHHTTCCC----CCC---TT-----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred H--HHHHH---HHhcCCCC----CCC---cc-----CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 1 11111 11111110 011 11 123688999999999999999999999999998764
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-41 Score=351.16 Aligned_cols=239 Identities=23% Similarity=0.242 Sum_probs=187.2
Q ss_pred cccccccCceEEEEEEEC-CCcEEEEEEeCCCC--chhHHHHHHHHHHHhcc-CCCCccceEEEEEeCCceeEEEeccCC
Q 005102 408 AFVLGKSGIGIVYKVVLE-DGHTLAVRRLGEGG--SQRFKEFQTEVEAIGKI-RHSNIVTLRAYYWSVDEKLLIYDYIPN 483 (714)
Q Consensus 408 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~e~~~~ 483 (714)
.+.||+|+||+||+|++. +|+.||||++.... ......+..|+..+.++ +||||++++++|.+.+..++||||+ +
T Consensus 62 ~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~e~~-~ 140 (311)
T 3p1a_A 62 LSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELC-G 140 (311)
T ss_dssp EEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC-C
T ss_pred eheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEEecc-C
Confidence 357999999999999987 69999999987643 23334566677766666 8999999999999999999999999 6
Q ss_pred CCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCC
Q 005102 484 GSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGG 563 (714)
Q Consensus 484 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 563 (714)
++|.+++.... ..++|..+..|+.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++.....
T Consensus 141 ~~L~~~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~-- 210 (311)
T 3p1a_A 141 PSLQQHCEAWG-----ASLPEAQVWGYLRDTLLALAHLHS---QGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTA-- 210 (311)
T ss_dssp CBHHHHHHHHC-----SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECGGGCEEECCCTTCEECC----
T ss_pred CCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEECCCCCEEEccceeeeecccC--
Confidence 79999887653 459999999999999999999999 89999999999999999999999999998754321
Q ss_pred CCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCccccCCCCc
Q 005102 564 SPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGSSE 643 (714)
Q Consensus 564 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~~~~~~~~ 643 (714)
.......||+.|+|||++.+ .++.++|||||||++|||++|..|+...
T Consensus 211 ---------------------------~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~---- 258 (311)
T 3p1a_A 211 ---------------------------GAGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGG---- 258 (311)
T ss_dssp -------------------------------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSH----
T ss_pred ---------------------------CCCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCc----
Confidence 11223457999999999876 7999999999999999999998776321
Q ss_pred chhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 005102 644 MDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISD 704 (714)
Q Consensus 644 ~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 704 (714)
.. + .. +.... ......+ .....+.+++.+||+.||++|||++|+++
T Consensus 259 ~~---~-~~-~~~~~-~~~~~~~---------~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 304 (311)
T 3p1a_A 259 EG---W-QQ-LRQGY-LPPEFTA---------GLSSELRSVLVMMLEPDPKLRATAEALLA 304 (311)
T ss_dssp HH---H-HH-HTTTC-CCHHHHT---------TSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred cH---H-HH-HhccC-CCccccc---------CCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 11 1 11 11111 0000000 11236889999999999999999999975
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-40 Score=340.42 Aligned_cols=244 Identities=20% Similarity=0.236 Sum_probs=196.8
Q ss_pred cccccccCceEEEEEEECC-CcEEEEEEeCCCCchhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCCCH
Q 005102 408 AFVLGKSGIGIVYKVVLED-GHTLAVRRLGEGGSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGSL 486 (714)
Q Consensus 408 ~~~lG~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL 486 (714)
.+.||+|+||.||+|.... +..||+|++........+.+.+|++++++++||||+++++++...+..++||||+++++|
T Consensus 14 ~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 93 (277)
T 3f3z_A 14 ENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGEL 93 (277)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCCSCBH
T ss_pred eeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEeccCCCcH
Confidence 3579999999999999865 779999999876555668899999999999999999999999999999999999999999
Q ss_pred hhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeee---CCCCCeEEcccchhhhhhccCC
Q 005102 487 ATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILL---GHNMEPHVSDFGLARLANIAGG 563 (714)
Q Consensus 487 ~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl---~~~~~~kl~DFGla~~~~~~~~ 563 (714)
.+++... ..+++..+.+|+.|++.||+|||+ ++|+||||||+||++ +.++.+||+|||+++......
T Consensus 94 ~~~~~~~------~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~- 163 (277)
T 3f3z_A 94 FERVVHK------RVFRESDAARIMKDVLSAVAYCHK---LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK- 163 (277)
T ss_dssp HHHHHHH------CSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTS-
T ss_pred HHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCcc-
Confidence 9988754 458999999999999999999999 899999999999999 788999999999987543211
Q ss_pred CCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCccccCCCCc
Q 005102 564 SPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGSSE 643 (714)
Q Consensus 564 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~~~~~~~~ 643 (714)
......||+.|+|||.+.+ .++.++||||||+++|||++|+.||.... .
T Consensus 164 ----------------------------~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~--~ 212 (277)
T 3f3z_A 164 ----------------------------MMRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPT--D 212 (277)
T ss_dssp ----------------------------CBCCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSCCSS--H
T ss_pred ----------------------------chhccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCCCCC--H
Confidence 1123357889999999865 48999999999999999999999994322 1
Q ss_pred chhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 005102 644 MDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISD 704 (714)
Q Consensus 644 ~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 704 (714)
.+.................. .....+.+++.+||+.||++|||+.|+++
T Consensus 213 ---~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~li~~~l~~dp~~R~s~~~~l~ 261 (277)
T 3f3z_A 213 ---SEVMLKIREGTFTFPEKDWL---------NVSPQAESLIRRLLTKSPKQRITSLQALE 261 (277)
T ss_dssp ---HHHHHHHHHCCCCCCHHHHT---------TSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred ---HHHHHHHHhCCCCCCchhhh---------cCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 11222222221111100000 11236889999999999999999999975
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-40 Score=346.74 Aligned_cols=245 Identities=23% Similarity=0.258 Sum_probs=197.4
Q ss_pred cccccccCceEEEEEEEC-CCcEEEEEEeCCCCc------hhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEec
Q 005102 408 AFVLGKSGIGIVYKVVLE-DGHTLAVRRLGEGGS------QRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDY 480 (714)
Q Consensus 408 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~ 480 (714)
.+.||+|+||.||+|+.. +|+.||||++..... ...+.+.+|++++++++||||+++++++...+..++||||
T Consensus 17 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 96 (321)
T 2a2a_A 17 GEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVLILEL 96 (321)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred eeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEEEc
Confidence 458999999999999986 589999999876422 1357899999999999999999999999999999999999
Q ss_pred cCCCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCC----CeEEcccchhh
Q 005102 481 IPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNM----EPHVSDFGLAR 556 (714)
Q Consensus 481 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~----~~kl~DFGla~ 556 (714)
+++++|.+++... ..+++..+..++.|++.||+|||+ .+|+||||||+||++++++ .+||+|||+++
T Consensus 97 ~~~~~L~~~l~~~------~~~~~~~~~~i~~qi~~aL~~lH~---~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~ 167 (321)
T 2a2a_A 97 VSGGELFDFLAQK------ESLSEEEATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH 167 (321)
T ss_dssp CCSCBHHHHHHTC------SCEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCTTSSSCCEEECCCTTCE
T ss_pred CCCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCChHHEEEecCCCCcCCEEEccCccce
Confidence 9999999999765 458999999999999999999999 8999999999999999887 79999999997
Q ss_pred hhhccCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCcc
Q 005102 557 LANIAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAV 636 (714)
Q Consensus 557 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~ 636 (714)
...... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||
T Consensus 168 ~~~~~~-----------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf 218 (321)
T 2a2a_A 168 EIEDGV-----------------------------EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 218 (321)
T ss_dssp ECCTTC-----------------------------CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSS
T ss_pred ecCccc-----------------------------cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCC
Confidence 643211 112335788999999999999999999999999999999999999
Q ss_pred ccCCCCcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 005102 637 VQVGSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISD 704 (714)
Q Consensus 637 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 704 (714)
.... . .+................ .. .....+.+++.+||+.||++|||++|+++
T Consensus 219 ~~~~--~---~~~~~~i~~~~~~~~~~~----~~-----~~~~~~~~li~~~l~~dp~~Rps~~e~l~ 272 (321)
T 2a2a_A 219 LGDT--K---QETLANITSVSYDFDEEF----FS-----HTSELAKDFIRKLLVKETRKRLTIQEALR 272 (321)
T ss_dssp CCSS--H---HHHHHHHHTTCCCCCHHH----HT-----TCCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred CCCC--H---HHHHHHHHhcccccChhh----hc-----ccCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 4321 1 122222222111111000 00 11235789999999999999999999986
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=348.82 Aligned_cols=257 Identities=21% Similarity=0.265 Sum_probs=193.4
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeCCCCchhHHHHHHHHHHHhcc-CCCCccceEEEEEeCCceeEEEeccCCCCH
Q 005102 409 FVLGKSGIGIVYKVVLE-DGHTLAVRRLGEGGSQRFKEFQTEVEAIGKI-RHSNIVTLRAYYWSVDEKLLIYDYIPNGSL 486 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~e~~~~gsL 486 (714)
++||+|+||.||+|... +++.||||++........+.+.+|++++.++ +||||+++++++...+..++||||+++|+|
T Consensus 19 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 98 (316)
T 2ac3_A 19 DVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSI 98 (316)
T ss_dssp CCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTCBH
T ss_pred ceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEEcCCCCcH
Confidence 47999999999999965 5899999999876655667899999999985 799999999999999999999999999999
Q ss_pred hhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCC---eEEcccchhhhhhccCC
Q 005102 487 ATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNME---PHVSDFGLARLANIAGG 563 (714)
Q Consensus 487 ~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~---~kl~DFGla~~~~~~~~ 563 (714)
.+++... ..+++..+..++.|++.||+|||+ .+|+||||||+|||++.++. +||+|||+++.......
T Consensus 99 ~~~l~~~------~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~ 169 (316)
T 2ac3_A 99 LSHIHKR------RHFNELEASVVVQDVASALDFLHN---KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGD 169 (316)
T ss_dssp HHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-------
T ss_pred HHHHhcc------CCCCHHHHHHHHHHHHHHHHHHHh---CCceeCCCCHHHEEEccCCCcCceEEEEccCccccccCCc
Confidence 9999764 458999999999999999999999 89999999999999998776 99999999876542211
Q ss_pred CCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCC-----CCCCchhhhHHHHHHHHHHHhCCCcccc
Q 005102 564 SPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKV-----VKPSQKWDIYSYGVILLEMITGRTAVVQ 638 (714)
Q Consensus 564 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~~~DVwS~Gvvl~elltG~~p~~~ 638 (714)
... ..........||+.|+|||++.+ ..++.++|||||||++|||++|+.||..
T Consensus 170 ~~~---------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~ 228 (316)
T 2ac3_A 170 CSP---------------------ISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVG 228 (316)
T ss_dssp ---------------------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCC
T ss_pred ccc---------------------ccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcc
Confidence 000 00111223457999999999864 4578999999999999999999999954
Q ss_pred CCCCcch----------hHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 005102 639 VGSSEMD----------LVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISD 704 (714)
Q Consensus 639 ~~~~~~~----------l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 704 (714)
....+.. .................... ......+.+++.+||+.||++|||++|+++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~---------~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 295 (316)
T 2ac3_A 229 RCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDW---------AHISCAAKDLISKLLVRDAKQRLSAAQVLQ 295 (316)
T ss_dssp CCCSCSCC----CCHHHHHHHHHHHHHCCCCCCHHHH---------TTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred cccccccccccccchhHHHHHHHHHhccCcccCchhc---------ccCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence 3322110 01111111111111100000 011236889999999999999999999986
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=341.33 Aligned_cols=239 Identities=24% Similarity=0.348 Sum_probs=192.9
Q ss_pred ccccccCceEEEEEEECC-CcEEEEEEeCCCC---chhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCC
Q 005102 409 FVLGKSGIGIVYKVVLED-GHTLAVRRLGEGG---SQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNG 484 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~~-g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~g 484 (714)
+.||+|+||.||+|.+.. +..||||++.... ......+.+|++++++++||||+++++++.+.+..++||||+++|
T Consensus 15 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 94 (279)
T 3fdn_A 15 RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLG 94 (279)
T ss_dssp EEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCTTE
T ss_pred eEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEEEecCCCC
Confidence 479999999999999765 7799999986532 122467899999999999999999999999999999999999999
Q ss_pred CHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCC
Q 005102 485 SLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGS 564 (714)
Q Consensus 485 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 564 (714)
+|.+++... ..+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||++......
T Consensus 95 ~l~~~l~~~------~~~~~~~~~~~~~qi~~~l~~LH~---~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~--- 162 (279)
T 3fdn_A 95 TVYRELQKL------SKFDEQRTATYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS--- 162 (279)
T ss_dssp EHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHT---TTCEECCCCGGGEEECTTSCEEECSCCEESCC------
T ss_pred cHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHh---CCEecccCChHhEEEcCCCCEEEEeccccccCCcc---
Confidence 999998754 458999999999999999999999 89999999999999999999999999988643211
Q ss_pred CCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCccccCCCCcc
Q 005102 565 PTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGSSEM 644 (714)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~~~~~~~~~ 644 (714)
......||+.|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 163 ---------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~----- 210 (279)
T 3fdn_A 163 ---------------------------RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN----- 210 (279)
T ss_dssp --------------------------------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCS-----
T ss_pred ---------------------------cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCC-----
Confidence 112335688999999999999999999999999999999999999432
Q ss_pred hhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 005102 645 DLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISD 704 (714)
Q Consensus 645 ~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 704 (714)
............... .... ....+.+++.+||+.||++|||++|+++
T Consensus 211 ~~~~~~~~~~~~~~~--------~~~~-----~~~~~~~li~~~l~~~p~~Rps~~e~l~ 257 (279)
T 3fdn_A 211 TYQETYKRISRVEFT--------FPDF-----VTEGARDLISRLLKHNPSQRPMLREVLE 257 (279)
T ss_dssp SHHHHHHHHHHTCCC--------CCTT-----SCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred cHHHHHHHHHhCCCC--------CCCc-----CCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 112222222221111 1111 1225789999999999999999999986
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=358.49 Aligned_cols=245 Identities=21% Similarity=0.298 Sum_probs=186.4
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeCCCCchhHHHHHHHHHHHhcc-CCCCccceEEEEEe----CCceeEEEeccC
Q 005102 409 FVLGKSGIGIVYKVVLE-DGHTLAVRRLGEGGSQRFKEFQTEVEAIGKI-RHSNIVTLRAYYWS----VDEKLLIYDYIP 482 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~----~~~~~lV~e~~~ 482 (714)
++||+|+||+||+|.+. +|+.||||++... ..+.+|++++.++ +||||+++++++.. .+..|+||||++
T Consensus 68 ~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv~E~~~ 142 (400)
T 1nxk_A 68 QVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLD 142 (400)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCC
T ss_pred ceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEEEEeCC
Confidence 47999999999999986 4899999998642 4577899887554 89999999999875 557899999999
Q ss_pred CCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCC---CCCeEEcccchhhhhh
Q 005102 483 NGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGH---NMEPHVSDFGLARLAN 559 (714)
Q Consensus 483 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~---~~~~kl~DFGla~~~~ 559 (714)
+|+|.+++..... ..+++..+..|+.||+.||+|||+ .+|+||||||+|||++. ++.+||+|||+++...
T Consensus 143 gg~L~~~l~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~ 215 (400)
T 1nxk_A 143 GGELFSRIQDRGD----QAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT 215 (400)
T ss_dssp SEEHHHHHHCC-------CCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred CCcHHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCcCcceEEEecCCCCccEEEEecccccccC
Confidence 9999999986532 358999999999999999999999 89999999999999997 7899999999997543
Q ss_pred ccCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCccccC
Q 005102 560 IAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQV 639 (714)
Q Consensus 560 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~~~~ 639 (714)
.. .......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 216 ~~-----------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~ 266 (400)
T 1nxk_A 216 SH-----------------------------NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSN 266 (400)
T ss_dssp ----------------------------------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCC
T ss_pred CC-----------------------------CccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCC
Confidence 11 1122345789999999999999999999999999999999999999543
Q ss_pred CCCcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 005102 640 GSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISD 704 (714)
Q Consensus 640 ~~~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 704 (714)
....... ............. ..+.. .....++.+++.+||+.||++|||++|+++
T Consensus 267 ~~~~~~~-~~~~~i~~~~~~~---~~~~~------~~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 321 (400)
T 1nxk_A 267 HGLAISP-GMKTRIRMGQYEF---PNPEW------SEVSEEVKMLIRNLLKTEPTQRMTITEFMN 321 (400)
T ss_dssp TTCSSCC-SHHHHHHHTCCCC---CTTTT------TTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ccccccH-HHHHHHHcCcccC---CCccc------ccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 3221110 0111111111111 01100 112236889999999999999999999986
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=381.70 Aligned_cols=251 Identities=21% Similarity=0.289 Sum_probs=198.3
Q ss_pred ccccccCceEEEEEEEC---CCcEEEEEEeCCCC--chhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCC
Q 005102 409 FVLGKSGIGIVYKVVLE---DGHTLAVRRLGEGG--SQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPN 483 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~---~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~ 483 (714)
+.||+|+||.||+|.+. +++.||||+++... ....++|.+|+++|++++|||||++++++. .+..++||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-~~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-AESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEE-SSSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCCEEEEEEccCC
Confidence 47999999999999763 36789999998643 334578999999999999999999999996 4568999999999
Q ss_pred CCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCC
Q 005102 484 GSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGG 563 (714)
Q Consensus 484 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 563 (714)
|+|.+++... ..+++..+..|+.||+.||+|||+ ++|+||||||+|||+++++.+||+|||+++.......
T Consensus 454 g~L~~~l~~~------~~l~~~~~~~i~~qi~~~L~yLH~---~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~ 524 (635)
T 4fl3_A 454 GPLNKYLQQN------RHVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN 524 (635)
T ss_dssp EEHHHHHHHC------TTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC---
T ss_pred CCHHHHHhhC------CCCCHHHHHHHHHHHHHHHHHHHH---CCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcc
Confidence 9999999755 458999999999999999999999 8999999999999999999999999999987643211
Q ss_pred CCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHh-CCCccccCCCC
Q 005102 564 SPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMIT-GRTAVVQVGSS 642 (714)
Q Consensus 564 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~ellt-G~~p~~~~~~~ 642 (714)
. ........+|+.|+|||++.+..++.++|||||||++|||+| |+.||.....
T Consensus 525 ~-------------------------~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~- 578 (635)
T 4fl3_A 525 Y-------------------------YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG- 578 (635)
T ss_dssp -----------------------------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH-
T ss_pred c-------------------------cccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH-
Confidence 0 111122345778999999999899999999999999999999 9999943221
Q ss_pred cchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhhhhc
Q 005102 643 EMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDALDRLIV 711 (714)
Q Consensus 643 ~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~ 711 (714)
. +.... +..... ...... ...++.+++.+||+.||++|||+++|++.|+++..
T Consensus 579 -~---~~~~~-i~~~~~------~~~p~~-----~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~ 631 (635)
T 4fl3_A 579 -S---EVTAM-LEKGER------MGCPAG-----CPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY 631 (635)
T ss_dssp -H---HHHHH-HHTTCC------CCCCTT-----CCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred -H---HHHHH-HHcCCC------CCCCCC-----CCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 1 11211 112111 111111 22368899999999999999999999999998753
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=367.75 Aligned_cols=243 Identities=22% Similarity=0.254 Sum_probs=188.0
Q ss_pred cccccccCceEEEEEEEC-CCcEEEEEEeCCC---CchhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCC
Q 005102 408 AFVLGKSGIGIVYKVVLE-DGHTLAVRRLGEG---GSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPN 483 (714)
Q Consensus 408 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~ 483 (714)
.+.||+|+||.||+|... +|+.||||++... .......+.+|++++++++||||+++++++...+..++||||+++
T Consensus 153 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~ 232 (446)
T 4ejn_A 153 LKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANG 232 (446)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEEECCCSS
T ss_pred eEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEEEeeCCC
Confidence 358999999999999975 5899999999753 233345678999999999999999999999999999999999999
Q ss_pred CCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCC
Q 005102 484 GSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGG 563 (714)
Q Consensus 484 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 563 (714)
|+|.+++... ..+++..+..++.||+.||+|||+. .+|+||||||+|||++.++.+||+|||+|+.....
T Consensus 233 ~~L~~~l~~~------~~~~~~~~~~~~~qi~~aL~~LH~~--~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~-- 302 (446)
T 4ejn_A 233 GELFFHLSRE------RVFSEDRARFYGAEIVSALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD-- 302 (446)
T ss_dssp CBHHHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHHH--TCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC---
T ss_pred CcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHhhc--CCEEECCCCHHHEEECCCCCEEEccCCCceeccCC--
Confidence 9999999754 4589999999999999999999952 58999999999999999999999999999753211
Q ss_pred CCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCccccCCCCc
Q 005102 564 SPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGSSE 643 (714)
Q Consensus 564 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~~~~~~~~ 643 (714)
........||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 303 --------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~--- 353 (446)
T 4ejn_A 303 --------------------------GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD--- 353 (446)
T ss_dssp ------------------------------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS---
T ss_pred --------------------------CcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCC---
Confidence 112234567999999999999999999999999999999999999994321
Q ss_pred chhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCC-----CHHHHHH
Q 005102 644 MDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRP-----TMRHISD 704 (714)
Q Consensus 644 ~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----t~~evl~ 704 (714)
..............+ .... ...+.+++.+||+.||++|| |++|+++
T Consensus 354 --~~~~~~~i~~~~~~~--------p~~~-----~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~ 404 (446)
T 4ejn_A 354 --HEKLFELILMEEIRF--------PRTL-----GPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ 404 (446)
T ss_dssp --HHHHHHHHHHCCCCC--------CTTS-----CHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred --HHHHHHHHHhCCCCC--------CccC-----CHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence 122222222222111 1111 13578999999999999999 9999875
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=351.86 Aligned_cols=239 Identities=23% Similarity=0.383 Sum_probs=192.3
Q ss_pred ccccccCceEEEEEEE-CCCcEEEEEEeCCCCc---hhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCC
Q 005102 409 FVLGKSGIGIVYKVVL-EDGHTLAVRRLGEGGS---QRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNG 484 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~g 484 (714)
+.||+|+||.||+|+. .+|+.||||++..... ...+.+.+|++++++++||||+++++++...+..++||||+. |
T Consensus 60 ~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~-g 138 (348)
T 1u5q_A 60 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL-G 138 (348)
T ss_dssp EEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCS-E
T ss_pred eEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEEecCC-C
Confidence 5799999999999997 4689999999975432 234678999999999999999999999999999999999997 6
Q ss_pred CHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCC
Q 005102 485 SLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGS 564 (714)
Q Consensus 485 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 564 (714)
+|.+++.... ..+++..+..++.|++.||+|||+ .+|+||||||+|||+++++.+||+|||+++....
T Consensus 139 ~l~~~l~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~---- 206 (348)
T 1u5q_A 139 SASDLLEVHK-----KPLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP---- 206 (348)
T ss_dssp EHHHHHHHHT-----SCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS----
T ss_pred CHHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEeeccCceecCC----
Confidence 8888886432 458999999999999999999999 8999999999999999999999999999875421
Q ss_pred CCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccC---CCCCCchhhhHHHHHHHHHHHhCCCccccCCC
Q 005102 565 PTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLK---VVKPSQKWDIYSYGVILLEMITGRTAVVQVGS 641 (714)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~~~DVwS~Gvvl~elltG~~p~~~~~~ 641 (714)
.....||+.|+|||++. ...++.++|||||||++|||++|+.||....
T Consensus 207 ----------------------------~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~- 257 (348)
T 1u5q_A 207 ----------------------------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN- 257 (348)
T ss_dssp ----------------------------BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC-
T ss_pred ----------------------------CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC-
Confidence 11235789999999984 5678999999999999999999999995332
Q ss_pred CcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 005102 642 SEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISD 704 (714)
Q Consensus 642 ~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 704 (714)
....+........ +...... ....+.+++.+||+.||++|||++++++
T Consensus 258 ----~~~~~~~~~~~~~-------~~~~~~~----~~~~l~~li~~~l~~dP~~Rps~~~ll~ 305 (348)
T 1u5q_A 258 ----AMSALYHIAQNES-------PALQSGH----WSEYFRNFVDSCLQKIPQDRPTSEVLLK 305 (348)
T ss_dssp ----HHHHHHHHHHSCC-------CCCCCTT----SCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred ----hHHHHHHHHhcCC-------CCCCCCC----CCHHHHHHHHHHcccChhhCcCHHHHhh
Confidence 1122222222211 1111111 1235789999999999999999999875
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=359.32 Aligned_cols=267 Identities=22% Similarity=0.276 Sum_probs=197.7
Q ss_pred cccccc--CceEEEEEEEC-CCcEEEEEEeCCCC--chhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCC
Q 005102 409 FVLGKS--GIGIVYKVVLE-DGHTLAVRRLGEGG--SQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPN 483 (714)
Q Consensus 409 ~~lG~G--~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~ 483 (714)
+.||+| +||.||+|+.. +|+.||||++.... ....+.+.+|++++++++||||+++++++...+..++||||+++
T Consensus 31 ~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 110 (389)
T 3gni_B 31 TVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAY 110 (389)
T ss_dssp EEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred ecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEEEEEccCC
Confidence 479999 99999999987 58999999997643 33456788999999999999999999999999999999999999
Q ss_pred CCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCC
Q 005102 484 GSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGG 563 (714)
Q Consensus 484 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 563 (714)
|+|.+++..... ..+++..+..|+.||+.||+|||+ .+|+||||||+|||++.++.+||+|||.+........
T Consensus 111 ~~L~~~l~~~~~----~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~~~~ 183 (389)
T 3gni_B 111 GSAKDLICTHFM----DGMNELAIAYILQGVLKALDYIHH---MGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQ 183 (389)
T ss_dssp CBHHHHHHHTCT----TCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCGGGCEECEETTE
T ss_pred CCHHHHHhhhcc----cCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEcccccceeeccccc
Confidence 999999976532 358999999999999999999999 8999999999999999999999999999875432211
Q ss_pred CCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCC--CCCCchhhhHHHHHHHHHHHhCCCccccCCC
Q 005102 564 SPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKV--VKPSQKWDIYSYGVILLEMITGRTAVVQVGS 641 (714)
Q Consensus 564 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~~~DVwS~Gvvl~elltG~~p~~~~~~ 641 (714)
... ..........||+.|+|||++.+ ..++.++|||||||++|||++|+.||.....
T Consensus 184 ~~~---------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~ 242 (389)
T 3gni_B 184 RQR---------------------VVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPA 242 (389)
T ss_dssp ECS---------------------CBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCS
T ss_pred ccc---------------------ccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCH
Confidence 000 00112233467899999999987 5789999999999999999999999954332
Q ss_pred CcchhHHHHHHHHhhc----C-C----------------cccccC---C-----CCCCCCCcHHHHHHHHHHHhHccCCC
Q 005102 642 SEMDLVNWMQLCIEEK----K-P----------------LADVLD---P-----YLAPDADKEEEIIAVLKIAMACVHSS 692 (714)
Q Consensus 642 ~~~~l~~~~~~~~~~~----~-~----------------~~~~~d---~-----~~~~~~~~~~~~~~l~~li~~Cl~~d 692 (714)
... +...+....... . + ..+... + ..............+.+++.+||+.|
T Consensus 243 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~d 321 (389)
T 3gni_B 243 TQM-LLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRN 321 (389)
T ss_dssp TTH-HHHC--------------------------------------------------------CCHHHHHHHHHHTCSC
T ss_pred HHH-HHHHhcCCCCccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcC
Confidence 221 111110000000 0 0 000000 0 00000001112346889999999999
Q ss_pred CCCCCCHHHHHH
Q 005102 693 PEKRPTMRHISD 704 (714)
Q Consensus 693 P~~RPt~~evl~ 704 (714)
|++|||++|+++
T Consensus 322 P~~Rpta~ell~ 333 (389)
T 3gni_B 322 PDARPSASTLLN 333 (389)
T ss_dssp TTTSCCHHHHTT
T ss_pred cccCCCHHHHhc
Confidence 999999999974
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-41 Score=363.57 Aligned_cols=245 Identities=22% Similarity=0.258 Sum_probs=194.1
Q ss_pred ccccccCceEEEEEEECC-CcEEEEEEeCCCC---chhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCC
Q 005102 409 FVLGKSGIGIVYKVVLED-GHTLAVRRLGEGG---SQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNG 484 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~~-g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~g 484 (714)
+.||+|+||+||+|+++. ++.||+|++.+.. ....+.+.+|+.+++.++||||+++++++.+.+..|+||||+++|
T Consensus 75 ~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~E~~~gg 154 (410)
T 3v8s_A 75 KVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGG 154 (410)
T ss_dssp EEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTTE
T ss_pred EEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCC
Confidence 579999999999999864 8899999986521 112235789999999999999999999999999999999999999
Q ss_pred CHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCC
Q 005102 485 SLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGS 564 (714)
Q Consensus 485 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 564 (714)
+|.+++... .+++..+..++.||+.||+|||+ .+|+||||||+|||++.++++||+|||+|+......
T Consensus 155 ~L~~~l~~~-------~~~e~~~~~~~~qi~~aL~~LH~---~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~-- 222 (410)
T 3v8s_A 155 DLVNLMSNY-------DVPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEG-- 222 (410)
T ss_dssp EHHHHHHHC-------CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTS--
T ss_pred cHHHHHHcC-------CCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeeECCCCCEEEeccceeEeeccCC--
Confidence 999999643 48899999999999999999999 899999999999999999999999999997643211
Q ss_pred CCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCC----CCchhhhHHHHHHHHHHHhCCCccccCC
Q 005102 565 PTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVK----PSQKWDIYSYGVILLEMITGRTAVVQVG 640 (714)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~s~~~DVwS~Gvvl~elltG~~p~~~~~ 640 (714)
........||+.|+|||++.+.. ++.++|||||||++|||++|+.||...
T Consensus 223 -------------------------~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~- 276 (410)
T 3v8s_A 223 -------------------------MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYAD- 276 (410)
T ss_dssp -------------------------EEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCS-
T ss_pred -------------------------cccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCC-
Confidence 11233456899999999997655 789999999999999999999999532
Q ss_pred CCcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCC--CCCHHHHHH
Q 005102 641 SSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEK--RPTMRHISD 704 (714)
Q Consensus 641 ~~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~--RPt~~evl~ 704 (714)
+.............. ..-|.. .. ....+.+++.+||..+|.+ ||+++||++
T Consensus 277 ----~~~~~~~~i~~~~~~---~~~p~~-~~-----~s~~~~~li~~lL~~~~~rlgR~~~~ei~~ 329 (410)
T 3v8s_A 277 ----SLVGTYSKIMNHKNS---LTFPDD-ND-----ISKEAKNLICAFLTDREVRLGRNGVEEIKR 329 (410)
T ss_dssp ----SHHHHHHHHHTHHHH---CCCCTT-CC-----CCHHHHHHHHHHSSCGGGCTTSSCHHHHHT
T ss_pred ----ChhhHHHHHHhcccc---ccCCCc-cc-----ccHHHHHHHHHHccChhhhCCCCCHHHHhc
Confidence 112222222221100 000100 01 1235789999999999988 999999875
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-40 Score=342.58 Aligned_cols=260 Identities=15% Similarity=0.177 Sum_probs=198.7
Q ss_pred ccccccCceEEEEEEE-CCCcEEEEEEeCCCCchhHHHHHHHHHHHhccCCCCccceEEEE-EeCCceeEEEeccCCCCH
Q 005102 409 FVLGKSGIGIVYKVVL-EDGHTLAVRRLGEGGSQRFKEFQTEVEAIGKIRHSNIVTLRAYY-WSVDEKLLIYDYIPNGSL 486 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~-~~~~~~~lV~e~~~~gsL 486 (714)
+.||+|+||.||+|+. .+++.||||++...... +.+.+|++++++++|++++..++++ ...+..++||||+ +++|
T Consensus 15 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L 91 (296)
T 4hgt_A 15 RKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPSL 91 (296)
T ss_dssp EEEEECSSSEEEEEEETTTTEEEEEEEEEC---C--CCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-CCBH
T ss_pred eeecCCCCeEEEEEEEcCCCceEEEEeecccccc--hHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEEcc-CCCH
Confidence 5799999999999997 46899999987654322 3578899999999988877777666 5566789999999 9999
Q ss_pred hhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeee---CCCCCeEEcccchhhhhhccCC
Q 005102 487 ATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILL---GHNMEPHVSDFGLARLANIAGG 563 (714)
Q Consensus 487 ~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl---~~~~~~kl~DFGla~~~~~~~~ 563 (714)
.+++.... ..+++..+..++.|++.||+|||+ .+|+||||||+|||+ ++++.+||+|||+++.......
T Consensus 92 ~~~~~~~~-----~~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~ 163 (296)
T 4hgt_A 92 EDLFNFCS-----RKFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDART 163 (296)
T ss_dssp HHHHHHTT-----SCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTTT
T ss_pred HHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeeeeccCCCCeEEEecCccceeccCccc
Confidence 99997543 458999999999999999999999 899999999999999 7889999999999987643221
Q ss_pred CCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCccccCCCCc
Q 005102 564 SPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGSSE 643 (714)
Q Consensus 564 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~~~~~~~~ 643 (714)
..... ........||+.|+|||.+.+..++.++|||||||++|||++|+.||.......
T Consensus 164 ~~~~~---------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~ 222 (296)
T 4hgt_A 164 HQHIP---------------------YRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAAT 222 (296)
T ss_dssp CCBCC---------------------CCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSS
T ss_pred CccCC---------------------CCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhh
Confidence 10000 112234567899999999999999999999999999999999999995433222
Q ss_pred c-hhHH-HHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhhhhcc
Q 005102 644 M-DLVN-WMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDALDRLIVS 712 (714)
Q Consensus 644 ~-~l~~-~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~~ 712 (714)
. .... ........ + ....... ....+.+++.+||+.||++|||++++++.|+++...
T Consensus 223 ~~~~~~~~~~~~~~~--~-~~~~~~~---------~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~ 281 (296)
T 4hgt_A 223 KRQKYERISEKKMST--P-IEVLCKG---------YPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR 281 (296)
T ss_dssp SSSHHHHHHHHHHHS--C-HHHHTTT---------SCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHH
T ss_pred hhhhhhhhhcccccc--h-hhhhhcc---------CCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHH
Confidence 1 1111 11111111 1 0111111 123688999999999999999999999999998753
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=363.24 Aligned_cols=248 Identities=23% Similarity=0.276 Sum_probs=195.4
Q ss_pred ccccccCceEEEEEEECC-CcEEEEEEeCCCC---chhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCC
Q 005102 409 FVLGKSGIGIVYKVVLED-GHTLAVRRLGEGG---SQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNG 484 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~~-g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~g 484 (714)
++||+|+||+||+|++++ ++.||||++.+.. ......+.+|+.++..++||||++++++|.+.+..|+||||+++|
T Consensus 80 ~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV~Ey~~gg 159 (437)
T 4aw2_A 80 KVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGG 159 (437)
T ss_dssp EEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEECCCTTC
T ss_pred EEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEEEEEecCCCC
Confidence 579999999999999875 7899999997531 112234889999999999999999999999999999999999999
Q ss_pred CHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCC
Q 005102 485 SLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGS 564 (714)
Q Consensus 485 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 564 (714)
+|.+++.... ..+++..++.|+.||+.||+|||+ .+|+||||||+|||++.++++||+|||+|+......
T Consensus 160 ~L~~~l~~~~-----~~l~e~~~~~~~~qi~~aL~~LH~---~giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~-- 229 (437)
T 4aw2_A 160 DLLTLLSKFE-----DRLPEEMARFYLAEMVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG-- 229 (437)
T ss_dssp BHHHHHHTTT-----TCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTS--
T ss_pred cHHHHHHHcc-----CCCCHHHHHHHHHHHHHHHHHHHh---CCeEecccCHHHeeEcCCCCEEEcchhhhhhcccCC--
Confidence 9999998643 458999999999999999999999 899999999999999999999999999997543211
Q ss_pred CCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccC-----CCCCCchhhhHHHHHHHHHHHhCCCccccC
Q 005102 565 PTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLK-----VVKPSQKWDIYSYGVILLEMITGRTAVVQV 639 (714)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~~DVwS~Gvvl~elltG~~p~~~~ 639 (714)
........||+.|+|||++. ...++.++|||||||++|||++|+.||...
T Consensus 230 -------------------------~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~ 284 (437)
T 4aw2_A 230 -------------------------TVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAE 284 (437)
T ss_dssp -------------------------CEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred -------------------------CcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCC
Confidence 11223456899999999986 566899999999999999999999999532
Q ss_pred CCCcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCC--CCCHHHHHH
Q 005102 640 GSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEK--RPTMRHISD 704 (714)
Q Consensus 640 ~~~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~--RPt~~evl~ 704 (714)
. ..+.......... ...-|...... ...+.+++.+||..+|++ ||+++|+++
T Consensus 285 --~---~~~~~~~i~~~~~---~~~~p~~~~~~-----s~~~~dLi~~lL~~~~~r~~r~~~~eil~ 338 (437)
T 4aw2_A 285 --S---LVETYGKIMNHKE---RFQFPTQVTDV-----SENAKDLIRRLICSREHRLGQNGIEDFKK 338 (437)
T ss_dssp --S---HHHHHHHHHTHHH---HCCCCSSCCCS-----CHHHHHHHHTTSSCGGGCTTTTTTHHHHT
T ss_pred --C---hhHHHHhhhhccc---cccCCcccccC-----CHHHHHHHHHHhcccccccCCCCHHHHhC
Confidence 1 1222222222110 00011111111 225789999999988888 999999875
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=346.12 Aligned_cols=251 Identities=27% Similarity=0.390 Sum_probs=203.6
Q ss_pred ccccccCceEEEEEEECC-CcEEEEEEeCCCCchhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCCCHh
Q 005102 409 FVLGKSGIGIVYKVVLED-GHTLAVRRLGEGGSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGSLA 487 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL~ 487 (714)
+.||+|+||.||+|.+.. +..||+|++.... ...+.+.+|++++++++||||+++++++...+..++||||+++|+|.
T Consensus 19 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~ 97 (288)
T 3kfa_A 19 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLL 97 (288)
T ss_dssp EESGGGTTCSEEEEEEGGGTEEEEEEEECSCS-THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCTTEEHH
T ss_pred eecCCCCceeEEEeEecCCCEEEEEEecCcCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEEcCCCCcHH
Confidence 479999999999999875 8899999997643 34578999999999999999999999999999999999999999999
Q ss_pred hhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCCCCc
Q 005102 488 TALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTL 567 (714)
Q Consensus 488 ~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 567 (714)
+++..... ..+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++......
T Consensus 98 ~~~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~----- 165 (288)
T 3kfa_A 98 DYLRECNR----QEVSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT----- 165 (288)
T ss_dssp HHHHHCCT----TTSCHHHHHHHHHHHHHHHHHHHH---HTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSS-----
T ss_pred HHHHhccc----CCccHhHHHHHHHHHHHHHHHHHH---CCccCCCCCcceEEEcCCCCEEEccCccceeccCCc-----
Confidence 99976432 458999999999999999999999 899999999999999999999999999998653211
Q ss_pred cCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHh-CCCccccCCCCcchh
Q 005102 568 QSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMIT-GRTAVVQVGSSEMDL 646 (714)
Q Consensus 568 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~ellt-G~~p~~~~~~~~~~l 646 (714)
........+|+.|+|||.+.+..++.++||||||+++|||++ |+.||..... ...
T Consensus 166 ----------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~--~~~ 221 (288)
T 3kfa_A 166 ----------------------YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL--SQV 221 (288)
T ss_dssp ----------------------SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG--GGH
T ss_pred ----------------------cccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH--HHH
Confidence 011112234677999999998899999999999999999999 9999843321 122
Q ss_pred HHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhhhhc
Q 005102 647 VNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDALDRLIV 711 (714)
Q Consensus 647 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~ 711 (714)
...+ .... ....... ....+.+++.+||+.||++|||++|+++.|+++..
T Consensus 222 ~~~~----~~~~------~~~~~~~-----~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~ 271 (288)
T 3kfa_A 222 YELL----EKDY------RMERPEG-----CPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 271 (288)
T ss_dssp HHHH----HTTC------CCCCCTT-----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHH----hccC------CCCCCCC-----CCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHH
Confidence 2111 1111 0111111 12368899999999999999999999999998764
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-40 Score=344.54 Aligned_cols=256 Identities=20% Similarity=0.311 Sum_probs=193.4
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeCCC---CchhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCC
Q 005102 409 FVLGKSGIGIVYKVVLE-DGHTLAVRRLGEG---GSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNG 484 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~g 484 (714)
+.||+|+||.||+|... +|+.||||++... .....+.+.+|++++++++||||+++++++...+..++||||+++|
T Consensus 38 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 117 (310)
T 2wqm_A 38 KKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAG 117 (310)
T ss_dssp EEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCCSC
T ss_pred EeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEEecCCCC
Confidence 57999999999999974 6899999999753 2334567899999999999999999999999999999999999999
Q ss_pred CHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCC
Q 005102 485 SLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGS 564 (714)
Q Consensus 485 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 564 (714)
+|.+++...... ...+++..+.+++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++......
T Consensus 118 ~L~~~l~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~~~-- 190 (310)
T 2wqm_A 118 DLSRMIKHFKKQ--KRLIPERTVWKYFVQLCSALEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT-- 190 (310)
T ss_dssp BHHHHHHHHHHT--TCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCC------------
T ss_pred CHHHHHHHhccc--ccCCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCcHHHEEEcCCCCEEEEeccceeeecCCC--
Confidence 999998642110 1458999999999999999999999 899999999999999999999999999987653211
Q ss_pred CCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCccccCCCCcc
Q 005102 565 PTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGSSEM 644 (714)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~~~~~~~~~ 644 (714)
.......||+.|+|||.+.+..++.++||||||+++|||++|+.||......
T Consensus 191 --------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-- 242 (310)
T 2wqm_A 191 --------------------------TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN-- 242 (310)
T ss_dssp ----------------------------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CC--
T ss_pred --------------------------ccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchh--
Confidence 1112234688899999999999999999999999999999999999543222
Q ss_pred hhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhhhhc
Q 005102 645 DLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDALDRLIV 711 (714)
Q Consensus 645 ~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~ 711 (714)
............. +..... .....+.+++.+||+.||++|||+++|++.|+++..
T Consensus 243 -~~~~~~~~~~~~~-------~~~~~~----~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~ 297 (310)
T 2wqm_A 243 -LYSLCKKIEQCDY-------PPLPSD----HYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHA 297 (310)
T ss_dssp -HHHHHHHHHTTCS-------CCCCTT----TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -HHHHHHHhhcccC-------CCCccc----ccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHH
Confidence 2222222211111 111101 112368899999999999999999999999999864
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=351.26 Aligned_cols=265 Identities=24% Similarity=0.312 Sum_probs=193.4
Q ss_pred ccccccCceEEEEEEECCCcEEEEEEeCCCCchhHHHHHHHHHH--HhccCCCCccceEEEEEe-----CCceeEEEecc
Q 005102 409 FVLGKSGIGIVYKVVLEDGHTLAVRRLGEGGSQRFKEFQTEVEA--IGKIRHSNIVTLRAYYWS-----VDEKLLIYDYI 481 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~--l~~l~H~niv~l~~~~~~-----~~~~~lV~e~~ 481 (714)
+.||+|+||.||+|+. +++.||||++.... ...+..|.++ +..++||||+++++++.. ....++||||+
T Consensus 19 ~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~ 94 (336)
T 3g2f_A 19 ELIGRGRYGAVYKGSL-DERPVAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYY 94 (336)
T ss_dssp EEEEECSSEEEEEEEE-TTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEEEEECCC
T ss_pred eecccCCCeEEEEEEE-CCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCcchhhheecccccccCCCceEEEEEecC
Confidence 4799999999999987 58999999997543 2344444444 556899999999987653 22468999999
Q ss_pred CCCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCC---------CceecCCCCCCeeeCCCCCeEEccc
Q 005102 482 PNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPK---------KYVHGDLKPSNILLGHNMEPHVSDF 552 (714)
Q Consensus 482 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~---------~ivHrDlkp~NILl~~~~~~kl~DF 552 (714)
++|+|.+++... ..++..+.+|+.|++.||+|||+ . +|+||||||+|||++.++.+||+||
T Consensus 95 ~~g~L~~~l~~~-------~~~~~~~~~i~~qi~~~L~~LH~---~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DF 164 (336)
T 3g2f_A 95 PNGSLXKYLSLH-------TSDWVSSCRLAHSVTRGLAYLHT---ELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDF 164 (336)
T ss_dssp TTCBHHHHHHHC-------CBCHHHHHHHHHHHHHHHHHHHC---CBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCC
T ss_pred CCCcHHHHHhhc-------ccchhHHHHHHHHHHHHHHHHHh---hhccccccccceeecccccceEEEcCCCcEEEeec
Confidence 999999999654 35899999999999999999999 7 9999999999999999999999999
Q ss_pred chhhhhhccCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCC-------CCCCchhhhHHHHHH
Q 005102 553 GLARLANIAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKV-------VKPSQKWDIYSYGVI 625 (714)
Q Consensus 553 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~s~~~DVwS~Gvv 625 (714)
|+++.......... ...........||+.|+|||++.+ ..++.++|||||||+
T Consensus 165 G~a~~~~~~~~~~~--------------------~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~i 224 (336)
T 3g2f_A 165 GLSMRLTGNRLVRP--------------------GEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLI 224 (336)
T ss_dssp TTCEECSSSSCC-----------------------------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHH
T ss_pred cceeecccccccCc--------------------cccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHH
Confidence 99986543211000 000112234568999999999986 356789999999999
Q ss_pred HHHHHhCCCccccCCCCcchh------------HHHHHHHHhhcCCcccccCCCCCCCC-CcHHHHHHHHHHHhHccCCC
Q 005102 626 LLEMITGRTAVVQVGSSEMDL------------VNWMQLCIEEKKPLADVLDPYLAPDA-DKEEEIIAVLKIAMACVHSS 692 (714)
Q Consensus 626 l~elltG~~p~~~~~~~~~~l------------~~~~~~~~~~~~~~~~~~d~~~~~~~-~~~~~~~~l~~li~~Cl~~d 692 (714)
+|||+||+.||.......... ...+........ ..+.+.... ........+.+++.+||+.|
T Consensus 225 l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~l~~li~~cl~~d 299 (336)
T 3g2f_A 225 YWEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREK-----QRPKFPEAWKENSLAVRSLKETIEDCWDQD 299 (336)
T ss_dssp HHHHHTTBGGGSTTSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSC-----CCCCCCTTCCCCSHHHHHHHHHHHHHSCSS
T ss_pred HHHHHhcCCcCCCccchhHHHHhhhcccCCCchHHHHHhhhcccc-----cCCCCCcccccccchHHHHHHHHHHHhcCC
Confidence 999999988874432221100 011111111111 111111111 11235567999999999999
Q ss_pred CCCCCCHHHHHHHHhhhhcc
Q 005102 693 PEKRPTMRHISDALDRLIVS 712 (714)
Q Consensus 693 P~~RPt~~evl~~L~~i~~~ 712 (714)
|++|||++|+++.|+++...
T Consensus 300 P~~Rps~~e~l~~L~~ll~~ 319 (336)
T 3g2f_A 300 AEARLTAQXAEERMAELMMI 319 (336)
T ss_dssp GGGSCCHHHHHHHHHHHHHC
T ss_pred hhhCcchHHHHHHHHHHHHH
Confidence 99999999999999998754
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-40 Score=341.52 Aligned_cols=250 Identities=20% Similarity=0.307 Sum_probs=197.5
Q ss_pred ccccccCceEEEEEEECC----CcEEEEEEeCCCC-chhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCC
Q 005102 409 FVLGKSGIGIVYKVVLED----GHTLAVRRLGEGG-SQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPN 483 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~~----g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~ 483 (714)
+.||+|+||.||+|++.+ +..||||++.... ....+.+.+|++++++++||||+++++++.. +..++||||+++
T Consensus 18 ~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~~ 96 (281)
T 3cc6_A 18 RILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTWIIMELYPY 96 (281)
T ss_dssp EEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCEEEEECCTT
T ss_pred EEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCEEEEecCCC
Confidence 579999999999998653 3469999998753 3445789999999999999999999999864 567899999999
Q ss_pred CCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCC
Q 005102 484 GSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGG 563 (714)
Q Consensus 484 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 563 (714)
++|.+++.... ..+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++......
T Consensus 97 ~~L~~~l~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~- 167 (281)
T 3cc6_A 97 GELGHYLERNK-----NSLKVLTLVLYSLQICKAMAYLES---INCVHRDIAVRNILVASPECVKLGDFGLSRYIEDED- 167 (281)
T ss_dssp CBHHHHHHHHT-----TTCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEEEETTEEEECCCCGGGCC-----
T ss_pred CCHHHHHHhcc-----ccCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCccceEEECCCCcEEeCccCCCccccccc-
Confidence 99999997543 358999999999999999999999 899999999999999999999999999998653211
Q ss_pred CCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHh-CCCccccCCCC
Q 005102 564 SPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMIT-GRTAVVQVGSS 642 (714)
Q Consensus 564 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~ellt-G~~p~~~~~~~ 642 (714)
........+|+.|+|||.+.+..++.++||||||+++|||+| |+.||......
T Consensus 168 --------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~ 221 (281)
T 3cc6_A 168 --------------------------YYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENK 221 (281)
T ss_dssp -------------------------------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGG
T ss_pred --------------------------ccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChH
Confidence 011123345778999999988899999999999999999998 99999543222
Q ss_pred cchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhhhhc
Q 005102 643 EMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDALDRLIV 711 (714)
Q Consensus 643 ~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~ 711 (714)
+....+ ..... . ..... ....+.+++.+||+.||++|||++|+++.|+++..
T Consensus 222 --~~~~~~---~~~~~-~------~~~~~-----~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~ 273 (281)
T 3cc6_A 222 --DVIGVL---EKGDR-L------PKPDL-----CPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQ 273 (281)
T ss_dssp --GHHHHH---HHTCC-C------CCCTT-----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --HHHHHH---hcCCC-C------CCCCC-----CCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHH
Confidence 222211 11111 0 01111 12358899999999999999999999999998864
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-40 Score=340.60 Aligned_cols=261 Identities=15% Similarity=0.168 Sum_probs=200.1
Q ss_pred ccccccCceEEEEEEE-CCCcEEEEEEeCCCCchhHHHHHHHHHHHhccCCCCccceEEEE-EeCCceeEEEeccCCCCH
Q 005102 409 FVLGKSGIGIVYKVVL-EDGHTLAVRRLGEGGSQRFKEFQTEVEAIGKIRHSNIVTLRAYY-WSVDEKLLIYDYIPNGSL 486 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~-~~~~~~~lV~e~~~~gsL 486 (714)
+.||+|+||.||+|+. .+|+.||||++...... +.+.+|++++++++|++++..++++ ...+..++||||+ +++|
T Consensus 15 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L 91 (296)
T 3uzp_A 15 RKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPSL 91 (296)
T ss_dssp EEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC--CHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-CCBH
T ss_pred EEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch--hHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEEec-CCCH
Confidence 4799999999999997 56899999998765433 4688999999999998877766665 4566779999999 8999
Q ss_pred hhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeee---CCCCCeEEcccchhhhhhccCC
Q 005102 487 ATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILL---GHNMEPHVSDFGLARLANIAGG 563 (714)
Q Consensus 487 ~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl---~~~~~~kl~DFGla~~~~~~~~ 563 (714)
.+++.... ..+++..+..++.|++.||+|||+ ++|+||||||+|||+ ++++.+||+|||+++.......
T Consensus 92 ~~~~~~~~-----~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~ 163 (296)
T 3uzp_A 92 EDLFNFCS-----RKFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDART 163 (296)
T ss_dssp HHHHHHTT-----TCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTT
T ss_pred HHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccccccc
Confidence 99997443 458999999999999999999999 899999999999999 4788999999999987643221
Q ss_pred CCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCccccCCCCc
Q 005102 564 SPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGSSE 643 (714)
Q Consensus 564 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~~~~~~~~ 643 (714)
.... .........||+.|+|||.+.+..++.++|||||||++|||++|+.||.......
T Consensus 164 ~~~~---------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~ 222 (296)
T 3uzp_A 164 HQHI---------------------PYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAAT 222 (296)
T ss_dssp CCBC---------------------CCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSS
T ss_pred cccc---------------------ccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchh
Confidence 1000 0112234567899999999999999999999999999999999999995433221
Q ss_pred -chhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhhhhcc
Q 005102 644 -MDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDALDRLIVS 712 (714)
Q Consensus 644 -~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~~ 712 (714)
......+...... .+ .....+. ....+.+++.+||+.||++|||++++++.|+++...
T Consensus 223 ~~~~~~~~~~~~~~-~~-~~~~~~~---------~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 281 (296)
T 3uzp_A 223 KRQKYERISEKKMS-TP-IEVLCKG---------YPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR 281 (296)
T ss_dssp SSSHHHHHHHHHHH-SC-HHHHTTT---------SCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHH
T ss_pred hhhhhhhhcccccC-Cc-hHHHHhh---------CCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHh
Confidence 1122111111111 11 0111111 113688999999999999999999999999998754
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=347.47 Aligned_cols=259 Identities=23% Similarity=0.360 Sum_probs=193.0
Q ss_pred cccccccCceEEEEEEECC----CcEEEEEEeCCCC--chhHHHHHHHHHHHhccCCCCccceEEEEEeCC-----ceeE
Q 005102 408 AFVLGKSGIGIVYKVVLED----GHTLAVRRLGEGG--SQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVD-----EKLL 476 (714)
Q Consensus 408 ~~~lG~G~~g~Vy~~~~~~----g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~-----~~~l 476 (714)
.+.||+|+||.||+|.+.. +..||||++.... ....+.+.+|++++++++||||+++++++...+ ..++
T Consensus 39 ~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 118 (313)
T 3brb_A 39 GKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMV 118 (313)
T ss_dssp EEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-------CEEE
T ss_pred ccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccccCCcccEE
Confidence 4579999999999998642 4589999987643 334567999999999999999999999998755 3499
Q ss_pred EEeccCCCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhh
Q 005102 477 IYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLAR 556 (714)
Q Consensus 477 V~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~ 556 (714)
||||+++|+|.+++...........+++..+.+|+.|++.||.|||+ .+|+||||||+||++++++.+||+|||+++
T Consensus 119 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dikp~NIli~~~~~~kl~Dfg~~~ 195 (313)
T 3brb_A 119 ILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSN---RNFLHRDLAARNCMLRDDMTVCVADFGLSK 195 (313)
T ss_dssp EEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHT---TTCCCCCCSGGGEEECTTSCEEECSCSCC-
T ss_pred EEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEcCCCcEEEeecCcce
Confidence 99999999999998543211122569999999999999999999999 899999999999999999999999999998
Q ss_pred hhhccCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHh-CCCc
Q 005102 557 LANIAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMIT-GRTA 635 (714)
Q Consensus 557 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~ellt-G~~p 635 (714)
....... ........+++.|+|||.+.+..++.++||||||+++|||++ |+.|
T Consensus 196 ~~~~~~~--------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p 249 (313)
T 3brb_A 196 KIYSGDY--------------------------YRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTP 249 (313)
T ss_dssp -----------------------------------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCS
T ss_pred ecccccc--------------------------cCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCC
Confidence 6542210 011123345778999999999999999999999999999999 8888
Q ss_pred cccCCCCcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhhhhcc
Q 005102 636 VVQVGSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDALDRLIVS 712 (714)
Q Consensus 636 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~~ 712 (714)
|..... ..... ....... +..... ....+.+++.+||+.||++|||++++++.|+++...
T Consensus 250 ~~~~~~--~~~~~---~~~~~~~-------~~~~~~-----~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~ 309 (313)
T 3brb_A 250 YPGVQN--HEMYD---YLLHGHR-------LKQPED-----CLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLES 309 (313)
T ss_dssp STTCCG--GGHHH---HHHTTCC-------CCCBTT-----CCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CccCCH--HHHHH---HHHcCCC-------CCCCcc-----ccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 843322 11211 1111111 111111 223688999999999999999999999999998754
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=349.93 Aligned_cols=259 Identities=24% Similarity=0.384 Sum_probs=203.1
Q ss_pred ccccccCceEEEEEEE-----CCCcEEEEEEeCCCCchhHHHHHHHHHHHhccCCCCccceEEEEEeCC--ceeEEEecc
Q 005102 409 FVLGKSGIGIVYKVVL-----EDGHTLAVRRLGEGGSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVD--EKLLIYDYI 481 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~-----~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~--~~~lV~e~~ 481 (714)
+.||+|+||.||+|++ .+++.||||++........+.+.+|++++++++||||+++++++...+ ..++||||+
T Consensus 47 ~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~ 126 (326)
T 2w1i_A 47 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYL 126 (326)
T ss_dssp EEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CCEEEECCC
T ss_pred eeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCceEEEEECC
Confidence 5799999999999984 358999999998876666788999999999999999999999987654 679999999
Q ss_pred CCCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhcc
Q 005102 482 PNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIA 561 (714)
Q Consensus 482 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 561 (714)
++|+|.+++.... ..+++.++.+++.|++.||+|||+ .+|+||||||+||++++++.+||+|||+++.....
T Consensus 127 ~~~~L~~~l~~~~-----~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~~~ 198 (326)
T 2w1i_A 127 PYGSLRDYLQKHK-----ERIDHIKLLQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQD 198 (326)
T ss_dssp TTCBHHHHHHHST-----TSSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCTTCEECCSS
T ss_pred CCCCHHHHHHhcc-----cCCCHHHHHHHHHHHHHHHHHHHh---CCEeccCCCcceEEEcCCCcEEEecCcchhhcccc
Confidence 9999999997653 358999999999999999999999 89999999999999999999999999999865422
Q ss_pred CCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCccccCC-
Q 005102 562 GGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVG- 640 (714)
Q Consensus 562 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~~~~~- 640 (714)
.. .........++..|+|||.+.+..++.++||||||+++|||+||+.|+....
T Consensus 199 ~~-------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~ 253 (326)
T 2w1i_A 199 KE-------------------------YYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPA 253 (326)
T ss_dssp CS-------------------------EEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHH
T ss_pred cc-------------------------ccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHH
Confidence 10 0111223345778999999988889999999999999999999999984210
Q ss_pred -------CCc--chhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhhhhc
Q 005102 641 -------SSE--MDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDALDRLIV 711 (714)
Q Consensus 641 -------~~~--~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~ 711 (714)
... ......+......... ..... ....++.+++.+||+.||++|||++|+++.|+++..
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~-----~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~ 322 (326)
T 2w1i_A 254 EFMRMIGNDKQGQMIVFHLIELLKNNGR------LPRPD-----GCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD 322 (326)
T ss_dssp HHHHHHCTTCCTHHHHHHHHHHHHTTCC------CCCCT-----TCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHhhccccchhhhHHHHHHHhhcCCC------CCCCC-----cccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 000 0011111111111110 00111 122368899999999999999999999999999865
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-40 Score=342.73 Aligned_cols=250 Identities=21% Similarity=0.303 Sum_probs=197.4
Q ss_pred cccccCceEEEEEEEC---CCcEEEEEEeCCCC--chhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCC
Q 005102 410 VLGKSGIGIVYKVVLE---DGHTLAVRRLGEGG--SQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNG 484 (714)
Q Consensus 410 ~lG~G~~g~Vy~~~~~---~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~g 484 (714)
.||+|+||.||+|.+. +++.||||++.... ....+.+.+|++++++++||||+++++++ ..+..++||||++++
T Consensus 24 ~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e~~~~~ 102 (291)
T 1xbb_A 24 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELG 102 (291)
T ss_dssp EEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEEEEEECCTTE
T ss_pred ccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcEEEEEeCCCC
Confidence 7999999999999653 36899999997653 23357899999999999999999999999 667789999999999
Q ss_pred CHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCC
Q 005102 485 SLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGS 564 (714)
Q Consensus 485 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 564 (714)
+|.+++... ..+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++........
T Consensus 103 ~L~~~l~~~------~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 173 (291)
T 1xbb_A 103 PLNKYLQQN------RHVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY 173 (291)
T ss_dssp EHHHHHHHC------TTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSE
T ss_pred CHHHHHHhC------cCCCHHHHHHHHHHHHHHHHHHHh---CCeEcCCCCcceEEEeCCCcEEEccCCcceeeccCCCc
Confidence 999999765 458999999999999999999999 89999999999999999999999999999765322100
Q ss_pred CCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHh-CCCccccCCCCc
Q 005102 565 PTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMIT-GRTAVVQVGSSE 643 (714)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~ellt-G~~p~~~~~~~~ 643 (714)
........+++.|+|||.+.+..++.++||||||+++|||+| |+.||.... .
T Consensus 174 -------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~--~ 226 (291)
T 1xbb_A 174 -------------------------YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK--G 226 (291)
T ss_dssp -------------------------EEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCC--H
T ss_pred -------------------------ccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCC--H
Confidence 111222345778999999988889999999999999999999 999994322 1
Q ss_pred chhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhhhhc
Q 005102 644 MDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDALDRLIV 711 (714)
Q Consensus 644 ~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~ 711 (714)
..+ .. ....... +..... ....+.+++.+||+.||++|||+.++++.|+++..
T Consensus 227 ~~~---~~-~~~~~~~------~~~~~~-----~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~ 279 (291)
T 1xbb_A 227 SEV---TA-MLEKGER------MGCPAG-----CPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY 279 (291)
T ss_dssp HHH---HH-HHHTTCC------CCCCTT-----CCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred HHH---HH-HHHcCCC------CCCCCC-----CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 111 11 1111111 111111 12368899999999999999999999999999864
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=350.34 Aligned_cols=251 Identities=23% Similarity=0.349 Sum_probs=193.6
Q ss_pred ccccccCceEEEEEEECC-Cc----EEEEEEeCCC-CchhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccC
Q 005102 409 FVLGKSGIGIVYKVVLED-GH----TLAVRRLGEG-GSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIP 482 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~~-g~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~ 482 (714)
+.||+|+||.||+|++.. ++ .||+|.+... .....+.+.+|+.++++++||||+++++++... ..++||||++
T Consensus 21 ~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-~~~~v~~~~~ 99 (327)
T 3lzb_A 21 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQLMP 99 (327)
T ss_dssp EEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESS-SEEEEECCCS
T ss_pred EEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecC-CceEEEEecC
Confidence 479999999999999753 44 3578877654 334567899999999999999999999999865 4889999999
Q ss_pred CCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccC
Q 005102 483 NGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAG 562 (714)
Q Consensus 483 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 562 (714)
+|+|.+++.... ..+++..++.|+.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++......
T Consensus 100 ~g~L~~~l~~~~-----~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~~~ 171 (327)
T 3lzb_A 100 FGCLLDYVREHK-----DNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 171 (327)
T ss_dssp SCBHHHHHHHTT-----TCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCTTC--------
T ss_pred CCcHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHhh---CCCcCCCCCHHHEEEcCCCCEEEccCcceeEccCcc
Confidence 999999997653 458999999999999999999999 899999999999999999999999999998754321
Q ss_pred CCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHh-CCCccccCCC
Q 005102 563 GSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMIT-GRTAVVQVGS 641 (714)
Q Consensus 563 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~ellt-G~~p~~~~~~ 641 (714)
. ........+|+.|+|||.+.+..++.++|||||||++|||++ |+.||.....
T Consensus 172 ~--------------------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~ 225 (327)
T 3lzb_A 172 K--------------------------EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA 225 (327)
T ss_dssp ----------------------------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCG
T ss_pred c--------------------------cccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCH
Confidence 1 111122345778999999999999999999999999999999 9999953322
Q ss_pred CcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhhhhc
Q 005102 642 SEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDALDRLIV 711 (714)
Q Consensus 642 ~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~ 711 (714)
..+... ...... ...... ....+.+++.+||+.||++|||++|+++.|+++..
T Consensus 226 --~~~~~~----~~~~~~------~~~~~~-----~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 278 (327)
T 3lzb_A 226 --SEISSI----LEKGER------LPQPPI-----CTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp --GGHHHH----HHTTCC------CCCCTT-----BCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHT
T ss_pred --HHHHHH----HHcCCC------CCCCcc-----CCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 222221 111111 001111 12358899999999999999999999999998864
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-40 Score=340.31 Aligned_cols=247 Identities=21% Similarity=0.319 Sum_probs=190.9
Q ss_pred cccccccCceEEEEEEEC-CCcEEEEEEeCCCC-chhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCCC
Q 005102 408 AFVLGKSGIGIVYKVVLE-DGHTLAVRRLGEGG-SQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGS 485 (714)
Q Consensus 408 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gs 485 (714)
.+.||+|+||.||+|... ++..||+|++.... ....+.+.+|++++++++||||+++++++...+..++||||+++|+
T Consensus 27 ~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~ 106 (285)
T 3is5_A 27 KRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGE 106 (285)
T ss_dssp EEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCSCCB
T ss_pred cceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEeCCCCc
Confidence 358999999999999975 48999999987653 3345789999999999999999999999999999999999999999
Q ss_pred HhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeee---CCCCCeEEcccchhhhhhccC
Q 005102 486 LATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILL---GHNMEPHVSDFGLARLANIAG 562 (714)
Q Consensus 486 L~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl---~~~~~~kl~DFGla~~~~~~~ 562 (714)
|.+++...... ...+++..+..|+.|++.||+|||+ .+|+||||||+||++ +.++.+||+|||+++......
T Consensus 107 L~~~l~~~~~~--~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~ 181 (285)
T 3is5_A 107 LLERIVSAQAR--GKALSEGYVAELMKQMMNALAYFHS---QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDE 181 (285)
T ss_dssp HHHHHHHHHHH--TCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-----
T ss_pred HHHHHHhhhhc--ccCCCHHHHHHHHHHHHHHHHHHHh---CCEEECCCCHHHEEEecCCCCCCEEEEeeecceecCCcc
Confidence 99988543110 0458999999999999999999999 899999999999999 456789999999997643211
Q ss_pred CCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCccccCCCC
Q 005102 563 GSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGSS 642 (714)
Q Consensus 563 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~~~~~~~ 642 (714)
......||+.|+|||.+. ..++.++||||||+++|||++|+.||....
T Consensus 182 -----------------------------~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~-- 229 (285)
T 3is5_A 182 -----------------------------HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTS-- 229 (285)
T ss_dssp ----------------------------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSS--
T ss_pred -----------------------------cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCC--
Confidence 112345788999999985 568999999999999999999999994321
Q ss_pred cchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 005102 643 EMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISD 704 (714)
Q Consensus 643 ~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 704 (714)
................ ... .. ....+.+++.+||+.||++|||++|+++
T Consensus 230 ---~~~~~~~~~~~~~~~~----~~~-~~-----~~~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 230 ---LEEVQQKATYKEPNYA----VEC-RP-----LTPQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp ---HHHHHHHHHHCCCCCC----C---CC-----CCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred ---HHHHHhhhccCCcccc----ccc-Cc-----CCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1122221111111110 000 00 1235779999999999999999999975
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-40 Score=362.35 Aligned_cols=251 Identities=21% Similarity=0.288 Sum_probs=187.6
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeCCC--CchhHHHHHHHHHHHhccCCCCccceEEEEEeCC------ceeEEEe
Q 005102 409 FVLGKSGIGIVYKVVLE-DGHTLAVRRLGEG--GSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVD------EKLLIYD 479 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~------~~~lV~e 479 (714)
+.||+|+||+||+|.+. +|+.||||++... .....+.+.+|+.+++.++||||+++++++...+ +.|+|||
T Consensus 68 ~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~lv~E 147 (464)
T 3ttj_A 68 KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVME 147 (464)
T ss_dssp EEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEEEEEE
T ss_pred EEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCCeEEEEEe
Confidence 47999999999999975 4899999999764 3344567899999999999999999999997543 4699999
Q ss_pred ccCCCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhh
Q 005102 480 YIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLAN 559 (714)
Q Consensus 480 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~ 559 (714)
|+++ +|.+.+. ..+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+|+...
T Consensus 148 ~~~~-~l~~~~~--------~~l~~~~~~~~~~qil~aL~~lH~---~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 215 (464)
T 3ttj_A 148 LMDA-NLCQVIQ--------MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 215 (464)
T ss_dssp CCSE-EHHHHHT--------SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCCCC----
T ss_pred CCCC-CHHHHHh--------hcCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChHhEEEeCCCCEEEEEEEeeeecC
Confidence 9976 5777664 248899999999999999999999 899999999999999999999999999998653
Q ss_pred ccCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCccccC
Q 005102 560 IAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQV 639 (714)
Q Consensus 560 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~~~~ 639 (714)
.. .......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 216 ~~-----------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~ 266 (464)
T 3ttj_A 216 TS-----------------------------FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGR 266 (464)
T ss_dssp -C-----------------------------CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred CC-----------------------------cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 21 1122346799999999999999999999999999999999999999432
Q ss_pred CCCcchhHHHHHHHHhhcCCcccc--------------------------cCCCCCCCCC--cHHHHHHHHHHHhHccCC
Q 005102 640 GSSEMDLVNWMQLCIEEKKPLADV--------------------------LDPYLAPDAD--KEEEIIAVLKIAMACVHS 691 (714)
Q Consensus 640 ~~~~~~l~~~~~~~~~~~~~~~~~--------------------------~d~~~~~~~~--~~~~~~~l~~li~~Cl~~ 691 (714)
+..+....+.... +.+..+. ......+... .......+.+++.+||+.
T Consensus 267 --~~~~~~~~i~~~l--g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~ 342 (464)
T 3ttj_A 267 --DYIDQWNKVIEQL--GTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVI 342 (464)
T ss_dssp --SHHHHHHHHHHHH--CSCCHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCS
T ss_pred --CHHHHHHHHHHhc--CCCCHHHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCC
Confidence 1111111111100 0000000 0000000000 111245689999999999
Q ss_pred CCCCCCCHHHHHH
Q 005102 692 SPEKRPTMRHISD 704 (714)
Q Consensus 692 dP~~RPt~~evl~ 704 (714)
||++|||++|+++
T Consensus 343 dP~~R~ta~e~L~ 355 (464)
T 3ttj_A 343 DPAKRISVDDALQ 355 (464)
T ss_dssp STTTSCCHHHHHT
T ss_pred ChhhCCCHHHHhc
Confidence 9999999999875
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=351.67 Aligned_cols=244 Identities=21% Similarity=0.315 Sum_probs=188.9
Q ss_pred ccccccCceEEEEEEECCCcEEEEEEeCCC--CchhHHHHHHHHHHHhccCC--CCccceEEEEEeCCceeEEEeccCCC
Q 005102 409 FVLGKSGIGIVYKVVLEDGHTLAVRRLGEG--GSQRFKEFQTEVEAIGKIRH--SNIVTLRAYYWSVDEKLLIYDYIPNG 484 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H--~niv~l~~~~~~~~~~~lV~e~~~~g 484 (714)
+.||+|+||.||++...+++.||||++... .....+.+.+|++++++++| |||+++++++...+..++|||| .+|
T Consensus 15 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e~-~~~ 93 (343)
T 3dbq_A 15 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNI 93 (343)
T ss_dssp EEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECC-CSE
T ss_pred EEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEEEeC-CCC
Confidence 479999999999999988999999998754 33345679999999999976 9999999999999999999995 588
Q ss_pred CHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCC
Q 005102 485 SLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGS 564 (714)
Q Consensus 485 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 564 (714)
+|.+++... ..+++.++..|+.|++.||+|||+ .+|+||||||+|||++ ++.+||+|||+++.......
T Consensus 94 ~L~~~l~~~------~~~~~~~~~~i~~qi~~al~~lH~---~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~~- 162 (343)
T 3dbq_A 94 DLNSWLKKK------KSIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTT- 162 (343)
T ss_dssp EHHHHHHHS------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC------
T ss_pred CHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCcceEEEE-CCcEEEeecccccccCcccc-
Confidence 999999865 458999999999999999999999 8999999999999997 57899999999986542210
Q ss_pred CCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCC-----------CCCCchhhhHHHHHHHHHHHhCC
Q 005102 565 PTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKV-----------VKPSQKWDIYSYGVILLEMITGR 633 (714)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~s~~~DVwS~Gvvl~elltG~ 633 (714)
........||+.|+|||++.+ ..++.++|||||||++|||++|+
T Consensus 163 -------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~ 217 (343)
T 3dbq_A 163 -------------------------SVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 217 (343)
T ss_dssp --------------------------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSS
T ss_pred -------------------------cccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCC
Confidence 111223467999999999864 67899999999999999999999
Q ss_pred CccccCCCCcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 005102 634 TAVVQVGSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISD 704 (714)
Q Consensus 634 ~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 704 (714)
.||..... ............. ........ ...+.+++.+||+.||++|||++|+++
T Consensus 218 ~pf~~~~~----~~~~~~~~~~~~~------~~~~~~~~-----~~~l~~li~~~L~~dp~~Rpt~~e~l~ 273 (343)
T 3dbq_A 218 TPFQQIIN----QISKLHAIIDPNH------EIEFPDIP-----EKDLQDVLKCCLKRDPKQRISIPELLA 273 (343)
T ss_dssp CTTTTCCS----HHHHHHHHHCTTS------CCCCCCCS-----CHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred Ccchhhhh----HHHHHHHHhcCCc------ccCCcccC-----CHHHHHHHHHHcCCChhHCCCHHHHHh
Confidence 99953221 1111111111111 01111111 125789999999999999999999975
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-40 Score=338.34 Aligned_cols=244 Identities=23% Similarity=0.291 Sum_probs=195.6
Q ss_pred ccccccCceEEEEEEECC-CcEEEEEEeCCCC--chhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCCC
Q 005102 409 FVLGKSGIGIVYKVVLED-GHTLAVRRLGEGG--SQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGS 485 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~~-g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gs 485 (714)
+.||+|+||.||+|.+.. |+.||+|++.... ....+.+.+|++++++++||||+++++++...+..++||||+++|+
T Consensus 12 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~ 91 (284)
T 3kk8_A 12 EELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGE 91 (284)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred hhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEEecCCCCC
Confidence 479999999999999764 8999999987542 3345678899999999999999999999999999999999999999
Q ss_pred HhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCC---eEEcccchhhhhhccC
Q 005102 486 LATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNME---PHVSDFGLARLANIAG 562 (714)
Q Consensus 486 L~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~---~kl~DFGla~~~~~~~ 562 (714)
|.+.+... ..+++..+..++.|++.||+|||+ .+|+||||||+||+++.++. +||+|||++......
T Consensus 92 l~~~~~~~------~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~- 161 (284)
T 3kk8_A 92 LFEDIVAR------EFYSEADASHCIQQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS- 161 (284)
T ss_dssp HHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSS-
T ss_pred HHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccC-
Confidence 99988755 458999999999999999999999 89999999999999986655 999999998754321
Q ss_pred CCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCccccCCCC
Q 005102 563 GSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGSS 642 (714)
Q Consensus 563 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~~~~~~~ 642 (714)
.......||+.|+|||.+.+..++.++||||||+++|||++|+.||....
T Consensus 162 ----------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~-- 211 (284)
T 3kk8_A 162 ----------------------------EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED-- 211 (284)
T ss_dssp ----------------------------CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS--
T ss_pred ----------------------------ccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCc--
Confidence 11123457889999999999999999999999999999999999994321
Q ss_pred cchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 005102 643 EMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISD 704 (714)
Q Consensus 643 ~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 704 (714)
. .............. ..+.. . .....+.+++.+||+.||++|||++|+++
T Consensus 212 ~---~~~~~~~~~~~~~~---~~~~~-~-----~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (284)
T 3kk8_A 212 Q---HRLYAQIKAGAYDY---PSPEW-D-----TVTPEAKSLIDSMLTVNPKKRITADQALK 261 (284)
T ss_dssp H---HHHHHHHHHTCCCC---CTTTT-T-----TSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred h---hHHHHHHHhccccC---Cchhh-c-----ccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 1 12222222221111 11110 0 11235789999999999999999999976
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=369.40 Aligned_cols=246 Identities=24% Similarity=0.260 Sum_probs=197.8
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeCCCC---chhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCC
Q 005102 409 FVLGKSGIGIVYKVVLE-DGHTLAVRRLGEGG---SQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNG 484 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~g 484 (714)
++||+|+||.||+|+.+ +|+.||||++.+.. ......+.+|+++|++++||||+++++++.+.+..|+||||+++|
T Consensus 190 ~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmEy~~gg 269 (576)
T 2acx_A 190 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGG 269 (576)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSC
T ss_pred EEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEEEEcCCCC
Confidence 57999999999999986 59999999996531 223466889999999999999999999999999999999999999
Q ss_pred CHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCC
Q 005102 485 SLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGS 564 (714)
Q Consensus 485 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 564 (714)
+|.+++..... ..+++..++.|+.||+.||+|||+ .+|+||||||+|||++.++++||+|||+++......
T Consensus 270 ~L~~~l~~~~~----~~l~e~~~~~i~~qIl~aL~yLH~---~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~~-- 340 (576)
T 2acx_A 270 DLKFHIYHMGQ----AGFPEARAVFYAAEICCGLEDLHR---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ-- 340 (576)
T ss_dssp BHHHHHHSSSS----CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCTTCEECCTTC--
T ss_pred cHHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHH---CCEeccCCchheEEEeCCCCeEEEecccceecccCc--
Confidence 99999976532 348999999999999999999999 899999999999999999999999999997643210
Q ss_pred CCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCccccCCCCcc
Q 005102 565 PTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGSSEM 644 (714)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~~~~~~~~~ 644 (714)
......||+.|+|||++.+..++.++|||||||++|||++|+.||.......
T Consensus 341 ---------------------------~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~- 392 (576)
T 2acx_A 341 ---------------------------TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKI- 392 (576)
T ss_dssp ---------------------------CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCC-
T ss_pred ---------------------------cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccch-
Confidence 1123468999999999999899999999999999999999999995432211
Q ss_pred hhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCC-----CHHHHHH
Q 005102 645 DLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRP-----TMRHISD 704 (714)
Q Consensus 645 ~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----t~~evl~ 704 (714)
............... ..... ...+.+++.+||+.||++|| +++||++
T Consensus 393 ~~~~i~~~i~~~~~~--------~p~~~-----s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~ 444 (576)
T 2acx_A 393 KREEVERLVKEVPEE--------YSERF-----SPQARSLCSQLLCKDPAERLGCRGGSAREVKE 444 (576)
T ss_dssp CHHHHHHHHHHCCCC--------CCTTS-----CHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred hHHHHHHHhhccccc--------CCccC-----CHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence 112222222221111 11111 23678999999999999999 6777764
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-40 Score=366.55 Aligned_cols=244 Identities=23% Similarity=0.283 Sum_probs=196.5
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeCCCC---chhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCC
Q 005102 409 FVLGKSGIGIVYKVVLE-DGHTLAVRRLGEGG---SQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNG 484 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~g 484 (714)
++||+|+||.||+|+.+ +|+.||||++.+.. ....+.+.+|++++++++||||+++++++...+..|+||||+++|
T Consensus 191 ~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmE~~~gg 270 (543)
T 3c4z_A 191 RVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGG 270 (543)
T ss_dssp EEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTTC
T ss_pred EEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEEEeccCC
Confidence 47999999999999986 59999999997542 233467889999999999999999999999999999999999999
Q ss_pred CHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCC
Q 005102 485 SLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGS 564 (714)
Q Consensus 485 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 564 (714)
+|.+++...... ...+++..+..|+.||+.||+|||+ .+|+||||||+|||++.++++||+|||+++......
T Consensus 271 ~L~~~l~~~~~~--~~~l~e~~~~~~~~qi~~aL~~LH~---~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~~~-- 343 (543)
T 3c4z_A 271 DIRYHIYNVDED--NPGFQEPRAIFYTAQIVSGLEHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQ-- 343 (543)
T ss_dssp BHHHHHHTSSTT--SCSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCTTCEECCTTC--
T ss_pred CHHHHHHHhhcc--cccccHHHHHHHHHHHHHHHHHHHH---cCCcccCCChHHEEEeCCCCEEEeecceeeeccCCC--
Confidence 999998764321 1468999999999999999999999 899999999999999999999999999998653211
Q ss_pred CCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCccccCCCCcc
Q 005102 565 PTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGSSEM 644 (714)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~~~~~~~~~ 644 (714)
.......||+.|+|||++.+..++.++|||||||++|||+||+.||...... .
T Consensus 344 --------------------------~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~-~ 396 (543)
T 3c4z_A 344 --------------------------TKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEK-V 396 (543)
T ss_dssp --------------------------CCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCC-C
T ss_pred --------------------------cccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccc-h
Confidence 1122346899999999999999999999999999999999999999543221 1
Q ss_pred hhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCH
Q 005102 645 DLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTM 699 (714)
Q Consensus 645 ~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~ 699 (714)
......+......... .... ...+.+++.+||+.||++||++
T Consensus 397 ~~~~~~~~i~~~~~~~--------p~~~-----s~~~~~li~~lL~~dP~~R~~~ 438 (543)
T 3c4z_A 397 ENKELKQRVLEQAVTY--------PDKF-----SPASKDFCEALLQKDPEKRLGF 438 (543)
T ss_dssp CHHHHHHHHHHCCCCC--------CTTS-----CHHHHHHHHHHSCSSGGGSCCC
T ss_pred hHHHHHHHHhhcccCC--------Cccc-----CHHHHHHHHHhccCCHhHCCCC
Confidence 2223333333322111 1111 2357899999999999999976
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-40 Score=350.62 Aligned_cols=245 Identities=21% Similarity=0.251 Sum_probs=193.0
Q ss_pred cccccccCceEEEEEEEC-CCcEEEEEEeCCCCchhHHHHHHHHHHHhcc-CCCCccceEEEEEeCCceeEEEeccCCCC
Q 005102 408 AFVLGKSGIGIVYKVVLE-DGHTLAVRRLGEGGSQRFKEFQTEVEAIGKI-RHSNIVTLRAYYWSVDEKLLIYDYIPNGS 485 (714)
Q Consensus 408 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~e~~~~gs 485 (714)
.+.||+|+||.||+|..+ +|+.||||++.+.... +.+|++++.++ +||||+++++++.+.+..|+||||+++|+
T Consensus 27 ~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~----~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~gg~ 102 (342)
T 2qr7_A 27 KEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD----PTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGE 102 (342)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC----CHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred EEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC----hHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEeCCCCCc
Confidence 357999999999999986 4899999999765432 35688899888 79999999999999999999999999999
Q ss_pred HhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCC----CCeEEcccchhhhhhcc
Q 005102 486 LATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHN----MEPHVSDFGLARLANIA 561 (714)
Q Consensus 486 L~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~----~~~kl~DFGla~~~~~~ 561 (714)
|.+++... ..+++..+..++.||+.||+|||+ .+|+||||||+|||+.++ +.+||+|||+++.....
T Consensus 103 L~~~i~~~------~~~~~~~~~~~~~qi~~al~~lH~---~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~ 173 (342)
T 2qr7_A 103 LLDKILRQ------KFFSEREASAVLFTITKTVEYLHA---QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAE 173 (342)
T ss_dssp HHHHHHTC------TTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCT
T ss_pred HHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCC
Confidence 99999765 458999999999999999999999 899999999999998543 35999999999865321
Q ss_pred CCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCccccCCC
Q 005102 562 GGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGS 641 (714)
Q Consensus 562 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~~~~~~ 641 (714)
. .......||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus 174 ~----------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~ 225 (342)
T 2qr7_A 174 N----------------------------GLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPD 225 (342)
T ss_dssp T----------------------------CCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTT
T ss_pred C----------------------------CceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCc
Confidence 1 112234578999999999887789999999999999999999999954321
Q ss_pred CcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 005102 642 SEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISD 704 (714)
Q Consensus 642 ~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 704 (714)
....+............. ...... ....+.+++.+||..||++|||++|+++
T Consensus 226 --~~~~~~~~~i~~~~~~~~----~~~~~~-----~s~~~~~li~~~L~~dP~~R~t~~~il~ 277 (342)
T 2qr7_A 226 --DTPEEILARIGSGKFSLS----GGYWNS-----VSDTAKDLVSKMLHVDPHQRLTAALVLR 277 (342)
T ss_dssp --SCHHHHHHHHHHCCCCCC----STTTTT-----SCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred --CCHHHHHHHHccCCcccC----cccccc-----CCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 222233333322222111 000011 1236789999999999999999999875
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-40 Score=342.38 Aligned_cols=244 Identities=25% Similarity=0.325 Sum_probs=193.7
Q ss_pred cccccccCceEEEEEEEC-CCcEEEEEEeCCCCchhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCCCH
Q 005102 408 AFVLGKSGIGIVYKVVLE-DGHTLAVRRLGEGGSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGSL 486 (714)
Q Consensus 408 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL 486 (714)
.+.||+|+||.||+|+.. +|+.||+|++........+.+.+|++++++++||||+++++++...+..++||||+++++|
T Consensus 14 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 93 (304)
T 2jam_A 14 MEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLVSGGEL 93 (304)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBH
T ss_pred eeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEcCCCccH
Confidence 357999999999999986 5899999999876554556789999999999999999999999999999999999999999
Q ss_pred hhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeee---CCCCCeEEcccchhhhhhccCC
Q 005102 487 ATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILL---GHNMEPHVSDFGLARLANIAGG 563 (714)
Q Consensus 487 ~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl---~~~~~~kl~DFGla~~~~~~~~ 563 (714)
.+++... ..+++..+..++.|++.||+|||+ .+|+||||||+||++ ++++.+||+|||+++.....
T Consensus 94 ~~~l~~~------~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~-- 162 (304)
T 2jam_A 94 FDRILER------GVYTEKDASLVIQQVLSAVKYLHE---NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG-- 162 (304)
T ss_dssp HHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCB--
T ss_pred HHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEecCCCCCCEEEccCCcceecCCC--
Confidence 9998654 458999999999999999999999 899999999999999 78899999999998643211
Q ss_pred CCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCccccCCCCc
Q 005102 564 SPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGSSE 643 (714)
Q Consensus 564 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~~~~~~~~ 643 (714)
......||+.|+|||.+.+..++.++||||||+++|||++|+.||.... .
T Consensus 163 ----------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~--~ 212 (304)
T 2jam_A 163 ----------------------------IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEET--E 212 (304)
T ss_dssp ----------------------------TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSC--H
T ss_pred ----------------------------ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCC--H
Confidence 0011235788999999999999999999999999999999999994321 1
Q ss_pred chhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 005102 644 MDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISD 704 (714)
Q Consensus 644 ~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 704 (714)
............... .+ .... ....+.+++.+||+.||++|||++|+++
T Consensus 213 ---~~~~~~i~~~~~~~~---~~-~~~~-----~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (304)
T 2jam_A 213 ---SKLFEKIKEGYYEFE---SP-FWDD-----ISESAKDFICHLLEKDPNERYTCEKALS 261 (304)
T ss_dssp ---HHHHHHHHHCCCCCC---TT-TTTT-----SCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred ---HHHHHHHHcCCCCCC---cc-cccc-----CCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 122222222211110 11 1111 1236889999999999999999999975
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-40 Score=355.04 Aligned_cols=244 Identities=21% Similarity=0.310 Sum_probs=190.1
Q ss_pred ccccccCceEEEEEEECCCcEEEEEEeCCC--CchhHHHHHHHHHHHhccC--CCCccceEEEEEeCCceeEEEeccCCC
Q 005102 409 FVLGKSGIGIVYKVVLEDGHTLAVRRLGEG--GSQRFKEFQTEVEAIGKIR--HSNIVTLRAYYWSVDEKLLIYDYIPNG 484 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~--H~niv~l~~~~~~~~~~~lV~e~~~~g 484 (714)
+.||+|+||.||+|...+++.||||++... .....+.+.+|++++++++ ||||+++++++...+..++||| +.++
T Consensus 62 ~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~E-~~~~ 140 (390)
T 2zmd_A 62 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNI 140 (390)
T ss_dssp EEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEE-CCSE
T ss_pred EEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEEe-cCCC
Confidence 579999999999999988999999998754 3344578999999999996 5999999999999999999999 5688
Q ss_pred CHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCC
Q 005102 485 SLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGS 564 (714)
Q Consensus 485 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 564 (714)
+|.+++... ..+++.++..|+.||+.||+|||+ .+|+||||||+|||++ ++.+||+|||+++.......
T Consensus 141 ~L~~~l~~~------~~~~~~~~~~i~~qi~~aL~~lH~---~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~- 209 (390)
T 2zmd_A 141 DLNSWLKKK------KSIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTT- 209 (390)
T ss_dssp EHHHHHHHC------SSCCHHHHHHHHHHHHHHHHHHHT---TTCCCCCCCGGGEEES-SSCEEECCCSSSCCC------
T ss_pred CHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHEEEE-CCeEEEEecCccccccCCCc-
Confidence 999999865 458899999999999999999999 8999999999999996 57899999999986532210
Q ss_pred CCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCC-----------CCCCchhhhHHHHHHHHHHHhCC
Q 005102 565 PTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKV-----------VKPSQKWDIYSYGVILLEMITGR 633 (714)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~s~~~DVwS~Gvvl~elltG~ 633 (714)
........||+.|+|||++.+ ..++.++|||||||++|||++|+
T Consensus 210 -------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~ 264 (390)
T 2zmd_A 210 -------------------------SVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 264 (390)
T ss_dssp -----------------------------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSS
T ss_pred -------------------------cccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCC
Confidence 111234468999999999865 46899999999999999999999
Q ss_pred CccccCCCCcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 005102 634 TAVVQVGSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISD 704 (714)
Q Consensus 634 ~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 704 (714)
.||..... ....+......... ....... ...+.+++.+||+.||++|||++|+++
T Consensus 265 ~Pf~~~~~----~~~~~~~~~~~~~~------~~~~~~~-----~~~~~~li~~~L~~dP~~Rps~~ell~ 320 (390)
T 2zmd_A 265 TPFQQIIN----QISKLHAIIDPNHE------IEFPDIP-----EKDLQDVLKCCLKRDPKQRISIPELLA 320 (390)
T ss_dssp CTTTTCCC----HHHHHHHHHCTTSC------CCCCCCS-----CHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CcchhhhH----HHHHHHHHhCcccc------CCCCccc-----hHHHHHHHHHHcccChhhCCCHHHHhh
Confidence 99953221 11112222211110 0111111 235789999999999999999999975
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-40 Score=350.89 Aligned_cols=248 Identities=14% Similarity=0.181 Sum_probs=196.9
Q ss_pred ccccccCceEEEEEE------ECCCcEEEEEEeCCCCchhHHHHHHHHHHHhccC---CCCccceEEEEEeCCceeEEEe
Q 005102 409 FVLGKSGIGIVYKVV------LEDGHTLAVRRLGEGGSQRFKEFQTEVEAIGKIR---HSNIVTLRAYYWSVDEKLLIYD 479 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~------~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---H~niv~l~~~~~~~~~~~lV~e 479 (714)
+.||+|+||+||+|. ..+++.||||++.... ..++.+|++++.+++ |+||+++++++...+..++|||
T Consensus 71 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~~~~lv~e 147 (365)
T 3e7e_A 71 HLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN---PWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGE 147 (365)
T ss_dssp EEEEECSSEEEEEEEC-------CCCCEEEEEESSCC---HHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSSCEEEEEC
T ss_pred EEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC---hhHHHHHHHHHHHhhhhhhhhhhhhheeeecCCCcEEEEe
Confidence 479999999999994 4468999999997653 356778888888876 9999999999999999999999
Q ss_pred ccCCCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCC-----------CCCeE
Q 005102 480 YIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGH-----------NMEPH 548 (714)
Q Consensus 480 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~-----------~~~~k 548 (714)
|+++|+|.+++...... ....+++..++.|+.||+.||+|||+ ++|+||||||+|||++. ++.+|
T Consensus 148 ~~~~g~L~~~l~~~~~~-~~~~l~~~~~~~i~~qi~~~L~~lH~---~~ivHrDiKp~NIll~~~~~~~~~~~~~~~~~k 223 (365)
T 3e7e_A 148 LYSYGTLLNAINLYKNT-PEKVMPQGLVISFAMRMLYMIEQVHD---CEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLA 223 (365)
T ss_dssp CCCSCBHHHHHHHHHTS-TTCSCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCSGGGEEECGGGTCC------CTTEE
T ss_pred ccCCCcHHHHHHHhhcc-cccCCCHHHHHHHHHHHHHHHHHHhh---CCeecCCCCHHHEEecccccCccccccccCCEE
Confidence 99999999999742110 01469999999999999999999999 89999999999999998 89999
Q ss_pred EcccchhhhhhccCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHH
Q 005102 549 VSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLE 628 (714)
Q Consensus 549 l~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~e 628 (714)
|+|||+|+....... ........||+.|+|||++.+..++.++|||||||++||
T Consensus 224 l~DFG~a~~~~~~~~--------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~e 277 (365)
T 3e7e_A 224 LIDLGQSIDMKLFPK--------------------------GTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYC 277 (365)
T ss_dssp ECCCTTCEEGGGSCT--------------------------TEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHH
T ss_pred EeeCchhhhhhccCC--------------------------CceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHH
Confidence 999999976532110 112234568999999999999999999999999999999
Q ss_pred HHhCCCccccCCCCcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCC-CCHHHHHHHHh
Q 005102 629 MITGRTAVVQVGSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKR-PTMRHISDALD 707 (714)
Q Consensus 629 lltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~R-Pt~~evl~~L~ 707 (714)
|+||+.||........ ........... ...+.+++..|++.+|.+| |+++++.+.|+
T Consensus 278 lltg~~pf~~~~~~~~------------------~~~~~~~~~~~----~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~ 335 (365)
T 3e7e_A 278 MLFGTYMKVKNEGGEC------------------KPEGLFRRLPH----LDMWNEFFHVMLNIPDCHHLPSLDLLRQKLK 335 (365)
T ss_dssp HHHSSCCCEEEETTEE------------------EECSCCTTCSS----HHHHHHHHHHHHCCCCTTCCCCHHHHHHHHH
T ss_pred HHhCCCccccCCCCce------------------eechhccccCc----HHHHHHHHHHHcCCCCCCcchHHHHHHHHHH
Confidence 9999999943322111 01111111111 2356688999999999999 78899999988
Q ss_pred hhhc
Q 005102 708 RLIV 711 (714)
Q Consensus 708 ~i~~ 711 (714)
++..
T Consensus 336 ~~l~ 339 (365)
T 3e7e_A 336 KVFQ 339 (365)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 8654
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=341.61 Aligned_cols=242 Identities=22% Similarity=0.347 Sum_probs=176.2
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeCCCC---chhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCC
Q 005102 409 FVLGKSGIGIVYKVVLE-DGHTLAVRRLGEGG---SQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNG 484 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~g 484 (714)
+.||+|+||.||+|+.. +|+.||||++.... ....+.+.+|++++++++||||+++++++...+..++||||++++
T Consensus 17 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 96 (278)
T 3cok_A 17 NLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVLEMCHNG 96 (278)
T ss_dssp EEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEEECCTTE
T ss_pred eeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEEecCCCC
Confidence 47999999999999974 68999999986532 223467899999999999999999999999999999999999999
Q ss_pred CHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCC
Q 005102 485 SLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGS 564 (714)
Q Consensus 485 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 564 (714)
+|.+++.... ..+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++......
T Consensus 97 ~L~~~l~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~-- 166 (278)
T 3cok_A 97 EMNRYLKNRV-----KPFSENEARHFMHQIITGMLYLHS---HGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPH-- 166 (278)
T ss_dssp EHHHHHHTCS-----SCCCHHHHHHHHHHHHHHHHHHHH---TTEECSSCCGGGEEECTTCCEEECCCTTCEECC-----
T ss_pred cHHHHHhhcc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEEEeecceeeccCCC--
Confidence 9999998653 458999999999999999999999 899999999999999999999999999987643211
Q ss_pred CCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCccccCCCCcc
Q 005102 565 PTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGSSEM 644 (714)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~~~~~~~~~ 644 (714)
.......||+.|+|||.+.+..++.++||||||+++|||++|+.||........
T Consensus 167 --------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~ 220 (278)
T 3cok_A 167 --------------------------EKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNT 220 (278)
T ss_dssp ---------------------------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC--
T ss_pred --------------------------CcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHH
Confidence 011223468889999999988899999999999999999999999953322110
Q ss_pred hhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 005102 645 DLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISD 704 (714)
Q Consensus 645 ~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 704 (714)
.. .. ... +...... ....+.+++.+||+.||++|||++++++
T Consensus 221 -----~~----~~-~~~---~~~~~~~-----~~~~~~~li~~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 221 -----LN----KV-VLA---DYEMPSF-----LSIEAKDLIHQLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp ------------C-CSS---CCCCCTT-----SCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred -----HH----HH-hhc---ccCCccc-----cCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence 00 00 000 1111111 1236789999999999999999999875
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-40 Score=346.78 Aligned_cols=260 Identities=24% Similarity=0.338 Sum_probs=202.4
Q ss_pred cccccccCceEEEEEEE------CCCcEEEEEEeCCCCc-hhHHHHHHHHHHHhcc-CCCCccceEEEEEeCC-ceeEEE
Q 005102 408 AFVLGKSGIGIVYKVVL------EDGHTLAVRRLGEGGS-QRFKEFQTEVEAIGKI-RHSNIVTLRAYYWSVD-EKLLIY 478 (714)
Q Consensus 408 ~~~lG~G~~g~Vy~~~~------~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~-~~~lV~ 478 (714)
.+.||+|+||.||+|++ .+++.||||++..... ...+.+.+|++++.++ +||||+++++++...+ ..++||
T Consensus 32 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~~lv~ 111 (316)
T 2xir_A 32 GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIV 111 (316)
T ss_dssp EEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSCCEEEE
T ss_pred eeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecCCCceEEEE
Confidence 35799999999999985 2468999999987543 3446799999999999 7999999999998755 489999
Q ss_pred eccCCCCHhhhhhCCCCCC----------CcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeE
Q 005102 479 DYIPNGSLATALHGKPGMV----------SFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPH 548 (714)
Q Consensus 479 e~~~~gsL~~~l~~~~~~~----------~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~k 548 (714)
||+++|+|.+++....... ....+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+|
T Consensus 112 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dikp~Nil~~~~~~~k 188 (316)
T 2xir_A 112 EFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVK 188 (316)
T ss_dssp ECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEE
T ss_pred EcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHh---CCcccccCccceEEECCCCCEE
Confidence 9999999999998654210 01238899999999999999999999 8999999999999999999999
Q ss_pred EcccchhhhhhccCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHH
Q 005102 549 VSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLE 628 (714)
Q Consensus 549 l~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~e 628 (714)
|+|||+++....... ........||+.|+|||.+.+..++.++||||||+++||
T Consensus 189 l~Dfg~~~~~~~~~~--------------------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~ 242 (316)
T 2xir_A 189 ICDFGLARDIYKDPD--------------------------YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWE 242 (316)
T ss_dssp ECCCGGGSCTTTCTT--------------------------SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHH
T ss_pred ECCCccccccccCcc--------------------------ceeccCCCcceeecCchhhccccccchhHHHHHHHHHHH
Confidence 999999986532110 011122335778999999998899999999999999999
Q ss_pred HHh-CCCccccCCCCcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHh
Q 005102 629 MIT-GRTAVVQVGSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDALD 707 (714)
Q Consensus 629 llt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~ 707 (714)
|+| |+.||....... . +......... ...... ....+.+++.+||+.||++|||++|+++.|+
T Consensus 243 l~t~g~~p~~~~~~~~-~----~~~~~~~~~~------~~~~~~-----~~~~l~~li~~~l~~dp~~Rps~~ell~~L~ 306 (316)
T 2xir_A 243 IFSLGASPYPGVKIDE-E----FCRRLKEGTR------MRAPDY-----TTPEMYQTMLDCWHGEPSQRPTFSELVEHLG 306 (316)
T ss_dssp HHTTSCCSSTTCCCSH-H----HHHHHHHTCC------CCCCTT-----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHhCCCCCCcccchhH-H----HHHHhccCcc------CCCCCC-----CCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 998 999995432221 1 1111222111 111111 1235889999999999999999999999999
Q ss_pred hhhcc
Q 005102 708 RLIVS 712 (714)
Q Consensus 708 ~i~~~ 712 (714)
++...
T Consensus 307 ~~~~~ 311 (316)
T 2xir_A 307 NLLQA 311 (316)
T ss_dssp HHHHH
T ss_pred HHHhh
Confidence 98753
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-40 Score=341.12 Aligned_cols=242 Identities=19% Similarity=0.311 Sum_probs=196.7
Q ss_pred cccccccCceEEEEEEECC-CcEEEEEEeCCC---CchhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCC
Q 005102 408 AFVLGKSGIGIVYKVVLED-GHTLAVRRLGEG---GSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPN 483 (714)
Q Consensus 408 ~~~lG~G~~g~Vy~~~~~~-g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~ 483 (714)
.+.||+|+||.||+|...+ ++.||+|++... .....+.+.+|+.++++++||||+++++++...+..++||||+++
T Consensus 20 ~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 99 (294)
T 2rku_A 20 GRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRR 99 (294)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCTT
T ss_pred EEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEEecCCC
Confidence 3589999999999999874 789999998754 223456789999999999999999999999999999999999999
Q ss_pred CCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCC
Q 005102 484 GSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGG 563 (714)
Q Consensus 484 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 563 (714)
++|.+++... ..+++.++..++.|++.||+|||+ .+|+||||||+||++++++.+||+|||+++......
T Consensus 100 ~~L~~~~~~~------~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~- 169 (294)
T 2rku_A 100 RSLLELHKRR------KALTEPEARYYLRQIVLGCQYLHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG- 169 (294)
T ss_dssp CBHHHHHHHH------CSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECCSTT-
T ss_pred CCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChHhEEEcCCCCEEEEeccCceecccCc-
Confidence 9999988754 458999999999999999999999 899999999999999999999999999987643211
Q ss_pred CCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCccccCCCCc
Q 005102 564 SPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGSSE 643 (714)
Q Consensus 564 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~~~~~~~~ 643 (714)
.......||+.|+|||.+.+..++.++||||||+++|||++|+.||....
T Consensus 170 ---------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~--- 219 (294)
T 2rku_A 170 ---------------------------ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSC--- 219 (294)
T ss_dssp ---------------------------CCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSS---
T ss_pred ---------------------------cccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC---
Confidence 01123456889999999998889999999999999999999999994321
Q ss_pred chhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 005102 644 MDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISD 704 (714)
Q Consensus 644 ~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 704 (714)
..+........... ..... ...+.+++.+||+.||++|||++|+++
T Consensus 220 --~~~~~~~~~~~~~~--------~~~~~-----~~~~~~li~~~l~~~p~~Rps~~~ll~ 265 (294)
T 2rku_A 220 --LKETYLRIKKNEYS--------IPKHI-----NPVAASLIQKMLQTDPTARPTINELLN 265 (294)
T ss_dssp --HHHHHHHHHTTCCC--------CCTTS-----CHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred --HHHHHHHHhhccCC--------Ccccc-----CHHHHHHHHHHcccChhhCcCHHHHhh
Confidence 11112222111111 11111 125789999999999999999999886
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=335.81 Aligned_cols=247 Identities=24% Similarity=0.315 Sum_probs=197.8
Q ss_pred cccccccCceEEEEEEEC-CCcEEEEEEeCCCC-chhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCCC
Q 005102 408 AFVLGKSGIGIVYKVVLE-DGHTLAVRRLGEGG-SQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGS 485 (714)
Q Consensus 408 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gs 485 (714)
.+.||+|+||.||+|... +++.||||++.... ....+.+.+|+.++++++||||+++++++...+..++||||+++++
T Consensus 12 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 91 (276)
T 2yex_A 12 VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGE 91 (276)
T ss_dssp EEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEE
T ss_pred EEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEEecCCCc
Confidence 357999999999999986 58999999987543 3345778999999999999999999999999999999999999999
Q ss_pred HhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCCC
Q 005102 486 LATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSP 565 (714)
Q Consensus 486 L~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 565 (714)
|.+++... ..+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++.......
T Consensus 92 L~~~l~~~------~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~-- 160 (276)
T 2yex_A 92 LFDRIEPD------IGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR-- 160 (276)
T ss_dssp GGGGSBTT------TBCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTE--
T ss_pred HHHHHhhc------cCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcc--
Confidence 99998754 458999999999999999999999 8999999999999999999999999999876532110
Q ss_pred CccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCC-CchhhhHHHHHHHHHHHhCCCccccCCCCcc
Q 005102 566 TLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKP-SQKWDIYSYGVILLEMITGRTAVVQVGSSEM 644 (714)
Q Consensus 566 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~~DVwS~Gvvl~elltG~~p~~~~~~~~~ 644 (714)
........||+.|+|||.+.+..+ +.++||||||+++|||++|+.||........
T Consensus 161 ------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~ 216 (276)
T 2yex_A 161 ------------------------ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ 216 (276)
T ss_dssp ------------------------ECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSH
T ss_pred ------------------------hhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHH
Confidence 111233457889999999987665 7899999999999999999999965433322
Q ss_pred hhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 005102 645 DLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISD 704 (714)
Q Consensus 645 ~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 704 (714)
....+. ..... ..+ .......+.+++.+||+.||++|||++|+++
T Consensus 217 ~~~~~~----~~~~~----~~~-------~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (276)
T 2yex_A 217 EYSDWK----EKKTY----LNP-------WKKIDSAPLALLHKILVENPSARITIPDIKK 261 (276)
T ss_dssp HHHHHH----TTCTT----STT-------GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred HHHHhh----hcccc----cCc-------hhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence 222221 11100 000 0112235789999999999999999999875
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-40 Score=346.40 Aligned_cols=258 Identities=21% Similarity=0.329 Sum_probs=202.4
Q ss_pred cccccccCceEEEEEEEC------CCcEEEEEEeCCCCc-hhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEec
Q 005102 408 AFVLGKSGIGIVYKVVLE------DGHTLAVRRLGEGGS-QRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDY 480 (714)
Q Consensus 408 ~~~lG~G~~g~Vy~~~~~------~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~ 480 (714)
.+.||+|+||.||+|++. +++.||||++..... .....+.+|++++++++||||+++++++...+..++||||
T Consensus 30 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 109 (322)
T 1p4o_A 30 SRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMEL 109 (322)
T ss_dssp EEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred eeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCCccEEEEEe
Confidence 357999999999999865 368899999986533 3445789999999999999999999999999999999999
Q ss_pred cCCCCHhhhhhCCCC----CCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhh
Q 005102 481 IPNGSLATALHGKPG----MVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLAR 556 (714)
Q Consensus 481 ~~~gsL~~~l~~~~~----~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~ 556 (714)
+++|+|.+++..... ......+++..+.+++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||+++
T Consensus 110 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~NIli~~~~~~kl~Dfg~~~ 186 (322)
T 1p4o_A 110 MTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTR 186 (322)
T ss_dssp CTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCSGGGEEECTTCCEEECCTTCCC
T ss_pred CCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHH---CCCccCCCccceEEEcCCCeEEECcCcccc
Confidence 999999999864210 0001347899999999999999999999 899999999999999999999999999998
Q ss_pred hhhccCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHh-CCCc
Q 005102 557 LANIAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMIT-GRTA 635 (714)
Q Consensus 557 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~ellt-G~~p 635 (714)
....... ........+|+.|+|||.+.+..++.++||||||+++|||+| |+.|
T Consensus 187 ~~~~~~~--------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p 240 (322)
T 1p4o_A 187 DIYETDY--------------------------YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP 240 (322)
T ss_dssp GGGGGGC--------------------------EEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCT
T ss_pred ccccccc--------------------------cccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCc
Confidence 6542210 111222345778999999998899999999999999999999 8888
Q ss_pred cccCCCCcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhhhhc
Q 005102 636 VVQVGSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDALDRLIV 711 (714)
Q Consensus 636 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~ 711 (714)
|.... ............. . ..... ....+.+++.+||+.||++|||+.|+++.|+++..
T Consensus 241 ~~~~~-----~~~~~~~~~~~~~--~-----~~~~~-----~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~ 299 (322)
T 1p4o_A 241 YQGLS-----NEQVLRFVMEGGL--L-----DKPDN-----CPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 299 (322)
T ss_dssp TTTSC-----HHHHHHHHHTTCC--C-----CCCTT-----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred cccCC-----HHHHHHHHHcCCc--C-----CCCCC-----CCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence 84321 1122222222111 0 01111 22358899999999999999999999999998754
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-40 Score=348.45 Aligned_cols=256 Identities=20% Similarity=0.244 Sum_probs=192.7
Q ss_pred cccccccCceEEEEEEEC-CCcEEEEEEeCCC-----CchhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEecc
Q 005102 408 AFVLGKSGIGIVYKVVLE-DGHTLAVRRLGEG-----GSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYI 481 (714)
Q Consensus 408 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~ 481 (714)
.+.||+|+||.||+|... ++..||+|++... .....+.+.+|++++++++||||+++++++.+.+..++||||+
T Consensus 31 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 110 (345)
T 3hko_A 31 KGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELC 110 (345)
T ss_dssp EEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred cceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEEEEEeCC
Confidence 458999999999999985 4889999998653 2344578999999999999999999999999999999999999
Q ss_pred CCCCHhhhhhCCCCC----------------------------------CCcCCCCHHHHHHHHHHHHHHHHHHhcCCCC
Q 005102 482 PNGSLATALHGKPGM----------------------------------VSFTPVPWSVRVKIIKGIAKGLVYLHEFSPK 527 (714)
Q Consensus 482 ~~gsL~~~l~~~~~~----------------------------------~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~ 527 (714)
++|+|.+++...... .....+++..+..|+.|++.||+|||+ .
T Consensus 111 ~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~---~ 187 (345)
T 3hko_A 111 HGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHN---Q 187 (345)
T ss_dssp CSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHHHH---T
T ss_pred CCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHH---C
Confidence 999999998521000 000124577788999999999999999 8
Q ss_pred CceecCCCCCCeeeCCCC--CeEEcccchhhhhhccCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCC
Q 005102 528 KYVHGDLKPSNILLGHNM--EPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAP 605 (714)
Q Consensus 528 ~ivHrDlkp~NILl~~~~--~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP 605 (714)
+|+||||||+||+++.++ .+||+|||+++......... ........||+.|+||
T Consensus 188 ~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~------------------------~~~~~~~~gt~~y~aP 243 (345)
T 3hko_A 188 GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGE------------------------YYGMTTKAGTPYFVAP 243 (345)
T ss_dssp TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------------------------------CCCGGGCCH
T ss_pred CccccCCChhhEEEecCCCceEEEeeccccccccccCccc------------------------cccccccCCCccccCc
Confidence 999999999999998776 89999999998654321100 1112334578999999
Q ss_pred cccCC--CCCCchhhhHHHHHHHHHHHhCCCccccCCCCcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHH
Q 005102 606 ESLKV--VKPSQKWDIYSYGVILLEMITGRTAVVQVGSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLK 683 (714)
Q Consensus 606 E~~~~--~~~s~~~DVwS~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~ 683 (714)
|.+.+ ..++.++|||||||++|||++|+.||..... .+............. .+. .......+.+
T Consensus 244 E~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-----~~~~~~~~~~~~~~~---~~~------~~~~~~~~~~ 309 (345)
T 3hko_A 244 EVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVND-----ADTISQVLNKKLCFE---NPN------YNVLSPLARD 309 (345)
T ss_dssp HHHTCSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHHHHHHCCCCTT---SGG------GGGSCHHHHH
T ss_pred hhhccCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCh-----HHHHHHHHhcccccC---Ccc------cccCCHHHHH
Confidence 99965 6789999999999999999999999943221 122222222221110 010 0112236889
Q ss_pred HHhHccCCCCCCCCCHHHHHH
Q 005102 684 IAMACVHSSPEKRPTMRHISD 704 (714)
Q Consensus 684 li~~Cl~~dP~~RPt~~evl~ 704 (714)
++.+||+.||++|||+.|+++
T Consensus 310 li~~~l~~~p~~Rps~~~~l~ 330 (345)
T 3hko_A 310 LLSNLLNRNVDERFDAMRALQ 330 (345)
T ss_dssp HHHHHSCSCTTTSCCHHHHHH
T ss_pred HHHHHcCCChhHCCCHHHHhc
Confidence 999999999999999999976
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-40 Score=348.30 Aligned_cols=241 Identities=19% Similarity=0.311 Sum_probs=196.7
Q ss_pred ccccccCceEEEEEEECC-CcEEEEEEeCCC---CchhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCC
Q 005102 409 FVLGKSGIGIVYKVVLED-GHTLAVRRLGEG---GSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNG 484 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~~-g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~g 484 (714)
+.||+|+||.||++.+.+ ++.||+|++... .....+.+.+|+.++++++||||+++++++.+.+..++||||++++
T Consensus 47 ~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 126 (335)
T 2owb_A 47 RFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRR 126 (335)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCTTC
T ss_pred EEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEecCCCC
Confidence 479999999999999865 789999998754 2334567899999999999999999999999999999999999999
Q ss_pred CHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCC
Q 005102 485 SLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGS 564 (714)
Q Consensus 485 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 564 (714)
+|.+++... ..+++.++..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++......
T Consensus 127 ~L~~~~~~~------~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~-- 195 (335)
T 2owb_A 127 SLLELHKRR------KALTEPEARYYLRQIVLGCQYLHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG-- 195 (335)
T ss_dssp BHHHHHHHH------CSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCTTCEECCSTT--
T ss_pred CHHHHHhcc------CCCCHHHHHHHHHHHHHHHHHHHH---CCCEecCCCchhEEEcCCCCEEEeeccCceecccCc--
Confidence 999998754 458999999999999999999999 899999999999999999999999999997653211
Q ss_pred CCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCccccCCCCcc
Q 005102 565 PTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGSSEM 644 (714)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~~~~~~~~~ 644 (714)
.......||+.|+|||++.+..++.++||||||+++|||++|+.||....
T Consensus 196 --------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~---- 245 (335)
T 2owb_A 196 --------------------------ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSC---- 245 (335)
T ss_dssp --------------------------CCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSS----
T ss_pred --------------------------ccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCC----
Confidence 11123457889999999998889999999999999999999999994321
Q ss_pred hhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 005102 645 DLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISD 704 (714)
Q Consensus 645 ~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 704 (714)
..+........... +.... ...+.+++.+||+.||++|||++|+++
T Consensus 246 -~~~~~~~~~~~~~~--------~~~~~-----~~~~~~li~~~l~~dp~~Rps~~ell~ 291 (335)
T 2owb_A 246 -LKETYLRIKKNEYS--------IPKHI-----NPVAASLIQKMLQTDPTARPTINELLN 291 (335)
T ss_dssp -HHHHHHHHHHTCCC--------CCTTS-----CHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred -HHHHHHHHhcCCCC--------CCccC-----CHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 11222222222111 11111 125778999999999999999999876
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=352.77 Aligned_cols=236 Identities=17% Similarity=0.274 Sum_probs=192.9
Q ss_pred cccccccCceEEEEEEEC-CCcEEEEEEeCCCCc--------hhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEE
Q 005102 408 AFVLGKSGIGIVYKVVLE-DGHTLAVRRLGEGGS--------QRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIY 478 (714)
Q Consensus 408 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 478 (714)
.+.||+|+||.||+|+.. +++.||||++..... ...+.+.+|++++++++||||+++++++...+..++||
T Consensus 29 ~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~ 108 (335)
T 3dls_A 29 MSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGFFQLVM 108 (335)
T ss_dssp EEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred EeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCCEEEEEE
Confidence 357999999999999975 589999999976431 12345778999999999999999999999999999999
Q ss_pred eccCCC-CHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhh
Q 005102 479 DYIPNG-SLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARL 557 (714)
Q Consensus 479 e~~~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 557 (714)
||+..| +|.+++... ..+++..+..|+.|++.||+|||+ .+|+||||||+|||+++++.+||+|||+++.
T Consensus 109 e~~~~g~~l~~~~~~~------~~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~ 179 (335)
T 3dls_A 109 EKHGSGLDLFAFIDRH------PRLDEPLASYIFRQLVSAVGYLRL---KDIIHRDIKDENIVIAEDFTIKLIDFGSAAY 179 (335)
T ss_dssp ECCTTSCBHHHHHHTC------CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred EeCCCCccHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHh---CCeEEeccCHHHEEEcCCCcEEEeecccceE
Confidence 999777 999999765 458999999999999999999999 8999999999999999999999999999976
Q ss_pred hhccCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCC-CchhhhHHHHHHHHHHHhCCCcc
Q 005102 558 ANIAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKP-SQKWDIYSYGVILLEMITGRTAV 636 (714)
Q Consensus 558 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~~DVwS~Gvvl~elltG~~p~ 636 (714)
..... ......||+.|+|||++.+..+ +.++|||||||++|||++|+.||
T Consensus 180 ~~~~~-----------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf 230 (335)
T 3dls_A 180 LERGK-----------------------------LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPF 230 (335)
T ss_dssp CCTTC-----------------------------CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSC
T ss_pred CCCCC-----------------------------ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCch
Confidence 53211 1122347899999999988776 88999999999999999999999
Q ss_pred ccCCCCcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 005102 637 VQVGSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDA 705 (714)
Q Consensus 637 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 705 (714)
..... ........... ....+.+++.+||+.||++|||++|+++.
T Consensus 231 ~~~~~---------------------~~~~~~~~~~~---~~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 231 CELEE---------------------TVEAAIHPPYL---VSKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp SSGGG---------------------GTTTCCCCSSC---CCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred hhHHH---------------------HHhhccCCCcc---cCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 43110 00011110100 12358899999999999999999999873
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-40 Score=341.47 Aligned_cols=243 Identities=24% Similarity=0.396 Sum_probs=197.3
Q ss_pred cccccccCceEEEEEEEC-CCcEEEEEEeCCCCchhHHHHHHHHHHHhccCCCCccceEEEEEe----------------
Q 005102 408 AFVLGKSGIGIVYKVVLE-DGHTLAVRRLGEGGSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWS---------------- 470 (714)
Q Consensus 408 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~---------------- 470 (714)
.+.||+|+||.||+|.+. +++.||+|++.... +.+.+|++++++++||||+++++++..
T Consensus 16 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 91 (284)
T 2a19_B 16 IELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSK 91 (284)
T ss_dssp EEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC---------CCE
T ss_pred eeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccccccccC
Confidence 357999999999999986 69999999997654 356789999999999999999999864
Q ss_pred CCceeEEEeccCCCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEc
Q 005102 471 VDEKLLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVS 550 (714)
Q Consensus 471 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~ 550 (714)
....++||||+++|+|.+++..... ..+++..+..++.|++.||+|||+ .+|+||||||+||++++++.+||+
T Consensus 92 ~~~~~lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~ 164 (284)
T 2a19_B 92 TKCLFIQMEFCDKGTLEQWIEKRRG----EKLDKVLALELFEQITKGVDYIHS---KKLINRDLKPSNIFLVDTKQVKIG 164 (284)
T ss_dssp EEEEEEEECCCCSCBHHHHHHHGGG----SCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEEC
T ss_pred cceEEEEEeccCCCCHHHHHhhccC----CCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCCHHHEEEcCCCCEEEC
Confidence 3457899999999999999975422 458999999999999999999999 899999999999999999999999
Q ss_pred ccchhhhhhccCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHH
Q 005102 551 DFGLARLANIAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMI 630 (714)
Q Consensus 551 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~ell 630 (714)
|||+++...... ......||+.|+|||.+.+..++.++||||||+++|||+
T Consensus 165 Dfg~~~~~~~~~-----------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~ 215 (284)
T 2a19_B 165 DFGLVTSLKNDG-----------------------------KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELL 215 (284)
T ss_dssp CCTTCEESSCCS-----------------------------CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHH
T ss_pred cchhheeccccc-----------------------------cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHH
Confidence 999987653211 112234688999999999889999999999999999999
Q ss_pred hCCCccccCCCCcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhhhh
Q 005102 631 TGRTAVVQVGSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDALDRLI 710 (714)
Q Consensus 631 tG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~ 710 (714)
+|..|+... ..+.... .. .......+ ..+.+++.+||+.||++|||+.|+++.|+.+.
T Consensus 216 ~~~~~~~~~-------~~~~~~~-~~---------~~~~~~~~-----~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~ 273 (284)
T 2a19_B 216 HVCDTAFET-------SKFFTDL-RD---------GIISDIFD-----KKEKTLLQKLLSKKPEDRPNTSEILRTLTVWK 273 (284)
T ss_dssp SCCSSHHHH-------HHHHHHH-HT---------TCCCTTSC-----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHT
T ss_pred hcCCcchhH-------HHHHHHh-hc---------ccccccCC-----HHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence 999988321 1111111 11 11111111 25778999999999999999999999999887
Q ss_pred cc
Q 005102 711 VS 712 (714)
Q Consensus 711 ~~ 712 (714)
.+
T Consensus 274 ~~ 275 (284)
T 2a19_B 274 KS 275 (284)
T ss_dssp C-
T ss_pred hC
Confidence 54
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-40 Score=350.15 Aligned_cols=191 Identities=28% Similarity=0.369 Sum_probs=168.9
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeCCCC-chhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCCCH
Q 005102 409 FVLGKSGIGIVYKVVLE-DGHTLAVRRLGEGG-SQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGSL 486 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL 486 (714)
+.||+|+||.||+|.+. +++.||+|++.... ....+.+.+|++++++++||||+++++++...+..++||||+++|+|
T Consensus 39 ~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 118 (360)
T 3eqc_A 39 SELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSL 118 (360)
T ss_dssp EEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECCCTTCBH
T ss_pred eeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEECCCCCCH
Confidence 47999999999999986 58999999997653 33456799999999999999999999999999999999999999999
Q ss_pred hhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCC-CceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCCC
Q 005102 487 ATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPK-KYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSP 565 (714)
Q Consensus 487 ~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~-~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 565 (714)
.+++... ..+++..+.+|+.|++.||+|||+ . +|+||||||+||+++.++.+||+|||+++.....
T Consensus 119 ~~~l~~~------~~~~~~~~~~i~~~i~~~l~~lh~---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~---- 185 (360)
T 3eqc_A 119 DQVLKKA------GRIPEQILGKVSIAVIKGLTYLRE---KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---- 185 (360)
T ss_dssp HHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHH---HHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH----
T ss_pred HHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---hCCEEcCCccHHHEEECCCCCEEEEECCCCcccccc----
Confidence 9999764 458999999999999999999998 6 8999999999999999999999999999765421
Q ss_pred CccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCcccc
Q 005102 566 TLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQ 638 (714)
Q Consensus 566 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~~~ 638 (714)
......||+.|+|||++.+..++.++|||||||++|||+||+.||..
T Consensus 186 --------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 232 (360)
T 3eqc_A 186 --------------------------MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPP 232 (360)
T ss_dssp --------------------------C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSC
T ss_pred --------------------------cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 11233578899999999999999999999999999999999999954
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-40 Score=340.48 Aligned_cols=241 Identities=22% Similarity=0.325 Sum_probs=190.3
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeCCC--CchhHHHHHHHHHHHhccCCCCccceEEEEEe----CCceeEEEecc
Q 005102 409 FVLGKSGIGIVYKVVLE-DGHTLAVRRLGEG--GSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWS----VDEKLLIYDYI 481 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~----~~~~~lV~e~~ 481 (714)
..||+|+||.||+|.+. ++..||+|++... .....+.+.+|+.++++++||||+++++++.. ....++||||+
T Consensus 32 ~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~ 111 (290)
T 1t4h_A 32 IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELM 111 (290)
T ss_dssp EEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEEECC
T ss_pred eeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEEEEEec
Confidence 47999999999999975 4789999998754 33445679999999999999999999999875 34579999999
Q ss_pred CCCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCC--ceecCCCCCCeeeC-CCCCeEEcccchhhhh
Q 005102 482 PNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKK--YVHGDLKPSNILLG-HNMEPHVSDFGLARLA 558 (714)
Q Consensus 482 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~--ivHrDlkp~NILl~-~~~~~kl~DFGla~~~ 558 (714)
++|+|.+++... ..+++..+..|+.|++.||+|||+ .+ |+||||||+||+++ +++.+||+|||+++..
T Consensus 112 ~~~~L~~~l~~~------~~~~~~~~~~~~~qi~~~l~~lH~---~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~ 182 (290)
T 1t4h_A 112 TSGTLKTYLKRF------KVMKIKVLRSWCRQILKGLQFLHT---RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK 182 (290)
T ss_dssp CSCBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHT---SSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred CCCCHHHHHHHc------cCCCHHHHHHHHHHHHHHHHHHHc---CCCCEEECCCCHHHEEEECCCCCEEEeeCCCcccc
Confidence 999999999754 458999999999999999999999 77 99999999999998 7899999999999753
Q ss_pred hccCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCcccc
Q 005102 559 NIAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQ 638 (714)
Q Consensus 559 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~~~ 638 (714)
... ......||+.|+|||.+. ..++.++||||||+++|||++|+.||..
T Consensus 183 ~~~------------------------------~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~ 231 (290)
T 1t4h_A 183 RAS------------------------------FAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSE 231 (290)
T ss_dssp CTT------------------------------SBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred ccc------------------------------ccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCC
Confidence 211 111234688999999886 4699999999999999999999999953
Q ss_pred CCCCcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 005102 639 VGSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISD 704 (714)
Q Consensus 639 ~~~~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 704 (714)
... ........ ..... ....+. . ....+.+++.+||+.||++|||++|+++
T Consensus 232 ~~~----~~~~~~~~-~~~~~-~~~~~~----~-----~~~~l~~li~~~l~~dp~~Rps~~ell~ 282 (290)
T 1t4h_A 232 CQN----AAQIYRRV-TSGVK-PASFDK----V-----AIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp CSS----HHHHHHHH-TTTCC-CGGGGG----C-----CCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cCc----HHHHHHHH-hccCC-ccccCC----C-----CCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 322 11122111 11111 111111 0 1135889999999999999999999975
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-40 Score=339.98 Aligned_cols=247 Identities=23% Similarity=0.336 Sum_probs=194.7
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeCCCCchhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCCCHh
Q 005102 409 FVLGKSGIGIVYKVVLE-DGHTLAVRRLGEGGSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGSLA 487 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL~ 487 (714)
.+||+|+||.||+|.+. +++.||||++........+.+.+|+.++++++||||+++++++...+..++||||+++++|.
T Consensus 28 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 107 (295)
T 2clq_A 28 VVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLS 107 (295)
T ss_dssp CEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCSEEEHH
T ss_pred EEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCCCCCHH
Confidence 47999999999999975 58899999998776666678999999999999999999999999999999999999999999
Q ss_pred hhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCC-CCCeEEcccchhhhhhccCCCCC
Q 005102 488 TALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGH-NMEPHVSDFGLARLANIAGGSPT 566 (714)
Q Consensus 488 ~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~-~~~~kl~DFGla~~~~~~~~~~~ 566 (714)
+++...... ..+++..+..++.|++.||+|||+ .+|+||||||+||+++. ++.+||+|||+++......
T Consensus 108 ~~l~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~---- 177 (295)
T 2clq_A 108 ALLRSKWGP---LKDNEQTIGFYTKQILEGLKYLHD---NQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN---- 177 (295)
T ss_dssp HHHHHTTCC---CTTCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC------
T ss_pred HHHHhhccC---CCccHHHHHHHHHHHHHHHHHHHh---CCEEccCCChhhEEEECCCCCEEEeecccccccCCCC----
Confidence 999765322 346789999999999999999999 89999999999999987 8999999999987543210
Q ss_pred ccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCC--CCchhhhHHHHHHHHHHHhCCCccccCCCCcc
Q 005102 567 LQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVK--PSQKWDIYSYGVILLEMITGRTAVVQVGSSEM 644 (714)
Q Consensus 567 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~s~~~DVwS~Gvvl~elltG~~p~~~~~~~~~ 644 (714)
.......||+.|+|||.+.+.. ++.++||||||+++|||++|+.||........
T Consensus 178 ------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~ 233 (295)
T 2clq_A 178 ------------------------PCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQA 233 (295)
T ss_dssp ---------------------------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHH
T ss_pred ------------------------CcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhH
Confidence 1112345788999999997643 88999999999999999999999954322211
Q ss_pred hhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 005102 645 DLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISD 704 (714)
Q Consensus 645 ~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 704 (714)
......... ..+...... ...+.+++.+||+.||++|||++|+++
T Consensus 234 ---~~~~~~~~~-------~~~~~~~~~-----~~~~~~li~~~l~~dp~~Rps~~~ll~ 278 (295)
T 2clq_A 234 ---AMFKVGMFK-------VHPEIPESM-----SAEAKAFILKCFEPDPDKRACANDLLV 278 (295)
T ss_dssp ---HHHHHHHHC-------CCCCCCTTS-----CHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred ---HHHhhcccc-------ccccccccC-----CHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 111111111 111222111 236789999999999999999999875
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=350.12 Aligned_cols=259 Identities=22% Similarity=0.294 Sum_probs=202.6
Q ss_pred cccccccCceEEEEEEECC------CcEEEEEEeCCCCc-hhHHHHHHHHHHHhcc-CCCCccceEEEEEeCCceeEEEe
Q 005102 408 AFVLGKSGIGIVYKVVLED------GHTLAVRRLGEGGS-QRFKEFQTEVEAIGKI-RHSNIVTLRAYYWSVDEKLLIYD 479 (714)
Q Consensus 408 ~~~lG~G~~g~Vy~~~~~~------g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~e 479 (714)
.+.||+|+||.||+|.+.. ...||+|++..... ...+.+.+|+++++++ +||||+++++++...+..++|||
T Consensus 51 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e 130 (333)
T 2i1m_A 51 GKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITE 130 (333)
T ss_dssp EEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred eeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCCceEEEEe
Confidence 3589999999999999753 24799999986533 3456799999999999 89999999999999999999999
Q ss_pred ccCCCCHhhhhhCCCCC--------CCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcc
Q 005102 480 YIPNGSLATALHGKPGM--------VSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSD 551 (714)
Q Consensus 480 ~~~~gsL~~~l~~~~~~--------~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~D 551 (714)
|+++|+|.+++...... .....+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|
T Consensus 131 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~D 207 (333)
T 2i1m_A 131 YCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLAS---KNCIHRDVAARNVLLTNGHVAKIGD 207 (333)
T ss_dssp CCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGCEEEGGGEEEBCC
T ss_pred cCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhc---CCcccCCcccceEEECCCCeEEECc
Confidence 99999999998643100 001357999999999999999999999 8999999999999999999999999
Q ss_pred cchhhhhhccCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHh
Q 005102 552 FGLARLANIAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMIT 631 (714)
Q Consensus 552 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~ellt 631 (714)
||+++....... ........+|+.|+|||.+.+..++.++||||||+++|||+|
T Consensus 208 fg~~~~~~~~~~--------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t 261 (333)
T 2i1m_A 208 FGLARDIMNDSN--------------------------YIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261 (333)
T ss_dssp CGGGCCGGGCTT--------------------------SEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTT
T ss_pred cccccccccccc--------------------------eeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHc
Confidence 999986543211 111223345778999999988899999999999999999999
Q ss_pred -CCCccccCCCCcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhhhh
Q 005102 632 -GRTAVVQVGSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDALDRLI 710 (714)
Q Consensus 632 -G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~ 710 (714)
|+.||....... .+......... +..... ....+.+++.+||+.||++|||++|+++.|+++.
T Consensus 262 ~g~~p~~~~~~~~-----~~~~~~~~~~~------~~~~~~-----~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~ 325 (333)
T 2i1m_A 262 LGLNPYPGILVNS-----KFYKLVKDGYQ------MAQPAF-----APKNIYSIMQACWALEPTHRPTFQQICSFLQEQA 325 (333)
T ss_dssp TSCCSSTTCCSSH-----HHHHHHHHTCC------CCCCTT-----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCCcccchhH-----HHHHHHhcCCC------CCCCCC-----CCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHH
Confidence 999995432221 11122222211 111111 1236889999999999999999999999999875
Q ss_pred c
Q 005102 711 V 711 (714)
Q Consensus 711 ~ 711 (714)
.
T Consensus 326 ~ 326 (333)
T 2i1m_A 326 Q 326 (333)
T ss_dssp H
T ss_pred H
Confidence 4
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-40 Score=344.24 Aligned_cols=257 Identities=20% Similarity=0.317 Sum_probs=192.5
Q ss_pred ccccccCceEEEEEEECC-CcEEEEEEeCCCCc--hhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCCC
Q 005102 409 FVLGKSGIGIVYKVVLED-GHTLAVRRLGEGGS--QRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGS 485 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~~-g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gs 485 (714)
+.||+|+||+||+|++.. |+.||||++..... ...+.+.+|++++++++||||+++++++...+..++||||+++++
T Consensus 9 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 88 (311)
T 4agu_A 9 GKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYCDHTV 88 (311)
T ss_dssp EEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSEEH
T ss_pred eEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEEeCCCch
Confidence 479999999999999864 89999999876533 234678899999999999999999999999999999999999999
Q ss_pred HhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCCC
Q 005102 486 LATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSP 565 (714)
Q Consensus 486 L~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 565 (714)
|.+++... ..+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++......
T Consensus 89 l~~~~~~~------~~~~~~~~~~i~~~l~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--- 156 (311)
T 4agu_A 89 LHELDRYQ------RGVPEHLVKSITWQTLQAVNFCHK---HNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPS--- 156 (311)
T ss_dssp HHHHHHTS------SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECC------
T ss_pred HHHHHhhh------cCCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcc---
Confidence 99988755 458999999999999999999999 899999999999999999999999999997653211
Q ss_pred CccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCC-CCCCchhhhHHHHHHHHHHHhCCCccccCCCCcc
Q 005102 566 TLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKV-VKPSQKWDIYSYGVILLEMITGRTAVVQVGSSEM 644 (714)
Q Consensus 566 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DVwS~Gvvl~elltG~~p~~~~~~~~~ 644 (714)
.......||+.|+|||.+.+ ..++.++||||||+++|||++|+.||.... ..
T Consensus 157 -------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~--~~ 209 (311)
T 4agu_A 157 -------------------------DYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKS--DV 209 (311)
T ss_dssp ----------------------------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSS--HH
T ss_pred -------------------------cccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC--HH
Confidence 11123356888999999976 568999999999999999999999994332 22
Q ss_pred hhHHHHHHHHhh-----------cCCcccccCCCCCCCCCc----HHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 005102 645 DLVNWMQLCIEE-----------KKPLADVLDPYLAPDADK----EEEIIAVLKIAMACVHSSPEKRPTMRHISD 704 (714)
Q Consensus 645 ~l~~~~~~~~~~-----------~~~~~~~~d~~~~~~~~~----~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 704 (714)
+....+...... .........+........ ......+.+++.+||+.||++|||++|+++
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 284 (311)
T 4agu_A 210 DQLYLIRKTLGDLIPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH 284 (311)
T ss_dssp HHHHHHHHHHCSCCHHHHHHHHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred HHHHHHHHHhcccccccccccccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 222211111110 000000000000000000 012335789999999999999999999975
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=336.20 Aligned_cols=250 Identities=22% Similarity=0.284 Sum_probs=197.0
Q ss_pred cccccccCceEEEEEEEC-CCcEEEEEEeCCCCc------hhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEec
Q 005102 408 AFVLGKSGIGIVYKVVLE-DGHTLAVRRLGEGGS------QRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDY 480 (714)
Q Consensus 408 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~ 480 (714)
.+.||+|+||.||+|+.. +|+.||+|++..... ...+.+.+|++++++++||||+++++++...+..++||||
T Consensus 10 ~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 89 (283)
T 3bhy_A 10 GEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVVLILEL 89 (283)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred HHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEEEEEee
Confidence 357999999999999987 589999999875421 2357899999999999999999999999999999999999
Q ss_pred cCCCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCC----CeEEcccchhh
Q 005102 481 IPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNM----EPHVSDFGLAR 556 (714)
Q Consensus 481 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~----~~kl~DFGla~ 556 (714)
+++++|.+++... ..+++..+..++.|++.||+|||+ .+|+||||||+||+++.++ .+||+|||+++
T Consensus 90 ~~~~~L~~~l~~~------~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~ 160 (283)
T 3bhy_A 90 VSGGELFDFLAEK------ESLTEDEATQFLKQILDGVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAH 160 (283)
T ss_dssp CCSCBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred cCCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCChHHEEEecCCCCCCceEEEecccce
Confidence 9999999999754 458999999999999999999999 8999999999999998877 89999999987
Q ss_pred hhhccCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCcc
Q 005102 557 LANIAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAV 636 (714)
Q Consensus 557 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~ 636 (714)
...... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||
T Consensus 161 ~~~~~~-----------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~ 211 (283)
T 3bhy_A 161 KIEAGN-----------------------------EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 211 (283)
T ss_dssp ECC-------------------------------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTT
T ss_pred eccCCC-----------------------------cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCC
Confidence 543211 112234688999999999999999999999999999999999999
Q ss_pred ccCCCCcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHH--HHhhh
Q 005102 637 VQVGSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISD--ALDRL 709 (714)
Q Consensus 637 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~--~L~~i 709 (714)
.... . .................. .. .....+.+++.+||+.||++|||++|+++ .++.+
T Consensus 212 ~~~~--~---~~~~~~~~~~~~~~~~~~----~~-----~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~ 272 (283)
T 3bhy_A 212 LGET--K---QETLTNISAVNYDFDEEY----FS-----NTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAI 272 (283)
T ss_dssp CCSS--H---HHHHHHHHTTCCCCCHHH----HT-----TCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHH
T ss_pred CCcc--h---HHHHHHhHhcccCCcchh----cc-----cCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHH
Confidence 4321 1 111211111111100000 00 11235789999999999999999999987 44444
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-40 Score=358.32 Aligned_cols=247 Identities=20% Similarity=0.236 Sum_probs=193.0
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeCCCCc---hhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCC
Q 005102 409 FVLGKSGIGIVYKVVLE-DGHTLAVRRLGEGGS---QRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNG 484 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~g 484 (714)
+.||+|+||+||+|+.+ +|+.||||++.+... ...+.+.+|++++.+++||||+++++++.+.+..|+||||+++|
T Consensus 67 ~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lVmE~~~gg 146 (412)
T 2vd5_A 67 KVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGG 146 (412)
T ss_dssp EEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEECCCCSC
T ss_pred EEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEcCCCCC
Confidence 57999999999999986 589999999975321 12235789999999999999999999999999999999999999
Q ss_pred CHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCC
Q 005102 485 SLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGS 564 (714)
Q Consensus 485 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 564 (714)
+|.+++.... ..+++..++.++.||+.||+|||+ .+|+||||||+|||++.++++||+|||+++......
T Consensus 147 ~L~~~l~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~---~giiHrDLKp~NILld~~g~vkL~DFGla~~~~~~~-- 216 (412)
T 2vd5_A 147 DLLTLLSKFG-----ERIPAEMARFYLAEIVMAIDSVHR---LGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADG-- 216 (412)
T ss_dssp BHHHHHHHHS-----SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTS--
T ss_pred cHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecccCHHHeeecCCCCEEEeechhheeccCCC--
Confidence 9999997542 358999999999999999999999 899999999999999999999999999997653211
Q ss_pred CCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccC-------CCCCCchhhhHHHHHHHHHHHhCCCccc
Q 005102 565 PTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLK-------VVKPSQKWDIYSYGVILLEMITGRTAVV 637 (714)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~s~~~DVwS~Gvvl~elltG~~p~~ 637 (714)
........||+.|+|||++. ...++.++|||||||++|||++|+.||.
T Consensus 217 -------------------------~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~ 271 (412)
T 2vd5_A 217 -------------------------TVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFY 271 (412)
T ss_dssp -------------------------CEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTC
T ss_pred -------------------------ccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCC
Confidence 11223456899999999997 3568999999999999999999999995
Q ss_pred cCCCCcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCC---CCHHHHHH
Q 005102 638 QVGSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKR---PTMRHISD 704 (714)
Q Consensus 638 ~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~R---Pt~~evl~ 704 (714)
... . .+........... ..-|..... ...++.+++.+||. +|++| |+++|+++
T Consensus 272 ~~~--~---~~~~~~i~~~~~~---~~~p~~~~~-----~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~ 327 (412)
T 2vd5_A 272 ADS--T---AETYGKIVHYKEH---LSLPLVDEG-----VPEEARDFIQRLLC-PPETRLGRGGAGDFRT 327 (412)
T ss_dssp CSS--H---HHHHHHHHTHHHH---CCCC----C-----CCHHHHHHHHTTSS-CGGGCTTTTTHHHHHT
T ss_pred CCC--H---HHHHHHHHhcccC---cCCCccccC-----CCHHHHHHHHHHcC-ChhhcCCCCCHHHHhc
Confidence 321 1 1222222211100 000111111 12367899999999 99998 58888764
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=347.52 Aligned_cols=190 Identities=24% Similarity=0.278 Sum_probs=166.3
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeCCCCchhHHHHHHHHHHHhccC-----CCCccceEEEEEeCCceeEEEeccC
Q 005102 409 FVLGKSGIGIVYKVVLE-DGHTLAVRRLGEGGSQRFKEFQTEVEAIGKIR-----HSNIVTLRAYYWSVDEKLLIYDYIP 482 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----H~niv~l~~~~~~~~~~~lV~e~~~ 482 (714)
+.||+|+||+||+|++. +++.||||++... ....+.+..|++++++++ ||||+++++++...+..++||||+
T Consensus 41 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~~~~lv~e~~- 118 (360)
T 3llt_A 41 RKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDHMCLIFEPL- 118 (360)
T ss_dssp EEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETTEEEEEECCC-
T ss_pred EEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECCeeEEEEcCC-
Confidence 57999999999999985 5899999999753 233466788999999986 999999999999999999999999
Q ss_pred CCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCC-------------------
Q 005102 483 NGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGH------------------- 543 (714)
Q Consensus 483 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~------------------- 543 (714)
+++|.+++..... ..+++..+..|+.||+.||+|||+ ++|+||||||+|||+++
T Consensus 119 ~~~L~~~~~~~~~----~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~~~~ 191 (360)
T 3llt_A 119 GPSLYEIITRNNY----NGFHIEDIKLYCIEILKALNYLRK---MSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKI 191 (360)
T ss_dssp CCBHHHHHHHTTT----CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCTTCCEEEEEEECTTTCCEE
T ss_pred CCCHHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCcccEEEccccccccccchhcccccccc
Confidence 8999999976532 358999999999999999999999 89999999999999976
Q ss_pred ------CCCeEEcccchhhhhhccCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchh
Q 005102 544 ------NMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKW 617 (714)
Q Consensus 544 ------~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~ 617 (714)
++.+||+|||+++.... ......||+.|+|||++.+..++.++
T Consensus 192 ~~~~~~~~~~kl~DFG~a~~~~~-------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~ 240 (360)
T 3llt_A 192 QIYRTKSTGIKLIDFGCATFKSD-------------------------------YHGSIINTRQYRAPEVILNLGWDVSS 240 (360)
T ss_dssp EEEEESCCCEEECCCTTCEETTS-------------------------------CCCSCCSCGGGCCHHHHTTCCCCTTH
T ss_pred cccccCCCCEEEEeccCceecCC-------------------------------CCcCccCcccccCcHHHcCCCCCCcc
Confidence 78999999999975321 11234578899999999999999999
Q ss_pred hhHHHHHHHHHHHhCCCcccc
Q 005102 618 DIYSYGVILLEMITGRTAVVQ 638 (714)
Q Consensus 618 DVwS~Gvvl~elltG~~p~~~ 638 (714)
|||||||++|||+||+.||..
T Consensus 241 DiwslG~il~ell~g~~pf~~ 261 (360)
T 3llt_A 241 DMWSFGCVLAELYTGSLLFRT 261 (360)
T ss_dssp HHHHHHHHHHHHHHSSCSCCC
T ss_pred chHHHHHHHHHHHHCCCCCCC
Confidence 999999999999999999953
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=343.47 Aligned_cols=247 Identities=22% Similarity=0.285 Sum_probs=194.6
Q ss_pred cccccccCceEEEEEEEC-CCcEEEEEEeCCC--CchhHHHHHHHHHHHhccC-CCCccceEEEEEeCCceeEEEeccCC
Q 005102 408 AFVLGKSGIGIVYKVVLE-DGHTLAVRRLGEG--GSQRFKEFQTEVEAIGKIR-HSNIVTLRAYYWSVDEKLLIYDYIPN 483 (714)
Q Consensus 408 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lV~e~~~~ 483 (714)
.+.||+|+||.||+|... +++.||||++... .......+.+|+.++.+++ ||||+++++++...+..++||||+++
T Consensus 34 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~lv~e~~~~ 113 (327)
T 3lm5_A 34 SKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAG 113 (327)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEECCTT
T ss_pred cceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEEEEEEecCC
Confidence 367999999999999986 4899999998764 2334578999999999994 69999999999999999999999999
Q ss_pred CCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCC---CCCeEEcccchhhhhhc
Q 005102 484 GSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGH---NMEPHVSDFGLARLANI 560 (714)
Q Consensus 484 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~---~~~~kl~DFGla~~~~~ 560 (714)
|+|.+++..... ..+++.++..|+.|++.||+|||+ .+|+||||||+||+++. ++.+||+|||+++....
T Consensus 114 ~~L~~~~~~~~~----~~~~~~~~~~i~~ql~~~L~~LH~---~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~ 186 (327)
T 3lm5_A 114 GEIFSLCLPELA----EMVSENDVIRLIKQILEGVYYLHQ---NNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGH 186 (327)
T ss_dssp EEGGGGGSSCC-----CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC--
T ss_pred CcHHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHH---CCeecCcCChHHEEEecCCCCCcEEEeeCccccccCC
Confidence 999999865432 458999999999999999999999 89999999999999998 78999999999986532
Q ss_pred cCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCccccCC
Q 005102 561 AGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVG 640 (714)
Q Consensus 561 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~~~~~ 640 (714)
.. ......||+.|+|||++.+..++.++||||||+++|||++|+.||....
T Consensus 187 ~~-----------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~ 237 (327)
T 3lm5_A 187 AC-----------------------------ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGED 237 (327)
T ss_dssp ------------------------------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred cc-----------------------------ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 11 1123457899999999999999999999999999999999999994321
Q ss_pred CCcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 005102 641 SSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISD 704 (714)
Q Consensus 641 ~~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 704 (714)
. ............... ..... .....+.+++.+||+.||++|||++|+++
T Consensus 238 ~-----~~~~~~i~~~~~~~~----~~~~~-----~~~~~~~~li~~~L~~dP~~Rpt~~~ll~ 287 (327)
T 3lm5_A 238 N-----QETYLNISQVNVDYS----EETFS-----SVSQLATDFIQSLLVKNPEKRPTAEICLS 287 (327)
T ss_dssp H-----HHHHHHHHHTCCCCC----TTTTT-----TSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred c-----hHHHHHHHhcccccC----chhhc-----ccCHHHHHHHHHHcCCChhhCcCHHHHhC
Confidence 1 111111111111110 10101 12235789999999999999999999875
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-40 Score=346.44 Aligned_cols=255 Identities=22% Similarity=0.291 Sum_probs=185.7
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeCCCCch--hHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCCC
Q 005102 409 FVLGKSGIGIVYKVVLE-DGHTLAVRRLGEGGSQ--RFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGS 485 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gs 485 (714)
+.||+|+||+||+|+.. +++.||||++...... ..+.+.+|++++++++||||+++++++...+..++||||++ |+
T Consensus 40 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~ 118 (329)
T 3gbz_A 40 TKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAE-ND 118 (329)
T ss_dssp EEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEEECCS-EE
T ss_pred EEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEEecCC-CC
Confidence 47999999999999975 5899999999765322 24567899999999999999999999999999999999997 59
Q ss_pred HhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeee-----CCCCCeEEcccchhhhhhc
Q 005102 486 LATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILL-----GHNMEPHVSDFGLARLANI 560 (714)
Q Consensus 486 L~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl-----~~~~~~kl~DFGla~~~~~ 560 (714)
|.+++... ..+++..+..|+.||+.||+|||+ ++|+||||||+|||+ ++++.+||+|||+++....
T Consensus 119 L~~~~~~~------~~~~~~~~~~i~~ql~~~l~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~~ 189 (329)
T 3gbz_A 119 LKKYMDKN------PDVSMRVIKSFLYQLINGVNFCHS---RRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGI 189 (329)
T ss_dssp HHHHHHHC------TTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC-
T ss_pred HHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHHh---CCEECCCCCHHHEEEecCCCCccceEEECcCCCccccCC
Confidence 99999765 458999999999999999999999 899999999999999 4556699999999987642
Q ss_pred cCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCC-CCchhhhHHHHHHHHHHHhCCCccccC
Q 005102 561 AGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVK-PSQKWDIYSYGVILLEMITGRTAVVQV 639 (714)
Q Consensus 561 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s~~~DVwS~Gvvl~elltG~~p~~~~ 639 (714)
.. .......||+.|+|||++.+.. ++.++|||||||++|||++|+.||...
T Consensus 190 ~~----------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~ 241 (329)
T 3gbz_A 190 PI----------------------------RQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGD 241 (329)
T ss_dssp --------------------------------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred cc----------------------------cccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCC
Confidence 21 1122334688899999998754 899999999999999999999999432
Q ss_pred CCCcchhHHHHHHHHhhcC--Cccc------ccC--CCCCCCCCcH-----HHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 005102 640 GSSEMDLVNWMQLCIEEKK--PLAD------VLD--PYLAPDADKE-----EEIIAVLKIAMACVHSSPEKRPTMRHISD 704 (714)
Q Consensus 640 ~~~~~~l~~~~~~~~~~~~--~~~~------~~d--~~~~~~~~~~-----~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 704 (714)
. ..+....+........ .... ... +..... ... ....++.+++.+||+.||++|||++|+++
T Consensus 242 ~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 318 (329)
T 3gbz_A 242 S--EIDQLFKIFEVLGLPDDTTWPGVTALPDWKQSFPKFRGK-TLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE 318 (329)
T ss_dssp S--HHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCC-CHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred C--HHHHHHHHHHHhCCCchhhhhhhhhhhhhhhhhhhhccc-cHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence 1 1111111111110000 0000 000 000000 000 02246789999999999999999999875
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-40 Score=346.07 Aligned_cols=265 Identities=26% Similarity=0.341 Sum_probs=198.9
Q ss_pred ccccccCceEEEEEEE-CCCcEEEEEEeCCCCchhHHHHHHHHHHHhccCCCCccceEEEEEe----CCceeEEEeccCC
Q 005102 409 FVLGKSGIGIVYKVVL-EDGHTLAVRRLGEGGSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWS----VDEKLLIYDYIPN 483 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~----~~~~~lV~e~~~~ 483 (714)
+.||+|+||.||+++. .+++.||||++........+.+.+|++++++++||||+++++++.. ....++||||+++
T Consensus 35 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~~ 114 (317)
T 2buj_A 35 QKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKR 114 (317)
T ss_dssp EEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEEEEECCTT
T ss_pred EEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEEEEEeCCC
Confidence 4799999999999997 4689999999977666667789999999999999999999999873 3467899999999
Q ss_pred CCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCC
Q 005102 484 GSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGG 563 (714)
Q Consensus 484 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 563 (714)
|+|.+++...... ...+++.++..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++.......
T Consensus 115 ~~L~~~l~~~~~~--~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~~ 189 (317)
T 2buj_A 115 GTLWNEIERLKDK--GNFLTEDQILWLLLGICRGLEAIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVE 189 (317)
T ss_dssp CBHHHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCSSCEESCEEEE
T ss_pred CcHHHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEcCCCCEEEEecCcchhcccccc
Confidence 9999998752111 1458999999999999999999999 8999999999999999999999999998875431100
Q ss_pred CCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCC---CCchhhhHHHHHHHHHHHhCCCccccCC
Q 005102 564 SPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVK---PSQKWDIYSYGVILLEMITGRTAVVQVG 640 (714)
Q Consensus 564 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~s~~~DVwS~Gvvl~elltG~~p~~~~~ 640 (714)
. .... ..........||+.|+|||.+.+.. ++.++||||||+++|||++|+.||....
T Consensus 190 ~--------------~~~~-----~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~ 250 (317)
T 2buj_A 190 G--------------SRQA-----LTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVF 250 (317)
T ss_dssp S--------------HHHH-----HHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHH
T ss_pred c--------------cccc-----ccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhh
Confidence 0 0000 0000011223588899999997654 6899999999999999999999994321
Q ss_pred CCcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhhhhcc
Q 005102 641 SSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDALDRLIVS 712 (714)
Q Consensus 641 ~~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~~ 712 (714)
.......... ...... + .... ....+.+++.+||+.||++|||++++++.|+++...
T Consensus 251 ~~~~~~~~~~----~~~~~~-----~-~~~~-----~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~ 307 (317)
T 2buj_A 251 QKGDSVALAV----QNQLSI-----P-QSPR-----HSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPP 307 (317)
T ss_dssp HTTSCHHHHH----HCC--C-----C-CCTT-----SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCC
T ss_pred cccchhhHHh----hccCCC-----C-cccc-----CCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCC
Confidence 1111111111 111000 0 0011 123688999999999999999999999999998654
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-40 Score=340.15 Aligned_cols=246 Identities=25% Similarity=0.400 Sum_probs=192.8
Q ss_pred ccccccCceEEEEEEECCCcEEEEEEeCCCCchhHHHHHHHHHHHhccCCCCccceEEEEEeC-CceeEEEeccCCCCHh
Q 005102 409 FVLGKSGIGIVYKVVLEDGHTLAVRRLGEGGSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSV-DEKLLIYDYIPNGSLA 487 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~-~~~~lV~e~~~~gsL~ 487 (714)
+.||+|+||.||++.+. |+.||||++.... ..+.+.+|++++++++||||+++++++... +..++||||+++|+|.
T Consensus 27 ~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~~~L~ 103 (278)
T 1byg_A 27 QTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLV 103 (278)
T ss_dssp EEEEECSSCEEEEEEET-TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTEEHH
T ss_pred eEEecCCCceEEEEEEc-CCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEecCCCCCHH
Confidence 57999999999999985 8899999997643 346799999999999999999999997654 4789999999999999
Q ss_pred hhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCCCCc
Q 005102 488 TALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTL 567 (714)
Q Consensus 488 ~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 567 (714)
+++..... ..+++..+.+++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||+++.....
T Consensus 104 ~~l~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~------ 170 (278)
T 1byg_A 104 DYLRSRGR----SVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST------ 170 (278)
T ss_dssp HHHHHHHH----HHCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTSCEEECCCCC-------------
T ss_pred HHHHhccc----ccCCHHHHHHHHHHHHHHHHHHHh---CCccccCCCcceEEEeCCCcEEEeecccccccccc------
Confidence 99975421 237899999999999999999999 89999999999999999999999999998754311
Q ss_pred cCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHh-CCCccccCCCCcchh
Q 005102 568 QSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMIT-GRTAVVQVGSSEMDL 646 (714)
Q Consensus 568 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~ellt-G~~p~~~~~~~~~~l 646 (714)
.....+++.|+|||.+.+..++.++||||||+++|||+| |+.||..... .+.
T Consensus 171 -------------------------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~--~~~ 223 (278)
T 1byg_A 171 -------------------------QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL--KDV 223 (278)
T ss_dssp ------------------------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCG--GGH
T ss_pred -------------------------ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCH--HHH
Confidence 111234678999999988899999999999999999998 9999953322 111
Q ss_pred HHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhhhhcc
Q 005102 647 VNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDALDRLIVS 712 (714)
Q Consensus 647 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~~ 712 (714)
.. . ..... .+..... ....+.+++.+||+.||++|||++|+++.|+++...
T Consensus 224 ~~---~-~~~~~------~~~~~~~-----~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~ 274 (278)
T 1byg_A 224 VP---R-VEKGY------KMDAPDG-----CPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 274 (278)
T ss_dssp HH---H-HTTTC------CCCCCTT-----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HH---H-HhcCC------CCCCccc-----CCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhh
Confidence 11 1 11111 1111111 123688999999999999999999999999998653
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=340.94 Aligned_cols=257 Identities=23% Similarity=0.294 Sum_probs=190.9
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeCCCC-----chhHHHHHHHHHHHhccC---CCCccceEEEEEeCC-----ce
Q 005102 409 FVLGKSGIGIVYKVVLE-DGHTLAVRRLGEGG-----SQRFKEFQTEVEAIGKIR---HSNIVTLRAYYWSVD-----EK 474 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~---H~niv~l~~~~~~~~-----~~ 474 (714)
+.||+|+||+||+|++. +++.||||++.... ......+.+|++++++++ ||||+++++++.... ..
T Consensus 15 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~~~~~~~~ 94 (308)
T 3g33_A 15 AEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSRTDREIKV 94 (308)
T ss_dssp EEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECCSSSEEEE
T ss_pred EEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccCCCCceeE
Confidence 47999999999999974 58999999986432 112246778888887775 999999999998765 47
Q ss_pred eEEEeccCCCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccch
Q 005102 475 LLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGL 554 (714)
Q Consensus 475 ~lV~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGl 554 (714)
++||||+. |+|.+++..... ..+++..+..|+.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+
T Consensus 95 ~lv~e~~~-~~L~~~~~~~~~----~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~ 166 (308)
T 3g33_A 95 TLVFEHVD-QDLRTYLDKAPP----PGLPAETIKDLMRQFLRGLDFLHA---NCIVHRDLKPENILVTSGGTVKLADFGL 166 (308)
T ss_dssp EEEEECCC-CBHHHHHHTCCT----TCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCTTTEEECTTSCEEECSCSC
T ss_pred EEEehhhh-cCHHHHHhhccC----CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCCCCEEEeeCcc
Confidence 89999996 699999987643 348999999999999999999999 8999999999999999999999999999
Q ss_pred hhhhhccCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCC
Q 005102 555 ARLANIAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRT 634 (714)
Q Consensus 555 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~ 634 (714)
++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.
T Consensus 167 a~~~~~~~-----------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~ 217 (308)
T 3g33_A 167 ARIYSYQM-----------------------------ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKP 217 (308)
T ss_dssp TTTSTTCC-----------------------------CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSC
T ss_pred ccccCCCc-----------------------------ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCC
Confidence 97653211 1122346889999999999999999999999999999999999
Q ss_pred ccccCCCCcchhHHHHHHHHhhcCC--ccccc---CCCCCCC-CCc-----HHHHHHHHHHHhHccCCCCCCCCCHHHHH
Q 005102 635 AVVQVGSSEMDLVNWMQLCIEEKKP--LADVL---DPYLAPD-ADK-----EEEIIAVLKIAMACVHSSPEKRPTMRHIS 703 (714)
Q Consensus 635 p~~~~~~~~~~l~~~~~~~~~~~~~--~~~~~---d~~~~~~-~~~-----~~~~~~l~~li~~Cl~~dP~~RPt~~evl 703 (714)
||... ...+....+......... ..... ....... ... .+....+.+++.+||+.||++|||++|++
T Consensus 218 pf~~~--~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l 295 (308)
T 3g33_A 218 LFCGN--SEADQLGKIFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRAL 295 (308)
T ss_dssp SCCCS--SHHHHHHHHHHHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHH
T ss_pred CCCCC--CHHHHHHHHHHHhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHh
Confidence 99432 222222211111111000 00000 0000000 000 01224678999999999999999999987
Q ss_pred H
Q 005102 704 D 704 (714)
Q Consensus 704 ~ 704 (714)
+
T Consensus 296 ~ 296 (308)
T 3g33_A 296 Q 296 (308)
T ss_dssp T
T ss_pred c
Confidence 5
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=336.82 Aligned_cols=239 Identities=21% Similarity=0.319 Sum_probs=194.9
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeCCCC---chhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCC
Q 005102 409 FVLGKSGIGIVYKVVLE-DGHTLAVRRLGEGG---SQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNG 484 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~g 484 (714)
+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|++++++++||||+++++++...+..++||||+++|
T Consensus 20 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 99 (284)
T 2vgo_A 20 RPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRG 99 (284)
T ss_dssp EEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCTTE
T ss_pred heecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEEEeCCCC
Confidence 57999999999999986 47899999986532 223467899999999999999999999999999999999999999
Q ss_pred CHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCC
Q 005102 485 SLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGS 564 (714)
Q Consensus 485 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 564 (714)
+|.+++... ..+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||++......
T Consensus 100 ~L~~~l~~~------~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~--- 167 (284)
T 2vgo_A 100 ELYKELQKH------GRFDEQRSATFMEELADALHYCHE---RKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSL--- 167 (284)
T ss_dssp EHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCSGGGEEECTTCCEEECCCTTCEECSSS---
T ss_pred cHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCHHHEEEcCCCCEEEecccccccCccc---
Confidence 999999754 458999999999999999999999 89999999999999999999999999998643211
Q ss_pred CCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCccccCCCCcc
Q 005102 565 PTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGSSEM 644 (714)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~~~~~~~~~ 644 (714)
......|++.|+|||.+.+..++.++||||||+++|||++|+.||....
T Consensus 168 ---------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~---- 216 (284)
T 2vgo_A 168 ---------------------------RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPS---- 216 (284)
T ss_dssp ---------------------------CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS----
T ss_pred ---------------------------ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCC----
Confidence 1123356889999999999899999999999999999999999994321
Q ss_pred hhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 005102 645 DLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISD 704 (714)
Q Consensus 645 ~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 704 (714)
............. ...... ...+.+++.+||+.||++|||++|+++
T Consensus 217 -~~~~~~~~~~~~~--------~~~~~~-----~~~~~~li~~~l~~~p~~Rps~~~ll~ 262 (284)
T 2vgo_A 217 -HTETHRRIVNVDL--------KFPPFL-----SDGSKDLISKLLRYHPPQRLPLKGVME 262 (284)
T ss_dssp -HHHHHHHHHTTCC--------CCCTTS-----CHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred -HhHHHHHHhcccc--------CCCCcC-----CHHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence 1111222222111 111111 235789999999999999999999975
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-40 Score=358.66 Aligned_cols=245 Identities=20% Similarity=0.297 Sum_probs=184.2
Q ss_pred cccccccCceEEEEEEECC-CcEEEEEEeCCCC--------chhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEE
Q 005102 408 AFVLGKSGIGIVYKVVLED-GHTLAVRRLGEGG--------SQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIY 478 (714)
Q Consensus 408 ~~~lG~G~~g~Vy~~~~~~-g~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 478 (714)
.+.||+|+||.||+|.... ++.||||++.... ......+.+|+++|++++||||+++++++. .+..++||
T Consensus 140 ~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~~~~~lv~ 218 (419)
T 3i6u_A 140 SKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD-AEDYYIVL 218 (419)
T ss_dssp EEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-SSEEEEEE
T ss_pred EeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCceEEEE
Confidence 3579999999999999764 8999999987532 111235889999999999999999999975 45689999
Q ss_pred eccCCCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCC---CCeEEcccchh
Q 005102 479 DYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHN---MEPHVSDFGLA 555 (714)
Q Consensus 479 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~---~~~kl~DFGla 555 (714)
||+++|+|.+++... ..+++..+..|+.|++.||+|||+ ++|+||||||+|||++.+ +.+||+|||++
T Consensus 219 e~~~~g~L~~~l~~~------~~~~~~~~~~i~~qi~~~l~~LH~---~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a 289 (419)
T 3i6u_A 219 ELMEGGELFDKVVGN------KRLKEATCKLYFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHS 289 (419)
T ss_dssp ECCTTCBGGGGTSSS------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSSSCCEEECCSSTT
T ss_pred EcCCCCcHHHHHhcc------CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChHhEEEecCCCcceEEEeecccc
Confidence 999999999998755 458999999999999999999999 899999999999999654 45999999999
Q ss_pred hhhhccCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCC---CCCCchhhhHHHHHHHHHHHhC
Q 005102 556 RLANIAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKV---VKPSQKWDIYSYGVILLEMITG 632 (714)
Q Consensus 556 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~s~~~DVwS~Gvvl~elltG 632 (714)
+..... .......||+.|+|||++.+ ..++.++|||||||++|||+||
T Consensus 290 ~~~~~~-----------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg 340 (419)
T 3i6u_A 290 KILGET-----------------------------SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 340 (419)
T ss_dssp TSCC----------------------------------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHS
T ss_pred eecCCC-----------------------------ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHC
Confidence 865321 11123457899999999863 5688999999999999999999
Q ss_pred CCccccCCCCcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 005102 633 RTAVVQVGSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISD 704 (714)
Q Consensus 633 ~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 704 (714)
+.||....... .+...+ ........ +... ......+.+++.+||+.||++|||++|+++
T Consensus 341 ~~pf~~~~~~~-~~~~~i---~~~~~~~~----~~~~-----~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 399 (419)
T 3i6u_A 341 YPPFSEHRTQV-SLKDQI---TSGKYNFI----PEVW-----AEVSEKALDLVKKLLVVDPKARFTTEEALR 399 (419)
T ss_dssp SCSSCCCSSSC-CHHHHH---HTTCCCCC----HHHH-----TTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CCCCCCCcchH-HHHHHH---hcCCCCCC----chhh-----cccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 99995432221 121111 11111000 0000 011236889999999999999999999876
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-40 Score=343.17 Aligned_cols=245 Identities=20% Similarity=0.334 Sum_probs=192.4
Q ss_pred ccccccCceEEEEEEECC-CcEEEEEEeCCCCchhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCCCHh
Q 005102 409 FVLGKSGIGIVYKVVLED-GHTLAVRRLGEGGSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGSLA 487 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL~ 487 (714)
+.||+|+||.||+|.+.. ++.||+|++........+.+.+|++++++++||||+++++++...+..++||||+++++|.
T Consensus 25 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~ 104 (302)
T 2j7t_A 25 GELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVD 104 (302)
T ss_dssp EEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEECCTTEEHH
T ss_pred ceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEeCCCCcHH
Confidence 479999999999999864 8999999998776666788999999999999999999999999999999999999999999
Q ss_pred hhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCCCCc
Q 005102 488 TALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTL 567 (714)
Q Consensus 488 ~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 567 (714)
+++.... ..+++..+..++.|++.||.|||+ .+|+||||||+||+++.++.+||+|||++......
T Consensus 105 ~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~------ 170 (302)
T 2j7t_A 105 AIMLELD-----RGLTEPQIQVVCRQMLEALNFLHS---KRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKT------ 170 (302)
T ss_dssp HHHHHHT-----SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHH------
T ss_pred HHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHHHEEECCCCCEEEEECCCCcccccc------
Confidence 9886532 458999999999999999999999 89999999999999999999999999998654221
Q ss_pred cCCCCCCCCchhhhcccccceeecccCCCCCCccccCCccc-----CCCCCCchhhhHHHHHHHHHHHhCCCccccCCCC
Q 005102 568 QSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESL-----KVVKPSQKWDIYSYGVILLEMITGRTAVVQVGSS 642 (714)
Q Consensus 568 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-----~~~~~s~~~DVwS~Gvvl~elltG~~p~~~~~~~ 642 (714)
........||+.|+|||.+ .+..++.++||||||+++|||++|+.||....
T Consensus 171 ----------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~-- 226 (302)
T 2j7t_A 171 ----------------------LQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELN-- 226 (302)
T ss_dssp ----------------------HHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSC--
T ss_pred ----------------------ccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCC--
Confidence 0111233578899999998 46778999999999999999999999994322
Q ss_pred cchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 005102 643 EMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISD 704 (714)
Q Consensus 643 ~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 704 (714)
.............. .... .......+.+++.+||+.||++|||++|+++
T Consensus 227 ---~~~~~~~~~~~~~~--~~~~--------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 227 ---PMRVLLKIAKSDPP--TLLT--------PSKWSVEFRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp ---HHHHHHHHHHSCCC--CCSS--------GGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred ---HHHHHHHHhccCCc--ccCC--------ccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 11122222222111 0000 1112236889999999999999999999875
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-40 Score=351.84 Aligned_cols=247 Identities=23% Similarity=0.279 Sum_probs=194.3
Q ss_pred ccccccCceEEEEEEE----CCCcEEEEEEeCCCC----chhHHHHHHHHHHHhcc-CCCCccceEEEEEeCCceeEEEe
Q 005102 409 FVLGKSGIGIVYKVVL----EDGHTLAVRRLGEGG----SQRFKEFQTEVEAIGKI-RHSNIVTLRAYYWSVDEKLLIYD 479 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~----~~g~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~e 479 (714)
+.||+|+||.||+|+. .+++.||||+++... ....+.+.+|+++++++ +||||+++++++...+..++|||
T Consensus 60 ~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e 139 (355)
T 1vzo_A 60 KVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILD 139 (355)
T ss_dssp EEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEEEEEC
T ss_pred EEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCceEEEEee
Confidence 5799999999999998 368999999987532 12335677899999999 69999999999999999999999
Q ss_pred ccCCCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhh
Q 005102 480 YIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLAN 559 (714)
Q Consensus 480 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~ 559 (714)
|+++|+|.+++... ..+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++...
T Consensus 140 ~~~~~~L~~~l~~~------~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~ 210 (355)
T 1vzo_A 140 YINGGELFTHLSQR------ERFTEHEVQIYVGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFV 210 (355)
T ss_dssp CCCSCBHHHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEESCSSEEEECC
T ss_pred cCCCCCHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCcEEEeeCCCCeecc
Confidence 99999999999754 458999999999999999999999 899999999999999999999999999997543
Q ss_pred ccCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCC--CCCCchhhhHHHHHHHHHHHhCCCccc
Q 005102 560 IAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKV--VKPSQKWDIYSYGVILLEMITGRTAVV 637 (714)
Q Consensus 560 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~~~DVwS~Gvvl~elltG~~p~~ 637 (714)
... ........||+.|+|||++.+ ..++.++|||||||++|||+||+.||.
T Consensus 211 ~~~---------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~ 263 (355)
T 1vzo_A 211 ADE---------------------------TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFT 263 (355)
T ss_dssp GGG---------------------------GGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTS
T ss_pred cCC---------------------------CCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCc
Confidence 211 111223357899999999986 347899999999999999999999995
Q ss_pred cCCCCcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCC-----CHHHHHHH
Q 005102 638 QVGSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRP-----TMRHISDA 705 (714)
Q Consensus 638 ~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----t~~evl~~ 705 (714)
..... .....+.......... ..... ...+.+++.+||+.||++|| |++|+++.
T Consensus 264 ~~~~~-~~~~~~~~~~~~~~~~--------~~~~~-----~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h 322 (355)
T 1vzo_A 264 VDGEK-NSQAEISRRILKSEPP--------YPQEM-----SALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH 322 (355)
T ss_dssp CTTSC-CCHHHHHHHHHHCCCC--------CCTTS-----CHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred cCCcc-chHHHHHHHHhccCCC--------CCccc-----CHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcC
Confidence 43222 2223333332222211 11111 23578999999999999999 88888753
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=333.67 Aligned_cols=240 Identities=23% Similarity=0.315 Sum_probs=188.8
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeCCCC---chhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCC
Q 005102 409 FVLGKSGIGIVYKVVLE-DGHTLAVRRLGEGG---SQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNG 484 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~g 484 (714)
+.||+|+||.||+|.+. +|+.||||++.... ....+.+.+|++++++++||||+++++++...+..++||||++++
T Consensus 17 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 96 (276)
T 2h6d_A 17 DTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGG 96 (276)
T ss_dssp EEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCCSC
T ss_pred eeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEEeccCCC
Confidence 47999999999999986 68999999986532 233467899999999999999999999999999999999999999
Q ss_pred CHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCC
Q 005102 485 SLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGS 564 (714)
Q Consensus 485 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 564 (714)
+|.+++... ..+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++......
T Consensus 97 ~L~~~l~~~------~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~-- 165 (276)
T 2h6d_A 97 ELFDYICKH------GRVEEMEARRLFQQILSAVDYCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE-- 165 (276)
T ss_dssp BHHHHHHHH------CSCCHHHHHHHHHHHHHHHHHHHH---HCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC----
T ss_pred cHHHHHhcc------CCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCChhhEEECCCCCEEEeecccccccCCCc--
Confidence 999999754 358999999999999999999999 899999999999999999999999999987643210
Q ss_pred CCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCC-CchhhhHHHHHHHHHHHhCCCccccCCCCc
Q 005102 565 PTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKP-SQKWDIYSYGVILLEMITGRTAVVQVGSSE 643 (714)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~~DVwS~Gvvl~elltG~~p~~~~~~~~ 643 (714)
......||+.|+|||.+.+..+ +.++||||||+++|||++|+.||...
T Consensus 166 ---------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~---- 214 (276)
T 2h6d_A 166 ---------------------------FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDE---- 214 (276)
T ss_dssp --------------------------------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCS----
T ss_pred ---------------------------ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCC----
Confidence 1112346888999999987765 68999999999999999999999432
Q ss_pred chhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 005102 644 MDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISD 704 (714)
Q Consensus 644 ~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 704 (714)
............... .... ....+.+++.+||+.||++|||++|+++
T Consensus 215 -~~~~~~~~~~~~~~~--------~~~~-----~~~~l~~li~~~l~~~p~~Rps~~~~l~ 261 (276)
T 2h6d_A 215 -HVPTLFKKIRGGVFY--------IPEY-----LNRSVATLLMHMLQVDPLKRATIKDIRE 261 (276)
T ss_dssp -SHHHHHHHHHHCCCC--------CCTT-----SCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -cHHHHHHHhhcCccc--------Cchh-----cCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence 112222222221111 1111 1235789999999999999999999986
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-39 Score=341.58 Aligned_cols=257 Identities=22% Similarity=0.292 Sum_probs=197.9
Q ss_pred ccccccCceEEEEEEE------CCCcEEEEEEeCCC-CchhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEecc
Q 005102 409 FVLGKSGIGIVYKVVL------EDGHTLAVRRLGEG-GSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYI 481 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~------~~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~ 481 (714)
+.||+|+||.||+|++ .++..||||++... ......++.+|+.++++++||||+++++++...+..++||||+
T Consensus 36 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 115 (327)
T 2yfx_A 36 RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELM 115 (327)
T ss_dssp EECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred EEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCcEEEEecC
Confidence 4799999999999984 24779999999754 3344567999999999999999999999999999999999999
Q ss_pred CCCCHhhhhhCCCCCC-CcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCC---CCCeEEcccchhhh
Q 005102 482 PNGSLATALHGKPGMV-SFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGH---NMEPHVSDFGLARL 557 (714)
Q Consensus 482 ~~gsL~~~l~~~~~~~-~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~---~~~~kl~DFGla~~ 557 (714)
++|+|.+++....... ....+++.++..++.|++.||+|||+ .+|+||||||+|||++. +..+||+|||+++.
T Consensus 116 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~---~~i~H~dlkp~NIli~~~~~~~~~kl~Dfg~~~~ 192 (327)
T 2yfx_A 116 AGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE---NHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARD 192 (327)
T ss_dssp TTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESCSSTTCCEEECCCHHHHH
T ss_pred CCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhh---CCeecCcCCHhHEEEecCCCcceEEECccccccc
Confidence 9999999997653211 11358999999999999999999999 89999999999999984 45699999999986
Q ss_pred hhccCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHh-CCCcc
Q 005102 558 ANIAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMIT-GRTAV 636 (714)
Q Consensus 558 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~ellt-G~~p~ 636 (714)
...... ........||+.|+|||.+.+..++.++||||||+++|||+| |+.||
T Consensus 193 ~~~~~~--------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~ 246 (327)
T 2yfx_A 193 IYRASY--------------------------YRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPY 246 (327)
T ss_dssp HHC--------------------------------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred cccccc--------------------------cccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCC
Confidence 543211 011122345788999999988899999999999999999998 99998
Q ss_pred ccCCCCcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhhhhc
Q 005102 637 VQVGSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDALDRLIV 711 (714)
Q Consensus 637 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~ 711 (714)
.... .. ........... +..... ....+.+++.+||+.||++|||++++++.|+.+..
T Consensus 247 ~~~~--~~---~~~~~~~~~~~-------~~~~~~-----~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~ 304 (327)
T 2yfx_A 247 PSKS--NQ---EVLEFVTSGGR-------MDPPKN-----CPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ 304 (327)
T ss_dssp TTCC--HH---HHHHHHHTTCC-------CCCCTT-----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCcC--HH---HHHHHHhcCCC-------CCCCCC-----CCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhc
Confidence 4321 11 12221111111 111111 12368899999999999999999999999998754
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=346.12 Aligned_cols=254 Identities=22% Similarity=0.284 Sum_probs=190.8
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeCCCCchh-----HHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccC
Q 005102 409 FVLGKSGIGIVYKVVLE-DGHTLAVRRLGEGGSQR-----FKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIP 482 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~-----~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~ 482 (714)
+.||+|+||.||+|++. +|+.||||++....... .+.+.+|++++++++||||+++++++...+..++||||++
T Consensus 16 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 95 (346)
T 1ua2_A 16 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFME 95 (346)
T ss_dssp EEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECCS
T ss_pred eEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCceEEEEEcCC
Confidence 57999999999999986 48999999997542211 2468899999999999999999999999999999999997
Q ss_pred CCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccC
Q 005102 483 NGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAG 562 (714)
Q Consensus 483 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 562 (714)
+ +|.+++.... ..+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++......
T Consensus 96 ~-~l~~~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~ 166 (346)
T 1ua2_A 96 T-DLEVIIKDNS-----LVLTPSHIKAYMLMTLQGLEYLHQ---HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN 166 (346)
T ss_dssp E-EHHHHHTTCC-----SSCCSSHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC
T ss_pred C-CHHHHHHhcC-----cCCCHHHHHHHHHHHHHHHHHHHH---CCEECCCCCHHHEEEcCCCCEEEEecccceeccCCc
Confidence 5 8998887653 458889999999999999999999 899999999999999999999999999998653211
Q ss_pred CCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCC-CCCchhhhHHHHHHHHHHHhCCCccccCCC
Q 005102 563 GSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVV-KPSQKWDIYSYGVILLEMITGRTAVVQVGS 641 (714)
Q Consensus 563 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DVwS~Gvvl~elltG~~p~~~~~~ 641 (714)
.......||+.|+|||.+.+. .++.++|||||||++|||++|..||...
T Consensus 167 ----------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~-- 216 (346)
T 1ua2_A 167 ----------------------------RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGD-- 216 (346)
T ss_dssp ----------------------------CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCS--
T ss_pred ----------------------------ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCC--
Confidence 112234568899999999764 4899999999999999999999998432
Q ss_pred CcchhHHHHHHHHhh-cCCccc-ccC---------CCCCCCCCc----HHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 005102 642 SEMDLVNWMQLCIEE-KKPLAD-VLD---------PYLAPDADK----EEEIIAVLKIAMACVHSSPEKRPTMRHISD 704 (714)
Q Consensus 642 ~~~~l~~~~~~~~~~-~~~~~~-~~d---------~~~~~~~~~----~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 704 (714)
...+. +...... ..+..+ ..+ ....+.... ......+.+++.+||+.||++|||++|+++
T Consensus 217 ~~~~~---~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 291 (346)
T 1ua2_A 217 SDLDQ---LTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 291 (346)
T ss_dssp SHHHH---HHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred CHHHH---HHHHHHHcCCCChhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhc
Confidence 11111 1122111 110000 000 000000000 111246889999999999999999999975
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=345.87 Aligned_cols=261 Identities=21% Similarity=0.263 Sum_probs=183.3
Q ss_pred cccccccCceEEEEEEEC-CCcEEEEEEeCCCCchhHHHHHHHHHHHhccC-CCCccceEEEEEe--------CCceeEE
Q 005102 408 AFVLGKSGIGIVYKVVLE-DGHTLAVRRLGEGGSQRFKEFQTEVEAIGKIR-HSNIVTLRAYYWS--------VDEKLLI 477 (714)
Q Consensus 408 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~--------~~~~~lV 477 (714)
.+.||+|+||.||+|++. +++.||||++........+.+.+|+.+++++. ||||+++++++.. ....++|
T Consensus 33 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~~~lv 112 (337)
T 3ll6_A 33 RRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLL 112 (337)
T ss_dssp EEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSEEEEEE
T ss_pred EEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCCceEEEE
Confidence 358999999999999975 58999999997766666678999999999996 9999999999953 3347899
Q ss_pred EeccCCCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCC--ceecCCCCCCeeeCCCCCeEEcccchh
Q 005102 478 YDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKK--YVHGDLKPSNILLGHNMEPHVSDFGLA 555 (714)
Q Consensus 478 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~--ivHrDlkp~NILl~~~~~~kl~DFGla 555 (714)
|||+. |+|.+++...... ..+++.++..|+.||+.||+|||+ .+ |+||||||+|||++.++.+||+|||++
T Consensus 113 ~e~~~-g~L~~~l~~~~~~---~~~~~~~~~~i~~qi~~~l~~LH~---~~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~ 185 (337)
T 3ll6_A 113 TELCK-GQLVEFLKKMESR---GPLSCDTVLKIFYQTCRAVQHMHR---QKPPIIHRDLKVENLLLSNQGTIKLCDFGSA 185 (337)
T ss_dssp EECCS-EEHHHHHHHHHTT---CSCCHHHHHHHHHHHHHHHHHHHT---SSSCCBCCCCCGGGCEECTTSCEEBCCCTTC
T ss_pred EEecC-CCHHHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHHh---CCCCEEEccCCcccEEECCCCCEEEecCccc
Confidence 99995 7999988642111 458999999999999999999999 77 999999999999999999999999999
Q ss_pred hhhhccCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCccc---CCCCCCchhhhHHHHHHHHHHHhC
Q 005102 556 RLANIAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESL---KVVKPSQKWDIYSYGVILLEMITG 632 (714)
Q Consensus 556 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~---~~~~~s~~~DVwS~Gvvl~elltG 632 (714)
+............. ............||+.|+|||++ .+..++.++|||||||++|||+||
T Consensus 186 ~~~~~~~~~~~~~~----------------~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g 249 (337)
T 3ll6_A 186 TTISHYPDYSWSAQ----------------RRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFR 249 (337)
T ss_dssp BCCSSCC-----------------------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHS
T ss_pred eeccccCccccccc----------------ccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhC
Confidence 86543211100000 00001112234578899999998 566789999999999999999999
Q ss_pred CCccccCCCCcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhhhhc
Q 005102 633 RTAVVQVGSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDALDRLIV 711 (714)
Q Consensus 633 ~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~ 711 (714)
+.||...... .. ...... ....... ...+.+++.+||+.||++|||++|+++.|+++..
T Consensus 250 ~~p~~~~~~~-----~~----~~~~~~------~~~~~~~-----~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~ 308 (337)
T 3ll6_A 250 QHPFEDGAKL-----RI----VNGKYS------IPPHDTQ-----YTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAA 308 (337)
T ss_dssp SCCC---------------------CC------CCTTCCS-----SGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCcchhHH-----Hh----hcCccc------CCccccc-----chHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 9999432111 00 011100 0000111 1247789999999999999999999999998864
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-40 Score=347.35 Aligned_cols=257 Identities=21% Similarity=0.295 Sum_probs=188.8
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeCCCCchh-HHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCCCH
Q 005102 409 FVLGKSGIGIVYKVVLE-DGHTLAVRRLGEGGSQR-FKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGSL 486 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL 486 (714)
+.||+|+||+||+|+.. +++.||||++....... ...+.+|++++++++||||+++++++...+..++||||++ |+|
T Consensus 8 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l 86 (324)
T 3mtl_A 8 DKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLD-KDL 86 (324)
T ss_dssp EEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEECCS-EEH
T ss_pred EEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecccc-cCH
Confidence 47999999999999986 58999999997643221 1245679999999999999999999999999999999997 599
Q ss_pred hhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCCCC
Q 005102 487 ATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPT 566 (714)
Q Consensus 487 ~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 566 (714)
.+++.... ..+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++......
T Consensus 87 ~~~~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~---- 154 (324)
T 3mtl_A 87 KQYLDDCG-----NIINMHNVKLFLFQLLRGLAYCHR---QKVLHRDLKPQNLLINERGELKLADFGLARAKSIPT---- 154 (324)
T ss_dssp HHHHHHTT-----TCCCHHHHHHHHHHHHHHHHHHHH---TTEEESSCCGGGEEECTTCCEEECSSSEEECC--------
T ss_pred HHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCcCHHHEEECCCCCEEEccCcccccccCCc----
Confidence 99887653 358999999999999999999999 899999999999999999999999999997543211
Q ss_pred ccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCC-CCCCchhhhHHHHHHHHHHHhCCCccccCCCCcch
Q 005102 567 LQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKV-VKPSQKWDIYSYGVILLEMITGRTAVVQVGSSEMD 645 (714)
Q Consensus 567 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DVwS~Gvvl~elltG~~p~~~~~~~~~~ 645 (714)
.......||+.|+|||++.+ ..++.++|||||||++|||++|+.||... ...+
T Consensus 155 ------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~--~~~~ 208 (324)
T 3mtl_A 155 ------------------------KTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGS--TVEE 208 (324)
T ss_dssp --------------------------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCS--SHHH
T ss_pred ------------------------cccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC--CHHH
Confidence 11223356889999999876 56899999999999999999999999432 2222
Q ss_pred hHHHHHHHHhhcCC--cccccC---------CCCCCCCC---cHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 005102 646 LVNWMQLCIEEKKP--LADVLD---------PYLAPDAD---KEEEIIAVLKIAMACVHSSPEKRPTMRHISD 704 (714)
Q Consensus 646 l~~~~~~~~~~~~~--~~~~~d---------~~~~~~~~---~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 704 (714)
....+......... ...... +....... .......+.+++.+||+.||++|||++|+++
T Consensus 209 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 281 (324)
T 3mtl_A 209 QLHFIFRILGTPTEETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK 281 (324)
T ss_dssp HHHHHHHHHCCCCTTTSTTGGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred HHHHHHHHhCCCChHhchhhhcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 22222222111100 000000 00000000 0011235789999999999999999999975
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=343.32 Aligned_cols=258 Identities=23% Similarity=0.349 Sum_probs=192.9
Q ss_pred ccccccCceEEEEEEECC-CcEEEEEEeCCCCc--hhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCCC
Q 005102 409 FVLGKSGIGIVYKVVLED-GHTLAVRRLGEGGS--QRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGS 485 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~~-g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gs 485 (714)
..||+|+||.||+|+... |+.||||++..... ...+.+.+|++++++++||||+++++++...+..++||||+++++
T Consensus 31 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 110 (331)
T 4aaa_A 31 GLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDHTI 110 (331)
T ss_dssp EEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSEEH
T ss_pred eEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEecCCcch
Confidence 479999999999999865 89999999865433 234568899999999999999999999999999999999999999
Q ss_pred HhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCCC
Q 005102 486 LATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSP 565 (714)
Q Consensus 486 L~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 565 (714)
|.+++... ..+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++......
T Consensus 111 l~~~~~~~------~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--- 178 (331)
T 4aaa_A 111 LDDLELFP------NGLDYQVVQKYLFQIINGIGFCHS---HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG--- 178 (331)
T ss_dssp HHHHHHST------TCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCTTC----------
T ss_pred HHHHHhhc------cCCCHHHHHHHHHHHHHHHHHHHH---CCEEccCcChheEEEcCCCcEEEEeCCCceeecCCc---
Confidence 98887654 458999999999999999999999 899999999999999999999999999997653211
Q ss_pred CccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCC-CCCchhhhHHHHHHHHHHHhCCCccccCCCCcc
Q 005102 566 TLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVV-KPSQKWDIYSYGVILLEMITGRTAVVQVGSSEM 644 (714)
Q Consensus 566 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DVwS~Gvvl~elltG~~p~~~~~~~~~ 644 (714)
.......||+.|+|||.+.+. .++.++|||||||++|||++|+.||...... .
T Consensus 179 -------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-~ 232 (331)
T 4aaa_A 179 -------------------------EVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDI-D 232 (331)
T ss_dssp ------------------------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-H
T ss_pred -------------------------cccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcH-H
Confidence 111233568899999999875 6899999999999999999999999433211 1
Q ss_pred hhHHHHH----------HHHhhcCCcccccCCCCCCCCCcH----HHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 005102 645 DLVNWMQ----------LCIEEKKPLADVLDPYLAPDADKE----EEIIAVLKIAMACVHSSPEKRPTMRHISD 704 (714)
Q Consensus 645 ~l~~~~~----------~~~~~~~~~~~~~d~~~~~~~~~~----~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 704 (714)
.+...+. ..............+......... .....+.+++.+||+.||++|||++|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 306 (331)
T 4aaa_A 233 QLYHIMMCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH 306 (331)
T ss_dssp HHHHHHHHHCSCCHHHHHHHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred HHHHHHHHhCCCChhhhhHhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 1111110 011111111111111111111100 12346889999999999999999998875
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=343.14 Aligned_cols=256 Identities=25% Similarity=0.395 Sum_probs=198.0
Q ss_pred cccccccCceEEEEEEEC-CCcE--EEEEEeCCC-CchhHHHHHHHHHHHhcc-CCCCccceEEEEEeCCceeEEEeccC
Q 005102 408 AFVLGKSGIGIVYKVVLE-DGHT--LAVRRLGEG-GSQRFKEFQTEVEAIGKI-RHSNIVTLRAYYWSVDEKLLIYDYIP 482 (714)
Q Consensus 408 ~~~lG~G~~g~Vy~~~~~-~g~~--vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~e~~~ 482 (714)
.+.||+|+||.||+|++. ++.. ||+|++... .....+.+.+|+++++++ +||||+++++++...+..++||||++
T Consensus 30 ~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~ 109 (327)
T 1fvr_A 30 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAP 109 (327)
T ss_dssp EEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEECCCT
T ss_pred eeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEEEecCC
Confidence 357999999999999975 4554 499988753 233446789999999999 89999999999999999999999999
Q ss_pred CCCHhhhhhCCCC----------CCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEccc
Q 005102 483 NGSLATALHGKPG----------MVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDF 552 (714)
Q Consensus 483 ~gsL~~~l~~~~~----------~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DF 552 (714)
+|+|.+++..... ......+++.++..++.|++.||+|||+ .+|+||||||+||+++.++.+||+||
T Consensus 110 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIl~~~~~~~kL~Df 186 (327)
T 1fvr_A 110 HGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADF 186 (327)
T ss_dssp TCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECGGGCEEECCT
T ss_pred CCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCccceEEEcCCCeEEEccc
Confidence 9999999976530 0011368999999999999999999999 89999999999999999999999999
Q ss_pred chhhhhhccCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHh-
Q 005102 553 GLARLANIAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMIT- 631 (714)
Q Consensus 553 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~ellt- 631 (714)
|+++..... .......+++.|+|||.+.+..++.++||||||+++|||+|
T Consensus 187 g~~~~~~~~-----------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~ 237 (327)
T 1fvr_A 187 GLSRGQEVY-----------------------------VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSL 237 (327)
T ss_dssp TCEESSCEE-----------------------------CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTT
T ss_pred CcCcccccc-----------------------------ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcC
Confidence 998743211 11122335778999999988889999999999999999998
Q ss_pred CCCccccCCCCcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhhhhc
Q 005102 632 GRTAVVQVGSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDALDRLIV 711 (714)
Q Consensus 632 G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~ 711 (714)
|+.||.... ..+..... .... ....... ....+.+++.+||+.||++|||++|+++.|+++..
T Consensus 238 g~~pf~~~~-----~~~~~~~~-~~~~------~~~~~~~-----~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 300 (327)
T 1fvr_A 238 GGTPYCGMT-----CAELYEKL-PQGY------RLEKPLN-----CDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 300 (327)
T ss_dssp SCCTTTTCC-----HHHHHHHG-GGTC------CCCCCTT-----BCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCCCCc-----HHHHHHHh-hcCC------CCCCCCC-----CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 999994321 11111111 1111 1111111 12368899999999999999999999999999865
Q ss_pred c
Q 005102 712 S 712 (714)
Q Consensus 712 ~ 712 (714)
.
T Consensus 301 ~ 301 (327)
T 1fvr_A 301 E 301 (327)
T ss_dssp S
T ss_pred h
Confidence 3
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-39 Score=359.35 Aligned_cols=244 Identities=24% Similarity=0.324 Sum_probs=194.6
Q ss_pred cccccccCceEEEEEEEC-CCcEEEEEEeCCC--CchhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCC
Q 005102 408 AFVLGKSGIGIVYKVVLE-DGHTLAVRRLGEG--GSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNG 484 (714)
Q Consensus 408 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~g 484 (714)
.+.||+|+||+||+|+.. +++.||||++... .......+.+|++++++++||||+++++++...+..++||||+++|
T Consensus 27 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~ 106 (486)
T 3mwu_A 27 VCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGG 106 (486)
T ss_dssp EEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSC
T ss_pred eEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEEEcCCCC
Confidence 358999999999999986 5899999998643 2234577899999999999999999999999999999999999999
Q ss_pred CHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeC---CCCCeEEcccchhhhhhcc
Q 005102 485 SLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLG---HNMEPHVSDFGLARLANIA 561 (714)
Q Consensus 485 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~---~~~~~kl~DFGla~~~~~~ 561 (714)
+|.+.+... ..+++..+..|+.|++.||+|||+ .+|+||||||+|||++ .++.+||+|||+++.....
T Consensus 107 ~L~~~~~~~------~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~ 177 (486)
T 3mwu_A 107 ELFDEIIKR------KRFSEHDAARIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN 177 (486)
T ss_dssp BHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC
T ss_pred cHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCC
Confidence 999988754 458999999999999999999999 8999999999999995 4567999999999765321
Q ss_pred CCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCccccCCC
Q 005102 562 GGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGS 641 (714)
Q Consensus 562 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~~~~~~ 641 (714)
.......||+.|+|||++.+ .++.++||||+||++|||++|+.||...
T Consensus 178 -----------------------------~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~-- 225 (486)
T 3mwu_A 178 -----------------------------TKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGK-- 225 (486)
T ss_dssp ---------------------------------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCS--
T ss_pred -----------------------------CccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCC--
Confidence 11223457999999999975 5999999999999999999999999432
Q ss_pred CcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 005102 642 SEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISD 704 (714)
Q Consensus 642 ~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 704 (714)
.. .+............. .+ ........+.+++.+||+.||++|||+.|+++
T Consensus 226 ~~---~~~~~~i~~~~~~~~---~~------~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~ 276 (486)
T 3mwu_A 226 NE---YDILKRVETGKYAFD---LP------QWRTISDDAKDLIRKMLTFHPSLRITATQCLE 276 (486)
T ss_dssp SH---HHHHHHHHHTCCCSC---SG------GGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred CH---HHHHHHHHhCCCCCC---Cc------ccCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 11 222222222221110 00 00112236789999999999999999999986
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-39 Score=345.99 Aligned_cols=244 Identities=24% Similarity=0.366 Sum_probs=194.3
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeCCCCc--------hhHHHHHHHHHHHhcc-CCCCccceEEEEEeCCceeEEE
Q 005102 409 FVLGKSGIGIVYKVVLE-DGHTLAVRRLGEGGS--------QRFKEFQTEVEAIGKI-RHSNIVTLRAYYWSVDEKLLIY 478 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~ 478 (714)
+.||+|+||.||+|++. +|+.||||++..... ...+.+.+|+++++++ +||||+++++++...+..++||
T Consensus 100 ~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~ 179 (365)
T 2y7j_A 100 DVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVF 179 (365)
T ss_dssp EEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSSEEEEEE
T ss_pred eEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCCEEEEEE
Confidence 68999999999999986 699999999876431 1135688999999999 7999999999999999999999
Q ss_pred eccCCCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhh
Q 005102 479 DYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLA 558 (714)
Q Consensus 479 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~ 558 (714)
||+++|+|.+++... ..+++..+..++.||+.||+|||+ .+|+||||||+||++++++.+||+|||++...
T Consensus 180 e~~~g~~L~~~l~~~------~~l~~~~~~~i~~qi~~~L~~LH~---~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~ 250 (365)
T 2y7j_A 180 DLMRKGELFDYLTEK------VALSEKETRSIMRSLLEAVSFLHA---NNIVHRDLKPENILLDDNMQIRLSDFGFSCHL 250 (365)
T ss_dssp CCCTTCBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred EeCCCCcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEEEecCccccc
Confidence 999999999999754 458999999999999999999999 89999999999999999999999999998765
Q ss_pred hccCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCC------CCCCchhhhHHHHHHHHHHHhC
Q 005102 559 NIAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKV------VKPSQKWDIYSYGVILLEMITG 632 (714)
Q Consensus 559 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~s~~~DVwS~Gvvl~elltG 632 (714)
.... ......||+.|+|||++.+ ..++.++|||||||++|||+||
T Consensus 251 ~~~~-----------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g 301 (365)
T 2y7j_A 251 EPGE-----------------------------KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAG 301 (365)
T ss_dssp CTTC-----------------------------CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHS
T ss_pred CCCc-----------------------------ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHC
Confidence 3211 1223457899999999853 3578999999999999999999
Q ss_pred CCccccCCCCcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 005102 633 RTAVVQVGSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISD 704 (714)
Q Consensus 633 ~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 704 (714)
+.||.... . ................ +.. . .....+.+++.+||+.||++|||++|+++
T Consensus 302 ~~pf~~~~--~---~~~~~~i~~~~~~~~~---~~~-~-----~~~~~~~~li~~~L~~dP~~Rps~~ell~ 359 (365)
T 2y7j_A 302 SPPFWHRR--Q---ILMLRMIMEGQYQFSS---PEW-D-----DRSSTVKDLISRLLQVDPEARLTAEQALQ 359 (365)
T ss_dssp SCSSCCSS--H---HHHHHHHHHTCCCCCH---HHH-S-----SSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CCCCCCCC--H---HHHHHHHHhCCCCCCC---ccc-c-----cCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 99994321 1 1112222222111000 000 0 11235889999999999999999999976
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=351.58 Aligned_cols=212 Identities=25% Similarity=0.356 Sum_probs=157.0
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeCCC--CchhHHHHHHHHHHHhccC-CCCccceEEEEEeCC--ceeEEEeccC
Q 005102 409 FVLGKSGIGIVYKVVLE-DGHTLAVRRLGEG--GSQRFKEFQTEVEAIGKIR-HSNIVTLRAYYWSVD--EKLLIYDYIP 482 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~--~~~lV~e~~~ 482 (714)
+.||+|+||.||+|.+. +|+.||||++... .....+.+.+|+.+++++. ||||+++++++...+ ..|+||||++
T Consensus 15 ~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~ 94 (388)
T 3oz6_A 15 KKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVYLVFDYME 94 (388)
T ss_dssp EC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEEEEEECCS
T ss_pred EEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEEEEecccC
Confidence 47999999999999975 5899999999654 3344567889999999997 999999999998654 6899999997
Q ss_pred CCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccC
Q 005102 483 NGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAG 562 (714)
Q Consensus 483 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 562 (714)
|+|.+++... .+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+|+......
T Consensus 95 -~~L~~~~~~~-------~~~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 163 (388)
T 3oz6_A 95 -TDLHAVIRAN-------ILEPVHKQYVVYQLIKVIKYLHS---GGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIR 163 (388)
T ss_dssp -EEHHHHHHHT-------CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEESSSCC
T ss_pred -cCHHHHHHcC-------CCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHeEEcCCCCEEecCCcccccccccc
Confidence 6999988643 48899999999999999999999 899999999999999999999999999998654321
Q ss_pred CCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCC-CCCCchhhhHHHHHHHHHHHhCCCcccc
Q 005102 563 GSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKV-VKPSQKWDIYSYGVILLEMITGRTAVVQ 638 (714)
Q Consensus 563 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DVwS~Gvvl~elltG~~p~~~ 638 (714)
.......... .. . .. .............||+.|+|||++.+ ..++.++|||||||++|||++|+.||..
T Consensus 164 ~~~~~~~~~~-~~-~----~~-~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~ 233 (388)
T 3oz6_A 164 RVTNNIPLSI-NE-N----TE-NFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPG 233 (388)
T ss_dssp CCCCCGGGCC-C---------------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred cccccccccc-cc-c----cc-ccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCC
Confidence 1000000000 00 0 00 00000122344578999999999976 6789999999999999999999999953
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=374.56 Aligned_cols=236 Identities=21% Similarity=0.272 Sum_probs=193.8
Q ss_pred ccccccCceEEEEEEECC-CcEEEEEEeCCC---CchhHHHHHHHHHHHhcc-CCCCccceEEEEEeCCceeEEEeccCC
Q 005102 409 FVLGKSGIGIVYKVVLED-GHTLAVRRLGEG---GSQRFKEFQTEVEAIGKI-RHSNIVTLRAYYWSVDEKLLIYDYIPN 483 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~~-g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~e~~~~ 483 (714)
++||+|+||+||+|+++. ++.||||++++. .....+.+..|..++..+ +||+|+++++++.+.+..|+||||+++
T Consensus 347 ~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~lV~E~~~g 426 (674)
T 3pfq_A 347 MVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNG 426 (674)
T ss_dssp EESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEEEEECCCS
T ss_pred EEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEEEEeCcCC
Confidence 579999999999999864 889999999753 223346788999999988 799999999999999999999999999
Q ss_pred CCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCC
Q 005102 484 GSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGG 563 (714)
Q Consensus 484 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 563 (714)
|+|.+++... ..+++..++.|+.||+.||+|||+ ++||||||||+|||++.++++||+|||+|+.....
T Consensus 427 g~L~~~l~~~------~~~~~~~~~~~~~qi~~aL~~LH~---~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~-- 495 (674)
T 3pfq_A 427 GDLMYHIQQV------GRFKEPHAVFYAAEIAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWD-- 495 (674)
T ss_dssp CBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHH---TSEECCCCCSTTEEECSSSCEEECCCTTCEECCCT--
T ss_pred CcHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHh---CCeEeccCChhhEEEcCCCcEEEeecceeeccccC--
Confidence 9999999765 458999999999999999999999 89999999999999999999999999999753211
Q ss_pred CCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCccccCCCCc
Q 005102 564 SPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGSSE 643 (714)
Q Consensus 564 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~~~~~~~~ 643 (714)
........||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 496 --------------------------~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~---- 545 (674)
T 3pfq_A 496 --------------------------GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGE---- 545 (674)
T ss_dssp --------------------------TCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCS----
T ss_pred --------------------------CcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCC----
Confidence 11223456899999999999999999999999999999999999999432
Q ss_pred chhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCH
Q 005102 644 MDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTM 699 (714)
Q Consensus 644 ~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~ 699 (714)
+..+..+........+ +.. ...++.+|+.+||+.||++||++
T Consensus 546 -~~~~~~~~i~~~~~~~--------p~~-----~s~~~~~li~~lL~~dP~~R~~~ 587 (674)
T 3pfq_A 546 -DEDELFQSIMEHNVAY--------PKS-----MSKEAVAICKGLMTKHPGKRLGC 587 (674)
T ss_dssp -SHHHHHHHHHSSCCCC--------CTT-----SCHHHHHHHHHHSCSSSTTCTTC
T ss_pred -CHHHHHHHHHhCCCCC--------Ccc-----CCHHHHHHHHHHccCCHHHCCCC
Confidence 1222333333322211 111 12357899999999999999997
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=361.02 Aligned_cols=244 Identities=24% Similarity=0.344 Sum_probs=196.4
Q ss_pred cccccccCceEEEEEEEC-CCcEEEEEEeCCCC---chhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCC
Q 005102 408 AFVLGKSGIGIVYKVVLE-DGHTLAVRRLGEGG---SQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPN 483 (714)
Q Consensus 408 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~ 483 (714)
.+.||+|+||.||+|+.. +|+.||||++.... ....+.+.+|++++++++||||+++++++...+..++||||+.+
T Consensus 31 ~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~ 110 (484)
T 3nyv_A 31 QRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTG 110 (484)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred eeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEecCCC
Confidence 357999999999999986 68999999986542 33457899999999999999999999999999999999999999
Q ss_pred CCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeee---CCCCCeEEcccchhhhhhc
Q 005102 484 GSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILL---GHNMEPHVSDFGLARLANI 560 (714)
Q Consensus 484 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl---~~~~~~kl~DFGla~~~~~ 560 (714)
|+|.+++... ..+++..+..|+.||+.||+|||+ ++|+||||||+|||+ +.++.+||+|||+++....
T Consensus 111 ~~L~~~~~~~------~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~ 181 (484)
T 3nyv_A 111 GELFDEIISR------KRFSEVDAARIIRQVLSGITYMHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA 181 (484)
T ss_dssp CBHHHHHHTC------SCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCC
T ss_pred CCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEccc
Confidence 9999999765 458999999999999999999999 899999999999999 5678999999999986542
Q ss_pred cCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCccccCC
Q 005102 561 AGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVG 640 (714)
Q Consensus 561 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~~~~~ 640 (714)
.. ......||+.|+|||++.+ .++.++||||+||++|||++|+.||...
T Consensus 182 ~~-----------------------------~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~- 230 (484)
T 3nyv_A 182 SK-----------------------------KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGA- 230 (484)
T ss_dssp CC-----------------------------SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCS-
T ss_pred cc-----------------------------ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCC-
Confidence 11 1112347899999999875 6999999999999999999999999432
Q ss_pred CCcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 005102 641 SSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISD 704 (714)
Q Consensus 641 ~~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 704 (714)
... +.+........... .+ ........+.+++.+||+.||++|||++|+++
T Consensus 231 -~~~---~~~~~i~~~~~~~~---~~------~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 281 (484)
T 3nyv_A 231 -NEY---DILKKVEKGKYTFE---LP------QWKKVSESAKDLIRKMLTYVPSMRISARDALD 281 (484)
T ss_dssp -SHH---HHHHHHHHCCCCCC---SG------GGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -CHH---HHHHHHHcCCCCCC---Cc------ccccCCHHHHHHHHHHCCCChhHCcCHHHHhh
Confidence 222 22222222221110 00 00112236789999999999999999999975
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-39 Score=359.38 Aligned_cols=244 Identities=21% Similarity=0.301 Sum_probs=190.9
Q ss_pred cccccccCceEEEEEEEC-CCcEEEEEEeCCCC--chhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCC
Q 005102 408 AFVLGKSGIGIVYKVVLE-DGHTLAVRRLGEGG--SQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNG 484 (714)
Q Consensus 408 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~g 484 (714)
.+.||+|+||+||+|+.+ ++..||||++.... ......+.+|++++++++||||+++++++...+..++||||+++|
T Consensus 42 ~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g 121 (494)
T 3lij_A 42 VKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGG 121 (494)
T ss_dssp EEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCCSC
T ss_pred eeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecCCCC
Confidence 357999999999999986 58899999997642 233467899999999999999999999999999999999999999
Q ss_pred CHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCC---CCCeEEcccchhhhhhcc
Q 005102 485 SLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGH---NMEPHVSDFGLARLANIA 561 (714)
Q Consensus 485 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~---~~~~kl~DFGla~~~~~~ 561 (714)
+|.+.+... ..+++..+..|+.||+.||+|||+ .+|+||||||+|||++. ++.+||+|||+++.....
T Consensus 122 ~L~~~~~~~------~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~ 192 (494)
T 3lij_A 122 ELFDEIIHR------MKFNEVDAAVIIKQVLSGVTYLHK---HNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQ 192 (494)
T ss_dssp BHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTT
T ss_pred cHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCC
Confidence 999988654 458999999999999999999999 89999999999999976 455999999999765321
Q ss_pred CCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCccccCCC
Q 005102 562 GGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGS 641 (714)
Q Consensus 562 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~~~~~~ 641 (714)
.......||+.|+|||++. ..++.++||||+||++|||++|+.||....
T Consensus 193 -----------------------------~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~- 241 (494)
T 3lij_A 193 -----------------------------KKMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQT- 241 (494)
T ss_dssp -----------------------------BCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSS-
T ss_pred -----------------------------ccccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCC-
Confidence 1122345799999999986 569999999999999999999999994321
Q ss_pred CcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 005102 642 SEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISD 704 (714)
Q Consensus 642 ~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 704 (714)
. .+............. .+... .....+.+++.+||+.||++|||++|+++
T Consensus 242 -~---~~~~~~i~~~~~~~~---~~~~~------~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 291 (494)
T 3lij_A 242 -D---QEILRKVEKGKYTFD---SPEWK------NVSEGAKDLIKQMLQFDSQRRISAQQALE 291 (494)
T ss_dssp -H---HHHHHHHHHTCCCCC---SGGGT------TSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred -H---HHHHHHHHhCCCCCC---chhcc------cCCHHHHHHHHHHCCCChhhCccHHHHhc
Confidence 1 222222222221111 11110 11235789999999999999999999874
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-39 Score=334.19 Aligned_cols=242 Identities=23% Similarity=0.373 Sum_probs=197.2
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeCCCC-chhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCCCH
Q 005102 409 FVLGKSGIGIVYKVVLE-DGHTLAVRRLGEGG-SQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGSL 486 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL 486 (714)
+.||+|+||.||+|... +++.||||++.... ....+.+.+|+.++++++||||+++++++...+..++||||+++++|
T Consensus 28 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 107 (303)
T 3a7i_A 28 EKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSA 107 (303)
T ss_dssp EEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEH
T ss_pred hhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEeCCCCcH
Confidence 47999999999999975 58999999997653 34457899999999999999999999999999999999999999999
Q ss_pred hhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCCCC
Q 005102 487 ATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPT 566 (714)
Q Consensus 487 ~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 566 (714)
.+++.. ..+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++......
T Consensus 108 ~~~~~~-------~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~---- 173 (303)
T 3a7i_A 108 LDLLEP-------GPLDETQIATILREILKGLDYLHS---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ---- 173 (303)
T ss_dssp HHHHTT-------SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTB----
T ss_pred HHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCChheEEECCCCCEEEeecccceecCccc----
Confidence 999864 358999999999999999999999 899999999999999999999999999987653211
Q ss_pred ccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCccccCCCCcchh
Q 005102 567 LQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGSSEMDL 646 (714)
Q Consensus 567 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~~~~~~~~~~l 646 (714)
.......||+.|+|||.+.+..++.++||||||+++|||++|+.||.... .
T Consensus 174 ------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~--~--- 224 (303)
T 3a7i_A 174 ------------------------IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELH--P--- 224 (303)
T ss_dssp ------------------------CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC--H---
T ss_pred ------------------------cccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcC--H---
Confidence 11223457889999999999999999999999999999999999994321 1
Q ss_pred HHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHHH
Q 005102 647 VNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDA 705 (714)
Q Consensus 647 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~ 705 (714)
............ +...... ...+.+++.+||+.||++|||++|+++.
T Consensus 225 ~~~~~~~~~~~~-------~~~~~~~-----~~~l~~li~~~l~~dp~~Rps~~~ll~~ 271 (303)
T 3a7i_A 225 MKVLFLIPKNNP-------PTLEGNY-----SKPLKEFVEACLNKEPSFRPTAKELLKH 271 (303)
T ss_dssp HHHHHHHHHSCC-------CCCCSSC-----CHHHHHHHHHHCCSSGGGSCCHHHHTTC
T ss_pred HHHHHHhhcCCC-------CCCcccc-----CHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 111111111111 1111111 2358899999999999999999999763
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=357.16 Aligned_cols=238 Identities=14% Similarity=0.136 Sum_probs=183.0
Q ss_pred ccccccCceEEEEEEE-CCCcEEEEEEeCCC---CchhHHHHHHHH---HHHhccCCCCccceE-------EEEEeCCc-
Q 005102 409 FVLGKSGIGIVYKVVL-EDGHTLAVRRLGEG---GSQRFKEFQTEV---EAIGKIRHSNIVTLR-------AYYWSVDE- 473 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~-~~g~~vavK~~~~~---~~~~~~~~~~E~---~~l~~l~H~niv~l~-------~~~~~~~~- 473 (714)
+.||+|+||.||+|++ .+|+.||||++... .....+.+.+|+ +++++++|||||+++ +++...+.
T Consensus 79 ~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~ 158 (377)
T 3byv_A 79 TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKK 158 (377)
T ss_dssp EEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEEECTTSC
T ss_pred ceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhhhccCCc
Confidence 5799999999999996 45999999999743 334557899999 556666899999998 77765543
Q ss_pred ----------------eeEEEeccCCCCHhhhhhCCCCCC-CcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCC
Q 005102 474 ----------------KLLIYDYIPNGSLATALHGKPGMV-SFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKP 536 (714)
Q Consensus 474 ----------------~~lV~e~~~~gsL~~~l~~~~~~~-~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp 536 (714)
.++||||+ +|+|.+++....... ....+++..+.+|+.||+.||+|||+ .+|+||||||
T Consensus 159 ~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivHrDikp 234 (377)
T 3byv_A 159 KMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH---YGLVHTYLRP 234 (377)
T ss_dssp SEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHH---TTEECSCCCG
T ss_pred cccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHh---CCeecCCCCH
Confidence 78999999 689999997532100 01235568889999999999999999 8999999999
Q ss_pred CCeeeCCCCCeEEcccchhhhhhccCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCC-----
Q 005102 537 SNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVV----- 611 (714)
Q Consensus 537 ~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----- 611 (714)
+|||++.++.+||+|||+|+.... ......| +.|+|||++.+.
T Consensus 235 ~NIll~~~~~~kL~DFG~a~~~~~-------------------------------~~~~~~g-~~y~aPE~~~~~~~~~~ 282 (377)
T 3byv_A 235 VDIVLDQRGGVFLTGFEHLVRDGA-------------------------------RVVSSVS-RGFEPPELEARRATISY 282 (377)
T ss_dssp GGEEECTTCCEEECCGGGCEETTC-------------------------------EEECCCC-TTCCCHHHHHHHTSTHH
T ss_pred HHEEEcCCCCEEEEechhheecCC-------------------------------cccCCCC-cCccChhhhcccccccc
Confidence 999999999999999999974321 1122345 789999999877
Q ss_pred ------CCCchhhhHHHHHHHHHHHhCCCccccCCCCcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHH
Q 005102 612 ------KPSQKWDIYSYGVILLEMITGRTAVVQVGSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIA 685 (714)
Q Consensus 612 ------~~s~~~DVwS~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li 685 (714)
.++.++|||||||++|||+||+.||........ ...+... . ... ...+.+++
T Consensus 283 ~~~~~~~~~~~~DvwSlG~il~elltg~~Pf~~~~~~~~---------------~~~~~~~-~-~~~-----~~~~~~li 340 (377)
T 3byv_A 283 HRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAALGG---------------SEWIFRS-C-KNI-----PQPVRALL 340 (377)
T ss_dssp HHCCEEECCHHHHHHHHHHHHHHHHHSSCCC------CC---------------SGGGGSS-C-CCC-----CHHHHHHH
T ss_pred cccccccCChhhhHHHHHHHHHHHHHCCCCCcccccccc---------------hhhhhhh-c-cCC-----CHHHHHHH
Confidence 899999999999999999999999943221110 1111111 0 111 23688999
Q ss_pred hHccCCCCCCCCCHHHHHH
Q 005102 686 MACVHSSPEKRPTMRHISD 704 (714)
Q Consensus 686 ~~Cl~~dP~~RPt~~evl~ 704 (714)
.+||+.||++|||+.|+++
T Consensus 341 ~~~L~~dp~~Rpt~~e~l~ 359 (377)
T 3byv_A 341 EGFLRYPKEDRLLPLQAME 359 (377)
T ss_dssp HHHTCSSGGGCCCHHHHHT
T ss_pred HHHcCCCchhCCCHHHHhh
Confidence 9999999999999999985
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-39 Score=354.53 Aligned_cols=259 Identities=15% Similarity=0.202 Sum_probs=199.6
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeCCCCchhHHHHHHHHHHHhccCC-CCccceEEEEEeCCceeEEEeccCCCCH
Q 005102 409 FVLGKSGIGIVYKVVLE-DGHTLAVRRLGEGGSQRFKEFQTEVEAIGKIRH-SNIVTLRAYYWSVDEKLLIYDYIPNGSL 486 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H-~niv~l~~~~~~~~~~~lV~e~~~~gsL 486 (714)
+.||+|+||.||+|++. +++.||||++...... .++.+|+++++.++| ++|..+..++...+..++||||+ +++|
T Consensus 13 ~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~~-g~sL 89 (483)
T 3sv0_A 13 RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSL 89 (483)
T ss_dssp CCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS--CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEECC-CCBH
T ss_pred EEEeeCCCEEEEEEEECCCCcEEEEEEecccccc--HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEECC-CCCH
Confidence 47999999999999974 5899999988754332 357899999999987 55666666777788889999999 9999
Q ss_pred hhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeee---CCCCCeEEcccchhhhhhccCC
Q 005102 487 ATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILL---GHNMEPHVSDFGLARLANIAGG 563 (714)
Q Consensus 487 ~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl---~~~~~~kl~DFGla~~~~~~~~ 563 (714)
.+++.... ..+++.+++.|+.||+.||+|||+ ++|+||||||+|||+ +.++.+||+|||+++.......
T Consensus 90 ~~ll~~~~-----~~l~~~~~~~i~~qi~~aL~yLH~---~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~ 161 (483)
T 3sv0_A 90 EDLFNFCS-----RKLSLKTVLMLADQMINRVEFVHS---KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTST 161 (483)
T ss_dssp HHHHHHTT-----TCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTT
T ss_pred HHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccCcceEEEecCCCCCeEEEEeCCcceeccCCcc
Confidence 99997543 459999999999999999999999 899999999999999 6889999999999987653221
Q ss_pred CCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCccccCCCCc
Q 005102 564 SPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGSSE 643 (714)
Q Consensus 564 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~~~~~~~~ 643 (714)
..... ........||..|+|||++.+..++.++|||||||++|||++|+.||.......
T Consensus 162 ~~~~~---------------------~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~ 220 (483)
T 3sv0_A 162 HQHIP---------------------YRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT 220 (483)
T ss_dssp CCBCC---------------------CCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSS
T ss_pred ccccc---------------------cccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchh
Confidence 10000 112234568999999999999999999999999999999999999995443222
Q ss_pred chhHHHHHHHHhhc--CCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhhhhc
Q 005102 644 MDLVNWMQLCIEEK--KPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDALDRLIV 711 (714)
Q Consensus 644 ~~l~~~~~~~~~~~--~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~ 711 (714)
....+....... .....+.. . ...++.+++..||+.||++||++++|++.|+++..
T Consensus 221 --~~~~~~~i~~~~~~~~~~~l~~-----~-----~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~ 278 (483)
T 3sv0_A 221 --KKQKYEKISEKKVATSIEALCR-----G-----YPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFI 278 (483)
T ss_dssp --HHHHHHHHHHHHHHSCHHHHHT-----T-----SCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHH
T ss_pred --HHHHHHHHhhccccccHHHHhc-----C-----CcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHH
Confidence 111111111111 11111111 1 12368899999999999999999999999999864
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=354.53 Aligned_cols=208 Identities=24% Similarity=0.385 Sum_probs=156.6
Q ss_pred HHHHHHhccccccccCceEEEEEEEC---CCcEEEEEEeCCCCchhHHHHHHHHHHHhccCCCCccceEEEEEe--CCce
Q 005102 400 LDELLKASAFVLGKSGIGIVYKVVLE---DGHTLAVRRLGEGGSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWS--VDEK 474 (714)
Q Consensus 400 ~~~l~~~~~~~lG~G~~g~Vy~~~~~---~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~--~~~~ 474 (714)
+++.+...+++||+|+||+||+|+++ +++.||||++...... ..+.+|+++|++++||||+++++++.. ....
T Consensus 18 ~~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 95 (405)
T 3rgf_A 18 VEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGIS--MSACREIALLRELKHPNVISLQKVFLSHADRKV 95 (405)
T ss_dssp HHHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCC--HHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEE
T ss_pred hhhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCC--HHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeE
Confidence 44444444668999999999999976 4789999999765433 568899999999999999999999965 5678
Q ss_pred eEEEeccCCCCHhhhhhCCCC---CCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeee----CCCCCe
Q 005102 475 LLIYDYIPNGSLATALHGKPG---MVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILL----GHNMEP 547 (714)
Q Consensus 475 ~lV~e~~~~gsL~~~l~~~~~---~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl----~~~~~~ 547 (714)
++||||+. |+|.+++..... ......+++..++.|+.||+.||+|||+ .+|+||||||+|||+ +.++.+
T Consensus 96 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~ 171 (405)
T 3rgf_A 96 WLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRV 171 (405)
T ss_dssp EEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECCSSTTTTCE
T ss_pred EEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHh---CCEeCCCcCHHHeEEecCCCCCCcE
Confidence 99999996 588887753210 0011348999999999999999999999 899999999999999 778999
Q ss_pred EEcccchhhhhhccCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCC-CCCchhhhHHHHHHH
Q 005102 548 HVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVV-KPSQKWDIYSYGVIL 626 (714)
Q Consensus 548 kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DVwS~Gvvl 626 (714)
||+|||+|+........ ........||+.|+|||++.+. .++.++|||||||++
T Consensus 172 kl~Dfg~a~~~~~~~~~-------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il 226 (405)
T 3rgf_A 172 KIADMGFARLFNSPLKP-------------------------LADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIF 226 (405)
T ss_dssp EECCTTCCC-----------------------------------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHH
T ss_pred EEEECCCceecCCCCcc-------------------------cccCCCceecCcccCchhhcCCCcccchhhhHHHHHHH
Confidence 99999999865422100 1122345679999999999874 489999999999999
Q ss_pred HHHHhCCCcccc
Q 005102 627 LEMITGRTAVVQ 638 (714)
Q Consensus 627 ~elltG~~p~~~ 638 (714)
|||++|+.||..
T Consensus 227 ~ell~g~~pf~~ 238 (405)
T 3rgf_A 227 AELLTSEPIFHC 238 (405)
T ss_dssp HHHHHSSCTTCC
T ss_pred HHHHhCCCCCCC
Confidence 999999999953
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-39 Score=340.83 Aligned_cols=252 Identities=19% Similarity=0.247 Sum_probs=192.3
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeCCCCchhHHHHHHHHHHHhccC-CCCccceEEEEEe--CCceeEEEeccCCC
Q 005102 409 FVLGKSGIGIVYKVVLE-DGHTLAVRRLGEGGSQRFKEFQTEVEAIGKIR-HSNIVTLRAYYWS--VDEKLLIYDYIPNG 484 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~--~~~~~lV~e~~~~g 484 (714)
+.||+|+||.||+|+.. +++.||||++.... .+.+.+|++++++++ ||||+++++++.. ....++||||++++
T Consensus 42 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~ 118 (330)
T 3nsz_A 42 RKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNT 118 (330)
T ss_dssp EEEEECSSEEEEEEEETTTCCEEEEEEECSCC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEEECCCCC
T ss_pred EEecccCCeEEEEEEECCCCcEEEEEEecccc---hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEEeccCch
Confidence 47999999999999874 58999999997543 367899999999997 9999999999987 56789999999999
Q ss_pred CHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCC-CeEEcccchhhhhhccCC
Q 005102 485 SLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNM-EPHVSDFGLARLANIAGG 563 (714)
Q Consensus 485 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~-~~kl~DFGla~~~~~~~~ 563 (714)
+|.+++. .+++..+..++.|++.||+|||+ .+|+||||||+|||++.++ .+||+|||+++......
T Consensus 119 ~l~~~~~---------~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~- 185 (330)
T 3nsz_A 119 DFKQLYQ---------TLTDYDIRFYMYEILKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ- 185 (330)
T ss_dssp CHHHHGG---------GCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTTC-
T ss_pred hHHHHHH---------hCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCC-
Confidence 9999883 47889999999999999999999 8999999999999999776 89999999997653211
Q ss_pred CCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCC-CCCCchhhhHHHHHHHHHHHhCCCccccCCCC
Q 005102 564 SPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKV-VKPSQKWDIYSYGVILLEMITGRTAVVQVGSS 642 (714)
Q Consensus 564 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DVwS~Gvvl~elltG~~p~~~~~~~ 642 (714)
......||..|+|||.+.+ ..++.++|||||||++|||++|+.||......
T Consensus 186 ----------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~ 237 (330)
T 3nsz_A 186 ----------------------------EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN 237 (330)
T ss_dssp ----------------------------CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSH
T ss_pred ----------------------------ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCch
Confidence 1223456888999999977 66899999999999999999999999544333
Q ss_pred cchhHHHHHHHH--------hh-cCCc----ccccCCCC-------CCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHH
Q 005102 643 EMDLVNWMQLCI--------EE-KKPL----ADVLDPYL-------APDADKEEEIIAVLKIAMACVHSSPEKRPTMRHI 702 (714)
Q Consensus 643 ~~~l~~~~~~~~--------~~-~~~~----~~~~d~~~-------~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev 702 (714)
...+........ .. .... .+...... ............+.+++.+||+.||++|||++|+
T Consensus 238 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~ 317 (330)
T 3nsz_A 238 YDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREA 317 (330)
T ss_dssp HHHHHHHHHHHCHHHHHHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHH
T ss_pred HHHHHHHHHhcCCchhhhHHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHH
Confidence 222222111100 00 0000 00000000 0000011123468899999999999999999999
Q ss_pred HH
Q 005102 703 SD 704 (714)
Q Consensus 703 l~ 704 (714)
++
T Consensus 318 l~ 319 (330)
T 3nsz_A 318 ME 319 (330)
T ss_dssp HT
T ss_pred hc
Confidence 86
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=346.99 Aligned_cols=250 Identities=24% Similarity=0.344 Sum_probs=185.1
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeCCC--CchhHHHHHHHHHHHhccCCCCccceEEEEEeCC------ceeEEEe
Q 005102 409 FVLGKSGIGIVYKVVLE-DGHTLAVRRLGEG--GSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVD------EKLLIYD 479 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~------~~~lV~e 479 (714)
+.||+|+||.||+|.+. +|+.||||++... .....+.+.+|++++++++||||+++++++...+ ..|+|||
T Consensus 31 ~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~lv~e 110 (367)
T 1cm8_A 31 QPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMP 110 (367)
T ss_dssp EEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCEEEEE
T ss_pred EEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCceEEEEEe
Confidence 47999999999999985 5899999999654 2333567899999999999999999999998653 4599999
Q ss_pred ccCCCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhh
Q 005102 480 YIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLAN 559 (714)
Q Consensus 480 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~ 559 (714)
|+ +++|.+++... .+++..+..++.|+++||+|||+ .+|+||||||+|||++.++.+||+|||+++...
T Consensus 111 ~~-~~~L~~~~~~~-------~l~~~~~~~~~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 179 (367)
T 1cm8_A 111 FM-GTDLGKLMKHE-------KLGEDRIQFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQAD 179 (367)
T ss_dssp CC-SEEHHHHHHHC-------CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred cC-CCCHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHH---CCccccCcCHHHEEEcCCCCEEEEeeecccccc
Confidence 99 78999998643 48899999999999999999999 899999999999999999999999999997542
Q ss_pred ccCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCC-CCCCchhhhHHHHHHHHHHHhCCCcccc
Q 005102 560 IAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKV-VKPSQKWDIYSYGVILLEMITGRTAVVQ 638 (714)
Q Consensus 560 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DVwS~Gvvl~elltG~~p~~~ 638 (714)
. ......+|+.|+|||++.+ ..++.++||||+||++|||++|+.||..
T Consensus 180 ~-------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~ 228 (367)
T 1cm8_A 180 S-------------------------------EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKG 228 (367)
T ss_dssp S-------------------------------SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCC
T ss_pred c-------------------------------ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCC
Confidence 1 1123456899999999876 6799999999999999999999999943
Q ss_pred CCCCcchhHHHHHHHHhhcCCcccccC--------------CCCC-CCCC--cHHHHHHHHHHHhHccCCCCCCCCCHHH
Q 005102 639 VGSSEMDLVNWMQLCIEEKKPLADVLD--------------PYLA-PDAD--KEEEIIAVLKIAMACVHSSPEKRPTMRH 701 (714)
Q Consensus 639 ~~~~~~~l~~~~~~~~~~~~~~~~~~d--------------~~~~-~~~~--~~~~~~~l~~li~~Cl~~dP~~RPt~~e 701 (714)
. ...+....+.... +.+..+... +... .... .......+.+++.+||..||++|||++|
T Consensus 229 ~--~~~~~l~~i~~~~--g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e 304 (367)
T 1cm8_A 229 S--DHLDQLKEIMKVT--GTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGE 304 (367)
T ss_dssp S--SHHHHHHHHHHHH--CCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred C--CHHHHHHHHHHhc--CCCCHHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHH
Confidence 2 1111111111110 000000000 0000 0000 0011236789999999999999999999
Q ss_pred HHH
Q 005102 702 ISD 704 (714)
Q Consensus 702 vl~ 704 (714)
+++
T Consensus 305 ~l~ 307 (367)
T 1cm8_A 305 ALA 307 (367)
T ss_dssp HHH
T ss_pred Hhc
Confidence 986
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-39 Score=343.52 Aligned_cols=261 Identities=19% Similarity=0.278 Sum_probs=193.8
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeCCCCc--hhHHHHHHHHHHHhccCCCCccceEEEEEeC--------CceeEE
Q 005102 409 FVLGKSGIGIVYKVVLE-DGHTLAVRRLGEGGS--QRFKEFQTEVEAIGKIRHSNIVTLRAYYWSV--------DEKLLI 477 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--------~~~~lV 477 (714)
+.||+|+||.||+|+.. +|+.||||++..... .....+.+|++++++++||||+++++++... +..++|
T Consensus 23 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~lv 102 (351)
T 3mi9_A 23 AKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLV 102 (351)
T ss_dssp EECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------CEEEEE
T ss_pred EEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCCceEEEE
Confidence 47999999999999984 689999999865432 2245788999999999999999999999873 467999
Q ss_pred EeccCCCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhh
Q 005102 478 YDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARL 557 (714)
Q Consensus 478 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 557 (714)
|||+++ +|.+.+.... ..+++.++..|+.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++.
T Consensus 103 ~e~~~~-~l~~~l~~~~-----~~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~ 173 (351)
T 3mi9_A 103 FDFCEH-DLAGLLSNVL-----VKFTLSEIKRVMQMLLNGLYYIHR---NKILHRDMKAANVLITRDGVLKLADFGLARA 173 (351)
T ss_dssp EECCSE-EHHHHHHCTT-----SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred EeccCC-CHHHHHhhcc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCHHHEEEcCCCCEEEccchhccc
Confidence 999975 8888776553 458999999999999999999999 8999999999999999999999999999986
Q ss_pred hhccCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCC-CCCCchhhhHHHHHHHHHHHhCCCcc
Q 005102 558 ANIAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKV-VKPSQKWDIYSYGVILLEMITGRTAV 636 (714)
Q Consensus 558 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DVwS~Gvvl~elltG~~p~ 636 (714)
........ ........||+.|+|||++.+ ..++.++|||||||++|||+||+.||
T Consensus 174 ~~~~~~~~------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf 229 (351)
T 3mi9_A 174 FSLAKNSQ------------------------PNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIM 229 (351)
T ss_dssp CCCCSSSS------------------------CCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred cccccccc------------------------ccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCC
Confidence 54221100 112234567899999999876 45799999999999999999999999
Q ss_pred ccCCCCcchhHHHHHHHHhhcC-Cc-ccc-----cCC---CCCCCCCcHHH------HHHHHHHHhHccCCCCCCCCCHH
Q 005102 637 VQVGSSEMDLVNWMQLCIEEKK-PL-ADV-----LDP---YLAPDADKEEE------IIAVLKIAMACVHSSPEKRPTMR 700 (714)
Q Consensus 637 ~~~~~~~~~l~~~~~~~~~~~~-~~-~~~-----~d~---~~~~~~~~~~~------~~~l~~li~~Cl~~dP~~RPt~~ 700 (714)
... ...+....+........ .. ... .+. ........... ...+.+++.+||+.||++|||++
T Consensus 230 ~~~--~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ 307 (351)
T 3mi9_A 230 QGN--TEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSD 307 (351)
T ss_dssp CCS--SHHHHHHHHHHHHCCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHH
T ss_pred CCC--ChHHHHHHHHHHhCCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHH
Confidence 532 22222222222111110 00 000 000 00000011111 23578999999999999999999
Q ss_pred HHHH
Q 005102 701 HISD 704 (714)
Q Consensus 701 evl~ 704 (714)
|+++
T Consensus 308 e~l~ 311 (351)
T 3mi9_A 308 DALN 311 (351)
T ss_dssp HHHT
T ss_pred HHhC
Confidence 9875
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-39 Score=356.96 Aligned_cols=213 Identities=18% Similarity=0.305 Sum_probs=150.4
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeCCC--CchhHHHHHHHHHHHhccCCCCccceEEEEEeC-----CceeEEEec
Q 005102 409 FVLGKSGIGIVYKVVLE-DGHTLAVRRLGEG--GSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSV-----DEKLLIYDY 480 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~-----~~~~lV~e~ 480 (714)
+.||+|+||+||+|++. +++.||||++... .....+.+.+|+++|++++||||+++++++... +..|+||||
T Consensus 59 ~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~ 138 (458)
T 3rp9_A 59 HLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEI 138 (458)
T ss_dssp CC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEEEECC
T ss_pred eEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceEEEEEec
Confidence 57999999999999976 5899999999764 333456799999999999999999999999543 568999999
Q ss_pred cCCCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhc
Q 005102 481 IPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANI 560 (714)
Q Consensus 481 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 560 (714)
+ +|+|.+++... ..+++..+..|+.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+|+....
T Consensus 139 ~-~~~L~~~~~~~------~~l~~~~~~~~~~qi~~aL~~LH~---~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~ 208 (458)
T 3rp9_A 139 A-DSDFKKLFRTP------VYLTELHIKTLLYNLLVGVKYVHS---AGILHRDLKPANCLVNQDCSVKVCDFGLARTVDY 208 (458)
T ss_dssp C-SEEHHHHHHSS------CCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTCCEEECCCTTCBCTTS
T ss_pred c-ccchhhhcccC------CCCCHHHHHHHHHHHHHHHHHHHh---CCcCCCCCChhhEEECCCCCEeecccccchhccC
Confidence 8 57999999765 458999999999999999999999 8999999999999999999999999999987653
Q ss_pred cCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCccc-CCCCCCchhhhHHHHHHHHHHHhC
Q 005102 561 AGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESL-KVVKPSQKWDIYSYGVILLEMITG 632 (714)
Q Consensus 561 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~s~~~DVwS~Gvvl~elltG 632 (714)
........... +........................||+.|+|||++ .+..++.++|||||||++|||+||
T Consensus 209 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg 280 (458)
T 3rp9_A 209 PENGNSQLPIS-PREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM 280 (458)
T ss_dssp CTTCCCCCC----------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred ccccccccccC-ccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence 22110000000 000000000000000011233456789999999976 456799999999999999999993
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-40 Score=339.32 Aligned_cols=254 Identities=24% Similarity=0.339 Sum_probs=190.6
Q ss_pred ccccccCceEEEEEEEC--CCc--EEEEEEeCCC---CchhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEecc
Q 005102 409 FVLGKSGIGIVYKVVLE--DGH--TLAVRRLGEG---GSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYI 481 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~--~g~--~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~ 481 (714)
+.||+|+||.||+|++. +++ .||||++... .....+.+.+|++++++++||||+++++++...+ .++||||+
T Consensus 24 ~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~v~e~~ 102 (291)
T 1u46_A 24 EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MKMVTELA 102 (291)
T ss_dssp EECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-CEEEEECC
T ss_pred eeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-ceeeEecc
Confidence 47999999999999863 233 6899998764 2344578999999999999999999999997654 88999999
Q ss_pred CCCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhcc
Q 005102 482 PNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIA 561 (714)
Q Consensus 482 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 561 (714)
++|+|.+++.... ..+++..+.+++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++.....
T Consensus 103 ~~~~L~~~l~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 174 (291)
T 1u46_A 103 PLGSLLDRLRKHQ-----GHFLLGTLSRYAVQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQN 174 (291)
T ss_dssp TTCBHHHHHHHHG-----GGSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCTTCEECCC-
T ss_pred cCCCHHHHHHhcc-----CCcCHHHHHHHHHHHHHHHHHHHh---CCcccCCCchheEEEcCCCCEEEcccccccccccc
Confidence 9999999997542 458999999999999999999999 89999999999999999999999999999765322
Q ss_pred CCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHh-CCCccccCC
Q 005102 562 GGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMIT-GRTAVVQVG 640 (714)
Q Consensus 562 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~ellt-G~~p~~~~~ 640 (714)
... ........+|..|+|||.+.+..++.++||||||+++|||++ |+.||....
T Consensus 175 ~~~-------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~ 229 (291)
T 1u46_A 175 DDH-------------------------YVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLN 229 (291)
T ss_dssp CCE-------------------------EEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred ccc-------------------------hhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCC
Confidence 110 111223446778999999988889999999999999999999 999994321
Q ss_pred CCcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhhhhcc
Q 005102 641 SSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDALDRLIVS 712 (714)
Q Consensus 641 ~~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~~ 712 (714)
..+.+......... ..... .....+.+++.+||+.||++|||++++++.|+++...
T Consensus 230 -----~~~~~~~~~~~~~~------~~~~~-----~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 285 (291)
T 1u46_A 230 -----GSQILHKIDKEGER------LPRPE-----DCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPT 285 (291)
T ss_dssp -----HHHHHHHHHTSCCC------CCCCT-----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred -----HHHHHHHHHccCCC------CCCCc-----CcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCcc
Confidence 12222222222111 00111 1223688999999999999999999999999988654
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-39 Score=336.93 Aligned_cols=243 Identities=21% Similarity=0.360 Sum_probs=191.9
Q ss_pred ccccccCceEEEEEEECC-CcEEEEEEeCCCCchhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCCCHh
Q 005102 409 FVLGKSGIGIVYKVVLED-GHTLAVRRLGEGGSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGSLA 487 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL~ 487 (714)
+.||+|+||.||+|.+.. |+.||||++..... .+.+.+|++++++++||||+++++++...+..++||||+++|+|.
T Consensus 35 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 112 (314)
T 3com_A 35 EKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD--LQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVS 112 (314)
T ss_dssp EECC----CEEEEEEETTTCCEEEEEEEETTSC--CHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEEHH
T ss_pred eeeccCCCeEEEEEEECCCCCEEEEEecCchHH--HHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEeecCCCCCHH
Confidence 579999999999999864 89999999976532 367899999999999999999999999999999999999999999
Q ss_pred hhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCCCCc
Q 005102 488 TALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTL 567 (714)
Q Consensus 488 ~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 567 (714)
+++.... ..+++..+..++.|++.||.|||+ .+|+||||||+||+++.++.+||+|||+++.....
T Consensus 113 ~~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~------ 178 (314)
T 3com_A 113 DIIRLRN-----KTLTEDEIATILQSTLKGLEYLHF---MRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDT------ 178 (314)
T ss_dssp HHHHHHT-----CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECBTT------
T ss_pred HHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHh---CCCcCCCcCHHHEEECCCCCEEEeecccchhhhhh------
Confidence 9986432 458999999999999999999999 89999999999999999999999999998754321
Q ss_pred cCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCccccCCCCcchhH
Q 005102 568 QSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGSSEMDLV 647 (714)
Q Consensus 568 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~~~~~~~~~~l~ 647 (714)
........||+.|+|||.+.+..++.++||||||+++|||++|+.||..... .
T Consensus 179 ----------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----~ 231 (314)
T 3com_A 179 ----------------------MAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHP-----M 231 (314)
T ss_dssp ----------------------BSCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCH-----H
T ss_pred ----------------------ccccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCh-----H
Confidence 0112234578899999999998999999999999999999999999953221 1
Q ss_pred HHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 005102 648 NWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISD 704 (714)
Q Consensus 648 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 704 (714)
........... .....+ ......+.+++.+||+.||++|||+.++++
T Consensus 232 ~~~~~~~~~~~--~~~~~~--------~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 232 RAIFMIPTNPP--PTFRKP--------ELWSDNFTDFVKQCLVKSPEQRATATQLLQ 278 (314)
T ss_dssp HHHHHHHHSCC--CCCSSG--------GGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred HHHHHHhcCCC--cccCCc--------ccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 11111111111 000000 111236889999999999999999999975
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=335.38 Aligned_cols=249 Identities=20% Similarity=0.294 Sum_probs=193.8
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeCCCC--chhHHHHHHHHHHHhccCCCCccceEEEEEe--CCceeEEEeccCC
Q 005102 409 FVLGKSGIGIVYKVVLE-DGHTLAVRRLGEGG--SQRFKEFQTEVEAIGKIRHSNIVTLRAYYWS--VDEKLLIYDYIPN 483 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~--~~~~~lV~e~~~~ 483 (714)
+.||+|+||.||+|... +++.||+|++.... ....+.+.+|++++++++||||+++++++.. .+..++||||+++
T Consensus 12 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~ 91 (279)
T 2w5a_A 12 YTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEG 91 (279)
T ss_dssp EEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEEEEECCTT
T ss_pred hhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEEEEeCCCC
Confidence 47999999999999986 58999999997643 3345679999999999999999999998854 5678999999999
Q ss_pred CCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCC-----ceecCCCCCCeeeCCCCCeEEcccchhhhh
Q 005102 484 GSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKK-----YVHGDLKPSNILLGHNMEPHVSDFGLARLA 558 (714)
Q Consensus 484 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~-----ivHrDlkp~NILl~~~~~~kl~DFGla~~~ 558 (714)
|+|.+++...... ...+++..+.+++.|++.||+|||+ .+ |+||||||+||++++++.+||+|||+++..
T Consensus 92 ~~L~~~l~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~---~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~~~ 166 (279)
T 2w5a_A 92 GDLASVITKGTKE--RQYLDEEFVLRVMTQLTLALKECHR---RSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL 166 (279)
T ss_dssp EEHHHHHHHHHHT--TCCCCHHHHHHHHHHHHHHHHHHHH---HC------CCCCCSGGGEEECSSSCEEECCCCHHHHC
T ss_pred CCHHHHHHhhccc--CCCCCHHHHHHHHHHHHHHHHHHhc---ccCCCCeeEEeccchhhEEEcCCCCEEEecCchheee
Confidence 9999998753211 1348999999999999999999999 77 999999999999999999999999999865
Q ss_pred hccCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCcccc
Q 005102 559 NIAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQ 638 (714)
Q Consensus 559 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~~~ 638 (714)
.... .......||+.|+|||.+.+..++.++||||||+++|||+||+.||..
T Consensus 167 ~~~~----------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~ 218 (279)
T 2w5a_A 167 NHDT----------------------------SFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTA 218 (279)
T ss_dssp ---C----------------------------HHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred cccc----------------------------ccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcc
Confidence 3210 000112357889999999988999999999999999999999999943
Q ss_pred CCCCcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHh
Q 005102 639 VGSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDALD 707 (714)
Q Consensus 639 ~~~~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~ 707 (714)
.. . ............ +.+... ....+.+++.+||+.||++|||++|+++.+.
T Consensus 219 ~~--~---~~~~~~i~~~~~-------~~~~~~-----~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~ 270 (279)
T 2w5a_A 219 FS--Q---KELAGKIREGKF-------RRIPYR-----YSDELNEIITRMLNLKDYHRPSVEEILENPL 270 (279)
T ss_dssp SS--H---HHHHHHHHHTCC-------CCCCTT-----SCHHHHHHHHHHTCSSGGGSCCHHHHHTSTT
T ss_pred cC--H---HHHHHHHhhccc-------ccCCcc-----cCHHHHHHHHHHcCCCcccCCCHHHHHhChh
Confidence 31 1 112222222111 111111 1236889999999999999999999987654
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-39 Score=351.31 Aligned_cols=190 Identities=21% Similarity=0.307 Sum_probs=164.3
Q ss_pred ccccccCceEEEEEEECC-CcEEEEEEeCCCCchhHHHHHHHHHHHhcc------CCCCccceEEEEEeCCceeEEEecc
Q 005102 409 FVLGKSGIGIVYKVVLED-GHTLAVRRLGEGGSQRFKEFQTEVEAIGKI------RHSNIVTLRAYYWSVDEKLLIYDYI 481 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~E~~~l~~l------~H~niv~l~~~~~~~~~~~lV~e~~ 481 (714)
+.||+|+||.||+|.... ++.||||++.... ...+.+.+|+++++.+ +|+||+++++++...+..++||||+
T Consensus 103 ~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~ 181 (429)
T 3kvw_A 103 KVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK-RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFELL 181 (429)
T ss_dssp EEEEESSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEEEEEECCC
T ss_pred EEcccCccEEEEEEEECCCCcEEEEEEECCcc-chHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeEEEEEecc
Confidence 589999999999998764 8999999997643 3345678888888877 5779999999999999999999999
Q ss_pred CCCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCC--eEEcccchhhhhh
Q 005102 482 PNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNME--PHVSDFGLARLAN 559 (714)
Q Consensus 482 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~--~kl~DFGla~~~~ 559 (714)
. ++|.+++..... ..+++..+.+|+.||+.||+|||+ .+|+||||||+|||++.++. +||+|||+++...
T Consensus 182 ~-~~L~~~l~~~~~----~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~~~ 253 (429)
T 3kvw_A 182 S-MNLYELIKKNKF----QGFSLPLVRKFAHSILQCLDALHK---NRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEH 253 (429)
T ss_dssp C-CBHHHHHHHTTT----CCCCHHHHHHHHHHHHHHHHHHHH---HTEECSCCSGGGEEESSTTSCCEEECCCTTCEETT
T ss_pred C-CCHHHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEEccCCCcceEEeecccceecC
Confidence 6 699999876532 358999999999999999999999 89999999999999999887 9999999987532
Q ss_pred ccCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCcccc
Q 005102 560 IAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQ 638 (714)
Q Consensus 560 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~~~ 638 (714)
. ......||+.|+|||++.+..++.++|||||||++|||+||+.||..
T Consensus 254 ~-------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~ 301 (429)
T 3kvw_A 254 Q-------------------------------RVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPG 301 (429)
T ss_dssp C-------------------------------CCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred C-------------------------------cccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCC
Confidence 1 11234578899999999999999999999999999999999999943
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-39 Score=358.20 Aligned_cols=243 Identities=22% Similarity=0.272 Sum_probs=191.5
Q ss_pred ccccccCceEEEEEEECC-CcEEEEEEeCCCCc-------------hhHHHHHHHHHHHhccCCCCccceEEEEEeCCce
Q 005102 409 FVLGKSGIGIVYKVVLED-GHTLAVRRLGEGGS-------------QRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEK 474 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~~-g~~vavK~~~~~~~-------------~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~ 474 (714)
+.||+|+||+||+|+.+. ++.||||++..... ...+.+.+|++++++++||||+++++++.+.+..
T Consensus 42 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 121 (504)
T 3q5i_A 42 RKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYF 121 (504)
T ss_dssp EEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred eEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEE
Confidence 479999999999999864 78999999875421 2346789999999999999999999999999999
Q ss_pred eEEEeccCCCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCC---CeEEcc
Q 005102 475 LLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNM---EPHVSD 551 (714)
Q Consensus 475 ~lV~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~---~~kl~D 551 (714)
++||||+++|+|.+++... ..+++..+..|+.||+.||+|||+ .+|+||||||+|||++.++ .+||+|
T Consensus 122 ~lv~e~~~gg~L~~~l~~~------~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~D 192 (504)
T 3q5i_A 122 YLVTEFYEGGELFEQIINR------HKFDECDAANIMKQILSGICYLHK---HNIVHRDIKPENILLENKNSLLNIKIVD 192 (504)
T ss_dssp EEEEECCTTCBHHHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESSTTCCSSEEECC
T ss_pred EEEEecCCCCcHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCcHHHEEEecCCCCccEEEEE
Confidence 9999999999999998754 458999999999999999999999 8999999999999998775 699999
Q ss_pred cchhhhhhccCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHh
Q 005102 552 FGLARLANIAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMIT 631 (714)
Q Consensus 552 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~ellt 631 (714)
||+++..... .......||+.|+|||++. ..++.++||||+||++|||++
T Consensus 193 fg~a~~~~~~-----------------------------~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~ 242 (504)
T 3q5i_A 193 FGLSSFFSKD-----------------------------YKLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLC 242 (504)
T ss_dssp CTTCEECCTT-----------------------------SCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHH
T ss_pred CCCCEEcCCC-----------------------------CccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHh
Confidence 9999865321 1122345789999999987 468999999999999999999
Q ss_pred CCCccccCCCCcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 005102 632 GRTAVVQVGSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISD 704 (714)
Q Consensus 632 G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 704 (714)
|+.||... .. .+.+.............. .......+.+++.+||+.||.+|||++|+++
T Consensus 243 g~~pf~~~--~~---~~~~~~i~~~~~~~~~~~---------~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~ 301 (504)
T 3q5i_A 243 GYPPFGGQ--ND---QDIIKKVEKGKYYFDFND---------WKNISDEAKELIKLMLTYDYNKRCTAEEALN 301 (504)
T ss_dssp SSCSSCCS--SH---HHHHHHHHHCCCCCCHHH---------HTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCCCCCCC--CH---HHHHHHHHcCCCCCCccc---------cCCCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 99999432 11 222222222211100000 0011236889999999999999999999875
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-39 Score=333.34 Aligned_cols=240 Identities=22% Similarity=0.292 Sum_probs=190.4
Q ss_pred cccccccCceEEEEEEEC-CCcEEEEEEeCCC--CchhHHHHHHHHHHHhcc-CCCCccceEEEEEeCCceeEEEeccCC
Q 005102 408 AFVLGKSGIGIVYKVVLE-DGHTLAVRRLGEG--GSQRFKEFQTEVEAIGKI-RHSNIVTLRAYYWSVDEKLLIYDYIPN 483 (714)
Q Consensus 408 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~e~~~~ 483 (714)
.+.||+|+||.||+|... +++.||||++... ......++.+|+..+.++ +||||+++++++...+..++||||+++
T Consensus 16 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 95 (289)
T 1x8b_A 16 LEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNG 95 (289)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred hhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEEecCC
Confidence 357999999999999986 6899999998764 333456788999999999 999999999999999999999999999
Q ss_pred CCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCC-------------------C
Q 005102 484 GSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGH-------------------N 544 (714)
Q Consensus 484 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~-------------------~ 544 (714)
|+|.+++...... ...+++..+..|+.||+.||+|||+ ++|+||||||+||+++. .
T Consensus 96 ~~L~~~l~~~~~~--~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~ 170 (289)
T 1x8b_A 96 GSLADAISENYRI--MSYFKEAELKDLLLQVGRGLRYIHS---MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNK 170 (289)
T ss_dssp CBHHHHHHHHHHH--TCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEC--------------------C
T ss_pred CcHHHHHHhhccc--ccCCCHHHHHHHHHHHHHHHHHHHh---CCEeecCCCHHHEEEcCCCCCcccccccccccccCCc
Confidence 9999999753210 0348999999999999999999999 89999999999999984 4
Q ss_pred CCeEEcccchhhhhhccCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCC-CCCchhhhHHHH
Q 005102 545 MEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVV-KPSQKWDIYSYG 623 (714)
Q Consensus 545 ~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DVwS~G 623 (714)
..+||+|||.++..... ....||+.|+|||.+.+. .++.++||||||
T Consensus 171 ~~~kl~Dfg~~~~~~~~--------------------------------~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG 218 (289)
T 1x8b_A 171 VMFKIGDLGHVTRISSP--------------------------------QVEEGDSRFLANEVLQENYTHLPKADIFALA 218 (289)
T ss_dssp CCEEECCCTTCEETTCS--------------------------------CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHH
T ss_pred eEEEEcccccccccCCc--------------------------------cccCCCccccChhHhcCCCCCCchhhHHHHH
Confidence 47999999998754321 122368899999999766 567899999999
Q ss_pred HHHHHHHhCCCccccCCCCcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHH
Q 005102 624 VILLEMITGRTAVVQVGSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHIS 703 (714)
Q Consensus 624 vvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl 703 (714)
|++|||++|..|+... . . ........ . +...... ...+.+++.+||+.||++|||++|++
T Consensus 219 ~il~~l~~~~~~~~~~----~-~---~~~~~~~~--~-----~~~~~~~-----~~~~~~li~~~l~~dp~~Rps~~~ll 278 (289)
T 1x8b_A 219 LTVVCAAGAEPLPRNG----D-Q---WHEIRQGR--L-----PRIPQVL-----SQEFTELLKVMIHPDPERRPSAMALV 278 (289)
T ss_dssp HHHHHHTTCCCCCSSS----H-H---HHHHHTTC--C-----CCCSSCC-----CHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred HHHHHHhcCCCCCcch----h-H---HHHHHcCC--C-----CCCCccc-----CHHHHHHHHHHhCCCcccCCCHHHHh
Confidence 9999999998876321 1 1 11111111 1 1111111 23688999999999999999999987
Q ss_pred H
Q 005102 704 D 704 (714)
Q Consensus 704 ~ 704 (714)
+
T Consensus 279 ~ 279 (289)
T 1x8b_A 279 K 279 (289)
T ss_dssp T
T ss_pred h
Confidence 5
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-39 Score=344.40 Aligned_cols=250 Identities=21% Similarity=0.302 Sum_probs=185.2
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeCCC--CchhHHHHHHHHHHHhccCCCCccceEEEEEeCC------ceeEEEe
Q 005102 409 FVLGKSGIGIVYKVVLE-DGHTLAVRRLGEG--GSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVD------EKLLIYD 479 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~------~~~lV~e 479 (714)
+.||+|+||.||+|... +++.||||++... .....+.+.+|+.+++.++||||+++++++...+ ..++|||
T Consensus 31 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~lv~e 110 (371)
T 2xrw_A 31 KPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVME 110 (371)
T ss_dssp EEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCEEEEEEE
T ss_pred eeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccceEEEEE
Confidence 47999999999999975 5899999999754 2334567889999999999999999999997654 6799999
Q ss_pred ccCCCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhh
Q 005102 480 YIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLAN 559 (714)
Q Consensus 480 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~ 559 (714)
|++ |+|.+.+. ..+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++...
T Consensus 111 ~~~-~~l~~~~~--------~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~ 178 (371)
T 2xrw_A 111 LMD-ANLCQVIQ--------MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 178 (371)
T ss_dssp CCS-EEHHHHHH--------SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCCCC-----
T ss_pred cCC-CCHHHHHh--------hccCHHHHHHHHHHHHHHHHHHHH---CCeecccCCHHHEEEcCCCCEEEEEeecccccc
Confidence 997 58888885 238899999999999999999999 899999999999999999999999999997543
Q ss_pred ccCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCccccC
Q 005102 560 IAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQV 639 (714)
Q Consensus 560 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~~~~ 639 (714)
.. .......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 179 ~~-----------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 229 (371)
T 2xrw_A 179 TS-----------------------------FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGT 229 (371)
T ss_dssp ----------------------------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred cc-----------------------------cccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCC
Confidence 21 0112345788999999999999999999999999999999999999432
Q ss_pred CCCcchhHHHHHHHHhhc-CCccc--------------------------ccCCCCCCCCC--cHHHHHHHHHHHhHccC
Q 005102 640 GSSEMDLVNWMQLCIEEK-KPLAD--------------------------VLDPYLAPDAD--KEEEIIAVLKIAMACVH 690 (714)
Q Consensus 640 ~~~~~~l~~~~~~~~~~~-~~~~~--------------------------~~d~~~~~~~~--~~~~~~~l~~li~~Cl~ 690 (714)
. .. ..+....... .+..+ .......+... .......+.+++.+||+
T Consensus 230 ~--~~---~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~ 304 (371)
T 2xrw_A 230 D--HI---DQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLV 304 (371)
T ss_dssp S--HH---HHHHHHHC-CCCCCHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSC
T ss_pred C--HH---HHHHHHHHHhCCCCHHHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCc
Confidence 1 11 1111111100 00000 00000000000 11235578999999999
Q ss_pred CCCCCCCCHHHHHH
Q 005102 691 SSPEKRPTMRHISD 704 (714)
Q Consensus 691 ~dP~~RPt~~evl~ 704 (714)
.||++|||++|+++
T Consensus 305 ~dP~~R~t~~e~l~ 318 (371)
T 2xrw_A 305 IDASKRISVDEALQ 318 (371)
T ss_dssp SSGGGSCCHHHHHH
T ss_pred CChhhCCCHHHHhC
Confidence 99999999999976
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-39 Score=350.80 Aligned_cols=212 Identities=20% Similarity=0.323 Sum_probs=161.3
Q ss_pred ccccccCceEEEEEEECC-CcEEEEEEeCCC--CchhHHHHHHHHHHHhccCCCCccceEEEEEeC-----CceeEEEec
Q 005102 409 FVLGKSGIGIVYKVVLED-GHTLAVRRLGEG--GSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSV-----DEKLLIYDY 480 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~~-g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~-----~~~~lV~e~ 480 (714)
+.||+|+||.||+|++.. ++.||||++... .....+.+.+|+++|++++||||+++++++... +..|+||||
T Consensus 32 ~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~e~ 111 (432)
T 3n9x_A 32 HLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEI 111 (432)
T ss_dssp EEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEEEEEC
T ss_pred EEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCeEEEEEec
Confidence 579999999999999764 889999999764 333456899999999999999999999999776 568999999
Q ss_pred cCCCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhc
Q 005102 481 IPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANI 560 (714)
Q Consensus 481 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 560 (714)
+. |+|.+++... ..+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+|+....
T Consensus 112 ~~-~~L~~~~~~~------~~l~~~~~~~i~~qil~aL~~LH~---~givHrDlkp~NILl~~~~~~kL~DFGla~~~~~ 181 (432)
T 3n9x_A 112 AD-SDLKKLFKTP------IFLTEEHIKTILYNLLLGENFIHE---SGIIHRDLKPANCLLNQDCSVKVCDFGLARTINS 181 (432)
T ss_dssp CS-EEHHHHHHSS------CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEEC--
T ss_pred CC-cCHHHHHhcc------CCCCHHHHHHHHHHHHHHHHHHHH---CCCCCCCCCHHHeEECCCCCEEEccCCCcccccc
Confidence 96 5999999765 458999999999999999999999 8999999999999999999999999999987643
Q ss_pred cCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCccc-CCCCCCchhhhHHHHHHHHHHHhCCCcc
Q 005102 561 AGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESL-KVVKPSQKWDIYSYGVILLEMITGRTAV 636 (714)
Q Consensus 561 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~s~~~DVwS~Gvvl~elltG~~p~ 636 (714)
............ . ..................||+.|+|||++ ....++.++|||||||++|||++|..||
T Consensus 182 ~~~~~~~~~~~~--~----~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~ 252 (432)
T 3n9x_A 182 EKDTNIVNDLEE--N----EEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSH 252 (432)
T ss_dssp -----------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTT
T ss_pred cccccccccccc--c----ccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccc
Confidence 221100000000 0 00000000011223556789999999986 5566999999999999999999865544
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=331.97 Aligned_cols=244 Identities=22% Similarity=0.304 Sum_probs=189.9
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeCCCC----chhHHHHHHHHHHHhccCCCCccceEEEEE--eCCceeEEEecc
Q 005102 409 FVLGKSGIGIVYKVVLE-DGHTLAVRRLGEGG----SQRFKEFQTEVEAIGKIRHSNIVTLRAYYW--SVDEKLLIYDYI 481 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~H~niv~l~~~~~--~~~~~~lV~e~~ 481 (714)
+.||+|+||.||+|... +++.||+|++.... ....+.+.+|++++++++||||+++++++. ..+..++||||+
T Consensus 11 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~ 90 (305)
T 2wtk_C 11 DLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYC 90 (305)
T ss_dssp CEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CEEEEEECC
T ss_pred eEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEEEEehhc
Confidence 47999999999999975 58899999997642 234567999999999999999999999985 445789999999
Q ss_pred CCCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhcc
Q 005102 482 PNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIA 561 (714)
Q Consensus 482 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 561 (714)
+++ |.+++..... ..+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++.....
T Consensus 91 ~~~-l~~~~~~~~~----~~~~~~~~~~~~~qi~~al~~LH~---~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~ 162 (305)
T 2wtk_C 91 VCG-MQEMLDSVPE----KRFPVCQAHGYFCQLIDGLEYLHS---QGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPF 162 (305)
T ss_dssp SEE-HHHHHHHSTT----CSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEECCTT
T ss_pred cCC-HHHHHHhCcc----cccCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCcccEEEcCCCcEEeeccccccccCcc
Confidence 876 7777765432 468999999999999999999999 89999999999999999999999999999765321
Q ss_pred CCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCC--CCchhhhHHHHHHHHHHHhCCCccccC
Q 005102 562 GGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVK--PSQKWDIYSYGVILLEMITGRTAVVQV 639 (714)
Q Consensus 562 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~s~~~DVwS~Gvvl~elltG~~p~~~~ 639 (714)
.. ........||+.|+|||++.+.. ++.++||||||+++|||++|+.||...
T Consensus 163 ~~--------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 216 (305)
T 2wtk_C 163 AA--------------------------DDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGD 216 (305)
T ss_dssp CS--------------------------SCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred cc--------------------------ccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCc
Confidence 10 11122345788999999997654 378999999999999999999999432
Q ss_pred CCCcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 005102 640 GSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISD 704 (714)
Q Consensus 640 ~~~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 704 (714)
...+........... .... ....+.+++.+||+.||++|||++|+++
T Consensus 217 -----~~~~~~~~i~~~~~~--------~~~~-----~~~~l~~li~~~l~~dp~~Rps~~~ll~ 263 (305)
T 2wtk_C 217 -----NIYKLFENIGKGSYA--------IPGD-----CGPPLSDLLKGMLEYEPAKRFSIRQIRQ 263 (305)
T ss_dssp -----SHHHHHHHHHHCCCC--------CCSS-----SCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred -----hHHHHHHHHhcCCCC--------CCCc-----cCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 122222222222111 1111 1235789999999999999999999985
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-39 Score=333.45 Aligned_cols=246 Identities=22% Similarity=0.291 Sum_probs=178.8
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeCCCCc-hhH-HHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCCC
Q 005102 409 FVLGKSGIGIVYKVVLE-DGHTLAVRRLGEGGS-QRF-KEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGS 485 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~-~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gs 485 (714)
+.||+|+||.||+|... +|+.||||++..... ... +.+..+...++.++||||+++++++...+..++||||++ |+
T Consensus 13 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~e~~~-~~ 91 (290)
T 3fme_A 13 MELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICMELMD-TS 91 (290)
T ss_dssp EEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEEECCS-EE
T ss_pred HhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEEehhc-cc
Confidence 47999999999999984 689999999976532 222 334455556888899999999999999999999999997 58
Q ss_pred HhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCC-CceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCC
Q 005102 486 LATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPK-KYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGS 564 (714)
Q Consensus 486 L~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~-~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 564 (714)
|.+++...... ...+++..+..|+.|++.||+|||+ + +|+||||||+||+++.++.+||+|||+++......
T Consensus 92 l~~~l~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-- 164 (290)
T 3fme_A 92 LDKFYKQVIDK--GQTIPEDILGKIAVSIVKALEHLHS---KLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDV-- 164 (290)
T ss_dssp HHHHHHHHHHT--TCCCCHHHHHHHHHHHHHHHHHHHH---HSCCCCCCCSGGGCEECTTCCEEBCCC------------
T ss_pred hHHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHhh---cCCeecCCCCHHHEEECCCCCEEEeecCCcccccccc--
Confidence 88877531100 1468999999999999999999999 7 99999999999999999999999999998653211
Q ss_pred CCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCccc----CCCCCCchhhhHHHHHHHHHHHhCCCccccCC
Q 005102 565 PTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESL----KVVKPSQKWDIYSYGVILLEMITGRTAVVQVG 640 (714)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~s~~~DVwS~Gvvl~elltG~~p~~~~~ 640 (714)
......||+.|+|||.+ .+..++.++||||||+++|||+||+.||....
T Consensus 165 ---------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 217 (290)
T 3fme_A 165 ---------------------------AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWG 217 (290)
T ss_dssp --------------------------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCS
T ss_pred ---------------------------cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccC
Confidence 11223478889999996 56678999999999999999999999995432
Q ss_pred CCcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 005102 641 SSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISD 704 (714)
Q Consensus 641 ~~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 704 (714)
.... .+........ +..... .....+.+++.+||+.||++|||++|+++
T Consensus 218 ~~~~----~~~~~~~~~~-------~~~~~~----~~~~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 218 TPFQ----QLKQVVEEPS-------PQLPAD----KFSAEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp CHHH----HHHHHHHSCC-------CCCCTT----TSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred chHH----HHHHHhccCC-------CCcccc----cCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 2211 1111222211 111111 11236889999999999999999999976
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-39 Score=338.47 Aligned_cols=254 Identities=23% Similarity=0.284 Sum_probs=192.2
Q ss_pred ccccccCceEEEEEEECCCcEEEEEEeCCCC--chhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCCCH
Q 005102 409 FVLGKSGIGIVYKVVLEDGHTLAVRRLGEGG--SQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGSL 486 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL 486 (714)
+.||+|+||.||+|.+.+ .||+|++.... ....+.+.+|+.++++++||||+++++++...+..++||||+++++|
T Consensus 39 ~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L 116 (319)
T 2y4i_B 39 ELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTL 116 (319)
T ss_dssp CBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEECBCCCSEEH
T ss_pred eEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEeecccCCcH
Confidence 589999999999999864 59999987542 22335678899999999999999999999999999999999999999
Q ss_pred hhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCCCC
Q 005102 487 ATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPT 566 (714)
Q Consensus 487 ~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 566 (714)
.+++.... ..+++..+..++.|++.||+|||+ .+|+||||||+||+++ ++.+||+|||+++.........
T Consensus 117 ~~~l~~~~-----~~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~~~- 186 (319)
T 2y4i_B 117 YSVVRDAK-----IVLDVNKTRQIAQEIVKGMGYLHA---KGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGR- 186 (319)
T ss_dssp HHHTTSSC-----CCCCSHHHHHHHHHHHHHHHHHHH---TTCCCCCCCSTTEEEC---CCEECCCSCCC----------
T ss_pred HHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHh---CCccccCCChhhEEEe-CCCEEEeecCCccccccccccc-
Confidence 99997653 358999999999999999999999 8999999999999998 6799999999987643211100
Q ss_pred ccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCC---------CCCCchhhhHHHHHHHHHHHhCCCccc
Q 005102 567 LQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKV---------VKPSQKWDIYSYGVILLEMITGRTAVV 637 (714)
Q Consensus 567 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---------~~~s~~~DVwS~Gvvl~elltG~~p~~ 637 (714)
.........||+.|+|||.+.+ ..++.++||||||+++|||++|+.||.
T Consensus 187 ----------------------~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~ 244 (319)
T 2y4i_B 187 ----------------------REDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFK 244 (319)
T ss_dssp -----------------------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSS
T ss_pred ----------------------cccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 0112223457889999999864 457999999999999999999999994
Q ss_pred cCCCCcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhhhhcc
Q 005102 638 QVGSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDALDRLIVS 712 (714)
Q Consensus 638 ~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~~ 712 (714)
.... ............ +...... ...++.+++.+||+.||++|||++++++.|+++...
T Consensus 245 ~~~~-----~~~~~~~~~~~~-------~~~~~~~----~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~ 303 (319)
T 2y4i_B 245 TQPA-----EAIIWQMGTGMK-------PNLSQIG----MGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKR 303 (319)
T ss_dssp SCCH-----HHHHHHHHTTCC-------CCCCCSS----CCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC---
T ss_pred CCCH-----HHHHHHhccCCC-------CCCCcCC----CCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHh
Confidence 3211 111111111111 1111100 112478999999999999999999999999998653
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-39 Score=335.49 Aligned_cols=260 Identities=23% Similarity=0.375 Sum_probs=178.8
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeCCCC-chhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCCCH
Q 005102 409 FVLGKSGIGIVYKVVLE-DGHTLAVRRLGEGG-SQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGSL 486 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL 486 (714)
+.||+|+||.||+|... +++.||||++.... ....+++.+|++++++++||||+++++++...+..++||||+++|+|
T Consensus 21 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 100 (303)
T 2vwi_A 21 EVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSV 100 (303)
T ss_dssp EECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEEECCTTCBH
T ss_pred heeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEehhccCCch
Confidence 47999999999999864 58999999987543 23346788999999999999999999999999999999999999999
Q ss_pred hhhhhCCC--CCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCC
Q 005102 487 ATALHGKP--GMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGS 564 (714)
Q Consensus 487 ~~~l~~~~--~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 564 (714)
.+++.... .......+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++........
T Consensus 101 ~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~ 177 (303)
T 2vwi_A 101 LDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHK---NGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDI 177 (303)
T ss_dssp HHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEECTTCCEEECCCHHHHHCC-----
T ss_pred HHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCCCCCCCChhhEEEcCCCCEEEEeccchheeccCCCc
Confidence 99986310 00011458999999999999999999999 89999999999999999999999999999865432110
Q ss_pred CCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCC-CCCCchhhhHHHHHHHHHHHhCCCccccCCCCc
Q 005102 565 PTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKV-VKPSQKWDIYSYGVILLEMITGRTAVVQVGSSE 643 (714)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DVwS~Gvvl~elltG~~p~~~~~~~~ 643 (714)
. .........||+.|+|||.+.+ ..++.++||||||+++|||++|+.||.......
T Consensus 178 ~-----------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~ 234 (303)
T 2vwi_A 178 T-----------------------RNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMK 234 (303)
T ss_dssp ---------------------------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGG
T ss_pred c-----------------------chhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhh
Confidence 0 0111223457889999999865 568999999999999999999999995432211
Q ss_pred chhHHHHHHHHhhcCC-ccc-ccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 005102 644 MDLVNWMQLCIEEKKP-LAD-VLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISD 704 (714)
Q Consensus 644 ~~l~~~~~~~~~~~~~-~~~-~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 704 (714)
. .......... ... ..++..... ....+.+++.+||+.||++|||++|+++
T Consensus 235 --~---~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~li~~~l~~dp~~Rps~~~ll~ 287 (303)
T 2vwi_A 235 --V---LMLTLQNDPPSLETGVQDKEMLKK-----YGKSFRKMISLCLQKDPEKRPTAAELLR 287 (303)
T ss_dssp --H---HHHHHTSSCCCTTC-----CCCCC-----CCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred --H---HHHHhccCCCccccccccchhhhh-----hhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 1 1111111111 000 011111111 1235789999999999999999999975
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-40 Score=352.11 Aligned_cols=248 Identities=12% Similarity=0.040 Sum_probs=172.9
Q ss_pred cccccccCceEEEEEEEC-CCcEEEEEEeCCCCc---hhHHHHHHHHHHHhcc--CCCCccceE-------EEEEeCC--
Q 005102 408 AFVLGKSGIGIVYKVVLE-DGHTLAVRRLGEGGS---QRFKEFQTEVEAIGKI--RHSNIVTLR-------AYYWSVD-- 472 (714)
Q Consensus 408 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l--~H~niv~l~-------~~~~~~~-- 472 (714)
.+.||+|+||.||+|++. +|+.||||++..... ...+.+.+|+++++.+ +||||++++ +++...+
T Consensus 67 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~~~~~~ 146 (371)
T 3q60_A 67 VEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQP 146 (371)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEEETTSC
T ss_pred eeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehheecCCCC
Confidence 357999999999999976 689999999987543 2345677885444444 699988755 5554332
Q ss_pred ---------------ceeEEEeccCCCCHhhhhhCCCCCCCcCCCCHHHH------HHHHHHHHHHHHHHhcCCCCCcee
Q 005102 473 ---------------EKLLIYDYIPNGSLATALHGKPGMVSFTPVPWSVR------VKIIKGIAKGLVYLHEFSPKKYVH 531 (714)
Q Consensus 473 ---------------~~~lV~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~------~~i~~~ia~gL~~LH~~~~~~ivH 531 (714)
..++||||++ |+|.+++.... ..+++..+ ..++.||+.||+|||+ ++|+|
T Consensus 147 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~-----~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~---~~ivH 217 (371)
T 3q60_A 147 PFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLD-----FVYVFRGDEGILALHILTAQLIRLAANLQS---KGLVH 217 (371)
T ss_dssp SSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHH-----HSCCCCHHHHHHHHHHHHHHHHHHHHHHHH---TTEEE
T ss_pred CeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhc-----cccchhhhhhhhhHHHHHHHHHHHHHHHHH---CCCcc
Confidence 3799999998 89999997542 23455556 7888999999999999 89999
Q ss_pred cCCCCCCeeeCCCCCeEEcccchhhhhhccCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCC-
Q 005102 532 GDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKV- 610 (714)
Q Consensus 532 rDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~- 610 (714)
|||||+|||++.++.+||+|||+|+..... .....+|+.|+|||++.+
T Consensus 218 rDikp~NIll~~~~~~kL~DFG~a~~~~~~-------------------------------~~~~~~t~~y~aPE~~~~~ 266 (371)
T 3q60_A 218 GHFTPDNLFIMPDGRLMLGDVSALWKVGTR-------------------------------GPASSVPVTYAPREFLNAS 266 (371)
T ss_dssp TTCSGGGEEECTTSCEEECCGGGEEETTCE-------------------------------EEGGGSCGGGCCHHHHTCS
T ss_pred CcCCHHHEEECCCCCEEEEecceeeecCCC-------------------------------ccCccCCcCCcChhhccCC
Confidence 999999999999999999999999854311 001234688999999987
Q ss_pred -CCCCchhhhHHHHHHHHHHHhCCCccccCCCCcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHcc
Q 005102 611 -VKPSQKWDIYSYGVILLEMITGRTAVVQVGSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACV 689 (714)
Q Consensus 611 -~~~s~~~DVwS~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl 689 (714)
..++.++|||||||++|||+||+.||........... ................ ........+.+++.+||
T Consensus 267 ~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~--------~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L 337 (371)
T 3q60_A 267 TATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSW--------KRPSLRVPGTDSLAFG-SCTPLPDFVKTLIGRFL 337 (371)
T ss_dssp EEECCHHHHHHHHHHHHHHHHHSSCSTTBCCTTCTTCC--------CBCCTTSCCCCSCCCT-TSSCCCHHHHHHHHHHT
T ss_pred CCCcCccccHHHHHHHHHHHHhCCCCCCCcCcccccch--------hhhhhhhccccccchh-hccCCCHHHHHHHHHHc
Confidence 6799999999999999999999999954422211000 0000000000000000 00112346889999999
Q ss_pred CCCCCCCCCHHHHHH
Q 005102 690 HSSPEKRPTMRHISD 704 (714)
Q Consensus 690 ~~dP~~RPt~~evl~ 704 (714)
+.||++|||++|+++
T Consensus 338 ~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 338 NFDRRRRLLPLEAME 352 (371)
T ss_dssp CSSTTTCCCHHHHTT
T ss_pred CCChhhCCCHHHHhc
Confidence 999999999999864
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=337.97 Aligned_cols=254 Identities=21% Similarity=0.283 Sum_probs=194.6
Q ss_pred ccccccCceEEEEEEE-C-CCcEEEEEEeCCCCchhHHHHHHHHHHHhccCCCC------ccceEEEEEeCCceeEEEec
Q 005102 409 FVLGKSGIGIVYKVVL-E-DGHTLAVRRLGEGGSQRFKEFQTEVEAIGKIRHSN------IVTLRAYYWSVDEKLLIYDY 480 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~-~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n------iv~l~~~~~~~~~~~lV~e~ 480 (714)
+.||+|+||.||+|.. . +++.||||++.... ...+.+.+|+++++.++|++ ++++++++...+..++||||
T Consensus 20 ~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~ 98 (339)
T 1z57_A 20 DTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVD-RYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHICIVFEL 98 (339)
T ss_dssp EEEEEETTEEEEEEEETTTTTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTEEEEEEEC
T ss_pred EEEecCCCeEEEEEEecCCCCcEEEEEEEecCC-chhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCcEEEEEcC
Confidence 4799999999999997 3 58899999997543 33467889999999987654 99999999999999999999
Q ss_pred cCCCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCC-----------------
Q 005102 481 IPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGH----------------- 543 (714)
Q Consensus 481 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~----------------- 543 (714)
+ +++|.+++..... ..+++..+..++.|++.||+|||+ ++|+||||||+|||++.
T Consensus 99 ~-~~~l~~~l~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~~~ 170 (339)
T 1z57_A 99 L-GLSTYDFIKENGF----LPFRLDHIRKMAYQICKSVNFLHS---NKLTHTDLKPENILFVQSDYTEAYNPKIKRDERT 170 (339)
T ss_dssp C-CCBHHHHHHHTTT----CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESCCCEEEEEC----CEEEE
T ss_pred C-CCCHHHHHHhcCC----CCCcHHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHHHEEEeccccccccCCcccccccc
Confidence 9 8899999976532 358899999999999999999999 89999999999999987
Q ss_pred --CCCeEEcccchhhhhhccCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHH
Q 005102 544 --NMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYS 621 (714)
Q Consensus 544 --~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS 621 (714)
++.+||+|||+++..... .....||+.|+|||++.+..++.++||||
T Consensus 171 ~~~~~~kl~Dfg~~~~~~~~-------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~Di~s 219 (339)
T 1z57_A 171 LINPDIKVVDFGSATYDDEH-------------------------------HSTLVSTRHYRAPEVILALGWSQPCDVWS 219 (339)
T ss_dssp ESCCCEEECCCSSCEETTSC-------------------------------CCSSCSCGGGCCHHHHTTSCCCTHHHHHH
T ss_pred ccCCCceEeeCcccccCccc-------------------------------cccccCCccccChHHhhCCCCCcchhhHH
Confidence 668999999998753211 12335688999999999999999999999
Q ss_pred HHHHHHHHHhCCCccccCCCCcchhHHHHHHHHhhcCC-------cccc---------------------cCCCCCCCCC
Q 005102 622 YGVILLEMITGRTAVVQVGSSEMDLVNWMQLCIEEKKP-------LADV---------------------LDPYLAPDAD 673 (714)
Q Consensus 622 ~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~-------~~~~---------------------~d~~~~~~~~ 673 (714)
|||++|||++|+.||.... ..+....+......... .... ..+.......
T Consensus 220 lG~il~el~~g~~pf~~~~--~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (339)
T 1z57_A 220 IGCILIEYYLGFTVFPTHD--SKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLS 297 (339)
T ss_dssp HHHHHHHHHHSSCSCCCSC--HHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSC
T ss_pred HHHHHHHHHhCCCCCCCCC--hHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhccc
Confidence 9999999999999995332 22222222111110000 0000 0000000011
Q ss_pred cHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 005102 674 KEEEIIAVLKIAMACVHSSPEKRPTMRHISD 704 (714)
Q Consensus 674 ~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 704 (714)
.......+.+++.+||+.||++|||++|+++
T Consensus 298 ~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 328 (339)
T 1z57_A 298 QDVEHERLFDLIQKMLEYDPAKRITLREALK 328 (339)
T ss_dssp CSHHHHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred chhhHHHHHHHHHHHhCcCcccccCHHHHhc
Confidence 1234567899999999999999999999985
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=331.21 Aligned_cols=244 Identities=22% Similarity=0.326 Sum_probs=194.3
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeCCCC---------chhHHHHHHHHHHHhccC-CCCccceEEEEEeCCceeEE
Q 005102 409 FVLGKSGIGIVYKVVLE-DGHTLAVRRLGEGG---------SQRFKEFQTEVEAIGKIR-HSNIVTLRAYYWSVDEKLLI 477 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---------~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lV 477 (714)
+.||+|+||.||+|... +|+.||||++.... ....+.+.+|++++++++ ||||+++++++...+..++|
T Consensus 23 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv 102 (298)
T 1phk_A 23 EILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLV 102 (298)
T ss_dssp EEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred eeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeeccCCeEEEE
Confidence 47999999999999986 58999999997543 122356889999999996 99999999999999999999
Q ss_pred EeccCCCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhh
Q 005102 478 YDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARL 557 (714)
Q Consensus 478 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 557 (714)
|||+++++|.+++... ..+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++.
T Consensus 103 ~e~~~~~~L~~~l~~~------~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~ 173 (298)
T 1phk_A 103 FDLMKKGELFDYLTEK------VTLSEKETRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQ 173 (298)
T ss_dssp EECCTTCBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred EeccCCCcHHHHHhcc------CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEEcCCCcEEEecccchhh
Confidence 9999999999999754 458999999999999999999999 8999999999999999999999999999876
Q ss_pred hhccCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccC------CCCCCchhhhHHHHHHHHHHHh
Q 005102 558 ANIAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLK------VVKPSQKWDIYSYGVILLEMIT 631 (714)
Q Consensus 558 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~s~~~DVwS~Gvvl~ellt 631 (714)
..... ......||+.|+|||.+. ...++.++||||||+++|||++
T Consensus 174 ~~~~~-----------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~ 224 (298)
T 1phk_A 174 LDPGE-----------------------------KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLA 224 (298)
T ss_dssp CCTTC-----------------------------CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHH
T ss_pred cCCCc-----------------------------ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHH
Confidence 43211 112335688999999984 4568999999999999999999
Q ss_pred CCCccccCCCCcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 005102 632 GRTAVVQVGSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISD 704 (714)
Q Consensus 632 G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 704 (714)
|+.||.... . .............. ..+ ........+.+++.+||+.||++|||++|+++
T Consensus 225 g~~p~~~~~--~---~~~~~~~~~~~~~~---~~~------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 225 GSPPFWHRK--Q---MLMLRMIMSGNYQF---GSP------EWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp SSCSSCCSS--H---HHHHHHHHHTCCCC---CTT------TGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred CCCCCcCcc--H---HHHHHHHhcCCccc---Ccc------cccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 999994321 1 11222222221110 001 00112336889999999999999999999875
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-39 Score=343.43 Aligned_cols=250 Identities=23% Similarity=0.339 Sum_probs=175.7
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeCCC--CchhHHHHHHHHHHHhccCCCCccceEEEEEeC------CceeEEEe
Q 005102 409 FVLGKSGIGIVYKVVLE-DGHTLAVRRLGEG--GSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSV------DEKLLIYD 479 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~------~~~~lV~e 479 (714)
+.||+|+||.||+|... +|+.||||++... .....+.+.+|++++++++||||+++++++... ...++|||
T Consensus 35 ~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~~lv~e 114 (367)
T 2fst_X 35 SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTH 114 (367)
T ss_dssp EECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCEEEEE
T ss_pred eEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCeEEEEec
Confidence 47999999999999975 5899999999764 233456788999999999999999999999754 56799999
Q ss_pred ccCCCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhh
Q 005102 480 YIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLAN 559 (714)
Q Consensus 480 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~ 559 (714)
|+ +++|.+++.. ..+++..+..++.||++||+|||+ .+|+||||||+|||++.++.+||+|||+++...
T Consensus 115 ~~-~~~L~~~~~~-------~~l~~~~~~~i~~qi~~aL~~LH~---~givH~Dlkp~NIll~~~~~~kL~DFG~a~~~~ 183 (367)
T 2fst_X 115 LM-GADLNNIVKC-------QKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTA 183 (367)
T ss_dssp CC-CEECC------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECC--------
T ss_pred cc-CCCHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHhhEEECCCCCEEEeecccccccc
Confidence 99 7899988854 348999999999999999999999 899999999999999999999999999997542
Q ss_pred ccCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCC-CCCCchhhhHHHHHHHHHHHhCCCcccc
Q 005102 560 IAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKV-VKPSQKWDIYSYGVILLEMITGRTAVVQ 638 (714)
Q Consensus 560 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DVwS~Gvvl~elltG~~p~~~ 638 (714)
. ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||..
T Consensus 184 ~-------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~ 232 (367)
T 2fst_X 184 D-------------------------------EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 232 (367)
T ss_dssp --------------------------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCC
T ss_pred c-------------------------------cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 1 1123457889999999977 6789999999999999999999999943
Q ss_pred CCCCcchhHHHHHHHHhhcCCcccccCCC-----------CC--CCCCcH----HHHHHHHHHHhHccCCCCCCCCCHHH
Q 005102 639 VGSSEMDLVNWMQLCIEEKKPLADVLDPY-----------LA--PDADKE----EEIIAVLKIAMACVHSSPEKRPTMRH 701 (714)
Q Consensus 639 ~~~~~~~l~~~~~~~~~~~~~~~~~~d~~-----------~~--~~~~~~----~~~~~l~~li~~Cl~~dP~~RPt~~e 701 (714)
. ...+....+..... .+..+..... +. +..... .....+.+++.+||..||++|||++|
T Consensus 233 ~--~~~~~l~~i~~~~g--~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e 308 (367)
T 2fst_X 233 T--DHIDQLKLILRLVG--TPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQ 308 (367)
T ss_dssp S--SHHHHHHHHHHHHC--SCCHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHH
T ss_pred C--CHHHHHHHHHHHhC--CCCHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHH
Confidence 2 22222221111111 0000100000 00 000000 01235789999999999999999999
Q ss_pred HHH
Q 005102 702 ISD 704 (714)
Q Consensus 702 vl~ 704 (714)
+++
T Consensus 309 ~L~ 311 (367)
T 2fst_X 309 ALA 311 (367)
T ss_dssp HHT
T ss_pred Hhc
Confidence 975
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=346.32 Aligned_cols=256 Identities=21% Similarity=0.223 Sum_probs=192.4
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeCCCCchhHHHHHHHHHHHhccC--------CCCccceEEEEE----eCCcee
Q 005102 409 FVLGKSGIGIVYKVVLE-DGHTLAVRRLGEGGSQRFKEFQTEVEAIGKIR--------HSNIVTLRAYYW----SVDEKL 475 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--------H~niv~l~~~~~----~~~~~~ 475 (714)
+.||+|+||+||+|+.. +++.||||++... ....+.+.+|++++++++ |+||+++++++. .....+
T Consensus 43 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~~~~~~~ 121 (397)
T 1wak_A 43 RKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGVNGTHIC 121 (397)
T ss_dssp EEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEETTEEEEE
T ss_pred EEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCCCCceEE
Confidence 47999999999999975 4889999999754 233467899999999995 788999999988 455789
Q ss_pred EEEeccCCCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCC-CceecCCCCCCeeeCCCC---------
Q 005102 476 LIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPK-KYVHGDLKPSNILLGHNM--------- 545 (714)
Q Consensus 476 lV~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~-~ivHrDlkp~NILl~~~~--------- 545 (714)
+||||+ +++|.+.+..... ..+++..++.|+.||+.||+|||+ + +|+||||||+|||++.++
T Consensus 122 lv~e~~-~~~l~~~~~~~~~----~~~~~~~~~~i~~qi~~aL~~lH~---~~givHrDikp~NIll~~~~~~~~~~~~~ 193 (397)
T 1wak_A 122 MVFEVL-GHHLLKWIIKSNY----QGLPLPCVKKIIQQVLQGLDYLHT---KCRIIHTDIKPENILLSVNEQYIRRLAAE 193 (397)
T ss_dssp EEECCC-CCBHHHHHHHTTT----SCCCHHHHHHHHHHHHHHHHHHHH---TTCEECCCCSGGGEEECCCHHHHHHHHHH
T ss_pred EEEecc-CccHHHHHHhccc----CCCCHHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHeeEeccchhhhhhhhh
Confidence 999999 5677766654422 458999999999999999999999 8 999999999999999775
Q ss_pred ----------------------------------------CeEEcccchhhhhhccCCCCCccCCCCCCCCchhhhcccc
Q 005102 546 ----------------------------------------EPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQKSV 585 (714)
Q Consensus 546 ----------------------------------------~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 585 (714)
.+||+|||+++.....
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~------------------------ 249 (397)
T 1wak_A 194 ATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH------------------------ 249 (397)
T ss_dssp HC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC------------------------
T ss_pred hHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc------------------------
Confidence 7999999999764321
Q ss_pred cceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCccccCCCCcch-hHHHHHHHHhh-cC-----
Q 005102 586 SLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGSSEMD-LVNWMQLCIEE-KK----- 658 (714)
Q Consensus 586 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~~~~~~~~~~-l~~~~~~~~~~-~~----- 658 (714)
.....||+.|+|||++.+..++.++|||||||++|||+||+.||......... -...+...... +.
T Consensus 250 -------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~ 322 (397)
T 1wak_A 250 -------FTEDIQTRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKL 322 (397)
T ss_dssp -------SCSCCSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHH
T ss_pred -------CccCCCCCcccCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHH
Confidence 12335789999999999999999999999999999999999999544332211 11111111110 00
Q ss_pred -----CcccccCCCC--------CC----------CCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 005102 659 -----PLADVLDPYL--------AP----------DADKEEEIIAVLKIAMACVHSSPEKRPTMRHISD 704 (714)
Q Consensus 659 -----~~~~~~d~~~--------~~----------~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 704 (714)
...+...... .+ ..........+.+++.+||+.||++|||++|+++
T Consensus 323 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 391 (397)
T 1wak_A 323 IVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391 (397)
T ss_dssp HHHCTTGGGTBCTTSSBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred hhcccccccccCCccccccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence 0000000000 00 0012345667899999999999999999999975
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-39 Score=346.74 Aligned_cols=256 Identities=21% Similarity=0.336 Sum_probs=184.5
Q ss_pred ccccccCceEEEEEEECCCcEEEEEEeCCCCchhHHHHHHHHHHHhccCCCCccceEEEEEeCCc------eeEEEeccC
Q 005102 409 FVLGKSGIGIVYKVVLEDGHTLAVRRLGEGGSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDE------KLLIYDYIP 482 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~------~~lV~e~~~ 482 (714)
+.||+|+||.||+|++.++..||+|++...... ..+|+++++.++||||+++++++...+. .++||||++
T Consensus 46 ~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~----~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~lv~e~~~ 121 (394)
T 4e7w_A 46 KVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF----KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVP 121 (394)
T ss_dssp EEEEEETTEEEEEEEETTTEEEEEEEEECCTTS----CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEEEEECCS
T ss_pred EEEeeCCCeEEEEEEECCCCeEEEEEEecCcch----HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEEEeeccC
Confidence 579999999999999988778999988654322 2469999999999999999999976543 789999998
Q ss_pred CCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeC-CCCCeEEcccchhhhhhcc
Q 005102 483 NGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLG-HNMEPHVSDFGLARLANIA 561 (714)
Q Consensus 483 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~-~~~~~kl~DFGla~~~~~~ 561 (714)
++.+......... ...+++..+..++.||++||+|||+ .+|+||||||+|||++ .++.+||+|||+|+.....
T Consensus 122 ~~l~~~~~~~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~~~ 195 (394)
T 4e7w_A 122 ETVYRASRHYAKL---KQTMPMLLIKLYMYQLLRSLAYIHS---IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAG 195 (394)
T ss_dssp EEHHHHHHHHHHT---TSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEEECCCTTCEECCTT
T ss_pred ccHHHHHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCCCHHHEEEcCCCCcEEEeeCCCcccccCC
Confidence 7543333221100 1468999999999999999999999 8999999999999999 7999999999999865321
Q ss_pred CCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCC-CCCchhhhHHHHHHHHHHHhCCCccccCC
Q 005102 562 GGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVV-KPSQKWDIYSYGVILLEMITGRTAVVQVG 640 (714)
Q Consensus 562 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DVwS~Gvvl~elltG~~p~~~~~ 640 (714)
. ......||+.|+|||++.+. .++.++|||||||++|||++|+.||....
T Consensus 196 ~-----------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~ 246 (394)
T 4e7w_A 196 E-----------------------------PNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGES 246 (394)
T ss_dssp C-----------------------------CCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred C-----------------------------CCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 1 11234568899999998765 58999999999999999999999995322
Q ss_pred CCcchhHHHHHHH-------H-hhcCCcccccCCCCCCCCC----cHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 005102 641 SSEMDLVNWMQLC-------I-EEKKPLADVLDPYLAPDAD----KEEEIIAVLKIAMACVHSSPEKRPTMRHISD 704 (714)
Q Consensus 641 ~~~~~l~~~~~~~-------~-~~~~~~~~~~d~~~~~~~~----~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 704 (714)
. ...+...+... + .......+..-+....... ......++.+++.+||+.||++|||+.|+++
T Consensus 247 ~-~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 321 (394)
T 4e7w_A 247 G-IDQLVEIIKVLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALC 321 (394)
T ss_dssp H-HHHHHHHHHHHCCCCHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred H-HHHHHHHHHHhCCCCHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhc
Confidence 1 11122211110 0 0000000000011110000 0012236889999999999999999999975
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-39 Score=339.09 Aligned_cols=245 Identities=20% Similarity=0.293 Sum_probs=187.1
Q ss_pred cccccccCceEEEEEEECC-CcEEEEEEeCCCCc--------hhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEE
Q 005102 408 AFVLGKSGIGIVYKVVLED-GHTLAVRRLGEGGS--------QRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIY 478 (714)
Q Consensus 408 ~~~lG~G~~g~Vy~~~~~~-g~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 478 (714)
.+.||+|+||.||+|.... ++.||||++..... .....+.+|++++++++||||+++++++... ..++||
T Consensus 15 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~lv~ 93 (322)
T 2ycf_A 15 SKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE-DYYIVL 93 (322)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS-SEEEEE
T ss_pred eeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC-ceEEEE
Confidence 3579999999999999864 88999999875421 1224588999999999999999999998765 489999
Q ss_pred eccCCCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCC---eEEcccchh
Q 005102 479 DYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNME---PHVSDFGLA 555 (714)
Q Consensus 479 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~---~kl~DFGla 555 (714)
||+++|+|.+++... ..+++..+..++.||+.||+|||+ .+|+||||||+||+++.++. +||+|||++
T Consensus 94 e~~~~~~L~~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~ 164 (322)
T 2ycf_A 94 ELMEGGELFDKVVGN------KRLKEATCKLYFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHS 164 (322)
T ss_dssp ECCTTEETHHHHSTT------CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESSSSSSCCEEECCCTTC
T ss_pred ecCCCCcHHHHHhcc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEecCCCCCeEEEccCccc
Confidence 999999999998754 458999999999999999999999 89999999999999987654 999999998
Q ss_pred hhhhccCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccC---CCCCCchhhhHHHHHHHHHHHhC
Q 005102 556 RLANIAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLK---VVKPSQKWDIYSYGVILLEMITG 632 (714)
Q Consensus 556 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~~~DVwS~Gvvl~elltG 632 (714)
+..... .......||+.|+|||++. ...++.++|||||||++|||++|
T Consensus 165 ~~~~~~-----------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g 215 (322)
T 2ycf_A 165 KILGET-----------------------------SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 215 (322)
T ss_dssp EECCCC-----------------------------HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHS
T ss_pred eecccc-----------------------------cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhC
Confidence 754311 0011123688899999973 56789999999999999999999
Q ss_pred CCccccCCCCcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 005102 633 RTAVVQVGSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISD 704 (714)
Q Consensus 633 ~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 704 (714)
+.||....... .+...+ ........ +.... .....+.+++.+||+.||++|||++|+++
T Consensus 216 ~~pf~~~~~~~-~~~~~~---~~~~~~~~----~~~~~-----~~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 216 YPPFSEHRTQV-SLKDQI---TSGKYNFI----PEVWA-----EVSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp SCSSCSTTCSS-CHHHHH---HHTCCCCC----HHHHT-----TSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CCCCcccchHH-HHHHHH---HhCccccC----chhhh-----hcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 99995433221 222211 11111100 00000 11236889999999999999999999874
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=365.06 Aligned_cols=251 Identities=19% Similarity=0.304 Sum_probs=198.3
Q ss_pred cccccccCceEEEEEEECC----CcEEEEEEeCCCC-chhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccC
Q 005102 408 AFVLGKSGIGIVYKVVLED----GHTLAVRRLGEGG-SQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIP 482 (714)
Q Consensus 408 ~~~lG~G~~g~Vy~~~~~~----g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~ 482 (714)
.+.||+|+||.||+|.+.. +..||||++.... ....+.|.+|+.++++++||||+++++++. .+..++||||++
T Consensus 395 ~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~lv~E~~~ 473 (656)
T 2j0j_A 395 GRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIMELCT 473 (656)
T ss_dssp EEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECCT
T ss_pred eeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceEEEEEcCC
Confidence 4579999999999999753 4679999987643 333467999999999999999999999984 567899999999
Q ss_pred CCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccC
Q 005102 483 NGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAG 562 (714)
Q Consensus 483 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 562 (714)
+|+|.+++.... ..+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++......
T Consensus 474 ~g~L~~~l~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDikp~NILl~~~~~vkL~DFG~a~~~~~~~ 545 (656)
T 2j0j_A 474 LGELRSFLQVRK-----FSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST 545 (656)
T ss_dssp TCBHHHHHHHTT-----TTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCCCCCCSCCC--
T ss_pred CCcHHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHh---CCccccccchHhEEEeCCCCEEEEecCCCeecCCCc
Confidence 999999997553 358999999999999999999999 899999999999999999999999999998653211
Q ss_pred CCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHh-CCCccccCCC
Q 005102 563 GSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMIT-GRTAVVQVGS 641 (714)
Q Consensus 563 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~ellt-G~~p~~~~~~ 641 (714)
........+|+.|+|||.+.+..++.++|||||||++|||++ |+.||....
T Consensus 546 ---------------------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~- 597 (656)
T 2j0j_A 546 ---------------------------YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK- 597 (656)
T ss_dssp -----------------------------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC-
T ss_pred ---------------------------ceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCC-
Confidence 011122345778999999988899999999999999999997 999994322
Q ss_pred CcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhhhhc
Q 005102 642 SEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDALDRLIV 711 (714)
Q Consensus 642 ~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~ 711 (714)
.. +.+........ +..... ....+.+++.+||+.||++|||+.|+++.|+++..
T Consensus 598 -~~---~~~~~i~~~~~-------~~~~~~-----~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~ 651 (656)
T 2j0j_A 598 -NN---DVIGRIENGER-------LPMPPN-----CPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 651 (656)
T ss_dssp -HH---HHHHHHHHTCC-------CCCCTT-----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -HH---HHHHHHHcCCC-------CCCCcc-----ccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence 11 22222222111 111111 12368899999999999999999999999999864
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-38 Score=333.47 Aligned_cols=244 Identities=23% Similarity=0.345 Sum_probs=187.9
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeCCCCchhHHHHHHHHHHHhcc-CCCCccceEEEEEe------CCceeEEEec
Q 005102 409 FVLGKSGIGIVYKVVLE-DGHTLAVRRLGEGGSQRFKEFQTEVEAIGKI-RHSNIVTLRAYYWS------VDEKLLIYDY 480 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~------~~~~~lV~e~ 480 (714)
+.||+|+||.||+|++. +|+.||||++...... .+.+.+|+++++++ +||||+++++++.. .+..++||||
T Consensus 30 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~ 108 (326)
T 2x7f_A 30 ELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE-EEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEF 108 (326)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEECCSST-THHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCEEEEEEEC
T ss_pred EEeccCCCEEEEEEEECCCCCeEEEEEEecCccc-HHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccceEEEEEEc
Confidence 57999999999999985 5899999998765332 36789999999999 79999999999987 4578999999
Q ss_pred cCCCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhc
Q 005102 481 IPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANI 560 (714)
Q Consensus 481 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 560 (714)
+++|+|.+++..... ..+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++....
T Consensus 109 ~~~~~L~~~l~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 181 (326)
T 2x7f_A 109 CGAGSVTDLIKNTKG----NTLKEEWIAYICREILRGLSHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDR 181 (326)
T ss_dssp CTTEEHHHHHHHSGG----GCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEECTTCCEEECCCTTTC----
T ss_pred CCCCcHHHHHHhccc----CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCcHHHEEEcCCCCEEEeeCcCceecCc
Confidence 999999999976432 458999999999999999999999 8999999999999999999999999999876532
Q ss_pred cCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccC-----CCCCCchhhhHHHHHHHHHHHhCCCc
Q 005102 561 AGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLK-----VVKPSQKWDIYSYGVILLEMITGRTA 635 (714)
Q Consensus 561 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~~DVwS~Gvvl~elltG~~p 635 (714)
.. .......||+.|+|||.+. +..++.++|||||||++|||++|+.|
T Consensus 182 ~~----------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p 233 (326)
T 2x7f_A 182 TV----------------------------GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPP 233 (326)
T ss_dssp -------------------------------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCT
T ss_pred Cc----------------------------cccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCC
Confidence 11 1112335788999999987 56789999999999999999999999
Q ss_pred cccCCCCcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 005102 636 VVQVGSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISD 704 (714)
Q Consensus 636 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 704 (714)
|..... ............ +...... ....+.+++.+||..||++|||++++++
T Consensus 234 ~~~~~~-----~~~~~~~~~~~~-------~~~~~~~----~~~~l~~li~~~l~~dp~~Rps~~~ll~ 286 (326)
T 2x7f_A 234 LCDMHP-----MRALFLIPRNPA-------PRLKSKK----WSKKFQSFIESCLVKNHSQRPATEQLMK 286 (326)
T ss_dssp TTTSCH-----HHHHHHHHHSCC-------CCCSCSC----SCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred CCCCcH-----HHHHHHhhcCcc-------ccCCccc----cCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 943221 111111111111 1111111 1236889999999999999999999986
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-38 Score=340.03 Aligned_cols=248 Identities=23% Similarity=0.332 Sum_probs=187.7
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeCCCC--chhHHHHHHHHHHHhccCCCCccceEEEEEeCCce------eEEEe
Q 005102 409 FVLGKSGIGIVYKVVLE-DGHTLAVRRLGEGG--SQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEK------LLIYD 479 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~------~lV~e 479 (714)
+.||+|+||.||+|.+. +|+.||||++.... ....+.+.+|+.++++++||||+++++++...+.. ++|||
T Consensus 48 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e 127 (371)
T 4exu_A 48 THVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMP 127 (371)
T ss_dssp EEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCCCEEEEE
T ss_pred eEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccceeEEEEEc
Confidence 47999999999999976 58999999997643 33356789999999999999999999999876654 99999
Q ss_pred ccCCCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhh
Q 005102 480 YIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLAN 559 (714)
Q Consensus 480 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~ 559 (714)
|+. ++|.+++. ..+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++...
T Consensus 128 ~~~-~~l~~~~~--------~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~ 195 (371)
T 4exu_A 128 FMQ-TDLQKIMG--------MEFSEEKIQYLVYQMLKGLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFGLARHAD 195 (371)
T ss_dssp CCC-EEHHHHTT--------SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECSTTCC----
T ss_pred ccc-ccHHHHhh--------cCCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCcCHHHeEECCCCCEEEEecCcccccc
Confidence 997 68988874 348999999999999999999999 899999999999999999999999999997543
Q ss_pred ccCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCC-CCCCchhhhHHHHHHHHHHHhCCCcccc
Q 005102 560 IAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKV-VKPSQKWDIYSYGVILLEMITGRTAVVQ 638 (714)
Q Consensus 560 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DVwS~Gvvl~elltG~~p~~~ 638 (714)
.. .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||..
T Consensus 196 ~~-------------------------------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 244 (371)
T 4exu_A 196 AE-------------------------------MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKG 244 (371)
T ss_dssp -----------------------------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCC
T ss_pred cC-------------------------------cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCC
Confidence 11 123356889999999987 6789999999999999999999999943
Q ss_pred CCCCcchhHHHHHHHHhh-cCCcccccCCC-----------C--CCCCCc----HHHHHHHHHHHhHccCCCCCCCCCHH
Q 005102 639 VGSSEMDLVNWMQLCIEE-KKPLADVLDPY-----------L--APDADK----EEEIIAVLKIAMACVHSSPEKRPTMR 700 (714)
Q Consensus 639 ~~~~~~~l~~~~~~~~~~-~~~~~~~~d~~-----------~--~~~~~~----~~~~~~l~~li~~Cl~~dP~~RPt~~ 700 (714)
.. ..+. +...... +.+..+..... . ...... ......+.+++.+||+.||++|||++
T Consensus 245 ~~--~~~~---~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ 319 (371)
T 4exu_A 245 KD--YLDQ---LTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAA 319 (371)
T ss_dssp SS--HHHH---HHHHHHHHCCCCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHH
T ss_pred CC--hHHH---HHHHHHHhCCCcHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHH
Confidence 21 1111 1111110 00000000000 0 000000 01134688999999999999999999
Q ss_pred HHHH
Q 005102 701 HISD 704 (714)
Q Consensus 701 evl~ 704 (714)
|+++
T Consensus 320 ell~ 323 (371)
T 4exu_A 320 QALT 323 (371)
T ss_dssp HHHT
T ss_pred HHhc
Confidence 9875
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=347.46 Aligned_cols=256 Identities=22% Similarity=0.337 Sum_probs=184.7
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeCCCCchhHHHHHHHHHHHhccCCCCccceEEEEEeCC------ceeEEEecc
Q 005102 409 FVLGKSGIGIVYKVVLE-DGHTLAVRRLGEGGSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVD------EKLLIYDYI 481 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~------~~~lV~e~~ 481 (714)
+.||+|+||.||+|++. +|+.||||++..... .+.+|+++|++++||||+++++++...+ ..++||||+
T Consensus 60 ~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e~~ 135 (420)
T 1j1b_A 60 KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV 135 (420)
T ss_dssp EEEEECSSEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEEEEECC
T ss_pred eEEeeCCCEEEEEEEECCCCcEEEEEEecccch----hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEeehhcc
Confidence 47999999999999986 489999999865432 2347999999999999999999986532 257999999
Q ss_pred CCCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCC-CCeEEcccchhhhhhc
Q 005102 482 PNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHN-MEPHVSDFGLARLANI 560 (714)
Q Consensus 482 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~-~~~kl~DFGla~~~~~ 560 (714)
++ ++.+.+..... ....+++..+..++.||++||+|||+ .+|+||||||+|||++.+ +.+||+|||+++....
T Consensus 136 ~~-~l~~~~~~~~~--~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~~ 209 (420)
T 1j1b_A 136 PE-TVYRVARHYSR--AKQTLPVIYVKLYMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR 209 (420)
T ss_dssp CE-EHHHHHHHHHH--TTCCCCHHHHHHHHHHHHHHHHHHHT---TTEECSCCSGGGEEEETTTTEEEECCCTTCEECCT
T ss_pred cc-cHHHHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChhhEEEeCCCCeEEeccchhhhhccc
Confidence 75 66665542100 01468999999999999999999999 899999999999999965 5689999999986432
Q ss_pred cCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCC-CCCchhhhHHHHHHHHHHHhCCCccccC
Q 005102 561 AGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVV-KPSQKWDIYSYGVILLEMITGRTAVVQV 639 (714)
Q Consensus 561 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DVwS~Gvvl~elltG~~p~~~~ 639 (714)
.. ......||+.|+|||++.+. .++.++|||||||++|||++|+.||...
T Consensus 210 ~~-----------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~ 260 (420)
T 1j1b_A 210 GE-----------------------------PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGD 260 (420)
T ss_dssp TC-----------------------------CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred CC-----------------------------CceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCC
Confidence 11 11234568999999999765 6899999999999999999999999532
Q ss_pred CCCcchhHHHHHHH-------H-hhcCCcccccCCCCCCCCC----cHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 005102 640 GSSEMDLVNWMQLC-------I-EEKKPLADVLDPYLAPDAD----KEEEIIAVLKIAMACVHSSPEKRPTMRHISD 704 (714)
Q Consensus 640 ~~~~~~l~~~~~~~-------~-~~~~~~~~~~d~~~~~~~~----~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 704 (714)
.. ...+.+.+... + .......+..-+.+..... ......++.+|+.+||+.||++|||+.|+++
T Consensus 261 ~~-~~~l~~i~~~lg~p~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~ 336 (420)
T 1j1b_A 261 SG-VDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 336 (420)
T ss_dssp SH-HHHHHHHHHHHCSCCHHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CH-HHHHHHHHHHhCCCCHHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC
Confidence 21 11122222110 0 0000111111111111000 0011246889999999999999999999974
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-38 Score=338.03 Aligned_cols=192 Identities=23% Similarity=0.317 Sum_probs=162.4
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeCCCCchhHHHHHHHHHHHhccC-CC-----CccceEEEEEeCCceeEEEecc
Q 005102 409 FVLGKSGIGIVYKVVLE-DGHTLAVRRLGEGGSQRFKEFQTEVEAIGKIR-HS-----NIVTLRAYYWSVDEKLLIYDYI 481 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~-----niv~l~~~~~~~~~~~lV~e~~ 481 (714)
+.||+|+||+||+|... +++.||||++.... ....++.+|+++++.++ |+ +|+++++++...+..++||||+
T Consensus 60 ~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~ 138 (382)
T 2vx3_A 60 SLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKK-AFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEML 138 (382)
T ss_dssp EEEEEETTEEEEEEEETTTTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEEEEEEECC
T ss_pred EEEeecCCEEEEEEEEcCCCcEEEEEEEeccH-HHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCceEEEEecC
Confidence 57999999999999976 58899999997542 33467788999988885 44 4999999999999999999999
Q ss_pred CCCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeC--CCCCeEEcccchhhhhh
Q 005102 482 PNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLG--HNMEPHVSDFGLARLAN 559 (714)
Q Consensus 482 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~--~~~~~kl~DFGla~~~~ 559 (714)
+ |+|.+++..... ..+++..+..++.|++.||+|||+.. .+|+||||||+|||++ .++.+||+|||+++...
T Consensus 139 ~-~~L~~~l~~~~~----~~~~~~~~~~i~~qi~~al~~lH~~~-~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~~~~ 212 (382)
T 2vx3_A 139 S-YNLYDLLRNTNF----RGVSLNLTRKFAQQMCTALLFLATPE-LSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLG 212 (382)
T ss_dssp C-CBHHHHHHHTTT----SCCCHHHHHHHHHHHHHHHHHHTSTT-TCEECCCCSGGGEEESSTTSCCEEECCCTTCEETT
T ss_pred C-CCHHHHHhhcCc----CCCCHHHHHHHHHHHHHHHHHhccCC-CCEEcCCCCcccEEEecCCCCcEEEEeccCceecc
Confidence 6 599999976532 35899999999999999999999421 6899999999999994 57889999999997653
Q ss_pred ccCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCcccc
Q 005102 560 IAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQ 638 (714)
Q Consensus 560 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~~~ 638 (714)
.. .....||+.|+|||++.+..++.++|||||||++|||+||+.||..
T Consensus 213 ~~-------------------------------~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~ 260 (382)
T 2vx3_A 213 QR-------------------------------IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSG 260 (382)
T ss_dssp CC-------------------------------CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred cc-------------------------------cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 11 1234568899999999999999999999999999999999999953
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-38 Score=328.20 Aligned_cols=258 Identities=24% Similarity=0.377 Sum_probs=186.3
Q ss_pred cccccccCceEEEEEEEC-CCcEEEEEEeCCCCchhHHHHHHHHHHHhccCCCCccceEEEEEe-------------CCc
Q 005102 408 AFVLGKSGIGIVYKVVLE-DGHTLAVRRLGEGGSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWS-------------VDE 473 (714)
Q Consensus 408 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~-------------~~~ 473 (714)
.+.||+|+||.||+|+.. +++.||||++... ....+.+.+|++++++++||||+++++++.. .+.
T Consensus 11 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 89 (303)
T 1zy4_A 11 IAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKST 89 (303)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC------CEEE
T ss_pred hheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcccccCCc
Confidence 357999999999999975 6899999999653 3345678999999999999999999999865 346
Q ss_pred eeEEEeccCCCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccc
Q 005102 474 KLLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFG 553 (714)
Q Consensus 474 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFG 553 (714)
.++||||+++|+|.+++.... ..+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dlkp~Nil~~~~~~~kl~dfg 161 (303)
T 1zy4_A 90 LFIQMEYCENGTLYDLIHSEN-----LNQQRDEYWRLFRQILEALSYIHS---QGIIHRDLKPMNIFIDESRNVKIGDFG 161 (303)
T ss_dssp EEEEEECCCSCBHHHHHHHSC-----GGGCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCCC
T ss_pred eEEEEecCCCCCHHHhhhccc-----cccchHHHHHHHHHHHHHHHHHHh---CCeecccCCHHhEEEcCCCCEEEeeCc
Confidence 789999999999999997543 457889999999999999999999 899999999999999999999999999
Q ss_pred hhhhhhccCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCC-CCCchhhhHHHHHHHHHHHhC
Q 005102 554 LARLANIAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVV-KPSQKWDIYSYGVILLEMITG 632 (714)
Q Consensus 554 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DVwS~Gvvl~elltG 632 (714)
+++................+ ..........||+.|+|||.+.+. .++.++|||||||++|||++
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~--------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~- 226 (303)
T 1zy4_A 162 LAKNVHRSLDILKLDSQNLP--------------GSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY- 226 (303)
T ss_dssp CCSCTTC---------------------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS-
T ss_pred chhhcccccchhcccccccc--------------ccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh-
Confidence 99865422110000000000 001122344578899999999764 68999999999999999998
Q ss_pred CCccccCCCCcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 005102 633 RTAVVQVGSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISD 704 (714)
Q Consensus 633 ~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 704 (714)
||.. ..+.............. ..+.... .....+.+++.+||+.||++|||++|+++
T Consensus 227 --p~~~----~~~~~~~~~~~~~~~~~----~~~~~~~-----~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 283 (303)
T 1zy4_A 227 --PFST----GMERVNILKKLRSVSIE----FPPDFDD-----NKMKVEKKIIRLLIDHDPNKRPGARTLLN 283 (303)
T ss_dssp --CCSS----HHHHHHHHHHHHSTTCC----CCTTCCT-----TTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred --ccCC----chhHHHHHHhccccccc----cCccccc-----cchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence 4421 11112222222111111 1111111 12235789999999999999999999986
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=335.17 Aligned_cols=255 Identities=23% Similarity=0.358 Sum_probs=185.3
Q ss_pred ccccccCceEEEEEEECC-CcEEEEEEeCCCCchhHHHHHHHHHHHhccCCCCccceEEEEE--------------eCCc
Q 005102 409 FVLGKSGIGIVYKVVLED-GHTLAVRRLGEGGSQRFKEFQTEVEAIGKIRHSNIVTLRAYYW--------------SVDE 473 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~--------------~~~~ 473 (714)
+.||+|+||.||+|.... ++.||||++........+.+.+|++++++++||||+++++++. ..+.
T Consensus 17 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~ 96 (320)
T 2i6l_A 17 KPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNS 96 (320)
T ss_dssp EECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----CCSCSE
T ss_pred EEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccccccccCc
Confidence 479999999999999875 8999999998776666788999999999999999999999884 3356
Q ss_pred eeEEEeccCCCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeC-CCCCeEEccc
Q 005102 474 KLLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLG-HNMEPHVSDF 552 (714)
Q Consensus 474 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~-~~~~~kl~DF 552 (714)
.++||||++ |+|.+++.. ..+++..+..++.|++.||+|||+ .+|+||||||+||+++ +++.+||+||
T Consensus 97 ~~lv~e~~~-~~L~~~~~~-------~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~kl~Df 165 (320)
T 2i6l_A 97 VYIVQEYME-TDLANVLEQ-------GPLLEEHARLFMYQLLRGLKYIHS---ANVLHRDLKPANLFINTEDLVLKIGDF 165 (320)
T ss_dssp EEEEEECCS-EEHHHHHTT-------CCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEEETTTTEEEECCC
T ss_pred eeEEeeccC-CCHHHHhhc-------CCccHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCeEEEccC
Confidence 799999997 699999864 348899999999999999999999 8999999999999997 5679999999
Q ss_pred chhhhhhccCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCC-CCCCchhhhHHHHHHHHHHHh
Q 005102 553 GLARLANIAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKV-VKPSQKWDIYSYGVILLEMIT 631 (714)
Q Consensus 553 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DVwS~Gvvl~ellt 631 (714)
|+++........ ........+|..|+|||.+.+ ..++.++||||||+++|||+|
T Consensus 166 g~~~~~~~~~~~-------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~ 220 (320)
T 2i6l_A 166 GLARIMDPHYSH-------------------------KGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLT 220 (320)
T ss_dssp TTCBCC---------------------------------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHH
T ss_pred ccccccCCCccc-------------------------ccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHh
Confidence 999865321100 011122345788999998865 678999999999999999999
Q ss_pred CCCccccCCCCcchhHHHHHHHHhhcCCc------------ccccCCCCC-CCCCc----HHHHHHHHHHHhHccCCCCC
Q 005102 632 GRTAVVQVGSSEMDLVNWMQLCIEEKKPL------------ADVLDPYLA-PDADK----EEEIIAVLKIAMACVHSSPE 694 (714)
Q Consensus 632 G~~p~~~~~~~~~~l~~~~~~~~~~~~~~------------~~~~d~~~~-~~~~~----~~~~~~l~~li~~Cl~~dP~ 694 (714)
|+.||.... .. ..+.......... ......... +.... .....++.+++.+||+.||+
T Consensus 221 g~~pf~~~~--~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~ 295 (320)
T 2i6l_A 221 GKTLFAGAH--EL---EQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPM 295 (320)
T ss_dssp SSCSSCCSS--HH---HHHHHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGG
T ss_pred CCCCCCCCC--HH---HHHHHHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCcc
Confidence 999995332 11 1111111111000 000000000 00000 01134688999999999999
Q ss_pred CCCCHHHHHH
Q 005102 695 KRPTMRHISD 704 (714)
Q Consensus 695 ~RPt~~evl~ 704 (714)
+|||++|+++
T Consensus 296 ~Rpt~~ell~ 305 (320)
T 2i6l_A 296 DRLTAEEALS 305 (320)
T ss_dssp GSCCHHHHHT
T ss_pred ccCCHHHHhC
Confidence 9999999975
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=342.46 Aligned_cols=256 Identities=22% Similarity=0.271 Sum_probs=186.0
Q ss_pred ccccccCceEEEEEEECCCcEEEEEEeCCCCc-----------hhHHHHHHHHHHHhccCCCCccceEEEEEeC-----C
Q 005102 409 FVLGKSGIGIVYKVVLEDGHTLAVRRLGEGGS-----------QRFKEFQTEVEAIGKIRHSNIVTLRAYYWSV-----D 472 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~-----------~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~-----~ 472 (714)
+.||+|+||.||+|...+|+.||||++..... ...+.+.+|++++++++||||+++++++... .
T Consensus 28 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 107 (362)
T 3pg1_A 28 RFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMH 107 (362)
T ss_dssp EEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEEECCTTTCC
T ss_pred EEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEEeccCCCcc
Confidence 57999999999999998899999999865321 1236799999999999999999999998653 3
Q ss_pred ceeEEEeccCCCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEccc
Q 005102 473 EKLLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDF 552 (714)
Q Consensus 473 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DF 552 (714)
..++||||++ |+|.+.+.... ..+++..+..|+.|++.||+|||+ .+|+||||||+||+++.++.+||+||
T Consensus 108 ~~~lv~e~~~-~~l~~~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Df 178 (362)
T 3pg1_A 108 KLYLVTELMR-TDLAQVIHDQR-----IVISPQHIQYFMYHILLGLHVLHE---AGVVHRDLHPGNILLADNNDITICDF 178 (362)
T ss_dssp EEEEEEECCS-EEHHHHHHCTT-----SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCT
T ss_pred eEEEEEccCC-CCHHHHHHhcc-----cCCCHHHHHHHHHHHHHHHHHHHH---CcCEecCCChHHEEEcCCCCEEEEec
Confidence 5699999997 68999887553 458999999999999999999999 89999999999999999999999999
Q ss_pred chhhhhhccCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCC-CCCCchhhhHHHHHHHHHHHh
Q 005102 553 GLARLANIAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKV-VKPSQKWDIYSYGVILLEMIT 631 (714)
Q Consensus 553 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DVwS~Gvvl~ellt 631 (714)
|+++..... .......||+.|+|||++.+ ..++.++|||||||++|||++
T Consensus 179 g~~~~~~~~-----------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~ 229 (362)
T 3pg1_A 179 NLAREDTAD-----------------------------ANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFN 229 (362)
T ss_dssp TC--------------------------------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHH
T ss_pred Ccccccccc-----------------------------cccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHh
Confidence 999753321 11223356888999999876 678999999999999999999
Q ss_pred CCCccccCCCCcchhHHHHHHHHhhcC----------CcccccCCCCCCCC--Cc----HHHHHHHHHHHhHccCCCCCC
Q 005102 632 GRTAVVQVGSSEMDLVNWMQLCIEEKK----------PLADVLDPYLAPDA--DK----EEEIIAVLKIAMACVHSSPEK 695 (714)
Q Consensus 632 G~~p~~~~~~~~~~l~~~~~~~~~~~~----------~~~~~~d~~~~~~~--~~----~~~~~~l~~li~~Cl~~dP~~ 695 (714)
|+.||.... ..+....+........ ...+.......... .. ......+.+++.+||+.||++
T Consensus 230 g~~pf~~~~--~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 307 (362)
T 3pg1_A 230 RKALFRGST--FYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQR 307 (362)
T ss_dssp SSCSCCCSS--HHHHHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGG
T ss_pred CCCCCCCCC--HHHHHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhh
Confidence 999994322 1111111111100000 00000000000000 00 011235889999999999999
Q ss_pred CCCHHHHHH
Q 005102 696 RPTMRHISD 704 (714)
Q Consensus 696 RPt~~evl~ 704 (714)
|||++|+++
T Consensus 308 Rpt~~ell~ 316 (362)
T 3pg1_A 308 RISTEQALR 316 (362)
T ss_dssp SCCHHHHHT
T ss_pred CCCHHHHHc
Confidence 999999975
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-38 Score=325.92 Aligned_cols=244 Identities=24% Similarity=0.316 Sum_probs=193.0
Q ss_pred cccccccCceEEEEEEEC-CCcEEEEEEeCCC--CchhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCC
Q 005102 408 AFVLGKSGIGIVYKVVLE-DGHTLAVRRLGEG--GSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNG 484 (714)
Q Consensus 408 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~g 484 (714)
.+.||+|+||.||+|+.. +++.||||++... .....+.+.+|++++++++||||+++++++...+..++||||++++
T Consensus 27 ~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 106 (287)
T 2wei_A 27 VCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGG 106 (287)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCCSC
T ss_pred eEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEEEccCCC
Confidence 357999999999999986 5899999998654 2334578999999999999999999999999999999999999999
Q ss_pred CHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCC---CCeEEcccchhhhhhcc
Q 005102 485 SLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHN---MEPHVSDFGLARLANIA 561 (714)
Q Consensus 485 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~---~~~kl~DFGla~~~~~~ 561 (714)
+|.+.+... ..+++.++..++.|++.||+|||+ .+|+||||||+||+++.+ +.+||+|||+++.....
T Consensus 107 ~L~~~l~~~------~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~ 177 (287)
T 2wei_A 107 ELFDEIIKR------KRFSEHDAARIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN 177 (287)
T ss_dssp BHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCC
T ss_pred CHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCChhhEEEecCCCcccEEEeccCcceeecCC
Confidence 999988654 458999999999999999999999 899999999999999764 47999999999865321
Q ss_pred CCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCccccCCC
Q 005102 562 GGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGS 641 (714)
Q Consensus 562 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~~~~~~ 641 (714)
. ......||+.|+|||.+.+ .++.++||||||+++|||++|+.||....
T Consensus 178 ~-----------------------------~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~- 226 (287)
T 2wei_A 178 T-----------------------------KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKN- 226 (287)
T ss_dssp S-----------------------------SCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSS-
T ss_pred C-----------------------------ccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCC-
Confidence 1 0111124678999999875 58999999999999999999999995321
Q ss_pred CcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 005102 642 SEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISD 704 (714)
Q Consensus 642 ~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 704 (714)
. ............... .+.. ......+.+++.+||+.||++|||++|+++
T Consensus 227 -~---~~~~~~~~~~~~~~~---~~~~------~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 276 (287)
T 2wei_A 227 -E---YDILKRVETGKYAFD---LPQW------RTISDDAKDLIRKMLTFHPSLRITATQCLE 276 (287)
T ss_dssp -H---HHHHHHHHHCCCCCC---SGGG------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -H---HHHHHHHHcCCCCCC---chhh------hhcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence 1 122222222211100 0000 011236889999999999999999999987
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=339.16 Aligned_cols=255 Identities=21% Similarity=0.242 Sum_probs=194.5
Q ss_pred ccccccCceEEEEEEECCCcEEEEEEeCCCCch-----------------hHHHHHHHHHHHhccCCCCccceEEEEEeC
Q 005102 409 FVLGKSGIGIVYKVVLEDGHTLAVRRLGEGGSQ-----------------RFKEFQTEVEAIGKIRHSNIVTLRAYYWSV 471 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~-----------------~~~~~~~E~~~l~~l~H~niv~l~~~~~~~ 471 (714)
+.||+|+||.||+|.. +|+.||||++...... ..+.+.+|++++++++||||+++++++...
T Consensus 37 ~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 115 (348)
T 2pml_X 37 RTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGIITNY 115 (348)
T ss_dssp EEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCCSEEEESS
T ss_pred EEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceEEEEEeeC
Confidence 4799999999999999 8999999998753211 127899999999999999999999999999
Q ss_pred CceeEEEeccCCCCHhhh------hhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCC
Q 005102 472 DEKLLIYDYIPNGSLATA------LHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNM 545 (714)
Q Consensus 472 ~~~~lV~e~~~~gsL~~~------l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~ 545 (714)
+..++||||+++|+|.++ +..... ..+++..+..++.|++.||+|||+. .+|+||||||+||+++.++
T Consensus 116 ~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~--~~i~H~dl~p~Nil~~~~~ 189 (348)
T 2pml_X 116 DEVYIIYEYMENDSILKFDEYFFVLDKNYT----CFIPIQVIKCIIKSVLNSFSYIHNE--KNICHRDVKPSNILMDKNG 189 (348)
T ss_dssp SEEEEEEECCTTCBSSEESSSEESSCSSSC----CCCCHHHHHHHHHHHHHHHHHHHHT--SCEECCCCCGGGEEECTTS
T ss_pred CeEEEEEeccCCCcHHHHHHHhhhhhhccc----cCCCHHHHHHHHHHHHHHHHHHhcc--CCEeecCCChHhEEEcCCC
Confidence 999999999999999998 544211 5699999999999999999999962 5899999999999999999
Q ss_pred CeEEcccchhhhhhccCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCC-CCCc-hhhhHHHH
Q 005102 546 EPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVV-KPSQ-KWDIYSYG 623 (714)
Q Consensus 546 ~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~-~~DVwS~G 623 (714)
.+||+|||+++..... ......||+.|+|||.+.+. .++. ++||||||
T Consensus 190 ~~kl~dfg~~~~~~~~------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG 239 (348)
T 2pml_X 190 RVKLSDFGESEYMVDK------------------------------KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLG 239 (348)
T ss_dssp CEEECCCTTCEECBTT------------------------------EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHH
T ss_pred cEEEeccccccccccc------------------------------cccCCCCCcCccCchhhcCCCCCCcchhhHHHHH
Confidence 9999999998754211 11234568899999999877 5666 99999999
Q ss_pred HHHHHHHhCCCccccCCCCcchhHHHHHHHHhhcCCcccc----cCCCCCCC--CCcHHHHHHHHHHHhHccCCCCCCCC
Q 005102 624 VILLEMITGRTAVVQVGSSEMDLVNWMQLCIEEKKPLADV----LDPYLAPD--ADKEEEIIAVLKIAMACVHSSPEKRP 697 (714)
Q Consensus 624 vvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~----~d~~~~~~--~~~~~~~~~l~~li~~Cl~~dP~~RP 697 (714)
+++|||++|+.||...... . +............... ..+..... .........+.+++.+||+.||++||
T Consensus 240 ~il~~l~~g~~pf~~~~~~-~---~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp 315 (348)
T 2pml_X 240 ICLYVMFYNVVPFSLKISL-V---ELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERI 315 (348)
T ss_dssp HHHHHHHHSSCSSCCSSCS-H---HHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSC
T ss_pred HHHHHHHhCCCCCCCCCcH-H---HHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCC
Confidence 9999999999999543221 1 1222211111111100 00000000 00011234688999999999999999
Q ss_pred CHHHHHH
Q 005102 698 TMRHISD 704 (714)
Q Consensus 698 t~~evl~ 704 (714)
|++|+++
T Consensus 316 s~~e~l~ 322 (348)
T 2pml_X 316 TSEDALK 322 (348)
T ss_dssp CHHHHHT
T ss_pred CHHHHhc
Confidence 9999986
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-38 Score=335.91 Aligned_cols=256 Identities=21% Similarity=0.295 Sum_probs=192.4
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeCCCCc-hhHHHHHHHHHHHhccCCCCccceEEEEEeC-----CceeEEEecc
Q 005102 409 FVLGKSGIGIVYKVVLE-DGHTLAVRRLGEGGS-QRFKEFQTEVEAIGKIRHSNIVTLRAYYWSV-----DEKLLIYDYI 481 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~-----~~~~lV~e~~ 481 (714)
+.||+|+||.||+|... +++.||||++..... ...+.+.+|++++++++||||+++++++... ...++||||+
T Consensus 33 ~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~iv~e~~ 112 (364)
T 3qyz_A 33 SYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM 112 (364)
T ss_dssp EEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEEEECC
T ss_pred EEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceEEEEEccc
Confidence 47999999999999976 588999999986433 3346789999999999999999999999765 3679999999
Q ss_pred CCCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhcc
Q 005102 482 PNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIA 561 (714)
Q Consensus 482 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 561 (714)
. |+|.+++... .+++..+..|+.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++.....
T Consensus 113 ~-~~L~~~l~~~-------~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~ 181 (364)
T 3qyz_A 113 E-TDLYKLLKTQ-------HLSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPD 181 (364)
T ss_dssp S-EEHHHHHHHC-------CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECCGG
T ss_pred C-cCHHHHHHhC-------CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCChHhEEECCCCCEEEEeCcceEecCCC
Confidence 7 5999988643 48999999999999999999999 89999999999999999999999999999865422
Q ss_pred CCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCC-CCCCchhhhHHHHHHHHHHHhCCCccccCC
Q 005102 562 GGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKV-VKPSQKWDIYSYGVILLEMITGRTAVVQVG 640 (714)
Q Consensus 562 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DVwS~Gvvl~elltG~~p~~~~~ 640 (714)
... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||....
T Consensus 182 ~~~-------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~ 236 (364)
T 3qyz_A 182 HDH-------------------------TGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKH 236 (364)
T ss_dssp GCB-------------------------CCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred CCc-------------------------cccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCC
Confidence 110 111234467999999998754 458999999999999999999999994332
Q ss_pred CCcchhHHHHHHHHhhcCCcccccC------------CCC-CCCCCc----HHHHHHHHHHHhHccCCCCCCCCCHHHHH
Q 005102 641 SSEMDLVNWMQLCIEEKKPLADVLD------------PYL-APDADK----EEEIIAVLKIAMACVHSSPEKRPTMRHIS 703 (714)
Q Consensus 641 ~~~~~l~~~~~~~~~~~~~~~~~~d------------~~~-~~~~~~----~~~~~~l~~li~~Cl~~dP~~RPt~~evl 703 (714)
..+....+....... ..+... ... ...... ......+.+++.+||+.||++|||++|++
T Consensus 237 --~~~~~~~i~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l 312 (364)
T 3qyz_A 237 --YLDQLNHILGILGSP--SQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQAL 312 (364)
T ss_dssp --GGGHHHHHHHHHCSC--CHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHH
T ss_pred --hHHHHHHHHHHhCCC--CHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHh
Confidence 222222221111100 000000 000 000000 01123578999999999999999999997
Q ss_pred H
Q 005102 704 D 704 (714)
Q Consensus 704 ~ 704 (714)
+
T Consensus 313 ~ 313 (364)
T 3qyz_A 313 A 313 (364)
T ss_dssp T
T ss_pred c
Confidence 5
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-38 Score=330.16 Aligned_cols=244 Identities=21% Similarity=0.313 Sum_probs=188.4
Q ss_pred ccccccCceEEEEEEECCCcEEEEEEeCCC--CchhHHHHHHHHHHHhccC--CCCccceEEEEEeCCceeEEEeccCCC
Q 005102 409 FVLGKSGIGIVYKVVLEDGHTLAVRRLGEG--GSQRFKEFQTEVEAIGKIR--HSNIVTLRAYYWSVDEKLLIYDYIPNG 484 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~--H~niv~l~~~~~~~~~~~lV~e~~~~g 484 (714)
+.||+|+||.||++...+++.||||++... .....+.+.+|++++++++ ||||+++++++...+..++||| +.++
T Consensus 34 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e-~~~~ 112 (313)
T 3cek_A 34 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNI 112 (313)
T ss_dssp EEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEEEEC-CCSE
T ss_pred EEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEEEEe-cCCC
Confidence 479999999999999988999999998754 3334578999999999997 5999999999999999999999 5588
Q ss_pred CHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCC
Q 005102 485 SLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGS 564 (714)
Q Consensus 485 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 564 (714)
+|.+++... ..+++..+..++.|++.||+|||+ .+|+||||||+||++++ +.+||+|||+++.......
T Consensus 113 ~L~~~l~~~------~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~~~~~- 181 (313)
T 3cek_A 113 DLNSWLKKK------KSIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTT- 181 (313)
T ss_dssp EHHHHHHHC------SSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEET-TEEEECCCSSSCC-------
T ss_pred cHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcccEEEEC-CeEEEeeccccccccCccc-
Confidence 999999765 458999999999999999999999 89999999999999965 7999999999986542210
Q ss_pred CCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCC-----------CCCCchhhhHHHHHHHHHHHhCC
Q 005102 565 PTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKV-----------VKPSQKWDIYSYGVILLEMITGR 633 (714)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~s~~~DVwS~Gvvl~elltG~ 633 (714)
........||+.|+|||.+.+ ..++.++||||||+++|||++|+
T Consensus 182 -------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~ 236 (313)
T 3cek_A 182 -------------------------SVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 236 (313)
T ss_dssp ---------------------------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSS
T ss_pred -------------------------cccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCC
Confidence 011123457899999999875 46899999999999999999999
Q ss_pred CccccCCCCcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 005102 634 TAVVQVGSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISD 704 (714)
Q Consensus 634 ~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 704 (714)
.||...... ...+........ ........ ...+.+++.+||+.||++|||++|+++
T Consensus 237 ~pf~~~~~~----~~~~~~~~~~~~------~~~~~~~~-----~~~l~~li~~~l~~dp~~Rps~~ell~ 292 (313)
T 3cek_A 237 TPFQQIINQ----ISKLHAIIDPNH------EIEFPDIP-----EKDLQDVLKCCLKRDPKQRISIPELLA 292 (313)
T ss_dssp CTTTTCCSH----HHHHHHHHCTTS------CCCCCCCS-----CHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CchhhHHHH----HHHHHHHHhccc------ccCCcccc-----hHHHHHHHHHHccCCcccCcCHHHHhc
Confidence 999533221 111111111111 01111111 235789999999999999999999985
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-38 Score=339.92 Aligned_cols=256 Identities=21% Similarity=0.304 Sum_probs=184.2
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeCCCCchhHHHHHHHHHHHhccCCCCccceEEEEEeCC---------------
Q 005102 409 FVLGKSGIGIVYKVVLE-DGHTLAVRRLGEGGSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVD--------------- 472 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~--------------- 472 (714)
+.||+|+||.||+|+.. +|+.||||++...... ..+|+++++.++||||+++++++...+
T Consensus 13 ~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~----~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~ 88 (383)
T 3eb0_A 13 KTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY----KNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNK 88 (383)
T ss_dssp EEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS----CCHHHHHHTTCCCTTBCCEEEEEEEC----------------
T ss_pred EEEEeccCEEEEEEEECCCCCEEEEEEEecCcch----HHHHHHHHHHcCCCCccchhheeeecCccccccccccccccc
Confidence 57999999999999974 6899999998754322 347999999999999999999985432
Q ss_pred -----------------------ceeEEEeccCCCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCc
Q 005102 473 -----------------------EKLLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKY 529 (714)
Q Consensus 473 -----------------------~~~lV~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~i 529 (714)
..++||||++ |+|.+.+...... ...+++..+..|+.|+++||+|||+ .+|
T Consensus 89 ~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~---~gi 162 (383)
T 3eb0_A 89 LGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRS--GRSIPMNLISIYIYQLFRAVGFIHS---LGI 162 (383)
T ss_dssp ---------------------CCEEEEEECCCS-EEHHHHHHHHHHT--TCCCCHHHHHHHHHHHHHHHHHHHT---TTE
T ss_pred ccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHH---CcC
Confidence 3789999998 5887776531100 1468999999999999999999999 899
Q ss_pred eecCCCCCCeeeC-CCCCeEEcccchhhhhhccCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCccc
Q 005102 530 VHGDLKPSNILLG-HNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESL 608 (714)
Q Consensus 530 vHrDlkp~NILl~-~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 608 (714)
+||||||+|||++ +++.+||+|||+|+...... ......||+.|+|||.+
T Consensus 163 ~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~-----------------------------~~~~~~~t~~y~aPE~~ 213 (383)
T 3eb0_A 163 CHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE-----------------------------PSVAYICSRFYRAPELM 213 (383)
T ss_dssp ECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS-----------------------------CCCCCCCCSSCCCHHHH
T ss_pred ccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC-----------------------------CCcCcccCCCccCHHHh
Confidence 9999999999997 68899999999998653211 12234568889999998
Q ss_pred CCCC-CCchhhhHHHHHHHHHHHhCCCccccCCCCcchhHHHHHHH--------HhhcCCcccccCCCCCCCC----CcH
Q 005102 609 KVVK-PSQKWDIYSYGVILLEMITGRTAVVQVGSSEMDLVNWMQLC--------IEEKKPLADVLDPYLAPDA----DKE 675 (714)
Q Consensus 609 ~~~~-~s~~~DVwS~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~--------~~~~~~~~~~~d~~~~~~~----~~~ 675 (714)
.+.. ++.++||||+||++|||++|+.||..... ...+...+... ........+..-+...... ...
T Consensus 214 ~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (383)
T 3eb0_A 214 LGATEYTPSIDLWSIGCVFGELILGKPLFSGETS-IDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPE 292 (383)
T ss_dssp TTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCT
T ss_pred cCCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCh-HHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCC
Confidence 7754 89999999999999999999999953211 11111111100 0000000111001110000 000
Q ss_pred HHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 005102 676 EEIIAVLKIAMACVHSSPEKRPTMRHISD 704 (714)
Q Consensus 676 ~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 704 (714)
.....+.+++.+||+.||++|||+.|+++
T Consensus 293 ~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 321 (383)
T 3eb0_A 293 GTPSLAIDLLEQILRYEPDLRINPYEAMA 321 (383)
T ss_dssp TCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred CCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 12235889999999999999999999974
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-38 Score=338.70 Aligned_cols=258 Identities=19% Similarity=0.260 Sum_probs=176.7
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeCCCCchhHHHHHHHHHHHhccCCCCccceEEEEEeCCc-------eeEEEec
Q 005102 409 FVLGKSGIGIVYKVVLE-DGHTLAVRRLGEGGSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDE-------KLLIYDY 480 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~-------~~lV~e~ 480 (714)
+.||+|+||.||+|++. +|+.||||++...... ...+.+|++.++.++||||+++++++...+. .++||||
T Consensus 29 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~~lv~e~ 107 (360)
T 3e3p_A 29 RMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRF-RNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEY 107 (360)
T ss_dssp ----------CEEEEETTTCCEEEEEEEECCTTC-CCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCEEEEEEEEC
T ss_pred EEEecCCCeEEEEEEECCCCCEEEEEEEecCccc-cHHHHHHHHHHHhcCCCCcccHHHhhhccccccccceeEEEEeec
Confidence 47999999999999985 5899999998654322 2456788888999999999999999976443 7899999
Q ss_pred cCCCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHh--cCCCCCceecCCCCCCeeeCC-CCCeEEcccchhhh
Q 005102 481 IPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLH--EFSPKKYVHGDLKPSNILLGH-NMEPHVSDFGLARL 557 (714)
Q Consensus 481 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH--~~~~~~ivHrDlkp~NILl~~-~~~~kl~DFGla~~ 557 (714)
+++ +|.+.+..... ....+++..+..++.|++.||.||| + ++|+||||||+|||++. ++.+||+|||+++.
T Consensus 108 ~~~-~l~~~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~~---~~ivH~Dlkp~NIll~~~~~~~kl~Dfg~a~~ 181 (360)
T 3e3p_A 108 VPD-TLHRCCRNYYR--RQVAPPPILIKVFLFQLIRSIGCLHLPS---VNVCHRDIKPHNVLVNEADGTLKLCDFGSAKK 181 (360)
T ss_dssp CSC-BHHHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHTSTT---TCCBCSCCCGGGEEEETTTTEEEECCCTTCBC
T ss_pred ccc-cHHHHHHHHhh--cccCCCHHHHHHHHHHHHHHHHHHhCCC---CCeecCcCCHHHEEEeCCCCcEEEeeCCCcee
Confidence 976 55544332100 0145889999999999999999999 7 89999999999999996 89999999999986
Q ss_pred hhccCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCC-CCchhhhHHHHHHHHHHHhCCCcc
Q 005102 558 ANIAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVK-PSQKWDIYSYGVILLEMITGRTAV 636 (714)
Q Consensus 558 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s~~~DVwS~Gvvl~elltG~~p~ 636 (714)
..... ......||+.|+|||++.+.. ++.++|||||||++|||+||+.||
T Consensus 182 ~~~~~-----------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf 232 (360)
T 3e3p_A 182 LSPSE-----------------------------PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIF 232 (360)
T ss_dssp CCTTS-----------------------------CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred cCCCC-----------------------------CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCc
Confidence 53211 112345688999999987654 899999999999999999999999
Q ss_pred ccCCCCcchhHHHHHHHHhhcC-CcccccCCCC-------CCCCC--------cHHHHHHHHHHHhHccCCCCCCCCCHH
Q 005102 637 VQVGSSEMDLVNWMQLCIEEKK-PLADVLDPYL-------APDAD--------KEEEIIAVLKIAMACVHSSPEKRPTMR 700 (714)
Q Consensus 637 ~~~~~~~~~l~~~~~~~~~~~~-~~~~~~d~~~-------~~~~~--------~~~~~~~l~~li~~Cl~~dP~~RPt~~ 700 (714)
.... .......+........ ......++.. ..... .......+.+++.+||+.||++|||+.
T Consensus 233 ~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ 310 (360)
T 3e3p_A 233 RGDN--SAGQLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPY 310 (360)
T ss_dssp CCSS--HHHHHHHHHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHH
T ss_pred CCCC--hHHHHHHHHHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHH
Confidence 5322 1111111111110000 0000000000 00000 001345788999999999999999999
Q ss_pred HHHH
Q 005102 701 HISD 704 (714)
Q Consensus 701 evl~ 704 (714)
|+++
T Consensus 311 e~l~ 314 (360)
T 3e3p_A 311 EALC 314 (360)
T ss_dssp HHTT
T ss_pred HHhc
Confidence 9975
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-38 Score=333.09 Aligned_cols=257 Identities=23% Similarity=0.289 Sum_probs=190.1
Q ss_pred ccccccCceEEEEEEEC--CCcEEEEEEeCCCCc--hhHHHHHHHHHHHhcc---CCCCccceEEEEE-----eCCceeE
Q 005102 409 FVLGKSGIGIVYKVVLE--DGHTLAVRRLGEGGS--QRFKEFQTEVEAIGKI---RHSNIVTLRAYYW-----SVDEKLL 476 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~--~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~H~niv~l~~~~~-----~~~~~~l 476 (714)
+.||+|+||.||+|++. +|+.||||++..... .....+.+|+++++++ +||||+++++++. .....++
T Consensus 17 ~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~~l 96 (326)
T 1blx_A 17 AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTL 96 (326)
T ss_dssp EEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEEEEEE
T ss_pred eeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccCCCceEEE
Confidence 47999999999999983 588999999865321 1123567788877776 8999999999987 4567899
Q ss_pred EEeccCCCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhh
Q 005102 477 IYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLAR 556 (714)
Q Consensus 477 V~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~ 556 (714)
||||++ |+|.+++..... ..+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++
T Consensus 97 v~e~~~-~~L~~~l~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~---~gi~H~dlkp~Nili~~~~~~kl~Dfg~~~ 168 (326)
T 1blx_A 97 VFEHVD-QDLTTYLDKVPE----PGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLAR 168 (326)
T ss_dssp EEECCS-CBHHHHHHHSCT----TCSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECSCCSCC
T ss_pred EEecCC-CCHHHHHHhccc----CCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCCHHHeEEcCCCCEEEecCcccc
Confidence 999997 699999976532 348999999999999999999999 899999999999999999999999999987
Q ss_pred hhhccCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCcc
Q 005102 557 LANIAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAV 636 (714)
Q Consensus 557 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~ 636 (714)
..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||
T Consensus 169 ~~~~~-----------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf 219 (326)
T 1blx_A 169 IYSFQ-----------------------------MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLF 219 (326)
T ss_dssp CCCGG-----------------------------GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred cccCC-----------------------------CCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCC
Confidence 54311 1122345688999999999999999999999999999999999999
Q ss_pred ccCCCCcchhHHHHHHHHhhcC--Cccc-------ccCCCCCCCC--CcHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 005102 637 VQVGSSEMDLVNWMQLCIEEKK--PLAD-------VLDPYLAPDA--DKEEEIIAVLKIAMACVHSSPEKRPTMRHISD 704 (714)
Q Consensus 637 ~~~~~~~~~l~~~~~~~~~~~~--~~~~-------~~d~~~~~~~--~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 704 (714)
.... ..+....+........ .... .......... ........+.+++.+||+.||++|||++|+++
T Consensus 220 ~~~~--~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 296 (326)
T 1blx_A 220 RGSS--DVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 296 (326)
T ss_dssp CCSS--HHHHHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CCCC--HHHHHHHHHHHcCCCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 4322 2222221111111000 0000 0000000000 00012235789999999999999999999984
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=348.28 Aligned_cols=252 Identities=21% Similarity=0.243 Sum_probs=183.9
Q ss_pred ccccccCceEEEEEEECCCcEEEEEEeCCCCchhHHHHHHHHHHHhcc-CCCCccceEEEEEeCCceeEEEeccCCCCHh
Q 005102 409 FVLGKSGIGIVYKVVLEDGHTLAVRRLGEGGSQRFKEFQTEVEAIGKI-RHSNIVTLRAYYWSVDEKLLIYDYIPNGSLA 487 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~e~~~~gsL~ 487 (714)
++||+|+||+||.+...+|+.||||++... ..+.+.+|++++.++ +||||+++++++.+.+..++||||+. |+|.
T Consensus 21 ~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~-gsL~ 96 (434)
T 2rio_A 21 KILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN-LNLQ 96 (434)
T ss_dssp EEEEECSTTCEEEEEESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS-EEHH
T ss_pred CeEeeCCCeEEEEEEEECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC-CCHH
Confidence 579999999998877778999999998653 235678999999987 89999999999999999999999995 6999
Q ss_pred hhhhCCCCCCCc-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCC-------------CCeEEcccc
Q 005102 488 TALHGKPGMVSF-TPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHN-------------MEPHVSDFG 553 (714)
Q Consensus 488 ~~l~~~~~~~~~-~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~-------------~~~kl~DFG 553 (714)
+++......... ...++..+..|+.||+.||+|||+ .+|+||||||+|||++.+ +.+||+|||
T Consensus 97 ~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~DFG 173 (434)
T 2rio_A 97 DLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFG 173 (434)
T ss_dssp HHHHTC------------CCHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEECCCT
T ss_pred HHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHH---CCccccCCChHhEEEecCcccccccccCCCceEEEEcccc
Confidence 999865321100 111334567899999999999999 899999999999999654 489999999
Q ss_pred hhhhhhccCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCC-------CCCCchhhhHHHHHHH
Q 005102 554 LARLANIAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKV-------VKPSQKWDIYSYGVIL 626 (714)
Q Consensus 554 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~s~~~DVwS~Gvvl 626 (714)
+++........ .........||+.|+|||++.+ ..++.++|||||||++
T Consensus 174 ~a~~~~~~~~~------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il 229 (434)
T 2rio_A 174 LCKKLDSGQSS------------------------FRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVF 229 (434)
T ss_dssp TCEECCC--------------------------------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHH
T ss_pred cceecCCCCcc------------------------ceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHH
Confidence 99865432110 0111233467999999999975 5689999999999999
Q ss_pred HHHHh-CCCccccCCCCcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 005102 627 LEMIT-GRTAVVQVGSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISD 704 (714)
Q Consensus 627 ~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 704 (714)
|||+| |+.||....... . ........... . ..........++.+++.+||+.||++|||+.|+++
T Consensus 230 ~ellt~g~~Pf~~~~~~~---~----~i~~~~~~~~~-----~-~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 230 YYILSKGKHPFGDKYSRE---S----NIIRGIFSLDE-----M-KCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp HHHHTTSCCTTCSTTTHH---H----HHHHTCCCCCC-----C-TTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHhCCCCCCCCchhhH---H----HHhcCCCCccc-----c-cccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 99999 999994322111 1 11111111111 1 11122345567899999999999999999999975
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=336.27 Aligned_cols=245 Identities=21% Similarity=0.290 Sum_probs=167.1
Q ss_pred cccccccCceEEEEEEEC-CCcEEEEEEeCCCCchhHHHHHHHH-HHHhccCCCCccceEEEEEe----CCceeEEEecc
Q 005102 408 AFVLGKSGIGIVYKVVLE-DGHTLAVRRLGEGGSQRFKEFQTEV-EAIGKIRHSNIVTLRAYYWS----VDEKLLIYDYI 481 (714)
Q Consensus 408 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~-~~l~~l~H~niv~l~~~~~~----~~~~~lV~e~~ 481 (714)
.++||+|+||.||+|.+. +|+.||||++.... ...+|+ ..++.++||||+++++++.. ....++||||+
T Consensus 34 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~ 108 (336)
T 3fhr_A 34 KQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP-----KARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECM 108 (336)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEESSH-----HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECC
T ss_pred ceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH-----HHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEEEEEecc
Confidence 347999999999999987 58999999986532 222333 34566799999999999976 34579999999
Q ss_pred CCCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCC---CCCeEEcccchhhhh
Q 005102 482 PNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGH---NMEPHVSDFGLARLA 558 (714)
Q Consensus 482 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~---~~~~kl~DFGla~~~ 558 (714)
++|+|.+++..... ..+++.++..|+.|++.||+|||+ ++|+||||||+||+++. ++.+||+|||+++..
T Consensus 109 ~gg~L~~~l~~~~~----~~l~~~~~~~i~~ql~~~l~~LH~---~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~ 181 (336)
T 3fhr_A 109 EGGELFSRIQERGD----QAFTEREAAEIMRDIGTAIQFLHS---HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKET 181 (336)
T ss_dssp TTEEHHHHHHTC-C----CCCBHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC
T ss_pred CCCCHHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEEecCCCceEEEeccccceec
Confidence 99999999986542 358999999999999999999999 89999999999999976 455999999998754
Q ss_pred hccCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCcccc
Q 005102 559 NIAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQ 638 (714)
Q Consensus 559 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~~~ 638 (714)
... ......||+.|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus 182 ~~~------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 231 (336)
T 3fhr_A 182 TQN------------------------------ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYS 231 (336)
T ss_dssp ----------------------------------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC--
T ss_pred ccc------------------------------ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence 311 11223468889999999888899999999999999999999999954
Q ss_pred CCCCcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 005102 639 VGSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISD 704 (714)
Q Consensus 639 ~~~~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 704 (714)
...... ............ .....+. .......+.+++.+||+.||++|||++|+++
T Consensus 232 ~~~~~~--~~~~~~~~~~~~--~~~~~~~------~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 287 (336)
T 3fhr_A 232 NTGQAI--SPGMKRRIRLGQ--YGFPNPE------WSEVSEDAKQLIRLLLKTDPTERLTITQFMN 287 (336)
T ss_dssp -----------------------CCCTTT------STTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred ccchhh--hhhHHHhhhccc--cccCchh------hccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 322111 000000000000 0000000 0112336889999999999999999999987
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=333.34 Aligned_cols=249 Identities=21% Similarity=0.284 Sum_probs=187.3
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeCCCC--chhHHHHHHHHHHHhccCCCCccceEEEEEeCCc------eeEEEe
Q 005102 409 FVLGKSGIGIVYKVVLE-DGHTLAVRRLGEGG--SQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDE------KLLIYD 479 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~------~~lV~e 479 (714)
..||+|+||.||+|.+. +|+.||||++.... ....+.+.+|+.++++++||||+++++++...+. .++|||
T Consensus 30 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e 109 (353)
T 3coi_A 30 THVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMP 109 (353)
T ss_dssp EEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCEEEEE
T ss_pred eeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccceeEEEEec
Confidence 47999999999999985 58999999997643 2334678999999999999999999999987654 499999
Q ss_pred ccCCCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhh
Q 005102 480 YIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLAN 559 (714)
Q Consensus 480 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~ 559 (714)
|+. |+|.+++. ..+++..+..++.||+.||+|||+ .+|+||||||+||++++++.+||+|||+++...
T Consensus 110 ~~~-~~l~~~~~--------~~~~~~~~~~i~~qi~~al~~LH~---~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 177 (353)
T 3coi_A 110 FMQ-TDLQKIMG--------LKFSEEKIQYLVYQMLKGLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFGLARHAD 177 (353)
T ss_dssp CCS-EEGGGTTT--------SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCCGGGEEECTTCCEEECSTTCTTC--
T ss_pred ccc-CCHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEeECCCCcEEEeecccccCCC
Confidence 997 68888774 348999999999999999999999 899999999999999999999999999987542
Q ss_pred ccCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCC-CCCCchhhhHHHHHHHHHHHhCCCcccc
Q 005102 560 IAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKV-VKPSQKWDIYSYGVILLEMITGRTAVVQ 638 (714)
Q Consensus 560 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DVwS~Gvvl~elltG~~p~~~ 638 (714)
.. .....||+.|+|||.+.+ ..++.++|||||||++|||++|+.||..
T Consensus 178 ~~-------------------------------~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~ 226 (353)
T 3coi_A 178 AE-------------------------------MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKG 226 (353)
T ss_dssp -------------------------------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBS
T ss_pred CC-------------------------------ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 11 122356889999999876 6789999999999999999999999953
Q ss_pred CCCCcchhHHHHHHHHhhcC-----------------CcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHH
Q 005102 639 VGSSEMDLVNWMQLCIEEKK-----------------PLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRH 701 (714)
Q Consensus 639 ~~~~~~~l~~~~~~~~~~~~-----------------~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~e 701 (714)
.. ..+....+........ .+.....+..... .......+.+++.+||+.||++|||++|
T Consensus 227 ~~--~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~L~~dp~~Rpt~~e 302 (353)
T 3coi_A 227 KD--YLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQL--FPRASPQAADLLEKMLELDVDKRLTAAQ 302 (353)
T ss_dssp SC--HHHHHHHHHHHHCBCCHHHHTTCSCHHHHHHHHTSCBCSSCCTTTT--CTTSCHHHHHHHHHHSCSCTTTSCCHHH
T ss_pred CC--HHHHHHHHHHHhCCCCHHHHHHHhhHHHHHHHHhCcCCCCccHHHh--cCCcCHHHHHHHHHHcCCCcccCCCHHH
Confidence 32 1111111111000000 0000000000000 0112346889999999999999999999
Q ss_pred HHH
Q 005102 702 ISD 704 (714)
Q Consensus 702 vl~ 704 (714)
+++
T Consensus 303 ~l~ 305 (353)
T 3coi_A 303 ALT 305 (353)
T ss_dssp HHT
T ss_pred Hhc
Confidence 975
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-38 Score=334.78 Aligned_cols=254 Identities=20% Similarity=0.273 Sum_probs=191.8
Q ss_pred ccccccCceEEEEEEECC-C-cEEEEEEeCCCCchhHHHHHHHHHHHhccCCCC------ccceEEEEEeCCceeEEEec
Q 005102 409 FVLGKSGIGIVYKVVLED-G-HTLAVRRLGEGGSQRFKEFQTEVEAIGKIRHSN------IVTLRAYYWSVDEKLLIYDY 480 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~~-g-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n------iv~l~~~~~~~~~~~lV~e~ 480 (714)
+.||+|+||.||+|.... + +.||||+++... ...+.+.+|++++++++|++ ++.+++++...+..++||||
T Consensus 25 ~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~ 103 (355)
T 2eu9_A 25 GNLGEGTFGKVVECLDHARGKSQVALKIIRNVG-KYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHMCIAFEL 103 (355)
T ss_dssp EEEEEETTEEEEEEEETTTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTEEEEEEEC
T ss_pred EEeeccCCeEEEEEEecCCCceEEEEEEEcccc-cchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCeEEEEEec
Confidence 479999999999999753 4 689999997543 33467889999999998766 99999999999999999999
Q ss_pred cCCCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeee-------------------
Q 005102 481 IPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILL------------------- 541 (714)
Q Consensus 481 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl------------------- 541 (714)
+ ++++.+++..... ..+++.++..|+.||+.||+|||+ .+|+||||||+|||+
T Consensus 104 ~-~~~l~~~l~~~~~----~~~~~~~~~~i~~qi~~~L~~lH~---~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~~~ 175 (355)
T 2eu9_A 104 L-GKNTFEFLKENNF----QPYPLPHVRHMAYQLCHALRFLHE---NQLTHTDLKPENILFVNSEFETLYNEHKSCEEKS 175 (355)
T ss_dssp C-CCBHHHHHHHTTT----CCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEESCCCEEEEECCC-CCCEEE
T ss_pred c-CCChHHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEecccccccccccccccccc
Confidence 9 6677777765432 458999999999999999999999 899999999999999
Q ss_pred CCCCCeEEcccchhhhhhccCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHH
Q 005102 542 GHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYS 621 (714)
Q Consensus 542 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS 621 (714)
+.++.+||+|||+++.... ......||+.|+|||++.+..++.++||||
T Consensus 176 ~~~~~~kl~Dfg~~~~~~~-------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s 224 (355)
T 2eu9_A 176 VKNTSIRVADFGSATFDHE-------------------------------HHTTIVATRHYRPPEVILELGWAQPCDVWS 224 (355)
T ss_dssp ESCCCEEECCCTTCEETTS-------------------------------CCCSSCSCGGGCCHHHHTTCCCCTHHHHHH
T ss_pred cCCCcEEEeecCccccccc-------------------------------cccCCcCCCcccCCeeeecCCCCCccchHH
Confidence 5678999999999975321 112345789999999999999999999999
Q ss_pred HHHHHHHHHhCCCccccCCCCcchhHHHHHHHHhhc--------CCcccccC--------------------CCCCCCCC
Q 005102 622 YGVILLEMITGRTAVVQVGSSEMDLVNWMQLCIEEK--------KPLADVLD--------------------PYLAPDAD 673 (714)
Q Consensus 622 ~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~--------~~~~~~~d--------------------~~~~~~~~ 673 (714)
|||++|||++|+.||.... ..+....+....... ........ +.......
T Consensus 225 lG~il~el~~g~~pf~~~~--~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (355)
T 2eu9_A 225 IGCILFEYYRGFTLFQTHE--NREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQ 302 (355)
T ss_dssp HHHHHHHHHHSSCSCCCSS--HHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSC
T ss_pred HHHHHHHHHhCCCCCCCCC--HHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccc
Confidence 9999999999999995322 222222221111100 00000000 00000011
Q ss_pred cHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 005102 674 KEEEIIAVLKIAMACVHSSPEKRPTMRHISD 704 (714)
Q Consensus 674 ~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 704 (714)
.......+.+++.+||+.||++|||++|+++
T Consensus 303 ~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~ 333 (355)
T 2eu9_A 303 DSLEHVQLFDLMRRMLEFDPAQRITLAEALL 333 (355)
T ss_dssp CSHHHHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred cchhHHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 1233557889999999999999999999874
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=332.70 Aligned_cols=264 Identities=20% Similarity=0.267 Sum_probs=191.0
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeCCCCc-hhHHHHHHHHHHHhccCCCCccceEEEEEeC-----CceeEEEecc
Q 005102 409 FVLGKSGIGIVYKVVLE-DGHTLAVRRLGEGGS-QRFKEFQTEVEAIGKIRHSNIVTLRAYYWSV-----DEKLLIYDYI 481 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~-----~~~~lV~e~~ 481 (714)
+.||+|+||.||+|.+. +|+.||||++..... .....+.+|++++++++||||+++++++... ...++||||+
T Consensus 17 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~ 96 (353)
T 2b9h_A 17 SLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELM 96 (353)
T ss_dssp EEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCEEEEECCC
T ss_pred eEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceEEEEEecc
Confidence 47999999999999986 589999999975433 3346788999999999999999999998754 5789999999
Q ss_pred CCCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhcc
Q 005102 482 PNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIA 561 (714)
Q Consensus 482 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 561 (714)
. |+|.+++... .+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++.....
T Consensus 97 ~-~~L~~~~~~~-------~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~ 165 (353)
T 2b9h_A 97 Q-TDLHRVISTQ-------MLSDDHIQYFIYQTLRAVKVLHG---SNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDES 165 (353)
T ss_dssp S-EEHHHHHHHC-------CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCTTCEECC--
T ss_pred C-ccHHHHHhhc-------CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEEcCCCcEEEEecccccccccc
Confidence 7 6999988643 48999999999999999999999 89999999999999999999999999999876432
Q ss_pred CCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCC-CCCCchhhhHHHHHHHHHHHhCCCccccCC
Q 005102 562 GGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKV-VKPSQKWDIYSYGVILLEMITGRTAVVQVG 640 (714)
Q Consensus 562 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DVwS~Gvvl~elltG~~p~~~~~ 640 (714)
....... ...........||+.|+|||++.+ ..++.++|||||||++|||++|+.||....
T Consensus 166 ~~~~~~~------------------~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 227 (353)
T 2b9h_A 166 AADNSEP------------------TGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRD 227 (353)
T ss_dssp --------------------------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred cccccCc------------------cccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 1100000 000111234567999999998754 678999999999999999999999995332
Q ss_pred CCcchhHHHHHHHHhhcCC---cc--------cccC--CCCCCCCCc----HHHHHHHHHHHhHccCCCCCCCCCHHHHH
Q 005102 641 SSEMDLVNWMQLCIEEKKP---LA--------DVLD--PYLAPDADK----EEEIIAVLKIAMACVHSSPEKRPTMRHIS 703 (714)
Q Consensus 641 ~~~~~l~~~~~~~~~~~~~---~~--------~~~d--~~~~~~~~~----~~~~~~l~~li~~Cl~~dP~~RPt~~evl 703 (714)
..+....+......... .. +... +... .... ......+.+++.+||+.||++|||++|++
T Consensus 228 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell 304 (353)
T 2b9h_A 228 --YRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYP-AAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEAL 304 (353)
T ss_dssp --HHHHHHHHHHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCC-CCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred --cHHHHHHHHHHhCCCchhccccccccchhhHHhhcccCCC-CcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHh
Confidence 11111111111110000 00 0000 0000 0000 01223678999999999999999999998
Q ss_pred H
Q 005102 704 D 704 (714)
Q Consensus 704 ~ 704 (714)
+
T Consensus 305 ~ 305 (353)
T 2b9h_A 305 E 305 (353)
T ss_dssp T
T ss_pred c
Confidence 6
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=341.61 Aligned_cols=244 Identities=21% Similarity=0.272 Sum_probs=180.9
Q ss_pred ccccccCceEEEEEEECCCcEEEEEEeCCCCchhHHHHHHHHHHHhcc-CCCCccceEEEEEeCCceeEEEeccCCCCHh
Q 005102 409 FVLGKSGIGIVYKVVLEDGHTLAVRRLGEGGSQRFKEFQTEVEAIGKI-RHSNIVTLRAYYWSVDEKLLIYDYIPNGSLA 487 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~e~~~~gsL~ 487 (714)
++||+|+||+||.....+|+.||||++...... .+.+|+++++++ +|||||++++++.+.+..|+||||+. |+|.
T Consensus 30 ~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~~---~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~-g~L~ 105 (432)
T 3p23_A 30 DVLGHGAEGTIVYRGMFDNRDVAVKRILPECFS---FADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA-ATLQ 105 (432)
T ss_dssp EEEEECGGGCEEEEEESSSSEEEEEEECTTTEE---ECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECCS-EEHH
T ss_pred CeeecCcCEEEEEEEEeCCeEEEEEEECHHHHH---HHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECCC-CCHH
Confidence 489999999976666667999999999765432 356899999999 79999999999999999999999996 6999
Q ss_pred hhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCC-----CCCeEEcccchhhhhhccC
Q 005102 488 TALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGH-----NMEPHVSDFGLARLANIAG 562 (714)
Q Consensus 488 ~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~-----~~~~kl~DFGla~~~~~~~ 562 (714)
+++..... ..++..+..|+.||+.||+|||+ .+|+||||||+|||++. ...+||+|||+|+......
T Consensus 106 ~~l~~~~~-----~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~ 177 (432)
T 3p23_A 106 EYVEQKDF-----AHLGLEPITLLQQTTSGLAHLHS---LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGR 177 (432)
T ss_dssp HHHHSSSC-----CCCSSCHHHHHHHHHHHHHHHHH---TTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC----
T ss_pred HHHHhcCC-----CccchhHHHHHHHHHHHHHHHHH---CcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCCC
Confidence 99986642 24455678999999999999999 89999999999999943 3468899999998654221
Q ss_pred CCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccC---CCCCCchhhhHHHHHHHHHHHh-CCCcccc
Q 005102 563 GSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLK---VVKPSQKWDIYSYGVILLEMIT-GRTAVVQ 638 (714)
Q Consensus 563 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~~~DVwS~Gvvl~ellt-G~~p~~~ 638 (714)
.. ........||+.|+|||++. ...++.++|||||||++|||+| |+.||..
T Consensus 178 ~~-------------------------~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~ 232 (432)
T 3p23_A 178 HS-------------------------FSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGK 232 (432)
T ss_dssp ---------------------------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBS
T ss_pred cc-------------------------eeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcch
Confidence 00 11223456899999999997 4567889999999999999999 8989832
Q ss_pred CCCCcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 005102 639 VGSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISD 704 (714)
Q Consensus 639 ~~~~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 704 (714)
.... .... ...... . .... ........+.+++.+||+.||++|||++||++
T Consensus 233 ~~~~------~~~~-~~~~~~-~----~~~~---~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 233 SLQR------QANI-LLGACS-L----DCLH---PEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp TTTH------HHHH-HTTCCC-C----TTSC---TTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hhHH------HHHH-HhccCC-c----cccC---ccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 2111 1111 111111 0 0011 11123445789999999999999999999983
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=329.43 Aligned_cols=250 Identities=21% Similarity=0.279 Sum_probs=172.3
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeCCCC-chhHHHHHHHHH-HHhccCCCCccceEEEEEeCCceeEEEeccCCCC
Q 005102 409 FVLGKSGIGIVYKVVLE-DGHTLAVRRLGEGG-SQRFKEFQTEVE-AIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGS 485 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~-~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gs 485 (714)
+.||+|+||.||+|... +|+.||||++.... .....++.+|+. +++.++||||+++++++...+..++||||+++ +
T Consensus 28 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e~~~~-~ 106 (327)
T 3aln_A 28 GEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMST-S 106 (327)
T ss_dssp CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEECCCSE-E
T ss_pred heeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEeecCC-C
Confidence 47999999999999985 58999999997653 233455666766 67788999999999999999999999999975 8
Q ss_pred HhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCC-CceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCC
Q 005102 486 LATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPK-KYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGS 564 (714)
Q Consensus 486 L~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~-~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 564 (714)
|.+++...... ....+++..+.+++.|++.||.|||+ . +|+||||||+||+++.++.+||+|||+++......
T Consensus 107 l~~~~~~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~---~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~-- 180 (327)
T 3aln_A 107 FDKFYKYVYSV-LDDVIPEEILGKITLATVKALNHLKE---NLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSI-- 180 (327)
T ss_dssp HHHHHHHHHHT-TCCCCCHHHHHHHHHHHHHHHHHHHH---HHSCCCSCCCGGGEEEETTTEEEECCCSSSCC-------
T ss_pred hHHHHHHHHhh-hcccCcHHHHHHHHHHHHHHHHHHhc---cCCEeECCCCHHHEEEcCCCCEEEccCCCceeccccc--
Confidence 88777531000 01458999999999999999999999 8 99999999999999999999999999987653211
Q ss_pred CCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCccc----CCCCCCchhhhHHHHHHHHHHHhCCCccccCC
Q 005102 565 PTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESL----KVVKPSQKWDIYSYGVILLEMITGRTAVVQVG 640 (714)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~s~~~DVwS~Gvvl~elltG~~p~~~~~ 640 (714)
......||+.|+|||.+ .+..++.++||||||+++|||++|+.||....
T Consensus 181 ---------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 233 (327)
T 3aln_A 181 ---------------------------AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWN 233 (327)
T ss_dssp ----------------------------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-
T ss_pred ---------------------------ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcc
Confidence 11122468889999998 45678999999999999999999999995322
Q ss_pred CCcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 005102 641 SSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISD 704 (714)
Q Consensus 641 ~~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 704 (714)
.... .+ .. ......+.+.... .......+.+++.+||+.||++|||++|+++
T Consensus 234 ~~~~----~~----~~---~~~~~~~~~~~~~-~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 234 SVFD----QL----TQ---VVKGDPPQLSNSE-EREFSPSFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp --------------CC---CCCSCCCCCCCCS-SCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred hHHH----HH----HH---HhcCCCCCCCCcc-cccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence 1110 00 00 0000011111100 0012236889999999999999999999875
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-38 Score=337.12 Aligned_cols=256 Identities=17% Similarity=0.223 Sum_probs=190.8
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeCCCCchhHHHHHHHHHHHhccC-----------CCCccceEEEEEeCC----
Q 005102 409 FVLGKSGIGIVYKVVLE-DGHTLAVRRLGEGGSQRFKEFQTEVEAIGKIR-----------HSNIVTLRAYYWSVD---- 472 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------H~niv~l~~~~~~~~---- 472 (714)
+.||+|+||.||+|+.. +++.||||++.... ...+.+.+|++++++++ ||||+++++++...+
T Consensus 25 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 103 (373)
T 1q8y_A 25 RKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGV 103 (373)
T ss_dssp EEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEETTEE
T ss_pred EeeeecCCeEEEEEEecCCCcEEEEEEecCCc-cchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhccCCCCc
Confidence 47999999999999974 58999999997542 33467889999999886 899999999998654
Q ss_pred ceeEEEeccCCCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCC-CceecCCCCCCeeeC------CCC
Q 005102 473 EKLLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPK-KYVHGDLKPSNILLG------HNM 545 (714)
Q Consensus 473 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~-~ivHrDlkp~NILl~------~~~ 545 (714)
..++||||+ +++|.+++..... ..+++..+..|+.||+.||+|||+ + +|+||||||+|||++ ..+
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~~~~----~~~~~~~~~~i~~qi~~aL~~lH~---~~~ivH~Dikp~NIll~~~~~~~~~~ 175 (373)
T 1q8y_A 104 HVVMVFEVL-GENLLALIKKYEH----RGIPLIYVKQISKQLLLGLDYMHR---RCGIIHTDIKPENVLMEIVDSPENLI 175 (373)
T ss_dssp EEEEEECCC-CEEHHHHHHHTTT----SCCCHHHHHHHHHHHHHHHHHHHH---TTCEECSCCSGGGEEEEEEETTTTEE
T ss_pred eEEEEEecC-CCCHHHHHHHhhc----cCCcHHHHHHHHHHHHHHHHHHHh---cCCEEecCCChHHeEEeccCCCcCcc
Confidence 679999999 8899999976432 458999999999999999999999 8 999999999999994 445
Q ss_pred CeEEcccchhhhhhccCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHH
Q 005102 546 EPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVI 625 (714)
Q Consensus 546 ~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvv 625 (714)
.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||+
T Consensus 176 ~~kl~Dfg~a~~~~~~-------------------------------~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i 224 (373)
T 1q8y_A 176 QIKIADLGNACWYDEH-------------------------------YTNSIQTREYRSPEVLLGAPWGCGADIWSTACL 224 (373)
T ss_dssp EEEECCCTTCEETTBC-------------------------------CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHH
T ss_pred eEEEcccccccccCCC-------------------------------CCCCCCCccccCcHHHhCCCCCchHhHHHHHHH
Confidence 8999999999765321 122356889999999999999999999999999
Q ss_pred HHHHHhCCCccccCCCCcc-hhHHHHHHHHhhcCCcc-----------cccCC------CCCC------------CCCcH
Q 005102 626 LLEMITGRTAVVQVGSSEM-DLVNWMQLCIEEKKPLA-----------DVLDP------YLAP------------DADKE 675 (714)
Q Consensus 626 l~elltG~~p~~~~~~~~~-~l~~~~~~~~~~~~~~~-----------~~~d~------~~~~------------~~~~~ 675 (714)
+|||+||+.||........ .....+......-.... ..++. .... .....
T Consensus 225 l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (373)
T 1q8y_A 225 IFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSK 304 (373)
T ss_dssp HHHHHHSSCCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCH
T ss_pred HHHHHhCCCCCCCCcccccCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCc
Confidence 9999999999954322110 00111111111000000 00000 0000 00123
Q ss_pred HHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 005102 676 EEIIAVLKIAMACVHSSPEKRPTMRHISD 704 (714)
Q Consensus 676 ~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 704 (714)
.....+.+++.+||+.||++|||++|+++
T Consensus 305 ~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 333 (373)
T 1q8y_A 305 DEAKEISDFLSPMLQLDPRKRADAGGLVN 333 (373)
T ss_dssp HHHHHHHHHHGGGGCSSTTTCBCHHHHHT
T ss_pred chHHHHHHHHHHHhccCccccCCHHHHhh
Confidence 45668899999999999999999999976
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-37 Score=323.22 Aligned_cols=244 Identities=21% Similarity=0.322 Sum_probs=173.8
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeCCCCch-hH-HHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCCC
Q 005102 409 FVLGKSGIGIVYKVVLE-DGHTLAVRRLGEGGSQ-RF-KEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGS 485 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~-~~-~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gs 485 (714)
+.||+|+||.||+|.+. +|+.||||++...... .. +.+..+..+++.++||||+++++++...+..++||||+ ++.
T Consensus 31 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~ 109 (318)
T 2dyl_A 31 GEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELM-GTC 109 (318)
T ss_dssp EEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCC-SEE
T ss_pred ceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEecc-CCc
Confidence 47999999999999986 5899999999765332 22 33445556788889999999999999999999999999 555
Q ss_pred HhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCC-CceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCC
Q 005102 486 LATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPK-KYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGS 564 (714)
Q Consensus 486 L~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~-~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 564 (714)
+..+..... ..+++..+..++.|++.||+|||+ . +|+||||||+||+++.++.+||+|||+++......
T Consensus 110 ~~~l~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~---~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~-- 179 (318)
T 2dyl_A 110 AEKLKKRMQ-----GPIPERILGKMTVAIVKALYYLKE---KHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDK-- 179 (318)
T ss_dssp HHHHHHHHT-----SCCCHHHHHHHHHHHHHHHHHHHH---HHCCCCCCCCGGGEEECTTSCEEECCCTTC---------
T ss_pred HHHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHHh---hCCEEeCCCCHHHEEECCCCCEEEEECCCchhccCCc--
Confidence 655554322 458999999999999999999998 6 99999999999999999999999999987553211
Q ss_pred CCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccC-----CCCCCchhhhHHHHHHHHHHHhCCCccccC
Q 005102 565 PTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLK-----VVKPSQKWDIYSYGVILLEMITGRTAVVQV 639 (714)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~~DVwS~Gvvl~elltG~~p~~~~ 639 (714)
......||+.|+|||.+. ...++.++||||||+++|||++|+.||...
T Consensus 180 ---------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 232 (318)
T 2dyl_A 180 ---------------------------AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNC 232 (318)
T ss_dssp ----------------------------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred ---------------------------cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCC
Confidence 111234688899999994 456899999999999999999999999543
Q ss_pred CCCcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 005102 640 GSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISD 704 (714)
Q Consensus 640 ~~~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 704 (714)
... ...+......... ....... ....+.+++.+||+.||++|||++|+++
T Consensus 233 ~~~----~~~~~~~~~~~~~-------~~~~~~~---~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (318)
T 2dyl_A 233 KTD----FEVLTKVLQEEPP-------LLPGHMG---FSGDFQSFVKDCLTKDHRKRPKYNKLLE 283 (318)
T ss_dssp CSH----HHHHHHHHHSCCC-------CCCSSSC---CCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred Ccc----HHHHHHHhccCCC-------CCCccCC---CCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 221 1222222222211 1111000 1235789999999999999999999875
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-38 Score=331.64 Aligned_cols=233 Identities=19% Similarity=0.277 Sum_probs=188.4
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeCCCCch------hHHHHHHHHHHHhccC--CCCccceEEEEEeCCceeEEEe
Q 005102 409 FVLGKSGIGIVYKVVLE-DGHTLAVRRLGEGGSQ------RFKEFQTEVEAIGKIR--HSNIVTLRAYYWSVDEKLLIYD 479 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~--H~niv~l~~~~~~~~~~~lV~e 479 (714)
+.||+|+||.||+|+.. +++.||||++...... ..+.+.+|+.++++++ ||||+++++++...+..++|||
T Consensus 49 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~~~~~lv~e 128 (320)
T 3a99_A 49 PLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILE 128 (320)
T ss_dssp EECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEEEEEEE
T ss_pred EEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecCCcEEEEEE
Confidence 47999999999999975 5899999998764221 1245678999999996 5999999999999999999999
Q ss_pred ccCC-CCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeC-CCCCeEEcccchhhh
Q 005102 480 YIPN-GSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLG-HNMEPHVSDFGLARL 557 (714)
Q Consensus 480 ~~~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~-~~~~~kl~DFGla~~ 557 (714)
|+.+ ++|.+++... ..+++..+..++.|++.||+|||+ .+|+||||||+|||++ +++.+||+|||+++.
T Consensus 129 ~~~~~~~L~~~l~~~------~~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~~kL~Dfg~~~~ 199 (320)
T 3a99_A 129 RPEPVQDLFDFITER------GALQEELARSFFWQVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSGAL 199 (320)
T ss_dssp CCSSEEEHHHHHHHH------CSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred cCCCCccHHHHHhcc------CCCCHHHHHHHHHHHHHHHHHHHH---CCcEeCCCCHHHEEEeCCCCCEEEeeCccccc
Confidence 9976 8999998764 458999999999999999999999 8999999999999999 789999999999876
Q ss_pred hhccCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCC-CchhhhHHHHHHHHHHHhCCCcc
Q 005102 558 ANIAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKP-SQKWDIYSYGVILLEMITGRTAV 636 (714)
Q Consensus 558 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~~DVwS~Gvvl~elltG~~p~ 636 (714)
.... ......||+.|+|||++.+..+ +.++||||||+++|||++|+.||
T Consensus 200 ~~~~------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf 249 (320)
T 3a99_A 200 LKDT------------------------------VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF 249 (320)
T ss_dssp CCSS------------------------------CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSC
T ss_pred cccc------------------------------cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCC
Confidence 4321 1122347889999999977665 78899999999999999999999
Q ss_pred ccCCCCcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 005102 637 VQVGSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISD 704 (714)
Q Consensus 637 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 704 (714)
... . ........ ..... ..++.+++.+||+.||++|||++|+++
T Consensus 250 ~~~----~-------~~~~~~~~--------~~~~~-----~~~~~~li~~~l~~dp~~Rps~~~ll~ 293 (320)
T 3a99_A 250 EHD----E-------EIIRGQVF--------FRQRV-----SSECQHLIRWCLALRPSDRPTFEEIQN 293 (320)
T ss_dssp CSH----H-------HHHHCCCC--------CSSCC-----CHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCh----h-------hhhccccc--------ccccC-----CHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 321 0 01111110 11111 135789999999999999999999986
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-38 Score=328.23 Aligned_cols=233 Identities=19% Similarity=0.282 Sum_probs=183.6
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeCCCCch------hHHHHHHHHHHHhcc----CCCCccceEEEEEeCCceeEE
Q 005102 409 FVLGKSGIGIVYKVVLE-DGHTLAVRRLGEGGSQ------RFKEFQTEVEAIGKI----RHSNIVTLRAYYWSVDEKLLI 477 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~------~~~~~~~E~~~l~~l----~H~niv~l~~~~~~~~~~~lV 477 (714)
+.||+|+||.||+|+.. +++.||||++...... ....+.+|+.++.++ +||||+++++++...+..++|
T Consensus 37 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~~~~~~~~v 116 (312)
T 2iwi_A 37 PLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQEGFMLV 116 (312)
T ss_dssp EEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC-----CEEE
T ss_pred eEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEecCCeEEEE
Confidence 47999999999999874 5889999999765321 223466799999998 899999999999999999999
Q ss_pred Eec-cCCCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeC-CCCCeEEcccchh
Q 005102 478 YDY-IPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLG-HNMEPHVSDFGLA 555 (714)
Q Consensus 478 ~e~-~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~-~~~~~kl~DFGla 555 (714)
||| +.+++|.+++... ..+++..+..++.|++.||+|||+ .+|+||||||+||+++ +++.+||+|||++
T Consensus 117 ~e~~~~~~~L~~~l~~~------~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~kl~dfg~~ 187 (312)
T 2iwi_A 117 LERPLPAQDLFDYITEK------GPLGEGPSRCFFGQVVAAIQHCHS---RGVVHRDIKDENILIDLRRGCAKLIDFGSG 187 (312)
T ss_dssp EECCSSEEEHHHHHHHH------CSCCHHHHHHHHHHHHHHHHHHHH---HTEECCCCSGGGEEEETTTTEEEECCCSSC
T ss_pred EEecCCCCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChhhEEEeCCCCeEEEEEcchh
Confidence 999 7899999999764 458999999999999999999999 8999999999999999 8899999999998
Q ss_pred hhhhccCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCC-CchhhhHHHHHHHHHHHhCCC
Q 005102 556 RLANIAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKP-SQKWDIYSYGVILLEMITGRT 634 (714)
Q Consensus 556 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~~DVwS~Gvvl~elltG~~ 634 (714)
+..... ......||..|+|||++.+..+ +.++||||||+++|||++|+.
T Consensus 188 ~~~~~~------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~ 237 (312)
T 2iwi_A 188 ALLHDE------------------------------PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDI 237 (312)
T ss_dssp EECCSS------------------------------CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSC
T ss_pred hhcccC------------------------------cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCC
Confidence 765321 1123346888999999876666 458999999999999999999
Q ss_pred ccccCCCCcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 005102 635 AVVQVGSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISD 704 (714)
Q Consensus 635 p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 704 (714)
||... . ........ .... ....+.+++.+||+.||++|||++|+++
T Consensus 238 pf~~~----~-------~~~~~~~~--------~~~~-----~~~~~~~li~~~l~~~p~~Rps~~e~l~ 283 (312)
T 2iwi_A 238 PFERD----Q-------EILEAELH--------FPAH-----VSPDCCALIRRCLAPKPSSRPSLEEILL 283 (312)
T ss_dssp SCCSH----H-------HHHHTCCC--------CCTT-----SCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred CCCCh----H-------HHhhhccC--------Cccc-----CCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 99321 0 01111111 1111 1235789999999999999999999986
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-37 Score=316.46 Aligned_cols=226 Identities=11% Similarity=0.079 Sum_probs=177.8
Q ss_pred ccccccCceEEEEEEECC-CcEEEEEEeCCCCc---hhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCC
Q 005102 409 FVLGKSGIGIVYKVVLED-GHTLAVRRLGEGGS---QRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNG 484 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~~-g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~g 484 (714)
+.||+|+||.||+|++.. ++.||||++..... ...+.+.+|+.++++++||||+++++++...+..|+||||++++
T Consensus 37 ~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~g~ 116 (286)
T 3uqc_A 37 IFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVAEWIRGG 116 (286)
T ss_dssp EEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCCEE
T ss_pred EEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEEEecCCC
Confidence 479999999999999865 89999999986532 33467999999999999999999999999999999999999999
Q ss_pred CHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCC
Q 005102 485 SLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGS 564 (714)
Q Consensus 485 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 564 (714)
+|.+++... ....++.+|+.|++.||+|||+ ++|+||||||+|||+++++.+||+++|
T Consensus 117 ~L~~~l~~~--------~~~~~~~~i~~ql~~aL~~lH~---~givH~Dikp~NIll~~~g~~kl~~~~----------- 174 (286)
T 3uqc_A 117 SLQEVADTS--------PSPVGAIRAMQSLAAAADAAHR---AGVALSIDHPSRVRVSIDGDVVLAYPA----------- 174 (286)
T ss_dssp EHHHHHTTC--------CCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEEETTSCEEECSCC-----------
T ss_pred CHHHHHhcC--------CChHHHHHHHHHHHHHHHHHHH---CCCccCCCCcccEEEcCCCCEEEEecc-----------
Confidence 999999532 3456788999999999999999 899999999999999999999998554
Q ss_pred CCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCccccCCCCcc
Q 005102 565 PTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGSSEM 644 (714)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~~~~~~~~~ 644 (714)
|++| ++.++|||||||++|||+||+.||........
T Consensus 175 -------------------------------------~~~~-------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~ 210 (286)
T 3uqc_A 175 -------------------------------------TMPD-------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSG 210 (286)
T ss_dssp -------------------------------------CCTT-------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCC
T ss_pred -------------------------------------ccCC-------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchh
Confidence 4543 68999999999999999999999954322110
Q ss_pred hhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhhhhcc
Q 005102 645 DLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDALDRLIVS 712 (714)
Q Consensus 645 ~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~~ 712 (714)
... .. ..............+ ....++.+++.+||+.||++| |++|+++.|+++...
T Consensus 211 ~~~-~~-~~~~~~~~~~~~~~~---------~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~ 266 (286)
T 3uqc_A 211 LAP-AE-RDTAGQPIEPADIDR---------DIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAV 266 (286)
T ss_dssp SEE-CC-BCTTSCBCCHHHHCT---------TSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC-
T ss_pred hHH-HH-HHhccCCCChhhccc---------CCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhcc
Confidence 000 00 000000000000001 122358899999999999999 999999999997654
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-37 Score=348.96 Aligned_cols=263 Identities=24% Similarity=0.299 Sum_probs=195.7
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeCCC-CchhHHHHHHHHHHHhccCCCCccceEEEEEe------CCceeEEEec
Q 005102 409 FVLGKSGIGIVYKVVLE-DGHTLAVRRLGEG-GSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWS------VDEKLLIYDY 480 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~------~~~~~lV~e~ 480 (714)
+.||+|+||.||+|.+. +|+.||||++... .....+.+.+|++++++++||||+++++++.. .+..++||||
T Consensus 20 ~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~~LVmEy 99 (676)
T 3qa8_A 20 ERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEY 99 (676)
T ss_dssp CCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSCCCEEEC
T ss_pred EEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeEEEEEEe
Confidence 47999999999999975 5899999998765 33445679999999999999999999999765 6677999999
Q ss_pred cCCCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCC---eEEcccchhhh
Q 005102 481 IPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNME---PHVSDFGLARL 557 (714)
Q Consensus 481 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~---~kl~DFGla~~ 557 (714)
+++|+|.+++...... ..+++..+..|+.|++.||+|||+ .+|+||||||+||+++.++. +||+|||+++.
T Consensus 100 ~~ggsL~~~L~~~~~~---~~lse~~i~~I~~QLl~aL~yLHs---~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a~~ 173 (676)
T 3qa8_A 100 CEGGDLRKYLNQFENC---CGLKEGPIRTLLSDISSALRYLHE---NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKE 173 (676)
T ss_dssp CSSCBHHHHHHSSSCT---TCCCSSHHHHHHHHHHHHHHHHHH---TTBCCCCCCSTTEEEECCSSSCEEEECSCCCCCB
T ss_pred CCCCCHHHHHHhcccC---CCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHeEeecCCCceeEEEcccccccc
Confidence 9999999999865322 358899999999999999999999 89999999999999997665 89999999986
Q ss_pred hhccCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCccc
Q 005102 558 ANIAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVV 637 (714)
Q Consensus 558 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~~ 637 (714)
..... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||.
T Consensus 174 ~~~~~-----------------------------~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~ 224 (676)
T 3qa8_A 174 LDQGE-----------------------------LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFL 224 (676)
T ss_dssp TTSCC-----------------------------CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCC
T ss_pred ccccc-----------------------------ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCC
Confidence 53211 1123457889999999999999999999999999999999999994
Q ss_pred cCCCCcchhHHHHHHHH---hhcCCcccccCC------CCC-CCCCcHHHHHHHHHHHhHccCCCCCCCCCHHH-----H
Q 005102 638 QVGSSEMDLVNWMQLCI---EEKKPLADVLDP------YLA-PDADKEEEIIAVLKIAMACVHSSPEKRPTMRH-----I 702 (714)
Q Consensus 638 ~~~~~~~~l~~~~~~~~---~~~~~~~~~~d~------~~~-~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~e-----v 702 (714)
... ....|..... .......+.... ... +..........+.+++.+||..||++|||++| .
T Consensus 225 ~~~----~~~~~~~~i~~~~~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~ 300 (676)
T 3qa8_A 225 PNW----QPVQWHGKVREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGC 300 (676)
T ss_dssp SSC----HHHHSSTTCC------CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTT
T ss_pred ccc----chhhhhhhhhcccchhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHH
Confidence 321 1111110000 000000000000 000 01111234567889999999999999999987 4
Q ss_pred HHHHhhhh
Q 005102 703 SDALDRLI 710 (714)
Q Consensus 703 l~~L~~i~ 710 (714)
.+.++.+.
T Consensus 301 F~~l~~iL 308 (676)
T 3qa8_A 301 FQALDSIL 308 (676)
T ss_dssp HHHHHHHH
T ss_pred HHHHHHHH
Confidence 45555554
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=353.35 Aligned_cols=233 Identities=21% Similarity=0.288 Sum_probs=186.6
Q ss_pred ccccccCceEEEEEEEC--CCcEEEEEEeCCCC-chhHHHHHHHHHHHhccCCCCccceEEEEEeCCc-----eeEEEec
Q 005102 409 FVLGKSGIGIVYKVVLE--DGHTLAVRRLGEGG-SQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDE-----KLLIYDY 480 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~--~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~-----~~lV~e~ 480 (714)
..||+|+||.||+|++. +|+.||||++.... ......+.+|++++++++||||+++++++...+. .|+||||
T Consensus 86 ~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~lv~E~ 165 (681)
T 2pzi_A 86 GCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEY 165 (681)
T ss_dssp EEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEEEEEEEC
T ss_pred EEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCceeEEEEEe
Confidence 47999999999999986 58999999987543 3445678999999999999999999999988765 6999999
Q ss_pred cCCCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhc
Q 005102 481 IPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANI 560 (714)
Q Consensus 481 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 560 (714)
+++++|.+++.. .+++.+++.|+.||+.||+|||+ ++|+||||||+|||++++ .+||+|||+++....
T Consensus 166 ~~g~~L~~~~~~--------~l~~~~~~~~~~qi~~aL~~lH~---~giiHrDlkp~NIll~~~-~~kl~DFG~a~~~~~ 233 (681)
T 2pzi_A 166 VGGQSLKRSKGQ--------KLPVAEAIAYLLEILPALSYLHS---IGLVYNDLKPENIMLTEE-QLKLIDLGAVSRINS 233 (681)
T ss_dssp CCCEECC----C--------CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECSS-CEEECCCTTCEETTC
T ss_pred CCCCcHHHHHhC--------CCCHHHHHHHHHHHHHHHHHHHH---CCCeecccChHHeEEeCC-cEEEEecccchhccc
Confidence 999999887643 48999999999999999999999 899999999999999986 899999999875431
Q ss_pred cCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCccccCC
Q 005102 561 AGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVG 640 (714)
Q Consensus 561 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~~~~~ 640 (714)
.....||+.|+|||++.+. ++.++|||||||++|||++|..||....
T Consensus 234 --------------------------------~~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~ 280 (681)
T 2pzi_A 234 --------------------------------FGYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRY 280 (681)
T ss_dssp --------------------------------CSCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEE
T ss_pred --------------------------------CCccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCcccc
Confidence 1234578999999998765 4899999999999999999998883211
Q ss_pred CCcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCC-CHHHHHHHHhhhh
Q 005102 641 SSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRP-TMRHISDALDRLI 710 (714)
Q Consensus 641 ~~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RP-t~~evl~~L~~i~ 710 (714)
... +............+.+++.+||+.||++|| +++++...|..+.
T Consensus 281 ~~~------------------------~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~ 327 (681)
T 2pzi_A 281 VDG------------------------LPEDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVL 327 (681)
T ss_dssp CSS------------------------CCTTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred ccc------------------------ccccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHH
Confidence 000 000111112334688999999999999999 5677777777653
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-36 Score=319.72 Aligned_cols=253 Identities=29% Similarity=0.553 Sum_probs=203.8
Q ss_pred CCchhHHHHHHHHHHhccCCCCCCCCCCCCCCCCCCc--ccceEecC----CcEEEEEcCCCCccc--cCCccccCCCCC
Q 005102 19 DSLNGEGYALLSFKQSVHEDPEGSLSNWNSSDENPCS--WNGITCKE----QRVVSVSIPKKKLLG--FLPSALGSLTDL 90 (714)
Q Consensus 19 ~~~~~~~~~l~~~~~~~~~~~~~~l~~w~~~~~~~c~--w~gv~c~~----~~~~~l~l~~~~l~g--~~p~~~~~l~~L 90 (714)
.|.+.|++||++||+++ .||. .+.+|..+ .+||. |.||+|+. .+|+.|+|++|+++| .+|+.|+++++|
T Consensus 2 ~c~~~~~~aL~~~k~~~-~~~~-~l~~W~~~-~~~C~~~w~gv~C~~~~~~~~l~~L~L~~~~l~~~~~~~~~l~~l~~L 78 (313)
T 1ogq_A 2 LCNPQDKQALLQIKKDL-GNPT-TLSSWLPT-TDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYL 78 (313)
T ss_dssp CSCHHHHHHHHHHHHHT-TCCG-GGTTCCTT-SCTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCGGGGGCTTC
T ss_pred CCCHHHHHHHHHHHHhc-CCcc-cccCCCCC-CCCCcCCCcceEeCCCCCCceEEEEECCCCCccCCcccChhHhCCCCC
Confidence 36778999999999999 5665 78999754 57888 99999984 799999999999999 899999999999
Q ss_pred CEEEccC-CCCcccCChhhcCCCCCCEEEcCCCcCcccCCcccCCCCCCCEEeccCccCCCCCCcccccccccceeeccc
Q 005102 91 RHVNLRN-NKFFGSLPLELLEAQGLQSLVLYGNSFSGSVPNEIGKLKYLQILDLSQNFFNGSLPVSIVQCKRLKALDLSQ 169 (714)
Q Consensus 91 ~~L~L~~-N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~ 169 (714)
++|+|++ |.+.+.+|..|.++++|++|+|++|.+++.+|..|+++++|++|+|++|++++.+|..+..+++|++|+|++
T Consensus 79 ~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~ 158 (313)
T 1ogq_A 79 NFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDG 158 (313)
T ss_dssp SEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCS
T ss_pred CeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCEEeCCCCccCCcCChHHhcCCCCCeEECcC
Confidence 9999994 999988998899999999999999988888888888888888888888888888888888888888888888
Q ss_pred CcCCCCCCcccccCcc-ccccccccCCcccccCCCC--------------------------------------------
Q 005102 170 NNFTGPLPNGFGSGLV-SLEKLNLSFNKFNGSIPSN-------------------------------------------- 204 (714)
Q Consensus 170 N~l~g~~p~~~~~~l~-~L~~L~l~~N~l~g~~p~~-------------------------------------------- 204 (714)
|+++|.+|..++. +. +|+.|+|++|++++.+|..
T Consensus 159 N~l~~~~p~~l~~-l~~~L~~L~L~~N~l~~~~~~~~~~l~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~ 237 (313)
T 1ogq_A 159 NRISGAIPDSYGS-FSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDL 237 (313)
T ss_dssp SCCEEECCGGGGC-CCTTCCEEECCSSEEEEECCGGGGGCCCSEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBG
T ss_pred CcccCcCCHHHhh-hhhcCcEEECcCCeeeccCChHHhCCcccEEECcCCcccCcCCHHHhcCCCCCEEECCCCceeeec
Confidence 8887777766643 43 5555555555554433332
Q ss_pred --CCCCcccccccccccccCCcCcCccccCCCCcccccCcCCcCCCCCCCCccccCCCCcccccCCCCCCCCCC
Q 005102 205 --TGNLSSLQGTVDFSHNLFSGSIPASLGNLPEKVYIDLTYNNLSGPIPQNGALMNRGPTAFIGNPRLCGPPLK 276 (714)
Q Consensus 205 --~~~l~~L~~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~~~~~~~~~~~~n~~~~~~~~~ 276 (714)
+..+++|+ .|++++|+|++.+|..+..+++|+.|++++|+++|.+|....+.......+.+|+.+|+.|+.
T Consensus 238 ~~~~~l~~L~-~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip~~~~l~~L~~l~l~~N~~lc~~p~~ 310 (313)
T 1ogq_A 238 GKVGLSKNLN-GLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSPLP 310 (313)
T ss_dssp GGCCCCTTCC-EEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCSTTGGGSCGGGTCSSSEEESTTSS
T ss_pred CcccccCCCC-EEECcCCcccCcCChHHhcCcCCCEEECcCCcccccCCCCccccccChHHhcCCCCccCCCCC
Confidence 23344555 677777777778888888888888888888888888888766666677788899999987764
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-35 Score=308.86 Aligned_cols=223 Identities=20% Similarity=0.268 Sum_probs=172.5
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeCCCCchhHHHHHHHHHHH-hccCCCCccceEEEEEe----CCceeEEEeccC
Q 005102 409 FVLGKSGIGIVYKVVLE-DGHTLAVRRLGEGGSQRFKEFQTEVEAI-GKIRHSNIVTLRAYYWS----VDEKLLIYDYIP 482 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l-~~l~H~niv~l~~~~~~----~~~~~lV~e~~~ 482 (714)
++||+|+||.||+|... +++.||||++... ..+.+|++++ +..+||||+++++++.. ....++||||++
T Consensus 24 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~ 98 (299)
T 3m2w_A 24 QVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLD 98 (299)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEECCCC
T ss_pred cccccCCCeEEEEEEEcCCCcEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEEEEeecC
Confidence 47999999999999985 5899999998642 4577899988 55589999999999987 667899999999
Q ss_pred CCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCC---CCCeEEcccchhhhhh
Q 005102 483 NGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGH---NMEPHVSDFGLARLAN 559 (714)
Q Consensus 483 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~---~~~~kl~DFGla~~~~ 559 (714)
+|+|.+++..... ..+++..+..|+.|++.||+|||+ .+|+||||||+||+++. ++.+||+|||+++...
T Consensus 99 ~~~L~~~l~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~ 171 (299)
T 3m2w_A 99 GGELFSRIQDRGD----QAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT 171 (299)
T ss_dssp SCBHHHHHHHCTT----CCCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECT
T ss_pred CCcHHHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEecCCCCCcEEEeccccccccc
Confidence 9999999986532 358999999999999999999999 89999999999999998 7899999999886321
Q ss_pred ccCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCccccC
Q 005102 560 IAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQV 639 (714)
Q Consensus 560 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~~~~ 639 (714)
+..++.++|||||||++|||+||+.||...
T Consensus 172 --------------------------------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~ 201 (299)
T 3m2w_A 172 --------------------------------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSN 201 (299)
T ss_dssp --------------------------------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-
T ss_pred --------------------------------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCC
Confidence 134678999999999999999999999433
Q ss_pred CCCcchhHHHHHHHHhhcCCcccccCCCCCCC-CCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 005102 640 GSSEMDLVNWMQLCIEEKKPLADVLDPYLAPD-ADKEEEIIAVLKIAMACVHSSPEKRPTMRHISD 704 (714)
Q Consensus 640 ~~~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~-~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 704 (714)
..... . . .....+........ .........+.+++.+||+.||++|||++|+++
T Consensus 202 ~~~~~---------~-~-~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~ 256 (299)
T 3m2w_A 202 HGLAI---------S-P-GMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 256 (299)
T ss_dssp ----------------C-CSCCSSCTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cchhh---------h-H-HHHHHHhhccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 21110 0 0 00000000000000 000112346889999999999999999999986
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-36 Score=328.11 Aligned_cols=237 Identities=14% Similarity=0.105 Sum_probs=172.0
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeCCCCc---hhHHHHHHHHHHHhccCC-CCcc---------ceE---------
Q 005102 409 FVLGKSGIGIVYKVVLE-DGHTLAVRRLGEGGS---QRFKEFQTEVEAIGKIRH-SNIV---------TLR--------- 465 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H-~niv---------~l~--------- 465 (714)
++||+|+||.||+|++. +|+.||||++..... ...+.|.+|+.+++.++| +|.. ...
T Consensus 84 ~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (413)
T 3dzo_A 84 TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKK 163 (413)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEECCC--
T ss_pred cccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhcccCCCC
Confidence 58999999999999965 589999999884322 224679999999999987 3211 111
Q ss_pred ---EEEEe-----CCceeEEEeccCCCCHhhhhhCCCC-CCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCC
Q 005102 466 ---AYYWS-----VDEKLLIYDYIPNGSLATALHGKPG-MVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKP 536 (714)
Q Consensus 466 ---~~~~~-----~~~~~lV~e~~~~gsL~~~l~~~~~-~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp 536 (714)
.++.. ....+++|+++ +++|.+++..... ......+++..++.|+.|+++||+|||+ ++|+||||||
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~iiHrDiKp 239 (413)
T 3dzo_A 164 KMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH---YGLVHTYLRP 239 (413)
T ss_dssp -------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHH---TTEECSCCCG
T ss_pred ccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCccc
Confidence 11111 12356777765 6899998841100 0001458889999999999999999999 8999999999
Q ss_pred CCeeeCCCCCeEEcccchhhhhhccCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCccc--------
Q 005102 537 SNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESL-------- 608 (714)
Q Consensus 537 ~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-------- 608 (714)
+|||++.++.+||+|||+++..... .....| +.|+|||++
T Consensus 240 ~NILl~~~~~~kL~DFG~a~~~~~~-------------------------------~~~~~g-~~y~aPE~~~~~~~~~~ 287 (413)
T 3dzo_A 240 VDIVLDQRGGVFLTGFEHLVRDGAS-------------------------------AVSPIG-RGFAPPETTAERMLPFG 287 (413)
T ss_dssp GGEEECTTCCEEECCGGGCEETTEE-------------------------------ECCCCC-TTTCCHHHHHHHTSTTG
T ss_pred ceEEEecCCeEEEEeccceeecCCc-------------------------------cccCCC-CceeCchhhhccccccc
Confidence 9999999999999999998754321 223345 789999999
Q ss_pred --CCCCCCchhhhHHHHHHHHHHHhCCCccccCCCCcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHh
Q 005102 609 --KVVKPSQKWDIYSYGVILLEMITGRTAVVQVGSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAM 686 (714)
Q Consensus 609 --~~~~~s~~~DVwS~Gvvl~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~ 686 (714)
.+..++.++|||||||++|||+||+.||....... ....++... ... ...+.+++.
T Consensus 288 ~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~---------------~~~~~~~~~--~~~-----~~~~~~li~ 345 (413)
T 3dzo_A 288 QHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALG---------------GSEWIFRSC--KNI-----PQPVRALLE 345 (413)
T ss_dssp GGCCEEECHHHHHHHHHHHHHHHHHSSCCCCTTGGGS---------------CSGGGGSSC--CCC-----CHHHHHHHH
T ss_pred cccCcCCCchhhHHHHHHHHHHHHHCCCCCCCcchhh---------------hHHHHHhhc--ccC-----CHHHHHHHH
Confidence 55668999999999999999999999994322111 011111111 011 136889999
Q ss_pred HccCCCCCCCCCHHHHH
Q 005102 687 ACVHSSPEKRPTMRHIS 703 (714)
Q Consensus 687 ~Cl~~dP~~RPt~~evl 703 (714)
+||+.||++|||+.|++
T Consensus 346 ~~l~~dP~~Rpt~~~~l 362 (413)
T 3dzo_A 346 GFLRYPKEDRLLPLQAM 362 (413)
T ss_dssp HHTCSSGGGSCCHHHHT
T ss_pred HHccCChhhCcCHHHHH
Confidence 99999999999977764
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-36 Score=317.61 Aligned_cols=236 Identities=14% Similarity=0.180 Sum_probs=177.7
Q ss_pred cccccccCceEEEEEEECCCcEEEEEEeCCCC--------chhHHHHHHHHHHHhccC---------CCCccceEEEEE-
Q 005102 408 AFVLGKSGIGIVYKVVLEDGHTLAVRRLGEGG--------SQRFKEFQTEVEAIGKIR---------HSNIVTLRAYYW- 469 (714)
Q Consensus 408 ~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~---------H~niv~l~~~~~- 469 (714)
.+.||+|+||+||+|++ +|+.||||++.... ....+.+.+|++++++++ ||||+++.+.+.
T Consensus 25 ~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l~~~~~~ 103 (336)
T 2vuw_A 25 CEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCV 103 (336)
T ss_dssp CEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCEEEEEEE
T ss_pred eeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhhcceeEe
Confidence 45899999999999998 68999999997642 223477899999998886 777777777643
Q ss_pred ----------------e-------------CCceeEEEeccCCCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHH
Q 005102 470 ----------------S-------------VDEKLLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVY 520 (714)
Q Consensus 470 ----------------~-------------~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~ 520 (714)
+ .+..++||||+++|++.+.+.. ..+++..++.|+.||+.||+|
T Consensus 104 ~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-------~~~~~~~~~~i~~qi~~aL~~ 176 (336)
T 2vuw_A 104 QGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-------KLSSLATAKSILHQLTASLAV 176 (336)
T ss_dssp ESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-------TCCCHHHHHHHHHHHHHHHHH
T ss_pred cCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-------cCCCHHHHHHHHHHHHHHHHH
Confidence 1 6788999999999977776643 347899999999999999999
Q ss_pred Hh-cCCCCCceecCCCCCCeeeCCCC--------------------CeEEcccchhhhhhccCCCCCccCCCCCCCCchh
Q 005102 521 LH-EFSPKKYVHGDLKPSNILLGHNM--------------------EPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQE 579 (714)
Q Consensus 521 LH-~~~~~~ivHrDlkp~NILl~~~~--------------------~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~ 579 (714)
|| + ++|+||||||+|||++.++ .+||+|||+|+....
T Consensus 177 lH~~---~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~------------------- 234 (336)
T 2vuw_A 177 AEAS---LRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD------------------- 234 (336)
T ss_dssp HHHH---HCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET-------------------
T ss_pred HHHh---CCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC-------------------
Confidence 99 8 8999999999999999887 899999999986431
Q ss_pred hhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHH-HHHHHhCCCccccCCCCcchhHHHHHHHHhhcC
Q 005102 580 RQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVI-LLEMITGRTAVVQVGSSEMDLVNWMQLCIEEKK 658 (714)
Q Consensus 580 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvv-l~elltG~~p~~~~~~~~~~l~~~~~~~~~~~~ 658 (714)
....||+.|+|||++.+.. +.++||||+|++ .+++++|..||.. ..|........
T Consensus 235 --------------~~~~gt~~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~--------~~~~~~~~~~~- 290 (336)
T 2vuw_A 235 --------------GIVVFCDVSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSN--------VLWLHYLTDKM- 290 (336)
T ss_dssp --------------TEEECCCCTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHH--------HHHHHHHHHHH-
T ss_pred --------------CcEEEeecccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcc--------hhhhhHHHHhh-
Confidence 1124688999999998766 999999998777 7889999999832 11211111100
Q ss_pred CcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHH
Q 005102 659 PLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHIS 703 (714)
Q Consensus 659 ~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl 703 (714)
......+.............++.+++.+||+.| |++|++
T Consensus 291 -~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d-----sa~e~l 329 (336)
T 2vuw_A 291 -LKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS-----SATDLL 329 (336)
T ss_dssp -HHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS-----SHHHHH
T ss_pred -hhhhccCcccchhhhhhcCHHHHHHHHHHhccC-----CHHHHH
Confidence 000000001111112345667999999999976 898887
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.1e-31 Score=313.51 Aligned_cols=230 Identities=32% Similarity=0.477 Sum_probs=196.5
Q ss_pred cccCCchhHHHHHHHHHHhccCCCCCCCCCCCCCCCCCCcccceEecCCcEEEEEcCCCCcccc---CC-----------
Q 005102 16 GFVDSLNGEGYALLSFKQSVHEDPEGSLSNWNSSDENPCSWNGITCKEQRVVSVSIPKKKLLGF---LP----------- 81 (714)
Q Consensus 16 ~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~w~~~~~~~c~w~gv~c~~~~~~~l~l~~~~l~g~---~p----------- 81 (714)
+++++.+.|++||++||+++. ||. .+++|+. +.+||.|.||+|+.++|+.|+|+++.+.|. +|
T Consensus 5 ~~~~~~~~~~~all~~k~~~~-~~~-~l~~W~~-~~~~C~w~gv~C~~~~v~~L~L~~~~l~g~~~~l~~~l~~L~~L~~ 81 (768)
T 3rgz_A 5 SPSQSLYREIHQLISFKDVLP-DKN-LLPDWSS-NKNPCTFDGVTCRDDKVTSIDLSSKPLNVGFSAVSSSLLSLTGLES 81 (768)
T ss_dssp ---CCHHHHHHHHHHHHTTCS-CTT-SSTTCCT-TSCGGGSTTEEEETTEEEEEECTTSCCCEEHHHHHHHTTTCTTCCE
T ss_pred ccccCCHHHHHHHHHHHhhCC-Ccc-cccCCCC-CCCCcCCcceEECCCcEEEEECCCCCcCCccCccChhHhccCcccc
Confidence 355667889999999999995 887 8999984 458999999999988999999999999987 54
Q ss_pred ------------ccccCCCCCCEEEccCCCCcccCCh--hhcCCCCCCEEEcCCCcCcccCCccc-CCCCCCCEEeccCc
Q 005102 82 ------------SALGSLTDLRHVNLRNNKFFGSLPL--ELLEAQGLQSLVLYGNSFSGSVPNEI-GKLKYLQILDLSQN 146 (714)
Q Consensus 82 ------------~~~~~l~~L~~L~L~~N~l~~~~p~--~~~~l~~L~~L~L~~N~l~g~~p~~~-~~l~~L~~L~Ls~N 146 (714)
+.|+.+++|++|+|++|.++|.+|. .+.++++|++|+|++|.+++.+|..+ .++++|++|+|++|
T Consensus 82 l~~~~~~~~~l~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~Ls~n 161 (768)
T 3rgz_A 82 LFLSNSHINGSVSGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSAN 161 (768)
T ss_dssp EECTTSCEEECCCCCCCCTTCCEEECCSSEEEEEGGGGGGGGGCTTCCEEECCSSEEECCSSCCSCCCCTTCSEEECCSS
T ss_pred cCCcCCCcCCCchhhccCCCCCEEECCCCcCCCcCCChHHHhCCCCCCEEECcCCccCCcCCHHHhccCCCCCEEECCCC
Confidence 4677788888888888888888888 88888888888888888888888776 78888888888888
Q ss_pred cCCCCCCcc---cccccccceeecccCcCCCCCCcccccCccccccccccCCcccccCCCCCCCCcccccccccccccCC
Q 005102 147 FFNGSLPVS---IVQCKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLNLSFNKFNGSIPSNTGNLSSLQGTVDFSHNLFS 223 (714)
Q Consensus 147 ~l~g~~p~~---~~~l~~L~~L~l~~N~l~g~~p~~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~~l~l~~N~l~ 223 (714)
++++..|.. +.++++|++|+|++|.+++.+|. ..+++|++|+|++|++++.+|. ++++++|+ .|++++|.++
T Consensus 162 ~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~---~~l~~L~~L~Ls~n~l~~~~~~-l~~l~~L~-~L~Ls~n~l~ 236 (768)
T 3rgz_A 162 SISGANVVGWVLSDGCGELKHLAISGNKISGDVDV---SRCVNLEFLDVSSNNFSTGIPF-LGDCSALQ-HLDISGNKLS 236 (768)
T ss_dssp CCEEETHHHHHHTTCCTTCCEEECCSSEEESCCBC---TTCTTCCEEECCSSCCCSCCCB-CTTCCSCC-EEECCSSCCC
T ss_pred ccCCcCChhhhhhccCCCCCEEECCCCcccccCCc---ccCCcCCEEECcCCcCCCCCcc-cccCCCCC-EEECcCCcCC
Confidence 888877766 67888888888888888877665 3588999999999999988887 88999999 9999999999
Q ss_pred cCcCccccCCCCcccccCcCCcCCCCCCCC
Q 005102 224 GSIPASLGNLPEKVYIDLTYNNLSGPIPQN 253 (714)
Q Consensus 224 g~~p~~~~~l~~L~~l~l~~N~l~~~~p~~ 253 (714)
+.+|..++.+++|++|++++|++++.+|..
T Consensus 237 ~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~ 266 (768)
T 3rgz_A 237 GDFSRAISTCTELKLLNISSNQFVGPIPPL 266 (768)
T ss_dssp SCHHHHTTTCSSCCEEECCSSCCEESCCCC
T ss_pred CcccHHHhcCCCCCEEECCCCcccCccCcc
Confidence 999999999999999999999998887765
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.8e-31 Score=281.63 Aligned_cols=238 Identities=18% Similarity=0.231 Sum_probs=212.4
Q ss_pred ccCCchhHHHHHHHHHHhccCCCCCCCCCCC---CCCCCCCcccceEec----------CCcEEEEEcCCCCccccCCcc
Q 005102 17 FVDSLNGEGYALLSFKQSVHEDPEGSLSNWN---SSDENPCSWNGITCK----------EQRVVSVSIPKKKLLGFLPSA 83 (714)
Q Consensus 17 ~~~~~~~~~~~l~~~~~~~~~~~~~~l~~w~---~~~~~~c~w~gv~c~----------~~~~~~l~l~~~~l~g~~p~~ 83 (714)
...+...|+.||++||+++..||.+.+.+|. ....++|.|.|+.|. ..+|+.|+|++|+++ .+|+.
T Consensus 21 ~~~~~~~~~~aLl~~k~~~~~~~~~~~~~w~~~~~~~~~~~~~~g~~~~~~~~~l~~~~~~~l~~L~L~~n~l~-~lp~~ 99 (328)
T 4fcg_A 21 GSTALRPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQIETRTGRALKATADLLEDATQPGRVALELRSVPLP-QFPDQ 99 (328)
T ss_dssp --CCCCCHHHHHHHHHHHHHHCCTTHHHHHHHHTTTCTTSCCSHHHHHHHHHHHHHHHTSTTCCEEEEESSCCS-SCCSC
T ss_pred ccccCchHHHHHHHHHHhccCCchhhhhhhcccccccccccccCCcchhhhHHHHhcccccceeEEEccCCCch-hcChh
Confidence 3446678999999999998778888888994 445678999999995 378999999999998 78889
Q ss_pred ccCCCCCCEEEccCCCCcccCChhhcCCCCCCEEEcCCCcCcccCCcccCCCCCCCEEeccCccCCCCCCccccc-----
Q 005102 84 LGSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSGSVPNEIGKLKYLQILDLSQNFFNGSLPVSIVQ----- 158 (714)
Q Consensus 84 ~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~----- 158 (714)
++.+++|++|+|++|.++ .+|..+..+++|++|+|++|.++ .+|..++++++|+.|+|++|++.+.+|..+..
T Consensus 100 l~~l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~L~~n~~~~~~p~~~~~~~~~~ 177 (328)
T 4fcg_A 100 AFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASG 177 (328)
T ss_dssp GGGGTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEEEEEETTCCCCCSCSEEEC-CC
T ss_pred hhhCCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEECCCCCCccccChhHhhccchh
Confidence 999999999999999999 89999999999999999999999 89999999999999999999999999988765
Q ss_pred ----ccccceeecccCcCCCCCCcccccCccccccccccCCcccccCCCCCCCCcccccccccccccCCcCcCccccCCC
Q 005102 159 ----CKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLNLSFNKFNGSIPSNTGNLSSLQGTVDFSHNLFSGSIPASLGNLP 234 (714)
Q Consensus 159 ----l~~L~~L~l~~N~l~g~~p~~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~~l~l~~N~l~g~~p~~~~~l~ 234 (714)
+++|++|+|++|+++ .+|..+. .+++|+.|+|++|+++ .+|..++++++|+ .|++++|++.+.+|..++.++
T Consensus 178 ~~~~l~~L~~L~L~~n~l~-~lp~~l~-~l~~L~~L~L~~N~l~-~l~~~l~~l~~L~-~L~Ls~n~~~~~~p~~~~~l~ 253 (328)
T 4fcg_A 178 EHQGLVNLQSLRLEWTGIR-SLPASIA-NLQNLKSLKIRNSPLS-ALGPAIHHLPKLE-ELDLRGCTALRNYPPIFGGRA 253 (328)
T ss_dssp CEEESTTCCEEEEEEECCC-CCCGGGG-GCTTCCEEEEESSCCC-CCCGGGGGCTTCC-EEECTTCTTCCBCCCCTTCCC
T ss_pred hhccCCCCCEEECcCCCcC-cchHhhc-CCCCCCEEEccCCCCC-cCchhhccCCCCC-EEECcCCcchhhhHHHhcCCC
Confidence 999999999999998 8998874 6999999999999999 5777899999999 999999999999999999999
Q ss_pred CcccccCcCCcCCCCCCCCccccCCCC
Q 005102 235 EKVYIDLTYNNLSGPIPQNGALMNRGP 261 (714)
Q Consensus 235 ~L~~l~l~~N~l~~~~p~~~~~~~~~~ 261 (714)
+|+.|++++|++.+.+|..........
T Consensus 254 ~L~~L~L~~n~~~~~~p~~~~~l~~L~ 280 (328)
T 4fcg_A 254 PLKRLILKDCSNLLTLPLDIHRLTQLE 280 (328)
T ss_dssp CCCEEECTTCTTCCBCCTTGGGCTTCC
T ss_pred CCCEEECCCCCchhhcchhhhcCCCCC
Confidence 999999999999999997755444333
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.97 E-value=6.7e-31 Score=307.88 Aligned_cols=240 Identities=18% Similarity=0.306 Sum_probs=207.4
Q ss_pred CchhHHHHHHHHHHhccCCCCCCCCCCCCCC----CCC--Ccc------------cceEec-CCcEEEEEcCCCCccccC
Q 005102 20 SLNGEGYALLSFKQSVHEDPEGSLSNWNSSD----ENP--CSW------------NGITCK-EQRVVSVSIPKKKLLGFL 80 (714)
Q Consensus 20 ~~~~~~~~l~~~~~~~~~~~~~~l~~w~~~~----~~~--c~w------------~gv~c~-~~~~~~l~l~~~~l~g~~ 80 (714)
....|+.||++||+++ .+| +|+.++ .+| |.| .||+|+ .++|+.|+|+++++.|.+
T Consensus 266 ~~~~d~~ALl~~k~~l-~~~-----~W~~~~~~~~~~~~~C~W~~~~~~~~w~~~~GV~C~~~~~V~~L~Ls~~~L~G~i 339 (876)
T 4ecn_A 266 EYIKDYKALKAIWEAL-DGK-----NWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRV 339 (876)
T ss_dssp HHHHHHHHHHHHHHHT-TGG-----GCCCCCSSCSSCCCCCSCCCSSCGGGTTCCTTEEECTTSCEEEEECTTTCCEEEE
T ss_pred cchHHHHHHHHHHHHc-CCC-----CCCcCCCcccccCCccccccccccccccCcCceEecCCCCEEEEECccCCCCCcC
Confidence 3457999999999998 455 787554 345 999 999998 589999999999999999
Q ss_pred CccccCCCCCCEEEc-cCCCCccc--------------------------------------------------------
Q 005102 81 PSALGSLTDLRHVNL-RNNKFFGS-------------------------------------------------------- 103 (714)
Q Consensus 81 p~~~~~l~~L~~L~L-~~N~l~~~-------------------------------------------------------- 103 (714)
|++|++|++|++|+| ++|.++|.
T Consensus 340 p~~l~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~~~~s~l~~~~l~~~~~~~~i~~ 419 (876)
T 4ecn_A 340 PDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKK 419 (876)
T ss_dssp CGGGGGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHHTCTTSCCCCC
T ss_pred chHHhccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhccCcchhhhHHHHHHhhhCcccccccc
Confidence 999999999999999 77766554
Q ss_pred --------------------CChhhcCCCCCCEEEcCCCcCcc-----------------cCCcccC--CCCCCCEEecc
Q 005102 104 --------------------LPLELLEAQGLQSLVLYGNSFSG-----------------SVPNEIG--KLKYLQILDLS 144 (714)
Q Consensus 104 --------------------~p~~~~~l~~L~~L~L~~N~l~g-----------------~~p~~~~--~l~~L~~L~Ls 144 (714)
+|..+.++++|+.|+|++|.|+| .+|..++ ++++|+.|+|+
T Consensus 420 ~~~l~l~~l~l~~~~N~L~~IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~L~Ls 499 (876)
T 4ecn_A 420 DSRISLKDTQIGNLTNRITFISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELY 499 (876)
T ss_dssp CCCCCCCTTTTTCCSCEEEEECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEE
T ss_pred ccccchhhceeccccCcccchhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCCCEEECc
Confidence 88899999999999999999998 4999988 99999999999
Q ss_pred CccCCCCCCcccccccccceeecccCc-CCC-CCCcccccCcc-------ccccccccCCcccccCCC--CCCCCccccc
Q 005102 145 QNFFNGSLPVSIVQCKRLKALDLSQNN-FTG-PLPNGFGSGLV-------SLEKLNLSFNKFNGSIPS--NTGNLSSLQG 213 (714)
Q Consensus 145 ~N~l~g~~p~~~~~l~~L~~L~l~~N~-l~g-~~p~~~~~~l~-------~L~~L~l~~N~l~g~~p~--~~~~l~~L~~ 213 (714)
+|++.|.+|..|.++++|+.|+|++|+ ++| .+|..++ .+. +|+.|+|++|+|+ .+|. .++++++|+
T Consensus 500 ~N~l~~~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~-~L~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~l~~L~~L~- 576 (876)
T 4ecn_A 500 NCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWT-RLADDEDTGPKIQIFYMGYNNLE-EFPASASLQKMVKLG- 576 (876)
T ss_dssp SCTTCCSCCGGGGGCSSCCEEECTTCTTSCHHHHHHHHH-HHHHCTTTTTTCCEEECCSSCCC-BCCCHHHHTTCTTCC-
T ss_pred CCCCCccChHHHhCCCCCCEEECcCCCCcccccchHHHH-hhhhcccccCCccEEEeeCCcCC-ccCChhhhhcCCCCC-
Confidence 999999999999999999999999998 998 8998764 354 9999999999999 9999 999999999
Q ss_pred ccccccccCCcCcCccccCCCCcccccCcCCcCCCCCCCCccccCC-CCcccccCCCCC
Q 005102 214 TVDFSHNLFSGSIPASLGNLPEKVYIDLTYNNLSGPIPQNGALMNR-GPTAFIGNPRLC 271 (714)
Q Consensus 214 ~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~~~~~-~~~~~~~n~~~~ 271 (714)
.|+|++|+++ .+| .|+.+++|+.|++++|+++ .+|........ .......++.+.
T Consensus 577 ~L~Ls~N~l~-~lp-~~~~L~~L~~L~Ls~N~l~-~lp~~l~~l~~~L~~L~Ls~N~L~ 632 (876)
T 4ecn_A 577 LLDCVHNKVR-HLE-AFGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLK 632 (876)
T ss_dssp EEECTTSCCC-BCC-CCCTTSEESEEECCSSCCS-CCCTTSCEECTTCCEEECCSSCCC
T ss_pred EEECCCCCcc-cch-hhcCCCcceEEECcCCccc-cchHHHhhccccCCEEECcCCCCC
Confidence 9999999999 888 9999999999999999999 66655433332 333334444443
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.1e-30 Score=307.18 Aligned_cols=216 Identities=37% Similarity=0.641 Sum_probs=191.1
Q ss_pred CcEEEEEcCCCCccccCCccccCCCCCCEEEccCCCCcccCChhhcCCCCCCEEEcCCCcCcccCCcccCCCCCCCEEec
Q 005102 64 QRVVSVSIPKKKLLGFLPSALGSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSGSVPNEIGKLKYLQILDL 143 (714)
Q Consensus 64 ~~~~~l~l~~~~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L 143 (714)
..++.|+|++|+++|.+|..+.++++|++|+|++|++++.+|..+..+++|+.|+|++|+++|.+|..++.+++|+.|+|
T Consensus 466 ~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L 545 (768)
T 3rgz_A 466 KTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDL 545 (768)
T ss_dssp TTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEEECCGGGGGCTTCCEEEC
T ss_pred CCceEEEecCCcccCcCCHHHhcCCCCCEEEccCCccCCcCChHHhcCCCCCEEECCCCcccCcCCHHHcCCCCCCEEEC
Confidence 46777888888888888888888888888888888888888888888888888888888888888888888888888888
Q ss_pred cCccCCCCCCcccc------------------------------------------------------------------
Q 005102 144 SQNFFNGSLPVSIV------------------------------------------------------------------ 157 (714)
Q Consensus 144 s~N~l~g~~p~~~~------------------------------------------------------------------ 157 (714)
++|+++|.+|..+.
T Consensus 546 s~N~l~g~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~g~~~ 625 (768)
T 3rgz_A 546 NTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTS 625 (768)
T ss_dssp CSSEEESBCCGGGGTTTTCBCCSTTCSCEEEEEECCSCCTTCCSSEEEEECTTCCGGGGGGGGGTCCSCTTSCEEEEECC
T ss_pred CCCccCCcCChHHhcccchhhhhccccccccccccccccccccccccccccccccchhhhccccccccccccceecccCc
Confidence 88888887776543
Q ss_pred ----cccccceeecccCcCCCCCCcccccCccccccccccCCcccccCCCCCCCCcccccccccccccCCcCcCccccCC
Q 005102 158 ----QCKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLNLSFNKFNGSIPSNTGNLSSLQGTVDFSHNLFSGSIPASLGNL 233 (714)
Q Consensus 158 ----~l~~L~~L~l~~N~l~g~~p~~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~~l~l~~N~l~g~~p~~~~~l 233 (714)
.+++|+.|||++|+++|.+|..++ .+++|+.|+|++|+|+|.+|..++++++|+ .|||++|+++|.+|..++.+
T Consensus 626 ~~~~~l~~L~~LdLs~N~l~g~ip~~l~-~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~-~LdLs~N~l~g~ip~~l~~l 703 (768)
T 3rgz_A 626 PTFDNNGSMMFLDMSYNMLSGYIPKEIG-SMPYLFILNLGHNDISGSIPDEVGDLRGLN-ILDLSSNKLDGRIPQAMSAL 703 (768)
T ss_dssp CSCSSSBCCCEEECCSSCCBSCCCGGGG-GCTTCCEEECCSSCCCSCCCGGGGGCTTCC-EEECCSSCCEECCCGGGGGC
T ss_pred hhhhccccccEEECcCCcccccCCHHHh-ccccCCEEeCcCCccCCCCChHHhCCCCCC-EEECCCCcccCcCChHHhCC
Confidence 246788899999999999999885 599999999999999999999999999999 99999999999999999999
Q ss_pred CCcccccCcCCcCCCCCCCCccccCCCCcccccCCCCCCCCCCCCCCCC
Q 005102 234 PEKVYIDLTYNNLSGPIPQNGALMNRGPTAFIGNPRLCGPPLKNPCSSD 282 (714)
Q Consensus 234 ~~L~~l~l~~N~l~~~~p~~~~~~~~~~~~~~~n~~~~~~~~~~~~~~~ 282 (714)
++|++||+++|+|+|.+|...++..+....|.||+.+||.|+. .|...
T Consensus 704 ~~L~~L~ls~N~l~g~iP~~~~~~~~~~~~~~gN~~Lcg~~l~-~C~~~ 751 (768)
T 3rgz_A 704 TMLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCGYPLP-RCDPS 751 (768)
T ss_dssp CCCSEEECCSSEEEEECCSSSSGGGSCGGGGCSCTEEESTTSC-CCCSC
T ss_pred CCCCEEECcCCcccccCCCchhhccCCHHHhcCCchhcCCCCc-CCCCC
Confidence 9999999999999999999999988889999999999999876 77643
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=99.97 E-value=4.8e-31 Score=303.47 Aligned_cols=244 Identities=18% Similarity=0.310 Sum_probs=212.5
Q ss_pred chhHHHHHHHHHHhccCCCCCCC-------CCCCCCCCCCCcc---cceEec-CCcEEEEEcCCCCccccCCccccCCCC
Q 005102 21 LNGEGYALLSFKQSVHEDPEGSL-------SNWNSSDENPCSW---NGITCK-EQRVVSVSIPKKKLLGFLPSALGSLTD 89 (714)
Q Consensus 21 ~~~~~~~l~~~~~~~~~~~~~~l-------~~w~~~~~~~c~w---~gv~c~-~~~~~~l~l~~~~l~g~~p~~~~~l~~ 89 (714)
...|+.||.++|+++.++.+..- .+|+.+ .++|.| .||+|+ .++|+.|+|+++++.|.+|++|++|++
T Consensus 28 ~~~d~~aL~~~~~~~~~~~w~~~~~~~~~~~~W~~~-~~~c~w~~~~GV~C~~~~~V~~L~L~~~~l~g~lp~~l~~L~~ 106 (636)
T 4eco_A 28 YIKDYLALKEIWDALNGKNWSQQGFGTQPGANWNFN-KELDMWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLTE 106 (636)
T ss_dssp HHHHHHHHHHHHHHTTGGGCCCCC------CCCCCS-SCGGGTTCCTTEEECTTCCEEEEECTTSCCEEEECGGGGGCTT
T ss_pred HHHHHHHHHHHHHHcCCCCcccCCcCCccCCCCCCC-CCcccccCCCCeEEcCCCCEEEEEecCcccCCcCChHHhcCcc
Confidence 34689999999999876655433 389864 689999 999997 469999999999999999999999999
Q ss_pred CCEEEccCCC----------------------------------------------------------------------
Q 005102 90 LRHVNLRNNK---------------------------------------------------------------------- 99 (714)
Q Consensus 90 L~~L~L~~N~---------------------------------------------------------------------- 99 (714)
|++|+|++|.
T Consensus 107 L~~L~Ls~N~~~~~~~~~~~~~~~~~~~~~~~~~l~l~l~~~~l~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~~l~~l 186 (636)
T 4eco_A 107 LEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDT 186 (636)
T ss_dssp CCEEESCCGGGGGTCCSBSTTSBCTTCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHHHCTTSCCCCCCCCCCCCTT
T ss_pred ceEEECcCCccccCCccccccccccCchHHHHHHHHhhHHHhhhccCchhhHHHHHHHHhhcCccccccccccccchhhh
Confidence 9999999884
Q ss_pred --------CcccCChhhcCCCCCCEEEcCCCcCccc-----------------CCcccC--CCCCCCEEeccCccCCCCC
Q 005102 100 --------FFGSLPLELLEAQGLQSLVLYGNSFSGS-----------------VPNEIG--KLKYLQILDLSQNFFNGSL 152 (714)
Q Consensus 100 --------l~~~~p~~~~~l~~L~~L~L~~N~l~g~-----------------~p~~~~--~l~~L~~L~Ls~N~l~g~~ 152 (714)
++| +|..++++++|++|+|++|.|+|. +|..++ ++++|++|+|++|++.|.+
T Consensus 187 ~l~~~~n~l~~-ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l~~~~ 265 (636)
T 4eco_A 187 QIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKL 265 (636)
T ss_dssp TTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEECCTTCSSC
T ss_pred hhccccCCCcc-CCHHHhcccCCCEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCEEEecCCcCCccC
Confidence 445 889999999999999999999986 999999 9999999999999999999
Q ss_pred CcccccccccceeecccCc-CCC-CCCcccccCc------cccccccccCCcccccCCC--CCCCCcccccccccccccC
Q 005102 153 PVSIVQCKRLKALDLSQNN-FTG-PLPNGFGSGL------VSLEKLNLSFNKFNGSIPS--NTGNLSSLQGTVDFSHNLF 222 (714)
Q Consensus 153 p~~~~~l~~L~~L~l~~N~-l~g-~~p~~~~~~l------~~L~~L~l~~N~l~g~~p~--~~~~l~~L~~~l~l~~N~l 222 (714)
|..|.++++|++|+|++|+ ++| .+|..++. + ++|+.|+|++|+++ .+|. .++++++|+ .|++++|++
T Consensus 266 p~~l~~l~~L~~L~Ls~n~~l~~~~lp~~~~~-L~~~~~l~~L~~L~L~~n~l~-~ip~~~~l~~l~~L~-~L~L~~N~l 342 (636)
T 4eco_A 266 PTFLKALPEMQLINVACNRGISGEQLKDDWQA-LADAPVGEKIQIIYIGYNNLK-TFPVETSLQKMKKLG-MLECLYNQL 342 (636)
T ss_dssp CTTTTTCSSCCEEECTTCTTSCHHHHHHHHHH-HHHSGGGGTCCEEECCSSCCS-SCCCHHHHTTCTTCC-EEECCSCCC
T ss_pred hHHHhcCCCCCEEECcCCCCCccccchHHHHh-hhccccCCCCCEEECCCCcCC-ccCchhhhccCCCCC-EEeCcCCcC
Confidence 9999999999999999998 998 89988753 5 89999999999999 9999 999999999 999999999
Q ss_pred CcCcCccccCCCCcccccCcCCcCCCCCCCCccccCC-CCcccccCCCCC
Q 005102 223 SGSIPASLGNLPEKVYIDLTYNNLSGPIPQNGALMNR-GPTAFIGNPRLC 271 (714)
Q Consensus 223 ~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~~~~~-~~~~~~~n~~~~ 271 (714)
+|.+| .++.+++|+.|++++|+++ .+|........ .......++.+.
T Consensus 343 ~g~ip-~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~~L~~L~Ls~N~l~ 390 (636)
T 4eco_A 343 EGKLP-AFGSEIKLASLNLAYNQIT-EIPANFCGFTEQVENLSFAHNKLK 390 (636)
T ss_dssp EEECC-CCEEEEEESEEECCSSEEE-ECCTTSEEECTTCCEEECCSSCCS
T ss_pred ccchh-hhCCCCCCCEEECCCCccc-cccHhhhhhcccCcEEEccCCcCc
Confidence 99999 9999999999999999999 56655443333 333444444443
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.1e-30 Score=294.49 Aligned_cols=185 Identities=12% Similarity=0.057 Sum_probs=129.6
Q ss_pred ccccCceEEEEEE-ECCCcEEEEEEeCCCC----------chhHHHHHHHHHHHhcc-CCCCccceEEEEEeCCceeEEE
Q 005102 411 LGKSGIGIVYKVV-LEDGHTLAVRRLGEGG----------SQRFKEFQTEVEAIGKI-RHSNIVTLRAYYWSVDEKLLIY 478 (714)
Q Consensus 411 lG~G~~g~Vy~~~-~~~g~~vavK~~~~~~----------~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~ 478 (714)
.+.|+.|.++.++ +-.|+.+|||++.+.. ....++|.+|+++|+++ .|+||+++++++++.+..||||
T Consensus 242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVM 321 (569)
T 4azs_A 242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVM 321 (569)
T ss_dssp -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEE
T ss_pred cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEE
Confidence 4566666666544 2348999999997541 12345799999999999 7999999999999999999999
Q ss_pred eccCCCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhh
Q 005102 479 DYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLA 558 (714)
Q Consensus 479 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~ 558 (714)
||++|++|.++|... .+++.. +|+.||+.||+|+|+ +|||||||||+|||+++++++||+|||+|+..
T Consensus 322 Eyv~G~~L~d~i~~~------~~l~~~---~I~~QIl~AL~ylH~---~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~ 389 (569)
T 4azs_A 322 EKLPGRLLSDMLAAG------EEIDRE---KILGSLLRSLAALEK---QGFWHDDVRPWNVMVDARQHARLIDFGSIVTT 389 (569)
T ss_dssp ECCCSEEHHHHHHTT------CCCCHH---HHHHHHHHHHHHHHH---TTCEESCCCGGGEEECTTSCEEECCCTTEESC
T ss_pred ecCCCCcHHHHHHhC------CCCCHH---HHHHHHHHHHHHHHH---CCceeccCchHhEEECCCCCEEEeecccCeeC
Confidence 999999999999865 345543 589999999999999 99999999999999999999999999999865
Q ss_pred hccCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCcc
Q 005102 559 NIAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAV 636 (714)
Q Consensus 559 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~ 636 (714)
.... ....+..||++|||||++.+ .+..++|+||+|++++++.++..++
T Consensus 390 ~~~~----------------------------~~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~~ 438 (569)
T 4azs_A 390 PQDC----------------------------SWPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSNW 438 (569)
T ss_dssp C-------------------------------CCSHHHHHHHHHHHHHHC------------------CCCCTTHHHH
T ss_pred CCCC----------------------------ccccCceechhhccHHHhCC-CCCCcccccccccchhhhccccchh
Confidence 3211 11223457999999999975 5678899999999998887766554
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.93 E-value=2.2e-25 Score=228.34 Aligned_cols=218 Identities=22% Similarity=0.241 Sum_probs=184.5
Q ss_pred CCCcccceEec-CCcEEEEEcCCCCccccCCccccCCCCCCEEEccCCCCcccCChhhcCCCCCCEEEcCCCcCcccCCc
Q 005102 52 NPCSWNGITCK-EQRVVSVSIPKKKLLGFLPSALGSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSGSVPN 130 (714)
Q Consensus 52 ~~c~w~gv~c~-~~~~~~l~l~~~~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~ 130 (714)
+.|.|.|+.|. ...++.+++++++++. +|..+. ++|++|+|++|++++..+..|..+++|++|+|++|.++...+.
T Consensus 3 ~~C~~~~~~C~c~~~~~~l~~~~~~l~~-ip~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~~~ 79 (270)
T 2o6q_A 3 ALCKKDGGVCSCNNNKNSVDCSSKKLTA-IPSNIP--ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAG 79 (270)
T ss_dssp CCBGGGTCSBEEETTTTEEECTTSCCSS-CCSCCC--TTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCCTT
T ss_pred ccCCCCCCCCEeCCCCCEEEccCCCCCc-cCCCCC--CCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeChh
Confidence 67999999986 3457789999999995 676554 6899999999999977777899999999999999999965556
Q ss_pred ccCCCCCCCEEeccCccCCCCCCcccccccccceeecccCcCCCCCCcccccCccccccccccCCcccccCCCCCCCCcc
Q 005102 131 EIGKLKYLQILDLSQNFFNGSLPVSIVQCKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLNLSFNKFNGSIPSNTGNLSS 210 (714)
Q Consensus 131 ~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~ 210 (714)
.|.++++|++|+|++|++++..+..|..+++|++|+|++|++++..|..+ ..+++|+.|+|++|++++..+..+..+++
T Consensus 80 ~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~-~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~ 158 (270)
T 2o6q_A 80 IFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVF-DSLTKLTYLSLGYNELQSLPKGVFDKLTS 158 (270)
T ss_dssp TTSSCTTCCEEECCSSCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTT-TTCTTCCEEECCSSCCCCCCTTTTTTCTT
T ss_pred hhcCCCCCCEEECCCCcCCcCCHhHcccccCCCEEECCCCccCeeCHHHh-CcCcCCCEEECCCCcCCccCHhHccCCcc
Confidence 67899999999999999997666778999999999999999996544444 57999999999999999666666899999
Q ss_pred cccccccccccCCcCcCccccCCCCcccccCcCCcCCCCCCCCcc-ccCCCCcccccCCCCCCCC
Q 005102 211 LQGTVDFSHNLFSGSIPASLGNLPEKVYIDLTYNNLSGPIPQNGA-LMNRGPTAFIGNPRLCGPP 274 (714)
Q Consensus 211 L~~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~-~~~~~~~~~~~n~~~~~~~ 274 (714)
|+ .|++++|.+++..+..|..+++|+.|++++|++++.++.... +.......+.+|++.|.+.
T Consensus 159 L~-~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~ 222 (270)
T 2o6q_A 159 LK-ELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQENPWDCTCN 222 (270)
T ss_dssp CC-EEECCSSCCSCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCSSS
T ss_pred cc-eeEecCCcCcEeChhHhccCCCcCEEECCCCcCCcCCHHHhccccCCCEEEecCCCeeCCCc
Confidence 99 999999999988888899999999999999999987776543 3344456677888877653
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.1e-26 Score=260.61 Aligned_cols=188 Identities=15% Similarity=0.216 Sum_probs=144.8
Q ss_pred cccccccCceEEEEEEECCCcEEEEEEeCCCCc--h------hHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEe
Q 005102 408 AFVLGKSGIGIVYKVVLEDGHTLAVRRLGEGGS--Q------RFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYD 479 (714)
Q Consensus 408 ~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~--~------~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e 479 (714)
.++||+|+||+||+|.. .++.+|+|+...... . ..+++.+|++++++++||||+++..++...+..++|||
T Consensus 341 ~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVmE 419 (540)
T 3en9_A 341 EHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMMS 419 (540)
T ss_dssp -------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEEE
T ss_pred CCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEEE
Confidence 45899999999999955 478899998654321 1 13458999999999999999977777778888899999
Q ss_pred ccCCCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhh
Q 005102 480 YIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLAN 559 (714)
Q Consensus 480 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~ 559 (714)
|+++|+|.+++.. +..|+.|+++||+|||+ ++|+||||||+|||+++ ++||+|||+|+...
T Consensus 420 ~~~ggsL~~~l~~--------------~~~i~~qi~~aL~~LH~---~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~ 480 (540)
T 3en9_A 420 YINGKLAKDVIED--------------NLDIAYKIGEIVGKLHK---NDVIHNDLTTSNFIFDK--DLYIIDFGLGKISN 480 (540)
T ss_dssp CCCSEEHHHHSTT--------------CTHHHHHHHHHHHHHHH---TTEECTTCCTTSEEESS--SEEECCCTTCEECC
T ss_pred CCCCCCHHHHHHH--------------HHHHHHHHHHHHHHHHH---CcCccCCCCHHHEEECC--eEEEEECccCEECC
Confidence 9999999999853 45799999999999999 89999999999999998 99999999998754
Q ss_pred ccCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCC--CCCCchhhhHHHHHHHHHHHhCCCcc
Q 005102 560 IAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKV--VKPSQKWDIYSYGVILLEMITGRTAV 636 (714)
Q Consensus 560 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~~~DVwS~Gvvl~elltG~~p~ 636 (714)
.... . . ...........||+.|||||++.. ..|+..+|+||..+-..+.+.++.+|
T Consensus 481 ~~~~----------------~-~----~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 481 LDED----------------K-A----VDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp CHHH----------------H-H----HHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred Cccc----------------c-c----cchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 2110 0 0 000001123457899999999976 55788899999999999988888776
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=7.6e-25 Score=226.27 Aligned_cols=209 Identities=19% Similarity=0.142 Sum_probs=184.0
Q ss_pred CcEEEEEcCCCCccccCCccccCCCCCCEEEccCCCCcccCChhhcCCCCCCEEEcCCCc-CcccCCcccCCCCCCCEEe
Q 005102 64 QRVVSVSIPKKKLLGFLPSALGSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNS-FSGSVPNEIGKLKYLQILD 142 (714)
Q Consensus 64 ~~~~~l~l~~~~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~-l~g~~p~~~~~l~~L~~L~ 142 (714)
..++.|+|++|++++..+..|..+++|++|+|++|.+++..|..|..+++|++|+|++|. +++..|..+..+++|+.|+
T Consensus 32 ~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~l~~~~~~~~~~l~~L~~L~ 111 (285)
T 1ozn_A 32 AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLH 111 (285)
T ss_dssp TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEE
T ss_pred CCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCCCCCccccCHHHhcCCcCCCEEE
Confidence 478899999999999888899999999999999999998889999999999999999998 8766688999999999999
Q ss_pred ccCccCCCCCCcccccccccceeecccCcCCCCCCcccccCccccccccccCCcccccCCCCCCCCcccccccccccccC
Q 005102 143 LSQNFFNGSLPVSIVQCKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLNLSFNKFNGSIPSNTGNLSSLQGTVDFSHNLF 222 (714)
Q Consensus 143 Ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~~l~l~~N~l 222 (714)
|++|++++..|..+..+++|++|+|++|++++ +|...+..+++|+.|+|++|++++..+..+..+++|+ .|++++|.+
T Consensus 112 l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~-~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~-~L~l~~n~l 189 (285)
T 1ozn_A 112 LDRCGLQELGPGLFRGLAALQYLYLQDNALQA-LPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLD-RLLLHQNRV 189 (285)
T ss_dssp CTTSCCCCCCTTTTTTCTTCCEEECCSSCCCC-CCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCC-EEECCSSCC
T ss_pred CCCCcCCEECHhHhhCCcCCCEEECCCCcccc-cCHhHhccCCCccEEECCCCcccccCHHHhcCccccC-EEECCCCcc
Confidence 99999998888899999999999999999985 5544335699999999999999966666799999999 999999999
Q ss_pred CcCcCccccCCCCcccccCcCCcCCCCCCCCcc-ccCCCCcccccCCCCCCCC
Q 005102 223 SGSIPASLGNLPEKVYIDLTYNNLSGPIPQNGA-LMNRGPTAFIGNPRLCGPP 274 (714)
Q Consensus 223 ~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~-~~~~~~~~~~~n~~~~~~~ 274 (714)
++..|..|..+++|+.|++++|++++.++.... ........+.+|+..|.++
T Consensus 190 ~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~~~ 242 (285)
T 1ozn_A 190 AHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCR 242 (285)
T ss_dssp CEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGG
T ss_pred cccCHhHccCcccccEeeCCCCcCCcCCHHHcccCcccCEEeccCCCccCCCC
Confidence 999999999999999999999999987765333 3334456667887777654
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.92 E-value=6.3e-25 Score=231.47 Aligned_cols=192 Identities=21% Similarity=0.239 Sum_probs=178.8
Q ss_pred CCcEEEEEcCCCCccccCCccccCCCCCCEEEccCCCCcccCChhhcCCCCCCEEEcCCCcCcccCCcccCC--------
Q 005102 63 EQRVVSVSIPKKKLLGFLPSALGSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSGSVPNEIGK-------- 134 (714)
Q Consensus 63 ~~~~~~l~l~~~~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~-------- 134 (714)
..+++.|+|++|+++ .+|..++.+++|++|+|++|.++ .+|..+..+++|++|+|++|.+.+.+|..++.
T Consensus 103 l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~L~~n~~~~~~p~~~~~~~~~~~~~ 180 (328)
T 4fcg_A 103 LSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQ 180 (328)
T ss_dssp GTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEEEEEETTCCCCCSCSEEEC-CCCEE
T ss_pred CCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEECCCCCCccccChhHhhccchhhhc
Confidence 357899999999999 89999999999999999999999 88999999999999999999999999998765
Q ss_pred -CCCCCEEeccCccCCCCCCcccccccccceeecccCcCCCCCCcccccCccccccccccCCcccccCCCCCCCCccccc
Q 005102 135 -LKYLQILDLSQNFFNGSLPVSIVQCKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLNLSFNKFNGSIPSNTGNLSSLQG 213 (714)
Q Consensus 135 -l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~ 213 (714)
+++|+.|+|++|+++ .+|..+..+++|+.|+|++|+++ .+|..+. .+++|+.|+|++|++.+.+|..++++++|+
T Consensus 181 ~l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~-~l~~~l~-~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~- 256 (328)
T 4fcg_A 181 GLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS-ALGPAIH-HLPKLEELDLRGCTALRNYPPIFGGRAPLK- 256 (328)
T ss_dssp ESTTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCC-CCCGGGG-GCTTCCEEECTTCTTCCBCCCCTTCCCCCC-
T ss_pred cCCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCC-cCchhhc-cCCCCCEEECcCCcchhhhHHHhcCCCCCC-
Confidence 999999999999998 89999999999999999999999 4777774 699999999999999999999999999999
Q ss_pred ccccccccCCcCcCccccCCCCcccccCcCCcCCCCCCCCccccCCC
Q 005102 214 TVDFSHNLFSGSIPASLGNLPEKVYIDLTYNNLSGPIPQNGALMNRG 260 (714)
Q Consensus 214 ~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~~~~~~ 260 (714)
.|++++|++.+.+|..++.+++|+.|++++|++.+.+|.........
T Consensus 257 ~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~iP~~l~~L~~L 303 (328)
T 4fcg_A 257 RLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPAN 303 (328)
T ss_dssp EEECTTCTTCCBCCTTGGGCTTCCEEECTTCTTCCCCCGGGGGSCTT
T ss_pred EEECCCCCchhhcchhhhcCCCCCEEeCCCCCchhhccHHHhhccCc
Confidence 99999999999999999999999999999999999999876544433
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.92 E-value=2.1e-24 Score=218.53 Aligned_cols=195 Identities=22% Similarity=0.208 Sum_probs=172.8
Q ss_pred CCCcccceEecCCcEEEEEcCCCCccccCCccccCCCCCCEEEccCCCCcccCChhhcCCCCCCEEEcCCCcCcccCCcc
Q 005102 52 NPCSWNGITCKEQRVVSVSIPKKKLLGFLPSALGSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSGSVPNE 131 (714)
Q Consensus 52 ~~c~w~gv~c~~~~~~~l~l~~~~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~ 131 (714)
.||.|.|++|.. ..+.+++++++++. +|..+. ++|+.|+|++|.+++..+..|..+++|++|+|++|.+++..|..
T Consensus 3 ~Cp~~~gC~C~~-~~~~l~~~~~~l~~-~p~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~ 78 (251)
T 3m19_A 3 TCETVTGCTCNE-GKKEVDCQGKSLDS-VPSGIP--ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGV 78 (251)
T ss_dssp -CHHHHSSEEEG-GGTEEECTTCCCSS-CCSCCC--TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTT
T ss_pred cCCCCCceEcCC-CCeEEecCCCCccc-cCCCCC--CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhH
Confidence 356899999963 34578999999985 666665 68999999999999988889999999999999999999888888
Q ss_pred cCCCCCCCEEeccCccCCCCCCcccccccccceeecccCcCCCCCCcccccCccccccccccCCcccccCCCCCCCCccc
Q 005102 132 IGKLKYLQILDLSQNFFNGSLPVSIVQCKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLNLSFNKFNGSIPSNTGNLSSL 211 (714)
Q Consensus 132 ~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L 211 (714)
|..+++|+.|+|++|++++..+..|..+++|++|+|++|+++ .+|...+..+++|+.|+|++|+|++..|..+..+++|
T Consensus 79 ~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~-~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L 157 (251)
T 3m19_A 79 FDDLTELGTLGLANNQLASLPLGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNL 157 (251)
T ss_dssp TTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTC
T ss_pred hccCCcCCEEECCCCcccccChhHhcccCCCCEEEcCCCcCC-CcChhHhccCCcccEEECcCCcCCccCHHHcCcCcCC
Confidence 999999999999999999777788899999999999999999 4555554679999999999999997666789999999
Q ss_pred ccccccccccCCcCcCccccCCCCcccccCcCCcCCCCCCC
Q 005102 212 QGTVDFSHNLFSGSIPASLGNLPEKVYIDLTYNNLSGPIPQ 252 (714)
Q Consensus 212 ~~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~ 252 (714)
+ .|+|++|+|++..+..|..+++|+.|++++|++++....
T Consensus 158 ~-~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~~~~ 197 (251)
T 3m19_A 158 Q-TLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQFDCSRCE 197 (251)
T ss_dssp C-EEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCTTSTT
T ss_pred C-EEECCCCcCCccCHHHHhCCCCCCEEEeeCCceeCCccc
Confidence 9 999999999988888999999999999999999987443
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.91 E-value=1.3e-24 Score=226.95 Aligned_cols=200 Identities=21% Similarity=0.273 Sum_probs=154.7
Q ss_pred CCCCcccceEecC-----------CcEEEEEcCCCCccccCCccccCCCCCCEEEccCCCCc--ccCChhhcCCCCCCEE
Q 005102 51 ENPCSWNGITCKE-----------QRVVSVSIPKKKLLGFLPSALGSLTDLRHVNLRNNKFF--GSLPLELLEAQGLQSL 117 (714)
Q Consensus 51 ~~~c~w~gv~c~~-----------~~~~~l~l~~~~l~g~~p~~~~~l~~L~~L~L~~N~l~--~~~p~~~~~l~~L~~L 117 (714)
.+.|.|.+|.|+. ..++.|+|++|+++...+..|.++++|++|+|++|.++ +..|..+..+++|++|
T Consensus 4 ~C~C~~~~l~c~~~~l~~ip~~~~~~l~~L~L~~n~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L 83 (306)
T 2z66_A 4 RCSCSGTEIRCNSKGLTSVPTGIPSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYL 83 (306)
T ss_dssp TCEEETTEEECCSSCCSSCCSCCCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCEEEEEEHHHHSCSCCCEE
T ss_pred CCeeCCCEEEcCCCCcccCCCCCCCCCCEEECCCCccCccCHhHhhccccCCEEECCCCccCcccCcccccccccccCEE
Confidence 3568999999973 36889999999999665566899999999999999998 3346777788888888
Q ss_pred EcCCCcCcccCCcccCCCCCCCEEeccCccCCCCCC-cccccccccceeecccCcCCCCCCcccccCccccccccccCCc
Q 005102 118 VLYGNSFSGSVPNEIGKLKYLQILDLSQNFFNGSLP-VSIVQCKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLNLSFNK 196 (714)
Q Consensus 118 ~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p-~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~l~~L~~L~l~~N~ 196 (714)
+|++|.++ .+|..+..+++|+.|+|++|++++..+ ..+..+++|++|++++|.+++..|..+ ..+++|+.|+|++|+
T Consensus 84 ~Ls~n~i~-~l~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~-~~l~~L~~L~l~~n~ 161 (306)
T 2z66_A 84 DLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIF-NGLSSLEVLKMAGNS 161 (306)
T ss_dssp ECCSCSEE-EEEEEEETCTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTT-TTCTTCCEEECTTCE
T ss_pred ECCCCccc-cChhhcCCCCCCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhc-ccCcCCCEEECCCCc
Confidence 88888887 567777788888888888888875444 467777888888888888776555555 457778888888887
Q ss_pred ccc-cCCCCCCCCcccccccccccccCCcCcCccccCCCCcccccCcCCcCCCCCCCC
Q 005102 197 FNG-SIPSNTGNLSSLQGTVDFSHNLFSGSIPASLGNLPEKVYIDLTYNNLSGPIPQN 253 (714)
Q Consensus 197 l~g-~~p~~~~~l~~L~~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~~ 253 (714)
+++ .+|..+..+++|+ .|++++|.+++..|..+..+++|+.|++++|++++..+..
T Consensus 162 l~~~~~~~~~~~l~~L~-~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~ 218 (306)
T 2z66_A 162 FQENFLPDIFTELRNLT-FLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFP 218 (306)
T ss_dssp EGGGEECSCCTTCTTCC-EEECTTSCCCEECTTTTTTCTTCCEEECTTSCCSBCCSGG
T ss_pred cccccchhHHhhCcCCC-EEECCCCCcCCcCHHHhcCCCCCCEEECCCCccCccChhh
Confidence 775 5677777777777 7788888877777777777777888888888777665544
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.91 E-value=9.7e-24 Score=232.86 Aligned_cols=216 Identities=21% Similarity=0.195 Sum_probs=172.9
Q ss_pred ccceEecC-----------CcEEEEEcCCCCccccCCccccCCCCCCEEEccCCCCcccCChhhcCCCCCCEEEcCCCcC
Q 005102 56 WNGITCKE-----------QRVVSVSIPKKKLLGFLPSALGSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSF 124 (714)
Q Consensus 56 w~gv~c~~-----------~~~~~l~l~~~~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l 124 (714)
|..|.|.. ..++.|+|++|++++..|..|.++++|++|+|++|++++..|..|.++++|++|+|++|++
T Consensus 56 ~~~v~c~~~~l~~iP~~~~~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~l 135 (452)
T 3zyi_A 56 FSKVVCTRRGLSEVPQGIPSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWL 135 (452)
T ss_dssp SCEEECCSSCCSSCCSCCCTTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCC
T ss_pred CcEEEECCCCcCccCCCCCCCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECCCCcC
Confidence 56788862 3688999999999999999999999999999999999998889999999999999999999
Q ss_pred cccCCcccCCCCCCCEEeccCccCCCCCCcccc-------------------------cccccceeecccCcCCCCCCcc
Q 005102 125 SGSVPNEIGKLKYLQILDLSQNFFNGSLPVSIV-------------------------QCKRLKALDLSQNNFTGPLPNG 179 (714)
Q Consensus 125 ~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~-------------------------~l~~L~~L~l~~N~l~g~~p~~ 179 (714)
++..+..|..+++|+.|+|++|++++..+..|. .+++|+.|+|++|+++ .+|.
T Consensus 136 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~-~~~~- 213 (452)
T 3zyi_A 136 TVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIK-DMPN- 213 (452)
T ss_dssp SBCCTTTSSSCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTSCCS-SCCC-
T ss_pred CccChhhhcccCCCCEEECCCCCcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEEECCCCccc-cccc-
Confidence 977777799999999999999999854443444 4455556666666665 3343
Q ss_pred cccCccccccccccCCcccccCCCCCCCCcccccccccccccCCcCcCccccCCCCcccccCcCCcCCCCCCCCcc-ccC
Q 005102 180 FGSGLVSLEKLNLSFNKFNGSIPSNTGNLSSLQGTVDFSHNLFSGSIPASLGNLPEKVYIDLTYNNLSGPIPQNGA-LMN 258 (714)
Q Consensus 180 ~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~-~~~ 258 (714)
+ ..+++|+.|+|++|+|++..|..+.++++|+ .|++++|++++..|..|..+++|+.|++++|+|++.++.... +..
T Consensus 214 ~-~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~-~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~ 291 (452)
T 3zyi_A 214 L-TPLVGLEELEMSGNHFPEIRPGSFHGLSSLK-KLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRY 291 (452)
T ss_dssp C-TTCTTCCEEECTTSCCSEECGGGGTTCTTCC-EEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTSSTTCTT
T ss_pred c-cccccccEEECcCCcCcccCcccccCccCCC-EEEeCCCcCceECHHHhcCCCCCCEEECCCCcCCccChHHhccccC
Confidence 3 3467778888888888877788888888888 888888888888888888889999999999999877776544 333
Q ss_pred CCCcccccCCCCCCCCC
Q 005102 259 RGPTAFIGNPRLCGPPL 275 (714)
Q Consensus 259 ~~~~~~~~n~~~~~~~~ 275 (714)
.....+.+|++.|.+.+
T Consensus 292 L~~L~L~~Np~~CdC~~ 308 (452)
T 3zyi_A 292 LVELHLHHNPWNCDCDI 308 (452)
T ss_dssp CCEEECCSSCEECSTTT
T ss_pred CCEEEccCCCcCCCCCc
Confidence 44566778888887753
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=99.90 E-value=1.7e-24 Score=226.69 Aligned_cols=183 Identities=23% Similarity=0.409 Sum_probs=142.5
Q ss_pred CcEEEEEcCCCCccccCCccccCCCCCCEEEccCCCCcccCChhhcCCCCCCEEEcCCCcCcccCCcccCCCC-CCCEEe
Q 005102 64 QRVVSVSIPKKKLLGFLPSALGSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSGSVPNEIGKLK-YLQILD 142 (714)
Q Consensus 64 ~~~~~l~l~~~~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~-~L~~L~ 142 (714)
.+++.|+|++|++++.+|..|.++++|++|+|++|.+++.+|..+..+++|++|+|++|+++|.+|..++.++ +|+.|+
T Consensus 101 ~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~~L~~L~ 180 (313)
T 1ogq_A 101 TQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMT 180 (313)
T ss_dssp TTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEE
T ss_pred CCCCEEECcCCeeCCcCCHHHhCCCCCCEEeCCCCccCCcCChHHhcCCCCCeEECcCCcccCcCCHHHhhhhhcCcEEE
Confidence 4667777777777777777777777777777777777777777777777777777777777777777777776 777777
Q ss_pred ccCccCCCCCCcccc-----------------------cccccceeecccCcCCCCCCcccccCccccccccccCCcccc
Q 005102 143 LSQNFFNGSLPVSIV-----------------------QCKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLNLSFNKFNG 199 (714)
Q Consensus 143 Ls~N~l~g~~p~~~~-----------------------~l~~L~~L~l~~N~l~g~~p~~~~~~l~~L~~L~l~~N~l~g 199 (714)
|++|++++.+|..+. .+++|+.|+|++|++++.+|. + ..+++|+.|+|++|++++
T Consensus 181 L~~N~l~~~~~~~~~~l~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~-~~l~~L~~L~Ls~N~l~~ 258 (313)
T 1ogq_A 181 ISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGK-V-GLSKNLNGLDLRNNRIYG 258 (313)
T ss_dssp CCSSEEEEECCGGGGGCCCSEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGGG-C-CCCTTCCEEECCSSCCEE
T ss_pred CcCCeeeccCChHHhCCcccEEECcCCcccCcCCHHHhcCCCCCEEECCCCceeeecCc-c-cccCCCCEEECcCCcccC
Confidence 777776665555554 445555555555555544443 3 357899999999999999
Q ss_pred cCCCCCCCCcccccccccccccCCcCcCccccCCCCcccccCcCCc-CCCCC
Q 005102 200 SIPSNTGNLSSLQGTVDFSHNLFSGSIPASLGNLPEKVYIDLTYNN-LSGPI 250 (714)
Q Consensus 200 ~~p~~~~~l~~L~~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~-l~~~~ 250 (714)
.+|..+.++++|+ .|++++|+++|.+|.. +.+++|+.|++++|+ +.|.+
T Consensus 259 ~~p~~l~~l~~L~-~L~Ls~N~l~~~ip~~-~~l~~L~~l~l~~N~~lc~~p 308 (313)
T 1ogq_A 259 TLPQGLTQLKFLH-SLNVSFNNLCGEIPQG-GNLQRFDVSAYANNKCLCGSP 308 (313)
T ss_dssp CCCGGGGGCTTCC-EEECCSSEEEEECCCS-TTGGGSCGGGTCSSSEEESTT
T ss_pred cCChHHhcCcCCC-EEECcCCcccccCCCC-ccccccChHHhcCCCCccCCC
Confidence 9999999999999 9999999999999987 899999999999998 77753
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.90 E-value=2.4e-23 Score=228.87 Aligned_cols=216 Identities=19% Similarity=0.200 Sum_probs=169.7
Q ss_pred ccceEecC-----------CcEEEEEcCCCCccccCCccccCCCCCCEEEccCCCCcccCChhhcCCCCCCEEEcCCCcC
Q 005102 56 WNGITCKE-----------QRVVSVSIPKKKLLGFLPSALGSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSF 124 (714)
Q Consensus 56 w~gv~c~~-----------~~~~~l~l~~~~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l 124 (714)
|..|.|.. ..++.|+|++|++++..+..|.++++|++|+|++|.+++..+..|.++++|+.|+|++|++
T Consensus 45 ~~~v~c~~~~l~~iP~~~~~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l 124 (440)
T 3zyj_A 45 FSKVICVRKNLREVPDGISTNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRL 124 (440)
T ss_dssp SCEEECCSCCCSSCCSCCCTTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECCSSCC
T ss_pred CCEEEeCCCCcCcCCCCCCCCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECCCCcC
Confidence 66888863 3577899999999998889999999999999999999988888889999999999999999
Q ss_pred cccCCcccCCCCCCCEEeccCccCCCCCCcccc-------------------------cccccceeecccCcCCCCCCcc
Q 005102 125 SGSVPNEIGKLKYLQILDLSQNFFNGSLPVSIV-------------------------QCKRLKALDLSQNNFTGPLPNG 179 (714)
Q Consensus 125 ~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~-------------------------~l~~L~~L~l~~N~l~g~~p~~ 179 (714)
++..+..|..+++|+.|+|++|+++...+..|. ++++|+.|+|++|+++ .+|.
T Consensus 125 ~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~-~~~~- 202 (440)
T 3zyj_A 125 TTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIPN- 202 (440)
T ss_dssp SSCCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEEECTTSCCS-SCCC-
T ss_pred CeeCHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCeecCCCCcCc-cccc-
Confidence 866666788888999999988888754443444 4555555555556555 4443
Q ss_pred cccCccccccccccCCcccccCCCCCCCCcccccccccccccCCcCcCccccCCCCcccccCcCCcCCCCCCCCcc-ccC
Q 005102 180 FGSGLVSLEKLNLSFNKFNGSIPSNTGNLSSLQGTVDFSHNLFSGSIPASLGNLPEKVYIDLTYNNLSGPIPQNGA-LMN 258 (714)
Q Consensus 180 ~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~-~~~ 258 (714)
+ ..+++|+.|+|++|++++..|..|.++++|+ .|++++|++++..|..|..+++|+.|++++|+|++.++.... +..
T Consensus 203 ~-~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~-~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~ 280 (440)
T 3zyj_A 203 L-TPLIKLDELDLSGNHLSAIRPGSFQGLMHLQ-KLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHH 280 (440)
T ss_dssp C-TTCSSCCEEECTTSCCCEECTTTTTTCTTCC-EEECTTCCCCEECTTSSTTCTTCCEEECTTSCCCCCCTTTTSSCTT
T ss_pred c-CCCcccCEEECCCCccCccChhhhccCccCC-EEECCCCceeEEChhhhcCCCCCCEEECCCCCCCccChhHhccccC
Confidence 2 3467788888888888877788888888888 888888888888888888999999999999999987776544 334
Q ss_pred CCCcccccCCCCCCCCC
Q 005102 259 RGPTAFIGNPRLCGPPL 275 (714)
Q Consensus 259 ~~~~~~~~n~~~~~~~~ 275 (714)
.....+.+|++.|++.+
T Consensus 281 L~~L~L~~Np~~CdC~l 297 (440)
T 3zyj_A 281 LERIHLHHNPWNCNCDI 297 (440)
T ss_dssp CCEEECCSSCEECSSTT
T ss_pred CCEEEcCCCCccCCCCc
Confidence 45566778999897753
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.90 E-value=3.2e-23 Score=212.23 Aligned_cols=204 Identities=21% Similarity=0.258 Sum_probs=177.8
Q ss_pred CCCCCCCCCC--cccceEecC-----------CcEEEEEcCCCCccccCCccccCCCCCCEEEccCCCCcccCChhhcCC
Q 005102 45 NWNSSDENPC--SWNGITCKE-----------QRVVSVSIPKKKLLGFLPSALGSLTDLRHVNLRNNKFFGSLPLELLEA 111 (714)
Q Consensus 45 ~w~~~~~~~c--~w~gv~c~~-----------~~~~~l~l~~~~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l 111 (714)
.|.+. .+.| .|..|.|.. ..++.|+|++|++++..+..|.++++|++|+|++|.++...+..|..+
T Consensus 6 ~~~~~-~C~c~~~~~~l~~~~~~l~~ip~~~~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~~~~~~~l 84 (270)
T 2o6q_A 6 KKDGG-VCSCNNNKNSVDCSSKKLTAIPSNIPADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKEL 84 (270)
T ss_dssp GGGTC-SBEEETTTTEEECTTSCCSSCCSCCCTTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCCTTTTSSC
T ss_pred CCCCC-CCEeCCCCCEEEccCCCCCccCCCCCCCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeChhhhcCC
Confidence 56543 2334 477899962 257889999999999888899999999999999999996666667889
Q ss_pred CCCCEEEcCCCcCcccCCcccCCCCCCCEEeccCccCCCCCCcccccccccceeecccCcCCCCCCcccccCcccccccc
Q 005102 112 QGLQSLVLYGNSFSGSVPNEIGKLKYLQILDLSQNFFNGSLPVSIVQCKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLN 191 (714)
Q Consensus 112 ~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~l~~L~~L~ 191 (714)
++|++|+|++|.+++..+..|..+++|+.|+|++|++++..|..|..+++|+.|+|++|+++ .+|...+..+++|+.|+
T Consensus 85 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~-~~~~~~~~~l~~L~~L~ 163 (270)
T 2o6q_A 85 KNLETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQ-SLPKGVFDKLTSLKELR 163 (270)
T ss_dssp TTCCEEECCSSCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEE
T ss_pred CCCCEEECCCCcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEECCCCcCC-ccCHhHccCCcccceeE
Confidence 99999999999999777778899999999999999999877788999999999999999998 45655446799999999
Q ss_pred ccCCcccccCCCCCCCCcccccccccccccCCcCcCccccCCCCcccccCcCCcCCCCCC
Q 005102 192 LSFNKFNGSIPSNTGNLSSLQGTVDFSHNLFSGSIPASLGNLPEKVYIDLTYNNLSGPIP 251 (714)
Q Consensus 192 l~~N~l~g~~p~~~~~l~~L~~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p 251 (714)
|++|++++..+..+.++++|+ .|++++|++++..+..|..+++|+.|++++|.+....+
T Consensus 164 L~~n~l~~~~~~~~~~l~~L~-~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~ 222 (270)
T 2o6q_A 164 LYNNQLKRVPEGAFDKLTELK-TLKLDNNQLKRVPEGAFDSLEKLKMLQLQENPWDCTCN 222 (270)
T ss_dssp CCSSCCSCCCTTTTTTCTTCC-EEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCSSS
T ss_pred ecCCcCcEeChhHhccCCCcC-EEECCCCcCCcCCHHHhccccCCCEEEecCCCeeCCCc
Confidence 999999976667799999999 99999999998777789999999999999999987654
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=2.4e-23 Score=214.00 Aligned_cols=208 Identities=21% Similarity=0.184 Sum_probs=178.6
Q ss_pred cEEEEEcCCCCccccCCccccCCCCCCEEEccCCCCcccCChhhcCCCCCCEEEcCCCcCcccCCcccCCCCCCCEEecc
Q 005102 65 RVVSVSIPKKKLLGFLPSALGSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSGSVPNEIGKLKYLQILDLS 144 (714)
Q Consensus 65 ~~~~l~l~~~~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls 144 (714)
.++.|+|++|++++..+..|.++++|++|+|++|++++..+..|..+++|++|+|++|.+++..|..|.++++|+.|+++
T Consensus 29 ~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~ 108 (276)
T 2z62_A 29 STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAV 108 (276)
T ss_dssp TCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECT
T ss_pred CccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEECC
Confidence 68899999999999888899999999999999999998888889999999999999999998888999999999999999
Q ss_pred CccCCCCCCcccccccccceeecccCcCCC-CCCcccccCccccccccccCCcccccCCCCCCCCccccc---ccccccc
Q 005102 145 QNFFNGSLPVSIVQCKRLKALDLSQNNFTG-PLPNGFGSGLVSLEKLNLSFNKFNGSIPSNTGNLSSLQG---TVDFSHN 220 (714)
Q Consensus 145 ~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g-~~p~~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~---~l~l~~N 220 (714)
+|++++..+..+..+++|++|+|++|.+++ .+|..+. .+++|+.|+|++|++++..+..+..+.+++. .+++++|
T Consensus 109 ~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~-~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~l~l~L~ls~n 187 (276)
T 2z62_A 109 ETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFS-NLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLN 187 (276)
T ss_dssp TSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGG-GCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCEEEECCSS
T ss_pred CCCccccCchhcccCCCCCEEECcCCccceecCchhhc-cCCCCCEEECCCCCCCcCCHHHhhhhhhccccceeeecCCC
Confidence 999997777789999999999999999986 4688774 6999999999999999777777776666652 5789999
Q ss_pred cCCcCcCccccCCCCcccccCcCCcCCCCCCCCcc-ccCCCCcccccCCCCCCCC
Q 005102 221 LFSGSIPASLGNLPEKVYIDLTYNNLSGPIPQNGA-LMNRGPTAFIGNPRLCGPP 274 (714)
Q Consensus 221 ~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~-~~~~~~~~~~~n~~~~~~~ 274 (714)
.+++..+..+.. .+|+.|++++|++++.++.... ........+.+|+..|.++
T Consensus 188 ~l~~~~~~~~~~-~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~ 241 (276)
T 2z62_A 188 PMNFIQPGAFKE-IRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 241 (276)
T ss_dssp CCCEECTTSSCS-CCEEEEECCSSCCSCCCTTTTTTCCSCCEEECCSSCBCCCTT
T ss_pred cccccCccccCC-CcccEEECCCCceeecCHhHhcccccccEEEccCCcccccCC
Confidence 999766655554 4899999999999988776543 3444556677888887664
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=2.4e-23 Score=229.91 Aligned_cols=157 Identities=21% Similarity=0.250 Sum_probs=134.3
Q ss_pred CCCcccc--eEecC----------CcEEEEEcCCCCccccCCccccCCCCCCEEEccCCCCcccC-ChhhcCCCCCCEEE
Q 005102 52 NPCSWNG--ITCKE----------QRVVSVSIPKKKLLGFLPSALGSLTDLRHVNLRNNKFFGSL-PLELLEAQGLQSLV 118 (714)
Q Consensus 52 ~~c~w~g--v~c~~----------~~~~~l~l~~~~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~-p~~~~~l~~L~~L~ 118 (714)
..|.|.+ |.|.. .+++.|+|++|++++..|..|+++++|++|+|++|.+.+.+ |..|.++++|++|+
T Consensus 6 ~~c~~~~~~~~c~~~~l~~lp~l~~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~ 85 (455)
T 3v47_A 6 SECSVIGYNAICINRGLHQVPELPAHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILK 85 (455)
T ss_dssp -CCEEETTEEECCSSCCSSCCCCCTTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEEE
T ss_pred ceeEEEccccCcCCCCcccCCCCCCccCEEEecCCccCcCChhHhccCccccEEECcCCcccceECcccccccccCCEEe
Confidence 3465555 88863 36899999999999999999999999999999999998666 56688999999999
Q ss_pred cCCCcCcccCCcccCCCCCCCEEeccCccCCCCCCcc--cccccccceeecccCcCCCCCCcccccCccccccccccCCc
Q 005102 119 LYGNSFSGSVPNEIGKLKYLQILDLSQNFFNGSLPVS--IVQCKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLNLSFNK 196 (714)
Q Consensus 119 L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~--~~~l~~L~~L~l~~N~l~g~~p~~~~~~l~~L~~L~l~~N~ 196 (714)
|++|.+++..|..|+++++|++|+|++|++++.+|.. |..+++|++|+|++|++++..|..++..+++|+.|+|++|+
T Consensus 86 Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~ 165 (455)
T 3v47_A 86 LDYNQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNK 165 (455)
T ss_dssp CTTCTTCEECTTTTTTCTTCCEEECTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCCSCCCCGGGGGCTTCCEEECTTCC
T ss_pred CCCCccCccChhhccCcccCCEEeCCCCCCCccccCcccccCcccCCEEECCCCccCccCcccccCCCCcccEEeCCCCc
Confidence 9999999888999999999999999999998766655 88999999999999999987787755678999999999999
Q ss_pred ccccCCCCCCCC
Q 005102 197 FNGSIPSNTGNL 208 (714)
Q Consensus 197 l~g~~p~~~~~l 208 (714)
+++..|..+.++
T Consensus 166 l~~~~~~~l~~l 177 (455)
T 3v47_A 166 VKSICEEDLLNF 177 (455)
T ss_dssp BSCCCTTTSGGG
T ss_pred ccccChhhhhcc
Confidence 988777766543
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.89 E-value=7.6e-23 Score=211.51 Aligned_cols=203 Identities=24% Similarity=0.222 Sum_probs=167.8
Q ss_pred CcEEEEEcCCCCccccCCccccCCCCCCEEEccCCCCcccCChhhcCCCCCCEEEcCCCcCcccCCcccCCCCCCCEEec
Q 005102 64 QRVVSVSIPKKKLLGFLPSALGSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSGSVPNEIGKLKYLQILDL 143 (714)
Q Consensus 64 ~~~~~l~l~~~~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L 143 (714)
..++.+++++++++. +|..+. ++|+.|+|++|.+++..|..|..+++|+.|+|++|.+++. |.. +.+++|+.|+|
T Consensus 10 ~~l~~l~~~~~~l~~-ip~~~~--~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~-~~~-~~l~~L~~L~L 84 (290)
T 1p9a_G 10 ASHLEVNCDKRNLTA-LPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKL-QVD-GTLPVLGTLDL 84 (290)
T ss_dssp TTCCEEECTTSCCSS-CCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEE-ECC-SCCTTCCEEEC
T ss_pred CCccEEECCCCCCCc-CCCCCC--CCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCcc-cCC-CCCCcCCEEEC
Confidence 467788888888885 565554 6899999999999988888899999999999999999854 433 78999999999
Q ss_pred cCccCCCCCCcccccccccceeecccCcCCCCCCcccccCccccccccccCCcccccCCCCCCCCcccccccccccccCC
Q 005102 144 SQNFFNGSLPVSIVQCKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLNLSFNKFNGSIPSNTGNLSSLQGTVDFSHNLFS 223 (714)
Q Consensus 144 s~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~~l~l~~N~l~ 223 (714)
++|+++ .+|..+..+++|++|+|++|++++..|..+ ..+++|+.|+|++|+|++..+..+..+++|+ .|+|++|+|+
T Consensus 85 s~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~-~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~-~L~L~~N~l~ 161 (290)
T 1p9a_G 85 SHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGAL-RGLGELQELYLKGNELKTLPPGLLTPTPKLE-KLSLANNNLT 161 (290)
T ss_dssp CSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTT-TTCTTCCEEECTTSCCCCCCTTTTTTCTTCC-EEECTTSCCS
T ss_pred CCCcCC-cCchhhccCCCCCEEECCCCcCcccCHHHH-cCCCCCCEEECCCCCCCccChhhcccccCCC-EEECCCCcCC
Confidence 999998 788888999999999999999985444444 5799999999999999976667778899999 9999999999
Q ss_pred cCcCccccCCCCcccccCcCCcCCCCCCCCccccCCCCcccccCCCCCCCC
Q 005102 224 GSIPASLGNLPEKVYIDLTYNNLSGPIPQNGALMNRGPTAFIGNPRLCGPP 274 (714)
Q Consensus 224 g~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~~~~~~~~~~~~n~~~~~~~ 274 (714)
+..+..|..+++|+.|++++|+|+..++............+.+|++.|.+.
T Consensus 162 ~l~~~~~~~l~~L~~L~L~~N~l~~ip~~~~~~~~L~~l~L~~Np~~C~c~ 212 (290)
T 1p9a_G 162 ELPAGLLNGLENLDTLLLQENSLYTIPKGFFGSHLLPFAFLHGNPWLCNCE 212 (290)
T ss_dssp CCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCCCSEEECCSCCBCCSGG
T ss_pred ccCHHHhcCcCCCCEEECCCCcCCccChhhcccccCCeEEeCCCCccCcCc
Confidence 776777889999999999999999666555555555556677888888653
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.89 E-value=1.3e-23 Score=223.96 Aligned_cols=194 Identities=19% Similarity=0.211 Sum_probs=153.1
Q ss_pred CCCCcccceEec-------------CCcEEEEEcCCCCccccCCccccCCCCCCEEEccCCCCcccCChhhcCCCCCCEE
Q 005102 51 ENPCSWNGITCK-------------EQRVVSVSIPKKKLLGFLPSALGSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSL 117 (714)
Q Consensus 51 ~~~c~w~gv~c~-------------~~~~~~l~l~~~~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 117 (714)
.++|.|.|+ |+ ..+++.|+|++|++++..+..|.++++|++|+|++|++++..|..|.++++|++|
T Consensus 27 ~~~C~~~~~-c~~~~~~l~~iP~~~~~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 105 (353)
T 2z80_A 27 SLSCDRNGI-CKGSSGSLNSIPSGLTEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHL 105 (353)
T ss_dssp CCEECTTSE-EECCSTTCSSCCTTCCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEE
T ss_pred CCCCCCCeE-eeCCCCCcccccccccccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhhcCCCCCCCEE
Confidence 366889887 64 1378999999999999877799999999999999999998888899999999999
Q ss_pred EcCCCcCcccCCcccCCCCCCCEEeccCccCCCCCCc--ccccccccceeecccCc-CCCCCCcccccCccccccccccC
Q 005102 118 VLYGNSFSGSVPNEIGKLKYLQILDLSQNFFNGSLPV--SIVQCKRLKALDLSQNN-FTGPLPNGFGSGLVSLEKLNLSF 194 (714)
Q Consensus 118 ~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~--~~~~l~~L~~L~l~~N~-l~g~~p~~~~~~l~~L~~L~l~~ 194 (714)
+|++|.+++..+..++++++|++|+|++|+++ .+|. .+..+++|++|++++|+ ++ .++...+.++++|+.|++++
T Consensus 106 ~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~~~~l~~L~~L~l~~n~~~~-~~~~~~~~~l~~L~~L~l~~ 183 (353)
T 2z80_A 106 DLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYK-TLGETSLFSHLTKLQILRVGNMDTFT-KIQRKDFAGLTFLEELEIDA 183 (353)
T ss_dssp ECCSSCCSSCCHHHHTTCTTCSEEECTTCCCS-SSCSSCSCTTCTTCCEEEEEESSSCC-EECTTTTTTCCEEEEEEEEE
T ss_pred ECCCCcCCcCCHhHhCCCccCCEEECCCCCCc-ccCchhhhccCCCCcEEECCCCcccc-ccCHHHccCCCCCCEEECCC
Confidence 99999999544455999999999999999998 5555 78899999999999995 55 45443335799999999999
Q ss_pred CcccccCCCCCCCCcccccccccccccCCcCcCccccCCCCcccccCcCCcCCC
Q 005102 195 NKFNGSIPSNTGNLSSLQGTVDFSHNLFSGSIPASLGNLPEKVYIDLTYNNLSG 248 (714)
Q Consensus 195 N~l~g~~p~~~~~l~~L~~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~ 248 (714)
|++++..|..+.++++|+ .|++++|.++...+..+..+++|+.|++++|++++
T Consensus 184 n~l~~~~~~~l~~l~~L~-~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~l~~ 236 (353)
T 2z80_A 184 SDLQSYEPKSLKSIQNVS-HLILHMKQHILLLEIFVDVTSSVECLELRDTDLDT 236 (353)
T ss_dssp TTCCEECTTTTTTCSEEE-EEEEECSCSTTHHHHHHHHTTTEEEEEEESCBCTT
T ss_pred CCcCccCHHHHhccccCC-eecCCCCccccchhhhhhhcccccEEECCCCcccc
Confidence 999988899999888777 77777766642222222234444444444444443
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=7.4e-23 Score=211.30 Aligned_cols=188 Identities=21% Similarity=0.180 Sum_probs=171.3
Q ss_pred CCcEEEEEcCCCCccccCCccccCCCCCCEEEccCCC-CcccCChhhcCCCCCCEEEcCCCcCcccCCcccCCCCCCCEE
Q 005102 63 EQRVVSVSIPKKKLLGFLPSALGSLTDLRHVNLRNNK-FFGSLPLELLEAQGLQSLVLYGNSFSGSVPNEIGKLKYLQIL 141 (714)
Q Consensus 63 ~~~~~~l~l~~~~l~g~~p~~~~~l~~L~~L~L~~N~-l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L 141 (714)
..+++.|+|++|.+++..|..|..+++|++|+|++|. +....|..+..+++|+.|+|++|.+++..|..+.++++|+.|
T Consensus 55 ~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L 134 (285)
T 1ozn_A 55 CRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYL 134 (285)
T ss_dssp CTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEE
T ss_pred CCCCCEEECCCCccceeCHhhcCCccCCCEEeCCCCCCccccCHHHhcCCcCCCEEECCCCcCCEECHhHhhCCcCCCEE
Confidence 3589999999999999999999999999999999998 776668889999999999999999998889999999999999
Q ss_pred eccCccCCCCCCcccccccccceeecccCcCCCCCCcccccCccccccccccCCcccccCCCCCCCCccccccccccccc
Q 005102 142 DLSQNFFNGSLPVSIVQCKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLNLSFNKFNGSIPSNTGNLSSLQGTVDFSHNL 221 (714)
Q Consensus 142 ~Ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~~l~l~~N~ 221 (714)
+|++|++++..+..|..+++|+.|+|++|++++ +|...+..+++|+.|+|++|++++..|..+.++++|+ .|++++|.
T Consensus 135 ~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~-~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~-~L~l~~n~ 212 (285)
T 1ozn_A 135 YLQDNALQALPDDTFRDLGNLTHLFLHGNRISS-VPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLM-TLYLFANN 212 (285)
T ss_dssp ECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCE-ECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCC-EEECCSSC
T ss_pred ECCCCcccccCHhHhccCCCccEEECCCCcccc-cCHHHhcCccccCEEECCCCcccccCHhHccCccccc-EeeCCCCc
Confidence 999999997666779999999999999999984 5554335699999999999999998899999999999 99999999
Q ss_pred CCcCcCccccCCCCcccccCcCCcCCCCCCC
Q 005102 222 FSGSIPASLGNLPEKVYIDLTYNNLSGPIPQ 252 (714)
Q Consensus 222 l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~ 252 (714)
+++..+..+..+++|+.|++++|++....+.
T Consensus 213 l~~~~~~~~~~l~~L~~L~l~~N~~~c~~~~ 243 (285)
T 1ozn_A 213 LSALPTEALAPLRALQYLRLNDNPWVCDCRA 243 (285)
T ss_dssp CSCCCHHHHTTCTTCCEEECCSSCEECSGGG
T ss_pred CCcCCHHHcccCcccCEEeccCCCccCCCCc
Confidence 9987778899999999999999999876543
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=4.7e-22 Score=209.91 Aligned_cols=192 Identities=19% Similarity=0.272 Sum_probs=132.5
Q ss_pred CCCcccceEecC-----------CcEEEEEcCCCCccccCCccccCCCCCCEEEccCCCCcccCChhhcCCCCCCEEEcC
Q 005102 52 NPCSWNGITCKE-----------QRVVSVSIPKKKLLGFLPSALGSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLY 120 (714)
Q Consensus 52 ~~c~w~gv~c~~-----------~~~~~l~l~~~~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~ 120 (714)
+.|.|+.+.|.. ..++.|+|++|++++..+..|.++++|++|+|++|.+++..|..|..+++|++|+|+
T Consensus 29 c~c~l~~l~~~~~~l~~lp~~~~~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls 108 (330)
T 1xku_A 29 CQCHLRVVQCSDLGLEKVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLS 108 (330)
T ss_dssp CEEETTEEECTTSCCCSCCCSCCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECC
T ss_pred CcCCCeEEEecCCCccccCccCCCCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEECC
Confidence 446899999962 367889999999999888899999999999999999998889999999999999999
Q ss_pred CCcCcccCCcccCCCCCCCEEeccCccCCCCCCcccccccccceeecccCcCCC--CCCcccccCccccccccccCCccc
Q 005102 121 GNSFSGSVPNEIGKLKYLQILDLSQNFFNGSLPVSIVQCKRLKALDLSQNNFTG--PLPNGFGSGLVSLEKLNLSFNKFN 198 (714)
Q Consensus 121 ~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g--~~p~~~~~~l~~L~~L~l~~N~l~ 198 (714)
+|.++ .+|..+. ++|+.|++++|++++..+..|.++++|+.|++++|.++. ..+..+ ..+++|+.|++++|+++
T Consensus 109 ~n~l~-~l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~-~~l~~L~~L~l~~n~l~ 184 (330)
T 1xku_A 109 KNQLK-ELPEKMP--KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAF-QGMKKLSYIRIADTNIT 184 (330)
T ss_dssp SSCCS-BCCSSCC--TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGG-GGCTTCCEEECCSSCCC
T ss_pred CCcCC-ccChhhc--ccccEEECCCCcccccCHhHhcCCccccEEECCCCcCCccCcChhhc-cCCCCcCEEECCCCccc
Confidence 99998 6676554 567777777777765555556666666666666666642 333333 33555555555555555
Q ss_pred ccCCCCCCCCcccccccccccccCCcCcCccccCCCCcccccCcCCcCCCCCC
Q 005102 199 GSIPSNTGNLSSLQGTVDFSHNLFSGSIPASLGNLPEKVYIDLTYNNLSGPIP 251 (714)
Q Consensus 199 g~~p~~~~~l~~L~~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p 251 (714)
.+|..+. ++|+ .|++++|.+++..|..|..+++|+.|++++|++++..+
T Consensus 185 -~l~~~~~--~~L~-~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~ 233 (330)
T 1xku_A 185 -TIPQGLP--PSLT-ELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDN 233 (330)
T ss_dssp -SCCSSCC--TTCS-EEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECT
T ss_pred -cCCcccc--ccCC-EEECCCCcCCccCHHHhcCCCCCCEEECCCCcCceeCh
Confidence 3444332 4444 55555555555555555555555555555555555444
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=99.89 E-value=3.7e-22 Score=210.86 Aligned_cols=192 Identities=18% Similarity=0.246 Sum_probs=146.4
Q ss_pred CCcccceEecC-----------CcEEEEEcCCCCccccCCccccCCCCCCEEEccCCCCcccCChhhcCCCCCCEEEcCC
Q 005102 53 PCSWNGITCKE-----------QRVVSVSIPKKKLLGFLPSALGSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYG 121 (714)
Q Consensus 53 ~c~w~gv~c~~-----------~~~~~l~l~~~~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~ 121 (714)
.|.|+.+.|.. ..++.|+|++|++++..|..|.++++|++|+|++|++++..|..|.++++|++|+|++
T Consensus 32 ~c~l~~l~~~~~~l~~ip~~~~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~ 111 (332)
T 2ft3_A 32 HCHLRVVQCSDLGLKAVPKEISPDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISK 111 (332)
T ss_dssp EEETTEEECCSSCCSSCCSCCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEECCS
T ss_pred cccCCEEECCCCCccccCCCCCCCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEECCC
Confidence 47899999962 3688999999999998888999999999999999999998899999999999999999
Q ss_pred CcCcccCCcccCCCCCCCEEeccCccCCCCCCcccccccccceeecccCcCC--CCCCcccccCccccccccccCCcccc
Q 005102 122 NSFSGSVPNEIGKLKYLQILDLSQNFFNGSLPVSIVQCKRLKALDLSQNNFT--GPLPNGFGSGLVSLEKLNLSFNKFNG 199 (714)
Q Consensus 122 N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~--g~~p~~~~~~l~~L~~L~l~~N~l~g 199 (714)
|.++ .+|..+. ++|++|+|++|++++..+..|..+++|+.|++++|.++ +..|..+ ..+ +|+.|++++|+++
T Consensus 112 n~l~-~l~~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~-~~l-~L~~L~l~~n~l~- 185 (332)
T 2ft3_A 112 NHLV-EIPPNLP--SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAF-DGL-KLNYLRISEAKLT- 185 (332)
T ss_dssp SCCC-SCCSSCC--TTCCEEECCSSCCCCCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSS-CSC-CCSCCBCCSSBCS-
T ss_pred CcCC-ccCcccc--ccCCEEECCCCccCccCHhHhCCCccCCEEECCCCccccCCCCcccc-cCC-ccCEEECcCCCCC-
Confidence 9998 7777665 78999999999998655566888889999999998885 2445544 334 6666666666666
Q ss_pred cCCCCCCCCcccccccccccccCCcCcCccccCCCCcccccCcCCcCCCCCCCC
Q 005102 200 SIPSNTGNLSSLQGTVDFSHNLFSGSIPASLGNLPEKVYIDLTYNNLSGPIPQN 253 (714)
Q Consensus 200 ~~p~~~~~l~~L~~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~~ 253 (714)
.+|..+. ++|+ .|++++|.+++..|..+..+++|+.|++++|++++..|..
T Consensus 186 ~l~~~~~--~~L~-~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~ 236 (332)
T 2ft3_A 186 GIPKDLP--ETLN-ELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGS 236 (332)
T ss_dssp SCCSSSC--SSCS-CCBCCSSCCCCCCTTSSTTCTTCSCCBCCSSCCCCCCTTG
T ss_pred ccCcccc--CCCC-EEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCcCChhH
Confidence 3554443 4555 6666666666555556666666666666666666555543
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=1.2e-23 Score=216.29 Aligned_cols=128 Identities=16% Similarity=0.219 Sum_probs=106.8
Q ss_pred ccccccCceEEEEEEECCCcEEEEEEeCCCCc------------------hhHHHHHHHHHHHhccCCCCccceEEEEEe
Q 005102 409 FVLGKSGIGIVYKVVLEDGHTLAVRRLGEGGS------------------QRFKEFQTEVEAIGKIRHSNIVTLRAYYWS 470 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~------------------~~~~~~~~E~~~l~~l~H~niv~l~~~~~~ 470 (714)
+.||+|+||.||+|.+.+|+.||||.++.... .....+.+|++++++++ | +++.+++.
T Consensus 96 ~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~~~~~- 171 (282)
T 1zar_A 96 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVPKVYA- 171 (282)
T ss_dssp EEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSCCEEE-
T ss_pred CEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcCeEEe-
Confidence 68999999999999997799999999975321 13457899999999999 4 66666543
Q ss_pred CCceeEEEeccCCCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEc
Q 005102 471 VDEKLLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVS 550 (714)
Q Consensus 471 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~ 550 (714)
.+..++||||+++|+|.+ +.. .....++.|++.||+|||+ .+|+||||||+|||++ ++.+||+
T Consensus 172 ~~~~~lvmE~~~g~~L~~-l~~------------~~~~~i~~qi~~~l~~lH~---~giiHrDlkp~NILl~-~~~vkl~ 234 (282)
T 1zar_A 172 WEGNAVLMELIDAKELYR-VRV------------ENPDEVLDMILEEVAKFYH---RGIVHGDLSQYNVLVS-EEGIWII 234 (282)
T ss_dssp EETTEEEEECCCCEEGGG-CCC------------SCHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEEE-TTEEEEC
T ss_pred ccceEEEEEecCCCcHHH-cch------------hhHHHHHHHHHHHHHHHHH---CCCEeCCCCHHHEEEE-CCcEEEE
Confidence 356799999999999998 421 1245799999999999999 8999999999999999 9999999
Q ss_pred ccchhhh
Q 005102 551 DFGLARL 557 (714)
Q Consensus 551 DFGla~~ 557 (714)
|||+|+.
T Consensus 235 DFG~a~~ 241 (282)
T 1zar_A 235 DFPQSVE 241 (282)
T ss_dssp CCTTCEE
T ss_pred ECCCCeE
Confidence 9999874
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.88 E-value=1.6e-23 Score=219.34 Aligned_cols=184 Identities=23% Similarity=0.297 Sum_probs=152.7
Q ss_pred CCcEEEEEcCCCCccccCCccc--cCCCCCCEEEccCCCCcccCChhhcCC-----CCCCEEEcCCCcCcccCCcccCCC
Q 005102 63 EQRVVSVSIPKKKLLGFLPSAL--GSLTDLRHVNLRNNKFFGSLPLELLEA-----QGLQSLVLYGNSFSGSVPNEIGKL 135 (714)
Q Consensus 63 ~~~~~~l~l~~~~l~g~~p~~~--~~l~~L~~L~L~~N~l~~~~p~~~~~l-----~~L~~L~L~~N~l~g~~p~~~~~l 135 (714)
..+++.|+|++|++++.+|..+ ..+++|++|+|++|++++. |..+..+ ++|++|+|++|++++..|..|+.+
T Consensus 94 l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l 172 (312)
T 1wwl_A 94 ISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVF 172 (312)
T ss_dssp TSCCCEEEEEEEBCBSCCCCCSSSCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCC
T ss_pred cCCccEEEccCCcccchhHHHHHHhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccC
Confidence 3478889999999999888877 8899999999999999877 7777776 899999999999998888899999
Q ss_pred CCCCEEeccCccCCCC--CCccc--ccccccceeecccCcCCC--CCCcccccCccccccccccCCcccccCC-CCCCCC
Q 005102 136 KYLQILDLSQNFFNGS--LPVSI--VQCKRLKALDLSQNNFTG--PLPNGFGSGLVSLEKLNLSFNKFNGSIP-SNTGNL 208 (714)
Q Consensus 136 ~~L~~L~Ls~N~l~g~--~p~~~--~~l~~L~~L~l~~N~l~g--~~p~~~~~~l~~L~~L~l~~N~l~g~~p-~~~~~l 208 (714)
++|+.|+|++|++.|. +|..+ ..+++|++|+|++|++++ .++..++..+++|+.|+|++|++++.+| ..+..+
T Consensus 173 ~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l 252 (312)
T 1wwl_A 173 PALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWP 252 (312)
T ss_dssp SSCCEEECCSCTTCHHHHHHHHSCTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCCCC
T ss_pred CCCCEEECCCCCcCcchHHHHHHHhccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhhhhhc
Confidence 9999999999998765 34444 788999999999999873 3344444567899999999999998775 556678
Q ss_pred cccccccccccccCCcCcCccccCCCCcccccCcCCcCCCCCCC
Q 005102 209 SSLQGTVDFSHNLFSGSIPASLGNLPEKVYIDLTYNNLSGPIPQ 252 (714)
Q Consensus 209 ~~L~~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~ 252 (714)
++|+ .|++++|+|+ .+|..+. ++|+.|++++|++++. |.
T Consensus 253 ~~L~-~L~Ls~N~l~-~ip~~~~--~~L~~L~Ls~N~l~~~-p~ 291 (312)
T 1wwl_A 253 SQLN-SLNLSFTGLK-QVPKGLP--AKLSVLDLSYNRLDRN-PS 291 (312)
T ss_dssp TTCC-EEECTTSCCS-SCCSSCC--SEEEEEECCSSCCCSC-CC
T ss_pred CCCC-EEECCCCccC-hhhhhcc--CCceEEECCCCCCCCC-hh
Confidence 8888 9999999998 7887776 8899999999999987 44
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.88 E-value=1e-22 Score=204.50 Aligned_cols=184 Identities=14% Similarity=0.203 Sum_probs=163.5
Q ss_pred CcEEEEEcCCCCccccCCccccCCCCCCEEEccCCC-CcccCChhhcCCCCCCEEEcCC-CcCcccCCcccCCCCCCCEE
Q 005102 64 QRVVSVSIPKKKLLGFLPSALGSLTDLRHVNLRNNK-FFGSLPLELLEAQGLQSLVLYG-NSFSGSVPNEIGKLKYLQIL 141 (714)
Q Consensus 64 ~~~~~l~l~~~~l~g~~p~~~~~l~~L~~L~L~~N~-l~~~~p~~~~~l~~L~~L~L~~-N~l~g~~p~~~~~l~~L~~L 141 (714)
..++.|+|++|++++..+..|.++++|++|+|++|+ +++..+..|.++++|++|+|++ |.+++..+..|.++++|+.|
T Consensus 31 ~~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L 110 (239)
T 2xwt_C 31 PSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFL 110 (239)
T ss_dssp TTCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEE
T ss_pred CcccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEE
Confidence 478999999999999888899999999999999997 8877777899999999999999 99997777889999999999
Q ss_pred eccCccCCCCCCcccccccccc---eeecccC-cCCCCCCcccccCccccc-cccccCCcccccCCCCCCCCcccccccc
Q 005102 142 DLSQNFFNGSLPVSIVQCKRLK---ALDLSQN-NFTGPLPNGFGSGLVSLE-KLNLSFNKFNGSIPSNTGNLSSLQGTVD 216 (714)
Q Consensus 142 ~Ls~N~l~g~~p~~~~~l~~L~---~L~l~~N-~l~g~~p~~~~~~l~~L~-~L~l~~N~l~g~~p~~~~~l~~L~~~l~ 216 (714)
+|++|++++ +|. +..+++|+ .|++++| +++ .+|...+.++++|+ .|++++|+++ .+|......++|+ .++
T Consensus 111 ~l~~n~l~~-lp~-~~~l~~L~~L~~L~l~~N~~l~-~i~~~~~~~l~~L~~~L~l~~n~l~-~i~~~~~~~~~L~-~L~ 185 (239)
T 2xwt_C 111 GIFNTGLKM-FPD-LTKVYSTDIFFILEITDNPYMT-SIPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLD-AVY 185 (239)
T ss_dssp EEEEECCCS-CCC-CTTCCBCCSEEEEEEESCTTCC-EECTTTTTTTBSSEEEEECCSCCCC-EECTTTTTTCEEE-EEE
T ss_pred eCCCCCCcc-ccc-cccccccccccEEECCCCcchh-hcCcccccchhcceeEEEcCCCCCc-ccCHhhcCCCCCC-EEE
Confidence 999999995 776 88888888 9999999 887 45655446799999 9999999999 7777665558898 999
Q ss_pred ccccc-CCcCcCccccCC-CCcccccCcCCcCCCCCCC
Q 005102 217 FSHNL-FSGSIPASLGNL-PEKVYIDLTYNNLSGPIPQ 252 (714)
Q Consensus 217 l~~N~-l~g~~p~~~~~l-~~L~~l~l~~N~l~~~~p~ 252 (714)
+++|+ +++..+..|..+ ++|+.|++++|++++.++.
T Consensus 186 L~~n~~l~~i~~~~~~~l~~~L~~L~l~~N~l~~l~~~ 223 (239)
T 2xwt_C 186 LNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVTALPSK 223 (239)
T ss_dssp CTTCTTCCEECTTTTTTCSBCCSEEECTTCCCCCCCCT
T ss_pred cCCCCCcccCCHHHhhccccCCcEEECCCCccccCChh
Confidence 99995 997777889999 9999999999999976655
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.88 E-value=1.5e-22 Score=198.76 Aligned_cols=183 Identities=23% Similarity=0.267 Sum_probs=146.1
Q ss_pred CCCCcccceEecCCcEEEEEcCCCCccccCCccccCCCCCCEEEccCCCCcccCChhhcCCCCCCEEEcCCCcCcccCCc
Q 005102 51 ENPCSWNGITCKEQRVVSVSIPKKKLLGFLPSALGSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSGSVPN 130 (714)
Q Consensus 51 ~~~c~w~gv~c~~~~~~~l~l~~~~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~ 130 (714)
.+.|.|.+|.|... +++ .+|..+ .++|++|+|++|++++..+..+..+++|+.|+|++|++++..+.
T Consensus 4 ~C~C~~~~v~c~~~----------~l~-~~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~ 70 (208)
T 2o6s_A 4 RCSCSGTTVECYSQ----------GRT-SVPTGI--PAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNG 70 (208)
T ss_dssp TCEEETTEEECCSS----------CCS-SCCSCC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTT
T ss_pred CCEECCCEEEecCC----------Ccc-CCCCCC--CCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChh
Confidence 35688999999743 333 234333 45889999999999876666788899999999999999866666
Q ss_pred ccCCCCCCCEEeccCccCCCCCCcccccccccceeecccCcCCCCCCcccccCccccccccccCCcccccCCCCCCCCcc
Q 005102 131 EIGKLKYLQILDLSQNFFNGSLPVSIVQCKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLNLSFNKFNGSIPSNTGNLSS 210 (714)
Q Consensus 131 ~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~ 210 (714)
.|..+++|++|+|++|++++..+..|..+++|++|+|++|++++ +|...+..+++|+.|+|++|++++..+..+..+++
T Consensus 71 ~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~-~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~ 149 (208)
T 2o6s_A 71 VFNKLTSLTYLNLSTNQLQSLPNGVFDKLTQLKELALNTNQLQS-LPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTS 149 (208)
T ss_dssp TTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCC-CCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTT
T ss_pred hcCCCCCcCEEECCCCcCCccCHhHhcCccCCCEEEcCCCcCcc-cCHhHhccCCcCCEEECCCCccceeCHHHhccCCC
Confidence 78889999999999999986666667889999999999999985 44444356889999999999998666666888899
Q ss_pred cccccccccccCCcCcCccccCCCCcccccCcCCcCCCCCCCCcc
Q 005102 211 LQGTVDFSHNLFSGSIPASLGNLPEKVYIDLTYNNLSGPIPQNGA 255 (714)
Q Consensus 211 L~~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~ 255 (714)
|+ .+++++|.+.+ .+++|++|+++.|+++|.+|....
T Consensus 150 L~-~L~l~~N~~~~-------~~~~l~~L~~~~n~~~g~ip~~~~ 186 (208)
T 2o6s_A 150 LQ-YIWLHDNPWDC-------TCPGIRYLSEWINKHSGVVRNSAG 186 (208)
T ss_dssp CC-EEECCSCCBCC-------CTTTTHHHHHHHHHCTTTBBCTTS
T ss_pred cc-EEEecCCCeec-------CCCCHHHHHHHHHhCCceeeccCc
Confidence 98 99999998874 456788999999999999987644
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=1.4e-22 Score=223.84 Aligned_cols=190 Identities=21% Similarity=0.275 Sum_probs=119.4
Q ss_pred CcEEEEEcCCCCccccCCccccCCCCCCEEEccCCCCcccCChh--hcCCCCCCEEEcCCCcCcccCCcc-cCCCCCCCE
Q 005102 64 QRVVSVSIPKKKLLGFLPSALGSLTDLRHVNLRNNKFFGSLPLE--LLEAQGLQSLVLYGNSFSGSVPNE-IGKLKYLQI 140 (714)
Q Consensus 64 ~~~~~l~l~~~~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~--~~~l~~L~~L~L~~N~l~g~~p~~-~~~l~~L~~ 140 (714)
.+++.|+|++|++++..|..|+++++|++|+|++|.+++.+|.. +..+++|++|+|++|.+++..|.. +.++++|+.
T Consensus 79 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~ 158 (455)
T 3v47_A 79 SSLIILKLDYNQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHV 158 (455)
T ss_dssp TTCCEEECTTCTTCEECTTTTTTCTTCCEEECTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCCSCCCCGGGGGCTTCCE
T ss_pred ccCCEEeCCCCccCccChhhccCcccCCEEeCCCCCCCccccCcccccCcccCCEEECCCCccCccCcccccCCCCcccE
Confidence 46777777777777777777777777777777777777655444 666777777777777777665655 666677777
Q ss_pred EeccCccCCCCCCcccccc-------------------------------------------------------------
Q 005102 141 LDLSQNFFNGSLPVSIVQC------------------------------------------------------------- 159 (714)
Q Consensus 141 L~Ls~N~l~g~~p~~~~~l------------------------------------------------------------- 159 (714)
|+|++|++++..|..+..+
T Consensus 159 L~L~~n~l~~~~~~~l~~l~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~~~~ 238 (455)
T 3v47_A 159 LDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAG 238 (455)
T ss_dssp EECTTCCBSCCCTTTSGGGTTCEEEEEECTTCBCTTCSTTCTTHHHHCCTTTTCEEEEEECTTSCCCHHHHHHHHHHTTT
T ss_pred EeCCCCcccccChhhhhccccccccccccccCcccccchhhccccccccccccceeeeEecCCCcccccchhhhhccccc
Confidence 7777776665555443322
Q ss_pred ------------------------------------cccceeecccCcCCCCCCcccccCccccccccccCCcccccCCC
Q 005102 160 ------------------------------------KRLKALDLSQNNFTGPLPNGFGSGLVSLEKLNLSFNKFNGSIPS 203 (714)
Q Consensus 160 ------------------------------------~~L~~L~l~~N~l~g~~p~~~~~~l~~L~~L~l~~N~l~g~~p~ 203 (714)
++|+.|+|++|++++.+|..+ ..+++|+.|+|++|++++..|.
T Consensus 239 ~~L~~L~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~-~~l~~L~~L~Ls~n~l~~~~~~ 317 (455)
T 3v47_A 239 TKIQSLILSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFALLKSVF-SHFTDLEQLTLAQNEINKIDDN 317 (455)
T ss_dssp CCEEEEECTTCTTTSCCTTCCSSCCCCTTTTGGGTTSCCCEEECCSSCCCEECTTTT-TTCTTCCEEECTTSCCCEECTT
T ss_pred cceeeEeeccccccccccchhhhccCcccccccccccCceEEEecCccccccchhhc-ccCCCCCEEECCCCcccccChh
Confidence 133444444444444344444 3466666666666666666666
Q ss_pred CCCCCcccccccccccccCCcCcCccccCCCCcccccCcCCcCCCCCCCCcc
Q 005102 204 NTGNLSSLQGTVDFSHNLFSGSIPASLGNLPEKVYIDLTYNNLSGPIPQNGA 255 (714)
Q Consensus 204 ~~~~l~~L~~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~ 255 (714)
.+.++++|+ .|++++|.+++..|..|+.+++|+.|++++|++++.+|....
T Consensus 318 ~~~~l~~L~-~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~ 368 (455)
T 3v47_A 318 AFWGLTHLL-KLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRALGDQSFL 368 (455)
T ss_dssp TTTTCTTCC-EEECCSSCCCEECGGGGTTCTTCCEEECCSSCCCEECTTTTT
T ss_pred HhcCcccCC-EEECCCCccCCcChhHhcCcccCCEEECCCCcccccChhhcc
Confidence 666666666 666666666655566666666666666666666666555443
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.88 E-value=8e-22 Score=202.08 Aligned_cols=183 Identities=22% Similarity=0.282 Sum_probs=143.3
Q ss_pred CcEEEEEcCCCCccccCCccccCCCCCCEEEccCCCCcccCChhhcCCCCCCEEEcCCCcCcccCCcccCCCCCCCEEec
Q 005102 64 QRVVSVSIPKKKLLGFLPSALGSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSGSVPNEIGKLKYLQILDL 143 (714)
Q Consensus 64 ~~~~~l~l~~~~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L 143 (714)
.+++.|++.+|.++.. +.+..+++|++|+|++|.+++ + ..+..+++|++|+|++|.+++..|..++++++|+.|+|
T Consensus 41 ~~L~~L~l~~~~i~~~--~~l~~l~~L~~L~l~~n~l~~-~-~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 116 (272)
T 3rfs_A 41 NSIDQIIANNSDIKSV--QGIQYLPNVRYLALGGNKLHD-I-SALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVL 116 (272)
T ss_dssp TTCCEEECTTSCCCCC--TTGGGCTTCCEEECTTSCCCC-C-GGGTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEEC
T ss_pred cceeeeeeCCCCcccc--cccccCCCCcEEECCCCCCCC-c-hhhcCCCCCCEEECCCCccCccChhHhcCCcCCCEEEC
Confidence 4677788888877642 357788888888888888875 3 36778888888888888888777777788888888888
Q ss_pred cCccCCCCCCcccccccccceeecccCcCCCCCCcccccCccccccccccCCcccccCCCCCCCCcccccccccccccCC
Q 005102 144 SQNFFNGSLPVSIVQCKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLNLSFNKFNGSIPSNTGNLSSLQGTVDFSHNLFS 223 (714)
Q Consensus 144 s~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~~l~l~~N~l~ 223 (714)
++|++++..|..|..+++|++|+|++|++++ +|...+..+++|+.|+|++|++++..|..+.++++|+ .|++++|+++
T Consensus 117 ~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~-~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~-~L~L~~N~l~ 194 (272)
T 3rfs_A 117 VENQLQSLPDGVFDKLTNLTYLNLAHNQLQS-LPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLK-DLRLYQNQLK 194 (272)
T ss_dssp TTSCCCCCCTTTTTTCTTCCEEECCSSCCCC-CCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCC-EEECCSSCCS
T ss_pred CCCcCCccCHHHhccCCCCCEEECCCCccCc-cCHHHhccCccCCEEECCCCCcCccCHHHhcCCccCC-EEECCCCcCC
Confidence 8888886666667888888888888888874 4444334678888888888888866666678888888 8888888888
Q ss_pred cCcCccccCCCCcccccCcCCcCCCCCCC
Q 005102 224 GSIPASLGNLPEKVYIDLTYNNLSGPIPQ 252 (714)
Q Consensus 224 g~~p~~~~~l~~L~~l~l~~N~l~~~~p~ 252 (714)
+..|..++.+++|+.|++++|.+.+..|.
T Consensus 195 ~~~~~~~~~l~~L~~L~l~~N~~~~~~~~ 223 (272)
T 3rfs_A 195 SVPDGVFDRLTSLQYIWLHDNPWDCTCPG 223 (272)
T ss_dssp CCCTTTTTTCTTCCEEECCSSCBCCCTTT
T ss_pred ccCHHHHhCCcCCCEEEccCCCccccCcH
Confidence 87777788888888888888888877764
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.87 E-value=2.2e-22 Score=229.87 Aligned_cols=132 Identities=20% Similarity=0.200 Sum_probs=70.5
Q ss_pred EEEEEcCCCCccccCCccccCCCCCCEEEccCCCCcccCChhhcCCCCCCEEEcCCCcCcccCCcccCCCCCCCEEeccC
Q 005102 66 VVSVSIPKKKLLGFLPSALGSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSGSVPNEIGKLKYLQILDLSQ 145 (714)
Q Consensus 66 ~~~l~l~~~~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~ 145 (714)
+..+++.+|.+.+..+..|.++++|++|+|++|.+++..|..|..+++|+.|+|++|.+++..|..|+++++|+.|+|++
T Consensus 53 l~~l~l~~~~l~~lp~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~ 132 (597)
T 3oja_B 53 QKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLER 132 (597)
T ss_dssp CSEEEESSCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred ceEEEeeCCCCCCcCHHHHccCCCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEeeC
Confidence 34455555555554444455555555555555555555555555555555555555555555555555555555555555
Q ss_pred ccCCCCCCcccccccccceeecccCcCCCCCCcccccCccccccccccCCccc
Q 005102 146 NFFNGSLPVSIVQCKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLNLSFNKFN 198 (714)
Q Consensus 146 N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~l~~L~~L~l~~N~l~ 198 (714)
|.|++..+..|.++++|++|+|++|.+++..|..+ ..+++|+.|+|++|+++
T Consensus 133 n~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~-~~l~~L~~L~L~~N~l~ 184 (597)
T 3oja_B 133 NDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTF-QATTSLQNLQLSSNRLT 184 (597)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTT-TTCTTCCEEECTTSCCS
T ss_pred CCCCCCCHHHhccCCCCCEEEeeCCcCCCCChhhh-hcCCcCcEEECcCCCCC
Confidence 55553333334555555555555555554444333 23555555555555554
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.87 E-value=3.5e-22 Score=222.02 Aligned_cols=197 Identities=19% Similarity=0.181 Sum_probs=176.3
Q ss_pred cccceEecC-----------CcEEEEEcCCCCccccCCccccCCCCCCEEEccCCCCcccCChhhcCCCCCCEEEcCCCc
Q 005102 55 SWNGITCKE-----------QRVVSVSIPKKKLLGFLPSALGSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNS 123 (714)
Q Consensus 55 ~w~gv~c~~-----------~~~~~l~l~~~~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~ 123 (714)
.|..|.|.. ..++.|+|++|++++..|..|.++++|++|+|++|.+++..|..|.++++|++|+|++|.
T Consensus 12 ~~~~v~c~~~~l~~ip~~~~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~ 91 (477)
T 2id5_A 12 QDRAVLCHRKRFVAVPEGIPTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNR 91 (477)
T ss_dssp TTTEEECCSCCCSSCCSCCCTTCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSC
T ss_pred CCCEEEeCCCCcCcCCCCCCCCCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCCc
Confidence 377899962 367789999999999999999999999999999999999889999999999999999999
Q ss_pred CcccCCcccCCCCCCCEEeccCccCCCCCCcccccccccceeecccCcCCCCCCcccccCccccccccccCCcccccCCC
Q 005102 124 FSGSVPNEIGKLKYLQILDLSQNFFNGSLPVSIVQCKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLNLSFNKFNGSIPS 203 (714)
Q Consensus 124 l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~l~~L~~L~l~~N~l~g~~p~ 203 (714)
+++..+..|.++++|+.|+|++|++++..|..|..+++|+.|+|++|.+++..|..+ .++++|+.|+|++|++++..+.
T Consensus 92 l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~-~~l~~L~~L~l~~n~l~~~~~~ 170 (477)
T 2id5_A 92 LKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAF-SGLNSLEQLTLEKCNLTSIPTE 170 (477)
T ss_dssp CCSCCTTSSTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEECCTTCCEECTTSS-TTCTTCCEEEEESCCCSSCCHH
T ss_pred CCccCcccccCCCCCCEEECCCCccccCChhHccccccCCEEECCCCccceeChhhc-cCCCCCCEEECCCCcCcccChh
Confidence 996666678999999999999999998889999999999999999999987666666 5699999999999999966666
Q ss_pred CCCCCcccccccccccccCCcCcCccccCCCCcccccCcCCcCCCCCCCC
Q 005102 204 NTGNLSSLQGTVDFSHNLFSGSIPASLGNLPEKVYIDLTYNNLSGPIPQN 253 (714)
Q Consensus 204 ~~~~l~~L~~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~~ 253 (714)
.+.++++|+ .|++++|.+++..+..|..+++|+.|++++|++.+.+|..
T Consensus 171 ~l~~l~~L~-~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~ 219 (477)
T 2id5_A 171 ALSHLHGLI-VLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPN 219 (477)
T ss_dssp HHTTCTTCC-EEEEESCCCCEECTTCSCSCTTCCEEEEECCTTCCEECTT
T ss_pred HhcccCCCc-EEeCCCCcCcEeChhhcccCcccceeeCCCCccccccCcc
Confidence 788999999 9999999999888889999999999999999887776654
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=99.87 E-value=7.5e-23 Score=235.21 Aligned_cols=187 Identities=25% Similarity=0.380 Sum_probs=174.6
Q ss_pred CCcEEEEEcCCCCcccc-----------------CCcccc--CCCCCCEEEccCCCCcccCChhhcCCCCCCEEEcCCCc
Q 005102 63 EQRVVSVSIPKKKLLGF-----------------LPSALG--SLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNS 123 (714)
Q Consensus 63 ~~~~~~l~l~~~~l~g~-----------------~p~~~~--~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~ 123 (714)
..+++.|+|++|.++|. +|+.++ ++++|++|+|++|.+.|.+|..+.++++|+.|+|++|+
T Consensus 205 l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~ 284 (636)
T 4eco_A 205 LTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNR 284 (636)
T ss_dssp CTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEECCTTCSSCCTTTTTCSSCCEEECTTCT
T ss_pred ccCCCEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCEEEecCCcCCccChHHHhcCCCCCEEECcCCC
Confidence 56899999999999996 999999 99999999999999999999999999999999999999
Q ss_pred -Ccc-cCCcccCCC------CCCCEEeccCccCCCCCCc--ccccccccceeecccCcCCCCCCcccccCcccccccccc
Q 005102 124 -FSG-SVPNEIGKL------KYLQILDLSQNFFNGSLPV--SIVQCKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLNLS 193 (714)
Q Consensus 124 -l~g-~~p~~~~~l------~~L~~L~Ls~N~l~g~~p~--~~~~l~~L~~L~l~~N~l~g~~p~~~~~~l~~L~~L~l~ 193 (714)
++| .+|..++++ ++|+.|+|++|+++ .+|. .+.++++|+.|+|++|+++|.+| .+ ..+++|+.|+|+
T Consensus 285 ~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~-~ip~~~~l~~l~~L~~L~L~~N~l~g~ip-~~-~~l~~L~~L~L~ 361 (636)
T 4eco_A 285 GISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK-TFPVETSLQKMKKLGMLECLYNQLEGKLP-AF-GSEIKLASLNLA 361 (636)
T ss_dssp TSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCS-SCCCHHHHTTCTTCCEEECCSCCCEEECC-CC-EEEEEESEEECC
T ss_pred CCccccchHHHHhhhccccCCCCCEEECCCCcCC-ccCchhhhccCCCCCEEeCcCCcCccchh-hh-CCCCCCCEEECC
Confidence 999 899998887 99999999999999 8998 99999999999999999999999 66 469999999999
Q ss_pred CCcccccCCCCCCCCcc-cccccccccccCCcCcCccccCCC--CcccccCcCCcCCCCCCCCcc
Q 005102 194 FNKFNGSIPSNTGNLSS-LQGTVDFSHNLFSGSIPASLGNLP--EKVYIDLTYNNLSGPIPQNGA 255 (714)
Q Consensus 194 ~N~l~g~~p~~~~~l~~-L~~~l~l~~N~l~g~~p~~~~~l~--~L~~l~l~~N~l~~~~p~~~~ 255 (714)
+|+++ .+|..+.++++ |+ .|++++|.++ .+|..+..++ +|+.|++++|++++.+|....
T Consensus 362 ~N~l~-~lp~~l~~l~~~L~-~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~ 423 (636)
T 4eco_A 362 YNQIT-EIPANFCGFTEQVE-NLSFAHNKLK-YIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFD 423 (636)
T ss_dssp SSEEE-ECCTTSEEECTTCC-EEECCSSCCS-SCCSCCCTTCSSCEEEEECCSSCTTTTTTCSSC
T ss_pred CCccc-cccHhhhhhcccCc-EEEccCCcCc-ccchhhhhcccCccCEEECcCCcCCCcchhhhc
Confidence 99999 99999999999 99 9999999999 8898888765 899999999999998887544
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=2.2e-22 Score=230.71 Aligned_cols=209 Identities=17% Similarity=0.125 Sum_probs=182.0
Q ss_pred CcEEEEEcCCCCcccc--CCccccCCCCCCEEEccCCCCcccCChhhcCCCCCCEEEcCCCcCcccCC-cccCCCCCCCE
Q 005102 64 QRVVSVSIPKKKLLGF--LPSALGSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSGSVP-NEIGKLKYLQI 140 (714)
Q Consensus 64 ~~~~~l~l~~~~l~g~--~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p-~~~~~l~~L~~ 140 (714)
.+++.|+|++|.+++. +|..+..+++|++|+|++|.+++ +|..+..+++|+.|+|++|.+++..| ..+.++++|+.
T Consensus 350 ~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~ 428 (606)
T 3vq2_A 350 PSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAII-MSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLY 428 (606)
T ss_dssp TTCCEEECCSSCEEEEEECCHHHHCCSCCCEEECCSCSEEE-ECCCCTTCTTCCEEECTTSEEESTTTTTTTTTCTTCCE
T ss_pred CCCCEEECcCCccCCCcchhhhhccCCcccEeECCCCcccc-chhhccCCCCCCeeECCCCccCCccChhhhhccccCCE
Confidence 4788899999999887 48889999999999999999885 66888999999999999999998877 68999999999
Q ss_pred EeccCccCCCCCCcccccccccceeecccCcCCCC-CCcccccCccccccccccCCcccccCCCCCCCCccccccccccc
Q 005102 141 LDLSQNFFNGSLPVSIVQCKRLKALDLSQNNFTGP-LPNGFGSGLVSLEKLNLSFNKFNGSIPSNTGNLSSLQGTVDFSH 219 (714)
Q Consensus 141 L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~-~p~~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~~l~l~~ 219 (714)
|+|++|++++..|..+..+++|+.|+|++|++++. +|..+ ..+++|+.|+|++|++++.+|..+.++++|+ .|++++
T Consensus 429 L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~-~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~-~L~Ls~ 506 (606)
T 3vq2_A 429 LDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVF-ANTTNLTFLDLSKCQLEQISWGVFDTLHRLQ-LLNMSH 506 (606)
T ss_dssp EECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCC-TTCTTCCEEECTTSCCCEECTTTTTTCTTCC-EEECCS
T ss_pred EECcCCCCCccchhhhcCCCCCCEEECCCCcCCCcchHHhh-ccCCCCCEEECCCCcCCccChhhhcccccCC-EEECCC
Confidence 99999999998999999999999999999999974 56666 5699999999999999999999999999999 999999
Q ss_pred ccCCcCcCccccCCCCcccccCcCCcCCCCCCCCcccc-CCCCcccccCCCCCCCCC
Q 005102 220 NLFSGSIPASLGNLPEKVYIDLTYNNLSGPIPQNGALM-NRGPTAFIGNPRLCGPPL 275 (714)
Q Consensus 220 N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~~~-~~~~~~~~~n~~~~~~~~ 275 (714)
|++++.+|..|+.+++|+.|++++|+++..++....+. ......+.+|+..|.++.
T Consensus 507 N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~p~~~~~l~~~L~~l~l~~N~~~c~c~~ 563 (606)
T 3vq2_A 507 NNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSVACICEH 563 (606)
T ss_dssp SCCSCEEGGGTTTCTTCCEEECTTSCCCCEESCGGGSCTTCCEEECCSCCCCCSSTT
T ss_pred CcCCCcCHHHccCCCcCCEEECCCCcCcccCHhHhhhcccCcEEEccCCCcccCCcc
Confidence 99999999999999999999999999995544423332 245567789998887764
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.87 E-value=1.4e-21 Score=201.94 Aligned_cols=180 Identities=22% Similarity=0.169 Sum_probs=161.9
Q ss_pred CcEEEEEcCCCCccccCCccccCCCCCCEEEccCCCCcccCChhhcCCCCCCEEEcCCCcCcccCCcccCCCCCCCEEec
Q 005102 64 QRVVSVSIPKKKLLGFLPSALGSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSGSVPNEIGKLKYLQILDL 143 (714)
Q Consensus 64 ~~~~~l~l~~~~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L 143 (714)
..++.|+|++|++++..|..|.++++|++|+|++|.|++..+. ..+++|++|+|++|+++ .+|..+..+++|+.|+|
T Consensus 31 ~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~--~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~L~~L~l 107 (290)
T 1p9a_G 31 KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVD--GTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDV 107 (290)
T ss_dssp TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEECC--SCCTTCCEEECCSSCCS-SCCCCTTTCTTCCEEEC
T ss_pred CCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCcccCC--CCCCcCCEEECCCCcCC-cCchhhccCCCCCEEEC
Confidence 4788999999999999999999999999999999999965433 78999999999999998 88999999999999999
Q ss_pred cCccCCCCCCcccccccccceeecccCcCCCCCCcccccCccccccccccCCcccccCCCCCCCCcccccccccccccCC
Q 005102 144 SQNFFNGSLPVSIVQCKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLNLSFNKFNGSIPSNTGNLSSLQGTVDFSHNLFS 223 (714)
Q Consensus 144 s~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~~l~l~~N~l~ 223 (714)
++|+|++..|..|..+++|+.|+|++|+++ .+|...+..+++|+.|+|++|+|++..+..+..+++|+ .|++++|+|+
T Consensus 108 ~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~-~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~-~L~L~~N~l~ 185 (290)
T 1p9a_G 108 SFNRLTSLPLGALRGLGELQELYLKGNELK-TLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLD-TLLLQENSLY 185 (290)
T ss_dssp CSSCCCCCCSSTTTTCTTCCEEECTTSCCC-CCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCC-EEECCSSCCC
T ss_pred CCCcCcccCHHHHcCCCCCCEEECCCCCCC-ccChhhcccccCCCEEECCCCcCCccCHHHhcCcCCCC-EEECCCCcCC
Confidence 999999777788999999999999999999 45655556799999999999999955555678899999 9999999999
Q ss_pred cCcCccccCCCCcccccCcCCcCCCC
Q 005102 224 GSIPASLGNLPEKVYIDLTYNNLSGP 249 (714)
Q Consensus 224 g~~p~~~~~l~~L~~l~l~~N~l~~~ 249 (714)
.+|..+..+++|+.|++++|.+...
T Consensus 186 -~ip~~~~~~~~L~~l~L~~Np~~C~ 210 (290)
T 1p9a_G 186 -TIPKGFFGSHLLPFAFLHGNPWLCN 210 (290)
T ss_dssp -CCCTTTTTTCCCSEEECCSCCBCCS
T ss_pred -ccChhhcccccCCeEEeCCCCccCc
Confidence 7888888999999999999999753
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.87 E-value=9.4e-23 Score=226.56 Aligned_cols=202 Identities=20% Similarity=0.171 Sum_probs=141.3
Q ss_pred cEEEEEcCCCCccccCCccccCCCCCCEEEccCCCCcccCChhhcCCCCCCEEEcCCCcCcccCCc--------------
Q 005102 65 RVVSVSIPKKKLLGFLPSALGSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSGSVPN-------------- 130 (714)
Q Consensus 65 ~~~~l~l~~~~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~-------------- 130 (714)
+++.|+|++|.+++..|..|+.+++|++|+|++|.+++..| +..+++|++|+|++|.|++..+.
T Consensus 35 ~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l~~~~~L~~L~L~~N~l~ 112 (487)
T 3oja_A 35 NVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELLVGPSIETLHAANNNIS 112 (487)
T ss_dssp GCCEEECCSSCCCCCCGGGGTTCTTCCEEECTTSCCEEEEE--CTTCTTCCEEECCSSEEEEEEECTTCCEEECCSSCCC
T ss_pred CccEEEeeCCcCCCCCHHHHhCCCCCCEEEeeCCCCCCCcc--cccCCCCCEEEecCCcCCCCCCCCCcCEEECcCCcCC
Confidence 67778888888887777777888888888888888776555 67777777777777776643211
Q ss_pred --ccCCCCCCCEEeccCccCCCCCCcccccccccceeecccCcCCCCCCcccccCccccccccccCCcccccCCCCCCCC
Q 005102 131 --EIGKLKYLQILDLSQNFFNGSLPVSIVQCKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLNLSFNKFNGSIPSNTGNL 208 (714)
Q Consensus 131 --~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l 208 (714)
....+++|+.|+|++|.+++..|..+..+++|+.|+|++|.+++.+|..+...+++|+.|+|++|.|++. |. ...+
T Consensus 113 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l~~~-~~-~~~l 190 (487)
T 3oja_A 113 RVSCSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV-KG-QVVF 190 (487)
T ss_dssp CEEECCCSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE-EC-CCCC
T ss_pred CCCccccCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCccccc-cc-cccC
Confidence 0123567778888888887777777788888888888888888777776654577888888888888755 32 3347
Q ss_pred cccccccccccccCCcCcCccccCCCCcccccCcCCcCCCCCCCCccccCCCCcccccCCCCCC
Q 005102 209 SSLQGTVDFSHNLFSGSIPASLGNLPEKVYIDLTYNNLSGPIPQNGALMNRGPTAFIGNPRLCG 272 (714)
Q Consensus 209 ~~L~~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~~~~~~~~~~~~n~~~~~ 272 (714)
++|+ .|+|++|.|++. |..+..+++|+.|++++|+|++.++....+.......+.+|+..|+
T Consensus 191 ~~L~-~L~Ls~N~l~~~-~~~~~~l~~L~~L~Ls~N~l~~lp~~l~~l~~L~~L~l~~N~l~c~ 252 (487)
T 3oja_A 191 AKLK-TLDLSSNKLAFM-GPEFQSAAGVTWISLRNNKLVLIEKALRFSQNLEHFDLRGNGFHCG 252 (487)
T ss_dssp TTCC-EEECCSSCCCEE-CGGGGGGTTCSEEECTTSCCCEECTTCCCCTTCCEEECTTCCBCHH
T ss_pred CCCC-EEECCCCCCCCC-CHhHcCCCCccEEEecCCcCcccchhhccCCCCCEEEcCCCCCcCc
Confidence 7777 888888888864 4457788888888888888887544333333444455556666554
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=1.8e-22 Score=228.58 Aligned_cols=194 Identities=16% Similarity=0.185 Sum_probs=173.4
Q ss_pred CCcccceEecC-------------CcEEEEEcCCCCccccCCccccCCCCCCEEEccCCCCcccCChhhcCCCCCCEEEc
Q 005102 53 PCSWNGITCKE-------------QRVVSVSIPKKKLLGFLPSALGSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVL 119 (714)
Q Consensus 53 ~c~w~gv~c~~-------------~~~~~l~l~~~~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 119 (714)
.|.|.|| |+. ..++.|+|++|++++..|..|.++++|++|+|++|++++..|..|..+++|++|+|
T Consensus 3 ~C~~~~~-c~~~~~~l~~ip~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L 81 (549)
T 2z81_A 3 SCDASGV-CDGRSRSFTSIPSGLTAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDL 81 (549)
T ss_dssp EECTTSE-EECTTSCCSSCCSCCCTTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEC
T ss_pred cCCCCce-EECCCCccccccccCCCCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChhhccccccCCEEEC
Confidence 4888888 752 37999999999999999999999999999999999999988899999999999999
Q ss_pred CCCcCcccCCcccCCCCCCCEEeccCccCCC-CCCcccccccccceeecccCcCCCCCCcccccCccccccccccCCccc
Q 005102 120 YGNSFSGSVPNEIGKLKYLQILDLSQNFFNG-SLPVSIVQCKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLNLSFNKFN 198 (714)
Q Consensus 120 ~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g-~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~l~~L~~L~l~~N~l~ 198 (714)
++|.+++..|..|+++++|++|+|++|++++ .+|..+.++++|++|++++|.+.+.+|...+.++++|+.|++++|+++
T Consensus 82 s~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~l~ 161 (549)
T 2z81_A 82 SDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLR 161 (549)
T ss_dssp TTSCCCSCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCC
T ss_pred CCCccCccCHHHhccCCCCcEEECCCCcccccchhhhhhccCCccEEECCCCccccccCHhhhhcccccCeeeccCCccc
Confidence 9999998777779999999999999999986 467889999999999999999767787544467999999999999999
Q ss_pred ccCCCCCCCCcccccccccccccCCcCcCcc-ccCCCCcccccCcCCcCCCC
Q 005102 199 GSIPSNTGNLSSLQGTVDFSHNLFSGSIPAS-LGNLPEKVYIDLTYNNLSGP 249 (714)
Q Consensus 199 g~~p~~~~~l~~L~~~l~l~~N~l~g~~p~~-~~~l~~L~~l~l~~N~l~~~ 249 (714)
+.+|..++++++|+ .++++.|.+. .+|.. +..+++|++|++++|++++.
T Consensus 162 ~~~~~~l~~l~~L~-~L~l~~n~~~-~~~~~~~~~l~~L~~L~L~~n~l~~~ 211 (549)
T 2z81_A 162 NYQSQSLKSIRDIH-HLTLHLSESA-FLLEIFADILSSVRYLELRDTNLARF 211 (549)
T ss_dssp EECTTTTTTCSEEE-EEEEECSBST-THHHHHHHSTTTBSEEEEESCBCTTC
T ss_pred ccChhhhhccccCc-eEecccCccc-ccchhhHhhcccccEEEccCCccccc
Confidence 99999999999999 9999999987 44544 46799999999999999985
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.87 E-value=4.4e-22 Score=236.45 Aligned_cols=210 Identities=21% Similarity=0.174 Sum_probs=119.1
Q ss_pred cEEEEEcCCCCccccCCccccCCCCCCEEEccCCCCcccCChhhcCCCCCCEEEcCCCcCcccCCcccCCCCCCCEEecc
Q 005102 65 RVVSVSIPKKKLLGFLPSALGSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSGSVPNEIGKLKYLQILDLS 144 (714)
Q Consensus 65 ~~~~l~l~~~~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls 144 (714)
.++.|+|++|.+.+..|..|..+++|+.|+|++|++++..|..|..+++|+.|+|++|.+++..|..|..+++|+.|+|+
T Consensus 267 ~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~ 346 (844)
T 3j0a_A 267 SVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQ 346 (844)
T ss_dssp CCCEEECTTCCCCEECSCCSSSCCCCCEEEEESCCCCEECTTTTTTCSSCCEEEEESCCCSCCCSCSCSSCTTCCEEECC
T ss_pred CccEEECCCCcccccChhhhhcCCCCCEEECCCCcCCCCChHHhcCCCCCCEEECCCCCCCccCHHHhcCCCCCCEEECC
Confidence 45666666666666666666666666666666666666556666666666666666666665556666666666666666
Q ss_pred CccCCCCCCcccccccccceeecccCcCCC--------------------------------------------------
Q 005102 145 QNFFNGSLPVSIVQCKRLKALDLSQNNFTG-------------------------------------------------- 174 (714)
Q Consensus 145 ~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g-------------------------------------------------- 174 (714)
+|++++..+..|..+++|+.|+|++|.+++
T Consensus 347 ~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~L~~L~l~~N~l~~l~~~~~~l~~L~ls~N~l~~l~~~~~~~~l~ 426 (844)
T 3j0a_A 347 KNHIAIIQDQTFKFLEKLQTLDLRDNALTTIHFIPSIPDIFLSGNKLVTLPKINLTANLIHLSENRLENLDILYFLLRVP 426 (844)
T ss_dssp SCCCCCCCSSCSCSCCCCCEEEEETCCSCCCSSCCSCSEEEEESCCCCCCCCCCTTCCEEECCSCCCCSSTTHHHHTTCT
T ss_pred CCCCCccChhhhcCCCCCCEEECCCCCCCcccCCCCcchhccCCCCcccccccccccceeecccCccccCchhhhhhcCC
Confidence 666654444455555555555555555442
Q ss_pred --------------CCCcccccCccccccccccCCccc-----ccCCCCCCCCcccccccccccccCCcCcCccccCCCC
Q 005102 175 --------------PLPNGFGSGLVSLEKLNLSFNKFN-----GSIPSNTGNLSSLQGTVDFSHNLFSGSIPASLGNLPE 235 (714)
Q Consensus 175 --------------~~p~~~~~~l~~L~~L~l~~N~l~-----g~~p~~~~~l~~L~~~l~l~~N~l~g~~p~~~~~l~~ 235 (714)
..+......+++|+.|+|++|.++ +..|..+..+++|+ .|+|++|+|++..|..|..+++
T Consensus 427 ~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~l~~L~-~L~Ls~N~l~~~~~~~~~~l~~ 505 (844)
T 3j0a_A 427 HLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQ-VLYLNHNYLNSLPPGVFSHLTA 505 (844)
T ss_dssp TCCEEEEESCCCCCCCSSSSSCSCTTCCBCEEESCCCSSSCCSCCCSSCSSCBCCEE-CCCCCHHHHTTCCTTSSSSCCS
T ss_pred ccceeeCCCCcccccccccccccCCccccccCCCCccccccccccchhhhcCccccc-EEECCCCcccccChhHccchhh
Confidence 111111112233333344444333 22234455666666 6666666666666666666666
Q ss_pred cccccCcCCcCCCCCCCCcc--------------------ccCCCCcccccCCCCCCCCC
Q 005102 236 KVYIDLTYNNLSGPIPQNGA--------------------LMNRGPTAFIGNPRLCGPPL 275 (714)
Q Consensus 236 L~~l~l~~N~l~~~~p~~~~--------------------~~~~~~~~~~~n~~~~~~~~ 275 (714)
|+.|++++|+|++.+|.... +.......+.+|++.|.++.
T Consensus 506 L~~L~Ls~N~l~~l~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~L~~l~l~~Np~~C~c~~ 565 (844)
T 3j0a_A 506 LRGLSLNSNRLTVLSHNDLPANLEILDISRNQLLAPNPDVFVSLSVLDITHNKFICECEL 565 (844)
T ss_dssp CSEEEEESCCCSSCCCCCCCSCCCEEEEEEECCCCCCSCCCSSCCEEEEEEECCCCSSSC
T ss_pred hheeECCCCCCCccChhhhhccccEEECCCCcCCCCChhHhCCcCEEEecCCCccccccc
Confidence 66666666666655443321 12333456678999997764
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.87 E-value=1e-21 Score=201.32 Aligned_cols=182 Identities=24% Similarity=0.233 Sum_probs=163.2
Q ss_pred CCcEEEEEcCCCCccccCCccccCCCCCCEEEccCCCCcccCChhhcCCCCCCEEEcCCCcCcccCCcccCCCCCCCEEe
Q 005102 63 EQRVVSVSIPKKKLLGFLPSALGSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSGSVPNEIGKLKYLQILD 142 (714)
Q Consensus 63 ~~~~~~l~l~~~~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ 142 (714)
..+++.|+|++|.+++. +.+..+++|++|+|++|.+++..+..+..+++|++|+|++|++++..|..|+.+++|+.|+
T Consensus 62 l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 139 (272)
T 3rfs_A 62 LPNVRYLALGGNKLHDI--SALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLN 139 (272)
T ss_dssp CTTCCEEECTTSCCCCC--GGGTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEE
T ss_pred CCCCcEEECCCCCCCCc--hhhcCCCCCCEEECCCCccCccChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCCEEE
Confidence 46899999999999983 4899999999999999999988888889999999999999999988888899999999999
Q ss_pred ccCccCCCCCCcccccccccceeecccCcCCCCCCcccccCccccccccccCCcccccCCCCCCCCcccccccccccccC
Q 005102 143 LSQNFFNGSLPVSIVQCKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLNLSFNKFNGSIPSNTGNLSSLQGTVDFSHNLF 222 (714)
Q Consensus 143 Ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~~l~l~~N~l 222 (714)
|++|++++..|..+..+++|+.|+|++|++++..|..+ ..+++|+.|+|++|++++..|..+.++++|+ .+++++|.+
T Consensus 140 L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~-~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~-~L~l~~N~~ 217 (272)
T 3rfs_A 140 LAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLPEGVF-DKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQ-YIWLHDNPW 217 (272)
T ss_dssp CCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTT-TTCTTCCEEECCSSCCSCCCTTTTTTCTTCC-EEECCSSCB
T ss_pred CCCCccCccCHHHhccCccCCEEECCCCCcCccCHHHh-cCCccCCEEECCCCcCCccCHHHHhCCcCCC-EEEccCCCc
Confidence 99999997777778999999999999999995444444 5699999999999999988888889999999 999999999
Q ss_pred CcCcCccccCCCCcccccCcCCcCCCCCCCCcc
Q 005102 223 SGSIPASLGNLPEKVYIDLTYNNLSGPIPQNGA 255 (714)
Q Consensus 223 ~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~ 255 (714)
++. +++|++|++..|+++|.+|....
T Consensus 218 ~~~-------~~~l~~l~~~~n~~~g~ip~~~~ 243 (272)
T 3rfs_A 218 DCT-------CPGIRYLSEWINKHSGVVRNSAG 243 (272)
T ss_dssp CCC-------TTTTHHHHHHHHHTGGGBBCTTS
T ss_pred ccc-------CcHHHHHHHHHHhCCCcccCccc
Confidence 854 55799999999999999997643
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.86 E-value=2.2e-22 Score=235.93 Aligned_cols=186 Identities=19% Similarity=0.237 Sum_probs=164.5
Q ss_pred CCccccCCCCCCEEEccCCCCcc-----------------cCChhhc--CCCCCCEEEcCCCcCcccCCcccCCCCCCCE
Q 005102 80 LPSALGSLTDLRHVNLRNNKFFG-----------------SLPLELL--EAQGLQSLVLYGNSFSGSVPNEIGKLKYLQI 140 (714)
Q Consensus 80 ~p~~~~~l~~L~~L~L~~N~l~~-----------------~~p~~~~--~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~ 140 (714)
+|..|++|++|++|+|++|+|+| .+|..++ ++++|+.|+|++|.+.|.+|..|+++++|+.
T Consensus 440 IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~ 519 (876)
T 4ecn_A 440 ISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQS 519 (876)
T ss_dssp ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEESCTTCCSCCGGGGGCSSCCE
T ss_pred hhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCCCEEECcCCCCCccChHHHhCCCCCCE
Confidence 89999999999999999999998 4999987 9999999999999999999999999999999
Q ss_pred EeccCcc-CCC-CCCccccccc-------ccceeecccCcCCCCCCc--ccccCccccccccccCCcccccCCCCCCCCc
Q 005102 141 LDLSQNF-FNG-SLPVSIVQCK-------RLKALDLSQNNFTGPLPN--GFGSGLVSLEKLNLSFNKFNGSIPSNTGNLS 209 (714)
Q Consensus 141 L~Ls~N~-l~g-~~p~~~~~l~-------~L~~L~l~~N~l~g~~p~--~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~ 209 (714)
|+|++|+ |+| .+|..+..++ +|+.|+|++|+++ .+|. .+ ..+++|+.|+|++|+++ .+| .+++++
T Consensus 520 L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~l-~~L~~L~~L~Ls~N~l~-~lp-~~~~L~ 595 (876)
T 4ecn_A 520 LNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE-EFPASASL-QKMVKLGLLDCVHNKVR-HLE-AFGTNV 595 (876)
T ss_dssp EECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC-BCCCHHHH-TTCTTCCEEECTTSCCC-BCC-CCCTTS
T ss_pred EECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcCC-ccCChhhh-hcCCCCCEEECCCCCcc-cch-hhcCCC
Confidence 9999998 998 8999888777 9999999999999 8998 77 46999999999999999 999 999999
Q ss_pred ccccccccccccCCcCcCccccCCCC-cccccCcCCcCCCCCCCCccccCC--CCcccccCCCCCC
Q 005102 210 SLQGTVDFSHNLFSGSIPASLGNLPE-KVYIDLTYNNLSGPIPQNGALMNR--GPTAFIGNPRLCG 272 (714)
Q Consensus 210 ~L~~~l~l~~N~l~g~~p~~~~~l~~-L~~l~l~~N~l~~~~p~~~~~~~~--~~~~~~~n~~~~~ 272 (714)
+|+ .|++++|+++ .+|..+..+++ |+.|++++|+++ .+|........ .......++.+++
T Consensus 596 ~L~-~L~Ls~N~l~-~lp~~l~~l~~~L~~L~Ls~N~L~-~lp~~~~~~~~~~L~~L~Ls~N~l~g 658 (876)
T 4ecn_A 596 KLT-DLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLK-YIPNIFNAKSVYVMGSVDFSYNKIGS 658 (876)
T ss_dssp EES-EEECCSSCCS-CCCTTSCEECTTCCEEECCSSCCC-SCCSCCCTTCSSCEEEEECCSSCTTT
T ss_pred cce-EEECcCCccc-cchHHHhhccccCCEEECcCCCCC-cCchhhhccccCCCCEEECcCCcCCC
Confidence 999 9999999999 89999999999 999999999999 66655443322 2233344444544
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.86 E-value=8.5e-22 Score=212.95 Aligned_cols=132 Identities=22% Similarity=0.257 Sum_probs=79.8
Q ss_pred cEEEEEcCCCCccccCCccccCCCCCCEEEccCCCCcccCChhhcCCCCCCEEEcCCCcCcccCCcccCCCCCCCEEecc
Q 005102 65 RVVSVSIPKKKLLGFLPSALGSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSGSVPNEIGKLKYLQILDLS 144 (714)
Q Consensus 65 ~~~~l~l~~~~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls 144 (714)
.++.+++.++.++...+..|..+++|++|+|++|.+++..+..|..+++|++|+|++|.+++..|..|+++++|+.|+|+
T Consensus 46 ~l~~l~l~~~~l~~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 125 (390)
T 3o6n_A 46 NQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLE 125 (390)
T ss_dssp CCSEEEEESCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred CceEEEecCCchhhCChhHhcccccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEECC
Confidence 45556666666655444445666666666666666665555566666666666666666665555566666666666666
Q ss_pred CccCCCCCCcc-cccccccceeecccCcCCCCCCcccccCccccccccccCCccc
Q 005102 145 QNFFNGSLPVS-IVQCKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLNLSFNKFN 198 (714)
Q Consensus 145 ~N~l~g~~p~~-~~~l~~L~~L~l~~N~l~g~~p~~~~~~l~~L~~L~l~~N~l~ 198 (714)
+|+++ .+|.. |..+++|++|+|++|++++..|..+ ..+++|+.|++++|+++
T Consensus 126 ~n~l~-~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~-~~l~~L~~L~l~~n~l~ 178 (390)
T 3o6n_A 126 RNDLS-SLPRGIFHNTPKLTTLSMSNNNLERIEDDTF-QATTSLQNLQLSSNRLT 178 (390)
T ss_dssp SSCCC-CCCTTTTTTCTTCCEEECCSSCCCBCCTTTT-SSCTTCCEEECCSSCCS
T ss_pred CCccC-cCCHHHhcCCCCCcEEECCCCccCccChhhc-cCCCCCCEEECCCCcCC
Confidence 66666 33333 4566666666666666664434333 34566666666666655
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.86 E-value=4.6e-22 Score=208.01 Aligned_cols=180 Identities=20% Similarity=0.259 Sum_probs=157.1
Q ss_pred cEEEEEcCCCCccccCCccc--cCCCCCCEEEccCCCCcccCC----hhhcCCCCCCEEEcCCCcCcccCCcccCCCCCC
Q 005102 65 RVVSVSIPKKKLLGFLPSAL--GSLTDLRHVNLRNNKFFGSLP----LELLEAQGLQSLVLYGNSFSGSVPNEIGKLKYL 138 (714)
Q Consensus 65 ~~~~l~l~~~~l~g~~p~~~--~~l~~L~~L~L~~N~l~~~~p----~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L 138 (714)
+++.|+|++|++++..|..+ ..+++|++|+|++|.+++..+ ..+..+++|++|+|++|.+++..|..|+.+++|
T Consensus 92 ~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L 171 (310)
T 4glp_A 92 RLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWLKPGLKVLSIAQAHSPAFSCEQVRAFPAL 171 (310)
T ss_dssp CCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTBCSCCCEEEEECCSSCCCCTTSCCCCTTC
T ss_pred ceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhhccCCCEEEeeCCCcchhhHHHhccCCCC
Confidence 58999999999999999998 999999999999999998666 445679999999999999998888999999999
Q ss_pred CEEeccCccCCCC--C--CcccccccccceeecccCcCCCCCCcc---cccCccccccccccCCcccccCCCCCCCC---
Q 005102 139 QILDLSQNFFNGS--L--PVSIVQCKRLKALDLSQNNFTGPLPNG---FGSGLVSLEKLNLSFNKFNGSIPSNTGNL--- 208 (714)
Q Consensus 139 ~~L~Ls~N~l~g~--~--p~~~~~l~~L~~L~l~~N~l~g~~p~~---~~~~l~~L~~L~l~~N~l~g~~p~~~~~l--- 208 (714)
++|+|++|++.+. + +..+..+++|++|+|++|+++ .+|.. +...+++|+.|+|++|++++.+|..+..+
T Consensus 172 ~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~ 250 (310)
T 4glp_A 172 TSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGME-TPTGVCAALAAAGVQPHSLDLSHNSLRATVNPSAPRCMWS 250 (310)
T ss_dssp CEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCC-CHHHHHHHHHHHTCCCSSEECTTSCCCCCCCSCCSSCCCC
T ss_pred CEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCC-chHHHHHHHHhcCCCCCEEECCCCCCCccchhhHHhccCc
Confidence 9999999998752 2 233478899999999999997 44442 33457999999999999998889888887
Q ss_pred cccccccccccccCCcCcCccccCCCCcccccCcCCcCCCC
Q 005102 209 SSLQGTVDFSHNLFSGSIPASLGNLPEKVYIDLTYNNLSGP 249 (714)
Q Consensus 209 ~~L~~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~ 249 (714)
++|+ .|++++|+|+ .+|..+. ++|+.|++++|++++.
T Consensus 251 ~~L~-~L~Ls~N~l~-~lp~~~~--~~L~~L~Ls~N~l~~~ 287 (310)
T 4glp_A 251 SALN-SLNLSFAGLE-QVPKGLP--AKLRVLDLSSNRLNRA 287 (310)
T ss_dssp TTCC-CEECCSSCCC-SCCSCCC--SCCSCEECCSCCCCSC
T ss_pred CcCC-EEECCCCCCC-chhhhhc--CCCCEEECCCCcCCCC
Confidence 5898 9999999999 7788775 8999999999999985
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=99.86 E-value=8.9e-22 Score=225.58 Aligned_cols=207 Identities=23% Similarity=0.244 Sum_probs=134.6
Q ss_pred cEEEEEcCCCCccccC--CccccCCCCCCEEEccCCCCcccCChhhcCCCCCCEEEcCCCcCcccCCcc-cCCCCCCCEE
Q 005102 65 RVVSVSIPKKKLLGFL--PSALGSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSGSVPNE-IGKLKYLQIL 141 (714)
Q Consensus 65 ~~~~l~l~~~~l~g~~--p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~-~~~l~~L~~L 141 (714)
+++.|+|++|.+++.. |..+..+++|++|+|++|.+.+..|..+..+++|+.|+|++|.+++..|.. +..+++|+.|
T Consensus 351 ~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L 430 (606)
T 3t6q_A 351 NLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVL 430 (606)
T ss_dssp TCCEEECCSSCCCEEEESTTTTTTCTTCCEEECCSCSCEEECTTTTTTCTTCSEEECTTCCEECCTTCCTTTTCTTCCEE
T ss_pred cCCEEECCCCccccccCcchhcccCCCCCEEECCCCcCCcCCHHHhcCCccCCeEECCCCcCCCcccchhhhCcccCCEE
Confidence 4555555555555544 455566666666666666666556666666666666666666666555443 6666666666
Q ss_pred eccCccCCCCCCcccccccccceeecccCcCCCC---CCcccccCccccccccccCCcccccCCCCCCCCcccccccccc
Q 005102 142 DLSQNFFNGSLPVSIVQCKRLKALDLSQNNFTGP---LPNGFGSGLVSLEKLNLSFNKFNGSIPSNTGNLSSLQGTVDFS 218 (714)
Q Consensus 142 ~Ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~---~p~~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~~l~l~ 218 (714)
+|++|.+++..|..+..+++|+.|+|++|++++. .+..+ ..+++|+.|+|++|++++..|..+.++++|+ .|+++
T Consensus 431 ~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~-~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~-~L~Ls 508 (606)
T 3t6q_A 431 NLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSL-QTLGRLEILVLSFCDLSSIDQHAFTSLKMMN-HVDLS 508 (606)
T ss_dssp ECTTCCCBTTCTTTTTTCTTCCEEECTTCBCGGGEECSSCGG-GGCTTCCEEECTTSCCCEECTTTTTTCTTCC-EEECC
T ss_pred ECCCCccCCcCHHHHhCCCCCCEEECCCCCCCccccccchhh-ccCCCccEEECCCCccCccChhhhccccCCC-EEECC
Confidence 6666666666666666677777777777776642 12233 3467777777777777777777777777777 77777
Q ss_pred cccCCcCcCccccCCCCcccccCcCCcCCCCCCCCcc-ccCCCCcccccCCCCCCCC
Q 005102 219 HNLFSGSIPASLGNLPEKVYIDLTYNNLSGPIPQNGA-LMNRGPTAFIGNPRLCGPP 274 (714)
Q Consensus 219 ~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~-~~~~~~~~~~~n~~~~~~~ 274 (714)
+|++++..|..+..+++| .|++++|++++.+|.... +.......+.+|+..|.++
T Consensus 509 ~N~l~~~~~~~l~~l~~L-~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~ 564 (606)
T 3t6q_A 509 HNRLTSSSIEALSHLKGI-YLNLASNHISIILPSLLPILSQQRTINLRQNPLDCTCS 564 (606)
T ss_dssp SSCCCGGGGGGGTTCCSC-EEECCSSCCCCCCGGGHHHHHTSSEEECTTCCEECSGG
T ss_pred CCccCcCChhHhCccccc-EEECcCCcccccCHhhcccCCCCCEEeCCCCCccccCC
Confidence 777777777777777777 777777777777665433 2334455566777777543
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.86 E-value=7.4e-22 Score=206.02 Aligned_cols=208 Identities=20% Similarity=0.191 Sum_probs=181.1
Q ss_pred CCcEEEEEcCCCCccc--cCCccccCCCCCCEEEccCCCCcccCChhhcCCCCCCEEEcCCCcCcccCC-cccCCCCCCC
Q 005102 63 EQRVVSVSIPKKKLLG--FLPSALGSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSGSVP-NEIGKLKYLQ 139 (714)
Q Consensus 63 ~~~~~~l~l~~~~l~g--~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p-~~~~~l~~L~ 139 (714)
..+++.|+|++|+++. ..|..+..+++|++|+|++|.+. .+|..+..+++|+.|+|++|.+++..+ ..+..+++|+
T Consensus 51 l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~-~l~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~ 129 (306)
T 2z66_A 51 LTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLI 129 (306)
T ss_dssp CTTCSEEECCSSCCCEEEEEEHHHHSCSCCCEEECCSCSEE-EEEEEEETCTTCCEEECTTSEEESSTTTTTTTTCTTCC
T ss_pred cccCCEEECCCCccCcccCcccccccccccCEEECCCCccc-cChhhcCCCCCCCEEECCCCcccccccchhhhhccCCC
Confidence 4589999999999984 44778888999999999999998 577789999999999999999996655 5799999999
Q ss_pred EEeccCccCCCCCCcccccccccceeecccCcCCC-CCCcccccCccccccccccCCcccccCCCCCCCCcccccccccc
Q 005102 140 ILDLSQNFFNGSLPVSIVQCKRLKALDLSQNNFTG-PLPNGFGSGLVSLEKLNLSFNKFNGSIPSNTGNLSSLQGTVDFS 218 (714)
Q Consensus 140 ~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g-~~p~~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~~l~l~ 218 (714)
.|+|++|.+++..|..+..+++|++|+|++|.+++ .+|..+ ..+++|+.|+|++|++++..|..+.++++|+ .|+++
T Consensus 130 ~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~-~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~-~L~L~ 207 (306)
T 2z66_A 130 YLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIF-TELRNLTFLDLSQCQLEQLSPTAFNSLSSLQ-VLNMS 207 (306)
T ss_dssp EEECTTSCCEECSTTTTTTCTTCCEEECTTCEEGGGEECSCC-TTCTTCCEEECTTSCCCEECTTTTTTCTTCC-EEECT
T ss_pred EEECCCCcCCccchhhcccCcCCCEEECCCCccccccchhHH-hhCcCCCEEECCCCCcCCcCHHHhcCCCCCC-EEECC
Confidence 99999999998889999999999999999999986 467666 4699999999999999988899999999999 99999
Q ss_pred cccCCcCcCccccCCCCcccccCcCCcCCCCCCCCcccc--CCCCcccccCCCCCCC
Q 005102 219 HNLFSGSIPASLGNLPEKVYIDLTYNNLSGPIPQNGALM--NRGPTAFIGNPRLCGP 273 (714)
Q Consensus 219 ~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~~~--~~~~~~~~~n~~~~~~ 273 (714)
+|.+++..+..+..+++|+.|++++|++++.+|...... ........+|+.-|.+
T Consensus 208 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~L~~N~~~~~c 264 (306)
T 2z66_A 208 HNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTC 264 (306)
T ss_dssp TSCCSBCCSGGGTTCTTCCEEECTTSCCCBCSSSSCCCCCTTCCEEECTTCCEECSG
T ss_pred CCccCccChhhccCcccCCEeECCCCCCcccCHHHHHhhhccCCEEEccCCCeeccc
Confidence 999998888889999999999999999999888765443 3445556677766654
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.86 E-value=2.1e-21 Score=199.33 Aligned_cols=188 Identities=21% Similarity=0.196 Sum_probs=166.2
Q ss_pred CCcEEEEEcCCCCccccCCccccCCCCCCEEEccCCCCcccCChhhcCCCCCCEEEcCCCcCcccCCcccCCCCCCCEEe
Q 005102 63 EQRVVSVSIPKKKLLGFLPSALGSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSGSVPNEIGKLKYLQILD 142 (714)
Q Consensus 63 ~~~~~~l~l~~~~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ 142 (714)
..+++.|+|++|++++..+..|.++++|++|+|++|.+++..+..+.++++|+.|+|++|.+++..+..++.+++|+.|+
T Consensus 51 l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ 130 (276)
T 2z62_A 51 FPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELN 130 (276)
T ss_dssp CTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEE
T ss_pred ccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEECCCCCccccCchhcccCCCCCEEE
Confidence 35899999999999998888999999999999999999988889999999999999999999987777899999999999
Q ss_pred ccCccCCCC-CCcccccccccceeecccCcCCCCCCcccccCccccc----cccccCCcccccCCCCCCCCccccccccc
Q 005102 143 LSQNFFNGS-LPVSIVQCKRLKALDLSQNNFTGPLPNGFGSGLVSLE----KLNLSFNKFNGSIPSNTGNLSSLQGTVDF 217 (714)
Q Consensus 143 Ls~N~l~g~-~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~l~~L~----~L~l~~N~l~g~~p~~~~~l~~L~~~l~l 217 (714)
|++|++++. +|..+..+++|+.|+|++|++++..+..+ ..+.+|+ .|++++|++++..+. .....+|+ .|++
T Consensus 131 l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~~~~~-~~l~~L~~l~l~L~ls~n~l~~~~~~-~~~~~~L~-~L~L 207 (276)
T 2z62_A 131 VAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDL-RVLHQMPLLNLSLDLSLNPMNFIQPG-AFKEIRLK-ELAL 207 (276)
T ss_dssp CCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGG-HHHHTCTTCCEEEECCSSCCCEECTT-SSCSCCEE-EEEC
T ss_pred CcCCccceecCchhhccCCCCCEEECCCCCCCcCCHHHh-hhhhhccccceeeecCCCcccccCcc-ccCCCccc-EEEC
Confidence 999999863 79999999999999999999996555555 4467777 899999999955444 44455888 9999
Q ss_pred ccccCCcCcCccccCCCCcccccCcCCcCCCCCCCC
Q 005102 218 SHNLFSGSIPASLGNLPEKVYIDLTYNNLSGPIPQN 253 (714)
Q Consensus 218 ~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~~ 253 (714)
++|++++..+..|..+++|+.|++++|++++..|..
T Consensus 208 ~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~~l 243 (276)
T 2z62_A 208 DTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRI 243 (276)
T ss_dssp CSSCCSCCCTTTTTTCCSCCEEECCSSCBCCCTTTT
T ss_pred CCCceeecCHhHhcccccccEEEccCCcccccCCch
Confidence 999999877778899999999999999999887654
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.86 E-value=4e-21 Score=194.39 Aligned_cols=169 Identities=21% Similarity=0.229 Sum_probs=151.4
Q ss_pred cccceEecC-----------CcEEEEEcCCCCccccCCccccCCCCCCEEEccCCCCcccCChhhcCCCCCCEEEcCCCc
Q 005102 55 SWNGITCKE-----------QRVVSVSIPKKKLLGFLPSALGSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNS 123 (714)
Q Consensus 55 ~w~gv~c~~-----------~~~~~l~l~~~~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~ 123 (714)
.|..|.|.. ..++.|+|++|++++..+..|.++++|++|+|++|.|++..|..|..+++|++|+|++|.
T Consensus 15 ~~~~l~~~~~~l~~~p~~~~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~ 94 (251)
T 3m19_A 15 GKKEVDCQGKSLDSVPSGIPADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQ 94 (251)
T ss_dssp GGTEEECTTCCCSSCCSCCCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSC
T ss_pred CCeEEecCCCCccccCCCCCCCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEECCCCc
Confidence 466777752 368889999999999999999999999999999999999888889999999999999999
Q ss_pred CcccCCcccCCCCCCCEEeccCccCCCCCCcccccccccceeecccCcCCCCCCcccccCccccccccccCCcccccCCC
Q 005102 124 FSGSVPNEIGKLKYLQILDLSQNFFNGSLPVSIVQCKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLNLSFNKFNGSIPS 203 (714)
Q Consensus 124 l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~l~~L~~L~l~~N~l~g~~p~ 203 (714)
+++..+..|..+++|+.|+|++|+|++..+..|..+++|+.|+|++|++++..|..+ ..+++|+.|+|++|+|++..|.
T Consensus 95 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~-~~l~~L~~L~L~~N~l~~~~~~ 173 (251)
T 3m19_A 95 LASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAF-DKLTNLQTLSLSTNQLQSVPHG 173 (251)
T ss_dssp CCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTT-TTCTTCCEEECCSSCCSCCCTT
T ss_pred ccccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEECcCCcCCccCHHHc-CcCcCCCEEECCCCcCCccCHH
Confidence 998777889999999999999999997666678999999999999999995444345 5699999999999999977777
Q ss_pred CCCCCcccccccccccccCCcC
Q 005102 204 NTGNLSSLQGTVDFSHNLFSGS 225 (714)
Q Consensus 204 ~~~~l~~L~~~l~l~~N~l~g~ 225 (714)
.+.++++|+ .+++++|++++.
T Consensus 174 ~~~~l~~L~-~L~l~~N~~~c~ 194 (251)
T 3m19_A 174 AFDRLGKLQ-TITLFGNQFDCS 194 (251)
T ss_dssp TTTTCTTCC-EEECCSCCBCTT
T ss_pred HHhCCCCCC-EEEeeCCceeCC
Confidence 899999999 999999999865
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.86 E-value=2.8e-22 Score=209.76 Aligned_cols=180 Identities=19% Similarity=0.202 Sum_probs=158.0
Q ss_pred CCcEEEEEcCCCCccccCCccccCC-----CCCCEEEccCCCCcccCChhhcCCCCCCEEEcCCCcCccc--CCccc--C
Q 005102 63 EQRVVSVSIPKKKLLGFLPSALGSL-----TDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSGS--VPNEI--G 133 (714)
Q Consensus 63 ~~~~~~l~l~~~~l~g~~p~~~~~l-----~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~--~p~~~--~ 133 (714)
..+++.|+|++|++++. |..++.+ ++|++|+|++|++++..|..|..+++|+.|+|++|++.|. +|..+ +
T Consensus 120 l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~ 198 (312)
T 1wwl_A 120 GPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPL 198 (312)
T ss_dssp SCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCTTCHHHHHHHHSCTT
T ss_pred CCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCCCCEEECCCCCcCcchHHHHHHHhc
Confidence 45899999999999998 8888887 9999999999999988889999999999999999999876 34455 8
Q ss_pred CCCCCCEEeccCccCCC--CCC-cccccccccceeecccCcCCCCCCcccccCccccccccccCCcccccCCCCCCCCcc
Q 005102 134 KLKYLQILDLSQNFFNG--SLP-VSIVQCKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLNLSFNKFNGSIPSNTGNLSS 210 (714)
Q Consensus 134 ~l~~L~~L~Ls~N~l~g--~~p-~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~ 210 (714)
.+++|+.|+|++|++++ .++ ..+..+++|+.|+|++|++++.+|...+..+++|+.|+|++|+|+ .+|..+. ++
T Consensus 199 ~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~-~ip~~~~--~~ 275 (312)
T 1wwl_A 199 KFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGLP--AK 275 (312)
T ss_dssp SCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCCCCTTCCEEECTTSCCS-SCCSSCC--SE
T ss_pred cCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhhhhhcCCCCEEECCCCccC-hhhhhcc--CC
Confidence 99999999999999983 223 234578999999999999998776554456899999999999999 8998887 78
Q ss_pred cccccccccccCCcCcCccccCCCCcccccCcCCcCCCC
Q 005102 211 LQGTVDFSHNLFSGSIPASLGNLPEKVYIDLTYNNLSGP 249 (714)
Q Consensus 211 L~~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~ 249 (714)
|+ .|++++|+|++. |. +..+++|+.|++++|++++.
T Consensus 276 L~-~L~Ls~N~l~~~-p~-~~~l~~L~~L~L~~N~l~~~ 311 (312)
T 1wwl_A 276 LS-VLDLSYNRLDRN-PS-PDELPQVGNLSLKGNPFLDS 311 (312)
T ss_dssp EE-EEECCSSCCCSC-CC-TTTSCEEEEEECTTCTTTCC
T ss_pred ce-EEECCCCCCCCC-hh-HhhCCCCCEEeccCCCCCCC
Confidence 88 999999999976 66 99999999999999999864
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.85 E-value=1.6e-21 Score=216.75 Aligned_cols=209 Identities=19% Similarity=0.181 Sum_probs=147.9
Q ss_pred CcEEEEEcCCCCccccCCccccCCCCCCEEEccCCCCcccCChhhcCCCCCCEEEcCCCcCcccCCcccCCCCCCCEEec
Q 005102 64 QRVVSVSIPKKKLLGFLPSALGSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSGSVPNEIGKLKYLQILDL 143 (714)
Q Consensus 64 ~~~~~l~l~~~~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L 143 (714)
.+++.|+|++|++++..|..|..+++|++|+|++|.+++..|..|..+++|+.|+|++|.+++..+..|.++++|+.|+|
T Consensus 104 ~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l 183 (477)
T 2id5_A 104 SNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRL 183 (477)
T ss_dssp TTCCEEECTTSCCCEECTTTTTTCTTCCEEEECCTTCCEECTTSSTTCTTCCEEEEESCCCSSCCHHHHTTCTTCCEEEE
T ss_pred CCCCEEECCCCccccCChhHccccccCCEEECCCCccceeChhhccCCCCCCEEECCCCcCcccChhHhcccCCCcEEeC
Confidence 45666666666666666666666666666666666666666666666666666666666666444444555555555555
Q ss_pred cCccCCCCCCcccccc------------------------cccceeecccCcCCCCCCcccccCccccccccccCCcccc
Q 005102 144 SQNFFNGSLPVSIVQC------------------------KRLKALDLSQNNFTGPLPNGFGSGLVSLEKLNLSFNKFNG 199 (714)
Q Consensus 144 s~N~l~g~~p~~~~~l------------------------~~L~~L~l~~N~l~g~~p~~~~~~l~~L~~L~l~~N~l~g 199 (714)
++|.+.+..+..|..+ .+|+.|+|++|+++ .+|...+..+++|+.|+|++|++++
T Consensus 184 ~~n~i~~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~-~~~~~~~~~l~~L~~L~Ls~n~l~~ 262 (477)
T 2id5_A 184 RHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLT-AVPYLAVRHLVYLRFLNLSYNPIST 262 (477)
T ss_dssp ESCCCCEECTTCSCSCTTCCEEEEECCTTCCEECTTTTTTCCCSEEEEESSCCC-SCCHHHHTTCTTCCEEECCSSCCCE
T ss_pred CCCcCcEeChhhcccCcccceeeCCCCccccccCcccccCccccEEECcCCccc-ccCHHHhcCccccCeeECCCCcCCc
Confidence 5555554444444444 45666666667776 4554444568999999999999998
Q ss_pred cCCCCCCCCcccccccccccccCCcCcCccccCCCCcccccCcCCcCCCCCCCCcc-ccCCCCcccccCCCCCCCC
Q 005102 200 SIPSNTGNLSSLQGTVDFSHNLFSGSIPASLGNLPEKVYIDLTYNNLSGPIPQNGA-LMNRGPTAFIGNPRLCGPP 274 (714)
Q Consensus 200 ~~p~~~~~l~~L~~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~-~~~~~~~~~~~n~~~~~~~ 274 (714)
..+..+.++++|+ .|++++|++++..|..|..+++|+.|++++|++++..+..+. +.......+.+|+..|.+.
T Consensus 263 ~~~~~~~~l~~L~-~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~c~c~ 337 (477)
T 2id5_A 263 IEGSMLHELLRLQ-EIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLILDSNPLACDCR 337 (477)
T ss_dssp ECTTSCTTCTTCC-EEECCSSCCSEECTTTBTTCTTCCEEECCSSCCSCCCGGGBSCGGGCCEEECCSSCEECSGG
T ss_pred cChhhccccccCC-EEECCCCccceECHHHhcCcccCCEEECCCCcCceeCHhHcCCCcccCEEEccCCCccCccc
Confidence 8788899999999 999999999999999999999999999999999988776543 3344556677888888654
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.85 E-value=2.2e-21 Score=221.52 Aligned_cols=185 Identities=18% Similarity=0.121 Sum_probs=150.5
Q ss_pred CcEEEEEcCCCCccccCCccccCCCCCCEEEccCCCCcccCChhhcCCCCCCEEEcCCCcCcccCCcccCCCCCCCEEec
Q 005102 64 QRVVSVSIPKKKLLGFLPSALGSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSGSVPNEIGKLKYLQILDL 143 (714)
Q Consensus 64 ~~~~~l~l~~~~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L 143 (714)
.+++.|+|++|.+++..|..|+.+++|++|+|++|.+++..|..|..+++|++|+|++|.+++..+..|+++++|+.|+|
T Consensus 75 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L 154 (597)
T 3oja_B 75 RQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSM 154 (597)
T ss_dssp CCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEeeCCCCCCCCHHHhccCCCCCEEEe
Confidence 47888999999999999999999999999999999999988888999999999999999999655556799999999999
Q ss_pred cCccCCCCCCcccccccccceeecccCcCCCCCCcccccCc-------------------------------------cc
Q 005102 144 SQNFFNGSLPVSIVQCKRLKALDLSQNNFTGPLPNGFGSGL-------------------------------------VS 186 (714)
Q Consensus 144 s~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~l-------------------------------------~~ 186 (714)
++|.+++..|..|..+++|+.|+|++|.+++. +......| .+
T Consensus 155 s~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~-~~~~l~~L~~L~l~~n~l~~l~~~~~L~~L~ls~n~l~~~~~~~~~~ 233 (597)
T 3oja_B 155 SNNNLERIEDDTFQATTSLQNLQLSSNRLTHV-DLSLIPSLFHANVSYNLLSTLAIPIAVEELDASHNSINVVRGPVNVE 233 (597)
T ss_dssp CSSCCCBCCTTTTTTCTTCCEEECTTSCCSBC-CGGGCTTCSEEECCSSCCSEEECCTTCSEEECCSSCCCEEECSCCSC
T ss_pred eCCcCCCCChhhhhcCCcCcEEECcCCCCCCc-ChhhhhhhhhhhcccCccccccCCchhheeeccCCcccccccccCCC
Confidence 99999988888999999999999999999853 32111111 23
Q ss_pred cccccccCCcccccCCCCCCCCcccccccccccccCCcCcCccccCCCCcccccCcCCcCCCCCCC
Q 005102 187 LEKLNLSFNKFNGSIPSNTGNLSSLQGTVDFSHNLFSGSIPASLGNLPEKVYIDLTYNNLSGPIPQ 252 (714)
Q Consensus 187 L~~L~l~~N~l~g~~p~~~~~l~~L~~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~ 252 (714)
|+.|+|++|.+++ +..+.++++|+ .|+|++|.+++.+|..|+.+++|+.|++++|++++.++.
T Consensus 234 L~~L~L~~n~l~~--~~~l~~l~~L~-~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~ 296 (597)
T 3oja_B 234 LTILKLQHNNLTD--TAWLLNYPGLV-EVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVALNLY 296 (597)
T ss_dssp CCEEECCSSCCCC--CGGGGGCTTCS-EEECCSSCCCEEESGGGTTCSSCCEEECTTSCCCEEECS
T ss_pred CCEEECCCCCCCC--ChhhccCCCCC-EEECCCCccCCCCHHHhcCccCCCEEECCCCCCCCCCcc
Confidence 5555555555554 34567777777 888888888888888888888888888888888775433
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=99.85 E-value=3.4e-21 Score=223.80 Aligned_cols=209 Identities=24% Similarity=0.236 Sum_probs=138.3
Q ss_pred CcEEEEEcCCCCccccCCccccCCCCCCEEEccCCCCcccCC-hhhcCCCCCCEEEcCCCcCcc----------------
Q 005102 64 QRVVSVSIPKKKLLGFLPSALGSLTDLRHVNLRNNKFFGSLP-LELLEAQGLQSLVLYGNSFSG---------------- 126 (714)
Q Consensus 64 ~~~~~l~l~~~~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~g---------------- 126 (714)
..++.|+|++|++++..|..|..+++|+.|+|++|.+++.+| ..+..+++|+.|+|++|++++
T Consensus 381 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~ 460 (680)
T 1ziw_A 381 SPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLM 460 (680)
T ss_dssp SCCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCEEECCSGGGTTCTTCCEEECCSCSEEECCTTTTTTCTTCCEEE
T ss_pred CcCceEECCCCCCCeEChhhhhCCCCCCEEeCCCCcCccccCcccccCcccccEEecCCCCcceeChhhhhcCcccccch
Confidence 367777777777777777777777777777777777776655 456667777777777776654
Q ss_pred ----------cCCcccCCCCCCCEEeccCccCCCCCCcccccccccceeecccCcCCCCC----C---cccccCcccccc
Q 005102 127 ----------SVPNEIGKLKYLQILDLSQNFFNGSLPVSIVQCKRLKALDLSQNNFTGPL----P---NGFGSGLVSLEK 189 (714)
Q Consensus 127 ----------~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~----p---~~~~~~l~~L~~ 189 (714)
.+|..|.++++|+.|+|++|++++..|..|..+++|+.|+|++|++++.. | ...+.++++|+.
T Consensus 461 l~~n~l~~~~~~p~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~~~~l~~L~~ 540 (680)
T 1ziw_A 461 LRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHI 540 (680)
T ss_dssp CTTSCCBCTTCSSCTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCGGGGSTTSTTSCCCTTTTCTTCCE
T ss_pred hccccccccccCCcccccCCCCCEEECCCCCCCcCChhhhccccccCEEeCCCCCccccchhhccCCcchhhcCCCCCCE
Confidence 44555666666666666666666555555666666666666666665321 1 111245667777
Q ss_pred ccccCCcccccCC-CCCCCCcccccccccccccCCcCcCccccCCCCcccccCcCCcCCCCCCCCcc--ccCCCCccccc
Q 005102 190 LNLSFNKFNGSIP-SNTGNLSSLQGTVDFSHNLFSGSIPASLGNLPEKVYIDLTYNNLSGPIPQNGA--LMNRGPTAFIG 266 (714)
Q Consensus 190 L~l~~N~l~g~~p-~~~~~l~~L~~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~--~~~~~~~~~~~ 266 (714)
|+|++|+++ .+| ..|.++++|+ .+++++|++++..+..|..+++|+.|++++|++++.+|.... +.......+.+
T Consensus 541 L~L~~N~l~-~i~~~~~~~l~~L~-~L~Ls~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~l~l~~ 618 (680)
T 1ziw_A 541 LNLESNGFD-EIPVEVFKDLFELK-IIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRF 618 (680)
T ss_dssp EECCSSCCC-CCCTTTTTTCTTCC-EEECCSSCCCCCCTTTTTTCTTCCEEECTTSCCCBCCHHHHHHHHTTCSEEECTT
T ss_pred EECCCCCCC-CCCHHHcccccCcc-eeECCCCCCCcCCHhHhCCCCCCCEEECCCCcCCccChhHhcccccccCEEEccC
Confidence 777777776 444 3467777777 777777777766666667777777777777777776665432 33444566778
Q ss_pred CCCCCCCC
Q 005102 267 NPRLCGPP 274 (714)
Q Consensus 267 n~~~~~~~ 274 (714)
|++.|+++
T Consensus 619 N~~~c~c~ 626 (680)
T 1ziw_A 619 NPFDCTCE 626 (680)
T ss_dssp CCCCBCCC
T ss_pred CCcccCCc
Confidence 88888765
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=99.85 E-value=1.2e-20 Score=199.18 Aligned_cols=201 Identities=19% Similarity=0.256 Sum_probs=167.8
Q ss_pred CCcEEEEEcCCCCccccCCccccCCCCCCEEEccCCCCcccCChhhcCCCCCCEEEcCCCcCcccCCcccCCCCCCCEEe
Q 005102 63 EQRVVSVSIPKKKLLGFLPSALGSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSGSVPNEIGKLKYLQILD 142 (714)
Q Consensus 63 ~~~~~~l~l~~~~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ 142 (714)
..+++.|+|++|++++..|..|.++++|++|+|++|+++ .+|..+. ++|+.|+|++|.+++..+..|..+++|+.|+
T Consensus 77 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~ 153 (332)
T 2ft3_A 77 LQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNHLV-EIPPNLP--SSLVELRIHDNRIRKVPKGVFSGLRNMNCIE 153 (332)
T ss_dssp CTTCCEEECCSSCCCEECGGGSTTCTTCCEEECCSSCCC-SCCSSCC--TTCCEEECCSSCCCCCCSGGGSSCSSCCEEE
T ss_pred CCCCcEEECCCCccCccCHhHhhCcCCCCEEECCCCcCC-ccCcccc--ccCCEEECCCCccCccCHhHhCCCccCCEEE
Confidence 458999999999999999999999999999999999998 6776665 8999999999999976666799999999999
Q ss_pred ccCccCC--CCCCcccccccccceeecccCcCCCCCCcccccCccccccccccCCcccccCCCCCCCCcccccccccccc
Q 005102 143 LSQNFFN--GSLPVSIVQCKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLNLSFNKFNGSIPSNTGNLSSLQGTVDFSHN 220 (714)
Q Consensus 143 Ls~N~l~--g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~~l~l~~N 220 (714)
|++|.++ +..|..+..+ +|+.|++++|+++ .+|..+. ++|+.|+|++|++++..|..+.++++|+ .|++++|
T Consensus 154 l~~n~l~~~~~~~~~~~~l-~L~~L~l~~n~l~-~l~~~~~---~~L~~L~l~~n~i~~~~~~~l~~l~~L~-~L~L~~N 227 (332)
T 2ft3_A 154 MGGNPLENSGFEPGAFDGL-KLNYLRISEAKLT-GIPKDLP---ETLNELHLDHNKIQAIELEDLLRYSKLY-RLGLGHN 227 (332)
T ss_dssp CCSCCCBGGGSCTTSSCSC-CCSCCBCCSSBCS-SCCSSSC---SSCSCCBCCSSCCCCCCTTSSTTCTTCS-CCBCCSS
T ss_pred CCCCccccCCCCcccccCC-ccCEEECcCCCCC-ccCcccc---CCCCEEECCCCcCCccCHHHhcCCCCCC-EEECCCC
Confidence 9999996 4778888888 8999999999998 4787663 6899999999999987778899999999 9999999
Q ss_pred cCCcCcCccccCCCCcccccCcCCcCCCCCCCCccccCCCCcccccCCCCCCC
Q 005102 221 LFSGSIPASLGNLPEKVYIDLTYNNLSGPIPQNGALMNRGPTAFIGNPRLCGP 273 (714)
Q Consensus 221 ~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~~~~~~~~~~~~n~~~~~~ 273 (714)
++++..|..++.+++|+.|++++|+++ .+|...............++.+...
T Consensus 228 ~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~l~~~ 279 (332)
T 2ft3_A 228 QIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITKV 279 (332)
T ss_dssp CCCCCCTTGGGGCTTCCEEECCSSCCC-BCCTTGGGCTTCCEEECCSSCCCBC
T ss_pred cCCcCChhHhhCCCCCCEEECCCCcCe-ecChhhhcCccCCEEECCCCCCCcc
Confidence 999888888999999999999999998 4555433333333333344444433
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.84 E-value=4.1e-21 Score=228.19 Aligned_cols=200 Identities=17% Similarity=0.095 Sum_probs=178.8
Q ss_pred CcccceEecCCcEEEEEcCCCCccccCCccccCCCCCCEEEccCCCCcccC-ChhhcCCCCCCEEEcCCCcCcccCCccc
Q 005102 54 CSWNGITCKEQRVVSVSIPKKKLLGFLPSALGSLTDLRHVNLRNNKFFGSL-PLELLEAQGLQSLVLYGNSFSGSVPNEI 132 (714)
Q Consensus 54 c~w~gv~c~~~~~~~l~l~~~~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~-p~~~~~l~~L~~L~L~~N~l~g~~p~~~ 132 (714)
|.|..|-+-..+++.|+|++|.+++..|..|.++++|++|+|++|.+.+.+ |..|.++++|++|+|++|.+++..|..|
T Consensus 14 ~~L~~vP~lp~~l~~LdLs~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~~p~~~ 93 (844)
T 3j0a_A 14 CNLTQVPQVLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAF 93 (844)
T ss_dssp CCSSCCCSSCTTCCEEEEESCCCCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCCEECTTSS
T ss_pred CCCCCCCCCCCCcCEEECCCCcCCccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCcccCHhHc
Confidence 456666654578999999999999999999999999999999999777666 7789999999999999999999999999
Q ss_pred CCCCCCCEEeccCccCCCCCCcc--cccccccceeecccCcCCCCCCcccccCccccccccccCCcccccCCCCCCCC--
Q 005102 133 GKLKYLQILDLSQNFFNGSLPVS--IVQCKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLNLSFNKFNGSIPSNTGNL-- 208 (714)
Q Consensus 133 ~~l~~L~~L~Ls~N~l~g~~p~~--~~~l~~L~~L~l~~N~l~g~~p~~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l-- 208 (714)
+++++|++|+|++|.+++.+|.. |.++++|++|+|++|.+++..|...+.++++|+.|+|++|.+++..|..+..+
T Consensus 94 ~~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~~~~~~~l~~l~~ 173 (844)
T 3j0a_A 94 QGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQG 173 (844)
T ss_dssp CSCSSCCCEECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEESSCCCCCCSGGGHHHHH
T ss_pred cCCcccCEeeCcCCCCCcccccCccccccCCCCEEECCCCcccccccchhHhhCCCCCEEECCCCcCCeeCHHHcccccC
Confidence 99999999999999999877765 89999999999999999976664444679999999999999999999988877
Q ss_pred cccccccccccccCCcCcCccccCCCC------cccccCcCCcCCCCCCCCc
Q 005102 209 SSLQGTVDFSHNLFSGSIPASLGNLPE------KVYIDLTYNNLSGPIPQNG 254 (714)
Q Consensus 209 ~~L~~~l~l~~N~l~g~~p~~~~~l~~------L~~l~l~~N~l~~~~p~~~ 254 (714)
++|+ .|+++.|.+++..|..++.+++ |+.|++++|++++.+|...
T Consensus 174 ~~L~-~L~L~~n~l~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~ 224 (844)
T 3j0a_A 174 KTLS-FFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNF 224 (844)
T ss_dssp CSSC-CCEECCSBSCCCCCCCCCSSSCTTTTCCBSEEBCSSCCSSTTTTSGG
T ss_pred Cccc-eEECCCCccccccccchhhcCCccccCceeEEecCCCcCchhHHHHH
Confidence 7888 9999999999999998888776 9999999999998877543
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=99.84 E-value=5e-21 Score=219.34 Aligned_cols=183 Identities=18% Similarity=0.175 Sum_probs=164.4
Q ss_pred CcEEEEEcCCCCccccCCccccCCCCCCEEEccCCCCcccCChhhcCCCCCCEEEcCCCcCcccCCcccCCCCCCCEEec
Q 005102 64 QRVVSVSIPKKKLLGFLPSALGSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSGSVPNEIGKLKYLQILDL 143 (714)
Q Consensus 64 ~~~~~l~l~~~~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L 143 (714)
.+++.|+|++|++++..+..|.++++|++|+|++|.+++..|..|.++++|++|+|++|.+++..|..|+++++|++|+|
T Consensus 32 ~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L 111 (606)
T 3vq2_A 32 SSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVA 111 (606)
T ss_dssp TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCCCCTTSSTTCTTCCEEEC
T ss_pred CCcCEEECCCCCcCEeChhhccCCccCcEEeCCCCcccccCHHHhhchhhcCEeECCCCcccccChhhcCCcccCCEEEc
Confidence 47889999999999999989999999999999999999888999999999999999999999888999999999999999
Q ss_pred cCccCCCCCCcccccccccceeecccCcCCC-CCCcccccCccccccccccCCcccccCCCCCCCCccccc---cccccc
Q 005102 144 SQNFFNGSLPVSIVQCKRLKALDLSQNNFTG-PLPNGFGSGLVSLEKLNLSFNKFNGSIPSNTGNLSSLQG---TVDFSH 219 (714)
Q Consensus 144 s~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g-~~p~~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~---~l~l~~ 219 (714)
++|++++..|..+.++++|++|+|++|.+++ .+|..+. ++++|+.|+|++|++++..|..++.+.+|+. .+++++
T Consensus 112 ~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~-~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~~l~~L~l~~ 190 (606)
T 3vq2_A 112 VETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFS-NLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSL 190 (606)
T ss_dssp TTSCCCCSSSSCCTTCTTCCEEECCSSCCCCCCCCGGGG-TCTTCCEEECCSSCCCEECTTTTHHHHHCTTCCCEEECTT
T ss_pred cCCccccccccccCCCCCCCEEeCCCCcccceechHhHh-hcCCCCEEEccCCcceecChhhhhhhhccccccceeeccC
Confidence 9999997777889999999999999999986 6788884 6999999999999999888888888777642 699999
Q ss_pred ccCCcCcCccccCCCCcccccCcCCcCCC
Q 005102 220 NLFSGSIPASLGNLPEKVYIDLTYNNLSG 248 (714)
Q Consensus 220 N~l~g~~p~~~~~l~~L~~l~l~~N~l~~ 248 (714)
|.+++..+..+... +|+.|++++|.+++
T Consensus 191 n~l~~~~~~~~~~~-~L~~L~L~~n~~~~ 218 (606)
T 3vq2_A 191 NPIDFIQDQAFQGI-KLHELTLRGNFNSS 218 (606)
T ss_dssp CCCCEECTTTTTTC-EEEEEEEESCCSCH
T ss_pred CCcceeCcccccCc-eeeeeeccCCccch
Confidence 99997666666655 89999999998873
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.84 E-value=3.7e-21 Score=218.29 Aligned_cols=162 Identities=23% Similarity=0.223 Sum_probs=136.7
Q ss_pred cCCCCCCEEEcCCCcCcccCCcccCCCCCCCEEeccCccCCC--CCCcccccccccceeecccCcCCCCCCcccccCccc
Q 005102 109 LEAQGLQSLVLYGNSFSGSVPNEIGKLKYLQILDLSQNFFNG--SLPVSIVQCKRLKALDLSQNNFTGPLPNGFGSGLVS 186 (714)
Q Consensus 109 ~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g--~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~l~~ 186 (714)
..+++|+.|+|++|++++.+|..++++++|+.|+|++|++++ .+|..+..+++|+.|+|++|++++.+|...+..+++
T Consensus 350 ~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~ 429 (562)
T 3a79_B 350 PSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAES 429 (562)
T ss_dssp SSCCCCCEEECCSSCCCTTTTTTCCSCSSCCEEECCSSCCCBTTHHHHTTTTCTTCCEEECTTSCCBSCCSSCCCCCCTT
T ss_pred cCCCCceEEECCCCccccchhhhhcccCCCCEEECCCCCcCCcccchhhhcCCCCCCEEECCCCcCCCccChhhhcCccc
Confidence 577899999999999999899999999999999999999986 335678899999999999999998788876677999
Q ss_pred cccccccCCcccccCCCCCCCCcccccccccccccCCcCcCccccCCCCcccccCcCCcCCCCCCC-CccccCCCCcccc
Q 005102 187 LEKLNLSFNKFNGSIPSNTGNLSSLQGTVDFSHNLFSGSIPASLGNLPEKVYIDLTYNNLSGPIPQ-NGALMNRGPTAFI 265 (714)
Q Consensus 187 L~~L~l~~N~l~g~~p~~~~~l~~L~~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~-~~~~~~~~~~~~~ 265 (714)
|+.|+|++|++++.+|..+. ++|+ .|++++|+|+ .+|..+..+++|+.|++++|++++.++. ...+.........
T Consensus 430 L~~L~l~~n~l~~~~~~~l~--~~L~-~L~L~~N~l~-~ip~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~l~ 505 (562)
T 3a79_B 430 ILVLNLSSNMLTGSVFRCLP--PKVK-VLDLHNNRIM-SIPKDVTHLQALQELNVASNQLKSVPDGVFDRLTSLQYIWLH 505 (562)
T ss_dssp CCEEECCSSCCCGGGGSSCC--TTCS-EEECCSSCCC-CCCTTTTSSCCCSEEECCSSCCCCCCTTSTTTCTTCCCEECC
T ss_pred CCEEECCCCCCCcchhhhhc--CcCC-EEECCCCcCc-ccChhhcCCCCCCEEECCCCCCCCCCHHHHhcCCCCCEEEec
Confidence 99999999999988887765 6788 9999999998 7888888999999999999999965554 2333444556677
Q ss_pred cCCCCCCCC
Q 005102 266 GNPRLCGPP 274 (714)
Q Consensus 266 ~n~~~~~~~ 274 (714)
+|++.|.++
T Consensus 506 ~N~~~c~c~ 514 (562)
T 3a79_B 506 DNPWDCTCP 514 (562)
T ss_dssp SCCBCCCHH
T ss_pred CCCcCCCcc
Confidence 888888654
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.84 E-value=1e-20 Score=204.51 Aligned_cols=184 Identities=18% Similarity=0.115 Sum_probs=144.0
Q ss_pred CcEEEEEcCCCCccccCCccccCCCCCCEEEccCCCCcccCChhhcCCCCCCEEEcCCCcCcccCCcccCCCCCCCEEec
Q 005102 64 QRVVSVSIPKKKLLGFLPSALGSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSGSVPNEIGKLKYLQILDL 143 (714)
Q Consensus 64 ~~~~~l~l~~~~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L 143 (714)
.+++.|+|++|.+++..+..|..+++|++|+|++|.+++..|..+..+++|++|+|++|.++...+..|+++++|++|+|
T Consensus 69 ~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L 148 (390)
T 3o6n_A 69 RQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSM 148 (390)
T ss_dssp CCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred ccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEECCCCccCcCCHHHhcCCCCCcEEEC
Confidence 47888999999999988889999999999999999999888888999999999999999998444444689999999999
Q ss_pred cCccCCCCCCcccccccccceeecccCcCCCCCCcccccC-------------------------------------ccc
Q 005102 144 SQNFFNGSLPVSIVQCKRLKALDLSQNNFTGPLPNGFGSG-------------------------------------LVS 186 (714)
Q Consensus 144 s~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~-------------------------------------l~~ 186 (714)
++|++++..|..|..+++|+.|+|++|++++. +...... .++
T Consensus 149 ~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~-~~~~l~~L~~L~l~~n~l~~~~~~~~L~~L~l~~n~l~~~~~~~~~~ 227 (390)
T 3o6n_A 149 SNNNLERIEDDTFQATTSLQNLQLSSNRLTHV-DLSLIPSLFHANVSYNLLSTLAIPIAVEELDASHNSINVVRGPVNVE 227 (390)
T ss_dssp CSSCCCBCCTTTTSSCTTCCEEECCSSCCSBC-CGGGCTTCSEEECCSSCCSEEECCSSCSEEECCSSCCCEEECCCCSS
T ss_pred CCCccCccChhhccCCCCCCEEECCCCcCCcc-ccccccccceeecccccccccCCCCcceEEECCCCeeeecccccccc
Confidence 99999987788899999999999999998743 2211111 124
Q ss_pred cccccccCCcccccCCCCCCCCcccccccccccccCCcCcCccccCCCCcccccCcCCcCCCCCC
Q 005102 187 LEKLNLSFNKFNGSIPSNTGNLSSLQGTVDFSHNLFSGSIPASLGNLPEKVYIDLTYNNLSGPIP 251 (714)
Q Consensus 187 L~~L~l~~N~l~g~~p~~~~~l~~L~~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p 251 (714)
|+.|+|++|++++. ..+.++++|+ .|++++|.+++..|..|..+++|+.|++++|++++..+
T Consensus 228 L~~L~l~~n~l~~~--~~l~~l~~L~-~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~ 289 (390)
T 3o6n_A 228 LTILKLQHNNLTDT--AWLLNYPGLV-EVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVALNL 289 (390)
T ss_dssp CCEEECCSSCCCCC--GGGGGCTTCS-EEECCSSCCCEEESGGGTTCSSCCEEECCSSCCCEEEC
T ss_pred ccEEECCCCCCccc--HHHcCCCCcc-EEECCCCcCCCcChhHccccccCCEEECCCCcCcccCc
Confidence 55555555555532 3566677777 78888888887777788888888888888888776543
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.84 E-value=5.1e-21 Score=214.53 Aligned_cols=183 Identities=23% Similarity=0.346 Sum_probs=147.2
Q ss_pred CCCCCCCCCCCC-----cccce-EecCCcEEEEEcCCCCccccCCccccCCCCCCEEEccCCCCcccCChhhcCCCCCCE
Q 005102 43 LSNWNSSDENPC-----SWNGI-TCKEQRVVSVSIPKKKLLGFLPSALGSLTDLRHVNLRNNKFFGSLPLELLEAQGLQS 116 (714)
Q Consensus 43 l~~w~~~~~~~c-----~w~gv-~c~~~~~~~l~l~~~~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~ 116 (714)
+.+|.. +.+|| .|.|+ .|...+++.|+|++|+|++ +|..+. ++|++|+|++|+|+ .+| ..+++|+.
T Consensus 33 l~~W~~-~~~~~~~~~~~~~~l~~C~~~~L~~L~Ls~n~L~~-lp~~l~--~~L~~L~Ls~N~l~-~ip---~~l~~L~~ 104 (571)
T 3cvr_A 33 WDKWEK-QALPGENRNEAVSLLKECLINQFSELQLNRLNLSS-LPDNLP--PQITVLEITQNALI-SLP---ELPASLEY 104 (571)
T ss_dssp HHHHHT-TCCTTCCHHHHHHHHHHHHHTTCSEEECCSSCCSC-CCSCCC--TTCSEEECCSSCCS-CCC---CCCTTCCE
T ss_pred HHHHhc-cCCccccccchhhhccccccCCccEEEeCCCCCCc-cCHhHc--CCCCEEECcCCCCc-ccc---cccCCCCE
Confidence 345754 34678 69999 8987899999999999998 787663 88999999999998 677 45789999
Q ss_pred EEcCCCcCcccCCcccCCCCCCCEEeccCccCCCCCCcccccccccceeecccCcCCCCCCcccccCccccccccccCCc
Q 005102 117 LVLYGNSFSGSVPNEIGKLKYLQILDLSQNFFNGSLPVSIVQCKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLNLSFNK 196 (714)
Q Consensus 117 L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~l~~L~~L~l~~N~ 196 (714)
|+|++|.|++ +|. +.+ +|+.|+|++|+|++ +|. .+++|+.|+|++|+|++ +|. .+++|+.|+|++|+
T Consensus 105 L~Ls~N~l~~-ip~-l~~--~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~l~~-lp~----~l~~L~~L~Ls~N~ 171 (571)
T 3cvr_A 105 LDACDNRLST-LPE-LPA--SLKHLDVDNNQLTM-LPE---LPALLEYINADNNQLTM-LPE----LPTSLEVLSVRNNQ 171 (571)
T ss_dssp EECCSSCCSC-CCC-CCT--TCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC----CCTTCCEEECCSSC
T ss_pred EEccCCCCCC-cch-hhc--CCCEEECCCCcCCC-CCC---cCccccEEeCCCCccCc-CCC----cCCCcCEEECCCCC
Confidence 9999999996 777 765 99999999999986 776 67899999999999985 776 36789999999999
Q ss_pred ccccCCCCCCCCcccccccccccccCCcCcCccccCCCCc-------ccccCcCCcCCCCCCCCcc
Q 005102 197 FNGSIPSNTGNLSSLQGTVDFSHNLFSGSIPASLGNLPEK-------VYIDLTYNNLSGPIPQNGA 255 (714)
Q Consensus 197 l~g~~p~~~~~l~~L~~~l~l~~N~l~g~~p~~~~~l~~L-------~~l~l~~N~l~~~~p~~~~ 255 (714)
|++ +|. +. ++|+ .|+|++|+|+ .+|. +.. +| +.|++++|+|+..++....
T Consensus 172 L~~-lp~-l~--~~L~-~L~Ls~N~L~-~lp~-~~~--~L~~~~~~L~~L~Ls~N~l~~lp~~l~~ 228 (571)
T 3cvr_A 172 LTF-LPE-LP--ESLE-ALDVSTNLLE-SLPA-VPV--RNHHSEETEIFFRCRENRITHIPENILS 228 (571)
T ss_dssp CSC-CCC-CC--TTCC-EEECCSSCCS-SCCC-CC----------CCEEEECCSSCCCCCCGGGGG
T ss_pred CCC-cch-hh--CCCC-EEECcCCCCC-chhh-HHH--hhhcccccceEEecCCCcceecCHHHhc
Confidence 985 777 65 7888 8999999998 6676 554 66 8899999999864433333
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.84 E-value=5.7e-22 Score=230.30 Aligned_cols=229 Identities=18% Similarity=0.184 Sum_probs=141.5
Q ss_pred CchhHHHHHHHHHHhccCCCCCCCCCCCCCCCCCCcccceEecCCcEEEEEcCCCCccccCCccccCCCCCCE-----EE
Q 005102 20 SLNGEGYALLSFKQSVHEDPEGSLSNWNSSDENPCSWNGITCKEQRVVSVSIPKKKLLGFLPSALGSLTDLRH-----VN 94 (714)
Q Consensus 20 ~~~~~~~~l~~~~~~~~~~~~~~l~~w~~~~~~~c~w~gv~c~~~~~~~l~l~~~~l~g~~p~~~~~l~~L~~-----L~ 94 (714)
....++++|+++.+++.+..+..-.+|.......+.|.++.++..+++.|+|.+|.+... +..+.....|.. ++
T Consensus 129 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~~l~L~~n~~~~~-~~~~l~~l~Ls~~~i~~~~ 207 (727)
T 4b8c_D 129 LVDCTKQALMEMADTLTDSKTAKKQQPTGDSTPSGTATNSAVSTPLTPKIELFANGKDEA-NQALLQHKKLSQYSIDEDD 207 (727)
T ss_dssp ---CCCHHHHHHHHHHHHHHTTC---------------------------------------------------------
T ss_pred ccccchhhhhhhhhhcccccCcccCCCcCCCCccccCCCceecCCccceEEeeCCCCCcc-hhhHhhcCccCcccccCcc
Confidence 345678999999988866656666678665555678999999999999999999998873 433332222222 23
Q ss_pred ccCCCCcccCChhhcCCCCCCEEEcCCCcCcccCCcccCCCCCCCEEeccCccCCCCCCcccccccccceeecccCcCCC
Q 005102 95 LRNNKFFGSLPLELLEAQGLQSLVLYGNSFSGSVPNEIGKLKYLQILDLSQNFFNGSLPVSIVQCKRLKALDLSQNNFTG 174 (714)
Q Consensus 95 L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g 174 (714)
++.|++. ..|..+..+++|+.|+|++|.+. .+|..+.++++|+.|+|++|+|+ .+|..|.+|++|+.|+|++|+|+
T Consensus 208 ~~~n~~~-~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~- 283 (727)
T 4b8c_D 208 DIENRMV-MPKDSKYDDQLWHALDLSNLQIF-NISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT- 283 (727)
T ss_dssp ---------------CCCCCCEEECTTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS-
T ss_pred cccccee-cChhhhccCCCCcEEECCCCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC-
Confidence 3344444 45777889999999999999998 88988889999999999999998 89999999999999999999999
Q ss_pred CCCcccccCccccccccccCCcccccCCCCCCCCcccccccccccccCCcCcCccccCCCC-cccccCcCCcCCCCCCCC
Q 005102 175 PLPNGFGSGLVSLEKLNLSFNKFNGSIPSNTGNLSSLQGTVDFSHNLFSGSIPASLGNLPE-KVYIDLTYNNLSGPIPQN 253 (714)
Q Consensus 175 ~~p~~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~~l~l~~N~l~g~~p~~~~~l~~-L~~l~l~~N~l~~~~p~~ 253 (714)
.+|..++ .|++|+.|+|++|.|+ .+|..|+++++|+ .|+|++|.|++.+|..+..+.. +..|++++|.++|.+|..
T Consensus 284 ~lp~~~~-~l~~L~~L~L~~N~l~-~lp~~~~~l~~L~-~L~L~~N~l~~~~p~~~~~~~~~~~~l~l~~N~l~~~~p~~ 360 (727)
T 4b8c_D 284 SLPAELG-SCFQLKYFYFFDNMVT-TLPWEFGNLCNLQ-FLGVEGNPLEKQFLKILTEKSVTGLIFYLRDNRPEIPLPHE 360 (727)
T ss_dssp SCCSSGG-GGTTCSEEECCSSCCC-CCCSSTTSCTTCC-CEECTTSCCCSHHHHHHHHHHHHHHHHHHHHCCCCCCCCCC
T ss_pred ccChhhc-CCCCCCEEECCCCCCC-ccChhhhcCCCcc-EEeCCCCccCCCChHHHhhcchhhhHHhhccCcccCcCccc
Confidence 8899885 5999999999999997 8999999999999 9999999999999988876543 345889999999999986
Q ss_pred ccc
Q 005102 254 GAL 256 (714)
Q Consensus 254 ~~~ 256 (714)
...
T Consensus 361 l~~ 363 (727)
T 4b8c_D 361 RRF 363 (727)
T ss_dssp ---
T ss_pred cce
Confidence 543
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.84 E-value=3.3e-21 Score=216.61 Aligned_cols=204 Identities=25% Similarity=0.214 Sum_probs=171.6
Q ss_pred cEEEEEcCCCCccccCCccc-----cCCCCCCEEEccCCCCcccCC-hh-------------------------hcCCCC
Q 005102 65 RVVSVSIPKKKLLGFLPSAL-----GSLTDLRHVNLRNNKFFGSLP-LE-------------------------LLEAQG 113 (714)
Q Consensus 65 ~~~~l~l~~~~l~g~~p~~~-----~~l~~L~~L~L~~N~l~~~~p-~~-------------------------~~~l~~ 113 (714)
+++.|++++|+++|.+|..+ +.+++|+.+++++|.+ .+| .. +..+++
T Consensus 248 ~L~~L~l~~n~l~~~~p~~~~~~~~~~l~~L~~l~l~~n~~--~~p~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~l~~ 325 (520)
T 2z7x_B 248 TVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVF--GFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISP 325 (520)
T ss_dssp SCSEEEEEEEEEESCCCCCCCCCCSCCCCEEEEEEEEECCC--CSCTHHHHHHHHTCCCSEEEEESSCCCCCCCCSSCCC
T ss_pred cccEEEeecccccCccccchhhcccccCceeEeccccccce--ecchhhhhcccccCceeEEEcCCCccccccchhhCCc
Confidence 78889999999999999888 7787777777777776 344 11 157889
Q ss_pred CCEEEcCCCcCcccCCcccCCCCCCCEEeccCccCCC--CCCcccccccccceeecccCcCCCCCCcccccCcccccccc
Q 005102 114 LQSLVLYGNSFSGSVPNEIGKLKYLQILDLSQNFFNG--SLPVSIVQCKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLN 191 (714)
Q Consensus 114 L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g--~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~l~~L~~L~ 191 (714)
|+.|+|++|.+++.+|..++.+++|+.|+|++|++++ .+|..+..+++|+.|+|++|++++.+|...+..+++|+.|+
T Consensus 326 L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~ 405 (520)
T 2z7x_B 326 FLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLN 405 (520)
T ss_dssp CCEEECCSSCCCTTTTTTCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGGCSCCCCTTCCEEE
T ss_pred ccEEEeECCccChhhhhhhccCCCCCEEEccCCccCccccchHHHhhCCCCCEEECCCCcCCcccccchhccCccCCEEE
Confidence 9999999999999999999999999999999999996 56778999999999999999999878887556789999999
Q ss_pred ccCCcccccCCCCCCCCcccccccccccccCCcCcCccccCCCCcccccCcCCcCCCCCCCCc-cccCCCCcccccCCCC
Q 005102 192 LSFNKFNGSIPSNTGNLSSLQGTVDFSHNLFSGSIPASLGNLPEKVYIDLTYNNLSGPIPQNG-ALMNRGPTAFIGNPRL 270 (714)
Q Consensus 192 l~~N~l~g~~p~~~~~l~~L~~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~-~~~~~~~~~~~~n~~~ 270 (714)
|++|++++.+|..+. ++|+ .|++++|+|+ .+|..+..+++|+.|++++|+++..++... .+.........+|+..
T Consensus 406 Ls~N~l~~~~~~~l~--~~L~-~L~Ls~N~l~-~ip~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~l~~N~~~ 481 (520)
T 2z7x_B 406 MSSNILTDTIFRCLP--PRIK-VLDLHSNKIK-SIPKQVVKLEALQELNVASNQLKSVPDGIFDRLTSLQKIWLHTNPWD 481 (520)
T ss_dssp CCSSCCCGGGGGSCC--TTCC-EEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCBC
T ss_pred CcCCCCCcchhhhhc--ccCC-EEECCCCccc-ccchhhhcCCCCCEEECCCCcCCccCHHHhccCCcccEEECcCCCCc
Confidence 999999999888775 6788 9999999999 889888899999999999999996555423 3334455667788877
Q ss_pred CCCC
Q 005102 271 CGPP 274 (714)
Q Consensus 271 ~~~~ 274 (714)
|.++
T Consensus 482 c~c~ 485 (520)
T 2z7x_B 482 CSCP 485 (520)
T ss_dssp CCHH
T ss_pred ccCC
Confidence 7654
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.83 E-value=2.9e-21 Score=202.55 Aligned_cols=194 Identities=21% Similarity=0.166 Sum_probs=129.6
Q ss_pred CcEEEEEcCCCCccccCCccccCCCCCCEEEccCCCCcccCChhhcCCCCCCEEEcCCCcCcccCCcccCCCCCCCEEec
Q 005102 64 QRVVSVSIPKKKLLGFLPSALGSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSGSVPNEIGKLKYLQILDL 143 (714)
Q Consensus 64 ~~~~~l~l~~~~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L 143 (714)
.+++.|+|++|.+++..| +..+++|++|+|++|++++.. ..++|+.|+|++|++++..+. .+++|+.|+|
T Consensus 58 ~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~Ls~n~l~~l~-----~~~~L~~L~l~~n~l~~~~~~---~~~~L~~L~l 127 (317)
T 3o53_A 58 TKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELL-----VGPSIETLHAANNNISRVSCS---RGQGKKNIYL 127 (317)
T ss_dssp TTCCEEECTTSCCEEEEE--ETTCTTCCEEECCSSEEEEEE-----ECTTCCEEECCSSCCSEEEEC---CCSSCEEEEC
T ss_pred CcCCEEECCCCcCCcchh--hhhcCCCCEEECcCCcccccc-----CCCCcCEEECCCCccCCcCcc---ccCCCCEEEC
Confidence 345555555555554433 555555555555555554321 224555555555555543333 3577888888
Q ss_pred cCccCCCCCCcccccccccceeecccCcCCCCCCcccccCccccccccccCCcccccCCCCCCCCcccccccccccccCC
Q 005102 144 SQNFFNGSLPVSIVQCKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLNLSFNKFNGSIPSNTGNLSSLQGTVDFSHNLFS 223 (714)
Q Consensus 144 s~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~~l~l~~N~l~ 223 (714)
++|++++..|..+..+++|+.|+|++|.+++..|..+...+++|+.|+|++|++++. |.. ..+++|+ .|++++|+++
T Consensus 128 ~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~-~~~-~~l~~L~-~L~Ls~N~l~ 204 (317)
T 3o53_A 128 ANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV-KGQ-VVFAKLK-TLDLSSNKLA 204 (317)
T ss_dssp CSSCCCSGGGBCTGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE-ECC-CCCTTCC-EEECCSSCCC
T ss_pred CCCCCCCccchhhhccCCCCEEECCCCCCCcccHHHHhhccCcCCEEECCCCcCccc-ccc-cccccCC-EEECCCCcCC
Confidence 888888777778888889999999999988766666655678899999999998844 433 3478888 8999999998
Q ss_pred cCcCccccCCCCcccccCcCCcCCCCCCCCccccCCCCcccccCCCCC
Q 005102 224 GSIPASLGNLPEKVYIDLTYNNLSGPIPQNGALMNRGPTAFIGNPRLC 271 (714)
Q Consensus 224 g~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~~~~~~~~~~~~n~~~~ 271 (714)
+ +|..+..+++|+.|++++|++++.++............+.+|+..|
T Consensus 205 ~-l~~~~~~l~~L~~L~L~~N~l~~l~~~~~~l~~L~~L~l~~N~~~~ 251 (317)
T 3o53_A 205 F-MGPEFQSAAGVTWISLRNNKLVLIEKALRFSQNLEHFDLRGNGFHC 251 (317)
T ss_dssp E-ECGGGGGGTTCSEEECTTSCCCEECTTCCCCTTCCEEECTTCCCBH
T ss_pred c-chhhhcccCcccEEECcCCcccchhhHhhcCCCCCEEEccCCCccC
Confidence 5 4556888899999999999998654333233334444555666554
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=99.83 E-value=3.7e-20 Score=195.29 Aligned_cols=205 Identities=21% Similarity=0.267 Sum_probs=169.3
Q ss_pred CCcEEEEEcCCCCccccCCccccCCCCCCEEEccCCCCcccCChhhcCCCCCCEEEcCCCcCcccCCcccCCCCCCCEEe
Q 005102 63 EQRVVSVSIPKKKLLGFLPSALGSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSGSVPNEIGKLKYLQILD 142 (714)
Q Consensus 63 ~~~~~~l~l~~~~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ 142 (714)
..+++.|+|++|++++..|..|.++++|++|+|++|.++ .+|..+. ++|+.|+|++|.+++..+..+.++++|+.|+
T Consensus 75 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ 151 (330)
T 1xku_A 75 LKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK-ELPEKMP--KTLQELRVHENEITKVRKSVFNGLNQMIVVE 151 (330)
T ss_dssp CTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCS-BCCSSCC--TTCCEEECCSSCCCBBCHHHHTTCTTCCEEE
T ss_pred CCCCCEEECCCCcCCeeCHHHhcCCCCCCEEECCCCcCC-ccChhhc--ccccEEECCCCcccccCHhHhcCCccccEEE
Confidence 468999999999999999999999999999999999998 6776655 7899999999999987777899999999999
Q ss_pred ccCccCCC--CCCcccccccccceeecccCcCCCCCCcccccCccccccccccCCcccccCCCCCCCCcccccccccccc
Q 005102 143 LSQNFFNG--SLPVSIVQCKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLNLSFNKFNGSIPSNTGNLSSLQGTVDFSHN 220 (714)
Q Consensus 143 Ls~N~l~g--~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~~l~l~~N 220 (714)
|++|.++. ..+..+..+++|+.|++++|.++ .+|..+. ++|+.|+|++|++++..|..+..+++|+ .|++++|
T Consensus 152 l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~-~l~~~~~---~~L~~L~l~~n~l~~~~~~~~~~l~~L~-~L~Ls~n 226 (330)
T 1xku_A 152 LGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGLP---PSLTELHLDGNKITKVDAASLKGLNNLA-KLGLSFN 226 (330)
T ss_dssp CCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCC-SCCSSCC---TTCSEEECTTSCCCEECTGGGTTCTTCC-EEECCSS
T ss_pred CCCCcCCccCcChhhccCCCCcCEEECCCCccc-cCCcccc---ccCCEEECCCCcCCccCHHHhcCCCCCC-EEECCCC
Confidence 99999963 67888999999999999999998 5777653 7899999999999988888899999998 9999999
Q ss_pred cCCcCcCccccCCCCcccccCcCCcCCCCCCCCccccCCCCcccccCCCCCCCCCC
Q 005102 221 LFSGSIPASLGNLPEKVYIDLTYNNLSGPIPQNGALMNRGPTAFIGNPRLCGPPLK 276 (714)
Q Consensus 221 ~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~~~~~~~~~~~~n~~~~~~~~~ 276 (714)
.+++..+..+..+++|+.|++++|+++ .+|...............++.+...+..
T Consensus 227 ~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~i~~~~~~ 281 (330)
T 1xku_A 227 SISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSN 281 (330)
T ss_dssp CCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCCCCCTT
T ss_pred cCceeChhhccCCCCCCEEECCCCcCc-cCChhhccCCCcCEEECCCCcCCccChh
Confidence 999888888999999999999999998 4444433333333344444445544433
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=99.83 E-value=1.9e-20 Score=214.50 Aligned_cols=182 Identities=24% Similarity=0.293 Sum_probs=129.2
Q ss_pred CcEEEEEcCCCCccccCCccccCCCCCCEEEccCCCCcccCChhhcCCCCCCEEEcCCCcCcccCCcc-cCCCCCCCEEe
Q 005102 64 QRVVSVSIPKKKLLGFLPSALGSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSGSVPNE-IGKLKYLQILD 142 (714)
Q Consensus 64 ~~~~~l~l~~~~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~-~~~l~~L~~L~ 142 (714)
.+++.|+|++|+++ .+|..+..+++|++|+|++|.+.+..|..+..+++|+.|+|++|.+.+.+|.. +..+++|+.|+
T Consensus 278 ~~L~~L~l~~n~l~-~lp~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~ 356 (606)
T 3t6q_A 278 SGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELD 356 (606)
T ss_dssp TTCSEEECTTSCCS-CCCSSCCSCTTCCEEECTTCCCSBGGGGCGGGCTTCSEEECCSCSSCCBCCSSTTTTCTTCCEEE
T ss_pred cCCCEEeccCCccC-CCChhhcccccCCEEECccCCcCcCchhhhhccCcCCEEECCCCCcccccchhhhhccCcCCEEE
Confidence 46777788877777 56777777778888888888777766777777777777777777777666654 67777777777
Q ss_pred ccCccCCCCC--CcccccccccceeecccCcCCCCCCcccccCccccccccccCCcccccCCCC-CCCCccccccccccc
Q 005102 143 LSQNFFNGSL--PVSIVQCKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLNLSFNKFNGSIPSN-TGNLSSLQGTVDFSH 219 (714)
Q Consensus 143 Ls~N~l~g~~--p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~l~~L~~L~l~~N~l~g~~p~~-~~~l~~L~~~l~l~~ 219 (714)
|++|++++.. |..+..+++|+.|++++|++++..|..+ ..+++|+.|++++|++++..|.. +.++++|+ .|++++
T Consensus 357 l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~-~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~-~L~l~~ 434 (606)
T 3t6q_A 357 LSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAF-KECPQLELLDLAFTRLKVKDAQSPFQNLHLLK-VLNLSH 434 (606)
T ss_dssp CCSSCCCEEEESTTTTTTCTTCCEEECCSCSCEEECTTTT-TTCTTCSEEECTTCCEECCTTCCTTTTCTTCC-EEECTT
T ss_pred CCCCccccccCcchhcccCCCCCEEECCCCcCCcCCHHHh-cCCccCCeEECCCCcCCCcccchhhhCcccCC-EEECCC
Confidence 7777776544 5667777777777777777765555555 34677777777777776665543 66677777 777777
Q ss_pred ccCCcCcCccccCCCCcccccCcCCcCCC
Q 005102 220 NLFSGSIPASLGNLPEKVYIDLTYNNLSG 248 (714)
Q Consensus 220 N~l~g~~p~~~~~l~~L~~l~l~~N~l~~ 248 (714)
|.+++..|..++.+++|+.|++++|++++
T Consensus 435 n~l~~~~~~~~~~l~~L~~L~L~~n~l~~ 463 (606)
T 3t6q_A 435 SLLDISSEQLFDGLPALQHLNLQGNHFPK 463 (606)
T ss_dssp CCCBTTCTTTTTTCTTCCEEECTTCBCGG
T ss_pred CccCCcCHHHHhCCCCCCEEECCCCCCCc
Confidence 77776667777777777777777777765
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.83 E-value=2.8e-20 Score=204.37 Aligned_cols=182 Identities=20% Similarity=0.250 Sum_probs=150.5
Q ss_pred CcEEEEEcCCCCccccCCccccCCCCCCEEEccCCCCcccCChhhcCCCCCCEEEcCCCcCcccCC--------------
Q 005102 64 QRVVSVSIPKKKLLGFLPSALGSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSGSVP-------------- 129 (714)
Q Consensus 64 ~~~~~l~l~~~~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p-------------- 129 (714)
.+++.|+|++|++++..+..|.++++|++|+|++|+|++..+..|..+++|+.|+|++|.+++..+
T Consensus 88 ~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l 167 (440)
T 3zyj_A 88 RHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDL 167 (440)
T ss_dssp SSCCEEECCSSCCCEECGGGGTTCSSCCEEECCSSCCSSCCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEEC
T ss_pred CCCCEEECCCCcCCccChhhccCCccCCEEECCCCcCCeeCHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeCC
Confidence 467778888888877777777778888888888887776555567777777777777777664333
Q ss_pred -----------cccCCCCCCCEEeccCccCCCCCCcccccccccceeecccCcCCCCCCcccccCccccccccccCCccc
Q 005102 130 -----------NEIGKLKYLQILDLSQNFFNGSLPVSIVQCKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLNLSFNKFN 198 (714)
Q Consensus 130 -----------~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~l~~L~~L~l~~N~l~ 198 (714)
..|.++++|+.|+|++|+++ .+| .+..+++|+.|+|++|++++..|..+ .++++|+.|+|++|+++
T Consensus 168 ~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~-~~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~-~~l~~L~~L~L~~n~l~ 244 (440)
T 3zyj_A 168 GELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIP-NLTPLIKLDELDLSGNHLSAIRPGSF-QGLMHLQKLWMIQSQIQ 244 (440)
T ss_dssp CCCTTCCEECTTTTTTCSSCCEEECTTSCCS-SCC-CCTTCSSCCEEECTTSCCCEECTTTT-TTCTTCCEEECTTCCCC
T ss_pred CCCCCcceeCcchhhcccccCeecCCCCcCc-ccc-ccCCCcccCEEECCCCccCccChhhh-ccCccCCEEECCCCcee
Confidence 24667788888888888887 566 48889999999999999997667666 57999999999999999
Q ss_pred ccCCCCCCCCcccccccccccccCCcCcCccccCCCCcccccCcCCcCCCC
Q 005102 199 GSIPSNTGNLSSLQGTVDFSHNLFSGSIPASLGNLPEKVYIDLTYNNLSGP 249 (714)
Q Consensus 199 g~~p~~~~~l~~L~~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~ 249 (714)
+..|..+.++++|+ .|+|++|+|++..+..|..+++|+.|++++|.+.-.
T Consensus 245 ~~~~~~~~~l~~L~-~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~Cd 294 (440)
T 3zyj_A 245 VIERNAFDNLQSLV-EINLAHNNLTLLPHDLFTPLHHLERIHLHHNPWNCN 294 (440)
T ss_dssp EECTTSSTTCTTCC-EEECTTSCCCCCCTTTTSSCTTCCEEECCSSCEECS
T ss_pred EEChhhhcCCCCCC-EEECCCCCCCccChhHhccccCCCEEEcCCCCccCC
Confidence 98899999999999 999999999988888899999999999999998743
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.83 E-value=5.2e-20 Score=180.48 Aligned_cols=173 Identities=22% Similarity=0.227 Sum_probs=148.0
Q ss_pred CcccceEec----CCcEEEEEcCCCCccccCCccccCCCCCCEEEccCCCCcccCChhhcCCCCCCEEEcCCCcCcccCC
Q 005102 54 CSWNGITCK----EQRVVSVSIPKKKLLGFLPSALGSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSGSVP 129 (714)
Q Consensus 54 c~w~gv~c~----~~~~~~l~l~~~~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p 129 (714)
|+..|++.- ..+++.|+|++|++++..+..|..+++|++|+|++|++++..+..|..+++|++|+|++|.+++..+
T Consensus 14 c~~~~l~~~p~~~~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~ 93 (208)
T 2o6s_A 14 CYSQGRTSVPTGIPAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQSLPN 93 (208)
T ss_dssp CCSSCCSSCCSCCCTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCT
T ss_pred ecCCCccCCCCCCCCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEECCCCcCCccCH
Confidence 555554332 3478999999999998877788999999999999999997766678899999999999999997767
Q ss_pred cccCCCCCCCEEeccCccCCCCCCcccccccccceeecccCcCCCCCCcccccCccccccccccCCcccccCCCCCCCCc
Q 005102 130 NEIGKLKYLQILDLSQNFFNGSLPVSIVQCKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLNLSFNKFNGSIPSNTGNLS 209 (714)
Q Consensus 130 ~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~ 209 (714)
..|.++++|+.|+|++|++++..+..|..+++|+.|+|++|++++ +|...+..+++|+.|+|++|.+.+.. +
T Consensus 94 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~-~~~~~~~~l~~L~~L~l~~N~~~~~~-------~ 165 (208)
T 2o6s_A 94 GVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKS-VPDGVFDRLTSLQYIWLHDNPWDCTC-------P 165 (208)
T ss_dssp TTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSC-CCTTTTTTCTTCCEEECCSCCBCCCT-------T
T ss_pred hHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccce-eCHHHhccCCCccEEEecCCCeecCC-------C
Confidence 778999999999999999997666678999999999999999995 55554457999999999999988554 4
Q ss_pred ccccccccccccCCcCcCccccCCCC
Q 005102 210 SLQGTVDFSHNLFSGSIPASLGNLPE 235 (714)
Q Consensus 210 ~L~~~l~l~~N~l~g~~p~~~~~l~~ 235 (714)
.++ .++++.|+++|.+|.+++.++.
T Consensus 166 ~l~-~L~~~~n~~~g~ip~~~~~l~~ 190 (208)
T 2o6s_A 166 GIR-YLSEWINKHSGVVRNSAGSVAP 190 (208)
T ss_dssp TTH-HHHHHHHHCTTTBBCTTSSBCT
T ss_pred CHH-HHHHHHHhCCceeeccCccccC
Confidence 677 8999999999999999988764
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=99.82 E-value=8.2e-20 Score=212.19 Aligned_cols=188 Identities=20% Similarity=0.115 Sum_probs=134.9
Q ss_pred CCcEEEEEcCCCCccccC--CccccCC--CCCCEEEccCCCCcccCChhhcCCCCCCEEEcCCCcCcccCC-cccCCCCC
Q 005102 63 EQRVVSVSIPKKKLLGFL--PSALGSL--TDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSGSVP-NEIGKLKY 137 (714)
Q Consensus 63 ~~~~~~l~l~~~~l~g~~--p~~~~~l--~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p-~~~~~l~~ 137 (714)
..+++.|+|++|.+.+.. +..+..+ ++|+.|+|++|++++..|..+..+++|+.|+|++|.+++.+| ..+.++++
T Consensus 352 l~~L~~L~Ls~n~~~~~~l~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~ 431 (680)
T 1ziw_A 352 LINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLEN 431 (680)
T ss_dssp CTTCCEEECTTCBSCCCEECTTTTGGGTTSCCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCEEECCSGGGTTCTT
T ss_pred ccCCcEEECCCCchhhhhcchhhhcccccCcCceEECCCCCCCeEChhhhhCCCCCCEEeCCCCcCccccCcccccCccc
Confidence 358999999999865432 2334333 589999999999999999999999999999999999998777 67899999
Q ss_pred CCEEeccCccCCCCCCcccccccccceeecccCcCC--CCCCcccccCccccccccccCCcccccCCCCCCCCccccccc
Q 005102 138 LQILDLSQNFFNGSLPVSIVQCKRLKALDLSQNNFT--GPLPNGFGSGLVSLEKLNLSFNKFNGSIPSNTGNLSSLQGTV 215 (714)
Q Consensus 138 L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~--g~~p~~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~~l 215 (714)
|+.|+|++|++.+..+..|..+++|+.|++++|.++ +.+|..+ ..+++|+.|+|++|++++..|..+..+++|+ .|
T Consensus 432 L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~p~~~-~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~-~L 509 (680)
T 1ziw_A 432 IFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPF-QPLRNLTILDLSNNNIANINDDMLEGLEKLE-IL 509 (680)
T ss_dssp CCEEECCSCSEEECCTTTTTTCTTCCEEECTTSCCBCTTCSSCTT-TTCTTCCEEECCSSCCCCCCTTTTTTCTTCC-EE
T ss_pred ccEEecCCCCcceeChhhhhcCcccccchhccccccccccCCccc-ccCCCCCEEECCCCCCCcCChhhhccccccC-EE
Confidence 999999999988766666666666666666666665 3455555 3466666666666666655555566666666 66
Q ss_pred ccccccCCcCcC--------ccccCCCCcccccCcCCcCCCCCCC
Q 005102 216 DFSHNLFSGSIP--------ASLGNLPEKVYIDLTYNNLSGPIPQ 252 (714)
Q Consensus 216 ~l~~N~l~g~~p--------~~~~~l~~L~~l~l~~N~l~~~~p~ 252 (714)
++++|++++..+ ..|..+++|+.|++++|+++..++.
T Consensus 510 ~Ls~N~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~ 554 (680)
T 1ziw_A 510 DLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVE 554 (680)
T ss_dssp ECCSSCCGGGGSTTSTTSCCCTTTTCTTCCEEECCSSCCCCCCTT
T ss_pred eCCCCCccccchhhccCCcchhhcCCCCCCEEECCCCCCCCCCHH
Confidence 666666654321 1255666666666666666644433
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.82 E-value=6.4e-20 Score=182.68 Aligned_cols=159 Identities=23% Similarity=0.270 Sum_probs=121.4
Q ss_pred CCCCcccceEecCCcEEEEEcCCCCccccCCccccCCCCCCEEEccCCCCcccCChhhcCCCCCCEEEcCCCcCcccCCc
Q 005102 51 ENPCSWNGITCKEQRVVSVSIPKKKLLGFLPSALGSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSGSVPN 130 (714)
Q Consensus 51 ~~~c~w~gv~c~~~~~~~l~l~~~~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~ 130 (714)
.+.|+|.+|.|... +++ .+|..+. ++|++|+|++|.|++..|..|..+++|+.|+|++|+|++..+.
T Consensus 16 ~~~Cs~~~v~c~~~----------~l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~ 82 (229)
T 3e6j_A 16 QCSCSGTTVDCRSK----------RHA-SVPAGIP--TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVG 82 (229)
T ss_dssp TCEEETTEEECTTS----------CCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTT
T ss_pred CCEEeCCEeEccCC----------CcC-ccCCCCC--CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChh
Confidence 46799999999743 332 4555443 7889999999999988888888888999999999998755556
Q ss_pred ccCCCCCCCEEeccCccCCCCCCcccccccccceeecccCcCCCCCCcccccCccccccccccCCcccccCCCCCCCCcc
Q 005102 131 EIGKLKYLQILDLSQNFFNGSLPVSIVQCKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLNLSFNKFNGSIPSNTGNLSS 210 (714)
Q Consensus 131 ~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~ 210 (714)
.|..+++|+.|+|++|+|++..+..|..+++|+.|+|++|+|+ .+|..+ ..+++|+.|+|++|+|++..+..+..+++
T Consensus 83 ~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~-~~l~~L~~L~L~~N~l~~~~~~~~~~l~~ 160 (229)
T 3e6j_A 83 VFDSLTQLTVLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGI-ERLTHLTHLALDQNQLKSIPHGAFDRLSS 160 (229)
T ss_dssp TTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTG-GGCTTCSEEECCSSCCCCCCTTTTTTCTT
T ss_pred hcccCCCcCEEECCCCcCCccChhHhCcchhhCeEeccCCccc-ccCccc-ccCCCCCEEECCCCcCCccCHHHHhCCCC
Confidence 6788888888888888888666666778888888888888887 677776 35778888888888777554455666667
Q ss_pred cccccccccccCCcC
Q 005102 211 LQGTVDFSHNLFSGS 225 (714)
Q Consensus 211 L~~~l~l~~N~l~g~ 225 (714)
|+ .+++++|.+++.
T Consensus 161 L~-~L~l~~N~~~c~ 174 (229)
T 3e6j_A 161 LT-HAYLFGNPWDCE 174 (229)
T ss_dssp CC-EEECTTSCBCTT
T ss_pred CC-EEEeeCCCccCC
Confidence 76 677777766643
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.82 E-value=3.9e-20 Score=204.01 Aligned_cols=184 Identities=20% Similarity=0.193 Sum_probs=158.0
Q ss_pred CCcEEEEEcCCCCccccCCccccCCCCCCEEEccCCCCcccCChhhcCCCCCCEEEcCCCcCcccCCc------------
Q 005102 63 EQRVVSVSIPKKKLLGFLPSALGSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSGSVPN------------ 130 (714)
Q Consensus 63 ~~~~~~l~l~~~~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~------------ 130 (714)
..+++.|+|++|++++..|..|.++++|++|+|++|+|++..+..|..+++|+.|+|++|.+++..+.
T Consensus 98 l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 177 (452)
T 3zyi_A 98 LHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLD 177 (452)
T ss_dssp CTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSBCCTTTSSSCTTCCEEECCSCCCCEECTTTTTTCTTCCEEE
T ss_pred CCCCCEEECCCCccCCcChhhccCcccCCEEECCCCcCCccChhhhcccCCCCEEECCCCCcceeCHhHHhcCCcccEEe
Confidence 35788899999999988888899999999999999998876666788888888888888888744332
Q ss_pred -------------ccCCCCCCCEEeccCccCCCCCCcccccccccceeecccCcCCCCCCcccccCccccccccccCCcc
Q 005102 131 -------------EIGKLKYLQILDLSQNFFNGSLPVSIVQCKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLNLSFNKF 197 (714)
Q Consensus 131 -------------~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~l~~L~~L~l~~N~l 197 (714)
.|.++++|+.|+|++|++++ +| .+..+++|+.|+|++|++++..|..+ .++++|+.|+|++|++
T Consensus 178 l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~-~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~-~~l~~L~~L~L~~n~l 254 (452)
T 3zyi_A 178 LGELKKLEYISEGAFEGLFNLKYLNLGMCNIKD-MP-NLTPLVGLEELEMSGNHFPEIRPGSF-HGLSSLKKLWVMNSQV 254 (452)
T ss_dssp CCCCTTCCEECTTTTTTCTTCCEEECTTSCCSS-CC-CCTTCTTCCEEECTTSCCSEECGGGG-TTCTTCCEEECTTSCC
T ss_pred CCCCCCccccChhhccCCCCCCEEECCCCcccc-cc-cccccccccEEECcCCcCcccCcccc-cCccCCCEEEeCCCcC
Confidence 35667788888888888874 45 58889999999999999997667766 5799999999999999
Q ss_pred cccCCCCCCCCcccccccccccccCCcCcCccccCCCCcccccCcCCcCCCCC
Q 005102 198 NGSIPSNTGNLSSLQGTVDFSHNLFSGSIPASLGNLPEKVYIDLTYNNLSGPI 250 (714)
Q Consensus 198 ~g~~p~~~~~l~~L~~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~ 250 (714)
++..|..+.++++|+ .|+|++|+|++..+..|..+++|+.|++++|.+...-
T Consensus 255 ~~~~~~~~~~l~~L~-~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~CdC 306 (452)
T 3zyi_A 255 SLIERNAFDGLASLV-ELNLAHNNLSSLPHDLFTPLRYLVELHLHHNPWNCDC 306 (452)
T ss_dssp CEECTTTTTTCTTCC-EEECCSSCCSCCCTTSSTTCTTCCEEECCSSCEECST
T ss_pred ceECHHHhcCCCCCC-EEECCCCcCCccChHHhccccCCCEEEccCCCcCCCC
Confidence 998899999999999 9999999999888888999999999999999987543
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.82 E-value=2.5e-20 Score=211.88 Aligned_cols=205 Identities=20% Similarity=0.189 Sum_probs=164.0
Q ss_pred cEEEEEcCCCCccccCCccccCCCCCCEEEccCCCCcccC--ChhhcCCCCCCEEEcCCCcCcccCCcccCCCCCCCEEe
Q 005102 65 RVVSVSIPKKKLLGFLPSALGSLTDLRHVNLRNNKFFGSL--PLELLEAQGLQSLVLYGNSFSGSVPNEIGKLKYLQILD 142 (714)
Q Consensus 65 ~~~~l~l~~~~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~--p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ 142 (714)
.++.|++.+|.+.+.++. ..+++|++|+|++|.+++.. |..+..+++|+.|+|++|.+++. |..+..+++|+.|+
T Consensus 326 ~L~~L~l~~n~~~~~~~~--~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~-~~~~~~l~~L~~L~ 402 (570)
T 2z63_A 326 SLKRLTFTSNKGGNAFSE--VDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITM-SSNFLGLEQLEHLD 402 (570)
T ss_dssp SCCEEEEESCBSCCBCCC--CBCTTCCEEECCSSCCBEEEEEEHHHHTCSCCCEEECCSCSEEEE-EEEEETCTTCCEEE
T ss_pred ccCEEeCcCCcccccccc--ccCCCCCEEeCcCCccCccccccccccccCccCEEECCCCccccc-cccccccCCCCEEE
Confidence 455555556655555443 67888999999999888654 77888899999999999999854 44488899999999
Q ss_pred ccCccCCCCCC-cccccccccceeecccCcCCCCCCcccccCccccccccccCCccc-ccCCCCCCCCcccccccccccc
Q 005102 143 LSQNFFNGSLP-VSIVQCKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLNLSFNKFN-GSIPSNTGNLSSLQGTVDFSHN 220 (714)
Q Consensus 143 Ls~N~l~g~~p-~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~l~~L~~L~l~~N~l~-g~~p~~~~~l~~L~~~l~l~~N 220 (714)
+++|++++..| ..+..+++|+.|+|++|.+++.+|..+ .++++|+.|+|++|+++ +.+|..+..+++|+ .|++++|
T Consensus 403 l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~-~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~-~L~l~~n 480 (570)
T 2z63_A 403 FQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIF-NGLSSLEVLKMAGNSFQENFLPDIFTELRNLT-FLDLSQC 480 (570)
T ss_dssp CTTSEEESCTTSCTTTTCTTCCEEECTTSCCEECCTTTT-TTCTTCCEEECTTCEEGGGEECSCCTTCTTCC-EEECTTS
T ss_pred ccCCccccccchhhhhcCCCCCEEeCcCCcccccchhhh-hcCCcCcEEECcCCcCccccchhhhhcccCCC-EEECCCC
Confidence 99999987666 467889999999999999987777766 46899999999999997 67899999999999 9999999
Q ss_pred cCCcCcCccccCCCCcccccCcCCcCCCCCCCCcc-ccCCCCcccccCCCCCCCC
Q 005102 221 LFSGSIPASLGNLPEKVYIDLTYNNLSGPIPQNGA-LMNRGPTAFIGNPRLCGPP 274 (714)
Q Consensus 221 ~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~-~~~~~~~~~~~n~~~~~~~ 274 (714)
++++..|..|+.+++|+.|++++|++++.+|.... +.......+.+|+..|.++
T Consensus 481 ~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 535 (570)
T 2z63_A 481 QLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 535 (570)
T ss_dssp CCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTT
T ss_pred ccccCChhhhhcccCCCEEeCCCCcCCCCCHHHhhcccCCcEEEecCCcccCCCc
Confidence 99988899999999999999999999988876543 3344455666777666544
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.82 E-value=1.5e-20 Score=213.65 Aligned_cols=189 Identities=20% Similarity=0.172 Sum_probs=173.7
Q ss_pred CCcEEEEEcCCCCccccC--CccccCCCCCCEEEccCCCCcccCChhhcCCCCCCEEEcCCCcCcccCC-cccCCCCCCC
Q 005102 63 EQRVVSVSIPKKKLLGFL--PSALGSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSGSVP-NEIGKLKYLQ 139 (714)
Q Consensus 63 ~~~~~~l~l~~~~l~g~~--p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p-~~~~~l~~L~ 139 (714)
..+++.|+|++|++++.. |..+.++++|++|+|++|.+.+..+ .+..+++|+.|+|++|.+++..| ..+.++++|+
T Consensus 346 ~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~-~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~ 424 (570)
T 2z63_A 346 LPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSS-NFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLI 424 (570)
T ss_dssp CTTCCEEECCSSCCBEEEEEEHHHHTCSCCCEEECCSCSEEEEEE-EEETCTTCCEEECTTSEEESCTTSCTTTTCTTCC
T ss_pred CCCCCEEeCcCCccCccccccccccccCccCEEECCCCccccccc-cccccCCCCEEEccCCccccccchhhhhcCCCCC
Confidence 468999999999999765 7889999999999999999996544 49999999999999999998776 5689999999
Q ss_pred EEeccCccCCCCCCcccccccccceeecccCcCC-CCCCcccccCccccccccccCCcccccCCCCCCCCcccccccccc
Q 005102 140 ILDLSQNFFNGSLPVSIVQCKRLKALDLSQNNFT-GPLPNGFGSGLVSLEKLNLSFNKFNGSIPSNTGNLSSLQGTVDFS 218 (714)
Q Consensus 140 ~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~-g~~p~~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~~l~l~ 218 (714)
.|+|++|++++..|..+..+++|+.|+|++|.++ +.+|..+ ..+++|+.|+|++|++++..|..+.++++|+ .|+++
T Consensus 425 ~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~-~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~-~L~l~ 502 (570)
T 2z63_A 425 YLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIF-TELRNLTFLDLSQCQLEQLSPTAFNSLSSLQ-VLNMA 502 (570)
T ss_dssp EEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCC-TTCTTCCEEECTTSCCCEECTTTTTTCTTCC-EEECC
T ss_pred EEeCcCCcccccchhhhhcCCcCcEEECcCCcCccccchhhh-hcccCCCEEECCCCccccCChhhhhcccCCC-EEeCC
Confidence 9999999999999999999999999999999998 5788777 4699999999999999988899999999999 99999
Q ss_pred cccCCcCcCccccCCCCcccccCcCCcCCCCCCCCc
Q 005102 219 HNLFSGSIPASLGNLPEKVYIDLTYNNLSGPIPQNG 254 (714)
Q Consensus 219 ~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~ 254 (714)
+|++++..|..|..+++|+.|++++|++++..|...
T Consensus 503 ~n~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~~~ 538 (570)
T 2z63_A 503 SNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRID 538 (570)
T ss_dssp SSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTTTTH
T ss_pred CCcCCCCCHHHhhcccCCcEEEecCCcccCCCcchH
Confidence 999999988999999999999999999999988754
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.81 E-value=5.1e-20 Score=206.91 Aligned_cols=137 Identities=21% Similarity=0.199 Sum_probs=106.0
Q ss_pred CcEEEEEcCCCCccccCCccccCCCCCCEEEccCCCCcccCChhhcCCCCCCEEEcCCCcCcccCCcccCCCCCCCEEec
Q 005102 64 QRVVSVSIPKKKLLGFLPSALGSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSGSVPNEIGKLKYLQILDL 143 (714)
Q Consensus 64 ~~~~~l~l~~~~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L 143 (714)
.+++.|+|++|++++..|..|.++++|++|+|++|++++..|..|..+++|++|+|++|+++ .+|.. .+++|++|+|
T Consensus 21 ~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~--~l~~L~~L~L 97 (520)
T 2z7x_B 21 QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLV-KISCH--PTVNLKHLDL 97 (520)
T ss_dssp TTCSEEECCSSCCCCCCHHHHTTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSSCCC-EEECC--CCCCCSEEEC
T ss_pred ccccEEECCCCcccccChhhccccccccEEecCCCccCCcChHHhhcccCCCEEecCCCcee-ecCcc--ccCCccEEec
Confidence 47888888888888887788888888888888888888877888888888888888888888 56666 7888888888
Q ss_pred cCccCCC-CCCcccccccccceeecccCcCCCCCCcccccCcccc--ccccccCCcc--cccCCCCCCC
Q 005102 144 SQNFFNG-SLPVSIVQCKRLKALDLSQNNFTGPLPNGFGSGLVSL--EKLNLSFNKF--NGSIPSNTGN 207 (714)
Q Consensus 144 s~N~l~g-~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~l~~L--~~L~l~~N~l--~g~~p~~~~~ 207 (714)
++|++++ .+|..|+.+++|++|+|++|++++ ..+ ..+++| +.|+|++|++ .+.+|..+..
T Consensus 98 ~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~---~~~-~~l~~L~L~~L~l~~n~l~~~~~~~~~l~~ 162 (520)
T 2z7x_B 98 SFNAFDALPICKEFGNMSQLKFLGLSTTHLEK---SSV-LPIAHLNISKVLLVLGETYGEKEDPEGLQD 162 (520)
T ss_dssp CSSCCSSCCCCGGGGGCTTCCEEEEEESSCCG---GGG-GGGTTSCEEEEEEEECTTTTSSCCTTTTTT
T ss_pred cCCccccccchhhhccCCcceEEEecCcccch---hhc-cccccceeeEEEeecccccccccccccccc
Confidence 8888886 477888888888888888888764 122 235555 6667776666 5555555554
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.81 E-value=3.7e-20 Score=210.03 Aligned_cols=162 Identities=25% Similarity=0.311 Sum_probs=146.4
Q ss_pred cCCCCCCEEEccCCCCcccCChhhcCCCCCCEEEcCCCcCcc--cCCcccCCCCCCCEEeccCccCCCCCCc-ccccccc
Q 005102 85 GSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSG--SVPNEIGKLKYLQILDLSQNFFNGSLPV-SIVQCKR 161 (714)
Q Consensus 85 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g--~~p~~~~~l~~L~~L~Ls~N~l~g~~p~-~~~~l~~ 161 (714)
..+++|++|+|++|++++.+|..+..+++|+.|+|++|++++ .+|..++++++|+.|+|++|++++.+|. .+..+++
T Consensus 350 ~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~ 429 (562)
T 3a79_B 350 PSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAES 429 (562)
T ss_dssp SSCCCCCEEECCSSCCCTTTTTTCCSCSSCCEEECCSSCCCBTTHHHHTTTTCTTCCEEECTTSCCBSCCSSCCCCCCTT
T ss_pred cCCCCceEEECCCCccccchhhhhcccCCCCEEECCCCCcCCcccchhhhcCCCCCCEEECCCCcCCCccChhhhcCccc
Confidence 788999999999999999999999999999999999999996 3456799999999999999999986776 4888999
Q ss_pred cceeecccCcCCCCCCcccccCccccccccccCCcccccCCCCCCCCcccccccccccccCCcCcCcc-ccCCCCccccc
Q 005102 162 LKALDLSQNNFTGPLPNGFGSGLVSLEKLNLSFNKFNGSIPSNTGNLSSLQGTVDFSHNLFSGSIPAS-LGNLPEKVYID 240 (714)
Q Consensus 162 L~~L~l~~N~l~g~~p~~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~~l~l~~N~l~g~~p~~-~~~l~~L~~l~ 240 (714)
|+.|+|++|++++.+|..+. ++|+.|+|++|+++ .+|..+.++++|+ .|++++|+|+ .+|.. +..+++|+.|+
T Consensus 430 L~~L~l~~n~l~~~~~~~l~---~~L~~L~L~~N~l~-~ip~~~~~l~~L~-~L~L~~N~l~-~l~~~~~~~l~~L~~L~ 503 (562)
T 3a79_B 430 ILVLNLSSNMLTGSVFRCLP---PKVKVLDLHNNRIM-SIPKDVTHLQALQ-ELNVASNQLK-SVPDGVFDRLTSLQYIW 503 (562)
T ss_dssp CCEEECCSSCCCGGGGSSCC---TTCSEEECCSSCCC-CCCTTTTSSCCCS-EEECCSSCCC-CCCTTSTTTCTTCCCEE
T ss_pred CCEEECCCCCCCcchhhhhc---CcCCEEECCCCcCc-ccChhhcCCCCCC-EEECCCCCCC-CCCHHHHhcCCCCCEEE
Confidence 99999999999987776552 69999999999999 8999888999999 9999999999 56665 99999999999
Q ss_pred CcCCcCCCCCCC
Q 005102 241 LTYNNLSGPIPQ 252 (714)
Q Consensus 241 l~~N~l~~~~p~ 252 (714)
+++|++.+..|.
T Consensus 504 l~~N~~~c~c~~ 515 (562)
T 3a79_B 504 LHDNPWDCTCPG 515 (562)
T ss_dssp CCSCCBCCCHHH
T ss_pred ecCCCcCCCcch
Confidence 999999987664
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.81 E-value=9.9e-20 Score=180.08 Aligned_cols=153 Identities=21% Similarity=0.206 Sum_probs=109.5
Q ss_pred EEEcCCCCccccCCccccCCCCCCEEEccCCCCcccCCh-hhcCCCCCCEEEcCCCcCcccCCcccCCCCCCCEEeccCc
Q 005102 68 SVSIPKKKLLGFLPSALGSLTDLRHVNLRNNKFFGSLPL-ELLEAQGLQSLVLYGNSFSGSVPNEIGKLKYLQILDLSQN 146 (714)
Q Consensus 68 ~l~l~~~~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~-~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N 146 (714)
.+++++|+++. +|..+. ..+++|+|++|+|++..|. .|..+++|+.|+|++|++++..|..|.++++|+.|+|++|
T Consensus 15 ~l~~s~n~l~~-iP~~~~--~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N 91 (220)
T 2v70_A 15 TVDCSNQKLNK-IPEHIP--QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSN 91 (220)
T ss_dssp EEECCSSCCSS-CCSCCC--TTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred EeEeCCCCccc-CccCCC--CCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCCC
Confidence 34445666664 566553 3568888888888876553 4678888888888888888777777888888888888888
Q ss_pred cCCCCCCcccccccccceeecccCcCCCCCCcccccCccccccccccCCcccccCCCCCCCCcccccccccccccCCcC
Q 005102 147 FFNGSLPVSIVQCKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLNLSFNKFNGSIPSNTGNLSSLQGTVDFSHNLFSGS 225 (714)
Q Consensus 147 ~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~~l~l~~N~l~g~ 225 (714)
++++..|..|..+++|++|+|++|++++..|..+ .++++|+.|+|++|+|++..|..+..+++|+ .|++++|.+++.
T Consensus 92 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~-~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~-~L~L~~N~l~c~ 168 (220)
T 2v70_A 92 RLENVQHKMFKGLESLKTLMLRSNRITCVGNDSF-IGLSSVRLLSLYDNQITTVAPGAFDTLHSLS-TLNLLANPFNCN 168 (220)
T ss_dssp CCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSS-TTCTTCSEEECTTSCCCCBCTTTTTTCTTCC-EEECCSCCEECS
T ss_pred ccCccCHhHhcCCcCCCEEECCCCcCCeECHhHc-CCCccCCEEECCCCcCCEECHHHhcCCCCCC-EEEecCcCCcCC
Confidence 8886666667777888888888888776555555 3567777777777777766666666666666 666666666544
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.81 E-value=2.2e-20 Score=195.20 Aligned_cols=179 Identities=19% Similarity=0.135 Sum_probs=152.9
Q ss_pred CCcEEEEEcCCCCccccCC----ccccCCCCCCEEEccCCCCcccCChhhcCCCCCCEEEcCCCcCccc--C--CcccCC
Q 005102 63 EQRVVSVSIPKKKLLGFLP----SALGSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSGS--V--PNEIGK 134 (714)
Q Consensus 63 ~~~~~~l~l~~~~l~g~~p----~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~--~--p~~~~~ 134 (714)
..+++.|+|++|.+++..+ ..+..+++|++|+|++|++++..|..+..+++|++|+|++|++.+. + +..++.
T Consensus 116 ~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~ 195 (310)
T 4glp_A 116 GLALSSLRLRNVSWATGRSWLAELQQWLKPGLKVLSIAQAHSPAFSCEQVRAFPALTSLDLSDNPGLGERGLMAALCPHK 195 (310)
T ss_dssp CBCCSSCEEESCCCSSTTSSHHHHHTTBCSCCCEEEEECCSSCCCCTTSCCCCTTCCEEECCSCTTCHHHHHHTTSCTTS
T ss_pred CCCCCEEEeecccccchhhhhHHHHhhhccCCCEEEeeCCCcchhhHHHhccCCCCCEEECCCCCCccchhhhHHHhhhc
Confidence 4578899999999998766 4556899999999999999988889999999999999999998753 3 233578
Q ss_pred CCCCCEEeccCccCCCCCCc----ccccccccceeecccCcCCCCCCcccccC--ccccccccccCCcccccCCCCCCCC
Q 005102 135 LKYLQILDLSQNFFNGSLPV----SIVQCKRLKALDLSQNNFTGPLPNGFGSG--LVSLEKLNLSFNKFNGSIPSNTGNL 208 (714)
Q Consensus 135 l~~L~~L~Ls~N~l~g~~p~----~~~~l~~L~~L~l~~N~l~g~~p~~~~~~--l~~L~~L~l~~N~l~g~~p~~~~~l 208 (714)
+++|++|+|++|+++ .+|. .+..+++|++|+|++|++++.+|..++.. +++|+.|+|++|+|+ .+|..+.
T Consensus 196 l~~L~~L~Ls~N~l~-~l~~~~~~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~-~lp~~~~-- 271 (310)
T 4glp_A 196 FPAIQNLALRNTGME-TPTGVCAALAAAGVQPHSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLE-QVPKGLP-- 271 (310)
T ss_dssp SCCCCSCBCCSSCCC-CHHHHHHHHHHHTCCCSSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCC-SCCSCCC--
T ss_pred CCCCCEEECCCCCCC-chHHHHHHHHhcCCCCCEEECCCCCCCccchhhHHhccCcCcCCEEECCCCCCC-chhhhhc--
Confidence 999999999999997 4444 25788999999999999998878777532 269999999999999 8898875
Q ss_pred cccccccccccccCCcCcCccccCCCCcccccCcCCcCCC
Q 005102 209 SSLQGTVDFSHNLFSGSIPASLGNLPEKVYIDLTYNNLSG 248 (714)
Q Consensus 209 ~~L~~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~ 248 (714)
++|+ .|++++|+|++. |. +..+++|+.|++++|+++.
T Consensus 272 ~~L~-~L~Ls~N~l~~~-~~-~~~l~~L~~L~L~~N~l~~ 308 (310)
T 4glp_A 272 AKLR-VLDLSSNRLNRA-PQ-PDELPEVDNLTLDGNPFLV 308 (310)
T ss_dssp SCCS-CEECCSCCCCSC-CC-TTSCCCCSCEECSSTTTSC
T ss_pred CCCC-EEECCCCcCCCC-ch-hhhCCCccEEECcCCCCCC
Confidence 7898 999999999964 43 6888999999999999974
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.81 E-value=3.6e-20 Score=197.36 Aligned_cols=187 Identities=20% Similarity=0.243 Sum_probs=163.0
Q ss_pred cceEecCCcEEEEEcCCCCccccCCccccCCCCCCEEEccCCCCcccCChhhcCCCCCCEEEcCCCcCcccCCcccCCCC
Q 005102 57 NGITCKEQRVVSVSIPKKKLLGFLPSALGSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSGSVPNEIGKLK 136 (714)
Q Consensus 57 ~gv~c~~~~~~~l~l~~~~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~ 136 (714)
..+.|....+ .++++++++. +|..+. ++|++|+|++|++++..+..+.++++|+.|+|++|.+++..|..|++++
T Consensus 26 ~~~~C~~~~~--c~~~~~~l~~-iP~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~ 100 (353)
T 2z80_A 26 ASLSCDRNGI--CKGSSGSLNS-IPSGLT--EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLG 100 (353)
T ss_dssp -CCEECTTSE--EECCSTTCSS-CCTTCC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCT
T ss_pred cCCCCCCCeE--eeCCCCCccc-cccccc--ccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhhcCCCC
Confidence 3577876555 7889999885 676655 5899999999999987777899999999999999999988888999999
Q ss_pred CCCEEeccCccCCCCCCcccccccccceeecccCcCCCCCCc-ccccCccccccccccCC-cccccCCCCCCCCcccccc
Q 005102 137 YLQILDLSQNFFNGSLPVSIVQCKRLKALDLSQNNFTGPLPN-GFGSGLVSLEKLNLSFN-KFNGSIPSNTGNLSSLQGT 214 (714)
Q Consensus 137 ~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~-~~~~~l~~L~~L~l~~N-~l~g~~p~~~~~l~~L~~~ 214 (714)
+|++|+|++|++++..+..|.++++|++|+|++|+++ .+|. ..+..+++|+.|++++| .+.+..|..+.++++|+ .
T Consensus 101 ~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~-~ 178 (353)
T 2z80_A 101 SLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYK-TLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLE-E 178 (353)
T ss_dssp TCCEEECCSSCCSSCCHHHHTTCTTCSEEECTTCCCS-SSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEE-E
T ss_pred CCCEEECCCCcCCcCCHhHhCCCccCCEEECCCCCCc-ccCchhhhccCCCCcEEECCCCccccccCHHHccCCCCCC-E
Confidence 9999999999999544445899999999999999998 5776 44467999999999999 47766678899999999 9
Q ss_pred cccccccCCcCcCccccCCCCcccccCcCCcCCCCC
Q 005102 215 VDFSHNLFSGSIPASLGNLPEKVYIDLTYNNLSGPI 250 (714)
Q Consensus 215 l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~ 250 (714)
|++++|.+++..|..++.+++|+.|++++|+++...
T Consensus 179 L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~ 214 (353)
T 2z80_A 179 LEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLL 214 (353)
T ss_dssp EEEEETTCCEECTTTTTTCSEEEEEEEECSCSTTHH
T ss_pred EECCCCCcCccCHHHHhccccCCeecCCCCccccch
Confidence 999999999999999999999999999999986543
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=99.81 E-value=5.7e-20 Score=211.42 Aligned_cols=205 Identities=22% Similarity=0.214 Sum_probs=104.1
Q ss_pred CCCCCCCCCCCC---CCCcc----cceEecC-----------CcEEEEEcCCCCccccCCccccCCCCCCEEEccCCCCc
Q 005102 40 EGSLSNWNSSDE---NPCSW----NGITCKE-----------QRVVSVSIPKKKLLGFLPSALGSLTDLRHVNLRNNKFF 101 (714)
Q Consensus 40 ~~~l~~w~~~~~---~~c~w----~gv~c~~-----------~~~~~l~l~~~~l~g~~p~~~~~l~~L~~L~L~~N~l~ 101 (714)
...++.|+.+-+ +||.+ ..|.|.. ..++.|+|++|+|++..|.+|.++++|++|+|++|+|+
T Consensus 10 ~~~~~~~~~~~p~~~~~c~~~~~~~~~~c~~~~l~~vP~~lp~~~~~LdLs~N~i~~l~~~~f~~l~~L~~L~Ls~N~i~ 89 (635)
T 4g8a_A 10 DDKLAAANSSIPESWEPCVEVVPNITYQCMELNFYKIPDNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ 89 (635)
T ss_dssp ---------------CCSEEEETTTEEECTTSCCSSCCSSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCC
T ss_pred cchhhcccCCCCCCCCCccccCCCCEEECCCCCcCccCCCCCcCCCEEEeeCCCCCCCCHHHHhCCCCCCEEECCCCcCC
Confidence 345666664422 34543 2466752 24555666666666555555666666666666666666
Q ss_pred ccCChhhcCCCCCCEEEcCCCcCcccCCcccCCCCCCCEEeccCccCCCCCCcccccccccceeecccCcCCC-CCCccc
Q 005102 102 GSLPLELLEAQGLQSLVLYGNSFSGSVPNEIGKLKYLQILDLSQNFFNGSLPVSIVQCKRLKALDLSQNNFTG-PLPNGF 180 (714)
Q Consensus 102 ~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g-~~p~~~ 180 (714)
+..|..|.++++|++|+|++|+|++..+..|.++++|++|+|++|++++..+..|+++++|++|+|++|.+++ .+|..+
T Consensus 90 ~i~~~~f~~L~~L~~L~Ls~N~l~~l~~~~f~~L~~L~~L~Ls~N~l~~l~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~ 169 (635)
T 4g8a_A 90 TIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYF 169 (635)
T ss_dssp EECTTTTTTCTTCCEEECTTCCCCEECGGGGTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGG
T ss_pred CcChhHhcCCCCCCEEEccCCcCCCCCHHHhcCCCCCCEEECCCCcCCCCChhhhhcCcccCeeccccCccccCCCchhh
Confidence 5555556666666666666666654444455666666666666666654444455666666666666666653 233333
Q ss_pred ccCccccccccccCCcccccCCCCCCCCcccc---cccccccccCCcCcCccccCCCCcccccCcCCcC
Q 005102 181 GSGLVSLEKLNLSFNKFNGSIPSNTGNLSSLQ---GTVDFSHNLFSGSIPASLGNLPEKVYIDLTYNNL 246 (714)
Q Consensus 181 ~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~---~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l 246 (714)
..+++|+.|+|++|+|++..|..+..+.++. ..++++.|.++...+..+.. ..+..+++.+|..
T Consensus 170 -~~l~~L~~L~L~~N~l~~~~~~~l~~L~~l~~~~~~~~ls~n~l~~i~~~~~~~-~~~~~l~l~~n~~ 236 (635)
T 4g8a_A 170 -SNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKE-IRLHKLTLRNNFD 236 (635)
T ss_dssp -GGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCCEEECTTCCCCEECTTTTTT-CEEEEEEEESCCS
T ss_pred -ccchhhhhhcccCccccccccccccchhhhhhhhhhhhcccCcccccCcccccc-hhhhhhhhhcccc
Confidence 3456666666666666655555544433322 13445555555433333322 2344455555543
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.81 E-value=1.2e-19 Score=179.56 Aligned_cols=157 Identities=24% Similarity=0.256 Sum_probs=112.5
Q ss_pred CCCcccceEecCCcEEEEEcCCCCccccCCccccCCCCCCEEEccCCCCcccCChhhcCCCCCCEEEcCCCcCcccCCcc
Q 005102 52 NPCSWNGITCKEQRVVSVSIPKKKLLGFLPSALGSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSGSVPNE 131 (714)
Q Consensus 52 ~~c~w~gv~c~~~~~~~l~l~~~~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~ 131 (714)
+.|.|..|.|. +++++. +|..+. ++|+.|+|++|+|++..+..|..+++|+.|+|++|++++..|..
T Consensus 9 C~C~~~~v~c~----------~~~l~~-iP~~l~--~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~ 75 (220)
T 2v9t_B 9 CTCSNNIVDCR----------GKGLTE-IPTNLP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDA 75 (220)
T ss_dssp SEEETTEEECT----------TSCCSS-CCSSCC--TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTT
T ss_pred CEECCCEEEcC----------CCCcCc-CCCccC--cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHH
Confidence 44677777775 344443 455443 67888888888888777777888888888888888888777888
Q ss_pred cCCCCCCCEEeccCccCCCCCCcccccccccceeecccCcCCCCCCcccccCccccccccccCCcccccCCCCCCCCccc
Q 005102 132 IGKLKYLQILDLSQNFFNGSLPVSIVQCKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLNLSFNKFNGSIPSNTGNLSSL 211 (714)
Q Consensus 132 ~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L 211 (714)
|.++++|+.|+|++|+|+...+..|..+++|+.|+|++|++++..|..+ ..+++|+.|+|++|+|++..+..+..+++|
T Consensus 76 ~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~-~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L 154 (220)
T 2v9t_B 76 FQGLRSLNSLVLYGNKITELPKSLFEGLFSLQLLLLNANKINCLRVDAF-QDLHNLNLLSLYDNKLQTIAKGTFSPLRAI 154 (220)
T ss_dssp TTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTT-TTCTTCCEEECCSSCCSCCCTTTTTTCTTC
T ss_pred hhCCcCCCEEECCCCcCCccCHhHccCCCCCCEEECCCCCCCEeCHHHc-CCCCCCCEEECCCCcCCEECHHHHhCCCCC
Confidence 8888888888888888874444456777788888888888775555544 457777777777777775555556666666
Q ss_pred ccccccccccCC
Q 005102 212 QGTVDFSHNLFS 223 (714)
Q Consensus 212 ~~~l~l~~N~l~ 223 (714)
+ .+++++|++.
T Consensus 155 ~-~L~L~~N~~~ 165 (220)
T 2v9t_B 155 Q-TMHLAQNPFI 165 (220)
T ss_dssp C-EEECCSSCEE
T ss_pred C-EEEeCCCCcC
Confidence 6 6666666665
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.81 E-value=1.1e-19 Score=179.70 Aligned_cols=154 Identities=23% Similarity=0.263 Sum_probs=139.9
Q ss_pred CEEEccCCCCcccCChhhcCCCCCCEEEcCCCcCcccCCcccCCCCCCCEEeccCccCCCCCCcccccccccceeecccC
Q 005102 91 RHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSGSVPNEIGKLKYLQILDLSQNFFNGSLPVSIVQCKRLKALDLSQN 170 (714)
Q Consensus 91 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~N 170 (714)
+.+++++|.++ .+|..+. ++|+.|+|++|++++..+..|..+++|+.|+|++|++++..|..|.++++|++|+|++|
T Consensus 14 ~~v~c~~~~l~-~iP~~l~--~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N 90 (220)
T 2v9t_B 14 NIVDCRGKGLT-EIPTNLP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGN 90 (220)
T ss_dssp TEEECTTSCCS-SCCSSCC--TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSS
T ss_pred CEEEcCCCCcC-cCCCccC--cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCC
Confidence 57889999998 5776654 68999999999999877789999999999999999999888999999999999999999
Q ss_pred cCCCCCCcccccCccccccccccCCcccccCCCCCCCCcccccccccccccCCcCcCccccCCCCcccccCcCCcCCCC
Q 005102 171 NFTGPLPNGFGSGLVSLEKLNLSFNKFNGSIPSNTGNLSSLQGTVDFSHNLFSGSIPASLGNLPEKVYIDLTYNNLSGP 249 (714)
Q Consensus 171 ~l~g~~p~~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~ 249 (714)
+|+ .+|..++.++++|+.|+|++|+|++..|..+..+++|+ .|+|++|+|++..+..|..+++|+.|++++|.+...
T Consensus 91 ~l~-~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~-~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~ 167 (220)
T 2v9t_B 91 KIT-ELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLN-LLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFICD 167 (220)
T ss_dssp CCC-CCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCC-EEECCSSCCSCCCTTTTTTCTTCCEEECCSSCEECS
T ss_pred cCC-ccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCC-EEECCCCcCCEECHHHHhCCCCCCEEEeCCCCcCCC
Confidence 998 67777667799999999999999988899999999999 999999999988888899999999999999999753
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.80 E-value=4.3e-21 Score=213.15 Aligned_cols=181 Identities=21% Similarity=0.182 Sum_probs=150.7
Q ss_pred CCcEEEEEcCCCCccccCCccccCCCCCCEEEccCCCCcccCCh----------------hhcCCCCCCEEEcCCCcCcc
Q 005102 63 EQRVVSVSIPKKKLLGFLPSALGSLTDLRHVNLRNNKFFGSLPL----------------ELLEAQGLQSLVLYGNSFSG 126 (714)
Q Consensus 63 ~~~~~~l~l~~~~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~----------------~~~~l~~L~~L~L~~N~l~g 126 (714)
...++.|+|++|.+++..| |+.+++|++|+|++|.|++..+. ....+++|+.|+|++|.+++
T Consensus 57 l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l~~~~~L~~L~L~~N~l~~~~~~~l~~L~~L~L~~N~l~~ 134 (487)
T 3oja_A 57 FTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELLVGPSIETLHAANNNISRVSCSRGQGKKNIYLANNKITM 134 (487)
T ss_dssp CTTCCEEECTTSCCEEEEE--CTTCTTCCEEECCSSEEEEEEECTTCCEEECCSSCCCCEEECCCSSCEEEECCSSCCCS
T ss_pred CCCCCEEEeeCCCCCCCcc--cccCCCCCEEEecCCcCCCCCCCCCcCEEECcCCcCCCCCccccCCCCEEECCCCCCCC
Confidence 4577888888888887665 77788888777777777643211 01235789999999999998
Q ss_pred cCCcccCCCCCCCEEeccCccCCCCCCcccc-cccccceeecccCcCCCCCCcccccCccccccccccCCcccccCCCCC
Q 005102 127 SVPNEIGKLKYLQILDLSQNFFNGSLPVSIV-QCKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLNLSFNKFNGSIPSNT 205 (714)
Q Consensus 127 ~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~-~l~~L~~L~l~~N~l~g~~p~~~~~~l~~L~~L~l~~N~l~g~~p~~~ 205 (714)
..|..++++++|+.|+|++|.|++.+|..+. .+++|+.|+|++|.|++. |... .+++|+.|+|++|+|++ +|..+
T Consensus 135 ~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l~~~-~~~~--~l~~L~~L~Ls~N~l~~-~~~~~ 210 (487)
T 3oja_A 135 LRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV-KGQV--VFAKLKTLDLSSNKLAF-MGPEF 210 (487)
T ss_dssp GGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE-ECCC--CCTTCCEEECCSSCCCE-ECGGG
T ss_pred CCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCccccc-cccc--cCCCCCEEECCCCCCCC-CCHhH
Confidence 8899999999999999999999998888886 799999999999999864 4433 48999999999999996 55569
Q ss_pred CCCcccccccccccccCCcCcCccccCCCCcccccCcCCcCC-CCCC
Q 005102 206 GNLSSLQGTVDFSHNLFSGSIPASLGNLPEKVYIDLTYNNLS-GPIP 251 (714)
Q Consensus 206 ~~l~~L~~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~-~~~p 251 (714)
..+++|+ .|++++|.|++ +|..+..+++|+.|++++|.+. +.+|
T Consensus 211 ~~l~~L~-~L~Ls~N~l~~-lp~~l~~l~~L~~L~l~~N~l~c~~~~ 255 (487)
T 3oja_A 211 QSAAGVT-WISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHCGTLR 255 (487)
T ss_dssp GGGTTCS-EEECTTSCCCE-ECTTCCCCTTCCEEECTTCCBCHHHHH
T ss_pred cCCCCcc-EEEecCCcCcc-cchhhccCCCCCEEEcCCCCCcCcchH
Confidence 9999999 99999999995 7888999999999999999998 4444
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.80 E-value=1.5e-19 Score=178.78 Aligned_cols=156 Identities=21% Similarity=0.196 Sum_probs=139.7
Q ss_pred CEEEccCCCCcccCChhhcCCCCCCEEEcCCCcCcccCC-cccCCCCCCCEEeccCccCCCCCCcccccccccceeeccc
Q 005102 91 RHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSGSVP-NEIGKLKYLQILDLSQNFFNGSLPVSIVQCKRLKALDLSQ 169 (714)
Q Consensus 91 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p-~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~ 169 (714)
+.+++++|.++ .+|..+. ..++.|+|++|+|++..| ..|..+++|+.|+|++|+|++..|..|..+++|++|+|++
T Consensus 14 ~~l~~s~n~l~-~iP~~~~--~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~ 90 (220)
T 2v70_A 14 TTVDCSNQKLN-KIPEHIP--QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTS 90 (220)
T ss_dssp TEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred CEeEeCCCCcc-cCccCCC--CCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCC
Confidence 58999999998 5777654 457899999999997755 4589999999999999999987778999999999999999
Q ss_pred CcCCCCCCcccccCccccccccccCCcccccCCCCCCCCcccccccccccccCCcCcCccccCCCCcccccCcCCcCCCC
Q 005102 170 NNFTGPLPNGFGSGLVSLEKLNLSFNKFNGSIPSNTGNLSSLQGTVDFSHNLFSGSIPASLGNLPEKVYIDLTYNNLSGP 249 (714)
Q Consensus 170 N~l~g~~p~~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~ 249 (714)
|++++..|..+ .++++|+.|+|++|+|++..|..+..+++|+ .|+|++|+|++..|..|..+++|+.|++++|.+++.
T Consensus 91 N~l~~~~~~~~-~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~-~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~ 168 (220)
T 2v70_A 91 NRLENVQHKMF-KGLESLKTLMLRSNRITCVGNDSFIGLSSVR-LLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFNCN 168 (220)
T ss_dssp SCCCCCCGGGG-TTCSSCCEEECTTSCCCCBCTTSSTTCTTCS-EEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEECS
T ss_pred CccCccCHhHh-cCCcCCCEEECCCCcCCeECHhHcCCCccCC-EEECCCCcCCEECHHHhcCCCCCCEEEecCcCCcCC
Confidence 99996555445 5799999999999999988899999999999 999999999999999999999999999999999976
Q ss_pred CC
Q 005102 250 IP 251 (714)
Q Consensus 250 ~p 251 (714)
.+
T Consensus 169 c~ 170 (220)
T 2v70_A 169 CY 170 (220)
T ss_dssp GG
T ss_pred Cc
Confidence 55
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.79 E-value=2.5e-19 Score=186.92 Aligned_cols=172 Identities=24% Similarity=0.372 Sum_probs=118.7
Q ss_pred CcEEEEEcCCCCccccCCccccCCCCCCEEEccCCCCcccCChhhcCCCCCCEEEcCCCcCcccCCcccCCCCCCCEEec
Q 005102 64 QRVVSVSIPKKKLLGFLPSALGSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSGSVPNEIGKLKYLQILDL 143 (714)
Q Consensus 64 ~~~~~l~l~~~~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L 143 (714)
.+++.|++.+++++. +| .+..+++|++|+|++|.+++..+ +..+++|+.|+|++|.+++ +| .+..+++|+.|+|
T Consensus 41 ~~L~~L~l~~~~i~~-l~-~~~~l~~L~~L~L~~n~i~~~~~--~~~l~~L~~L~L~~n~l~~-~~-~~~~l~~L~~L~l 114 (308)
T 1h6u_A 41 DGITTLSAFGTGVTT-IE-GVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLKN-VS-AIAGLQSIKTLDL 114 (308)
T ss_dssp HTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCSC-CG-GGTTCTTCCEEEC
T ss_pred CCcCEEEeeCCCccC-ch-hhhccCCCCEEEccCCcCCCChh--HccCCCCCEEEccCCcCCC-ch-hhcCCCCCCEEEC
Confidence 366777777777765 33 57777777777777777774333 7777777777777777764 33 5777777777777
Q ss_pred cCccCCCCCCcccccccccceeecccCcCCCCCCcccccCccccccccccCCcccccCCCCCCCCcccccccccccccCC
Q 005102 144 SQNFFNGSLPVSIVQCKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLNLSFNKFNGSIPSNTGNLSSLQGTVDFSHNLFS 223 (714)
Q Consensus 144 s~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~~l~l~~N~l~ 223 (714)
++|++++ +|. +..+++|+.|+|++|.+++ ++. + ..+++|+.|+|++|++++ ++. +..+++|+ .|++++|.++
T Consensus 115 ~~n~l~~-~~~-l~~l~~L~~L~l~~n~l~~-~~~-l-~~l~~L~~L~l~~n~l~~-~~~-l~~l~~L~-~L~l~~n~l~ 186 (308)
T 1h6u_A 115 TSTQITD-VTP-LAGLSNLQVLYLDLNQITN-ISP-L-AGLTNLQYLSIGNAQVSD-LTP-LANLSKLT-TLKADDNKIS 186 (308)
T ss_dssp TTSCCCC-CGG-GTTCTTCCEEECCSSCCCC-CGG-G-GGCTTCCEEECCSSCCCC-CGG-GTTCTTCC-EEECCSSCCC
T ss_pred CCCCCCC-chh-hcCCCCCCEEECCCCccCc-Ccc-c-cCCCCccEEEccCCcCCC-Chh-hcCCCCCC-EEECCCCccC
Confidence 7777764 333 6777777777777777764 333 3 357777777777777774 333 66777777 7777777777
Q ss_pred cCcCccccCCCCcccccCcCCcCCCCCC
Q 005102 224 GSIPASLGNLPEKVYIDLTYNNLSGPIP 251 (714)
Q Consensus 224 g~~p~~~~~l~~L~~l~l~~N~l~~~~p 251 (714)
+..+ +..+++|+.|++++|++++..|
T Consensus 187 ~~~~--l~~l~~L~~L~L~~N~l~~~~~ 212 (308)
T 1h6u_A 187 DISP--LASLPNLIEVHLKNNQISDVSP 212 (308)
T ss_dssp CCGG--GGGCTTCCEEECTTSCCCBCGG
T ss_pred cChh--hcCCCCCCEEEccCCccCcccc
Confidence 5443 6777777777777777776653
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.79 E-value=2e-19 Score=191.27 Aligned_cols=199 Identities=18% Similarity=0.183 Sum_probs=163.1
Q ss_pred CCCcccceEecC-----------CcEEEEEcCCCCccccCCccccCCCCCCEEEccCCCCcccCCh-hhcCCCCCCE-EE
Q 005102 52 NPCSWNGITCKE-----------QRVVSVSIPKKKLLGFLPSALGSLTDLRHVNLRNNKFFGSLPL-ELLEAQGLQS-LV 118 (714)
Q Consensus 52 ~~c~w~gv~c~~-----------~~~~~l~l~~~~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~-~~~~l~~L~~-L~ 118 (714)
|-|+|+.|.|+. ..++.|+|++|+|+...+.+|.+|++|++|+|++|++.+.+|. .|.++++|+. +.
T Consensus 7 C~C~~~~v~C~~~~Lt~iP~~l~~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~ 86 (350)
T 4ay9_X 7 CHCSNRVFLCQESKVTEIPSDLPRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRI 86 (350)
T ss_dssp SEEETTEEEEESTTCCSCCTTCCTTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEE
T ss_pred cEeeCCEEEecCCCCCccCcCcCCCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhc
Confidence 457899999973 3578899999999987777899999999999999999877765 5678888774 77
Q ss_pred cCCCcCcccCCcccCCCCCCCEEeccCccCCCCCCcccccccccceeecccC-cCCCCCCcccccCc-cccccccccCCc
Q 005102 119 LYGNSFSGSVPNEIGKLKYLQILDLSQNFFNGSLPVSIVQCKRLKALDLSQN-NFTGPLPNGFGSGL-VSLEKLNLSFNK 196 (714)
Q Consensus 119 L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~N-~l~g~~p~~~~~~l-~~L~~L~l~~N~ 196 (714)
+++|+++...|..|..+++|+.|++++|++++..+..+....++..|+++++ ++. .+|...+..+ ..|+.|+|++|+
T Consensus 87 ~~~N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~-~l~~~~f~~~~~~l~~L~L~~N~ 165 (350)
T 4ay9_X 87 EKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIH-TIERNSFVGLSFESVILWLNKNG 165 (350)
T ss_dssp EEETTCCEECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEESCTTCC-EECTTSSTTSBSSCEEEECCSSC
T ss_pred ccCCcccccCchhhhhccccccccccccccccCCchhhcccchhhhhhhccccccc-cccccchhhcchhhhhhcccccc
Confidence 7889999888889999999999999999999766667777788899999764 555 5665443444 468899999999
Q ss_pred ccccCCCCCCCCccccccccccc-ccCCcCcCccccCCCCcccccCcCCcCCCCCCCC
Q 005102 197 FNGSIPSNTGNLSSLQGTVDFSH-NLFSGSIPASLGNLPEKVYIDLTYNNLSGPIPQN 253 (714)
Q Consensus 197 l~g~~p~~~~~l~~L~~~l~l~~-N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~~ 253 (714)
|+ .+|.......+++ .+++++ |.++...+..|..+++|+.||+++|+|+..++..
T Consensus 166 i~-~i~~~~f~~~~L~-~l~l~~~n~l~~i~~~~f~~l~~L~~LdLs~N~l~~lp~~~ 221 (350)
T 4ay9_X 166 IQ-EIHNSAFNGTQLD-ELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYG 221 (350)
T ss_dssp CC-EECTTSSTTEEEE-EEECTTCTTCCCCCTTTTTTEECCSEEECTTSCCCCCCSSS
T ss_pred cc-CCChhhccccchh-HHhhccCCcccCCCHHHhccCcccchhhcCCCCcCccChhh
Confidence 99 7777777788898 889875 5666444457899999999999999999776654
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.79 E-value=1e-19 Score=184.55 Aligned_cols=132 Identities=19% Similarity=0.187 Sum_probs=104.3
Q ss_pred ccccccCceEEEEEEE-CCCcE--EEEEEeCCCCch------------------------hHHHHHHHHHHHhccCCCCc
Q 005102 409 FVLGKSGIGIVYKVVL-EDGHT--LAVRRLGEGGSQ------------------------RFKEFQTEVEAIGKIRHSNI 461 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~-~~g~~--vavK~~~~~~~~------------------------~~~~~~~E~~~l~~l~H~ni 461 (714)
..||+|+||.||+|.+ .+|+. ||||+++..... ....+.+|+++|.+++|+++
T Consensus 53 ~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 132 (258)
T 1zth_A 53 GVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAKEAGV 132 (258)
T ss_dssp EEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred CEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHHhCCC
Confidence 5799999999999998 67988 999987653111 11368899999999998864
Q ss_pred --cceEEEEEeCCceeEEEeccCC-C----CHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHh-cCCCCCceecC
Q 005102 462 --VTLRAYYWSVDEKLLIYDYIPN-G----SLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLH-EFSPKKYVHGD 533 (714)
Q Consensus 462 --v~l~~~~~~~~~~~lV~e~~~~-g----sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH-~~~~~~ivHrD 533 (714)
..++++ +..++||||+.+ | +|.++... .++..+..++.|++.||.||| + .+|+|||
T Consensus 133 ~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~---------~~~~~~~~i~~qi~~~l~~lH~~---~givHrD 196 (258)
T 1zth_A 133 SVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE---------LKELDVEGIFNDVVENVKRLYQE---AELVHAD 196 (258)
T ss_dssp CCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG---------GGGSCHHHHHHHHHHHHHHHHHT---SCEECSS
T ss_pred CCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc---------cChHHHHHHHHHHHHHHHHHHHH---CCEEeCC
Confidence 344432 367899999942 4 66665421 234467889999999999999 8 8999999
Q ss_pred CCCCCeeeCCCCCeEEcccchhhhh
Q 005102 534 LKPSNILLGHNMEPHVSDFGLARLA 558 (714)
Q Consensus 534 lkp~NILl~~~~~~kl~DFGla~~~ 558 (714)
|||+|||+++ .++|+|||+|...
T Consensus 197 lkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 197 LSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp CSTTSEEESS--SEEECCCTTCEET
T ss_pred CCHHHEEEcC--cEEEEECcccccC
Confidence 9999999998 9999999999754
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.79 E-value=8e-20 Score=195.17 Aligned_cols=174 Identities=24% Similarity=0.232 Sum_probs=141.9
Q ss_pred EEcCCCCccccCCccccCCCCCCEEEccCCCCcccCChhhc-CCCCCCEEEcCCCcCcccCCcccCCCCCCCEEeccCcc
Q 005102 69 VSIPKKKLLGFLPSALGSLTDLRHVNLRNNKFFGSLPLELL-EAQGLQSLVLYGNSFSGSVPNEIGKLKYLQILDLSQNF 147 (714)
Q Consensus 69 l~l~~~~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~-~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~ 147 (714)
+++++++|+. +|..+. ..|+.|+|++|+|++..+..+. .+++|+.|+|++|+|++..|..|.++++|+.|+|++|+
T Consensus 23 l~c~~~~l~~-iP~~~~--~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~ 99 (361)
T 2xot_A 23 LSCSKQQLPN-VPQSLP--SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSNH 99 (361)
T ss_dssp EECCSSCCSS-CCSSCC--TTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSC
T ss_pred EEeCCCCcCc-cCccCC--CCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCCCc
Confidence 4445666665 565554 4589999999999987777777 89999999999999998777889999999999999999
Q ss_pred CCCCCCcccccccccceeecccCcCCCCCCcccccCccccccccccCCcccccCCCCC----CCCcccccccccccccCC
Q 005102 148 FNGSLPVSIVQCKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLNLSFNKFNGSIPSNT----GNLSSLQGTVDFSHNLFS 223 (714)
Q Consensus 148 l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~l~~L~~L~l~~N~l~g~~p~~~----~~l~~L~~~l~l~~N~l~ 223 (714)
|++..+..|..+++|+.|+|++|+|++..|..+ .++++|+.|+|++|+|+ .+|..+ .++++|+ .|+|++|+|+
T Consensus 100 l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~-~~l~~L~~L~L~~N~l~-~l~~~~~~~~~~l~~L~-~L~L~~N~l~ 176 (361)
T 2xot_A 100 LHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAF-EDMAQLQKLYLSQNQIS-RFPVELIKDGNKLPKLM-LLDLSSNKLK 176 (361)
T ss_dssp CCEECTTTTTTCTTCCEEECCSSCCCEECTTTT-TTCTTCCEEECCSSCCC-SCCGGGTC----CTTCC-EEECCSSCCC
T ss_pred CCcCCHHHhCCCcCCCEEECCCCcccEECHHHh-CCcccCCEEECCCCcCC-eeCHHHhcCcccCCcCC-EEECCCCCCC
Confidence 987767788999999999999999986556655 56999999999999999 456544 5688898 9999999999
Q ss_pred cCcCccccCCCCc--ccccCcCCcCCC
Q 005102 224 GSIPASLGNLPEK--VYIDLTYNNLSG 248 (714)
Q Consensus 224 g~~p~~~~~l~~L--~~l~l~~N~l~~ 248 (714)
+..+..+..++.+ +.|++++|.+..
T Consensus 177 ~l~~~~~~~l~~~~l~~l~l~~N~~~C 203 (361)
T 2xot_A 177 KLPLTDLQKLPAWVKNGLYLHNNPLEC 203 (361)
T ss_dssp CCCHHHHHHSCHHHHTTEECCSSCEEC
T ss_pred ccCHHHhhhccHhhcceEEecCCCccC
Confidence 7666778888874 789999998874
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.79 E-value=5.6e-19 Score=175.83 Aligned_cols=156 Identities=22% Similarity=0.230 Sum_probs=139.1
Q ss_pred CCEEEccCCCCcccCChhhcCCCCCCEEEcCCCcCcccCCcccCCCCCCCEEeccCccCCCCCCcccccccccceeeccc
Q 005102 90 LRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSGSVPNEIGKLKYLQILDLSQNFFNGSLPVSIVQCKRLKALDLSQ 169 (714)
Q Consensus 90 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~ 169 (714)
.+.++.+++.++ .+|..+. ++|+.|+|++|.+++..|..|.++++|+.|+|++|+|++..+..|..+++|+.|+|++
T Consensus 21 ~~~v~c~~~~l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~ 97 (229)
T 3e6j_A 21 GTTVDCRSKRHA-SVPAGIP--TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGT 97 (229)
T ss_dssp TTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CCEeEccCCCcC-ccCCCCC--CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCcCEEECCC
Confidence 457889999887 6776554 8999999999999998899999999999999999999855556689999999999999
Q ss_pred CcCCCCCCcccccCccccccccccCCcccccCCCCCCCCcccccccccccccCCcCcCccccCCCCcccccCcCCcCCCC
Q 005102 170 NNFTGPLPNGFGSGLVSLEKLNLSFNKFNGSIPSNTGNLSSLQGTVDFSHNLFSGSIPASLGNLPEKVYIDLTYNNLSGP 249 (714)
Q Consensus 170 N~l~g~~p~~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~ 249 (714)
|+|++ +|...+..+++|+.|+|++|+|+ .+|..+..+++|+ .|+|++|+|++..+..|..+++|+.|++++|.+.+.
T Consensus 98 N~l~~-l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~-~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~ 174 (229)
T 3e6j_A 98 NQLTV-LPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLT-HLALDQNQLKSIPHGAFDRLSSLTHAYLFGNPWDCE 174 (229)
T ss_dssp SCCCC-CCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCS-EEECCSSCCCCCCTTTTTTCTTCCEEECTTSCBCTT
T ss_pred CcCCc-cChhHhCcchhhCeEeccCCccc-ccCcccccCCCCC-EEECCCCcCCccCHHHHhCCCCCCEEEeeCCCccCC
Confidence 99995 55554467999999999999999 8999999999999 999999999988778899999999999999999977
Q ss_pred CC
Q 005102 250 IP 251 (714)
Q Consensus 250 ~p 251 (714)
.+
T Consensus 175 c~ 176 (229)
T 3e6j_A 175 CR 176 (229)
T ss_dssp BG
T ss_pred cc
Confidence 65
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.79 E-value=2.1e-19 Score=180.27 Aligned_cols=175 Identities=18% Similarity=0.207 Sum_probs=152.4
Q ss_pred CCcEEEEEcCCCC-ccccCCccccCCCCCCEEEccC-CCCcccCChhhcCCCCCCEEEcCCCcCcccCCcccCCCCCCC-
Q 005102 63 EQRVVSVSIPKKK-LLGFLPSALGSLTDLRHVNLRN-NKFFGSLPLELLEAQGLQSLVLYGNSFSGSVPNEIGKLKYLQ- 139 (714)
Q Consensus 63 ~~~~~~l~l~~~~-l~g~~p~~~~~l~~L~~L~L~~-N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~- 139 (714)
..+++.|+|++|+ +++..+..|.++++|++|+|++ |++++..+..|.++++|+.|+|++|.+++ +|. +..+++|+
T Consensus 54 l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L~l~~n~l~~-lp~-~~~l~~L~~ 131 (239)
T 2xwt_C 54 LPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLKM-FPD-LTKVYSTDI 131 (239)
T ss_dssp CTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEEEEEEECCCS-CCC-CTTCCBCCS
T ss_pred CCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEEeCCCCCCcc-ccc-ccccccccc
Confidence 3589999999997 8887777999999999999999 99998777889999999999999999996 776 88999998
Q ss_pred --EEeccCc-cCCCCCCcccccccccc-eeecccCcCCCCCCcccccCccccccccccCCc-ccccCCCCCCCC-ccccc
Q 005102 140 --ILDLSQN-FFNGSLPVSIVQCKRLK-ALDLSQNNFTGPLPNGFGSGLVSLEKLNLSFNK-FNGSIPSNTGNL-SSLQG 213 (714)
Q Consensus 140 --~L~Ls~N-~l~g~~p~~~~~l~~L~-~L~l~~N~l~g~~p~~~~~~l~~L~~L~l~~N~-l~g~~p~~~~~l-~~L~~ 213 (714)
.|+|++| ++++..+..|..+++|+ .|+|++|+++ .+|...+.. ++|+.|+|++|+ +++..+..+..+ ++|+
T Consensus 132 L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~-~i~~~~~~~-~~L~~L~L~~n~~l~~i~~~~~~~l~~~L~- 208 (239)
T 2xwt_C 132 FFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNG-TKLDAVYLNKNKYLTVIDKDAFGGVYSGPS- 208 (239)
T ss_dssp EEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCC-EECTTTTTT-CEEEEEECTTCTTCCEECTTTTTTCSBCCS-
T ss_pred ccEEECCCCcchhhcCcccccchhcceeEEEcCCCCCc-ccCHhhcCC-CCCCEEEcCCCCCcccCCHHHhhccccCCc-
Confidence 9999999 99866667799999999 9999999998 788776654 899999999995 996666788899 9999
Q ss_pred ccccccccCCcCcCccccCCCCcccccCcCCc
Q 005102 214 TVDFSHNLFSGSIPASLGNLPEKVYIDLTYNN 245 (714)
Q Consensus 214 ~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~ 245 (714)
.+++++|++++ +|.. .+++|+.|+++++.
T Consensus 209 ~L~l~~N~l~~-l~~~--~~~~L~~L~l~~~~ 237 (239)
T 2xwt_C 209 LLDVSQTSVTA-LPSK--GLEHLKELIARNTW 237 (239)
T ss_dssp EEECTTCCCCC-CCCT--TCTTCSEEECTTC-
T ss_pred EEECCCCcccc-CChh--HhccCceeeccCcc
Confidence 99999999995 4543 67788888887753
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=99.79 E-value=1.6e-19 Score=204.23 Aligned_cols=184 Identities=20% Similarity=0.212 Sum_probs=164.2
Q ss_pred eEecCCcEEEEEcCCCCccccCCccccCCCCCCEEEccCCCCcccCChhhcCCCCCCEEEcCCCcCcccCCcccCCCCCC
Q 005102 59 ITCKEQRVVSVSIPKKKLLGFLPSALGSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSGSVPNEIGKLKYL 138 (714)
Q Consensus 59 v~c~~~~~~~l~l~~~~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L 138 (714)
..|....+ .+.++++++. +|..+. ++|++|+|++|++++..|..|.++++|++|+|++|++++..|..|+++++|
T Consensus 2 ~~C~~~~~--c~~~~~~l~~-ip~~~~--~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L 76 (549)
T 2z81_A 2 LSCDASGV--CDGRSRSFTS-IPSGLT--AAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSL 76 (549)
T ss_dssp CEECTTSE--EECTTSCCSS-CCSCCC--TTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTC
T ss_pred ccCCCCce--EECCCCcccc-ccccCC--CCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChhhccccccC
Confidence 35765555 7888999884 676664 799999999999999999999999999999999999999888999999999
Q ss_pred CEEeccCccCCCCCCcccccccccceeecccCcCCC-CCCcccccCccccccccccCCcccccCC-CCCCCCcccccccc
Q 005102 139 QILDLSQNFFNGSLPVSIVQCKRLKALDLSQNNFTG-PLPNGFGSGLVSLEKLNLSFNKFNGSIP-SNTGNLSSLQGTVD 216 (714)
Q Consensus 139 ~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g-~~p~~~~~~l~~L~~L~l~~N~l~g~~p-~~~~~l~~L~~~l~ 216 (714)
++|+|++|++++..|..|.++++|++|+|++|.+++ .+|..+ ..+++|+.|++++|++.+.+| ..+.++++|+ .|+
T Consensus 77 ~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~-~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~-~L~ 154 (549)
T 2z81_A 77 EHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLF-PNLTNLQTLRIGNVETFSEIRRIDFAGLTSLN-ELE 154 (549)
T ss_dssp CEEECTTSCCCSCCHHHHTTCTTCCEEECTTCCCSSSCSSCSC-TTCTTCCEEEEEESSSCCEECTTTTTTCCEEE-EEE
T ss_pred CEEECCCCccCccCHHHhccCCCCcEEECCCCcccccchhhhh-hccCCccEEECCCCccccccCHhhhhcccccC-eee
Confidence 999999999997777779999999999999999986 456666 569999999999999666776 6899999999 999
Q ss_pred cccccCCcCcCccccCCCCcccccCcCCcCCCC
Q 005102 217 FSHNLFSGSIPASLGNLPEKVYIDLTYNNLSGP 249 (714)
Q Consensus 217 l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~ 249 (714)
+++|.+++.+|..++.+++|+.|++++|.+...
T Consensus 155 L~~n~l~~~~~~~l~~l~~L~~L~l~~n~~~~~ 187 (549)
T 2z81_A 155 IKALSLRNYQSQSLKSIRDIHHLTLHLSESAFL 187 (549)
T ss_dssp EEETTCCEECTTTTTTCSEEEEEEEECSBSTTH
T ss_pred ccCCcccccChhhhhccccCceEecccCccccc
Confidence 999999999999999999999999999998643
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.79 E-value=4.1e-19 Score=185.24 Aligned_cols=172 Identities=20% Similarity=0.321 Sum_probs=150.9
Q ss_pred CCcEEEEEcCCCCccccCCccccCCCCCCEEEccCCCCcccCChhhcCCCCCCEEEcCCCcCcccCCcccCCCCCCCEEe
Q 005102 63 EQRVVSVSIPKKKLLGFLPSALGSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSGSVPNEIGKLKYLQILD 142 (714)
Q Consensus 63 ~~~~~~l~l~~~~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ 142 (714)
..+++.|+|++|++++..+ +..+++|++|+|++|++++ ++ .+..+++|+.|+|++|.+++ +|. +..+++|+.|+
T Consensus 62 l~~L~~L~L~~n~i~~~~~--~~~l~~L~~L~L~~n~l~~-~~-~~~~l~~L~~L~l~~n~l~~-~~~-l~~l~~L~~L~ 135 (308)
T 1h6u_A 62 LNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLKN-VS-AIAGLQSIKTLDLTSTQITD-VTP-LAGLSNLQVLY 135 (308)
T ss_dssp CTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCSC-CG-GGTTCTTCCEEECTTSCCCC-CGG-GTTCTTCCEEE
T ss_pred cCCCCEEEccCCcCCCChh--HccCCCCCEEEccCCcCCC-ch-hhcCCCCCCEEECCCCCCCC-chh-hcCCCCCCEEE
Confidence 4689999999999998655 9999999999999999986 34 68999999999999999985 444 99999999999
Q ss_pred ccCccCCCCCCcccccccccceeecccCcCCCCCCcccccCccccccccccCCcccccCCCCCCCCcccccccccccccC
Q 005102 143 LSQNFFNGSLPVSIVQCKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLNLSFNKFNGSIPSNTGNLSSLQGTVDFSHNLF 222 (714)
Q Consensus 143 Ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~~l~l~~N~l 222 (714)
|++|++++. +. +..+++|+.|+|++|++++ ++. + ..+++|+.|+|++|++++..+ +..+++|+ .|++++|++
T Consensus 136 l~~n~l~~~-~~-l~~l~~L~~L~l~~n~l~~-~~~-l-~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~-~L~L~~N~l 207 (308)
T 1h6u_A 136 LDLNQITNI-SP-LAGLTNLQYLSIGNAQVSD-LTP-L-ANLSKLTTLKADDNKISDISP--LASLPNLI-EVHLKNNQI 207 (308)
T ss_dssp CCSSCCCCC-GG-GGGCTTCCEEECCSSCCCC-CGG-G-TTCTTCCEEECCSSCCCCCGG--GGGCTTCC-EEECTTSCC
T ss_pred CCCCccCcC-cc-ccCCCCccEEEccCCcCCC-Chh-h-cCCCCCCEEECCCCccCcChh--hcCCCCCC-EEEccCCcc
Confidence 999999854 43 8899999999999999985 555 4 569999999999999995443 88899999 999999999
Q ss_pred CcCcCccccCCCCcccccCcCCcCCCCC
Q 005102 223 SGSIPASLGNLPEKVYIDLTYNNLSGPI 250 (714)
Q Consensus 223 ~g~~p~~~~~l~~L~~l~l~~N~l~~~~ 250 (714)
++..| +..+++|+.|++++|++++..
T Consensus 208 ~~~~~--l~~l~~L~~L~l~~N~i~~~~ 233 (308)
T 1h6u_A 208 SDVSP--LANTSNLFIVTLTNQTITNQP 233 (308)
T ss_dssp CBCGG--GTTCTTCCEEEEEEEEEECCC
T ss_pred Ccccc--ccCCCCCCEEEccCCeeecCC
Confidence 97664 899999999999999998743
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.78 E-value=5.1e-19 Score=198.30 Aligned_cols=164 Identities=25% Similarity=0.311 Sum_probs=143.5
Q ss_pred CcEEEEEcCCCCccccCCccccCCCCCCEEEccCCCCcccCChhhcCCCCCCEEEcCCCcCcccCCcccCCCCCCCEEec
Q 005102 64 QRVVSVSIPKKKLLGFLPSALGSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSGSVPNEIGKLKYLQILDL 143 (714)
Q Consensus 64 ~~~~~l~l~~~~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L 143 (714)
.+++.|+|++|+|+ .+| ..+++|++|+|++|+|++ +|. +.+ +|+.|+|++|.|++ +|. .+++|+.|+|
T Consensus 80 ~~L~~L~Ls~N~l~-~ip---~~l~~L~~L~Ls~N~l~~-ip~-l~~--~L~~L~Ls~N~l~~-lp~---~l~~L~~L~L 147 (571)
T 3cvr_A 80 PQITVLEITQNALI-SLP---ELPASLEYLDACDNRLST-LPE-LPA--SLKHLDVDNNQLTM-LPE---LPALLEYINA 147 (571)
T ss_dssp TTCSEEECCSSCCS-CCC---CCCTTCCEEECCSSCCSC-CCC-CCT--TCCEEECCSSCCSC-CCC---CCTTCCEEEC
T ss_pred CCCCEEECcCCCCc-ccc---cccCCCCEEEccCCCCCC-cch-hhc--CCCEEECCCCcCCC-CCC---cCccccEEeC
Confidence 46899999999999 577 568999999999999997 777 665 99999999999996 777 6899999999
Q ss_pred cCccCCCCCCcccccccccceeecccCcCCCCCCcccccCccccccccccCCcccccCCCCCCCCccc-------ccccc
Q 005102 144 SQNFFNGSLPVSIVQCKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLNLSFNKFNGSIPSNTGNLSSL-------QGTVD 216 (714)
Q Consensus 144 s~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L-------~~~l~ 216 (714)
++|+|++ +|. .+++|+.|+|++|+|++ +|. +. ++|+.|+|++|+|+ .+|. +.. +| + .|+
T Consensus 148 s~N~l~~-lp~---~l~~L~~L~Ls~N~L~~-lp~-l~---~~L~~L~Ls~N~L~-~lp~-~~~--~L~~~~~~L~-~L~ 213 (571)
T 3cvr_A 148 DNNQLTM-LPE---LPTSLEVLSVRNNQLTF-LPE-LP---ESLEALDVSTNLLE-SLPA-VPV--RNHHSEETEI-FFR 213 (571)
T ss_dssp CSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC-CC---TTCCEEECCSSCCS-SCCC-CC----------CCE-EEE
T ss_pred CCCccCc-CCC---cCCCcCEEECCCCCCCC-cch-hh---CCCCEEECcCCCCC-chhh-HHH--hhhcccccce-EEe
Confidence 9999996 776 57899999999999996 888 53 89999999999999 8888 654 66 7 999
Q ss_pred cccccCCcCcCccccCCCCcccccCcCCcCCCCCCCCc
Q 005102 217 FSHNLFSGSIPASLGNLPEKVYIDLTYNNLSGPIPQNG 254 (714)
Q Consensus 217 l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~ 254 (714)
|++|+|+ .+|..+..+++|+.|++++|+|++.+|...
T Consensus 214 Ls~N~l~-~lp~~l~~l~~L~~L~L~~N~l~~~~p~~l 250 (571)
T 3cvr_A 214 CRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESL 250 (571)
T ss_dssp CCSSCCC-CCCGGGGGSCTTEEEECCSSSCCHHHHHHH
T ss_pred cCCCcce-ecCHHHhcCCCCCEEEeeCCcCCCcCHHHH
Confidence 9999999 689989899999999999999999887653
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.77 E-value=1.3e-18 Score=179.91 Aligned_cols=171 Identities=22% Similarity=0.302 Sum_probs=149.0
Q ss_pred CcEEEEEcCCCCccccCCccccCCCCCCEEEccCCCCcccCChhhcCCCCCCEEEcCCCcCcccCCcccCCCCCCCEEec
Q 005102 64 QRVVSVSIPKKKLLGFLPSALGSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSGSVPNEIGKLKYLQILDL 143 (714)
Q Consensus 64 ~~~~~l~l~~~~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L 143 (714)
.+++.|++++|.+... + .+..+++|++|+|++|++++..+ +..+++|+.|+|++|.+++ +| .+..+++|+.|+|
T Consensus 46 ~~L~~L~l~~~~i~~~-~-~~~~l~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~-~~-~l~~l~~L~~L~L 119 (291)
T 1h6t_A 46 NSIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVKD-LS-SLKDLKKLKSLSL 119 (291)
T ss_dssp HTCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-GG-GGTTCTTCCEEEC
T ss_pred CcccEEEccCCCcccC-h-hHhcCCCCCEEEccCCccCCCcc--cccCCCCCEEECCCCcCCC-Ch-hhccCCCCCEEEC
Confidence 4788999999999875 3 58999999999999999996544 8999999999999999985 44 4999999999999
Q ss_pred cCccCCCCCCcccccccccceeecccCcCCCCCCcccccCccccccccccCCcccccCCCCCCCCcccccccccccccCC
Q 005102 144 SQNFFNGSLPVSIVQCKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLNLSFNKFNGSIPSNTGNLSSLQGTVDFSHNLFS 223 (714)
Q Consensus 144 s~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~~l~l~~N~l~ 223 (714)
++|++++ + +.+..+++|+.|+|++|++++ + ..+ ..+++|+.|+|++|++++..| +..+++|+ .|++++|.++
T Consensus 120 ~~n~i~~-~-~~l~~l~~L~~L~l~~n~l~~-~-~~l-~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~-~L~L~~N~i~ 191 (291)
T 1h6t_A 120 EHNGISD-I-NGLVHLPQLESLYLGNNKITD-I-TVL-SRLTKLDTLSLEDNQISDIVP--LAGLTKLQ-NLYLSKNHIS 191 (291)
T ss_dssp TTSCCCC-C-GGGGGCTTCCEEECCSSCCCC-C-GGG-GGCTTCSEEECCSSCCCCCGG--GTTCTTCC-EEECCSSCCC
T ss_pred CCCcCCC-C-hhhcCCCCCCEEEccCCcCCc-c-hhh-ccCCCCCEEEccCCccccchh--hcCCCccC-EEECCCCcCC
Confidence 9999985 3 578899999999999999985 4 344 469999999999999996555 88999999 9999999999
Q ss_pred cCcCccccCCCCcccccCcCCcCCCCC
Q 005102 224 GSIPASLGNLPEKVYIDLTYNNLSGPI 250 (714)
Q Consensus 224 g~~p~~~~~l~~L~~l~l~~N~l~~~~ 250 (714)
+ +| .+..+++|+.|++++|+++...
T Consensus 192 ~-l~-~l~~l~~L~~L~l~~n~i~~~~ 216 (291)
T 1h6t_A 192 D-LR-ALAGLKNLDVLELFSQECLNKP 216 (291)
T ss_dssp B-CG-GGTTCTTCSEEEEEEEEEECCC
T ss_pred C-Ch-hhccCCCCCEEECcCCcccCCc
Confidence 6 44 4999999999999999998643
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.77 E-value=2.3e-19 Score=188.01 Aligned_cols=176 Identities=17% Similarity=0.160 Sum_probs=152.1
Q ss_pred CCcEEEEEcCCCCccccCCccccCCCCCCEEEccCCCCcccCChhhcCCCCCCEEEcCCCcCcccCCcccCCCCCCCEEe
Q 005102 63 EQRVVSVSIPKKKLLGFLPSALGSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSGSVPNEIGKLKYLQILD 142 (714)
Q Consensus 63 ~~~~~~l~l~~~~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ 142 (714)
...++.|+|++|++++.. ..++|++|++++|++++..+.. +++|+.|+|++|++++..|..++.+++|+.|+
T Consensus 79 l~~L~~L~Ls~n~l~~l~-----~~~~L~~L~l~~n~l~~~~~~~---~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~ 150 (317)
T 3o53_A 79 LSTLRTLDLNNNYVQELL-----VGPSIETLHAANNNISRVSCSR---GQGKKNIYLANNKITMLRDLDEGCRSRVQYLD 150 (317)
T ss_dssp CTTCCEEECCSSEEEEEE-----ECTTCCEEECCSSCCSEEEECC---CSSCEEEECCSSCCCSGGGBCTGGGSSEEEEE
T ss_pred cCCCCEEECcCCcccccc-----CCCCcCEEECCCCccCCcCccc---cCCCCEEECCCCCCCCccchhhhccCCCCEEE
Confidence 468999999999998743 3489999999999999765543 67899999999999988888999999999999
Q ss_pred ccCccCCCCCCcccc-cccccceeecccCcCCCCCCcccccCccccccccccCCcccccCCCCCCCCccccccccccccc
Q 005102 143 LSQNFFNGSLPVSIV-QCKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLNLSFNKFNGSIPSNTGNLSSLQGTVDFSHNL 221 (714)
Q Consensus 143 Ls~N~l~g~~p~~~~-~l~~L~~L~l~~N~l~g~~p~~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~~l~l~~N~ 221 (714)
|++|++++..|..+. .+++|++|+|++|.+++ +|... .+++|+.|+|++|+++ .+|..+..+++|+ .|++++|+
T Consensus 151 Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~-~~~~~--~l~~L~~L~Ls~N~l~-~l~~~~~~l~~L~-~L~L~~N~ 225 (317)
T 3o53_A 151 LKLNEIDTVNFAELAASSDTLEHLNLQYNFIYD-VKGQV--VFAKLKTLDLSSNKLA-FMGPEFQSAAGVT-WISLRNNK 225 (317)
T ss_dssp CTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCE-EECCC--CCTTCCEEECCSSCCC-EECGGGGGGTTCS-EEECTTSC
T ss_pred CCCCCCCcccHHHHhhccCcCCEEECCCCcCcc-ccccc--ccccCCEEECCCCcCC-cchhhhcccCccc-EEECcCCc
Confidence 999999987777774 78999999999999984 45443 3899999999999999 5666799999999 99999999
Q ss_pred CCcCcCccccCCCCcccccCcCCcCC-CCCCC
Q 005102 222 FSGSIPASLGNLPEKVYIDLTYNNLS-GPIPQ 252 (714)
Q Consensus 222 l~g~~p~~~~~l~~L~~l~l~~N~l~-~~~p~ 252 (714)
|+ .+|..+..+++|+.|++++|+++ +.+|.
T Consensus 226 l~-~l~~~~~~l~~L~~L~l~~N~~~~~~~~~ 256 (317)
T 3o53_A 226 LV-LIEKALRFSQNLEHFDLRGNGFHCGTLRD 256 (317)
T ss_dssp CC-EECTTCCCCTTCCEEECTTCCCBHHHHHH
T ss_pred cc-chhhHhhcCCCCCEEEccCCCccCcCHHH
Confidence 99 57889999999999999999998 54443
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.77 E-value=5.2e-19 Score=188.88 Aligned_cols=179 Identities=23% Similarity=0.186 Sum_probs=148.4
Q ss_pred CEEEccCCCCcccCChhhcCCCCCCEEEcCCCcCcccCCcccC-CCCCCCEEeccCccCCCCCCcccccccccceeeccc
Q 005102 91 RHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSGSVPNEIG-KLKYLQILDLSQNFFNGSLPVSIVQCKRLKALDLSQ 169 (714)
Q Consensus 91 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~-~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~ 169 (714)
+.+++++|.|+ .+|..+. ..++.|+|++|+|++..+..+. ++++|+.|+|++|+|++..|..|..+++|+.|+|++
T Consensus 21 ~~l~c~~~~l~-~iP~~~~--~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~ 97 (361)
T 2xot_A 21 NILSCSKQQLP-NVPQSLP--SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSS 97 (361)
T ss_dssp TEEECCSSCCS-SCCSSCC--TTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred CEEEeCCCCcC-ccCccCC--CCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCC
Confidence 57899999998 5776654 4589999999999988888887 999999999999999987778899999999999999
Q ss_pred CcCCCCCCcccccCccccccccccCCcccccCCCCCCCCcccccccccccccCCcCcCccc---cCCCCcccccCcCCcC
Q 005102 170 NNFTGPLPNGFGSGLVSLEKLNLSFNKFNGSIPSNTGNLSSLQGTVDFSHNLFSGSIPASL---GNLPEKVYIDLTYNNL 246 (714)
Q Consensus 170 N~l~g~~p~~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~~l~l~~N~l~g~~p~~~---~~l~~L~~l~l~~N~l 246 (714)
|+|++ +|...+.++++|+.|+|++|+|++..|..|.++++|+ .|+|++|+|++..+..| ..+++|+.|+|++|+|
T Consensus 98 N~l~~-~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~-~L~L~~N~l~~l~~~~~~~~~~l~~L~~L~L~~N~l 175 (361)
T 2xot_A 98 NHLHT-LDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQ-KLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKL 175 (361)
T ss_dssp SCCCE-ECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCC-EEECCSSCCCSCCGGGTC----CTTCCEEECCSSCC
T ss_pred CcCCc-CCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCC-EEECCCCcCCeeCHHHhcCcccCCcCCEEECCCCCC
Confidence 99984 5554446799999999999999988899999999999 99999999996555555 6799999999999999
Q ss_pred CCCCCCCccccC---CCCcccccCCCCCCCC
Q 005102 247 SGPIPQNGALMN---RGPTAFIGNPRLCGPP 274 (714)
Q Consensus 247 ~~~~p~~~~~~~---~~~~~~~~n~~~~~~~ 274 (714)
++..+....... .....+.+|++.|.+.
T Consensus 176 ~~l~~~~~~~l~~~~l~~l~l~~N~~~C~C~ 206 (361)
T 2xot_A 176 KKLPLTDLQKLPAWVKNGLYLHNNPLECDCK 206 (361)
T ss_dssp CCCCHHHHHHSCHHHHTTEECCSSCEECCHH
T ss_pred CccCHHHhhhccHhhcceEEecCCCccCCcC
Confidence 976654332221 1345677899888764
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.76 E-value=1.1e-17 Score=184.17 Aligned_cols=162 Identities=17% Similarity=0.212 Sum_probs=82.5
Q ss_pred cEEEEEcCCCCccccCCccccCCCCCCEEEccCCCCcccCChhhcCCCCCCEEEcCCCcCcccCCcccCCCCCCCEEecc
Q 005102 65 RVVSVSIPKKKLLGFLPSALGSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSGSVPNEIGKLKYLQILDLS 144 (714)
Q Consensus 65 ~~~~l~l~~~~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls 144 (714)
+++.|+|++|++++. | ++.+++|++|+|++|.|++. | +..+++|++|+|++|++++ +| ++.+++|+.|+++
T Consensus 65 ~L~~L~Ls~n~l~~~-~--~~~l~~L~~L~Ls~N~l~~~-~--~~~l~~L~~L~L~~N~l~~-l~--~~~l~~L~~L~l~ 135 (457)
T 3bz5_A 65 GLTKLICTSNNITTL-D--LSQNTNLTYLACDSNKLTNL-D--VTPLTKLTYLNCDTNKLTK-LD--VSQNPLLTYLNCA 135 (457)
T ss_dssp TCSEEECCSSCCSCC-C--CTTCTTCSEEECCSSCCSCC-C--CTTCTTCCEEECCSSCCSC-CC--CTTCTTCCEEECT
T ss_pred CCCEEEccCCcCCeE-c--cccCCCCCEEECcCCCCcee-e--cCCCCcCCEEECCCCcCCe-ec--CCCCCcCCEEECC
Confidence 444455555554442 2 44455555555555555432 2 4445555555555555543 22 4455555555555
Q ss_pred CccCCCCCCcccccccccceeecccCcCCCCCCcccccCccccccccccCCcccccCCCCCCCCcccccccccccccCCc
Q 005102 145 QNFFNGSLPVSIVQCKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLNLSFNKFNGSIPSNTGNLSSLQGTVDFSHNLFSG 224 (714)
Q Consensus 145 ~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~~l~l~~N~l~g 224 (714)
+|++++ +| +..+++|++|++++|+..+.++ + ..+++|+.|++++|++++ +| ++.+++|+ .|++++|++++
T Consensus 136 ~N~l~~-l~--l~~l~~L~~L~l~~n~~~~~~~--~-~~l~~L~~L~ls~n~l~~-l~--l~~l~~L~-~L~l~~N~l~~ 205 (457)
T 3bz5_A 136 RNTLTE-ID--VSHNTQLTELDCHLNKKITKLD--V-TPQTQLTTLDCSFNKITE-LD--VSQNKLLN-RLNCDTNNITK 205 (457)
T ss_dssp TSCCSC-CC--CTTCTTCCEEECTTCSCCCCCC--C-TTCTTCCEEECCSSCCCC-CC--CTTCTTCC-EEECCSSCCSC
T ss_pred CCccce-ec--cccCCcCCEEECCCCCcccccc--c-ccCCcCCEEECCCCccce-ec--cccCCCCC-EEECcCCcCCe
Confidence 555543 22 4444555555555554433442 2 235556666666666653 44 55555555 66666666654
Q ss_pred CcCccccCCCCcccccCcCCcCCC
Q 005102 225 SIPASLGNLPEKVYIDLTYNNLSG 248 (714)
Q Consensus 225 ~~p~~~~~l~~L~~l~l~~N~l~~ 248 (714)
. .++.+++|+.|++++|++++
T Consensus 206 ~---~l~~l~~L~~L~Ls~N~l~~ 226 (457)
T 3bz5_A 206 L---DLNQNIQLTFLDCSSNKLTE 226 (457)
T ss_dssp C---CCTTCTTCSEEECCSSCCSC
T ss_pred e---ccccCCCCCEEECcCCcccc
Confidence 3 25566666666666666665
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.75 E-value=1.2e-17 Score=183.78 Aligned_cols=166 Identities=19% Similarity=0.197 Sum_probs=149.2
Q ss_pred CCcEEEEEcCCCCccccCCccccCCCCCCEEEccCCCCcccCChhhcCCCCCCEEEcCCCcCcccCCcccCCCCCCCEEe
Q 005102 63 EQRVVSVSIPKKKLLGFLPSALGSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSGSVPNEIGKLKYLQILD 142 (714)
Q Consensus 63 ~~~~~~l~l~~~~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ 142 (714)
..+++.|+|++|++++. | .++.+++|++|+|++|++++. | +..+++|++|+|++|.+++. | ++++++|++|+
T Consensus 41 l~~L~~L~Ls~n~l~~~-~-~l~~l~~L~~L~Ls~n~l~~~-~--~~~l~~L~~L~Ls~N~l~~~-~--~~~l~~L~~L~ 112 (457)
T 3bz5_A 41 LATLTSLDCHNSSITDM-T-GIEKLTGLTKLICTSNNITTL-D--LSQNTNLTYLACDSNKLTNL-D--VTPLTKLTYLN 112 (457)
T ss_dssp HTTCCEEECCSSCCCCC-T-TGGGCTTCSEEECCSSCCSCC-C--CTTCTTCSEEECCSSCCSCC-C--CTTCTTCCEEE
T ss_pred cCCCCEEEccCCCcccC-h-hhcccCCCCEEEccCCcCCeE-c--cccCCCCCEEECcCCCCcee-e--cCCCCcCCEEE
Confidence 35889999999999985 5 799999999999999999974 4 88999999999999999974 4 99999999999
Q ss_pred ccCccCCCCCCcccccccccceeecccCcCCCCCCcccccCccccccccccCCcccccCCCCCCCCcccccccccccccC
Q 005102 143 LSQNFFNGSLPVSIVQCKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLNLSFNKFNGSIPSNTGNLSSLQGTVDFSHNLF 222 (714)
Q Consensus 143 Ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~~l~l~~N~l 222 (714)
|++|++++ +| +..+++|++|++++|++++ +| + ..+++|+.|++++|+..+.+ .++.+++|+ .|++++|++
T Consensus 113 L~~N~l~~-l~--~~~l~~L~~L~l~~N~l~~-l~--l-~~l~~L~~L~l~~n~~~~~~--~~~~l~~L~-~L~ls~n~l 182 (457)
T 3bz5_A 113 CDTNKLTK-LD--VSQNPLLTYLNCARNTLTE-ID--V-SHNTQLTELDCHLNKKITKL--DVTPQTQLT-TLDCSFNKI 182 (457)
T ss_dssp CCSSCCSC-CC--CTTCTTCCEEECTTSCCSC-CC--C-TTCTTCCEEECTTCSCCCCC--CCTTCTTCC-EEECCSSCC
T ss_pred CCCCcCCe-ec--CCCCCcCCEEECCCCccce-ec--c-ccCCcCCEEECCCCCccccc--ccccCCcCC-EEECCCCcc
Confidence 99999996 55 8999999999999999996 54 4 46899999999999877777 478899999 999999999
Q ss_pred CcCcCccccCCCCcccccCcCCcCCCC
Q 005102 223 SGSIPASLGNLPEKVYIDLTYNNLSGP 249 (714)
Q Consensus 223 ~g~~p~~~~~l~~L~~l~l~~N~l~~~ 249 (714)
++ +| ++.+++|+.|++++|++++.
T Consensus 183 ~~-l~--l~~l~~L~~L~l~~N~l~~~ 206 (457)
T 3bz5_A 183 TE-LD--VSQNKLLNRLNCDTNNITKL 206 (457)
T ss_dssp CC-CC--CTTCTTCCEEECCSSCCSCC
T ss_pred ce-ec--cccCCCCCEEECcCCcCCee
Confidence 97 55 89999999999999999986
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=99.75 E-value=2.4e-18 Score=197.81 Aligned_cols=207 Identities=20% Similarity=0.201 Sum_probs=162.5
Q ss_pred cEEEEEcCCCCcc--ccCCccccCCCCCCEEEccCCCCcccCChhhcCCCCCCEEEcCCCcCcccCC-cccCCCCCCCEE
Q 005102 65 RVVSVSIPKKKLL--GFLPSALGSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSGSVP-NEIGKLKYLQIL 141 (714)
Q Consensus 65 ~~~~l~l~~~~l~--g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p-~~~~~l~~L~~L 141 (714)
.++.+++++|.+. +..+..+..+.+|+.|+++.|.+.+ ++..+..+++|+.+++++|.+....+ ..+.++.+|+.+
T Consensus 372 ~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~~~~~~~~~-~~~~~~~l~~L~~l~l~~~~~~~~~~~~~~~~l~~l~~l 450 (635)
T 4g8a_A 372 SLEFLDLSRNGLSFKGCCSQSDFGTISLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYL 450 (635)
T ss_dssp TCCEEECCSSCCBEEEECCHHHHSCSCCCEEECCSCSEEE-ECSCCTTCTTCCEEECTTSEEESTTSSCTTTTCTTCCEE
T ss_pred ccccchhhccccccccccccchhhhhhhhhhhcccccccc-ccccccccccccchhhhhccccccccccccccccccccc
Confidence 4445555555553 2344445555556666666655542 34456667778888888777765554 357889999999
Q ss_pred eccCccCCCCCCcccccccccceeecccCcCCCC-CCcccccCccccccccccCCcccccCCCCCCCCcccccccccccc
Q 005102 142 DLSQNFFNGSLPVSIVQCKRLKALDLSQNNFTGP-LPNGFGSGLVSLEKLNLSFNKFNGSIPSNTGNLSSLQGTVDFSHN 220 (714)
Q Consensus 142 ~Ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~-~p~~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~~l~l~~N 220 (714)
+++.|.+.+..|..+..+++|+.|+|++|++... +|..+ ..+++|+.|+|++|+|++..|..|.++++|+ .|+|++|
T Consensus 451 ~ls~n~l~~~~~~~~~~~~~L~~L~Ls~N~~~~~~~~~~~-~~l~~L~~L~Ls~N~L~~l~~~~f~~l~~L~-~L~Ls~N 528 (635)
T 4g8a_A 451 DISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIF-TELRNLTFLDLSQCQLEQLSPTAFNSLSSLQ-VLNMSHN 528 (635)
T ss_dssp ECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCC-TTCTTCCEEECTTSCCCEECTTTTTTCTTCC-EEECTTS
T ss_pred cccccccccccccccccchhhhhhhhhhcccccccCchhh-hhccccCEEECCCCccCCcChHHHcCCCCCC-EEECCCC
Confidence 9999999998899999999999999999986544 45555 5799999999999999999999999999999 9999999
Q ss_pred cCCcCcCccccCCCCcccccCcCCcCCCCCCCCcccc--CCCCcccccCCCCCCCC
Q 005102 221 LFSGSIPASLGNLPEKVYIDLTYNNLSGPIPQNGALM--NRGPTAFIGNPRLCGPP 274 (714)
Q Consensus 221 ~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~~~--~~~~~~~~~n~~~~~~~ 274 (714)
+|++..|..|..+++|+.||+++|+|++.+|...... ........+||+.|.|.
T Consensus 529 ~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~~L~~L~L~~Np~~C~C~ 584 (635)
T 4g8a_A 529 NFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCE 584 (635)
T ss_dssp CCCBCCCGGGTTCTTCCEEECTTSCCCBCCSSCTTCCCTTCCEEECTTCCBCCSGG
T ss_pred cCCCCChhHHhCCCCCCEEECCCCcCCCCCHHHHHhhhCcCCEEEeeCCCCcccCC
Confidence 9999999999999999999999999999999876533 34456678999999775
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.75 E-value=4.3e-18 Score=192.87 Aligned_cols=174 Identities=22% Similarity=0.280 Sum_probs=152.0
Q ss_pred CCcEEEEEcCCCCccccCCccccCCCCCCEEEccCCCCcccCChhhcCCCCCCEEEcCCCcCcccCCcccCCCCCCCEEe
Q 005102 63 EQRVVSVSIPKKKLLGFLPSALGSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSGSVPNEIGKLKYLQILD 142 (714)
Q Consensus 63 ~~~~~~l~l~~~~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ 142 (714)
...++.|+|++|.+... | .|..|++|+.|+|++|+|++..| +..+++|+.|+|++|.|++ +| .+..+++|+.|+
T Consensus 42 L~~L~~L~l~~n~i~~l-~-~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~-l~-~l~~l~~L~~L~ 115 (605)
T 1m9s_A 42 LNSIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLDENKIKD-LS-SLKDLKKLKSLS 115 (605)
T ss_dssp HTTCCCCBCTTCCCCCC-T-TGGGCTTCCEEECTTSCCCCCGG--GGGCTTCCEEECCSSCCCC-CT-TSTTCTTCCEEE
T ss_pred CCCCCEEECcCCCCCCC-h-HHccCCCCCEEEeeCCCCCCChh--hccCCCCCEEECcCCCCCC-Ch-hhccCCCCCEEE
Confidence 35678899999998764 4 69999999999999999997555 8999999999999999985 44 799999999999
Q ss_pred ccCccCCCCCCcccccccccceeecccCcCCCCCCcccccCccccccccccCCcccccCCCCCCCCcccccccccccccC
Q 005102 143 LSQNFFNGSLPVSIVQCKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLNLSFNKFNGSIPSNTGNLSSLQGTVDFSHNLF 222 (714)
Q Consensus 143 Ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~~l~l~~N~l 222 (714)
|++|+|++ + +.+..|++|+.|+|++|++++ + ..+ ..+++|+.|+|++|+|++..| +..+++|+ .|+|++|+|
T Consensus 116 Ls~N~l~~-l-~~l~~l~~L~~L~Ls~N~l~~-l-~~l-~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~-~L~Ls~N~i 187 (605)
T 1m9s_A 116 LEHNGISD-I-NGLVHLPQLESLYLGNNKITD-I-TVL-SRLTKLDTLSLEDNQISDIVP--LAGLTKLQ-NLYLSKNHI 187 (605)
T ss_dssp CTTSCCCC-C-GGGGGCTTCSEEECCSSCCCC-C-GGG-GSCTTCSEEECCSSCCCCCGG--GTTCTTCC-EEECCSSCC
T ss_pred ecCCCCCC-C-ccccCCCccCEEECCCCccCC-c-hhh-cccCCCCEEECcCCcCCCchh--hccCCCCC-EEECcCCCC
Confidence 99999985 4 468999999999999999985 4 345 469999999999999997766 89999999 999999999
Q ss_pred CcCcCccccCCCCcccccCcCCcCCCCCCC
Q 005102 223 SGSIPASLGNLPEKVYIDLTYNNLSGPIPQ 252 (714)
Q Consensus 223 ~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~ 252 (714)
++. ..+..+++|+.|+|++|++++.+..
T Consensus 188 ~~l--~~l~~l~~L~~L~L~~N~l~~~p~~ 215 (605)
T 1m9s_A 188 SDL--RALAGLKNLDVLELFSQECLNKPIN 215 (605)
T ss_dssp CBC--GGGTTCTTCSEEECCSEEEECCCCC
T ss_pred CCC--hHHccCCCCCEEEccCCcCcCCccc
Confidence 974 4699999999999999999976543
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=99.75 E-value=4.1e-18 Score=188.53 Aligned_cols=171 Identities=28% Similarity=0.377 Sum_probs=97.4
Q ss_pred cEEEEEcCCCCccccCCccccCCCCCCEEEccCCCCcccCChhhcCCCCCCEEEcCCCcCcccCCcccCCCCCCCEEecc
Q 005102 65 RVVSVSIPKKKLLGFLPSALGSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSGSVPNEIGKLKYLQILDLS 144 (714)
Q Consensus 65 ~~~~l~l~~~~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls 144 (714)
+++.|++++|.+++..| ++.+++|+.|+|++|.+++. ..+..+++|+.|+|++|.+++..| +..+++|+.|+|+
T Consensus 200 ~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~ 273 (466)
T 1o6v_A 200 NLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLG 273 (466)
T ss_dssp TCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECC
T ss_pred CCCEEEecCCccccccc--ccccCCCCEEECCCCCcccc--hhhhcCCCCCEEECCCCccccchh--hhcCCCCCEEECC
Confidence 45555555555554433 44455555555555555432 235555566666666666654333 5566666666666
Q ss_pred CccCCCCCCcccccccccceeecccCcCCCCCCcccccCccccccccccCCcccccCCCCCCCCcccccccccccccCCc
Q 005102 145 QNFFNGSLPVSIVQCKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLNLSFNKFNGSIPSNTGNLSSLQGTVDFSHNLFSG 224 (714)
Q Consensus 145 ~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~~l~l~~N~l~g 224 (714)
+|++++..| +..+++|+.|+|++|++++..| + ..+++|+.|+|++|++++..| +..+++|+ .|++++|.+++
T Consensus 274 ~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~-~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~-~L~l~~n~l~~ 345 (466)
T 1o6v_A 274 ANQISNISP--LAGLTALTNLELNENQLEDISP--I-SNLKNLTYLTLYFNNISDISP--VSSLTKLQ-RLFFYNNKVSD 345 (466)
T ss_dssp SSCCCCCGG--GTTCTTCSEEECCSSCCSCCGG--G-GGCTTCSEEECCSSCCSCCGG--GGGCTTCC-EEECCSSCCCC
T ss_pred CCccCcccc--ccCCCccCeEEcCCCcccCchh--h-cCCCCCCEEECcCCcCCCchh--hccCccCC-EeECCCCccCC
Confidence 666654322 5556666666666666654322 2 345666666666666665444 45566666 66666666665
Q ss_pred CcCccccCCCCcccccCcCCcCCCCCC
Q 005102 225 SIPASLGNLPEKVYIDLTYNNLSGPIP 251 (714)
Q Consensus 225 ~~p~~~~~l~~L~~l~l~~N~l~~~~p 251 (714)
. ..+..+++|+.|++++|++++.+|
T Consensus 346 ~--~~l~~l~~L~~L~l~~n~l~~~~~ 370 (466)
T 1o6v_A 346 V--SSLANLTNINWLSAGHNQISDLTP 370 (466)
T ss_dssp C--GGGTTCTTCCEEECCSSCCCBCGG
T ss_pred c--hhhccCCCCCEEeCCCCccCccch
Confidence 4 356666666666666666666655
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.75 E-value=3.6e-19 Score=206.77 Aligned_cols=155 Identities=25% Similarity=0.307 Sum_probs=127.9
Q ss_pred cCCccccCCCCCCEEEccCCCCcccCChhhcCCCCCCEEEcCCCcCcccCCcccCCCCCCCEEeccCccCCCCCCccccc
Q 005102 79 FLPSALGSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSGSVPNEIGKLKYLQILDLSQNFFNGSLPVSIVQ 158 (714)
Q Consensus 79 ~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~ 158 (714)
..|..+..++.|+.|+|++|.+. .+|..++.+++|+.|+|++|.|+ .+|..|++|++|+.|+|++|+|+ .+|..|..
T Consensus 215 ~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~ 291 (727)
T 4b8c_D 215 MPKDSKYDDQLWHALDLSNLQIF-NISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT-SLPAELGS 291 (727)
T ss_dssp -------CCCCCCEEECTTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS-SCCSSGGG
T ss_pred cChhhhccCCCCcEEECCCCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC-ccChhhcC
Confidence 45788999999999999999998 78888999999999999999999 99999999999999999999999 88999999
Q ss_pred ccccceeecccCcCCCCCCcccccCccccccccccCCcccccCCCCCCCCcccccccccccccCCcCcCccccCCCCccc
Q 005102 159 CKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLNLSFNKFNGSIPSNTGNLSSLQGTVDFSHNLFSGSIPASLGNLPEKVY 238 (714)
Q Consensus 159 l~~L~~L~l~~N~l~g~~p~~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~~l~l~~N~l~g~~p~~~~~l~~L~~ 238 (714)
|++|+.|+|++|.|+ .+|..+ ..|++|+.|+|++|+|++.+|..+..+......++|++|.++|.+|..+. .
T Consensus 292 l~~L~~L~L~~N~l~-~lp~~~-~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~l~l~~N~l~~~~p~~l~------~ 363 (727)
T 4b8c_D 292 CFQLKYFYFFDNMVT-TLPWEF-GNLCNLQFLGVEGNPLEKQFLKILTEKSVTGLIFYLRDNRPEIPLPHERR------F 363 (727)
T ss_dssp GTTCSEEECCSSCCC-CCCSST-TSCTTCCCEECTTSCCCSHHHHHHHHHHHHHHHHHHHHCCCCCCCCCC---------
T ss_pred CCCCCEEECCCCCCC-ccChhh-hcCCCccEEeCCCCccCCCChHHHhhcchhhhHHhhccCcccCcCccccc------e
Confidence 999999999999997 899987 46999999999999999999988876544332578999999999997654 5
Q ss_pred ccCcCC
Q 005102 239 IDLTYN 244 (714)
Q Consensus 239 l~l~~N 244 (714)
|+++.|
T Consensus 364 l~l~~n 369 (727)
T 4b8c_D 364 IEINTD 369 (727)
T ss_dssp ------
T ss_pred eEeecc
Confidence 566666
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=99.74 E-value=4.1e-18 Score=180.84 Aligned_cols=174 Identities=22% Similarity=0.320 Sum_probs=95.2
Q ss_pred cEEEEEcCCCCccccCCccccCCCCCCEEEccCCCCcccCChhhcCCCCCCEEEcCCCcCc-------------------
Q 005102 65 RVVSVSIPKKKLLGFLPSALGSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFS------------------- 125 (714)
Q Consensus 65 ~~~~l~l~~~~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~------------------- 125 (714)
+++.|++++|...+.++. +..+++|++|++++|.+.+..+ +..+++|+.|++++|.++
T Consensus 133 ~L~~L~l~~n~~~~~~~~-~~~l~~L~~L~l~~~~~~~~~~--~~~l~~L~~L~l~~n~l~~~~~~~~l~~L~~L~l~~n 209 (347)
T 4fmz_A 133 KMYSLNLGANHNLSDLSP-LSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLSLNYNQIEDISPLASLTSLHYFTAYVN 209 (347)
T ss_dssp TCCEEECTTCTTCCCCGG-GTTCTTCCEEECCSSCCCCCGG--GGGCTTCSEEECTTSCCCCCGGGGGCTTCCEEECCSS
T ss_pred ceeEEECCCCCCcccccc-hhhCCCCcEEEecCCCcCCchh--hccCCCCCEEEccCCcccccccccCCCccceeecccC
Confidence 455555555544433332 5555555555555555543222 444455555555555544
Q ss_pred ---ccCCcccCCCCCCCEEeccCccCCCCCCcccccccccceeecccCcCCCCCCcccccCccccccccccCCcccccCC
Q 005102 126 ---GSVPNEIGKLKYLQILDLSQNFFNGSLPVSIVQCKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLNLSFNKFNGSIP 202 (714)
Q Consensus 126 ---g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~l~~L~~L~l~~N~l~g~~p 202 (714)
+..+ +..+++|+.|+|++|++++ +|. +..+++|++|++++|.+++ ++ .+ ..+++|+.|++++|++++ +
T Consensus 210 ~l~~~~~--~~~~~~L~~L~l~~n~l~~-~~~-~~~l~~L~~L~l~~n~l~~-~~-~~-~~l~~L~~L~l~~n~l~~-~- 280 (347)
T 4fmz_A 210 QITDITP--VANMTRLNSLKIGNNKITD-LSP-LANLSQLTWLEIGTNQISD-IN-AV-KDLTKLKMLNVGSNQISD-I- 280 (347)
T ss_dssp CCCCCGG--GGGCTTCCEEECCSSCCCC-CGG-GTTCTTCCEEECCSSCCCC-CG-GG-TTCTTCCEEECCSSCCCC-C-
T ss_pred CCCCCch--hhcCCcCCEEEccCCccCC-Ccc-hhcCCCCCEEECCCCccCC-Ch-hH-hcCCCcCEEEccCCccCC-C-
Confidence 2222 4555566666666666653 222 5556666666666666653 32 22 345666666666666663 3
Q ss_pred CCCCCCcccccccccccccCCcCcCccccCCCCcccccCcCCcCCCCCC
Q 005102 203 SNTGNLSSLQGTVDFSHNLFSGSIPASLGNLPEKVYIDLTYNNLSGPIP 251 (714)
Q Consensus 203 ~~~~~l~~L~~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p 251 (714)
..+..+++|+ .|++++|.+++..|..++.+++|+.|++++|++++.+|
T Consensus 281 ~~~~~l~~L~-~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~ 328 (347)
T 4fmz_A 281 SVLNNLSQLN-SLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP 328 (347)
T ss_dssp GGGGGCTTCS-EEECCSSCCCGGGHHHHHTCTTCSEEECCSSSCCCCGG
T ss_pred hhhcCCCCCC-EEECcCCcCCCcChhHhhccccCCEEEccCCccccccC
Confidence 2355566666 66666666666666666666666666666666666555
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.74 E-value=2.1e-18 Score=167.41 Aligned_cols=128 Identities=16% Similarity=0.255 Sum_probs=63.9
Q ss_pred cEEEEEcCCCCccccCCccccCCCCCCEEEccCCCCcccCChhhcCCCCCCEEEcCCCcCcccCCcccCCCCCCCEEecc
Q 005102 65 RVVSVSIPKKKLLGFLPSALGSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSGSVPNEIGKLKYLQILDLS 144 (714)
Q Consensus 65 ~~~~l~l~~~~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls 144 (714)
+++.|++++|+++ .+| .+..+++|++|++++|.++ .+..+..+++|++|+|++|.+++..|..++.+++|+.|+|+
T Consensus 45 ~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~--~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls 120 (197)
T 4ezg_A 45 SLTYITLANINVT-DLT-GIEYAHNIKDLTINNIHAT--NYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDIS 120 (197)
T ss_dssp TCCEEEEESSCCS-CCT-TGGGCTTCSEEEEESCCCS--CCGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCEEECC
T ss_pred CccEEeccCCCcc-ChH-HHhcCCCCCEEEccCCCCC--cchhhhcCCCCCEEEeECCccCcccChhhcCCCCCCEEEec
Confidence 4455555555555 233 3555555555555555443 22344555555555555555555455555555555555555
Q ss_pred CccCCCCCCcccccccccceeecccCcCCCCCCcccccCccccccccccCCccc
Q 005102 145 QNFFNGSLPVSIVQCKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLNLSFNKFN 198 (714)
Q Consensus 145 ~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~l~~L~~L~l~~N~l~ 198 (714)
+|++++..|..+..+++|++|+|++|++.+.+| .+ ..+++|+.|++++|+++
T Consensus 121 ~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~~~~-~l-~~l~~L~~L~l~~n~i~ 172 (197)
T 4ezg_A 121 HSAHDDSILTKINTLPKVNSIDLSYNGAITDIM-PL-KTLPELKSLNIQFDGVH 172 (197)
T ss_dssp SSBCBGGGHHHHTTCSSCCEEECCSCTBCCCCG-GG-GGCSSCCEEECTTBCCC
T ss_pred CCccCcHhHHHHhhCCCCCEEEccCCCCccccH-hh-cCCCCCCEEECCCCCCc
Confidence 555554445555555555555555554222343 22 23444444444444444
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.74 E-value=6.2e-18 Score=163.39 Aligned_cols=177 Identities=21% Similarity=0.243 Sum_probs=133.7
Q ss_pred CCCcccceEecCCcEEEEEcCCCCccccCCccccCCCCCCEEEccCCCCcccCCh-hhcCCCCCCEEEcCCCcCcccCCc
Q 005102 52 NPCSWNGITCKEQRVVSVSIPKKKLLGFLPSALGSLTDLRHVNLRNNKFFGSLPL-ELLEAQGLQSLVLYGNSFSGSVPN 130 (714)
Q Consensus 52 ~~c~w~gv~c~~~~~~~l~l~~~~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~-~~~~l~~L~~L~L~~N~l~g~~p~ 130 (714)
+.|.|+.|.| ++|+++ .+|..+.. +|++|+|++|+|++..+. .|..+++|++|+|++|+|++..|.
T Consensus 6 C~C~~~~l~~----------s~~~l~-~ip~~~~~--~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~ 72 (192)
T 1w8a_A 6 CHCEGTTVDC----------TGRGLK-EIPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPN 72 (192)
T ss_dssp SEEETTEEEC----------TTSCCS-SCCSCCCT--TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTT
T ss_pred CEECCCEEEc----------CCCCcC-cCccCCCC--CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHh
Confidence 3456765555 456663 56766644 899999999999977665 488999999999999999998899
Q ss_pred ccCCCCCCCEEeccCccCCCCCCcccccccccceeecccCcCCCCCCcccccCccccccccccCCcccccCCCCCCCCcc
Q 005102 131 EIGKLKYLQILDLSQNFFNGSLPVSIVQCKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLNLSFNKFNGSIPSNTGNLSS 210 (714)
Q Consensus 131 ~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~ 210 (714)
.|.++++|+.|+|++|+|++..|..|..+++|+.|+|++|+|++.+|..+ ..+++|+.|+|++|.+++..+... +..
T Consensus 73 ~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~-~~l~~L~~L~L~~N~l~c~c~l~~--~~~ 149 (192)
T 1w8a_A 73 AFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSF-EHLNSLTSLNLASNPFNCNCHLAW--FAE 149 (192)
T ss_dssp TTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSS-TTCTTCCEEECTTCCBCCSGGGHH--HHH
T ss_pred HcCCcccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHh-hcCCCCCEEEeCCCCccCcCcchH--HHH
Confidence 99999999999999999998888889999999999999999998778777 468999999999999997665211 111
Q ss_pred -cccccccccccCCcCcCccccCCCCcccccCcCCcCCC
Q 005102 211 -LQGTVDFSHNLFSGSIPASLGNLPEKVYIDLTYNNLSG 248 (714)
Q Consensus 211 -L~~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~ 248 (714)
+. ...+..+......|.. +......++..+.+.-
T Consensus 150 ~l~-~~~~~~~~~~C~~P~~---l~~~~l~~l~~~~~~C 184 (192)
T 1w8a_A 150 WLR-KKSLNGGAARCGAPSK---VRDVQIKDLPHSEFKC 184 (192)
T ss_dssp HHH-HHCCSGGGCBBCSSTT---TTTSBGGGSCTTTCCC
T ss_pred HHH-HcCCCCCCCCCCCChH---HcCCChhhCcHhhcCc
Confidence 11 2223334444344444 4445667777777753
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=99.73 E-value=8.5e-18 Score=185.98 Aligned_cols=172 Identities=28% Similarity=0.346 Sum_probs=153.3
Q ss_pred CCcEEEEEcCCCCccccCCccccCCCCCCEEEccCCCCcccCChhhcCCCCCCEEEcCCCcCcccCCcccCCCCCCCEEe
Q 005102 63 EQRVVSVSIPKKKLLGFLPSALGSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSGSVPNEIGKLKYLQILD 142 (714)
Q Consensus 63 ~~~~~~l~l~~~~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ 142 (714)
..+++.|+|++|++++. +.+..+++|++|+|++|.+++..| +..+++|+.|+|++|.+++..| +..+++|+.|+
T Consensus 220 l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~ 293 (466)
T 1o6v_A 220 LTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLE 293 (466)
T ss_dssp CTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCGG--GTTCTTCSEEE
T ss_pred cCCCCEEECCCCCcccc--hhhhcCCCCCEEECCCCccccchh--hhcCCCCCEEECCCCccCcccc--ccCCCccCeEE
Confidence 45789999999999874 468999999999999999997655 8899999999999999996544 89999999999
Q ss_pred ccCccCCCCCCcccccccccceeecccCcCCCCCCcccccCccccccccccCCcccccCCCCCCCCcccccccccccccC
Q 005102 143 LSQNFFNGSLPVSIVQCKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLNLSFNKFNGSIPSNTGNLSSLQGTVDFSHNLF 222 (714)
Q Consensus 143 Ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~~l~l~~N~l 222 (714)
|++|++++..| +..+++|+.|+|++|++++..| + ..+++|+.|++++|++++. ..+.++++|+ .|++++|++
T Consensus 294 L~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~-~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~-~L~l~~n~l 365 (466)
T 1o6v_A 294 LNENQLEDISP--ISNLKNLTYLTLYFNNISDISP--V-SSLTKLQRLFFYNNKVSDV--SSLANLTNIN-WLSAGHNQI 365 (466)
T ss_dssp CCSSCCSCCGG--GGGCTTCSEEECCSSCCSCCGG--G-GGCTTCCEEECCSSCCCCC--GGGTTCTTCC-EEECCSSCC
T ss_pred cCCCcccCchh--hcCCCCCCEEECcCCcCCCchh--h-ccCccCCEeECCCCccCCc--hhhccCCCCC-EEeCCCCcc
Confidence 99999996544 8899999999999999997655 3 4689999999999999964 4788999999 999999999
Q ss_pred CcCcCccccCCCCcccccCcCCcCCCCC
Q 005102 223 SGSIPASLGNLPEKVYIDLTYNNLSGPI 250 (714)
Q Consensus 223 ~g~~p~~~~~l~~L~~l~l~~N~l~~~~ 250 (714)
++..| +..+++|+.|++++|++++.+
T Consensus 366 ~~~~~--~~~l~~L~~L~l~~n~~~~~p 391 (466)
T 1o6v_A 366 SDLTP--LANLTRITQLGLNDQAWTNAP 391 (466)
T ss_dssp CBCGG--GTTCTTCCEEECCCEEEECCC
T ss_pred Cccch--hhcCCCCCEEeccCCcccCCc
Confidence 99888 899999999999999999854
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=99.73 E-value=6.7e-18 Score=179.21 Aligned_cols=170 Identities=22% Similarity=0.300 Sum_probs=142.3
Q ss_pred CcEEEEEcCCCCccccCCccccCCCCCCEEEccCCCCcccCChhhcCCCCCCEEEcCCCcCcccCCcccCCCCCCCEEec
Q 005102 64 QRVVSVSIPKKKLLGFLPSALGSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSGSVPNEIGKLKYLQILDL 143 (714)
Q Consensus 64 ~~~~~l~l~~~~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L 143 (714)
.+++.|++++|.+.+..+ +..+++|+.|++++|.+++..+ +..+++|+.|+|++|.+++. |. +..+++|+.|+|
T Consensus 177 ~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~n~l~~~-~~-~~~l~~L~~L~l 250 (347)
T 4fmz_A 177 TDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDL-SP-LANLSQLTWLEI 250 (347)
T ss_dssp TTCSEEECTTSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCC-GG-GTTCTTCCEEEC
T ss_pred CCCCEEEccCCccccccc--ccCCCccceeecccCCCCCCch--hhcCCcCCEEEccCCccCCC-cc-hhcCCCCCEEEC
Confidence 466777777777765433 7777778888888887775443 78899999999999999854 44 999999999999
Q ss_pred cCccCCCCCCcccccccccceeecccCcCCCCCCcccccCccccccccccCCcccccCCCCCCCCcccccccccccccCC
Q 005102 144 SQNFFNGSLPVSIVQCKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLNLSFNKFNGSIPSNTGNLSSLQGTVDFSHNLFS 223 (714)
Q Consensus 144 s~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~~l~l~~N~l~ 223 (714)
++|.+++ + +.+..+++|+.|++++|++++ +| .+ ..+++|+.|++++|++++..|..+..+++|+ .|++++|+++
T Consensus 251 ~~n~l~~-~-~~~~~l~~L~~L~l~~n~l~~-~~-~~-~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~-~L~L~~n~l~ 324 (347)
T 4fmz_A 251 GTNQISD-I-NAVKDLTKLKMLNVGSNQISD-IS-VL-NNLSQLNSLFLNNNQLGNEDMEVIGGLTNLT-TLFLSQNHIT 324 (347)
T ss_dssp CSSCCCC-C-GGGTTCTTCCEEECCSSCCCC-CG-GG-GGCTTCSEEECCSSCCCGGGHHHHHTCTTCS-EEECCSSSCC
T ss_pred CCCccCC-C-hhHhcCCCcCEEEccCCccCC-Ch-hh-cCCCCCCEEECcCCcCCCcChhHhhccccCC-EEEccCCccc
Confidence 9999985 4 568899999999999999985 44 34 4689999999999999998899999999999 9999999999
Q ss_pred cCcCccccCCCCcccccCcCCcCC
Q 005102 224 GSIPASLGNLPEKVYIDLTYNNLS 247 (714)
Q Consensus 224 g~~p~~~~~l~~L~~l~l~~N~l~ 247 (714)
+..| +..+++|+.|++++|.++
T Consensus 325 ~~~~--~~~l~~L~~L~l~~N~i~ 346 (347)
T 4fmz_A 325 DIRP--LASLSKMDSADFANQVIK 346 (347)
T ss_dssp CCGG--GGGCTTCSEESSSCC---
T ss_pred cccC--hhhhhccceeehhhhccc
Confidence 8777 889999999999999986
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.73 E-value=7.8e-18 Score=163.43 Aligned_cols=156 Identities=15% Similarity=0.192 Sum_probs=135.9
Q ss_pred ccCCCCCCEEEccCCCCcccCChhhcCCCCCCEEEcCCCcCcccCCcccCCCCCCCEEeccCccCCCCCCcccccccccc
Q 005102 84 LGSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSGSVPNEIGKLKYLQILDLSQNFFNGSLPVSIVQCKRLK 163 (714)
Q Consensus 84 ~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~ 163 (714)
...+++|++|++++|.++ .+| .+..+++|+.|+|++|.++ .+..+..+++|+.|+|++|++++..|..+..+++|+
T Consensus 40 ~~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~--~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~ 115 (197)
T 4ezg_A 40 EAQMNSLTYITLANINVT-DLT-GIEYAHNIKDLTINNIHAT--NYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLT 115 (197)
T ss_dssp HHHHHTCCEEEEESSCCS-CCT-TGGGCTTCSEEEEESCCCS--CCGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCC
T ss_pred hhhcCCccEEeccCCCcc-ChH-HHhcCCCCCEEEccCCCCC--cchhhhcCCCCCEEEeECCccCcccChhhcCCCCCC
Confidence 367789999999999998 667 6899999999999999775 445899999999999999999988899999999999
Q ss_pred eeecccCcCCCCCCcccccCccccccccccCCcccccCCCCCCCCcccccccccccccCCcCcCccccCCCCcccccCcC
Q 005102 164 ALDLSQNNFTGPLPNGFGSGLVSLEKLNLSFNKFNGSIPSNTGNLSSLQGTVDFSHNLFSGSIPASLGNLPEKVYIDLTY 243 (714)
Q Consensus 164 ~L~l~~N~l~g~~p~~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~ 243 (714)
+|+|++|++++..|..+. .+++|+.|+|++|++.+.+| .+..+++|+ .|++++|.+++ ++ .+..+++|+.|++++
T Consensus 116 ~L~Ls~n~i~~~~~~~l~-~l~~L~~L~L~~n~~i~~~~-~l~~l~~L~-~L~l~~n~i~~-~~-~l~~l~~L~~L~l~~ 190 (197)
T 4ezg_A 116 LLDISHSAHDDSILTKIN-TLPKVNSIDLSYNGAITDIM-PLKTLPELK-SLNIQFDGVHD-YR-GIEDFPKLNQLYAFS 190 (197)
T ss_dssp EEECCSSBCBGGGHHHHT-TCSSCCEEECCSCTBCCCCG-GGGGCSSCC-EEECTTBCCCC-CT-TGGGCSSCCEEEECB
T ss_pred EEEecCCccCcHhHHHHh-hCCCCCEEEccCCCCccccH-hhcCCCCCC-EEECCCCCCcC-hH-HhccCCCCCEEEeeC
Confidence 999999999987777774 69999999999999444777 688999999 99999999996 44 789999999999999
Q ss_pred CcCCC
Q 005102 244 NNLSG 248 (714)
Q Consensus 244 N~l~~ 248 (714)
|++.+
T Consensus 191 N~i~~ 195 (197)
T 4ezg_A 191 QTIGG 195 (197)
T ss_dssp C----
T ss_pred cccCC
Confidence 99864
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.73 E-value=4.2e-18 Score=173.21 Aligned_cols=168 Identities=24% Similarity=0.258 Sum_probs=138.4
Q ss_pred EEEEEcCCCCccccCCccccCCCCCCEEEccCCCCcccCChhhcCCCCCCEEEcCCCcCcccCCcccCCCCCCCEEeccC
Q 005102 66 VVSVSIPKKKLLGFLPSALGSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSGSVPNEIGKLKYLQILDLSQ 145 (714)
Q Consensus 66 ~~~l~l~~~~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~ 145 (714)
++.+++.++.+++.. .+..+++|++|++++|.++ .+| .+..+++|+.|+|++|++++. |. +..+++|+.|+|++
T Consensus 21 l~~l~l~~~~i~~~~--~~~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~L~~N~i~~~-~~-l~~l~~L~~L~L~~ 94 (263)
T 1xeu_A 21 AVKQNLGKQSVTDLV--SQKELSGVQNFNGDNSNIQ-SLA-GMQFFTNLKELHLSHNQISDL-SP-LKDLTKLEELSVNR 94 (263)
T ss_dssp HHHHHHTCSCTTSEE--CHHHHTTCSEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCC-GG-GTTCSSCCEEECCS
T ss_pred HHHHHhcCCCccccc--chhhcCcCcEEECcCCCcc-cch-HHhhCCCCCEEECCCCccCCC-hh-hccCCCCCEEECCC
Confidence 444567777777644 5788899999999999998 456 688899999999999999854 44 89999999999999
Q ss_pred ccCCCCCCcccccccccceeecccCcCCCCCCcccccCccccccccccCCcccccCCCCCCCCcccccccccccccCCcC
Q 005102 146 NFFNGSLPVSIVQCKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLNLSFNKFNGSIPSNTGNLSSLQGTVDFSHNLFSGS 225 (714)
Q Consensus 146 N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~~l~l~~N~l~g~ 225 (714)
|++++ +|.... ++|+.|+|++|++++ +| .+ ..+++|+.|+|++|++++ +| .+..+++|+ .|++++|++++.
T Consensus 95 N~l~~-l~~~~~--~~L~~L~L~~N~l~~-~~-~l-~~l~~L~~L~Ls~N~i~~-~~-~l~~l~~L~-~L~L~~N~i~~~ 165 (263)
T 1xeu_A 95 NRLKN-LNGIPS--ACLSRLFLDNNELRD-TD-SL-IHLKNLEILSIRNNKLKS-IV-MLGFLSKLE-VLDLHGNEITNT 165 (263)
T ss_dssp SCCSC-CTTCCC--SSCCEEECCSSCCSB-SG-GG-TTCTTCCEEECTTSCCCB-CG-GGGGCTTCC-EEECTTSCCCBC
T ss_pred CccCC-cCcccc--CcccEEEccCCccCC-Ch-hh-cCcccccEEECCCCcCCC-Ch-HHccCCCCC-EEECCCCcCcch
Confidence 99985 554333 889999999999985 44 34 468999999999999985 44 688899999 999999999976
Q ss_pred cCccccCCCCcccccCcCCcCCCCC
Q 005102 226 IPASLGNLPEKVYIDLTYNNLSGPI 250 (714)
Q Consensus 226 ~p~~~~~l~~L~~l~l~~N~l~~~~ 250 (714)
..+..+++|+.|++++|++++..
T Consensus 166 --~~l~~l~~L~~L~l~~N~~~~~~ 188 (263)
T 1xeu_A 166 --GGLTRLKKVNWIDLTGQKCVNEP 188 (263)
T ss_dssp --TTSTTCCCCCEEEEEEEEEECCC
T ss_pred --HHhccCCCCCEEeCCCCcccCCc
Confidence 67899999999999999998763
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.72 E-value=7.5e-18 Score=162.81 Aligned_cols=132 Identities=23% Similarity=0.330 Sum_probs=87.8
Q ss_pred CEEEccCCCCcccCChhhcCCCCCCEEEcCCCcCcccCCc-ccCCCCCCCEEeccCccCCCCCCcccccccccceeeccc
Q 005102 91 RHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSGSVPN-EIGKLKYLQILDLSQNFFNGSLPVSIVQCKRLKALDLSQ 169 (714)
Q Consensus 91 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~-~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~ 169 (714)
+++++++|.|+ .+|..+.. +|+.|+|++|.+++..+. .|+.+++|+.|+|++|+|++..|..|..+++|++|+|++
T Consensus 11 ~~l~~s~~~l~-~ip~~~~~--~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~ 87 (192)
T 1w8a_A 11 TTVDCTGRGLK-EIPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE 87 (192)
T ss_dssp TEEECTTSCCS-SCCSCCCT--TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred CEEEcCCCCcC-cCccCCCC--CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCC
Confidence 57777777775 56655543 677777777777755543 367777777777777777766677777777777777777
Q ss_pred CcCCCCCCcccccCccccccccccCCcccccCCCCCCCCcccccccccccccCCcCcC
Q 005102 170 NNFTGPLPNGFGSGLVSLEKLNLSFNKFNGSIPSNTGNLSSLQGTVDFSHNLFSGSIP 227 (714)
Q Consensus 170 N~l~g~~p~~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~~l~l~~N~l~g~~p 227 (714)
|+|++..|..+ .++++|+.|+|++|+|++.+|..+..+++|+ .+++++|++++..+
T Consensus 88 N~l~~~~~~~~-~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~-~L~L~~N~l~c~c~ 143 (192)
T 1w8a_A 88 NKIKEISNKMF-LGLHQLKTLNLYDNQISCVMPGSFEHLNSLT-SLNLASNPFNCNCH 143 (192)
T ss_dssp CCCCEECSSSS-TTCTTCCEEECCSSCCCEECTTSSTTCTTCC-EEECTTCCBCCSGG
T ss_pred CcCCccCHHHh-cCCCCCCEEECCCCcCCeeCHHHhhcCCCCC-EEEeCCCCccCcCc
Confidence 77765444444 3466677777777777666666666666666 66666666665443
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.71 E-value=3.2e-19 Score=188.48 Aligned_cols=179 Identities=23% Similarity=0.244 Sum_probs=151.4
Q ss_pred CcEEEEEcCCCCccccCCccccCCCCCCEEEccCCCCccc-CChhhcCCCCCCEEEcCCCcCcccCCcccCCCCCCCEEe
Q 005102 64 QRVVSVSIPKKKLLGFLPSALGSLTDLRHVNLRNNKFFGS-LPLELLEAQGLQSLVLYGNSFSGSVPNEIGKLKYLQILD 142 (714)
Q Consensus 64 ~~~~~l~l~~~~l~g~~p~~~~~l~~L~~L~L~~N~l~~~-~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ 142 (714)
.+++.+++++|.+.+..+. +..+++|++|+|++|.+++. +|..+..+++|+.|+|++|.+++..|..++.+++|+.|+
T Consensus 70 ~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~ 148 (336)
T 2ast_B 70 QGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLN 148 (336)
T ss_dssp TTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEE
T ss_pred ccceEEEcCCccccccchh-hccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEE
Confidence 5788889999998887665 66789999999999998866 888888999999999999999988888899999999999
Q ss_pred ccCc-cCCC-CCCcccccccccceeecccC-cCCCC-CCcccccCcc-ccccccccCC--ccc-ccCCCCCCCCcccccc
Q 005102 143 LSQN-FFNG-SLPVSIVQCKRLKALDLSQN-NFTGP-LPNGFGSGLV-SLEKLNLSFN--KFN-GSIPSNTGNLSSLQGT 214 (714)
Q Consensus 143 Ls~N-~l~g-~~p~~~~~l~~L~~L~l~~N-~l~g~-~p~~~~~~l~-~L~~L~l~~N--~l~-g~~p~~~~~l~~L~~~ 214 (714)
|++| .+++ .+|..+..+++|++|+|++| .+++. ++..+ ..++ +|+.|+|++| .++ +.+|..+.++++|+ .
T Consensus 149 L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~~~-~~l~~~L~~L~l~~~~~~~~~~~l~~~~~~~~~L~-~ 226 (336)
T 2ast_B 149 LSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAV-AHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLV-H 226 (336)
T ss_dssp CTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHH-HHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCS-E
T ss_pred CCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcChHHHHHHH-HhcccCCCEEEeCCCcccCCHHHHHHHHhhCCCCC-E
Confidence 9999 6775 36777888999999999999 88753 45545 4588 9999999999 455 56777777888998 9
Q ss_pred ccccccc-CCcCcCccccCCCCcccccCcCCc
Q 005102 215 VDFSHNL-FSGSIPASLGNLPEKVYIDLTYNN 245 (714)
Q Consensus 215 l~l~~N~-l~g~~p~~~~~l~~L~~l~l~~N~ 245 (714)
|++++|. +++..+..++.+++|+.|++++|.
T Consensus 227 L~l~~~~~l~~~~~~~l~~l~~L~~L~l~~~~ 258 (336)
T 2ast_B 227 LDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCY 258 (336)
T ss_dssp EECTTCTTCCGGGGGGGGGCTTCCEEECTTCT
T ss_pred EeCCCCCcCCHHHHHHHhCCCCCCEeeCCCCC
Confidence 9999998 777888889999999999999996
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.71 E-value=1.7e-19 Score=194.61 Aligned_cols=184 Identities=20% Similarity=0.245 Sum_probs=141.3
Q ss_pred CCcEEEEEcCC---CCccccCCccc-------cCCCCCCEEEccCCCCcc----cCChhhcCCCCCCEEEcCCCcCcccC
Q 005102 63 EQRVVSVSIPK---KKLLGFLPSAL-------GSLTDLRHVNLRNNKFFG----SLPLELLEAQGLQSLVLYGNSFSGSV 128 (714)
Q Consensus 63 ~~~~~~l~l~~---~~l~g~~p~~~-------~~l~~L~~L~L~~N~l~~----~~p~~~~~l~~L~~L~L~~N~l~g~~ 128 (714)
..+++.|+|++ +++++.+|..+ ..+++|++|+|++|.+++ .+|..+..+++|+.|+|++|.+++..
T Consensus 59 ~~~L~~L~Ls~~~~~~l~~~~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~~ 138 (386)
T 2ca6_A 59 KKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQA 138 (386)
T ss_dssp CTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHH
T ss_pred CCCccEEeCcccccCccccchhHHHHHHHHHHhhCCcccEEECCCCcCCHHHHHHHHHHHHhCCCCCEEECcCCCCCHHH
Confidence 45788888887 46667777665 688889999999998887 47778888889999999999887544
Q ss_pred CcccC----CC---------CCCCEEeccCccCC-CCCC---cccccccccceeecccCcCC--C---CCCcccccCccc
Q 005102 129 PNEIG----KL---------KYLQILDLSQNFFN-GSLP---VSIVQCKRLKALDLSQNNFT--G---PLPNGFGSGLVS 186 (714)
Q Consensus 129 p~~~~----~l---------~~L~~L~Ls~N~l~-g~~p---~~~~~l~~L~~L~l~~N~l~--g---~~p~~~~~~l~~ 186 (714)
+..+. .+ ++|+.|+|++|+++ +.+| ..+..+++|+.|+|++|+++ | .+|..+ ..+++
T Consensus 139 ~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l-~~~~~ 217 (386)
T 2ca6_A 139 GAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGL-AYCQE 217 (386)
T ss_dssp HHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTG-GGCTT
T ss_pred HHHHHHHHHHHhhhhhcccCCCCcEEECCCCCCCcHHHHHHHHHHHhCCCcCEEECcCCCCCHhHHHHHHHHHh-hcCCC
Confidence 44433 33 88899999999887 4455 46677888999999998886 2 233244 35788
Q ss_pred cccccccCCccc----ccCCCCCCCCcccccccccccccCCcC----cCccc--cCCCCcccccCcCCcCCC
Q 005102 187 LEKLNLSFNKFN----GSIPSNTGNLSSLQGTVDFSHNLFSGS----IPASL--GNLPEKVYIDLTYNNLSG 248 (714)
Q Consensus 187 L~~L~l~~N~l~----g~~p~~~~~l~~L~~~l~l~~N~l~g~----~p~~~--~~l~~L~~l~l~~N~l~~ 248 (714)
|+.|+|++|.++ +.+|..+..+++|+ .|+|++|.+++. +|..+ +.+++|+.|++++|++++
T Consensus 218 L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~-~L~L~~n~i~~~~~~~l~~~l~~~~~~~L~~L~L~~n~i~~ 288 (386)
T 2ca6_A 218 LKVLDLQDNTFTHLGSSALAIALKSWPNLR-ELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIEL 288 (386)
T ss_dssp CCEEECCSSCCHHHHHHHHHHHGGGCTTCC-EEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBH
T ss_pred ccEEECcCCCCCcHHHHHHHHHHccCCCcC-EEECCCCCCchhhHHHHHHHHhhccCCCeEEEECcCCcCCH
Confidence 889999999886 67888888888888 889999988866 56666 348888899999998887
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=99.71 E-value=4.2e-17 Score=179.28 Aligned_cols=154 Identities=29% Similarity=0.347 Sum_probs=71.8
Q ss_pred cEEEEEcCCCCccccCCccccCCCCCCEEEccCCCCcccCChhhcCCCCCCEEEcCCCcCcccCCcccCCCCCCCEEecc
Q 005102 65 RVVSVSIPKKKLLGFLPSALGSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSGSVPNEIGKLKYLQILDLS 144 (714)
Q Consensus 65 ~~~~l~l~~~~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls 144 (714)
+++.|++++|.++ .+| .++.+++|++|++++|++++ +|.. +++|+.|+|++|++++ +|.. +++|+.|+++
T Consensus 216 ~L~~L~l~~n~l~-~lp-~~~~l~~L~~L~l~~N~l~~-l~~~---~~~L~~L~l~~N~l~~-l~~~---~~~L~~L~ls 285 (454)
T 1jl5_A 216 SLESIVAGNNILE-ELP-ELQNLPFLTTIYADNNLLKT-LPDL---PPSLEALNVRDNYLTD-LPEL---PQSLTFLDVS 285 (454)
T ss_dssp TCCEEECCSSCCS-SCC-CCTTCTTCCEEECCSSCCSS-CCSC---CTTCCEEECCSSCCSC-CCCC---CTTCCEEECC
T ss_pred cccEEECcCCcCC-ccc-ccCCCCCCCEEECCCCcCCc-cccc---ccccCEEECCCCcccc-cCcc---cCcCCEEECc
Confidence 4455555555555 344 25555555555555555553 3321 2455555555555553 3332 2455555555
Q ss_pred CccCCC--CCCcccccccccceeecccCcCCCCCCcccccCccccccccccCCcccccCCCCCCCCcccccccccccccC
Q 005102 145 QNFFNG--SLPVSIVQCKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLNLSFNKFNGSIPSNTGNLSSLQGTVDFSHNLF 222 (714)
Q Consensus 145 ~N~l~g--~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~~l~l~~N~l 222 (714)
+|++++ .+| ++|+.|++++|++++ ++ ....+|+.|++++|++++ +|.. +++|+ .|++++|++
T Consensus 286 ~N~l~~l~~~~------~~L~~L~l~~N~l~~-i~----~~~~~L~~L~Ls~N~l~~-lp~~---~~~L~-~L~L~~N~l 349 (454)
T 1jl5_A 286 ENIFSGLSELP------PNLYYLNASSNEIRS-LC----DLPPSLEELNVSNNKLIE-LPAL---PPRLE-RLIASFNHL 349 (454)
T ss_dssp SSCCSEESCCC------TTCCEEECCSSCCSE-EC----CCCTTCCEEECCSSCCSC-CCCC---CTTCC-EEECCSSCC
T ss_pred CCccCcccCcC------CcCCEEECcCCcCCc-cc----CCcCcCCEEECCCCcccc-cccc---CCcCC-EEECCCCcc
Confidence 555554 222 122333333333221 11 001345555555555553 4433 23444 555555555
Q ss_pred CcCcCccccCCCCcccccCcCCcCCC
Q 005102 223 SGSIPASLGNLPEKVYIDLTYNNLSG 248 (714)
Q Consensus 223 ~g~~p~~~~~l~~L~~l~l~~N~l~~ 248 (714)
+ .+|. .+++|+.|++++|++++
T Consensus 350 ~-~lp~---~l~~L~~L~L~~N~l~~ 371 (454)
T 1jl5_A 350 A-EVPE---LPQNLKQLHVEYNPLRE 371 (454)
T ss_dssp S-CCCC---CCTTCCEEECCSSCCSS
T ss_pred c-cccc---hhhhccEEECCCCCCCc
Confidence 5 2443 24455555555555555
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.71 E-value=1.2e-17 Score=189.39 Aligned_cols=141 Identities=25% Similarity=0.328 Sum_probs=99.1
Q ss_pred CCCCCCCCCCCCCCcccce--------EecCCcEEEEEcCCCCccccCCccccCCCCCCEEEccCCCCcccCChhhcCCC
Q 005102 41 GSLSNWNSSDENPCSWNGI--------TCKEQRVVSVSIPKKKLLGFLPSALGSLTDLRHVNLRNNKFFGSLPLELLEAQ 112 (714)
Q Consensus 41 ~~l~~w~~~~~~~c~w~gv--------~c~~~~~~~l~l~~~~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~ 112 (714)
..+..|... .+||.|.|. .|....++.|++++|+|+ .+|..+. ++|++|+|++|.|+ .+|. .++
T Consensus 10 ~~w~~W~~~-~~~~~~~~r~~~~~~~~~c~~~~l~~L~ls~n~L~-~lp~~l~--~~L~~L~L~~N~l~-~lp~---~l~ 81 (622)
T 3g06_A 10 AVWSAWRRA-APAEESRGRAAVVQKMRACLNNGNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPA---LPP 81 (622)
T ss_dssp CHHHHHHHT-CCGGGHHHHHHHHHHHHHHHHHCCCEEECCSSCCS-CCCSCCC--TTCSEEEECSCCCS-CCCC---CCT
T ss_pred HHHHHHHhc-CCcchhccccccCcccccccCCCCcEEEecCCCcC-ccChhhC--CCCcEEEecCCCCC-CCCC---cCC
Confidence 344567543 467888653 344556888999999988 6777665 78899999999888 4565 567
Q ss_pred CCCEEEcCCCcCcccCCcccCCCCCCCEEeccCccCCCCCCcccccccccceeecccCcCCCCCCcccccCccccccccc
Q 005102 113 GLQSLVLYGNSFSGSVPNEIGKLKYLQILDLSQNFFNGSLPVSIVQCKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLNL 192 (714)
Q Consensus 113 ~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~l~~L~~L~l 192 (714)
+|++|+|++|.|+ .+|. .+++|+.|+|++|++++ +|. .+++|+.|+|++|+++ .+|.. +++|+.|+|
T Consensus 82 ~L~~L~Ls~N~l~-~lp~---~l~~L~~L~Ls~N~l~~-l~~---~l~~L~~L~L~~N~l~-~lp~~----l~~L~~L~L 148 (622)
T 3g06_A 82 ELRTLEVSGNQLT-SLPV---LPPGLLELSIFSNPLTH-LPA---LPSGLCKLWIFGNQLT-SLPVL----PPGLQELSV 148 (622)
T ss_dssp TCCEEEECSCCCS-CCCC---CCTTCCEEEECSCCCCC-CCC---CCTTCCEEECCSSCCS-CCCCC----CTTCCEEEC
T ss_pred CCCEEEcCCCcCC-cCCC---CCCCCCEEECcCCcCCC-CCC---CCCCcCEEECCCCCCC-cCCCC----CCCCCEEEC
Confidence 8888888888887 5665 56788888888888874 554 4566777777777776 35542 356667777
Q ss_pred cCCcccccCCC
Q 005102 193 SFNKFNGSIPS 203 (714)
Q Consensus 193 ~~N~l~g~~p~ 203 (714)
++|+++ .+|.
T Consensus 149 s~N~l~-~l~~ 158 (622)
T 3g06_A 149 SDNQLA-SLPA 158 (622)
T ss_dssp CSSCCS-CCCC
T ss_pred cCCcCC-CcCC
Confidence 777666 3443
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.70 E-value=1.9e-17 Score=171.02 Aligned_cols=163 Identities=26% Similarity=0.358 Sum_probs=138.7
Q ss_pred cCCCCccccCCccccCCCCCCEEEccCCCCcccCChhhcCCCCCCEEEcCCCcCcccCCcccCCCCCCCEEeccCccCCC
Q 005102 71 IPKKKLLGFLPSALGSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSGSVPNEIGKLKYLQILDLSQNFFNG 150 (714)
Q Consensus 71 l~~~~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g 150 (714)
+..+.+++..+ +..+++|+.|++++|.+... + .+..+++|+.|+|++|++++..| ++.+++|+.|+|++|++++
T Consensus 31 l~~~~~~~~~~--~~~l~~L~~L~l~~~~i~~~-~-~~~~l~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~ 104 (291)
T 1h6t_A 31 LKKKSVTDAVT--QNELNSIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVKD 104 (291)
T ss_dssp TTCSCTTSEEC--HHHHHTCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC
T ss_pred hcCCCcccccc--hhhcCcccEEEccCCCcccC-h-hHhcCCCCCEEEccCCccCCCcc--cccCCCCCEEECCCCcCCC
Confidence 44455554433 45789999999999999854 4 48889999999999999996544 9999999999999999985
Q ss_pred CCCcccccccccceeecccCcCCCCCCcccccCccccccccccCCcccccCCCCCCCCcccccccccccccCCcCcCccc
Q 005102 151 SLPVSIVQCKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLNLSFNKFNGSIPSNTGNLSSLQGTVDFSHNLFSGSIPASL 230 (714)
Q Consensus 151 ~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~~l~l~~N~l~g~~p~~~ 230 (714)
+| .+..+++|+.|+|++|++++ ++ .+ ..+++|+.|+|++|++++. ..+..+++|+ .|++++|++++..| +
T Consensus 105 -~~-~l~~l~~L~~L~L~~n~i~~-~~-~l-~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~-~L~L~~N~l~~~~~--l 174 (291)
T 1h6t_A 105 -LS-SLKDLKKLKSLSLEHNGISD-IN-GL-VHLPQLESLYLGNNKITDI--TVLSRLTKLD-TLSLEDNQISDIVP--L 174 (291)
T ss_dssp -GG-GGTTCTTCCEEECTTSCCCC-CG-GG-GGCTTCCEEECCSSCCCCC--GGGGGCTTCS-EEECCSSCCCCCGG--G
T ss_pred -Ch-hhccCCCCCEEECCCCcCCC-Ch-hh-cCCCCCCEEEccCCcCCcc--hhhccCCCCC-EEEccCCccccchh--h
Confidence 44 48999999999999999985 44 45 4689999999999999954 5788999999 99999999997766 9
Q ss_pred cCCCCcccccCcCCcCCCC
Q 005102 231 GNLPEKVYIDLTYNNLSGP 249 (714)
Q Consensus 231 ~~l~~L~~l~l~~N~l~~~ 249 (714)
..+++|+.|++++|++++.
T Consensus 175 ~~l~~L~~L~L~~N~i~~l 193 (291)
T 1h6t_A 175 AGLTKLQNLYLSKNHISDL 193 (291)
T ss_dssp TTCTTCCEEECCSSCCCBC
T ss_pred cCCCccCEEECCCCcCCCC
Confidence 9999999999999999975
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=99.70 E-value=6.6e-18 Score=185.65 Aligned_cols=164 Identities=22% Similarity=0.210 Sum_probs=85.7
Q ss_pred CcEEEEEcCCCCccccCCccccCCCCCCEEEccCCCCcccCChhhcCCCCC-------------CEEEcCCCcCcccCCc
Q 005102 64 QRVVSVSIPKKKLLGFLPSALGSLTDLRHVNLRNNKFFGSLPLELLEAQGL-------------QSLVLYGNSFSGSVPN 130 (714)
Q Consensus 64 ~~~~~l~l~~~~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L-------------~~L~L~~N~l~g~~p~ 130 (714)
.+++.|++++|++ |.+|++|++|++|++|++++|.+.|.+|..++++++| +.|++++|.+++ +|.
T Consensus 11 ~~L~~L~l~~n~l-~~iP~~i~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~c~~~~l~~L~l~~~~l~~-lp~ 88 (454)
T 1jl5_A 11 TFLQEPLRHSSNL-TEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLSS-LPE 88 (454)
T ss_dssp ------------------------CCHHHHHHHHHHHHHTSCTTSCCCHHHHHHHHHHHHHHTCSEEECTTSCCSC-CCS
T ss_pred ccchhhhcccCch-hhCChhHhcccchhhhhccCCcccccCCcccccchhcchhhhhhhhccCCCEEEecCCcccc-CCC
Confidence 4677788888888 7888888888888888888888888888887776653 777777777774 444
Q ss_pred ccCCCCCCCEEeccCccCCCCCCcccccccccceeecccCcCCCCCCcccccCccccccccccCCcccccCCCCCCCCcc
Q 005102 131 EIGKLKYLQILDLSQNFFNGSLPVSIVQCKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLNLSFNKFNGSIPSNTGNLSS 210 (714)
Q Consensus 131 ~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~ 210 (714)
. .++|+.|+|++|++++ +|..+ ++|+.|++++|++++ +|.. .++|++|++++|++++ +| .++++++
T Consensus 89 ~---~~~L~~L~l~~n~l~~-lp~~~---~~L~~L~l~~n~l~~-l~~~----~~~L~~L~L~~n~l~~-lp-~~~~l~~ 154 (454)
T 1jl5_A 89 L---PPHLESLVASCNSLTE-LPELP---QSLKSLLVDNNNLKA-LSDL----PPLLEYLGVSNNQLEK-LP-ELQNSSF 154 (454)
T ss_dssp C---CTTCSEEECCSSCCSS-CCCCC---TTCCEEECCSSCCSC-CCSC----CTTCCEEECCSSCCSS-CC-CCTTCTT
T ss_pred C---cCCCCEEEccCCcCCc-ccccc---CCCcEEECCCCccCc-ccCC----CCCCCEEECcCCCCCC-Cc-ccCCCCC
Confidence 2 2567777777777765 55432 456666666666653 3321 1455666666666653 55 3555556
Q ss_pred cccccccccccCCcCcCccccCCCCcccccCcCCcCCC
Q 005102 211 LQGTVDFSHNLFSGSIPASLGNLPEKVYIDLTYNNLSG 248 (714)
Q Consensus 211 L~~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~ 248 (714)
|+ .|++++|++++ +|..+ ++|++|++++|++++
T Consensus 155 L~-~L~l~~N~l~~-lp~~~---~~L~~L~L~~n~l~~ 187 (454)
T 1jl5_A 155 LK-IIDVDNNSLKK-LPDLP---PSLEFIAAGNNQLEE 187 (454)
T ss_dssp CC-EEECCSSCCSC-CCCCC---TTCCEEECCSSCCSS
T ss_pred CC-EEECCCCcCcc-cCCCc---ccccEEECcCCcCCc
Confidence 65 56666666553 44322 355555555555555
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.69 E-value=5.6e-17 Score=154.44 Aligned_cols=137 Identities=26% Similarity=0.324 Sum_probs=106.3
Q ss_pred CCCcccceEecCCcEEEEEcCCCCccccCCccccCCCCCCEEEccCCCCcccCChhhcCCCCCCEEEcCCCcCcccCCcc
Q 005102 52 NPCSWNGITCKEQRVVSVSIPKKKLLGFLPSALGSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSGSVPNE 131 (714)
Q Consensus 52 ~~c~w~gv~c~~~~~~~l~l~~~~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~ 131 (714)
+.|+|.+|.|.. ++++. +|..+ .++|++|+|++|++++..+..+..+++|++|+|++|++++..+..
T Consensus 5 C~C~~~~l~~~~----------~~l~~-~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~ 71 (177)
T 2o6r_A 5 CSCSGTEIRCNS----------KGLTS-VPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGV 71 (177)
T ss_dssp CEEETTEEECCS----------SCCSS-CCTTC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTT
T ss_pred CEeCCCEEEecC----------CCCcc-CCCCC--CCCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhH
Confidence 457899988864 34443 44433 368999999999998766667788999999999999998666667
Q ss_pred cCCCCCCCEEeccCccCCCCCCcccccccccceeecccCcCCCCCCcccccCccccccccccCCcccccCC
Q 005102 132 IGKLKYLQILDLSQNFFNGSLPVSIVQCKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLNLSFNKFNGSIP 202 (714)
Q Consensus 132 ~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~l~~L~~L~l~~N~l~g~~p 202 (714)
|+.+++|+.|+|++|++++..+..+..+++|+.|+|++|+++ .+|...+..+++|+.|+|++|.+++..|
T Consensus 72 ~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~-~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 141 (177)
T 2o6r_A 72 FDKLTKLTILYLHENKLQSLPNGVFDKLTQLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTNPWDCSCP 141 (177)
T ss_dssp TTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCS-CCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred ccCCCccCEEECCCCCccccCHHHhhCCcccCEEECcCCcce-EeCHHHhcCCcccCEEEecCCCeeccCc
Confidence 888999999999999998766666788888999999999888 4555554567888888888888875543
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.69 E-value=1.5e-19 Score=191.13 Aligned_cols=192 Identities=19% Similarity=0.236 Sum_probs=166.3
Q ss_pred cccceEecCCcEEEEEcCCCCccccCCccccCC--CCCCEEEccCCCCcccCChhhcCCCCCCEEEcCCCcCccc-CCcc
Q 005102 55 SWNGITCKEQRVVSVSIPKKKLLGFLPSALGSL--TDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSGS-VPNE 131 (714)
Q Consensus 55 ~w~gv~c~~~~~~~l~l~~~~l~g~~p~~~~~l--~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~-~p~~ 131 (714)
.|+++.|+...++.++++++.+. |..+..+ ++|+.|++++|.+.+..+. +..+++|+.|+|++|.+++. +|..
T Consensus 38 ~W~~~~~~~~~~~~l~l~~~~~~---~~~~~~~~~~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~~~~~~ 113 (336)
T 2ast_B 38 RWYRLASDESLWQTLDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVSTLHGI 113 (336)
T ss_dssp HHHHHHTCSTTSSEEECTTCBCC---HHHHHHHHHTTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHHHHHHH
T ss_pred HHHHHhcCchhheeeccccccCC---HHHHHhhhhccceEEEcCCccccccchh-hccCCCCCEEEccCCCcCHHHHHHH
Confidence 69999887777889999999887 5667777 8999999999999977665 66899999999999999876 8888
Q ss_pred cCCCCCCCEEeccCccCCCCCCcccccccccceeecccC-cCCCC-CCcccccCccccccccccCC-ccccc-CCCCCCC
Q 005102 132 IGKLKYLQILDLSQNFFNGSLPVSIVQCKRLKALDLSQN-NFTGP-LPNGFGSGLVSLEKLNLSFN-KFNGS-IPSNTGN 207 (714)
Q Consensus 132 ~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~N-~l~g~-~p~~~~~~l~~L~~L~l~~N-~l~g~-~p~~~~~ 207 (714)
+..+++|+.|+|++|.+++..|..+..+++|++|+|++| .+++. +|..+ ..+++|+.|+|++| ++++. ++..+.+
T Consensus 114 ~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~-~~~~~L~~L~l~~~~~l~~~~~~~~~~~ 192 (336)
T 2ast_B 114 LSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLL-SSCSRLDELNLSWCFDFTEKHVQVAVAH 192 (336)
T ss_dssp HTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHH-HHCTTCCEEECCCCTTCCHHHHHHHHHH
T ss_pred HhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHHHH-hcCCCCCEEcCCCCCCcChHHHHHHHHh
Confidence 999999999999999999888999999999999999999 67753 55545 46899999999999 99864 6777888
Q ss_pred Cc-ccccccccccc--cCC-cCcCccccCCCCcccccCcCCc-CCCCCCC
Q 005102 208 LS-SLQGTVDFSHN--LFS-GSIPASLGNLPEKVYIDLTYNN-LSGPIPQ 252 (714)
Q Consensus 208 l~-~L~~~l~l~~N--~l~-g~~p~~~~~l~~L~~l~l~~N~-l~~~~p~ 252 (714)
++ +|+ .|++++| .++ +.+|..+..+++|+.|++++|. +++..+.
T Consensus 193 l~~~L~-~L~l~~~~~~~~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~ 241 (336)
T 2ast_B 193 VSETIT-QLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQ 241 (336)
T ss_dssp SCTTCC-EEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGG
T ss_pred cccCCC-EEEeCCCcccCCHHHHHHHHhhCCCCCEEeCCCCCcCCHHHHH
Confidence 99 999 9999999 566 6678888999999999999999 6655443
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.69 E-value=6.3e-20 Score=206.73 Aligned_cols=178 Identities=22% Similarity=0.213 Sum_probs=128.2
Q ss_pred EEEcCCCCccccCCccccCCCCCCEEEccCCC-------------CcccCChhhcCCCCCCEEE-cCCCcCcccCCc---
Q 005102 68 SVSIPKKKLLGFLPSALGSLTDLRHVNLRNNK-------------FFGSLPLELLEAQGLQSLV-LYGNSFSGSVPN--- 130 (714)
Q Consensus 68 ~l~l~~~~l~g~~p~~~~~l~~L~~L~L~~N~-------------l~~~~p~~~~~l~~L~~L~-L~~N~l~g~~p~--- 130 (714)
.|+|++|+|+ .+|+.++++++|+.|++++|. +.+.+|..+..+++|+.|+ ++.|.+. .++.
T Consensus 353 ~L~Ls~n~L~-~Lp~~i~~l~~L~~L~l~~n~~l~~l~~ll~~~~~~~~~~~~l~~l~~L~~L~~l~~n~~~-~L~~l~l 430 (567)
T 1dce_A 353 RCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYLD-DLRSKFL 430 (567)
T ss_dssp SCCCCHHHHH-HHHHHHHHHHHHHHHCTTCHHHHHHHHHHHHHHCTGGGHHHHHHHHHHHHHHCGGGHHHHH-HHHHHHH
T ss_pred eccCChhhHH-hhHHHHHHHHHHHHhccccchhhhhHHHHHHhcccccCCHHHHHHHHhcccCcchhhcccc-hhhhhhh
Confidence 3444455543 345555555555555554443 3444444455555555554 3333221 0100
Q ss_pred ---ccCC--CCCCCEEeccCccCCCCCCcccccccccceeecccCcCCCCCCcccccCccccccccccCCcccccCCCCC
Q 005102 131 ---EIGK--LKYLQILDLSQNFFNGSLPVSIVQCKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLNLSFNKFNGSIPSNT 205 (714)
Q Consensus 131 ---~~~~--l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~l~~L~~L~l~~N~l~g~~p~~~ 205 (714)
.+.. ...|+.|+|++|+|++ +|. |..+++|+.|+|++|+|+ .+|..++ .+++|+.|+|++|+|++ +| .+
T Consensus 431 ~~n~i~~l~~~~L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~l~-~lp~~~~-~l~~L~~L~Ls~N~l~~-lp-~l 504 (567)
T 1dce_A 431 LENSVLKMEYADVRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNRLR-ALPPALA-ALRCLEVLQASDNALEN-VD-GV 504 (567)
T ss_dssp HHHHHHHHHHTTCSEEECTTSCCSS-CCC-GGGGTTCCEEECCSSCCC-CCCGGGG-GCTTCCEEECCSSCCCC-CG-GG
T ss_pred hcccccccCccCceEEEecCCCCCC-CcC-ccccccCcEeecCccccc-ccchhhh-cCCCCCEEECCCCCCCC-Cc-cc
Confidence 0000 1258899999999985 776 999999999999999998 8998885 69999999999999995 78 89
Q ss_pred CCCcccccccccccccCCcCc-CccccCCCCcccccCcCCcCCCCCCCCc
Q 005102 206 GNLSSLQGTVDFSHNLFSGSI-PASLGNLPEKVYIDLTYNNLSGPIPQNG 254 (714)
Q Consensus 206 ~~l~~L~~~l~l~~N~l~g~~-p~~~~~l~~L~~l~l~~N~l~~~~p~~~ 254 (714)
+++++|+ .|+|++|+|++.. |..++.+++|+.|++++|+|++.+|...
T Consensus 505 ~~l~~L~-~L~Ls~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~ 553 (567)
T 1dce_A 505 ANLPRLQ-ELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQE 553 (567)
T ss_dssp TTCSSCC-EEECCSSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSSCTT
T ss_pred CCCCCCc-EEECCCCCCCCCCCcHHHhcCCCCCEEEecCCcCCCCccHHH
Confidence 9999999 9999999999887 9999999999999999999999887543
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.69 E-value=1.3e-18 Score=187.74 Aligned_cols=185 Identities=18% Similarity=0.244 Sum_probs=155.4
Q ss_pred CCcEEEEEcCCCCccccCC----ccccCCCCCCEEEccCC---CCcccCChhh-------cCCCCCCEEEcCCCcCcc--
Q 005102 63 EQRVVSVSIPKKKLLGFLP----SALGSLTDLRHVNLRNN---KFFGSLPLEL-------LEAQGLQSLVLYGNSFSG-- 126 (714)
Q Consensus 63 ~~~~~~l~l~~~~l~g~~p----~~~~~l~~L~~L~L~~N---~l~~~~p~~~-------~~l~~L~~L~L~~N~l~g-- 126 (714)
...++.|+|++|++++..+ ..|..+++|++|+|++| ++++.+|..+ ..+++|++|+|++|.+++
T Consensus 31 ~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~~~~~~l~~~~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~ 110 (386)
T 2ca6_A 31 DDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTA 110 (386)
T ss_dssp CSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCSCCCCTTT
T ss_pred CCCccEEECCCCCCCHHHHHHHHHHHHhCCCccEEeCcccccCccccchhHHHHHHHHHHhhCCcccEEECCCCcCCHHH
Confidence 3578999999999998744 45789999999999995 5667777666 688999999999999997
Q ss_pred --cCCcccCCCCCCCEEeccCccCCCCCCccc----ccc---------cccceeecccCcCC-CCCC---cccccCcccc
Q 005102 127 --SVPNEIGKLKYLQILDLSQNFFNGSLPVSI----VQC---------KRLKALDLSQNNFT-GPLP---NGFGSGLVSL 187 (714)
Q Consensus 127 --~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~----~~l---------~~L~~L~l~~N~l~-g~~p---~~~~~~l~~L 187 (714)
.+|..+..+++|+.|+|++|.+++..+..+ ..+ ++|++|+|++|+++ +.+| ..+ ..+++|
T Consensus 111 ~~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l-~~~~~L 189 (386)
T 2ca6_A 111 QEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTF-QSHRLL 189 (386)
T ss_dssp HHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHH-HHCTTC
T ss_pred HHHHHHHHHhCCCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCcEEECCCCCCCcHHHHHHHHHH-HhCCCc
Confidence 578889999999999999999975444333 344 89999999999997 4455 233 357899
Q ss_pred ccccccCCccc--c---cCCCCCCCCcccccccccccccCC----cCcCccccCCCCcccccCcCCcCCCC
Q 005102 188 EKLNLSFNKFN--G---SIPSNTGNLSSLQGTVDFSHNLFS----GSIPASLGNLPEKVYIDLTYNNLSGP 249 (714)
Q Consensus 188 ~~L~l~~N~l~--g---~~p~~~~~l~~L~~~l~l~~N~l~----g~~p~~~~~l~~L~~l~l~~N~l~~~ 249 (714)
+.|+|++|+++ | .+|..+.++++|+ .|+|++|.++ +.+|..+..+++|+.|++++|++++.
T Consensus 190 ~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~-~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L~L~~n~i~~~ 259 (386)
T 2ca6_A 190 HTVKMVQNGIRPEGIEHLLLEGLAYCQELK-VLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSAR 259 (386)
T ss_dssp CEEECCSSCCCHHHHHHHHHTTGGGCTTCC-EEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHH
T ss_pred CEEECcCCCCCHhHHHHHHHHHhhcCCCcc-EEECcCCCCCcHHHHHHHHHHccCCCcCEEECCCCCCchh
Confidence 99999999998 3 4566888999999 9999999997 77899999999999999999999865
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.69 E-value=3.8e-17 Score=185.17 Aligned_cols=165 Identities=25% Similarity=0.353 Sum_probs=142.3
Q ss_pred EEcCCCCccccCCccccCCCCCCEEEccCCCCcccCChhhcCCCCCCEEEcCCCcCcccCCcccCCCCCCCEEeccCccC
Q 005102 69 VSIPKKKLLGFLPSALGSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSGSVPNEIGKLKYLQILDLSQNFF 148 (714)
Q Consensus 69 l~l~~~~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l 148 (714)
+.|..+.+...++ +..|++|+.|+|++|.+.. +| .+..+++|+.|+|++|+|++..| +..+++|+.|+|++|+|
T Consensus 26 l~l~~~~i~~~~~--~~~L~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l 99 (605)
T 1m9s_A 26 DNLKKKSVTDAVT--QNELNSIDQIIANNSDIKS-VQ-GIQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLDENKI 99 (605)
T ss_dssp HHTTCSCTTSEEC--HHHHTTCCCCBCTTCCCCC-CT-TGGGCTTCCEEECTTSCCCCCGG--GGGCTTCCEEECCSSCC
T ss_pred HhccCCCcccccc--hhcCCCCCEEECcCCCCCC-Ch-HHccCCCCCEEEeeCCCCCCChh--hccCCCCCEEECcCCCC
Confidence 3455566665544 5688999999999999984 44 58999999999999999996554 99999999999999999
Q ss_pred CCCCCcccccccccceeecccCcCCCCCCcccccCccccccccccCCcccccCCCCCCCCcccccccccccccCCcCcCc
Q 005102 149 NGSLPVSIVQCKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLNLSFNKFNGSIPSNTGNLSSLQGTVDFSHNLFSGSIPA 228 (714)
Q Consensus 149 ~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~~l~l~~N~l~g~~p~ 228 (714)
++ +| .+..|++|+.|+|++|++++ +| .+ ..+++|+.|+|++|+|++. ..+..+++|+ .|+|++|.|++..|
T Consensus 100 ~~-l~-~l~~l~~L~~L~Ls~N~l~~-l~-~l-~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~-~L~Ls~N~l~~~~~- 170 (605)
T 1m9s_A 100 KD-LS-SLKDLKKLKSLSLEHNGISD-IN-GL-VHLPQLESLYLGNNKITDI--TVLSRLTKLD-TLSLEDNQISDIVP- 170 (605)
T ss_dssp CC-CT-TSTTCTTCCEEECTTSCCCC-CG-GG-GGCTTCSEEECCSSCCCCC--GGGGSCTTCS-EEECCSSCCCCCGG-
T ss_pred CC-Ch-hhccCCCCCEEEecCCCCCC-Cc-cc-cCCCccCEEECCCCccCCc--hhhcccCCCC-EEECcCCcCCCchh-
Confidence 85 44 78999999999999999985 54 35 4699999999999999954 6788999999 99999999998877
Q ss_pred cccCCCCcccccCcCCcCCCC
Q 005102 229 SLGNLPEKVYIDLTYNNLSGP 249 (714)
Q Consensus 229 ~~~~l~~L~~l~l~~N~l~~~ 249 (714)
+..+++|+.|+|++|+|++.
T Consensus 171 -l~~l~~L~~L~Ls~N~i~~l 190 (605)
T 1m9s_A 171 -LAGLTKLQNLYLSKNHISDL 190 (605)
T ss_dssp -GTTCTTCCEEECCSSCCCBC
T ss_pred -hccCCCCCEEECcCCCCCCC
Confidence 99999999999999999985
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.67 E-value=1.8e-16 Score=179.77 Aligned_cols=167 Identities=25% Similarity=0.345 Sum_probs=92.4
Q ss_pred CCcEEEEEcCCCCccccCCccccCCCCCCEEEccCCCCcccCChhhcCCCCCCEEEcCCCcCcccCCcccCCCCCCCEEe
Q 005102 63 EQRVVSVSIPKKKLLGFLPSALGSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSGSVPNEIGKLKYLQILD 142 (714)
Q Consensus 63 ~~~~~~l~l~~~~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ 142 (714)
..+++.|+|++|++++ +|. .+++|++|+|++|++++ +|. .+++|+.|+|++|.++ .+|.. +++|+.|+
T Consensus 80 l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~l~~-l~~---~l~~L~~L~L~~N~l~-~lp~~---l~~L~~L~ 147 (622)
T 3g06_A 80 PPELRTLEVSGNQLTS-LPV---LPPGLLELSIFSNPLTH-LPA---LPSGLCKLWIFGNQLT-SLPVL---PPGLQELS 147 (622)
T ss_dssp CTTCCEEEECSCCCSC-CCC---CCTTCCEEEECSCCCCC-CCC---CCTTCCEEECCSSCCS-CCCCC---CTTCCEEE
T ss_pred CCCCCEEEcCCCcCCc-CCC---CCCCCCEEECcCCcCCC-CCC---CCCCcCEEECCCCCCC-cCCCC---CCCCCEEE
Confidence 3577888888888875 554 56777788888777774 333 3445555555555554 23332 24444444
Q ss_pred ccCccCCCCCCc---ccccc--------------cccceeecccCcCCCCCCcccc----------------cCcccccc
Q 005102 143 LSQNFFNGSLPV---SIVQC--------------KRLKALDLSQNNFTGPLPNGFG----------------SGLVSLEK 189 (714)
Q Consensus 143 Ls~N~l~g~~p~---~~~~l--------------~~L~~L~l~~N~l~g~~p~~~~----------------~~l~~L~~ 189 (714)
|++|++++ +|. .+..+ ++|+.|+|++|++++ +|..+. ..+++|+.
T Consensus 148 Ls~N~l~~-l~~~~~~L~~L~L~~N~l~~l~~~~~~L~~L~Ls~N~l~~-l~~~~~~L~~L~L~~N~l~~l~~~~~~L~~ 225 (622)
T 3g06_A 148 VSDNQLAS-LPALPSELCKLWAYNNQLTSLPMLPSGLQELSVSDNQLAS-LPTLPSELYKLWAYNNRLTSLPALPSGLKE 225 (622)
T ss_dssp CCSSCCSC-CCCCCTTCCEEECCSSCCSCCCCCCTTCCEEECCSSCCSC-CCCCCTTCCEEECCSSCCSSCCCCCTTCCE
T ss_pred CcCCcCCC-cCCccCCCCEEECCCCCCCCCcccCCCCcEEECCCCCCCC-CCCccchhhEEECcCCcccccCCCCCCCCE
Confidence 44444442 221 11111 445555555555542 332110 01255667
Q ss_pred ccccCCcccccCCCCCCCCcccccccccccccCCcCcCccccCCCCcccccCcCCcCCCCCCCC
Q 005102 190 LNLSFNKFNGSIPSNTGNLSSLQGTVDFSHNLFSGSIPASLGNLPEKVYIDLTYNNLSGPIPQN 253 (714)
Q Consensus 190 L~l~~N~l~g~~p~~~~~l~~L~~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~~ 253 (714)
|+|++|+|++ +| ..+++|+ .|++++|+|+ .+|. .+++|+.|++++|+|+ .+|..
T Consensus 226 L~Ls~N~L~~-lp---~~l~~L~-~L~Ls~N~L~-~lp~---~~~~L~~L~Ls~N~L~-~lp~~ 279 (622)
T 3g06_A 226 LIVSGNRLTS-LP---VLPSELK-ELMVSGNRLT-SLPM---LPSGLLSLSVYRNQLT-RLPES 279 (622)
T ss_dssp EECCSSCCSC-CC---CCCTTCC-EEECCSSCCS-CCCC---CCTTCCEEECCSSCCC-SCCGG
T ss_pred EEccCCccCc-CC---CCCCcCc-EEECCCCCCC-cCCc---ccccCcEEeCCCCCCC-cCCHH
Confidence 7777777763 55 2345566 6777777776 3454 4566777777777777 33433
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.67 E-value=3.4e-18 Score=182.68 Aligned_cols=108 Identities=24% Similarity=0.282 Sum_probs=48.9
Q ss_pred EEEEEcCCCCccccCC----ccccCCC-CCCEEEccCCCCcccCChhhcCC-----CCCCEEEcCCCcCcccCCcccCC-
Q 005102 66 VVSVSIPKKKLLGFLP----SALGSLT-DLRHVNLRNNKFFGSLPLELLEA-----QGLQSLVLYGNSFSGSVPNEIGK- 134 (714)
Q Consensus 66 ~~~l~l~~~~l~g~~p----~~~~~l~-~L~~L~L~~N~l~~~~p~~~~~l-----~~L~~L~L~~N~l~g~~p~~~~~- 134 (714)
++.|+|++|.+++..+ ..|..++ +|++|+|++|.+++..+..+..+ ++|+.|+|++|.+++..+..++.
T Consensus 24 L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~ 103 (362)
T 3goz_A 24 VTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANVTSLNLSGNFLSYKSSDELVKT 103 (362)
T ss_dssp CCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHH
T ss_pred ceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCCccEEECcCCcCChHHHHHHHHH
Confidence 4455555555444443 4444444 45555555555544444444432 44555555555554433332222
Q ss_pred ---C-CCCCEEeccCccCCCCCCccccc-----ccccceeecccCcCC
Q 005102 135 ---L-KYLQILDLSQNFFNGSLPVSIVQ-----CKRLKALDLSQNNFT 173 (714)
Q Consensus 135 ---l-~~L~~L~Ls~N~l~g~~p~~~~~-----l~~L~~L~l~~N~l~ 173 (714)
+ ++|+.|+|++|++++..+..+.. .++|++|+|++|.++
T Consensus 104 l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~ 151 (362)
T 3goz_A 104 LAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLG 151 (362)
T ss_dssp HHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGG
T ss_pred HHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCC
Confidence 2 44555555555554333322221 134555555555544
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.67 E-value=2.4e-18 Score=183.86 Aligned_cols=179 Identities=18% Similarity=0.215 Sum_probs=125.7
Q ss_pred EEcCCCCccccCCccccCCCCCCEEEccCCCCcccCC----hhhcCCC-CCCEEEcCCCcCcccCCcccCCC-----CCC
Q 005102 69 VSIPKKKLLGFLPSALGSLTDLRHVNLRNNKFFGSLP----LELLEAQ-GLQSLVLYGNSFSGSVPNEIGKL-----KYL 138 (714)
Q Consensus 69 l~l~~~~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p----~~~~~l~-~L~~L~L~~N~l~g~~p~~~~~l-----~~L 138 (714)
.+|+.|+++|.+|..+...++|++|+|++|.+++..+ ..+..++ +|+.|+|++|.+++..+..++.+ ++|
T Consensus 3 ~~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L 82 (362)
T 3goz_A 3 YKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANV 82 (362)
T ss_dssp EECCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTC
T ss_pred cccccccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCCc
Confidence 5677788888887777777778888888888876665 5666777 78888888888887767666664 788
Q ss_pred CEEeccCccCCCCCCcccccc-----cccceeecccCcCCCCCCccccc---C-ccccccccccCCcccc----cCCCCC
Q 005102 139 QILDLSQNFFNGSLPVSIVQC-----KRLKALDLSQNNFTGPLPNGFGS---G-LVSLEKLNLSFNKFNG----SIPSNT 205 (714)
Q Consensus 139 ~~L~Ls~N~l~g~~p~~~~~l-----~~L~~L~l~~N~l~g~~p~~~~~---~-l~~L~~L~l~~N~l~g----~~p~~~ 205 (714)
+.|+|++|++++..+..+... ++|+.|+|++|++++..+..+.. . ..+|+.|+|++|++++ .++..+
T Consensus 83 ~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l 162 (362)
T 3goz_A 83 TSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQIL 162 (362)
T ss_dssp CEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCHHHHHHHH
T ss_pred cEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHHHHHHHHH
Confidence 888888888876666544443 77888888888887554443321 1 2478888888888874 333333
Q ss_pred CCCc-ccccccccccccCCcCcCcccc----CC-CCcccccCcCCcCCC
Q 005102 206 GNLS-SLQGTVDFSHNLFSGSIPASLG----NL-PEKVYIDLTYNNLSG 248 (714)
Q Consensus 206 ~~l~-~L~~~l~l~~N~l~g~~p~~~~----~l-~~L~~l~l~~N~l~~ 248 (714)
..+. +|+ .|++++|++++..+..++ .+ ++|+.||+++|++++
T Consensus 163 ~~~~~~L~-~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~i~~ 210 (362)
T 3goz_A 163 AAIPANVN-SLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGL 210 (362)
T ss_dssp HTSCTTCC-EEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGG
T ss_pred hcCCcccc-EeeecCCCCchhhHHHHHHHHHhCCCCCCEEECCCCCCCh
Confidence 4444 677 888888888766665443 34 478888888888775
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.67 E-value=1.3e-16 Score=150.45 Aligned_cols=107 Identities=25% Similarity=0.264 Sum_probs=60.4
Q ss_pred CCCCEEEccCCCCc-ccCChhhcCCCCCCEEEcCCCcCcccCCcccCCCCCCCEEeccCccCCCCCCcccccccccceee
Q 005102 88 TDLRHVNLRNNKFF-GSLPLELLEAQGLQSLVLYGNSFSGSVPNEIGKLKYLQILDLSQNFFNGSLPVSIVQCKRLKALD 166 (714)
Q Consensus 88 ~~L~~L~L~~N~l~-~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~ 166 (714)
++|++|+|++|.++ +.+|..+..+++|+.|+|++|.+++. ..++.+++|+.|+|++|++++.+|..+..+++|+.|+
T Consensus 24 ~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 101 (168)
T 2ell_A 24 AAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLN 101 (168)
T ss_dssp TSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEE
T ss_pred ccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEe
Confidence 55666666666665 55555555666666666666666543 5556666666666666666655555555566666666
Q ss_pred cccCcCCCCCC--cccccCccccccccccCCccc
Q 005102 167 LSQNNFTGPLP--NGFGSGLVSLEKLNLSFNKFN 198 (714)
Q Consensus 167 l~~N~l~g~~p--~~~~~~l~~L~~L~l~~N~l~ 198 (714)
|++|++++ +| ..+ ..+++|+.|++++|.++
T Consensus 102 Ls~N~l~~-~~~~~~l-~~l~~L~~L~l~~N~l~ 133 (168)
T 2ell_A 102 LSGNKLKD-ISTLEPL-KKLECLKSLDLFNCEVT 133 (168)
T ss_dssp CBSSSCCS-SGGGGGG-SSCSCCCEEECCSSGGG
T ss_pred ccCCccCc-chhHHHH-hcCCCCCEEEeeCCcCc
Confidence 66666653 22 222 23455555555555554
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.66 E-value=3.8e-16 Score=150.85 Aligned_cols=125 Identities=26% Similarity=0.316 Sum_probs=101.3
Q ss_pred EEcCCCCccccCCccccCCCCCCEEEccCCCCcccCChhhcCCCCCCEEEcCCCcCcccCCcccCCCCCCCEEeccCccC
Q 005102 69 VSIPKKKLLGFLPSALGSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSGSVPNEIGKLKYLQILDLSQNFF 148 (714)
Q Consensus 69 l~l~~~~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l 148 (714)
+++++|+++ .+|..+. ++|++|+|++|+|+ .+|..|..+++|+.|+|++|.|++..+..|.++++|+.|+|++|+|
T Consensus 15 l~~~~~~l~-~ip~~~~--~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~l 90 (193)
T 2wfh_A 15 VRCSNKGLK-VLPKGIP--RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRL 90 (193)
T ss_dssp EECTTSCCS-SCCSCCC--TTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCC
T ss_pred EEcCCCCCC-cCCCCCC--CCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCCcc
Confidence 334456665 4565543 58999999999998 7788899999999999999999977778899999999999999999
Q ss_pred CCCCCcccccccccceeecccCcCCCCCCcccccCccccccccccCCccc
Q 005102 149 NGSLPVSIVQCKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLNLSFNKFN 198 (714)
Q Consensus 149 ~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~l~~L~~L~l~~N~l~ 198 (714)
++..|..|..+++|+.|+|++|+|+ .+|...+..+++|+.|+|++|.+.
T Consensus 91 ~~i~~~~f~~l~~L~~L~L~~N~l~-~~~~~~~~~l~~L~~L~L~~N~~~ 139 (193)
T 2wfh_A 91 RCIPPRTFDGLKSLRLLSLHGNDIS-VVPEGAFNDLSALSHLAIGANPLY 139 (193)
T ss_dssp CBCCTTTTTTCTTCCEEECCSSCCC-BCCTTTTTTCTTCCEEECCSSCEE
T ss_pred CEeCHHHhCCCCCCCEEECCCCCCC-eeChhhhhcCccccEEEeCCCCee
Confidence 9777778888999999999999988 455554456788888888888876
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.66 E-value=1.1e-16 Score=150.85 Aligned_cols=137 Identities=22% Similarity=0.168 Sum_probs=120.5
Q ss_pred CcEEEEEcCCCCcc-ccCCccccCCCCCCEEEccCCCCcccCChhhcCCCCCCEEEcCCCcCcccCCcccCCCCCCCEEe
Q 005102 64 QRVVSVSIPKKKLL-GFLPSALGSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSGSVPNEIGKLKYLQILD 142 (714)
Q Consensus 64 ~~~~~l~l~~~~l~-g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ 142 (714)
.+++.|+|++|+++ +.+|..+..+++|++|+|++|.+++. ..+..+++|++|+|++|++++.+|..+..+++|+.|+
T Consensus 24 ~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 101 (168)
T 2ell_A 24 AAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLN 101 (168)
T ss_dssp TSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEE
T ss_pred ccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEe
Confidence 57899999999998 88999999999999999999999965 7789999999999999999988888888899999999
Q ss_pred ccCccCCCCC-CcccccccccceeecccCcCCCCCCc---ccccCccccccccccCCcccccCCCC
Q 005102 143 LSQNFFNGSL-PVSIVQCKRLKALDLSQNNFTGPLPN---GFGSGLVSLEKLNLSFNKFNGSIPSN 204 (714)
Q Consensus 143 Ls~N~l~g~~-p~~~~~l~~L~~L~l~~N~l~g~~p~---~~~~~l~~L~~L~l~~N~l~g~~p~~ 204 (714)
|++|++++.. +..+..+++|+.|+|++|.+++ +|. ..+..+++|+.|++++|.+. .+|.+
T Consensus 102 Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~-~~~~~~~~~~~l~~L~~L~l~~n~~~-~~~~~ 165 (168)
T 2ell_A 102 LSGNKLKDISTLEPLKKLECLKSLDLFNCEVTN-LNDYRESVFKLLPQLTYLDGYDREDQ-EAPDS 165 (168)
T ss_dssp CBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGT-STTHHHHHHTTCSSCCEETTEETTSC-BCCSS
T ss_pred ccCCccCcchhHHHHhcCCCCCEEEeeCCcCcc-hHHHHHHHHHhCccCcEecCCCCChh-hcccc
Confidence 9999998532 2789999999999999999995 454 23356999999999999987 66654
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.64 E-value=2.9e-16 Score=165.39 Aligned_cols=134 Identities=11% Similarity=0.097 Sum_probs=98.8
Q ss_pred cccccccCceEEEEEEECCCcEEEEEEeCCCCc--------------hhH--------HHHHHHHHHHhccCCCCccceE
Q 005102 408 AFVLGKSGIGIVYKVVLEDGHTLAVRRLGEGGS--------------QRF--------KEFQTEVEAIGKIRHSNIVTLR 465 (714)
Q Consensus 408 ~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~--------------~~~--------~~~~~E~~~l~~l~H~niv~l~ 465 (714)
...||+|+||.||+|...+|+.||||+++.... ... ....+|...|.++.+.++....
T Consensus 100 ~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv~vp~ 179 (397)
T 4gyi_A 100 GSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGFPVPE 179 (397)
T ss_dssp EEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTCSCCC
T ss_pred cCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCCCCCe
Confidence 457999999999999999999999998764210 000 1134677778888655543222
Q ss_pred EEEEeCCceeEEEeccCCCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCC
Q 005102 466 AYYWSVDEKLLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNM 545 (714)
Q Consensus 466 ~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~ 545 (714)
-+.. ...++||||+++++|.++... .....++.|++.+|.|||. .+||||||||.|||+++++
T Consensus 180 p~~~--~~~~LVME~i~G~~L~~l~~~------------~~~~~l~~qll~~l~~lH~---~gIVHrDLKp~NILl~~dg 242 (397)
T 4gyi_A 180 PIAQ--SRHTIVMSLVDALPMRQVSSV------------PDPASLYADLIALILRLAK---HGLIHGDFNEFNILIREEK 242 (397)
T ss_dssp EEEE--ETTEEEEECCSCEEGGGCCCC------------SCHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEEEEEE
T ss_pred eeec--cCceEEEEecCCccHhhhccc------------HHHHHHHHHHHHHHHHHHH---CCCcCCCCCHHHEEEeCCC
Confidence 2221 234799999999888765421 1245688999999999999 8999999999999998776
Q ss_pred ----------CeEEcccchhhhh
Q 005102 546 ----------EPHVSDFGLARLA 558 (714)
Q Consensus 546 ----------~~kl~DFGla~~~ 558 (714)
.+.|+||+-+...
T Consensus 243 d~~d~~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 243 DAEDPSSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp CSSCTTSEEEEEEECCCTTCEET
T ss_pred CcccccccccceEEEEeCCcccC
Confidence 3889999977543
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.63 E-value=9.3e-16 Score=155.82 Aligned_cols=148 Identities=19% Similarity=0.241 Sum_probs=128.4
Q ss_pred CCcEEEEEcCCCCccccCCccccCCCCCCEEEccCCCCcccCChhhcCCCCCCEEEcCCCcCcccCCcccCCCCCCCEEe
Q 005102 63 EQRVVSVSIPKKKLLGFLPSALGSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSGSVPNEIGKLKYLQILD 142 (714)
Q Consensus 63 ~~~~~~l~l~~~~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ 142 (714)
..+++.|++++|+++. +| .+..+++|++|+|++|++++..+ +..+++|+.|+|++|++++ +|... . ++|+.|+
T Consensus 40 l~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~L~~N~i~~~~~--l~~l~~L~~L~L~~N~l~~-l~~~~-~-~~L~~L~ 112 (263)
T 1xeu_A 40 LSGVQNFNGDNSNIQS-LA-GMQFFTNLKELHLSHNQISDLSP--LKDLTKLEELSVNRNRLKN-LNGIP-S-ACLSRLF 112 (263)
T ss_dssp HTTCSEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCSSCCEEECCSSCCSC-CTTCC-C-SSCCEEE
T ss_pred cCcCcEEECcCCCccc-ch-HHhhCCCCCEEECCCCccCCChh--hccCCCCCEEECCCCccCC-cCccc-c-CcccEEE
Confidence 3578899999999985 45 79999999999999999996544 8999999999999999985 55433 3 9999999
Q ss_pred ccCccCCCCCCcccccccccceeecccCcCCCCCCcccccCccccccccccCCcccccCCCCCCCCcccccccccccccC
Q 005102 143 LSQNFFNGSLPVSIVQCKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLNLSFNKFNGSIPSNTGNLSSLQGTVDFSHNLF 222 (714)
Q Consensus 143 Ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~~l~l~~N~l 222 (714)
|++|++++ +| .+..+++|+.|+|++|++++ +| .+ ..+++|+.|+|++|++++. ..+..+++|+ .|++++|.+
T Consensus 113 L~~N~l~~-~~-~l~~l~~L~~L~Ls~N~i~~-~~-~l-~~l~~L~~L~L~~N~i~~~--~~l~~l~~L~-~L~l~~N~~ 184 (263)
T 1xeu_A 113 LDNNELRD-TD-SLIHLKNLEILSIRNNKLKS-IV-ML-GFLSKLEVLDLHGNEITNT--GGLTRLKKVN-WIDLTGQKC 184 (263)
T ss_dssp CCSSCCSB-SG-GGTTCTTCCEEECTTSCCCB-CG-GG-GGCTTCCEEECTTSCCCBC--TTSTTCCCCC-EEEEEEEEE
T ss_pred ccCCccCC-Ch-hhcCcccccEEECCCCcCCC-Ch-HH-ccCCCCCEEECCCCcCcch--HHhccCCCCC-EEeCCCCcc
Confidence 99999985 44 68999999999999999985 55 44 4699999999999999965 6788999999 999999999
Q ss_pred CcC
Q 005102 223 SGS 225 (714)
Q Consensus 223 ~g~ 225 (714)
++.
T Consensus 185 ~~~ 187 (263)
T 1xeu_A 185 VNE 187 (263)
T ss_dssp ECC
T ss_pred cCC
Confidence 865
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.62 E-value=1.4e-15 Score=146.72 Aligned_cols=127 Identities=29% Similarity=0.333 Sum_probs=74.2
Q ss_pred CEEEccCCCCcccCChhhcCCCCCCEEEcCCCcCcccCCcccCCCCCCCEEeccCccCCCCCCcccccccccceeecccC
Q 005102 91 RHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSGSVPNEIGKLKYLQILDLSQNFFNGSLPVSIVQCKRLKALDLSQN 170 (714)
Q Consensus 91 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~N 170 (714)
+.+++++|.++ .+|..+. ++|+.|+|++|.|+ .+|..|.++++|+.|+|++|+|++..|..|.++++|+.|+|++|
T Consensus 13 ~~l~~~~~~l~-~ip~~~~--~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N 88 (193)
T 2wfh_A 13 TVVRCSNKGLK-VLPKGIP--RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYN 88 (193)
T ss_dssp TEEECTTSCCS-SCCSCCC--TTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CEEEcCCCCCC-cCCCCCC--CCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCC
Confidence 46677777776 4554432 46666777776666 56666666666666666666666555555666666666666666
Q ss_pred cCCCCCCcccccCccccccccccCCcccccCCCCCCCCcccccccccccccCC
Q 005102 171 NFTGPLPNGFGSGLVSLEKLNLSFNKFNGSIPSNTGNLSSLQGTVDFSHNLFS 223 (714)
Q Consensus 171 ~l~g~~p~~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~~l~l~~N~l~ 223 (714)
+|++..|..+ .++++|+.|+|++|+|++..+..+..+++|+ .+++++|++.
T Consensus 89 ~l~~i~~~~f-~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~-~L~L~~N~~~ 139 (193)
T 2wfh_A 89 RLRCIPPRTF-DGLKSLRLLSLHGNDISVVPEGAFNDLSALS-HLAIGANPLY 139 (193)
T ss_dssp CCCBCCTTTT-TTCTTCCEEECCSSCCCBCCTTTTTTCTTCC-EEECCSSCEE
T ss_pred ccCEeCHHHh-CCCCCCCEEECCCCCCCeeChhhhhcCcccc-EEEeCCCCee
Confidence 6664333333 3455666666666665533333444455555 5555555444
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.62 E-value=2.2e-16 Score=145.75 Aligned_cols=108 Identities=26% Similarity=0.298 Sum_probs=66.3
Q ss_pred CCCCEEEccCCCCc-ccCChhhcCCCCCCEEEcCCCcCcccCCcccCCCCCCCEEeccCccCCCCCCcccccccccceee
Q 005102 88 TDLRHVNLRNNKFF-GSLPLELLEAQGLQSLVLYGNSFSGSVPNEIGKLKYLQILDLSQNFFNGSLPVSIVQCKRLKALD 166 (714)
Q Consensus 88 ~~L~~L~L~~N~l~-~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~ 166 (714)
++|+.|++++|.++ +.+|..+..+++|+.|+|++|.+++. ..++.+++|+.|+|++|++++.+|..+..+++|++|+
T Consensus 17 ~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~ 94 (149)
T 2je0_A 17 SDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLN 94 (149)
T ss_dssp GGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEE
T ss_pred ccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEE
Confidence 56677777777776 56666666666777777777766644 5566666666666666666655666555666666666
Q ss_pred cccCcCCCC-CCcccccCccccccccccCCccc
Q 005102 167 LSQNNFTGP-LPNGFGSGLVSLEKLNLSFNKFN 198 (714)
Q Consensus 167 l~~N~l~g~-~p~~~~~~l~~L~~L~l~~N~l~ 198 (714)
+++|.+++. .|..+ ..+++|+.|++++|+++
T Consensus 95 ls~N~i~~~~~~~~~-~~l~~L~~L~l~~N~l~ 126 (149)
T 2je0_A 95 LSGNKIKDLSTIEPL-KKLENLKSLDLFNCEVT 126 (149)
T ss_dssp CTTSCCCSHHHHGGG-GGCTTCCEEECTTCGGG
T ss_pred CCCCcCCChHHHHHH-hhCCCCCEEeCcCCccc
Confidence 666666531 12333 23555555555555554
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.62 E-value=2.4e-15 Score=159.67 Aligned_cols=206 Identities=15% Similarity=0.011 Sum_probs=154.1
Q ss_pred eEecCCcEEEEEcCCCCccccCCccccCCCCCCEEEccCCCCcccCChhhcCCCCCCEEEcCCCcCcccCCc-ccCCCCC
Q 005102 59 ITCKEQRVVSVSIPKKKLLGFLPSALGSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSGSVPN-EIGKLKY 137 (714)
Q Consensus 59 v~c~~~~~~~l~l~~~~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~-~~~~l~~ 137 (714)
.+|+.. .++-++++|+ .+|..+ .++|++|+|++|+|+...+..|.++++|++|+|++|++.+.+|. .|.++++
T Consensus 7 C~C~~~---~v~C~~~~Lt-~iP~~l--~~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~ 80 (350)
T 4ay9_X 7 CHCSNR---VFLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPK 80 (350)
T ss_dssp SEEETT---EEEEESTTCC-SCCTTC--CTTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTT
T ss_pred cEeeCC---EEEecCCCCC-ccCcCc--CCCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchh
Confidence 567642 4677889988 467766 36899999999999966666799999999999999999877775 5789988
Q ss_pred CCE-EeccCccCCCCCCcccccccccceeecccCcCCCCCCcccccCccccccccccC-CcccccCCCCCCCCcc-cccc
Q 005102 138 LQI-LDLSQNFFNGSLPVSIVQCKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLNLSF-NKFNGSIPSNTGNLSS-LQGT 214 (714)
Q Consensus 138 L~~-L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~l~~L~~L~l~~-N~l~g~~p~~~~~l~~-L~~~ 214 (714)
|+. ++++.|+++...|..|..+++|+.|++++|++++ +|...+....++..|++.+ |++....+..+..+.. ++ .
T Consensus 81 l~~~l~~~~N~l~~l~~~~f~~l~~L~~L~l~~n~l~~-~~~~~~~~~~~l~~l~l~~~~~i~~l~~~~f~~~~~~l~-~ 158 (350)
T 4ay9_X 81 LHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKH-LPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESV-I 158 (350)
T ss_dssp CCEEEEEEETTCCEECTTSBCCCTTCCEEEEEEECCSS-CCCCTTCCBSSCEEEEEESCTTCCEECTTSSTTSBSSCE-E
T ss_pred hhhhhcccCCcccccCchhhhhcccccccccccccccc-CCchhhcccchhhhhhhccccccccccccchhhcchhhh-h
Confidence 775 6777899997778889999999999999999985 4443334466788888866 5676444456777664 55 8
Q ss_pred cccccccCCcCcCccccCCCCcccccCcC-CcCCCCCCCCccccCCCCcccccCCCCCCC
Q 005102 215 VDFSHNLFSGSIPASLGNLPEKVYIDLTY-NNLSGPIPQNGALMNRGPTAFIGNPRLCGP 273 (714)
Q Consensus 215 l~l~~N~l~g~~p~~~~~l~~L~~l~l~~-N~l~~~~p~~~~~~~~~~~~~~~n~~~~~~ 273 (714)
|++++|+|+ .+|.......+|+.|++++ |+++...+..+............++.+..-
T Consensus 159 L~L~~N~i~-~i~~~~f~~~~L~~l~l~~~n~l~~i~~~~f~~l~~L~~LdLs~N~l~~l 217 (350)
T 4ay9_X 159 LWLNKNGIQ-EIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSL 217 (350)
T ss_dssp EECCSSCCC-EECTTSSTTEEEEEEECTTCTTCCCCCTTTTTTEECCSEEECTTSCCCCC
T ss_pred hcccccccc-CCChhhccccchhHHhhccCCcccCCCHHHhccCcccchhhcCCCCcCcc
Confidence 999999999 4555555677899999986 566655555555444444445555555433
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.62 E-value=2.7e-16 Score=145.14 Aligned_cols=126 Identities=22% Similarity=0.242 Sum_probs=59.5
Q ss_pred CCCEEEcCCCcCc-ccCCcccCCCCCCCEEeccCccCCCCCCcccccccccceeecccCcCCCCCCcccccCcccccccc
Q 005102 113 GLQSLVLYGNSFS-GSVPNEIGKLKYLQILDLSQNFFNGSLPVSIVQCKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLN 191 (714)
Q Consensus 113 ~L~~L~L~~N~l~-g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~l~~L~~L~ 191 (714)
+|+.|++++|.++ +.+|..+..+++|+.|+|++|++++. ..+..+++|+.|+|++|.+++.+|..+ ..+++|+.|+
T Consensus 18 ~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~-~~l~~L~~L~ 94 (149)
T 2je0_A 18 DVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLA-EKCPNLTHLN 94 (149)
T ss_dssp GCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHH-HHCTTCCEEE
T ss_pred cCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHh-hhCCCCCEEE
Confidence 4455555555554 44444445555555555555555432 344445555555555555544344333 2244555555
Q ss_pred ccCCccccc-CCCCCCCCcccccccccccccCCcCcC---ccccCCCCcccccCc
Q 005102 192 LSFNKFNGS-IPSNTGNLSSLQGTVDFSHNLFSGSIP---ASLGNLPEKVYIDLT 242 (714)
Q Consensus 192 l~~N~l~g~-~p~~~~~l~~L~~~l~l~~N~l~g~~p---~~~~~l~~L~~l~l~ 242 (714)
+++|++++. .|..+.++++|+ .|++++|.+++..+ ..++.+++|+.||++
T Consensus 95 ls~N~i~~~~~~~~~~~l~~L~-~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~ 148 (149)
T 2je0_A 95 LSGNKIKDLSTIEPLKKLENLK-SLDLFNCEVTNLNDYRENVFKLLPQLTYLDGY 148 (149)
T ss_dssp CTTSCCCSHHHHGGGGGCTTCC-EEECTTCGGGGSTTHHHHHHHHCTTCCEETTB
T ss_pred CCCCcCCChHHHHHHhhCCCCC-EEeCcCCcccchHHHHHHHHHHCCCcccccCC
Confidence 555555431 224444445554 55555555544333 344445555555443
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.61 E-value=1.8e-15 Score=143.89 Aligned_cols=131 Identities=24% Similarity=0.251 Sum_probs=79.4
Q ss_pred CCEEEccCCCCcccCChhhcCCCCCCEEEcCCCcCcccCCcccCCCCCCCEEeccCccCCCCCCcccccccccceeeccc
Q 005102 90 LRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSGSVPNEIGKLKYLQILDLSQNFFNGSLPVSIVQCKRLKALDLSQ 169 (714)
Q Consensus 90 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~ 169 (714)
.+.+++++|.++ .+|..+. ++|+.|+|++|.+++..+..|+.+++|+.|+|++|++++..+..|..+++|+.|+|++
T Consensus 9 ~~~l~~~~~~l~-~~p~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~ 85 (177)
T 2o6r_A 9 GTEIRCNSKGLT-SVPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHE 85 (177)
T ss_dssp TTEEECCSSCCS-SCCTTCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CCEEEecCCCCc-cCCCCCC--CCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCC
Confidence 466777777776 4454332 5677777777777755555567777777777777777654445566677777777777
Q ss_pred CcCCCCCCcccccCccccccccccCCcccccCCCCCCCCcccccccccccccCCcC
Q 005102 170 NNFTGPLPNGFGSGLVSLEKLNLSFNKFNGSIPSNTGNLSSLQGTVDFSHNLFSGS 225 (714)
Q Consensus 170 N~l~g~~p~~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~~l~l~~N~l~g~ 225 (714)
|++++ +|...+..+++|+.|+|++|+|++..+..+..+++|+ .+++++|++++.
T Consensus 86 N~l~~-~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~-~L~l~~N~~~~~ 139 (177)
T 2o6r_A 86 NKLQS-LPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQ-KIWLHTNPWDCS 139 (177)
T ss_dssp SCCCC-CCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCC-EEECCSSCBCCC
T ss_pred CCccc-cCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccC-EEEecCCCeecc
Confidence 77763 3333323466666666666666633333344555555 555555555543
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.58 E-value=1e-16 Score=180.48 Aligned_cols=158 Identities=21% Similarity=0.240 Sum_probs=131.7
Q ss_pred ccccCCccccCCCCCCEEE-ccCCCCcccCCh------hhcC--CCCCCEEEcCCCcCcccCCcccCCCCCCCEEeccCc
Q 005102 76 LLGFLPSALGSLTDLRHVN-LRNNKFFGSLPL------ELLE--AQGLQSLVLYGNSFSGSVPNEIGKLKYLQILDLSQN 146 (714)
Q Consensus 76 l~g~~p~~~~~l~~L~~L~-L~~N~l~~~~p~------~~~~--l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N 146 (714)
+.+.+|..+++|++|+.|+ ++.|.+.. ++. .+.. ...|+.|+|++|.|++ +|. |+.+++|+.|+|++|
T Consensus 397 ~~~~~~~~l~~l~~L~~L~~l~~n~~~~-L~~l~l~~n~i~~l~~~~L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N 473 (567)
T 1dce_A 397 PLLYEKETLQYFSTLKAVDPMRAAYLDD-LRSKFLLENSVLKMEYADVRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHN 473 (567)
T ss_dssp TGGGHHHHHHHHHHHHHHCGGGHHHHHH-HHHHHHHHHHHHHHHHTTCSEEECTTSCCSS-CCC-GGGGTTCCEEECCSS
T ss_pred cccCCHHHHHHHHhcccCcchhhcccch-hhhhhhhcccccccCccCceEEEecCCCCCC-CcC-ccccccCcEeecCcc
Confidence 6788888999999999998 66665431 111 1111 1359999999999995 776 999999999999999
Q ss_pred cCCCCCCcccccccccceeecccCcCCCCCCcccccCccccccccccCCcccccC-CCCCCCCcccccccccccccCCcC
Q 005102 147 FFNGSLPVSIVQCKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLNLSFNKFNGSI-PSNTGNLSSLQGTVDFSHNLFSGS 225 (714)
Q Consensus 147 ~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~l~~L~~L~l~~N~l~g~~-p~~~~~l~~L~~~l~l~~N~l~g~ 225 (714)
+|+ .+|..|..+++|+.|+|++|+|++ +| .+ ..+++|+.|+|++|+|++.+ |..++++++|+ .|+|++|+|++.
T Consensus 474 ~l~-~lp~~~~~l~~L~~L~Ls~N~l~~-lp-~l-~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~-~L~L~~N~l~~~ 548 (567)
T 1dce_A 474 RLR-ALPPALAALRCLEVLQASDNALEN-VD-GV-ANLPRLQELLLCNNRLQQSAAIQPLVSCPRLV-LLNLQGNSLCQE 548 (567)
T ss_dssp CCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GG-TTCSSCCEEECCSSCCCSSSTTGGGGGCTTCC-EEECTTSGGGGS
T ss_pred ccc-ccchhhhcCCCCCEEECCCCCCCC-Cc-cc-CCCCCCcEEECCCCCCCCCCCcHHHhcCCCCC-EEEecCCcCCCC
Confidence 999 899999999999999999999996 78 66 46999999999999999877 99999999999 999999999987
Q ss_pred cCcc---ccCCCCcccccC
Q 005102 226 IPAS---LGNLPEKVYIDL 241 (714)
Q Consensus 226 ~p~~---~~~l~~L~~l~l 241 (714)
.|.. +..+++|+.||+
T Consensus 549 ~~~~~~l~~~lp~L~~L~l 567 (567)
T 1dce_A 549 EGIQERLAEMLPSVSSILT 567 (567)
T ss_dssp SSCTTHHHHHCTTCSEEEC
T ss_pred ccHHHHHHHHCcccCccCC
Confidence 6632 345888888864
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.56 E-value=1.5e-17 Score=161.47 Aligned_cols=155 Identities=19% Similarity=0.258 Sum_probs=103.2
Q ss_pred ccCCCCCCEEEccCCCCcccCCh------hhcCCCCCCEEEcCCCcCcccCCcccCCCCCCCEEeccCccCCCCCCcccc
Q 005102 84 LGSLTDLRHVNLRNNKFFGSLPL------ELLEAQGLQSLVLYGNSFSGSVPNEIGKLKYLQILDLSQNFFNGSLPVSIV 157 (714)
Q Consensus 84 ~~~l~~L~~L~L~~N~l~~~~p~------~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~ 157 (714)
+.....++.++++.|.++|.+|. .+..+++|+.|+|++|.+++ +| .+..+++|+.|+|++|+++ .+|..+.
T Consensus 14 ~~~~~~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~ 90 (198)
T 1ds9_A 14 FEERKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDA 90 (198)
T ss_dssp HHHTTCCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHH
T ss_pred HHhcccccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhh
Confidence 34445566666666666666555 67777777777777777764 55 6677777777777777776 5666666
Q ss_pred cccccceeecccCcCCCCCCcccccCccccccccccCCcccccCC-CCCCCCcccccccccccccCCcCcCcc-------
Q 005102 158 QCKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLNLSFNKFNGSIP-SNTGNLSSLQGTVDFSHNLFSGSIPAS------- 229 (714)
Q Consensus 158 ~l~~L~~L~l~~N~l~g~~p~~~~~~l~~L~~L~l~~N~l~g~~p-~~~~~l~~L~~~l~l~~N~l~g~~p~~------- 229 (714)
.+++|+.|+|++|++++ +| .+ ..+++|+.|+|++|++++..+ ..+..+++|+ .+++++|++++.+|..
T Consensus 91 ~~~~L~~L~L~~N~l~~-l~-~~-~~l~~L~~L~l~~N~i~~~~~~~~l~~l~~L~-~L~l~~N~l~~~~~~~~~~~~~~ 166 (198)
T 1ds9_A 91 VADTLEELWISYNQIAS-LS-GI-EKLVNLRVLYMSNNKITNWGEIDKLAALDKLE-DLLLAGNPLYNDYKENNATSEYR 166 (198)
T ss_dssp HHHHCSEEEEEEEECCC-HH-HH-HHHHHSSEEEESEEECCCHHHHHHHTTTTTCS-EEEECSCHHHHHHHTTTTHHHHH
T ss_pred cCCcCCEEECcCCcCCc-CC-cc-ccCCCCCEEECCCCcCCchhHHHHHhcCCCCC-EEEecCCccccccccccchHHHH
Confidence 66777777777777764 44 34 346777777777777763221 3566677777 7777777777665543
Q ss_pred ---ccCCCCcccccCcCCcCC
Q 005102 230 ---LGNLPEKVYIDLTYNNLS 247 (714)
Q Consensus 230 ---~~~l~~L~~l~l~~N~l~ 247 (714)
+..+++|+.|| +|.++
T Consensus 167 ~~~~~~l~~L~~Ld--~~~i~ 185 (198)
T 1ds9_A 167 IEVVKRLPNLKKLD--GMPVD 185 (198)
T ss_dssp HHHHHHCSSCSEEC--CGGGT
T ss_pred HHHHHhCCCcEEEC--CcccC
Confidence 67788888776 55554
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.55 E-value=5.6e-15 Score=140.41 Aligned_cols=132 Identities=17% Similarity=0.115 Sum_probs=87.2
Q ss_pred cccCCCCCCEEEccCCCCcccCChhhcCCC-CCCEEEcCCCcCcccCCcccCCCCCCCEEeccCccCCCCCCcccccccc
Q 005102 83 ALGSLTDLRHVNLRNNKFFGSLPLELLEAQ-GLQSLVLYGNSFSGSVPNEIGKLKYLQILDLSQNFFNGSLPVSIVQCKR 161 (714)
Q Consensus 83 ~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~-~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~ 161 (714)
.+.++++|++|+|++|+++. +|. +..+. +|+.|+|++|.+++. ..++.+++|+.|+|++|+|++..|..+..+++
T Consensus 14 ~~~~~~~L~~L~l~~n~l~~-i~~-~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~ 89 (176)
T 1a9n_A 14 QYTNAVRDRELDLRGYKIPV-IEN-LGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPD 89 (176)
T ss_dssp EEECTTSCEEEECTTSCCCS-CCC-GGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTT
T ss_pred hcCCcCCceEEEeeCCCCch-hHH-hhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCC
Confidence 45667788888888888873 444 44444 788888888888754 56777888888888888887443344477788
Q ss_pred cceeecccCcCCCCCCc--ccccCccccccccccCCcccccCCCC----CCCCcccccccccccccC
Q 005102 162 LKALDLSQNNFTGPLPN--GFGSGLVSLEKLNLSFNKFNGSIPSN----TGNLSSLQGTVDFSHNLF 222 (714)
Q Consensus 162 L~~L~l~~N~l~g~~p~--~~~~~l~~L~~L~l~~N~l~g~~p~~----~~~l~~L~~~l~l~~N~l 222 (714)
|+.|+|++|+++ .+|. .+ ..+++|+.|++++|.++ .+|.. +..+++|+ .+|+++|.+
T Consensus 90 L~~L~L~~N~i~-~~~~~~~l-~~l~~L~~L~l~~N~i~-~~~~~~~~~~~~l~~L~-~Ld~~~n~~ 152 (176)
T 1a9n_A 90 LTELILTNNSLV-ELGDLDPL-ASLKSLTYLCILRNPVT-NKKHYRLYVIYKVPQVR-VLDFQKVKL 152 (176)
T ss_dssp CCEEECCSCCCC-CGGGGGGG-GGCTTCCEEECCSSGGG-GSTTHHHHHHHHCTTCS-EETTEECCH
T ss_pred CCEEECCCCcCC-cchhhHhh-hcCCCCCEEEecCCCCC-CcHhHHHHHHHHCCccc-eeCCCcCCH
Confidence 888888888875 5665 34 34667777777777766 44442 44444444 444444443
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=99.54 E-value=7.2e-17 Score=178.20 Aligned_cols=184 Identities=16% Similarity=0.062 Sum_probs=123.6
Q ss_pred CcEEEEEcCCCCccccCCcccc-----CCCCCCEEEccCCCCccc----CChhhcCCCCCCEEEcCCCcCcccC-----C
Q 005102 64 QRVVSVSIPKKKLLGFLPSALG-----SLTDLRHVNLRNNKFFGS----LPLELLEAQGLQSLVLYGNSFSGSV-----P 129 (714)
Q Consensus 64 ~~~~~l~l~~~~l~g~~p~~~~-----~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~g~~-----p 129 (714)
.+++.|+|++|.+++..+..+. .+++|++|+|++|.+++. ++..+..+++|+.|+|++|.+++.- +
T Consensus 170 ~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~ 249 (461)
T 1z7x_W 170 PDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCP 249 (461)
T ss_dssp TTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHH
T ss_pred CCCCEEECcCCCcchHHHHHHHHHHhcCCCCceEEEccCCCCcHHHHHHHHHHHHhCCCccEEeccCCcCChHHHHHHHH
Confidence 5788888888887765444443 356888888888888753 5666777788888888888876532 2
Q ss_pred cccCCCCCCCEEeccCccCCCC----CCcccccccccceeecccCcCCCCCCcccc----cCccccccccccCCccccc-
Q 005102 130 NEIGKLKYLQILDLSQNFFNGS----LPVSIVQCKRLKALDLSQNNFTGPLPNGFG----SGLVSLEKLNLSFNKFNGS- 200 (714)
Q Consensus 130 ~~~~~l~~L~~L~Ls~N~l~g~----~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~----~~l~~L~~L~l~~N~l~g~- 200 (714)
..+..+++|+.|+|++|+++.. ++..+..+++|++|+|++|.+++..+..+. ...++|+.|+|++|.+++.
T Consensus 250 ~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~ 329 (461)
T 1z7x_W 250 GLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAAC 329 (461)
T ss_dssp HHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGG
T ss_pred HHhcCCCCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECCCCCCchHHHHHHHHHhccCCccceeeEcCCCCCchHH
Confidence 2233577888888888888753 566667778888888888877543222222 1225777777777777754
Q ss_pred ---CCCCCCCCcccccccccccccCCcCcCccccC-----CCCcccccCcCCcCCC
Q 005102 201 ---IPSNTGNLSSLQGTVDFSHNLFSGSIPASLGN-----LPEKVYIDLTYNNLSG 248 (714)
Q Consensus 201 ---~p~~~~~l~~L~~~l~l~~N~l~g~~p~~~~~-----l~~L~~l~l~~N~l~~ 248 (714)
+|..+..+++|+ .|++++|.+++..+..+.. .++|+.|++++|++++
T Consensus 330 ~~~l~~~l~~~~~L~-~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~ 384 (461)
T 1z7x_W 330 CSHFSSVLAQNRFLL-ELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSD 384 (461)
T ss_dssp HHHHHHHHHHCSSCC-EEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCH
T ss_pred HHHHHHHHhhCCCcc-EEEccCCccccccHHHHHHHHcCCCCceEEEECCCCCCCh
Confidence 455555667777 7777777776554444432 5677777777777764
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.53 E-value=3.8e-15 Score=141.55 Aligned_cols=134 Identities=20% Similarity=0.237 Sum_probs=115.2
Q ss_pred hhhcCCCCCCEEEcCCCcCcccCCcccCCCC-CCCEEeccCccCCCCCCcccccccccceeecccCcCCCCCCcccccCc
Q 005102 106 LELLEAQGLQSLVLYGNSFSGSVPNEIGKLK-YLQILDLSQNFFNGSLPVSIVQCKRLKALDLSQNNFTGPLPNGFGSGL 184 (714)
Q Consensus 106 ~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~-~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~l 184 (714)
..+.++.+|+.|+|++|.++ .+|. +..+. +|+.|+|++|++++. ..+..+++|+.|+|++|+++ .+|..++..+
T Consensus 13 ~~~~~~~~L~~L~l~~n~l~-~i~~-~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~-~~~~~~~~~l 87 (176)
T 1a9n_A 13 AQYTNAVRDRELDLRGYKIP-VIEN-LGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRIC-RIGEGLDQAL 87 (176)
T ss_dssp CEEECTTSCEEEECTTSCCC-SCCC-GGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCC-EECSCHHHHC
T ss_pred HhcCCcCCceEEEeeCCCCc-hhHH-hhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCccc-ccCcchhhcC
Confidence 34667889999999999999 5565 55554 999999999999964 68899999999999999998 5666554569
Q ss_pred cccccccccCCcccccCCC--CCCCCcccccccccccccCCcCcCcc----ccCCCCcccccCcCCcCC
Q 005102 185 VSLEKLNLSFNKFNGSIPS--NTGNLSSLQGTVDFSHNLFSGSIPAS----LGNLPEKVYIDLTYNNLS 247 (714)
Q Consensus 185 ~~L~~L~l~~N~l~g~~p~--~~~~l~~L~~~l~l~~N~l~g~~p~~----~~~l~~L~~l~l~~N~l~ 247 (714)
++|+.|+|++|+++ .+|. .+..+++|+ .+++++|+++ .+|.. +..+++|+.||++.|.+.
T Consensus 88 ~~L~~L~L~~N~i~-~~~~~~~l~~l~~L~-~L~l~~N~i~-~~~~~~~~~~~~l~~L~~Ld~~~n~~~ 153 (176)
T 1a9n_A 88 PDLTELILTNNSLV-ELGDLDPLASLKSLT-YLCILRNPVT-NKKHYRLYVIYKVPQVRVLDFQKVKLK 153 (176)
T ss_dssp TTCCEEECCSCCCC-CGGGGGGGGGCTTCC-EEECCSSGGG-GSTTHHHHHHHHCTTCSEETTEECCHH
T ss_pred CCCCEEECCCCcCC-cchhhHhhhcCCCCC-EEEecCCCCC-CcHhHHHHHHHHCCccceeCCCcCCHH
Confidence 99999999999996 6776 888999999 9999999998 56664 899999999999999875
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.52 E-value=2.8e-17 Score=159.64 Aligned_cols=149 Identities=26% Similarity=0.292 Sum_probs=126.3
Q ss_pred cEEEEEcCCCCccccCCc------cccCCCCCCEEEccCCCCcccCChhhcCCCCCCEEEcCCCcCcccCCcccCCCCCC
Q 005102 65 RVVSVSIPKKKLLGFLPS------ALGSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSGSVPNEIGKLKYL 138 (714)
Q Consensus 65 ~~~~l~l~~~~l~g~~p~------~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L 138 (714)
+++.+++..+.++|.+|. .+..+++|++|+|++|.+++ +| .+..+++|+.|+|++|.++ .+|..+..+++|
T Consensus 19 ~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~~~~~L 95 (198)
T 1ds9_A 19 SVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADTL 95 (198)
T ss_dssp CCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHHHHHHC
T ss_pred cccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhhcCCcC
Confidence 455556666777777776 89999999999999999996 77 8999999999999999998 788888888999
Q ss_pred CEEeccCccCCCCCCcccccccccceeecccCcCCCCCCc--ccccCccccccccccCCcccccCCCC----------CC
Q 005102 139 QILDLSQNFFNGSLPVSIVQCKRLKALDLSQNNFTGPLPN--GFGSGLVSLEKLNLSFNKFNGSIPSN----------TG 206 (714)
Q Consensus 139 ~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~--~~~~~l~~L~~L~l~~N~l~g~~p~~----------~~ 206 (714)
+.|+|++|++++ +| .+..+++|+.|+|++|++++ +|. .+ ..+++|+.|++++|.+++.+|.. +.
T Consensus 96 ~~L~L~~N~l~~-l~-~~~~l~~L~~L~l~~N~i~~-~~~~~~l-~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~ 171 (198)
T 1ds9_A 96 EELWISYNQIAS-LS-GIEKLVNLRVLYMSNNKITN-WGEIDKL-AALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVK 171 (198)
T ss_dssp SEEEEEEEECCC-HH-HHHHHHHSSEEEESEEECCC-HHHHHHH-TTTTTCSEEEECSCHHHHHHHTTTTHHHHHHHHHH
T ss_pred CEEECcCCcCCc-CC-ccccCCCCCEEECCCCcCCc-hhHHHHH-hcCCCCCEEEecCCccccccccccchHHHHHHHHH
Confidence 999999999985 55 68899999999999999984 443 44 46999999999999999887764 77
Q ss_pred CCcccccccccccccCC
Q 005102 207 NLSSLQGTVDFSHNLFS 223 (714)
Q Consensus 207 ~l~~L~~~l~l~~N~l~ 223 (714)
.+++|+ .|| +|.++
T Consensus 172 ~l~~L~-~Ld--~~~i~ 185 (198)
T 1ds9_A 172 RLPNLK-KLD--GMPVD 185 (198)
T ss_dssp HCSSCS-EEC--CGGGT
T ss_pred hCCCcE-EEC--CcccC
Confidence 788888 665 67665
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=99.51 E-value=4e-16 Score=172.23 Aligned_cols=181 Identities=23% Similarity=0.157 Sum_probs=99.3
Q ss_pred cEEEEEcCCCCccc----cCCccccCCCCCCEEEccCCCCcccCChhhc-----CCCCCCEEEcCCCcCccc----CCcc
Q 005102 65 RVVSVSIPKKKLLG----FLPSALGSLTDLRHVNLRNNKFFGSLPLELL-----EAQGLQSLVLYGNSFSGS----VPNE 131 (714)
Q Consensus 65 ~~~~l~l~~~~l~g----~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~-----~l~~L~~L~L~~N~l~g~----~p~~ 131 (714)
+++.|+|++|+++. .+|..+..+++|++|+|++|.+++..+..+. ..++|+.|+|++|.+++. ++..
T Consensus 86 ~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~ 165 (461)
T 1z7x_W 86 KIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASV 165 (461)
T ss_dssp CCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHH
T ss_pred ceeEEEccCCCCCHHHHHHHHHHHccCCceeEEECCCCcCchHHHHHHHHHHhcCCCcceEEECCCCCCCHHHHHHHHHH
Confidence 46666666666662 4556666666666666666666543333222 134566666666666542 2444
Q ss_pred cCCCCCCCEEeccCccCCCCCCccccc-----ccccceeecccCcCCCC----CCcccccCccccccccccCCcccccC-
Q 005102 132 IGKLKYLQILDLSQNFFNGSLPVSIVQ-----CKRLKALDLSQNNFTGP----LPNGFGSGLVSLEKLNLSFNKFNGSI- 201 (714)
Q Consensus 132 ~~~l~~L~~L~Ls~N~l~g~~p~~~~~-----l~~L~~L~l~~N~l~g~----~p~~~~~~l~~L~~L~l~~N~l~g~~- 201 (714)
+..+++|+.|+|++|.++...+..+.. +++|+.|+|++|.+++. ++..+. .+++|+.|+|++|++++.-
T Consensus 166 l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~-~~~~L~~L~Ls~n~l~~~~~ 244 (461)
T 1z7x_W 166 LRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVA-SKASLRELALGSNKLGDVGM 244 (461)
T ss_dssp HHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHH-HCTTCCEEECCSSBCHHHHH
T ss_pred HhhCCCCCEEECcCCCcchHHHHHHHHHHhcCCCCceEEEccCCCCcHHHHHHHHHHHH-hCCCccEEeccCCcCChHHH
Confidence 455566666666666665433333321 34666666666666542 333332 3566666666666665321
Q ss_pred ----CCCCCCCcccccccccccccCCcC----cCccccCCCCcccccCcCCcCC
Q 005102 202 ----PSNTGNLSSLQGTVDFSHNLFSGS----IPASLGNLPEKVYIDLTYNNLS 247 (714)
Q Consensus 202 ----p~~~~~l~~L~~~l~l~~N~l~g~----~p~~~~~l~~L~~l~l~~N~l~ 247 (714)
+..+..+++|+ .|++++|.++.. ++..+..+++|+.|++++|+++
T Consensus 245 ~~l~~~~~~~~~~L~-~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~ 297 (461)
T 1z7x_W 245 AELCPGLLHPSSRLR-TLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELG 297 (461)
T ss_dssp HHHHHHHTSTTCCCC-EEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCH
T ss_pred HHHHHHHhcCCCCce-EEECcCCCCCHHHHHHHHHHHhhCCCcceEECCCCCCc
Confidence 22222455666 666666666643 4555556666666666666654
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.51 E-value=4.2e-14 Score=133.42 Aligned_cols=103 Identities=21% Similarity=0.172 Sum_probs=76.2
Q ss_pred EEcCCCCccccCCccccCCCCCCEEEccCCCCcccCChhhcCCCCCCEEEcCCCcCcccCCcccCCCCCCCEEeccCccC
Q 005102 69 VSIPKKKLLGFLPSALGSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSGSVPNEIGKLKYLQILDLSQNFF 148 (714)
Q Consensus 69 l~l~~~~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l 148 (714)
|++++|+|+. +|..+. ++|++|+|++|+|++..|..|..+++|++|+|++|+|++..|..|..+++|+.|+|++|+|
T Consensus 14 l~~s~n~l~~-ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~l 90 (170)
T 3g39_A 14 VDCSGKSLAS-VPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDNQL 90 (170)
T ss_dssp EECTTSCCSS-CCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCC
T ss_pred EEeCCCCcCc-cCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCCCcc
Confidence 4445666664 565553 7788888888888877777788888888888888888866666677888888888888888
Q ss_pred CCCCCcccccccccceeecccCcCCC
Q 005102 149 NGSLPVSIVQCKRLKALDLSQNNFTG 174 (714)
Q Consensus 149 ~g~~p~~~~~l~~L~~L~l~~N~l~g 174 (714)
++..+..|..+++|+.|+|++|.++.
T Consensus 91 ~~~~~~~~~~l~~L~~L~L~~N~~~c 116 (170)
T 3g39_A 91 KSIPRGAFDNLKSLTHIWLLNNPWDC 116 (170)
T ss_dssp CCCCTTTTTTCTTCCEEECCSSCBCT
T ss_pred CEeCHHHhcCCCCCCEEEeCCCCCCC
Confidence 76555567777778888887777764
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.48 E-value=1.1e-13 Score=130.53 Aligned_cols=106 Identities=25% Similarity=0.287 Sum_probs=76.2
Q ss_pred CCEEEccCCCCcccCChhhcCCCCCCEEEcCCCcCcccCCcccCCCCCCCEEeccCccCCCCCCcccccccccceeeccc
Q 005102 90 LRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSGSVPNEIGKLKYLQILDLSQNFFNGSLPVSIVQCKRLKALDLSQ 169 (714)
Q Consensus 90 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~ 169 (714)
.+.|++++|.|+ .+|..+. ++|+.|+|++|+|++..|..|.++++|+.|+|++|+|++..|..|..+++|++|+|++
T Consensus 11 ~~~l~~s~n~l~-~ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~ 87 (170)
T 3g39_A 11 GTTVDCSGKSLA-SVPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLND 87 (170)
T ss_dssp TTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CCEEEeCCCCcC-ccCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCC
Confidence 467888888887 4665553 6788888888888877777788888888888888888765555667777788888888
Q ss_pred CcCCCCCCcccccCccccccccccCCcccc
Q 005102 170 NNFTGPLPNGFGSGLVSLEKLNLSFNKFNG 199 (714)
Q Consensus 170 N~l~g~~p~~~~~~l~~L~~L~l~~N~l~g 199 (714)
|+|++ +|...+..+++|+.|+|++|.++.
T Consensus 88 N~l~~-~~~~~~~~l~~L~~L~L~~N~~~c 116 (170)
T 3g39_A 88 NQLKS-IPRGAFDNLKSLTHIWLLNNPWDC 116 (170)
T ss_dssp SCCCC-CCTTTTTTCTTCCEEECCSSCBCT
T ss_pred CccCE-eCHHHhcCCCCCCEEEeCCCCCCC
Confidence 87774 444333457777777777777763
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.46 E-value=2.6e-13 Score=128.48 Aligned_cols=104 Identities=23% Similarity=0.236 Sum_probs=77.0
Q ss_pred EEEEcCCCCccccCCccccCCCCCCEEEccCCCCcccCChhhcCCCCCCEEEcCCCcCcccCCcccCCCCCCCEEeccCc
Q 005102 67 VSVSIPKKKLLGFLPSALGSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSGSVPNEIGKLKYLQILDLSQN 146 (714)
Q Consensus 67 ~~l~l~~~~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N 146 (714)
+.+++++|+++ .+|..+. ++|++|+|++|+|++..|..|..+++|+.|+|++|+|++..+..|.++++|+.|+|++|
T Consensus 15 ~~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N 91 (174)
T 2r9u_A 15 TLVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDN 91 (174)
T ss_dssp SEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred cEEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCC
Confidence 45677777774 4666554 77888888888888777777888888888888888887655555677888888888888
Q ss_pred cCCCCCCcccccccccceeecccCcCC
Q 005102 147 FFNGSLPVSIVQCKRLKALDLSQNNFT 173 (714)
Q Consensus 147 ~l~g~~p~~~~~l~~L~~L~l~~N~l~ 173 (714)
+|++..+..|..+++|+.|+|++|.+.
T Consensus 92 ~l~~l~~~~~~~l~~L~~L~L~~N~~~ 118 (174)
T 2r9u_A 92 HLKSIPRGAFDNLKSLTHIYLYNNPWD 118 (174)
T ss_dssp CCCCCCTTTTTTCTTCSEEECCSSCBC
T ss_pred ccceeCHHHhccccCCCEEEeCCCCcc
Confidence 887544445777777777777777776
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.46 E-value=2e-13 Score=129.28 Aligned_cols=104 Identities=26% Similarity=0.298 Sum_probs=76.6
Q ss_pred CEEEccCCCCcccCChhhcCCCCCCEEEcCCCcCcccCCcccCCCCCCCEEeccCccCCCCCCcccccccccceeecccC
Q 005102 91 RHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSGSVPNEIGKLKYLQILDLSQNFFNGSLPVSIVQCKRLKALDLSQN 170 (714)
Q Consensus 91 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~N 170 (714)
+.+++++|+|+ .+|..+. ++|+.|+|++|+|++..|..|+++++|+.|+|++|+|++..+..|..+++|+.|+|++|
T Consensus 15 ~~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N 91 (174)
T 2r9u_A 15 TLVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDN 91 (174)
T ss_dssp SEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred cEEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCC
Confidence 67888888885 6666554 67888888888888777777888888888888888887544445677788888888888
Q ss_pred cCCCCCCcccccCccccccccccCCccc
Q 005102 171 NFTGPLPNGFGSGLVSLEKLNLSFNKFN 198 (714)
Q Consensus 171 ~l~g~~p~~~~~~l~~L~~L~l~~N~l~ 198 (714)
+|+ .+|...+..+++|+.|+|++|.+.
T Consensus 92 ~l~-~l~~~~~~~l~~L~~L~L~~N~~~ 118 (174)
T 2r9u_A 92 HLK-SIPRGAFDNLKSLTHIYLYNNPWD 118 (174)
T ss_dssp CCC-CCCTTTTTTCTTCSEEECCSSCBC
T ss_pred ccc-eeCHHHhccccCCCEEEeCCCCcc
Confidence 887 455443345777777777777776
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.46 E-value=1.5e-13 Score=145.55 Aligned_cols=110 Identities=20% Similarity=0.198 Sum_probs=94.2
Q ss_pred CCcccceEecCCcEEEEEcCCCCccccCCccccCCCCCCEEEccC-CCCcccCChhhcCCCCCCEEEcCCCcCcccCCcc
Q 005102 53 PCSWNGITCKEQRVVSVSIPKKKLLGFLPSALGSLTDLRHVNLRN-NKFFGSLPLELLEAQGLQSLVLYGNSFSGSVPNE 131 (714)
Q Consensus 53 ~c~w~gv~c~~~~~~~l~l~~~~l~g~~p~~~~~l~~L~~L~L~~-N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~ 131 (714)
.|.|..|.|+.. |+|++ +|. |..+++|+.|+|++ |+|++..|..|..+++|+.|+|++|+|++..|..
T Consensus 7 ~C~~~~v~~~~~---------n~l~~-ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~ 75 (347)
T 2ifg_A 7 PHGSSGLRCTRD---------GALDS-LHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDA 75 (347)
T ss_dssp CSSSSCEECCSS---------CCCTT-TTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTG
T ss_pred cccCCEEEcCCC---------CCCCc-cCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHH
Confidence 588988888531 26665 787 99999999999996 9999888889999999999999999999999999
Q ss_pred cCCCCCCCEEeccCccCCCCCCcccccccccceeecccCcCCC
Q 005102 132 IGKLKYLQILDLSQNFFNGSLPVSIVQCKRLKALDLSQNNFTG 174 (714)
Q Consensus 132 ~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g 174 (714)
|++|++|+.|+|++|+|++..|..|..+. |+.|+|++|.|..
T Consensus 76 ~~~l~~L~~L~l~~N~l~~~~~~~~~~~~-L~~l~l~~N~~~c 117 (347)
T 2ifg_A 76 FHFTPRLSRLNLSFNALESLSWKTVQGLS-LQELVLSGNPLHC 117 (347)
T ss_dssp GGSCSCCCEEECCSSCCSCCCSTTTCSCC-CCEEECCSSCCCC
T ss_pred hcCCcCCCEEeCCCCccceeCHHHcccCC-ceEEEeeCCCccC
Confidence 99999999999999999965555555555 9999999999974
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.30 E-value=3.6e-12 Score=134.91 Aligned_cols=105 Identities=23% Similarity=0.183 Sum_probs=89.1
Q ss_pred CEEEccCC-CCcccCChhhcCCCCCCEEEcCC-CcCcccCCcccCCCCCCCEEeccCccCCCCCCcccccccccceeecc
Q 005102 91 RHVNLRNN-KFFGSLPLELLEAQGLQSLVLYG-NSFSGSVPNEIGKLKYLQILDLSQNFFNGSLPVSIVQCKRLKALDLS 168 (714)
Q Consensus 91 ~~L~L~~N-~l~~~~p~~~~~l~~L~~L~L~~-N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~ 168 (714)
..++++++ +|+ .+|. +..+++|+.|+|++ |.|++..|..|++|++|+.|+|++|+|++..|..|.+|++|+.|+|+
T Consensus 11 ~~v~~~~~n~l~-~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~ 88 (347)
T 2ifg_A 11 SGLRCTRDGALD-SLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLS 88 (347)
T ss_dssp SCEECCSSCCCT-TTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECC
T ss_pred CEEEcCCCCCCC-ccCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCC
Confidence 35688887 888 4787 99999999999996 99998777889999999999999999998888889999999999999
Q ss_pred cCcCCCCCCcccccCccccccccccCCcccc
Q 005102 169 QNNFTGPLPNGFGSGLVSLEKLNLSFNKFNG 199 (714)
Q Consensus 169 ~N~l~g~~p~~~~~~l~~L~~L~l~~N~l~g 199 (714)
+|+|+ .+|..++..+. |+.|+|++|.|..
T Consensus 89 ~N~l~-~~~~~~~~~~~-L~~l~l~~N~~~c 117 (347)
T 2ifg_A 89 FNALE-SLSWKTVQGLS-LQELVLSGNPLHC 117 (347)
T ss_dssp SSCCS-CCCSTTTCSCC-CCEEECCSSCCCC
T ss_pred CCccc-eeCHHHcccCC-ceEEEeeCCCccC
Confidence 99998 46665555444 8899999988873
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.30 E-value=3.4e-12 Score=134.07 Aligned_cols=188 Identities=14% Similarity=0.067 Sum_probs=130.9
Q ss_pred CcEEEEEcCCCCcc--------------------ccCCccccC--------CCCCCEEEccCCCCcccCChhhcCCCCCC
Q 005102 64 QRVVSVSIPKKKLL--------------------GFLPSALGS--------LTDLRHVNLRNNKFFGSLPLELLEAQGLQ 115 (714)
Q Consensus 64 ~~~~~l~l~~~~l~--------------------g~~p~~~~~--------l~~L~~L~L~~N~l~~~~p~~~~~l~~L~ 115 (714)
.+++.|+|++|++. ..-+.+|.+ +++|+.|+|++ .++.+-+..|.++++|+
T Consensus 49 ~~L~~LdLs~n~i~~~~~~~~~~~~~~~~~~~~~~I~~~aF~~~~~~~~~g~~~L~~l~L~~-~i~~I~~~aF~~~~~L~ 127 (329)
T 3sb4_A 49 PSLKVLDISNAEIKMYSGKAGTYPNGKFYIYMANFVPAYAFSNVVNGVTKGKQTLEKVILSE-KIKNIEDAAFKGCDNLK 127 (329)
T ss_dssp TTCCEEEEEEEEECCEEESSSSSGGGCCEEECTTEECTTTTEEEETTEEEECTTCCC-CBCT-TCCEECTTTTTTCTTCC
T ss_pred ccCeEEecCcceeEEecCccccccccccccccccccCHHHhcccccccccccCCCcEEECCc-cccchhHHHhhcCcccc
Confidence 45667777777666 122235556 88899999988 77766667788889999
Q ss_pred EEEcCCCcCcccCCcccCCCCCCCEEeccCccC----CCCCCccc-----------------------------------
Q 005102 116 SLVLYGNSFSGSVPNEIGKLKYLQILDLSQNFF----NGSLPVSI----------------------------------- 156 (714)
Q Consensus 116 ~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l----~g~~p~~~----------------------------------- 156 (714)
.|+|++|.++...+..|.+..++..+.++.+.. ...-+..|
T Consensus 128 ~l~l~~n~i~~i~~~aF~~~~~l~~l~~~~~~~~~~~~~i~~~~f~~~~~L~~~i~~~~~~~l~~~~~~~~~~~~~~~~l 207 (329)
T 3sb4_A 128 ICQIRKKTAPNLLPEALADSVTAIFIPLGSSDAYRFKNRWEHFAFIEGEPLETTIQVGAMGKLEDEIMKAGLQPRDINFL 207 (329)
T ss_dssp EEEBCCSSCCEECTTSSCTTTCEEEECTTCTHHHHTSTTTTTSCEEESCCCEEEEEECTTCCHHHHHHHTTCCGGGCSEE
T ss_pred eEEcCCCCccccchhhhcCCCceEEecCcchhhhhccccccccccccccccceeEEecCCCcHHHHHhhcccCccccceE
Confidence 999998888766666677777777666655221 00000000
Q ss_pred ---------------ccccccceeecccCcCCCCCCcccccCccccccccccCCcccccCCCCCCCCccccccccccccc
Q 005102 157 ---------------VQCKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLNLSFNKFNGSIPSNTGNLSSLQGTVDFSHNL 221 (714)
Q Consensus 157 ---------------~~l~~L~~L~l~~N~l~g~~p~~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~~l~l~~N~ 221 (714)
..+++|+.|+|++|+++ .||...+.++.+|+.|+|.+| ++..-+..|.++.+|+..+++.+ .
T Consensus 208 ~~~~~l~~~~~~~l~~~~~~L~~l~L~~n~i~-~I~~~aF~~~~~L~~l~l~~n-i~~I~~~aF~~~~~L~~~l~l~~-~ 284 (329)
T 3sb4_A 208 TIEGKLDNADFKLIRDYMPNLVSLDISKTNAT-TIPDFTFAQKKYLLKIKLPHN-LKTIGQRVFSNCGRLAGTLELPA-S 284 (329)
T ss_dssp EEEECCCHHHHHHHHHHCTTCCEEECTTBCCC-EECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEEECT-T
T ss_pred EEeeeecHHHHHHHHHhcCCCeEEECCCCCcc-eecHhhhhCCCCCCEEECCcc-cceehHHHhhCChhccEEEEEcc-c
Confidence 02678888888888887 677777778888888888888 66444467778877754677776 6
Q ss_pred CCcCcCccccCCCCcccccCcCCcCCCCCCCCcc
Q 005102 222 FSGSIPASLGNLPEKVYIDLTYNNLSGPIPQNGA 255 (714)
Q Consensus 222 l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~ 255 (714)
++..-+.+|.++++|+.++++.|+++...+..+.
T Consensus 285 l~~I~~~aF~~c~~L~~l~l~~n~i~~I~~~aF~ 318 (329)
T 3sb4_A 285 VTAIEFGAFMGCDNLRYVLATGDKITTLGDELFG 318 (329)
T ss_dssp CCEECTTTTTTCTTEEEEEECSSCCCEECTTTTC
T ss_pred ceEEchhhhhCCccCCEEEeCCCccCccchhhhc
Confidence 7766678888888888888888888866555433
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.23 E-value=1.9e-11 Score=123.81 Aligned_cols=135 Identities=16% Similarity=0.110 Sum_probs=105.8
Q ss_pred cccccCceEEEEEEECCCcEEEEEEeCCCCchhHHHHHHHHHHHhccC-CCCccceEEEEEeCCceeEEEeccCCCCHhh
Q 005102 410 VLGKSGIGIVYKVVLEDGHTLAVRRLGEGGSQRFKEFQTEVEAIGKIR-HSNIVTLRAYYWSVDEKLLIYDYIPNGSLAT 488 (714)
Q Consensus 410 ~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lV~e~~~~gsL~~ 488 (714)
.++.|+.+.||++... +..+++|+...........+.+|+++++.+. |..+.++++++...+..|+||||++|.+|.+
T Consensus 21 ~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~ 99 (263)
T 3tm0_A 21 DTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSE 99 (263)
T ss_dssp CCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHH
T ss_pred eccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEecCCeehhh
Confidence 4677778999999864 6899999987532122245889999999984 6778899999988888999999999999887
Q ss_pred hhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCC-------------------------------------------
Q 005102 489 ALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFS------------------------------------------- 525 (714)
Q Consensus 489 ~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~------------------------------------------- 525 (714)
.+.. ......++.+++++|+.||+..
T Consensus 100 ~~~~-----------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 168 (263)
T 3tm0_A 100 EYED-----------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPR 168 (263)
T ss_dssp HCCT-----------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSSHH
T ss_pred ccCC-----------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCCCHH
Confidence 6321 1123578899999999999821
Q ss_pred -------------CCCceecCCCCCCeeeCCCCCeEEcccchhh
Q 005102 526 -------------PKKYVHGDLKPSNILLGHNMEPHVSDFGLAR 556 (714)
Q Consensus 526 -------------~~~ivHrDlkp~NILl~~~~~~kl~DFGla~ 556 (714)
+..++|+|++|.||+++++..+.|+||+.+.
T Consensus 169 ~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 169 ELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp HHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 1358999999999999876566799999875
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.22 E-value=1.6e-11 Score=128.84 Aligned_cols=186 Identities=12% Similarity=0.092 Sum_probs=133.3
Q ss_pred cEEEEEcCCCCccccCCccccC-CCCCCEEEccCCCCc--------------------ccCChhhcC--------CCCCC
Q 005102 65 RVVSVSIPKKKLLGFLPSALGS-LTDLRHVNLRNNKFF--------------------GSLPLELLE--------AQGLQ 115 (714)
Q Consensus 65 ~~~~l~l~~~~l~g~~p~~~~~-l~~L~~L~L~~N~l~--------------------~~~p~~~~~--------l~~L~ 115 (714)
+++.|.+.++ +.+.--..+.. +++|+.|||++|++. ...+..|.+ +++|+
T Consensus 26 ~l~~L~l~g~-i~~~~~~~l~~~l~~L~~LdLs~n~i~~~~~~~~~~~~~~~~~~~~~~I~~~aF~~~~~~~~~g~~~L~ 104 (329)
T 3sb4_A 26 SITHLTLTGK-LNAEDFRHLRDEFPSLKVLDISNAEIKMYSGKAGTYPNGKFYIYMANFVPAYAFSNVVNGVTKGKQTLE 104 (329)
T ss_dssp HCSEEEEEEE-ECHHHHHHHHHSCTTCCEEEEEEEEECCEEESSSSSGGGCCEEECTTEECTTTTEEEETTEEEECTTCC
T ss_pred ceeEEEEecc-ccHHHHHHHHHhhccCeEEecCcceeEEecCccccccccccccccccccCHHHhcccccccccccCCCc
Confidence 4566666542 21111123334 889999999999987 122345667 89999
Q ss_pred EEEcCCCcCcccCCcccCCCCCCCEEeccCccCCCCCCcccccccccceeecccCcC----C------------------
Q 005102 116 SLVLYGNSFSGSVPNEIGKLKYLQILDLSQNFFNGSLPVSIVQCKRLKALDLSQNNF----T------------------ 173 (714)
Q Consensus 116 ~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l----~------------------ 173 (714)
.|+|.+ .++..-+..|.++++|+.|+|++|.+....+..|..+.++..+.++.+.. .
T Consensus 105 ~l~L~~-~i~~I~~~aF~~~~~L~~l~l~~n~i~~i~~~aF~~~~~l~~l~~~~~~~~~~~~~i~~~~f~~~~~L~~~i~ 183 (329)
T 3sb4_A 105 KVILSE-KIKNIEDAAFKGCDNLKICQIRKKTAPNLLPEALADSVTAIFIPLGSSDAYRFKNRWEHFAFIEGEPLETTIQ 183 (329)
T ss_dssp C-CBCT-TCCEECTTTTTTCTTCCEEEBCCSSCCEECTTSSCTTTCEEEECTTCTHHHHTSTTTTTSCEEESCCCEEEEE
T ss_pred EEECCc-cccchhHHHhhcCcccceEEcCCCCccccchhhhcCCCceEEecCcchhhhhccccccccccccccccceeEE
Confidence 999998 88866666799999999999999999866667788888888777665321 0
Q ss_pred ----CCCCcccc---------------------------cCccccccccccCCcccccCCCCCCCCcccccccccccccC
Q 005102 174 ----GPLPNGFG---------------------------SGLVSLEKLNLSFNKFNGSIPSNTGNLSSLQGTVDFSHNLF 222 (714)
Q Consensus 174 ----g~~p~~~~---------------------------~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~~l~l~~N~l 222 (714)
+.++..++ ..+++|+.|+|++|+++..-+..|.++.+|+ .++|.+| +
T Consensus 184 ~~~~~~l~~~~~~~~~~~~~~~~l~~~~~l~~~~~~~l~~~~~~L~~l~L~~n~i~~I~~~aF~~~~~L~-~l~l~~n-i 261 (329)
T 3sb4_A 184 VGAMGKLEDEIMKAGLQPRDINFLTIEGKLDNADFKLIRDYMPNLVSLDISKTNATTIPDFTFAQKKYLL-KIKLPHN-L 261 (329)
T ss_dssp ECTTCCHHHHHHHTTCCGGGCSEEEEEECCCHHHHHHHHHHCTTCCEEECTTBCCCEECTTTTTTCTTCC-EEECCTT-C
T ss_pred ecCCCcHHHHHhhcccCccccceEEEeeeecHHHHHHHHHhcCCCeEEECCCCCcceecHhhhhCCCCCC-EEECCcc-c
Confidence 01111000 0267999999999999944446789999999 9999998 8
Q ss_pred CcCcCccccCCCCcc-cccCcCCcCCCCCCCCcc
Q 005102 223 SGSIPASLGNLPEKV-YIDLTYNNLSGPIPQNGA 255 (714)
Q Consensus 223 ~g~~p~~~~~l~~L~-~l~l~~N~l~~~~p~~~~ 255 (714)
+..-+.+|.++++|+ .+++.+ +++...+..+.
T Consensus 262 ~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~ 294 (329)
T 3sb4_A 262 KTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFM 294 (329)
T ss_dssp CEECTTTTTTCTTCCEEEEECT-TCCEECTTTTT
T ss_pred ceehHHHhhCChhccEEEEEcc-cceEEchhhhh
Confidence 767778899999999 999988 67655555444
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=99.19 E-value=1.8e-13 Score=155.88 Aligned_cols=105 Identities=13% Similarity=-0.011 Sum_probs=60.9
Q ss_pred CcEEEEEcCCCCccccCC-ccccCCCCCCEEEccCCCCcccCChhhcCCCCCCEEEcC-----------CCcCccc-CCc
Q 005102 64 QRVVSVSIPKKKLLGFLP-SALGSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLY-----------GNSFSGS-VPN 130 (714)
Q Consensus 64 ~~~~~l~l~~~~l~g~~p-~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~-----------~N~l~g~-~p~ 130 (714)
.+++.|+|++|.+++... ..+..+++|++|+|+++...+.++..+..+++|+.|+|+ .|.+++. ++.
T Consensus 293 ~~L~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~~~~~~~~l~~~~~~~~~L~~L~L~~g~~~~~~~~~~~~~~~~~~~~ 372 (592)
T 3ogk_B 293 AQIRKLDLLYALLETEDHCTLIQKCPNLEVLETRNVIGDRGLEVLAQYCKQLKRLRIERGADEQGMEDEEGLVSQRGLIA 372 (592)
T ss_dssp GGCCEEEETTCCCCHHHHHHHHTTCTTCCEEEEEGGGHHHHHHHHHHHCTTCCEEEEECCCCSSTTSSTTCCCCHHHHHH
T ss_pred CCCcEEecCCCcCCHHHHHHHHHhCcCCCEEeccCccCHHHHHHHHHhCCCCCEEEeecCccccccccccCccCHHHHHH
Confidence 478999999998776544 335777888888877332223333334556667777777 2455432 112
Q ss_pred ccCCCCCCCEEeccCccCCCCCCccccc-ccccceeecc
Q 005102 131 EIGKLKYLQILDLSQNFFNGSLPVSIVQ-CKRLKALDLS 168 (714)
Q Consensus 131 ~~~~l~~L~~L~Ls~N~l~g~~p~~~~~-l~~L~~L~l~ 168 (714)
.+..+++|+.|+|+.|++++..+..+.. +++|+.|+|+
T Consensus 373 l~~~~~~L~~L~l~~~~l~~~~~~~l~~~~~~L~~L~l~ 411 (592)
T 3ogk_B 373 LAQGCQELEYMAVYVSDITNESLESIGTYLKNLCDFRLV 411 (592)
T ss_dssp HHHHCTTCSEEEEEESCCCHHHHHHHHHHCCSCCEEEEE
T ss_pred HHhhCccCeEEEeecCCccHHHHHHHHhhCCCCcEEEEe
Confidence 2233566666666666665544444443 5556666664
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.18 E-value=1.9e-13 Score=145.67 Aligned_cols=159 Identities=18% Similarity=0.203 Sum_probs=86.1
Q ss_pred CCCCEEEccCCCCcccCChhhcCC-----CCCCEEEcCCCcCcccCCccc-CCCCCCCEEeccCccCCCCCCccc-----
Q 005102 88 TDLRHVNLRNNKFFGSLPLELLEA-----QGLQSLVLYGNSFSGSVPNEI-GKLKYLQILDLSQNFFNGSLPVSI----- 156 (714)
Q Consensus 88 ~~L~~L~L~~N~l~~~~p~~~~~l-----~~L~~L~L~~N~l~g~~p~~~-~~l~~L~~L~Ls~N~l~g~~p~~~----- 156 (714)
+.|+.|+|++|.|+......+... ++|+.|+|++|.++..-...+ ..+++|+.|+|++|+|+..-...+
T Consensus 72 ~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L~ 151 (372)
T 3un9_A 72 SSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLL 151 (372)
T ss_dssp TTCCEEECTTSCCCHHHHHHHHHHHSSCSSCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHHH
T ss_pred hhCCEEEecCCCCCHHHHHHHHHHHhhCCCCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHHH
Confidence 455666666666653322222221 456666666666543222222 223456666666666653222222
Q ss_pred ccccccceeecccCcCCCC----CCcccccCccccccccccCCcccc----cCCCCCCCCcccccccccccccCCcC---
Q 005102 157 VQCKRLKALDLSQNNFTGP----LPNGFGSGLVSLEKLNLSFNKFNG----SIPSNTGNLSSLQGTVDFSHNLFSGS--- 225 (714)
Q Consensus 157 ~~l~~L~~L~l~~N~l~g~----~p~~~~~~l~~L~~L~l~~N~l~g----~~p~~~~~l~~L~~~l~l~~N~l~g~--- 225 (714)
...++|+.|+|++|.|+.. ++..+ ...++|++|+|++|.|+. .++..+...+.|+ .|+|++|.|+..
T Consensus 152 ~~~~~L~~L~Ls~n~l~~~~~~~l~~~L-~~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~-~L~Ls~N~i~~~g~~ 229 (372)
T 3un9_A 152 HDQCQITTLRLSNNPLTAAGVAVLMEGL-AGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQ-ELNVAYNGAGDTAAL 229 (372)
T ss_dssp STTCCCCEEECCSSCCHHHHHHHHHHHH-HTCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCC-EEECCSSCCCHHHHH
T ss_pred hcCCccceeeCCCCCCChHHHHHHHHHH-hcCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcC-eEECCCCCCCHHHHH
Confidence 1235566666666666421 22222 234566666666666653 2234445556677 777777777642
Q ss_pred -cCccccCCCCcccccCcCCcCCC
Q 005102 226 -IPASLGNLPEKVYIDLTYNNLSG 248 (714)
Q Consensus 226 -~p~~~~~l~~L~~l~l~~N~l~~ 248 (714)
++..+...++|+.||+++|.++.
T Consensus 230 ~l~~~L~~~~~L~~L~Ls~N~i~~ 253 (372)
T 3un9_A 230 ALARAAREHPSLELLHLYFNELSS 253 (372)
T ss_dssp HHHHHHHHCSSCCEEECTTSSCCH
T ss_pred HHHHHHHhCCCCCEEeccCCCCCH
Confidence 34455567888888888888764
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.16 E-value=1.2e-13 Score=147.33 Aligned_cols=167 Identities=16% Similarity=0.145 Sum_probs=124.2
Q ss_pred CcEEEEEcCCCCccccCCccccCC-----CCCCEEEccCCCCcccCChhh-cCCCCCCEEEcCCCcCcccCCccc-----
Q 005102 64 QRVVSVSIPKKKLLGFLPSALGSL-----TDLRHVNLRNNKFFGSLPLEL-LEAQGLQSLVLYGNSFSGSVPNEI----- 132 (714)
Q Consensus 64 ~~~~~l~l~~~~l~g~~p~~~~~l-----~~L~~L~L~~N~l~~~~p~~~-~~l~~L~~L~L~~N~l~g~~p~~~----- 132 (714)
..++.|+|++|.++..-...|... ++|++|+|++|.++..-...+ ..+++|+.|+|++|.++..-...+
T Consensus 72 ~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L~ 151 (372)
T 3un9_A 72 SSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLL 151 (372)
T ss_dssp TTCCEEECTTSCCCHHHHHHHHHHHSSCSSCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHHH
T ss_pred hhCCEEEecCCCCCHHHHHHHHHHHhhCCCCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHHH
Confidence 578899999999987544444333 799999999999975433333 245689999999999975544444
Q ss_pred CCCCCCCEEeccCccCCC----CCCcccccccccceeecccCcCCCC----CCcccccCccccccccccCCcccc----c
Q 005102 133 GKLKYLQILDLSQNFFNG----SLPVSIVQCKRLKALDLSQNNFTGP----LPNGFGSGLVSLEKLNLSFNKFNG----S 200 (714)
Q Consensus 133 ~~l~~L~~L~Ls~N~l~g----~~p~~~~~l~~L~~L~l~~N~l~g~----~p~~~~~~l~~L~~L~l~~N~l~g----~ 200 (714)
...++|+.|+|++|.|+. .++..+..+++|++|+|++|.|+.. ++..+ ...++|+.|+|++|.|+. .
T Consensus 152 ~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~~L-~~~~~L~~L~Ls~N~i~~~g~~~ 230 (372)
T 3un9_A 152 HDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQL-DRNRQLQELNVAYNGAGDTAALA 230 (372)
T ss_dssp STTCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHHHHHHHG-GGCSCCCEEECCSSCCCHHHHHH
T ss_pred hcCCccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHHHHHHHH-hcCCCcCeEECCCCCCCHHHHHH
Confidence 356889999999999974 2445567789999999999998742 23333 246799999999999984 3
Q ss_pred CCCCCCCCcccccccccccccCCcCcCccccC
Q 005102 201 IPSNTGNLSSLQGTVDFSHNLFSGSIPASLGN 232 (714)
Q Consensus 201 ~p~~~~~l~~L~~~l~l~~N~l~g~~p~~~~~ 232 (714)
++..+...++|+ .|+|++|.|+..-...+..
T Consensus 231 l~~~L~~~~~L~-~L~Ls~N~i~~~g~~~L~~ 261 (372)
T 3un9_A 231 LARAAREHPSLE-LLHLYFNELSSEGRQVLRD 261 (372)
T ss_dssp HHHHHHHCSSCC-EEECTTSSCCHHHHHHHHH
T ss_pred HHHHHHhCCCCC-EEeccCCCCCHHHHHHHHH
Confidence 444455567888 9999999998665555544
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.16 E-value=6.5e-11 Score=119.54 Aligned_cols=130 Identities=15% Similarity=0.181 Sum_probs=99.0
Q ss_pred cc-ccCceEEEEEEECCCcEEEEEEeCCCCchhHHHHHHHHHHHhccCCCC--ccceEEEEEeCCceeEEEeccCCCCHh
Q 005102 411 LG-KSGIGIVYKVVLEDGHTLAVRRLGEGGSQRFKEFQTEVEAIGKIRHSN--IVTLRAYYWSVDEKLLIYDYIPNGSLA 487 (714)
Q Consensus 411 lG-~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n--iv~l~~~~~~~~~~~lV~e~~~~gsL~ 487 (714)
++ .|..+.||++...+|..+++|...... ...+.+|+++++.+.+.+ +.+++++....+..++||||+++.+|.
T Consensus 27 ~~~gg~~~~v~~~~~~~g~~~vlK~~~~~~---~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~ 103 (264)
T 1nd4_A 27 QTIGCSDAAVFRLSAQGRPVLFVKTDLSGA---LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL 103 (264)
T ss_dssp CSCTTSSCEEEEEECTTSCCEEEEEECSCT---TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT
T ss_pred cccCCCCceEEEEecCCCCeEEEEeCCccc---chhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcccC
Confidence 44 455699999988778889999976542 245788999999996544 556888888777889999999998873
Q ss_pred hhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCC------------------------------------------
Q 005102 488 TALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFS------------------------------------------ 525 (714)
Q Consensus 488 ~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~------------------------------------------ 525 (714)
... .+ ...++.++++.|..||+..
T Consensus 104 --~~~---------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 169 (264)
T 1nd4_A 104 --SSH---------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAE 169 (264)
T ss_dssp --TSC---------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHH
T ss_pred --cCc---------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHH
Confidence 211 11 2367788888888888732
Q ss_pred -------------CCCceecCCCCCCeeeCCCCCeEEcccchhhh
Q 005102 526 -------------PKKYVHGDLKPSNILLGHNMEPHVSDFGLARL 557 (714)
Q Consensus 526 -------------~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 557 (714)
+..++|+|++|.||+++++..+.|+||+.+..
T Consensus 170 ~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 170 LFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp HHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 11299999999999998876677999998763
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=99.12 E-value=2.8e-12 Score=146.07 Aligned_cols=174 Identities=11% Similarity=0.037 Sum_probs=93.3
Q ss_pred cEEEEEcCCCCcccc----CCccccCCCCCCEEEccCCCCc----ccCChhhcCCCCCCEEEcCCCcCcccCCcccCCCC
Q 005102 65 RVVSVSIPKKKLLGF----LPSALGSLTDLRHVNLRNNKFF----GSLPLELLEAQGLQSLVLYGNSFSGSVPNEIGKLK 136 (714)
Q Consensus 65 ~~~~l~l~~~~l~g~----~p~~~~~l~~L~~L~L~~N~l~----~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~ 136 (714)
+++.|+|++|.+++. ++..+.++++|++|+|++|.++ +.++..+.++++|+.|+|++|.+.+ +|..+.+++
T Consensus 165 ~L~~L~L~~~~~~~~~~~~l~~~~~~~~~L~~L~L~~n~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~-l~~~~~~~~ 243 (592)
T 3ogk_B 165 KIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEILE-LVGFFKAAA 243 (592)
T ss_dssp TCSEEECTTCEEECCCSHHHHHHHHHCCCCCEEECTTCCCSSCCHHHHHHHHHHCTTCCEEECSSCBGGG-GHHHHHHCT
T ss_pred CCCEEECccccccCcchhHHHHHHhcCCCccEEEeeccCCCccCHHHHHHHHhhCCCCcEEeccCccHHH-HHHHHhhhh
Confidence 455555555555444 3333445556666666666654 2233334455666666666666553 444555555
Q ss_pred CCCEEeccCccCC---CCCCcccccccccceeecccCcCCCCCCcccccCccccccccccCCcccccCC-CCCCCCcccc
Q 005102 137 YLQILDLSQNFFN---GSLPVSIVQCKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLNLSFNKFNGSIP-SNTGNLSSLQ 212 (714)
Q Consensus 137 ~L~~L~Ls~N~l~---g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~l~~L~~L~l~~N~l~g~~p-~~~~~l~~L~ 212 (714)
+|+.|+++.+... +..+..+..+++|+.|+++++.. +.+|..+ ..+++|+.|+|++|.+++... ..+.++++|+
T Consensus 244 ~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~~-~~l~~~~-~~~~~L~~L~Ls~~~l~~~~~~~~~~~~~~L~ 321 (592)
T 3ogk_B 244 NLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSYMGP-NEMPILF-PFAAQIRKLDLLYALLETEDHCTLIQKCPNLE 321 (592)
T ss_dssp TCCEEEECBCCCCTTCTTSSSCCCCCTTCCEEEETTCCT-TTGGGGG-GGGGGCCEEEETTCCCCHHHHHHHHTTCTTCC
T ss_pred HHHhhcccccccccchHHHHHHhhccccccccCccccch-hHHHHHH-hhcCCCcEEecCCCcCCHHHHHHHHHhCcCCC
Confidence 5555555532221 12334555666777777766533 2455544 346677777777777654333 2345566666
Q ss_pred cccccccccCCcCcCccccCCCCcccccCc
Q 005102 213 GTVDFSHNLFSGSIPASLGNLPEKVYIDLT 242 (714)
Q Consensus 213 ~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~ 242 (714)
.|++++|...+.++..+..+++|+.|+++
T Consensus 322 -~L~L~~~~~~~~l~~~~~~~~~L~~L~L~ 350 (592)
T 3ogk_B 322 -VLETRNVIGDRGLEVLAQYCKQLKRLRIE 350 (592)
T ss_dssp -EEEEEGGGHHHHHHHHHHHCTTCCEEEEE
T ss_pred -EEeccCccCHHHHHHHHHhCCCCCEEEee
Confidence 66666332223334444556666666666
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.00 E-value=7.9e-10 Score=117.42 Aligned_cols=139 Identities=14% Similarity=0.199 Sum_probs=105.3
Q ss_pred cccccCceEEEEEEECCCcEEEEEEeC--CCCc-hhHHHHHHHHHHHhccC--CCCccceEEEEEeC---CceeEEEecc
Q 005102 410 VLGKSGIGIVYKVVLEDGHTLAVRRLG--EGGS-QRFKEFQTEVEAIGKIR--HSNIVTLRAYYWSV---DEKLLIYDYI 481 (714)
Q Consensus 410 ~lG~G~~g~Vy~~~~~~g~~vavK~~~--~~~~-~~~~~~~~E~~~l~~l~--H~niv~l~~~~~~~---~~~~lV~e~~ 481 (714)
.++.|.++.||++...+ ..+++|+.. .... .....+.+|+++++.+. +..+.++++++.+. +..++||||+
T Consensus 45 ~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme~v 123 (359)
T 3dxp_A 45 QFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIMEFV 123 (359)
T ss_dssp ECCC-CCSCEEEEECSS-CEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEECC
T ss_pred EcCCcccceEEEEEECC-ceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEEec
Confidence 58889999999998764 678888876 4321 22346788999999997 45688899988766 4589999999
Q ss_pred CCCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCC------------------------------------
Q 005102 482 PNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFS------------------------------------ 525 (714)
Q Consensus 482 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~------------------------------------ 525 (714)
++..+.+... ..++..++..++.++++.|+.||...
T Consensus 124 ~G~~l~~~~~--------~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (359)
T 3dxp_A 124 SGRVLWDQSL--------PGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIP 195 (359)
T ss_dssp CCBCCCCTTC--------TTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCH
T ss_pred CCeecCCCcc--------ccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCCh
Confidence 9877754211 34678889999999999999999731
Q ss_pred -------------------CCCceecCCCCCCeeeCCCCC--eEEcccchhhh
Q 005102 526 -------------------PKKYVHGDLKPSNILLGHNME--PHVSDFGLARL 557 (714)
Q Consensus 526 -------------------~~~ivHrDlkp~NILl~~~~~--~kl~DFGla~~ 557 (714)
+..++|+|+++.||++++++. +.|+||+.+..
T Consensus 196 ~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 196 AMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 246899999999999997753 68999998864
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=98.94 E-value=4e-09 Score=113.29 Aligned_cols=167 Identities=14% Similarity=0.122 Sum_probs=67.6
Q ss_pred EEEEEcCCCCccccCCccccCCCCCCEEEccCCCCcccCChhhcCCCCCCEEEcCCCcCcccCCcccCCCCCCCEEeccC
Q 005102 66 VVSVSIPKKKLLGFLPSALGSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSGSVPNEIGKLKYLQILDLSQ 145 (714)
Q Consensus 66 ~~~l~l~~~~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~ 145 (714)
++.|.|+. ++...-+.+|.++++|+.++|++|+++. +|...+...+|+.+.|.+| ++..-...|.++++|+.++|..
T Consensus 159 L~~i~lp~-~l~~I~~~aF~~c~~L~~l~l~~n~l~~-I~~~aF~~~~L~~l~lp~~-l~~I~~~aF~~~~~L~~l~l~~ 235 (401)
T 4fdw_A 159 VQEIVFPS-TLEQLKEDIFYYCYNLKKADLSKTKITK-LPASTFVYAGIEEVLLPVT-LKEIGSQAFLKTSQLKTIEIPE 235 (401)
T ss_dssp CCEEECCT-TCCEECSSTTTTCTTCCEEECTTSCCSE-ECTTTTTTCCCSEEECCTT-CCEECTTTTTTCTTCCCEECCT
T ss_pred ceEEEeCC-CccEehHHHhhCcccCCeeecCCCcceE-echhhEeecccCEEEeCCc-hheehhhHhhCCCCCCEEecCC
Confidence 33344432 3333333444444444444444444442 2222222344444444422 3322333344444444444443
Q ss_pred ccCCCCCCcccccccccceeecccCcCCCCCCcccccCccccccccccCCccc-----ccCCCCCCCCcccccccccccc
Q 005102 146 NFFNGSLPVSIVQCKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLNLSFNKFN-----GSIPSNTGNLSSLQGTVDFSHN 220 (714)
Q Consensus 146 N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~l~~L~~L~l~~N~l~-----g~~p~~~~~l~~L~~~l~l~~N 220 (714)
| ++..-..+|.+ .+|+.+.| .|+++ .|+...+.++.+|+.+++.+|.+. ..-+..|.++.+|+ .++|. |
T Consensus 236 ~-l~~I~~~aF~~-~~L~~i~l-p~~i~-~I~~~aF~~c~~L~~l~l~~~~~~~~~~~~I~~~aF~~c~~L~-~l~l~-~ 309 (401)
T 4fdw_A 236 N-VSTIGQEAFRE-SGITTVKL-PNGVT-NIASRAFYYCPELAEVTTYGSTFNDDPEAMIHPYCLEGCPKLA-RFEIP-E 309 (401)
T ss_dssp T-CCEECTTTTTT-CCCSEEEE-ETTCC-EECTTTTTTCTTCCEEEEESSCCCCCTTCEECTTTTTTCTTCC-EECCC-T
T ss_pred C-ccCcccccccc-CCccEEEe-CCCcc-EEChhHhhCCCCCCEEEeCCccccCCcccEECHHHhhCCccCC-eEEeC-C
Confidence 3 22122222333 34444444 22232 333333344455555555444432 12223444444554 44444 2
Q ss_pred cCCcCcCccccCCCCcccccC
Q 005102 221 LFSGSIPASLGNLPEKVYIDL 241 (714)
Q Consensus 221 ~l~g~~p~~~~~l~~L~~l~l 241 (714)
.++..-..+|.++++|+.+++
T Consensus 310 ~i~~I~~~aF~~c~~L~~l~l 330 (401)
T 4fdw_A 310 SIRILGQGLLGGNRKVTQLTI 330 (401)
T ss_dssp TCCEECTTTTTTCCSCCEEEE
T ss_pred ceEEEhhhhhcCCCCccEEEE
Confidence 344333344555555555554
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.89 E-value=4.8e-11 Score=119.70 Aligned_cols=21 Identities=10% Similarity=-0.067 Sum_probs=14.7
Q ss_pred CCcccceEecCC--cEEEEEcCC
Q 005102 53 PCSWNGITCKEQ--RVVSVSIPK 73 (714)
Q Consensus 53 ~c~w~gv~c~~~--~~~~l~l~~ 73 (714)
.|.|.|+.|... +|..+..++
T Consensus 77 l~~~~g~i~~~~~~ki~~~v~~~ 99 (267)
T 3rw6_A 77 LKAVNYKILDRENRRISIIINSS 99 (267)
T ss_dssp HHHTTSSCBCTTSCBCCCEEEEC
T ss_pred HHhcCcEEECCCCCEEEEEEecC
Confidence 478999999743 666655544
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=98.87 E-value=9.9e-12 Score=141.52 Aligned_cols=180 Identities=9% Similarity=0.072 Sum_probs=108.4
Q ss_pred CcEEEEEcCCCCccccCC-ccccCCCCCCEEEccCCCCccc-CChhhcCCCCCCEEEcC---------CCcCcccCCccc
Q 005102 64 QRVVSVSIPKKKLLGFLP-SALGSLTDLRHVNLRNNKFFGS-LPLELLEAQGLQSLVLY---------GNSFSGSVPNEI 132 (714)
Q Consensus 64 ~~~~~l~l~~~~l~g~~p-~~~~~l~~L~~L~L~~N~l~~~-~p~~~~~l~~L~~L~L~---------~N~l~g~~p~~~ 132 (714)
.+++.|+|++|.+++... ..+..+++|++|+|++| ++.. ++.....+++|+.|+|+ .|.+++.....+
T Consensus 289 ~~L~~L~L~~~~l~~~~l~~~~~~~~~L~~L~l~~~-~~~~~l~~l~~~~~~L~~L~L~~~~~~g~~~~~~l~~~~l~~l 367 (594)
T 2p1m_B 289 SRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDY-IEDAGLEVLASTCKDLRELRVFPSEPFVMEPNVALTEQGLVSV 367 (594)
T ss_dssp TTCCEEECTTCCCCHHHHHHHHTTCTTCCEEEEEGG-GHHHHHHHHHHHCTTCCEEEEECSCTTCSSCSSCCCHHHHHHH
T ss_pred CCCCEEEccCCCCCHHHHHHHHhcCCCcCEEeCcCc-cCHHHHHHHHHhCCCCCEEEEecCcccccccCCCCCHHHHHHH
Confidence 578999999999776533 33568899999999988 4422 22223357888888883 345543322223
Q ss_pred C-CCCCCCEEeccCccCCCCCCcccc-cccccceeecc--c----CcCCCCCCcc-----cccCccccccccccCCcccc
Q 005102 133 G-KLKYLQILDLSQNFFNGSLPVSIV-QCKRLKALDLS--Q----NNFTGPLPNG-----FGSGLVSLEKLNLSFNKFNG 199 (714)
Q Consensus 133 ~-~l~~L~~L~Ls~N~l~g~~p~~~~-~l~~L~~L~l~--~----N~l~g~~p~~-----~~~~l~~L~~L~l~~N~l~g 199 (714)
. .+++|+.|+++.|.+++..+..+. .+++|+.|+|+ + |.+++ .|.. +...+++|+.|+|++ .+++
T Consensus 368 ~~~~~~L~~L~~~~~~l~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~-~~~~~~~~~l~~~~~~L~~L~L~~-~l~~ 445 (594)
T 2p1m_B 368 SMGCPKLESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPDYLTL-EPLDIGFGAIVEHCKDLRRLSLSG-LLTD 445 (594)
T ss_dssp HHHCTTCCEEEEEESCCCHHHHHHHHHHCTTCCEEEEEESSTTCCCTTTC-CCTHHHHHHHHHHCTTCCEEECCS-SCCH
T ss_pred HHhchhHHHHHHhcCCcCHHHHHHHHhhCCCcceeEeecccCCCcccccC-CchhhHHHHHHhhCCCccEEeecC-cccH
Confidence 2 367777777777777655444444 46777777777 3 44542 2211 123356677777755 4544
Q ss_pred cCCCCCCC-CcccccccccccccCCcCcCccc-cCCCCcccccCcCCcCC
Q 005102 200 SIPSNTGN-LSSLQGTVDFSHNLFSGSIPASL-GNLPEKVYIDLTYNNLS 247 (714)
Q Consensus 200 ~~p~~~~~-l~~L~~~l~l~~N~l~g~~p~~~-~~l~~L~~l~l~~N~l~ 247 (714)
..+..+.. +++|+ .|++++|.+++..+..+ ..+++|+.|++++|+++
T Consensus 446 ~~~~~l~~~~~~L~-~L~L~~~~i~~~~~~~l~~~~~~L~~L~L~~n~~~ 494 (594)
T 2p1m_B 446 KVFEYIGTYAKKME-MLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFG 494 (594)
T ss_dssp HHHHHHHHHCTTCC-EEEEESCCSSHHHHHHHHHHCTTCCEEEEESCSCC
T ss_pred HHHHHHHHhchhcc-EeeccCCCCcHHHHHHHHhcCCCcCEEECcCCCCc
Confidence 44334433 55666 66777776665544444 45666777777777664
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.86 E-value=1.2e-09 Score=113.08 Aligned_cols=134 Identities=19% Similarity=0.220 Sum_probs=98.4
Q ss_pred cccccCceEEEEEEECCCcEEEEEEeCCCCchhHHHHHHHHHHHhccC-CCC--ccceEEEEEeCC---ceeEEEeccCC
Q 005102 410 VLGKSGIGIVYKVVLEDGHTLAVRRLGEGGSQRFKEFQTEVEAIGKIR-HSN--IVTLRAYYWSVD---EKLLIYDYIPN 483 (714)
Q Consensus 410 ~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~n--iv~l~~~~~~~~---~~~lV~e~~~~ 483 (714)
.++.|....||++. ..+++|+.... .....+.+|+++|+.+. +.. +.+++.+....+ ..|+|||+++|
T Consensus 27 ~~~~G~~n~v~~v~----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~G 100 (304)
T 3sg8_A 27 ISGEGNDCIAYEIN----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIKG 100 (304)
T ss_dssp EEEECSSEEEEEST----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCCC
T ss_pred ecCCCCcceEEEEC----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccCC
Confidence 58899999999864 56889986543 33467889999998884 333 345555443332 34899999999
Q ss_pred CCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCC--------------------------------------
Q 005102 484 GSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFS-------------------------------------- 525 (714)
Q Consensus 484 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~-------------------------------------- 525 (714)
.++.+... ..++..++..++.++++.|+.||+..
T Consensus 101 ~~l~~~~~--------~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (304)
T 3sg8_A 101 VPLTPLLL--------NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKK 172 (304)
T ss_dssp EECCHHHH--------HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHH
T ss_pred eECCcccc--------ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHH
Confidence 88765332 23677788888999999999888611
Q ss_pred -----------------CCCceecCCCCCCeeeCC--CCCeEEcccchhhh
Q 005102 526 -----------------PKKYVHGDLKPSNILLGH--NMEPHVSDFGLARL 557 (714)
Q Consensus 526 -----------------~~~ivHrDlkp~NILl~~--~~~~kl~DFGla~~ 557 (714)
+..++|+|++|.||++++ ...+.|+||+.+..
T Consensus 173 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~ 223 (304)
T 3sg8_A 173 VDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAI 223 (304)
T ss_dssp HHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEE
T ss_pred HHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCcc
Confidence 134799999999999998 45678999998864
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=98.86 E-value=1.1e-08 Score=110.02 Aligned_cols=177 Identities=11% Similarity=0.074 Sum_probs=142.6
Q ss_pred CcEEEEEcCCCCccccCCccccCCCCCCEEEccCCCCcccCChhhcCCCCCCEEEcCCCcCcccCCcccCCCCCCCEEec
Q 005102 64 QRVVSVSIPKKKLLGFLPSALGSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSGSVPNEIGKLKYLQILDL 143 (714)
Q Consensus 64 ~~~~~l~l~~~~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L 143 (714)
.+++.|+|++|+++..-..+|. .++|+.+.|.+| +...-...|.++++|+.++|..| ++..-...|.+ .+|+.+.|
T Consensus 180 ~~L~~l~l~~n~l~~I~~~aF~-~~~L~~l~lp~~-l~~I~~~aF~~~~~L~~l~l~~~-l~~I~~~aF~~-~~L~~i~l 255 (401)
T 4fdw_A 180 YNLKKADLSKTKITKLPASTFV-YAGIEEVLLPVT-LKEIGSQAFLKTSQLKTIEIPEN-VSTIGQEAFRE-SGITTVKL 255 (401)
T ss_dssp TTCCEEECTTSCCSEECTTTTT-TCCCSEEECCTT-CCEECTTTTTTCTTCCCEECCTT-CCEECTTTTTT-CCCSEEEE
T ss_pred ccCCeeecCCCcceEechhhEe-ecccCEEEeCCc-hheehhhHhhCCCCCCEEecCCC-ccCcccccccc-CCccEEEe
Confidence 4789999999999987666776 689999999955 77666778999999999999976 55455556777 89999999
Q ss_pred cCccCCCCCCcccccccccceeecccCcCC----CCCCcccccCccccccccccCCcccccCCCCCCCCccccccccccc
Q 005102 144 SQNFFNGSLPVSIVQCKRLKALDLSQNNFT----GPLPNGFGSGLVSLEKLNLSFNKFNGSIPSNTGNLSSLQGTVDFSH 219 (714)
Q Consensus 144 s~N~l~g~~p~~~~~l~~L~~L~l~~N~l~----g~~p~~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~~l~l~~ 219 (714)
.|.++..-+..|.+|++|+.+++.+|.+. ..|+...+.++.+|+.++|. |.++-.-...|.++.+|+ .+.|..
T Consensus 256 -p~~i~~I~~~aF~~c~~L~~l~l~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~-~~i~~I~~~aF~~c~~L~-~l~lp~ 332 (401)
T 4fdw_A 256 -PNGVTNIASRAFYYCPELAEVTTYGSTFNDDPEAMIHPYCLEGCPKLARFEIP-ESIRILGQGLLGGNRKVT-QLTIPA 332 (401)
T ss_dssp -ETTCCEECTTTTTTCTTCCEEEEESSCCCCCTTCEECTTTTTTCTTCCEECCC-TTCCEECTTTTTTCCSCC-EEEECT
T ss_pred -CCCccEEChhHhhCCCCCCEEEeCCccccCCcccEECHHHhhCCccCCeEEeC-CceEEEhhhhhcCCCCcc-EEEECc
Confidence 45566455678999999999999998874 13666677889999999999 557744457888899999 999955
Q ss_pred ccCCcCcCccccCCCCcccccCcCCcCCCC
Q 005102 220 NLFSGSIPASLGNLPEKVYIDLTYNNLSGP 249 (714)
Q Consensus 220 N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~ 249 (714)
| ++..-+.+|.++ +|+.+++++|.+...
T Consensus 333 ~-l~~I~~~aF~~~-~L~~l~l~~n~~~~l 360 (401)
T 4fdw_A 333 N-VTQINFSAFNNT-GIKEVKVEGTTPPQV 360 (401)
T ss_dssp T-CCEECTTSSSSS-CCCEEEECCSSCCBC
T ss_pred c-ccEEcHHhCCCC-CCCEEEEcCCCCccc
Confidence 4 776667889999 999999999977643
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=98.84 E-value=3.8e-10 Score=119.17 Aligned_cols=181 Identities=16% Similarity=0.155 Sum_probs=124.3
Q ss_pred CcEEEEEcCCCCccc-c-------CCccccCCCCCCEEEccCCCCc---------ccCChhhcCCCCCCEEEcCCCcCcc
Q 005102 64 QRVVSVSIPKKKLLG-F-------LPSALGSLTDLRHVNLRNNKFF---------GSLPLELLEAQGLQSLVLYGNSFSG 126 (714)
Q Consensus 64 ~~~~~l~l~~~~l~g-~-------~p~~~~~l~~L~~L~L~~N~l~---------~~~p~~~~~l~~L~~L~L~~N~l~g 126 (714)
.+|+.|.+......| . +..++..+++|+.|.+..+... +.++..+..+++|+.|+|++|.-.
T Consensus 107 ~~v~~L~lg~~~~~~~~~~~~~~~L~~s~~~l~~L~~L~l~~~~~e~~~is~~~~~~L~~ll~~~P~L~~L~L~g~~~l- 185 (362)
T 2ra8_A 107 PSLKQITIGXWGYEGEDCSDIADGIVENKEKFAHFEGLFWGDIDFEEQEISWIEQVDLSPVLDAMPLLNNLKIKGTNNL- 185 (362)
T ss_dssp GGCSEEEECCCCSSSCCSHHHHHHHHTTHHHHTTCSEEEECCCCTTTCCGGGCBCCBCHHHHHTCTTCCEEEEECCBTC-
T ss_pred hhcceEEEcccccCCCcHHHHHHHHHHhhhhcchhhheeecCcchhhcccccccccCHHHHHhcCCCCcEEEEeCCCCc-
Confidence 467788877666442 1 2344567889999999776431 235566678899999999988421
Q ss_pred cCCcccCCCCCCCEEeccCccCCCCCCcccc--cccccceeeccc--CcCCCC-----CCcccc-cCccccccccccCCc
Q 005102 127 SVPNEIGKLKYLQILDLSQNFFNGSLPVSIV--QCKRLKALDLSQ--NNFTGP-----LPNGFG-SGLVSLEKLNLSFNK 196 (714)
Q Consensus 127 ~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~--~l~~L~~L~l~~--N~l~g~-----~p~~~~-~~l~~L~~L~l~~N~ 196 (714)
.++. +. +++|+.|+|..|.++......+. .+++|+.|+|+. |...|. +...+. ..+++|+.|+|++|.
T Consensus 186 ~l~~-~~-~~~L~~L~L~~~~l~~~~l~~l~~~~lp~L~~L~L~~~~~~~~~~~~~~~l~~~l~~~~~p~Lr~L~L~~~~ 263 (362)
T 2ra8_A 186 SIGK-KP-RPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAE 263 (362)
T ss_dssp BCCS-CB-CTTCSEEEEECSBCCHHHHHHHHHSBCTTCCEEEEECBCGGGTCCSCGGGTGGGSCTTTCTTCCEEEEESCT
T ss_pred eecc-cc-CCCCcEEEEecCCCChHHHHHHHHccCCCCcEEEEeccccccccchhHHHHHHHHhcCCCCCcCEEeCCCCC
Confidence 3444 43 89999999998887643333343 688999999863 332222 111121 236899999999999
Q ss_pred ccccCCCCC---CCCcccccccccccccCCcC----cCccccCCCCcccccCcCCcCCC
Q 005102 197 FNGSIPSNT---GNLSSLQGTVDFSHNLFSGS----IPASLGNLPEKVYIDLTYNNLSG 248 (714)
Q Consensus 197 l~g~~p~~~---~~l~~L~~~l~l~~N~l~g~----~p~~~~~l~~L~~l~l~~N~l~~ 248 (714)
+.+..+..+ ..+++|+ .|+|+.|.|+.. ++..+..+++|+.|++++|.++.
T Consensus 264 i~~~~~~~la~a~~~~~L~-~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n~i~d 321 (362)
T 2ra8_A 264 EQNVVVEMFLESDILPQLE-TMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSD 321 (362)
T ss_dssp THHHHHHHHHHCSSGGGCS-EEECCSSCCBHHHHHHHHTTHHHHTTCSEEECCSBBCCH
T ss_pred CchHHHHHHHhCccCCCCC-EEECCCCCCChHHHHHHHhhcccCCcceEEECCCCcCCH
Confidence 875443222 2578898 999999999864 44445677999999999998773
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=98.82 E-value=1.3e-10 Score=132.25 Aligned_cols=128 Identities=16% Similarity=0.169 Sum_probs=72.8
Q ss_pred CcEEEEEcCCCCccccCCcccc-CCCCCCEEEccCC-CCccc-CChhhcCCCCCCEEEcCCCcCcccCCcccC----CCC
Q 005102 64 QRVVSVSIPKKKLLGFLPSALG-SLTDLRHVNLRNN-KFFGS-LPLELLEAQGLQSLVLYGNSFSGSVPNEIG----KLK 136 (714)
Q Consensus 64 ~~~~~l~l~~~~l~g~~p~~~~-~l~~L~~L~L~~N-~l~~~-~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~----~l~ 136 (714)
.+++.|+|+++.+++..+..+. .+++|++|+|++| .++.. ++..+..+++|+.|+|++|.+++..+..+. .++
T Consensus 105 ~~L~~L~L~~~~~~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~~ 184 (594)
T 2p1m_B 105 TWLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYT 184 (594)
T ss_dssp TTCCEEEEESCBCCHHHHHHHHHHCTTCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCTTCC
T ss_pred CCCCeEEeeCcEEcHHHHHHHHHhCCCCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhhcCC
Confidence 4667777777777666655554 5677777777776 44322 333344667777777777776654433332 455
Q ss_pred CCCEEeccCcc--CCC-CCCcccccccccceeecccC-cCCCCCCcccccCcccccccccc
Q 005102 137 YLQILDLSQNF--FNG-SLPVSIVQCKRLKALDLSQN-NFTGPLPNGFGSGLVSLEKLNLS 193 (714)
Q Consensus 137 ~L~~L~Ls~N~--l~g-~~p~~~~~l~~L~~L~l~~N-~l~g~~p~~~~~~l~~L~~L~l~ 193 (714)
+|+.|+|++|. ++. .++..+..+++|+.|+|++| .+. .+|..+ ..+++|+.|+++
T Consensus 185 ~L~~L~l~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~~~~-~l~~~~-~~~~~L~~L~l~ 243 (594)
T 2p1m_B 185 SLVSLNISCLASEVSFSALERLVTRCPNLKSLKLNRAVPLE-KLATLL-QRAPQLEELGTG 243 (594)
T ss_dssp CCCEEECTTCCSCCCHHHHHHHHHHCTTCCEEECCTTSCHH-HHHHHH-HHCTTCSEEECS
T ss_pred cCcEEEecccCCcCCHHHHHHHHHhCCCCcEEecCCCCcHH-HHHHHH-hcCCcceEcccc
Confidence 77777777775 111 01111234567777777766 333 244433 235666666633
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=98.62 E-value=2.4e-09 Score=113.05 Aligned_cols=176 Identities=16% Similarity=0.179 Sum_probs=119.2
Q ss_pred CcEEEEEcCCCCc---------cccCCccccCCCCCCEEEccCCCCcccCChhhcCCCCCCEEEcCCCcCcccCCcccC-
Q 005102 64 QRVVSVSIPKKKL---------LGFLPSALGSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSGSVPNEIG- 133 (714)
Q Consensus 64 ~~~~~l~l~~~~l---------~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~- 133 (714)
.+++.|.|..+.. .+.++..+..+++|+.|+|++|.-. .++. + .+++|+.|+|..|.++......++
T Consensus 139 ~~L~~L~l~~~~~e~~~is~~~~~~L~~ll~~~P~L~~L~L~g~~~l-~l~~-~-~~~~L~~L~L~~~~l~~~~l~~l~~ 215 (362)
T 2ra8_A 139 AHFEGLFWGDIDFEEQEISWIEQVDLSPVLDAMPLLNNLKIKGTNNL-SIGK-K-PRPNLKSLEIISGGLPDSVVEDILG 215 (362)
T ss_dssp TTCSEEEECCCCTTTCCGGGCBCCBCHHHHHTCTTCCEEEEECCBTC-BCCS-C-BCTTCSEEEEECSBCCHHHHHHHHH
T ss_pred chhhheeecCcchhhcccccccccCHHHHHhcCCCCcEEEEeCCCCc-eecc-c-cCCCCcEEEEecCCCChHHHHHHHH
Confidence 4777887765432 1235566778899999999988311 2343 3 388999999999887654444444
Q ss_pred -CCCCCCEEeccC--ccCCCC-----CCccc--ccccccceeecccCcCCCCCCcccc--cCccccccccccCCccccc-
Q 005102 134 -KLKYLQILDLSQ--NFFNGS-----LPVSI--VQCKRLKALDLSQNNFTGPLPNGFG--SGLVSLEKLNLSFNKFNGS- 200 (714)
Q Consensus 134 -~l~~L~~L~Ls~--N~l~g~-----~p~~~--~~l~~L~~L~l~~N~l~g~~p~~~~--~~l~~L~~L~l~~N~l~g~- 200 (714)
.+++|+.|+|+. |...|. +...+ ..+++|+.|+|++|.+.+..+..+. ..+++|+.|+|+.|.+.+.
T Consensus 216 ~~lp~L~~L~L~~~~~~~~~~~~~~~l~~~l~~~~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~G 295 (362)
T 2ra8_A 216 SDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEG 295 (362)
T ss_dssp SBCTTCCEEEEECBCGGGTCCSCGGGTGGGSCTTTCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBHHH
T ss_pred ccCCCCcEEEEeccccccccchhHHHHHHHHhcCCCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCChHH
Confidence 789999999863 332221 11122 2478999999999998754333332 1478999999999999863
Q ss_pred ---CCCCCCCCcccccccccccccCCcCcCccccC-CCCcccccCcCCc
Q 005102 201 ---IPSNTGNLSSLQGTVDFSHNLFSGSIPASLGN-LPEKVYIDLTYNN 245 (714)
Q Consensus 201 ---~p~~~~~l~~L~~~l~l~~N~l~g~~p~~~~~-l~~L~~l~l~~N~ 245 (714)
++..+.++++|+ .|++++|.++...-..+.. + ...++++.|+
T Consensus 296 ~~~L~~~L~~l~~L~-~L~L~~n~i~d~~~~~l~~al--g~~~~~~~~~ 341 (362)
T 2ra8_A 296 ARLLLDHVDKIKHLK-FINMKYNYLSDEMKKELQKSL--PMKIDVSDSQ 341 (362)
T ss_dssp HHHHHTTHHHHTTCS-EEECCSBBCCHHHHHHHHHHC--CSEEECCSBC
T ss_pred HHHHHhhcccCCcce-EEECCCCcCCHHHHHHHHHHc--CCEEEecCCc
Confidence 555556678899 9999999987543333332 2 2457777766
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.51 E-value=2.6e-08 Score=99.77 Aligned_cols=106 Identities=24% Similarity=0.245 Sum_probs=72.8
Q ss_pred ccCCCCCCE--EEccCCCCc---ccCChhhcCCCCCCEEEcCCCcCcc--cCCcccCCCCCCCEEeccCccCCCCCCccc
Q 005102 84 LGSLTDLRH--VNLRNNKFF---GSLPLELLEAQGLQSLVLYGNSFSG--SVPNEIGKLKYLQILDLSQNFFNGSLPVSI 156 (714)
Q Consensus 84 ~~~l~~L~~--L~L~~N~l~---~~~p~~~~~l~~L~~L~L~~N~l~g--~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~ 156 (714)
|...+.|+. ++++.|+.. +.++....++++|+.|+|++|+|++ .+|..+..+++|+.|+|++|+|++. ..+
T Consensus 137 l~~dp~L~~~~l~l~~N~~~~~~~~l~i~~~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l 214 (267)
T 3rw6_A 137 LRSDPDLVAQNIDVVLNRRSCMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--REL 214 (267)
T ss_dssp GGGCHHHHHTTCCCCTTSHHHHHHHHHHHHHHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGG
T ss_pred cCCCcchhhcCccccCCHHHHHHHHHHHHHhhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhh
Confidence 444455554 667777433 2222233467888888888888887 5566777888899999999988854 345
Q ss_pred cccc--ccceeecccCcCCCCCCcc------cccCcccccccc
Q 005102 157 VQCK--RLKALDLSQNNFTGPLPNG------FGSGLVSLEKLN 191 (714)
Q Consensus 157 ~~l~--~L~~L~l~~N~l~g~~p~~------~~~~l~~L~~L~ 191 (714)
..+. +|++|+|++|.+.+.+|.. +...+++|+.||
T Consensus 215 ~~l~~l~L~~L~L~~Npl~~~~~~~~~y~~~il~~~P~L~~LD 257 (267)
T 3rw6_A 215 DKIKGLKLEELWLDGNSLCDTFRDQSTYISAIRERFPKLLRLD 257 (267)
T ss_dssp GGGTTSCCSEEECTTSTTGGGCSSHHHHHHHHHHHCTTCCEES
T ss_pred hhcccCCcceEEccCCcCccccCcchhHHHHHHHHCcccCeEC
Confidence 5555 8889999999988777632 223477888776
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.43 E-value=1.1e-06 Score=90.67 Aligned_cols=134 Identities=19% Similarity=0.200 Sum_probs=96.1
Q ss_pred cccccCceEEEEEEECCCcEEEEEEeCCCCchhHHHHHHHHHHHhccCCC---CccceEEEEE-eCCceeEEEeccCCCC
Q 005102 410 VLGKSGIGIVYKVVLEDGHTLAVRRLGEGGSQRFKEFQTEVEAIGKIRHS---NIVTLRAYYW-SVDEKLLIYDYIPNGS 485 (714)
Q Consensus 410 ~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~---niv~l~~~~~-~~~~~~lV~e~~~~gs 485 (714)
.++.|....||+. |..+++|+... ......+.+|.++|+.+.+. .+.+++.++. ..+..++||||++|..
T Consensus 26 ~l~~G~~n~v~~v----g~~~VlR~~~~--~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~~ 99 (306)
T 3tdw_A 26 SLGEGFRNYAILV----NGDWVFRFPKS--QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQI 99 (306)
T ss_dssp EEEECSSEEEEEE----TTTEEEEEESS--HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSEE
T ss_pred ecCCCcceeEEEE----CCEEEEEecCC--chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCeE
Confidence 5778888899988 56788888532 23346789999999999653 3566777764 3456789999999988
Q ss_pred HhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcC-----------------------------------------
Q 005102 486 LATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEF----------------------------------------- 524 (714)
Q Consensus 486 L~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~----------------------------------------- 524 (714)
+.+..- ..++..++..++.++++.|+.||+.
T Consensus 100 l~~~~~--------~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~ 171 (306)
T 3tdw_A 100 LGEDGM--------AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDY 171 (306)
T ss_dssp CHHHHH--------TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHH
T ss_pred Cchhhh--------hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHH
Confidence 766322 2245556666666666666666642
Q ss_pred ----------------CCCCceecCCCCCCeeeCC---CCC-eEEcccchhhh
Q 005102 525 ----------------SPKKYVHGDLKPSNILLGH---NME-PHVSDFGLARL 557 (714)
Q Consensus 525 ----------------~~~~ivHrDlkp~NILl~~---~~~-~kl~DFGla~~ 557 (714)
.+..++|+|+++.||++++ ++. +.|+||+.+..
T Consensus 172 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 172 LTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 1234699999999999987 455 48999998764
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.38 E-value=1.8e-08 Score=95.96 Aligned_cols=120 Identities=18% Similarity=0.195 Sum_probs=72.3
Q ss_pred cCCccccCCCCCCEEEccCC-CCccc----CChhhcCCCCCCEEEcCCCcCccc----CCcccCCCCCCCEEeccCccCC
Q 005102 79 FLPSALGSLTDLRHVNLRNN-KFFGS----LPLELLEAQGLQSLVLYGNSFSGS----VPNEIGKLKYLQILDLSQNFFN 149 (714)
Q Consensus 79 ~~p~~~~~l~~L~~L~L~~N-~l~~~----~p~~~~~l~~L~~L~L~~N~l~g~----~p~~~~~l~~L~~L~Ls~N~l~ 149 (714)
.+...+...+.|++|+|++| .+... +...+...++|++|+|++|.+... +...+...++|+.|+|++|.|.
T Consensus 27 ~l~~~l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~ 106 (185)
T 1io0_A 27 TLKRIQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFIS 106 (185)
T ss_dssp HHHHHHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCC
T ss_pred HHHHHHhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCC
Confidence 34455666777778888777 77532 344455567777788877777532 2333445567777888887776
Q ss_pred CC----CCcccccccccceeec--ccCcCCCCCCcccc---cCccccccccccCCccc
Q 005102 150 GS----LPVSIVQCKRLKALDL--SQNNFTGPLPNGFG---SGLVSLEKLNLSFNKFN 198 (714)
Q Consensus 150 g~----~p~~~~~l~~L~~L~l--~~N~l~g~~p~~~~---~~l~~L~~L~l~~N~l~ 198 (714)
.. +...+...++|++|+| ++|.+...-...+. ...++|+.|+|++|.+.
T Consensus 107 ~~g~~~l~~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i~ 164 (185)
T 1io0_A 107 GSGILALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG 164 (185)
T ss_dssp HHHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred HHHHHHHHHHHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCCC
Confidence 42 3445556667777777 66777532111111 12356666777766664
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.35 E-value=1.8e-06 Score=87.37 Aligned_cols=134 Identities=16% Similarity=0.199 Sum_probs=97.3
Q ss_pred ccccCce-EEEEEEECC-CcEEEEEEeCCCCchhHHHHHHHHHHHhccC-CCCccceEEEEEeCCceeEEEeccCCCCHh
Q 005102 411 LGKSGIG-IVYKVVLED-GHTLAVRRLGEGGSQRFKEFQTEVEAIGKIR-HSNIVTLRAYYWSVDEKLLIYDYIPNGSLA 487 (714)
Q Consensus 411 lG~G~~g-~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lV~e~~~~gsL~ 487 (714)
+..|..+ .||+..... +..+++|+-... ....+.+|...|+.+. +--+.++++++.+.+..++|||++++.++.
T Consensus 32 ~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~ 108 (272)
T 4gkh_A 32 DNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAF 108 (272)
T ss_dssp EECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHH
T ss_pred ccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCcccc
Confidence 4445554 699987654 678889986543 2356788999998884 334678899999889999999999998877
Q ss_pred hhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCC------------------------------------------
Q 005102 488 TALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFS------------------------------------------ 525 (714)
Q Consensus 488 ~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~------------------------------------------ 525 (714)
+..... ......++.+++..|+-||...
T Consensus 109 ~~~~~~----------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 178 (272)
T 4gkh_A 109 QVLEEY----------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQ 178 (272)
T ss_dssp HHHHHC----------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHH
T ss_pred ccccCC----------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHH
Confidence 654321 1223456667777777777421
Q ss_pred -------------CCCceecCCCCCCeeeCCCCCeEEcccchhhh
Q 005102 526 -------------PKKYVHGDLKPSNILLGHNMEPHVSDFGLARL 557 (714)
Q Consensus 526 -------------~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 557 (714)
+..++|+|+.+.||++++++.+-|+||+.+..
T Consensus 179 ~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 179 VWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 11379999999999999877778999998763
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.29 E-value=1.2e-07 Score=90.23 Aligned_cols=111 Identities=14% Similarity=0.101 Sum_probs=89.3
Q ss_pred CCcEEEEEcCCC-Ccccc----CCccccCCCCCCEEEccCCCCccc----CChhhcCCCCCCEEEcCCCcCccc----CC
Q 005102 63 EQRVVSVSIPKK-KLLGF----LPSALGSLTDLRHVNLRNNKFFGS----LPLELLEAQGLQSLVLYGNSFSGS----VP 129 (714)
Q Consensus 63 ~~~~~~l~l~~~-~l~g~----~p~~~~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~g~----~p 129 (714)
...++.|+|++| .+... +...+...++|++|+|++|.|... +...+...++|+.|+|++|.|+.. +.
T Consensus 35 ~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~g~~~l~ 114 (185)
T 1io0_A 35 DPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALV 114 (185)
T ss_dssp CTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHH
T ss_pred CCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHHHHHHHH
Confidence 568999999999 88753 556777889999999999999742 445566678999999999999753 45
Q ss_pred cccCCCCCCCEEec--cCccCCCC----CCcccccccccceeecccCcCC
Q 005102 130 NEIGKLKYLQILDL--SQNFFNGS----LPVSIVQCKRLKALDLSQNNFT 173 (714)
Q Consensus 130 ~~~~~l~~L~~L~L--s~N~l~g~----~p~~~~~l~~L~~L~l~~N~l~ 173 (714)
..+...++|+.|+| ++|.|... +...+...++|++|+|++|.+.
T Consensus 115 ~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i~ 164 (185)
T 1io0_A 115 EALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG 164 (185)
T ss_dssp HGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred HHHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCCC
Confidence 66778889999999 88999753 3344556689999999999885
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.26 E-value=1.2e-06 Score=92.67 Aligned_cols=79 Identities=9% Similarity=0.001 Sum_probs=55.8
Q ss_pred cc-cccCceEEEEEEEC-------CCcEEEEEEeCCCC---chhHHHHHHHHHHHhccC-C--CCccceEEEEEeC---C
Q 005102 410 VL-GKSGIGIVYKVVLE-------DGHTLAVRRLGEGG---SQRFKEFQTEVEAIGKIR-H--SNIVTLRAYYWSV---D 472 (714)
Q Consensus 410 ~l-G~G~~g~Vy~~~~~-------~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-H--~niv~l~~~~~~~---~ 472 (714)
.| +.|....+|+.... ++..+++|+..... ......+.+|+++++.+. + -.+.++++++.+. +
T Consensus 27 ~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~g 106 (357)
T 3ats_A 27 GVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVLG 106 (357)
T ss_dssp EECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTTS
T ss_pred ECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCccC
Confidence 56 77888999998764 26788898875432 101135778999998884 3 3567788887654 3
Q ss_pred ceeEEEeccCCCCHhh
Q 005102 473 EKLLIYDYIPNGSLAT 488 (714)
Q Consensus 473 ~~~lV~e~~~~gsL~~ 488 (714)
..++||||+++..+.+
T Consensus 107 ~~~~v~e~l~G~~l~~ 122 (357)
T 3ats_A 107 TPFFLMDYVEGVVPPD 122 (357)
T ss_dssp SCEEEEECCCCBCCCB
T ss_pred CceEEEEecCCCChhh
Confidence 5689999999876653
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.90 E-value=3.1e-05 Score=82.99 Aligned_cols=74 Identities=7% Similarity=0.115 Sum_probs=49.3
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeCCCCc-------hhHHHHHHHHHHHhccCC--CC-ccceEEEEEeCCceeEE
Q 005102 409 FVLGKSGIGIVYKVVLE-DGHTLAVRRLGEGGS-------QRFKEFQTEVEAIGKIRH--SN-IVTLRAYYWSVDEKLLI 477 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~H--~n-iv~l~~~~~~~~~~~lV 477 (714)
+.+|.|.++.||++... +++.++||....... .....+..|.++++.+.. +. +.+++.+ +.+..++|
T Consensus 36 ~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~lv 113 (397)
T 2olc_A 36 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV 113 (397)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred EECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEEE
Confidence 46899999999999764 468899998653211 122456789999888742 33 3455543 45567899
Q ss_pred EeccCCC
Q 005102 478 YDYIPNG 484 (714)
Q Consensus 478 ~e~~~~g 484 (714)
|||+++.
T Consensus 114 mE~l~g~ 120 (397)
T 2olc_A 114 MEDLSHL 120 (397)
T ss_dssp ECCCTTS
T ss_pred EEeCCCc
Confidence 9999763
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.87 E-value=6.4e-05 Score=78.50 Aligned_cols=142 Identities=19% Similarity=0.229 Sum_probs=80.0
Q ss_pred cccccCceEEEEEEECCCcEEEEEEeCCCCchhHHHHHHHHHHHhccC-----CCCccceE-E--EEEeCCceeEEEecc
Q 005102 410 VLGKSGIGIVYKVVLEDGHTLAVRRLGEGGSQRFKEFQTEVEAIGKIR-----HSNIVTLR-A--YYWSVDEKLLIYDYI 481 (714)
Q Consensus 410 ~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----H~niv~l~-~--~~~~~~~~~lV~e~~ 481 (714)
.|+.|..+.||++...+| .+++|+.... ..++..|++++..+. .|.++... | +....+..++||||+
T Consensus 39 ~l~gG~~n~~~~v~~~~~-~~vlk~~~~~----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~i 113 (346)
T 2q83_A 39 VIQGNQMALVWKVHTDSG-AVCLKRIHRP----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDWI 113 (346)
T ss_dssp ECC----CEEEEEEETTE-EEEEEEECSC----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEECC
T ss_pred eccccccCcEEEEEeCCC-CEEEEecCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEee
Confidence 456667889999988655 5889998752 133445566655553 34444310 0 122356678999999
Q ss_pred CCCCHh--------------hhhhCCCC-C-----C--CcCCCCHHHH-------------------------------H
Q 005102 482 PNGSLA--------------TALHGKPG-M-----V--SFTPVPWSVR-------------------------------V 508 (714)
Q Consensus 482 ~~gsL~--------------~~l~~~~~-~-----~--~~~~l~~~~~-------------------------------~ 508 (714)
++..+. ..+|.... . . ....-.|... .
T Consensus 114 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 193 (346)
T 2q83_A 114 EGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEID 193 (346)
T ss_dssp CCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHHH
T ss_pred cCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHHH
Confidence 986542 11221100 0 0 0001123221 0
Q ss_pred HHHHHHHHHHHHHhc----------CCCCCceecCCCCCCeeeCCCCCeEEcccchhh
Q 005102 509 KIIKGIAKGLVYLHE----------FSPKKYVHGDLKPSNILLGHNMEPHVSDFGLAR 556 (714)
Q Consensus 509 ~i~~~ia~gL~~LH~----------~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~ 556 (714)
.+...+..++++|+. ..+..++|+|+++.||+++.++.+.|+||+.+.
T Consensus 194 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 194 GFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred HHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 111223445666653 123689999999999999888889999999775
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.61 E-value=0.00028 Score=71.82 Aligned_cols=73 Identities=21% Similarity=0.301 Sum_probs=54.7
Q ss_pred cccccCceEEEEEEECCCcEEEEEEeCCCCchhHHHHHHHHHHHhccC-C--CCccceEEEEEeCCceeEEEeccCCCCH
Q 005102 410 VLGKSGIGIVYKVVLEDGHTLAVRRLGEGGSQRFKEFQTEVEAIGKIR-H--SNIVTLRAYYWSVDEKLLIYDYIPNGSL 486 (714)
Q Consensus 410 ~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H--~niv~l~~~~~~~~~~~lV~e~~~~gsL 486 (714)
.+|.|..+.||+.+..||+.|++|+...........|..|++.|+.+. . --+.+++++ +..++||||++.+..
T Consensus 22 ~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~----~~~~lv~e~l~~~~~ 97 (288)
T 3f7w_A 22 ERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW----DDRTLAMEWVDERPP 97 (288)
T ss_dssp EEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE----ETTEEEEECCCCCCC
T ss_pred ecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec----cCceEEEEeecccCC
Confidence 589999999999999999999999876554443356889999998884 2 134455554 245899999987643
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.58 E-value=0.00023 Score=73.16 Aligned_cols=139 Identities=14% Similarity=0.113 Sum_probs=91.7
Q ss_pred cccccCceEEEEEEECCCcEEEEEEeCCCCchhHHHHHHHHHHHhccC---CCCccceEEEEEeCCceeEEEeccCCCCH
Q 005102 410 VLGKSGIGIVYKVVLEDGHTLAVRRLGEGGSQRFKEFQTEVEAIGKIR---HSNIVTLRAYYWSVDEKLLIYDYIPNGSL 486 (714)
Q Consensus 410 ~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---H~niv~l~~~~~~~~~~~lV~e~~~~gsL 486 (714)
.|+.|....+|+... ++..+++|+.... ....+..|.+.|+.+. ...+.++++++...+..++||||+++..+
T Consensus 43 ~l~gG~~n~~y~v~~-~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~~~ 118 (312)
T 3jr1_A 43 KLYSGEMNEIWLIND-EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKSKN 118 (312)
T ss_dssp EECCSSSSEEEEEES-SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCCCC
T ss_pred EeCCccceeeeEEEE-CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCCCC
Confidence 578899999999986 4678889987643 2467889999999884 35688899988888889999999998764
Q ss_pred hh-----------hhhCCCCCCCc----------------CCCCHHHHH---HHHH----------------HHHHH-HH
Q 005102 487 AT-----------ALHGKPGMVSF----------------TPVPWSVRV---KIIK----------------GIAKG-LV 519 (714)
Q Consensus 487 ~~-----------~l~~~~~~~~~----------------~~l~~~~~~---~i~~----------------~ia~g-L~ 519 (714)
.. .||.......+ ..-+|.... ++.. .+... ..
T Consensus 119 ~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~l~~ 198 (312)
T 3jr1_A 119 KQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQIVAD 198 (312)
T ss_dssp CTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHHHHH
T ss_pred CchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHHHHH
Confidence 21 23332110000 012465321 1111 11111 22
Q ss_pred HHhc-CCCCCceecCCCCCCeeeCCCCCeEEcccc
Q 005102 520 YLHE-FSPKKYVHGDLKPSNILLGHNMEPHVSDFG 553 (714)
Q Consensus 520 ~LH~-~~~~~ivHrDlkp~NILl~~~~~~kl~DFG 553 (714)
.|.. ..+..++|+|+.+.||+++.++ +.|.||.
T Consensus 199 ~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 199 TLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 3421 1224799999999999999887 8999984
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.54 E-value=0.00023 Score=76.72 Aligned_cols=72 Identities=13% Similarity=0.178 Sum_probs=45.1
Q ss_pred ccccccCceEEEEEEECCCcEEEEEEeCCC------C-c--hhHHHHHHHHHHHhc-cCCCCccceEEEEEeCCceeEEE
Q 005102 409 FVLGKSGIGIVYKVVLEDGHTLAVRRLGEG------G-S--QRFKEFQTEVEAIGK-IRHSNIVTLRAYYWSVDEKLLIY 478 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~------~-~--~~~~~~~~E~~~l~~-l~H~niv~l~~~~~~~~~~~lV~ 478 (714)
+.+|.|..+.||++.. ++..++||..... . . .....+..|+..+.. .....+.+++.+. .+..++||
T Consensus 40 ~~l~~G~~n~vyrv~~-~~~~~vvK~~~p~~~~~~~~~~~~~~~~~~E~e~l~~~~~~~~~~vP~v~~~~--~~~~~lv~ 116 (420)
T 2pyw_A 40 KEVGDGNLNFVFIVVG-SSGSLVIKQALPYIRCIGESWPMTKERAYFEATTLRKHGNLSPDHVPEVYHFD--RTMALIGM 116 (420)
T ss_dssp EECCCSSSCEEEEEEC-SSCEEEEEECCSBCTTTCTTSBCCTTHHHHHHHHHHHHHHHSGGGSCCEEEEE--TTTTEEEE
T ss_pred EEccCCCcEEEEEEEc-CCceEEEEECchhhcccCcccccchhHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCccEEEE
Confidence 3588899999999965 4678999943211 1 1 122344444443322 2234566777665 56789999
Q ss_pred ecc-CC
Q 005102 479 DYI-PN 483 (714)
Q Consensus 479 e~~-~~ 483 (714)
||+ ++
T Consensus 117 e~l~~g 122 (420)
T 2pyw_A 117 RYLEPP 122 (420)
T ss_dssp CCCCTT
T ss_pred eecCCc
Confidence 999 76
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=97.44 E-value=0.0003 Score=75.13 Aligned_cols=171 Identities=14% Similarity=0.077 Sum_probs=87.8
Q ss_pred CcEEEEEcCCCCccccCCccccCCCCCCEEEccCCCCcccCChhhcCCCCCCEEEcCCCc--------------------
Q 005102 64 QRVVSVSIPKKKLLGFLPSALGSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNS-------------------- 123 (714)
Q Consensus 64 ~~~~~l~l~~~~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~-------------------- 123 (714)
..++.+.|+.+ +...-...|.++.+|+.+++..| ++-.-...|.+...|+.+.+..+.
T Consensus 162 ~~L~~i~l~~~-~~~I~~~~F~~c~~L~~i~l~~~-~~~I~~~~F~~~~~L~~i~~~~~~~~i~~~~~~~~~l~~i~ip~ 239 (394)
T 4fs7_A 162 ESLEYVSLPDS-METLHNGLFSGCGKLKSIKLPRN-LKIIRDYCFAECILLENMEFPNSLYYLGDFALSKTGVKNIIIPD 239 (394)
T ss_dssp TTCCEEECCTT-CCEECTTTTTTCTTCCBCCCCTT-CCEECTTTTTTCTTCCBCCCCTTCCEECTTTTTTCCCCEEEECT
T ss_pred CCCcEEecCCc-cceeccccccCCCCceEEEcCCC-ceEeCchhhccccccceeecCCCceEeehhhcccCCCceEEECC
Confidence 46777777654 34444567777888888888765 332333444455544444443321
Q ss_pred -CcccCCcccCCCCCCCEEeccCccCCCCCCcccccccccceeecccCcCCCCCCcccccCccccccccccCCcccccCC
Q 005102 124 -FSGSVPNEIGKLKYLQILDLSQNFFNGSLPVSIVQCKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLNLSFNKFNGSIP 202 (714)
Q Consensus 124 -l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~l~~L~~L~l~~N~l~g~~p 202 (714)
++..-...+.+..+|+.+.+..|... .-...|..+..|+.+.+..+. ++...+.++.+|+.+.+.++ ++..-.
T Consensus 240 ~~~~i~~~~f~~~~~l~~~~~~~~~~~-i~~~~F~~~~~l~~~~~~~~~----i~~~~F~~~~~L~~i~l~~~-i~~I~~ 313 (394)
T 4fs7_A 240 SFTELGKSVFYGCTDLESISIQNNKLR-IGGSLFYNCSGLKKVIYGSVI----VPEKTFYGCSSLTEVKLLDS-VKFIGE 313 (394)
T ss_dssp TCCEECSSTTTTCSSCCEEEECCTTCE-ECSCTTTTCTTCCEEEECSSE----ECTTTTTTCTTCCEEEECTT-CCEECT
T ss_pred CceecccccccccccceeEEcCCCcce-eeccccccccccceeccCcee----eccccccccccccccccccc-cceech
Confidence 11112234556677888887766543 334455555666655554443 22223334555555555433 331222
Q ss_pred CCCCCCcccccccccccccCCcCcCccccCCCCcccccCcCC
Q 005102 203 SNTGNLSSLQGTVDFSHNLFSGSIPASLGNLPEKVYIDLTYN 244 (714)
Q Consensus 203 ~~~~~l~~L~~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N 244 (714)
..|.++.+|+ .+++.++ ++..-..+|.++.+|+.+++..|
T Consensus 314 ~aF~~c~~L~-~i~lp~~-v~~I~~~aF~~c~~L~~i~lp~~ 353 (394)
T 4fs7_A 314 EAFESCTSLV-SIDLPYL-VEEIGKRSFRGCTSLSNINFPLS 353 (394)
T ss_dssp TTTTTCTTCC-EECCCTT-CCEECTTTTTTCTTCCEECCCTT
T ss_pred hhhcCCCCCC-EEEeCCc-ccEEhHHhccCCCCCCEEEECcc
Confidence 3445555555 5555322 44333445555555555555443
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=97.43 E-value=0.00053 Score=73.17 Aligned_cols=152 Identities=11% Similarity=0.072 Sum_probs=95.4
Q ss_pred cccCCCCCCEEEccCCCCcccCChhhcCCCCCCEEEcCCCcCcccCCcccCCCCCCCEEeccCccCCCCCCccccccccc
Q 005102 83 ALGSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSGSVPNEIGKLKYLQILDLSQNFFNGSLPVSIVQCKRL 162 (714)
Q Consensus 83 ~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L 162 (714)
.....+.|+.+.+.++ ++..-...+....+|+.+.+..+..+ .-...|.....|+.+.+..+.+. ...|..+.+|
T Consensus 225 ~~~~~~~l~~i~ip~~-~~~i~~~~f~~~~~l~~~~~~~~~~~-i~~~~F~~~~~l~~~~~~~~~i~---~~~F~~~~~L 299 (394)
T 4fs7_A 225 FALSKTGVKNIIIPDS-FTELGKSVFYGCTDLESISIQNNKLR-IGGSLFYNCSGLKKVIYGSVIVP---EKTFYGCSSL 299 (394)
T ss_dssp TTTTTCCCCEEEECTT-CCEECSSTTTTCSSCCEEEECCTTCE-ECSCTTTTCTTCCEEEECSSEEC---TTTTTTCTTC
T ss_pred hhcccCCCceEEECCC-ceecccccccccccceeEEcCCCcce-eeccccccccccceeccCceeec---cccccccccc
Confidence 3444567777777653 33234455667777888877766543 44556677777777777665432 2356677777
Q ss_pred ceeecccCcCCCCCCcccccCccccccccccCCcccccCCCCCCCCcccccccccccccCCcCcCccccCCCCcccccCc
Q 005102 163 KALDLSQNNFTGPLPNGFGSGLVSLEKLNLSFNKFNGSIPSNTGNLSSLQGTVDFSHNLFSGSIPASLGNLPEKVYIDLT 242 (714)
Q Consensus 163 ~~L~l~~N~l~g~~p~~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~ 242 (714)
+.+.+.++ ++ .|+...+.++.+|+.++|.++ ++..-...|.++.+|+ .+.+..| ++..-..+|.++++|+.+++.
T Consensus 300 ~~i~l~~~-i~-~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~c~~L~-~i~lp~~-l~~I~~~aF~~C~~L~~i~lp 374 (394)
T 4fs7_A 300 TEVKLLDS-VK-FIGEEAFESCTSLVSIDLPYL-VEEIGKRSFRGCTSLS-NINFPLS-LRKIGANAFQGCINLKKVELP 374 (394)
T ss_dssp CEEEECTT-CC-EECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCC-EECCCTT-CCEECTTTBTTCTTCCEEEEE
T ss_pred cccccccc-cc-eechhhhcCCCCCCEEEeCCc-ccEEhHHhccCCCCCC-EEEECcc-ccEehHHHhhCCCCCCEEEEC
Confidence 77777654 43 455555556777777777644 5522245667777777 7777655 554455677777777777765
Q ss_pred CC
Q 005102 243 YN 244 (714)
Q Consensus 243 ~N 244 (714)
.+
T Consensus 375 ~~ 376 (394)
T 4fs7_A 375 KR 376 (394)
T ss_dssp GG
T ss_pred CC
Confidence 43
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=97.39 E-value=0.00049 Score=73.46 Aligned_cols=129 Identities=16% Similarity=0.177 Sum_probs=51.3
Q ss_pred hhcCCCCCCEEEcCCCcCcccCCcccCCCCCCCEEeccCccCCCCCCcccccccccceeecccCcCCCCCCcccccCccc
Q 005102 107 ELLEAQGLQSLVLYGNSFSGSVPNEIGKLKYLQILDLSQNFFNGSLPVSIVQCKRLKALDLSQNNFTGPLPNGFGSGLVS 186 (714)
Q Consensus 107 ~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~l~~ 186 (714)
.|.++.+|+.+.+.++..+ .-...|.++.+|+.+.+. +.++..-...|.+|.+|+.++|..| ++ .|....+.++.+
T Consensus 260 aF~~c~~L~~i~lp~~~~~-I~~~aF~~c~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~-~I~~~aF~~C~~ 335 (394)
T 4gt6_A 260 AFDSCAYLASVKMPDSVVS-IGTGAFMNCPALQDIEFS-SRITELPESVFAGCISLKSIDIPEG-IT-QILDDAFAGCEQ 335 (394)
T ss_dssp TTTTCSSCCEEECCTTCCE-ECTTTTTTCTTCCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CC-EECTTTTTTCTT
T ss_pred eeeecccccEEecccccce-ecCcccccccccccccCC-CcccccCceeecCCCCcCEEEeCCc-cc-EehHhHhhCCCC
Confidence 3444445555555433322 223334444555555553 2233222234445555555555433 22 333333344555
Q ss_pred cccccccCCcccccCC-CCCCCCcccccccccccccCCcCcCccccCCCCcccccCcCCc
Q 005102 187 LEKLNLSFNKFNGSIP-SNTGNLSSLQGTVDFSHNLFSGSIPASLGNLPEKVYIDLTYNN 245 (714)
Q Consensus 187 L~~L~l~~N~l~g~~p-~~~~~l~~L~~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~ 245 (714)
|+.+.|..+ ++ .|. ..|.++.+|+ .+++.+|.... .++....+|+.+.+..|.
T Consensus 336 L~~i~ip~s-v~-~I~~~aF~~C~~L~-~i~~~~~~~~~---~~~~~~~~L~~i~i~~~~ 389 (394)
T 4gt6_A 336 LERIAIPSS-VT-KIPESAFSNCTALN-NIEYSGSRSQW---NAISTDSGLQNLPVAPGS 389 (394)
T ss_dssp CCEEEECTT-CC-BCCGGGGTTCTTCC-EEEESSCHHHH---HTCBCCCCC---------
T ss_pred CCEEEECcc-cC-EEhHhHhhCCCCCC-EEEECCceeeh---hhhhccCCCCEEEeCCCC
Confidence 555555332 33 222 3444555555 55554443221 234444555555554443
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=97.28 E-value=0.0015 Score=69.69 Aligned_cols=106 Identities=13% Similarity=0.257 Sum_probs=49.4
Q ss_pred CCCCCCCEEeccCccCCCCCCcccccccccceeecccCcCCCCCCcccccCccccccccccCCcccccCCCCCCCCcccc
Q 005102 133 GKLKYLQILDLSQNFFNGSLPVSIVQCKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLNLSFNKFNGSIPSNTGNLSSLQ 212 (714)
Q Consensus 133 ~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~ 212 (714)
.+..+|+.+.+..+..+ .-...|.++.+|+.+.+. +.++ .|+...+.++.+|+.++|..| ++..-...|.++.+|+
T Consensus 262 ~~c~~L~~i~lp~~~~~-I~~~aF~~c~~L~~i~l~-~~i~-~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~C~~L~ 337 (394)
T 4gt6_A 262 DSCAYLASVKMPDSVVS-IGTGAFMNCPALQDIEFS-SRIT-ELPESVFAGCISLKSIDIPEG-ITQILDDAFAGCEQLE 337 (394)
T ss_dssp TTCSSCCEEECCTTCCE-ECTTTTTTCTTCCEEECC-TTCC-EECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCC
T ss_pred eecccccEEecccccce-ecCcccccccccccccCC-Cccc-ccCceeecCCCCcCEEEeCCc-ccEehHhHhhCCCCCC
Confidence 33444455444433322 222344455555555553 2233 344444445555666555543 3312224455555555
Q ss_pred cccccccccCCcCcCccccCCCCcccccCcCC
Q 005102 213 GTVDFSHNLFSGSIPASLGNLPEKVYIDLTYN 244 (714)
Q Consensus 213 ~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N 244 (714)
.+.+..+ ++..-..+|.++++|+.+++.+|
T Consensus 338 -~i~ip~s-v~~I~~~aF~~C~~L~~i~~~~~ 367 (394)
T 4gt6_A 338 -RIAIPSS-VTKIPESAFSNCTALNNIEYSGS 367 (394)
T ss_dssp -EEEECTT-CCBCCGGGGTTCTTCCEEEESSC
T ss_pred -EEEECcc-cCEEhHhHhhCCCCCCEEEECCc
Confidence 5555332 44333445556666665555544
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.27 E-value=0.00052 Score=70.22 Aligned_cols=69 Identities=13% Similarity=0.164 Sum_probs=43.7
Q ss_pred cccccCceEEEEEEECCCcEEEEEEeCCCCchhHHHHHHHHHHHhccCCCCc-cceEEEEEeCCceeEEEecc-CCCCH
Q 005102 410 VLGKSGIGIVYKVVLEDGHTLAVRRLGEGGSQRFKEFQTEVEAIGKIRHSNI-VTLRAYYWSVDEKLLIYDYI-PNGSL 486 (714)
Q Consensus 410 ~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~~~~~~~~~~~lV~e~~-~~gsL 486 (714)
.|+.|....+|++ ..+++|+........ ....+|+.+++.+....+ .+++++ ..+.-++|+||+ ++.++
T Consensus 25 ~l~gG~tN~~~~~-----~~~vlR~~~~~~~~~-~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~g~~l 95 (301)
T 3dxq_A 25 ERLGGLTNLVFRA-----GDLCLRIPGKGTEEY-INRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAGAQTM 95 (301)
T ss_dssp EEESCSSEEEEEE-----TTEEEEEECC----C-CCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTTCEEC
T ss_pred EcCCcccccccee-----eeEEEECCCCCccce-eCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCCCccC
Confidence 5788888999999 568888876542211 123568888877743333 455544 344568999999 55433
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=97.19 E-value=0.002 Score=68.24 Aligned_cols=153 Identities=12% Similarity=0.104 Sum_probs=92.3
Q ss_pred ccCCCCCCEEEccCCCCcccCChhhcCCCCCCEEEcCCCcCcccCCcccCCCCCCCEEeccCccCCCCCCcccccccccc
Q 005102 84 LGSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSGSVPNEIGKLKYLQILDLSQNFFNGSLPVSIVQCKRLK 163 (714)
Q Consensus 84 ~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~ 163 (714)
+.....+..+.+..+.- ......+....+|+.+.+..+ ++..-...+.+..+|+.+.+..+ ++..-...|.++.+|+
T Consensus 190 ~~~~~~~~~~~~~~~~~-~i~~~~f~~~~~l~~i~~~~~-~~~i~~~~f~~~~~L~~i~lp~~-v~~I~~~aF~~~~~l~ 266 (379)
T 4h09_A 190 YPAAKTGTEFTIPSTVK-TVTAYGFSYGKNLKKITITSG-VTTLGDGAFYGMKALDEIAIPKN-VTSIGSFLLQNCTALK 266 (379)
T ss_dssp CCTTCCCSEEECCTTCC-EECTTTTTTCSSCSEEECCTT-CCEECTTTTTTCSSCCEEEECTT-CCEECTTTTTTCTTCC
T ss_pred cccccccccccccccee-EEeecccccccccceeeeccc-eeEEccccccCCccceEEEcCCC-ccEeCccccceeehhc
Confidence 44445555555554322 234455566667777777654 33244445666777777777655 4433345566777777
Q ss_pred eeecccCcCCCCCCcccccCccccccccccCCcccccCCCCCCCCcccccccccccccCCcCcCccccCCCCcccccCcC
Q 005102 164 ALDLSQNNFTGPLPNGFGSGLVSLEKLNLSFNKFNGSIPSNTGNLSSLQGTVDFSHNLFSGSIPASLGNLPEKVYIDLTY 243 (714)
Q Consensus 164 ~L~l~~N~l~g~~p~~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~ 243 (714)
.+.+..+ +. .++...+.++.+|+.+.+.+|.++..-...|.++.+|+ .+.|..+ ++..-..+|.++.+|+.+.+..
T Consensus 267 ~i~l~~~-i~-~i~~~aF~~c~~L~~i~l~~~~i~~I~~~aF~~c~~L~-~i~lp~~-l~~I~~~aF~~C~~L~~i~ip~ 342 (379)
T 4h09_A 267 TLNFYAK-VK-TVPYLLCSGCSNLTKVVMDNSAIETLEPRVFMDCVKLS-SVTLPTA-LKTIQVYAFKNCKALSTISYPK 342 (379)
T ss_dssp EEEECCC-CS-EECTTTTTTCTTCCEEEECCTTCCEECTTTTTTCTTCC-EEECCTT-CCEECTTTTTTCTTCCCCCCCT
T ss_pred ccccccc-ce-eccccccccccccccccccccccceehhhhhcCCCCCC-EEEcCcc-ccEEHHHHhhCCCCCCEEEECC
Confidence 7777544 33 45555556677777777777777633345667777777 7777543 5544456777777777776643
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=97.18 E-value=6.6e-05 Score=69.64 Aligned_cols=82 Identities=11% Similarity=0.079 Sum_probs=33.4
Q ss_pred CCCEEEccCCCCcccCChhhcCCCCCCEEEcCCCc-CcccCCcccCCC----CCCCEEeccCcc-CCCCCCccccccccc
Q 005102 89 DLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNS-FSGSVPNEIGKL----KYLQILDLSQNF-FNGSLPVSIVQCKRL 162 (714)
Q Consensus 89 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~-l~g~~p~~~~~l----~~L~~L~Ls~N~-l~g~~p~~~~~l~~L 162 (714)
.|++|||+++.++..-=..+.++++|+.|+|+++. +++.--..++.+ ++|+.|+|+++. ++..--..+..+++|
T Consensus 62 ~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~L 141 (176)
T 3e4g_A 62 KIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRNL 141 (176)
T ss_dssp CEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTTC
T ss_pred eEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCCC
Confidence 34555555544432222223344445555554442 332222223332 245555555542 332111223445555
Q ss_pred ceeecccC
Q 005102 163 KALDLSQN 170 (714)
Q Consensus 163 ~~L~l~~N 170 (714)
+.|+|++.
T Consensus 142 ~~L~L~~c 149 (176)
T 3e4g_A 142 KYLFLSDL 149 (176)
T ss_dssp CEEEEESC
T ss_pred CEEECCCC
Confidence 55555544
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.14 E-value=0.00092 Score=72.06 Aligned_cols=70 Identities=10% Similarity=0.128 Sum_probs=48.4
Q ss_pred cccccCceEEEEEEECC--------CcEEEEEEeCCCCchhHHHHHHHHHHHhccCCCCc-cceEEEEEeCCceeEEEec
Q 005102 410 VLGKSGIGIVYKVVLED--------GHTLAVRRLGEGGSQRFKEFQTEVEAIGKIRHSNI-VTLRAYYWSVDEKLLIYDY 480 (714)
Q Consensus 410 ~lG~G~~g~Vy~~~~~~--------g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~~~~~~~~~~~lV~e~ 480 (714)
.|+.|....||++...+ +..+++|+...... ...+.+|..+++.+...++ .++++.+.. .+||||
T Consensus 80 ~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~~--~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~e~ 153 (429)
T 1nw1_A 80 RIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPET--ESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEEY 153 (429)
T ss_dssp EECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCC--HHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEECC
T ss_pred EeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCCc--HHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEEEE
Confidence 57778889999998763 47899998854221 1455689999988853334 567766532 389999
Q ss_pred cCCCC
Q 005102 481 IPNGS 485 (714)
Q Consensus 481 ~~~gs 485 (714)
+++.+
T Consensus 154 l~G~~ 158 (429)
T 1nw1_A 154 IPSRP 158 (429)
T ss_dssp CCEEE
T ss_pred eCCcc
Confidence 97633
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.10 E-value=0.0033 Score=65.00 Aligned_cols=144 Identities=15% Similarity=0.116 Sum_probs=81.3
Q ss_pred cccccCceEEEEEEECCCcEEEEEEeCCCCchhHHHHHHHHHHHhccCCCC--ccceEEE-----EEeCCceeEEEeccC
Q 005102 410 VLGKSGIGIVYKVVLEDGHTLAVRRLGEGGSQRFKEFQTEVEAIGKIRHSN--IVTLRAY-----YWSVDEKLLIYDYIP 482 (714)
Q Consensus 410 ~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n--iv~l~~~-----~~~~~~~~lV~e~~~ 482 (714)
.++ |....||++...+|+.+++|....... ....+..|..++..+.... +.+++.. ....+..++||||++
T Consensus 33 ~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~-~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i~ 110 (328)
T 1zyl_A 33 PLN-SYENRVYQFQDEDRRRFVVKFYRPERW-TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVG 110 (328)
T ss_dssp EEC-CSSSEEEEECCTTCCCEEEEEECTTTS-CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCC
T ss_pred eec-CcccceEEEEcCCCCEEEEEEcCCCCC-CHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEecC
Confidence 355 777899998887788899999874322 2356677888887774222 3344432 122445678999998
Q ss_pred CCCHh-----hh---------hhCC---CCCCCcCCCCHHHH----------------------HHHHHHHHHHHHHHhc
Q 005102 483 NGSLA-----TA---------LHGK---PGMVSFTPVPWSVR----------------------VKIIKGIAKGLVYLHE 523 (714)
Q Consensus 483 ~gsL~-----~~---------l~~~---~~~~~~~~l~~~~~----------------------~~i~~~ia~gL~~LH~ 523 (714)
+..+. .. +|.. ........+++... ...+..++..+.-+..
T Consensus 111 G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 190 (328)
T 1zyl_A 111 GRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWR 190 (328)
T ss_dssp CEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCC
T ss_pred CCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHhh
Confidence 74432 00 1110 00000011222211 1111222222222211
Q ss_pred -CCCCCceecCCCCCCeeeCCCCCeEEcccchhhh
Q 005102 524 -FSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARL 557 (714)
Q Consensus 524 -~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 557 (714)
..+..++|+|+++.||+++ + .+.|+||+.+..
T Consensus 191 ~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 191 EDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp SCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred hcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 1235689999999999999 4 899999987754
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.05 E-value=0.0022 Score=66.53 Aligned_cols=142 Identities=13% Similarity=0.094 Sum_probs=73.0
Q ss_pred cccccCceE-EEEEEECCCcEEEEEEeCCCCchhHHHHHHHHHHHhccCC--CCccceEEEEEeCCceeEEEeccCCCCH
Q 005102 410 VLGKSGIGI-VYKVVLEDGHTLAVRRLGEGGSQRFKEFQTEVEAIGKIRH--SNIVTLRAYYWSVDEKLLIYDYIPNGSL 486 (714)
Q Consensus 410 ~lG~G~~g~-Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H--~niv~l~~~~~~~~~~~lV~e~~~~gsL 486 (714)
.|+.|.... +|+....+|..+++|....... ..+..|++++..+.. -.+.+++.+.. +.-++|||++.+..+
T Consensus 25 ~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~---~~~~~e~~~l~~L~~~g~~vP~v~~~d~--~~g~ll~e~l~~~~l 99 (333)
T 3csv_A 25 PLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG---GDTQPFVDLAQYLRNLDISAPEIYAEEH--ARGLLLIEDLGDALF 99 (333)
T ss_dssp C--------CCEEEECTTCCEEEEEECCTTTT---CCSHHHHHHHHHHHHTTCBCCCEEEEET--TTTEEEECCCCSCBH
T ss_pred ECCCCCCCceEEEEEcCCCCeEEEEECCCCCC---ccccHHHHHHHHHHhCCCCCCceeeecC--CCCEEEEeeCCCcch
Confidence 355554444 6677654467787876554321 233557777776642 23556666533 233789999977666
Q ss_pred hhhhhCC---------------------CCCCCcCCCCHHHHH-------H-------------HHHHHHHHHHHHh---
Q 005102 487 ATALHGK---------------------PGMVSFTPVPWSVRV-------K-------------IIKGIAKGLVYLH--- 522 (714)
Q Consensus 487 ~~~l~~~---------------------~~~~~~~~l~~~~~~-------~-------------i~~~ia~gL~~LH--- 522 (714)
.+.+... ... ....++..... . ....+...++.+.
T Consensus 100 ~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~ 178 (333)
T 3csv_A 100 TEVINNDPAQEMPLYRAAVDLLIHLHDAQTP-ELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQ 178 (333)
T ss_dssp HHHHHHCGGGHHHHHHHHHHHHHHHHTSCCC-CCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHH
T ss_pred HHHhcCCCccHHHHHHHHHHHHHHHhcCCCc-cCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhc
Confidence 5443211 000 00111111100 0 0001111222221
Q ss_pred cCCCCCceecCCCCCCeeeCCC----CCeEEcccchhhh
Q 005102 523 EFSPKKYVHGDLKPSNILLGHN----MEPHVSDFGLARL 557 (714)
Q Consensus 523 ~~~~~~ivHrDlkp~NILl~~~----~~~kl~DFGla~~ 557 (714)
...+..++|+|+.+.||+++.+ ..+.|+||+.+..
T Consensus 179 ~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 179 LEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp CCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred ccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 1123579999999999999874 6789999998764
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.05 E-value=0.00058 Score=70.55 Aligned_cols=144 Identities=13% Similarity=0.102 Sum_probs=79.1
Q ss_pred cccccCceEEEEEEECCCcEEEEEEeCCCCchhHHHHHHHHHHHhccCCCC--ccceEEE------EEeCCceeEEEecc
Q 005102 410 VLGKSGIGIVYKVVLEDGHTLAVRRLGEGGSQRFKEFQTEVEAIGKIRHSN--IVTLRAY------YWSVDEKLLIYDYI 481 (714)
Q Consensus 410 ~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n--iv~l~~~------~~~~~~~~lV~e~~ 481 (714)
.|+.|....+|+....+| .+++|....... ...+..|++++..+.... +.+++.. ....+..+++|+|+
T Consensus 29 ~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~~--~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~~l 105 (322)
T 2ppq_A 29 GIAEGVENSNFLLHTTKD-PLILTLYEKRVE--KNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALISFL 105 (322)
T ss_dssp EECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEECC
T ss_pred ccCCCcccceEEEEeCCc-cEEEEEeCCCCC--HHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEEEeC
Confidence 467788889999988666 688998876311 134556777777764222 2333311 12235678999999
Q ss_pred CCCCHhh--------------hhhCCC-CC-CC----cCCCCHHHHHH------------HHHHHHHHHHHHhc----CC
Q 005102 482 PNGSLAT--------------ALHGKP-GM-VS----FTPVPWSVRVK------------IIKGIAKGLVYLHE----FS 525 (714)
Q Consensus 482 ~~gsL~~--------------~l~~~~-~~-~~----~~~l~~~~~~~------------i~~~ia~gL~~LH~----~~ 525 (714)
++..+.. .+|... .. .. .....|..... +...+...+++++. ..
T Consensus 106 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~~~~ 185 (322)
T 2ppq_A 106 EGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPKDL 185 (322)
T ss_dssp CCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCCSS
T ss_pred CCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCcccC
Confidence 8754321 122110 00 00 00012322110 01123445555553 12
Q ss_pred CCCceecCCCCCCeeeCCCCCeEEcccchhh
Q 005102 526 PKKYVHGDLKPSNILLGHNMEPHVSDFGLAR 556 (714)
Q Consensus 526 ~~~ivHrDlkp~NILl~~~~~~kl~DFGla~ 556 (714)
+..++|+|+.+.||+++++..+.|+||+.+.
T Consensus 186 ~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 186 PAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp CEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred CcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 3579999999999999887656899999775
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=97.02 E-value=0.0033 Score=66.49 Aligned_cols=164 Identities=10% Similarity=0.016 Sum_probs=112.4
Q ss_pred CccccCCccccCCCCCCEEEccCCCCccc------------CChhhcCCCCCCEEEcCCCcCcccCCcccCCCCCCCEEe
Q 005102 75 KLLGFLPSALGSLTDLRHVNLRNNKFFGS------------LPLELLEAQGLQSLVLYGNSFSGSVPNEIGKLKYLQILD 142 (714)
Q Consensus 75 ~l~g~~p~~~~~l~~L~~L~L~~N~l~~~------------~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ 142 (714)
.++..-...+.....|+.+.+..+..... ....+.....+..+.+..+.-. .....+....+|+.+.
T Consensus 145 ~v~~i~~~~f~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-i~~~~f~~~~~l~~i~ 223 (379)
T 4h09_A 145 SVTTIKDGIGYKAENLEKIEVSSNNKNYVAENYVLYNKNKTILESYPAAKTGTEFTIPSTVKT-VTAYGFSYGKNLKKIT 223 (379)
T ss_dssp TCCEECSCTTTTCTTCCEEEECTTCSSEEEETTEEEETTSSEEEECCTTCCCSEEECCTTCCE-ECTTTTTTCSSCSEEE
T ss_pred eeeccccchhcccccccccccccccceeecccceecccccceeccccccccccccccccceeE-Eeecccccccccceee
Confidence 45555567788888888888876544211 1223344456666666544332 4455677778899988
Q ss_pred ccCccCCCCCCcccccccccceeecccCcCCCCCCcccccCccccccccccCCcccccCCCCCCCCcccccccccccccC
Q 005102 143 LSQNFFNGSLPVSIVQCKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLNLSFNKFNGSIPSNTGNLSSLQGTVDFSHNLF 222 (714)
Q Consensus 143 Ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~~l~l~~N~l 222 (714)
+..+ +...-...+.++.+|+.+.+..+ ++ .|....+.++.+|+.+.+..+ +...-...|.++.+|+ .+.+.+|.+
T Consensus 224 ~~~~-~~~i~~~~f~~~~~L~~i~lp~~-v~-~I~~~aF~~~~~l~~i~l~~~-i~~i~~~aF~~c~~L~-~i~l~~~~i 298 (379)
T 4h09_A 224 ITSG-VTTLGDGAFYGMKALDEIAIPKN-VT-SIGSFLLQNCTALKTLNFYAK-VKTVPYLLCSGCSNLT-KVVMDNSAI 298 (379)
T ss_dssp CCTT-CCEECTTTTTTCSSCCEEEECTT-CC-EECTTTTTTCTTCCEEEECCC-CSEECTTTTTTCTTCC-EEEECCTTC
T ss_pred eccc-eeEEccccccCCccceEEEcCCC-cc-EeCccccceeehhcccccccc-ceeccccccccccccc-ccccccccc
Confidence 8765 33244567788899999998766 44 465556667888998888654 5423345677888998 888988888
Q ss_pred CcCcCccccCCCCcccccCcCC
Q 005102 223 SGSIPASLGNLPEKVYIDLTYN 244 (714)
Q Consensus 223 ~g~~p~~~~~l~~L~~l~l~~N 244 (714)
+..-..+|.++.+|+.+++..+
T Consensus 299 ~~I~~~aF~~c~~L~~i~lp~~ 320 (379)
T 4h09_A 299 ETLEPRVFMDCVKLSSVTLPTA 320 (379)
T ss_dssp CEECTTTTTTCTTCCEEECCTT
T ss_pred ceehhhhhcCCCCCCEEEcCcc
Confidence 8666778999999999888643
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=97.01 E-value=0.00022 Score=66.09 Aligned_cols=84 Identities=8% Similarity=0.067 Sum_probs=66.0
Q ss_pred CcEEEEEcCCCCccccCCccccCCCCCCEEEccCCC-CcccCChhhcCC----CCCCEEEcCCCc-CcccCCcccCCCCC
Q 005102 64 QRVVSVSIPKKKLLGFLPSALGSLTDLRHVNLRNNK-FFGSLPLELLEA----QGLQSLVLYGNS-FSGSVPNEIGKLKY 137 (714)
Q Consensus 64 ~~~~~l~l~~~~l~g~~p~~~~~l~~L~~L~L~~N~-l~~~~p~~~~~l----~~L~~L~L~~N~-l~g~~p~~~~~l~~ 137 (714)
-+++.|+|+++.++..--..+.++++|++|+|+++. ++..-=..+..+ ++|+.|+|+++. +|..--..+..+++
T Consensus 61 ~~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~ 140 (176)
T 3e4g_A 61 YKIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRN 140 (176)
T ss_dssp CCEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTT
T ss_pred ceEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCC
Confidence 479999999999876655678899999999999985 664333345554 379999999985 77544456788999
Q ss_pred CCEEeccCcc
Q 005102 138 LQILDLSQNF 147 (714)
Q Consensus 138 L~~L~Ls~N~ 147 (714)
|+.|+|+++.
T Consensus 141 L~~L~L~~c~ 150 (176)
T 3e4g_A 141 LKYLFLSDLP 150 (176)
T ss_dssp CCEEEEESCT
T ss_pred CCEEECCCCC
Confidence 9999999875
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.98 E-value=0.0017 Score=68.41 Aligned_cols=143 Identities=20% Similarity=0.233 Sum_probs=83.7
Q ss_pred cccccCceEEEEEEECC--------CcEEEEEEeCCCCchhHHHHHHHHHHHhccC-CCCccceEEEEEeCCceeEEEec
Q 005102 410 VLGKSGIGIVYKVVLED--------GHTLAVRRLGEGGSQRFKEFQTEVEAIGKIR-HSNIVTLRAYYWSVDEKLLIYDY 480 (714)
Q Consensus 410 ~lG~G~~g~Vy~~~~~~--------g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lV~e~ 480 (714)
.+..|-...+|++...+ ++.+++|+.... ........+|.++++.+. +.-..++++++.+ .+||||
T Consensus 57 ~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e~ 131 (379)
T 3feg_A 57 PVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQY 131 (379)
T ss_dssp EC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEEC
T ss_pred EcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEEE
Confidence 45667778899998752 478999986442 223456678999998884 3333567766543 399999
Q ss_pred cCCCCHhhh-----------------hhCCCCCCCcCCC-CHHHHHHHHHHHHH-------------------HHHHHh-
Q 005102 481 IPNGSLATA-----------------LHGKPGMVSFTPV-PWSVRVKIIKGIAK-------------------GLVYLH- 522 (714)
Q Consensus 481 ~~~gsL~~~-----------------l~~~~~~~~~~~l-~~~~~~~i~~~ia~-------------------gL~~LH- 522 (714)
+++..|..- ||........... -|.++.++..++.. .+..|.
T Consensus 132 i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~ 211 (379)
T 3feg_A 132 IPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLRK 211 (379)
T ss_dssp CSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHHH
T ss_pred ecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHHH
Confidence 987554311 2222110000111 24555555544422 233332
Q ss_pred ---c-CCCCCceecCCCCCCeeeCCC----CCeEEcccchhhh
Q 005102 523 ---E-FSPKKYVHGDLKPSNILLGHN----MEPHVSDFGLARL 557 (714)
Q Consensus 523 ---~-~~~~~ivHrDlkp~NILl~~~----~~~kl~DFGla~~ 557 (714)
. ..+..++|+|+.+.||+++++ +.+.++||..|..
T Consensus 212 ~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 212 LLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 2 123468999999999999876 7899999998763
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.97 E-value=0.0031 Score=68.34 Aligned_cols=72 Identities=14% Similarity=0.139 Sum_probs=46.9
Q ss_pred cccccCceEEEEEEECC-CcEEEEEEeCCCCchhHHHHHHHHHHHhccCCCCc-cceEEEEEeCCceeEEEeccCCCCH
Q 005102 410 VLGKSGIGIVYKVVLED-GHTLAVRRLGEGGSQRFKEFQTEVEAIGKIRHSNI-VTLRAYYWSVDEKLLIYDYIPNGSL 486 (714)
Q Consensus 410 ~lG~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~~~~~~~~~~~lV~e~~~~gsL 486 (714)
.|+.|-...+|++...+ +..+++|+........ -+-.+|..++..+...++ .++++++. + .+||||+++.+|
T Consensus 115 ~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~-idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~l 188 (458)
T 2qg7_A 115 IINGGITNILIKVKDMSKQAKYLIRLYGPKTDEI-INREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYAL 188 (458)
T ss_dssp EECC--CEEEEEEEETTTTEEEEEEEECC-CCSC-SCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEEC
T ss_pred EcCCCeEeEEEEEEECCCCceEEEEECCCChhhh-cCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCccC
Confidence 57778888999999875 5788899875432211 112578999988865444 46777662 2 359999987443
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=96.92 E-value=5.4e-05 Score=71.62 Aligned_cols=87 Identities=21% Similarity=0.254 Sum_probs=44.1
Q ss_pred ccCCCCCCEEEccCC-CCcc----cCChhhcCCCCCCEEEcCCCcCcccCCcc----cCCCCCCCEEeccCccCCCC---
Q 005102 84 LGSLTDLRHVNLRNN-KFFG----SLPLELLEAQGLQSLVLYGNSFSGSVPNE----IGKLKYLQILDLSQNFFNGS--- 151 (714)
Q Consensus 84 ~~~l~~L~~L~L~~N-~l~~----~~p~~~~~l~~L~~L~L~~N~l~g~~p~~----~~~l~~L~~L~Ls~N~l~g~--- 151 (714)
+.+-+.|++|+|++| .|.. .+-..+..-+.|+.|+|++|++...--.. +..-+.|+.|+|++|.|...
T Consensus 37 l~~n~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga~ 116 (197)
T 1pgv_A 37 REDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLA 116 (197)
T ss_dssp HTTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHH
T ss_pred HhcCCCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHHH
Confidence 344456666666664 5532 13334444556666666666665322222 22335666666666666531
Q ss_pred -CCcccccccccceeecccC
Q 005102 152 -LPVSIVQCKRLKALDLSQN 170 (714)
Q Consensus 152 -~p~~~~~l~~L~~L~l~~N 170 (714)
+-..+..-+.|++|+|++|
T Consensus 117 ala~aL~~N~tL~~L~L~n~ 136 (197)
T 1pgv_A 117 RLLRSTLVTQSIVEFKADNQ 136 (197)
T ss_dssp HHHHHTTTTCCCSEEECCCC
T ss_pred HHHHHHhhCCceeEEECCCC
Confidence 1122223345666666644
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=96.83 E-value=0.002 Score=56.75 Aligned_cols=37 Identities=19% Similarity=0.131 Sum_probs=19.0
Q ss_pred CCCEEeccCccCCCCCCcccccccccceeecccCcCC
Q 005102 137 YLQILDLSQNFFNGSLPVSIVQCKRLKALDLSQNNFT 173 (714)
Q Consensus 137 ~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~ 173 (714)
+|+.|+|++|+|+..-+..|..+.+|+.|+|++|.+.
T Consensus 32 ~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~ 68 (130)
T 3rfe_A 32 DTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWR 68 (130)
T ss_dssp TCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCB
T ss_pred CCCEEECCCCcCCccChhhhhhccccCEEEecCCCee
Confidence 4555555555555333334455555555555555543
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=96.80 E-value=0.0014 Score=57.67 Aligned_cols=57 Identities=28% Similarity=0.408 Sum_probs=39.1
Q ss_pred CEEeccCccCC-CCCCcccccccccceeecccCcCCCCCCcccccCccccccccccCCccc
Q 005102 139 QILDLSQNFFN-GSLPVSIVQCKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLNLSFNKFN 198 (714)
Q Consensus 139 ~~L~Ls~N~l~-g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~l~~L~~L~l~~N~l~ 198 (714)
..++.+++.|+ ..+|..+. .+|+.|+|++|+|+ .+|...+..+++|+.|+|++|.+.
T Consensus 11 ~~v~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~-~l~~~~f~~l~~L~~L~L~~NP~~ 68 (130)
T 3rfe_A 11 TLVDCGRRGLTWASLPTAFP--VDTTELVLTGNNLT-ALPPGLLDALPALRTAHLGANPWR 68 (130)
T ss_dssp TEEECCSSCCCTTTSCSCCC--TTCSEEECTTSCCS-SCCTTTGGGCTTCCEEECCSSCCB
T ss_pred CEEEeCCCCCccccCCCCCC--cCCCEEECCCCcCC-ccChhhhhhccccCEEEecCCCee
Confidence 36677777775 35665443 35778888888887 576666666777777777777764
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.71 E-value=0.0024 Score=67.35 Aligned_cols=71 Identities=11% Similarity=0.112 Sum_probs=43.8
Q ss_pred cccccCceEEEEEEECC---------CcEEEEEEeCCCCchhHHHHHHHHHHHhccCCCC-ccceEEEEEeCCceeEEEe
Q 005102 410 VLGKSGIGIVYKVVLED---------GHTLAVRRLGEGGSQRFKEFQTEVEAIGKIRHSN-IVTLRAYYWSVDEKLLIYD 479 (714)
Q Consensus 410 ~lG~G~~g~Vy~~~~~~---------g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n-iv~l~~~~~~~~~~~lV~e 479 (714)
.++.|....+|++...+ +..+++|+....... ..+...|.++++.+...+ ..++++.. .-++|||
T Consensus 40 ~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~-~~~~~~E~~~l~~L~~~g~~P~~~~~~----~~~~v~e 114 (369)
T 3c5i_A 40 QILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDE-LYNTISEFEVYKTMSKYKIAPQLLNTF----NGGRIEE 114 (369)
T ss_dssp EC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGG-TSCHHHHHHHHHHHHHTTSSCCEEEEE----TTEEEEE
T ss_pred EeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccc-eecHHHHHHHHHHHHhcCCCCceEEec----CCcEEEE
Confidence 46777788999998764 268888887653221 112367888888885333 34666544 2378999
Q ss_pred ccCCCC
Q 005102 480 YIPNGS 485 (714)
Q Consensus 480 ~~~~gs 485 (714)
|+++..
T Consensus 115 ~i~G~~ 120 (369)
T 3c5i_A 115 WLYGDP 120 (369)
T ss_dssp CCCSEE
T ss_pred EecCCc
Confidence 998754
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=96.69 E-value=0.00047 Score=65.10 Aligned_cols=112 Identities=13% Similarity=0.095 Sum_probs=79.7
Q ss_pred ecCCcEEEEEcCCC-Cccc----cCCccccCCCCCCEEEccCCCCccc----CChhhcCCCCCCEEEcCCCcCccc----
Q 005102 61 CKEQRVVSVSIPKK-KLLG----FLPSALGSLTDLRHVNLRNNKFFGS----LPLELLEAQGLQSLVLYGNSFSGS---- 127 (714)
Q Consensus 61 c~~~~~~~l~l~~~-~l~g----~~p~~~~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~g~---- 127 (714)
.+...++.|+|++| ++.. .+..++..-+.|+.|+|++|.|... +...+..-+.|+.|+|++|.|...
T Consensus 38 ~~n~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga~a 117 (197)
T 1pgv_A 38 EDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLAR 117 (197)
T ss_dssp TTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHH
T ss_pred hcCCCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHHHH
Confidence 34668999999986 6653 2556778889999999999999742 344555678999999999999742
Q ss_pred CCcccCCCCCCCEEeccCcc---CCCC----CCcccccccccceeecccCcC
Q 005102 128 VPNEIGKLKYLQILDLSQNF---FNGS----LPVSIVQCKRLKALDLSQNNF 172 (714)
Q Consensus 128 ~p~~~~~l~~L~~L~Ls~N~---l~g~----~p~~~~~l~~L~~L~l~~N~l 172 (714)
+-..+..-+.|+.|+|++|. +... +-..+..-++|+.|+++.|.+
T Consensus 118 la~aL~~N~tL~~L~L~n~~~~~ig~~g~~~ia~aL~~N~tL~~L~l~~~~~ 169 (197)
T 1pgv_A 118 LLRSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFASM 169 (197)
T ss_dssp HHHHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCCH
T ss_pred HHHHHhhCCceeEEECCCCcCcCcCHHHHHHHHHHHHhCCCcCeEeccCCCc
Confidence 23345556789999999763 3211 222344446788888877654
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.63 E-value=0.0055 Score=63.71 Aligned_cols=31 Identities=23% Similarity=0.385 Sum_probs=27.6
Q ss_pred CCceecCCCCCCeeeCCCCCeEEcccchhhh
Q 005102 527 KKYVHGDLKPSNILLGHNMEPHVSDFGLARL 557 (714)
Q Consensus 527 ~~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 557 (714)
..++|+|+.+.||++++++.+.|+||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 4689999999999999888899999987764
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=95.87 E-value=0.077 Score=50.36 Aligned_cols=100 Identities=12% Similarity=-0.065 Sum_probs=65.2
Q ss_pred CCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCC
Q 005102 484 GSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGG 563 (714)
Q Consensus 484 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 563 (714)
-+|.++|.... .++++.+++.++.|.+.+|.-+-.. +.-..+=+.|..|++..+|.+.+.+ ..+..
T Consensus 33 vSL~eIL~~~~-----~PlsEEqaWALc~Qc~~~L~~~~~~--~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~~------ 98 (229)
T 2yle_A 33 LSLEEILRLYN-----QPINEEQAWAVCYQCCGSLRAAARR--RQPRHRVRSAAQIRVWRDGAVTLAP-AADDA------ 98 (229)
T ss_dssp EEHHHHHHHHT-----SCCCHHHHHHHHHHHHHHHHHHHHT--TCCCCCCCSGGGEEEETTSCEEECC-C----------
T ss_pred ccHHHHHHHcC-----CCcCHHHHHHHHHHHHHHHHhhhhc--ccCCceecCCcceEEecCCceeccc-ccccc------
Confidence 37889887654 6799999999999999998776210 0111223346889999999888764 21110
Q ss_pred CCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhC
Q 005102 564 SPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITG 632 (714)
Q Consensus 564 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG 632 (714)
....+.|||... ...+.+.=|||+|+++|.-+--
T Consensus 99 ----------------------------------~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDy 132 (229)
T 2yle_A 99 ----------------------------------GEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDY 132 (229)
T ss_dssp ------------------------------------------CCSS-SSSCHHHHHHHHHHHHHHHHTT
T ss_pred ----------------------------------cccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhc
Confidence 011267888764 3457889999999999998863
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=95.25 E-value=0.022 Score=60.87 Aligned_cols=142 Identities=14% Similarity=0.139 Sum_probs=83.3
Q ss_pred cccccCceEEEEEEECC--------CcEEEEEEeCCCCchhHHHHHHHHHHHhccC-CCCccceEEEEEeCCceeEEEec
Q 005102 410 VLGKSGIGIVYKVVLED--------GHTLAVRRLGEGGSQRFKEFQTEVEAIGKIR-HSNIVTLRAYYWSVDEKLLIYDY 480 (714)
Q Consensus 410 ~lG~G~~g~Vy~~~~~~--------g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lV~e~ 480 (714)
.+..|-...+|+....+ +..+++|+........ -+-.+|.++++.+. +.-..++++.+ .-++||||
T Consensus 77 ~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~-idR~~E~~~l~~L~~~gi~P~l~~~~----~~~~I~ef 151 (424)
T 3mes_A 77 QIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKF-YDSKVELDVFRYLSNINIAPNIIADF----PEGRIEEF 151 (424)
T ss_dssp EECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CC-CCHHHHHHHHHHHHHTTSSCCEEEEE----TTEEEEEC
T ss_pred EcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchh-cCHHHHHHHHHHHHhcCCCCCEEEEc----CCCEEEEE
Confidence 46667778999998763 5789999875542211 12357888888884 33344566543 23789999
Q ss_pred cCCCCHhh--------------h---hhCCCC-----CC--CcCCCCHHHHHHHHHHH-------------------HHH
Q 005102 481 IPNGSLAT--------------A---LHGKPG-----MV--SFTPVPWSVRVKIIKGI-------------------AKG 517 (714)
Q Consensus 481 ~~~gsL~~--------------~---l~~~~~-----~~--~~~~l~~~~~~~i~~~i-------------------a~g 517 (714)
+++..|.. . +|.... .. ...+.-|.++.++..++ ...
T Consensus 152 I~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~e 231 (424)
T 3mes_A 152 IDGEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNFQIDKELYSKILEE 231 (424)
T ss_dssp CCSEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC--CCHHHHHHHHHH
T ss_pred eCCccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccchhhccccHHHHHHH
Confidence 98865321 0 111100 00 01112244444444332 122
Q ss_pred HHHHhc---------------------CCCCCceecCCCCCCeeeCCCCCeEEcccchhhh
Q 005102 518 LVYLHE---------------------FSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARL 557 (714)
Q Consensus 518 L~~LH~---------------------~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 557 (714)
+.+|.+ ..+..++|+|+.+.||+ ++++.+.++||..|..
T Consensus 232 ~~~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~ 291 (424)
T 3mes_A 232 IDQLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSAI 291 (424)
T ss_dssp HHHHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred HHHHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCCc
Confidence 333321 11246899999999999 7788999999988764
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=90.39 E-value=0.65 Score=49.08 Aligned_cols=30 Identities=27% Similarity=0.448 Sum_probs=25.1
Q ss_pred CceecCCCCCCeee------CCCCCeEEcccchhhh
Q 005102 528 KYVHGDLKPSNILL------GHNMEPHVSDFGLARL 557 (714)
Q Consensus 528 ~ivHrDlkp~NILl------~~~~~~kl~DFGla~~ 557 (714)
.++|+|+.+.|||+ +++..++++||-.|..
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 35799999999999 4567799999998864
|
| >2k1k_A Ephrin type-A receptor 1; EPHA1, receptor tyrosine kinase, dimeric transmembrane domain, ATP-binding, glycoprotein, nucleotide-binding; NMR {Homo sapiens} PDB: 2k1l_A | Back alignment and structure |
|---|
Probab=89.26 E-value=0.034 Score=36.59 Aligned_cols=30 Identities=30% Similarity=0.470 Sum_probs=21.1
Q ss_pred CCCCcccEEEEeehhHHHHHHHHHHhheee
Q 005102 315 RGLSKSAIVAIIVSDVIGICLVGLLFSYCY 344 (714)
Q Consensus 315 ~~~s~~~iv~i~v~~~~~~~l~~~~~~~~~ 344 (714)
.+.+.++|++++++.++++.+++.+.++++
T Consensus 6 ~~ls~GaIAGiVvG~v~gv~li~~l~~~~~ 35 (38)
T 2k1k_A 6 RGLTGGEIVAVIFGLLLGAALLLGILVFRS 35 (38)
T ss_dssp TTCCHHHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred CCCCCCceeeeehHHHHHHHHHHHHHHHHe
Confidence 345677888888888887777666655443
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=88.53 E-value=2.3 Score=40.20 Aligned_cols=83 Identities=12% Similarity=0.085 Sum_probs=60.9
Q ss_pred CCCCccceEEEEEeCCceeEEEeccCCC-CHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCC
Q 005102 457 RHSNIVTLRAYYWSVDEKLLIYDYIPNG-SLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLK 535 (714)
Q Consensus 457 ~H~niv~l~~~~~~~~~~~lV~e~~~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlk 535 (714)
.||+++.. .+-.+.+...+.|+.-+.+ ++.. + ..++...+++++..|+....+++. -+|--|.
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~-i---------k~~~~~eKlr~l~ni~~l~~~~~~-----r~tf~L~ 106 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN-I---------KSFTKNEKLRYLLNIKNLEEVNRT-----RYTFVLA 106 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG-G---------GGSCHHHHHHHHHHGGGGGGGGGS-----SEECCCS
T ss_pred cCCcccce-EEEEcccEEEEEEEcCcccCCHHH-H---------HhcCHHHHHHHHHHHHHHHHHhcC-----ceEEEEe
Confidence 58888876 4555566555556544322 2222 2 457789999999999998876665 3788899
Q ss_pred CCCeeeCCCCCeEEcccchh
Q 005102 536 PSNILLGHNMEPHVSDFGLA 555 (714)
Q Consensus 536 p~NILl~~~~~~kl~DFGla 555 (714)
|+||+++.++.+++.-.|+-
T Consensus 107 P~NL~f~~~~~p~i~~RGik 126 (215)
T 4ann_A 107 PDELFFTRDGLPIAKTRGLQ 126 (215)
T ss_dssp GGGEEECTTSCEEESCCEET
T ss_pred cceEEEcCCCCEEEEEccCc
Confidence 99999999999999988864
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=84.06 E-value=2.3 Score=40.27 Aligned_cols=83 Identities=14% Similarity=0.112 Sum_probs=60.8
Q ss_pred CCCCccceEEEEEeCCceeEEEeccCCCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHH-HHhcCCCCCceecCCC
Q 005102 457 RHSNIVTLRAYYWSVDEKLLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLV-YLHEFSPKKYVHGDLK 535 (714)
Q Consensus 457 ~H~niv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~-~LH~~~~~~ivHrDlk 535 (714)
.||++ -..+-.+.+...+.|+.-+++.=+..+ ..++...+++++..|+.... ++++ -+|--|.
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i---------~~~~~~eKlrll~nl~~L~~~~~~~-----r~tf~l~ 111 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAI---------RKTTLLSRIRAAIHLVSKVKHHSAR-----RLIFIVC 111 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHH---------HTSCHHHHHHHHHHHHHHHSSCCSS-----SEECCCC
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHH---------HhcCHHHHHHHHHHHHHHHHHhhhC-----ceeEEEe
Confidence 57888 344445666666777655443323333 34678899999999988776 5555 4788899
Q ss_pred CCCeeeCCCCCeEEcccchh
Q 005102 536 PSNILLGHNMEPHVSDFGLA 555 (714)
Q Consensus 536 p~NILl~~~~~~kl~DFGla 555 (714)
|+||++|.++.+++.-.|+-
T Consensus 112 P~NL~f~~~~~p~i~hRGi~ 131 (219)
T 4ano_A 112 PENLMFNRALEPFFLHVGVK 131 (219)
T ss_dssp GGGEEECTTCCEEESCCEET
T ss_pred CceEEEeCCCcEEEEEcCCc
Confidence 99999999999999999964
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 714 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 3e-52 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 8e-48 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 3e-46 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 4e-45 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 4e-45 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 1e-44 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 2e-44 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 8e-44 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 1e-43 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 3e-43 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 4e-43 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 1e-42 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 4e-42 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 4e-42 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 6e-42 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 7e-41 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 1e-40 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 2e-40 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 3e-40 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 4e-40 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 4e-39 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 6e-39 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 3e-38 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 5e-38 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 7e-38 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 8e-38 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 8e-38 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 9e-38 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 4e-37 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 7e-37 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 1e-35 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 6e-35 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 1e-34 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 3e-34 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 2e-33 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 5e-32 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 5e-32 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 2e-31 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 6e-31 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 1e-30 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 2e-30 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 3e-30 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 2e-29 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 2e-29 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 1e-28 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 2e-28 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 4e-28 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 2e-27 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 2e-26 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 5e-26 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 1e-25 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 2e-25 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 2e-24 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 2e-24 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 4e-24 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 1e-23 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 1e-22 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 2e-22 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 7e-22 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 6e-20 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 1e-18 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 3e-18 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 1e-17 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 4e-13 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 5e-04 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 6e-16 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 7e-15 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 5e-13 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 1e-10 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 2e-05 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 6e-13 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 4e-10 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 0.001 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 4e-10 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 0.002 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 2e-09 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 2e-08 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 7e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 8e-09 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 8e-08 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-07 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 6e-07 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 3e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 3e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 3e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.002 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.002 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 9e-09 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 8e-07 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 1e-06 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 7e-06 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 4e-04 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 3e-05 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 2e-04 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 4e-05 | |
| d2ifga3 | 156 | c.10.2.7 (A:36-191) High affinity nerve growth fac | 3e-04 | |
| d2ifga3 | 156 | c.10.2.7 (A:36-191) High affinity nerve growth fac | 0.003 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 3e-04 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 0.002 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 0.003 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 0.002 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 0.002 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 0.004 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (457), Expect = 3e-52
Identities = 63/305 (20%), Positives = 117/305 (38%), Gaps = 54/305 (17%)
Query: 410 VLGKSGIGIVYKVVLEDGHTLAVRRLGEGGSQRFKEFQTEVEAIGKIRHSNIVTLRAYYW 469
+G G VYK + + + Q+ + F+ EV + K RH NI+ Y
Sbjct: 15 RIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST 74
Query: 470 SVDEKLLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKY 529
+ + ++ + SL LH + I + A+G+ YLH K
Sbjct: 75 A-PQLAIVTQWCEGSSLYHHLHIIET-----KFEMIKLIDIARQTAQGMDYLH---AKSI 125
Query: 530 VHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQKSVSLEV 589
+H DLK +NI L ++ + DFGLA + + GS +
Sbjct: 126 IHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSI--------------- 170
Query: 590 TTTNSSSNLGSYYQAPESLKVVKP---SQKWDIYSYGVILLEMITGRTAVVQVGSSEMDL 646
+ APE +++ S + D+Y++G++L E++TG+ S ++
Sbjct: 171 -----------LWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPY-----SNINN 214
Query: 647 VNWMQLCIEEKKPLADVLDPYLAPDADKEEEII--AVLKIAMACVHSSPEKRPTMRHISD 704
+ + + YL+PD K A+ ++ C+ ++RP I
Sbjct: 215 RDQIIFMVGRG---------YLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILA 265
Query: 705 ALDRL 709
+++ L
Sbjct: 266 SIELL 270
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (425), Expect = 8e-48
Identities = 61/305 (20%), Positives = 122/305 (40%), Gaps = 52/305 (17%)
Query: 410 VLGKSGIGIVYKVVLEDGHTLAVRRLGEGGSQRFKEFQTEVEAIGKIRHSNIVTLRAYYW 469
LG G V+ +AV+ L +G F E + +++H +V L A
Sbjct: 20 RLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP-DAFLAEANLMKQLQHQRLVRLYAVVT 78
Query: 470 SVDEKLLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKY 529
+ +I +Y+ NGSL L G+ + + + + IA+G+ ++ E + Y
Sbjct: 79 Q-EPIYIITEYMENGSLVDFLKTPSGI----KLTINKLLDMAAQIAEGMAFIEE---RNY 130
Query: 530 VHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQKSVSLEV 589
+H DL+ +NIL+ + ++DFGLARL +
Sbjct: 131 IHRDLRAANILVSDTLSCKIADFGLARL---------------------------IEDNE 163
Query: 590 TTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGSSEMDLVNW 649
T + + APE++ + K D++S+G++L E++T G + +++
Sbjct: 164 YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYP-GMTNPEVIQN 222
Query: 650 MQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDALDRL 709
++ +P + +E + ++ C PE RPT ++ L+
Sbjct: 223 LERGYRMVRP----------DNCPEE-----LYQLMRLCWKERPEDRPTFDYLRSVLEDF 267
Query: 710 IVSSD 714
+++
Sbjct: 268 FTATE 272
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (416), Expect = 3e-46
Identities = 66/320 (20%), Positives = 111/320 (34%), Gaps = 54/320 (16%)
Query: 410 VLGKSGIGIVYKVVLEDGHTLAVRRLGEGGSQRFKEFQTEVEAIGKIRHSNIVTLRAYYW 469
+GK G V++ G +AV+ + + + E+ +RH NI+ A
Sbjct: 10 SIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSW-FREAEIYQTVMLRHENILGFIAADN 67
Query: 470 SVDEKL----LIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEF- 524
+ L+ DY +GSL L+ V +K+ A GL +LH
Sbjct: 68 KDNGTWTQLWLVSDYHEHGSLFDYLNRYT-------VTVEGMIKLALSTASGLAHLHMEI 120
Query: 525 ----SPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQER 580
H DLK NIL+ N ++D GLA + A +
Sbjct: 121 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDT---------------- 164
Query: 581 QQKSVSLEVTTTNSSSNLGS-YYQAPESL------KVVKPSQKWDIYSYGVILLEMITGR 633
+ +G+ Y APE L K + ++ DIY+ G++ E+
Sbjct: 165 ---------IDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRC 215
Query: 634 T--AVVQVGSSEMDLVNWMQLCIEE--KKPLADVLDPYLAPDADKEEEIIAVLKIAMACV 689
+ + + + +EE K L P + E + + KI C
Sbjct: 216 SIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECW 275
Query: 690 HSSPEKRPTMRHISDALDRL 709
+++ R T I L +L
Sbjct: 276 YANGAARLTALRIKKTLSQL 295
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 161 bits (408), Expect = 4e-45
Identities = 68/310 (21%), Positives = 126/310 (40%), Gaps = 52/310 (16%)
Query: 410 VLGKSGIGIVYKVVL----EDGHTLAVRRLGEGGSQRF-KEFQTEVEAIGKIRHSNIVTL 464
V+G G V L + +A++ L G +++ ++F +E +G+ H N++ L
Sbjct: 33 VIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHL 92
Query: 465 RAYYWSVDEKLLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEF 524
++I +++ NGSL + L G V +++GIA G+ YL
Sbjct: 93 EGVVTKSTPVMIITEFMENGSLDSFLRQNDG-----QFTVIQLVGMLRGIAAGMKYLA-- 145
Query: 525 SPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQKS 584
YVH DL NIL+ N+ VSDFGL+R +
Sbjct: 146 -DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFL-----------------------EDD 181
Query: 585 VSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGSSEM 644
S T+ + + APE+++ K + D++SYG+++ E+++ +
Sbjct: 182 TSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYW-DMTNQ 240
Query: 645 DLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISD 704
D++N ++ D L P D + ++ + C RP I +
Sbjct: 241 DVINAIE------------QDYRLPPPMDCPSALH---QLMLDCWQKDRNHRPKFGQIVN 285
Query: 705 ALDRLIVSSD 714
LD++I + +
Sbjct: 286 TLDKMIRNPN 295
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (406), Expect = 4e-45
Identities = 67/305 (21%), Positives = 122/305 (40%), Gaps = 52/305 (17%)
Query: 410 VLGKSGIGIVYKVVLEDGHTLAVRRLGEGGSQRFKEFQTEVEAIGKIRHSNIVTLRAYYW 469
LG+ G V+ +A++ L + G+ + F E + + K+RH +V L A
Sbjct: 24 KLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 82
Query: 470 SVDEKLLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKY 529
+ ++ +Y+ GSL L G+ G + V + IA G+ Y+ Y
Sbjct: 83 -EEPIYIVTEYMSKGSLLDFLKGETGK----YLRLPQLVDMAAQIASGMAYVE---RMNY 134
Query: 530 VHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQKSVSLEV 589
VH DL+ +NIL+G N+ V+DFGLARL +
Sbjct: 135 VHRDLRAANILVGENLVCKVADFGLARL---------------------------IEDNE 167
Query: 590 TTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGSSEMDLVNW 649
T + + APE+ + + K D++S+G++L E+ T G ++++
Sbjct: 168 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYP-GMVNREVLDQ 226
Query: 650 MQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDALDRL 709
++ P P+ + + + C PE+RPT ++ L+
Sbjct: 227 VERGYRMPCP----------PECPES-----LHDLMCQCWRKEPEERPTFEYLQAFLEDY 271
Query: 710 IVSSD 714
S++
Sbjct: 272 FTSTE 276
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (402), Expect = 1e-44
Identities = 57/302 (18%), Positives = 106/302 (35%), Gaps = 54/302 (17%)
Query: 410 VLGKSGIGIVYKVVLEDGHTLAVRRLGEGGSQRFKEFQTEVEAIGKIRHSNIVTLRAYYW 469
+G G+V+ + +A++ + EG ++F E E + K+ H +V L
Sbjct: 12 EIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE-EDFIEEAEVMMKLSHPKLVQLYGVCL 70
Query: 470 SVDEKLLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKY 529
L+++++ +G L+ L + + + + +G+ YL E
Sbjct: 71 EQAPICLVFEFMEHGCLSDYLRTQ-----RGLFAAETLLGMCLDVCEGMAYLEE---ACV 122
Query: 530 VHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQKSVSLEV 589
+H DL N L+G N VSDFG+ R +
Sbjct: 123 IHRDLAARNCLVGENQVIKVSDFGMTRFVL----------------------------DD 154
Query: 590 TTTNSSSNLGS-YYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGSSEMDLVN 648
T+S+ + +PE + S K D++S+GV++ E+ + + S ++V
Sbjct: 155 QYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYE-NRSNSEVVE 213
Query: 649 WMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDALDR 708
+ KP V +I C PE RP + L
Sbjct: 214 DISTGFRLYKP---------------RLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAE 258
Query: 709 LI 710
+
Sbjct: 259 IA 260
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (399), Expect = 2e-44
Identities = 60/301 (19%), Positives = 111/301 (36%), Gaps = 58/301 (19%)
Query: 410 VLGKSGIGIVYKVVLEDGHTLAVRRLGEGGSQRFKEFQTEVEAIGKIRHSNIVTLRAYYW 469
+GK G V G+ +AV+ + + + F E + ++RHSN+V L
Sbjct: 14 TIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVIV 70
Query: 470 SVDEKL-LIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKK 528
L ++ +Y+ GSL L + + + +K + + + YL
Sbjct: 71 EEKGGLYIVTEYMAKGSLVDYLRSRGR----SVLGGDCLLKFSLDVCEAMEYLEG---NN 123
Query: 529 YVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQKSVSLE 588
+VH DL N+L+ + VSDFGL + E
Sbjct: 124 FVHRDLAARNVLVSEDNVAKVSDFGLTK-------------------------------E 152
Query: 589 VTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGSSEMDLVN 648
++T + L + APE+L+ K S K D++S+G++L E+ + D+V
Sbjct: 153 ASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYP-RIPLKDVVP 211
Query: 649 WMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDALDR 708
++ + P V ++ C H RP+ + + L+
Sbjct: 212 RVEKGYKMDAP----------DGCPPA-----VYEVMKNCWHLDAAMRPSFLQLREQLEH 256
Query: 709 L 709
+
Sbjct: 257 I 257
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 157 bits (398), Expect = 8e-44
Identities = 63/325 (19%), Positives = 116/325 (35%), Gaps = 70/325 (21%)
Query: 410 VLGKSGIGIVYKVVL------EDGHTLAVRRLGEGGSQRF-KEFQTEVEAIGKIRHSNIV 462
+G+ G V++ E +AV+ L E S +FQ E + + + NIV
Sbjct: 20 DIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIV 79
Query: 463 TLRAYYWSVDEKLLIYDYIPNGSLATALHGKPGMVSFT------------------PVPW 504
L L+++Y+ G L L + P+
Sbjct: 80 KLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSC 139
Query: 505 SVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGS 564
+ ++ I + +A G+ YL E K+VH DL N L+G NM ++DFGL+R
Sbjct: 140 AEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIY----- 191
Query: 565 PTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGV 624
S + + + + + PES+ + + + D+++YGV
Sbjct: 192 ---------------------SADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGV 230
Query: 625 ILLEMITGRTAVVQVGSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKI 684
+L E+ + G + +++ + V D + + + +
Sbjct: 231 VLWEIFSYGLQPYY-GMAHEEVIYY-------------VRDGNILACPENCPL--ELYNL 274
Query: 685 AMACVHSSPEKRPTMRHISDALDRL 709
C P RP+ I L R+
Sbjct: 275 MRLCWSKLPADRPSFCSIHRILQRM 299
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (399), Expect = 1e-43
Identities = 65/303 (21%), Positives = 118/303 (38%), Gaps = 44/303 (14%)
Query: 410 VLGKSGIGIVYKVV-LEDGHTLAVRRLGEGGSQRF-KEFQTEVEAIGKIRHSNIVTLRAY 467
LG G+V+KV G +A + + + E++ + + IV
Sbjct: 13 ELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGA 72
Query: 468 YWSVDEKLLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPK 527
++S E + +++ GSL L +P + K+ + KGL YL
Sbjct: 73 FYSDGEISICMEHMDGGSLDQVLKKA------GRIPEQILGKVSIAVIKGLTYLR--EKH 124
Query: 528 KYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQKSVSL 587
K +H D+KPSNIL+ E + DFG++
Sbjct: 125 KIMHRDVKPSNILVNSRGEIKLCDFGVSG------------------------------- 153
Query: 588 EVTTTNSSSNLGS-YYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGSSEMDL 646
++ + ++S +G+ Y +PE L+ S + DI+S G+ L+EM GR + + E++L
Sbjct: 154 QLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELEL 213
Query: 647 VNWMQLC--IEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISD 704
+ Q+ E P L+ +A+ ++ V+ P K P+ +
Sbjct: 214 MFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLE 273
Query: 705 ALD 707
D
Sbjct: 274 FQD 276
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (392), Expect = 3e-43
Identities = 75/311 (24%), Positives = 126/311 (40%), Gaps = 55/311 (17%)
Query: 410 VLGKSGIGIVYKVVLEDGH-----TLAVRRLGEGGSQRFK-EFQTEVEAIGKIRHSNIVT 463
V+G G VYK +L+ +A++ L G +++ + +F E +G+ H NI+
Sbjct: 14 VIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIR 73
Query: 464 LRAYYWSVDEKLLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHE 523
L ++I +Y+ NG+L L K G S V +++GIA G+ YL
Sbjct: 74 LEGVISKYKPMMIITEYMENGALDKFLREKDGEFS-----VLQLVGMLRGIAAGMKYLAN 128
Query: 524 FSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQK 583
YVH DL NIL+ N+ VSDFGL+R+
Sbjct: 129 ---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP--------------------- 164
Query: 584 SVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGSSE 643
E T T S + + APE++ K + D++S+G+++ E++T S
Sbjct: 165 ----EATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYW-ELSN 219
Query: 644 MDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHIS 703
+++ + P + A+ ++ M C +RP I
Sbjct: 220 HEVMKAINDGFRLPTP---------------MDCPSAIYQLMMQCWQQERARRPKFADIV 264
Query: 704 DALDRLIVSSD 714
LD+LI + D
Sbjct: 265 SILDKLIRAPD 275
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (392), Expect = 4e-43
Identities = 58/309 (18%), Positives = 113/309 (36%), Gaps = 56/309 (18%)
Query: 409 FVLGKSGIGIVYKVVL---EDGHTLAVRRLGEGGSQRF-KEFQTEVEAIGKIRHSNIVTL 464
LG G V + V + +A++ L +G + +E E + + ++ + IV L
Sbjct: 15 IELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRL 74
Query: 465 RAYYWSVDEKLLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEF 524
+ + +L+ + G L L GK +P S +++ ++ G+ YL
Sbjct: 75 IGVCQA-EALMLVMEMAGGGPLHKFLVGKRE-----EIPVSNVAELLHQVSMGMKYLE-- 126
Query: 525 SPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQKS 584
K +VH DL N+LL + +SDFGL++
Sbjct: 127 -EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALG------------------------- 160
Query: 585 VSLEVTTTNSSSNLGSY-YQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGSSE 643
+ + T S+ + APE + K S + D++SYGV + E ++ +
Sbjct: 161 -ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYK-KMKG 218
Query: 644 MDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHIS 703
+++ +++ + P P+ E + + C E RP +
Sbjct: 219 PEVMAFIEQGKRMECP----------PECPPE-----LYALMSDCWIYKWEDRPDFLTVE 263
Query: 704 DALDRLIVS 712
+ S
Sbjct: 264 QRMRACYYS 272
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 154 bits (389), Expect = 1e-42
Identities = 70/306 (22%), Positives = 120/306 (39%), Gaps = 52/306 (16%)
Query: 410 VLGKSGIGIVYKVVLED-GHTLAVRRLGEGGSQRFKEFQTEVEAIGKIRHSNIVTLRAYY 468
LG G VY+ V + T+AV+ L E + +EF E + +I+H N+V L
Sbjct: 24 KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQLLGVC 82
Query: 469 WSVDEKLLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKK 528
+I +++ G+L L V V + + I+ + YL + K
Sbjct: 83 TREPPFYIITEFMTYGNLLDYLRECNRQ----EVSAVVLLYMATQISSAMEYLEK---KN 135
Query: 529 YVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQKSVSLE 588
++H DL N L+G N V+DFGL+RL ++ +
Sbjct: 136 FIHRDLAARNCLVGENHLVKVADFGLSRL---------------------------MTGD 168
Query: 589 VTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGSSEMDLVN 648
T ++ + + APESL K S K D++++GV+L E+ T + G +
Sbjct: 169 TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYP-GIDLSQVYE 227
Query: 649 WMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDALDR 708
++ ++P E V ++ AC +P RP+ I A +
Sbjct: 228 LLEKDYRMERP---------------EGCPEKVYELMRACWQWNPSDRPSFAEIHQAFET 272
Query: 709 LIVSSD 714
+ S
Sbjct: 273 MFQESS 278
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (383), Expect = 4e-42
Identities = 60/294 (20%), Positives = 106/294 (36%), Gaps = 54/294 (18%)
Query: 410 VLGKSGIGIVYKVVLEDGHTLAVRRLGEGGSQRFKEFQTEVEAIGKIRHSNIVTLRAYYW 469
LG G+V + +A++ + EG EF E + + + H +V L
Sbjct: 11 ELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE-DEFIEEAKVMMNLSHEKLVQLYGVCT 69
Query: 470 SVDEKLLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKY 529
+I +Y+ NG L L +++ K + + + YL K++
Sbjct: 70 KQRPIFIITEYMANGCLLNYLREMRH-----RFQTQQLLEMCKDVCEAMEYLE---SKQF 121
Query: 530 VHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQKSVSLEV 589
+H DL N L+ VSDFGL+R +
Sbjct: 122 LHRDLAARNCLVNDQGVVKVSDFGLSRYVL----------------------------DD 153
Query: 590 TTTNSSSNLGS-YYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGSSEMDLVN 648
T+S + + PE L K S K DI+++GV++ E+ + + + +
Sbjct: 154 EYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYE-RFTNSETAE 212
Query: 649 WMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHI 702
I + L P+LA + V I +C H ++RPT + +
Sbjct: 213 H----IAQGLRL---YRPHLASE--------KVYTIMYSCWHEKADERPTFKIL 251
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (387), Expect = 4e-42
Identities = 69/345 (20%), Positives = 113/345 (32%), Gaps = 70/345 (20%)
Query: 391 PLDTQVAFDLD--ELLKASAFVLGKSGIGIVYKVVL------EDGHTLAVRRLGEGGSQR 442
P D + F + K LG G V + + T+AV+ L
Sbjct: 13 PYDHKWEFPRNRLSFGK----TLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLT 68
Query: 443 FKE-FQTEVEAIGKI-RHSNIVTLRAYYWSVDEKLLIYDYIPNGSLATALHGKPGMVSFT 500
+E +E++ + + H NIV L L+I +Y G L L K +
Sbjct: 69 EREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICS 128
Query: 501 ------------PVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPH 548
+ + +AKG+ +L K +H DL NILL H
Sbjct: 129 KTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITK 185
Query: 549 VSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESL 608
+ DFGLAR + R+P + APES+
Sbjct: 186 ICDFGLARDIKNDSNYVVKGNARLPV--------------------------KWMAPESI 219
Query: 609 KVVKPSQKWDIYSYGVILLEMITGRTAVVQVGSSEMDLVNWMQLCIEEKKPLADVLDPYL 668
+ + D++SYG+ L E+ + ++ + ++ P
Sbjct: 220 FNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSP--------- 270
Query: 669 APDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDALDRLIVSS 713
E + I C + P KRPT + I +++ I S
Sbjct: 271 ------EHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISES 309
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (386), Expect = 6e-42
Identities = 61/307 (19%), Positives = 111/307 (36%), Gaps = 54/307 (17%)
Query: 410 VLGKSGIGIVYKVVLED----GHTLAVRRLGEGGSQRF-KEFQTEVEAIGKIRHSNIVTL 464
V+G+ G VY L D AV+ L +F TE + H N+++L
Sbjct: 34 VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 93
Query: 465 RAYYWSVDEK-LLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHE 523
+ L++ Y+ +G L + + + +AKG+
Sbjct: 94 LGICLRSEGSPLVVLPYMKHGDLRNFIRNETH-----NPTVKDLIGFGLQVAKGM---KF 145
Query: 524 FSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQK 583
+ KK+VH DL N +L V+DFGLAR
Sbjct: 146 LASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMY------------------------ 181
Query: 584 SVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGSSE 643
+ + + L + A ESL+ K + K D++S+GV+L E++T +
Sbjct: 182 DKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP----YPD 237
Query: 644 MDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHIS 703
++ + ++ ++ L P PD + ++ + C H E RP+ +
Sbjct: 238 VNTFDITVYLLQGRRL----LQPEYCPD--------PLYEVMLKCWHPKAEMRPSFSELV 285
Query: 704 DALDRLI 710
+ +
Sbjct: 286 SRISAIF 292
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (377), Expect = 7e-41
Identities = 69/316 (21%), Positives = 123/316 (38%), Gaps = 63/316 (19%)
Query: 410 VLGKSGIGIVYKVVLEDGHTL---AVRRLGEGGSQR-FKEFQTEVEAIGKI-RHSNIVTL 464
V+G+ G V K ++ A++R+ E S+ ++F E+E + K+ H NI+ L
Sbjct: 17 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 76
Query: 465 RAYYWSVDEKLLIYDYIPNGSLATALHGKPGM----------VSFTPVPWSVRVKIIKGI 514
L +Y P+G+L L + + + + + +
Sbjct: 77 LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 136
Query: 515 AKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPA 574
A+G+ YL + K+++H DL NIL+G N ++DFGL+R
Sbjct: 137 ARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSR------------------ 175
Query: 575 EKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRT 634
EV + L + A ESL + D++SYGV+L E+++
Sbjct: 176 -----------GQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGG 224
Query: 635 AVVQVGSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPE 694
G + +L + +KP + D E V + C P
Sbjct: 225 TPYC-GMTCAELYEKLPQGYRLEKP----------LNCDDE-----VYDLMRQCWREKPY 268
Query: 695 KRPTMRHISDALDRLI 710
+RP+ I +L+R++
Sbjct: 269 ERPSFAQILVSLNRML 284
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (373), Expect = 1e-40
Identities = 58/300 (19%), Positives = 101/300 (33%), Gaps = 54/300 (18%)
Query: 410 VLGKSGIGIVYKVV-LEDGHTLAVRRL--GEGGSQRFKEFQTEVEAIGKIRHSNIVTLRA 466
+G G K+ DG L + L G + +EV + +++H NIV
Sbjct: 11 TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 70
Query: 467 YYWSVDEKLL--IYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEF 524
L + +Y G LA+ + + ++++ + L H
Sbjct: 71 RIIDRTNTTLYIVMEYCEGGDLASVITKGTK--ERQYLDEEFVLRVMTQLTLALKECHRR 128
Query: 525 SP--KKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQ 582
S +H DLKP+N+ L + DFGLAR+ N
Sbjct: 129 SDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILN----------------------- 165
Query: 583 KSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGSS 642
T+ + YY +PE + + ++K DI+S G +L E+ S
Sbjct: 166 -----HDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPF--TAFS 218
Query: 643 EMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHI 702
+ +L I E K + E + +I ++ RP++ I
Sbjct: 219 QKELAG----KIREGKF------RRIPYRYSDE-----LNEIITRMLNLKDYHRPSVEEI 263
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 148 bits (375), Expect = 2e-40
Identities = 54/301 (17%), Positives = 109/301 (36%), Gaps = 66/301 (21%)
Query: 410 VLGKSGIGIVYKVV-LEDGHTLAVRRL---GEGGSQRFKEFQTEVEAIGKIRHSNIVTLR 465
+G G VY + + +A++++ G+ ++++++ EV + K+RH N + R
Sbjct: 22 EIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYR 81
Query: 466 AYYWSVDEKLLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFS 525
Y L+ +Y + K P+ + G +GL YLH
Sbjct: 82 GCYLREHTAWLVMEYCLGSASDLLEVHK------KPLQEVEIAAVTHGALQGLAYLHS-- 133
Query: 526 PKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQKSV 585
+H D+K NILL + DFG A +
Sbjct: 134 -HNMIHRDVKAGNILLSEPGLVKLGDFGSASI---------------------------- 164
Query: 586 SLEVTTTNSSSNLGS-YYQAPESLKVVKPSQ---KWDIYSYGVILLEMITGRTAVVQVGS 641
++S +G+ Y+ APE + + Q K D++S G+ +E+ + +
Sbjct: 165 -----MAPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL----- 214
Query: 642 SEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRH 701
M+ ++ + + + P + + + +C+ P+ RPT
Sbjct: 215 FNMNAMSALYHIAQNESP--ALQSGHWSEYF---------RNFVDSCLQKIPQDRPTSEV 263
Query: 702 I 702
+
Sbjct: 264 L 264
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (374), Expect = 3e-40
Identities = 71/367 (19%), Positives = 118/367 (32%), Gaps = 80/367 (21%)
Query: 373 RKDESETLSENVEQYDLV-----PLDTQVAFDLD--ELLKASAFVLGKSGIGIVYKVVLE 425
+ + + +Y V D + F + E K VLG G V
Sbjct: 4 QLQMVQVTGSSDNEYFYVDFREYEYDLKWEFPRENLEFGK----VLGSGAFGKVMNATAY 59
Query: 426 D------GHTLAVRRLGEGGSQRFKE-FQTEVEAIGKI-RHSNIVTLRAYYWSVDEKLLI 477
+AV+ L E +E +E++ + ++ H NIV L LI
Sbjct: 60 GISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLI 119
Query: 478 YDYIPNGSLATALHGKPGMVS-----------------FTPVPWSVRVKIIKGIAKGLVY 520
++Y G L L K S + + + +AKG+ +
Sbjct: 120 FEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEF 179
Query: 521 LHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQER 580
L K VH DL N+L+ H + DFGLAR + R+P
Sbjct: 180 LEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPV------ 230
Query: 581 QQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVG 640
+ APESL + K D++SYG++L E+ +
Sbjct: 231 --------------------KWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGI 270
Query: 641 SSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMR 700
+ + +Q + +P Y + I +C KRP+
Sbjct: 271 PVDANFYKLIQNGFKMDQP------FYATEEI---------YIIMQSCWAFDSRKRPSFP 315
Query: 701 HISDALD 707
+++ L
Sbjct: 316 NLTSFLG 322
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (371), Expect = 4e-40
Identities = 57/311 (18%), Positives = 107/311 (34%), Gaps = 63/311 (20%)
Query: 399 DLDELLKASAFVLGKSGIGIVYKVV-LEDGHTLAVRRLGEGGSQRFKEFQTEVEAIGKIR 457
D E++ LG G VYK E A + + + +++ E++ +
Sbjct: 12 DFWEIIG----ELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCD 67
Query: 458 HSNIVTLRAYYWSVDEKLLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKG 517
H NIV L ++ + ++ ++ G++ + P+ S + K
Sbjct: 68 HPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELER-----PLTESQIQVVCKQTLDA 122
Query: 518 LVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKP 577
L YLH+ K +H DLK NIL + + ++DFG++
Sbjct: 123 LNYLHD---NKIIHRDLKAGNILFTLDGDIKLADFGVSAK-------------------- 159
Query: 578 QERQQKSVSLEVTTTNSSSNLGS-YYQAPESL-----KVVKPSQKWDIYSYGVILLEMIT 631
T S +G+ Y+ APE + K K D++S G+ L+EM
Sbjct: 160 ---------NTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAE 210
Query: 632 GRTAVVQVGSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHS 691
+ M ++ L I + +P + + C+
Sbjct: 211 IEPP--HHELNPMRVL----LKIAKSEPPTLAQPSRWSSNF---------KDFLKKCLEK 255
Query: 692 SPEKRPTMRHI 702
+ + R T +
Sbjct: 256 NVDARWTTSQL 266
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (362), Expect = 4e-39
Identities = 54/302 (17%), Positives = 99/302 (32%), Gaps = 56/302 (18%)
Query: 410 VLGKSGIGIVYKVVLED---GHTLAVRRLGEGGSQR--FKEFQTEVEAIGKIRHSNIVTL 464
LG G V K + T+AV+ L + E E + ++ + IV +
Sbjct: 14 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 73
Query: 465 RAYYWSVDEKLLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEF 524
+ +L+ + G L L V ++++ ++ G+ YL
Sbjct: 74 IGICE-AESWMLVMEMAELGPLNKYLQQNR------HVKDKNIIELVHQVSMGMKYLE-- 124
Query: 525 SPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQKS 584
+VH DL N+LL +SDFGL++ + E K+
Sbjct: 125 -ESNFVHRDLAARNVLLVTQHYAKISDFGLSKAL-----------------RADENYYKA 166
Query: 585 VSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGSSEM 644
+ + APE + K S K D++S+GV++ E + + G
Sbjct: 167 QTHGKWPV--------KWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYR-GMKGS 217
Query: 645 DLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISD 704
++ ++ P +E + + C E RP +
Sbjct: 218 EVTAMLEKGERMGCP----------AGCPRE-----MYDLMNLCWTYDVENRPGFAAVEL 262
Query: 705 AL 706
L
Sbjct: 263 RL 264
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (360), Expect = 6e-39
Identities = 62/297 (20%), Positives = 102/297 (34%), Gaps = 55/297 (18%)
Query: 410 VLGKSGIGIVYKVV-LEDGHTLAVRRLGEGGSQRFKE-FQTEVEAIGKIRHSNIVTLRAY 467
LG+ G V V +AV+ + + E + E+ + H N+V +
Sbjct: 12 TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 71
Query: 468 YWSVDEKLLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPK 527
+ + L +Y G L + GM P + + G+VYLH
Sbjct: 72 RREGNIQYLFLEYCSGGELFDRIEPDIGM------PEPDAQRFFHQLMAGVVYLHG---I 122
Query: 528 KYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQKSVSL 587
H D+KP N+LL +SDFGLA +
Sbjct: 123 GITHRDIKPENLLLDERDNLKISDFGLATV---------------------------FRY 155
Query: 588 EVTTTNSSSNLGSY-YQAPESLKVVKP-SQKWDIYSYGVILLEMITGRTAVVQVGSSEMD 645
+ G+ Y APE LK + ++ D++S G++L M+ G Q S +
Sbjct: 156 NNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE 215
Query: 646 LVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHI 702
+W + YL P + +A+L + +P R T+ I
Sbjct: 216 YSDWKE------------KKTYLNPWKKIDSAPLALLH---KILVENPSARITIPDI 257
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (356), Expect = 3e-38
Identities = 61/302 (20%), Positives = 112/302 (37%), Gaps = 63/302 (20%)
Query: 410 VLGKSGIGIVYKVVL-EDGHTLAVRRL--GEGGSQRFKEFQTEVEAIGKIRHSNIVTLRA 466
+G+ VYK + E +A L + + F+ E E + ++H NIV
Sbjct: 16 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 75
Query: 467 YYWSVDEK----LLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLH 522
+ S + +L+ + + +G+L T L F + V + I KGL +LH
Sbjct: 76 SWESTVKGKKCIVLVTELMTSGTLKTYLK------RFKVMKIKVLRSWCRQILKGLQFLH 129
Query: 523 EFSPKKYVHGDLKPSNILL-GHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQ 581
+P +H DLK NI + G + D GLA L
Sbjct: 130 TRTPP-IIHRDLKCDNIFITGPTGSVKIGDLGLATLKR---------------------- 166
Query: 582 QKSVSLEVTTTNSSSNLGS-YYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVG 640
+ + + +G+ + APE + K + D+Y++G+ +LEM T
Sbjct: 167 ---------ASFAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPY---- 212
Query: 641 SSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMR 700
S + + KP + D P+ +I C+ + ++R +++
Sbjct: 213 SECQNAAQIYRRVTSGVKPAS--FDKVAIPEVK---------EIIEGCIRQNKDERYSIK 261
Query: 701 HI 702
+
Sbjct: 262 DL 263
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (354), Expect = 5e-38
Identities = 59/298 (19%), Positives = 107/298 (35%), Gaps = 63/298 (21%)
Query: 410 VLGKSGIGIVYKVVL-EDGHTLAVRRLGEGGSQR---FKEFQTEVEAIGKIRHSNIVTLR 465
LGK G VY + LA++ L + ++ + + EVE +RH NI+ L
Sbjct: 13 PLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLY 72
Query: 466 AYYWSVDEKLLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFS 525
Y+ LI +Y P G++ L + I +A L Y H
Sbjct: 73 GYFHDATRVYLILEYAPLGTVYRELQ------KLSKFDEQRTATYITELANALSYCHS-- 124
Query: 526 PKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQKSV 585
K+ +H D+KP N+LLG E ++DFG +
Sbjct: 125 -KRVIHRDIKPENLLLGSAGELKIADFGWSV----------------------------- 154
Query: 586 SLEVTTTNSSSNLGS-YYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGSSEM 644
++ ++ G+ Y PE ++ +K D++S GV+ E + G+ ++
Sbjct: 155 --HAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF--EANTYQ 210
Query: 645 DLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHI 702
+ I + ++ A + + +P +RP +R +
Sbjct: 211 ETYKR----ISRVEF---TFPDFVTEGA---------RDLISRLLKHNPSQRPMLREV 252
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 142 bits (358), Expect = 7e-38
Identities = 51/296 (17%), Positives = 106/296 (35%), Gaps = 54/296 (18%)
Query: 410 VLGKSGIGIVYKVV-LEDGHTLAVRRLGEGGSQRFKEFQTEVEAIGKIRHSNIVTLRAYY 468
LG G+V++V G+ A + + + + E++ + +RH +V L +
Sbjct: 33 ELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF 92
Query: 469 WSVDEKLLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKK 528
+E ++IY+++ G L + + + V+ ++ + KGL ++HE
Sbjct: 93 EDDNEMVMIYEFMSGGELFEKVADEHN-----KMSEDEAVEYMRQVCKGLCHMHE---NN 144
Query: 529 YVHGDLKPSNILLGHNMEPHV--SDFGLARLANIAGGSPTLQSNRMPAEKPQERQQKSVS 586
YVH DLKP NI+ + DFGL
Sbjct: 145 YVHLDLKPENIMFTTKRSNELKLIDFGLTA-----------------------------H 175
Query: 587 LEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGSSEMDL 646
L+ + + + + APE + D++S GV+ +++G + G ++ +
Sbjct: 176 LDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPF--GGENDDET 233
Query: 647 VNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHI 702
++ + D ++ D + + P R T+
Sbjct: 234 ---LRNVKSCDWNMDDSAFSGISEDG---------KDFIRKLLLADPNTRMTIHQA 277
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (354), Expect = 8e-38
Identities = 54/295 (18%), Positives = 108/295 (36%), Gaps = 56/295 (18%)
Query: 410 VLGKSGIGIVYKVV-LEDGHTLAVRRLGEGGSQRFKEFQTEVEAIGKIRHSNIVTLRAYY 468
+G+ G VY + + G +A+R++ + + E+ + + ++ NIV Y
Sbjct: 27 KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 86
Query: 469 WSVDEKLLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKK 528
DE ++ +Y+ GSL + + + + + L +LH +
Sbjct: 87 LVGDELWVVMEYLAGGSLTDVVTET-------CMDEGQIAAVCRECLQALEFLHS---NQ 136
Query: 529 YVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQKSVSLE 588
+H D+K NILLG + ++DFG +
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFGFCA-----------------------------QIT 167
Query: 589 VTTTNSSSNLGS-YYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGSSEMDLV 647
+ S+ +G+ Y+ APE + K DI+S G++ +EMI G + +
Sbjct: 168 PEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPY-----LNENPL 222
Query: 648 NWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHI 702
+ L P ++ +P ++ C+ EKR + + +
Sbjct: 223 RALYLIATNGTP--ELQNPEKLSAIFRD--------FLNRCLDMDVEKRGSAKEL 267
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (355), Expect = 8e-38
Identities = 63/319 (19%), Positives = 114/319 (35%), Gaps = 61/319 (19%)
Query: 402 ELLKASAF----VLGKSGIGIVYKVV-LEDGHTL----AVRRLGEGGSQRF-KEFQTEVE 451
+LK + F VLG G VYK + + +G + A++ L E S + KE E
Sbjct: 4 RILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 63
Query: 452 AIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKII 511
+ + + ++ L + LI +P G L + + +
Sbjct: 64 VMASVDNPHVCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNI-----GSQYLLNWC 117
Query: 512 KGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNR 571
IAKG+ YL ++ VH DL N+L+ ++DFGLA+L + +
Sbjct: 118 VQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 174
Query: 572 MPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMIT 631
+P + A ES+ + + D++SYGV + E++T
Sbjct: 175 VPI--------------------------KWMALESILHRIYTHQSDVWSYGVTVWELMT 208
Query: 632 GRTAVVQVGSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHS 691
+ G ++ + ++ +P P D V I + C
Sbjct: 209 FGSKPYD-GIPASEISSILEKGERLPQP------PICTID---------VYMIMVKCWMI 252
Query: 692 SPEKRPTMRHISDALDRLI 710
+ RP R + ++
Sbjct: 253 DADSRPKFRELIIEFSKMA 271
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (352), Expect = 9e-38
Identities = 62/304 (20%), Positives = 104/304 (34%), Gaps = 56/304 (18%)
Query: 410 VLGKSGIGIVYKVVLE----DGHTLAVRRL---GEGGSQRFKEFQTEVEAIGKIRHSNIV 462
LG G+V + + ++AV+ L + +F EV A+ + H N++
Sbjct: 15 KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 74
Query: 463 TLRAYYWSVDEKLLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLH 522
L + ++ + P GSL L G + +A+G+ YL
Sbjct: 75 RLYGVVLT-PPMKMVTELAPLGSLLDRLRKHQG-----HFLLGTLSRYAVQVAEGMGYLE 128
Query: 523 EFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQ 582
K+++H DL N+LL + DFGL R +Q +R
Sbjct: 129 S---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHR----------- 174
Query: 583 KSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGSS 642
+ APESLK S D + +GV L EM T G +
Sbjct: 175 ------KVP--------FAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWI-GLN 219
Query: 643 EMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHI 702
+++ + + D ++ + + + C PE RPT +
Sbjct: 220 GSQILHKI---------DKEGERLPRPEDCPQD-----IYNVMVQCWAHKPEDRPTFVAL 265
Query: 703 SDAL 706
D L
Sbjct: 266 RDFL 269
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (347), Expect = 4e-37
Identities = 51/307 (16%), Positives = 103/307 (33%), Gaps = 59/307 (19%)
Query: 410 VLGKSGIGIVYKVVL----EDGHTLAVRRLGEGGSQRFKE-FQTEVEAIGKIRHSNIVTL 464
+G+ G V++ + +A++ S +E F E + + H +IV L
Sbjct: 14 CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 73
Query: 465 RAYYWSVDEKLLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEF 524
+ +I + G L + L + + + + ++ L YL
Sbjct: 74 IGVITE-NPVWIIMELCTLGELRSFLQVRKY-----SLDLASLILYAYQLSTALAYLES- 126
Query: 525 SPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQKS 584
K++VH D+ N+L+ N + DFGL+R
Sbjct: 127 --KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME------------------------- 159
Query: 585 VSLEVTTTNSSSNLGS-YYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGSSE 643
+ T +S + APES+ + + D++ +GV + E++ Q G
Sbjct: 160 ---DSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQ-GVKN 215
Query: 644 MDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHIS 703
D++ ++ P P+ + + C P +RP +
Sbjct: 216 NDVIGRIENGERLPMP----------PNCPPT-----LYSLMTKCWAYDPSRRPRFTELK 260
Query: 704 DALDRLI 710
L ++
Sbjct: 261 AQLSTIL 267
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (348), Expect = 7e-37
Identities = 62/312 (19%), Positives = 115/312 (36%), Gaps = 56/312 (17%)
Query: 410 VLGKSGIGIVYKVVL------EDGHTLAVRRLGEGGSQRFK-EFQTEVEAIGKIRHSNIV 462
LG+ G+VY+ V E +A++ + E S R + EF E + + ++V
Sbjct: 27 ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 86
Query: 463 TLRAYYWSVDEKLLIYDYIPNGSLATALHGKPGMVS----FTPVPWSVRVKIIKGIAKGL 518
L L+I + + G L + L ++ P S +++ IA G+
Sbjct: 87 RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGM 146
Query: 519 VYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQ 578
YL+ K+VH DL N ++ + + DFG+ R +P
Sbjct: 147 AYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR--- 200
Query: 579 ERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQ 638
+ +PESLK + D++S+GV+L E+ T Q
Sbjct: 201 -----------------------WMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQ 237
Query: 639 VGSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPT 698
G S ++ + V++ L D + + ++ C +P+ RP+
Sbjct: 238 -GLSNEQVLRF-------------VMEGGLLDKPDNCPD--MLFELMRMCWQYNPKMRPS 281
Query: 699 MRHISDALDRLI 710
I ++ +
Sbjct: 282 FLEIISSIKEEM 293
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (337), Expect = 1e-35
Identities = 70/342 (20%), Positives = 123/342 (35%), Gaps = 71/342 (20%)
Query: 391 PLDTQVAFDLD--ELLKASAFVLGKSGIGIVYKVVL--------EDGHTLAVRRLGEGGS 440
P D + D L K LG+ G V +AV+ L +
Sbjct: 3 PEDPRWELPRDRLVLGK----PLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDAT 58
Query: 441 QR-FKEFQTEVEAIGKI-RHSNIVTLRAYYWSVDEKLLIYDYIPNGSLATALHGK----- 493
++ + +E+E + I +H NI+ L +I +Y G+L L +
Sbjct: 59 EKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGL 118
Query: 494 -----PGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPH 548
P + V +A+G+ YL KK +H DL N+L+ +
Sbjct: 119 EYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMK 175
Query: 549 VSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESL 608
++DFGLAR + + R+P + APE+L
Sbjct: 176 IADFGLARDIHHIDYYKKTTNGRLPV--------------------------KWMAPEAL 209
Query: 609 KVVKPSQKWDIYSYGVILLEMITGRTAVVQVGSSEMDLVNWMQLCIEEKKPLADVLDPYL 668
+ + D++S+GV+L E+ T + G +L ++ KP
Sbjct: 210 FDRIYTHQSDVWSFGVLLWEIFTLGGSPYP-GVPVEELFKLLKEGHRMDKP--------- 259
Query: 669 APDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDALDRLI 710
+ E + + C H+ P +RPT + + + LDR++
Sbjct: 260 -SNCTNE-----LYMMMRDCWHAVPSQRPTFKQLVEDLDRIV 295
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 134 bits (337), Expect = 6e-35
Identities = 52/316 (16%), Positives = 108/316 (34%), Gaps = 58/316 (18%)
Query: 390 VPLDTQVAFDLDELLKASAFVLGKSGIGIVYKVV-LEDGHTLAVRRLGEGGSQRFKEFQT 448
V + +D ++L+ LG G+V++ V G + + +
Sbjct: 20 VEVKQGSVYDYYDILE----ELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKN 75
Query: 449 EVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRV 508
E+ + ++ H ++ L + E +LI +++ G L + + + + +
Sbjct: 76 EISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDY-----KMSEAEVI 130
Query: 509 KIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHV--SDFGLARLANIAGGSPT 566
++ +GL ++HE VH D+KP NI+ V DFGLA N
Sbjct: 131 NYMRQACEGLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLN------- 180
Query: 567 LQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVIL 626
+ V + T + APE + D+++ GV+
Sbjct: 181 --------------PDEIVKVTTATA--------EFAAPEIVDREPVGFYTDMWAIGVLG 218
Query: 627 LEMITGRTAVVQVGSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAM 686
+++G + G +++ +Q + ++P+A
Sbjct: 219 YVLLSGLSPF--AGEDDLET---LQNVKRCDWEFDEDAFSSVSPEA---------KDFIK 264
Query: 687 ACVHSSPEKRPTMRHI 702
+ P KR T+
Sbjct: 265 NLLQKEPRKRLTVHDA 280
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (333), Expect = 1e-34
Identities = 44/296 (14%), Positives = 99/296 (33%), Gaps = 55/296 (18%)
Query: 410 VLGKSGIGIVYKVV-LEDGHTLAVRRLGEGGSQRFKEFQTEVEAIGKIRHSNIVTLRAYY 468
LG+ GIV++ V T + + G+ + + E+ + RH NI+ L +
Sbjct: 12 DLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQ-VLVKKEISILNIARHRNILHLHESF 70
Query: 469 WSVDEKLLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKK 528
S++E ++I+++I + ++ + V + + + L +LH
Sbjct: 71 ESMEELVMIFEFISGLDIFERINTSAF-----ELNEREIVSYVHQVCEALQFLHS---HN 122
Query: 529 YVHGDLKPSNILLGHNMEPHV--SDFGLARLANIAGGSPTLQSNRMPAEKPQERQQKSVS 586
H D++P NI+ + +FG AR
Sbjct: 123 IGHFDIRPENIIYQTRRSSTIKIIEFGQARQ----------------------------- 153
Query: 587 LEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGSSEMDL 646
L+ Y APE + S D++S G ++ +++G + + +
Sbjct: 154 LKPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPF--LAETNQQI 211
Query: 647 VNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHI 702
++ + + + ++ +A + + + R T
Sbjct: 212 ---IENIMNAEYTFDEEAFKEISIEA---------MDFVDRLLVKERKSRMTASEA 255
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (327), Expect = 3e-34
Identities = 59/324 (18%), Positives = 113/324 (34%), Gaps = 65/324 (20%)
Query: 410 VLGKSGIGIVYKVV------LEDGHTLAVRRLGEGGSQ-RFKEFQTEVEAIGKIRHSNIV 462
LG+ G V + T+AV+ L EG + + +E++ + I H V
Sbjct: 20 PLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNV 79
Query: 463 TLRAYYWSVDEK--LLIYDYIPNGSLATALHGK----------PGMVSFTPVPWSVRVKI 510
+ ++I ++ G+L+T L K P + + +
Sbjct: 80 VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICY 139
Query: 511 IKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSN 570
+AKG+ +L +K +H DL NILL + DFGLAR
Sbjct: 140 SFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARD------------- 183
Query: 571 RMPAEKPQERQQKSVSLEVTTTNSSSNLGSY-YQAPESLKVVKPSQKWDIYSYGVILLEM 629
+ + + APE++ + + D++S+GV+L E+
Sbjct: 184 --------------IYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI 229
Query: 630 ITGRTAVVQVGSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACV 689
+ + + + ++E + Y P+ + + C
Sbjct: 230 FSLGASP----YPGVKIDEEFCRRLKEGTRMR--APDYTTPEM---------YQTMLDCW 274
Query: 690 HSSPEKRPTMRHISDALDRLIVSS 713
H P +RPT + + L L+ ++
Sbjct: 275 HGEPSQRPTFSELVEHLGNLLQAN 298
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (322), Expect = 2e-33
Identities = 49/304 (16%), Positives = 91/304 (29%), Gaps = 57/304 (18%)
Query: 410 VLGKSGIGIVYKVV-LEDGHTLAVRRL---GEGGSQRFKEFQTEVEAIGKIRHSNIVTLR 465
+LG+ V L A++ L + E + + ++ H V L
Sbjct: 15 ILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY 74
Query: 466 AYYWSVDEKLLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFS 525
+ ++ Y NG L + + I L YLH
Sbjct: 75 FTFQDDEKLYFGLSYAKNGELLKYIR------KIGSFDETCTRFYTAEIVSALEYLHG-- 126
Query: 526 PKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQKSV 585
K +H DLKP NILL +M ++DFG A++ + S
Sbjct: 127 -KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGT------------ 173
Query: 586 SLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGSSEMD 645
+ Y +PE L + D+++ G I+ +++ G +E
Sbjct: 174 --------------AQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP--FRAGNEYL 217
Query: 646 LVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDA 705
+ Q I+ + + P + +++ + KR +
Sbjct: 218 I---FQKIIKLEYDFPEKFFP----------KARDLVE---KLLVLDATKRLGCEEMEGY 261
Query: 706 LDRL 709
Sbjct: 262 GPLK 265
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 123 bits (310), Expect = 5e-32
Identities = 53/304 (17%), Positives = 103/304 (33%), Gaps = 57/304 (18%)
Query: 410 VLGKSGIGIVYKVV-LEDGHTLAVRRLGEGGSQRF---------KEFQTEVEAIGKIR-H 458
+LG+ +V + + AV+ + G F + EV+ + K+ H
Sbjct: 10 ILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGH 69
Query: 459 SNIVTLRAYYWSVDEKLLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGL 518
NI+ L+ Y + L++D + G L L K + KI++ + + +
Sbjct: 70 PNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKV------TLSEKETRKIMRALLEVI 123
Query: 519 VYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQ 578
LH+ VH DLKP NILL +M ++DFG + + G + P+
Sbjct: 124 CALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLD--PGEKLREVCGTPSYLAP 178
Query: 579 ERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQ 638
E + + ++ D++S GVI+ ++ G
Sbjct: 179 E---------------------IIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPF-- 215
Query: 639 VGSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPT 698
+M + +++ + + + + P+KR T
Sbjct: 216 WHRKQMLM---LRMIMSGNYQFGSPEWDDYSDTV---------KDLVSRFLVVQPQKRYT 263
Query: 699 MRHI 702
Sbjct: 264 AEEA 267
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 123 bits (309), Expect = 5e-32
Identities = 57/310 (18%), Positives = 112/310 (36%), Gaps = 59/310 (19%)
Query: 410 VLGKSGIGIVYKVV-LEDGHTLAVRRL---GEGGSQRFKEFQTEVEAIGKIRHSNIVTLR 465
+LG G+ V+ L +AV+ L + F+ E + + H IV +
Sbjct: 14 ILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 73
Query: 466 AYYWSVDEKL----LIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYL 521
+ ++ +Y+ +L +H + P+ +++I + L +
Sbjct: 74 DTGEAETPAGPLPYIVMEYVDGVTLRDIVH------TEGPMTPKRAIEVIADACQALNFS 127
Query: 522 HEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQ 581
H+ +H D+KP+NI++ V DFG+AR +G
Sbjct: 128 HQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGN------------------ 166
Query: 582 QKSVSLEVTTTNSSSNLGS-YYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVG 640
+ T +++ +G+ Y +PE + + D+YS G +L E++TG
Sbjct: 167 --------SVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPF---- 214
Query: 641 SSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRP-TM 699
+ V+ + E L+ D D + + + +PE R T
Sbjct: 215 -TGDSPVSVAYQHVREDPIPPSARHEGLSADLD---------AVVLKALAKNPENRYQTA 264
Query: 700 RHISDALDRL 709
+ L R+
Sbjct: 265 AEMRADLVRV 274
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 122 bits (307), Expect = 2e-31
Identities = 37/309 (11%), Positives = 88/309 (28%), Gaps = 47/309 (15%)
Query: 410 VLGKSGIGIVYKVV-LEDGHTLAVRRLGEGGSQRFKEFQTEVEAIGKIRHSNIVTLRAYY 468
+G G +Y + G +A++ + + E + ++ + +
Sbjct: 14 KIGSGSFGDIYLGTDIAAGEEVAIKLECV--KTKHPQLHIESKIYKMMQGGVGIPTIRWC 71
Query: 469 WSVDEKLLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKK 528
+ + ++ + SL + + + + + Y+H K
Sbjct: 72 GAEGDYNVMVMELLGPSLEDLFNFCSR-----KFSLKTVLLLADQMISRIEYIHS---KN 123
Query: 529 YVHGDLKPSNIL---LGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQKSV 585
++H D+KP N L ++ DFGLA+ A +
Sbjct: 124 FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYREN------------- 170
Query: 586 SLEVTTTNSSSNLGS-YYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGSSEM 644
+ G+ Y + + ++ S++ D+ S G +L+ G + ++
Sbjct: 171 ---------KNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATK 221
Query: 645 DLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISD 704
+ P+ L E C + +P ++
Sbjct: 222 RQKYERISEKKMSTPI-----EVLCKGYPSE-----FATYLNFCRSLRFDDKPDYSYLRQ 271
Query: 705 ALDRLIVSS 713
L
Sbjct: 272 LFRNLFHRQ 280
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 121 bits (303), Expect = 6e-31
Identities = 37/308 (12%), Positives = 89/308 (28%), Gaps = 49/308 (15%)
Query: 410 VLGKSGIGIVYKVV-LEDGHTLAVRRLGEGGSQRFKEFQTEVEAIGKIRHSNIVTLRAYY 468
+G+ G++++ L + +A++ + + E + + Y+
Sbjct: 12 RIGEGSFGVIFEGTNLLNNQQVAIKFEPR--RSDAPQLRDEYRTYKLLAGCTGIPNVYYF 69
Query: 469 WSVDEKLLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKK 528
++ + SL L K + + +HE K
Sbjct: 70 GQEGLHNVLVIDLLGPSLEDLLDLCGR-----KFSVKTVAMAAKQMLARVQSIHE---KS 121
Query: 529 YVHGDLKPSNILLGHNMEPH-----VSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQK 583
V+ D+KP N L+G + V DFG+ + +
Sbjct: 122 LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREK----------- 170
Query: 584 SVSLEVTTTNSSSNLGS-YYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGSS 642
+ G+ Y + + + S++ D+ + G + + + G G
Sbjct: 171 -----------KNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSL--PWQGLK 217
Query: 643 EMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHI 702
+ E+K+ L +E K + + + P ++
Sbjct: 218 AATNKQKYERIGEKKQST---PLRELCAGFPEE-----FYKYMHYARNLAFDATPDYDYL 269
Query: 703 SDALDRLI 710
+++
Sbjct: 270 QGLFSKVL 277
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (303), Expect = 1e-30
Identities = 51/299 (17%), Positives = 101/299 (33%), Gaps = 54/299 (18%)
Query: 410 VLGKSGIGIVYKVV-LEDGHTLAVRRLGEGGSQRFKEFQTEVEAIGKI-RHSNIVTLRAY 467
VLG G V ++ A++ L Q + + EVE + + +IV +
Sbjct: 19 VLGLGINGKVLQIFNKRTQEKFALKML-----QDCPKARREVELHWRASQCPHIVRIVDV 73
Query: 468 YWSVDEK----LLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHE 523
Y ++ L++ + + G L + + + +I+K I + + YLH
Sbjct: 74 YENLYAGRKCLLIVMECLDGGELFSRIQDRGDQ----AFTEREASEIMKSIGEAIQYLHS 129
Query: 524 FSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQK 583
H D+KP N+L + A +L +
Sbjct: 130 ---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTP--------- 177
Query: 584 SVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGSSE 643
YY APE L K + D++S GVI+ ++ G +
Sbjct: 178 -----------------YYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPF--YSNHG 218
Query: 644 MDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHI 702
+ + M+ I + + ++ EE+ +++ + + P +R T+
Sbjct: 219 LAISPGMKTRIRMGQY-----EFPNPEWSEVSEEVKMLIR---NLLKTEPTQRMTITEF 269
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 119 bits (299), Expect = 2e-30
Identities = 73/307 (23%), Positives = 123/307 (40%), Gaps = 56/307 (18%)
Query: 27 ALLSFKQSVHEDPEGSLSNWN-SSDENPCSWNGITC----KEQRVVSVSIPKKKLLGF-- 79
ALL K+ + +LS+W ++D +W G+ C + RV ++ + L
Sbjct: 10 ALLQIKKDLGNPT--TLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYP 67
Query: 80 LPSALGSLTDLRHVNLRNNKFF-GSLPLELLEAQGLQSLVLYGNSFSGSVPNEIGKLKYL 138
+PS+L +L L + + G +P + + L L + + SG++P+ + ++K L
Sbjct: 68 IPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTL 127
Query: 139 QILDLSQNFFNGSLPVSIVQCKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLNLSFNKFN 198
LD S N +G+LP SI L + N +G +P+ +GS + +S N+
Sbjct: 128 VTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLT 187
Query: 199 GSIPS---------------------------------------------NTGNLSSLQG 213
G IP LS
Sbjct: 188 GKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLN 247
Query: 214 TVDFSHNLFSGSIPASLGNLPEKVYIDLTYNNLSGPIPQNGALMNRGPTAFIGNPRLCGP 273
+D +N G++P L L +++++NNL G IPQ G L +A+ N LCG
Sbjct: 248 GLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGS 307
Query: 274 PLKNPCS 280
PL C+
Sbjct: 308 PLP-ACT 313
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 120 bits (302), Expect = 3e-30
Identities = 53/301 (17%), Positives = 91/301 (30%), Gaps = 60/301 (19%)
Query: 410 VLGKSGIGIVYKVV-LEDGHTLAVRRL------GEGGSQRFKEFQTEVEAIGKIRHSNIV 462
++G+ G G VY + G A++ L + G + + + IV
Sbjct: 11 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 70
Query: 463 TLRAYYWSVDEKLLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLH 522
+ + + D+ I D + G L L + I GL ++H
Sbjct: 71 CMSYAFHTPDKLSFILDLMNGGDLHYHLSQHG------VFSEADMRFYAAEIILGLEHMH 124
Query: 523 EFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQ 582
+ V+ DLKP+NILL + +SD GLA S E Q
Sbjct: 125 N---RFVVYRDLKPANILLDEHGHVRISDLGLACD---FSKKKPHASVGTHGYMAPEVLQ 178
Query: 583 KSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGSS 642
K G Y D +S G +L +++ G +
Sbjct: 179 K---------------GVAY-----------DSSADWFSLGCMLFKLLRGHSP--FRQHK 210
Query: 643 EMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHI 702
D ++ + L D P E+ ++L+ + +R
Sbjct: 211 TKDKHEIDRMTLTMAVELPDSFSP----------ELRSLLE---GLLQRDVNRRLGCLGR 257
Query: 703 S 703
Sbjct: 258 G 258
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 117 bits (293), Expect = 2e-29
Identities = 57/299 (19%), Positives = 99/299 (33%), Gaps = 59/299 (19%)
Query: 410 VLGKSGIGIVYKVV-LEDGHTLAVRRLGEGGSQRFKE-FQTEVEAIGKIRHSNIVTLRAY 467
VLG V +A++ + + + + + E+ + KI+H NIV L
Sbjct: 16 VLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDI 75
Query: 468 YWSVDEKLLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPK 527
Y S LI + G L + K ++I + + YLH+
Sbjct: 76 YESGGHLYLIMQLVSGGELFDRIVEKG------FYTERDASRLIFQVLDAVKYLHDL--- 126
Query: 528 KYVHGDLKPSNILL---GHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQKS 584
VH DLKP N+L + + +SDFGL+++ +
Sbjct: 127 GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED------------------------- 161
Query: 585 VSLEVTTTNSSSNLGS-YYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGSSE 643
+ S+ G+ Y APE L S+ D +S GVI ++ G +
Sbjct: 162 -----PGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPF-----YD 211
Query: 644 MDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHI 702
+ + ++ + ++ A + PEKR T
Sbjct: 212 ENDAKLFEQILKAEYEFDSPYWDDISDSA---------KDFIRHLMEKDPEKRFTCEQA 261
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (293), Expect = 2e-29
Identities = 56/297 (18%), Positives = 102/297 (34%), Gaps = 62/297 (20%)
Query: 410 VLGKSGIGIVYKVV-LEDGHTLAVRRL---GEGGSQRFKEFQTEVEAIGK-IRHSNIVTL 464
+LGK G V+ + A++ L + E + H + +
Sbjct: 9 MLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHM 68
Query: 465 RAYYWSVDEKLLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEF 524
+ + + + +Y+ G L + S I GL +LH
Sbjct: 69 FCTFQTKENLFFVMEYLNGGDLMYHIQSCH------KFDLSRATFYAAEIILGLQFLHS- 121
Query: 525 SPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQKS 584
K V+ DLK NILL + ++DFG+ +
Sbjct: 122 --KGIVYRDLKLDNILLDKDGHIKIADFGMCK---------------------------- 151
Query: 585 VSLEVTTTNSSSNLGS-YYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGSSE 643
+ +++ G+ Y APE L K + D +S+GV+L EM+ G++ G E
Sbjct: 152 -ENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPF--HGQDE 208
Query: 644 MDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMR 700
+L + +++ +P+ +KE + + PEKR +R
Sbjct: 209 EELFHSIRMD-----------NPFYPRWLEKE-----AKDLLVKLFVREPEKRLGVR 249
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (288), Expect = 1e-28
Identities = 59/321 (18%), Positives = 105/321 (32%), Gaps = 75/321 (23%)
Query: 410 VLGKSGIGIVYKVVL-EDGHTLAVRRLGEGGSQRFKEFQTEVEAIGKIRHSNIVTLRAYY 468
V+G G+VY+ L + G +A++++ Q + E++ + K+ H NIV LR ++
Sbjct: 27 VIGNGSFGVVYQAKLCDSGELVAIKKV----LQDKRFKNRELQIMRKLDHCNIVRLRYFF 82
Query: 469 WSVDEK------LLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLH 522
+S EK L+ DY+P A H + P + + + L Y+H
Sbjct: 83 YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTL---PVIYVKLYMYQLFRSLAYIH 139
Query: 523 EFSPKKYVHGDLKPSNILLGHNMEPH-VSDFGLARLANIAGGSPTLQSNRMPAEKPQERQ 581
H D+KP N+LL + + DFG A+ + G P +
Sbjct: 140 S---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ--LVRGEPNVSYICSRY------- 187
Query: 582 QKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGR-------- 633
Y + D++S G +L E++ G+
Sbjct: 188 -------------------YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSG 228
Query: 634 ------------TAVVQVGSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAV 681
T + + + P V P P+A
Sbjct: 229 VDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEA--------- 279
Query: 682 LKIAMACVHSSPEKRPTMRHI 702
+ + + +P R T
Sbjct: 280 IALCSRLLEYTPTARLTPLEA 300
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 113 bits (283), Expect = 2e-28
Identities = 59/308 (19%), Positives = 107/308 (34%), Gaps = 53/308 (17%)
Query: 410 VLGKSGIGIVYKVVLEDGHTLAVR--RLGEGGSQRFKEFQTEVEAIGKIRHSNIVTLRAY 467
+G+ G+VYK G T A++ RL + E+ + +++HSNIV L
Sbjct: 9 KIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68
Query: 468 YWSVDEKLLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPK 527
+ +L+++++ + G+ + + G+ Y H+ +
Sbjct: 69 IHTKKRLVLVFEHLDQDLKKLLDVCEGGL------ESVTAKSFLLQLLNGIAYCHD---R 119
Query: 528 KYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQKSVSL 587
+ +H DLKP N+L+ E ++DFGLAR + +
Sbjct: 120 RVLHRDLKPQNLLINREGELKIADFGLAR---------------------------AFGI 152
Query: 588 EVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGSSEMDLV 647
V Y + K S DI+S G I EM+ G G SE D +
Sbjct: 153 PVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLF--PGVSEADQL 210
Query: 648 -------------NWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPE 694
NW + K + L ++ + + + + + P
Sbjct: 211 MRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPN 270
Query: 695 KRPTMRHI 702
+R T +
Sbjct: 271 QRITAKQA 278
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (285), Expect = 4e-28
Identities = 56/318 (17%), Positives = 111/318 (34%), Gaps = 65/318 (20%)
Query: 410 VLGKSGIGIVYKVV-LEDGHTLAVRRLGEGGSQRF-KEFQTEVEAIGKIRHSNIVTLRAY 467
+G+ G+V + +A++++ Q + + E++ + + RH NI+ +
Sbjct: 15 YIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDI 74
Query: 468 YWSVDEKLLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPK 527
+ + + Y+ + L+ ++ + + I +GL Y+H
Sbjct: 75 IRAPTIEQMKDVYLVTHLMGADLYK---LLKTQHLSNDHICYFLYQILRGLKYIHS---A 128
Query: 528 KYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQKSVSL 587
+H DLKPSN+LL + + DFGLAR+A+ + +
Sbjct: 129 NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA-------------- 174
Query: 588 EVTTTNSSSNLGSYYQAPESLKVVKP-SQKWDIYSYGVILLEMITGR------------- 633
+Y+APE + K ++ DI+S G IL EM++ R
Sbjct: 175 -----------TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLN 223
Query: 634 ---------TAVVQVGSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKI 684
+ + N++ + K + L P A L +
Sbjct: 224 HILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKA---------LDL 274
Query: 685 AMACVHSSPEKRPTMRHI 702
+ +P KR +
Sbjct: 275 LDKMLTFNPHKRIEVEQA 292
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 111 bits (278), Expect = 2e-27
Identities = 55/298 (18%), Positives = 96/298 (32%), Gaps = 62/298 (20%)
Query: 410 VLGKSGIGIVYKVV-LEDGHTLAVRRLGEGGSQRFKE---FQTEVEAIGKIRHSNIVTLR 465
LG G V+ + +G A++ L + R K+ E + + H I+ +
Sbjct: 11 TLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMW 70
Query: 466 AYYWSVDEKLLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFS 525
+ + +I DYI G L + L P V + L YLH
Sbjct: 71 GTFQDAQQIFMIMDYIEGGELFSLLRKSQRF------PNPVAKFYAAEVCLALEYLHS-- 122
Query: 526 PKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQKSV 585
K ++ DLKP NILL N ++DFG A+
Sbjct: 123 -KDIIYRDLKPENILLDKNGHIKITDFGFAK----------------------------- 152
Query: 586 SLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGSSEMD 645
V + Y APE + ++ D +S+G+++ EM+ G T S+ M
Sbjct: 153 --YVPDVTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPF--YDSNTMK 208
Query: 646 LVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHIS 703
+ + + + ++ +L + +R
Sbjct: 209 T---YEKILNAELRFPPFFNE----------DVKDLLS---RLITRDLSQRLGNLQNG 250
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 107 bits (268), Expect = 2e-26
Identities = 60/320 (18%), Positives = 112/320 (35%), Gaps = 62/320 (19%)
Query: 402 ELLKASAFVLGKSGIGIVYKVV-LEDGHTLAVRRL-----GEGGSQRFKEFQTEVEAIGK 455
E L LG+ VYK +A++++ E + E++ + +
Sbjct: 1 EKLD----FLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQE 56
Query: 456 IRHSNIVTLRAYYWSVDEKLLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIA 515
+ H NI+ L + L++D++ + S +
Sbjct: 57 LSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVL------TPSHIKAYMLMTL 110
Query: 516 KGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAE 575
+GL YLH+ +H DLKP+N+LL N ++DFGLA+
Sbjct: 111 QGLEYLHQ---HWILHRDLKPNNLLLDENGVLKLADFGLAKSFG---------------- 151
Query: 576 KPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKP-SQKWDIYSYGVILLEMITGRT 634
++ + +V T +Y+APE L + D+++ G IL E++
Sbjct: 152 ----SPNRAYTHQVVTR--------WYRAPELLFGARMYGVGVDMWAVGCILAELLLRVP 199
Query: 635 AVVQVGSSEMDLVNWMQLCI----EEKKPLADVLDPYLAPDADKEEEIIAVLKIA----- 685
+ G S++D + + + EE+ P L Y+ + + + A
Sbjct: 200 FL--PGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLL 257
Query: 686 ---MACVHSSPEKRPTMRHI 702
+P R T
Sbjct: 258 DLIQGLFLFNPCARITATQA 277
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 106 bits (266), Expect = 5e-26
Identities = 61/312 (19%), Positives = 106/312 (33%), Gaps = 54/312 (17%)
Query: 410 VLGKSGIGIVYKV--VLEDGHTLAVRRL-----GEGGSQRFKEFQTEVEAIGKIRHSNIV 462
+G+ G V+K + G +A++R+ EG + + H N+V
Sbjct: 14 EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 73
Query: 463 TLRAYYWSVDEKLLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLH 522
L + + L V VP ++ + +GL +LH
Sbjct: 74 RLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH 133
Query: 523 EFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQ 582
+ VH DLKP NIL+ + + ++DFGLAR+ +
Sbjct: 134 S---HRVVHRDLKPQNILVTSSGQIKLADFGLARIYS----------------------- 167
Query: 583 KSVSLEVTTTNSSSNLGS-YYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGS 641
+S + + +Y+APE L + D++S G I EM + GS
Sbjct: 168 -------FQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLF--RGS 218
Query: 642 SEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIA-----------MACVH 690
S++D + + I D L A + + K + C+
Sbjct: 219 SDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLT 278
Query: 691 SSPEKRPTMRHI 702
+P KR +
Sbjct: 279 FNPAKRISAYSA 290
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 105 bits (263), Expect = 1e-25
Identities = 56/304 (18%), Positives = 101/304 (33%), Gaps = 63/304 (20%)
Query: 410 VLGKSGIGIVYKVV-LEDGHTLAVRRL------GEGGSQRFKEFQTEVEAIGKIRHSNIV 462
LG +V K G A + + ++ + EV + +I+H N++
Sbjct: 17 ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 76
Query: 463 TLRAYYWSVDEKLLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLH 522
TL Y + + +LI + + G L L K + + +K I G+ YLH
Sbjct: 77 TLHEVYENKTDVILILELVAGGELFDFLAEKESL------TEEEATEFLKQILNGVYYLH 130
Query: 523 EFSPKKYVHGDLKPSNILLGHNMEP----HVSDFGLARLANIAGGSPTLQSNRMPAEKPQ 578
+ H DLKP NI+L P + DFGLA
Sbjct: 131 S---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH---------------------- 165
Query: 579 ERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQ 638
++ + + APE + + D++S GVI +++G +
Sbjct: 166 -------KIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF-- 216
Query: 639 VGSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPT 698
+G ++ + + D + A + P+KR T
Sbjct: 217 LGDTKQET---LANVSAVNYEFEDEYFSNTSALA---------KDFIRRLLVKDPKKRMT 264
Query: 699 MRHI 702
++
Sbjct: 265 IQDS 268
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 104 bits (260), Expect = 2e-25
Identities = 49/305 (16%), Positives = 97/305 (31%), Gaps = 75/305 (24%)
Query: 410 VLGKSGIGIVYKVV-LEDGHTLAVRRL------GEGGSQRFKEFQTEVEAIGKIR--HSN 460
+LG G G VY + + D +A++ + G EV + K+ S
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 461 IVTLRAYYWSVDEKLLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVY 520
++ L ++ D +LI + + G + + + + + +
Sbjct: 71 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERG-----ALQEELARSFFWQVLEAVRH 125
Query: 521 LHEFSPKKYVHGDLKPSNILLGHN-MEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQE 579
H +H D+K NIL+ N E + DFG L
Sbjct: 126 CHN---CGVLHRDIKDENILIDLNRGELKLIDFGSGAL---------------------- 160
Query: 580 RQQKSVSLEVTTTNSSSNLGS-YYQAPESLKVVK-PSQKWDIYSYGVILLEMITGRTAVV 637
+ T + G+ Y PE ++ + + ++S G++L +M+ G
Sbjct: 161 ---------LKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF- 210
Query: 638 QVGSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRP 697
+ + Q+ ++ E +++ C+ P RP
Sbjct: 211 ----EHDEEIIRGQVFFRQRVS----------------SECQHLIR---WCLALRPSDRP 247
Query: 698 TMRHI 702
T I
Sbjct: 248 TFEEI 252
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 101 bits (253), Expect = 2e-24
Identities = 50/309 (16%), Positives = 98/309 (31%), Gaps = 53/309 (17%)
Query: 410 VLGKSGIGIVYKVV-LEDGHTLAVR--RLGEGGSQRFKEFQTEVEAIGKIRHSNIVTLRA 466
+G+ G V+K E +A++ RL + E+ + +++H NIV L
Sbjct: 9 KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHD 68
Query: 467 YYWSVDEKLLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSP 526
S + L++++ + + + + KGL + H
Sbjct: 69 VLHSDKKLTLVFEFCDQDLKKYFDSCNGDL------DPEIVKSFLFQLLKGLGFCH---S 119
Query: 527 KKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQKSVS 586
+ +H DLKP N+L+ N E +++FGLAR +
Sbjct: 120 RNVLHRDLKPQNLLINRNGELKLANFGLAR---------------------------AFG 152
Query: 587 LEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGSSEMDL 646
+ V ++ Y S D++S G I E+ + G+ D
Sbjct: 153 IPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFP-GNDVDDQ 211
Query: 647 VNWMQLC--------IEEKKPLADVLDPYLAPDADKEEEIIAVL-----KIAMACVHSSP 693
+ + L D + P ++ L + + +P
Sbjct: 212 LKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNP 271
Query: 694 EKRPTMRHI 702
+R +
Sbjct: 272 VQRISAEEA 280
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 101 bits (253), Expect = 2e-24
Identities = 57/310 (18%), Positives = 98/310 (31%), Gaps = 55/310 (17%)
Query: 410 VLGKSGIGIVYKVV-LEDGHTLAVR--RLGEGGSQRFKEFQTEVEAIGKIRHSNIVTLRA 466
+G+ G+VYK G +A++ RL E+ + ++ H NIV L
Sbjct: 9 KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL- 67
Query: 467 YYWSVDEKLLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSP 526
+ KL + + L + T +P + + + +GL + H
Sbjct: 68 DVIHTENKLYLVFEFLHQDLKKFMDASA----LTGIPLPLIKSYLFQLLQGLAFCHS--- 120
Query: 527 KKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQKSVS 586
+ +H DLKP N+L+ ++DFGLAR +
Sbjct: 121 HRVLHRDLKPQNLLINTEGAIKLADFGLAR---------------------------AFG 153
Query: 587 LEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRT------------ 634
+ V T Y L S DI+S G I EM+T R
Sbjct: 154 VPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLF 213
Query: 635 --AVVQVGSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSS 692
E+ + + + +E+ ++L +H
Sbjct: 214 RIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLS---QMLHYD 270
Query: 693 PEKRPTMRHI 702
P KR + +
Sbjct: 271 PNKRISAKAA 280
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 102 bits (254), Expect = 4e-24
Identities = 45/306 (14%), Positives = 84/306 (27%), Gaps = 66/306 (21%)
Query: 402 ELLKASAFVLGKSGIGIVYKVV-LEDGHTLAVRRLGEGGSQRFKE---FQTEVEAIGKIR 457
+ +K LG G V V E G+ A++ L + + K+ E + +
Sbjct: 44 DRIK----TLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 458 HSNIVTLRAYYWSVDEKLLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKG 517
+V L + ++ +Y+ G + + L I
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG------RFSEPHARFYAAQIVLT 153
Query: 518 LVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKP 577
YLH ++ DLKP N+L+ V+DFG A+
Sbjct: 154 FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK--------------------- 189
Query: 578 QERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVV 637
V + APE + ++ D ++ GV++ EM G
Sbjct: 190 ----------RVKGRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF- 238
Query: 638 QVGSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRP 697
+ + + + + D + + KR
Sbjct: 239 -FADQPIQIYEKIVSGKVR-------FPSHFSSDLK---------DLLRNLLQVDLTKRF 281
Query: 698 TMRHIS 703
Sbjct: 282 GNLKNG 287
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 100 bits (250), Expect = 1e-23
Identities = 58/313 (18%), Positives = 104/313 (33%), Gaps = 59/313 (18%)
Query: 410 VLGKSGIGIVYKVV-LEDGHTLAVRRLGEGGSQR--FKEFQTEVEAIGKIRHSNIVTLRA 466
+G G V V G +A+++L K E+ + +RH N++ L
Sbjct: 25 PVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLD 84
Query: 467 YYWSVDEKLLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSP 526
+ + D+ GK ++ + ++ + KGL Y+H
Sbjct: 85 VFTPDETLDDFTDFYLVMPFMGTDLGK--LMKHEKLGEDRIQFLVYQMLKGLRYIHA--- 139
Query: 527 KKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQKSVS 586
+H DLKP N+ + + E + DFGLAR A+
Sbjct: 140 AGIIHRDLKPGNLAVNEDCELKILDFGLARQAD--------------------------- 172
Query: 587 LEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGSSEMDL 646
+ Y L ++ +Q DI+S G I+ EMITG+T GS +D
Sbjct: 173 ---SEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLF--KGSDHLDQ 227
Query: 647 VNWMQLCIEEKKPLADVLDPYLAPDADKEEEII-----------------AVLKIAMACV 689
++ P A+ + + +A + + + + +
Sbjct: 228 --LKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKML 285
Query: 690 HSSPEKRPTMRHI 702
E+R T
Sbjct: 286 VLDAEQRVTAGEA 298
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 96.9 bits (240), Expect = 1e-22
Identities = 50/322 (15%), Positives = 113/322 (35%), Gaps = 65/322 (20%)
Query: 410 VLGKSGIGIVYKVV-LEDGHTLAVRRLGEGGSQR--FKEFQTEVEAIGKIRHSNIVTLRA 466
+G+ G V+K + G +A++++ + E++ + ++H N+V L
Sbjct: 17 KIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIE 76
Query: 467 YYWSVDEK--------LLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGL 518
+ L++D+ + + S ++++ + GL
Sbjct: 77 ICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKF------TLSEIKRVMQMLLNGL 130
Query: 519 VYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQ 578
Y+H K +H D+K +N+L+ + ++DFGLAR ++A S
Sbjct: 131 YYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQ------------- 174
Query: 579 ERQQKSVSLEVTTTNSSSNLGS-YYQAPESLKVVKP-SQKWDIYSYGVILLEMITGRTAV 636
++ + + +Y+ PE L + D++ G I+ EM T
Sbjct: 175 ------------PNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRS--P 220
Query: 637 VQVGSSEMDLVNWMQLCI----------EEKKPLADVLDPYLAPDADKEEEIIAVLKIAM 686
+ G++E + + + L + L+ ++ + A ++
Sbjct: 221 IMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPY 280
Query: 687 A------CVHSSPEKRPTMRHI 702
A + P +R
Sbjct: 281 ALDLIDKLLVLDPAQRIDSDDA 302
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 96.8 bits (240), Expect = 2e-22
Identities = 55/305 (18%), Positives = 94/305 (30%), Gaps = 63/305 (20%)
Query: 410 VLGKSGIGIVYKVV-LEDGHTLAVRRL---GEGGSQRFKEFQTEVEAIGKIRHSNIVTLR 465
+LGK G V V G A++ L TE + RH + L+
Sbjct: 12 LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 71
Query: 466 AYYWSVDEKLLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFS 525
+ + D + +Y G L L + I L YLH
Sbjct: 72 YAFQTHDRLCFVMEYANGGELFFHLSRERVF------TEERARFYGAEIVSALEYLHS-- 123
Query: 526 PKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQKSV 585
+ V+ D+K N++L + ++DFGL +
Sbjct: 124 -RDVVYRDIKLENLMLDKDGHIKITDFGLCK----------------------------- 153
Query: 586 SLEVTTTNSSSNLGS-YYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGSSEM 644
+ G+ Y APE L+ + D + GV++ EM+ GR
Sbjct: 154 EGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF--YNQDHE 211
Query: 645 DLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRH--I 702
L +L + E+ L P E ++L + P++R
Sbjct: 212 RL---FELILMEEIRFPRTLSP----------EAKSLLA---GLLKKDPKQRLGGGPSDA 255
Query: 703 SDALD 707
+ ++
Sbjct: 256 KEVME 260
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 94.9 bits (235), Expect = 7e-22
Identities = 61/309 (19%), Positives = 106/309 (34%), Gaps = 61/309 (19%)
Query: 402 ELLKASAFVLGKSGIGIVYKVVL----EDGHTLAVRRL----GEGGSQRFKEFQTEVEAI 453
ELLK VLG G V+ V + G A++ L ++ + +TE + +
Sbjct: 27 ELLK----VLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVL 82
Query: 454 GKIRHS-NIVTLRAYYWSVDEKLLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIK 512
IR S +VTL + + + LI DYI G L T L + +
Sbjct: 83 EHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERF------TEHEVQIYVG 136
Query: 513 GIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRM 572
I L +LH+ ++ D+K NILL N ++DFGL++
Sbjct: 137 EIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGT 193
Query: 573 PAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITG 632
+ + S + D +S GV++ E++TG
Sbjct: 194 IEYMAPDIVRGGDS-------------------------GHDKAVDWWSLGVLMYELLTG 228
Query: 633 RTAVVQVGSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSS 692
+ E + + I + +P ++ A +++I +
Sbjct: 229 ASPF--TVDGEKNSQAEISRRILKSEP---PYPQEMSALA---KDLI------QRLLMKD 274
Query: 693 PEKRPTMRH 701
P+KR
Sbjct: 275 PKKRLGCGP 283
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 89.5 bits (221), Expect = 6e-20
Identities = 45/318 (14%), Positives = 101/318 (31%), Gaps = 68/318 (21%)
Query: 410 VLGKSGIGIVYKVV-LEDGHTLAVRRLGEGGSQRFKEFQTEVEAIGKIR-HSNIVTLRAY 467
LG+ V++ + + + + V+ L + K+ + E++ + +R NI+TL
Sbjct: 42 KLGRGKYSEVFEAINITNNEKVVVKILKP---VKKKKIKREIKILENLRGGPNIITLADI 98
Query: 468 YWSVDEKL--LIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFS 525
+ L+++++ N + + I K L Y H
Sbjct: 99 VKDPVSRTPALVFEHVNNTDFKQLYQ---------TLTDYDIRFYMYEILKALDYCHS-- 147
Query: 526 PKKYVHGDLKPSNILLGH-NMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQKS 584
+H D+KP N+++ H + + + D+GLA + +
Sbjct: 148 -MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH---------------------PGQE 185
Query: 585 VSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRT---------- 634
++ V + + + D++S G +L MI +
Sbjct: 186 YNVRVASRY-------FKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYD 238
Query: 635 ---AVVQVGSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIA------ 685
+ +V +E + IE D+L + ++ ++
Sbjct: 239 QLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDF 298
Query: 686 -MACVHSSPEKRPTMRHI 702
+ + R T R
Sbjct: 299 LDKLLRYDHQSRLTAREA 316
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 85.8 bits (211), Expect = 1e-18
Identities = 58/328 (17%), Positives = 105/328 (32%), Gaps = 78/328 (23%)
Query: 410 VLGKSGIGIVYKVV-LEDGHTLAVRRL--GEGGSQRFKEFQTEVEAIGKIRHSNIVTLRA 466
+G GIV +A+++L K E+ + + H NI++L
Sbjct: 24 PIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLN 83
Query: 467 YYWS------VDEKLLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVY 520
+ + L+ + + + ++ + G+ +
Sbjct: 84 VFTPQKTLEEFQDVYLVMELMDANLCQVIQM---------ELDHERMSYLLYQMLCGIKH 134
Query: 521 LHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQER 580
LH +H DLKPSNI++ + + DFGLAR A
Sbjct: 135 LHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAG--------------------- 170
Query: 581 QQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVG 640
++ V T YY+APE + + + DI+S G I+ EM+ + G
Sbjct: 171 TSFMMTPYVVTR--------YYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILF--PG 220
Query: 641 SSEMDLVN-------------------WMQLCIEEKKPLADVLDPYLAPDADKEEEIIAV 681
+D N ++ +E + A + P L PD+ +
Sbjct: 221 RDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHN 280
Query: 682 LKIA-------MACVHSSPEKRPTMRHI 702
A + P KR ++
Sbjct: 281 KLKASQARDLLSKMLVIDPAKRISVDDA 308
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 84.9 bits (209), Expect = 3e-18
Identities = 60/313 (19%), Positives = 100/313 (31%), Gaps = 59/313 (18%)
Query: 410 VLGKSGIGIVYKVV-LEDGHTLAVRRL--GEGGSQRFKEFQTEVEAIGKIRHSNIVTLRA 466
+G G V + G +AV++L K E+ + ++H N++ L
Sbjct: 25 PVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 84
Query: 467 YYWSVDEKLLIYDYIPNGSLATALHGKPG--MVSFTPVPWSVRVKIIKGIAKGLVYLHEF 524
+ D L T L G +V + +I I +GL Y+H
Sbjct: 85 VFTPARSLEEFNDVY----LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS- 139
Query: 525 SPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQKS 584
+H DLKPSN+ + + E + DFGLAR +
Sbjct: 140 --ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD------------------------ 173
Query: 585 VSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGSSEM 644
Y L + +Q DI+S G I+ E++TGRT G+ +
Sbjct: 174 ------EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF--PGTDHI 225
Query: 645 DLVN-----------WMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAM----ACV 689
D + + I + + P + I +A+ +
Sbjct: 226 DQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKML 285
Query: 690 HSSPEKRPTMRHI 702
+KR T
Sbjct: 286 VLDSDKRITAAQA 298
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 83.1 bits (204), Expect = 1e-17
Identities = 46/186 (24%), Positives = 68/186 (36%), Gaps = 30/186 (16%)
Query: 85 GSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSGSVPNEIGKLKYLQILDLS 144
LT+L + NN+ PL + L L L GN + L L LDL+
Sbjct: 194 AKLTNLESLIATNNQISDITPLGI--LTNLDELSLNGNQLKD--IGTLASLTNLTDLDLA 249
Query: 145 QNFFNGSLPVSIVQCKRLKALDLSQNNFTGPLP-------------------NGFGSGLV 185
N + P+S +L L L N + P S L
Sbjct: 250 NNQISNLAPLS--GLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDISPISNLK 307
Query: 186 SLEKLNLSFNKFNGSIPSNTGNLSSLQGTVDFSHNLFSGSIPASLGNLPEKVYIDLTYNN 245
+L L L FN + P +L+ LQ + F++N S +SL NL ++ +N
Sbjct: 308 NLTYLTLYFNNISDISP--VSSLTKLQ-RLFFANNKVSD--VSSLANLTNINWLSAGHNQ 362
Query: 246 LSGPIP 251
+S P
Sbjct: 363 ISDLTP 368
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 69.3 bits (168), Expect = 4e-13
Identities = 36/200 (18%), Positives = 68/200 (34%), Gaps = 17/200 (8%)
Query: 1 MCFWVVLFLVLCNFNGFVDSLNGEGYALLSFKQSVHEDPEGSLSNWNSSDENPCSWNGIT 60
+ L + LS + +D G+L++ + + + N I+
Sbjct: 196 LTNLESLIATNNQISDITPLGILTNLDELSLNGNQLKDI-GTLASLTNLTDLDLANNQIS 254
Query: 61 -----CKEQRVVSVSIPKKKLLGFLPSALGSLTDLRHVNLRNNKFFGSLPLELLEAQGLQ 115
++ + + ++ P L LT L ++ L N+ P+ L + L
Sbjct: 255 NLAPLSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDISPISNL--KNLT 310
Query: 116 SLVLYGNSFSGSVPNEIGKLKYLQILDLSQNFFNGSLPVSIVQCKRLKALDLSQNNFTGP 175
L LY N+ S P + L LQ L + N + S+ + L N +
Sbjct: 311 YLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGHNQISDL 366
Query: 176 LPNGFGSGLVSLEKLNLSFN 195
P L + +L L+
Sbjct: 367 TPLA---NLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 40.8 bits (94), Expect = 5e-04
Identities = 15/78 (19%), Positives = 25/78 (32%), Gaps = 7/78 (8%)
Query: 135 LKYLQILDLSQNFFNGSLPVSIVQCKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLNLSF 194
L L + VS ++ L + +G L +L ++N S
Sbjct: 21 LAEKMKTVLGKTNVTD--TVSQTDLDQVTTLQADRLGIKSI--DGVEY-LNNLTQINFSN 75
Query: 195 NKFNGSIPSNTGNLSSLQ 212
N+ P NL+ L
Sbjct: 76 NQLTDITPL--KNLTKLV 91
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 77.8 bits (190), Expect = 6e-16
Identities = 41/236 (17%), Positives = 81/236 (34%), Gaps = 41/236 (17%)
Query: 410 VLGKSGIGIVYKVV-LEDGHTLAVRRLGEGGSQRFKEFQTEVEAIGKIRHSNIVTLRAYY 468
LG V+ + + +A++ + G + + E++ + ++ ++ +
Sbjct: 20 KLGWGHFSTVWLAKDMVNNTHVAMKIV-RGDKVYTEAAEDEIKLLQRVNDADNTKEDSMG 78
Query: 469 WSVDEKLLIY--DYIPNGSLATALHGKPGM--------VSFTPVPWSVRVKIIKGIAKGL 518
+ KLL + PNG + G +P +I K + GL
Sbjct: 79 ANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGL 138
Query: 519 VYLHEFSPKKYVHGDLKPSNILLGHN-MEPHVSDFGLARLANIAGGSPTLQSNRMPAEKP 577
Y+H +H D+KP N+L+ ++ +A L N
Sbjct: 139 DYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGN------------------ 178
Query: 578 QERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGR 633
+ ++S Y++PE L DI+S ++ E+ITG
Sbjct: 179 --------ACWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGD 226
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 71.4 bits (174), Expect = 7e-15
Identities = 20/157 (12%), Positives = 45/157 (28%), Gaps = 23/157 (14%)
Query: 410 VLGKSGIGIVYKVVLEDGHTLAVRRLGEGGS----------QRFKEFQTEVEAIGKIRHS 459
++G+ V+ E V+ G + F +
Sbjct: 7 LMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFR 66
Query: 460 NIVTLRAYYWSVDEKLLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLV 519
+ L+ +Y + N ++ L + +++ I + +
Sbjct: 67 ALQKLQGLAV-----PKVYAWEGN-AVLMELIDAKELYRVRVENP---DEVLDMILEEVA 117
Query: 520 YLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLAR 556
+ + VHGDL N+L+ + DF +
Sbjct: 118 KFYH---RGIVHGDLSQYNVLV-SEEGIWIIDFPQSV 150
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 67.9 bits (164), Expect = 5e-13
Identities = 39/159 (24%), Positives = 57/159 (35%), Gaps = 6/159 (3%)
Query: 90 LRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSGSVPNEIGKLKYLQILDLSQNFFN 149
L+++ L++N + L L L+GN S L L L L QN
Sbjct: 131 LQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVA 190
Query: 150 GSLPVSIVQCKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLNLSFNKFNGSIPSNTGNLS 209
P + RL L L NN + LP + L +L+ L L+ N + +
Sbjct: 191 HVHPHAFRDLGRLMTLYLFANNLS-ALPTEALAPLRALQYLRLNDNPWVCDCR-ARPLWA 248
Query: 210 SLQGTVDFSHNLFSGSIPASLGNLPEKVYIDLTYNNLSG 248
LQ S + S+P L L N+L G
Sbjct: 249 WLQ-KFRGSSSEVPCSLPQRLAGRD---LKRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 60.6 bits (145), Expect = 1e-10
Identities = 28/177 (15%), Positives = 51/177 (28%), Gaps = 6/177 (3%)
Query: 48 SSDENPCSWNGITCKEQRVVSVSIPKKKLLGFLPSALGSLTDLRHVNLRNNKFFGSLPLE 107
G+ + + + L L +L H+ L N+
Sbjct: 113 DRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERA 172
Query: 108 LLEAQGLQSLVLYGNSFSGSVPNEIGKLKYLQILDLSQNFFNGSLPVSIVQCKRLKALDL 167
L L+L+ N + P+ L L L L N + ++ + L+ L L
Sbjct: 173 FRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRL 232
Query: 168 SQNNFTGPLPNGFGSGLVSLEKLNLSFNKFNGSIPSNTGNLSSLQGTVDFSHNLFSG 224
+ N + L+K S ++ S+P + N G
Sbjct: 233 NDNPWVCDCRA--RPLWAWLQKFRGSSSEVPCSLPQRLAGRDLK----RLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.8 bits (104), Expect = 2e-05
Identities = 31/160 (19%), Positives = 51/160 (31%), Gaps = 4/160 (2%)
Query: 92 HVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSGSVPNEIGKLKYLQILDLSQNFFNGS 151
+ ++P+ + Q + L+GN S + L IL L N
Sbjct: 15 TTSCPQQGL-QAVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARI 71
Query: 152 LPVSIVQCKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLNLSFNKFNGSIPSNTGNLSSL 211
+ L+ LDLS N + GL L L+L P L++L
Sbjct: 72 DAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAAL 131
Query: 212 QGTVDFSHNLFSGSIPASLGNLPEKVYIDLTYNNLSGPIP 251
Q + N + +L ++ L N +S
Sbjct: 132 Q-YLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPE 170
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 67.8 bits (164), Expect = 6e-13
Identities = 38/200 (19%), Positives = 69/200 (34%), Gaps = 21/200 (10%)
Query: 54 CSWNGITCKEQRVVSVSIPKKKLLGFLPSALGSLTDLRHVNLRNNKFFGSLPLELLEAQG 113
C + C + + V P L D ++L+NNK + +
Sbjct: 10 CHLRVVQCSDLGLEKV-----------PKDLP--PDTALLDLQNNKITEIKDGDFKNLKN 56
Query: 114 LQSLVLYGNSFSGSVPNEIGKLKYLQILDLSQNFFNGSLPVSIVQCKRLKALDLSQNNFT 173
L +L+L N S P L L+ L LS+N LP + + + L + +N T
Sbjct: 57 LHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK-ELPEKMPKTLQE--LRVHENEIT 113
Query: 174 GPLPNGFG-SGLVSLEKLNLSFNKFNGSIPSNTGNLSSLQGTVDFSHNLFSGSIPASLGN 232
+ F + + +L + K +G + L + + + +IP L
Sbjct: 114 KVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLS-YIRIADTNIT-TIPQGL-- 169
Query: 233 LPEKVYIDLTYNNLSGPIPQ 252
P + L N ++
Sbjct: 170 PPSLTELHLDGNKITKVDAA 189
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 59.7 bits (143), Expect = 4e-10
Identities = 33/186 (17%), Positives = 56/186 (30%), Gaps = 14/186 (7%)
Query: 42 SLSNWNSSDENPCSWNGITCKEQRVVSVSIPKKKLLGFLPSALGSLTDLRHVNLRNNKFF 101
L + + VV + K G A + L ++ + +
Sbjct: 104 ELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNI- 162
Query: 102 GSLPLELLEAQGLQSLVLYGNSFSGSVPNEIGKLKYLQILDLSQNFFNGSLPVSIVQCKR 161
++P L + L L L GN + + L L L LS N + S+
Sbjct: 163 TTIPQGLPPS--LTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPH 220
Query: 162 LKALDLSQNNFTGPLPNGFGSGLVSLEKLNLSFNKFNGSIPSNT-------GNLSSLQGT 214
L+ L L+ N ++ + L N + +I SN +S
Sbjct: 221 LRELHLNNNKLVKVPGGLAD--HKYIQVVYLHNNNIS-AIGSNDFCPPGYNTKKASYS-G 276
Query: 215 VDFSHN 220
V N
Sbjct: 277 VSLFSN 282
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 39.3 bits (90), Expect = 0.001
Identities = 26/158 (16%), Positives = 46/158 (29%), Gaps = 10/158 (6%)
Query: 42 SLSNWNSSDENPCSWNGITCKEQRVVSVSIPKKKLLGFLPSALGSLTDLRHVNLRNNKFF 101
LS +D N + + + K+ ++L L +L + L N
Sbjct: 151 KLSYIRIADTNITTIPQGLPPSLTELHLD--GNKITKVDAASLKGLNNLAKLGLSFNSIS 208
Query: 102 GSLPLELLEAQGLQSLVLYGNSFSGSVPNEIGKLKYLQILDLSQNFFNG------SLPVS 155
L L+ L L N VP + KY+Q++ L N + P
Sbjct: 209 AVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGY 267
Query: 156 IVQCKRLKALDLSQNNFT-GPLPNGFGSGLVSLEKLNL 192
+ + L N + + + L
Sbjct: 268 NTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQL 305
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 59.3 bits (142), Expect = 4e-10
Identities = 19/98 (19%), Positives = 37/98 (37%), Gaps = 2/98 (2%)
Query: 115 QSLVLYGNSFSGSVPNEIGKLKYLQILDLSQNFFNGSLPVSIVQCKRLKALDLSQNNFTG 174
Q+L L G + V + + ++F + L R++ +DLS +
Sbjct: 3 QTLDLTGKNLHPDVTGRLLSQG-VIAFRCPRSFMDQPLAEHF-SPFRVQHMDLSNSVIEV 60
Query: 175 PLPNGFGSGLVSLEKLNLSFNKFNGSIPSNTGNLSSLQ 212
+G S L+ L+L + + I + S+L
Sbjct: 61 STLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLV 98
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.2 bits (87), Expect = 0.002
Identities = 15/92 (16%), Positives = 31/92 (33%), Gaps = 4/92 (4%)
Query: 92 HVNLRNNKFFGSLPLELLEAQGLQSLVLYG-NSFSGSVPNEIGKLKYLQILDLSQNFFNG 150
+ E + LQ L L E+G++ L+ L + +G
Sbjct: 180 LDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDG 239
Query: 151 SLPVSIVQCKRLKALDLSQNNFTGPLPNGFGS 182
+L + L+ ++ ++FT G+
Sbjct: 240 TLQLLKEALPHLQ---INCSHFTTIARPTIGN 268
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 57.5 bits (137), Expect = 2e-09
Identities = 22/93 (23%), Positives = 32/93 (34%), Gaps = 12/93 (12%)
Query: 143 LSQNFFNGSLPVSIVQCKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLNLSFNKFNGSIP 202
N + + L+ L++S N LP LE+L SFN +P
Sbjct: 267 YYLNASSNEIRSLCDLPPSLEELNVSNNKLIE-LPALPP----RLERLIASFNHLA-EVP 320
Query: 203 SNTGNLSSLQGTVDFSHNLFSG--SIPASLGNL 233
NL L +N IP S+ +L
Sbjct: 321 ELPQNLKQL----HVEYNPLREFPDIPESVEDL 349
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 54.8 bits (130), Expect = 2e-08
Identities = 20/94 (21%), Positives = 38/94 (40%), Gaps = 10/94 (10%)
Query: 119 LYGNSFSGSVPNEIGKLKYLQILDLSQNFFNGSLPVSIVQCKRLKALDLSQNNFTGPLPN 178
Y N+ S + + L+ L++S N LP RL+ L S N+ +P
Sbjct: 267 YYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALP---PRLERLIASFNHLAE-VPE 321
Query: 179 GFGSGLVSLEKLNLSFNKFNGSIPSNTGNLSSLQ 212
+L++L++ +N P ++ L+
Sbjct: 322 LPQ----NLKQLHVEYNPLR-EFPDIPESVEDLR 350
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 40.2 bits (92), Expect = 7e-04
Identities = 16/96 (16%), Positives = 30/96 (31%), Gaps = 11/96 (11%)
Query: 45 NWNSSDENPCSWNGITCKEQRVVSVSIPKKKLLGFLPSALGSLTDLRHVNLRNNKFFGSL 104
+ ++ N ++VS L LP+ L L N +
Sbjct: 267 YYLNASSNEIRSLCDLPPSLEELNVS---NNKLIELPALPPRLERL---IASFNH-LAEV 319
Query: 105 PLELLEAQGLQSLVLYGNSFSGSVPNEIGKLKYLQI 140
P Q L+ L + N P+ ++ L++
Sbjct: 320 PELP---QNLKQLHVEYNPLR-EFPDIPESVEDLRM 351
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 56.1 bits (133), Expect = 8e-09
Identities = 16/89 (17%), Positives = 32/89 (35%), Gaps = 9/89 (10%)
Query: 114 LQSLVLYGNSFSGSVPNEI-GKLKYLQILDLSQNFFNG----SLPVSIVQCKRLKALDLS 168
+QSL + S + E+ L+ Q++ L + ++ L L+L
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 169 QNNFTG----PLPNGFGSGLVSLEKLNLS 193
N + G + ++KL+L
Sbjct: 64 SNELGDVGVHCVLQGLQTPSCKIQKLSLQ 92
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 53.1 bits (125), Expect = 8e-08
Identities = 9/96 (9%), Positives = 23/96 (23%), Gaps = 5/96 (5%)
Query: 162 LKALDLSQNNFTGPLPNGFGSGLVSLEKLNLSFNKFNG----SIPSNTGNLSSLQGTVDF 217
+++LD+ + L + + L I S +L ++
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALA-ELNL 62
Query: 218 SHNLFSGSIPASLGNLPEKVYIDLTYNNLSGPIPQN 253
N + + + +L
Sbjct: 63 RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTG 98
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 51.5 bits (121), Expect = 2e-07
Identities = 15/74 (20%), Positives = 28/74 (37%), Gaps = 8/74 (10%)
Query: 138 LQILDLSQNFFNG----SLPVSIVQCKRLKALDLSQNNFTGPLPNGFGSGLVS----LEK 189
L++L L+ + SL +++ L+ LDLS N + LE+
Sbjct: 371 LRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQ 430
Query: 190 LNLSFNKFNGSIPS 203
L L ++ +
Sbjct: 431 LVLYDIYWSEEMED 444
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 50.0 bits (117), Expect = 6e-07
Identities = 16/89 (17%), Positives = 29/89 (32%), Gaps = 15/89 (16%)
Query: 159 CKRLKALDLSQNNFTGPLPNGFGSGLV---SLEKLNLSFNKFNG--------SIPSNTGN 207
L+ L L+ + + + + L+ SL +L+LS N S+
Sbjct: 368 GSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCL 427
Query: 208 LSSLQGTVDFSHNLFSGSIPASLGNLPEK 236
L L +S + L L +
Sbjct: 428 LEQL----VLYDIYWSEEMEDRLQALEKD 452
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 48.0 bits (112), Expect = 3e-06
Identities = 14/94 (14%), Positives = 33/94 (35%), Gaps = 10/94 (10%)
Query: 89 DLRHVNLRNNKFFGSLPLELLEA-QGLQSLVLYGNSFSG----SVPNEIGKLKYLQILDL 143
D++ ++++ + + ELL Q Q + L + + + + L L+L
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 144 SQNFFNGSLPVSIVQ-----CKRLKALDLSQNNF 172
N ++Q +++ L L
Sbjct: 63 RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCL 96
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.1 bits (107), Expect = 1e-05
Identities = 19/87 (21%), Positives = 33/87 (37%), Gaps = 13/87 (14%)
Query: 114 LQSLVLYGNSFSG----SVPNEIGKLKYLQILDLSQNFFNGSLPVSIVQ-----CKRLKA 164
L+ L L S S+ + L+ LDLS N + + +V+ L+
Sbjct: 371 LRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQ 430
Query: 165 LDLSQNNFTGPLPNGFGSGLVSLEKLN 191
L L ++ + + L +LEK
Sbjct: 431 LVLYDIYWSEEMED----RLQALEKDK 453
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.0 bits (104), Expect = 3e-05
Identities = 18/71 (25%), Positives = 35/71 (49%), Gaps = 9/71 (12%)
Query: 80 LPSALGSLTDLRHVNLRNNKFFGSLPLELLEA-----QGLQSLVLYGNSFSGSVPNEIGK 134
L + L + LR ++L NN + L+L+E+ L+ LVLY +S + + +
Sbjct: 389 LAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSEEMEDRLQA 448
Query: 135 LK----YLQIL 141
L+ L+++
Sbjct: 449 LEKDKPSLRVI 459
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.9 bits (96), Expect = 2e-04
Identities = 15/83 (18%), Positives = 30/83 (36%), Gaps = 9/83 (10%)
Query: 90 LRHVNLRNNKF----FGSLPLELLEAQGLQSLVLYGNSFSGSVPNEIGK-----LKYLQI 140
LR + L + SL LL L+ L L N + ++ + L+
Sbjct: 371 LRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQ 430
Query: 141 LDLSQNFFNGSLPVSIVQCKRLK 163
L L +++ + + ++ K
Sbjct: 431 LVLYDIYWSEEMEDRLQALEKDK 453
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.1 bits (94), Expect = 3e-04
Identities = 10/73 (13%), Positives = 23/73 (31%), Gaps = 6/73 (8%)
Query: 185 VSLEKLNLSFNKFNGS-IPSNTGNLSSLQGTVDFSHNLFSG----SIPASLGNLPEKVYI 239
+ ++ L++ + + + L Q V + I ++L P +
Sbjct: 2 LDIQSLDIQCEELSDARWAELLPLLQQCQ-VVRLDDCGLTEARCKDISSALRVNPALAEL 60
Query: 240 DLTYNNLSGPIPQ 252
+L N L
Sbjct: 61 NLRSNELGDVGVH 73
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.8 bits (88), Expect = 0.002
Identities = 14/84 (16%), Positives = 25/84 (29%), Gaps = 10/84 (11%)
Query: 178 NGFGSGLVSLEKLNLSFNKFNG----SIPSNTGNLSSLQGTVDFSHNLFSGSIPASLGNL 233
G G L L L+ + S+ + SL+ +D S+N + L
Sbjct: 362 QGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLR-ELDLSNNCLGDAGILQLVES 420
Query: 234 PEK-----VYIDLTYNNLSGPIPQ 252
+ + L S +
Sbjct: 421 VRQPGCLLEQLVLYDIYWSEEMED 444
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.8 bits (88), Expect = 0.002
Identities = 12/79 (15%), Positives = 19/79 (24%), Gaps = 9/79 (11%)
Query: 80 LPSALGSLTDLRHVNLRNNKF----FGSLPLELLEAQGLQSLVLYGNSFSGSVPNEIGKL 135
L L + V L + + L L L L N + + +
Sbjct: 19 WAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQG 78
Query: 136 -----KYLQILDLSQNFFN 149
+Q L L
Sbjct: 79 LQTPSCKIQKLSLQNCCLT 97
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 52.0 bits (124), Expect = 9e-09
Identities = 23/125 (18%), Positives = 41/125 (32%), Gaps = 8/125 (6%)
Query: 139 QILDLSQNFFNGSLPVSIVQCKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLNLSFNKFN 198
++L L+ ++ + Q + LDLS N P L +L L + N
Sbjct: 1 RVLHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRALPP-----ALAALRCLEVLQASDN 53
Query: 199 GSIPSNTGNLSSLQGTVDFSHN-LFSGSIPASLGNLPEKVYIDLTYNNLSGPIPQNGALM 257
+ + +N L + L + P V ++L N+L L
Sbjct: 54 ALENVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLA 113
Query: 258 NRGPT 262
P+
Sbjct: 114 EMLPS 118
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 46.2 bits (109), Expect = 8e-07
Identities = 23/121 (19%), Positives = 38/121 (31%), Gaps = 6/121 (4%)
Query: 91 RHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSGSVPNEIGKLKYLQILDLSQNFFNG 150
R ++L + ++ L + + L L N P + L+ L++L S N
Sbjct: 1 RVLHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNALEN 57
Query: 151 SLPVSIVQCKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLNLSFNKFNGSIPSNTGNLSS 210
+ RL+ L L N L LNL N L+
Sbjct: 58 --VDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ-EEGIQERLAE 114
Query: 211 L 211
+
Sbjct: 115 M 115
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 45.9 bits (108), Expect = 1e-06
Identities = 23/114 (20%), Positives = 41/114 (35%), Gaps = 8/114 (7%)
Query: 81 PSALGSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLY-GNSFSGSVPNEIGKLKYLQ 139
L L + H++L +N+ P L+ L + + + + + L LQ
Sbjct: 13 LCHLEQLLLVTHLDLSHNRLRALPP----ALAALRCLEVLQASDNALENVDGVANLPRLQ 68
Query: 140 ILDLSQNFFNG-SLPVSIVQCKRLKALDLSQNNFTG--PLPNGFGSGLVSLEKL 190
L L N + +V C RL L+L N+ + L S+ +
Sbjct: 69 ELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSI 122
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.9 bits (107), Expect = 7e-06
Identities = 32/206 (15%), Positives = 49/206 (23%), Gaps = 49/206 (23%)
Query: 85 GSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSGSVPNEIGKLKYLQILDLS 144
+ VN +LP +L + L L N + L L+L
Sbjct: 7 SKVASHLEVNCDKRNLT-ALPPDL--PKDTTILHLSENLLYTFSLATLMPYTRLTQLNLD 63
Query: 145 --------------------------------------------QNFFNGSLPVSIVQCK 160
SLP+ ++
Sbjct: 64 RAELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGL 123
Query: 161 RLKALDLSQNNFTGPLPNGFGSGLVSLEKLNLSFNKFNGSIPSNTGNLSSLQGTVDFSHN 220
+ N LP G + LEKL+L+ N L +L T+ N
Sbjct: 124 GELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLD-TLLLQEN 182
Query: 221 LFSGSIPASLGNLPEKVYIDLTYNNL 246
+IP + L N
Sbjct: 183 SLY-TIPKGFFGSHLLPFAFLHGNPW 207
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.5 bits (93), Expect = 4e-04
Identities = 14/80 (17%), Positives = 30/80 (37%), Gaps = 1/80 (1%)
Query: 45 NWNSSDENPCSWNGITCKEQRVVSVSIPKKKLLGFLPSALGSLTDLRHVNLRNNKFFGSL 104
+ +E G+ ++ +S+ L L L +L + L+ N + ++
Sbjct: 129 LYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TI 187
Query: 105 PLELLEAQGLQSLVLYGNSF 124
P + L L+GN +
Sbjct: 188 PKGFFGSHLLPFAFLHGNPW 207
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.5 bits (99), Expect = 3e-05
Identities = 24/123 (19%), Positives = 45/123 (36%), Gaps = 10/123 (8%)
Query: 77 LGFLPSALGSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSG--SVPNEIGK 134
L P L + +N R++ +L + L SL L N + + + K
Sbjct: 32 LRSDPD-LVAQNIDVVLNRRSS-MAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQK 89
Query: 135 LKYLQILDLSQNFFNGSLPVSIVQCKRLKALDLSQNNFTGPLPNGFG------SGLVSLE 188
L+IL+LS N + ++ +L+ L L N+ + + L
Sbjct: 90 APNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQSTYISAIRERFPKLL 149
Query: 189 KLN 191
+L+
Sbjct: 150 RLD 152
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.6 bits (94), Expect = 2e-04
Identities = 24/136 (17%), Positives = 40/136 (29%), Gaps = 18/136 (13%)
Query: 129 PNEIGKLKY---------LQILDLSQNFFNGSLPVSIVQCKRLKALDLSQNNFTGPLPNG 179
P ++ +LK Q LDL + L V L+ +
Sbjct: 6 PEQVEQLKLIMSKRYDGSQQALDLKGLRSDPDL----VAQNIDVVLNRRSSMAA--TLRI 59
Query: 180 FGSGLVSLEKLNLSFNKFNG--SIPSNTGNLSSLQGTVDFSHNLFSGSIPASLGNLPEKV 237
+ L LNLS N+ + S +L+ ++ S N +
Sbjct: 60 IEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLK-ILNLSGNELKSERELDKIKGLKLE 118
Query: 238 YIDLTYNNLSGPIPQN 253
+ L N+LS
Sbjct: 119 ELWLDGNSLSDTFRDQ 134
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.2 bits (98), Expect = 4e-05
Identities = 26/144 (18%), Positives = 47/144 (32%), Gaps = 9/144 (6%)
Query: 143 LSQNFFNGSLPVSIVQCKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLNLSFNKFNGSIP 202
L+ + R + LDL + N G+ L + ++ S N+
Sbjct: 3 LTAELIEQAA--QYTNAVRDRELDLRGYKIPV-IEN-LGATLDQFDAIDFSDNEIR--KL 56
Query: 203 SNTGNLSSLQGTVDFSHNLFSGSIPASLGNLPEKVYIDLTYNNLS--GPIPQNGALMNRG 260
L L+ T+ ++N LP+ + LT N+L G + +L +
Sbjct: 57 DGFPLLRRLK-TLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLT 115
Query: 261 PTAFIGNPRLCGPPLKNPCSSDVP 284
+ NP + VP
Sbjct: 116 YLCILRNPVTNKKHYRLYVIYKVP 139
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.8 bits (91), Expect = 3e-04
Identities = 16/120 (13%), Positives = 37/120 (30%), Gaps = 4/120 (3%)
Query: 158 QCKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLNLSFNKFNGSIPSNT-GNLSSLQGTVD 216
L +++ + G +L +L + + + L L+ +
Sbjct: 6 CPHGSSGLRCTRDGALD-SLHHLP-GAENLTELYIENQQHLQHLELRDLRGLGELR-NLT 62
Query: 217 FSHNLFSGSIPASLGNLPEKVYIDLTYNNLSGPIPQNGALMNRGPTAFIGNPRLCGPPLK 276
+ P + P ++L++N L + ++ GNP C L+
Sbjct: 63 IVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALR 122
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.1 bits (84), Expect = 0.003
Identities = 15/109 (13%), Positives = 29/109 (26%), Gaps = 3/109 (2%)
Query: 138 LQILDLSQNFFNGSLPVSIVQCKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLNLSFNKF 197
L +++ + + L L + L GL L L + +
Sbjct: 10 SSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGL 68
Query: 198 NGSIPSNTGNLSSLQGTVDFSHNLFSGSIPASLGNLPEKVYIDLTYNNL 246
P + ++ S N S+ + L+ N L
Sbjct: 69 RFVAPDAFHF-TPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPL 115
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 41.4 bits (95), Expect = 3e-04
Identities = 10/58 (17%), Positives = 17/58 (29%), Gaps = 5/58 (8%)
Query: 158 QCKRLKALDLSQNNFTGP----LPNGFGSGLVSLEKLNLSFNKFNGSIPSNTGNLSSL 211
+ L+ L L N L + L L L+ N+F + +
Sbjct: 271 ENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRF-SEEDDVVDEIREV 327
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 38.7 bits (88), Expect = 0.002
Identities = 13/83 (15%), Positives = 25/83 (30%), Gaps = 7/83 (8%)
Query: 136 KYLQILDLSQNFFNGSLPVSIVQCKRLKALDLSQNNFTGPLPNGFGSGLV---SLEKLNL 192
K L++ ++ S+ +++ +K + LS N + LE
Sbjct: 8 KSLKLDAITTEDEK-SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEF 66
Query: 193 SFN---KFNGSIPSNTGNLSSLQ 212
S + IP L
Sbjct: 67 SDIFTGRVKDEIPEALRLLLQAL 89
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 37.9 bits (86), Expect = 0.003
Identities = 12/66 (18%), Positives = 19/66 (28%), Gaps = 11/66 (16%)
Query: 119 LYGNSFSGSVPNEIG------KLKYLQILDLSQNFFNGSLPVSIVQ-----CKRLKALDL 167
L S + + LQ L L N ++ L L+L
Sbjct: 250 LNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLEL 309
Query: 168 SQNNFT 173
+ N F+
Sbjct: 310 NGNRFS 315
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 38.1 bits (87), Expect = 0.002
Identities = 15/76 (19%), Positives = 27/76 (35%), Gaps = 6/76 (7%)
Query: 144 SQNFFNGSLPVSIVQCKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLNLSFNKFNGSIPS 203
S S + +L L N + P L +L +++L N+ + P
Sbjct: 157 SIGNAQVSDLTPLANLSKLTTLKADDNKISDISPLA---SLPNLIEVHLKNNQISDVSP- 212
Query: 204 NTGNLSSLQGTVDFSH 219
N S+L V ++
Sbjct: 213 -LANTSNLF-IVTLTN 226
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 38.1 bits (87), Expect = 0.002
Identities = 12/55 (21%), Positives = 20/55 (36%), Gaps = 4/55 (7%)
Query: 114 LQSLVLYGNSFSGSVPNEIGKLKYLQILDLSQNFFNGSLPVSIVQCKRLKALDLS 168
L +L N S P + L L + L N + P++ L + L+
Sbjct: 175 LTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSPLA--NTSNLFIVTLT 225
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.6 bits (85), Expect = 0.004
Identities = 8/46 (17%), Positives = 13/46 (28%), Gaps = 4/46 (8%)
Query: 158 QCKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLNLSFNKFNGSIPS 203
LD+S+ G L L + K +P+
Sbjct: 199 GASGPVILDISRTRIHSLPSYGL-ENLKKLRARSTYNLK---KLPT 240
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 714 | |||
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.89 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.88 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.88 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.87 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.86 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.82 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.79 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.77 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.69 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.69 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.66 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.65 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.64 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.63 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.6 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.59 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.58 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.54 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.51 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.5 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.5 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.5 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.49 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.48 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.37 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.33 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.31 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.26 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.2 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 99.15 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.08 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 98.93 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 98.9 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 98.82 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 98.49 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.33 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.33 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.28 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 98.07 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.95 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.55 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.37 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.22 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.13 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 96.23 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.21 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 96.07 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 94.94 |
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-52 Score=423.19 Aligned_cols=252 Identities=22% Similarity=0.364 Sum_probs=197.9
Q ss_pred ccccccCceEEEEEEECCCcEEEEEEeCCCCchhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCCCHhh
Q 005102 409 FVLGKSGIGIVYKVVLEDGHTLAVRRLGEGGSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGSLAT 488 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL~~ 488 (714)
+.||+|+||+||+|++++++.||||+++.... ..++|.+|++++++++|||||+++|+|...+..++||||+++|+|.+
T Consensus 11 ~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~-~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~~g~L~~ 89 (263)
T d1sm2a_ 11 QEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSD 89 (263)
T ss_dssp EEEECCSSCCEEEEEETTTEEEEEEECCSSSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHH
T ss_pred EEEeeCCCeEEEEEEECCCCEEEEEEECCCcC-cHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecCCCcHHH
Confidence 47999999999999999999999999986543 34789999999999999999999999999999999999999999999
Q ss_pred hhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCCCCcc
Q 005102 489 ALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQ 568 (714)
Q Consensus 489 ~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 568 (714)
++.... ..++|..+.+|+.|||.||+|||+ ++|+||||||+|||+++++.+||+|||+|+......
T Consensus 90 ~l~~~~-----~~~~~~~~~~i~~qia~gl~~lH~---~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~------ 155 (263)
T d1sm2a_ 90 YLRTQR-----GLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ------ 155 (263)
T ss_dssp HHHTTT-----TCCCHHHHHHHHHHHHHHHHHHHH---TTCCCTTCSGGGEEECGGGCEEECSCC---------------
T ss_pred Hhhccc-----cCCCHHHHHHHHHHHHHHHHhhhc---cceeecccchhheeecCCCCeEecccchheeccCCC------
Confidence 987654 458999999999999999999999 899999999999999999999999999998654321
Q ss_pred CCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCccccCCCCcchhHH
Q 005102 569 SNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGSSEMDLVN 648 (714)
Q Consensus 569 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~~~~~~~~~~l~~ 648 (714)
........||+.|+|||++.+..++.++|||||||++|||+|+..|+.... .. .+
T Consensus 156 ---------------------~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~-~~---~~ 210 (263)
T d1sm2a_ 156 ---------------------YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR-SN---SE 210 (263)
T ss_dssp ------------------------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSC-CH---HH
T ss_pred ---------------------ceeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCC-CH---HH
Confidence 111223457889999999999999999999999999999999655543221 11 22
Q ss_pred HHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhhhhcc
Q 005102 649 WMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDALDRLIVS 712 (714)
Q Consensus 649 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~~ 712 (714)
.+........ ...|.. ...++.+++.+||+.||++||||+||++.|++|.++
T Consensus 211 ~~~~i~~~~~----~~~p~~--------~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~es 262 (263)
T d1sm2a_ 211 VVEDISTGFR----LYKPRL--------ASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAES 262 (263)
T ss_dssp HHHHHHHTCC----CCCCTT--------SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHhcCC----CCCccc--------cCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhC
Confidence 2222222111 111111 123688999999999999999999999999998754
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.1e-52 Score=422.40 Aligned_cols=255 Identities=24% Similarity=0.396 Sum_probs=198.8
Q ss_pred ccccccCceEEEEEEECCCcEEEEEEeCCC--CchhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCCCH
Q 005102 409 FVLGKSGIGIVYKVVLEDGHTLAVRRLGEG--GSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGSL 486 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL 486 (714)
+.||+|+||+||+|+++ ..||||+++.. .....+.|.+|+++|++++|||||++++++. .+..++||||+++|+|
T Consensus 14 ~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~-~~~~~lv~Ey~~~g~L 90 (276)
T d1uwha_ 14 QRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQLAIVTQWCEGSSL 90 (276)
T ss_dssp SEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEEECCCEEEH
T ss_pred EEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEe-ccEEEEEEecCCCCCH
Confidence 47999999999999875 36999999754 3445678999999999999999999999875 4568999999999999
Q ss_pred hhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCCCC
Q 005102 487 ATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPT 566 (714)
Q Consensus 487 ~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 566 (714)
.++++... ..+++.++++|+.|||+||+|||+ ++||||||||+|||+++++.+||+|||+|+.......
T Consensus 91 ~~~l~~~~-----~~~~~~~~~~i~~qi~~gl~yLH~---~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~--- 159 (276)
T d1uwha_ 91 YHHLHIIE-----TKFEMIKLIDIARQTAQGMDYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSG--- 159 (276)
T ss_dssp HHHHHTSC-----CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTSSEEECCCCCSCC---------
T ss_pred HHHHhhcc-----CCCCHHHHHHHHHHHHHHHHHHhc---CCEeccccCHHHEEEcCCCCEEEccccceeeccccCC---
Confidence 99997654 458999999999999999999999 8999999999999999999999999999986542211
Q ss_pred ccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCC---CCCCchhhhHHHHHHHHHHHhCCCccccCCCCc
Q 005102 567 LQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKV---VKPSQKWDIYSYGVILLEMITGRTAVVQVGSSE 643 (714)
Q Consensus 567 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~s~~~DVwS~Gvvl~elltG~~p~~~~~~~~ 643 (714)
........||+.|||||++.+ ..++.++|||||||++|||+||+.||......
T Consensus 160 -----------------------~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~- 215 (276)
T d1uwha_ 160 -----------------------SHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR- 215 (276)
T ss_dssp -----------------------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCH-
T ss_pred -----------------------cccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChH-
Confidence 112234568999999999864 35899999999999999999999999533221
Q ss_pred chhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhhhhcc
Q 005102 644 MDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDALDRLIVS 712 (714)
Q Consensus 644 ~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~~ 712 (714)
..+............. +..... ...++.+++.+||+.||++||||+||++.|+.+.++
T Consensus 216 ----~~~~~~~~~~~~~p~~--~~~~~~-----~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~ 273 (276)
T d1uwha_ 216 ----DQIIFMVGRGYLSPDL--SKVRSN-----CPKAMKRLMAECLKKKRDERPLFPQILASIELLARS 273 (276)
T ss_dssp ----HHHHHHHHHTSCCCCG--GGSCTT-----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred ----HHHHHHHhcCCCCCcc--hhcccc-----chHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHc
Confidence 1122222222111110 001111 223688999999999999999999999999998765
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-52 Score=423.15 Aligned_cols=254 Identities=23% Similarity=0.378 Sum_probs=205.1
Q ss_pred ccccccCceEEEEEEECCCcEEEEEEeCCCCchhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCCCHhh
Q 005102 409 FVLGKSGIGIVYKVVLEDGHTLAVRRLGEGGSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGSLAT 488 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL~~ 488 (714)
+.||+|+||+||+|++++++.||||+++.... ..+.|.+|+++|++++|||||+++|++. .+..++||||+++|+|.+
T Consensus 19 ~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~-~~~~~~~E~~~l~~l~HpnIv~~~g~~~-~~~~~iv~Ey~~~g~L~~ 96 (272)
T d1qpca_ 19 ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM-SPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYMENGSLVD 96 (272)
T ss_dssp EEEEEETTEEEEEEEETTTEEEEEEEECTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECCTTCBHHH
T ss_pred EEEecCCCcEEEEEEECCCCEEEEEEEccCcC-CHHHHHHHHHHHHhCCCCCEeEEEeeec-cCCeEEEEEeCCCCcHHH
Confidence 47999999999999999889999999976543 3478999999999999999999999875 456799999999999999
Q ss_pred hhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCCCCcc
Q 005102 489 ALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQ 568 (714)
Q Consensus 489 ~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 568 (714)
++..... .+++|.++++|+.||++||+|||+ ++|+||||||+|||+++++.+||+|||+|+......
T Consensus 97 ~~~~~~~----~~l~~~~~~~i~~qi~~gl~~lH~---~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~------ 163 (272)
T d1qpca_ 97 FLKTPSG----IKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE------ 163 (272)
T ss_dssp HTTSHHH----HTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSC------
T ss_pred HHhhcCC----CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCccchhheeeecccceeeccccceEEccCCc------
Confidence 8765432 358999999999999999999999 899999999999999999999999999998754221
Q ss_pred CCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCccccCCCCcchhHH
Q 005102 569 SNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGSSEMDLVN 648 (714)
Q Consensus 569 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~~~~~~~~~~l~~ 648 (714)
........||+.|+|||++.+..++.++|||||||++|||+||..|+..... . .+
T Consensus 164 ---------------------~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~-~---~~ 218 (272)
T d1qpca_ 164 ---------------------YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT-N---PE 218 (272)
T ss_dssp ---------------------EECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCC-H---HH
T ss_pred ---------------------cccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCC-H---HH
Confidence 1122344578899999999988999999999999999999997666533221 1 12
Q ss_pred HHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhhhhccCC
Q 005102 649 WMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDALDRLIVSSD 714 (714)
Q Consensus 649 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~~~~ 714 (714)
.++... ... .+..+.. ...++.+++.+||+.||++||||+||++.|+.+.+++|
T Consensus 219 ~~~~i~-~~~------~~~~p~~-----~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ftste 272 (272)
T d1qpca_ 219 VIQNLE-RGY------RMVRPDN-----CPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATE 272 (272)
T ss_dssp HHHHHH-TTC------CCCCCTT-----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC-
T ss_pred HHHHHH-hcC------CCCCccc-----ChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhhcCC
Confidence 222221 111 1111111 12368899999999999999999999999999988875
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.4e-51 Score=424.20 Aligned_cols=256 Identities=25% Similarity=0.447 Sum_probs=196.1
Q ss_pred ccccccCceEEEEEEECC-C---cEEEEEEeCCC-CchhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCC
Q 005102 409 FVLGKSGIGIVYKVVLED-G---HTLAVRRLGEG-GSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPN 483 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~~-g---~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~ 483 (714)
++||+|+||+||+|+++. + ..||||++... .....++|.+|+++|++++|||||+++|+|...+..++|||||++
T Consensus 32 ~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv~Ey~~~ 111 (299)
T d1jpaa_ 32 QVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMEN 111 (299)
T ss_dssp EEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTT
T ss_pred eEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEEEecCC
Confidence 589999999999999853 3 36899998765 334456899999999999999999999999999999999999999
Q ss_pred CCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCC
Q 005102 484 GSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGG 563 (714)
Q Consensus 484 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 563 (714)
|+|.+++.... ..++|.++.+|+.|||+||+|||+ ++|+||||||+|||++.++++||+|||+|+.......
T Consensus 112 g~L~~~~~~~~-----~~l~~~~~~~i~~qia~gl~yLH~---~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~ 183 (299)
T d1jpaa_ 112 GSLDSFLRQND-----GQFTVIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTS 183 (299)
T ss_dssp EEHHHHHHTTT-----TCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCC-----------
T ss_pred Ccceeeecccc-----CCCCHHHHHHHHHHHHHHHHHHhh---CCCccCccccceEEECCCCcEEECCcccceEccCCCC
Confidence 99999887654 458999999999999999999999 8999999999999999999999999999987653211
Q ss_pred CCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHh-CCCccccCCCC
Q 005102 564 SPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMIT-GRTAVVQVGSS 642 (714)
Q Consensus 564 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~ellt-G~~p~~~~~~~ 642 (714)
.. .........||+.|||||.+.+..++.++|||||||++|||+| |+.||....
T Consensus 184 ~~-----------------------~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~-- 238 (299)
T d1jpaa_ 184 DP-----------------------TYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMT-- 238 (299)
T ss_dssp -----------------------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC--
T ss_pred cc-----------------------eeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCC--
Confidence 10 0112223456889999999999999999999999999999998 899994332
Q ss_pred cchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhhhhcc
Q 005102 643 EMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDALDRLIVS 712 (714)
Q Consensus 643 ~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~~ 712 (714)
..++ +........ +.... ....++.+++.+||+.||++||||+||++.|++++++
T Consensus 239 ~~~~---~~~i~~~~~-------~~~~~-----~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~ 293 (299)
T d1jpaa_ 239 NQDV---INAIEQDYR-------LPPPM-----DCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRN 293 (299)
T ss_dssp HHHH---HHHHHTTCC-------CCCCT-----TCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred HHHH---HHHHHcCCC-------CCCCc-----cchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcC
Confidence 2222 222222111 10111 1233688999999999999999999999999998754
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.7e-51 Score=422.74 Aligned_cols=255 Identities=27% Similarity=0.361 Sum_probs=206.3
Q ss_pred cccccccCceEEEEEEECC-CcEEEEEEeCCCCchhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCCCH
Q 005102 408 AFVLGKSGIGIVYKVVLED-GHTLAVRRLGEGGSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGSL 486 (714)
Q Consensus 408 ~~~lG~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL 486 (714)
.+.||+|+||+||+|++++ |+.||||+++.... ..++|.+|+++|++++|||||+++|+|.+.+..++||||+++|+|
T Consensus 22 ~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~-~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~~g~l 100 (287)
T d1opja_ 22 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNL 100 (287)
T ss_dssp EEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCS-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBH
T ss_pred eeEEeeCCCeEEEEEEECCCCeEEEEEEECCccc-hHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeecccCcch
Confidence 3579999999999999864 88999999976543 457899999999999999999999999999999999999999999
Q ss_pred hhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCCCC
Q 005102 487 ATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPT 566 (714)
Q Consensus 487 ~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 566 (714)
.+++..... ..+++..+++|+.|||.||+|||+ ++|+||||||+|||+++++.+||+|||+|+......
T Consensus 101 ~~~l~~~~~----~~~~~~~~~~i~~qi~~gL~yLH~---~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~---- 169 (287)
T d1opja_ 101 LDYLRECNR----QEVSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT---- 169 (287)
T ss_dssp HHHHHHSCT----TTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSS----
T ss_pred HHHhhhccc----cchHHHHHHHHHHHHHHHHHHHHH---CCcccCccccCeEEECCCCcEEEccccceeecCCCC----
Confidence 999975432 468999999999999999999999 899999999999999999999999999998654211
Q ss_pred ccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCccccCCCCcchh
Q 005102 567 LQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGSSEMDL 646 (714)
Q Consensus 567 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~~~~~~~~~~l 646 (714)
........||+.|+|||++.+..++.++|||||||++|||++|..|+..... .
T Consensus 170 -----------------------~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~----~ 222 (287)
T d1opja_ 170 -----------------------YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID----L 222 (287)
T ss_dssp -----------------------SEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCC----H
T ss_pred -----------------------ceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcch----H
Confidence 1111223467889999999999999999999999999999998877743221 1
Q ss_pred HHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhhhhccC
Q 005102 647 VNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDALDRLIVSS 713 (714)
Q Consensus 647 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~~~ 713 (714)
..... .+..... +..... ...++.+++.+||+.||++||||+||++.|+.+...+
T Consensus 223 ~~~~~-~i~~~~~------~~~~~~-----~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~~~ 277 (287)
T d1opja_ 223 SQVYE-LLEKDYR------MERPEG-----CPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES 277 (287)
T ss_dssp HHHHH-HHHTTCC------CCCCTT-----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTSSS
T ss_pred HHHHH-HHhcCCC------CCCCcc-----chHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhC
Confidence 12111 1222211 111111 1236889999999999999999999999999986543
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-51 Score=412.30 Aligned_cols=240 Identities=24% Similarity=0.350 Sum_probs=198.5
Q ss_pred cccccccCceEEEEEEEC-CCcEEEEEEeCCC---CchhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCC
Q 005102 408 AFVLGKSGIGIVYKVVLE-DGHTLAVRRLGEG---GSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPN 483 (714)
Q Consensus 408 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~ 483 (714)
.+.||+|+||+||+|+++ +++.||||++.+. .....+.+.+|++++++++|||||++++++.+.+..|+||||+++
T Consensus 11 ~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivmEy~~~ 90 (263)
T d2j4za1 11 GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPL 90 (263)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCTT
T ss_pred EEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEEeecCC
Confidence 357999999999999986 5899999998653 223356789999999999999999999999999999999999999
Q ss_pred CCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCC
Q 005102 484 GSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGG 563 (714)
Q Consensus 484 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 563 (714)
|+|.+++... ..+++..+..|+.||+.||+|||+ ++|+||||||+|||+++++.+||+|||+|+.....
T Consensus 91 g~L~~~l~~~------~~l~e~~~~~i~~qi~~al~~lH~---~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~-- 159 (263)
T d2j4za1 91 GTVYRELQKL------SKFDEQRTATYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS-- 159 (263)
T ss_dssp CBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC--
T ss_pred CcHHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeeeeccccceecCCCCEeecccceeeecCCC--
Confidence 9999999755 468999999999999999999999 89999999999999999999999999999754311
Q ss_pred CCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCccccCCCCc
Q 005102 564 SPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGSSE 643 (714)
Q Consensus 564 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~~~~~~~~ 643 (714)
......||+.|||||++.+..++.++|||||||++|||+||+.||...
T Consensus 160 ----------------------------~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~---- 207 (263)
T d2j4za1 160 ----------------------------RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN---- 207 (263)
T ss_dssp ----------------------------CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCS----
T ss_pred ----------------------------cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCC----
Confidence 112345799999999999999999999999999999999999999432
Q ss_pred chhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 005102 644 MDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISD 704 (714)
Q Consensus 644 ~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 704 (714)
...+........... .+... ..++.+++.+||+.||++|||++|+++
T Consensus 208 -~~~~~~~~i~~~~~~--------~p~~~-----s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 208 -TYQETYKRISRVEFT--------FPDFV-----TEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp -SHHHHHHHHHTTCCC--------CCTTS-----CHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -CHHHHHHHHHcCCCC--------CCccC-----CHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence 122222222222211 11111 235789999999999999999999975
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7e-51 Score=413.68 Aligned_cols=246 Identities=24% Similarity=0.302 Sum_probs=196.3
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeCCCCc-hhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCCCH
Q 005102 409 FVLGKSGIGIVYKVVLE-DGHTLAVRRLGEGGS-QRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGSL 486 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL 486 (714)
+.||+|+||+||+|+++ +|+.||||++..... ...+.+.+|+++|++++|||||++++++.+.+..|+||||+++|+|
T Consensus 11 ~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy~~gg~L 90 (271)
T d1nvra_ 11 QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGEL 90 (271)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEEG
T ss_pred EEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEeccCCCcH
Confidence 47999999999999985 589999999976432 2345789999999999999999999999999999999999999999
Q ss_pred hhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCCCC
Q 005102 487 ATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPT 566 (714)
Q Consensus 487 ~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 566 (714)
.+++... ..+++.++..|+.||+.||+|||+ ++|+||||||+|||+++++.+||+|||+|+.......
T Consensus 91 ~~~l~~~------~~l~e~~~~~i~~qi~~al~ylH~---~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~--- 158 (271)
T d1nvra_ 91 FDRIEPD------IGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR--- 158 (271)
T ss_dssp GGGSBTT------TBCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTE---
T ss_pred HHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHH---cCCccCcccHHHEEECCCCCEEEccchhheeeccCCc---
Confidence 9999754 469999999999999999999999 8999999999999999999999999999987643210
Q ss_pred ccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCC-CchhhhHHHHHHHHHHHhCCCccccCCCCcch
Q 005102 567 LQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKP-SQKWDIYSYGVILLEMITGRTAVVQVGSSEMD 645 (714)
Q Consensus 567 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~~DVwS~Gvvl~elltG~~p~~~~~~~~~~ 645 (714)
........||+.|||||++.+..+ +.++||||+||++|||+||+.||.........
T Consensus 159 -----------------------~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~ 215 (271)
T d1nvra_ 159 -----------------------ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE 215 (271)
T ss_dssp -----------------------ECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHH
T ss_pred -----------------------cccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHH
Confidence 112344578999999999988776 67899999999999999999999544332221
Q ss_pred hHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 005102 646 LVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISD 704 (714)
Q Consensus 646 l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 704 (714)
... . ....... .+ ......++.+++.+||+.||++|||++|+++
T Consensus 216 ~~~----~-~~~~~~~---~~-------~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 216 YSD----W-KEKKTYL---NP-------WKKIDSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp HHH----H-HTTCTTS---TT-------GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred HHH----H-hcCCCCC---Cc-------cccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 111 1 1111100 00 0111235778999999999999999999865
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.5e-51 Score=416.98 Aligned_cols=256 Identities=28% Similarity=0.428 Sum_probs=198.7
Q ss_pred cccccccCceEEEEEEECCC-----cEEEEEEeCCCC-chhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEecc
Q 005102 408 AFVLGKSGIGIVYKVVLEDG-----HTLAVRRLGEGG-SQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYI 481 (714)
Q Consensus 408 ~~~lG~G~~g~Vy~~~~~~g-----~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~ 481 (714)
.++||+|+||+||+|.+++. ..||||++.... ....++|.+|++++++++|||||+++|++.+.+..++||||+
T Consensus 12 ~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~v~e~~ 91 (283)
T d1mqba_ 12 QKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYM 91 (283)
T ss_dssp EEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred eeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEEEEEec
Confidence 35899999999999997642 479999997653 334467999999999999999999999999999999999999
Q ss_pred CCCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhcc
Q 005102 482 PNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIA 561 (714)
Q Consensus 482 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 561 (714)
.+|++.+++.... ..++|.++++|+.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+|+.....
T Consensus 92 ~~~~l~~~~~~~~-----~~~~~~~~~~i~~~i~~gl~~lH~---~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~ 163 (283)
T d1mqba_ 92 ENGALDKFLREKD-----GEFSVLQLVGMLRGIAAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 163 (283)
T ss_dssp TTEEHHHHHHHTT-----TCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCCCC-------
T ss_pred ccCcchhhhhccc-----ccccHHHHHHHHHHHHHhhhhccc---cccccCccccceEEECCCCeEEEcccchhhcccCC
Confidence 9999999887553 459999999999999999999999 89999999999999999999999999999876432
Q ss_pred CCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCccccCCC
Q 005102 562 GGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGS 641 (714)
Q Consensus 562 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~~~~~~ 641 (714)
... ........||+.|||||++.+..++.++|||||||++|||+||..|+.....
T Consensus 164 ~~~-------------------------~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~ 218 (283)
T d1mqba_ 164 PEA-------------------------TYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELS 218 (283)
T ss_dssp -----------------------------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred Ccc-------------------------ceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCC
Confidence 110 1122334578899999999999999999999999999999997777643222
Q ss_pred CcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhhhhcc
Q 005102 642 SEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDALDRLIVS 712 (714)
Q Consensus 642 ~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~~ 712 (714)
..++ +.. +..+.. +.... ....++.+++.+||+.||++||||+||++.|+++.++
T Consensus 219 -~~~~---~~~-i~~~~~------~~~~~-----~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~ 273 (283)
T d1mqba_ 219 -NHEV---MKA-INDGFR------LPTPM-----DCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 273 (283)
T ss_dssp -HHHH---HHH-HHTTCC------CCCCT-----TCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred -HHHH---HHH-HhccCC------CCCch-----hhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhC
Confidence 1222 222 222211 11111 1224688999999999999999999999999998764
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-50 Score=414.11 Aligned_cols=243 Identities=22% Similarity=0.365 Sum_probs=200.3
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeCCCCchhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCCCHh
Q 005102 409 FVLGKSGIGIVYKVVLE-DGHTLAVRRLGEGGSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGSLA 487 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL~ 487 (714)
+.||+|+||+||+|+.. +|+.||||++........+.+.+|+++|++++|||||++++++.+.+..|+||||+++|+|.
T Consensus 26 ~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~~gg~L~ 105 (293)
T d1yhwa1 26 EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT 105 (293)
T ss_dssp EECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHH
T ss_pred EEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEecCCCcHH
Confidence 47999999999999974 59999999998766556678999999999999999999999999999999999999999999
Q ss_pred hhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCCCCc
Q 005102 488 TALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTL 567 (714)
Q Consensus 488 ~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 567 (714)
+++... .+++.++..|+.||+.||+|||+ ++|+||||||+|||++.++++||+|||+|+.+....
T Consensus 106 ~~~~~~-------~l~~~~~~~i~~qi~~aL~yLH~---~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~----- 170 (293)
T d1yhwa1 106 DVVTET-------CMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ----- 170 (293)
T ss_dssp HHHHHS-------CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT-----
T ss_pred HHhhcc-------CCCHHHHHHHHHHHHHHHHHHHH---CCCcccCCcHHHeEECCCCcEeeccchhheeecccc-----
Confidence 988643 48999999999999999999999 899999999999999999999999999998653211
Q ss_pred cCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCccccCCCCcchhH
Q 005102 568 QSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGSSEMDLV 647 (714)
Q Consensus 568 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~~~~~~~~~~l~ 647 (714)
.......||+.|+|||++.+..++.++|||||||++|||+||+.||.... . .
T Consensus 171 -----------------------~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~--~---~ 222 (293)
T d1yhwa1 171 -----------------------SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNEN--P---L 222 (293)
T ss_dssp -----------------------CCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSC--H---H
T ss_pred -----------------------ccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCC--H---H
Confidence 12234568999999999999999999999999999999999999994321 1 1
Q ss_pred HHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 005102 648 NWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISD 704 (714)
Q Consensus 648 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 704 (714)
..+......... ....+ ......+.+++.+||+.||++|||++|+++
T Consensus 223 ~~~~~~~~~~~~--~~~~~--------~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 223 RALYLIATNGTP--ELQNP--------EKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp HHHHHHHHHCSC--CCSSG--------GGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred HHHHHHHhCCCC--CCCCc--------ccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 222222222211 00000 112236789999999999999999999874
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-50 Score=407.63 Aligned_cols=248 Identities=24% Similarity=0.360 Sum_probs=204.9
Q ss_pred ccccccCceEEEEEEECCCcEEEEEEeCCCCchhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCCCHhh
Q 005102 409 FVLGKSGIGIVYKVVLEDGHTLAVRRLGEGGSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGSLAT 488 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL~~ 488 (714)
+.||+|+||+||+|++++++.||||+++..... .++|.+|++++++++||||++++|+|.+.+..++||||+++|+|.+
T Consensus 10 ~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~-~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~~g~l~~ 88 (258)
T d1k2pa_ 10 KELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS-EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLN 88 (258)
T ss_dssp CCCCEETTEEEEEEEETTTEEEEEEEEESSSSC-HHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCTTEEHHH
T ss_pred EEEecCCCeEEEEEEECCCCEEEEEEECcCcCC-HHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccCCCcHHH
Confidence 479999999999999998999999999875443 4789999999999999999999999999999999999999999999
Q ss_pred hhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCCCCcc
Q 005102 489 ALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTLQ 568 (714)
Q Consensus 489 ~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 568 (714)
++.... ..+++..+.+|+.|+|+||+|||+ ++|+||||||+|||+++++.+||+|||+|+......
T Consensus 89 ~~~~~~-----~~~~~~~~~~i~~qi~~gl~~LH~---~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~------ 154 (258)
T d1k2pa_ 89 YLREMR-----HRFQTQQLLEMCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE------ 154 (258)
T ss_dssp HHHSGG-----GCCCHHHHHHHHHHHHHHHHHHHH---TTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSS------
T ss_pred hhhccc-----cCCcHHHHHHHHHHHHHHHHHHhh---cCcccccccceeEEEcCCCcEEECcchhheeccCCC------
Confidence 987654 468999999999999999999999 899999999999999999999999999998654321
Q ss_pred CCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHh-CCCccccCCCCcchhH
Q 005102 569 SNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMIT-GRTAVVQVGSSEMDLV 647 (714)
Q Consensus 569 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~ellt-G~~p~~~~~~~~~~l~ 647 (714)
........||+.|+|||.+.+..++.++|||||||++|||+| |+.||.... ..
T Consensus 155 ---------------------~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~--~~--- 208 (258)
T d1k2pa_ 155 ---------------------YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFT--NS--- 208 (258)
T ss_dssp ---------------------CCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSC--HH---
T ss_pred ---------------------ceeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCC--HH---
Confidence 112223457889999999999999999999999999999998 899984332 11
Q ss_pred HHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhhh
Q 005102 648 NWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDALDRL 709 (714)
Q Consensus 648 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i 709 (714)
+.... +..... ...|.. ...++.+++.+||+.||++||||+|+++.|.+|
T Consensus 209 ~~~~~-i~~~~~---~~~p~~--------~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di 258 (258)
T d1k2pa_ 209 ETAEH-IAQGLR---LYRPHL--------ASEKVYTIMYSCWHEKADERPTFKILLSNILDV 258 (258)
T ss_dssp HHHHH-HHTTCC---CCCCTT--------CCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred HHHHH-HHhCCC---CCCccc--------ccHHHHHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence 22222 222211 111111 123688999999999999999999999998764
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-50 Score=412.96 Aligned_cols=250 Identities=24% Similarity=0.380 Sum_probs=201.9
Q ss_pred cccccCceEEEEEEEC---CCcEEEEEEeCCCC-chhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCCC
Q 005102 410 VLGKSGIGIVYKVVLE---DGHTLAVRRLGEGG-SQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGS 485 (714)
Q Consensus 410 ~lG~G~~g~Vy~~~~~---~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gs 485 (714)
.||+|+||+||+|.++ ++..||||+++... ....++|.+|+++|++++|||||+++|++.. +..|+||||+++|+
T Consensus 16 ~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lvmE~~~~g~ 94 (285)
T d1u59a_ 16 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP 94 (285)
T ss_dssp EEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTTEE
T ss_pred EEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEEEEeCCCCc
Confidence 3999999999999875 35579999998653 3445789999999999999999999999864 56899999999999
Q ss_pred HhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCCC
Q 005102 486 LATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSP 565 (714)
Q Consensus 486 L~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 565 (714)
|.+++.... ..+++.++.+|+.|||+||+|||+ ++|+||||||+|||++.++.+||+|||+|+.......
T Consensus 95 L~~~l~~~~-----~~l~~~~~~~i~~qi~~gL~ylH~---~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~-- 164 (285)
T d1u59a_ 95 LHKFLVGKR-----EEIPVSNVAELLHQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDS-- 164 (285)
T ss_dssp HHHHHTTCT-----TTSCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSC--
T ss_pred HHHHhhccc-----cCCCHHHHHHHHHHHHHHHHHHHh---CCeecCcCchhheeeccCCceeeccchhhhccccccc--
Confidence 999986553 459999999999999999999999 8999999999999999999999999999987643211
Q ss_pred CccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHh-CCCccccCCCCcc
Q 005102 566 TLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMIT-GRTAVVQVGSSEM 644 (714)
Q Consensus 566 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~ellt-G~~p~~~~~~~~~ 644 (714)
.........||+.|+|||++.+..++.++|||||||++|||+| |+.||..... .
T Consensus 165 -----------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~--~ 219 (285)
T d1u59a_ 165 -----------------------YYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG--P 219 (285)
T ss_dssp -----------------------EECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT--H
T ss_pred -----------------------ccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCH--H
Confidence 0122334457889999999998999999999999999999998 8999954322 2
Q ss_pred hhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhhhh
Q 005102 645 DLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDALDRLI 710 (714)
Q Consensus 645 ~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~ 710 (714)
++ ... +..+.. +..+.. ...++.+++.+||+.||++||||.+|++.|+.+.
T Consensus 220 ~~---~~~-i~~~~~------~~~p~~-----~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~ 270 (285)
T d1u59a_ 220 EV---MAF-IEQGKR------MECPPE-----CPPELYALMSDCWIYKWEDRPDFLTVEQRMRACY 270 (285)
T ss_dssp HH---HHH-HHTTCC------CCCCTT-----CCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HH---HHH-HHcCCC------CCCCCc-----CCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 22 222 222211 111111 2236889999999999999999999999998764
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-50 Score=411.79 Aligned_cols=250 Identities=21% Similarity=0.295 Sum_probs=198.2
Q ss_pred ccccccCceEEEEEEECC---CcEEEEEEeCCC--CchhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCC
Q 005102 409 FVLGKSGIGIVYKVVLED---GHTLAVRRLGEG--GSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPN 483 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~~---g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~ 483 (714)
+.||+|+||+||+|.+++ ++.||||+++.. +....++|.+|+++|++++|||||+++|+|.. +..++||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 469999999999998753 468999999754 33345689999999999999999999999864 567999999999
Q ss_pred CCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCC
Q 005102 484 GSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGG 563 (714)
Q Consensus 484 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 563 (714)
|+|.++++.. ..+++..+++|+.|||.||+|||+ ++|+||||||+|||++.++.+||+|||+|+.......
T Consensus 92 g~L~~~l~~~------~~l~~~~~~~i~~qi~~gl~ylH~---~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~ 162 (277)
T d1xbba_ 92 GPLNKYLQQN------RHVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN 162 (277)
T ss_dssp EEHHHHHHHC------TTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCS
T ss_pred CcHHHHHhhc------cCCCHHHHHHHHHHHHHHHhhHHh---CCcccCCCcchhhcccccCcccccchhhhhhcccccc
Confidence 9999999865 469999999999999999999999 8999999999999999999999999999986542210
Q ss_pred CCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHh-CCCccccCCCC
Q 005102 564 SPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMIT-GRTAVVQVGSS 642 (714)
Q Consensus 564 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~ellt-G~~p~~~~~~~ 642 (714)
.........||+.|+|||.+.+..++.++|||||||++|||+| |+.||....
T Consensus 163 -------------------------~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~-- 215 (277)
T d1xbba_ 163 -------------------------YYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK-- 215 (277)
T ss_dssp -------------------------EEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCC--
T ss_pred -------------------------ccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCC--
Confidence 0122334567899999999999999999999999999999998 899995322
Q ss_pred cchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhhhh
Q 005102 643 EMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDALDRLI 710 (714)
Q Consensus 643 ~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~ 710 (714)
..++ .. .+..+.. +..+.. ...++.+++.+||+.||++||||++|+++|+...
T Consensus 216 ~~~~---~~-~i~~~~~------~~~p~~-----~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~ 268 (277)
T d1xbba_ 216 GSEV---TA-MLEKGER------MGCPAG-----CPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY 268 (277)
T ss_dssp HHHH---HH-HHHTTCC------CCCCTT-----CCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred HHHH---HH-HHHcCCC------CCCCcc-----cCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHH
Confidence 1222 21 1222211 111111 2236889999999999999999999999998754
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.7e-51 Score=417.47 Aligned_cols=245 Identities=21% Similarity=0.312 Sum_probs=199.8
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeCCCCchhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCCCHh
Q 005102 409 FVLGKSGIGIVYKVVLE-DGHTLAVRRLGEGGSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGSLA 487 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL~ 487 (714)
+.||+|+||+||+|+++ +|+.||||++........+.|.+|+++|++++|||||++++++.+.+..++||||+++|+|.
T Consensus 18 ~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~~~g~L~ 97 (288)
T d2jfla1 18 GELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVD 97 (288)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEHH
T ss_pred EEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecCCCCcHH
Confidence 47999999999999986 58999999998776666678999999999999999999999999999999999999999999
Q ss_pred hhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCCCCc
Q 005102 488 TALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTL 567 (714)
Q Consensus 488 ~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 567 (714)
+++.... ..+++.++..|+.||+.||+|||+ ++|+||||||+|||++.++++||+|||+|+.....
T Consensus 98 ~~~~~~~-----~~l~e~~~~~i~~qi~~gL~ylH~---~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~------ 163 (288)
T d2jfla1 98 AVMLELE-----RPLTESQIQVVCKQTLDALNYLHD---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT------ 163 (288)
T ss_dssp HHHHHHT-----SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECHHH------
T ss_pred HHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHH---CCEEEeecChhheeECCCCCEEEEechhhhccCCC------
Confidence 9876542 458999999999999999999999 89999999999999999999999999999754321
Q ss_pred cCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccC-----CCCCCchhhhHHHHHHHHHHHhCCCccccCCCC
Q 005102 568 QSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLK-----VVKPSQKWDIYSYGVILLEMITGRTAVVQVGSS 642 (714)
Q Consensus 568 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~~DVwS~Gvvl~elltG~~p~~~~~~~ 642 (714)
........||+.|+|||++. +..|+.++|||||||++|||+||+.||.....
T Consensus 164 ----------------------~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~- 220 (288)
T d2jfla1 164 ----------------------IQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNP- 220 (288)
T ss_dssp ----------------------HHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCG-
T ss_pred ----------------------cccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCH-
Confidence 11223456899999999984 45689999999999999999999999954322
Q ss_pred cchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 005102 643 EMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISD 704 (714)
Q Consensus 643 ~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 704 (714)
.+ .+........+ ... .......++.+++.+||+.||++|||++|+++
T Consensus 221 -~~---~~~~i~~~~~~-------~~~---~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 221 -MR---VLLKIAKSEPP-------TLA---QPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp -GG---HHHHHHHSCCC-------CCS---SGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred -HH---HHHHHHcCCCC-------CCC---ccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 11 12222222211 010 00112236889999999999999999999875
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-50 Score=407.51 Aligned_cols=241 Identities=23% Similarity=0.330 Sum_probs=191.3
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeCCC--CchhHHHHHHHHHHHhccCCCCccceEEEEEe----CCceeEEEecc
Q 005102 409 FVLGKSGIGIVYKVVLE-DGHTLAVRRLGEG--GSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWS----VDEKLLIYDYI 481 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~----~~~~~lV~e~~ 481 (714)
+.||+|+||+||+|++. +++.||+|++... .....+.|.+|+++|++++|||||++++++.+ ....++||||+
T Consensus 15 ~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivmE~~ 94 (270)
T d1t4ha_ 15 IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELM 94 (270)
T ss_dssp EEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEEECC
T ss_pred eEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEEeCC
Confidence 36999999999999986 4889999998764 33445679999999999999999999999875 34578999999
Q ss_pred CCCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCC--ceecCCCCCCeeeC-CCCCeEEcccchhhhh
Q 005102 482 PNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKK--YVHGDLKPSNILLG-HNMEPHVSDFGLARLA 558 (714)
Q Consensus 482 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~--ivHrDlkp~NILl~-~~~~~kl~DFGla~~~ 558 (714)
++|+|.+++... ..+++..++.|+.||+.||+|||+ ++ |+||||||+|||++ +++.+||+|||+|+..
T Consensus 95 ~~g~L~~~l~~~------~~~~~~~~~~~~~qi~~gl~yLH~---~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~ 165 (270)
T d1t4ha_ 95 TSGTLKTYLKRF------KVMKIKVLRSWCRQILKGLQFLHT---RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK 165 (270)
T ss_dssp CSCBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHT---SSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred CCCcHHHHHhcc------ccccHHHHHHHHHHHHHHHHHHHH---CCCCEEeCCcChhhceeeCCCCCEEEeecCcceec
Confidence 999999999765 468999999999999999999999 66 99999999999996 5789999999999853
Q ss_pred hccCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCcccc
Q 005102 559 NIAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQ 638 (714)
Q Consensus 559 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~~~ 638 (714)
.. .......||+.|||||++.+ +++.++|||||||++|||+||+.||..
T Consensus 166 ~~------------------------------~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~ 214 (270)
T d1t4ha_ 166 RA------------------------------SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSE 214 (270)
T ss_dssp CT------------------------------TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred cC------------------------------CccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCC
Confidence 21 11123468999999999865 699999999999999999999999953
Q ss_pred CCCCcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 005102 639 VGSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISD 704 (714)
Q Consensus 639 ~~~~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 704 (714)
... .....+. +....... ..+. . ...++.+++.+||+.||++|||++|+++
T Consensus 215 ~~~----~~~~~~~-i~~~~~~~-~~~~----~-----~~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 215 CQN----AAQIYRR-VTSGVKPA-SFDK----V-----AIPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp CSS----HHHHHHH-HTTTCCCG-GGGG----C-----CCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ccc----HHHHHHH-HHcCCCCc-ccCc----c-----CCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 221 1112222 11111111 1111 1 1225789999999999999999999875
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-50 Score=406.61 Aligned_cols=249 Identities=21% Similarity=0.299 Sum_probs=186.6
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeCCCC--chhHHHHHHHHHHHhccCCCCccceEEEEEe--CCceeEEEeccCC
Q 005102 409 FVLGKSGIGIVYKVVLE-DGHTLAVRRLGEGG--SQRFKEFQTEVEAIGKIRHSNIVTLRAYYWS--VDEKLLIYDYIPN 483 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~--~~~~~lV~e~~~~ 483 (714)
+.||+|+||+||+|+.+ +|+.||||++.... ....+.+.+|+++|++++|||||++++++.+ .+..|+||||+++
T Consensus 10 ~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ivmEy~~~ 89 (269)
T d2java1 10 YTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEG 89 (269)
T ss_dssp EEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEEEECCTT
T ss_pred EEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEEEecCCC
Confidence 47999999999999975 58999999997653 3345678999999999999999999999865 4567999999999
Q ss_pred CCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCC--CCCceecCCCCCCeeeCCCCCeEEcccchhhhhhcc
Q 005102 484 GSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFS--PKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIA 561 (714)
Q Consensus 484 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~--~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 561 (714)
|+|.+++...... ...+++..++.|+.|++.||+|||+.. ..+|+||||||+|||+++++.+||+|||+|+.....
T Consensus 90 g~L~~~i~~~~~~--~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~ 167 (269)
T d2java1 90 GDLASVITKGTKE--RQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHD 167 (269)
T ss_dssp EEHHHHHHHHHHH--TCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHHC---
T ss_pred CcHHHHHHhcccc--CCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceeecccC
Confidence 9999998642110 145999999999999999999999821 124999999999999999999999999999876432
Q ss_pred CCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCccccCCC
Q 005102 562 GGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGS 641 (714)
Q Consensus 562 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~~~~~~ 641 (714)
. .......||+.|||||++.+..++.++|||||||++|||+||+.||...
T Consensus 168 ~----------------------------~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~-- 217 (269)
T d2java1 168 T----------------------------SFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAF-- 217 (269)
T ss_dssp ------------------------------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCS--
T ss_pred C----------------------------CccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCC--
Confidence 1 1123456799999999999999999999999999999999999999432
Q ss_pred CcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 005102 642 SEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISD 704 (714)
Q Consensus 642 ~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 704 (714)
.. .+.......... . .+.... ..++.+++.+||+.||++|||++|+++
T Consensus 218 ~~---~~~~~~i~~~~~--~-----~~~~~~-----s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 218 SQ---KELAGKIREGKF--R-----RIPYRY-----SDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp SH---HHHHHHHHHTCC--C-----CCCTTS-----CHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CH---HHHHHHHHcCCC--C-----CCCccc-----CHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 12 222222222211 1 111111 235889999999999999999999874
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-50 Score=420.02 Aligned_cols=192 Identities=28% Similarity=0.370 Sum_probs=170.7
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeCCC-CchhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCCCH
Q 005102 409 FVLGKSGIGIVYKVVLE-DGHTLAVRRLGEG-GSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGSL 486 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL 486 (714)
+.||+|+||+||+|++. +|+.||+|+++.. .....+++.+|+++|++++|||||+++++|.+.++.|+||||+++|+|
T Consensus 12 ~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmEy~~gg~L 91 (322)
T d1s9ja_ 12 SELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSL 91 (322)
T ss_dssp EEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEECCTTEEH
T ss_pred EEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCcH
Confidence 47999999999999975 5899999999765 333456799999999999999999999999999999999999999999
Q ss_pred hhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCC-CceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCCC
Q 005102 487 ATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPK-KYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSP 565 (714)
Q Consensus 487 ~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~-~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 565 (714)
.+++... ..+++..+..++.|++.||+|||+ + +|+||||||+|||+++++++||+|||+|+.....
T Consensus 92 ~~~l~~~------~~l~~~~~~~~~~qil~aL~yLH~---~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~---- 158 (322)
T d1s9ja_ 92 DQVLKKA------GRIPEQILGKVSIAVIKGLTYLRE---KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---- 158 (322)
T ss_dssp HHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHH---HHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH----
T ss_pred HHHHhhc------CCCCHHHHHHHHHHHHHHHHHHHH---hCCEEccccCHHHeeECCCCCEEEeeCCCccccCCC----
Confidence 9999755 458999999999999999999997 5 8999999999999999999999999999876432
Q ss_pred CccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCccccC
Q 005102 566 TLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQV 639 (714)
Q Consensus 566 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~~~~ 639 (714)
......||+.|||||++.+..|+.++||||+||++|||+||+.||...
T Consensus 159 --------------------------~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~ 206 (322)
T d1s9ja_ 159 --------------------------MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPP 206 (322)
T ss_dssp --------------------------TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCC
T ss_pred --------------------------ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence 122356899999999999999999999999999999999999999543
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-49 Score=406.76 Aligned_cols=254 Identities=26% Similarity=0.397 Sum_probs=200.1
Q ss_pred cccccccCceEEEEEEECCCcEEEEEEeCCCCchhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCCCHh
Q 005102 408 AFVLGKSGIGIVYKVVLEDGHTLAVRRLGEGGSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGSLA 487 (714)
Q Consensus 408 ~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL~ 487 (714)
.+.||+|+||+||+|++++++.||||++..... ..+.|.+|+.+|++++|||||+++|++. .+..++||||+++|+|.
T Consensus 22 ~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~-~~~~~~~E~~~l~~l~h~nIv~~~g~~~-~~~~~lv~Ey~~~g~l~ 99 (285)
T d1fmka3 22 EVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMSKGSLL 99 (285)
T ss_dssp EEEEEECSSCEEEEEEETTTEEEEEEECCTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEECCCTTCBHH
T ss_pred eeEEeeCCCeEEEEEEECCCCEEEEEEECcccC-CHHHHHHHHHHHHhcccCCEeEEEEEEe-cCCeEEEEEecCCCchh
Confidence 457999999999999999888999999976543 3478999999999999999999999985 45689999999999999
Q ss_pred hhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCCCCc
Q 005102 488 TALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPTL 567 (714)
Q Consensus 488 ~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 567 (714)
.++..... ..++|.++++|+.||+.||+|||+ .+|+||||||+|||+|+++++||+|||+|+......
T Consensus 100 ~~~~~~~~----~~l~~~~~~~i~~~i~~gl~~LH~---~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~----- 167 (285)
T d1fmka3 100 DFLKGETG----KYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE----- 167 (285)
T ss_dssp HHHSHHHH----TTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCTTC-----------
T ss_pred hhhhhccc----ccchHHHHHHHHHHHHHHHHHHhh---hheecccccceEEEECCCCcEEEcccchhhhccCCC-----
Confidence 98865421 358999999999999999999999 899999999999999999999999999998654221
Q ss_pred cCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCccccCCCCcchhH
Q 005102 568 QSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGSSEMDLV 647 (714)
Q Consensus 568 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~~~~~~~~~~l~ 647 (714)
........||+.|+|||++.++.++.++|||||||++|||+||..|+..... ..++.
T Consensus 168 ----------------------~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~-~~~~~ 224 (285)
T d1fmka3 168 ----------------------YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV-NREVL 224 (285)
T ss_dssp ------------------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC-HHHHH
T ss_pred ----------------------ceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCC-HHHHH
Confidence 1122334578999999999999999999999999999999998777643322 12222
Q ss_pred HHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhhhhccC
Q 005102 648 NWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDALDRLIVSS 713 (714)
Q Consensus 648 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~~~ 713 (714)
.. ... +.. +..... ...++.+++.+||+.||++||||++|+++|++..+++
T Consensus 225 ~~---i~~-~~~------~~~~~~-----~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~ 275 (285)
T d1fmka3 225 DQ---VER-GYR------MPCPPE-----CPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 275 (285)
T ss_dssp HH---HHT-TCC------CCCCTT-----SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred HH---HHh-cCC------CCCCcc-----cCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCC
Confidence 22 111 111 111111 2236889999999999999999999999999987654
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-49 Score=408.82 Aligned_cols=243 Identities=19% Similarity=0.243 Sum_probs=197.2
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeCCC---CchhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCC
Q 005102 409 FVLGKSGIGIVYKVVLE-DGHTLAVRRLGEG---GSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNG 484 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~g 484 (714)
+.||+|+||+||+|+++ +|+.||||++.+. .....+.+.+|+++|++++|||||++++++.+.+..|+||||+++|
T Consensus 14 ~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmEy~~gg 93 (288)
T d1uu3a_ 14 KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNG 93 (288)
T ss_dssp EEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEECCCTTE
T ss_pred EEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEEEccCCC
Confidence 58999999999999985 5899999998753 2234567999999999999999999999999999999999999999
Q ss_pred CHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCC
Q 005102 485 SLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGS 564 (714)
Q Consensus 485 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 564 (714)
+|.+++... ..+++..+..++.|++.||+|||+ ++|+||||||+|||+++++.+||+|||+|+.+.....
T Consensus 94 ~L~~~~~~~------~~l~e~~~~~~~~qi~~al~ylH~---~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~- 163 (288)
T d1uu3a_ 94 ELLKYIRKI------GSFDETCTRFYTAEIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK- 163 (288)
T ss_dssp EHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred CHHHhhhcc------CCCCHHHHHHHHHHHHHHHHhhcc---ccEEcCcCCccccccCCCceEEecccccceecccCCc-
Confidence 999998765 469999999999999999999999 8999999999999999999999999999987642211
Q ss_pred CCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCccccCCCCcc
Q 005102 565 PTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGSSEM 644 (714)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~~~~~~~~~ 644 (714)
........||+.|+|||++.+..++.++||||+||++|||+||+.||... +
T Consensus 164 -------------------------~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~--~-- 214 (288)
T d1uu3a_ 164 -------------------------QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAG--N-- 214 (288)
T ss_dssp -------------------------------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCS--S--
T ss_pred -------------------------ccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCc--C--
Confidence 11223456899999999999999999999999999999999999999432 1
Q ss_pred hhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 005102 645 DLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISD 704 (714)
Q Consensus 645 ~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 704 (714)
.............. +.... ..++.+++.+||+.||++|||++|+++
T Consensus 215 -~~~~~~~i~~~~~~--------~p~~~-----s~~~~~li~~~L~~dP~~R~t~~e~~~ 260 (288)
T d1uu3a_ 215 -EYLIFQKIIKLEYD--------FPEKF-----FPKARDLVEKLLVLDATKRLGCEEMEG 260 (288)
T ss_dssp -HHHHHHHHHTTCCC--------CCTTC-----CHHHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred -HHHHHHHHHcCCCC--------CCccC-----CHHHHHHHHHHccCCHhHCcCHHHHcC
Confidence 12222222222211 11111 235789999999999999999998743
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5.3e-49 Score=407.56 Aligned_cols=244 Identities=23% Similarity=0.270 Sum_probs=184.6
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeCCCCc-hhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCCCH
Q 005102 409 FVLGKSGIGIVYKVVLE-DGHTLAVRRLGEGGS-QRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGSL 486 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL 486 (714)
+.||+|+||+||+|+++ +|+.||||++..... ...+.+.+|+++|++++|||||++++++.+.+..|+||||+++|+|
T Consensus 15 ~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE~~~gg~L 94 (307)
T d1a06a_ 15 DVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGEL 94 (307)
T ss_dssp EESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCCSCBH
T ss_pred EEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCCCcH
Confidence 47999999999999986 589999999976532 2345688999999999999999999999999999999999999999
Q ss_pred hhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeC---CCCCeEEcccchhhhhhccCC
Q 005102 487 ATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLG---HNMEPHVSDFGLARLANIAGG 563 (714)
Q Consensus 487 ~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~---~~~~~kl~DFGla~~~~~~~~ 563 (714)
.+++... ..+++.++..|+.||+.||+|||+ ++|+||||||+|||+. +++.+||+|||+|+.....
T Consensus 95 ~~~l~~~------~~l~e~~~~~~~~qi~~al~ylH~---~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~-- 163 (307)
T d1a06a_ 95 FDRIVEK------GFYTERDASRLIFQVLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG-- 163 (307)
T ss_dssp HHHHHTC------SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSTTCCEEECCC-----------
T ss_pred HHhhhcc------cCCCHHHHHHHHHHHHHHHHhhhh---ceeeeEEecccceeecccCCCceEEEeccceeEEccCC--
Confidence 9999765 469999999999999999999999 9999999999999994 5789999999999865321
Q ss_pred CCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCccccCCCCc
Q 005102 564 SPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGSSE 643 (714)
Q Consensus 564 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~~~~~~~~ 643 (714)
.......||+.|||||++.+..++.++|||||||++|||+||+.||....
T Consensus 164 ---------------------------~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~--- 213 (307)
T d1a06a_ 164 ---------------------------SVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDEN--- 213 (307)
T ss_dssp ------------------------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS---
T ss_pred ---------------------------CeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCC---
Confidence 11223468999999999999999999999999999999999999994321
Q ss_pred chhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 005102 644 MDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISD 704 (714)
Q Consensus 644 ~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 704 (714)
..+............. ...... ....+.+++.+||+.||++|||++|+++
T Consensus 214 --~~~~~~~i~~~~~~~~----~~~~~~-----~s~~~~~li~~~L~~dP~~R~s~~eil~ 263 (307)
T d1a06a_ 214 --DAKLFEQILKAEYEFD----SPYWDD-----ISDSAKDFIRHLMEKDPEKRFTCEQALQ 263 (307)
T ss_dssp --HHHHHHHHHTTCCCCC----TTTTTT-----SCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred --HHHHHHHHhccCCCCC----CccccC-----CCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 1222222222222111 111111 1235789999999999999999999986
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-49 Score=415.22 Aligned_cols=256 Identities=24% Similarity=0.311 Sum_probs=199.8
Q ss_pred cccccccCceEEEEEEECC-C-----cEEEEEEeCCC-CchhHHHHHHHHHHHhcc-CCCCccceEEEEEeCCceeEEEe
Q 005102 408 AFVLGKSGIGIVYKVVLED-G-----HTLAVRRLGEG-GSQRFKEFQTEVEAIGKI-RHSNIVTLRAYYWSVDEKLLIYD 479 (714)
Q Consensus 408 ~~~lG~G~~g~Vy~~~~~~-g-----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~e 479 (714)
.+.||+|+||+||+|++.. + ..||||++... .......|.+|+.+|.++ +|||||++++++.+.+..++|||
T Consensus 42 ~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E 121 (325)
T d1rjba_ 42 GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFE 121 (325)
T ss_dssp EEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred eeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeEEEEEE
Confidence 4589999999999999753 2 36999998754 333346789999999998 89999999999999999999999
Q ss_pred ccCCCCHhhhhhCCCCCC-----------------CcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeC
Q 005102 480 YIPNGSLATALHGKPGMV-----------------SFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLG 542 (714)
Q Consensus 480 ~~~~gsL~~~l~~~~~~~-----------------~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~ 542 (714)
|+++|+|.++++...... ....+++..++.|+.||+.||+|||+ ++||||||||+|||++
T Consensus 122 y~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~---~~IiHRDlKp~Nill~ 198 (325)
T d1rjba_ 122 YCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVT 198 (325)
T ss_dssp CCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH---TTEEETTCSGGGEEEE
T ss_pred cCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCchhccccc
Confidence 999999999998654211 11358999999999999999999999 8999999999999999
Q ss_pred CCCCeEEcccchhhhhhccCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHH
Q 005102 543 HNMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSY 622 (714)
Q Consensus 543 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~ 622 (714)
.++++||+|||+|+....... ........||+.|||||++.+..++.++|||||
T Consensus 199 ~~~~~Kl~DFGla~~~~~~~~--------------------------~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~ 252 (325)
T d1rjba_ 199 HGKVVKICDFGLARDIMSDSN--------------------------YVVRGNARLPVKWMAPESLFEGIYTIKSDVWSY 252 (325)
T ss_dssp TTTEEEECCCGGGSCGGGCTT--------------------------SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHH
T ss_pred cCCeEEEeeccccccccCCCc--------------------------eeeeccccCCCccCChHHHcCCCCCcceeccch
Confidence 999999999999986543211 111223446889999999999999999999999
Q ss_pred HHHHHHHHh-CCCccccCCCCcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHH
Q 005102 623 GVILLEMIT-GRTAVVQVGSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRH 701 (714)
Q Consensus 623 Gvvl~ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~e 701 (714)
||++|||+| |+.||...... ..+ ...+..+.. +..+.. ...++.+|+.+||+.||++||||+|
T Consensus 253 Gvil~emlt~g~~Pf~~~~~~-~~~----~~~~~~~~~------~~~p~~-----~~~~l~~li~~cl~~dP~~RPt~~e 316 (325)
T d1rjba_ 253 GILLWEIFSLGVNPYPGIPVD-ANF----YKLIQNGFK------MDQPFY-----ATEEIYIIMQSCWAFDSRKRPSFPN 316 (325)
T ss_dssp HHHHHHHTTTSCCSSTTCCCS-HHH----HHHHHTTCC------CCCCTT-----CCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred hHHHHHHHhCCCCCCCCCCHH-HHH----HHHHhcCCC------CCCCCc-----CCHHHHHHHHHHcCCChhHCcCHHH
Confidence 999999998 89999543222 112 222222211 111111 1236889999999999999999999
Q ss_pred HHHHHhh
Q 005102 702 ISDALDR 708 (714)
Q Consensus 702 vl~~L~~ 708 (714)
|++.|..
T Consensus 317 i~~~L~~ 323 (325)
T d1rjba_ 317 LTSFLGC 323 (325)
T ss_dssp HHHHHHH
T ss_pred HHHHHhC
Confidence 9999863
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.1e-48 Score=405.23 Aligned_cols=239 Identities=22% Similarity=0.365 Sum_probs=194.4
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeCCCCc---hhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCC
Q 005102 409 FVLGKSGIGIVYKVVLE-DGHTLAVRRLGEGGS---QRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNG 484 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~g 484 (714)
+.||+|+||+||+|+.. +|+.||||++..... ...+.+.+|+++|++++|||||++++++.+.+..|+|||||++|
T Consensus 21 ~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~~g 100 (309)
T d1u5ra_ 21 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGS 100 (309)
T ss_dssp EEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSEE
T ss_pred EEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEEecCCC
Confidence 47999999999999975 588999999976532 33467899999999999999999999999999999999999999
Q ss_pred CHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCC
Q 005102 485 SLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGS 564 (714)
Q Consensus 485 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 564 (714)
+|..++... ..+++.++..|+.||+.||+|||+ ++||||||||+|||+++++.+||+|||+|+....
T Consensus 101 ~l~~~~~~~------~~l~e~~~~~i~~qi~~aL~yLH~---~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~---- 167 (309)
T d1u5ra_ 101 ASDLLEVHK------KPLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP---- 167 (309)
T ss_dssp HHHHHHHHT------SCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS----
T ss_pred chHHHHHhC------CCCCHHHHHHHHHHHHHHHHHHHh---CCEeccCCCcceEEECCCCCEEEeecccccccCC----
Confidence 998776544 469999999999999999999999 8999999999999999999999999999975321
Q ss_pred CCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCC---CCCCchhhhHHHHHHHHHHHhCCCccccCCC
Q 005102 565 PTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKV---VKPSQKWDIYSYGVILLEMITGRTAVVQVGS 641 (714)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~s~~~DVwS~Gvvl~elltG~~p~~~~~~ 641 (714)
.....||+.|||||++.+ ..|+.++|||||||++|||++|+.||.....
T Consensus 168 ----------------------------~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~ 219 (309)
T d1u5ra_ 168 ----------------------------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA 219 (309)
T ss_dssp ----------------------------BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH
T ss_pred ----------------------------CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCH
Confidence 123458999999999864 4589999999999999999999999953221
Q ss_pred CcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 005102 642 SEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISD 704 (714)
Q Consensus 642 ~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 704 (714)
.+.+........ +...... ....+.+++.+||+.||++|||++|+++
T Consensus 220 -----~~~~~~i~~~~~-------~~~~~~~----~s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 220 -----MSALYHIAQNES-------PALQSGH----WSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp -----HHHHHHHHHSCC-------CCCSCTT----SCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred -----HHHHHHHHhCCC-------CCCCCCC----CCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 122222222221 1111111 1236889999999999999999999875
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1.4e-48 Score=411.40 Aligned_cols=246 Identities=20% Similarity=0.282 Sum_probs=201.7
Q ss_pred cccccccCceEEEEEEEC-CCcEEEEEEeCCCCchhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCCCH
Q 005102 408 AFVLGKSGIGIVYKVVLE-DGHTLAVRRLGEGGSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGSL 486 (714)
Q Consensus 408 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL 486 (714)
.+.||+|+||+||+|+.+ +|+.||||++........+.+.+|+++|++++|||||++++++.+.+..|+|||||++|+|
T Consensus 31 ~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~L 110 (350)
T d1koaa2 31 HEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGEL 110 (350)
T ss_dssp EEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCCCSCBH
T ss_pred EEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCCH
Confidence 357999999999999975 5899999999887666677899999999999999999999999999999999999999999
Q ss_pred hhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeC--CCCCeEEcccchhhhhhccCCC
Q 005102 487 ATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLG--HNMEPHVSDFGLARLANIAGGS 564 (714)
Q Consensus 487 ~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~--~~~~~kl~DFGla~~~~~~~~~ 564 (714)
.+++.... ..+++..+..|+.||+.||+|||+ ++||||||||+|||++ .++.+||+|||+|+......
T Consensus 111 ~~~l~~~~-----~~l~e~~~~~i~~qi~~aL~ylH~---~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~-- 180 (350)
T d1koaa2 111 FEKVADEH-----NKMSEDEAVEYMRQVCKGLCHMHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ-- 180 (350)
T ss_dssp HHHHTCTT-----SCBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTS--
T ss_pred HHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHh---cCCeeeeechhHeeeccCCCCeEEEeecchheeccccc--
Confidence 99996543 459999999999999999999999 9999999999999995 46789999999998653211
Q ss_pred CCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCccccCCCCcc
Q 005102 565 PTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGSSEM 644 (714)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~~~~~~~~~ 644 (714)
......||+.|||||++.+..++.++|||||||++|||+||+.||... .
T Consensus 181 ---------------------------~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~--~-- 229 (350)
T d1koaa2 181 ---------------------------SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGE--N-- 229 (350)
T ss_dssp ---------------------------CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCS--S--
T ss_pred ---------------------------ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCC--C--
Confidence 112345799999999999999999999999999999999999999422 1
Q ss_pred hhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 005102 645 DLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISD 704 (714)
Q Consensus 645 ~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 704 (714)
..+.+..............- ......+.+++.+||..||++|||++|+++
T Consensus 230 -~~~~~~~i~~~~~~~~~~~~---------~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 279 (350)
T d1koaa2 230 -DDETLRNVKSCDWNMDDSAF---------SGISEDGKDFIRKLLLADPNTRMTIHQALE 279 (350)
T ss_dssp -HHHHHHHHHHTCCCSCCGGG---------GGCCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred -HHHHHHHHHhCCCCCCcccc---------cCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 22223333333222111100 111235789999999999999999999986
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-49 Score=398.60 Aligned_cols=246 Identities=25% Similarity=0.404 Sum_probs=193.8
Q ss_pred cccccccCceEEEEEEECCCcEEEEEEeCCCCchhHHHHHHHHHHHhccCCCCccceEEEEEe-CCceeEEEeccCCCCH
Q 005102 408 AFVLGKSGIGIVYKVVLEDGHTLAVRRLGEGGSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWS-VDEKLLIYDYIPNGSL 486 (714)
Q Consensus 408 ~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~-~~~~~lV~e~~~~gsL 486 (714)
.+.||+|+||.||+|+++ |..||||+++... ..+.|.+|++++++++||||++++|+|.+ .+..++||||+++|+|
T Consensus 12 ~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~~--~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~~g~L 88 (262)
T d1byga_ 12 LQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSL 88 (262)
T ss_dssp EEEEEECSSCEEEEEEET-TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTEEH
T ss_pred eEEEecCCCeEEEEEEEC-CeEEEEEEECcHH--HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEeccCCCCH
Confidence 357999999999999995 7899999997643 34689999999999999999999999865 4568999999999999
Q ss_pred hhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCCCC
Q 005102 487 ATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPT 566 (714)
Q Consensus 487 ~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 566 (714)
.+++..... ..++|..+++|+.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++.....
T Consensus 89 ~~~l~~~~~----~~l~~~~~~~i~~~i~~al~ylH~---~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~----- 156 (262)
T d1byga_ 89 VDYLRSRGR----SVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST----- 156 (262)
T ss_dssp HHHHHHHHH----HHCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTSCEEECCCCC------------
T ss_pred HHHHHhcCC----CCCCHHHHHHHHHHHHhhcccccc---CceeccccchHhheecCCCCEeecccccceecCCC-----
Confidence 999975421 358999999999999999999999 89999999999999999999999999999864321
Q ss_pred ccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHh-CCCccccCCCCcch
Q 005102 567 LQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMIT-GRTAVVQVGSSEMD 645 (714)
Q Consensus 567 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~ellt-G~~p~~~~~~~~~~ 645 (714)
.....+|..|+|||++.+..+++++|||||||++|||+| |+.||... ...+
T Consensus 157 --------------------------~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~--~~~~ 208 (262)
T d1byga_ 157 --------------------------QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI--PLKD 208 (262)
T ss_dssp -------------------------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTS--CGGG
T ss_pred --------------------------CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCC--CHHH
Confidence 112235778999999999999999999999999999999 67776432 2223
Q ss_pred hHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhhhhc
Q 005102 646 LVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDALDRLIV 711 (714)
Q Consensus 646 l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~ 711 (714)
+...+ ..+. .+...... ..++.+++.+||+.||++||||+|+++.|++|.+
T Consensus 209 ~~~~i----~~~~------~~~~~~~~-----~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~ 259 (262)
T d1byga_ 209 VVPRV----EKGY------KMDAPDGC-----PPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 259 (262)
T ss_dssp HHHHH----TTTC------CCCCCTTC-----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHH----HcCC------CCCCCccC-----CHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHh
Confidence 33322 1111 12222111 2368899999999999999999999999999875
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-48 Score=401.20 Aligned_cols=257 Identities=24% Similarity=0.360 Sum_probs=204.2
Q ss_pred cccccccCceEEEEEEECCC----cEEEEEEeCCC-CchhHHHHHHHHHHHhccCCCCccceEEEEEeC-CceeEEEecc
Q 005102 408 AFVLGKSGIGIVYKVVLEDG----HTLAVRRLGEG-GSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSV-DEKLLIYDYI 481 (714)
Q Consensus 408 ~~~lG~G~~g~Vy~~~~~~g----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~-~~~~lV~e~~ 481 (714)
.++||+|+||+||+|++.++ ..||||+++.. .....++|.+|+++|++++|||||+++|++... +..++|||||
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 35899999999999998542 36899999754 444567899999999999999999999998764 5789999999
Q ss_pred CCCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhcc
Q 005102 482 PNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIA 561 (714)
Q Consensus 482 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 561 (714)
++|+|.+++.... ..+++..+++++.|+|.||.|||+ ++|+||||||+|||+++++.+||+|||+++.....
T Consensus 112 ~~g~l~~~~~~~~-----~~~~~~~~~~i~~qia~gL~~lH~---~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~ 183 (311)
T d1r0pa_ 112 KHGDLRNFIRNET-----HNPTVKDLIGFGLQVAKGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 183 (311)
T ss_dssp TTCBHHHHHHCTT-----CCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTT
T ss_pred ecCchhhhhcccc-----ccchHHHHHHHHHHHHHhhhhhcc---cCcccCCccHHhEeECCCCCEEEecccchhhcccc
Confidence 9999999988664 457889999999999999999999 89999999999999999999999999999876532
Q ss_pred CCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCccccCCC
Q 005102 562 GGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGS 641 (714)
Q Consensus 562 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~~~~~~ 641 (714)
.... ........||+.|+|||.+.+..++.++||||||+++|||+||+.||.....
T Consensus 184 ~~~~------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~ 239 (311)
T d1r0pa_ 184 EFDS------------------------VHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN 239 (311)
T ss_dssp TCCC------------------------TTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC---
T ss_pred cccc------------------------ceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCC
Confidence 2110 1122334678999999999999999999999999999999998888743221
Q ss_pred CcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhhhhcc
Q 005102 642 SEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDALDRLIVS 712 (714)
Q Consensus 642 ~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~~ 712 (714)
..++.. ........ ..| .. ...++.+++.+||+.||++||||.||++.|+++..+
T Consensus 240 -~~~~~~---~i~~g~~~----~~p---~~-----~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~ 294 (311)
T d1r0pa_ 240 -TFDITV---YLLQGRRL----LQP---EY-----CPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 294 (311)
T ss_dssp ----CHH---HHHTTCCC----CCC---TT-----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred -HHHHHH---HHHcCCCC----CCc---cc-----CcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence 222222 22222211 111 11 123688999999999999999999999999998764
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=3.6e-48 Score=408.55 Aligned_cols=245 Identities=18% Similarity=0.249 Sum_probs=200.7
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeCCCCchhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCCCHh
Q 005102 409 FVLGKSGIGIVYKVVLE-DGHTLAVRRLGEGGSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGSLA 487 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL~ 487 (714)
+.||+|+||+||+|+.. +|+.||||++........+.+.+|+++|++++|||||++++++.+.+..|+||||+++|+|.
T Consensus 35 ~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~L~ 114 (352)
T d1koba_ 35 EELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELF 114 (352)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCCCCBHH
T ss_pred EEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCChHH
Confidence 47999999999999975 59999999998776666678899999999999999999999999999999999999999999
Q ss_pred hhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeC--CCCCeEEcccchhhhhhccCCCC
Q 005102 488 TALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLG--HNMEPHVSDFGLARLANIAGGSP 565 (714)
Q Consensus 488 ~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~--~~~~~kl~DFGla~~~~~~~~~~ 565 (714)
+++.... .++++.+++.|+.||+.||+|||+ ++|+||||||+|||++ .++.+||+|||+|+......
T Consensus 115 ~~~~~~~-----~~l~e~~~~~i~~qi~~aL~ylH~---~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~--- 183 (352)
T d1koba_ 115 DRIAAED-----YKMSEAEVINYMRQACEGLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE--- 183 (352)
T ss_dssp HHTTCTT-----CCBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS---
T ss_pred HHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecccccccccccccCCCeEEEeecccceecCCCC---
Confidence 9876543 459999999999999999999999 9999999999999998 67899999999998654211
Q ss_pred CccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCccccCCCCcch
Q 005102 566 TLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGSSEMD 645 (714)
Q Consensus 566 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~~~~~~~~~~ 645 (714)
......||+.|+|||++.+..++.++||||+||++|||+||+.||... .
T Consensus 184 --------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~--~--- 232 (352)
T d1koba_ 184 --------------------------IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGE--D--- 232 (352)
T ss_dssp --------------------------CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCS--S---
T ss_pred --------------------------ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCC--C---
Confidence 112234688999999999999999999999999999999999999432 1
Q ss_pred hHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 005102 646 LVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISD 704 (714)
Q Consensus 646 l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 704 (714)
..+.+........... +..... ...++.+++.+||+.||++|||++|+++
T Consensus 233 ~~~~~~~i~~~~~~~~----~~~~~~-----~s~~~~~li~~~L~~dp~~R~s~~eil~ 282 (352)
T d1koba_ 233 DLETLQNVKRCDWEFD----EDAFSS-----VSPEAKDFIKNLLQKEPRKRLTVHDALE 282 (352)
T ss_dssp HHHHHHHHHHCCCCCC----SSTTTT-----SCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred HHHHHHHHHhCCCCCC----cccccC-----CCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1222223333222111 111111 1235789999999999999999999975
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.6e-48 Score=400.76 Aligned_cols=256 Identities=23% Similarity=0.360 Sum_probs=202.6
Q ss_pred ccccccCceEEEEEEEC------CCcEEEEEEeCCCCch-hHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEecc
Q 005102 409 FVLGKSGIGIVYKVVLE------DGHTLAVRRLGEGGSQ-RFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYI 481 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~ 481 (714)
+.||+|+||+||+|+++ +++.||||++...... ..++|.+|+++|++++||||++++++|...+..++||||+
T Consensus 19 ~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~~v~e~~ 98 (301)
T d1lufa_ 19 RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYM 98 (301)
T ss_dssp EEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred EEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCceEEEEEec
Confidence 47999999999999974 3578999999865433 3567999999999999999999999999999999999999
Q ss_pred CCCCHhhhhhCCCCC------------------CCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCC
Q 005102 482 PNGSLATALHGKPGM------------------VSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGH 543 (714)
Q Consensus 482 ~~gsL~~~l~~~~~~------------------~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~ 543 (714)
++|+|.++++..... .....+++..+++|+.|++.||+|||+ ++||||||||+|||+|.
T Consensus 99 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~---~~ivHrDlKp~NILld~ 175 (301)
T d1lufa_ 99 AYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVGE 175 (301)
T ss_dssp TTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECG
T ss_pred CCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhccc---CCeEeeEEcccceEECC
Confidence 999999999643210 011358999999999999999999999 89999999999999999
Q ss_pred CCCeEEcccchhhhhhccCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHH
Q 005102 544 NMEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYG 623 (714)
Q Consensus 544 ~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~G 623 (714)
++++||+|||+|+....... ........||+.|+|||.+.+..++.++||||||
T Consensus 176 ~~~~Kl~DFGls~~~~~~~~--------------------------~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~G 229 (301)
T d1lufa_ 176 NMVVKIADFGLSRNIYSADY--------------------------YKADGNDAIPIRWMPPESIFYNRYTTESDVWAYG 229 (301)
T ss_dssp GGCEEECCCSCHHHHTGGGC--------------------------BC----CCBCGGGCCHHHHHHCCCCHHHHHHHHH
T ss_pred CCcEEEccchhheeccCCcc--------------------------ccccCCCCcCcCcCCHHHHccCCCChhhhhccch
Confidence 99999999999987643211 1122345578899999999999999999999999
Q ss_pred HHHHHHHhCC-CccccCCCCcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHH
Q 005102 624 VILLEMITGR-TAVVQVGSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHI 702 (714)
Q Consensus 624 vvl~elltG~-~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~ev 702 (714)
|++|||++|. +||... ... +.+... ..+.. +..... ...++.+|+.+||+.||++||||.||
T Consensus 230 vvl~ell~~~~~p~~~~--~~~---e~~~~v-~~~~~------~~~p~~-----~~~~~~~li~~cl~~~P~~RPt~~ev 292 (301)
T d1lufa_ 230 VVLWEIFSYGLQPYYGM--AHE---EVIYYV-RDGNI------LACPEN-----CPLELYNLMRLCWSKLPADRPSFCSI 292 (301)
T ss_dssp HHHHHHHTTTCCTTTTS--CHH---HHHHHH-HTTCC------CCCCTT-----CCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred hhHHHHHccCCCCCCCC--CHH---HHHHHH-HcCCC------CCCCcc-----chHHHHHHHHHHcCCChhHCcCHHHH
Confidence 9999999996 456322 222 222222 22211 111111 12368899999999999999999999
Q ss_pred HHHHhhhh
Q 005102 703 SDALDRLI 710 (714)
Q Consensus 703 l~~L~~i~ 710 (714)
+++|++|.
T Consensus 293 ~~~L~~i~ 300 (301)
T d1lufa_ 293 HRILQRMC 300 (301)
T ss_dssp HHHHHHTT
T ss_pred HHHHHHhc
Confidence 99999985
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.7e-48 Score=397.93 Aligned_cols=244 Identities=22% Similarity=0.286 Sum_probs=198.0
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeCCCC------chhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEecc
Q 005102 409 FVLGKSGIGIVYKVVLE-DGHTLAVRRLGEGG------SQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYI 481 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~ 481 (714)
+.||+|+||+||+|+++ +|+.||||++.+.. ....+.|.+|+++|++++|||||++++++.+.+..|+|||||
T Consensus 16 ~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~ 95 (293)
T d1jksa_ 16 EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELV 95 (293)
T ss_dssp EEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred EEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 57999999999999985 58999999986532 223578999999999999999999999999999999999999
Q ss_pred CCCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCC----CeEEcccchhhh
Q 005102 482 PNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNM----EPHVSDFGLARL 557 (714)
Q Consensus 482 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~----~~kl~DFGla~~ 557 (714)
++|+|.+++... ..+++..++.|+.|++.||+|||+ ++|+||||||+|||++.++ .+|++|||+|+.
T Consensus 96 ~gg~L~~~i~~~------~~l~~~~~~~~~~qi~~al~yLH~---~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~ 166 (293)
T d1jksa_ 96 AGGELFDFLAEK------ESLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK 166 (293)
T ss_dssp CSCBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEE
T ss_pred CCccccchhccc------cccchhHHHHHHHHHHHHHHhhhh---cceeecccccceEEEecCCCcccceEecchhhhhh
Confidence 999999999765 459999999999999999999999 8999999999999998776 499999999986
Q ss_pred hhccCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCccc
Q 005102 558 ANIAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVV 637 (714)
Q Consensus 558 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~~ 637 (714)
.... .......||+.|+|||++.+..++.++|||||||++|||+||+.||.
T Consensus 167 ~~~~-----------------------------~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~ 217 (293)
T d1jksa_ 167 IDFG-----------------------------NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL 217 (293)
T ss_dssp CTTS-----------------------------CBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred cCCC-----------------------------ccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCC
Confidence 5421 11233457889999999999999999999999999999999999995
Q ss_pred cCCCCcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 005102 638 QVGSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISD 704 (714)
Q Consensus 638 ~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 704 (714)
.. .. .+.+...............+ .....+.+++.+||+.||++|||++|+++
T Consensus 218 ~~--~~---~~~~~~i~~~~~~~~~~~~~---------~~s~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 218 GD--TK---QETLANVSAVNYEFEDEYFS---------NTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp CS--SH---HHHHHHHHTTCCCCCHHHHT---------TSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CC--CH---HHHHHHHHhcCCCCCchhcC---------CCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 32 11 12222222222111111111 11235789999999999999999999975
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-48 Score=393.86 Aligned_cols=251 Identities=19% Similarity=0.316 Sum_probs=192.7
Q ss_pred cccccccCceEEEEEEECC----CcEEEEEEeCCCC-chhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccC
Q 005102 408 AFVLGKSGIGIVYKVVLED----GHTLAVRRLGEGG-SQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIP 482 (714)
Q Consensus 408 ~~~lG~G~~g~Vy~~~~~~----g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~ 482 (714)
.+.||+|+||+||+|++.. +..||||+++... ....+.|.+|+++|++++|||||+++|++. .+..++||||++
T Consensus 12 ~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~iv~E~~~ 90 (273)
T d1mp8a_ 12 GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIMELCT 90 (273)
T ss_dssp EEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEEEECCT
T ss_pred EEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEEEEEecc
Confidence 3579999999999998753 4579999987653 334567999999999999999999999985 567899999999
Q ss_pred CCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccC
Q 005102 483 NGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAG 562 (714)
Q Consensus 483 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 562 (714)
+|+|.+++.... ..+++..++.++.||++||+|||+ ++|+||||||+||++++++.+||+|||+|+......
T Consensus 91 ~g~l~~~~~~~~-----~~l~~~~~~~~~~qi~~gl~ylH~---~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~~ 162 (273)
T d1mp8a_ 91 LGELRSFLQVRK-----YSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST 162 (273)
T ss_dssp TEEHHHHHHHTT-----TTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECC-----------
T ss_pred CCcHHhhhhccC-----CCCCHHHHHHHHHHHHHHhhhhcc---cCeeccccchhheeecCCCcEEEccchhheeccCCc
Confidence 999999876553 458999999999999999999999 999999999999999999999999999998754221
Q ss_pred CCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHh-CCCccccCCC
Q 005102 563 GSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMIT-GRTAVVQVGS 641 (714)
Q Consensus 563 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~ellt-G~~p~~~~~~ 641 (714)
........||+.|+|||++.+..++.++|||||||++|||+| |+.||....
T Consensus 163 ---------------------------~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~- 214 (273)
T d1mp8a_ 163 ---------------------------YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK- 214 (273)
T ss_dssp -----------------------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCC-
T ss_pred ---------------------------ceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCC-
Confidence 112233457889999999999999999999999999999998 888885432
Q ss_pred CcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhhhhc
Q 005102 642 SEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDALDRLIV 711 (714)
Q Consensus 642 ~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~ 711 (714)
..++...+ . .... +..... ...++.+++.+||+.||++|||++||++.|++++.
T Consensus 215 -~~~~~~~i---~-~~~~------~~~~~~-----~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~ 268 (273)
T d1mp8a_ 215 -NNDVIGRI---E-NGER------LPMPPN-----CPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 268 (273)
T ss_dssp -GGGHHHHH---H-TTCC------CCCCTT-----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -HHHHHHHH---H-cCCC------CCCCCC-----CCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 22222221 1 1111 111111 12368899999999999999999999999999864
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1.3e-47 Score=392.88 Aligned_cols=255 Identities=20% Similarity=0.275 Sum_probs=199.2
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeCCCC---chhHHHHHHHHHHHhccCCCCccceEEEEEeCCc----eeEEEec
Q 005102 409 FVLGKSGIGIVYKVVLE-DGHTLAVRRLGEGG---SQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDE----KLLIYDY 480 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~----~~lV~e~ 480 (714)
+.||+|+||+||+|++. +|+.||||+++... ....+.|.+|++++++++|||||++++++...+. .|+||||
T Consensus 13 ~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~~lvmE~ 92 (277)
T d1o6ya_ 13 EILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEY 92 (277)
T ss_dssp EEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEEEEEEEC
T ss_pred EEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceEEEEEEC
Confidence 47999999999999975 69999999997643 3334679999999999999999999999987543 7899999
Q ss_pred cCCCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhc
Q 005102 481 IPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANI 560 (714)
Q Consensus 481 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 560 (714)
+++|+|.+++... ..+++.+++.|+.||+.||+|||+ ++|+||||||+|||++.++..+++|||.++....
T Consensus 93 ~~g~~L~~~~~~~------~~l~~~~~~~i~~qi~~al~~lH~---~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~ 163 (277)
T d1o6ya_ 93 VDGVTLRDIVHTE------GPMTPKRAIEVIADACQALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIAD 163 (277)
T ss_dssp CCEEEHHHHHHHH------CSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTSCEEECCCTTCEECC-
T ss_pred CCCCEehhhhccc------CCCCHHHHHHHHHHHHHHHHHHHh---CCccCccccCcccccCccccceeehhhhhhhhcc
Confidence 9999999988755 468999999999999999999999 8999999999999999999999999998875432
Q ss_pred cCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCccccCC
Q 005102 561 AGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVG 640 (714)
Q Consensus 561 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~~~~~ 640 (714)
... .........||+.|+|||++.+..+++++|||||||++|||+||+.||...
T Consensus 164 ~~~-------------------------~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~- 217 (277)
T d1o6ya_ 164 SGN-------------------------SVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGD- 217 (277)
T ss_dssp ----------------------------------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCS-
T ss_pred ccc-------------------------cccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCc-
Confidence 110 012233456899999999999999999999999999999999999999432
Q ss_pred CCcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCC-CHHHHHHHHhhhhc
Q 005102 641 SSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRP-TMRHISDALDRLIV 711 (714)
Q Consensus 641 ~~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RP-t~~evl~~L~~i~~ 711 (714)
...+.................+. ...++.+++.+||+.||++|| |++++++.|.++..
T Consensus 218 ----~~~~~~~~~~~~~~~~~~~~~~~---------~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~n 276 (277)
T d1o6ya_ 218 ----SPVSVAYQHVREDPIPPSARHEG---------LSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN 276 (277)
T ss_dssp ----SHHHHHHHHHHCCCCCGGGTSSS---------CCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHC
T ss_pred ----CHHHHHHHHHhcCCCCCchhccC---------CCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHhC
Confidence 12223333333332222211111 123678999999999999999 89999999998763
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-48 Score=403.14 Aligned_cols=266 Identities=24% Similarity=0.252 Sum_probs=199.2
Q ss_pred ccccccCceEEEEEEECCCcEEEEEEeCCCCchhHHHHHHHHHHHhccCCCCccceEEEEEeCC----ceeEEEeccCCC
Q 005102 409 FVLGKSGIGIVYKVVLEDGHTLAVRRLGEGGSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVD----EKLLIYDYIPNG 484 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~----~~~lV~e~~~~g 484 (714)
+.||+|+||+||+|++ +|+.||||++..... ....++.|+..+.+++|||||++++++...+ ..++|||||++|
T Consensus 9 ~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~~-~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~Ey~~~g 86 (303)
T d1vjya_ 9 ESIGKGRFGEVWRGKW-RGEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHG 86 (303)
T ss_dssp EEEECCSSSEEEEEEE-TTEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTC
T ss_pred EEEeeCCCeEEEEEEE-CCEEEEEEEECccch-hHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEEecccCC
Confidence 4799999999999997 589999999975432 1122344556667889999999999998754 468999999999
Q ss_pred CHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCC-----CCCceecCCCCCCeeeCCCCCeEEcccchhhhhh
Q 005102 485 SLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFS-----PKKYVHGDLKPSNILLGHNMEPHVSDFGLARLAN 559 (714)
Q Consensus 485 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~-----~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~ 559 (714)
+|.++++.. .++|.++.+++.|+|.||+|||+.. .++||||||||+|||+++++.+||+|||+++...
T Consensus 87 ~L~~~l~~~-------~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~~ 159 (303)
T d1vjya_ 87 SLFDYLNRY-------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHD 159 (303)
T ss_dssp BHHHHHHHC-------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEEE
T ss_pred CHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcccccc
Confidence 999999754 4899999999999999999999731 2589999999999999999999999999998764
Q ss_pred ccCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCC------CCchhhhHHHHHHHHHHHhCC
Q 005102 560 IAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVK------PSQKWDIYSYGVILLEMITGR 633 (714)
Q Consensus 560 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~------~s~~~DVwS~Gvvl~elltG~ 633 (714)
.... ..........||+.|+|||++.+.. ++.++|||||||++|||+||.
T Consensus 160 ~~~~------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~ 215 (303)
T d1vjya_ 160 SATD------------------------TIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRC 215 (303)
T ss_dssp TTTT------------------------EECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTB
T ss_pred CCCc------------------------ceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCC
Confidence 3211 0112233567899999999987643 577999999999999999999
Q ss_pred CccccCCCCcc---------hhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 005102 634 TAVVQVGSSEM---------DLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISD 704 (714)
Q Consensus 634 ~p~~~~~~~~~---------~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 704 (714)
.||........ ............ +..+|.+.......+....+.+++.+||+.||++||||.||++
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~ 290 (303)
T d1vjya_ 216 SIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCE-----QKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 290 (303)
T ss_dssp CBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTT-----SCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHH
T ss_pred CCCCcccccccchhhcccccchHHHHHHHHhc-----cccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHH
Confidence 88733221111 011111111111 1123333333333345667899999999999999999999999
Q ss_pred HHhhhhcc
Q 005102 705 ALDRLIVS 712 (714)
Q Consensus 705 ~L~~i~~~ 712 (714)
.|+++...
T Consensus 291 ~L~~i~~~ 298 (303)
T d1vjya_ 291 TLSQLSQQ 298 (303)
T ss_dssp HHHHHHHH
T ss_pred HHHHHHHh
Confidence 99998754
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-47 Score=400.53 Aligned_cols=241 Identities=21% Similarity=0.268 Sum_probs=198.8
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeCCC---CchhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCC
Q 005102 409 FVLGKSGIGIVYKVVLE-DGHTLAVRRLGEG---GSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNG 484 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~g 484 (714)
+.||+|+||+||+|+.+ +|+.||||++.+. .....+.+.+|+.+|++++||||+++++++.+.+..|+||||+++|
T Consensus 11 ~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ey~~gg 90 (337)
T d1o6la_ 11 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 90 (337)
T ss_dssp EEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEECCTTC
T ss_pred EEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccceeccCCC
Confidence 47999999999999975 6999999999753 2234577899999999999999999999999999999999999999
Q ss_pred CHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCC
Q 005102 485 SLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGS 564 (714)
Q Consensus 485 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 564 (714)
+|.+++... ..+++..++.++.||+.||+|||+ ++|+||||||+|||+++++.+||+|||+|+.....
T Consensus 91 ~L~~~~~~~------~~~~e~~~~~~~~qil~al~ylH~---~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~--- 158 (337)
T d1o6la_ 91 ELFFHLSRE------RVFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD--- 158 (337)
T ss_dssp BHHHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT---
T ss_pred chhhhhhcc------cCCcHHHHHHHHHHHhhhhhhhhh---cCccccccCHHHeEecCCCCEEEeecccccccccC---
Confidence 999999865 458999999999999999999999 99999999999999999999999999999854321
Q ss_pred CCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCccccCCCCcc
Q 005102 565 PTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGSSEM 644 (714)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~~~~~~~~~ 644 (714)
........||+.|+|||++.+..|+.++||||+||++|||++|+.||....
T Consensus 159 -------------------------~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~---- 209 (337)
T d1o6la_ 159 -------------------------GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD---- 209 (337)
T ss_dssp -------------------------TCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSS----
T ss_pred -------------------------CcccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcC----
Confidence 112234568999999999999999999999999999999999999995322
Q ss_pred hhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCC-----HHHHHH
Q 005102 645 DLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPT-----MRHISD 704 (714)
Q Consensus 645 ~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt-----~~evl~ 704 (714)
..+..+........+ +... ..++.+++.+||++||++||+ ++|+++
T Consensus 210 -~~~~~~~i~~~~~~~--------p~~~-----s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 210 -HERLFELILMEEIRF--------PRTL-----SPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp -HHHHHHHHHHCCCCC--------CTTS-----CHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred -HHHHHHHHhcCCCCC--------CccC-----CHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence 222333333322211 1111 225789999999999999995 777764
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.9e-47 Score=397.46 Aligned_cols=238 Identities=21% Similarity=0.313 Sum_probs=198.1
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeCCC---CchhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCC
Q 005102 409 FVLGKSGIGIVYKVVLE-DGHTLAVRRLGEG---GSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNG 484 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~g 484 (714)
+.||+|+||+||+|+++ +|+.||||++++. .....+.+.+|+.+|++++|||||++++++.+.+..|+||||+++|
T Consensus 10 ~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg 89 (316)
T d1fota_ 10 RTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGG 89 (316)
T ss_dssp EEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECCCCSC
T ss_pred EEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEeeecCCc
Confidence 57999999999999985 5999999999753 2334578999999999999999999999999999999999999999
Q ss_pred CHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCC
Q 005102 485 SLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGS 564 (714)
Q Consensus 485 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 564 (714)
+|..++... ..+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+|+....
T Consensus 90 ~l~~~~~~~------~~~~~~~~~~~~~qi~~al~~lH~---~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~---- 156 (316)
T d1fota_ 90 ELFSLLRKS------QRFPNPVAKFYAAEVCLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD---- 156 (316)
T ss_dssp BHHHHHHHT------SSCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTSCEEECCCSSCEECSS----
T ss_pred ccccccccc------ccccccHHHHHHHHHHHhhhhhcc---CcEEccccCchheeEcCCCCEEEecCccceEecc----
Confidence 999998766 457889999999999999999999 9999999999999999999999999999986431
Q ss_pred CCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCccccCCCCcc
Q 005102 565 PTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGSSEM 644 (714)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~~~~~~~~~ 644 (714)
......||+.|||||++.+..++.++||||+||++|||+||+.||...
T Consensus 157 ---------------------------~~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~----- 204 (316)
T d1fota_ 157 ---------------------------VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDS----- 204 (316)
T ss_dssp ---------------------------CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCS-----
T ss_pred ---------------------------ccccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCc-----
Confidence 122356899999999999999999999999999999999999999432
Q ss_pred hhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCC-----CHHHHHH
Q 005102 645 DLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRP-----TMRHISD 704 (714)
Q Consensus 645 ~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----t~~evl~ 704 (714)
+..+............ ++.. ...+.+++.+||..||.+|| |++|+++
T Consensus 205 ~~~~~~~~i~~~~~~~--------p~~~-----s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~ 256 (316)
T d1fota_ 205 NTMKTYEKILNAELRF--------PPFF-----NEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 256 (316)
T ss_dssp SHHHHHHHHHHCCCCC--------CTTS-----CHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred CHHHHHHHHHcCCCCC--------CCCC-----CHHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence 2222333333332211 1111 12578999999999999996 8888874
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-47 Score=401.01 Aligned_cols=250 Identities=23% Similarity=0.358 Sum_probs=196.3
Q ss_pred ccccccCceEEEEEEECC-Cc----EEEEEEeCCC-CchhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccC
Q 005102 409 FVLGKSGIGIVYKVVLED-GH----TLAVRRLGEG-GSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIP 482 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~~-g~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~ 482 (714)
++||+|+||+||+|.+.. |+ .||||+++.. .....++|.+|++++++++|||||+++|+|.+ +..+++|||+.
T Consensus 15 ~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~-~~~~~v~e~~~ 93 (317)
T d1xkka_ 15 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT-STVQLITQLMP 93 (317)
T ss_dssp EEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCT
T ss_pred eEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCeeEEEEecc
Confidence 489999999999999753 43 6899998754 33446789999999999999999999999976 46788899999
Q ss_pred CCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccC
Q 005102 483 NGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAG 562 (714)
Q Consensus 483 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 562 (714)
+|+|.+++.... ..+++..+++|+.|||.||+|||+ ++||||||||+|||++.++++||+|||+|+......
T Consensus 94 ~~~l~~~~~~~~-----~~~~~~~~~~i~~qi~~gl~yLH~---~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~~ 165 (317)
T d1xkka_ 94 FGCLLDYVREHK-----DNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 165 (317)
T ss_dssp TCBHHHHHHHTS-----SSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTTC
T ss_pred CCcccccccccc-----cCCCHHHHHHHHHHHHHHHHHHHH---cCcccCcchhhcceeCCCCCeEeeccccceeccccc
Confidence 999999887653 468999999999999999999999 899999999999999999999999999999765322
Q ss_pred CCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHh-CCCccccCCC
Q 005102 563 GSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMIT-GRTAVVQVGS 641 (714)
Q Consensus 563 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~ellt-G~~p~~~~~~ 641 (714)
. ........||+.|+|||++.++.++.++|||||||++|||+| |+.||....
T Consensus 166 ~--------------------------~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~- 218 (317)
T d1xkka_ 166 K--------------------------EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP- 218 (317)
T ss_dssp C----------------------------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSC-
T ss_pred c--------------------------cccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCC-
Confidence 1 111223457899999999999999999999999999999999 788874332
Q ss_pred CcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhhhh
Q 005102 642 SEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDALDRLI 710 (714)
Q Consensus 642 ~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~ 710 (714)
..++...+ ..+.. +..... ....+.+++.+||+.||++|||++||++.|+.+.
T Consensus 219 -~~~~~~~i----~~~~~------~~~p~~-----~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~ 271 (317)
T d1xkka_ 219 -ASEISSIL----EKGER------LPQPPI-----CTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA 271 (317)
T ss_dssp -GGGHHHHH----HHTCC------CCCCTT-----BCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -HHHHHHHH----HcCCC------CCCCcc-----cCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHH
Confidence 22222222 22211 111111 2236889999999999999999999999998874
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.6e-48 Score=399.20 Aligned_cols=260 Identities=23% Similarity=0.305 Sum_probs=193.4
Q ss_pred cccccccCceEEEEEEEC------CCcEEEEEEeCCCC-chhHHHHHHHHHHHhcc-CCCCccceEEEEEeC-CceeEEE
Q 005102 408 AFVLGKSGIGIVYKVVLE------DGHTLAVRRLGEGG-SQRFKEFQTEVEAIGKI-RHSNIVTLRAYYWSV-DEKLLIY 478 (714)
Q Consensus 408 ~~~lG~G~~g~Vy~~~~~------~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~-~~~~lV~ 478 (714)
.+.||+|+||+||+|++. +++.||||+++... ....+.+.+|+.++.++ +|+||+.+++++... +..++||
T Consensus 18 ~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~~iv~ 97 (299)
T d1ywna1 18 GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIV 97 (299)
T ss_dssp EEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCCEEEE
T ss_pred eeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCCeEEEEE
Confidence 357999999999999964 24689999997643 33456788899988887 689999999998765 4679999
Q ss_pred eccCCCCHhhhhhCCCCC----------CCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeE
Q 005102 479 DYIPNGSLATALHGKPGM----------VSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPH 548 (714)
Q Consensus 479 e~~~~gsL~~~l~~~~~~----------~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~k 548 (714)
||+++|+|.++++..... .....+++.+++.|+.||++||+|||+ ++||||||||+|||+++++++|
T Consensus 98 E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~---~~ivHrDlKp~NILl~~~~~~K 174 (299)
T d1ywna1 98 EFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVK 174 (299)
T ss_dssp ECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECGGGCEE
T ss_pred EecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHh---CCCcCCcCCccceeECCCCcEE
Confidence 999999999999754210 011358999999999999999999999 8999999999999999999999
Q ss_pred EcccchhhhhhccCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHH
Q 005102 549 VSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLE 628 (714)
Q Consensus 549 l~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~e 628 (714)
|+|||+|+....... ........||+.|+|||++.+..++.++|||||||++||
T Consensus 175 l~DFGla~~~~~~~~--------------------------~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~e 228 (299)
T d1ywna1 175 ICDFGLARDIYKDPD--------------------------YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWE 228 (299)
T ss_dssp ECC------CCSCTT--------------------------SCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHH
T ss_pred EccCcchhhcccccc--------------------------ccccCceeeCccccchhHhhcCCCCcccceeehHHHHHH
Confidence 999999986542211 112334568999999999999999999999999999999
Q ss_pred HHhCC-CccccCCCCcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHh
Q 005102 629 MITGR-TAVVQVGSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDALD 707 (714)
Q Consensus 629 lltG~-~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~ 707 (714)
|+||. .||..... .. .+...+..+.. +..... ...++.+++.+||+.||++||||+||++.|+
T Consensus 229 llt~~~~p~~~~~~-~~----~~~~~~~~~~~------~~~~~~-----~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~ 292 (299)
T d1ywna1 229 IFSLGASPYPGVKI-DE----EFCRRLKEGTR------MRAPDY-----TTPEMYQTMLDCWHGEPSQRPTFSELVEHLG 292 (299)
T ss_dssp HHTTSCCSSTTCCC-SH----HHHHHHHHTCC------CCCCTT-----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHhCCCCCCCCCCH-HH----HHHHHHhcCCC------CCCCcc-----CCHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence 99975 46633221 11 12222222221 111111 1236889999999999999999999999999
Q ss_pred hhhcc
Q 005102 708 RLIVS 712 (714)
Q Consensus 708 ~i~~~ 712 (714)
+++.+
T Consensus 293 ~ilq~ 297 (299)
T d1ywna1 293 NLLQA 297 (299)
T ss_dssp HHHHH
T ss_pred HHHhC
Confidence 98753
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-47 Score=390.93 Aligned_cols=251 Identities=24% Similarity=0.344 Sum_probs=190.9
Q ss_pred ccccccCceEEEEEEECC--C--cEEEEEEeCCC---CchhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEecc
Q 005102 409 FVLGKSGIGIVYKVVLED--G--HTLAVRRLGEG---GSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYI 481 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~~--g--~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~ 481 (714)
+.||+|+||+||+|++.. + ..||||++.+. .....++|.+|+++|++++|||||+++|+|.+ +..++||||+
T Consensus 14 ~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~lv~e~~ 92 (273)
T d1u46a_ 14 EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMKMVTELA 92 (273)
T ss_dssp EECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECC
T ss_pred EEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchheeeeee
Confidence 369999999999998642 2 47899998754 33445789999999999999999999999965 5678999999
Q ss_pred CCCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhcc
Q 005102 482 PNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIA 561 (714)
Q Consensus 482 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 561 (714)
++|++.+.+.... ..+++..+++++.|||.||+|||+ ++|+||||||+|||++.++.+||+|||+++.....
T Consensus 93 ~~~~l~~~~~~~~-----~~l~~~~~~~~~~qi~~gl~ylH~---~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~~ 164 (273)
T d1u46a_ 93 PLGSLLDRLRKHQ-----GHFLLGTLSRYAVQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQN 164 (273)
T ss_dssp TTCBHHHHHHHHG-----GGSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCTTCEECCC-
T ss_pred cCcchhhhhhccc-----CCCCHHHHHHHHHHHHHHHHHhhh---CCEeeeeecHHHhccccccceeeccchhhhhcccC
Confidence 9999999887543 459999999999999999999999 89999999999999999999999999999875432
Q ss_pred CCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHh-CCCccccCC
Q 005102 562 GGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMIT-GRTAVVQVG 640 (714)
Q Consensus 562 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~ellt-G~~p~~~~~ 640 (714)
.. .........|+..|+|||.+.+..++.++|||||||++|||+| |+.||...
T Consensus 165 ~~-------------------------~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~- 218 (273)
T d1u46a_ 165 DD-------------------------HYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGL- 218 (273)
T ss_dssp CC-------------------------EEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTC-
T ss_pred CC-------------------------cceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCc-
Confidence 11 0122334456888999999999999999999999999999998 89999422
Q ss_pred CCcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhhh
Q 005102 641 SSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDALDRL 709 (714)
Q Consensus 641 ~~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i 709 (714)
. ..+.+......+.. +..... ....+.+++.+||+.||++||||+||++.|++.
T Consensus 219 -~---~~~~~~~i~~~~~~------~~~~~~-----~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 219 -N---GSQILHKIDKEGER------LPRPED-----CPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp -C---HHHHHHHHHTSCCC------CCCCTT-----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -C---HHHHHHHHHhCCCC------CCCccc-----ccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 2 22222222232221 111111 123688999999999999999999999999875
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.8e-48 Score=400.36 Aligned_cols=262 Identities=24% Similarity=0.313 Sum_probs=206.5
Q ss_pred cccccccCceEEEEEEEC------CCcEEEEEEeCCCCc-hhHHHHHHHHHHHhcc-CCCCccceEEEEEeCCceeEEEe
Q 005102 408 AFVLGKSGIGIVYKVVLE------DGHTLAVRRLGEGGS-QRFKEFQTEVEAIGKI-RHSNIVTLRAYYWSVDEKLLIYD 479 (714)
Q Consensus 408 ~~~lG~G~~g~Vy~~~~~------~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~e 479 (714)
.+.||+|+||.||+|++. +++.||||+++.... .....|.+|+.+++++ +|||||+++|+|.+.+..++|||
T Consensus 28 ~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~~~lvmE 107 (311)
T d1t46a_ 28 GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITE 107 (311)
T ss_dssp EEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred eeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCEEEEEEE
Confidence 458999999999999863 367899999986543 3456799999999999 69999999999999999999999
Q ss_pred ccCCCCHhhhhhCCCCC------------CCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCe
Q 005102 480 YIPNGSLATALHGKPGM------------VSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEP 547 (714)
Q Consensus 480 ~~~~gsL~~~l~~~~~~------------~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~ 547 (714)
|+++|+|.++++..... .....+++..+++|+.||++||+|||+ ++||||||||+||+++.++.+
T Consensus 108 ~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~---~~ivHrDLKp~NIl~~~~~~~ 184 (311)
T d1t46a_ 108 YCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRIT 184 (311)
T ss_dssp CCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEETTTEE
T ss_pred cCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccccccccccccCcc
Confidence 99999999999754321 112368999999999999999999999 899999999999999999999
Q ss_pred EEcccchhhhhhccCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHH
Q 005102 548 HVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILL 627 (714)
Q Consensus 548 kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~ 627 (714)
|++|||+++....... ........||+.|+|||++.+..++.++|||||||++|
T Consensus 185 ki~DfG~~~~~~~~~~--------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ 238 (311)
T d1t46a_ 185 KICDFGLARDIKNDSN--------------------------YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLW 238 (311)
T ss_dssp EECCCGGGSCTTSCTT--------------------------SEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHH
T ss_pred cccccchheeccCCCc--------------------------ceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHH
Confidence 9999999986543211 11223456789999999999999999999999999999
Q ss_pred HHHhCCCccccCCCCcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHh
Q 005102 628 EMITGRTAVVQVGSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDALD 707 (714)
Q Consensus 628 elltG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~ 707 (714)
||+|+..|+.........+.+. +..+.. +..... ....+.+|+.+||+.||++||||+||+++|+
T Consensus 239 ellt~g~p~~~~~~~~~~~~~~----i~~~~~------~~~~~~-----~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~ 303 (311)
T d1t46a_ 239 ELFSLGSSPYPGMPVDSKFYKM----IKEGFR------MLSPEH-----APAEMYDIMKTCWDADPLKRPTFKQIVQLIE 303 (311)
T ss_dssp HHHTTTCCSSTTCCSSHHHHHH----HHHTCC------CCCCTT-----SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHHhCCCCCCCCCCHHHHHHHH----HhcCCC------CCCccc-----ccHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence 9999655553333322222222 222211 111111 1236889999999999999999999999999
Q ss_pred hhhccC
Q 005102 708 RLIVSS 713 (714)
Q Consensus 708 ~i~~~~ 713 (714)
+++..+
T Consensus 304 ~~i~~~ 309 (311)
T d1t46a_ 304 KQISES 309 (311)
T ss_dssp HHHHHT
T ss_pred HhhccC
Confidence 876543
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-47 Score=391.76 Aligned_cols=259 Identities=24% Similarity=0.344 Sum_probs=201.3
Q ss_pred cccccccCceEEEEEEECC--------CcEEEEEEeCCCCc-hhHHHHHHHHHHHhcc-CCCCccceEEEEEeCCceeEE
Q 005102 408 AFVLGKSGIGIVYKVVLED--------GHTLAVRRLGEGGS-QRFKEFQTEVEAIGKI-RHSNIVTLRAYYWSVDEKLLI 477 (714)
Q Consensus 408 ~~~lG~G~~g~Vy~~~~~~--------g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV 477 (714)
.+.||+|+||.||+|+... +..||||+++.... ....++.+|+..+.++ +|||||+++++|.+.+..++|
T Consensus 18 ~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~~~~~v 97 (299)
T d1fgka_ 18 GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVI 97 (299)
T ss_dssp EEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred eeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccCCeEEEE
Confidence 3579999999999998642 34799999987543 3457889999999999 899999999999999999999
Q ss_pred EeccCCCCHhhhhhCCCCC----------CCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCe
Q 005102 478 YDYIPNGSLATALHGKPGM----------VSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEP 547 (714)
Q Consensus 478 ~e~~~~gsL~~~l~~~~~~----------~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~ 547 (714)
|||+++|+|.+++...... .....+++.++++++.||+.||+|||+ ++||||||||+|||++.++.+
T Consensus 98 ~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~---~~ivHrDiKp~NiLl~~~~~~ 174 (299)
T d1fgka_ 98 VEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVM 174 (299)
T ss_dssp ECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCE
T ss_pred EEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhh---CCEEeeeecccceeecCCCCe
Confidence 9999999999999765321 112468999999999999999999999 999999999999999999999
Q ss_pred EEcccchhhhhhccCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHH
Q 005102 548 HVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILL 627 (714)
Q Consensus 548 kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~ 627 (714)
||+|||+++....... ........||+.|+|||.+.++.|+.++|||||||++|
T Consensus 175 kl~dfg~~~~~~~~~~--------------------------~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ 228 (299)
T d1fgka_ 175 KIADFGLARDIHHIDY--------------------------YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLW 228 (299)
T ss_dssp EECSTTCCCCGGGCCT--------------------------TCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHH
T ss_pred Eeccchhhcccccccc--------------------------ccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHH
Confidence 9999999987653221 11233455788999999999999999999999999999
Q ss_pred HHHh-CCCccccCCCCcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHH
Q 005102 628 EMIT-GRTAVVQVGSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDAL 706 (714)
Q Consensus 628 ellt-G~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L 706 (714)
||+| |+.||.... ...+. ..+..+.. +..+.. ....+.+++.+||+.||++||||+||++.|
T Consensus 229 ell~~g~~p~~~~~--~~~~~----~~i~~~~~------~~~p~~-----~~~~l~~li~~cl~~dP~~Rps~~eil~~L 291 (299)
T d1fgka_ 229 EIFTLGGSPYPGVP--VEELF----KLLKEGHR------MDKPSN-----CTNELYMMMRDCWHAVPSQRPTFKQLVEDL 291 (299)
T ss_dssp HHHTTSCCSSTTCC--HHHHH----HHHHTTCC------CCCCSS-----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HhccCCCCCCCCCC--HHHHH----HHHHcCCC------CCCCcc-----chHHHHHHHHHHccCCHhHCcCHHHHHHHH
Confidence 9998 677773221 11122 12222211 111111 123688999999999999999999999999
Q ss_pred hhhhcc
Q 005102 707 DRLIVS 712 (714)
Q Consensus 707 ~~i~~~ 712 (714)
++|.+.
T Consensus 292 ~~i~a~ 297 (299)
T d1fgka_ 292 DRIVAL 297 (299)
T ss_dssp HHHHHH
T ss_pred HHHhhc
Confidence 998754
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.7e-47 Score=392.92 Aligned_cols=268 Identities=20% Similarity=0.304 Sum_probs=208.4
Q ss_pred cccCHHHHHHhccccccccCceEEEEEEEC------CCcEEEEEEeCCCC-chhHHHHHHHHHHHhccCCCCccceEEEE
Q 005102 396 VAFDLDELLKASAFVLGKSGIGIVYKVVLE------DGHTLAVRRLGEGG-SQRFKEFQTEVEAIGKIRHSNIVTLRAYY 468 (714)
Q Consensus 396 ~~~~~~~l~~~~~~~lG~G~~g~Vy~~~~~------~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~ 468 (714)
+.++.+++. ..+.||+|+||+||+|.++ +++.||||+++... ......|.+|++++++++|||||+++|+|
T Consensus 15 ~ei~~~~~~--l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~ 92 (308)
T d1p4oa_ 15 WEVAREKIT--MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVV 92 (308)
T ss_dssp TBCCGGGEE--EEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEE
T ss_pred eeecHHHeE--EeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEE
Confidence 344444432 2457999999999999874 25789999997653 33445799999999999999999999999
Q ss_pred EeCCceeEEEeccCCCCHhhhhhCCCC----CCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCC
Q 005102 469 WSVDEKLLIYDYIPNGSLATALHGKPG----MVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHN 544 (714)
Q Consensus 469 ~~~~~~~lV~e~~~~gsL~~~l~~~~~----~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~ 544 (714)
...+..++||||+++|+|.+++..... ......+++..+.+|+.|+|+||.|||+ ++|+||||||+|||++++
T Consensus 93 ~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~---~~ivHrDlk~~NiLld~~ 169 (308)
T d1p4oa_ 93 SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAED 169 (308)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCSGGGEEECTT
T ss_pred ecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhh---CCeeeceEcCCceeecCC
Confidence 999999999999999999998864310 0011357899999999999999999999 899999999999999999
Q ss_pred CCeEEcccchhhhhhccCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHH
Q 005102 545 MEPHVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGV 624 (714)
Q Consensus 545 ~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gv 624 (714)
+++||+|||+|+....... ........||+.|+|||.+.+..++.++|||||||
T Consensus 170 ~~~Kl~DFGla~~~~~~~~--------------------------~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~ 223 (308)
T d1p4oa_ 170 FTVKIGDFGMTRDIYETDY--------------------------YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGV 223 (308)
T ss_dssp CCEEECCTTCCCGGGGGGC--------------------------EEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHH
T ss_pred ceEEEeecccceeccCCcc--------------------------eeeccceecccccCCHHHHccCCCCcccccccHHH
Confidence 9999999999987643211 11223345688999999999999999999999999
Q ss_pred HHHHHHhCC-CccccCCCCcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHH
Q 005102 625 ILLEMITGR-TAVVQVGSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHIS 703 (714)
Q Consensus 625 vl~elltG~-~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl 703 (714)
++|||+||+ .||.. ....+.......... +..... ....+.+++.+||+.||++||||+||+
T Consensus 224 il~El~t~~~~p~~~-----~~~~~~~~~i~~~~~-------~~~p~~-----~~~~l~~li~~cl~~~P~~RPs~~~il 286 (308)
T d1p4oa_ 224 VLWEIATLAEQPYQG-----LSNEQVLRFVMEGGL-------LDKPDN-----CPDMLFELMRMCWQYNPKMRPSFLEII 286 (308)
T ss_dssp HHHHHHHTSCCTTTT-----SCHHHHHHHHHTTCC-------CCCCTT-----CCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred HHHHHHhCCCCCCCC-----CCHHHHHHHHHhCCC-------CCCccc-----chHHHHHHHHHHcCCChhHCcCHHHHH
Confidence 999999986 55522 222233333222211 111111 123688999999999999999999999
Q ss_pred HHHhhhhc
Q 005102 704 DALDRLIV 711 (714)
Q Consensus 704 ~~L~~i~~ 711 (714)
+.|++.++
T Consensus 287 ~~L~~~~~ 294 (308)
T d1p4oa_ 287 SSIKEEME 294 (308)
T ss_dssp HHHGGGSC
T ss_pred HHHHHhcC
Confidence 99998765
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-47 Score=394.07 Aligned_cols=256 Identities=24% Similarity=0.359 Sum_probs=198.5
Q ss_pred cccccccCceEEEEEEECC-Cc--EEEEEEeCCC-CchhHHHHHHHHHHHhcc-CCCCccceEEEEEeCCceeEEEeccC
Q 005102 408 AFVLGKSGIGIVYKVVLED-GH--TLAVRRLGEG-GSQRFKEFQTEVEAIGKI-RHSNIVTLRAYYWSVDEKLLIYDYIP 482 (714)
Q Consensus 408 ~~~lG~G~~g~Vy~~~~~~-g~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~e~~~ 482 (714)
.+.||+|+||+||+|++++ |. .||||++... .....+.|.+|+++|+++ +|||||+++|+|.+.+..++||||++
T Consensus 15 ~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV~ey~~ 94 (309)
T d1fvra_ 15 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAP 94 (309)
T ss_dssp EEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEECCCT
T ss_pred EEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEEEEecC
Confidence 3589999999999999864 43 5788888654 333456799999999999 79999999999999999999999999
Q ss_pred CCCHhhhhhCCCC----------CCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEccc
Q 005102 483 NGSLATALHGKPG----------MVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDF 552 (714)
Q Consensus 483 ~gsL~~~l~~~~~----------~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DF 552 (714)
+|+|.++++.... ......++|..+.+++.|||+||.|||+ ++|+||||||+|||++.++.+||+||
T Consensus 95 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~---~~iiHrDlkp~NIL~~~~~~~kl~Df 171 (309)
T d1fvra_ 95 HGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADF 171 (309)
T ss_dssp TCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECGGGCEEECCT
T ss_pred CCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhc---CCccccccccceEEEcCCCceEEccc
Confidence 9999999976421 0112569999999999999999999999 89999999999999999999999999
Q ss_pred chhhhhhccCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhC
Q 005102 553 GLARLANIAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITG 632 (714)
Q Consensus 553 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG 632 (714)
|+|+..... .......||..|+|||.+.+..++.++|||||||++|||++|
T Consensus 172 G~a~~~~~~-----------------------------~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~ 222 (309)
T d1fvra_ 172 GLSRGQEVY-----------------------------VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSL 222 (309)
T ss_dssp TCEESSCEE-----------------------------CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTT
T ss_pred ccccccccc-----------------------------ccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhc
Confidence 999754321 112234578899999999999999999999999999999997
Q ss_pred CCccccCCCCcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhhhhc
Q 005102 633 RTAVVQVGSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDALDRLIV 711 (714)
Q Consensus 633 ~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~ 711 (714)
..|+... .... +.+... ..+. .+..... ...++.+++.+||+.||++||||+||++.|+++..
T Consensus 223 ~~~p~~~-~~~~---~~~~~i-~~~~------~~~~~~~-----~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~ 285 (309)
T d1fvra_ 223 GGTPYCG-MTCA---ELYEKL-PQGY------RLEKPLN-----CDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 285 (309)
T ss_dssp SCCTTTT-CCHH---HHHHHG-GGTC------CCCCCTT-----BCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCCC-CCHH---HHHHHH-HhcC------CCCCCcc-----CCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 7543221 1122 222211 1111 1111111 22368899999999999999999999999999864
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.1e-46 Score=397.03 Aligned_cols=238 Identities=18% Similarity=0.215 Sum_probs=197.3
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeCCC---CchhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCC
Q 005102 409 FVLGKSGIGIVYKVVLE-DGHTLAVRRLGEG---GSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNG 484 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~g 484 (714)
+.||+|+||+||+|+++ +|+.||||++.+. .....+.+.+|+++|++++|||||++++++...+..++||||+.+|
T Consensus 47 ~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~e~~~~g 126 (350)
T d1rdqe_ 47 KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGG 126 (350)
T ss_dssp EEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTC
T ss_pred EEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccccccccc
Confidence 47999999999999985 5999999998653 2234567899999999999999999999999999999999999999
Q ss_pred CHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCC
Q 005102 485 SLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGS 564 (714)
Q Consensus 485 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~ 564 (714)
+|.+++... ..+++..++.|+.||+.||+|||+ ++||||||||+|||++.++.+||+|||+|+....
T Consensus 127 ~l~~~l~~~------~~l~e~~~~~i~~qi~~aL~yLH~---~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~---- 193 (350)
T d1rdqe_ 127 EMFSHLRRI------GRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG---- 193 (350)
T ss_dssp BHHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECSS----
T ss_pred chhhhHhhc------CCCCHHHHHHHHHHHHHHHHHHHh---CCEecCcCCHHHcccCCCCCEEeeeceeeeeccc----
Confidence 999999765 458999999999999999999999 8999999999999999999999999999986531
Q ss_pred CCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCccccCCCCcc
Q 005102 565 PTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGSSEM 644 (714)
Q Consensus 565 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~~~~~~~~~ 644 (714)
......||+.|||||++.+..++.++|||||||++|||+||+.||...
T Consensus 194 ---------------------------~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~----- 241 (350)
T d1rdqe_ 194 ---------------------------RTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFAD----- 241 (350)
T ss_dssp ---------------------------CBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS-----
T ss_pred ---------------------------ccccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCc-----
Confidence 112345799999999999999999999999999999999999999432
Q ss_pred hhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCC-----CHHHHHH
Q 005102 645 DLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRP-----TMRHISD 704 (714)
Q Consensus 645 ~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----t~~evl~ 704 (714)
+............... ... ....+.+++.+||+.||.+|+ |++|+++
T Consensus 242 ~~~~~~~~i~~~~~~~--------p~~-----~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 242 QPIQIYEKIVSGKVRF--------PSH-----FSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp SHHHHHHHHHHCCCCC--------CTT-----CCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred CHHHHHHHHhcCCCCC--------Ccc-----CCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence 2222233332222111 111 123578999999999999994 8888874
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-46 Score=387.90 Aligned_cols=257 Identities=20% Similarity=0.250 Sum_probs=191.6
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeCCCCchh-----HHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccC
Q 005102 409 FVLGKSGIGIVYKVVLE-DGHTLAVRRLGEGGSQR-----FKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIP 482 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~-----~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~ 482 (714)
++||+|+||+||+|+++ +|+.||||+++...... .+.+.+|+++|++++|||||++++++...+..|+||||+.
T Consensus 4 ~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~~ 83 (299)
T d1ua2a_ 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFME 83 (299)
T ss_dssp EEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECCS
T ss_pred eEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhhc
Confidence 47999999999999975 58999999997543221 2468899999999999999999999999999999999999
Q ss_pred CCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccC
Q 005102 483 NGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAG 562 (714)
Q Consensus 483 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 562 (714)
++++..+.... ..+++.++..|+.||+.||+|||+ ++|+||||||+|||+++++.+||+|||+|+......
T Consensus 84 ~~~~~~~~~~~------~~l~~~~~~~~~~qil~aL~~lH~---~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~ 154 (299)
T d1ua2a_ 84 TDLEVIIKDNS------LVLTPSHIKAYMLMTLQGLEYLHQ---HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN 154 (299)
T ss_dssp EEHHHHHTTCC------SSCCSSHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC
T ss_pred chHHhhhhhcc------cCCCHHHHHHHHHHHHHHHHHhhc---cceecccCCcceEEecCCCccccccCccccccCCCc
Confidence 88777666433 458889999999999999999999 999999999999999999999999999998654221
Q ss_pred CCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCC-CCCchhhhHHHHHHHHHHHhCCCccccCCC
Q 005102 563 GSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVV-KPSQKWDIYSYGVILLEMITGRTAVVQVGS 641 (714)
Q Consensus 563 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DVwS~Gvvl~elltG~~p~~~~~~ 641 (714)
.......||+.|+|||++.+. .++.++|||||||++|||+||+.||...
T Consensus 155 ----------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~-- 204 (299)
T d1ua2a_ 155 ----------------------------RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGD-- 204 (299)
T ss_dssp ----------------------------CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCS--
T ss_pred ----------------------------ccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCC--
Confidence 112234679999999998654 5799999999999999999999999432
Q ss_pred CcchhHHHHHHHHhhcC--CcccccC------CCCCCCCCcH----HHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 005102 642 SEMDLVNWMQLCIEEKK--PLADVLD------PYLAPDADKE----EEIIAVLKIAMACVHSSPEKRPTMRHISD 704 (714)
Q Consensus 642 ~~~~l~~~~~~~~~~~~--~~~~~~d------~~~~~~~~~~----~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 704 (714)
.+.+....+........ ....... -...+..... .....+.+++.+||+.||++|||++|+++
T Consensus 205 ~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~ 279 (299)
T d1ua2a_ 205 SDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279 (299)
T ss_dssp SHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred CHHHHHHHHHHhcCCCChhhccchhccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence 22222222221111000 0000000 0000000000 11246889999999999999999999975
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=2e-46 Score=397.32 Aligned_cols=242 Identities=21% Similarity=0.232 Sum_probs=190.5
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeCCCC---chhHHHH---HHHHHHHhccCCCCccceEEEEEeCCceeEEEecc
Q 005102 409 FVLGKSGIGIVYKVVLE-DGHTLAVRRLGEGG---SQRFKEF---QTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYI 481 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~---~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~ 481 (714)
++||+|+||+||+|++. +|+.||||++.+.. ......+ ..|+++++.++|||||++++++.+.+..|+||||+
T Consensus 10 ~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ivmE~~ 89 (364)
T d1omwa3 10 RIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLM 89 (364)
T ss_dssp EEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred eEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEEEEEEec
Confidence 57999999999999986 59999999986431 1112233 34577788889999999999999999999999999
Q ss_pred CCCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhcc
Q 005102 482 PNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIA 561 (714)
Q Consensus 482 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~ 561 (714)
++|+|.+++... ..+++..+..|+.||+.||+|||+ ++||||||||+|||+++++.+||+|||+|+.....
T Consensus 90 ~gg~L~~~l~~~------~~~~e~~~~~~~~qi~~aL~ylH~---~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~ 160 (364)
T d1omwa3 90 NGGDLHYHLSQH------GVFSEADMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK 160 (364)
T ss_dssp CSCBHHHHHHHH------CSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECSSSCEEECCCTTCEECSSS
T ss_pred CCCcHHHHHHhc------ccccHHHHHHHHHHHHHHHHHHHH---CCccceeeccceeEEcCCCcEEEeeeceeeecCCC
Confidence 999999999765 458899999999999999999999 99999999999999999999999999999865321
Q ss_pred CCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCC-CCCCchhhhHHHHHHHHHHHhCCCccccCC
Q 005102 562 GGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKV-VKPSQKWDIYSYGVILLEMITGRTAVVQVG 640 (714)
Q Consensus 562 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DVwS~Gvvl~elltG~~p~~~~~ 640 (714)
......||+.|+|||++.. ..++.++|||||||++|||+||+.||....
T Consensus 161 ------------------------------~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~ 210 (364)
T d1omwa3 161 ------------------------------KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHK 210 (364)
T ss_dssp ------------------------------CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSC
T ss_pred ------------------------------cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCC
Confidence 1223468999999999975 568999999999999999999999995443
Q ss_pred CCcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCC-----HHHHHH
Q 005102 641 SSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPT-----MRHISD 704 (714)
Q Consensus 641 ~~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt-----~~evl~ 704 (714)
... .....+..... .+...... ..++.+++.+||+.||++||| ++|+++
T Consensus 211 ~~~--~~~~~~~~~~~--------~~~~~~~~-----s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 211 TKD--KHEIDRMTLTM--------AVELPDSF-----SPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp SSC--HHHHHHHSSSC--------CCCCCSSS-----CHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred HHH--HHHHHHhcccC--------CCCCCCCC-----CHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence 322 11111111000 01111111 235789999999999999999 577764
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-46 Score=393.21 Aligned_cols=244 Identities=22% Similarity=0.312 Sum_probs=191.8
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeCCCCchhHHHHHHHHHHHhcc-CCCCccceEEEEEe----CCceeEEEeccC
Q 005102 409 FVLGKSGIGIVYKVVLE-DGHTLAVRRLGEGGSQRFKEFQTEVEAIGKI-RHSNIVTLRAYYWS----VDEKLLIYDYIP 482 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~----~~~~~lV~e~~~ 482 (714)
++||+|+||+||+|++. +++.||||+++.. +.+.+|++++.++ +|||||+++++|.+ ....|+|||||+
T Consensus 18 ~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ivmEy~~ 92 (335)
T d2ozaa1 18 QVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLD 92 (335)
T ss_dssp EEEEECSSCEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCC
T ss_pred EEeeeccCeEEEEEEECCCCCEEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEEEEECCC
Confidence 47999999999999974 5899999998643 4678899997665 89999999999875 356799999999
Q ss_pred CCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCC---CCCeEEcccchhhhhh
Q 005102 483 NGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGH---NMEPHVSDFGLARLAN 559 (714)
Q Consensus 483 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~---~~~~kl~DFGla~~~~ 559 (714)
+|+|.+++..... ..+++.++..|+.||+.||+|||+ ++|+||||||+|||+++ ++.+||+|||+|+...
T Consensus 93 gg~L~~~i~~~~~----~~l~e~~~~~i~~qi~~al~ylH~---~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~ 165 (335)
T d2ozaa1 93 GGELFSRIQDRGD----QAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT 165 (335)
T ss_dssp SEEHHHHHHSCSC----CCEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCSSTTCCEEECCCTTCEECC
T ss_pred CCcHHHHHHhcCC----CCcCHHHHHHHHHHHHHHHHHHHH---cCCccccccccccccccccccccccccccceeeecc
Confidence 9999999986532 469999999999999999999999 99999999999999985 5679999999998653
Q ss_pred ccCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCccccC
Q 005102 560 IAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQV 639 (714)
Q Consensus 560 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~~~~ 639 (714)
.. .......||+.|||||++.+..|+.++|||||||++|||+||+.||...
T Consensus 166 ~~-----------------------------~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~ 216 (335)
T d2ozaa1 166 SH-----------------------------NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSN 216 (335)
T ss_dssp CC-----------------------------CCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEET
T ss_pred CC-----------------------------CccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCC
Confidence 21 1123446899999999999999999999999999999999999999543
Q ss_pred CCCcchhHHHHHHHHhhcCCcccccCCCC-CCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 005102 640 GSSEMDLVNWMQLCIEEKKPLADVLDPYL-APDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISD 704 (714)
Q Consensus 640 ~~~~~~l~~~~~~~~~~~~~~~~~~d~~~-~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 704 (714)
.... ....+. ..+..... .+.........++.+++.+||+.||++|||++|+++
T Consensus 217 ~~~~--~~~~~~---------~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 271 (335)
T d2ozaa1 217 HGLA--ISPGMK---------TRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 271 (335)
T ss_dssp TCC-------------------CCCSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CHHH--HHHHHH---------HHHhcCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 2211 111110 00111111 111111223456889999999999999999999986
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=2.6e-46 Score=381.34 Aligned_cols=245 Identities=22% Similarity=0.335 Sum_probs=196.4
Q ss_pred cccccccCceEEEEEEEC-CCcEEEEEEeCCCCc---------hhHHHHHHHHHHHhccC-CCCccceEEEEEeCCceeE
Q 005102 408 AFVLGKSGIGIVYKVVLE-DGHTLAVRRLGEGGS---------QRFKEFQTEVEAIGKIR-HSNIVTLRAYYWSVDEKLL 476 (714)
Q Consensus 408 ~~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---------~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~l 476 (714)
.+.||+|+||+||+|+.. +|+.||||++..... ...+.+.+|+.++++++ ||||+++++++.+.+..|+
T Consensus 8 ~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~i 87 (277)
T d1phka_ 8 KEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFL 87 (277)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred ceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccCcceEE
Confidence 358999999999999975 589999999876421 12246889999999997 9999999999999999999
Q ss_pred EEeccCCCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhh
Q 005102 477 IYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLAR 556 (714)
Q Consensus 477 V~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~ 556 (714)
||||+++|+|.+++... ..+++.++++++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++
T Consensus 88 vmE~~~~g~L~~~l~~~------~~l~e~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nill~~~~~~kl~DFG~a~ 158 (277)
T d1phka_ 88 VFDLMKKGELFDYLTEK------VTLSEKETRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSC 158 (277)
T ss_dssp EEECCTTCBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred EEEcCCCchHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---cCCcccccccceEEEcCCCCeEEccchhee
Confidence 99999999999999755 469999999999999999999999 899999999999999999999999999998
Q ss_pred hhhccCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCC------CCCCchhhhHHHHHHHHHHH
Q 005102 557 LANIAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKV------VKPSQKWDIYSYGVILLEMI 630 (714)
Q Consensus 557 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~s~~~DVwS~Gvvl~ell 630 (714)
..... .......||+.|+|||.+.+ ..++.++||||+||++|||+
T Consensus 159 ~~~~~-----------------------------~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml 209 (277)
T d1phka_ 159 QLDPG-----------------------------EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLL 209 (277)
T ss_dssp ECCTT-----------------------------CCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHH
T ss_pred EccCC-----------------------------CceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhc
Confidence 65421 11233467999999999853 34688999999999999999
Q ss_pred hCCCccccCCCCcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 005102 631 TGRTAVVQVGSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISD 704 (714)
Q Consensus 631 tG~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 704 (714)
||+.||.... . ............... .+ .......++.+++.+||+.||++|||++||++
T Consensus 210 ~g~~Pf~~~~--~---~~~~~~i~~~~~~~~---~~------~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~ 269 (277)
T d1phka_ 210 AGSPPFWHRK--Q---MLMLRMIMSGNYQFG---SP------EWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269 (277)
T ss_dssp HSSCSSCCSS--H---HHHHHHHHHTCCCCC---TT------TGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred cCCCCCCCCC--H---HHHHHHHHhCCCCCC---Cc------ccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 9999995321 1 112222222222110 01 01112236889999999999999999999865
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-46 Score=390.80 Aligned_cols=244 Identities=18% Similarity=0.232 Sum_probs=197.7
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeCCCCchhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCCCHh
Q 005102 409 FVLGKSGIGIVYKVVLE-DGHTLAVRRLGEGGSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGSLA 487 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL~ 487 (714)
+.||+|+||+||+|.++ +|+.||||+++..... ...+.+|+++|++++|||||++++++.+.+..|+|||||++|+|.
T Consensus 11 ~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~-~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~~gg~L~ 89 (321)
T d1tkia_ 11 EDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD-QVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDIF 89 (321)
T ss_dssp EEEEECSSEEEEEEEETTTTEEEEEEEECCCTHH-HHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCCCBHH
T ss_pred EEEecCCCeEEEEEEECCCCcEEEEEEEcCCccc-HHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecCCCCcHH
Confidence 47999999999999986 5889999999875433 356889999999999999999999999999999999999999999
Q ss_pred hhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCC--CCeEEcccchhhhhhccCCCC
Q 005102 488 TALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHN--MEPHVSDFGLARLANIAGGSP 565 (714)
Q Consensus 488 ~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~--~~~kl~DFGla~~~~~~~~~~ 565 (714)
+++.... ..+++.++..|+.||+.||+|||+ .+|+||||||+|||++.+ ..+||+|||+++......
T Consensus 90 ~~i~~~~-----~~l~e~~~~~i~~qi~~al~yLH~---~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~--- 158 (321)
T d1tkia_ 90 ERINTSA-----FELNEREIVSYVHQVCEALQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD--- 158 (321)
T ss_dssp HHHTSSS-----CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC---
T ss_pred HHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHH---cCCCcccccccceeecCCCceEEEEcccchhhccccCC---
Confidence 9997653 358999999999999999999999 999999999999999854 589999999997643210
Q ss_pred CccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCccccCCCCcch
Q 005102 566 TLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGSSEMD 645 (714)
Q Consensus 566 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~~~~~~~~~~ 645 (714)
......+|+.|+|||...+..++.++||||+||++|||++|+.||....
T Consensus 159 --------------------------~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~----- 207 (321)
T d1tkia_ 159 --------------------------NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAET----- 207 (321)
T ss_dssp --------------------------EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSS-----
T ss_pred --------------------------cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCC-----
Confidence 1112346889999999999999999999999999999999999994321
Q ss_pred hHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 005102 646 LVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISD 704 (714)
Q Consensus 646 l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 704 (714)
..+.+.........+.....+. ...++.+++.+||..||++|||++|+++
T Consensus 208 ~~~~~~~i~~~~~~~~~~~~~~---------~s~~~~~li~~~L~~dp~~R~s~~eil~ 257 (321)
T d1tkia_ 208 NQQIIENIMNAEYTFDEEAFKE---------ISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp HHHHHHHHHHTCCCCCHHHHTT---------SCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHhCCCCCChhhccC---------CCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1222333333322221111111 1235789999999999999999999986
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-46 Score=392.01 Aligned_cols=240 Identities=21% Similarity=0.295 Sum_probs=194.7
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeCCC---CchhHHHHHHHHHHHh-ccCCCCccceEEEEEeCCceeEEEeccCC
Q 005102 409 FVLGKSGIGIVYKVVLE-DGHTLAVRRLGEG---GSQRFKEFQTEVEAIG-KIRHSNIVTLRAYYWSVDEKLLIYDYIPN 483 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~-~l~H~niv~l~~~~~~~~~~~lV~e~~~~ 483 (714)
+.||+|+||+||+|+++ +|+.||||++++. .....+.+.+|+.++. .++|||||++++++.+.+..|+||||+++
T Consensus 8 ~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yivmEy~~~ 87 (320)
T d1xjda_ 8 KMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNG 87 (320)
T ss_dssp EEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTT
T ss_pred eEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEEEeecCC
Confidence 58999999999999986 5899999999753 2233456778888776 68999999999999999999999999999
Q ss_pred CCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCC
Q 005102 484 GSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGG 563 (714)
Q Consensus 484 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~ 563 (714)
|+|.+++... ..+++.+++.++.||+.||+|||+ ++|+||||||+|||+++++++||+|||+|+.....
T Consensus 88 g~L~~~i~~~------~~~~e~~~~~~~~qi~~al~ylH~---~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~-- 156 (320)
T d1xjda_ 88 GDLMYHIQSC------HKFDLSRATFYAAEIILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG-- 156 (320)
T ss_dssp CBHHHHHHHH------SSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT--
T ss_pred CcHHHHhhcc------CCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCcccceeecCCCceeccccchhhhcccc--
Confidence 9999999765 458999999999999999999999 89999999999999999999999999999854321
Q ss_pred CCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCccccCCCCc
Q 005102 564 SPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGSSE 643 (714)
Q Consensus 564 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~~~~~~~~ 643 (714)
........||+.|+|||++.+..++.++|||||||++|||+||+.||... ..
T Consensus 157 --------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~--~~ 208 (320)
T d1xjda_ 157 --------------------------DAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQ--DE 208 (320)
T ss_dssp --------------------------TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS--SH
T ss_pred --------------------------cccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCC--CH
Confidence 11123346899999999999999999999999999999999999999432 22
Q ss_pred chhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHH-HHH
Q 005102 644 MDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMR-HIS 703 (714)
Q Consensus 644 ~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~-evl 703 (714)
. +.......... ..+... ..++.+++.+||+.||++|||+. |++
T Consensus 209 ~---~~~~~i~~~~~--------~~p~~~-----s~~~~dli~~~L~~dP~~R~s~~~~l~ 253 (320)
T d1xjda_ 209 E---ELFHSIRMDNP--------FYPRWL-----EKEAKDLLVKLFVREPEKRLGVRGDIR 253 (320)
T ss_dssp H---HHHHHHHHCCC--------CCCTTS-----CHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred H---HHHHHHHcCCC--------CCCccC-----CHHHHHHHHHhcccCCCCCcCHHHHHH
Confidence 2 22222222211 111111 23578999999999999999995 664
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-45 Score=379.45 Aligned_cols=255 Identities=24% Similarity=0.343 Sum_probs=190.6
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeCCCCc--hhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCCC
Q 005102 409 FVLGKSGIGIVYKVVLE-DGHTLAVRRLGEGGS--QRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGS 485 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gs 485 (714)
+.||+|+||+||+|++. +|+.||||+++.... ...+.+.+|+++|++++|||||++++++.+.+..|+||||+.+ +
T Consensus 8 ~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e~~~~-~ 86 (298)
T d1gz8a_ 8 EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-D 86 (298)
T ss_dssp EEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSE-E
T ss_pred cEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEeecCC-c
Confidence 47999999999999974 699999999975432 2346799999999999999999999999999999999999976 4
Q ss_pred HhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCCC
Q 005102 486 LATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSP 565 (714)
Q Consensus 486 L~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 565 (714)
+.+++..... ..+++..+..++.|++.||+|||+ ++||||||||+|||++.++.+||+|||+|+.....
T Consensus 87 ~~~~~~~~~~----~~l~e~~~~~~~~qil~~L~yLH~---~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~---- 155 (298)
T d1gz8a_ 87 LKKFMDASAL----TGIPLPLIKSYLFQLLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP---- 155 (298)
T ss_dssp HHHHHHHTTT----TCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCC----
T ss_pred hhhhhhhhcc----cCCCHHHHHHHHHHHHHHHHHhhc---CCEEccccCchheeecccCcceeccCCcceeccCC----
Confidence 4444433321 459999999999999999999999 89999999999999999999999999999876422
Q ss_pred CccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCC-CCchhhhHHHHHHHHHHHhCCCccccCCCCcc
Q 005102 566 TLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVK-PSQKWDIYSYGVILLEMITGRTAVVQVGSSEM 644 (714)
Q Consensus 566 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s~~~DVwS~Gvvl~elltG~~p~~~~~~~~~ 644 (714)
........||+.|+|||.+.... ++.++||||+||++|||++|+.||... +..
T Consensus 156 ------------------------~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~--~~~ 209 (298)
T d1gz8a_ 156 ------------------------VRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD--SEI 209 (298)
T ss_dssp ------------------------SBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCS--SHH
T ss_pred ------------------------cccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCC--CHH
Confidence 11223345789999999887665 588999999999999999999999532 111
Q ss_pred hhHHHHHHHHhhcCCcccccCC----------CCCC--CCCcH----HHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 005102 645 DLVNWMQLCIEEKKPLADVLDP----------YLAP--DADKE----EEIIAVLKIAMACVHSSPEKRPTMRHISD 704 (714)
Q Consensus 645 ~l~~~~~~~~~~~~~~~~~~d~----------~~~~--~~~~~----~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 704 (714)
+. +...........+..-+ .... ..... .....+.+++.+||+.||++|||++|+++
T Consensus 210 ~~---~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~ 282 (298)
T d1gz8a_ 210 DQ---LFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 282 (298)
T ss_dssp HH---HHHHHHHHCCCCTTTSTTGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HH---HHHHHHhcCCCchhhccccccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 11 11111111000110000 0000 00000 11246789999999999999999999987
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=9.1e-45 Score=373.54 Aligned_cols=257 Identities=22% Similarity=0.324 Sum_probs=192.6
Q ss_pred ccccccCceEEEEEEECCCcEEEEEEeCCCC--chhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCCCH
Q 005102 409 FVLGKSGIGIVYKVVLEDGHTLAVRRLGEGG--SQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGSL 486 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gsL 486 (714)
+.||+|+||+||+|++++|+.||||++.... ....+.+.+|+.+|++++|||||++++++...+..+++|||+.++.+
T Consensus 8 ~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~~~~~~~ 87 (286)
T d1ob3a_ 8 EKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLK 87 (286)
T ss_dssp EEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCSEEHH
T ss_pred cEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEeehhhhH
Confidence 4799999999999999999999999997653 22347899999999999999999999999999999999999988766
Q ss_pred hhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCCCC
Q 005102 487 ATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSPT 566 (714)
Q Consensus 487 ~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 566 (714)
..+.... ..+++..+..|+.||+.||+|||+ .+||||||||+|||++.++.+|++|||.|.......
T Consensus 88 ~~~~~~~------~~l~~~~~~~i~~qi~~~L~~LH~---~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~---- 154 (286)
T d1ob3a_ 88 KLLDVCE------GGLESVTAKSFLLQLLNGIAYCHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPV---- 154 (286)
T ss_dssp HHHHTST------TCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC------
T ss_pred HHHHhhc------CCcchhhhHHHHHHHHHHHHHhcc---CcEEecCCCCceeeEcCCCCEEecccccceecccCc----
Confidence 6665544 469999999999999999999999 899999999999999999999999999998764221
Q ss_pred ccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCC-CCCchhhhHHHHHHHHHHHhCCCccccCCCCcch
Q 005102 567 LQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVV-KPSQKWDIYSYGVILLEMITGRTAVVQVGSSEMD 645 (714)
Q Consensus 567 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DVwS~Gvvl~elltG~~p~~~~~~~~~~ 645 (714)
.......|++.|+|||.+.+. .++.++||||+||++|||++|+.||.... ..+
T Consensus 155 ------------------------~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~--~~~ 208 (286)
T d1ob3a_ 155 ------------------------RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVS--EAD 208 (286)
T ss_dssp -------------------------------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSS--HHH
T ss_pred ------------------------cccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCC--HHH
Confidence 112233468889999999764 46999999999999999999999995332 221
Q ss_pred hHHHHHHHHhhcC--C---cccc--cCCCCCC-CC-----CcHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 005102 646 LVNWMQLCIEEKK--P---LADV--LDPYLAP-DA-----DKEEEIIAVLKIAMACVHSSPEKRPTMRHISD 704 (714)
Q Consensus 646 l~~~~~~~~~~~~--~---~~~~--~d~~~~~-~~-----~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 704 (714)
...-+........ . .... .+..... .. ........+.+++.+||+.||++|||++|+++
T Consensus 209 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 209 QLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp HHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHHHHhhCCCChhhccchhhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1111111111000 0 0000 0000000 00 00111236789999999999999999999874
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-45 Score=375.87 Aligned_cols=233 Identities=19% Similarity=0.272 Sum_probs=187.9
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeCCCCc------hhHHHHHHHHHHHhccC--CCCccceEEEEEeCCceeEEEe
Q 005102 409 FVLGKSGIGIVYKVVLE-DGHTLAVRRLGEGGS------QRFKEFQTEVEAIGKIR--HSNIVTLRAYYWSVDEKLLIYD 479 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~--H~niv~l~~~~~~~~~~~lV~e 479 (714)
+.||+|+||+||+|+.. +|+.||||++.+... ....++.+|+.+|++++ |||||++++++.+.+..++|||
T Consensus 10 ~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~~~lv~e 89 (273)
T d1xwsa_ 10 PLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILE 89 (273)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEEEEEEE
T ss_pred EEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCeEEEEEE
Confidence 57999999999999975 589999999875321 11234678999999996 8999999999999999999999
Q ss_pred ccCC-CCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCC-CCCeEEcccchhhh
Q 005102 480 YIPN-GSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGH-NMEPHVSDFGLARL 557 (714)
Q Consensus 480 ~~~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~-~~~~kl~DFGla~~ 557 (714)
|+.+ +++.+++... ..+++.++..|+.||+.||+|||+ ++|+||||||+|||++. ++.+||+|||+|+.
T Consensus 90 ~~~~~~~l~~~~~~~------~~l~e~~~~~~~~qi~~al~~lH~---~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~ 160 (273)
T d1xwsa_ 90 RPEPVQDLFDFITER------GALQEELARSFFWQVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSGAL 160 (273)
T ss_dssp CCSSEEEHHHHHHHH------CSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred eccCcchHHHHHhcc------CCCCHHHHHHHHHHHHHHHHHHHH---CCCccccCcccceEEecCCCeEEECcccccee
Confidence 9976 6888887654 458999999999999999999999 99999999999999985 47999999999975
Q ss_pred hhccCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCC-CchhhhHHHHHHHHHHHhCCCcc
Q 005102 558 ANIAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKP-SQKWDIYSYGVILLEMITGRTAV 636 (714)
Q Consensus 558 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~~DVwS~Gvvl~elltG~~p~ 636 (714)
.... ......||+.|+|||++.+..+ +.++||||+||++|||+||+.||
T Consensus 161 ~~~~------------------------------~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf 210 (273)
T d1xwsa_ 161 LKDT------------------------------VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF 210 (273)
T ss_dssp CCSS------------------------------CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSC
T ss_pred cccc------------------------------cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCC
Confidence 4311 1223568999999999987665 67799999999999999999999
Q ss_pred ccCCCCcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 005102 637 VQVGSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISD 704 (714)
Q Consensus 637 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 704 (714)
... . ........ ..... ..++.+++.+||+.||++|||++|+++
T Consensus 211 ~~~----~-------~i~~~~~~--------~~~~~-----s~~~~~li~~~L~~dp~~R~s~~eil~ 254 (273)
T d1xwsa_ 211 EHD----E-------EIIRGQVF--------FRQRV-----SSECQHLIRWCLALRPSDRPTFEEIQN 254 (273)
T ss_dssp CSH----H-------HHHHCCCC--------CSSCC-----CHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCc----h-------HHhhcccC--------CCCCC-----CHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 421 1 11111111 11111 135789999999999999999999976
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-44 Score=371.18 Aligned_cols=257 Identities=22% Similarity=0.267 Sum_probs=187.9
Q ss_pred ccccccCceEEEEEEEC-C-CcEEEEEEeCCCC--chhHHHHHHHHHHHhcc---CCCCccceEEEEEe-----CCceeE
Q 005102 409 FVLGKSGIGIVYKVVLE-D-GHTLAVRRLGEGG--SQRFKEFQTEVEAIGKI---RHSNIVTLRAYYWS-----VDEKLL 476 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~-~-g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~H~niv~l~~~~~~-----~~~~~l 476 (714)
+.||+|+||+||+|++. + ++.||||+++... ......+.+|+++|+.+ +||||++++++|.. ....++
T Consensus 13 ~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~~~~~~~ 92 (305)
T d1blxa_ 13 AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTL 92 (305)
T ss_dssp EEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEEEEEE
T ss_pred EEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccccCceEEE
Confidence 47999999999999974 4 6679999986532 12223567788887766 79999999999863 246789
Q ss_pred EEeccCCCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhh
Q 005102 477 IYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLAR 556 (714)
Q Consensus 477 V~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~ 556 (714)
+|||+.++++........ ..+++..++.++.|++.||+|||+ ++||||||||+|||+++++.+||+|||+++
T Consensus 93 ~~e~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~qi~~aL~yLH~---~~ivHrDiKp~NILi~~~~~~kl~dfg~~~ 164 (305)
T d1blxa_ 93 VFEHVDQDLTTYLDKVPE-----PGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLAR 164 (305)
T ss_dssp EEECCSCBHHHHHHHSCT-----TCSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECSCCSCC
T ss_pred EEEeccCCchhhhhhccC-----CCCCHHHHHHHHHHHHHHHHHHHh---CCEEecCCCccEEEEcCCCCeeecchhhhh
Confidence 999998877765554433 458999999999999999999999 999999999999999999999999999987
Q ss_pred hhhccCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCcc
Q 005102 557 LANIAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAV 636 (714)
Q Consensus 557 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~ 636 (714)
.... ........||+.|+|||++.+..++.++||||+||++|||+||+.||
T Consensus 165 ~~~~-----------------------------~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf 215 (305)
T d1blxa_ 165 IYSF-----------------------------QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLF 215 (305)
T ss_dssp CCCG-----------------------------GGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred hhcc-----------------------------cccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCC
Confidence 5422 12234556899999999999999999999999999999999999999
Q ss_pred ccCCCCcchhHHHHHHHHhhcC--------Cccc-ccCCCCCCCC--CcHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 005102 637 VQVGSSEMDLVNWMQLCIEEKK--------PLAD-VLDPYLAPDA--DKEEEIIAVLKIAMACVHSSPEKRPTMRHISD 704 (714)
Q Consensus 637 ~~~~~~~~~l~~~~~~~~~~~~--------~~~~-~~d~~~~~~~--~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 704 (714)
... ...+...-+........ .... .......... ........+.+|+.+||+.||++|||++|+++
T Consensus 216 ~~~--~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~ 292 (305)
T d1blxa_ 216 RGS--SDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292 (305)
T ss_dssp CCS--SHHHHHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CCC--CHHHHHHHHHHhhCCCchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 532 22222111111111000 0000 0000000000 00011235778999999999999999999975
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-43 Score=365.89 Aligned_cols=261 Identities=18% Similarity=0.241 Sum_probs=189.2
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeCCC--CchhHHHHHHHHHHHhccCCCCccceEEEEEe--------CCceeEE
Q 005102 409 FVLGKSGIGIVYKVVLE-DGHTLAVRRLGEG--GSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWS--------VDEKLLI 477 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~--------~~~~~lV 477 (714)
+.||+|+||+||+|++. +|+.||||++... .....+++.+|+++|++++||||+++++++.. .+..++|
T Consensus 16 ~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~~~~~iv 95 (318)
T d3blha1 16 AKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLV 95 (318)
T ss_dssp EEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC----------CEEEE
T ss_pred EEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccCceEEEE
Confidence 47999999999999975 6999999998654 22334678999999999999999999999865 3467999
Q ss_pred EeccCCCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhh
Q 005102 478 YDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARL 557 (714)
Q Consensus 478 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 557 (714)
|||+.++.+....... ..++...++.|+.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++.
T Consensus 96 ~e~~~~~~~~~~~~~~------~~~~~~~~~~i~~qil~~l~~lH~---~~ivHrDlKp~NILl~~~~~~kl~dfg~~~~ 166 (318)
T d3blha1 96 FDFCEHDLAGLLSNVL------VKFTLSEIKRVMQMLLNGLYYIHR---NKILHRDMKAANVLITRDGVLKLADFGLARA 166 (318)
T ss_dssp EECCCEEHHHHHTCTT------CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred EeccCCCccchhhhcc------cccccHHHHHHHHHHHHHHHHhcc---CCEEecCcCchheeecCCCcEEeeecceeee
Confidence 9999887666554333 458899999999999999999999 8999999999999999999999999999976
Q ss_pred hhccCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCC-CCCchhhhHHHHHHHHHHHhCCCcc
Q 005102 558 ANIAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVV-KPSQKWDIYSYGVILLEMITGRTAV 636 (714)
Q Consensus 558 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DVwS~Gvvl~elltG~~p~ 636 (714)
....... .........||+.|+|||.+.+. .+++++||||+||++|||++|+.||
T Consensus 167 ~~~~~~~------------------------~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf 222 (318)
T d3blha1 167 FSLAKNS------------------------QPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIM 222 (318)
T ss_dssp CCC-----------------------------CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred ccccccc------------------------ccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCC
Confidence 5422110 01122345689999999998765 5899999999999999999999999
Q ss_pred ccCCCCcchhHHHHHHHHhhcC-CcccccC---------CCCCCCCCcHH------HHHHHHHHHhHccCCCCCCCCCHH
Q 005102 637 VQVGSSEMDLVNWMQLCIEEKK-PLADVLD---------PYLAPDADKEE------EIIAVLKIAMACVHSSPEKRPTMR 700 (714)
Q Consensus 637 ~~~~~~~~~l~~~~~~~~~~~~-~~~~~~d---------~~~~~~~~~~~------~~~~l~~li~~Cl~~dP~~RPt~~ 700 (714)
... .+......+........ ......+ ..........+ ....+.+|+.+||+.||++|||++
T Consensus 223 ~~~--~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~ 300 (318)
T d3blha1 223 QGN--TEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSD 300 (318)
T ss_dssp CCS--SHHHHHHHHHHHHCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHH
T ss_pred CCC--CHHHHHHHHHHhcCCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHH
Confidence 432 22222222222211100 0000000 00000111111 123567899999999999999999
Q ss_pred HHHH
Q 005102 701 HISD 704 (714)
Q Consensus 701 evl~ 704 (714)
|+++
T Consensus 301 elL~ 304 (318)
T d3blha1 301 DALN 304 (318)
T ss_dssp HHHH
T ss_pred HHHc
Confidence 9975
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.2e-43 Score=363.49 Aligned_cols=258 Identities=16% Similarity=0.181 Sum_probs=192.5
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeCCCCchhHHHHHHHHHHHhccCCCCccc-eEEEEEeCCceeEEEeccCCCCH
Q 005102 409 FVLGKSGIGIVYKVVLE-DGHTLAVRRLGEGGSQRFKEFQTEVEAIGKIRHSNIVT-LRAYYWSVDEKLLIYDYIPNGSL 486 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~-l~~~~~~~~~~~lV~e~~~~gsL 486 (714)
+.||+|+||+||+|++. +|+.||||++...... +++.+|++++++++|+|++. +.+++...+..++||||+ +|++
T Consensus 13 ~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~-~~~l 89 (299)
T d1ckia_ 13 RKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPSL 89 (299)
T ss_dssp EEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS--CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECC-CCBH
T ss_pred EEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC--HHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEEc-CCch
Confidence 47999999999999975 5899999998764332 45789999999998776555 455556777889999999 5577
Q ss_pred hhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeC---CCCCeEEcccchhhhhhccCC
Q 005102 487 ATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLG---HNMEPHVSDFGLARLANIAGG 563 (714)
Q Consensus 487 ~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~---~~~~~kl~DFGla~~~~~~~~ 563 (714)
.+.+.... ..+++..+..++.|++.||+|||+ ++|+||||||+|||++ .+..+||+|||+|+.......
T Consensus 90 ~~~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~---~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~ 161 (299)
T d1ckia_ 90 EDLFNFCS-----RKFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDART 161 (299)
T ss_dssp HHHHHHTT-----TCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTT
T ss_pred hhhhhhcc-----CCCcHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHhhccccccCCCceeeeeccCcceecccccc
Confidence 77665443 468999999999999999999999 9999999999999975 456799999999997654321
Q ss_pred CCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCccccCCCCc
Q 005102 564 SPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGSSE 643 (714)
Q Consensus 564 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~~~~~~~~ 643 (714)
... ..........||+.|||||.+.+..++.++|||||||++|||+||+.||.......
T Consensus 162 ~~~---------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~ 220 (299)
T d1ckia_ 162 HQH---------------------IPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAAT 220 (299)
T ss_dssp CCB---------------------CCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC---
T ss_pred ccc---------------------eeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHH
Confidence 110 00122345578999999999999999999999999999999999999995443322
Q ss_pred chhHHHHHHHHhh--cCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhhhh
Q 005102 644 MDLVNWMQLCIEE--KKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDALDRLI 710 (714)
Q Consensus 644 ~~l~~~~~~~~~~--~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~ 710 (714)
.. ..+...... ..+... ..+ . ...++.+++..||+.||++||+++++.+.|+.+.
T Consensus 221 ~~--~~~~~~~~~~~~~~~~~-~~~----~-----~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~ 277 (299)
T d1ckia_ 221 KR--QKYERISEKKMSTPIEV-LCK----G-----YPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLF 277 (299)
T ss_dssp ------HHHHHHHHHHSCHHH-HTT----T-----SCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHH
T ss_pred HH--HHHHHhhcccCCCChhH-hcc----C-----CCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHH
Confidence 11 111111111 111111 111 1 1236889999999999999999999999998864
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=1.2e-42 Score=358.30 Aligned_cols=259 Identities=14% Similarity=0.154 Sum_probs=201.3
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeCCCCchhHHHHHHHHHHHhccCC-CCccceEEEEEeCCceeEEEeccCCCCH
Q 005102 409 FVLGKSGIGIVYKVVLE-DGHTLAVRRLGEGGSQRFKEFQTEVEAIGKIRH-SNIVTLRAYYWSVDEKLLIYDYIPNGSL 486 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H-~niv~l~~~~~~~~~~~lV~e~~~~gsL 486 (714)
+.||+|+||+||+|++. +|+.||||++...... ..+.+|+++++.++| +|++.+++++......++||||+ +|+|
T Consensus 11 ~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~~-~~~l 87 (293)
T d1csna_ 11 RRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-GPSL 87 (293)
T ss_dssp EEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS--CCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-CCBH
T ss_pred EEEecCCCeEEEEEEECCCCCEEEEEEEccccCc--HHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEec-CCCH
Confidence 47999999999999976 5899999998654322 356789999999965 89999999999999999999999 6899
Q ss_pred hhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCC-----CCCeEEcccchhhhhhcc
Q 005102 487 ATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGH-----NMEPHVSDFGLARLANIA 561 (714)
Q Consensus 487 ~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~-----~~~~kl~DFGla~~~~~~ 561 (714)
.+++.... ..+++.++..++.|++.||+|||+ ++|+||||||+|||++. ++.+||+|||+|+.....
T Consensus 88 ~~~~~~~~-----~~~~~~~~~~i~~q~~~~l~~lH~---~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~ 159 (293)
T d1csna_ 88 EDLLDLCG-----RKFSVKTVAMAAKQMLARVQSIHE---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDP 159 (293)
T ss_dssp HHHHHHTT-----TCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCT
T ss_pred HHHHHhhc-----cchhhHHHHHHHHHHHHHHHHHHH---CCceeccCCccceeecCcccccCCceEEcccceeEEcccC
Confidence 99987653 458999999999999999999999 99999999999999974 578999999999976533
Q ss_pred CCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCccccCCC
Q 005102 562 GGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQVGS 641 (714)
Q Consensus 562 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~~~~~~ 641 (714)
...... .........||+.|||||++.+..++.++|||||||++|||+||+.||.....
T Consensus 160 ~~~~~~---------------------~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~ 218 (293)
T d1csna_ 160 VTKQHI---------------------PYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKA 218 (293)
T ss_dssp TTCCBC---------------------CCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCS
T ss_pred ccccce---------------------eecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccc
Confidence 211100 01223456789999999999999999999999999999999999999954332
Q ss_pred CcchhHHHHHHHHhh--cCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHHHHhhhhc
Q 005102 642 SEMDLVNWMQLCIEE--KKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISDALDRLIV 711 (714)
Q Consensus 642 ~~~~l~~~~~~~~~~--~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~~L~~i~~ 711 (714)
... .......... .....+. .+.+ +.++.+++..|+..+|++||+++.+.+.|+++..
T Consensus 219 ~~~--~~~~~~i~~~~~~~~~~~l-~~~~---------p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~ 278 (293)
T d1csna_ 219 ATN--KQKYERIGEKKQSTPLREL-CAGF---------PEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLE 278 (293)
T ss_dssp CCH--HHHHHHHHHHHHHSCHHHH-TTTS---------CHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHH
T ss_pred hhH--HHHHHHHHhccCCCChHHh-cCCC---------CHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHH
Confidence 221 1111111111 1111111 1111 1358889999999999999999999999988764
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-43 Score=369.77 Aligned_cols=256 Identities=23% Similarity=0.338 Sum_probs=184.0
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeCCCCchhHHHHHHHHHHHhccCCCCccceEEEEEeC------CceeEEEecc
Q 005102 409 FVLGKSGIGIVYKVVLE-DGHTLAVRRLGEGGSQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSV------DEKLLIYDYI 481 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~------~~~~lV~e~~ 481 (714)
++||+|+||+||+|++. +|+.||||++...... +.+|+++|++++||||++++++|... .+.++||||+
T Consensus 26 k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~----~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~Ey~ 101 (350)
T d1q5ka_ 26 KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF----KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV 101 (350)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS----CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEEEECC
T ss_pred eEEeeCcCeEEEEEEECCCCCEEEEEEECccchH----HHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEEEecc
Confidence 47999999999999986 5899999999765432 34799999999999999999998643 2468999999
Q ss_pred CCCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCC-CeEEcccchhhhhhc
Q 005102 482 PNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNM-EPHVSDFGLARLANI 560 (714)
Q Consensus 482 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~-~~kl~DFGla~~~~~ 560 (714)
+++.+..+.+.... ...+++.+++.|+.||+.||+|||+ ++|+||||||+|||++.++ .+||+|||+++....
T Consensus 102 ~~~~~~~l~~~~~~---~~~l~~~~~~~i~~qil~aL~yLH~---~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~ 175 (350)
T d1q5ka_ 102 PETVYRVARHYSRA---KQTLPVIYVKLYMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR 175 (350)
T ss_dssp SEEHHHHHHHHHHT---TCCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTTCCEEECCCTTCEECCT
T ss_pred CCccHHHHHhhhhc---cCCCCHHHHHHHHHHHHHHHHHHHh---cCCcccCCCcceEEEecCCCceeEecccchhhccC
Confidence 87644443321111 1469999999999999999999999 9999999999999999775 899999999986532
Q ss_pred cCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCC-CCCCchhhhHHHHHHHHHHHhCCCccccC
Q 005102 561 AGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKV-VKPSQKWDIYSYGVILLEMITGRTAVVQV 639 (714)
Q Consensus 561 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DVwS~Gvvl~elltG~~p~~~~ 639 (714)
.. ......||+.|+|||.+.+ ..++.++||||+||++|||++|+.||...
T Consensus 176 ~~-----------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~ 226 (350)
T d1q5ka_ 176 GE-----------------------------PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGD 226 (350)
T ss_dssp TS-----------------------------CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCS
T ss_pred Cc-----------------------------ccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCC
Confidence 11 1223457889999998865 46899999999999999999999999533
Q ss_pred CCCcchhHHHHHH-------HH-hhcCCcccccCCCCCCC----CCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 005102 640 GSSEMDLVNWMQL-------CI-EEKKPLADVLDPYLAPD----ADKEEEIIAVLKIAMACVHSSPEKRPTMRHISD 704 (714)
Q Consensus 640 ~~~~~~l~~~~~~-------~~-~~~~~~~~~~d~~~~~~----~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 704 (714)
... ..+...... .. .......+..-+..... .........+.+|+.+||+.||++|||++|+++
T Consensus 227 ~~~-~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 302 (350)
T d1q5ka_ 227 SGV-DQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 302 (350)
T ss_dssp SHH-HHHHHHHHHHCCCCHHHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CHH-HHHHHHHHHhCCChHHhhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 211 111111110 00 00000000000000000 000112235789999999999999999999985
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-42 Score=359.35 Aligned_cols=258 Identities=19% Similarity=0.233 Sum_probs=196.8
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeCCCC--chhHHHHHHHHHHHhccCCCCccceEEEEEeCCceeEEEeccCCCC
Q 005102 409 FVLGKSGIGIVYKVVLE-DGHTLAVRRLGEGG--SQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVDEKLLIYDYIPNGS 485 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~e~~~~gs 485 (714)
+.||+|+||+||+|++. +|+.||||+++... ....+++.+|+.+|++++||||+++++++...+..++||||+.+++
T Consensus 8 ~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~~~~~~~ 87 (292)
T d1unla_ 8 EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDL 87 (292)
T ss_dssp EEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCSEEH
T ss_pred eEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEeeeccccc
Confidence 47999999999999975 58999999986542 3345789999999999999999999999999999999999999999
Q ss_pred HhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccCCCC
Q 005102 486 LATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAGGSP 565 (714)
Q Consensus 486 L~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 565 (714)
+..++... ..+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||.|+......
T Consensus 88 l~~~~~~~------~~~~~~~~~~~~~q~~~aL~~lH~---~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~--- 155 (292)
T d1unla_ 88 KKYFDSCN------GDLDPEIVKSFLFQLLKGLGFCHS---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV--- 155 (292)
T ss_dssp HHHHHHTT------TCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCC---
T ss_pred cccccccc------cccchhHHHHHHHHHHHHHHHhhc---CCEeeecccCcccccccCCceeeeecchhhcccCCC---
Confidence 98888755 458899999999999999999999 899999999999999999999999999998654221
Q ss_pred CccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCC-CCchhhhHHHHHHHHHHHhCCCccccCCCCcc
Q 005102 566 TLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVK-PSQKWDIYSYGVILLEMITGRTAVVQVGSSEM 644 (714)
Q Consensus 566 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s~~~DVwS~Gvvl~elltG~~p~~~~~~~~~ 644 (714)
.......+++.|+|||.+.+.. ++.++||||+||++|||++|+.||...... .
T Consensus 156 -------------------------~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~-~ 209 (292)
T d1unla_ 156 -------------------------RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDV-D 209 (292)
T ss_dssp -------------------------SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSH-H
T ss_pred -------------------------ccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCH-H
Confidence 1122334577899999987665 699999999999999999999998543322 2
Q ss_pred hhHHHHHHHHhhcC--C---cccccCC----CC----CCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 005102 645 DLVNWMQLCIEEKK--P---LADVLDP----YL----APDADKEEEIIAVLKIAMACVHSSPEKRPTMRHISD 704 (714)
Q Consensus 645 ~l~~~~~~~~~~~~--~---~~~~~d~----~~----~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 704 (714)
+...-+........ . .....+. .. ............+.+|+.+||+.||.+|||++|+++
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~ 282 (292)
T d1unla_ 210 DQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp HHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred HHHHHHHhhcCCCChhhhhhhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 22221111111100 0 0000000 00 000001112235789999999999999999999875
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-42 Score=364.16 Aligned_cols=255 Identities=24% Similarity=0.322 Sum_probs=185.7
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeCCCC--chhHHHHHHHHHHHhccCCCCccceEEEEEeCC------ceeEEEe
Q 005102 409 FVLGKSGIGIVYKVVLE-DGHTLAVRRLGEGG--SQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVD------EKLLIYD 479 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~------~~~lV~e 479 (714)
+.||+|+||+||+|.+. +|+.||||+++... ....+.+.+|+++|++++|||||+++++|...+ +.|+|||
T Consensus 24 ~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e 103 (346)
T d1cm8a_ 24 QPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMP 103 (346)
T ss_dssp EEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCEEEEE
T ss_pred EEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccceEEEEEe
Confidence 47999999999999975 59999999998642 333567899999999999999999999998654 4699999
Q ss_pred ccCCCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhh
Q 005102 480 YIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLAN 559 (714)
Q Consensus 480 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~ 559 (714)
|+ +++|..+.+. ..+++..++.++.||+.||+|||+ ++|+||||||+|||++.++.+|++|||+|+...
T Consensus 104 ~~-~~~l~~~~~~-------~~l~~~~~~~~~~qi~~aL~~LH~---~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~ 172 (346)
T d1cm8a_ 104 FM-GTDLGKLMKH-------EKLGEDRIQFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQAD 172 (346)
T ss_dssp CC-SEEHHHHHHH-------CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred cc-cccHHHHHHh-------ccccHHHHHHHHHHHHHHHHHHHh---CCCcccccCcchhhcccccccccccccceeccC
Confidence 99 5688887753 359999999999999999999999 999999999999999999999999999997543
Q ss_pred ccCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCC-CCCchhhhHHHHHHHHHHHhCCCcccc
Q 005102 560 IAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVV-KPSQKWDIYSYGVILLEMITGRTAVVQ 638 (714)
Q Consensus 560 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~DVwS~Gvvl~elltG~~p~~~ 638 (714)
. ......||+.|+|||.+.+. .++.++||||+||++|||++|+.||..
T Consensus 173 ~-------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~ 221 (346)
T d1cm8a_ 173 S-------------------------------EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKG 221 (346)
T ss_dssp S-------------------------------SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCC
T ss_pred C-------------------------------ccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCC
Confidence 1 12334578999999998764 569999999999999999999999943
Q ss_pred CCCCcchhHHHHHHHHhhcCCccccc--------------CCCCCC-CC--CcHHHHHHHHHHHhHccCCCCCCCCCHHH
Q 005102 639 VGSSEMDLVNWMQLCIEEKKPLADVL--------------DPYLAP-DA--DKEEEIIAVLKIAMACVHSSPEKRPTMRH 701 (714)
Q Consensus 639 ~~~~~~~l~~~~~~~~~~~~~~~~~~--------------d~~~~~-~~--~~~~~~~~l~~li~~Cl~~dP~~RPt~~e 701 (714)
.. ..+.......... ....+.. .+.... .. ........+.+|+.+||..||++|||++|
T Consensus 222 ~~--~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e 297 (346)
T d1cm8a_ 222 SD--HLDQLKEIMKVTG--TPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGE 297 (346)
T ss_dssp SS--HHHHHHHHHHHHC--CCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred CC--hHHHHHHHHhccC--CCcHHHHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHH
Confidence 31 1111111111000 0000000 000000 00 00011235779999999999999999999
Q ss_pred HHHH--Hhhh
Q 005102 702 ISDA--LDRL 709 (714)
Q Consensus 702 vl~~--L~~i 709 (714)
+++- ++++
T Consensus 298 iL~Hp~f~~~ 307 (346)
T d1cm8a_ 298 ALAHPYFESL 307 (346)
T ss_dssp HHHSGGGTTT
T ss_pred HhcChhhCcC
Confidence 9863 4443
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-42 Score=364.36 Aligned_cols=258 Identities=21% Similarity=0.283 Sum_probs=188.2
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeCCCC-chhHHHHHHHHHHHhccCCCCccceEEEEEeCC----ceeEEEeccC
Q 005102 409 FVLGKSGIGIVYKVVLE-DGHTLAVRRLGEGG-SQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSVD----EKLLIYDYIP 482 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~----~~~lV~e~~~ 482 (714)
+.||+|+||+||+|+.. +|+.||||++.+.. ....+.+.+|+++|++++||||+++++++.... ..+++++|+.
T Consensus 14 ~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~l~~~~~ 93 (345)
T d1pmea_ 14 SYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLM 93 (345)
T ss_dssp EECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEEEECC
T ss_pred EEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEEEEEeec
Confidence 47999999999999974 69999999997653 334568899999999999999999999997643 2355566677
Q ss_pred CCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhccC
Q 005102 483 NGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANIAG 562 (714)
Q Consensus 483 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~~~ 562 (714)
+|+|.+++... .+++..++.++.|++.||+|||+ ++||||||||+|||+++++.+||+|||+|+......
T Consensus 94 ~g~L~~~l~~~-------~l~~~~i~~i~~qil~al~yLH~---~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~ 163 (345)
T d1pmea_ 94 GADLYKLLKTQ-------HLSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH 163 (345)
T ss_dssp CEEHHHHHHHC-------CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGG
T ss_pred CCchhhhhhcC-------CCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCCCcceEEECCCCCEEEcccCceeeccCCC
Confidence 99999999643 48999999999999999999999 899999999999999999999999999998654321
Q ss_pred CCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCC-CCCCchhhhHHHHHHHHHHHhCCCccccCCC
Q 005102 563 GSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKV-VKPSQKWDIYSYGVILLEMITGRTAVVQVGS 641 (714)
Q Consensus 563 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~DVwS~Gvvl~elltG~~p~~~~~~ 641 (714)
.. ........||+.|+|||.+.. ..++.++||||+||++|||++|+.||....
T Consensus 164 ~~-------------------------~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~- 217 (345)
T d1pmea_ 164 DH-------------------------TGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKH- 217 (345)
T ss_dssp CB-------------------------CCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSS-
T ss_pred cc-------------------------ceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCC-
Confidence 10 112234567999999999854 557899999999999999999999994332
Q ss_pred CcchhHHHHHHHHhhcCC----------ccc--ccCCCCCCCCCcH----HHHHHHHHHHhHccCCCCCCCCCHHHHHH
Q 005102 642 SEMDLVNWMQLCIEEKKP----------LAD--VLDPYLAPDADKE----EEIIAVLKIAMACVHSSPEKRPTMRHISD 704 (714)
Q Consensus 642 ~~~~l~~~~~~~~~~~~~----------~~~--~~d~~~~~~~~~~----~~~~~l~~li~~Cl~~dP~~RPt~~evl~ 704 (714)
..+.............. ... ...+.... .... ....++.+++.+||+.||++|||++|+++
T Consensus 218 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~ 294 (345)
T d1pmea_ 218 -YLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNK-VPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 294 (345)
T ss_dssp -HHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCC-CCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred -HHHHHHHHhhhccCCChhhhhhhhhhhhhcccccCCccCC-CCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 11111111111100000 000 00000000 0000 01125789999999999999999999986
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=2.7e-42 Score=362.24 Aligned_cols=251 Identities=19% Similarity=0.258 Sum_probs=189.3
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeCCCCchhHHHHHHHHHHHhccC-CCCccceEEEEEeC--CceeEEEeccCCC
Q 005102 409 FVLGKSGIGIVYKVVLE-DGHTLAVRRLGEGGSQRFKEFQTEVEAIGKIR-HSNIVTLRAYYWSV--DEKLLIYDYIPNG 484 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~--~~~~lV~e~~~~g 484 (714)
+.||+|+||+||+|+.. +|+.||||+++... .+++.+|+++|++++ ||||+++++++... ...++||||+++|
T Consensus 41 ~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e~~~~~ 117 (328)
T d3bqca1 41 RKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNT 117 (328)
T ss_dssp EEEEECSSEEEEEEEETTTTEEEEEEEECSSC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEECCCSC
T ss_pred EEEecCcCeEEEEEEECCCCCEEEEEEECHHH---HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEeecCCC
Confidence 47999999999999984 58999999997643 367899999999995 99999999999754 5689999999999
Q ss_pred CHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCC-CeEEcccchhhhhhccCC
Q 005102 485 SLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNM-EPHVSDFGLARLANIAGG 563 (714)
Q Consensus 485 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~-~~kl~DFGla~~~~~~~~ 563 (714)
+|..+. +.+++..++.++.||+.||+|||+ ++|+||||||+|||++.++ .+||+|||+|+......
T Consensus 118 ~L~~~~---------~~l~e~~i~~i~~qil~aL~~LH~---~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~- 184 (328)
T d3bqca1 118 DFKQLY---------QTLTDYDIRFYMYEILKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ- 184 (328)
T ss_dssp BGGGTT---------TSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTTC-
T ss_pred cHHHHh---------cCCCHHHHHHHHHHHHHHHHHHhh---cccccccccccceEEcCCCCeeeecccccceeccCCC-
Confidence 997764 458999999999999999999999 9999999999999998655 68999999998654211
Q ss_pred CCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCC-CCchhhhHHHHHHHHHHHhCCCccccCCCC
Q 005102 564 SPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVK-PSQKWDIYSYGVILLEMITGRTAVVQVGSS 642 (714)
Q Consensus 564 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s~~~DVwS~Gvvl~elltG~~p~~~~~~~ 642 (714)
......+|+.|+|||.+.+.. ++.++||||+||++|||++|+.||......
T Consensus 185 ----------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~ 236 (328)
T d3bqca1 185 ----------------------------EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN 236 (328)
T ss_dssp ----------------------------CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSH
T ss_pred ----------------------------cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchh
Confidence 123345788999999987654 799999999999999999999999544332
Q ss_pred cchhHHHHHHHH---------h-hcCC----cccccCCC-------CCCCCCcHHHHHHHHHHHhHccCCCCCCCCCHHH
Q 005102 643 EMDLVNWMQLCI---------E-EKKP----LADVLDPY-------LAPDADKEEEIIAVLKIAMACVHSSPEKRPTMRH 701 (714)
Q Consensus 643 ~~~l~~~~~~~~---------~-~~~~----~~~~~d~~-------~~~~~~~~~~~~~l~~li~~Cl~~dP~~RPt~~e 701 (714)
...... +.... . .... ........ ............++.+|+.+||+.||++|||++|
T Consensus 237 ~~~~~~-i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e 315 (328)
T d3bqca1 237 YDQLVR-IAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTARE 315 (328)
T ss_dssp HHHHHH-HHHHHCHHHHHHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHH
T ss_pred HHHHHH-HHHHHCCchhhhhhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHH
Confidence 211111 11100 0 0000 00000000 0001111122346789999999999999999999
Q ss_pred HHH
Q 005102 702 ISD 704 (714)
Q Consensus 702 vl~ 704 (714)
+++
T Consensus 316 ~L~ 318 (328)
T d3bqca1 316 AME 318 (328)
T ss_dssp HHT
T ss_pred Hhc
Confidence 975
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-42 Score=362.18 Aligned_cols=247 Identities=23% Similarity=0.263 Sum_probs=193.1
Q ss_pred cccccccCceEEEEEEEC----CCcEEEEEEeCCCC----chhHHHHHHHHHHHhccCC-CCccceEEEEEeCCceeEEE
Q 005102 408 AFVLGKSGIGIVYKVVLE----DGHTLAVRRLGEGG----SQRFKEFQTEVEAIGKIRH-SNIVTLRAYYWSVDEKLLIY 478 (714)
Q Consensus 408 ~~~lG~G~~g~Vy~~~~~----~g~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~H-~niv~l~~~~~~~~~~~lV~ 478 (714)
.+.||+|+||+||+|+.. +|+.||||+++... ....+.+.+|++++++++| |||+++++++.+.+..++||
T Consensus 29 ~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~~~~v~ 108 (322)
T d1vzoa_ 29 LKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLIL 108 (322)
T ss_dssp EEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEEEEE
T ss_pred EEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCceeeee
Confidence 347999999999999862 47899999987532 2234568899999999976 89999999999999999999
Q ss_pred eccCCCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhh
Q 005102 479 DYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLA 558 (714)
Q Consensus 479 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~ 558 (714)
||+.+|+|.+++... ..++...+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+|+.+
T Consensus 109 e~~~~~~L~~~i~~~------~~~~e~~~~~~~~Qi~~al~~lH~---~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~ 179 (322)
T d1vzoa_ 109 DYINGGELFTHLSQR------ERFTEHEVQIYVGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEF 179 (322)
T ss_dssp CCCCSCBHHHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEESCSSEEEEC
T ss_pred ecccccHHHHHHHhc------ccccHHHHHHHHHHHHHHHHHhhc---CCEEeccCCccceeecCCCCEEEeeccchhhh
Confidence 999999999999765 457888999999999999999999 89999999999999999999999999999865
Q ss_pred hccCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCC--CCCchhhhHHHHHHHHHHHhCCCcc
Q 005102 559 NIAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVV--KPSQKWDIYSYGVILLEMITGRTAV 636 (714)
Q Consensus 559 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~s~~~DVwS~Gvvl~elltG~~p~ 636 (714)
.... ........|++.|+|||.+.+. .++.++|||||||++|||+||+.||
T Consensus 180 ~~~~---------------------------~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF 232 (322)
T d1vzoa_ 180 VADE---------------------------TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPF 232 (322)
T ss_dssp CGGG---------------------------GGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTT
T ss_pred cccc---------------------------cccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCC
Confidence 3221 1112234578899999999765 4688999999999999999999999
Q ss_pred ccCCCCcchhHHHHHHHHhhcCCcccccCCCCCCCCCcHHHHHHHHHHHhHccCCCCCCCC-----CHHHHHH
Q 005102 637 VQVGSSEMDLVNWMQLCIEEKKPLADVLDPYLAPDADKEEEIIAVLKIAMACVHSSPEKRP-----TMRHISD 704 (714)
Q Consensus 637 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----t~~evl~ 704 (714)
....... ......+....... ..... ...++.+++.+||++||++|| |++|+++
T Consensus 233 ~~~~~~~-~~~~i~~~~~~~~~--------~~~~~-----~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 233 TVDGEKN-SQAEISRRILKSEP--------PYPQE-----MSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp SCTTSCC-CHHHHHHHHHHCCC--------CCCTT-----SCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred CCCCHHH-HHHHHHHhcccCCC--------CCccc-----CCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 5443222 12222222222211 11111 223688999999999999999 4788765
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-41 Score=357.16 Aligned_cols=253 Identities=21% Similarity=0.281 Sum_probs=182.9
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeCCCC--chhHHHHHHHHHHHhccCCCCccceEEEEEeC------CceeEEEe
Q 005102 409 FVLGKSGIGIVYKVVLE-DGHTLAVRRLGEGG--SQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSV------DEKLLIYD 479 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~------~~~~lV~e 479 (714)
+.||+|+||+||+|++. +|+.||||++.... ....+++.+|+.++++++|||||++++++... .+.|+|||
T Consensus 23 ~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~~~iv~E 102 (355)
T d2b1pa1 23 KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVME 102 (355)
T ss_dssp EECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEEEEEE
T ss_pred EEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCceeEEEEe
Confidence 47999999999999986 59999999997642 33446789999999999999999999999643 57799999
Q ss_pred ccCCCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhh
Q 005102 480 YIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLAN 559 (714)
Q Consensus 480 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~ 559 (714)
|+.++ +.+.+. ..+++..++.++.||+.||+|||+ .+|+||||||+|||++.++.+|++|||+++...
T Consensus 103 y~~~~-l~~~~~--------~~~~~~~i~~~~~qil~gl~~LH~---~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~ 170 (355)
T d2b1pa1 103 LMDAN-LCQVIQ--------MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 170 (355)
T ss_dssp CCSEE-HHHHHT--------SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred ccchH-HHHhhh--------cCCCHHHHHHHHHHHHHHHHHhhh---cccccccCCccccccccccceeeechhhhhccc
Confidence 99664 555553 348899999999999999999999 999999999999999999999999999987643
Q ss_pred ccCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHHHHHhCCCccccC
Q 005102 560 IAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILLEMITGRTAVVQV 639 (714)
Q Consensus 560 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~elltG~~p~~~~ 639 (714)
.. .......+|+.|+|||++.+..+++++||||+||++|||++|+.||...
T Consensus 171 ~~-----------------------------~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~ 221 (355)
T d2b1pa1 171 TS-----------------------------FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGR 221 (355)
T ss_dssp ---------------------------------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred cc-----------------------------cccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCC
Confidence 21 1223345688999999999999999999999999999999999999432
Q ss_pred CCCcchhHHHHH-------------------HHHhhcCCc-----ccccCCCCCCCC--CcHHHHHHHHHHHhHccCCCC
Q 005102 640 GSSEMDLVNWMQ-------------------LCIEEKKPL-----ADVLDPYLAPDA--DKEEEIIAVLKIAMACVHSSP 693 (714)
Q Consensus 640 ~~~~~~l~~~~~-------------------~~~~~~~~~-----~~~~d~~~~~~~--~~~~~~~~l~~li~~Cl~~dP 693 (714)
. ......-+. ......... ............ ........+.+|+.+||+.||
T Consensus 222 ~--~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP 299 (355)
T d2b1pa1 222 D--YIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDP 299 (355)
T ss_dssp S--HHHHHHHHHHHHCCCCHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSST
T ss_pred C--HHHHHHHHHHhccCCCHHHHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCCh
Confidence 1 111111110 001110000 000000000011 112345578899999999999
Q ss_pred CCCCCHHHHHH
Q 005102 694 EKRPTMRHISD 704 (714)
Q Consensus 694 ~~RPt~~evl~ 704 (714)
++|||++|+++
T Consensus 300 ~~R~ta~elL~ 310 (355)
T d2b1pa1 300 AKRISVDDALQ 310 (355)
T ss_dssp TTSCCHHHHHT
T ss_pred hHCcCHHHHhc
Confidence 99999999974
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-41 Score=355.04 Aligned_cols=251 Identities=23% Similarity=0.306 Sum_probs=186.2
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeCCCC--chhHHHHHHHHHHHhccCCCCccceEEEEEeC-----CceeEEEec
Q 005102 409 FVLGKSGIGIVYKVVLE-DGHTLAVRRLGEGG--SQRFKEFQTEVEAIGKIRHSNIVTLRAYYWSV-----DEKLLIYDY 480 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~-----~~~~lV~e~ 480 (714)
+.||+|+||+||+|++. +|+.||||++.... ....+.+.+|+++|++++|||||++++++... ...+++|+|
T Consensus 24 ~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~~~i~~~ 103 (348)
T d2gfsa1 24 SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTH 103 (348)
T ss_dssp EECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCCCEEEEE
T ss_pred EEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCceEEEEEe
Confidence 47999999999999974 69999999998653 33446789999999999999999999998643 334677788
Q ss_pred cCCCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEEcccchhhhhhc
Q 005102 481 IPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHVSDFGLARLANI 560 (714)
Q Consensus 481 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~~~~ 560 (714)
+.+|+|.+++.. .++++.+++.|+.||+.||+|||+ ++|+||||||+|||++.++.+|++|||++.....
T Consensus 104 ~~gg~L~~~~~~-------~~l~e~~~~~i~~qil~aL~~LH~---~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~~ 173 (348)
T d2gfsa1 104 LMGADLNNIVKC-------QKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD 173 (348)
T ss_dssp CCSEEHHHHHTT-------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCC----CCTG
T ss_pred ecCCchhhhccc-------ccccHHHHHHHHHHHHHHHHHHHh---CCCcccccCCccccccccccccccccchhcccCc
Confidence 889999999854 348999999999999999999999 9999999999999999999999999999875432
Q ss_pred cCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCC-CCchhhhHHHHHHHHHHHhCCCccccC
Q 005102 561 AGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVK-PSQKWDIYSYGVILLEMITGRTAVVQV 639 (714)
Q Consensus 561 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s~~~DVwS~Gvvl~elltG~~p~~~~ 639 (714)
......||+.|+|||...+.. ++.++||||+||++|||++|+.||...
T Consensus 174 -------------------------------~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~ 222 (348)
T d2gfsa1 174 -------------------------------EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 222 (348)
T ss_dssp -------------------------------GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred -------------------------------ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCC
Confidence 122345688899999876654 689999999999999999999999432
Q ss_pred CCCcchhHHHHHHHHhhcCCcccccCC-----------CCC--CCCCcH----HHHHHHHHHHhHccCCCCCCCCCHHHH
Q 005102 640 GSSEMDLVNWMQLCIEEKKPLADVLDP-----------YLA--PDADKE----EEIIAVLKIAMACVHSSPEKRPTMRHI 702 (714)
Q Consensus 640 ~~~~~~l~~~~~~~~~~~~~~~~~~d~-----------~~~--~~~~~~----~~~~~l~~li~~Cl~~dP~~RPt~~ev 702 (714)
+.......+...... ...+.... ... ...... .....+.+|+.+||+.||++|||++|+
T Consensus 223 --~~~~~~~~i~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~el 298 (348)
T d2gfsa1 223 --DHIDQLKLILRLVGT--PGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQA 298 (348)
T ss_dssp --SHHHHHHHHHHHHCC--CCHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred --CHHHHHHHHHHhcCC--CChHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHH
Confidence 222221111111100 00000000 000 000000 112357899999999999999999999
Q ss_pred HH
Q 005102 703 SD 704 (714)
Q Consensus 703 l~ 704 (714)
++
T Consensus 299 L~ 300 (348)
T d2gfsa1 299 LA 300 (348)
T ss_dssp HT
T ss_pred hc
Confidence 86
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=100.00 E-value=8.1e-38 Score=325.94 Aligned_cols=253 Identities=28% Similarity=0.517 Sum_probs=217.5
Q ss_pred CCchhHHHHHHHHHHhccCCCCCCCCCCCCCCCCCC--cccceEecC----CcEEEEEcCCCCccc--cCCccccCCCCC
Q 005102 19 DSLNGEGYALLSFKQSVHEDPEGSLSNWNSSDENPC--SWNGITCKE----QRVVSVSIPKKKLLG--FLPSALGSLTDL 90 (714)
Q Consensus 19 ~~~~~~~~~l~~~~~~~~~~~~~~l~~w~~~~~~~c--~w~gv~c~~----~~~~~l~l~~~~l~g--~~p~~~~~l~~L 90 (714)
.|.+.|++||++||+++. || ..+++|..+ .||| .|.||+|+. .||+.|+|++++++| .+|++|++|++|
T Consensus 2 ~c~~~e~~aLl~~k~~~~-~~-~~l~sW~~~-~d~C~~~w~gv~C~~~~~~~~v~~L~L~~~~l~g~~~lp~~l~~L~~L 78 (313)
T d1ogqa_ 2 LCNPQDKQALLQIKKDLG-NP-TTLSSWLPT-TDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYL 78 (313)
T ss_dssp CSCHHHHHHHHHHHHHTT-CC-GGGTTCCTT-SCTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCGGGGGCTTC
T ss_pred CCCHHHHHHHHHHHHHCC-CC-CcCCCCCCC-CCCCCCcCCCeEEeCCCCcEEEEEEECCCCCCCCCCCCChHHhcCccc
Confidence 367899999999999995 55 378999754 4788 599999973 279999999999998 589999999999
Q ss_pred CEEEccC-CCCcccCChhhcCCCCCCEEEcCCCcCcccCCcccCCCCCCCEEeccCccCCCCCCcccccccccceeeccc
Q 005102 91 RHVNLRN-NKFFGSLPLELLEAQGLQSLVLYGNSFSGSVPNEIGKLKYLQILDLSQNFFNGSLPVSIVQCKRLKALDLSQ 169 (714)
Q Consensus 91 ~~L~L~~-N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~ 169 (714)
++|+|++ |+++|.+|..|.++++|++|+|++|++++..|..+..+.+|+.+++++|++.+.+|..+.++++|+.+++++
T Consensus 79 ~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~N~~~~~~p~~l~~l~~L~~l~l~~ 158 (313)
T d1ogqa_ 79 NFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDG 158 (313)
T ss_dssp SEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCS
T ss_pred cccccccccccccccccccccccccchhhhccccccccccccccchhhhcccccccccccccCchhhccCcccceeeccc
Confidence 9999996 899999999999999999999999999999998888899999999999999888898899999999999988
Q ss_pred CcCCCCCCccccc-----------------------------------------------CccccccccccCCcccccCC
Q 005102 170 NNFTGPLPNGFGS-----------------------------------------------GLVSLEKLNLSFNKFNGSIP 202 (714)
Q Consensus 170 N~l~g~~p~~~~~-----------------------------------------------~l~~L~~L~l~~N~l~g~~p 202 (714)
|.++|.+|..++. .+++|+.|++++|.+++.+|
T Consensus 159 n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~~l~l~~~~~~~~~~~~~~~~~~l~~l~~~~~~l~~~~~ 238 (313)
T d1ogqa_ 159 NRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLG 238 (313)
T ss_dssp SCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCSEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGG
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 8888877765431 13456666666777665554
Q ss_pred CCCCCCcccccccccccccCCcCcCccccCCCCcccccCcCCcCCCCCCCCccccCCCCcccccCCCCCCCCCC
Q 005102 203 SNTGNLSSLQGTVDFSHNLFSGSIPASLGNLPEKVYIDLTYNNLSGPIPQNGALMNRGPTAFIGNPRLCGPPLK 276 (714)
Q Consensus 203 ~~~~~l~~L~~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~~~~~~~~~~~~n~~~~~~~~~ 276 (714)
.++.+++++ .|++++|+|+|.+|.+|+++++|++|+|++|+|+|.+|+...+.......+.+|+.+||.|++
T Consensus 239 -~~~~~~~L~-~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~~~L~~L~~l~l~~N~~l~g~plp 310 (313)
T d1ogqa_ 239 -KVGLSKNLN-GLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSPLP 310 (313)
T ss_dssp -GCCCCTTCC-EEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCSTTGGGSCGGGTCSSSEEESTTSS
T ss_pred -ccccccccc-cccCccCeecccCChHHhCCCCCCEEECcCCcccccCCCcccCCCCCHHHhCCCccccCCCCC
Confidence 466677887 899999999999999999999999999999999999998777777777888899999998764
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.5e-36 Score=321.25 Aligned_cols=258 Identities=17% Similarity=0.200 Sum_probs=181.5
Q ss_pred ccccccCceEEEEEEEC-CCcEEEEEEeCCCCchhHHHHHHHHHHHhccC-----------CCCccceEEEEEeC--Cce
Q 005102 409 FVLGKSGIGIVYKVVLE-DGHTLAVRRLGEGGSQRFKEFQTEVEAIGKIR-----------HSNIVTLRAYYWSV--DEK 474 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------H~niv~l~~~~~~~--~~~ 474 (714)
+.||+|+||+||+|+.. +|+.||||++++... ..+.+.+|++++++++ |+||+++++++... ...
T Consensus 19 ~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~-~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~~~~~~ 97 (362)
T d1q8ya_ 19 RKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV-YTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGV 97 (362)
T ss_dssp EEEEECSSEEEEEEEETTTTEEEEEEEECSCHH-HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEETTEE
T ss_pred EEEeeCCCeEEEEEEECCCCCEEEEEEEecccc-chHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeeccccce
Confidence 48999999999999975 699999999986532 2367788999988875 57899999988653 455
Q ss_pred eEEEeccCCCCHhhh-hhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCC------Ce
Q 005102 475 LLIYDYIPNGSLATA-LHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNM------EP 547 (714)
Q Consensus 475 ~lV~e~~~~gsL~~~-l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~------~~ 547 (714)
+++|+++..+..... ...... ..+++..+..++.||+.||+|||+. .+|+||||||+|||++.++ .+
T Consensus 98 ~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~i~~i~~qil~al~~lh~~--~~IvHrDlKp~NIll~~~~~~~~~~~~ 171 (362)
T d1q8ya_ 98 HVVMVFEVLGENLLALIKKYEH----RGIPLIYVKQISKQLLLGLDYMHRR--CGIIHTDIKPENVLMEIVDSPENLIQI 171 (362)
T ss_dssp EEEEEECCCCEEHHHHHHHTTT----SCCCHHHHHHHHHHHHHHHHHHHHT--TCEECSCCSGGGEEEEEEETTTTEEEE
T ss_pred eeeeeecccccccccccccccc----cCCcHHHHHHHHHHHHHHHHHHhhh--cCcccccCChhHeeeeccCccccccee
Confidence 677776655443332 222211 5688999999999999999999963 5899999999999998664 38
Q ss_pred EEcccchhhhhhccCCCCCccCCCCCCCCchhhhcccccceeecccCCCCCCccccCCcccCCCCCCchhhhHHHHHHHH
Q 005102 548 HVSDFGLARLANIAGGSPTLQSNRMPAEKPQERQQKSVSLEVTTTNSSSNLGSYYQAPESLKVVKPSQKWDIYSYGVILL 627 (714)
Q Consensus 548 kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~DVwS~Gvvl~ 627 (714)
|++|||.|+.... ......||+.|+|||++.+..++.++||||+||+++
T Consensus 172 kl~dfg~s~~~~~-------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ 220 (362)
T d1q8ya_ 172 KIADLGNACWYDE-------------------------------HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIF 220 (362)
T ss_dssp EECCCTTCEETTB-------------------------------CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHH
T ss_pred eEeeccccccccc-------------------------------ccccccccccccChhhccccCCCccccccchHHHHH
Confidence 9999999875421 123345789999999999999999999999999999
Q ss_pred HHHhCCCccccCCCCc-ch----hHHHHHHH-------HhhcCCcccccCC-----CCCC-------------CCCcHHH
Q 005102 628 EMITGRTAVVQVGSSE-MD----LVNWMQLC-------IEEKKPLADVLDP-----YLAP-------------DADKEEE 677 (714)
Q Consensus 628 elltG~~p~~~~~~~~-~~----l~~~~~~~-------~~~~~~~~~~~d~-----~~~~-------------~~~~~~~ 677 (714)
||++|+.||....... .. +...+... ...........+. .... .......
T Consensus 221 el~~g~~pF~~~~~~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (362)
T d1q8ya_ 221 ELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDE 300 (362)
T ss_dssp HHHHSSCCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHH
T ss_pred HHHHCCCCCCCCccccccchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCccc
Confidence 9999999995332211 11 11111000 0000000000000 0000 0012345
Q ss_pred HHHHHHHHhHccCCCCCCCCCHHHHHH
Q 005102 678 IIAVLKIAMACVHSSPEKRPTMRHISD 704 (714)
Q Consensus 678 ~~~l~~li~~Cl~~dP~~RPt~~evl~ 704 (714)
...+.+|+.+||+.||++|||++|+++
T Consensus 301 ~~~~~dll~~mL~~dP~~Rpta~e~L~ 327 (362)
T d1q8ya_ 301 AKEISDFLSPMLQLDPRKRADAGGLVN 327 (362)
T ss_dssp HHHHHHHHGGGGCSSTTTCBCHHHHHT
T ss_pred CHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 667999999999999999999999976
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.89 E-value=1.1e-22 Score=205.15 Aligned_cols=201 Identities=26% Similarity=0.243 Sum_probs=163.8
Q ss_pred EEEEEcCCCCccccCCccccCCCCCCEEEccCCCCcccCChhhcCCCCCCEEEcCCCcCcccCCcccCCCCCCCEEeccC
Q 005102 66 VVSVSIPKKKLLGFLPSALGSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSGSVPNEIGKLKYLQILDLSQ 145 (714)
Q Consensus 66 ~~~l~l~~~~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~ 145 (714)
...++.++++|+. +|+.+. ++|++|+|++|+|++..+..|.++++|+.|+|++|+|+ .+|. ++.+++|+.|+|++
T Consensus 12 ~~~v~C~~~~L~~-iP~~lp--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~-~l~~-~~~l~~L~~L~Ls~ 86 (266)
T d1p9ag_ 12 HLEVNCDKRNLTA-LPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQV-DGTLPVLGTLDLSH 86 (266)
T ss_dssp CCEEECTTSCCSS-CCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCC-EEEC-CSCCTTCCEEECCS
T ss_pred CeEEEccCCCCCe-eCcCcC--cCCCEEECcCCcCCCcCHHHhhcccccccccccccccc-cccc-cccccccccccccc
Confidence 3445666777774 676664 57899999999999776778899999999999999998 4553 57899999999999
Q ss_pred ccCCCCCCcccccccccceeecccCcCCCCCCcccccCccccccccccCCcccccCCCCCCCCcccccccccccccCCcC
Q 005102 146 NFFNGSLPVSIVQCKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLNLSFNKFNGSIPSNTGNLSSLQGTVDFSHNLFSGS 225 (714)
Q Consensus 146 N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~~l~l~~N~l~g~ 225 (714)
|+++ .+|..+..+++|+.|++++|.+.+ ++...+..+.+|+.|++++|.++...+..+..++.++ .+++++|+|++.
T Consensus 87 N~l~-~~~~~~~~l~~L~~L~l~~~~~~~-~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~-~l~l~~N~l~~~ 163 (266)
T d1p9ag_ 87 NQLQ-SLPLLGQTLPALTVLDVSFNRLTS-LPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLE-KLSLANNNLTEL 163 (266)
T ss_dssp SCCS-SCCCCTTTCTTCCEEECCSSCCCC-CCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCC-EEECTTSCCSCC
T ss_pred cccc-ccccccccccccccccccccccce-eeccccccccccccccccccccceeccccccccccch-hccccccccccc
Confidence 9998 567788899999999999999984 4444446789999999999999966667777888998 999999999988
Q ss_pred cCccccCCCCcccccCcCCcCCCCCCCCccccCCCCcccccCCCCCCCC
Q 005102 226 IPASLGNLPEKVYIDLTYNNLSGPIPQNGALMNRGPTAFIGNPRLCGPP 274 (714)
Q Consensus 226 ~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~~~~~~~~~~~~n~~~~~~~ 274 (714)
.+..|..+++|++|+|++|+|+..++..+...........|||+.|++.
T Consensus 164 ~~~~~~~l~~L~~L~Ls~N~L~~lp~~~~~~~~L~~L~L~~Np~~CdC~ 212 (266)
T d1p9ag_ 164 PAGLLNGLENLDTLLLQENSLYTIPKGFFGSHLLPFAFLHGNPWLCNCE 212 (266)
T ss_dssp CTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCCCSEEECCSCCBCCSGG
T ss_pred CccccccccccceeecccCCCcccChhHCCCCCCCEEEecCCCCCCCcc
Confidence 8888999999999999999999544444444455566778999999764
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.88 E-value=8.2e-24 Score=202.31 Aligned_cols=130 Identities=17% Similarity=0.213 Sum_probs=104.8
Q ss_pred cccccccCceEEEEEEECCCcEEEEEEeCCCCc------------------hhHHHHHHHHHHHhccCCCCccceEEEEE
Q 005102 408 AFVLGKSGIGIVYKVVLEDGHTLAVRRLGEGGS------------------QRFKEFQTEVEAIGKIRHSNIVTLRAYYW 469 (714)
Q Consensus 408 ~~~lG~G~~g~Vy~~~~~~g~~vavK~~~~~~~------------------~~~~~~~~E~~~l~~l~H~niv~l~~~~~ 469 (714)
++.||+|+||+||+|+..+|+.||||+++.... .....+.+|...+.++.|.+++..+++.
T Consensus 5 g~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~~- 83 (191)
T d1zara2 5 GKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAWE- 83 (191)
T ss_dssp EEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEEE-
T ss_pred CCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEec-
Confidence 568999999999999999999999998764211 0123456789999999999999987653
Q ss_pred eCCceeEEEeccCCCCHhhhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCCCCCceecCCCCCCeeeCCCCCeEE
Q 005102 470 SVDEKLLIYDYIPNGSLATALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFSPKKYVHGDLKPSNILLGHNMEPHV 549 (714)
Q Consensus 470 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivHrDlkp~NILl~~~~~~kl 549 (714)
..++||||+++..+.+ ++......++.|++.||+|||+ .+|+||||||+|||++++ .++|
T Consensus 84 ---~~~lvme~~~~~~~~~-------------l~~~~~~~i~~ql~~~l~~lH~---~giiHrDiKP~NILv~~~-~~~l 143 (191)
T d1zara2 84 ---GNAVLMELIDAKELYR-------------VRVENPDEVLDMILEEVAKFYH---RGIVHGDLSQYNVLVSEE-GIWI 143 (191)
T ss_dssp ---TTEEEEECCCCEEGGG-------------CCCSCHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEEETT-EEEE
T ss_pred ---CCEEEEEeeccccccc-------------hhhHHHHHHHHHHHHHHHHHhh---CCEEEccCChhheeeeCC-CEEE
Confidence 3479999998765433 3334467899999999999999 899999999999999965 5899
Q ss_pred cccchhhhh
Q 005102 550 SDFGLARLA 558 (714)
Q Consensus 550 ~DFGla~~~ 558 (714)
+|||+|+..
T Consensus 144 iDFG~a~~~ 152 (191)
T d1zara2 144 IDFPQSVEV 152 (191)
T ss_dssp CCCTTCEET
T ss_pred EECCCcccC
Confidence 999998754
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.88 E-value=1.2e-23 Score=217.92 Aligned_cols=185 Identities=25% Similarity=0.364 Sum_probs=154.8
Q ss_pred CCcEEEEEcCC-CCccccCCccccCCCCCCEEEccCCCCcccCChhhcCCCCCCEEEcCCCcCcccCCcccCCCCCCCEE
Q 005102 63 EQRVVSVSIPK-KKLLGFLPSALGSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSGSVPNEIGKLKYLQIL 141 (714)
Q Consensus 63 ~~~~~~l~l~~-~~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L 141 (714)
-..++.|+|++ |+++|.+|++|++|++|++|+|++|++.+..|..+..+..|+.|++++|.+.+.+|..++++++|+.+
T Consensus 75 L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~N~~~~~~p~~l~~l~~L~~l 154 (313)
T d1ogqa_ 75 LPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGI 154 (313)
T ss_dssp CTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEE
T ss_pred CccccccccccccccccccccccccccccchhhhccccccccccccccchhhhcccccccccccccCchhhccCccccee
Confidence 35788899987 89999999999999999999999999999888888888888888888888888888888888888888
Q ss_pred eccCccCCCCCCcccccccc------------------------------------------------cceeecccCcCC
Q 005102 142 DLSQNFFNGSLPVSIVQCKR------------------------------------------------LKALDLSQNNFT 173 (714)
Q Consensus 142 ~Ls~N~l~g~~p~~~~~l~~------------------------------------------------L~~L~l~~N~l~ 173 (714)
++++|.++|.+|..+..+.+ |+.|++++|.++
T Consensus 155 ~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~~l~l~~~~~~~~~~~~~~~~~~l~~l~~~~~~l~ 234 (313)
T d1ogqa_ 155 TFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLA 234 (313)
T ss_dssp ECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCSEEECCSSEEEECCGGGCCTTSCCSEEECCSSEEC
T ss_pred eccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 88888888777776655443 344455555555
Q ss_pred CCCCcccccCccccccccccCCcccccCCCCCCCCcccccccccccccCCcCcCccccCCCCcccccCcCCc-CCCC-CC
Q 005102 174 GPLPNGFGSGLVSLEKLNLSFNKFNGSIPSNTGNLSSLQGTVDFSHNLFSGSIPASLGNLPEKVYIDLTYNN-LSGP-IP 251 (714)
Q Consensus 174 g~~p~~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~-l~~~-~p 251 (714)
+.+| .+ ..+++|+.|+|++|+|+|.+|..++++++|+ .|+|++|+|+|.+| +++++++|+.+++++|+ +.|. +|
T Consensus 235 ~~~~-~~-~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~-~L~Ls~N~l~g~iP-~~~~L~~L~~l~l~~N~~l~g~plp 310 (313)
T d1ogqa_ 235 FDLG-KV-GLSKNLNGLDLRNNRIYGTLPQGLTQLKFLH-SLNVSFNNLCGEIP-QGGNLQRFDVSAYANNKCLCGSPLP 310 (313)
T ss_dssp CBGG-GC-CCCTTCCEEECCSSCCEECCCGGGGGCTTCC-EEECCSSEEEEECC-CSTTGGGSCGGGTCSSSEEESTTSS
T ss_pred cccc-cc-ccccccccccCccCeecccCChHHhCCCCCC-EEECcCCcccccCC-CcccCCCCCHHHhCCCccccCCCCC
Confidence 4433 23 3478999999999999999999999999999 99999999999999 46899999999999997 6775 44
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.87 E-value=6.5e-22 Score=199.54 Aligned_cols=179 Identities=23% Similarity=0.185 Sum_probs=162.8
Q ss_pred CcEEEEEcCCCCccccCCccccCCCCCCEEEccCCCCcccCChhhcCCCCCCEEEcCCCcCcccCCcccCCCCCCCEEec
Q 005102 64 QRVVSVSIPKKKLLGFLPSALGSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSGSVPNEIGKLKYLQILDL 143 (714)
Q Consensus 64 ~~~~~l~l~~~~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L 143 (714)
..++.|+|++|+|++..+..|.++++|++|+|++|+|+. +| .+..+++|+.|+|++|+++ .+|..+.++++|+.|++
T Consensus 31 ~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~~-l~-~~~~l~~L~~L~Ls~N~l~-~~~~~~~~l~~L~~L~l 107 (266)
T d1p9ag_ 31 KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTK-LQ-VDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDV 107 (266)
T ss_dssp TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCE-EE-CCSCCTTCCEEECCSSCCS-SCCCCTTTCTTCCEEEC
T ss_pred cCCCEEECcCCcCCCcCHHHhhccccccccccccccccc-cc-ccccccccccccccccccc-ccccccccccccccccc
Confidence 368899999999999888899999999999999999984 44 3578999999999999998 56888999999999999
Q ss_pred cCccCCCCCCcccccccccceeecccCcCCCCCCcccccCccccccccccCCcccccCCCCCCCCcccccccccccccCC
Q 005102 144 SQNFFNGSLPVSIVQCKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLNLSFNKFNGSIPSNTGNLSSLQGTVDFSHNLFS 223 (714)
Q Consensus 144 s~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~~l~l~~N~l~ 223 (714)
++|.+.+..+..+..+.+|+.|++++|.++ .+|..++..+++|+.|++++|+|++..+..+..+++|+ .|+|++|+|+
T Consensus 108 ~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~-~l~~~~~~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~-~L~Ls~N~L~ 185 (266)
T d1p9ag_ 108 SFNRLTSLPLGALRGLGELQELYLKGNELK-TLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLD-TLLLQENSLY 185 (266)
T ss_dssp CSSCCCCCCSSTTTTCTTCCEEECTTSCCC-CCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCC-EEECCSSCCC
T ss_pred cccccceeeccccccccccccccccccccc-eeccccccccccchhcccccccccccCccccccccccc-eeecccCCCc
Confidence 999999877888899999999999999998 56666667799999999999999987778899999999 9999999999
Q ss_pred cCcCccccCCCCcccccCcCCcCCC
Q 005102 224 GSIPASLGNLPEKVYIDLTYNNLSG 248 (714)
Q Consensus 224 g~~p~~~~~l~~L~~l~l~~N~l~~ 248 (714)
.+|..+..+++|+.|+|++|.+.-
T Consensus 186 -~lp~~~~~~~~L~~L~L~~Np~~C 209 (266)
T d1p9ag_ 186 -TIPKGFFGSHLLPFAFLHGNPWLC 209 (266)
T ss_dssp -CCCTTTTTTCCCSEEECCSCCBCC
T ss_pred -ccChhHCCCCCCCEEEecCCCCCC
Confidence 899999999999999999999874
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.86 E-value=9.7e-22 Score=200.34 Aligned_cols=208 Identities=18% Similarity=0.125 Sum_probs=180.5
Q ss_pred cEEEEEcCCCCccccCCccccCCCCCCEEEccCCCCcccCChhhcCCCCCCEEEcC-CCcCcccCCcccCCCCCCCEEec
Q 005102 65 RVVSVSIPKKKLLGFLPSALGSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLY-GNSFSGSVPNEIGKLKYLQILDL 143 (714)
Q Consensus 65 ~~~~l~l~~~~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~-~N~l~g~~p~~~~~l~~L~~L~L 143 (714)
.++.|+|++|+|++..+..|.++++|++|++++|++.+..+..+..+..++.|+.. .|.++...|..|.++++|+.|+|
T Consensus 33 ~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~~l~~L~~L~l 112 (284)
T d1ozna_ 33 ASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHL 112 (284)
T ss_dssp TCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEEC
T ss_pred CCCEEECcCCcCCCCCHHHhhccccccccccccccccccccccccccccccccccccccccccccchhhcccccCCEEec
Confidence 46789999999998877889999999999999999998888888889999998765 66777666888999999999999
Q ss_pred cCccCCCCCCcccccccccceeecccCcCCCCCCcccccCccccccccccCCcccccCCCCCCCCcccccccccccccCC
Q 005102 144 SQNFFNGSLPVSIVQCKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLNLSFNKFNGSIPSNTGNLSSLQGTVDFSHNLFS 223 (714)
Q Consensus 144 s~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~~l~l~~N~l~ 223 (714)
++|.+....+..+..+.+|+.+++++|+++ .+|...+..+++|+.|+|++|+|++..|..+.++++|+ .+++++|+++
T Consensus 113 ~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~-~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~-~l~l~~N~l~ 190 (284)
T d1ozna_ 113 DRCGLQELGPGLFRGLAALQYLYLQDNALQ-ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLD-RLLLHQNRVA 190 (284)
T ss_dssp TTSCCCCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCC-EEECCSSCCC
T ss_pred CCcccccccccccchhcccchhhhcccccc-ccChhHhccccchhhcccccCcccccchhhhccccccc-hhhhhhcccc
Confidence 999998777778888999999999999998 45555556789999999999999987788999999999 9999999999
Q ss_pred cCcCccccCCCCcccccCcCCcCCCCCCCCccc-cCCCCcccccCCCCCCCC
Q 005102 224 GSIPASLGNLPEKVYIDLTYNNLSGPIPQNGAL-MNRGPTAFIGNPRLCGPP 274 (714)
Q Consensus 224 g~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~~-~~~~~~~~~~n~~~~~~~ 274 (714)
+..|..|..+++|++||+++|++++.+|..... .......+.+|++.|.++
T Consensus 191 ~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C~C~ 242 (284)
T d1ozna_ 191 HVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCR 242 (284)
T ss_dssp EECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGG
T ss_pred ccChhHhhhhhhcccccccccccccccccccccccccCEEEecCCCCCCCcc
Confidence 999999999999999999999999988765433 334455667888888654
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.82 E-value=4.2e-20 Score=190.11 Aligned_cols=191 Identities=21% Similarity=0.327 Sum_probs=127.1
Q ss_pred CCCcccceEecC-----------CcEEEEEcCCCCccccCCccccCCCCCCEEEccCCCCcccCChhhcCCCCCCEEEcC
Q 005102 52 NPCSWNGITCKE-----------QRVVSVSIPKKKLLGFLPSALGSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLY 120 (714)
Q Consensus 52 ~~c~w~gv~c~~-----------~~~~~l~l~~~~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~ 120 (714)
|-|.|++|.|+. ..++.|+|++|+|+...+..|.++++|++|++++|.+....|..|.++++|+.|+|+
T Consensus 8 c~c~~~~~~C~~~~L~~lP~~l~~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l~ 87 (305)
T d1xkua_ 8 CQCHLRVVQCSDLGLEKVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLS 87 (305)
T ss_dssp CEEETTEEECTTSCCCSCCCSCCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECC
T ss_pred CEecCCEEEecCCCCCccCCCCCCCCCEEECcCCcCCCcChhHhhccccccccccccccccccchhhhhCCCccCEeccc
Confidence 457899999974 357789999999998777789999999999999999998888899999999999999
Q ss_pred CCcCcccCCccc------------------------------------------------CCCCCCCEEeccCccCCCCC
Q 005102 121 GNSFSGSVPNEI------------------------------------------------GKLKYLQILDLSQNFFNGSL 152 (714)
Q Consensus 121 ~N~l~g~~p~~~------------------------------------------------~~l~~L~~L~Ls~N~l~g~~ 152 (714)
+|+++ .+|..+ ..+++|+.+++++|.++ .+
T Consensus 88 ~n~l~-~l~~~~~~~l~~L~~~~n~l~~l~~~~~~~~~~~~~l~~~~n~~~~~~~~~~~~~~l~~L~~l~l~~n~l~-~l 165 (305)
T d1xkua_ 88 KNQLK-ELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TI 165 (305)
T ss_dssp SSCCS-BCCSSCCTTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCC-SC
T ss_pred CCccC-cCccchhhhhhhhhccccchhhhhhhhhhccccccccccccccccccCCCccccccccccCccccccCCcc-cc
Confidence 99987 455432 12333444444444443 23
Q ss_pred CcccccccccceeecccCcCCCCCCcccccCccccccccccCCcccccCCCCCCCCcccccccccccccCCcCcCccccC
Q 005102 153 PVSIVQCKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLNLSFNKFNGSIPSNTGNLSSLQGTVDFSHNLFSGSIPASLGN 232 (714)
Q Consensus 153 p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~~l~l~~N~l~g~~p~~~~~ 232 (714)
|..+ +++|+.|++++|.+++..+..+ ..++.++.|++++|++++..|..+.++++|+ +|+|++|+|+ .+|.+|..
T Consensus 166 ~~~~--~~~L~~L~l~~n~~~~~~~~~~-~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~-~L~L~~N~L~-~lp~~l~~ 240 (305)
T d1xkua_ 166 PQGL--PPSLTELHLDGNKITKVDAASL-KGLNNLAKLGLSFNSISAVDNGSLANTPHLR-ELHLNNNKLV-KVPGGLAD 240 (305)
T ss_dssp CSSC--CTTCSEEECTTSCCCEECTGGG-TTCTTCCEEECCSSCCCEECTTTGGGSTTCC-EEECCSSCCS-SCCTTTTT
T ss_pred Cccc--CCccCEEECCCCcCCCCChhHh-hccccccccccccccccccccccccccccce-eeeccccccc-cccccccc
Confidence 3322 2445555555555544444333 3355566666666666655555555666666 6666666665 44556666
Q ss_pred CCCcccccCcCCcCCCC
Q 005102 233 LPEKVYIDLTYNNLSGP 249 (714)
Q Consensus 233 l~~L~~l~l~~N~l~~~ 249 (714)
+++|++|++++|+|+..
T Consensus 241 l~~L~~L~Ls~N~i~~i 257 (305)
T d1xkua_ 241 HKYIQVVYLHNNNISAI 257 (305)
T ss_dssp CSSCCEEECCSSCCCCC
T ss_pred ccCCCEEECCCCccCcc
Confidence 66666666666666644
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.79 E-value=3.1e-19 Score=181.54 Aligned_cols=186 Identities=22% Similarity=0.186 Sum_probs=168.4
Q ss_pred CcEEEEEcCCCCccccCCccccCCCCCCEEEcc-CCCCcccCChhhcCCCCCCEEEcCCCcCcccCCcccCCCCCCCEEe
Q 005102 64 QRVVSVSIPKKKLLGFLPSALGSLTDLRHVNLR-NNKFFGSLPLELLEAQGLQSLVLYGNSFSGSVPNEIGKLKYLQILD 142 (714)
Q Consensus 64 ~~~~~l~l~~~~l~g~~p~~~~~l~~L~~L~L~-~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~ 142 (714)
..++.|++++|++.+..+..+..++.++.++.+ .|.+....|..|.++++|++|+|++|.+....+..+..+.+|+.++
T Consensus 56 ~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~ 135 (284)
T d1ozna_ 56 RNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLY 135 (284)
T ss_dssp TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEE
T ss_pred ccccccccccccccccccccccccccccccccccccccccccchhhcccccCCEEecCCcccccccccccchhcccchhh
Confidence 478999999999999999999999999999875 5667766688899999999999999999877788899999999999
Q ss_pred ccCccCCCCCCcccccccccceeecccCcCCCCCCcccccCccccccccccCCcccccCCCCCCCCcccccccccccccC
Q 005102 143 LSQNFFNGSLPVSIVQCKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLNLSFNKFNGSIPSNTGNLSSLQGTVDFSHNLF 222 (714)
Q Consensus 143 Ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~~l~l~~N~l 222 (714)
+++|+|++..+..|..+++|+.|+|++|++++ +|+..+.++++|+.|++++|++++..|..|.++++|+ .+++++|.+
T Consensus 136 l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~-l~~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~-~L~l~~N~i 213 (284)
T d1ozna_ 136 LQDNALQALPDDTFRDLGNLTHLFLHGNRISS-VPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLM-TLYLFANNL 213 (284)
T ss_dssp CCSSCCCCCCTTTTTTCTTCCEEECCSSCCCE-ECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCC-EEECCSSCC
T ss_pred hccccccccChhHhccccchhhcccccCcccc-cchhhhccccccchhhhhhccccccChhHhhhhhhcc-ccccccccc
Confidence 99999997667788899999999999999985 5545556899999999999999999999999999999 999999999
Q ss_pred CcCcCccccCCCCcccccCcCCcCCCCCC
Q 005102 223 SGSIPASLGNLPEKVYIDLTYNNLSGPIP 251 (714)
Q Consensus 223 ~g~~p~~~~~l~~L~~l~l~~N~l~~~~p 251 (714)
++..|..|+.+++|++|++++|.+.+.-+
T Consensus 214 ~~~~~~~~~~~~~L~~L~l~~N~l~C~C~ 242 (284)
T d1ozna_ 214 SALPTEALAPLRALQYLRLNDNPWVCDCR 242 (284)
T ss_dssp SCCCHHHHTTCTTCCEEECCSSCEECSGG
T ss_pred ccccccccccccccCEEEecCCCCCCCcc
Confidence 99999999999999999999999997644
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.77 E-value=3e-19 Score=170.35 Aligned_cols=178 Identities=20% Similarity=0.181 Sum_probs=137.9
Q ss_pred CCCcccceEecCCcEEEEEcCCCCccccCCccccCCCCCCEEEccCCCCcccC-ChhhcCCCCCCEEEcCCCcCcccCCc
Q 005102 52 NPCSWNGITCKEQRVVSVSIPKKKLLGFLPSALGSLTDLRHVNLRNNKFFGSL-PLELLEAQGLQSLVLYGNSFSGSVPN 130 (714)
Q Consensus 52 ~~c~w~gv~c~~~~~~~l~l~~~~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~-p~~~~~l~~L~~L~L~~N~l~g~~p~ 130 (714)
|-|+|..|.|+ +++|+ .+|..+. +++++|+|++|+|++.+ +..|..+++|+.|+|++|.+++..+.
T Consensus 6 C~C~~~~v~Cs----------~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~ 72 (192)
T d1w8aa_ 6 CHCEGTTVDCT----------GRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPN 72 (192)
T ss_dssp SEEETTEEECT----------TSCCS-SCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTT
T ss_pred CEEcCCEEEEe----------CCCcC-ccCCCCC--CCCCEEEeCCCCCcccccccccCCCceEeeeecccccccccccc
Confidence 34667777775 45565 4676653 68999999999998755 55578899999999999999989999
Q ss_pred ccCCCCCCCEEeccCccCCCCCCcccccccccceeecccCcCCCCCCcccccCccccccccccCCcccccCCCCCCCCcc
Q 005102 131 EIGKLKYLQILDLSQNFFNGSLPVSIVQCKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLNLSFNKFNGSIPSNTGNLSS 210 (714)
Q Consensus 131 ~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~ 210 (714)
.+..+++|+.|+|++|+|+...|..|.++++|++|+|++|+|++ +|+..+..+++|++|+|++|.+....+.... ...
T Consensus 73 ~~~~~~~L~~L~Ls~N~l~~l~~~~F~~l~~L~~L~L~~N~l~~-i~~~~f~~l~~L~~l~L~~N~~~~~~~~~~~-~~~ 150 (192)
T d1w8aa_ 73 AFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISC-VMPGSFEHLNSLTSLNLASNPFNCNCHLAWF-AEW 150 (192)
T ss_dssp TTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEECCSSCCCE-ECTTSSTTCTTCCEEECTTCCBCCSGGGHHH-HHH
T ss_pred ccccccccceeeeccccccccCHHHHhCCCcccccccCCccccc-cCHHHhcCCcccccccccccccccccchHHH-hhh
Confidence 99999999999999999997777789999999999999999984 5555556799999999999999754332111 122
Q ss_pred cccccccccccCCcCcCccccCCCCcccccCcCCcCCC
Q 005102 211 LQGTVDFSHNLFSGSIPASLGNLPEKVYIDLTYNNLSG 248 (714)
Q Consensus 211 L~~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~ 248 (714)
+. ...+..|.++...|..+ ..++.++++.|+|.-
T Consensus 151 l~-~~~l~~~~~~c~~p~~l---~~~~l~~L~~n~l~C 184 (192)
T d1w8aa_ 151 LR-KKSLNGGAARCGAPSKV---RDVQIKDLPHSEFKC 184 (192)
T ss_dssp HH-HHCCSGGGCBBCSSTTT---TTSBGGGSCTTTCCC
T ss_pred hh-hhcccCCCeEeCCChhh---cCCEeeecCHhhCcC
Confidence 33 55677788877677544 456678888888763
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.69 E-value=2.4e-17 Score=156.92 Aligned_cols=157 Identities=20% Similarity=0.253 Sum_probs=128.3
Q ss_pred CEEEccCCCCcccCChhhcCCCCCCEEEcCCCcCcccC-CcccCCCCCCCEEeccCccCCCCCCcccccccccceeeccc
Q 005102 91 RHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSGSV-PNEIGKLKYLQILDLSQNFFNGSLPVSIVQCKRLKALDLSQ 169 (714)
Q Consensus 91 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~-p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~ 169 (714)
++++.++|+|+ .+|..+. +++++|+|++|+|++.+ +..|.++++|+.|+|++|++.+..+..|..+++|+.|+|++
T Consensus 11 ~~v~Cs~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~ 87 (192)
T d1w8aa_ 11 TTVDCTGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE 87 (192)
T ss_dssp TEEECTTSCCS-SCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred CEEEEeCCCcC-ccCCCCC--CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeecc
Confidence 47899999998 7787653 68999999999998755 55678999999999999999988888999999999999999
Q ss_pred CcCCCCCCcccccCccccccccccCCcccccCCCCCCCCcccccccccccccCCcCcCccccCCCCcccccCcCCcCCCC
Q 005102 170 NNFTGPLPNGFGSGLVSLEKLNLSFNKFNGSIPSNTGNLSSLQGTVDFSHNLFSGSIPASLGNLPEKVYIDLTYNNLSGP 249 (714)
Q Consensus 170 N~l~g~~p~~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~ 249 (714)
|+|+ .+|+..+.++++|++|+|++|+|++..|..|..+++|+ +++|++|.+....+..+ -...++.+.+..|.++..
T Consensus 88 N~l~-~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~-~l~L~~N~~~~~~~~~~-~~~~l~~~~l~~~~~~c~ 164 (192)
T d1w8aa_ 88 NKIK-EISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLT-SLNLASNPFNCNCHLAW-FAEWLRKKSLNGGAARCG 164 (192)
T ss_dssp CCCC-EECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCC-EEECTTCCBCCSGGGHH-HHHHHHHHCCSGGGCBBC
T ss_pred cccc-ccCHHHHhCCCcccccccCCccccccCHHHhcCCcccc-cccccccccccccchHH-HhhhhhhhcccCCCeEeC
Confidence 9998 45555557899999999999999977778889999999 99999999986543222 123466777888888766
Q ss_pred CCCC
Q 005102 250 IPQN 253 (714)
Q Consensus 250 ~p~~ 253 (714)
.|..
T Consensus 165 ~p~~ 168 (192)
T d1w8aa_ 165 APSK 168 (192)
T ss_dssp SSTT
T ss_pred CChh
Confidence 6654
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.69 E-value=1.3e-16 Score=163.57 Aligned_cols=179 Identities=27% Similarity=0.335 Sum_probs=130.9
Q ss_pred eEecCCcEEEEEcCCCCccccCCccccCCCCCCEEEccCCCCcccCChhhcCCCCCCEEEcCCCcCcccCCcccCCCCCC
Q 005102 59 ITCKEQRVVSVSIPKKKLLGFLPSALGSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSGSVPNEIGKLKYL 138 (714)
Q Consensus 59 v~c~~~~~~~l~l~~~~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L 138 (714)
..|. ...++=++++|+ .+|+.+. ++|++|+|++|+|+...+..|.++++|+.|++++|.++...|..|.++++|
T Consensus 8 c~c~---~~~~~C~~~~L~-~lP~~l~--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L 81 (305)
T d1xkua_ 8 CQCH---LRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKL 81 (305)
T ss_dssp CEEE---TTEEECTTSCCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTC
T ss_pred CEec---CCEEEecCCCCC-ccCCCCC--CCCCEEECcCCcCCCcChhHhhccccccccccccccccccchhhhhCCCcc
Confidence 4563 334677777888 4677664 689999999999996666689999999999999999998788899999999
Q ss_pred CEEeccCccCCCCCCcccc------------------------------------------------cccccceeecccC
Q 005102 139 QILDLSQNFFNGSLPVSIV------------------------------------------------QCKRLKALDLSQN 170 (714)
Q Consensus 139 ~~L~Ls~N~l~g~~p~~~~------------------------------------------------~l~~L~~L~l~~N 170 (714)
+.|++++|+++ .+|..+. .+++|+.+++++|
T Consensus 82 ~~L~l~~n~l~-~l~~~~~~~l~~L~~~~n~l~~l~~~~~~~~~~~~~l~~~~n~~~~~~~~~~~~~~l~~L~~l~l~~n 160 (305)
T d1xkua_ 82 ERLYLSKNQLK-ELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADT 160 (305)
T ss_dssp CEEECCSSCCS-BCCSSCCTTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSS
T ss_pred CEecccCCccC-cCccchhhhhhhhhccccchhhhhhhhhhccccccccccccccccccCCCccccccccccCccccccC
Confidence 99999999987 3443321 2234455555555
Q ss_pred cCCCCCCcccccCccccccccccCCcccccCCCCCCCCcccccccccccccCCcCcCccccCCCCcccccCcCCcCCCC
Q 005102 171 NFTGPLPNGFGSGLVSLEKLNLSFNKFNGSIPSNTGNLSSLQGTVDFSHNLFSGSIPASLGNLPEKVYIDLTYNNLSGP 249 (714)
Q Consensus 171 ~l~g~~p~~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~ 249 (714)
.++ .+|..+ +++|+.|++++|.+++..+..+.+++.++ .|++++|.+++..+..+..+++|++|++++|+|+..
T Consensus 161 ~l~-~l~~~~---~~~L~~L~l~~n~~~~~~~~~~~~~~~l~-~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~~l 234 (305)
T d1xkua_ 161 NIT-TIPQGL---PPSLTELHLDGNKITKVDAASLKGLNNLA-KLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKV 234 (305)
T ss_dssp CCC-SCCSSC---CTTCSEEECTTSCCCEECTGGGTTCTTCC-EEECCSSCCCEECTTTGGGSTTCCEEECCSSCCSSC
T ss_pred Ccc-ccCccc---CCccCEEECCCCcCCCCChhHhhcccccc-ccccccccccccccccccccccceeeeccccccccc
Confidence 554 344433 45666777777777766666677777776 777777777766677777777777777777777744
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.66 E-value=1.7e-16 Score=153.20 Aligned_cols=164 Identities=23% Similarity=0.302 Sum_probs=135.8
Q ss_pred CcEEEEEcCCCCccccCCccccCCCCCCEEEccCCCCcccCChhhcCCCCCCEEEcCCCcCcccCCcccCCCCCCCEEec
Q 005102 64 QRVVSVSIPKKKLLGFLPSALGSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSGSVPNEIGKLKYLQILDL 143 (714)
Q Consensus 64 ~~~~~l~l~~~~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L 143 (714)
..++.|++.++.++... .+..+++|++|+|++|++++ ++ .+..+++|+.|++++|++++ +| .+..+++|+.|++
T Consensus 46 ~~L~~L~l~~~~i~~l~--~l~~l~~L~~L~L~~n~i~~-l~-~~~~l~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~l 119 (210)
T d1h6ta2 46 NSIDQIIANNSDIKSVQ--GIQYLPNVTKLFLNGNKLTD-IK-PLANLKNLGWLFLDENKVKD-LS-SLKDLKKLKSLSL 119 (210)
T ss_dssp HTCCEEECTTSCCCCCT--TGGGCTTCCEEECCSSCCCC-CG-GGTTCTTCCEEECCSSCCCC-GG-GGTTCTTCCEEEC
T ss_pred cCccEEECcCCCCCCch--hHhhCCCCCEEeCCCccccC-cc-ccccCccccccccccccccc-cc-ccccccccccccc
Confidence 36788999999988643 48889999999999999986 44 36789999999999999984 55 5889999999999
Q ss_pred cCccCCCCCCcccccccccceeecccCcCCCCCCcccccCccccccccccCCcccccCCCCCCCCcccccccccccccCC
Q 005102 144 SQNFFNGSLPVSIVQCKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLNLSFNKFNGSIPSNTGNLSSLQGTVDFSHNLFS 223 (714)
Q Consensus 144 s~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~~l~l~~N~l~ 223 (714)
++|.+. .+ ..+..+++|+.+++++|.+++ ++ .+ ..+++|+.+++++|++++ ++ .+.++++|+ .|++++|+++
T Consensus 120 ~~~~~~-~~-~~l~~l~~l~~l~~~~n~l~~-~~-~~-~~l~~L~~l~l~~n~l~~-i~-~l~~l~~L~-~L~Ls~N~i~ 191 (210)
T d1h6ta2 120 EHNGIS-DI-NGLVHLPQLESLYLGNNKITD-IT-VL-SRLTKLDTLSLEDNQISD-IV-PLAGLTKLQ-NLYLSKNHIS 191 (210)
T ss_dssp TTSCCC-CC-GGGGGCTTCCEEECCSSCCCC-CG-GG-GGCTTCSEEECCSSCCCC-CG-GGTTCTTCC-EEECCSSCCC
T ss_pred cccccc-cc-ccccccccccccccccccccc-cc-cc-cccccccccccccccccc-cc-cccCCCCCC-EEECCCCCCC
Confidence 999986 33 468889999999999999974 33 23 458999999999999985 44 388899999 9999999998
Q ss_pred cCcCccccCCCCcccccCcC
Q 005102 224 GSIPASLGNLPEKVYIDLTY 243 (714)
Q Consensus 224 g~~p~~~~~l~~L~~l~l~~ 243 (714)
. +| .++.+++|++|++++
T Consensus 192 ~-l~-~l~~l~~L~~L~Ls~ 209 (210)
T d1h6ta2 192 D-LR-ALAGLKNLDVLELFS 209 (210)
T ss_dssp B-CG-GGTTCTTCSEEEEEE
T ss_pred C-Ch-hhcCCCCCCEEEccC
Confidence 4 55 689999999999864
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.65 E-value=1.8e-16 Score=156.58 Aligned_cols=200 Identities=16% Similarity=0.118 Sum_probs=154.3
Q ss_pred CCCcccceEecC-----------CcEEEEEcCCCCccccCCccccCCCCCCEEEccCCCCcccCC-hhhcCCCCCCEEEc
Q 005102 52 NPCSWNGITCKE-----------QRVVSVSIPKKKLLGFLPSALGSLTDLRHVNLRNNKFFGSLP-LELLEAQGLQSLVL 119 (714)
Q Consensus 52 ~~c~w~gv~c~~-----------~~~~~l~l~~~~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~L 119 (714)
|-|+++.|.|.. ..++.|+|++|+++...+..|.++++|++|+|++|.+...++ ..|..+++++.|++
T Consensus 6 C~C~~~~i~c~~~~l~~iP~~l~~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~ 85 (242)
T d1xwdc1 6 CHCSNRVFLCQESKVTEIPSDLPRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRI 85 (242)
T ss_dssp EEECSSEEEEESCSCSSCCSCSCSCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEE
T ss_pred CCCcCCEEEEeCCCCCCcCCCCCCCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeeccccccccccccccc
Confidence 447888899962 268889999999987767789999999999999999876554 45788999999987
Q ss_pred C-CCcCcccCCcccCCCCCCCEEeccCccCCCCCCc-ccccccccceeecccCcCCCCCCcccccCc-cccccccccCCc
Q 005102 120 Y-GNSFSGSVPNEIGKLKYLQILDLSQNFFNGSLPV-SIVQCKRLKALDLSQNNFTGPLPNGFGSGL-VSLEKLNLSFNK 196 (714)
Q Consensus 120 ~-~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~-~~~~l~~L~~L~l~~N~l~g~~p~~~~~~l-~~L~~L~l~~N~ 196 (714)
. .|.+....+..|.++++|+.|++++|++....+. .+..+..|..+..+++.+. .++...+.++ ..++.|++++|+
T Consensus 86 ~~~n~l~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~-~i~~~~~~~~~~~l~~L~l~~n~ 164 (242)
T d1xwdc1 86 EKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIH-TIERNSFVGLSFESVILWLNKNG 164 (242)
T ss_dssp ECCTTCCEECTTSEECCTTCCEEEEESCCCCSCCCCTTTCBSSCEEEEEESCTTCC-EECTTSSTTSBSSCEEEECCSSC
T ss_pred cccccccccccccccccccccccccchhhhcccccccccccccccccccccccccc-cccccccccccccceeeeccccc
Confidence 5 5788878888899999999999999999743222 3345566666677777776 4444333334 478889999999
Q ss_pred ccccCCCCCCCCcccccccccccccCCcCcCccccCCCCcccccCcCCcCCCCCCCC
Q 005102 197 FNGSIPSNTGNLSSLQGTVDFSHNLFSGSIPASLGNLPEKVYIDLTYNNLSGPIPQN 253 (714)
Q Consensus 197 l~g~~p~~~~~l~~L~~~l~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~~ 253 (714)
++ .++....+..++...+++++|+++...+..|.++++|++|++++|+++..++..
T Consensus 165 l~-~i~~~~~~~~~l~~~~~l~~n~l~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~ 220 (242)
T d1xwdc1 165 IQ-EIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYG 220 (242)
T ss_dssp CC-EECTTTTTTCCEEEEECTTCTTCCCCCTTTTTTSCCCSEEECTTSCCCCCCSSS
T ss_pred cc-ccccccccchhhhccccccccccccccHHHhcCCCCCCEEECCCCcCCccCHHH
Confidence 99 666666667777645678889998655567999999999999999999665543
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.64 E-value=6.6e-16 Score=147.62 Aligned_cols=158 Identities=25% Similarity=0.376 Sum_probs=89.0
Q ss_pred cEEEEEcCCCCccccCCccccCCCCCCEEEccCCCCcccCChhhcCCCCCCEEEcCCCcCcccCCcccCCCCCCCEEecc
Q 005102 65 RVVSVSIPKKKLLGFLPSALGSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSGSVPNEIGKLKYLQILDLS 144 (714)
Q Consensus 65 ~~~~l~l~~~~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls 144 (714)
+++.|++.+++++.. +.+..+++|++|+|++|++++..| +.++++|+.|++++|.+. .++ .+.++++|+.|+++
T Consensus 41 ~l~~L~l~~~~i~~l--~~l~~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L~l~~n~~~-~~~-~l~~l~~L~~L~l~ 114 (199)
T d2omxa2 41 QVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIA-DIT-PLANLTNLTGLTLF 114 (199)
T ss_dssp TCCEEECTTSCCCCC--TTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCC-CCG-GGTTCTTCSEEECC
T ss_pred CCCEEECCCCCCCCc--cccccCCCcCcCccccccccCccc--ccCCcccccccccccccc-ccc-cccccccccccccc
Confidence 555666666666542 235566666666666666664322 566666666666666665 333 25666666666666
Q ss_pred CccCCCCCCcccccccccceeecccCcCCCCCCcccccCccccccccccCCcccccCCCCCCCCcccccccccccccCCc
Q 005102 145 QNFFNGSLPVSIVQCKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLNLSFNKFNGSIPSNTGNLSSLQGTVDFSHNLFSG 224 (714)
Q Consensus 145 ~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~~l~l~~N~l~g 224 (714)
+|.+... ..+..+++|+.|++++|++. .+| .+ ..+++|+.|++++|++++ ++ .++++++|+ .|++++|+++.
T Consensus 115 ~~~~~~~--~~~~~l~~L~~L~l~~n~l~-~~~-~l-~~~~~L~~L~l~~n~l~~-l~-~l~~l~~L~-~L~ls~N~i~~ 186 (199)
T d2omxa2 115 NNQITDI--DPLKNLTNLNRLELSSNTIS-DIS-AL-SGLTSLQQLNFSSNQVTD-LK-PLANLTTLE-RLDISSNKVSD 186 (199)
T ss_dssp SSCCCCC--GGGTTCTTCSEEECCSSCCC-CCG-GG-TTCTTCSEEECCSSCCCC-CG-GGTTCTTCC-EEECCSSCCCC
T ss_pred ccccccc--cccchhhhhHHhhhhhhhhc-ccc-cc-cccccccccccccccccC-Cc-cccCCCCCC-EEECCCCCCCC
Confidence 6666532 23555666666666666665 333 23 235666666666666653 22 255566666 66666666653
Q ss_pred CcCccccCCCCccc
Q 005102 225 SIPASLGNLPEKVY 238 (714)
Q Consensus 225 ~~p~~~~~l~~L~~ 238 (714)
++ .++.+++|+.
T Consensus 187 -i~-~l~~L~~L~~ 198 (199)
T d2omxa2 187 -IS-VLAKLTNLES 198 (199)
T ss_dssp -CG-GGGGCTTCSE
T ss_pred -Cc-cccCCCCCCc
Confidence 22 3555555544
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.63 E-value=6.3e-16 Score=147.76 Aligned_cols=164 Identities=20% Similarity=0.281 Sum_probs=135.8
Q ss_pred EcCCCCccccCCccccCCCCCCEEEccCCCCcccCChhhcCCCCCCEEEcCCCcCcccCCcccCCCCCCCEEeccCccCC
Q 005102 70 SIPKKKLLGFLPSALGSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSGSVPNEIGKLKYLQILDLSQNFFN 149 (714)
Q Consensus 70 ~l~~~~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~ 149 (714)
.+..+++++.++ ...+.+|++|++++|.++. ++ .+..+++|++|+|++|++++..| ++++++|+.|++++|.+.
T Consensus 24 ~l~~~~~~~~~~--~~~l~~l~~L~l~~~~i~~-l~-~l~~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L~l~~n~~~ 97 (199)
T d2omxa2 24 VLGKTNVTDTVS--QTDLDQVTTLQADRLGIKS-ID-GVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIA 97 (199)
T ss_dssp HTTCSSTTSEEC--HHHHTTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCC
T ss_pred HhCCCCCCCccC--HHHhcCCCEEECCCCCCCC-cc-ccccCCCcCcCccccccccCccc--ccCCcccccccccccccc
Confidence 355666666543 3467899999999999984 43 47889999999999999996433 999999999999999997
Q ss_pred CCCCcccccccccceeecccCcCCCCCCcccccCccccccccccCCcccccCCCCCCCCcccccccccccccCCcCcCcc
Q 005102 150 GSLPVSIVQCKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLNLSFNKFNGSIPSNTGNLSSLQGTVDFSHNLFSGSIPAS 229 (714)
Q Consensus 150 g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~~l~l~~N~l~g~~p~~ 229 (714)
.+| .+.++++|+.|++++|.+.. ++ .+ ..+++|+.|++++|++. .+| .+..+++++ .+++++|++++.. .
T Consensus 98 -~~~-~l~~l~~L~~L~l~~~~~~~-~~-~~-~~l~~L~~L~l~~n~l~-~~~-~l~~~~~L~-~L~l~~n~l~~l~--~ 167 (199)
T d2omxa2 98 -DIT-PLANLTNLTGLTLFNNQITD-ID-PL-KNLTNLNRLELSSNTIS-DIS-ALSGLTSLQ-QLNFSSNQVTDLK--P 167 (199)
T ss_dssp -CCG-GGTTCTTCSEEECCSSCCCC-CG-GG-TTCTTCSEEECCSSCCC-CCG-GGTTCTTCS-EEECCSSCCCCCG--G
T ss_pred -ccc-cccccccccccccccccccc-cc-cc-chhhhhHHhhhhhhhhc-ccc-ccccccccc-ccccccccccCCc--c
Confidence 454 48899999999999999874 33 23 45899999999999997 454 588899999 9999999998643 4
Q ss_pred ccCCCCcccccCcCCcCCCC
Q 005102 230 LGNLPEKVYIDLTYNNLSGP 249 (714)
Q Consensus 230 ~~~l~~L~~l~l~~N~l~~~ 249 (714)
++.+++|+.|++++|+++..
T Consensus 168 l~~l~~L~~L~ls~N~i~~i 187 (199)
T d2omxa2 168 LANLTTLERLDISSNKVSDI 187 (199)
T ss_dssp GTTCTTCCEEECCSSCCCCC
T ss_pred ccCCCCCCEEECCCCCCCCC
Confidence 89999999999999999864
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.60 E-value=1.8e-15 Score=159.86 Aligned_cols=172 Identities=26% Similarity=0.365 Sum_probs=134.3
Q ss_pred CcEEEEEcCCCCccccCCccccCCCCCCEEEccCCCCcccCChhhcCCCCCCEEEcCCCcCcccCCcccCCCCCCCEEec
Q 005102 64 QRVVSVSIPKKKLLGFLPSALGSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSGSVPNEIGKLKYLQILDL 143 (714)
Q Consensus 64 ~~~~~l~l~~~~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L 143 (714)
..+..+++.+|.+++..| +...++|+.|++++|+++. + +.+..+++|+.|++++|.+++..+ ++.+++|+.|++
T Consensus 197 ~~~~~l~l~~n~i~~~~~--~~~~~~L~~L~l~~n~l~~-~-~~l~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l 270 (384)
T d2omza2 197 TNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKD-I-GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKL 270 (384)
T ss_dssp TTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCC-C-GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEEC
T ss_pred cccceeeccCCccCCCCc--ccccCCCCEEECCCCCCCC-c-chhhcccccchhccccCccCCCCc--ccccccCCEeec
Confidence 467778888888887654 5667889999999998874 3 367788899999999999885433 778889999999
Q ss_pred cCccCCCCCCcccccccccceeecccCcCCCCCCcccccCccccccccccCCcccccCCCCCCCCcccccccccccccCC
Q 005102 144 SQNFFNGSLPVSIVQCKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLNLSFNKFNGSIPSNTGNLSSLQGTVDFSHNLFS 223 (714)
Q Consensus 144 s~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~~l~l~~N~l~ 223 (714)
++|++++.. .+..+..++.++++.|.+++ ++. + ..+++|+.|++++|++++.. .+..+++|+ .|++++|+|+
T Consensus 271 ~~~~l~~~~--~~~~~~~l~~l~~~~n~l~~-~~~-~-~~~~~l~~L~ls~n~l~~l~--~l~~l~~L~-~L~L~~n~l~ 342 (384)
T d2omza2 271 GANQISNIS--PLAGLTALTNLELNENQLED-ISP-I-SNLKNLTYLTLYFNNISDIS--PVSSLTKLQ-RLFFANNKVS 342 (384)
T ss_dssp CSSCCCCCG--GGTTCTTCSEEECCSSCCSC-CGG-G-GGCTTCSEEECCSSCCSCCG--GGGGCTTCC-EEECCSSCCC
T ss_pred cCcccCCCC--cccccccccccccccccccc-ccc-c-chhcccCeEECCCCCCCCCc--ccccCCCCC-EEECCCCCCC
Confidence 999987533 36778888888888888874 332 3 35788888899999888543 267788888 8889988887
Q ss_pred cCcCccccCCCCcccccCcCCcCCCCCC
Q 005102 224 GSIPASLGNLPEKVYIDLTYNNLSGPIP 251 (714)
Q Consensus 224 g~~p~~~~~l~~L~~l~l~~N~l~~~~p 251 (714)
+ ++ .++.+++|++|++++|++++.+|
T Consensus 343 ~-l~-~l~~l~~L~~L~l~~N~l~~l~~ 368 (384)
T d2omza2 343 D-VS-SLANLTNINWLSAGHNQISDLTP 368 (384)
T ss_dssp C-CG-GGGGCTTCCEEECCSSCCCBCGG
T ss_pred C-Ch-hHcCCCCCCEEECCCCcCCCChh
Confidence 4 44 58888889999999998887765
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.59 E-value=1.8e-15 Score=145.86 Aligned_cols=164 Identities=24% Similarity=0.327 Sum_probs=135.4
Q ss_pred EcCCCCccccCCccccCCCCCCEEEccCCCCcccCChhhcCCCCCCEEEcCCCcCcccCCcccCCCCCCCEEeccCccCC
Q 005102 70 SIPKKKLLGFLPSALGSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSGSVPNEIGKLKYLQILDLSQNFFN 149 (714)
Q Consensus 70 ~l~~~~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~ 149 (714)
.+..+.+++.++. ..|.+|++|++++|.++.. + .+..+++|+.|+|++|.+++ ++ .++.+++|+.|++++|+++
T Consensus 30 ~l~~~~~~~~~~~--~~L~~L~~L~l~~~~i~~l-~-~l~~l~~L~~L~L~~n~i~~-l~-~~~~l~~L~~L~l~~n~i~ 103 (210)
T d1h6ta2 30 NLKKKSVTDAVTQ--NELNSIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTD-IK-PLANLKNLGWLFLDENKVK 103 (210)
T ss_dssp HTTCSCTTSEECH--HHHHTCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCC-CG-GGTTCTTCCEEECCSSCCC
T ss_pred HhCcCccCCccCH--HHhcCccEEECcCCCCCCc-h-hHhhCCCCCEEeCCCccccC-cc-ccccCcccccccccccccc
Confidence 4556666666553 3577899999999999853 3 37889999999999999995 44 3789999999999999998
Q ss_pred CCCCcccccccccceeecccCcCCCCCCcccccCccccccccccCCcccccCCCCCCCCcccccccccccccCCcCcCcc
Q 005102 150 GSLPVSIVQCKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLNLSFNKFNGSIPSNTGNLSSLQGTVDFSHNLFSGSIPAS 229 (714)
Q Consensus 150 g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~~l~l~~N~l~g~~p~~ 229 (714)
.+| .+..+++|+.|++++|.+. .++. + ..+++|+.+++++|.+++ +..+.++++|+ .+++++|++++.. .
T Consensus 104 -~l~-~l~~l~~L~~L~l~~~~~~-~~~~-l-~~l~~l~~l~~~~n~l~~--~~~~~~l~~L~-~l~l~~n~l~~i~--~ 173 (210)
T d1h6ta2 104 -DLS-SLKDLKKLKSLSLEHNGIS-DING-L-VHLPQLESLYLGNNKITD--ITVLSRLTKLD-TLSLEDNQISDIV--P 173 (210)
T ss_dssp -CGG-GGTTCTTCCEEECTTSCCC-CCGG-G-GGCTTCCEEECCSSCCCC--CGGGGGCTTCS-EEECCSSCCCCCG--G
T ss_pred -ccc-ccccccccccccccccccc-cccc-c-cccccccccccccccccc--ccccccccccc-ccccccccccccc--c
Confidence 455 5888999999999999987 4543 4 358999999999999984 33567889999 9999999998643 3
Q ss_pred ccCCCCcccccCcCCcCCCC
Q 005102 230 LGNLPEKVYIDLTYNNLSGP 249 (714)
Q Consensus 230 ~~~l~~L~~l~l~~N~l~~~ 249 (714)
++++++|+.|++++|+++..
T Consensus 174 l~~l~~L~~L~Ls~N~i~~l 193 (210)
T d1h6ta2 174 LAGLTKLQNLYLSKNHISDL 193 (210)
T ss_dssp GTTCTTCCEEECCSSCCCBC
T ss_pred ccCCCCCCEEECCCCCCCCC
Confidence 89999999999999999853
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.58 E-value=3.9e-15 Score=145.39 Aligned_cols=172 Identities=24% Similarity=0.346 Sum_probs=141.8
Q ss_pred CcEEEEEcCCCCccccCCccccCCCCCCEEEccCCCCcccCChhhcCCCCCCEEEcCCCcCcccCCcccCCCCCCCEEec
Q 005102 64 QRVVSVSIPKKKLLGFLPSALGSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSGSVPNEIGKLKYLQILDL 143 (714)
Q Consensus 64 ~~~~~l~l~~~~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L 143 (714)
..++.|++.+|+++.. + .+..+++|++|+|++|++++..| +..+++|+.|++++|.++ .++ .+..+++|+.|++
T Consensus 41 ~~L~~L~l~~~~i~~l-~-~l~~l~~L~~L~ls~n~i~~~~~--l~~l~~l~~l~~~~n~~~-~i~-~l~~l~~L~~l~l 114 (227)
T d1h6ua2 41 DGITTLSAFGTGVTTI-E-GVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLK-NVS-AIAGLQSIKTLDL 114 (227)
T ss_dssp HTCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCS-CCG-GGTTCTTCCEEEC
T ss_pred CCcCEEECCCCCCCcc-h-hHhcCCCCcEeecCCceeecccc--cccccccccccccccccc-ccc-ccccccccccccc
Confidence 4789999999999864 3 58999999999999999986444 889999999999999997 444 5889999999999
Q ss_pred cCccCCCCCCcccccccccceeecccCcCCCCCCcccccCccccccccccCCcccccCCCCCCCCcccccccccccccCC
Q 005102 144 SQNFFNGSLPVSIVQCKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLNLSFNKFNGSIPSNTGNLSSLQGTVDFSHNLFS 223 (714)
Q Consensus 144 s~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~~l~l~~N~l~ 223 (714)
++|...+. ..+.....+..+.++.+.+....+ + ...++|+.|++++|.+++.. .+.++++|+ .|++++|+++
T Consensus 115 ~~~~~~~~--~~~~~~~~~~~l~~~~~~~~~~~~--~-~~~~~L~~L~l~~n~~~~~~--~l~~l~~L~-~L~Ls~n~l~ 186 (227)
T d1h6ua2 115 TSTQITDV--TPLAGLSNLQVLYLDLNQITNISP--L-AGLTNLQYLSIGNAQVSDLT--PLANLSKLT-TLKADDNKIS 186 (227)
T ss_dssp TTSCCCCC--GGGTTCTTCCEEECCSSCCCCCGG--G-GGCTTCCEEECCSSCCCCCG--GGTTCTTCC-EEECCSSCCC
T ss_pred cccccccc--chhccccchhhhhchhhhhchhhh--h-ccccccccccccccccccch--hhcccccce-ecccCCCccC
Confidence 99998753 346677889999999998874332 3 35789999999999987433 378899999 9999999998
Q ss_pred cCcCccccCCCCcccccCcCCcCCCCCC
Q 005102 224 GSIPASLGNLPEKVYIDLTYNNLSGPIP 251 (714)
Q Consensus 224 g~~p~~~~~l~~L~~l~l~~N~l~~~~p 251 (714)
+. + .++.+++|++|++++|++++..|
T Consensus 187 ~l-~-~l~~l~~L~~L~Ls~N~lt~i~~ 212 (227)
T d1h6ua2 187 DI-S-PLASLPNLIEVHLKNNQISDVSP 212 (227)
T ss_dssp CC-G-GGGGCTTCCEEECTTSCCCBCGG
T ss_pred CC-h-hhcCCCCCCEEECcCCcCCCCcc
Confidence 64 3 38899999999999999986543
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.54 E-value=1.1e-14 Score=153.71 Aligned_cols=165 Identities=27% Similarity=0.349 Sum_probs=131.9
Q ss_pred CcEEEEEcCCCCccccCCccccCCCCCCEEEccCCCCcccCChhhcCCCCCCEEEcCCCcCcccCCcccCCCCCCCEEec
Q 005102 64 QRVVSVSIPKKKLLGFLPSALGSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSGSVPNEIGKLKYLQILDL 143 (714)
Q Consensus 64 ~~~~~l~l~~~~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~L 143 (714)
.+++.|++.+|.++.. +.+..+++|+.|++++|.+++..+ +..+++|+.|++++|.+++.. .+..++.++.+++
T Consensus 219 ~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~~~l~~~~--~~~~~~~l~~l~~ 292 (384)
T d2omza2 219 TNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNIS--PLAGLTALTNLEL 292 (384)
T ss_dssp TTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCG--GGTTCTTCSEEEC
T ss_pred CCCCEEECCCCCCCCc--chhhcccccchhccccCccCCCCc--ccccccCCEeeccCcccCCCC--ccccccccccccc
Confidence 4778888888888763 467888899999999998886443 777888999999999887433 3778888999999
Q ss_pred cCccCCCCCCcccccccccceeecccCcCCCCCCcccccCccccccccccCCcccccCCCCCCCCcccccccccccccCC
Q 005102 144 SQNFFNGSLPVSIVQCKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLNLSFNKFNGSIPSNTGNLSSLQGTVDFSHNLFS 223 (714)
Q Consensus 144 s~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~~l~l~~N~l~ 223 (714)
+.|.+++ +..+..+.+++.|++++|++++ ++. + ..+++|+.|+|++|+|+ .+| .+.++++|+ .|++++|+|+
T Consensus 293 ~~n~l~~--~~~~~~~~~l~~L~ls~n~l~~-l~~-l-~~l~~L~~L~L~~n~l~-~l~-~l~~l~~L~-~L~l~~N~l~ 364 (384)
T d2omza2 293 NENQLED--ISPISNLKNLTYLTLYFNNISD-ISP-V-SSLTKLQRLFFANNKVS-DVS-SLANLTNIN-WLSAGHNQIS 364 (384)
T ss_dssp CSSCCSC--CGGGGGCTTCSEEECCSSCCSC-CGG-G-GGCTTCCEEECCSSCCC-CCG-GGGGCTTCC-EEECCSSCCC
T ss_pred ccccccc--ccccchhcccCeEECCCCCCCC-Ccc-c-ccCCCCCEEECCCCCCC-CCh-hHcCCCCCC-EEECCCCcCC
Confidence 9998875 3457788889999999999885 432 3 45888999999999887 455 588888888 8999999998
Q ss_pred cCcCccccCCCCcccccCcCC
Q 005102 224 GSIPASLGNLPEKVYIDLTYN 244 (714)
Q Consensus 224 g~~p~~~~~l~~L~~l~l~~N 244 (714)
+..| +.++++|+.|++++|
T Consensus 365 ~l~~--l~~l~~L~~L~L~~N 383 (384)
T d2omza2 365 DLTP--LANLTRITQLGLNDQ 383 (384)
T ss_dssp BCGG--GTTCTTCSEEECCCE
T ss_pred CChh--hccCCCCCEeeCCCC
Confidence 7665 888889999999887
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.51 E-value=3.5e-14 Score=138.44 Aligned_cols=172 Identities=19% Similarity=0.300 Sum_probs=142.3
Q ss_pred cccceEecCCcEEEEEcCCCCccccCCccccCCCCCCEEEccCCCCcccCChhhcCCCCCCEEEcCCCcCcccCCcccCC
Q 005102 55 SWNGITCKEQRVVSVSIPKKKLLGFLPSALGSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSGSVPNEIGK 134 (714)
Q Consensus 55 ~w~gv~c~~~~~~~l~l~~~~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~ 134 (714)
+..|+. ...+++.|+|++|.+++..| +..+++|++|++++|.++ .++ .+..+++|+.|++++|...+. ..+..
T Consensus 55 ~l~~l~-~l~~L~~L~ls~n~i~~~~~--l~~l~~l~~l~~~~n~~~-~i~-~l~~l~~L~~l~l~~~~~~~~--~~~~~ 127 (227)
T d1h6ua2 55 TIEGVQ-YLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLK-NVS-AIAGLQSIKTLDLTSTQITDV--TPLAG 127 (227)
T ss_dssp CCTTGG-GCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCS-CCG-GGTTCTTCCEEECTTSCCCCC--GGGTT
T ss_pred cchhHh-cCCCCcEeecCCceeecccc--cccccccccccccccccc-ccc-ccccccccccccccccccccc--chhcc
Confidence 445542 35689999999999998654 899999999999999997 344 578999999999999998743 34677
Q ss_pred CCCCCEEeccCccCCCCCCcccccccccceeecccCcCCCCCCcccccCccccccccccCCcccccCCCCCCCCcccccc
Q 005102 135 LKYLQILDLSQNFFNGSLPVSIVQCKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLNLSFNKFNGSIPSNTGNLSSLQGT 214 (714)
Q Consensus 135 l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~~ 214 (714)
.+.++.+.++++.+... ..+..+++|+.|++++|.+++. +. + .++++|+.|+|++|++++ +| .+.++++|+ .
T Consensus 128 ~~~~~~l~~~~~~~~~~--~~~~~~~~L~~L~l~~n~~~~~-~~-l-~~l~~L~~L~Ls~n~l~~-l~-~l~~l~~L~-~ 199 (227)
T d1h6ua2 128 LSNLQVLYLDLNQITNI--SPLAGLTNLQYLSIGNAQVSDL-TP-L-ANLSKLTTLKADDNKISD-IS-PLASLPNLI-E 199 (227)
T ss_dssp CTTCCEEECCSSCCCCC--GGGGGCTTCCEEECCSSCCCCC-GG-G-TTCTTCCEEECCSSCCCC-CG-GGGGCTTCC-E
T ss_pred ccchhhhhchhhhhchh--hhhccccccccccccccccccc-hh-h-cccccceecccCCCccCC-Ch-hhcCCCCCC-E
Confidence 89999999999999743 3477889999999999999743 32 4 468999999999999984 55 378899999 9
Q ss_pred cccccccCCcCcCccccCCCCcccccCcC
Q 005102 215 VDFSHNLFSGSIPASLGNLPEKVYIDLTY 243 (714)
Q Consensus 215 l~l~~N~l~g~~p~~~~~l~~L~~l~l~~ 243 (714)
|++++|++++.. .++++++|+.|++++
T Consensus 200 L~Ls~N~lt~i~--~l~~l~~L~~L~lsn 226 (227)
T d1h6ua2 200 VHLKNNQISDVS--PLANTSNLFIVTLTN 226 (227)
T ss_dssp EECTTSCCCBCG--GGTTCTTCCEEEEEE
T ss_pred EECcCCcCCCCc--ccccCCCCCEEEeeC
Confidence 999999999654 389999999999874
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.50 E-value=1.2e-13 Score=135.84 Aligned_cols=206 Identities=13% Similarity=-0.034 Sum_probs=149.9
Q ss_pred cceEecCCcEEEEEcCCCCccccCCccccCCCCCCEEEccCCCCcccCChhhcCCCCCCEEEcCCCcCcccCCc-ccCCC
Q 005102 57 NGITCKEQRVVSVSIPKKKLLGFLPSALGSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSGSVPN-EIGKL 135 (714)
Q Consensus 57 ~gv~c~~~~~~~l~l~~~~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~-~~~~l 135 (714)
+-..|.. + .++.++++++ .+|+.+. +++++|+|++|+|+...+..|.++++|++|+|++|.+...+|. .|.++
T Consensus 4 ~~C~C~~-~--~i~c~~~~l~-~iP~~l~--~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l 77 (242)
T d1xwdc1 4 RICHCSN-R--VFLCQESKVT-EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNL 77 (242)
T ss_dssp SSEEECS-S--EEEEESCSCS-SCCSCSC--SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESC
T ss_pred CcCCCcC-C--EEEEeCCCCC-CcCCCCC--CCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeeccccccc
Confidence 3345643 3 5677788888 6776653 5899999999999966666789999999999999999866554 68899
Q ss_pred CCCCEEecc-CccCCCCCCcccccccccceeecccCcCCCCCCcccccCccccccccccCCcccccCCCCCCCCc-cccc
Q 005102 136 KYLQILDLS-QNFFNGSLPVSIVQCKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLNLSFNKFNGSIPSNTGNLS-SLQG 213 (714)
Q Consensus 136 ~~L~~L~Ls-~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~-~L~~ 213 (714)
++++.|++. .|++....+..|.++++|++|++++|.+....+......+..|..+..+++.+...-+..+..+. .+.
T Consensus 78 ~~l~~l~~~~~n~l~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i~~~~~~~~~~~l~- 156 (242)
T d1xwdc1 78 PKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESV- 156 (242)
T ss_dssp TTCCEEEEECCTTCCEECTTSEECCTTCCEEEEESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEECTTSSTTSBSSCE-
T ss_pred cccccccccccccccccccccccccccccccccchhhhcccccccccccccccccccccccccccccccccccccccce-
Confidence 999999986 47888777788999999999999999997443333334566777777788888755556666665 455
Q ss_pred ccccccccCCcCcCccccCCCCc-ccccCcCCcCCCCCCCCccccCCCCcccccCCCC
Q 005102 214 TVDFSHNLFSGSIPASLGNLPEK-VYIDLTYNNLSGPIPQNGALMNRGPTAFIGNPRL 270 (714)
Q Consensus 214 ~l~l~~N~l~g~~p~~~~~l~~L-~~l~l~~N~l~~~~p~~~~~~~~~~~~~~~n~~~ 270 (714)
.+++++|+++...+..+ ..+++ +.+++++|+++...+..+............++.+
T Consensus 157 ~L~l~~n~l~~i~~~~~-~~~~l~~~~~l~~n~l~~l~~~~f~~l~~L~~L~Ls~N~l 213 (242)
T d1xwdc1 157 ILWLNKNGIQEIHNCAF-NGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRI 213 (242)
T ss_dssp EEECCSSCCCEECTTTT-TTCCEEEEECTTCTTCCCCCTTTTTTSCCCSEEECTTSCC
T ss_pred eeecccccccccccccc-cchhhhccccccccccccccHHHhcCCCCCCEEECCCCcC
Confidence 89999999995555444 44554 4557888999977665554433334444444333
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.50 E-value=1.3e-14 Score=133.19 Aligned_cols=112 Identities=17% Similarity=0.070 Sum_probs=83.9
Q ss_pred cccCCCCCCEEEccCCCCcccCChhhcCCCCCCEEEcCCCcCcccCCcccCCCCCCCEEeccCccCCCCCCccccccccc
Q 005102 83 ALGSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSGSVPNEIGKLKYLQILDLSQNFFNGSLPVSIVQCKRL 162 (714)
Q Consensus 83 ~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L 162 (714)
.+.+...|++|+|++|+|+ .+|..+..+++|+.|+|++|.++ .++ .|..+++|+.|+|++|+++...+..+..+++|
T Consensus 13 ~~~n~~~lr~L~L~~n~I~-~i~~~~~~l~~L~~L~Ls~N~i~-~l~-~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L 89 (162)
T d1a9na_ 13 QYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KLD-GFPLLRRLKTLLVNNNRICRIGEGLDQALPDL 89 (162)
T ss_dssp EEECTTSCEEEECTTSCCC-SCCCGGGGTTCCSEEECCSSCCC-EEC-CCCCCSSCCEEECCSSCCCEECSCHHHHCTTC
T ss_pred hccCcCcCcEEECCCCCCC-ccCccccccccCCEEECCCCCCC-ccC-CcccCcchhhhhcccccccCCCcccccccccc
Confidence 4667788899999999987 45666677888999999999888 443 47888889999999999885444445678888
Q ss_pred ceeecccCcCCCCCCc-ccccCccccccccccCCccc
Q 005102 163 KALDLSQNNFTGPLPN-GFGSGLVSLEKLNLSFNKFN 198 (714)
Q Consensus 163 ~~L~l~~N~l~g~~p~-~~~~~l~~L~~L~l~~N~l~ 198 (714)
+.|+|++|+++ .++. .....+++|+.|++++|.++
T Consensus 90 ~~L~L~~N~i~-~~~~l~~l~~l~~L~~L~l~~N~i~ 125 (162)
T d1a9na_ 90 TELILTNNSLV-ELGDLDPLASLKSLTYLCILRNPVT 125 (162)
T ss_dssp CEEECCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGG
T ss_pred ccceecccccc-ccccccccccccccchhhcCCCccc
Confidence 88888888886 4443 22245677777777777765
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.50 E-value=4.6e-15 Score=136.25 Aligned_cols=128 Identities=21% Similarity=0.251 Sum_probs=106.8
Q ss_pred hhcCCCCCCEEEcCCCcCcccCCcccCCCCCCCEEeccCccCCCCCCcccccccccceeecccCcCCCCCCcccccCccc
Q 005102 107 ELLEAQGLQSLVLYGNSFSGSVPNEIGKLKYLQILDLSQNFFNGSLPVSIVQCKRLKALDLSQNNFTGPLPNGFGSGLVS 186 (714)
Q Consensus 107 ~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~l~~ 186 (714)
.+.+..+|+.|+|++|+|+ .+|..+..+++|+.|+|++|+++ .++ .|..+++|++|++++|+++ .+|..++..+++
T Consensus 13 ~~~n~~~lr~L~L~~n~I~-~i~~~~~~l~~L~~L~Ls~N~i~-~l~-~~~~l~~L~~L~ls~N~i~-~l~~~~~~~l~~ 88 (162)
T d1a9na_ 13 QYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KLD-GFPLLRRLKTLLVNNNRIC-RIGEGLDQALPD 88 (162)
T ss_dssp EEECTTSCEEEECTTSCCC-SCCCGGGGTTCCSEEECCSSCCC-EEC-CCCCCSSCCEEECCSSCCC-EECSCHHHHCTT
T ss_pred hccCcCcCcEEECCCCCCC-ccCccccccccCCEEECCCCCCC-ccC-CcccCcchhhhhccccccc-CCCccccccccc
Confidence 3567788999999999998 67877788999999999999998 564 5889999999999999998 566666556899
Q ss_pred cccccccCCcccccCC--CCCCCCcccccccccccccCCcCcC----ccccCCCCcccccC
Q 005102 187 LEKLNLSFNKFNGSIP--SNTGNLSSLQGTVDFSHNLFSGSIP----ASLGNLPEKVYIDL 241 (714)
Q Consensus 187 L~~L~l~~N~l~g~~p--~~~~~l~~L~~~l~l~~N~l~g~~p----~~~~~l~~L~~l~l 241 (714)
|+.|+|++|+++ .++ ..+..+++|+ .+++++|+++. .| ..++.+|+|++||-
T Consensus 89 L~~L~L~~N~i~-~~~~l~~l~~l~~L~-~L~l~~N~i~~-~~~~r~~~i~~lp~L~~LD~ 146 (162)
T d1a9na_ 89 LTELILTNNSLV-ELGDLDPLASLKSLT-YLCILRNPVTN-KKHYRLYVIYKVPQVRVLDF 146 (162)
T ss_dssp CCEEECCSCCCC-CGGGGGGGGGCTTCC-EEECCSSGGGG-STTHHHHHHHHCTTCSEETT
T ss_pred cccceecccccc-ccccccccccccccc-hhhcCCCcccc-ccchHHHHHHHCCCcCeeCC
Confidence 999999999998 444 3677888998 99999999974 34 35788899998873
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.49 E-value=5e-14 Score=122.90 Aligned_cols=101 Identities=29% Similarity=0.365 Sum_probs=61.7
Q ss_pred EEEcCCCCccccCCccccCCCCCCEEEccCCCCcccCChhhcCCCCCCEEEcCCCcCcccCCcccCCCCCCCEEeccCcc
Q 005102 68 SVSIPKKKLLGFLPSALGSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSGSVPNEIGKLKYLQILDLSQNF 147 (714)
Q Consensus 68 ~l~l~~~~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~ 147 (714)
.|+|++|+++. ++ .+..+++|++|+|++|+|+ .+|..+..+++|+.|++++|.|+ .+| .++.+++|+.|++++|+
T Consensus 2 ~L~Ls~n~l~~-l~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~-~l~-~~~~l~~L~~L~l~~N~ 76 (124)
T d1dcea3 2 VLHLAHKDLTV-LC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVD-GVANLPRLQELLLCNNR 76 (124)
T ss_dssp EEECTTSCCSS-CC-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCC-CCG-GGTTCSSCCEEECCSSC
T ss_pred EEEcCCCCCCC-Cc-ccccCCCCCEEECCCCccC-cchhhhhhhhccccccccccccc-ccC-ccccccccCeEECCCCc
Confidence 35666666663 23 3666666666666666665 45556666666666666666666 333 36666666666666666
Q ss_pred CCCCC-CcccccccccceeecccCcCC
Q 005102 148 FNGSL-PVSIVQCKRLKALDLSQNNFT 173 (714)
Q Consensus 148 l~g~~-p~~~~~l~~L~~L~l~~N~l~ 173 (714)
++... ...+..+++|+.|++++|+++
T Consensus 77 i~~~~~~~~l~~~~~L~~L~l~~N~i~ 103 (124)
T d1dcea3 77 LQQSAAIQPLVSCPRLVLLNLQGNSLC 103 (124)
T ss_dssp CCSSSTTGGGGGCTTCCEEECTTSGGG
T ss_pred cCCCCCchhhcCCCCCCEEECCCCcCC
Confidence 65321 134566666666666666665
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.48 E-value=4.9e-14 Score=122.94 Aligned_cols=102 Identities=23% Similarity=0.246 Sum_probs=76.8
Q ss_pred CEEEccCCCCcccCChhhcCCCCCCEEEcCCCcCcccCCcccCCCCCCCEEeccCccCCCCCCcccccccccceeecccC
Q 005102 91 RHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSGSVPNEIGKLKYLQILDLSQNFFNGSLPVSIVQCKRLKALDLSQN 170 (714)
Q Consensus 91 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~N 170 (714)
|+|+|++|+++ .++ .+..+++|++|+|++|+|+ .+|+.++.+++|+.|++++|+|+ .+| .+..+++|++|++++|
T Consensus 1 R~L~Ls~n~l~-~l~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~-~l~-~~~~l~~L~~L~l~~N 75 (124)
T d1dcea3 1 RVLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVD-GVANLPRLQELLLCNN 75 (124)
T ss_dssp SEEECTTSCCS-SCC-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCC-CCG-GGTTCSSCCEEECCSS
T ss_pred CEEEcCCCCCC-CCc-ccccCCCCCEEECCCCccC-cchhhhhhhhccccccccccccc-ccC-ccccccccCeEECCCC
Confidence 57888888887 444 4778888888888888887 67777888888888888888887 444 4778888888888888
Q ss_pred cCCCCCCc-ccccCccccccccccCCccc
Q 005102 171 NFTGPLPN-GFGSGLVSLEKLNLSFNKFN 198 (714)
Q Consensus 171 ~l~g~~p~-~~~~~l~~L~~L~l~~N~l~ 198 (714)
+++. +|. .....+++|+.|++++|+++
T Consensus 76 ~i~~-~~~~~~l~~~~~L~~L~l~~N~i~ 103 (124)
T d1dcea3 76 RLQQ-SAAIQPLVSCPRLVLLNLQGNSLC 103 (124)
T ss_dssp CCCS-SSTTGGGGGCTTCCEEECTTSGGG
T ss_pred ccCC-CCCchhhcCCCCCCEEECCCCcCC
Confidence 8873 332 22245777888888888776
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.37 E-value=1.5e-12 Score=118.27 Aligned_cols=110 Identities=23% Similarity=0.214 Sum_probs=86.2
Q ss_pred CCCcccceEecCCcEEEEEcCCCCccccCCccccCCCCCCEEEccCC-CCcccCChhhcCCCCCCEEEcCCCcCcccCCc
Q 005102 52 NPCSWNGITCKEQRVVSVSIPKKKLLGFLPSALGSLTDLRHVNLRNN-KFFGSLPLELLEAQGLQSLVLYGNSFSGSVPN 130 (714)
Q Consensus 52 ~~c~w~gv~c~~~~~~~l~l~~~~l~g~~p~~~~~l~~L~~L~L~~N-~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~ 130 (714)
.|+.+.+|+|.. ++++ .+|..+..+++|++|+|++| .|+..-+..|.++++|+.|+|++|+|+...|.
T Consensus 6 ~c~~~~~l~c~~----------~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~ 74 (156)
T d2ifga3 6 CPHGSSGLRCTR----------DGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPD 74 (156)
T ss_dssp CCSSSSCEECCS----------SCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTT
T ss_pred CcCCCCeEEecC----------CCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccc
Confidence 344577788853 3333 35677888999999999766 48766667788899999999999999977778
Q ss_pred ccCCCCCCCEEeccCccCCCCCCcccccccccceeecccCcCC
Q 005102 131 EIGKLKYLQILDLSQNFFNGSLPVSIVQCKRLKALDLSQNNFT 173 (714)
Q Consensus 131 ~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~ 173 (714)
.|..+++|+.|+|++|+|+ .+|.......+|+.|+|++|.|.
T Consensus 75 ~f~~l~~L~~L~Ls~N~l~-~l~~~~~~~~~l~~L~L~~Np~~ 116 (156)
T d2ifga3 75 AFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLH 116 (156)
T ss_dssp GGGSCSCCCEEECCSSCCS-CCCSTTTCSCCCCEEECCSSCCC
T ss_pred cccccccccceeccCCCCc-ccChhhhccccccccccCCCccc
Confidence 8999999999999999998 66665555557889999999885
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.33 E-value=1.1e-14 Score=138.42 Aligned_cols=114 Identities=25% Similarity=0.236 Sum_probs=71.0
Q ss_pred CCccccCCCCCCEEEccCCCCcccCChhhcCCCCCCEEEcCCCcCcccCCcccCCCCCCCEEeccCccCCCCCCcccccc
Q 005102 80 LPSALGSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSGSVPNEIGKLKYLQILDLSQNFFNGSLPVSIVQC 159 (714)
Q Consensus 80 ~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l 159 (714)
+|.++..|++|++|+|++|+|+ .++ .+..+++|+.|+|++|.++ .+|..+..+++|+.|++++|+++ .+ +.+..+
T Consensus 40 l~~sl~~L~~L~~L~Ls~n~I~-~i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~-~l-~~~~~l 114 (198)
T d1m9la_ 40 MDATLSTLKACKHLALSTNNIE-KIS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIA-SL-SGIEKL 114 (198)
T ss_dssp CHHHHHHTTTCCEEECSEEEES-CCC-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECC-CH-HHHHHH
T ss_pred hhhHHhcccccceeECcccCCC-Ccc-cccCCccccChhhcccccc-ccccccccccccccccccccccc-cc-cccccc
Confidence 4456677777777777777776 343 3666777777777777776 45554444556777777777776 33 236666
Q ss_pred cccceeecccCcCCCCCCc-ccccCccccccccccCCcccc
Q 005102 160 KRLKALDLSQNNFTGPLPN-GFGSGLVSLEKLNLSFNKFNG 199 (714)
Q Consensus 160 ~~L~~L~l~~N~l~g~~p~-~~~~~l~~L~~L~l~~N~l~g 199 (714)
++|+.|+|++|+++ .++. .....+++|+.|+|++|.+..
T Consensus 115 ~~L~~L~L~~N~i~-~~~~~~~l~~l~~L~~L~L~~N~l~~ 154 (198)
T d1m9la_ 115 VNLRVLYMSNNKIT-NWGEIDKLAALDKLEDLLLAGNPLYN 154 (198)
T ss_dssp HHSSEEEESEEECC-CHHHHHHHTTTTTCSEEEECSSHHHH
T ss_pred ccccccccccchhc-cccccccccCCCccceeecCCCcccc
Confidence 67777777777765 3332 112346666666666666653
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.31 E-value=2.1e-12 Score=117.29 Aligned_cols=109 Identities=19% Similarity=0.116 Sum_probs=90.5
Q ss_pred CCCCCEEEccCCCCcccCChhhcCCCCCCEEEcCCC-cCcccCCcccCCCCCCCEEeccCccCCCCCCccccccccccee
Q 005102 87 LTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGN-SFSGSVPNEIGKLKYLQILDLSQNFFNGSLPVSIVQCKRLKAL 165 (714)
Q Consensus 87 l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N-~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L 165 (714)
....+.++.+++.+. ..|..+..+++|+.|+|++| .++..-+..|.++++|+.|+|++|+|+...|..|..+++|++|
T Consensus 7 c~~~~~l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L 85 (156)
T d2ifga3 7 PHGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRL 85 (156)
T ss_dssp CSSSSCEECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEE
T ss_pred cCCCCeEEecCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccce
Confidence 344566888888887 57788888999999999766 4886666779999999999999999997777889999999999
Q ss_pred ecccCcCCCCCCcccccCccccccccccCCccc
Q 005102 166 DLSQNNFTGPLPNGFGSGLVSLEKLNLSFNKFN 198 (714)
Q Consensus 166 ~l~~N~l~g~~p~~~~~~l~~L~~L~l~~N~l~ 198 (714)
+|++|+|+ .+|...+. ..+|+.|+|++|.|.
T Consensus 86 ~Ls~N~l~-~l~~~~~~-~~~l~~L~L~~Np~~ 116 (156)
T d2ifga3 86 NLSFNALE-SLSWKTVQ-GLSLQELVLSGNPLH 116 (156)
T ss_dssp ECCSSCCS-CCCSTTTC-SCCCCEEECCSSCCC
T ss_pred eccCCCCc-ccChhhhc-cccccccccCCCccc
Confidence 99999998 77777655 447999999999885
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.26 E-value=2.9e-14 Score=135.50 Aligned_cols=130 Identities=21% Similarity=0.287 Sum_probs=109.1
Q ss_pred cCChhhcCCCCCCEEEcCCCcCcccCCcccCCCCCCCEEeccCccCCCCCCcccccccccceeecccCcCCCCCCccccc
Q 005102 103 SLPLELLEAQGLQSLVLYGNSFSGSVPNEIGKLKYLQILDLSQNFFNGSLPVSIVQCKRLKALDLSQNNFTGPLPNGFGS 182 (714)
Q Consensus 103 ~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~ 182 (714)
.+|..+..+++|+.|+|++|+++ .++ .|.++++|+.|+|++|+++ .+|..+..+.+|+.|++++|+++ .++. + .
T Consensus 39 ~l~~sl~~L~~L~~L~Ls~n~I~-~i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~-~l~~-~-~ 112 (198)
T d1m9la_ 39 KMDATLSTLKACKHLALSTNNIE-KIS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIA-SLSG-I-E 112 (198)
T ss_dssp CCHHHHHHTTTCCEEECSEEEES-CCC-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECC-CHHH-H-H
T ss_pred hhhhHHhcccccceeECcccCCC-Ccc-cccCCccccChhhcccccc-ccccccccccccccccccccccc-cccc-c-c
Confidence 46778999999999999999998 565 5889999999999999997 67776677788999999999998 4543 4 3
Q ss_pred CccccccccccCCcccccCC--CCCCCCcccccccccccccCCcCcCcc----------ccCCCCccccc
Q 005102 183 GLVSLEKLNLSFNKFNGSIP--SNTGNLSSLQGTVDFSHNLFSGSIPAS----------LGNLPEKVYID 240 (714)
Q Consensus 183 ~l~~L~~L~l~~N~l~g~~p--~~~~~l~~L~~~l~l~~N~l~g~~p~~----------~~~l~~L~~l~ 240 (714)
.+++|+.|+|++|+++ .++ ..+..+++|+ .|++++|++....+.. +..+|+|+.||
T Consensus 113 ~l~~L~~L~L~~N~i~-~~~~~~~l~~l~~L~-~L~L~~N~l~~~~~~~~~~~~~r~~vi~~lp~L~~LD 180 (198)
T d1m9la_ 113 KLVNLRVLYMSNNKIT-NWGEIDKLAALDKLE-DLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD 180 (198)
T ss_dssp HHHHSSEEEESEEECC-CHHHHHHHTTTTTCS-EEEECSSHHHHHHCTTTTHHHHHHHHHHHCSSCCEES
T ss_pred ccccccccccccchhc-cccccccccCCCccc-eeecCCCccccCcccccchhhHHHHHHHHCCCcCEeC
Confidence 5899999999999998 444 4678899999 9999999987655433 56789999987
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.20 E-value=1.2e-10 Score=120.27 Aligned_cols=75 Identities=21% Similarity=0.304 Sum_probs=44.2
Q ss_pred cEEEEEcCCCCccccCCccccCCCCCCEEEccCCCCcccCChhhcCCCCCCEEEcCCCcCcccCCcccCCCCCCCEEecc
Q 005102 65 RVVSVSIPKKKLLGFLPSALGSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSGSVPNEIGKLKYLQILDLS 144 (714)
Q Consensus 65 ~~~~l~l~~~~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls 144 (714)
.++.|+|++|+|+ .+|..+ .+|+.|++++|+++ .++.- .++|++|+|++|.++ .+|. ++.+++|+.|+++
T Consensus 59 ~L~~L~Ls~N~l~-~lp~~~---~~L~~L~l~~n~l~-~l~~l---p~~L~~L~L~~n~l~-~lp~-~~~l~~L~~L~l~ 128 (353)
T d1jl5a_ 59 HLESLVASCNSLT-ELPELP---QSLKSLLVDNNNLK-ALSDL---PPLLEYLGVSNNQLE-KLPE-LQNSSFLKIIDVD 128 (353)
T ss_dssp TCSEEECCSSCCS-SCCCCC---TTCCEEECCSSCCS-CCCSC---CTTCCEEECCSSCCS-SCCC-CTTCTTCCEEECC
T ss_pred CCCEEECCCCCCc-ccccch---hhhhhhhhhhcccc-hhhhh---ccccccccccccccc-cccc-hhhhccceeeccc
Confidence 4666677777666 445433 35566666666655 22210 134777777777776 4553 4667777777777
Q ss_pred CccCC
Q 005102 145 QNFFN 149 (714)
Q Consensus 145 ~N~l~ 149 (714)
+|.+.
T Consensus 129 ~~~~~ 133 (353)
T d1jl5a_ 129 NNSLK 133 (353)
T ss_dssp SSCCS
T ss_pred ccccc
Confidence 66665
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.15 E-value=1.2e-12 Score=132.03 Aligned_cols=180 Identities=19% Similarity=0.175 Sum_probs=135.8
Q ss_pred CcEEEEEcCCCCcccc-CCccccCCCCCCEEEccCCCCcccCChhhcCCCCCCEEEcCCC-cCccc-CCcccCCCCCCCE
Q 005102 64 QRVVSVSIPKKKLLGF-LPSALGSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGN-SFSGS-VPNEIGKLKYLQI 140 (714)
Q Consensus 64 ~~~~~l~l~~~~l~g~-~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N-~l~g~-~p~~~~~l~~L~~ 140 (714)
.+++.|+|+++.+++. ++..+..+++|++|+|+++.+++..+..+..+++|+.|+|+++ .++.. +..-..++++|+.
T Consensus 46 ~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~L~~ 125 (284)
T d2astb2 46 FRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDE 125 (284)
T ss_dssp BCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCE
T ss_pred CCCCEEECCCCccCHHHHHHHHHhCCCcccccccccCCCcHHHHHHhcCCCCcCccccccccccccccchhhHHHHhccc
Confidence 3788999999888754 4556788999999999999998888888999999999999985 55532 2222456799999
Q ss_pred EeccCc-cCCCC-CCccccc-ccccceeecccC--cCCCCCCcccccCccccccccccCC-cccccCCCCCCCCcccccc
Q 005102 141 LDLSQN-FFNGS-LPVSIVQ-CKRLKALDLSQN--NFTGPLPNGFGSGLVSLEKLNLSFN-KFNGSIPSNTGNLSSLQGT 214 (714)
Q Consensus 141 L~Ls~N-~l~g~-~p~~~~~-l~~L~~L~l~~N--~l~g~~p~~~~~~l~~L~~L~l~~N-~l~g~~p~~~~~l~~L~~~ 214 (714)
|+|+++ .++.. +...+.. +++|+.|++++. .++..--..+...+++|+.|+|++| .+++.....+.++++|+ +
T Consensus 126 L~ls~c~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~-~ 204 (284)
T d2astb2 126 LNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQ-H 204 (284)
T ss_dssp EECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCC-E
T ss_pred cccccccccccccchhhhcccccccchhhhcccccccccccccccccccccccccccccccCCCchhhhhhcccCcCC-E
Confidence 999985 44421 2223333 468999999864 3432211223345789999999986 57877888888999999 9
Q ss_pred ccccc-ccCCcCcCccccCCCCcccccCcCC
Q 005102 215 VDFSH-NLFSGSIPASLGNLPEKVYIDLTYN 244 (714)
Q Consensus 215 l~l~~-N~l~g~~p~~~~~l~~L~~l~l~~N 244 (714)
|++++ +.++......++++++|+.|+++++
T Consensus 205 L~L~~C~~i~~~~l~~L~~~~~L~~L~l~~~ 235 (284)
T d2astb2 205 LSLSRCYDIIPETLLELGEIPTLKTLQVFGI 235 (284)
T ss_dssp EECTTCTTCCGGGGGGGGGCTTCCEEECTTS
T ss_pred EECCCCCCCChHHHHHHhcCCCCCEEeeeCC
Confidence 99998 5788777778899999999999876
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.08 E-value=5e-10 Score=115.51 Aligned_cols=166 Identities=24% Similarity=0.283 Sum_probs=111.6
Q ss_pred ecCCcEEEEEcCCCCccccCCccccCCCCCCEEEccCCCCcccCChhhcCCCCCCEEEcCCCcCcccCCcccCCCCCCCE
Q 005102 61 CKEQRVVSVSIPKKKLLGFLPSALGSLTDLRHVNLRNNKFFGSLPLELLEAQGLQSLVLYGNSFSGSVPNEIGKLKYLQI 140 (714)
Q Consensus 61 c~~~~~~~l~l~~~~l~g~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~ 140 (714)
|...+++.|+|++++|+. +|+. +++|++|+|++|+|+ .+|.. +.+|+.|++++|+++ .++.. .+.|++
T Consensus 35 c~~~~l~~LdLs~~~L~~-lp~~---~~~L~~L~Ls~N~l~-~lp~~---~~~L~~L~l~~n~l~-~l~~l---p~~L~~ 102 (353)
T d1jl5a_ 35 CLDRQAHELELNNLGLSS-LPEL---PPHLESLVASCNSLT-ELPEL---PQSLKSLLVDNNNLK-ALSDL---PPLLEY 102 (353)
T ss_dssp HHHHTCSEEECTTSCCSC-CCSC---CTTCSEEECCSSCCS-SCCCC---CTTCCEEECCSSCCS-CCCSC---CTTCCE
T ss_pred HHHcCCCEEEeCCCCCCC-CCCC---CCCCCEEECCCCCCc-ccccc---hhhhhhhhhhhcccc-hhhhh---cccccc
Confidence 333467899999999985 7753 578999999999998 67865 468999999999998 55532 256999
Q ss_pred EeccCccCCCCCCcccccccccceeecccCcCCCCCCcccccCccccccccccCCcccccCCCCCCCCcccccccccccc
Q 005102 141 LDLSQNFFNGSLPVSIVQCKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLNLSFNKFNGSIPSNTGNLSSLQGTVDFSHN 220 (714)
Q Consensus 141 L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~~l~l~~N 220 (714)
|+|++|.+. .+|. ++.+++|+.|++++|.+.. .|.. ...+..|.+..+... .+..+..++.++ .+++++|
T Consensus 103 L~L~~n~l~-~lp~-~~~l~~L~~L~l~~~~~~~-~~~~----~~~l~~l~~~~~~~~--~~~~l~~l~~l~-~L~l~~n 172 (353)
T d1jl5a_ 103 LGVSNNQLE-KLPE-LQNSSFLKIIDVDNNSLKK-LPDL----PPSLEFIAAGNNQLE--ELPELQNLPFLT-AIYADNN 172 (353)
T ss_dssp EECCSSCCS-SCCC-CTTCTTCCEEECCSSCCSC-CCCC----CTTCCEEECCSSCCS--SCCCCTTCTTCC-EEECCSS
T ss_pred ccccccccc-cccc-hhhhccceeeccccccccc-cccc----cccccchhhcccccc--ccccccccccce-ecccccc
Confidence 999999998 6775 6789999999999999874 3332 234444444444432 223344444454 5555555
Q ss_pred cCCcCc------------------CccccCCCCcccccCcCCcCCC
Q 005102 221 LFSGSI------------------PASLGNLPEKVYIDLTYNNLSG 248 (714)
Q Consensus 221 ~l~g~~------------------p~~~~~l~~L~~l~l~~N~l~~ 248 (714)
.+.... ...+..++.|+.+++++|....
T Consensus 173 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~L~~l~l~~n~~~~ 218 (353)
T d1jl5a_ 173 SLKKLPDLPLSLESIVAGNNILEELPELQNLPFLTTIYADNNLLKT 218 (353)
T ss_dssp CCSSCCCCCTTCCEEECCSSCCSSCCCCTTCTTCCEEECCSSCCSS
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccc
Confidence 443211 1124455666666666666553
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.93 E-value=3.1e-11 Score=121.30 Aligned_cols=179 Identities=22% Similarity=0.212 Sum_probs=128.5
Q ss_pred EEEcCCCCccccCCccccCCCCCCEEEccCCCCccc-CChhhcCCCCCCEEEcCCCcCcccCCcccCCCCCCCEEeccCc
Q 005102 68 SVSIPKKKLLGFLPSALGSLTDLRHVNLRNNKFFGS-LPLELLEAQGLQSLVLYGNSFSGSVPNEIGKLKYLQILDLSQN 146 (714)
Q Consensus 68 ~l~l~~~~l~g~~p~~~~~l~~L~~L~L~~N~l~~~-~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~Ls~N 146 (714)
.+.+....+...+. ......+|++|||+++.++.. +...+..+++|+.|+|+++.+++..+..++.+++|+.|+|+++
T Consensus 27 ~lrl~~~~~~~~~~-~~~~~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~c 105 (284)
T d2astb2 27 AFRCPRSFMDQPLA-EHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGC 105 (284)
T ss_dssp EEECTTCEECSCCC-SCCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTC
T ss_pred Eeeccccccccchh-hhccCCCCCEEECCCCccCHHHHHHHHHhCCCcccccccccCCCcHHHHHHhcCCCCcCcccccc
Confidence 34444444333222 234556899999999988744 4455678999999999999999888889999999999999994
Q ss_pred -cCCCC-CCcccccccccceeecccC-cCCC-CCCcccccCccccccccccCC--cccc-cCCCCCCCCccccccccccc
Q 005102 147 -FFNGS-LPVSIVQCKRLKALDLSQN-NFTG-PLPNGFGSGLVSLEKLNLSFN--KFNG-SIPSNTGNLSSLQGTVDFSH 219 (714)
Q Consensus 147 -~l~g~-~p~~~~~l~~L~~L~l~~N-~l~g-~~p~~~~~~l~~L~~L~l~~N--~l~g-~~p~~~~~l~~L~~~l~l~~ 219 (714)
.++.. +..-+.++++|++|+++++ .++. .++..+....++|+.|++++. .++. .+...+.++++|+ .|++++
T Consensus 106 ~~itd~~l~~l~~~~~~L~~L~ls~c~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~i~~~~l~~l~~~~~~L~-~L~L~~ 184 (284)
T d2astb2 106 SGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLV-HLDLSD 184 (284)
T ss_dssp BSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCS-EEECTT
T ss_pred ccccccccchhhHHHHhccccccccccccccccchhhhcccccccchhhhccccccccccccccccccccccc-cccccc
Confidence 56521 2223457899999999985 4442 122223333578999999864 3432 2333345678898 999998
Q ss_pred c-cCCcCcCccccCCCCcccccCcC-CcCCC
Q 005102 220 N-LFSGSIPASLGNLPEKVYIDLTY-NNLSG 248 (714)
Q Consensus 220 N-~l~g~~p~~~~~l~~L~~l~l~~-N~l~~ 248 (714)
| .++......++.+++|++|++++ +++++
T Consensus 185 ~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~ 215 (284)
T d2astb2 185 SVMLKNDCFQEFFQLNYLQHLSLSRCYDIIP 215 (284)
T ss_dssp CTTCCGGGGGGGGGCTTCCEEECTTCTTCCG
T ss_pred ccCCCchhhhhhcccCcCCEEECCCCCCCCh
Confidence 6 58888888999999999999999 45654
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=98.90 E-value=2.3e-11 Score=125.97 Aligned_cols=181 Identities=21% Similarity=0.271 Sum_probs=84.0
Q ss_pred cEEEEEcCCCCcccc----CCccccCCCCCCEEEccCCCCcccCCh-------------hhcCCCCCCEEEcCCCcCccc
Q 005102 65 RVVSVSIPKKKLLGF----LPSALGSLTDLRHVNLRNNKFFGSLPL-------------ELLEAQGLQSLVLYGNSFSGS 127 (714)
Q Consensus 65 ~~~~l~l~~~~l~g~----~p~~~~~l~~L~~L~L~~N~l~~~~p~-------------~~~~l~~L~~L~L~~N~l~g~ 127 (714)
+++.|+|.+|.++.. +...+...++|++|+|++|.+...-.. .....+.|+.|++++|.++..
T Consensus 94 ~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~~~~~~~~~~L~~l~l~~n~i~~~ 173 (344)
T d2ca6a1 94 KLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENG 173 (344)
T ss_dssp TCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGG
T ss_pred CcccccccccccccccccchhhhhcccccchheecccccccccccccccccccccccccccccCcccceeeccccccccc
Confidence 455556655555442 223334455566666665555311000 012334555666665555421
Q ss_pred ----CCcccCCCCCCCEEeccCccCCCC-----CCcccccccccceeecccCcCCCC----CCcccccCccccccccccC
Q 005102 128 ----VPNEIGKLKYLQILDLSQNFFNGS-----LPVSIVQCKRLKALDLSQNNFTGP----LPNGFGSGLVSLEKLNLSF 194 (714)
Q Consensus 128 ----~p~~~~~l~~L~~L~Ls~N~l~g~-----~p~~~~~l~~L~~L~l~~N~l~g~----~p~~~~~~l~~L~~L~l~~ 194 (714)
+...+...+.|+.|+|++|++... +...+..+++|+.|+|++|.++.. +...+ ...++|+.|+|++
T Consensus 174 ~~~~l~~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l-~~~~~L~~L~Ls~ 252 (344)
T d2ca6a1 174 SMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIAL-KSWPNLRELGLND 252 (344)
T ss_dssp GHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHG-GGCTTCCEEECTT
T ss_pred ccccccchhhhhhhhcccccccccccccccccchhhhhcchhhhcccccccccccccccccccccc-cccccchhhhhhc
Confidence 122233445566666666665421 222344555666666666655321 11122 2345566666666
Q ss_pred Cccccc----CCCCCC--CCcccccccccccccCCcC----cCcccc-CCCCcccccCcCCcCC
Q 005102 195 NKFNGS----IPSNTG--NLSSLQGTVDFSHNLFSGS----IPASLG-NLPEKVYIDLTYNNLS 247 (714)
Q Consensus 195 N~l~g~----~p~~~~--~l~~L~~~l~l~~N~l~g~----~p~~~~-~l~~L~~l~l~~N~l~ 247 (714)
|.|++. +-..+. ....|+ .|++++|+++.. +...+. ++++|+.|++++|++.
T Consensus 253 n~i~~~g~~~l~~~l~~~~~~~L~-~L~ls~N~i~~~~~~~l~~~l~~~~~~L~~L~l~~N~~~ 315 (344)
T d2ca6a1 253 CLLSARGAAAVVDAFSKLENIGLQ-TLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFS 315 (344)
T ss_dssp CCCCHHHHHHHHHHHHTCSSCCCC-EEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSC
T ss_pred CccCchhhHHHHHHhhhccCCCCC-EEECCCCcCChHHHHHHHHHHHccCCCCCEEECCCCcCC
Confidence 665532 111111 123455 566666665432 122221 3455666666666654
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=98.82 E-value=1.3e-10 Score=120.10 Aligned_cols=184 Identities=16% Similarity=0.145 Sum_probs=117.3
Q ss_pred CcEEEEEcCCCCcccc----CCccccCCCCCCEEEccCCCCccc----------CChhhcCCCCCCEEEcCCCcCccc--
Q 005102 64 QRVVSVSIPKKKLLGF----LPSALGSLTDLRHVNLRNNKFFGS----------LPLELLEAQGLQSLVLYGNSFSGS-- 127 (714)
Q Consensus 64 ~~~~~l~l~~~~l~g~----~p~~~~~l~~L~~L~L~~N~l~~~----------~p~~~~~l~~L~~L~L~~N~l~g~-- 127 (714)
..++.|+|++|.+... +...+...++|+.|+++++.+... +...+...++|+.|+|++|.++..
T Consensus 31 ~~l~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~l~l~~~~~~~~~~~~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~ 110 (344)
T d2ca6a1 31 DSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQ 110 (344)
T ss_dssp SCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCSCCCCTTTH
T ss_pred CCCCEEECcCCcCCHHHHHHHHHHHHhCCCCCEEECCCCcccccccccchHHHHHHHHHhhCCCcccccccccccccccc
Confidence 4677788888877542 344566778888888887654321 122344567788888888887653
Q ss_pred --CCcccCCCCCCCEEeccCccCCCCCCcc-------------cccccccceeecccCcCCCCCCccc---ccCcccccc
Q 005102 128 --VPNEIGKLKYLQILDLSQNFFNGSLPVS-------------IVQCKRLKALDLSQNNFTGPLPNGF---GSGLVSLEK 189 (714)
Q Consensus 128 --~p~~~~~l~~L~~L~Ls~N~l~g~~p~~-------------~~~l~~L~~L~l~~N~l~g~~p~~~---~~~l~~L~~ 189 (714)
+...+...++|+.|++++|.+...-... ......|+.|++++|+++..--..+ ......|+.
T Consensus 111 ~~l~~~l~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~~~~~~~~~~L~~l~l~~n~i~~~~~~~l~~~l~~~~~L~~ 190 (344)
T d2ca6a1 111 EPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHT 190 (344)
T ss_dssp HHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCE
T ss_pred cchhhhhcccccchheecccccccccccccccccccccccccccccCcccceeecccccccccccccccchhhhhhhhcc
Confidence 2334456678888888888774211001 1234567888888887752211111 123567888
Q ss_pred ccccCCcccc-----cCCCCCCCCcccccccccccccCCcC----cCccccCCCCcccccCcCCcCCC
Q 005102 190 LNLSFNKFNG-----SIPSNTGNLSSLQGTVDFSHNLFSGS----IPASLGNLPEKVYIDLTYNNLSG 248 (714)
Q Consensus 190 L~l~~N~l~g-----~~p~~~~~l~~L~~~l~l~~N~l~g~----~p~~~~~l~~L~~l~l~~N~l~~ 248 (714)
|+|++|+++. .+...+..++.|+ .|++++|.++.. +...+..+++|+.|++++|.+++
T Consensus 191 L~L~~n~i~~~g~~~~l~~~l~~~~~L~-~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L~Ls~n~i~~ 257 (344)
T d2ca6a1 191 VKMVQNGIRPEGIEHLLLEGLAYCQELK-VLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSA 257 (344)
T ss_dssp EECCSSCCCHHHHHHHHHTTGGGCTTCC-EEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCH
T ss_pred cccccccccccccccchhhhhcchhhhc-ccccccccccccccccccccccccccchhhhhhcCccCc
Confidence 8888888753 1344566677777 888888887532 44556778888888888887763
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.49 E-value=2.7e-09 Score=113.98 Aligned_cols=183 Identities=20% Similarity=0.128 Sum_probs=97.0
Q ss_pred CcEEEEEcCCCCccc-----cCCccccCCCCCCEEEccCCCCccc----CChhhcCCCCCCEEEcCCCcCcccCCccc--
Q 005102 64 QRVVSVSIPKKKLLG-----FLPSALGSLTDLRHVNLRNNKFFGS----LPLELLEAQGLQSLVLYGNSFSGSVPNEI-- 132 (714)
Q Consensus 64 ~~~~~l~l~~~~l~g-----~~p~~~~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~g~~p~~~-- 132 (714)
..+..+++..|.+.. .++........|+.|++++|.+... ....+...+.++.+++++|.++..-...+
T Consensus 226 ~~~~~l~~~~n~~~~~~~~~~~~~~~~~~~~l~~l~l~~n~i~~~~~~~~~~~l~~~~~l~~l~l~~n~i~~~~~~~l~~ 305 (460)
T d1z7xw1 226 ASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCE 305 (460)
T ss_dssp TTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHH
T ss_pred ccccccchhhccccccccchhhcccccccccccccccccccccccccccccccccccccccccccccccccccccchhhc
Confidence 345566666665432 2233344556677777777766532 22234456667777777776653221111
Q ss_pred ---CCCCCCCEEeccCccCCCCCCcc----cccccccceeecccCcCCCC----CCcccccCccccccccccCCcccc--
Q 005102 133 ---GKLKYLQILDLSQNFFNGSLPVS----IVQCKRLKALDLSQNNFTGP----LPNGFGSGLVSLEKLNLSFNKFNG-- 199 (714)
Q Consensus 133 ---~~l~~L~~L~Ls~N~l~g~~p~~----~~~l~~L~~L~l~~N~l~g~----~p~~~~~~l~~L~~L~l~~N~l~g-- 199 (714)
.....|+.+++++|.++...... +..+.+|++|+|++|+++.. ++..+......|+.|+|++|+|+.
T Consensus 306 ~l~~~~~~L~~l~l~~~~l~~~~~~~l~~~~~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~L~Ls~n~i~~~~ 385 (460)
T d1z7xw1 306 TLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSS 385 (460)
T ss_dssp HHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHH
T ss_pred cccccccccccccccccchhhhhhhhcccccccccchhhhheeeecccCcccchhhhhhhcccCCCCEEECCCCCCChHH
Confidence 12346777777777765432222 23345677777777776431 222232234457777777777653
Q ss_pred --cCCCCCCCCcccccccccccccCCcCcCccc----c-CCCCcccccCcCCcCC
Q 005102 200 --SIPSNTGNLSSLQGTVDFSHNLFSGSIPASL----G-NLPEKVYIDLTYNNLS 247 (714)
Q Consensus 200 --~~p~~~~~l~~L~~~l~l~~N~l~g~~p~~~----~-~l~~L~~l~l~~N~l~ 247 (714)
.++..+..+++|+ +|++++|+|+......| . +...|+.|++.+|.+.
T Consensus 386 ~~~l~~~l~~~~~L~-~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~l~l~~~~~~ 439 (460)
T d1z7xw1 386 CSSLAATLLANHSLR-ELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWS 439 (460)
T ss_dssp HHHHHHHHHHCCCCC-EEECCSSSCCHHHHHHHHHHHTSTTCCCCEEECTTCCCC
T ss_pred HHHHHHHHhcCCCCC-EEECCCCcCCHHHHHHHHHHHHhCCCccCEEECCCCCCC
Confidence 2333444456666 67777777653322222 1 2235666666666665
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.33 E-value=9.9e-09 Score=93.15 Aligned_cols=11 Identities=18% Similarity=0.410 Sum_probs=7.2
Q ss_pred ccCCCCccccc
Q 005102 230 LGNLPEKVYID 240 (714)
Q Consensus 230 ~~~l~~L~~l~ 240 (714)
+..+|+|+.||
T Consensus 142 ~~~~P~L~~LD 152 (162)
T d1koha1 142 RERFPKLLRLD 152 (162)
T ss_dssp HTTSTTCCEET
T ss_pred HHHCCCCCEEC
Confidence 45667777665
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.33 E-value=2e-08 Score=91.04 Aligned_cols=68 Identities=24% Similarity=0.178 Sum_probs=36.5
Q ss_pred cCCCCCCCEEeccCccCCCC--CCcccccccccceeecccCcCCCCCCcccccCccccccccccCCccccc
Q 005102 132 IGKLKYLQILDLSQNFFNGS--LPVSIVQCKRLKALDLSQNNFTGPLPNGFGSGLVSLEKLNLSFNKFNGS 200 (714)
Q Consensus 132 ~~~l~~L~~L~Ls~N~l~g~--~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~~l~~L~~L~l~~N~l~g~ 200 (714)
+..+++|+.|+|++|+++.. ++..+..+++|+.|+|++|.++ .++.-......+|+.|+|++|.+...
T Consensus 61 ~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~-~l~~l~~l~~~~L~~L~L~~Npl~~~ 130 (162)
T d1koha1 61 EENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELK-SERELDKIKGLKLEELWLDGNSLSDT 130 (162)
T ss_dssp HHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCC-CGGGHHHHTTCCCSSCCCTTSTTSSS
T ss_pred HHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccc-cchhhhhhhccccceeecCCCCcCcC
Confidence 34556666666666666532 1233455666666666666665 33331111233566666666666543
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.28 E-value=9.3e-07 Score=86.53 Aligned_cols=130 Identities=16% Similarity=0.139 Sum_probs=92.2
Q ss_pred ceEEEEEEECCCcEEEEEEeCCCCchhHHHHHHHHHHHhccC-CCCccceEEEEEeCCceeEEEeccCCCCHhhhhhCCC
Q 005102 416 IGIVYKVVLEDGHTLAVRRLGEGGSQRFKEFQTEVEAIGKIR-HSNIVTLRAYYWSVDEKLLIYDYIPNGSLATALHGKP 494 (714)
Q Consensus 416 ~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~ 494 (714)
.+.||+... ++..+++|+...........+.+|...+..+. +--+.+++++....+..++||+++++.++.+.....
T Consensus 27 ~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~G~~~~~~~~~~- 104 (263)
T d1j7la_ 27 PAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYEDE- 104 (263)
T ss_dssp SSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHHTTTC-
T ss_pred CCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEeccccccccccccc-
Confidence 368999875 46677889887654433345778888887774 433677888888888899999999998876654221
Q ss_pred CCCCcCCCCHHHHHHHHHHHHHHHHHHhcCC-------------------------------------------------
Q 005102 495 GMVSFTPVPWSVRVKIIKGIAKGLVYLHEFS------------------------------------------------- 525 (714)
Q Consensus 495 ~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~------------------------------------------------- 525 (714)
.....++.++++.++.||+..
T Consensus 105 ----------~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 174 (263)
T d1j7la_ 105 ----------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFL 174 (263)
T ss_dssp ----------SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSSHHHHHHHH
T ss_pred ----------ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchHHHHHHHHH
Confidence 112335566666666666421
Q ss_pred -------CCCceecCCCCCCeeeCCCCCeEEcccchhhh
Q 005102 526 -------PKKYVHGDLKPSNILLGHNMEPHVSDFGLARL 557 (714)
Q Consensus 526 -------~~~ivHrDlkp~NILl~~~~~~kl~DFGla~~ 557 (714)
+..++|+|+.|.||+++++..+-|+||+.+..
T Consensus 175 ~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 175 KTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp HHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 11378999999999999876677999998763
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.07 E-value=2e-07 Score=98.89 Aligned_cols=109 Identities=21% Similarity=0.210 Sum_probs=77.1
Q ss_pred cEEEEEcCCCCccccC-CccccCCCCCCEEEccCCCCcc----cCChhhcCCCCCCEEEcCCCcCccc----CCcccC-C
Q 005102 65 RVVSVSIPKKKLLGFL-PSALGSLTDLRHVNLRNNKFFG----SLPLELLEAQGLQSLVLYGNSFSGS----VPNEIG-K 134 (714)
Q Consensus 65 ~~~~l~l~~~~l~g~~-p~~~~~l~~L~~L~L~~N~l~~----~~p~~~~~l~~L~~L~L~~N~l~g~----~p~~~~-~ 134 (714)
++++|+++.|++++.- ...+..+++|++|+|++|.++. .++..+...++|+.|||++|.++.. +...+. .
T Consensus 3 ~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~~ 82 (460)
T d1z7xw1 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTP 82 (460)
T ss_dssp EEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCST
T ss_pred CCCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhcC
Confidence 5788899999887642 3345567888899999998862 3455567788899999998888531 222232 2
Q ss_pred CCCCCEEeccCccCCCC----CCcccccccccceeecccCcCC
Q 005102 135 LKYLQILDLSQNFFNGS----LPVSIVQCKRLKALDLSQNNFT 173 (714)
Q Consensus 135 l~~L~~L~Ls~N~l~g~----~p~~~~~l~~L~~L~l~~N~l~ 173 (714)
..+|+.|+|++|+++.. ++..+..+++|++|+|++|.++
T Consensus 83 ~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~ 125 (460)
T d1z7xw1 83 SCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLG 125 (460)
T ss_dssp TCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCH
T ss_pred CCCCCEEECCCCCccccccccccchhhccccccccccccccch
Confidence 35788888888888643 4455667788888888888775
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.95 E-value=1.8e-05 Score=76.52 Aligned_cols=129 Identities=16% Similarity=0.166 Sum_probs=85.9
Q ss_pred ccccCc-eEEEEEEECCCcEEEEEEeCCCCchhHHHHHHHHHHHhccCC--CCccceEEEEEeCCceeEEEeccCCCCHh
Q 005102 411 LGKSGI-GIVYKVVLEDGHTLAVRRLGEGGSQRFKEFQTEVEAIGKIRH--SNIVTLRAYYWSVDEKLLIYDYIPNGSLA 487 (714)
Q Consensus 411 lG~G~~-g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H--~niv~l~~~~~~~~~~~lV~e~~~~gsL~ 487 (714)
+..|.. +.||+....++..+++|........ .+..|.+.++.+.. -.+.+++++..+.+..++||+|+++.++.
T Consensus 18 ~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~~---~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~~ 94 (255)
T d1nd4a_ 18 QTIGCSDAAVFRLSAQGRPVLFVKTDLSGALN---ELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL 94 (255)
T ss_dssp CSCTTSSCEEEEEECTTSCCEEEEEECSCTTS---CHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT
T ss_pred cCCcccCCeEEEEEeCCCCEEEEEeCCccCHh---HHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeeccccc
Confidence 344443 6899999888888999987665432 45678888877743 33567788888888899999999876543
Q ss_pred hhhhCCCCCCCcCCCCHHHHHHHHHHHHHHHHHHhcCC------------------------------------------
Q 005102 488 TALHGKPGMVSFTPVPWSVRVKIIKGIAKGLVYLHEFS------------------------------------------ 525 (714)
Q Consensus 488 ~~l~~~~~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~------------------------------------------ 525 (714)
+.. .. ...++.++++.|+-||+..
T Consensus 95 ~~~-----------~~---~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (255)
T d1nd4a_ 95 SSH-----------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAE 160 (255)
T ss_dssp TSC-----------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHH
T ss_pred ccc-----------cc---HHHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHH
Confidence 210 11 0112223333333333210
Q ss_pred -------------CCCceecCCCCCCeeeCCCCCeEEcccchhh
Q 005102 526 -------------PKKYVHGDLKPSNILLGHNMEPHVSDFGLAR 556 (714)
Q Consensus 526 -------------~~~ivHrDlkp~NILl~~~~~~kl~DFGla~ 556 (714)
+..++|+|+.|.|||++++..+-|+||+.+.
T Consensus 161 ~~~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~ 204 (255)
T d1nd4a_ 161 LFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 204 (255)
T ss_dssp HHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence 1237999999999999987667899999875
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.55 E-value=0.00012 Score=75.61 Aligned_cols=75 Identities=8% Similarity=0.109 Sum_probs=48.5
Q ss_pred ccccccCceEEEEEEECC-CcEEEEEEeCCC-------CchhHHHHHHHHHHHhccC-C--CCccceEEEEEeCCceeEE
Q 005102 409 FVLGKSGIGIVYKVVLED-GHTLAVRRLGEG-------GSQRFKEFQTEVEAIGKIR-H--SNIVTLRAYYWSVDEKLLI 477 (714)
Q Consensus 409 ~~lG~G~~g~Vy~~~~~~-g~~vavK~~~~~-------~~~~~~~~~~E~~~l~~l~-H--~niv~l~~~~~~~~~~~lV 477 (714)
+.||.|....||++...+ ++.|+||.-... ......+...|.+.|+.+. + ..+.+++.+ +.+..++|
T Consensus 32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~lv 109 (392)
T d2pula1 32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV 109 (392)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEEE
Confidence 358999999999998765 678999975421 1112234567888887662 3 345555544 45667899
Q ss_pred EeccCCCC
Q 005102 478 YDYIPNGS 485 (714)
Q Consensus 478 ~e~~~~gs 485 (714)
||++++..
T Consensus 110 mE~L~~~~ 117 (392)
T d2pula1 110 MEDLSHLK 117 (392)
T ss_dssp ECCCTTSE
T ss_pred EeccCCcc
Confidence 99997644
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.37 E-value=3.6e-05 Score=69.23 Aligned_cols=87 Identities=20% Similarity=0.248 Sum_probs=40.5
Q ss_pred CCCCCEEEccCC-CCccc----CChhhcCCCCCCEEEcCCCcCcccCC----cccCCCCCCCEEeccCccCCCC----CC
Q 005102 87 LTDLRHVNLRNN-KFFGS----LPLELLEAQGLQSLVLYGNSFSGSVP----NEIGKLKYLQILDLSQNFFNGS----LP 153 (714)
Q Consensus 87 l~~L~~L~L~~N-~l~~~----~p~~~~~l~~L~~L~L~~N~l~g~~p----~~~~~l~~L~~L~Ls~N~l~g~----~p 153 (714)
.+.|++|+|+++ .++.. +-..+...+.|+.|+|++|.+...-. ..+...++|+.|+|++|.++.. +-
T Consensus 14 ~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~l~ 93 (167)
T d1pgva_ 14 DTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLL 93 (167)
T ss_dssp CSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHH
T ss_pred CCCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHHHH
Confidence 355555666542 33311 12223344556666666665542211 1223345566666666665531 11
Q ss_pred cccccccccceeecccCcCC
Q 005102 154 VSIVQCKRLKALDLSQNNFT 173 (714)
Q Consensus 154 ~~~~~l~~L~~L~l~~N~l~ 173 (714)
..+...++|++|+|++|.+.
T Consensus 94 ~aL~~n~sL~~L~l~~n~~~ 113 (167)
T d1pgva_ 94 RSTLVTQSIVEFKADNQRQS 113 (167)
T ss_dssp HHTTTTCCCSEEECCCCSSC
T ss_pred HHHHhCCcCCEEECCCCcCC
Confidence 12334455666666665543
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.22 E-value=3.6e-05 Score=69.25 Aligned_cols=109 Identities=13% Similarity=0.066 Sum_probs=72.1
Q ss_pred CCcEEEEEcCCC-Ccccc----CCccccCCCCCCEEEccCCCCccc----CChhhcCCCCCCEEEcCCCcCccc----CC
Q 005102 63 EQRVVSVSIPKK-KLLGF----LPSALGSLTDLRHVNLRNNKFFGS----LPLELLEAQGLQSLVLYGNSFSGS----VP 129 (714)
Q Consensus 63 ~~~~~~l~l~~~-~l~g~----~p~~~~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~g~----~p 129 (714)
...++.|+|+++ .++.. +-..+...+.|++|+|++|.+... +...+...+.|+.|+|++|.++.. +-
T Consensus 14 ~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~l~ 93 (167)
T d1pgva_ 14 DTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLL 93 (167)
T ss_dssp CSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHH
T ss_pred CCCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHHHH
Confidence 457888999864 45432 344567778899999999888632 233455567899999999988742 22
Q ss_pred cccCCCCCCCEEeccCccCCCC-------CCcccccccccceeecccCc
Q 005102 130 NEIGKLKYLQILDLSQNFFNGS-------LPVSIVQCKRLKALDLSQNN 171 (714)
Q Consensus 130 ~~~~~l~~L~~L~Ls~N~l~g~-------~p~~~~~l~~L~~L~l~~N~ 171 (714)
..+..-++|+.|+|++|.+... +...+...++|+.|+++.+.
T Consensus 94 ~aL~~n~sL~~L~l~~n~~~~~g~~~~~~l~~~L~~n~sL~~l~l~~~~ 142 (167)
T d1pgva_ 94 RSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFAS 142 (167)
T ss_dssp HHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCC
T ss_pred HHHHhCCcCCEEECCCCcCCCccHHHHHHHHHHHHhCCCccEeeCcCCC
Confidence 3466668899999988876521 22233345667777776554
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.13 E-value=0.00062 Score=68.04 Aligned_cols=137 Identities=15% Similarity=0.112 Sum_probs=78.0
Q ss_pred eEEEEEEECCCcEEEEEEeCCCCchhHHHHHHHHHHHhccCCCCcc--ceEE-----EEEeCCceeEEEeccCCCCHh--
Q 005102 417 GIVYKVVLEDGHTLAVRRLGEGGSQRFKEFQTEVEAIGKIRHSNIV--TLRA-----YYWSVDEKLLIYDYIPNGSLA-- 487 (714)
Q Consensus 417 g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~niv--~l~~-----~~~~~~~~~lV~e~~~~gsL~-- 487 (714)
-.||++..++|..|++|+.+.+... .+++..|.+.+..+....+. ..+. .+...+..+.++++++|..+.
T Consensus 36 N~vy~v~~~dg~~~VlK~~rp~~~s-~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~~ 114 (325)
T d1zyla1 36 NRVYQFQDEDRRRFVVKFYRPERWT-ADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEAD 114 (325)
T ss_dssp SEEEEECCTTCCCEEEEEECTTTSC-HHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCSS
T ss_pred ceeEEEEcCCCCEEEEEEeCCCCCC-HHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCCC
Confidence 4799999999999999998775433 36678888888877422221 1111 123355678899998763221
Q ss_pred ---hh---------hh----CCCCCCCcCCCCHH----------------------HHHHHHHHHHHHHHHH-hcCCCCC
Q 005102 488 ---TA---------LH----GKPGMVSFTPVPWS----------------------VRVKIIKGIAKGLVYL-HEFSPKK 528 (714)
Q Consensus 488 ---~~---------l~----~~~~~~~~~~l~~~----------------------~~~~i~~~ia~gL~~L-H~~~~~~ 528 (714)
.+ +| ..... ....+++. .....+.++...+.-. .+..+.+
T Consensus 115 ~~~~~~~lG~~LA~lH~~~~~~~~~-~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~ 193 (325)
T d1zyla1 115 NIDQMEAVGRYLGRMHQTGRKQLFI-HRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVL 193 (325)
T ss_dssp CHHHHHHHHHHHHHHHHHHTSSCCS-SSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCE
T ss_pred CHHHHHHHHHHHHHHHhhcccCCcc-ccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCce
Confidence 00 11 11000 00111111 1122223333332222 2233457
Q ss_pred ceecCCCCCCeeeCCCCCeEEcccchhhh
Q 005102 529 YVHGDLKPSNILLGHNMEPHVSDFGLARL 557 (714)
Q Consensus 529 ivHrDlkp~NILl~~~~~~kl~DFGla~~ 557 (714)
+||+|+.+.|||++++ ..++||+-+..
T Consensus 194 liHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 194 RLHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp ECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred eecCCCCcccEEEeCC--ceEEechhccc
Confidence 8999999999999754 46899997763
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=96.23 E-value=0.0004 Score=61.97 Aligned_cols=112 Identities=20% Similarity=0.236 Sum_probs=52.5
Q ss_pred cCCCCCCEEEccC-CCCccc----CChhhcCCCCCCEEEcCCCcCcccCC----cccCCCCCCCEEeccCccCCCC----
Q 005102 85 GSLTDLRHVNLRN-NKFFGS----LPLELLEAQGLQSLVLYGNSFSGSVP----NEIGKLKYLQILDLSQNFFNGS---- 151 (714)
Q Consensus 85 ~~l~~L~~L~L~~-N~l~~~----~p~~~~~l~~L~~L~L~~N~l~g~~p----~~~~~l~~L~~L~Ls~N~l~g~---- 151 (714)
.+.+.|++|+|++ +.++.. +-..+...+.|+.|+|++|.++..-- ..+...++|+.|++++|.+...
T Consensus 14 ~~~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~~ 93 (166)
T d1io0a_ 14 NNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILA 93 (166)
T ss_dssp TTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHH
T ss_pred hcCCCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhHHH
Confidence 3445666666665 334311 22223345556666666665543211 1233445666666666665421
Q ss_pred CCcccccccccceeec--ccCcCCC----CCCcccccCccccccccccCCcc
Q 005102 152 LPVSIVQCKRLKALDL--SQNNFTG----PLPNGFGSGLVSLEKLNLSFNKF 197 (714)
Q Consensus 152 ~p~~~~~l~~L~~L~l--~~N~l~g----~~p~~~~~~l~~L~~L~l~~N~l 197 (714)
+-..+...++|+.++| ++|.+.. .+...+ ...++|+.|+++.|..
T Consensus 94 l~~~l~~~~~L~~l~L~l~~n~i~~~~~~~La~~L-~~n~~L~~L~l~~~~~ 144 (166)
T d1io0a_ 94 LVEALQSNTSLIELRIDNQSQPLGNNVEMEIANML-EKNTTLLKFGYHFTQQ 144 (166)
T ss_dssp HHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHH-HHCSSCCEEECCCSSH
T ss_pred HHHHHHhCccccEEeeccCCCcCcHHHHHHHHHHH-HhCCCcCEEeCcCCCC
Confidence 1233444555655333 3444431 111122 1245666666665543
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.21 E-value=0.0068 Score=61.90 Aligned_cols=71 Identities=11% Similarity=0.075 Sum_probs=46.9
Q ss_pred cccccCceEEEEEEECCC--------cEEEEEEeCCCCchhHHHHHHHHHHHhccC-CCCccceEEEEEeCCceeEEEec
Q 005102 410 VLGKSGIGIVYKVVLEDG--------HTLAVRRLGEGGSQRFKEFQTEVEAIGKIR-HSNIVTLRAYYWSVDEKLLIYDY 480 (714)
Q Consensus 410 ~lG~G~~g~Vy~~~~~~g--------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lV~e~ 480 (714)
.|+-|-.=.+|++...++ +.|.+++... ... .-...+|..+++.+. +.-..++++++. -.+||||
T Consensus 49 ~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~-~~~-~idr~~E~~i~~~ls~~gl~Pkll~~~~----~g~I~ef 122 (395)
T d1nw1a_ 49 RIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN-PET-ESHLVAESVIFTLLSERHLGPKLYGIFS----GGRLEEY 122 (395)
T ss_dssp EECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS-CCC-HHHHHHHHHHHHHHHHTTSSSCEEEEET----TEEEECC
T ss_pred EcCCccccceEEEEeCCCCccccCCCCcEEEEecCC-cch-hhHHHHHHHHHHHHHhCCCCCeEEEEcC----CceEEEE
Confidence 466677779999987543 4566666653 222 234568999998885 433446777763 2689999
Q ss_pred cCCCCH
Q 005102 481 IPNGSL 486 (714)
Q Consensus 481 ~~~gsL 486 (714)
+++..+
T Consensus 123 i~g~~l 128 (395)
T d1nw1a_ 123 IPSRPL 128 (395)
T ss_dssp CCEEEC
T ss_pred eccccC
Confidence 986433
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=96.07 E-value=0.00021 Score=63.84 Aligned_cols=110 Identities=15% Similarity=0.106 Sum_probs=66.5
Q ss_pred CCcEEEEEcCC-CCcccc----CCccccCCCCCCEEEccCCCCccc----CChhhcCCCCCCEEEcCCCcCccc----CC
Q 005102 63 EQRVVSVSIPK-KKLLGF----LPSALGSLTDLRHVNLRNNKFFGS----LPLELLEAQGLQSLVLYGNSFSGS----VP 129 (714)
Q Consensus 63 ~~~~~~l~l~~-~~l~g~----~p~~~~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~g~----~p 129 (714)
...++.|+|.+ +.++.. +-.++...++|++|+|++|.++.. +-..+...++|+.|++++|.++.. +-
T Consensus 16 ~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~~l~ 95 (166)
T d1io0a_ 16 DPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALV 95 (166)
T ss_dssp CTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHH
T ss_pred CCCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhHHHHH
Confidence 45677777776 344322 334556777788888888877543 223344567788888888777532 22
Q ss_pred cccCCCCCCCEEec--cCccCCC----CCCcccccccccceeecccCcC
Q 005102 130 NEIGKLKYLQILDL--SQNFFNG----SLPVSIVQCKRLKALDLSQNNF 172 (714)
Q Consensus 130 ~~~~~l~~L~~L~L--s~N~l~g----~~p~~~~~l~~L~~L~l~~N~l 172 (714)
..+...++|+.++| ++|.+.. .+...+...++|+.|+++.|..
T Consensus 96 ~~l~~~~~L~~l~L~l~~n~i~~~~~~~La~~L~~n~~L~~L~l~~~~~ 144 (166)
T d1io0a_ 96 EALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQ 144 (166)
T ss_dssp HGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSH
T ss_pred HHHHhCccccEEeeccCCCcCcHHHHHHHHHHHHhCCCcCEEeCcCCCC
Confidence 34556677776555 4556642 2333445667788887766654
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=94.94 E-value=0.011 Score=58.10 Aligned_cols=32 Identities=25% Similarity=0.310 Sum_probs=28.2
Q ss_pred CCCCceecCCCCCCeeeCCCCCeEEcccchhh
Q 005102 525 SPKKYVHGDLKPSNILLGHNMEPHVSDFGLAR 556 (714)
Q Consensus 525 ~~~~ivHrDlkp~NILl~~~~~~kl~DFGla~ 556 (714)
.+.++||+|+.+.||+++++...-|.||+.+.
T Consensus 181 L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 181 LPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp SCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred cccccccCCcchhhhhcccccceeEecccccc
Confidence 35689999999999999988777899999875
|